PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Cho, YI; Ahn, YK; Tripathi, S; Kim, JH; Lee, HE; Kim, DS				Cho, Young-Il; Ahn, Yul-Kyun; Tripathi, Swati; Kim, Jeong-Ho; Lee, Hye-Eun; Kim, Do-Sun			Comparative Analysis of Disease-Linked Single Nucleotide Polymorphic Markers from Brassica rapa for Their Applicability to Brassica oleracea	PLOS ONE			English	Article							ARABIDOPSIS-THALIANA; LINKAGE MAP; MICROSATELLITE MARKERS; NAPUS GENOME; SEQUENCE; REGIONS; EVOLUTION; PROJECT; SEGMENT; GENES	Numerous studies using single nucleotide polymorphisms (SNPs) have been conducted in humans, and other animals, and in major crops, including rice, soybean, and Chinese cabbage. However, the number of SNP studies in cabbage is limited. In this present study, we evaluated whether 7,645 SNPs previously identified as molecular markers linked to disease resistance in the Brassica rapa genome could be applied to B. oleracea. In a BLAST analysis using the SNP sequences of B. rapa and B. oleracea genomic sequence data registered in the NCBI database, 256 genes for which SNPs had been identified in B. rapa were found in B. oleracea. These genes were classified into three functional groups: molecular function (64 genes), biological process (96 genes), and cellular component (96 genes). A total of 693 SNP markers, including 145 SNP markers [BRH-developed from the B. rapa genome for high-resolution melt (HRM) analysis], 425 SNP markers (BRP-based on the B. rapa genome that could be applied to B. oleracea), and 123 new SNP markers (BRS-derived from BRP and designed for HRM analysis), were investigated for their ability to amplify sequences from cabbage genomic DNA. In total, 425 of the SNP markers (BRP-based on B. rapa genome), selected from 7,645 SNPs, were successfully applied to B. oleracea. Using PCR, 108 of 145 BRH (74.5%), 415 of 425 BRP (97.6%), and 118 of 123 BRS (95.9%) showed amplification, suggesting that it is possible to apply SNP markers developed based on the B. rapa genome to B. oleracea. These results provide valuable information that can be utilized in cabbage genetics and breeding programs using molecular markers derived from other Brassica species.	[Cho, Young-Il; Ahn, Yul-Kyun; Tripathi, Swati; Kim, Jeong-Ho; Lee, Hye-Eun; Kim, Do-Sun] Rural Dev Adm, Natl Inst Hort & Herbal Sci, Vegetable Res Div, Suwon, South Korea	National Institute of Horticultural & Herbal Science (NIHHS), Republic of Korea; Rural Development Administration (RDA), Republic of Korea	Ahn, YK (corresponding author), Rural Dev Adm, Natl Inst Hort & Herbal Sci, Vegetable Res Div, Suwon, South Korea.	aykyun@korea.kr	TRIPATHI, SWATI/AAB-6433-2021	TRIPATHI, SWATI/0000-0003-1710-9232	"Cooperative Research Program for Agriculture Science & Technology Development" Rural Development Administration, Republic of Korea [J010264022015]	"Cooperative Research Program for Agriculture Science & Technology Development" Rural Development Administration, Republic of Korea(Rural Development Administration (RDA), Republic of Korea)	This work was carried out with the support of "Cooperative Research Program for Agriculture Science & Technology Development (Project No. J010264022015)" Rural Development Administration, Republic of Korea. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ayele M, 2005, GENOME RES, V15, P487, DOI 10.1101/gr.3176505; Babula D, 2003, MOL GENET GENOMICS, V268, P656, DOI 10.1007/s00438-002-0782-2; Brookes AJ, 1999, GENE, V234, P177, DOI 10.1016/S0378-1119(99)00219-X; Cavell AC, 1998, GENOME, V41, P62, DOI 10.1139/gen-41-1-62; Choi SR, 2007, THEOR APPL GENET, V115, P777, DOI 10.1007/s00122-007-0608-z; Fashey JW, 1995, ROLE CRUCITERS CANC; Fusari CM, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-7; Griffin TJ, 2000, TRENDS BIOTECHNOL, V18, P77, DOI 10.1016/S0167-7799(99)01401-8; Higdon JV, 2007, PHARMACOL RES, V55, P224, DOI 10.1016/j.phrs.2007.01.009; Iniguez-Luy FL, 2008, THEOR APPL GENET, V117, P977, DOI 10.1007/s00122-008-0837-9; Jander G, 2002, PLANT PHYSIOL, V129, P440, DOI 10.1104/pp.003533; Jin C, 2010, J PHARMACEUT BIOMED, V53, P43, DOI 10.1016/j.jpba.2010.03.021; Johnston JS, 2005, ANN BOT-LONDON, V95, P229, DOI 10.1093/aob/mci016; Jorde LB, 2000, GENOME RES, V10, P1435, DOI 10.1101/gr.144500; Kim H, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-432; Kwok PY, 2001, ANNU REV GENOM HUM G, V2, P235, DOI 10.1146/annurev.genom.2.1.235; Lan TH, 2000, GENOME RES, V10, P776, DOI 10.1101/gr.10.6.776; Li F, 2009, DNA RES, V16, P311, DOI 10.1093/dnares/dsp020; Li HT, 2011, MOL BREEDING, V28, P585, DOI 10.1007/s11032-010-9509-y; Iniguez-Luy FL, 2009, THEOR APPL GENET, V120, P31, DOI 10.1007/s00122-009-1157-4; Mun JH, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-10-r111; Mun JH, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-280; O'Neill CM, 2000, PLANT J, V23, P233, DOI 10.1046/j.1365-313x.2000.00781.x; Park S, 2010, MOL GENET GENOMICS, V283, P135, DOI 10.1007/s00438-009-0504-0; Parkin IAP, 2005, GENETICS, V171, P765, DOI 10.1534/genetics.105.042093; Paterson AH, 2001, GENOME BIOL, V2, DOI 10.1186/gb-2001-2-3-reviews1011; Quiros CF, 2001, GENETICS, V157, P1321; Rafalski A, 2002, CURR OPIN PLANT BIOL, V5, P94, DOI 10.1016/S1369-5266(02)00240-6; Ramchiary N, 2011, DNA RES, V18, P305, DOI 10.1093/dnares/dsr017; Rozen S, 2000, Methods Mol Biol, V132, P365; Schlotterer C, 2004, NAT REV GENET, V5, P63, DOI 10.1038/nrg1249; Sebastian RL, 2000, THEOR APPL GENET, V100, P75, DOI 10.1007/s001220050011; Soengas P, 2009, MOL BREEDING, V23, P389, DOI 10.1007/s11032-008-9241-z; van Hintum TJL, 2007, THEOR APPL GENET, V114, P777, DOI 10.1007/s00122-006-0456-2; Yang TJ, 2006, PLANT CELL, V18, P1339, DOI 10.1105/tpc.105.040535; Yang TJ, 2005, COMP FUNCT GENOM, V6, P138, DOI 10.1002/cfg.465; Yang YW, 1999, J MOL EVOL, V48, P597, DOI 10.1007/PL00006502	37	2	2	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2015	10	3							e0120163	10.1371/journal.pone.0120163	http://dx.doi.org/10.1371/journal.pone.0120163			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD9NQ	25790283	Green Submitted, gold, Green Published			2022-12-27	WOS:000351425400137
J	Herrero, AB; San Miguel, J; Gutierrez, NC				Herrero, Ana B.; San Miguel, Jess; Gutierrez, Norma C.			Deregulation of DNA Double-Strand Break Repair in Multiple Myeloma: Implications for Genome Stability	PLOS ONE			English	Article							NONHOMOLOGOUS END; HOMOLOGOUS RECOMBINATION; LIGASE-III; HEMATOPOIETIC-CELLS; NHEJ PATHWAYS; HISTONE H2AX; TUMOR-CELLS; COMET ASSAY; INSTABILITY; DAMAGE	Multiple myeloma (MM) is a hematological malignancy characterized by frequent chromosome abnormalities. However, the molecular basis for this genome instability remains unknown. Since both impaired and hyperactive double strand break (DSB) repair pathways can result in DNA rearrangements, we investigated the functionality of DSB repair in MM cells. Repair kinetics of ionizing-radiation (IR)-induced DSBs was similar in MM and normal control lymphoblastoid cell lines, as revealed by the comet assay. However, four out of seven MM cell lines analyzed exhibited a subset of persistent DSBs, marked by gamma-H2AX and Rad51 foci that elicited a prolonged G2/M DNA damage checkpoint activation and hypersensitivity to IR, especially in the presence of checkpoint inhibitors. An analysis of the proteins involved in DSB repair in MM cells revealed upregulation of DNA-PKcs, Artemis and XRCC4, that participate in non-homologous end joining (NHEJ), and Rad51, involved in homologous recombination (HR). Accordingly, activity of both NHEJ and HR were elevated in MM cells compared to controls, as determined by in vivo functional assays. Interestingly, levels of proteins involved in a highly mutagenic, translocation-promoting, alternative NHEJ subpathway (Alt-NHEJ) were also increased in all MM cell lines, with the Alt-NHEJ protein DNA ligase III alpha, also overexpressed in several plasma cell samples isolated from MM patients. Overactivation of the Alt-NHEJ pathway was revealed in MM cells by larger deletions and higher sequence microhomology at repair junctions, which were reduced by chemical inhibition of the pathway. Taken together, our results uncover a deregulated DSB repair in MM that might underlie the characteristic genome instability of the disease, and could be therapeutically exploited.	[Herrero, Ana B.; Gutierrez, Norma C.] Univ Hosp, IBMCC USAL CSIC, IBSAL, Serv Hematol, Salamanca, Spain; [San Miguel, Jess] Univ Navarra Clin, CIMA, Pamplona, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC-USAL - Instituto de Biologia Molecular y Celular del Cancer de Salamanca (IBMCC); University of Navarra	Gutierrez, NC (corresponding author), Univ Hosp, IBMCC USAL CSIC, IBSAL, Serv Hematol, Salamanca, Spain.	normagu@usal.es	San-Miguel, Jesús F./V-8977-2018; Herrero, Ana/AAF-1694-2021	San-Miguel, Jesús F./0000-0002-9183-4857; Gutierrez, Norma/0000-0001-5834-9510; Herrero, Ana/0000-0002-1414-6532	Spanish Myeloma Network Program [RD12/0036/0058]; Gerencia Regional de Salud, Junta de Castilla y Leon [GRS 702/A/11]; Asociacion Espanola Contra el Cancer (AECC) [GCB-120981SAN]	Spanish Myeloma Network Program; Gerencia Regional de Salud, Junta de Castilla y Leon(Junta de Castilla y Leon); Asociacion Espanola Contra el Cancer (AECC)	This work was partially supported by the Spanish Myeloma Network Program (RD12/0036/0058), the "Gerencia Regional de Salud, Junta de Castilla y Leon" (GRS 702/A/11) and grant GCB-120981SAN from the "Asociacion Espanola Contra el Cancer (AECC)". The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Audebert M, 2004, J BIOL CHEM, V279, P55117, DOI 10.1074/jbc.M404524200; Banath JP, 2004, CANCER RES, V64, P7144, DOI 10.1158/0008-5472.CAN-04-1433; Banath JP, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-4; Bishop AJR, 2001, BBA-REV CANCER, V1471, pM109, DOI 10.1016/S0304-419X(01)00018-X; Busby EC, 2000, CANCER RES, V60, P2108; Cahill D, 2006, FRONT BIOSCI-LANDMRK, V11, P1958, DOI 10.2741/1938; Chakraborty S, 2012, BLOOD, V119, P6187, DOI 10.1182/blood-2011-05-352252; Ching WJ, 2009, ENVIRON MOL MUTAGEN, V50, P697, DOI 10.1002/em.20528; Corneo B, 2007, NATURE, V449, P483, DOI 10.1038/nature06168; Deckbar D, 2011, CRIT REV BIOCHEM MOL, V46, P271, DOI 10.3109/10409238.2011.575764; Della-Maria J, 2011, J BIOL CHEM, V286, P33845, DOI 10.1074/jbc.M111.274159; Diaz-Rodriguez E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027583; Dupre A, 2008, NAT CHEM BIOL, V4, P119, DOI 10.1038/nchembio.63; Fan JS, 2010, BLOOD, V116, P5298, DOI 10.1182/blood-2010-03-272591; Francis R, 2007, GENE DEV, V21, P1064, DOI 10.1101/gad.1522807; Garrett MD, 2011, TRENDS PHARMACOL SCI, V32, P308, DOI 10.1016/j.tips.2011.02.014; Gyori BM, 2014, REDOX BIOL, V2, P457, DOI 10.1016/j.redox.2013.12.020; Hahnel PS, 2014, BLOOD, V123, P2355, DOI 10.1182/blood-2013-01-477620; Helleday T, 2010, CARCINOGENESIS, V31, P955, DOI 10.1093/carcin/bgq064; Jeggo P, 2007, ONCOGENE, V26, P7717, DOI 10.1038/sj.onc.1210868; Kalocsay M, 2009, MOL CELL, V33, P335, DOI 10.1016/j.molcel.2009.01.016; Klokov D, 2006, RADIOTHER ONCOL, V80, P223, DOI 10.1016/j.radonc.2006.07.026; Kotnis A, 2009, PHILOS T R SOC B, V364, P653, DOI 10.1098/rstb.2008.0196; Kovala AT, 2000, FASEB J, V14, P2486, DOI 10.1096/fj.00-0147com; Liang L, 2008, NUCLEIC ACIDS RES, V36, P3297, DOI 10.1093/nar/gkn184; Lieber MR, 2008, J BIOL CHEM, V283, P1, DOI 10.1074/jbc.R700039200; Lobrich M, 2010, CELL CYCLE, V9, P662, DOI 10.4161/cc.9.4.10764; Luoto KR, 2010, CANCER RES, V70, P8748, DOI 10.1158/0008-5472.CAN-10-0944; Magin S, 2013, DNA REPAIR, V12, P148, DOI 10.1016/j.dnarep.2012.11.008; Mao ZY, 2008, DNA REPAIR, V7, P1765, DOI 10.1016/j.dnarep.2008.06.018; Mladenov E, 2011, MUTAT RES-FUND MOL M, V711, P61, DOI 10.1016/j.mrfmmm.2011.02.005; Morgan GJ, 2012, NAT REV CANCER, V12, P335, DOI 10.1038/nrc3257; Nussenzweig A, 2007, CELL, V131, P223, DOI 10.1016/j.cell.2007.10.005; Olive PL, 2006, NAT PROTOC, V1, P23, DOI 10.1038/nprot.2006.5; Olive PL, 2011, RADIOTHER ONCOL, V101, P18, DOI 10.1016/j.radonc.2011.05.055; Paull TT, 2000, CURR BIOL, V10, P886, DOI 10.1016/S0960-9822(00)00610-2; Pierce AJ, 2001, MOL CELL, V8, P1160, DOI 10.1016/S1097-2765(01)00424-5; Qi WQ, 2002, RADIAT RES, V157, P166, DOI 10.1667/0033-7587(2002)157[0166:CITIGP]2.0.CO;2; Richardson C, 2004, ONCOGENE, V23, P546, DOI 10.1038/sj.onc.1207098; Roddam PL, 2010, BRIT J HAEMATOL, V149, P258, DOI 10.1111/j.1365-2141.2010.08088.x; Rothkamm K, 2003, MOL CELL BIOL, V23, P5706, DOI 10.1128/MCB.23.16.5706-5715.2003; Sallmyr A, 2008, BLOOD, V112, P1413, DOI 10.1182/blood-2007-07-104257; Sarkaria JN, 1998, CANCER RES, V58, P4375; Seluanov A, 2004, P NATL ACAD SCI USA, V101, P7624, DOI 10.1073/pnas.0400726101; Shammas MA, 2009, BLOOD, V113, P2290, DOI 10.1182/blood-2007-05-089193; Simsek D, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002080; Slupianek A, 2006, DNA REPAIR, V5, P243, DOI 10.1016/j.dnarep.2005.10.005; Tobin LA, 2013, ONCOGENE, V32, P1784, DOI 10.1038/onc.2012.203; Volcic M, 2012, NUCLEIC ACIDS RES, V40, P181, DOI 10.1093/nar/gkr687; Walters DK, 2011, LEUKEMIA, V25, P1344, DOI 10.1038/leu.2011.94; Wang HC, 2005, CANCER RES, V65, P4020, DOI 10.1158/0008-5472.CAN-04-3055; Wang ML, 2006, NUCLEIC ACIDS RES, V34, P6170, DOI 10.1093/nar/gkl840; Wang X, 2002, CANCER RES, V62, P6031; Willmore E, 2008, CLIN CANCER RES, V14, P3984, DOI 10.1158/1078-0432.CCR-07-5158; Yan CT, 2007, NATURE, V449, P478, DOI 10.1038/nature06020; Yang C, 2009, MUTAT RES-FUND MOL M, V660, P66, DOI 10.1016/j.mrfmmm.2008.10.019; Yuan JS, 2010, FEBS LETT, V584, P3717, DOI 10.1016/j.febslet.2010.05.021	57	39	39	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2015	10	3							e0121581	10.1371/journal.pone.0121581	http://dx.doi.org/10.1371/journal.pone.0121581			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD9NQ	25790254	Green Published, gold, Green Submitted			2022-12-27	WOS:000351425400197
J	Hsiau, THC; Sukovich, D; Elms, P; Prince, RN; Stritmatter, T; Ruan, P; Curry, B; Anderson, P; Sampson, J; Anderson, JC				Hsiau, Timothy H. -C.; Sukovich, David; Elms, Phillip; Prince, Robin N.; Stritmatter, Tobias; Ruan, Paul; Curry, Bo; Anderson, Paige; Sampson, Jeff; Anderson, J. Christopher			A Method for Multiplex Gene Synthesis Employing Error Correction Based on Expression	PLOS ONE			English	Article							GREEN FLUORESCENT PROTEIN; ESCHERICHIA-COLI; IN-VIVO; AMPLIFICATION; OPTIMIZATION; STABILITY; SEQUENCES; LIBRARIES; SELECTION; COMPLEX	Our ability to engineer organisms with new biosynthetic pathways and genetic circuits is limited by the availability of protein characterization data and the cost of synthetic DNA. With new tools for reading and writing DNA, there are opportunities for scalable assays that more efficiently and cost effectively mine for biochemical protein characteristics. To that end, we have developed the Multiplex Library Synthesis and Expression Correction (MuLSEC) method for rapid assembly, error correction, and expression characterization of many genes as a pooled library. This methodology enables gene synthesis from microarray-synthesized oligonucleotide pools with a one-pot technique, eliminating the need for robotic liquid handling. Post assembly, the gene library is subjected to an ampicillin based quality control selection, which serves as both an error correction step and a selection for proteins that are properly expressed and folded in E. coli. Next generation sequencing of post selection DNA enables quantitative analysis of gene expression characteristics. We demonstrate the feasibility of this approach by building and testing over 90 genes for empirical evidence of soluble expression. This technique reduces the problem of part characterization to multiplex oligonucleotide synthesis and deep sequencing, two technologies under extensive development with projected cost reduction.	[Hsiau, Timothy H. -C.; Sukovich, David; Elms, Phillip; Prince, Robin N.; Stritmatter, Tobias; Anderson, J. Christopher] Univ Calif Berkeley, Dept Bioengn, Berkeley, CA 94720 USA; [Ruan, Paul] Univ Calif Berkeley, Dept Elect Engn & Comp Sci, Berkeley, CA 94720 USA; [Curry, Bo; Anderson, Paige; Sampson, Jeff] Agilent Technol, Santa Clara, CA USA; [Anderson, J. Christopher] Univ Calif Berkeley, Synthet Biol Inst, Berkeley, CA 94720 USA	University of California System; University of California Berkeley; University of California System; University of California Berkeley; Agilent Technologies; University of California System; University of California Berkeley	Anderson, JC (corresponding author), Univ Calif Berkeley, Dept Bioengn, Berkeley, CA 94720 USA.	jcanderson@berkeley.edu		Strittmatter, Tobias/0000-0003-4579-1013	Agilent Technologies via the Synthetic Biology Institute	Agilent Technologies via the Synthetic Biology Institute	Work was supported by funding from Agilent Technologies via the Synthetic Biology Institute. Agilent provided some of the software development. Additional software and wetlab experiments were performed at UC Berkeley. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson JC, 2003, BIOCHEMISTRY-US, V42, P9598, DOI 10.1021/bi034550w; Apweiler R, 2014, NUCLEIC ACIDS RES, V42, P7486, DOI 10.1093/nar/gku469; Blakeley BD, 2012, MOL BIOSYST, V8, P2036, DOI 10.1039/c2mb25130b; Borovkov AY, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq677; Cabantous S, 2005, NAT BIOTECHNOL, V23, P102, DOI 10.1038/nbt1044; Cabantous S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002387; Fisher AC, 2006, PROTEIN SCI, V15, P449, DOI 10.1110/ps.051902606; Foit L, 2009, MOL CELL, V36, P861, DOI 10.1016/j.molcel.2009.11.022; Kim H, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks546; Kim I, 2013, MOL CELL PROTEOMICS, V12, P3370, DOI 10.1074/mcp.O113.031708; Kittleson JT, 2012, CURR OPIN CHEM BIOL, V16, P329, DOI 10.1016/j.cbpa.2012.06.009; Kittleson JT, 2011, J BIOL ENG, V5, DOI 10.1186/1754-1611-5-10; Kosuri S, 2013, P NATL ACAD SCI USA, V110, P14024, DOI 10.1073/pnas.1301301110; Kosuri S, 2010, NAT BIOTECHNOL, V28, P1295, DOI 10.1038/nbt.1716; LeProust EM, 2010, NUCLEIC ACIDS RES, V38, P2522, DOI 10.1093/nar/gkq163; Lim HK, 2009, PROTEIN SCI, V18, P2537, DOI 10.1002/pro.262; Lucks JB, 2011, P NATL ACAD SCI USA, V108, P11063, DOI 10.1073/pnas.1106501108; Quan JY, 2011, NAT BIOTECHNOL, V29, P449, DOI 10.1038/nbt.1847; Schomburg I, 2013, NUCLEIC ACIDS RES, V41, pD764, DOI 10.1093/nar/gks1049; Shagin D, 1999, NUCLEIC ACIDS RES, V27, pi; Ueyama T, 2008, J IMMUNOL, V181, P629, DOI 10.4049/jimmunol.181.1.629; Waldo GS, 1999, NAT BIOTECHNOL, V17, P691, DOI 10.1038/10904; Wan W, 2014, NUCLEIC ACIDS RES, V42, DOI 10.1093/nar/gku405; Williams R, 2006, NAT METHODS, V3, P545, DOI 10.1038/NMETH896; Xu L, 2006, MOL BIOL EVOL, V23, P1107, DOI 10.1093/molbev/msk019; Xu QK, 2009, P NATL ACAD SCI USA, V106, P2289, DOI 10.1073/pnas.0812506106; Zhou XC, 2004, NUCLEIC ACIDS RES, V32, P5409, DOI 10.1093/nar/gkh879	27	5	5	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2015	10	3							e0119927	10.1371/journal.pone.0119927	http://dx.doi.org/10.1371/journal.pone.0119927			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD9NQ	25790188	Green Published, gold, Green Submitted			2022-12-27	WOS:000351425400116
J	Panda, S; Bisht, S; Malakar, D; Mohanty, AK; Kaushik, JK				Panda, Santanu; Bisht, Sonu; Malakar, Dhruba; Mohanty, Ashok K.; Kaushik, Jai K.			In Vitro Culture of Functionally Active Buffalo Hepatocytes Isolated by Using a Simplified Manual Perfusion Method	PLOS ONE			English	Article							BIOARTIFICIAL LIVER; GENE-EXPRESSION; BOVINE HEPATOCYTES; PARENCHYMAL-CELLS; SANDWICH; METABOLISM; WHOLE	Background In farm animals, there is no suitable cell line available to understand liver-specific functions. This has limited our understanding of liver function and metabolism in farm animals. Culturing and maintenance of functionally active hepatocytes is difficult, since they survive no more than few days. Establishing primary culture of hepatocytes can help in studying cellular metabolism, drug toxicity, hepatocyte specific gene function and regulation. Here we provide a simple in vitro method for isolation and short-term culture of functionally active buffalo hepatocytes. Results Buffalo hepatocytes were isolated from caudate lobes by using manual enzymatic perfusion and mechanical disruption of liver tissue. Hepatocyte yield was (5.3 +/- 0.66)x10(7) cells per gram of liver tissue with a viability of 82.3 +/- 3.5%. Freshly isolated hepatocytes were spherical with well contrasted border. After 24 hours of seeding onto fibroblast feeder layer and different extracellular matrices like dry collagen, matrigel and sandwich collagen coated plates, hepatocytes formed confluent monolayer with frequent clusters. Cultured hepatocytes exhibited typical cuboidal and polygonal shape with restored cellular polarity. Cells expressed hepatocyte-specific marker genes or proteins like albumin, hepatocyte nuclear factor 4 alpha, glucose-6-phosphatase, tyrosine aminotransferase, cytochromes, cytokeratin and alpha 1-antitrypsin. Hepatocytes could be immunostained with anti-cytokeratins, anti-albumin and anti alpha 1-antitrypsin antibodies. Abundant lipid droplets were detected in the cytosol of hepatocytes using oil red stain. In vitro cultured hepatocytes could be grown for five days and maintained for up to nine days on buffalo skin fibroblast feeder layer. Cultured hepatocytes were viable for functional studies. Conclusion We developed a convenient and cost effective technique for hepatocytes isolation for short-term culture that exhibited morphological and functional characteristics of active hepatocytes for studying gene expression, regulation, hepatic genomics and proteomics in farm animals.	[Panda, Santanu; Bisht, Sonu; Malakar, Dhruba; Mohanty, Ashok K.; Kaushik, Jai K.] Natl Dairy Res Inst, Anim Biotechnol Ctr, Karnal 132001, Haryana, India	Indian Council of Agricultural Research (ICAR); ICAR - National Dairy Research Institute	Kaushik, JK (corresponding author), Natl Dairy Res Inst, Anim Biotechnol Ctr, Karnal 132001, Haryana, India.	jaikr1@gmail.com		Kaushik, Jai/0000-0002-8872-0066	Indian Council of Agricultural Research	Indian Council of Agricultural Research(Indian Council of Agricultural Research (ICAR))	The running grant of the division was used for purchasing chemicals and other consumables. SP received Institute fellowship provided by Indian Council of Agricultural Research during initial years of the study.	AIELLO RJ, 1987, COMP BIOCHEM PHYS B, V88, P193, DOI 10.1016/0305-0491(87)90100-3; Allen JW, 2001, HEPATOLOGY, V34, P447, DOI 10.1053/jhep.2001.26753; Baker TK, 2001, CHEM RES TOXICOL, V14, P1218, DOI 10.1021/tx015518a; BERRY MN, 1969, J CELL BIOL, V43, P506, DOI 10.1083/jcb.43.3.506; Bhogal RH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018222; Bhogal RH, 2010, LIVER TRANSPLANT, V16, P1303, DOI 10.1002/lt.22157; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Choi HJ, 2013, J KOREAN SURG SOC, V84, P202, DOI 10.4174/jkss.2013.84.4.202; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1016/0003-2697(87)90021-2; Corlu A, 1997, CELL BIOL TOXICOL, V13, P235, DOI 10.1023/A:1007475122321; DIXIT V, 1992, ARTIF ORGANS, V16, P336; DONKIN SS, 1993, J ANIM SCI, V71, P2218, DOI 10.2527/1993.7182218x; DORKO K, 1994, CELL TRANSPLANT, V3, P387, DOI 10.1177/096368979400300505; DUNN JCY, 1989, FASEB J, V3, P174, DOI 10.1096/fasebj.3.2.2914628; DUNN JCY, 1992, J CELL BIOL, V116, P1043, DOI 10.1083/jcb.116.4.1043; FABRE G, 1988, BIOCHEM PHARMACOL, V37, P4389, DOI 10.1016/0006-2952(88)90622-3; FRASLIN JM, 1985, EMBO J, V4, P2487, DOI 10.1002/j.1460-2075.1985.tb03960.x; Funaki N, 2002, ONCOL REP, V9, P713; Guguen-Guillouzo C, 1986, ISOLATED CULTURED HE, P259; HOWARD RB, 1967, J CELL BIOL, V35, P675, DOI 10.1083/jcb.35.3.675; Hughes RD, 2006, LIVER TRANSPLANT, V12, P713, DOI 10.1002/lt.20732; Kidambi S, 2009, P NATL ACAD SCI USA, V106, P15714, DOI 10.1073/pnas.0906820106; KONO Y, 1995, EXP CELL RES, V221, P478, DOI 10.1006/excr.1995.1399; Krasko A, 2003, CRIT CARE CLIN, V19, P155, DOI 10.1016/S0749-0704(02)00051-9; KURIHARCUCH W, 1989, DIFFERENTIATION, V41, P148, DOI 10.1111/j.1432-0436.1989.tb00742.x; Li Jun, 2005, Hepatobiliary Pancreat Dis Int, V4, P249; Montesissa C, 1996, VET RES COMMUN, V20, P449, DOI 10.1007/BF00419182; OKA M, 1992, BIOSCI BIOTECH BIOCH, V56, P1472, DOI 10.1271/bbb.56.1472; Patterson Jr MK, 1973, TISSUE CULTURE METHO, P406; Puviani AC, 1998, COMP BIOCHEM PHYS A, V121, P99, DOI 10.1016/S1095-6433(98)10109-5; ROZGA J, 1993, HEPATOLOGY, V17, P258, DOI 10.1016/0270-9139(93)90086-3; Seglen P O, 1976, Methods Cell Biol, V13, P29, DOI 10.1016/S0091-679X(08)61797-5; SHULL LR, 1987, XENOBIOTICA, V17, P345, DOI 10.3109/00498258709043944; Soltys KA, 2010, J HEPATOL, V53, P769, DOI 10.1016/j.jhep.2010.05.010; Spotorno VG, 2006, CYTOTECHNOLOGY, V51, P51, DOI 10.1007/s10616-006-9000-0; Strom SC, 2001, ILTS ELTA LICATE JOI, P62; Talamini MA, 1997, HEPATOLOGY, V25, P167, DOI 10.1053/jhep.1997.v25.pm0008985285; Tchaparian EH, 2011, DRUG METAB DISPOS, V39, P2387, DOI 10.1124/dmd.111.039545; UPRETI GC, 1991, SMALL RUMINANT RES, V4, P175, DOI 10.1016/0921-4488(91)90063-V; Wang YJ, 2004, WORLD J GASTROENTERO, V10, P699, DOI 10.3748/wjg.v10.i5.699; Yin LY, 2011, ARTERIOSCL THROM VAS, V31, P328, DOI 10.1161/ATVBAHA.110.217828	41	5	6	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2015	10	3							e0118841	10.1371/journal.pone.0118841	http://dx.doi.org/10.1371/journal.pone.0118841			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD9NQ	25790478	Green Submitted, gold, Green Published			2022-12-27	WOS:000351425400049
J	Paschou, SA; Ioannidis, D; Vassilatou, E; Mizamtsidi, M; Panagou, M; Lilis, D; Tzavara, I; Vryonidou, A				Paschou, Stavroula A.; Ioannidis, Dimitrios; Vassilatou, Evangeline; Mizamtsidi, Maria; Panagou, Maria; Lilis, Dimitrios; Tzavara, Ioanna; Vryonidou, Andromachi			Birth Weight and Polycystic Ovary Syndrome in Adult Life: Is There a Causal Link?	PLOS ONE			English	Article							PITUITARY-ADRENAL AXIS; CHILDREN BORN SMALL; INSULIN-RESISTANCE; BODY-SIZE; GESTATIONAL-AGE; SEX-HORMONES; WOMEN; HYPERANDROGENISM; ORIGINS; GROWTH	Objectives Several studies have demonstrated associations of birth weight with metabolic and reproductive abnormalities in adults. The aim of this study was to investigate the birth weight in women with PCOS and its correlation with clinical and biochemical characteristics of the syndrome. Materials and Methods We studied 288 women with PCOS according to the NIH criteria and 166 women with normal cycle and without clinical hyperandrogenism. Birth weight and anthropometric characteristics were recorded, and levels of serum androgens, SHBG, insulin and fasting glucose were measured. Results Birth weight data were available for 243/288 women with PCOS and age- and BMI-matched 101/166 controls. No differences were found (p > 0.05) in birth weight among women with PCOS and normal controls. Birth weight of PCOS women was negatively correlated with DHEAS levels (p = 0.031, r = -0.143) and positively correlated with waist circumference (p < 0.001, r = 0.297) and body mass index (BMI) (p = 0.040, r = 0.132). Birth weight of controls was negatively correlated with SHBG levels (p = 0.021, r = -0.234). Women from both groups were further divided in 6 categories according to birth weight (A. <2.500 gr, B. 2.501-3.000 gr, C. 3.001-3.500 gr, D. 3.501-4.000 gr, E. 4.001-4.500 gr, F. > 4.500 gr). No statistically significant differences were observed in the distribution percentages between PCOS women and controls. (A. 7% vs 7.9%, B. 26.8% vs 20.8%, C. 39.1% vs 48.5%, D. 21.4% vs 20.8%, E. 4.9% vs 2%, F. 0.8% vs 0%), (in all comparisons, p > 0.05). Conclusions Women with PCOS do not differ from controls in birth weight distribution. However, birth weight may contribute to subtypes of the syndrome that are characterized by adrenal hyperandrogenism and central obesity.	[Paschou, Stavroula A.; Mizamtsidi, Maria; Vryonidou, Andromachi] Hellen Red Cross Hosp, Dept Endocrinol & Diabet, Athens, Greece; [Ioannidis, Dimitrios; Panagou, Maria; Lilis, Dimitrios; Tzavara, Ioanna] Amalia Fleming Hosp, Dept Endocrinol & Diabet, Athens, Greece; [Vassilatou, Evangeline] Attikon Univ Hosp, Dept Med 2, Endocrine Unit, Athens, Greece	University Hospital Attikon	Vryonidou, A (corresponding author), Hellen Red Cross Hosp, Dept Endocrinol & Diabet, Athens, Greece.	mahi_vr@hotmail.com	Vassilatou, Evangeline/ABE-2651-2020					Azziz R, 1998, J CLIN ENDOCR METAB, V83, P2317, DOI 10.1210/jc.83.7.2317; Azziz R, 2008, J CLIN ENDOCR METAB, V93, P1579, DOI 10.1210/jc.2008-0477; Barker DJP, 1998, CLIN SCI, V95, P115, DOI 10.1042/CS19980019; Cnattingius S, 2012, INT J OBESITY, V36, P1320, DOI 10.1038/ijo.2011.248; Conway G, 2014, EUR J ENDOCRINOL, V171, pP1, DOI 10.1530/EJE-14-0253; Cresswell JL, 1997, LANCET, V350, P1131, DOI 10.1016/S0140-6736(97)06062-5; Davies MJ, 2012, HUM REPROD, V27, P1475, DOI 10.1093/humrep/des027; de Zegher F, 2009, J CLIN ENDOCR METAB, V94, P3682, DOI 10.1210/jc.2009-1608; Diamanti-Kandarakis E, 2012, ENDOCR REV, V33, P981, DOI 10.1210/er.2011-1034; Ding EL, 2009, NEW ENGL J MED, V361, P1152, DOI 10.1056/NEJMoa0804381; Escobar-Morreale HF, 2007, TRENDS ENDOCRIN MET, V18, P266, DOI 10.1016/j.tem.2007.07.003; Gennarelli G, 1999, J CLIN ENDOCR METAB, V84, P76, DOI 10.1210/jc.84.1.76; Gluckman PD, 2005, BIOL NEONATE, V87, P127, DOI 10.1159/000082311; Goodarzi MO, 2014, J STEROID BIOCH MOL; Harder T, 2007, AM J EPIDEMIOL, V165, P849, DOI 10.1093/aje/kwk071; HATCH R, 1981, AM J OBSTET GYNECOL, V140, P815, DOI 10.1016/0002-9378(81)90746-8; Hediger ML, 1998, ARCH PEDIAT ADOL MED, V152, P1225; Ibanez L, 2000, CLIN ENDOCRINOL, V53, P523, DOI 10.1046/j.1365-2265.2000.01133.x; Ibanez L, 1998, J CLIN ENDOCR METAB, V83, P3558, DOI 10.1210/jc.83.10.3558; Jaquet D, 1999, J CLIN ENDOCR METAB, V84, P3945, DOI 10.1210/jc.84.11.3945; Laitinen J, 2003, INT J OBESITY, V27, P710, DOI 10.1038/sj.ijo.0802301; Legro RS, 2010, J CLIN ENDOCR METAB, V95, P789, DOI 10.1210/jc.2009-1849; Markopoulos MC, 2011, J CLIN ENDOCR METAB, V96, P623, DOI 10.1210/jc.2010-0130; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; Melo AS, 2010, HUM REPROD, V25, P2124, DOI 10.1093/humrep/deq162; Michelmore K, 2001, CLIN ENDOCRINOL, V55, P439, DOI 10.1046/j.1365-2265.2001.01375.x; Mumm H, 2013, FERTIL STERIL, V99, P777, DOI 10.1016/j.fertnstert.2012.11.004; Opdahl S, 2008, BRIT J CANCER, V99, P201, DOI 10.1038/sj.bjc.6604449; Pandolfi C, 2008, METABOLISM, V57, P999, DOI 10.1016/j.metabol.2008.02.018; Pasquali R, 2012, ANN NY ACAD SCI, V1264, P20, DOI 10.1111/j.1749-6632.2012.06569.x; Puurunen J, 2009, J CLIN ENDOCR METAB, V94, P1973, DOI 10.1210/jc.2008-2583; Roos N, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d6309; Rosner W, 2006, CELL, V124, P455, DOI 10.1016/j.cell.2006.01.026; Ross MG, 2013, CLIN OBSTET GYNECOL, V56, P529, DOI 10.1097/GRF.0b013e318299c39d; Ruder EH, 2011, CANCER CAUSE CONTROL, V22, P611, DOI 10.1007/s10552-011-9734-7; Sir-Petermann T, 2005, HUM REPROD, V20, P2122, DOI 10.1093/humrep/dei009; Tenhola S, 2002, J PEDIATR-US, V141, P477, DOI 10.1067/mpd.2002.126923; Tworoger SS, 2006, CANCER EPIDEM BIOMAR, V15, P2494, DOI 10.1158/1055-9965.EPI-06-0671; Villa J, 2011, CURR DIABETES REP, V11, P179, DOI 10.1007/s11892-011-0189-8; Xita N, 2010, MOL CELL ENDOCRINOL, V316, P60, DOI 10.1016/j.mce.2009.08.025; Xita N, 2010, ANN NY ACAD SCI, V1205, P148, DOI 10.1111/j.1749-6632.2010.05658.x; Zawadski J., 1992, POLYCYSTIC OVARY SYN, P377	42	12	12	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2015	10	3							e0122050	10.1371/journal.pone.0122050	http://dx.doi.org/10.1371/journal.pone.0122050			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD9NQ	25790331	Green Published, gold, Green Submitted			2022-12-27	WOS:000351425400208
J	Edwards-Jones, B; Aw, R; Barton, GR; Tredwell, GD; Bundy, JG; Leak, DJ				Edwards-Jones, Bryn; Aw, Rochelle; Barton, Geraint R.; Tredwell, Gregory D.; Bundy, Jacob G.; Leak, David J.			Translational Arrest Due to Cytoplasmic Redox Stress Delays Adaptation to Growth on Methanol and Heterologous Protein Expression in a Typical Fed-Batch Culture of Pichia pastoris	PLOS ONE			English	Article							UNFOLDED PROTEIN; ENDOPLASMIC-RETICULUM; ASPERGILLUS-NIGER; ALCOHOL OXIDASE; GENE-EXPRESSION; CARBON-SOURCES; D-ARABITOL; ANNOTATION; INITIATION; YEAST	Results We have followed a typical fed-batch induction regime for heterologous protein production under the control of the AOX1 promoter using bothmicroarray and metabolomic analysis. The genetic constructs involved 1 and 3 copies of the TRY1 gene, encoding human trypsinogen. In small-scale laboratory cultures, expression of the 3 copy-number construct induced the unfolded protein response (UPR) sufficiently that titres of extracellular trypsinogen were lower in the 3-copy construct than with the 1-copy construct. In the fed-batch-culture, a similar pattern was observed, with higher expression from the 1-copy construct, but in this case there was no significant induction of UPR with the 3-copy strain. Analysis of the microarray and metabolomic information indicates that the 3-copy strain was undergoing cytoplasmic redox stress at the point of induction withmethanol. In this Crabtree-negative yeast, this redox stress appeared to delay the adaptation to growth on methanol and supressed heterologous protein production, probably due to a block in translation. Conclusion Although redox imbalance as a result of artificially imposed hypoxia has previously been described, this is the first time that it has been characterised as a result of a transient metabolic imbalance and shown to involve a stress response which can lead to translational arrest. Without detailed analysis of the underlying processes it could easily have been mis-interpreted as secretion stress, transmitted through the UPR.	[Edwards-Jones, Bryn; Aw, Rochelle; Barton, Geraint R.; Leak, David J.] Univ London Imperial Coll Sci Technol & Med, Dept Life Sci, Fac Nat Sci, London SW7 2AZ, England; [Tredwell, Gregory D.; Bundy, Jacob G.] Univ London Imperial Coll Sci Technol & Med, Dept Surg Canc, Fac Med, London SW7 2AZ, England; [Leak, David J.] Univ Bath, Dept Biol & Biochem, Bath BA2 7AY, Avon, England	Imperial College London; Imperial College London; University of Bath	Leak, DJ (corresponding author), Univ London Imperial Coll Sci Technol & Med, Dept Life Sci, Fac Nat Sci, London SW7 2AZ, England.	d.j.leak@bath.ac.uk	Tredwell, Greg/L-2294-2015; Bundy, Jacob G/C-2131-2008	Tredwell, Greg/0000-0002-0020-5626; Bundy, Jacob G/0000-0002-1164-8465; Aw, Rochelle/0000-0002-8480-9813	Bioprocessing Research Industry Club [BBF0049071]; Fujifilm Diosynth Biotechnologies; BBSRC [BB/F004907/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/F004907/1] Funding Source: researchfish	Bioprocessing Research Industry Club; Fujifilm Diosynth Biotechnologies; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	The authors are grateful to the Bioprocessing Research Industry Club (supported by contributions from industrial members and the Biotechnology and Biological Sciences Research Council http://www.bbsrc.ac.uk) for grant (BBF0049071) support to DJL and JRB, and, together with Avecia Biologics Ltd (now Fujifilm Diosynth Biotechnologies) CASE studentship support to RA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ansell R, 1997, EMBO J, V16, P2179, DOI 10.1093/emboj/16.9.2179; Bakker BM, 2001, FEMS MICROBIOL REV, V25, P15, DOI 10.1016/S0168-6445(00)00039-5; Barbet NC, 1996, MOL BIOL CELL, V7, P25, DOI 10.1091/mbc.7.1.25; Baumann K, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-141; Beckonert O, 2007, NAT PROTOC, V2, P2692, DOI 10.1038/nprot.2007.376; BELLINGER Y, 1988, CAN J MICROBIOL, V34, P605, DOI 10.1139/m88-100; Berset C, 1998, P NATL ACAD SCI USA, V95, P4264, DOI 10.1073/pnas.95.8.4264; Brauer MJ, 2008, MOL BIOL CELL, V19, P352, DOI 10.1091/mbc.E07-08-0779; Brown A D, 1978, Adv Microb Physiol, V17, P181, DOI 10.1016/S0065-2911(08)60058-2; Castrillo Juan I, 2007, J Biol, V6, P4, DOI 10.1186/jbiol54; Cereghino JL, 2000, FEMS MICROBIOL REV, V24, P45, DOI 10.1111/j.1574-6976.2000.tb00532.x; De Schutter K, 2009, NAT BIOTECHNOL, V27, P561, DOI 10.1038/nbt.1544; Diano A, 2006, BIOTECHNOL BIOENG, V94, P899, DOI 10.1002/bit.20915; Diano A, 2009, BIOTECHNOL BIOENG, V103, P956, DOI 10.1002/bit.22329; Dieterle F, 2006, ANAL CHEM, V78, P4281, DOI 10.1021/ac051632c; Dragosits M, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-207; Graf A, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-390; Grousl T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057083; Guarna MM, 1997, BIOTECHNOL BIOENG, V56, P279, DOI 10.1002/(SICI)1097-0290(19971105)56:3<279::AID-BIT5>3.0.CO;2-G; Guerfal M, 2010, MICROB CELL FACT, V9, DOI 10.1186/1475-2859-9-49; Harding HP, 2000, MOL CELL, V6, P1099, DOI 10.1016/S1097-2765(00)00108-8; Hartner FS, 2006, MICROB CELL FACT, V5, DOI 10.1186/1475-2859-5-39; Hesketh AR, 2013, APPL MICROBIOL BIOT, V97, P9747, DOI 10.1007/s00253-013-5186-1; Hinnebusch AG, 2005, ANNU REV MICROBIOL, V59, P407, DOI 10.1146/annurev.micro.59.031805.133833; Hohenblum H, 2004, BIOTECHNOL BIOENG, V85, P367, DOI 10.1002/bit.10904; Inan M, 2001, J BIOSCI BIOENG, V92, P585, DOI 10.1263/jbb.92.585; Jungo C, 2007, J BIOTECHNOL, V130, P236, DOI 10.1016/j.jbiotec.2007.04.004; Kamada Y, 2010, MOL CELL BIOL, V30, P1049, DOI 10.1128/MCB.01344-09; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Kanehisa M, 2012, NUCLEIC ACIDS RES, V40, pD109, DOI 10.1093/nar/gkr988; Kayingo G, 2005, MICROBIOL-SGM, V151, P2987, DOI 10.1099/mic.0.28040-0; Kedersha N, 2009, PROG MOL BIOL TRANSL, V90, P155, DOI 10.1016/S1877-1173(09)90004-7; Krainer FW, 2012, MICROB CELL FACT, V11, DOI 10.1186/1475-2859-11-22; Kurtzman CP, 2009, J IND MICROBIOL BIOT, V36, P1435, DOI 10.1007/s10295-009-0638-4; Lewis IA, 2009, MAGN RESON CHEM, V47, pS123, DOI 10.1002/mrc.2526; Liang SL, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-738; Love KR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037915; Macauley-Patrick S, 2005, YEAST, V22, P249, DOI 10.1002/yea.1208; Mao XZ, 2005, BIOINFORMATICS, V21, P3787, DOI 10.1093/bioinformatics/bti430; Morano KA, 2012, GENETICS, V190, P1157, DOI 10.1534/genetics.111.128033; Patil C, 2001, CURR OPIN CELL BIOL, V13, P349, DOI 10.1016/S0955-0674(00)00219-2; Rucktaschel R, 2011, BBA-BIOMEMBRANES, V1808, P892, DOI 10.1016/j.bbamem.2010.07.020; Smyth G, 2005, LIMMA LINEAR MODELS; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [DOI 10.2202/1544-6115.1027, 10.2202/1544-6115.1027]; Sreekrishna K, 2009, ENCY IND BIOTECHNOLO; Stein LD, 2002, GENOME RES, V12, P1599, DOI 10.1101/gr.403602; Tredwell GD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016286; Uesono Y, 2002, J BIOL CHEM, V277, P13848, DOI 10.1074/jbc.M108848200; Upton GJG, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-613; van der Klei IJ, 2006, BBA-MOL CELL RES, V1763, P1453, DOI 10.1016/j.bbamcr.2006.07.016; van der Zand A, 2012, CELL, V149, P397, DOI 10.1016/j.cell.2012.01.054; Warner JR, 2001, COLD SPRING HARB SYM, V66, P567, DOI 10.1101/sqb.2001.66.567; WONG B, 1995, J BACTERIOL, V177, P2971, DOI 10.1128/jb.177.11.2971-2976.1995; Wu JM, 2006, NUCLEIC ACIDS RES, V34, pW720, DOI 10.1093/nar/gkl167; Xiao LJ, 2009, CURR GENOMICS, V10, P198, DOI 10.2174/138920209788185261; Xie C, 2011, NUCLEIC ACIDS RES, V39, pW316, DOI 10.1093/nar/gkr483; Zaman S, 2008, ANNU REV GENET, V42, P27, DOI 10.1146/annurev.genet.41.110306.130206	57	10	10	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2015	10	3							e0119637	10.1371/journal.pone.0119637	http://dx.doi.org/10.1371/journal.pone.0119637			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9BN	25785713	Green Published, gold, Green Submitted			2022-12-27	WOS:000352138500124
J	Hernandez, JC; Giraldo, DM; Paul, S; Urcuqui-Inchima, S				Hernandez, Juan C.; Giraldo, Diana M.; Paul, Stephane; Urcuqui-Inchima, Silvio			Involvement of Neutrophil Hyporesponse and the Role of Toll-Like Receptors in Human Immunodeficiency Virus 1 Protection	PLOS ONE			English	Article							IMPAIRED OXIDATIVE BURST; INNATE IMMUNE-RESPONSE; INFECTED PATIENTS; TYPE-1 INFECTION; HIV-1 INFECTION; VIRAL LOAD; L-SELECTIN; ACTIVATION; EXPRESSION; CELLS	Objectives Neutrophils contribute to pathogen clearance through pattern recognition receptors (PRRs) activation. However, the role of PRRs in neutrophils in both HIV-1-infected [HIV-1(+)] and HIV-1-exposed seronegative individuals (HESN) is unknown. Here, a study was carried out to evaluate the level of PRR mRNAs and cytokines produced after activation of neutrophils from HIV-1(+), HESN and healthy donors. Methods The neutrophils were stimulated with specific agonists for TLR2, TLR4 and TLR9 in the presence of HIV-1 particles. Pro-inflammatory cytokine production, expression of neutrophil activation markers and reactive oxygen species (ROS) production were analyzed in neutrophils from HESN, HIV-1(+) and healthy donors (controls). Results We found that neutrophils from HESN presented reduced expression of PRR mRNAs (TLR4, TLR9, NOD1, NOD2, NLRC4 and RIG-I) and reduced expression of cytokine mRNAs (IL-1 beta, IL-6, IL-18, TNF-alpha and TGF-beta). Moreover, neutrophils from HESN were less sensitive to stimulation through TLR4. Furthermore, neutrophils from HESN challenged with HIV-1 and stimulated with TLR2 and TLR4 agonists, produced significantly lower levels of reactive oxygen species, versus HIV-1(+). Conclusions A differential pattern of PRR expression and release of innate immune factors in neutrophils from HESN is evident. Our results suggest that lower neutrophil activation can be involved in protection against HIV-1 infection.	[Hernandez, Juan C.] Univ Cooperat Colombia, Fac Med, INFETTARE, Medellin, Colombia; [Giraldo, Diana M.; Urcuqui-Inchima, Silvio] Univ Antioquia, Fac Med, Grupo Inmunovirol, Medellin, Colombia; [Paul, Stephane] Univ Lyon, Fac Med St Etienne, GIMAP EA3064, Lyon, France	Universidad Cooperativa de Colombia; Universidad de Antioquia	Urcuqui-Inchima, S (corresponding author), Univ Antioquia, Fac Med, Grupo Inmunovirol, Medellin, Colombia.	silviourcuqui@gmail.com	Hernandez, Juan C./C-1621-2018	Hernandez, Juan C./0000-0002-9200-5698; Urcuqui-Inchima, Silvio/0000-0002-2865-3041; Giraldo Giraldo, Diana Marcela/0000-0002-3455-6846; paul, stephane/0000-0002-8830-4273	COLCIENCIAS, Colombia [111549326099]; Universidad de Antioquia (Sostenibilidad)	COLCIENCIAS, Colombia(Departamento Administrativo de Ciencia, Tecnologia e Innovacion Colciencias); Universidad de Antioquia (Sostenibilidad)	This study was supported by COLCIENCIAS, grant number 111549326099, Colombia, and Universidad de Antioquia (Sostenibilidad 2014-2015). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akira S, 2011, PHILOS T R SOC B, V366, P2748, DOI 10.1098/rstb.2011.0106; Barquero AA, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/989101; Asehnoune K, 2004, J IMMUNOL, V172, P2522, DOI 10.4049/jimmunol.172.4.2522; Babadoko A A, 2008, Niger J Med, V17, P57; Bosinger SE, 2009, J CLIN INVEST, V119, P3556, DOI 10.1172/JCI40115; Brenchley JM, 2006, NAT MED, V12, P1365, DOI 10.1038/nm1511; Card CM, 2009, J INFECT DIS, V199, P1318, DOI 10.1086/597801; Cavrois M, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000051; Chege D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043670; Chun TW, 1998, J EXP MED, V188, P83, DOI 10.1084/jem.188.1.83; CLERICI M, 1991, J INFECT DIS, V164, P178, DOI 10.1093/infdis/164.1.178; Cooke KR, 2002, J ENDOTOXIN RES, V8, P441, DOI 10.1179/096805102125001046; Correa RG, 2012, BIOSCIENCE REP, V32, P597, DOI 10.1042/BSR20120055; Cote SC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067735; Ekman AK, 2010, IMMUNOLOGY, V130, P55, DOI 10.1111/j.1365-2567.2009.03212.x; ELBIM C, 1994, BLOOD, V84, P2759, DOI 10.1182/blood.V84.8.2759.bloodjournal8482759; Elbim C, 1999, J VIROL, V73, P4561, DOI 10.1128/JVI.73.6.4561-4566.1999; Epaulard O, 2014, J IMMUNOL, V193, P2416, DOI 10.4049/jimmunol.1303339; Freguja R, 2012, AIDS, V26, P765, DOI 10.1097/QAD.0b013e3283514350; Gabali AM, 2004, J VIROL, V78, P10833, DOI 10.1128/JVI.78.19.10833-10836.2004; Ghosh M, 2013, AM J REPROD IMMUNOL, V69, P41, DOI 10.1111/aji.12019; Goh WC, 1999, J INFECT DIS, V179, P548, DOI 10.1086/314632; Hayashi F, 2003, BLOOD, V102, P2660, DOI 10.1182/blood-2003-04-1078; Hernandez JC, 2014, INTERVIROLOGY, V57, P36, DOI 10.1159/000353902; Hernandez JC, 2011, AIDS RES HUM RETROV, V27, P1099, DOI [10.1089/aid.2010.0302, 10.1089/AID.2010.0302]; Hernandez JC, 2012, AIDS RES HUM RETROV, V28, P1313, DOI 10.1089/aid.2011.0297; Izquierdo-Useros N, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000740; Jadhav VS, 2014, J NEUROCHEM; Jennes W, 2006, CLIN EXP IMMUNOL, V143, P435, DOI 10.1111/j.1365-2249.2006.03017.x; KIMURA T, 1993, FEBS LETT, V326, P232, DOI 10.1016/0014-5793(93)81797-4; Kourtis AP, 2000, AIDS, V14, P2429, DOI 10.1097/00002030-200011100-00003; Koziel H, 2000, AM J RESP CELL MOL, V23, P452, DOI 10.1165/ajrcmb.23.4.4084; Kurt-Jones EA, 2002, BLOOD, V100, P1860, DOI 10.1182/blood.V100.5.1860.h81702001860_1860_1868; Lajoie J, 2012, MUCOSAL IMMUNOL, V5, P277, DOI 10.1038/mi.2012.7; Levinson P, 2009, AIDS, V23, P309, DOI 10.1097/QAD.0b013e328321809c; Marodon G, 1999, AIDS RES HUM RETROV, V15, P161, DOI 10.1089/088922299311583; McLaren PJ, 2010, J INFECT DIS, V202, pS339, DOI 10.1086/655968; Pavot V, 2013, J CONTROL RELEASE, V167, P60, DOI 10.1016/j.jconrel.2013.01.015; Pine SO, 2009, AIDS, V23, P2387, DOI 10.1097/QAD.0b013e328330b489; POLI G, 1990, J EXP MED, V172, P151, DOI 10.1084/jem.172.1.151; Pontillo A, 2012, JAIDS-J ACQ IMM DEF, V59, P121, DOI 10.1097/QAI.0b013e3182392ebe; Pontillo A, 2010, JAIDS-J ACQ IMM DEF, V54, P236, DOI 10.1097/QAI.0b013e3181dd17d4; Prince LR, 2011, CURR OPIN PHARMACOL, V11, P397, DOI 10.1016/j.coph.2011.06.007; Pyo CW, 2008, BIOCHEM BIOPH RES CO, V376, P180, DOI 10.1016/j.bbrc.2008.08.114; RANKI A, 1989, AIDS, V3, P63, DOI 10.1097/00002030-198902000-00002; Remer KA, 2003, IMMUNOL LETT, V85, P75, DOI 10.1016/S0165-2478(02)00210-9; Roberts L, 2012, J INFECT DIS, V205, P194, DOI 10.1093/infdis/jir715; Roy A, 2008, FREE RADICAL BIO MED, V45, P686, DOI 10.1016/j.freeradbiomed.2008.05.026; Sabroe I, 2003, J IMMUNOL, V170, P5268, DOI 10.4049/jimmunol.170.10.5268; Sabroe I, 2002, J IMMUNOL, V168, P4701, DOI 10.4049/jimmunol.168.9.4701; Saitoh T, 2012, CELL HOST MICROBE, V12, P109, DOI 10.1016/j.chom.2012.05.015; Sawahata R, 2011, MICROBES INFECT, V13, P350, DOI 10.1016/j.micinf.2010.12.003; Schwartz R, 2010, BIOMED PHARMACOTHER, V64, P572, DOI 10.1016/j.biopha.2010.03.005; Solis M, 2011, J VIROL, V85, P1224, DOI 10.1128/JVI.01635-10; Songok EM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030048; Takeuchi O, 2001, INT IMMUNOL, V13, P933, DOI 10.1093/intimm/13.7.933; Tomescu C, 2011, CLIN EXP IMMUNOL, V164, P158, DOI 10.1111/j.1365-2249.2011.04379.x; Victoria S, 2013, IMMUNOBIOLOGY, V218, P1529, DOI 10.1016/j.imbio.2013.06.006; Yao XD, 2014, MUCOSAL IMMUNOL, V7, P268, DOI 10.1038/mi.2013.44; Zapata W, 2008, CURR HIV RES, V6, P531, DOI 10.2174/157016208786501463	60	16	17	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2015	10	3							e0119844	10.1371/journal.pone.0119844	http://dx.doi.org/10.1371/journal.pone.0119844			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9BN	25785697	Green Published, gold, Green Submitted			2022-12-27	WOS:000352138500132
J	Johnson, EO; Hancock, DB; Gaddis, NC; Levy, JL; Page, G; Novak, SP; Glasheen, C; Saccone, NL; Rice, JP; Moreau, MP; Doheny, KF; Romm, JM; Brooks, AI; Aouizerat, BE; Bierut, LJ; Kral, AH				Johnson, Eric O.; Hancock, Dana B.; Gaddis, Nathan C.; Levy, Joshua L.; Page, Grier; Novak, Scott P.; Glasheen, Cristie; Saccone, Nancy L.; Rice, John P.; Moreau, Michael P.; Doheny, Kimberly F.; Romm, Jane M.; Brooks, Andrew I.; Aouizerat, Bradley E.; Bierut, Laura J.; Kral, Alex H.			Novel Genetic Locus Implicated for HIV-1 Acquisition with Putative Regulatory Links to HIV Replication and Infectivity: A Genome-Wide Association Study	PLOS ONE			English	Article							INJECTION-DRUG USERS; SAN-FRANCISCO; METAANALYSIS; TRANSMISSION; INDIVIDUALS; RESISTANCE; RISK; DISEQUILIBRIUM; POLYMORPHISM; POPULATION	Fifty percent of variability in HIV-1 susceptibility is attributable to host genetics. Thus identifying genetic associations is essential to understanding pathogenesis of HIV-1 and important for targeting drug development. To date, however, CCR5 remains the only gene conclusively associated with HIV acquisition. To identify novel host genetic determinants of HIV-1 acquisition, we conducted a genome-wide association study among a high-risk sample of 3,136 injection drug users (IDUs) from the Urban Health Study (UHS). In addition to being IDUs, HIV-controls were frequency-matched to cases on environmental exposures to enhance detection of genetic effects. We tested independent replication in the Women's Interagency HIV Study (N=2,533). We also examined publicly available gene expression data to link SNPs associated with HIV acquisition to known mechanisms affecting HIV replication/infectivity. Analysis of the UHS nominated eight genetic regions for replication testing. SNP rs4878712 in FRMPD1 met multiple testing correction for independent replication (P=1.38x10(-4)), although the UHS-WIHS meta-analysis p-value did not reach genome-wide significance (P=4.47x10(-7) vs. P<5.0x10(-8)) Gene expression analyses provided promising biological support for the protective G allele at rs4878712 lowering risk of HIV: (1) the G allele was associated with reduced expression of FBXO10 (r=-0.49, P=6.9x10(-5)); (2) FBXO10 is a component of the Skp1-Cul1-F-box protein E3 ubiquitin ligase complex that targets Bcl-2 protein for degradation; (3) lower FBXO10 expression was associated with higher BCL2 expression (r=-0.49, P=8x10(-5)); (4) higher basal levels of Bcl-2 are known to reduce HIV replication and infectivity in human and animal in vitro studies. These results suggest new potential biological pathways by which host genetics affect susceptibility to HIV upon exposure for follow-up in subsequent studies.	[Johnson, Eric O.; Hancock, Dana B.; Gaddis, Nathan C.; Levy, Joshua L.; Page, Grier; Novak, Scott P.; Glasheen, Cristie; Kral, Alex H.] RTI Int, Res Triangle Pk, NC 27709 USA; [Saccone, Nancy L.; Rice, John P.; Bierut, Laura J.] Washington Univ, Sch Med, St Louis, MO USA; [Moreau, Michael P.; Brooks, Andrew I.] Rutgers Univ Cell & DNA Repository RUCDR, Piscataway, NJ USA; [Doheny, Kimberly F.; Romm, Jane M.] Johns Hopkins Univ, CIDR, Baltimore, MD USA; [Aouizerat, Bradley E.] Univ Calif San Francisco, Sch Nursing, San Francisco, CA 94143 USA; [Aouizerat, Bradley E.] Univ Calif San Francisco, Inst Human Genet, San Francisco, CA 94143 USA	Research Triangle Institute; Washington University (WUSTL); Johns Hopkins University; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Johnson, EO (corresponding author), RTI Int, Res Triangle Pk, NC 27709 USA.	ejohnson@rti.org	Bierut, Laura Jean/W-6806-2019; Gaddis, Nathan/GXG-6395-2022; Gaddis, Nathan/GXG-6447-2022	Bierut, Laura Jean/0000-0002-9952-4810; Kral, Alex/0000-0002-9092-3671; Johnson, Eric Otto/0000-0002-8870-1949; Page, Grier/0000-0003-2582-3786; Gaddis, Nathan/0000-0001-5205-7138; Hancock, Dana/0000-0003-2240-3604	National Institute of Drug Abuse (NIDA) [R01 DA026141, X01 HG005275]; NIDA Center [N01DA-09-7770]; NIH [HHSN268201100011I, HHSN268200782096C]; National Institute of Allergy and Infectious Diseases [UO1-AI-35004, UO1-AI-31834, UO1-AI-34994, UO1-AI-34989, UO1-AI-34993, UO1-AI-42590]; Eunice Kennedy Shriver National Institute of Child Health and Human Development [UO1-HD-32632]; National Cancer Institute; National Institute on Drug Abuse; National Institute on Deafness and Other Communication Disorders; National Center for Research Resources (UCSF-CTSI) [UL1 RR024131];  [AI034989-S17]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [U01HD032632] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024131] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI034994, U01AI034993, U01AI034989, U01AI031834, U01AI042590, U01AI035004] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA038632, R01DA026141] Funding Source: NIH RePORTER	National Institute of Drug Abuse (NIDA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NIDA Center; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Eunice Kennedy Shriver National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); National Institute on Deafness and Other Communication Disorders(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); National Center for Research Resources (UCSF-CTSI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); ; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by the National Institute of Drug Abuse (NIDA) grants R01 DA026141 and X01 HG005275: EOJ. Storage and processing of UHS serum samples for DNA extraction and genotyping was conducted by the Rutgers University Cell and DNA Repository was supported by the NIDA Center for Genetics under contract (N01DA-09-7770). Genotyping was conducted by the Center for Inherited Disease and supported by NIH contracts HHSN268201100011I and HHSN268200782096C. Women's Interagency HIV Study: Data in this manuscript were collected by the Women's Interagency HIV Study (WIHS) Collaborative Study Group with centers (Principal Investigators) at New York City/Bronx Consortium (Kathryn Anastos); Brooklyn, NY (Howard Minkoff); Washington DC Metropolitan Consortium (Mary Young); The Connie Wofsy Study Consortium of Northern California (Ruth Greenblatt); Los Angeles County/Southern California Consortium (Alexandra Levine); Chicago Consortium (Mardge Cohen); Data Coordinating Center (Stephen Gange). The WIHS is funded by the National Institute of Allergy and Infectious Diseases (UO1-AI-35004, UO1-AI-31834, UO1-AI-34994, UO1-AI-34989, UO1-AI-34993, and UO1-AI-42590) and by the Eunice Kennedy Shriver National Institute of Child Health and Human Development (UO1-HD-32632). The study is co-funded by the National Cancer Institute, the National Institute on Drug Abuse, and the National Institute on Deafness and Other Communication Disorders. Funding is also provided by the National Center for Research Resources (UCSF-CTSI Grant Number UL1 RR024131). The contents of this publication are solely the responsibility of the authors and do not necessarily represent the official views of the National Institutes of Health. Genome-wide genotyping of the WIHS samples was supported by supplemental funding AI034989-S17: BEA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aillet F, 1998, J VIROL, V72, P9698, DOI 10.1128/JVI.72.12.9698-9705.1998; Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; An NF, 2008, J BIOL CHEM, V283, P24718, DOI 10.1074/jbc.M803497200; An P, 2010, TRENDS GENET, V26, P119, DOI 10.1016/j.tig.2010.01.002; [Anonymous], 1992, BMJ, V304, P809; Bacon MC, 2005, CLIN DIAGN LAB IMMUN, V12, P1013, DOI 10.1128/CDLI.12.9.1013-1019.2005; Blazkova J, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000554; Carrington M, 1999, HUM MOL GENET, V8, P1939, DOI 10.1093/hmg/8.10.1939; Chiorazzi M, 2013, P NATL ACAD SCI USA, V110, P3943, DOI 10.1073/pnas.1217271110; Craigie R, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006890; Dickson SP, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000294; Fellay J, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001033; Goldstein DB, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001008; Grundberg E, 2012, NAT GENET, V44, P1084, DOI 10.1038/ng.2394; Guo YR, 2013, HUM MOL GENET, V22, P184, DOI 10.1093/hmg/dds396; Howie B, 2011, G3-GENES GENOM GENET, V1, P457, DOI 10.1534/g3.111.001198; Joubert BR, 2010, GENOME MED, V2, DOI 10.1186/gm138; Kral AH, 2003, AM J EPIDEMIOL, V157, P915, DOI 10.1093/aje/kwg070; Kral AH, 2001, LANCET, V357, P1397, DOI 10.1016/S0140-6736(00)04562-1; Lane J, 2013, HUM MOL GENET, V22, P1903, DOI 10.1093/hmg/ddt033; Lanktree MB, 2011, AM J HUM GENET, V88, P6, DOI 10.1016/j.ajhg.2010.11.007; Larsson M, 2013, RETROVIROLOGY, V10, DOI 10.1186/1742-4690-10-31; Li J, 2005, HEREDITY, V95, P221, DOI 10.1038/sj.hdy.6800717; Limou S, 2012, J INFECT DIS, V205, P1155, DOI 10.1093/infdis/jis028; Lingappa JR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028632; Loeuillet C, 2008, PLOS BIOL, V6, P319, DOI 10.1371/journal.pbio.0060032; Luo M, 2012, J VIROL, V86, P11899, DOI 10.1128/JVI.01499-12; McLaren PJ, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003515; Montgomery SB, 2010, NATURE, V464, P773, DOI 10.1038/nature08903; Morris AP, 2011, GENET EPIDEMIOL, V35, P809, DOI 10.1002/gepi.20630; Myers RA, 2012, J ALLERGY CLIN IMMUN, V130, P1294, DOI 10.1016/j.jaci.2012.07.054; Nyholt DR, 2004, AM J HUM GENET, V74, P765, DOI 10.1086/383251; Pan Z, 2013, J MOL BIOL, V425, P1039, DOI 10.1016/j.jmb.2013.01.003; Pe'er I, 2008, GENET EPIDEMIOL, V32, P381, DOI 10.1002/gepi.20303; Petrovski S, 2011, AIDS, V25, P513, DOI 10.1097/QAD.0b013e328343817b; Pulit SL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012600; Samson M, 1996, NATURE, V382, P722, DOI 10.1038/382722a0; Selliah N, 2001, CELL DEATH DIFFER, V8, P127, DOI 10.1038/sj.cdd.4400822; Stranger BE, 2012, PLOS GENET, V8, P272, DOI 10.1371/journal.pgen.1002639; Telenti A, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a007203; Torgerson DG, 2011, NAT GENET, V43, P887, DOI 10.1038/ng.888; Varghese B, 2002, SEX TRANSM DIS, V29, P38, DOI 10.1097/00007435-200201000-00007; Vassena L, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002636; Ward LD, 2012, NUCLEIC ACIDS RES, V40, pD930, DOI 10.1093/nar/gkr917; Whetstine JR, 2006, CELL, V125, P467, DOI 10.1016/j.cell.2006.03.028; Willer CJ, 2010, BIOINFORMATICS, V26, P2190, DOI 10.1093/bioinformatics/btq340; Wray NR, 2005, TWIN RES HUM GENET, V8, P87; Xu X, 2012, MOL CARCINOG; Yang TP, 2010, BIOINFORMATICS, V26, P2474, DOI 10.1093/bioinformatics/btq452	49	17	17	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2015	10	3							e0118149	10.1371/journal.pone.0118149	http://dx.doi.org/10.1371/journal.pone.0118149			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9BN	25786224	Green Submitted, gold, Green Published			2022-12-27	WOS:000352138500022
J	Kim, K; Kim, JS				Kim, KyungHee; Kim, Ji-Su			The Association between Alcohol Consumption Patterns and Health-Related Quality of Life in a Nationally Representative Sample of South Korean Adults	PLOS ONE			English	Article							POPULATION-BASED SAMPLE; DRINKING PATTERNS; WHOQOL-BREF; EQ-5D	This study examined the relationship between alcohol consumption and health-related quality of life (HRQOL) in a nationally representative sample of middle-aged to older South Koreans. Data collected from 3,408 men and 3,361 women aged >= 40 years were obtained from the 2010 and 2011 Korea National Health and Nutrition Examination Survey. Based on the World Health Organization guidelines, the participants were categorized into zones I (0-7), II (8-15), III (16-19), or IV (20-40) according to their Alcohol Use Disorders Identification Test (AUDIT) scores, with a higher zone indicating a higher level of alcohol consumption. Data collected from the AUDIT and EuroQol 5-Dimension (EQ-5D) test were subjected to multiple regression analysis in order to examine the relationship between alcohol consumption patterns and health-related quality of life, and to identify intersex and interzone differences. Significant intersex differences were found for the mean total AUDIT and EQ-5D scores and the proportion of participants rating their pain/discomfort and impairment in mobility and usual activities as "moderate" or "severe" (p < 0.001). The analysis of the EQ-5D scores by alcohol consumption pattern and sex suggested the existence of an inverted U-shaped relationship between the total AUDIT and EQ-5D scores. The HRQOL of moderate alcohol drinkers was higher than that of non-drinkers and heavy drinkers. The results of this study will be valuable in designing appropriate interventions to increase the HRQOL impaired by the harmful use of alcohol, in comparing HRQOL among different countries, and in implementing alcohol-related health projects.	[Kim, KyungHee; Kim, Ji-Su] Chung Ang Univ, Red Cross Coll Nursing, Seoul 156756, South Korea	Chung Ang University	Kim, JS (corresponding author), Chung Ang Univ, Red Cross Coll Nursing, Seoul 156756, South Korea.	jisu-1980@hanmail.net						Brooks R., 2003, MEASUREMENT VALUATIO; Choi JY, 2013, MENOPAUSE, V20, P85, DOI 10.1097/gme.0b013e31825d26b6; Coulson CE, 2013, AGING CLIN EXP RES, V25, P183, DOI 10.1007/s40520-013-0026-9; Dawson DA, 2008, DRUG ALCOHOL DEPEN, V95, P62, DOI 10.1016/j.drugalcdep.2007.12.007; Foster JH, 2002, ADDICT BIOL, V7, P55, DOI 10.1080/135562101200100616; Ginieri-Coccossis M, 2007, IN VIVO, V21, P99; Gunther O, 2007, DRUG ALCOHOL DEPEN, V86, P253, DOI 10.1016/j.drugalcdep.2006.07.001; Harper A, 1998, PSYCHOL MED, V28, P551, DOI 10.1017/S0033291798006667; Higgins-Biddle J., 2010, ALCOHOL USE DISORDER; Jeon GS., 2010, J KOREAN ACAD PUBLIC, V24, P182; Kalafateli M, 2013, ANN GASTROENTOL, V26, P1; KCDC, 2012, KOR HLTH STAT 2011 K; Kim J, 2013, SPACE, P18; Korea Centers for Disease Control and Prevention (KCDC), 2011, KOR HLTH STAT 2011 K; Lee H, 2012, J KOREAN ALCOHOL SCI, V13, P109; Lima AFBD, 2005, QUAL LIFE RES, V14, P473; Mathiesen EF, 2012, QUAL LIFE RES, V21, P1527, DOI 10.1007/s11136-011-0080-8; Ministry of Health & Welfare The Korea Institute for Health and Social Affairs, 2013, OECD HLTH DAT 2013; Nam HS., 2007, EQ 5D KOREAN VALUATI; Park JH., 2012, KOREAN J SOCIAL WELF, V33, P1; Paul LA, 2011, ADDICT BEHAV, V36, P1240, DOI 10.1016/j.addbeh.2011.07.034; Polen MR, 2010, ADDICT RES THEORY, V18, P122, DOI 10.3109/16066350903398486; Rabin R, 2001, ANN MED, V33, P337, DOI 10.3109/07853890109002087; Saarni SI, 2008, ALCOHOL ALCOHOLISM, V43, P376, DOI 10.1093/alcalc/agn003; Senbanjo R, 2007, ADDICTION, V102, P257, DOI 10.1111/j.1360-0443.2006.01683.x; So K, 2013, KOREAN J FAM MED, V34, P11, DOI 10.4082/kjfm.2013.34.1.11; Stranges S, 2006, ADDICTION, V101, P1265, DOI 10.1111/j.1360-0443.2006.01517.x; Sun S, 2011, QUAL LIFE RES, V20, P309, DOI 10.1007/s11136-010-9762-x; Tsiligianni I, 2011, PRIM CARE RESP J, V20, P257, DOI 10.4104/pcrj.2011.00029; Valencia-Martin JL, 2013, PREV MED, V57, P703, DOI 10.1016/j.ypmed.2013.09.007; Van Dijk AP, 2004, J STUD ALCOHOL, V65, P241, DOI 10.15288/jsa.2004.65.241; WHO, 2014, GLOBAL STATUS REPORT ON VIOLENCE PREVENTION 2014, P1; World Health Organization, 2011, GLOB STAT REP ALC HL	33	23	24	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2015	10	3							e0119245	10.1371/journal.pone.0119245	http://dx.doi.org/10.1371/journal.pone.0119245			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CE9BN	25786249	Green Published, Green Submitted, gold			2022-12-27	WOS:000352138500088
J	Ma, PS; Foote, DC; Sinnamon, AJ; Brass, LF				Ma, Peisong; Foote, Darci C.; Sinnamon, Andrew J.; Brass, Lawrence F.			Dissociation of SHP-1 from Spinophilin during Platelet Activation Exposes an Inhibitory Binding Site for Protein Phosphatase-1 (PP1)	PLOS ONE			English	Article							OKADAIC ACID; COUPLED-RECEPTORS; PHOSPHORYLATION; AGGREGATION; SPECIFICITY; ISOFORMS; SUBUNIT; GAMMA-1; COMPLEX; CELLS	We have recently shown that a critical regulatory node in the platelet signaling network lies immediately downstream of platelet receptors for thrombin and TxA2. This node is comprised of a scaffold protein (spinophilin, SPL), a protein tyrosine phosphatase (SHP-1), and either of the two members of the Regulators of G protein Signaling family predominantly expressed in platelets (RGS10 or RGS18). The SPL/RGS/SHP-1 complex is present in resting platelets, dissociating when thrombin or TxA2, but not ADP or collagen, activate SHP-1 and release RGS10 and RGS18 to dampen signaling. Here we demonstrate an additional regulatory role for spinophilin, showing that dissociation of SHP-1 from spinophilin is followed by an increase in the binding of spinophilin to PP1, a serine/threonine phosphatase whose binding site maps to a region close to the SHP-1 binding site. The increase in PP1 binding to spinophilin is limited to platelet agonists that cause dissociation of the complex and is selective for the a and. isoforms of PP1. Studies in cell culture show that SHP-1 and PP1 can compete for binding to spinophilin and that binding inhibits PP1 activity since over-expression of wild type spinophilin, but not spinophilin with a disabled PP1 binding site, causes an increase in the phosphorylation of myosin light chain, a well-characterized PP1 substrate. Collectively, these results indicate that in addition to regulating RGS protein availability in resting platelets, spinophilin can serve as a time-dependent, agonist-and isoform-selective regulator of PP1, inhibiting its activity when decay of the SPL/RGS/SHP-1 complex releases SHP-1 from spinophilin, exposing a binding site for PP1.	[Ma, Peisong; Foote, Darci C.; Sinnamon, Andrew J.; Brass, Lawrence F.] Univ Penn, Dept Med & Pharmacol, Philadelphia, PA 19104 USA	University of Pennsylvania	Ma, PS (corresponding author), Univ Penn, Dept Med & Pharmacol, Philadelphia, PA 19104 USA.	peisong@mail.med.upenn.edu; brass@mail.med.upenn.edu	Ma, Peisong/AAM-7211-2020	Ma, Peisong/0000-0002-5486-8695	National Institute of Health (NIH) [R01-HL93123]; American heart Association (AHA) [14SDG20380473]; American Society of Hematology; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL093123] Funding Source: NIH RePORTER	National Institute of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American heart Association (AHA)(American Heart Association); American Society of Hematology; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	These studies were supported by National Institute of Health (NIH) R01-HL93123 (L.F.B.) and American heart Association (AHA) 14SDG20380473 (P.M.). A.S. and D.F. were supported by American Society of Hematology trainee research awards. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramow-Newerly M, 2006, CELL SIGNAL, V18, P579, DOI 10.1016/j.cellsig.2005.08.010; Aburima A, 2013, BLOOD, V122, P3533, DOI 10.1182/blood-2013-03-487850; Allen PB, 1997, P NATL ACAD SCI USA, V94, P9956, DOI 10.1073/pnas.94.18.9956; Andreassen PR, 1998, J CELL BIOL, V141, P1207, DOI 10.1083/jcb.141.5.1207; Brass LF, 2012, BLOOD, V119, P3651, DOI 10.1182/blood-2012-02-406629; Brass LF, 2013, PLATELETS, P367, DOI DOI 10.3109/09537104.2013.821602; Burkhart JM, 2012, BLOOD, V120, pE73, DOI 10.1182/blood-2012-04-416594; Carmody LC, 2008, FASEB J, V22, P1660, DOI 10.1096/fj.07-092841; Delesque-Touchard N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113215; Ferrer I, 2011, CELL CYCLE, V10, P2751, DOI 10.4161/cc.10.16.16422; Gegenbauer K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080251; Gegenbauer K, 2012, BLOOD, V119, P3799, DOI 10.1182/blood-2011-11-390369; Getz TM, 2010, J THROMB HAEMOST, V8, P2283, DOI 10.1111/j.1538-7836.2010.04000.x; Gushiken FC, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008304; HIGASHIHARA M, 1992, FEBS LETT, V307, P206, DOI 10.1016/0014-5793(92)80768-C; HOYT CH, 1995, BIOCHEMISTRY-US, V34, P9565, DOI 10.1021/bi00029a033; Hsieh-Wilson LC, 1999, BIOCHEMISTRY-US, V38, P4365, DOI 10.1021/bi982900m; Johnson GJ, 2007, J THROMB HAEMOST, V5, P1516, DOI 10.1111/j.1538-7836.2007.02611.x; Korrodi-Gregorio L, 2014, TRANSL RES, V164, P366, DOI 10.1016/j.trsl.2014.07.001; Lambert NA, 2010, P NATL ACAD SCI USA, V107, P7066, DOI 10.1073/pnas.0912934107; Leon C, 2007, BLOOD, V110, P3183, DOI 10.1182/blood-2007-03-080184; LEREA KM, 1991, BIOCHEMISTRY-US, V30, P6819, DOI 10.1021/bi00242a003; Ma PS, 2012, BLOOD, V119, P1935, DOI 10.1182/blood-2011-10-387910; NISHIKAWA M, 1994, CELL SIGNAL, V6, P59, DOI 10.1016/0898-6568(94)90061-2; Peti W, 2013, FEBS J, V280, P596, DOI 10.1111/j.1742-4658.2012.08509.x; Ragusa MJ, 2010, NAT STRUCT MOL BIOL, V17, P459, DOI 10.1038/nsmb.1786; Rowley JW, 2011, BLOOD, V118, pE101, DOI 10.1182/blood-2011-03-339705; Sarrouilhe D, 2006, BIOCHIMIE, V88, P1099, DOI 10.1016/j.biochi.2006.04.010; Signarvic RS, 2010, BLOOD, V116, P6092, DOI 10.1182/blood-2010-05-283846; Stalker TJ, 2013, BLOOD, V121, P1875, DOI 10.1182/blood-2012-09-457739; Vijayan KV, 2004, J BIOL CHEM, V279, P33039, DOI 10.1074/jbc.C400239200; Wang XH, 2005, NAT CELL BIOL, V7, P405, DOI 10.1038/ncb1237; Wang X, 2007, EMBO J, V26, P2768, DOI 10.1038/sj.emboj.7601701; Zeiler M, 2014, MOL CELL PROTEOMICS, V13, P3435, DOI 10.1074/mcp.M114.038513; Zhang J, 1996, BIOCHEMISTRY-US, V35, P6276, DOI 10.1021/bi952954l; Zsuzsa S, 2010, PLATELETS, V21, P555, DOI 10.3109/09537104.2010.499156	36	16	16	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2015	10	3							e0119496	10.1371/journal.pone.0119496	http://dx.doi.org/10.1371/journal.pone.0119496			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9BN	25785436	Green Published, gold, Green Submitted			2022-12-27	WOS:000352138500106
J	Qiu, FF; Sun, R; Deng, N; Guo, TY; Cao, YG; Yu, Y; Wang, XJ; Zou, BC; Zhang, SM; Jing, T; Ling, T; Xie, J; Zhang, Q				Qiu, Feifei; Sun, Rui; Deng, Ning; Guo, Tianyu; Cao, Yange; Yu, Ying; Wang, Xuejun; Zou, Bingcheng; Zhang, Songmei; Jing, Tao; Ling, Tao; Xie, Jun; Zhang, Qing			miR-29a/b Enhances Cell Migration and Invasion in Nasopharyngeal Carcinoma Progression by Regulating SPARC and COL3A1 Gene Expression	PLOS ONE			English	Article							EXTRACELLULAR-MATRIX; MICRORNA EXPRESSION; GROWTH-FACTOR; PROTEIN; CANCER; PROLIFERATION; SIGNATURE; REVEALS; BINDING; OSTEONECTIN	Nasopharyngeal carcinoma (NPC) is a malignant tumor associated with a genetic predisposition, Epstein-Barr virus infection and chromosomal abnormalities. Recently, several miRNAs have been shown to target specific mRNAs to regulate NPC development and progression. However, the involvement of miRNAs in processes leading to NPC migration and invasion remains to be elucidated. We predicted that miR-29a/b are associated with dysregulated genes controlling NPC through an integrated interaction network of miRNAs and genes. miR-29a/b over-expression in NPC cell lines had no significant effect on proliferation, whereas miR-29b mildly increased the percentage of cells in the G1 phase with a concomitant decrease in the percentage of cells in S phase. Furthermore, we demonstrated that miR-29a/b might be responsible for increasing S18 cell migration and invasion, and only COL3A1 was identified as a direct target of miR-29b despite the fact that both SPARC and COL3A1 were inhibited by miR-29a/b over-expression. Meanwhile, SPARC proteins were increased in metastatic NPC tissue and are involved in NPC progression. Unexpectedly, we identified that miRNA-29b expression was elevated in the serum of NPC patients with a high risk of metastasis. The 5-year actuarial overall survival rates in NPC patients with high serum miR-29b expression was significantly shorter than those with low serum miR-29b expression; therefore, serum miR-29b expression could be a promising prognostic marker.	[Qiu, Feifei; Guo, Tianyu; Cao, Yange; Yu, Ying; Wang, Xuejun; Zou, Bingcheng; Zhang, Songmei; Jing, Tao; Ling, Tao; Zhang, Qing] Sun Yat Sen Univ, Sch Life Sci, State Key Lab Biocontrol, Guangzhou 510275, Guangdong, Peoples R China; [Sun, Rui] Sun Yat Sen Univ, Ctr Canc, State Key Lab Oncol Southern China, Collaborat Innovat Ctr Canc Med, Guangzhou 510275, Guangdong, Peoples R China; [Deng, Ning] Jinan Univ, Antibody Engn Ctr, Key Lab Mol Immunol & Antibody Engn Guangdong Pro, Guangzhou, Guangdong, Peoples R China; [Xie, Jun] CAFS, Key Lab Trop & Subtrop Fishery Resource Applicat, Minist Agr, Pearl River Fisheries Res Inst, Guangzhou, Guangdong, Peoples R China	Sun Yat Sen University; State Key Lab Oncology South China; Sun Yat Sen University; Jinan University; Chinese Academy of Fishery Sciences; Pearl River Fisheries Research Institute, CAFS; Ministry of Agriculture & Rural Affairs	Xie, J (corresponding author), CAFS, Key Lab Trop & Subtrop Fishery Resource Applicat, Minist Agr, Pearl River Fisheries Res Inst, Guangzhou, Guangdong, Peoples R China.	xiejunhy@yahoo.com.cn; lsszq@mail.sysu.edu.cn	guo, tianyu/AAO-3591-2021	ZHANG, QING/0000-0003-3522-1471	National Natural Science Foundation of China [30770923, 31371163, J1310025]; Sci-Tech Project Foundation of Guangdong Province [2011B090400561, 2013B021800065]; Fundamental Research Funds for the Shenzhen of China [GJHZ201404221516216]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Sci-Tech Project Foundation of Guangdong Province; Fundamental Research Funds for the Shenzhen of China	This work was supported by National Natural Science Foundation of China Grant (30770923, 31371163 and J1310025), Sci-Tech Project Foundation of Guangdong Province (2011B090400561 and 2013B021800065) and Fundamental Research Funds for the Shenzhen of China (GJHZ201404221516216). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambros V, 2003, CELL, V113, P673, DOI 10.1016/S0092-8674(03)00428-8; Amodio N, 2012, ONCOTARGET, V3, P1246; Brekken RA, 2000, MATRIX BIOL, V19, P569, DOI 10.1016/S0945-053X(00)00105-0; Chen HC, 2009, BRIT J CANCER, V100, P1002, DOI 10.1038/sj.bjc.6604948; Cortez MA, 2010, GENE CHROMOSOME CANC, V49, P981, DOI 10.1002/gcc.20808; Cushing L, 2011, AM J RESP CELL MOL, V45, P287, DOI 10.1165/rcmb.2010-0323OC; Dalgleish R, 1998, NUCLEIC ACIDS RES, V26, P253, DOI 10.1093/nar/26.1.253; Fabbri M, 2007, P NATL ACAD SCI USA, V104, P15805, DOI 10.1073/pnas.0707628104; Fang JH, 2011, HEPATOLOGY, V54, P1729, DOI 10.1002/hep.24577; Framson PE, 2004, J CELL BIOCHEM, V92, P679, DOI 10.1002/jcb.20091; Francki A, 1999, J BIOL CHEM, V274, P32145, DOI 10.1074/jbc.274.45.32145; FUNK SE, 1991, P NATL ACAD SCI USA, V88, P2648, DOI 10.1073/pnas.88.7.2648; Garzon R, 2009, ANNU REV MED, V60, P167, DOI 10.1146/annurev.med.59.053006.104707; Gebeshuber CA, 2009, EMBO REP, V10, P400, DOI 10.1038/embor.2009.9; Gerson KD, 2012, J BIOL CHEM, V287, P9835, DOI 10.1074/jbc.M111.317727; Huang DY, 2008, J PATHOL, V214, P445, DOI 10.1002/path.2299; Huang JC, 2007, NAT METHODS, V4, P1045, DOI 10.1038/nmeth1130; Huang QH, 2008, NAT CELL BIOL, V10, P202, DOI 10.1038/ncb1681; Ji JF, 2009, NEW ENGL J MED, V361, P1437, DOI 10.1056/NEJMoa0901282; Kapinas K, 2009, J CELL BIOCHEM, V108, P216, DOI 10.1002/jcb.22243; Khanfira A, 2007, CANCER RADIOTHER, V11, P461, DOI 10.1016/j.canrad.2007.06.006; Kohfeldt E, 1998, J MOL BIOL, V282, P99, DOI 10.1006/jmbi.1998.2004; Kong GY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019518; Kupprion C, 1998, J BIOL CHEM, V273, P29635, DOI 10.1074/jbc.273.45.29635; Li T, 2011, ONCOL REP, V25, P1353, DOI 10.3892/or.2011.1204; [李晓霞 LI Xiaoxia], 2007, [中山大学学报. 医学科学版, Journal of Sun Yat-sen University. Medical Sciences], V28, P607; Li ZY, 2009, J BIOL CHEM, V284, P15676, DOI 10.1074/jbc.M809787200; Lin JC, 2003, J CLIN ONCOL, V21, P631, DOI 10.1200/JCO.2003.06.158; Liu Ning-bo, 2013, Journal of Signal Processing, V29, P1; Liu TL, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000804; Luna C, 2009, MOL VIS, V15, P2488; Luo JH, 2007, EUR J EPIDEMIOL, V22, P513, DOI 10.1007/s10654-007-9148-8; Luo ZH, 2012, BMC MED GENOMICS, V5, DOI 10.1186/1755-8794-5-3; Muniyappa MK, 2009, EUR J CANCER, V45, P3104, DOI 10.1016/j.ejca.2009.09.014; Nilsen TW, 2007, TRENDS GENET, V23, P243, DOI 10.1016/j.tig.2007.02.011; Park SY, 2009, NAT STRUCT MOL BIOL, V16, P23, DOI 10.1038/nsmb.1533; Provenzano PP, 2006, BMC MED, V4, DOI 10.1186/1741-7015-4-38; Qian CN, 2006, CANCER RES, V66, P10365, DOI 10.1158/0008-5472.CAN-06-2977; RAINES EW, 1992, P NATL ACAD SCI USA, V89, P1281, DOI 10.1073/pnas.89.4.1281; Ramaswamy S, 2003, NAT GENET, V33, P49, DOI 10.1038/ng1060; Ryschich E, 2009, PANCREAS, V38, P804, DOI 10.1097/MPA.0b013e3181b9dfda; SAGE H, 1989, J CELL BIOL, V109, P341, DOI 10.1083/jcb.109.1.341; Sengupta S, 2008, P NATL ACAD SCI USA, V105, P5874, DOI 10.1073/pnas.0801130105; Sengupta S, 2006, CANCER RES, V66, P7999, DOI 10.1158/0008-5472.CAN-05-4399; SOININEN R, 1987, FEBS LETT, V225, P188; Steele Robert, 2010, Genes Cancer, V1, P381; Tazawa H, 2007, P NATL ACAD SCI USA, V104, P15472, DOI 10.1073/pnas.0707351104; Ueda T, 2010, LANCET ONCOL, V11, P136, DOI 10.1016/S1470-2045(09)70343-2; van Rooij E, 2008, P NATL ACAD SCI USA, V105, P13027, DOI 10.1073/pnas.0805038105; Villarreal G, 2011, INVEST OPHTH VIS SCI, V52, P3391, DOI 10.1167/iovs.10-6165; Volinia S, 2006, P NATL ACAD SCI USA, V103, P2257, DOI 10.1073/pnas.0510565103; Wang C, 2011, MOL CELL BIOCHEM, V352, P197, DOI 10.1007/s11010-011-0755-z; Wang HY, 2011, J CLIN ONCOL, V29, P4516, DOI 10.1200/JCO.2010.33.7741; Wang L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005878; Wang Y, 2013, EUR J CELL BIOL, V92, P123, DOI 10.1016/j.ejcb.2012.11.004; Wang YP, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-218; Wei HY, 2012, ACTA OPHTHALMOL, V90, pe138, DOI 10.1111/j.1755-3768.2011.02283.x; Wong TS, 2011, J CANCER RES CLIN, V137, P415, DOI 10.1007/s00432-010-0898-4; WU CY, 1995, J CELL SCI, V108, P2511; Wu L, 2008, MOL CELL, V29, P1, DOI 10.1016/j.molcel.2007.12.010; Yu SL, 2008, CANCER CELL, V13, P48, DOI 10.1016/j.ccr.2007.12.008; Zhu SM, 2008, CELL RES, V18, P350, DOI 10.1038/cr.2008.24; Zhu XC, 2012, INT J MOL MED, V30, P1321, DOI 10.3892/ijmm.2012.1140	63	57	61	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2015	10	3							e0120969	10.1371/journal.pone.0120969	http://dx.doi.org/10.1371/journal.pone.0120969			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9BN	25786138	Green Published, gold, Green Submitted			2022-12-27	WOS:000352138500199
J	Song, ZW; Wu, Y; Liu, WQ; Xiao, JH				Song, Zhiwen; wu, Ye; Liu, Weiqing; Xiao, Jinghua			Experimental Study of the Irrational Phase Synchronization of Coupled Nonidentical Mechanical Metronomes	PLOS ONE			English	Article							DESYNCHRONIZATION; OSCILLATORS	It has recently been observed in numerical simulations that the phases of two coupled nonlinear oscillators can become locked into an irrational ratio, exhibiting the phenomenon of irrational phase synchronization (IPS) [Phys. Rev. E 69, 056228 (2004)]. Here, using two coupled nonidentical periodic mechanical metronomes, we revisit this interesting phenomenon through experimental studies. It is demonstrated that under suitable couplings, the phases of the metronomes indeed can become locked into irrational ratios. Numerical simulations confirm the experimental observations and also reveal that in the IPS state, the system dynamics are chaotic. Our studies provide a solid step toward further studies of IPS.	[Song, Zhiwen; wu, Ye; Xiao, Jinghua] Beijing Univ Posts & Telecommun, Sch Sci, Beijing 100876, Peoples R China; [Liu, Weiqing] Jiangxi Univ Sci & Technol, Sch Sci, Ganzhou 341000, Peoples R China	Beijing University of Posts & Telecommunications; Jiangxi University of Science & Technology	Xiao, JH (corresponding author), Beijing Univ Posts & Telecommun, Sch Sci, Beijing 100876, Peoples R China.	jhxiao@bupt.edu.cn	Ye, Wu/AAI-4292-2021; Wu, Ye/S-8530-2016; liu, weiqing/CAI-9917-2022; jinghua, xiao/F-3710-2012; ye, wu/G-6089-2011; Liu, Weiqing/E-4544-2012	Wu, Ye/0000-0001-9038-2900; ye, wu/0000-0001-9038-2900; Liu, Weiqing/0000-0003-2265-0402	National Natural Science Foundation of China [61377067, 11375033, 11262006]; Fundamental Research Funds for the Central Universities [2013XZ02]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This work was supported by the National Natural Science Foundation of China (Grant Nos. 61377067, 11375033, 11262006) and the Fundamental Research Funds for the Central Universities (Grant No. 2013XZ02). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arenas A, 2008, PHYS REP, V469, P93, DOI 10.1016/j.physrep.2008.09.002; Baptista MS, 2004, PHYS REV E, V69, DOI 10.1103/PhysRevE.69.056228; Baptista MS, 2003, PHYS REV E, V67, DOI 10.1103/PhysRevE.67.056212; Boccaletti S, 2002, PHYS REP, V366, P1, DOI 10.1016/S0370-1573(02)00137-0; Czolczynski K, 2011, CHAOS, V21, DOI 10.1063/1.3602225; Czolczynski K, 2009, PROG THEOR PHYS, V122, P1027, DOI 10.1143/PTP.122.1027; Hinrichs N, 1997, CHAOS SOLITON FRACT, V8, P535, DOI 10.1016/S0960-0779(96)00121-X; Hong H, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.054102; Hu Q, 2013, EUR J PHYS, V34, P291, DOI 10.1088/0143-0807/34/2/291; Huang XD, 2011, PHYS REV E, V83, DOI 10.1103/PhysRevE.83.061917; Kapitaniak M, 2012, PHYS REP, V517, P1, DOI 10.1016/j.physrep.2012.03.002; MULLER PC, 1995, CHAOS SOLITON FRACT, V5, P1671, DOI 10.1016/0960-0779(94)00170-U; Neda Z, 2000, NATURE, V403, P849, DOI 10.1038/35002660; Pantaleone J, 2002, AM J PHYS, V70, P992, DOI 10.1119/1.1501118; Perlikowski P, 2012, INT J BIFURCAT CHAOS, V22, DOI 10.1142/S0218127412502884; Rosa E, 2000, INT J BIFURCAT CHAOS, V10, P2551, DOI 10.1142/S0218127400001638; Schafer C, 1999, PHYS REV E, V60, P857, DOI 10.1103/PhysRevE.60.857; Stankovski T, 2014, PHYS REV E, V89, DOI 10.1103/PhysRevE.89.062909; STROGATZ SH, 1993, SCI AM, V269, P102, DOI 10.1038/scientificamerican1293-102; Strogatz Steven H., 1994, Lecture Notes in Biomathematics, V100, P122; Tass PA, 2002, BIOL CYBERN, V87, P102, DOI 10.1007/s00422-002-0322-5; Tass PA, 2001, EUROPHYS LETT, V53, P15, DOI 10.1209/epl/i2001-00117-6; Taylor D, 2010, PHYS REV E, V81, DOI 10.1103/PhysRevE.81.046214; Ulrichs H, 2009, CHAOS, V19, DOI 10.1063/1.3266924; Wu Y, 2012, CHAOS, V22, DOI 10.1063/1.4729456; Zou Y, 2007, PHYS REV E, V76, DOI 10.1103/PhysRevE.76.016210	26	2	2	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2015	10	3							e0118986	10.1371/journal.pone.0118986	http://dx.doi.org/10.1371/journal.pone.0118986			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9BN	25786222	gold, Green Published, Green Submitted			2022-12-27	WOS:000352138500063
J	Paladino, LC; Muntaabski, I; Lanzavecchia, S; Le Bagousse-Pinguet, Y; Viscarret, M; Juri, M; Fueyo-Sanchez, L; Papeschi, A; Cladera, J; Bressa, MJ				Carabajal Paladino, Leonela; Muntaabski, Irina; Lanzavecchia, Silvia; Le Bagousse-Pinguet, Yoann; Viscarret, Mariana; Juri, Marianela; Fueyo-Sanchez, Luciana; Papeschi, Alba; Cladera, Jorge; Jose Bressa, Maria			Complementary Sex Determination in the Parasitic Wasp Diachasmimorpha longicaudata	PLOS ONE			English	Article							DIPLOID MALES; HEBETOR HYMENOPTERA; COTESIA-GLOMERATA; MATING SYSTEM; BRACONIDAE; HABROBRACON; POPULATION; EVOLUTION; FEMALES; TEPHRITIDAE	We studied the sex determination in Diachasmimorpha longicaudata, a parasitoid braconid wasp widely used as biological control agent of fruit pest tephritid flies. We tested the complementary sex determination hypothesis (CSD) known in at least 60 species of Hymenoptera. According to CSD, male or female development depends on the allelic composition of one sex locus (single-locus CSD) or multiple sex loci (multiple-locus CSD). Hemizygote individuals are normal haploid males, and heterozygotes for at least one sex locus are normal diploid females, but homozygotes for all the sex loci are diploid males. In order to force the occurrence of diploid males in D. longicaudata, we established highly inbred lines and examined their offspring using chromosome counting, flow cytometry, and sex ratio analysis. We found that when mother-son crosses were studied, this wasp produced about 20% of diploid males out of the total male progeny. Our results suggest that this parasitoid may represent the second genus with multiple-locus CSD in Hymenoptera. Knowledge about the sex determination system in D. longicaudata is relevant for the improvement of mass rearing protocols of this species. This information also provides the necessary background for further investigations on the underlying molecular mechanisms of sex determination in this species, and a better insight into the evolution of this pathway in Hymenoptera in particular and insects in general.	[Carabajal Paladino, Leonela] Czech Acad Sci, Ctr Biol, Inst Entomol, Ceske Budejovice, Czech Republic; [Carabajal Paladino, Leonela; Muntaabski, Irina; Lanzavecchia, Silvia; Juri, Marianela; Cladera, Jorge] Inst Nacl Tecnol Agr, Inst Genet Ewald A Favret, Hurlingham, Argentina; [Le Bagousse-Pinguet, Yoann] Univ South Bohemia, Dept Bot, Ceske Budejovice, Czech Republic; [Viscarret, Mariana] Inst Nacl Tecnol Agr, Inst Microbiol & Zool Agr, Hurlingham, Argentina; [Juri, Marianela; Papeschi, Alba; Jose Bressa, Maria] Consejo Nacl Invest Cient & Tecn, RA-1033 Buenos Aires, DF, Argentina; [Fueyo-Sanchez, Luciana] Univ Nacl Lujan, Inst Ecol & Desarrollo Sustentable, Lujan, Argentina; [Papeschi, Alba; Jose Bressa, Maria] Univ Buenos Aires, Fac Ciencias Exactas & Nat, Dept Ecol Genet Evoluc, RA-1053 Buenos Aires, DF, Argentina; [Jose Bressa, Maria] Univ Buenos Aires, Fac Ciencias Exactas & Nat, Inst Ecol Genet Evoluc Buenos Aires, RA-1053 Buenos Aires, DF, Argentina	Czech Academy of Sciences; Biology Centre of the Czech Academy of Sciences; Instituto Nacional de Tecnologia Agropecuaria (INTA); University of South Bohemia Ceske Budejovice; Instituto Nacional de Tecnologia Agropecuaria (INTA); Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Universidad Nacional de Lujan; University of Buenos Aires; University of Buenos Aires	Paladino, LC (corresponding author), Czech Acad Sci, Ctr Biol, Inst Entomol, Ceske Budejovice, Czech Republic.	carabajal@entu.cas.cz	Carabajal Paladino, Leonela Z/I-1361-2014; Carabajal Paladino, Leonela Zusel/AAD-9546-2022; Le Bagousse-Pinguet, Yoann/I-2413-2016	Carabajal Paladino, Leonela Z/0000-0001-9312-0260; Carabajal Paladino, Leonela Zusel/0000-0001-9312-0260; Le Bagousse-Pinguet, Yoann/0000-0002-5615-5541; Lanzavecchia, Silvia/0000-0001-5965-4082; Muntaabski, Irina/0000-0002-0631-791X	University of Buenos Aires [UBACyTX164]; CONICET [PIP 0281]; ANPCyT [PICT 2007-00635, PICT 2008-0502]; European Social Fund; Czech State Budget [Postdok_BIOGLOBE CZ.1.07/2.3.00/30.0032]	University of Buenos Aires(University of Buenos Aires); CONICET(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); ANPCyT(ANPCyT); European Social Fund(European Social Fund (ESF)); Czech State Budget	The work was supported by University of Buenos Aires (UBACyT X164); CONICET (PIP 0281); ANPCyT (PICT 2007-00635 and PICT 2008-0502); and European Social Fund and Czech State Budget (Postdok_BIOGLOBE CZ.1.07/2.3.00/30.0032). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANTOLIN MF, 1992, ECOL ENTOMOL, V17, P1, DOI 10.1111/j.1365-2311.1992.tb01032.x; Asplen MK, 2009, J EVOLUTION BIOL, V22, P1762, DOI 10.1111/j.1420-9101.2009.01774.x; Beukeboom LW, 2007, SEMIN CELL DEV BIOL, V18, P371, DOI 10.1016/j.semcdb.2006.12.015; BEUKEBOOM LW, 1995, BIOESSAYS, V17, P813, DOI 10.1002/bies.950170911; Beukeboom LW, 2000, HEREDITY, V84, P29, DOI 10.1046/j.1365-2540.2000.00628.x; Beye M, 1999, GENETICS, V153, P1701; Bostian CH, 1934, GENETICS, V180, P280; Bressa MJ, 2009, CYTOGENET GENOME RES, V125, P292, DOI 10.1159/000235936; Bretman A, 2009, MOL ECOL, V18, P3340, DOI 10.1111/j.1365-294X.2009.04301.x; Cancino JL, 1998, PROCEDIMIENTOS FUNDA; Carabajal Paladino L, 2013, EUR J ENTOMOL, V110, P401, DOI 10.14411/eje.2013.054; Paladino LZC, 2010, J INSECT SCI, V10, DOI 10.1673/031.010.5601; Carabajal Paladino LZ, 2011, 40 C ARG GEN 3 SIMP; Charlesworth B, 2009, COLD SH Q B, V74, P177, DOI 10.1101/sqb.2009.74.015; CLARK AM, 1963, AM NAT, V97, P203, DOI 10.1086/282271; COOK JM, 1993, HEREDITY, V71, P421, DOI 10.1038/hdy.1993.157; COOK JM, 1995, TRENDS ECOL EVOL, V10, P281, DOI 10.1016/0169-5347(95)90011-X; Cowan DP, 2004, P NATL ACAD SCI USA, V101, P10374, DOI 10.1073/pnas.0402481101; CROZIER RH, 1977, ANNU REV ENTOMOL, V22, P263, DOI 10.1146/annurev.en.22.010177.001403; CROZIER RH, 1971, AM NAT, V105, P399, DOI 10.1086/282733; DACUNHA AB, 1957, FORMA FUNCTIO, V1, P33; de Boer JG, 2007, HEREDITY, V99, P288, DOI 10.1038/sj.hdy.6800995; de Boer JG, 2008, GENETICS, V180, P1525, DOI 10.1534/genetics.107.083907; de Boer JG, 2012, EVOL APPL, V5, P444, DOI 10.1111/j.1752-4571.2012.00270.x; Dobson SL, 1998, HEREDITY, V81, P261, DOI 10.1046/j.1365-2540.1998.00372.x; Dowton M, 2002, J MOL EVOL, V54, P210, DOI 10.1007/s00239-001-0003-3; Elias J, 2010, MOL ECOL, V19, P2336, DOI 10.1111/j.1365-294X.2010.04645.x; Elias J, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-366; Elias J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006024; Gokhman V. E., 2009, KARYOTYPES PARASITIC; Gu HN, 2003, ANIM BEHAV, V66, P259, DOI 10.1006/anbe.2003.2185; Harpur BA, 2013, ENTOMOL EXP APPL, V146, P156, DOI 10.1111/j.1570-7458.2012.01306.x; Heimpel GE, 2008, ANNU REV ENTOMOL, V53, P209, DOI 10.1146/annurev.ento.53.103106.093441; Hein S, 2009, ECOL MODEL, V220, P1663, DOI 10.1016/j.ecolmodel.2009.04.001; Holloway AK, 1999, ANN ENTOMOL SOC AM, V92, P110, DOI 10.1093/aesa/92.1.110; JMicroVision, 2012, IM AN TOOLB MEAS QUA; Kitthawee Sangvorn, 1999, Cytologia (Tokyo), V64, P111, DOI 10.1508/cytologia.64.111; Leather SR., 1995, INSECT REPROD; LI Y, 1992, J HERED, V83, P448, DOI 10.1093/oxfordjournals.jhered.a111250; Liebert AE, 2004, INSECT SOC, V51, P205, DOI 10.1007/s00040-004-0754-0; Ma WJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060459; Montoya P, 2000, ANN ENTOMOL SOC AM, V93, P47, DOI 10.1603/0013-8746(2000)093[0047:FRASBD]2.0.CO;2; Niyibigira EI, 2004, APPL ENTOMOL ZOOL, V39, P705, DOI 10.1303/aez.2004.705; ODE PJ, 1995, ANIM BEHAV, V49, P1239, DOI 10.1006/anbe.1995.0156; Otto F, 1990, Methods Cell Biol, V33, P105; Paxton RJ, 2000, BIOL J LINN SOC, V69, P483, DOI 10.1111/j.1095-8312.2000.tb01220.x; R Core Team, 2012, R LANG ENV STAT COMP; Rueppell O, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047220; Ruf D, 2013, BIOL J LINN SOC, V108, P79, DOI 10.1111/j.1095-8312.2012.01976.x; Salin C, 2004, BELG J ZOOL, V134, P15; Sanchez L, 2008, INT J DEV BIOL, V52, P837, DOI 10.1387/ijdb.072396ls; Simmons LW, 2005, ANNU REV ECOL EVOL S, V36, P125, DOI 10.1146/annurev.ecolsys.36.102403.112501; Sirvio A, 2011, BMC GENET, V12, DOI 10.1186/1471-2156-12-95; Sivinski JM, 1996, FRUIT FLY PESTS, P369; Snell GD, 1935, P NATL ACAD SCI USA, V21, P446, DOI 10.1073/pnas.21.7.446; Speicher BR, 1940, AM NAT, V74, P379, DOI 10.1086/280904; STOUTHAMER R, 1992, ENVIRON ENTOMOL, V21, P427, DOI 10.1093/ee/21.3.427; TERAN H R, 1977, Revista Agronomica del Noroeste Argentino, V14, P17; TRAUT W, 1976, CHROMOSOMA, V58, P275, DOI 10.1007/BF00292094; Tregenza T, 2002, NATURE, V415, P71, DOI 10.1038/415071a; Tregenza T, 2000, MOL ECOL, V9, P1013, DOI 10.1046/j.1365-294x.2000.00964.x; van Wilgenburg Ellen, 2006, Frontiers in Zoology, V3, P1, DOI 10.1186/1742-9994-3-1; Viscarret MM, 2006, BIOL CONTROL, V36, P147, DOI 10.1016/j.biocontrol.2005.08.009; Whitehorn PR, 2009, APIDOLOGIE, V40, P627, DOI 10.1051/apido/2009050; Whiting PW, 1925, SCIENCE, V62, P437, DOI 10.1126/science.62.1611.437; Whiting PW, 1943, GENETICS, V28, P365; Wu Z, 2005, HEREDITY, V95, P228, DOI 10.1038/sj.hdy.6800720; Zayed A, 2005, P NATL ACAD SCI USA, V102, P10742, DOI 10.1073/pnas.0502271102; Zayed A, 2004, HEREDITY, V93, P627, DOI 10.1038/sj.hdy.6800588; Zeh JA, 1997, P ROY SOC B-BIOL SCI, V264, P69, DOI 10.1098/rspb.1997.0010	70	11	11	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2015	10	3							e0119619	10.1371/journal.pone.0119619	http://dx.doi.org/10.1371/journal.pone.0119619			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD9NQ	25789748	Green Published, gold, Green Submitted			2022-12-27	WOS:000351425400092
J	Ha, NT; Gross, JJ; van Dorland, A; Tetens, J; Thaller, G; Schlather, M; Bruckmaier, R; Simianer, H				Ha, Ngoc-Thuy; Gross, Josef Johann; van Dorland, Annette; Tetens, Jens; Thaller, Georg; Schlather, Martin; Bruckmaier, Rupert; Simianer, Henner			Gene-Based Mapping and Pathway Analysis of Metabolic Traits in Dairy Cows	PLOS ONE			English	Article							NEGATIVE-ENERGY BALANCE; EARLY LACTATION; ASSOCIATION ANALYSIS; HEPATIC REGULATION; LIPID-METABOLISM; MILK-PRODUCTION; TRANSITION; LIVER; EXPRESSION; PERFORMANCE	The metabolic adaptation of dairy cows during the transition period has been studied intensively in the last decades. However, until now, only few studies have paid attention to the genetic aspects of this process. Here, we present the results of a gene-based mapping and pathway analysis with the measurements of three key metabolites, (1) non-esterified fatty acids (NEFA), (2) beta-hydroxybutyrate (BHBA) and (3) glucose, characterizing the metabolic adaptability of dairy cows before and after calving. In contrast to the conventional single-marker approach, we identify 99 significant and biologically sensible genes associated with at least one of the considered phenotypes and thus giving evidence for a genetic basis of the metabolic adaptability. Moreover, our results strongly suggest three pathways involved in the metabolism of steroids and lipids are potential candidates for the adaptive regulation of dairy cows in their early lactation. From our perspective, a closer investigation of our findings will lead to a step forward in understanding the variability in the metabolic adaptability of dairy cows in their early lactation.	[Ha, Ngoc-Thuy; Gross, Josef Johann; van Dorland, Annette; Bruckmaier, Rupert] Univ Bern, Vetsuisse Fac, Vet Physiol, Bern, Switzerland; [Ha, Ngoc-Thuy; Simianer, Henner] Univ Gottingen, Dept Anim Sci, Anim Breeding & Genet Grp, D-37073 Gottingen, Germany; [Tetens, Jens; Thaller, Georg] Univ Kiel, Inst Anim Breeding & Husb, Kiel, Germany; [Schlather, Martin] Univ Mannheim, Chair Math Stat, D-68131 Mannheim, Germany	University of Bern; University of Gottingen; University of Kiel; University of Mannheim	Ha, NT (corresponding author), Univ Bern, Vetsuisse Fac, Vet Physiol, Bern, Switzerland.	ngoc-thuy.ha@vetsuisse.unibe.ch	Gross, Josef J./C-3833-2016; Simianer, Henner/A-6574-2015	Gross, Josef J./0000-0002-2578-6076; Simianer, Henner/0000-0002-7551-3797; Tetens, Jens/0000-0001-5352-464X	Swiss Commission for Technology and Innovation CTI [13948.2 PFLS-LS]	Swiss Commission for Technology and Innovation CTI	NH and JJG were supported by Swiss Commission for Technology and Innovation CTI (grant number: 13948.2 PFLS-LS, website: http://www.kti.admin.ch). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackermann M, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-47; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bobe G, 2004, J DAIRY SCI, V87, P3105, DOI 10.3168/jds.S0022-0302(04)73446-3; Browning BL, 2009, AM J HUM GENET, V84, P210, DOI 10.1016/j.ajhg.2009.01.005; Contreras GA, 2011, COMP IMMUNOL MICROB, V34, P281, DOI 10.1016/j.cimid.2011.01.004; Drackley JK, 1999, J DAIRY SCI, V82, P2259, DOI 10.3168/jds.S0022-0302(99)75474-3; Flicek P, 2013, NUCLEIC ACIDS RES, V41, pD48, DOI 10.1093/nar/gks1236; Freytag S, 2014, STAT MED, V33, P1828, DOI 10.1002/sim.6063; Graber M, 2012, J ANIM PHYSIOL AN N, V96, P75, DOI 10.1111/j.1439-0396.2010.01124.x; Graber M, 2010, J DAIRY SCI, V93, P5200, DOI 10.3168/jds.2010-3265; Gross J, 2011, J DAIRY SCI, V94, P3484, DOI 10.3168/jds.2011-4251; Gross J, 2011, J DAIRY SCI, V94, P1820, DOI 10.3168/jds.2010-3707; Gross JJ, 2013, J DAIRY SCI, V96, P5008, DOI 10.3168/jds.2012-6245; Huang HL, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002177; Hung JH, 2012, BRIEF BIOINFORM, V13, P281, DOI 10.1093/bib/bbr049; Jiang L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013661; Kanehisa M, 2012, NUCLEIC ACIDS RES, V40, pD109, DOI 10.1093/nar/gkr988; Kang GL, 2013, CURR GENOMICS, V14, P250, DOI 10.2174/13892029113149990001; Kessel S, 2008, J ANIM SCI, V86, P2903, DOI 10.2527/jas.2008-1016; Kessler EC, 2014, J DAIRY SCI, V97, P5481, DOI 10.3168/jds.2014-7926; Klein MS, 2012, J PROTEOME RES, V11, P1373, DOI 10.1021/pr201017n; Kusuhara K, 2007, INT J IMMUNOGENET, V34, P35, DOI 10.1111/j.1744-313X.2007.00653.x; LeBlanc SJ, 2004, J DAIRY SCI, V87, P609, DOI 10.3168/jds.S0022-0302(04)73203-8; Li MX, 2011, AM J HUM GENET, V88, P283, DOI 10.1016/j.ajhg.2011.01.019; Li MY, 2009, BIOINFORMATICS, V25, P497, DOI 10.1093/bioinformatics/btn641; Liu JZ, 2010, AM J HUM GENET, V87, P139, DOI 10.1016/j.ajhg.2010.06.009; Mai MD, 2010, J ANIM SCI, V88, P3522, DOI 10.2527/jas.2009-2713; MARKS PA, 1960, P NATL ACAD SCI USA, V46, P447, DOI 10.1073/pnas.46.4.447; Neale BM, 2004, AM J HUM GENET, V75, P353, DOI 10.1086/423901; Pan W, 2009, GENET EPIDEMIOL, V33, P497, DOI 10.1002/gepi.20402; Patterson N, 2006, PLOS GENET, V2, P2074, DOI 10.1371/journal.pgen.0020190; Peng G, 2010, EUR J HUM GENET, V18, P111, DOI 10.1038/ejhg.2009.115; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Tetens J, 2013, ANIM GENET, V44, P1, DOI 10.1111/j.1365-2052.2012.02357.x; van Dorland HA, 2009, J DAIRY SCI, V92, P1924, DOI 10.3168/jds.2008-1454; Vanhatalo A, 1999, J DAIRY SCI, V82, P2674, DOI 10.3168/jds.S0022-0302(99)75524-4; Weber C, 2013, J DAIRY SCI, V96, P5670, DOI 10.3168/jds.2012-6277; Wellnitz O, 1999, MILK SCI INT, P54; Zarrin M, 2013, J DAIRY SCI, V96, P2960, DOI 10.3168/jds.2012-6224; Zhang JT, 2005, J AM STAT ASSOC, V100, P273, DOI 10.1198/016214504000000575	40	19	20	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2015	10	3							e0122325	10.1371/journal.pone.0122325	http://dx.doi.org/10.1371/journal.pone.0122325			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD9NQ	25789767	Green Published, Green Submitted, gold			2022-12-27	WOS:000351425400212
J	Liu, HP; Cheng, Y; Du, B; Tong, CF; Liang, SL; Han, SY; Zheng, SP; Lin, Y				Liu, Huiping; Cheng, Yu; Du, Bing; Tong, Chaofan; Liang, Shuli; Han, Shuangyan; Zheng, Suiping; Lin, Ying			Overexpression of a Novel Thermostable and Chloride-Tolerant Laccase from Thermus thermophilus SG0.5JP17-16 in Pichia pastoris and Its Application in Synthetic Dye Decolorization	PLOS ONE			English	Article							BIOCHEMICAL-CHARACTERIZATION; BACILLUS-LICHENIFORMIS; MULTICOPPER OXIDASE; PURIFICATION; EXPRESSION; BIODEGRADATION; HYDROCARBONS; EVOLUTION; BACTERIAL; CLONING	Laccases have been used for the decolorization and detoxification of synthetic dyes due to their ability to oxidize a wide variety of dyes with water as the sole byproduct. A putative laccase gene (LacTT) from Thermus thermophilus SG0.5JP17-16 was screened using the genome mining approach, and it was highly expressed in Pichia pastoris, yielding a high laccase activity of 6130 U/L in a 10-L fermentor. The LacTT open reading frame encoded a protein of 466 amino acid residues with four putative Cu-binding regions. The optimal pH of the recombinant LacTT was 4.5, 6.0, 7.5 and 8.0 with 2,2 '-azino-bis(3-ethylbenzothazoline-6-sulfonic acid) (ABTS), syringaldazine (SGZ), guaiacol, and 2,6-dimethoxyphenol (2,6-DMP) as the substrate, respectively. The optimal temperature of LacTT was 90 degrees C with guaiacol as the substrate. LacTT was highly stable at pH 4.0-11.0 and thermostable at 40 degrees C-90 degrees C, confirming that it is a pH-stable and thermostable laccase. Furthermore, LacTT also exhibited high tolerance to halides such as NaCl, NaBr and NaF, and decolorized 100%, 94%, 94% and 73% of Congo Red, Reactive Black B and Reactive Black WNN, and Remazol Brilliant Blue R, respectively. Interestingly, addition of high concentration of NaCl increased the RBBR decolorization efficiency of LacTT. These results suggest that LacTT is a good candidate for industrial applications such as dyestuff processing and degradation of dyes in textile wastewaters.	[Liu, Huiping; Cheng, Yu; Tong, Chaofan; Liang, Shuli; Han, Shuangyan; Zheng, Suiping; Lin, Ying] S China Univ Technol, Sch Biosci & Bioengn, Guangzhou 510006, Guangdong, Peoples R China; [Du, Bing] South China Agr Univ, Coll Food Sci & Engn, Guangzhou 510642, Guangdong, Peoples R China	South China University of Technology; South China Agricultural University	Lin, Y (corresponding author), S China Univ Technol, Sch Biosci & Bioengn, Guangzhou 510006, Guangdong, Peoples R China.	feylin@scut.edu.cn		Ying, Lin/0000-0001-8686-7868	Natural Science Foundation of Guangdong province [2008A010900002, 2010A010500003]	Natural Science Foundation of Guangdong province(National Natural Science Foundation of Guangdong Province)	This study was supported by Natural Science Foundation of Guangdong province (2008A010900002 and 2010A010500003). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baldrian P, 2006, FEMS MICROBIOL REV, V30, P215, DOI 10.1111/j.1574-4976.2005.00010.x; Bello M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040700; Camarero S, 2012, APPL ENVIRON MICROB, V78, P1370, DOI 10.1128/AEM.07530-11; Champagne PP, 2013, APPL MICROBIOL BIOT, V97, P6263, DOI 10.1007/s00253-012-4525-y; Damasceno LM, 2012, APPL MICROBIOL BIOT, V93, P31, DOI 10.1007/s00253-011-3654-z; Das N, 2001, J BASIC MICROB, V41, P261, DOI 10.1002/1521-4028(200110)41:5&lt;261::AID-JOBM261&gt;3.0.CO;2-V; Freixo MD, 2008, PROCESS BIOCHEM, V43, P1265, DOI 10.1016/j.procbio.2008.07.013; Dwivedi UN, 2011, J MOL CATAL B-ENZYM, V68, P117, DOI 10.1016/j.molcatb.2010.11.002; Fan B, 2013, J SOIL SEDIMENT, V13, P1232, DOI 10.1007/s11368-013-0705-3; Fang ZM, 2012, BIORESOURCE TECHNOL, V111, P36, DOI 10.1016/j.biortech.2012.01.172; Fang Z, 2011, APPL MICROBIOL BIOT, V89, P1103, DOI 10.1007/s00253-010-2934-3; Forootanfar H, 2011, BIORESOURCE TECHNOL, V102, P1808, DOI 10.1016/j.biortech.2010.09.043; Giardina P, 2010, CELL MOL LIFE SCI, V67, P369, DOI 10.1007/s00018-009-0169-1; Gunne M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052360; Haritash AK, 2009, J HAZARD MATER, V169, P1, DOI 10.1016/j.jhazmat.2009.03.137; Hsu CA, 2012, ENVIRON SCI TECHNOL, V46, P5109, DOI 10.1021/es2047014; Kiiskinen LL, 2002, APPL MICROBIOL BIOT, V59, P198, DOI 10.1007/s00253-002-1012-x; Kim H, 2012, APPL BIOCHEM BIOTECH, V166, P159, DOI 10.1007/s12010-011-9412-y; Kittl R, 2012, J BIOTECHNOL, V157, P304, DOI 10.1016/j.jbiotec.2011.11.021; Koschorreck K, 2008, APPL MICROBIOL BIOT, V79, P217, DOI 10.1007/s00253-008-1417-2; Kumar P, 2007, J HAZARD MATER, V149, P26, DOI 10.1016/j.jhazmat.2007.03.051; Lin-Cereghino J, 2008, YEAST, V25, P293, DOI 10.1002/yea.1587; Lu L, 2013, BIORESOURCE TECHNOL, V134, P81, DOI 10.1016/j.biortech.2013.02.015; Lu L, 2012, BIORESOURCE TECHNOL, V115, P35, DOI 10.1016/j.biortech.2011.07.111; Mate D, 2010, CHEM BIOL, V17, P1030, DOI 10.1016/j.chembiol.2010.07.010; Miyazaki K, 2005, EXTREMOPHILES, V9, P415, DOI 10.1007/s00792-005-0458-z; Mohammadian M, 2010, J IND MICROBIOL BIOT, V37, P863, DOI 10.1007/s10295-010-0734-5; Morozova V, 2007, BIOCHEMISTRY-MOSCOW+, V72, P1136, DOI 10.1134/S0006297907100112; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Reiss R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065633; Reiss R, 2011, BMC BIOTECHNOL, V11, DOI 10.1186/1472-6750-11-9; Ruijssenaars HJ, 2004, APPL MICROBIOL BIOT, V65, P177, DOI 10.1007/s00253-004-1571-0; Santhanam N, 2011, TRENDS BIOTECHNOL, V29, P480, DOI 10.1016/j.tibtech.2011.04.005; Serrano-Posada H, 2011, ACTA CRYSTALLOGR F, V67, P1595, DOI 10.1107/S174430911103805X; Si J, 2013, BIORESOURCE TECHNOL, V128, P49, DOI 10.1016/j.biortech.2012.10.085; Sun YF, 2012, APPL MICROBIOL BIOT, V96, P1539, DOI 10.1007/s00253-012-4264-0; Wong KS, 2012, BIORESOURCE TECHNOL, V104, P157, DOI 10.1016/j.biortech.2011.10.097; Ye M, 2010, APPL MICROBIOL BIOT, V87, P1023, DOI 10.1007/s00253-010-2507-5; Zhao XL, 2013, PROCESS BIOCHEM, V48, P1317, DOI 10.1016/j.procbio.2013.06.021	39	18	26	13	86	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2015	10	3							e0119833	10.1371/journal.pone.0119833	http://dx.doi.org/10.1371/journal.pone.0119833			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD9NQ	25790466	gold, Green Published, Green Submitted			2022-12-27	WOS:000351425400109
J	Ross, AW; Russell, L; Helfer, G; Thomson, LM; Dalby, MJ; Morgan, PJ				Ross, Alexander W.; Russell, Laura; Helfer, Gisela; Thomson, Lynn M.; Dalby, Matthew J.; Morgan, Peter J.			Photoperiod Regulates Lean Mass Accretion, but Not Adiposity, in Growing F344 Rats Fed a High Fat Diet	PLOS ONE			English	Article							GROWTH-HORMONE-SECRETION; HYPOTHALAMIC NEUROPEPTIDE-Y; GH-RELEASING FACTOR; OBESE ZUCKER RATS; ENERGY-BALANCE; SIBERIAN HAMSTER; MESSENGER-RNA; BODY-WEIGHT; FOOD-INTAKE; GENE-EXPRESSION	In this study the effects of photoperiod and diet, and their interaction, were examined for their effects on growth and body composition in juvenile F344 rats over a 4-week period. On long (16L:8D), relative to short (8L:16D), photoperiod food intake and growth rate were increased, but percentage adiposity remained constant (ca 3-4%). On a high fat diet (HFD), containing 22.8% fat (45% energy as fat), food intake was reduced, but energy intake increased on both photoperiods. This led to a small increase in adiposity (up to 10%) without overt change in body weight. These changes were also reflected in plasma leptin and lipid levels. Importantly while both lean and adipose tissue were strongly regulated by photoperiod on a chow diet, this regulation was lost for adipose, but not lean tissue, on HFD. This implies that a primary effect of photoperiod is the regulation of growth and lean mass accretion. Consistent with this both hypothalamic GHRH gene expression and serum IGF-1 levels were photoperiod dependent. As for other animals and humans, there was evidence of central hyposomatotropism in response to obesity, as GHRH gene expression was suppressed by the HFD. Gene expression of hypothalamic AgRP and CRH, but not NPY nor POMC, accorded with the energy balance status on long and short photoperiod. However, there was a general dissociation between plasma leptin levels and expression of these hypothalamic energy balance genes. Similarly there was no interaction between the HFD and photoperiod at the level of the genes involved in thyroid hormone metabolism (Dio2, Dio3, TSH beta or NMU), which are important mediators of the photoperiodic response. These data suggest that photoperiod and HFD influence body weight and body composition through independent mechanisms but in each case the role of the hypothalamic energy balance genes not predictable based on their known function.	[Ross, Alexander W.; Russell, Laura; Helfer, Gisela; Thomson, Lynn M.; Dalby, Matthew J.; Morgan, Peter J.] Univ Aberdeen, Rowett Inst Nutr & Hlth, Aberdeen, Scotland	University of Aberdeen	Morgan, PJ (corresponding author), Univ Aberdeen, Rowett Inst Nutr & Hlth, Aberdeen, Scotland.	p.morgan@abdn.ac.uk	Helfer, Gisela/S-9189-2019	Helfer, Gisela/0000-0003-0634-4683; Morgan, Peter/0000-0002-5071-6512; Dalby, Matthew/0000-0002-0528-3359; Dalby, Matthew John/0000-0002-1137-4337; Ross, Alexander/0000-0002-1799-1432	Scottish Government (Rural and Environment Science and Analytical Services Division); BBSRC [BB/K001043/1]; Biotechnology and Biological Sciences Research Council [BB/K001043/1, 1279840] Funding Source: researchfish	Scottish Government (Rural and Environment Science and Analytical Services Division); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	The authors would like to acknowledge the Scottish Government (Rural and Environment Science and Analytical Services Division, http://www.scotland. gov. uk/), AWR LR LMT PJM and the BBSRC, (http://www.bbsrc.ac.uk/home/home.aspx, grant BB/K001043/1), AWR GH PJM for their financial support of this work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahima RS, 2000, FRONT NEUROENDOCRIN, V21, P263, DOI 10.1006/frne.2000.0197; AHMAD I, 1993, NEUROENDOCRINOLOGY, V58, P332, DOI 10.1159/000126558; ARASE K, 1988, AM J PHYSIOL, V255, pE255, DOI 10.1152/ajpendo.1988.255.3.E255; Barrett P, 2007, ENDOCRINOLOGY, V148, P3608, DOI 10.1210/en.2007-0316; Barsh GS, 2002, NAT REV GENET, V3, P589, DOI [10.1038/nrn902, 10.1038/nrg862]; Baskin DG, 1999, HORM METAB RES, V31, P345, DOI 10.1055/s-2007-978751; Berryman DE, 2013, NAT REV ENDOCRINOL, V9, P346, DOI 10.1038/nrendo.2013.64; Carro E, 1997, ENDOCRINOLOGY, V138, P2203, DOI 10.1210/en.138.5.2203; CASANUEVA FF, 1987, J CLIN ENDOCR METAB, V65, P634, DOI 10.1210/jcem-65-4-634; Cattaneo L, 1996, J ENDOCRINOL, V148, P347, DOI 10.1677/joe.0.1480347; Cattaneo L, 1997, PHARMACOL RES, V36, P49, DOI 10.1006/phrs.1997.0203; Considine RV, 1996, NEW ENGL J MED, V334, P292, DOI 10.1056/NEJM199602013340503; Dardente H, 2014, FRONT ENDOCRINOL, V5, DOI 10.3389/fendo.2014.00019; Ebling FJP, 2014, HORM BEHAV, V66, P56, DOI 10.1016/j.yhbeh.2014.03.009; El-Bakry HA, 1999, PHYSIOL BEHAV, V68, P87, DOI 10.1016/S0031-9384(99)00151-1; Ellis C, 2008, AM J PHYSIOL-REG I, V294, pR1148, DOI 10.1152/ajpregu.00825.2007; Graham ES, 2003, J NEUROCHEM, V87, P1165, DOI 10.1046/j.1471-4159.2003.02079.x; Hanon EA, 2008, CURR BIOL, V18, P1147, DOI 10.1016/j.cub.2008.06.076; Heideman PD, 1997, BIOL REPROD, V57, P134, DOI 10.1095/biolreprod57.1.134; Helfer G, 2013, J NEUROENDOCRINOL, V25, P1264, DOI 10.1111/jne.12116; Helfer G, 2012, ENDOCRINOLOGY, V153, P815, DOI 10.1210/en.2011-1792; Huang L, 2012, ENDOCRINOLOGY, V153, P4380, DOI 10.1210/en.2012-1178; IMAKI T, 1986, ENDOCRINOLOGY, V118, P2390, DOI 10.1210/endo-118-6-2390; Iwakura H, 2007, AM J PHYSIOL-ENDOC M, V293, pE819, DOI 10.1152/ajpendo.00681.2006; KAMEGAI J, 1994, ENDOCRINOLOGY, V135, P2765, DOI 10.1210/en.135.6.2765; Lobley GE, 2007, BRIT J NUTR, V97, P1099, DOI 10.1017/S0007114507691934; Luque RM, 2006, ENDOCRINOLOGY, V147, P2754, DOI 10.1210/en.2005-1549; Marcovecchio ML, 2013, WORLD REV NUTR DIET, V106, P135, DOI 10.1159/000342545; MCELROY JF, 1986, AM J PHYSIOL, V250, pR383, DOI 10.1152/ajpregu.1986.250.3.R383; Melhorn SJ, 2010, PHYSIOL BEHAV, V99, P33, DOI 10.1016/j.physbeh.2009.10.004; Mercer JG, 1997, AM J PHYSIOL-REG I, V273, pR768, DOI 10.1152/ajpregu.1997.273.2.R768; Mercer JG, 2000, AM J PHYSIOL-REG I, V278, pR271, DOI 10.1152/ajpregu.2000.278.1.R271; Messager S, 1999, P NATL ACAD SCI USA, V96, P9938, DOI 10.1073/pnas.96.17.9938; Morgan PJ, 2006, PROG BRAIN RES, V153, P325, DOI 10.1016/S0079-6123(06)53019-5; Muller EE, 1999, PHYSIOL REV, V79, P511, DOI 10.1152/physrev.1999.79.2.511; Nakao N, 2008, NATURE, V452, P317, DOI 10.1038/nature06738; OLCHOVSKY D, 1990, ENDOCRINOLOGY, V126, P53, DOI 10.1210/endo-126-1-53; Paxinos G., 2007, RAT BRAIN STEREOTAXI, V6th ed.; Peacock WL, 2001, PHYSIOL BEHAV, V74, P65, DOI 10.1016/S0031-9384(01)00533-9; Pendergast JS, 2013, EUR J NEUROSCI, V37, P1350, DOI 10.1111/ejn.12133; RENIER G, 1990, NEUROENDOCRINOLOGY, V52, P284; Ross AW, 2009, J NEUROENDOCRINOL, V21, P610, DOI 10.1111/j.1365-2826.2009.01878.x; Ross AW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021351; Ross AW, 2004, ENDOCRINOLOGY, V145, P13, DOI 10.1210/en.2003-0838; SAGHER FA, 1991, BRIT J NUTR, V65, P21, DOI 10.1079/BJN19910062; Scacchi M, 1999, INT J OBESITY, V23, P260, DOI 10.1038/sj.ijo.0800807; Shearer KD, 2012, TRENDS NEUROSCI, V35, P733, DOI 10.1016/j.tins.2012.08.005; TANNENBAUM GS, 1990, ENDOCRINOLOGY, V127, P3087, DOI 10.1210/endo-127-6-3087; THOMSON ABR, 1986, J CLIN INVEST, V77, P279, DOI 10.1172/JCI112288; Togo Y, 2012, AM J PHYSIOL-ENDOC M, V303, pE777, DOI 10.1152/ajpendo.00209.2012; Tuominen JA, 1997, EUR J CLIN INVEST, V27, P206, DOI 10.1046/j.1365-2362.1997.940642.x; Tuominen JA, 1997, ACTA PHYSIOL SCAND, V160, P83, DOI 10.1046/j.1365-201X.1997.00102.x; WADE GN, 1983, PHYSIOL BEHAV, V30, P131, DOI 10.1016/0031-9384(83)90048-3; Watanabe M, 2004, ENDOCRINOLOGY, V145, P1546, DOI 10.1210/en.2003-1593	54	18	18	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2015	10	3							e0119763	10.1371/journal.pone.0119763	http://dx.doi.org/10.1371/journal.pone.0119763			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD9NQ	25789758	Green Submitted, Green Published, gold			2022-12-27	WOS:000351425400102
J	Wolfe, K; Graba-Landry, A; Dworjanyn, SA; Byrne, M				Wolfe, Kennedy; Graba-Landry, Alexia; Dworjanyn, Symon A.; Byrne, Maria			Larval Starvation to Satiation: Influence of Nutrient Regime on the Success of Acanthaster planci	PLOS ONE			English	Article							OF-THORNS STARFISH; GREAT-BARRIER-REEF; FOOD-LIMITED GROWTH; WATER-QUALITY; POPULATION-DYNAMICS; SEA-URCHINS; CORAL COVER; OUTBREAKS; METAMORPHOSIS; LAGOON	High density populations of the crown-of-thorns seastar, Acanthaster planci, are a major contributor to the decline of coral reefs, however the causes behind periodic outbreaks of this species are not understood. The enhanced nutrients hypothesis posits that pulses of enhanced larval food in eutrophic waters facilitate metamorphic success with a flow-on effect for population growth. The larval resilience hypothesis suggests that Acanthaster planci larvae naturally thrive in tropical oligotrophic waters. Both hypotheses remain to be tested empirically. We raised Acanthaster planci larvae in a range of food regimes from starvation (no food) to satiation (excess food). Algal cell concentration and chlorophyll levels were used to reflect phytoplankton conditions in nature for oligotrophic waters (0-100 cells ml(-1); 0-0.01 mu g chl a L-1), natural background levels of nutrients on the Great Barrier Reef (GBR) (1,000-10,000 cells ml(-1); 0.1-1.0 mu g chl a L-1), and enhanced eutrophic conditions following runoff events (100,000 cells ml(-1); 10 mu g chl a L-1). We determine how these food levels affected larval growth and survival, and the metamorphic link between larval experience and juvenile quality (size) in experiments where food ration per larvae was carefully controlled. Phytoplankton levels of 1 mu g chl a L-1, close to background levels for some reefs on the GBR and following flood events, were optimal for larval success. Development was less successful above and below this food treatment. Enhanced larval performance at 1 mu g chl a L-1 provides empirical support for the enhanced nutrients hypothesis, but up to a limit, and emphasizes the need for appropriate mitigation strategies to reduce eutrophication and the consequent risk of Acanthaster planci outbreaks.	[Wolfe, Kennedy; Byrne, Maria] Univ Sydney, Sch Med Sci, Sydney, NSW 2006, Australia; [Graba-Landry, Alexia; Dworjanyn, Symon A.] So Cross Univ, Natl Marine Sci Ctr, Coffs Harbour, NSW 2450, Australia; [Byrne, Maria] Univ Sydney, Sch Biol Sci, Sydney, NSW 2006, Australia	University of Sydney; Southern Cross University; University of Sydney	Wolfe, K (corresponding author), Univ Sydney, Sch Med Sci, Sydney, NSW 2006, Australia.	kennedywolfe90@gmail.com	Dworjanyn, Symon A/O-5633-2017; Graba-Landry, Alexia/AAF-5862-2020; Byrne, Maria/K-6355-2016	Dworjanyn, Symon A/0000-0002-6690-8033; Graba-Landry, Alexia/0000-0002-1176-2321; Byrne, Maria/0000-0002-8902-9808; Wolfe, Kennedy/0000-0002-9502-6769				ALLISON GW, 1994, MAR BIOL, V118, P255, DOI 10.1007/BF00349792; BABCOCK RC, 1992, AUST J MAR FRESH RES, V43, P525; Baird AH, 2013, CORAL REEFS; BIRKELAND C, 1982, MAR BIOL, V69, P175, DOI 10.1007/BF00396897; BIRKELAND C, 1990, MAJOR MANAGEMENT PRO; Brodie J, 2007, MAR FRESHWATER RES, V58, P342, DOI 10.1071/MF06236; Brodie J, 2005, MAR POLLUT BULL, V51, P266, DOI 10.1016/j.marpolbul.2004.10.035; Carpenter KE, 2008, SCIENCE, V321, P560, DOI 10.1126/science.1159196; De'ath G, 2012, P NATL ACAD SCI USA, V109, P17995, DOI 10.1073/pnas.1208909109; De'ath G, 2010, ECOL APPL, V20, P840, DOI 10.1890/08-2023.1; Devlin M, 2001, GBRMPA RES PUBLICATI, V68; Done TJ, 1997, GREAT BARRIER REEF M, V846, P97; Dove SG, 2013, PNAS; Dulvy NK, 2004, ECOL LETT, V7, P410, DOI 10.1111/j.1461-0248.2004.00593.x; Dworjanyn SA, 2008, AQUACULTURE, V274, P268, DOI 10.1016/j.aquaculture.2007.11.030; Endean R, 1969, REPORT INVESTIGATION; Engelhardt U., 1997, GREAT BARRIER REEF S; Fabricius KE, 2010, CORAL REEFS, V29, P593, DOI 10.1007/s00338-010-0628-z; FENAUX L, 1994, LIMNOL OCEANOGR, V39, P84, DOI 10.4319/lo.1994.39.1.0084; FURNAS MJ, 1986, CONT SHELF RES, V6, P363, DOI 10.1016/0278-4343(86)90078-6; GEORGE SB, 1994, ECHINODERMS THROUGH TIME, P297; George SB, 1996, OCEANOL ACTA, V19, P297; George SB, 1999, J EXP MAR BIOL ECOL, V237, P203, DOI 10.1016/S0022-0981(98)00205-6; Gosselin LA, 1997, MAR ECOL PROG SER, V146, P265, DOI 10.3354/meps146265; Haynes D, 2001, GREAT BARRIER REEF W; Haynes D, 2007, ENVIRON MANAGE, V40, P993, DOI 10.1007/s00267-007-9009-y; Hock K, 2014, J APPL ECOL; HOEGHGULDBERG O, 1994, MAR BIOL, V120, P55; Hughes TP, 2010, TRENDS ECOL EVOL, V25, P633, DOI 10.1016/j.tree.2010.07.011; JEFFREY SW, 1975, BIOCHEM PHYSIOL PFL, V167, P191, DOI 10.1016/s0015-3796(17)30778-3; JOHNSON CR, 1994, MAR BIOL, V120, P305, DOI 10.1007/BF00349692; Kamya PZ, 2014, GLOBAL CHANGE BIOL, V20, P3365, DOI 10.1111/gcb.12530; Kayal M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047363; KEESING JK, 1992, AUST J MAR FRESH RES, V43, P635; Lamare MD, 2001, MAR ECOL PROG SER, V218, P153, DOI 10.3354/meps218153; Lane DJW, 2012, J MAR BIOL ASSOC UK, V92, P803, DOI 10.1017/S0025315411000890; Lourey MJ, 2000, MAR ECOL PROG SER, V196, P179, DOI 10.3354/meps196179; LUCAS JS, 1982, J EXP MAR BIOL ECOL, V65, P173, DOI 10.1016/0022-0981(82)90043-0; Miller BA, 1999, J EXP MAR BIOL ECOL, V235, P67, DOI 10.1016/S0022-0981(98)00164-6; MORAN PJ, 1986, OCEANOGR MAR BIOL, V24, P379; Nakamura M, 2014, MAR BIOL, V161, P2521, DOI 10.1007/s00227-014-2524-5; Okaji K, 1997, CORAL REEFS, V16, P47, DOI 10.1007/s003380050058; Okaji K, 1996, THESIS; OLSON RR, 1989, ANNU REV ECOL SYST, V20, P225; OLSON RR, 1987, LIMNOL OCEANOGR, V32, P895, DOI 10.4319/lo.1987.32.4.0895; Osborne K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017516; Pace DA, 2007, J EXP MAR BIOL ECOL, V353, P89, DOI 10.1016/j.jembe.2007.09.005; Pandolfi JM, 2011, SCIENCE, V333, P418, DOI 10.1126/science.1204794; PAULAY G, 1985, J EXP MAR BIOL ECOL, V93, P1, DOI 10.1016/0022-0981(85)90145-5; Pechenik JA, 1996, J EXP MAR BIOL ECOL, V199, P137; Pechenik JA, 2006, INTEGR COMP BIOL, V46, P323, DOI 10.1093/icb/icj028; PECHENIK JA, 1993, MAR BIOL, V115, P287, DOI 10.1007/BF00346346; Pratchett MS, 2014, OCEANOGR MAR BIOL, V52, P133; Quinn GP, 2003, EXPT DESIGN DATA ANA; SAMMARCO PW, 1984, MAR BIOL, V82, P167, DOI 10.1007/BF00394100; Schaffelke B, 2012, MAR POLLUT BULL, V65, P249, DOI 10.1016/j.marpolbul.2011.10.031; Seymour RM, 1999, MAR ECOL PROG SER, V176, P1, DOI 10.3354/meps176001; STRATHMANN RR, 1992, EVOLUTION, V46, P972, DOI 10.1111/j.1558-5646.1992.tb00613.x; STRATHMANN RR, 1993, BIOL BULL, V185, P232, DOI 10.2307/1542003; Sweatman H, 2011, CORAL REEFS, V30, P521, DOI 10.1007/s00338-010-0715-1; Sweatman H, 2008, CURR BIOL, V18, pR598, DOI 10.1016/j.cub.2008.05.033; Uthicke S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082938; Uthicke S, 2009, ECOL MONOGR, V79, P3, DOI 10.1890/07-2136.1; Vine P, 1973, ATOLL RES BULL, V166; Wallace RB, 2014, ESTUAR COAST SHELF S; Wooldridge S, 2006, MAR POLLUT BULL, V52, P1467, DOI 10.1016/j.marpolbul.2006.05.009; Yamaguchi M., 1973, P369; YAMAGUCHI M, 1974, PAC SCI, V28, P123	68	51	52	5	65	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2015	10	3							e0122010	10.1371/journal.pone.0122010	http://dx.doi.org/10.1371/journal.pone.0122010			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD9NQ	25790074	gold, Green Published, Green Submitted			2022-12-27	WOS:000351425400205
J	Yu, N; Zhang, YY; Niu, XY; Xu, Y; Ma, RX; Zhang, W; Jiang, XB				Yu, Ning; Zhang, Yue-yue; Niu, Xiao-yan; Xu, Yan; Ma, Rui-xia; Zhang, Wei; Jiang, Xiu-bo			Evaluation of Shear Wave Velocity and Human Bone Morphogenetic Protein-7 for the Diagnosis of Diabetic Kidney Disease	PLOS ONE			English	Article							RADIATION FORCE IMPULSE; TOUCH TISSUE QUANTIFICATION; IN-VIVO; ELASTOGRAPHY; FIBROSIS; LIVER; ELASTICITY; SPLEEN	Purpose The aim of this study was to determine the diagnostic values of kidney shear wave velocity (SWV) and bone morphogenetic protein-7 (BMP-7), and their correlation in the diagnosis of early diabetic kidney disease. Methods A total of 150 patients with type 2 diabetes mellitus were divided into three equal groups based on the urinary albumin-creatinine ratio (ACR): normal albuminuria (normo-group, ACR < 30 mg/g creatinine, n = 50), microalbuminuria (micro-group, 30 <= ACR < 300 mg/g creatinine, n = 50), and macroalbuminuria (macro-group, ACR >= 300 mg/g creatinine and estimated glomerular filtration rate (eGFR) >= 30 ml/min/1.73 m(2), n = 50). Fifty healthy volunteers were recruited to serve as controls (control group). The levels of serum BMP-7 were detected, and virtual touch tissue quantification was used to detect the renal SWV value in all study subjects. Correlations between groups as well as SWV and BMP-7 were analyzed. Results Serum BMP-7 and SWV were significantly and progressively decreased and increased, respectively, during the development of renal disease, from the normo-to the micro-and to the macro-groups (all P < 0.01 between each other for BMP-7 and SWV). Moreover, no significant differences between the normo-and control groups were observed for either BMP-7 or SWV (both P > 0.05). In addition, a significant correlation was found between SWV and BMP-7, with a coefficient of -0.569 (P < 0.05). Conclusion The determination of SWV together with serum BMP-7 may play an important role in the diagnosis of diabetic kidney disease.	[Yu, Ning; Niu, Xiao-yan] Qingdao Univ, Affiliated Hosp, Dept Ultrasound, Qingdao, Shandong, Peoples R China; [Zhang, Yue-yue] Shanghai Jiao Tong Univ, Affiliated Peoples Hosp 1, Dept Nephrol, Shanghai 200030, Peoples R China; [Xu, Yan; Ma, Rui-xia; Zhang, Wei] Qingdao Univ, Affiliated Hosp, Dept Nephrol, Qingdao, Shandong, Peoples R China; [Jiang, Xiu-bo] Qingdao Univ, Coll Med, Dept Publ Hlth Epidemiol, Qingdao, Shandong, Peoples R China	Qingdao University; Shanghai Jiao Tong University; Qingdao University; Qingdao University	Xu, Y (corresponding author), Qingdao Univ, Affiliated Hosp, Dept Nephrol, Qingdao, Shandong, Peoples R China.	xuyanqyfy@126.com			Science and Technology Project of Universities of Shandong Province [J12LL08]	Science and Technology Project of Universities of Shandong Province	This study was supported by the Science and Technology Project of Universities of Shandong Province (J12LL08). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amer Diabet Assoc, 2010, DIABETES CARE, V33, pS11, DOI 10.2337/dc10-S011; De Petris L, 2007, NEPHROL DIAL TRANSPL, V22, P3442, DOI 10.1093/ndt/gfm503; Denizli N, 2013, RENAL FAILURE, V35, P1112, DOI 10.3109/0886022X.2013.815106; Gallotti A, 2010, RADIOL MED, V115, P889, DOI 10.1007/s11547-010-0504-5; Gennisson JL, 2012, ULTRASOUND MED BIOL, V38, P1559, DOI 10.1016/j.ultrasmedbio.2012.04.013; Guo LH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068925; He WY, 2014, ULTRASOUND MED BIOL, V40, P322, DOI 10.1016/j.ultrasmedbio.2013.10.003; Holdsworth A, 2014, VET RADIOL ULTRASOUN, V55, P620, DOI 10.1111/vru.12169; Hruska KA, 2000, AM J PHYSIOL-RENAL, V279, pF130, DOI 10.1152/ajprenal.2000.279.1.F130; Lee MJ, 2013, EUR J RADIOL, V82, pE290, DOI 10.1016/j.ejrad.2013.01.018; Levin A, 2007, AM J KIDNEY DIS, V49, pS10, DOI 10.1053/j.ajkd.2006.12.004; Lund RJ, 2004, J AM SOC NEPHROL, V15, P359, DOI 10.1097/01.ASN.0000109671.99498.08; Lv SS, 2014, DIABETES VASC DIS RE, V11, P251, DOI 10.1177/1479164114531300; Michos O, 2007, DEVELOPMENT, V134, P2397, DOI 10.1242/dev.02861; Nightingale K, 2011, CURR MED IMAGING, V7, P328, DOI 10.2174/157340511798038657; Sohn B, 2014, ULTRASONOGRAPHY, V33, P116, DOI 10.14366/usg.14002; Takahashi H, 2010, LIVER INT, V30, P538, DOI 10.1111/j.1478-3231.2009.02130.x; Tian F, 2014, ULTRASOUND MED BIOL, V40, P1394, DOI 10.1016/j.ultrasmedbio.2014.01.013; Wang L, 2014, EUR RADIOL, V24, P1694, DOI 10.1007/s00330-014-3162-5; Wang SN, 2001, J AM SOC NEPHROL, V12, P2392, DOI 10.1681/ASN.V12112392; Wong MG, 2013, KIDNEY INT, V83, P278, DOI 10.1038/ki.2012.383; Yeh CH, 2009, BIOCHEM BIOPH RES CO, V382, P292, DOI 10.1016/j.bbrc.2009.03.011; Yu N, 2014, J ULTRAS MED, V33, P787, DOI 10.7863/ultra.33.5.787; Zeisberg M, 2008, PEDIATR NEPHROL, V23, P1395, DOI 10.1007/s00467-008-0818-x	24	3	3	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2015	10	3							e0119713	10.1371/journal.pone.0119713	http://dx.doi.org/10.1371/journal.pone.0119713			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD9NQ	25790348	Green Submitted, gold, Green Published			2022-12-27	WOS:000351425400098
J	Doorenweerd, C; van Nieukerken, EJ; Menken, SBJ				Doorenweerd, Camiel; van Nieukerken, Erik J.; Menken, Steph B. J.			A Global Phylogeny of Leafmining Ectoedemia Moths (Lepidoptera: Nepticulidae): Exploring Host Plant Family Shifts and Allopatry as Drivers of Speciation	PLOS ONE			English	Article							ENEMY-FREE-SPACE; ECOLOGICAL SPECIATION; SAWFLIES HYMENOPTERA; DIVERSITY; INSECT; SPECIALIZATION; ASSOCIATIONS; EVOLUTION; INFERENCE; ACCURACY	Background Host association patterns in Ectoedemia (Lepidoptera: Nepticulidae) are also encountered in other insect groups with intimate plant relationships, including a high degree of monophagy, a preference for ecologically dominant plant families (e.g. Fagaceae, Rosaceae, Salicaceae, and Betulaceae) and a tendency for related insect species to feed on related host plant species. The evolutionary processes underlying these patterns are only partly understood, we therefore assessed the role of allopatry and host plant family shifts in speciation within Ectoedemia. Methodology Six nuclear and mitochondrial DNA markers with a total aligned length of 3692 base pairs were used to infer phylogenetic relationships among 92 species belonging to the subgenus Ectoedemia of the genus Ectoedemia, representing a thorough taxon sampling with a global coverage. The results support monophyletic species groups that are congruent with published findings based on morphology. We used the obtained phylogeny to explore host plant family association and geographical distribution to investigate if host shifts and allopatry have been instrumental in the speciation of these leafmining insects. Significance We found that, even though most species within species groups commonly feed on plants from one family, shifts to a distantly related host family have occasionally occurred throughout the phylogeny and such shifts are most commonly observed towards Betulaceae. The largest radiations have occurred within species groups that feed on Fagaceae, Rosaceae, and Salicaceae. Most species are restricted to one of the seven global biogeographic regions, but within species groups representatives are commonly found in different biogeographic regions. Although we find general patterns with regard to host use and biogeography, there are differences between clades that suggest that different drivers of speciation, and perhaps drivers that we did not examine, have shaped diversity patterns in different clades.	[Doorenweerd, Camiel; van Nieukerken, Erik J.] Naturalis Biodivers Ctr, Dept Terr Zool, Leiden, Netherlands; [Doorenweerd, Camiel; Menken, Steph B. J.] Univ Amsterdam, Inst Biodivers & Ecosyst Dynam, Amsterdam, Netherlands	Naturalis Biodiversity Center; University of Amsterdam	Doorenweerd, C (corresponding author), Naturalis Biodivers Ctr, Dept Terr Zool, Leiden, Netherlands.	camiel.doorenweerd@naturalis.nl	Doorenweerd, Camiel/AAO-4314-2020; van Nieukerken, Erik/B-4512-2012	Doorenweerd, Camiel/0000-0002-0418-4439; van Nieukerken, Erik/0000-0002-5721-1840	Uyttenboogaart Eliasen Stichting [SUB.2010.05.12, SUB.2011.12.14]; EU	Uyttenboogaart Eliasen Stichting; EU(European Commission)	Field collecting by the authors was partly funded by the following grants from the Uyttenboogaart Eliasen Stichting (http://www.ue-stichting.nl/): SUB.2010.05.12 to CD for the USA and SUB.2011.12.14 to EJvN for Korea and Taiwan. Field work was further funded by the EU-funded EDIT WP 7 project 'All Taxa Biodiversity Inventories (http://www.atbi.eu/wp7/) in the Mercantour/Alpi Marittime natural parks'. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aberer AJ, 2013, SYST BIOL, V62, P162, DOI 10.1093/sysbio/sys078; Ayres DL, 2012, SYST BIOL, V61, P170, DOI [10.1093/sysbio/syr100, 10.1093/sysbio/sys029]; Becerra JX, 2009, P NATL ACAD SCI USA, V106, P18062, DOI 10.1073/pnas.0904456106; Becerra JX, 2003, P NATL ACAD SCI USA, V100, P12804, DOI 10.1073/pnas.2133013100; Byng JW, 2016, BOT J LINN SOC, V181, P1, DOI 10.1111/boj.12385; De Prins J, 2011, GLOBAL TAXONOMIC DAT; De Prins J, 2012, ZOOTAXA, P1; de Vienne DM, 2013, NEW PHYTOL, V198, P347, DOI 10.1111/nph.12150; Diskus A., 2003, P318; Emmet AM, 1988, FIELD GUIDE SMALLER; Farrell BD, 2004, EVOLUTION, V58, P1984; Fordyce JA, 2010, P ROY SOC B-BIOL SCI, V277, P3735, DOI 10.1098/rspb.2010.0211; Futuyma DJ, 2009, P NATL ACAD SCI USA, V106, P18054, DOI 10.1073/pnas.0904106106; Gomez-Zurita J, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000360; Heath TA, 2008, J SYST EVOL, V46, P239, DOI 10.3724/SP.J.1002.2008.08016; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; JEFFRIES MJ, 1984, BIOL J LINN SOC, V23, P269, DOI 10.1111/j.1095-8312.1984.tb00145.x; Knolke S, 2005, INSECT SYST EVOL, V35, P401, DOI 10.1163/187631204788912463; Kumar S, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-357; Leppanen SA, 2012, MOL PHYLOGENET EVOL, V64, P331, DOI 10.1016/j.ympev.2012.04.005; Lewinsohn TM, 2005, ANNU REV ECOL EVOL S, V36, P597, DOI 10.1146/annurev.ecolsys.36.091704.175520; Lopez-Vaamonde C, 2006, J EVOLUTION BIOL, V19, P1314, DOI 10.1111/j.1420-9101.2005.01070.x; Lopez-Vaamonde C, 2003, EVOLUTION, V57, P1804, DOI 10.1111/j.0014-3820.2003.tb00588.x; Manos PS, 2001, INT J PLANT SCI, V162, pS77, DOI 10.1086/323280; Matsubayashi KW, 2010, ENTOMOL EXP APPL, V134, P1, DOI 10.1111/j.1570-7458.2009.00916.x; Matzkin LM, 2006, MOL ECOL, V15, P4635, DOI 10.1111/j.1365-294X.2006.03102.x; MAYR E, 1947, EVOLUTION, V1, P263, DOI 10.2307/2405327; Mayr E., 1963, ANIMAL SPECIES EVOLU; McBride CS, 2007, P NATL ACAD SCI USA, V104, P4996, DOI 10.1073/pnas.0608424104; McLeish MJ, 2013, BMC EVOL BIOL, V13, DOI 10.1186/1471-2148-13-188; MENKEN SBJ, 1988, ENTOMOL EXP APPL, V49, P141, DOI 10.1007/BF00188247; Menken SBJ, 2010, EVOLUTION, V64, P1098, DOI 10.1111/j.1558-5646.2009.00889.x; Mey Wolfram, 2004, Esperiana Memoir, V1, P27; Miller M.A., 2010, P GAT COMP ENV WORKS; Morales-Hojas R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049552; Nyman T, 2006, EVOLUTION, V60, P1622, DOI 10.1111/j.0014-3820.2006.tb00507.x; Nyman T, 2012, ECOL LETT, V15, P889, DOI 10.1111/j.1461-0248.2012.01782.x; Nyman T, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-266; Nyman T, 2010, BIOL REV, V85, P393, DOI 10.1111/j.1469-185X.2009.00109.x; Ogden TH, 2005, CLADISTICS, V21, P295, DOI 10.1111/j.1096-0031.2005.00061.x; Ohshima I, 2014, J NAT HIST, P1; Ohshima I, 2008, BIOL J LINN SOC, V93, P135, DOI 10.1111/j.1095-8312.2007.00949.x; Page RDM, 2003, TANGLED TREES: PHYLOGENY, COSPECIATION AND COEVOLUTION, P1; Pena C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039071; Percy DM, 2004, SYST BIOL, V53, P120, DOI 10.1080/10635150490264996; Posada D, 2012, FINDMODEL; Puplesis R, 1994, NEPTICULIDAE E EUROP; Puplesis Rimantas, 2000, Bulletin of the Natural History Museum Entomology Series, V69, P3; Regier JC, 2005, BIOTECHNIQUES, V38, P34, DOI 10.2144/05381BM02; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Rota J, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000045; Schluter D, 2001, TRENDS ECOL EVOL, V16, P372, DOI 10.1016/S0169-5347(01)02198-X; Schluter D, 2009, SCIENCE, V323, P737, DOI 10.1126/science.1160006; SCOBLE M J, 1979, Annals of the Transvaal Museum, V32, P35; SCOBLE MJ, 1978, J ENTOMOL SOC S AFR, V41, P81; Suzuki H, 2011, ENTOMOL EXP APPL, V138, P212, DOI 10.1111/j.1570-7458.2010.01092.x; Swofford DL., 2003, PAUP PHYLOGENETIC AN; Thompson JN, 2013, RELENTLESS EVOLUTION, P211; Tilmon KJ, 2008, EVOLUTIONARY BIOL HE; van Nieukerken E.J., 1985, Tijdschrift voor Entomologie, V128, P1; van Nieukerken EJ, 2012, CONTRIB ZOOL, V81, P1; van Nieukerken EJ, 2010, ZOOKEYS, P1, DOI 10.3897/zookeys.32.282; Wahlberg N, 2001, EVOLUTION, V55, P522, DOI 10.1554/0014-3820(2001)055[0522:TPABOH]2.0.CO;2; Wahlberg N, 2008, SYST BIOL, V57, P231, DOI 10.1080/10635150802033006; Wahlberg N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080875; Wallace A.R., 1876, GEOGRAPHICAL DISTRIB, VI; Wheat CW, 2007, P NATL ACAD SCI USA, V104, P20427, DOI 10.1073/pnas.0706229104; WILKINSON C, 1981, Tijdschrift voor Entomologie, V124, P93; WILKINSON C, 1981, Tijdschrift voor Entomologie, V124, P27; Winkler IS, 2008, SPECIALIZATION, SPECIATION, AND RADIATION: THE EVOLUTIONARY BIOLOGY OF HERBIVOROUS INSECTS, P240; Zhang ZQ, 2011, ZOOTAXA, P7, DOI 10.11646/zootaxa.3148.1.3	71	27	28	2	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2015	10	3							e0119586	10.1371/journal.pone.0119586	http://dx.doi.org/10.1371/journal.pone.0119586			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9BN	25785630	Green Published, Green Submitted, gold			2022-12-27	WOS:000352138500115
J	Gai, QY; Jiao, J; Luo, M; Wei, ZF; Zu, YG; Ma, W; Fu, YJ				Gai, Qing-Yan; Jiao, Jiao; Luo, Meng; Wei, Zuo-Fu; Zu, Yuan-Gang; Ma, Wei; Fu, Yu-Jie			Establishment of Hairy Root Cultures by Agrobacterium Rhizogenes Mediated Transformation of Isatis Tinctoria L. for the Efficient Production of Flavonoids and Evaluation of Antioxidant Activities	PLOS ONE			English	Article							LIQUID-CHROMATOGRAPHY; INDIGOTICA; ACCUMULATION; PROSPECTS; EXTRACTS; LEAVES; MS/MS; FOOD; PH	In this work, Isatis tinctoria hairy root cultures (ITHRCs) were established as an alternative source for flavonoids (FL) production. I. tinctoria hairy root line V was found to be the most efficient line and was further confirmed by the PCR amplification of rolB, rolC and aux1 genes. Culture parameters of ITHRCs were optimized by Box-Behnken design (BBD), and eight bioactive FL constituents (rutin, neohesperidin, buddleoside, liquiritigenin, quercetin, isorhamnetin, kaempferol and isoliquiritigenin) were quali-quantitatively determined by LCMS/MS. Under optimal conditions, the total FL accumulation of ITHRCs (24 day-old) achieved was 438.10 mu g/g dry weight (DW), which exhibited significant superiority as against that of 2 year-old field grown roots (341.73 mu g/g DW). Additionally, in vitro antioxidant assays demonstrated that ITHRCs extracts exhibited better antioxidant activities with lower IC50 values (0.41 and 0.39, mg/mL) as compared to those of field grown roots (0.56 and 0.48, mg/mL). To the best of our knowledge, this is the first report describing FL production and antioxidant activities from ITHRCs.	[Gai, Qing-Yan; Luo, Meng; Wei, Zuo-Fu; Zu, Yuan-Gang; Fu, Yu-Jie] Northeast Forestry Univ, Minist Educ, Key Lab Forest Plant Ecol, Harbin 150040, Peoples R China; [Gai, Qing-Yan; Luo, Meng; Wei, Zuo-Fu; Zu, Yuan-Gang; Fu, Yu-Jie] Collaborat Innovat Ctr Dev & Utilizat Forest Reso, Harbin 150040, Peoples R China; [Jiao, Jiao; Ma, Wei] Northeast Forestry Univ, State Key Lab Tree Genet & Breeding, Harbin 150040, Peoples R China; [Ma, Wei] Heilongjiang Univ Chinese Med, Sch Pharmaceut, Harbin 150040, Peoples R China	Northeast Forestry University - China; Northeast Forestry University - China; Heilongjiang University of Chinese Medicine	Fu, YJ (corresponding author), Northeast Forestry Univ, Minist Educ, Key Lab Forest Plant Ecol, Harbin 150040, Peoples R China.	yujie_fu2011@yahoo.com	ma, wei/GVU-3235-2022		Application Technology Research and Development Program of Harbin [2013AA3BS014]; Fundamental Research Funds for the Central Universities [2572015AA14, 2572014AA06]; National Natural Science Foundation of China [31270618]; Agricultural Science and Technology Achievements Transformation and Program [2012GB23600641]	Application Technology Research and Development Program of Harbin; Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Agricultural Science and Technology Achievements Transformation and Program	This study was supported by Application Technology Research and Development Program of Harbin (2013AA3BS014), Fundamental Research Funds for the Central Universities (2572015AA14), Fundamental Research Funds for the Central Universities (2572014AA06), Special Fund of National Natural Science Foundation of China (31270618), and Agricultural Science and Technology Achievements Transformation and Program (2012GB23600641). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bulgakov VP, 2008, BIOTECHNOL ADV, V26, P318, DOI 10.1016/j.biotechadv.2008.03.001; Chandra S, 2011, PHYTOCHEM REV, V10, P371, DOI 10.1007/s11101-011-9210-8; Chen JF, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-857; Chen MH, 2012, J NAT PROD, V75, P1167, DOI 10.1021/np3002833; Davies KM, 2014, CURR OPIN BIOTECH, V26, P133, DOI 10.1016/j.copbio.2013.12.010; Dehghan E, 2012, PLANT CELL TISS ORG, V110, P35, DOI 10.1007/s11240-012-0127-8; Fattahi M, 2013, IND CROP PROD, V50, P256, DOI 10.1016/j.indcrop.2013.07.029; Guillon S, 2006, CURR OPIN PLANT BIOL, V9, P341, DOI 10.1016/j.pbi.2006.03.008; Hu ZB, 2006, J INTEGR PLANT BIOL, V48, P121, DOI 10.1111/j.1744-7909.2006.00121.x; Jeong CS, 2009, ACTA PHYSIOL PLANT, V31, P219, DOI 10.1007/s11738-008-0206-y; Lee EJ, 2015, PLANT CELL TISS ORG, V120, P1, DOI [10.1007/s11240-014-0567-4, 10.1007/s11240-014-0467-7]; Lee JS, 2005, RAPID COMMUN MASS SP, V19, P3539, DOI 10.1002/rcm.2230; Lin CW, 2005, ANTIVIR RES, V68, P36, DOI 10.1016/j.antiviral.2005.07.002; Matkowski A, 2008, BIOTECHNOL ADV, V26, P548, DOI 10.1016/j.biotechadv.2008.07.001; Mohn T, 2008, PLANTA MED, V74, P582, DOI 10.1055/s-2008-1074504; Naik PM, 2010, PLANT CELL TISS ORG, V100, P235, DOI 10.1007/s11240-009-9639-2; *NAT COMM CHIN PHA, 2005, CHIN PHARM, P142; Ono NN, 2011, PLANT SCI, V180, P439, DOI 10.1016/j.plantsci.2010.11.012; Praveen N, 2012, IND CROP PROD, V35, P241, DOI 10.1016/j.indcrop.2011.07.009; Shi YH, 2012, INT J MOL SCI, V13, P9035, DOI 10.3390/ijms13079035; Shohael AM, 2006, PLANT CELL TISS ORG, V85, P219, DOI 10.1007/s11240-005-9075-x; Taneja J, 2010, PLANT CELL REP, V29, P1119, DOI 10.1007/s00299-010-0895-8; Terato M, 2011, PLANT BIOTECHNOL-NAR, V28, P317, DOI 10.5511/plantbiotechnology.11.0330a; Theboral J, 2014, PLANT CELL TISS ORG, V117, P477, DOI 10.1007/s11240-014-0450-3; Tsimogiannis D, 2007, MOLECULES, V12, P593, DOI 10.3390/12030593; Wang Y., 2011, J GUANGZHOU U TRADIT, V28, P419, DOI [10.13359/j.cnki.gzxbtcm.2011.04.025, DOI 10.13359/J.CNKI.GZXBTCM.2011.04.025]; Wilson SA, 2014, CURR OPIN BIOTECH, V26, P174, DOI 10.1016/j.copbio.2014.01.006; Wu N, 2010, J AGR FOOD CHEM, V58, P4737, DOI [10.1021/jf904593n, 10.1021/jf103970b]; Wu N, 2009, MOLECULES, V14, P1032, DOI 10.3390/molecules14031032	29	27	29	1	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2015	10	3							e0119022	10.1371/journal.pone.0119022	http://dx.doi.org/10.1371/journal.pone.0119022			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9BN	25785699	Green Submitted, Green Published, gold			2022-12-27	WOS:000352138500067
J	Ramp, C; Delarue, J; Palsboll, PJ; Sears, R; Hammond, PS				Ramp, Christian; Delarue, Julien; Palsboll, Per J.; Sears, Richard; Hammond, Philip S.			Adapting to a Warmer Ocean-Seasonal Shift of Baleen Whale Movements over Three Decades	PLOS ONE			English	Article							CLIMATE-CHANGE; HUMPBACK WHALES; NORTH-ATLANTIC; ST-LAWRENCE; BALAENOPTERA-PHYSALUS; BOWHEAD WHALES; MARINE MAMMALS; FIN WHALES; MIGRATION; GULF	Global warming poses particular challenges to migratory species, which face changes to the multiple environments occupied during migration. For many species, the timing of migration between summer and winter grounds and also within-season movements are crucial to maximise exploitation of temporarily abundant prey resources in feeding areas, themselves adapting to the warming planet. We investigated the temporal variation in the occurrence of fin (Balaenoptera physalus) and humpback whales (Megaptera novaeangliae) in a North Atlantic summer feeding ground, the Gulf of St. Lawrence (Canada), from 1984 to 2010 using a long-term study of individually identifiable animals. These two sympatric species both shifted their date of arrival at a previously undocumented rate of more than 1 day per year earlier over the study period thus maintaining the approximate 2-week difference in arrival of the two species and enabling the maintenance of temporal niche separation. However, the departure date of both species also shifted earlier but at different rates resulting in increasing temporal overlap over the study period indicating that this separation may be starting to erode. Our analysis revealed that the trend in arrival was strongly related to earlier ice break-up and rising sea surface temperature, likely triggering earlier primary production. The observed changes in phenology in response to ocean warming are a remarkable example of phenotypic plasticity and may partly explain how baleen whales were able to survive a number of changes in climate over the last several million years. However, it is questionable whether the observed rate of change in timing can be maintained. Substantial modification to the distribution or annual life cycle of these species might be required to keep up with the ongoing warming of the oceans.	[Ramp, Christian; Delarue, Julien; Sears, Richard] Mingan Isl Cetacean Study, St Lambert, PQ, Canada; [Ramp, Christian; Hammond, Philip S.] Univ St Andrews, Scottish Oceans Inst, Sea Mammal Res Unit, St Andrews, Fife, Scotland; [Palsboll, Per J.] Univ Groningen, Marine Evolut & Conservat, Ctr Ecol & Evolutionary Studies, Groningen, Netherlands	University of St Andrews; University of Groningen	Ramp, C (corresponding author), Mingan Isl Cetacean Study, St Lambert, PQ, Canada.	car@rorqual.com	Palsbøll, Per J/L-3494-2013; Palsboll, Per J/G-6988-2011	Palsbøll, Per J/0000-0002-4198-7599; Palsboll, Per J/0000-0002-4198-7599; Ramp, Christian/0000-0001-5528-1733; Hammond, Philip/0000-0002-2381-8302	Natural Environment Research Council [smru10001] Funding Source: researchfish	Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))		Agler B.A., 1990, Reports of the International Whaling Commission Special Issue, P349; Akaike H., 1985, CELEBRATION STAT, P1; Barco Susan G., 2002, Journal of Cetacean Research and Management, V4, P135; Bergerud A.T., 2007, RETURN CARIBOU UNGAV; Berube M, 1998, MOL ECOL, V7, P585, DOI 10.1046/j.1365-294x.1998.00359.x; Both C, 2005, GLOBAL CHANGE BIOL, V11, P1606, DOI 10.1111/j.1365-2486.2005.01038.x; Both C, 2006, NATURE, V441, P81, DOI 10.1038/nature04539; Both C, 2001, NATURE, V411, P296, DOI 10.1038/35077063; BRODIE PF, 1975, ECOLOGY, V56, P152, DOI 10.2307/1935307; Canese S, 2006, J MAR BIOL ASSOC UK, V86, P903, DOI 10.1017/S0025315406013853; Casey KS, 2010, OCEANOGRAPHY FROM SPACE: REVISITED, P273, DOI 10.1007/978-90-481-8681-5_16; CHITTLEBOROUGH R. G., 1965, AUSTRALIAN J MAR FRESHWATER RES, V16, P33; Clapham Phillip J., 1993, Symposia of the Zoological Society of London, V66, P131; Corkeron PJ, 1999, MAR MAMMAL SCI, V15, P1228, DOI 10.1111/j.1748-7692.1999.tb00887.x; Dawbin W.H., 1966, WHALES DOLPHINS PORP, P145; DFO, 2010, 201O030 DFO; Dingle H, 1996, BIOL LIFE MOVE; Dingle H, 2007, BIOSCIENCE, V57, P113, DOI 10.1641/B570206; Doniol-Valcroze T., 2008, THESIS MCGILL U MONT; Edwards M, 2004, NATURE, V430, P881, DOI 10.1038/nature02808; Fiedler W, 2004, ADV ECOL RES, V35, P49, DOI 10.1016/S0065-2504(04)35003-8; Galbraith PS, 2013, 2013 DFO, V026; Gavrilchuk K, 2014, MAR ECOL PROG SER, V497, P285, DOI 10.3354/meps10578; George JC, 1999, CAN J ZOOL, V77, P571, DOI 10.1139/cjz-77-4-571; Greenberg R., 2005, BIRDS 2 WORLDS ECOLO; Hawkes Lucy A., 2009, Endangered Species Research, V7, P137, DOI 10.3354/esr00198; Hazen EL, 2013, NAT CLIM CHANGE, V3, P234, DOI 10.1038/NCLIMATE1686; Horton TW, 2011, BIOL LETTERS, V7, P674, DOI 10.1098/rsbl.2011.0279; Huber C, 2006, EARTH PLANET SC LETT, V243, P504, DOI 10.1016/j.epsl.2006.01.002; Ingebrigtsen A., 1929, Rapport Conseil Exploration Mer Copenhague, V56, P1; International Whaling Commission, 2009, J CETACEAN RES MANAG, V11, P114; IPCC (Intergovernmental Panel on Climate Change), 2013, CLIMATE CHANGE 2013; Jacobsen K, 2006, MAR MAMMAL SCI, V20, P161; Jenni L, 2003, P ROY SOC B-BIOL SCI, V270, P1467, DOI 10.1098/rspb.2003.2394; Kaschner K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019653; Katona S.K., 1981, Polar Record, V20, P439; KATONA S. K., 1990, REPORT INT WHALING C, P295; Kingsley MCS, 1998, CAN J ZOOL, V76, P1529, DOI 10.1139/cjz-76-8-1529; Le Fouest V, 2005, J GEOPHYS RES-OCEANS, V110, DOI 10.1029/2004JC002423; Leaper R, 2006, BIOL LETTERS, V2, P289, DOI 10.1098/rsbl.2005.0431; Learmonth JA, 2006, OCEANOGR MAR BIOL, V44, P431; Lehikoinen E, 2004, ADV ECOL RES, V35, P1, DOI 10.1016/S0065-2504(04)35001-4; Mauchline J, 1969, Adv. mar. Biol., V7, P1; Melvin GD, 2009, ICES J MAR SCI, V66, P1784, DOI 10.1093/icesjms/fsp173; Moore SE, 2008, ECOL APPL, V18, pS157, DOI 10.1890/06-0571.1; Moore SE, 2006, ECOL APPL, V16, P932, DOI 10.1890/1051-0761(2006)016[0932:TISICW]2.0.CO;2; MYERS GS, 1949, COPEIA, P89; Notarbartolo-di-Sciara G, 2003, MAMMAL REV, V33, P105, DOI 10.1046/j.1365-2907.2003.00005.x; Parsons JL, 1981, DISTRIBUTION ABUNDAN; PETRIE B, 1996, CAN TECH REP HYDROGR, V178; R Core Team, 2011, R LANG ENV STAT COMP; Ramp C, 2014, ENDANGER SPECIES RES, V23, P125, DOI 10.3354/esr00571; Ramp C, 2010, MAR ECOL PROG SER, V400, P267, DOI 10.3354/meps08426; Robbins J., 2007, THESIS U ST ANDREWS; Robbins Jooke, 2011, Endangered Species Research, V13, P117, DOI 10.3354/esr00328; Robinson Robert A., 2009, Endangered Species Research, V7, P87, DOI 10.3354/esr00095; Schmidt M, 2011, NAT ED KNOWL, V3, P1; Sears R, 2002, MAR MAMMAL SCI, V18, P281, DOI 10.1111/j.1748-7692.2002.tb01034.x; Sergeant D. E., 1977, Report int. Whal. Commn, V27, P460; Sigurjonsson J, 1995, DEV MAR BIO, V4, P425; Simmonds MP, 2009, J MAR BIOL ASSOC UK, V89, P203, DOI 10.1017/S0025315408003196; Sparks TH, 2002, INT J CLIMATOL, V22, P1715, DOI 10.1002/joc.821; Stafford KM, 2007, ARCTIC, V60, P167; Stevick PT, 2003, J ZOOL, V259, P231, DOI 10.1017/S0952836902003151; Svaas S., 2001, CHANGES WINTERING SI; Tynan CT, 1997, ARCTIC, V50, P308, DOI 10.14430/arctic1113; Vaisanen R.V., 1997, LINNUT VUOSIKIRJA, P70; Van Buskirk J, 2009, GLOBAL CHANGE BIOL, V15, P760, DOI 10.1111/j.1365-2486.2008.01751.x; Visser F, 2011, MAR ECOL PROG SER, V440, P267, DOI 10.3354/meps09349; Visser ME, 2004, ADV ECOL RES, V35, P89, DOI 10.1016/S0065-2504(04)35005-1; WHITEHEAD H, 1982, CAN J ZOOL, V60, P2203, DOI 10.1139/z82-282; Williams TM, 1999, PHILOS T R SOC B, V354, P193, DOI 10.1098/rstb.1999.0371; [No title captured]	73	72	77	3	176	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2015	10	3							e0121374	10.1371/journal.pone.0121374	http://dx.doi.org/10.1371/journal.pone.0121374			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9BN	25785462	Green Published, Green Submitted, gold			2022-12-27	WOS:000352138500210
J	Sera, F; Ferrari, P				Sera, Francesco; Ferrari, Pietro			A Multilevel Model to Estimate the Within- and the Between-Center Components of the Exposure/Disease Association in the EPIC Study	PLOS ONE			English	Article							MEASUREMENT ERROR; CANCER; CALIBRATION; MULTICENTER; DIET; DESIGN; COHORT; RISK; BIAS	In a multicenter study, the overall relationship between exposure and the risk of cancer can be broken down into a within-center component, which reflects the individual level association, and a between-center relationship, which captures the association at the aggregate level. A piecewise exponential proportional hazards model with random effects was used to evaluate the association between dietary fiber intake and colorectal cancer (CRC) risk in the EPIC study. During an average follow-up of 11.0 years, 4,517 CRC events occurred among study participants recruited in 28 centers from ten European countries. Models were adjusted by relevant confounding factors. Heterogeneity among centers was modelled with random effects. Linear regression calibration was used to account for errors in dietary questionnaire (DQ) measurements. Risk ratio estimates for a 10 g/day increment in dietary fiber were equal to 0.90 (95% CI: 0.85, 0.96) and 0.85 (0.64, 1.14), at the individual and aggregate levels, respectively, while calibrated estimates were 0.85 (0.76, 0.94), and 0.87 (0.65, 1.15), respectively. In multicenter studies, over a straightforward ecological analysis, random effects models allow information at the individual and ecologic levels to be captured, while controlling for confounding at both levels of evidence.	[Sera, Francesco] ISPO, Canc Prevent & Res, Mol & Nutr Epidemiol Unit, Florence, Italy; [Ferrari, Pietro] Int Agcy Res Canc, Nutr & Metab Sect, F-69372 Lyon, France	World Health Organization; International Agency for Research on Cancer (IARC)	Ferrari, P (corresponding author), Int Agcy Res Canc, Nutr & Metab Sect, 150 Cours Albert Thomas, F-69372 Lyon, France.	ferrarip@iarc.fr		Sera, Francesco/0000-0002-8890-6848				BRENNER H, 1992, AM J EPIDEMIOL, V135, P85, DOI 10.1093/oxfordjournals.aje.a116205; Dallongeville J, 1998, J NUTR, V128, P1450; Darmon N, 2008, AM J CLIN NUTR, V87, P1107, DOI 10.1093/ajcn/87.5.1107; Ferrari P, 2004, AM J EPIDEMIOL, V160, P814, DOI 10.1093/aje/kwh280; Ferrari P, 2009, EUR J CLIN NUTR, V63, pS179, DOI 10.1038/ejcn.2009.80; Ferrari P, 2008, STAT MED, V27, P6037, DOI 10.1002/sim.3444; Ferrari P, 2008, INT J EPIDEMIOL, V37, P368, DOI 10.1093/ije/dym242; Ferrari P, 2007, INT J CANCER, V121, P2065, DOI 10.1002/ijc.22966; Goldstein H, 2002, STAT MED, V21, P3291, DOI 10.1002/sim.1264; Greenland S, 2002, STAT MED, V21, P389, DOI 10.1002/sim.1024; GREENLAND S, 1989, INT J EPIDEMIOL, V18, P269, DOI 10.1093/ije/18.1.269; GREENLAND S, 1994, AM J EPIDEMIOL, V139, P747, DOI 10.1093/oxfordjournals.aje.a117069; KAAKS R, 1994, AM J CLIN NUTR, V59, p245S, DOI 10.1093/ajcn/59.1.245S; Kaaks R, 1997, INT J EPIDEMIOL, V26, pS15, DOI 10.1093/ije/26.suppl_1.S15; KAAKS R, 1995, AM J EPIDEMIOL, V142, P548, DOI 10.1093/oxfordjournals.aje.a117673; Kipnis V, 2003, AM J EPIDEMIOL, V158, P14, DOI 10.1093/aje/kwg091; KLEIN JP, 1992, BIOMETRICS, V48, P795, DOI 10.2307/2532345; Matsuyama Y, 1998, STAT MED, V17, P1893; MORGENSTERN H, 1995, ANNU REV PUBL HEALTH, V16, P61, DOI 10.1146/annurev.pu.16.050195.000425; Morgenstern H, 2008, MODERN EPIDEMIOLOGY, P511; Murphy N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039361; NAVIDI W, 1994, ENVIRON HEALTH PERSP, V102, P25, DOI 10.1289/ehp.94102s825; Neuhaus JM, 1998, BIOMETRICS, V54, P638, DOI 10.2307/3109770; Rasbash J, 2009, MLWIN VERSION 21; Riboli E, 2002, PUBLIC HEALTH NUTR, V5, P1113, DOI 10.1079/PHN2002394; ROSNER B, 1989, STAT MED, V8, P1051, DOI 10.1002/sim.4780080905; Rubin D. B., 2004, MULTIPLE IMPUTATION; SHEPPARD L, 1995, BIOMETRICS, V51, P853, DOI 10.2307/2532987; Skrondal A., 2004, GEN LATENT VARIABLE; Slimani N, 2002, PUBLIC HEALTH NUTR, V5, P1125, DOI 10.1079/PHN2002395; Slimani N, 2000, EUR J CLIN NUTR, V54, P900, DOI 10.1038/sj.ejcn.1601107; Snjiders T., 1999, MULTILEVEL ANAL INTR; StataCorp, 2011, STAT STAT SOFTW REL, P173; Swihart BJ, 2012, STAT MED, V31, P855, DOI 10.1002/sim.4457; Therneau T.M., 2000, MODELING SURVIVAL DA; Vaida F, 2000, STAT MED, V19, P3309, DOI 10.1002/1097-0258(20001230)19:24<3309::AID-SIM825>3.0.CO;2-9; WILLETT W, 1989, STAT MED, V8, P1031, DOI 10.1002/sim.4780080903; Wong MCM, 2006, STAT MED, V25, P447, DOI 10.1002/sim.2235; Yamaguchi T, 2002, STAT METHODS MED RES, V11, P221, DOI 10.1191/0962280202sm284ra	39	4	4	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2015	10	3							e0117815	10.1371/journal.pone.0117815	http://dx.doi.org/10.1371/journal.pone.0117815			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9BN	25785729	Green Submitted, Green Published, gold			2022-12-27	WOS:000352138500018
J	Brunello, GHV; Nakano, EY				Vatanabe Brunello, Gabriel Hideki; Nakano, Eduardo Yoshio			Bayesian Inference on Proportional Elections	PLOS ONE			English	Article								Polls for majoritarian voting systems usually show estimates of the percentage of votes for each candidate. However, proportional vote systems do not necessarily guarantee the candidate with the most percentage of votes will be elected. Thus, traditional methods used in majoritarian elections cannot be applied on proportional elections. In this context, the purpose of this paper was to perform a Bayesian inference on proportional elections considering the Brazilian system of seats distribution. More specifically, a methodology to answer the probability that a given party will have representation on the chamber of deputies was developed. Inferences were made on a Bayesian scenario using the Monte Carlo simulation technique, and the developed methodology was applied on data from the Brazilian elections for Members of the Legislative Assembly and Federal Chamber of Deputies in 2010. A performance rate was also presented to evaluate the efficiency of the methodology. Calculations and simulations were carried out using the free R statistical software.	[Vatanabe Brunello, Gabriel Hideki; Nakano, Eduardo Yoshio] Univ Brasilia, Dept Stat, Brasilia, DF, Brazil	Universidade de Brasilia	Nakano, EY (corresponding author), Univ Brasilia, Dept Stat, Campus Darcy Ribeiro, Brasilia, DF, Brazil.	eynakano@gmail.com	Nakano, Eduardo Y/G-1660-2011	Nakano, Eduardo Y/0000-0002-9071-8512	National Council for Scientific and Technological Development (CNPq); Decanato de Pesquisa e Posgraduacao (DPP) of the University of Brasilia (UNB)	National Council for Scientific and Technological Development (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Decanato de Pesquisa e Posgraduacao (DPP) of the University of Brasilia (UNB)	The authors are grateful to the National Council for Scientific and Technological Development (CNPq) and to Decanato de Pesquisa e Posgraduacao (DPP) of the University of Brasilia (UNB) for the financial support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2014, R LANG ENV STAT COMP; Gelman A., 2004, BAYESIAN DATA ANAL; Nicolau JM, 1993, SISTEMA ELEITORAL RE	4	0	0	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2015	10	3							e0116924	10.1371/journal.pone.0116924	http://dx.doi.org/10.1371/journal.pone.0116924			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9BN	25786259	gold, Green Published, Green Submitted			2022-12-27	WOS:000352138500015
J	Wu, XY; Tao, SM; Zhang, YK; Zhang, SC; Tao, FB				Wu, Xiaoyan; Tao, Shuman; Zhang, Yukun; Zhang, Shichen; Tao, Fangbiao			Low Physical Activity and High Screen Time Can Increase the Risks of Mental Health Problems and Poor Sleep Quality among Chinese College Students	PLOS ONE			English	Article							SCHOOL-AGED CHILDREN; SEDENTARY BEHAVIOR; ADOLESCENTS; TELEVISION; EXERCISE; ASSOCIATIONS; INSTRUMENT; DEPRESSION; FITNESS; HABITS	Objective To test the independent and interactive associations of physical activity (PA) and screen time (ST) with self-reported mental health and sleep quality among Chinese college students. Method Data were collected in October, 2013. The gender, age, residential background, body mass index (BMI), perceived family economy and perceived study burden were obtained from a total of 4747 college students (41.6% males and 58.4% females). The outcomes were self-reported PA status, ST, anxiety, depression, psychopathological symptoms and sleep quality. Analyses were conducted with logistic regression models. Results Overall, 16.3%, 15.9% and 17.3% of the students had psychological problems, such as anxiety, depression and psychopathological symptoms, respectively. The prevalence of poor sleep quality was 9.8%. High ST was significantly positively associated with anxiety (OR=1.38, 95% CI: 1.15-1.65), depression (OR=1.76, 95% CI: 1.47-2.09), psychopathological symptoms (OR=1.69, 95% CI: 1.43-2.01) and poor sleep quality (OR=1.32, 95% CI: 1.06-1.65). High PA was insignificantly negatively associated with anxiety, depression, psychopathological symptoms and poor sleep. Low PA and high ST were independently and interactively associated with increased risks of mental health problems and poor sleep quality (p<0.05 for all). Conclusion Interventions are needed to reduce ST and increase PA in the lifestyles of young people. Future research should develop and measure the impacts of interventions and their potential consequences on sleep, health, and well being.	[Wu, Xiaoyan; Tao, Shuman; Zhang, Yukun; Zhang, Shichen; Tao, Fangbiao] Anhui Med Univ, Sch Publ Hlth, Dept Maternal Child & Adolescent Hlth, Hefei, Peoples R China; [Wu, Xiaoyan; Zhang, Shichen; Tao, Fangbiao] Anhui Prov Key Lab Populat Hlth & Aristogen, Hefei, Peoples R China	Anhui Medical University	Tao, FB (corresponding author), Anhui Med Univ, Sch Publ Hlth, Dept Maternal Child & Adolescent Hlth, Hefei, Peoples R China.	fbtao@ahmu.edu.cn	张, 诗晨/HGD-5158-2022		National Natural Science Foundation of China [81302448]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	National Natural Science Foundation of China (grant number 81302448) URL: http://www.nsfc.gov.cn/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams TB, 2007, WOMEN HEALTH, V45, P69, DOI 10.1300/J013v45n01_05; Biddle SJH, 2011, BRIT J SPORT MED, V45, P886, DOI 10.1136/bjsports-2011-090185; Brand S, 2010, J ADOLESCENT HEALTH, V46, P133, DOI 10.1016/j.jadohealth.2009.06.018; Buysse D J, 1989, Psychiatry Res, V28, P193; Cain N, 2010, SLEEP MED, V11, P735, DOI 10.1016/j.sleep.2010.02.006; Cao H, 2011, PREV MED, V53, P316, DOI 10.1016/j.ypmed.2011.09.002; Castillo LG, 2013, J CLIN PSYCHOL, V69, P291, DOI 10.1002/jclp.21972; Chao X., 2008, CHIN J PUBLIC HLTH, V24, P1031, DOI [10.11847/zgggws2008-24-09-68, DOI 10.11847/ZGGGWS2008-24-09-68]; Chennaoui M, 2014, SLEEP MED REV; Cooney GM, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004366.pub6; Feng Q, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0100914, 10.1371/journal.pone.0104348]; Goldbacher EM, 2007, ANN BEHAV MED, V34, P240, DOI 10.1007/BF02874549; Hale L, 2014, SLEEP MED REV; Hallal PC, 2012, LANCET, V380, P247, DOI 10.1016/S0140-6736(12)60646-1; Hamer M, 2010, AM J PREV MED, V38, P375, DOI 10.1016/j.amepre.2009.12.030; Hamer M, 2009, PEDIATRICS, V123, P1263, DOI 10.1542/peds.2008-1523; Iannotti RJ, 2009, INT J PUBLIC HEALTH, V54, P191, DOI 10.1007/s00038-009-5410-z; Iannotti RJ, 2009, J ADOLESCENT HEALTH, V44, P493, DOI 10.1016/j.jadohealth.2008.10.142; Janssen I, 2010, INT J BEHAV NUTR PHY, V7, DOI 10.1186/1479-5868-7-40; Jayakody K, 2014, BRIT J SPORT MED, V48, P187, DOI 10.1136/bjsports-2012-091287; Kamijo K, 2009, CLIN NEUROPHYSIOL, V120, P511, DOI 10.1016/j.clinph.2008.11.022; Katzmarzyk PT, 2010, DIABETES, V59, P2717, DOI 10.2337/db10-0822; Kim YS, 2012, PREV MED, V55, P458, DOI 10.1016/j.ypmed.2012.08.021; Kjonniksen L, 2008, INT J BEHAV NUTR PHY, V5, DOI 10.1186/1479-5868-5-69; Kremer P, 2014, J SCI MED SPORT, V17, P183, DOI 10.1016/j.jsams.2013.03.012; [凌宇 LING Yu], 2008, [中国临床心理学杂志, Chinese Journal of Clinical Psychology], V16, P265; Liu XC, 1996, J MOL RECOGNIT, V9, P462, DOI 10.1002/(SICI)1099-1352(199634/12)9:5/6<462::AID-JMR283>3.0.CO;2-G; Mammen G, 2013, AM J PREV MED, V45, P649, DOI 10.1016/j.amepre.2013.08.001; Matamura M, 2014, J SLEEP RES, V23, P290, DOI 10.1111/jsr.12127; Melkevik O, 2010, INT J BEHAV NUTR PHY, V7, DOI 10.1186/1479-5868-7-46; Must A, 2005, INT J OBESITY, V29, pS84, DOI 10.1038/sj.ijo.0803064; Nuutinen T, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-684; O'Donovan G, 2010, J SPORT SCI, V28, P573, DOI 10.1080/02640411003671212; Ploughman M, 2008, DEV NEUROREHABIL, V11, P236, DOI 10.1080/17518420801997007; Rocha SD, 2014, MED PROBL PERFORM AR, V29, P111, DOI 10.21091/mppa.2014.2022; Rothon C, 2010, BMC MED, V8, DOI 10.1186/1741-7015-8-32; Soric M, 2015, ANN HUM BIOL, V42, P31, DOI 10.3109/03014460.2014.928367; Tao F., 2008, CHIN J DIS CONTROL P, V12, P309, DOI [10.3969/j.issn.1674-3679.2008.04.003, DOI 10.3969/J.ISSN.1674-3679.2008.04.003]; Themanson JR, 2008, NEUROSCIENCE, V157, P319, DOI 10.1016/j.neuroscience.2008.09.014; Tibber MS, 2013, FRONT PSYCHOL, V4, DOI [10.3389/fpsyg.2013.00088, 10.3389/fpsyt.2013.00027]; Tremblay MS, 2011, INT J BEHAV NUTR PHY, V8, DOI 10.1186/1479-5868-8-98; Trost SG, 2014, BRIT J SPORT MED, V48, P169, DOI 10.1136/bjsports-2013-093372; Tyson P, 2010, J MENT HEALTH, V19, P492, DOI 10.3109/09638230902968308; VanKim NA, 2013, AM J HEALTH PROMOT, V28, P7, DOI 10.4278/ajhp.111101-QUAN-395; Velez Juan Carlos, 2013, Sleep Disord, V2013, P910104, DOI 10.1155/2013/910104; Wang H, 2014, J SPORT MED PHYS FIT, V54, P518; Wijndaele K, 2011, INT J EPIDEMIOL, V40, P150, DOI 10.1093/ije/dyq105; Yu Qian-chun, 2013, Zhonghua Yu Fang Yi Xue Za Zhi, V47, P542; ZUNG WWK, 1971, PSYCHOSOMATICS, V12, P371	49	119	123	5	90	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2015	10	3							e0119607	10.1371/journal.pone.0119607	http://dx.doi.org/10.1371/journal.pone.0119607			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CE9BN	25786030	Green Submitted, Green Published, gold			2022-12-27	WOS:000352138500118
J	Joensuu, JT; Huoponen, S; Aaltonen, KJ; Konttinen, YT; Nordstrom, D; Blom, M				Joensuu, Jaana T.; Huoponen, Saara; Aaltonen, Kalle J.; Konttinen, Yrjo T.; Nordstrom, Dan; Blom, Marja			The Cost-Effectiveness of Biologics for the Treatment of Rheumatoid Arthritis: A Systematic Review	PLOS ONE			English	Review							TUMOR-NECROSIS-FACTOR; MODIFYING ANTIRHEUMATIC DRUGS; FACTOR-ALPHA INHIBITORS; EULAR RECOMMENDATIONS; TREATMENT STRATEGIES; ECONOMIC-EVALUATION; INADEQUATE RESPONSE; CLINICAL-PRACTICE; UTILITY ANALYSIS; TNF-INHIBITORS	Background and Objectives Economic evaluations provide information to aid the optimal utilization of limited healthcare resources. Costs of biologics for Rheumatoid arthritis (RA) are remarkably high, which makes these agents an important target for economic evaluations. This systematic review aims to identify existing studies examining the cost-effectiveness of biologics for RA, assess their quality and report their results systematically. Methods A literature search covering Medline, Scopus, Cochrane library, ACP Journal club and Web of Science was performed in March 2013. The cost-utility analyses (CUAs) of one or more available biological drugs for the treatment of RA in adults were included. Two independent investigators systematically collected information and assessed the quality of the studies. To enable the comparison of the results, all costs were converted to 2013 euro. Results Of the 4890 references found in the literature search, 41 CUAs were included in the current systematic review. While considering only direct costs, the incremental cost-effectiveness ratio (ICER) of the tumor necrosis factor inhibitors (TNFi) ranged from 39,000 to 1 273,000 (sic)/quality adjusted life year (QALY) gained in comparison to conventional disease-modifying antirheumatic drugs (cDMARDs) in cDMARD naive patients. Among patients with an insufficient response to cDMARDs, biologics were associated with ICERs ranging from 12,000 to 708,000 (sic)/QALY. Rituximab was found to be the most cost-effective alternative compared to other biologics among the patients with an insufficient response to TNFi. Conclusions When 35,000 (sic)/QALY is considered as a threshold for the ICER, TNFis do not seem to be cost-effective among cDMARD naive patients and patients with an insufficient response to cDMARDs. With thresholds of 50,000 to 100,000 (sic)/QALY biologics might be cost-effective among patients with an inadequate response to cDMARDs. Standardization of multiattribute utility instruments and a validated standard conversion method for missing utility measures would enable better comparison between CUAs.	[Joensuu, Jaana T.; Huoponen, Saara; Aaltonen, Kalle J.; Blom, Marja] Univ Helsinki, Fac Pharm, Helsinki, Finland; [Konttinen, Yrjo T.; Nordstrom, Dan] Univ Helsinki, Inst Clin Med, Helsinki, Finland; [Konttinen, Yrjo T.; Nordstrom, Dan] Univ Helsinki, Cent Hosp, Helsinki, Finland	University of Helsinki; University of Helsinki; University of Helsinki; Helsinki University Central Hospital	Joensuu, JT (corresponding author), Univ Helsinki, Fac Pharm, Helsinki, Finland.	jaana.joensuu@helsinki.fi		Joensuu, Jaana/0000-0002-5116-6380	Research Foundation of the University of Helsinki	Research Foundation of the University of Helsinki	JTJ has received a 22,000(sic) grant from the Research Foundation of the University of Helsinki (http://www.helsinki.fi/tiedesaatio/grants/). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aaltonen KJ, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0043508, 10.1371/journal.pone.0030275]; Alamanos Y, 2006, SEMIN ARTHRITIS RHEU, V36, P182, DOI 10.1016/j.semarthrit.2006.08.006; Bansback NJ, 2005, ANN RHEUM DIS, V64, P995, DOI 10.1136/ard.2004.027565; Barbieri M, 2005, PHARMACOECONOMICS, V23, P607, DOI 10.2165/00019053-200523060-00007; Barton P, 2004, HEALTH TECHNOL ASSES, V8, P1; Brennan A, 2007, RHEUMATOLOGY, V46, P1345, DOI 10.1093/rheumatology/kem115; Brennan A, 2004, RHEUMATOLOGY, V43, P62, DOI 10.1093/rheumatology/keg451; Brodszky V, 2010, MED SCI MONITOR, V16, P1; Canadian Agency for Drugs and Technologies in Health, 2010, CADTH THERAPEUTIC RE; Chen YF, 2006, HEALTH TECHNOL ASSES, V10, P1, DOI 10.3310/hta10420; Chiou Chiun-Fang, 2004, Expert Rev Pharmacoecon Outcomes Res, V4, P307, DOI 10.1586/14737167.4.3.307; Clark W, 2004, HEALTH TECHNOL ASSES, V8, P1; Coyle D, 2006, TECHNOLOGY REPORT NO; Davies A, 2009, J RHEUMATOL, V36, P16, DOI 10.3899/jrheum.080257; Diamantopoulos Alexander, 2012, J Med Econ, V15, P576, DOI 10.3111/13696998.2012.665110; Drummond M, 2005, METHODS FOR ECONOMIC; Drummond MF, 1996, BRIT MED J, V313, P275, DOI 10.1136/bmj.313.7052.275; Farahani P, 2006, J EVAL CLIN PRACT, V12, P463, DOI 10.1111/j.1365-2753.2006.00731.x; Finckh A, 2009, ANN INTERN MED, V151, P612, DOI 10.7326/0003-4819-151-9-200911030-00006; Hallinen TA, 2010, RHEUMATOLOGY, V49, P767, DOI 10.1093/rheumatology/kep425; Hoaglin DC, 2011, VALUE HEALTH, V14, P429, DOI 10.1016/j.jval.2011.01.011; Jobanputra P, 2002, HEALTH TECHNOL ASSES, V6, P1, DOI DOI 10.3310/hta6210; Kielhorn A, 2008, CURR MED RES OPIN, V24, P2639, DOI [10.1185/03007990802321683, 10.1185/03007990802321683 ]; Kobelt G, 2005, ANN RHEUM DIS, V64, P1174, DOI 10.1136/ard.2004.032789; Kobelt G, 2004, ANN RHEUM DIS, V63, P4, DOI 10.1136/ard.2003.010629; Kobelt G, 2003, RHEUMATOLOGY, V42, P326, DOI 10.1093/rheumatology/keg107; Kobelt G, 2011, INT J TECHNOL ASSESS, V27, P193, DOI 10.1017/S0266462311000195; Lekander I, 2013, EUR J HEALTH ECON, V14, P863, DOI 10.1007/s10198-012-0431-6; Lekander I, 2010, INT J TECHNOL ASSESS, V26, P54, DOI 10.1017/S0266462309990596; Lindgren P, 2009, INT J TECHNOL ASSESS, V25, P181, DOI 10.1017/S0266462309090230; Lundkvist J, 2008, EUR J HEALTH ECON, V8, pS49, DOI 10.1007/s10198-007-0088-8; Malottki K, 2011, HEALTH TECHNOL ASSES, V15, P1, DOI 10.3310/hta15140; Marra CA, 2007, J CLIN EPIDEMIOL, V60, P616, DOI 10.1016/j.jclinepi.2006.09.006; Merkesdal S, 2010, EUR J HEALTH ECON, V11, P95, DOI 10.1007/s10198-009-0205-y; Nam JL, 2010, ANN RHEUM DIS, V69, P976, DOI 10.1136/ard.2009.126573; Nam JL, 2014, ANN RHEUM DIS, V73, P516, DOI 10.1136/annrheumdis-2013-204577; National Institution for Health and Clinical Excellence, 2013, GUIDE TO THE METHODS; Nguyen CM, 2012, PHARMACOECONOMICS, V30, P575, DOI 10.2165/11594990-000000000-00000; Philips Z, 2004, HEALTH TECHNOL ASSES, V8, P1; Schipper LG, 2011, RHEUMATOLOGY, V50, P1320, DOI 10.1093/rheumatology/ker084; Schoels M, 2010, ANN RHEUM DIS, V69, P995, DOI 10.1136/ard.2009.126714; Shemilt I, 2008, COCHRANE HDB SYSTEMA, P449, DOI DOI 10.1002/14651858.CD004741.PUB2; Smolen JS, 2014, ANN RHEUM DIS, V73, P492, DOI 10.1136/annrheumdis-2013-204573; Soini E J, 2012, J Med Econ, V15, P340, DOI 10.3111/13696998.2011.649327; Spalding JR, 2006, PHARMACOECONOMICS, V24, P1221, DOI 10.2165/00019053-200624120-00006; Tanno Makoto, 2006, Mod Rheumatol, V16, P77; Tsao NW, 2012, BEST PRACT RES CL RH, V26, P659, DOI 10.1016/j.berh.2012.07.012; van den Hout WB, 2009, ARTHRIT RHEUM-ARTHR, V61, P291, DOI 10.1002/art.24169; van der Velde G, 2011, ARTHRIT CARE RES, V63, P65, DOI 10.1002/acr.20338; Vera-Llonch M, 2008, RHEUMATOLOGY, V47, P535, DOI 10.1093/rheumatology/ken007; Vera-Llonch M, 2008, J RHEUMATOL, V35, P1745; Wailoo AJ, 2008, ARTHRITIS RHEUM-US, V58, P939, DOI 10.1002/art.23374; Welsing PMJ, 2004, ARTHRIT RHEUM-ARTHR, V51, P964, DOI 10.1002/art.20843; Wong JB, 2002, AM J MED, V113, P400, DOI 10.1016/S0002-9343(02)01243-3; Wu B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047373; Yuan Yong, 2010, J Med Econ, V13, P33, DOI 10.3111/13696990903508021	56	69	70	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2015	10	3							e0119683	10.1371/journal.pone.0119683	http://dx.doi.org/10.1371/journal.pone.0119683			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7QC	25781999	Green Published, gold, Green Submitted			2022-12-27	WOS:000351284600085
J	de Gardelle, V; Mamassian, P				de Gardelle, Vincent; Mamassian, Pascal			Weighting Mean and Variability during Confidence Judgments	PLOS ONE			English	Article							INTERINDIVIDUAL DIFFERENCES; SIGNAL-DETECTION; ACCURACY; DECISION; REPRESENTATION; MISPERCEPTION; MEMORY; TIME	Humans can not only perform some visual tasks with great precision, they can also judge how good they are in these tasks. However, it remains unclear how observers produce such metacognitive evaluations, and how these evaluations might be dissociated from the performance in the visual task. Here, we hypothesized that some stimulus variables could affect confidence judgments above and beyond their impact on performance. In a motion categorization task on moving dots, we manipulated the mean and the variance of the motion directions, to obtain a low-mean low-variance condition and a high-mean high-variance condition with matched performances. Critically, in terms of confidence, observers were not indifferent between these two conditions. Observers exhibited marked preferences, which were heterogeneous across individuals, but stable within each observer when assessed one week later. Thus, confidence and performance are dissociable and observers' confidence judgments put different weights on the stimulus variables that limit performance.	[de Gardelle, Vincent; Mamassian, Pascal] CNRS, Lab Psychol Percept, Paris, France; [de Gardelle, Vincent; Mamassian, Pascal] Univ Paris 05, Paris, France; [de Gardelle, Vincent] CNRS, Ctr Econ Sorbonne, Paris, France; [de Gardelle, Vincent] Univ Paris 01, F-75231 Paris 05, France; [de Gardelle, Vincent] Paris Sch Econ, Paris, France; [Mamassian, Pascal] CNRS, Lab Syst Perceptifs, Paris, France; [Mamassian, Pascal] Ecole Normale Super, F-75231 Paris, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); heSam Universite; Universite Pantheon-Sorbonne; Paris School of Economics; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; PSL Research University Paris; Ecole Normale Superieure (ENS)	de Gardelle, V (corresponding author), CNRS, Lab Psychol Percept, Paris, France.	vincent.gardelle@gmail.com	de Gardelle, Vincent/I-1226-2014; Mamassian, Pascal/F-4781-2012	de Gardelle, Vincent/0000-0001-5977-5597; Mamassian, Pascal/0000-0002-1605-4607	Agence Nationale de la Recherche [ANR-10-BLAN-1910]	Agence Nationale de la Recherche(French National Research Agency (ANR))	This work was supported by an Agence Nationale de la Recherche grant to PM [ANR-10-BLAN-1910 "Visual Confidence"]. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BARANSKI JV, 1994, PERCEPT PSYCHOPHYS, V55, P412, DOI 10.3758/BF03205299; Barthelme S, 2010, P NATL ACAD SCI USA, V107, P20834, DOI 10.1073/pnas.1007704107; Barthelme S, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000504; Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; Busey TA, 2000, PSYCHON B REV, V7, P26, DOI 10.3758/BF03210724; CLARKE FR, 1959, J ACOUST SOC AM, V31, P629, DOI 10.1121/1.1907764; de Gardelle V, 2014, PSYCHOL SCI, V25, P1286, DOI 10.1177/0956797614528956; de Gardelle V, 2011, P NATL ACAD SCI USA, V108, P13341, DOI 10.1073/pnas.1104517108; Drugowitsch J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096511; Fleming SM, 2010, SCIENCE, V329, P1541, DOI 10.1126/science.1191883; Galvin SJ, 2003, PSYCHON B REV, V10, P843, DOI 10.3758/BF03196546; Gonzalez R, 1999, COGNITIVE PSYCHOL, V38, P129, DOI 10.1006/cogp.1998.0710; Gorea A, 2000, P NATL ACAD SCI USA, V97, P12380, DOI 10.1073/pnas.97.22.12380; Green DM, 1966, SIGNAL DETECTION THE; Kanai R, 2011, NAT REV NEUROSCI, V12, P231, DOI 10.1038/nrn3000; Kareev Y, 2002, J EXP PSYCHOL GEN, V131, P287, DOI 10.1037//0096-3445.131.2.287; Kiani R, 2009, SCIENCE, V324, P759, DOI 10.1126/science.1169405; Koriat A, 1997, J EXP PSYCHOL GEN, V126, P349, DOI 10.1037/0096-3445.126.4.349; Kornell N, 2011, PSYCHOL SCI, V22, P787, DOI 10.1177/0956797611407929; Maniscalco B, 2012, CONSCIOUS COGN, V21, P422, DOI 10.1016/j.concog.2011.09.021; Pelli DG, 1997, SPATIAL VISION, V10, P437, DOI 10.1163/156856897X00366; Pierce CS., 1885, MEMOIRS NATL ACAD SC, V3, P73; Pleskac TJ, 2010, PSYCHOL REV, V117, P864, DOI 10.1037/a0019737; Rahnev D, 2012, J NEUROPHYSIOL, V107, P1556, DOI 10.1152/jn.00985.2011; Rahnev D, 2011, NAT NEUROSCI, V14, P1513, DOI 10.1038/nn.2948; Ratcliff R, 2009, PSYCHOL REV, V116, P59, DOI 10.1037/a0014086; Rhodes MG, 2008, J EXP PSYCHOL GEN, V137, P615, DOI 10.1037/a0013684; Rounis E, 2010, COGN NEUROSCI-UK, V1, P165, DOI 10.1080/17588921003632529; Song C, 2011, CONSCIOUS COGN, V20, P1787, DOI 10.1016/j.concog.2010.12.011; Wilimzig C, 2008, J VISION, V8, DOI 10.1167/8.5.7; Zizlsperger L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041136; Zylberberg A, 2014, CONSCIOUS COGN, V27, P246, DOI 10.1016/j.concog.2014.05.012	32	34	34	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2015	10	3							e0120870	10.1371/journal.pone.0120870	http://dx.doi.org/10.1371/journal.pone.0120870			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CE8HY	25793275	gold, Green Submitted, Green Published			2022-12-27	WOS:000352083900084
J	Carozzo, A; Diez, F; Gomez, N; Cabrera, M; Shayo, C; Davio, C; Fernandez, N				Carozzo, Alejandro; Diez, Federico; Gomez, Natalia; Cabrera, Maia; Shayo, Carina; Davio, Carlos; Fernandez, Natalia			Dual Role of cAMP in the Transcriptional Regulation of Multidrug Resistance-Associated Protein 4 (MRP4) in Pancreatic Adenocarcinoma Cell Lines	PLOS ONE			English	Article							SIGNALING MOLECULES; REDUCED GLUTATHIONE; CONFERS RESISTANCE; EFFLUX TRANSPORTER; CYCLIC-NUCLEOTIDES; ABCC4; CANCER; EXPRESSION; DRUGS; EPAC	Cyclic AMP represents one of the most studied signaling molecules and its role in proliferation and differentiation processes has been well established. Intracellular cAMP levels are tightly regulated where the MRP4 transporter plays a major role. In the present study, we sought to establish whether cAMP modulated MRP4 expression in pancreatic adenocarcinoma cell lines. Quantitative PCR and western blot studies showed that cAMP-increasing agents enhanced MRP4 transcripts and protein levels in PANC-1 cells. Reporter luciferase experiments carried out in pancreatic AR42J cells showed that intracellular cAMP up-regulates MRP4 through an Epac2-and Rap1-mediated mechanism whereas extracellular cAMP reduced MRP4 promoter activity by a MEK/ ERK-mediated pathway. Present results show that cAMP regulates MRP4 promoter activity, and further indicate that the balance between intracellular and extracellular cAMP levels determines MRP4 expression.	[Carozzo, Alejandro; Diez, Federico; Gomez, Natalia; Cabrera, Maia; Shayo, Carina; Davio, Carlos; Fernandez, Natalia] Univ Buenos Aires, Fac Farm & Bioquim, Dept Farmacol, Catedra Quim Med,Lab Farmacol Receptores, RA-1113 Buenos Aires, DF, Argentina; [Shayo, Carina] Inst Biol & Med Expt, Lab Patol & Farmacol Mol, RA-1428 Buenos Aires, DF, Argentina; [Carozzo, Alejandro; Diez, Federico; Gomez, Natalia; Cabrera, Maia; Davio, Carlos; Fernandez, Natalia] Consejo Nacl Invest Cient & Tecn, Buenos Aires, DF, Argentina	University of Buenos Aires; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Institute of Biology & Experimental Medicine; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)	Fernandez, N (corresponding author), Univ Buenos Aires, Fac Farm & Bioquim, Dept Farmacol, Catedra Quim Med,Lab Farmacol Receptores, RA-1113 Buenos Aires, DF, Argentina.	natycfernandez@gmail.com			Universidad de Buenos Aires [UBACyT 20020400100601]; Agencia Nacional de Promocion Cientifica y Tecnologica [PICT-2010-1571]; Consejo Nacional de Investigaciones Cientificas y Tecnicas [PIP0344]	Universidad de Buenos Aires(University of Buenos Aires); Agencia Nacional de Promocion Cientifica y Tecnologica(ANPCyT); Consejo Nacional de Investigaciones Cientificas y Tecnicas(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET))	This work was supported by grants from Universidad de Buenos Aires (UBACyT 20020400100601), Agencia Nacional de Promocion Cientifica y Tecnologica (PICT-2010-1571), and Consejo Nacional de Investigaciones Cientificas y Tecnicas (PIP0344). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bagnoli M, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/143202; Beavo JA, 2002, NAT REV MOL CELL BIO, V3, P710, DOI 10.1038/nrm911; Breckler M, 2011, CELL SIGNAL, V23, P1257, DOI 10.1016/j.cellsig.2011.03.007; Broderdorf S, 2014, PHARMACOGENET GENOM, V24, P522, DOI 10.1097/FPC.0000000000000084; Burgun C, 2000, FEBS LETT, V484, P189, DOI 10.1016/S0014-5793(00)02153-0; Chen ZS, 2002, CANCER RES, V62, P3144; Chen ZS, 2001, J BIOL CHEM, V276, P33747, DOI 10.1074/jbc.M104833200; Copsel S, 2011, J BIOL CHEM, V286, P6979, DOI 10.1074/jbc.M110.166868; DAVIO CA, 1995, BIOCHEM PHARMACOL, V50, P91, DOI 10.1016/0006-2952(95)00108-C; Dreuw A, 2005, J INVEST DERMATOL, V124, P28, DOI 10.1111/j.0022-202X.2004.23499.x; Gloerich M, 2010, ANNU REV PHARMACOL, V50, P355, DOI 10.1146/annurev.pharmtox.010909.105714; Gu XS, 2010, DRUG METAB REV, V42, P482, DOI 10.3109/03602531003654915; Hochbaum D, 2003, J BIOL CHEM, V278, P33738, DOI 10.1074/jbc.M305208200; Hofer AM, 2007, PHYSIOLOGY, V22, P320, DOI 10.1152/physiol.00019.2007; Huynh T, 2012, FRONT ONCOL, V2, DOI 10.3389/fonc.2012.00178; Leggas M, 2004, MOL CELL BIOL, V24, P7612, DOI 10.1128/MCB.24.17.7612-7621.2004; Lohr M, 2006, NAT CLIN PRACT GASTR, V3, P236, DOI 10.1038/ncpgasthep0469; Montani M, 2013, VIRCHOWS ARCH, V462, P437, DOI 10.1007/s00428-013-1390-8; Norris MD, 2005, MOL CANCER THER, V4, P547, DOI 10.1158/1535-7163.MCT-04-0161; O'Hayre M, 2013, NAT REV CANCER, V13, P412, DOI 10.1038/nrc3521; Osycka-Salut C, 2014, MOL HUM REPROD, V20, P89, DOI 10.1093/molehr/gat053; Qian ZL, 2014, GENE CHROMOSOME CANC, V53, P883, DOI 10.1002/gcc.22196; Rahib L, 2014, CANCER RES, V74, P2913, DOI 10.1158/0008-5472.CAN-14-0155; Reid G, 2003, MOL PHARMACOL, V63, P1094, DOI 10.1124/mol.63.5.1094; Reid G, 2003, P NATL ACAD SCI USA, V100, P9244, DOI 10.1073/pnas.1033060100; Ritter CA, 2005, DRUG METAB REV, V37, P253, DOI 10.1081/DMR-200047984; Rius M, 2006, AM J PHYSIOL-GASTR L, V290, pG640, DOI 10.1152/ajpgi.00354.2005; Rius M, 2003, HEPATOLOGY, V38, P374, DOI 10.1053/jhep.2003.50331; Rodriguez MR, 2011, GASTROENTEROLOGY, V140, P1292, DOI 10.1053/j.gastro.2010.12.053; Russel FGM, 2008, TRENDS PHARMACOL SCI, V29, P200, DOI 10.1016/j.tips.2008.01.006; Stork PJS, 2002, TRENDS CELL BIOL, V12, P258, DOI 10.1016/S0962-8924(02)02294-8; Sun YL, 2014, CARCINOGENESIS, V35, P1941, DOI 10.1093/carcin/bgu043; Van Aubel RAMH, 2002, J AM SOC NEPHROL, V13, DOI 10.1681/ASN.V133595; Wielinga PR, 2003, J BIOL CHEM, V278, P17664, DOI 10.1074/jbc.M212723200; Yu ZQ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085446; Zelcer N, 2003, BIOCHEM J, V371, P361, DOI 10.1042/BJ20021886; Zhang Z, 2012, GENE, V491, P194, DOI 10.1016/j.gene.2011.09.029; Zhao XT, 2014, ONCOTARGETS THER, V7, P343, DOI 10.2147/OTT.S56029	38	16	16	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2015	10	3							e0120651	10.1371/journal.pone.0120651	http://dx.doi.org/10.1371/journal.pone.0120651			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD9NQ	25790437	Green Submitted, gold, Green Published			2022-12-27	WOS:000351425400168
J	Freire, JEC; Vasconcelos, IM; Moreno, FBMB; Batista, AB; Lobo, MDP; Pereira, ML; Lima, JPMS; Almeida, RVM; Sousa, AJS; Monteiro-Moreira, ACO; Oliveira, JTA; Grangeiro, TB				Freire, Jose E. C.; Vasconcelos, Ilka M.; Moreno, Frederico B. M. B.; Batista, Adelina B.; Lobo, Marina D. P.; Pereira, Mirella L.; Lima, Joao P. M. S.; Almeida, Ricardo V. M.; Sousa, Antonio J. S.; Monteiro-Moreira, Ana C. O.; Oliveira, Jose T. A.; Grangeiro, Thalles B.			Mo-CBP3, an Antifungal Chitin-Binding Protein from Moringa oleifera Seeds, Is a Member of the 2S Albumin Family	PLOS ONE			English	Article							STABLE SWEET PROTEIN; FLOCCULANT-ACTIVE PROTEINS; VIGNA-UNGUICULATA VICILINS; SODIUM DODECYL-SULFATE; 7S STORAGE GLOBULINS; STRUCTURAL-CHARACTERIZATION; HOMOLOGOUS PROTEIN; SEQUENCE ALIGNMENT; IDENTIFICATION; PURIFICATION	Mo-CBP3 is a chitin-binding protein from M. oleifera seeds that inhibits the germination and mycelial growth of phytopathogenic fungi. This protein is highly thermostable and resistant to pH changes, and therefore may be useful in the development of new antifungal drugs. However, the relationship of MoCBP3 with the known families of carbohydrate-binding domains has not been established. In the present study, full-length cDNAs encoding 4 isoforms of Mo-CBP3 (Mo-CBP3-1, Mo-CBP3-2, Mo-CBP3-3 and Mo-CBP3-4) were cloned from developing seeds. The polypeptides encoded by the Mo-CBP3 cDNAs were predicted to contain 160 (Mo-CBP3-3) and 163 amino acid residues (Mo-CBP3-1, Mo-CBP3-2 and Mo-CBP3-4) with a signal peptide of 20-residues at the N-terminal region. A comparative analysis of the deduced amino acid sequences revealed that Mo-CBP3 is a typical member of the 2S albumin family, as shown by the presence of an eight-cysteine motif, which is a characteristic feature of the prolamin superfamily. Furthermore, mass spectrometry analysis demonstrated that Mo-CBP3 is a mixture of isoforms that correspond to different mRNA products. The identification of Mo-CBP3 as a genuine member of the 2S albumin family reinforces the hypothesis that these seed storage proteins are involved in plant defense. Moreover, the chitin-binding ability of Mo-CBP3 reveals a novel functionality for a typical 2S albumin.	[Freire, Jose E. C.; Vasconcelos, Ilka M.; Batista, Adelina B.; Sousa, Antonio J. S.; Oliveira, Jose T. A.] Univ Fed Ceara, Ctr Ciencias, Dept Bioquim & Biol Mol, Fortaleza, Ceara, Brazil; [Moreno, Frederico B. M. B.; Lobo, Marina D. P.; Monteiro-Moreira, Ana C. O.] Univ Fed Ceara, Nucl Biol Expt, Fortaleza, Ceara, Brazil; [Pereira, Mirella L.; Grangeiro, Thalles B.] Univ Fed Ceara, Ctr Ciencias, Dept Biol, Fortaleza, Ceara, Brazil; [Lima, Joao P. M. S.; Almeida, Ricardo V. M.] Univ Fed Rio Grande do Norte, Inst Med Trop IMT RN, BR-59072970 Natal, RN, Brazil	Universidade Federal do Ceara; Universidade Federal do Ceara; Universidade Federal do Ceara; Universidade Federal do Rio Grande do Norte	Grangeiro, TB (corresponding author), Univ Fed Ceara, Ctr Ciencias, Dept Biol, Fortaleza, Ceara, Brazil.	tbgrangeiro@gmail.com	SOUSA, ANTÔNIO JUSCELINO SUDÁRIO/L-6603-2016; Lima, João Paulo Matos Santos/AAS-7878-2021; Lima, Joao Paulo/G-4023-2014; da Cruz Freire, José Ednésio/D-8645-2016; Monteiro-Moreira, Ana Cristina O/F-3685-2014; Grangeiro, Thalles Barbosa/E-9606-2010	Lima, João Paulo Matos Santos/0000-0002-6113-8834; Lima, Joao Paulo/0000-0002-6113-8834; da Cruz Freire, José Ednésio/0000-0002-0660-0459; Monteiro-Moreira, Ana Cristina O/0000-0002-3606-6808; Grangeiro, Thalles Barbosa/0000-0001-8276-3092; Sudario Sousa, Antonio Juscelino/0000-0002-4511-8796	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES); Fundacao Cearense de Apoio ao Desenvolvimento Cientifico e Tecnologico (FUNCAP)	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Fundacao Cearense de Apoio ao Desenvolvimento Cientifico e Tecnologico (FUNCAP)(Fundacao Cearense de Apoio ao Desenvolvimento Cientifico e Tecnologico (FUNCAP))	This work was supported by research grants from Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq), Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES) and Fundacao Cearense de Apoio ao Desenvolvimento Cientifico e Tecnologico (FUNCAP). TBG, JTAO, JPMSL and IMV are senior investigators of CNPq.	Agizzio AP, 2006, PLANT SCI, V171, P515, DOI 10.1016/j.plantsci.2006.06.001; Agizzio AP, 2003, ARCH BIOCHEM BIOPHYS, V416, P188, DOI 10.1016/S0003-9861(03)00313-8; Ahmed F, 2011, FRONT PLANT SCI, V2, DOI 10.3389/fpls.2011.00084; Almira Ernesto C, 2003, J Biomol Tech, V14, P270; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; ANDERSEN NH, 1993, BIOCHEMISTRY-US, V32, P1407, DOI 10.1021/bi00057a004; ANDREWS P, 1965, BIOCHEM J, V96, P595, DOI 10.1042/bj0960595; ARCHER BL, 1960, BIOCHEM J, V75, P236, DOI 10.1042/bj0750236; ASENSIO JL, 1995, EUR J BIOCHEM, V230, P621; Barral P, 2005, BIOCHEM J, V390, P77, DOI 10.1042/BJ20050456; Batista AB, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111427; Bond CS, 2009, ACTA CRYSTALLOGR D, V65, P510, DOI 10.1107/S0907444909007835; Boraston AB, 2004, BIOCHEM J, V382, P769, DOI 10.1042/BJ20040892; Bormann C, 1999, J BACTERIOL, V181, P7421, DOI 10.1128/JB.181.24.7421-7429.1999; Breiteneder H, 2004, J ALLERGY CLIN IMMUN, V113, P821, DOI [10.1016/j.jaci.2004.01.779, 10.1016/j.jaci.2004.01.079]; BURKS AW, 1992, J ALLERGY CLIN IMMUN, V90, P962, DOI 10.1016/0091-6749(92)90469-I; Cantarel BL, 2009, NUCLEIC ACIDS RES, V37, pD233, DOI 10.1093/nar/gkn663; Dubovskii PV, 2011, BIOCHEM BIOPH RES CO, V411, P14, DOI 10.1016/j.bbrc.2011.06.058; Dunwell JM, 2001, TRENDS BIOCHEM SCI, V26, P740, DOI 10.1016/S0968-0004(01)01981-8; EDMAN P, 1950, ACTA CHEM SCAND, V4, P283, DOI 10.3891/acta.chem.scand.04-0283; Ewing B, 1998, GENOME RES, V8, P186, DOI 10.1101/gr.8.3.186; Fang EF, 2010, FEBS LETT, V584, P4089, DOI 10.1016/j.febslet.2010.08.041; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; GASSEN HG, 1990, BIOL CHEM H-S, V371, P760; GASSENSCHMIDT U, 1995, BBA-GEN SUBJECTS, V1243, P477, DOI 10.1016/0304-4165(94)00176-X; GASSENSCHMIDT U, 1991, BIOL CHEM H-S, V372, P659; Gehrig PM, 1996, P NATL ACAD SCI USA, V93, P3647, DOI 10.1073/pnas.93.8.3647; Ghebremichael KA, 2005, WATER RES, V39, P2338, DOI 10.1016/j.watres.2005.04.012; Gifoni JM, 2012, BIOPOLYMERS, V98, P406, DOI 10.1002/bip.22068; Gomes VM, 1998, PLANT SCI, V138, P81, DOI 10.1016/S0168-9452(98)00148-4; Gomes VM, 1997, J AGR FOOD CHEM, V45, P4110, DOI 10.1021/jf960942g; Gomes VM, 1998, BBA-GEN SUBJECTS, V1379, P207, DOI 10.1016/S0304-4165(97)00100-1; GONNET GH, 1992, SCIENCE, V256, P1443, DOI 10.1126/science.1604319; Gordon D, 1998, GENOME RES, V8, P195, DOI 10.1101/gr.8.3.195; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; HARAHISHIMURA I, 1993, PLANT J, V4, P793, DOI 10.1046/j.1365-313X.1993.04050793.x; Hegedus D, 2009, ANNU REV ENTOMOL, V54, P285, DOI 10.1146/annurev.ento.54.110807.090559; Huang RH, 2004, BIOCHEMISTRY-US, V43, P6005, DOI 10.1021/bi036263y; Jose-Estanyol M, 2004, PLANT PHYSIOL BIOCH, V42, P355, DOI 10.1016/j.plaphy.2004.03.009; Joshi CP, 1997, PLANT MOL BIOL, V35, P993, DOI 10.1023/A:1005816823636; Kansal SK, 2014, CHEM REV, V114, P4993, DOI 10.1021/cr400093w; Katre UV, 2008, INT J BIOL MACROMOL, V42, P203, DOI 10.1016/j.ijbiomac.2007.10.024; Kim Y, 2014, NUCLEIC ACIDS RES, V42, P485, DOI 10.1093/nar/gkt864; KORTT AA, 1990, PHYTOCHEMISTRY, V29, P2805, DOI 10.1016/0031-9422(90)87080-E; KREBBERS E, 1988, PLANT PHYSIOL, V87, P859, DOI 10.1104/pp.87.4.859; KREIS M, 1985, J MOL BIOL, V183, P499, DOI 10.1016/0022-2836(85)90017-8; Li DF, 2008, J STRUCT BIOL, V162, P50, DOI 10.1016/j.jsb.2007.12.007; LIU XZ, 1993, EUR J BIOCHEM, V211, P281, DOI 10.1111/j.1432-1033.1993.tb19896.x; Loke JC, 2005, PLANT PHYSIOL, V138, P1457, DOI 10.1104/pp.105.060541; Lorenz R, 2011, ALGORITHM MOL BIOL, V6, DOI 10.1186/1748-7188-6-26; Lukaszewicz M, 2000, PLANT SCI, V154, P89, DOI 10.1016/S0168-9452(00)00195-3; Luz LD, 2013, INT J BIOL MACROMOL, V58, P31, DOI 10.1016/j.ijbiomac.2013.03.044; MACEDO MLR, 1993, COMP BIOCHEM PHYS C, V105, P89, DOI 10.1016/0742-8413(93)90063-Q; Marchler-Bauer A, 2013, NUCLEIC ACIDS RES, V41, pD348, DOI 10.1093/nar/gks1243; Martin KC, 2009, CELL, V136, P719, DOI 10.1016/j.cell.2009.01.044; Mignone F, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-3-reviews0004; Moreno FJ, 2005, BBA-PROTEINS PROTEOM, V1752, P142, DOI 10.1016/j.bbapap.2005.07.022; Muzzarelli RAA, 1999, EXS, V87, P1; Mylne JS, 2014, FUNCT PLANT BIOL, V41, P671, DOI 10.1071/FP14035; NDABIGENGESERE A, 1995, WATER RES, V29, P703, DOI 10.1016/0043-1354(94)00161-Y; NIRASAWA S, 1993, BIOCHIM BIOPHYS ACTA, V1202, P277, DOI 10.1016/0167-4838(93)90016-K; Nirasawa S, 1996, GENE, V181, P225, DOI 10.1016/S0378-1119(96)00465-9; Okuda T, 2001, WATER RES, V35, P405, DOI 10.1016/S0043-1354(00)00290-6; Paes EV, 2008, ENTOMOL EXP APPL, V129, P11, DOI 10.1111/j.1570-7458.2008.00746.x; Perkins DN, 1999, ELECTROPHORESIS, V20, P3551, DOI 10.1002/(SICI)1522-2683(19991201)20:18<3551::AID-ELPS3551>3.0.CO;2-2; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; PEUMANS WJ, 1995, PLANT PHYSIOL, V109, P347, DOI 10.1104/pp.109.2.347; PITTRIVE.R, 1968, BIOCHEM J, V109, P825, DOI 10.1042/bj1090825; Rogers GW, 1999, J BIOL CHEM, V274, P12236, DOI 10.1074/jbc.274.18.12236; Rundqvist L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046435; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Sales MP, 2001, BRAZ J MED BIOL RES, V34, P27, DOI 10.1590/S0100-879X2001000100003; Sales MP, 1996, BRAZ J MED BIOL RES, V29, P319; Sambrook J, 1989, MOL CLONING LAB MANU, V2nd; SCHAGGER H, 1987, ANAL BIOCHEM, V166, P368, DOI 10.1016/0003-2697(87)90587-2; Shevchenko A, 2006, NAT PROTOC, V1, P2856, DOI 10.1038/nprot.2006.468; SHEWRY PR, 1995, PLANT CELL, V7, P945, DOI 10.1105/tpc.7.7.945; Sievers F, 2014, METHODS MOL BIOL, V1079, P105, DOI 10.1007/978-1-62703-646-7_6; Suyama M, 2006, NUCLEIC ACIDS RES, V34, pW609, DOI 10.1093/nar/gkl315; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; TERRAS FRG, 1993, FEBS LETT, V316, P233, DOI 10.1016/0014-5793(93)81299-F; TERRAS FRG, 1992, J BIOL CHEM, V267, P15301; TERRAS FRG, 1993, PLANT PHYSIOL, V103, P1311, DOI 10.1104/pp.103.4.1311; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Tomar PPS, 2014, APPL BIOCHEM BIOTECH, V174, P471, DOI 10.1007/s12010-014-1078-9; Tomar PPS, 2014, BIOCHEM BIOPH RES CO, V448, P349, DOI 10.1016/j.bbrc.2014.04.158; Van Damme EJM, 2008, ADV BOT RES, V48, P107, DOI 10.1016/S0065-2296(08)00403-5; Vatcher G, 2002, BIOTECHNIQUES, V33, P532, DOI 10.2144/02333st03_11824a; Vizcaino JA, 2014, NAT BIOTECHNOL, V32, P223, DOI 10.1038/nbt.2839; VONHEIJNE G, 1983, EUR J BIOCHEM, V133, P17; Wan Y, 2011, NAT REV GENET, V12, P641, DOI 10.1038/nrg3049; YOULE RJ, 1978, PLANT PHYSIOL, V61, P13, DOI 10.1104/pp.61.1.13; Zuckerkandl E, 1965, EVOL GENES PROTEINS, P97, DOI DOI 10.1016/B978-1-4832-2734-4.50017-6	93	39	40	2	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2015	10	3							e0119871	10.1371/journal.pone.0119871	http://dx.doi.org/10.1371/journal.pone.0119871			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD9NQ	25789746	Green Published, gold, Green Submitted			2022-12-27	WOS:000351425400112
J	Gaire, BP; Kwon, OW; Park, SH; Chun, KH; Kim, SY; Shin, DY; Choi, JW				Gaire, Bhakta Prasad; Kwon, Oh Wook; Park, Sung Hyuk; Chun, Kwang-Hoon; Kim, Sun Yeou; Shin, Dong Yun; Choi, Ji Woong			Neuroprotective Effect of 6-Paradol in Focal Cerebral Ischemia Involves the Attenuation of Neuroinflammatory Responses in Activated Microglia	PLOS ONE			English	Article							TUMOR-NECROSIS-FACTOR; NITRIC-OXIDE SYNTHASE; ZINGIBER-OFFICINALE; CHAIN LENGTH; MICE LACKING; BRAIN-INJURY; FACTOR-ALPHA; GINGER; 6-SHOGAOL; DEFICITS	Paradols are non-pungent and biotransformed metabolites of shogaols and reduce inflammatory responses as well as oxidative stress as shogaols. Recently, shogaol has been noted to possess therapeutic potential against several central nervous system (CNS) disorders, including cerebral ischemia, by reducing neuroinflammation in microglia. Therefore, paradol could be used to improve neuroinflammation-associated CNS disorders. Here, we synthesized paradol derivatives (2-to 10-paradols). Through the initial screening for antiinflammatory activities using lipopolysaccharide (LPS)-stimulated BV2 microglia, 6-paradol was chosen to be the most effective compound without cytotoxicity. Pretreatment with 6paradol reduced neuroinflammatory responses in LPS-stimulated BV2 microglia by a concentration-dependent manner, which includes reduced NO production by inhibiting iNOS upregulation and lowered secretion of proinflammatory cytokines (IL-6 and TNF-alpha). To pursue whether the beneficial in vitro effects of 6-paradol leads towards in vivo therapeutic effects on transient focal cerebral ischemia characterized by neuroinflammation, we employed middle cerebral artery occlusion (MCAO)/reperfusion (M/R). Administration of 6-paradol immediately after reperfusion significantly reduced brain damage in M/R-challenged mice as assessed by brain infarction, neurological deficit, and neural cell survival and death. Furthermore, as observed in cultured microglia, 6-paradol administration markedly reduced neuroinflammation in M/R-challenged brains by attenuating microglial activation and reducing the number of cells expressing iNOS and TNF-alpha, both of which are known to be produced in microglia following M/R challenge. Collectively, this study provides evidences that 6-paradol effectively protects brain after cerebral ischemia, likely by attenuating neuroinflammation in microglia, suggesting it as a potential therapeutic agent to treat cerebral ischemia.	[Gaire, Bhakta Prasad; Choi, Ji Woong] Gachon Univ, Coll Pharm, Pharmacol Lab, Incheon, South Korea; [Gaire, Bhakta Prasad; Choi, Ji Woong] Gachon Univ, Gachon Inst Pharmaceut Sci, Incheon, South Korea; [Kwon, Oh Wook; Kim, Sun Yeou] Gachon Univ, Coll Pharm, Lab Pharmacognosy, Incheon, South Korea; [Park, Sung Hyuk; Shin, Dong Yun] Gachon Univ, Coll Pharm, Med Chem Lab, Incheon, South Korea; [Chun, Kwang-Hoon] Gachon Univ, Coll Pharm, Biochem Lab, Incheon, South Korea	Gachon University; Gachon University; Gachon University; Gachon University; Gachon University	Shin, DY (corresponding author), Gachon Univ, Coll Pharm, Med Chem Lab, Incheon, South Korea.	dyshin@gachon.ac.kr; pharmchoi@gachon.ac.kr	Gaire, Bhakta Prasad/AAA-4211-2020; Gaire, Bhakta Prasad/I-7776-2019		National Research Foundation of Republic of Korea [NRF-2013R1A1A1A05005520, NRF-2012R1A1A1007057]; Korean Health Technology R&D Project, Ministry of Health & Welfare, Republic of Korea [HI13C18200000]; Research program for Gachon Pharmaceutical Sciences	National Research Foundation of Republic of Korea(National Research Foundation of Korea); Korean Health Technology R&D Project, Ministry of Health & Welfare, Republic of Korea; Research program for Gachon Pharmaceutical Sciences	This work was supported by the National Research Foundation of Republic of Korea (NRF-2013R1A1A1A05005520, NRF-2012R1A1A1007057); the Korean Health Technology R&D Project, Ministry of Health & Welfare, Republic of Korea (HI13C18200000); Research program for Gachon Pharmaceutical Sciences. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed HH, 2013, J MED FOOD, V16, P437, DOI 10.1089/jmf.2012.0165; Ali BH, 2008, FOOD CHEM TOXICOL, V46, P409, DOI 10.1016/j.fct.2007.09.085; Barone FC, 1997, STROKE, V28, P1233, DOI 10.1161/01.STR.28.6.1233; Barone FC, 2009, CURR OPIN INVEST DR, V10, P220; Boscia F, 2009, STROKE, V40, P3608, DOI 10.1161/STROKEAHA.109.557439; Bruce AJ, 1996, NAT MED, V2, P788, DOI 10.1038/nm0796-788; Butt MS, 2011, CRIT REV FOOD SCI, V51, P383, DOI 10.1080/10408391003624848; Chen JL, 2001, STROKE, V32, P2682, DOI 10.1161/hs1101.098367; Chen Yuh-Fung, 2012, Front Biosci (Elite Ed), V4, P809, DOI 10.2741/E420; CHUNG IY, 1990, J IMMUNOL, V144, P2999; Chung WY, 2001, MUTAT RES-GEN TOX EN, V496, P199, DOI 10.1016/S1383-5718(01)00221-2; Craggs L, 2011, NEUROREPORT, V22, P1, DOI 10.1097/WNR.0b013e328342741c; Doyle KP, 2008, NEUROPHARMACOLOGY, V55, P310, DOI 10.1016/j.neuropharm.2008.01.005; Dugasani S, 2010, J ETHNOPHARMACOL, V127, P515, DOI 10.1016/j.jep.2009.10.004; Erickson MA, 2012, NEUROIMMUNOMODULAT, V19, P121, DOI 10.1159/000330247; Graeber MB, 2010, ACTA NEUROPATHOL, V119, P89, DOI 10.1007/s00401-009-0622-0; Gu Y, 2014, J NEUROIMMUNE PHARM, V9, P313, DOI 10.1007/s11481-014-9525-5; Ha SK, 2012, NEUROPHARMACOLOGY, V63, P211, DOI 10.1016/j.neuropharm.2012.03.016; Haratake A, 2014, J AGR FOOD CHEM, V62, P6166, DOI 10.1021/jf500873a; Iadecola C, 1997, J NEUROSCI, V17, P9157; Ito D, 2001, STROKE, V32, P1208, DOI 10.1161/01.STR.32.5.1208; Jeon S, 2011, J ETHNOPHARMACOL, V137, P783, DOI 10.1016/j.jep.2011.06.046; Kannappan R, 2011, MOL NEUROBIOL, V44, P142, DOI 10.1007/s12035-011-8168-2; Kim DH, 2015, NEUROSCIENCE, V284, P42, DOI 10.1016/j.neuroscience.2014.09.074; Kim DSHL, 2004, BIOORG MED CHEM LETT, V14, P1287, DOI 10.1016/j.bmcl.2003.12.041; Kim J, 2013, NEUROCHEM INT, V63, P732, DOI 10.1016/j.neuint.2013.09.013; Kim MO, 2014, CARCINOGENESIS, V35, P683, DOI 10.1093/carcin/bgt365; Kubra IR, 2012, CRIT REV FOOD SCI, V52, P651, DOI 10.1080/10408398.2010.505689; Lakhan SE, 2009, J TRANSL MED, V7, DOI 10.1186/1479-5876-7-97; Li T, 2013, BRAIN, V136, P3578, DOI 10.1093/brain/awt287; Liu Shimin, 2010, J Exp Stroke Transl Med, V3, P47; Mccoy MK, 2008, J NEUROINFLAMM, V5, DOI 10.1186/1742-2094-5-45; Moon M, 2014, BIOCHEM BIOPH RES CO, V449, P8, DOI 10.1016/j.bbrc.2014.04.121; Mythri RB, 2012, RECENT PATENTS ENDOC, V6, P181, DOI 10.2174/187221412802481793; NAGASAWA H, 1989, STROKE, V20, P1037, DOI 10.1161/01.STR.20.8.1037; Nawashiro H, 1997, J CEREBR BLOOD F MET, V17, P229, DOI 10.1097/00004647-199702000-00013; Nurtjahja-Tjendraputra E, 2003, THROMB RES, V111, P259, DOI 10.1016/j.thromres.2003.09.009; Pannu R, 2006, NEUROCHEM INT, V49, P170, DOI 10.1016/j.neuint.2006.04.010; Park G, 2013, ACTA PHARMACOL SIN, V34, P1131, DOI 10.1038/aps.2013.57; Sang SM, 2009, J AGR FOOD CHEM, V57, P10645, DOI 10.1021/jf9027443; Shih HC, 2014, INT J MOL SCI, V15, P3926, DOI 10.3390/ijms15033926; Suresh K, 2010, PHARMACOL REP, V62, P1178, DOI 10.1016/S1734-1140(10)70380-7; Thomson M, 2002, PROSTAG LEUKOTR ESS, V67, P475, DOI 10.1054/plef.2002.0441; Welser-Alves JV, 2013, NEUROCHEM INT, V63, P47, DOI 10.1016/j.neuint.2013.04.007; Wood LD, 2010, DRUG AGING, V27, P295, DOI 10.2165/11318330-000000000-00000; Wu H, 2010, MOL NUTR FOOD RES, V54, P1296, DOI 10.1002/mnfr.200900409; Zeng GF, 2013, REJUV RES, V16, P124, DOI 10.1089/rej.2012.1389; Zick SM, 2008, CANCER EPIDEM BIOMAR, V17, P1930, DOI 10.1158/1055-9965.EPI-07-2934	48	63	67	2	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2015	10	3							e0120203	10.1371/journal.pone.0120203	http://dx.doi.org/10.1371/journal.pone.0120203			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD9NQ	25789481	gold, Green Submitted, Green Published			2022-12-27	WOS:000351425400140
J	Halbach, MV; Stehning, T; Damrath, E; Jendrach, M; Sen, NE; Basak, AN; Auburger, G				Halbach, Melanie Vanessa; Stehning, Tanja; Damrath, Ewa; Jendrach, Marina; Sen, Nesli Ece; Basak, A. Nazli; Auburger, Georg			Both Ubiquitin Ligases FBXW8 and PARK2 Are Sequestrated into Insolubility by ATXN2 PolyQ Expansions, but Only FBXW8 Expression Is Dysregulated	PLOS ONE			English	Article							SPINOCEREBELLAR ATAXIA TYPE-2; LENGTH POLYGLUTAMINE EXPANSIONS; F-BOX; INTRANUCLEAR INCLUSIONS; TRINUCLEOTIDE REPEAT; DROSOPHILA HOMOLOG; PROTEIN; SCA2; GENE; RNA	The involvement of the ubiquitin-proteasome system (UPS) in the course of various age-associated neurodegenerative diseases is well established. The single RING finger type E3 ubiquitin-protein ligase PARK2 is mutated in a Parkinson's disease (PD) variant and was found to interact with ATXN2, a protein where polyglutamine expansions cause Spinocerebellar ataxia type 2 (SCA2) or increase the risk for Levodopa-responsive PD and for the motor neuron disease Amyotrophic lateral sclerosis (ALS). We previously reported evidence for a transcriptional induction of the multi-subunit RING finger Skp1/Cul/F-box (SCF) type E3 ubiquitin-protein ligase complex component FBXW8 in global microarray profiling of ATXN2-expansion mouse cerebellum and demonstrated its role for ATXN2 degradation in vitro. Now, we documented co-localization in vitro and co-immunoprecipitations both in vitro and in vivo, which indicate associations of FBXW8 with ATXN2 and PARK2. Both FBXW8 and PARK2 proteins are driven into insolubility by expanded ATXN2. Whereas the FBXW8 transcript upregulation by ATXN2-expansion was confirmed also in qPCR of skin fibroblasts and blood samples of SCA2 patients, a FBXW8 expression dysregulation was not observed in ATXN2-deficient mice, nor was a PARK2 transcript dysregulation observed in any samples. Jointly, all available data suggest that the degradation of wildtype and mutant ATXN2 is dependent on FBXW8, and that ATXN2 accumulation selectively modulates FBXW8 levels, while PARK2 might act indirectly through FBXW8. The effects of ATXN2-expansions on FBXW8 expression in peripheral tissues like blood may become useful for clinical diagnostics.	[Halbach, Melanie Vanessa; Stehning, Tanja; Damrath, Ewa; Jendrach, Marina; Auburger, Georg] Goethe Univ Frankfurt, Dept Neurol, Sch Med, Expt Neurol, Theodor Stern Kai 7, D-60590 Frankfurt, Germany; [Sen, Nesli Ece; Basak, A. Nazli] Bogazici Univ, Dept Genet & Mol Biol, Neurodegenerat Res Lab NDAL, TR-34470 Istanbul, Turkey	Goethe University Frankfurt; Bogazici University	Auburger, G (corresponding author), Goethe Univ Frankfurt, Dept Neurol, Sch Med, Expt Neurol, Theodor Stern Kai 7, D-60590 Frankfurt, Germany.	auburger@em.uni-frankfurt.de		Rollmann, Ewa/0000-0001-9777-4608	Deutsche Forschungsgemeinschaft [AU96/11-1]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	Deutsche Forschungsgemeinschaft AU96/11-1. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Affaitati A, 2001, GENE, V267, P89, DOI 10.1016/S0378-1119(01)00402-4; Auburger G, 2014, WORLD J DIABETES, V5, P316, DOI 10.4239/wjd.v5.i3.316; Auburger Georg W J, 2012, Handb Clin Neurol, V103, P423, DOI 10.1016/B978-0-444-51892-7.00026-7; Bauer PO, 2009, J NEUROCHEM, V110, P1737, DOI 10.1111/j.1471-4159.2009.06302.x; Benbrook D. M., 2012, Experimental Oncology, V34, P286; Boesch SM, 2004, MOVEMENT DISORD, V19, P1320, DOI 10.1002/mds.20159; Carrard G, 2002, INT J BIOCHEM CELL B, V34, P1461, DOI 10.1016/S1357-2725(02)00085-7; Charles P, 2007, NEUROLOGY, V69, P1970, DOI 10.1212/01.wnl.0000269323.21969.db; Corti O, 2011, PHYSIOL REV, V91, P1161, DOI 10.1152/physrev.00022.2010; Damrath E, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002920; DIAZ GO, 1990, NEUROLOGY, V40, P1369, DOI 10.1212/WNL.40.9.1369; DiFiglia M, 1997, SCIENCE, V277, P1990, DOI 10.1126/science.277.5334.1990; Drost J, 2013, J MOL NEUROSCI, V51, P68, DOI 10.1007/s12031-012-9949-4; Duyckaerts C, 1999, ACTA NEUROPATHOL, V97, P201, DOI 10.1007/s004010050975; Ekholm-Reed S, 2013, MOL CELL BIOL, V33, P3627, DOI 10.1128/MCB.00535-13; Elden AC, 2010, NATURE, V466, P1069, DOI 10.1038/nature09320; Estrada R, 1999, ACTA NEUROPATHOL, V97, P306, DOI 10.1007/s004010050989; Freund HJ, 2007, MOVEMENT DISORD, V22, P732, DOI 10.1002/mds.21338; Galvao R, 2001, BRAIN RES BULL, V56, P191, DOI 10.1016/S0361-9230(01)00651-7; Gierga K, 2005, ACTA NEUROPATHOLOGIC, P109; Gispert S, 2012, NEUROBIOL DIS, V45, P356, DOI 10.1016/j.nbd.2011.08.021; Gwinn-Hardy K, 2000, NEUROLOGY, V55, P800, DOI 10.1212/WNL.55.6.800; Hallen L, 2011, HUM MOL GENET, V20, P104, DOI 10.1093/hmg/ddq436; HERNANDEZ A, 1995, GENOMICS, V25, P433, DOI 10.1016/0888-7543(95)80043-L; Ho MS, 2008, CELL MOL LIFE SCI, V65, P1977, DOI 10.1007/s00018-008-7592-6; Holmberg M, 1998, HUM MOL GENET, V7, P913, DOI 10.1093/hmg/7.5.913; Huynh DP, 2000, NAT GENET, V26, P44, DOI 10.1038/79162; Huynh DP, 2007, EXP NEUROL, V203, P531, DOI 10.1016/j.expneurol.2006.09.009; Imbert G, 1996, NAT GENET, V14, P285, DOI 10.1038/ng1196-285; Kitada T, 1998, NATURE, V392, P605, DOI 10.1038/33416; Klinkenberg M, 2012, NEUROGENETICS, V13, P9, DOI 10.1007/s10048-011-0303-8; Koch P, 2011, NATURE, V480, P543, DOI 10.1038/nature10671; Lahut S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042956; Lastres-Becker I, 2008, CEREBELLUM, V7, P115, DOI 10.1007/s12311-008-0019-y; Lastres-Becker I, 2008, HUM MOL GENET, V17, P1465, DOI 10.1093/hmg/ddn035; Lee T, 2011, HUM MOL GENET, V20, P1697, DOI 10.1093/hmg/ddr045; Li X, 2010, HUM MOL GENET, V19, P2445, DOI 10.1093/hmg/ddq127; Li XJ, 2011, NEUROBIOL DIS, V43, P4, DOI 10.1016/j.nbd.2010.11.018; Lieberman AP, 2002, HUM MOL GENET, V11, P1967, DOI 10.1093/hmg/11.17.1967; Lim C, 2013, SCIENCE, V340, P875, DOI 10.1126/science.1234785; Lim J, 2008, NATURE, V452, P713, DOI 10.1038/nature06731; Lindenberg KS, 2000, BRAIN PATHOL, V10, P385; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; McCann C, 2011, P NATL ACAD SCI USA, V108, pE655, DOI 10.1073/pnas.1107198108; Nonhoff U, 2007, MOL BIOL CELL, V18, P1385, DOI 10.1091/mbc.E06-12-1120; Nonis D, 2008, CELL SIGNAL, V20, P1725, DOI 10.1016/j.cellsig.2008.05.018; Orr HT, 2007, ANNU REV NEUROSCI, V30, P575, DOI 10.1146/annurev.neuro.29.051605.113042; Orr HT, 2012, CURR OPIN GENET DEV, V22, P251, DOI 10.1016/j.gde.2012.01.001; Ortega Z, 2014, FRONT MOL NEUROSCI, V7, DOI [10.3389/fnmol.2014.00077, 10.3389/fnmo1.2014.00077]; Paulson HL, 1997, NEURON, V19, P333, DOI 10.1016/S0896-6273(00)80943-5; Petroi D, 2012, J BIOL CHEM, V287, P27567, DOI 10.1074/jbc.M112.361865; Pulst SM, 1996, NAT GENET, V14, P269, DOI 10.1038/ng1196-269; Ralser M, 2005, J MOL BIOL, V346, P203, DOI 10.1016/j.jmb.2004.11.024; Rub U, 2005, J NEURAL TRANSM, V112, P1523, DOI 10.1007/s00702-005-0287-3; Rub U, 2004, NEUROLOGY, V63, P1258, DOI 10.1212/01.WNL.0000140498.24112.8C; Rub U, 2003, NEUROPATH APPL NEURO, V29, P418, DOI 10.1046/j.1365-2990.2003.00504.x; Rub U, 2003, BRAIN, V126, P2257, DOI 10.1093/brain/awg234; Sanpei K, 1996, NAT GENET, V14, P277, DOI 10.1038/ng1196-277; Satterfield TF, 2006, HUM MOL GENET, V15, P2523, DOI 10.1093/hmg/ddl173; Satterfield TF, 2002, GENETICS, V162, P1687; Schipper-Krom S, 2014, FEBS LETT, V588, P151, DOI 10.1016/j.febslet.2013.11.023; Schipper-Krom S, 2012, BIOCHEM RES INT, V2012, DOI 10.1155/2012/837015; Scoles DR, 2012, HUM MOL GENET, V21, P5048, DOI 10.1093/hmg/dds349; Scuderi S, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/690796; Shibata H, 2000, HUM MOL GENET, V9, P1303, DOI 10.1093/hmg/9.9.1303; Skowyra D, 1997, CELL, V91, P209, DOI 10.1016/S0092-8674(00)80403-1; Staropoli JF, 2003, NEURON, V37, P735, DOI 10.1016/S0896-6273(03)00084-9; Sudhakaran IP, 2014, P NATL ACAD SCI USA, V111, pE99, DOI 10.1073/pnas.1309543111; van de Loo S, 2009, EXP NEUROL, V215, P110, DOI 10.1016/j.expneurol.2008.09.020; Velazquez-Perez L, 2014, LANCET NEUROL, V13, P482, DOI 10.1016/S1474-4422(14)70027-4; von Coelln R, 2004, CELL TISSUE RES, V318, P175, DOI 10.1007/s00441-004-0924-4; Yamashita C, 2014, NEUROBIOL AGING, V35, DOI 10.1016/j.neurobiolaging.2014.01.022; Yang H, 2014, SCI REP-UK, V4, DOI 10.1038/srep06410; Zhang Y, 2013, SCIENCE, V340, P879, DOI 10.1126/science.1234746	74	17	17	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2015	10	3							e0121089	10.1371/journal.pone.0121089	http://dx.doi.org/10.1371/journal.pone.0121089			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD9NQ	25790475	Green Submitted, Green Published, gold			2022-12-27	WOS:000351425400189
J	Storm, FA; Heller, BW; Mazza, C				Storm, Fabio A.; Heller, Ben W.; Mazza, Claudia			Step Detection and Activity Recognition Accuracy of Seven Physical Activity Monitors	PLOS ONE			English	Article							ENERGY-EXPENDITURE; ACCELEROMETRY; RELIABILITY; PEDOMETER; VALIDITY; ADULTS; GAIT	The aim of this study was to compare the seven following commercially available activity monitors in terms of step count detection accuracy: Movemonitor (Mc Roberts), Up (Jawbone), One (Fitbit), ActivPAL (PAL Technologies Ltd.), Nike+ Fuelband (Nike Inc.), Tractivity (Kineteks Corp.) and Sensewear Armband Mini (Bodymedia). Sixteen healthy adults consented to take part in the study. The experimental protocol included walking along an indoor straight walkway, descending and ascending 24 steps, free outdoor walking and free indoor walking. These tasks were repeated at three self-selected walking speeds. Angular velocity signals collected at both shanks using two wireless inertial measurement units (OPAL, ADPM Inc) were used as a reference for the step count, computed using previously validated algorithms. Step detection accuracy was assessed using the mean absolute percentage error computed for each sensor. The Movemonitor and the ActivPAL were also tested within a nine-minute activity recognition protocol, during which the participants performed a set of complex tasks. Posture classifications were obtained from the two monitors and expressed as a percentage of the total task duration. The Movemonitor, One, ActivPAL, Nike+ Fuelband and Sensewear Armband Mini underestimated the number of steps in all the observed walking speeds, whereas the Tractivity significantly overestimated step count. The Movemonitor was the best performing sensor, with an error lower than 2% at all speeds and the smallest error obtained in the outdoor walking. The activity recognition protocol showed that the Movemonitor performed best in the walking recognition, but had difficulty in discriminating between standing and sitting. Results of this study can be used to inform choice of a monitor for specific applications.	[Storm, Fabio A.; Mazza, Claudia] Univ Sheffield, Dept Mech Engn, Sheffield, S Yorkshire, England; [Storm, Fabio A.; Mazza, Claudia] Univ Sheffield, INSIGNEO Inst In Silico Med, Sheffield, S Yorkshire, England; [Heller, Ben W.] Sheffield Hallam Univ, Ctr Sports Engn Res, Sheffield S1 1WB, S Yorkshire, England	University of Sheffield; University of Sheffield; Sheffield Hallam University	Storm, FA (corresponding author), Univ Sheffield, Dept Mech Engn, Sheffield, S Yorkshire, England.	fastorm1@sheffield.ac.uk	Storm, Fabio/AAE-2334-2019	Storm, Fabio/0000-0002-5977-8090; Mazza, Claudia/0000-0002-5215-1746	EC [FP7-ICT-2011-9, 600803]; Sheffield National Centre for Sport and Exercise Medicine	EC(European CommissionEuropean Commission Joint Research Centre); Sheffield National Centre for Sport and Exercise Medicine	This study was funded by the EC contract FP7-ICT-2011-9, No. 600803 (MISSION-T2D, URL: http://www.mission-t2d.eu/MISSION-T2D/Welcome.html), and by the Sheffield National Centre for Sport and Exercise Medicine (URL: http://www.scci.org.uk/home/projects/national-centre-for-sport-and-exercisemedicine-ncsem/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aminian K, 2002, J BIOMECH, V35, P689, DOI 10.1016/S0021-9290(02)00008-8; Ayabe M, 2008, J SPORT SCI MED, V7, P249; Bonomi AG, 2012, INT J OBESITY, V36, P167, DOI 10.1038/ijo.2011.99; Brage S, 2005, EUR J CLIN NUTR, V59, P561, DOI 10.1038/sj.ejcn.1602118; Brandes M, 2012, MED SCI SPORT EXER, V44, P2235, DOI 10.1249/MSS.0b013e318260402b; Chen KY, 2012, MED SCI SPORT EXER, V44, pS13, DOI 10.1249/MSS.0b013e3182399bc8; Colbert LH, 2011, MED SCI SPORT EXER, V43, P867, DOI 10.1249/MSS.0b013e3181fc7162; de Groot S, 2013, MED ENG PHYS, V35, P1499, DOI 10.1016/j.medengphy.2013.04.004; Dijkstra B, 2008, AGE AGEING, V37, P436, DOI 10.1093/ageing/afn097; Dijkstra B, 2010, ARCH PHYS MED REHAB, V91, P1272, DOI 10.1016/j.apmr.2010.05.004; Furlanetto KC, 2010, ARCH PHYS MED REHAB, V91, P261, DOI 10.1016/j.apmr.2009.10.024; Harrison SL, 2013, HEART LUNG, V42, P361, DOI 10.1016/j.hrtlng.2013.06.004; Johannsen DL, 2010, MED SCI SPORT EXER, V42, P2134, DOI 10.1249/MSS.0b013e3181e0b3ff; Lee J.-M., 2014, MED SCI SPORTS EXERC; Lowe SA, 2014, MED ENG PHYS, V36, P147, DOI 10.1016/j.medengphy.2013.11.010; Motl RW, 2010, ARCH PHYS MED REHAB, V91, P1942, DOI 10.1016/j.apmr.2010.08.011; Nusser SM, 2012, J PHYS ACT HEALTH, V9, pS56, DOI 10.1123/jpah.9.s1.s56; Rabinovich R a, 2013, EUR RESP J OFF  0308; Ryan J, 2013, EUR J SPORT SCI 0308, V13, P681, DOI [10.1080/17461391.2014.908956, DOI 10.1080/17461391.2014.908956]; van Hees VT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061691; Van Remoortel H, 2012, INT J BEHAV NUTR PHY, V9, DOI 10.1186/1479-5868-9-84; Van Remoortel H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039198; Welk GJ, 2012, MED SCI SPORT EXER, V44, pS39, DOI 10.1249/MSS.0b013e3182399d8f	23	100	103	0	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2015	10	3							e0118723	10.1371/journal.pone.0118723	http://dx.doi.org/10.1371/journal.pone.0118723			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD9NQ	25789630	Green Submitted, Green Accepted, Green Published, gold			2022-12-27	WOS:000351425400041
J	Suzuki, M; Tada, A; Kanmani, P; Watanabe, H; Aso, H; Suda, Y; Nochi, T; Miyazawa, K; Yoda, K; He, F; Hosoda, M; Saito, T; Villena, J; Kitazawa, H				Suzuki, Masahiko; Tada, Asuka; Kanmani, Paulraj; Watanabe, Hitoshi; Aso, Hisashi; Suda, Yoshihito; Nochi, Tomonori; Miyazawa, Kenji; Yoda, Kazutoyo; He, Fang; Hosoda, Masataka; Saito, Tadao; Villena, Julio; Kitazawa, Haruki			Advanced Application of Porcine Intramuscular Adipocytes for Evaluating Anti-Adipogenic and Anti-Inflammatory Activities of Immunobiotics	PLOS ONE			English	Article							NECROSIS-FACTOR-ALPHA; LACTOBACILLUS-GASSERI TMC0356; TNF-ALPHA; INSULIN-RESISTANCE; ADIPOSE-TISSUE; IMMUNE-RESPONSES; IN-VIVO; EXPRESSION; OBESE; DIFFERENTIATION	We previously established a clonal porcine intramuscular preadipocyte (PIP) line and we were able to establish a protocol to obtain functional mature adipocytes from PIP cells. We hypothesized that both PIP cells and mature adipocytes are likely to be useful in vitro tools for increasing our understanding of immunobiology of adipose tissue, and for the selection and study of immunoregulatory probiotics (immunobiotics) able to modulate adipocytes immune responses. In this study, we investigated the immunobiology of PIP cells and mature adipocytes in relation to their response to TNF-alpha stimulation. In addition, we evaluated the possibility that immunobiotic microorganisms modify adipogenesis and immune functions of porcine adipose tissue through Peyer's patches (PPs) immune-competent cells. We treated the porcine PPs immune cells with different probiotic strains; and we evaluated the effect of conditioned media from probiotic-stimulated immune cells in PIP cells and mature adipocytes. The Lactobacillus GG and L. gasseri TMC0356 showed remarkable effects, and were able to significantly reduce the expression of pro-inflammatory factors and negative regulators (A20, Bcl-3, and MKP-1) in adipocytes challenged with TNF-alpha. The results of this study demonstrated that the evaluation of IL-6, and MCP-1 production, and A20 and Bcl-3 down-regulation in TNF-alpha-challenged adipocytes could function as biomarkers to screen and select potential immunobiotic strains. Taking into consideration that several in vivo and in vitro studies clearly demonstrated the beneficial effects of Lactobacillus GG and L. gasseri TMC0356 in adipose inflammation, the results presented in this work indicate that the PIP cells and porcine adipocytes could be used for the screening and the selection of new immunobiotic strains with the potential to functionally modulate adipose inflammation when orally administered.	[Suzuki, Masahiko; Tada, Asuka; Kanmani, Paulraj; Saito, Tadao; Kitazawa, Haruki] Tohoku Univ, Grad Sch Agr Sci, Food & Feed Immunol Grp, Sendai, Miyagi 9818555, Japan; [Watanabe, Hitoshi; Aso, Hisashi; Nochi, Tomonori] Tohoku Univ, Grad Sch Agr Sci, Cell Biol Lab, Sendai, Miyagi 9818555, Japan; [Villena, Julio] Reference Ctr Lactobacilli CERELA CONICET, Lab Immunobiotechnol, San Miguel De Tucuman, Argentina; [Suda, Yoshihito] Miyagi Univ, Dept Food Agr & Environm, Sendai, Miyagi 9820215, Japan; [Miyazawa, Kenji; Yoda, Kazutoyo; He, Fang; Hosoda, Masataka] Takanashi Milk Prod Co Ltd, Tech Res Lab, Yokohama, Kanagawa 2410023, Japan	Tohoku University; Tohoku University; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Miyagi University	Villena, J (corresponding author), Reference Ctr Lactobacilli CERELA CONICET, Lab Immunobiotechnol, San Miguel De Tucuman, Argentina.	jcvillena@cerela.org.ar; haruki@bios.tohoku.ac.jp	Nochi, Tomonori/U-2533-2019	Nochi, Tomonori/0000-0003-1800-6972; Kitazawa, Haruki/0000-0003-4586-5553; Watanabe, Hitoshi/0000-0002-9236-7744; Tada, Asuka/0000-0003-2364-9462	Japanese Society for the Promotion of Science (JSPS) [24380146, 26660216]; Research Project on Development of Agricultural Products and Foods with Health-promoting benefits (NARO), Japan; JSPS Postdoctoral Fellowship for Foreign Researchers [25-03397]; Takanashi Milk Products Co., Ltd.; Grants-in-Aid for Scientific Research [15H04586, 26660217, 26660216] Funding Source: KAKEN	Japanese Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Research Project on Development of Agricultural Products and Foods with Health-promoting benefits (NARO), Japan; JSPS Postdoctoral Fellowship for Foreign Researchers(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Takanashi Milk Products Co., Ltd.; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported by a Grant-in-Aid for Scientific Research (B)(2) (No. 24380146) and Challenging Exploratory Research (No. 26660216) from the Japanese Society for the Promotion of Science (JSPS) to Dr. H. Kitazawa, and the Research Project on Development of Agricultural Products and Foods with Health-promoting benefits (NARO), Japan to Dr. H. Aso. Dr. Paulraj Kanmani was supported by JSPS Postdoctoral Fellowship for Foreign Researchers, Program No. 25-03397. Takanashi Milk Products Co., Ltd., provided support in the form of salaries for authors KM, KY, FH and MH but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the "author contributions" section.	Batra A, 2007, AM J PATHOL, V170, P1931, DOI 10.2353/ajpath.2007.060699; Bes-Houtmann S, 2007, HISTOCHEM CELL BIOL, V127, P131, DOI 10.1007/s00418-006-0230-1; Bruun JM, 2003, AM J PHYSIOL-ENDOC M, V285, pE527, DOI 10.1152/ajpendo.00110.2003; Burcelin R, 2013, DIABETES OBES METAB, V15, P61, DOI 10.1111/dom.12157; Carvalho BM, 2013, MEDIAT INFLAMM, V2013, DOI 10.1155/2013/986734; Cawthorn WP, 2008, FEBS LETT, V582, P117, DOI 10.1016/j.febslet.2007.11.051; Cheung AT, 1998, ENDOCRINOLOGY, V139, P4928, DOI 10.1210/en.139.12.4928; Chi W, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097675; Constant VA, 2006, DIABETOLOGIA, V49, P1402, DOI 10.1007/s00125-006-0253-0; Curat CA, 2004, DIABETES, V53, P1285, DOI 10.2337/diabetes.53.5.1285; Desruisseaux MS, 2007, INFECT IMMUN, V75, P1066, DOI 10.1128/IAI.01455-06; DiBaise JK, 2008, MAYO CLIN PROC, V83, P460, DOI 10.4065/83.4.460; Dorronsoro A, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.494; Harata G, 2009, MICROBIOL IMMUNOL, V53, P475, DOI 10.1111/j.1348-0421.2009.00146.x; Heilbronn LK, 2008, CURR PHARM DESIGN, V14, P1225, DOI 10.2174/138161208784246153; HOTAMISLIGIL GS, 1993, SCIENCE, V259, P87, DOI 10.1126/science.7678183; Huebner L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075703; Jansson JO, 2007, J APPL PHYSIOL, V102, P821, DOI 10.1152/japplphysiol.01353.2006; Jernas M, 2006, FASEB J, V20, P1540, DOI 10.1096/fj.05-5678fje; Kanda H, 2006, J CLIN INVEST, V116, P1494, DOI 10.1172/JCI26498; Kawase M, 2007, MICROBIOL IMMUNOL, V51, P1109, DOI 10.1111/j.1348-0421.2007.tb04006.x; Kawase M, 2006, BIOSCI BIOTECH BIOCH, V70, P3025, DOI 10.1271/bbb.60152; Khazen W, 2007, BIOCHIMIE, V89, P669, DOI 10.1016/j.biochi.2007.01.003; Kim SW, 2013, BIOCHEM BIOPH RES CO, V431, P258, DOI 10.1016/j.bbrc.2012.12.121; Kim S, 2014, BMB REP, V47, P173, DOI 10.5483/BMBRep.2014.47.3.272; Lee YH, 2005, DIABETOLOGIA, V48, P1776, DOI 10.1007/s00125-005-1867-3; Lo J, 2007, AM J PHYSIOL-ENDOC M, V293, pE102, DOI 10.1152/ajpendo.00089.2007; Maury E, 2009, J CLIN ENDOCR METAB, V94, P1393, DOI 10.1210/jc.2008-2196; Miyazawa K, 2012, MICROBIOL IMMUNOL, V56, P847, DOI 10.1111/j.1348-0421.2012.00512.x; Moller DE, 2000, TRENDS ENDOCRIN MET, V11, P212, DOI 10.1016/S1043-2760(00)00272-1; Moue M, 2008, BBA-GEN SUBJECTS, V1780, P134, DOI 10.1016/j.bbagen.2007.11.006; Nobusue H, 2010, J CELL BIOCHEM, V109, P542, DOI 10.1002/jcb.22431; Oliver E, 2010, P NUTR SOC, V69, P232, DOI 10.1017/S0029665110000042; Park JE, 2014, J SCI FOOD AGR, V94, P2514, DOI 10.1002/jsfa.6588; Poulain-Godefroy O, 2010, MEDIAT INFLAMM, V2010, DOI 10.1155/2010/823486; Prins JB, 1997, DIABETES, V46, P1939, DOI 10.2337/diabetes.46.12.1939; Salva S, 2014, INT IMMUNOPHARMACOL, V22, P209, DOI 10.1016/j.intimp.2014.06.017; Salva S, 2010, INT J FOOD MICROBIOL, V141, P82, DOI 10.1016/j.ijfoodmicro.2010.03.013; Sanosaka M, 2008, COMP BIOCHEM PHYS B, V149, P285, DOI 10.1016/j.cbpb.2007.09.019; Sartipy P, 2003, P NATL ACAD SCI USA, V100, P7265, DOI 10.1073/pnas.1133870100; Schroeder K, 2009, ARTERIOSCL THROM VAS, V29, P239, DOI 10.1161/ATVBAHA.108.174219; Sethi JK, 1999, SEMIN CELL DEV BIOL, V10, P19, DOI 10.1006/scdb.1998.0273; Shimazu T, 2012, INFECT IMMUN, V80, P276, DOI 10.1128/IAI.05729-11; Skurk T, 2007, J CLIN ENDOCR METAB, V92, P1023, DOI 10.1210/jc.2006-1055; Spalding KL, 2008, NATURE, V453, P783, DOI 10.1038/nature06902; Stanley TL, 2011, J CLIN ENDOCR METAB, V96, pE146, DOI 10.1210/jc.2010-1170; Tomosada Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059259; Toral M, 2014, CLIN SCI, V127, P33, DOI 10.1042/CS20130339; Tsai YT, 2014, APPL MICROBIOL BIOT, V98, P1, DOI 10.1007/s00253-013-5346-3; Uysal KT, 1997, NATURE, V389, P610, DOI 10.1038/39335; VANDERPOLL T, AM J PHYSL, V261, pE457; Villena J, 2013, IMMUNOBIOTICS IMMUNO, P89; Villena J, 2012, BMC IMMUNOL, V13, DOI 10.1186/1471-2172-13-53; Yoda K, 2012, J APPL MICROBIOL, V113, P155, DOI 10.1111/j.1365-2672.2012.05316.x; Zhang HM, 2009, NUTR METAB CARDIOVAS, V19, P736, DOI 10.1016/j.numecd.2008.12.016; Zhu HJ, 2013, J DIABETES INVEST, V4, P252, DOI 10.1111/jdi.12046	56	5	6	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2015	10	3							e0119644	10.1371/journal.pone.0119644	http://dx.doi.org/10.1371/journal.pone.0119644			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD9NQ	25789857	gold, Green Submitted, Green Published			2022-12-27	WOS:000351425400093
J	Tanaka-Arakawa, MM; Matsui, M; Tanaka, C; Uematsu, A; Uda, S; Miura, K; Sakai, T; Noguchi, K				Tanaka-Arakawa, Megumi M.; Matsui, Mie; Tanaka, Chiaki; Uematsu, Akiko; Uda, Satoshi; Miura, Kayoko; Sakai, Tomoko; Noguchi, Kyo			Developmental Changes in the Corpus Callosum from Infancy to Early Adulthood: A Structural Magnetic Resonance Imaging Study	PLOS ONE			English	Article							LOCALLY WEIGHTED REGRESSION; SEX-DIFFERENCES; WHITE-MATTER; BRAIN-DEVELOPMENT; FIBER COMPOSITION; GENDER; SIZE; ADOLESCENCE; CHILDHOOD; CHILDREN	Previous research has reported on the development trajectory of the corpus callosum morphology. However, there have been only a few studies that have included data on infants. The goal of the present study was to examine the morphology of the corpus callosum in healthy participants of both sexes, from infancy to early adulthood. We sought to characterize normal development of the corpus callosum and possible sex differences in development. We performed a morphometric magnetic resonance imaging (MRI) study of 114 healthy individuals, aged 1 month to 25 years old, measuring the size of the corpus callosum. The corpus callosum was segmented into seven subareas of the rostrum, genu, rostral body, anterior midbody, posterior midbody, isthmus and splenium. Locally weighted regression analysis (LOESS) indicated significant non-linear age-related changes regardless of sex, particularly during the first few years of life. After this increase, curve slopes gradually became flat during adolescence and adulthood in both sexes. Age of local maximum for each subarea of the corpus callosum differed across the sexes. Ratios of total corpus callosum and genu, posterior midbody, as well as splenium to the whole brain were significantly higher in females compared with males. The present results demonstrate that the developmental trajectory of the corpus callosum during early life in healthy individuals is non-linear and dynamic. This pattern resembles that found for the cerebral cortex, further suggesting that this period plays a very important role in neural and functional development. In addition, developmental trajectories and changes in growth do show some sex differences.	[Tanaka-Arakawa, Megumi M.; Matsui, Mie; Uematsu, Akiko; Uda, Satoshi; Miura, Kayoko] Toyama Univ, Grad Sch Med & Pharmaceut Sci, Dept Psychol, Toyama 930, Japan; [Tanaka, Chiaki] Toyama Univ, Grad Sch Med & Pharmaceut Sci, Dept Pediat, Toyama 930, Japan; [Noguchi, Kyo] Toyama Univ, Grad Sch Med & Pharmaceut Sci, Dept Radiol, Toyama 930, Japan; [Sakai, Tomoko] Keio Univ, Sch Med, Dept Physiol, Tokyo 160, Japan	University of Toyama; University of Toyama; University of Toyama; Keio University	Matsui, M (corresponding author), Toyama Univ, Grad Sch Med & Pharmaceut Sci, Dept Psychol, Toyama 930, Japan.	mmatsui@las.u-toyama.ac.jp		Miura, Kayoko/0000-0001-6012-5583; Noguchi, Kyo/0000-0002-6305-8045; Uematsu, Akiko/0000-0001-6123-4247	Japan Society for the Promotion of Science (JSPS) [20330141, 21243040]; JSPS Asian Core Program	Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); JSPS Asian Core Program(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This study was supported by a Grant-in-Aid for Scientific Research (B) 20330141 and (A) 21243040 from the Japan Society for the Promotion of Science (JSPS) and JSPS Asian Core Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABOITIZ F, 1992, BRAIN RES, V598, P143, DOI 10.1016/0006-8993(92)90178-C; Achiron R, 2001, ULTRASOUND OBST GYN, V18, P343, DOI 10.1046/j.0960-7692.2001.00512.x; ALLEN LS, 1991, J NEUROSCI, V11, P933; Anderson NG, 2005, AM J NEURORADIOL, V26, P2685; BARKOVICH AJ, 1988, AM J ROENTGENOL, V151, P171, DOI 10.2214/ajr.151.1.171; Casey BJ, 2000, BIOL PSYCHOL, V54, P241, DOI 10.1016/S0301-0511(00)00058-2; Chura LR, 2010, PSYCHONEUROENDOCRINO, V35, P122, DOI 10.1016/j.psyneuen.2009.09.009; CLARKE JM, 1994, BEHAV BRAIN RES, V64, P185, DOI 10.1016/0166-4328(94)90131-7; CLARKE S, 1989, J COMP NEUROL, V280, P213, DOI 10.1002/cne.902800205; CLEVELAND WS, 1979, J AM STAT ASSOC, V74, P829, DOI 10.2307/2286407; CLEVELAND WS, 1988, J AM STAT ASSOC, V83, P596, DOI 10.2307/2289282; COWELL PE, 1992, DEV BRAIN RES, V66, P187, DOI 10.1016/0165-3806(92)90079-C; Davatzikos C, 1998, CEREB CORTEX, V8, P635, DOI 10.1093/cercor/8.7.635; DELACOSTE MC, 1986, HUM NEUROBIOL, V5, P93; DELACOSTE MC, 1985, J NEUROPATH EXP NEUR, V44, P578, DOI 10.1097/00005072-198511000-00004; DELACOSTEUTAMSING C, 1982, SCIENCE, V216, P1431, DOI 10.1126/science.7089533; Fabri M, 2013, NEURAL PLAST, V2013, DOI 10.1155/2013/251308; Fjell AM, 2010, NEUROIMAGE, V50, P1376, DOI 10.1016/j.neuroimage.2010.01.061; Garel C, 2011, AM J NEURORADIOL, V32, P1436, DOI 10.3174/ajnr.A2542; Gazzaniga MS, 2000, BRAIN, V123, P1293, DOI 10.1093/brain/123.7.1293; Giedd JN, 1996, DEV BRAIN RES, V91, P274; Giedd JN, 1999, PROG NEURO-PSYCHOPH, V23, P571; Gilmore JH, 2007, AM J NEURORADIOL, V28, P1789, DOI 10.3174/ajnr.A0751; HABIB M, 1991, BRAIN COGNITION, V16, P41, DOI 10.1016/0278-2626(91)90084-L; Highley JR, 1999, BRAIN, V122, P99, DOI 10.1093/brain/122.1.99; Hwang SJ, 2004, NEUROREPORT, V15, P1029, DOI 10.1097/00001756-200404290-00019; Jancke L, 1997, CEREB CORTEX, V7, P48, DOI 10.1093/cercor/7.1.48; Just MA, 2007, CEREB CORTEX, V17, P951, DOI 10.1093/cercor/bhl006; Kameyama T, 1981, SEISHIN IGAKU, V23, P1271; Keshavan MS, 2002, LIFE SCI, V70, P1909, DOI 10.1016/S0024-3205(02)01492-3; LAMANTIA AS, 1990, J COMP NEUROL, V291, P520, DOI 10.1002/cne.902910404; Luders E, 2006, NEUROREPORT, V17, P1103, DOI 10.1097/01.wnr.0000227987.77304.cc; Matsuzawa J, 2001, CEREB CORTEX, V11, P335, DOI 10.1093/cercor/11.4.335; Miller MB, 2010, NEUROPSYCHOLOGIA, V48, P2215, DOI 10.1016/j.neuropsychologia.2010.02.021; Paul LK, 2007, NAT REV NEUROSCI, V8, P287, DOI 10.1038/nrn2107; Paus T, 1999, SCIENCE, V283, P1908, DOI 10.1126/science.283.5409.1908; Piven J, 1997, AM J PSYCHIAT, V154, P1051; PUJOL J, 1993, ANN NEUROL, V34, P71, DOI 10.1002/ana.410340113; RAKIC P, 1968, J COMP NEUROL, V132, P45, DOI 10.1002/cne.901320103; RYMAR K, 1984, CORTEX, V20, P441, DOI 10.1016/S0010-9452(84)80013-1; Salat D, 1997, NEUROBIOL AGING, V18, P191, DOI 10.1016/S0197-4580(97)00014-6; Tanaka C, 2012, DEV NEUROSCI-BASEL, V34, P477, DOI 10.1159/000345152; TOMASCH J, 1954, ANAT REC, V119, P119, DOI 10.1002/ar.1091190109; Uematsu A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046970; Venkatasubramanian G, 2007, PSYCHIAT RES-NEUROIM, V156, P209, DOI 10.1016/j.pscychresns.2006.12.010; Westlye LT, 2010, CEREB CORTEX, V20, P2055, DOI 10.1093/cercor/bhp280; WITELSON SF, 1989, BRAIN, V112, P799, DOI 10.1093/brain/112.3.799; WOODRUFF PWR, 1995, J NEUROL NEUROSUR PS, V58, P457, DOI 10.1136/jnnp.58.4.457	48	41	42	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2015	10	3							e0118760	10.1371/journal.pone.0118760	http://dx.doi.org/10.1371/journal.pone.0118760			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD9NQ	25790124	Green Published, gold, Green Submitted			2022-12-27	WOS:000351425400045
J	Zhang, TP; Kho, DH; Wang, Y; Harazono, Y; Nakajima, K; Xie, Y; Raz, A				Zhang, Tianpeng; Kho, Dhong Hyo; Wang, Ying; Harazono, Yosuke; Nakajima, Kosei; Xie, Youming; Raz, Avraham			Gp78, an E3 Ubiquitin Ligase Acts as a Gatekeeper Suppressing Nonalcoholic Steatohepatitis (NASH) and Liver Cancer	PLOS ONE			English	Article							ENDOPLASMIC-RETICULUM STRESS; UNFOLDED PROTEIN RESPONSE; ER-ASSOCIATED DEGRADATION; MOTILITY FACTOR-RECEPTOR; HMG-COA REDUCTASE; DISEASE; INSIG-1; CELLS; KAI1	Nonalcoholic steatohepatitis (NASH) is related to metabolic dysregulation and the perturbation of endoplasmic reticulum (ER) homeostasis that frequently develops into hepatocellular carcinoma (HCC). Gp78 is E3 ligase, which regulates endoplasmic reticulum-associated degradation (ERAD) by ubiquitinylation of misfolded ER proteins. Here, we report that upon ageing (12 months), gp78(-/-) mice developed obesity, recapitulating age-related human NASH. Liver histology of gp78(-/-) mice revealed typical steatosis, hepatic inflammation and fibrosis, followed by progression to hepatocellular tumors. Acute ER stress revealed that loss of gp78 results in up regulation of unfolded protein response (UPR) pathways and SREBP-1 regulating de novo lipogenesis, responsible for fatty liver. Tissue array of human hepatocellular carcinoma (HCC) demonstrated that the expression of gp78 was inversely correlated with clinical grades of cancer. Here, we have described the generation of the first preclinical experimental model system which spontaneously develops age-related NASH and HCC, linking ERAD to hepatosteatosis, cirrhosis, and cancer. It suggests that gp78 is a regulator of normal liver homeostasis and a tumor suppressor in human liver.	[Raz, Avraham] Wayne State Univ, Sch Med, Dept Oncol, Detroit, MI 48202 USA; Wayne State Univ, Sch Med, Dept Pathol, Detroit, MI 48201 USA; Karmanos Canc Inst, Detroit, MI USA	Wayne State University; Wayne State University; Barbara Ann Karmanos Cancer Institute	Raz, A (corresponding author), Wayne State Univ, Sch Med, Dept Oncol, Detroit, MI 48202 USA.	raza@karmanos.org						Anstee QM, 2006, INT J EXP PATHOL, V87, P1, DOI 10.1111/j.0959-9673.2006.00465.x; Basseri S, 2008, DEV CELL, V15, P795, DOI 10.1016/j.devcel.2008.11.013; Brodsky JL, 2012, CELL, V151, P1163, DOI 10.1016/j.cell.2012.11.012; Brown MK, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00263; Chen ZL, 2014, J GENET GENOMICS, V41, P357, DOI 10.1016/j.jgg.2014.05.005; Cohen JC, 2011, SCIENCE, V332, P1519, DOI 10.1126/science.1204265; Curtis R, 2005, NAT REV DRUG DISCOV, V4, P569, DOI 10.1038/nrd1777; DeZwaan-McCabe D, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003937; Espenshade PJ, 2007, ANNU REV GENET, V41, P401, DOI 10.1146/annurev.genet.41.110306.130315; Fairbank M, 2009, MOL BIOSYST, V5, P793, DOI 10.1039/b820820b; Fang SY, 2001, P NATL ACAD SCI USA, V98, P14422, DOI 10.1073/pnas.251401598; Fu M, 2011, CELL DEATH DIFFER, V18, P1057, DOI 10.1038/cdd.2010.181; Gougelet A, 2012, J HEPATOL, V2012, DOI [10.1155/2012/816125, DOI 10.1155/2012/816125]; Hansen GM, 2008, GENOME RES, V18, P1670, DOI 10.1101/gr.078352.108; Hetz C, 2012, NAT REV MOL CELL BIO, V13, P89, DOI 10.1038/nrm3270; Hotamisligil GS, 2010, CELL, V140, P900, DOI 10.1016/j.cell.2010.02.034; Joshi B, 2010, J BIOL CHEM, V285, P8830, DOI 10.1074/jbc.M109.074344; Kho DH, 2014, CANCER RES, V74, P2229, DOI 10.1158/0008-5472.CAN-13-2937; Kho DH, 2013, CANCER RES, V73, P1411, DOI 10.1158/0008-5472.CAN-12-2149; Li GT, 2006, P NATL ACAD SCI USA, V103, P8348, DOI 10.1073/pnas.0602747103; Liu TF, 2012, CELL METAB, V16, P213, DOI 10.1016/j.cmet.2012.06.014; Malhi H, 2011, J HEPATOL, V54, P795, DOI 10.1016/j.jhep.2010.11.005; Marra F, 2008, TRENDS MOL MED, V14, P72, DOI 10.1016/j.molmed.2007.12.003; Muller JMM, 2007, BIOCHEM BIOPH RES CO, V354, P459, DOI 10.1016/j.bbrc.2006.12.206; Naik A, 2013, GENOMICS, V102, P84, DOI 10.1016/j.ygeno.2013.03.007; Pagliassotti MJ, 2012, ANNU REV NUTR, V32, P17, DOI 10.1146/annurev-nutr-071811-150644; Romisch K, 2005, ANNU REV CELL DEV BI, V21, P435, DOI 10.1146/annurev.cellbio.21.012704.133250; Song BL, 2005, MOL CELL, V19, P829, DOI 10.1016/j.molcel.2005.08.009; Starley BQ, 2010, HEPATOLOGY, V51, P1820, DOI 10.1002/hep.23594; Szegezdi E, 2006, EMBO REP, V7, P880, DOI 10.1038/sj.embor.7400779; Todd DJ, 2008, NAT REV IMMUNOL, V8, P663, DOI 10.1038/nri2359; Travers KJ, 2000, CELL, V101, P249, DOI 10.1016/S0092-8674(00)80835-1; Tsai B, 2002, NAT REV MOL CELL BIO, V3, P246, DOI 10.1038/nrm780; Tsai YC, 2007, NAT MED, V13, P1504, DOI 10.1038/nm1686; Tsai YC, 2012, MOL BIOL CELL, V23, P4484, DOI 10.1091/mbc.E12-08-0631; Tsai Yien Che, 2010, Genes Cancer, V1, P764; Vandewynckel YP, 2013, ANTICANCER RES, V33, P4683; Vembar SS, 2008, NAT REV MOL CELL BIO, V9, P944, DOI 10.1038/nrm2546; Wang Y, 2014, ONCOTARGET, V5, P2044, DOI 10.18632/oncotarget.1478; Yagishita N, 2005, J BIOL CHEM, V280, P7909, DOI 10.1074/jbc.M410863200; Ye J, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a004754	41	36	36	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2015	10	3							e0118448	10.1371/journal.pone.0118448	http://dx.doi.org/10.1371/journal.pone.0118448			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD9NQ	25789613	Green Submitted, Green Published, gold			2022-12-27	WOS:000351425400031
J	Ahmad, Z; Jasnos, L; Gil, V; Howell, L; Hallsworth, A; Petrie, K; Sawado, T; Chesler, L				Ahmad, Zai; Jasnos, Lukasz; Gil, Veronica; Howell, Louise; Hallsworth, Albert; Petrie, Kevin; Sawado, Tomoyuki; Chesler, Louis			Molecular and In Vivo Characterization of Cancer-Propagating Cells Derived from MYCN-Dependent Medulloblastoma	PLOS ONE			English	Article							STEM-CELLS; N-MYC; DIVISION SYMMETRY; MOUSE MODEL; EXPRESSION; IDENTIFICATION; HEDGEHOG; LINEAGE; INHIBITION; PROTEIN	Medulloblastoma (MB) is the most common malignant pediatric brain tumor. While the pathways that are deregulated in MB remain to be fully characterized, amplification and/or overexpression of the MYCN gene, which is has a critical role in cerebellar development as a regulator of neural progenitor cell fate, has been identified in several MB subgroups. Phenotypically, aberrant expression of MYCN is associated with the large-cell/anaplastic MB variant, which accounts for 5-15% of cases and is associated with aggressive disease and poor clinical outcome. To better understand the role of MYCN in MB in vitro and in vivo and to aid the development of MYCN-targeted therapeutics we established tumor-derived neurosphere cell lines from the GTML (Glt1-tTA/TRE-MYCN-Luc) genetically engineered mouse model. A fraction of GTML neurospheres were found to be growth factor independent, expressed CD133 (a marker of neural stem cells), failed to differentiate upon MYCN withdrawal and were highly tumorigenic when orthotopically implanted into the cerebellum. Principal component analyzes using single cell RNA assay data suggested that the clinical candidate aurora-A kinase inhibitor MLN8237 converts GTML neurospheres to resemble non-MYCN expressors. Correlating with this, MLN8237 significantly extended the survival of mice bearing GTML MB allografts. In summary, our results demonstrate that MYCN plays a critical role in expansion and survival of aggressive MB-propagating cells, and establish GTML neurospheres as an important resource for the development of novel therapeutic strategies.	[Ahmad, Zai; Gil, Veronica; Hallsworth, Albert; Petrie, Kevin; Chesler, Louis] Inst Canc Res, Div Clin Studies, London SM2 5NG, England; [Jasnos, Lukasz; Howell, Louise; Sawado, Tomoyuki] Inst Canc Res, Div Mol Pathol, London SM2 5NG, England	Royal Marsden NHS Foundation Trust; University of London; Institute of Cancer Research - UK; Royal Marsden NHS Foundation Trust; University of London; Institute of Cancer Research - UK	Sawado, T (corresponding author), Inst Canc Res, Div Mol Pathol, London SM2 5NG, England.	tomoyuki.sawado@icr.ac.uk	Petrie, Kevin/I-7115-2015	Petrie, Kevin/0000-0002-9805-9152; Chesler, Louis/0000-0001-7842-2068	Institute of Cancer Research, American Institute for Cancer Research [11-0301]; Cancer Research United Kingdom [C34648/A12054]; Brain Tumour Charity [SDBTT 6/88]; Cancer Research UK [18339] Funding Source: researchfish	Institute of Cancer Research, American Institute for Cancer Research; Cancer Research United Kingdom(Cancer Research UK); Brain Tumour Charity; Cancer Research UK(Cancer Research UK)	This work was supported by funds from the Institute of Cancer Research, American Institute for Cancer Research (11-0301), Cancer Research United Kingdom (C34648/A12054), and Brain Tumour Charity (SDBTT 6/88). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brockmann M, 2013, CANCER CELL, V24, P75, DOI 10.1016/j.ccr.2013.05.005; Chesler L, 2006, CANCER RES, V66, P8139, DOI 10.1158/0008-5472.CAN-05-2769; Deloulme JC, 2004, MOL CELL NEUROSCI, V27, P453, DOI 10.1016/j.mcn.2004.07.008; Eberhart CG, 2012, CANCER CELL, V21, P137, DOI 10.1016/j.ccr.2012.01.013; ENG LF, 1985, J NEUROIMMUNOL, V8, P203, DOI 10.1016/S0165-5728(85)80063-1; Hatton BA, 2006, CANCER RES, V66, P8655, DOI 10.1158/0008-5472.CAN-06-1621; Hemmati HD, 2003, P NATL ACAD SCI USA, V100, P15178, DOI 10.1073/pnas.2036535100; Hill RM, 2015, CANCER CELL, V27, P72, DOI 10.1016/j.ccell.2014.11.002; Jasnos L, 2014, NAT PROTOC, V9, P505, DOI 10.1038/nprot.2014.032; Jasnos L, 2013, STEM CELL REP, V1, P360, DOI 10.1016/j.stemcr.2013.08.005; Jones DTW, 2012, NATURE, V488, P100, DOI 10.1038/nature11284; Kawauchi D, 2012, CANCER CELL, V21, P168, DOI 10.1016/j.ccr.2011.12.023; Kenney AM, 2004, DEVELOPMENT, V131, P217, DOI 10.1242/dev.00891; Knoepfler PS, 2002, GENE DEV, V16, P2699, DOI 10.1101/gad.1021202; Kool M, 2012, ACTA NEUROPATHOL, V123, P473, DOI 10.1007/s00401-012-0958-8; Kool M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003088; Korshunov A, 2012, ACTA NEUROPATHOL, V123, P515, DOI 10.1007/s00401-011-0918-8; LEE MK, 1990, CELL MOTIL CYTOSKEL, V17, P118, DOI 10.1002/cm.970170207; Lim DA, 1999, P NATL ACAD SCI USA, V96, P7526, DOI 10.1073/pnas.96.13.7526; Lu QR, 2000, NEURON, V25, P317, DOI 10.1016/S0896-6273(00)80897-1; Manoranjan B, 2013, CANCER LETT, V338, P23, DOI 10.1016/j.canlet.2012.07.010; Mao P, 2013, P NATL ACAD SCI USA, V110, P8644, DOI 10.1073/pnas.1221478110; Marie Y, 2001, LANCET, V358, P298, DOI 10.1016/S0140-6736(01)05499-X; Michiels EMC, 1999, PHYSIOL GENOMICS, V1, P83, DOI 10.1152/physiolgenomics.1999.1.2.83; Monje M, 2011, J CLIN ONCOL, V29, P1395, DOI 10.1200/JCO.2010.34.0547; Northcott PA, 2012, NATURE, V488, P49, DOI 10.1038/nature11327; Northcott PA, 2009, CANCER RES, V69, P3249, DOI 10.1158/0008-5472.CAN-08-4710; Oliver TG, 2003, P NATL ACAD SCI USA, V100, P7331, DOI 10.1073/pnas.0832317100; Pei YX, 2012, CANCER CELL, V21, P155, DOI 10.1016/j.ccr.2011.12.021; Pfister S, 2009, J CLIN ONCOL, V27, P1627, DOI 10.1200/JCO.2008.17.9432; Poschl J, 2014, ACTA NEUROPATHOL, V128, P123, DOI 10.1007/s00401-014-1297-8; Pugh TJ, 2012, NATURE, V488, P106, DOI 10.1038/nature11329; Read TA, 2009, CANCER CELL, V15, P135, DOI 10.1016/j.ccr.2008.12.016; Robinson G, 2012, NATURE, V488, P43, DOI 10.1038/nature11213; Rostomily RC, 1997, CANCER RES, V57, P3526; Roussel MF, 2013, COLD SPRING HARB PER, P3; Sakakibara S, 1996, DEV BIOL, V176, P230, DOI 10.1006/dbio.1996.0130; Singh SK, 2003, CANCER RES, V63, P5821; Singh SK, 2004, NATURE, V432, P396, DOI 10.1038/nature03128; Sjostrom SK, 2005, DEV CELL, V9, P327, DOI 10.1016/j.devcel.2005.07.014; Sun YR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005498; Swartling FJ, 2012, CANCER CELL, V21, P601, DOI 10.1016/j.ccr.2012.04.012; Swartling FJ, 2010, GENE DEV, V24, P1059, DOI 10.1101/gad.1907510; Taylor MD, 2012, ACTA NEUROPATHOL, V123, P465, DOI 10.1007/s00401-011-0922-z; Uchida N, 2000, P NATL ACAD SCI USA, V97, P14720, DOI 10.1073/pnas.97.26.14720; Van Brocklyn JR, 2014, CANCER RES, V74, P5364, DOI 10.1158/0008-5472.CAN-14-0386; Ward RJ, 2009, CANCER RES, V69, P4682, DOI 10.1158/0008-5472.CAN-09-0342; Weiss WA, 1997, EMBO J, V16, P2985, DOI 10.1093/emboj/16.11.2985; Yang ZJ, 2008, CANCER CELL, V14, P135, DOI 10.1016/j.ccr.2008.07.003; Zhou Q, 2000, NEURON, V25, P331, DOI 10.1016/S0896-6273(00)80898-3	50	14	14	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2015	10	3							e0119834	10.1371/journal.pone.0119834	http://dx.doi.org/10.1371/journal.pone.0119834			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9BN	25785590	Green Submitted, gold, Green Published, Green Accepted			2022-12-27	WOS:000352138500131
J	Evers, E; de Vries, H; Spruijt, BM; Sterck, EHM				Evers, Ellen; de Vries, Han; Spruijt, Berry M.; Sterck, Elisabeth H. M.			Emotional Bookkeeping and High Partner Selectivity Are Necessary for the Emergence of Partner-Specific Reciprocal Affiliation in an Agent-Based Model of Primate Groups	PLOS ONE			English	Article							GROOMING SITE PREFERENCES; MACAQUES MACACA-MULATTA; SOCIAL RELATIONSHIPS; GROUP-SIZE; DOMINANCE RELATIONS; LONG-TERM; JAPANESE MACAQUES; BARBARY MACAQUES; STABILITY; ANIMALS	Primate affiliative relationships are differentiated, individual-specific and often reciprocal. However, the required cognitive abilities are still under debate. Recently, we introduced the EMO-model, in which two emotional dimensions regulate social behaviour: anxiety-FEAR and satisfaction-LIKE. Emotional bookkeeping is modelled by providing each individual with partner-specific LIKE attitudes in which the emotional experiences of earlier affiliations with others are accumulated. Individuals also possess fixed partner-specific FEAR attitudes, reflecting the stable dominance hierarchy. In this paper, we focus on one key parameter of the model, namely the degree of partner selectivity, i.e. the extent to which individuals rely on their LIKE attitudes when choosing affiliation partners. Studying the effect of partner selectivity on the emergent affiliative relationships, we found that at high selectivity, individuals restricted their affiliative behaviours more to similar-ranking individuals and that reciprocity of affiliation was enhanced. We compared the emotional bookkeeping model with a control model, in which individuals had fixed LIKE attitudes simply based on the (fixed) rank-distance, instead of dynamic LIKE attitudes based on earlier events. Results from the control model were very similar to the emotional bookkeeping model: high selectivity resulted in preference of similar-ranking partners and enhanced reciprocity. However, only in the emotional bookkeeping model did high selectivity result in the emergence of reciprocal affiliative relationships that were highly partner-specific. Moreover, in the emotional bookkeeping model, LIKE attitude predicted affiliative behaviour better than rank-distance, especially at high selectivity. Our model suggests that emotional bookkeeping is a likely candidate mechanism to underlie partner-specific reciprocal affiliation.	[Evers, Ellen; de Vries, Han; Spruijt, Berry M.; Sterck, Elisabeth H. M.] Univ Utrecht, Anim Ecol, Utrecht, Netherlands; [Sterck, Elisabeth H. M.] Biomed Primate Res Ctr, Ethol Res, Rijswijk, Netherlands	Utrecht University	Sterck, EHM (corresponding author), Univ Utrecht, Anim Ecol, Utrecht, Netherlands.	e.h.m.sterck@uu.nl	de Vries, Han/B-9359-2011; Sterck, Elisabeth/C-1063-2011	Sterck, Elisabeth/0000-0003-1101-6027	Netherlands Science Organization (NWO) [864.05.009]	Netherlands Science Organization (NWO)(Netherlands Organization for Scientific Research (NWO))	This research was funded by a VIDI grant to EHM Sterck by the Netherlands Science Organization (NWO, grant number 864.05.009); URL: http://www.nwo.nl/en. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adachi I, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023345; Adiseshan A, 2011, AM J PRIMATOL, V73, P1107, DOI 10.1002/ajp.20987; Aureli F, 2002, BEHAVIOUR, V139, P393, DOI 10.1163/156853902760102726; Aureli F, 1999, J COMP PSYCHOL, V113, P59, DOI 10.1037/0735-7036.113.1.59; Aureli Filippo, 2012, P531; Aureli F, 2010, BIOL LETTERS, V6, P27, DOI 10.1098/rsbl.2009.0513; Barrett L, 2002, BEHAVIOUR, V139, P263, DOI 10.1163/156853902760102672; Barrett L, 2007, PHILOS T R SOC B, V362, P561, DOI 10.1098/rstb.2006.1995; BARTON R, 1985, INT J PRIMATOL, V6, P519, DOI 10.1007/BF02735574; Berghanel A, 2011, BEHAVIOUR, V148, P1257, DOI 10.1163/000579511X600628; Bergstrom ML, 2010, BEHAVIOUR, V147, P899, DOI 10.1163/000579510X497283; BERNSTEIN IS, 1986, ANIM BEHAV, V34, P739, DOI 10.1016/S0003-3472(86)80057-4; BERNSTEIN IS, 1969, ANIM BEHAV, V17, P452, DOI 10.1016/0003-3472(69)90146-8; BOCCIA ML, 1989, PHYSIOL BEHAV, V45, P667, DOI 10.1016/0031-9384(89)90089-9; Boissy A, 2007, PHYSIOL BEHAV, V92, P375, DOI 10.1016/j.physbeh.2007.02.003; Bovet D, 2003, J COMP PSYCHOL, V117, P400, DOI 10.1037/0735-7036.117.4.400; BRAMBLETT CA, 1982, AM J PRIMATOL, V2, P43, DOI 10.1002/ajp.1350020107; Brosnan SF, 2002, HUM NATURE-INT BIOS, V13, P129, DOI 10.1007/s12110-002-1017-2; Bryson JJ, 2007, PHILOS T R SOC B, V362, P1685, DOI 10.1098/rstb.2007.2061; BUZAS MA, 1969, SCIENCE, V163, P72, DOI 10.1126/science.163.3862.72; Campenni M, 2014, J THEOR BIOL, V344, P49, DOI 10.1016/j.jtbi.2013.11.019; Carne C, 2011, AM J PRIMATOL, V73, P1127, DOI 10.1002/ajp.20979; Castles DL, 1996, ANIM BEHAV, V52, P389, DOI 10.1006/anbe.1996.0183; Chapman CA, 2000, ON THE MOVE HOW AND, p[24, 41]; Cheney DL, 1999, ANIM BEHAV, V58, P67, DOI 10.1006/anbe.1999.1131; CHENEY DL, 1980, ANIM BEHAV, V28, P362, DOI 10.1016/S0003-3472(80)80044-3; Clayton NS, 2003, NAT REV NEUROSCI, V4, P685, DOI 10.1038/nrn1180; Crockford C, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2012.2765; Cronin KA, 2012, ANIM BEHAV, V84, P1085, DOI 10.1016/j.anbehav.2012.08.009; Curley JP, 2005, TRENDS ECOL EVOL, V20, P561, DOI 10.1016/j.tree.2005.05.018; de Vries H, 2009, BEHAVIOUR, V146, P843, DOI 10.1163/156853909X412241; De Waal FBM, 2000, ANIM BEHAV, V60, P253, DOI 10.1006/anbe.2000.1471; DEVRIES H, 1993, PSYCHOMETRIKA, V58, P53, DOI 10.1007/BF02294470; DEWAAL FBM, 1991, ANIM BEHAV, V41, P383, DOI 10.1016/S0003-3472(05)80839-5; Dunbar RIM, 2010, NEUROSCI BIOBEHAV R, V34, P260, DOI 10.1016/j.neubiorev.2008.07.001; DUNBAR RIM, 1992, J HUM EVOL, V22, P469, DOI 10.1016/0047-2484(92)90081-J; Dunbar RIM, 2010, BEHAVIOUR, V147, P775, DOI 10.1163/000579510X501151; Evers E, THE TIMEFRAME OF EMO; Evers E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087955; Evers E, 2012, BEHAV ECOL SOCIOBIOL, V66, P931, DOI 10.1007/s00265-012-1342-3; Evers E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026189; FOODEN J, 1990, J HUM EVOL, V19, P607, DOI 10.1016/0047-2484(90)90002-S; Fooden Jack, 2006, Fieldiana Zoology, P1; Giske J, 2013, AM NAT, V182, P689, DOI 10.1086/673533; Grimm V, 2010, ECOL MODEL, V221, P2760, DOI 10.1016/j.ecolmodel.2010.08.019; HAUSFATER G, 1982, SCIENCE, V217, P752, DOI 10.1126/science.217.4561.752; Hemelrijk CK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037271; Hemelrijk CK, 1999, P ROY SOC B-BIOL SCI, V266, P361, DOI 10.1098/rspb.1999.0646; Hemelrijk CK, 2000, ANIM BEHAV, V59, P1035, DOI 10.1006/anbe.2000.1400; HEMELRIJK CK, 1990, ANIM BEHAV, V39, P1013, DOI 10.1016/S0003-3472(05)80775-4; Henzi SP, 2007, ADV STUD BEHAV, V37, P43, DOI 10.1016/S0065-3454(07)37002-2; HOGEWEG P, 1983, BEHAV ECOL SOCIOBIOL, V12, P271, DOI 10.1007/BF00302895; Jaeggi AV, 2013, EVOL HUM BEHAV, V34, P69, DOI 10.1016/j.evolhumbehav.2012.09.005; KUMAR A, 1995, PRIMATES, V36, P1, DOI 10.1007/BF02381911; KUMMER H, 1978, SOC SCI INFORM, V17, P687, DOI 10.1177/053901847801700418; Lehmann J, 2007, ANIM BEHAV, V74, P1617, DOI 10.1016/j.anbehav.2006.10.025; Leinfelder I, 2001, AM J PRIMATOL, V55, P25, DOI 10.1002/ajp.1036; Leiva D., 2010, P MEAS BEH 2010, P162; Massen JJM, 2013, INT J PRIMATOL, V34, P770, DOI 10.1007/s10764-013-9695-7; Massen JJM, 2010, BEHAVIOUR, V147, P1379, DOI 10.1163/000579510X528224; Massen JJM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009734; Melnick DJ, 1987, CERCOPITHECINES IN M; MISSAKIAN E A, 1972, Primates, V13, P169, DOI 10.1007/BF01840878; Nakamichi M, 2003, INT J PRIMATOL, V24, P607, DOI 10.1023/A:1023744515134; Noe R, 2006, COOPERATION IN PRIMATES AND HUMANS: MECHANISMS AND EVOLUTIONS, P233, DOI 10.1007/3-540-28277-7_13; Ostner J, 2008, HORM BEHAV, V54, P613, DOI 10.1016/j.yhbeh.2008.05.020; Puga-Gonzalez I, 2015, BEHAV ECOL SOCIOBIOL, V69, P383, DOI 10.1007/s00265-014-1850-4; Puga-Gonzalez I, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000630; R Core Team, 2012, R LANG ENV STAT COMP; RHINE RJ, 1989, AM J PRIMATOL, V19, P69, DOI 10.1002/ajp.1350190202; Robbins MM, 2005, BEHAVIOUR, V142, P779, DOI 10.1163/1568539054729123; SAMUELS A, 1987, ANIM BEHAV, V35, P785, DOI 10.1016/S0003-3472(87)80115-X; Schaffner CM, 2012, PRIMATES, V53, P49, DOI 10.1007/s10329-011-0271-5; Schell A, 2011, ANIM COGN, V14, P503, DOI 10.1007/s10071-011-0383-8; SCHINO G, 1988, AM J PRIMATOL, V16, P43, DOI 10.1002/ajp.1350160106; Schino G, 2008, BIOL J LINN SOC, V95, P439, DOI 10.1111/j.1095-8312.2008.01067.x; Schino G, 2010, EVOL ANTHROPOL, V19, P130, DOI 10.1002/evan.20270; Schino G, 2010, ECOL LETT, V13, P45, DOI 10.1111/j.1461-0248.2009.01396.x; Schino G, 2009, ADV STUD BEHAV, V39, P45, DOI 10.1016/S0065-3454(09)39002-6; Schulke O, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059789; SEYFARTH RM, 1977, J THEOR BIOL, V65, P671, DOI 10.1016/0022-5193(77)90015-7; Seyfarth RM, 2012, ANNU REV PSYCHOL, V63, P153, DOI 10.1146/annurev-psych-120710-100337; Shutt K, 2007, BIOLOGY LETT, V3, P231, DOI 10.1098/rsbl.2007.0052; Silk JB, 2002, BEHAVIOUR, V139, P421, DOI 10.1163/156853902760102735; SILK JB, 1988, AM NAT, V132, P1, DOI 10.1086/284834; Silk JB, 2006, BEHAV ECOL SOCIOBIOL, V61, P183, DOI 10.1007/s00265-006-0249-2; Silk JB, 2010, BEHAV ECOL SOCIOBIOL, V64, P1733, DOI 10.1007/s00265-010-0986-0; SMUTS BB, 1987, PRIMATE SOCIETIES; Sterck Elisabeth H.M., 2012, P65; TERRY RL, 1970, J PSYCHOL, V76, P129, DOI 10.1080/00223980.1970.9916830; Tibbetts EA, 2007, TRENDS ECOL EVOL, V22, P529, DOI 10.1016/j.tree.2007.09.001; Tiddi B, 2011, BEHAV ECOL, V22, P663, DOI 10.1093/beheco/arr028; VANSCHAIK CP, 1983, BEHAV ECOL SOCIOBIOL, V13, P173, DOI 10.1007/BF00299920; Widdig A, 2001, P NATL ACAD SCI USA, V98, P13769, DOI 10.1073/pnas.241210198; Wilenski U, 2007, NETLOGO 5 0 2; Xia DP, 2013, AM J PRIMATOL, V75, P1009, DOI 10.1002/ajp.22165; Zamma K, 2002, PRIMATES, V43, P41, DOI 10.1007/BF02629575	97	15	15	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2015	10	3							e0118921	10.1371/journal.pone.0118921	http://dx.doi.org/10.1371/journal.pone.0118921			33	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9BN	25785601	Green Published, Green Submitted, gold			2022-12-27	WOS:000352138500058
J	Grossohmichen, M; Salcher, R; Kreipe, HH; Lenarz, T; Maier, H				Grossoehmichen, Martin; Salcher, Rolf; Kreipe, Hans-Heinrich; Lenarz, Thomas; Maier, Hannes			The Codacs (TM) Direct Acoustic Cochlear Implant Actuator: Exploring Alternative Stimulation Sites and Their Stimulation Efficiency	PLOS ONE			English	Article							MIDDLE-EAR IMPLANT; ROUND-WINDOW STIMULATION; BONE-CONDUCTION STIMULATION; OSSICULAR CHAIN; PERFORMANCE; AIR	This work assesses the efficiency of the Codacs system actuator (Cochlear Ltd., Sydney Australia) in different inner ear stimulation modalities. Originally the actuator was intended for direct perilymph stimulation after stapedotomy using a piston prosthesis. A possible alternative application is the stimulation of middle ear structures or the round window (RW). Here the perilymph stimulation with a K-piston through a stapes footplate (SFP) fenestration (N = 10) as well as stimulation of the stapes head (SH) with a Bell prosthesis (N = 9), SFP stimulation with an Omega/Aerial prosthesis (N = 8) and reverse RW stimulation (N = 10) were performed in cadaveric human temporal bones (TBs). Codacs actuator output is expressed as equivalent sound pressure level (eq. SPL) using RW and SFP displacement responses, measured by Laser Doppler velocimetry as reference. The axial actuator coupling force in stimulation of stapes and RW was adjusted to similar to 5 mN. The Bell prosthesis and Omega/Aerial prosthesis stimulation generated similar mean eq. SPLs (Bell: 127.5-141.8 eq. dB SPL; Omega/Aerial: 123.6-143.9 eq. dB SPL), being significantly more efficient than K-piston perilymph stimulation (108.6-131.6 eq. dB SPL) and RW stimulation (108.3-128.2 eq. dB SPL). Our results demonstrate that SH, SFP and RW are adequate alternative stimulation sites for the Codacs actuator using coupling prostheses and an axial coupling force of similar to 5 mN. Based on the eq. SPLs, all investigated methods were adequate for in vivo hearing aid applications, provided that experimental conditions including constant coupling force will be implemented.	[Grossoehmichen, Martin; Salcher, Rolf; Lenarz, Thomas; Maier, Hannes] Hannover Med Sch, Dept Otolaryngol, Hannover, Germany; [Grossoehmichen, Martin; Salcher, Rolf; Lenarz, Thomas; Maier, Hannes] Hannover Med Sch, Inst Audioneurotechnol VIANNA, Hannover, Germany; [Kreipe, Hans-Heinrich] Hannover Med Sch, Inst Pathol, Hannover, Germany	Hannover Medical School; Hannover Medical School; Hannover Medical School	Maier, H (corresponding author), Hannover Med Sch, Dept Otolaryngol, Hannover, Germany.	Maier.Hannes@MH-Hannover.de	Grossöhmichen, Martin/F-1032-2015; Hannes, Maier/AAE-5070-2020; Hannes, Maier/A-9457-2012	Grossöhmichen, Martin/0000-0002-5720-0981; Hannes, Maier/0000-0001-8457-5327; Hannes, Maier/0000-0001-8457-5327	Cochlear Ltd.	Cochlear Ltd.	This work is part of the doctoral thesis of MG and was supported by Cochlear Ltd. MG and HM received travel support by Cochlear Ltd. to meetings. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Society for Testing and Materials (ASTM), 2005, F250405 ASTM, DOI [10.1520/F2504-05, DOI 10.1520/F2504-05]; Asai M, 1999, ACTA OTO-LARYNGOL, V119, P356; Bernhard H, 2011, IEEE T BIO-MED ENG, V58, P420, DOI 10.1109/TBME.2010.2087756; Busch S, 2013, OTOL NEUROTOL, V34, P1711, DOI 10.1097/MAO.0000000000000225; Chatzimichalis M, 2012, AUDIOL NEURO-OTOL, V17, P299, DOI 10.1159/000339214; Deveze A, 2013, OTOL NEUROTOL, V34, P158, DOI 10.1097/MAO.0b013e3182785261; Deveze A, 2010, OTOL NEUROTOL, V31, P1027, DOI 10.1097/MAO.0b013e3181edb6d1; Haeusler R, 2008, AUDIOL NEURO-OTOL, V13, P247, DOI 10.1159/000115434; Hutenbrink KB, 2008, OTOL NEUROTOL, V29, P965, DOI 10.1097/MAO.0b013e318185fad8; KRINGLEBOTN M, 1995, J ACOUST SOC AM, V98, P192, DOI 10.1121/1.413746; Lauxmann M, 2014, J ACOUST SOC AM, V136, P1756, DOI 10.1121/1.4895696; Lee J, 2014, HEARING RES, V314, P65, DOI 10.1016/j.heares.2014.04.003; Lenarz T, 2013, OTOL NEUROTOL, V34, P1215, DOI 10.1097/MAO.0b013e318298aa76; Lupo JE, 2011, OTOLARYNG HEAD NECK, V145, P641, DOI 10.1177/0194599811409674; Maier H, 2013, HEARING RES, V301, P115, DOI 10.1016/j.heares.2012.12.010; Rosowski JJ, 2007, AUDIOL NEURO-OTOL, V12, P265, DOI 10.1159/000101474; Schraven SP, 2012, AUDIOL NEURO-OTOL, V17, P133, DOI 10.1159/000333807; Stenfelt S, 2004, HEARING RES, V198, P10, DOI 10.1016/j.heares.2004.07.008; Stenfelt S, 2004, J ACOUST SOC AM, V115, P797, DOI 10.1121/1.1639903; Stieger C, 2013, HEARING RES, V301, P105, DOI 10.1016/j.heares.2012.11.005; Tringali S, 2011, ACTA OTO-LARYNGOL, V131, P27, DOI 10.3109/00016489.2010.507779; Tringali S, 2010, AUDIOL NEURO-OTOL, V15, P291, DOI 10.1159/000283006; vonBekesy G., 1960, EXPT HEARING	23	16	17	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2015	10	3							e0119601	10.1371/journal.pone.0119601	http://dx.doi.org/10.1371/journal.pone.0119601			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9BN	25785860	Green Published, Green Submitted, gold			2022-12-27	WOS:000352138500117
J	Joe, SG; Yoon, YH; Choi, JA; Koh, JY				Joe, Soo Geun; Yoon, Young Hee; Choi, Jeong A.; Koh, Jae-Young			Anti-Angiogenic Effect of Metformin in Mouse Oxygen-Induced Retinopathy Is Mediated by Reducing Levels of the Vascular Endothelial Growth Factor Receptor Flk-1	PLOS ONE			English	Article							CANCER; RISK; VEGF; BEVACIZUMAB; METASTASIS; ACTIVATION; SIGNALS; CELLS; MODEL	Purpose To evaluate the effect of metformin on vascular changes in oxygen-induced retinopathy (OIR) in mouse, and to elucidate the possible underlying mechanism. Methods OIR mice were treated with metformin by intraperitoneal injection from postnatal day 12 (P12) to P17 or P21. At P17 and P21, vessel formation and avascular areas were assessed using retinal flat mounts. Levels of vascular endothelial growth factor (VEGF) were measured by enzyme-linked immunosorbent assays, and the effects of metformin on VEGF-induced proliferation of human umbilical vein endothelial cells (HUVECs) were assessed. The effects of metformin on the levels of Flk1 (VEGF receptor-2) and phosphorylated Flk1 (pFlk1) were measured by Western blotting (HUVECs) and immunohistochemistry (retinal tissue). Results Retinal morphologic changes were analyzed between two groups (saline-treated OIR; metformin-treated OIR). Metformin treatment did not change the extent of avascular areas at P17. However, at P21, when OIR pathology was markedly improved in the saline-treated group, OIR pathology still remained in the metformin-treated OIR group. VEGF expression levels did not differ between metformin-and saline-treated OIR groups at P17 and P21, but Flk1 levels were significantly reduced in the metformin group compared with saline-treated OIR group. Moreover, metformin inhibited VEGF-induced cell proliferation and decreased levels of Flk1 and pFlk1, consistent with the interpretation that metformin inhibits vascular growth by reducing Flk1 levels. Conclusion Metformin exerts anti-angiogenesis effects and delays the normal vessel formation in the recovery phase of OIR in mice, likely by suppressing the levels of Flk1.	[Joe, Soo Geun; Yoon, Young Hee] Univ Ulsan, Coll Med, Asan Med Ctr, Dept Ophthalmol, Seoul, South Korea; [Koh, Jae-Young] Univ Ulsan, Coll Med, Asan Med Ctr, Dept Neurol, Seoul, South Korea; [Choi, Jeong A.; Koh, Jae-Young] Univ Ulsan, Coll Med, Asan Inst Life Sci, Neural Injury Res Ctr, Seoul, South Korea	University of Ulsan; Asan Medical Center; University of Ulsan; Asan Medical Center; University of Ulsan	Koh, JY (corresponding author), Univ Ulsan, Coll Med, Asan Med Ctr, Dept Neurol, Seoul, South Korea.	jkko@amc.seoul.kr	Koh, Jae-Young/C-9014-2011	Koh, Jae-Young/0000-0002-4318-495X	National Research Foundation of Korea [NRF: 2005-0093836]; Korean Health Technology R&D Project, Ministry of Health Welfare [KHIDI: A092042]; Asan Institute for Life Sciences [2014-193, 2014-624]	National Research Foundation of Korea(National Research Foundation of Korea); Korean Health Technology R&D Project, Ministry of Health Welfare; Asan Institute for Life Sciences	National Research Foundation of Korea (NRF: 2005-0093836), http://www.nrf.re.kr, JYK; Korean Health Technology R&D Project, Ministry of Health & Welfare (KHIDI: A092042), http://www.khidi.or.kr, JYK; Asan Institute for Life Sciences (2014-193, 2014-624), http://ails.amc.seoul.kr, JYK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akinyeke T, 2013, CARCINOGENESIS, V34, P2823, DOI 10.1093/carcin/bgt307; Antonetti DA, 2012, NEW ENGL J MED, V366, P1227, DOI 10.1056/NEJMra1005073; Barbato DL, 2014, BBA-REV CANCER, V1845, P317, DOI 10.1016/j.bbcan.2014.02.003; Connor KM, 2009, NAT PROTOC, V4, P1565, DOI 10.1038/nprot.2009.187; Dallaglio K, 2014, CARCINOGENESIS, V35, P1055, DOI 10.1093/carcin/bgu001; Ersoy C, 2008, DIABETES RES CLIN PR, V81, P56, DOI 10.1016/j.diabres.2008.02.006; Esfahanian N, 2012, MOL MED REP, V5, P1068, DOI 10.3892/mmr.2012.753; Evans JMM, 2005, BMJ-BRIT MED J, V330, P1304, DOI 10.1136/bmj.38415.708634.F7; Giuliari GP, 2012, CURR DIABETES REV, V8, P32, DOI 10.2174/157339912798829188; Hadad SM, 2009, BREAST CANCER RES TR, V114, P391, DOI 10.1007/s10549-008-0016-3; He H, 1999, J BIOL CHEM, V274, P25130, DOI 10.1074/jbc.274.35.25130; Higgins RD, 1999, CURR EYE RES, V18, P20, DOI 10.1076/ceyr.18.1.20.5390; Holmes K, 2007, CELL SIGNAL, V19, P2003, DOI 10.1016/j.cellsig.2007.05.013; Lee J, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3006666; Leone A, 2014, CANCER TREAT RES, V159, P355, DOI 10.1007/978-3-642-38007-5_21; Li DH, 2009, GASTROENTEROLOGY, V137, P482, DOI 10.1053/j.gastro.2009.04.013; Liao H, 2012, ONCOL REP, V27, P1873, DOI 10.3892/or.2012.1745; Libby G, 2009, DIABETES CARE, V32, P1620, DOI 10.2337/dc08-2175; Martin MJ, 2012, CANCER DISCOV, V2, P344, DOI 10.1158/2159-8290.CD-11-0280; Micieli JA, 2009, AM J OPHTHALMOL, V148, P536, DOI 10.1016/j.ajo.2009.05.031; Miller JW, 2013, OPHTHALMOLOGY, V120, P106, DOI 10.1016/j.ophtha.2012.07.038; Mintz-Hittner HA, 2011, NEW ENGL J MED, V364, P603, DOI 10.1056/NEJMoa1007374; Molavi B, 2007, VASC HEALTH RISK MAN, V3, P967; Munie M, 2014, EFFECT METFORMIN DEV, P1069; Phoenix KN, 2009, BREAST CANCER RES TR, V113, P101, DOI 10.1007/s10549-008-9916-5; Qu C, 2014, MOL CELL BIOCHEM, V386, P63, DOI 10.1007/s11010-013-1845-x; Rattan R, 2011, NEOPLASIA, V13, P483, DOI 10.1593/neo.11148; Risau W, 1995, ANNU REV CELL DEV BI, V11, P73, DOI 10.1146/annurev.cb.11.110195.000445; Rivera JC, 2011, NEONATOLOGY, V100, P343, DOI 10.1159/000330174; Shibuya M, 2014, BIOMOL THER, V22, P1, DOI 10.4062/biomolther.2013.113; SMITH LEH, 1994, INVEST OPHTH VIS SCI, V35, P101; Stitt AW, 2013, CLIN SCI, V125, P1, DOI 10.1042/CS20120588; Tan BK, 2009, CARDIOVASC RES, V83, P566, DOI 10.1093/cvr/cvp131; Tarr Joanna M, 2013, ISRN Ophthalmol, V2013, P343560, DOI 10.1155/2013/343560; Turner RC, 1998, LANCET, V352, P854, DOI 10.1016/s0140-6736(98)07037-8; Viollet B, 2012, CLIN SCI, V122, P253, DOI 10.1042/CS20110386; Wu BC, 2012, ONCOL REP, V28, P903, DOI 10.3892/or.2012.1890; Xavier DO, 2010, BIOMED PHARMACOTHER, V64, P220, DOI 10.1016/j.biopha.2009.08.004	38	27	27	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2015	10	3							e0119708	10.1371/journal.pone.0119708	http://dx.doi.org/10.1371/journal.pone.0119708			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9BN	25785990	Green Published, gold, Green Submitted			2022-12-27	WOS:000352138500126
J	Lee, SW; Hartley, CA; Coppo, MJC; Vaz, PK; Legione, AR; Quinteros, JA; Noormohammadi, AH; Markham, PF; Browning, GF; Devlin, JM				Lee, Sang-Won; Hartley, Carol A.; Coppo, Mauricio J. C.; Vaz, Paola K.; Legione, Alistair R.; Quinteros, Jose A.; Noormohammadi, Amir H.; Markham, Phillip F.; Browning, Glenn F.; Devlin, Joanne M.			Growth Kinetics and Transmission Potential of Existing and Emerging Field Strains of Infectious Laryngotracheitis Virus	PLOS ONE			English	Article							MAREKS-DISEASE VIRUS; ATTENUATED VACCINES; BROILER-CHICKENS; GLYCOPROTEIN-G; VIRULENCE; VACCINATION; DEFICIENT; EVOLUTION; POULTRY; GENES	Attenuated live infectious laryngotracheitis virus (ILTV) vaccines are widely used in the poultry industry to control outbreaks of disease. Natural recombination between commercial ILTV vaccines has resulted in virulent recombinant viruses that cause severe disease, and that have now emerged as the dominant field strains in important poultry producing regions in Australia. Genotype analysis using PCR-restriction fragment length polymorphism has shown one recombinant virus (class 9) has largely replaced the previously dominant class 2 field strain. To examine potential reasons for this displacement we compared the growth kinetics and transmission potential of class 2 and class 9 viruses. The class 9 ILTV grew to higher titres in cell culture and embryonated eggs, but no differences were observed in entry kinetics or egress into the allantoic fluid from the chorioallantoic membrane. In vivo studies showed that birds inoculated with class 9 ILTV had more severe tracheal pathology and greater weight loss than those inoculated with the class 2 virus. Consistent with the predominance of class 9 field strains, birds inoculated with 102 or 103 plaque forming units of class 9 ILTV consistently transmitted virus to in-contact birds, whereas this could only be seen in birds inoculated with 104 PFU of the class 2 virus. Taken together, the improved growth kinetics and transmission potential of the class 9 virus is consistent with improved fitness of the recombinant virus over the previously dominant field strain.	[Lee, Sang-Won; Hartley, Carol A.; Coppo, Mauricio J. C.; Vaz, Paola K.; Legione, Alistair R.; Quinteros, Jose A.; Markham, Phillip F.; Browning, Glenn F.; Devlin, Joanne M.] Univ Melbourne, Fac Vet & Agr Sci, Asia Pacific Ctr Anim Hlth, Melbourne, Vic 3010, Australia; [Noormohammadi, Amir H.] Univ Melbourne, Fac Vet & Agr Sci, Asia Pacific Ctr Anim Hlth, Werribee, Vic 3030, Australia	University of Melbourne; University of Melbourne	Hartley, CA (corresponding author), Univ Melbourne, Fac Vet & Agr Sci, Asia Pacific Ctr Anim Hlth, Melbourne, Vic 3010, Australia.	carolah@unimelb.edu.au	Legione, Alistair/L-9102-2015; Legione, Alistair/AAX-6064-2020; Browning, Glenn Francis/P-4459-2014; Vaz, Paola K./D-8713-2015; Quinteros, Jose Antonio/Q-2482-2016	Legione, Alistair/0000-0003-2407-4496; Legione, Alistair/0000-0003-2407-4496; Browning, Glenn Francis/0000-0002-0903-2469; Vaz, Paola K./0000-0001-6877-7383; Quinteros, Jose Antonio/0000-0002-3194-9783; NOORMOHAMMADI, AMIR/0000-0003-3459-2692; Devlin, Joanne/0000-0003-0400-9670; Hartley, Carol/0000-0001-6174-7341; Coppo, Mauricio/0000-0002-4344-9532	Australian Research Council [DP130103991]; Australian Research Council; RIRDC	Australian Research Council(Australian Research Council); Australian Research Council(Australian Research Council); RIRDC	Funding provided by Australian Research Council DP130103991 (http://www.arc.gov.au). The funders (Australian Research Council) had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Rural Industries Research and Development Corporation PRJ-008792 (http://www.rirdc.gov.au). The funders (RIRDC) had contributed to study design and approved publication of the manuscript but did not have any role in data collection and analysis or the preparation of the manuscript.	Atkins KE, 2013, EVOLUTION, V67, P851, DOI 10.1111/j.1558-5646.2012.01803.x; Baigent SJ, 2013, AVIAN DIS, V57, P440, DOI 10.1637/10356-091012-Reg.1; Blacker HP, 2011, AUST VET J, V89, P89, DOI 10.1111/j.1751-0813.2010.00665.x; Coppo MJC, 2013, AVIAN PATHOL, V42, P195, DOI 10.1080/03079457.2013.800634; Devlin JM, 2006, J GEN VIROL, V87, P2839, DOI 10.1099/vir.0.82194-0; Devlin JM, 2006, ARCH VIROL, V151, P1281, DOI 10.1007/s00705-005-0721-8; Devlin JM, 2007, VACCINE, V25, P3561, DOI 10.1016/j.vaccine.2007.01.080; Gandon S, 2008, VACCINE, V26, pC4, DOI 10.1016/j.vaccine.2008.02.007; Garcia M, 2013, VIROLOGY, V440, P64, DOI 10.1016/j.virol.2013.02.007; Gimeno IM, 2011, AVIAN PATHOL, V40, P395, DOI 10.1080/03079457.2011.588196; GUY JS, 1990, AVIAN DIS, V34, P106, DOI 10.2307/1591340; Guy JS, 2003, DIS POULTRY, V11th, P121; Haq K, 2013, DEV COMP IMMUNOL, V41, P439, DOI 10.1016/j.dci.2013.04.001; KAWAGUCHI T, 1987, CANCER RES, V47, P4460; Kirkpatrick NC, 2006, AVIAN PATHOL, V35, P449, DOI 10.1080/03079450601028803; Kirkpatrick NC, 2006, AVIAN DIS, V50, P28, DOI 10.1637/7414-072205R.1; Lee SW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055121; Lee SW, 2012, SCIENCE, V337, P188, DOI 10.1126/science.1217134; Lee SW, 2011, VACCINE, V29, P9583, DOI 10.1016/j.vaccine.2011.10.055; Mahmoudian A, 2011, AVIAN PATHOL, V40, P237, DOI 10.1080/03079457.2011.553582; Morrow C., 2004, MAREKS DIS EVOLVING, P49, DOI DOI 10.1016/B978-012088379-0/50009-8; Mundt A, 2011, J GEN VIROL, V92, P2586, DOI 10.1099/vir.0.031443-0; NHMRC, 2013, AUSTR COD CAR US AN, V8th; Rasband W., 2006, IMAGEJ; Reddy VR, 2014, AVIAN PATHOL, P1, DOI [10.1080/03079457.2014.977223, DOI 10.1080/03079457.2014.977223]; Vagnozzi A, 2012, AVIAN PATHOL, V41, P21, DOI 10.1080/03079457.2011.631983; Veits J, 2003, J GEN VIROL, V84, P3343, DOI 10.1099/vir.0.19570-0; Witter RL, 1997, AVIAN DIS, V41, P149, DOI 10.2307/1592455	28	23	24	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2015	10	3							e0120282	10.1371/journal.pone.0120282	http://dx.doi.org/10.1371/journal.pone.0120282			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9BN	25785629	gold, Green Published, Green Submitted			2022-12-27	WOS:000352138500163
J	Li, ZY; Ding, LL; Li, JM; Xu, BL; Yang, L; Bi, KS; Wang, ZT				Li, Ze-Yun; Ding, Li-Li; Li, Jin-Mei; Xu, Bao-Li; Yang, Li; Bi, Kai-Shun; Wang, Zheng-Tao			H-1-NMR and MS Based Metabolomics Study of the Intervention Effect of Curcumin on Hyperlipidemia Mice Induced by High-Fat Diet	PLOS ONE			English	Article							INSULIN-RESISTANCE; CARNITINE METABOLISM; NMR; MECHANISMS; URINE; LONGA; CHAIN; ACIDS; RATS; METABONOMICS	Curcumin, a principle bioactive component of Curcuma longa L, is well known for its anti-hyperlipidemia effect. However, no holistic metabolic information of curcumin on hyperlipidemia models has been revealed, which may provide us an insight into the underlying mechanism. In the present work, NMR and MS based metabolomics was conducted to investigate the intervention effect of curcumin on hyperlipidemia mice induced by high-fat diet (HFD) feeding for 12 weeks. The HFD induced animals were orally administered with curcumin (40, 80 mg/kg) or lovastatin (30 mg/kg, positive control) once a day during the inducing period. Serum biochemistry assay of TC, TG, LDL-c, and HDL-c was conducted and proved that treatment of curcumin or lovastatin can significantly improve the lipid profiles. Subsequently, metabolomics analysis was carried out for urine samples. Orthogonal Partial Least Squares-Discriminant analysis (OPLS-DA) was employed to investigate the anti-hyperlipidemia effect of curcumin and to detect related potential biomarkers. Totally, 35 biomarkers were identified, including 31 by NMR and nine by MS (five by both). It turned out that curcumin treatment can partially recover the metabolism disorders induced by HFD, with the following metabolic pathways involved: TCA cycle, glycolysis and gluconeogenesis, synthesis of ketone bodies and cholesterol, ketogenesis of branched chain amino acid, choline metabolism, and fatty acid metabolism. Besides, NMR and MS based metabolomics proved to be powerful tools in investigating pharmacodynamics effect of natural products and underlying mechanisms.	[Li, Ze-Yun; Ding, Li-Li; Li, Jin-Mei; Xu, Bao-Li; Yang, Li; Wang, Zheng-Tao] Shanghai Univ Tradit Chinese Med, Inst Chinese Mat Med, Shanghai, Peoples R China; [Li, Ze-Yun; Bi, Kai-Shun] Shenyang Pharmaceut Univ, Dept Pharmacol, Shenyang, Peoples R China	Shanghai University of Traditional Chinese Medicine; Shenyang Pharmaceutical University	Bi, KS (corresponding author), Shenyang Pharmaceut Univ, Dept Pharmacol, Shenyang, Peoples R China.	kaishunbi.syphu@gmail.com; ztwang@shutcm.edu.cn	Wang, Zhengtao/AAH-7360-2019	Wang, Zhengtao/0000-0003-2797-4625				Aggarwal BB, 2003, ANTICANCER RES, V23, P363; Babu PS, 1997, MOL CELL BIOCHEM, V166, P169, DOI 10.1023/A:1006819605211; BERNSON VSM, 1974, EUR J BIOCHEM, V47, P517, DOI 10.1111/j.1432-1033.1974.tb03720.x; BIEBER LL, 1982, FED PROC, V41, P2858; CASTELAO AM, 1993, TRANSPLANT P, V25, P1043; CHALMERS RA, 1984, PEDIATR RES, V18, P1325, DOI 10.1203/00006450-198412000-00021; Demyen M, 2013, CLIN LIVER DIS, V17, P699, DOI 10.1016/j.cld.2013.07.016; Dieterle F, 2011, METHODS MOL BIOL, V691, P385, DOI 10.1007/978-1-60761-849-2_24; Dou XB, 2008, PLANTA MED, V74, P1374, DOI 10.1055/s-2008-1081316; FRISHMAN WH, 1989, MED CLIN N AM, V73, P437, DOI 10.1016/S0025-7125(16)30681-2; FROHLICH J, 1978, METABOLISM, V27, P555, DOI 10.1016/0026-0495(78)90022-7; GENUTH SM, 1981, METABOLISM, V30, P393, DOI 10.1016/0026-0495(81)90121-9; Goodpaster AM, 2011, ANAL CHEM, V83, P896, DOI 10.1021/ac102572b; Guan MM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060409; Il'yasova D, 2012, CLIN CHIM ACTA, V413, P1446, DOI 10.1016/j.cca.2012.06.012; JACKSON S, 1992, J CLIN INVEST, V90, P1219, DOI 10.1172/JCI115983; Jacob N, 1999, ATHEROSCLEROSIS, V146, P53, DOI 10.1016/S0021-9150(99)00128-8; Jang EM, 2008, METABOLISM, V57, P1576, DOI 10.1016/j.metabol.2008.06.014; Jiang CY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066786; JIN SJ, 1989, J LIPID RES, V30, P1611; Jurenka JS, 2009, ALTERN MED REV, V14, P141; Kim HK, 2011, TRENDS BIOTECHNOL, V29, P267, DOI 10.1016/j.tibtech.2011.02.001; Lu JY, 2013, FRONT MED-PRC, V7, P53, DOI 10.1007/s11684-013-0255-5; Manjunatha H, 2007, CAN J PHYSIOL PHARM, V85, P588, DOI 10.1139/Y07-044; Murakami S, 2000, ADV EXP MED BIOL, V483, P177; Mutoh M, 2006, JPN J CLIN ONCOL, V36, P166, DOI 10.1093/jjco/hyi233; Nicholson JK, 2002, NAT REV DRUG DISCOV, V1, P153, DOI 10.1038/nrd728; Nicholson JK, 2005, NAT REV MICROBIOL, V3, P431, DOI 10.1038/nrmicro1152; Pan ZZ, 2007, ANAL BIOANAL CHEM, V387, P525, DOI 10.1007/s00216-006-0687-8; Peschel D, 2007, J NUTR BIOCHEM, V18, P113, DOI 10.1016/j.jnutbio.2006.03.007; Piloquet H, 2003, AM J PHYSIOL-ENDOC M, V285, pE561, DOI 10.1152/ajpendo.00042.2003; REBOUCHE CJ, 1986, ANNU REV NUTR, V6, P41, DOI 10.1146/annurev.nu.06.070186.000353; Rubingh CM, 2006, METABOLOMICS, V2, P53, DOI 10.1007/s11306-006-0022-6; Ryan D, 2011, ANAL CHIM ACTA, V684, P17, DOI 10.1016/j.aca.2010.10.035; Sham TT, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/925302; Shearer J, 2008, DIABETES OBES METAB, V10, P950, DOI 10.1111/j.1463-1326.2007.00837.x; Shin SK, 2011, MOL NUTR FOOD RES, V55, P1829, DOI 10.1002/mnfr.201100440; Sim KG, 2002, CLIN CHIM ACTA, V323, P37, DOI 10.1016/S0009-8981(02)00182-1; Song XF, 2013, J PHARMACEUT BIOMED, V78-79, P202, DOI 10.1016/j.jpba.2013.02.014; Stein O, 1999, ATHEROSCLEROSIS, V144, P285, DOI 10.1016/S0021-9150(99)00065-9; Sun J, 2008, J CHROMATOGR B, V871, P328, DOI 10.1016/j.jchromb.2008.04.008; TANAKA K, 1982, J CHROMATOGR, V239, P301, DOI 10.1016/S0021-9673(00)81990-1; TSERNG KY, 1991, BIOCHEMISTRY-US, V30, P2508, DOI 10.1021/bi00223a030; Venkatesan P, 2000, J PHARM PHARMACOL, V52, P1123, DOI 10.1211/0022357001774886; Wang M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078731; Wang YL, 2005, J AGR FOOD CHEM, V53, P191, DOI 10.1021/jf0403282; Williams RE, 2002, XENOBIOTICA, V32, P783, DOI 10.1080/00498250210143047; Witkin JM, 2013, CNS NEUROL DISORD-DR, V12, P487, DOI 10.2174/1871527311312040007; Xu EY, 2009, CURR OPIN DRUG DISC, V12, P40; Yang Shao-Ji, 2004, Hepatobiliary Pancreat Dis Int, V3, P10; Yu JN, 2000, PRIMARY CARE, V27, P541, DOI 10.1016/S0095-4543(05)70164-0; Zhang AH, 2012, CLIN CHIM ACTA, V414, P65, DOI 10.1016/j.cca.2012.08.016; Zhao T, 2012, J PHARMACEUT BIOMED, V60, P32, DOI 10.1016/j.jpba.2011.11.010; Zhou YT, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088281; Zingg JM, 2013, BIOFACTORS, V39, P101, DOI 10.1002/biof.1072	55	8	13	4	62	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2015	10	3							e0120950	10.1371/journal.pone.0120950	http://dx.doi.org/10.1371/journal.pone.0120950			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9BN	25786031	Green Submitted, Green Published, gold			2022-12-27	WOS:000352138500198
J	Sena-Evangelista, KCM; Pedrosa, LFC; Paiva, MSMO; Dias, PCS; Ferreira, DQC; Cozzolino, SMF; Faulin, TES; Abdalla, DSP				Mauricio Sena-Evangelista, Karine Cavalcanti; Campos Pedrosa, Lucia Fatima; Moura Oliveira Paiva, Maria Sanali; Silveira Dias, Paula Cristina; Cabral Ferreira, Diana Quiteria; Franciscato Cozzolino, Silvia Maria; Santo Faulin, Tanize Espirito; Parra Abdalla, Dulcineia Saes			The Hypolipidemic and Pleiotropic Effects of Rosuvastatin Are Not Enhanced by Its Association with Zinc and Selenium Supplementation in Coronary Artery Disease Patients: A Double Blind Randomized Controlled Study	PLOS ONE			English	Article							ABNORMAL GLUCOSE REGULATION; LOW-DENSITY LIPOPROTEINS; TRACE-ELEMENT STATUS; ENZYME-ACTIVITIES; OXIDATIVE STRESS; STATIN THERAPY; ANTIOXIDANT; SELENOPROTEINS; CONSEQUENCES; PREVALENCE	Objective Statins treatment may modify the levels of zinc and selenium, minerals that can improve vascular function and reduce oxidative damage and inflammation in atherosclerotic patients. This study aimed to evaluate the effects of rosuvastatin, alone or associated with zinc and selenium supplementation, on lipid profile, antioxidant enzymes and mineral status in coronary artery disease patients. Material and Methods A double-blind randomized clinical trial was performed in which patients (n = 76) were treated with 10 mg rosuvastatin over 4 months associated or not with zinc (30 mg/d) and selenium (150 mu g/d) supplementation. The following parameters were analyzed before and after the intervention: anthropometric measurements, lipid profile, high sensitivity C-reactive protein (hs-CRP), electronegative low density lipoprotein (LDL(-)) concentrations, activities of glutathione peroxidase (GPx), superoxide dismutase (SOD), zinc and selenium concentrations in blood plasma and erythocytes. Significance was determined using an a of 5% (two-tailed). Results We found that rosuvastatin therapy was efficient in reducing total cholesterol, LDL-cholesterol, non-HDL cholesterol, triglycerides, and hs-CRP independently of mineral supplementation. Neither treatment was associated with significant changes in LDL(-). Similarly, the antioxidant enzymes GPx and SOD activity were unchanged by treatments. Neither treatment was associated with significant differences in concentrations of zinc or selenium in blood plasma and erythocytes of studied groups. Conclusion Rosuvastatin treatment did not affect zinc and selenium levels in coronary artery disease patients. The zinc and selenium supplementation at doses used in this study did not change lipid profile or SOD and GPx activity in patients receiving rosuvastatin. Further studies should be focused on testing alternative doses and supplements in different populations to contribute for a consensus on the ideal choice of antioxidants to be used as possible complementary therapies in atherosclerotic patients.	[Mauricio Sena-Evangelista, Karine Cavalcanti; Campos Pedrosa, Lucia Fatima] Univ Fed Rio Grande do Norte, Dept Nutr, Natal, RN, Brazil; [Moura Oliveira Paiva, Maria Sanali] Univ Fed Rio Grande do Norte, Onofre Lopes Univ Hosp, Natal, RN, Brazil; [Silveira Dias, Paula Cristina; Cabral Ferreira, Diana Quiteria] Univ Fed Rio Grande do Norte, Postgrad Program Pharmaceut Sci, Natal, RN, Brazil; [Franciscato Cozzolino, Silvia Maria] Univ Sao Paulo, Fac Pharmaceut Sci, Dept Food & Expt Nutr, Sao Paulo, SP, Brazil; [Santo Faulin, Tanize Espirito; Parra Abdalla, Dulcineia Saes] Univ Sao Paulo, Fac Pharmaceut Sci, Dept Clin & Toxicol Anal, Sao Paulo, SP, Brazil	Universidade Federal do Rio Grande do Norte; Universidade Federal do Rio Grande do Norte; Universidade Federal do Rio Grande do Norte; Universidade de Sao Paulo; Universidade de Sao Paulo	Abdalla, DSP (corresponding author), Univ Sao Paulo, Fac Pharmaceut Sci, Dept Clin & Toxicol Anal, Sao Paulo, SP, Brazil.	dspa@usp.br	Cozzolino, Silvia M.F/K-7623-2016; Duarte, Graziela Biude Silva/Q-7728-2016; Pedrosa, Lucia Fatima Campos/N-7343-2019	Pedrosa, Lucia Fatima Campos/0000-0002-5436-5115; Cozzolino, Silvia/0000-0003-1505-7627	Fundacao de Apoio a Pesquisa do Rio Grande do Norte (FAPERN), Brazil [PROJ-981-199697778]	Fundacao de Apoio a Pesquisa do Rio Grande do Norte (FAPERN), Brazil	This work was supported by the Fundacao de Apoio a Pesquisa do Rio Grande do Norte (FAPERN, www.fapern.rn.gov.br, Brazil (grant PROJ-981-199697778). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander DD, 2013, J AM COLL NUTR, V32, P339, DOI 10.1080/07315724.2013.839909; Andersen HR, 1997, CLIN CHEM, V43, P562; Arnaud J, 2009, J TRACE ELEM MED BIO, V23, P21, DOI 10.1016/j.jtemb.2008.08.001; Ashton K, 2009, AM J CLIN NUTR, V89, p2025S, DOI 10.3945/ajcn.2009.27230F; Bartnik M, 2004, EUR HEART J, V25, P1880, DOI 10.1016/j.ehj.2004.07.027; Beattie JH, 2004, BRIT J NUTR, V91, P177, DOI 10.1079/BJN20031072; Bruckdorfer KR, 2008, P NUTR SOC, V67, P214, DOI 10.1017/S0029665108007052; Burk RF, 2006, CANCER EPIDEM BIOMAR, V15, P804, DOI 10.1158/1055-9965.EPI-05-0950; Costarelli L, 2008, REJUV RES, V11, P287, DOI 10.1089/rej.2008.0665; Cragg RA, 2005, GUT, V54, P469, DOI 10.1136/gut.2004.041962; da Luz PL, 2005, AM J CARDIOL, V96, P1640, DOI 10.1016/j.amjcard.2005.07.080; De Sena KCM, 2005, BIOL TRACE ELEM RES, V105, P1, DOI 10.1385/BTER:105:1-3:001; Fairweather-Tait SJ, 2010, AM J CLIN NUTR, V91, p1484S, DOI 10.3945/ajcn.2010.28674J; Farrokhi F, 2012, CLIN LAB, V58, P1005, DOI 10.7754/Clin.Lab.2011.111120; Feillet-Coudray C, 2006, BRIT J NUTR, V95, P1134, DOI 10.1079/BJN20061762; Ghayour-Mobarhan M, 2005, J TRACE ELEM MED BIO, V19, P61, DOI 10.1016/j.jtemb.2005.06.003; Gomez-Garcia A, 2007, REV ESP CARDIOL, V60, P1242, DOI 10.1157/13113929; Grundy SM, 2002, CIRCULATION, V106, P3143, DOI 10.1161/circ.106.25.3143; Hao DQ, 1996, TALANTA, V43, P595, DOI 10.1016/0039-9140(95)01786-0; Hu DY, 2006, EUR HEART J, V27, P2573, DOI 10.1093/eurheartj/ehl207; Johnson Felicity, 2005, Molecular Aspects of Medicine, V26, P340, DOI 10.1016/j.mam.2005.07.006; Kaliora AC, 2006, ATHEROSCLEROSIS, V187, P1, DOI 10.1016/j.atherosclerosis.2005.11.001; Leonhardt W, 1997, EUR J CLIN PHARMACOL, V53, P65, DOI 10.1007/s002280050338; Lim Sang Yup, 2013, Chonnam Med J, V49, P1, DOI 10.4068/cmj.2013.49.1.1; Little PJ, 2010, NUTRITION, V26, P1050, DOI 10.1016/j.nut.2010.03.007; Mariani E, 2008, EXP GERONTOL, V43, P445, DOI 10.1016/j.exger.2007.10.012; Mocchegiani E, 2008, CURR PHARM DESIGN, V14, P2719, DOI 10.2174/138161208786264188; Moosmann B, 2004, TRENDS CARDIOVAS MED, V14, P273, DOI 10.1016/j.tcm.2004.08.003; Neve J, 1993, J Pharm Belg, V48, P5; Oliveira JA, 2006, CLIN BIOCHEM, V39, P708, DOI 10.1016/j.clinbiochem.2006.05.002; Otero-Losada M, 2013, OXID MED CELL LONGEV, V2013, DOI 10.1155/2013/408260; Papp LV, 2010, ANTIOXID REDOX SIGN, V12, P793, DOI 10.1089/ars.2009.2973; Pereira EC, 2004, FREE RADICAL BIO MED, V37, P1440, DOI 10.1016/j.freeradbiomed.2004.07.019; Prasad AS, 2008, EXP GERONTOL, V43, P370, DOI 10.1016/j.exger.2007.10.013; Prasad AS, 2004, FREE RADICAL BIO MED, V37, P1182, DOI 10.1016/j.freeradbiomed.2004.07.007; Roussel AM, 2003, J AM COLL NUTR, V22, P316, DOI 10.1080/07315724.2003.10719310; Rubba P, 2009, VASC HEALTH RISK MAN, V5, P343; Faulin TDS, 2008, CLIN CHEM LAB MED, V46, P1769, DOI 10.1515/CCLM.2008.333; Schuster H, 2003, CARDIOLOGY, V99, P126, DOI 10.1159/000070669; Seet RCS, 2011, ATHEROSCLEROSIS, V219, P231, DOI 10.1016/j.atherosclerosis.2011.07.097; Tanguy S, 2012, MOL NUTR FOOD RES, V56, P1106, DOI 10.1002/mnfr.201100766; Taubert G, 2003, AM HEART J, V145, P285, DOI 10.1067/mhj.2003.134; Tinggi Ujang, 2008, Environmental Health and Preventive Medicine, V13, P102, DOI 10.1007/s12199-007-0019-4; Yilmaz MI, 2004, BIOL TRACE ELEM RES, V98, P119, DOI 10.1385/BTER:98:2:119; Zhang F, 2002, ATHEROSCLEROSIS, V161, P381, DOI 10.1016/S0021-9150(01)00672-4	45	8	8	2	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2015	10	3							e0119830	10.1371/journal.pone.0119830	http://dx.doi.org/10.1371/journal.pone.0119830			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9BN	25785441	Green Published, Green Submitted, gold			2022-12-27	WOS:000352138500130
J	Palinkas, A; Bulik, S; Bockmayr, A; Holzhutter, HG				Palinkas, Aljoscha; Bulik, Sascha; Bockmayr, Alexander; Holzhuetter, Hermann-Georg			Sequential Metabolic Phases as a Means to Optimize Cellular Output in a Constant Environment	PLOS ONE			English	Article							AMINO-ACID REGULATION; GENE-EXPRESSION; ESCHERICHIA-COLI; DIVISION; GLUCOSE; MODELS; RED	Temporal changes of gene expression are a well-known regulatory feature of all cells, which is commonly perceived as a strategy to adapt the proteome to varying external conditions. However, temporal (rhythmic and non-rhythmic) changes of gene expression are also observed under virtually constant external conditions. Here we hypothesize that such changes are a means to render the synthesis of the metabolic output more efficient than under conditions of constant gene activities. In order to substantiate this hypothesis, we used a flux-balance model of the cellular metabolism. The total time span spent on the production of a given set of target metabolites was split into a series of shorter time intervals (metabolic phases) during which only selected groups of metabolic genes are active. The related flux distributions were calculated under the constraint that genes can be either active or inactive whereby the amount of protein related to an active gene is only controlled by the number of active genes: the lower the number of active genes the more protein can be allocated to the enzymes carrying non-zero fluxes. This concept of a predominantly protein-limited efficiency of gene expression clearly differs from other concepts resting on the assumption of an optimal gene regulation capable of allocating to all enzymes and transporters just that fraction of protein necessary to prevent rate limitation. Applying this concept to a simplified metabolic network of the central carbon metabolism with glucose or lactate as alternative substrates, we demonstrate that switching between optimally chosen stationary flux modes comprising different sets of active genes allows producing a demanded amount of target metabolites in a significantly shorter time than by a single optimal flux mode at fixed gene activities. Our model-based findings suggest that temporal expression of metabolic genes can be advantageous even under conditions of constant external substrate supply.	[Palinkas, Aljoscha; Bockmayr, Alexander] Free Univ Berlin, FB Math & Informat, D-14195 Berlin, Germany; [Bulik, Sascha; Holzhuetter, Hermann-Georg] Charite, Inst Biochem, D-10117 Berlin, Germany	Free University of Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Palinkas, A (corresponding author), Free Univ Berlin, FB Math & Informat, Arnimallee 6, D-14195 Berlin, Germany.	aljoscha.palinkas@fu-berlin.de		Bockmayr, Alexander/0000-0002-5074-1347; Holzhutter, Hermann-Georg/0000-0002-5054-6023	DFG	DFG(German Research Foundation (DFG))	AP was funded by DFG (www.dfg.de) via the Research Training Group 1772. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Averous J, 2003, J NUTR, V133, p2040S, DOI 10.1093/jn/133.6.2040S; Balch WE, 2008, SCIENCE, V319, P916, DOI 10.1126/science.1141448; Bartl M, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3243; Beg QK, 2007, P NATL ACAD SCI USA, V104, P12663, DOI 10.1073/pnas.0609845104; BROWN GC, 1991, J THEOR BIOL, V153, P195, DOI 10.1016/S0022-5193(05)80422-9; Chubukov V, 2013, MOL SYST BIOL, V9, DOI 10.1038/msb.2013.66; Chubukov V, 2012, P NATL ACAD SCI USA, V109, P5127, DOI 10.1073/pnas.1114235109; Covert MW, 2001, J THEOR BIOL, V213, P73, DOI 10.1006/jtbi.2001.2405; COX BG, 1983, P NATL ACAD SCI-BIOL, V80, P4233, DOI 10.1073/pnas.80.14.4233; Dorsaz N, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.120601; Eckel-Mahan KL, 2012, P NATL ACAD SCI USA, V109, P5541, DOI 10.1073/pnas.1118726109; GOODYEAR LJ, 1991, AM J PHYSIOL, V261, pE556, DOI 10.1152/ajpendo.1991.261.5.E556; Griva I, 2009, OTHER TITL APPL MATH, V108, P1, DOI 10.1137/1.9780898717730; Hertz L, 2005, J NEUROSCI RES, V79, P11, DOI 10.1002/jnr.20294; Hoffmann Sabrina, 2006, Genome Inform, V17, P195; Hoffmann S, 2009, ANN NY ACAD SCI, V1158, P57, DOI 10.1111/j.1749-6632.2008.03753.x; Jefferson LS, 2001, J NUTR, V131, p2460S, DOI 10.1093/jn/131.9.2460S; Jin XW, 1999, CELL, V96, P57, DOI 10.1016/S0092-8674(00)80959-9; Klipp E, 2002, EUR J BIOCHEM, V269, P5406, DOI 10.1046/j.1432-1033.2002.03223.x; Laurent JM, 2010, PROTEOMICS, V10, P4209, DOI 10.1002/pmic.201000327; Maier T, 2009, FEBS LETT, V583, P3966, DOI 10.1016/j.febslet.2009.10.036; Nagoshi E, 2005, METHOD ENZYMOL, V393, P543, DOI 10.1016/S0076-6879(05)93028-0; Oyarzun DA, 2009, B MATH BIOL, V71, P1851, DOI 10.1007/s11538-009-9427-5; Price MN, 2013, MOL SYST BIOL, V9, DOI 10.1038/msb.2013.16; Roostalu J, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-68; ROUSSET M, 1981, CANCER RES, V41, P1165; Schibler U, 2005, CURR OPIN CELL BIOL, V17, P223, DOI 10.1016/j.ceb.2005.01.007; SCHUSTER R, 1995, EUR J BIOCHEM, V229, P403, DOI 10.1111/j.1432-1033.1995.0403k.x; Shlomi T, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002018; Shoval O, 2012, SCIENCE, V336, P1157, DOI 10.1126/science.1217405; Silverman SJ, 2010, P NATL ACAD SCI USA, V107, P6946, DOI 10.1073/pnas.1002422107; Slavov N, 2011, P NATL ACAD SCI USA, V108, P19090, DOI 10.1073/pnas.1116998108; Snel B, 2004, NUCLEIC ACIDS RES, V32, P4725, DOI 10.1093/nar/gkh815; Suraweera A, 2012, MOL CELL, V48, P242, DOI 10.1016/j.molcel.2012.08.003; TOPHAM CM, 1986, EUR J BIOCHEM, V156, P555, DOI 10.1111/j.1432-1033.1986.tb09615.x; Tu BP, 2005, SCIENCE, V310, P1152, DOI 10.1126/science.1120499	36	1	1	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2015	10	3							e0118347	10.1371/journal.pone.0118347	http://dx.doi.org/10.1371/journal.pone.0118347			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9BN	25786979	Green Published, gold, Green Submitted			2022-12-27	WOS:000352138500028
J	Solchenberger, B; Russell, C; Kremmer, E; Haass, C; Schmid, B				Solchenberger, Barbara; Russell, Claire; Kremmer, Elisabeth; Haass, Christian; Schmid, Bettina			Granulin Knock Out Zebrafish Lack Frontotemporal Lobar Degeneration and Neuronal Ceroid Lipofuscinosis Pathology	PLOS ONE			English	Article							PROGRANULIN-DEFICIENT MICE; TRAUMATIC BRAIN-INJURY; IN-VIVO; ACTIVATED MICROGLIA; EARLY MACROPHAGES; GENE-EXPRESSION; HOST-DEFENSE; MUTATIONS; MODEL; DEMENTIA	Loss of function mutations in granulin (GRN) are linked to two distinct neurological disorders, frontotemporal lobar degeneration (FTLD) and neuronal ceroid lipofuscinosis (NCL). It is so far unknown how a complete loss of GRN in NCL and partial loss of GRN in FTLD can result in such distinct diseases. In zebrafish, there are two GRN homologues, Granulin A (Grna) and Granulin B (Grnb). We have generated stable Grna and Grnb loss of function zebrafish mutants by zinc finger nuclease mediated genome editing. Surprisingly, the grna and grnb single and double mutants display neither spinal motor neuron axonopathies nor a reduced number of myogenic progenitor cells as previously reported for Grna and Grnb knock down embryos. Additionally, grna(-/-);grnb(-/-) double mutants have no obvious FTLD- and NCL-related biochemical and neuropathological phenotypes. Taken together, the Grna and Grnb single and double knock out zebrafish lack any obvious morphological, pathological and biochemical phenotypes. Loss of zebrafish Grna and Grnb might therefore either be fully compensated or only become symptomatic upon additional challenge.	[Solchenberger, Barbara; Haass, Christian; Schmid, Bettina] Univ Munich, Adolf Butenandt Inst Biochem, Munich, Germany; [Russell, Claire] Univ London Royal Vet Coll, Dept Comparat Biomed Sci, London, England; [Kremmer, Elisabeth] Helmholtz Ctr Munich, Inst Mol Immunol, Munich, Germany; [Haass, Christian; Schmid, Bettina] Munich Cluster Syst Neurol SyNergy, Munich, Germany; [Haass, Christian; Schmid, Bettina] German Ctr Neurodegenerat Dis DZNE Munich, Munich, Germany	University of Munich; University of London; University of London Royal Veterinary College; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; University of Munich; Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE)	Schmid, B (corresponding author), Univ Munich, Adolf Butenandt Inst Biochem, Munich, Germany.	Bettina.Schmid@dzne.de	Russell, Claire/A-4879-2012	Russell, Claire/0000-0002-6748-9301	International Max Planck Research School for Molecular and Cellular Life Sciences; Elite Network of Bavaria; Short Term Scientific Mission COST Action [BM0804]; Batten Disease Family Association; European Research Council under the European Union [321366-Amyloid];  [Sonderforschungsbereich 596]	International Max Planck Research School for Molecular and Cellular Life Sciences; Elite Network of Bavaria; Short Term Scientific Mission COST Action; Batten Disease Family Association; European Research Council under the European Union(European Research Council (ERC)); 	This work was supported by the Sonderforschungsbereich 596, International Max Planck Research School for Molecular and Cellular Life Sciences (B. So.), the Elite Network of Bavaria (B. So.), a Short Term Scientific Mission COST Action BM0804 (B. So.), the Batten Disease Family Association (C.R.), the European Research Council under the European Union's Seventh Framework Program FP7/2007-2013)/ ERC Grant Agreement No. 321366-Amyloid (advanced grant to C.H.), the general legacy of Mrs. Ammer (to the Ludwig-Maximilians University/ C.H.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed Z, 2010, AM J PATHOL, V177, P311, DOI 10.2353/ajpath.2010.090915; Baker M, 2006, NATURE, V442, P916, DOI 10.1038/nature05016; Baraban SC, 2005, NEUROSCIENCE, V131, P759, DOI 10.1016/j.neuroscience.2004.11.031; Baumgart EV, 2012, GLIA, V60, P343, DOI 10.1002/glia.22269; Bonvicini C, 2014, NEUROBIOL AGING, V35, P1206, DOI 10.1016/j.neurobiolaging.2013.10.097; Borst LB, 2013, VET PATHOL, V50, P457, DOI 10.1177/0300985811424731; Cadieux B, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-156; Chen-Plotkin AS, 2010, ACTA NEUROPATHOL, V119, P111, DOI 10.1007/s00401-009-0576-2; Chitramuthu BP, 2010, MOL NEURODEGENER, V5, DOI 10.1186/1750-1326-5-41; Craig Sonya E L, 2008, J Ocul Biol Dis Infor, V1, P73, DOI 10.1007/s12177-008-9011-5; Cruts M, 2006, NATURE, V442, P920, DOI 10.1038/nature05017; da Rosa CE, 2010, EXP GERONTOL, V45, P449, DOI 10.1016/j.exger.2010.03.012; Daniel R, 2000, J HISTOCHEM CYTOCHEM, V48, P999, DOI 10.1177/002215540004800713; De Muynck L, 2013, NEUROBIOLOGY AGING; Del Bo R, 2011, NEUROBIOL AGING, V32, P1157, DOI 10.1016/j.neurobiolaging.2009.06.006; den Broeder MJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007910; Dormann D, 2011, TRENDS NEUROSCI, V34, P339, DOI 10.1016/j.tins.2011.05.002; Filiano AJ, 2013, J NEUROSCI, V33, P5352, DOI 10.1523/JNEUROSCI.6103-11.2013; Finch N, 2009, BRAIN, V132, P583, DOI 10.1093/brain/awn352; Follo C, 2013, INT J BIOCHEM CELL B, V45, P273, DOI 10.1016/j.biocel.2012.10.010; Follo C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021908; Garneau NL, 2007, NAT REV MOL CELL BIO, V8, P113, DOI 10.1038/nrm2104; Gemberling M, 2013, TRENDS GENET, V29, P611, DOI 10.1016/j.tig.2013.07.003; Ghidoni R, 2012, BRAIN RES, V1476, P172, DOI 10.1016/j.brainres.2012.01.075; Ghoshal N, 2012, NEUROBIOL DIS, V45, P395, DOI 10.1016/j.nbd.2011.08.029; Gijselinck I, 2008, HUM MUTAT, V29, P53, DOI 10.1002/humu.20651; Gotzl JK, 2014, ACTA NEUROPATHOL, V127, P845, DOI 10.1007/s00401-014-1262-6; Herbomel P, 2001, DEV BIOL, V238, P274, DOI 10.1006/dbio.2001.0393; Huang T, 2012, BIOCHEM BIOPH RES CO, V421, P214, DOI 10.1016/j.bbrc.2012.03.139; Josephs KA, 2007, J NEUROPATH EXP NEUR, V66, P142, DOI 10.1097/nen.0b013e31803020cf; Kabashi E, 2010, HUM MOL GENET, V19, P671, DOI 10.1093/hmg/ddp534; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; Kishi S, 2003, EXP GERONTOL, V38, P777, DOI 10.1016/S0531-5565(03)00108-6; Kishi S, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000152; Kleinberger G, 2013, MOL NEUROBIOL, V47, P337, DOI 10.1007/s12035-012-8380-8; Laird AS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013368; Li YH, 2013, SCI REP-UK, V3, DOI 10.1038/srep01176; Lien CL, 2006, PLOS BIOL, V4, P1386, DOI 10.1371/journal.pbio.0040260; Mackenzie IRA, 2007, ACTA NEUROPATHOL, V114, P49, DOI 10.1007/s00401-007-0223-8; Mackenzie IRA, 2006, BRAIN, V129, P3081, DOI 10.1093/brain/awl271; Mahmood F, 2013, BRAIN, V136, P1488, DOI 10.1093/brain/awt043; Martens LH, 2012, J CLIN INVEST, V122, P3955, DOI 10.1172/JCI63113; Mathew LK, 2009, J BIOL CHEM, V284, P33642, DOI 10.1074/jbc.M109.011668; Matthews M, 2012, ILAR J, V53, P192, DOI 10.1093/ilar.53.2.192; Meijer AH, 2005, MOL IMMUNOL, V42, P1185, DOI 10.1016/j.molimm.2004.11.014; Meijering E, 2012, METHOD ENZYMOL, V504, P183, DOI 10.1016/B978-0-12-391857-4.00009-4; Nicolas Celine S, 2013, JAKSTAT, V2, pe22925, DOI 10.4161/jkst.22925; Paquet D, 2009, J CLIN INVEST, V119, P1382, DOI 10.1172/JCI37537; Patterson SE, 2008, DEV DYNAM, V237, P307, DOI 10.1002/dvdy.21400; Peri F, 2008, CELL, V133, P916, DOI 10.1016/j.cell.2008.04.037; Petkau TL, 2012, NEUROBIOL DIS, V45, P711, DOI 10.1016/j.nbd.2011.10.016; Preibisch S, 2009, BIOINFORMATICS, V25, P1463, DOI 10.1093/bioinformatics/btp184; Schmid B, 2013, J NEUROCHEM, V127, P461, DOI 10.1111/jnc.12460; Schmid B, 2013, P NATL ACAD SCI USA, V110, P4986, DOI 10.1073/pnas.1218311110; Seger C, 2011, DEV DYNAM, V240, P2440, DOI 10.1002/dvdy.22745; Shankaran SS, 2008, J BIOL CHEM, V283, P1744, DOI 10.1074/jbc.M705115200; Sieger D, 2012, DEV CELL, V22, P1138, DOI 10.1016/j.devcel.2012.04.012; Siintola E, 2006, BRAIN, V129, P1438, DOI 10.1093/brain/awl107; Sleegers K, 2008, NEUROLOGY, V71, P253, DOI 10.1212/01.wnl.0000289191.54852.75; Smith KR, 2012, AM J HUM GENET, V90, P1102, DOI 10.1016/j.ajhg.2012.04.021; Svahn AJ, 2013, DEV NEUROBIOL, V73, P60, DOI 10.1002/dneu.22039; Tanaka Y, 2013, NEUROSCIENCE, V250, P8, DOI 10.1016/j.neuroscience.2013.06.049; Tanaka Y, 2013, NEUROSCIENCE, V231, P49, DOI 10.1016/j.neuroscience.2012.11.032; Tucker B, 2006, HUM MOL GENET, V15, P3446, DOI 10.1093/hmg/ddl422; van Swieten JC, 2008, LANCET NEUROL, V7, P965, DOI 10.1016/S1474-4422(08)70194-7; Wils H, 2012, J PATHOL, V228, P67, DOI 10.1002/path.4043; Yin FF, 2010, FASEB J, V24, P4639, DOI 10.1096/fj.10-161471; Yin FF, 2010, J EXP MED, V207, P117, DOI 10.1084/jem.20091568; Zakrzewska A, 2010, BLOOD, V116, pE1, DOI 10.1182/blood-2010-01-262873; Zhu J, 2002, CELL, V111, P867, DOI 10.1016/S0092-8674(02)01141-8	70	16	16	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2015	10	3							e0118956	10.1371/journal.pone.0118956	http://dx.doi.org/10.1371/journal.pone.0118956			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9BN	25785851	Green Published, gold, Green Submitted			2022-12-27	WOS:000352138500060
J	Zhang, L; Liu, SR; Sun, PS; Wang, TL; Wang, GY; Zhang, XD; Wang, LL				Zhang, Lei; Liu, Shirong; Sun, Pengsen; Wang, Tongli; Wang, Guangyu; Zhang, Xudong; Wang, Linlin			Consensus Forecasting of Species Distributions: The Effects of Niche Model Performance and Niche Properties	PLOS ONE			English	Article							CLIMATICALLY SUITABLE AREAS; CLIMATE-CHANGE; RANGE SHIFTS; PSEUDO-ABSENCES; PREDICTION; UNCERTAINTY; PROJECTIONS; SCENARIOS; ENSEMBLES; PATTERNS	Ensemble forecasting is advocated as a way of reducing uncertainty in species distribution modeling (SDM). This is because it is expected to balance accuracy and robustness of SDM models. However, there are little available data regarding the spatial similarity of the combined distribution maps generated by different consensus approaches. Here, using eight niche-based models, nine split-sample calibration bouts (or nine random model-training subsets), and nine climate change scenarios, the distributions of 32 forest tree species in China were simulated under current and future climate conditions. The forecasting ensembles were combined to determine final consensual prediction maps for target species using three simple consensus approaches (average, frequency, and median [PCA]). Species' geographic ranges changed (area change and shifting distance) in response to climate change, but the three consensual projections did not differ significantly with respect to how much or in which direction, but they did differ with respect to the spatial similarity of the three consensual predictions. Incongruent areas were observed primarily at the edges of species' ranges. Multiple stepwise regression models showed the three factors (niche marginality and specialization, and niche model accuracy) to be related to the observed variations in consensual prediction maps among consensus approaches. Spatial correspondence among prediction maps was the highest when niche model accuracy was high and marginality and specialization were low. The difference in spatial predictions suggested that more attention should be paid to the range of spatial uncertainty before any decisions regarding specialist species can be made based on map outputs. The niche properties and singlemodel predictive performance provide promising insights that may further understanding of uncertainties in SDM.	[Zhang, Lei; Zhang, Xudong] Chinese Acad Forestry, Res Inst Forestry, Key Lab Forest Silviculture State Forestry Adm, Beijing, Peoples R China; [Liu, Shirong; Sun, Pengsen] Chinese Acad Forestry, Inst Forest Ecol Environm & Protect, Beijing, Peoples R China; [Wang, Tongli] Univ British Columbia, Dept Forest Sci, Ctr Forest Conservat Genet, Vancouver, BC V6T 1W5, Canada; [Wang, Guangyu] Univ British Columbia, Fac Forestry, Vancouver, BC V6T 1W5, Canada; [Wang, Linlin] Beijing Agr Univ, Beijing 100094, Peoples R China	Chinese Academy of Forestry; Research Institute of Forestry, CAF; Chinese Academy of Forestry; Research Institute of Forest Ecology, Environment and Protection, CAF; University of British Columbia; University of British Columbia; Beijing University of Agriculture	Liu, SR (corresponding author), Chinese Acad Forestry, Inst Forest Ecol Environm & Protect, Beijing, Peoples R China.	liusr@caf.ac.cn	Zhang, Lei/N-4381-2017; Wang, Tongli/AAC-8644-2020; Wang, Tongli/AAW-4427-2020	Zhang, Lei/0000-0002-2381-7852; Wang, Tongli/0000-0002-9967-6769	China's National Natural Science Foundation [41301056]; Special Foundation of Chinese Academy of Forestry [CAFYBB2014QB006, RIF2012-04]	China's National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); Special Foundation of Chinese Academy of Forestry	This work was funded by the China's National Natural Science Foundation (41301056) and the Special Foundation of Chinese Academy of Forestry (CAFYBB2014QB006, RIF2012-04). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2010, R LANG ENV STAT COMP; Araujo MB, 2005, GLOBAL ECOL BIOGEOGR, V14, P529, DOI 10.1111/j.1466-822x.2005.00182.x; Araujo MB, 2007, TRENDS ECOL EVOL, V22, P42, DOI 10.1016/j.tree.2006.09.010; Barbet-Massin M, 2012, METHODS ECOL EVOL, V3, P327, DOI 10.1111/j.2041-210X.2011.00172.x; Beaumont LJ, 2008, ECOL LETT, V11, P1135, DOI 10.1111/j.1461-0248.2008.01231.x; Bialozyt R, 2012, J BIOGEOGR, V39, P665, DOI 10.1111/j.1365-2699.2011.02665.x; Botts EA, 2013, GLOBAL ECOL BIOGEOGR, V22, P567, DOI 10.1111/geb.12027; Broennimann O, 2006, GLOBAL CHANGE BIOL, V12, P1709; Buisson L, 2010, GLOBAL CHANGE BIOL, V16, P1145, DOI 10.1111/j.1365-2486.2009.02000.x; Calenge C, 2006, ECOL MODEL, V197, P516, DOI 10.1016/j.ecolmodel.2006.03.017; Chefaoui RM, 2008, ECOL MODEL, V210, P478, DOI 10.1016/j.ecolmodel.2007.08.010; CLEMEN RT, 1989, INT J FORECASTING, V5, P559, DOI 10.1016/0169-2070(89)90012-5; Crimmins SM, 2013, ECOL MODEL, V266, P126, DOI 10.1016/j.ecolmodel.2013.07.006; Diniz JAF, 2009, ECOGRAPHY, V32, P897, DOI 10.1111/j.1600-0587.2009.06196.x; Dixon PM, 2005, ECOLOGY, V86, P1114, DOI 10.1890/04-0601; Dormann CF, 2012, J BIOGEOGR, V39, P2119, DOI 10.1111/j.1365-2699.2011.02659.x; Engler R, 2004, J APPL ECOL, V41, P263, DOI 10.1111/j.0021-8901.2004.00881.x; Diniz JAF, 2010, REV BRAS ENTOMOL, V54, P339, DOI 10.1590/S0085-56262010000300001; Fielding AH, 1997, ENVIRON CONSERV, V24, P38, DOI 10.1017/S0376892997000088; Garcia RA, 2012, GLOBAL CHANGE BIOL, V18, P1253, DOI 10.1111/j.1365-2486.2011.02605.x; Granitto PM, 2005, ARTIF INTELL, V163, P139, DOI 10.1016/j.artint.2004.09.006; Grenouillet G, 2014, GLOBAL CHANGE BIOL, V20, P3080, DOI 10.1111/gcb.12570; Grenouillet G, 2011, ECOGRAPHY, V34, P9, DOI 10.1111/j.1600-0587.2010.06152.x; Iverson LR, 2008, FOREST ECOL MANAG, V254, P390, DOI 10.1016/j.foreco.2007.07.023; Jones CC, 2012, FOREST ECOL MANAG, V284, P69, DOI 10.1016/j.foreco.2012.07.024; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Lawler JJ, 2006, GLOBAL CHANGE BIOL, V12, P1568, DOI 10.1111/j.1365-2486.2006.01191.x; Liu CR, 2013, J BIOGEOGR, V40, P778, DOI 10.1111/jbi.12058; Marmion M, 2009, DIVERS DISTRIB, V15, P59, DOI 10.1111/j.1472-4642.2008.00491.x; Meller L, 2014, DIVERS DISTRIB, V20, P309, DOI 10.1111/ddi.12162; Meynard CN, 2013, J BIOGEOGR, V40, P1, DOI 10.1111/jbi.12006; Morin X, 2009, ECOLOGY, V90, P1301, DOI 10.1890/08-0134.1; Pearson RG, 2006, J BIOGEOGR, V33, P1704, DOI 10.1111/j.1365-2699.2006.01460.x; Peters J, 2007, ECOL MODEL, V207, P304, DOI 10.1016/j.ecolmodel.2007.05.011; Pinheiro J, 2020, R PACKAGE VERSION 31; Segurado P, 2004, J BIOGEOGR, V31, P1555, DOI 10.1111/j.1365-2699.2004.01076.x; Syphard AD, 2009, ECOGRAPHY, V32, P907, DOI 10.1111/j.1600-0587.2009.05883.x; Thuiller W, 2005, GLOBAL ECOL BIOGEOGR, V14, P347, DOI 10.1111/j.1466-822x.2005.00162.x; Thuiller W, 2004, GLOBAL CHANGE BIOL, V10, P2020, DOI 10.1111/j.1365-2486.2004.00859.x; Thuiller W, 2010, BIOMOD SPECIES CLIMA; Tsoar A, 2007, DIVERS DISTRIB, V13, P397, DOI 10.1111/j.1472-4642.2007.00346.x; Virkkala R, 2010, ACTA OECOL, V36, P269, DOI 10.1016/j.actao.2010.01.006; Wang T, 2006, INT J CLIMATOL, V26, P383, DOI 10.1002/joc.1247; Wisz MS, 2008, DIVERS DISTRIB, V14, P763, DOI 10.1111/j.1472-4642.2008.00482.x; Wisz Mary S., 2009, BMC Ecology, V9, P8, DOI 10.1186/1472-6785-9-8; Zhang Lei, 2011, Chinese Journal of Plant Ecology, V35, P1091, DOI 10.3724/SP.J.1258.2011.01091	46	67	72	0	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2015	10	3							e0120056	10.1371/journal.pone.0120056	http://dx.doi.org/10.1371/journal.pone.0120056			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9BN	25786217	Green Submitted, gold, Green Published			2022-12-27	WOS:000352138500152
J	Jiang, Y; Yang, ZQ; Wang, XY; Hou, YX				Jiang, Yuan; Yang, Zhongqi; Wang, Xiaoyi; Hou, Yuxia			Molecular Identification of Sibling Species of Sclerodermus (Hymenoptera: Bethylidae) That Parasitize Buprestid and Cerambycid Beetles by Using Partial Sequences of Mitochondrial DNA Cytochrome Oxidase Subunit 1 and 28S Ribosomal RNA Gene	PLOS ONE			English	Article							AGRILUS-PLANIPENNIS COLEOPTERA; PHYLOGENY	The species belonging to Sclerodermus (Hymenoptera: Bethylidae) are currently the most important insect natural enemies of wood borer pests, mainly buprestid and cerambycid beetles, in China. However, some sibling species of this genus are very difficult to distinguish because of their similar morphological features. To address this issue, we conducted phylogenetic and genetic analyses of cytochrome oxidase subunit I (COI) and 28S RNA gene sequences from eight species of Sclerodermus reared from different wood borer pests. The eight sibling species were as follows: S. guani Xiao et Wu, S. sichuanensis Xiao, S. pupariae Yang et Yao, and Sclerodermus spp. (Nos. 1-5). A 594-bp fragment of COI and 750-bp fragment of 28S were subsequently sequenced. For COI, the G-C content was found to be low in all the species, averaging to about 30.0%. Sequence divergences (Kimura-2-parameter distances) between congeneric species averaged to 4.5%, and intra-specific divergences averaged to about 0.09%. Further, the maximum sequence divergences between congeneric species and Sclerodermus sp. (No. 5) averaged to about 16.5%. All 136 samples analyzed were included in six reciprocally monophyletic clades in the COI neighbor-joining (NJ) tree. The NJ tree inferred from the 28S rRNA sequence yielded almost identical results, but the samples from S. guani, S. sichuanensis, S. pupariae, and Sclerodermus spp. (Nos. 1-4) clustered together and only Sclerodermus sp. (No. 5) clustered separately. Our findings indicate that the standard barcode region of COI can be efficiently used to distinguish morphologically similar Sclerodermus species. Further, we speculate that Sclerodermus sp. (No. 5) might be a new species of Sclerodermus.	[Jiang, Yuan; Yang, Zhongqi; Wang, Xiaoyi] Chinese Acad Forestry, China State Forestry Adm, Res Inst Forest Ecol, Key Lab Forest Protect, Beijing 100091, Peoples R China; [Hou, Yuxia] China Agr Univ, Coll Sci, Beijing 100094, Peoples R China	Chinese Academy of Forestry; Research Institute of Forest Ecology, Environment and Protection, CAF; China Agricultural University	Yang, ZQ (corresponding author), Chinese Acad Forestry, China State Forestry Adm, Res Inst Forest Ecol, Key Lab Forest Protect, Beijing 100091, Peoples R China.	yangzhqi@126.com		Wang, Xiaoyi/0000-0001-8136-6642	State Key Program of National Natural Science Foundation of China [31230015]	State Key Program of National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	Zhongqi Yang received the State Key Program of National Natural Science Foundation of China (No. 31230015). The funder had an important role in study design.	Alencar IDCC, 2013, SYST ENTOMOL, V38, P45, DOI 10.1111/j.1365-3113.2012.00648.x; Banks JC, 2006, MOL PHYLOGENET EVOL, V41, P690, DOI 10.1016/j.ympev.2006.06.001; Belshaw R, 1997, MOL PHYLOGENET EVOL, V7, P281, DOI 10.1006/mpev.1996.0400; Brothers Denis J., 1993, Journal of Hymenoptera Research, V2, P227; Carr M, 2010, INSECT SYST EVOL, V41, P55, DOI 10.1163/187631210X486995; Deng J, 2012, MOL ECOL RESOUR, V12, P791, DOI 10.1111/j.1755-0998.2012.03152.x; EVANS H E, 1978, Memoirs of the American Entomological Institute (Gainesville), P1; EVANS HOWARD E., 1964, BULL MUS COMP ZOOL HARVARD UNIV, V132, P1; Gauld ID, 1988, HYMENOPTERA, P332; Gordh G., 1990, MEM AM ENTOMOL I, V46, P1, DOI DOI 10.1111/J.1440-6055.1990.TB00341.X; Goulet H, 1993, HYMENOPTERA WORLD ID; Guo XH, 2008, J LIAONING FORESTRY, V5, P5, DOI [10.1002/mrd.22451, DOI 10.1002/MRD.22451]; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, P313, DOI 10.1098/rspb.2002.2218; Kang WenTong, 2008, Journal of Fujian Agriculture and Forestry University (Natural Science Edition), V37, P575; Lanes GO, 2008, INSECT SYST EVOL, V39, P55, DOI 10.1163/187631208788784165; Li SQ, 2007, J PEST SCI, V80, P119, DOI 10.1007/s10340-006-0158-1; Mardulyn P, 1999, MOL PHYLOGENET EVOL, V12, P282, DOI 10.1006/mpev.1999.0618; Melo GAR, 1993, P ENTOMOL SOC WASH, V92, P258; Shaw SR, 2005, ZOOTAXA, P49; Shi J, 2009, CULT DIVERS ETHN MIN, V4, P117; SIMON C, 1994, ANN ENTOMOL SOC AM, V87, P651, DOI 10.1093/aesa/87.6.651; Wang Xiao-jun, 2007, Zhongguo Senlin Bingchong, V26, P28; Wang Xiao-Yi, 2010, Acta Entomologica Sinica, V53, P675; Wei JR, 2009, BIOCONTROL, V54, P733, DOI 10.1007/s10526-009-9224-y; Wu Hui, 2008, Acta Entomologica Sinica, V51, P46; Yang Hong, 2007, Acta Entomologica Sinica, V50, P807; Yang ZQ, 2014, ANN ENTOMOL SOC AM, V107, P407, DOI 10.1603/AN13150; Yang ZQ, 2012, ANN ENTOMOL SOC AM, V105, P619, DOI 10.1603/AN12017; [姚万军 YAO WanJun], 2008, [环境昆虫学报, Journal of Environmental Entomology], V30, P127; Zhang X, 2007, J SICHUAN FORESTRY S, V28, P16	30	14	18	1	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2015	10	3							e0119573	10.1371/journal.pone.0119573	http://dx.doi.org/10.1371/journal.pone.0119573			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7QC	25782000	Green Submitted, Green Published, gold			2022-12-27	WOS:000351284600075
J	Bogaerts, E; Heindryckx, F; Devisscher, L; Paridaens, A; Vandewynckel, YP; Van den Bussche, A; Verhelst, X; Libbrecht, L; van Grunsven, LA; Geerts, A; Van Vlierberghe, H				Bogaerts, Eliene; Heindryckx, Femke; Devisscher, Lindsey; Paridaens, Annelies; Vandewynckel, Yves-Paul; Van den Bussche, Anja; Verhelst, Xavier; Libbrecht, Louis; van Grunsven, Leo A.; Geerts, Anja; Van Vlierberghe, Hans			Time-Dependent Effect of Hypoxia on Tumor Progression and Liver Progenitor Cell Markers in Primary Liver Tumors	PLOS ONE			English	Article							PLACENTAL GROWTH-FACTOR; HEPATOCELLULAR-CARCINOMA; CYTOKERATIN-19 EXPRESSION; INDUCIBLE FACTOR; FACTOR-BETA; HEPATOCYTES; INHIBITION; CHOLANGIOCARCINOMA; CHEMORESISTANCE; RESISTANCE	Background & Aims Expression of liver progenitor cell (LPC) characteristics has been proposed as a negative prognostic marker in primary liver tumors. Hypoxia has been linked to activation of the Notch pathway which is responsible for activation and proliferation of LPCs and hypoxia- induced LPC activation has been shown in hepatocellular carcinoma. Our aim was to elucidate the time-dependent effects of hypoxia on the LPC niche in hepatocellular carcinoma which could aid in determining a safe time frame for use of hypoxia inducing therapies. Methods We used dimethyloxaloylglycine to mimic a hypoxic reaction in mice by stabilizing hypoxia-inducible factor 1 alpha at three distinct time points in diethylnitrosamine induced hepatocarcinogenesis. LPC, metastasis and Notch pathway markers were determined by quantitative PCR and (immune) histochemistry (heamatoxillin-eosin, reticulin, Sirius red and cytokeratin 19 staining). Results Activating the hypoxia inducible pathway early in hepatocarcinogenesis resulted in an increased incidence of both cholangioma and hepatocellular lesions, associated with high expression of LPC, metastatic and Notch pathway markers. Adversely, activating the hypoxic response during tumor development resulted in decreased incidence of hepatocellular lesions and increased cholangioma incidence, with an unaltered gene expression profile of LPC-, Notch pathway-and metastatic markers. A hypoxic insult at advanced stages of hepatocarcinogenesis severely increased the expression of LPC characteristics, however without increased expression of actors of the Notch pathway and metastatic markers and minor changes in incidence of hepatocellular and cholangioma lesions. Conclusion Our results indicate that increased hypoxia at the onset of tumor development has detrimental effects on tumor progression; patients with HCC developed in a background of fibrosis/cirrhosis might therefore represent a more difficult treatment group. In contrast, hypoxia during tumor development appears to favor tumor outcome, highlighting the importance of early detection. Finally, hypoxia in advanced stages resulted in increased expression of LPC characteristics indicating poor outcome.	[Bogaerts, Eliene; Devisscher, Lindsey; Paridaens, Annelies; Vandewynckel, Yves-Paul; Van den Bussche, Anja; Verhelst, Xavier; Geerts, Anja; Van Vlierberghe, Hans] Univ Ghent, Gastroenterol & Hepatol, B-9000 Ghent, Belgium; [Heindryckx, Femke] Uppsala Univ, Dept Med Biochem & Microbiol, Uppsala, Sweden; [Libbrecht, Louis] Univ Hosp Ghent, Dept Pathol, Ghent, Belgium; [van Grunsven, Leo A.] Vrije Univ Brussel, Liver Cell Biol Lab, Brussels, Belgium	Ghent University; Uppsala University; Ghent University; Ghent University Hospital; Vrije Universiteit Brussel	Van Vlierberghe, H (corresponding author), Univ Ghent, Gastroenterol & Hepatol, B-9000 Ghent, Belgium.	hans.vanvlierberghe@ugent.be	van Grunsven, Leo/E-5839-2010; Devisscher, Lindsey/AAD-5969-2021; Vandewynckel, Yves-Paul/H-3699-2019; Verhelst, Xavier/ABF-6965-2021	van Grunsven, Leo/0000-0002-0990-7034; Devisscher, Lindsey/0000-0003-4862-9580; Vandewynckel, Yves-Paul/0000-0002-7829-6732; Verhelst, Xavier/0000-0002-2798-5415; geerts, anja/0000-0002-2218-9081; Van Vlierberghe, Hans/0000-0003-0647-9238; Heindryckx, Femke/0000-0002-1987-7676	research foundation Flanders (FWO) project [G033313N]; "Emmanuel van der Schueren" grant by the flemmish league against cancer (VLK); Wenner-Gren Foundation-Sweden; Ghent University [01D20510, B/12531/01]	research foundation Flanders (FWO) project(FWO); "Emmanuel van der Schueren" grant by the flemmish league against cancer (VLK); Wenner-Gren Foundation-Sweden; Ghent University(Ghent University)	This study was supported by the research foundation Flanders (FWO) project (G033313N) and Xavier Verhelst and Hans Van Vlierberghe are clinical investigators for the research foundation Flanders (FWO) (www.FWO.be). Eliene Bogaerts was funded by an "Emmanuel van der Schueren" grant by the flemmish league against cancer (VLK). Femke Heindryckx received funding from the Wenner-Gren Foundation-Sweden. Lindsey Devisscher and Yves-Paul Vandewynckel are supported by a grant of the special research fund (BOF) from Ghent University (01D20510 and B/12531/01) (www.UGent.be). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bogaerts E, 2014, INT J ONCOL, V44, P1015, DOI 10.3892/ijo.2014.2286; Borght SV, 2008, LIVER INT, V28, P1370, DOI 10.1111/j.1478-3231.2008.01889.x; Boulter L, 2012, NAT MED; Choi BY, 2005, J CLIN GASTROENTEROL, V39, P401, DOI 10.1097/01.mcg.0000159226.63037.a2; Copple BL, 2010, LIVER INT, V30, P669, DOI 10.1111/j.1478-3231.2010.02205.x; Devisscher L, 2011, BIOCHEM BIOPH RES CO, V416, P307, DOI 10.1016/j.bbrc.2011.11.031; Ding SJ, 2004, MOL CELL PROTEOMICS, V3, P73, DOI 10.1074/mcp.M300094-MCP200; Durnez A, 2006, HISTOPATHOLOGY, V49, P138, DOI 10.1111/j.1365-2559.2006.02468.x; Ebos JML, 2009, CANCER CELL, V15, P232, DOI 10.1016/j.ccr.2009.01.021; Fausto N, 2004, HEPATOLOGY, V39, P1477, DOI 10.1002/hep.20214; Geerts AM, 2008, INT J EXP PATHOL, V89, P251, DOI 10.1111/j.1365-2613.2008.00597.x; Govaere O, 1468, KERATIN 19 KEY ROLE, P1468; Heindryckx F CS, 2012, J HEPATOL UNPUB; Heindryckx F, 2013, J HEPATOL, V58, P319, DOI 10.1016/j.jhep.2012.09.032; Heindryckx F, 2012, EUR J GASTROEN HEPAT, V24, P1020, DOI 10.1097/MEG.0b013e3283554219; Heindryckx F, 2012, J HEPATOL, V57, P61, DOI 10.1016/j.jhep.2012.02.021; Heindryckx F, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-219; Ke QD, 2006, MOL PHARMACOL, V70, P1469, DOI 10.1124/mol.106.027029; Lau CK, 2009, CLIN CANCER RES, V15, P3462, DOI 10.1158/1078-0432.CCR-08-2127; Liang YJ, 2013, HEPATOLOGY, V57, P1847, DOI 10.1002/hep.26224; Llovet JM, 2008, NEW ENGL J MED, V359, P378, DOI 10.1056/NEJMoa0708857; Ma S, 2008, ONCOGENE, V27, P1749, DOI 10.1038/sj.onc.1210811; Mathieu J, 2011, CANCER RES, V71, P4640, DOI 10.1158/0008-5472.CAN-10-3320; Michalopoulos GK, 2005, HEPATOLOGY, V41, P535, DOI 10.1002/hep.20600; Michalopoulos GK, 2002, HEPATOLOGY, V36, P278, DOI 10.1053/jhep.2002.34858; Okabe M, 2009, DEVELOPMENT, V136, P1951, DOI 10.1242/dev.031369; Paez-Ribes M, 2009, CANCER CELL, V15, P220, DOI 10.1016/j.ccr.2009.01.027; Roskams TA, 2003, SEMIN LIVER DIS, V23, P385; Sapisochin G, 2011, LIVER TRANSPLANT, V17, P934, DOI 10.1002/lt.22307; Schnell U, 2013, BBA-BIOMEMBRANES, V1828, P1989, DOI 10.1016/j.bbamem.2013.04.018; Spee B, 2010, GUT, V59, P247, DOI 10.1136/gut.2009.188367; Strazzabosco M, 2013, J HEPATOL, V58, P181, DOI 10.1016/j.jhep.2012.08.006; Timme CR, 2013, APOPTOSIS, V18, P1163, DOI 10.1007/s10495-013-0883-x; Uenishi T, 2003, CANCER SCI, V94, P851, DOI 10.1111/j.1349-7006.2003.tb01366.x; Van Hul NKM, 2009, HEPATOLOGY, V49, P1625, DOI 10.1002/hep.22820; Van Steenkiste C, 2011, HEPATOLOGY, V53, P1629, DOI 10.1002/hep.24238; Webb JD, 2009, CELL MOL LIFE SCI, V66, P3539, DOI 10.1007/s00018-009-0147-7; Yang W, 2012, J HEPATOL, V57, P613, DOI 10.1016/j.jhep.2012.04.024; Zen C, 2011, LIVER TRANSPLANT, V17, P943, DOI 10.1002/lt.22314; Zhang CC, 2013, STEM CELL TRANSL MED, V2, P233, DOI 10.5966/sctm.2012-0096; Zulehner G, 2010, AM J PATHOL, V176, P472, DOI 10.2353/ajpath.2010.090300	41	11	12	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2015	10	3							e0119555	10.1371/journal.pone.0119555	http://dx.doi.org/10.1371/journal.pone.0119555			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8IA	25793288	Green Submitted, Green Published, gold			2022-12-27	WOS:000352084200095
J	Berkman, ET; Lukinova, E; Menshikov, I; Myagkov, M				Berkman, Elliot T.; Lukinova, Evgeniya; Menshikov, Ivan; Myagkov, Mikhail			Sociality as a Natural Mechanism of Public Goods Provision	PLOS ONE			English	Article							IMPLICIT ASSOCIATION TEST; PROSPECT-THEORY; COOPERATION; EVOLUTION; CATEGORIZATION; METAANALYSIS; RECIPROCITY; IDENTITY; FAIRNESS; MARKERS	In the recent literature, several hypotheses have been offered to explain patterns of human behavior in social environments. In particular, these patterns include 'prosocial' ones, such as fairness, cooperation, and collective good provision. Psychologists suggest that these prosocial behaviors are driven not by miscalculations, but by salience of social identity, ingroup favoritism, emotion, or evolutionary adaptations. This paper imports psychology scholarship into an economic model and results in a sustainable solution to collective action problems without any external enforcement mechanisms. This natural mechanism of public goods provision is created, analyzed, and observed in a controlled laboratory environment using experimental techniques.	[Berkman, Elliot T.] Univ Oregon, Dept Psychol, Eugene, OR 97403 USA; [Lukinova, Evgeniya; Myagkov, Mikhail] Skolkovo Inst Sci & Technol, Skolkovo, Russia; [Menshikov, Ivan] Moscow Inst Sci & Technol, Dept Appl Math & Management, Dolgoprudnyi, Russia; [Myagkov, Mikhail] Univ Oregon, Dept Polit Sci, Eugene, OR 97403 USA	University of Oregon; Skolkovo Institute of Science & Technology; Moscow Institute of Physics & Technology; University of Oregon	Lukinova, E (corresponding author), Skolkovo Inst Sci & Technol, Skolkovo, Russia.	e.lukinova@skoltech.ru	Myagkov, Mikhail G./G-6049-2017; Lukinova, Evgeniya/K-1569-2019; Lukinova, Evgeniya/K-4466-2019; Menshikov, Ivan S/B-6381-2018; Berkman, Elliot T./Q-5233-2016	Lukinova, Evgeniya/0000-0002-8357-9307; Berkman, Elliot T./0000-0002-7113-5792	Skolkovo Institute of Science and Technology; NATIONAL CANCER INSTITUTE [R21CA175241] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG048840] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [P50DA035763] Funding Source: NIH RePORTER	Skolkovo Institute of Science and Technology; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	The study was funded by Mikhail Myagkov through his personal research fund at Skolkovo Institute of Science and Technology. Mikhail Myagkov, as one of the co-authors of the manuscript took part in study design and decision to publish the manuscript. No external grants or funding sources were used.	Amodio DM, 2006, NAT REV NEUROSCI, V7, P268, DOI 10.1038/nrn1884; ANDREONI J, 1995, AM ECON REV, V85, P891; Aronson E., 1972, SOCIAL ANIMAL; Ball SB, 1996, PSYCHOL MARKET, V13, P381, DOI 10.1002/(SICI)1520-6793(199607)13:4<379::AID-MAR4>3.0.CO;2-7; Becker G., 1976, EC APPROACH HUMAN BE; Bohm R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056152; Bowlby J, 1969, ATTACHMENT LOSS SEPA; Brewer MB, 1996, INT J INTERCULT REL, V20, P291, DOI 10.1016/0147-1767(96)00020-X; Brock WA, 2001, REV ECON STUD, V68, P235, DOI 10.1111/1467-937X.00168; Camerer CF, 2006, SCIENCE, V311, P47, DOI 10.1126/science.1110600; Cohen, 2007, HDB CULTURAL PSYCHOL, P307; Dasgupta N., 2004, SOCIAL JUSTICE RES, V17, P143, DOI DOI 10.1023/B:SORE.0000027407.70241.15; Fehr E, 2002, NATURE, V415, P137, DOI 10.1038/415137a; Fehr E, 1999, Q J ECON, V114, P817, DOI 10.1162/003355399556151; Fehr E, 2010, J ECON BEHAV ORGAN, V73, P101, DOI 10.1016/j.jebo.2009.12.001; Fischbacher U, 2001, ECON LETT, V71, P397, DOI 10.1016/S0165-1765(01)00394-9; FRANK MG, 1993, J PERS SOC PSYCHOL, V64, P83, DOI 10.1037/0022-3514.64.1.83; Frey BS, 2005, OXFORD ECON PAP, V57, P90, DOI 10.1093/oep/gpi002; Fu F, 2008, PHYS REV E, V78, DOI 10.1103/PhysRevE.78.016104; Greenwald AG, 2009, J PERS SOC PSYCHOL, V97, P17, DOI 10.1037/a0015575; Grujic J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013749; Hofmann W, 2005, PERS SOC PSYCHOL B, V31, P1369, DOI 10.1177/0146167205275613; Hogg MA, 2000, ACAD MANAGE REV, V25, P121, DOI 10.1093/cdj/bsi087; KAHNEMAN D, 1979, ECONOMETRICA, V47, P263, DOI 10.2307/1914185; Kubota JT, 2013, PSYCHOL SCI, V24, P2498, DOI 10.1177/0956797613496435; Lakshminarayanan VR, 2011, J EXP SOC PSYCHOL, V47, P689, DOI 10.1016/j.jesp.2010.12.011; Ledyard JO, 1995, HDB EXPT EC, P111, DOI DOI 10.3987/CONTENTS-12-85-7; Lester BY, 2011, J SOCIO-ECON, V40, P949, DOI 10.1016/j.socec.2011.08.024; Liebrand WB, 1996, FRONTIERS SOCIAL DIL; Lukinova E, 2014, FORESIGHT, V16, P309, DOI 10.1108/FS-11-2012-0086; McDermott R, 2008, J POLIT, V70, P335, DOI 10.1017/S0022381608080341; Morishima Y, 2012, NEURON, V75, P73, DOI 10.1016/j.neuron.2012.05.021; Myagkov M., 2006, Journal of Bioeconomics, V8, P67, DOI 10.1007/s10818-006-0004-9; Myagkov M, 1997, AM ECON REV, V87, P801; Neugebauer T, 2009, J ECON PSYCHOL, V30, P52, DOI 10.1016/j.joep.2008.04.005; Nosek BA, 2005, J EXP PSYCHOL GEN, V134, P565, DOI 10.1037/0096-3445.134.4.565; Nowak MA, 1998, NATURE, V393, P573, DOI 10.1038/31225; Nowak MA, 2006, SCIENCE, V314, P1560, DOI 10.1126/science.1133755; Ostrom E., 1990, GOVERNING COMMONS EV; Ostrom E, 2006, J ECON BEHAV ORGAN, V61, P149, DOI 10.1016/j.jebo.2005.02.008; Riolo RL, 2001, NATURE, V414, P441, DOI 10.1038/35106555; Ruffle BJ, 2006, J ECON BEHAV ORGAN, V60, P147, DOI 10.1016/j.jebo.2004.07.007; Scharlemann JPW, 2001, J ECON PSYCHOL, V22, P617, DOI 10.1016/S0167-4870(01)00059-9; SCHUESSLER R, 1989, J CONFLICT RESOLUT, V33, P728, DOI 10.1177/0022002789033004007; Smaldino PE, 2013, AM NAT, V181, P451, DOI 10.1086/669615; Stroebe K, 2005, PERS SOC PSYCHOL B, V31, P831, DOI 10.1177/0146167204271659; TAJFEL H, 1971, EUR J SOC PSYCHOL, V1, P149, DOI 10.1002/ejsp.2420010202; TAJFEL H, 1982, ANNU REV PSYCHOL, V33, P1, DOI 10.1146/annurev.ps.33.020182.000245; Tajfel H., 1981, HUMAN GROUPS SOCIAL, DOI DOI 10.1002/EJSP.2420120209; Traulsen A, 2003, PHYS REV E, V68, DOI 10.1103/PhysRevE.68.046129; Wang Z, 2013, PHYS REV E, V88, DOI 10.1103/PhysRevE.88.042145; Wang Z, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040218; Waytz A, 2013, J EXP SOC PSYCHOL, V49, P1027, DOI 10.1016/j.jesp.2013.07.002; YOUNG HP, 1991, GAME ECON BEHAV, V3, P145, DOI 10.1016/0899-8256(91)90010-C; Zaki J, 2011, P NATL ACAD SCI USA, V108, P19761, DOI 10.1073/pnas.1112324108	55	6	6	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2015	10	3							e0119685	10.1371/journal.pone.0119685	http://dx.doi.org/10.1371/journal.pone.0119685			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CD9NQ	25790099	Green Submitted, Green Published, gold			2022-12-27	WOS:000351425400095
J	Deng, Y; Nagachar, N; Fang, L; Luan, X; Catchmark, JM; Tien, M; Kao, TH				Deng, Ying; Nagachar, Nivedita; Fang, Lin; Luan, Xin; Catchmark, Jeffrey M.; Tien, Ming; Kao, Teh-hui			Isolation and Characterization of Two Cellulose Morphology Mutants of Gluconacetobacter hansenii ATCC23769 Producing Cellulose with Lower Crystallinity	PLOS ONE			English	Article							ACETOBACTER-XYLINUM; BACTERIAL CELLULOSE; MICROBIAL CELLULOSE; POLYSACCHARIDES; EXOPOLYSACCHARIDES; BIOSYNTHESIS; STRAIN; ACETAN; NMR	Gluconacetobacter hansenii, a Gram-negative bacterium, produces and secrets highly crystalline cellulose into growth medium, and has long been used as a model system for studying cellulose synthesis in higher plants. Cellulose synthesis involves the formation of beta-1,4 glucan chains via the polymerization of glucose units by a multi-enzyme cellulose synthase complex (CSC). These glucan chains assemble into ordered structures including crystalline microfibrils. AcsA is the catalytic subunit of the cellulose synthase enzymes in the CSC, and AcsC is required for the secretion of cellulose. However, little is known about other proteins required for the assembly of crystalline cellulose. To address this question, we visually examined cellulose pellicles formed in growth media of 763 individual colonies of G. hansenii generated via Tn5 transposon insertion mutagenesis, and identified 85 that produced cellulose with altered morphologies. X-ray diffraction analysis of these 85 mutants identified two that produced cellulose with significantly lower crystallinity than wild type. The gene disrupted in one of these two mutants encoded a lysine decarboxylase and that in the other encoded an alanine racemase. Solid-state NMR analysis revealed that cellulose produced by these two mutants contained increased amounts of non-crystalline cellulose and monosaccharides associated with non-cellulosic polysaccharides as compared to the wild type. Monosaccharide analysis detected higher percentages of galactose and mannose in cellulose produced by both mutants. Field emission scanning electron microscopy showed that cellulose produced by the mutants was unevenly distributed, with some regions appearing to contain deposition of non-cellulosic polysaccharides; however, the width of the ribbon was comparable to that of normal cellulose. As both lysine decarboxylase and alanine racemase are required for the integrity of peptidoglycan, we propose a model for the role of peptidoglycan in the assembly of crystalline cellulose.	[Deng, Ying; Nagachar, Nivedita; Luan, Xin; Tien, Ming; Kao, Teh-hui] Penn State Univ, Dept Biochem & Mol Biol, University Pk, PA 16802 USA; [Fang, Lin; Catchmark, Jeffrey M.] Penn State Univ, Dept Agr & Biol Engn, University Pk, PA 16802 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Kao, TH (corresponding author), Penn State Univ, Dept Biochem & Mol Biol, University Pk, PA 16802 USA.	txk3@psu.edu	Dalla Zuanna, Teresa/G-3133-2015		Center for Lignocellulose Structure and Formation; U.S. Department of Energy, Office of Science, Office of Basic Energy Sciences [DE-SC0001090]	Center for Lignocellulose Structure and Formation; U.S. Department of Energy, Office of Science, Office of Basic Energy Sciences(United States Department of Energy (DOE))	This work was supported by a grant to JMC, MT and THK from The Center for Lignocellulose Structure and Formation, an Energy Frontier Research Center funded by the U.S. Department of Energy (http://www.energy.gov), Office of Science, Office of Basic Energy Sciences under Award Number DE-SC0001090. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BROWN RM, 1976, P NATL ACAD SCI USA, V73, P4565, DOI 10.1073/pnas.73.12.4565; Cabeen MT, 2005, NAT REV MICROBIOL, V3, P601, DOI 10.1038/nrmicro1205; Chanzy H., 1982, CARBOHYD POLYM, V2, P229, DOI [DOI 10.1016/0144-8617(82)90021-2, 10.1016/0144-8617(82)90021-2]; Chawla PR, 2009, FOOD TECHNOL BIOTECH, V47, P107; COLQUHOUN IJ, 1995, CARBOHYD RES, V269, P319, DOI 10.1016/0008-6215(94)00367-O; COUSO RO, 1987, J GEN MICROBIOL, V133, P2123; Czaja W, 2006, BIOMATERIALS, V27, P145, DOI 10.1016/j.biomaterials.2005.07.035; Deng Y, 2013, J BACTERIOL, V195, P5072, DOI 10.1128/JB.00767-13; Dick-Perez M, 2011, BIOCHEMISTRY-US, V50, P989, DOI 10.1021/bi101795q; Fang L, 2015, CARBOHYD POLYM, V115, P663, DOI 10.1016/j.carbpol.2014.09.028; Fang L, 2014, CELLULOSE, V21, P3965, DOI 10.1007/s10570-014-0443-8; Fenwick KM, 1999, PHYTOCHEMISTRY, V51, P17, DOI 10.1016/S0031-9422(98)00723-7; Gu J, 2012, CARBOHYD POLYM, V88, P547, DOI 10.1016/j.carbpol.2011.12.040; Habibi Y, 2004, CARBOHYD RES, V339, P1119, DOI 10.1016/j.carres.2004.02.005; Haigler CH., 1985, CELLULOSE CHEM ITS A, P30; HALL PE, 1992, PLASMID, V28, P194, DOI 10.1016/0147-619X(92)90051-B; Hantus S, 1997, CARBOHYD RES, V304, P11, DOI 10.1016/S0008-6215(97)00200-0; Harris D, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002897; HESTRIN S, 1954, BIOCHEM J, V58, P345, DOI 10.1042/bj0580345; Iyer PR, 2013, ARCH BIOCHEM BIOPHYS, V529, P92, DOI 10.1016/j.abb.2012.12.002; Iyer PR, 2010, J BACTERIOL, V192, P4256, DOI 10.1128/JB.00588-10; JANSSON PE, 1993, CARBOHYD RES, V245, P303, DOI 10.1016/0008-6215(93)80079-T; Kumar AS, 2007, J BASIC MICROB, V47, P103, DOI 10.1002/jobm.200610203; Newman RH, 2004, CELLULOSE, V11, P23, DOI 10.1023/B:CELL.0000014778.49291.c6; Park S, 2010, BIOTECHNOL BIOFUELS, V3, DOI 10.1186/1754-6834-3-10; ROSS P, 1991, MICROBIOL REV, V55, P35, DOI 10.1128/MMBR.55.1.35-58.1991; Shoda M, 2005, BIOTECHNOL BIOPROC E, V10, P1, DOI 10.1007/BF02931175; Sluiter A., 2008, LAB ANAL PROCED, V1617, P1; Szxena IM, 1994, J BACTERIOL, V176, P5735; Takatsuka Y, 2004, BIOSCI BIOTECH BIOCH, V68, P1, DOI 10.1271/bbb.68.1; Tang HR, 2000, SOLID STATE NUCL MAG, V15, P239, DOI 10.1016/S0926-2040(99)00064-8; Thygesen A, 2005, CELLULOSE, V12, P563, DOI 10.1007/s10570-005-9001-8; VALLA S, 1981, CAN J MICROBIOL, V27, P599, DOI 10.1139/m81-091; Vignon MR, 2004, CARBOHYD RES, V339, P123, DOI 10.1016/j.carres.2003.09.023; WHITFIELD C, 1988, CAN J MICROBIOL, V34, P415, DOI 10.1139/m88-073; Whitney SEC, 2006, AM J BOT, V93, P1402, DOI 10.3732/ajb.93.10.1402; Whitney SEC, 1998, CARBOHYD RES, V307, P299, DOI 10.1016/S0008-6215(98)00004-4	37	23	23	1	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2015	10	3							e0119504	10.1371/journal.pone.0119504	http://dx.doi.org/10.1371/journal.pone.0119504			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD9NQ	25790428	Green Published, Green Submitted, gold			2022-12-27	WOS:000351425400088
J	Liu, EB; Liu, XL; Zeng, SY; Zhao, KM; Zhu, CF; Liu, Y; Breria, MC; Zhang, BJ; Hong, DL				Liu, Erbao; Liu, Xiaoli; Zeng, Siyuan; Zhao, Kaiming; Zhu, Changfeng; Liu, Yang; Breria, Manamik Caleb; Zhang, Baojuan; Hong, Delin			Time-Course Association Mapping of the Grain-Filling Rate in Rice (Oryza sativa L.)	PLOS ONE			English	Article							QUANTITATIVE TRAIT LOCUS; PHOTOPERIOD SENSITIVITY; LINKAGE DISEQUILIBRIUM; GENETIC DIVERSITY; NATURAL VARIATION; MAJOR QTL; YIELD; ENCODES; QUALITY; WIDTH	Detecting quantity trait locus (QTLs) and elite alleles that are associated with grain-filling rate (GFR) in rice is essential for promoting the utilization of hybrid japonica rice and improving rice yield. Ninety-five varieties including 58 landraces and 37 elite varieties from the core germplasm collection were genotyped with 263 simple sequence repeat (SSR) markers. The GFR of the 95 varieties was evaluated at five stages, 7, 14, 21, 28 and 35 days after flowering (DAF) both in 2011 and 2012. We found abundant phenotypic and genetic diversity in the studied population. A population structure analysis identified seven subpopulations. A linkage disequilibrium (LD) analysis indicated that the levels of LD ranged from 60.3 cM to 84.8 cM and artificial selection had enhanced the LD. A time-course association analysis detected 31 marker-GFR associations involving 24 SSR markers located on chromosomes 1, 2, 3, 4, 5, 6, 8, 9, 11 and 12 of rice at five stages. The elite alleles for high GFR at each stage were detected. Fifteen excellent parental combinations were predicted, and the best parental combination 'Nannongjing62401xLaolaihong' could theoretically increase 4.086 mg grain(-1) d(-1) at the five stages. Our results demonstrate that the time-course association mapping for GFR in rice could detect elite alleles at different filling stages and that these elite alleles could be used to improve the GFR via pyramiding breeding.	[Liu, Erbao; Liu, Xiaoli; Zeng, Siyuan; Zhao, Kaiming; Zhu, Changfeng; Liu, Yang; Breria, Manamik Caleb; Zhang, Baojuan; Hong, Delin] Nanjing Agr Univ, State Key Lab Crop Genet & Germplasm Enhancement, Nanjing, Jiangsu, Peoples R China	Nanjing Agricultural University	Hong, DL (corresponding author), Nanjing Agr Univ, State Key Lab Crop Genet & Germplasm Enhancement, Nanjing, Jiangsu, Peoples R China.	delinhong@njau.edu.cn	hong, delin/R-3398-2017; Liu, Xiaoli/HGE-7614-2022	hong, delin/0000-0002-2899-9739; Breria, Caleb Manamik/0000-0002-0976-6956	National High-tech R&D Program of China (863 Program) [2010AA101301]; Research Fund for the Doctoral Program of Higher Education of China [B0201100690, B0201300662]	National High-tech R&D Program of China (863 Program)(National High Technology Research and Development Program of China); Research Fund for the Doctoral Program of Higher Education of China(Research Fund for the Doctoral Program of Higher Education of China (RFDP)Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP))	This work was supported by following funders: (1) National High-tech R&D Program of China (863 Program) Grant number: 2010AA101301, URL: http://www.most.gov.cn/, the author that received the funding: DH, (2) Research Fund for the Doctoral Program of Higher Education of China Grant numbers: B0201100690 and B0201300662, URL: http://www.cutech.edu.cn/cn/kyjj/gdxxbsdkyjj/A010301index_1.htm, the author that received the funding: DH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrama HA, 2007, MOL BREEDING, V19, P341, DOI 10.1007/s11032-006-9066-6; Akihiro T, 2005, PLANT CELL PHYSIOL, V46, P937, DOI 10.1093/pcp/pci101; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bradbury PJ, 2007, BIOINFORMATICS, V23, P2633, DOI 10.1093/bioinformatics/btm308; Cassman KG, 1999, P NATL ACAD SCI USA, V96, P5952, DOI 10.1073/pnas.96.11.5952; Cheng BaoShan, 2007, Journal of Nanjing Agricultural University, V30, P1; Cock J. H., 1972, Proceedings of the Crop Science Society of Japan, V41, P226; Cui D, 2013, EUPHYTICA, V193, P369, DOI 10.1007/s10681-013-0935-x; Dang XJ, 2014, PLANTA, V239, P1309, DOI 10.1007/s00425-014-2060-z; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Falush D, 2003, GENETICS, V164, P1567; Fan CH, 2006, THEOR APPL GENET, V112, P1164, DOI 10.1007/s00122-006-0218-1; Flavio B, 2006, GENETICS, V172, P1165, DOI DOI 10.1534/GENETICS.105.044586; Flint-Garcia SA, 2003, ANNU REV PLANT BIOL, V54, P357, DOI 10.1146/annurev.arplant.54.031902.134907; Gao H, 2014, P NATL ACAD SCI USA, V111, P16337, DOI 10.1073/pnas.1418204111; Gao H, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003281; Garris AJ, 2005, GENETICS, V169, P1631, DOI 10.1534/genetics.104.035642; Hirose T, 2004, PLANTA, V220, P9, DOI 10.1007/s00425-004-1314-6; Hong DeLin, 2004, Rice Science, V11, P255; Huang JW, 1996, BIOSCI BIOTECH BIOCH, V60, P233, DOI 10.1271/bbb.60.233; [贾小丽 Jia Xiaoli], 2012, [中国农学通报, Chinese Agricultural Science Bulletin], V28, P22; Jin L, 2010, THEOR APPL GENET, V121, P475, DOI 10.1007/s00122-010-1324-7; Jin WeiDong, 2008, Scientia Agricultura Sinica, V41, P3822; Kato T, 1996, CROP SCI, V36, P1135, DOI 10.2135/cropsci1996.0011183X003600050011x; Khush GS, 2005, PLANT MOL BIOL, V59, P1, DOI 10.1007/s11103-005-2159-5; Lapitan VC, 2007, BREEDING SCI, V57, P263, DOI 10.1270/jsbbs.57.263; Li YB, 2011, NAT GENET, V43, P1266, DOI 10.1038/ng.977; Liu Er-bao, 2013, Chinese Journal of Rice Science, V27, P473, DOI 10.3969/j.issn.1001-7216.2013.05.004; Liu KJ, 2005, BIOINFORMATICS, V21, P2128, DOI 10.1093/bioinformatics/bti282; Ma Lin, 2010, Zhongguo Shuidao Kexue, V24, P237, DOI 10.3969/j.issn.1001-7216.2010.03.005; Mao CX, 2010, ACCELERATING HYBRID, P581; McCouch SR, 2002, DNA RES, V9, P199, DOI 10.1093/dnares/9.6.199; NEI M, 1983, J MOL EVOL, V19, P153, DOI 10.1007/BF02300753; OKAGAKI RJ, 1992, PLANT MOL BIOL, V19, P513, DOI 10.1007/BF00023402; Peng S, 1999, CROP SCI, V39, P1552, DOI 10.2135/cropsci1999.3961552x; Peng SB, 2008, FIELD CROP RES, V108, P32, DOI 10.1016/j.fcr.2008.04.001; Pritchard JK, 1999, AM J HUM GENET, V65, P220, DOI 10.1086/302449; Remington DL, 2001, P NATL ACAD SCI USA, V98, P11479, DOI 10.1073/pnas.201394398; Risch N, 1996, SCIENCE, V273, P1516, DOI 10.1126/science.273.5281.1516; Song XJ, 2007, NAT GENET, V39, P623, DOI 10.1038/ng2014; Takahashi Y, 2001, P NATL ACAD SCI USA, V98, P7922, DOI 10.1073/pnas.111136798; Takai T, 2005, J EXP BOT, V56, P2107, DOI 10.1093/jxb/eri209; Temnykh S, 2000, THEOR APPL GENET, V100, P697, DOI 10.1007/s001220051342; Tian ZX, 2009, P NATL ACAD SCI USA, V106, P21760, DOI 10.1073/pnas.0912396106; VIRMANI SS, 1982, THEOR APPL GENET, V63, P373, DOI 10.1007/BF00303911; Wang E, 2008, NAT GENET, V40, P1370, DOI 10.1038/ng.220; Wang LQ, 2007, THEOR APPL GENET, V115, P463, DOI 10.1007/s00122-007-0580-7; Wang SK, 2012, NAT GENET, V44, P950, DOI 10.1038/ng.2327; Wei XJ, 2010, PLANT PHYSIOL, V153, P1747, DOI 10.1104/pp.110.156943; Weir BS, 2002, ANNU REV GENET, V36, P721, DOI 10.1146/annurev.genet.36.050802.093940; Weng JF, 2008, CELL RES, V18, P1199, DOI 10.1038/cr.2008.307; Xue WY, 2008, NAT GENET, V40, P761, DOI 10.1038/ng.143; Yang JC, 2010, J EXP BOT, V61, P1, DOI 10.1093/jxb/erp348; Yano M, 2001, CURR OPIN PLANT BIOL, V4, P130, DOI 10.1016/S1369-5266(00)00148-5; Yano M, 2000, PLANT CELL, V12, P2473, DOI 10.1105/tpc.12.12.2473; Yoshida S., 1981, Fundamentals of rice crop science.; Yu YQ, 2012, FIELD CROP RES, V136, P65, DOI 10.1016/j.fcr.2012.07.021; Yuan LP., 1994, HYBRID RICE TECHNOLO, P1; Zhang GuoHua, 2013, Acta Agronomica Sinica, V39, P1187, DOI 10.3724/SP.J.1006.2013.01187; Zhang PF, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0020827, 10.1371/journal.pone.0027565]; Zhang XJ, 2012, P NATL ACAD SCI USA, V109, P21534, DOI 10.1073/pnas.1219776110	61	16	20	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2015	10	3							e0119959	10.1371/journal.pone.0119959	http://dx.doi.org/10.1371/journal.pone.0119959			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD9NQ	25789629	Green Published, gold, Green Submitted			2022-12-27	WOS:000351425400121
J	Terra, M; Bagatin, E; Nery, LE; Napolis, LM; Neder, JA; Meirelles, GDP; Silva, CI; Muller, NL				Terra-Filho, Mario; Bagatin, Ericson; Nery, Luiz Eduardo; Napolis, Lara Maris; Neder, Jose Alberto; Portes Meirelles, Gustavo de Souza; Isabela Silva, C.; Muller, Nestor L.			Screening of Miners and Millers at Decreasing Levels of Asbestos Exposure: Comparison of Chest Radiography and Thin-Section Computed Tomography	PLOS ONE			English	Article							HIGH-RESOLUTION CT; PLEURAL PLAQUES; LUNG-FUNCTION; WORKERS; DISEASE; FIBROSIS; SMOKING; ABNORMALITIES; MANAGEMENT	Background Chest radiography (CXR) is inferior to Thin-section computed tomography in the detection of asbestos related interstitial and pleural abnormalities. It remains unclear, however, whether these limitations are large enough to impair CXR's ability in detecting the expected reduction in the frequency of these asbestos-related abnormalities (ARA) as exposure decreases. Methods Clinical evaluation, CXR, Thin-section CT and spirometry were obtained in 1418 miners and millers who were exposed to progressively lower airborne concentrations of asbestos. They were separated into four groups according to the type, period and measurements of exposure and/or procedures for controlling exposure: Group I (1940-1966/tremolite and chrysotile, without measurements of exposure and procedures for controlling exposure); Group II (1967-1976/chrysotile only, without measurements of exposure and procedures for controlling exposure); Group III (1977-1980/chrysotile only, initiated measurements of exposure and procedures for controlling exposure) and Group IV (after 1981/chrysotile only, implemented measurements of exposure and a comprehensive procedures for controlling exposure). Results In all groups, CXR suggested more frequently interstitial abnormalities and less frequently pleural plaques than observed on Thin-section CT (p < 0.050). The odds for asbestosis in groups of decreasing exposure diminished to greater extent at Thin-section CT than on CXR. Lung function was reduced in subjects who had pleural plaques evident only on Thin-section CT (p < 0.050). In a longitudinal evaluation of 301 subjects without interstitial and pleural abnormalities on CXR and Thin-section CT in a previous evaluation, only Thin-section CT indicated that these ARA reduced as exposure decreased. Conclusions CXR compared to Thin-section CT was associated with false-positives for interstitial abnormalities and false-negatives for pleural plaques, regardless of the intensity of asbestos exposure. Also, CXR led to a substantial misinformation of the effects of the progressively lower asbestos concentrations in the occurrence of asbestos-related diseases in miners and millers.	[Terra-Filho, Mario] Univ Sao Paulo, Fac Med, Hosp Clin, Inst Heart,Div Pulm, Sao Paulo, Brazil; [Bagatin, Ericson] Univ Estadual Campinas, Fac Ciencias Med, Dept Social & Prevent Med, Occupat Hlth Area, Sao Paulo, Brazil; [Bagatin, Ericson] Fac Med Jundiai, Dept Clin Med, Sao Paulo, Brazil; [Nery, Luiz Eduardo; Napolis, Lara Maris; Neder, Jose Alberto] Univ Fed Sao Paulo, Escola Paulista Med, Dept Med, Div Resp, Sao Paulo, Brazil; [Portes Meirelles, Gustavo de Souza] Univ Fed Sao Paulo, Escola Paulista Med, Dept Radiol, Div Radiol, Sao Paulo, Brazil; [Portes Meirelles, Gustavo de Souza] Fleury Grp, Div Radiol, Sao Paulo, Brazil; [Isabela Silva, C.] Delfin Clin, Dept Radiol, Salvador, BA, Brazil; [Isabela Silva, C.] Portuguese Hosp, Salvador, BA, Brazil; [Muller, Nestor L.] Univ British Columbia, Dept Radiol, Vancouver, BC, Canada	Universidade de Sao Paulo; Universidade Estadual de Campinas; Faculdade de Medicina de Jundiai; Universidade Federal de Sao Paulo (UNIFESP); Universidade Federal de Sao Paulo (UNIFESP); FLEURY GROUP; University of British Columbia	Terra, M (corresponding author), Univ Sao Paulo, Fac Med, Hosp Clin, Inst Heart,Div Pulm, Sao Paulo, Brazil.	pnemario@incor.usp.br	Terra-Filho, Mario/H-5806-2012; Nery, Luiz E/C-3194-2015	Terra-Filho, Mario/0000-0002-8642-5354; 	Research Foundation of the State of Sao Paulo, Brazil (FAPESP) [1996/10415-6]; Brazilian Research National Council (CNPq) [420001/2006-9]; FUNAPE - Goias State Government [54.023]; SAMA [2P-04559-98]; Brazilian Crysotile Institute (IBC)	Research Foundation of the State of Sao Paulo, Brazil (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Brazilian Research National Council (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); FUNAPE - Goias State Government; SAMA; Brazilian Crysotile Institute (IBC)	This work was supported by a Research Grants from the Research Foundation of the State of Sao Paulo, Brazil (FAPESP) no 1996/10415-6, the Brazilian Research National Council (CNPq) no 420001/2006-9, FUNAPE - Goias State Government no 54.023, Institutional Grant to State University of Campinas from SAMA, no 2P-04559-98 and Brazilian Crysotile Institute (IBC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABERLE DR, 1988, RADIOLOGY, V166, P729, DOI 10.1148/radiology.166.3.3340770; AKIRA M, 1991, RADIOLOGY, V178, P409, DOI 10.1148/radiology.178.2.1987601; Bagatin E, 2005, OCCUP ENVIRON MED, V62, P381, DOI 10.1136/oem.2004.016188; Becklake MR, 2007, INT J TUBERC LUNG D, V11, P356; ELMES PC, 1981, BRIT J IND MED, V38, P1; FRIEDMAN AC, 1988, AM J ROENTGENOL, V150, P269, DOI 10.2214/ajr.150.2.269; Gevenois PA, 1998, EUR RESPIR J, V11, P1021, DOI 10.1183/09031936.98.11051021; GEVENOIS PA, 1994, ACTA RADIOL, V35, P226; Guidotti TL, 2004, AM J RESP CRIT CARE, V170, P691, DOI 10.1164/rccm.200310-1436ST; Harkin TJ, 1996, J OCCUP ENVIRON MED, V38, P46, DOI 10.1097/00043764-199601000-00016; International Labour Office, 2000, GUID US INT CLASS RA; Kitamura S, 1999, CRITERIOM ESTIMATE O; MacRedmond R, 2004, THORAX, V59, P237, DOI 10.1136/thx.2003.008821; Marinaccio A, 2006, Med Lav, V97, P482; MCDONALD JC, 1974, ARCH ENVIRON HEALTH, V28, P61, DOI 10.1080/00039896.1974.10666438; Miller A, 1996, OCCUP ENVIRON MED, V53, P808, DOI 10.1136/oem.53.12.808; MULLER NL, 1991, AM J ROENTGENOL, V157, P1163; Neri S, 1996, AM J IND MED, V30, P588, DOI 10.1002/(SICI)1097-0274(199611)30:5<588::AID-AJIM6>3.0.CO;2-P; Nogueira CR, 2011, AM J IND MED, V54, P185, DOI 10.1002/ajim.20922; OKSA P, 1994, INT ARCH OCC ENV HEA, V65, P299, DOI 10.1007/BF00405693; Paris C, 2004, SCAND J WORK ENV HEA, V30, P206, DOI 10.5271/sjweh.781; Paris C, 2009, EUR RESPIR J, V34, P72, DOI 10.1183/09031936.00094008; Pereira CAC, 1992, J PNEUMOL, V18, P10; Schiavon F, 1995, Monaldi Arch Chest Dis, V50, P211; Selikoff IJ, 1977, CLIN SURVEY CHRYSOTI; [Services UDoHaH Services UDoHaH], 1984, DHHS PUBL, V94-113; Silva CIS, 2008, J THORAC IMAG, V23, P251, DOI 10.1097/RTI.0b013e31817e352a; STAPLES CA, 1989, AM REV RESPIR DIS, V139, P1502, DOI 10.1164/ajrccm/139.6.1502; Terra- Filho M., 2010, ENV ASBESTOS PROJECT; Vehmas T, 2003, EUR RESPIR J, V21, P866, DOI 10.1183/09031936.03.00029002; Vierikko T, 2007, EUR RESPIR J, V29, P78, DOI 10.1183/09031936.00073606; Vierikko T, 2010, INT ARCH OCC ENV HEA, V83, P47, DOI 10.1007/s00420-009-0462-1; Wagner G, 1996, HEALTH; Wagner JL, FEASIBILITY EC EVALU; Welch LS, 2007, CHEST, V131, P863, DOI 10.1378/chest.06-1155; Wilken D, 2011, J OCCUP MED TOXICOL, V6, DOI 10.1186/1745-6673-6-21; 1995, AM J RESP CRITICAL C, V152, P1107	37	10	11	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2015	10	3							e0118585	10.1371/journal.pone.0118585	http://dx.doi.org/10.1371/journal.pone.0118585			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD9NQ	25790222	Green Published, Green Submitted, gold			2022-12-27	WOS:000351425400036
J	Valeri, M; Paccani, SR; Kasendra, M; Nesta, B; Serino, L; Pizza, M; Soriani, M				Valeri, Maria; Paccani, Silvia Rossi; Kasendra, Magdalena; Nesta, Barbara; Serino, Laura; Pizza, Mariagrazia; Soriani, Marco			Pathogenic E-coli Exploits SslE Mucinase Activity to Translocate through the Mucosal Barrier and Get Access to Host Cells	PLOS ONE			English	Article							INTESTINAL EPITHELIAL MONOLAYERS; GEL-FORMING MUCINS; SALMONELLA-TYPHIMURIUM; SHIGELLA-FLEXNERI; BIOFILM FORMATION; GROWTH; SECRETION; MUCUS; EXPRESSION; COLONIZATION	SslE is a zinc-metalloprotease involved in the degradation of mucin substrates and recently proposed as a potential vaccine candidate against pathogenic E. coli. In this paper, by exploiting a human in vitro model of mucus-secreting cells, we demonstrated that bacteria expressing SslE have a metabolic benefit which results in an increased growth rate postulating the importance of this antigen in enhancing E. coli fitness. We also observed that SslE expression facilitates E. coli penetration of the mucus favouring bacteria adhesion to host cells. Moreover, we found that SslE-mediated opening of the mucosae contributed to the activation of pro-inflammatory events. Indeed, intestinal cells infected with SslE-secreting bacteria showed an increased production of IL-8 contributing to neutrophil recruitment. The results presented in this paper conclusively designate SslE as an important colonization factor favouring E. coli access to both metabolic substrates and target cells.	[Valeri, Maria; Paccani, Silvia Rossi; Nesta, Barbara; Serino, Laura; Pizza, Mariagrazia; Soriani, Marco] Novartis Vaccines & Diagnost Srl, Siena, Italy; [Kasendra, Magdalena] Harvard Univ, Sch Med, Childrens Hosp Boston, Boston, MA 02115 USA	Novartis; Harvard University; Boston Children's Hospital; Harvard Medical School	Soriani, M (corresponding author), Novartis Vaccines & Diagnost Srl, Via Fiorentina 1, Siena, Italy.	marco.soriani@novartis.com	Nesta, Barbara/AAL-3753-2020; Kasendra, Magdalena J/L-7259-2016	Kasendra, Magdalena J/0000-0002-6376-2489; SORIANI, Marco/0000-0002-9752-5844	Novartis Vaccines and Diagnostics; Italian "Ministero dell'Istruzione, dell'Universia e della Ricerca" [PON01_00117]; EMIDA ERA-NET "Coordination of European Research on Emerging and Major Infectious Diseases of Livestock" (financed by the European Commission's Seventh Framework Programme) [219235]	Novartis Vaccines and Diagnostics; Italian "Ministero dell'Istruzione, dell'Universia e della Ricerca"; EMIDA ERA-NET "Coordination of European Research on Emerging and Major Infectious Diseases of Livestock" (financed by the European Commission's Seventh Framework Programme)	This work was mainly supported by internal funding from Novartis Vaccines and Diagnostics. However, it was also partly supported by funding under both the grant PON01_00117 from the Italian "Ministero dell'Istruzione, dell'Universia e della Ricerca" and the EMIDA ERA-NET "Coordination of European Research on Emerging and Major Infectious Diseases of Livestock" (financed by the European Commission's Seventh Framework Programme project no. 219235) as part of the project "Combatting colibacillosis-a genomics-based approach." The funder provided support in the form of salaries for authors MV, SRP, BN, LS, MGP, MS, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section. The affiliation to the commercial funder of this research study " Novartis Vaccines and Diagnostics S.r.l." does not alter the authors' adherence to PLOS ONE policies on sharing data and materials.	A Zisakis, 2007, Int J Biomed Sci, V3, P46; ACHTMAN M, 1983, INFECT IMMUN, V39, P315, DOI 10.1128/IAI.39.1.315-335.1983; Alemka A, 2010, INFECT IMMUN, V78, P2812, DOI 10.1128/IAI.01249-09; Baldi DL, 2012, INFECT IMMUN, V80, P2042, DOI 10.1128/IAI.06160-11; Connaris S, 1997, GLYCOCONJUGATE J, V14, P879, DOI 10.1023/A:1018554408558; Deriu E, 2013, CELL HOST MICROBE, V14, P26, DOI 10.1016/j.chom.2013.06.007; Dharmani P, 2009, J INNATE IMMUN, V1, P123, DOI 10.1159/000163037; Dolan B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047300; Gouyer V, 2001, BBA-MOL CELL RES, V1539, P71, DOI 10.1016/S0167-4889(01)00092-1; Grys TE, 2005, INFECT IMMUN, V73, P1295, DOI 10.1128/IAI.73.3.1295-1303.2005; Henderson IR, 1999, INFECT IMMUN, V67, P5587, DOI 10.1128/IAI.67.11.5587-5596.1999; Hernandes RT, 2013, INFECT IMMUN, V81, P3793, DOI 10.1128/IAI.00620-13; HUET C, 1987, J CELL BIOL, V105, P345, DOI 10.1083/jcb.105.1.345; Kaper JB, 2005, INT J MED MICROBIOL, V295, P355, DOI 10.1016/j.ijmm.2005.06.008; Kim M, 2010, CELL HOST MICROBE, V8, P20, DOI 10.1016/j.chom.2010.06.006; LESUFFLEUR T, 1990, CANCER RES, V50, P6334; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Luo QW, 2014, INFECT IMMUN, V82, P509, DOI 10.1128/IAI.01106-13; Madara J L, 1990, Monogr Pathol, P306; MANTLE M, 1993, INFECT IMMUN, V61, P4131, DOI 10.1128/IAI.61.10.4131-4138.1993; MCCORMICK BA, 1988, INFECT IMMUN, V56, P2209, DOI 10.1128/IAI.56.9.2209-2217.1988; MCCORMICK BA, 1993, J CELL BIOL, V123, P895, DOI 10.1083/jcb.123.4.895; McGuckin MA, 2011, NAT REV MICROBIOL, V9, P265, DOI 10.1038/nrmicro2538; Moriel DG, 2010, P NATL ACAD SCI USA, V107, P9072, DOI 10.1073/pnas.0915077107; Nesta B, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004124; Pastorello I, 2013, MBIO, V4, DOI 10.1128/mBio.00206-13; PRIZONT R, 1991, MICROB PATHOGENESIS, V11, P129, DOI 10.1016/0882-4010(91)90006-V; ROBERTON AM, 1982, APPL ENVIRON MICROB, V43, P325, DOI 10.1128/AEM.43.2.325-330.1982; Sansonetti PJ, 2004, NAT REV IMMUNOL, V4, P953, DOI 10.1038/nri1499; Savkovic SD, 1996, INFECT IMMUN, V64, P4480, DOI 10.1128/IAI.64.11.4480-4487.1996; SCHNEIDER DR, 1982, J INFECT DIS, V145, P474, DOI 10.1093/infdis/145.4.474; Silva AJ, 2003, MICROBIOL-SGM, V149, P1883, DOI 10.1099/mic.0.26086-0; Sperandio B, 2013, INFECT IMMUN, V81, P3632, DOI 10.1128/IAI.00551-13; STANLEY RA, 1986, APPL ENVIRON MICROB, V51, P1104, DOI 10.1128/AEM.51.5.1104-1109.1986; Svanborg C, 1999, CURR OPIN MICROBIOL, V2, P99, DOI 10.1016/S1369-5274(99)80017-4; Uehling DT, 1999, WORLD J UROL, V17, P351, DOI 10.1007/s003450050160; Vieira MAM, 2010, INFECT IMMUN, V78, P927, DOI 10.1128/IAI.01115-09; WADOLKOWSKI EA, 1988, INFECT IMMUN, V56, P1030, DOI 10.1128/IAI.56.5.1030-1035.1988	38	39	39	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2015	10	3							e0117486	10.1371/journal.pone.0117486	http://dx.doi.org/10.1371/journal.pone.0117486			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD9NQ	25789808	gold, Green Submitted, Green Published			2022-12-27	WOS:000351425400023
J	van der Made, SM; Plat, J; Mensink, RP				van der Made, Sanne M.; Plat, Jogchum; Mensink, Ronald P.			Resveratrol Does Not Influence Metabolic Risk Markers Related to Cardiovascular Health in Overweight and Slightly Obese Subjects: A Randomized, Placebo-Controlled Crossover Trial	PLOS ONE			English	Article							CORONARY-HEART-DISEASE; APOLIPOPROTEIN-A-I; DENSITY-LIPOPROTEIN CHOLESTEROL; HDL CHOLESTEROL; CLINICAL-TRIAL; SUPPLEMENTATION; ATHEROSCLEROSIS; ALPHA; CONSUMPTION; PREVENTION	Background In vitro and animal studies have shown positive effects of resveratrol on lipid and lipoprotein metabolism, but human studies specifically designed to examine these effects are lacking. Objective The primary outcome parameter of this study in overweight and slightly obese subjects was the effect of resveratrol on apoA-I concentrations. Secondary outcome parameters were effects on other markers of lipid and lipoprotein metabolism, glucose metabolism, and markers for inflammation and endothelial function. Design This randomized, placebo-controlled crossover study was conducted in 45 overweight and slightly obese men (n = 25) and women (n = 20) with a mean age of 61 +/- 7 years. Subjects received in random order resveratrol (150 mg per day) or placebo capsules for 4 weeks, separated by a 4-week wash-out period. Fasting blood samples were collected at baseline and at the end of each intervention period. Results Compliance was excellent as indicated by capsule count and changes in resveratrol and dihydroresveratrol concentrations. No difference between resveratrol and placebo was found in any of the fasting serum or plasma metabolic risk markers (mean +/- SD for differences between day 28 values of resveratrol vs. placebo: apoA-I; 0.00 +/- 0.12 g/L (P = 0.791), apoB100; -0.01 +/- 0.11 g/L (P = 0.545), HDL cholesterol; 0.00 +/- 0.09 mmol/L P = 0.721), LDL cholesterol -0.03 +/- 0.57 mmol/L (P = 0.718), triacylglycerol; 0.10 +/- 0.54 mmol/L (P = 0.687), glucose; -0.08 +/- 0.28 mmol/L (P = 0.064), insulin; -0.3 +/- 2.5 mU/L (P = 0.516)). Also, no effects on plasma markers for inflammation and endothelial function were observed. No adverse events related to resveratrol intake were observed. Conclusion 150 mg of daily resveratrol intake for 4 weeks does not change metabolic risk markers related to cardiovascular health in overweight and slightly obese men and women. Effects on glucose metabolism warrant further study.	[van der Made, Sanne M.; Plat, Jogchum; Mensink, Ronald P.] Maastricht Univ, Med Ctr, Dept Human Biol, NUTRIM Sch Nutr, NL-6200 MD Maastricht, Netherlands; [van der Made, Sanne M.; Mensink, Ronald P.] Top Inst Food & Nutr, Wageningen, Netherlands	Maastricht University; Top Institute Food & Nutrition	Mensink, RP (corresponding author), Maastricht Univ, Med Ctr, Dept Human Biol, NUTRIM Sch Nutr, NL-6200 MD Maastricht, Netherlands.	r.mensink@maastrichtuniversity.nl			TI Food and Nutrition, a public-private partnership on precompetitive research in food and nutrition	TI Food and Nutrition, a public-private partnership on precompetitive research in food and nutrition	The project is funded by TI Food and Nutrition, a public-private partnership on precompetitive research in food and nutrition. The public partners are responsible for the study design, data collection and analysis, decision to publish, and preparation of the manuscript. Trans-resveratrol capsules were provided by DSM Nutritional Products Ltd. (Kaiseraugst, Switzerland).	Agarwal B, 2013, INT J CARDIOL, V166, P246, DOI 10.1016/j.ijcard.2012.09.027; Assmann G, 1996, ATHEROSCLEROSIS, V124, pS11, DOI 10.1016/0021-9150(96)05852-2; Barter PJ, 2007, NEW ENGL J MED, V357, P2109, DOI 10.1056/NEJMoa0706628; Bhatt JK, 2012, NUTR RES, V32, P537, DOI 10.1016/j.nutres.2012.06.003; Bode LM, 2013, AM J CLIN NUTR, V97, P295, DOI 10.3945/ajcn.112.049379; Boden WE, 2011, NEW ENGL J MED, V365, P2255, DOI 10.1056/NEJMoa1107579; Boekholdt SM, 2013, CIRCULATION, V128, P1504, DOI 10.1161/CIRCULATIONAHA.113.002670; Brasnyo P, 2011, BRIT J NUTR, V106, P383, DOI 10.1017/S0007114511000316; CASTELLI WP, 1986, JAMA-J AM MED ASSOC, V256, P2835, DOI 10.1001/jama.256.20.2835; Csiszar A, 2006, AM J PHYSIOL-HEART C, V291, pH1694, DOI 10.1152/ajpheart.00340.2006; Dash S, 2013, ARTERIOSCL THROM VAS, V33, P2895, DOI 10.1161/ATVBAHA.113.302342; Erlund I, 2008, AM J CLIN NUTR, V87, P323, DOI 10.1093/ajcn/87.2.323; Fan EG, 2008, J MED FOOD, V11, P610, DOI 10.1089/jmf.2007.0091; FRIEDEWALD WT, 1972, CLIN CHEM, V18, P499; GORDON T, 1977, AM J MED, V62, P707, DOI 10.1016/0002-9343(77)90874-9; Hansen HC, 2010, EUR J MED CHEM, V45, P2018, DOI 10.1016/j.ejmech.2009.12.076; HERTOG MGL, 1993, LANCET, V342, P1007, DOI 10.1016/0140-6736(93)92876-U; Hovingh GK, 2010, CURR OPIN LIPIDOL, V21, P481, DOI 10.1097/MOL.0b013e3283404507; Iannelli P, 2007, NUTR METAB CARDIOVAS, V17, P247, DOI 10.1016/j.numecd.2005.12.011; Inoue H, 2003, NEUROSCI LETT, V352, P203, DOI 10.1016/j.neulet.2003.09.001; Manach C, 2005, CURR OPIN LIPIDOL, V16, P77, DOI 10.1097/00041433-200502000-00013; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; Nicholls Stephen J, 2011, Curr Cardiol Rep, V13, P537, DOI 10.1007/s11886-011-0223-0; Poulsen MM, 2013, DIABETES, V62, P1186, DOI 10.2337/db12-0975; Sacanella E, 2007, AM J CLIN NUTR, V86, P1463, DOI 10.1093/ajcn/86.5.1463; Sahebkar A, 2013, NUTR REV; Schwartz GG, 2012, NEW ENGL J MED, V367, P2089, DOI 10.1056/NEJMoa1206797; Sharrett AR, 2001, CIRCULATION, V104, P1108, DOI 10.1161/hc3501.095214; Timmers S, 2011, CELL METAB, V14, P612, DOI 10.1016/j.cmet.2011.10.002; Wong RHX, 2013, J HYPERTENS, V31, P1819, DOI 10.1097/HJH.0b013e328362b9d6; Yoshino J, 2012, CELL METAB, V16, P658, DOI 10.1016/j.cmet.2012.09.015	31	87	87	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2015	10	3							e0118393	10.1371/journal.pone.0118393	http://dx.doi.org/10.1371/journal.pone.0118393			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD9NQ	25790328	Green Published, gold, Green Submitted			2022-12-27	WOS:000351425400028
J	Byeon, H; Hong, S				Byeon, Haewon; Hong, Saemi			Relationship between Television Viewing and Language Delay in Toddlers: Evidence from a Korea National Cross-Sectional Survey	PLOS ONE			English	Article							CHILDREN; INFANTS; EXPOSURE; SPEECH	Purpose This study investigated the relationship between 2-year-old children's exposure to TV and language delay. Methods The subjects of this study were 1,778 toddlers (906 males and 872 females) who participated in the Panel Study on Korean Children conducted in 2010. The linguistic ability of the toddlers was measured with the K-ASQ (Korean-Ages and Stages Questionnaire). The relationship between the amount of young children's exposure to TV and language delay was analyzed with Poisson regression. Results The average daily TV watching time of 2-year-old Korean toddlers in this study was 1.21 hours. After all confounding variables were adjusted, toddlers with over 2 hours and less than 3 hours of TV watching time had 2.7 times more risk (RR = 2.74, 95% CI: 1.13-6.65) of language delay than those with less than 1 hour of TV watching time. Those with more than 3 hours of TV watching time had approximately 3 times (RR = 3.03, 95% CI: 1.12-8.21) more risk (p<0.05). In addition, the risk of language delay increased proportionately with the increase in toddlers' TV watching time (p = 0.004). Conclusion Two-year-old Korean toddlers' average daily TV watching time of more than 2 hours was related with language delay.	[Byeon, Haewon] Nambu Univ, Dept Speech Language Pathol & Audiol, Gwangju, South Korea; [Byeon, Haewon] Nambu Univ, Speech Language Pathol Ctr, Gwangju, South Korea; [Hong, Saemi] Asan Med Ctr, Dept Rehabil Med, Seoul, South Korea	Nambu University; Nambu University; University of Ulsan; Asan Medical Center	Byeon, H (corresponding author), Nambu Univ, Sch Publ Hlth, Dept Speech Language Pathol & Audiol, Cheomdanro 23, Gwangju, South Korea.	byeon@nambu.ac.kr	Byeon, Haewon/R-2113-2019	Byeon, Haewon/0000-0002-3363-390X				Bar-on ME, 2001, PEDIATRICS, V107, P423, DOI 10.1542/peds.107.2.423; Barr R, 2010, MERRILL PALMER QUART, V56, P21; Berk, 2012, CHILD DEV; Brown A, 2011, PEDIATRICS, V128, P1040, DOI 10.1542/peds.2011-1753; Chonchaiya W, 2008, ACTA PAEDIATR, V97, P977, DOI 10.1111/j.1651-2227.2008.00831.x; Christakis DA, 2004, PEDIATRICS, V113, P708, DOI 10.1542/peds.113.4.708; Christakis DA, 2009, ARCH PEDIAT ADOL MED, V163, P554, DOI 10.1001/archpediatrics.2009.61; Common Sense Media, ZER 8 CHILDR MED US; Garrison M., 2005, TEACHER LIVING ROOM; Heo KH, 2006, KASQ KOREAN AGES STA; Hoff E., 2013, LANGUAGE DEV; International Telecommunication Union, WORLD TEL ICT IND DA; Jordan AB, 2006, PEDIATRICS, V118, pE1303, DOI 10.1542/peds.2006-0732; Kelly DP, 1999, DEV BEHAV PEDIAT; Korea Centers for Disease Control and Prevention, 2007, 2007 CHILDR AS PHYS; Korea Information Society Development Institute, 2013, BROADC MED SURV 2013; Korea Institute of Child Care and Education, 2012, PAN STUD KOR CHILDR; Korean Women's Development Institute, 2014, GENDER REV, V34, P34; Krcmar M, 2007, MEDIA PSYCHOL, V10, P41; Linebarger DL, 2010, DEV REV, V30, P176, DOI 10.1016/j.dr.2010.03.006; Linebarger DL, 2005, AM BEHAV SCI, V48, P624, DOI 10.1177/0002764204271505; Pempek TA, 2014, J CHILD MEDIA, V8, P211, DOI 10.1080/17482798.2014.920715; Schmidt ME, 2009, PEDIATRICS, V123, pe370, DOI 10.1542/peds.2008-3221; Schmitt KL, 2003, J COMMUN, V53, P265, DOI 10.1111/j.1460-2466.2003.tb02590.x; Squires J., 1999, AGES STAGES QUESTION; Strasburger VC, 2010, PEDIATRICS, V126, P1012, DOI 10.1542/peds.2010-1636; Takeuchi H, 2013, CEREB CORTEX; Tanimura M, 2007, ARCH PEDIAT ADOL MED, V161, P618, DOI 10.1001/archpedi.161.6.618-b; Thakkar RR, 2006, PEDIATRICS, V118, P2025, DOI 10.1542/peds.2006-1307; Wartella, 2003, ZERO 6 ELECT MEDIA L; Wartella E, 2007, J CHILD MEDIA, V1, P35, DOI 10.1080/17482790601005207; Werker JF, 2002, INFANCY, V3, P1, DOI 10.1207/S15327078IN0301_1; Zimmerman FJ, 2005, ARCH PEDIAT ADOL MED, V159, P619, DOI 10.1001/archpedi.159.7.619; Zimmerman FJ, 2007, J PEDIATR-US, V151, P364, DOI 10.1016/j.jpeds.2007.04.071; Zimmerman FJ, 2009, PEDIATRICS, V124, P342, DOI 10.1542/peds.2008-2267	35	49	54	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2015	10	3							e0120663	10.1371/journal.pone.0120663	http://dx.doi.org/10.1371/journal.pone.0120663			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CE9BN	25785449	Green Published, Green Submitted, gold			2022-12-27	WOS:000352138500186
J	Ge, HA; Zhang, Q; Sun, YQ; Li, J; Sun, L; Cheng, B				Ge, Heng'an; Zhang, Qiang; Sun, Yeqing; Li, Jie; Sun, Lin; Cheng, Biao			Tenotomy or Tenodesis for the Long Head of Biceps Lesions in Shoulders: A Systematic Review and Meta-Analysis	PLOS ONE			English	Article							ROTATOR CUFF TEARS; TENDON; BRACHII; ANTERIOR; MUSCLE; PATHOLOGY; INJURIES; QUALITY; LABRUM; REPAIR	Background Both tenotomy and tenodesis have been widely used for the treatment of long head of biceps tendon (LHBT) lesions, but the optimal strategy remains considerably controversial. In this meta-analysis of published studies, we compared the results of the two procedures. Methods A literature search that compared tenotomy with tenodesis was performed using MEDLINE, and Embase until August 2014. A total of 7 studies reporting data on 622 subjects were included. Study quality was evaluated using the PEDro critical appraisal tool and the NO quality assessment tool. Results Data synthesis showed higher functional outcomes, a lower complication rate, and longer surgical time in patients managed with tenodesis compared to tenotomy (Constant score, P = 0.02; Popeye sign, P < 0.001; cramp pain, P = 0.04; surgical time, P < 0.001, respectively). Conclusion This meta-analysis indicates that tenodesis results in better arm function and lower incidences of cramp pain and Popeye sign in LHBT lesions, while the procedure required longer surgical time compared to tenotomy. More sufficiently powered studies would be required to further determine the optimal strategy.	[Ge, Heng'an; Sun, Yeqing; Li, Jie; Sun, Lin; Cheng, Biao] Tongji Univ, Sch Med, Shanghai Peoples Hosp 10, Dept Orthoped, Shanghai 200092, Peoples R China; [Zhang, Qiang] Nanjing Med Univ, Changzhou Peoples Hosp 2, Dept Orthoped, Changzhou, Peoples R China	Tongji University; Nanjing Medical University	Cheng, B (corresponding author), Tongji Univ, Sch Med, Shanghai Peoples Hosp 10, Dept Orthoped, Shanghai 200092, Peoples R China.	sybiaoc@163.com						Ahmad CS, 2007, ARTHROSCOPY, V23, P537, DOI 10.1016/j.arthro.2006.12.030; Ahrens PM, 2007, J BONE JOINT SURG BR, V89B, P1001, DOI 10.1302/0301-620X.89B8; Barber F Alan, 2008, Instr Course Lect, V57, P527; Berlemann U, 1995, J Shoulder Elbow Surg, V4, P429, DOI 10.1016/S1058-2746(05)80034-5; Boileau P, 2002, ARTHROSCOPY, V18, P1002, DOI 10.1053/jars.2002.36488; Boileau P, 2007, J BONE JOINT SURG AM, V89A, P747, DOI 10.2106/JBJS.E.01097; Checchia SL, 2005, J SHOULDER ELB SURG, V14, P138, DOI 10.1016/j.jse.2004.07.013; Cho NS, 2014, AM J SPORT MED, V42, P1161, DOI 10.1177/0363546514523719; De Carli A, 2012, KNEE SURG SPORT TR A, V20, P2553, DOI 10.1007/s00167-012-1918-5; Delle Rose Giacomo, 2012, Musculoskelet Surg, V96 Suppl 1, pS47, DOI 10.1007/s12306-012-0189-0; Desmarais S, 2008, MOL PHARMACOL, V73, P147, DOI 10.1124/mol.107.039511; Edwards T Bradley, 2006, J Bone Joint Surg Am, V88 Suppl 1 Pt 1, P1, DOI 10.2106/JBJS.E.00842; Elkousy HA, 2005, ORTHOPEDICS, V28, P1316; Elser F, 2011, ARTHROSCOPY, V27, P581, DOI 10.1016/j.arthro.2010.10.014; Franceschi F, 2008, AM J SPORT MED, V36, P247, DOI 10.1177/0363546507308194; Franceschi F, 2007, INT ORTHOP, V31, P537, DOI 10.1007/s00264-006-0206-8; Frost A, 2009, AM J SPORT MED, V37, P828, DOI 10.1177/0363546508322179; Gill TJ, 2001, J SHOULDER ELB SURG, V10, P247, DOI 10.1067/mse.2001.114259; Hsu AR, 2011, J SHOULDER ELB SURG, V20, P326, DOI 10.1016/j.jse.2010.08.019; ITOI E, 1993, J BONE JOINT SURG BR, V75, P546, DOI 10.1302/0301-620X.75B4.8331107; Kelly AM, 2005, AM J SPORT MED, V33, P208, DOI 10.1177/0363546504269555; Kim SH, 2001, ARTHROSCOPY, V17, P864, DOI 10.1053/jars.2001.19980; Klepps S, 2002, ARTHROSCOPY, V18, P1040, DOI 10.1053/jars.2002.36467; Koh KH, 2010, AM J SPORT MED, V38, P1584, DOI 10.1177/0363546510364053; Maher CG, 2003, PHYS THER, V83, P713, DOI 10.1093/ptj/83.8.713; Miller T, 2011, INT J SHOULDER SURG, V5, P68, DOI 10.4103/0973-6042.86236; Nassos Jonathan T, 2009, Am J Orthop (Belle Mead NJ), V38, P279; Osbahr DC, 2002, ARTHROSCOPY, V18, P483, DOI 10.1053/jars.2002.32233; Randelli P, 2012, KNEE SURG SPORT TR A, V20, P803, DOI 10.1007/s00167-011-1673-z; Redondo-Alonso L, 2014, BMC MUSCULOSKEL DIS, V15, DOI 10.1186/1471-2474-15-377; RODOSKY MW, 1994, AM J SPORT MED, V22, P121, DOI 10.1177/036354659402200119; Sethi N, 1999, J SHOULDER ELB SURG, V8, P644, DOI 10.1016/S1058-2746(99)90105-2; Slenker NR, 2012, ARTHROSCOPY, V28, P576, DOI 10.1016/j.arthro.2011.10.017; Stang A, 2010, EUR J EPIDEMIOL, V25, P603, DOI 10.1007/s10654-010-9491-z; Su WR, 2010, ARTHROSCOPY, V26, P578, DOI 10.1016/j.arthro.2009.09.007; Walch G, 2005, J SHOULDER ELB SURG, V14, P238, DOI 10.1016/j.jse.2004.07.008; Yamaguchi K, 1997, CLIN ORTHOP RELAT R, P122; Zhang Q., 2013, KNEE SURG SPORTS TRA	38	39	43	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2015	10	3							e0121286	10.1371/journal.pone.0121286	http://dx.doi.org/10.1371/journal.pone.0121286			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9BN	25786125	Green Published, gold, Green Submitted			2022-12-27	WOS:000352138500207
J	Li, WQ; Wang, FQ; Wang, J; Fan, FJ; Zhu, JY; Yang, J; Liu, FQ; Zhong, WG				Li, Wenqi; Wang, Fangquan; Wang, Jun; Fan, Fangjun; Zhu, Jinyan; Yang, Jie; Liu, Fengquan; Zhong, Weigong			Overexpressing CYP71Z2 Enhances Resistance to Bacterial Blight by Suppressing Auxin Biosynthesis in Rice	PLOS ONE			English	Article							GLUCOSINOLATE BIOSYNTHESIS; DISEASE RESISTANCE; CYTOCHROME-P450 MONOOXYGENASE; CONSTITUTIVE EXPRESSION; CAMALEXIN BIOSYNTHESIS; SIGNALING PATHWAY; RESPONSE PATHWAY; ARABIDOPSIS; PATHOGEN; GROWTH	Background The hormone auxin plays an important role not only in the growth and development of rice, but also in its defense responses. We've previously shown that the P450 gene CYP71Z2 enhances disease resistance to pathogens through regulation of phytoalexin biosynthesis in rice, though it remains unclear if auxin is involved in this process or not. Methodology and Principal Findings The expression of CYP71Z2 was induced by Xanthomonas oryzae pv. oryzae (Xoo) inoculation was analyzed by qRT-PCR, with GUS histochemical staining showing that CYP71Z2 expression was limited to roots, blades and nodes. Overexpression of CYP71Z2 in rice durably and stably increased resistance to Xoo, though no significant difference in disease resistance was detected between CYP71Z2-RNA interference (RNAi) rice and wild-type. Moreover, IAA concentration was determined using the HPLC/electrospray ionization/tandem mass spectrometry system. The accumulation of IAA was significantly reduced in CYP71Z2-overexpressing rice regardless of whether plants were inoculated or not, whereas it was unaffected in CYP71Z2-RNAi rice. Furthermore, the expression of genes related to IAA, expansin and SA/JA signaling pathways was suppressed in CYP71Z2-overexpressing rice with or without inoculation. Conclusions and Significance These results suggest that CYP71Z2-mediated resistance to Xoo may be via suppression of IAA signaling in rice. Our studies also provide comprehensive insight into molecular mechanism of resistance to Xoo mediated by IAA in rice. Moreover, an available approach for understanding the P450 gene functions in interaction between rice and pathogens has been provided.	[Li, Wenqi; Wang, Fangquan; Wang, Jun; Fan, Fangjun; Zhu, Jinyan; Yang, Jie; Zhong, Weigong] Jiangsu Acad Agr Sci, Inst Food Crops, Nanjing Branch, Chinese Natl Ctr Rice Improvement,Jiangsu High Qu, Nanjing 210014, Peoples R China; [Liu, Fengquan] Jiangsu Acad Agr Sci, Inst Plant Protect, Nanjing 210014, Peoples R China	Jiangsu Academy of Agricultural Sciences; Jiangsu Academy of Agricultural Sciences	Yang, J (corresponding author), Jiangsu Acad Agr Sci, Inst Food Crops, Nanjing Branch, Chinese Natl Ctr Rice Improvement,Jiangsu High Qu, Nanjing 210014, Peoples R China.	yangjie168@aliyun.com; fqliu20011@sina.com	fan, fang/GQY-9173-2022; Fan, Fang/GRO-2696-2022		National Natural Science Foundation of China [31301652]; Key Projects in the National Science & Technology Pillar Program [2011BAD16B03]; Natural Science Foundation of Jiangsu Province of China [BK20130723]; Jiangsu Province Independent Innovation Project [CX(14)5003]; Special Fund for Agro-scientific Research in the Public Interest [201303102]; special fund of Jiangsu Province for the Transformation of Scientific and Technological Achievements [BAAA2014134]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Key Projects in the National Science & Technology Pillar Program; Natural Science Foundation of Jiangsu Province of China(Natural Science Foundation of Jiangsu Province); Jiangsu Province Independent Innovation Project; Special Fund for Agro-scientific Research in the Public Interest; special fund of Jiangsu Province for the Transformation of Scientific and Technological Achievements	This work was supported by the National Natural Science Foundation of China (31301652), the Key Projects in the National Science & Technology Pillar Program (2011BAD16B03), the Natural Science Foundation of Jiangsu Province of China (BK20130723) and the Jiangsu Province Independent Innovation Project no. CX(14)5003.), the Special Fund for Agro-scientific Research in the Public Interest (201303102), the special fund of Jiangsu Province for the Transformation of Scientific and Technological Achievements (BAAA2014134). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abu-Zaitoon YM, 2012, PHYSIOL PLANTARUM, V146, P487, DOI 10.1111/j.1399-3054.2012.01649.x; Bak S, 2001, PLANT CELL, V13, P101, DOI 10.1105/tpc.13.1.101; Bak S, 2001, PLANT PHYSIOL, V127, P108, DOI 10.1104/pp.127.1.108; Barlier I, 2000, P NATL ACAD SCI USA, V97, P14819, DOI 10.1073/pnas.260502697; Block A, 2011, CURR OPIN MICROBIOL, V14, P39, DOI 10.1016/j.mib.2010.12.011; Chen ZY, 2007, P NATL ACAD SCI USA, V104, P20131, DOI 10.1073/pnas.0704901104; COSGROVE DJ, 1993, NEW PHYTOL, V124, P1, DOI 10.1111/j.1469-8137.1993.tb03795.x; Ding XH, 2008, PLANT CELL, V20, P228, DOI 10.1105/tpc.107.055657; Domingo C, 2009, MOL PLANT MICROBE IN, V22, P201, DOI 10.1094/MPMI-22-2-0201; Durrant WE, 2004, ANNU REV PHYTOPATHOL, V42, P185, DOI 10.1146/annurev.phyto.42.040803.140421; Eshraghi L, 2014, BMC PLANT BIOL, V14, DOI 10.1186/1471-2229-14-68; FETT WF, 1987, APPL ENVIRON MICROB, V53, P1839, DOI 10.1128/AEM.53.8.1839-1845.1987; Fu J, 2011, FRONT PLANT SCI, V2, DOI 10.3389/fpls.2011.00074; Fu J, 2011, PLANT PHYSIOL, V155, P589, DOI 10.1104/pp.110.163774; Glawischnig E, 2004, P NATL ACAD SCI USA, V101, P8245, DOI 10.1073/pnas.0305876101; Hull AK, 2000, P NATL ACAD SCI USA, V97, P2379, DOI 10.1073/pnas.040569997; Jain Mukesh, 2006, Functional & Integrative Genomics, V6, P47, DOI 10.1007/s10142-005-0005-0; Jones JDG, 2006, NATURE, V444, P323, DOI 10.1038/nature05286; Kazan K, 2009, TRENDS PLANT SCI, V14, P373, DOI 10.1016/j.tplants.2009.04.005; KESSMANN H, 1994, ANNU REV PHYTOPATHOL, V32, P439, DOI 10.1146/annurev.py.32.090194.002255; Khalid A, 2004, AUST J SOIL RES, V42, P921, DOI 10.1071/SR04019; Li H, 2010, PLANT CELL, V22, P173, DOI 10.1105/tpc.109.070326; Li WQ, 2013, PLANT SCI, V207, P98, DOI 10.1016/j.plantsci.2013.02.005; Ljung K, 2013, DEVELOPMENT, V140, P43, DOI [10.1242/dev.085290, DOI 10.1242/DEV.085290]; Llorente F, 2008, MOL PLANT, V1, P496, DOI 10.1093/mp/ssn025; Mano Y, 2012, J EXP BOT, V63, P2853, DOI 10.1093/jxb/ers091; Mashiguchi K, 2011, P NATL ACAD SCI USA, V108, P18512, DOI 10.1073/pnas.1108434108; McSteen P, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a001479; Mikkelsen MD, 2000, J BIOL CHEM, V275, P33712, DOI 10.1074/jbc.M001667200; Mikkelsen MD, 2004, PLANT J, V37, P770, DOI 10.1111/j.1365-313X.2004.02002.x; Nafisi M, 2007, PLANT CELL, V19, P2039, DOI 10.1105/tpc.107.051383; Navarro L, 2006, SCIENCE, V312, P436, DOI 10.1126/science.1126088; Nelson DR, 2004, PLANT PHYSIOL, V135, P756, DOI 10.1104/pp.104.039826; Novak O, 2012, PLANT J, V72, P523, DOI 10.1111/j.1365-313X.2012.05085.x; Patten CL, 1996, CAN J MICROBIOL, V42, P207, DOI 10.1139/m96-032; Rupasinghe Sanjeewa, 2006, Phytochemistry Reviews, V5, P473, DOI 10.1007/s11101-006-9028-y; Schuhegger R, 2007, J PLANT PHYSIOL, V164, P636, DOI 10.1016/j.jplph.2006.04.012; Schuler MA, 2003, ANNU REV PLANT BIOL, V54, P629, DOI 10.1146/annurev.arplant.54.031902.134840; Song YL, 2009, PLANT MOL BIOL, V70, P297, DOI 10.1007/s11103-009-9474-1; Spaepen S, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a001438; Spoel SH, 2008, CELL HOST MICROBE, V3, P348, DOI 10.1016/j.chom.2008.05.009; Sugawara S, 2009, P NATL ACAD SCI USA, V106, P5430, DOI 10.1073/pnas.0811226106; Teale WD, 2006, NAT REV MOL CELL BIO, V7, P847, DOI 10.1038/nrm2020; Wang D, 2007, CURR BIOL, V17, P1784, DOI 10.1016/j.cub.2007.09.025; Wang MY, 2012, J INTEGR PLANT BIOL, V54, P471, DOI 10.1111/j.1744-7909.2012.01131.x; Wittstock U, 2002, TRENDS PLANT SCI, V7, P263, DOI 10.1016/S1360-1385(02)02273-2; Woodward AW, 2005, ANN BOT-LONDON, V95, P707, DOI 10.1093/aob/mci083; Yamamoto Y, 2007, PLANT PHYSIOL, V143, P1362, DOI 10.1104/pp.106.091561; Yang DL, 2013, MOL PLANT, V6, P675, DOI 10.1093/mp/sst056; Zhang J, 2008, CELL RES, V18, P508, DOI 10.1038/cr.2007.104; Zhao YD, 2002, GENE DEV, V16, P3100, DOI 10.1101/gad.1035402; Zhu YY, 2000, NATURE, V406, P718, DOI 10.1038/35021046; Zhu YY, 2006, PLANT CELL, V18, P442, DOI 10.1105/tpc.105.038455; Zipfel C, 2009, CURR OPIN PLANT BIOL, V12, P414, DOI 10.1016/j.pbi.2009.06.003	54	21	24	6	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2015	10	3							e0119867	10.1371/journal.pone.0119867	http://dx.doi.org/10.1371/journal.pone.0119867			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9BN	25786239	gold, Green Published, Green Submitted			2022-12-27	WOS:000352138500137
J	Matsuba, Y; Zi, JC; Jones, AD; Peters, RJ; Pichersky, E				Matsuba, Yuki; Zi, Jiachen; Jones, A. Daniel; Peters, Reuben J.; Pichersky, Eran			Biosynthesis of the Diterpenoid Lycosantalonol via Nerylneryl Diphosphate in Solanum lycopersicum	PLOS ONE			English	Article							TERPENE SYNTHASES; GLANDULAR TRICHOMES; EVOLUTION; GENES; TOMATO; VECTORS; CYTOCHROME-P450; METABOLISM; EXPRESSION; DIVERSITY	We recently reported that three genes involved in the biosynthesis of monoterpenes in trichomes, a cis-prenyltransferase named neryl diphosphate synthase 1 (NDPS1) and two terpene synthases (TPS19 and TPS20), are present in close proximity to each other at the tip of chromosome 8 in the genome of the cultivated tomato (Solanum lycopersicum). This terpene gene "cluster" also contains a second cis-prenyltransferase gene (CPT2), three other TPS genes, including TPS21, and the cytochrome P450-oxidoreductase gene CYP71BN1. CPT2 encodes a neryneryl diphosphate synthase. Co-expression in E. coli of CPT2 and TPS21 led to the formation of the diterpene lycosantalene, and co-expression in E. coli of CPT2, TPS21 and CYP71BN1 led to the formation of lycosantalonol, an oxidation product of lycosantalene. Here we show that maximal expression of all three genes occurs in the petiolule part of the leaf, but little expression of these genes occurs in the trichomes present on the petiolules. While lycosantalene or lycosantalonol cannot be detected in the petiolules of wild-type plants (or anywhere else in the plant), lycosantalene and lycosantalonol are detected in petiolules of transgenic tomato plants expressing CPT2 under the control of the 35S CaMV promoter. These results suggest that lycosantalene and lycosantalonol are produced in the petiolules and perhaps in other tissues of wild-type plants, but that low rate of synthesis, controlled by the rate-limiting enzyme CPT2, results in product levels that are too low for detection under our current methodology. It is also possible that these compounds are further modified in the plant. The involvement of CPT2, TPS21 and CYP71BN1 in a diterpenoid biosynthetic pathway outside the trichomes, together with the involvement of other genes in the cluster in the synthesis of monoterpenes in trichomes, indicates that this cluster is further evolving into "sub-clusters" with unique biochemical, and likely physiological, roles.	[Matsuba, Yuki; Pichersky, Eran] Univ Michigan, Dept Mol Cellular & Dev Biol, Ann Arbor, MI 48109 USA; [Zi, Jiachen; Peters, Reuben J.] Iowa State Univ, Dept Biochem Biophys & Mol Biol, Ames, IA USA; [Jones, A. Daniel] Michigan State Univ, Dept Biochem, E Lansing, MI 48824 USA	University of Michigan System; University of Michigan; Iowa State University; Michigan State University	Pichersky, E (corresponding author), Univ Michigan, Dept Mol Cellular & Dev Biol, Ann Arbor, MI 48109 USA.	lelx@umich.edu	Jones, Arthur D/C-2670-2013; Peters, Reuben J./D-1196-2010	Peters, Reuben J./0000-0003-4691-8477; Jones, A. Daniel/0000-0002-7408-6690	National Science Foundation [IOS-1025636]; National Institutes of Health [GM076324]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM076324] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This research was supported by grants from National Science Foundation to EP (IOS-1025636, http://www.nsf.gov/) and National Institutes of Health to RJP (GM076324, http://www.nih.gov/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akhtar TA, 2013, PLANT J, V73, P640, DOI 10.1111/tpj.12063; Chen F, 2011, PLANT J, V66, P212, DOI 10.1111/j.1365-313X.2011.04520.x; Dicke M, 2010, TRENDS PLANT SCI, V15, P167, DOI 10.1016/j.tplants.2009.12.002; Dudareva N, 2000, PLANT PHYSIOL, V122, P627, DOI 10.1104/pp.122.3.627; Dudareva N, 2013, NEW PHYTOL, V198, P16, DOI 10.1111/nph.12145; Falara V, 2014, PLANT PHYSIOL, V166, P428, DOI 10.1104/pp.114.243246; Foster TM, 2002, PLANT CELL, V14, P1497, DOI 10.1105/tpc.001685; Frey M, 2003, PHYTOCHEMISTRY, V62, P371, DOI 10.1016/S0031-9422(02)00556-3; Frey M, 2009, PHYTOCHEMISTRY, V70, P1645, DOI 10.1016/j.phytochem.2009.05.012; Gershenzon J, 2007, NAT CHEM BIOL, V3, P408, DOI 10.1038/nchembio.2007.5; Goderis IJWM, 2002, PLANT MOL BIOL, V50, P17, DOI 10.1023/A:1016052416053; Gonzales-Vigil E, 2012, PLANT J, V71, P921, DOI 10.1111/j.1365-313X.2012.05040.x; HAJDUKIEWICZ P, 1994, PLANT MOL BIOL, V25, P989, DOI 10.1007/BF00014672; Hamberger B, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2012.0426; Inagaki YS, 2011, NEW PHYTOL, V191, P432, DOI 10.1111/j.1469-8137.2011.03712.x; Jonczyk R, 2008, PLANT PHYSIOL, V146, P1053, DOI 10.1104/pp.107.111237; Kang JH, 2014, PLANT PHYSIOL, V164, P80, DOI 10.1104/pp.113.230466; Matsuba Y, 2013, PLANT CELL, V25, P2022, DOI 10.1105/tpc.113.111013; Michelmore RW, 1998, GENOME RES, V8, P1113, DOI 10.1101/gr.8.11.1113; Nelson D, 2011, PLANT J, V66, P194, DOI 10.1111/j.1365-313X.2011.04529.x; Nguyen DT, 2010, J BIOL CHEM, V285, P16588, DOI 10.1074/jbc.M110.111757; Nomura T, 2003, PLANTA, V217, P776, DOI 10.1007/s00425-003-1040-5; Nomura T, 2002, MOL GENET GENOMICS, V267, P210, DOI 10.1007/s00438-002-0653-x; Nutzmann HW, 2014, CURR OPIN BIOTECH, V26, P91, DOI 10.1016/j.copbio.2013.10.009; Pichersky E, 2011, ANNU REV PLANT BIOL, V62, P549, DOI 10.1146/annurev-arplant-042110-103814; Qi X, 2004, P NATL ACAD SCI USA, V101, P8233, DOI 10.1073/pnas.0401301101; Ro DK, 2006, NATURE, V440, P940, DOI 10.1038/nature04640; Sallaud C, 2012, PLANT J, V72, P1, DOI 10.1111/j.1365-313X.2012.05068.x; Sallaud C, 2009, PLANT CELL, V21, P301, DOI 10.1105/tpc.107.057885; Sasaki N, 2015, PLANT CELL PHYSIOL, V56, P28, DOI 10.1093/pcp/pcu097; Schilmiller AL, 2009, P NATL ACAD SCI USA, V106, P10865, DOI 10.1073/pnas.0904113106; Swiezewska E, 2005, PROG LIPID RES, V44, P235, DOI 10.1016/j.plipres.2005.05.002; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Teoh KH, 2006, FEBS LETT, V580, P1411, DOI 10.1016/j.febslet.2006.01.065; Thulasiram HV, 2007, SCIENCE, V316, P73, DOI 10.1126/science.1137786; Tzfira T, 2005, PLANT MOL BIOL, V57, P503, DOI 10.1007/s11103-005-0340-5; Vickers CE, 2009, NAT CHEM BIOL, V5, P283, DOI 10.1038/nchembio.158; von Rad U, 2001, PLANT J, V28, P633, DOI 10.1046/j.1365-313x.2001.01161.x; Wilderman PR, 2004, PLANT PHYSIOL, V135, P2098, DOI 10.1104/pp.104.045971; Zi JC, 2014, J AM CHEM SOC, V136, P16951, DOI 10.1021/ja508477e	40	33	37	0	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2015	10	3							e0119302	10.1371/journal.pone.0119302	http://dx.doi.org/10.1371/journal.pone.0119302			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9BN	25786135	Green Submitted, gold, Green Published			2022-12-27	WOS:000352138500095
J	Roberts, ET; Horne, A; Martin, SS; Blaha, MJ; Blankstein, R; Budoff, MJ; Sibley, C; Polak, JF; Frick, KD; Blumenthal, RS; Nasir, K				Roberts, Eric T.; Horne, Aaron; Martin, Seth S.; Blaha, Michael J.; Blankstein, Ron; Budoff, Matthew J.; Sibley, Christopher; Polak, Joseph F.; Frick, Kevin D.; Blumenthal, Roger S.; Nasir, Khurram			Cost-Effectiveness of Coronary Artery Calcium Testing for Coronary Heart and Cardiovascular Disease Risk Prediction to Guide Statin Allocation: The Multi-Ethnic Study of Atherosclerosis (MESA)	PLOS ONE			English	Article							C-REACTIVE PROTEIN; PRIMARY PREVENTION; NONCARDIAC FINDINGS; AMERICAN-COLLEGE; THERAPY; CHOLESTEROL; EVENTS; SCORE; CALCIFICATION; INTERMEDIATE	Background The Multi-Ethnic Study of Atherosclerosis (MESA) showed that the addition of coronary artery calcium (CAC) to traditional risk factors improves risk classification, particularly in intermediate risk asymptomatic patients with LDL cholesterol levels < 160 mg/dL. However, the cost-effectiveness of incorporating CAC into treatment decision rules has yet to be clearly delineated. Objective To model the cost-effectiveness of CAC for cardiovascular risk stratification in asymptomatic, intermediate risk patients not taking a statin. Treatment based on CAC was compared to (1) treatment of all intermediate-risk patients, and (2) treatment on the basis of United States guidelines. Methods We developed a Markov model of first coronary heart disease (CHD) and cardiovascular disease (CVD) events. We modeled statin treatment in intermediate risk patients with CAC >= 1 and CAC >= 100, with different intensities of statins based on the CAC score. We compared these CAC-based treatment strategies to a "treat all" strategy and to treatment according to the Adult Treatment Panel III (ATP III) guidelines. Clinical and economic outcomes were modeled over both five-and ten-year time horizons. Outcomes consisted of CHD and CVD events and Quality-Adjusted Life Years (QALYs). Sensitivity analyses considered the effect of higher event rates, different CAC and statin costs, indirect costs, and re-scanning patients with incidentalomas. Results We project that it is both cost-saving and more effective to scan intermediate-risk patients for CAC and to treat those with CAC >= 1, compared to treatment based on established risk-assessment guidelines. Treating patients with CAC >= 100 is also preferred to existing guidelines when we account for statin side effects and the disutility of statin use. Conclusion Compared to the alternatives we assessed, CAC testing is both effective and cost saving as a risk-stratification tool, particularly if there are adverse effects of long-term statin use. CAC may enable providers to better tailor preventive therapy to patients' risks of CVD.	[Roberts, Eric T.] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Hlth Policy & Management, Baltimore, MD USA; [Horne, Aaron; Martin, Seth S.; Blaha, Michael J.; Blumenthal, Roger S.; Nasir, Khurram] Johns Hopkins Univ, Sch Med, Ciccarone Ctr Prevent Heart Dis, Baltimore, MD 21218 USA; [Blankstein, Ron] Brigham & Womens Hosp, Div Cardiovasc, Boston, MA 02115 USA; [Budoff, Matthew J.] UCLA Sch Med, Dept Cardiol, Los Angeles, CA 90048 USA; [Sibley, Christopher] Oregon Hlth & Sci Univ, Knight Cardiovasc Inst, Portland, OR 97201 USA; [Polak, Joseph F.] Tufts Univ, Lemuel Shattuck Hosp, Sch Med, Boston, MA 02111 USA; [Frick, Kevin D.] Johns Hopkins Carey Business Sch, Baltimore, MD USA; [Frick, Kevin D.] Johns Hopkins Bloomberg Sch Publ Hlth, Baltimore, MD USA; [Nasir, Khurram] Baptist Hlth South Florida, Ctr Healthcare Adv & Outcomes, Miami, FL USA; [Nasir, Khurram] Baptist Hlth South Florida, MCVI, Miami, FL USA; [Nasir, Khurram] Florida Int Univ, Robert Stempel Coll Publ Hlth, Dept Epidemiol, Miami, FL 33199 USA	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University; Harvard University; Brigham & Women's Hospital; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Oregon Health & Science University; Tufts University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Baptist Cardiac & Vascular Institute; State University System of Florida; Florida International University	Nasir, K (corresponding author), Johns Hopkins Univ, Sch Med, Ciccarone Ctr Prevent Heart Dis, Baltimore, MD 21218 USA.	KhurramN@baptisthealth.net	Budoff, Matthew/ABD-5175-2021; Blumenthal, Roger S/H-3223-2018	Budoff, Matthew/0000-0002-9616-1946; Blumenthal, Roger S/0000-0003-1910-3168; Martin, Seth/0000-0002-7021-7622; Frick, Kevin/0000-0002-0178-5319; Roberts, Eric/0000-0002-7439-0799	T32 National Research Service Award; Agency for Healthcare Research and Quality; Hal R. Cohen Blue Cross Scholarship for Health Economics; Pollin Cardiovascular Prevention Fellowship; Marie-Josee and Henry R. Kravis endowed fellowship; National Institutes of Health [T32HL07024]; Kenneth Jay Pollin Professorship in Cardiology; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007024] Funding Source: NIH RePORTER	T32 National Research Service Award; Agency for Healthcare Research and Quality(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); Hal R. Cohen Blue Cross Scholarship for Health Economics; Pollin Cardiovascular Prevention Fellowship; Marie-Josee and Henry R. Kravis endowed fellowship; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Kenneth Jay Pollin Professorship in Cardiology; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Eric T. Roberts received financial support from a T32 National Research Service Award from the Agency for Healthcare Research and Quality and from the Hal R. Cohen Blue Cross Scholarship for Health Economics while completing this work. Seth S. Martin is supported by the Pollin Cardiovascular Prevention Fellowship, Marie-Josee and Henry R. Kravis endowed fellowship, and a National Institutes of Health training grant (T32HL07024) directed. Roger S. Blumenthal is supported by the Kenneth Jay Pollin Professorship in Cardiology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amin NP, 2014, J AM COLL CARDIOL, V63, P2789, DOI 10.1016/j.jacc.2014.04.010; Baigent C, 2010, LANCET, V376, P1670, DOI 10.1016/S0140-6736(10)61350-5; Blaha MJ, 2011, LANCET, V378, P684, DOI 10.1016/S0140-6736(11)60784-8; Bridges JFP, 2010, PHARMACOECONOMICS, V28, P175, DOI 10.2165/11530650-000000000-00000; Brugts JJ, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b2376; Bureau of Labor Statistics, CONS PRIC IND MED CA; Bureau of Labor Statistics, CURR EMPL STAT; Cleeman JI, 2001, JAMA-J AM MED ASSOC, V285, P2486, DOI 10.1001/jama.285.19.2486; Desai Chintan S, 2014, BMJ, V349, pg3743, DOI 10.1136/bmj.g3743; Fontana M, 2014, CIRCULATION, V129, P2539, DOI 10.1161/CIRCULATIONAHA.113.007595; Go AS, 2014, CIRCULATION, V129, P399, DOI 10.1161/01.cir.0000442015.53336.12; Goff DC, 2014, J AM COLL CARDIOL, V63, P2935, DOI [10.1016/j.jacc.2013.11.005, 10.1161/01.cir.0000437741.48606.98]; Greenland P, 2004, JAMA-J AM MED ASSOC, V291, P210, DOI 10.1001/jama.291.2.210; Greenland P, 2010, J AM COLL CARDIOL, V56, pE50, DOI 10.1016/j.jacc.2010.09.001; Grosse Scott D, 2008, Expert Rev Pharmacoecon Outcomes Res, V8, P165, DOI 10.1586/14737167.8.2.165; Grover SA, 2003, ARCH INTERN MED, V163, P333, DOI 10.1001/archinte.163.3.333; Horton KM, 2002, CIRCULATION, V106, P532, DOI 10.1161/01.CIR.0000027136.56615.DE; Kalia NK, 2006, ATHEROSCLEROSIS, V185, P394, DOI 10.1016/j.atherosclerosis.2005.06.018; Kim KP, 2009, ARCH INTERN MED, V169, P1188, DOI 10.1001/archinternmed.2009.162; Lazar LD, 2011, CIRCULATION, V124, P146, DOI 10.1161/CIRCULATIONAHA.110.986349; Lee KK, 2010, CIRCULATION, V122, P1478, DOI 10.1161/CIRCULATIONAHA.110.947960; MacHaalany J, 2009, J AM COLL CARDIOL, V54, P1533, DOI 10.1016/j.jacc.2009.06.026; Martin SS, 2014, J AM COLL CARDIOL, V63, P2674, DOI 10.1016/j.jacc.2014.02.578; Martin SS, 2014, ANN INTERN MED, V160, P356, DOI 10.7326/M13-2805; Martin SS, 2014, CIRCULATION, V129, P77, DOI 10.1161/CIRCULATIONAHA.113.003625; Min JK, 2010, J AM COLL CARDIOL, V55, P1110, DOI 10.1016/j.jacc.2009.08.088; Nasir K, 2012, CIRC-CARDIOVASC IMAG, V5, P467, DOI 10.1161/CIRCIMAGING.111.964528; Newhouse JP, 2012, HEALTH AFFAIR, V31, P2618, DOI 10.1377/hlthaff.2012.0345; O'Sullivan AK, 2011, PHARMACOECONOMICS, V29, P693, DOI 10.2165/11584620-000000000-00000; Pletcher MJ, 2014, CIRC-CARDIOVASC QUAL, V7, P276, DOI 10.1161/CIRCOUTCOMES.113.000799; Polonsky TS, 2010, JAMA-J AM MED ASSOC, V303, P1610, DOI 10.1001/jama.2010.461; Richardson L, 2010, J AM ACAD NURSE PRAC, V22, P178, DOI 10.1111/j.1745-7599.2010.00494.x; Schragin JG, 2004, J THORAC IMAG, V19, P82, DOI 10.1097/00005382-200404000-00004; Shah PK, 2010, J AM COLL CARDIOL, V56, P98, DOI 10.1016/j.jacc.2009.09.081; Silverman MG, 2014, EUR HEART J, V35, P2232, DOI 10.1093/eurheartj/eht508; Sniderman AD, 2012, AM J CARDIOL, V110, P530, DOI 10.1016/j.amjcard.2012.04.025; Stone NJ, 2014, J AM COLL CARDIOL, V63, P2889, DOI 10.1016/j.jacc.2013.11.002; Taylor AJ, 2008, J AM COLL CARDIOL, V51, P1337, DOI 10.1016/j.jacc.2007.11.069; Tonelli M, 2011, CAN MED ASSOC J, V183, pE1189, DOI 10.1503/cmaj.101280; United States Life Tables, CDC NATL VITAL STAT, V58; van Kempen BJH, 2011, J AM COLL CARDIOL, V58, P1690, DOI 10.1016/j.jacc.2011.05.056; Ward S, 2007, HEALTH TECHNOL ASSES, V11, P1, DOI 10.3310/hta11140	42	61	62	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2015	10	3							e0116377	10.1371/journal.pone.0116377	http://dx.doi.org/10.1371/journal.pone.0116377			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9BN	25786208	Green Published, gold			2022-12-27	WOS:000352138500006
J	Uppangala, S; Dhiman, S; Salian, SR; Singh, VJ; Kalthur, G; Adiga, SK				Uppangala, Shubhashree; Dhiman, Shilly; Salian, Sujit Raj; Singh, Vikram Jeet; Kalthur, Guruprasad; Adiga, Satish Kumar			In Vitro Matured Oocytes Are More Susceptible than In Vivo Matured Oocytes to Mock ICSI Induced Functional and Genetic Changes	PLOS ONE			English	Article							INTRACYTOPLASMIC SPERM INJECTION; HISTONE H2AX PHOSPHORYLATION; DNA-DAMAGE; EMBRYONIC-DEVELOPMENT; REPRODUCTIVE TECHNOLOGIES; ACTIVE MITOCHONDRIA; FERTILIZATION; RISK; MATURATION; CELLS	Background Concerns regarding the safety of ICSI have been intensified recently due to increased risk of birth defects in ICSI born children. Although fertilization rate is significantly higher in ICSI cycles, studies have failed to demonstrate the benefits of ICSI in improving the pregnancy rate. Poor technical skill, and suboptimal in vitro conditions may account for the ICSI results however, there is no report on the effects of oocyte manipulations on the ICSI outcome. Objective The present study elucidates the influence of mock ICSI on the functional and genetic integrity of the mouse oocytes. Methods Reactive Oxygen Species (ROS) level, mitochondrial status, and phosphorylation of H2AX were assessed in the in vivo matured and IVM oocytes subjected to mock ICSI. Results A significant increase in ROS level was observed in both in vivo matured and IVM oocytes subjected to mock ICSI (P<0.05-0.001) whereas unique mitochondrial distribution pattern was found only in IVM oocytes (P<0.01-0.001). Importantly, differential H2AX phosphorylation was observed in both in vivo matured and IVM oocytes subjected to mock ICSI (P < 0.001). Conclusion The data from this study suggests that mock ICSI can alter genetic and functional integrity in oocytes and IVM oocytes are more vulnerable to mock ICSI induced changes.	[Uppangala, Shubhashree; Dhiman, Shilly; Salian, Sujit Raj; Singh, Vikram Jeet; Kalthur, Guruprasad; Adiga, Satish Kumar] Manipal Univ, Div Clin Embryol, Dept Obstet & Gynecol, Kasturba Med Coll, Manipal 576104, India	Manipal Academy of Higher Education (MAHE); Kasturba Medical College, Manipal	Adiga, SK (corresponding author), Manipal Univ, Div Clin Embryol, Dept Obstet & Gynecol, Kasturba Med Coll, Manipal 576104, India.	satish.adiga@manipal.edu	Adiga, Satish Kumar/AAU-4386-2020; Uppangala, Shubhashree/AAA-4965-2021	Adiga, Satish Kumar/0000-0002-2897-4697; Uppangala, Shubhashree/0000-0002-5633-3977	Kasturba Medical College, Manipal University, Manipal; Dr. TMA Pai Endowment Chair Fund of Manipal University	Kasturba Medical College, Manipal University, Manipal; Dr. TMA Pai Endowment Chair Fund of Manipal University	This work was supported by the intramural grant from Kasturba Medical College, Manipal University, Manipal-576104 and Dr. TMA Pai Endowment Chair Fund of Manipal University sanctioned to SKA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adiga SK, 2007, ONCOGENE, V26, P6141, DOI 10.1038/sj.onc.1210444; Adiga SK, 2010, FERTIL STERIL, V93, P2486, DOI 10.1016/j.fertnstert.2009.06.015; Bakos HW, 2008, INT J ANDROL, V31, P518, DOI 10.1111/j.1365-2605.2007.00803.x; Bavister B D, 2000, Hum Reprod, V15 Suppl 2, P189; Blondin P, 1997, J ANDROL, V18, P454; Brevini TAL, 2005, BIOL REPROD, V72, P1218, DOI 10.1095/biolreprod.104.038141; Martinez MC, 2010, FERTIL STERIL, V93, P289, DOI 10.1016/j.fertnstert.2009.07.989; Cox GF, 2002, AM J HUM GENET, V71, P162, DOI 10.1086/341096; Curnow EC, 2010, HUM REPROD, V25, P2465, DOI 10.1093/humrep/deq225; Davies MJ, 2012, NEW ENGL J MED, V366, P1803, DOI 10.1056/NEJMoa1008095; Dumollard R, 2007, CURR TOP DEV BIOL, V77, P21, DOI 10.1016/S0070-2153(06)77002-8; Dumoulin JCM, 2001, HUM REPROD, V16, P306, DOI 10.1093/humrep/16.2.306; Edwards RG, 1999, NAT MED, V5, P377, DOI 10.1038/7370; Griffiths TA, 2000, HUM REPROD, V15, P1592, DOI 10.1093/humrep/15.7.1592; Hansen M, 2002, NEW ENGL J MED, V346, P725, DOI 10.1056/NEJMoa010035; Harris SE, 2010, HUM REPROD, V25, P2305, DOI 10.1093/humrep/deq181; Jean M, 2001, FERTIL STERIL, V76, P419, DOI 10.1016/S0015-0282(01)01874-X; JOHNSON LV, 1980, P NATL ACAD SCI-BIOL, V77, P990, DOI 10.1073/pnas.77.2.990; Kato Y, 2009, THERIOGENOLOGY, V72, P624, DOI 10.1016/j.theriogenology.2009.04.018; Lei T, 2014, INT J CLIN EXP PATHO, V7, P1159; Lim D, 2009, HUM REPROD, V24, P741, DOI 10.1093/humrep/den406; Liu L, 2002, BIOL REPROD, V66, P204, DOI 10.1095/biolreprod66.1.204; Liu S, 2010, FERTIL STERIL, V93, P1550, DOI 10.1016/j.fertnstert.2009.03.050; Ma JY, 2013, CELL CYCLE, V12, P1233, DOI 10.4161/cc.24311; Mah LJ, 2010, EPIGENETICS-US, V5, P129, DOI 10.4161/epi.5.2.11080; Mansour R, 2014, HUM REPROD, V29, P1536, DOI 10.1093/humrep/deu084; Mathias FJ, 2014, SYST BIOL REPROD MED, V60, P317, DOI 10.3109/19396368.2014.923542; McManus KJ, 2005, MOL BIOL CELL, V16, P5013, DOI 10.1091/mbc.E05-01-0065; Mizuno K, 2002, HUM REPROD, V17, P2350, DOI 10.1093/humrep/17.9.2350; Morado S, 2013, REPRODUCTION, V145, P471, DOI 10.1530/REP-13-0017; Morgia F, 2006, FERTIL STERIL, V85, P1415, DOI 10.1016/j.fertnstert.2005.10.050; Morozumi K, 2005, P NATL ACAD SCI USA, V102, P14209, DOI 10.1073/pnas.0507005102; Morris ID, 2002, HUM REPROD, V17, P990, DOI 10.1093/humrep/17.4.990; Motoishi M, 1996, HUM REPROD, V11, P618, DOI 10.1093/HUMREP/11.3.618; Nagy IZ, 2001, ANN NY ACAD SCI, V928, P187; Paull TT, 2000, CURR BIOL, V10, P886, DOI 10.1016/S0960-9822(00)00610-2; Renard JP, 1998, REPROD FERT DEVELOP, V10, P573, DOI 10.1071/RD98086; Rogakou EP, 1998, J BIOL CHEM, V273, P5858, DOI 10.1074/jbc.273.10.5858; Salian SR, 2012, FERTIL STERIL, V98, P321, DOI 10.1016/j.fertnstert.2012.04.040; Sanfins A, 2003, BIOL REPROD, V69, P2059, DOI 10.1095/biolreprod.103.020537; Schramm RD, 2002, HUM REPROD, V17, P1597, DOI 10.1093/humrep/17.6.1597; Shkolnik K, 2011, P NATL ACAD SCI USA, V108, P1462, DOI 10.1073/pnas.1017213108; Shoukir Y, 1998, HUM REPROD, V13, P1632, DOI 10.1093/humrep/13.6.1632; Silber S, 2003, FERTIL STERIL, V79, P30, DOI 10.1016/S0015-0282(02)04407-2; Simon C, 1999, FERTIL STERIL, V72, P1061, DOI 10.1016/S0015-0282(99)00408-2; Squirrell JM, 2001, BIOL REPROD, V64, P1845, DOI 10.1095/biolreprod64.6.1845; Stein P, 2010, METHOD ENZYMOL, V476, P251, DOI 10.1016/S0076-6879(10)76014-6; Sudhakaran S, 2014, REPROD FERTIL DEV; Sun QY, 2001, REPRODUCTION, V122, P155, DOI 10.1530/rep.0.1220155; Takenaka M, 2007, P NATL ACAD SCI USA, V104, P14289, DOI 10.1073/pnas.0706687104; Tanaka T, 2006, CELL PROLIFERAT, V39, P313, DOI 10.1111/j.1365-2184.2006.00387.x; Tournaye H, 2002, FERTIL STERIL, V78, P1030, DOI 10.1016/S0015-0282(02)03377-0; Van Blerkom J, 2003, HUM REPROD, V18, P2429, DOI 10.1093/humrep/deg466; Winston RML, 2002, NAT MED, V8, P14; Yamagata K, 2009, HUM REPROD, V24, P2490, DOI 10.1093/humrep/dep236; Yanagimachi R, 2005, REPROD BIOMED ONLINE, V10, P247, DOI 10.1016/S1472-6483(10)60947-9; Ye J, 2007, REPRODUCTION, V133, P877, DOI 10.1530/REP-06-0318; Zini A, 2008, HUM REPROD, V23, P2663, DOI 10.1093/humrep/den321	58	7	8	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2015	10	3							e0119735	10.1371/journal.pone.0119735	http://dx.doi.org/10.1371/journal.pone.0119735			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9BN	25786120	gold, Green Published, Green Submitted			2022-12-27	WOS:000352138500127
J	Nica, DV; Filimon, MN; Bordean, DM; Harmanescu, M; Draghici, GA; Dragan, S; Gergen, II				Nica, Dragos V.; Filimon, Marioara Nicoleta; Bordean, Despina-Maria; Harmanescu, Monica; Draghici, George Andrei; Dragan, Simona; Gergen, Iosif I.			Impact of Soil Cadmium on Land Snails: A Two-Stage Exposure Approach under Semi-Field Conditions Using Bioaccumulative and Conchological End-Points of Exposure	PLOS ONE			English	Article							HELIX-ASPERSA SNAILS; CD-METALLOTHIONEIN; GROWTH; SHELL; ACCUMULATION; FIELD; COPPER; ZINC; LEAD; PB	Land snails are highly tolerant to cadmium exposure and are able to accumulate soil cadmium independently of food ingestion. However, little information exists on the kinetics of cadmium retention in terrestrial gastropods exposed to an increase in the soil cadmium content, over time. There is also little knowledge about how exposure to cadmium-polluted soils influences shell growth and architecture. In this context, we examined cadmium accumulation in the hepatopancreas and shell of juvenile Cantareus aspersus exposed to elevating high levels of cadmium in soil. Also, the toxicity of cadmium to snails was assessed using a range of conchological endpoints, including shell height, width, volume, allometry and integrity. Test snails, aged three months, were reared under semi-field conditions, fed an uncontaminated diet and exposed first, for a period of 30 days, to a series of soil cadmium concentrations, and then, for a second period of 30 days, to soils with higher cadmium content. Cadmium showed a dose-dependent accumulation in both the hepatopancreas and shell. The kinetics of cadmium retention in the hepatopancreas of snails previously exposed to cadmium-spiked soils was significantly influenced by a new exposure event. The shell was not a relevant bioaccumulator for soil cadmium. Under the present experimental conditions, only high cadmium exposure significantly affected either the shell growth or snail survival. There was no consistent effect on shell allometry, but the shell integrity, especially in rapidly growing parts, appeared to be affected by high cadmium exposure. Our results attest to the value of hepatopancreas for describing cadmium retention in land snails and to the difficulty of using conchological parameters in field surveys for estimating the environmental hazard of soil cadmium.	[Nica, Dragos V.] Banats Univ Agr Sci & Vet Med King Michael I Roma, Fac Anim Sci & Biotechnol, Timisoara, Timis, Romania; [Filimon, Marioara Nicoleta] West Univ Timisoara, Fac Chem Biol Geog, Timisoara, Timis, Romania; [Bordean, Despina-Maria; Draghici, George Andrei; Gergen, Iosif I.] Banats Univ Agr Sci & Vet Med King Michael I Roma, Fac Food Proc Technol, Timisoara, Timis, Romania; [Harmanescu, Monica] Banats Univ Agr Sci & Vet Med King Michael I Roma, Fac Agr, Timisoara, Timis, Romania; [Dragan, Simona] Victor Babes Univ Med & Pharm, Dept Cardiol, Timisoara, Timis, Romania	Banat University of Agricultural Sciences & Veterinary Medicine; West University of Timisoara; Banat University of Agricultural Sciences & Veterinary Medicine; Banat University of Agricultural Sciences & Veterinary Medicine; Victor Babes University of Medicine & Pharmacy, Timisoara	Nica, DV (corresponding author), Banats Univ Agr Sci & Vet Med King Michael I Roma, Fac Anim Sci & Biotechnol, Timisoara, Timis, Romania.	nicadragos@gmail.com	Harmanescu, Monica/AAQ-4906-2020; Filimon, Marioara Nicoleta/C-1904-2012; Dragan, Simona/AAA-6142-2019; Drăghici, George Andrei/AAA-4084-2019; Bordean, Despina Maria/N-8613-2014; Gergen, Iosif/O-3321-2014	Filimon, Marioara Nicoleta/0000-0002-3392-9858; Drăghici, George Andrei/0000-0002-8042-0966; Bordean, Despina Maria/0000-0002-1647-7992; Gergen, Iosif/0000-0002-8144-1961	project "Post-doctoral School Of Agriculture And Veterinary Medicine" [POSDRU/89/1.5/S/62371]; European Social Fund through Sectorial Operational Programme for the Human Resources Development	project "Post-doctoral School Of Agriculture And Veterinary Medicine"; European Social Fund through Sectorial Operational Programme for the Human Resources Development	The present work was funded by the project "Post-doctoral School Of Agriculture And Veterinary Medicine POSDRU/89/1.5/S/62371", cofinanced by the European Social Fund through the Sectorial Operational Programme for the Human Resources Development 2007-2013. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akesson A, 2006, ENVIRON HEALTH PERSP, V114, P830, DOI 10.1289/ehp.8763; Al-Oud S. S., 2008, Journal of Environmental Science and Technology, V1, P135, DOI 10.3923/jest.2008.135.142; Amune M., 2012, INT J PURE APPL SCI, V13, P42; [Anonymous], 2001, BIOL TERRESTRIAL MOL; Bardos DC, 2005, B MATH BIOL, V67, P529, DOI 10.1016/j.bulm.2004.08.009; BERGER B, 1989, OECOLOGIA, V79, P60, DOI 10.1007/BF00378240; Bordean DM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085384; Bura M, 2004, CRESTEREA MELCILOR A; Chabicovsky M, 2004, ENVIRON TOXICOL CHEM, V23, P648, DOI 10.1897/02-617; Coeurdassier M, 2002, ECOTOX ENVIRON SAFE, V53, P425, DOI 10.1016/S0147-6513(02)00004-0; Dallinger R, 2004, ECOTOXICOLOGY, V13, P757, DOI 10.1007/s10646-003-4474-4; Dallinger R., 2001, P489, DOI 10.1079/9780851993188.0489; Dallinger R., 1993, ECOTOXICOLOGY METALS; de Paula SM, 2009, MICRON, V40, P669, DOI 10.1016/j.micron.2009.05.006; De Vaufleury A, 2006, ENVIRON TOXICOL CHEM, V25, P797, DOI 10.1897/04-560R.1; Ebenso IE, 2008, POLLUT RES INDIA, V27, P75; Eeva T, 2010, SCI TOTAL ENVIRON, V408, P4165, DOI 10.1016/j.scitotenv.2010.05.028; Egg M, 2009, MOL ECOL, V18, P2426, DOI 10.1111/j.1365-294X.2009.04191.x; Faroon O., 2012, TOXICOLOGICAL PROFIL; Florkin M, 1994, CHEM ZOOLOGY, VVII; Fritsch C, 2011, ECOTOXICOLOGY, V20, P739, DOI 10.1007/s10646-011-0619-z; Garcia A, 2006, LAB ANIM-UK, V40, P309, DOI 10.1258/002367706777611505; Gheoca Voichita, 2005, Transylvanian Review of Systematical and Ecological Research, V2, P67; Gimbert F, 2008, ENVIRON POLLUT, V152, P736, DOI 10.1016/j.envpol.2007.06.044; Gimbert F, 2008, ECOTOX ENVIRON SAFE, V70, P138, DOI 10.1016/j.ecoenv.2007.05.014; Girnbert F, 2006, ENVIRON INT, V32, P866, DOI 10.1016/j.envint.2006.05.006; Gomot A, 1997, ARCH ENVIRON CON TOX, V33, P209, DOI 10.1007/s002449900245; Gomot A, 1997, ECOTOX ENVIRON SAFE, V38, P85, DOI 10.1006/eesa.1997.1566; Hodl E, 2010, CELL TISSUE RES, V341, P159, DOI 10.1007/s00441-010-0980-x; IRELAND MP, 1991, COMP BIOCHEM PHYS A, V98, P111, DOI 10.1016/0300-9629(91)90587-3; Jatto E.O., 2010, ACAEDMIA ARENA, V2, P32; Jordaens K, 2006, SCI TOTAL ENVIRON, V363, P285, DOI 10.1016/j.scitotenv.2005.12.002; Kano N, 2013, ENG BIOMASS NOW SUST, P101; KEMP P, 1984, P NATL ACAD SCI-BIOL, V81, P811, DOI 10.1073/pnas.81.3.811; Kerney M.P., 1979, FIELD GUIDE LAND SNA; Klein J. P., 2003, SURVIVAL ANAL TECHNI; Laskowski R, 1996, ENVIRON POLLUT, V91, P289, DOI 10.1016/0269-7491(95)00070-4; Locher R, 2000, INVERTEBR REPROD DEV, V38, P53, DOI 10.1080/07924259.2000.9652436; Madejon P, 2013, J SCI FOOD AGR, V93, P2259, DOI 10.1002/jsfa.6035; Madrid L, 2006, J ENVIRON MONITOR, V8, P1158, DOI 10.1039/b607980f; Massaro, 1997, HDB HUMAN TOXICOLOGY, DOI 10.1201/9781439805756; McBride M.B., 1994, ENV CHEM SOILS, P416; Mierzwa Dominika, 2011, Folia Malacologica, V19, P97; Moisa C., 2012, Research Journal of Agricultural Science, V44, P86; Mulvey M, 1996, J MOLLUS STUD, V62, P213, DOI 10.1093/mollus/62.2.213; Nica DV, 2012, CHEM CENT J, V6, DOI 10.1186/1752-153X-6-55; Notten MJM, 2006, ENVIRON POLLUT, V139, P296, DOI 10.1016/j.envpol.2005.05.007; Nowakowska A, 2012, POL J ENVIRON STUD, V21, P1369; Pauget B, 2011, J HAZARD MATER, V192, P1804, DOI 10.1016/j.jhazmat.2011.07.016; Pauget B, 2013, ECOL INDIC, V29, P445, DOI 10.1016/j.ecolind.2013.01.012; Rabitsch WB, 1996, B ENVIRON CONTAM TOX, V56, P734, DOI 10.1007/s001289900108; RUSSELL LK, 1981, B ENVIRON CONTAM TOX, V26, P634, DOI 10.1007/BF01622148; Scheifler R, 2003, ENVIRON POLLUT, V122, P343, DOI 10.1016/S0269-7491(02)00333-0; Scheifler R, 2003, ENVIRON SCI TECHNOL, V37, P81, DOI 10.1021/es025677w; Soido C, 2009, BRAZ ARCH BIOL TECHN, V52, P93, DOI 10.1590/S1516-89132009000100012; SUNILA I, 1985, ESTUAR COAST SHELF S, V21, P555, DOI 10.1016/0272-7714(85)90056-3; van Gestel CAM, 2012, ZOOKEYS, P275, DOI 10.3897/zookeys.176.2275; Veltman K, 2008, SCI TOTAL ENVIRON, V406, P413, DOI 10.1016/j.scitotenv.2008.05.049; Wei BG, 2010, MICROCHEM J, V94, P99, DOI 10.1016/j.microc.2009.09.014; WHO/ Europe, 2007, HLTH RISKS HEAV MET; WILLIAMSON P, 1980, OECOLOGIA, V44, P213, DOI 10.1007/BF00572682	61	15	16	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2015	10	3							e0116397	10.1371/journal.pone.0116397	http://dx.doi.org/10.1371/journal.pone.0116397			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD9NQ	25790135	Green Submitted, Green Published, gold			2022-12-27	WOS:000351425400015
J	Tan, YN; Fu, JF; Li, XF; Yang, J; Jiang, MJ; Ding, KF; Xu, JH; Li, J; Yuan, Y				Tan, Yinuo; Fu, Jianfei; Li, Xiaofen; Yang, Jiao; Jiang, Mengjie; Ding, Kefeng; Xu, Jinghong; Li, Jun; Yuan, Ying			A Minor (< 50%) Signet-Ring Cell Component Associated with Poor Prognosis in Colorectal Cancer Patients: A 26-Year Retrospective Study in China	PLOS ONE			English	Article							MUCINOUS HISTOLOGY PREDICTS; CLINICOPATHOLOGICAL CHARACTERISTICS; MOLECULAR-FEATURES; COLON-CANCER; CARCINOMA; ADENOCARCINOMA; SURVIVAL; OUTCOMES; DIFFERENTIATION	Background We performed a retrospective study to determine the cancer-specific survival of colorectal cancer patients with a component of signet-ring cells or mucin comprising < 50% of the tumor mass. Methods A total of 2454 patients seen in our hospital from 1985 to 2011 were retrospectively studied. The patients were divided into five groups according to type of cancer: signet-ring cell carcinoma (with > 50% signet-ring cell, n = 36), partial signet-ring cell carcinoma (with < 50% signet-ring cell, n = 28), mucinous adenocarcinoma (with > 50% mucin lacking signet-ring cell, n = 267), partial mucinous adenocarcinoma (with < 50% mucin lacking signet-ring cell, n = 145), and classic adenocarcinoma (with absence of either mucin or signet-ring cell, n = 1978). Results Patients with > 50% or < 50% signet-ring cell had the lowest 5-year survival rates (35.5% and 29.7%, respectively), followed by patients with > 50% mucin (48.8%). Patients who had partial mucinous adenocarcinoma with < 50% mucin and classic adenocarcinoma patients had the highest 5-year survival rates (64.8% and 65.3%, respectively). Stratified and multivariate analysis showed that signet-ring cell carcinoma, partial signet-ring cell carcinoma and mucinous adenocarcinoma were independent predictors of decreased survival (hazard ratio 1.699, P = 0.016; hazard ratio 2.182, P = 0.005; hazard ratio 1.532, P < 0.001; respectively), and partial mucinous adenocarcinoma was not (hazard ratio 1.137, P = 0.431). Conclusions Patients with a component of signet-ring cells, regardless of the extent, had poor prognoses. Patients with mucinous adenocarcinoma containing >50% mucin had poor prognoses as well, whereas those with < 50% mucin had survival rates similar to those of classic adenocarcinoma patients. Therefore, in clinical practice, patients with a component of signet-ring cells, regardless of the extent, should be given significant clinical attention.	[Tan, Yinuo; Li, Xiaofen; Yang, Jiao; Jiang, Mengjie; Yuan, Ying] Zhejiang Univ, Sch Med, Hosp 2, Dept Med Oncol, Hangzhou 310003, Zhejiang, Peoples R China; [Fu, Jianfei] Jinhua Cent Hosp, Dept Oncol, Jinhua, Peoples R China; [Ding, Kefeng; Li, Jun] Zhejiang Univ, Sch Med, Hosp 2, Dept Surg Oncol, Hangzhou 310003, Zhejiang, Peoples R China; [Ding, Kefeng; Yuan, Ying] China Natl Minist Educ, Key Lab Mol Biol Med Sci, Inst Canc, Key Lab Canc Prevent & Intervent, Hangzhou, Zhejiang, Peoples R China; [Xu, Jinghong] Zhejiang Univ, Sch Med, Hosp 2, Dept Pathol, Hangzhou 310003, Zhejiang, Peoples R China	Zhejiang University; Zhejiang University; Zhejiang University	Yuan, Y (corresponding author), Zhejiang Univ, Sch Med, Hosp 2, Dept Med Oncol, Hangzhou 310003, Zhejiang, Peoples R China.	yuanying1999@zju.edu.cn	xu, jing/GRR-8698-2022		National Natural Science Foundation of China [81101580]; Key Projects in the National Science & Technology Pillar Program during the Twelfth Five-year Plan Period [2014BAI09B07]; National High Technology Research and Development Program of China (863 Program) [2012AA02A506, 2012AA02A204]; Training Program of the Major Research Plan of the National Natural Science Foundation of China [91229104]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Key Projects in the National Science & Technology Pillar Program during the Twelfth Five-year Plan Period; National High Technology Research and Development Program of China (863 Program)(National High Technology Research and Development Program of China); Training Program of the Major Research Plan of the National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This research was supported by grants from the National Natural Science Foundation of China (81101580), Key Projects in the National Science & Technology Pillar Program during the Twelfth Five-year Plan Period (2014BAI09B07), the National High Technology Research and Development Program of China (863 Program) (2012AA02A506), the National High Technology Research and Development Program of China (863 Program) (2012AA02A204), and the Training Program of the Major Research Plan of the National Natural Science Foundation of China (91229104). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn JB, 2012, J CLIN ONCOL, V30; Bittorf B, 2004, LANGENBECK ARCH SURG, V389, P178, DOI 10.1007/s00423-004-0474-y; Bosman F. T., 2010, WHO CLASSIFICATION O; Catalano V, 2009, J CLIN ONCOL, V27; Catalano V, 2009, BRIT J CANCER, V100, P881, DOI 10.1038/sj.bjc.6604955; Catalano V, 2008, J CLIN ONCOL, V26; Chang DT, 2012, MODERN PATHOL, V25, P1128, DOI 10.1038/modpathol.2012.61; Chen JX, 2012, ASIAN PAC J CANCER P, V13, P3427, DOI 10.7314/APJCP.2012.13.7.3427; Consorti F, 2000, J SURG ONCOL, V73, P70, DOI 10.1002/(SICI)1096-9098(200002)73:2<70::AID-JSO3>3.0.CO;2-J; Du WB, 2004, DIS COLON RECTUM, V47, P78, DOI 10.1007/s10350-003-0014-9; Farhat MH, 2008, WORLD J GASTROENTERO, V14, P6981, DOI 10.3748/wjg.14.6981; Fu JF, 2013, WORLD J GASTROENTERO, V19, P8078, DOI 10.3748/wjg.v19.i44.8078; Fu JF, 2014, MEDICINE, V93, DOI 10.1097/MD.0000000000000135; Gao P, 2013, HISTOPATHOLOGY, V63, P603, DOI 10.1111/his.12190; Gopalan V, 2011, INT J COLORECTAL DIS, V26, P127, DOI 10.1007/s00384-010-1037-z; GREEN JB, 1993, DIS COLON RECTUM, V36, P49, DOI 10.1007/BF02050301; HALVORSEN TB, 1988, J CLIN PATHOL, V41, P1068, DOI 10.1136/jcp.41.10.1068; Hyngstrom JR, 2012, ANN SURG ONCOL, V19, P2814, DOI 10.1245/s10434-012-2321-7; Kang HJ, 2005, DIS COLON RECTUM, V48, P1161, DOI 10.1007/s10350-004-0932-1; Kim SH, 2013, ANN SURG ONCOL, V20, P3407, DOI 10.1245/s10434-013-3169-1; Langner C, 2012, HISTOPATHOLOGY, V60, P1060, DOI 10.1111/j.1365-2559.2011.04155.x; Lee WS, 2007, AM J SURG, V194, P294, DOI 10.1016/j.amjsurg.2006.12.041; Maisano R, 2012, J CHEMOTHERAPY, V24, P212, DOI 10.1179/1973947812Y.0000000013; Mekenkamp LJM, 2012, EUR J CANCER, V48, P3128, DOI 10.1016/j.ejca.2012.08.014; Mizushima T, 2010, SURG TODAY, V40, P234, DOI 10.1007/s00595-009-4057-y; Negri FV, 2005, ANN ONCOL, V16, P1305, DOI 10.1093/annonc/mdi244; Nozoe T, 2000, J SURG ONCOL, V75, P103, DOI 10.1002/1096-9098(200010)75:2<103::AID-JSO6>3.3.CO;2-3; Ogino S, 2006, MODERN PATHOL, V19, P59, DOI 10.1038/modpathol.3800482; Ooi BS, 2001, ANZ J SURG, V71, P703, DOI 10.1046/j.1445-1433.2001.02269.x; Pande R, 2008, DIS COLON RECTUM, V51, P50, DOI 10.1007/s10350-007-9073-7; Papadopoulos V N, 2004, Tech Coloproctol, V8 Suppl 1, ps123, DOI 10.1007/s10151-004-0131-z; Psathakis D, 1999, DIS COLON RECTUM, V42, P1618, DOI 10.1007/BF02236218; Sasaki S, 1998, JPN J CLIN ONCOL, V28, P202, DOI 10.1093/jjco/28.3.202; Song W, 2009, CHINESE MED J-PEKING, V122, P1486, DOI 10.3760/cma.j.issn.0366-6999.2009.13.002; SUMA KS, 1992, J SURG ONCOL, V51, P60, DOI 10.1002/jso.2930510115; Sung CO, 2008, MODERN PATHOL, V21, P1533, DOI 10.1038/modpathol.2008.170; Verhulst J, 2012, J CLIN PATHOL, V65, P381, DOI 10.1136/jclinpath-2011-200340; Yamaguchi T, 2012, HISTOPATHOLOGY, V61, P162, DOI 10.1111/j.1365-2559.2012.04235.x	38	18	19	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2015	10	3							e0121944	10.1371/journal.pone.0121944	http://dx.doi.org/10.1371/journal.pone.0121944			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD9NQ	25789685	gold, Green Submitted, Green Published			2022-12-27	WOS:000351425400202
J	Tominaga, M; Ike, K; Kawai-Noma, S; Saito, K; Umeno, D				Tominaga, Masahiro; Ike, Kohei; Kawai-Noma, Shigeko; Saito, Kyoichi; Umeno, Daisuke			Rapid and Liquid-Based Selection of Genetic Switches Using Nucleoside Kinase Fused with Aminoglycoside Phosphotransferase	PLOS ONE			English	Article							DUAL SELECTION; CHLORAMPHENICOL; CIRCUITS; DESIGN	The evolutionary design of genetic switches and circuits requires iterative rounds of positive (ON-) and negative (OFF-) selection. We previously reported a rapid OFF selection system based on the kinase activity of herpes simplex virus thymidine kinase (hsvTK) on the artificial mutator nucleoside dP. By fusing hsvTK with the kanamycin resistance marker aminoglycoside-(3')-phosphotransferase (APH), we established a novel selector system for genetic switches. Due to the bactericidal nature of kanamycin and nucleoside-based lethal mutagenesis, both positive and negative selection could be completed within several hours. Using this new selector system, we isolated a series of homoserine lactone-inducible genetic switches with different expression efficiencies from libraries of the Vibrio fischeri lux promoter in two days, using only liquid handling.	[Tominaga, Masahiro; Ike, Kohei; Kawai-Noma, Shigeko; Saito, Kyoichi; Umeno, Daisuke] Chiba Univ, Fac Engn, Dept Appl Chem & Biotechnol, Inage Ku, Yayoi Cyo, Chiba, Japan; [Umeno, Daisuke] Japan Sci & Technol Agcy JST, Precursory Res Embryon Sci & Technol PRESTO, Kawaguchi, Saitama, Japan	Chiba University; Japan Science & Technology Agency (JST)	Umeno, D (corresponding author), Chiba Univ, Fac Engn, Dept Appl Chem & Biotechnol, Inage Ku, Yayoi Cyo, Chiba, Japan.	umeno@faculty.chiba-u.jp	Tominaga, Masahiro/GYJ-1256-2022	Tominaga, Masahiro/0000-0001-9691-0428	Precursory Research for Embryonic Science and Technology (PRESTO) program of the Japan Science and Technology Agency (JST); Ministry of Education, Culture, Sports, Science and Technology (MEXT)/ Japan Society for Promotion of Science (JSPS) [23108507]; commission for Development of Artificial Gene Synthesis Technology for Creating Innovative Biomaterial from the Ministry of Economy, Trade and Industry (METI), Japan	Precursory Research for Embryonic Science and Technology (PRESTO) program of the Japan Science and Technology Agency (JST); Ministry of Education, Culture, Sports, Science and Technology (MEXT)/ Japan Society for Promotion of Science (JSPS); commission for Development of Artificial Gene Synthesis Technology for Creating Innovative Biomaterial from the Ministry of Economy, Trade and Industry (METI), Japan	This work is supported by the Precursory Research for Embryonic Science and Technology (PRESTO) program of the Japan Science and Technology Agency (JST), Grant-in-Aid for Scientific Research on Innovative Areas (23108507) from the Ministry of Education, Culture, Sports, Science and Technology (MEXT)/ Japan Society for Promotion of Science (JSPS), and the commission for Development of Artificial Gene Synthesis Technology for Creating Innovative Biomaterial from the Ministry of Economy, Trade and Industry (METI), Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antunes LCM, 2008, J BACTERIOL, V190, P4392, DOI 10.1128/JB.01443-07; Basu S, 2004, P NATL ACAD SCI USA, V101, P6355, DOI 10.1073/pnas.0307571101; Brenner K, 2007, P NATL ACAD SCI USA, V104, P17300, DOI 10.1073/pnas.0704256104; BROCK TD, 1961, BACTERIOL REV, V25, P32, DOI 10.1128/MMBR.25.1.32-48.1961; Candotti F, 2000, CANCER GENE THER, V7, P574, DOI 10.1038/sj.cgt.7700153; Collins CH, 2006, NAT BIOTECHNOL, V24, P708, DOI 10.1038/nbt1209; DAVIES J, 1978, ANNU REV MICROBIOL, V32, P469, DOI 10.1146/annurev.mi.32.100178.002345; GARRETT ER, 1973, J PHARM SCI-US, V62, P1666, DOI 10.1002/jps.2600621018; Haseltine EL, 2007, ANNU REV BIOPH BIOM, V36, P1, DOI 10.1146/annurev.biophys.36.040306.132600; HEMSLEY A, 1989, NUCLEIC ACIDS RES, V17, P6545, DOI 10.1093/nar/17.16.6545; Muranaka N, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp039; Negishi K, 2002, GENETICS, V161, P1363; Nomura Y, 2007, BIOSYSTEMS, V90, P115, DOI 10.1016/j.biosystems.2006.07.006; Patterson AV, 2003, CURR PHARM DESIGN, V9, P2131, DOI 10.2174/1381612033454117; Pedelacq JD, 2006, NAT BIOTECHNOL, V24, P79, DOI 10.1038/nbt1172; Rackham O, 2005, NAT CHEM BIOL, V1, P159, DOI 10.1038/nchembio719; Salis HM, 2009, NAT BIOTECHNOL, V27, P946, DOI 10.1038/nbt.1568; Schaerli Y, 2013, MOL BIOSYST, V9, P1559, DOI 10.1039/c2mb25483b; Schmidt-Dannert C, 2000, NAT BIOTECHNOL, V18, P750, DOI 10.1038/77319; SCHWARTZ F, 1991, P NATL ACAD SCI USA, V88, P10416, DOI 10.1073/pnas.88.23.10416; SHAW WV, 1983, CRC CR REV BIOCH MOL, V14, P1, DOI 10.3109/10409238309102789; Tamsir A, 2011, NATURE, V469, P212, DOI 10.1038/nature09565; Tashiro Y, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkq1070; Topp S, 2008, CHEMBIOCHEM, V9, P210, DOI 10.1002/cbic.200700546; Yokobayashi Yohei, 2005, Natural Computing, V4, P245, DOI 10.1007/s11047-004-7442-x	25	8	8	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2015	10	3							e0120243	10.1371/journal.pone.0120243	http://dx.doi.org/10.1371/journal.pone.0120243			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD9NQ	25790096	Green Published, gold, Green Submitted			2022-12-27	WOS:000351425400145
J	Wainer, J; Eckmann, M; Rocha, A				Wainer, Jacques; Eckmann, Michael; Rocha, Anderson			Peer-Selected "Best Papers"-Are They Really That "Good"?	PLOS ONE			English	Article							BIBLIOMETRIC INDICATORS; COMPUTER-SCIENCE; H-INDEX; CITATIONS; JOURNALS; F1000; WORK	Background Peer evaluation is the cornerstone of science evaluation. In this paper, we analyze whether or not a form of peer evaluation, the pre-publication selection of the best papers in Computer Science (CS) conferences, is better than random, when considering future citations received by the papers. Methods Considering 12 conferences (for several years), we collected the citation counts from Scopus for both the best papers and the non-best papers. For a different set of 17 conferences, we collected the data from Google Scholar. For each data set, we computed the proportion of cases whereby the best paper has more citations. We also compare this proportion for years before 2010 and after to evaluate if there is a propaganda effect. Finally, we count the proportion of best papers that are in the top 10% and 20% most cited for each conference instance. Results The probability that a best paper will receive more citations than a non best paper is 0.72 (95% CI = 0.66, 0.77) for the Scopus data, and 0.78 (95% CI = 0.74, 0.81) for the Scholar data. There are no significant changes in the probabilities for different years. Also, 51% of the best papers are among the top 10% most cited papers in each conference/year, and 64% of them are among the top 20% most cited. Discussion There is strong evidence that the selection of best papers in Computer Science conferences is better than a random selection, and that a significant number of the best papers are among the top cited papers in the conference.	[Wainer, Jacques; Rocha, Anderson] Univ Estadual Campinas, Comp Inst, Campinas, SP, Brazil; [Eckmann, Michael] Skidmore Coll, Dept Math & Comp Sci, Saratoga Springs, NY 12866 USA	Universidade Estadual de Campinas; Skidmore College	Wainer, J (corresponding author), Univ Estadual Campinas, Comp Inst, Campinas, SP, Brazil.	wainer@ic.unicamp.br	Wainer, Jacques/AAQ-6029-2021; Wainer, Jacques/B-4241-2012	Wainer, Jacques/0000-0001-5201-1244; Wainer, Jacques/0000-0001-5201-1244				Alonso S, 2009, J INFORMETR, V3, P273, DOI 10.1016/j.joi.2009.04.001; Bar-Ilan J, 2010, SCIENTOMETRICS, V83, P809, DOI 10.1007/s11192-009-0145-4; Bornmann L, 2005, SCIENTOMETRICS, V65, P391, DOI 10.1007/s11192-005-0281-4; Bornmann L, 2008, J AM SOC INF SCI TEC, V59, P830, DOI 10.1002/asi.20806; Bornmann L, 2013, J INFORMETR, V7, P286, DOI 10.1016/j.joi.2012.12.003; Cabezas-Clavijo A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068258; Coupe T, 2013, RES POLICY, V42, P295, DOI 10.1016/j.respol.2012.05.004; DICICCIO TJ, 1988, J ROY STAT SOC B MET, V50, P338; Franceschet M., 2010, COMMUNICATIONS ACM, V53, P129; Franceschet M, 2011, J INFORMETR, V5, P275, DOI 10.1016/j.joi.2010.12.002; Freyne J, 2010, COMMUN ACM, V53, P124, DOI DOI 10.1145/1839676.1839701; Halpern JY, 2011, COMMUN ACM, V54, P36, DOI 10.1145/1978542.1978555; Hirsch JE, 2005, P NATL ACAD SCI USA, V102, P16569, DOI 10.1073/pnas.0507655102; Michayluk D, 2014, SCIENTOMETRICS, V98, P961, DOI 10.1007/s11192-013-1115-4; Oppenheim C, 1997, J DOC, V53, P477, DOI 10.1108/EUM0000000007207; Rinia EJ, 1998, RES POLICY, V27, P95, DOI 10.1016/S0048-7333(98)00026-2; Sen R, 2012, J PROF ISS ENG ED PR, V138, P107, DOI 10.1061/(ASCE)EI.1943-5541.0000092; Vardi MY, 2009, COMMUN ACM, V52, P5, DOI 10.1145/1592761.1592762; Vieira ES, 2014, J INFORMETR, V8, P390, DOI 10.1016/j.joi.2014.01.012; Wainer J, 2013, COMMUN ACM, V56, P67, DOI 10.1145/2492007.2492026; Wainer J, 2013, SCIENTOMETRICS, V96, P395, DOI 10.1007/s11192-013-0969-9; Wainer J, 2011, COMMUN ACM, V54, P141, DOI 10.1145/1941487.1941517; Waltman L, 2014, J ASSOC INF SCI TECH, V65, P433, DOI 10.1002/asi.23040	23	3	3	3	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2015	10	3							e0118446	10.1371/journal.pone.0118446	http://dx.doi.org/10.1371/journal.pone.0118446			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CD9NQ	25789480	Green Published, Green Submitted, gold			2022-12-27	WOS:000351425400030
J	Boyer, L; Chouaid, C; Bastuji-Garin, S; Marcos, E; Margarit, L; Le Corvoisier, P; Vervoitte, L; Hamidou, L; Frih, L; Audureau, E; Covali-Noroc, A; Andujar, P; Saakashvili, Z; Lino, A; Ghaleh, B; Hue, S; Derumeaux, G; Housset, B; Dubois-Rande, JL; Boczkowski, J; Maitre, B; Adnot, S				Boyer, Laurent; Chouaid, Christos; Bastuji-Garin, Sylvie; Marcos, Elisabeth; Margarit, Laurent; Le Corvoisier, Philippe; Vervoitte, Laetitia; Hamidou, Leila; Frih, Lamia; Audureau, Etienne; Covali-Noroc, Ala; Andujar, Pascal; Saakashvili, Zakaria; Lino, Anne; Ghaleh, Bijan; Hue, Sophie; Derumeaux, Genevieve; Housset, Bruno; Dubois-Rande, Jean-Luc; Boczkowski, Jorge; Maitre, Bernard; Adnot, Serge			Aging-Related Systemic Manifestations in COPD Patients and Cigarette Smokers	PLOS ONE			English	Article							OBSTRUCTIVE PULMONARY-DISEASE; ARTERIAL STIFFNESS; CELL SENESCENCE; TELOMERE LENGTH; COMORBIDITIES; INFLAMMATION; LUNG; OSTEOPOROSIS; PROGRESSION	Rationale Chronic obstructive pulmonary disease (COPD) is often associated with age-related systemic abnormalities that adversely affect the prognosis. Whether these manifestations are linked to the lung alterations or are independent complications of smoking remains unclear. Objectives To look for aging-related systemic manifestations and telomere shortening in COPD patients and smokers with minor lung destruction responsible for a decline in the diffusing capacity for carbon monoxide (DLCO) corrected for alveolar volume (KCO). Methods Cross-sectional study in 301 individuals (100 with COPD, 100 smokers without COPD, and 101 nonsmokers without COPD). Measurements and Main Results Compared to control smokers, patients with COPD had higher aortic pulse-wave velocity (PWV), lower bone mineral density (BMD) and appendicular skeletal muscle mass index (ASMMI), and shorter telomere length (TL). Insulin resistance (HOMA-IR) and glomerular filtration rate (GFR) were similar between control smokers and COPD patients. Smokers did not differ from nonsmokers for any of these parameters. However, smokers with normal spirometry but low K-CO had lower ASMMI values compared to those with normal K-CO. Moreover, female smokers with low K-CO, had lower BMD and shorter TL compared to those with normal K-CO. Conclusions Aging-related abnormalities in patients with COPD are also found in smokers with minor lung dysfunction manifesting as a K-CO decrease. Decreased K-CO might be useful, particularly among women, for identifying smokers at high risk for aging-related systemic manifestations and telomere shortening.	[Boyer, Laurent; Margarit, Laurent; Hamidou, Leila; Covali-Noroc, Ala; Lino, Anne; Derumeaux, Genevieve; Adnot, Serge] Hop Henri Mondor, AP HP, DHU ATVB, Dept Physiol Explorat Fonct, F-94010 Creteil, France; [Boyer, Laurent; Chouaid, Christos; Derumeaux, Genevieve; Boczkowski, Jorge; Maitre, Bernard; Adnot, Serge] INSERM U955, F-94010 Creteil, France; [Boyer, Laurent; Chouaid, Christos; Derumeaux, Genevieve; Boczkowski, Jorge; Maitre, Bernard; Adnot, Serge] Univ Paris Est UPEC, UMR U955, Fac Med, F-94010 Creteil, France; [Chouaid, Christos; Marcos, Elisabeth; Andujar, Pascal; Saakashvili, Zakaria; Housset, Bruno; Maitre, Bernard] Ctr Hosp Intercommunal, DHU ATVB, Dept Pneumol & Pathol Profess, F-94000 Creteil, France; [Bastuji-Garin, Sylvie; Audureau, Etienne] Hop Henri Mondor, AP HP, Dept Sante Publ, F-94010 Creteil, France; [Bastuji-Garin, Sylvie; Audureau, Etienne] Univ Paris Est UPEC, Fac Med, LIC, EA4393, F-94010 Creteil, France; [Le Corvoisier, Philippe; Vervoitte, Laetitia] Hop Henri Mondor, AP HP, INSERM, Ctr Invest Clin 1430, F-94010 Creteil, France; [Frih, Lamia] Hop Henri Mondor, AP HP, Dept Addictol, F-94010 Creteil, France; [Ghaleh, Bijan] Hop Henri Mondor, AP HP, Plateforme Ressources Biol, F-94010 Creteil, France; [Hue, Sophie] Hop Henri Mondor, AP HP, Dept Immunol Biol, F-94010 Creteil, France; [Dubois-Rande, Jean-Luc] Hop Henri Mondor, AP HP, DHU ATVB, Dept Cardiol, F-94010 Creteil, France	Assistance Publique Hopitaux Paris (APHP); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Hopital Universitaire Henri-Mondor - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); CHI Creteil; Assistance Publique Hopitaux Paris (APHP); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Hopital Universitaire Henri-Mondor - APHP; Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Assistance Publique Hopitaux Paris (APHP); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Hopital Universitaire Henri-Mondor - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); Assistance Publique Hopitaux Paris (APHP); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Hopital Universitaire Henri-Mondor - APHP; Assistance Publique Hopitaux Paris (APHP); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Hopital Universitaire Henri-Mondor - APHP; Assistance Publique Hopitaux Paris (APHP); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Hopital Universitaire Henri-Mondor - APHP; Assistance Publique Hopitaux Paris (APHP); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Hopital Universitaire Henri-Mondor - APHP	Boyer, L (corresponding author), Hop Henri Mondor, AP HP, DHU ATVB, Dept Physiol Explorat Fonct, F-94010 Creteil, France.	laurent.boyer@hmn.aphp.fr	christos, chouaid/R-4477-2018; le corvoisier, philippe/AAO-2862-2020; Boczkowski, Jorge/S-7474-2018; Audureau, Etienne/AHE-2826-2022; Audureau, Etienne/R-4359-2018; Bastuji-Garin, Sylvie/R-3479-2018; DERUMEAUX, Genevieve A/T-2489-2018; Andujar, Pascal/A-2395-2013	christos, chouaid/0000-0002-4290-5524; Boczkowski, Jorge/0000-0001-6619-5785; Audureau, Etienne/0000-0002-6166-149X; Audureau, Etienne/0000-0002-6166-149X; Bastuji-Garin, Sylvie/0000-0001-9855-5183; DERUMEAUX, Genevieve A/0000-0003-1471-1631; Le Corvoisier, Philippe/0000-0003-0402-9591; Boyer, Laurent/0000-0002-2608-6696; Maitre, Bernard/0000-0002-8061-1252; Ghaleh, Bijan/0000-0003-0061-5462; Andujar, Pascal/0000-0002-9408-7033; HUE, Sophie/0000-0002-2530-7346	Institut National de la Sante et de la Recherche Medicale (INSERM) [C09-11]	Institut National de la Sante et de la Recherche Medicale (INSERM)(Institut National de la Sante et de la Recherche Medicale (Inserm))	This research was supported by the Institut National de la Sante et de la Recherche Medicale (INSERM) grant C09-11. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amsellem V, 2011, AM J RESP CRIT CARE, V184, P1358, DOI 10.1164/rccm.201105-0802OC; Barnes PJ, 2009, EUR RESPIR J, V33, P1165, DOI 10.1183/09031936.00128008; Baumgartner RN, 1998, AM J EPIDEMIOL, V147, P755, DOI 10.1093/oxfordjournals.aje.a009520; Benetos A, 2001, HYPERTENSION, V37, P381, DOI 10.1161/01.HYP.37.2.381; Bon J, 2011, AM J RESP CRIT CARE, V183, P885, DOI 10.1164/rccm.201004-0666OC; Campisi J, 2005, CELL, V120, P513, DOI 10.1016/j.cell.2005.02.003; CAUBERGHS M, 1993, AM REV RESPIR DIS, V147, P379, DOI 10.1164/ajrccm/147.2.379; Chandra D, 2012, CHEST, V142, P655, DOI 10.1378/chest.11-1456; Conboy IM, 2005, NATURE, V433, P760, DOI 10.1038/nature03260; Dagouassat M, 2013, AM J RESP CRIT CARE, V187, P703, DOI 10.1164/rccm.201208-1361OC; Ferguson GT, 2009, CHEST, V136, P1456, DOI 10.1378/chest.08-3016; Gordon C, 2011, AM J RESP CRIT CARE, V184, P224, DOI 10.1164/rccm.201012-2061OC; Hoesein FAAM, 2011, EUR RESPIR J, V38, P1012, DOI 10.1183/09031936.00050711; Kirby M, 2013, THORAX, V68, P752, DOI 10.1136/thoraxjnl-2012-203108; Koenker R, 2001, J ECON PERSPECT, V15, P143, DOI 10.1038/s41592-019-0406-y; Kuilman T, 2008, CELL, V133, P1019, DOI 10.1016/j.cell.2008.03.039; Marquis K, 2002, AM J RESP CRIT CARE, V166, P809, DOI 10.1164/rccm.2107031; McAllister DA, 2007, AM J RESP CRIT CARE, V176, P1208, DOI 10.1164/rccm.200707-1080OC; Morla M, 2006, EUR RESPIR J, V27, P525, DOI 10.1183/09031936.06.00087005; Noureddine H, 2011, CIRC RES, V109, P543, DOI 10.1161/CIRCRESAHA.111.241299; QUANJER PH, 1993, EUR RESPIR J, V6, P5, DOI 10.1183/09041950.005s1693; Sabit R, 2007, AM J RESP CRIT CARE, V175, P1259, DOI 10.1164/rccm.200701-067OC; Savale L, 2009, AM J RESP CRIT CARE, V179, P566, DOI 10.1164/rccm.200809-1398OC; Sin DD, 2003, CIRCULATION, V107, P1514, DOI 10.1161/01.CIR.0000056767.69054.B3; Thomsen M, 2012, AM J RESP CRIT CARE, V186, P982, DOI 10.1164/rccm.201206-1113OC; Tsuji T, 2006, AM J RESP CRIT CARE, V174, P886, DOI 10.1164/rccm.200509-1374OC; Valdes AM, 2005, LANCET, V366, P662, DOI 10.1016/S0140-6736(05)66630-5; Van Remoortel H, 2014, AM J RESP CRIT CARE, V189, P30, DOI 10.1164/rccm.201307-1240OC; Vanfleteren LEGW, 2013, AM J RESP CRIT CARE, V187, P728, DOI 10.1164/rccm.201209-1665OC; Villeda SA, 2011, NATURE, V477, P90, DOI 10.1038/nature10357	30	22	23	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2015	10	3							e0121539	10.1371/journal.pone.0121539	http://dx.doi.org/10.1371/journal.pone.0121539			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9BN	25785739	gold, Green Published, Green Submitted			2022-12-27	WOS:000352138500212
J	Chen, T; Wang, C; Wu, F; Zhang, XB; Yang, H; Deng, X; He, QC; Li, WF; Li, G				Chen, Tian; Wang, Chen; Wu, Fang; Zhang, Xuebang; Yang, Han; Deng, Xia; He, Qiancheng; Li, Wenfeng; Li, Gang			Altered Localization of p120 Catenin in the Cytoplasm Rather than the Membrane Correlates with Poor Prognosis in Esophageal Squamous Cell Carcinoma	PLOS ONE			English	Article							E-CADHERIN; P120(CTN) EXPRESSION; REDUCED EXPRESSION; BETA-CATENIN; ADHESION; CANCER; P120-CATENIN; SURVIVAL; BINDING; REGION	Background P120 catenin (p120ctn), a regulator of cell adhesion, has previously been found in many malignancies, and suggested a role in invasion, metastasis and survival. The aim of this study was to investigate correlations between altered localization of p120ctn and clinical-pathological characteristics in esophageal squamous cell carcinoma (ESCC). Methods Immunohistochemical staining for p120(ctn) was performed on tissue samples from 118 patients with ESCC. The expression of p120(ctn) was scored for intensity and cellular localization by Image-pro Plus 6.0. Correlations between immunohistochemical staining of p120(ctn) and pathological characteristics and clinical prognosis were determined using SPSS 18.0 software. Results Membrane expression of p120(ctn) in ESCCs was lower than that in adjacentnormal esophageal epithelial tissues (P = 0.041), while overall cellular expression of p120(ctn) was not different between the two tissue types (P = 0.787). Furthermore, neither overall cellular expression nor localized membrane expression was associated with histological and clinical variables. The high ratio of membrane expression to overall cellular expression (M/C) of p120(ctn) was inversely associated with lymph node invasion (P = 0.001), tumor differentiation (P = 0.012) and advanced tumor stage (P = 0.005); however, it was poorly associated with T stage (P = 0.274). The high M/C ratio of p120(ctn) was inversely correlated with poor survival; the 5-year OS (overall survival) and the 5-year DFS (disease free survival) for the high M/C ratio group were significantly higher than those of the low M/C ratio group (41.0% vs. 6.7%, P = 0.000; 44.1% vs. 24.9%, P = 0.007). Both the M/C ratio of p120(ctn) and N status were independent variables for the prediction of overall survival (P = 0.007 and P = 0.027). The M/C of p120(ctn) predicted a 0.49-fold risk of ESCC death (p = 0.007, 95% CI 0.29-0.83). Conclusions The reduced M/C ratio of p120(ctn) acted as an independent prognostic factor for ESCC patient survival and for the migration and invasive behavior of the disease.	[Chen, Tian] Ningbo Med Treatment Ctr Lihuili Hosp, Dept Radiotherapy, Ningbo, Zhejiang, Peoples R China; [Wang, Chen] Taizhou Enze Med Ctr Luqiao Hosp, Dept Gastroenterol, Taizhou, Zhejiang, Peoples R China; [Wu, Fang] Wenzhou Med Univ, Dept Gastroenterol, Affiliated Hosp 1, Wenzhou, Zhejiang, Peoples R China; [Zhang, Xuebang; Yang, Han; Deng, Xia; Li, Wenfeng; Li, Gang] Wenzhou Med Univ, Dept Chemoradiat Oncol, Affiliated Hosp 1, Wenzhou, Zhejiang, Peoples R China; [He, Qiancheng] Wenzhou Med Univ, Affiliated Hosp 1, Dept Gen Med, Wenzhou, Zhejiang, Peoples R China	Wenzhou Medical University; Wenzhou Medical University; Wenzhou Medical University	Wu, F (corresponding author), Wenzhou Med Univ, Dept Gastroenterol, Affiliated Hosp 1, Wenzhou, Zhejiang, Peoples R China.	wufangfyy@163.com; zhangxuebangfyy@163.com; leewf2012@163.com; andrewlee0923@163.com			Wenzhou Bureau of Science and Technology [Y20140366, Y20140281, Y20140354]	Wenzhou Bureau of Science and Technology	This work was supported by the Medicine and Health Grant from Wenzhou Bureau of Science and Technology (Y20140366, Y20140281, Y20140354). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams CL, 1998, J CELL BIOL, V142, P1105, DOI 10.1083/jcb.142.4.1105; Adams CL, 1996, J CELL BIOL, V135, P1899, DOI 10.1083/jcb.135.6.1899; Anastasiadis PZ, 2000, J CELL SCI, V113, P1319; Bellovin DI, 2005, CANCER RES, V65, P10938, DOI 10.1158/0008-5472.CAN-05-1947; Chung Y, 2007, ANN SURG ONCOL, V14, P3260, DOI 10.1245/s10434-007-9511-8; Corsino PE, 2008, NEOPLASIA, V10, P1240, DOI 10.1593/neo.08710; Enzinger PC, 2003, NEW ENGL J MED, V349, P2241, DOI 10.1056/NEJMra035010; Feng ZE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026399; Gold JS, 1998, CANCER LETT, V132, P193, DOI 10.1016/S0304-3835(98)00190-6; Grosheva I, 2001, J CELL SCI, V114, P695; Ishizaki Y, 2004, J DERMATOL SCI, V34, P99, DOI 10.1016/j.jdermsci.2003.12.001; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Kowalczyk AP, 2004, CURR OPIN CELL BIOL, V16, P522, DOI 10.1016/j.ceb.2004.07.001; Lo Muzio L, 2002, ORAL ONCOL, V38, P64, DOI 10.1016/S1368-8375(01)00027-6; Mariner DJ, 2001, J BIOL CHEM, V276, P28006, DOI 10.1074/jbc.M102443200; Mayerle J, 2003, GASTROENTEROLOGY, V124, P949, DOI 10.1053/gast.2003.50142; Neto BS, 2008, BJU INT, V101, P746, DOI 10.1111/j.1464-410X.2007.07264.x; Ohkubo T, 1999, J BIOL CHEM, V274, P21409, DOI 10.1074/jbc.274.30.21409; Parkin DM, 2005, CA CANC J CLIN, V55, P74; Petak I, 2010, NAT REV DRUG DISCOV, V9, P523, DOI 10.1038/nrd3135; Petrova YI, 2012, MOL BIOL CELL, V23, P2092, DOI 10.1091/mbc.E11-12-1060; REYNOLDS AB, 1994, MOL CELL BIOL, V14, P8333, DOI 10.1128/MCB.14.12.8333; REYNOLDS AB, 1992, ONCOGENE, V7, P2439; Reynolds AB, 2007, BBA-MOL CELL RES, V1773, P2, DOI 10.1016/j.bbamcr.2006.09.019; Sarrio D, 2004, ONCOGENE, V23, P3272, DOI 10.1038/sj.onc.1207439; Sato F, 2001, BRIT J SURG, V88, P426, DOI 10.1046/j.1365-2168.2001.01687.x; Shibata T, 2004, AM J PATHOL, V164, P2269, DOI 10.1016/S0002-9440(10)63783-2; STAPPERT J, 1994, CELL ADHES COMMUN, V2, P319, DOI 10.3109/15419069409014207; Tachibana M, 2004, AM J SURG, V188, P254, DOI 10.1016/j.amjsurg.2004.06.004; Talvinen K, 2010, J CANCER RES CLIN, V136, P1377, DOI 10.1007/s00432-010-0789-8; Thoreson MA, 2002, DIFFERENTIATION, V70, P583, DOI 10.1046/j.1432-0436.2002.700911.x; Thoreson MA, 2000, J CELL BIOL, V148, P189, DOI 10.1083/jcb.148.1.189; van Oort IM, 2007, PROSTATE, V67, P1432, DOI 10.1002/pros.20626; Wang EH, 2006, HISTOL HISTOPATHOL, V21, P841, DOI 10.14670/HH-21.841; Wijnhoven BPL, 2005, J SURG ONCOL, V92, P116, DOI 10.1002/jso.20344; Xiao ZF, 2005, INT J RADIAT ONCOL, V62, P82, DOI 10.1016/j.ijrobp.2004.08.046; Yap AS, 1998, J CELL BIOL, V141, P779, DOI 10.1083/jcb.141.3.779; Zhai B, 2008, WORLD J GASTROENTERO, V14, P3739, DOI 10.3748/wjg.14.3739	38	18	22	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2015	10	3							e0118645	10.1371/journal.pone.0118645	http://dx.doi.org/10.1371/journal.pone.0118645			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9BN	25785604	Green Published, gold, Green Submitted			2022-12-27	WOS:000352138500042
J	Gentile, MT; Ciniglia, C; Reccia, MG; Volpicelli, F; Gatti, M; Thellung, S; Florio, T; Melone, MAB; Colucci-D'Amato, L				Gentile, Maria Teresa; Ciniglia, Claudia; Reccia, Mafalda G.; Volpicelli, Floriana; Gatti, Monica; Thellung, Stefano; Florio, Tullio; Melone, Mariarosa A. B.; Colucci-D'Amato, Luca			Ruta graveolens L. Induces Death of Glioblastoma Cells and Neural Progenitors, but Not of Neurons, via ERK 1/2 and AKT Activation	PLOS ONE			English	Article							ESTROGEN-BINDING-SITES; IN-VITRO; NATURAL-PRODUCTS; TERMINAL DIFFERENTIATION; SOMATOSTATIN INHIBITION; DRUG DISCOVERY; RET ONCOGENE; GLIOMA-CELLS; EXPRESSION; PROLIFERATION	Glioblastoma multiforme is a highly aggressive brain tumor whose prognosis is very poor. Due to early invasion of brain parenchyma, its complete surgical removal is nearly impossible, and even after aggressive combined treatment (association of surgery and chemo-and radio-therapy) five-year survival is only about 10%. Natural products are sources of novel compounds endowed with therapeutic properties in many human diseases, including cancer. Here, we report that the water extract of Ruta graveolens L., commonly known as rue, induces death in different glioblastoma cell lines (U87MG, C6 and U138) widely used to test novel drugs in preclinical studies. Ruta graveolens' effect was mediated by ERK1/2 and AKT activation, and the inhibition of these pathways, via PD98058 and wortmannin, reverted its antiproliferative activity. Rue extract also affects survival of neural precursor cells (A1) obtained from embryonic mouse CNS. As in the case of glioma cells, rue stimulates the activation of ERK1/2 and AKT in A1 cells, whereas their blockade by pharmacological inhibitors prevents cell death. Interestingly, upon induction of differentiation and cell cycle exit, A1 cells become resistant to rue's noxious effects but not to those of temozolomide and cisplatin, two alkylating agents widely used in glioblastoma therapy. Finally, rutin, a major component of the Ruta graveolens water extract, failed to cause cell death, suggesting that rutin by itself is not responsible for the observed effects. In conclusion, we report that rue extracts induce glioma cell death, discriminating between proliferating/undifferentiated and non-proliferating/differentiated neurons. Thus, it can be a promising tool to isolate novel drugs and also to discover targets for therapeutic intervention.	[Gentile, Maria Teresa; Ciniglia, Claudia; Reccia, Mafalda G.; Colucci-D'Amato, Luca] Univ Naples 2, Dept Environm Biol & Pharmaceut Sci & Technol, Lab Mol & Cellular Pathol, Caserta, Italy; [Volpicelli, Floriana] Univ Naples Federico II, Dept Pharm, Naples, Italy; [Volpicelli, Floriana] CNR, Inst Genet & Biophys Adriano Buzzati Traverso, I-80125 Naples, Italy; [Gatti, Monica; Thellung, Stefano; Florio, Tullio] Univ Genoa, Dept Internal Med, Pharmacol Sect, I-16126 Genoa, Italy; [Gatti, Monica; Thellung, Stefano; Florio, Tullio] Univ Genoa, CEBR, Genoa, Italy; [Melone, Mariarosa A. B.] Univ Naples 2, Dept Clin & Expt Med & Surg, Div Neurol, Naples, Italy; [Melone, Mariarosa A. B.; Colucci-D'Amato, Luca] Univ Naples 2, CIRN, Naples, Italy	Universita della Campania Vanvitelli; University of Naples Federico II; Consiglio Nazionale delle Ricerche (CNR); Istituto di Genetica e Biofisica "Adriano Buzzati-Traverso" (IGB-CNR); University of Genoa; University of Genoa; Universita della Campania Vanvitelli; Universita della Campania Vanvitelli	Colucci-D'Amato, L (corresponding author), Univ Naples 2, Dept Environm Biol & Pharmaceut Sci & Technol, Lab Mol & Cellular Pathol, Caserta, Italy.	luca.colucci@unina2.it	terracciano, chiara/C-2955-2018; Melone, Mariarosa Anna Beatrice/N-6788-2015; Thellung, Stefano/L-8802-2015; FLORIO, TULLIO/ABG-3182-2020; Florio, Tullio/A-2211-2012; CINIGLIA, CLAUDIA/D-7053-2017	terracciano, chiara/0000-0002-1853-5578; Melone, Mariarosa Anna Beatrice/0000-0002-7213-9277; Thellung, Stefano/0000-0002-2010-331X; Florio, Tullio/0000-0002-2394-996X; GENTILE, Maria Teresa/0000-0003-4239-5330; Reccia, Mafalda Giovanna/0000-0002-5568-0221; CINIGLIA, CLAUDIA/0000-0001-5819-6921; Monica, Gatti/0000-0002-2016-0285; Volpicelli, Floriana/0000-0003-0618-5504	Progetto Sicurezza, sostenibilita e competitivita nelle produzioni Agroalimentari delle Campania "CARINA"; Network per la salvaguardia e la gestione delle risorse genetiche agro-alimentari "AGRIGENET"; Programma di Ricerca Scientifica di Rilevante Interesse Nazionale (PRIN) [20109MXHMR_004]	Progetto Sicurezza, sostenibilita e competitivita nelle produzioni Agroalimentari delle Campania "CARINA"; Network per la salvaguardia e la gestione delle risorse genetiche agro-alimentari "AGRIGENET"; Programma di Ricerca Scientifica di Rilevante Interesse Nazionale (PRIN)(Ministry of Education, Universities and Research (MIUR))	This work was supported by Progetto Sicurezza, sostenibilita e competitivita nelle produzioni Agroalimentari delle Campania "CARINA" (POR FSE 2007-2013), Network per la salvaguardia e la gestione delle risorse genetiche agro-alimentari "AGRIGENET" (PSR 2007/2013, to CC), and Programma di Ricerca Scientifica di Rilevante Interesse Nazionale (PRIN, 20109MXHMR_004, to MABM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashida H, 2000, FEBS LETT, V476, P213, DOI 10.1016/S0014-5793(00)01730-0; Auf G, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-597; Barbieri F, 2008, ENDOCRINOLOGY, V149, P4736, DOI 10.1210/en.2007-1762; BASTIDA E, 1984, BLOOD, V64, P177; BENDA P, 1968, SCIENCE, V161, P370, DOI 10.1126/science.161.3839.370; Brower V, 2008, J NATL CANCER I, V100, P838, DOI 10.1093/jnci/djn199; Brzezianska E, 2011, FRONT BIOSCI-LANDMRK, V16, P422, DOI 10.2741/3696; Burrell K, 2014, CANCER RES, V74, P3727, DOI 10.1158/0008-5472.CAN-13-3119; Califano D, 2000, J BIOL CHEM, V275, P19297, DOI 10.1074/jbc.M905866199; Califano D, 1996, P NATL ACAD SCI USA, V93, P7933, DOI 10.1073/pnas.93.15.7933; Chappell WH, 2011, ONCOTARGET, V2, P135, DOI 10.18632/oncotarget.240; Chen CC, 2001, J NAT PROD, V64, P990, DOI 10.1021/np000582y; Cheng Yen-Po, 2014, Surg Neurol Int, V5, P78, DOI 10.4103/2152-7806.133205; Clara CA, 2014, NEUROPATHOLOGY, V34, P343, DOI 10.1111/neup.12111; Colucci-D'Amato GL, 2000, J BIOL CHEM, V275, P19306, DOI 10.1074/jbc.275.25.19306; Colucci-D'Amato GL, 1999, EXP CELL RES, V252, P383, DOI 10.1006/excr.1999.4636; Colucci-D'Amato L, 2003, BIOESSAYS, V25, P1085, DOI 10.1002/bies.10355; CONWAY GA, 1979, J ETHNOPHARMACOL, V1, P241, DOI 10.1016/S0378-8741(79)80014-8; Deschenes-Simard X, 2014, CANCER RES, V74, P412, DOI 10.1158/0008-5472.CAN-13-2381; Fadlalla K, 2011, ANTICANCER RES, V31, P233; Florio T, 1999, MOL ENDOCRINOL, V13, P24, DOI 10.1210/me.13.1.24; Florio T, 2012, DRUG DISCOV TODAY, V17, P1103, DOI 10.1016/j.drudis.2012.06.001; Friedmann-Morvinski D, 2014, EMBO REP, V15, P244, DOI 10.1002/embr.201338254; Friedmann-Morvinski D, 2012, SCIENCE, V338, P1080, DOI 10.1126/science.1226929; Gentile MT, 2012, J NEUROCHEM, V123, P963, DOI 10.1111/jnc.12004; Gong X, 2011, NEUROLOGY, V76, P1126, DOI 10.1212/WNL.0b013e318212a89f; Gronych J, 2014, CELL, V157, P525, DOI 10.1016/j.cell.2014.04.001; Gutierrez-Pajares JL, 2003, REPROD TOXICOL, V17, P667, DOI 10.1016/j.reprotox.2003.07.002; Haghighitalab A, 2014, Z NATURFORSCH C, V69, P99, DOI 10.5560/ZNC.2013-0006; Hilario A, 2014, AM J NEURORADIOL, V35, P1096, DOI 10.3174/ajnr.A3837; Holand K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094132; Holland EC, 2000, NAT GENET, V25, P55, DOI 10.1038/75596; Ianora A, 2004, NATURE, V429, P403, DOI 10.1038/nature02526; Ilkanizadeh S, 2014, ADV CANCER RES, V121, P1, DOI 10.1016/B978-0-12-800249-0.00001-9; Jing Y, 2012, TOXICOL SCI, V125, P10, DOI 10.1093/toxsci/kfr256; Johnson BE, 2014, SCIENCE, V343, P189, DOI 10.1126/science.1239947; Kamson DO, 2014, NEURO-ONCOLOGY, V16, P1373, DOI 10.1093/neuonc/nou042; Kuzovkina I, 2004, PHYTOCHEMISTRY, V65, P1095, DOI 10.1016/j.phytochem.2004.03.003; Lee JS, 2014, NEURO-ONCOLOGY, V16, P191, DOI 10.1093/neuonc/not167; Li JWH, 2009, SCIENCE, V325, P161, DOI 10.1126/science.1168243; Li L, 2015, ONCOGENE, V34, P129, DOI 10.1038/onc.2013.534; Li L, 2014, INT J BIOCHEM CELL B, V53, P224, DOI 10.1016/j.biocel.2014.05.021; Luo F, 2014, MOL BIOSYST, V10, P1912, DOI 10.1039/c4mb00105b; Mace TA, 2014, CANCER IMMUNOL IMMUN, V63, P889, DOI 10.1007/s00262-014-1564-5; MARKAVERICH BM, 1984, CANCER RES, V44, P1515; Massa A, 2004, J BIOL CHEM, V279, P29004, DOI 10.1074/jbc.M403573200; McNamara Mairead G, 2013, Cancers (Basel), V5, P1103, DOI 10.3390/cancers5031103; Mielcke TR, 2012, EUR J MED CHEM, V48, P255, DOI 10.1016/j.ejmech.2011.12.023; Nguyen TTT, 2004, CARCINOGENESIS, V25, P647, DOI 10.1093/carcin/bgh052; Oszvald A, 2012, J NEURO-ONCOL, V109, P341, DOI 10.1007/s11060-012-0898-0; Pathak S, 2003, INT J ONCOL, V23, P975; Pollio A, 2008, J ETHNOPHARMACOL, V116, P469, DOI 10.1016/j.jep.2007.12.013; Porcile C, 2014, J CELL PHYSIOL, V229, P1444, DOI 10.1002/jcp.24582; Preethi KC, 2008, ASIAN PAC J CANCER P, V9, P763; Preusser M, 2011, ANN NEUROL, V70, P9, DOI 10.1002/ana.22425; RANELLETTI FO, 1992, INT J CANCER, V50, P486, DOI 10.1002/ijc.2910500326; Ratheesh M, 2013, INFLAMM RES, V62, P367, DOI 10.1007/s00011-013-0588-1; Ratheesh M, 2011, EXP TOXICOL PATHOL, V63, P285, DOI 10.1016/j.etp.2010.01.007; REHEMTULLA A, 1988, BIOCHEM CELL BIOL, V66, P1270, DOI 10.1139/o88-147; Reme T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066574; Rethy B, 2007, PLANTA MED, V73, P41, DOI 10.1055/s-2006-951747; Rizzo C, 1996, J BIOL CHEM, V271, P29497, DOI 10.1074/jbc.271.46.29497; Ruggiero A, 2013, J NEURO-ONCOL, V113, P513, DOI 10.1007/s11060-013-1145-z; Sallam AA, 2014, ORG BIOMOL CHEM, V12, P5295, DOI 10.1039/c4ob00553h; Seo BR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095588; Shi ZZ, 2010, MOL CANCER RES, V8, P615, DOI 10.1158/1541-7786.MCR-09-0264; Shibahara I, 2015, NEURO-ONCOLOGY, V17, P136, DOI 10.1093/neuonc/nou112; Skropeta D, 2014, NAT PROD REP, V31, P999, DOI 10.1039/c3np70118b; Spencer D, 2011, NEUROLOGY, V76, pE69, DOI 10.1212/WNL.0b013e318215b914; Sun YY, 2014, P NATL ACAD SCI USA, V111, P3538, DOI 10.1073/pnas.1313814111; Tamura K, 2014, J NEUROSURG, V120, P1010; van den Bent MJ, 2006, EUR J CANCER, V42, P582, DOI 10.1016/j.ejca.2005.06.031; Velazquez KT, 2014, J NUTR, V144, P868, DOI 10.3945/jn.113.188367; Vredenburgh JJ, 2009, NEURO-ONCOLOGY, V11, P80, DOI 10.1215/15228517-2008-075; Wang CY, 2014, AM J CHINESE MED, V42, P543, DOI 10.1142/S0192415X14500359; Xie J, 2014, ONCOL LETT, V7, P131, DOI 10.3892/ol.2013.1685; Ye Q, 2014, ONCOGENE, V33, P1828, DOI 10.1038/onc.2013.122; Yi L, 2014, NEUROMOL MED, V16, P578, DOI 10.1007/s12017-014-8310-1; Youland RS, 2013, NEURO-ONCOLOGY, V15, P1102, DOI 10.1093/neuonc/not080; Zheng HW, 2008, NATURE, V455, P1129, DOI 10.1038/nature07443; Zhuang WZ, 2012, CANCER SCI, V103, P684, DOI 10.1111/j.1349-7006.2011.02198.x; Zustovich F, 2009, ANTICANCER RES, V29, P4275	82	32	32	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2015	10	3							e0118864	10.1371/journal.pone.0118864	http://dx.doi.org/10.1371/journal.pone.0118864			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9BN	25785932	Green Published, gold, Green Submitted			2022-12-27	WOS:000352138500053
J	Hsu, YHH; Huang, ZY; Ferl, GZ; Ng, CM				Hsu, Yu-Han H.; Huang, Ziyin; Ferl, Gregory Z.; Ng, Chee M.			GPU-Accelerated Compartmental Modeling Analysis of DCE-MRI Data from Glioblastoma Patients Treated with Bevacizumab	PLOS ONE			English	Article							NONPARAMETRIC KINETIC-ANALYSIS; ANTIVASCULAR THERAPIES; CLINICAL-TRIALS; TUMORS	The compartment model analysis using medical imaging data is the well-established but extremely time consuming technique for quantifying the changes in microvascular physiology of targeted organs in clinical patients after antivascular therapies. In this paper, we present a first graphics processing unit-accelerated method for compartmental modeling of medical imaging data. Using this approach, we performed the analysis of dynamic contrast-enhanced magnetic resonance imaging data from bevacizumab-treated glioblastoma patients in less than one minute per slice without losing accuracy. This approach reduced the computation time by more than 120-fold comparing to a central processing unit-based method that performed the analogous analysis steps in serial and more than 17-fold comparing to the algorithm that optimized for central processing unit computation. The method developed in this study could be of significant utility in reducing the computational times required to assess tumor physiology from dynamic contrast-enhanced magnetic resonance imaging data in preclinical and clinical development of antivascular therapies and related fields.	[Hsu, Yu-Han H.; Huang, Ziyin; Ng, Chee M.] Childrens Hosp Philadelphia, Div Clin Pharmacol & Therapeut, Philadelphia, PA 19104 USA; [Ferl, Gregory Z.] Genentech Inc, Early Dev Pharmacokinet & Pharmacodynam, San Francisco, CA 94080 USA; [Ng, Chee M.] Univ Penn, Dept Pediat, Philadelphia, PA 19104 USA; [Ng, Chee M.] Univ Penn, Perelman Sch Med, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; Roche Holding; Genentech; University of Pennsylvania; University of Pennsylvania; Pennsylvania Medicine	Ng, CM (corresponding author), Childrens Hosp Philadelphia, Div Clin Pharmacol & Therapeut, Philadelphia, PA 19104 USA.	ngc1@email.chop.edu	Huang, Ziyin/L-2807-2013	Huang, Ziyin/0000-0002-7685-4278; Ferl, Gregory/0000-0002-9943-1569				BENET LZ, 1972, J PHARM SCI, V61, P536, DOI 10.1002/jps.2600610408; Bergamino M, 2014, PHYS MEDICA, V30, P635, DOI 10.1016/j.ejmp.2014.04.005; Eklund A, 2013, MED IMAGE ANAL, V17, P1073, DOI 10.1016/j.media.2013.05.008; Ferl GZ, 2012, CLIN PHARMACOL THER, V92, P118, DOI 10.1038/clpt.2012.63; Ferl GZ, 2011, J STAT SOFTW, V44, P1; Ferl GZ, 2010, MAGN RESON MED, V63, P1366, DOI 10.1002/mrm.22335; Hsu YHH, 2013, MAGN RESON IMAGING, V31, P618, DOI 10.1016/j.mri.2012.09.007; Huang S, 2009, IPDPS RSQUO 09 P 200; Leach MO, 2005, BRIT J CANCER, V92, P1599, DOI 10.1038/sj.bjc.6602550; List, 2014, TOP 500 SUP SIT; McClanahan C, 2012, GPU TECHN C; NAKASHIMA E, 1989, J PHARMACOKINET BIOP, V17, P673, DOI 10.1007/BF01062124; NELDER JA, 1965, COMPUT J, V7, P308, DOI 10.1093/comjnl/7.4.308; O'Connor JPB, 2007, BRIT J CANCER, V96, P189, DOI 10.1038/sj.bjc.6603515; O'Connor JPB, 2012, NAT REV CLIN ONCOL, V9, P167, DOI 10.1038/nrclinonc.2012.2; Oldenhuis R, 2009, MINIMIZE FILE ID 242; Port RE, 1999, JMRI-J MAGN RESON IM, V10, P233; Port RE, 2010, MAGN RESON MED, V64, P408, DOI 10.1002/mrm.22399; Pratx G, 2011, MED PHYS, V38, P2685, DOI 10.1118/1.3578605; Rowland M, 1995, CLIN PHARMACOKINETIC; Sanders J., 2011, CUDA EXAMPLE INTRO G; Shams R, 2010, IEEE SIGNAL PROC MAG, V27, P50, DOI 10.1109/MSP.2009.935387; Shi L, 2012, QUANT IMAGING MED SU, V2, P63, DOI [10.3978/j.issn.2223-4292.2012.01.05, 10.3978/j.issn.2223-4292.2012.08.02]; Stone SS, 2008, J PARALLEL DISTR COM, V68, P1307, DOI 10.1016/j.jpdc.2008.05.013; Tofts PS, 1997, JMRI-J MAGN RESON IM, V7, P91, DOI 10.1002/jmri.1880070113; Vredenburgh JJ, 2007, CLIN CANCER RES, V13, P1253, DOI 10.1158/1078-0432.CCR-06-2309; Wang Chun-Hao, 2014, World J Methodol, V4, P46, DOI 10.5662/wjm.v4.i2.46; Yang XY, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/732848; Zweifel M, 2010, EUR J NUCL MED MOL I, V37, pS164, DOI 10.1007/s00259-010-1451-z	29	3	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2015	10	3							e0118421	10.1371/journal.pone.0118421	http://dx.doi.org/10.1371/journal.pone.0118421			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9BN	25786263	gold, Green Published, Green Submitted			2022-12-27	WOS:000352138500032
J	Jacob, MM; Pangeni, G; Gomes, BD; Souza, GS; da Silva, M; Silveira, LCL; Maguire, J; Parry, NRA; McKeefry, DJ; Kremers, J				Jacob, Mellina M.; Pangeni, Gobinda; Gomes, Bruno D.; Souza, Givago S.; da Silva Filho, Manoel; Silveira, Luiz Carlos L.; Maguire, John; Parry, Neil R. A.; McKeefry, Declan J.; Kremers, Jan			The Spatial Properties of L- and M-Cone Inputs to Electroretinograms That Reflect Different Types of Post-Receptoral Processing	PLOS ONE			English	Article							SPECTRAL SENSITIVITY; GANGLION-CELLS; FLICKER ERGS; TOPOGRAPHY; RESPONSES; SIGNALS; RETINA; SQUARE; SINE	We studied the spatial arrangement of L- and M-cone driven electroretinograms (ERGs) reflecting the activity of magno- and parvocellular pathways. L- and M-cone isolating sine wave stimuli were created with a four primary LED stimulator using triple silent substitution paradigms. Temporal frequencies were 8 and 12 Hz, to reflect cone opponent activity, and 30, 36 and 48 Hz to reflect luminance activity. The responses were measured for full-field stimuli and for different circular and annular stimuli. The ERG data confirm the presence of two different mechanisms at intermediate and high temporal frequencies. The responses measured at high temporal frequencies strongly depended upon spatial stimulus configuration. In the full-field conditions, the L-cone driven responses were substantially larger than the full-field M-cone driven responses and also than the L-cone driven responses with smaller stimuli. The M-cone driven responses at full-field and with 70 degrees diameter stimuli displayed similar amplitudes. The L-and M-cone driven responses measured at 8 and 12 Hz were of similar amplitude and approximately in counter-phase. The amplitudes were constant for most stimulus configurations. The results indicate that, when the ERG reflects luminance activity, it is positively correlated with stimulus size. Beyond 35 degrees retinal eccentricity, the retina mainly contains L-cones. Small stimuli are sufficient to obtain maximal ERGs at low temporal frequencies where the ERGs are also sensitive to cone-opponent processing.	[Jacob, Mellina M.; Pangeni, Gobinda; Kremers, Jan] Univ Hosp Erlangen, Dept Ophthalmol, Erlangen, Germany; [Jacob, Mellina M.; Gomes, Bruno D.; Souza, Givago S.; da Silva Filho, Manoel; Silveira, Luiz Carlos L.] Fed Univ Para, Inst Ciencias Biol, BR-66059 Belem, Para, Brazil; [Souza, Givago S.; Silveira, Luiz Carlos L.] Fed Univ Para, Nucleo Med Trop, BR-66059 Belem, Para, Brazil; [Parry, Neil R. A.] Univ Manchester, Inst Human Dev, Ctr Hearing & Vis Res, Manchester M13 9PL, Lancs, England; [Maguire, John; Parry, Neil R. A.] Cent Manchester Univ Hosp NHS Fdn Trust, Manchester Acad Hlth Sci Ctr, Manchester Royal Eye Hosp, Vis Sci Ctr, Manchester, Lancs, England; [Maguire, John; Parry, Neil R. A.; McKeefry, Declan J.; Kremers, Jan] Univ Bradford, Sch Optometry & Vis Sci, Bradford BD7 1DP, W Yorkshire, England	University of Erlangen Nuremberg; Universidade Federal do Para; Universidade Federal do Para; University of Manchester; Manchester Royal Eye Hospital; University of Manchester; University of Bradford	Kremers, J (corresponding author), Univ Hosp Erlangen, Dept Ophthalmol, Erlangen, Germany.	jan.kremers@uk-erlangen.de	Jacob, Mellina M/D-8507-2016; Souza, Givago/W-6393-2019; Gomes, Bruno Duarte/I-4499-2013; Kremers, Jan/X-3125-2019	Souza, Givago/0000-0002-4525-3971; Kremers, Jan/0000-0002-9293-7380; Monteiro Jacob, Mellina/0000-0002-0268-0332	DFG [KR1317/13-1]; CNPq; Hertie Foundation; CNPq [486545/2012-1]	DFG(German Research Foundation (DFG)); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Hertie Foundation; CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This work was supported by the DFG grant KR1317/13-1 to JK. MMJ was supported by a CNPq "Science without Borders" fellowship. MSF and LCLS are CNPq research fellows. JK was supported by the Hertie Foundation. NRAP's and JM's participations were facilitated by the Manchester Biomedical Research Centre and the Greater Manchester Comprehensive Local Research Network. GSS was supported by CNPq grant #486545/2012-1. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brainard DH, 2000, J OPT SOC AM A, V17, P607, DOI 10.1364/JOSAA.17.000607; Challa NK, 2010, OPHTHAL PHYSL OPT, V30, P503, DOI 10.1111/j.1475-1313.2010.00758.x; ESTEVEZ O, 1982, VISION RES, V22, P681, DOI 10.1016/0042-6989(82)90104-3; ESTEVEZ O, 1974, VISION RES, V14, P823, DOI 10.1016/0042-6989(74)90147-3; Hagstrom SA, 1997, DOC OPHTH P, V59, P59; Hagstrom SA, 1998, NEUROREPORT, V9, P1963, DOI 10.1097/00001756-199806220-00009; Hagstrom SA, 2000, J OPT SOC AM A, V17, P527, DOI 10.1364/JOSAA.17.000527; Harwerth RS, 2002, PROG RETIN EYE RES, V21, P91, DOI 10.1016/S1350-9462(01)00022-2; Hofer H, 2005, J NEUROSCI, V25, P9669, DOI 10.1523/JNEUROSCI.2414-05.2005; Jacobs GH, 1996, VISION RES, V36, P2587, DOI 10.1016/0042-6989(95)00335-5; Jacobs GH, 1997, VISUAL NEUROSCI, V14, P921, DOI 10.1017/S0952523800011639; Jacobs GH, 1993, COLOUR VISION DEFICI, VXI, P107; Kommanapalli D, 2014, J OPT SOC AM A, V31, pA113, DOI 10.1364/JOSAA.31.00A113; Kondo M, 2002, INVEST OPHTH VIS SCI, V43, P2500; Kremers J, 2003, J VISION, V3, P146, DOI 10.1167/3.2.3; Kremers J, 2003, PROG RETIN EYE RES, V22, P579, DOI 10.1016/S1350-9462(03)00049-1; Kremers J, 2000, J OPT SOC AM A, V17, P517, DOI 10.1364/JOSAA.17.000517; Kremers J, 2014, J OPT SOC AM A, V31, pA170, DOI 10.1364/JOSAA.31.00A170; Kremers J, 2012, J OPT SOC AM A, V29, pA306, DOI 10.1364/JOSAA.29.00A306; Kremers J, 2008, J VISION, V8, DOI 10.1167/8.15.11; Kremers J, 2010, INVEST OPHTH VIS SCI, V51, P577, DOI 10.1167/iovs.09-3899; Kuchenbecker JA, 2008, VISUAL NEUROSCI, V25, P301, DOI 10.1017/S0952523808080474; Maguire J., 2012, THESIS U MANCHESTER; McKeefry D, 2014, J OPT SOC AM A, V31, pA159, DOI 10.1364/JOSAA.31.00A159; Murray IJ, 2008, VISUAL NEUROSCI, V25, P327, DOI 10.1017/S095252380808036X; Murray IJ, 2004, VISUAL NEUROSCI, V21, P231, DOI 10.1017/S0952523804213268; NEITZ J, 1984, J OPT SOC AM A, V1, P1175, DOI 10.1364/JOSAA.1.001175; ODOM JV, 1992, OPTOMETRY VISION SCI, V69, P106, DOI 10.1097/00006324-199202000-00003; Pangeni G, 2010, VISUAL NEUROSCI, V27, P79, DOI 10.1017/S0952523810000179; Parry NRA, 2012, J PHYSIOL-LONDON, V590, P3141, DOI 10.1113/jphysiol.2011.226951; Shapiro AG, 1996, J OPT SOC AM A, V13, P2319, DOI 10.1364/JOSAA.13.002319; SMITH VC, 1992, J PHYSIOL-LONDON, V458, P191, DOI 10.1113/jphysiol.1992.sp019413; Solomon SG, 2002, VISION RES, V42, P2893, DOI 10.1016/S0042-6989(02)00414-5	33	19	19	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2015	10	3							e0121218	10.1371/journal.pone.0121218	http://dx.doi.org/10.1371/journal.pone.0121218			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9BN	25785459	Green Published, Green Submitted, gold			2022-12-27	WOS:000352138500202
J	Kono, H; Shirayama, K; Arimura, Y; Tachiwana, H; Kurumizaka, H				Kono, Hidetoshi; Shirayama, Kazuyoshi; Arimura, Yasuhiro; Tachiwana, Hiroaki; Kurumizaka, Hitoshi			Two Arginine Residues Suppress the Flexibility of Nucleosomal DNA in the Canonical Nucleosome Core	PLOS ONE			English	Article							MOLECULAR-DYNAMICS SIMULATIONS; CENP-A; CENTROMERIC NUCLEOSOME; ANGSTROM RESOLUTION; CRYSTAL-STRUCTURE; HISTONE VARIANT; PARTICLE; PARAMETERS; SOFTWARE; H3	The dynamics of nucleosomes containing either canonical H3 or its centromere-specific variant CENP-A were investigated using molecular dynamics simulations. The simulations showed that the histone cores were structurally stable during simulation periods of 100 ns and 50 ns, while DNA was highly flexible at the entry and exit regions and partially dissociated from the histone core. In particular, approximately 20-25 bp of DNA at the entry and exit regions of the CENP-A nucleosome exhibited larger fluctuations than DNA at the entry and exit regions of the H3 nucleosome. Our detailed analysis clarified that this difference in dynamics was attributable to a difference in two basic amino acids in the aN helix; two arginine (Arg) residues in H3 were substituted by lysine (Lys) residues at the corresponding sites in CENP-A. The difference in the ability to form hydrogen bonds with DNA of these two residues regulated the flexibility of nucleosomal DNA at the entry and exit regions. Our exonuclease III assay consistently revealed that replacement of these two Arg residues in the H3 nucleosome by Lys enhanced endonuclease susceptibility, suggesting that the DNA ends of the CENP-A nucleosome are more flexible than those of the H3 nucleosome. This difference in the dynamics between the two types of nucleosomes may be important for forming higher order structures in different phases.	[Kono, Hidetoshi] Japan Atom Energy Agcy, Mol Modeling & Simulat, Kyoto 6190215, Japan; [Shirayama, Kazuyoshi; Arimura, Yasuhiro; Tachiwana, Hiroaki; Kurumizaka, Hitoshi] Waseda Univ, Grad Sch Adv Sci & Engn, Struct Biol Lab, Shinjuku Ku, Tokyo 1628480, Japan	Japan Atomic Energy Agency; Waseda University	Kono, H (corresponding author), Japan Atom Energy Agcy, Mol Modeling & Simulat, 8-1-7 Kizugawa, Kyoto 6190215, Japan.	kono.hidetoshi@jaea.go.jp	Tachiwana, Hiroaki/AHB-3091-2022; Arimura, Yauhiro/GQH-5158-2022	Tachiwana, Hiroaki/0000-0001-9227-7653; arimura, yasuhiro/0000-0002-1903-6076; Kurumizaka, Hitoshi/0000-0001-7412-3722; Kono, Hidetoshi/0000-0001-5729-8707	Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan [23114723, 25116003]; MEXT [25116003]; Grants-in-Aid for Scientific Research [13J03931] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); MEXT(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This research was supported by Grants-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan [Nos. 23114723 and 25116003 to H.K]. Funding for open access charge: MEXT, No. 25116003. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2008, AMBER 10; BERENDSEN HJC, 1984, J CHEM PHYS, V81, P3684, DOI 10.1063/1.448118; Bishop TC, 2005, J BIOMOL STRUCT DYN, V22, P673, DOI 10.1080/07391102.2005.10507034; Biswas M, 2013, WIRES COMPUT MOL SCI, V3, P378, DOI 10.1002/wcms.1139; Biswas M, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002279; Black BE, 2008, CURR OPIN CELL BIOL, V20, P91, DOI 10.1016/j.ceb.2007.11.007; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; Davey CA, 2002, J MOL BIOL, V319, P1097, DOI 10.1016/S0022-2836(02)00386-8; DeRouchey J, 2013, BIOCHEMISTRY-US, V52, P3000, DOI 10.1021/bi4001408; Dunleavy EM, 2013, NAT STRUCT MOL BIOL, V20, P648, DOI 10.1038/nsmb.2602; Ettig R, 2011, BIOPHYS J, V101, P1999, DOI 10.1016/j.bpj.2011.07.057; Ferreira H, 2007, MOL CELL BIOL, V27, P4037, DOI 10.1128/MCB.02229-06; Hornak V, 2006, PROTEINS, V65, P712, DOI 10.1002/prot.21123; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Joung IS, 2008, J PHYS CHEM B, V112, P9020, DOI 10.1021/jp8001614; Kono H, 1999, PROTEINS, V35, P114, DOI 10.1002/(SICI)1097-0134(19990401)35:1<114::AID-PROT11>3.0.CO;2-T; Korolev N, 2014, BIOPOLYMERS, V101, P1051, DOI 10.1002/bip.22499; Lewis JD, 2003, CHROMOSOMA, V111, P473, DOI 10.1007/s00412-002-0226-0; Lu XJ, 2003, NUCLEIC ACIDS RES, V31, P5108, DOI 10.1093/nar/gkg680; Luger K, 1997, NATURE, V389, P251, DOI 10.1038/38444; Materese CK, 2009, J AM CHEM SOC, V131, P15005, DOI 10.1021/ja905376q; Maze I, 2014, NAT REV GENET, V15, P259, DOI 10.1038/nrg3673; Panchenko T, 2011, P NATL ACAD SCI USA, V108, P16588, DOI 10.1073/pnas.1113621108; Perez A, 2007, BIOPHYS J, V92, P3817, DOI 10.1529/biophysj.106.097782; Ponomarev SY, 2009, PHYS CHEM CHEM PHYS, V11, P10633, DOI 10.1039/b910937b; QUERALT R, 1995, J MOL EVOL, V40, P601, DOI 10.1007/BF00160507; Roccatano D, 2007, BIOPOLYMERS, V85, P407, DOI 10.1002/bip.20690; Roe DR, 2013, J CHEM THEORY COMPUT, V9, P3084, DOI 10.1021/ct400341p; Rohs R, 2009, NATURE, V461, P1248, DOI 10.1038/nature08473; Ruscio JZ, 2006, BIOPHYS J, V91, P4121, DOI 10.1529/biophysj.106.082099; RYCKAERT JP, 1977, J COMPUT PHYS, V23, P327, DOI 10.1016/0021-9991(77)90098-5; Sekulic N, 2010, NATURE, V467, P347, DOI 10.1038/nature09323; Silva NCE, 2007, J MOL BIOL, V370, P555, DOI 10.1016/j.jmb.2007.04.064; Tachiwana H, 2011, NATURE, V476, P232, DOI 10.1038/nature10258; Tachiwana H, 2010, P NATL ACAD SCI USA, V107, P10454, DOI 10.1073/pnas.1003064107; Voltz K, 2012, BIOPHYS J, V102, P849, DOI 10.1016/j.bpj.2011.11.4028	36	24	24	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2015	10	3							e0120635	10.1371/journal.pone.0120635	http://dx.doi.org/10.1371/journal.pone.0120635			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9BN	25786215	Green Published, Green Submitted, gold			2022-12-27	WOS:000352138500184
J	Nair, S; Schensul, JJ; Begum, S; Pednekar, MS; Oncken, C; Bilgi, SM; Pasi, AR; Donta, B				Nair, Saritha; Schensul, Jean J.; Begum, Shahina; Pednekar, Mangesh S.; Oncken, Cheryl; Bilgi, Sameena M.; Pasi, Achhelal R.; Donta, Balaiah			Use of Smokeless Tobacco by Indian Women Aged 18-40 Years during Pregnancy and Reproductive Years	PLOS ONE			English	Article							NICOTINE DEPENDENCE; ORAL-CANCER; PAN-MASALA; BETEL QUID; PRODUCTS; HEALTH; PREVALENCE; ABSORPTION; PATTERNS; MUMBAI	Objectives This paper discusses patterns of daily smokeless tobacco (SLT) use and correlates of poly SLT use among married women aged 18-40 years in a Mumbai slum community with implications for tobacco control. Methods Using a mixed methods approach, the study included a structured survey with 409 daily SLT users and in-depth interviews with 42 women. Participants for the survey were selected using a systematic sampling procedure (one woman in every fourth eligible household). Univariate and bivariate analysis, and multiple logistic regressions were conducted to identify demographic and social factors associated with women's use of poly SLT products. To illustrate survey results, in-depth interviews were analyzed using Atlas ti software. Results Sixty-four percent of the women surveyed used only one type of SLT; of these, 30% used mishri, 32% used pan with tobacco and the rest used chewed tobacco (11%), gul (17%) or gutkha (10%). Thirty-six percent used more than one type of SLT. Poly SLT users chewed or rubbed 50% more tobacco as compared to single users (mean consumption of tobacco per day: 9.54 vs. 6.49 grams; p<0.001). Women were more likely to be poly SLT users if they were illiterate as compared to literate (adjusted odds ratio [AOR]= 1.67; 95% confidence interval [CI]= 1.07-2.71), if they had lived in Mumbai for 10 years or more, versus less than ten years (AOR= 1.67, 95% CI= 1.03-2.71); and if their husband was a poly SLT user as compared to a non SLT user (AOR= 2.78, 95% CI= 1.63-4.76). No differences were noted between pregnant and non-pregnant women in SLT consumption patterns. Conclusions Tobacco control policies and programs must focus specifically on both social context and use patterns to address SLT use among women of reproductive age with special attention to poly SLT users, an understudied and vulnerable population.	Natl Inst Med Stat, New Delhi, India; [Schensul, Jean J.] Inst Community Res, Hartford, CT USA; [Begum, Shahina; Bilgi, Sameena M.; Pasi, Achhelal R.; Donta, Balaiah] Natl Inst Res Reprod Hlth, Mumbai, Maharashtra, India; [Pednekar, Mangesh S.] Healis Sekhsaria Inst Publ Hlth, Mumbai, Maharashtra, India; [Oncken, Cheryl] Univ Connecticut, Mansfield, CT USA	Indian Council of Medical Research (ICMR); ICMR - National Institute of Medical Statistics (NIMS); Indian Council of Medical Research (ICMR); ICMR - National Institute for Research in Reproductive Health (NIRRH); University of Connecticut		nairs@icmr.org.in		Nair, Saritha/0000-0002-4560-6124; Pednekar, Mangesh/0000-0001-6266-5356; Begum, Shahina/0000-0001-5590-2210	National Institutes of Health, USA [1R03TW008350-01]; Fogarty Center/National Cancer Institutes; FOGARTY INTERNATIONAL CENTER [R03TW008350] Funding Source: NIH RePORTER	National Institutes of Health, USA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Fogarty Center/National Cancer Institutes; FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC))	1. Grant Number 1R03TW008350-01 entitled: Smokeless Tobacco Use and Reproductive Health among Married Women in a Low-income area of Mumbai, India, National Institutes of Health, USA, Fogarty Center/National Cancer Institutes Drs J. Schensul and S Nair. 2. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amos A, 2012, TOB CONTROL, V21, P236, DOI 10.1136/tobaccocontrol-2011-050280; Benowitz N L, 1997, Adv Dent Res, V11, P336; BENOWITZ NL, 1988, CLIN PHARMACOL THER, V44, P23, DOI 10.1038/clpt.1988.107; Bhisey RA, 2012, INDIAN J CANCER, V49, P364, DOI 10.4103/0019-509X.107735; Bloch M, 2014, LANCET GLOB HEALTH, V2, pE489, DOI 10.1016/S2214-109X(14)70294-3; Boffetta P, 2008, LANCET ONCOL, V9, P667, DOI 10.1016/S1470-2045(08)70173-6; Crome IB, 2007, SEMIN FETAL NEONAT M, V12, P98, DOI 10.1016/j.siny.2006.12.002; Deshmukh J S, 1998, Indian Pediatr, V35, P33; DiFranza JR, 2012, PSYCHOPHARMACOLOGY, V219, P815, DOI 10.1007/s00213-011-2411-4; Digard H, 2013, NICOTINE TOB RES, V15, P255, DOI 10.1093/ntr/nts123; FAGERSTROM K O, 1990, Ear Nose and Throat Journal, V69, P763; FAGERSTROM KO, 1989, J BEHAV MED, V12, P159, DOI 10.1007/BF00846549; Fidler JA, 2011, ADDICTION, V106, P631, DOI 10.1111/j.1360-0443.2010.03226.x; Giovino GA, 2012, LANCET, V380, P668, DOI 10.1016/S0140-6736(12)61085-X; Government of India, 2013, PRESS NOT POV EST 20; Gupta P C, 1996, Tob Control, V5, P114, DOI 10.1136/tc.5.2.114; Gupta PC, 2012, INDIAN J CANCER, V49, P393, DOI 10.4103/0019-509X.107746; Gupta PC, 2006, EPIDEMIOLOGY, V17, P47, DOI 10.1097/01.ede.0000190545.19168.c4; Gupta PC, 2004, BMJ-BRIT MED J, V328, P1538, DOI 10.1136/bmj.38113.687882.EB; Gupta PC, 2003, RESPIROLOGY, V8, P419, DOI 10.1046/j.1440-1843.2003.00507.x; Gupta Prakash C, 2011, Indian J Public Health, V55, P199, DOI 10.4103/0019-557X.89948; Hussain HY, 2013, TOB INDUC DIS, V11, DOI 10.1186/1617-9625-11-14; Indian Institute of Population Sciences (IIPS), 2010, GLOB AD TOB SURV IND; International Institute for Population Sciences (IIPS) and Macro International, 2008, NAT FAM HLTH SURV NF; Jacob BJ, 2004, ORAL ONCOL, V40, P697, DOI 10.1016/j.oraloncology.2004.01.005; John RM, 2005, HEALTH POLICY, V71, P213, DOI 10.1016/j.healthpol.2004.08.008; Kostick KM, 2010, CULT MED PSYCHIAT, V34, P529, DOI 10.1007/s11013-010-9185-8; KRISHNA K, 1978, BRIT J OBSTET GYNAEC, V85, P726, DOI 10.1111/j.1471-0528.1978.tb15591.x; McNeill A, 2006, TOB CONTROL, V15, P64, DOI 10.1136/tc.2005.013011; Mehrotra P, 2014, INT J SEXUAL HLTH; Muhr T, 2010, ATLAS TI SCI SOFTWAR; Mukherjea A, 2012, TOB CONTROL, V21, P422, DOI 10.1136/tc.2010.042309; Nair S, 2012, INDIAN J CANCER, V49, P443, DOI 10.4103/0019-509X.107754; Nair U, 2004, MUTAGENESIS, V19, P251, DOI 10.1093/mutage/geh036; Narain Jai P, 2011, Indian J Public Health, V55, P151, DOI 10.4103/0019-557X.89940; Nemeth JM, 2012, J COMMUN HEALTH, V37, P1208, DOI 10.1007/s10900-012-9556-x; Nichter M, 2004, SOC SCI MED, V59, P415, DOI 10.1016/j.socscimed.2003.10.032; Norberg M, 2011, GLOB HLTH ACTION, P4; Patten CA, 2008, MATERN CHILD HLTH J, V12, pS30, DOI 10.1007/s10995-008-0331-7; Prasad J, 2003, NATL MED J INDIA, V16, P303; Pratinidhi Asha, 2010, Indian J Community Med, V35, P14, DOI 10.4103/0970-0218.62547; Radhika AG, 2014, OPEN J OBSTET GYNECO, V4, P371, DOI [10.4236/ojog.2014.47055, DOI 10.4236/OJOG.2014.47055]; Rastogi T, 2008, INT J EPIDEMIOL, V37, P147, DOI 10.1093/ije/dym219; Ravishankar T L, 2009, Indian J Dent Res, V20, P346, DOI 10.4103/0970-9290.57382; Reddy K, 2010, IMPLEMENTATION FRAME; Reddy KS, 2004, REPORT TOBACCO CONTR; Sankaranarayanan R, 2006, J MED SCREEN, V13, pS35; Schensul JJ, 2013, TOB CONTROL, V22, P324, DOI 10.1136/tobaccocontrol-2011-050148; Schensul JJ, 2005, ADDICT BEHAV, V30, P571, DOI 10.1016/j.addbeh.2004.05.022; Singh V, 2006, J ASSOC PHYSICIAN I, V54, P609; Thankappan KR, 2007, INDIAN J MED RES, V126, P300; Verma R C, 1983, Indian Pediatr, V20, P105; World Health Organization, 2013, WHO REC PREV MAN TOB	53	21	21	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2015	10	3							e0119814	10.1371/journal.pone.0119814	http://dx.doi.org/10.1371/journal.pone.0119814			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CE9BN	25786247	Green Published, gold, Green Submitted			2022-12-27	WOS:000352138500129
J	Pardo, MA; Gerrodette, T; Beier, E; Gendron, D; Forney, KA; Chivers, SJ; Barlow, J; Palacios, DM				Pardo, Mario A.; Gerrodette, Tim; Beier, Emilio; Gendron, Diane; Forney, Karin A.; Chivers, Susan J.; Barlow, Jay; Palacios, Daniel M.			Inferring Cetacean Population Densities from the Absolute Dynamic Topography of the Ocean in a Hierarchical Bayesian Framework	PLOS ONE			English	Article							EASTERN TROPICAL PACIFIC; SARDINE SARDINOPS-SAGAX; STATE-SPACE MODEL; NORTH PACIFIC; BLUE WHALE; DOLPHIN HABITATS; INTERANNUAL VARIABILITY; BALAENOPTERA-MUSCULUS; SPAWNING HABITAT; ENSO VARIABILITY	We inferred the population densities of blue whales (Balaenoptera musculus) and short-beaked common dolphins (Delphinus delphis) in the Northeast Pacific Ocean as functions of the water-column's physical structure by implementing hierarchical models in a Bayesian framework. This approach allowed us to propagate the uncertainty of the field observations into the inference of species-habitat relationships and to generate spatially explicit population density predictions with reduced effects of sampling heterogeneity. Our hypothesis was that the large-scale spatial distributions of these two cetacean species respond primarily to ecological processes resulting from shoaling and outcropping of the pycnocline in regions of wind-forced upwelling and eddy-like circulation. Physically, these processes affect the thermodynamic balance of the water column, decreasing its volume and thus the height of the absolute dynamic topography (ADT). Biologically, they lead to elevated primary productivity and persistent aggregation of low-trophic-level prey. Unlike other remotely sensed variables, ADT provides information about the structure of the entire water column and it is also routinely measured at high spatial-temporal resolution by satellite altimeters with uniform global coverage. Our models provide spatially explicit population density predictions for both species, even in areas where the pycnocline shoals but does not outcrop (e.g. the Costa Rica Dome and the North Equatorial Countercurrent thermocline ridge). Interannual variations in distribution during El Nino anomalies suggest that the population density of both species decreases dramatically in the Equatorial Cold Tongue and the Costa Rica Dome, and that their distributions retract to particular areas that remain productive, such as the more oceanic waters in the central California Current System, the northern Gulf of California, the North Equatorial Countercurrent thermocline ridge, and the more southern portion of the Humboldt Current System. We posit that such reductions in available foraging habitats during climatic disturbances could incur high energetic costs on these populations, ultimately affecting individual fitness and survival.	[Pardo, Mario A.] Univ Nacl Autonoma Mexico, Posgrado Ciencias Mar & Limnol, Mexico City 04510, DF, Mexico; [Pardo, Mario A.; Beier, Emilio] Ctr Invest Cient & Educ Super Ensenada, Unidad La Paz, La Paz 23050, Baja California, Mexico; [Gerrodette, Tim; Forney, Karin A.; Chivers, Susan J.; Barlow, Jay] NOAA, Marine Mammal & Turtle Div, Southwest Fisheries Sci Ctr, Natl Marine Fisheries Serv, La Jolla, CA 92037 USA; [Gendron, Diane] Inst Politecn Nacl, Ctr Interdisciplinario Ciencias Marinas, La Paz 23096, Baja California, Mexico; [Palacios, Daniel M.] Oregon State Univ, Marine Mammal Inst, Newport, OR 97365 USA	Universidad Nacional Autonoma de Mexico; CICESE - Centro de Investigacion Cientifica y de Educacion Superior de Ensenada; National Oceanic Atmospheric Admin (NOAA) - USA; Instituto Politecnico Nacional - Mexico; Oregon State University	Pardo, MA (corresponding author), Univ Nacl Autonoma Mexico, Posgrado Ciencias Mar & Limnol, Mexico City 04510, DF, Mexico.	mpardo@cicese.mx	Palacios, Daniel M./B-9180-2008; Pardo, Mario A./F-9815-2015; Barlow, Jay/D-3565-2019	Palacios, Daniel M./0000-0001-7069-7913; Pardo, Mario A./0000-0003-1248-3399; Barlow, Jay/0000-0001-7862-855X; Beier, Emilio/0000-0001-8478-7709	U.S. National Marine Fisheries Service; Consejo Nacional de Ciencia y Tecnologia (CONACyT) [168034-T-1753]; Posgrado en Ciencias del Mar y Limnologia at Universidad Nacional Autonoma de Mexico; Laboratorio de Ecologia de Cetaceos y Quelonios at Centro Interdisciplinario de Ciencias Marinas, Instituto Politecnico Nacional [SIP-20070803]; Cetacean Society International; Ocean Foundation; American Cetacean Society; Sociedad Mexicana de Mastozoologia Marina (SOMEMMA); Consejo Sudcaliforniano de Ciencia y Tecnologia (COSCyT); Interagency NASA Climate and Biological Response Program [NNX11AP71G]	U.S. National Marine Fisheries Service; Consejo Nacional de Ciencia y Tecnologia (CONACyT)(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); Posgrado en Ciencias del Mar y Limnologia at Universidad Nacional Autonoma de Mexico; Laboratorio de Ecologia de Cetaceos y Quelonios at Centro Interdisciplinario de Ciencias Marinas, Instituto Politecnico Nacional; Cetacean Society International; Ocean Foundation; American Cetacean Society; Sociedad Mexicana de Mastozoologia Marina (SOMEMMA); Consejo Sudcaliforniano de Ciencia y Tecnologia (COSCyT); Interagency NASA Climate and Biological Response Program	The survey cruises for cetacean data collection were funded by the U.S. National Marine Fisheries Service as part of its annual budget. This study received funds from Consejo Nacional de Ciencia y Tecnologia (CONACyT; http://www.conacyt.mx/), through the project "Un estudio de la corriente costera Mexicana y el Pacifico adyacente, con SeaGlider, cruceros oceanograficos y datos de satelite" (Grant No. 168034-T-1753; PI: EB), a Ph.D. scholarship and an international internship grant to MAP. The authors also received financial support from Posgrado en Ciencias del Mar y Limnologia (http://www.pcml.unam.mx/) at Universidad Nacional Autonoma de Mexico, and Laboratorio de Ecologia de Cetaceos y Quelonios at Centro Interdisciplinario de Ciencias Marinas, Instituto Politecnico Nacional (http://www.cicimar.ipn.mx/oacis/), through the project "Estructura poblacional y movimiento de algunos cetaceos del Golfo de California" (Grant No. SIP-20070803; PI: DG). MAP received grants from Cetacean Society International (http://www.csiwhalesalive.org/index.php), The Ocean Foundation (http://www.oceanfdn.org/), American Cetacean Society (http://acsonline.org/), Sociedad Mexicana de Mastozoologia Marina (SOMEMMA; http://www.somemma.org/somemma/), and Consejo Sudcaliforniano de Ciencia y Tecnologia (COSCyT; http://www.coscyt.edu.mx/). DMP was funded by the Interagency NASA Climate and Biological Response Program (Grant No. NNX11AP71G; PI: H. Bailey). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahrestani FS, 2013, SCI REP-UK, V3, DOI 10.1038/srep03125; Nino-Torres CA, 2006, MAR MAMMAL SCI, V22, P831, DOI 10.1111/j.1748-7692.2006.00065.x; An SI, 2004, J CLIMATE, V17, P2399, DOI 10.1175/1520-0442(2004)017<2399:NAAOE>2.0.CO;2; Archer FI, 2010, MAR ECOL PROG SER, V410, P245, DOI 10.3354/meps08641; Asch RG, 2013, DEEP-SEA RES PT I, V71, P79, DOI 10.1016/j.dsr.2012.08.006; AU DWK, 1985, FISH B-NOAA, V83, P623; AVISO, 2014, SSALTO DUACS USER HA; Bailey Helen, 2010, Endangered Species Research, V10, P93, DOI 10.3354/esr00239; Ballance LT, 2006, PROG OCEANOGR, V69, P360, DOI 10.1016/j.pocean.2006.03.013; Barlow J, 2008, MAR ECOL PROG SER, V371, P285, DOI 10.3354/meps07695; Barlow J, 2009, NOAA TECH MEMO NMFS; Barlow J, 2007, FISH B-NOAA, V105, P509; Barlow Jay, 2001, Journal of Cetacean Research and Management, V3, P201; Becker E. A., 2012, Endangered Species Research, V16, P97, DOI 10.3354/esr00390; Becker EA, 2010, MAR ECOL PROG SER, V413, P163, DOI 10.3354/meps08696; Beier E, 1997, J PHYS OCEANOGR, V27, P615, DOI 10.1175/1520-0485(1997)027<0615:ANIOTA>2.0.CO;2; Benson SR, 2002, PROG OCEANOGR, V54, P279, DOI 10.1016/S0079-6611(02)00054-X; Branch TA, 2007, MAMMAL REV, V37, P116, DOI 10.1111/j.1365-2907.2007.00106.x; Branch TA, 2004, MAR MAMMAL SCI, V20, P726, DOI 10.1111/j.1748-7692.2004.tb01190.x; BRINTON E, 1979, Progress in Oceanography, V8, P125, DOI 10.1016/0079-6611(79)90001-6; Buckland S.T., 2001, pi; Burnham K.P., 2002, PRACTICAL INFORM THE, V2nd ed., DOI [DOI 10.1007/B97636, 10.1007/b97636]; BURNHAM KP, 1976, BIOMETRICS, V32, P325, DOI 10.2307/2529501; Burtenshaw JC, 2004, DEEP-SEA RES PT II, V51, P967, DOI 10.1016/j.dsr2.2004.06.020; Calambokidis J, 2004, MAR MAMMAL SCI, V20, P63, DOI 10.1111/j.1748-7692.2004.tb01141.x; Calambokidis J, 2009, MAR MAMMAL SCI, V25, P816, DOI 10.1111/j.1748-7692.2009.00298.x; Campbell GS, 2015, DEEP-SEA RES PT II, V112, P143, DOI 10.1016/j.dsr2.2014.10.008; CANE MA, 1983, SCIENCE, V222, P1189, DOI 10.1126/science.222.4629.1189; Carretta J V, 2003, MAR FISH REV, V66, P21; CASELLA G, 1992, AM STAT, V46, P167, DOI 10.2307/2685208; Chavez FP, 2003, SCIENCE, V299, P217, DOI 10.1126/science.1075880; CHAVEZ FP, 1987, DEEP-SEA RES, V34, P1229, DOI 10.1016/0198-0149(87)90073-2; Clapham PJ, 1999, MAMMAL REV, V29, P35; CLAPHAM PJ, 2002, ENCY MARINE MAMMALS, P1328; Clark J. S, 2007, MODELS ECOLOGICAL DA; Cressie N, 2009, ECOL APPL, V19, P553, DOI 10.1890/07-0744.1; Croll DA, 2005, MAR ECOL PROG SER, V289, P117, DOI 10.3354/meps289117; da Rocha HR, 2009, J GEOPHYS RES-BIOGEO, V114, DOI 10.1029/2007JG000640; Danil K, 2006, MAR ECOL PROG SER, V318, P277, DOI 10.3354/meps318277; Diaz HF, 2001, INT J CLIMATOL, V21, P1845, DOI 10.1002/joc.631; Dibarboure G, 2014, J ATMOS OCEAN TECH, V31, P1337, DOI 10.1175/JTECH-D-13-00081.1; Doniol-Valcroze T, 2007, MAR ECOL PROG SER, V335, P207, DOI 10.3354/meps335207; Etnoyer P, 2006, DEEP-SEA RES PT II, V53, P340, DOI 10.1016/j.dsr2.2006.01.010; Felix-Uraga R, 2004, CAL COOP OCEAN FISH, V45, P146; Ferguson MC, 2006, ECOL MODEL, V193, P645, DOI 10.1016/j.ecolmodel.2005.10.034; Fiedler PC, 2013, MAR ECOL PROG SER, V484, P1, DOI 10.3354/meps10378; Fiedler PC, 2013, J CLIMATE, V26, P583, DOI 10.1175/JCLI-D-11-00728.1; FIEDLER PC, 1994, FISH B-NOAA, V92, P451; Fiedler PC, 1998, DEEP-SEA RES PT II, V45, P1781, DOI 10.1016/S0967-0645(98)80017-9; FIEDLER PC, 1991, LIMNOL OCEANOGR, V36, P1834, DOI 10.4319/lo.1991.36.8.1834; Fiedler PC, 2002, DEEP-SEA RES PT I, V49, P321, DOI 10.1016/S0967-0637(01)00057-7; Forney KA, 2000, CONSERV BIOL, V14, P1271, DOI 10.1046/j.1523-1739.2000.99412.x; Forney Karin A., 2012, Endangered Species Research, V16, P113, DOI 10.3354/esr00393; Gelman A, 1996, STAT SINICA, V6, P733; Gelman A., 2004, BAYESIAN DATA ANAL; Gergis JL, 2009, CLIMATIC CHANGE, V92, P343, DOI 10.1007/s10584-008-9476-z; Gerrodette T, 2005, MAR ECOL PROG SER, V291, P1, DOI 10.3354/meps291001; Gerrodette T, 1996, LJ9610 SW FISH SCI C; Gerrodette T, 2008, NOAATMNMFSSWFSC422 N, V422, P1; Gerrodette Tim, 2011, Endangered Species Research, V15, P159, DOI 10.3354/esr00369; Gerrodette T, 2011, MAR ECOL-EVOL PERSP, V32, P404, DOI 10.1111/j.1439-0485.2011.00466.x; GILKS WR, 1994, STATISTICIAN, V43, P169, DOI 10.2307/2348941; Gregr EJ, 2000, MAR MAMMAL SCI, V16, P699, DOI 10.1111/j.1748-7692.2000.tb00967.x; HASTINGS WK, 1970, BIOMETRIKA, V57, P97, DOI 10.2307/2334940; Havens KE, 2000, ENVIRON MANAGE, V25, P1; Hillborn R., 1997, ECOLOGICAL DETECTIVE; Hoeting JA, 1999, STAT SCI, V14, P382, DOI 10.1214/ss/1009212519; Irvine LM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102959; Kadane JB, 2004, J AM STAT ASSOC, V99, P279, DOI 10.1198/016214504000000269; Kaschner K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044075; Kery M, 2012, BAYESIAN POPULATION ANALYSIS USING WINBUGS: A HIERARCHICAL PERSPECTIVE, P1; Kery M., 2010, INTRO WINBUGS ECOLOG; Kessler WS, 2006, PROG OCEANOGR, V69, P181, DOI 10.1016/j.pocean.2006.03.009; Kinzey D, 2000, MARINE MAMMAL DATA C; Kitano H, 2002, SCIENCE, V295, P1662, DOI 10.1126/science.1069492; Kudela RM, 2008, OCEANOGRAPHY, V21, P46, DOI 10.5670/oceanog.2008.04; LLUCHBELDA D, 1989, S AFR J MARINE SCI, V8, P195, DOI 10.2989/02577618909504561; Logerwell EA, 2001, PROG OCEANOGR, V49, P391, DOI 10.1016/S0079-6611(01)00032-5; Lunn D., 2012, BUGS BOOK PRACTICAL; Marques FFC, 2003, BIOMETRICS, V59, P924, DOI 10.1111/j.0006-341X.2003.00107.x; Marques FFC, 2004, ADVANCED DISTANCE SAMPLING: ESTIMATING ABUNDANCE OF BIOLOGICAL POPULATIONS, P31; McCarthy MA, 2007, BAYESIAN METHODS FOR ECOLOGY, P1; Millar RB, 2009, BIOMETRICS, V65, P962, DOI 10.1111/j.1541-0420.2008.01162.x; Misund OA, 2003, AFR J MAR SCI, V25, P185, DOI 10.2989/18142320309504009; Moore JE, 2014, ENDANGER SPECIES RES, V25, P141, DOI 10.3354/esr00633; Moore JE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0052770; Moore JE, 2011, J APPL ECOL, V48, P1195, DOI 10.1111/j.1365-2664.2011.02018.x; Olson Donald B., 2002, P187; Palacios DM, 2006, DEEP-SEA RES PT II, V53, P250, DOI 10.1016/j.dsr2.2006.03.004; Palacios DM, 2013, ENDANGER SPECIES RES, V22, P191, DOI 10.3354/esr00558; Palacios DM, 1998, J CETACEAN RES MANAG, V1, P41; Pauly D, 1998, ICES J MAR SCI, V55, P467, DOI 10.1006/jmsc.1997.0280; Pennington JT, 2006, PROG OCEANOGR, V69, P285, DOI 10.1016/j.pocean.2006.03.012; R Core Team, 2021, R LANGUAGE ENV STAT; REBERT JP, 1985, J GEOPHYS RES-OCEANS, V90, P1719, DOI 10.1029/JC090iC06p11719; REEVES R, 2003, MANAGEMENT TODAY, P35; REILLY SB, 1990, MAR MAMMAL SCI, V6, P265, DOI 10.1111/j.1748-7692.1990.tb00357.x; REILLY SB, 1994, FISH B-NOAA, V92, P434; Reiss CS, 2008, FISH OCEANOGR, V17, P126, DOI 10.1111/j.1365-2419.2008.00469.x; Rio MH, 2004, J GEOPHYS RES-OCEANS, V109, DOI 10.1029/2003JC002226; Roman J, 2013, ANN NY ACAD SCI, V1286, P29, DOI 10.1111/nyas.12040; Royle J. A., 2008, HIERARCHICAL MODELIN; Rykaczewski RR, 2008, P NATL ACAD SCI USA, V105, P1965, DOI 10.1073/pnas.0711777105; Sanino Gian Paolo, 2003, Boletin del Museo Nacional de Historia Natural Chile, V52, P97; Santora JA, 2012, PROG OCEANOGR, V106, P154, DOI 10.1016/j.pocean.2012.08.005; Scott MD, 1998, MAR MAMMAL SCI, V14, P401, DOI 10.1111/j.1748-7692.1998.tb00735.x; Sears R, 2013, ENDANGER SPECIES RES, V22, P23, DOI 10.3354/esr00532; Skaug HJ, 2006, ENVIRON ECOL STAT, V13, P199, DOI 10.1007/s10651-005-0006-0; Spiegelhalter DJ, 2002, J R STAT SOC B, V64, P583, DOI 10.1111/1467-9868.00353; Stafford Kathleen M., 2001, Journal of Cetacean Research and Management, V3, P65; Stafforda KM, 2007, J ACOUST SOC AM, V122, P3378, DOI 10.1121/1.2799905; TERSHY BR, 1992, J MAMMAL, V73, P477, DOI 10.2307/1382013; TERSHY BR, 1991, MAR ECOL PROG SER, V69, P299, DOI 10.3354/meps069299; Torres-Florez JP, 2014, MOL ECOL, V23, P5998, DOI 10.1111/mec.12990; Tsonis AA, 2003, METEOROL ATMOS PHYS, V84, P229, DOI 10.1007/s00703-003-0001-7; TSUCHIYA M, 1972, J GEOPHYS RES, V77, P5981, DOI 10.1029/JC077i030p05981; Vaillancourt RD, 2003, DEEP-SEA RES PT I, V50, P829, DOI 10.1016/S0967-0637(03)00059-1; Von ARX WILLIAM S., 1965, LIMNOL OCEANOGR, V10, pR265; WADE LS, 1979, FISH B-NOAA, V76, P915; Wade P.R., 1993, REPORTS INT WHALING, V43, P477; Wang CZ, 2006, PROG OCEANOGR, V69, P239, DOI 10.1016/j.pocean.2006.03.004; WHITE JR, 1995, DEEP-SEA RES PT II, V42, P715, DOI 10.1016/0967-0645(95)00033-M; Wilson C, 2005, J GEOPHYS RES-OCEANS, V110, DOI 10.1029/2004JC002724; Wilson C, 2001, J GEOPHYS RES-OCEANS, V106, P31175, DOI 10.1029/2000JC000724; Wolter K., 1998, WEATHER, V53, P315, DOI DOI 10.1002/J.1477-8696.1998.TB06408.X; Wolter K, 2011, INT J CLIMATOL, V31, P1074, DOI 10.1002/joc.2336; WYRTKI K, 1981, J PHYS OCEANOGR, V11, P1205, DOI 10.1175/1520-0485(1981)011<1205:AEOEUI>2.0.CO;2; Wyrtki K, 1964, FISH B, V63, P355	128	20	22	0	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2015	10	3							e0120727	10.1371/journal.pone.0120727	http://dx.doi.org/10.1371/journal.pone.0120727			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9BN	25785692	Green Submitted, Green Published, gold			2022-12-27	WOS:000352138500188
J	Pepping, CA; Davis, PJ; O'Donovan, A				Pepping, Christopher A.; Davis, Penelope J.; O'Donovan, Analise			The Association between State Attachment Security and State Mindfulness	PLOS ONE			English	Article							EMOTION REGULATION; INDIVIDUAL-DIFFERENCES; DISPOSITIONAL MINDFULNESS; BASE SCHEMA; FOUNDATIONS; TOLERANCE; HEALTH	Recent research suggests that attachment and mindfulness are related, though the nature of this association is unclear. Here we present two studies examining whether there is a causal relationship between state attachment and state mindfulness. Study 1 investigated the effects of experimentally increasing state mindfulness on state attachment security. State mindfulness was successfully enhanced, but this led to no change in state attachment security. Study 2 investigated the effects of experimentally enhancing state attachment security on state mindfulness. State attachment security was successfully enhanced, but this did not lead to any change in state mindfulness. These findings suggest that there is not a direct, immediate causal relationship between state attachment and state mindfulness as a result of brief experimental manipulations. Future research should examine these associations in longer term interventions.	[Pepping, Christopher A.; Davis, Penelope J.; O'Donovan, Analise] Griffith Univ, Sch Appl Psychol, Brisbane, Qld 4111, Australia; [Pepping, Christopher A.; O'Donovan, Analise] Griffith Univ, Behav Basis Hlth, Brisbane, Qld 4111, Australia; [Pepping, Christopher A.; O'Donovan, Analise] Griffith Univ, Griffith Hlth Inst, Gold Coast, Qld, Australia	Griffith University; Griffith University; Griffith University; Menzies Health Institute Queensland	Pepping, CA (corresponding author), La Trobe Univ, Sch Psychol Sci, Melbourne, Vic, Australia.	c.pepping@latrobe.edu.au						[Anonymous], 2004, ADULT ATTACHMENT THE; [Anonymous], 2009, ACT MADE SIMPLE; Arch JJ, 2006, BEHAV RES THER, V44, P1849, DOI 10.1016/j.brat.2005.12.007; Baer RA, 2006, ASSESSMENT, V13, P27, DOI 10.1177/1073191105283504; Bowlby J, 1969, ATTACHMENT LOSS SEPA; Broderick P, 2005, COGNITIVE THER RES, V29, P501, DOI 10.1007/s10608-005-3888-0; Brown KW, 2007, PSYCHOL INQ, V18, P211, DOI 10.1080/10478400701598298; Brown KW, 2003, J PERS SOC PSYCHOL, V84, P822, DOI 10.1037/0022-3514.84.4.822; Caldwell J. D., 2013, INTERPERSONA, V7; Caldwell JG, 2015, MINDFULNESS, V6, P624, DOI 10.1007/s12671-014-0298-y; Calkins SD., 2009, HDB EMOTION REGULATI, P229; Forsyth J., 2007, MINDFULNESS ACCEPTAN; Fraley RC, 2000, J PERS SOC PSYCHOL, V78, P350, DOI 10.1037/0022-3514.78.2.350; Gillath O, 2009, J RES PERS, V43, P362, DOI 10.1016/j.jrp.2008.12.009; Goodall K, 2012, PERS INDIV DIFFER, V52, P622, DOI 10.1016/j.paid.2011.12.008; Hayes AM, 2004, CLIN PSYCHOL-SCI PR, V11, P255, DOI 10.1093/clipsy/bph080; HAZAN C, 1987, J PERS SOC PSYCHOL, V52, P511, DOI 10.1037/0022-3514.52.3.511; Kabat-Zinn J., 1994, WHEREVER YOU GO THER; Keng SL, 2011, CLIN PSYCHOL REV, V31, P1041, DOI 10.1016/j.cpr.2011.04.006; Liu XH, 2013, STRESS HEALTH, V29, P199, DOI 10.1002/smi.2446; Lykins ELB, 2009, J COGN PSYCHOTHER, V23, P226, DOI 10.1891/0889-8391.23.3.226; Mikulincer M, 2003, MOTIV EMOTION, V27, P77, DOI 10.1023/A:1024515519160; Mikulincer M, 2001, J PERS SOC PSYCHOL, V81, P97, DOI 10.1037//0022-3514.81.1.97; Mikulincer M, 2001, J PERS SOC PSYCHOL, V81, P305, DOI 10.1037//0022-3514.81.2.305; Mikulincer M, 2001, J PERS SOC PSYCHOL, V81, P1205, DOI 10.1037/0022-3514.81.6.1205; Mikulincer M., 2007, ATTACHMENT ADULTHOOD; Mikulincer M, 2007, PSYCHOL INQ, V18, P139, DOI 10.1080/10478400701512646; Modinos G, 2010, SOC COGN AFFECT NEUR, V5, P369, DOI 10.1093/scan/nsq006; Pepping CA, 2015, SELF IDENTITY, V14, P104, DOI 10.1080/15298868.2014.955050; Pepping CA, 2014, MINDFULNESS, V5, P392, DOI 10.1007/s12671-012-0193-3; Pepping CA, 2013, J POSIT PSYCHOL, V8, P376, DOI 10.1080/17439760.2013.807353; Pepping CA, 2013, PERS INDIV DIFFER, V54, P453, DOI 10.1016/j.paid.2012.10.006; Ryan RM, 2007, PSYCHOL INQ, V18, P177, DOI 10.1080/10478400701512778; Sandra BK, 2011, EMOTION, V11, P299, DOI 10.1037/a0022764; Shaver PR, 2007, PSYCHOL INQ, V18, P264, DOI 10.1080/10478400701598389; Siegel D. J., 2007, SIEGEL; Thompson RA, 2009, HDB EMOTION REGULATI, P229; Walsh JJ, 2009, PERS INDIV DIFFER, V46, P94, DOI 10.1016/j.paid.2008.09.008	38	19	21	2	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2015	10	3							e0116779	10.1371/journal.pone.0116779	http://dx.doi.org/10.1371/journal.pone.0116779			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CE9BN	25786134	gold, Green Published			2022-12-27	WOS:000352138500013
J	Acosta-Reyes, FJ; Alechaga, E; Subirana, JA; Campos, JL				Acosta-Reyes, Francisco J.; Alechaga, Elida; Subirana, Juan A.; Lourdes Campos, J.			Structure of the DNA Duplex d(ATTAAT)(2) with Hoogsteen Hydrogen Bonds	PLOS ONE			English	Article							POLYMERASE-IOTA; BASE-PAIRS; CRYSTAL; COMPLEX; REPLICATION; REFINEMENT; SOFTWARE; REFMAC5	The traditional Watson-Crick base pairs in DNA may occasionally adopt a Hoogsteen conformation, with a different organization of hydrogen bonds. Previous crystal structures have shown that the Hoogsteen conformation is favored in alternating AT sequences of DNA. Here we present new data for a different sequence, d(ATTAAT)(2), which is also found in the Hoogsteen conformation. Thus we demonstrate that other all-AT sequences of DNA with a different sequence may be found in the Hoogsteen conformation. We conclude that any all-AT sequence might acquire this conformation under appropriate conditions. We also compare the detailed features of DNA in either the Hoogsteen or Watson-Crick conformations.	[Acosta-Reyes, Francisco J.; Alechaga, Elida; Subirana, Juan A.; Lourdes Campos, J.] Univ Politecn Cataluna, Dept Engn Quim, E-08028 Barcelona, Spain	Universitat Politecnica de Catalunya	Campos, JL (corresponding author), Univ Politecn Cataluna, Dept Engn Quim, Diagonal 647, E-08028 Barcelona, Spain.	lourdes.campos@upc.edu	Campos, J.Lourdes/N-7336-2014; Subirana, juan/L-7192-2014	Campos, J.Lourdes/0000-0002-4136-7082; Acosta-Reyes, Francisco J./0000-0001-8524-1484; Subirana, juan/0000-0002-1706-9341	FEDER; Ministerio de Ciencia e Inovacion [BFU-2009-10380]; Generalitat de Catalunya [SRG2009-1208]; Consejo Nacional de Ciencia y Tecnologia (CONACYT) [212993]	FEDER(European Commission); Ministerio de Ciencia e Inovacion(Spanish Government); Generalitat de Catalunya(Generalitat de Catalunya); Consejo Nacional de Ciencia y Tecnologia (CONACYT)(Consejo Nacional de Ciencia y Tecnologia (CONACyT))	This work was partially supported by FEDER funds and the Ministerio de Ciencia e Inovacion, project BFU-2009-10380 to JLC and Generalitat de Catalunya, project SRG2009-1208 to JLC. FJA acknowledges a fellowship from Consejo Nacional de Ciencia y Tecnologia (CONACYT-reg: 212993). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrescia NGA, 2004, BIOCHEMISTRY-US, V43, P4092, DOI 10.1021/bi0355140; Abrescia NGA, 2002, P NATL ACAD SCI USA, V99, P2806, DOI 10.1073/pnas.052675499; Campos L, 2006, BIOPHYS J, V91, P892, DOI 10.1529/biophysj.106.084210; Cubero E, 2003, J AM CHEM SOC, V125, P14603, DOI 10.1021/ja035918f; HOOGSTEEN K, 1963, ACTA CRYSTALLOGR, V16, P907, DOI 10.1107/S0365110X63002437; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kirouac KN, 2009, EMBO J, V28, P1644, DOI 10.1038/emboj.2009.122; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Lu XJ, 2003, NUCLEIC ACIDS RES, V31, P5108, DOI 10.1093/nar/gkg680; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Moreno T, 2010, ACTA CRYSTALLOGR D, V66, P251, DOI 10.1107/S0907444909055693; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Nair DT, 2005, STRUCTURE, V13, P1569, DOI 10.1016/j.str.2005.08.010; Nair DT, 2004, NATURE, V430, P377, DOI 10.1038/nature02692; Nicholls RA, 2012, ACTA CRYSTALLOGR D, V68, P404, DOI 10.1107/S090744491105606X; Nikolova EN, 2013, BIOPOLYMERS, V99, P955, DOI 10.1002/bip.22334; Nikolova EN, 2012, J AM CHEM SOC, V134, P3667, DOI 10.1021/ja2117816; Nikolova EN, 2011, NATURE, V470, P498, DOI 10.1038/nature09775; Pfoh R, 2009, ACTA CRYSTALLOGR F, V65, P660, DOI 10.1107/S1744309109019654; Pous J, 2008, J AM CHEM SOC, V130, P6755, DOI 10.1021/ja078022+; Sehgal N, 2014, CHROMOSOMA, V123, P499, DOI 10.1007/s00412-014-0480-y; Subirana JA, 2011, J THEOR BIOL, V283, P28, DOI 10.1016/j.jtbi.2011.05.025; Valls N, 2005, ACTA CRYSTALLOGR D, V61, P1587, DOI 10.1107/S0907444905029781; Yakovchuk P, 2006, NUCLEIC ACIDS RES, V34, P564, DOI 10.1093/nar/gkj454; Yang W, 2014, BIOCHEMISTRY-US, V53, P2793, DOI 10.1021/bi500019s	25	15	15	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2015	10	3							e0120241	10.1371/journal.pone.0120241	http://dx.doi.org/10.1371/journal.pone.0120241			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7QC	25781995	Green Published, gold, Green Submitted			2022-12-27	WOS:000351284600145
J	Warburton, B; Gormley, AM				Warburton, Bruce; Gormley, Andrew M.			Optimising the Application of Multiple-Capture Traps for Invasive Species Management Using Spatial Simulation	PLOS ONE			English	Article							POSSUM TRICHOSURUS-VULPECULA; STOATS MUSTELA-ERMINEA; RATS RATTUS-RATTUS; NEW-ZEALAND; HOME-RANGE; BRUSHTAIL POSSUMS; SHIP RATS; BEECH FOREST; DENSITY; ISLAND	Internationally, invasive vertebrate species pose a significant threat to biodiversity, agricultural production and human health. To manage these species a wide range of tools, including traps, are used. In New Zealand, brushtail possums (Trichosurus vulpecula), stoats (Mustela ermine), and ship rats (Rattus rattus) are invasive and there is an ongoing demand for cost-effective non-toxic methods for controlling these pests. Recently, traps with multiple-capture capability have been developed which, because they do not require regular operator-checking, are purported to be more cost-effective than traditional single-capture traps. However, when pest populations are being maintained at low densities (as is typical of orchestrated pest management programmes) it remains uncertain if it is more cost-effective to use fewer multiple-capture traps or more single-capture traps. To address this uncertainty, we used an individual-based spatially explicit modelling approach to determine the likely maximum animal-captures per trap, given stated pest densities and defined times traps are left between checks. In the simulation, single-or multiple-capture traps were spaced according to best practice pest-control guidelines. For possums with maintenance densities set at the lowest level (i.e. 0.5/ha), 98% of all simulated possums were captured with only a single capacity trap set at each site. When possum density was increased to moderate levels of 3/ha, having a capacity of three captures per trap caught 97% of all simulated possums. Results were similar for stoats, although only two potential captures per site were sufficient to capture 99% of simulated stoats. For rats, which were simulated at their typically higher densities, even a six-capture capacity per trap site only resulted in 80% kill. Depending on target species, prevailing density and extent of immigration, the most cost-effective strategy for pest control in New Zealand might be to deploy several single-capture traps rather than investing in fewer, but more expense, multiple-capture traps.	[Warburton, Bruce; Gormley, Andrew M.] Landcare Res Manaaki Whenua, Lincoln 7640, New Zealand	Landcare Research - New Zealand	Warburton, B (corresponding author), Landcare Res Manaaki Whenua, POB 40, Lincoln 7640, New Zealand.	warburtonb@landcareresearch.co.nz		Gormley, Andrew/0000-0001-9833-7012	New Zealand's Ministry of Business, Innovation and Employment [C09X1007]	New Zealand's Ministry of Business, Innovation and Employment(New Zealand Ministry of Business, Innovation and Employment (MBIE))	This study was supported by grant funding from New Zealand's Ministry of Business, Innovation and Employment (http://www.msi.govt.nz/get-funded/) awarded to BW (grant no. C09X1007). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alterio N, 1998, ECOGRAPHY, V21, P18, DOI 10.1111/j.1600-0587.1998.tb00390.x; Ball SJ, 2005, WILDLIFE RES, V32, P217, DOI 10.1071/WR03125; Choquenot D, 2001, BIOL CONSERV, V99, P29, DOI 10.1016/S0006-3207(00)00186-5; CLAPPERTON BK, 1994, NEW ZEAL J ZOOL, V21, P279, DOI 10.1080/03014223.1994.9517995; Efford M, 2000, WILDLIFE RES, V27, P117, DOI 10.1071/WR99005; Gillies CA, 2003, NEW ZEAL J ZOOL, V30, P399, DOI 10.1080/03014223.2003.9518349; Green W, 2012, J ROY SOC NEW ZEAL, V42, P185, DOI 10.1080/03036758.2011.556130; INNES J, 1995, NEW ZEAL J ECOL, V19, P5; King C.M., 1990, P288; King CM., 2005, HDB NZ MAMMALS; Morgan DR, 2006, WILDLIFE RES, V33, P605, DOI 10.1071/WR06055; Nugent G, 2011, WILDLIFE RES, V38, P249, DOI 10.1071/WR10198; Pimentel D, 2005, ECOL ECON, V52, P273, DOI 10.1016/j.ecolecon.2004.10.002; Pryde M, 2005, NEW ZEAL J ZOOL, V32, P139, DOI 10.1080/03014223.2005.9518406; Ramsey DSL, 2010, J APPL ECOL, V47, P911, DOI 10.1111/j.1365-2664.2010.01839.x; Ramsey DSL, 2008, IDENTIFYING OPTIMAL; Ruscoe WA, 2011, ECOL LETT, V14, P1035, DOI 10.1111/j.1461-0248.2011.01673.x; Scofield RP, 2011, NEW ZEAL J ECOL, V35, P312; Smith DHV, 2008, NEW ZEAL J ECOL, V32, P166; Spurr EB, 1999, NZ SCI CONSERVATIO A, V127A, P1; Team RDC, 2012, R LANG ENV STAT COMP, DOI [10.1002/jcc.22917, DOI 10.1002/JCC.22917]; Theuerkauf J, 2011, ANN ZOOL FENN, V48, P308, DOI 10.5735/086.048.0505; Thomas MD, 2003, N Z PLANT PROTECT-SE, V56, P77, DOI 10.30843/nzpp.2003.56.6089; Tompkins DM, 2007, WILDLIFE RES, V34, P67, DOI 10.1071/WR05109; Warburton B, 2012, ANIM WELFARE, V21, P141, DOI 10.7120/096272812X13345905674123; Warburton B, 1996, NEW ZEAL J ZOOL, V23, P307, DOI 10.1080/03014223.1996.9518089; WARD GD, 1984, NEW ZEAL J ZOOL, V11, P85, DOI 10.1080/03014223.1984.10428231; Whitehead AL, 2008, BIOL CONSERV, V141, P2784, DOI 10.1016/j.biocon.2008.08.013; Wilson DJ, 2007, NEW ZEAL J ECOL, V31, P47	29	7	7	1	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2015	10	3							e0120373	10.1371/journal.pone.0120373	http://dx.doi.org/10.1371/journal.pone.0120373			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7QC	25782018	Green Published, Green Submitted, gold			2022-12-27	WOS:000351284600155
J	Xiao, FH; He, YH; Li, QG; Wu, H; Luo, LH; Kong, QP				Xiao, Fu-Hui; He, Yong-Han; Li, Qi-Gang; Wu, Huan; Luo, Long-Hai; Kong, Qing-Peng			A Genome-Wide Scan Reveals Important Roles of DNA Methylation in Human Longevity by Regulating Age-Related Disease Genes	PLOS ONE			English	Article							ALZHEIMERS-DISEASE; HEALTH-STATUS; CENTENARIANS; CANCER; EXPRESSION; CADHERINS	It is recognized that genetic factors contribute to human longevity. Besides the hypothesis of existence of longevity genes, another suggests that a lower frequency of risk alleles decreases the incidence of age-related diseases in the long-lived people. However, the latter finds no support from recent genetic studies. Considering the crucial role of epigenetic modification in gene regulation, we then hypothesize that suppressing disease-related genes in longevity individuals is likely achieved by epigenetic modification, e.g. DNA methylation. To test this hypothesis, we investigated the genome-wide methylation profile in 4 Chinese female centenarians and 4 middle-aged controls using methyl-DNA immunoprecipitation sequencing. 626 differentially methylated regions (DMRs) were observed between both groups. Interestingly, genes with these DMRs were enriched in age-related diseases, including type-2 diabetes, cardiovascular disease, stroke and Alzheimer's disease. This pattern remains rather stable after including methylomes of two white individuals. Further analyses suggest that the observed DMRs likely have functional roles in regulating disease-associated gene expressions, with some genes [e.g. caspase 3 (CASP3)] being down-regulated whereas the others [i.e. interleukin 1 receptor, type 2 (IL1R2)] up-regulated. Therefore, our study suggests that suppressing the disease-related genes via epigenetic modification is an important contributor to human longevity.	[Xiao, Fu-Hui; He, Yong-Han; Li, Qi-Gang; Wu, Huan; Kong, Qing-Peng] Chinese Acad Sci, Kunming Inst Zool, State Key Lab Genet Resources & Evolut, Kunming, Yunnan Province, Peoples R China; [Xiao, Fu-Hui; He, Yong-Han; Li, Qi-Gang; Wu, Huan; Kong, Qing-Peng] KIZ CUHK Joint Lab Bioresources & Mol Res Common, Kunming, Yunnan Province, Peoples R China; [Xiao, Fu-Hui] Univ Chinese Acad Sci, Beijing, Peoples R China; [Luo, Long-Hai] Beijing Genome Inst Shenzhen, Shenzhen, Peoples R China	Chinese Academy of Sciences; Kunming Institute of Zoology; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Beijing Genomics Institute (BGI)	Luo, LH (corresponding author), Beijing Genome Inst Shenzhen, Shenzhen, Peoples R China.	luolh@genomics.cn; kongqp@mail.kiz.ac.cn	He, Yonghan/P-7271-2014	He, Yonghan/0000-0003-4409-4590; Xiao, Fu-Hui/0000-0001-7478-7801	National Basic Research Program of China [2013CB530802]; National Basic Research Program of Yunnan Province [2011FA024, 2013FB069]; Chinese Academy of Sciences, Natural Science Foundation of China [31123005, 31322029]	National Basic Research Program of China(National Basic Research Program of China); National Basic Research Program of Yunnan Province; Chinese Academy of Sciences, Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)Chinese Academy of Sciences)	This work was supported by grants from the National Basic Research Program of China (2013CB530802), Yunnan Province (2011FA024, 2013FB069), the Chinese Academy of Sciences, Natural Science Foundation of China (31123005, 31322029). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altshuler D, 2005, NATURE, V437, P1299, DOI 10.1038/nature04226; Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632; Beekman M, 2010, P NATL ACAD SCI USA, V107, P18046, DOI 10.1073/pnas.1003540107; Chavez L, 2010, GENOME RES, V20, P1441, DOI 10.1101/gr.110114.110; Ehrlich M, 2002, ONCOGENE, V21, P5400, DOI 10.1038/sj.onc.1205651; Evert J, 2003, J GERONTOL A-BIOL, V58, P232; He YH, 2014, J AM GERIATR SOC, V62, P1402, DOI 10.1111/jgs.12895; Herskind AM, 1996, HUM GENET, V97, P319, DOI 10.1007/s004390050042; Heyn H, 2013, GENOME RES, V23, P1363, DOI 10.1101/gr.154187.112; Heyn H, 2012, P NATL ACAD SCI USA, V109, P10522, DOI 10.1073/pnas.1120658109; Hitt R, 1999, LANCET, V354, P652, DOI 10.1016/S0140-6736(99)01987-X; Jeanes A, 2008, ONCOGENE, V27, P6920, DOI 10.1038/onc.2008.343; Jones PA, 2001, SCIENCE, V293, P1068, DOI 10.1126/science.1063852; KENYON C, 1993, NATURE, V366, P461, DOI 10.1038/366461a0; Krueger F, 2011, BIOINFORMATICS, V27, P1571, DOI 10.1093/bioinformatics/btr167; Li N, 2010, METHODS, V52, P203, DOI 10.1016/j.ymeth.2010.04.009; Li RQ, 2009, BIOINFORMATICS, V25, P1966, DOI 10.1093/bioinformatics/btp336; Lin K, 1997, SCIENCE, V278, P1319, DOI 10.1126/science.278.5341.1319; Lindblad-Toh K, 2011, NATURE, V478, P476, DOI 10.1038/nature10530; Louneva N, 2008, AM J PATHOL, V173, P1488, DOI 10.2353/ajpath.2008.080434; Maiese K, 2008, PHARMACOL THERAPEUT, V118, P58, DOI 10.1016/j.pharmthera.2008.01.004; MAZUREK MF, 1987, NEUROLOGY, V37, P1001, DOI 10.1212/WNL.37.6.1001; MCGUE M, 1993, J GERONTOL, V48, pB237, DOI 10.1093/geronj/48.6.B237; Mi HY, 2013, NUCLEIC ACIDS RES, V41, pD377, DOI 10.1093/nar/gks1118; Neumann D, 2000, J IMMUNOL, V165, P3350, DOI 10.4049/jimmunol.165.6.3350; Post WS, 1999, CARDIOVASC RES, V43, P985, DOI 10.1016/S0008-6363(99)00153-4; Pou J, 2011, BBA-MOL CELL BIOL L, V1811, P556, DOI 10.1016/j.bbalip.2011.05.014; Resink TJ, 2009, SWISS MED WKLY, V139, P122, DOI smw-12429; Richardson B, 2003, AGEING RES REV, V2, P245, DOI 10.1016/S1568-1637(03)00010-2; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Rohn TT, 2009, INT J CLIN EXP PATHO, V2, P108; Safran M, 2010, DATABASE-OXFORD, DOI 10.1093/database/baq020; SCHACHTER F, 1994, NAT GENET, V6, P29, DOI 10.1038/ng0194-29; Sebastiani P, 2012, PLOS ONE, V7; Selim AJ, 2005, J GERONTOL A-BIOL, V60, P515, DOI 10.1093/gerona/60.4.515; Terry DF, 2004, J AM GERIATR SOC, V52, P2074, DOI 10.1111/j.1532-5415.2004.52561.x; Thinakaran G, 2004, PHARMACOL RES, V50, P411, DOI 10.1016/j.phrs.2003.12.026; Tissenbaum HA, 2001, NATURE, V410, P227, DOI 10.1038/35065638; Toperoff G, 2012, HUM MOL GENET, V21, P371, DOI 10.1093/hmg/ddr472	39	34	35	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2015	10	3							e0120388	10.1371/journal.pone.0120388	http://dx.doi.org/10.1371/journal.pone.0120388			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8HY	25793257	Green Submitted, gold, Green Published			2022-12-27	WOS:000352083900021
J	Baek, SH; Choi, SW; Park, SJ; Lee, SH; Chun, HS; Kim, SH				Baek, Seung-hwa; Choi, Sik-Won; Park, Sang-Joon; Lee, Sang-Han; Chun, Hang-Suk; Kim, Seong Hwan			Quinoline Compound KM11073 Enhances BMP-2-Dependent Osteogenic Differentiation of C2C12 Cells via Activation of p38 Signaling and Exhibits In Vivo Bone Forming Activity	PLOS ONE			English	Article							MORPHOGENETIC PROTEIN-2; OSTEOBLASTIC DIFFERENTIATION; GENE-EXPRESSION; BMP-2; MOLECULES; INDUCTION; MATRIX; DEFECT; MAPK; SMAD	Recombinant human bone morphogenetic protein (rhBMP)-2 has been approved by the FDA for clinical application, but its use is limited due to high cost and a supra-physiological dose for therapeutic efficacy. Therefore, recent studies have focused on the generation of new therapeutic small molecules to induce bone formation or potentiate the osteogenic activity of BMP-2. Here, we show that [4-(7-chloroquinolin-4-yl) piperazino][1-phenyl-5-(trifluoromethyl)- 1H-pyrazol-4-yl] methanone (KM11073) strongly enhances the BMP-2stimulated induction of alkaline phosphatase (ALP), an early phase biomarker of osteoblast differentiation, in bi-potential mesenchymal progenitor C2C12 cells. The KM11073-mediated ALP induction was inhibited by the BMP antagonist noggin, suggesting that its osteogenic activity occurs via BMP signaling. In addition, a pharmacological inhibition study suggested the involvement of p38 activation in the osteogenic action of KM11073 accompanied by enhanced expression of BMP-2, -6, and -7 mRNA. Furthermore, the in vivo osteogenic activity of KM11073 was confirmed in zebrafish and mouse calvarial bone formation models, suggesting the possibility of its single use for bone formation. In conclusion, the combination of rhBMP-2 with osteogenic small molecules could reduce the use of expensive rhBMP-2, mitigating the undesirable side effects of its supra-physiological dose for therapeutic efficacy. Moreover, due to their inherent physical properties, small molecules could represent the next generation of regenerative medicine.	[Baek, Seung-hwa; Choi, Sik-Won; Kim, Seong Hwan] Korea Res Inst Chem Technol, Pharmacol Res Ctr, Lab Translat Therapeut, Taejon 305600, South Korea; [Baek, Seung-hwa; Lee, Sang-Han] Kyungpook Natl Univ, Dept Food Sci & Biotechnol, Taegu 702701, South Korea; [Park, Sang-Joon] Kyungpook Natl Univ, Coll Vet Med, Dept Histol, Taegu 702701, South Korea; [Chun, Hang-Suk] Korea Inst Toxicol, Dept Predict Toxicol, Alternat Toxicol Methods Res Ctr, Taejon 305600, South Korea	Korea Research Institute of Chemical Technology (KRICT); Kyungpook National University; Kyungpook National University; Korea Institute of Toxicology; Korea Research Institute of Chemical Technology (KRICT)	Kim, SH (corresponding author), Korea Res Inst Chem Technol, Pharmacol Res Ctr, Lab Translat Therapeut, Taejon 305600, South Korea.	hwan@krict.re.kr		Choi, Sik-Won/0000-0003-1726-2536	Ministry of Knowledge Economy, Republic of Korea [SI-1404]	Ministry of Knowledge Economy, Republic of Korea(Ministry of Trade, Industry & Energy (MOTIE), Republic of KoreaGeneral Electric)	This work was supported by KRICT's project, SI-1404, funded by the Ministry of Knowledge Economy, Republic of Korea. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Carragee EJ, 2011, SPINE J, V11, P471, DOI 10.1016/j.spinee.2011.04.023; Chen D, 1997, CALCIFIED TISSUE INT, V60, P283, DOI 10.1007/s002239900230; Cheng HW, 2003, J BONE JOINT SURG AM, V85A, P1544, DOI 10.2106/00004623-200308000-00017; Flores MV, 2004, GENE EXPR PATTERNS, V4, P573, DOI 10.1016/j.modgep.2004.01.016; Gallea S, 2001, BONE, V28, P491, DOI 10.1016/S8756-3282(01)00415-X; Garrett IR, 2007, CURR TOP DEV BIOL, V78, P127, DOI 10.1016/S0070-2153(06)78004-8; Ghosh-Choudhury N, 2007, J BIOL CHEM, V282, P4983, DOI 10.1074/jbc.M606706200; GITELMAN SE, 1995, CELL GROWTH DIFFER, V6, P827; Hassel S, 2003, J BONE JOINT SURG AM, V85A, P44, DOI 10.2106/00004623-200300003-00009; Hollinger JO, 1998, J BIOMED MATER RES, V43, P356, DOI 10.1002/(SICI)1097-4636(199824)43:4<356::AID-JBM3>3.0.CO;2-7; Ishibashi O, 2010, J CELL PHYSIOL, V222, P465, DOI 10.1002/jcp.21968; Jadlowiec JA, 2006, J BIOL CHEM, V281, P5341, DOI 10.1074/jbc.M506158200; KATAGIRI T, 1994, J CELL BIOL, V127, P1755, DOI 10.1083/jcb.127.6.1755; Kato S, 2011, MOL CELL BIOCHEM, V349, P97, DOI 10.1007/s11010-010-0664-6; Kawai M, 2006, BMC MUSCULOSKEL DIS, V7, DOI 10.1186/1471-2474-7-62; Kim HJ, 2010, AMINO ACIDS, V39, P1217, DOI 10.1007/s00726-010-0557-8; Kim SN, 2012, AMINO ACIDS, V42, P1455, DOI 10.1007/s00726-011-0901-7; Lee KS, 2002, ONCOGENE, V21, P7156, DOI 10.1038/sj.onc.1205937; Li N, 2009, DEV DYNAM, V238, P459, DOI 10.1002/dvdy.21838; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lo KWH, 2012, REGEN MED, V7, P535, DOI [10.2217/RME.12.33, 10.2217/rme.12.33]; MartinezBarbera JP, 1997, GENE, V198, P53, DOI 10.1016/S0378-1119(97)00292-8; Mckay WF, 2007, INT ORTHOP, V31, P729, DOI 10.1007/s00264-007-0418-6; Murakami N, 2003, BIOMATERIALS, V24, P2153, DOI 10.1016/S0142-9612(03)00041-3; Nakamura Y, 2005, J BONE MINER METAB, V23, P426, DOI 10.1007/s00774-005-0624-5; Nakashima M, 2003, NAT BIOTECHNOL, V21, P1025, DOI 10.1038/nbt864; Nikaido M, 1997, MECH DEVELOP, V61, P75, DOI 10.1016/S0925-4773(96)00625-9; Nishimura R, 1998, J BIOL CHEM, V273, P1872, DOI 10.1074/jbc.273.4.1872; Noth U, 2003, EXP CELL RES, V291, P201, DOI 10.1016/S0014-4827(03)00386-0; Rodan GA, 2000, SCIENCE, V289, P1508, DOI 10.1126/science.289.5484.1508; Rozen S, 2000, Methods Mol Biol, V132, P365; Seeherman H, 2005, CYTOKINE GROWTH F R, V16, P329, DOI 10.1016/j.cytogfr.2005.05.001; Takayama K, 2009, J BONE MINER METAB, V27, P402, DOI 10.1007/s00774-009-0054-x; Teitelbaum SL, 2003, NAT REV GENET, V4, P638, DOI 10.1038/nrg1122; Valentin-Opran A, 2002, CLIN ORTHOP RELAT R, P110; Vogelin E, 2005, J BONE JOINT SURG AM, V87A, P1323, DOI 10.2106/JBJS.C.00913; Vrijens K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059045; Westerfield M, 2000, ZEBRAFISH BOOK GUIDE; White AP, 2007, INT ORTHOP, V31, P735, DOI 10.1007/s00264-007-0422-x; Yamachika E, 2009, J BIOMED MATER RES A, V88A, P599, DOI 10.1002/jbm.a.31833; Yamaguchi A, 1996, BIOCHEM BIOPH RES CO, V220, P366, DOI 10.1006/bbrc.1996.0411; Yeh LCC, 2002, J CELL BIOCHEM, V87, P292, DOI 10.1002/jcb.10315	42	6	8	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2015	10	3							e0120150	10.1371/journal.pone.0120150	http://dx.doi.org/10.1371/journal.pone.0120150			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD9NQ	25789987	Green Published, Green Submitted, gold			2022-12-27	WOS:000351425400134
J	Bajor, G; Likus, W; Kuszewski, P; Kostro, K; Los, A; Klakus, P				Bajor, Grzegorz; Likus, Wirginia; Kuszewski, Piotr; Kostro, Karol; Los, Andrzej; Klakus, Piotr			"Mortui Vivos Docent" or Who Gives His Body to Science? The Analysis of the Personal Questionnaires of Polish Donors in the Conscious Body Donation Program	PLOS ONE			English	Article							MEDICAL-SCHOOLS; DISSECTION; ATTITUDES; CADAVERS	The Conscious Body Donation Program conducted since 2003 by the Department of Human Anatomy, Medical University of Silesia in Katowice was the first innovative project aimed at obtaining informed donors' bodies for the purpose of teaching anatomy in Poland. The aim of this prospective study was to determine the declared donors' characteristics and to establish the possible motivation for body donation. A total of 244 application files were reviewed and the following information was analyzed: donor's age, age at which the decision to donate the body was made, donor's place of residence and declared nationality, family background, education and profession, family structure and religion. Our results showed that mainly elderly people decided to donate their bodies (68.5 +/- 11.84 years), living mostly in large and medium-sized cities. Men - donors often lived in small towns. Most of the donors were of blue-collar parentage, completed secondary education and at the time of taking decision to donate where married and retired. Widows were more likely to make the decision to donate than widowers. Most of our donors were Catholic. Our analysis of the profile of Polish donors may be useful to understand better for which groups of people death is not to be perceived as the end, and may become a value, which can be beneficial to living people.	[Bajor, Grzegorz; Likus, Wirginia; Kuszewski, Piotr; Kostro, Karol; Los, Andrzej; Klakus, Piotr] Med Univ Silesia, Sch Med Katowice, Dept Human Anat, Katowice, Poland	Medical University Silesia	Likus, W (corresponding author), Med Univ Silesia, Sch Med Katowice, Dept Human Anat, Katowice, Poland.	wirginia.likus@gmail.com		Kostro, Karol/0000-0001-7182-2325; Likus, Wirginia/0000-0002-4738-6102; Bajor, Grzegorz/0000-0002-7195-8422				Adams N., 1990, DEAD NIGHT; Agthong S, 2002, SE ASIAN J TROP MED, V33, pS166; Akinola OB, 2011, ANAT SCI EDUC, V4, P239, DOI 10.1002/ase.226; Anyanwu GE, 2011, CLIN ANAT, V24, P831, DOI 10.1002/ca.21187; Asad AL, 2014, SOC SCI MED, V106, P53, DOI 10.1016/j.socscimed.2014.01.041; ATTEBY M., 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0042673, DOI 10.1371/JOURNAL.PONE.0042673]; Aziz M. Ashraf, 2002, Anatomical Record, V269, P20, DOI 10.1002/ar.10046; Baumel J J, 1968, Nebr State Med J, V53, P90; Bolt S, 2012, CLIN ANAT, V25, P168, DOI 10.1002/ca.21215; Bolt S, 2010, ANN ANAT, V192, P70, DOI 10.1016/j.aanat.2010.02.002; Boulware LE, 2004, CLIN ANAT, V17, P570, DOI 10.1002/ca.10225; Central Statistical Office of Poland, 2011, CENS; Cornwall J, 2012, ANAT SCI EDUC, V5, P208, DOI 10.1002/ase.1278; Dluzen D E, 1996, Clin Anat, V9, P183, DOI 10.1002/(SICI)1098-2353(1996)9:3<183::AID-CA10>3.0.CO;2-N; Gangata H, 2010, ANAT SCI EDUC, V3, P174, DOI 10.1002/ase.157; Lagwinski M, 1998, CLIN ANAT, V11, P253, DOI 10.1002/(SICI)1098-2353(1998)11:4<253::AID-CA6>3.3.CO;2-E; Lin SC, 2009, BMJ-BRIT MED J, V339, P19; McClea K, 2010, NEW ZEAL MED J, V123, P9; Park JT, 2011, ANAT SCI EDUC, V4, P33, DOI 10.1002/ase.198; Pawlina W, 2011, MAYO CLIN PROC, V86, P139, DOI 10.4065/mcp.2010.0625; RICHARDSON R, 1995, LANCET, V346, P277, DOI 10.1016/S0140-6736(95)92166-4; Rizzolo Lawrence J, 2006, Anat Rec B New Anat, V289, P215, DOI 10.1002/ar.b.20117; Saltarelli AJ, 2014, ANAT SCI EDUC, V7, P331, DOI 10.1002/ase.1429; SANNER M, 1994, JAMA-J AM MED ASSOC, V271, P284, DOI 10.1001/jama.271.4.284; Sehirli US, 2004, CLIN ANAT, V17, P677, DOI 10.1002/ca.20056; Wijbenga BS, 2010, ANN ANAT, V192, P2, DOI 10.1016/j.aanat.2009.09.001	26	18	18	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2015	10	3							e0121061	10.1371/journal.pone.0121061	http://dx.doi.org/10.1371/journal.pone.0121061			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD9NQ	25790303	Green Submitted, Green Published, gold			2022-12-27	WOS:000351425400187
J	Dave, J; Millar, M; Maxeiner, H; Freedman, J; Meade, R; Rosmarin, C; Jordan, M; Andrews, N; Holliman, R; Sefton, A				Dave, Jayshree; Millar, Michael; Maxeiner, Horst; Freedman, Joanne; Meade, Rachel; Rosmarin, Caryn; Jordan, Matthew; Andrews, Nick; Holliman, Richard; Sefton, Armine			East London Experience with Enteric Fever 2007-2012	PLOS ONE			English	Article							PUBLIC-HEALTH MANAGEMENT; TYPHOID-FEVER; BURDEN	Purpose The clinical presentation and epidemiology for patients with enteric fever at two hospitals in East London during 2007-2012 is described with the aim to identify preventive opportunities and to reduce the cost of treatment. Methods A retrospective analysis of case notes from patients admitted with enteric fever during 2007 to 2012 with a microbiologically confirmed diagnosis was undertaken. Details on clinical presentation, travel history, demographic data, laboratory parameters, treatment, patient outcome and vaccination status were collected. Results Clinical case notes were available for 98/129 (76%) patients including 69 Salmonella enterica serovar Typhi (S. Typhi) and 29 Salmonella enterica serovar Paratyphi (S. Paratyphi). Thirty-four patients (35%) were discharged from emergency medicine without a diagnosis of enteric fever and then readmitted after positive blood cultures. Seventy-one of the 98 patients (72%) were UK residents who had travelled abroad, 23 (23%) were foreign visitors/new entrants to the UK and four (4%) had not travelled abroad. Enteric fever was not considered in the initial differential diagnosis for 48/98 (49%) cases. The median length of hospital stay was 7 days (range 0-57 days). The total cost of bed days for managing enteric fever was 454,000 pound in the two hospitals (mean 75,666 pound/year). Median time to clinical resolution was five days (range 1-20). Seven of 98 (7%) patients were readmitted with relapsed or continued infection. Six of the 71 (8%) patients had received typhoid vaccination, 34 (48%) patients had not received vaccination, and for 31 cases (44%) vaccination status was unknown. Conclusions Further interventions regarding education and vaccination of travellers and recognition of the condition by emergency medicine clinicians in travellers to South Asia is required.	[Dave, Jayshree; Maxeiner, Horst; Meade, Rachel; Jordan, Matthew; Holliman, Richard] Publ Hlth England, Publ Hlth Lab London, London, England; [Millar, Michael; Rosmarin, Caryn] Barts Hlth NHS Trust, Royal London Hosp, Div Infect, London, England; [Freedman, Joanne] Publ Hlth England, Ctr Infect Dis Surveillance & Control, Travel & Migrant Hlth Sect, London, England; [Andrews, Nick] Publ Hlth England, Ctr Infect Dis Surveillance & Control, Stat Modelling & Econ Dept, London, England; [Sefton, Armine] Queen Mary Univ London, Barts & London Sch Med & Dent, Blizard Inst, Ctr Immunol & Infect Dis, London, England	Public Health England; Barts Health NHS Trust; Royal London Hospital; Public Health England; Public Health England; University of London; Queen Mary University London	Dave, J (corresponding author), Publ Hlth England, Publ Hlth Lab London, London, England.	jayshree.dave@phe.gov.uk		Freedman, Joanne/0000-0002-7840-473X				Addiman S, 2013, PUBLIC HEALTH, V127, P207, DOI 10.1016/j.puhe.2012.12.015; Balasegaram S, 2012, J INFECTION, V65, P197, DOI 10.1016/j.jinf.2012.05.005; Barrett Freja Cecille, 2013, BMC Res Notes, V6, P315, DOI 10.1186/1756-0500-6-315; BEHRENS RH, 1994, BRIT MED J, V309, P918, DOI 10.1136/bmj.309.6959.918; Buckle Geoffrey C, 2012, J Glob Health, V2, P010401, DOI 10.7189/jogh.02.010401; Crump JA, 2004, B WORLD HEALTH ORGAN, V82, P346; Crump JA, 2010, CLIN INFECT DIS, V50, P241, DOI 10.1086/649541; GILMAN RH, 1975, LANCET, V1, P1211; Health Protection Agency, 2008, PIL ENH SURV ENT FEV; Health Protection Agency, HPA MIGR HLTH GUID E; Health Protection Agency, 2014, ENH SURV ENT FEV; Health Protection Agency, 2012, TYPH FEV VACC REC; Health Protection Agency Migrant Health, 2011, INF DIS NONUK BORN P; IVANOFF B, 1994, B WORLD HEALTH ORGAN, V72, P957; Mandell GL, 2010, MANDELL DOUGLAS BENN, DOI [10.1056/NEJMoa1304839. Two, DOI 10.1056/NEJMOA1304839]; Maskey AP, 2006, CLIN INFECT DIS, V42, P1247, DOI 10.1086/503033; Meltzer E, 2005, J TRAVEL MED, V12, P275, DOI 10.2310/7060.2005.12507; Ochiai RL, 2008, B WORLD HEALTH ORGAN, V86, P260, DOI 10.2471/BLT.06.039818; Office for National Statistics. International Passenger Survey, 2012, INT PASS SURV 2012; Organization WH, 2003, BACKGR DOC DIAGN TRE, V15, P460; Parry CM, 2002, NEW ENGL J MED, V347, P1770, DOI 10.1056/NEJMra020201; PHE, 2014, ENT FEV TYPH PAR ENG; Public Health England, 2013, TYPH GREEN BOOK; Reddy S, 2011, TRAVEL MED INFECT DI, V9, P206, DOI 10.1016/j.tmaid.2011.03.003; Waddington C, 2014, J INFECTION, V68, P38	25	9	9	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2015	10	3							e0120926	10.1371/journal.pone.0120926	http://dx.doi.org/10.1371/journal.pone.0120926			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD9NQ	25790017	Green Published, gold, Green Submitted			2022-12-27	WOS:000351425400184
J	Kilpatrick, K; Zeng, YM; Hancock, T; Segatori, L				Kilpatrick, Kiri; Zeng, Yimeng; Hancock, Tommy; Segatori, Laura			Genetic and Chemical Activation of TFEB Mediates Clearance of Aggregated alpha-Synuclein	PLOS ONE			English	Article							UBIQUITIN-PROTEASOME SYSTEM; PARKINSONS-DISEASE; BETA-CYCLODEXTRINS; IN-VITRO; AUTOPHAGY; DEGRADATION; CHOLESTEROL; NEURODEGENERATION; MACROAUTOPHAGY; DEPLETION	Aggregation of a-synuclein (alpha-syn) is associated with the development of a number of neurodegenerative diseases, including Parkinson's disease (PD). The formation of alpha-syn aggregates results from aberrant accumulation of misfolded alpha-syn and insufficient or impaired activity of the two main intracellular protein degradation systems, namely the ubiquitin-proteasome system and the autophagy-lysosomal pathway. In this study, we investigated the role of transcription factor EB (TFEB), a master regulator of the autophagy-lysosomal pathway, in preventing the accumulation of alpha-syn aggregates in human neuroglioma cells. We found that TFEB overexpression reduces the accumulation of aggregated alpha-syn by inducing autophagic clearance of alpha-syn. Furthermore, we showed that pharmacological activation of TFEB using 2-hydroxypropyl-beta-cyclodextrin promotes autophagic clearance of aggregated alpha-syn. In summary, our findings demonstrate that TFEB modulates autophagic clearance of alpha-syn and suggest that pharmacological activation of TFEB is a promising strategy to enhance the degradation of alpha-syn aggregates.	[Kilpatrick, Kiri; Zeng, Yimeng; Hancock, Tommy; Segatori, Laura] Rice Univ, Dept Chem & Biomol Engn, Houston, TX 77005 USA; [Segatori, Laura] Rice Univ, Dept Bioengn, Houston, TX USA; [Segatori, Laura] Rice Univ, Dept Biochem & Cell Biol, Houston, TX 77251 USA	Rice University; Rice University; Rice University	Segatori, L (corresponding author), Rice Univ, Dept Chem & Biomol Engn, Houston, TX 77005 USA.	segatori@rice.edu			National Science Foundation [CBET-1336053, CBET 1254318]; National Institute of Health [R21 NS084005]; Welch Foundation [C-1824]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS084005] Funding Source: NIH RePORTER; Div Of Chem, Bioeng, Env, & Transp Sys [1336053] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Welch Foundation(The Welch Foundation); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Div Of Chem, Bioeng, Env, & Transp Sys(National Science Foundation (NSF)NSF - Directorate for Engineering (ENG))	This work was funded by The National Science Foundation (CBET-1336053 and CBET 1254318), the National Institute of Health (R21 NS084005), and the Welch Foundation (C-1824). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bar-On P, 2006, J NEUROCHEMISTRY, V98; Chen FW, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015054; Cheng JL, 2006, BIOCHEM BIOPH RES CO, V351, P246, DOI 10.1016/j.bbrc.2006.10.042; Christian AE, 1997, J LIPID RES, V38, P2264; Cook NP, 2012, J AM CHEM SOC, V134, P20776, DOI 10.1021/ja3100287; Cooper AA, 2006, SCIENCE, V313, P324, DOI 10.1126/science.1129462; Crews L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009313; Cuervo AM, 2004, SCIENCE, V305, P1292, DOI 10.1126/science.1101738; Cuervo AM, 2005, AUTOPHAGY, V1, P131, DOI 10.4161/auto.1.3.2017; Dauer W, 2003, NEURON, V39, P889, DOI 10.1016/S0896-6273(03)00568-3; Davidson CD, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006951; Davis ME, 2004, NAT REV DRUG DISCOV, V3, P1023, DOI 10.1038/nrd1576; Decressac M, 2013, P NATL ACAD SCI USA, V110, pE1817, DOI 10.1073/pnas.1305623110; Dehay B, 2010, J NEUROSCI, V30, P12535, DOI 10.1523/JNEUROSCI.1920-10.2010; Ebrahimi-Fakhari D, 2011, J NEUROSCI, V31, P14508, DOI 10.1523/JNEUROSCI.1560-11.2011; Fortin DL, 2004, J NEUROSCI, V24, P6715, DOI 10.1523/JNEUROSCI.1594-04.2004; Goedert M, 2001, NAT REV NEUROSCI, V2, P492, DOI 10.1038/35081564; Hansen C, 2013, NEUROBIOL DIS, V56, P145, DOI 10.1016/j.nbd.2013.04.017; Huang Y, 2012, TRANSL NEURODEGENER, V1, DOI 10.1186/2047-9158-1-2; Iwata A, 2005, J BIOL CHEM, V280, P40282, DOI 10.1074/jbc.M508786200; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; Kilpatrick K, 2013, ACS CHEM BIOL, V8, P1460, DOI 10.1021/cb400017h; KILSDONK EPC, 1995, J BIOL CHEM, V270, P17250, DOI 10.1074/jbc.270.29.17250; Li WW, 2012, CELL MOL LIFE SCI, V69, P1125, DOI 10.1007/s00018-011-0865-5; Maxfield FR, 2005, NATURE, V438, P612, DOI 10.1038/nature04399; McNaught KSP, 2001, NAT REV NEUROSCI, V2, P589, DOI 10.1038/35086067; Mizushima N, 2011, CELL, V147, P728, DOI 10.1016/j.cell.2011.10.026; Mizushima N, 2010, CELL, V140, P313, DOI 10.1016/j.cell.2010.01.028; Monnaert V, 2004, J PHARMACOL EXP THER, V310, P745, DOI 10.1124/jpet.104.067512; Nedelsky NB, 2008, BBA-MOL BASIS DIS, V1782, P691, DOI 10.1016/j.bbadis.2008.10.002; Pan TH, 2008, NEUROBIOL DIS, V32, P16, DOI 10.1016/j.nbd.2008.06.003; Pandey UB, 2007, NATURE, V447, P859, DOI 10.1038/nature05853; Rajewski RA, 1996, J PHARM SCI, V85, P1142, DOI 10.1021/js960075u; Rideout HJ, 2001, J NEUROCHEM, V78, P899, DOI 10.1046/j.1471-4159.2001.00474.x; Roczniak-Ferguson A, 2012, SCI SIGNAL, V5, DOI [10.1126/scisignal.2002437, DOI 10.1126/SCISIGNAL.2002437]; Rosenbaum AI, 2010, P NATL ACAD SCI USA, V107, P5477, DOI 10.1073/pnas.0914309107; Rubinsztein DC, 2006, NATURE, V443, P780, DOI 10.1038/nature05291; Rubinsztein DC, 2012, NAT REV DRUG DISCOV, V11, P709, DOI 10.1038/nrd3802; Saito Y, 2004, J NEUROPATH EXP NEUR, V63, P323, DOI 10.1093/jnen/63.4.323; Sardiello M, 2009, SCIENCE, V325, P473, DOI 10.1126/science.1174447; Settembre C, 2011, AUTOPHAGY, V7, P1379, DOI 10.4161/auto.7.11.17166; Settembre C, 2011, SCIENCE, V332, P1429, DOI 10.1126/science.1204592; Shen D, 2011, CELL BIOCHEM BIOPHYS, V60, P173, DOI 10.1007/s12013-010-9138-4; Song WS, 2014, J BIOL CHEM, V289, P10211, DOI 10.1074/jbc.M113.506246; Song WS, 2013, HUM MOL GENET, V22, P1994, DOI 10.1093/hmg/ddt052; Spencer B, 2009, J NEUROSCI, V29, P13578, DOI 10.1523/JNEUROSCI.4390-09.2009; Spillantini MG, 1997, NATURE, V388, P839, DOI 10.1038/42166; Tsunemi T, 2012, SCIENCE TRANSLATIONA, V4, DOI [10.1126/scitranslmed.3003722, DOI 10.1126/SCITRANSLMED.3003722]; Uversky VN, 2008, CURR PROTEIN PEPT SC, V9, P507, DOI 10.2174/138920308785915218; Varkonyi J, 2003, AM J MED GENET A, V116A, P348, DOI 10.1002/ajmg.a.10028; Wang CW, 2003, MOL MED, V9, P65, DOI 10.1007/BF03402040; Webb JL, 2003, J BIOL CHEM, V278, P25009, DOI 10.1074/jbc.M300227200; Winslow AR, 2010, J CELL BIOL, V190, P1023, DOI 10.1083/jcb.201003122; Wong E, 2010, COLD SPRING HARBOR P, V2, DOI [10.1101/cshperspect.a004390, DOI 10.1101/CSHPERSPECT.A004390]; Yamamoto A, 1998, CELL STRUCT FUNCT, V23, P33, DOI 10.1247/csf.23.33	55	94	96	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2015	10	3							e0120819	10.1371/journal.pone.0120819	http://dx.doi.org/10.1371/journal.pone.0120819			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD9NQ	25790376	Green Published, gold, Green Submitted			2022-12-27	WOS:000351425400178
J	Kim, S; Ahn, C; Bong, N; Choe, S; Lee, DK				Kim, Sooho; Ahn, Chihoon; Bong, Naeun; Choe, Senyon; Lee, Dong Kun			Biphasic Effects of FGF2 on Adipogenesis	PLOS ONE			English	Article							MESENCHYMAL STEM-CELLS; FIBROBLAST GROWTH FACTOR-2; CHICK LIMB BUD; ADIPOCYTE DIFFERENTIATION; PPAR-GAMMA; ADIPOSE-TISSUE; OSTEOGENIC DIFFERENTIATION; EXPRESSION; KINASE; ACTIVATION	Although stem cells from mice deficient of FGF2 have been reported to display enhanced capacity for adipogenesis, the literature using in vitro cell culture system has so far reported conflicting results on the role of FGF2 in adipogenesis. We here demonstrate that FGF2, depending on concentration, can function as either a positive or negative factor of in vitro adipogenesis by regulating activation of the ERK signaling pathway. FGF2 at concentrations lower than 2 ng/ml enhanced in vitro adipogenesis of human adipose-derived stem cells (hASCs). However, FGF2 at concentrations higher than 10 ng/ml was able to suppress adipogenesis by maintaining sustained phosphorylation of ERK and function as a dominant negative adipogenic factor toward BMP ligands. Expression levels of FGF2 in the fat tissues from high fat diet induced obese C57BL/6 mice were lower than those from normal chow diet mice, indicating that expression levels of FGF2 in the fat tissues might be in reverse correlation with the size of fat tissues. Our observation of concentration dependent biphasic effect as well as dominant negative effect of FGF2 on adipogenesis provides a mechanistic basis to understand roles of FGF2 in adipogenesis and development of fat tissues.	[Kim, Sooho; Bong, Naeun; Lee, Dong Kun] Joint Ctr Biosci, Lab Genome Drug Med, Inchon, South Korea; [Ahn, Chihoon; Choe, Senyon] Joint Ctr Biosci, Lab Synthet Biol, Inchon, South Korea		Lee, DK (corresponding author), Joint Ctr Biosci, Lab Genome Drug Med, Inchon, South Korea.	dklee.jcb@gmail.com			Korean Health Technology R&D Project, Ministry for Health, Welfare Family Affairs [HI12C0328]; IFEZ, Korea	Korean Health Technology R&D Project, Ministry for Health, Welfare Family Affairs; IFEZ, Korea	This study was supported by the Korean Health Technology R&D Project, Ministry for Health, Welfare & Family Affairs (HI12C0328) and IFEZ, Korea. The funders had no role in study design, data collection and analysis, or preparation of the manuscript.	Bikfalvi A, 1997, ENDOCR REV, V18, P26, DOI 10.1210/er.18.1.26; Bost F, 2005, DIABETES, V54, P402, DOI 10.2337/diabetes.54.2.402; Bost F, 2005, BIOCHIMIE, V87, P51, DOI 10.1016/j.biochi.2004.10.018; Bressan RB, 2014, EXP CELL RES, V327, P37, DOI 10.1016/j.yexcr.2014.05.020; Byun MR, 2014, BONE, V58, P72, DOI 10.1016/j.bone.2013.09.024; Camp HS, 1997, J BIOL CHEM, V272, P10811; Cristancho AG, 2011, NAT REV MOL CELL BIO, V12, P722, DOI 10.1038/nrm3198; Gabrielsson BG, 2002, OBES RES, V10, P608, DOI 10.1038/oby.2002.83; Hu ED, 1996, SCIENCE, V274, P2100, DOI 10.1126/science.274.5295.2100; Jonker JW, 2012, NATURE, V485, P391, DOI 10.1038/nature10998; Kakudo N, 2007, BIOCHEM BIOPH RES CO, V359, P239, DOI 10.1016/j.bbrc.2007.05.070; Kang Q, 2009, STEM CELLS DEV, V18, P545, DOI 10.1089/scd.2008.0130; KENGAKU M, 1995, DEVELOPMENT, V121, P3121; Kim KA, 2007, MOL CELL BIOL, V27, P2294, DOI 10.1128/MCB.02207-06; Kim SW, 2001, J BIOL CHEM, V276, P10199, DOI 10.1074/jbc.M010640200; Kuo MMC, 2014, BIOMATERIALS, V35, P3172, DOI 10.1016/j.biomaterials.2013.12.063; Lai WT, 2011, STEM CELLS, V29, P1102, DOI 10.1002/stem.661; Lee MJ, 2013, J CELL MOL MED, V17, P1188, DOI 10.1111/jcmm.12098; Neubauer M, 2004, FEBS LETT, V577, P277, DOI 10.1016/j.febslet.2004.10.020; Nikbakht N, 1997, CELL MOL LIFE SCI, V53, P447, DOI 10.1007/s000180050054; Patel NG, 2005, J CLIN ENDOCR METAB, V90, P1226, DOI 10.1210/jc.2004-1309; Prusty D, 2002, J BIOL CHEM, V277, P46226, DOI 10.1074/jbc.M207776200; Qian SW, 2013, P NATL ACAD SCI USA, V110, pE798, DOI 10.1073/pnas.1215236110; RILEY BB, 1993, DEVELOPMENT, V118, P95; Rosen ED, 2006, NAT REV MOL CELL BIO, V7, P885, DOI 10.1038/nrm2066; Sakaue H, 2004, J BIOL CHEM, V279, P39951, DOI 10.1074/jbc.M407353200; Suh JM, 2014, NATURE, V513, P436, DOI 10.1038/nature13540; Tseng YH, 2008, NATURE, V454, P1000, DOI 10.1038/nature07221; Whittle AJ, 2012, CELL, V149, P871, DOI 10.1016/j.cell.2012.02.066; Widberg CH, 2009, AM J PHYSIOL-ENDOC M, V296, pE121, DOI 10.1152/ajpendo.90602.2008; Xiao LP, 2010, BONE, V47, P360, DOI 10.1016/j.bone.2010.05.021; Xue JC, 1996, MOL CELL BIOL, V16, P1567; Zaragosi LE, 2006, STEM CELLS, V24, P2412, DOI 10.1634/stemcells.2006-0006	33	25	26	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2015	10	3							e0120073	10.1371/journal.pone.0120073	http://dx.doi.org/10.1371/journal.pone.0120073			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD9NQ	25790378	gold, Green Submitted, Green Published			2022-12-27	WOS:000351425400128
J	Suzuki, N; Mukai, HY; Yamamoto, M				Suzuki, Norio; Mukai, Harumi Y.; Yamamoto, Masayuki			In Vivo Regulation of Erythropoiesis by Chemically Inducible Dimerization of the Erythropoietin Receptor Intracellular Domain	PLOS ONE			English	Article							GENE-EXPRESSION; TRANSGENIC MICE; STRESS ERYTHROPOIESIS; HEMATOPOIETIC-CELLS; GATA-1; PROLIFERATION; DISTINCT; PROGENITORS; ACTIVATION; SIGNALS	Erythropoietin (Epo) and its receptor (EpoR) are required for the regulation of erythropoiesis. Epo binds to the EpoR homodimer on the surface of erythroid progenitors and erythroblasts, and positions the intracellular domains of the homodimer to be in close proximity with each other. This conformational change is sufficient for the initiation of Epo-EpoR signal transduction. Here, we established a system of chemically regulated erythropoiesis in transgenic mice expressing a modified EpoR intracellular domain (amino acids 247-406) in which dimerization is induced using a specific compound (chemical inducer of dimerization, CID). Erythropoiesis is reversibly induced by oral administration of the CID to the transgenic mice. Because transgene expression is limited to hematopoietic cells by the Gata1 gene regulatory region, the effect of the CID is limited to erythropoiesis without adverse effects. Additionally, we show that the 160 amino acid sequence is the minimal essential domain of EpoR for intracellular signaling of chemically inducible erythropoiesis in vivo. We propose that the CID-dependent dimerization system combined with the EpoR intracellular domain and the Gata1 gene regulatory region generates a novel peroral strategy for the treatment of anemia.	[Suzuki, Norio] Tohoku Univ, Grad Sch Med, United Ctr Adv Res & Translat Med, Div Interdisciplinary Med Sci,Ctr Oxygen Med, Sendai, Miyagi 980, Japan; [Mukai, Harumi Y.; Yamamoto, Masayuki] Tohoku Univ, Grad Sch Med, Dept Med Biochem, Sendai, Miyagi 980, Japan	Tohoku University; Tohoku University	Suzuki, N (corresponding author), Tohoku Univ, Grad Sch Med, United Ctr Adv Res & Translat Med, Div Interdisciplinary Med Sci,Ctr Oxygen Med, Sendai, Miyagi 980, Japan.	sunorio@med.tohoku.ac.jp	Yamamoto, Masayuki/A-4873-2010	Yamamoto, Masayuki/0000-0002-9073-9436	Ministry of Education, Culture, Sports, Science and Technology; Japan Society for the Promotion of Science KAKENHI; Takeda Science Foundation; Inamori Foundation; Grants-in-Aid for Scientific Research [26111002] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Takeda Science Foundation(Takeda Science Foundation (TSF)); Inamori Foundation; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by the platform for Drug Discovery, Informatics, and Structural Life Science from Ministry of Education, Culture, Sports, Science and Technology (NS, MY), and by grants from the Japan Society for the Promotion of Science KAKENHI < http://www.jsps.go.jp > (NS, MY), Takeda Science Foundation < http://www.takeda-sci.or.jp > (NS), and Inamori Foundation < http://www.inamori-f.or.jp > (NS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alami R, 2000, HUM MOL GENET, V9, P631, DOI 10.1093/hmg/9.4.631; Arumugam PI, 2009, MOL THER, V17, P1929, DOI 10.1038/mt.2009.183; Blau C. Anthony, 2006, V349, P163; Blau CA, 1997, P NATL ACAD SCI USA, V94, P3076, DOI 10.1073/pnas.94.7.3076; BROUDY VC, 1991, BLOOD, V77, P2583, DOI 10.1182/blood.V77.12.2583.2583; Bunn HF, 2007, BLOOD, V109, P868, DOI 10.1182/blood-2006-08-019083; Elliott S, 2008, EXP HEMATOL, V36, P1573, DOI 10.1016/j.exphem.2008.08.003; Flint-Ashtamker G, 2002, FEBS LETT, V518, P189, DOI 10.1016/S0014-5793(02)02691-1; Frank SJ, 2002, ENDOCRINOLOGY, V143, P2, DOI 10.1210/en.143.1.2; Gross AW, 2006, J BIOL CHEM, V281, P2024, DOI 10.1074/jbc.M510493200; Huang LJS, 2001, MOL CELL, V8, P1327, DOI 10.1016/S1097-2765(01)00401-4; Jelkmann W, 2013, TRANSFUS MED HEMOTH, V40, P302, DOI 10.1159/000356193; Jin LQ, 2000, NAT GENET, V26, P64, DOI 10.1038/79194; Jin LQ, 1998, BLOOD, V91, P890, DOI 10.1182/blood.V91.3.890.890_890_897; Ketteler R, 2002, J BIOL CHEM, V277, P26547, DOI 10.1074/jbc.M202287200; Kim K, 2010, TOHOKU J EXP MED, V220, P127, DOI 10.1620/tjem.220.127; Koury MJ, 2014, BLOOD REV, V28, P49, DOI 10.1016/j.blre.2014.01.002; Livnah O, 1999, SCIENCE, V283, P987, DOI 10.1126/science.283.5404.987; Menon MP, 2006, J CLIN INVEST, V116, P683, DOI 10.1172/JCI25227; Miller CP, 2008, GENE THER, V15, P759, DOI 10.1038/gt.2008.43; Miller CP, 1999, BLOOD, V94, P3381, DOI 10.1182/blood.V94.10.3381.422k25_3381_3387; Miyata T, 2013, KIDNEY INT, V84, P693, DOI 10.1038/ki.2013.74; Motohashi H, 2000, CELL, V103, P865, DOI 10.1016/S0092-8674(00)00190-2; Neubauer H, 1998, CELL, V93, P397, DOI 10.1016/S0092-8674(00)81168-X; Ohmori S, 2012, MOL CELL BIOL, V32, P4742, DOI 10.1128/MCB.00718-12; Ohneda K, 2002, GENES CELLS, V7, P1243, DOI 10.1046/j.1365-2443.2002.00595.x; Onodera K, 1997, P NATL ACAD SCI USA, V94, P4487, DOI 10.1073/pnas.94.9.4487; Otto KG, 2001, BLOOD, V98, P2077, DOI 10.1182/blood.V98.7.2077; Pelletier S, 2006, MOL CELL BIOL, V26, P8527, DOI 10.1128/MCB.01035-06; Pollock C, 2008, CLIN J AM SOC NEPHRO, V3, P193, DOI 10.2215/CJN.02440607; Socolovsky M, 2001, BLOOD, V98, P3261, DOI 10.1182/blood.V98.12.3261; Souma T, 2013, J AM SOC NEPHROL, V24, P1599, DOI 10.1681/ASN.2013010030; SPENCER DM, 1993, SCIENCE, V262, P1019, DOI 10.1126/science.7694365; Suzuki M, 2006, BLOOD, V108, P726, DOI 10.1182/blood-2005-10-4064; Suzuki N, 2003, BLOOD, V102, P3575, DOI 10.1182/blood-2003-04-1154; Suzuki N, 2002, BLOOD, V100, P2279, DOI 10.1182/blood-2002-01-0124; Suzuki N, 2007, METHOD ENZYMOL, V435, P157, DOI 10.1016/S0076-6879(07)35009-X; Suzuki N, 2011, MOL CELL BIOL, V31, P3896, DOI 10.1128/MCB.05463-11; Takahashi S, 2000, BLOOD, V96, P910, DOI 10.1182/blood.V96.3.910.015k29_910_916; Wojchowski DM, 2010, CURR OPIN HEMATOL, V17, P169, DOI 10.1097/MOH.0b013e328338008b; WU H, 1995, CELL, V83, P59, DOI 10.1016/0092-8674(95)90234-1; YOSHIMURA A, 1990, P NATL ACAD SCI USA, V87, P4139, DOI 10.1073/pnas.87.11.4139; Zang HS, 2001, EMBO J, V20, P3156, DOI 10.1093/emboj/20.12.3156; Zeng H, 2001, BLOOD, V98, P328, DOI 10.1182/blood.V98.2.328; Zhou XO, 2014, BLOOD, V123, P3895, DOI 10.1182/blood-2014-01-551671	45	8	9	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2015	10	3							e0119442	10.1371/journal.pone.0119442	http://dx.doi.org/10.1371/journal.pone.0119442			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD9NQ	25790231	gold, Green Published, Green Submitted			2022-12-27	WOS:000351425400086
J	Weng, Y; Chabot, JR; Bernardo, B; Yan, QY; Zhu, YM; Brenner, MB; Vage, C; Logan, A; Calle, R; Talukdar, S				Weng, Yan; Chabot, Jeffrey R.; Bernardo, Barbara; Yan, Qingyun; Zhu, Yimin; Brenner, Martin B.; Vage, Chandra; Logan, Alison; Calle, Roberto; Talukdar, Saswata			Pharmacokinetics (PK), Pharmacodynamics (PD) and Integrated PK/PD Modeling of a Novel Long Acting FGF21 Clinical Candidate PF-05231023 in Diet-Induced Obese and Leptin-Deficient Obese Mice	PLOS ONE			English	Article							INCREASES ENERGY-EXPENDITURE; INSULIN SENSITIVITY; GROWTH; KLOTHO; BIOSYNTHESIS; TISSUES; BRAIN	Pharmacological administration of fibroblast growth factor 21 (FGF21) improves metabolic profile in preclinical species and humans. FGF21 exerts its metabolic effects through formation of beta-klotho (KLB)/FGF receptor 1c FGFR1c complex and subsequent signaling. Data from various in vitro systems demonstrate the intact C-and N-terminus of FGF21 is required for binding with KLB, and interaction with FGFR1c, respectively. However the relative roles of the termini for in vivo pharmacological effects are unclear. Here we report PF-05231023, a long-acting FGF21 analogue which is unique in that the half-life and subcutaneous (SC) bioavailability of the intact C-terminus are significantly different from those of the intact N-terminus (2 vs. 22 hr for half-life and 4 similar to 7 vs. similar to 50% SC bioavailability). Therefore, this molecule serves as a valuable tool to evaluate the relative roles of intact C-terminus vs. N-terminus in in vivo pharmacology studies in preclinical species. We determined the effects of PF-05231023 administration on body weight (BW) loss and glucose reduction during an oral glucose tolerance test (OGTT) following SC and intravenous (IV) administration in diet-induced obese (DIO) and leptin-deficient obese (ob/ob) mice, respectively. Our data show that the intact N-terminus of FGF21 in PF-05231023 appears to be sufficient to drive glucose lowering during OGTT and sustain BW loss in DIOs. Further, PK/PD modeling suggests that while the intact FGF21 C-terminus is not strictly required for glucose lowering during OGTT in ob/ob mice or for BW reduction in DIO mice, the higher potency conferred by intact C-terminus contributes to a rapid initiation of pharmacodynamic effects immediately following dosing. These results provide additional insight into the strategy of developing stabilized versions of FGF21 analogs to harness the full spectrum of its metabolic benefits.	[Weng, Yan; Chabot, Jeffrey R.; Bernardo, Barbara; Yan, Qingyun; Zhu, Yimin; Brenner, Martin B.; Logan, Alison; Calle, Roberto; Talukdar, Saswata] Pfizer Worldwide Res & Dev, Cardiovasc Metab & Endocrine Dis CVMED Res Unit, Cambridge, MA 02139 USA; [Weng, Yan; Chabot, Jeffrey R.; Vage, Chandra] Pfizer Worldwide Res & Dev, Pharmacokinet Dynam & Metab, Cambridge, MA 02139 USA	Pfizer; Pfizer	Talukdar, S (corresponding author), Pfizer Worldwide Res & Dev, Cardiovasc Metab & Endocrine Dis CVMED Res Unit, 610 Main St, Cambridge, MA 02139 USA.	Saswata.Talukdar@pfizer.com	Bernardo, Barbara/N-7101-2019	Calle, Roberto/0000-0001-6577-5657	Pfizer Inc.	Pfizer Inc.(Pfizer)	Pfizer Inc. provided funding for this study. The funder provided support in the form of salaries for all authors listed, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams AC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065763; Adams AC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038438; Coskun T, 2008, ENDOCRINOLOGY, V149, P6018, DOI 10.1210/en.2008-0816; Ding XS, 2012, CELL METAB, V16, P387, DOI 10.1016/j.cmet.2012.08.002; Fisher FM, 2012, GENE DEV, V26, P271, DOI 10.1101/gad.177857.111; Foltz IN, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004690; Gaich G, 2013, CELL METAB, V18, P333, DOI 10.1016/j.cmet.2013.08.005; Gimeno RE, 2014, TRENDS ENDOCRINOL ME; Goetz R, 2007, MOL CELL BIOL, V27, P3417, DOI 10.1128/MCB.02249-06; Goetz R, 2013, NAT REV MOL CELL BIO, V14, P166, DOI 10.1038/nrm3528; Guo J, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000511; Hager T, 2013, ANAL CHEM, V85, P2731, DOI 10.1021/ac303203y; Hall KD, 2008, INT J OBESITY, V32, P573, DOI 10.1038/sj.ijo.0803720; Holland WL, 2013, CELL METAB, V17, P790, DOI 10.1016/j.cmet.2013.03.019; Huang J, 2013, J PHARMACOL EXP THER, V346, P270, DOI 10.1124/jpet.113.204420; Kharitonenkov A, 2005, J CLIN INVEST, V115, P1627, DOI 10.1172/JCI23606; Kharitonenkov A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058575; Kharitonenkov A, 2011, TRENDS ENDOCRIN MET, V22, P81, DOI 10.1016/j.tem.2010.11.003; Kim HW, 2013, ENDOCRINOLOGY, V154, P3366, DOI 10.1210/en.2012-2276; Kliewer SA, 2010, AM J CLIN NUTR, V91, p254S, DOI 10.3945/ajcn.2009.28449B; Li PP, 2013, CELL, V155, P200, DOI 10.1016/j.cell.2013.08.054; Lin ZF, 2013, CELL METAB, V17, P779, DOI 10.1016/j.cmet.2013.04.005; Lin ZF, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018398; Lu M, 2013, J BIOL CHEM, V288, P10722, DOI 10.1074/jbc.M112.443606; Micanovic R, 2009, J CELL PHYSIOL, V219, P227, DOI 10.1002/jcp.21675; Ming AYK, 2012, J BIOL CHEM, V287, P19997, DOI 10.1074/jbc.M111.325670; Mu J, 2012, DIABETES, V61, P505, DOI 10.2337/db11-0838; Owen BM, 2014, CELL METAB; Reitman ML, 2013, CELL METAB, V18, P307, DOI 10.1016/j.cmet.2013.08.014; Sarruf DA, 2010, DIABETES, V59, P1817, DOI 10.2337/db09-1878; Stein S, 2009, DIABETES CARE, V32, P126, DOI 10.2337/dc08-1054; Tacer KF, 2010, MOL ENDOCRINOL, V24, P2050, DOI 10.1210/me.2010-0142; Tschop MH, 2012, NAT METHODS, V9, P57, DOI [10.1038/NMETH.1806, 10.1038/nmeth.1806]; Veniant MM, 2012, ENDOCRINOLOGY, V153, P4192, DOI 10.1210/en.2012-1211; Veniant MM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040164; Wu AL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017868; Xu J, 2009, DIABETES, V58, P250, DOI 10.2337/db08-0392; Yie JM, 2009, FEBS LETT, V583, P19, DOI 10.1016/j.febslet.2008.11.023	38	45	48	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2015	10	3							e0119104	10.1371/journal.pone.0119104	http://dx.doi.org/10.1371/journal.pone.0119104			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD9NQ	25790234	Green Submitted, gold, Green Published			2022-12-27	WOS:000351425400066
J	De Craemer, M; Lateva, M; Iotova, V; De Decker, E; Verloigne, M; De Bourdeaudhuij, I; Androutsos, O; Socha, P; Kulaga, Z; Moreno, L; Koletzko, B; Manios, Y; Cardon, G				De Craemer, Marieke; Lateva, Mina; Iotova, Violeta; De Decker, Ellen; Verloigne, Maite; De Bourdeaudhuij, Ilse; Androutsos, Odysseas; Socha, Piotr; Kulaga, Zbigniew; Moreno, Luis; Koletzko, Berthold; Manios, Yannis; Cardon, Greet		ToyBox-Study Grp	Differences in Energy Balance-Related Behaviours in European Preschool Children: The ToyBox-Study	PLOS ONE			English	Article							PHYSICAL-ACTIVITY; SEDENTARY BEHAVIOR; FOCUS GROUPS; CHILDHOOD; OBESITY; INTERVENTION; ASSOCIATIONS; EXPLORATION; TRACKING; PARENTS	Background The aim of the current study was to compare levels of energy balance-related behaviours (physical activity, sedentary behaviour, and dietary behaviours (more specifically water consumption, sugar-sweetened beverage consumption and unhealthy snacking)) in four-to six-year-old preschoolers from six European countries (Belgium, Bulgaria, Germany, Greece, Poland, and Spain) within the ToyBox cross-sectional study. Methods A sample of 4,045 preschoolers (4.77 +/- 0.43 years; 52.2% boys) had valid physical activity data (steps per day), parents of 8,117 preschoolers (4.78 +/- 0.46 years; 53.0% boys) completed a parental questionnaire with questions on sedentary behaviours (television viewing, computer use, and quiet play), and parents of 7,244 preschoolers (4.77 +/- 0.44 years; 52.0% boys) completed a food frequency questionnaire with questions on water consumption, sugar-sweetened beverage consumption and unhealthy snacking. Results The highest levels of physical activity were found in Spain (12,669 steps/day on weekdays), while the lowest levels were found in Bulgaria and Greece (9,777 and 9,656 steps/day on weekdays, respectively). German preschoolers spent the least amount of time in television viewing (43.3 min/day on weekdays), while Greek preschoolers spent the most time in television viewing (88.5 min/day on weekdays). A considerable amount of time was spent in quiet play in all countries, with the highest levels in Poland (104.9 min/day on weekdays), and the lowest levels in Spain (60.4 min/day on weekdays). Belgian, German, and Polish preschoolers had the lowest intakes of water and the highest intakes of sugar-sweetened beverages. The intake of snacks was the highest in Belgian preschoolers (73.1 g/day) and the lowest in Greek preschoolers (53.3 g/day). Conclusions Across six European countries, differences in preschoolers' energy balance-related behaviours were found. Future interventions should target European preschoolers' energy balance-related behaviours simultaneously, but should apply country-specific adaptations.	[De Craemer, Marieke; De Decker, Ellen; Verloigne, Maite; De Bourdeaudhuij, Ilse; Cardon, Greet] Univ Ghent, B-9000 Ghent, Belgium; [Lateva, Mina; Iotova, Violeta] Med Univ Varna, Varna, Bulgaria; [Verloigne, Maite] Res Fdn Flanders, Brussels, Belgium; [Androutsos, Odysseas; Manios, Yannis] Harokopio Univ, Athens, Greece; [Socha, Piotr; Kulaga, Zbigniew] Childrens Mem Hlth Inst, Warsaw, Poland; [Moreno, Luis] Univ Zaragoza, Zaragoza, Spain; [Koletzko, Berthold] Univ Munich, Med Ctr, Munich, Germany	Ghent University; Medical University Varna; Harokopio University Athens; Children's Memorial Health Institute; University of Zaragoza; University of Munich	De Craemer, M (corresponding author), Univ Ghent, B-9000 Ghent, Belgium.	marieke.decraemer@ugent.be	Radkova, Zhaneta/AAM-1538-2020; Paw, Mai Chin A/N-1665-2019; Moreno, Luis/S-1780-2019; De Craemer, Marieke/P-6072-2016; Gibson, Leigh/B-5010-2010; De+Bourdeaudhuij, Ilse/AAC-5528-2019; Iotova, Violeta/AAO-2387-2021; Androutsos, Odysseas/ABF-8670-2021; De Craemer, Marieke/Z-3050-2019; Manios, Yannis/AAM-8953-2021; De Miguel-Etayo, Pilar/B-5258-2014	Radkova, Zhaneta/0000-0003-2007-8019; Paw, Mai Chin A/0000-0001-6259-2441; Moreno, Luis/0000-0003-0454-653X; Gibson, Leigh/0000-0002-9789-7429; De+Bourdeaudhuij, Ilse/0000-0001-9969-7597; De Craemer, Marieke/0000-0002-5220-7850; Manios, Yannis/0000-0001-6486-114X; Gozdz, Magdalena/0000-0002-9753-568X; De Miguel-Etayo, Pilar/0000-0001-6173-5850; Ward, Dianne Stanton/0000-0001-6389-0168; Gurzkowska, Beata/0000-0003-2681-3221; Moore, Helen J/0000-0002-0165-7552; Iotova, Violeta/0000-0003-4160-1200; te Velde, Saskia/0000-0002-4674-8052; Cardon, Greet/0000-0003-4983-6557; Socha, Piotr/0000-0002-1621-464X; Kulaga, Zbigniew/0000-0003-0509-1004	European Commission [245200]	European Commission(European CommissionEuropean Commission Joint Research Centre)	The ToyBox-study is funded by the Seventh Framework Programme (CORDIS FP7) of the European Commission under grant agreement no 245200. The content of this article reflects only the authors' views and the European Community is not liable for any use that may be made of the information contained therein. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alghaeed Z, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071854; Ammerman Alice S, 2007, Prev Chronic Dis, V4, pA67; [Anonymous], 2009, PHYS ACT GUID DOC; Atkin AJ, 2012, INT J EPIDEMIOL, V41, P1460, DOI 10.1093/ije/dys118; Australian Department of Health and Aging, 2009, GET GROW HLTH EAT PH; Bayer O, 2009, CLIN NUTR, V28, P122, DOI 10.1016/j.clnu.2009.01.001; Belgian Health Council, 2009, VOED BELG HERZ VERS; Biddle SJH, 2011, BRIT J SPORT MED, V45, P937, DOI 10.1136/bjsports-2011-090205; Biddle SJH, 2010, PREV MED, V51, P345, DOI 10.1016/j.ypmed.2010.07.018; CALFAS KJ, 1991, J DEV BEHAV PEDIATR, V12, P185; De Craemer M, 2014, J SPORTS SCI, V18, P1; De Craemer M, 2014, J SCI MED SPORT; De Craemer M, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-278; De Decker E, 2012, OBES REV, V13, P75, DOI 10.1111/j.1467-789X.2011.00961.x; De Decker E, 2013, J SCHOOL HEALTH, V83, P654, DOI 10.1111/josh.12078; De Martelaer K., 2007, ONDERWIJSONDERZOEK R, P191; de Onis M, 2010, AM J CLIN NUTR, V92, P1257, DOI 10.3945/ajcn.2010.29786; Dennison BA, 2004, ARCH PEDIAT ADOL MED, V158, P170, DOI 10.1001/archpedi.158.2.170; Department of Health, 2011, START ACT STAY ACT R; Epstein LH, 2008, ARCH PEDIAT ADOL MED, V162, P239, DOI 10.1001/archpediatrics.2007.45; European Food Information Council, 2009, FOOD BAS DIET GUID E; Flemish Government Department Health and Family, 2012, VLAAMS CONS VERB EV; Healy GN, 2008, DIABETES CARE, V31, P661, DOI 10.2337/dc07-2046; Hill JO, 2003, SCIENCE, V299, P853, DOI 10.1126/science.1079857; Hinkley T, 2010, INT J BEHAV NUTR PHY, V7, DOI 10.1186/1479-5868-7-66; Institute of Medicine of the National Academies, 2011, EARL CHILDH OB PREV; Janz KF, 2002, PREV MED, V35, P563, DOI 10.1006/pmed.2002.1113; Jones RA, 2013, AM J PREV MED, V44, P651, DOI 10.1016/j.amepre.2013.03.001; KELDER SH, 1994, AM J PUBLIC HEALTH, V84, P1121, DOI 10.2105/AJPH.84.7.1121; Kremers SPJ, 2006, INT J BEHAV NUTR PHY, V3, DOI 10.1186/1479-5868-3-9; Manios Y, 2012, OBES REV, V13, P3, DOI 10.1111/j.1467-789X.2011.00974.x; Mikkila V, 2005, BRIT J NUTR, V93, P923, DOI 10.1079/BJN20051418; Ministerie van Welzijn Volksgezondheid en Gezin, 2012, NAAR EV VOED BEW; National Association for Sports and Physical Education (NASPE), 2009, ACT START STAT PHYS; Northstone K, 2008, BRIT J NUTR, V100, P1069, DOI 10.1017/S0007114508968264; Nutrition Information Center, 2006, ACT VOED KLEUT; Puhse U, 2005, CONCEPTS PROBLEMS PR, P588; Reilly JJ, 2004, LANCET, V363, P211, DOI 10.1016/S0140-6736(03)15331-7; Rowe DA, 2004, PEDIATR EXERC SCI, V16, P343, DOI 10.1123/pes.16.4.343; van Stralen MM, 2012, OBES REV, V13, P29, DOI 10.1111/j.1467-789X.2011.00959.x; World Health Organization, 2013, HLTH TOP DIS PREV PH; World Health Organization, 2012, GLOB DAT IMPL NUTR A; World Health Organization, 2013, GLOB NUTR POL REV WH	43	55	56	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2015	10	3							e0118303	10.1371/journal.pone.0118303	http://dx.doi.org/10.1371/journal.pone.0118303			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9BN	25785738	Green Published, Green Submitted, gold			2022-12-27	WOS:000352138500026
J	Hashimoto, Y; Honda, T; Matsumura, K; Nakao, M; Soga, K; Katano, K; Yokota, T; Mizusawa, H; Nagao, S; Ishikawa, K				Hashimoto, Yuji; Honda, Takeru; Matsumura, Ken; Nakao, Makoto; Soga, Kazumasa; Katano, Kazuhiko; Yokota, Takanori; Mizusawa, Hidehiro; Nagao, Soichi; Ishikawa, Kinya			Quantitative Evaluation of Human Cerebellum-Dependent Motor Learning through Prism Adaptation of Hand-Reaching Movement	PLOS ONE			English	Article							MULTIPLE SYSTEM ATROPHY; SPINOCEREBELLAR ATAXIA; HUNTINGTONS-DISEASE; NATURAL-HISTORY; INTERNAL-MODELS; FORCE-FIELD; EYEBLINK; LESIONS; INVOLVEMENT; MEMORY	The cerebellum plays important roles in motor coordination and learning. However, motor learning has not been quantitatively evaluated clinically. It thus remains unclear how motor learning is influenced by cerebellar diseases or aging, and is related with incoordination. Here, we present a new application for testing human cerebellum-dependent motor learning using prism adaptation. In our paradigm, the participant wearing prism-equipped goggles touches their index finger to the target presented on a touchscreen in every trial. The whole test consisted of three consecutive sessions: (1) 50 trials with normal vision (BASELINE), (2) 100 trials wearing the prism that shifts the visual field 25 degrees rightward (PRISM), and (3) 50 trials without the prism (REMOVAL). In healthy subjects, the prism-induced finger-touch error, i.e., the distance between touch and target positions, was decreased gradually by motor learning through repetition of trials. We found that such motor learning could be quantified using the "adaptability index (AI)", which was calculated by multiplying each probability of [acquisition in the last 10 trials of PRISM], [retention in the initial five trials of REMOVAL], and [extinction in the last 10 trials of REMOVAL]. The AI of cerebellar patients less than 70 years old (mean, 0.227; n = 62) was lower than that of age-matched healthy subjects (0.867, n = 21; p < 0.0001). While AI did not correlate with the magnitude of dysmetria in ataxic patients, it declined in parallel with disease progression, suggesting a close correlation between the impaired cerebellar motor leaning and the dysmetria. Furthermore, AI decreased with aging in the healthy subjects over 70 years old compared with that in the healthy subjects less than 70 years old. We suggest that our paradigm of prism adaptation may allow us to quantitatively assess cerebellar motor learning in both normal and diseased conditions.	[Hashimoto, Yuji; Honda, Takeru; Matsumura, Ken; Soga, Kazumasa; Yokota, Takanori; Mizusawa, Hidehiro; Nagao, Soichi; Ishikawa, Kinya] Tokyo Med & Dent Univ, Grad Sch, Dept Neurol & Neurol Sci, Bunkyo Ku, Tokyo, Japan; [Honda, Takeru; Nakao, Makoto; Nagao, Soichi] RIKEN Brain Sci Inst, Lab Motor Learning Control, Wako, Saitama, Japan; [Honda, Takeru] Japan Soc Promot Sci, Chiyoda Ku, Tokyo, Japan; [Katano, Kazuhiko] KATANO TOOL SOFTWARE, Ichikawa, Chiba, Japan; [Nagao, Soichi] Nozomi Hosp, Nozomi Higher Brain Funct Lab, Ina, Saitama, Japan	Tokyo Medical & Dental University (TMDU); RIKEN; Japan Society for the Promotion of Science	Honda, T (corresponding author), Tokyo Med & Dent Univ, Grad Sch, Dept Neurol & Neurol Sci, Bunkyo Ku, Tokyo, Japan.	takeru@brain.riken.jp; nagaos@brain.riken.jp; pico.nuro@tmd.ac.jp		Yokota, Takanori/0000-0002-6490-3263	Ministry of Education, Culture Sports, Science and Technology of Japan; RIKEN; KATANO TOOL SOFTWARE	Ministry of Education, Culture Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); RIKEN; KATANO TOOL SOFTWARE	This work was supported by the Strategic Research for the Brain Sciences by the Ministry of Education, Culture Sports, Science and Technology of Japan and research fund from RIKEN. KATANO TOOL SOFTWARE provided support in the form of a salary for author KK, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of the authors are articulated in the 'author contributions' section.	Ackermann H, 2008, TRENDS NEUROSCI, V31, P265, DOI 10.1016/j.tins.2008.02.011; Akobeng AK, 2007, ACTA PAEDIATR, V96, P644, DOI 10.1111/j.1651-2227.2006.00178.x; Alexis B, 2007, SPINOCEREBELLAR DEGE; ANSARI AR, 1960, ANN MATH STAT, V31, P1174, DOI 10.1214/aoms/1177705688; Babinski F, 1899, REV NEUROLOGIQUE, V7, P806; Baizer JS, 1999, J NEUROPHYSIOL, V81, P1960, DOI 10.1152/jn.1999.81.4.1960; Baizer JS, 1974, J PHYSIOL-LONDON, V236, p34P; Barash S, 1999, J NEUROSCI, V19, P10931, DOI 10.1523/JNEUROSCI.19-24-10931.1999; Block HJ, 2012, NEUROPSYCHOLOGIA, V50, P1766, DOI 10.1016/j.neuropsychologia.2012.03.034; Brusse E, 2007, CLIN GENET, V71, P12, DOI 10.1111/j.1399-0004.2006.00722.x; Burciu RG, 2014, EXP BRAIN RES, V232, P2847, DOI 10.1007/s00221-014-3956-3; Chapman HL, 2010, NEUROPSYCHOLOGIA, V48, P2595, DOI 10.1016/j.neuropsychologia.2010.05.006; Clower DM, 1996, NATURE, V383, P618, DOI 10.1038/383618a0; Danckert J, 2008, EUR J NEUROSCI, V28, P1696, DOI 10.1111/j.1460-9568.2008.06460.x; DELONG ER, 1988, BIOMETRICS, V44, P837, DOI 10.2307/2531595; Donchin O, 2012, J NEUROPHYSIOL, V107, P134, DOI 10.1152/jn.00007.2011; DURKIN M, 1993, PSYCHOL AGING, V8, P571, DOI 10.1037/0882-7974.8.4.571; Fernandez-Ruiz J, 1999, LEARN MEMORY, V6, P47; Fernandez-Ruiz J, 2009, BRAIN RES COGN BRAIN, V9, P223; Gerwig M, 2007, CEREBELLUM, V6, P38, DOI 10.1080/14734220701225904; Geser F, 2006, MOVEMENT DISORD, V21, P179, DOI 10.1002/mds.20678; Gilman S, 2008, NEUROLOGY, V71, P670, DOI 10.1212/01.wnl.0000324625.00404.15; Holmes G, 1939, BRAIN, V62, P1, DOI 10.1093/brain/62.1.1; Ikeda Y, 2012, NEUROLOGY, V79, P333, DOI 10.1212/WNL.0b013e318260436f; Ilg W, 2012, NEUROLOGY, V79, P2056, DOI 10.1212/WNL.0b013e3182749e67; Ishikawa K, 1999, J NEUROL NEUROSUR PS, V67, P86, DOI 10.1136/jnnp.67.1.86; Ito M, 1984, CEREBELLUM NEURAL CO; Ito M, 2011, THE CEREBELLUM BRAIN; Ito M, 2008, NAT REV NEUROSCI, V9, P304, DOI 10.1038/nrn2332; Jacobi H, 2011, NEUROLOGY, V77, P1035, DOI 10.1212/WNL.0b013e31822e7ca0; King BR, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00142; Kitazawa S, 1998, NATURE, V392, P494, DOI 10.1038/33141; Kobayashi H, 2011, AM J HUM GENET, V89, P121, DOI 10.1016/j.ajhg.2011.05.015; Kuper M, 2014, HUM BRAIN MAPP, V35, P1574, DOI 10.1002/hbm.22274; Lalkhen AG, 2008, BJA EDUC, V8, P221, DOI 10.1093/bjaceaccp/mkn041; LEINER HC, 1986, BEHAV NEUROSCI, V100, P443, DOI 10.1037/0735-7044.100.4.443; Lisberger S.G., 2013, PRINCIPLES NEURAL SC, P960; Lowe J, 2004, BASIC NEUROPATHOLOGY, P169; Luaute J, 2009, J NEUROSCI, V29, P169, DOI 10.1523/JNEUROSCI.3054-08.2009; Manto M, 2009, CURR OPIN NEUROL, V22, P419, DOI 10.1097/WCO.0b013e32832b9897; Gutierrez-Garralda JM, 2013, EUR J NEUROSCI, V38, P2933, DOI 10.1111/ejn.12288; Martin TA, 1996, BRAIN, V119, P1183, DOI 10.1093/brain/119.4.1183; Nagao S, 2013, NEURAL NETWORKS, V47, P72, DOI 10.1016/j.neunet.2013.01.017; Norris SA, 2011, J NEUROPHYSIOL, V105, P2248, DOI 10.1152/jn.01009.2010; Ohki M, 2009, J NEUROPHYSIOL, V101, P934, DOI [10.1152/jn.90440.2008, 10.1152/jn.90440.2009]; Owada K, 2005, NEUROLOGY, V65, P629, DOI 10.1212/01.wnl.0000173065.75680.e2; Rabe K, 2009, J NEUROPHYSIOL, V101, P1961, DOI 10.1152/jn.91069.2008; RAICHLE ME, 1994, CEREB CORTEX, V4, P8, DOI 10.1093/cercor/4.1.8; Raz N, 2005, CEREB CORTEX, V15, P1676, DOI 10.1093/cercor/bhi044; Redding GM, 1996, J EXP PSYCHOL HUMAN, V22, P379, DOI 10.1037/0096-1523.22.2.379; Redding GM, 2005, NEUROSCI BIOBEHAV R, V29, P431, DOI 10.1016/j.neubiorev.2004.12.004; Sato N, 2009, AM J HUM GENET, V85, P544, DOI 10.1016/j.ajhg.2009.09.019; Schmitz-Hubsch T, 2010, NEUROLOGY, V74, P678, DOI 10.1212/WNL.0b013e3181d1a6c9; Schmitz-Hubsch T, 2006, NEUROLOGY, V66, P1717, DOI 10.1212/01.wnl.0000219042.60538.92; Seidel K, 2012, ACTA NEUROPATHOL, V124, P1, DOI 10.1007/s00401-012-1000-x; SHELHAMER M, 1994, EXP BRAIN RES, V100, P328; Smith MA, 2005, J NEUROPHYSIOL, V93, P2809, DOI 10.1152/jn.00943.2004; SOLOMON PR, 1989, PSYCHOL AGING, V4, P34, DOI 10.1037/0882-7974.4.1.34; Stoodley CJ, 2010, CORTEX, V46, P831, DOI 10.1016/j.cortex.2009.11.008; SWETS JA, 1979, INVEST RADIOL, V14, P109, DOI 10.1097/00004424-197903000-00002; THACH WT, 1992, ANNU REV NEUROSCI, V15, P403, DOI 10.1146/annurev.neuro.15.1.403; Thieme A, 2013, BRAIN, V136, P2063, DOI 10.1093/brain/awt107; TOPKA H, 1993, BRAIN, V116, P961, DOI 10.1093/brain/116.4.961; Walker MF, 1999, ANN NY ACAD SCI, V871, P205, DOI 10.1111/j.1749-6632.1999.tb09186.x; Watanabe H, 2002, BRAIN, V125, P1070, DOI 10.1093/brain/awf117; WEINER MJ, 1983, NEUROLOGY, V33, P766, DOI 10.1212/WNL.33.6.766; Wolpert DM, 1998, NEURAL NETWORKS, V11, P1317, DOI 10.1016/S0893-6080(98)00066-5; Woodruff-Pak DS, 1998, PSYCHOL AGING, V13, P193, DOI 10.1037/0882-7974.13.2.193; WoodruffPak DS, 1996, NEUROPSYCHOLOGY, V10, P443; Yamada M, 2008, ACTA NEUROPATHOL, V115, P71, DOI 10.1007/s00401-007-0287-5; YOUNG IT, 1977, J HISTOCHEM CYTOCHEM, V25, P935, DOI 10.1177/25.7.894009; Zhang CZ, 2010, CELL TISSUE RES, V341, P341, DOI 10.1007/s00441-010-1016-2	72	20	20	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2015	10	3							e0119376	10.1371/journal.pone.0119376	http://dx.doi.org/10.1371/journal.pone.0119376			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9BN	25785588	Green Published, Green Submitted, gold			2022-12-27	WOS:000352138500099
J	Li, Z; Wu, TM; Ming, WJ; Chen, X; Xiao, XM				Li Zhe; Wu Tian-mei; Ming Wei-jie; Chen Xin; Xiao Xiao-min			The Influence of Maternal Islet Beta-Cell Autoantibodies in Conjunction with Gestational Hyperglycemia on Neonatal Outcomes	PLOS ONE			English	Article							STIFF-MAN SYNDROME; DIABETES-MELLITUS; GAD ANTIBODIES; T-CELLS; TYPE-1; MOTHERS; PREGNANCY; WOMEN; POSTPARTUM; CHILDREN	Objective To determine the predictive value of the presence of maternal islet beta-cell autoantibodies with respect to neonatal outcomes. Methods A total of 311 pregnant women with abnormal 75 g oral glucose tolerance test (OGTT) results were enrolled in this study. Maternal glutamic acid decarboxylase autoantibodies (GADA), islet cell autoantibodies (ICA) and insulin autoantibodies (IAA) were tested in fasting blood both on the day following the routine OGTT and before delivery. The birth weight, Apgar score, blood glucose and outcomes of each neonate were later evaluated and recorded. Results 1. In this study, 33.9% of the pregnant women with gestational hyperglycemia had detectable levels of one or more types of anti-islet cell antibodies in the third trimester. The proportion of women who produced GADA and/or ICA was significantly higher in the group of women with gestational hyperglycemia than in the control group (P<0.05). The groups similarly differed in the proportion of women who tested positive for any anti-islet cell antibody (P<0.05). 2. Of the patients in our study, those who produced GADA exhibited an increase in uterine and umbilical arterial pulsatility indexes (PIs) during the third trimesters compared with the control group (P 0.05). Additionally, an increased frequency of fetal growth restriction (FGR) was observed in the infants of women who produced IAA during pregnancy compared with those without autoantibodies (P 0.05). 3. The rate of newborn admission to the neonatal intensive care unit (NICU) was significantly associated with the presence of maternal ICA during the third trimester (OR, 6.36; 95% CI, 1.22-33.26). 4. The incidence of neonatal asphyxia was associated with the presence of maternal GADA in both the second (OR, 10.44; 95% CI, 1.46-74.92) and the third (OR, 8.33; 95% CI, 1.45-47.82) trimesters. Conclusion Approximately one-third of the women with gestational hyperglycemia produced anti-islet cell antibodies. The incidence of FGR was higher in women with gestational hyperglycemia who produced IAA than in those without autoantibodies. Maternal ICA production in the third trimester was a risk factor for the subsequent admission of newborns to the NICU. Furthermore, the presence of maternal GADA placed the neonate at increased risk for asphyxia.	[Li Zhe; Wu Tian-mei; Ming Wei-jie; Chen Xin; Xiao Xiao-min] Jinan Univ, Affiliated Hosp 1, Dept Obstet & Gynecol, Guangzhou, Guangdong, Peoples R China	Jinan University	Li, Z (corresponding author), Jinan Univ, Affiliated Hosp 1, Dept Obstet & Gynecol, Guangzhou, Guangdong, Peoples R China.	mcal@foxmail.com; xiaoxiaomin55@163.com	Ming, Wai-kit/AAH-5989-2019	Ming, Wai-kit/0000-0002-8846-7515				BOTTAZZO GF, 1974, LANCET, V2, P1279, DOI 10.1016/S0140-6736(74)90140-8; BUSCHARD K, 1990, DIABETOLOGIA, V33, P31, DOI 10.1007/BF00586458; DIMARIO U, 1987, DIABETOLOGIA, V30, P66, DOI 10.1007/BF00274573; Fuchtenbusch M, 1997, DIABETES, V46, P1459, DOI 10.2337/diabetes.46.9.1459; Hedderson MM, 2010, OBSTET GYNECOL, V115, P597, DOI 10.1097/AOG.0b013e3181cfce4f; Holm BC, 2006, CLIN EXP IMMUNOL, V146, P493, DOI 10.1111/j.1365-2249.2006.03243.x; Jarvela IY, 2006, DIABETES CARE, V29, P607, DOI 10.2337/diacare.29.03.06.dc05-1118; Lapolla A, 1999, DIABETES NUTR METAB, V12, P394; Lapolla A, 2009, NUTR METAB CARDIOVAS, V19, P674, DOI 10.1016/j.numecd.2009.04.004; Li Fang, 2005, CHINESE J PRACTICAL, V21, P425; Lobner K, 2006, DIABETES, V55, P792, DOI 10.2337/diabetes.55.03.06.db05-0746; Nilsson C, 2007, DIABETES CARE, V30, P1968, DOI 10.2337/dc07-0157; PALMER JP, 1983, SCIENCE, V222, P1337, DOI 10.1126/science.6362005; ROLL U, 1994, DIABETOLOGIA, V37, P1132, DOI 10.1007/BF00418377; Rong Yuan, 2010, HAINAN MED J, V21, P32; SOLIMENA M, 1988, NEW ENGL J MED, V318, P1012, DOI 10.1056/NEJM198804213181602; SOLIMENA M, 1990, NEW ENGL J MED, V322, P1555, DOI 10.1056/NEJM199005313222202; [吴天梅 Wu Tianmei], 2011, [广东医学, Guangdong Medical Journal], V32, P585; Wucher H, 2011, DIABETES METAB, V37, P47, DOI 10.1016/j.diabet.2010.07.005; Yu SH, 2009, DIABETES-METAB RES, V25, P329, DOI 10.1002/dmrr.963	20	1	1	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2015	10	3							e0120414	10.1371/journal.pone.0120414	http://dx.doi.org/10.1371/journal.pone.0120414			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9BN	25785598	Green Published, gold			2022-12-27	WOS:000352138500171
J	Musmeci, N; Aste, T; Di Matteo, T				Musmeci, Nicolo; Aste, Tomaso; Di Matteo, T.			Relation between Financial Market Structure and the Real Economy: Comparison between Clustering Methods	PLOS ONE			English	Article							SPANNING-TREES; ASSET TREES; NETWORKS	We quantify the amount of information ltered by dierent hierarchical clustering methods on correlations between stock returns comparing the clustering structure with the underlying industrial activity classication. We apply, for the rst time to nancial data, a novel hierarchical clustering approach, the Directed Bubble Hierarchical Tree and we compare it with other methods including the Linkage and k-medoids. By taking the industrial sector classication of stocks as a benchmark partition, we evaluate how the dierent methods retrieve this classication. The results show that the Directed Bubble Hierarchical Tree can outperform other methods, being able to retrieve more information with fewer clusters. Moreover, we show that the economic information is hidden at dierent levels of the hierarchical structures depending on the clustering method. The dynamical analysis on a rolling window also reveals that the dierent methods show dierent degrees of sensitivity to events aecting nancial markets, like crises. These results can be of interest for all the applications of clustering methods to portfolio optimization and risk hedging.	[Musmeci, Nicolo; Di Matteo, T.] Kings Coll London, Dept Math, London WC2R 2LS, England; [Aste, Tomaso] UCL, Dept Comp Sci, London WC1E 6BT, England; Univ London London Sch Econ & Polit Sci, System Risk Ctr, London WC2A 2AE, England	University of London; King's College London; University of London; University College London; University of London; London School Economics & Political Science	Aste, T (corresponding author), UCL, Dept Comp Sci, Gower St, London WC1E 6BT, England.	t.aste@ucl.ac.uk	DiMatteo, Tiziana/AGZ-7196-2022; Aste, Tomaso/ABA-8973-2020	Aste, Tomaso/0000-0002-4219-0215; Di Matteo, Tiziana/0000-0002-5913-3268	COST Action [TD1210]; ESRC [ES/K002309/1]; Economic and Social Research Council [ES/K002309/1] Funding Source: researchfish	COST Action(European Cooperation in Science and Technology (COST)); ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC))	Partial funding from: COST Action TD1210; ESRC ES/K002309/1. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderberg M. R., 1973, CLUSTER ANAL APPL; [Anonymous], [No title captured]; [Anonymous], [No title captured]; [Anonymous], 2008, INTRO PROBABILITY TH; [Anonymous], 2007, TECHNICAL REPORT; Aste T, 2005, PHYSICA A, V346, P20, DOI 10.1016/j.physa.2004.08.045; Aste T, 2010, NEW J PHYS, V12, DOI 10.1088/1367-2630/12/8/085009; Aste T, 2012, AN ALGORITHM TO COMP; Bartolozzi M, 2007, EUR PHYS J B, V58, P207, DOI 10.1140/epjb/e2007-00216-2; Bonanno G, 2003, PHYS REV E, V68, DOI 10.1103/PhysRevE.68.046130; Borghesi C, 2007, PHYS REV E, V76, DOI 10.1103/PhysRevE.76.026104; Cont R, 2001, QUANT FINANC, V1, P223, DOI [10.1080/713665670, 10.1088/1469-7688/1/2/304]; Coronnello C, 2005, ACTA PHYS POL B, V36, P2653; Di Matteo T, 2005, PHYSICA A, V355, P21, DOI 10.1016/j.physa.2005.02.063; Di Matteo T, 2004, PHYSICA A, V339, P181, DOI 10.1016/j.physa.2004.03.041; Di Matteo T, 2010, EUR PHYS J B, V73, P3, DOI 10.1140/epjb/e2009-00286-0; EFRON B, 1979, ANN STAT, V7, P1, DOI 10.1214/aos/1176344552; Fenn DJ, 2012, QUANT FINANC, V12, P1493, DOI 10.1080/14697688.2012.668288; Fiedor P, 2014, PHYS REV E, V89, DOI 10.1103/PhysRevE.89.052801; Fortunato S, 2010, PHYS REP, V486, P75, DOI 10.1016/j.physrep.2009.11.002; HUBERT L, 1985, J CLASSIF, V2, P193, DOI 10.1007/BF01908075; Kaufman L., 1987, Statistical Data Analysis Based on the L1-Norm and Related Methods. First International Conference, P405; Kendall MG, 1938, BIOMETRIKA, V30, P81, DOI 10.2307/2332226; MacQueen J., 1967, P 5 BERKELEY S MATH, VVolume 1, P281, DOI DOI 10.1007/S11665-016-2173-6; Mantegna RN, 1999, EUR PHYS J B, V11, P193, DOI 10.1007/s100510050929; MANTEGNA RN, 2000, INTRO ECONOPHYSICS C; Morales R, 2014, SCI REP-UK, V4, DOI 10.1038/srep04589; Nanda SR, 2010, EXPERT SYST APPL, V37, P8793, DOI 10.1016/j.eswa.2010.06.026; Onnela JP, 2003, PHYS SCRIPTA, VT106, P48, DOI 10.1238/Physica.Topical.106a00048; Onnela JP, 2003, PHYSICA A, V324, P247, DOI 10.1016/S0378-4371(02)01882-4; Pai GAV, 2009, IEEE T EVOLUT COMPUT, V13, P1030, DOI 10.1109/TEVC.2009.2014360; Pearson Karl, 1895, P ROY SOC LONDON, V58, P240, DOI [DOI 10.1098/RSPL.1895.0041, 10.1098/rspl.1895.0041]; Pozzi F, 2013, SCI REP-UK, V3, DOI 10.1038/srep01665; Pozzi F, 2012, EUR PHYS J B, V85, DOI 10.1140/epjb/e2012-20697-x; Ross GJ, 2014, PHYS REV E, V89, DOI 10.1103/PhysRevE.89.022809; SHANNON CE, 1948, BELL SYST TECH J, V27, P379, DOI 10.1002/j.1538-7305.1948.tb01338.x; Song WM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031929; Song WM, 2011, DISCRETE APPL MATH, V159, P2135, DOI 10.1016/j.dam.2011.07.018; Tola V, 2008, J ECON DYN CONTROL, V32, P235, DOI 10.1016/j.jedc.2007.01.034; Tumminello M, 2007, EUR PHYS J B, V55, P209, DOI 10.1140/epjb/e2006-00414-4; Tumminello M, 2005, P NATL ACAD SCI USA, V102, P10421, DOI 10.1073/pnas.0500298102; Tumminello M, 2007, INT J BIFURCAT CHAOS, V17, P2319, DOI 10.1142/S0218127407018415; Tumminello M, 2007, PHYS REV E, V76, DOI 10.1103/PhysRevE.76.031123; Tumminello M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017994; Tumminello M, 2011, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2011/01/P01019; Tumminello M, 2010, J ECON BEHAV ORGAN, V75, P40, DOI 10.1016/j.jebo.2010.01.004	46	33	33	2	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2015	10	3							e0116201	10.1371/journal.pone.0116201	http://dx.doi.org/10.1371/journal.pone.0116201			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CE9BN	25786703	gold, Green Published, Green Submitted			2022-12-27	WOS:000352138500004
J	Simmons, D; Prevost, AT; Bunn, C; Holman, D; Parker, RA; Cohn, S; Donald, S; Paddison, CAM; Ward, C; Robins, P; Graffy, J				Simmons, David; Prevost, A. Toby; Bunn, Chris; Holman, Daniel; Parker, Richard A.; Cohn, Simon; Donald, Sarah; Paddison, Charlotte A. M.; Ward, Candice; Robins, Peter; Graffy, Jonathan			Impact of Community Based Peer Support in Type 2 Diabetes: A Cluster Randomised Controlled Trial of Individual and/or Group Approaches	PLOS ONE			English	Article							GLYCEMIC CONTROL; ADULTS; CARE; DISTRESS; VALIDITY; PEOPLE	Background Diabetes peer support, where one person with diabetes helps guide and support others, has been proposed as a way to improve diabetes management. We have tested whether different diabetes peer support strategies can improve metabolic and/or psychological outcomes. Methods People with type 2 diabetes (n = 1,299) were invited to participate as either 'peer' or 'peer support facilitator' (PSF) in a 2x2 factorial randomised cluster controlled trial across rural communities (130 clusters) in England. Peer support was delivered over 8-12 months by trained PSFs, supported by monthly meetings with a diabetes educator. Primary end point was HbA1c. Secondary outcomes included quality of life, diabetes distress, blood pressure, waist, total cholesterol and weight. Outcome assessors and investigators were masked to arm allocation. Main factors were 1:1 or group intervention. Analysis was by intention-totreat adjusting for baseline. Results The 4 arms were well matched (Group n = 330, 1:1(individual) n = 325, combined n = 322, control n = 322); 1035 (79.7%) completed the mid-point postal questionnaire and 1064 (81.9%) had a final HbA1c. A limitation was that although 92.6% PSFs and peers were in telephone contact, only 61.4% of intervention participants attended a face to face session. Mean baseline HbA1c was 57 mmol/mol (7.4%), with no significant change across arms. Follow up systolic blood pressure was 2.3mm Hg (0.6 to 4.0) lower among those allocated group peer-support and 3.0mm Hg (1.1 to 5.0) lower if the group support was attended at least once. There was no impact on other outcomes by intention to treat or significant differences between arms in self-reported adherence or medication. Conclusions Group diabetes peer support over 8-12 months was associated with a small improvement in blood pressure but no other significant outcomes. Long term benefits should be investigated.	[Simmons, David; Bunn, Chris; Donald, Sarah; Ward, Candice; Robins, Peter] Cambridge Univ Hosp NHS Fdn Trust, Inst Metab Sci, Cambridge, Cambs, England; [Prevost, A. Toby; Holman, Daniel; Parker, Richard A.; Cohn, Simon; Paddison, Charlotte A. M.; Graffy, Jonathan] Univ Cambridge, Dept Publ Hlth & Primary Care, Primary Care Unit, Cambridge, Cambs, England	University of Cambridge; University of Cambridge	Simmons, D (corresponding author), Cambridge Univ Hosp NHS Fdn Trust, Inst Metab Sci, Cambridge, Cambs, England.	dsworkster@gmail.com		Bunn, Christopher/0000-0001-6604-1305; Prevost, A. Toby/0000-0003-1723-0796; Holman, Daniel/0000-0003-4134-6238	peers for progress; National Institute for Health Research [PB-PG-0610-22311]; UK National Institute for Health Research [PB-PG-0610-22311]; NIHR West Anglia Comprehensive Local Research Network; NHS Cambridgeshire; NIHR Biomedical Research Centre at Guy's and St Thomas' NHS Foundation Trust; King's College London	peers for progress; National Institute for Health Research(National Institute for Health Research (NIHR)); UK National Institute for Health Research(National Institute for Health Research (NIHR)); NIHR West Anglia Comprehensive Local Research Network; NHS Cambridgeshire; NIHR Biomedical Research Centre at Guy's and St Thomas' NHS Foundation Trust; King's College London	This work was supported by peers for progress (peersforprogress.org - no grant number) and National Institute for Health Research for Patient Benefit Programme (Ref PB-PG-0610-22311). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Additional funding for linked work on peer support was received from the UK National Institute for Health Research for Patient Benefit Programme (Ref PB-PG-0610-22311). Recruitment and follow up assessments were largely undertaken by the NIHR Primary Care Research Network and additional funding to support recruitment was provided by the NIHR West Anglia Comprehensive Local Research Network. NHS Cambridgeshire funded research nurses to link with the Peer Support Facilitators. ATP was supported by the NIHR Biomedical Research Centre at Guy's and St Thomas' NHS Foundation Trust and King's College London. The views expressed are those of the authors and not necessarily those of the NHS, the NIHR or the Department of Health.	Adler AI, 2000, BMJ-BRIT MED J, V321, P412, DOI 10.1136/bmj.321.7258.412; Anderson RJ, 2001, DIABETES CARE, V24, P1069, DOI 10.2337/diacare.24.6.1069; [Anonymous], DIABETES MANAGEMENT; [Anonymous], 2013, NLME LINEAR NONLINEA; Chan JCN, 2014, JAMA INTERN MED, V174, P972, DOI 10.1001/jamainternmed.2014.655; Dale JR, 2012, DIABETIC MED, V29, P1361, DOI 10.1111/j.1464-5491.2012.03749.x; Eborall HC, 2007, BMJ-BRIT MED J, V335, P486, DOI 10.1136/bmj.39303.723449.55; EuroQol Group, 2010, EQ 5D STAND INSTR US; Fisher EB, 2010, FAM PRACT, V27, pI6, DOI 10.1093/fampra/cmp013; Fisher L, 2008, DIABETIC MED, V25, P1096, DOI 10.1111/j.1464-5491.2008.02533.x; Fisher L, 2008, ANN FAM MED, V6, P246, DOI 10.1370/afm.842; Fitzgerald JT, 1998, DIABETES CARE, V21, P706, DOI 10.2337/diacare.21.5.706; Graffy J, 2010, BRIT J GEN PRACT, V60, P158, DOI 10.3399/bjgp10X483463; Heisler M, 2007, DIABETES SPECTR, V20, P214, DOI [10.2337/diaspect.20.4.214, DOI 10.2337/DIASPECT.20.4.214]; Heisler M, 2010, ANN INTERN MED, V153, P507, DOI 10.7326/0003-4819-153-8-201010190-00007; Holmes J, 2000, Value Health, V3 Suppl 1, P47; House of Commons Committee of Public Accounts Department of Health, 2012, DEP HLTH MAN AD DIAB; Ismail K, 2004, LANCET, V363, P1589, DOI 10.1016/S0140-6736(04)16202-8; Kirk A, 2003, DIABETES CARE, V26, P1186, DOI 10.2337/diacare.26.4.1186; Kroenke K, 2009, J AFFECT DISORDERS, V114, P163, DOI 10.1016/j.jad.2008.06.026; Long JA, 2012, ANN INTERN MED, V156, P416, DOI 10.7326/0003-4819-156-6-201203200-00004; McAlister FA, 2003, JAMA-J AM MED ASSOC, V289, P2545, DOI 10.1001/jama.289.19.2545; Montgomery Alan A, 2003, BMC Med Res Methodol, V3, P26, DOI 10.1186/1471-2288-3-26; MORISKY DE, 1986, MED CARE, V24, P67, DOI 10.1097/00005650-198601000-00007; Schulz Ute, 2008, Psychol Health Med, V13, P423, DOI 10.1080/13548500701660442; Simmons D, 1998, DIABETIC MED, V15, P958, DOI 10.1002/(SICI)1096-9136(1998110)15:11<958::AID-DIA687>3.3.CO;2-0; Simmons D, 2013, BMC FAM PRACT, V14, DOI 10.1186/1471-2296-14-5; Smith SM, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d715; Stanford Patient Education Research Center, DIAB SELF EFF SCAL R; Thom DH, 2013, ANN FAM MED, V11, P137, DOI 10.1370/afm.1443; White IR, 2005, STAT MED, V24, P993, DOI 10.1002/sim.1981	31	59	61	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2015	10	3							e0120277	10.1371/journal.pone.0120277	http://dx.doi.org/10.1371/journal.pone.0120277			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9BN	25785452	gold, Green Published, Green Accepted			2022-12-27	WOS:000352138500162
J	Wang, YL; Liou, GG; Lin, CH; Chen, ML; Kuo, TM; Tsai, KN; Huang, CC; Chen, YL; Huang, LR; Chou, YC; Chang, CM				Wang, Yi-Ling; Liou, Gan-Guang; Lin, Chao-Hsiung; Chen, Mong-Liang; Kuo, Tzer-Min; Tsai, Kuen-Nan; Huang, Chien-Choao; Chen, Ya-Ling; Huang, Li-Rung; Chou, Yu-Chi; Chang, Chungming			The Inhibitory Effect of the Hepatitis B Virus Singly-Spliced RNA-Encoded p21.5 Protein on HBV Nucleocapsid Formation	PLOS ONE			English	Article							SURFACE FUSION PROTEIN; IN-VIVO; VIRAL REPLICATION; GENE-EXPRESSION; PRECORE PROTEIN; TRANSGENIC MICE; CAPSID PROTEIN; MESSENGER-RNA; CORE PROTEIN; HEPG2 CELLS	Hepatitis B virus (HBV) is the smallest DNA virus and the major cause of acute and chronic hepatitis. The 3.2 kb HBV viral genome generates four major species of unspliced viral transcript as well as several alternatively spliced RNAs. A 2.2 kb singly-spliced RNA is the most abundant spliced RNA and is widely expressed among all HBV genotypes. The expression of the singly-spliced RNA, as well as that of its encoded protein HBSP, is strongly associated with hepatopathology during HBV infection. Here, we report a novel inhibitory role of a p21.5 protein, which is encoded by a 2.2 kb singly-spliced RNA, in the modulation of HBV replication. We show that overexpression of the singly-spliced RNA is able to efficiently inhibit HBV replication. Furthermore, a mutation in the ATG start codon of the precore region completely abolishes the inhibitory effect of the singly-spliced RNA, indicating that a viral protein (p21.5) derived from the singly-spliced RNA is the mediator of the inhibition. Furthermore, p21.5 is able to form a homodimer that interacts with core dimers forming hybrid viral assembly components. Sucrose gradient fractionation revealed that co-expression of p21.5 resulted in a spread distribution pattern of core proteins ranging from low to high sucrose densities. When compared with p22, p21.5 is almost ten times more efficient at destabilizing HBV nucleocapsid assembly in Huh7 cells overexpressing either p21.5 or p22 protein. Moreover, in vivo expression of p21.5 protein by tail vein injection was found to decrease the amount of nucleocapsid in the livers of HBV-expressing BALB/c mice. In conclusion, our study reveals that the HBV 2.2 kb singly-spliced RNA encodes a 21.5 kDa viral protein that significantly interferes with the assembly of nucleocapsids during HBV nucleocapsid formation. These findings provide a possible strategy for elimination of HBV particles inside cells.	[Wang, Yi-Ling; Chang, Chungming] Natl Yang Ming Univ, Inst Microbiol & Immunol, Taipei 112, Taiwan; [Wang, Yi-Ling; Liou, Gan-Guang; Kuo, Tzer-Min; Tsai, Kuen-Nan; Huang, Chien-Choao; Chen, Ya-Ling; Huang, Li-Rung; Chang, Chungming] Natl Hlth Res Inst, Inst Mol & Genom Med, Miaoli, Taiwan; [Lin, Chao-Hsiung] Natl Yang Ming Univ, Inst Biomed Informat, Taipei 112, Taiwan; [Chen, Mong-Liang] China Med Univ & Hosp, Ctr Mol Med, Taichung, Taiwan; [Chou, Yu-Chi] Acad Sinica, Inst Mol Biol, Taipei, Taiwan	National Yang Ming Chiao Tung University; National Health Research Institutes - Taiwan; National Yang Ming Chiao Tung University; China Medical University Taiwan; China Medical University Hospital - Taiwan; Academia Sinica - Taiwan	Chou, YC (corresponding author), Acad Sinica, Inst Mol Biol, Taipei, Taiwan.	chou0315@imb.sinica.edu.tw; tonychang@nhri.org.tw	Tsai, Kuen-Nan/G-4606-2019; Liou, Gunn‐Guang/AAI-9787-2020		National Science Council [NSC 101-2320-B-400-009]	National Science Council(Ministry of Science and Technology, Taiwan)	This research was supported by the National Science Council grant (NSC 101-2320-B-400-009). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abend JR, 2009, J GEN VIROL, V90, P1238, DOI 10.1099/vir.0.009159-0; Akter P, 2003, J GEN VIROL, V84, P1117, DOI 10.1099/vir.0.18952-0; Baumert TF, 2007, WORLD J GASTROENTERO, V13, P82, DOI 10.3748/wjg.v13.i1.82; Biermer M, 2003, J VIROL, V77, P4033, DOI 10.1128/JVI.77.7.4033-4042.2003; CARLIER D, 1995, J GEN VIROL, V76, P1041, DOI 10.1099/0022-1317-76-4-1041; Chen WN, 2010, J GEN VIROL, V91, P2592, DOI 10.1099/vir.0.022517-0; Chou YC, 2005, J VIROL, V79, P1813, DOI 10.1128/JVI.79.3.1813-1823.2005; Doitsh G, 2004, MOL CELL BIOL, V24, P1799, DOI 10.1128/MCB.24.4.1799-1808.2004; El Chaar M, 2012, J CLIN MICROBIOL, V50, P3159, DOI 10.1128/JCM.01251-12; Glenn M, 1999, J VIROL, V73, P6953, DOI 10.1128/JVI.73.8.6953-6963.1999; Gunther S, 1997, VIROLOGY, V238, P363, DOI 10.1006/viro.1997.8863; Hacker HJ, 2003, BIOCHEM PHARMACOL, V66, P2273, DOI 10.1016/j.bcp.2003.08.001; HATTON T, 1992, J VIROL, V66, P5232, DOI 10.1128/JVI.66.9.5232-5241.1992; Heise T, 1999, J VIROL, V73, P474, DOI 10.1128/JVI.73.1.474-481.1999; Heise T, 1999, J VIROL, V73, P5767, DOI 10.1128/JVI.73.7.5767-5776.1999; Huang CC, 2013, VIRUS RES, V174, P18, DOI 10.1016/j.virusres.2013.02.004; Huang HL, 2000, VIROLOGY, V275, P398, DOI 10.1006/viro.2000.0478; Huang LR, 2006, P NATL ACAD SCI USA, V103, P17862, DOI 10.1073/pnas.0608578103; Locarnini S, 2004, SEMIN LIVER DIS, V24, P3, DOI 10.1055/s-2004-828672; Lu YW, 2006, BIOCHEM BIOPH RES CO, V351, P64, DOI 10.1016/j.bbrc.2006.10.002; Mancini-Bourgine M, 2007, J VIROL, V81, P4963, DOI 10.1128/JVI.02619-06; NASSAL M, 1992, J MOL BIOL, V225, P1013, DOI 10.1016/0022-2836(92)90101-O; Obert S, 1996, EMBO J, V15, P2565, DOI 10.1002/j.1460-2075.1996.tb00614.x; ORITA S, 1991, FEBS LETT, V295, P127, DOI 10.1016/0014-5793(91)81402-T; Park GS, 2008, VIRUS RES, V136, P166, DOI 10.1016/j.virusres.2008.05.005; Puro R, 2007, J VIROL, V81, P7351, DOI 10.1128/JVI.00554-07; Robek MD, 2004, P NATL ACAD SCI USA, V101, P1743, DOI 10.1073/pnas.0308340100; ROSMORDUC O, 1995, HEPATOLOGY, V22, P10, DOI 10.1016/0270-9139(95)90346-1; ROTHNIE HM, 1994, ADV VIRUS RES, V44, P1, DOI 10.1016/S0065-3527(08)60327-9; Scaglioni PP, 1997, J VIROL, V71, P345, DOI 10.1128/JVI.71.1.345-353.1997; SCHLICHT HJ, 1991, J VIROL, V65, P6817, DOI 10.1128/JVI.65.12.6817-6825.1991; Seeger C, 2000, MICROBIOL MOL BIOL R, V64, P51, DOI 10.1128/MMBR.64.1.51-68.2000; Shepard CW, 2006, EPIDEMIOL REV, V28, P112, DOI 10.1093/epirev/mxj009; Soussan P, 2000, J CLIN INVEST, V105, P55, DOI 10.1172/JCI8098; Soussan P, 2003, J HEPATOL, V38, P343, DOI 10.1016/S0168-8278(02)00422-1; Soussan P, 2008, J INFECT DIS, V198, P218, DOI 10.1086/589623; SU TS, 1989, J VIROL, V63, P4011, DOI 10.1128/JVI.63.9.4011-4018.1989; SU TS, 1989, HEPATOLOGY, V9, P180, DOI 10.1002/hep.1840090203; TERRE S, 1991, J VIROL, V65, P5539; Tsui LV, 1995, P NATL ACAD SCI USA, V92, P12398, DOI 10.1073/pnas.92.26.12398; WU HL, 1991, J VIROL, V65, P1680, DOI 10.1128/JVI.65.4.1680-1686.1991; Yu XM, 1997, J VIROL, V71, P9366, DOI 10.1128/JVI.71.12.9366-9374.1997; Yu XM, 1996, J VIROL, V70, P8719, DOI 10.1128/JVI.70.12.8719-8726.1996; ZHOU SL, 1992, J VIROL, V66, P5393, DOI 10.1128/JVI.66.9.5393-5398.1992	44	8	8	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2015	10	3							e0119625	10.1371/journal.pone.0119625	http://dx.doi.org/10.1371/journal.pone.0119625			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9BN	25785443	Green Published, Green Submitted, gold			2022-12-27	WOS:000352138500122
J	Pena-Bello, L; Pertega-Diaz, S; Outeirino-Blanco, E; Garcia-Buela, J; Tovar, S; Sangiao-Alvarellos, S; Dieguez, C; Cordido, F				Pena-Bello, Lara; Pertega-Diaz, Sonia; Outeirino-Blanco, Elena; Garcia-Buela, Jesus; Tovar, Sulay; Sangiao-Alvarellos, Susana; Dieguez, Carlos; Cordido, Fernando			Effect of Oral Glucose Administration on Rebound Growth Hormone Release in Normal and Obese Women: The Role of Adiposity, Insulin Sensitivity and Ghrelin	PLOS ONE			English	Article							PULSATILE GH SECRETION; BETA-CELL FUNCTION; ACYL-GHRELIN; WEIGHT-GAIN; HEALTHY; SUPPRESSION; ADULTS; ASSOCIATION; HUMANS; MICE	Context Metabolic substrates and nutritional status play a major role in growth hormone (GH) secretion. Uncovering the mechanisms involved in GH secretion following oral glucose (OG) administration in normal and obese patients is a pending issue. Objective The aim of this study was to investigate GH after OG in relation with adiposity, insulin secretion and action, and ghrelin secretion in obese and healthy women, to further elucidate the mechanism of GH secretion after OG and the altered GH secretion in obesity. Participants and Methods We included 64 healthy and obese women. After an overnight fast, 75 g of OG were administered; GH, glucose, insulin and ghrelin were obtained during 300 minutes. Insulin secretion and action indices and the area under the curve (AUC) were calculated for GH, glucose, insulin and ghrelin. Univariate and multivariate linear regression analyses were employed. Results The AUC of GH (mu g/L.min) was lower in obese (249.8 +/- 41.8) than in healthy women (490.4 +/- 74.6), P=0.001. The AUC of total ghrelin (pg/mL.min) was lower in obese (240995.5 +/- 11094.2) than in healthy women (340797.5 +/- 37757.5), P=0.042. There were significant correlations between GH secretion and the different adiposity, insulin secretion and action, and ghrelin secretion indices. After multivariate analysis only ghrelin AUC remained a significant predictor for fasting and peak GH.	[Pena-Bello, Lara; Sangiao-Alvarellos, Susana; Cordido, Fernando] Univ A Coruna, Fac Hlth Sci, Dept Med, La Coruna, Spain; [Pena-Bello, Lara; Garcia-Buela, Jesus; Sangiao-Alvarellos, Susana; Cordido, Fernando] Univ Hosp A Coruna, Inst Invest Biomed INIBIC, La Coruna, Spain; [Pertega-Diaz, Sonia] Univ Hosp A Coruna, Clin Epidemiol & Biostat Unit, La Coruna, Spain; [Outeirino-Blanco, Elena; Cordido, Fernando] Univ Hosp A Coruna, Dept Endocrinol, La Coruna, Spain; [Tovar, Sulay; Dieguez, Carlos] Univ Santiago de Compostela, Dept Physiol CIMUS, Sch Med, Inst Invest Sanitarias IDIS, Santiago De Compostela, Spain; [Tovar, Sulay; Dieguez, Carlos] CIBER Fisiopatol Obesidad & Nutr CIBERobn, Santiago De Compostela, Spain	Universidade da Coruna; Complejo Hospitalario Universitario A Coruna; Universidade da Coruna; Instituto de Investigacion Biomedica de A Coruna (INIBIC); Complejo Hospitalario Universitario A Coruna; Complejo Hospitalario Universitario A Coruna; Universidade de Santiago de Compostela; CIBER - Centro de Investigacion Biomedica en Red; CIBEROBN	Cordido, F (corresponding author), Univ A Coruna, Fac Hlth Sci, Dept Med, La Coruna, Spain.	Fernando.Cordido.Carballido@sergas.es	Sangiao-Alvarellos, Susana/J-1758-2016; PENA, LARA/ABF-9908-2020; Pértega-Díaz, Sonia/E-4353-2013; Tovar, Sulay/ABF-4037-2021; Cordido, Fernando/L-6175-2019; Sangiao-Alvarellos, Susana/AAQ-5752-2020	Sangiao-Alvarellos, Susana/0000-0003-1207-4667; Pértega-Díaz, Sonia/0000-0003-3891-3203; Sangiao-Alvarellos, Susana/0000-0003-1207-4667; Tovar, Sulay/0000-0001-7813-6520; Cordido, Fernando/0000-0003-3528-8174; dieguez, carlos/0000-0002-0919-4337	Fondo de Investigacion Sanitaria del Instituto de Salud Carlos III (FEDER from E.U.) [PI10/00088, PI13/00322]; Xunta de Galicia, Spain [IN845B-2010/187, 10CSA916014PR, CN2012/312]	Fondo de Investigacion Sanitaria del Instituto de Salud Carlos III (FEDER from E.U.); Xunta de Galicia, Spain(Xunta de Galicia)	This work was supported in part by Fondo de Investigacion Sanitaria del Instituto de Salud Carlos III PI10/00088, PI13/00322 (FEDER from E.U.) and Xunta de Galicia IN845B-2010/187, 10CSA916014PR to FC and CN2012/312 to SSA, Spain. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arafat AM, 2013, J CLIN ENDOCR METAB, V98, P4133, DOI 10.1210/jc.2013-1635; Avram AM, 2005, J CLIN ENDOCR METAB, V90, P2982, DOI 10.1210/jc.2004-1785; Barazzoni R, 2013, OBESITY, V21, P718, DOI 10.1002/oby.20272; Berryman DE, 2013, NAT REV ENDOCRINOL, V9, P346, DOI 10.1038/nrendo.2013.64; Blatnik M, 2011, CLIN ENDOCRINOL, V74, P325, DOI 10.1111/j.1365-2265.2010.03916.x; Bredella MA, 2009, J CLIN ENDOCR METAB, V94, P3995, DOI 10.1210/jc.2009-0438; Carro E, 1997, ENDOCRINOLOGY, V138, P2203, DOI 10.1210/en.138.5.2203; Chan JL, 2003, J CLIN INVEST, V111, P1409, DOI 10.1172/JCI200317490; Clasey JL, 2001, J CLIN ENDOCR METAB, V86, P3845, DOI 10.1210/jc.86.8.3845; CORDIDO F, 1993, J CLIN ENDOCR METAB, V76, P819, DOI 10.1210/jc.76.4.819; Cordido F, 1998, J CLIN ENDOCR METAB, V83, P4350, DOI 10.1210/jc.83.12.4350; Cordoba-Chacon J, 2014, ENDOCRINOLOGY, V155, P726, DOI 10.1210/en.2013-1825; Cornford AS, 2011, J CLIN ENDOCR METAB, V96, P824, DOI 10.1210/jc.2010-1895; DeFronzo RA, 2013, DIABETES CARE, V36, P3607, DOI 10.2337/dc13-0520; Espelund U, 2005, J CLIN ENDOCR METAB, V90, P741, DOI 10.1210/jc.2004-0604; Garin MC, 2013, J CLIN ENDOCR METAB, V98, P1826, DOI 10.1210/jc.2012-4247; Gibbons C, 2013, J CLIN ENDOCR METAB, V98, pE847, DOI 10.1210/jc.2012-3835; Grottoli S, 1997, J CLIN ENDOCR METAB, V82, P2261, DOI 10.1210/jc.82.7.2261; Huang L, 2012, ENDOCRINOLOGY, V153, P4380, DOI 10.1210/en.2012-1178; Iranmanesh A, 2012, J CLIN ENDOCR METAB, V97, P2172, DOI 10.1210/jc.2011-3317; Karra E, 2010, MOL CELL ENDOCRINOL, V316, P120, DOI 10.1016/j.mce.2009.06.010; Koutkia P, 2005, AM J PHYSIOL-ENDOC M, V289, pE814, DOI 10.1152/ajpendo.00093.2005; Lanzi R, 1997, J CLIN ENDOCR METAB, V82, P2239, DOI 10.1210/jc.82.7.2239; Luque RM, 2006, J MOL ENDOCRINOL, V37, P25, DOI 10.1677/jme.1.02042; Malin SK, 2014, INT J OBESITY, V38, P364, DOI 10.1038/ijo.2013.196; Martos-Moreno GA, 2011, J ENDOCRINOL INVEST, V34, P117, DOI [10.1007/BF03347041, 10.3275/7139]; Marzullo P, 2004, J CLIN ENDOCR METAB, V89, P936, DOI 10.1210/jc.2003-031328; McLaughlin T, 2004, J CLIN ENDOCR METAB, V89, P1630, DOI 10.1210/jc.2003-031572; Misra M, 2005, AM J PHYSIOL-ENDOC M, V289, pE347, DOI 10.1152/ajpendo.00615.2004; Nass R, 2008, J CLIN ENDOCR METAB, V93, P1988, DOI 10.1210/jc.2007-2234; Nass R, 2014, J CLIN ENDOCR METAB, V99, P602, DOI 10.1210/jc.2013-3158; Oliveira CRP, 2012, J CLIN ENDOCR METAB, V97, P1013, DOI 10.1210/jc.2011-2590; Outeirino-Blanco E, 2012, HORM METAB RES, V44, P533, DOI 10.1055/s-0032-1304578; Outeirino-Blanco E, 2011, HORM METAB RES, V43, P580, DOI 10.1055/s-0031-1279779; Pacifico L, 2009, EUR J ENDOCRINOL, V161, P861, DOI 10.1530/EJE-09-0375; Pantel J, 2009, J CLIN ENDOCR METAB, V94, P4334, DOI 10.1210/jc.2009-1327; RASMUSSEN MH, 1995, J CLIN ENDOCR METAB, V80, P1407, DOI 10.1210/jc.80.4.1407; Rodriguez A, 2009, INT J OBESITY, V33, P541, DOI 10.1038/ijo.2009.40; Roemmler J, 2011, CLIN ENDOCRINOL OXF; Shiiya T, 2002, J CLIN ENDOCR METAB, V87, P240, DOI 10.1210/jc.87.1.240; Steyn FJ, 2013, J ENDOCRINOL, V218, P233, DOI 10.1530/JOE-13-0084; Tong J, 2013, J CLIN ENDOCR METAB, V98, P2536, DOI 10.1210/jc.2012-4162; van der Klaauw AA, 2013, J CLIN ENDOCR METAB, V98, pE288, DOI 10.1210/jc.2012-2553; Veldhuis JD, 2012, J CLIN ENDOCR METAB, V97, P4753, DOI 10.1210/jc.2012-2567; Zhao TJ, 2010, P NATL ACAD SCI USA, V107, P7467, DOI 10.1073/pnas.1002271107	45	12	14	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2015	10	3							e0121087	10.1371/journal.pone.0121087	http://dx.doi.org/10.1371/journal.pone.0121087			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7QC	25782001	gold, Green Published, Green Submitted			2022-12-27	WOS:000351284600195
J	Seimon, TA; Olson, SH; Lee, KJ; Rosen, G; Ondzie, A; Cameron, K; Reed, P; Anthony, SJ; Joly, DO; McAloose, D; Lipkin, WI				Seimon, Tracie A.; Olson, Sarah H.; Lee, Kerry Jo; Rosen, Gail; Ondzie, Alain; Cameron, Kenneth; Reed, Patricia; Anthony, Simon J.; Joly, Damien O.; McAloose, Denise; Lipkin, W. Ian			Adenovirus and Herpesvirus Diversity in Free-Ranging Great Apes in the Sangha Region of the Republic of Congo	PLOS ONE			English	Article							NATIONAL-PARK; EVOLUTION; CYTOMEGALOVIRUS; CHIMPANZEES; GORILLAS; METAPNEUMOVIRUS; IDENTIFICATION; COINFECTIONS; INFECTION; OUTBREAK	Infectious diseases have caused die-offs in both free-ranging gorillas and chimpanzees. Understanding pathogen diversity and disease ecology is therefore critical for conserving these endangered animals. To determine viral diversity in free-ranging, non-habituated gorillas and chimpanzees in the Republic of Congo, genetic testing was performed on great-ape fecal samples collected near Odzala-Kokoua National Park. Samples were analyzed to determine ape species, identify individuals in the population, and to test for the presence of herpesviruses, adenoviruses, poxviruses, bocaviruses, flaviviruses, paramyxoviruses, coronaviruses, filoviruses, and simian immunodeficiency virus (SIV). We identified 19 DNA viruses representing two viral families, Herpesviridae and Adenoviridae, of which three herpesviruses had not been previously described. Co-detections of multiple herpesviruses and/or adenoviruses were present in both gorillas and chimpanzees. Cytomegalovirus (CMV) and lymphocryptovirus (LCV) were found primarily in the context of co-association with each other and adenoviruses. Using viral discovery curves for herpesviruses and adenoviruses, the total viral richness in the sample population of gorillas and chimpanzees was estimated to be a minimum of 23 viruses, corresponding to a detection rate of 83%. These findings represent the first description of DNA viral diversity in feces from free-ranging gorillas and chimpanzees in or near the Odzala-Kokoua National Park and form a basis for understanding the types of viruses circulating among great apes in this region.	[Seimon, Tracie A.; McAloose, Denise] Wildlife Conservat Soc, Zool Hlth Program, Bronx, NY 10460 USA; [Olson, Sarah H.; Ondzie, Alain; Cameron, Kenneth; Reed, Patricia; Joly, Damien O.] Wildlife Conservat Soc, Wildlife Hlth & Hlth Policy Program, Bronx, NY USA; [Seimon, Tracie A.; Lee, Kerry Jo; Rosen, Gail; Anthony, Simon J.; Lipkin, W. Ian] Columbia Univ, Ctr Infect & Immun, New York, NY USA; [Olson, Sarah H.] Univ Wisconsin, Ctr Sustainabil & Global Environm, Madison, WI USA	Wildlife Conservation Society; Wildlife Conservation Society; Columbia University; University of Wisconsin System; University of Wisconsin Madison	Seimon, TA (corresponding author), Wildlife Conservat Soc, Zool Hlth Program, Bronx, NY 10460 USA.	tseimon@wcs.org	Lipkin, W. Ian/ABE-6216-2020	Lipkin, W. Ian/0000-0002-8768-9386	United States Agency for International Development (USAID) Emerging Pandemic Threats program; National Institute of Health Centers of Excellence for Translational Research (CETR) [1U19AI109761]; United States Fish and the Wildlife (USFWS) Great Ape Conservation Fund; Neu Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI109761] Funding Source: NIH RePORTER	United States Agency for International Development (USAID) Emerging Pandemic Threats program(United States Agency for International Development (USAID)); National Institute of Health Centers of Excellence for Translational Research (CETR); United States Fish and the Wildlife (USFWS) Great Ape Conservation Fund; Neu Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This study was made possible by the generous support of the American people through the United States Agency for International Development (USAID) Emerging Pandemic Threats program, PREDICT project to WIL and DJ; from the National Institute of Health Centers of Excellence for Translational Research (CETR) grant No. 1U19AI109761 to WIL, from the United States Fish and the Wildlife (USFWS) Great Ape Conservation Fund, the Neu Foundation, Mr. and Mrs. Bradley L. Goldberg to KC and TR, and donors supporting the Wildlife Conservation Society Zoological and Wildlife Health and Health Policy Programs to TS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anthony SJ, 2013, MBIO, V4, DOI 10.1128/mBio.00598-13; Benko M, 2003, CURR TOP MICROBIOL, V272, P3; Benko M, 2014, FUTURE MICROBIOL, V9, P269, DOI 10.2217/fmb.13.170; Bermejo M, 2006, SCIENCE, V314, P1564, DOI 10.1126/science.1133105; Bracht AJ, 2006, ARCH VIROL, V151, P423, DOI 10.1007/s00705-005-0679-6; Chen EC, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002155; Chiu CY, 2013, MBIO, V4, DOI 10.1128/mBio.00084-13; Chmielewicz B, 2001, VIRUS RES, V75, P87, DOI 10.1016/S0168-1702(00)00252-5; Clewley JP, 1998, J VIROL, V72, P10305, DOI 10.1128/JVI.72.12.10305-10309.1998; Coaquette A, 2004, CLIN INFECT DIS, V39, P155, DOI 10.1086/421496; Cooper Natalie, 2013, Evolution Medicine and Public Health, P27, DOI 10.1093/emph/eot001; Davison AJ, 2003, J GEN VIROL, V84, P2895, DOI 10.1099/vir.0.19497-0; Davison AJ, 2002, VET MICROBIOL, V86, P69, DOI 10.1016/S0378-1135(01)00492-8; Devos C, 2008, AM J PRIMATOL, V70, P439, DOI 10.1002/ajp.20514; Gray GC, 2007, CLIN INFECT DIS, V45, P1120, DOI 10.1086/522188; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Jones KE, 2008, NATURE, V451, P990, DOI 10.1038/nature06536; Kapoor A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011948; Karesh WB, 2012, LANCET, V380, P1936, DOI 10.1016/S0140-6736(12)61678-X; Kaur T, 2008, AM J PRIMATOL, V70, P755, DOI 10.1002/ajp.20565; King A.M.Q., 2012, NINTH REPORT OF THEI, P125; KOCHER TD, 1989, P NATL ACAD SCI USA, V86, P6196, DOI 10.1073/pnas.86.16.6196; Leendertz FH, 2009, J GEN VIROL, V90, P2386, DOI 10.1099/vir.0.011866-0; Lewis PF, 2009, J INFECT DIS, V199, P1427, DOI 10.1086/598521; Lilja AE, 2008, P NATL ACAD SCI USA, V105, P19950, DOI 10.1073/pnas.0811063106; Lilly AA, 2002, INT J PRIMATOL, V23, P555, DOI 10.1023/A:1014969617036; Liu WM, 2010, NATURE, V467, P420, DOI 10.1038/nature09442; McVey D, 2013, VIROLOGY, V444, P119, DOI 10.1016/j.virol.2013.05.041; Michaels MG, 1997, J INFECT DIS, V176, P1476, DOI 10.1086/514144; Moureau G, 2007, VECTOR-BORNE ZOONOT, V7, P467, DOI 10.1089/vbz.2007.0206; Muller R, 2009, J VIROL METHODS, V155, P161, DOI 10.1016/j.jviromet.2008.10.014; Noble Rachel T., 2003, Journal of Water and Health, V1, P195; Oates JF, IUCN 2013 IUCN RED L; Olson S, 2012, EMERG HLTH THREATS J, V5; Palacios G, 2011, EMERG INFECT DIS, V17, P711, DOI 10.3201/eid1704.100883; Prepens S, 2007, VIROL J, V4, P1; Prugnolle F, 2010, P NATL ACAD SCI USA, V107, P1458, DOI 10.1073/pnas.0914440107; Quan PL, 2010, MBIO, V1, DOI 10.1128/mBio.00208-10; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Reed PE, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003143; Roy S, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000503; Ruuskanen O, 1997, CLINICAL VIROLOGY, P1355; Ryan SJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029030; Takehisa J, 2009, J VIROL, V83, P1635, DOI 10.1128/JVI.02311-08; Tong S, 2008, J CLIN MICROBIOL, V46, P2652, DOI 10.1128/JCM.00192-08; VanDevanter DR, 1996, J CLIN MICROBIOL, V34, P1666, DOI 10.1128/JCM.34.7.1666-1671.1996; Vora GJ, 2006, EMERG INFECT DIS, V12, P921, DOI 10.3201/eid1206.050245; Walsh PD, IUCN 2013 IUCN RED L; Wang S, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0074141, 10.1371/journal.pone.0073946]; Wang X, 2010, VIROL J, V7, DOI [10.1186/1743-1422X-1187-1247, DOI 10.1186/1743-1422X-1187-1247]; Watanabe S, 2010, EMERG INFECT DIS, V16, P1217, DOI 10.3201/eid1608.100208; Wertheim JO, 2014, MOL BIOL EVOL, V31, P2356, DOI 10.1093/molbev/msu185; Wevers D, 2010, VIROL J, V7, DOI [10.1186/1743-1422X-1187-1303, DOI 10.1186/1743-1422X-1187-1303]; Wevers D, 2011, J VIROL, V85, P10774, DOI 10.1128/JVI.00810-11; Wolfe ND, 2007, NATURE, V447, P279, DOI 10.1038/nature05775; Wroblewski EE, 2009, ANIM BEHAV, V77, P873, DOI 10.1016/j.anbehav.2008.12.014; Zhai JH, 2007, J CLIN MICROBIOL, V45, P224, DOI 10.1128/JCM.01893-06	57	27	27	2	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2015	10	3							e0118543	10.1371/journal.pone.0118543	http://dx.doi.org/10.1371/journal.pone.0118543			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7QC	25781992	Green Published, gold			2022-12-27	WOS:000351284600025
J	Chen, LX; Ma, SM; Zhang, P; Fan, ZC; Xiong, M; Cheng, GQ; Yang, Y; Qiu, ZL; Zhou, WH; Li, J				Chen, Long-Xia; Ma, Si-Min; Zhang, Peng; Fan, Zi Chuan; Xiong, Man; Cheng, Guo-Qiang; Yang, Yi; Qiu, Zi-Long; Zhou, Wen-Hao; Li, Jin			Neuroprotective Effects of Oligodendrocyte Progenitor Cell Transplantation in Premature Rat Brain following Hypoxic-Ischemic Injury	PLOS ONE			English	Article							NEURAL STEM-CELLS; CENTRAL-NERVOUS-SYSTEM; SPINAL-CORD; PERIVENTRICULAR LEUKOMALACIA; CEREBRAL-ISCHEMIA; NEONATAL BRAIN; BDNF PROTECTS; MODEL; REMYELINATION; DEMYELINATION	Periventricular leukomalacia (PVL) is a common ischemic brain injury in premature infants for which there is no effective treatment. The objective of this study was to determine whether transplanted mouse oligodendrocyte progenitor cells (OPCs) have neuroprotective effects in a rat model of PVL. Hypoxia-ischemia (HI) was induced in 3-day-old rat pups by left carotid artery ligation, followed by exposure to 6% oxygen for 2.5 h. Animals were assigned to OPC transplantation or sham control groups and injected with OPCs or PBS, respectively, and sacrificed up to 6 weeks later for immunohistochemical analysis to investigate the survival and differentiation of transplanted OPCs. Apoptosis was evaluated by double immunolabeling of brain sections for caspase-3 and neuronal nuclei (NeuN), while proliferation was assessed using a combination of anti-Nestin and -bromodeoxyuridine antibodies. The expression of brain-derived neurotrophic factor (BDNF) and Bcl-2 was examined 7 days after OPC transplantation. The Morris water maze was used to test spatial learning and memory. The results showed that transplanted OPCs survived and formed a myelin sheath, and stimulated BDNF and Bcl-2 expression and the proliferation of neural stem cells (NSC), while inhibiting HI-induced neuronal apoptosis relative to control animals. Moreover, deficits in spatial learning and memory resulting from HI were improved by OPC transplantation. These results demonstrate an important neuroprotective role for OPCs that can potentially be exploited in cell-based therapeutic approaches to minimize HI-induced brain injury.	[Ma, Si-Min; Cheng, Guo-Qiang; Zhou, Wen-Hao] Fudan Univ, Childrens Hosp, Dept Neonatol, Shanghai 201102, Peoples R China; [Chen, Long-Xia; Fan, Zi Chuan] Fudan Univ, Childrens Hosp, Key Lab Birth Defect, Shanghai 201102, Peoples R China; [Chen, Long-Xia; Ma, Si-Min; Zhang, Peng; Xiong, Man; Yang, Yi; Zhou, Wen-Hao] Fudan Univ, Childrens Hosp, Key Lab Neonatal Dis, Minist Hlth, Shanghai 201102, Peoples R China; [Qiu, Zi-Long] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Neurosci, Shanghai 200031, Peoples R China; [Li, Jin] Fudan Univ, Inst Biomed Sci, Shanghai 201102, Peoples R China	Fudan University; Fudan University; Fudan University; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Fudan University	Zhou, WH (corresponding author), Fudan Univ, Childrens Hosp, Dept Neonatol, Shanghai 201102, Peoples R China.	zwhchfu@126.com; lijina_74@163.com	wenhao, zhou/AAA-1505-2020		National Natural Science Foundation of China [30901615]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by the National Natural Science Foundation of China (NO. 30901615).	Almli CR, 2000, EXP NEUROL, V166, P99, DOI 10.1006/exnr.2000.7492; Bambakidis NC, 2004, SPINE J OFFICIAL J N, V4; Blumenthal I, 2004, EUR J PEDIATR, V163, P435, DOI 10.1007/s00431-004-1477-y; Borlongan CV, 2011, PEDIATR RES, V70, P3, DOI 10.1203/PDR.0b013e31821d0d00; Chen B, 2009, BRAIN RES, V1284, P1, DOI 10.1016/j.brainres.2009.05.100; Chen CP, 2007, STEM CELL REV, V3, P280, DOI 10.1007/s12015-007-9006-9; Donega V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0051253; Du ZW, 2006, MOL CELL NEUROSCI, V33, P371, DOI 10.1016/j.mcn.2006.08.007; Erceg S, 2010, STEM CELLS, V28, P1541, DOI 10.1002/stem.489; Fang CZ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066748; Franklin RJM, 1996, EXP NEUROL, V137, P263, DOI 10.1006/exnr.1996.0025; Franklin RJM, 2008, NAT REV NEUROSCI, V9, P839, DOI 10.1038/nrn2480; Franklin RJM, 2008, J NEUROL, V255, P19, DOI 10.1007/s00415-008-1004-6; Han BH, 2000, J NEUROSCI, V20, P5775, DOI 10.1523/jneurosci.20-15-05775.2000; Huang ZH, 2009, BRAIN RES, V1301, P100, DOI 10.1016/j.brainres.2009.09.006; Inder TE, 2005, PEDIATRICS, V115, P286, DOI 10.1542/peds.2004-0326; Kondo Yoichi, 2009, V549, P175, DOI 10.1007/978-1-60327-931-4_12; Lee HD, 2010, EXP MECH, V50, P661, DOI 10.1007/s11340-009-9245-6; Martino G, 2006, NAT REV NEUROSCI, V7, P395, DOI 10.1038/nrn1908; Mothe AJ, 2008, EXP NEUROL, V213, P176, DOI 10.1016/j.expneurol.2008.05.024; Northington FJ, 2001, NEUROBIOL DIS, V8, P207, DOI 10.1006/nbdi.2000.0371; Obenaus A, 2011, ANN NEUROL, V69, P282, DOI 10.1002/ana.22168; OLeary MT, 1997, J NEUROSCI RES, V48, P159, DOI 10.1002/(SICI)1097-4547(19970415)48:2<159::AID-JNR8>3.0.CO;2-B; Park KI, 2006, EXP NEUROL, V199, P156, DOI 10.1016/j.expneurol.2006.04.002; Pierson CR, 2007, ACTA NEUROPATHOL, V114, P619, DOI 10.1007/s00401-007-0295-5; Pimentel-Coelho PM, 2010, STEM CELLS DEV, V19, P351, DOI 10.1089/scd.2009.0049; Rosenkranz K, 2012, CELL TISSUE RES, V348, P429, DOI 10.1007/s00441-012-1401-0; SCHULTHEISS TE, 1995, INT J RADIAT ONCOL, V31, P1093, DOI 10.1016/0360-3016(94)00655-5; Seo JH, 2013, J CLIN INVEST, V123, P782, DOI 10.1172/JCI65863; Sheldon RA, 1996, BIOL NEONATE, V69, P327; Sun Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057534; Tajiri N, 2014, J NEUROSCI, V34, P313, DOI 10.1523/JNEUROSCI.2425-13.2014; Tirotta E, 2010, J NEUROIMMUNOL, V224, P101, DOI 10.1016/j.jneuroim.2010.05.013; Tuzun F, 2012, NEUROSCI LETT, V520, P6, DOI 10.1016/j.neulet.2012.04.076; Vigano F, 2013, NAT NEUROSCI, V16, P1370, DOI 10.1038/nn.3503; Volpe JJ, 2009, LANCET NEUROL, V8, P110, DOI 10.1016/S1474-4422(08)70294-1; Vorhees CV, 2006, NAT PROTOC, V1, P848, DOI 10.1038/nprot.2006.116; Wang XL, 2013, BRAIN RES, V1518, P26, DOI 10.1016/j.brainres.2013.04.038; Webber DJ, 2009, AM J PATHOL, V175, P2332, DOI 10.2353/ajpath.2009.090051; Wilkins A, 2001, GLIA, V36, P48, DOI 10.1002/glia.1094; Wilkins A, 2005, J NEUROCHEM, V92, P1487, DOI 10.1111/j.1471-4159.2004.02981.x; Wilkins A, 2003, J NEUROSCI, V23, P4967, DOI 10.1523/jneurosci.23-12-04967.2003; Windrem MS, 2004, NAT MED, V10, P93, DOI 10.1038/nm974; Xia GZ, 2010, J PERINAT MED, V38, P215, DOI 10.1515/jpm.2010.021; Xiong M, 2008, NEUROBIOL DIS, V32, P433, DOI 10.1016/j.nbd.2008.08.007; Zhang P, 2009, ACTA ANAESTH SCAND, V53, P1184, DOI 10.1111/j.1399-6576.2009.02024.x; Zheng T, 2013, METHODS MOL BIOL, V1059, P147, DOI 10.1007/978-1-62703-574-3_13; Zhu LH, 2014, BRAIN RES	48	25	29	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2015	10	3							e0115997	10.1371/journal.pone.0115997	http://dx.doi.org/10.1371/journal.pone.0115997			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD9NQ	25790286	Green Published, gold, Green Submitted			2022-12-27	WOS:000351425400007
J	Manosalva, C; Mena, J; Velasquez, Z; Colenso, CK; Brauchi, S; Burgos, RA; Hidalgo, MA				Manosalva, Carolina; Mena, Jaqueline; Velasquez, Zahady; Colenso, Charlotte K.; Brauchi, Sebastian; Burgos, Rafael A.; Hidalgo, Maria A.			Cloning, Identification and Functional Characterization of Bovine Free Fatty Acid Receptor-1 (FFAR1/GPR40) in Neutrophils	PLOS ONE			English	Article							INTRACELLULAR CALCIUM MOBILIZATION; INSULIN-SECRETION; SUPEROXIDE-PRODUCTION; MAPK PHOSPHORYLATION; PHOSPHOLIPASE-C; GRANULE RELEASE; OLEIC-ACID; GPR40; ACTIVATION; AGONIST	Long chain fatty acids (LCFAs), which are ligands for the G-protein coupled receptor FFAR1 (GPR40), are increased in cow plasma after parturition, a period in which they are highly susceptible to infectious diseases. This study identified and analyzed the functional role of the FFAR1 receptor in bovine neutrophils, the first line of host defense against infectious agents. We cloned the putative FFAR1 receptor from bovine neutrophils and analyzed the sequence to construct a homology model. Our results revealed that the sequence of bovine FFAR1 shares 84% identity with human FFAR1 and 31% with human FFAR3/GPR41. Therefore, we constructed a homology model of bovine FFAR1 using human as the template. Expression of the bovine FFAR1 receptor in Chinese hamster ovary (CHO)-K1 cells increased the levels of intracellular calcium induced by the LCFAs, oleic acid (OA) and linoleic acid (LA); no increase in calcium mobilization was observed in the presence of the short chain fatty acid propionic acid. Additionally, the synthetic agonist GW9508 increased intracellular calcium in CHO-K1/bFFAR1 cells. OA and LA increased intracellular calcium in bovine neutrophils. Furthermore, GW1100 (antagonist of FFAR1) and U73122 (phospholipase C (PLC) inhibitor) reduced FFAR1 ligand-induced intracellular calcium in CHO-K1/bFFAR1 cells and neutrophils. Additionally, inhibition of FFAR1, PLC and PKC reduced the FFAR1 ligand-induced release of matrix metalloproteinase (MMP)-9 granules and reactive oxygen species (ROS) production. Thus, we identified the bovine FFAR1 receptor and demonstrate a functional role for this receptor in neutrophils activated with oleic or linoleic acid.	[Manosalva, Carolina; Mena, Jaqueline; Velasquez, Zahady; Burgos, Rafael A.; Hidalgo, Maria A.] Univ Austral Chile, Fac Vet Sci, Inst Pharmacol, Mol Pharmacol Lab, Valdivia, Chile; [Mena, Jaqueline] Univ Narino, Dept Biol, Pasto, Colombia; [Colenso, Charlotte K.; Brauchi, Sebastian] Univ Austral Chile, Fac Med, Inst Physiol, Valdivia, Chile	Universidad Austral de Chile; Universidad Austral de Chile	Hidalgo, MA (corresponding author), Univ Austral Chile, Fac Vet Sci, Inst Pharmacol, Mol Pharmacol Lab, Valdivia, Chile.	mahidalgo@uach.cl	Brauchi, Sebastian E/A-2395-2008	Brauchi, Sebastian E/0000-0002-8494-9912; Mena Huertas, Sandra Jaqueline/0000-0002-3991-7671	Fondo Nacional de Desarrollo Cientifico y Tecnologico (FONDECYT) [11100413]; Direccion de Investigacion y Desarrollo (DID)-UACH [S-2014-23]; scholarship Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT) [21100559, 24121495]; Mecesup Program [AUS1203]; scholarship Mecesup [AUS0704, DID-UACH D-201302]; FONDECYT [3140233]	Fondo Nacional de Desarrollo Cientifico y Tecnologico (FONDECYT)(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT); Direccion de Investigacion y Desarrollo (DID)-UACH; scholarship Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)); Mecesup Program; scholarship Mecesup; FONDECYT(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT)	This study was supported by the following grants: Grant Fondo Nacional de Desarrollo Cientifico y Tecnologico (FONDECYT) No. 11100413 and Direccion de Investigacion y Desarrollo (DID)-UACH S-2014-23. CM is a Ph.D. student supported by scholarship Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT) No. 21100559 and 24121495, and Mecesup Program AUS1203. JM is a Ph.D. student supported by scholarship Mecesup No. AUS0704 and DID-UACH D-201302. CKC is supported by Grant FONDECYT No. 3140233. MAH and SB Laboratories are part of CISNe-UACh, and SB Laboratory is part of the UACh Program in Cellular Dynamics and Microscopy. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bertram A, 2011, ARCH IMMUNOL THER EX, V59, P79, DOI 10.1007/s00005-011-0112-7; Borregaard N, 2007, TRENDS IMMUNOL, V28, P340, DOI 10.1016/j.it.2007.06.002; BOYER JL, 1992, J BIOL CHEM, V267, P25451; Briscoe CP, 2006, BRIT J PHARMACOL, V148, P619, DOI 10.1038/sj.bjp.0706770; Briscoe CP, 2003, J BIOL CHEM, V278, P11303, DOI 10.1074/jbc.M211495200; Camacho C, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-421; CAMPS M, 1992, NATURE, V360, P684, DOI 10.1038/360684a0; CAMPS M, 1992, EUR J BIOCHEM, V206, P821, DOI 10.1111/j.1432-1033.1992.tb16990.x; Carretta MD, 2013, J DAIRY SCI, V96, P2507, DOI 10.3168/jds.2012-6111; Carrillo C, 2011, CELL PHYSIOL BIOCHEM, V28, P329, DOI 10.1159/000331749; Chakrabarti S, 2006, J LEUKOCYTE BIOL, V79, P214, DOI 10.1189/jlb.0605353; Chakrabarti S, 2005, J LEUKOCYTE BIOL, V78, P279, DOI 10.1189/jlb.1004612; Conejeros I, 2012, RES VET SCI, V92, P103, DOI 10.1016/j.rvsc.2010.10.005; Contreras GA, 2010, J DAIRY SCI, V93, P2508, DOI 10.3168/jds.2009-2876; Dahlgren C, 1999, J IMMUNOL METHODS, V232, P3, DOI 10.1016/S0022-1759(99)00146-5; De Lima TM, 2007, CLIN SCI, V113, P65, DOI 10.1042/CS20070006; Doupnik CA, 2004, METHOD ENZYMOL, V389, P131; Ehrenfeld P, 2009, J LEUKOCYTE BIOL, V86, P1179, DOI 10.1189/jlb.0109012; Faurschou M, 2003, MICROBES INFECT, V5, P1317, DOI 10.1016/j.micinf.2003.09.008; Futosi K, 2013, INT IMMUNOPHARMACOL, V17, P1185, DOI 10.1016/j.intimp.2013.11.010; Graciano MF, 2013, ISLETS, V5, P139, DOI 10.4161/isl.25459; Graciano MFR, 2011, J CELL PHYSIOL, V226, P1110, DOI 10.1002/jcp.22432; Hardy S, 2005, J BIOL CHEM, V280, P13285, DOI 10.1074/jbc.M410922200; HARDY SJ, 1994, J NEUROCHEM, V62, P1546; Harfi I, 2004, J IMMUNOL, V173, P4154, DOI 10.4049/jimmunol.173.6.4154; Hatanaka E, 2006, FREE RADICAL BIO MED, V41, P1124, DOI 10.1016/j.freeradbiomed.2006.06.014; Hidalgo MA, 2004, BRIT J PHARMACOL, V141, P311, DOI 10.1038/sj.bjp.0705590; Hidalgo MA, 2011, BIOCHEM BIOPH RES CO, V409, P280, DOI 10.1016/j.bbrc.2011.04.144; Hirasawa A, 2005, NAT MED, V11, P90, DOI 10.1038/nm1168; Hooft RWW, 1996, NATURE, V381, P272, DOI 10.1038/381272a0; Itoh Y, 2003, NATURE, V422, P173, DOI 10.1038/nature01478; Lacetera N, 2004, J DAIRY SCI, V87, P1012, DOI 10.3168/jds.S0022-0302(04)73246-4; Le Poul E, 2003, J BIOL CHEM, V278, P25481, DOI 10.1074/jbc.M301403200; Li XM, 1999, VET IMMUNOL IMMUNOP, V67, P247, DOI 10.1016/S0165-2427(98)00228-1; Mena J, 2013, VET IMMUNOL IMMUNOP, V151, P275, DOI 10.1016/j.vetimm.2012.11.017; Morgan NG, 2009, BIOCHEM PHARMACOL, V78, P1419, DOI 10.1016/j.bcp.2009.07.020; Oh DY, 2010, CELL, V142, P687, DOI 10.1016/j.cell.2010.07.041; Ou HY, 2013, AM J PHYSIOL-ENDOC M, V304, pE668, DOI 10.1152/ajpendo.00419.2012; PARK DG, 1993, J BIOL CHEM, V268, P4573; Scalia D, 2006, J DAIRY SCI, V89, P147, DOI 10.3168/jds.S0022-0302(06)72078-1; Siemsen DW, 2014, METHODS MOL BIOL, V1124, P19, DOI 10.1007/978-1-62703-845-4_3; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Soto-Guzman A, 2010, CLIN EXP METASTAS, V27, P505, DOI 10.1007/s10585-010-9340-1; Srivastava A, 2014, NATURE, V513, P124, DOI 10.1038/nature13494; Suh HN, 2008, AM J PHYSIOL-CELL PH, V295, pC1518, DOI 10.1152/ajpcell.00368.2008; Wauquier F, 2013, J BIOL CHEM, V288, P6542, DOI 10.1074/jbc.M112.429084; Webb Benjamin, 2016, Curr Protoc Protein Sci, V86, DOI [10.1002/cpbi.3, 10.1002/0471250953.bi0506s15, 10.1002/0471140864.ps0209s50, 10.1002/cpps.20]; Yaqoob P, 2007, BRIT J NUTR, V98, pS41, DOI 10.1017/S0007114507832995; Yonezawa T, 2004, BIOCHEM BIOPH RES CO, V314, P805, DOI 10.1016/j.bbrc.2003.12.175; Yonezawa T, 2008, BIOCHEM BIOPH RES CO, V367, P729, DOI 10.1016/j.bbrc.2007.12.190	50	21	23	2	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2015	10	3							e0119715	10.1371/journal.pone.0119715	http://dx.doi.org/10.1371/journal.pone.0119715			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD9NQ	25790461	Green Published, Green Submitted, gold			2022-12-27	WOS:000351425400099
J	Pacholewska, A; Drogemuller, M; Klukowska-Rotzler, J; Lanz, S; Hamza, E; Dermitzakis, ET; Marti, E; Gerber, V; Leeb, T; Jagannathan, V				Pacholewska, Alicja; Droegemueller, Michaela; Klukowska-Roetzler, Jolanta; Lanz, Simone; Hamza, Eman; Dermitzakis, Emmanouil T.; Marti, Eliane; Gerber, Vincent; Leeb, Tosso; Jagannathan, Vidhya			The Transcriptome of Equine Peripheral Blood Mononuclear Cells	PLOS ONE			English	Article							RNA-SEQ; SEQUENCE; EXPRESSION; GENE; HORSES; ANNOTATION; GENERATION; ALIGNMENT; GENOMES; HEAVES	Complete transcriptomic data at high resolution are available only for a few model organisms with medical importance. The gene structures of non-model organisms are mostly computationally predicted based on comparative genomics with other species. As a result, more than half of the horse gene models are known only by projection. Experimental data supporting these gene models are scarce. Moreover, most of the annotated equine genes are single-transcript genes. Utilizing RNA sequencing (RNA-seq) the experimental validation of predicted transcriptomes has become accessible at reasonable costs. To improve the horse genome annotation we performed RNA-seq on 561 samples of peripheral blood mononuclear cells (PBMCs) derived from 85 Warmblood horses. The mapped sequencing reads were used to build a new transcriptome assembly. The new assembly revealed many alternative isoforms associated to known genes or to those predicted by the Ensembl and/or Gnomon pipelines. We also identified 7,531 transcripts not associated with any horse gene annotated in public databases. Of these, 3,280 transcripts did not have a homologous match to any sequence deposited in the NCBI EST database suggesting horse specificity. The unknown transcripts were categorized as coding and noncoding based on predicted coding potential scores. Among them 230 transcripts had high coding potential score, at least 2 exons, and an open reading frame of at least 300 nt. We experimentally validated 9 new equine coding transcripts using RT-PCR and Sanger sequencing. Our results provide valuable detailed information on many transcripts yet to be annotated in the horse genome.	[Pacholewska, Alicja; Klukowska-Roetzler, Jolanta; Lanz, Simone; Gerber, Vincent] Univ Bern & Agroscope, Vetsuisse Fac, Swiss Inst Equine Med, Bern, Switzerland; [Pacholewska, Alicja; Droegemueller, Michaela; Klukowska-Roetzler, Jolanta; Leeb, Tosso; Jagannathan, Vidhya] Univ Bern, Vetsuisse Fac, Inst Genet, Bern, Switzerland; [Klukowska-Roetzler, Jolanta] Univ Hosp Bern, Dept Pediat, Div Pediat Hematol Oncol, CH-3010 Bern, Switzerland; [Hamza, Eman; Marti, Eliane] Univ Bern, Dept Clin Res & Vet Publ Hlth, Clin Immunol Grp, Bern, Switzerland; [Dermitzakis, Emmanouil T.] Univ Geneva, Sch Med, Dept Genet Med & Dev, CH-1211 Geneva, Switzerland; [Dermitzakis, Emmanouil T.] Swiss Inst Bioinformat, Inst Genet & Genom Geneva, Geneva, Switzerland	Swiss Federal Research Station Agroscope; University of Bern; University of Bern; University of Bern; University Hospital of Bern; University of Bern; University of Geneva; Swiss Institute of Bioinformatics	Pacholewska, A (corresponding author), Univ Bern & Agroscope, Vetsuisse Fac, Swiss Inst Equine Med, Bern, Switzerland.	alicja.pacholewska@vetsuisse.unibe.ch	Pacholewska, Alicja/A-3267-2015; Leeb, Tosso/G-3187-2014; Jagannathan, Vidhya/P-1055-2019	Pacholewska, Alicja/0000-0002-4888-4883; Leeb, Tosso/0000-0003-0553-4880; Jagannathan, Vidhya/0000-0002-8155-0041; Hamza, Eman/0000-0001-9798-842X	Swiss National Science Foundation [310030-138295, 310000-116803/1]; Swiss Institute of Equine Medicine Research	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Swiss Institute of Equine Medicine Research	The presented study was funded by Swiss National Science Foundation (www.snf.ch): grant No. 310030-138295 and 310000-116803/1; and Swiss Institute of Equine Medicine Research (ismequine.ch). VG and EM have received the funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Bellone RR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078280; Bryant CE, 2007, VET IMMUNOL IMMUNOP, V116, P182, DOI 10.1016/j.vetimm.2007.01.013; Capomaccio S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083504; Coleman SJ, 2010, ANIM GENET, V41, P121, DOI 10.1111/j.1365-2052.2010.02118.x; Coleman SJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070125; CROWTHER D, 1969, J EXP MED, V129, P849, DOI 10.1084/jem.129.5.849; Curwen V, 2004, GENOME RES, V14, P942, DOI 10.1101/gr.1858004; Das PJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056535; Ewing B, 1998, GENOME RES, V8, P186, DOI 10.1101/gr.8.3.186; Ewing B, 1998, GENOME RES, V8, P175, DOI 10.1101/gr.8.3.175; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Haas BJ, 2013, NAT PROTOC, V8, P1494, DOI 10.1038/nprot.2013.084; Hamza E, 2007, INT ARCH ALLERGY IMM, V144, P325, DOI 10.1159/000106459; Iqbal K, 2014, BIOL REPROD, V90, DOI 10.1095/biolreprod.113.113928; Kong L, 2007, NUCLEIC ACIDS RES, V35, pW345, DOI 10.1093/nar/gkm391; Koressaar T, 2007, BIOINFORMATICS, V23, P1289, DOI 10.1093/bioinformatics/btm091; Lanz S, 2013, VET IMMUNOL IMMUNOP, V155, P229, DOI 10.1016/j.vetimm.2013.07.005; Lavoie JP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029440; Leclere M, 2011, RESPIROLOGY, V16, P1027, DOI 10.1111/j.1440-1843.2011.02033.x; Leise B.S., 2014, EQUINE VET J; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; MAGNO M, 1990, EUR RESPIR J, V3, pS557; Magno M, 1990, EUR RESPIR J, V12, p562S; Marco-Sola S, 2012, NAT METHODS, V9, P1185, DOI [10.1038/NMETH.2221, 10.1038/nmeth.2221]; Martin JA, 2011, NAT REV GENET, V12, P671, DOI 10.1038/nrg3068; McGivney BA, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-398; MCLAUGHLIN RF, 1983, AM REV RESPIR DIS, V128, pS57; McWilliam HEG, 2010, INT J PARASITOL, V40, P265, DOI 10.1016/j.ijpara.2009.08.004; Montgomery SB, 2010, NATURE, V464, P773, DOI 10.1038/nature08903; Moreton J, 2014, PEERJ, V2, DOI 10.7717/peerj.382; Pan Q, 2008, NAT GENET, V40, P1413, DOI 10.1038/ng.259; Park KD, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-473; Pickrell JK, 2010, NATURE, V464, P768, DOI 10.1038/nature08872; Pirie RS, 2002, EQUINE VET J, V34, P332, DOI 10.2746/042516402776249092; Pruitt K., 2002, NCBI HDB, P1; Pruitt KD, 2005, NUCLEIC ACIDS RES, V33, pD501, DOI 10.1093/nar/gki025; Roberts A, 2011, BIOINFORMATICS, V27, P2325, DOI 10.1093/bioinformatics/btr355; Schulz MH, BIOINFORMATICS; Serteyn D, 2010, J ORTHOP RES, V28, P965, DOI 10.1002/jor.21089; Souvorov A., 2010, GNOMON NCBI EUKARYOT, P1; Trapnell C, 2013, NAT BIOTECHNOL, V31, P46, DOI 10.1038/nbt.2450; Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Untergasser A, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks596; Wade CM, 2009, SCIENCE, V326, P865, DOI 10.1126/science.1178158; Wang ET, 2008, NATURE, V456, P470, DOI 10.1038/nature07509; Wang LG, 2012, BIOINFORMATICS, V28, P2184, DOI 10.1093/bioinformatics/bts356; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; Weikard R, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-789; Wu CH, 2006, NUCLEIC ACIDS RES, V34, pD187, DOI 10.1093/nar/gkj161; Xie Y., 2014, BIOINFORMATICS; Zhang ZF, 2013, GENOME MED, V5, DOI 10.1186/gm437	53	16	16	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2015	10	3							e0122011	10.1371/journal.pone.0122011	http://dx.doi.org/10.1371/journal.pone.0122011			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD9NQ	25790166	Green Published, Green Submitted, gold			2022-12-27	WOS:000351425400206
J	Peeters, SCT; van de Ven, V; Gronenschild, EHBM; Patel, AX; Habets, P; Goebel, R; van Os, J; Marcelis, M				Peeters, Sanne C. T.; van de Ven, Vincent; Gronenschild, Ed H. B. M.; Patel, Ameera X.; Habets, Petra; Goebel, Rainer; van Os, Jim; Marcelis, Machteld		Genetic Risk Outcome Phychosis	Default Mode Network Connectivity as a Function of Familial and Environmental Risk for Psychotic Disorder	PLOS ONE			English	Article							NEGATIVE-SYNDROME-SCALE; RESTING-STATE NETWORKS; SPECTRUM DISORDER; SOCIAL COGNITION; SCHIZOPHRENIA; BRAIN; FMRI; STRESS; SELF; ACTIVATION	Background Research suggests that altered interregional connectivity in specific networks, such as the default mode network (DMN), is associated with cognitive and psychotic symptoms in schizophrenia. In addition, frontal and limbic connectivity alterations have been associated with trauma, drug use and urban upbringing, though these environmental exposures have never been examined in relation to DMN functional connectivity in psychotic disorder. Methods Resting-state functional MRI scans were obtained from 73 patients with psychotic disorder, 83 non-psychotic siblings of patients with psychotic disorder and 72 healthy controls. Posterior cingulate cortex (PCC) seed-based correlation analysis was used to estimate functional connectivity within the DMN. DMN functional connectivity was examined in relation to group (familial risk), group x environmental exposure (to cannabis, developmental trauma and urbanicity) and symptomatology. Results There was a significant association between group and PCC connectivity with the inferior parietal lobule (IPL), the precuneus (PCu) and the medial prefrontal cortex (MPFC). Compared to controls, patients and siblings had increased PCC connectivity with the IPL, PCu and MPFC. In the IPL and PCu, the functional connectivity of siblings was intermediate to that of controls and patients. No significant associations were found between DMN connectivity and (subclinical) psychotic/cognitive symptoms. In addition, there were no significant interactions between group and environmental exposures in the model of PCC functional connectivity. Discussion Increased functional connectivity in individuals with (increased risk for) psychotic disorder may reflect trait-related network alterations. The within-network "connectivity at rest" intermediate phenotype was not associated with (subclinical) psychotic or cognitive symptoms. The association between familial risk and DMN connectivity was not conditional on environmental exposure.	[Peeters, Sanne C. T.; Gronenschild, Ed H. B. M.; Habets, Petra; van Os, Jim; Marcelis, Machteld] Maastricht Univ, Med Ctr, Sch Mental Hlth & Neurosci, Dept Psychiat & Psychol,EURON, NL-6200 MD Maastricht, Netherlands; [van de Ven, Vincent; Goebel, Rainer] Maastricht Univ, Fac Psychol & Neurosci, Dept Cognit Neurosci, NL-6200 MD Maastricht, Netherlands; [Patel, Ameera X.] Univ Cambridge, Dept Psychiat, Behav & Clin Neurosci Inst, Cambridge, England; [van Os, Jim] Univ London, Kings Coll London, Inst Psychiat, Kings Hlth Partners,Dept Psychosis, London SW3 6LX, England; [Marcelis, Machteld] Inst Mental Hlth Care Eindhoven GGzE, Eindhoven, Netherlands	Maastricht University; Maastricht University; University of Cambridge; University of London; King's College London	Marcelis, M (corresponding author), Maastricht Univ, Med Ctr, Sch Mental Hlth & Neurosci, Dept Psychiat & Psychol,EURON, NL-6200 MD Maastricht, Netherlands.	M.Marcelis@maastrichtuniversity.nl	van Os, Jim/C-2113-2014; Vasconcelos, Ana Carolina Souza de/GXW-3453-2022; Lang, Steven/AAE-8102-2021; Myin-Germeys, Inez/L-5106-2014; van Os, Jim/V-8884-2019; van de Ven, Vincent/D-3003-2009; Peeters, Sanne/AAA-9523-2021; Habets, Petra/AAZ-1258-2021	Lang, Steven/0000-0003-1669-9146; van Os, Jim/0000-0002-7245-1586; van de Ven, Vincent/0000-0001-8735-3711; Habets, Petra/0000-0001-9184-517X; Bruggeman, Richard/0000-0002-3238-8471; Marcelis, Machteld/0000-0003-0045-9244; Patel, Ameera/0000-0002-4157-2705; Goebel, Rainer/0000-0003-1780-2467; Myin-Germeys, Inez/0000-0002-3731-4930; Peeters, Sanne/0000-0002-3004-4261	Dutch organization for scientific research NWO (Genetic Risk and Outcome of Psychosis [G.R.O.U.P.]); European Community's Seventh Framework Programme [HEALTH-F2-2009-241909]	Dutch organization for scientific research NWO (Genetic Risk and Outcome of Psychosis [G.R.O.U.P.])(Netherlands Organization for Scientific Research (NWO)); European Community's Seventh Framework Programme	This work was sponsored by the Dutch organization for scientific research NWO (Genetic Risk and Outcome of Psychosis [G.R.O.U.P.]) and the European Community's Seventh Framework Programme under Grant Agreement No. HEALTH-F2-2009-241909 (European Network of National Schizophrenia Networks Studying Gene-Environment Interactions Consortium). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Psychiatric Association, 2000, DIAGN STAT MAN MENT; Andreasen NC, 2010, BIOL PSYCHIAT, V67, P255, DOI 10.1016/j.biopsych.2009.08.040; ANDREASEN NC, 1992, ARCH GEN PSYCHIAT, V49, P615; ANNETT M, 1970, BRIT J PSYCHOL, V61, P303, DOI 10.1111/j.2044-8295.1970.tb01248.x; Anticevic A, 2013, SCHIZOPHRENIA BULL, V39, P168, DOI 10.1093/schbul/sbr107; Assaf M, 2010, NEUROIMAGE, V53, P247, DOI 10.1016/j.neuroimage.2010.05.067; Beer JS, 2007, TRENDS COGN SCI, V11, P187, DOI 10.1016/j.tics.2007.02.004; Bernstein DP, 1997, J AM ACAD CHILD PSY, V36, P340, DOI 10.1097/00004583-199703000-00012; Bluhm RL, 2007, SCHIZOPHRENIA BULL, V33, P1004, DOI 10.1093/schbul/sbm052; Bluhm RL, 2009, J PSYCHIATR NEUROSCI, V34, P187; Broyd SJ, 2009, NEUROSCI BIOBEHAV R, V33, P279, DOI 10.1016/j.neubiorev.2008.09.002; Buckner RL, 2008, ANN NY ACAD SCI, V1124, P1, DOI 10.1196/annals.1440.011; Camchong J, 2011, SCHIZOPHRENIA BULL, V37, P640, DOI 10.1093/schbul/sbp131; Cavanna AE, 2006, BRAIN, V129, P564, DOI 10.1093/brain/awl004; Central Bureau of Statistics, 1993, BEV GEM NED; Chang X, 2014, BRAIN RES, V1562, P87, DOI 10.1016/j.brainres.2014.03.024; Cole DM, 2010, FRONT SYST NEUROSCI, V4, DOI 10.3389/fnsys.2010.00008; CORCORAN R, 1995, SCHIZOPHR RES, V17, P5, DOI 10.1016/0920-9964(95)00024-G; Cox RW, 1996, COMPUT BIOMED RES, V29, P162, DOI 10.1006/cbmr.1996.0014; Ding X, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059331; Dodell-Feder D, 2014, SCHIZOPHR RES, V156, P87, DOI 10.1016/j.schres.2014.03.031; Duncan NW, 2013, J PSYCHIATR NEUROSCI, V38, P84, DOI 10.1503/jpn.120059; Esposito F, 2009, ARCH ITAL BIOL, V147, P11; Farrer C, 2003, NEUROIMAGE, V18, P324, DOI 10.1016/S1053-8119(02)00041-1; FORMAN SD, 1995, MAGNET RESON MED, V33, P636, DOI 10.1002/mrm.1910330508; Fransson P, 2008, NEUROIMAGE, V42, P1178, DOI 10.1016/j.neuroimage.2008.05.059; FRISTON KJ, 1995, CLIN NEUROSCI, V3, P89; Friston KJ, 1998, SCHIZOPHR RES, V30, P115, DOI 10.1016/S0920-9964(97)00140-0; Garrity AG, 2007, AM J PSYCHIAT, V164, P450, DOI 10.1176/appi.ajp.164.3.450; Genovese CR, 2002, NEUROIMAGE, V15, P870, DOI 10.1006/nimg.2001.1037; Geoffroy Pierre Alexis, 2013, Front Psychiatry, V4, P136, DOI 10.3389/fpsyt.2013.00136; Goebel R, 2006, HUM BRAIN MAPP, V27, P392, DOI 10.1002/hbm.20249; Green MF, 2008, SCHIZOPHRENIA BULL, V34, P670, DOI 10.1093/schbul/sbn045; Guo WB, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091102; Guo WB, 2014, EUR NEUROPSYCHOPHARM, V24, P545, DOI 10.1016/j.euroneuro.2014.01.004; Gusnard DA, 2001, NAT REV NEUROSCI, V2, P685, DOI 10.1038/35094500; Habets P, 2011, BIOL PSYCHIAT, V69, P487, DOI 10.1016/j.biopsych.2010.08.010; Hampson M, 2006, J NEUROSCI, V26, P13338, DOI 10.1523/JNEUROSCI.3408-06.2006; Hills, 1993, STAT MODELS EPIDEMIO; Jang JH, 2011, SCHIZOPHR RES, V127, P58, DOI 10.1016/j.schres.2010.12.022; Jenkinson M, 2002, NEUROIMAGE, V17, P825, DOI 10.1006/nimg.2002.1132; Jenkinson M, 2001, MED IMAGE ANAL, V5, P143, DOI 10.1016/S1361-8415(01)00036-6; Jo HJ, 2013, J APPL MATH, DOI 10.1155/2013/935154; Karbasforoushan H, 2012, CURR TOP MED CHEM, V12, P2404, DOI 10.2174/156802612805289863; KAY SR, 1987, SCHIZOPHRENIA BULL, V13, P261, DOI 10.1093/schbul/13.2.261; Kennedy DP, 2008, NEUROIMAGE, V39, P1877, DOI 10.1016/j.neuroimage.2007.10.052; Khadka S, 2013, BIOL PSYCHIAT, V74, P458, DOI 10.1016/j.biopsych.2013.04.024; Kindler J, 2013, SCHIZOPHR B; Lederbogen F, 2011, NATURE, V474, P498, DOI 10.1038/nature10190; Lee MH, 2013, AM J NEURORADIOL, V34, P1866, DOI 10.3174/ajnr.A3263; Lindner M, 2008, NEUROIMAGE, V40, P963, DOI 10.1016/j.neuroimage.2007.12.022; Liu HH, 2012, SCHIZOPHRENIA BULL, V38, P285, DOI 10.1093/schbul/sbq074; Ma N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016560; Mannell MV, 2010, HUM BRAIN MAPP, V31, P424, DOI 10.1002/hbm.20876; Meda SA, 2014, P NATL ACAD SCI USA, V111, pE2066, DOI 10.1073/pnas.1313093111; Metzak PD, 2012, SCHIZOPHRENIA BULL, V38, P803, DOI 10.1093/schbul/sbq154; Monk CS, 2009, NEUROIMAGE, V47, P764, DOI 10.1016/j.neuroimage.2009.04.069; Orliac F, 2013, SCHIZOPHR RES, V148, P74, DOI 10.1016/j.schres.2013.05.007; Patel AX, 2014, NEUROIMAGE, V95, P287, DOI 10.1016/j.neuroimage.2014.03.012; Pujol J, 2014, J PSYCHIATR RES, V51, P68, DOI 10.1016/j.jpsychires.2013.12.008; Repovs G, 2011, BIOL PSYCHIAT, V69, P967, DOI 10.1016/j.biopsych.2010.11.009; Roberts GMP, 2010, NEUROIMAGE, V52, P429, DOI 10.1016/j.neuroimage.2010.04.192; Rotarska-Jagiela A, 2010, SCHIZOPHR RES, V117, P21, DOI 10.1016/j.schres.2010.01.001; Schilbach L, 2008, CONSCIOUS COGN, V17, P457, DOI 10.1016/j.concog.2008.03.013; Schlosser R, 2003, NEUROIMAGE, V19, P751, DOI 10.1016/S1053-8119(03)00106-X; Schurhoff F, 2003, AM J PSYCHIAT, V160, P1313, DOI 10.1176/appi.ajp.160.7.1313; Shenton ME, 2001, SCHIZOPHR RES, V49, P1, DOI 10.1016/S0920-9964(01)00163-3; Shim G, 2010, BEHAV BRAIN FUNCT, V6, DOI 10.1186/1744-9081-6-58; SIMES RJ, 1986, BIOMETRIKA, V73, P751, DOI 10.2307/2336545; Sinha R, 2004, ANN NY ACAD SCI, V1032, P254, DOI 10.1196/annals.1314.032; Sripada RK, 2014, NEUROPSYCHOPHARMACOL, V39, P2244, DOI 10.1038/npp.2014.75; StataCorp, 2011, STAT STAT SOFTW REL, P173; Stephan KE, 2001, PSYCHOL MED, V31, P1065, DOI 10.1017/S0033291701004330; Tang JS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071061; Tienari P, 2004, BRIT J PSYCHIAT, V184, P216, DOI 10.1192/bjp.184.3.216; Tomasi D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010815; van Buuren M, 2012, SCHIZOPHR RES, V142, P237, DOI 10.1016/j.schres.2012.09.017; van de Ven V., 2012, NEUROSCIENCE HALLUCI, P393; van der Gaag M, 2006, SCHIZOPHR RES, V85, P280, DOI 10.1016/j.schres.2006.03.021; van Os J, 2004, AM J PSYCHIAT, V161, P2312, DOI 10.1176/appi.ajp.161.12.2312; van Os J, 2010, NATURE, V468, P203, DOI 10.1038/nature09563; van Winkel R, 2008, SCHIZOPHRENIA BULL, V34, P1095, DOI 10.1093/schbul/sbn101; Veer IM, 2010, FRONT SYST NEUROSCI, V4, DOI 10.3389/fnsys.2010.00041; Volkow ND, 2008, PSYCHIAT RES-NEUROIM, V162, P205, DOI 10.1016/j.pscychresns.2007.04.010; Vollema MG, 2000, SCHIZOPHRENIA BULL, V26, P619, DOI 10.1093/oxfordjournals.schbul.a033482; Wechsler D., 1997, WECHSLER ADULT INTEL; Whitfield-Gabrieli S, 2012, ANNU REV CLIN PSYCHO, V8, P49, DOI 10.1146/annurev-clinpsy-032511-143049; Whitfield-Gabrieli S, 2009, P NATL ACAD SCI USA, V106, P1279, DOI 10.1073/pnas.0809141106; Wible CG, 2009, BRAIN IMAGING BEHAV, V3, P85, DOI 10.1007/s11682-008-9052-1; Williamson PC, 2012, FRONT HUM NEUROSCI, V6, DOI 10.3389/fnhum.2012.00184; Woodward ND, 2011, SCHIZOPHR RES, V130, P86, DOI 10.1016/j.schres.2011.03.010; World Health Organization, 1990, COMP INT DIAGN INT C; Wotruba D., 2013, SCHIZOPHR B	93	24	26	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2015	10	3							e0120030	10.1371/journal.pone.0120030	http://dx.doi.org/10.1371/journal.pone.0120030			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CD9NQ	25790002	Green Published, gold, Green Submitted			2022-12-27	WOS:000351425400124
J	Wang, XY; Liu, CL; Li, SD; Xu, Y; Chen, P; Liu, Y; Ding, Q; Wahafu, W; Hong, BF; Yang, MH				Wang, XiYou; Liu, CuiLong; Li, ShaoDan; Xu, Yong; Chen, Ping; Liu, Yi; Ding, Qiang; Wahafu, Wasilijiang; Hong, BaoFa; Yang, MingHui			Hypoxia Precondition Promotes Adipose-Derived Mesenchymal Stem Cells Based Repair of Diabetic Erectile Dysfunction via Augmenting Angiogenesis and Neuroprotection	PLOS ONE			English	Article							MARROW STROMAL CELLS; ISCHEMIC RAT-BRAIN; BONE-MARROW; IN-VITRO; INFARCTED MYOCARDIUM; GENE-THERAPY; TRANSPLANTATION; SURVIVAL; DIFFERENTIATION; IMPROVES	The aim of the present study was to examine whether hypoxia preconditioning could improve therapeutic effects of adipose derived mesenchymal stem cells (AMSCs) for diabetes induced erectile dysfunction (DED). AMSCs were pretreated with normoxia (20% O-2, N-AMSCs) or sub-lethal hypoxia (1% O-2, H-AMSCs). The hypoxia exposure up-regulated the expression of several angiogenesis and neuroprotection related cytokines in AMSCs, including vascular endothelial growth factor (VEGF) and its receptor FIK-1, angiotensin (Ang-1), basic fibroblast growth factor (bFGF), brain-derived neurotrophic factor (BDNF), glial cell-derived neurotrophic factor (GDNF), stromal derived factor-1 (SDF-1) and its CXC chemokine receptor 4 (CXCR4). DED rats were induced via intraperitoneal injection of streptozotocin (60 mg/kg) and were randomly divided into three groups-Saline group: intracavernous injection with phosphate buffer saline; N-AMSCs group: N-AMSCs injection; H-AMSCs group: H-AMSCs injection. Ten rats without any treatment were used as normal control. Four weeks after injection, the mean arterial pressure (MAP) and intracavernosal pressure (ICP) were measured. The contents of endothelial, smooth muscle, dorsal nerve in cavernoursal tissue were assessed. Compared with N-AMSCs and saline, intracavernosum injection of H-AMSCs significantly raised ICP and ICP/MAP (p<0.05). Immunofluorescent staining analysis demonstrated that improved erectile function by MSCs was significantly associated with increased expression of endothelial markers (CD31 and vWF) (p<0.01) and smooth muscle markers (alpha-SMA) (p<0.01). Meanwhile, the expression of nNOS was also significantly higher in rats receiving H-AMSCs injection than those receiving N-AMSCs or saline injection. The results suggested that hypoxic preconditioning of MSCs was an effective approach to enhance their therapeutic effect for DED, which may be due to their augmented angiogenesis and neuroprotection.	[Wang, XiYou; Li, ShaoDan; Liu, Yi; Yang, MingHui] Chinese Peoples Liberat Army Gen Hosp, Dept Tradit Chinese Med, Beijing 100853, Peoples R China; [Liu, CuiLong] PLA Navy Gen Hosp, Dept Urol, Beijing 100048, Peoples R China; [Xu, Yong; Chen, Ping; Ding, Qiang; Wahafu, Wasilijiang; Hong, BaoFa] Chinese Peoples Liberat Army Gen Hosp, Dept Urol, Beijing 100853, Peoples R China	Chinese People's Liberation Army General Hospital; Sixth Medical Center of Chinese PLA General Hospital; Chinese People's Liberation Army General Hospital	Yang, MH (corresponding author), Chinese Peoples Liberat Army Gen Hosp, Dept Tradit Chinese Med, 28 Fuxing Rd, Beijing 100853, Peoples R China.	yangminghuipla@126.com			China postdoctoral science foundation [2013M532197]	China postdoctoral science foundation(China Postdoctoral Science Foundation)	The work was supported by China postdoctoral science foundation (2013M532197). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ACHESON A, 1995, NATURE, V374, P450, DOI 10.1038/374450a0; Aytac IA, 1999, BJU INT, V84, P50; Bivalacqua TJ, 2005, J SEX MED, V2, P187, DOI 10.1111/j.1743-6109.2005.20228_1.x; Bivalacqua TJ, 2007, AM J PHYSIOL-HEART C, V292, pH1278, DOI 10.1152/ajpheart.00685.2006; Brant WO, 2007, ENDOCRIN METAB CLIN, V36, P465, DOI 10.1016/j.ecl.2007.02.001; Ceradini DJ, 2004, NAT MED, V10, P858, DOI 10.1038/nm1075; Chang W, 2013, J VET SCI, V14, P69, DOI 10.4142/jvs.2013.14.1.69; Chen XG, 2002, NEUROPATHOLOGY, V22, P275, DOI 10.1046/j.1440-1789.2002.00450.x; Cheng ZK, 2008, MOL THER, V16, P571, DOI 10.1038/sj.mt.6300374; de Tejada IS, 2005, J SEX MED, V2, P26, DOI 10.1111/j.1743-6109.2005.20103.x; Drela K, 2014, CYTOTHERAPY; Efimenko A, 2011, J TRANSL MED, V9, DOI 10.1186/1479-5876-9-10; Fall PA, 2009, EUR UROL, V56, P716, DOI 10.1016/j.eururo.2008.09.059; FELDMAN HA, 1994, J UROLOGY, V151, P54, DOI 10.1016/S0022-5347(17)34871-1; Francis KR, 2010, CELL DEATH DIS, V1, DOI 10.1038/cddis.2009.22; Gao XD, 2014, MOL CELL ENDOCRINOL, V388, P41, DOI 10.1016/j.mce.2014.03.004; HEATON JPW, 1991, J UROLOGY, V145, P1099, DOI 10.1016/S0022-5347(17)38543-9; Hu XD, 2011, J COMB OPTIM, V21, P1, DOI 10.1007/s10878-010-9361-3; Hu XY, 2008, J THORAC CARDIOV SUR, V135, P799, DOI 10.1016/j.jtcvs.2007.07.071; Huang EJ, 2001, ANNU REV NEUROSCI, V24, P677, DOI 10.1146/annurev.neuro.24.1.677; Huang YP, 2011, J SEX MED, V8, P840, DOI 10.1111/j.1743-6109.2010.02141.x; Kim Ju-Yeon, 2012, World J Stem Cells, V4, P110, DOI 10.4252/wjsc.v4.i11.110; Kurozumi K, 2005, MOL THER, V11, P96, DOI 10.1016/j.ymthe.2004.09.020; Lalu MM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047559; Lee RH, 2011, J CELL BIOCHEM, V112, P3073, DOI 10.1002/jcb.23250; Lennon DP, 2001, J CELL PHYSIOL, V187, P345, DOI 10.1002/jcp.1081; Li TS, 2002, AM J PHYSIOL-HEART C, V283, pH468, DOI 10.1152/ajpheart.00261.2002; Li Y, 2006, EXP NEUROL, V198, P313, DOI 10.1016/j.expneurol.2005.11.029; Lin CS, 2008, ASIAN J ANDROL, V10, P171, DOI 10.1111/j.1745-7262.2008.00389.x; Liu GH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072790; Liu HB, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0034608, 10.1371/journal.pone.0050785]; Liu LQ, 2013, CELL BIOL INT, V37, P551, DOI 10.1002/cbin.10097; Liu ZQ, 2012, BIOMATERIALS, V33, P3093, DOI 10.1016/j.biomaterials.2011.12.044; Long T, 2012, J SEX MED, V9, P1801, DOI 10.1111/j.1743-6109.2012.02739.x; Malavige LS, 2009, J SEX MED, V6, P1232, DOI 10.1111/j.1743-6109.2008.01168.x; Malgieri A, 2010, INT J CLIN EXP MED, V3, P248; MCCULLOCH DK, 1980, DIABETOLOGIA, V18, P279; Morizono K, 2003, HUM GENE THER, V14, P59, DOI 10.1089/10430340360464714; Ni L, 2014, SPINE J; Park JH, 2012, DIABETES RES CLIN PR, V98, P465, DOI 10.1016/j.diabres.2012.09.034; Pasha Z, 2008, CARDIOVASC RES, V77, P134, DOI 10.1093/cvr/cvm025; Portalska KJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046842; Qiu XF, 2012, J SEX MED, V9, P1834, DOI 10.1111/j.1743-6109.2012.02753.x; Qiu XF, 2011, J ANDROL, V33, P37, DOI 10.2164/jandrol.110.012666; Qiu XF, 2011, J SEX MED, V8, P427, DOI 10.1111/j.1743-6109.2010.02118.x; Saigal CS, 2006, ARCH INTERN MED, V166, P207, DOI 10.1001/archinte.166.2.207; Sharp FR, 2001, ADV EXP MED BIOL, V502, P273; Shyu WC, 2004, CIRCULATION, V110, P1847, DOI 10.1161/01.CIR.0000142616.07367.66; Stuckey BGA, 2003, DIABETES CARE, V26, P279, DOI 10.2337/diacare.26.2.279; Sun DC, 2014, J CELL MOL MED, V18, P434, DOI 10.1111/jcmm.12157; Theus MH, 2008, EXP NEUROL, V210, P656, DOI 10.1016/j.expneurol.2007.12.020; Thorve VS, 2011, J DIABETES COMPLICAT, V25, P129, DOI 10.1016/j.jdiacomp.2010.03.003; Tse WT, 2003, TRANSPLANTATION, V75, P389, DOI 10.1097/01.TP.0000045055.63901.A9; Wei L, 2012, NEUROBIOL DIS, V46, P635, DOI 10.1016/j.nbd.2012.03.002; Yang R, 2009, J SEX MED, V6, P696, DOI 10.1111/j.1743-6109.2008.01054.x; Young A, 2010, J NEUROSCI RES, V88, P3222, DOI 10.1002/jnr.22499; Zhang ZC, 2014, CHINESE MED J-PEKING, V127, P314, DOI 10.3760/cma.j.issn.0366-6999.20130584	57	56	61	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2015	10	3							e0118951	10.1371/journal.pone.0118951	http://dx.doi.org/10.1371/journal.pone.0118951			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD9NQ	25790284	Green Published, Green Submitted, gold			2022-12-27	WOS:000351425400057
J	Zefferman, EP				Zefferman, Emily P.			Experimental Tests of Priority Effects and Light Availability on Relative Performance of Myriophyllum spicatum and Elodea nuttallii Propagules in Artificial Stream Channels	PLOS ONE			English	Article							FRESH-WATER MACROPHYTES; EURASIAN WATERMILFOIL; HYDRILLA-VERTICILLATA; COMPETITION; INVASION; GROWTH; SUCCESS; REHABILITATION; ESTABLISHMENT; ECOSYSTEMS	Submersed macrophytes have important ecological functions in many streams, but fostering growth of beneficial native species while suppressing weedy invasives may be challenging. Two approaches commonly used in management of terrestrial plant communities may be useful in this context: (1) altering resource availability and (2) establishing desirable species before weeds can invade (priority effects). However, these approaches are rarely used in aquatic systems, despite widespread need for sustainable solutions to aquatic weed problems. In artificial stream channels in California, USA, I conducted experiments with asexual propagules of non-native invasive Myriophyllum spicatum (Eurasian watermilfoil) and native Elodea nuttallii (western waterweed) to address the questions: (1) How does light availability affect relative performance of the two species?; (2) Does planting the native earlier than the invasive decrease survival or growth rate of the invasive?; and (3) Do light level and priority effects interact? The relative performance between E. nuttallii and M. spicatum had an interesting and unexpected pattern: M. spicatum had higher growth rates than E. nuttallii in the zero and medium shade levels, but had similar performance in the low and high shade levels. This pattern is most likely the result of E. nutallii's sensitivity to both very low and very high light, and M. spicatum's sensitivity to very low light only. Native priority did not significantly affect growth rate or survival of M. spicatum, possibly because of unexpectedly poor growth of the E. nuttallii planted early. This study suggests that altering light levels could be effective in reducing growth of an invasive macrophyte, and for changing the competitive balance between a native and a non-native species in the establishment phase. Further investigations into the use of priority effects and resource alteration for submersed macrophyte management are warranted, given their mixed results in other (limited) studies.	[Zefferman, Emily P.] Univ Calif Davis, Dept Plant Sci, Davis, CA 95616 USA; [Zefferman, Emily P.] Univ Calif Davis, Grad Grp Ecol, Davis, CA 95616 USA	University of California System; University of California Davis; University of California System; University of California Davis	Zefferman, EP (corresponding author), Univ Calif Davis, Dept Plant Sci, Davis, CA 95616 USA.	epeffer@ucdavis.edu			University of California Davis Plant Sciences Graduate Fellowship; Henry A. Jastro Research Fellowship; Ben A. Madson Scholarship	University of California Davis Plant Sciences Graduate Fellowship; Henry A. Jastro Research Fellowship; Ben A. Madson Scholarship	Research funding and personal support were provided by the University of California Davis Plant Sciences Graduate Fellowship, the Henry A. Jastro Research Fellowship, and the Ben A. Madson Scholarship. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AIKEN SG, 1979, CAN J PLANT SCI, V59, P201, DOI 10.4141/cjps79-028; Alpert Peter, 2000, Perspectives in Plant Ecology Evolution and Systematics, V3, P52, DOI 10.1078/1433-8319-00004; Anderson L., 2011, ENCY BIOL INVASIONS, P248; Angelstein S, 2009, FUND APPL LIMNOL, V175, P49, DOI 10.1127/1863-9135/2009/0175-0049; Angelstein S, 2009, PLANT ECOL, V202, P91, DOI 10.1007/s11258-008-9500-4; BARKO JW, 1982, CAN J BOT, V60, P877, DOI 10.1139/b82-113; Boylen CW, 1999, HYDROBIOLOGIA, V415, P207, DOI 10.1023/A:1003804612998; CANFIELD DE, 1988, CAN J FISH AQUAT SCI, V45, P1467, DOI 10.1139/f88-171; CARPENTER SR, 1986, AQUAT BOT, V26, P341, DOI 10.1016/0304-3770(86)90031-8; Chadwell TB, 2008, J APPL ECOL, V45, P515, DOI 10.1111/j.1365-2664.2007.01384.x; Cheruvelil KS, 2001, J AQUAT PLANT MANAGE, V39, P67; Daehler CC, 2003, ANNU REV ECOL EVOL S, P83; DAWSON FH, 1979, INT REV GES HYDROBIO, V64, P437, DOI 10.1002/iroh.19790640402; Dukes JS, 1999, TRENDS ECOL EVOL, V14, P135, DOI 10.1016/S0169-5347(98)01554-7; Funk JL, 2007, NATURE, V446, P1079, DOI 10.1038/nature05719; Funk JL, 2013, CONSERV PHYSIOL, V1, DOI 10.1093/conphys/cot026; Hussner A, 2010, AQUAT BOT, V93, P17, DOI 10.1016/j.aquabot.2010.02.003; Kardol P, 2013, OIKOS, V122, P84, DOI 10.1111/j.1600-0706.2012.20546.x; KEAST A, 1984, CAN J ZOOL, V62, P1289, DOI 10.1139/z84-186; Lacoul P, 2006, ENVIRON REV, V14, P89, DOI 10.1139/a06-001; Larned ST, 2006, RESTOR ECOL, V14, P429, DOI 10.1111/j.1526-100X.2006.00151.x; MADSEN JD, 1991, J AQUAT PLANT MANAGE, V29, P94; Mjelde M, 2012, ANN LIMNOL-INT J LIM, V48, P225, DOI 10.1051/limn/2012016; Mony C, 2007, AQUAT BOT, V86, P236, DOI 10.1016/j.aquabot.2006.11.007; Moore JE, 2012, J VEG SCI, V23, P647, DOI 10.1111/j.1654-1103.2012.01388.x; NEWMAN RM, 1991, J N AM BENTHOL SOC, V10, P89, DOI 10.2307/1467571; Northwest Hydraulic Consultants, 2008, SPEC ID SEAS BIOM FL; Peffer E., 2013, AQUATIC VEGETATION A; Pimentel D, 2005, ECOL ECON, V52, P273, DOI 10.1016/j.ecolecon.2004.10.002; Reinhart KO, 2006, ECOL APPL, V16, P1821, DOI 10.1890/1051-0761(2006)016[1821:ITQEIS]2.0.CO;2; Rejmankova Eliska, 2011, Journal of Ecology and Field Biology, V34, P333, DOI 10.5141/JEFB.2011.044; Riis T, 2009, AQUAT ECOL, V43, P935, DOI 10.1007/s10452-008-9213-8; SANDJENSEN K, 1991, J ECOL, V79, P749, DOI 10.2307/2260665; Schultz R, HYDROBIOLOGIA, V684, P1; Sculthorpe CD., 1967, BIOL AQUATIC VASCULA; SMITH CS, 1990, J AQUAT PLANT MANAGE, V28, P55; Su Wen-Hua, 2004, Acta Hydrobiologica Sinica, V28, P391; Suren AM, 2009, RESTOR ECOL, V17, P873, DOI 10.1111/j.1526-100X.2008.00446.x; Tukey JW, 1962, ANN MATH STAT, V33, P17; Van TK, 1999, AQUAT BOT, V62, P225, DOI 10.1016/S0304-3770(98)00100-4; Vaughn KJ, ECOL APPL IN PRESS; Weaver MJ, 1997, CAN J FISH AQUAT SCI, V54, P2277, DOI 10.1139/cjfas-54-10-2277; Wilson SJ, 2009, CAN J FISH AQUAT SCI, V66, P18, DOI 10.1139/F08-187; Young TP, 2001, ECOL RESTOR, V19, P5, DOI [10.3368/er.19.1.5, DOI 10.3368/ER.19.1.5]; Zefferman E, 2014, HYDROBIOLOGIA, V734, P159, DOI 10.1007/s10750-014-1877-6	45	8	8	3	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2015	10	3							e0120248	10.1371/journal.pone.0120248	http://dx.doi.org/10.1371/journal.pone.0120248			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD9NQ	25790180	Green Submitted, Green Published, gold			2022-12-27	WOS:000351425400146
J	Zhang, YR; Hu, G; Zhang, L; Mayo, R; Chen, LW				Zhang, Yurong; Hu, Gang; Zhang, Lu; Mayo, Rachel; Chen, Liwei			A Novel Testing Model for Opportunistic Screening of Pre-Diabetes and Diabetes	PLOS ONE			English	Article							IMPAIRED GLUCOSE-TOLERANCE; RISK SCORE; GLYCATED HEMOGLOBIN; PLASMA-GLUCOSE; TYPE-2; MELLITUS; HBA(1C); POPULATION; PREVALENCE; NIDDM	Objective The study aim was to evaluate the performance of a novel simultaneous testing model, based on the Finnish Diabetes Risk Score (FINDRISC) and HbA1c, in detecting undiagnosed diabetes and pre-diabetes in Americans. Research Design and Methods This cross-sectional analysis included 3,886 men and women (>= 20 years) without known diabetes from the U.S. National Health and Nutrition Examination Survey (NHANES) 2005-2010. The FINDRISC was developed based on eight variables (age, BMI, waist circumference, use of antihypertensive drug, history of high blood glucose, family history of diabetes, daily physical activity and fruit & vegetable intake). The sensitivity, specificity, and the receiver operating characteristic (ROC) curve of the testing model were calculated for undiagnosed diabetes and pre-diabetes, determined by oral glucose tolerance test (OGTT). Results The prevalence of undiagnosed diabetes was 7.0% and 43.1% for pre-diabetes (27.7% for isolated impaired fasting glucose (IFG), 5.1% for impaired glucose tolerance (IGT), and 10.3% for having both IFG and IGT). The sensitivity and specificity of using the HbA1c alone was 24.2% and 99.6% for diabetes (cutoff of >= 6.5%), and 35.2% and 86.4% for prediabetes (cutoff of >= 5.7%). The sensitivity and specificity of using the FINDRISC alone (cutoff of >= 9) was 79.1% and 48.6% for diabetes and 60.2% and 61.4% for pre-diabetes. Using the simultaneous testing model with a combination of FINDRISC and HbA1c improved the sensitivity to 84.2% for diabetes and 74.2% for pre-diabetes. The specificity for the simultaneous testing model was 48.4% of diabetes and 53.0% for pre-diabetes. Conclusions This simultaneous testing model is a practical and valid tool in diabetes screening in the general U.S. population.	[Zhang, Yurong] Xi An Jiao Tong Univ, Sch Med, Affiliated Hosp 1, Xian 710049, Shaanxi, Peoples R China; [Hu, Gang] Pennington Biomed Res Ctr, Baton Rouge, LA 70808 USA; [Zhang, Lu] Louisiana State Univ, Program Epidemiol, Sch Publ Hlth, Hlth Sci Ctr, New Orleans, LA USA; [Mayo, Rachel; Chen, Liwei] Clemson Univ, Dept Publ Hlth Sci, Clemson, SC 29634 USA	Xi'an Jiaotong University; Louisiana State University System; Louisiana State University; Pennington Biomedical Research Center; Louisiana State University System; Louisiana State University Health Sciences Center New Orleans; Clemson University	Chen, LW (corresponding author), Clemson Univ, Dept Publ Hlth Sci, Clemson, SC 29634 USA.	liweic@clemson.edu	Hu, Gang/V-7947-2019; Hu, Gang/N-1971-2017	Hu, Gang/0000-0002-6172-8017; Hu, Gang/0000-0002-6172-8017	Clemson University (US); Natural Science Foundation of Shaanxi Province [2014JM4107]; Basic Research Foundation of Xi'an Jiaotong University [08143002]	Clemson University (US); Natural Science Foundation of Shaanxi Province(Natural Science Foundation of Shaanxi Province); Basic Research Foundation of Xi'an Jiaotong University	This work was partially supported by Clemson University (US), the Natural Science Foundation of Shaanxi Province (China: No. 2014JM4107), and the Basic Research Foundation of Xi'an Jiaotong University (China: No. 08143002). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbasi A, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e5900; Alberti KGMM, 2007, DIABETIC MED, V24, P451, DOI 10.1111/j.1464-5491.2007.02157.x; Amer Diabet Assoc, 2013, DIABETES CARE, V36, P1033, DOI 10.2337/dc12-2625; Amer Diabet Assoc, 2013, DIABETES CARE, V36, pS67, DOI [10.2337/dc13-S067, 10.2337/dc10-S062, 10.2337/dc12-s064, 10.2337/dc11-S062]; American Diabetes Association, 2004, Diabetes Care, V27 Suppl 1, pS11; [Anonymous], 2010, Diabetes Care, V33 Suppl 1, pS4, DOI 10.2337/dc10-S004; Bennett CM, 2007, DIABETIC MED, V24, P333, DOI 10.1111/j.1464-5491.2007.02106.x; Bergmann A, 2007, HORM METAB RES, V39, P677, DOI 10.1055/s-2007-985353; Buell C, 2007, DIABETES CARE, V30, P2233, DOI 10.2337/dc07-0585; Calonge N, 2008, ANN INTERN MED, V148, P846, DOI 10.7326/0003-4819-148-11-200806030-00007; Colagiuri S, 2004, DIABETES CARE, V27, P367, DOI 10.2337/diacare.27.2.367; Droumaguet C, 2006, DIABETES CARE, V29, P1619, DOI 10.2337/dc05-2525; Ealovega MW, 2004, DIABETES CARE, V27, P9, DOI 10.2337/diacare.27.1.9; Engelgau MM, 2004, ANN INTERN MED, V140, P945, DOI 10.7326/0003-4819-140-11-200406010-00035; Franciosi M, 2005, DIABETES CARE, V28, P1187, DOI 10.2337/diacare.28.5.1187; Garca-Alcala H, 2012, DIABET METAB SYND OB, V5, P403, DOI 10.2147/DMSO.S35545; Goldstein David E, 2003, Diabetes Care, V26 Suppl 1, pS106; Haas L, 2013, DIABETES CARE, V36, pS100, DOI [10.2337/dc13-S100, 10.2337/dc13-S004]; Handelsman Y, 2011, ENDOCR PRACT, V17, P1, DOI 10.4158/EP.17.S2.1; HARRIS MI, 1993, DIABETES CARE, V16, P642, DOI 10.2337/diacare.16.4.642; HARRIS MI, 1992, DIABETES CARE, V15, P815, DOI 10.2337/diacare.15.7.815; Hellgren MI, 2012, DIABETIC MED, V29, P1501, DOI 10.1111/j.1464-5491.2012.03664.x; Home P, 2006, DIABETIC MED, V23, P579; Hu FB, 2001, NEW ENGL J MED, V345, P790, DOI 10.1056/NEJMoa010492; Lee H, 2013, DIABETES RES CLIN PR, V99, P231, DOI 10.1016/j.diabres.2012.09.030; Lin JW, 2009, DIABETES CARE, V32, P2294, DOI 10.2337/dc09-0694; Lindstrom J, 2003, DIABETES CARE, V26, P725, DOI 10.2337/diacare.26.3.725; Makrilakis K, 2011, DIABETES METAB, V37, P144, DOI 10.1016/j.diabet.2010.09.006; Mannucci E, 2003, ACTA DIABETOL, V40, P181, DOI 10.1007/s00592-003-0109-8; Nakagami T, 2007, DIABETES RES CLIN PR, V76, P251, DOI 10.1016/j.diabres.2006.09.015; Pottie K, 2012, CAN MED ASSOC J, V184, P1687, DOI 10.1503/cmaj.120732; Rohlfing CL, 2002, DIABETES CARE, V25, P275, DOI 10.2337/diacare.25.2.275; Rohlfing CL, 2000, DIABETES CARE, V23, P187, DOI 10.2337/diacare.23.2.187; Saudek CD, 2008, J CLIN ENDOCR METAB, V93, P2447, DOI 10.1210/jc.2007-2174; Saydah SH, 2002, DIABETES CARE, V25, P1940, DOI 10.2337/diacare.25.11.1940; Schwarz PEH, 2009, HORM METAB RES, V41, P86, DOI 10.1055/s-0028-1087203; Simmons RK, 2012, LANCET, V380, P1741, DOI 10.1016/S0140-6736(12)61422-6; Soriguer F, 2012, MED CLIN-BARCELONA, V138, P371, DOI 10.1016/j.medcli.2011.05.025; Tankova T, 2011, DIABETES RES CLIN PR, V92, P46, DOI 10.1016/j.diabres.2010.12.020; Waugh N, 2007, HEALTH TECHNOL ASSES, V11, P1; Wild S, 2004, DIABETES CARE, V27, P1047, DOI 10.2337/diacare.27.5.1047; Winkler G, 2013, MED SCI MONITOR, V19, P67, DOI 10.12659/MSM.883747; Zhang L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097865	43	15	16	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2015	10	3							e0120382	10.1371/journal.pone.0120382	http://dx.doi.org/10.1371/journal.pone.0120382			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD9NQ	25790106	Green Submitted, Green Published, gold			2022-12-27	WOS:000351425400155
J	Kim, H; Kim, HK; Lee, S; Yun, SH				Kim, Hun; Kim, Hee-Kyoung; Lee, Seunghoon; Yun, Sung-Hwan			The White Collar Complex Is Involved in Sexual Development of Fusarium graminearum	PLOS ONE			English	Article							GIBBERELLA-ZEAE ANAMORPH; BLUE-LIGHT; SECONDARY METABOLISM; GENE; NEUROSPORA; PATHOGENICITY; PHOTORECEPTOR; REPRODUCTION; REGULATOR	Sexual spores (ascospores) of Fusarium graminearum, a homothallic ascomycetous fungus, are believed to be the primary inocula for epidemics of the diseases caused by this species in cereal crops. Based on the light requirement for the formation of fruiting bodies (perithecia) of F. graminearum under laboratory conditions, we explored whether photoreceptors play an important role in sexual development. Here, we evaluated the roles of three genes encoding putative photoreceptors [a phytochrome gene (FgFph) and two white collar genes (FgWc-1 and FgWc-2)] during sexual development in F. graminearum. For functional analyses, we generated transgenic strains lacking one or two genes from the self-fertile Z3643 strain. Unlike the wild-type (WT) and add-back strains, the single deletion strains (Delta FgWc-1 and Delta FgWc-2) produced fertile perithecia under constant light on complete medium (CM, an unfavorable medium for sexual development) as well as on carrot agar (a perithecial induction condition). The expression of mating-type (MAT) genes increased significantly in the gene deletion strains compared to the WT under both conditions. Deletion of FgFph had no significant effect on sexual development or MAT gene expression. In contrast, all of the deletion strains examined did not show significant changes in other traits such as hyphal growth, mycotoxin production, and virulence. A split luciferase assay confirmed the in vivo protein-protein interactions among three photoreceptors along with FgLaeA, a global regulator of secondary metabolism and fungal development. Introduction of an intact copy of the A. nidulans LreA and LreB genes, which are homologs of FgWc-1 and FgWc-2, into the Delta FgWc-1 and Delta FgWc-2 strains, respectively, failed to repress perithecia formation on CM in the gene deletion strains. Taken together, these results demonstrate that FgWc-1 and FgWc-2, two central components of the blue-light sensing system, negatively regulate sexual development in F. graminearum, which differs from the regulation pattern in A. nidulans.	[Kim, Hun] Korea Res Inst Chem Technol, Div Convergence Chem, Res Ctr Biobased Chem, Taejon 305606, South Korea; [Kim, Hee-Kyoung; Lee, Seunghoon; Yun, Sung-Hwan] Soonchunhyang Univ, Dept Med Biotechnol, Asan, South Korea	Korea Research Institute of Chemical Technology (KRICT); Soonchunhyang University	Yun, SH (corresponding author), Soonchunhyang Univ, Dept Med Biotechnol, Asan, South Korea.	sy14@sch.ac.kr			Rural Development Administration, Republic of Korea [PJ008210]; Strategic Initiative for Microbiomes in Agriculture and Food, Ministry of Agriculture, Food and Rural Affairs, Republic of Korea	Rural Development Administration, Republic of Korea(Rural Development Administration (RDA), Republic of Korea); Strategic Initiative for Microbiomes in Agriculture and Food, Ministry of Agriculture, Food and Rural Affairs, Republic of Korea	This research was supported by grants from the Next-Generation Bio Green21 Program (no. PJ008210), the Rural Development Administration, Republic of Korea, and from the Strategic Initiative for Microbiomes in Agriculture and Food, Ministry of Agriculture, Food and Rural Affairs, Republic of Korea. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambra R, 2004, FUNGAL GENET BIOL, V41, P688, DOI 10.1016/j.fgb.2004.02.004; [Anonymous], 2006, BLACKWELL PUB PROF; Avalos J, 2010, FUNGAL GENET BIOL, V47, P930, DOI 10.1016/j.fgb.2010.05.001; Ballario P, 1996, EMBO J, V15, P1650, DOI 10.1002/j.1460-2075.1996.tb00510.x; CAPPELLINI RA, 1965, MYCOLOGIA, V57, P962, DOI 10.2307/3756895; Casas-Flores S, 2004, MICROBIOL-SGM, V150, P3561, DOI 10.1099/mic.0.27346-0; Cheng P, 2003, P NATL ACAD SCI USA, V100, P5938, DOI 10.1073/pnas.1031791100; Corrochano LM, 2007, PHOTOCH PHOTOBIO SCI, V6, P725, DOI 10.1039/b702155k; Corrochano LM, 2010, CELLULAR AND MOLECULAR BIOLOGY OF FILAMENTOUS FUNGI, P417; Estrada AF, 2008, FUNGAL GENET BIOL, V45, P705, DOI 10.1016/j.fgb.2007.12.003; Froehlich AC, 2005, EUKARYOT CELL, V4, P2140, DOI 10.1128/EC.4.12.2140-2152.2005; Fuller KK, 2013, MBIO, V4, DOI 10.1128/mBio.00142-13; Guenther JC, 2005, MYCOLOGIA, V97, P229, DOI 10.3852/mycologia.97.1.229; Hou ZM, 2002, MOL PLANT MICROBE IN, V15, P1119, DOI 10.1094/MPMI.2002.15.11.1119; Idnurm A, 2005, PLOS BIOL, V3, P615, DOI 10.1371/journal.pbio.0030095; Kihara J, 2007, FEMS MICROBIOL LETT, V266, P110, DOI 10.1111/j.1574-6968.2006.00514.x; Kim H, 2014, J APPL MICROBIOL, V116, P380, DOI 10.1111/jam.12381; Kim HK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068441; Kim HK, 2012, CURR GENET, V58, P179, DOI 10.1007/s00294-012-0375-5; Kim H, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002113; Kim H, 2011, PLANT PATHOLOGY J, V27, P103, DOI 10.5423/PPJ.2011.27.2.103; Kim S, 2011, FUNGAL GENET BIOL, V48, P400, DOI 10.1016/j.fgb.2011.01.004; Lee J, 2012, MICROBIOL-SGM, V158, P1723, DOI 10.1099/mic.0.059188-0; Lee T, 2002, APPL ENVIRON MICROB, V68, P2148, DOI 10.1128/AEM.68.5.2148-2154.2002; Linden H, 1997, FUNGAL GENET BIOL, V22, P141, DOI 10.1006/fgbi.1997.1013; Linden H, 1997, EMBO J, V16, P98, DOI 10.1093/emboj/16.1.98; Loros JJ, 2006, MYCOTA, V13, P53; Namiki F, 2001, MOL PLANT MICROBE IN, V14, P580, DOI 10.1094/MPMI.2001.14.4.580; O'Donnell K, 2000, P NATL ACAD SCI USA, V97, P7905, DOI 10.1073/pnas.130193297; Purschwitz J, 2008, CURR BIOL, V18, P255, DOI 10.1016/j.cub.2008.01.061; Ruiz-Roldan MC, 2008, EUKARYOT CELL, V7, P1227, DOI 10.1128/EC.00072-08; Sutton J. C., 1982, Canadian Journal of Plant Pathology, V4, P195; Thoma F, 1999, EMBO J, V18, P6585, DOI 10.1093/emboj/18.23.6585; Trail F, 2002, MYCOLOGIA, V94, P181, DOI 10.2307/3761794; TSCHANZ AT, 1976, MYCOLOGIA, V68, P327, DOI 10.2307/3759003; Urban M, 2003, MOL PLANT PATHOL, V4, P347, DOI 10.1046/J.1364-3703.2003.00183.X; Yang T, 2014, FEMS MICROBIOL LETT, V352, P190, DOI 10.1111/1574-6968.12393; Yu HY, 2008, MICROBIOL-SGM, V154, P392, DOI 10.1099/mic.0.2007/012260-0; Yu JH, 2004, FUNGAL GENET BIOL, V41, P973, DOI 10.1016/j.fgb.2004.08.001; Yun SH, 1998, THESIS CORNELL U	40	16	18	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2015	10	3							e0120293	10.1371/journal.pone.0120293	http://dx.doi.org/10.1371/journal.pone.0120293			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9BN	25785736	Green Published, Green Submitted, gold			2022-12-27	WOS:000352138500164
J	Mesbah-Uddin, M; Elango, R; Banaganapalli, B; Shaik, NA; Al-Abbasi, FA				Mesbah-Uddin, Md.; Elango, Ramu; Banaganapalli, Babajan; Shaik, Noor Ahmad; Al-Abbasi, Fahad A.			In-Silico Analysis of Inflammatory Bowel Disease (IBD) GWAS Loci to Novel Connections	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; GENE-EXPRESSION; IMMUNE CELLS; RISK-FACTORS; VARIANTS; IDENTIFICATION; POLYMORPHISMS; PATHOGENESIS; ANNOTATION; SELECTION	Genome-wide association studies (GWASs) for many complex diseases, including inflammatory bowel disease (IBD), produced hundreds of disease-associated loci-the majority of which are noncoding. The number of GWAS loci is increasing very rapidly, but the process of translating single nucleotide polymorphisms (SNPs) from these loci to genomic medicine is lagging. In this study, we investigated 4,734 variants from 152 IBD associated GWAS loci (IBD associated 152 lead noncoding SNPs identified from pooled GWAS results + 4,582 variants in strong linkage-disequilibrium (LD) (r(2) >= 0.8) for EUR population of 1K Genomes Project) using four publicly available bioinformatics tools, e.g. dbPSHP, CADD, GWAVA, and RegulomeDB, to annotate and prioritize putative regulatory variants. Of the 152 lead noncoding SNPs, around 11% are under strong negative selection (GERP++ RS >= 2); and similar to 30% are under balancing selection (Tajima's D score > 2) in CEU population (1K Genomes Project)-though these regions are positively selected (GERP++ RS < 0) in mammalian evolution. The analysis of 4,734 variants using three integrative annotation tools produced 929 putative functional SNPs, of which 18 SNPs (from 15 GWAS loci) are in concordance with all three classifiers. These prioritized noncoding SNPs may contribute to IBD pathogenesis by dysregulating the expression of nearby genes. This study showed the usefulness of integrative annotation for prioritizing fewer functional variants from a large number of GWAS markers.	[Mesbah-Uddin, Md.; Al-Abbasi, Fahad A.] King Abdulaziz Univ, Fac Sci, Dept Biochem, Jeddah, Saudi Arabia; [Elango, Ramu; Banaganapalli, Babajan; Shaik, Noor Ahmad] King Abdulaziz Univ, Princess Al Jawhara Al Brahim Ctr Excellence Res, Jeddah, Saudi Arabia; [Shaik, Noor Ahmad] King Abdulaziz Univ, Fac Med, Dept Med Genet, Jeddah, Saudi Arabia	King Abdulaziz University; King Abdulaziz University; King Abdulaziz University	Mesbah-Uddin, M (corresponding author), King Abdulaziz Univ, Fac Sci, Dept Biochem, Jeddah, Saudi Arabia.	mdmesbah@gmail.com; alabassif@hotmail.com	Banaganapalli, Babajan/A-6282-2013; Shaik, Noor ahmad/ABE-4084-2020; Elango, Ramu/I-7812-2013; Al-Abbasi, Fahad/H-8940-2012; Elango, Ramu/C-7684-2014; Uddin, Mesbah/J-1276-2014	Banaganapalli, Babajan/0000-0001-8089-2210; Shaik, Noor ahmad/0000-0002-7133-656X; Elango, Ramu/0000-0003-4264-2135; Uddin, Mesbah/0000-0003-1846-0411; Al-Abbasi, Fahad/0000-0001-5609-4913				Amundsen SS, 2014, GENES IMMUN, V15, P355, DOI 10.1038/gene.2014.26; Ananthakrishnan AN, 2013, INFLAMM BOWEL DIS, V19, P2021, DOI 10.1097/MIB.0b013e318281f5c5; [Anonymous], 2014, R LANG ENV STAT COMP; Aujnarain Amiirah, 2013, Curr Gastroenterol Rep, V15, P326, DOI 10.1007/s11894-013-0326-4; Bader GD, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-2; Bank S, 2014, PHARMACOGENOMICS J, V14, P526, DOI 10.1038/tpj.2014.19; Biancheri P, 2013, TRENDS IMMUNOL, V34, P564, DOI 10.1016/j.it.2013.08.002; Boyle AP, 2012, GENOME RES, V22, P1790, DOI 10.1101/gr.137323.112; Buckley JP, 2013, INFLAMM BOWEL DIS, V19, P2725, DOI 10.1097/01.MIB.0000435442.07237.a4; Cader MZ, 2013, GUT, V62, P1653, DOI 10.1136/gutjnl-2012-303955; Chen H.B., 2013, VENNDIAGRAM GENERATE; Cooper GM, 2005, GENOME RES, V15, P901, DOI 10.1101/gr.3577405; Cooper GM, 2011, NAT REV GENET, V12, P628, DOI 10.1038/nrg3046; Cortes A, 2013, NAT GENET, V45, P730, DOI 10.1038/ng.2667; Davydov EV, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1001025; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Ellinghaus D, 2012, AM J HUM GENET, V90, P636, DOI 10.1016/j.ajhg.2012.02.020; Flicek P, 2014, NUCLEIC ACIDS RES, V42, pD749, DOI 10.1093/nar/gkt1196; Forrest ARR, 2014, NATURE, V507, P462, DOI 10.1038/nature13182; Fowler SA, 2014, J CROHNS COLITIS, V8, P845, DOI 10.1016/j.crohns.2014.01.003; Fransen K, 2010, HUM MOL GENET, V19, P3482, DOI 10.1093/hmg/ddq264; Hu ZB, 2013, NAT GENET, V45, P1499, DOI 10.1038/ng.2809; Hutchinson JN, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098464; Jacobson EM, 2005, ENDOCRINOLOGY, V146, P2684, DOI 10.1210/en.2004-1617; Jostins L, 2012, NATURE, V491, P119, DOI 10.1038/nature11582; Kabakchiev B, 2013, GASTROENTEROLOGY, V144, P1488, DOI 10.1053/j.gastro.2013.03.001; Kaser A, 2010, ANNU REV IMMUNOL, V28, P573, DOI 10.1146/annurev-immunol-030409-101225; Khor B, 2011, NATURE, V474, P307, DOI 10.1038/nature10209; Kircher M, 2014, NAT GENET, V46, P310, DOI 10.1038/ng.2892; Knights D, 2013, GUT, V62, P1505, DOI 10.1136/gutjnl-2012-303954; Li MLJ, 2014, NUCLEIC ACIDS RES, V42, pD910, DOI 10.1093/nar/gkt1052; Lill CM, 2013, J MED GENET, V50, P140, DOI 10.1136/jmedgenet-2012-101411; McCarthy JJ, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3005785; McCarthy MI, 2008, HUM MOL GENET, V17, pR156, DOI 10.1093/hmg/ddn289; McLaren W, 2010, BIOINFORMATICS, V26, P2069, DOI 10.1093/bioinformatics/btq330; Mokry M, 2014, GASTROENTEROLOGY, V146, P1040, DOI 10.1053/j.gastro.2013.12.003; Molodecky NA, 2012, GASTROENTEROLOGY, V142, P46, DOI 10.1053/j.gastro.2011.10.001; Ng SC, 2013, GUT, V62, P630, DOI 10.1136/gutjnl-2012-303661; Nguyen GC, 2014, J CROHNS COLITIS, V8, P288, DOI 10.1016/j.crohns.2013.09.001; Parkes M, 2013, NAT REV GENET, V14, P661, DOI 10.1038/nrg3502; Parmar AS, 2012, GENES IMMUN, V13, P474, DOI 10.1038/gene.2012.21; Paul DS, 2014, BIOESSAYS, V36, P191, DOI 10.1002/bies.201300126; Prideaux L, 2012, J GASTROEN HEPATOL, V27, P1266, DOI 10.1111/j.1440-1746.2012.07150.x; Ritchie GRS, 2014, NAT METHODS, V11, P294, DOI 10.1038/nmeth.2832; Robinson MR, 2014, TRENDS GENET, V30, P124, DOI 10.1016/j.tig.2014.02.003; Rosenthal SL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095152; Saito R, 2012, NAT METHODS, V9, P1069, DOI [10.1038/nmeth.2212, 10.1038/NMETH.2212]; Schaub MA, 2012, GENOME RES, V22, P1748, DOI 10.1101/gr.136127.111; Seal RL, 2011, NUCLEIC ACIDS RES, V39, pD514, DOI 10.1093/nar/gkq892; Sokolova EA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061032; Stenson PD, 2014, HUM GENET, V133, P1, DOI 10.1007/s00439-013-1358-4; TAJIMA F, 1989, GENETICS, V123, P585; Tang HY, 2014, NAT GENET, V46, P45, DOI 10.1038/ng.2827; Tsoi LC, 2012, NAT GENET, V44, P1341, DOI 10.1038/ng.2467; van der Valk ME, 2014, J CROHNS COLITIS, V8, P590, DOI 10.1016/j.crohns.2013.11.019; van der Valk ME, 2014, GUT, V63, P72, DOI 10.1136/gutjnl-2012-303376; Ward LD, 2012, NAT BIOTECHNOL, V30, P1095, DOI 10.1038/nbt.2422; Ward LD, 2012, SCIENCE, V337, P1675, DOI 10.1126/science.1225057; Ward LD, 2012, NUCLEIC ACIDS RES, V40, pD930, DOI 10.1093/nar/gkr917; Welter D, 2014, NUCLEIC ACIDS RES, V42, pD1001, DOI 10.1093/nar/gkt1229; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1; Wright FA, 2014, NAT GENET, V46, P430, DOI 10.1038/ng.2951; Yang M, 2009, HUM MUTAT, V30, P1320, DOI 10.1002/humu.21060; Yun Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097289; Zhang B, 2014, NAT GENET, V46, P533, DOI 10.1038/ng.2985; Zuberi K, 2013, NUCLEIC ACIDS RES, V41, pW115, DOI 10.1093/nar/gkt533	66	15	15	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2015	10	3							e0119420	10.1371/journal.pone.0119420	http://dx.doi.org/10.1371/journal.pone.0119420			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9BN	25786114	Green Published, gold, Green Submitted			2022-12-27	WOS:000352138500103
J	Pannkuk, EL; Risch, TS; Savary, BJ				Pannkuk, Evan L.; Risch, Thomas S.; Savary, Brett J.			Isolation and Identification of an Extracellular Subtilisin-Like Serine Protease Secreted by the Bat Pathogen Pseudogymnoascus destructans	PLOS ONE			English	Article							WHITE-NOSE SYNDROME; DATABASE; DIVERSIFICATION; PURIFICATION; PROTEINS; ENZYMES; BLAST	White nose syndrome (WNS) is a cutaneous fungal disease of bats. WNS is responsible for unprecedented mortalities in North American cave bat populations. There have been few descriptions of enzyme activities that may function in WNS host/pathogen interactions, while no study has isolated and described secreted proteases. To address the hypothesis that Pseudogymnoascus destructans secretes extracellular proteases that function in wing necrosis during WNS infection, the object of this study was to culture P. destructans on various media, then isolate and structurally identify those proteases accumulated stably in the culture medium. We found a single dominant protease activity on minimal nutrient broth enriched with protein substrates, which was strongly inhibited by phenylmethylsulfonyl fluoride. This P. destructans serine protease (PdSP1) was isolated by preparative isoelectric focusing and concanavalin A lectin affinity chromatography. PdSP1 showed a molecular weight 27,900 (estimated by SDS-PAGE), broad pH optimum 6-8, and temperature optimum 60 degrees C. Structural characterization of PdSP1 by MALDI-TOF MS, Orbitrap MS/MS, and Edman amino-terminal peptide sequencing matched it directly to a hypothetical protein accession from the sequenced P. destructans genome that is further identified as a MEROPS family S8A subtilisin-like serine peptidase. Two additional isoforms, PdSP2 and PdSP3, were identified in the P. destructans genome with 90% and 53% homology, respectively. P. destructans S8A serine proteases showed closer sequence conservation to P. pannorum and plant pathogenic fungi than to human pathogenic dermatophytes. Peptide-specific polyclonal antibodies developed from the PdSP1 sequence detected the protein in western blots. These subtilisin-like serine proteases are candidates for further functional studies in WNS host-pathogen interaction.	[Pannkuk, Evan L.] Arkansas State Univ, Grad Program Environm Sci, Jonesboro, AR USA; [Risch, Thomas S.] Arkansas State Univ, Dept Biol Sci, Jonesboro, AR USA; [Savary, Brett J.] Arkansas State Univ, Arkansas Biosci Inst, Jonesboro, AR USA	Arkansas State University; Arkansas State University; Arkansas State University	Pannkuk, EL (corresponding author), Georgetown Univ, Dept Biochem & Mol & Cellular Biol, Washington, DC 20057 USA.	elp44@georgetown.edu; bsavary@astate.edu	Pannkuk, Evan/ABF-6170-2021	Pannkuk, Evan/0000-0002-4953-9715	U.S. Fish and Wildlife Service State Wildlife Grant (Arkansas Game and Fish Commission) [AR T-40-R-1]; National Speleological Society; Center for North American Bat Research and Conservation at Indiana State University	U.S. Fish and Wildlife Service State Wildlife Grant (Arkansas Game and Fish Commission); National Speleological Society; Center for North American Bat Research and Conservation at Indiana State University	This study was funded by U.S. Fish and Wildlife Service 2012 State Wildlife Grant (Arkansas Game and Fish Commission, AR T-40-R-1), the National Speleological Society, and The Center for North American Bat Research and Conservation at Indiana State University. The MALDI-TOF MS instrument was provided through the NSF EPSCoR, RII: Arkansas ASSET Initiative P3 Center (EPS-0701890) in the Arkansas Biosciences Institute at Arkansas State University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Bagga S, 2004, GENE, V324, P159, DOI 10.1016/j.gene.2003.09.031; Blehert DS, 2009, SCIENCE, V323, P227, DOI 10.1126/science.1163874; Boyles JG, 2011, SCIENCE, V332, P41, DOI 10.1126/science.1201366; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Bragulla HH, 2009, J ANAT, V214, P516, DOI 10.1111/j.1469-7580.2009.01066.x; Byrum SD, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt822; Chaturvedi V, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010783; CHAVIRA R, 1984, ANAL BIOCHEM, V136, P446, DOI 10.1016/0003-2697(84)90242-2; Cryan PM, 2013, J WILDLIFE DIS, V49, P398, DOI 10.7589/2012-04-121; Cryan PM, 2010, BMC BIOL, V8, DOI 10.1186/1741-7007-8-135; Dereeper A, 2008, NUCLEIC ACIDS RES, V36, pW465, DOI 10.1093/nar/gkn180; Dereeper A, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-8; Frick WF, 2010, SCIENCE, V329, P679, DOI 10.1126/science.1188594; Fuller NW, 2011, ECOHEALTH, V8, P154, DOI 10.1007/s10393-011-0705-y; Gargas A, 2009, MYCOTAXON, V108, P147, DOI 10.5248/108.147; HARTLEY BS, 1960, ANNU REV BIOCHEM, V29, P45, DOI 10.1146/annurev.bi.29.070160.000401; Heithaus E.R., 1982, P327; Hu G, 2004, J EVOLUTION BIOL, V17, P1204, DOI 10.1111/j.1420-9101.2004.00786.x; Jain E, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-136; Johnson JS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112502; KLUGER MJ, 1970, COMP BIOCHEM PHYSIOL, V32, P219, DOI 10.1016/0010-406X(70)90935-7; Kunz TH, 2011, ANN NY ACAD SCI, V1223, P1, DOI 10.1111/j.1749-6632.2011.06004.x; Kwon H, 2013, INSECT BIOCHEM MOLEC, V43, P588, DOI 10.1016/j.ibmb.2013.03.005; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lorch JM, 2011, NATURE, V480, P376, DOI 10.1038/nature10590; Madej JP, 2013, ACTA ZOOL-STOCKHOLM, V94, P478, DOI 10.1111/j.1463-6395.2012.00578.x; Meteyer CU, 2012, VIRULENCE, V3, P583, DOI 10.4161/viru.22330; Meteyer CU, 2009, J VET DIAGN INVEST, V21, P411, DOI 10.1177/104063870902100401; Muszewska A, 2011, MOL BIOL EVOL, V28, P3395, DOI 10.1093/molbev/msr176; Pruitt KD, 2005, NUCLEIC ACIDS RES, V33, pD501, DOI 10.1093/nar/gki025; Raudabaugh DB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078300; RAWLINGS ND, 1993, BIOCHEM J, V290, P205, DOI 10.1042/bj2900205; Rawlings ND, 2012, NUCLEIC ACIDS RES, V40, pD343, DOI [10.1093/nar/gkr987, 10.1093/nar/gkt953]; Reichard JD, 2009, ACTA CHIROPTEROL, V11, P457, DOI 10.3161/150811009X485684; Reynolds HT, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086437; Savary BJ, 2002, J AGR FOOD CHEM, V50, P3553, DOI 10.1021/jf020060j; Savary BJ, 2011, RECOMBINANT GENE EXP; Shoulders MD, 2009, ANNU REV BIOCHEM, V78, P929, DOI 10.1146/annurev.biochem.77.032207.120833; U.S. Fish Wildlife Service [USFWS], 2012, N AM BAT DEATH TOLL; Vieira DF, 2004, ACTA BIOCH BIOPH SIN, V36, P798, DOI 10.1093/abbs/36.12.798; von Helversen O, 2003, BAT ECOLOGY, P346; Warnecke L, 2013, BIOL LETTERS, V9, DOI 10.1098/rsbl.2013.0177; Warnecke L, 2012, P NATL ACAD SCI USA, V109, P6999, DOI 10.1073/pnas.1200374109; Willis CKR, 2011, INTEGR COMP BIOL, V51, P364, DOI 10.1093/icb/icr076; Yang JK, 2007, APPL MICROBIOL BIOT, V75, P21, DOI 10.1007/s00253-007-0881-4; Yike I, 2011, MYCOPATHOLOGIA, V171, P299, DOI 10.1007/s11046-010-9386-2; Yuan HC, 2000, J APPL PHYSIOL, V89, P3, DOI 10.1152/jappl.2000.89.1.3	48	29	32	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2015	10	3							e0120508	10.1371/journal.pone.0120508	http://dx.doi.org/10.1371/journal.pone.0120508			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9BN	25785714	Green Submitted, Green Published, gold			2022-12-27	WOS:000352138500180
J	Wilkie, IC; Fassini, D; Cullora, E; Barbaglio, A; Tricarico, S; Sugni, M; Del Giacco, L; Carnevali, MDC				Wilkie, Iain C.; Fassini, Dario; Cullora, Emanuele; Barbaglio, Alice; Tricarico, Serena; Sugni, Michela; Del Giacco, Luca; Carnevali, M. Daniela Candia			Mechanical Properties of the Compass Depressors of the Sea-Urchin Paracentrotus lividus (Echinodermata, Echinoidea) and the Effects of Enzymes, Neurotransmitters and Synthetic Tensilin-Like Protein	PLOS ONE			English	Article							CRINOID METACRINUS-ROTUNDUS; CONNECTIVE-TISSUE; STRESS-RELAXATION; VARIABLE TENSILITY; COLLAGEN FIBRILS; CATCH APPARATUS; STIFFEST STATE; FINE-STRUCTURE; SPINE-JOINT; BODY-WALL	The compass depressors (CDs) of the sea-urchin lantern are ligaments consisting mainly of discontinuous collagen fibrils associated with a small population of myocytes. They are mutable collagenous structures, which can change their mechanical properties rapidly and reversibly under nervous control. The aims of this investigation were to characterise the baseline (i.e. unmanipulated) static mechanical properties of the CDs of Paracentrotus lividus by means of creep tests and incremental force-extension tests, and to determine the effects on their mechanical behaviour of a range of agents. Under constant load the CDs exhibited a three-phase creep curve, the mean coefficient of viscosity being 561 +/- 365 MPa. s. The stress-strain curve showed toe, linear and yield regions; the mean strain at the toelinear inflection was 0.86 +/- 0.61; the mean Young's modulus was 18.62 +/- 10.30 MPa; and the mean tensile strength was 8.14 +/- 5.73 MPa. Hyaluronidase from Streptomyces hyalurolyticus had no effect on creep behaviour, whilst chondroitinase ABC prolonged primary creep but had no effect on secondary creep or on any force-extension parameters; it thus appears that neither hyaluronic acid nor sulphated glycosaminoglycans have an interfibrillar load transfer function in the CD. Acetylcholine, the muscarinic agonists arecoline and methacholine, and the nicotinic agonists nicotine and 1-[1-(3,4-dimethyl-phenyl)-ethyl]-piperazine produced an abrupt increase in CD viscosity; the CDs were not differentially sensitive to muscarinic or nicotinic agonists. CDs showed either no, or no consistent, response to adrenaline, L-glutamic acid, 5-hydroxytryptamine and.-aminobutyric acid. Synthetic echinoid tensilin-like protein had a weak and inconsistent stiffening effect, indicating that, in contrast to holothurian tensilins, the echinoid molecule may not be involved in the regulation of collagenous tissue tensility. We compare in detail the mechanical behaviour of the CD with that of mammalian tendon and highlight its potential as a model system for investigating poorly understood aspects of the ontogeny and phylogeny of vertebrate collagenous tissues.	[Wilkie, Iain C.] Glasgow Caledonian Univ, Dept Life Sci, Glasgow G4 0BA, Lanark, Scotland; [Fassini, Dario; Cullora, Emanuele; Barbaglio, Alice; Tricarico, Serena; Sugni, Michela; Del Giacco, Luca; Carnevali, M. Daniela Candia] Univ Milan, Dipartimento Biosci, Milan, Italy	Glasgow Caledonian University; University of Milan	Wilkie, IC (corresponding author), Glasgow Caledonian Univ, Dept Life Sci, Glasgow G4 0BA, Lanark, Scotland.	i.wilkie@gcu.ac.uk	Candia Carnevali, M. Daniela/I-8048-2015; Del Giacco, Luca P C/A-5812-2014; Barbaglio, Alice/A-4365-2012	Candia Carnevali, M. Daniela/0000-0002-0215-8843; Barbaglio, Alice/0000-0003-0122-0331	Fondazione Cassa di Risparmio delle Provincie Lombarde (CARIPLO Foundation)	Fondazione Cassa di Risparmio delle Provincie Lombarde (CARIPLO Foundation)(Fondazione Cariplo)	This research received financial support from the Fondazione Cassa di Risparmio delle Provincie Lombarde (CARIPLO Foundation) Advanced Material Projects 2009 (MIMESIS - Marine Invertebrate Models & Engineered Substrates for Innovative bio-Scaffolds). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmadzadeh H, 2013, J BIOMECH, V46, P2497, DOI 10.1016/j.jbiomech.2013.07.008; Atkinson TS, 1999, J BIOMECH, V32, P907, DOI 10.1016/S0021-9290(99)00089-5; Bairati A, 2004, J STRUCT BIOL, V147, P159, DOI 10.1016/j.jsb.2004.03.004; Barbaglio A, 2012, MAR ENVIRON RES, V76, P108, DOI 10.1016/j.marenvres.2011.07.006; Barbaglio A, 2015, ZOOLOGY JEN IN PRESS, DOI [10.1016/j.zool.2015.01.001, DOI 10.1016/J.ZOOL.2015.01.001]; Benjamin M, 2008, J ANAT, V212, P211, DOI 10.1111/j.1469-7580.2008.00864.x; Birenheide R, 1996, BIOL BULL, V190, P231, DOI 10.2307/1542543; Birenheide R, 2000, P ROY SOC B-BIOL SCI, V267, P7, DOI 10.1098/rspb.2000.0959; BIRK DE, 1995, DEV DYNAM, V202, P229, DOI 10.1002/aja.1002020303; Brew K, 2000, BBA-PROTEIN STRUCT M, V1477, P267, DOI 10.1016/S0167-4838(99)00279-4; Brew K, 2010, BBA-MOL CELL RES, V1803, P55, DOI 10.1016/j.bbamcr.2010.01.003; Capadona JR, 2008, SCIENCE, V319, P1370, DOI 10.1126/science.1153307; COBB JLS, 1985, CELL TISSUE RES, V242, P685; COHEN RE, 1976, J BIOMECH, V9, P175, DOI 10.1016/0021-9290(76)90002-6; Dahners LE, 2000, J ORTHOPAED RES, V18, P532, DOI 10.1002/jor.1100180404; Davis FM, 2012, ANN BIOMED ENG, V40, P2541, DOI 10.1007/s10439-012-0596-2; Deutzmann R, 2000, DEVELOPMENT, V127, P4669; DeVente JE, 1997, J ELECTRON MICROSC, V46, P353, DOI 10.1093/oxfordjournals.jmicro.a023530; Di Benedetto C, 2014, MAR DRUGS, V12, P4912, DOI 10.3390/md12094912; Dolmatov IY, 2007, CELL TISSUE RES, V327, P371, DOI 10.1007/s00441-006-0314-1; Duenwald SE, 2009, ANN BIOMED ENG, V37, P1131, DOI 10.1007/s10439-009-9687-0; Ellers O, 1996, P ROY SOC B-BIOL SCI, V263, P39, DOI 10.1098/rspb.1996.0007; Eppell SJ, 2006, J R SOC INTERFACE, V3, P117, DOI 10.1098/rsif.2005.0100; ERNST S, 1995, CRIT REV BIOCHEM MOL, V30, P387, DOI 10.3109/10409239509083490; Eylers JP, 1988, ECHINODERM BIOL; Fessel G, 2009, MATRIX BIOL, V28, P503, DOI 10.1016/j.matbio.2009.08.002; Franchi M, 2007, THESCIENTIFICWORLDJO, V7, P404, DOI 10.1100/TSW.2007.92; GARRONE R, 1975, J ULTRA MOL STRUCT R, V52, P261, DOI 10.1016/S0022-5320(75)80117-1; GREENBERG AR, 1984, J BIOMECH, V17, P161, DOI 10.1016/0021-9290(84)90006-X; Hennebert E, 2010, J EXP BIOL, V213, P1162, DOI 10.1242/jeb.037903; HIDAKA M, 1983, J EXP BIOL, V103, P1; Hilgers H., 1982, Zoologische Jahrbuecher Abteilung fuer Anatomie und Ontogenie der Tiere, V107, P442; Humason G. L., 1979, ANIMAL TISSUE TECHNI; Hyman L. H., 1955, INVERTEBRATES; JEWELL BR, 1959, J PHYSIOL-LONDON, V149, P154, DOI 10.1113/jphysiol.1959.sp006332; JUNQUEIRA LCU, 1980, REV CAN BIOL EXPTL, V39, P157; Kannus P, 2000, SCAND J MED SCI SPOR, V10, P312, DOI 10.1034/j.1600-0838.2000.010006312.x; Kjaer M., 2008, P249; Koob TJ, 1999, J EXP BIOL, V202, P2291; Lanzavecchia G., 1988, P649; Liao HY, 1999, J BIOMECH, V32, P183, DOI 10.1016/S0021-9290(98)00169-9; Liao J, 2007, J BIOMECH, V40, P390, DOI 10.1016/j.jbiomech.2005.12.011; Lujan TJ, 2007, J ORTHOP RES, V25, P894, DOI 10.1002/jor.20351; Matsumura T, 1974, CONNECT TISSUE RES, V275, P451; MCBRIDE DJ, 1988, INT J BIOL MACROMOL, V10, P194, DOI 10.1016/0141-8130(88)90048-7; McKew M., 1999, P103; MORALES M, 1993, COMP BIOCHEM PHYS C, V105, P25, DOI 10.1016/0742-8413(93)90052-M; MOTOKAWA T, 1983, J ZOOL, V201, P223; MOTOKAWA T, 1984, J EXP BIOL, V109, P63; Motokawa T, 2004, BIOL BULL-US, V206, P4, DOI 10.2307/1543193; Motokawa T, 2003, BIOL BULL-US, V205, P261, DOI 10.2307/1543290; MOTOKAWA T, 1987, COMP BIOCHEM PHYS C, V86, P333, DOI 10.1016/0742-8413(87)90089-2; Motokawa T, 2011, BIOL BULL-US, V221, P280, DOI 10.1086/BBLv221n3p280; Ng BH, 2004, P I MECH ENG H, V218, P203, DOI 10.1243/095441104323118923; Nichols D., 1969, ECHINODERMS; ONeill PL, 1995, MAR FRESHW BEHAV PHY, V25, P245, DOI 10.1080/10236249509378921; Park Y, 1997, BBA-PROTEIN STRUCT M, V1337, P217, DOI 10.1016/S0167-4838(96)00167-7; PETERS BH, 1985, CELL TISSUE RES, V239, P219, DOI 10.1007/BF00214922; Pioletti DP, 2000, J BIOMECH, V33, P1729, DOI 10.1016/S0021-9290(00)00128-7; Redaelli A, 2003, J BIOMECH, V36, P1555, DOI 10.1016/S0021-9290(03)00133-7; Ribeiro AR, 2012, BIOINTERPHASES, V7, DOI 10.1007/s13758-012-0038-6; Ribeiro AR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049016; Ribeiro AR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024822; Rigozzi S, 2013, J BIOMECH, V46, P813, DOI 10.1016/j.jbiomech.2012.11.017; Ritty TM, 2003, STRUCTURE, V11, P1179, DOI 10.1016/S0969-2126(03)00181-3; SAITA A, 1969, Istituto Lombardo Accademia di Scienze e Lettere Rendiconti Scienze Biologische e Mediche B, V103, P297; Santos R, 2005, J EXP BIOL, V208, P2277, DOI 10.1242/jeb.01641; Scott JE, 2003, J PHYSIOL-LONDON, V553, P335, DOI 10.1113/jphysiol.2003.050179; SCOTT JE, 1988, BIOCHEM J, V252, P313, DOI 10.1042/bj2520313; Screen HRC, 2004, P I MECH ENG H, V218, P109, DOI 10.1243/095441104322984004; Shen ZLL, 2010, BIOPHYS J, V99, P1986, DOI 10.1016/j.bpj.2010.07.021; Silver FH, 2008, COLLAGEN STRUCTURE B; SMITH DS, 1981, TISSUE CELL, V13, P299, DOI 10.1016/0040-8166(81)90007-0; STAUBER M, 1993, ZOOMORPHOLOGY, V113, P137, DOI 10.1007/BF00403091; Szczesny SE, 2014, ACTA BIOMATER, V10, P2582, DOI 10.1016/j.actbio.2014.01.032; Takemae N, 2005, BIOL BULL-US, V208, P29, DOI 10.2307/3593098; Tamori M, 2006, J EXP BIOL, V209, P1594, DOI 10.1242/jeb.02178; Theis N, 2012, J ELECTROMYOGR KINES, V22, P947, DOI 10.1016/j.jelekin.2012.06.004; Thurmond FA, 1997, CONNECT TISSUE RES, V36, P211, DOI 10.3109/03008209709160221; Tipper JR, 2002, MATRIX BIOL, V21, P625, DOI 10.1016/S0945-053X(02)00090-2; Tregear RT., 1966, PHYS FUNCTIONS SKIN; Tricarico S, 2013, THESIS U MILAN; Tricarico S, 2012, ZOOSYMPOSIA, V7, P279, DOI 10.11646/zoosymposia.7.1.26; TROTTER JA, 1994, CELL TISSUE RES, V275, P451, DOI 10.1007/BF00318814; TROTTER JA, 1989, CELL TISSUE RES, V258, P527; Trowbridge JM, 2002, GLYCOBIOLOGY, V12, p117R, DOI 10.1093/glycob/cwf066; Ubukata K, 2001, ECHINODERMS 2000, P555; Vanderby R, 2003, J BIOMECH, V36, P1523, DOI 10.1016/S0021-9290(03)00132-5; Vincent J., 2012, STRUCTURAL BIOMATERI, DOI 10.2307/j.ctt7tbgv.; Vogel S, 2013, COMP BIOMECHANICS, V2nd; Wang JHC, 2006, J BIOMECH, V39, P1563, DOI 10.1016/j.jbiomech.2005.05.011; WANG XT, 1995, J EXP BIOL, V198, P831; Wilkie I.C., 2004, P371, DOI 10.1201/9780203970881.ch61; Wilkie IC, 2010, J EXP BIOL, V213, P2104, DOI 10.1242/jeb.039578; Wilkie IC, 1995, ECHINODERM RESEARCH 1995, P147; WILKIE IC, 1990, ECHINODERM RESEARCH, P301; Wilkie IC, 1998, ZOOMORPHOLOGY, V118, P87, DOI 10.1007/s004350050060; WILKIE IC, 1992, ZOOMORPHOLOGY, V112, P143, DOI 10.1007/BF01633105; Wilkie IC, 2005, PROG MOLEC, V39, P221; WILKIE IC, 1993, COMP BIOCHEM PHYS A, V105, P493, DOI 10.1016/0300-9629(93)90425-4; WILKIE IC, 1992, J ZOOL, V228, P5, DOI 10.1111/j.1469-7998.1992.tb04429.x; WILKIE IC, 1984, MAR BEHAV PHYSIOL, V11, P1, DOI 10.1080/10236248409387032; WILKIE IC, 1992, ECHINODERM RESEARCH 1991, P99; Wilkie IC, 1976, THESIS U GLASGOW; Wren TAL, 2003, ANN BIOMED ENG, V31, P710, DOI 10.1114/1.1569267; Yamada A, 2010, J EXP BIOL, V213, P3416, DOI 10.1242/jeb.044149; Yoon J. H., 2005, Journal of Musculoskeletal & Neuronal Interactions, V5, P22	107	9	9	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2015	10	3							e0120339	10.1371/journal.pone.0120339	http://dx.doi.org/10.1371/journal.pone.0120339			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9BN	25786033	Green Published, gold			2022-12-27	WOS:000352138500166
J	Yuan, LX; Sun, LG; Fortin, D; Wang, YH; Yin, XB				Yuan, Linxi; Sun, Liguang; Fortin, Danielle; Wang, Yuhong; Yin, Xuebin			Microscale Characterization and Trace Element Distribution in Bacteriogenic Ferromanganese Coatings on Sand Grains from an Intertidal Zone of the East China Sea	PLOS ONE			English	Article							RARE-EARTH-ELEMENTS; MANGANESE OXIDE; PINAL-CREEK; IRON-OXYHYDROXIDE; DIAGENETIC IRON; NATURAL-WATERS; HEAVY-METALS; HUMIC-ACID; MN OXIDES; CERIUM	An ancient wood layer dated at about 5600 yr BP by accelerator mass spectrometry (AMS) C-14 was discovered in an intertidal zone of the East China Sea. Extensive and horizontally stratified sediments with black color on the top and yellowish-red at the bottom, and some nodule-cemented concretions with brown surface and black inclusions occurred in this intertidal zone. Microscale analysis methods were employed to study the microscale characterization and trace element distribution in the stratified sediments and concretions. Light microscopy, scanning electron microscopy (SEM) and backscattered electron imaging (BSE) revealed the presence of different coatings on the sand grains. The main mineral compositions of the coatings were ferrihydrite and goethite in the yellowish-red parts, and birnessite in the black parts using X-ray powder diffraction (XRD). SEM observations showed that bacteriogenic products and bacterial remnants extensively occurred in the coatings, indicating that bacteria likely played an important role in the formation of ferromanganese coatings. Post-Archean Australian Shale (PAAS)-normalized middle rare earth element (MREE) enrichment patterns of the coatings indicated that they were caused by two sub-sequential processes: (1) preferentially release of Fe-Mn from the beach rocks by fermentation of ancient woods and colloidal flocculation in the mixing water zone and (2) preferential adsorption of MREE by Fe-Mn oxyhydroxides from the seawater. The chemical results indicated that the coatings were enriched with Sc, V, Cr, Co, Ni, Cu, Zn, Ba, especially with respect to Co, Ni. The findings of the present study provide an insight in the microscale features of ferromanganese coatings and the Fe-Mn biogeochemical cycling during the degradation of buried organic matter in intertidal zones or shallow coasts.	[Yuan, Linxi; Sun, Liguang; Yin, Xuebin] Univ Sci & Technol China, Sch Earth & Space Sci, Hefei 230026, Peoples R China; [Yuan, Linxi; Yin, Xuebin] Jiangsu Bioengn Res Ctr Selenium, Suzhou 215123, Peoples R China; [Yuan, Linxi; Yin, Xuebin] Univ Sci & Technol China, Suzhou Inst Adv Study, Adv Lab Selenium & Human Hlth, Suzhou 215123, Peoples R China; [Fortin, Danielle] Univ Ottawa, Dept Earth Sci, Ottawa, ON K1N 6N5, Canada; [Wang, Yuhong] NIH, Bethesda, MD 20892 USA	Chinese Academy of Sciences; University of Science & Technology of China, CAS; Chinese Academy of Sciences; University of Science & Technology of China, CAS; University of Ottawa; National Institutes of Health (NIH) - USA	Yuan, LX (corresponding author), Univ Sci & Technol China, Sch Earth & Space Sci, Hefei 230026, Peoples R China.	yuanli@ustc.edu.cn; slg@ustc.edu.cn	Yuan, Linxi/Y-9313-2019	Yuan, Linxi/0000-0002-1043-8933	Natural Science Youth Foundation of Jiangsu Province for Youth, China [BK2012202]; National 973 Program [2010CB428902]; Chinese Postdoctoral Science Foundation [2013M540518]; Jiangsu Provincial Postdoctoral Science Foundation [1302080C]	Natural Science Youth Foundation of Jiangsu Province for Youth, China; National 973 Program(National Basic Research Program of China); Chinese Postdoctoral Science Foundation(China Postdoctoral Science Foundation); Jiangsu Provincial Postdoctoral Science Foundation(China Postdoctoral Science Foundation)	This work was supported by Natural Science Youth Foundation of Jiangsu Province for Youth, China (BK2012202) (http://www.jstd.gov.cn/), National 973 Program (Grant No 2010CB428902) (http://www.most.gov.cn/), Chinese Postdoctoral Science Foundation (2013M540518) (http://res.chinapostdoctor.org.cn/BshWeb/index.shtml) and Jiangsu Provincial Postdoctoral Science Foundation (1302080C) (http://www.jsbsh.gov.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bargar JR, 2009, GEOCHIM COSMOCHIM AC, V73, P889, DOI 10.1016/j.gca.2008.10.036; Bargar JR, 2000, GEOCHIM COSMOCHIM AC, V64, P2775, DOI 10.1016/S0016-7037(00)00368-9; Bau M, 1999, GEOCHIM COSMOCHIM AC, V63, P67, DOI 10.1016/S0016-7037(99)00014-9; Bau M, 1996, GEOCHIM COSMOCHIM AC, V60, P1709, DOI 10.1016/0016-7037(96)00063-4; Bau M, 1998, CHEM GEOL, V151, P293, DOI 10.1016/S0009-2541(98)00086-2; Bau M, 1996, CONTRIB MINERAL PETR, V123, P323, DOI 10.1007/s004100050159; Bilinski H, 2002, AM MINERAL, V87, P580; Davranche M, 2005, GEOCHIM COSMOCHIM AC, V69, P4825, DOI 10.1016/j.gca.2005.06.005; Davranche M, 2004, J COLLOID INTERF SCI, V277, P271, DOI 10.1016/j.jcis.2004.04.007; Davranche M, 2008, CHEM GEOL, V247, P154, DOI 10.1016/j.chemgeo.2007.10.010; De Carlo EH, 1997, AQUAT GEOCHEM, V3, P357, DOI 10.1023/A:1009664626181; Duckworth OW, 2009, BIOMETALS, V22, P605, DOI 10.1007/s10534-009-9220-9; Dzombak DA, 1990, SURFACE COMPLEXATION, P89; Feng JL, 2010, CHEM GEOL, V271, P112, DOI 10.1016/j.chemgeo.2010.01.003; Feng XH, 2010, GEOCHIM COSMOCHIM AC, V74, P3232, DOI 10.1016/j.gca.2010.03.005; Fernandez-Caliani JC, 2009, GEODERMA, V149, P393, DOI 10.1016/j.geoderma.2009.01.004; Ferris FG, 2005, GEOMICROBIOL J, V22, P79, DOI 10.1080/01490450590945861; Ferris FG, 2000, APPL GEOCHEM, V15, P1035, DOI 10.1016/S0883-2927(99)00093-1; Fortin D, 2005, EARTH-SCI REV, V72, P1, DOI 10.1016/j.earscirev.2005.03.002; FORTIN D, 1993, GEOCHIM COSMOCHIM AC, V57, P4391, DOI 10.1016/0016-7037(93)90490-N; Fortin D, 2003, RECENT RES DEV MINER, P47; Frierdich AJ, 2011, CHEM GEOL, V284, P82, DOI 10.1016/j.chemgeo.2011.02.009; Fuller CC, 2000, ENVIRON SCI TECHNOL, V34, P1150, DOI 10.1021/es990714d; HALLBECK L, 1991, J GEN MICROBIOL, V137, P2657, DOI 10.1099/00221287-137-11-2657; Johannesson KH, 1996, CHEM GEOL, V133, P125, DOI 10.1016/S0009-2541(96)00072-1; Johannesson KH, 1999, GEOCHIM COSMOCHIM AC, V63, P153, DOI 10.1016/S0016-7037(98)00291-9; Jones B, 2009, J SEDIMENT RES, V79, P689, DOI 10.2110/jsr.2009.071; Kappler A, 2005, REV MINERAL GEOCHEM, V59, P85, DOI 10.2138/rmg.2005.59.5; Kappler A, 2004, GEOCHIM COSMOCHIM AC, V68, P1217, DOI 10.1016/j.gca.2003.09.006; Kappler A, 2004, FEMS MICROBIOL ECOL, V47, P85, DOI 10.1016/S0168-6496(03)00245-9; Kay JT, 2001, ENVIRON SCI TECHNOL, V35, P4719, DOI 10.1021/es010514d; KOEPPENKASTROP D, 1992, CHEM GEOL, V95, P251, DOI 10.1016/0009-2541(92)90015-W; Koschinsky A, 2003, MAR GEOL, V198, P331, DOI 10.1016/S0025-3227(03)00122-1; Lack JG, 2002, APPL ENVIRON MICROB, V68, P2704, DOI 10.1128/AEM.68.6.2704-2710.2002; Lawrence MG, 2006, MAR CHEM, V100, P147, DOI 10.1016/j.marchem.2005.11.007; Learman DR, 2011, NAT GEOSCI, V4, P95, DOI [10.1038/ngeo1055, 10.1038/NGEO1055]; Leybourne MI, 2008, GEOCHIM COSMOCHIM AC, V72, P5962, DOI 10.1016/j.gca.2008.09.022; Leybourne MI, 2001, CAN MINERAL, V39, P1597, DOI 10.2113/gscanmin.39.6.1597; Manceau A, 2007, GEOCHIM COSMOCHIM AC, V71, P95, DOI 10.1016/j.gca.2006.08.036; Manceau A, 2012, AM MINERAL, V97, P816, DOI 10.2138/am.2012.3903; MCKENZIE RM, 1980, AUST J SOIL RES, V18, P61, DOI 10.1071/SR9800061; McLemnan SM, 1989, REV MINERALOGY, V21, P169; Melim LA, 2008, J CAVE KARST STUD, V70, P135; Miller AZ, 2012, CHEM GEOL, V322, P181, DOI 10.1016/j.chemgeo.2012.07.005; MOFFETT JW, 1994, GEOCHIM COSMOCHIM AC, V58, P695, DOI 10.1016/0016-7037(94)90499-5; Morgan JJ, 2000, MET IONS BIOL SYST, V37, P1; Murray KJ, 2007, APPL ENVIRON MICROB, V73, P6905, DOI 10.1128/AEM.00971-07; Palumbo B, 2001, CHEM GEOL, V173, P257, DOI 10.1016/S0009-2541(00)00284-9; Pattan JN, 2005, CHEM GEOL, V221, P260, DOI 10.1016/j.chemgeo.2005.06.009; Penn RL, 2001, GEOLOGY, V29, P843, DOI 10.1130/0091-7613(2001)029<0843:IOCOSG>2.0.CO;2; Piepenbrock A, 2014, ENVIRON SCI TECHNOL, V48, P1656, DOI 10.1021/es404497h; Post JE, 1999, P NATL ACAD SCI USA, V96, P3447, DOI 10.1073/pnas.96.7.3447; Shimizu M, 2013, ENVIRON SCI TECHNOL, V47, P13375, DOI 10.1021/es402812j; Sholkovitz ER, 1995, AQUAT GEOCHEM, V1, P1, DOI 10.1007/BF01025229; SKINNER HCW, 1993, PRECAMBRIAN RES, V61, P209, DOI 10.1016/0301-9268(93)90114-H; Spilde MN, 2005, GEOMICROBIOL J, V22, P99, DOI 10.1080/01490450590945889; Spiro TG, 2010, ACCOUNTS CHEM RES, V43, P2, DOI 10.1021/ar800232a; Stumm W., 1996, AQUATIC CHEM CHEM EQ, P672; Swartz CH, 1997, GEOCHIM COSMOCHIM AC, V61, P707, DOI 10.1016/S0016-7037(96)00376-6; Takahashi Y, 2000, GEOCHIM COSMOCHIM AC, V64, P2929, DOI 10.1016/S0016-7037(00)00403-8; Takahashi Y, 2007, GEOCHIM COSMOCHIM AC, V71, P984, DOI 10.1016/j.gca.2006.11.016; Tan H, 2010, APPL GEOCHEM, V25, P389, DOI 10.1016/j.apgeochem.2009.12.006; Tani Y, 2003, APPL GEOCHEM, V18, P1541, DOI 10.1016/S0883-2927(03)00075-1; Tazaki K, 2000, CLAY CLAY MINER, V48, P511, DOI 10.1346/CCMN.2000.0480503; Tebo BM, 2004, ANNU REV EARTH PL SC, V32, P287, DOI 10.1146/annurev.earth.32.101802.120213; Tebo BM, 1997, REV MINERAL, V35, P225; Tessier A, 1996, GEOCHIM COSMOCHIM AC, V60, P387, DOI 10.1016/0016-7037(95)00413-0; Toner B, 2006, GEOCHIM COSMOCHIM AC, V70, P27, DOI 10.1016/j.gca.2005.08.029; Webb SM, 2005, AM MINERAL, V90, P1342, DOI 10.2138/am.2005.1669; Webb SM, 2005, P NATL ACAD SCI USA, V102, P5558, DOI 10.1073/pnas.0409119102; White WB, 2009, J CAVE KARST STUD, V71, P136; Wu CY, 2013, MICROB BIOTECHNOL, V6, P141, DOI 10.1111/1751-7915.12003; Wu ZJ, 2008, CHINESE SCI BULL, V53, P1894, DOI 10.1007/s11434-008-0082-2; Wu ZJ, 2009, GEOCHEM J, V43, P167, DOI 10.2343/geochemj.1.0016; Yuan LX, 2009, CHINESE SCI BULL, V54, P1931, DOI 10.1007/s11434-009-0334-9	75	7	8	2	66	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2015	10	3							e0119080	10.1371/journal.pone.0119080	http://dx.doi.org/10.1371/journal.pone.0119080			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9BN	25786213	Green Submitted, Green Published, gold			2022-12-27	WOS:000352138500071
J	Bailey, EL; Bazigou, E; Sowinski, PSJ; Weinberg, PD				Bailey, Emma L.; Bazigou, Eleni; Sowinski, Piotr S. J.; Weinberg, Peter D.			Mass Transport Properties of the Rabbit Aortic Wall	PLOS ONE			English	Article							TERM ALBUMIN UPTAKE; THORACIC AORTA; BLOOD-FLOW; SHEAR-STRESS; PERMEABILITY; BRANCHES; AGE; PATTERNS; SITES; INTERCOSTAL	Uptake of circulating macromolecules by the arterial wall may be a critical step in atherogenesis. Here we investigate the age-related changes in patterns of uptake that occur in the rabbit. In immature aortas, uptake was elevated in a triangle downstream of branch ostia, a region prone to disease in immature rabbits and children. By 16-22 months, uptake was high lateral to ostia, as is lesion prevalence in mature rabbits and young adults. In older rabbits there was a more upstream pattern, similar to the disease distribution in older people. These variations were predominantly caused by the branches themselves, rather than reflecting larger patterns within which the branches happened to be situated (as may occur with patterns of haemodynamic wall shear stress). The narrow streaks of high uptake reported in some previous studies were shown to be post mortem artefacts. Finally, heparin (which interferes with the NO pathway) had no effect on the difference in uptake between regions upstream and downstream of branches in immature rabbits but reversed the difference in older rabbits, as does inhibiting NO synthesis directly. Nevertheless, examination of uptake all around the branch showed that changes occurred at both ages and that they were quite subtle, potentially explaining why inhibiting NO has only minor effects on lesion patterns in mature rabbits and contradicting the earlier conclusion that mechanotransduction pathways change with age. We suggest that recently-established changes in the patterns of haemodynamic forces themselves are more likely to account for the age-dependence of uptake patterns.	[Bailey, Emma L.; Bazigou, Eleni; Sowinski, Piotr S. J.; Weinberg, Peter D.] Univ London Imperial Coll Sci Technol & Med, Dept Bioengn, London, England	Imperial College London	Weinberg, PD (corresponding author), Univ London Imperial Coll Sci Technol & Med, Dept Bioengn, London, England.	p.weinberg@imperial.ac.uk			British Heart Foundation [RG11/5/28743]; British Heart Foundation [RG/11/5/28743] Funding Source: researchfish	British Heart Foundation(British Heart Foundation); British Heart Foundation(British Heart Foundation)	The study was funded by Programme Grant RG11/5/28743 from the British Heart Foundation www.bhf.org.uk. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anitschkow N.N., 1933, ARTERIOSCLEROSIS, P271; BALDWIN AL, 1982, ARTERY, V10, P420; BARAKAT AI, 1992, J BIOMECH ENG-T ASME, V114, P283, DOI 10.1115/1.2891385; Barnes SE, 2001, EXP MOL PATHOL, V71, P161, DOI 10.1006/exmp.2001.2395; Bond AR, 2011, ARTERIOSCL THROM VAS, V31, P543, DOI 10.1161/ATVBAHA.110.219683; BRATZLER RL, 1977, CIRC RES, V40, P182, DOI 10.1161/01.RES.40.2.182; Clarke LA, 2012, ATHEROSCLEROSIS, V224, P417, DOI 10.1016/j.atherosclerosis.2012.08.001; Ewins BA, 2002, J BIOMECH ENG-T ASME, V124, P684, DOI 10.1115/1.1517063; Forster BA, 1997, ARTERIOSCL THROM VAS, V17, P1361, DOI 10.1161/01.ATV.17.7.1361; HERRMANN RA, 1994, ARTERIOSCLER THROMB, V14, P313, DOI 10.1161/01.ATV.14.2.313; Mohamied Y, 2014, ANN BIOMED ENG; Otsu N, 1979, IEEE T SYST MAN CYB, V9; Peiffer V, 2013, J BIOMECH, V46, P2651, DOI 10.1016/j.jbiomech.2013.08.003; Peiffer V, 2012, ATHEROSCLEROSIS, V223, P114, DOI 10.1016/j.atherosclerosis.2012.04.020; SCHWENKE DC, 1988, CIRC RES, V62, P699, DOI 10.1161/01.RES.62.4.699; Sebkhi A, 1996, ARTERIOSCL THROM VAS, V16, P317, DOI 10.1161/01.ATV.16.2.317; SEBKHI A, 1994, ATHEROSCLEROSIS, V106, P1, DOI 10.1016/0021-9150(94)90077-9; SINZINGER H, 1980, BLOOD VESSELS, V17, P44; Sloop GD, 1998, ATHEROSCLEROSIS, V141, P153, DOI 10.1016/S0021-9150(98)00167-1; Staughton TJ, 2004, TRENDS IN ATHEROSCLEROSIS RESEARCH, P123; Staughton TJ, 2004, EXP PHYSIOL, V89, P109, DOI 10.1113/expphysiol.2003.002635; Staughton TJ, 2001, AM J PHYSIOL-HEART C, V281, pH53, DOI 10.1152/ajpheart.2001.281.1.H53; VanTeeffelen JWGE, 2007, HYPERTENSION, V50, P261, DOI 10.1161/HYPERTENSIONAHA.107.089250; Vincent PE, 2011, J R SOC INTERFACE, V8, P1708, DOI 10.1098/rsif.2011.0116; Weinberg PD, 2004, J VASC RES, V41, P1, DOI 10.1159/000076124	25	6	6	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2015	10	3							e0120363	10.1371/journal.pone.0120363	http://dx.doi.org/10.1371/journal.pone.0120363			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7QC	25781997	Green Submitted, Green Published, Green Accepted, gold			2022-12-27	WOS:000351284600154
J	Xu, JS; Menon, SN; Singh, R; Garnier, NB; Sinha, S; Pumir, A				Xu, Jinshan; Menon, Shakti N.; Singh, Rajeev; Garnier, Nicolas B.; Sinha, Sitabhra; Pumir, Alain			The Role of Cellular Coupling in the Spontaneous Generation of Electrical Activity in Uterine Tissue	PLOS ONE			English	Article							CAJAL-LIKE CELLS; SMOOTH-MUSCLE; INTERSTITIAL-CELLS; GAP-JUNCTIONS; RAT UTERUS; MYOCYTES; FIBROBLASTS; PROPAGATION; CALCIUM; CONTRACTIONS	The spontaneous emergence of contraction-inducing electrical activity in the uterus at the beginning of labor remains poorly understood, partly due to the seemingly contradictory observation that isolated uterine cells are not spontaneously active. It is known, however, that the expression of gap junctions increases dramatically in the approach to parturition, by more than one order of magnitude, which results in a significant increase in inter-cellular electrical coupling. In this paper, we build upon previous studies of the activity of electrically excitable smooth muscle cells (myocytes) and investigate the mechanism through which the coupling of these cells to electrically passive cells results in the generation of spontaneous activity in the uterus. Using a recently developed, realistic model of uterine muscle cell dynamics, we investigate a system consisting of a myocyte coupled to passive cells. We then extend our analysis to a simple two-dimensional lattice model of the tissue, with each myocyte being coupled to its neighbors, as well as to a random number of passive cells. We observe that different dynamical regimes can be observed over a range of gap junction conductances: at low coupling strength, corresponding to values measured long before delivery, the activity is confined to cell clusters, while the activity for high coupling, compatible with values measured shortly before delivery, may spread across the entire tissue. Additionally, we find that the system supports the spontaneous generation of spiral wave activity. Our results are both qualitatively and quantitatively consistent with observations from in vitro experiments. In particular, we demonstrate that the increase in inter-cellular electrical coupling observed experimentally strongly facilitates the appearance of spontaneous action potentials that may eventually lead to parturition.	[Xu, Jinshan] Zhejiang Univ Technol, Coll Comp Sci, Hangzhou, Zhejiang, Peoples R China; [Menon, Shakti N.; Singh, Rajeev; Sinha, Sitabhra] Inst Math Sci, Madras 600113, Tamil Nadu, India; [Garnier, Nicolas B.; Pumir, Alain] Ecole Normale Super Lyon, Phys Lab, F-69007 Lyon, France; [Pumir, Alain] Max Planck Inst Dynam & Self Org, D-37073 Gottingen, Germany	Zhejiang University of Technology; Institute of Mathematical Sciences (IMSc) India; Ecole Normale Superieure de Lyon (ENS de LYON); Max Planck Society	Pumir, A (corresponding author), Ecole Normale Super Lyon, Phys Lab, F-69007 Lyon, France.	alain.pumir@ens-lyon.fr	Pumir, Alain/AAH-6566-2020; Garnier, Nicolas B/H-4439-2012; Singh, Rajeev/F-8854-2019	Garnier, Nicolas B/0000-0002-1094-7201; Singh, Rajeev/0000-0002-0768-6549; Menon, Shakti/0000-0001-5307-2153; Sinha, Sitabhra/0000-0002-3004-1079	Chinese National Science Foundation [11405145]; Institute of Mathematical Sciences in Chennai; Ecole Normale Superieure de Lyon; CNRS; Humboldt foundation; JoriSS exchange program from ENS Lyon; Indo-French Center for Applied Mathematics program	Chinese National Science Foundation(National Natural Science Foundation of China (NSFC)); Institute of Mathematical Sciences in Chennai; Ecole Normale Superieure de Lyon(Grant Agency of the Czech Republic); CNRS(Centre National de la Recherche Scientifique (CNRS)); Humboldt foundation(Alexander von Humboldt Foundation); JoriSS exchange program from ENS Lyon; Indo-French Center for Applied Mathematics program(French National Research Agency (ANR))	JX is supported by the Chinese National Science Foundation (11405145). RS, SNM and SS received funding from their institution, the Institute of Mathematical Sciences in Chennai. NBG and AP received funding from their institution, the Ecole Normale Superieure de Lyon and CNRS. AP received support from the Humboldt foundation. Computer time on the "Annapurna" supercomputer was provided by the Institute for Mathematical Science in Chennai. Collaborative work was funded by the JoriSS exchange program from ENS Lyon, and by the Indo-French Center for Applied Mathematics program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BENGTSSON B, 1984, AM J PHYSIOL, V246, pC216, DOI 10.1152/ajpcell.1984.246.3.C216; Bub G, 2002, PHYS REV LETT, V88, DOI 10.1103/PhysRevLett.88.058101; Burdyga T, 2007, ANN NY ACAD SCI, V1101, P85, DOI 10.1196/annals.1389.002; Bursztyn L, 2007, ANN NY ACAD SCI, V1101, P110, DOI 10.1196/annals.1389.025; Chen W, 2009, EPL-EUROPHYS LETT, V86, DOI 10.1209/0295-5075/86/18001; Chilton L, 2007, J PHYSIOL-LONDON, V583, P225, DOI 10.1113/jphysiol.2007.135038; CSAPO IA, 1963, J PHYSIOL-LONDON, V165, P575, DOI 10.1113/jphysiol.1963.sp007081; Doring B, 2006, J CELL SCI, V119, P1715, DOI 10.1242/jcs.02892; Duquette RA, 2005, BIOL REPROD, V72, P276, DOI 10.1095/biolreprod.104.033506; Garfield RE, 2007, SEMIN CELL DEV BIOL, V18, P289, DOI 10.1016/j.semcdb.2007.05.004; Guckenheimer J, 2013, APPL MATH SCI, V42; Jacquemet V, 2006, PHYS REV E, V74, DOI 10.1103/PhysRevE.74.011908; Kirchhoff S, 1998, CURR BIOL, V8, P299, DOI 10.1016/S0960-9822(98)70114-9; Kiseleva I, 1998, J MOL CELL CARDIOL, V30, P1083, DOI 10.1006/jmcc.1998.0673; Kohl P, 2005, J ELECTROCARDIOL, V38, P45, DOI 10.1016/j.jelectrocard.2005.06.096; KOHL P, 1994, EXP PHYSIOL, V79, P943, DOI 10.1113/expphysiol.1994.sp003819; Kryukov AK, 2008, CHAOS, V18, DOI 10.1063/1.2956985; Lammers WJEP, 2008, AM J PHYSIOL-REG I, V294, pR919, DOI 10.1152/ajpregu.00704.2007; Lammers WJEP, 2013, REPROD SCI, V20, P182, DOI 10.1177/1933719112446082; Lammers WJEP, 1997, PFLUG ARCH EUR J PHY, V433, P287; Lammers WJEP, 1999, PFLUG ARCH EUR J PHY, V437, P363, DOI 10.1007/s004240050790; LANDA JF, 1959, AM J PHYSIOL, V196, P905, DOI 10.1152/ajplegacy.1959.196.4.905; Loch-Caruso Rita K, 2003, Reprod Biol Endocrinol, V1, P62, DOI 10.1186/1477-7827-1-62; Maggio CD, 2012, B MATH BIOL, V74, P143, DOI 10.1007/s11538-011-9681-1; Majumder R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045040; Malmstrom E, 2007, MOL HUM REPROD, V13, P333, DOI 10.1093/molehr/gal117; Martin JA, 2009, TECHNICAL REPORT; Mathews TJ, 2012, NATL VITAL STAT REPO, V60; McHale N, 2006, J PHYSIOL-LONDON, V570, P23, DOI 10.1113/jphysiol.2005.098376; MILLER SM, 1989, AM J PHYSIOL, V256, pC130, DOI 10.1152/ajpcell.1989.256.1.C130; Miyoshi H, 1996, BIOPHYS J, V71, P1324, DOI 10.1016/S0006-3495(96)79332-3; Norman JE, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000153; Parkington HC, 1999, AM J OBSTET GYNECOL, V181, P1445, DOI 10.1016/S0002-9378(99)70390-X; Pervolaraki Eleftheria, 2012, Information Processing in Cells and Tissues. Proceedings of the 9th International Conference, IPCAT 2012, P162, DOI 10.1007/978-3-642-28792-3_21; Popescu LM, 2010, J CELL MOL MED, V14, P729, DOI 10.1111/j.1582-4934.2010.01059.x; Popescu LM, 2007, ANN NY ACAD SCI, V1101, P139, DOI 10.1196/annals.1389.022; Popescu LM, 2005, J CELL MOL MED, V9, P479, DOI 10.1111/j.1582-4934.2005.tb00376.x; Pumir A, 2005, BIOPHYS J, V89, P2332, DOI 10.1529/biophysj.105.061820; Rihana S, 2009, MED BIOL ENG COMPUT, V47, P665, DOI 10.1007/s11517-009-0433-4; Sergeant GP, 2000, J PHYSIOL-LONDON, V526, P359, DOI 10.1111/j.1469-7793.2000.t01-2-00359.x; Singh R, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.068102; Takemura M, 2005, MOL HUM REPROD, V11, P659, DOI 10.1093/molehr/gah229; Tong WC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018685; Tsai ML, 1998, TOXICOL APPL PHARM, V152, P18, DOI 10.1006/taap.1998.8516; Valiunas V, 2004, J PHYSIOL-LONDON, V555, P617, DOI 10.1113/jphysiol.2003.058719; Wang CT, 2002, TOXICOL APPL PHARM, V182, P136, DOI 10.1006/taap.2002.9411; Wang SY, 1998, J GEN PHYSIOL, V112, P737, DOI 10.1085/jgp.112.6.737; Weber CR, 2001, J GEN PHYSIOL, V117, P119, DOI 10.1085/jgp.117.2.119; Wray S, 2001, EXP PHYSIOL, V86, P239, DOI 10.1113/eph8602114; Xu JS, 2013, NEW J PHYS, V15, DOI 10.1088/1367-2630/15/9/093046; Yoshino M, 1997, J GEN PHYSIOL, V110, P565, DOI 10.1085/jgp.110.5.565; Young RC, 2007, ANN NY ACAD SCI, V1101, P72, DOI 10.1196/annals.1389.038	52	10	10	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2015	10	3							e0118443	10.1371/journal.pone.0118443	http://dx.doi.org/10.1371/journal.pone.0118443			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8IA	25793276	gold, Green Submitted, Green Published			2022-12-27	WOS:000352084200023
J	Andreasen, N; Simeoni, M; Ostlund, H; Lisjo, PI; Fladby, T; Loercher, AE; Byrne, GJ; Murray, F; Scott-Stevens, PT; Wallin, A; Zhang, YY; Bronge, LH; Zetterberg, H; Nordberg, AK; Yeo, AJ; Khan, SA; Hilpert, J; Mistry, PC				Andreasen, Niels; Simeoni, Monica; Ostlund, Henrik; Lisjo, Pia I.; Fladby, Tormod; Loercher, Amy E.; Byrne, Gerard J.; Murray, Frances; Scott-Stevens, Paul T.; Wallin, Anders; Zhang, Yinghua Y.; Bronge, Lena H.; Zetterberg, Henrik; Nordberg, Agneta K.; Yeo, Astrid J.; Khan, Shahid A.; Hilpert, Jan; Mistry, Prafull C.			First Administration of the Fc-Attenuated Anti-beta Amyloid Antibody GSK933776 to Patients with Mild Alzheimer's Disease: A Randomized, Placebo-Controlled Study	PLOS ONE			English	Article							CONTROLLED CLINICAL-TRIAL; INTRAVENOUS BAPINEUZUMAB; CEREBROSPINAL-FLUID; PHASE-3 TRIALS; DOUBLE-BLIND; SOLANEZUMAB	Objective To assess the safety, tolerability, pharmacokinetics, and pharmacodynamics of the Fcinactivated anti-beta amyloid (A beta) monoclonal antibody (mAb) GSK933776 in patients with mild Alzheimer's disease (AD) or mild cognitive impairment (MCI). Methods This was a two-part, single blind, placebo-controlled, first-time-in-human (FTIH) study of single (n = 18) and repeat dose (n = 32) intravenous GSK933776 0.001-6 mg/kg (ClinicalTrials. gov: NCT00459550). Additional safety data from an open-label, uncontrolled, single dose study of intravenous GSK933776 1-6 mg/kg (n = 18) are included (ClinicalTrials. gov: NCT01424436). Results There were no cases of amyloid-related imaging abnormalities-edema (ARIA-E) or hemorrhage (ARIA-H) after GSK933776 administration in both studies. Three patientsacross the two studies developed anti-GSK933776 antibodies. Plasma GSK933776 half-life (t(1/2)) was 10-15 days after repeat dosing. After each of three administrations of GSK933776, plasma levels of total A beta 42 and A beta increased whereas plasma levels of free A beta decreased dose dependently; no changes were observed for placebo. For total A beta 42 the peak: trough ratio was <= 2 at doses >= 3 mg/kg; for total A beta the ratio was <= 2 at 6 mg/kg. CSF concentrations of A beta showed increases from baseline to week 12 for A beta X-38 (week 12: baseline ratio: 1.65; 95% CI: 1.38, 1.93) and A beta X-42 (week 12: baseline ratio: 1.18; 95% CI: 1.06, 1.30) for values pooled across doses. Conclusion In this FTIH study the Fc-inactivated anti-A beta mAb GSK933776 engaged its target in plasma and CSF without causing brain ARIA-E/H in patients with mild AD or MCI.	[Andreasen, Niels] Karolinska Univ Sjukhuset, Geriatriska Klin, Stockholm, Sweden; [Simeoni, Monica] GlaxoSmithKline, Quantitat Sci, Stockley Pk, England; [Ostlund, Henrik] Skanes Univ Hosp, Memory Clin, Malmo, Sweden; [Lisjo, Pia I.] TrialCo AB, Clin Operat, Gothenburg, Sweden; [Fladby, Tormod] Akershus Univ Hosp, Div Med & Lab Sci, Clin Neurosci Grp, Lorenskog, Norway; [Loercher, Amy E.] GlaxoSmithKline, Clin Immunol, Upper Merion, PA USA; [Byrne, Gerard J.] Univ Queensland, Royal Brisbane & Womens Hosp, Mental Hlth Ctr, Discipline Psychiat,Sch Med, Herston, Qld, Australia; [Murray, Frances] GlaxoSmithKline, CPSSO Projects Clin Platforms & Sci, Res Triangle Pk, NC USA; [Scott-Stevens, Paul T.] GlaxoSmithKline, Platform Technol & Sci Drug Metab & Pharmacokinet, Ware, Herts, England; [Wallin, Anders] Sahlgrens Univ Hosp, Memory Clin, Molndal, Sweden; [Zhang, Yinghua Y.] GlaxoSmithKline, Quantitat Sci, Upper Merion, PA USA; [Bronge, Lena H.] Aleris Diagnost AB Sabbatsberg, Stockholm, Sweden; [Zetterberg, Henrik] Univ Gothenburg, Sahlgrenska Acad, Dept Psychiat & Neurochem, Inst Neurosci & Physiol, Molndal, Sweden; [Zetterberg, Henrik] UCL Inst Neurol, London, England; [Mistry, Prafull C.] GlaxoSmithKline, Quantitat Sci, Stevenage, Herts, England; [Khan, Shahid A.] GlaxoSmithKline, Biopharm Project Management, Stevenage, Herts, England; [Hilpert, Jan] GlaxoSmithKline, Neurosci Therapeut Area, Shanghai, Peoples R China	GlaxoSmithKline; University of Oslo; GlaxoSmithKline; Royal Brisbane & Women's Hospital; University of Queensland; GlaxoSmithKline; GlaxoSmithKline; Sahlgrenska University Hospital; GlaxoSmithKline; University of Gothenburg; University of London; University College London; GlaxoSmithKline; GlaxoSmithKline; GlaxoSmithKline	Mistry, PC (corresponding author), GlaxoSmithKline, Quantitat Sci, Stevenage, Herts, England.	prafull.c.mistry@gsk.com	Byrne, Gerard/A-5995-2008; nordberg, agneta/ABD-2479-2021	Byrne, Gerard/0000-0001-8259-3812; Nordberg, Agneta/0000-0001-7345-5151; Fladby, Tormod/0000-0002-9984-9797	GlaxoSmithKline	GlaxoSmithKline(GlaxoSmithKline)	GlaxoSmithKline funded this study (http://www.gsk.com/). The funder provided support in the form of salaries for authors MS, AL, FM, PSS, YZ, PM, AY, SK & JH but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The funder has a policy aiming to publish all clinical trial results. The specific roles of these authors are articulated in the "author contributions" section	Black RS, 2010, ALZ DIS ASSOC DIS, V24, P198, DOI 10.1097/WAD.0b013e3181c53b00; Blennow K, 2012, ARCH NEUROL-CHICAGO, V69, P1002, DOI 10.1001/archneurol.2012.90; Carlson C, 2011, ALZHEIMERS DEMENT, V7, P396, DOI 10.1016/j.jalz.2011.05.2353; Davda JP, 2010, MABS-AUSTIN, V2, P576, DOI 10.4161/mabs.2.5.12833; Doody RS, 2014, NEW ENGL J MED, V370, P311, DOI 10.1056/NEJMoa1312889; Farlow M, 2012, ALZHEIMERS DEMENT, V8, P261, DOI 10.1016/j.jalz.2011.09.224; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Kabat EA, 1991, SEQUENCES PROTEINS I; Karran E, 2014, NEW ENGL J MED, V370, P377, DOI 10.1056/NEJMe1313943; Karran E, 2011, NAT REV DRUG DISCOV, V10, P698, DOI 10.1038/nrd3505; Kerchner GA, 2010, EXPERT OPIN BIOL TH, V10, P1121, DOI 10.1517/14712598.2010.493872; Leyhe T, 2014, ALZHEIMERS IN PRESS; Ostrowitzki S, 2012, ARCH NEUROL-CHICAGO, V69, P198, DOI 10.1001/archneurol.2011.1538; Rinne JO, 2010, LANCET NEUROL, V9, P363, DOI 10.1016/S1474-4422(10)70043-0; Salloway S, 2012, EUR J NEUROL, V19, P70; Salloway S, 2009, NEUROLOGY, V73, P2061, DOI 10.1212/WNL.0b013e3181c67808; Salloway S, 2014, NEW ENGL J MED, V370, P322, DOI 10.1056/NEJMoa1304839; Sjogren M, 2001, CLIN CHEM, V47, P1776; Sperling R, 2012, EUR J NEUROL, V19, P70; Sperling RA, 2011, ALZHEIMERS DEMENT, V7, P367, DOI 10.1016/j.jalz.2011.05.2351; Zetterberg H, 2003, NEUROSCI LETT, V352, P67, DOI 10.1016/j.neulet.2003.08.011	21	24	27	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2015	10	3							e0098153	10.1371/journal.pone.0098153	http://dx.doi.org/10.1371/journal.pone.0098153			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD9NQ	25789616	Green Published, Green Submitted, gold			2022-12-27	WOS:000351425400001
J	Chen, HY; Shen, H; Jia, B; Zhang, YS; Wang, XH; Zeng, XC				Chen, Han Ying; Shen, Hong; Bin Jia; Zhang, Yong Sheng; Wang, Xu Hai; Zeng, Xian Cun			Differential Gene Expression in Ovaries of Qira Black Sheep and Hetian Sheep Using RNA-Seq Technique	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; FOLLICULAR DEVELOPMENT; GRANULOSA-CELLS; MESSENGER-RNA; FACTOR VEGF; FACTOR-BETA; IN-VITRO; TRANSCRIPTOME; IDENTIFICATION; FOLLICLES	The Qira black sheep and the Hetian sheep are two local breeds in the Northwest of China, which are characterized by high-fecundity and low-fecundity breed respectively. The elucidation of mRNA expression profiles in the ovaries among different sheep breeds representing fecundity extremes will helpful for identification and utilization of major prolificacy genes in sheep. In the present study, we performed RNA-seq technology to compare the difference in ovarian mRNA expression profiles between Qira black sheep and Hetian sheep. From the Qira black sheep and the Hetian sheep libraries, we obtained a total of 11,747,582 and 11,879,968 sequencing reads, respectively. After aligning to the reference sequences, the two libraries included 16,763 and 16,814 genes respectively. A total of 1,252 genes were significantly differentially expressed at Hetian sheep compared with Qira black sheep. Eight differentially expressed genes were randomly selected for validation by real-time RTPCR. This study provides a basic data for future research of the sheep reproduction.	[Chen, Han Ying] Shihezi Univ, Sch Pharm, Shihezi, Xinjiang, Peoples R China; [Shen, Hong; Bin Jia; Zhang, Yong Sheng; Wang, Xu Hai; Zeng, Xian Cun] Shihezi Univ, Coll Anim Sci & Technol, Shihezi, Xinjiang, Peoples R China	Shihezi University; Shihezi University	Zeng, XC (corresponding author), Shihezi Univ, Coll Anim Sci & Technol, Shihezi, Xinjiang, Peoples R China.	zengxiancun@163.com			National Natural Science Foundation of China [31260536]; Special Launching Funds for High-Level Talents of Shihezi University [RCZX201202]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Special Launching Funds for High-Level Talents of Shihezi University	This work was supported by the National Natural Science Foundation of China (31260536) and Special Launching Funds for High-Level Talents of Shihezi University (RCZX201202). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Argov N, 2004, MOL REPROD DEV, V68, P169, DOI 10.1002/mrd.20072; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Audic S, 1997, GENOME RES, V7, P986, DOI 10.1101/gr.7.10.986; Bai J, 2007, THESIS U SHIHEZI; Benjamini Y, 2001, ANN STAT, V29, P1165; Bonnet A, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-904; Cannon Matthew V, 2011, Reprod Med Biol, V10, P251, DOI 10.1007/s12522-011-0101-x; Chitwood JL, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-350; Cossigny DA, 2012, REPRODUCTION, V143, P221, DOI 10.1530/REP-11-0105; Driver AM, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-118; Du ZQ, 2014, ANIM GENET, V45, P198, DOI 10.1111/age.12124; Esteve-Codina A, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-552; Fernandez-Rodriguez A, 2011, BIOL REPROD, V84, P299, DOI 10.1095/biolreprod.110.085589; Fraser HM, 2006, REPROD BIOL ENDOCRIN, V4, DOI 10.1186/1477-7827-4-18; Garosi P, 2005, BRIT J NUTR, V93, P425, DOI 10.1079/BJN20041385; Geng RQ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062704; Greenaway J, 2005, BIOL REPROD, V72, P1071, DOI 10.1095/biolreprod.104.031120; HARROUK W, 1995, MOL REPROD DEV, V41, P29, DOI 10.1002/mrd.1080410106; Harwood BN, 2008, DEV DYNAM, V237, P1099, DOI 10.1002/dvdy.21491; Hatzirodos N, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-40; Hatzirodos N, 2014, BMC GENOMICS, V15, DOI [10.1186/1471-2164-15-24, 10.1186/1471-2164-15-40]; Ibeagha-Awemu EM, 2008, MAMM GENOME, V19, P591, DOI 10.1007/s00335-008-9141-x; Irusta G, 2010, MOL CELL ENDOCRINOL, V325, P93, DOI 10.1016/j.mce.2010.04.018; Jager M, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-158; Javanmard A, 2011, VET RES COMMUN, V35, P157, DOI 10.1007/s11259-011-9467-9; Juengel Jennifer L, 2004, Reprod Biol Endocrinol, V2, P78, DOI 10.1186/1477-7827-2-78; Kanehisa M, 2008, NUCLEIC ACIDS RES, V36, pD480, DOI 10.1093/nar/gkm882; Li RQ, 2009, BIOINFORMATICS, V25, P1966, DOI 10.1093/bioinformatics/btp336; Manna Pulak R., 2004, Biol Proced Online, V6, P83, DOI 10.1251/bpo76; Mardis ER, 2008, TRENDS GENET, V24, P133, DOI 10.1016/j.tig.2007.12.007; McCabe M, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-193; McNatty KP, 2005, GENET SEL EVOL, V37, pS25, DOI 10.1051/gse:2004029; Miao XY, 2013, REPRODUCTION, V145, P587, DOI 10.1530/REP-12-0507; Miller WL, 2011, ENDOCR REV, V32, P81, DOI 10.1210/er.2010-0013; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Oldknow KJ, 2013, ENDOCRINOLOGY, V154, P1310, DOI 10.1210/en.2012-1886; Ott CE, 2011, BONE, V48, pS162, DOI 10.1016/j.bone.2011.03.360; Qiu Y, 2012, REPRODUCTION, V143, P501, DOI 10.1530/REP-11-0091; Robertson RD, 2012, BIOCHEM BIOPH RES CO, V427, P568, DOI 10.1016/j.bbrc.2012.09.098; Samborski A, 2013, BIOL REPROD, V88, DOI 10.1095/biolreprod.113.107870; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Sheppard D, 2005, CANCER METAST REV, V24, P395, DOI 10.1007/s10555-005-5131-6; Shi HC, 2010, AFR J BIOTECHNOL, V9, P8498; Shimasaki S, 1999, P NATL ACAD SCI USA, V96, P7282, DOI 10.1073/pnas.96.13.7282; Shimizu T, 2006, J REPROD DEVELOP, V52, P23, DOI 10.1262/jrd.17072; Thomas Fiona H, 2003, Reprod Biol Endocrinol, V1, P76, DOI 10.1186/1477-7827-1-76; Vinet A, 2012, MAMM GENOME, V23, P727, DOI 10.1007/s00335-012-9412-4; Wang HX, 2009, MOL HUM REPROD, V15, P11, DOI 10.1093/molehr/gan070; Wang LK, 2010, BIOINFORMATICS, V26, P136, DOI 10.1093/bioinformatics/btp612; Welt C, 2002, EXP BIOL MED, V227, P724, DOI 10.1177/153537020222700905; Xu T, 2013, GENE, V520, P30, DOI 10.1016/j.gene.2013.01.068; Yamashita H, 2011, MOL CELL BIOCHEM, V348, P183, DOI 10.1007/s11010-010-0653-9; Yang MY, 2007, MOL REPROD DEV, V74, P1095, DOI 10.1002/mrd.20633; Ye J, 2006, NUCLEIC ACIDS RES, V34, pW293, DOI 10.1093/nar/gkl031; Yee WKW, 2013, CURR BIOL, V23, pR55, DOI 10.1016/j.cub.2012.12.002; Ying SJ, 2013, J ANIM SCI, V91, P5229, DOI 10.2527/jas.2013-6450; Yu JG, 2011, GRASS FEEDING LIVEST, V2, P7; Zhang CL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072686; Zhu X., 2013, THESIS CHINESE ACAD	59	41	46	4	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2015	10	3							e0120170	10.1371/journal.pone.0120170	http://dx.doi.org/10.1371/journal.pone.0120170			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD9NQ	25790350	Green Published, Green Submitted, gold			2022-12-27	WOS:000351425400138
J	Cruz-Mora, J; Perez-Valdespino, A; Gupta, S; Withange, N; Kuwana, R; Takamatsu, H; Christie, G; Setlow, P				Cruz-Mora, Jose; Perez-Valdespino, Abigail; Gupta, Srishti; Withange, Nilumi; Kuwana, Ritsuko; Takamatsu, Hiromu; Christie, Graham; Setlow, Peter			The GerW Protein Is Not Involved in the Germination of Spores of Bacillus Species	PLOS ONE			English	Article							AMINO-ACID SUBSTITUTIONS; INNER MEMBRANE; SUBTILIS; LOCALIZATION; DORMANT	Germination of dormant spores of Bacillus species is initiated when nutrient germinants bind to germinant receptors in spores' inner membrane and this interaction triggers the release of dipicolinic acid and cations from the spore core and their replacement by water. Bacillus subtilis spores contain three functional germinant receptors encoded by the gerA, gerB, and gerK operons. The GerA germinant receptor alone triggers germination with L-valine or L-alanine, and the GerB and GerK germinant receptors together trigger germination with a mixture of L-asparagine, D-glucose, D-fructose and KCl (AGFK). Recently, it was reported that the B. subtilis gerW gene is expressed only during sporulation in developing spores, and that GerW is essential for L-alanine germination of B. subtilis spores but not for germination with AGFK. However, we now find that loss of the B. subtilis gerW gene had no significant effects on: i) rates of spore germination with L-alanine; ii) spores' levels of germination proteins including GerA germinant receptor subunits; iii) AGFK germination; iv) spore germination by germinant receptor-independent pathways; and v) outgrowth of germinated spores. Studies in Bacillus megaterium did find that gerW was expressed in the developing spore during sporulation, and in a temperature-dependent manner. However, disruption of gerW again had no effect on the germination of B. megaterium spores, whether germination was triggered via germinant receptor-dependent or germinant receptor-independent pathways.	[Cruz-Mora, Jose; Perez-Valdespino, Abigail; Setlow, Peter] Univ Connecticut, Ctr Hlth, Dept Mol Biol & Biophys, Farmington, CT 06032 USA; [Gupta, Srishti; Withange, Nilumi; Christie, Graham] Univ Cambridge, Dept Chem Engn & Biotechnol, Cambridge, England; [Kuwana, Ritsuko; Takamatsu, Hiromu] Setsunan Univ, Fac Pharmaceut Sci, Hirakata, Osaka 57301, Japan	University of Connecticut; University of Cambridge; Setsunan University	Setlow, P (corresponding author), Univ Connecticut, Ctr Hlth, Dept Mol Biol & Biophys, Farmington, CT 06032 USA.	setlow@nso2.uchc.edu		PEREZ VALDESPINO, ABIGAIL/0000-0002-2885-592X	Department of Defense Multi-disciplinary University Research Initiative through the U.S. Army Research Laboratory; U.S. Army Research Office [W911F-09-1-0286]; Army Research Office [W911NF-12-1-0325]; Gonville and Caius College, University of Cambridge	Department of Defense Multi-disciplinary University Research Initiative through the U.S. Army Research Laboratory; U.S. Army Research Office; Army Research Office; Gonville and Caius College, University of Cambridge	This work was supported by a Department of Defense Multi-disciplinary University Research Initiative through the U.S. Army Research Laboratory and the U.S. Army Research Office under contract number W911F-09-1-0286 (PS/YQL), and by a grant from the Army Research Office under contract number W911NF-12-1-0325. SG was the recipient of an R.A. Fisher Bursary Award from Gonville and Caius College, University of Cambridge. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angert ER, 2005, NAT REV MICROBIOL, V3, P214, DOI 10.1038/nrmicro1096; Butzin XY, 2012, J BACTERIOL, V194, P5749, DOI 10.1128/JB.01276-12; Christie G, 2008, J BACTERIOL, V190, P2014, DOI 10.1128/JB.01687-07; Christie G, 2008, J BACTERIOL, V190, P8009, DOI 10.1128/JB.01073-08; Fisher N, 2005, J BACTERIOL, V187, P8055, DOI 10.1128/JB.187.23.8055-8062.2005; Ghosh S, 2012, J BACTERIOL, V194, P2221, DOI 10.1128/JB.00151-12; Griffiths KK, 2011, MOL MICROBIOL, V81, P1061, DOI 10.1111/j.1365-2958.2011.07753.x; Gupta S, 2013, J BACTERIOL, V195, P3045, DOI 10.1128/JB.00325-13; Higgins D, 2012, FEMS MICROBIOL REV, V36, P131, DOI 10.1111/j.1574-6976.2011.00310.x; Kobayashi K, 2008, MICROBIOL-SGM, V154, P54, DOI 10.1099/mic.0.2007/011783-0; Korza G, 2013, J BACTERIOL, V195, P1484, DOI 10.1128/JB.02262-12; Kuwana R, 2002, MICROBIOL-SGM, V148, P3971, DOI 10.1099/00221287-148-12-3971; Kuwana R, 2013, J BIOCHEM, V154, P409, DOI 10.1093/jb/mvt072; Mongkolthanaruk W, 2011, J BACTERIOL, V193, P2268, DOI 10.1128/JB.01398-10; Mongkolthanaruk W, 2009, MICROBIOL-SGM, V155, P1146, DOI 10.1099/mic.0.023853-0; Nicholson WL., 1990, MOL BIOL METHODS BAC, P391, DOI DOI 10.1111/J.1751-1097.1991.TB02087.X; Paidhungat M, 2000, J BACTERIOL, V182, P5505, DOI 10.1128/JB.182.19.5505-5512.2000; Paredes-Sabja D, 2011, TRENDS MICROBIOL, V19, P85, DOI 10.1016/j.tim.2010.10.004; Pelczar PL, 2008, J BACTERIOL, V190, P5635, DOI 10.1128/JB.00670-08; Ramirez-Peralta A, 2013, J BACTERIOL, V195, P3009, DOI 10.1128/JB.00257-13; Ramirez-Peralta A, 2012, J BACTERIOL, V194, P3417, DOI 10.1128/JB.00504-12; Ramirez-Peralta A, 2012, APPL ENVIRON MICROB, V78, P2689, DOI 10.1128/AEM.07908-11; Ross C, 2010, CURR ISSUES MOL BIOL, V12, P147; Setlow P, 2006, J APPL MICROBIOL, V101, P514, DOI 10.1111/j.1365-2672.2005.02736.x; Setlow P, 2013, J APPL MICROBIOL, V115, P1251, DOI 10.1111/jam.12343; SPIZIZEN J, 1958, P NATL ACAD SCI USA, V44, P1072, DOI 10.1073/pnas.44.10.1072; Vepachedu VR, 2005, J BACTERIOL, V187, P5677, DOI 10.1128/JB.187.16.5677-5682.2005; Wang ST, 2006, J MOL BIOL, V358, P16, DOI 10.1016/j.jmb.2006.01.059; WITTCHEN KD, 1995, APPL MICROBIOL BIOT, V42, P871, DOI 10.1007/s002530050345; Yi X, 2011, APPL ENVIRON MICROB, V77, P5536, DOI 10.1128/AEM.00577-11; Yi XA, 2010, J BACTERIOL, V192, P3424, DOI 10.1128/JB.00326-10	31	4	4	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2015	10	3							e0119125	10.1371/journal.pone.0119125	http://dx.doi.org/10.1371/journal.pone.0119125			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD9NQ	25790435	Green Published, gold, Green Submitted			2022-12-27	WOS:000351425400068
J	de Frutos, A; Navarro, T; Pueyo, Y; Alados, CL				de Frutos, Angel; Navarro, Teresa; Pueyo, Yolanda; Alados, Concepcion L.			Inferring Resilience to Fragmentation-Induced Changes in Plant Communities in a Semi-Arid Mediterranean Ecosystem	PLOS ONE			English	Article							FUNCTIONAL DIVERSITY INDEXES; LAND-USE INTENSIFICATION; RESPONSE DIVERSITY; SPATIAL-PATTERNS; HABITAT FRAGMENTATION; SELF-ORGANIZATION; DISPERSAL; TRAITS; BIODIVERSITY; REDUNDANCY	Predicting the capacity of ecosystems to absorb impacts from disturbance events (resilience), including land-use intensification and landscape fragmentation, is challenging in the face of global change. Little is known about the impacts of fragmentation on ecosystem functioning from a multi-dimensional perspective (multiple traits). This study used 58 500-m linear transects to quantify changes in the functional composition and resilience of vascular plant communities in response to an increase in landscape fragmentation in 18 natural scrubland fragments embedded within a matrix of abandoned crop fields in Cabo de Gata-Nijar Natural Park, Almeria, Spain. Changes in functional community composition were measured using functional diversity indices (functional richness and functional dispersion) that were based on 12 plant traits. Resilience was evaluated using the functional redundancy and response diversity from the perspective of plant dispersal, which is important, particularly, in fragmented landscapes. Scrubland fragmentation was measured using the Integral Index of Connectivity (IIC). The functional richness of the plant communities was higher in the most fragmented scrubland. Conversely, the functional dispersion (i.e., spread) of trait values among species in the functional trait space was lower at the most fragmented sites; consequently, the ecological tolerance of the vegetation to scrubland fragmentation decreased. Classifying the plant species into four functional groups indicated that fragmentation favoured an increase in functional redundancy in the 'short basal annual forbs and perennial forbs' group, most of which are species adapted to degraded soils. An assessment based on the traits associated with plant dispersal indicated that the resilience of 'woody plants', an important component in the Mediterranean scrubland, and habitat fragmentation were negatively correlated; however, the correlation was positive in the 'short basal annual forbs and perennial forbs' and the 'grasses' groups.	[de Frutos, Angel] CSIC, Pyrenean Inst Ecol, Jaca, Huesca, Spain; [Pueyo, Yolanda; Alados, Concepcion L.] CSIC, Pyrenean Inst Ecol, Zaragoza, Spain; [Navarro, Teresa] Univ Malaga, Dept Biol Vegetal, E-29071 Malaga, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto Pirenaico de Ecologia (IPE); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto Pirenaico de Ecologia (IPE); Universidad de Malaga	de Frutos, A (corresponding author), CSIC, Pyrenean Inst Ecol, Jaca, Huesca, Spain.	adefrutost@gmail.com	Navarro, Teresa/AAE-8157-2019; Pueyo, Yolanda/I-4248-2015; Alados, Concepción L/K-8085-2014	Pueyo, Yolanda/0000-0001-6970-7790; Alados, Concepción L/0000-0002-6227-861X; de Frutos, Angel/0000-0002-5250-9488; Navarro del Aguila, Maria Teresa/0000-0002-8410-1954	JAE-DOC from the Spanish Research Council (CSIC); Fondo Social Europeo; Spanish Ministry of Economy and Competitiveness [CGL2011-27259, CGL2012-37508]	JAE-DOC from the Spanish Research Council (CSIC); Fondo Social Europeo(European Social Fund (ESF)European Commission); Spanish Ministry of Economy and Competitiveness(Spanish Government)	AF was financed by a JAE-DOC postdoctoral contract from the Spanish Research Council (CSIC) (http://www.csic.es/web/guest/home) and Fondo Social Europeo (http://ec.europa.eu/esf/home.jsp?langId=en). The authors acknowledge financial support from the Spanish Ministry of Economy and Competitiveness (research project: CGL2011-27259 and CGL2012-37508). This funder had a role in study design, data collection and analysis.	Alados CL, 2009, ECOL COMPLEX, V6, P197, DOI 10.1016/j.ecocom.2008.10.015; Alados CL, 2006, BIOL J LINN SOC, V87, P103, DOI 10.1111/j.1095-8312.2006.00559.x; Alados CL, 2004, ECOL MODEL, V180, P523, DOI 10.1016/j.ecolmodel.2003.10.034; Alados CL, 2004, LANDSCAPE ECOL, V19, P543; Alados CL, 2003, ECOL MODEL, V163, P1, DOI 10.1016/S0304-3800(02)00294-6; Alados CL, 2010, BIOL J LINN SOC, V100, P935, DOI 10.1111/j.1095-8312.2010.01465.x; Arthaud F, 2012, AQUAT SCI, V74, P471, DOI 10.1007/s00027-011-0241-4; Atkinson B. W., 1981, MESO SCALE ATMOSPHER; Azorin-Molina C, 2009, ATMOSFERA, V22, P33; Barragan F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017976; BARROSO FG, 1995, J ARID ENVIRON, V31, P205, DOI 10.1006/jare.1995.0061; Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; Baudena M, 2013, THEOR ECOL-NETH, V6, P131, DOI 10.1007/s12080-012-0165-1; Belda A, 2011, SPAN J AGRIC RES, V9, P1197, DOI [10.5424/http://dx.doi.org/10.5424/sjar/20110904-470-10, 10.5424/sjar/20110904-470-10]; BOJA, 2008, B OFICIAL JUNTA ANDA, V59, P114; Butterfield BJ, 2013, J ECOL, V101, P9, DOI 10.1111/1365-2745.12013; Carranza ML, 2012, PLANT ECOL DIVERS, V5, P541, DOI 10.1080/17550874.2012.740509; Castroviejo S., 1986, FLORA IBERICA, V1; Chapin III F.S., 2001, GLOBAL BIODIVERSITY; Chesson P, 2000, ANNU REV ECOL SYST, V31, P343, DOI 10.1146/annurev.ecolsys.31.1.343; Chillo V, 2011, ECOSYSTEMS, V14, P1168, DOI 10.1007/s10021-011-9475-1; Cornelissen JHC, 2003, AUST J BOT, V51, P335, DOI 10.1071/BT02124; de Frutos A, 2007, ECOL MODEL, V200, P33, DOI 10.1016/j.ecolmodel.2006.07.007; Diaz S, 1998, J VEG SCI, V9, P113, DOI 10.2307/3237229; Elmqvist T, 2003, FRONT ECOL ENVIRON, V1, P488, DOI 10.2307/3868116; Fahrig L, 1997, J WILDLIFE MANAGE, V61, P603, DOI 10.2307/3802168; Fahrig L, 2003, ANNU REV ECOL EVOL S, V34, P487, DOI 10.1146/annurev.ecolsys.34.011802.132419; Fahrig L, 2013, J BIOGEOGR, V40, P1649, DOI 10.1111/jbi.12130; Fischer J, 2007, GLOBAL ECOL BIOGEOGR, V16, P265, DOI 10.1111/j.1466-8238.2007.00287.x; Foley JA, 2005, SCIENCE, V309, P570, DOI 10.1126/science.1111772; Fox John, 2003, J STAT SOFTW, V8, P1, DOI [10.18637/jss.v008.i15, DOI 10.18637/JSS.V008.I15]; GOODALL DW, 1952, AUST J SCI RES SER B, V5, P1, DOI 10.1071/BI9520001; HAASE P, 1995, J ARID ENVIRON, V31, P55, DOI 10.1006/jare.1995.0048; Hanski I, 2011, AMBIO, V40, P248, DOI 10.1007/s13280-011-0147-3; Hillebrand H, 2009, ECOL LETT, V12, P1405, DOI 10.1111/j.1461-0248.2009.01388.x; Hooper DU, 2005, ECOL MONOGR, V75, P3, DOI 10.1890/04-0922; INE, 2009, CENS POBL VIV 2009; Katovai E, 2012, BIOL CONSERV, V145, P214, DOI 10.1016/j.biocon.2011.11.008; Kefi S, 2007, NATURE, V449, P213, DOI 10.1038/nature06111; Komac B, 2015, APPL VEG SCI, V18, P75, DOI 10.1111/avsc.12119; Laliberte E., 2011, FD MEASURING FUNCTIO; Laliberte E, 2010, ECOLOGY, V91, P299, DOI 10.1890/08-2244.1; Laliberte E, 2010, ECOL LETT, V13, P76, DOI 10.1111/j.1461-0248.2009.01403.x; Laurance WF, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001017; Lavorel S, 2002, FUNCT ECOL, V16, P545, DOI 10.1046/j.1365-2435.2002.00664.x; Legendre P., 2012, NUMERICAL ECOLOGY; Maestre FT, 2009, ECOL LETT, V12, P930, DOI 10.1111/j.1461-0248.2009.01352.x; Maestre FT, 2005, ACTA OECOL, V27, P161, DOI 10.1016/j.actao.2004.11.003; Maru YT, 2010, 201004 CSIRO SUST EC; Mason NWH, 2013, J VEG SCI, V24, P794, DOI 10.1111/jvs.12013; Metzger JP, 2009, BIOL CONSERV, V142, P1166, DOI 10.1016/j.biocon.2009.01.033; Mori AS, 2013, BIOL REV, V88, P349, DOI 10.1111/brv.12004; Mouchet MA, 2010, FUNCT ECOL, V24, P867, DOI 10.1111/j.1365-2435.2010.01695.x; Mouillot D, 2013, TRENDS ECOL EVOL, V28, P167, DOI 10.1016/j.tree.2012.10.004; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; Navarro T, 2009, J ARID ENVIRON, V73, P103, DOI 10.1016/j.jaridenv.2008.09.009; Navarro T, 2009, CANDOLLEA, V64, P69; Pakeman RJ, 2011, J ECOL, V99, P1143, DOI 10.1111/j.1365-2745.2011.01853.x; Pascual-Hortal L, 2006, LANDSCAPE ECOL, V21, P959, DOI 10.1007/s10980-006-0013-z; Peinado M., 1992, VEGETATION SE SPAIN; Pillar VD, 2013, J VEG SCI, V24, P963, DOI 10.1111/jvs.12047; Pinheiro J, 2020, R PACKAGE VERSION 31; Pueyo Y, 2009, RESTOR ECOL, V17, P908, DOI 10.1111/j.1526-100X.2008.00474.x; Pugnaire FI, 2000, ANN BOT-LONDON, V86, P807, DOI 10.1006/anbo.2000.1240; R Core Team, 2021, R LANGUAGE ENV STAT; Realpe-Gomez J, 2013, ECOL COMPLEX, V15, P97, DOI 10.1016/j.ecocom.2013.04.002; Reiss J, 2009, TRENDS ECOL EVOL, V24, P505, DOI 10.1016/j.tree.2009.03.018; Rietkerk M, 2004, SCIENCE, V305, P1926, DOI 10.1126/science.1101867; Rietkerk M, 2002, AM NAT, V160, P524, DOI 10.1086/342078; Rietkerk M, 2008, TRENDS ECOL EVOL, V23, P169, DOI 10.1016/j.tree.2007.10.013; Rybicki J, 2013, ECOL LETT, V16, P27, DOI 10.1111/ele.12065; Saiz H, 2011, ECOL COMPLEX, V8, P184, DOI 10.1016/j.ecocom.2011.02.001; Saiz H, 2011, ECOL RES, V26, P595, DOI 10.1007/s11284-011-0818-3; SAUNDERS DA, 1991, CONSERV BIOL, V5, P18, DOI 10.1111/j.1523-1739.1991.tb00384.x; Saura S, 2009, ENVIRON MODELL SOFTW, V24, P135, DOI 10.1016/j.envsoft.2008.05.005; Saura S, 2010, ECOGRAPHY, V33, P523, DOI 10.1111/j.1600-0587.2009.05760.x; Schleuter D, 2010, ECOL MONOGR, V80, P469, DOI 10.1890/08-2225.1; Schoning C, 2004, J ARID ENVIRON, V56, P43, DOI 10.1016/S0140-1963(03)00024-7; SILBERBAUERGOTTSBERGER I, 1984, PLANT SYST EVOL, V147, P1, DOI 10.1007/BF00984577; SORIANO A, 1994, VEGETATIO, V111, P127, DOI 10.1007/BF00040332; Standish RJ, 2014, BIOL CONSERV, V177, P43, DOI 10.1016/j.biocon.2014.06.008; Suarez F., 2010, ALONDRA RICOTI CHERS; Trombulak SC, 2004, CONSERV BIOL, V18, P1180, DOI 10.1111/j.1523-1739.2004.01851.x; Tscharntke T, 2012, BIOL REV, V87, P661, DOI 10.1111/j.1469-185X.2011.00216.x; Villeger S, 2008, ECOLOGY, V89, P2290, DOI 10.1890/07-1206.1; Villeger S, 2010, ECOL APPL, V20, P1512, DOI 10.1890/09-1310.1; Violle C, 2007, OIKOS, V116, P882, DOI 10.1111/j.2007.0030-1299.15559.x; Walker B. H., 1992, Conservation Biology, V6, P18, DOI 10.1046/j.1523-1739.1992.610018.x; Zuur Alain F., 2009, P1	89	10	10	1	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2015	10	3							e0118837	10.1371/journal.pone.0118837	http://dx.doi.org/10.1371/journal.pone.0118837			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD9NQ	25790432	Green Published, Green Submitted, gold			2022-12-27	WOS:000351425400048
J	Holler, JG; Bech, CN; Henriksen, DP; Mikkelsen, S; Pedersen, C; Lassen, AT				Holler, Jon Gitz; Bech, Camilla Norgaard; Henriksen, Daniel Pilsgaard; Mikkelsen, Soren; Pedersen, Court; Lassen, Annmarie Touborg			Nontraumatic Hypotension and Shock in the Emergency Department and the Prehospital setting, Prevalence, Etiology, and Mortality: A Systematic Review	PLOS ONE			English	Article							SYSTOLIC BLOOD-PRESSURE; RESUSCITATION; OUTCOMES; PREDICTOR; DOPAMINE; CARE	Background Acute patients presenting with hypotension in the prehospital or emergency department (ED) setting are in need of focused management and knowledge of the epidemiology characteristics might help the clinician. The aim of this review was to address prevalence, etiology and mortality of nontraumatic hypotension (SBP <= 90 mmHg) with or without the presence of shock in the prehospital and ED setting. Methods We performed a systematic literature search up to August 2013, using Medline, Embase, Cinahl, Dare and The Cochrane Library. The analysis and eligibility criteria were documented according to the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA-guidelines) and The Cochrane Collaboration. No restrictions on language, publication date, or status were imposed. We used the Newcastle-Ottawa quality assessment scale (NOS-scale) and the Strengthening the Reporting of Observational studies in Epidemiology (STROBE-statement) to assess the quality. Results Six observational studies were considered eligible for analysis based on the evaluation of 11,880 identified papers. Prehospital prevalence of hypotension was 19.5/1000 emergency medicine service (EMS) contacts, and the prevalence of hypotensive shock was 9.5-19/1000 EMS contacts with an inhospital mortality of shock between 33 to 52%. ED prevalence of hypotension was 4-13/1000 contacts with a mortality of 12%. Information on mortality, prevalence and etiology of shock in the ED was limited. A meta-analysis was not feasible due to substantial heterogeneity between studies. Conclusion There is inadequate evidence to establish concise estimates of the characteristics of non-traumatic hypotension and shock in the ED or in the prehospital setting. The available studies suggest that 2% of EMS contacts present with nontraumatic hypotension while 1-2% present with shock. The inhospital mortality of prehospital shock is 33-52%. Prevalence of hypotension in the ED is 1% with an inhospital mortality of 12%. Prevalence, etiology and mortality of shock in the ED are not well described.	[Holler, Jon Gitz; Bech, Camilla Norgaard; Lassen, Annmarie Touborg] Odense Univ Hosp, Dept Emergency Med, DK-5000 Odense, Denmark; [Henriksen, Daniel Pilsgaard] Odense Univ Hosp, Dept Clin Chem & Pharmacol, DK-5000 Odense, Denmark; [Mikkelsen, Soren] Odense Univ Hosp, Dept Anaesthesiol & Intens Care Med, DK-5000 Odense, Denmark; [Pedersen, Court] Odense Univ Hosp, Dept Infect Dis, DK-5000 Odense, Denmark	University of Southern Denmark; Odense University Hospital; University of Southern Denmark; Odense University Hospital; University of Southern Denmark; Odense University Hospital; University of Southern Denmark; Odense University Hospital	Holler, JG (corresponding author), Odense Univ Hosp, Dept Emergency Med, DK-5000 Odense, Denmark.	Jon.Gitz.Holler@dadlnet.dk	Mikkelsen, Soren/R-1890-2019; Lassen, Annmarie/AAA-5816-2019	Mikkelsen, Soren/0000-0002-5187-7027; Henriksen, Daniel Pilsgaard/0000-0003-1303-6195; Lassen, Annmarie/0000-0003-4942-6152	University of Southern Denmark; Research Foundation of Odense University Hospital; philanthropically private fund TrygFonden	University of Southern Denmark; Research Foundation of Odense University Hospital; philanthropically private fund TrygFonden	JGH was supported by University of Southern Denmark, The Research Foundation of Odense University Hospital, as well as an unrestricted grant from the philanthropically private fund TrygFonden given to the University of Southern Denmark. ATL was supported by an unrestricted grant from the philanthropically private fund TrygFonden given to University of Southern Denmark, and is employed as a consultant at the Department of Emergency Medicine, Odense University Hospital. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Babaev A, 2005, JAMA-J AM MED ASSOC, V294, P448, DOI 10.1001/jama.294.4.448; BARTHELL E, 1988, ANN EMERG MED, V17, P1221, DOI 10.1016/S0196-0644(88)80074-X; Boniatti MM, 2010, RESUSCITATION, V81, P667, DOI 10.1016/j.resuscitation.2010.01.025; Breitkreutz R, 2010, RESUSCITATION, V81, P1527, DOI 10.1016/j.resuscitation.2010.07.013; Bruns B, 2008, J TRAUMA, V65, P1217, DOI 10.1097/TA.0b013e318184ee63; Chenaitia H, 2011, EUR J EMERG MED, V18, P99, DOI 10.1097/MEJ.0b013e3283402249; De Backer D, 2010, NEW ENGL J MED, V362, P779, DOI 10.1056/NEJMoa0907118; Dellinger RP, 2013, INTENS CARE MED, V41, P580, DOI [10.1097/CCM.0b013e31827e83af, DOI 10.1007/s00134-012-2769-8]; Dellinger RP, 2013, INTENS CARE MED, V41, P580, DOI [DOI 10.1007/s00134-012-2769-8, 10.1007/s00134-012-2769-8]; DIPROSE P, 1993, ARCH EMERG MED, V10, P135; Hasdai D, 2000, LANCET, V356, P749, DOI 10.1016/S0140-6736(00)02640-4; Hasler RM, 2012, RESUSCITATION, V83, P476, DOI 10.1016/j.resuscitation.2011.10.018; Havel C, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003709.pub3; Herlitz J, 2002, AM J EMERG MED, V20, P588, DOI 10.1053/ajem.2002.35461; Holthaus C, 2011, ANN EMERG MED, V58, pS282, DOI 10.1016/j.annemergmed.2011.06.343; Jones AE, 2004, SHOCK, V22, P410, DOI 10.1097/01.shk.0000142186.95718.82; Jones AE, 2004, CRIT CARE MED, V32, P1703, DOI 10.1097/01.CCM.0000133017.34137.82; Jones AE, 2004, ANN EMERG MED, V43, P106, DOI 10.1016/j.annemergmed.2003.08.008; Jones AE, 2006, CHEST, V130, P941, DOI 10.1378/chest.130.4.941; Lalezarzadeh F, 2009, AM SURGEON, V75, P1009; Levy MM, 2012, LANCET INFECT DIS, V12, P919, DOI 10.1016/S1473-3099(12)70239-6; Liberati A, 2009, PLOS MED, V6, DOI [10.1371/journal.pmed.1000100, 10.1136/bmj.b2700, 10.7326/0003-4819-151-4-200908180-00136]; Luckner G, 2005, CRIT CARE MED, V33, P2659, DOI 10.1097/01.CCM.0000186749.34028.40; MCLAUGHLIN JS, 1969, ANN SURG, V169, P42, DOI 10.1097/00000658-196901000-00004; Merz TM, 2011, CRIT CARE, V15, DOI 10.1186/cc9972; Mikkelsen ME, 2010, CHEST, V138, P551, DOI 10.1378/chest.09-2210; MITTY WF, 1972, AM FAM PHYSICIAN, V5, P76; Nguyen HB, 2000, ACAD EMERG MED, V7, P1354, DOI 10.1111/j.1553-2712.2000.tb00492.x; OConnell D, 2019, NEWCASTLE OTTAWA SCA; Poloujadoff MP, 2006, RESUSCITATION, V69, P185, DOI 10.1016/j.resuscitation.2005.08.016; Quach JL, 2008, J CRIT CARE, V23, P325, DOI 10.1016/j.jcrc.2007.11.002; Sakr Y, 2006, CRIT CARE MED, V34, P589, DOI 10.1097/01.CCM.0000201896.45809.E3; Sasser Scott M, 2012, MMWR Recomm Rep, V61, P1; SCHRIGER DL, 1991, ANN EMERG MED, V20, P601, DOI 10.1016/S0196-0644(05)82375-3; Schuetz P, 2011, SHOCK, V36, P104, DOI 10.1097/SHK.0b013e31821e4e04; Schwartz B, 2004, ACAD EMERG MED, V11, P656, DOI 10.1197/j.aem.2003.12.023; Sebat F, 2005, CHEST, V127, P1729, DOI 10.1378/chest.127.5.1729; Seymour CW, 2013, ACAD EMERG MED, V20, P597, DOI 10.1111/acem.12142; Shoemaker WC, 1996, ACAD EMERG MED, V3, P675, DOI 10.1111/j.1553-2712.1996.tb03489.x; SHOEMAKER WC, 1983, CRIT CARE MED, V11, P630, DOI 10.1097/00003246-198308000-00009; The Cochrane Collaboration, 2011, COCHRANE HDB SYSTEMA, DOI DOI 10.1002/9780470712184.CH9; Vandenbroucke JP., 2007, EXPLAN ELAB, V4, P1628; Vincent JL, 2014, NEW ENGL J MED, V370, P583, DOI 10.1056/NEJMc1314999; Wang HE, 2011, CRIT CARE MED, V39, P2431, DOI 10.1097/CCM.0b013e3182257310; Younes RN, 1997, SHOCK, V7, P79, DOI 10.1097/00024382-199702000-00001; YOUNES RN, 1992, SURGERY, V111, P380; Zhang Shu-wen, 2007, Zhongguo Wei Zhong Bing Ji Jiu Yi Xue, V19, P2; [No title captured]; [No title captured]; [No title captured]; [No title captured]	51	31	31	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2015	10	3							e0119331	10.1371/journal.pone.0119331	http://dx.doi.org/10.1371/journal.pone.0119331			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD9NQ	25789927	gold, Green Published, Green Submitted			2022-12-27	WOS:000351425400074
J	Hu, FP; Jiao, CY; Zhao, SP; Dong, HH; Liu, X; Yi, YJ; Wang, J				Hu, Fengpei; Jiao, Changyong; Zhao, Songpo; Dong, Huahua; Liu, Xiao; Yi, Yuji; Wang, Jun			The Effects of Attention Pre-Allocation and Target-Background Integration on Object-Based Attention	PLOS ONE			English	Article							SELECTIVE ATTENTION; VISUAL-ATTENTION; MECHANISMS; EXPERIENCE; MODULATION; CORTEX	Object-based attention has been documented as an important mechanism with which to control attention in several studies. To date, two main hypotheses have been proposed to interpret object-based attention: attention spreading and prioritization of search. There is evidence that supports these hypotheses in the literature. In the present study, we sought to compare these two hypotheses systematically by manipulating two factors: the integration of the target and background and the presence of attention pre-allocation. For this purpose, we used a flanker task in which the location of the task-relevant target was fixed, but the relationship between the target and the background varied. In addition, attention pre-allocation was presented in only half of the conditions. The results revealed that the attention spreading hypothesis was supported only when attention was not pre-allocated and target-background integration was high; however, the prioritization hypothesis was supported in all other conditions. Our findings provide insight into the comparisons of the attention spreading and prioritization hypotheses. Furthermore, our findings suggest that attention resources may be the underlying factor determining appropriate strategy in the control of attention.	[Hu, Fengpei; Jiao, Changyong; Dong, Huahua] Zhejiang Univ Technol, Coll Econ & Management, Hangzhou, Zhejiang, Peoples R China; [Zhao, Songpo; Liu, Xiao] Zhejiang Sci Tech Univ, Dept Psychol, Hangzhou 310018, Zhejiang, Peoples R China; [Yi, Yuji] New York State Psychiat Inst & Hosp, New York, NY 10032 USA; [Wang, Jun] Univ Texas SW Med Ctr Dallas, Dept Psychiat, Dallas, TX 75390 USA	Zhejiang University of Technology; Zhejiang Sci-Tech University; New York State Psychiatry Institute; University of Texas System; University of Texas Southwestern Medical Center Dallas	Hu, FP (corresponding author), Zhejiang Univ Technol, Coll Econ & Management, Hangzhou, Zhejiang, Peoples R China.	fengpei@zjut.edu.cn; Jun.Wang@UTSouthwestern.edu			Key Research Center of Philosophy and Social Science of Zhejiang Province (Zhejiang Technological Innovation and Enterprise Internationalization Research Center); National Social Science Foundation of China [14BSH070]; Zhejiang Provincial Natural Science Foundation of China [LY14C090002]; National Natural Science Foundation of China [71302122, 71101128]	Key Research Center of Philosophy and Social Science of Zhejiang Province (Zhejiang Technological Innovation and Enterprise Internationalization Research Center); National Social Science Foundation of China; Zhejiang Provincial Natural Science Foundation of China(Natural Science Foundation of Zhejiang Province); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This present work was supported by Key Research Center of Philosophy and Social Science of Zhejiang Province (Zhejiang Technological Innovation and Enterprise Internationalization Research Center), National Social Science Foundation of China (No. 14BSH070), Zhejiang Provincial Natural Science Foundation of China (No. LY14C090002) and National Natural Science Foundation of China (No. 71302122, No. 71101128). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alkam T, 2011, BEHAV BRAIN RES, V220, P185, DOI 10.1016/j.bbr.2011.01.039; Avrahami J, 1999, PERCEPT PSYCHOPHYS, V61, P1604, DOI 10.3758/BF03213121; Carrasco M, 2000, VISION RES, V40, P1203, DOI 10.1016/S0042-6989(00)00024-9; Carrasco M, 2002, J VISION, V2, DOI 10.1167/2.6.4; Chen Z, 2006, PERCEPT PSYCHOPHYS, V68, P992, DOI 10.3758/BF03193360; Ciaramitaro VM, 2011, J NEUROPHYSIOL, V105, P1258, DOI 10.1152/jn.00680.2010; DESIMONE R, 1995, ANNU REV NEUROSCI, V18, P193, DOI 10.1146/annurev.ne.18.030195.001205; Drummond L, 2010, ATTEN PERCEPT PSYCHO, V72, P1743, DOI 10.3758/APP.72.7.1743; Eckstein MP, 2000, PERCEPT PSYCHOPHYS, V62, P425, DOI 10.3758/BF03212096; EGLY R, 1994, J EXP PSYCHOL GEN, V123, P161, DOI 10.1037/0096-3445.123.2.161; Ho MC, 2011, ACTA PSYCHOL, V138, P45, DOI 10.1016/j.actpsy.2011.05.004; Ho MC, 2009, J EXP PSYCHOL HUMAN, V35, P1661, DOI 10.1037/a0016893; Ho MC, 2009, ACTA PSYCHOL, V132, P31, DOI 10.1016/j.actpsy.2009.02.004; Kastner S, 1998, SCIENCE, V282, P108, DOI 10.1126/science.282.5386.108; KRAMER AF, 1991, PERCEPT PSYCHOPHYS, V50, P267, DOI 10.3758/BF03206750; Kramer AF, 1999, PSYCHOL AGING, V14, P99, DOI 10.1037/0882-7974.14.1.99; Lamy D, 2002, PERCEPT PSYCHOPHYS, V64, P52, DOI 10.3758/BF03194557; Li XS, 2008, PSYCHON B REV, V15, P945, DOI 10.3758/PBR.15.5.945; Lin SY, 2011, ATTEN PERCEPT PSYCHO, V73, P678, DOI 10.3758/s13414-010-0078-2; Luo CM, 2011, Q J EXP PSYCHOL, V64, P2455, DOI 10.1080/17470218.2011.591935; Marino AC, 2005, PERCEPT PSYCHOPHYS, V67, P1140, DOI 10.3758/BF03193547; Matsukura M, 2011, ATTEN PERCEPT PSYCHO, V73, P447, DOI 10.3758/s13414-010-0039-9; Moore CM, 1998, PSYCHOL SCI, V9, P104, DOI 10.1111/1467-9280.00019; Reynolds JH, 1999, J NEUROSCI, V19, P1736; Richard AM, 2008, J EXP PSYCHOL HUMAN, V34, P842, DOI 10.1037/0096-1523.34.4.842; Roelfsema PR, 1998, NATURE, V395, P376, DOI 10.1038/26475; SHIU LP, 1994, J EXP PSYCHOL HUMAN, V20, P1037, DOI 10.1037/0096-1523.20.5.1037; Shomstein S, 2004, PSYCHON B REV, V11, P247, DOI 10.3758/BF03196566; Shomstein S, 2002, PERCEPT PSYCHOPHYS, V64, P41, DOI 10.3758/BF03194556; Shomstein S, 2008, PERCEPT PSYCHOPHYS, V70, P132, DOI 10.3758/PP.70.1.132; Shomstein S, 2012, WIRES COGN SCI, V3, P163, DOI 10.1002/wcs.1162; Ushitani T, 2010, VISION RES, V50, P577, DOI 10.1016/j.visres.2010.01.003; Wang J, 2007, NEUROPSYCHOLOGIA, V45, P1393, DOI 10.1016/j.neuropsychologia.2006.10.019; Watson SE, 1999, PERCEPT PSYCHOPHYS, V61, P31, DOI 10.3758/BF03211947; Wuhr P, 2008, J EXP PSYCHOL GEN, V137, P116, DOI 10.1037/0096-3445.137.1.116; Yeari M, 2010, J EXP PSYCHOL HUMAN, V36, P565, DOI 10.1037/a0016897; Yeshurun Y, 2009, VISION RES, V49, P1329, DOI 10.1016/j.visres.2008.01.014; Zemel RS, 2002, J EXP PSYCHOL HUMAN, V28, P202, DOI 10.1037//0096-1523.28.1.202; Zhao JJ, 2013, ATTEN PERCEPT PSYCHO, V75, P876, DOI 10.3758/s13414-013-0445-x	39	0	0	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2015	10	3							e0119414	10.1371/journal.pone.0119414	http://dx.doi.org/10.1371/journal.pone.0119414			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CD9NQ	25789772	Green Published, Green Submitted, gold			2022-12-27	WOS:000351425400082
J	Hu, R; Li, YX; Zhang, ZX; Yan, WR				Hu, Rong; Li, Yingxue; Zhang, Zhixia; Yan, Weirong			Antenatal Depressive Symptoms and the Risk of Preeclampsia or Operative Deliveries: A Meta-Analysis	PLOS ONE			English	Article							LOW-BIRTH-WEIGHT; BODY-MASS INDEX; PREGNANT-WOMEN; PRETERM BIRTH; PRENATAL DEPRESSION; ANTIDEPRESSANT USE; NEONATAL OUTCOMES; ELEVATED RISK; HEALTH; MODE	Background The purpose of the study was to investigate the association between depression and/or depressive symptoms during pregnancy and the risk of an operative delivery or preeclampsia, and to quantify the strength of the association. Methods A search of the PubMed, SCI/SSCI, Proquest PsycARTICLES and CINAHL databases was supplemented by manual searches of bibliographies of key retrieved articles and review articles. We aimed to include case control or cohort studies that reported data on antenatal depression and/or depressive symptoms and the risk of an operative delivery and/or preeclampsia. Results Twelve studies with self-reported screening instruments were eligible for inclusion with a total of 8400 participants. Seven articles that contained 4421 total participants reported the risk for an operative delivery, and five articles that contained 3979 total participants reported the risk for preeclampsia. The pooled analyses showed that both operative delivery and preeclampsia had a statistically significant association with antenatal depressive symptoms (RR = 1.24; 95% CI, 1.14 to 1.35, and OR = 1.63, 95% CI, 1.32 to 2.02, respectively). When the pre-pregnancy body mass indices were controlled in their initial design, the risk for preeclampsia still existed (OR = 1.48, 95% CI, 1.04 to 2.01), while the risk for an operative delivery became uncertain (RR = 1.01, 95% CI, 0.85 to 1.22). Conclusions Antenatal depressive symptoms are associated with a moderately increased risk of an operative delivery and preeclampsia. An abnormal pre-pregnancy body mass index may modify this association.	[Hu, Rong; Li, Yingxue; Zhang, Zhixia; Yan, Weirong] Huazhong Univ Sci & Technol, Tongji Med Coll, Sch Publ Hlth, Dept Epidemiol & Biostat, Wuhan 430074, Hubei, Peoples R China	Huazhong University of Science & Technology	Yan, WR (corresponding author), Huazhong Univ Sci & Technol, Tongji Med Coll, Sch Publ Hlth, Dept Epidemiol & Biostat, Wuhan 430074, Hubei, Peoples R China.	weirongy@gmail.com			National Natural Science Foundation of China [81172679/H2605]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This research was supported and funded by National Natural Science Foundation of China (grant number: 81172679/H2605) (https://isis.nsfc.gov.cn). The funders had no role in design, data collection and analysis, decision to publish, or preparation of the manuscript.	ACOG Committee on Obstetric Practice, 2002, Int J Gynaecol Obstet, V77, P67; Bae HS, 2010, NUTR RES PRACT, V4, P323, DOI 10.4162/nrp.2010.4.4.323; Bansil P, 2010, J WOMENS HEALTH, V19, P329, DOI 10.1089/jwh.2009.1387; Bodnar LM, 2005, ANN EPIDEMIOL, V15, P475, DOI 10.1016/j.annepidem.2004.12.008; Chamberlain G, 1999, BRIT MED J, V318, P1260; Chung TKH, 2001, PSYCHOSOM MED, V63, P830, DOI 10.1097/00006842-200109000-00017; Da Costa D, 2000, J AFFECT DISORDERS, V59, P31, DOI 10.1016/S0165-0327(99)00128-7; Dayan J, 2009, HUM REPROD, V24, P2044, DOI 10.1093/humrep/dep220; Direkvand-Moghadam A, 2012, ACTA BIOCHIM POL, V59, P673; Fairlie TG, 2009, J WOMENS HEALTH, V18, P945, DOI 10.1089/jwh.2008.0998; Gaynes B N, 2005, Evid Rep Technol Assess (Summ), P1; Grigoriadis S, 2013, J CLIN PSYCHIAT, V74, pE321, DOI 10.4088/JCP.12r07968; Grote NK, 2010, ARCH GEN PSYCHIAT, V67, P1012, DOI 10.1001/archgenpsychiatry.2010.111; Henrichs J, 2010, PSYCHOL MED, V40, P633, DOI 10.1017/S0033291709990894; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; Hildingsson I, 2002, BJOG-INT J OBSTET GY, V109, P618, DOI 10.1111/j.1471-0528.2002.01393.x; Huang H, 2014, GEN HOSP PSYCHIAT, V36, P13, DOI 10.1016/j.genhosppsych.2013.08.002; Imran N, 2010, ASIA-PAC PSYCHIAT, V2, P26, DOI 10.1111/j.1758-5872.2009.00028.x; Kessler RC, 1997, J AFFECT DISORDERS, V45, P19, DOI 10.1016/S0165-0327(97)00056-6; Kharaghani R, 2012, ARCH GYNECOL OBSTET, V286, P249, DOI 10.1007/s00404-012-2260-3; Kim DR, 2013, ARCH WOMEN MENT HLTH, V16, P475, DOI 10.1007/s00737-013-0371-x; Kurki T, 2000, OBSTET GYNECOL, V95, P487, DOI 10.1016/S0029-7844(99)00602-X; Lam N, 2008, REV PERU EPIDEMIOL, V13, P1; Lancaster CA, 2010, J WOMENS HEALTH, V19, P31, DOI 10.1089/jwh.2009.1383; Larsson C, 2004, OBSTET GYNECOL, V104, P459, DOI 10.1097/01.AOG.0000136087.46864.e4; Luginaah IN, 1999, CAN J PUBLIC HEALTH, V90, P377, DOI 10.1007/BF03404138; Luo J, 2013, THEORY PRACTICE SYST, P118; Mancuso A, 2006, ACTA OBSTET GYN SCAN, V85, P694, DOI 10.1080/00016340600645255; Meng L, 2012, J HYPERTENS, V30, P842, DOI 10.1097/HJH.0b013e32835080b7; Morken NH, 2013, ACTA OBSTET GYN SCAN, V92, P809, DOI 10.1111/aogs.12115; Murray CJL, 1997, LANCET, V349, P1436, DOI 10.1016/S0140-6736(96)07495-8; Murray D, 1990, J REPROD INFANT PSYC, V8, P99, DOI DOI 10.1080/02646839008403615; Neggers Y, 2006, ACTA OBSTET GYN SCAN, V85, P277, DOI 10.1080/00016340600566121; Osborne LM, 2013, PSYCHONEUROENDOCRINO, V38, P1929, DOI 10.1016/j.psyneuen.2013.03.019; Palladino CL, 2011, J WOMENS HEALTH, V20, P953, DOI 10.1089/jwh.2010.2380; Palmsten K, 2013, EPIDEMIOLOGY, V24, P682, DOI 10.1097/EDE.0b013e31829e0aaa; Palmsten K, 2012, AM J EPIDEMIOL, V175, P988, DOI 10.1093/aje/kwr394; Qiu C., 2007, BMC WOMENS HEALTH, V7, DOI [10.1186/1472-6874-7-15, DOI 10.1186/1472-6874-7-15]; Schuit E, 2012, BJOG-INT J OBSTET GY, V119, P915, DOI 10.1111/j.1471-0528.2012.03334.x; Sidebottom AC, 2012, ARCH WOMEN MENT HLTH, V15, P367, DOI 10.1007/s00737-012-0295-x; Stroup DF, 2000, JAMA-J AM MED ASSOC, V283, P2008, DOI 10.1001/jama.283.15.2008; Su KP, 2007, GEN HOSP PSYCHIAT, V29, P436, DOI 10.1016/j.genhosppsych.2007.05.005; Suri R, 2007, AM J PSYCHIAT, V164, P1206, DOI 10.1176/appi.ajp.2007.06071172; Van de Pol G, 2006, J PSYCHOSOM OBST GYN, V27, P231, DOI 10.1080/01674820600868966; Vollebregt KC, 2008, BJOG-INT J OBSTET GY, V115, P607, DOI 10.1111/j.1471-0528.2008.01665.x; Wang SY, 2010, J WOMENS HEALTH, V19, P2247, DOI 10.1089/jwh.2010.1988; Wells GA., 2015, NEWCASTLE OTTAWA SCA; Wu J, 2002, AM J OBSTET GYNECOL, V187, P864, DOI 10.1067/mob.2002.127126	49	71	73	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2015	10	3							e0119018	10.1371/journal.pone.0119018	http://dx.doi.org/10.1371/journal.pone.0119018			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD9NQ	25789626	gold, Green Published, Green Submitted			2022-12-27	WOS:000351425400061
J	Lunghi, B; De Cunto, G; Cavarra, E; Fineschi, S; Bartalesi, B; Lungarella, G; Lucattelli, M				Lunghi, Benedetta; De Cunto, Giovanna; Cavarra, Eleonora; Fineschi, Silvia; Bartalesi, Barbara; Lungarella, Giuseppe; Lucattelli, Monica			Smoking p66Shc Knocked Out Mice Develop Respiratory Bronchiolitis with Fibrosis but Not Emphysema	PLOS ONE			English	Article							OBSTRUCTIVE PULMONARY-DISEASE; CIGARETTE-SMOKE; OXIDATIVE STRESS; LIFE-SPAN; SIGNALING PATHWAY; REDOX REGULATION; APOPTOSIS; MACROPHAGES; EXPRESSION; PROTEINS	The adaptor protein p66Shc regulates intracellular oxidant levels through the modulation of a forkhead-related transcription factor (FOXO3a). The genetic ablation of p66(Shc) (p66(Shc-/-)) renders mice resistant to oxidative stress and p53-dependent apoptosis. We investigated whether p66(Shc) ablation in mice modifies lung cellular and molecular responses to cigarette smoke (CS) exposure. No differences between wild type (WT) and p66(Shc-/-) mice were observed in terms of inflammation and oxidant burden after acute CS exposure; however, p66(Shc) ablation modifies specific features of chronic inflammation induced by repeated exposure to CS. Unlike WT mice, p66(Shc-/-) mice did not develop emphysema, showing protection toward oxidative damage to DNA and apoptosis as revealed by a trivial 8-hydroxyguanosine staining and faint TUNEL and caspase-3 positivity on alveolar epithelial cells. Unexpectedly, CS exposure in p66(Shc-/-) mice resulted in respiratory bronchiolitis with fibrosis in surrounded alveoli. Respiratory bronchiolitis was characterized by peribronchiolar infiltrates of lymphocytes and histiocytes, accumulation of ageing pigmented macrophages within and around bronchioles, and peribronchiolar fibrosis. The blockage of apoptosis interferes with the macrophage "clearance" from alveolar spaces, favouring the accumulation of aging macrophages into alveoli and the progressive accumulation of iron pigment in long-lived senescent cells. The presence of areas of interstitial and alveolar fibrosis in peripheral parenchyma often accompanied the bronchiolar changes. Macrophages from smoking p66(Shc-/-) mice elaborate M2 cytokines (i.e., IL-4 and IL-13) and enzymes (i.e., chitinase and arginase I), which can promote TGF-beta expression, collagen deposition, and fibrosis in the surrounding areas. We demonstrate here that resistance to oxidative stress and p53-dependent apoptosis can modify tissue responses to CS caused by chronic inflammation without influencing early inflammatory response to CS exposure.	[Lunghi, Benedetta; De Cunto, Giovanna; Cavarra, Eleonora; Fineschi, Silvia; Bartalesi, Barbara; Lungarella, Giuseppe; Lucattelli, Monica] Univ Siena, Dept Life Sci, Expt Pathol Sect, Via Laterina 8, I-53100 Siena, Italy	University of Siena	Lucattelli, M (corresponding author), Univ Siena, Dept Life Sci, Expt Pathol Sect, Via Laterina 8, I-53100 Siena, Italy.	monica.lucattelli@unisi.it		De Cunto, Giovanna/0000-0002-3869-4621; CAVARRA, ELEONORA/0000-0002-4600-0546; LUNGARELLA, Giuseppe/0000-0002-3796-7317	Ministero dell'Istruzione, Universita e Ricerca, Rome, Italy [2004067923]	Ministero dell'Istruzione, Universita e Ricerca, Rome, Italy(Ministry of Education, Universities and Research (MIUR))	This study was supported by grants from the Ministero dell'Istruzione, Universita e Ricerca, Rome, Italy (grant no. 2004067923) to ML. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Thoracic Society/European Respiratory Society International Multidisciplinary Consensus Classification of the Idiopathic Interstitial Pneumonias, 2002, AM J RESP CRIT CARE, V165, P277, DOI [DOI 10.1164/AJRCCM.165.2.ATS01, 10.1164/ajrccm.165.2.ats01]; [Anonymous], 1996, Am J Respir Crit Care Med, V153, P861; Aoshiba K, 2001, AM J PHYSIOL-LUNG C, V281, pL1392, DOI 10.1152/ajplung.2001.281.6.L1392; Atzori L, 2009, AM J RESP CELL MOL, V41, P680, DOI 10.1165/rcmb.2007-0386OC; Bartalesi B, 2005, EUR RESPIR J, V25, P15, DOI 10.1183/09031936.04.00067204; Boorsma CE, 2013, MEDIAT INFLAMM, V2013, DOI [10.1155/2013/769214, DOI 10.1155/2013/769214]; CAMPBELL H, 1952, NATURE, V170, P117, DOI 10.1038/170117a0; Cardini S, 2012, AM J RESP CELL MOL, V47, P332, DOI 10.1165/rcmb.2012-0036OC; Cavarra E, 2001, AM J RESP CRIT CARE, V164, P886, DOI 10.1164/ajrccm.164.5.2010032; Churg A, 2008, AM J PHYSIOL-LUNG C, V294, pL612, DOI 10.1152/ajplung.00390.2007; Cocci F, 2002, INT J BIOCHEM CELL B, V34, P594, DOI 10.1016/S1357-2725(02)00015-8; EIDELMAN DH, 1990, LUNG, V168, P159, DOI 10.1007/BF02719687; Francia P, 2004, CIRCULATION, V110, P2889, DOI 10.1161/01.CIR.0000147731.24444.4D; Frankenberger M, 2004, CLIN EXP IMMUNOL, V138, P507, DOI 10.1111/j.1365-2249.2004.02637.x; Giorgio M, 2005, CELL, V122, P221, DOI 10.1016/j.cell.2005.05.011; Graiani G, 2005, HYPERTENSION, V46, P433, DOI 10.1161/01.HYP.0000174986.73346.ba; Habeeb A F, 1972, Methods Enzymol, V25, P457, DOI 10.1016/S0076-6879(72)25041-8; Hesse M, 2001, J IMMUNOL, V167, P6533, DOI 10.4049/jimmunol.167.11.6533; Hiemstra Pieter S, 2013, Ann Am Thorac Soc, V10 Suppl, pS180, DOI 10.1513/AnnalsATS.201305-123AW; Hu YY, 2005, MOL BIOL CELL, V16, P3705, DOI 10.1091/mbc.E05-04-0301; Hwang JW, 2011, J IMMUNOL, V187, P987, DOI 10.4049/jimmunol.1001861; Kasai H, 2005, RESP RES, V6, DOI 10.1186/1465-9921-6-56; Koch OR, 2008, LAB INVEST, V88, P750, DOI 10.1038/labinvest.2008.44; Lee MK, 2014, AM J PHYSIOL-LUNG C, V306, pL316, DOI 10.1152/ajplung.00062.2013; MacNee W, 1999, AM J RESP CRIT CARE, V160, pS58, DOI 10.1164/ajrccm.160.supplement_1.15; Migliaccio E, 1999, NATURE, V402, P309, DOI 10.1038/46311; MILLER NJ, 1993, CLIN SCI, V84, P407, DOI 10.1042/cs0840407; Mills CD, 2000, J IMMUNOL, V164, P6166, DOI 10.4049/jimmunol.164.12.6166; Mills CD, 2012, CRIT REV IMMUNOL, V32, P463, DOI 10.1615/CritRevImmunol.v32.i6.10; MYERS JL, 1987, AM REV RESPIR DIS, V135, P880, DOI 10.1164/arrd.1987.135.4.880; Napoli C, 2003, P NATL ACAD SCI USA, V100, P2112, DOI 10.1073/pnas.0336359100; Nemoto S, 2002, SCIENCE, V295, P2450, DOI 10.1126/science.1069004; Ohtani N, 2001, NATURE, V409, P1067, DOI 10.1038/35059131; Pastukh VM, 2011, INT J CHRONIC OBSTR, V6, P209, DOI 10.2147/COPD.S15922; Pellegrini M, 2005, APOPTOSIS, V10, P13, DOI 10.1007/s10495-005-6057-8; Petrache I, 2008, AM J PHYSIOL-LUNG C, V295, pL44, DOI 10.1152/ajplung.00448.2007; Rahman I, 2006, EUR RESPIR J, V28, P219, DOI 10.1183/09031936.06.00053805; Rahman I, 2002, AM J RESP CRIT CARE, V166, P490, DOI 10.1164/rccm.2110101; Ramsey JJ, 2014, J GERONTOL A-BIOL, V69, P1177, DOI 10.1093/gerona/glt198; Reddy Taryn L, 2013, Ann Am Thorac Soc, V10, P590, DOI 10.1513/AnnalsATS.201304-088OC; Sayin VI, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3007653; Teramoto S, 2005, CHEST, V127, P1079, DOI 10.1378/chest.127.3.1079; THURLBEC.WM, 1967, AM REV RESPIR DIS, V95, P765; THURLBEC.WM, 1967, AM REV RESPIR DIS, V95, P752; TIETZE F, 1969, ANAL BIOCHEM, V27, P502, DOI 10.1016/0003-2697(69)90064-5; Tran Hien, 2003, Sci STKE, V2003, pRE5, DOI 10.1126/stke.2003.172.re5; Trinei M, 2002, ONCOGENE, V21, P3872, DOI 10.1038/sj.onc.1205513; Tuder Rubin M, 2012, Proc Am Thorac Soc, V9, P62, DOI 10.1513/pats.201201-012MS; Tugal D, 2013, ARTERIOSCL THROM VAS, V33, P1135, DOI 10.1161/ATVBAHA.113.301453; Winer J, 1999, ANAL BIOCHEM, V270, P41, DOI 10.1006/abio.1999.4085; Yoshida T, 2007, PHYSIOL REV, V87, P1047, DOI 10.1152/physrev.00048.2006; Yu Q, 2000, GENE DEV, V14, P163; Zaccagnini G, 2004, CIRCULATION, V109, P2917, DOI 10.1161/01.CIR.0000129309.58874.0F	53	17	17	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2015	10	3							e0119797	10.1371/journal.pone.0119797	http://dx.doi.org/10.1371/journal.pone.0119797			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD9NQ	25790295	Green Published, Green Submitted, gold			2022-12-27	WOS:000351425400107
J	Meena, NK; Ahuja, V; Meena, K; Paul, J				Meena, Naresh Kumar; Ahuja, Vineet; Meena, Kusumlata; Paul, Jaishree			Association of TLR5 Gene Polymorphisms in Ulcerative Colitis Patients of North India and Their Role in Cytokine Homeostasis	PLOS ONE			English	Article							INFLAMMATORY-BOWEL-DISEASE; TOLL-LIKE RECEPTOR; SINGLE-NUCLEOTIDE POLYMORPHISMS; EXPRESSION	Background and Aim In health, TLR signaling protects the intestinal epithelial barrier and in disease, aberrant TLR signaling stimulates diverse inflammatory responses. Association of TLR polymorphisms is ethnicity dependent but how they impact the complex pathogenesis of IBD is not clearly defined. So we propose to study the status of polymorphisms in TLR family of genes and their effect on cytokines level in UC patients. Methods The genotypes of the six loci TLR1-R80T, TLR2-R753Q, TLR3-S258G, TLR5-R392X, TLR5-N592S and TLR6-S249P were determined in 350 controls and 328 UC patients by PCR-RFLP and sequencing. Cytokine levels were measured by ELISA in blood plasma samples. Data were analyzed statistically by SPSS software. Results TLR5 variants R392X and N592S showed significant association (p = 0.007, 0.021) with UC patients but TLR 1, 2, 3, 6 variants did not show any association. Unlike other studies carried out in different ethnic groups, TLR 6 (S249P) SNP was universally present in our population irrespective of disease. Genotype-phenotype correlation analysis revealed that the patients having combination of multiple SNPs both in TLR5 and TLR4 gene suffered from severe disease condition and diagnosed at an early age. The level of TNF alpha (p = 0.004), IL-6 (p = 0.0001) and IFN gamma (p = 0.006) significantly increased in patients as compared to controls having wild genotypes for the studied SNPs. However, there was decreased level of TNF alpha (p = 0.014), IL-6 (p = 0.028) and IFN gamma (p = 0.001) in patients carrying TLR5-R392X variant as compared to wild type patients. Patients carrying two simultaneous SNPs D299G in TLR4 gene and N592S in TLR5 gene showed significant decrease in the levels of TNFa (p = 0.011) and IFN. (p = 0.016). Conclusion Polymorphisms in TLR 5 genes were significantly associated with the UC in North Indian population. The cytokine level was significantly modulated in patients with different genotypes of TLR4 and TLR5 SNPs.	[Meena, Naresh Kumar; Paul, Jaishree] Jawaharlal Nehru Univ, Sch Life Sci, New Delhi 110067, India; [Ahuja, Vineet] All India Inst Med Sci, Dept Gastroenterol, New Delhi, India; [Meena, Kusumlata] SMS Med Coll & Hosp, Dept Obstet & Gynaecol, Jaipur, Rajasthan, India	Jawaharlal Nehru University, New Delhi; All India Institute of Medical Sciences (AIIMS) New Delhi; SMS Medical College & Hospital	Paul, J (corresponding author), Jawaharlal Nehru Univ, Sch Life Sci, New Delhi 110067, India.	jpaul33@hotmail.com	Meena, Naresh Kumar/GLU-8350-2022; Ahuja, Vineet/N-1705-2019	Ahuja, Vineet/0000-0002-5474-9709; Meena, Naresh Kumar/0000-0001-5450-5184	Department of Science and Technology, Government of India [SR/SO/HS-98/2005]; Council of scientific and industrial research, Government of India in the School of Life Sciences, at the Jawaharlal Nehru University, India [37(1387)/09/EMR-II]; University Grants Commission, New Delhi, India	Department of Science and Technology, Government of India(Department of Science & Technology (India)); Council of scientific and industrial research, Government of India in the School of Life Sciences, at the Jawaharlal Nehru University, India; University Grants Commission, New Delhi, India(University Grants Commission, India)	This work was supported in part by the research grant received by JP from the Department of Science and Technology, Government of India (D.O. No. SR/SO/HS-98/2005), and partially by Council of scientific and industrial research, Government of India (Grant No. 37(1387)/09/EMR-II) in the School of Life Sciences, at the Jawaharlal Nehru University, India. NKM is grateful to the University Grants Commission, New Delhi, India for Research fellowships. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beutler B, 2003, J LEUKOCYTE BIOL, V74, P479, DOI 10.1189/jlb.0203082; Buwitt-Beckmann U, 2005, EUR J IMMUNOL, V35, P282, DOI 10.1002/eji.200424955; Cario E, 2000, INFECT IMMUN, V68, P7010, DOI 10.1128/IAI.68.12.7010-7017.2000; Chen L, 2012, WORLD J GASTROENTERO, V18, P6856, DOI 10.3748/wjg.v18.i46.6856; Gazouli M, 2005, WORLD J GASTROENTERO, V11, P681, DOI 10.3748/wjg.v11.i5.681; Gewirtz AT, 2006, AM J PHYSIOL-GASTR L, V290, pG1157, DOI 10.1152/ajpgi.00544.2005; Haerynck F, 2013, HUM IMMUNOL, V74, P1649, DOI 10.1016/j.humimm.2013.08.282; Hawn TR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005990; Hawn TR, 2003, J EXP MED, V198, P1563, DOI 10.1084/jem.20031220; Hibi T, 2006, J GASTROENTEROL, V41, P10, DOI 10.1007/s00535-005-1744-3; Himmel ME, 2008, IMMUNOLOGY, V125, P145, DOI 10.1111/j.1365-2567.2008.02939.x; Kao YL, 2004, MOL CELL PROBE, V18, P205, DOI 10.1016/j.mcp.2004.01.004; Kaser A, 2010, ANNU REV IMMUNOL, V28, P573, DOI 10.1146/annurev-immunol-030409-101225; Kim EJ, 2012, J KOREAN MED SCI, V27, P72, DOI [10.3346/jkms.2011.27.1.72, 10.3346/jkms.2012.27.1.72]; Klimosch SN, 2013, CANCER RES, V73, P7232, DOI 10.1158/0008-5472.CAN-13-1746; Meena NK, 2013, J CLIN GASTROENTEROL, V47, P773, DOI 10.1097/MCG.0b013e31828a6e93; MILLER SA, 1988, NUCLEIC ACIDS RES, V16, P1215, DOI 10.1093/nar/16.3.1215; Nguyen GC, 2006, AM J GASTROENTEROL, V101, P1012, DOI 10.1111/j.1572-0241.2006.00504.x; Pierik M, 2006, INFLAMM BOWEL DIS, V12, P1, DOI 10.1097/01.MIB.0000195389.11645.ab; Pirie FJ, 2005, TISSUE ANTIGENS, V66, P125, DOI 10.1111/j.1399-0039.2005.00454.x; Podolsky DK, 2002, NEW ENGL J MED, V347, P417, DOI 10.1056/NEJMra0804647; Satsangi J, 2006, GUT, V55, P749, DOI 10.1136/gut.2005.082909; Szkaradkiewicz A, 2009, ARCH IMMUNOL THER EX, V57, P291, DOI 10.1007/s00005-009-0031-z; Takeuchi O, 2001, INT IMMUNOL, V13, P933, DOI 10.1093/intimm/13.7.933; Trejo-de la O A, 2008, CLIN IMMUNOL, V129, P333, DOI 10.1016/j.clim.2008.07.009; Ueta M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043650; Yang XQ, 2012, MOL BIOL REP, V39, P7003, DOI 10.1007/s11033-012-1530-2; Yang ZH, 2012, CANCER SCI, V103, P653, DOI 10.1111/j.1349-7006.2012.02210.x; Zhang DK, 2004, SCIENCE, V303, P1522, DOI 10.1126/science.1094351	30	28	32	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2015	10	3							e0120697	10.1371/journal.pone.0120697	http://dx.doi.org/10.1371/journal.pone.0120697			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD9NQ	25789623	Green Submitted, Green Published, gold			2022-12-27	WOS:000351425400171
J	Szymkowiak, J; Kuczynski, L				Szymkowiak, Jakub; Kuczynski, Lechoslaw			Predation-Related Costs and Benefits of Conspecific Attraction in Songbirds-An Agent-Based Approach	PLOS ONE			English	Article							WARBLER PHYLLOSCOPUS-SIBILATRIX; SOCIAL INFORMATION USE; HABITAT SELECTION; PUBLIC INFORMATION; NEST PREDATION; ECOLOGICAL TRAPS; PRIMEVAL FOREST; ANIMAL BEHAVIOR; DENSITY; BIRDS	Songbirds that follow a conspecific attraction strategy in the habitat selection process prefer to settle in habitat patches already occupied by other individuals. This largely affects the patterns of their spatio-temporal distribution and leads to clustered breeding. Although making informed settlement decisions is expected to be beneficial for individuals, such territory clusters may potentially provide additional fitness benefits (e.g., through the dilution effect) or costs (e.g., possibly facilitating nest localization if predators respond functionally to prey distribution). Thus, we hypothesized that the fitness consequences of following a conspecific attraction strategy may largely depend on the composition of the predator community. We developed an agent-based model in which we simulated the settling behavior of birds that use a conspecific attraction strategy and breed in a multi-predator landscape with predators that exhibited different foraging strategies. Moreover, we investigated whether Bayesian updating of prior settlement decisions according to the perceived predation risk may improve the fitness of birds that rely on conspecific cues. Our results provide evidence that the fitness consequences of conspecific attraction are predation-related. We found that in landscapes dominated by predators able to respond functionally to prey distribution, clustered breeding led to fitness costs. However, this cost could be reduced if birds performed Bayesian updating of prior settlement decisions and perceived nesting with too many neighbors as a threat. Our results did not support the hypothesis that in landscapes dominated by incidental predators, clustered breeding as a byproduct of conspecific attraction provides fitness benefits through the dilution effect. We suggest that this may be due to the spatial scale of songbirds' aggregative behavior. In general, we provide evidence that when considering the fitness consequences of conspecific attraction for songbirds, one should expect a trade-off between the benefits of making informed decisions and the costs of clustering.	[Szymkowiak, Jakub; Kuczynski, Lechoslaw] Adam Mickiewicz Univ, Fac Biol, Inst Environm Biol, Dept Avian Biol & Ecol, Poznan, Poland	Adam Mickiewicz University	Szymkowiak, J (corresponding author), Adam Mickiewicz Univ, Fac Biol, Inst Environm Biol, Dept Avian Biol & Ecol, Poznan, Poland.	jszym@amu.edu.pl	Kuczyński, Lechosław/E-5525-2011; Szymkowiak, Jakub/D-6669-2016	Kuczyński, Lechosław/0000-0003-3498-5445; Szymkowiak, Jakub/0000-0002-4595-1876	National Science Centre in Poland [2012/07/N/NZ8/00129]	National Science Centre in Poland(National Science Centre, Poland)	This work was supported by the National Science Centre in Poland (grant number 2012/07/N/NZ8/00129). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahlering MA, 2006, AUK, V123, P301, DOI 10.1642/0004-8038(2006)123[301:AHMMCA]2.0.CO;2; Ahlering MA, 2010, CONDOR, V112, P252, DOI 10.1525/cond.2010.090239; ALATALO RV, 1982, BIRD BEHAV, V4, P42, DOI 10.3727/015613882791560576; Andren H., 1991, ANIM BEHAV, V41, P1063; Battin J, 2004, CONSERV BIOL, V18, P1482, DOI 10.1111/j.1523-1739.2004.00417.x; Bayard TS, 2012, WETLANDS, V32, P521, DOI 10.1007/s13157-012-0287-7; BEEHLER BM, 1988, AM NAT, V131, P203, DOI 10.1086/284786; Betts MG, 2008, ECOGRAPHY, V31, P592, DOI 10.1111/j.0906-7590.2008.05490.x; CLARK KL, 1979, BEHAV ECOL SOCIOBIOL, V5, P359, DOI 10.1007/BF00292524; Codling EA, 2008, J R SOC INTERFACE, V5, P813, DOI 10.1098/rsif.2008.0014; Dall SRX, 2005, TRENDS ECOL EVOL, V20, P187, DOI 10.1016/j.tree.2005.01.010; Danchin E, 2004, SCIENCE, V305, P487, DOI 10.1126/science.1098254; Diong CH, 1982, THESIS U HAWAII MANO; Doligez B, 2003, ANIM BEHAV, V66, P973, DOI 10.1006/anbe.2002.2270; Doligez B, 2004, J ANIM ECOL, V73, P75, DOI 10.1111/j.1365-2656.2004.00782.x; Forsman JT, 2007, BEHAV ECOL, V18, P888, DOI 10.1093/beheco/arm048; Fuller R.J., 2012, BIRDS HABITAT RELATI; Gilroy JJ, 2007, TRENDS ECOL EVOL, V22, P351, DOI 10.1016/j.tree.2007.03.014; Gilroy JJ, 2010, IBIS, V152, P90, DOI 10.1111/j.1474-919X.2009.00988.x; Giraldeau LA, 2002, PHILOS T R SOC B, V357, P1559, DOI 10.1098/rstb.2002.1065; Glutz von Blotzheim U., 1991, HDB VOGEL MITTELEURO; Grimm V, 2006, ECOL MODEL, V198, P115, DOI 10.1016/j.ecolmodel.2006.04.023; Grimm V, 2010, ECOL MODEL, V221, P2760, DOI 10.1016/j.ecolmodel.2010.08.019; Hahn BA, 2007, ANIM CONSERV, V10, P436, DOI 10.1111/j.1469-1795.2007.00128.x; HAMILTON WD, 1971, J THEOR BIOL, V31, P295, DOI 10.1016/0022-5193(71)90189-5; Ioannou CC, 2008, ANIM BEHAV, V75, P1383, DOI 10.1016/j.anbehav.2007.09.012; Kery M., 2010, INTRO WINBUGS ECOLOG; KRAUSE J, 1995, ANIM BEHAV, V50, P465, DOI 10.1006/anbe.1995.0260; Lima SL, 2009, BIOL REV, V84, P485, DOI 10.1111/j.1469-185X.2009.00085.x; Mallord JW, 2012, BIRD STUDY, V59, P286, DOI 10.1080/00063657.2012.669359; MCNAMARA J, 1980, J THEOR BIOL, V85, P673, DOI 10.1016/0022-5193(80)90265-9; McNamara JM, 2006, OIKOS, V112, P243, DOI 10.1111/j.0030-1299.2006.14228.x; Monkkonen Mikko, 2002, Ornithological Science, V1, P41, DOI 10.2326/osj.1.41; Morosinotto C, 2010, J ANIM ECOL, V79, P327, DOI 10.1111/j.1365-2656.2009.01638.x; NetLogo Wilensky U., 1999, NETLOGO; Nocera JJ, 2006, P ROY SOC B-BIOL SCI, V273, P349, DOI 10.1098/rspb.2005.3318; Phillips ML, 2004, J MAMMAL, V85, P187, DOI 10.1644/1545-1542(2004)085&lt;0187:AOPMIP&gt;2.0.CO;2; Plummer M., 2003, DSC 2003 WORKING PAP, DOI 10.1002/ana.1067; R Development Core Team, 2013, LANG ENV STAT COMP; Reynolds AM, 2009, ECOLOGY, V90, P877, DOI 10.1890/08-0153.1; Rieucau G, 2011, PHILOS T R SOC B, V366, P949, DOI 10.1098/rstb.2010.0325; Ringelman KM, 2014, OIKOS, V123, P239, DOI 10.1111/j.1600-0706.2013.00851.x; Ringelman KM, 2014, ECOL MODEL, V272, P141, DOI 10.1016/j.ecolmodel.2013.09.028; Ringelman KM, 2012, OECOLOGIA, V169, P695, DOI 10.1007/s00442-011-2228-1; Schmidt KA, 1999, OIKOS, V87, P65, DOI 10.2307/3546997; Schmidt KA, 2010, OIKOS, V119, P304, DOI 10.1111/j.1600-0706.2009.17573.x; Seppanen JT, 2007, ECOLOGY, V88, P1622, DOI 10.1890/06-1757.1; Seymour AS, 2004, ECOL MODEL, V175, P101, DOI 10.1016/j.ecolmodel.2003.10.012; Sridhar H, 2009, ANIM BEHAV, V78, P337, DOI 10.1016/j.anbehav.2009.05.008; STAMPS JA, 1991, BEHAV ECOL SOCIOBIOL, V28, P29; STAMPS JA, 1988, AM NAT, V131, P329, DOI 10.1086/284793; Su Y., 2014, R2JAGS PACKAGE RUNNI; Szymkowiak J., 2013, SPRINGER SCI REV, V1, P115, DOI DOI 10.1007/s40362-013-0012-9; Thomson RL, 2006, ECOGRAPHY, V29, P507; TURNER GF, 1986, AM NAT, V128, P228, DOI 10.1086/284556; Valone TJ, 2006, OIKOS, V112, P252; Ward MP, 2004, CONSERV BIOL, V18, P519, DOI 10.1111/j.1523-1739.2004.00494.x; WESOLOWSKI T, 1985, ORNIS SCAND, V16, P49, DOI 10.2307/3676575; Wesolowski T, 2009, ACTA ORNITHOL, V44, P69, DOI 10.3161/000164509X464902; Wesolowski T, 2009, BIRD STUDY, V56, P26, DOI 10.1080/00063650802681540	60	5	5	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2015	10	3							e0119132	10.1371/journal.pone.0119132	http://dx.doi.org/10.1371/journal.pone.0119132			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD9NQ	25790479	Green Published, Green Submitted, gold			2022-12-27	WOS:000351425400069
J	Wang, J; Chen, R; Tang, SW; Lv, XZ; Wu, SS; Zhang, Y; Xia, YY; Gao, P; Tu, DH; Chen, DF; Zhan, SY				Wang, Jing; Chen, Ru; Tang, Shaowen; Lv, Xiaozhen; Wu, Shanshan; Zhang, Yuan; Xia, Yinyin; Gao, Pei; Tu, Dehua; Chen, Dafang; Zhan, Siyan			Analysis of IL-6, STAT3 and HSPA1L Gene Polymorphisms in Anti-Tuberculosis DrugInduced Hepatitis in a Nested Case-Control Study	PLOS ONE			English	Article							INDUCED LIVER-INJURY; CELL-MEDIATED HEPATITIS; HEAT-SHOCK PROTEINS; INDUCED HEPATOTOXICITY; INTERLEUKIN-6; SUSCEPTIBILITY; HEPATOCYTES; ASSOCIATION; EXPRESSION; INDUCTION	Objectives To investigate the association of IL-6, STAT3 and HSPA1L polymorphisms with the risk of anti-tuberculosis drug-induced hepatitis (ATDH) in Chinese Han population. Methods The study was designed as a nested case-control study within a prospective cohort. Each case was matched with four controls by sex, age at baseline (+/- 5 years), treatment history, disease severity, drug dosage and place of sample collection. Genetic polymorphisms of IL6, STAT3 and HSPA1L were determined blindly by TaqMan single-nucleotide polymorphism (SNP) genotyping assay. Odds ratio (OR) with 95% confidence intervals (CIs) was estimated by conditional logistic regression model to measure the association between selected SNPs and the risk of ATDH. Results A total of 89 incident ATDH cases and 356 ATDH-free controls were genotyped for IL-6 (rs2066992, rs2069837, rs1524107), STAT3 (rs1053004, rs1053023, rs1053005) and HSPA1L (rs2227956). In genotype analysis, no significant difference was observed in genotypes frequencies of the seven selected SNPs between case and control group after Bonferroni correction. In haplotype analysis, carriers with STAT3 GAT and AGC (rs1053023-rs1053005-rs1053004) haplotypes had a significantly higher risk of ATDH compared with wild-type haplotype (P<0.0001). Conclusion This study suggested that genetic variants of STAT3 might contribute to ATDH susceptibility in Chinese Han population. Studies in larger, varied populations are required to confirm these findings.	[Wang, Jing; Chen, Ru; Tang, Shaowen; Wu, Shanshan; Gao, Pei; Chen, Dafang; Zhan, Siyan] Peking Univ, Dept Epidemiol & Biostat, Sch Publ Hlth, Hlth Sci Ctr, Beijing 100871, Peoples R China; [Tang, Shaowen] Nanjing Med Univ, Sch Publ Hlth, Dept Epidemiol & Biostat, Nanjing, Jiangsu, Peoples R China; [Lv, Xiaozhen] Peking Univ, Div Clin Res, Inst Mental Hlth, Beijing 100871, Peoples R China; [Lv, Xiaozhen] Minist Hlth, Key Lab Mental Hlth, Beijing, Peoples R China; [Zhang, Yuan] McMaster Univ, Dept Clin Epidemiol & Biostat, Hamilton, ON, Canada; [Xia, Yinyin] Chinese Ctr Dis Control & Prevent, Ctr TB Control & Prevent, Beijing, Peoples R China; [Tu, Dehua] Beijing Inst TB Control, Dept TB Treatment, Beijing, Peoples R China	Peking University; Nanjing Medical University; Peking University; McMaster University; Chinese Center for Disease Control & Prevention	Zhan, SY (corresponding author), Peking Univ, Dept Epidemiol & Biostat, Sch Publ Hlth, Hlth Sci Ctr, Beijing 100871, Peoples R China.	siyan-zhan@bjmu.edu.cn		Wang, Jing/0000-0001-5701-476X; Tang, Shaowen/0000-0001-5879-8594	National Natural Science Foundation of China [81072387]; Beijing Natural Science Foundation [7111006]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Beijing Natural Science Foundation(Beijing Natural Science Foundation)	This study is funded by National Natural Science Foundation of China (NO. 81072387) and Beijing Natural Science Foundation (NO. 7111006). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afzal AR, 2008, CARDIOLOGY, V110, P45, DOI 10.1159/000109406; Aithal GP, 2004, HEPATOLOGY, V39, P1430, DOI 10.1002/hep.20205; Awofeso N., 2008, B WHO, V86; Bajramovic JJ, 2000, J NEUROIMMUNOL, V106, P14, DOI 10.1016/S0165-5728(99)00260-X; BENICHOU C, 1990, J HEPATOL, V11, P272; Bollrath J, 2009, EMBO REP, V10, P1314, DOI 10.1038/embor.2009.243; Camargo CA, 1997, HEPATOLOGY, V26, P1513, DOI 10.1002/hep.510260619; Carr DF, 2007, PHARMACOGENET GENOM, V17, P961, DOI 10.1097/FPC.0b013e3282f00919; Chen J, 2013, J GASTROEN HEPATOL, V28, P814, DOI 10.1111/jgh.12163; Chiu H, 2002, TOXICOL APPL PHARM, V181, P106, DOI 10.1006/taap.2002.9409; Daly AK, 2007, GASTROENTEROLOGY, V132, P272, DOI 10.1053/j.gastro.2006.11.023; Daly AK, 2009, NAT GENET, V41, P816, DOI 10.1038/ng.379; DiBonaventura MD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086070; Didelot C, 2006, HANDB EXP PHARM, V172, P171; Gao B, 2005, CELL MOL IMMUNOL, V2, P92; He L, 2014, SCI WORLD J, DOI 10.1155/2014/540309; Hong F, 2002, ONCOGENE, V21, P32, DOI 10.1038/sj.onc.1205016; Hong F, 2002, J CLIN INVEST, V110, P1503, DOI 10.1172/JCI200215841; Huang YS, 2002, HEPATOLOGY, V35, P883, DOI 10.1053/jhep.2002.32102; Inns T., 2013, EUROSURVEILLANCE, V18, P20654; James LP, 2005, J CLIN PHARMACOL, V45, P1165, DOI 10.1177/0091270005280296; Kaona FAD, 2004, BMC PUBLIC HEALTH, V4, DOI 10.1186/1471-2458-4-68; Kim SH, 2012, LIVER INT, V32, P809, DOI 10.1111/j.1478-3231.2011.02697.x; Lee SW, 2010, INT J TUBERC LUNG D, V14, P622; Li W, 2002, J BIOL CHEM, V277, P28411, DOI 10.1074/jbc.M202807200; Liang X, 2013, CLIN TRANSL ONCOL, V15, P331, DOI 10.1007/s12094-012-0936-6; Lv XZ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065037; Masubachi Y, 2003, BIOCHEM BIOPH RES CO, V304, P207, DOI 10.1016/S0006-291X(03)00572-2; Mayer MP, 2005, CELL MOL LIFE SCI, V62, P670, DOI 10.1007/s00018-004-4464-6; National Tuberculosis Association of the USA, 1961, DIAGN STAND CLASS TU; Obayashi Y, 2012, AMINO ACIDS, V43, P2371, DOI 10.1007/s00726-012-1317-8; Ohno M, 2000, INT J TUBERC LUNG D, V4, P256; Pachkoria K, 2008, J HEPATOL, V49, P107, DOI 10.1016/j.jhep.2008.03.017; Rokutan K, 2000, J GASTROEN HEPATOL, V15, pD12, DOI 10.1046/j.1440-1746.2000.02144.x; Saukkonen JJ, 2006, AM J RESP CRIT CARE, V174, P935, DOI 10.1164/rccm.200510-1666ST; Shang PH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021836; Sliwinska-Kowalska M, 2013, MUTAT RES-REV MUTAT, V752, P61, DOI 10.1016/j.mrrev.2012.11.001; Song JY, 2007, EXP TOXICOL PATHOL, V59, P29, DOI 10.1016/j.etp.2007.02.005; Sun R, 2004, J IMMUNOL, V172, P5648, DOI 10.4049/jimmunol.172.9.5648; Taub R, 2003, J CLIN INVEST, V112, P978, DOI 10.1172/JCI20031200319974; Teuber M, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-81; Ucisik-Akkaya E, 2010, CELL STRESS CHAPERON, V15, P475, DOI 10.1007/s12192-009-0161-6; Urban TJ, 2012, PHARMACOGENET GENOM, V22, P784, DOI 10.1097/FPC.0b013e3283589a76; Wang H, 2011, INT J BIOL SCI, V7, P536, DOI 10.7150/ijbs.7.536; World Health Organization, 2005, US WHO UMC SYST STAN; World Hlth Org, 2002, INT J TUBERC LUNG D, V6, P378; Xia YY, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-267; Xia Yin-Yin, 2007, Zhonghua Jiehe He Huxi Zazhi, V30, P419	48	5	10	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2015	10	3							e0118862	10.1371/journal.pone.0118862	http://dx.doi.org/10.1371/journal.pone.0118862			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD9NQ	25789467	gold, Green Published, Green Submitted			2022-12-27	WOS:000351425400050
J	Strick-Marchand, H; Dusseaux, M; Darche, S; Huntington, ND; Legrand, N; Masse-Ranson, G; Corcuff, E; Ahodantin, J; Weijer, K; Spits, H; Kremsdorf, D; Di Santo, JP				Strick-Marchand, Helene; Dusseaux, Mathilde; Darche, Sylvie; Huntington, Nicholas D.; Legrand, Nicolas; Masse-Ranson, Guillemette; Corcuff, Erwan; Ahodantin, James; Weijer, Kees; Spits, Hergen; Kremsdorf, Dina; Di Santo, James P.			A Novel Mouse Model for Stable Engraftment of a Human Immune System and Human Hepatocytes	PLOS ONE			English	Article							C VIRUS-INFECTION; IN-VIVO; HEPATITIS-C; ANIMAL-MODELS; PLASMINOGEN-ACTIVATOR; ANTIBODY-RESPONSES; CELL MATURATION; T-CELLS; MICE; LIVER	Hepatic infections by hepatitis B virus (HBV), hepatitis C virus (HCV) and Plasmodium parasites leading to acute or chronic diseases constitute a global health challenge. The species tropism of these hepatotropic pathogens is restricted to chimpanzees and humans, thus model systems to study their pathological mechanisms are severely limited. Although these pathogens infect hepatocytes, disease pathology is intimately related to the degree and quality of the immune response. As a first step to decipher the immune response to infected hepatocytes, we developed an animal model harboring both a human immune system ( HIS) and human hepatocytes (HUHEP) in BALB/c Rag2(-/)-IL-2R gamma c(-/)-NOD. sirpa uPA(tg/tg) mice. The extent and kinetics of human hepatocyte engraftment were similar between HUHEP and HIS-HUHEP mice. Transplanted human hepatocytes were polarized and mature in vivo, resulting in 20-50% liver chimerism in these models. Human myeloid and lymphoid cell lineages developed at similar frequencies in HIS and HIS-HUHEP mice, and splenic and hepatic compartments were humanized with mature B cells, NK cells and naive T cells, as well as monocytes and dendritic cells. Taken together, these results demonstrate that HIS-HUHEP mice can be stably (> 5 months) and robustly engrafted with a humanized immune system and chimeric human liver. This novel HIS-HUHEP model provides a platform to investigate human immune responses against hepatotropic pathogens and to test novel drug strategies or vaccine candidates.	[Strick-Marchand, Helene; Dusseaux, Mathilde; Darche, Sylvie; Huntington, Nicholas D.; Masse-Ranson, Guillemette; Corcuff, Erwan; Di Santo, James P.] Inst Pasteur, Dept Immunol, Innate Immun Unit, F-75724 Paris, France; [Strick-Marchand, Helene; Dusseaux, Mathilde; Darche, Sylvie; Huntington, Nicholas D.; Masse-Ranson, Guillemette; Corcuff, Erwan; Di Santo, James P.] INSERM, U668, Paris, France; [Legrand, Nicolas; Weijer, Kees; Spits, Hergen] Univ Amsterdam, Acad Med Ctr, NL-1105 AZ Amsterdam, Netherlands; [Ahodantin, James; Kremsdorf, Dina] Fac Med Paris Descartes, INSERM, U845, Paris, France	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Institut National de la Sante et de la Recherche Medicale (Inserm); University of Amsterdam; Academic Medical Center Amsterdam; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite	Di Santo, JP (corresponding author), Inst Pasteur, Dept Immunol, Innate Immun Unit, F-75724 Paris, France.	james.di-santo@pasteur.fr	Huntington, NICHOLAS/AAV-4704-2020; Ahodantin, James/AAB-7216-2022; Legrand, Nicolas/B-1794-2009; Di Santo, James P/M-4298-2014; Kremsdorf, Dina/O-9797-2017; Ahodantin, James/AAK-3326-2020; Strick-Marchand, Helene/M-6525-2014	Huntington, NICHOLAS/0000-0002-5267-7211; Ahodantin, James/0000-0003-4405-2593; Legrand, Nicolas/0000-0002-0236-7653; Di Santo, James P/0000-0002-7146-1862; Ahodantin, James/0000-0003-4405-2593; Strick-Marchand, Helene/0000-0002-0519-214X	Bill & Melinda Gates foundation [37869]; Agence Nationale de la recherche programme Emergence [ANR-11-EMMA-026]; Agence Nationale de la recherche programme LABEX [ANR-10-LBX-73]; Agence Nationale deRecherches sur le Sida et les hepatites virales [2013-105]; European Commission Seventh Framework Programme PathCO [HEALTH-F3-2012-305578]	Bill & Melinda Gates foundation(Bill & Melinda Gates Foundation); Agence Nationale de la recherche programme Emergence(French National Research Agency (ANR)); Agence Nationale de la recherche programme LABEX(French National Research Agency (ANR)); Agence Nationale deRecherches sur le Sida et les hepatites virales(ANRSFrench National Research Agency (ANR)); European Commission Seventh Framework Programme PathCO	This study was supported by Bill & Melinda Gates foundation global health program grant # 37869. Agence Nationale de la recherche programme Emergence grant #ANR-11-EMMA-026. Agence Nationale de la recherche programme LABEX grant #ANR-10-LBX-73. Agence Nationale deRecherches sur le Sida et les hepatites virales grant #2013-105. European Commission Seventh Framework Programme PathCO grant #HEALTH-F3-2012-305578. AXENIS provided support in the form of salaries for authors Nicolas Legrand and Erwan Corcuff, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Azuma H, 2007, NAT BIOTECHNOL, V25, P903, DOI 10.1038/nbt1326; Billerbeck E, 2013, J IMMUNOL, V191, P1753, DOI 10.4049/jimmunol.1201518; Bissig KD, 2010, J CLIN INVEST, V120, P924, DOI 10.1172/JCI40094; Brezillon N, 2008, DIS MODEL MECH, V1, P113, DOI 10.1242/dmm.000463; Bukh J, 2004, HEPATOLOGY, V39, P1469, DOI 10.1002/hep.20268; Bukh J, 2012, GASTROENTEROLOGY, V142, P1279, DOI 10.1053/j.gastro.2012.02.016; Chen QF, 2012, J IMMUNOL, V189, P5223, DOI 10.4049/jimmunol.1201789; Dandri M, 2001, HEPATOLOGY, V33, P981, DOI 10.1053/jhep.2001.23314; Dandri M, 2013, SEMIN IMMUNOPATHOL, V35, P7, DOI 10.1007/s00281-012-0335-7; Decaens C, 2008, BIOL CELL, V100, P387, DOI 10.1042/BC20070127; Ding YT, 2014, J IMMUNOL, V192, P1982, DOI 10.4049/jimmunol.1302391; Dusseaux M, 2014, METHODS MOL BIOL, V1213, P81, DOI 10.1007/978-1-4939-1453-1_8; Foster JR, 2014, XENOBIOTICA, V44, P109, DOI 10.3109/00498254.2013.867553; Gimeno R, 2004, BLOOD, V104, P3886, DOI 10.1182/blood-2004-02-0656; Guidotti LG, 2006, ANNU REV PATHOL-MECH, V1, P23, DOI 10.1146/annurev.pathol.1.110304.100230; Gutti TL, 2014, AM J PATHOL, V184, P101, DOI 10.1016/j.ajpath.2013.09.008; Haridass D, 2009, AM J PATHOL, V175, P1483, DOI 10.2353/ajpath.2009.090117; HECKEL JL, 1990, CELL, V62, P447, DOI 10.1016/0092-8674(90)90010-C; Huntington ND, 2011, P NATL ACAD SCI USA, V108, P6217, DOI 10.1073/pnas.1019167108; Huntington ND, 2009, J EXP MED, V206, P25, DOI 10.1084/jem.20082013; Lang JL, 2013, J IMMUNOL, V190, P2090, DOI 10.4049/jimmunol.1202810; Legrand N, 2011, P NATL ACAD SCI USA, V108, P13224, DOI 10.1073/pnas.1101398108; Legrand N, 2009, CELL HOST MICROBE, V6, P5, DOI 10.1016/j.chom.2009.06.006; Lerat H, 2011, EXPERT REV GASTROENT, V5, P341, DOI [10.1586/egh.11.14, 10.1586/EGH.11.14]; Mercer DF, 2001, NAT MED, V7, P927, DOI 10.1038/90968; Mestas J, 2004, J IMMUNOL, V172, P2731, DOI 10.4049/jimmunol.172.5.2731; Meuleman P, 2008, ANTIVIR RES, V80, P231, DOI 10.1016/j.antiviral.2008.07.006; Morosan S, 2006, J INFECT DIS, V193, P996, DOI 10.1086/500840; Rongvaux A, 2013, ANNU REV IMMUNOL, V31, P635, DOI 10.1146/annurev-immunol-032712-095921; SANDGREN EP, 1991, CELL, V66, P245, DOI 10.1016/0092-8674(91)90615-6; Shultz LD, 2012, NAT REV IMMUNOL, V12, P786, DOI 10.1038/nri3311; STAMATOGLOU SC, 1994, FASEB J, V8, P420, DOI 10.1096/fasebj.8.6.8168692; Strick-Marchand H, 2008, J IMMUNOL, V181, P2764, DOI 10.4049/jimmunol.181.4.2764; Tanaka S, 2012, J IMMUNOL, V188, P6145, DOI 10.4049/jimmunol.1103660; Tateno C, 2004, AM J PATHOL, V165, P901, DOI 10.1016/S0002-9440(10)63352-4; Traggiai E, 2004, SCIENCE, V304, P104, DOI 10.1126/science.1093933; Vanwolleghem T, 2010, J HEPATOL, V53, P468, DOI 10.1016/j.jhep.2010.03.024; Washburn ML, 2011, GASTROENTEROLOGY, V140, P1334, DOI 10.1053/j.gastro.2011.01.001; Wilson EM, 2014, STEM CELL RES, V13, P404, DOI 10.1016/j.scr.2014.08.006; Yusa K, 2011, NATURE, V478, P391, DOI 10.1038/nature10424	40	59	63	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2015	10	3							e0119820	10.1371/journal.pone.0119820	http://dx.doi.org/10.1371/journal.pone.0119820			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7QC	25782010	gold, Green Published, Green Submitted			2022-12-27	WOS:000351284600095
J	Deng, XH; Xu, ZM				Deng, Xiaohong; Xu, Zhongmin			Green Auctions and Reduction of Information Rents in Payments for Environmental Services: An Experimental Investigation in Sunan County, Northwestern China	PLOS ONE			English	Article							CONSERVATION CONTRACTS; OPPORTUNITY COSTS; LAND VALUES	Reducing information rents is an important task for government agencies wishing to purchase maximal environmental services with limited budgets. This paper reports on several green auction options for reducing information rents and improving the performance of the "Grain for Green" Payments for environmental services (PES) program implemented in northwestern China. In r experimental auctions and investigations, door-to-door interviews were conducted and bidding envelopes and survey questionnaires were used to determine the offers and the foregone profits of the participants. Three scenarios are analyzed in this paper: a uniform price auction, a discriminatory price auction, and an opportunity-cost system. The results show that compared to the uniform price auction system, the other auction systems can increase the cost-effectiveness of conservation contracting. Competitive bidding can reveal true opportunity costs and can reduce information rents extracted from the government by farmers using private information. The demographics and average bids of these auction types were also analyzed. "Perfect information" in the opportunity-cost offer system has the best performance but is very hard to implement in reality. The results of this research show that the auction is a valuable tool for purchasing conservation contracts in northwestern China, but that in the future, the performance of these auctions should be studied with relaxed model assumptions.	[Deng, Xiaohong; Xu, Zhongmin] Chinese Acad Sci, Key Lab Ecohydrol Inland River Basin, Cold & Arid Reg Environm & Engn Res Inst, Lanzhou, Gansu, Peoples R China	Chinese Academy of Sciences; Cold & Arid Regions Environmental & Engineering Research Institute, CAS	Deng, XH (corresponding author), Chinese Acad Sci, Key Lab Ecohydrol Inland River Basin, Cold & Arid Reg Environm & Engn Res Inst, Lanzhou, Gansu, Peoples R China.	dengxiaohong2528@163.com			National Natural Science Foundation of China [41401645, 91125019, 40971291]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	The research was financed by the National Natural Science Foundation of China (Nos. 41401645, 91125019 and 40971291).	Ando A, 1998, SCIENCE, V279, P2126, DOI 10.1126/science.279.5359.2126; [Anonymous], 2002, PAYMENTS ENV SERVICE; Bennett MT, 2008, ECOL ECON, V65, P699, DOI 10.1016/j.ecolecon.2007.09.017; Bolton P., 2005, CONTRACT THEORY; Bryan BA, 2011, ECOL INDIC, V11, P199, DOI 10.1016/j.ecolind.2009.02.005; Connor JD, 2008, AUST J AGR RESOUR EC, V52, P303, DOI 10.1111/j.1467-8489.2007.00417.x; Engel S, 2008, ECOL ECON, V65, P663, DOI 10.1016/j.ecolecon.2008.03.011; Ferraro PJ, 2008, ECOL ECON, V65, P810, DOI 10.1016/j.ecolecon.2007.07.029; Hartshorn G., 2005, EVALUATION WORLD BAN; LataczLohmann U, 1997, AM J AGR ECON, V79, P407, DOI 10.2307/1244139; Liu YS, 2010, J GEOGR SCI, V20, P876, DOI 10.1007/s11442-010-0817-2; MCAFEE RP, 1987, J ECON LIT, V25, P699; MYERSON RB, 1981, MATH OPER RES, V6, P58, DOI 10.1287/moor.6.1.58; Naidoo R, 2006, CONSERV BIOL, V20, P490, DOI 10.1111/j.1523-1739.2006.00304.x; Naidoo R, 2005, P NATL ACAD SCI USA, V102, P16712, DOI 10.1073/pnas.0508036102; Pagiola S., 2007, PAYMENTS ENV SERVICE; RILEY JG, 1981, AM ECON REV, V71, P381; SHOEMAKER R, 1989, LAND ECON, V65, P131, DOI 10.2307/3146787; Sinden JA, 2004, J ENVIRON MANAGE, V70, P351, DOI 10.1016/j.jenvman.2003.12.013; Stoneham G, 2003, AUST J AGR RESOUR EC, V47, P477, DOI 10.1111/j.1467-8489.2003.t01-1-00224.x; Tietenberg T., 2006, ENV NATURAL RESOURCE; Uchida E, 2009, AM J AGR ECON, V91, P70, DOI 10.1111/j.1467-8276.2008.01184.x; VICKREY W, 1961, J FINANC, V16, P8, DOI 10.2307/2977633; Vukina T, 2006, DO FARMERS VALUE ENV; Westphal MI, 2007, LANDSCAPE URBAN PLAN, V81, P56, DOI 10.1016/j.landurbplan.2006.10.015	25	4	5	1	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2015	10	3							e0118978	10.1371/journal.pone.0118978	http://dx.doi.org/10.1371/journal.pone.0118978			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CE8IA	25793263	gold, Green Submitted, Green Published			2022-12-27	WOS:000352084200050
J	Slama, D; Haouas, N; Mezhoud, H; Babba, H; Chaker, E				Slama, Darine; Haouas, Najoua; Mezhoud, Habib; Babba, Hamouda; Chaker, Emna			Blood Meal Analysis of Culicoides (Diptera: Ceratopogonidae) in Central Tunisia	PLOS ONE			English	Article							BITING MIDGES DIPTERA; BLUETONGUE VIRUS; SPECIES COMPOSITION; IDENTIFICATION; MOSQUITO; HOSTS; LATREILLE; VECTORS; ABUNDANCE; EPIDEMIC	To evaluate the host preferences of Culicoidesspecies (Diptera: Ceratopogonidae) in Central Tunisia, we identified the source of blood meals of field collected specimens by sequencing of the cytochrome b (cyt b) mitochondrial locus and Prepronociceptine single copy nuclear gene. The study includes the most common and abundant livestock associated species of biting midges in Tunisia: C. imicola, C. jumineri, C. newsteadi, C. paolae, C. cataneii, C. circumscriptus, C. kingi, C. pseudojumineri, C. submaritimus, C. langeroni, C. jumineri varand some unidentified C. species. Analysis of cyt b PCR products from 182 field collected blood-engorged females' midges revealed that 92% of them fed solely on mammalian species, 1.6% on birds, 2.4% on insects and 0.8% on reptiles. The blast results identified the blood origin of biting midges to the species level with exact or nearly exact matches (>= 98%). The results confirm the presence of several Culicoides species, including proven vectors in Central Tunisia. Blood meal analyses show that these species will indeed feed on bigger mammals, thereby highlighting the risk that these viruses will be able to spread in Tunisia.	[Slama, Darine; Haouas, Najoua; Mezhoud, Habib; Babba, Hamouda; Chaker, Emna] Univ Monastir, Dept Clin Biol B, Lab Parasitol Mycol Med & Mol, Monastir, Tunisia; [Babba, Hamouda] Lab Matern & Neonatol Ctr Monastir, Monastir, Tunisia	Universite de Monastir	Chaker, E (corresponding author), Univ Monastir, Dept Clin Biol B, Lab Parasitol Mycol Med & Mol, Monastir, Tunisia.	emna.chaker@gmail.com	Haouas, Najoua/AAV-7118-2021	, Najoua/0000-0001-8853-352X	Tunisian Ministry of Scientific Research, Technology and Competences Development	Tunisian Ministry of Scientific Research, Technology and Competences Development	This work was supported by finances from the Tunisian Ministry of Scientific Research, Technology and Competences Development. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript	Bartsch S, 2009, PARASITOL RES, V105, P373, DOI 10.1007/s00436-009-1408-y; Ben Fredj S, 2003, REV ELEV MED VET PAY, V56, P121, DOI DOI 10.19182/REMVT.9852; BENNETT GORDON F., 1960, CANADIAN JOUR ZOOL, V38, P377, DOI 10.1139/z60-042; BISHOP AL, 1995, AUST VET J, V72, P198, DOI 10.1111/j.1751-0813.1995.tb03515.x; Boakye DA, 1999, MED VET ENTOMOL, V13, P282, DOI 10.1046/j.1365-2915.1999.00193.x; Borkent Art, 2005, P113; Braverman Y, 1996, VET MICROBIOL, V51, P19, DOI 10.1016/0378-1135(96)00009-0; BRAVERMAN Y, 1977, RHOD J AGR RES, V15, P101; Calvete C, 2008, MED VET ENTOMOL, V22, P124, DOI 10.1111/j.1365-2915.2008.00728.x; Calvo JH, 2012, B ENTOMOL RES, V102, P692, DOI 10.1017/S0007485312000284; Carpenter S, 2013, ANTIVIR RES, V100, P102, DOI 10.1016/j.antiviral.2013.07.020; Chaker E, 2005, PARASITE, V12, P359, DOI 10.1051/parasite/2005124359; Chaker E, 1981, THESIS; De Liberato C, 2005, VET REC, V156, P301, DOI 10.1136/vr.156.10.301; Delecolle JC, 1985, THESIS; Felippe-Bauer ML, 2008, ENTOMOL NEWS, V119, P185, DOI 10.3157/0013-872X(2008)119[185:CPDCII]2.0.CO;2; Foxi C, 2010, MED VET ENTOMOL, V24, P199, DOI 10.1111/j.1365-2915.2010.00861.x; Garros C, 2011, INFECT GENET EVOL, V11, P1103, DOI 10.1016/j.meegid.2011.04.002; Garvin MC, 2003, J WILDLIFE DIS, V39, P170, DOI 10.7589/0090-3558-39.1.170; Haouas N, 2007, AM J TROP MED HYG, V77, P1054, DOI 10.4269/ajtmh.2007.77.1054; HARRIS P, 1969, SCIENCE, V164, P184, DOI 10.1126/science.164.3876.184; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, P313, DOI 10.1098/rspb.2002.2218; HENDRY G, 1988, Scottish Forestry, V42, P113; Hendry G, 2011, BELL AND BAIN; HENRY LG, 1975, ANN ENTOMOL SOC AM, V68, P321, DOI 10.1093/aesa/68.2.321; Hoffmann B, 2012, EMERG INFECT DIS, V18, P469, DOI 10.3201/eid1803.111905; Humair PF, 2007, J MED ENTOMOL, V44, P869, DOI 10.1603/0022-2585(2007)44[869:MIOBSI]2.0.CO;2; Killeen GF, 2001, T ROY SOC TROP MED H, V95, P469, DOI 10.1016/S0035-9203(01)90005-7; KOCHER TD, 1989, P NATL ACAD SCI USA, V86, P6196, DOI 10.1073/pnas.86.16.6196; KREMER M, 1974, MOSQ NEWS, V34, P471; Lah Ernieenor Faraliana Che, 2012, Asian Pacific Journal of Tropical Biomedicine, V2, P223, DOI 10.1016/S2221-1691(12)60046-X; Lassen SB, 2012, PARASITE VECTOR, V5, DOI 10.1186/1756-3305-5-143; Lassen SB, 2011, PARASITOL RES, V108, P823, DOI 10.1007/s00436-010-2123-4; LeDuc J. W., 1989, The arboviruses: epidemiology and ecology. Volume IV., P1; Lefevre T, 2009, AM J TROP MED HYG, V81, P1023, DOI 10.4269/ajtmh.2009.09-0124; LEPRINCE DJ, 1989, J AM MOSQUITO CONTR, V5, P100; LINLEY JR, 1983, J MED ENTOMOL, V20, P347, DOI 10.1093/jmedent/20.4.347; LINLEY JR, 1971, J ECON ENTOMOL, V64, P264, DOI 10.1093/jee/64.1.264; Lyimo IN, 2009, TRENDS PARASITOL, V25, P189, DOI 10.1016/j.pt.2009.01.005; Ma YJ, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-326; Martinez-de la Puente J, 2009, PARASITOLOGY, V136, P1033, DOI 10.1017/S0031182009006374; Mehlhorn H, 2007, PARASITOL RES, V101, P219, DOI 10.1007/s00436-007-0519-6; Mehlhorn H, 2009, PARASITOL RES, V105, P313, DOI 10.1007/s00436-009-1416-y; Meiswinkel R, 2008, PREV VET MED, V87, P55, DOI 10.1016/j.prevetmed.2008.06.005; Meiswinkel R, 2007, VET REC, V161, P564, DOI 10.1136/vr.161.16.564; Meiswinkel R., 2004, Infectious diseases of livestock, Volume One, P93; Mellor PS, 2000, ANNU REV ENTOMOL, V45, P307, DOI 10.1146/annurev.ento.45.1.307; Mellor PS., 1996, VET B, V66, P1; MEZENEV NP, 1990, PARAZITOLOGIYA+, V24, P28; Mollereau C, 1996, P NATL ACAD SCI USA, V93, P8666, DOI 10.1073/pnas.93.16.8666; Mukabana WR, 2002, TRENDS PARASITOL, V18, P505, DOI 10.1016/S1471-4922(02)02364-4; Mullens BA, 2004, VETER ITAL SER, V40, P160; Murphy WJ, 2001, SCIENCE, V294, P2348, DOI 10.1126/science.1067179; Ngo KA, 2003, J MED ENTOMOL, V40, P215, DOI 10.1603/0022-2585-40.2.215; Nielsen SA, 2010, PARASITOL RES, V106, P1197, DOI 10.1007/s00436-010-1791-4; Ninio C, 2011, PARASITOL RES, V108, P657, DOI 10.1007/s00436-010-2110-9; Oura CAL, 2011, EPIDEMIOL INFECT, V139, P1396, DOI 10.1017/S0950268810002396; Parson W, 2000, INT J LEGAL MED, V114, P23, DOI 10.1007/s004140000134; Sghaier S, 2009, REV ELEV MED VET PAY, V62, P2; Sherlock IA, 1964, MEM I OSWALDO CRUZ, V63, P27; Slama D, 2014, PARASITOL RES, V113, P2435, DOI 10.1007/s00436-014-3873-1; Thiry E, 2006, VET REC, V159, P327, DOI 10.1136/vr.159.10.327; Townzen JS, 2008, MED VET ENTOMOL, V22, P386, DOI 10.1111/j.1365-2915.2008.00760.x; van Sittert SJ, 2013, J S AFR VET ASSOC, V84, DOI 10.4102/jsava.v84i1.948; Videvall E, 2013, MED VET ENTOMOL, V27, P104, DOI 10.1111/j.1365-2915.2012.01038.x; WIRTH WW, 1971, ANN ENTOMOL SOC AM, V64, P15, DOI 10.1093/aesa/64.1.15	66	28	29	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2015	10	3							e0120528	10.1371/journal.pone.0120528	http://dx.doi.org/10.1371/journal.pone.0120528			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8HY	25793285	Green Published, gold, Green Submitted			2022-12-27	WOS:000352083900048
J	Abubakr, A; Alimon, AR; Yaakub, H; Abdullah, N; Ivan, M				Abubakr, Abdelrahim; Alimon, Abdul Razak; Yaakub, Halimatun; Abdullah, Norhani; Ivan, Michael			Effect of Feeding Palm Oil By-Products Based Diets on Muscle Fatty Acid Composition in Goats	PLOS ONE			English	Article							CHEMICAL-COMPOSITION; CARCASS CHARACTERISTICS; MEAT; QUALITY; BEEF; CHOLESTEROL; PROFILES; TRAITS; GROWTH; LAMB	The present study aims to evaluate the effects of feeding palm oil by-products based diets on different muscle fatty acid profiles in goats. Thirty-two Cacang x Boer goats were randomly assigned to four dietary treatments: (1) control diet (CD), (2) 80% decanter cake diet (DCD), (3) 80% palm kernel cake diet (PKCD) and (4) CD plus 5% palm oil (PO) supplemented diet (CPOD). After 100 days of feeding, four goats from each group were slaughtered and longissimus dorsi (LD), infraspinatus (IS) and biceps femoris (BF) were sampled for analysis of fatty acids. Goats fed the PKCD had higher (P<0.05) concentration of lauric acid (C12: 0) than those fed the other diets in all the muscles tested. Compared to the other diets, the concentrations of palmitic acid (C16: 0) and stearic acid (C18: 0) were lower (P<0.05) and that of linoleic acid (C18: 2 n-6) was higher (P<0.05) in the muscles from goats fed the CD. It was concluded that palm kernel cake and decanter cake can be included in the diet of goats up to 80% with more beneficial than detrimental effects on the fatty acid profile of their meat.	[Abubakr, Abdelrahim; Alimon, Abdul Razak; Yaakub, Halimatun] Univ Putra Malaysia, Dept Anim Sci, Serdang 43400, Selangor, Malaysia; [Alimon, Abdul Razak; Abdullah, Norhani; Ivan, Michael] Univ Putra Malaysia, Inst Trop Agr, Serdang 43400, Selangor, Malaysia; [Abdullah, Norhani] Univ Putra Malaysia, Dept Biochem, Serdang 43400, Selangor, Malaysia; [Abubakr, Abdelrahim] Univ Bahri, Dept Anim Nutr, Khartoum, Sudan	Universiti Putra Malaysia; Universiti Putra Malaysia; Universiti Putra Malaysia	Alimon, AR (corresponding author), Univ Putra Malaysia, Dept Anim Sci, Serdang 43400, Selangor, Malaysia.	ralimon@agri.upm.edu.my	Abubakr, Abdelrahim/B-1592-2009	Abubakr, Abdelrahim/0000-0003-0858-3952; Yaakub, Halimatun/0000-0003-2691-6984				Abubakr AR, 2013, SMALL RUMINANT RES, V112, P91, DOI 10.1016/j.smallrumres.2012.11.003; Almeida AM, 2006, TROP ANIM HEALTH PRO, V38, P443, DOI 10.1007/s11250-006-4368-6; AOAC, 2000, OFF METH AN, DOI [DOI 10.1007/978-3-642-31241-0, 10.3109/15563657608988149]; BABIKER SA, 1990, MEAT SCI, V28, P273, DOI 10.1016/0309-1740(90)90041-4; Barton L, 2008, J SCI FOOD AGR, V88, P2622, DOI 10.1002/jsfa.3381; Bas P, 2000, LIVEST PROD SCI, V64, P61, DOI 10.1016/S0301-6226(00)00176-7; COLOMERROCHER F, 1992, SMALL RUMINANT RES, V7, P161, DOI 10.1016/0921-4488(92)90205-I; Coltro WKT, 2005, MEAT SCI, V71, P358, DOI 10.1016/j.meatsci.2005.04.016; CORNELIUS J A, 1977, Progress in the Chemistry of Fats and Other Lipids, V15, P5, DOI 10.1016/0079-6832(77)90005-2; Costa P, 2008, MEAT SCI, V78, P502, DOI 10.1016/j.meatsci.2007.07.020; Daley CA, 2010, NUTR J, V9, DOI 10.1186/1475-2891-9-10; de Carvalho GGP, 2004, PESQUI AGROPECU BRAS, V39, P919; De Smet S, 2004, ANIM RES, V53, P81, DOI 10.1051/animres:2004003; Devendra C, 1990, P INT GOAT PROD S 22; Diaz MT, 2002, SMALL RUMINANT RES, V43, P257, DOI 10.1016/S0921-4488(02)00016-0; Dilzer A, 2012, CRIT REV FOOD SCI, V52, P488, DOI 10.1080/10408398.2010.501409; Ebrahimi M, 2012, J ANIM PHYSIOL AN N, V96, P962, DOI 10.1111/j.1439-0396.2011.01206.x; Enser M, 1998, MEAT SCI, V49, P329, DOI 10.1016/S0309-1740(97)00144-7; Enser M, 1996, MEAT SCI, V42, P443, DOI 10.1016/0309-1740(95)00037-2; Field R. A., 1992, Sheep Research Journal, V8, P77; FOLCH J, 1957, J BIOL CHEM, V226, P497; HMSO, 1994, NUTR ASPECTS CARDIOV; Hristov AN, 2009, J DAIRY SCI, V92, P5561, DOI 10.3168/jds.2009-2383; Islam M, 2000, ASIAN AUSTRAL J ANIM, V13, P941, DOI 10.5713/ajas.2000.941; JENKINS TC, 1993, J DAIRY SCI, V76, P3851, DOI 10.3168/jds.S0022-0302(93)77727-9; JOHNSON DD, 1995, J ANIM SCI, V73, P296; Lee JH, 2008, SMALL RUMINANT RES, V75, P177, DOI 10.1016/j.smallrumres.2007.10.003; Mensink RP, 2003, AM J CLIN NUTR, V77, P1146, DOI 10.1093/ajcn/77.5.1146; Morand-Fehr P, 2005, SMALL RUMINANT RES, V60, P25, DOI 10.1016/j.smallrumres.2005.06.004; Mushi DE, 2010, MEAT SCI, V86, P337, DOI 10.1016/j.meatsci.2010.05.006; Noakes M, 1996, AM J CLIN NUTR, V63, P42, DOI 10.1093/ajcn/63.1.42; NOCEK JE, 1991, J DAIRY SCI, V74, P3598, DOI 10.3168/jds.S0022-0302(91)78552-4; PARK YW, 1993, J FOOD SCI, V58, P245, DOI 10.1111/j.1365-2621.1993.tb04248.x; Partida JA, 2007, MEAT SCI, V76, P444, DOI 10.1016/j.meatsci.2006.12.009; Pena F, 2011, ITAL J ANIM SCI, V10, P212, DOI 10.4081/ijas.2011.e40; Phengvichith V, 2007, TROP ANIM HEALTH PRO, V39, P59, DOI 10.1007/s11250-006-4443-z; Pratiwi NMW, 2007, MEAT SCI, V75, P168, DOI 10.1016/j.meatsci.2006.06.026; RAJION MA, 1985, AUST J BIOL SCI, V38, P33, DOI 10.1071/BI9850033; Rhee KS, 2000, MEAT SCI, V54, P313, DOI 10.1016/S0309-1740(99)00094-7; Ribeiro RDX, 2011, ASIAN AUSTRAL J ANIM, V24, P1399, DOI 10.5713/ajas.2011.11110; Robertson J.B., 1981, ANAL DIETARY FIBER F, P123, DOI DOI 10.1016/S0031-9384(00)00286-9; Sackmann JR, 2003, J ANIM SCI, V81, P3174; SAS, 2003, SAS US GUID STAT; Seephueak W., 2011, Songklanakarin Journal of Science and Technology, V33, P271; Silva HGD, 2005, PESQUI AGROPECU BRAS, V40, P405, DOI 10.1590/S0100-204X2005000400013; SMITH GC, 1978, J ANIM SCI, V46, P1229, DOI 10.2527/jas1978.4651229x; SOLOMON MB, 1991, J ANIM SCI, V69, P4055, DOI 10.2527/1991.69104055x; SOLOMON MB, 1992, J ANIM SCI, V70, P2746, DOI 10.2527/1992.7092746x; Steel R. G. D., 1980, Principles and procedures of statistics, a biometrical approach.; Talpur FN, 2008, MEAT SCI, V80, P819, DOI 10.1016/j.meatsci.2008.03.028; Todaro M, 2004, SMALL RUMINANT RES, V54, P191, DOI 10.1016/j.smallrumres.2003.11.011; van Harten S, 2003, NUTR RES, V23, P1447, DOI 10.1016/S0271-5317(03)00152-0; Van Niekerk W. A., 1988, SMALL RUMINANT RES, V1, P355, DOI [10.1016/0921-4488(88)90061-2, DOI 10.1016/0921-4488(88)90061-2]; VANSOEST PJ, 1991, J DAIRY SCI, V74, P3583, DOI 10.3168/jds.S0022-0302(91)78551-2; Vicenti A., 2001, Zootecnica e Nutrizione Animale, V27, P23; Webb EC, 2005, SMALL RUMINANT RES, V60, P153, DOI 10.1016/j.smallrumres.2005.06.009	56	14	16	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2015	10	3							e0119756	10.1371/journal.pone.0119756	http://dx.doi.org/10.1371/journal.pone.0119756			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD9NQ	25789610	Green Submitted, Green Published, gold			2022-12-27	WOS:000351425400101
J	Bougault, V; Blouin, E; Turmel, J; Boulet, LP				Bougault, Valerie; Blouin, Evelyne; Turmel, Julie; Boulet, Louis-Philippe			Airway Response to Methacholine following Eucapnic Voluntary Hyperpnea in Athletes	PLOS ONE			English	Article							MECHANICAL STRAIN MEMORY; SMOOTH-MUSCLE; REFRACTORY PERIOD; BRONCHIAL HYPERRESPONSIVENESS; INDUCED BRONCHOCONSTRICTION; ASTHMATIC SUBJECTS; HYPERVENTILATION CHALLENGE; CLINICAL-SIGNIFICANCE; EXERCISE CHALLENGE; INHALED HISTAMINE	Aim To evaluate the changes in airway responsiveness to methacholine inhalation test (MIT) when performed after an eucapnic voluntary hyperpnea challenge (EVH) in athletes. Methods Two MIT preceded (visit 1) or not (visit 2) by an EVH, were performed in 28 athletes and 24 non-athletes. Twelve athletes and 13 non-athletes had airway hyperresponsiveness (AHR) to methacholine, and 11 athletes and 11 non-athletes had AHR to EVH (EVH+). Results The MIT PC20 post-EVH was significantly lower compared to baseline MIT PC20 by 1.3 +/- 0.7 doubling-concentrations in EVH+ athletes only (p<0.0001). No significant change was observed in EVH-athletes and EVH+/EVH- non-athletes. A significant correlation between the change in MIT PC20 post-EVH and EVH+/EVH- status and athlete/nonathlete status was found (Adjusted R-2=0.26 and p<0.001). Three (11%) athletes and one (4%) non-athlete had a change in the diagnosis of AHR when MIT was performed consecutively to EVH. Conclusion The responsiveness to methacholine was increased by a previous indirect challenge in EVH+ athletes only. The mechanisms for such increase remain to be determined. MIT and EVH should ideally be performed on separate occasions as there is a small but possible risk to obtain a false-positive response to methacholine when performed immediately after the EVH.	[Bougault, Valerie; Blouin, Evelyne; Turmel, Julie; Boulet, Louis-Philippe] Inst Univ Cardiol & Pneumol Quebec, Ctr Rech, Quebec City, PQ, Canada; [Bougault, Valerie] Univ Lille, Act Phys, Muscle, EA4488, Lille, France	Laval University; Universite de Lille - ISITE; Universite de Lille	Boulet, LP (corresponding author), Inst Univ Cardiol & Pneumol Quebec, Ctr Rech, Quebec City, PQ, Canada.	lpboulet@med.ulaval.calp	Bougault, Valerie/G-9904-2018	Bougault, Valerie/0000-0002-2258-6562	Canadian Institutes of Health Research (CIHR)	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR))	Evelyne Blouin was funded by a grant from the Canadian Institutes of Health Research (CIHR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AHMED T, 1988, CHEST, V93, P1132, DOI 10.1378/chest.93.6.1132; AMIRAV I, 1993, CHEST, V104, P171, DOI 10.1378/chest.104.1.171; Anderson SD, 2003, CLIN REV ALLERG IMMU, V24, P27, DOI 10.1385/CRIAI:24:1:27; Anderson SD, 2001, BRIT J SPORT MED, V35, P344, DOI 10.1136/bjsm.35.5.344; ARGYROS GJ, 1995, CHEST, V108, P419, DOI 10.1378/chest.108.2.419; BENDOV I, 1983, THORAX, V38, P849, DOI 10.1136/thx.38.11.849; Berend N, 2008, RESPIROLOGY, V13, P624, DOI 10.1111/j.1440-1843.2008.01330.x; Bolger C, 2011, MED SCI SPORT EXER, V43, P1207, DOI 10.1249/MSS.0b013e31820750d8; Bosse Y, 2011, RESP PHYSIOL NEUROBI, V179, P269, DOI 10.1016/j.resp.2011.09.003; Bougault V, 2010, CHEST, V138, p31S, DOI 10.1378/chest.09-1689; Chan WL, 2000, AM J PHYSIOL-CELL PH, V278, pC895, DOI 10.1152/ajpcell.2000.278.5.C895; Cockcroft DW, 2010, CHEST, V138, p18S, DOI 10.1378/chest.10-0088; Crapo RO, 2000, AM J RESP CRIT CARE, V161, P309; Fitch KD, 2008, J ALLERGY CLIN IMMUN, V122, P254, DOI 10.1016/j.jaci.2008.07.003; Fredberg JJ, 1999, AM J RESP CRIT CARE, V159, P959, DOI 10.1164/ajrccm.159.3.9804060; Gade E, 2009, CLIN EXP ALLERGY, V39, P966, DOI 10.1111/j.1365-2222.2009.03274.x; HURWITZ KM, 1994, AM J RESP CRIT CARE, V149, P1452, DOI 10.1164/ajrccm.149.6.8004298; JUNIPER EF, 1978, THORAX, V33, P705, DOI 10.1136/thx.33.6.705; Kapsali T, 2000, J APPL PHYSIOL, V89, P711, DOI 10.1152/jappl.2000.89.2.711; Kim HR, 2005, CAN J PHYSIOL PHARM, V83, P811, DOI 10.1139/Y05-060; Kippelen P, 2010, MED SCI SPORT EXER, V42, P1853, DOI 10.1249/MSS.0b013e3181da4f7d; Kippelen P, 2010, MED SCI SPORT EXER, V42, P273, DOI 10.1249/MSS.0b013e3181b541b1; KNUDSON RJ, 1983, AM REV RESPIR DIS, V127, P725; Ma XF, 2002, AM J PHYSIOL-LUNG C, V283, pL1181, DOI 10.1152/ajplung.00389.2001; MALO JL, 1986, B EUR PHYSIOPATH RES, V22, P473; Miller MR, 2005, EUR RESPIR J, V26, P319, DOI 10.1183/09031936.05.00034805; Pedersen L, 2008, MED SCI SPORT EXER, V40, P1567, DOI 10.1249/MSS.0b013e31875719a; Pichon AL, 2005, CHEST, V127, P23, DOI 10.1378/chest.127.1.23; ROSENTHAL R R, 1984, Journal of Allergy and Clinical Immunology, V73, P179; ROSENTHAL RR, 1990, AM REV RESPIR DIS, V141, P368, DOI 10.1164/ajrccm/141.2.368; Scichilone N, 2001, AM J RESP CRIT CARE, V163, P413, DOI 10.1164/ajrccm.163.2.2003119; SKLOOT G, 1995, J CLIN INVEST, V96, P2393, DOI 10.1172/JCI118296; Solway J, 1997, AM J RESP CELL MOL, V17, P144, DOI 10.1165/ajrcmb.17.2.f137; Sompradeekul S, 1998, CLIN SCI, V95, P611, DOI 10.1042/cs0950611; Sue-Chu M, 2010, BRIT J SPORT MED, V44, P827, DOI 10.1136/bjsm.2009.071043; SUZUKI S, 1985, ANN ALLERGY, V54, P136; TESSIER P, 1988, EUR RESPIR J, V1, P133; Thorpe CW, 2004, J APPL PHYSIOL, V97, P1643, DOI 10.1152/japplphysiol.01300.2003; Turmel J, 2012, PHYSICIAN SPORTSMED, V40, P55, DOI 10.3810/psm.2012.09.1982; ZAWADSKI DK, 1988, J APPL PHYSIOL, V64, P812, DOI 10.1152/jappl.1988.64.2.812	40	2	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2015	10	3							e0121781	10.1371/journal.pone.0121781	http://dx.doi.org/10.1371/journal.pone.0121781			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD9NQ	25789614	Green Published, Green Submitted, gold			2022-12-27	WOS:000351425400201
J	Chen, S; Fleischer, SJ; Saunders, MC; Thomas, MB				Chen, Shi; Fleischer, Shelby J.; Saunders, Michael C.; Thomas, Matthew B.			The Influence of Diurnal Temperature Variation on Degree-Day Accumulation and Insect Life History	PLOS ONE			English	Article							BERRY MOTH LEPIDOPTERA; CLIMATE-CHANGE; VIRUS TRANSMISSION; GRAPE; RANGE; MODEL; VARIABILITY; ECTOTHERMS; EVOLUTION; VOLTINISM	Ectotherms, such as insects, experience non-constant temperatures in nature. Daily mean temperatures can be derived from the daily maximum and minimum temperatures. However, the converse is not true and environments with the same mean temperature can exhibit very different diurnal temperate ranges. Here we apply a degree-day model for development of the grape berry moth (Paralobesia viteana, a significant vineyard pest in the northeastern USA) to investigate how different diurnal temperature range conditions can influence degree-day accumulation and, hence, insect life history. We first consider changes in diurnal temperature range independent of changes in mean temperatures. We then investigate grape berry moth life history under potential climate change conditions, increasing mean temperature via variable patterns of change to diurnal temperature range. We predict that diurnal temperature range change can substantially alter insect life history. Altering diurnal temperature range independent of the mean temperature can affect development rate and voltinism, with the magnitude of the effects dependent on whether changes occur to the daily minimum temperature (Tmin), daily maximum temperature (Tmax), or both. Allowing for an increase in mean temperature produces more marked effects on life history but, again, the patterns and magnitude depend on the nature of the change to diurnal temperature range together with the starting conditions in the local environment. The study highlights the importance of characterizing the influence of diurnal temperature range in addition to mean temperature alone.	[Chen, Shi] N Carolina State Univ, Dept Populat Hlth & Pathobiol, Raleigh, NC 27695 USA; [Chen, Shi] Natl Inst Math & Biol Synth, Knoxville, TN USA; [Fleischer, Shelby J.; Saunders, Michael C.; Thomas, Matthew B.] Penn State Univ, Dept Entomol, University Pk, PA 16802 USA; [Thomas, Matthew B.] Penn State Univ, Ctr Infect Dis Dynam, University Pk, PA 16802 USA	University of North Carolina; North Carolina State University; University of Tennessee System; University of Tennessee Knoxville; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Chen, S (corresponding author), N Carolina State Univ, Dept Populat Hlth & Pathobiol, Raleigh, NC 27695 USA.	schen31@ncsu.edu	Fleischer, Shelby/AAD-6663-2020; Fleischer, Shelby/AAN-1392-2020					Allen J, 2011, ENVIRON ENTOMOL, V5, P388; Blanford JI, 2013, SCI REP-UK, V3, DOI 10.1038/srep01300; Bozinovic F, 2011, PHYSIOL BIOCHEM ZOOL, V84, P543, DOI 10.1086/662551; Carrington LB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058824; Chen S, 2013, VECTOR-BORNE ZOONOT, V13, P489, DOI 10.1089/vbz.2012.1094; Chen S, 2011, ENVIRON ENTOMOL, V40, P505, DOI 10.1603/EN10099; Deutsch CA, 2008, P NATL ACAD SCI USA, V105, P6668, DOI 10.1073/pnas.0709472105; Easterling DR, 2000, SCIENCE, V289, P2068, DOI 10.1126/science.289.5487.2068; Easterling DR, 1997, SCIENCE, V277, P364, DOI 10.1126/science.277.5324.364; Folguera G, 2011, COMP BIOCHEM PHYS A, V159, P242, DOI 10.1016/j.cbpa.2011.03.002; Folguera G, 2009, COMP BIOCHEM PHYS A, V154, P389, DOI 10.1016/j.cbpa.2009.07.008; FORSYTHE WC, 1995, ECOL MODEL, V80, P87, DOI 10.1016/0304-3800(94)00034-F; Hoffmann AA, 2011, NATURE, V470, P479, DOI 10.1038/nature09670; Hong G, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2008GL036108; IPCC Apndice, 2007, AR4 CLIMATE CHANGE 2; Lafferty KD, 2009, ECOLOGY, V90, P888, DOI 10.1890/08-0079.1; Lambrechts L, 2011, P NATL ACAD SCI USA, V108, P7460, DOI 10.1073/pnas.1101377108; Letcher M, 2009, CLIMATE CHANGE OBSER; LIU SS, 1995, ANN ENTOMOL SOC AM, V88, P107, DOI 10.1093/aesa/88.2.107; LOGAN JA, 1976, ENVIRON ENTOMOL, V5, P1133, DOI 10.1093/ee/5.6.1133; Lowry WP, 1989, FUNDAMENTALS BIOMETE; Meehl GA, 2000, B AM METEOROL SOC, V81, P413, DOI 10.1175/1520-0477(2000)081<0413:AITTIE>2.3.CO;2; Nagarkatti S, 2001, ENVIRON ENTOMOL, V30, P540, DOI 10.1603/0046-225X-30.3.540; Paaijmans KP, 2013, GLOBAL CHANGE BIOL, V19, P2373, DOI 10.1111/gcb.12240; Paaijmans KP, 2010, P NATL ACAD SCI USA, V107, P15135, DOI 10.1073/pnas.1006422107; Pennsylvania Department of Environmental Protection, 2009, PENNS FIN CLIM CHANG; R Core Team, 2013, R LANG ENV STAT COMP, DOI [10.3758/s13428-013-0330-5, DOI 10.3758/S13428-013-0330-5]; Ribeiro PL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032083; Shein KA, 2013, B AM METEOROL SOC, V94, P393, DOI 10.1175/BAMS-D-11-00013.1; Sternberg ED, 2014, TRENDS PARASITOL, V30, P115, DOI 10.1016/j.pt.2013.12.010; TAYLOR F, 1981, AM NAT, V117, P1, DOI 10.1086/283683; Terblanche JS, 2010, ENTOMOL EXP APPL, V137, P304, DOI 10.1111/j.1570-7458.2010.01067.x; Tobin PC, 2008, GLOBAL CHANGE BIOL, V14, P951, DOI 10.1111/j.1365-2486.2008.01561.x; Tobin PC, 2003, ENVIRON ENTOMOL, V32, P340, DOI 10.1603/0046-225X-32.2.340; Tobin PC, 2002, ENVIRON ENTOMOL, V31, P708, DOI 10.1603/0046-225X-31.4.708; Tobin PC, 2001, ENVIRON ENTOMOL, V30, P692, DOI 10.1603/0046-225X-30.4.692; Travis DJ, 2004, J CLIMATE, V17, P1123, DOI 10.1175/1520-0442(2004)017<1123:RVIUDT>2.0.CO;2; Travis DJ, 2002, NATURE, V418, P601, DOI 10.1038/418601a; Union of Concerned Scientists, 2011, CLIM CHANG US NE CLI; Urbanski J, 2012, AM NAT, V179, P490, DOI 10.1086/664709; Virginia Office of Inspector General, 2013, REV VAS PROGR ADDR C; WIESE AM, 1987, WEED SCI, V35, P177; Wild M., 2007, GEOPHYS RES LETT, V34	43	14	17	0	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2015	10	3							e0120772	10.1371/journal.pone.0120772	http://dx.doi.org/10.1371/journal.pone.0120772			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD9NQ	25790195	gold, Green Published, Green Submitted			2022-12-27	WOS:000351425400176
J	Chocron, SE; Weisberger, BM; Ben-Yoav, H; Winkler, TE; Kim, E; Kelly, DL; Payne, GF; Ghodssi, R				Chocron, Sheryl E.; Weisberger, Bryce M.; Ben-Yoav, Hadar; Winkler, Thomas E.; Kim, Eunkyoung; Kelly, Deanna L.; Payne, Gregory F.; Ghodssi, Reza			Multidimensional Mapping Method Using an Arrayed Sensing System for Cross-Reactivity Screening	PLOS ONE			English	Article							GLASSY-CARBON ELECTRODE; URIC-ACID; VOLTAMMETRIC DETERMINATION; ELECTROCHEMICAL OXIDATION; ASCORBIC-ACID; L-CYSTEINE; MENTAL-HEALTH; PLASMA; CLOZAPINE; BIOMARKERS	When measuring chemical information in biological fluids, challenges of cross-reactivity arise, especially in sensing applications where no biological recognition elements exist. An understanding of the cross-reactions involved in these complex matrices is necessary to guide the design of appropriate sensing systems. This work presents a methodology for investigating cross-reactions in complex fluids. First, a systematic screening of matrix components is demonstrated in buffer-based solutions. Second, to account for the effect of the simultaneous presence of these species in complex samples, the responses of buffer-based simulated mixtures of these species were characterized using an arrayed sensing system. We demonstrate that the sensor array, consisting of electrochemical sensors with varying input parameters, generated differential responses that provide synergistic information of sample. By mapping the sensing array response onto multidimensional heat maps, characteristic signatures were compared across sensors in the array and across different matrices. Lastly, the arrayed sensing system was applied to complex biological samples to discern and match characteristic signatures between the simulated mixtures and the complex sample responses. As an example, this methodology was applied to screen interfering species relevant to the application of schizophrenia management. Specifically, blood serum measurement of antipsychotic clozapine and antioxidant species can provide useful information regarding therapeutic efficacy and psychiatric symptoms. This work proposes an investigational tool that can guide multi-analyte sensor design, chemometric modeling and biomarker discovery.	[Chocron, Sheryl E.; Weisberger, Bryce M.; Ben-Yoav, Hadar; Winkler, Thomas E.; Ghodssi, Reza] Univ Maryland, MEMS Sensors & Actuators Lab MSAL, College Pk, MD 20742 USA; [Chocron, Sheryl E.; Weisberger, Bryce M.; Winkler, Thomas E.; Payne, Gregory F.; Ghodssi, Reza] Univ Maryland, Fischell Dept Bioengn, College Pk, MD 20742 USA; [Ben-Yoav, Hadar; Ghodssi, Reza] Univ Maryland, Dept Elect & Comp Engn, Syst Res Inst, College Pk, MD 20742 USA; [Kim, Eunkyoung; Payne, Gregory F.] Univ Maryland, Inst Biosci & Biotechnol Res, College Pk, MD 20742 USA; [Kelly, Deanna L.] Univ Maryland, Sch Med, Maryland Psychiat Res Ctr, Baltimore, MD 21201 USA	University System of Maryland; University of Maryland College Park; University System of Maryland; University of Maryland College Park; University System of Maryland; University of Maryland College Park; University System of Maryland; University of Maryland College Park; University System of Maryland; University of Maryland Baltimore	Ghodssi, R (corresponding author), Univ Maryland, Dept Elect & Comp Engn, Syst Res Inst, College Pk, MD 20742 USA.	ghodssi@umd.edu	Ben-Yoav, Hadar/J-8568-2015; Winkler, Thomas E./H-3369-2011	Ben-Yoav, Hadar/0000-0002-6237-0440; Winkler, Thomas E./0000-0002-2331-4833; Kim, Eunkyoung/0000-0003-2566-4041	National Science Foundation [DGE00750616]; Robert W. Deutsch Foundation	National Science Foundation(National Science Foundation (NSF)); Robert W. Deutsch Foundation	Financial support was provided by the National Science Foundation Graduate Research Fellowship Program Grant No. DGE00750616 and the Robert W. Deutsch Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albert KJ, 2000, CHEM REV, V100, P2595, DOI 10.1021/cr980102w; Arai K, 1996, ANAL BIOCHEM, V240, P109, DOI 10.1006/abio.1996.0336; Arvand M, 2012, ELECTROANAL, V24, P683, DOI 10.1002/elan.201100587; Bai YH, 2009, BIOSENS BIOELECTRON, V24, P2985, DOI 10.1016/j.bios.2009.03.008; Bakhtiar Ray, 2008, Journal of Pharmacological and Toxicological Methods, V57, P85, DOI 10.1016/j.vascn.2007.10.002; Basten G, 2011, INTRO CLIN BIOCH INT; Bateman RJ, 2012, NEW ENGL J MED, V367, P795, DOI 10.1056/NEJMoa1202753; Ben-Yoav H, 2013, BIOAMPLIFYING LAB ON, P317; Ben-Yoav H, 2014, ELECTROCHIM ACTA, V130, P497, DOI 10.1016/j.electacta.2014.03.045; Beydoun H, 2008, PAEDIATR PERINAT EP, V22, P438, DOI 10.1111/j.1365-3016.2008.00951.x; Buur-Rasmussen B, 1999, EUR NEUROPSYCHOPHARM, V9, P453, DOI 10.1016/S0924-977X(99)00033-4; Chawla R., 2014, PRACTICAL CLIN BIOCH; Chen PH, 1996, ANAL CHEM, V68, P3958, DOI 10.1021/ac960492r; CLSI, 2002, EP07A2 CLSI; CONWAY BE, 1995, PROG SURF SCI, V49, P331, DOI 10.1016/0079-6816(95)00040-6; DEINHAMMER RS, 1994, LANGMUIR, V10, P1306, DOI 10.1021/la00016a054; DHARIWAL KR, 1991, AM J CLIN NUTR, V54, P712, DOI 10.1093/ajcn/54.4.712; Domenici E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009166; Elias RJ, 2005, J AGR FOOD CHEM, V53, P10248, DOI 10.1021/jf0521698; Frustaci A, 2012, FREE RADICAL BIO MED, V52, P2128, DOI 10.1016/j.freeradbiomed.2012.03.011; Gaw A, 2013, CLIN BIOCH ILLUSTRAT; GROOTVELD M, 1987, BIOCHEM J, V243, P803, DOI 10.1042/bj2430803; Gubala V, 2012, ANAL CHEM, V84, P487, DOI 10.1021/ac2030199; Gutes A, 2007, MICROCHIM ACTA, V157, P1, DOI 10.1007/s00604-006-0660-4; Gutierrez M, 2008, BIOSENS BIOELECTRON, V23, P795, DOI 10.1016/j.bios.2007.08.019; Hoffman R, 2013, HEMATOLOGY BASIC PRI, V6th; Huang F, 2007, TALANTA, V72, P457, DOI 10.1016/j.talanta.2006.11.004; Jaffee SR, 2007, MOL PSYCHIATR, V12, P432, DOI 10.1038/sj.mp.4001950; Jones DP, 2004, FASEB J, V18, P1246, DOI 10.1096/fj.03-0971fje; KAMAU GN, 1988, ANAL CHIM ACTA, V207, P1, DOI 10.1016/S0003-2670(00)80777-1; KAUFFMANN JM, 1979, ANAL LETT PT B, V12, P1217, DOI 10.1080/00032717908067911; KAUR H, 1990, CHEM-BIOL INTERACT, V73, P235, DOI 10.1016/0009-2797(90)90006-9; KREBS HA, 1950, ANNU REV BIOCHEM, V19, P409, DOI 10.1146/annurev.bi.19.070150.002205; Lavigne JJ, 2001, ANGEW CHEM INT EDIT, V40, P3118, DOI 10.1002/1521-3773(20010903)40:17<3118::AID-ANIE3118>3.0.CO;2-Y; Lu M, 2014, ANALYST, V139, P4599, DOI 10.1039/c4an00866a; Martins de Souza D, 2010, J PSYCHIATR RES, V44, P1176, DOI [10.1016/j.jpsychires.2010.04.014, DOI 10.1016/J.JPSYCHIRES.2010.04.014]; Mashhadizadeh MH, 2013, ELECTROCHIM ACTA, V87, P816, DOI 10.1016/j.electacta.2012.09.004; O'Neill RD, 2004, BIOSENS BIOELECTRON, V19, P1521, DOI 10.1016/j.bios.2003.12.004; Oertel-Knochel V, 2011, PROG NEUROBIOL, V95, P686, DOI 10.1016/j.pneurobio.2011.05.006; Olesen OV, 1998, CLIN PHARMACOKINET, V34, P497, DOI 10.2165/00003088-199834060-00005; PALLESCHI G, 1986, ANAL BIOCHEM, V159, P114, DOI 10.1016/0003-2697(86)90315-5; Price CP, 2001, BMJ-BRIT MED J, V322, P1285, DOI 10.1136/bmj.322.7297.1285; Psychogios N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016957; Raj CR, 2003, J ELECTROANAL CHEM, V540, P69; Sanghavi BJ, 2015, MICROCHIM ACTA, V182, P1, DOI 10.1007/s00604-014-1308-4; Schwarz E, 2010, BIOMARK INSIGHTS, V5, P39; Scott SM, 2006, MICROCHIM ACTA, V156, P183, DOI 10.1007/s00604-006-0623-9; Seplaki CL, 2004, J GERONTOL A-BIOL, V59, P201; Netto LES, 2007, COMP BIOCHEM PHYS C, V146, P180, DOI 10.1016/j.cbpc.2006.07.014; Spataru N, 2001, ANAL CHEM, V73, P514, DOI 10.1021/ac000220v; St-Louis P, 2000, CLIN BIOCHEM, V33, P427, DOI 10.1016/S0009-9120(00)00138-7; Staufenbiel SM, 2013, PSYCHONEUROENDOCRINO, V38, P1220, DOI 10.1016/j.psyneuen.2012.11.015; SUBOTICANEC K, 1990, BIOL PSYCHIAT, V28, P959, DOI 10.1016/0006-3223(90)90061-6; Takahashi M, 2010, SCHIZOPHR RES, V119, P210, DOI 10.1016/j.schres.2009.12.024; Tonyushkina Ksenia, 2009, J Diabetes Sci Technol, V3, P971; van Leeuwen SM, 2005, ANAL BIOANAL CHEM, V382, P742, DOI 10.1007/s00216-005-3053-3; Vlasov Y, 2005, PURE APPL CHEM, V77, P1965, DOI 10.1351/pac200577111965; Wang CH, 2006, MICROCHIM ACTA, V155, P365, DOI 10.1007/s00604-006-0616-8; Wang CY, 2006, J PHARMACEUT BIOMED, V42, P237, DOI 10.1016/j.jpba.2006.03.038; Weickert CS, 2013, DIS MARKERS, V2013, P3, DOI 10.1155/2013/510402; Yao JK, 1998, PSYCHIAT RES, V80, P29, DOI 10.1016/S0165-1781(98)00051-1; Yao JK, 1998, SCHIZOPHR RES, V32, P1, DOI 10.1016/S0920-9964(98)00030-9; Yoo EH, 2010, SENSORS-BASEL, V10, P4558, DOI 10.3390/s100504558; Zhang XY, 2012, SCHIZOPHR RES, V139, P66, DOI 10.1016/j.schres.2012.04.009; Zhou M, 2007, ANAL CHEM, V79, P5328, DOI 10.1021/ac0703707	65	8	8	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2015	10	3							e0116310	10.1371/journal.pone.0116310	http://dx.doi.org/10.1371/journal.pone.0116310			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD9NQ	25789880	gold, Green Submitted, Green Published			2022-12-27	WOS:000351425400013
J	Field, D; Gaudin, N; Lyons, F; O'Connor, PM; Cotter, PD; Hill, C; Ross, RP				Field, Des; Gaudin, Noemie; Lyons, Francy; O'Connor, Paula M.; Cotter, Paul D.; Hill, Colin; Ross, R. Paul			A Bioengineered Nisin Derivative to Control Biofilms of Staphylococcus pseudintermedius	PLOS ONE			English	Article							ANTIMICROBIAL CATIONIC PEPTIDES; IN-VITRO ACTIVITIES; METHICILLIN-RESISTANT; ENHANCED ACTIVITY; AUREUS BIOFILMS; LANTIBIOTICS; COMBINATION; COWS; BIOSYNTHESIS; BACTERIOCINS	Antibiotic resistance and the shortage of novel antimicrobials are among the biggest challenges facing society. One of the major factors contributing to resistance is the use of frontline clinical antibiotics in veterinary practice. In order to properly manage dwindling antibiotic resources, we must identify antimicrobials that are specifically targeted to veterinary applications. Nisin is a member of the lantibiotic family of antimicrobial peptides that exhibit potent antibacterial activity against many gram-positive bacteria, including human and animal pathogens such as Staphylococcus, Bacillus, Listeria, and Clostridium. Although not currently used in human medicine, nisin is already employed commercially as an anti-mastitis product in the veterinary field. Recently we have used bioengineering strategies to enhance the activity of nisin against several high profile targets, including multi-drug resistant clinical pathogens such as methicillin-resistant Staphylococcus aureus (MRSA) and vancomycin-resistant enterococci (VRE) and also against staphylococci and streptococci associated with bovine mastitis. However, newly emerging pathogens such as methicillin resistant Staphylococcus pseudintermedius (MRSP) pose a significant threat in terms of veterinary health and as a reservoir for antibiotic resistance determinants. In this study we created a nisin derivative with enhanced antimicrobial activity against S. pseudintermedius. In addition, the novel nisin derivative exhibits an enhanced ability to impair biofilm formation and to reduce the density of established biofilms. The activities of this peptide represent a significant improvement over that of the wild-type nisin peptide and merit further investigation with a view to their use to treat S. pseudintermedius infections.	[Field, Des; Gaudin, Noemie; Lyons, Francy; Hill, Colin] Natl Univ Ireland Univ Coll Cork, Sch Microbiol, Cork, Ireland; [O'Connor, Paula M.; Cotter, Paul D.; Ross, R. Paul] Teagasc Food Res Ctr, Fermoy, Cork, Ireland; [Cotter, Paul D.; Hill, Colin; Ross, R. Paul] Natl Univ Ireland Univ Coll Cork, Alimentary Pharmabiot Ctr, Cork, Ireland	University College Cork; Teagasc; University College Cork	Field, D (corresponding author), Natl Univ Ireland Univ Coll Cork, Sch Microbiol, Cork, Ireland.	des.field@ucc.ie; c.hill@ucc.ie	Hill, Colin/A-5611-2012; Ross, Paul/A-7584-2015; Field, Des/AAU-6785-2021; Cotter, Paul/AAX-5449-2021; Cotter, Paul/B-7781-2008; STANTON, CATHERINE/A-9549-2015	Hill, Colin/0000-0002-8527-1445; Ross, Paul/0000-0003-4876-8839; Cotter, Paul/0000-0002-5465-9068; Cotter, Paul/0000-0002-5465-9068; STANTON, CATHERINE/0000-0002-6724-7011; Field, Des/0000-0003-4425-5817; O'Connor, Paula M./0000-0001-6462-2077	Irish Government under the National Development Plan, through Science Foundation Ireland Investigator [10/IN. 1/B3027]	Irish Government under the National Development Plan, through Science Foundation Ireland Investigator(Science Foundation Ireland)	This work was supported by the Irish Government under the National Development Plan, through Science Foundation Ireland Investigator awards (10/IN. 1/B3027 (http://www.sfi.ie). DF would like to acknowledge receipt of a Society for Applied Microbiology (http://www.sfam.org.uk) Students into Work Grant for FL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Appleyard AN, 2009, CHEM BIOL, V16, P490, DOI 10.1016/j.chembiol.2009.03.011; Bierbaum G, 2009, CURR PHARM BIOTECHNO, V10, P2, DOI 10.2174/138920109787048616; Breukink E, 1999, SCIENCE, V286, P2361, DOI 10.1126/science.286.5448.2361; Breukink E, 1999, BBA-BIOMEMBRANES, V1462, P223, DOI 10.1016/S0005-2736(99)00208-4; Cao LT, 2007, J DAIRY SCI, V90, P3980, DOI 10.3168/jds.2007-0153; Chatterjee C, 2005, CHEM REV, V105, P633, DOI 10.1021/cr030105v; Corbin A, 2011, ANTIMICROB AGENTS CH, V55, P3338, DOI 10.1128/AAC.00206-11; Cotter PD, 2013, NAT REV MICROBIOL, V11, P95, DOI 10.1038/nrmicro2937; Cotter PD, 2005, CURR PROTEIN PEPT SC, V6, P61, DOI 10.2174/1389203053027584; Cotter PD, 2005, NAT REV MICROBIOL, V3, P777, DOI 10.1038/nrmicro1273; Davison WM, 2010, ANTIMICROB AGENTS CH, V54, P2920, DOI 10.1128/AAC.01734-09; Delves-Broughton J, 2005, FOOD AUST, V57, P525; DiCicco M, 2012, BMC VET RES, V8, DOI 10.1186/1746-6148-8-225; Donlan RM, 2002, EMERG INFECT DIS, V8, P881, DOI 10.3201/eid0809.020063; Dosler S, 2013, PEPTIDES, V49, P53, DOI 10.1016/j.peptides.2013.08.008; Dosler S, 2011, CHEMOTHERAPY, V57, P511, DOI 10.1159/000335598; Field D, 2008, MOL MICROBIOL, V69, P218, DOI 10.1111/j.1365-2958.2008.06279.x; Field D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046884; Field D, 2010, MICROB BIOTECHNOL, V3, P473, DOI 10.1111/j.1751-7915.2010.00184.x; Fitzgerald JR, 1997, EPIDEMIOL INFECT, V119, P261, DOI 10.1017/S0950268897007802; Flemming HC, 2010, NAT REV MICROBIOL, V8, P623, DOI 10.1038/nrmicro2415; Frank LA, 2009, P N AM VET DERMATOLO, V20, P219; Healy B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079563; Herron LL, 2002, INFECT IMMUN, V70, P3978, DOI 10.1128/IAI.70.7.3978-3981.2002; Islam MR, 2009, MOL MICROBIOL, V72, P1438, DOI 10.1111/j.1365-2958.2009.06733.x; Jain A, 2009, J MICROBIOL METH, V76, P88, DOI 10.1016/j.mimet.2008.09.017; Kelly D, 2012, LETT APPL MICROBIOL, V54, P286, DOI 10.1111/j.1472-765X.2012.03205.x; Kuipers OP, 1996, ANTON LEEUW INT J G, V69, P161, DOI 10.1007/BF00399421; Loeffler A, 2007, VET DERMATOL, V18, P412, DOI 10.1111/j.1365-3164.2007.00635.x; Mataraci E, 2012, ANTIMICROB AGENTS CH, V56, P6366, DOI 10.1128/AAC.01180-12; Molloy EM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058530; Murayama N, 2013, VET DERMATOL, V24, P126, DOI 10.1111/j.1365-3164.2012.01103.x; O'Toole GA, 2011, JOVE-J VIS EXP, DOI 10.3791/2437; Okuda K, 2013, ANTIMICROB AGENTS CH, V57, P5572, DOI 10.1128/AAC.00888-13; Paul NC, 2011, ZOONOSES PUBLIC HLTH, V58, P533, DOI 10.1111/j.1863-2378.2011.01398.x; Perin LM, 2014, BMC MICROBIOL, V14, DOI 10.1186/1471-2180-14-36; Perreten V, 2010, J ANTIMICROB CHEMOTH, V65, P1145, DOI 10.1093/jac/dkq078; Piper Clare, 2009, Curr Drug Discov Technol, V6, P1; Rankin SC, 2007, VET DERMATOL, V18, P175; Rink R, 2007, APPL ENVIRON MICROB, V73, P5809, DOI 10.1128/AEM.01104-07; ROLLEMA HS, 1995, APPL ENVIRON MICROB, V61, P2873, DOI 10.1128/AEM.61.8.2873-2878.1995; Rouse S, 2012, MICROB BIOTECHNOL, V5, P501, DOI 10.1111/j.1751-7915.2011.00324.x; Ruscher C, 2009, VET MICROBIOL, V136, P197, DOI 10.1016/j.vetmic.2008.10.023; SAHL HG, 1995, EUR J BIOCHEM, V230, P827, DOI 10.1111/j.1432-1033.1995.tb20627.x; SEARS PM, 1992, J DAIRY SCI, V75, P3185, DOI 10.3168/jds.S0022-0302(92)78083-7; Singh A, 2013, BMC VET RES, V9, DOI 10.1186/1746-6148-9-93; Stepanovic S, 2000, J MICROBIOL METH, V40, P175, DOI 10.1016/S0167-7012(00)00122-6; Vazquez-Sanchez D, 2014, FOOD CONTROL, V39, P8, DOI 10.1016/j.foodcont.2013.09.029; Weese JS, 2010, VET MICROBIOL, V140, P418, DOI 10.1016/j.vetmic.2009.01.039; Wirawan RE, 2006, APPL ENVIRON MICROB, V72, P1148, DOI 10.1128/AEM.72.2.1148-1156.2006; Wu JQ, 2007, ANTIMICROB AGENTS CH, V51, P3131, DOI 10.1128/AAC.00629-07; Yoo JH, 2010, J MICROBIOL BIOTECHN, V20, P798, DOI 10.4014/jmb.0910.10044; Yoon JW, 2010, J MICROBIOL BIOTECHN, V20, P1764, DOI 10.4014/jmb.1001.01011; Yuan J, 2004, APPL MICROBIOL BIOT, V64, P806, DOI 10.1007/s00253-004-1599-1	54	56	59	1	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2015	10	3							e0119684	10.1371/journal.pone.0119684	http://dx.doi.org/10.1371/journal.pone.0119684			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD9NQ	25789988	Green Submitted, Green Published, gold			2022-12-27	WOS:000351425400094
J	Groza, T; Verspoor, K				Groza, Tudor; Verspoor, Karin			Assessing the Impact of Case Sensitivity and Term Information Gain on Biomedical Concept Recognition	PLOS ONE			English	Article							WEB SERVICES; TEXT; ONTOLOGIES; ANNOTATION; KNOWLEDGE; PROTEIN; SYSTEM	Concept recognition (CR) is a foundational task in the biomedical domain. It supports the important process of transforming unstructured resources into structured knowledge. To date, several CR approaches have been proposed, most of which focus on a particular set of biomedical ontologies. Their underlying mechanisms vary from shallow natural language processing and dictionary lookup to specialized machine learning modules. However, no prior approach considers the case sensitivity characteristics and the term distribution of the underlying ontology on the CR process. This article proposes a framework that models the CR process as an information retrieval task in which both case sensitivity and the information gain associated with tokens in lexical representations (e.g., term labels, synonyms) are central components of a strategy for generating term variants. The case sensitivity of a given ontology is assessed based on the distribution of so-called case sensitive tokens in its terms, while information gain is modelled using a combination of divergence from randomness and mutual information. An extensive evaluation has been carried out using the CRAFT corpus. Experimental results show that case sensitivity awareness leads to an increase of up to 0.07 F1 against a non-case sensitive baseline on the Protein Ontology and GO Cellular Component. Similarly, the use of information gain leads to an increase of up to 0.06 F1 against a standard baseline in the case of GO Biological Process and Molecular Function and GO Cellular Component. Overall, subject to the underlying token distribution, these methods lead to valid complementary strategies for augmenting term label sets to improve concept recognition.	[Groza, Tudor] Univ Queensland, Sch Informat Technol & Elect Engn, St Lucia, Qld, Australia; [Verspoor, Karin] Univ Melbourne, Dept Comp & Informat Syst, Melbourne, Vic, Australia; [Verspoor, Karin] Univ Melbourne, Hlth & Biomed Informat Ctr, Melbourne, Vic, Australia	University of Queensland; University of Melbourne; University of Melbourne	Groza, T (corresponding author), Univ Queensland, Sch Informat Technol & Elect Engn, St Lucia, Qld, Australia.	t.groza@garvan.org.au	Verspoor, Karin/G-6034-2016	Verspoor, Karin/0000-0002-8661-1544; Groza, Tudor/0000-0003-2267-8333	Australian Research Council (ARC) [DECRA: DE120100508]	Australian Research Council (ARC)(Australian Research Council)	This work was supported by the Australian Research Council (ARC) Discovery Early Career Researcher Award (DECRA: DE120100508). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akhondi SA, 2013, BIONLP 2007, V2, P113; Arighi CN, 2013, P 4 BIOCREATIVE CHAL; Aronson AR, 2001, J AM MED INFORM ASSN, P17; Bada M, 2014, METHODS MOL BIOL, V1159, P33, DOI 10.1007/978-1-4939-0709-0_3; Bada M, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-161; Baumgartner WA, 2007, BIOINFORMATICS, V23, pI41, DOI 10.1093/bioinformatics/btm229; Blair DR, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003799; Browne AC, 2000, NATL LIB MED TECHNIC, P18; Campos D, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-281; Campos D, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-54; Chapman WW, 2001, J BIOMED INFORM, V34, P301, DOI 10.1006/jbin.2001.1029; Claveau V., 2013, P BIONLP SHAR TASK 2, P188; Cover T. M., 1991, ELEMENTS INFORM THEO; Dai M, 2008, P AMIA SUMM TRANSL B; Ferrucci D., 2004, Natural Language Engineering, V10, P327, DOI 10.1017/S1351324904003523; Funk C, 2014, BMC BIOINFORMATICS, V15, DOI 10.1186/1471-2105-15-59; Gaudan S, 2008, EURASIP J BIOINFORM, DOI 10.1155/2008/342746; Goulart R.R.V., 2011, J BRAZILIAN COMPUTER, V17, P103, DOI [DOI 10.1007/S13173-011-0031-9, 10.1007/s13173-011-0031-9]; Hanisch D, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-S1-S14; Harter SP, 1974, THESIS U CHICAGO; Hettne KM, 2009, BIOINFORMATICS, V25, P2983, DOI 10.1093/bioinformatics/btp535; Jonquet Clement, 2009, Summit Transl Bioinform, V2009, P56; Li LS, 2012, J BIOMED INFORM, V45, P156, DOI 10.1016/j.jbi.2011.10.004; Li Y, 2013, BIOCREATIVE CHALL EV, V1, P162; Liu S., 2005, IT Professional, V7, P17, DOI 10.1109/MITP.2005.122; Lund K, 1996, BEHAV RES METH INSTR, V28, P203, DOI 10.3758/BF03204766; MCCRAY AT, 1993, B MED LIBR ASSOC, V81, P184; Nedellec Claire, 2013, P BIONLP SHAR TASK 2; Nunes T, 2013, BIOINFORMATICS, V29, P1915, DOI 10.1093/bioinformatics/btt317; Ounis I, 2005, LECT NOTES COMPUT SC, V3408, P517; Rebholz-Schuhmann D, 2008, BIOINFORMATICS, V24, P296, DOI 10.1093/bioinformatics/btm557; Sagae K, 2007, P 2007 JOINT C EMP M, P1044; Saha SK, 2009, J BIOMED INFORM, V42, P905, DOI 10.1016/j.jbi.2008.12.012; Sasaki Y, 2008, P 3 INT S SEM MIN BI, V3, P109; Savova GK, 2010, J AM MED INFORM ASSN, V17, P507, DOI 10.1136/jamia.2009.001560; Smith B, 2007, NAT BIOTECHNOL, V25, P1251, DOI 10.1038/nbt1346; Tanenblatt M, 2010, LREC 2010 - SEVENTH INTERNATIONAL CONFERENCE ON LANGUAGE RESOURCES AND EVALUATION; Tsuruoka Y, 2005, P C HUMAN LANGUAGE T, P467, DOI DOI 10.3115/1220575.1220634; Verspoor K, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-S1-S20; Whetzel PL, 2011, NUCLEIC ACIDS RES, V39, pW541, DOI 10.1093/nar/gkr469; Zhu D, 2013, P 4 BIOCREATIVE CHAL, V1, P146	41	7	7	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2015	10	3							e0119091	10.1371/journal.pone.0119091	http://dx.doi.org/10.1371/journal.pone.0119091			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD9NQ	25790125	Green Published, gold			2022-12-27	WOS:000351425400065
J	Hagy, HM; Kaminski, RM				Hagy, Heath M.; Kaminski, Richard M.			Determination of Foraging Thresholds and Effects of Application on Energetic Carrying Capacity for Waterfowl	PLOS ONE			English	Article							MOIST-SOIL WETLANDS; FUNCTIONAL-RESPONSE; WOOD DUCKS; PATCH USE; FOOD USE; MODELS; DEPLETION; DENSITY; SWANS; ABUNDANCE	Energetic carrying capacity of habitats for wildlife is a fundamental concept used to better understand population ecology and prioritize conservation efforts. However, carrying capacity can be difficult to estimate accurately and simplified models often depend on many assumptions and few estimated parameters. We demonstrate the complex nature of parameterizing energetic carrying capacity models and use an experimental approach to describe a necessary parameter, a foraging threshold (i.e., density of food at which animals no longer can efficiently forage and acquire energy), for a guild of migratory birds. We created foraging patches with different fixed prey densities and monitored the numerical and behavioral responses of waterfowl (Anatidae) and depletion of foods during winter. Dabbling ducks (Anatini) fed extensively in plots and all initial densities of supplemented seed were rapidly reduced to 10 kg/ha and other natural seeds and tubers combined to 170 kg/ha, despite different starting densities. However, ducks did not abandon or stop foraging in wetlands when seed reduction ceased approximately two weeks into the winter-long experiment nor did they consistently distribute according to ideal-free predictions during this period. Dabbling duck use of experimental plots was not related to initial seed density, and residual seed and tuber densities varied among plant taxa and wetlands but not plots. Herein, we reached several conclusions: 1) foraging effort and numerical responses of dabbling ducks in winter were likely influenced by factors other than total food densities (e.g., predation risk, opportunity costs, forager condition), 2) foraging thresholds may vary among foraging locations, and 3) the numerical response of dabbling ducks may be an inconsistent predictor of habitat quality relative to seed and tuber density. We describe implications on habitat conservation objectives of using different foraging thresholds in energetic carrying capacity models and suggest scientists reevaluate assumptions of these models used to guide habitat conservation.	[Hagy, Heath M.] Univ Illinois, Prairie Res Inst, Illinois Nat Hist Survey, Forbes Biol Stn,Bellrose Waterfowl Res Ctr, Havana, IL 62644 USA; [Kaminski, Richard M.] Mississippi State Univ, Dept Wildlife Fisheries & Aquaculture, Mississippi State, MS 39762 USA	Illinois Natural History Survey; University of Illinois System; Mississippi State University	Hagy, HM (corresponding author), Univ Illinois, Prairie Res Inst, Illinois Nat Hist Survey, Forbes Biol Stn,Bellrose Waterfowl Res Ctr, Havana, IL 62644 USA.	hhagy@illinois.edu			Mississippi Department of Wildlife, Fisheries, and Parks; Forest and Wildlife Research Center at Mississippi State University; Ducks Unlimited	Mississippi Department of Wildlife, Fisheries, and Parks; Forest and Wildlife Research Center at Mississippi State University; Ducks Unlimited	The authors' research was supported financially by the Mississippi Department of Wildlife, Fisheries, and Parks (http://www.mdwfp.com/); The Forest and Wildlife Research Center at Mississippi State University (http://fwrc.msstate.edu/); and Ducks Unlimited (http://www.ducks.org). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams-Hunt Melissa M., 2007, P105; Castillo-Guerrero JA, 2009, WATERBIRDS, V32, P400, DOI 10.1675/063.032.0304; Amano T, 2004, J APPL ECOL, V41, P675, DOI 10.1111/j.0021-8901.2004.00923.x; Amano T, 2006, ETHOLOGY, V112, P544, DOI 10.1111/j.1439-0310.2006.01196.x; Anderson JT, 1999, WILDLIFE SOC B, V27, P281; [Anonymous], 2006, SAS MIXED MODELS; ARENGO F, 1995, CONDOR, V97, P325, DOI 10.2307/1369018; Arzel C, 2007, BEHAV PROCESS, V75, P66, DOI 10.1016/j.beproc.2007.01.001; BALDASSARRE GA, 1984, J WILDLIFE MANAGE, V48, P63, DOI 10.2307/3808453; Ballard BM, 2004, J WILDLIFE MANAGE, V68, P371, DOI 10.2193/0022-541X(2004)068[0371:DANONP]2.0.CO;2; Barras SC, 1996, J WILDLIFE MANAGE, V60, P592, DOI 10.2307/3802077; Bellrose F, 1980, DUCKS GEESE SWANS N; BERNSTEIN C, 1988, J ANIM ECOL, V57, P1007, DOI 10.2307/5108; Brasher MG, 2010, THESIS OHIO STATE U; BROWN JS, 1988, BEHAV ECOL SOCIOBIOL, V22, P37, DOI 10.1007/BF00395696; BROWN JS, 1989, AM NAT, V133, P168, DOI 10.1086/284908; Callicutt JT, 2011, J FISH WILDL MANAG, V2, P29, DOI 10.3996/102010-JFWM-038; CARACO T, 1980, ECOLOGY, V61, P119, DOI 10.2307/1937162; Central Valley Joint Venture Implementation Plan (CVJV), 2006, CENTR VALL JOINT VEN; CHARNOV EL, 1976, THEOR POPUL BIOL, V9, P129, DOI 10.1016/0040-5809(76)90040-X; Combs DL, 1996, J WILDLIFE MANAGE, V60, P603, DOI 10.2307/3802078; Cramer DM, 2012, J WILDLIFE MANAGE, V76, P214, DOI 10.1002/jwmg.252; CRESSWELL W, 1994, J ANIM ECOL, V63, P589, DOI 10.2307/5225; DELNICKI D, 1986, J WILDLIFE MANAGE, V50, P43, DOI 10.2307/3801486; Dobbs RC, 2007, J FIELD ORNITHOL, V78, P133, DOI 10.1111/j.1557-9263.2007.00096.x; Ehrle B, 1995, WILDLIFE SOC B, V23, P774; Fleming K.S., 2010, THESIS MISSISSIPPI S THESIS MISSISSIPPI S; Fretwell S.D., 1970, ACTA BIOTHEOR, V19, P16, DOI DOI 10.1007/BF01601953; Fritz H, 2001, OIKOS, V93, P488, DOI 10.1034/j.1600-0706.2001.930314.x; Gawlik DE, 2002, ECOL MONOGR, V72, P329, DOI 10.1890/0012-9615(2002)072[0329:TEOPAO]2.0.CO;2; Goss-Custard JD, 2002, BIOL CONSERV, V105, P27, DOI 10.1016/S0006-3207(01)00175-6; Goss-Custard JD, 2003, J APPL ECOL, V40, P176, DOI 10.1046/j.1365-2664.2003.00785.x; Gray MJ, 2013, WETLAND TECHNIQUES, P121; Greer AK, 2007, J WILDLIFE MANAGE, V71, P1561, DOI 10.2193/2006-376; Greer DM, 2009, J WILDLIFE MANAGE, V73, P1125, DOI 10.2193/2008-250; Guillemain M, 2001, J AVIAN BIOL, V32, P345, DOI 10.1111/j.0908-8857.2001.320409.x; Gurd DB, 2006, ZOOLOGY, V109, P120, DOI 10.1016/j.zool.2005.10.002; Hagy H. M., 2011, P ANN C SE ASS FISH, V65, P56; Hagy Heath M., 2014, Wildfowl, P436; Hagy HM, 2012, WILDLIFE SOC B, V36, P512, DOI 10.1002/wsb.165; Hagy HM, 2012, J WILDLIFE MANAGE, V76, P1053, DOI 10.1002/jwmg.325; Hagy HM, 2011, J WILDLIFE MANAGE, V75, P959, DOI 10.1002/jwmg.115; Inger R, 2006, J APPL ECOL, V43, P1022, DOI 10.1111/j.1365-2664.2006.01207.x; Johnson MD, 2007, CONDOR, V109, P489, DOI 10.1650/8347.1; Kahler BM, 2012, UPPER MISSISSIPPI RI; Kaminski RM, 2003, J WILDLIFE MANAGE, V67, P542, DOI 10.2307/3802712; KAMINSKI RM, 1981, AUK, V98, P115; Kirk M, 2008, OECOLOGIA, V155, P859, DOI 10.1007/s00442-007-0947-0; Klaassen RHG, 2007, J ANIM ECOL, V76, P20, DOI 10.1111/j.1365-2656.2006.01184.x; Kotler BP, 2007, ISR J ECOL EVOL, V53, P237, DOI 10.1560/IJEE.53.3.237; Kross J, 2008, J WILDLIFE MANAGE, V72, P707, DOI 10.2193/2007-100; Loesch C. R., 1994, LOWER MISSISSIPPI VA; Lovvorn JR, 1996, ECOLOGY, V77, P435, DOI 10.2307/2265620; LOVVORN JR, 1994, J ANIM ECOL, V63, P11, DOI 10.2307/5578; LOVVORN JR, 1989, J APPL ECOL, V26, P113, DOI 10.2307/2403655; LOVVORN JR, 1994, HYDROBIOLOGIA, V279, P223, DOI 10.1007/BF00027856; Lyons JE, 2005, CONDOR, V107, P41, DOI 10.1650/7462; MARTIN TE, 1995, ECOL MONOGR, V65, P101, DOI 10.2307/2937160; Miller MR, 2006, CONDOR, V108, P166, DOI 10.1650/0010-5422(2006)108[0166:TARBRM]2.0.CO;2; Moon JA, 2008, P ANN C SE ASS FISH, V62, P32; Morris DW, 2007, ECOLOGY, V88, P597, DOI 10.1890/06-0389; Nakagawa S, 2013, METHODS ECOL EVOL, V4, P133, DOI 10.1111/j.2041-210x.2012.00261.x; Naylor L.W., 2002, THESIS U CALIFORNIA; Nielsen SE, 2010, BIOL CONSERV, V143, P1623, DOI 10.1016/j.biocon.2010.04.007; Nolet BA, 2006, OIKOS, V112, P353, DOI 10.1111/j.0030-1299.2006.13463.x; Nolet BA, 2002, J ANIM ECOL, V71, P979, DOI 10.1046/j.1365-2656.2002.00662.x; Nolet BA, 2001, ECOLOGY, V82, P1655, DOI 10.1890/0012-9658(2001)082[1655:SVITDB]2.0.CO;2; Nolet BA, 2009, OIKOS, V118, P431, DOI 10.1111/j.1600-0706.2008.16857.x; Percival SM, 1998, J APPL ECOL, V35, P57, DOI 10.1046/j.1365-2664.1998.00273.x; PYKE GH, 1977, Q REV BIOL, V52, P137, DOI 10.1086/409852; Reinecke K.J., 1989, P203; Richman SE, 2009, J ANIM ECOL, V78, P1033, DOI 10.1111/j.1365-2656.2009.01556.x; Richman SE, 2004, ECOL APPL, V14, P1217, DOI 10.1890/03-5032; SAS Institute Inc., 2008, SAS 9 3 ENH LOGG FAC; Smith RV, 2011, 201137 IL NAT HIST S; Soulliere G. J., 2007, UPPER MISSISSIPPI RI; Sponberg AF, 2005, ECOLOGY, V86, P2127, DOI 10.1890/04-1335; van Gils JA, 2007, AM NAT, V169, P609, DOI 10.1086/513114; van Gils JA, 2003, AM NAT, V161, P777, DOI 10.1086/374205; van Gils JA, 2004, OIKOS, V104, P197, DOI 10.1111/j.0030-1299.2003.12214.x; VanderMeer J, 1997, J ANIM ECOL, V66, P846; VANEERDEN MR, 1997, PATCHWORK PATCH USE, P165; West AD, 2005, BIOL CONSERV, V123, P211, DOI 10.1016/j.biocon.2004.11.010; WIENS JA, 1976, ANNU REV ECOL SYST, V7, P81, DOI 10.1146/annurev.es.07.110176.000501; Ydenberg Ronald C., 2007, P1; Zar J.H., 2009, BIOSTATISTICAL ANAL	86	27	27	1	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2015	10	3							e0118349	10.1371/journal.pone.0118349	http://dx.doi.org/10.1371/journal.pone.0118349			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD9NQ	25790255	Green Submitted, Green Published, gold			2022-12-27	WOS:000351425400027
J	Shibayama, J; Yuzyuk, TN; Cox, J; Makaju, A; Miller, M; Lichter, J; Li, H; Leavy, JD; Franklin, S; Zaitsev, AV				Shibayama, Junko; Yuzyuk, Tatiana N.; Cox, James; Makaju, Aman; Miller, Mickey; Lichter, Justin; Li, Hui; Leavy, Jane D.; Franklin, Sarah; Zaitsev, Alexey V.			Metabolic Remodeling in Moderate Synchronous versus Dyssynchronous Pacing-Induced Heart Failure: Integrated Metabolomics and Proteomics Study	PLOS ONE			English	Article							FATTY-ACID OXIDATION; CARDIAC RESYNCHRONIZATION THERAPY; FAILING HUMAN HEART; IDIOPATHIC DILATED CARDIOMYOPATHY; PROTEIN EXPRESSION; GENE-EXPRESSION; DOWN-REGULATION; MITOCHONDRIAL-FUNCTION; PRESSURE-OVERLOAD; ENERGY-METABOLISM	Heart failure (HF) is accompanied by complex alterations in myocardial energy metabolism. Up to 40% of HF patients have dyssynchronous ventricular contraction, which is an independent indicator of mortality. We hypothesized that electromechanical dyssynchrony significantly affects metabolic remodeling in the course of HF. We used a canine model of tachypacing-induced HF. Animals were paced at 200 bpm for 6 weeks either in the right atrium (synchronous HF, SHF) or in the right ventricle (dyssynchronous HF, DHF). We collected biopsies from left ventricular apex and performed comprehensive metabolic pathway analysis using multi-platform metabolomics (GC/MS; MS/MS; HPLC) and LC-MS/MS labelfree proteomics. We found important differences in metabolic remodeling between SHF and DHF. As compared to Control, ATP, phosphocreatine (PCr), creatine, and PCr/ATP (prognostic indicator of mortality in HF patients) were all significantly reduced in DHF, but not SHF. In addition, the myocardial levels of carnitine (mitochondrial fatty acid carrier) and fatty acids (12:0, 14:0) were significantly reduced in DHF, but not SHF. Carnitine parmitoyltransferase I, a key regulatory enzyme of fatty acid beta-oxidation, was significantly upregulated in SHF but was not different in DHF, as compared to Control. Both SHF and DHF exhibited a reduction, but to a different degree, in creatine and the intermediates of glycolysis and the TCA cycle. In contrast to this, the enzymes of creatine kinase shuttle were upregulated, and the enzymes of glycolysis and the TCA cycle were predominantly upregulated or unchanged in both SHF and DHF. These data suggest a systemic mismatch between substrate supply and demand in pacing-induced HF. The energy deficit observed in DHF, but not in SHF, may be associated with a critical decrease in fatty acid delivery to the beta-oxidation pipeline, primarily due to a reduction in myocardial carnitine content.	[Shibayama, Junko; Makaju, Aman; Miller, Mickey; Lichter, Justin; Li, Hui; Franklin, Sarah; Zaitsev, Alexey V.] Univ Utah, Nora Eccles Harrison Cardiovasc Res & Training In, Salt Lake City, UT 84112 USA; [Shibayama, Junko; Leavy, Jane D.; Franklin, Sarah] Univ Utah, Sch Med, Dept Internal Med, Salt Lake City, UT USA; [Yuzyuk, Tatiana N.] Univ Utah, Sch Med, Dept Pathol, Salt Lake City, UT USA; [Yuzyuk, Tatiana N.] ARUP Labs, Salt Lake City, UT USA; [Cox, James] Univ Utah, Metabol Core Res Facil, Salt Lake City, UT USA; [Cox, James; Franklin, Sarah] Univ Utah, Dept Biochem, Salt Lake City, UT USA; [Lichter, Justin; Zaitsev, Alexey V.] Univ Utah, Dept Bioengn, Salt Lake City, UT 84112 USA	Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; ARUP Laboratories; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah	Zaitsev, AV (corresponding author), Univ Utah, Nora Eccles Harrison Cardiovasc Res & Training In, Salt Lake City, UT 84112 USA.	zaitsev@cvrti.utah.edu	li, hui/A-3135-2017	Cox, James/0000-0002-5977-2350; Zaitsev, Artem/0000-0002-2314-0482	United States National Institutes of Health NRSA fellowship [F32HL097576]; United States National Institutes of Health [R01HL103877, R01HL094464, R00HL107674]; Nora Eccles Treadwell Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K99HL107674, F32HL097576, R01HL094464, R01HL103877, R00HL107674] Funding Source: NIH RePORTER	United States National Institutes of Health NRSA fellowship; United States National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Nora Eccles Treadwell Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This study was supported by the United States National Institutes of Health NRSA fellowship F32HL097576 (JS), the United States National Institutes of Health Grants R01HL103877 (AVZ), R01HL094464 (FBS), R00HL107674 ( SF), and Nora Eccles Treadwell Foundation research grant (AVZ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agnetti G, 2010, CIRC-CARDIOVASC GENE, V3, P78, DOI 10.1161/CIRCGENETICS.109.871236; Aiba T, 2009, CIRCULATION, V119, P1220, DOI 10.1161/CIRCULATIONAHA.108.794834; Ardehali H, 2012, EUR J HEART FAIL, V14, P120, DOI 10.1093/eurjhf/hfr173; ARMSTRONG PW, 1986, CIRCULATION, V74, P1075, DOI 10.1161/01.CIR.74.5.1075; Barth AS, 2011, CIRC-CARDIOVASC GENE, V4, P475, DOI 10.1161/CIRCGENETICS.110.957571; BETZ A, 1965, ARCH BIOCHEM BIOPHYS, V109, P585, DOI 10.1016/0003-9861(65)90404-2; Birner C, 2012, J CARD FAIL, V18, P660, DOI 10.1016/j.cardfail.2012.06.418; Bugger H, 2010, CARDIOVASC RES, V85, P376, DOI 10.1093/cvr/cvp344; Calmettes G, 2013, J GEN PHYSIOL, V142, P425, DOI 10.1085/jgp.201310968; Cha YM, 2006, AM J PHYSIOL-HEART C, V290, pH1686, DOI 10.1152/ajpheart.00384.2005; Chakir K, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3001909; Chakir K, 2009, CIRCULATION, V119, P1231, DOI 10.1161/CIRCULATIONAHA.108.774752; Chandler MP, 2004, AM J PHYSIOL-HEART C, V287, pH1538, DOI 10.1152/ajpheart.00281.2004; Cieniewski-Bernard C, 2008, J PROTEOME RES, V7, P5004, DOI 10.1021/pr800409u; Cordero-Reyes AM, 2014, J MOL CELL CARDIOL, V68, P98, DOI 10.1016/j.yjmcc.2013.12.029; Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511; Doenst T, 2010, CARDIOVASC RES, V86, P461, DOI 10.1093/cvr/cvp414; El-Aroussy W, 2000, MOL CELL BIOCHEM, V213, P37, DOI 10.1023/A:1007142919941; Fueger PT, 2005, J PHYSIOL-LONDON, V566, P533, DOI 10.1113/jphysiol.2005.085043; Gao Z, 2008, PHYSIOL GENOMICS, V35, P222, DOI 10.1152/physiolgenomics.00100.2007; Garcia-Rua V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037505; Garnier A, 2003, J PHYSIOL-LONDON, V551, P491, DOI 10.1113/jphysiol.2003.045104; Gibala MJ, 2000, ACTA PHYSIOL SCAND, V168, P657, DOI 10.1046/j.1365-201x.2000.00717.x; Grube M, 2011, AM J PATHOL, V178, P2547, DOI 10.1016/j.ajpath.2011.02.020; Hammer E, 2011, J PROTEOME RES, V10, P2161, DOI 10.1021/pr1008042; Ingwall JS, 2006, CURR HYPERTENS REP, V8, P457, DOI 10.1007/s11906-006-0023-x; Ingwall JS, 2009, CARDIOVASC RES, V81, P412, DOI 10.1093/cvr/cvn301; Ingwall JS, 2004, CIRC RES, V95, P135, DOI 10.1161/01.RES.0000137170.41939.d9; Iuliano S, 2002, AM HEART J, V143, P1085, DOI 10.1067/mhj.2002.122516; Johannsson E, 2001, CIRCULATION, V104, P729, DOI 10.1161/hc3201.092286; Karamanlidis G, 2010, CIRC RES, V106, P1541, DOI 10.1161/CIRCRESAHA.109.212753; Karbowska J, 2003, CELL MOL BIOL LETT, V8, P49; Kodde IF, 2007, COMP BIOCHEM PHYS A, V146, P26, DOI 10.1016/j.cbpa.2006.09.014; Lei B, 2004, J MOL CELL CARDIOL, V36, P567, DOI 10.1016/j.yjmcc.2004.02.004; Lichter JG, 2014, J MOL CELL CARDIOL, V72, P186, DOI 10.1016/j.yjmcc.2014.03.012; Lionetti V, 2011, CARDIOVASC RES, V90, P202, DOI 10.1093/cvr/cvr038; Lloyd-Jones D, 2010, CIRCULATION, V121, pE46, DOI 10.1161/CIRCULATIONAHA.109.192667; Lopaschuk GD, 2010, PHYSIOL REV, V90, P207, DOI 10.1152/physrev.00015.2009; Luber CA, 2010, IMMUNITY, V32, P279, DOI 10.1016/j.immuni.2010.01.013; Marin-Garcia J, 2001, CARDIOVASC RES, V52, P103, DOI 10.1016/S0008-6363(01)00368-6; Martin MA, 2000, BBA-MOL BASIS DIS, V1502, P330, DOI 10.1016/S0925-4439(00)00061-2; MONTGOMERY C, 1992, J APPL PHYSIOL, V73, P2363, DOI 10.1152/jappl.1992.73.6.2363; Morgan EE, 2006, EUR J HEART FAIL, V8, P687, DOI 10.1016/j.ejheart.2006.01.005; Neglia D, 2007, AM J PHYSIOL-HEART C, V293, pH3270, DOI 10.1152/ajpheart.00887.2007; Neubauer S, 1997, CIRCULATION, V96, P2190; Oka S, 2011, CELL METAB, V14, P598, DOI 10.1016/j.cmet.2011.10.001; Osorio JC, 2002, CIRCULATION, V106, P606, DOI 10.1161/01.CIR.0000023531.22727.C1; Pak PH, 1997, J AM COLL CARDIOL, V30, P576, DOI 10.1016/S0735-1097(97)00193-9; Pieske B, 2002, CIRCULATION, V106, P447, DOI 10.1161/01.CIR.0000023042.50192.F4; Razeghi P, 2001, CIRCULATION, V104, P2923, DOI 10.1161/hc4901.100526; RICHTER PH, 1980, BIOPHYS CHEM, V12, P285, DOI 10.1016/0301-4622(80)80006-8; Rosiers CD, 2011, CARDIOVASC RES, V90, P210, DOI 10.1093/cvr/cvr055; Sachse FB, 2012, CIRC RES, V110, P588, DOI 10.1161/CIRCRESAHA.111.257428; Sack MN, 1996, CIRCULATION, V94, P2837, DOI 10.1161/01.CIR.94.11.2837; Schupp M, 2006, EUR J HEART FAIL, V8, P290, DOI 10.1016/j.ejheart.2005.09.003; Shakoury-Elizeh M, 2010, J BIOL CHEM, V285, P14823, DOI 10.1074/jbc.M109.091710; Shen WQ, 1999, CIRCULATION, V100, P2113, DOI 10.1161/01.CIR.100.20.2113; Shibayama J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057821; Sihag S, 2009, J MOL CELL CARDIOL, V46, P201, DOI 10.1016/j.yjmcc.2008.10.025; Southworth R, 2007, AM J PHYSIOL-HEART C, V292, pH378, DOI 10.1152/ajpheart.00664.2006; Spragg DD, 2003, CIRCULATION, V108, P929, DOI 10.1161/01.CIR.0000088782.99568.CA; Ueland T, 2013, INT J CARDIOL, V167, P1892, DOI 10.1016/j.ijcard.2012.04.150; Ventura-Clapier R, 2011, BBA-MOL CELL RES, V1813, P1360, DOI 10.1016/j.bbamcr.2010.09.006; Wang TJ, 2013, J CLIN INVEST, V123, P4309, DOI 10.1172/JCI64801; Weisiger RA, 2002, MOL CELL BIOCHEM, V239, P35, DOI 10.1023/A:1020550405578; WILLIAMS RE, 1994, CIRC RES, V75, P615, DOI 10.1161/01.RES.75.4.615; WILSON JR, 1987, CIRCULATION, V75, P857, DOI 10.1161/01.CIR.75.4.857; Xia JG, 2012, NUCLEIC ACIDS RES, V40, pW127, DOI 10.1093/nar/gks374; Xia JG, 2009, NUCLEIC ACIDS RES, V37, pW652, DOI 10.1093/nar/gkp356; Yazaki Y, 1999, HEART, V81, P153, DOI 10.1136/hrt.81.2.153	70	28	29	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2015	10	3							e0118974	10.1371/journal.pone.0118974	http://dx.doi.org/10.1371/journal.pone.0118974			32	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD9NQ	25790351	Green Submitted, Green Published, gold			2022-12-27	WOS:000351425400058
J	Tao, Y; Ruan, HZ; Guo, X; Li, LX; Shen, WH				Tao, Yi; Ruan, Hangze; Guo, Xia; Li, Lixin; Shen, Wanhua			HDAC1 Regulates the Proliferation of Radial Glial Cells in the Developing Xenopus Tectum	PLOS ONE			English	Article							HISTONE DEACETYLASES 1; NEURAL STEM-CELLS; IN-VIVO; DEVELOPMENTAL REFINEMENT; RECEPTIVE-FIELDS; MEMORY FORMATION; GENE-EXPRESSION; VISUAL-SYSTEM; NEUROGENESIS; ACETYLATION	In the developing central nervous system (CNS), progenitor cells differentiate into progeny to form functional neural circuits. Radial glial cells (RGs) are a transient progenitor cell type that is present during neurogenesis. It is thought that a combination of neural trophic factors, neurotransmitters and electrical activity regulates the proliferation and differentiation of RGs. However, it is less clear how epigenetic modulation changes RG proliferation. We sought to explore the effect of histone deacetylase (HDAC) activity on the proliferation of RGs in the visual optic tectum of Xenopus laevis. We found that the number of BrdU-labeled precursor cells along the ventricular layer of the tectum decrease developmentally from stage 46 to stage 49. The co-labeling of BrdU-positive cells with brain lipid-binding protein (BLBP), a radial glia marker, showed that the majority of BrdU-labeled cells along the tectal midline are RGs. BLBP-positive cells are also developmentally decreased with the maturation of the brain. Furthermore, HDAC1 expression is developmentally down-regulated in tectal cells, especially in the ventricular layer of the tectum. Pharmacological blockade of HDACs using Trichostatin A (TSA) or Valproic acid (VPA) decreased the number of BrdU-positive, BLBP-positive and co-labeling cells. Specific knockdown of HDAC1 by a morpholino (HDAC1-MO) decreased the number of BrdU-and BLBP-labeled cells and increased the acetylation level of histone H4 at lysine 12 (H4K12). The visual deprivation-induced increase in BrdU-and BLBP-positive cells was blocked by HDAC1 knockdown at stage 49 tadpoles. These data demonstrate that HDAC1 regulates radial glia cell proliferation in the developing optical tectum of Xenopus laevis.	[Tao, Yi; Li, Lixin] Nanjing Med Univ, Affiliated Hosp 1, Dept Neurosurg, Nanjing 210029, Jiangsu, Peoples R China; [Ruan, Hangze; Guo, Xia; Shen, Wanhua] Hangzhou Normal Univ, Coll Life & Environm Sci, Zhejiang Key Lab Organ Dev & Regenerat, Hangzhou, Zhejiang, Peoples R China	Nanjing Medical University; Hangzhou Normal University	Li, LX (corresponding author), Nanjing Med Univ, Affiliated Hosp 1, Dept Neurosurg, 300 Guangzhou Rd, Nanjing 210029, Jiangsu, Peoples R China.	lilixin2@hotmail.com; shen@hznu.edu.cn	Shen, Wanhua/B-5554-2011	Shen, Wanhua/0000-0002-5178-9561	National Natural Science Foundation of China [81171147, 31271176]; Open Project Program of Zhejiang Key Laboratory of Organ Development and Regeneration; "Xingwei Project" Key Personal Medical Research Foundation of Health Department of Jiangsu Province [RC201156]; "Six Categories of Key Person" Research Foundation of Jiangsu Province [16 069]; Priority Academic Program Development of Jiangsu Higher Education Institutions [JX10231801]; Science Foundation for Hangzhou "131" Talents	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Open Project Program of Zhejiang Key Laboratory of Organ Development and Regeneration; "Xingwei Project" Key Personal Medical Research Foundation of Health Department of Jiangsu Province; "Six Categories of Key Person" Research Foundation of Jiangsu Province; Priority Academic Program Development of Jiangsu Higher Education Institutions; Science Foundation for Hangzhou "131" Talents	This work was supported by grants from the National Natural Science Foundation of China (No. 81171147 to LL and No. 31271176 to WS), the Open Project Program of Zhejiang Key Laboratory of Organ Development and Regeneration to YT, the "Xingwei Project" Key Personal Medical Research Foundation of Health Department of Jiangsu Province (No. RC201156 to LL), the "Six Categories of Key Person" Research Foundation of Jiangsu Province (No. 16 069 to LL), the Priority Academic Program Development of Jiangsu Higher Education Institutions (No. JX10231801 to LL), and the Science Foundation for Hangzhou "131" Talents to WS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe T, 2008, CURR OPIN PHARMACOL, V8, P57, DOI 10.1016/j.coph.2007.12.002; Aizenman CD, 2003, NEURON, V39, P831, DOI 10.1016/S0896-6273(03)00527-0; Akhtar MW, 2009, J NEUROSCI, V29, P8288, DOI 10.1523/JNEUROSCI.0097-09.2009; ALMOUZNI G, 1994, DEV BIOL, V165, P654, DOI 10.1006/dbio.1994.1283; Anthony TE, 2004, NEURON, V41, P881, DOI 10.1016/S0896-6273(04)00140-0; Bestman JE, 2012, J COMP NEUROL, V520, P401, DOI 10.1002/cne.22795; D'Amico LA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066487; D'Amico LA, 2011, BRAIN RES, V1405, P31, DOI 10.1016/j.brainres.2011.06.032; Deisseroth K, 2004, NEURON, V42, P535, DOI 10.1016/S0896-6273(04)00266-1; Del Bene F, 2008, CELL, V134, P1055, DOI 10.1016/j.cell.2008.07.017; Dong W, 2012, J NEUROSCI, V32, P16872, DOI 10.1523/JNEUROSCI.2372-12.2012; Dovey OM, 2010, P NATL ACAD SCI USA, V107, P8242, DOI 10.1073/pnas.1000478107; Falk J, 2007, BMC DEV BIOL, V7, DOI 10.1186/1471-213X-7-107; FENG L, 1994, NEURON, V12, P895, DOI 10.1016/0896-6273(94)90341-7; Graff J, 2013, ANNU REV PHARMACOL, V53, P311, DOI 10.1146/annurev-pharmtox-011112-140216; Guan JS, 2009, NATURE, V459, P55, DOI 10.1038/nature07925; Haas K, 2002, DIFFERENTIATION, V70, P148, DOI 10.1046/j.1432-0436.2002.700404.x; Haberland M, 2009, NAT REV GENET, V10, P32, DOI 10.1038/nrg2485; Hartfuss E, 2001, DEV BIOL, V229, P15, DOI 10.1006/dbio.2000.9962; Hsieh J, 2005, CURR OPIN CELL BIOL, V17, P664, DOI 10.1016/j.ceb.2005.09.002; KEATING MJ, 1987, NEUROSCIENCE, V21, P519, DOI 10.1016/0306-4522(87)90138-2; Kim JY, 2010, NAT NEUROSCI, V13, P180, DOI 10.1038/nn.2471; Kiyota T, 2008, DEV BIOL, V315, P579, DOI 10.1016/j.ydbio.2007.12.013; Kriegstein A, 2009, ANNU REV NEUROSCI, V32, P149, DOI 10.1146/annurev.neuro.051508.135600; Lagger G, 2002, EMBO J, V21, P2672, DOI 10.1093/emboj/21.11.2672; Leavitt BR, 1999, EXP NEUROL, V157, P43, DOI 10.1006/exnr.1999.6982; MacDonald JL, 2008, DEV DYNAM, V237, P2256, DOI 10.1002/dvdy.21626; McKeown CR, 2013, J COMP NEUROL, V521, P2262, DOI 10.1002/cne.23283; Merkle FT, 2004, P NATL ACAD SCI USA, V101, P17528, DOI 10.1073/pnas.0407893101; Mizutani K, 2007, NATURE, V449, P351, DOI 10.1038/nature06090; Montgomery RL, 2007, GENE DEV, V21, P1790, DOI 10.1101/gad.1563807; Montgomery RL, 2009, P NATL ACAD SCI USA, V106, P7876, DOI 10.1073/pnas.0902750106; Nieuwkoop P, 1956, NORMAL TABLE OF XENO; Noctor SC, 2001, NATURE, V409, P714, DOI 10.1038/35055553; Ogawa Y, 2005, DEV NEUROSCI-BASEL, V27, P364, DOI 10.1159/000088452; Peixoto L, 2013, NEUROPSYCHOPHARMACOL, V38, P62, DOI 10.1038/npp.2012.86; Peleg S, 2010, SCIENCE, V328, P753, DOI 10.1126/science.1186088; Peunova N, 2001, J NEUROSCI, V21, P8809, DOI 10.1523/JNEUROSCI.21-22-08809.2001; Sharma P, 2010, NEURON, V68, P442, DOI 10.1016/j.neuron.2010.09.028; Shen WH, 2014, CELL REP, V6, P737, DOI 10.1016/j.celrep.2014.01.024; Shen WH, 2011, J NEUROPHYSIOL, V106, P2285, DOI 10.1152/jn.00641.2011; Shen WH, 2009, J NEUROSCI, V29, P5032, DOI 10.1523/JNEUROSCI.5331-08.2009; Sild M, 2011, NEUROSCIENTIST, V17, P288, DOI 10.1177/1073858410385870; Spitzer NC, 2006, NATURE, V444, P707, DOI 10.1038/nature05300; Strahl BD, 2000, NATURE, V403, P41, DOI 10.1038/47412; Summers AR, 2013, J CLIN INVEST, V123, P3112, DOI 10.1172/JCI60806; Tao HW, 2005, NEURON, V45, P829, DOI 10.1016/j.neuron.2005.01.046; Tremblay M, 2009, J NEUROSCI, V29, P14066, DOI 10.1523/JNEUROSCI.3542-09.2009; Tseng AS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026382; Vislay-Meltzer R, 2006, NEURON, V50, P101, DOI 10.1016/j.neuron.2006.02.016; Wu GY, 1999, J NEUROSCI, V19, P4472; Yoshida M, 2001, DEV NEUROSCI-BASEL, V23, P299, DOI 10.1159/000048713; Zeng Y, 2011, J NEUROSCI, V31, P17800, DOI 10.1523/JNEUROSCI.3878-11.2011; Zhang M, 2011, J NEUROSCI, V31, P5460, DOI 10.1523/JNEUROSCI.6220-10.2011; Zhao CM, 2008, CELL, V132, P645, DOI 10.1016/j.cell.2008.01.033; Zupkovitz G, 2006, MOL CELL BIOL, V26, P7913, DOI 10.1128/MCB.01220-06	56	16	17	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2015	10	3							e0120118	10.1371/journal.pone.0120118	http://dx.doi.org/10.1371/journal.pone.0120118			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD9NQ	25789466	gold, Green Published, Green Submitted			2022-12-27	WOS:000351425400130
J	Wang, X; Wang, ZW; Sidhu, PS; Desai, UR; Zhou, QB				Wang, Xing; Wang, Zhiwei; Sidhu, Preetpal Singh; Desai, Umesh R.; Zhou, Qibing			6-Hydroxyflavone and Derivatives Exhibit Potent Anti-Inflammatory Activity among Mono-, Di- and Polyhydroxylated Flavones in Kidney Mesangial Cells	PLOS ONE			English	Article							INHIBITORS; INFLAMMATION; APOPTOSIS; PATHWAY; AGENT	Inflammatory responses by kidney mesangial cells play a critical role in the glomerulonephritis. The anti-inflammatory potential of nineteen mono-, di- and polyhydroxylated flavones including fisetin, quercetin, morin, tricetin, gossypetin, apigenin and myricetin were investigated on rat mesangial cells with lipopolysaccharide (LPS) as the inflammatory stimuli. 6-Hydroxyflavone and 40,6-dihydroxyflavone exhibited high activity with IC50 in the range of 2.0 mu M, a much better inhibition potential in comparison to the well-studied polyhydroxylated flavones. Interestingly, the anti-inflammatory activity was not due to direct quenching of NO radicals. Investigation on derivatives with methylation, acetylation or sulfation of 6-hydroxyl group revealed that 6-methoxyflavone was the most potent with an IC50 of 192 nM. Mechanistic study indicated that the anti-inflammatory activity of 6-methoxyflavone arose via the inhibition of LPS-induced downstream inducible NO synthase in mesangial cells. The identification of 6-hydroxyflavone and 6-methoxyflavone with potent anti-inflammatory activity in kidney mesangial cells provides a new flavone scaffold and direction to develop naturally derived products for potential nephritis prevention and treatment.	[Wang, Xing; Wang, Zhiwei; Zhou, Qibing] Huazhong Univ Sci & Technol, Coll Life Sci & Technol, Dept Nanomed & Biopharmaceut, Wuhan 430074, Hubei, Peoples R China; [Sidhu, Preetpal Singh; Desai, Umesh R.; Zhou, Qibing] Virginia Commonwealth Univ, Dept Med Chem, Richmond, VA 23298 USA; [Sidhu, Preetpal Singh; Desai, Umesh R.; Zhou, Qibing] Virginia Commonwealth Univ, Inst Struct Biol & Drug Discovery, Richmond, VA USA	Huazhong University of Science & Technology; Virginia Commonwealth University; Virginia Commonwealth University	Zhou, QB (corresponding author), Huazhong Univ Sci & Technol, Coll Life Sci & Technol, Dept Nanomed & Biopharmaceut, Wuhan 430074, Hubei, Peoples R China.	qibingzhou@hust.edu.cn	Desai, Umesh/D-3741-2013	Desai, Umesh/0000-0002-1976-6597	National Basic Research Program of China [2011CB933100]; National Heart Lung and Blood Institute, USA [HL090586]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL090586] Funding Source: NIH RePORTER	National Basic Research Program of China(National Basic Research Program of China); National Heart Lung and Blood Institute, USA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by National Basic Research Program of China (2011CB933100 to QZ) and National Heart Lung and Blood Institute, USA (HL090586 to URD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abboud HE, 2012, EXP CELL RES, V318, P979, DOI 10.1016/j.yexcr.2012.02.025; Amrutha K, 2014, BIOORG MED CHEM LETT, V24, P4735, DOI 10.1016/j.bmcl.2014.07.093; Domitrovic R, 2013, TOXICOLOGY, V310, P115, DOI 10.1016/j.tox.2013.05.015; Geraets L, 2009, BIOCHEM BIOPH RES CO, V382, P598, DOI 10.1016/j.bbrc.2009.03.071; Gupta SC, 2014, ARCH BIOCHEM BIOPHYS, V559, P91, DOI 10.1016/j.abb.2014.06.006; Khan A, 2013, INT J RADIAT BIOL, V89, P965, DOI 10.3109/09553002.2013.811310; Lee IT, 2012, CELL COMMUN SIGNAL, V10, DOI 10.1186/1478-811X-10-33; Liu CM, 2012, BBA-GEN SUBJECTS, V1820, P1693, DOI 10.1016/j.bbagen.2012.06.011; Liu M, 2001, J MED CHEM, V44, P4443, DOI 10.1021/jm0101747; NATOLI M, 1990, TETRAHEDRON LETT, V31, P7371, DOI 10.1016/S0040-4039(00)88570-6; Ozcan F, 2012, CLIN EXP MED, V12, P265, DOI 10.1007/s10238-011-0167-0; Pandurangan N, 2011, BIOORG MED CHEM LETT, V21, P5328, DOI 10.1016/j.bmcl.2011.07.008; Patel A, 2010, PHARMACOGN RES, V2, P152, DOI 10.4103/0974-8490.65509; Shui HA, 2007, RHEUMATOLOGY, V46, P1277, DOI 10.1093/rheumatology/kem136; Si DY, 2009, DRUG METAB DISPOS, V37, P629, DOI 10.1124/dmd.108.023416; Singh M, 2014, EUR J MED CHEM, V84, P206, DOI 10.1016/j.ejmech.2014.07.013; Tran TA, 2014, ARCH BIOCHEM BIOPHYS, V562, P92, DOI 10.1016/j.abb.2014.08.001; Verghese J, 2009, BIOORG MED CHEM LETT, V19, P4126, DOI 10.1016/j.bmcl.2009.06.013; Xie CH, 2012, J NUTR BIOCHEM, V23, P1184, DOI 10.1016/j.jnutbio.2011.06.013; Zhou QB, 2006, CHEM RES TOXICOL, V19, P1415, DOI 10.1021/tx0601307; Zhou SF, 2009, CURR MED CHEM, V16, P3480, DOI 10.2174/092986709789057635	21	21	21	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2015	10	3							e0116409	10.1371/journal.pone.0116409	http://dx.doi.org/10.1371/journal.pone.0116409			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD9NQ	25790236	Green Published, Green Submitted, gold			2022-12-27	WOS:000351425400016
J	Williams, MR; Walter, W				Williams, Matthew R.; Walter, Wayne			Development of a Prototype Over-Actuated Biomimetic Prosthetic Hand	PLOS ONE			English	Article							UPPER-LIMB PROSTHESIS; GRIP FORCE; DESIGN	The loss of a hand can greatly affect quality of life. A prosthetic device that can mimic normal hand function is very important to physical and mental recuperation after hand amputation, but the currently available prosthetics do not fully meet the needs of the amputee community. Most prosthetic hands are not dexterous enough to grasp a variety of shaped objects, and those that are tend to be heavy, leading to discomfort while wearing the device. In order to attempt to better simulate human hand function, a dexterous hand was developed that uses an over-actuated mechanism to form grasp shape using intrinsic joint mounted motors in addition to a finger tendon to produce large flexion force for a tight grip. This novel actuation method allows the hand to use small actuators for grip shape formation, and the tendon to produce high grip strength. The hand was capable of producing fingertip flexion force suitable for most activities of daily living. In addition, it was able to produce a range of grasp shapes with natural, independent finger motion, and appearance similar to that of a human hand. The hand also had a mass distribution more similar to a natural forearm and hand compared to contemporary prosthetics due to the more proximal location of the heavier components of the system. This paper describes the design of the hand and controller, as well as the test results.	[Williams, Matthew R.] Louis Stokes Cleveland Dept Vet Affairs Med Ctr, Cleveland Funct Elect Stimulat Ctr, Cleveland, OH 44106 USA; [Walter, Wayne] Rochester Inst Technol, Dept Mech Engn, Rochester, NY 14623 USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); Case Western Reserve University; Louis Stokes Cleveland Veterans Affairs Medical Center; Rochester Institute of Technology	Williams, MR (corresponding author), Louis Stokes Cleveland Dept Vet Affairs Med Ctr, Cleveland Funct Elect Stimulat Ctr, Cleveland, OH 44106 USA.	mwilliams@FEScenter.org			Kate Gleason Foundation	Kate Gleason Foundation	Funding from Kate Gleason Foundation endowed chair funds. Wayne Walter (last author) was the Kate Gleason endowed chair at the time the work was done and assisted in data analysis and manuscript preparation. The funding foundation was not directly involved in the work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2013, TOUCH BIONICS; Armiger RS, 2013, J HOPKINS APL TECH D, V31, P345; Atkins DJ., 1996, J PROSTHET ORTHOT, V8, P2, DOI DOI 10.1097/00008526-199600810-00003; Behrend C, 2011, J HAND SURG-AM, V36A, P1711, DOI 10.1016/j.jhsa.2011.07.024; Biddiss EA, 2007, PROSTHET ORTHOT INT, V31, P236, DOI 10.1080/03093640600994581; Blackwell JR, 1999, APPL ERGON, V30, P401, DOI 10.1016/S0003-6870(98)00055-6; Branemark R, 2001, J REHABIL RES DEV, V38, P175; Butterfass J, 1998, IEEE INT CONF ROBOT, P2081; Caffaz A, 1998, IEEE INT CONF ROBOT, P2075, DOI 10.1109/ROBOT.1998.680623; Carrozza MC, 2006, BIOL CYBERN, V95, P629, DOI 10.1007/s00422-006-0124-2; Carrozza MC, 2002, IEEE-ASME T MECH, V7, P108, DOI 10.1109/TMECH.2002.1011247; Controzzi M, 2010, IEEE ENG MED BIO, P499, DOI 10.1109/IEMBS.2010.5627148; CROSBY CA, 1994, J HAND SURG-AM, V19A, P665, DOI 10.1016/0363-5023(94)90280-1; Greiner TM, 1991, HAND ANTHROPOMERY US; Guinnessy P, 2006, PHYS TODAY, V59, P24, DOI 10.1063/1.2364231; Harvey Zach T, 2012, J Surg Orthop Adv, V21, P58; Jacobsen S. C., 1986, Proceedings 1986 IEEE International Conference on Robotics and Automation (Cat. No.86CH2282-2), P1520; Johannes MS, 2011, J HOPKINS APL TECH D, V30, P207; Kang NV, 2010, J HAND SURG-AM, V35A, P1130, DOI 10.1016/j.jhsa.2010.03.037; Kong YK, 2005, INT J IND ERGONOM, V35, P495, DOI 10.1016/j.ergon.2004.11.003; Kyberd PJ, 1998, ROBOTICA, V16, P531, DOI 10.1017/S0263574798000691; Leitkam ST, 2014, J BIOMECH ENG-T ASME, V136, DOI 10.1115/1.4026255; Light C. M., 2002, Journal of Medical Engineering and Technology, V26, P139, DOI 10.1080/03091900210142459; Light CM, 2000, MED ENG PHYS, V22, P679, DOI 10.1016/S1350-4533(01)00017-0; Lin LR, 1998, J MECH DESIGN, V120, P282, DOI 10.1115/1.2826970; Lord M, 1997, ORTHOPEDIC PROSTHETI; Lovchik CS, 1999, ICRA '99: IEEE INTERNATIONAL CONFERENCE ON ROBOTICS AND AUTOMATION, VOLS 1-4, PROCEEDINGS, P907, DOI 10.1109/ROBOT.1999.772420; Man-Systems Integration Standards, 1995, NASASTD3000; Massa B, 2002, 2002 IEEE INTERNATIONAL CONFERENCE ON ROBOTICS AND AUTOMATION, VOLS I-IV, PROCEEDINGS, P3374, DOI 10.1109/ROBOT.2002.1014232; McFarland LV, 2010, J REHABIL RES DEV, V47, P299, DOI 10.1682/JRRD.2009.03.0027; MINGRINO A, 1994, IROS '94 - INTELLIGENT ROBOTS AND SYSTEMS: ADVANCED ROBOTIC SYSTEMS AND THE REAL WORLD, VOLS 1-3, P1803, DOI 10.1109/IROS.1994.407614; Pasquina PF, 2006, ARCH PHYS MED REHAB, V87, pS34, DOI 10.1016/j.apmr.2005.11.026; Pellerin C., 1991, Industrial Robot, V18, P25, DOI 10.1108/eb004571; Pons JL, 2004, AUTON ROBOT, V16, P143, DOI 10.1023/B:AURO.0000016862.38337.f1; Pylatiuk C, 2004, P ANN INT IEEE EMBS, V26, P4260; Pylatiuk C, 2004, ARTIF ORGANS, V28, P980, DOI 10.1111/j.1525-1594.2004.00014.x; Ravitz AD, 2013, J HOPKINS APL TECH D, V31, P366; Resnik L, 2014, PROSTHET ORTHOT INT, V38, P492, DOI 10.1177/0309364613506913; Resnik L, 2014, PROSTHET ORTHOT INT, V38, P456, DOI 10.1177/0309364613506914; Resnik L, 2012, ARCH PHYS MED REHAB, V93, P710, DOI 10.1016/j.apmr.2011.11.010; Schultz AE, 2011, PM&R, V3, P55, DOI 10.1016/j.pmrj.2010.06.016; Schulz S, 2005, ROBOTICA, V23, P293, DOI 10.1017/S0263574704001316; Schulz S, 2001, IEEE INT CONF ROBOT, P2437, DOI 10.1109/ROBOT.2001.932988; Smurr LM, 2008, J HAND THER, V21, P160, DOI 10.1197/j.jht.2007.09.006; Tan D, SCI TRANSL IN PRESS; Tennent DJ, 2014, INJURY, V45, P965, DOI 10.1016/j.injury.2014.02.009; Yang JZ, 2004, MECH MACH THEORY, V39, P555, DOI 10.1016/j.mechmachtheory.2004.01.002; Zhao DW, 2006, 2006 IEEE INTERNATIONAL CONFERENCE ON ROBOTICS AND BIOMIMETICS, VOLS 1-3, P878, DOI 10.1109/ROBIO.2006.340336; Ziegler-Graham K, 2008, ARCH PHYS MED REHAB, V89, P422, DOI 10.1016/j.apmr.2007.11.005	49	21	22	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2015	10	3							e0118817	10.1371/journal.pone.0118817	http://dx.doi.org/10.1371/journal.pone.0118817			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD9NQ	25790306	Green Published, Green Submitted, gold			2022-12-27	WOS:000351425400047
J	Yang, YM; Du, LT; Yang, XY; Qu, AL; Zhang, X; Zhou, CJ; Wang, CX				Yang, Yongmei; Du, Lutao; Yang, Xiaoyun; Qu, Ailin; Zhang, Xin; Zhou, Chengjun; Wang, Chuanxin			Aberrant CCR4 Expression Is Involved in Tumor Invasion of Lymph Node-Negative Human Gastric Cancer	PLOS ONE			English	Article							CHEMOKINE RECEPTOR CCR4; CHRONIC LYMPHOCYTIC-LEUKEMIA; CELL INVASION; LIGAND SDF-1; METASTASIS; CXCR4; MMP-9; SURVIVAL; PATHWAY; CCL22	Cellular chemotaxis is the best-known function of chemokine receptors which are closely linked with tumor metastasis. In fact, positive expression of chemokine receptors could also be identified even in some patients without metastatic tumors, while the clinical relevance of this data has not been fully established. Our studies were designed to clarify the CCR4 expression profiles and to explore its potential role in histologically node-negative (pN0) gastric cancer (GC). Immunohistochemistry (IHC) or immunohistofluorescence (IHF) analysis was performed on specimens obtained from 108 patients with pN0 GC. We found that CCR4 was aberrantly over-expressed inpN0 GC tissues, with different expression patterns on tumor cells and being associated with T-stage (P = 0.002). The matrigel in vitro invasion assay revealed that over-expression of CCR4 in GC cell lines significantly enhanced the invasive capacity of these cells. Results from real-time RT-PCR and gelatinzymography showed a significant increase in matrix metalloproteinase (MMP)-9 production induced by the forced expression of CCR4 in GC cell lines. Our data suggest that the aberrant CCR4 expression is involved in tumor invasion of pN0 GC and, conceivably, antagonists of CCR4 might be useful candidates for controlling early events in tumor progression.	[Yang, Yongmei; Du, Lutao; Qu, Ailin; Zhang, Xin; Wang, Chuanxin] Shandong Univ, Qilu Hosp, Dept Clin Lab, Jinan 250100, Shandong, Peoples R China; [Yang, Xiaoyun] Shandong Univ, Qilu Hosp, Dept Gastroenterol, Jinan 250100, Shandong, Peoples R China; [Zhou, Chengjun] Shandong Univ, Hosp 2, Dept Digest Dis, Jinan 250100, Shandong, Peoples R China	Shandong University; Shandong University; Shandong University	Wang, CX (corresponding author), Shandong Univ, Qilu Hosp, Dept Clin Lab, Jinan 250100, Shandong, Peoples R China.	cxwang@sdu.edu.cn			National Natural Science Foundation of China [81271916, 81301506]; Research Fund for the Doctoral Program of Higher Education of China [20120131110055]; Independent Innovation Foundation of Shandong University (IIFSDU) [2012TS174]; Shandong Technological Development Project (STDP) [2013GSF11859]; Natural Science Foundation of Shandong [ZR2013HM104]; National Key Clinical Medical Specialties Foundation	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Research Fund for the Doctoral Program of Higher Education of China(Research Fund for the Doctoral Program of Higher Education of China (RFDP)Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP)); Independent Innovation Foundation of Shandong University (IIFSDU); Shandong Technological Development Project (STDP); Natural Science Foundation of Shandong(Natural Science Foundation of Shandong Province); National Key Clinical Medical Specialties Foundation	This study was supported by the National Natural Science Foundation of China (Grant Nos 81271916 and 81301506), the Research Fund for the Doctoral Program of Higher Education of China (No. 20120131110055), Independent Innovation Foundation of Shandong University (IIFSDU, 2012TS174), the Shandong Technological Development Project (STDP, 2013GSF11859), the Natural Science Foundation of Shandong (Grant No. ZR2013HM104) and the National Key Clinical Medical Specialties Foundation.	[Anonymous], 1997, J CLIN PATHOL; Arigami T, 2009, INT J ONCOL, V35, P19, DOI 10.3892/ijo_00000308; Chan VWF, 1999, BLOOD, V93, P3610, DOI 10.1182/blood.V93.11.3610.411a48_3610_3616; Chen G, 2012, J BIOL CHEM, V287, P12132, DOI 10.1074/jbc.M111.302299; Chou HH, 2013, AM J SURG, V205, P623, DOI 10.1016/j.amjsurg.2012.04.014; Don-Salu-Hewage AS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057194; Gobert M, 2009, CANCER RES, V69, P2000, DOI 10.1158/0008-5472.CAN-08-2360; He HY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071864; Ishida T, 2011, CANCER SCI, V102, P44, DOI 10.1111/j.1349-7006.2010.01767.x; Iwasa S, 2009, ANTICANCER RES, V29, P4751; Kim Jin-Pok, 1998, Gastric Cancer, V1, P125, DOI 10.1007/s101200050006; Lee CC, 2007, J GASTROEN HEPATOL, V22, P1014, DOI 10.1111/j.1440-1746.2006.04488.x; Lee JH, 2009, ANN SURG, V249, P933, DOI 10.1097/SLA.0b013e3181a77ccc; Li J, 2011, DIGEST LIVER DIS, V43, P40, DOI 10.1016/j.dld.2010.05.013; Liu YF, 2012, WORLD J SURG, V36, P109, DOI 10.1007/s00268-011-1192-6; Mariani M, 2004, EUR J IMMUNOL, V34, P231, DOI 10.1002/eji.200324429; Mashino K, 2002, CANCER RES, V62, P2937; Mizukami Y, 2008, INT J CANCER, V122, P2286, DOI 10.1002/ijc.23392; Muller A, 2001, NATURE, V410, P50, DOI 10.1038/35065016; Nakamura ES, 2006, CLIN EXP METASTAS, V23, P9, DOI 10.1007/s10585-006-9006-1; Olkhanud PB, 2009, CANCER RES, V69, P5996, DOI 10.1158/0008-5472.CAN-08-4619; Qiu MZ, 2011, TUMOR BIOL, V32, P489, DOI 10.1007/s13277-010-0142-5; Redondo-Munoz J, 2008, BLOOD, V111, P383, DOI 10.1182/blood-2007-08-107300; Redondo-Munoz J, 2006, BLOOD, V108, P3143, DOI 10.1182/blood-2006-03-007294; Sier CFM, 1996, BRIT J CANCER, V74, P413, DOI 10.1038/bjc.1996.374; Siewert JR, 1998, ANN SURG, V228, P449, DOI 10.1097/00000658-199810000-00002; Speetjens FM, 2009, CANCER MICROENVIRON, V2, P1, DOI 10.1007/s12307-008-0016-1; Tsujikawa T, 2013, INT J CANCER, V132, P2755, DOI 10.1002/ijc.27966; Wang LH, 2009, ONCOL REP, V22, P1333, DOI 10.3892/or_00000572; Wang WN, 2013, TUMOR BIOL, V34, P1865, DOI 10.1007/s13277-013-0728-9; *WHO, 1988, INT HIST CLASS TUM; Yang YM, 2011, CANCER SCI, V102, P1264, DOI 10.1111/j.1349-7006.2011.01934.x; Yu T, 2011, MOL CANCER RES, V9, P161, DOI 10.1158/1541-7786.MCR-10-0386; Zheng HC, 2006, ANTICANCER RES, V26, P3579; Zlotnik A, 2000, IMMUNITY, V12, P121, DOI 10.1016/S1074-7613(00)80165-X	35	10	11	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2015	10	3							e0120059	10.1371/journal.pone.0120059	http://dx.doi.org/10.1371/journal.pone.0120059			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD9NQ	25790118	Green Published, Green Submitted, gold			2022-12-27	WOS:000351425400125
J	Zhao, JN; Liu, Y; Li, HC				Zhao, Jiang-nan; Liu, Yao; Li, Huai-chen			Aspiration-Related Acute Respiratory Distress Syndrome in Acute Stroke Patient	PLOS ONE			English	Article							MEDICAL COMPLICATIONS; RISK-FACTORS; PNEUMONIA; MORTALITY; PREDICTORS; MULTICENTER; DEFINITION; OUTCOMES; COHORT	Background Aspiration of oral or gastric contents into the larynx and lower respiratory tract is a common problem in acute stroke patients, which significantly increases the incidence of acute respiratory distress syndrome (ARDS). However, little is known about the clinical characteristics of aspiration-related ARDS in acute stroke patients. Methods Over 17-month period a retrospective cohort study was done on 1495 consecutive patients with acute stroke. The data including demographic characteristics, clinical manifestations, laboratory examinations, chest imaging, and hospital discharge status were collected to analysis. Results Aspiration-related ARDS was diagnosed in 54 patients (3.6%). The most common presenting symptom was tachypnea (respiratory rate >= 25 breaths/min) in 50 cases. Computed tomography (CT) images usually demonstrated diffuse ground-glass opacities (GGOs) and inhomogeneous patchy consolidations involving the low lobes. Age, NIHSS score, GCS score, dysphagia, dysarthria, hemoglobin concentration, serum aspertate aminotransferase (AST), serum albumin, serum sodium, and admission glucose level were independently associated with aspiration-related ARDS (odds ratio (OR) 1.05, 95% confidence interval (CI) (1.04-1.07); OR 2.87, (2.68-3.63); OR 4.21, (3.57-5.09); OR 2.18, (1.23-3.86); OR 1.67, (1.31-2.14); OR 2.31, (1.11-4.84); OR 1.68, (1.01-2.80); OR 2.15, (1.19-3.90); OR 1.92, (1.10-3.36) and OR 1.14, (1.06-1.21) respectively). Conclusions Aspiration-related ARDS frequently occurs in acute stroke patient with impairment consciousness. It is advisable that performing chest CT timely may identify disease early and prompt treatment to rescue patients.	[Zhao, Jiang-nan; Liu, Yao; Li, Huai-chen] Shandong Univ, Prov Hosp, Dept Resp Med, Jinan 250021, Shandong, Peoples R China	Shandong University	Li, HC (corresponding author), Shandong Univ, Prov Hosp, Dept Resp Med, Jinan 250021, Shandong, Peoples R China.	zjn911016@126.com			Science and technology development plan of Shandong Province [2009GG10002054]	Science and technology development plan of Shandong Province	Funding provided by Science and technology development plan of Shandong Province (Number: 2009GG10002054). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armstrong JR, 2011, NEUROHOSPITALIST, V1, P85, DOI 10.1177/1941875210395775; Bakowitz M, 2012, SCAND J TRAUMA RESUS, V20, DOI 10.1186/1757-7241-20-54; Bamet Berris, 1965, CAN MED ASSOC J, P92; Chumbler NR, 2010, NEUROEPIDEMIOLOGY, V34, P193, DOI 10.1159/000289350; Fanelli V, 2013, J THORAC DIS, V5, P326, DOI 10.3978/j.issn.2072-1439.2013.04.05; Gattinoni L, 2001, AM J RESP CRIT CARE, V164, P1701, DOI 10.1164/ajrccm.164.9.2103121; Gattinoni L, 1986, J Thorac Imaging, V1, P25, DOI 10.1097/00005382-198607000-00005; Grysiewicz RA, 2008, NEUROL CLIN, V26, P871, DOI 10.1016/j.ncl.2008.07.003; Heuschmann PU, 2004, ARCH INTERN MED, V164, P1761, DOI 10.1001/archinte.164.16.1761; Hilker R, 2003, STROKE, V34, P975, DOI 10.1161/01.STR.0000063373.70993.CD; Hoffmann S, 2012, STROKE, V43, P2617, DOI 10.1161/STROKEAHA.112.653055; Jansson C, 2008, ALIMENT PHARM THER, V27, P58, DOI 10.1111/j.1365-2036.2007.03537.x; Ji RJ, 2013, STROKE, V44, P3436, DOI 10.1161/STROKEAHA.113.001931; Langhorne P, 2000, STROKE, V31, P1223, DOI 10.1161/01.STR.31.6.1223; Lanspa MJ, 2013, J HOSP MED, V8, P83, DOI 10.1002/jhm.1996; Lee A, 2014, CHEST, V146, P899, DOI 10.1378/chest.13-3028; Levitt JE, 2012, CRIT CARE, V16, DOI 10.1186/cc11144; Martino R, 2005, STROKE, V36, P2756, DOI 10.1161/01.STR.0000190056.76543.eb; Paul E, 2001, NEW ENGL J MED, V344, P9; Prather AD, 2014, J THORAC IMAG, V29, P304, DOI 10.1097/RTI.0000000000000092; Raghavendran K, 2011, CRIT CARE MED, V39, P818, DOI 10.1097/CCM.0b013e31820a856b; Ranieri VM, 2012, JAMA-J AM MED ASSOC, V307, P2526, DOI 10.1001/jama.2012.5669; Routly JJ, 2003, CRIT CARE MED, V31, pS285, DOI 10.1097/01.CCM.0000057905.74813.BC; Sellars C, 2007, STROKE, V38, P2284, DOI 10.1161/STROKEAHA.106.478156; Sheu CC, 2010, CHEST, V138, P559, DOI 10.1378/chest.09-2933; Spratt N, 2003, J CLIN NEUROSCI, V10, P665, DOI 10.1016/j.jocn.2002.12.001; Walter U, 2007, J NEUROL, V254, P1323, DOI 10.1007/s00415-007-0520-0; Ware LB, 2000, NEW ENGL J MED, V342, P1334, DOI 10.1056/NEJM200005043421806; Westendorp WF, 2011, BMC NEUROL, V11, DOI 10.1186/1471-2377-11-110; Wilson RD, 2012, J STROKE CEREBROVASC, V21, P61, DOI 10.1016/j.jstrokecerebrovasdis.2010.05.002; Yende S, 2010, THORAX, V65, P870, DOI 10.1136/thx.2010.136317	31	9	9	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2015	10	3							e0118682	10.1371/journal.pone.0118682	http://dx.doi.org/10.1371/journal.pone.0118682			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD9NQ	25790377	Green Published, Green Submitted, gold			2022-12-27	WOS:000351425400038
J	Brahma, B; Kumar, S; De, BC; Mishra, P; Patra, MC; Gaur, D; Chopra, M; Gautam, D; Mahanty, S; Malik, H; Malakar, D; Datta, TK; De, S				Brahma, Biswajit; Kumar, Sushil; De, Bidhan Chandra; Mishra, Purusottam; Patra, Mahesh Chandra; Gaur, Deepak; Chopra, Meenu; Gautam, Devika; Mahanty, Sourav; Malik, Hrudananda; Malakar, Dhruba; Datta, Tirtha Kumar; De, Sachinandan			Comparative Genomic Analysis of Buffalo (Bubalus bubalis) NOD1 and NOD2 Receptors and Their Functional Role in In-Vitro Cellular Immune Response	PLOS ONE			English	Article							DELTA T-CELLS; TOLL-LIKE RECEPTORS; NF-KAPPA-B; INTESTINAL EPITHELIAL-CELLS; MURAMYL DIPEPTIDE; NUCLEOTIDE-BINDING; CRITICAL RESIDUES; PROTEIN MODELS; SENSORS NOD1; GAMMA	Nucleotide binding and oligomerization domain (NOD)-like receptors (NLRs) are innate immune receptors that recognize bacterial cell wall components and initiate host immune response. Structure and function of NLRs have been well studied in human and mice, but little information exists on genetic composition and role of these receptors in innate immune system of water buffalo-a species known for its exceptional disease resistance. Here, a comparative study on the functional domains of NOD1 and NOD2 was performed across different species. The NOD mediated in-vitro cellular responses were studied in buffalo peripheral blood mononuclear cells, resident macrophages, mammary epithelial, and fibroblast cells. Buffalo NOD1 (buNOD1) and buNOD2 showed conserved domain architectures as found in other mammals. The domains of buNOD1 and buNOD2 showed analogy in secondary and tertiary conformations. Constitutive expressions of NODs were ubiquitous in different tissues. Following treatment with NOD agonists, peripheral lymphocytes showed an IFN-gamma response along-with production of pro-inflammatory cytokines. Alveolar macrophages and mammary epithelial cells showed NOD mediated in-vitro immune response through NF-kappa B dependent pathway. Fibroblasts showed pro-inflammatory cytokine response following agonist treatment. Our study demonstrates that both immune and non-immune cells could generate NOD-mediated responses to pathogens though the type and magnitude of response depend on the cell types. The structural basis of ligand recognition by buffalo NODs and knowledge of immune response by different cell types could be useful for development of non-infective innate immune modulators and next generation anti-inflammatory compounds.	[Brahma, Biswajit; Kumar, Sushil; De, Bidhan Chandra; Mishra, Purusottam; Patra, Mahesh Chandra; Gaur, Deepak; Chopra, Meenu; Gautam, Devika; Mahanty, Sourav; Malik, Hrudananda; Malakar, Dhruba; Datta, Tirtha Kumar; De, Sachinandan] Natl Dairy Res Inst, Anim Genom Lab, Anim Biotechnol Ctr, Karnal 132001, Haryana, India; [Brahma, Biswajit] SKUAST Jammu, Krishi Vigyan Kendra, Jammu, India; [De, Bidhan Chandra] Kazan Volga Reg Fed Univ, Dept Pharmaceut Res, Kazan, Russia; [De, Bidhan Chandra] Kazan Volga Reg Fed Univ, Educ Ctr, Kazan, Russia	Indian Council of Agricultural Research (ICAR); ICAR - National Dairy Research Institute; Sher-e-Kashmir University of Agricultural Sciences & Technology of Jammu (SKUAST Jammu); Kazan Federal University; Kazan Federal University	De, S (corresponding author), Natl Dairy Res Inst, Anim Genom Lab, Anim Biotechnol Ctr, Karnal 132001, Haryana, India.	sachinandan@ndri.res.in	DE, BIDHAN CHANDRA/P-1606-2015; Malik, Hrudananda/AAU-1515-2020; Patra, Mahesh/I-9746-2014	DE, BIDHAN CHANDRA/0000-0002-9379-8909; Malik, Hrudananda/0000-0003-1213-4455; Brahma, Biswajit/0000-0003-0052-5029; De, Sachinandan/0000-0002-3182-0904; Patra, Mahesh/0000-0003-0471-6236	Department of Biotechnology [BT/PR3111/AAQ/1/474/2011]; Indian Council of Agricultural Research (NICRA/NDRI component)	Department of Biotechnology; Indian Council of Agricultural Research (NICRA/NDRI component)	This study was supported by the Department of Biotechnology; (http://dbtindia.nic.in/; No.: BT/PR3111/AAQ/1/474/2011); and the Indian Council of Agricultural Research (http://www.icar.org.in/; NICRA/NDRI component). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anand V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040469; Barnich N, 2005, J CELL BIOL, V170, P21, DOI 10.1083/jcb.200502153; Borriello G, 2006, INFECT IMMUN, V74, P2115, DOI 10.1128/IAI.74.4.2115-2120.2006; Boyle JP, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00317; Chamaillard M, 2003, NAT IMMUNOL, V4, P702, DOI 10.1038/ni945; COLOVOS C, 1993, PROTEIN SCI, V2, P1511, DOI 10.1002/pro.5560020916; Council N.R., 1981, WATER BUFFALO NEW PR; Coussens NP, 2007, BIOCHEM BIOPH RES CO, V353, P1, DOI 10.1016/j.bbrc.2006.11.122; Ekman AK, 2010, IMMUNOLOGY, V130, P55, DOI 10.1111/j.1365-2567.2009.03212.x; FAO, 2000, WAT BUFF ASS UND, P1; Fiser A, 2003, METHOD ENZYMOL, V374, P461, DOI 10.1016/S0076-6879(03)74020-8; Fridh V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034375; Fritz JH, 2006, NAT IMMUNOL, V7, P1250, DOI 10.1038/ni1412; Garcia VE, 1998, J IMMUNOL, V160, P4322; Girardin SE, 2003, J BIOL CHEM, V278, P8869, DOI 10.1074/jbc.C200651200; Girardin SE, 2003, J BIOL CHEM, V278, P41702, DOI 10.1074/jbc.M307198200; Girardin SE, 2005, J BIOL CHEM, V280, P38648, DOI 10.1074/jbc.M509537200; Girardin SE, 2001, EMBO REP, V2, P736, DOI 10.1093/embo-reports/kve155; Girardin SE, 2003, SCIENCE, V300, P1584, DOI 10.1126/science.1084677; Goldammer T, 2004, CLIN DIAGN LAB IMMUN, V11, P174, DOI 10.1128/CDLI.11.1.174-185.2004; Grimes CL, 2012, J AM CHEM SOC, V134, P13535, DOI 10.1021/ja303883c; Gutierrez O, 2002, J BIOL CHEM, V277, P41701, DOI 10.1074/jbc.M206473200; Hanson PI, 2005, NAT REV MOL CELL BIO, V6, P519, DOI 10.1038/nrm1684; Hasegawa M, 2006, J BIOL CHEM, V281, P29054, DOI 10.1074/jbc.M602638200; Hayday AC, 2000, ANNU REV IMMUNOL, V18, P975, DOI 10.1146/annurev.immunol.18.1.975; HEIN WR, 1991, IMMUNOL TODAY, V12, P30, DOI 10.1016/0167-5699(91)90109-7; Heul AMV, 2013, J BIOL CHEM, V288, P6890, DOI 10.1074/jbc.M112.413781; Hisamatsu T, 2003, GASTROENTEROLOGY, V124, P993, DOI 10.1053/gast.2003.50153; Inohara N, 2000, J BIOL CHEM, V275, P27823; Inohara N, 1999, J BIOL CHEM, V274, P14560, DOI 10.1074/jbc.274.21.14560; JONES DT, 1992, COMPUT APPL BIOSCI, V8, P275, DOI 10.1093/bioinformatics/8.3.275; Kaufmann SHE, 1996, P NATL ACAD SCI USA, V93, P2272, DOI 10.1073/pnas.93.6.2272; Kerns HMM, 2009, CELL IMMUNOL, V257, P38, DOI 10.1016/j.cellimm.2009.02.004; Kim YG, 2008, IMMUNITY, V28, P246, DOI 10.1016/j.immuni.2007.12.012; Kobayashi K, 2002, NATURE, V416, P194, DOI 10.1038/416194a; Kvarnhammar AM, 2012, IMMUNOLOGY, V136, P11, DOI 10.1111/j.1365-2567.2012.03556.x; Laroui H, 2011, J BIOL CHEM, V286, P31003, DOI 10.1074/jbc.M111.257501; Lee KH, 2012, J BIOL CHEM, V287, DOI 10.1074/jbc.M112.410027; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; LUTHY R, 1992, NATURE, V356, P83, DOI 10.1038/356083a0; Manon F, 2007, J MOL BIOL, V365, P160, DOI 10.1016/j.jmb.2006.09.067; Marina-Garcia N, 2008, J IMMUNOL, V180, P4050, DOI 10.4049/jimmunol.180.6.4050; Marina-Garcia N, 2009, J IMMUNOL, V182, P4321, DOI 10.4049/jimmunol.0802197; Marischen L, 2011, SCAND J IMMUNOL, V74, P126, DOI 10.1111/j.1365-3083.2011.02560.x; Mayle S, 2014, J BIOL CHEM, V289, P22900, DOI 10.1074/jbc.M114.557900; Mo JY, 2012, J BIOL CHEM, V287, P23057, DOI 10.1074/jbc.M112.344283; Monie TP, 2013, TRENDS BIOCHEM SCI, V38, P131, DOI 10.1016/j.tibs.2013.01.001; Nembrini C, 2009, J BIOL CHEM, V284, P19183, DOI 10.1074/jbc.M109.006353; O'Neill LAJ, 2011, J LEUKOCYTE BIOL, V89, P173, DOI 10.1189/jlb.0910521; Ogura T, 2004, J STRUCT BIOL, V146, P106, DOI 10.1016/j.jsb.2003.11.008; Ogura Y, 2003, GUT, V52, P1591, DOI 10.1136/gut.52.11.1591; Ogura Y, 2001, J BIOL CHEM, V276, P4812, DOI 10.1074/jbc.M008072200; Park JH, 2007, J IMMUNOL, V178, P2380, DOI 10.4049/jimmunol.178.4.2380; Petterson T, 2011, IMMUNOLOGY, V133, P84, DOI 10.1111/j.1365-2567.2011.03414.x; Petterson T, 2011, J LEUKOCYTE BIOL, V89, P177, DOI 10.1189/jlb.0210061; Philpott DJ, 2014, NAT REV IMMUNOL, V14, P9, DOI 10.1038/nri3565; Porcherie A, 2012, VET RES, V43, DOI 10.1186/1297-9716-43-14; Proell M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002119; R Core Team, 2021, R LANGUAGE ENV STAT; Richardt-Pargmann D, 2011, IMMUNOBIOLOGY, V216, P12, DOI 10.1016/j.imbio.2010.03.011; Schroder K, 2010, CELL, V140, P821, DOI 10.1016/j.cell.2010.01.040; Scott MJ, 2010, J HEPATOL, V53, P693, DOI 10.1016/j.jhep.2010.04.026; Shigeoka AA, 2010, J IMMUNOL, V184, P2297, DOI 10.4049/jimmunol.0903065; Singh M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089788; SKEEN MJ, 1995, J IMMUNOL, V154, P5832; Sorbara MT, 2013, IMMUNITY, V39, P858, DOI 10.1016/j.immuni.2013.10.013; Srimathi T, 2008, BIOCHEMISTRY-US, V47, P1319, DOI 10.1021/bi7016602; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tanabe T, 2004, EMBO J, V23, P1587, DOI 10.1038/sj.emboj.7600175; Ting JPY, 2008, IMMUNITY, V28, P285, DOI 10.1016/j.immuni.2008.02.005; Travassos LH, 2010, NAT IMMUNOL, V11, P55, DOI 10.1038/ni.1823; Travassos LH, 2004, EMBO REP, V5, P1000, DOI 10.1038/sj.embor.7400248; Uehara A, 2008, CLIN VACCINE IMMUNOL, V15, P1060, DOI 10.1128/CVI.00137-08; Uehara A, 2007, MOL IMMUNOL, V44, P3100, DOI 10.1016/j.molimm.2007.02.007; Ueta C, 1996, EUR J IMMUNOL, V26, P3066, DOI 10.1002/eji.1830261237; Vavricka SR, 2004, GASTROENTEROLOGY, V127, P1401, DOI 10.1053/j.gastro.2004.07.024; Wallner B, 2003, PROTEIN SCI, V12, P1073, DOI 10.1110/ps.0236803; Wesch D, 2006, J IMMUNOL, V176, P1348, DOI 10.4049/jimmunol.176.3.1348; Wesch D, 2011, CELL MOL LIFE SCI, V68, P2357, DOI 10.1007/s00018-011-0699-1	79	4	4	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2015	10	3							e0119178	10.1371/journal.pone.0119178	http://dx.doi.org/10.1371/journal.pone.0119178			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9BN	25786158	Green Submitted, gold, Green Published			2022-12-27	WOS:000352138500079
J	Chen, J; Kang, Q; Jiang, WH; Fan, J; Zhang, MD; Yu, SY; Zhang, C				Chen, Jue; Kang, Qing; Jiang, Wenhui; Fan, Juan; Zhang, Mingdao; Yu, Shunying; Zhang, Chen			The 5-HTTLPR Confers Susceptibility to Anorexia Nervosa in Han Chinese: Evidence from a Case-Control and Family-Based Study	PLOS ONE			English	Article							SEROTONIN TRANSPORTER GENE; LINKED POLYMORPHIC REGION; EATING-DISORDERS; RISK-FACTORS; PSYCHOPATHOLOGICAL TRAITS; ASSOCIATION; DEPRESSION; PROMOTER; BULIMIA; WEIGHT	Accumulating evidence has implied that serotonin system dysfunction may be involved in the etiology of anorexia nervosa (AN). Serotonin-transporter-linked promoter region (5-HTTLPR) polymorphism is the genetic variant coding for the serotonin transporter and has a modulatory effect on its expression. This study aimed to investigate the possible association between the 5-HTTLPR and the susceptibility and severity of AN in Han Chinese using a case-control (255 patients and 351 controls) and family based study (198 trios). Eating disorder examination was used to measure the severity of AN behavioral symptoms. For the case-control study, the 5-HTTLPR showed significant association with AN in our sample (genotypic P = 0.03). The frequency of S allele was significantly higher in patients than that in controls (OR = 1.38, 95% CI: 1.06-1.79, P = 0.017). For the family-based study, the S allele of 5-HTTLPR was preferentially transmitted rather than non-transmitted from the parents to affected offspring (P = 0.013). The results of ANCOVA test revealed no significant association between the 5-HTTLPR polymorphism and severity of AN. Our findings suggested that 5-HTTLPR is able to confer susceptibility to AN in Han Chinese.	[Chen, Jue; Kang, Qing; Jiang, Wenhui; Fan, Juan; Zhang, Mingdao; Yu, Shunying; Zhang, Chen] Shanghai Jiao Tong Univ, Sch Med, Shanghai Mental Hlth Ctr, Shanghai 200030, Peoples R China	Shanghai Jiao Tong University	Yu, SY (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Shanghai Mental Hlth Ctr, Shanghai 200030, Peoples R China.	yushuny@yahoo.com; zhangchen645@gmail.com	jiang, wen/GYI-9662-2022		National Natural Science Foundation of China [81201055]; National Key Clinical Disciplines at Shanghai Mental Health Center [OMA-MH2011-873]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key Clinical Disciplines at Shanghai Mental Health Center	This work was supported by the National Natural Science Foundation of China (81201055) and the National Key Clinical Disciplines at Shanghai Mental Health Center (OMA-MH2011-873).	Aberg KA, 2013, JAMA PSYCHIAT, V70, P573, DOI 10.1001/jamapsychiatry.2013.288; Antypa N, 2013, EUR NEUROPSYCHOPHARM, V23, P1125, DOI 10.1016/j.euroneuro.2013.03.013; Bailer UF, 2007, PSYCHOPHARMACOLOGY, V195, P315, DOI 10.1007/s00213-007-0896-7; Blaya C, 2010, NEUROSCI LETT, V485, P11, DOI 10.1016/j.neulet.2010.08.042; Caspi A, 2010, AM J PSYCHIAT, V167, P509, DOI 10.1176/appi.ajp.2010.09101452; Castellini G, 2012, AM J MED GENET B, V159B, P491, DOI 10.1002/ajmg.b.32052; Denys D, 2006, J AFFECT DISORDERS, V91, P39, DOI 10.1016/j.jad.2005.12.011; Di Bella D, 2000, MOL PSYCHIATR, V5, P233, DOI 10.1038/sj.mp.4000689; Fairburn CG, 1999, ARCH GEN PSYCHIAT, V56, P468, DOI 10.1001/archpsyc.56.5.468; Favaro A, 2014, PSYCHIAT RES-NEUROIM, V223, P157, DOI 10.1016/j.pscychresns.2014.05.006; Fuglset TS, 2015, NEUROCASE, V21, P169, DOI 10.1080/13554794.2013.878728; Fumeron F, 2001, MOL PSYCHIATR, V6, P9, DOI 10.1038/sj.mp.4000824; Gadow KD, 2013, PROG NEURO-PSYCHOPH, V40, P292, DOI 10.1016/j.pnpbp.2012.10.019; Gauthier C, 2014, PSYCHONEUROENDOCRINO, V39, P170, DOI 10.1016/j.psyneuen.2013.09.009; Gervasini G, 2013, J CLIN PSYCHOPHARM, V33, P551, DOI 10.1097/JCP.0b013e3182970469; Gervasini G, 2012, J CLIN PSYCHOPHARM, V32, P426, DOI 10.1097/JCP.0b013e3182539f2b; Giordano GD, 2001, J ENDOCRINOL INVEST, V24, P510, DOI 10.1007/BF03343884; Godart NT, 2007, J AFFECT DISORDERS, V97, P37, DOI 10.1016/j.jad.2006.06.023; Grilo CM, 2004, INT J EAT DISORDER, V35, P80, DOI 10.1002/eat.10238; Heils A, 1996, J NEUROCHEM, V66, P2621; Hinney A, 1997, LIFE SCI, V61, pPL295, DOI 10.1016/S0024-3205(97)00888-6; Hoyer D, 2002, PHARMACOL BIOCHEM BE, V71, P533, DOI 10.1016/S0091-3057(01)00746-8; Kaye WH, 2009, NAT REV NEUROSCI, V10, P573, DOI 10.1038/nrn2682; Klump KL, 2005, INT J EAT DISORDER, V37, pS43, DOI 10.1002/eat.20116; Kotte A, 2013, AM J MED GENET B, V162, P718, DOI 10.1002/ajmg.b.32171; Lauzurica N, 2003, NEUROSCI LETT, V352, P226, DOI 10.1016/j.neulet.2003.08.058; Lee Y, 2010, INT J EAT DISORDER, V43, P498, DOI 10.1002/eat.20732; Li Q, 2006, MOL NEUROBIOL, V34, P51, DOI 10.1385/MN:34:1:51; Lohoff FW, 2013, PHARMACOGENOMICS J, V13, P464, DOI 10.1038/tpj.2012.33; Lonsdorf TB, 2009, PROG NEURO-PSYCHOPH, V33, P1479, DOI 10.1016/j.pnpbp.2009.08.004; Mainz V, 2012, PSYCHOSOM MED, V74, P574, DOI 10.1097/PSY.0b013e31824ef10e; Matsushita S, 2004, AM J MED GENET B, V128B, P114, DOI 10.1002/ajmg.b.30022; Mehta D, 2012, J AFFECT DISORDERS, V136, P1192, DOI 10.1016/j.jad.2011.11.042; Monteleone P, 2008, PHARMACOGENOMICS, V9, P1487, DOI 10.2217/14622416.9.10.1487; Nisoli E, 2007, EAT WEIGHT DISORD-ST, V12, P91, DOI 10.1007/BF03327583; Pike KM, 2008, PSYCHOL MED, V38, P1443, DOI 10.1017/S0033291707002310; Ricca V, 2004, NEUROSCI LETT, V365, P92, DOI 10.1016/j.neulet.2004.04.057; Rizvi SL, 2000, INT J EAT DISORDER, V28, P311, DOI 10.1002/1098-108X(200011)28:3<311::AID-EAT8>3.0.CO;2-K; Rybakowski F, 2006, NEUROPSYCHOBIOLOGY, V53, P33, DOI 10.1159/000090701; Saiz PA, 2007, PROG NEURO-PSYCHOPH, V31, P741, DOI 10.1016/j.pnpbp.2007.01.012; Shi YY, 2005, CELL RES, V15, P97, DOI 10.1038/sj.cr.7290272; Sullivan PF, 2012, NAT REV GENET, V13, P537, DOI 10.1038/nrg3240; Sundaramurthy D, 2000, AM J MED GENET, V96, P53, DOI 10.1002/(SICI)1096-8628(20000207)96:1<53::AID-AJMG11>3.0.CO;2-X; Wankerl M, 2014, TRANSL PSYCHIAT, V4, DOI 10.1038/tp.2014.37; Xu J, 2013, LUPUS, V22, P1001, DOI 10.1177/0961203313498793; Zhang C, 2014, AM J MED GENET B, V165, P564, DOI 10.1002/ajmg.b.32259; Zhang C, 2014, PROG NEURO-PSYCHOPH, V50, P110, DOI 10.1016/j.pnpbp.2013.12.010; Zhang C, 2009, NEUROSCI LETT, V462, P308, DOI 10.1016/j.neulet.2009.06.085	48	8	10	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2015	10	3							e0119378	10.1371/journal.pone.0119378	http://dx.doi.org/10.1371/journal.pone.0119378			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9BN	25785698	Green Published, Green Submitted, gold			2022-12-27	WOS:000352138500100
J	Kilic, U; Gok, O; Erenberk, U; Dundaroz, MR; Torun, E; Kucukardali, Y; Elibol-Can, B; Uysal, O; Dundar, T				Kilic, Ulkan; Gok, Ozlem; Erenberk, Ufuk; Dundaroz, Mehmet Rusen; Torun, Emel; Kucukardali, Yasar; Elibol-Can, Birsen; Uysal, Omer; Dundar, Tolga			A Remarkable Age-Related Increase in SIRT1 Protein Expression against Oxidative Stress in Elderly: SIRT1 Gene Variants and Longevity in Human	PLOS ONE			English	Article							NITRIC-OXIDE SYNTHASE; EXTENDS LIFE-SPAN; ENDOTHELIAL DYSFUNCTION; CALORIC RESTRICTION; CELL-SURVIVAL; POLYMORPHISMS; ASSOCIATION; MECHANISMS; NUCLEAR; RISK	Aging is defined as the accumulation of progressive organ dysfunction. Controlling the rate of aging by clarifying the complex pathways has a significant clinical importance. Nowadays, sirtuins have become famous molecules for slowing aging and decreasing age-related disorders. In the present study, we analyzed the SIRT1 gene polymorphisms (rs7895833 A>G, rs7069102 C>G and rs2273773 C>T) and its relation with levels of SIRT1, eNOS, PON-1, cholesterol, TAS, TOS, and OSI to demonstrate the association between genetic variation in SIRT1 and phenotype at different ages in humans. We observed a significant increase in the SIRT1 level in older people and found a significant positive correlation between SIRT1 level and age in the overall studied population. The oldest people carrying AG genotypes for rs7895833 have the highest SIRT1 level suggesting an association between rs7895833 SNP and lifespan longevity. Older people have lower PON-1 levels than those of adults and children which may explain the high levels of SIRT1 protein as a compensatory mechanism for oxidative stress in the elderly. The eNOS protein level was significantly decreased in older people as compared to adults. There was no significant difference in the eNOS level between older people and children. The current study is the first to demonstrate age-related changes in SIRT1 levels in humans and it is important for a much better molecular understanding of the role of the longevity gene SIRT1 and its protein product in aging. It is also the first study presenting the association between SIRT1 expression in older people and rs7895833 in SIRT1 gene.	[Kilic, Ulkan; Gok, Ozlem] Istanbul Medipol Univ, Int Sch Med, Dept Med Biol, Istanbul, Turkey; [Kilic, Ulkan; Gok, Ozlem] Istanbul Medipol Univ, Int Sch Med, Regenerat & Restorat Med Res Ctr REMER, Istanbul, Turkey; [Erenberk, Ufuk; Dundaroz, Mehmet Rusen; Torun, Emel] Bezmialem Vakif Univ, Dept Pediat, Fac Med, Istanbul, Turkey; [Kucukardali, Yasar] Yeditepe Univ, Dept Internal Med, Fac Med, Istanbul, Turkey; [Elibol-Can, Birsen] Bezmialem Vakif Univ, Dept Med Biol, Fac Med, Istanbul, Turkey; [Uysal, Omer] Bezmialem Vakif Univ, Dept Biostat, Fac Med, Istanbul, Turkey; [Dundar, Tolga] Bezmialem Vakif Univ, Dept Neurosurg, Fac Med, Istanbul, Turkey	Istanbul Medipol University; Istanbul Medipol University; Bezmialem Vakif University; Yeditepe University; Bezmialem Vakif University; Bezmialem Vakif University; Bezmialem Vakif University	Kilic, U (corresponding author), Istanbul Medipol Univ, Int Sch Med, Dept Med Biol, Istanbul, Turkey.	uckilic@yahoo.com	Uysal, Ömer/AAR-4220-2020; Elibol, Birsen/AAQ-7696-2020; Dundar, Tolga Turan/X-1831-2019; Elibol, Birsen/C-8369-2018	Uysal, Ömer/0000-0002-8833-697X; Elibol, Birsen/0000-0002-9462-0862; Elibol, Birsen/0000-0002-9462-0862	University Research Council, Bezmialem Vakif University [BAP: 6.2013/21]	University Research Council, Bezmialem Vakif University(Bezmialem Vakif University)	This study was supported partially by a grant from the University Research Council, Bezmialem Vakif University (BAP: 6.2013/21) and partially by Ulkan Kilic, PhD, PhD. University Research Council, Bezmialem Vakif University had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript; however, Ulkan Kilic, PhD, PhD had a role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alcendor RR, 2007, CIRC RES, V100, P1512, DOI 10.1161/01.RES.0000267723.65696.4a; Alcendor RR, 2004, CIRC RES, V95, P971, DOI 10.1161/01.RES.0000147557.75257.ff; Atsuta Yoshiko, 2003, Rinsho Byori, V51, P886; Besler C, 2011, J CLIN INVEST, V121, P2693, DOI 10.1172/JCI42946; Bhattacharyya T, 2008, JAMA-J AM MED ASSOC, V299, P1265, DOI 10.1001/jama.299.11.1265; Bohr VA, 2002, FREE RADICAL BIO MED, V32, P804, DOI 10.1016/S0891-5849(02)00787-6; Botden IPG, 2012, DIABETES CARE, V35, P424, DOI 10.2337/dc11-1203; Braidy N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019194; Breitenstein A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053106; Canto C, 2009, TRENDS ENDOCRIN MET, V20, P325, DOI 10.1016/j.tem.2009.03.008; Cau SBA, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00218; Cernadas MR, 1998, CIRC RES, V83, P279, DOI 10.1161/01.RES.83.3.279; Challah M, 1997, AM J PHYSIOL-HEART C, V273, pH1941, DOI 10.1152/ajpheart.1997.273.4.H1941; Cheng HL, 2003, P NATL ACAD SCI USA, V100, P10794, DOI 10.1073/pnas.1934713100; Clark SJ, 2012, OBESITY, V20, P178, DOI 10.1038/oby.2011.200; Cohen HY, 2004, SCIENCE, V305, P390, DOI 10.1126/science.1099196; Cui YH, 2012, BIOCHEM BIOPH RES CO, V426, P232, DOI 10.1016/j.bbrc.2012.08.071; Donato AJ, 2011, J PHYSIOL-LONDON, V589, P4545, DOI 10.1113/jphysiol.2011.211219; Dong Y, 2011, MOL GENET METAB, V104, P661, DOI 10.1016/j.ymgme.2011.08.001; Erel O, 2004, CLIN BIOCHEM, V37, P112, DOI 10.1016/j.clinbiochem.2003.10.014; Erel O, 2005, CLIN BIOCHEM, V38, P1103, DOI 10.1016/j.clinbiochem.2005.08.008; Figarska SM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058636; Flachsbart F, 2006, EXP GERONTOL, V41, P98, DOI 10.1016/j.exger.2005.09.008; Getz GS, 2004, CURR OPIN LIPIDOL, V15, P261, DOI 10.1097/00041433-200406000-00005; Goettsch W, 2001, BIOCHEM BIOPH RES CO, V280, P908, DOI 10.1006/bbrc.2000.4180; Guarente L, 2011, NEW ENGL J MED, V364, P2235, DOI 10.1056/NEJMra1100831; HARMAN D, 1956, J GERONTOL, V11, P298, DOI 10.1093/geronj/11.3.298; Huang Jin, 2013, Zhonghua Yi Xue Yi Chuan Xue Za Zhi, V30, P55, DOI 10.3760/cma.j.issn.1003-9406.2013.01.013; Huen K, 2010, TOXICOL APPL PHARM, V244, P181, DOI 10.1016/j.taap.2009.12.031; Jiang JC, 2000, FASEB J, V14, P2135; Kaeberlein M, 1999, GENE DEV, V13, P2570, DOI 10.1101/gad.13.19.2570; Kavakli HS, 2010, HONG KONG J EMERG ME, V17, P250, DOI 10.1177/102490791001700308; Kilic U, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090428; Kim MY, 2005, GENE DEV, V19, P1951, DOI 10.1101/gad.1331805; Koltai E, 2010, MECH AGEING DEV, V131, P21, DOI 10.1016/j.mad.2009.11.002; Koubova J, 2003, GENE DEV, V17, P313, DOI 10.1101/gad.1052903; Kuningas M, 2007, J GERONTOL A-BIOL, V62, P960, DOI 10.1093/gerona/62.9.960; Li HL, 2003, J MOL MED, V81, P766, DOI 10.1007/s00109-003-0481-4; Li JP, 2005, GENET MED, V7, P58, DOI 10.1097/01.GIM.0000151152.78092.CA; Lim JH, 2012, OXID MED CELL LONGEV, V2012, DOI 10.1155/2012/171383; Longo VD, 2006, CELL, V126, P257, DOI 10.1016/j.cell.2006.07.002; Masoro EJ, 2000, EXP GERONTOL, V35, P299, DOI 10.1016/S0531-5565(00)00084-X; Mattagajasingh I, 2007, P NATL ACAD SCI USA, V104, P14855, DOI 10.1073/pnas.0704329104; Mercken EM, 2014, AGING CELL, V13, P193, DOI 10.1111/acel.12151; MILLER SA, 1988, NUCLEIC ACIDS RES, V16, P1215, DOI 10.1093/nar/16.3.1215; Morena M, 2000, NEPHROL DIAL TRANSPL, V15, P389, DOI 10.1093/ndt/15.3.389; Olmos Y, 2013, ANTIOXID REDOX SIGN, V19, P1507, DOI 10.1089/ars.2012.4713; Ota H, 2007, J MOL CELL CARDIOL, V43, P571, DOI 10.1016/j.yjmcc.2007.08.008; Ota H, 2010, J ATHEROSCLER THROMB, V17, P431, DOI 10.5551/jat.3525; Peeters AV, 2008, HUM GENET, V124, P431, DOI 10.1007/s00439-008-0567-8; Puca AA, 2012, IMMUN AGEING, V9, DOI 10.1186/1742-4933-9-26; Quintas A, 2012, EXP GERONTOL, V47, P198, DOI 10.1016/j.exger.2011.11.010; Ramsey KM, 2008, AGING CELL, V7, P78, DOI 10.1111/j.1474-9726.2007.00355.x; Rodriguez-Manas L, 2009, AGING CELL, V8, P226, DOI 10.1111/j.1474-9726.2009.00466.x; Rogina B, 2004, P NATL ACAD SCI USA, V101, P15998, DOI 10.1073/pnas.0404184101; Salazar LA, 1998, CLIN CHEM, V44, P1748; Salminen A, 2013, INT J MOL SCI, V14, P3834, DOI 10.3390/ijms14023834; Satoh A, 2013, CELL METAB, V18, P416, DOI 10.1016/j.cmet.2013.07.013; Shang LS, 2009, J CELL MOL MED, V13, P4176, DOI 10.1111/j.1582-4934.2008.00468.x; Shimoyama Y, 2012, J RENAL NUTR, V22, P114, DOI 10.1053/j.jrn.2011.10.025; Shimoyama Y, 2011, TRANSL RES, V157, P339, DOI 10.1016/j.trsl.2011.02.004; Sinclair DA, 2002, MECH AGEING DEV, V123, P857, DOI 10.1016/S0047-6374(02)00023-4; Tanno M, 2010, J BIOL CHEM, V285, P8375, DOI 10.1074/jbc.M109.090266; Tissenbaum HA, 2001, NATURE, V410, P227, DOI 10.1038/35065638; Turan N, 2010, EPIGENETICS-US, V5, P16, DOI 10.4161/epi.5.1.10557; Ungvari Z, 2008, CIRC RES, V102, P519, DOI 10.1161/CIRCRESAHA.107.168369; Wang Ke, 2011, Yichuan, V33, P182, DOI 10.3724/SP.J.1005.2011.00182; Yang YM, 2009, AM J PHYSIOL-HEART C, V297, pH1829, DOI 10.1152/ajpheart.00230.2009; Yoon HJ, 2010, MECH AGEING DEV, V131, P119, DOI 10.1016/j.mad.2009.12.010; Yuan HF, 2012, J MOL MED, V90, P389, DOI 10.1007/s00109-011-0825-4; Zarrabeitia MT, 2012, ARCH MED RES, V43, P363, DOI 10.1016/j.arcmed.2012.06.012; Zhang WG, 2010, CLIN CHIM ACTA, V411, P1679, DOI 10.1016/j.cca.2010.06.030; Zheng TY, 2011, CURR EYE RES, V36, P449, DOI 10.3109/02713683.2011.559301; Zhu W, 2014, NUTR METAB, V11, DOI 10.1186/1743-7075-11-35; Zillikens MC, 2009, FREE RADICAL BIO MED, V46, P836, DOI 10.1016/j.freeradbiomed.2008.12.022	75	61	65	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2015	10	3							e0117954	10.1371/journal.pone.0117954	http://dx.doi.org/10.1371/journal.pone.0117954			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9BN	25785999	Green Submitted, gold, Green Published			2022-12-27	WOS:000352138500020
J	Ng, KM; Reaz, MBI				Ng, Kok Mun; Reaz, Mamun Bin Ibne			An Integrated Approach for Platoon-based Simulation and Its Feasibility Assessment	PLOS ONE			English	Article							KINEMATIC WAVES; QUEUE-LENGTH; PREDICTION; MODELS; DELAY	Research on developing mathematical and simulative models to evaluate performance of signalized arterials is still ongoing. In this paper, an integrated model (IM) based on Rakha vehicle dynamics and LWR model is proposed. The IM which imitates actuated performance measurement in signalized arterials is described using continuous timed Petri net with variable speeds (VCPN). This enables systematic discretized description of platoon movement from an upstream signalized intersection towards a downstream signalized intersection. The integration is based on the notion that speed and travel time characteristics in a link can be provided using Rakha model. This will assist the LWR to estimate arrival profiles of vehicles at downstream intersection. One immediate benefit of the model is that platoon arrival profile obtained from the IM can be directly manipulated to estimate queues and delays at the target intersection using input-output analysis without considering the effect of shockwaves. This is less tedious as compared to analysing the LWR model through tracing trajectory of shockwave. Besides, time parameters of a platoon could be estimated for self-scheduling control approach from a cycle to cycle basis. The proposed IM is applied to a test intersection where simulated queues and average delays from the IM are compared with the platoon dispersion model (PDM) implemented in TRANSYT, cell transmission model (CTM) and HCM2000 for both under-saturated and oversaturated situations. The comparisons yielded acceptable and reasonable results, thus ascertained the feasibility and validity of the model.	[Ng, Kok Mun] Univ Teknol Mara, Fac Elect Engn, Shah Alam, Selangor, Malaysia; [Reaz, Mamun Bin Ibne] Univ Kebangsaan Malaysia, Fac Engn & Built Environm, Dept Elect Elect & Syst Engn, Ukm Bangi, Selangor, Malaysia	Universiti Teknologi MARA; Universiti Kebangsaan Malaysia	Ng, KM (corresponding author), Univ Teknol Mara, Fac Elect Engn, Shah Alam, Selangor, Malaysia.	kokmun77@yahoo.com.sg	Bin Ibne Reaz, Mamun/E-7221-2010	Bin Ibne Reaz, Mamun/0000-0002-0459-0365; Ng, Kok Mun/0000-0003-1765-9488	Ministry of Higher Education (MOHE) through FRGS grant [FRGS/1/2014/TK07/UKM/01/1]	Ministry of Higher Education (MOHE) through FRGS grant	The authors would like to express sincere gratitude to the Ministry of Higher Education (MOHE) for supporting this research project through its FRGS grant FRGS/1/2014/TK07/UKM/01/1. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1956, PROGR BUNCH VEHICLES; Benekohal RF, 2001, TRANSPORT RES A-POL, V35, P625, DOI 10.1016/S0965-8564(00)00012-4; Binning JC, 2011, TRANSYST 14 USER GUI, V65; DAGANZO CF, 1994, TRANSPORT RES B-METH, V28, P269, DOI 10.1016/0191-2615(94)90002-7; Feldman O, 2002, U TRANSP STUD GROUP; Geroliminis N, 2005, TRANSPORT RES REC, P116, DOI 10.3141/1934-12; Hanabusa H, 2010, LECT NOTES ARTIF INT, V6279, P308, DOI 10.1007/978-3-642-15384-6_33; Kim SO, 2005, J TRANSP ENG, V131, P917, DOI 10.1061/(ASCE)0733-947X(2005)131:12(917); Lammer S, 2008, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2008/04/P04019; LIGHTHILL MJ, 1955, PROC R SOC LON SER-A, V229, P281, DOI 10.1098/rspa.1955.0088; Liu HX, 2012, TRANSPORTMETRICA, V8, P87, DOI 10.1080/18128600903502298; Liu HX, 2009, TRANSPORT RES C-EMER, V17, P412, DOI 10.1016/j.trc.2009.02.003; Marinica N, 2012, P AMER CONTR CONF, P6563; MICHALOPOULOS PG, 1981, TRANSPORT RES B-METH, V15, P35, DOI 10.1016/0191-2615(81)90045-X; NEWELL GF, 1993, TRANSPORT RES B-METH, V27, P281, DOI 10.1016/0191-2615(93)90038-C; Ng KM, 2014, P INT CONF INTELL, P490, DOI 10.1109/ISMS.2014.90; Ng KM, 2013, IEEE T INTELL TRANSP, V14, P858, DOI 10.1109/TITS.2013.2246153; Rakha H, 2001, J TRANSP ENG-ASCE, V127, P418, DOI 10.1061/(ASCE)0733-947X(2001)127:5(418); RICHARDS PI, 1956, OPER RES, V4, P42, DOI 10.1287/opre.4.1.42; Robertson DI, 1969, TRANSYT A TRAFFIC NE; Sharma A, 2007, TRANSP RES RECORD, P69, DOI 10.3141/2035-08; Shen F, 2008, 8 INT C CHIN LOG TRA, P4313; Snare MC, 2002, THESIS STATE U; Tang JJ, 2013, PHYSICA A, V392, P4192, DOI 10.1016/j.physa.2013.05.012; Tolba C, 2005, SIMUL MODEL PRACT TH, V13, P407, DOI 10.1016/j.simpat.2005.01.001; Tolba C, 2001, P 2001 IEEE INT C SY, P1323; Transportation Research Board (TRB), 2016, HIGHWAY CAPACITY MAN; Viloria F, 2000, TRANSPORT RES REC, P222; Xie XF, 2011, IEEE INT C INTELL TR, P879, DOI 10.1109/ITSC.2011.6082849	29	2	2	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2015	10	3							e0114406	10.1371/journal.pone.0114406	http://dx.doi.org/10.1371/journal.pone.0114406			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9BN	25785693	Green Submitted, Green Published, gold			2022-12-27	WOS:000352138500001
J	Ren, SP; Chai, L; Wang, CY; Li, CL; Ren, QQ; Yang, LH; Wang, FM; Qiao, ZX; Li, WJ; He, M; Riker, AI; Han, Y; Yu, Q				Ren, Suping; Chai, Lina; Wang, Chunyan; Li, Changlan; Ren, Qiquan; Yang, Lihua; Wang, Fumei; Qiao, Zhixin; Li, Weijing; He, Min; Riker, Adam I.; Han, Ying; Yu, Qun			Human Malignant Melanoma-Derived Progestagen-Associated Endometrial Protein Immunosuppresses T Lymphocytes In Vitro	PLOS ONE			English	Article							PLACENTAL PROTEIN-14; EMBRYO IMPLANTATION; GLYCODELIN-A; ACTIVATION; EXPRESSION; GENE; DIFFERENTIATION; SUPPRESSION; METASTASIS; INHIBITION	Progestagen-associated endometrial protein (PAEP) is a glycoprotein of the lipocalin family that acts as a negative regulator of T cell receptor-mediated activation. However, the function of tumor-derived PAEP on the human immune system in the tumor microenvironment is unknown. PAEP is highly expressed in intermediate and thick primary melanomas (Breslow's 2.5mm or greater) and metastatic melanomas, correlating with its expression in daughter cell lines established in vitro. The current study investigates the role of melanoma cell-secreted PAEP protein in regulating T cell function. Upon the enrichment of CD3(+), CD4(+) and CD8(+) T cells from human peripheral blood mononuclear cells, each subset was then mixed with either melanoma-derived PAEP protein or PAEP-poor supernatant of gene-silenced tumor cells. IL-2 and IFN-gamma secretion of CD4(+) T cells significantly decreased with the addition of PAEP-rich supernatant. And the addition of PAEP-positive cell supernatant to activated lymphocytes significantly inhibited lymphocyte proliferation and cytotoxic T cell activity, while increasing lymphocyte apoptosis. Our result suggests that melanoma cell-secreted PAEP protein immunosuppresses the activation, proliferation and cytotoxicity of T lymphocytes, which might partially explain the mechanism of immune tolerance induced by melanoma cells within the tumor microenvironment.	[Ren, Suping; Chai, Lina; Wang, Chunyan; Li, Changlan; Qiao, Zhixin; Li, Weijing; He, Min; Han, Ying; Yu, Qun] Beijing Inst Transfus Med, Dept Immunohematol, Beijing, Peoples R China; [Wang, Chunyan] Beijing 307 Hosp, Dept Poisoning Treatment, Beijing, Peoples R China; [Ren, Qiquan; Yang, Lihua; Wang, Fumei] Peoples Hosp Anqiu City, Shandong, Peoples R China; [Riker, Adam I.] Advocate Christ Med Ctr, Advocate Canc Inst, Oak Lawn, IL USA	Fifth Medical Center of Chinese PLA General Hospital	Ren, SP (corresponding author), Beijing Inst Transfus Med, Dept Immunohematol, Beijing, Peoples R China.	rensp12@yahoo.com; yuqun1970@gmail.com	Ren, Suping/AAC-9167-2020		National Natural Science Foundation of China [PDRC-81071709]; Science and Technology Project of Beijing Municipal [Z141100000214003]; Program for the 12th Five-year Plan of China [2012ZX10001003]; National Scientific and Technological Major Project for Significant New Drugs Development [2011ZXJ09302]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and Technology Project of Beijing Municipal; Program for the 12th Five-year Plan of China; National Scientific and Technological Major Project for Significant New Drugs Development	This research was supported by grants from the National Natural Science Foundation of China (PDRC-81071709), the Science and Technology Project of Beijing Municipal (Z141100000214003), the Program for the 12th Five-year Plan of China (2012ZX10001003) and the National Scientific and Technological Major Project for Significant New Drugs Development (2011ZXJ09302). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bobinet M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051716; Chai LN, 2013, MOL MED REP, V8, P1390, DOI 10.3892/mmr.2013.1679; Chen G, 2013, CANCER IMMUNOL IMMUN, V62, P203, DOI 10.1007/s00262-012-1388-0; Chen KY, 2012, IMMUNOL RES, V53, P182, DOI 10.1007/s12026-012-8295-5; Connor JP, 2000, GYNECOL ONCOL, V79, P216, DOI 10.1006/gyno.2000.5941; Cruikshank WW, 1996, J IMMUNOL, V157, P5240; Gray-Schopfer V, 2007, NATURE, V445, P851, DOI 10.1038/nature05661; Hoozemans DA, 2004, REPROD BIOMED ONLINE, V9, P692, DOI 10.1016/S1472-6483(10)61781-6; Itzhaki O, 2013, IMMUNOTHERAPY-UK, V5, P79, DOI 10.2217/imt.12.143; Jayachandran R, 2004, J BIOL CHEM, V279, P8585, DOI 10.1074/jbc.M310480200; Jeschke U, 2006, HISTOPATHOLOGY, V48, P394, DOI 10.1111/j.1365-2559.2006.02351.x; KEHRL JH, 1986, J EXP MED, V163, P1037, DOI 10.1084/jem.163.5.1037; Liao W, 2013, IMMUNITY, V38, P13, DOI 10.1016/j.immuni.2013.01.004; Mandelin E, 2003, CANCER RES, V63, P6258; Mishan-Eisenberg G, 2004, J IMMUNOL, V173, P5524, DOI 10.4049/jimmunol.173.9.5524; Murray MJ, 1999, SEMIN REPROD ENDOCR, V17, P275, DOI 10.1055/s-2007-1016235; OEHNINGER S, 1995, FERTIL STERIL, V63, P377; OKAMOTO N, 1991, AM J REPROD IMMUNOL, V26, P137, DOI 10.1111/j.1600-0897.1991.tb00713.x; Panelli MC, 2000, J IMMUNOL, V164, P4382, DOI 10.4049/jimmunol.164.8.4382; Poggi A, 2006, ARCH IMMUNOL THER EX, V54, P323, DOI 10.1007/s00005-006-0038-7; Rachmilewitz J, 1999, CELL IMMUNOL, V191, P26, DOI 10.1006/cimm.1998.1408; Rachmilewitz J, 2001, BLOOD, V98, P3727, DOI 10.1182/blood.V98.13.3727; Ren SP, 2006, CANCER IMMUNOL IMMUN, V55, P375, DOI 10.1007/s00262-005-0011-z; Ren Su-Ping, 2006, Zhongguo Shi Yan Xue Ye Xue Za Zhi, V14, P54; Ren SP, 2010, J CELL MOL MED, V14, P1432, DOI 10.1111/j.1582-4934.2009.00922.x; Ren Suping, 2008, Cancer Control, V15, P202; Rutkowski MR, 2012, CELL IMMUNOL, V278, P21, DOI 10.1016/j.cellimm.2012.06.014; Seppala M, 2009, EUR J ENDOCRINOL, V160, P121, DOI 10.1530/EJE-08-0756; Seppala M, 2002, ENDOCR REV, V23, P401, DOI 10.1210/er.2001-0026; Shabani N, 2005, ANTICANCER RES, V25, P1761; Sheu BC, 2009, FRONT BIOSCI-LANDMRK, V14, P1571, DOI 10.2741/3325; Tseng L, 2002, FRONT BIOSCI, V7, pD1566, DOI 10.2741/tseng; Uchida H, 2007, ENDOCRINOLOGY, V148, P896, DOI 10.1210/en.2006-0896; Vigne JL, 2001, J BIOL CHEM, V276, P17101, DOI 10.1074/jbc.M010451200; Yaniv E, 2003, CELL IMMUNOL, V222, P156, DOI 10.1016/S0008-8749(03)00129-1; Zhang M, 2013, CLIN CANCER RES, V19, P247, DOI 10.1158/1078-0432.CCR-12-2753	36	2	2	3	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2015	10	3							e0119038	10.1371/journal.pone.0119038	http://dx.doi.org/10.1371/journal.pone.0119038			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9BN	25785839	Green Published, gold, Green Submitted			2022-12-27	WOS:000352138500068
J	Ryzak, M; Bieganowski, A; Polakowski, C				Ryzak, Magdalena; Bieganowski, Andrzej; Polakowski, Cezary			Effect of Soil Moisture Content on the Splash Phenomenon Reproducibility	PLOS ONE			English	Article							SINGLE RAINDROPS; KINETIC-ENERGY; DETACHMENT; EROSION; IMPACT; EROSIVITY; DISTANCE; FORCE	One of the methods for testing splash (the first phase of water erosion) may be an analysis of photos taken using so-called high-speed cameras. The aim of this study was to determine the reproducibility of measurements using a single drop splash of simulated precipitation. The height from which the drops fell resulted in a splash of 1.5 m. Tests were carried out using two types of soil: Eutric Cambisol (loamy silt) and Orthic Luvisol (sandy loam); three initial pressure heads were applied equal to 16 kPa, 3.1 kPa, and 0.1 kPa. Images for one, five, and 10 drops were recorded at a rate of 2000 frames per second. It was found that (i) the dispersion of soil caused by the striking of the 1st drop was significantly different from the splash impact caused by subsequent drops; (ii) with every drop, the splash phenomenon proceeded more reproducibly, that is, the number of particles of soil and/or water that splashed were increasingly close to each other; (iii) the number of particles that were detached during the splash were strongly correlated with its surface area; and (iv) the higher the water film was on the surface the smaller the width of the crown was.	[Ryzak, Magdalena; Bieganowski, Andrzej; Polakowski, Cezary] Polish Acad Sci, Inst Agrophys, PL-20236 Lublin, Poland	Polish Academy of Sciences; Bohdan Dobrzanski Institute of Agrophysics of the Polish Academy of Sciences	Ryzak, M (corresponding author), Polish Acad Sci, Inst Agrophys, PL-20236 Lublin, Poland.	m.ryzak@ipan.lublin.pl	Polakowski, Cezary/H-7294-2013	Polakowski, Cezary/0000-0002-1658-8334; Ryzak, Magdalena/0000-0002-6400-5375; Bieganowski, Andrzej/0000-0002-3571-3241	National Centre for Science [N N310777640]; National Science Centre (Poland) [DEC-2012/07/N/ST10/03280];  [IP2011 047471]	National Centre for Science; National Science Centre (Poland); 	The study was partially funded by the budget for science within the framework of Project No. IP2011 047471 (2011-2014), by the National Centre for Science within the framework of Project No. N N310777640 (2011-2014) and from the National Science Centre (Poland), based on decision no. DEC-2012/07/N/ST10/03280 (2013-2015). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn S, 2013, EARTH SURF PROC LAND, V38, P1225, DOI 10.1002/esp.3364; ALDURRAH M, 1981, SOIL SCI SOC AM J, V45, P949, DOI 10.2136/sssaj1981.03615995004500050026x; ALDURRAH MM, 1982, SOIL SCI SOC AM J, V46, P1086, DOI 10.2136/sssaj1982.03615995004600050040x; ALDURRAH MM, 1982, SOIL SCI SOC AM J, V46, P836, DOI 10.2136/sssaj1982.03615995004600040034x; Bieganowski A, 2013, INT AGROPHYS, V27, P335, DOI 10.2478/intag-2013-0003; BRADFORD JM, 1986, SOIL SCI SOC AM J, V50, P1547, DOI 10.2136/sssaj1986.03615995005000060033x; Brodowski R, 2000, ACTA AGROPHYSICA, V16, P255; EPEMA GF, 1983, CATENA, P1; FERREIRA AG, 1985, SOIL SCI SOC AM J, V49, P1537, DOI 10.2136/sssaj1985.03615995004900060041x; Furbish DJ, 2007, J GEOPHYS RES-EARTH, V112, DOI 10.1029/2006JF000498; GHADIRI H, 1988, J SOIL SCI, V39, P563, DOI 10.1111/j.1365-2389.1988.tb01240.x; Ghahramani A, 2012, EARTH SURF PROC LAND, V37, P473, DOI 10.1002/esp.2253; Glinski J, 2013, SOIL SCI ANNU, V64, P67, DOI 10.2478/ssa-2013-0012; Govers G., 1991, Catena, Supplement, P15; Imerson AC, 1981, CATENA, V8, P83; International Organization for Standardization, 2007, ISO IEC GUID 99 INT; Issa OM, 2006, EARTH SURF PROC LAND, V31, P929, DOI 10.1002/esp.1303; Jayawardena AW, 2000, HYDROL PROCESS, V14, P37, DOI [10.1002/(SICI)1099-1085(200001)14:1<37::AID-HYP908>3.0.CO;2-M, 10.1002/(SICI)1099-1085(200001)14:1&lt;37::AID-HYP908&gt;3.0.CO;2-M]; Jomaa S, 2010, J HYDROL, V395, P117, DOI 10.1016/j.jhydrol.2010.10.021; Legout C, 2005, GEODERMA, V124, P279, DOI 10.1016/j.geoderma.2004.05.006; Leguedois S, 2005, SOIL SCI SOC AM J, V69, P30, DOI 10.2136/sssaj2005.0030; Long EJ, 2014, PHYS REV E, V89, DOI 10.1103/PhysRevE.89.032201; Mouzai L, 2011, EARTH SURF PROC LAND, V36, P87, DOI 10.1002/esp.2021; Mouzai L, 2003, J HYDRAUL RES, V41, P61, DOI 10.1080/00221680309499929; NEARING MA, 1987, SOIL SCI SOC AM J, V51, P425, DOI 10.2136/sssaj1987.03615995005100020031x; NEARING MA, 1986, SOIL SCI SOC AM J, V50, P1532, DOI 10.2136/sssaj1986.03615995005000060030x; NEARING MA, 1985, SOIL SCI SOC AM J, V49, P547, DOI 10.2136/sssaj1985.03615995004900030003x; PALMER R., 1964, Publ. int. Ass. sci. Hydrol., V65, P141; Paluszek J, 2013, SOIL SCI ANNU, V64, P41, DOI 10.2478/ssa-2013-0008; Pietravalle S, 2001, AGR FOREST METEOROL, V109, P171, DOI 10.1016/S0168-1923(01)00267-2; Planchon O, 2010, SOIL SCI SOC AM J, V74, P1092, DOI 10.2136/sssaj2009.0063; Rejman J, 2010, LAND DEGRAD DEV, V21, P401, DOI 10.1002/ldr.963; Ryzak M, 2012, SENSORS-BASEL, V12, P11527, DOI 10.3390/s120911527; Salles C, 2000, WATER RESOUR RES, V36, P2721, DOI 10.1029/2000WR900024; SAVAT J, 1981, EARTH SURF PROC LAND, V6, P275, DOI 10.1002/esp.3290060308; SHARMA PP, 1993, SOIL SCI SOC AM J, V57, P674, DOI 10.2136/sssaj1993.03615995005700030007x; SHARMA PP, 1989, SOIL SCI SOC AM J, V53, P1005, DOI 10.2136/sssaj1989.03615995005300040003x; SHARMA PP, 1991, SOIL SCI SOC AM J, V55, P301, DOI 10.2136/sssaj1991.03615995005500020001x; TERRY JP, 1993, EARTH SURF PROC LAND, V18, P519, DOI 10.1002/esp.3290180605; van Dijk AIJM, 2002, SOIL SCI SOC AM J, V66, P1466, DOI 10.2136/sssaj2002.1466	40	24	24	2	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2015	10	3							e0119269	10.1371/journal.pone.0119269	http://dx.doi.org/10.1371/journal.pone.0119269			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9BN	25785859	Green Published, Green Submitted, gold			2022-12-27	WOS:000352138500093
J	Chan, CW; Sakihama, N; Tachibana, SI; Idris, ZM; Lum, JK; Tanabe, K; Kaneko, A				Chan, Chim W.; Sakihama, Naoko; Tachibana, Shin-Ichiro; Idris, Zulkarnain Md; Lum, J. Koji; Tanabe, Kazuyuki; Kaneko, Akira			Plasmodium vivax and Plasmodium falciparum at the Crossroads of Exchange among Islands in Vanuatu: Implications for Malaria Elimination Strategies	PLOS ONE			English	Article							MEROZOITE SURFACE PROTEIN-1; ANOPHELES-FARAUTI-S.S.; GENETIC DIVERSITY; POPULATION-STRUCTURE; AMA1 GENES; RECOMBINATION; EPIDEMIOLOGY; SETTLEMENT; EVOLUTION; PATTERNS	Understanding the transmission and movement of Plasmodium parasites is crucial for malaria elimination and prevention of resurgence. Located at the limit of malaria transmission in the Pacific, Vanuatu is an ideal candidate for elimination programs due to low endemicity and the isolated nature of its island setting. We analyzed the variation in the merozoite surface protein 1 (msp1) and the circumsporozoite protein (csp) of P. falciparum and P. vivax populations to examine the patterns of gene flow and population structures among seven sites on five islands in Vanuatu. Genetic diversity was in general higher in P. vivax than P. falciparum from the same site. In P. vivax, high genetic diversity was likely maintained by greater extent of gene flow among sites and among islands. Consistent with the different patterns of gene flow, the proportion of genetic variance found among islands was substantially higher in P. falciparum (28.81-31.23%) than in P. vivax (-0.53-3.99%). Our data suggest that the current island-by-island malaria elimination strategy in Vanuatu, while adequate for P. falciparum elimination, might need to be complemented with more centrally integrated measures to control P. vivax movement across islands.	[Chan, Chim W.; Idris, Zulkarnain Md; Kaneko, Akira] Karolinska Inst, Dept Microbiol Tumor & Cell Biol, Isl Malaria Grp, Stockholm, Sweden; [Sakihama, Naoko; Tachibana, Shin-Ichiro; Tanabe, Kazuyuki] Osaka Univ, Microbial Dis Res Inst, Lab Malariol, Osaka, Japan; [Lum, J. Koji] SUNY Binghamton, Lab Evolutionary Anthropol & Hlth, Binghamton, NY USA; [Lum, J. Koji] SUNY Binghamton, Dept Anthropol, Binghamton, NY USA; [Lum, J. Koji] SUNY Binghamton, Dept Biol Sci, Binghamton, NY USA; [Kaneko, Akira] Osaka City Univ, Grad Sch Med, Dept Parasitol, Osaka 558, Japan; [Kaneko, Akira] Nagasaki Univ, Inst Trop Med, Nagasaki 852, Japan	Karolinska Institutet; Osaka University; State University of New York (SUNY) System; State University of New York (SUNY) Binghamton; State University of New York (SUNY) System; State University of New York (SUNY) Binghamton; State University of New York (SUNY) System; State University of New York (SUNY) Binghamton; Osaka Metropolitan University; Nagasaki University	Chan, CW (corresponding author), Karolinska Inst, Dept Microbiol Tumor & Cell Biol, Isl Malaria Grp, Stockholm, Sweden.	chim.chan@ki.se	Idris, Zulkarnain Md/V-6615-2018	Chan, Chim/0000-0002-4039-2649	Swedish Research Council [523-2009-3233, 348-2012-6346, 348-2013-6311]; Japan Society for the Promotion of Science (JSPS); B. Asia-Africa Science Platforms; JSPS KAKENHI [24390141, 26257504]; Health Labour Sciences Research Grant; Research on Global Health issues; Nagasaki University Institute of Tropical Medicine	Swedish Research Council(Swedish Research CouncilEuropean Commission); Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); B. Asia-Africa Science Platforms; JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Health Labour Sciences Research Grant(Ministry of Health, Labour and Welfare, Japan); Research on Global Health issues; Nagasaki University Institute of Tropical Medicine	Financial support for this study was provided to AK by the Swedish Research Council (www.vr.se, grant numbers 523-2009-3233, 348-2012-6346, and 348-2013-6311), the Japan Society for the Promotion of Science (JSPS, https://www.jsps.go.jp/english/) Core-to-Core Program, B. Asia-Africa Science Platforms, JSPS KAKENHI (grant numbers 24390141 and 26257504), Health Labour Sciences Research Grant, Research on Global Health issues, and Nagasaki University Institute of Tropical Medicine collaborative research grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonso PL, 2013, NAT MED, V19, P150, DOI 10.1038/nm.3077; Anderson TJC, 2000, MOL BIOL EVOL, V17, P1467, DOI 10.1093/oxfordjournals.molbev.a026247; Arnott A, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-233; Arnott A, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-14; Asia Pacific Malaria Elimination Network, 2013, COUNTR BRIEF EL MAL; Atkins C, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-218; Bousema T, 2011, CLIN MICROBIOL REV, V24, P377, DOI 10.1128/CMR.00051-10; Buckley HR, 2005, BIOARCHAEOLOGY SE AS, P309; CLARK JT, 1993, AM ANTHROPOL, V95, P612, DOI 10.1525/aa.1993.95.3.02a00040; Cohen JM, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-122; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Feachem RGA, 2010, LANCET, V376, P1566, DOI 10.1016/S0140-6736(10)61270-6; Galinski MR, 2013, ADV PARASIT, V81, P1, DOI 10.1016/B978-0-12-407826-0.00001-1; Gray KA, 2013, SOLOMON ISLANDS MALA, V12, P429, DOI DOI 10.1186/1475-2875-12-429; Groube L. M., 1993, COMMUNITY CULTURE PE, P164; HEDRICK JD, 1971, J POLYNESIAN SOC, V80, P5; Huffman Kirk, 1996, ARTS OF VANUATU, P182; Imwong M, 2005, MALARIA J, V4, DOI 10.1186/1475-2875-4-20; Kaneko A, 1998, ACTA TROP, V70, P285, DOI 10.1016/S0001-706X(98)00035-7; Kaneko A, 2000, LANCET, V356, P1560, DOI 10.1016/S0140-6736(00)03127-5; Kaneko A, 2014, INFECT IMMUN, V82, P243, DOI 10.1128/IAI.00931-13; KERR PJ, 1994, MOL BIOCHEM PARASIT, V66, P241, DOI 10.1016/0166-6851(94)90151-1; Kim JR, 2006, MALARIA J, V5, DOI 10.1186/1475-2875-5-71; Lum JK, 2007, ACTA TROP, V103, P102, DOI 10.1016/j.actatropica.2007.05.012; Macdonald G., 1957, EPIDEMIOLOGY CONTROL; Murhandarwati EEH, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-130; Neafsey DE, 2012, NAT GENET, V44, P1046, DOI 10.1038/ng.2373; Nei M., 1987, MOL EVOLUTIONARY GEN; Ord RL, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003366; Orjuela-Sanchez P, 2013, EXP PARASITOL, V134, P318, DOI 10.1016/j.exppara.2013.03.029; Pacheco MA, 2007, INFECT GENET EVOL, V7, P180, DOI 10.1016/j.meegid.2006.08.002; Parobek CM, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002796; Price RN, 2007, AM J TROP MED HYG, V77, P79, DOI 10.4269/ajtmh.2007.77.79; Putaporntip C, 2002, P NATL ACAD SCI USA, V99, P16348, DOI 10.1073/pnas.252348999; Reiff DM, 2007, J MED ENTOMOL, V44, P601, DOI 10.1603/0022-2585(2007)44[601:PSAGFO]2.0.CO;2; Sakihama N, 2001, EXP PARASITOL, V97, P50, DOI 10.1006/expr.2000.4591; Sakihama N, 2001, GENE, V279, P41, DOI 10.1016/S0378-1119(01)00748-X; Sheppard PJ, 2006, J POLYNESIAN SOC, V115, P47; Tanabe K, 2004, SCIENCE, V303, P493, DOI 10.1126/science.1092077; Tanabe K, 2007, MOL BIOCHEM PARASIT, V156, P74, DOI 10.1016/j.molbiopara.2007.07.002	40	4	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2015	10	3							e0119475	10.1371/journal.pone.0119475	http://dx.doi.org/10.1371/journal.pone.0119475			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8IA	25793260	Green Published, gold, Green Submitted			2022-12-27	WOS:000352084200086
J	Huber, B; Schellenbacher, C; Jindra, C; Fink, D; Shafti-Keramat, S; Kirnbauer, R				Huber, Bettina; Schellenbacher, Christina; Jindra, Christoph; Fink, Dieter; Shafti-Keramat, Saeed; Kirnbauer, Reinhard			A Chimeric 18L1-45RG1 Virus-Like Particle Vaccine Cross-Protects against Oncogenic Alpha-7 Human Papillomavirus Types	PLOS ONE			English	Article							MINOR CAPSID PROTEIN; INVASIVE CERVICAL-CANCER; NEUTRALIZING EPITOPE; ADENOSQUAMOUS CARCINOMA; UTERINE CERVIX; HPV-TYPE; ADENOCARCINOMA; L2; L1; EFFICACY	Persistent infection with oncogenic human papillomaviruses (HPV) types causes all cervical and a subset of other anogenital and oropharyngeal carcinomas. Four high-risk (hr) mucosal types HPV16, 18, 45, or 59 cause almost all cervical adenocarcinomas (AC), a subset of cervical cancer (CxC). Although the incidence of cervical squamous cell carcinoma (SCC) has dramatically decreased following introduction of Papanicolaou (PAP) screening, the proportion of AC has relatively increased. Cervical SCC arise mainly from the ectocervix, whereas AC originate primarily from the endocervical canal, which is less accessible to obtain viable PAP smears. Licensed (bivalent and quadrivalent) HPV vaccines comprise virus-like particles (VLP) of the most important hr HPV16 and 18, self-assembled from the major capsid protein L1. Due to mainly type-restricted efficacy, both vaccines do not target 13 additional hr mucosal types causing 30% of CxC. The papillomavirus genus alpha species 7 (alpha 7) includes a group of hr types of which HPV18, 45, 59 are proportionally overrepresented in cervical AC and only partially (HPV18) targeted by current vaccines. To target these types, we generated a chimeric vaccine antigen that consists of a cross-neutralizing epitope (homologue of HPV16 RG1) of the L2 minor capsid protein of HPV45 genetically inserted into a surface loop of HPV18 L1 VLP (18L1-45RG1). Vaccination of NZW rabbits with 18L1-45RG1 VLP plus alum-MPL adjuvant induced high-titer neutralizing antibodies against homologous HPV18, that cross-neutralized non-cognate hr a7 types HPV39, 45, 68, but not HPV59, and low risk HPV70 in vitro, and induced a robust L1-specific cellular immune response. Passive immunization protected mice against experimental vaginal challenge with pseudovirions of HPV18, 39, 45 and 68, but not HPV59 or the distantly related a9 type HPV16. 18L1-45RG1 VLP might be combined with our previously described 16L116RG1 VLP to develop a second generation bivalent vaccine with extended spectrum against hr HPV.	[Huber, Bettina; Schellenbacher, Christina; Jindra, Christoph; Shafti-Keramat, Saeed; Kirnbauer, Reinhard] Med Univ Vienna MUW, LVO, DIAID, Dept Dermatol, Vienna, Austria; [Fink, Dieter] Vet Univ Vienna, Dept Biomed Sci, Inst Lab Anim Sci, A-1030 Vienna, Austria	Medical University of Vienna; University of Veterinary Medicine Vienna	Kirnbauer, R (corresponding author), Med Univ Vienna MUW, LVO, DIAID, Dept Dermatol, Vienna, Austria.	reinhard.kirnbauer@meduniwien.ac.at		Shafti-Keramat, Saeed/0000-0002-4180-8853; Huber, Bettina/0000-0002-8086-7848	Vienna Science and Technology Fund [LS11-006]	Vienna Science and Technology Fund	This research was supported by a grant to RK from the Vienna Science and Technology Fund (www.wwtf.at) (Life Science Call 2011) (LS11-006). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alphs HH, 2008, P NATL ACAD SCI USA, V105, P5850, DOI 10.1073/pnas.0800868105; Andersson S, 2001, EUR J CANCER, V37, P246, DOI 10.1016/S0959-8049(00)00376-2; Baalbergen A, 2013, GYNECOL ONCOL, V128, P530, DOI 10.1016/j.ygyno.2012.12.013; Bernard HU, 2010, VIROLOGY, V401, P70, DOI 10.1016/j.virol.2010.02.002; Bray F, 2005, CANCER EPIDEM BIOMAR, V14, P2191, DOI 10.1158/1055-9965.EPI-05-0231; Bruni L, 2010, J INFECT DIS, V202, P1789, DOI 10.1086/657321; Buck CB, 2004, J VIROL, V78, P751, DOI 10.1128/JVI.78.2.751-757.2004; Buck Christopher B, 2007, Curr Protoc Cell Biol, VChapter 26, DOI 10.1002/0471143030.cb2601s37; Castellsague X, 2006, JNCI-J NATL CANCER I, V98, P303, DOI 10.1093/jnci/djj067; Clifford G, 2006, VACCINE, V24, P26, DOI 10.1016/j.vaccine.2006.05.026; Costa S, 2007, GYNECOL ONCOL, V106, P170, DOI 10.1016/j.ygyno.2007.03.016; Dabic MM, 2008, ACTA OBSTET GYN SCAN, V87, P366, DOI 10.1080/00016340801936560; Day PM, 2012, CLIN VACCINE IMMUNOL, V19, P1075, DOI 10.1128/CVI.00139-12; de Sanjose S, 2010, LANCET ONCOL, V11, P1048, DOI 10.1016/S1470-2045(10)70230-8; Gambhira R, 2007, J VIROL, V81, P13927, DOI 10.1128/JVI.00936-07; Gambhira R, 2007, J VIROL, V81, P11585, DOI 10.1128/JVI.01577-07; Gaukroger JM, 1996, J GEN VIROL, V77, P1577, DOI 10.1099/0022-1317-77-7-1577; HAGENSEE ME, 1993, J VIROL, V67, P315, DOI 10.1128/JVI.67.1.315-322.1993; Jagu S, 2010, VACCINE, V28, P4478, DOI 10.1016/j.vaccine.2010.04.039; Jagu S, 2009, JNCI-J NATL CANCER I, V101, P782, DOI 10.1093/jnci/djp106; Kawana K, 1998, VIROLOGY, V245, P353, DOI 10.1006/viro.1998.9168; Kawana K, 1999, J VIROL, V73, P6188, DOI 10.1128/JVI.73.7.6188-6190.1999; Kirnbauer R, 2009, HAUTARZT, V60, P878, DOI 10.1007/s00105-009-1803-4; KIRNBAUER R, 1993, J VIROL, V67, P6929, DOI 10.1128/JVI.67.12.6929-6936.1993; KIRNBAUER R, 1992, P NATL ACAD SCI USA, V89, P12180, DOI 10.1073/pnas.89.24.12180; Kondo K, 2008, J MED VIROL, V80, P841, DOI 10.1002/jmv.21124; Liu SL, 2001, CAN MED ASSOC J, V164, P1151; Malagon T, 2012, LANCET INFECT DIS, V12, P781, DOI 10.1016/S1473-3099(12)70187-1; McGrath M, 2013, ARCH VIROL, V158, P2079, DOI 10.1007/s00705-013-1713-8; Pastrana DV, 2005, VIROLOGY, V337, P365, DOI 10.1016/j.virol.2005.04.011; Pineo CB, 2013, PLANT BIOTECHNOL J, V11, P964, DOI 10.1111/pbi.12089; Pirog EC, 2000, AM J PATHOL, V157, P1055, DOI 10.1016/S0002-9440(10)64619-6; Rizk RZ, 2008, J GEN VIROL, V89, P117, DOI 10.1099/vir.0.83145-0; Roberts JN, 2007, NAT MED, V13, P857, DOI 10.1038/nm1598; Roden RBS, 2000, VIROLOGY, V270, P254, DOI 10.1006/viro.2000.0272; Roden R, 2006, NAT REV CANCER, V6, P753, DOI 10.1038/nrc1973; Ronco G, 2014, LANCET, V383, P524, DOI 10.1016/S0140-6736(13)62218-7; Rubio I, 2011, VIROLOGY, V409, P348, DOI 10.1016/j.virol.2010.10.017; Sasieni P, 2001, LANCET, V357, P1490, DOI 10.1016/S0140-6736(00)04646-8; Schellenbacher C, 2013, J INVEST DERMATOL, V133, P2706, DOI 10.1038/jid.2013.253; Seitz H, 2013, CLIN VACCINE IMMUNOL, V20, P1061, DOI 10.1128/CVI.00195-13; Slupetzky K, 2007, VACCINE, V25, P2001, DOI 10.1016/j.vaccine.2006.11.049; Smith HO, 2000, GYNECOL ONCOL, V78, P97, DOI 10.1006/gyno.2000.5826; Tumban E, 2013, VACCINE, V31, P4647, DOI 10.1016/j.vaccine.2013.07.052; Varsani A, 2003, J VIROL, V77, P8386, DOI 10.1128/JVI.77.15.8386-8393.2003; Vinokurova S, 2008, CANCER RES, V68, P307, DOI 10.1158/0008-5472.CAN-07-2754; Vizcaino AP, 1998, INT J CANCER, V75, P536, DOI 10.1002/(SICI)1097-0215(19980209)75:4<536::AID-IJC8>3.0.CO;2-U; Walboomers JMM, 1999, J PATHOL, V189, P12, DOI 10.1002/(SICI)1096-9896(199909)189:1&lt;12::AID-PATH431&gt;3.0.CO;2-F; Wheeler CM, 2009, JNCI-J NATL CANCER I, V101, P475, DOI 10.1093/jnci/djn510	49	21	24	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2015	10	3							e0120152	10.1371/journal.pone.0120152	http://dx.doi.org/10.1371/journal.pone.0120152			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD9NQ	25790098	Green Published, Green Submitted, gold			2022-12-27	WOS:000351425400135
J	Kowalsky, CA; Klesmith, JR; Stapleton, JA; Kelly, V; Reichkitzer, N; Whitehead, TA				Kowalsky, Caitlin A.; Klesmith, Justin R.; Stapleton, James A.; Kelly, Vince; Reichkitzer, Nolan; Whitehead, Timothy A.			High-Resolution Sequence-Function Mapping of Full-Length Proteins	PLOS ONE			English	Article							YEAST SURFACE DISPLAY; SATURATION MUTAGENESIS; POLYPEPTIDE LIBRARIES; IN-VITRO; AFFINITY; ANTIBODIES; PHAGE; SITE; OPTIMIZATION; SPECIFICITY	Comprehensive sequence-function mapping involves detailing the fitness contribution of every possible single mutation to a gene by comparing the abundance of each library variant before and after selection for the phenotype of interest. Deep sequencing of library DNA allows frequency reconstruction for tens of thousands of variants in a single experiment, yet short read lengths of current sequencers makes it challenging to probe genes encoding full-length proteins. Here we extend the scope of sequence-function maps to entire protein sequences with a modular, universal sequence tiling method. We demonstrate the approach with both growth-based selections and FACS screening, offer parameters and best practices that simplify design of experiments, and present analytical solutions to normalize data across independent selections. Using this protocol, sequence-function maps covering full sequences can be obtained in four to six weeks. Best practices introduced in this manuscript are fully compatible with, and complementary to, other recently published sequence-function mapping protocols.	[Kowalsky, Caitlin A.; Stapleton, James A.; Kelly, Vince; Reichkitzer, Nolan; Whitehead, Timothy A.] Michigan State Univ, Dept Chem Engn & Mat Sci, E Lansing, MI 48824 USA; [Klesmith, Justin R.] Michigan State Univ, Dept Biochem & Mol Biol, E Lansing, MI 48824 USA; [Whitehead, Timothy A.] Michigan State Univ, Dept Biosyst & Agr Engn, E Lansing, MI 48824 USA	Michigan State University; Michigan State University; Michigan State University	Whitehead, TA (corresponding author), Michigan State Univ, Dept Chem Engn & Mat Sci, E Lansing, MI 48824 USA.	taw@msu.edu		Whitehead, Timothy/0000-0003-3177-1361; Klesmith, Justin/0000-0003-2908-9355	National Science Foundation as a CAREER grant [CBET-1254238]; National Institutes of Health (NIH) NRSA Fellowship; Div Of Chem, Bioeng, Env, & Transp Sys [1254238] Funding Source: National Science Foundation	National Science Foundation as a CAREER grant; National Institutes of Health (NIH) NRSA Fellowship; Div Of Chem, Bioeng, Env, & Transp Sys(National Science Foundation (NSF)NSF - Directorate for Engineering (ENG))	This study was supported by the National Science Foundation (www.nsf.gov) as a CAREER grant to TAW (Award #CBET-1254238). JAS was supported by a National Institutes of Health (NIH) NRSA Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Althoff EA, 2012, PROTEIN SCI, V21, P717, DOI 10.1002/pro.2059; Araya CL, 2011, TRENDS BIOTECHNOL, V29, P435, DOI 10.1016/j.tibtech.2011.04.003; Benatuil L, 2010, PROTEIN ENG DES SEL, V23, P155, DOI 10.1093/protein/gzq002; Bienick MS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109105; Boder ET, 1998, BIOTECHNOL PROGR, V14, P55, DOI 10.1021/bp970144q; Boder ET, 1997, NAT BIOTECHNOL, V15, P553, DOI 10.1038/nbt0697-553; Bosley AD, 2005, BIOMOL ENG, V22, P57, DOI 10.1016/j.bioeng.2004.11.002; Chao G, 2006, NAT PROTOC, V1, P755, DOI 10.1038/nprot.2006.94; Chubiz LM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047959; CLACKSON T, 1991, NATURE, V352, P624, DOI 10.1038/352624a0; CUNNINGHAM BC, 1989, SCIENCE, V244, P1081, DOI 10.1126/science.2471267; Dai JH, 2009, WORLD J MICROB BIOT, V25, P1589, DOI 10.1007/s11274-009-0048-9; Firnberg E, 2014, MOL BIOL EVOL; Firnberg E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052031; Fowler DM, 2014, NAT PROTOC, V9, P2267, DOI 10.1038/nprot.2014.153; Fowler DM, 2014, NAT METHODS, V11, P801, DOI [10.1038/NMETH.3027, 10.1038/nmeth.3027]; Fowler DM, 2011, BIOINFORMATICS, V27, P3430, DOI 10.1093/bioinformatics/btr577; Fowler DM, 2010, NAT METHODS, V7, P741, DOI 10.1038/nmeth.1492; Gibson DG, 2009, NAT METHODS, V6, P343, DOI [10.1038/NMETH.1318, 10.1038/nmeth.1318]; Goldsmith M, 2007, PROTEIN ENG DES SEL, V20, P315, DOI 10.1093/protein/gzm026; GRAM H, 1992, P NATL ACAD SCI USA, V89, P3576, DOI 10.1073/pnas.89.8.3576; Hammond SM, 2000, NATURE, V404, P293, DOI 10.1038/35005107; Hietpas R, 2012, NAT PROTOC, V7, P1382, DOI 10.1038/nprot.2012.069; Hietpas RT, 2011, P NATL ACAD SCI USA, V108, P7896, DOI 10.1073/pnas.1016024108; HILL DE, 1986, SCIENCE, V234, P451, DOI 10.1126/science.3532321; Hogrefe HH, 2002, BIOTECHNIQUES, V33, P1158, DOI 10.2144/02335pf01; Jain PC, 2014, ANAL BIOCHEM, V449, P90, DOI 10.1016/j.ab.2013.12.002; Lee E., 2012, 2012 IEEE 28 S MASS, P1; Lee SY, 2003, TRENDS BIOTECHNOL, V21, P45, DOI 10.1016/S0167-7799(02)00006-9; Levy R, 2007, J MOL BIOL, V365, P196, DOI 10.1016/j.jmb.2006.09.084; Lofblom J, 2005, FEMS MICROBIOL LETT, V248, P189, DOI 10.1016/j.femsle.2005.05.040; Matochko WL, 2012, METHODS, V58, P47, DOI 10.1016/j.ymeth.2012.07.006; McLaughlin RN, 2012, NATURE, V491, P138, DOI 10.1038/nature11500; Michener JK, 2012, METAB ENG, V14, P306, DOI 10.1016/j.ymben.2012.04.004; Moretti R, 2013, PROTEINS, V81, P1980, DOI 10.1002/prot.24356; Pal G, 2006, J BIOL CHEM, V281, P22378, DOI 10.1074/jbc.M603826200; Perez OD, 2002, NAT BIOTECHNOL, V20, P155, DOI 10.1038/nbt0202-155; Povolotskaya IS, 2010, NATURE, V465, P922, DOI 10.1038/nature09105; Rajpal A, 2005, P NATL ACAD SCI USA, V102, P8466, DOI 10.1073/pnas.0503543102; Roscoe BP, 2013, J MOL BIOL, V425, P1363, DOI 10.1016/j.jmb.2013.01.032; Sambrook J., 2001, MOL CLONING LAB MANU; SMITH GP, 1985, SCIENCE, V228, P1315, DOI 10.1126/science.4001944; STEMMER WPC, 1994, NATURE, V370, P389, DOI 10.1038/370389a0; Tang SY, 2008, J AM CHEM SOC, V130, P5267, DOI 10.1021/ja7109053; Thomas A., 1991, METHOD ENZYMOL, V204, P125; Tinberg CE, 2013, NATURE, V501, P212, DOI 10.1038/nature12443; Tripathi A, 2014, CURR OPIN STRUC BIOL, V24, P63, DOI 10.1016/j.sbi.2013.12.001; Weiss GA, 2000, P NATL ACAD SCI USA, V97, P8950, DOI 10.1073/pnas.160252097; Whitehead TA, 2012, NAT BIOTECHNOL, V30, P543, DOI 10.1038/nbt.2214	49	41	41	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2015	10	3							e0118193	10.1371/journal.pone.0118193	http://dx.doi.org/10.1371/journal.pone.0118193			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD9NQ	25790064	Green Published, gold, Green Submitted			2022-12-27	WOS:000351425400025
J	Li, BJ; Shao, DY; Luo, YG; Wang, P; Liu, CH; Zhang, XY; Cui, RJ				Li, Bingjin; Shao, Dongyuan; Luo, Yungang; Wang, Pu; Liu, Changhong; Zhang, Xingyi; Cui, Ranji			Role of 5-HT3 Receptor on Food Intake in Fed and Fasted Mice	PLOS ONE			English	Article							MEDIATED APPETITE SUPPRESSION; HYPOTHALAMIC NEUROPEPTIDE-Y; SOLITARY TRACT NUCLEUS; C-FOS EXPRESSION; CATECHOLAMINE NEURONS; INDUCED SATIETY; RATS; ACTIVATION; SEROTONIN; RELEASE	Background Many studies have shown that 5-hydroxytryptamine (5-HT) receptor subtypes are involved in the regulation of feeding behavior. However, the relative contribution of 5-HT3 receptor remains unclear. The present study was aimed to investigate the role of 5-HT3 receptor in control of feeding behavior in fed and fasted mice. Methodology/Principal Findings Food intake and expression of c-Fos, tyrosine hydroxylase (TH), proopiomelanocortin ( POMC) and 5-HT in the brain were examined after acute treatment with 5-HT3 receptor agonist SR-57227 alone or in combination with 5-HT3 receptor antagonist ondansetron. Food intake was significantly inhibited within 3 h after acute treatment with SR 57227 in fasted mice but not fed mice, and this inhibition was blocked by ondansetron. Immunohistochemical study revealed that fasting-induced c-Fos expression was further enhanced by SR 57227 in the brainstem and the hypothalamus, and this enhancement was also blocked by ondansetron. Furthermore, the fasting-induced downregulation of POMC expression in the hypothalamus and the TH expression in the brain stem was blocked by SR 57227 in the fasted mice, and this effect of SR 57227 was also antagonized by ondansetron. Conclusion/Significance Taken together, our findings suggest that the effect of SR 57227 on the control of feeding behavior in fasted mice may be, at least partially, related to the c-Fos expression in hypothalamus and brain stem, as well as POMC system in the hypothalamus and the TH system in the brain stem.	[Li, Bingjin; Luo, Yungang; Zhang, Xingyi; Cui, Ranji] Jilin Univ, Hosp 2, Jilin Prov Key Lab Mol & Chem Genet, Changchun 130024, Peoples R China; [Shao, Dongyuan; Wang, Pu; Liu, Changhong] NE Normal Univ, Natl Engn Lab Druggable Gene & Prot Screening, Changchun 130024, Peoples R China	Jilin University; Northeast Normal University - China	Cui, RJ (corresponding author), Jilin Univ, Hosp 2, Jilin Prov Key Lab Mol & Chem Genet, Changchun 130024, Peoples R China.	cuiranji@hotmail.com	cui, ranji/AAV-6234-2021		Natural Science Foundation of China [31171123, 31300850, 81328011]; Program for New Century Excellent Talents in University [NCET-13-0715]; Jilin Provincial Department of Human Resources and Social Security Project [[2012]39]; Jilin Science and Technology Agency funding [20110726]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Program for New Century Excellent Talents in University(Program for New Century Excellent Talents in University (NCET)); Jilin Provincial Department of Human Resources and Social Security Project; Jilin Science and Technology Agency funding	This work was supported by Natural Science Foundation of China (31171123; 31300850; 81328011). The project was supported by Program for New Century Excellent Talents in University (NCET-13-0715); Jilin Provincial Department of Human Resources and Social Security Project ([2012]39); Jilin Science and Technology Agency funding (20110726). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript" in the first page of manuscript.	Batterham RL, 2007, NATURE, V450, P106, DOI 10.1038/nature06212; Becskei C, 2008, BRAIN BEHAV IMMUN, V22, P56, DOI 10.1016/j.bbi.2007.06.002; Bedford FK, 1996, HORM RES, V45, P19, DOI 10.1159/000184822; BLUNDELL JE, 1992, AM J CLIN NUTR, V55, P155, DOI 10.1093/ajcn/55.1.155s; Burton-Freeman B, 1999, AM J PHYSIOL-REG I, V276, pR429, DOI 10.1152/ajpregu.1999.276.2.R429; Cui RJ, 2012, J NEUROSCI, V32, P16530, DOI 10.1523/JNEUROSCI.1372-12.2012; Cui RJ, 2011, J NEUROSCI, V31, P3484, DOI 10.1523/JNEUROSCI.3187-10.2011; Daughters RS, 2001, PEPTIDES, V22, P1331, DOI 10.1016/S0196-9781(01)00460-0; DEBOER SF, 1989, PHYSIOL BEHAV, V45, P989, DOI 10.1016/0031-9384(89)90226-6; Depot M, 1999, NEUROPSYCHOPHARMACOL, V20, P177, DOI 10.1016/S0893-133X(98)00074-8; Ferezou I, 2002, J NEUROSCI, V22, P7389; Fetissov SO, 2000, NEUROSCIENCE, V101, P657, DOI 10.1016/S0306-4522(00)00374-2; Filippi A, 2010, J COMP NEUROL, V518, P423, DOI 10.1002/cne.22213; Franklin K.B.J., 2008, MOUSE BRAIN STEREOTA; FRIEDMAN E, 1973, LIFE SCI, V12, P317, DOI 10.1016/0024-3205(73)90415-3; Gao Q, 2007, ANNU REV NEUROSCI, V30, P367, DOI 10.1146/annurev.neuro.30.051606.094324; Gholipour T, 2010, SEIZURE-EUR J EPILEP, V19, P17, DOI 10.1016/j.seizure.2009.10.006; Hagemann LF, 1998, PHYSIOL BEHAV, V64, P645, DOI 10.1016/S0031-9384(98)00121-8; Hayes MR, 2005, PEPTIDES, V26, P2322, DOI 10.1016/j.peptides.2005.03.045; Hedge S S, 1994, J Pharmacol Exp Ther, V271, P741; Hsieh YS, 2007, BEHAV NEUROSCI, V121, P933, DOI 10.1037/0735-7044.121.5.933; Huo LH, 2006, DIABETES, V55, P567, DOI 10.2337/diabetes.55.03.06.db05-1143; Janssen P, 2011, NEUROGASTROENT MOTIL, V23, DOI 10.1111/j.1365-2982.2010.01655.x; Kazuyoshi K, 1994, J NEUROPHYSIOL, V71, P1935; Kuo DY, 2012, NEUROPHARMACOLOGY, V63, P842, DOI 10.1016/j.neuropharm.2012.06.018; Lam DD, 2010, PHARMACOL BIOCHEM BE, V97, P84, DOI 10.1016/j.pbb.2010.09.003; Li BJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093158; Li BJ, 2014, PROG NEURO-PSYCHOPH, V48, P199, DOI 10.1016/j.pnpbp.2013.08.015; Li BJ, 2013, J BIOCHEM MOL TOXIC, V27, P486, DOI 10.1002/jbt.21510; Li YL, 2009, BRAIN RES, V1268, P181, DOI 10.1016/j.brainres.2009.02.075; Liu L, 2012, J PHARMACOL SCI, V120, P280, DOI 10.1254/jphs.12163FP; Lopez JF, 1997, ANN NY ACAD SCI, V836, P106, DOI 10.1111/j.1749-6632.1997.tb52357.x; Maniscalco JW, 2013, PHYSIOL BEHAV, V121, P35, DOI 10.1016/j.physbeh.2013.01.012; Masaki T, 2004, DIABETES, V53, P2250, DOI 10.2337/diabetes.53.9.2250; Mazda T, 2004, AM J PHYSIOL-GASTR L, V287, pG228, DOI 10.1152/ajpgi.00373.2003; Mizuno TM, 1999, ENDOCRINOLOGY, V140, P4551, DOI 10.1210/en.140.10.4551; Moscarello JM, 2009, BEHAV BRAIN RES, V197, P9, DOI 10.1016/j.bbr.2008.07.025; Roerig B, 1992, J NEUROSCI, V17, P199; Ronde P, 1997, CELL CALCIUM, V22, P357, DOI 10.1016/S0143-4160(97)90020-8; Savastano DM, 2005, AM J PHYSIOL-REG I, V288, pR1499, DOI 10.1152/ajpregu.00745.2004; SHU SY, 1988, NEUROSCI LETT, V85, P169, DOI 10.1016/0304-3940(88)90346-1; Simansky KJ, 1996, BEHAV BRAIN RES, V73, P37, DOI 10.1016/0166-4328(96)00066-6; STACHOWIAK M, 1978, ACTA NEUROBIOL EXP, V38, P157; Sugimoto Y, 1996, EUR J PHARMACOL, V316, P15, DOI 10.1016/S0014-2999(96)00660-7; SUGITA S, 1992, NEURON, V8, P199, DOI 10.1016/0896-6273(92)90121-S; Teubner BJW, 2013, AM J PHYSIOL-REG I, V305, pR323, DOI 10.1152/ajpregu.00097.2013; van Hooft JA, 2000, TRENDS NEUROSCI, V23, P605, DOI 10.1016/S0166-2236(00)01662-3; VANDERHOEK GA, 1994, NEUROPHARMACOLOGY, V33, P805, DOI 10.1016/0028-3908(94)90120-1; Wu Q, 2012, NATURE, V483, P594, DOI 10.1038/nature10899; Yakel JL, 2000, HANDB EXP PHARM, V147, P541	50	15	16	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2015	10	3							e0121473	10.1371/journal.pone.0121473	http://dx.doi.org/10.1371/journal.pone.0121473			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD9NQ	25789930	Green Published, gold, Green Submitted			2022-12-27	WOS:000351425400194
J	Tan, AL; Virk, RK; Tambyah, PA; Inoue, M; Lim, EAS; Chan, KW; Chelvi, CS; Ooi, ST; Chua, C; Tan, BH				Tan, Aidan Lyanzhiang; Virk, Ramandeep Kaur; Tambyah, Paul Anantharajah; Inoue, Masafumi; Lim, Elizabeth Ai-Sim; Chan, Ka-Wei; Chelvi, C. Senthamarai; Ooi, Say-Tat; Chua, Catherine; Tan, Boon-Huan			Surveillance and Clinical Characterization of Influenza in a University Cohort in Singapore	PLOS ONE			English	Article							VIRUS; INFECTION; ILLNESS	Background Southeast Asia is a potential locus for the emergence of novel influenza strains. However, information on influenza within the region is limited. Objectives This study was to determine the proportion of influenza-like illness (ILI) caused by influenza A and B viruses in a university cohort in Singapore, identify important distinctive clinical features of influenza infection and potential factors associated with influenza infection compared with other causes of ILI. Methodology A surveillance study was conducted from 2007 to 2009, at the University Health and Wellness Centre, National University of Singapore (NUS). Basic demographic information and nasopharyngeal swabs were collected from consenting students and staff with ILI, with Influenza A and B identified by both culture and molecular methods. Results Proportions of influenza A and B virus infections in subjects with ILI were 153/500 (30.6%) and 11/500 (2.2%) respectively. The predominant subtype was A/H1N1, including both the seasonal strain (20/153) and the pandemic strain (72/153). The clinical symptom of fever was more common in subjects with laboratory confirmed influenza than other ILIs. On-campus hostel residence and being a student (compared with staff) were associated with increased risk of laboratory confirmed influenza A/H1N1 2009 infection. Conclusions This study provides a baseline prevalence of influenza infection within young adults in Singapore in a university setting. Potential risk factors, such as hostel residence, were identified, allowing for more targeted infection control measures in the event of a future influenza pandemic.	[Tan, Aidan Lyanzhiang; Virk, Ramandeep Kaur; Tambyah, Paul Anantharajah; Chelvi, C. Senthamarai] Natl Univ Singapore, Dept Med, Singapore 117548, Singapore; [Inoue, Masafumi] Agcy Sci Technol & Res, Singapore, Singapore; [Lim, Elizabeth Ai-Sim; Chan, Ka-Wei; Tan, Boon-Huan] DSO Natl Labs, Detect & Diagnost Lab, Singapore, Singapore; [Ooi, Say-Tat] Khoo Teck Puat Hosp, Dept Gen Med, Singapore, Singapore; [Chua, Catherine] Natl Univ Singapore, Univ Hlth Ctr, Singapore 117548, Singapore; [Tan, Boon-Huan] Natl Univ Singapore, Dept Epidemiol & Publ Hlth, Singapore 117548, Singapore	National University of Singapore; Agency for Science Technology & Research (A*STAR); National University of Singapore; National University of Singapore	Tan, AL (corresponding author), Natl Univ Singapore, Dept Med, Singapore 117548, Singapore.	hi.aidan@gmail.com	Tan, Aidan/R-6346-2019; Tan, Boon Huan/ABB-8381-2021	Tan, Aidan/0000-0003-4081-2209; Tan, Boon Huan/0000-0002-4976-7988	Infectious Diseases Research Fund; NUS-MINDEF JPP grant; Ministry of Defence, Singapore; Biomedical Research Council, Singapore's Agency for Science, Technology and Research (A*STAR)	Infectious Diseases Research Fund; NUS-MINDEF JPP grant; Ministry of Defence, Singapore(Ministry of Defence, Singapore); Biomedical Research Council, Singapore's Agency for Science, Technology and Research (A*STAR)(Agency for Science Technology & Research (A*STAR))	Funding and support for the work at NUS was by the Infectious Diseases Research Fund and NUS-MINDEF JPP grant. Funding for the work at the DSO National Laboratories was by the Ministry of Defence, Singapore. Funding for the work at the Institute of Molecular and Cell Biology (IMCB) was supported by the Biomedical Research Council, which is part of Singapore's Agency for Science, Technology and Research (A*STAR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguilera JF, 2003, EUR J EPIDEMIOL, V18, P751, DOI 10.1023/A:1025337616327; Campbell DS, 1997, J OCCUPATIONAL ENV M, V39; Carrat F, 1999, CLIN INFECT DIS, V28, P283, DOI 10.1086/515117; DORAISINGHAM S, 1988, B WORLD HEALTH ORGAN, V66, P57; Dwyer DE, 2006, MED J AUSTRALIA, V185, pS48; Eggers M, 2012, EUR J CLIN MICROBIOL, V31, P1257, DOI 10.1007/s10096-011-1437-1; Falcao IM, 1998, J EPIDEMIOL COMMUN H, V52, p39S; Gavin P.J., 2004, CLIN APPL IMMUNOL RE, V4, P151, DOI DOI 10.1016/S1529-1049(03)00064-3; Govaert TM, 1998, FAM PRACT, V15, P15; JOHNSON N, 1991, BRIT MED J, V302, P763, DOI 10.1136/bmj.302.6779.763; Kadri Z N, 1970, Singapore Med J, V11, P30; Louie JK, 2005, CLIN INFECT DIS, V41, P822, DOI 10.1086/432800; Manuguerra J.C, 2000, Euro Surveill, V5, P63; Mullins J, 2011, J AM COLL HEALTH, V59, P246, DOI 10.1080/07448481.2010.502197; Ng TP, 2002, ANN ACAD MED SINGAP, V31, P182; Nicholson KG, 2003, LANCET, V362, P1733, DOI 10.1016/S0140-6736(03)14854-4; Pelletier L, 1999, Can Commun Dis Rep, V25, P185; Seah SGK, 2010, J CLIN VIROL, V47, P289, DOI 10.1016/j.jcv.2009.12.011; Shek Lynette Pei-Chi, 2003, Paediatr Respir Rev, V4, P105, DOI 10.1016/S1526-0542(03)00024-1; Thomson J, 2000, COMMUNICABLE DIS INT, V24, P145; Virk RK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088345	21	2	2	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2015	10	3							e0119485	10.1371/journal.pone.0119485	http://dx.doi.org/10.1371/journal.pone.0119485			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD9NQ	25790305	Green Published, Green Submitted, gold			2022-12-27	WOS:000351425400087
J	Yang, H; Chen, HH; Guo, HW; Li, W; Tang, JM; Xu, BJ; Sun, MN; Ding, GX; Jiang, L; Cui, D; Zheng, XQ; Duan, Y				Yang, Hui; Chen, Huanhuan; Guo, Hongwei; Li, Wen; Tang, Jinmei; Xu, Bojin; Sun, Minne; Ding, Guoxian; Jiang, Lin; Cui, Dai; Zheng, Xuqin; Duan, Yu			Molecular Mechanisms of 2, 3', 4, 4', 5-Pentachlorobiphenyl-Induced Thyroid Dysfunction in FRTL-5 Cells	PLOS ONE			English	Article							SODIUM/IODIDE SYMPORTER EXPRESSION; POLYCHLORINATED BIPHENYL CONGENERS; GENE-EXPRESSION; ACTIVATION; THYROTROPIN; EXPOSURE; PROLIFERATION; CONTAMINANTS; CONSEQUENCES; INHIBITION	Polychlorinated biphenyls (PCBs) can severely interfere with multiple animals and human systems. To explore the molecular mechanisms underlying 2, 30, 4, 40, 5-pentachlorobiphenyl (PCB118)-induced thyroid dysfunction, Fischer rat thyroid cell line-5(FRTL-5) cells were treated with either different concentrations of PCB118 or dimethyl sulfoxide (DMSO). The effects of PCB118 on FRTL-5 cells viability and apoptosis were assessed by using a Cell Counting Kit-8 assay and apoptosis assays, respectively. Quantitative real-time polymerase chain reaction was used to quantify protein kinase B (Akt), Forkhead box protein O3a (FoxO3a), and sodium/iodide symporter (NIS) mRNA expression levels. Western blotting was used to detect Akt, phospho-Akt (p-Akt), FoxO3a, phospho-FoxO3a (p-FoxO3a), and NIS protein levels. Luciferase reporter gene technology was used to detect the transcriptional activities of FoxO3a and NIS promoters. The effects of the constitutively active Akt (CA-Akt) and dominant-negative Akt (DN-Akt) plasmids on p-Akt, p-FoxO3a, and NIS levels were examined in PCB118-treated FRTL-5 cells. The effects of FoxO3a siRNA on FoxO3a, p-FoxO3a, and NIS protein levels were examined in the PCB118-treated FRTL-5 cells. The effects of pcDNA3 (plsmid vectors designed for high-level stable and transient expression in mammalian host)-FoxO3a on NIS promoter activity were examined in the PCB118-treated FRTL-5 cells. Our results indicated that relatively higher PCB118 concentrations can inhibit cell viability in a concentration-and time-dependent manner. Akt, p-Akt, and p-FoxO3a protein or mRNA levels increased significantly in PCB118-treated groups and NIS protein and mRNA levels decreased considerably compared with the control groups. FoxO3a promoter activity increased significantly, whereas NIS promoter activity decreased. These effects on p-FoxO3a and NIS could be decreased by the DN-Akt plasmid, enhanced by the CA-Akt plasmid, and blocked by FoxO3a siRNA. The overexpressed FoxO3a could reduce NIS promoter activity. Our results suggested that PCB118 induces thyroid cell dysfunction through the Akt/FoxO3a/NIS signaling pathway.	[Yang, Hui; Chen, Huanhuan; Guo, Hongwei; Li, Wen; Tang, Jinmei; Xu, Bojin; Sun, Minne; Jiang, Lin; Cui, Dai; Zheng, Xuqin; Duan, Yu] Nanjing Med Univ, Affiliated Hosp 1, Dept Endocrinol, Nanjing, Jiangsu, Peoples R China; [Ding, Guoxian] Nanjing Med Univ, Affiliated Hosp 1, Dept Gerontol, Nanjing, Jiangsu, Peoples R China	Nanjing Medical University; Nanjing Medical University	Duan, Y (corresponding author), Nanjing Med Univ, Affiliated Hosp 1, Dept Endocrinol, Nanjing, Jiangsu, Peoples R China.	duanyu@medmail.com.cn	Cui, Dai/ABD-7918-2021; tang, jinmei/AFL-9035-2022; tang, jinmei/AAG-9650-2022	Cui, Dai/0000-0001-5534-9558; 	Natural Science Foundation of China (NSFC) [81170726]; Key Medical Talents from Jiangsu Provincial Health Bureau of China (Duanyu); Program for Development of Innovative Research Team in the First Affiliated Hospital of NJMU [20110312]; Priority Academic Program Development of Jiangsu Higher Education Institutions	Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); Key Medical Talents from Jiangsu Provincial Health Bureau of China (Duanyu); Program for Development of Innovative Research Team in the First Affiliated Hospital of NJMU; Priority Academic Program Development of Jiangsu Higher Education Institutions	This work was supported by the Natural Science Foundation of China (NSFC 81170726), Key Medical Talents from Jiangsu Provincial Health Bureau of China (Duanyu 2011), and the Program for Development of Innovative Research Team in the First Affiliated Hospital of NJMU (20110312). The project was funded by the Priority Academic Program Development of Jiangsu Higher Education Institutions. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Anati L, 2010, TOXICOL APPL PHARM, V249, P166, DOI 10.1016/j.taap.2010.09.004; ARNOLD DL, 1995, FOOD CHEM TOXICOL, V33, P457, DOI 10.1016/0278-6915(95)00018-W; Bauer TM, 2014, PHARMACOL THERAPEUT, P8; Bloom MS, 2003, ENVIRON RES, V93, P52, DOI 10.1016/S0013-9351(02)00085-3; Boas M, 2006, EUR J ENDOCRINOL, V154, P599, DOI 10.1530/eje.1.02128; Brown SB, 2004, ENVIRON TOXICOL CHEM, V23, P1680, DOI 10.1897/03-242; Brunet A, 1999, CELL, V96, P857, DOI 10.1016/S0092-8674(00)80595-4; Dal Col J, 2008, BLOOD, V111, P5142, DOI 10.1182/blood-2007-07-103481; Dohan O, 2003, ENDOCR REV, V24, P48, DOI 10.1210/er.2001-0029; Downward J, 1998, CURR OPIN CELL BIOL, V10, P262, DOI 10.1016/S0955-0674(98)80149-X; Golden R, 2009, CRIT REV TOXICOL, V39, P299, DOI 10.1080/10408440802291521; Guerrieri F, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.302; Howard AS, 2003, TOXICOL APPL PHARM, V190, P72, DOI 10.1016/S0041-008X(03)00156-X; Ishihara A, 2003, MOL CELL ENDOCRINOL, V199, P105, DOI 10.1016/S0303-7207(02)00302-7; Kato Y, 2004, TOXICOL SCI, V81, P309, DOI 10.1093/toxsci/kfh225; Kawashima A, 2011, ENDOCRINOLOGY, V152, P1702, DOI 10.1210/en.2010-1132; Kogai T, 2006, ENDOCR-RELAT CANCER, V13, P797, DOI 10.1677/erc.1.01143; Kogai T, 2008, J ENDOCRINOL, V199, P243, DOI [10.1677/JOE-08-0333, 10.1677/JOE-08-0333e]; Kops GJPL, 2002, NATURE, V419, P316, DOI 10.1038/nature01036; Lan L, 2007, J CLIN ENDOCR METAB, V92, P3681, DOI 10.1210/jc.2007-0281; Liu XH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037096; Liu YY, 2012, ENDOCR-RELAT CANCER, V19, P291, DOI 10.1530/ERC-11-0288; Liu Z, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031729; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Luo X, 2007, EMBO J, V26, P380, DOI 10.1038/sj.emboj.7601484; Manning BD, 2007, CELL, V129, P1261, DOI 10.1016/j.cell.2007.06.009; MCFARLAND VA, 1989, ENVIRON HEALTH PERSP, V81, P225, DOI 10.2307/3430833; Medema RH, 2000, NATURE, V404, P782, DOI 10.1038/35008115; Medina DL, 2000, EUR J ENDOCRINOL, V143, P161, DOI 10.1530/eje.0.1430161; Merritt RL, 2007, J TOXICOL ENV HEAL A, V70, P19, DOI 10.1080/15287390600748807; Ohashi E, 2006, J VET MED SCI, V68, P797, DOI 10.1292/jvms.68.797; Olmos Y, 2009, J BIOL CHEM, V284, P14476, DOI 10.1074/jbc.M807397200; Pocar P, 2006, TOXICOL SCI, V89, P408, DOI 10.1093/toxsci/kfj042; Portigal CL, 2002, TOXICOL APPL PHARM, V179, P185, DOI 10.1006/taap.2002.9371; Rankouhi TR, 2004, TOXICOL SCI, V81, P90, DOI 10.1093/toxsci/kfh176; Rodon J, 2013, NAT REV CLIN ONCOL, V10, P143, DOI 10.1038/nrclinonc.2013.10; Rolland RM, 2000, J WILDLIFE DIS, V36, P615, DOI 10.7589/0090-3558-36.4.615; Rosich L, 2014, ONCOTARGET, V5, P6788, DOI 10.18632/oncotarget.2253; Sanchez-Alonso JA, 2003, TOXICOL LETT, V144, P337, DOI 10.1016/S0378-4274(03)00238-8; Sastre-Perona A, 2014, MOL ENDOCRINOL, V28, P681, DOI 10.1210/me.2013-1377; Serrano-Nascimento C, 2014, ENDOCRINOLOGY, V155, P1145, DOI 10.1210/en.2013-1665; Tang JM, 2013, EXP TOXICOL PATHOL, V65, P989, DOI 10.1016/j.etp.2013.02.001; Tarkowski S, 1996, Int J Occup Med Environ Health, V9, P1; van der Heide LP, 2004, BIOCHEM J, V380, P297, DOI 10.1042/BJ20040167; Venkatesha VA, 2010, TOXICOL LETT, V196, P110, DOI 10.1016/j.toxlet.2010.04.005; Wassermann M, 1979, Ann N Y Acad Sci, V320, P69; Weidinger C, 2011, J CLIN ENDOCR METAB, V96, pE1361, DOI 10.1210/jc.2010-2453; Zaballos MA, 2008, MOL ENDOCRINOL, V22, P1183, DOI 10.1210/me.2007-0093; Zhao GF, 2009, SCI TOTAL ENVIRON, V407, P4831, DOI 10.1016/j.scitotenv.2009.05.031; Zheng XQ, 2010, INT J ONCOL, V37, P307, DOI 10.3892/ijo_00000679	50	12	13	2	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2015	10	3							e0120133	10.1371/journal.pone.0120133	http://dx.doi.org/10.1371/journal.pone.0120133			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD9NQ	25789747	Green Published, gold, Green Submitted			2022-12-27	WOS:000351425400132
J	Zhou, ZL; Su, YF; Campbell, B; Zhou, ZY; Gao, JM; Yu, Q; Chen, JH; Pan, YS				Zhou, Zhongliang; Su, Yanfang; Campbell, Benjamin; Zhou, Zhiying; Gao, Jianmin; Yu, Qiang; Chen, Jiuhao; Pan, Yishan			The Financial Impact of the 'Zero-Markup Policy for Essential Drugs' on Patients in County Hospitals in Western Rural China	PLOS ONE			English	Article							ESSENTIAL MEDICINES; HEALTH-CARE	Objective With a quasi-experimental design, this study aims to assess whether the Zero-markup Policy for Essential Drugs (ZPED) reduces the medical expense for patients at county hospitals, the major healthcare provider in rural China. Methods Data from Ningshan county hospital and Zhenping county hospital, China, include 2014 outpatient records and 9239 inpatient records. Quantitative methods are employed to evaluate ZPED. Both hospital-data difference-in-differences and individual-data regressions are applied to analyze the data from inpatient and outpatient departments. Results In absolute terms, the total expense per visit reduced by 19.02 CNY (3.12 USD) for outpatient services and 399.6 CNY (65.60 USD) for inpatient services. In relative terms, the expense per visit was reduced by 11% for both outpatient and inpatient services. Due to the reduction of inpatient expense, the estimated reduction of outpatient visits is 2% among the general population and 3.39% among users of outpatient services. The drug expense per visit dropped by 27.20 CNY (4.47 USD) for outpatient services and 278.7 CNY (45.75 USD) for inpatient services. The proportion of drug expense out of total expense per visit dropped by 11.73 percentage points in outpatient visits and by 3.92 percentage points in inpatient visits. Conclusion Implementation of ZPED is a benefit for patients in both absolute and relative terms. The absolute monetary reduction of the per-visit inpatient expense is 20 times of that in outpatient care. According to cross-price elasticity, the substitution between inpatient and outpatient due to the change in inpatient price is small. Furthermore, given that the relative reductions are the same for outpatient and inpatient visits, according to relative thinking theory, the incentive to utilize outpatient or inpatient care attributed to ZPED is equivalent, regardless of the 20-times price difference in absolute terms.	[Zhou, Zhongliang; Gao, Jianmin] Xi An Jiao Tong Univ, Sch Publ Policy & Adm, Xian 710049, Peoples R China; [Su, Yanfang] Harvard Univ, Sch Publ Hlth, Dept Global Hlth & Populat, Boston, MA 02115 USA; [Campbell, Benjamin] Bryn Mawr Coll, Bryn Mawr, PA USA; [Zhou, Zhiying] Xi An Jiao Tong Univ, Hlth Sci Ctr, Sch Publ Hlth, Xian 710049, Peoples R China; [Yu, Qiang] Ankang Municipal Dev & Reform Commiss, Ankang, Peoples R China; [Chen, Jiuhao] Ningshan Cty Hosp, Ankang, Shaanxi, Peoples R China; [Pan, Yishan] Zhenping Cty Hosp, Ankang, Shaanxi, Peoples R China	Xi'an Jiaotong University; Harvard University; Harvard T.H. Chan School of Public Health; Bryn Mawr College; Xi'an Jiaotong University	Su, YF (corresponding author), Harvard Univ, Sch Publ Hlth, Dept Global Hlth & Populat, 665 Huntington Ave, Boston, MA 02115 USA.	yanfangsu@mail.harvard.edu	Pan, Yi/AAJ-2341-2021	Su, Yanfang/0000-0001-7557-8518	National Natural Science Fund of China [71203177]; Shaanxi Social Science Fund [12Q036]; China Medical Board (CMB)	National Natural Science Fund of China(National Natural Science Foundation of China (NSFC)); Shaanxi Social Science Fund; China Medical Board (CMB)	This study was funded by National Natural Science Fund of China (Serial number: 71203177), Shaanxi Social Science Fund (Serial number: 12Q036) and China Medical Board (CMB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angrist JD, 2009, MOSTLY HARMLESS ECONOMETRICS: AN EMPIRICISTS COMPANION, P1; Azar O.H., 2007, J SOCIO-ECON, V36, P1, DOI [10.1016/j.socec.2005.12.014, DOI 10.1016/J.SOCEC.2005.12.014]; Center for Health Statistics and Information National Health and Family Planning Commission, 2009, AN REP NAT HLTH SERV; Chen M, 2013, CHINESE HLTH RESOURC, V16, P93; Chen YBB, 2013, CHINESE J HLTH POLIC, V6, P34; Craig SR, 2009, SOC SCI MED, V69, P1681, DOI 10.1016/j.socscimed.2009.08.024; Eggleston K, 2012, MILKEN I REV; Geest Sjaak van der, 1996, ANNU REV ANTHROPOL, V25, P153; Gulliford Martin, 2002, J Health Serv Res Policy, V7, P186, DOI 10.1258/135581902760082517; He P, 2011, CHINESE J HLTH POLIC, V4, P11; Hogerzeil HV, 2004, BRIT MED J, V329, P1169, DOI 10.1136/bmj.329.7475.1169; Hu J, 2007, CHIN J PREVCONTRCHRO, V15, P189; Lagarde M, 2008, B WORLD HEALTH ORGAN, V86, P839, DOI 10.2471/BLT.07.049197; Lee J.W., 2000, FRAMEWORK R D EVALUA; Li L, 2008, CHINESE HLTH EC, V27, P41; Ministry of Health, 2011, STAT B CHIN HLTH SER; Nichter M., 2008, GLOBAL HLTH WHY CULT; Petryna A., 2006, GLOBAL PHARM ETHICS; Potter W, 2009, HLTH CARE IND VS HLT; Ratanawijitrasin S, 2001, SOC SCI MED, V53, P831, DOI 10.1016/S0277-9536(00)00390-7; Shen R, 2013, CHINESE HOSP, V17, P62; [石亚丽 Shi Yali], 2013, [中国药房, China Pharmacy], V24, P300; Song Y, 2012, CHINESE HLTH SERVICE, V8, P586; Song Yan, 2014, J Pharm Policy Pract, V7, P12, DOI 10.1186/2052-3211-7-12; Sun Q, 2012, CHINESE HLTH EC, V31, P65, DOI [10.1016/j.clnu.2011.08.009, DOI 10.1016/J.CLNU.2011.08.009]; Sussmuth-Dyckerhoff C., 2010, HLTH INT, V10, P55; Wagstaff A, 2003, HEALTH ECON, V12, P921, DOI 10.1002/hec.776; Wang H, 2012, CHINESE J HLTH POLIC, V5, P30; Wang J, 2013, CHINA PHARM, V23, P2982, DOI DOI 10.6039/J.ISSN.1001-0408.2012.32.03; WHO, 1988, DEV IMPL NAT DRUG PO; Whyte S., 2003, SOCIAL LIVES MED; Wooldridge J., 2005, INTRO ECONOMETRICS M, V3; Yang LP, 2013, HEALTH POLICY PLANN, V28, P750, DOI 10.1093/heapol/czs116; Yip W, 2009, SOC SCI MED, V68, P201, DOI 10.1016/j.socscimed.2008.09.066; [周忠良 Zhou Zhongliang], 2013, [中国卫生政策研究, Chinese Journal of Health Policy], V6, P25; Zhou ZL, 2013, INT J EQUITY HEALTH, V12, DOI 10.1186/1475-9276-12-34; Zhou ZL, 2011, HEALTH POLICY, V103, P255, DOI 10.1016/j.healthpol.2011.09.005; Zhou ZL, 2015, J ASIAN PUBLIC POLIC	38	25	28	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2015	10	3							e0121630	10.1371/journal.pone.0121630	http://dx.doi.org/10.1371/journal.pone.0121630			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CD9NQ	25790443	Green Published, Green Submitted, gold			2022-12-27	WOS:000351425400199
J	Akib, NAM; Tam, BM; Phumee, P; Abidin, MZ; Tamadoni, S; Mather, PB; Nor, SAM				Akib, Noor Adelyna Mohammed; Tam, Bui Minh; Phumee, Preeda; Abidin, Muchlisin Zainal; Tamadoni, Saied; Mather, Peter B.; Nor, Siti Azizah Mohd			High Connectivity in Rastrelliger kanagurta: Influence of Historical Signatures and Migratory Behaviour Inferred from mtDNA Cytochrome b	PLOS ONE			English	Article							POPULATION GENETIC-STRUCTURE; MARINE FISHES; DEMOGRAPHIC HISTORY; THUNNUS-ALBACARES; SOUTHEAST-ASIA; YELLOWFIN TUNA; SEA LEVELS; DIVERSITY; GROWTH; DIFFERENTIATION	Phylogeographic patterns and population structure of the pelagic Indian mackerel, Rastrelliger kanagurta were examined in 23 populations collected from the Indonesian-Malaysian Archipelago (IMA) and the West Indian Ocean (WIO). Despite the vast expanse of the IMA and neighbouring seas, no evidence for geographical structure was evident. An indication that R. kanagurta populations across this region are essentially panmictic. This study also revealed that historical isolation was insufficient for R. kanagurta to attain migration drift equilibrium. Two distinct subpopulations were detected between the WIO and the IMA (and adjacent populations); interpopulation genetic variation was high. A plausible explanation for the genetic differentiation observed between the IMA and WIO regions suggest historical isolation as a result of fluctuations in sea levels during the late Pleistocene. This occurrence resulted in the evolution of a phylogeographic break for this species to the north of the Andaman Sea.	[Akib, Noor Adelyna Mohammed] Univ Sains Malaysia, Ctr Global Sustainabil Studies, George Town, Malaysia; [Tam, Bui Minh] Can Tho Univ, Coll Aquaculture & Fisheries, Can Tho City, Vietnam; [Phumee, Preeda] Rajamangala Univ Technol, Fac Sci & Fisheries & Technol, Trang, Thailand; [Abidin, Muchlisin Zainal] Univ Syiah Kuala, Fac Marine & Fishery, Dept Aquaculture, Jl T Nyak Arief Darussal, Banda Aceh, Indonesia; [Tamadoni, Saied] Persian Gulf & Oman Sea Ecol Res Inst, Bandar Abbass, Iran; [Mather, Peter B.] Queensland Univ Technol, Earth Environm & Biol Sci, Brisbane, Qld 4001, Australia; [Nor, Siti Azizah Mohd] Univ Sains Malaysia, Sch Biol Sci, George Town, Malaysia; [Nor, Siti Azizah Mohd] Univ Sains Malaysia, Ctr Marine & Coastal Studies, George Town, Malaysia	Universiti Sains Malaysia; Can Tho University; Rajamangala University of Technology Thanyaburi; Universitas Syiah Kuala; Queensland University of Technology (QUT); Universiti Sains Malaysia; Universiti Sains Malaysia	Akib, NAM (corresponding author), Univ Sains Malaysia, Ctr Global Sustainabil Studies, George Town, Malaysia.	adelyna@usm.my	Muchlisin, Zainal A./H-9599-2019; Muchlisin, Zainal Abidin/E-2317-2015; Nor, Siti Azizah Mohd/A-8275-2011	Muchlisin, Zainal A./0000-0002-0858-1853; Muchlisin, Zainal Abidin/0000-0002-0858-1853; Tamadoni Jahromi, Saeid/0000-0001-9245-8745	Universiti Sains Malaysia [1001/PBIOLOGI/815051, 1001/PPANTAI/844103]	Universiti Sains Malaysia(Universiti Sains Malaysia)	Universiti Sains Malaysia funded this project under the Research University Grant (1001/PBIOLOGI/815051) and the Postgraduate Research Grant Scheme (1001/PPANTAI/844103).	Aboim MA, 2005, MOL ECOL, V14, P1343, DOI 10.1111/j.1365-294X.2005.02518.x; Ahmad Faisal G, 2012, ASIAN J BIOL BIOTECH, V1, pe100; Arnason U, 1996, MOL BIOL EVOL, V13, P407, DOI 10.1093/oxfordjournals.molbev.a025599; Arnaud S, 1999, MAR BIOL, V135, P699, DOI 10.1007/s002270050671; Avise J. C., 2000, PHYLOGEOGRAPHY HIST; AVISE JC, 1984, J MOL EVOL, V20, P99, DOI 10.1007/BF02257369; BAKER CS, 1993, P NATL ACAD SCI USA, V90, P8239, DOI 10.1073/pnas.90.17.8239; Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; Bird MI, 2006, PALAEOGEOGR PALAEOCL, V241, P531, DOI 10.1016/j.palaeo.2006.05.003; Bird MI, 2005, QUATERNARY SCI REV, V24, P2228, DOI 10.1016/j.quascirev.2005.04.004; Cardenas L, 2005, MOL PHYLOGENET EVOL, V35, P496, DOI 10.1016/j.ympev.2005.01.011; Chen CA, 2004, MAR BIOTECHNOL, V6, P312, DOI 10.1007/s10126-003-0028-2; COLLETTE BB, 1984, FISH B-NOAA, V82, P545; Collette BB, 1983, FAO FISH SYNOPOSIS, V125, P137; Darlina MN, 2011, GENET MOL RES, V10, P2078, DOI 10.4238/vol10-3gmr1249; Drummond AJ, 2005, MOL BIOL EVOL, V22, P1185, DOI [10.1093/molbev/msi103, 10.1093/molbev/mss075]; Dupanloup I, 2002, MOL ECOL, V11, P2571, DOI 10.1046/j.1365-294X.2002.01650.x; Ely B, 2005, BMC EVOL BIOL, V5, DOI 10.1186/1471-2148-5-19; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Farias IP, 2001, J MOL EVOL, V53, P89, DOI 10.1007/s002390010197; Forster P, 2001, MOL BIOL EVOL, V18, P1864, DOI 10.1093/oxfordjournals.molbev.a003728; Frankel OH, 1981, CONSERVATION EVOLUTI; Franklin I.R., 1980, CONSERVATION BIOL EV; Fu YX, 1997, GENETICS, V147, P915; Grant WS, 1998, J HERED, V89, P415, DOI 10.1093/jhered/89.5.415; Grosberg R, 2001, MARINE COMMUNITY ECOLOGY, P61; Han ZQ, 2008, AFR J BIOTECHNOL, V7, P1774; Hanebuth T, 2000, SCIENCE, V288, P1033, DOI 10.1126/science.288.5468.1033; HARPENDING HC, 1994, HUM BIOL, V66, P591; Hewitt G, 2000, NATURE, V405, P907, DOI 10.1038/35016000; HUDSON RR, 1992, MOL BIOL EVOL, V9, P138; Jayasankar P., 2004, Asian Fisheries Science, V17, P201; Johns GC, 1998, MOL BIOL EVOL, V15, P1481, DOI 10.1093/oxfordjournals.molbev.a025875; Lambeck K, 2002, NATURE, V419, P199, DOI 10.1038/nature01089; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Liu JX, 2007, MOL ECOL, V16, P275, DOI 10.1111/j.1365-294X.2006.03140.x; Liu JX, 2006, MOL PHYLOGENET EVOL, V39, P799, DOI 10.1016/j.ympev.2006.01.009; LYNCH M, 1990, MOL BIOL EVOL, V7, P377; Mansor MI, 1996, FISHERIES B, V99; Mansor MI, 1989, FISHERIES B, V59; MCMILLAN WO, 1995, P ROY SOC B-BIOL SCI, V260, P229, DOI 10.1098/rspb.1995.0085; Menezes Maria R., 1995, Indian Journal of Fisheries, V40, P135; NEI M, 1973, P NATL ACAD SCI USA, V70, P3321, DOI 10.1073/pnas.70.12.3321; Nelson JS, 2000, MAR BIOL, V137, P727, DOI 10.1007/s002270000379; Nielsen EE, 2004, MOL ECOL, V13, P585, DOI 10.1046/j.1365-294X.2004.02097.x; O'Reilly PT, 2004, MOL ECOL, V13, P1799, DOI 10.1111/j.1365-294X.2004.02214.x; O'Reilly PT, 1998, ANIM GENET, V29, P363, DOI 10.1046/j.1365-2052.1998.295359.x; Palumbi SR, 2003, ECOL APPL, V13, pS146; POGSON GH, 1995, GENETICS, V139, P375; Posada D, 2001, TRENDS ECOL EVOL, V16, P37, DOI 10.1016/S0169-5347(00)02026-7; Posada D., 2004, COLLAPSE VER 1 2 TOO; Rambaut A., 2007, TRACER V1 4; Ramos-Onsins SE, 2002, MOL BIOL EVOL, V19, P2092, DOI 10.1093/oxfordjournals.molbev.a004034; Ray N, 2003, MOL BIOL EVOL, V20, P76, DOI 10.1093/molbev/msg009; Reiss H, 2009, FISH FISH, V10, P361, DOI 10.1111/j.1467-2979.2008.00324.x; ROGERS AR, 1995, EVOLUTION, V49, P608, DOI 10.1111/j.1558-5646.1995.tb02297.x; ROGERS AR, 1992, MOL BIOL EVOL, V9, P552; Roques S, 2002, MAR BIOL, V140, P297, DOI 10.1007/s002270100705; Rousset F, 1997, GENETICS, V145, P1219; Russell AL, 2005, MOL ECOL, V14, P2207, DOI 10.1111/j.1365-294X.2005.02552.x; Santos Mudjekeewis D., 2010, Philippine Journal of Science, V139, P43; Schneider S, 1999, GENETICS, V152, P1079; SCOLES DR, 1993, FISH B-NOAA, V91, P690; Shankar D, 2002, PROG OCEANOGR, V52, P63, DOI 10.1016/S0079-6611(02)00024-1; SLATKIN M, 1991, GENETICS, V129, P555; Sun P, 2012, BIOCHEM SYST ECOL, V43, P54, DOI 10.1016/j.bse.2012.02.028; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Theisen TC, 2008, MOL ECOL, V17, P4233, DOI 10.1111/j.1365-294X.2008.03913.x; Tjia H.D., 1996, TECTONIC EVOLUTION S, V106, P291, DOI DOI 10.1144/GSL.SP.1996.106.01.19; Tzeng TD, 2007, ZOOL STUD, V46, P656; Voris HK, 2000, J BIOGEOGR, V27, P1153, DOI 10.1046/j.1365-2699.2000.00489.x; Wang L, 2011, INT J MOL SCI, V12, P4378, DOI 10.3390/ijms12074378; WARD RD, 1994, REV FISH BIOL FISHER, V4, P300, DOI 10.1007/BF00042907; Ward RD, 2000, HYDROBIOLOGIA, V420, P191, DOI 10.1023/A:1003928327503; Ward Robert D., 2002, P200, DOI 10.1002/9780470693803.ch9; Wright S, 1931, GENETICS, V16, P0097; Zhang JB, 2006, ICES J MAR SCI, V63, P693, DOI 10.1016/j.icesjms.2006.01.004	77	17	17	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2015	10	3							e0119749	10.1371/journal.pone.0119749	http://dx.doi.org/10.1371/journal.pone.0119749			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9BN	25786216	gold, Green Published, Green Submitted			2022-12-27	WOS:000352138500128
J	Ebert, DD; Zarski, AC; Christensen, H; Stikkelbroek, Y; Cuijpers, P; Berking, M; Riper, H				Ebert, David Daniel; Zarski, Anna-Carlotta; Christensen, Helen; Stikkelbroek, Yvonne; Cuijpers, Pim; Berking, Matthias; Riper, Heleen			Internet and Computer-Based Cognitive Behavioral Therapy for Anxiety and Depression in Youth: A Meta-Analysis of Randomized Controlled Outcome Trials	PLOS ONE			English	Article							TEENS-CD-ROM; MENTAL-HEALTH; ADOLESCENT DEPRESSION; YOUNG-PEOPLE; SERVICE USE; DISORDERS; CHILDREN; PSYCHOTHERAPY; COMORBIDITY; CHILDHOOD	Background Anxiety and depression in children and adolescents are undertreated. Computer-and Internet-based cognitive behavioral treatments (cCBT) may be an attractive treatment alternative to regular face-to-face treatment. This meta-analysis aims to evaluate whether cCBT is effective for treating symptoms of anxiety and depression in youth. Methods and Findings We conducted systematic searches in bibliographical databases (Pubmed, Cochrane controlled trial register, PsychInfo) up to December 4, 2013. Only randomized controlled trials in which a computer-, Internet-or mobile-based cognitive behavioral intervention targeting either depression, anxiety or both in children or adolescents up to the age of 25 were compared to a control condition were selected. We employed a random-effects pooling model in overall effect analyses and a mixed effect model for sub-group analyses. Searches resulted in identifying 13 randomized trials, including 796 children and adolescents that met inclusion criteria. Seven studies were directed at treating anxiety, four studies at depression, and two were of a transdiagnostic nature, targeting both anxiety and depression. The overall mean effect size (Hedges' g) of cCBT on symptoms of anxiety or depression at post-test was g=0.72 (95% CI: 0.55-0.90, numbers needed to be treated (NNT)=2.56). Heterogeneity was low (I-2=20.14%, 95% CI: 0-58%). The superiority of cCBT over controls was evident for interventions targeting anxiety (g=0.68; 95% CI: 0.45-0.92; p < .001; NNT=2.70) and for interventions targeting depression (g=0.76; 95% CI: 0.41-0.12; p < .001; NNT=2.44) as well as for transdiagnostic interventions (g=0.94; 95% CI: 0.23-2.66; p < .001; NNT=2.60). Conclusions Results provide evidence for the efficacy of cCBT in the treatment of anxiety and depressive symptoms in youth. Hence, such interventions may be a promising treatment alternative when evidence based face-to-face treatment is not feasible. Future studies should examine long-term effects of treatments and should focus on obtaining patient-level data from existing studies, to perform an individual patient data meta-analysis.	[Ebert, David Daniel; Zarski, Anna-Carlotta; Cuijpers, Pim; Berking, Matthias; Riper, Heleen] Leuphana Univ, Innovat Incubator, Div Hlth Trainings Online, Luneburg, Germany; [Ebert, David Daniel; Berking, Matthias] Univ Erlangen Nurnberg, Dept Psychol Clin Psychol & Psychotherapy, D-91054 Erlangen, Germany; [Christensen, Helen] Black Dog Inst, Sydney, NSW, Australia; [Stikkelbroek, Yvonne] Univ Utrecht, Ctr Child & Adolescent Studies, NL-3508 TC Utrecht, Netherlands; [Cuijpers, Pim; Riper, Heleen] Vrije Univ Amsterdam Med Ctr, Reg Mental Hlth Serv Ctr, GGZ inGeest, Amsterdam, Netherlands; [Ebert, David Daniel; Cuijpers, Pim; Riper, Heleen] Vrije Univ Amsterdam, Dept Clin Psychol, Amsterdam, Netherlands; [Ebert, David Daniel; Cuijpers, Pim; Riper, Heleen] Vrije Univ Amsterdam, EMGO Inst Hlth & Care Res, Amsterdam, Netherlands	Leuphana University Luneburg; University of Erlangen Nuremberg; Black Dog Institute; Utrecht University; Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER; Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam	Ebert, DD (corresponding author), Leuphana Univ, Innovat Incubator, Div Hlth Trainings Online, Luneburg, Germany.	ebert@inkubator.leuphana.de	Stikkelbroek, Yvonne/ABG-8003-2021; Christensen, Helen/F-5053-2012; Cuijpers, Pim/G-1703-2013	Christensen, Helen/0000-0003-0435-2065; Ebert, David Daniel/0000-0001-6820-0146; Cuijpers, Pim/0000-0001-5497-2743	European Union [EFRE: ZW6-80119999, CCI 2007DE161PR001]	European Union(European Commission)	This study is funded by the European Union (EFRE: ZW6-80119999, CCI 2007DE161PR001). The funders played no role in study design, collection, analysis, interpretation of data, writing of the report, or in the decision to submit the paper for publication.	Andersson G., WORLD PSYCH IN PRESS; Andrews G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013196; Angold A, 1998, AM J PUBLIC HEALTH, V88, P75, DOI 10.2105/AJPH.88.1.75; ANGOLD A, 1993, AM J PSYCHIAT, V150, P1779; Axelson DA, 2001, DEPRESS ANXIETY, V14, P67, DOI 10.1002/da.1048; Barrett PM, 1996, J CONSULT CLIN PSYCH, V64, P333, DOI 10.1037/0022-006X.64.2.333; Bodden DHM, 2008, J ABNORM CHILD PSYCH, V36, P487, DOI 10.1007/s10802-007-9194-4; Borenstein M, 2009, INTRO META ANAL; BRADY EU, 1992, PSYCHOL BULL, V111, P244, DOI 10.1037/0033-2909.111.2.244; Buntrock C, 2014, BMC PSYCHIATRY, V14, DOI 10.1186/1471-244X-14-25; BURNS BJ, 1995, HEALTH AFFAIR, V14, P147, DOI 10.1377/hlthaff.14.3.147; Calear AL, 2010, MED J AUSTRALIA, V192, pS12; Calear AL, 2009, J CONSULT CLIN PSYCH, V77, P1021, DOI 10.1037/a0017391; Compton SN, 2004, J AM ACAD CHILD PSY, V43, P930, DOI 10.1097/01.chi.0000127589.57468.bf; Costello EJ, 2003, ARCH GEN PSYCHIAT, V60, P837, DOI 10.1001/archpsyc.60.8.837; Cunningham MJ, 2009, EUR CHILD ADOLES PSY, V18, P125, DOI 10.1007/s00787-008-0703-y; Duval S, 2000, BIOMETRICS, V56, P455, DOI 10.1111/j.0006-341X.2000.00455.x; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Ehrenreich JT, 2009, CHILD FAM BEHAV THER, V31, P20, DOI 10.1080/07317100802701228; Essau CA, 2005, DEPRESS ANXIETY, V22, P130, DOI 10.1002/da.20115; Fleming T, 2012, BEHAV COGN PSYCHOTH, V40, P529, DOI 10.1017/S1352465811000695; Ford T, 1999, AIRCR ENG AEROSP TEC, V71, P42, DOI 10.1108/00022669910252169; Gulliver A, 2010, BMC PSYCHIATRY, V10, DOI 10.1186/1471-244X-10-113; Haug T, 2012, CLIN PSYCHOL REV, V32, P425, DOI 10.1016/j.cpr.2012.04.002; Hedman E, 2012, EXPERT REV PHARM OUT, V12, P745, DOI [10.1586/erp.12.67, 10.1586/ERP.12.67]; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Hofstra MB, 2002, J AM ACAD CHILD PSY, V41, P182, DOI 10.1097/00004583-200202000-00012; Ioannidis JPA, 2007, BRIT MED J, V335, P914, DOI 10.1136/bmj.39343.408449.80; James AC, 2013, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD004690.pub3, 10.1002/14651858.CD004690.pub4]; Kataoka SH, 2002, AM J PSYCHIAT, V159, P1548, DOI 10.1176/appi.ajp.159.9.1548; Kazdin AE, 2002, RES DESIGN CLIN PSYC, P1000; Keller M. A., 2009, THESIS; Khanna MS, 2010, J CONSULT CLIN PSYCH, V78, P737, DOI 10.1037/a0019739; Klein JB, 2007, J AM ACAD CHILD PSY, V46, P1403, DOI 10.1097/chi.0b013e3180592aaa; Kontopantelis E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069930; Kraemer HC, 2006, BIOL PSYCHIAT, V59, P990, DOI 10.1016/j.biopsych.2005.09.014; LAUPACIS A, 1988, NEW ENGL J MED, V318, P1728, DOI 10.1056/NEJM198806303182605; Lin J, 2013, REHABILITATION, V52, P155, DOI 10.1055/s-0033-1343491; Macdonald Geraldine, 2012, Cochrane Database Syst Rev, pCD001930, DOI 10.1002/14651858.CD001930.pub3; Makarushka MM, 2011, THESIS U OREGON OREG; March S, 2009, J PEDIATR PSYCHOL, V34, P474, DOI 10.1093/jpepsy/jsn099; Merikangas KR, 2010, J AM ACAD CHILD PSY, V49, P980, DOI 10.1016/j.jaac.2010.05.017; Michael KD, 2002, CLIN PSYCHOL REV, V22, P247, DOI 10.1016/S0272-7358(01)00089-7; Orsini N., 2013, HETEROGI STATA MODUL; ORVASCHEL H, 1995, J AM ACAD CHILD PSY, V34, P1525, DOI 10.1097/00004583-199511000-00020; Parker G, 2003, J AFFECT DISORDERS, V74, P131, DOI 10.1016/S0165-0327(02)00002-2; RAO U, 1995, J AM ACAD CHILD PSY, V34, P566, DOI 10.1097/00004583-199505000-00009; Reynolds S, 2012, CLIN PSYCHOL REV, V32, P251, DOI 10.1016/j.cpr.2012.01.005; Rozental A., 2014, INTERNET INTERVENTIO, V1, P12, DOI [10.1016/j.invent.2014.02.001, DOI 10.1016/J.INVENT.2014.02.001]; Sawyer MG, 2001, AUST NZ J PSYCHIAT, V35, P806, DOI 10.1046/j.1440-1614.2001.00964.x; Sethi S, 2010, J TECHNOL HUMAN SERV, V28, P144, DOI 10.1080/15228835.2010.508317; Spence SH, 2011, J CONSULT CLIN PSYCH, V79, P629, DOI 10.1037/a0024512; Stallard P, 2011, BEHAV COGN PSYCHOTH, V39, P273, DOI 10.1017/S135246581000086X; Stasiak K, 2012, BEHAV COGN PSYCHOTH, V20, P1; Storch EA, 2011, PSYCHIAT RES, V189, P407, DOI 10.1016/j.psychres.2011.05.047; Tillfors M, 2008, DEPRESS ANXIETY, V25, P708, DOI 10.1002/da.20416; Tillfors Maria, 2011, Cognitive Behaviour Therapy, V40, P147, DOI 10.1080/16506073.2011.555486; Trosper SE, 2009, CLIN CHILD FAM PSYCH, V12, P234, DOI 10.1007/s10567-009-0043-6; van der Zanden R, 2012, J MED INTERNET RES, V14, P274, DOI 10.2196/jmir.2033; van Zoonen K, 2014, INT J EPIDEMIOL, V43, P318, DOI 10.1093/ije/dyt175; Weisz JR, 2013, JAMA PSYCHIAT, V70, P750, DOI 10.1001/jamapsychiatry.2013.1176; Weisz JR, 2006, PSYCHOL BULL, V132, P132, DOI 10.1037/0033-2909.132.1.132; WEISZ JR, 1995, PSYCHOL BULL, V117, P450, DOI 10.1037/0033-2909.117.3.450; Woodward LJ, 2001, J AM ACAD CHILD PSY, V40, P1086, DOI 10.1097/00004583-200109000-00018; Wuthrich VM, 2012, J AM ACAD CHILD PSY, V51, P261, DOI 10.1016/j.jaac.2011.12.002; Zachrisson HD, 2006, BMC PUBLIC HEALTH, V6, DOI 10.1186/1471-2458-6-34	66	260	264	3	114	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2015	10	3							e0119895	10.1371/journal.pone.0119895	http://dx.doi.org/10.1371/journal.pone.0119895			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CE9BN	25786025	Green Submitted, gold, Green Published			2022-12-27	WOS:000352138500142
J	Kriticos, DJ; Ota, N; Hutchison, WD; Beddow, J; Walsh, T; Tay, WT; Borchert, DM; Paula-Moreas, SV; Czepak, C; Zalucki, MP				Kriticos, Darren J.; Ota, Noboru; Hutchison, William D.; Beddow, Jason; Walsh, Tom; Tay, Wee Tek; Borchert, Daniel M.; Paula-Moreas, Silvana V.; Czepak, Cecilia; Zalucki, Myron P.			The Potential Distribution of Invading Helicoverpa armigera in North America: Is It Just a Matter of Time?	PLOS ONE			English	Article							NEW-SOUTH-WALES; HELIOTHIS-PUNCTIGERA WALLENGREN; LIGHT-TRAP DATA; LEPIDOPTERA-NOCTUIDAE; HUBNER LEPIDOPTERA; HOST-PLANT; COTTON BOLLWORM; INSECTICIDE RESISTANCE; SPRING EMERGENCE; SPP. LEPIDOPTERA	Helicoverpa armigera has recently invaded South and Central America, and appears to be spreading rapidly. We update a previously developed potential distribution model to highlight the global invasion threat, with emphasis on the risks to the United States. The continued range expansion of H. armigera in Central America is likely to change the invasion threat it poses to North America qualitatively, making natural dispersal from either the Caribbean islands or Mexico feasible. To characterise the threat posed by H. armigera, we collated the value of the major host crops in the United States growing within its modelled potential range, including that area where it could expand its range during favourable seasons. We found that the annual value of crops that would be exposed to H. armigera totalled approximately US$ 78 billion p.a., with US$ 843 million p.a. worth growing in climates that are optimal for the pest. Elsewhere, H. armigera has developed broad-spectrum pesticide resistance; meaning that if it invades the United States, protecting these crops from significant production impacts could be challenging. It may be cost-effective to undertake preemptive biosecurity activities such as slowing the spread of H. armigera throughout the Americas, improving the system for detecting H. armigera, and methods for rapid identification, especially distinguishing between H. armigera, H. zea and potential H. armigera x H. zea hybrids. Developing biological control programs, especially using inundative techniques with entomopathogens and parasitoids could slow the spread of H. armigera, and reduce selective pressure for pesticide resistance. The rapid spread of H. armigera through South America into Central America suggests that its spread into North America is a matter of time. The likely natural dispersal routes preclude aggressive incursion responses, emphasizing the value of preparatory communication with agricultural producers in areas suitable for invasion by H. armigera.	[Kriticos, Darren J.; Walsh, Tom; Tay, Wee Tek] CSIRO, Canberra, ACT, Australia; [Kriticos, Darren J.; Zalucki, Myron P.] Univ Queensland, Fac Sci, Sch Biol Sci, Brisbane, Qld 4072, Australia; [Ota, Noboru] CSIRO, Wembley, WA, Australia; [Hutchison, William D.] Univ Minnesota, Dept Entomol, St Paul, MN USA; [Beddow, Jason] Univ Minnesota, Dept Appl Econ, St Paul, MN 55108 USA; [Borchert, Daniel M.] Plant Epidemiol & Risk Anal Lab, Anim & Plant Hlth Inspect Service, Plant Protect & Quarantine, Ctr Plant Hlth Sci & Technol, Raleigh, NC USA; [Paula-Moreas, Silvana V.] Embrapa Cerrados, Planaltina, DF, Brazil; [Czepak, Cecilia] Univ Fed Goias, Escola Agron & Engn Alimentos, BR-131 Goiania, Go, Brazil	Commonwealth Scientific & Industrial Research Organisation (CSIRO); University of Queensland; Commonwealth Scientific & Industrial Research Organisation (CSIRO); University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; Empresa Brasileira de Pesquisa Agropecuaria (EMBRAPA); Universidade Federal de Goias	Kriticos, DJ (corresponding author), CSIRO, GPO Box 1700, Canberra, ACT, Australia.	darren.kriticos@csiro.au	Walsh, Thomas K/C-1263-2009; Tay, Wee Tek/C-1818-2008; Ota, Noboru/ABE-4698-2020; Kriticos, Darren J/A-4170-2008; Zalucki, Myron P/G-7983-2012; Tay, Wee Tek/GPF-6142-2022; czepak, cecilia/ABI-8498-2020	Walsh, Thomas K/0000-0001-8425-0135; Tay, Wee Tek/0000-0002-8451-0811; Kriticos, Darren J/0000-0003-2599-8105; Zalucki, Myron P/0000-0001-9603-7577; Tay, Wee Tek/0000-0002-8451-0811; czepak, cecilia/0000-0002-7508-7986; , Noboru/0000-0002-8759-9030; Hutchison, William D./0000-0001-9605-2996	Cotton Inc.; Commonwealth Scientific and Industrial Research Organisation; University of Queensland	Cotton Inc.; Commonwealth Scientific and Industrial Research Organisation(Commonwealth Scientific & Industrial Research Organisation (CSIRO)); University of Queensland(University of Queensland)	DJK and MPZ were partly financially supported by Cotton Inc., but otherwise were supported by their employers, the Commonwealth Scientific and Industrial Research Organisation and The University of Queensland respectively with non-specific funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allsopp PGG, 1991, HELIOTHIS RES METHOD, P90, DOI DOI 10.1007/978-1-4612-3016-8_8; Bai Lixin, 1997, Acta Phytophylacica Sinica, V24, P1; Baker GH, 2011, B ENTOMOL RES, V101, P9, DOI 10.1017/S0007485310000106; Behere GT, 2008, B ENTOMOL RES, V98, P599, DOI 10.1017/S0007485308005956; Behere GT, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-117; Behere GT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053448; Brown JH, 1996, ANNU REV ECOL SYST, V27, P597, DOI 10.1146/annurev.ecolsys.27.1.597; Bues R, 2005, CROP PROT, V24, P814, DOI 10.1016/j.cropro.2005.01.006; CABI, 1993, HEL ARM HUBN; CABI, 2013, HEL ARM HUBN; COAKER T. H., 1959, BULL ENT RES, V50, P487, DOI 10.1017/S0007485300053062; Correa-Ferreira BS, 2014, INIMIGOS NATURAIS HE, P80; Cunningham JP, 2014, J ECON ENTOMOL, V107, P881, DOI 10.1603/EC14036; Czepak Cecília, 2013, Pesqui. Agropecu. Trop., V43, P110, DOI 10.1590/S1983-40632013000100015; Dosdall L, 2001, ORIGINS INFESTATIONS, P95; Downes S, 2010, EVOL APPL, V3, P574, DOI 10.1111/j.1752-4571.2010.00146.x; Duffield SJ, 2005, AUST J ENTOMOL, V44, P316, DOI 10.1111/j.1440-6055.2005.00486.x; EMBRAPA, 2013, NOT TECN RES TRAB IN, DOI 10.13140/RG.2.1.294667685; EVANS D. E., 1964, Empire Cotton Growing Review, V41, P202; FARROW RA, 1987, AUST J ZOOL, V35, P1, DOI 10.1071/ZO9870001; Feng HQ, 2004, J ECON ENTOMOL, V97, P1874, DOI 10.1603/0022-0493-97.6.1874; FITT GP, 1989, ANNU REV ENTOMOL, V34, P17, DOI 10.1146/annurev.en.34.010189.000313; FITT GP, 1990, J ECON ENTOMOL, V83, P1827, DOI 10.1093/jee/83.5.1827; Murua MG, 2014, FLA ENTOMOL, V97, P854, DOI 10.1653/024.097.0279; Ge F, 2005, ENTOMOL EXP APPL, V116, P1, DOI 10.1111/j.1570-7458.2005.00305.x; GREGG PC, 1995, INSECT MIGRATION: TRACKING RESOURCES THROUGH SPACE AND TIME, P151; Hardwick D. F., 1965, MEM ENTOMOL SOC CAN, V97, P5, DOI DOI 10.4039/ENTM9740FV; HMIMINA M, 1993, J APPL ENTOMOL, V116, P273, DOI 10.1111/j.1439-0418.1993.tb01196.x; Hutchison W., 2007, PLANT HLTH PROGR, DOI [10.1094/PHP-2007-0719-02-RV, DOI 10.1094/PHP-2007-0719-02-RV]; Jadhav D. R., 2013, Asian Journal of Agricultural Sciences, V5, P40; Jallow MFA, 2004, CROP PROT, V23, P955, DOI 10.1016/j.cropro.2004.02.008; Jallow MFA, 2001, APPL ENTOMOL ZOOL, V36, P427, DOI 10.1303/aez.2001.427; Joussen N, 2012, P NATL ACAD SCI USA, V109, P15206, DOI 10.1073/pnas.1202047109; Kakimoto T, 2003, ANN ENTOMOL SOC AM, V96, P793, DOI 10.1603/0013-8746(2003)096[0793:ELPLDA]2.0.CO;2; Kriticos DJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054861; Kriticos DJ, 2012, METHODS ECOL EVOL, V3, P53, DOI 10.1111/j.2041-210X.2011.00134.x; Lammers J. W., 2007, REPORT PEST RISK ANA; LASTER ML, 1995, J ECON ENTOMOL, V88, P77, DOI 10.1093/jee/88.1.77; LINGREN PD, 1994, ENVIRON ENTOMOL, V23, P562, DOI 10.1093/ee/23.3.562; Liu ZD, 2010, ENVIRON ENTOMOL, V39, P552, DOI 10.1603/EN09129; Lu ZZ, 2013, J PEST SCI, V86, P695, DOI 10.1007/s10340-013-0517-7; Maelzer D, 1996, B ENTOMOL RES, V86, P547, DOI 10.1017/S0007485300039341; Maelzer DA, 1999, B ENTOMOL RES, V89, P455, DOI 10.1017/S0007485399000590; Maelzer DA, 2000, B ENTOMOL RES, V90, P133, DOI 10.1017/S0007485300000249; Manjunath TM, 1989, INDIA ASSESSMENT THE; Mastrangelo T, 2014, J ECON ENTOMOL, V107, P970, DOI 10.1603/EC13403; Matthews M, 1999, HELIOTHINE MOTHS AUS; Michael PJ, 1980, ENTOMOLOGICAL REV CO; Mironidis GK, 2008, ENVIRON ENTOMOL, V37, P16, DOI 10.1603/0046-225X(2008)37[16:DSAROH]2.0.CO;2; Mironidis GK, 2010, ENVIRON ENTOMOL, V39, P1068, DOI 10.1603/EN09148; Morey AC, 2012, ENVIRON ENTOMOL, V41, P172, DOI 10.1603/EN11026; Murray DAH, 1991, INVESTIGATIONS DEV S; Nibouche S, 1998, ENTOMOL EXP APPL, V87, P271, DOI 10.1023/A:1003234203159; North American Plant Protection Organization, 2014, DET OLD WORLD BOLLW; Pardey PG, 2013, SCIENCE, V340, P147, DOI 10.1126/science.122970; Perkins LE, 2010, B ENTOMOL RES, V100, P591, DOI 10.1017/S0007485309990654; Perkins LE, 2009, ARTHROPOD-PLANT INTE, V3, P173, DOI 10.1007/s11829-009-9069-4; Perkins LE, 2008, ARTHROPOD-PLANT INTE, V2, P197, DOI 10.1007/s11829-008-9047-2; Pinkard EA, 2010, ECOL MODEL, V221, P2828, DOI 10.1016/j.ecolmodel.2010.08.017; Rochester WA, 2002, COMPUT ELECTRON AGR, V35, P139, DOI 10.1016/S0168-1699(02)00015-7; Rochester WA, 1996, ECOL MODEL, V86, P151, DOI 10.1016/0304-3800(95)00043-7; ROOME RE, 1979, B ENTOMOL RES, V69, P149, DOI 10.1017/S0007485300017983; Schellhorn NA, 2008, AUST J EXP AGR, V48, P1549, DOI 10.1071/EA08112; Schneider SS, 2004, ANNU REV ENTOMOL, V49, P351, DOI 10.1146/annurev.ento.49.061802.123359; Sharma H.C., 2005, HELIOTHIS HELICOVERP; Shimizu K, 2006, APPL ENTOMOL ZOOL, V41, P151, DOI 10.1303/aez.2006.151; Siebert S, 2005, HYDROL EARTH SYST SC, V9, P535, DOI 10.5194/hess-9-535-2005; Sisterson MS, 2005, J ECON ENTOMOL, V98, P1751, DOI 10.1603/0022-0493-98.6.1751; Soleimannejad S, 2010, J ECON ENTOMOL, V103, P1420, DOI 10.1603/EC10022; Specht A, 2013, PESQUI AGROPECU BRAS, V48, P689, DOI 10.1590/S0100-204X2013000600015; Stanaway MA, 2001, AUST J ENTOMOL, V40, P180, DOI 10.1046/j.1440-6055.2001.00215.x; Sutherst R W, 2007, CLIMEX VERSION 3 USE; Sutherst RW, 2005, ENVIRON ENTOMOL, V34, P317, DOI 10.1603/0046-225X-34.2.317; SUTHERST RW, 1985, AGR ECOSYST ENVIRON, V13, P281, DOI 10.1016/0167-8809(85)90016-7; Tabashnik BE, 2013, NAT BIOTECHNOL, V31, P510, DOI 10.1038/nbt.2597; Tay WT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080134; TOPPER CP, 1987, B ENTOMOL RES, V77, P525, DOI 10.1017/S0007485300012013; Torres-Vila LM, 2002, CROP PROT, V21, P1003, DOI 10.1016/S0261-2194(02)00081-9; Venette R. C., 2003, MINIRISK ASSESSMENT; Westbrook JK, 1999, AGR FOREST METEOROL, V97, P263, DOI 10.1016/S0168-1923(99)00071-4; WILSON AGL, 1979, B ENTOMOL RES, V69, P97, DOI 10.1017/S0007485300017934; Wu KM, 2005, ANNU REV ENTOMOL, V50, P31, DOI 10.1146/annurev.ento.50.071803.130349; Wu KM, 2008, SCIENCE, V321, P1676, DOI 10.1126/science.1160550; Wu Kongming, 2000, Acta Phytophylacica Sinica, V27, P23; Yonow T, 1998, AUST J AGR RES, V49, P935, DOI 10.1071/A97152; You L, 2014, SPATIAL PRODUCTION A; ZALUCKI MP, 1986, AUST J ZOOL, V34, P779, DOI 10.1071/ZO9860779; ZALUCKI MP, 1994, AUST J ZOOL, V42, P329, DOI 10.1071/ZO9940329; Zalucki Myron P., 2005, Insect Science, V12, P45, DOI 10.1111/j.1672-9609.2005.00007.x; Zalucki MP, 2009, AUST J ENTOMOL, V48, P85, DOI 10.1111/j.1440-6055.2009.00690.x; Zhou XF, 2000, ENVIRON ENTOMOL, V29, P1289, DOI 10.1603/0046-225X-29.6.1289; Zhu M, 2006, AGR FOREST METEOROL, V138, P192, DOI 10.1016/j.agrformet.2006.05.001	92	131	142	2	79	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2015	10	3							e0119618	10.1371/journal.pone.0119618	http://dx.doi.org/10.1371/journal.pone.0119618			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9BN	25786260	Green Published, gold			2022-12-27	WOS:000352138500121
J	Liu, LL; Zhan, P; Zhou, XD; Song, Y; Zhou, XJ; Yu, L; Wang, JD				Liu, Leilei; Zhan, Ping; Zhou, Xiaodie; Song, Yong; Zhou, Xiaojun; Yu, Like; Wang, Jiandong			Detection of EML4-ALK in Lung Adenocarcinoma Using Pleural Effusion with FISH, IHC, and RT-PCR Methods	PLOS ONE			English	Article							CANCER STATISTICS; KINASE INHIBITOR; FUSION GENE; IDENTIFICATION; REARRANGEMENT; CHEMOTHERAPY; DIAGNOSIS; ACCURACY; LYMPHOMA; CYTOLOGY	Anaplastic lymphoma kinase (ALK) and echinoderm microtubule-associated protein-like 4 (EML4) gene rearrangements occur in approximately 5% of non-small-cell lung cancers (NSCLC), leading to the overexpression of anaplastic lymphoma kinase and predicting a response to the targeted inhibitor, crizotinib. Malignant pleural effusion occurs in most patients with advanced lung cancer, especially adenocarcinoma, and tissue samples are not always available from these patients. We attempted to clarify the feasibility of detecting the EML4-ALK fusion gene in pleural effusion cells using different methods. We obtained 66 samples of pleural effusion from NSCLC patients. The pleural effusion fluid was centrifuged, and the cellular components obtained were formalin fixed and paraffin embedded. The EML4-ALK fusion gene status was determined with fluorescent in situ hybridization (FISH), reverse transcription-polymerase chain reaction (RT-PCR), and immunohistochemistry (IHC). EML4-ALK was detected in three of 66 patient samples (4.5%) with RT-PCR. When the RTPCR data were used as the standard, one false positive and one false negative samples were identified with IHC; and one false negative sample was identified with FISH. These results suggest that a block of pleural effusion cells can be used to detect the EML4-ALK fusion gene. IHC had good sensitivity, but low specificity. FISH had low sensitivity, but high specificity. RT-PCR is a good candidate method for detecting EML4-ALK in blocks of pleural effusion cells from lung cancer patients.	[Liu, Leilei; Zhou, Xiaodie; Zhou, Xiaojun; Wang, Jiandong] Nanjing Univ, Sch Med, Dept Pathol, Jinling Hosp, Nanjing 210008, Jiangsu, Peoples R China; [Zhan, Ping; Yu, Like] Nanjing Thorac Hosp, Dept Med, Nanjing, Jiangsu, Peoples R China; [Song, Yong] Nanjing Univ, Sch Med, Dept Resp Med, Jinling Hosp, Nanjing 210008, Jiangsu, Peoples R China	Nanjing University; Nanjing University	Wang, JD (corresponding author), Nanjing Univ, Sch Med, Dept Pathol, Jinling Hosp, Nanjing 210008, Jiangsu, Peoples R China.	yulike66@163.com			National Natural Science Foundation of China [81371611, 81171391, 81372743]; National Basic Research Priorities Program 973 Project of the Ministry of Science and Technology of China [2014CB744504]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Priorities Program 973 Project of the Ministry of Science and Technology of China	This work was supported, in part, by the National Natural Science Foundation of China (81371611, 81171391, 81372743) and the National Basic Research Priorities Program 973 Project (2014CB744504) of the Ministry of Science and Technology of China. The work was financially supported by listed funders, which including buying FISH kits and RT-PCR kits.	Aoki T, 2014, ONCOL LETT, V7, P1771, DOI 10.3892/ol.2014.1973; Bi L, 2013, BIOMED REP, V1, P213, DOI 10.3892/br.2012.33; Cabillic F, 2014, J THORAC ONCOL, V9, P295, DOI 10.1097/JTO.0000000000000072; Choi YL, 2008, CANCER RES, V68, P4971, DOI 10.1158/0008-5472.CAN-07-6158; Franco R, 2013, EXPERT REV ANTICANC, V13, P407, DOI [10.1586/era.13.18, 10.1586/ERA.13.18]; Govindan R, 2011, LANCET ONCOL, V12, P983, DOI 10.1016/S1470-2045(11)70253-4; Horn L, 2009, J CLIN ONCOL, V27, P4232, DOI 10.1200/JCO.2009.23.6661; Inamura K, 2008, J THORAC ONCOL, V3, P13, DOI 10.1097/JTO.0b013e31815e8b60; Kim C, 2014, INT J CANC; Koivunen JP, 2008, CLIN CANCER RES, V14, P4275, DOI 10.1158/1078-0432.CCR-08-0168; Le Quesne J, 2014, J THORAC ONCOL, V9, P769, DOI 10.1097/JTO.0000000000000157; Li YL, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003074; Liu CY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090163; Liu XQ, 2013, J CLIN PATHOL, V66, P1065, DOI 10.1136/jclinpath-2013-201728; Long J, 2014, CANCER LETT, V346, P273, DOI 10.1016/j.canlet.2014.01.004; Masago K, 2011, CLIN LUNG CANCER, V12, P307, DOI 10.1016/j.cllc.2011.06.004; Mazza F, 2014, SURG TODAY; Miyoshi S, 2014, INT J CLIN ONCOL; Mok T, 2014, J THORAC ONCOL, V9, P848, DOI 10.1097/JTO.0000000000000160; Molina JR, 2014, LUNG CANCER, V85, P245, DOI 10.1016/j.lungcan.2014.03.004; Morgensztern D, 2012, J THORAC ONCOL, V7, P1485, DOI 10.1097/JTO.0b013e318267223a; Onn A, 2014, LANCET ONCOL, V15, P124, DOI 10.1016/S1470-2045(14)70010-5; Perkins SL, 2005, BRIT J HAEMATOL, V131, P624, DOI 10.1111/j.1365-2141.2005.05808.x; Ren SX, 2014, J THORAC ONCOL, V9, pE21, DOI 10.1097/JTO.0000000000000013; Savic S, 2013, J THORAC ONCOL, V8, P1004, DOI 10.1097/JTO.0b013e3182936ca9; Shaw AT, 2009, J CLIN ONCOL, V27, P4247, DOI 10.1200/JCO.2009.22.6993; Shinmura K, 2010, EXP THER MED, V1, P271, DOI 10.3892/etm_00000042; Shital P, 2014, J CANCER RES CLIN, V140, P809, DOI 10.1007/s00432-014-1602-x; Siegel R, 2014, CA-CANCER J CLIN, V64, P9, DOI 10.3322/caac.21208; Soda M, 2007, NATURE, V448, P561, DOI 10.1038/nature05945; Soda M, 2012, CLIN CANCER RES, V18, P5682, DOI 10.1158/1078-0432.CCR-11-2947; Strimpakos A, 2014, LUNG CANCER, V85, P186, DOI 10.1016/j.lungcan.2014.04.015; Tuononen K, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/757490; Wang JH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101551; Wu YC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070839; Zhang XZ, 2008, LUNG CANCER, V60, P175, DOI 10.1016/j.lungcan.2007.10.011; Zhang YG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064821	37	31	32	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2015	10	3							e0117032	10.1371/journal.pone.0117032	http://dx.doi.org/10.1371/journal.pone.0117032			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9BN	25785456	Green Published, gold, Green Submitted			2022-12-27	WOS:000352138500016
J	Reguzova, A; Antonets, D; Karpenko, L; Ilyichev, A; Maksyutov, R; Bazhan, S				Reguzova, Alena; Antonets, Denis; Karpenko, Larisa; Ilyichev, Alexander; Maksyutov, Rinat; Bazhan, Sergei			Design and Evaluation of Optimized Artificial HIV-1 Poly-T Cell-Epitope Immunogens	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; HLA CLASS-I; DNA VACCINES; ANTIVIRAL PROTECTION; MEMBRANE-PROTEIN; CYTOPLASMIC TAIL; FLANKING REGION; DENDRITIC CELLS; LIMP-II; ANTIGEN	A successful HIV vaccine in addition to induction of antibody responses should elicit effective T cell responses. Here we described possible strategies for rational design of T-cell vaccine capable to induce high levels of both CD4+ and CD8+ T-cell responses. We developed artificial HIV-1 polyepitope T-cell immunogens based on the conserved natural CD8+ and CD4+ T cell epitopes from different HIV-1 strains and restricted by the most frequent major human leukocyte antigen (HLA) alleles. Designed immunogens contain optimized core polyepitope sequence and additional "signal" sequences which increase epitope processing and presentation to CD8+ and CD4+ T-lymphocytes: N-terminal ubiquitin, N-terminal signal peptide and C-terminal tyrosine motif of LAMP-1 protein. As a result we engineered three T cell immunogens - TCI-N, TCI-N2, and TCI-N3, with different combinations of signal sequences. All designed immunogens were able to elicit HIV-specific CD4+ and CD8+ T cell responses following immunization. Attachment of either ubiquitin or ER-signal/LAMP-1 sequences increased both CD4+ and CD8+ mediated HIV-specific T cell responses in comparison with polyepitope immunogen without any additional signal sequences. Moreover, TCI-N3 polyepitope immunogen with ubiquitin generated highest magnitude of HIV-specific CD4+ and CD8+ T cell responses in our study. Obtained data suggests that attachment of signal sequences targeting polyepitope immunogens to either MHC class I or MHC class II presentation pathways may improve immunogenicity of T-cell vaccines. These results support the strategy of the rational T cell immunogen design and contribute to the development of effective HIV-1 vaccine.	[Reguzova, Alena; Antonets, Denis; Karpenko, Larisa; Ilyichev, Alexander; Maksyutov, Rinat; Bazhan, Sergei] State Res Ctr Virol & Biotechnol Vector, Koltsov 630559, Novosibirsk Reg, Russia	State Research Center of Virology & Biotechnology VECTOR	Bazhan, S (corresponding author), State Res Ctr Virol & Biotechnol Vector, Koltsov 630559, Novosibirsk Reg, Russia.	bazhan@vector.nsc.ru	Karpenko, Larisa Ivanovna/A-9682-2014; Antonets, Denis V/N-2549-2013; Antonets, Denis/AAF-5359-2019; Ilyichev, Alexander/AAT-9390-2020; Ilyicheva, Tatyana N./B-1327-2012; Bazhan, Sergei I/A-5774-2014	Antonets, Denis V/0000-0002-1823-9701; Antonets, Denis/0000-0002-1823-9701; Ilyichev, Alexander/0000-0001-5356-0843; Ilyicheva, Tatyana N./0000-0002-2354-7688; Bazhan, Sergei I/0000-0002-6016-4002; Karpenko, Larisa/0000-0003-4365-8809	Russian Foundation for Basic Research [12-04-00857-a]; Russian Science Foundation [14-14-00660]	Russian Foundation for Basic Research(Russian Foundation for Basic Research (RFBR)); Russian Science Foundation(Russian Science Foundation (RSF))	The part of work concerning immunogens design and DNA vaccine construction was supported by grant 12-04-00857-a from Russian Foundation for Basic Research (www.rfbr.ru). The study of the HIV-specific immune response and data analysis were supported by Russian Science Foundation grant 14-14-00660 (www.rscf.ru).	Akinsiku OT, 2011, JAIDS-J ACQ IMM DEF, V58, P132, DOI 10.1097/QAI.0b013e318224d2e9; ALEXANDER J, 1994, IMMUNITY, V1, P751, DOI 10.1016/S1074-7613(94)80017-0; Andersson HA, 2004, MOL THER, V10, P432, DOI 10.1016/j.ymthe.2004.05.035; [Anonymous], 2014, R LANG ENV STAT COMP; Anton LC, 1997, J IMMUNOL, V158, P2535; Antonets DV, 2010, MOL BIOL+, V44, P119, DOI 10.1134/S0026893310010152; Antonets Denis V, 2013, BMC Res Notes, V6, P407, DOI 10.1186/1756-0500-6-407; Barouch DH, 2012, NATURE, V482, P89, DOI 10.1038/nature10766; Bauer R, 2006, J ALLERGY CLIN IMMUN, V118, P269, DOI 10.1016/j.jaci.2006.03.033; Bazhan SI, 2010, MOL IMMUNOL, V47, P1507, DOI 10.1016/j.molimm.2010.01.020; Bazhan SI, 2004, VACCINE, V22, P1672, DOI 10.1016/j.vaccine.2003.09.048; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Berzofsky JA, 2001, NAT REV IMMUNOL, V1, P209, DOI 10.1038/35105075; Bonehill A, 2004, J IMMUNOL, V172, P6649, DOI 10.4049/jimmunol.172.11.6649; Bonini C, 2001, J IMMUNOL, V166, P5250, DOI 10.4049/jimmunol.166.8.5250; Borthwick N, 2014, MOL THER, V22, P464, DOI 10.1038/mt.2013.248; Cardinaud S, 2009, AIDS, V23, P1945, DOI 10.1097/QAD.0b013e32832fae88; Chen WS, 2000, IMMUNITY, V12, P83, DOI 10.1016/S1074-7613(00)80161-2; De Arruda LB, 2004, IMMUNOLOGY, V112, P126, DOI 10.1111/j.1365-2567.2004.01823.x; Delogu G, 2000, INFECT IMMUN, V68, P3097, DOI 10.1128/IAI.68.6.3097-3102.2000; Dennes A, 2002, J BIOL CHEM, V277, P12288, DOI 10.1074/jbc.M112295200; Esparza J, 2012, EXPERT REV VACCINES, V11, P539, DOI [10.1586/ERV.12.21, 10.1586/erv.12.21]; GOLDBERG AL, 1992, NATURE, V357, P375, DOI 10.1038/357375a0; GRANT EP, 1995, J IMMUNOL, V155, P3750; Hanke T, 2014, EXPERT OPIN BIOL TH, V14, P601, DOI 10.1517/14712598.2014.885946; Hanke T, 2011, EUR J IMMUNOL, V41, P3390, DOI 10.1002/eji.201190072; Haucke V, 2003, DEV CELL, V4, P153, DOI 10.1016/S1534-5807(03)00026-1; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; Ishioka GY, 1999, J IMMUNOL, V162, P3915; Ji HX, 1999, HUM GENE THER, V10, P2727, DOI 10.1089/10430349950016474; Karpenko LI, 2007, VACCINE, V25, P4312, DOI 10.1016/j.vaccine.2007.02.058; Karpenko LI, 2014, EXPERT REV VACCINES, V13, P155, DOI 10.1586/14760584.2014.861748; Korber BT, 2009, J VIROL, V83, P8300, DOI 10.1128/JVI.00114-09; Koup RA, 2011, COLD SPRING HARBOR P, V1, DOI [10.1101/cshperspect.a009316, DOI 10.1101/CSHPERSPECT.A009316]; LALVANI A, 1994, RES IMMUNOL, V145, P461, DOI 10.1016/S0923-2494(94)80177-0; Leitner WW, 2003, J CLIN INVEST, V112, P22, DOI 10.1172/JCI200319069; Li FS, 2007, CURR HIV RES, V5, P97, DOI 10.2174/157016207779316260; Livingston BD, 2001, VACCINE, V19, P4652, DOI 10.1016/S0264-410X(01)00233-X; Mudd PA, 2012, NATURE, V491, P129, DOI 10.1038/nature11443; OGATA S, 1994, J BIOL CHEM, V269, P5210; Peters B, 2005, PLOS BIOL, V3, P379, DOI 10.1371/journal.pbio.0030091; Peters B, 2003, BIOINFORMATICS, V19, P1765, DOI 10.1093/bioinformatics/btg247; Porgador A, 1997, IMMUNITY, V6, P715, DOI 10.1016/S1074-7613(00)80447-1; RAMMENSEE HG, 1993, CURR OPIN IMMUNOL, V5, P35, DOI 10.1016/0952-7915(93)90078-7; Reuter MA, 2012, CYTOKINE GROWTH F R, V23, P181, DOI 10.1016/j.cytogfr.2012.05.005; Rodriguez F, 1998, J VIROL, V72, P5174, DOI 10.1128/JVI.72.6.5174-5181.1998; Rodriguez F, 1997, J VIROL, V71, P8497, DOI 10.1128/JVI.71.11.8497-8503.1997; Rodriguez F, 2001, J VIROL, V75, P10421, DOI 10.1128/JVI.75.21.10421-10430.2001; SANDOVAL IV, 1994, J BIOL CHEM, V269, P6622; Schmid D, 2007, IMMUNITY, V26, P79, DOI 10.1016/j.immuni.2006.10.018; Schneider SC, 2000, J IMMUNOL, V165, P20, DOI 10.4049/jimmunol.165.1.20; Sette A, 1998, CURR OPIN IMMUNOL, V10, P478, DOI 10.1016/S0952-7915(98)80124-6; Sidney J, 1996, IMMUNOL TODAY, V17, P261, DOI 10.1016/0167-5699(96)80542-1; Song J, 2006, PLANT CELL, V18, P2258, DOI 10.1105/tpc.105.039123; Thalhamer J, 2012, GENE VACCINES, P1, DOI 10.1007/978-3-7091-0439-2; Tobery TW, 1997, J EXP MED, V185, P909, DOI 10.1084/jem.185.5.909; Toes REM, 2001, J EXP MED, V194, P1, DOI 10.1084/jem.194.1.1; Uebel S, 1999, CURR OPIN IMMUNOL, V11, P203, DOI 10.1016/S0952-7915(99)80034-X; Varshavsky A, 2000, METHOD ENZYMOL, V327, P578, DOI 10.1016/S0076-6879(00)27303-5; Voges D, 1999, ANNU REV BIOCHEM, V68, P1015, DOI 10.1146/annurev.biochem.68.1.1015; Weinberger EE, 2013, VACCINE, V31, P6113, DOI 10.1016/j.vaccine.2013.08.005; Wilson CC, 2001, J VIROL, V75, P4195, DOI 10.1128/JVI.75.9.4195-4207.2001; WU TC, 1995, P NATL ACAD SCI USA, V92, P11671, DOI 10.1073/pnas.92.25.11671; York IA, 1996, ANNU REV IMMUNOL, V14, P369, DOI 10.1146/annurev.immunol.14.1.369; Zhu H, 2005, J IMMUNOL, V175, P2252, DOI 10.4049/jimmunol.175.4.2252	65	14	16	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2015	10	3							e0116412	10.1371/journal.pone.0116412	http://dx.doi.org/10.1371/journal.pone.0116412			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9BN	25786238	Green Published, gold, Green Submitted			2022-12-27	WOS:000352138500007
J	Zeng, Y; Liu, Y; Shang, J; Ma, JW; Wang, R; Deng, L; Guo, YM; Zhong, F; Bai, MF; Zhang, SJ; Wu, DC				Zeng, Yun; Liu, Yang; Shang, Jin; Ma, Jingwen; Wang, Rong; Deng, Lei; Guo, Youmin; Zhong, Fan; Bai, Mingfeng; Zhang, Shaojuan; Wu, Daocheng			Phosphorescence Monitoring of Hypoxic Microenvironment in Solid-Tumors to Evaluate Chemotherapeutic Effects Using the Hypoxia-Sensitive Iridium (III) Coordination Compound	PLOS ONE			English	Article							ANTI-VEGF TREATMENT; LUNG-CANCER; IN-VITRO; CISPLATIN; RESISTANCE; GROWTH; CELLS; NORMALIZATION; ANGIOGENESIS; PET/CT	Objectives To utilize phosphorescence to monitor hypoxic microenvironment in solid-tumors and investigate cancer chemotherapeutic effects in vivo. Methods A hypoxia-sensitive probe named BTP was used to monitor hypoxic microenvironment in solid-tumors. The low-dose metronomic treatment with cisplatin was used in anti-angiogenetic chemotherapeutic programs. The phosphorescence properties of BTP were detected by a spectrofluorometer. BTP cytotoxicity utilized cell necrosis and apoptosis, which were evaluated by trypan blue dye exclusion and Hoechst33342 plus propidium iodide assays. Tumor-bearing mouse models of colon adenocarcinoma were used for tumor imaging in vivo. Monitoring of the hypoxic microenvironment in tumors was performed with a Maestro 2 fluorescence imaging system. Tumor tissues in each group were harvested regularly and treated with pathological hematoxylin and eosin and immunohistochemical staining to confirm imaging results. Results BTP did not feature obvious cytotoxicity for cells, and tumor growth in low-dose metronomic cisplatin treated mice was significantly inhibited by chemotherapy. Hypoxic levels significantly increased due to cisplatin, as proven by the expression level of related proteins. Phosphorescence intensity in the tumors of mice in the cisplatin group was stronger and showed higher contrast than that in tumors of saline treated mice. Conclusions We develop a useful phosphorescence method to evaluate the chemotherapeutic effects of cisplatin. The proposed method shows potential as a phosphorescence imaging approach for evaluating chemotherapeutic effects in vivo, especially anti-angiogenesis.	[Zeng, Yun; Ma, Jingwen; Wu, Daocheng] Xi An Jiao Tong Univ, Sch Life Sci & Technol, Minist Educ, Key Lab Biomed Informat Engn, Xian 710049, Peoples R China; [Liu, Yang; Zhong, Fan] Fudan Univ, Sch Life Sci, Shanghai 200433, Peoples R China; [Liu, Yang; Zhong, Fan] Fudan Univ, Inst Biomed Sci, Shanghai 200433, Peoples R China; [Shang, Jin; Wang, Rong; Deng, Lei; Guo, Youmin; Zhang, Shaojuan] Xi An Jiao Tong Univ, Dept Radiol, Affiliated Hosp 1, Xian 710049, Peoples R China; [Bai, Mingfeng; Zhang, Shaojuan] Univ Pittsburgh, Sch Med, Dept Radiol, Mol Imaging Lab, Pittsburgh, PA USA	Xi'an Jiaotong University; Fudan University; Fudan University; Xi'an Jiaotong University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Zhang, SJ (corresponding author), Xi An Jiao Tong Univ, Dept Radiol, Affiliated Hosp 1, Xian 710049, Peoples R China.	zhangs2@upmc.edu; wudaocheng@mail.xjtu.edu.cn	ZENG, YUN/A-9785-2018; Wu, Daocheng/H-5661-2017	ZENG, YUN/0000-0002-5747-3349; Liu, Yang/0000-0003-3849-9049; Wu, Daocheng/0000-0002-6183-539X				Adamski J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065304; Bocci G, 2002, CANCER RES, V62, P6938; Brown JM, 2004, NAT REV CANCER, V4, P437, DOI 10.1038/nrc1367; Carlin S, 2012, J NUCL MED, V53, P1171, DOI 10.2967/jnumed.111.099770; Denko NC, 2008, NAT REV CANCER, V8, P705, DOI 10.1038/nrc2468; Dmitriev RI, 2012, CELL MOL LIFE SCI, V69, P2025, DOI 10.1007/s00018-011-0914-0; Ellis LM, 2008, CLIN CANCER RES, V14, P6371, DOI 10.1158/1078-0432.CCR-07-5287; Grothey A, 2009, NAT REV CLIN ONCOL, V6, P507, DOI 10.1038/nrclinonc.2009.110; Guba M, 2002, NAT MED, V8, P128, DOI 10.1038/nm0202-128; Harris AL, 2002, NAT REV CANCER, V2, P38, DOI 10.1038/nrc704; Hoigebazar Lathika, 2013, Recent Results Cancer Res, V194, P285, DOI 10.1007/978-3-642-27994-2_15; Jain RK, 2005, SCIENCE, V307, P58, DOI 10.1126/science.1104819; Kerbel RS, 2004, NAT REV CANCER, V4, P423, DOI 10.1038/nrc1369; Keunen O, 2011, P NATL ACAD SCI USA, V108, P3749, DOI 10.1073/pnas.1014480108; Kizaka-Kondoh S, 2009, J TOXICOL PATHOL, V22, P93, DOI 10.1293/tox.22.93; Kizaka-Kondoh S, 2009, ADV DRUG DELIVER REV, V61, P623, DOI 10.1016/j.addr.2009.01.006; Lakowicz J. R., 2007, PRINCIPLES FLUORESCE, P54; Lamansky S, 2001, J AM CHEM SOC, V123, P4304, DOI 10.1021/ja003693s; Lemaire-Ewing S, 2005, CELL BIOL TOXICOL, V21, P97, DOI 10.1007/s10565-005-0141-2; Li N, 2012, J CANCER RES CLIN, V138, P1131, DOI 10.1007/s00432-012-1189-z; Lyons MA, 1999, INT J BIOCHEM CELL B, V31, P369, DOI 10.1016/S1357-2725(98)00123-X; Minagawa Y, 2011, ANN NUCL MED, V25, P339, DOI 10.1007/s12149-011-0471-5; Mortensen LS, 2012, RADIOTHER ONCOL, V105, P14, DOI 10.1016/j.radonc.2012.09.015; Pittman RN, 2011, ACTA PHYSIOL, V202, P311, DOI 10.1111/j.1748-1716.2010.02232.x; Pore N, 2006, CANCER RES, V66, P3197, DOI 10.1158/0008-5472.CAN-05-3090; Ren Y, 2012, INVEST RADIOL, V47, P25, DOI 10.1097/RLI.0b013e31823a82f6; Segard T, 2013, CLIN NUCL MED, V38, P1, DOI 10.1097/RLU.0b013e3182708777; Semenza GL, 2002, TRENDS MOL MED, V8, pS62, DOI 10.1016/S1471-4914(02)02317-1; Semenza GL, 2003, NAT REV CANCER, V3, P721, DOI 10.1038/nrc1187; Shen FZ, 2010, INT J EXP PATHOL, V91, P10, DOI 10.1111/j.1365-2613.2009.00684.x; Song XR, 2006, CANCER CHEMOTH PHARM, V58, P776, DOI 10.1007/s00280-006-0224-7; Sun XL, 2011, MOL IMAGING BIOL, V13, P399, DOI 10.1007/s11307-010-0420-z; Tonini Giuseppe, 2007, Future Oncol, V3, P183, DOI 10.2217/14796694.3.2.183; VAUPEL P, 1991, CANCER RES, V51, P3316; Vaupel P, 2007, CANCER METAST REV, V26, P225, DOI 10.1007/s10555-007-9055-1; Viola RJ, 2008, AM J ROENTGENOL, V191, P1779, DOI 10.2214/AJR.07.4060; Wilson WR, 2011, NAT REV CANCER, V11, P393, DOI 10.1038/nrc3064; Wohlkoenig C, 2011, CANCER LETT, V308, P134, DOI 10.1016/j.canlet.2011.03.014; Yoshihara T, 2015, J PHOTOCH PHOTOBIO A, V299, P172, DOI 10.1016/j.jphotochem.2014.11.004; Zeng Y, 2013, NANOSCALE, V5, P12633, DOI 10.1039/c3nr04349e; Zhang SJ, 2010, CANCER RES, V70, P4490, DOI 10.1158/0008-5472.CAN-09-3948; Zhou J, 2006, CANCER LETT, V237, P10, DOI 10.1016/j.canlet.2005.05.028	42	13	13	1	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2015	10	3							e0121293	10.1371/journal.pone.0121293	http://dx.doi.org/10.1371/journal.pone.0121293			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9BN	25786221	Green Published, gold, Green Submitted, Green Accepted			2022-12-27	WOS:000352138500208
J	Julian, E; Baelo, A; Gavalda, J; Torrents, E				Julian, Esther; Baelo, Aida; Gavalda, Joan; Torrents, Eduard			Methyl-Hydroxylamine as an Efficacious Antibacterial Agent That Targets the Ribonucleotide Reductase Enzyme	PLOS ONE			English	Article							GRAM-NEGATIVE BACTERIA; BACILLUS-ANTHRACIS; IN-VITRO; MYCOBACTERIUM-TUBERCULOSIS; PSEUDOMONAS-AERUGINOSA; RADICAL SCAVENGERS; MURINE MACROPHAGES; ELECTRON-TRANSFER; ESCHERICHIA-COLI; GENE-EXPRESSION	The emergence of multidrug-resistant bacteria has encouraged vigorous efforts to develop antimicrobial agents with new mechanisms of action. Ribonucleotide reductase (RNR) is a key enzyme in DNA replication that acts by converting ribonucleotides into the corresponding deoxyribonucleotides, which are the building blocks of DNA replication and repair. RNR has been extensively studied as an ideal target for DNA inhibition, and several drugs that are already available on the market are used for anticancer and antiviral activity. However, the high toxicity of these current drugs to eukaryotic cells does not permit their use as antibacterial agents. Here, we present a radical scavenger compound that inhibited bacterial RNR, and the compound's activity as an antibacterial agent together with its toxicity in eukaryotic cells were evaluated. First, the efficacy of N-methyl-hydroxylamine (M-HA) in inhibiting the growth of different Gram-positive and Gram-negative bacteria was demonstrated, and no effect on eukaryotic cells was observed. M-HA showed remarkable efficacy against Mycobacterium bovis BCG and Pseudomonas aeruginosa. Thus, given the M-HA activity against these two bacteria, our results showed that M-HA has intracellular antimycobacterial activity against BCG-infected macrophages, and it is efficacious in partially disassembling and inhibiting the further formation of P. aeruginosa biofilms. Furthermore, M-HA and ciprofloxacin showed a synergistic effect that caused a massive reduction in a P. aeruginosa biofilm. Overall, our results suggest the vast potential of M-HA as an antibacterial agent, which acts by specifically targeting a bacterial RNR enzyme.	[Julian, Esther] Univ Autonoma Barcelona, Fac Biociencies, Dept Genet & Microbiol, Bellaterra, Spain; [Baelo, Aida; Torrents, Eduard] Inst Bioengn Catalonia IBEC, Bacterial Infect & Antimicrobial Therapies, Barcelona, Spain; [Gavalda, Joan] Hosp Univ Vall dHebron, Vall dHebron Res Inst, Infect Dis Res Lab, Dept Infect Dis, Barcelona, Spain	Autonomous University of Barcelona; Barcelona Institute of Science & Technology; Institut de Bioenginyeria de Catalunya; University of Barcelona; Autonomous University of Barcelona; Hospital Universitari Vall d'Hebron; Vall d'Hebron Institut de Recerca (VHIR)	Torrents, E (corresponding author), Inst Bioengn Catalonia IBEC, Bacterial Infect & Antimicrobial Therapies, Baldiri Reixac 15-21, Barcelona, Spain.	etorrents@ibecbarcelona.eu	Julián, Esther/E-9216-2013; Torrents, Eduard/C-7184-2008	Julián, Esther/0000-0002-6558-3978; Torrents, Eduard/0000-0002-3010-1609; Gavalda, Joan/0000-0002-9829-3141	Ministerio de Economia y Competitividad [BFU2011-24066]; Generalitat de Catalunya [2009SGR66, 2014SGR1442, 2009SGR-108]; Instituto de Ivestigacion Carlos III [IIIPI10/01438]	Ministerio de Economia y Competitividad(Spanish Government); Generalitat de Catalunya(Generalitat de Catalunya); Instituto de Ivestigacion Carlos III	Funding provided by BFU2011-24066. Ministerio de Economia y Competitividad. Principal investigator: Dr. Eduard Torrents. 2009SGR66 and 2014SGR1442 from the Generalitat de Catalunya to Eduard Torrents. 2009SGR-108 from the Generalitat de Catalunya to Dr. Esther Julian. IIIPI10/01438 from the Instituto de Ivestigacion Carlos III. Principal Investigator Dr. Esther Julian. ERA-Net pathogenomics from the Ministerio de Economia y Competitividad. Principal investigator: Dr. Eduard Torrents. Catalan and Spanish cystic foundation federations. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altaf M, 2010, TUBERCULOSIS, V90, P333, DOI 10.1016/j.tube.2010.09.002; Anes E, 2006, CELL MICROBIOL, V8, P939, DOI 10.1111/j.1462-5822.2005.00675.x; Arko-Mensah J, 2007, SCAND J IMMUNOL, V65, P148, DOI 10.1111/j.1365-3083.2006.01888.x; Atamna H, 2000, J BIOL CHEM, V275, P6741, DOI 10.1074/jbc.275.10.6741; Aye Y, 2014, ONCOGENE IN PRESS; Basu A, 2012, CURR TOP MED CHEM, V12, P2827; Bhatnagar S, 2007, BLOOD, V110, P3234, DOI 10.1182/blood-2007-03-079152; Cerqueira NMFSA, 2007, RECENT PAT ANTI-CANC, V2, P11; Chan MMY, 2002, BIOCHEM PHARMACOL, V63, P99, DOI 10.1016/S0006-2952(01)00886-3; Cotruvo JA, 2011, ANNU REV BIOCHEM, V80, P733, DOI 10.1146/annurev-biochem-061408-095817; Crona M, 2011, J BIOL CHEM, V286, P33053, DOI 10.1074/jbc.M111.278119; Cui W, 2003, J ENDOTOXIN RES, V9, P225, DOI 10.1179/096805103225001422; Davies BW, 2009, MOL CELL, V36, P845, DOI 10.1016/j.molcel.2009.11.024; Dochertyl JJ, 2007, J ANTIMICROB CHEMOTH, V59, P1182, DOI 10.1093/jac/dkm099; Dorhoi A, 2014, SEMIN IMMUNOL, V26, P203, DOI 10.1016/j.smim.2014.04.003; Ekberg M, 1996, J BIOL CHEM, V271, P20655, DOI 10.1074/jbc.271.34.20655; GEREZ C, 1992, BIOCHEMISTRY-US, V31, P780, DOI 10.1021/bi00118a020; Hammerstad M, 2014, J BIOL INORG CHEM, V19, P893, DOI 10.1007/s00775-014-1121-x; Hassett DJ, 2010, EXPERT OPIN THER TAR, V14, P117, DOI 10.1517/14728220903454988; Heydorn A, 2000, MICROBIOL-SGM, V146, P2395, DOI 10.1099/00221287-146-10-2395; Hofer A, 2012, CRIT REV BIOCHEM MOL, V47, P50, DOI 10.3109/10409238.2011.630372; Jordao L, 2008, CELL MICROBIOL, V10, P529, DOI 10.1111/j.1462-5822.2007.01067.x; Lanaro C, 2009, J LEUKOCYTE BIOL, V85, P235, DOI 10.1189/jlb.0708445; LASSMANN G, 1992, BIOCHEM BIOPH RES CO, V188, P879, DOI 10.1016/0006-291X(92)91138-G; Lundin D, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-383; Lundin D, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-589; Luo JH, 2011, ARCH BIOCHEM BIOPHYS, V516, P29, DOI 10.1016/j.abb.2011.09.003; May M, 2014, NATURE, V509, pS4, DOI 10.1038/509S4a; Mendez S, 2009, ANTIMICROB AGENTS CH, V53, P5114, DOI 10.1128/AAC.01146-09; Moorthy NSHN, 2013, MINI-REV MED CHEM, V13, P1862, DOI 10.2174/13895575113136660090; Navarra P, 1997, J PHARMACOL EXP THER, V280, P477; Navarra P, 2006, J NEUROIMMUNOL, V179, P94, DOI 10.1016/j.jneuroim.2006.06.007; Nordlund N, 2006, ANNU REV BIOCHEM, V75, P681, DOI 10.1146/annurev.biochem.75.103004.142443; Overhage J, 2008, INFECT IMMUN, V76, P4176, DOI 10.1128/IAI.00318-08; Payne DJ, 2008, SCIENCE, V321, P1644, DOI 10.1126/science.1164586; Peteroy-Kelly M, 2001, INFECT IMMUN, V69, P5823, DOI 10.1128/IAI.69.9.5823-5831.2001; Saban N, 2009, CANCER CHEMOTH PHARM, V64, P213, DOI 10.1007/s00280-009-0991-z; Secanella-Fandos S, 2013, J UROLOGY, V189, P711, DOI 10.1016/j.juro.2012.09.049; Shao J, 2006, CURR CANCER DRUG TAR, V6, P409, DOI 10.2174/156800906777723949; Smith AW, 2005, ADV DRUG DELIVER REV, V57, P1539, DOI 10.1016/j.addr.2005.04.007; Spellberg B, 2008, CLIN INFECT DIS, V46, P155, DOI 10.1086/524891; Stanley SA, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1003946; Stepanovic S, 2007, APMIS, V115, P891, DOI 10.1111/j.1600-0463.2007.apm_630.x; Stubbe J, 2003, CHEM REV, V103, P2167, DOI 10.1021/cr020421u; Tamma PD, 2012, CLIN MICROBIOL REV, V25, P450, DOI 10.1128/CMR.05041-11; Tolker-Nielsen T, 2011, CURR PROTOC MICROBIO, DOI [10.1002/9780471729259.mc01b02s21, DOI 10.1002/9780471729259.MC01B02S21]; Torrents E, 2005, P NATL ACAD SCI USA, V102, P17946, DOI 10.1073/pnas.0506410102; Torrents E, 2008, RIBONUCLEOTIDE REDUC, P17; Torrents E, 2006, J BIOL CHEM, V281, P25287, DOI 10.1074/jbc.M601794200; Torrents E, 2014, FRONT CELL INFECT MI, V4, DOI 10.3389/fcimb.2014.00052; Torrents E, 2010, BIOL CHEM, V391, P229, DOI [10.1515/BC.2010.017, 10.1515/bc.2010.017]; Trifilieff A, 2000, J IMMUNOL, V165, P1526, DOI 10.4049/jimmunol.165.3.1526; Wang J, 1999, J CLIN INVEST, V103, P1023, DOI 10.1172/JCI6224; Weinberg A, 2001, CLIN DIAGN LAB IMMUN, V8, P702, DOI 10.1128/CDLI.8.4.702-705.2001	54	8	8	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2015	10	3							e0122049	10.1371/journal.pone.0122049	http://dx.doi.org/10.1371/journal.pone.0122049			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7QC	25782003	Green Published, Green Submitted, gold			2022-12-27	WOS:000351284600215
J	Bae, SH; Han, HW; Moon, J				Bae, Sang-Hun; Han, Hyun Wook; Moon, Jisook			Functional Analysis of the Molecular Interactions of TATA Box-Containing Genes and Essential Genes	PLOS ONE			English	Article							ENVIRONMENTAL-CHANGES; INTERACTION NETWORKS; METABOLISM; STRESS; GENOME; IDENTIFICATION; EXPRESSION; PROMOTERS; PATHWAY	Genes can be divided into TATA-containing genes and TATA-less genes according to the presence of TATA box elements at promoter regions. TATA-containing genes tend to be stress-responsive, whereas many TATA-less genes are known to be related to cell growth or "housekeeping" functions. In a previous study, we demonstrated that there are striking differences among four gene sets defined by the presence of TATA box (TATA-containing) and essentiality (TATA-less) with respect to number of associated transcription factors, amino acid usage, and functional annotation. Extending this research in yeast, we identified KEGG (Kyoto Encyclopedia of Genes and Genomes) pathways that are statistically enriched in TATA-containing or TATA-less genes and evaluated the possibility that the enriched pathways are related to stress or growth as reflected by the individual functions of the genes involved. According to their enrichment for either of these two gene sets, we sorted KEGG pathways into TATA-containing-gene-enriched pathways (TEPs) and essential- gene-enriched pathways (EEPs). As expected, genes in TEPs and EEPs exhibited opposite results in terms of functional category, transcriptional regulation, codon adaptation index, and network properties, suggesting the possibility that the bipolar patterns in these pathways also contribute to the regulation of the stress response and to cell survival. Our findings provide the novel insight that significant enrichment of TATA-binding or TATA-less genes defines pathways as stress-responsive or growth-related.	[Bae, Sang-Hun; Han, Hyun Wook; Moon, Jisook] CHA Univ, Dept Bioengn, Coll Life Sci, Seoul, South Korea; [Bae, Sang-Hun; Han, Hyun Wook; Moon, Jisook] Gangnam CHA Gen Hosp, Gen Res Inst, Seoul, South Korea	Pochon Cha University	Moon, J (corresponding author), CHA Univ, Dept Bioengn, Coll Life Sci, Seoul, South Korea.	jmoon@cha.ac.kr			Ministry of health and welfare [A120300]; Korea Science and Engineering Foundation [2011-0013280]	Ministry of health and welfare(Ministry of Health, Labour and Welfare, Japan); Korea Science and Engineering Foundation(Korea Science and Engineering Foundation)	This work was supported by Ministry of health and welfare, A120300, http://english.mw.go.kr/front_eng/index.jsp (JM), and Korea Science and Engineering Foundation, 2011-0013280, www.nrf.re.kr (JM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acar M, 2008, NAT GENET, V40, P471, DOI 10.1038/ng.110; Bader GD, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-2; Basehoar AD, 2004, CELL, V116, P699, DOI 10.1016/S0092-8674(04)00205-3; Choi JK, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003002; Ermolaeva M D, 2001, Curr Issues Mol Biol, V3, P91; Gasch AP, 2000, MOL BIOL CELL, V11, P4241, DOI 10.1091/mbc.11.12.4241; Han HW, 2013, FEBS LETT, V587, P444, DOI 10.1016/j.febslet.2012.12.030; Helenius A, 2004, ANNU REV BIOCHEM, V73, P1019, DOI 10.1146/annurev.biochem.73.011303.073752; Huisinga KL, 2004, MOL CELL, V13, P573, DOI 10.1016/S1097-2765(04)00087-5; Jeong H, 2001, NATURE, V411, P41, DOI 10.1038/35075138; Kanehisa M, 2004, NUCLEIC ACIDS RES, V32, pD277, DOI 10.1093/nar/gkh063; Lopez-Maury L, 2008, NAT REV GENET, V9, P583, DOI 10.1038/nrg2398; Luo WJ, 2013, BIOINFORMATICS, V29, P1830, DOI 10.1093/bioinformatics/btt285; Micheli V, 2011, CURR TOP MED CHEM, V11, P923, DOI 10.2174/156802611795347645; MIZOCK BA, 1995, AM J MED, V98, P75, DOI 10.1016/S0002-9343(99)80083-7; Perl A, 2011, TRENDS MOL MED, V17, P395, DOI 10.1016/j.molmed.2011.01.014; Rivals I, 2007, BIOINFORMATICS, V23, P401, DOI 10.1093/bioinformatics/btl633; Savinkova LK, 2009, BIOCHEMISTRY-MOSCOW+, V74, P117, DOI 10.1134/S0006297909020011; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1; Wu G, 2005, MICROBIOL-SGM, V151, P2175, DOI 10.1099/mic.0.27833-0; Yang CH, 2007, GENE, V389, P52, DOI 10.1016/j.gene.2006.09.029	22	24	24	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2015	10	3							e0120848	10.1371/journal.pone.0120848	http://dx.doi.org/10.1371/journal.pone.0120848			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD9NQ	25789484	Green Published, Green Submitted, gold			2022-12-27	WOS:000351425400180
J	Hsu, KH; Ho, CC; Hsia, TC; Tseng, JS; Su, KY; Wu, MF; Chiu, KL; Yang, TY; Chen, KC; Ooi, H; Wu, TC; Chen, HJ; Chen, HY; Chang, CS; Hsu, CP; Hsia, JY; Chuang, CY; Lin, CH; Chen, JJW; Chen, KY; Liao, WY; Shih, JY; Yu, SL; Yu, CJ; Yang, PC; Chang, GC				Hsu, Kuo-Hsuan; Ho, Chao-Chi; Hsia, Te-Chun; Tseng, Jeng-Sen; Su, Kang-Yi; Wu, Ming-Fang; Chiu, Kuo-Liang; Yang, Tsung-Ying; Chen, Kun-Chieh; Ooi, Hean; Wu, Tzu-Chin; Chen, Hung-Jen; Chen, Hsuan-Yu; Chang, Chi-Sheng; Hsu, Chung-Ping; Hsia, Jiun-Yi; Chuang, Cheng-Yen; Lin, Chin-Hung; Chen, Jeremy J. W.; Chen, Kuan-Yu; Liao, Wei-Yu; Shih, Jin-Yuan; Yu, Sung-Liang; Yu, Chong-Jen; Yang, Pan-Chyr; Chang, Gee-Chen			Identification of Five Driver Gene Mutations in Patients with Treatment-Naive Lung Adenocarcinoma in Taiwan	PLOS ONE			English	Article							GROWTH-FACTOR RECEPTOR; EML4-ALK FUSION GENE; KINASE INHIBITOR; EGFR MUTATIONS; CANCER; IMPACT; KRAS; GEFITINIB; PATHWAYS; SURVIVAL	Background It is important to select appropriate targeted therapies for subgroups of patients with lung adenocarcinoma who have specific gene alterations. Methods This prospective study was a multicenter project conducted in Taiwan for assessment of lung adenocarcinoma genetic tests. Five oncogenic drivers, including EGFR, KRAS, BRAF, HER2 and EML4-ALK fusion mutations, were tested. EGFR, KRAS, BRAF and HER2 mutations were assessed by MALDI-TOF MS (Cohort 1). EML4-ALK translocation was tested by Ventana method in EGFR-wild type patients (Cohort 2). Results From August 2011 to November 2013, a total of 1772 patients with lung adenocarcinoma were enrolled. In Cohort 1 analysis, EGFR, KRAS, HER2 and BRAF mutations were identified in 987 (55.7%), 93 (5.2%), 36 (2.0%) and 12 (0.7%) patients, respectively. Most of these mutations were mutually exclusive, except for co-mutations in seven patients (3 with EGFR + KRAS, 3 with EGFR + HER2 and 1 with KRAS + BRAF). In Cohort 2 analysis, 29 of 295 EGFR-wild type patients (9.8%) were positive for EML4-ALK translocation. EGFR mutations were more common in female patients and non-smokers and KRAS mutations were more common in male patients and smokers. Gender and smoking status were not correlated significantly with HER2, BRAF and EML4-ALK mutations. EML4-ALK translocation was more common in patients with younger age. Conclusion This was the first study in Taiwan to explore the incidence of five oncogenic drivers in patients with lung adenocarcinoma and the results could be valuable for physicians in consideration of targeted therapy and inclusion of clinical trials.	[Hsu, Kuo-Hsuan] Taichung Vet Gen Hosp, Dept Internal Med, Div Crit Care & Resp Therapy, Taichung, Taiwan; [Hsu, Kuo-Hsuan; Tseng, Jeng-Sen; Chen, Kun-Chieh; Chen, Jeremy J. W.; Chang, Gee-Chen] Natl Chung Hsing Univ, Inst Biomed Sci, Taichung 40227, Taiwan; [Ho, Chao-Chi; Chen, Kuan-Yu; Liao, Wei-Yu; Shih, Jin-Yuan; Yu, Chong-Jen; Yang, Pan-Chyr] Natl Taiwan Univ Hosp, Dept Internal Med, Div Pulm Med, Taipei 100, Taiwan; [Ho, Chao-Chi; Chen, Kuan-Yu; Liao, Wei-Yu; Shih, Jin-Yuan; Yu, Chong-Jen; Yang, Pan-Chyr] Natl Taiwan Univ, Coll Med, Taipei 10764, Taiwan; [Hsia, Te-Chun] China Med Univ Hosp, Dept Internal Med, Taichung, Taiwan; [Hsia, Te-Chun; Chen, Hung-Jen] China Med Univ, Dept Resp Therapy, Taichung, Taiwan; [Tseng, Jeng-Sen; Yang, Tsung-Ying; Chen, Kun-Chieh; Chang, Gee-Chen] Taichung Vet Gen Hosp, Dept Internal Med, Div Chest Med, Taichung, Taiwan; [Su, Kang-Yi; Yu, Sung-Liang] Natl Taiwan Univ, Coll Med, Dept Clin Lab Sci & Med Biotechnol, Taipei 10764, Taiwan; [Su, Kang-Yi; Yu, Sung-Liang] Natl Taiwan Univ Hosp, Dept Lab Med, Taipei, Taiwan; [Wu, Ming-Fang] Chung Shan Med Univ Hosp, Dept Internal Med, Div Med Oncol, Taichung 40201, Taiwan; [Wu, Ming-Fang] Chung Shan Med Univ Hosp, Dept Internal Med, Div Pulm Med, Taichung 40201, Taiwan; [Wu, Ming-Fang; Wu, Tzu-Chin] Chung Shan Med Univ, Sch Med, Taichung, Taiwan; [Chiu, Kuo-Liang] Taichung Tzu Chi Hosp, Dept Internal Med, Div Chest Med, Taichung, Taiwan; [Chiu, Kuo-Liang] Tzu Chi Univ, Sch Postbaccalaureate Chinese Med, Hualien, Taiwan; [Yang, Tsung-Ying; Chang, Gee-Chen] Natl Yang Ming Univ, Sch Med, Fac Med, Taipei 112, Taiwan; [Ooi, Hean] Taichung Tzu Chi Hosp, Dept Crit Care Med, Taichung, Taiwan; [Ooi, Hean] Cent Taiwan Univ Sci & Technol, Dept Med Imaging & Radiol Sci, Taichung, Taiwan; [Ooi, Hean] China Med Univ, Dept Med Res, China Med Univ Hosp, Taichung, Taiwan; [Ooi, Hean] Tzu Chi Univ, Sch Med, Hualien, Taiwan; [Wu, Tzu-Chin] Chung Shan Med Univ Hosp, Div Pulm Med, Taichung 40201, Taiwan; [Chen, Hung-Jen] China Med Univ Hosp, Div Pulm & Crit Care Med, Taichung, Taiwan; [Chen, Hsuan-Yu; Chang, Chi-Sheng] Acad Sinica, Inst Stat Sci, Taipei 11529, Taiwan; [Hsu, Chung-Ping; Hsia, Jiun-Yi; Chuang, Cheng-Yen; Lin, Chin-Hung] Taichung Vet Gen Hosp, Dept Surg, Div Thorac Surg, Taichung, Taiwan; [Hsu, Chung-Ping] Natl Yang Ming Univ, Sch Med, Taipei 112, Taiwan; [Shih, Jin-Yuan] Natl Taiwan Univ, Coll Med, Grad Inst Clin Med, Taipei 10764, Taiwan; [Yu, Sung-Liang] Natl Taiwan Univ, Coll Med, NTU Ctr Genom Med, Taipei 10764, Taiwan; [Yu, Sung-Liang] Natl Taiwan Univ, Coll Med, Dept Pathol, Taipei, Taiwan; [Yu, Sung-Liang] Natl Taiwan Univ, Coll Med, Grad Inst Pathol, Taipei 10764, Taiwan; [Yu, Sung-Liang] Natl Taiwan Univ, Coll Med, Ctr Optoelect Biomed, Taipei 10764, Taiwan	Taichung Veterans General Hospital; National Chung Hsing University; National Taiwan University; National Taiwan University Hospital; National Taiwan University; China Medical University Taiwan; China Medical University Hospital - Taiwan; China Medical University Taiwan; Taichung Veterans General Hospital; National Taiwan University; National Taiwan University; National Taiwan University Hospital; Chung Shan Medical University; Chung Shan Medical University Hospital; Chung Shan Medical University; Chung Shan Medical University Hospital; Chung Shan Medical University; Buddhist Tzu Chi General Hospital; Taichung Tzu Chi Hospital; Tzu Chi University; National Yang Ming Chiao Tung University; Buddhist Tzu Chi General Hospital; Taichung Tzu Chi Hospital; Central Taiwan University Science & Technology; China Medical University Taiwan; China Medical University Hospital - Taiwan; Tzu Chi University; Chung Shan Medical University; Chung Shan Medical University Hospital; China Medical University Taiwan; China Medical University Hospital - Taiwan; Academia Sinica - Taiwan; Taichung Veterans General Hospital; National Yang Ming Chiao Tung University; National Taiwan University; National Taiwan University; National Taiwan University; National Taiwan University; National Taiwan University	Yu, SL (corresponding author), Natl Taiwan Univ, Coll Med, Dept Clin Lab Sci & Med Biotechnol, Taipei 10764, Taiwan.	slyu@ntu.edu.tw; jefferycjyu@ntu.edu.tw; august@vghtc.gov.tw	Chen, Hsuan-Yu/AAE-8428-2019; Liao, Wei-Yu/HGE-3881-2022; SU, KANG-YI/GNM-5753-2022	SU, KANG-YI/0000-0002-6538-9526; LIAO, WEI-YU/0000-0001-6383-3470; Yu, Chong-Jen/0000-0001-5664-9392; Tseng, Jeng-Sen/0000-0003-2341-4495; YANG, PAN-CHYR/0000-0001-6330-6048; YU, SUNG-LIANG/0000-0003-4535-9036; HO, CHAO-CHI/0000-0002-8156-2413; Chen, Jeremy J.W./0000-0003-1049-3825; Wu, Ming-Fang/0000-0002-7208-7067				An SJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040109; Barlesi F, 2013, J CLIN ONCOL, V31; Bell DW, 2008, CLIN CANCER RES, V14, P4079, DOI 10.1158/1078-0432.CCR-07-5030; Bronte G, 2010, CANCER TREAT REV, V36, pS21, DOI 10.1016/S0305-7372(10)70016-5; Cancer Genome Atlas Research Network, 2014, Nature, V511, P543, DOI [10.1038/s41586-018-0228-6, 10.1038/nature13385]; Cardarella S, 2013, AM J RESP CRIT CARE, V188, P770, DOI 10.1164/rccm.201305-0843PP; Chen D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101354; Ding L, 2008, NATURE, V455, P1069, DOI 10.1038/nature07423; Downward J, 2003, NAT REV CANCER, V3, P11, DOI 10.1038/nrc969; Edge SB, 2009, AJCC CANC STAGING HD; Eisenhauer EA, 2009, EUR J CANCER, V45, P228, DOI 10.1016/j.ejca.2008.10.026; Ihle NT, 2012, JNCI-J NATL CANCER I, V104, P228, DOI 10.1093/jnci/djr523; Izar B, 2014, J THORAC ONCOL, V9, P1363, DOI 10.1097/JTO.0000000000000266; Koivunen JP, 2008, CLIN CANCER RES, V14, P4275, DOI 10.1158/1078-0432.CCR-08-0168; Kris MG, 2014, JAMA-J AM MED ASSOC, V311, P1998, DOI 10.1001/jama.2014.3741; Kwak EL, 2010, NEW ENGL J MED, V363, P1693, DOI 10.1056/NEJMoa1006448; Lee CK, 2013, JNCI-J NATL CANCER I, V105, P595, DOI 10.1093/jnci/djt072; Mazieres J, 2013, J CLIN ONCOL, V31, P1997, DOI 10.1200/JCO.2012.45.6095; Mino-Kenudson M, 2010, CLIN CANCER RES, V16, P1561, DOI 10.1158/1078-0432.CCR-09-2845; Mok TS, 2009, NEW ENGL J MED, V361, P947, DOI 10.1056/NEJMoa0810699; Murakami Y, 2012, FRONT ONCOL, V2, DOI 10.3389/fonc.2012.00024; Perera SA, 2009, P NATL ACAD SCI USA, V106, P474, DOI 10.1073/pnas.0808930106; Planchard D, 2014, ANN ONCOL, V25, P1, DOI [10.1093/annonc/mdu438, DOI 10.1093/ANNONC/MDU438]; RODENHUIS S, 1992, CANCER RES, V52, pS2665; Sasaki T, 2010, EUR J CANCER, V46, P1773, DOI 10.1016/j.ejca.2010.04.002; Seo JS, 2012, GENOME RES, V22, P2109, DOI 10.1101/gr.145144.112; Serizawa M, 2014, CANCER-AM CANCER SOC, V120, P1471, DOI 10.1002/cncr.28604; Shaw AT, 2014, NEW ENGL J MED, V370, P2537, DOI 10.1056/NEJMc1404894; Shaw AT, 2013, NEW ENGL J MED, V368, P2385, DOI 10.1056/NEJMoa1214886; Shi Y, 2014, J THORAC ONCOL, V9, P154, DOI 10.1097/JTO.0000000000000033; Shimamura T, 2006, CANCER RES, V66, P6487, DOI 10.1158/0008-5472.CAN-06-0971; Siegel R, 2014, CA-CANCER J CLIN, V64, P9, DOI 10.3322/caac.21208; Soda M, 2007, NATURE, V448, P561, DOI 10.1038/nature05945; Su KY, 2012, J CLIN ONCOL, V30, P433, DOI 10.1200/JCO.2011.38.3224; Sun JM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064816; Tam IYS, 2006, CLIN CANCER RES, V12, P1647, DOI 10.1158/1078-0432.CCR-05-1981; Thongprasert S, 2011, J THORAC ONCOL, V6, P1872, DOI 10.1097/JTO.0b013e31822adaf7; Tsai TH, 2012, EUR RESPIR J, V39, P677, DOI 10.1183/09031936.00043511; Tseng JS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107160; West H, 2009, CHEST, V136, P1112, DOI 10.1378/chest.08-2484; Ying J, 2013, ANN ONCOL, V24, P2589, DOI 10.1093/annonc/mdt295	41	75	77	2	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2015	10	3							e0120852	10.1371/journal.pone.0120852	http://dx.doi.org/10.1371/journal.pone.0120852			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD9NQ	25789627	Green Published, Green Submitted, gold			2022-12-27	WOS:000351425400181
J	Nakane, S; Higuchi, O; Koga, M; Kanda, T; Murata, K; Suzuki, T; Kurono, H; Kunimoto, M; Kaida, K; Mukaino, A; Sakai, W; Maeda, Y; Matsuo, H				Nakane, Shunya; Higuchi, Osamu; Koga, Michiaki; Kanda, Takashi; Murata, Kenya; Suzuki, Takashi; Kurono, Hiroko; Kunimoto, Masanari; Kaida, Ken-ichi; Mukaino, Akihiro; Sakai, Waka; Maeda, Yasuhiro; Matsuo, Hidenori			Clinical Features of Autoimmune Autonomic Ganglionopathy and the Detection of Subunit-Specific Autoantibodies to the Ganglionic Acetylcholine Receptor in Japanese Patients	PLOS ONE			English	Article							MYASTHENIA-GRAVIS; RHEUMATOID-ARTHRITIS; PARKINSONS-DISEASE; GAUSSIA LUCIFERASE; SJOGRENS-SYNDROME; NEUROPATHY; ANTIBODIES; SYSTEM; INVOLVEMENT; DYSFUNCTION	Autoimmune autonomic ganglionopathy (AAG) is a rare acquired channelopathy that is characterized by pandysautonomia, in which autoantibodies to ganglionic nicotinic acetylcholine receptors (gAChR) may play a central role. Radioimmunoprecipitation (RIP) assays have been used for the sensitive detection of autoantibodies to gAChR in the serum of patients with AAG. Here, we developed luciferase immunoprecipitation systems (LIPS) to diagnose AAG based on IgGs to both the alpha 3 and beta 4 gAChR subunits in patient serum. We reviewed the serological and clinical data of 50 Japanese patients who were diagnosed with AAG. With the LIPS testing, we detected anti-alpha 3 and -beta 4 gAChR antibodies in 48% (24/ 50) of the patients. A gradual mode of onset was more common in the seropositive group than in the seronegative group. Patients with AAG frequently have orthostatic hypotension and upper and lower gastrointestinal tract symptoms, with or without anti-gAChR. The occurrence of autonomic symptoms was not significantly different between the seropositive and seronegative group, with the exception of achalasia in three patients from the seropositive group. In addition, we found a significant overrepresentation of autoimmune diseases in the seropositive group and endocrinological abnormalities as an occasional complication of AAG. Our results demonstrated that the LIPS assay was a useful novel tool for detecting autoantibodies against gAChR in patients with AAG.	[Nakane, Shunya; Higuchi, Osamu] Nagasaki Kawatana Med Ctr, Dept Clin Res, Nagasaki, Japan; [Nakane, Shunya; Sakai, Waka; Maeda, Yasuhiro; Matsuo, Hidenori] Nagasaki Kawatana Med Ctr, Dept Neurol, Nagasaki, Japan; [Koga, Michiaki; Kanda, Takashi] Yamaguchi Univ, Grad Sch Med, Dept Neurol & Clin Neurosci, Yamaguchi, Japan; [Murata, Kenya] Wakayama Med Univ, Dept Neurol, Wakayama, Japan; [Suzuki, Takashi] Joetsu Gen Hosp, Dept Neurol, Niigata, Japan; [Kurono, Hiroko; Kunimoto, Masanari] Saiseikai Kanagawa Prefecture Hosp, Dept Neurol, Yokohama, Kanagawa, Japan; [Kaida, Ken-ichi] Natl Def Med Coll, Dept Internal Med 3, Div Neurol, Saitama, Japan; [Mukaino, Akihiro] Nagasaki Univ, Grad Sch Biomed Sci, Dept Clin Neurosci & Neurol, Nagasaki 852, Japan	Yamaguchi University; Wakayama Medical University; National Defense Medical College - Japan; Nagasaki University	Nakane, S (corresponding author), Nagasaki Kawatana Med Ctr, Dept Clin Res, Nagasaki, Japan.	nakaneshunya@gmail.com	Nakane, Shunya/AAF-3715-2022; Koga, Michiaki/L-4825-2019; Nakane, Shunya/AFB-9194-2022	Koga, Michiaki/0000-0002-1356-955X; 	Neuroimmunological Disease Research Committee; Ministry of Health, Labour and Welfare, Japan; Ministry of Education, Culture, Sports, Science and Technology of Japan [25461305]	Neuroimmunological Disease Research Committee; Ministry of Health, Labour and Welfare, Japan(Ministry of Health, Labour and Welfare, Japan); Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported in part by grants from the Neuroimmunological Disease Research Committee and the Ministry of Health, Labour and Welfare, Japan. This work was also supported by the Ministry of Education, Culture, Sports, Science and Technology of Japan in the form of a Grant-in-Aid for Scientific Research (C) (JSPS KAKENHI Grant Number 25461305). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amaral TN, 2013, SEMIN ARTHRITIS RHEU, V43, P335, DOI 10.1016/j.semarthrit.2013.05.002; Baker SK, 2009, AUTON NEUROSCI-BASIC, V146, P29, DOI 10.1016/j.autneu.2008.10.016; Balestra B, 2000, J NEUROIMMUNOL, V102, P89, DOI 10.1016/S0165-5728(99)00145-9; Burbelo Peter D, 2009, J Vis Exp, DOI 10.3791/1549; Burbelo PD, 2010, CLIN VACCINE IMMUNOL, V17, P904, DOI 10.1128/CVI.00476-09; Ching KH, 2011, NEUROMUSCULAR DISORD, V21, P204, DOI 10.1016/j.nmd.2010.12.003; Conti-Fine BM, 2006, J CLIN INVEST, V116, P2843, DOI 10.1172/JCI29894; Druschky A, 2000, J NEUROL SCI, V175, P3, DOI 10.1016/S0022-510X(00)00279-3; Fukuda Mitsumasa, 1995, No To Hattatsu, V27, P41; Gibbons CH, 2008, ARCH NEUROL-CHICAGO, V65, P213, DOI 10.1001/archneurol.2007.60; Goto H, 2000, J NEUROL NEUROSUR PS, V69, P135, DOI 10.1136/jnnp.69.1.135; Hayashi M, 2009, AUTON NEUROSCI-BASIC, V146, P26, DOI 10.1016/j.autneu.2008.12.013; Higuchi O, 2011, ANN NEUROL, V69, P418, DOI 10.1002/ana.22312; Imrich R, 2009, CLIN AUTON RES, V19, P259, DOI 10.1007/s10286-009-0012-7; Inoue Y, 1989, Rinsho Shinkeigaku, V29, P1265; Iodice V, 2009, NEUROLOGY, V72, P2002, DOI 10.1212/WNL.0b013e3181a92b52; Iodice V, 2009, AUTON NEUROSCI-BASIC, V146, P22, DOI 10.1016/j.autneu.2008.11.001; Kim SB, 2011, ANAL CHEM, V83, P8732, DOI 10.1021/ac2021882; Kimpinski K, 2009, NEUROLOGY, V73, P1501, DOI 10.1212/WNL.0b013e3181bf995f; Kobayashi S, 2013, J NEUROIMMUNOL, V257, P102, DOI 10.1016/j.jneuroim.2012.12.010; Kondo T, 2009, AUTON NEUROSCI-BASIC, V146, P33, DOI 10.1016/j.autneu.2008.12.002; Lennon VA, 2003, J CLIN INVEST, V111, P907, DOI 10.1172/JCI200317429; Manganelli F, 2011, ARCH NEUROL-CHICAGO, V68, P504, DOI 10.1001/archneurol.2011.60; Matsui M, 1983, Rinsho Shinkeigaku, V23, P526; Mori K, 2005, BRAIN, V128, P2518, DOI 10.1093/brain/awh605; Nishihara H., 2015, CLIN EXP NEUROIMMUNO, V6, P191, DOI 10.1111/cen3.12137; Pavlakis PP, 2011, J NEUROL NEUROSUR PS, V82, P798, DOI 10.1136/jnnp.2010.222109; Peltier AC, 2010, MUSCLE NERVE, V41, P416, DOI 10.1002/mus.21528; Philip NS, 2010, PSYCHOPHARMACOLOGY, V212, P1, DOI 10.1007/s00213-010-1932-6; Ramos-Remus C, 2012, CLIN RHEUMATOL, V31, P1, DOI 10.1007/s10067-011-1841-z; Reuter M, 2012, NEUROREPORT, V23, P717, DOI 10.1097/WNR.0b013e32835671ba; Sandroni P, 2004, ARCH NEUROL-CHICAGO, V61, P44, DOI 10.1001/archneur.61.1.44; Sandroni P, 2009, AUTON NEUROSCI-BASIC, V146, P13, DOI 10.1016/j.autneu.2008.10.022; Skok MV, 1999, NEUROSCIENCE, V93, P1427, DOI 10.1016/S0306-4522(99)00160-8; Spiegel J, 2007, MOVEMENT DISORD, V22, P1004, DOI 10.1002/mds.21499; Stacher G, 2000, J RHEUMATOL, V27, P692; Stojanovich L, 2007, LUPUS, V16, P181, DOI 10.1177/0961203306076223; Streifler Jonathan Y, 2014, Handb Clin Neurol, V119, P463, DOI 10.1016/B978-0-7020-4086-3.00030-8; Tannous BA, 2005, MOL THER, V11, P435, DOI 10.1016/j.ymthe.2004.10.016; Ustinova J, 2014, J IMMUNOL METHODS, V405, P67, DOI 10.1016/j.jim.2014.01.009; Verhaegen M, 2002, ANAL CHEM, V74, P4378, DOI 10.1021/ac025742k; Vernino S, 1998, NEUROLOGY, V50, P1806, DOI 10.1212/WNL.50.6.1806; Vernino S, 2000, NEW ENGL J MED, V343, P847, DOI 10.1056/NEJM200009213431204; Vernino S, 2004, J NEUROSCI, V24, P7037, DOI 10.1523/JNEUROSCI.1485-04.2004; Vernino S, 2003, J NEUROPHYSIOL, V90, P2053, DOI 10.1152/jn.00408.2003; Vernino S, 2001, AUTON NEUROSCI-BASIC, V88, P187, DOI 10.1016/S1566-0702(01)00239-9; Vernino S, 2008, J NEUROIMMUNOL, V197, P63, DOI 10.1016/j.jneuroim.2008.03.017; Vernino S, 2008, NEUROLOGY, V70, P1926, DOI 10.1212/01.wnl.0000312280.44805.5d; Vernino S, 2009, AUTON NEUROSCI-BASIC, V146, P3, DOI 10.1016/j.autneu.2008.09.005; Wang Z, 2007, NEUROLOGY, V68, P1917, DOI 10.1212/01.wnl.0000263185.30294.61; Wang ZB, 2010, EXP NEUROL, V222, P114, DOI 10.1016/j.expneurol.2009.12.016; Watson R, 2005, NEUROLOGY, V65, P1802, DOI 10.1212/01.wnl.0000191566.86977.04; WIELAND DM, 1981, J NUCL MED, V22, P22; Winston N, 2010, CURR OPIN NEUROL, V23, P514, DOI 10.1097/WCO.0b013e32833d4c7f	54	52	53	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2015	10	3							e0118312	10.1371/journal.pone.0118312	http://dx.doi.org/10.1371/journal.pone.0118312			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD9NQ	25790156	gold, Green Published, Green Submitted			2022-12-27	WOS:000351425400026
J	Robijn, S; Vervaet, BA; D'Haese, PC; Verhulst, A				Robijn, Stef; Vervaet, Benjamin A.; D'Haese, Patrick C.; Verhulst, Anja			Evaluation of Intestinal Phosphate Binding to Improve the Safety Profile of Oral Sodium Phosphate Bowel Cleansing	PLOS ONE			English	Article							PLUS BISACODYL TABLETS; RENAL-FAILURE; PARATHYROID-HORMONE; LAVAGE SOLUTION; COLONOSCOPY; NEPHROPATHY; NEPHROCALCINOSIS; TRIAL; ABSORPTION; EFFICACY	Prior to colonoscopy, bowel cleansing is performed for which frequently oral sodium phosphate (OSP) is used. OSP results in significant hyperphosphatemia and cases of acute kidney injury (AKI) referred to as acute phosphate nephropathy (APN; characterized by nephrocalcinosis) are reported after OSP use, which led to a US-FDA warning. To improve the safety profile of OSP, it was evaluated whether the side-effects of OSP could be prevented with intestinal phosphate binders. Hereto a Wistar rat model of APN was developed. OSP administration (2 times 1.2 g phosphate by gavage) with a 12h time interval induced bowel cleansing (severe diarrhea) and significant hyperphosphatemia (21.79 +/- 5.07 mg/dl 6h after the second OSP dose versus 8.44 +/- 0.97 mg/dl at baseline). Concomitantly, serum PTH levels increased fivefold and FGF-23 levels showed a threefold increase, while serum calcium levels significantly decreased from 11.29 +/- 0.53 mg/dl at baseline to 8.68 +/- 0.79 mg/dl after OSP. OSP administration induced weaker NaPi-2a staining along the apical proximal tubular membrane. APN was induced: serum creatinine increased (1.5 times baseline) and nephrocalcinosis developed (increased renal calcium and phosphate content and calcium phosphate deposits on Von Kossa stained kidney sections). Intestinal phosphate binding (lanthanum carbonate or aluminum hydroxide) was not able to attenuate the OSP induced side-effects. In conclusion, a clinically relevant rat model of APN was developed. Animals showed increased serum phosphate levels similar to those reported in humans and developed APN. No evidence was found for an improved safety profile of OSP by using intestinal phosphate binders.	[Robijn, Stef; Vervaet, Benjamin A.; D'Haese, Patrick C.; Verhulst, Anja] Univ Antwerp, Lab Pathophysiol, B-2020 Antwerp, Belgium	University of Antwerp	D'Haese, PC (corresponding author), Univ Antwerp, Lab Pathophysiol, B-2020 Antwerp, Belgium.	patrick.dhaese@uantwerpen.be	Vervaet, Benjamin/AAU-4679-2020; D'Haese, Patrick C/C-9599-2019	Vervaet, Benjamin/0000-0002-8589-5469	Agency for Innovation by Science and Technology in Flanders; FWO [G.0583.09]	Agency for Innovation by Science and Technology in Flanders; FWO(FWO)	SR was funded by a PhD grant of the Agency for Innovation by Science and Technology in Flanders (http://www.iwt.be/). AV is a postdoctoral fellow of the Fund for Scientific Research Flanders (http://www.fwo.be/). This research was funded by FWO research grant G.0583.09.	Aasebo W, 2007, NEPHROL DIAL TRANSPL, V22, P920, DOI 10.1093/ndt/gfl694; Bacic D, 2006, KIDNEY INT, V69, P495, DOI 10.1038/sj.ki.5000148; Becaria A, 2002, TOXICOL IND HEALTH, V18, P309, DOI 10.1191/0748233702th157oa; Behets GJ, 2004, CURR OPIN NEPHROL HY, V13, P403, DOI 10.1097/01.mnh.0000133973.86816.e9; Belsey J, 2007, ALIMENT PHARM THER, V25, P373, DOI 10.1111/j.1365-2036.2006.03212.x; Bourquin Vincent, 2011, Rev Med Suisse, V7, P2227; Caswell M, 2007, J POPUL THER CLIN PH, V14, pE260; Connor A, 2012, GUT, V61, P1525, DOI 10.1136/gutjnl-2011-300861; Desmeules S, 2003, NEW ENGL J MED, V349, P1006, DOI 10.1056/NEJM200309043491020; DiPalma JA, 1996, DIGEST DIS SCI, V41, P749, DOI 10.1007/BF02213131; Eckardt KU, 2012, KIDNEY INT SUPPL, V2, P7, DOI 10.1038/kisup.2012.8; Eto N, 2006, DRUG METAB PHARMACOK, V21, P217, DOI 10.2133/dmpk.21.217; Giral H, 2009, AM J PHYSIOL-RENAL, V297, pF1466, DOI 10.1152/ajprenal.00279.2009; Gonlusen G, 2006, ARCH PATHOL LAB MED, V130, P101; Gracia-Iguacel C, 2013, J BONE MINER METAB, V31, P703, DOI 10.1007/s00774-013-0435-z; Han SH, 2010, CLIN NEPHROL, V74, P159; Hassan C, 2013, ENDOSCOPY, V45, P142, DOI 10.1055/s-0032-1326186; Heher EC, 2008, CLIN J AM SOC NEPHRO, V3, P1494, DOI 10.2215/CJN.02040408; Hurst FP, 2009, CURR OPIN NEPHROL HY, V18, P513, DOI 10.1097/MNH.0b013e32833096af; Hutchison AJ, 2009, KIDNEY INT, V75, P906, DOI 10.1038/ki.2009.60; Isakova T, 2011, KIDNEY INT, V79, P1370, DOI 10.1038/ki.2011.47; Isakova T, 2010, KIDNEY INT, V78, P947, DOI 10.1038/ki.2010.281; Johanson JF, 2007, AM J GASTROENTEROL, V102, P2238, DOI 10.1111/j.1572-0241.2007.01363.x; Korsten MA, 2010, DIGEST DIS SCI, V55, P2021, DOI 10.1007/s10620-009-1013-z; Landreneau Stephen W, 2013, Curr Gastroenterol Rep, V15, P341, DOI 10.1007/s11894-013-0341-5; Lichtenstein GR, 2007, ALIMENT PHARM THER, V26, P1361, DOI 10.1111/j.1365-2036.2007.03496.x; Lien YHH, 2008, NAT CLIN PRACT NEPHR, V4, P606, DOI 10.1038/ncpneph0939; Lochy S, 2013, INT J NEPHROL RENOV, V6, P61, DOI 10.2147/IJNRD.S41428; Mackey AC, 2009, AM J GASTROENTEROL, V104, P1903, DOI 10.1038/ajg.2009.342; Manfro RC, 2009, TRANSPLANTATION, V87, P618, DOI 10.1097/TP.0b013e318196a59c; Markowitz GS, 2009, KIDNEY INT, V76, P1027, DOI 10.1038/ki.2009.308; Markowitz GS, 2005, J AM SOC NEPHROL, V16, P3389, DOI 10.1681/ASN.2005050496; Markowitz GS, 2005, NEPHROL DIAL TRANSPL, V20, P850, DOI 10.1093/ndt/gfh718; Markowitz GS, 2004, HUM PATHOL, V35, P675, DOI 10.1016/j.humpath.2003.12.005; Marks J, 2013, CURR OPIN NEPHROL HY, V22, P481, DOI 10.1097/MNH.0b013e3283621310; Palmadottir VK, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013484; Patel V, 2007, HUM PATHOL, V38, P193, DOI 10.1016/j.humpath.2006.10.008; Patel V, 2009, AM J GASTROENTEROL, V104, P953, DOI 10.1038/ajg.2008.124; Pelham RW, 2010, AM J GASTROENTEROL, V105, P476, DOI 10.1038/ajg.2009.571; Rex DK, 2007, ANN PHARMACOTHER, V41, P1466, DOI 10.1345/aph.1K206; Rex DK, 2006, AM J GASTROENTEROL, V101, P2594, DOI 10.1111/j.1572-0241.2006.00776.x; Rex DK, 2009, CAN J GASTROENTEROL, V23, P210, DOI 10.1155/2009/417296; Rocuts AK, 2009, KIDNEY INT, V75, P987, DOI 10.1038/ki.2008.293; Rodriguez-Ortiz ME, 2012, J AM SOC NEPHROL, V23, P1190, DOI 10.1681/ASN.2011101006; Rostom A, 2006, GASTROINTEST ENDOSC, V64, P544, DOI 10.1016/j.gie.2005.09.030; Sabbagh Y, 2009, J AM SOC NEPHROL, V20, P2348, DOI 10.1681/ASN.2009050559; Seeff LC, 2004, GASTROENTEROLOGY, V127, P1670, DOI 10.1053/j.gastro.2004.09.051; Segawa H, 2007, AM J PHYSIOL-RENAL, V292, pF395, DOI 10.1152/ajprenal.00100.2006; Slee TM, 2008, NETH J MED, V66, P438; Tan JJY, 2006, COLORECTAL DIS, V8, P247, DOI 10.1111/j.1463-1318.2006.00970.x; VANNER SJ, 1990, AM J GASTROENTEROL, V85, P422	51	2	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2015	10	3							e0116590	10.1371/journal.pone.0116590	http://dx.doi.org/10.1371/journal.pone.0116590			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD9NQ	25790436	gold, Green Published, Green Submitted			2022-12-27	WOS:000351425400018
J	Tornqvist, R; Jarsjo, J; Thorslund, J; Rao, PSC; Basu, NB; Destouni, G				Tornqvist, Rebecka; Jarsjo, Jerker; Thorslund, Josefin; Rao, P. Suresh C.; Basu, Nandita B.; Destouni, Georgia			Mechanisms of Basin-Scale Nitrogen Load Reductions under Intensified Irrigated Agriculture	PLOS ONE			English	Article							RIVER-BASIN; AMU-DARYA; RIO-GRANDE; ARAL SEA; WATER; NUTRIENT; EXPORT; TRANSPORT; QUALITY; UZBEKISTAN	Irrigated agriculture can modify the cycling and transport of nitrogen (N), due to associated water diversions, water losses, and changes in transport flow-paths. We investigate dominant processes behind observed long-term changes in dissolved inorganic nitrogen (DIN) concentrations and loads of the extensive (465,000 km(2)) semi-arid Amu Darya River basin (ADRB) in Central Asia. We specifically considered a 40-year period (1960-2000) of large irrigation expansion, reduced river water flows, increased fertilizer application and net increase of N input into the soil-water system. Results showed that observed decreases in riverine DIN concentration near the Aral Sea outlet of ADRB primarily were due to increased recirculation of irrigation water, which extends the flow-path lengths and enhances N attenuation. The observed DIN concentrations matched a developed analytical relation between concentration attenuation and recirculation ratio, showing that a fourfold increase in basin-scale recirculation can increase DIN attenuation from 85 to 99%. Such effects have previously only been observed at small scales, in laboratory experiments and at individual agricultural plots. These results imply that increased recirculation can have contributed to observed increases in N attenuation in agriculturally dominated drainage basins in different parts of the world. Additionally, it can be important for basin scale attenuation of other pollutants, including phosphorous, metals and organic matter. A six-fold lower DIN export from ADRB during the period 1981-2000, compared to the period 1960-1980, was due to the combined result of drastic river flow reduction of almost 70%, and decreased DIN concentrations at the basin outlet. Several arid and semi-arid regions around the world are projected to undergo similar reductions in discharge as the ADRB due to climate change and agricultural intensification, and may therefore undergo comparable shifts in DIN export as shown here for the ADRB. For example, projected future increases of irrigation water withdrawals between 2005 and 2050 may decrease the DIN export from arid world regions by 40%.	[Tornqvist, Rebecka; Jarsjo, Jerker; Thorslund, Josefin; Destouni, Georgia] Stockholm Univ, Dept Phys Geog & Quaternary Geol, S-10691 Stockholm, Sweden; [Tornqvist, Rebecka; Jarsjo, Jerker; Thorslund, Josefin; Destouni, Georgia] Stockholm Univ, Bolin Ctr Climate Res, S-10691 Stockholm, Sweden; [Rao, P. Suresh C.] Purdue Univ, Sch Civil Engn, W Lafayette, IN 47907 USA; [Rao, P. Suresh C.] Purdue Univ, Dept Agron, W Lafayette, IN 47907 USA; [Basu, Nandita B.] Univ Waterloo, Dept Civil & Environm Engn & Earth & Environm Sci, Waterloo, ON N2L 3G1, Canada	Stockholm University; Stockholm University; Purdue University System; Purdue University; Purdue University West Lafayette Campus; Purdue University System; Purdue University; Purdue University West Lafayette Campus; University of Waterloo	Tornqvist, R (corresponding author), Stockholm Univ, Dept Phys Geog & Quaternary Geol, S-10691 Stockholm, Sweden.	rebecka.tornqvist@natgeo.su.se	Destouni, Georgia/M-9662-2016; Srinivasa Rao, Prof. P/ABG-1688-2021; Destouni, Georgia/AAS-5375-2020	Destouni, Georgia/0000-0001-9408-4425; Srinivasa Rao, Prof. P/0000-0003-1379-4906; Destouni, Georgia/0000-0001-9408-4425	Swedish International Development Cooperation Agency (SIDA); Linnaeus grant from the Swedish Research Council (VR); Swedish Research Council for Environment, Agricultural Sciences and Spatial Planning (Formas)	Swedish International Development Cooperation Agency (SIDA); Linnaeus grant from the Swedish Research Council (VR); Swedish Research Council for Environment, Agricultural Sciences and Spatial Planning (Formas)(Swedish Research Council Formas)	The authors gratefully acknowledge financial support from the Swedish International Development Cooperation Agency (SIDA, www.sida.se). The work has been carried out within the Bolin Centre for Climate Research, which is supported by a Linnaeus grant from the Swedish Research Council (VR, www.vr.se) and the Swedish Research Council for Environment, Agricultural Sciences and Spatial Planning (Formas, www.formas.se). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2003, WAT SUST WORLD LTD S, P247; Asarin A.E., 2010, ARAL SEA ENV, P101; Awan UK, 2011, IRRIG DRAIN, V60, P600, DOI 10.1002/ird.612; Basu NB, 2010, GEOPHYS RES LETT, V37, DOI 10.1029/2010GL045168; Beek TAD, 2011, PHYS CHEM EARTH, V36, P684, DOI 10.1016/j.pce.2011.03.004; Bouraoui F, 2011, SCI TOTAL ENVIRON, V409, P4899, DOI 10.1016/j.scitotenv.2011.08.015; Bouwman AF, 2009, GLOBAL BIOGEOCHEM CY, V23, DOI 10.1029/2009GB003576; Bouwman AF, 2005, GLOBAL BIOGEOCHEM CY, V19, DOI 10.1029/2004GB002314; Brown JB, 2011, J AM WATER RESOUR AS, V47, P1034, DOI 10.1111/j.1752-1688.2011.00584.x; Bruinsma J., 2009, FEED WORLD 2050, P24; Caraco NF, 1999, AMBIO, V28, P167; Caraco NF, 2001, MAR FRESHWATER RES, V52, P119, DOI 10.1071/MF00083; Causape J, 2006, ENVIRON MONIT ASSESS, V117, P451, DOI 10.1007/s10661-006-0763-8; Crosa G, 2006, ENVIRON SCI POLLUT R, V13, P37, DOI 10.1065/espr2006.01.007; Darracq A, 2010, ENVIRON FLUID MECH, V10, P103, DOI 10.1007/s10652-009-9147-2; de Wit MJM, 2001, HYDROL PROCESS, V15, P743, DOI 10.1002/hyp.175; Destouni G, 2010, GEOPHYS RES LETT, V37, DOI 10.1029/2010GL044153; Djumaniyazova Y, 2010, FIELD CROP RES, V116, P239, DOI 10.1016/j.fcr.2010.01.001; Dumont E, 2005, GLOBAL BIOGEOCHEM CY, V19, DOI 10.1029/2005GB002488; Eriksson H, 2007, BIOGEOCHEMISTRY, V85, P153, DOI 10.1007/s10533-007-9126-y; FAO, 2003, FERT US CROP UZB; FAO, 2003, FAO WAT REP; Feng YW, 2004, AGR WATER MANAGE, V68, P47, DOI 10.1016/j.agwat.2004.02.012; Foley JA, 2005, SCIENCE, V309, P570, DOI 10.1126/science.1111772; Galloway J., 2010, Livestock in a changing landscape, Volume 1: drivers, consequences and responses, P83; Galloway JN, 2004, BIOGEOCHEMISTRY, V70, P153, DOI 10.1007/s10533-004-0370-0; Garcia-Garizabal I, 2010, J HYDROL, V385, P36, DOI 10.1016/j.jhydrol.2010.02.002; Glantz M., 1999, CREEPING ENV PROBLEM; Global Water Partnership GWP, 2013, NAT STAK CONS WAT SU; Gordon LJ, 2008, TRENDS ECOL EVOL, V23, P211, DOI 10.1016/j.tree.2007.11.011; Hama T, 2012, IRRIGATION WATER MAN; Hitomi T, 2006, WATER SCI TECHNOL, V53, P101, DOI 10.2166/wst.2006.043; Holmes RM, 2000, WATER RESOUR RES, V36, P2309, DOI 10.1029/2000WR900099; Holmes RM, 2001, MAR CHEM, V75, P219, DOI 10.1016/S0304-4203(01)00038-X; Howarth RW, 2008, HARMFUL ALGAE, V8, P14, DOI 10.1016/j.hal.2008.08.015; Howden NJK, 2013, ANN ASSOC AM GEOGR, V103, P397, DOI 10.1080/00045608.2013.754672; IMF, 2008, REP UZB POV RED STRA; Jarsjo J, 2012, HYDROL EARTH SYST SC, V16, P1335, DOI 10.5194/hess-16-1335-2012; Kienzler KM, 2011, AGR SYST, V104, P411, DOI 10.1016/j.agsy.2011.01.005; Kienzler KM, 2010, THESIS RHEINISCHEN F; Kubota H, 1979, T JPN SOC IRRIG DRAI, V84, P22; Langbein WB, 1949, 52 US GEOL SURV US D, P52; Lassaletta L, 2012, BIOGEOSCIENCES, V9, P57, DOI 10.5194/bg-9-57-2012; Lassaletta L, 2009, SCI TOTAL ENVIRON, V407, P6034, DOI 10.1016/j.scitotenv.2009.08.002; Lohrenz SE, 2008, CONT SHELF RES, V28, P1466, DOI 10.1016/j.csr.2007.06.019; Ludwig W, 2009, PROG OCEANOGR, V80, P199, DOI 10.1016/j.pocean.2009.02.001; Luo PP, 2011, J ENVIRON MONITOR, V13, P2819, DOI 10.1039/c1em10339c; Mitchell TD, 2005, INT J CLIMATOL, V25, P693, DOI 10.1002/joc.1181; Nasrulin A, 2002, J PROB MECH, V4, P38; Nezlin NP, 2004, J MARINE SYST, V47, P67, DOI 10.1016/j.jmarsys.2003.12.009; Oberhansli H, 2009, J MARINE SYST, V76, P310, DOI 10.1016/j.jmarsys.2008.03.019; Oelsner GP, 2007, J AM WATER RESOUR AS, V43, P850, DOI 10.1111/j.1752-1688.2007.00071.x; Olsson O, 2008, NATO SCI PEACE SECUR, P277, DOI 10.1007/978-1-4020-8960-2_20; Ongley ED, 1996, CROP EVAPOTRANSPIRAT, V55, P37; Passell HD, 2005, SCI TOTAL ENVIRON, V345, P239, DOI 10.1016/j.scitotenv.2004.11.010; Persson K, 2011, HYDROL EARTH SYST SC, V15, P3195, DOI 10.5194/hess-15-3195-2011; Rakhmatullaev S, 2010, ENVIRON EARTH SCI, V59, P1183, DOI 10.1007/s12665-009-0107-4; Roll G, 2004, REG WORKSH EUR CENTR; Saiko TA, 2000, APPL GEOGR, V20, P349, DOI 10.1016/S0143-6228(00)00014-X; Scheer C, 2009, PLANT SOIL, V314, P273, DOI 10.1007/s11104-008-9728-8; Scheer C, 2008, SOIL BIOL BIOCHEM, V40, P290, DOI 10.1016/j.soilbio.2007.08.007; Schepers J.S., 2008, NITROGEN AGR SYSTEMS; Schluter M, 2013, GLOBAL PLANET CHANGE, V110, P114, DOI 10.1016/j.gloplacha.2013.05.007; Seitzinger S, 2006, ECOL APPL, V16, P2064, DOI 10.1890/1051-0761(2006)016[2064:DALAWA]2.0.CO;2; Seitzinger SP, 2010, GLOBAL BIOGEOCHEM CY, V24, DOI [10.1029/2010GB003851, 10.1029/2009GB003587]; Seitzinger SP, 2002, ESTUARIES, V25, P640, DOI 10.1007/BF02804897; Shanafield M, 2010, BIOGEOCHEMISTRY, V101, P357, DOI 10.1007/s10533-010-9509-3; Shibuo Y, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2007GL031465; Siebert S, 2005, HYDROL EARTH SYST SC, V9, P535, DOI 10.5194/hess-9-535-2005; Smil V, 1999, GLOBAL BIOGEOCHEM CY, V13, P647, DOI 10.1029/1999GB900015; Smith VH, 2003, ENVIRON SCI POLLUT R, V10, P126, DOI 10.1065/espr2002.12.142; Sobota DJ, 2009, BIOGEOCHEMISTRY, V94, P43, DOI 10.1007/s10533-009-9307-y; Solomon S, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P1; Takeda I, 1997, WATER RES, V31, P2685, DOI 10.1016/S0043-1354(97)00117-6; Tao Y, 2010, ESTUAR COAST SHELF S, V86, P345, DOI 10.1016/j.ecss.2009.05.014; Taylor WA., 2000, CHANGE POINT ANAL PO; Thompson SE, 2011, WATER RESOUR RES, V47, DOI [10.1029/2010WR009605, 10.1029/2010WR009998]; Thorslund J, 2012, J ENVIRON MONITOR, V14, P2780, DOI 10.1039/c2em30643c; Tornqvist R, 2012, WATER RESOUR MANAG, V26, P949, DOI 10.1007/s11269-011-9819-9; Tornqvist R, 2011, SUSTAINABLE AGRICULTURAL DEVELOPMENT: RECENT APPROACHES IN RESOURCES MANAGEMENT AND ENVIRONMENTALLY-BALANCED PRODUCTION ENHANCEMENT, P157, DOI 10.1007/978-94-007-0519-7_11; Tornqvist R, 2011, ENVIRON INT, V37, P435, DOI 10.1016/j.envint.2010.11.006; TURC L., 1954, Annales Agronomiques, V5, P491; United States Environmental Protection Agency USEPA, 2005, 510R04002 USEPA; Urynowicz MA, 2007, J ENVIRON ENG, V133, P464, DOI 10.1061/(ASCE)0733-9372(2007)133:5(464); van Kessel C, 2009, J ENVIRON QUAL, V38, P393, DOI 10.2134/jeq2008.0277; Vanni MJ, 2001, BIOGEOCHEMISTRY, V54, P85, DOI 10.1023/A:1010681229460; Vorosmarty CJ, 2000, BIOSCIENCE, V50, P753, DOI 10.1641/0006-3568(2000)050[0753:ADOTTW]2.0.CO;2; Weng LP, 2002, ENVIRON SCI TECHNOL, V36, P4804, DOI 10.1021/es0200084; Who, 2011, GUID DRINK WAT QUAL, Vfourth, DOI DOI 10.1016/S1462-0758(00)00006-6; Yasin JA, 2010, GLOBAL BIOGEOCHEM CY, V24, DOI 10.1029/2009GB003568; Zhulidov AV, 2003, WATER QUALITY MONITO	91	23	23	1	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2015	10	3							e0120015	10.1371/journal.pone.0120015	http://dx.doi.org/10.1371/journal.pone.0120015			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD9NQ	25789866	gold, Green Published, Green Submitted			2022-12-27	WOS:000351425400123
J	Stavale, EJ; Vu, H; Sampath, A; Ramstedt, U; Warfield, KL				Stavale, Eric J.; Hong Vu; Sampath, Aruna; Ramstedt, Urban; Warfield, Kelly L.			In Vivo Therapeutic Protection against Influenza A (H1N1) Oseltamivir-Sensitive and Resistant Viruses by the Iminosugar UV-4	PLOS ONE			English	Article							N-LINKED GLYCANS; HEMAGGLUTININ; GLYCOPROTEIN; CALNEXIN; CASTANOSPERMINE; CELGOSIVIR; INFECTION; EFFICACY; GLYCOSYLATION; ASSOCIATION	Our lead iminosugar analog called UV-4 or N-(9-methoxynonyl)-1-deoxynojirimycin inhibits activity of endoplasmic reticulum (ER) alpha-glucosidases I and II and is a potent, host-targeted antiviral candidate. The mechanism of action for the antiviral activity of iminosugars is proposed to be inhibition of ER alpha-glucosidases leading to misfolding of critical viral glycoproteins. These misfolded glycoproteins would then be incorporated into defective virus particles or targeted for degradation resulting in a reduction of infectious progeny virions. UV-4, and its hydrochloride salt known as UV-4B, is highly potent against dengue virus in vitro and promotes complete survival in a lethal dengue virus mouse model. In the current studies, UV-4 was shown to be highly efficacious via oral gavage against both oseltamivir-sensitive and -resistant influenza A (H1N1) infections in mice even if treatment was initiated as late as 48-72 hours after infection. The minimal effective dose was found to be 80-100 mg/kg when administered orally thrice daily. UV-4 treatment did not affect the development of protective antibody responses after either influenza infection or vaccination. Therefore, UV-4 is a promising candidate for further development as a therapeutic intervention against influenza.	[Stavale, Eric J.; Hong Vu] Integrated Biotherapeut Inc, Gaithersburg, MD USA; [Sampath, Aruna; Ramstedt, Urban; Warfield, Kelly L.] Unither Virol LLC, Silver Spring, MD 20910 USA		Warfield, KL (corresponding author), Unither Virol LLC, Silver Spring, MD 20910 USA.	kwarfield@unithervirology.com			NIAID DMID - Unither Virology, LLC. [HHSN272201100030C]	NIAID DMID - Unither Virology, LLC.	The studies described here were partially funded by NIAID DMID (http://www.niaid.nih.gov/ABOUT/ORGANIZATION/DMID/Pages/default.aspx) contract HHSN272201100030C with the remainder of the studies being sponsored directly by Unither Virology, LLC. NIAID approved study designs performed under their contract but had no role in data collection and analysis, decision to publish, or preparation of the manuscript. Unither Virology provided support in the form of salaries for authors AS, UR, and KLW, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. EJS and HV are employees of Integrated Biotherapeutics, Inc. Integrated Biotherapeutics, Inc., provided support in the form of salaries for authors EJS and HV, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Belmatoug N, 2011, J INHERIT METAB DIS, V34, P991, DOI 10.1007/s10545-011-9368-7; BRAAKMAN I, 1991, J CELL BIOL, V114, P401, DOI 10.1083/jcb.114.3.401; BRIDGES CG, 1995, GLYCOBIOLOGY, V5, P249, DOI 10.1093/glycob/5.2.249; Chang JH, 2013, ANTIVIR RES, V99, P251, DOI 10.1016/j.antiviral.2013.06.011; Dalziel M, 2014, SCIENCE, V343, P37, DOI 10.1126/science.1235681; Daniels R, 2003, MOL CELL, V11, P79, DOI 10.1016/S1097-2765(02)00821-3; DATEMA R, 1984, ARCH VIROL, V81, P25, DOI 10.1007/BF01309294; Durantel D, 2009, CURR OPIN INVEST DR, V10, P860; FISCHL MA, 1994, J ACQ IMMUN DEF SYND, V7, P139; Gagnon RC, 1998, J PHARMACOKINET BIOP, V26, P87, DOI 10.1023/A:1023228925137; Gamblin SJ, 2010, J BIOL CHEM, V285, P28403, DOI 10.1074/jbc.R110.129809; HAMMOND C, 1994, P NATL ACAD SCI USA, V91, P913, DOI 10.1073/pnas.91.3.913; HAMMOND C, 1994, SCIENCE, V266, P456, DOI 10.1126/science.7939687; HEBERT DN, 1995, CELL, V81, P425, DOI 10.1016/0092-8674(95)90395-X; Hebert DN, 1996, EMBO J, V15, P2961, DOI 10.1002/j.1460-2075.1996.tb00659.x; Hebert DN, 1997, J CELL BIOL, V139, P613, DOI 10.1083/jcb.139.3.613; Helenius A, 2004, ANNU REV BIOCHEM, V73, P1019, DOI 10.1146/annurev.biochem.73.011303.073752; Hierholzer J. C., 1996, VIROLOGY METHODS MAN, P25; HORZINEK MC, 1985, KOMPENDIUM ALLGEMEIN; Hurt AC, 2014, CURR OPIN VIROL, V8, P22, DOI 10.1016/j.coviro.2014.04.009; Hussain S, 2014, J ANTIMICROB CHEMOTH; Karaivanova VK, 1998, GLYCOBIOLOGY, V8, P725, DOI 10.1093/glycob/8.7.725; Loregian A, 2014, CELL MOL LIFE SCI; Low JG, 2014, LANCET INFECT DIS, V14, P706, DOI 10.1016/S1473-3099(14)70730-3; MCDOWELL W, 1987, VIROLOGY, V161, P37, DOI 10.1016/0042-6822(87)90168-1; Nayak DP, 2004, VIRUS RES, V106, P147, DOI 10.1016/j.virusres.2004.08.012; PAN YT, 1983, BIOCHEMISTRY-US, V22, P3975, DOI 10.1021/bi00285a038; Pascua PNQ, 2014, CLIN EXP VACCINE RES, V3, P140, DOI 10.7774/cevr.2014.3.2.140; Perry ST, 2013, ANTIVIR RES, V98, P35, DOI 10.1016/j.antiviral.2013.01.004; ROMERO PA, 1983, VIROLOGY, V130, P238, DOI 10.1016/0042-6822(83)90133-2; RUPRECHT RM, 1989, J ACQ IMMUN DEF SYND, V2, P149; Sadat MA, 2014, NEW ENGL J MED, V370, P1615, DOI 10.1056/NEJMoa1302846; Saito T, 2000, J VET MED SCI, V62, P575, DOI 10.1292/jvms.62.575; Suzuki Y, 2005, BIOL PHARM BULL, V28, P399, DOI 10.1248/bpb.28.399; Watanabe S, 2012, ANTIVIR RES, V96, P32, DOI 10.1016/j.antiviral.2012.07.008; Watanabe T, 2014, TRENDS MICROBIOLOGY; WHITE JM, 1997, STRUCTURAL BIOL VIRU, P80	37	22	22	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2015	10	3							e0121662	10.1371/journal.pone.0121662	http://dx.doi.org/10.1371/journal.pone.0121662			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9BN	25786028	gold, Green Submitted, Green Published			2022-12-27	WOS:000352138500214
J	Vehkala, M; Shubin, M; Connor, TR; Thomson, NR; Corander, J				Vehkala, Minna; Shubin, Mikhail; Connor, Thomas R.; Thomson, Nicholas R.; Corander, Jukka			Novel R Pipeline for Analyzing Biolog Phenotypic Microarray Data	PLOS ONE			English	Article							COMMUNITY; SAMPLES	Data produced by Biolog Phenotype MicroArrays are longitudinal measurements of cells' respiration on distinct substrates. We introduce a three-step pipeline to analyze phenotypic microarray data with novel procedures for grouping, normalization and effect identification. Grouping and normalization are standard problems in the analysis of phenotype microarrays defined as categorizing bacterial responses into active and non-active, and removing systematic errors from the experimental data, respectively. We expand existing solutions by introducing an important assumption that active and non-active bacteria manifest completely different metabolism and thus should be treated separately. Effect identification, in turn, provides new insights into detecting differing respiration patterns between experimental conditions, e.g. between different combinations of strains and temperatures, as not only the main effects but also their interactions can be evaluated. In the effect identification, the multilevel data are effectively processed by a hierarchical model in the Bayesian framework. The pipeline is tested on a data set of 12 phenotypic plates with bacterium Yersinia enterocolitica. Our pipeline is implemented in R language on the top of opm R package and is freely available for research purposes.	[Vehkala, Minna; Shubin, Mikhail; Corander, Jukka] Univ Helsinki, Dept Math & Stat, Helsinki, Finland; [Connor, Thomas R.; Thomson, Nicholas R.] Wellcome Trust Sanger Inst, Pathogen Genom, Cambridge, England; [Connor, Thomas R.] Cardiff Univ, Sch Biosci, Cardiff CF10 3AX, S Glam, Wales; [Thomson, Nicholas R.] London Sch Hyg & Trop Med, Dept Infect & Trop Dis, London WC1, England	University of Helsinki; Wellcome Trust Sanger Institute; Cardiff University; University of London; London School of Hygiene & Tropical Medicine	Vehkala, M (corresponding author), Univ Helsinki, Dept Math & Stat, Helsinki, Finland.	minna.vehkala@helsinki.fi	Connor, Thomas/ABD-6533-2021; Thomson, Nicholas R/P-5988-2014; Connor, Thomas/ABE-5989-2020	Thomson, Nicholas R/0000-0002-4432-8505; Connor, Thomas/0000-0003-2394-6504	ERC [239784]; AoF [251170]; Wellcome Trust [098051]	ERC(European Research Council (ERC)European Commission); AoF; Wellcome Trust(Wellcome TrustEuropean Commission)	This work was supported by ERC grant no. 239784 and AoF grant no. 251170. TC and NRT were funded by Wellcome Trust, grant no. 098051 to Wellcome Trust Sanger Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arioli S, 2014, FEMS MICROBIOLOGY LE, P1; Boccuto L, 2013, MOL AUTISM, V4, DOI 10.1186/2040-2392-4-16; Bochner BR, 2009, FEMS MICROBIOL REV, V33, P191, DOI 10.1111/j.1574-6976.2008.00149.x; Bochner BR, 2003, NAT REV GENET, V4, P309, DOI 10.1038/nrg1046; Bochner BR, 2001, GENOME RES, V11, P1246, DOI 10.1101/gr.186501; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Borglin S, 2011, CURRENT OPINION BIOT, V23, P1; DEMPSTER AP, 1977, J ROY STAT SOC B MET, V39, P1, DOI 10.1111/j.2517-6161.1977.tb01600.x; DeNittis M, 2011, LETT APPL MICROBIOL, V52, P96, DOI 10.1111/j.1472-765X.2010.02961.x; Garland JL, 1996, SOIL BIOL BIOCHEM, V28, P213, DOI 10.1016/0038-0717(95)00112-3; Garland JL, 2001, SOIL BIOL BIOCHEM, V33, P1059, DOI 10.1016/S0038-0717(01)00011-6; HAACK SK, 1995, APPL ENVIRON MICROB, V61, P1458, DOI 10.1128/AEM.61.4.1458-1468.1995; Hackett CA, 1997, J MICROBIOL METH, V30, P63, DOI 10.1016/S0167-7012(97)00045-6; Laajala TD, 2012, CLIN CANCER RES, V18, P4385, DOI 10.1158/1078-0432.CCR-11-3215; Lee AJX, 2011, CANCER RES, V71, P1858, DOI 10.1158/0008-5472.CAN-10-3604; Lindstrom JE, 1998, SOIL BIOL BIOCHEM, V30, P231, DOI 10.1016/S0038-0717(97)00113-2; Reuter S, 2014, P NATL ACAD SCI USA, V111, P6768, DOI 10.1073/pnas.1317161111; Sturino J, 2010, INT J BIOSTAT, V6, DOI 10.2202/1557-4679.1227; Vaas LAI, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034846; Weber KP, 2007, J MICROBIOL METH, V69, P461, DOI 10.1016/j.mimet.2007.02.013	20	16	16	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2015	10	3							e0118392	10.1371/journal.pone.0118392	http://dx.doi.org/10.1371/journal.pone.0118392			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9BN	25786143	gold, Green Published, Green Submitted, Green Accepted			2022-12-27	WOS:000352138500030
J	Watanabe, S; Tanimoto, Y; Nishiwaki, H; Watanabe, Y				Watanabe, Seiya; Tanimoto, Yoshiaki; Nishiwaki, Hisashi; Watanabe, Yasuo			Identification and Characterization of Bifunctional Proline Racemase/Hydroxyproline Epimerase from Archaea: Discrimination of Substrates and Molecular Evolution	PLOS ONE			English	Article							TRANS-3-HYDROXY-L-PROLINE DEHYDRATASE; TRYPANOSOMA-CRUZI; CRYSTAL-STRUCTURE; DEHYDROGENASE; RACEMASE; METABOLISM	Proline racemase (ProR) is a member of the pyridoxal 5'-phosphate-independent racemase family, and is involved in the Stickland reaction (fermentation) in certain clostridia as well as the mechanisms underlying the escape of parasites from host immunity in eukaryotic Trypanosoma. Hydroxyproline epimerase (HypE), which is in the same protein family as ProR, catalyzes the first step of the trans-4-hydroxy-L-proline metabolism of bacteria. Their substrate specificities were previously considered to be very strict, in spite of similarities in their structures and catalytic mechanisms, and no racemase/epimerase from the ProR superfamily has been found in archaea. We here characterized the ProR-like protein (OCC_00372) from the hyperthermophilic archaeon, Thermococcus litoralis (TlProR). This protein could reversibly catalyze not only the racemization of proline, but also the epimerization of 4-hydroxyproline and 3-hydroxyproline with similar kinetic constants. Among the four (putative) ligand binding sites, one amino acid substitution was detected between TlProR (tryptophan at the position of 241) and natural ProR (phenylalanine). TheW241F mutant showed a significant preference for proline over hydroxyproline, suggesting that this (hydrophobic and bulky) tryptophan residue played an importance role in the recognition of hydroxyproline (more hydrophilic and bulky than proline), and substrate specificity for hydroxyproline was evolutionarily acquired separately between natural HypE and ProR. A phylogenetic analysis indicated that such unique broad substrate specificity was derived from an ancestral enzyme of this superfamily.	[Watanabe, Seiya; Tanimoto, Yoshiaki; Nishiwaki, Hisashi; Watanabe, Yasuo] Ehime Univ, Fac Agr, Matsuyama, Ehime 7908566, Japan	Ehime University	Watanabe, S (corresponding author), Ehime Univ, Fac Agr, Matsuyama, Ehime 7908566, Japan.	irab@agr.ehime-u.ac.jp						Akanuma S, 2013, P NATL ACAD SCI USA, V110, P11067, DOI 10.1073/pnas.1308215110; Berneman A., 2010, J MICROBIAL BIOCH TE, V2, P139; Bouillaut L, 2013, J BACTERIOL, V195, P844, DOI 10.1128/JB.01492-12; Buschiazzo A, 2006, P NATL ACAD SCI USA, V103, P1705, DOI 10.1073/pnas.0509010103; Chamond N, 2003, J BIOL CHEM, V278, P15484, DOI 10.1074/jbc.M210830200; Chamond N, 2009, MOL BIOCHEM PARASIT, V165, P170, DOI 10.1016/j.molbiopara.2009.02.002; FINLAY TH, 1970, J BIOL CHEM, V245, P5248; Fisher SL, 2008, MICROB BIOTECHNOL, V1, P345, DOI 10.1111/j.1751-7915.2008.00031.x; Goytia M, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000885; Jackson S, 2006, J BACTERIOL, V188, P8487, DOI 10.1128/JB.01370-06; JENSEN RA, 1976, ANNU REV MICROBIOL, V30, P409, DOI 10.1146/annurev.mi.30.100176.002205; Kawakami R, 2005, FEBS J, V272, P4044, DOI 10.1111/j.1742-4658.2005.04810.x; Kawakami R, 2004, EXTREMOPHILES, V8, P99, DOI 10.1007/s00792-003-0368-x; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lamosa P, 1998, APPL ENVIRON MICROB, V64, P3591; Long ZQ, 2001, BIOCHEM BIOPH RES CO, V281, P317, DOI 10.1006/bbrc.2001.4353; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Madern D, 2000, EXTREMOPHILES, V4, P91, DOI 10.1007/s007920050142; NEUNER A, 1990, ARCH MICROBIOL, V153, P205, DOI 10.1007/BF00247822; Penning TM, 2001, CHEM REV, V101, P3027, DOI 10.1021/cr000049n; Reina-San-Martin B, 2000, NAT MED, V6, P890, DOI 10.1038/78651; Sakuraba H, 2012, J BIOL CHEM, V287, P20070, DOI 10.1074/jbc.M111.319038; Sambrook J., 2001, MOL CLONING LAB MANU; Satomura T, 2002, J BIOL CHEM, V277, P12861, DOI 10.1074/jbc.M112272200; Visser WF, 2012, J BIOL CHEM, V287, P21654, DOI 10.1074/jbc.M112.363218; Watanabe S, 2007, J BIOL CHEM, V282, P6685, DOI 10.1074/jbc.M611057200; Watanabe S, 2015, J BIOTECHNOL, V199, P9, DOI 10.1016/j.jbiotec.2015.01.026; Watanabe S, 2014, FEBS OPEN BIO, V4, P617, DOI 10.1016/j.fob.2014.07.005; Watanabe S, 2014, FEBS OPEN BIO, V4, P240, DOI 10.1016/j.fob.2014.02.010; Watanabe S, 2012, J BIOL CHEM, V287, P32674, DOI 10.1074/jbc.M112.374272; White CE, 2012, MOL MICROBIOL, V85, P1133, DOI 10.1111/j.1365-2958.2012.08164.x; Wu GY, 2011, AMINO ACIDS, V40, P1053, DOI 10.1007/s00726-010-0715-z; Zhao SW, 2014, ELIFE, V3, DOI 10.7554/eLife.03275	33	15	15	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2015	10	3							e0120349	10.1371/journal.pone.0120349	http://dx.doi.org/10.1371/journal.pone.0120349			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9BN	25786142	gold, Green Published, Green Submitted			2022-12-27	WOS:000352138500167
J	Lopez-Delgado, JC; Esteve, F; Manez, R; Torrado, H; Carrio, ML; Rodriguez-Castro, D; Farrero, E; Javierre, C; Skaltsa, K; Ventura, JL				Carlos Lopez-Delgado, Juan; Esteve, Francisco; Manez, Rafael; Torrado, Herminia; Carrio, Maria L.; Rodriguez-Castro, David; Farrero, Elisabet; Javierre, Casimiro; Skaltsa, Konstantina; Ventura, Josep L.			The Influence of Body Mass Index on Outcomes in Patients Undergoing Cardiac Surgery: Does the Obesity Paradox Really Exist?	PLOS ONE			English	Article							CARDIOVASCULAR-DISEASE; ADIPOSE-TISSUE; HEART-FAILURE; RISK-FACTOR; MORTALITY; COMPLICATIONS; INFLAMMATION; ASSOCIATION; VENTILATION; PROGRESSION	Purpose Obesity influences risk stratification in cardiac surgery in everyday practice. However, some studies have reported better outcomes in patients with a high body mass index (BMI): this is known as the obesity paradox. The aim of this study was to quantify the effect of diverse degrees of high BMI on clinical outcomes after cardiac surgery, and to assess the existence of an obesity paradox in our patients. Methods A total of 2,499 consecutive patients requiring all types of cardiac surgery with cardiopulmonary bypass between January 2004 and February 2009 were prospectively studied at our institution. Patients were divided into four groups based on BMI: normal weight (18.5-24.9 kg.m(-2); n = 523; 21.4%), overweight (25-29.9kg.m(-2); n = 1150; 47%), obese (>= 30-<= 34.9kg.m(-2); n = 624; 25.5%) and morbidly obese (>= 35kg.m(-2); n = 152; 6.2%). Follow-up was performed in 2,379 patients during the first year. Results After adjusting for confounding factors, patients with higher BMI presented worse oxygenation and better nutritional status, reflected by lower PaO2/FiO(2) at 24h and higher albumin levels 48h after admission respectively. Obese patients showed a higher risk for Perioperative Myocardial Infarction (OR: 1.768; 95% CI: 1.035-3.022; p = 0.037) and septicaemia (OR: 1.489; 95% CI: 1.282-1.997; p = 0.005). In-hospital mortality was 4.8% (n = 118) and 1-year mortality was 10.1% (n = 252). No differences were found regarding in-hospital mortality between BMI groups. The overweight group showed better 1-year survival than normal weight patients (91.2% vs. 87.6%; Log Rank: p = 0.029. HR: 1.496; 95% CI: 1.062-2.108; p = 0.021). Conclusions In our population, obesity increases Perioperative Myocardial Infarction and septicaemia after cardiac surgery, but does not influence in-hospital mortality. Although we found better 1-year survival in overweight patients, our results do not support any protective effect of obesity in patients undergoing cardiac surgery.	[Carlos Lopez-Delgado, Juan; Esteve, Francisco; Manez, Rafael; Torrado, Herminia; Carrio, Maria L.; Rodriguez-Castro, David; Farrero, Elisabet; Ventura, Josep L.] Hosp Univ Bellvitge, Dept Intens Care, IDIBELL Inst Invest Biomed Bellvitge, Biomed Invest Inst Bellvitge, C Feixa Llarga S-N, Barcelona 08907, Spain; [Javierre, Casimiro] Univ Barcelona, Dept Physiol Sci 2, Barcelona, Spain; [Skaltsa, Konstantina] Univ Barcelona, Dept Publ Hlth, Barcelona, Spain	Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); Bellvitge University Hospital; University of Barcelona; University of Barcelona; University of Barcelona	Lopez-Delgado, JC (corresponding author), Hosp Univ Bellvitge, Dept Intens Care, IDIBELL Inst Invest Biomed Bellvitge, Biomed Invest Inst Bellvitge, C Feixa Llarga S-N, Barcelona 08907, Spain.	juancarloslopezde@hotmail.com	Lopez-Delgado, Juan Carlos/ABF-3341-2020	Lopez-Delgado, Juan Carlos/0000-0003-3324-1129; Manez, Rafael/0000-0002-0884-5564				Ahmed D, 2011, J CARDIOVASC SURG, V52, P99; Aldenkortt M, 2012, BRIT J ANAESTH, V109, P493, DOI 10.1093/bja/aes338; Arbogast PG, 2011, AM J EPIDEMIOL, V174, P613, DOI 10.1093/aje/kwr143; Sa MPBD, 2012, REV BRAS CIR CARDIOV, V27, P217, DOI 10.5935/1678-9741.20120037; Birkmeyer NJO, 1998, CIRCULATION, V97, P1689, DOI 10.1161/01.CIR.97.17.1689; Campbell DJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081798; Cook TM, 2012, BRIT J ANAESTH, V109, pI68, DOI 10.1093/bja/aes393; Dossett LA, 2009, SURG INFECT, V10, P137, DOI 10.1089/sur.2008.028; Eagle Kim A, 2004, Circulation, V110, pe340; Engelman DT, 1999, J THORAC CARDIOV SUR, V118, P866, DOI 10.1016/S0022-5223(99)70056-5; Gabrielle F, 1997, EUR J CARDIO-THORAC, V11, P406, DOI 10.1016/S1010-7940(96)01110-4; Golia E, 2014, WORLD J CARDIOL, V6, P539, DOI 10.4330/wjc.v6.i7.539; Gustafsson F, 2005, EUR HEART J, V26, P58, DOI 10.1093/eurheartj/ehi022; Hotamisligil GS, 2006, NATURE, V444, P860, DOI 10.1038/nature05485; HUBERT HB, 1983, CIRCULATION, V67, P968, DOI 10.1161/01.CIR.67.5.968; Hulsmans M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030414; Kilger E, 2011, MINERVA ANESTESIOL, V77, P268; Klasen J, 2004, OBES SURG, V14, P275, DOI 10.1381/096089204322857708; Kunt AG, 2013, INTERACT CARDIOV TH, V16, P625, DOI 10.1093/icvts/ivt022; Kurabayashi M, 2010, CIRC J, V74, P2066, DOI 10.1253/circj.CJ-10-0336; Lavie CJ, 2009, J AM COLL CARDIOL, V53, P1925, DOI 10.1016/j.jacc.2008.12.068; Silva PL, 2012, MINERVA ANESTESIOL, V78, P1136; Martinez-Comendador JM, 2009, EUR J CARDIO-THORAC, V36, P998, DOI 10.1016/j.ejcts.2009.05.022; Martino JL, 2011, CHEST, V140, P1198, DOI 10.1378/chest.10-3023; McGill HC, 2002, CIRCULATION, V105, P2712, DOI 10.1161/01.CIR.0000018121.67607.CE; Mohamed-Ali V, 1999, AM J PHYSIOL-ENDOC M, V277, pE971, DOI 10.1152/ajpendo.1999.277.6.E971; Moulton MJ, 1996, CIRCULATION, V94, P87; Oreopoulos A, 2008, AM HEART J, V156, P13, DOI 10.1016/j.ahj.2008.02.014; Pietrucha AZ, 2011, ADV MED SCI-POLAND, V56, P241, DOI 10.2478/v10039-011-0054-7; Rahmanian PB, 2010, ANN THORAC SURG, V90, P1221, DOI 10.1016/j.athoracsur.2010.05.015; Ranucci M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093992; Rapp-Kesek D, 2004, CLIN NUTR, V23, P1398, DOI 10.1016/j.clnu.2004.06.006; Romero-Corral A, 2006, LANCET, V368, P666, DOI 10.1016/S0140-6736(06)69251-9; Rudiger A, 2007, CRIT CARE MED, V35, P1599, DOI 10.1097/01.CCM.0000266683.64081.02; Sakr Y, 2008, INTENS CARE MED, V34, P1999, DOI 10.1007/s00134-008-1243-0; Stamou SC, 2011, ANN THORAC SURG, V91, P42, DOI 10.1016/j.athoracsur.2010.08.047; Tosa S, 2009, INT HEART J, V50, P173, DOI 10.1536/ihj.50.173; Vaduganathan M, 2012, AM J CARDIOL, V110, P1667, DOI 10.1016/j.amjcard.2012.07.041; Valentijn TM, 2013, SURG-J R COLL SURG E, V11, P169, DOI 10.1016/j.surge.2013.02.003; Wurzinger B, 2010, WIEN KLIN WOCHENSCHR, V122, P31, DOI 10.1007/s00508-009-1241-4	40	41	41	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2015	10	3							e0118858	10.1371/journal.pone.0118858	http://dx.doi.org/10.1371/journal.pone.0118858			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7QC	25781994	Green Published, Green Submitted, gold			2022-12-27	WOS:000351284600035
J	Sun, WJ; Yu, YQ; Yuan, JQ; Li, CW; Liu, TT; Lin, DD; Lau, A; Zhong, CK; Xu, T; Shan, GL				Sun, Wenjie; Yu, Yaqin; Yuan, Jingqin; Li, Changwei; Liu, Tingting; Lin, Dongdong; Lau, Abby; Zhong, Chongke; Xu, Tan; Shan, GuangLiang			Sleep Duration and Quality among Different Occupations-China National Study	PLOS ONE			English	Article							HEALTH INTERVIEW SURVEY; LIFE-STYLE; PREVALENCE; DISPARITIES; INDUSTRY; WOMEN	Objective To examine the associations between occupation, sleep duration and sleep quality. Methods The data for this study was extracted from data collected from the 2008 Chinese Suboptimal Health Study. Our study sample consisted of 18,316 Chinese subjects aged 18-65. Occupation and other relevant characteristics to sleep were collected. We used the Pittsburgh Sleep Quality Index (PSQI) to measure sleep quality and multiple logistic regression models to examine the association of occupation with shortened sleep duration and poor sleep quality. Results Farmers had the longest sleep duration (mean=8.22 hours) while the civil servants had the shortest sleep duration (mean=7.85 hours). Farmers also had the best sleep quality (mean score=3.74) while professional workers had the worst sleep quality (mean score=4.87). Compared to civil servants, the OR of shortened sleep duration and poor sleep quality for blue collar workers is 1.39 (95% CI: 1.11-1.73) and 1.28 (95%-CI: 1.15-1.42), respectively, after adjusting for age, sex, marital status, education, area, smoking, drinking, pain, and health status. Conclusion sleep duration and quality varied among different Chinese occupation populations. The blue collar workers are more likely to have shortened sleep duration and poor sleep quality.	[Sun, Wenjie] Guangdong Pharmaceut Univ, Sch Food Sci, Zhongshan 528458, Peoples R China; [Sun, Wenjie] Tulane Univ, Sch Publ Hlth & Trop Med, New Orleans, LA 70112 USA; [Yu, Yaqin] Jilin Univ, Sch Publ Hlth, Dept Epidemiol, Changchun 130021, Peoples R China; [Yuan, Jingqin] Ningxia Autonomous Reg Dept Publ Hlth, Yinchuan 750001, Ningxia, Peoples R China; [Li, Changwei; Xu, Tan] Tulane Univ, Sch Publ Hlth & Trop Med, Dept Epidemiol, New Orleans, LA 70112 USA; [Liu, Tingting] Emory Univ, Nell Hodgson Woodruff Sch Nursing, Atlanta, GA 30322 USA; [Lin, Dongdong] Tulane Univ, Sch Sci & Engn, New Orleans, LA 70112 USA; [Lau, Abby] Tulane Univ, Dept Infect Dis, Sch Med, New Orleans, LA 70112 USA; [Zhong, Chongke; Xu, Tan] Soochow Univ, Coll Med, Sch Publ Hlth, Dept Epidemiol, Suzhou 215123, Jiangsu, Peoples R China; [Shan, GuangLiang] Chinese Acad Med Sci, Inst Basic Med Sci, Dept Epidemiol & Stat, Beijing, Peoples R China; [Shan, GuangLiang] Peking Union Med Coll, Sch Basic Med, Beijing, Peoples R China	Guangdong Pharmaceutical University; Tulane University; Jilin University; Tulane University; Emory University; Tulane University; Tulane University; Soochow University - China; Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Basic Medical Sciences - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College	Xu, T (corresponding author), Tulane Univ, Sch Publ Hlth & Trop Med, Dept Epidemiol, New Orleans, LA 70112 USA.	xutan@suda.edu.cn; guangliang_shan@hotmail.com	Zhong, Chongke/AAI-6454-2020; Li, Changwei/S-5615-2016; Lin, Dongdong/A-8337-2017; Sun, Wenjie/I-7692-2013; Liu, Tingting/S-3995-2016	Li, Changwei/0000-0002-9203-304X; Liu, Tingting/0000-0002-7348-809X	National High Technology Research and Development Program of China (863 Program) [2006AA02Z428]; Fogarty International Center of the National Institutes of Health [D43TW009107]	National High Technology Research and Development Program of China (863 Program)(National High Technology Research and Development Program of China); Fogarty International Center of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC))	This study was funded by National High Technology Research and Development Program of China (863 Program) (NO. 2006AA02Z428) and Fogarty International Center of the National Institutes of Health under Award Number D43TW009107. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anders MP, 2013, EUR J PUBLIC HLTH; Cappuccio FP, 2010, SLEEP, V33, P585, DOI 10.1093/sleep/33.5.585; Chien Pei-Li, 2013, Sleep Disord, V2013, P283490, DOI 10.1155/2013/283490; Gamaldo AA, 2014, J CLIN SLEEP MED, V10, P725, DOI 10.5664/jcsm.3858; Geroldi C, 1996, GERONTOLOGY, V42, P163; Gildner TE, 2014, AM J HUM BIOL; Hoefelmann LP, 2012, SLEEP MED, V13, P1198, DOI 10.1016/j.sleep.2012.05.009; Jackson CL, 2014, SOC SCI MED, V118, P71, DOI 10.1016/j.socscimed.2014.07.059; Jackson CL, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-552; Jean-Louis G, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-290; Luckhaupt SE, 2010, SLEEP, V33, P149, DOI 10.1093/sleep/33.2.149; Luo JF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081261; Luxton DD, 2011, SLEEP, V34, P1189, DOI 10.5665/SLEEP.1236; Mozaffarian D, 2011, NEW ENGL J MED, V364, P2392, DOI 10.1056/NEJMoa1014296; Peltzer K, 2014, SLEEP BREATH; Tom SE, 2013, WOMEN HEALTH ISS, V23, pE295, DOI 10.1016/j.whi.2013.06.002; Whinnery J, 2014, SLEEP, V37, P601, DOI 10.5665/sleep.3508; Wu MC, 2012, PREV MED, V55, P305, DOI 10.1016/j.ypmed.2012.07.013; Zhan YQ, 2014, SLEEP MED, V15, P833, DOI 10.1016/j.sleep.2014.02.006; Zizi F, 2012, AM J MED, V125, P162, DOI 10.1016/j.amjmed.2011.08.020	20	28	32	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2015	10	3							e0117700	10.1371/journal.pone.0117700	http://dx.doi.org/10.1371/journal.pone.0117700			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7QC	25782005	Green Published, Green Submitted, gold			2022-12-27	WOS:000351284600015
J	Shih, CH; Chen, HY; Lee, HC; Tsai, HJ				Shih, Chen-Han; Chen, Hsiao-Yin; Lee, Hung-Chieh; Tsai, Huai-Jen			Purple Chromoprotein Gene Serves as a New Selection Marker for Transgenesis of the Microalga Nannochloropsis oculata	PLOS ONE			English	Article							CHLAMYDOMONAS-REINHARDTII CHLOROPLAST; SITE-SPECIFIC RECOMBINATION; DOMINANT SELECTABLE MARKER; NUCLEAR TRANSFORMATION; REPORTER GENE; HEAT-SHOCK; PLANTS; EXPRESSION; EXCISION; REMOVAL	Among the methods used to screen transgenic microalgae, antibiotics selection has raised environmental and food safety concerns, while the observation of fluorescence proteins could be influenced by the endogenous fluorescence of host chloroplasts. As an alternative, this study isolated the purple chromoprotein (CP) from Stichodacyla haddoni (shCP). A plasmid in which shCP cDNA is driven by a heat-inducible promoter was linearized and electroporated into 2.5x10(8) protoplasts of Nannochloropsis oculata. Following regeneration and cultivation on an f/2 medium plate for two weeks, we observed 26 colonies that displayed a slightly dark green coloration. After individually subculturing and performing five hours of heat shock at 42 degrees C, a dark brown color was mosaically displayed in five of these colonies, indicating that both untransformed and transformed cells were mixed together in each colony. To obtain a uniform expression of shCP throughout the whole colony, we continuously isolated each transformed cell that exhibited brown coloration and subcultured it on a fresh plate, resulting in the generation of five transgenic lines of N. oculata which stably harbored the shCP gene for at least 22 months, as confirmed by PCR detection and observation by the naked eye. As shown by Western blot, exogenous shCP protein was expressed in these transgenic microalgae. Since shCP protein is biodegradable and originates from a marine organism, both environmental and food safety concerns have been eliminated, making this novel shCP reporter gene a simple, but effective and ecologically safe, marker for screening and isolating transgenic microalgae.	[Shih, Chen-Han; Chen, Hsiao-Yin; Lee, Hung-Chieh; Tsai, Huai-Jen] Natl Taiwan Univ, Inst Mol & Cellular Biol, Taipei 10764, Taiwan; [Lee, Hung-Chieh; Tsai, Huai-Jen] MacKay Med Coll, Inst Biomed Sci, New Taipei City, Taiwan	National Taiwan University; Mackay Medical College	Tsai, HJ (corresponding author), Natl Taiwan Univ, Inst Mol & Cellular Biol, Taipei 10764, Taiwan.	hjtsai@ntu.edu.tw			National Science Council, Taiwan [NSC 103-2313-B-002 -048 -MY2]	National Science Council, Taiwan(Ministry of Science and Technology, Taiwan)	This work was supported by the National Science Council, Taiwan, under grant NSC 103-2313-B-002 -048 -MY2. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allnutt FCT, 2000, United States of America Patent Number, Patent No. 6027900; Apt KE, 1999, J PHYCOL, V35, P215, DOI 10.1046/j.1529-8817.1999.3520215.x; Apt KE, 1996, MOL GEN GENET, V252, P572, DOI 10.1007/s004380050264; Atkins TW, 1998, BIOMATERIALS, V19, P61, DOI 10.1016/S0142-9612(97)00156-7; Bhattacharya Anjanabha, 2012, Methods Mol Biol, V877, P401, DOI 10.1007/978-1-61779-818-4_29; Chen HC, 2013, PLANT BIOTECHNOL J, V11, P818, DOI 10.1111/pbi.12073; Chen Y, 2001, CURR GENET, V39, P365, DOI 10.1007/s002940100205; Chiang CY, 2014, MAR BIOTECHNOL, V16, P436, DOI 10.1007/s10126-014-9563-2; Coll JM, 2006, SPAN J AGRIC RES, V4, P316; Coppoolse ER, 2003, PLANT MOL BIOL, V51, P263, DOI 10.1023/A:1021174726070; DALE EC, 1991, P NATL ACAD SCI USA, V88, P10558, DOI 10.1073/pnas.88.23.10558; Dawson HN, 1997, CURR MICROBIOL, V35, P356, DOI 10.1007/s002849900268; Day A, 2011, PLANT BIOTECHNOL J, V9, P540, DOI 10.1111/j.1467-7652.2011.00604.x; DEBUCHY R, 1989, EMBO J, V8, P2803, DOI 10.1002/j.1460-2075.1989.tb08426.x; Duerr EO, 1998, J MAR BIOTECHNOL, V6, P65; FERNANDEZ E, 1989, P NATL ACAD SCI USA, V86, P6449, DOI 10.1073/pnas.86.17.6449; Fischer N, 1996, MOL GEN GENET, V251, P373, DOI 10.1007/s004380050179; Franklin S, 2002, PLANT J, V30, P733, DOI 10.1046/j.1365-313X.2002.01319.x; Guillard R.R.L., 1975, CULTURE MARINE INVER, P29, DOI [10.1007/978-1-4615-8714-9_3., 10.1007/978-1-4615-8714-9_3]; HALL LM, 1993, GENE, V124, P75, DOI 10.1016/0378-1119(93)90763-S; Hare PD, 2002, NAT BIOTECHNOL, V20, P575, DOI 10.1038/nbt0602-575; Heifetz PB, 2000, BIOCHIMIE, V82, P655, DOI 10.1016/S0300-9084(00)00608-8; Heitzer M, 2007, ADV EXP MED BIOL, V616, P46; Kilian O, 2011, P NATL ACAD SCI USA, V108, P21265, DOI 10.1073/pnas.1105861108; Klaus SMJ, 2004, NAT BIOTECHNOL, V22, P225, DOI 10.1038/nbt933; KROPAT J, 1995, MOL GEN GENET, V248, P727, DOI 10.1007/BF02191713; Kropat J, 1997, P NATL ACAD SCI USA, V94, P14168, DOI 10.1073/pnas.94.25.14168; LANDY A, 1989, ANNU REV BIOCHEM, V58, P913, DOI 10.1146/annurev.biochem.58.1.913; Lauersen KJ, 2013, J BIOTECHNOL, V167, P101, DOI 10.1016/j.jbiotec.2012.10.010; Lavens P, 1996, FAO FISHERIES TECHNI; Li SS, 2009, FISH SHELLFISH IMMUN, V26, P316, DOI 10.1016/j.fsi.2008.07.004; Lim FY, 2012, METHOD ENZYMOL, V517, P303, DOI 10.1016/B978-0-12-404634-4.00015-2; Mats B, 2002, BR PHYCOL J, V2, P401; Mayfield SP, 2004, PLANT J, V37, P449, DOI 10.1046/j.1365-313X.2003.01965.x; Miki B, 2004, J BIOTECHNOL, V107, P193, DOI 10.1016/j.jbiotec.2003.10.011; NELSON JAE, 1994, MOL CELL BIOL, V14, P4011, DOI 10.1128/MCB.14.6.4011; ONOUCHI H, 1995, MOL GEN GENET, V247, P653, DOI 10.1007/BF00290396; Radakovits R, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1688; Rochaix JD, 1997, TRENDS PLANT SCI, V2, P419, DOI 10.1016/S1360-1385(97)90025-X; Schroda M, 2000, PLANT J, V21, P121, DOI 10.1046/j.1365-313x.2000.00652.x; Scutt CP, 2002, BIOCHIMIE, V84, P1119, DOI 10.1016/S0300-9084(02)00021-4; Shields RJ, 2012, J ANIM SCI, V21, P23; Sizova I, 2001, GENE, V277, P221, DOI 10.1016/S0378-1119(01)00616-3; Sreekala C, 2005, PLANT CELL REP, V24, P86, DOI 10.1007/s00299-004-0909-5; Srivastava V, 1999, P NATL ACAD SCI USA, V96, P11117, DOI 10.1073/pnas.96.20.11117; Stevens DR, 1996, MOL GEN GENET, V251, P23; SUKENIK A, 1991, AQUACULTURE, V97, P61, DOI 10.1016/0044-8486(91)90279-G; Trautwein EA, 2001, EUR J LIPID SCI TECH, V103, P45, DOI 10.1002/1438-9312(200101)103:1<45::AID-EJLT45>3.0.CO;2-9; Upadhyaya CP, 2010, BOT STUD, V51, P277; Walker TL, 2005, PLANT CELL REP, V24, P629, DOI 10.1007/s00299-005-0004-6; Wang HH, 2009, J GENET GENOMICS, V36, P387, DOI 10.1016/S1673-8527(08)60128-9; Woo HJ, 2009, TRANSGENIC RES, V18, P455, DOI 10.1007/s11248-008-9236-x; Yamaguchi K., 1997, J APPL PHYCOL, V8, P487; Yau YY, 2013, BMC BIOTECHNOL, V13, DOI 10.1186/1472-6750-13-36; Zhang W, 2003, THEOR APPL GENET, V107, P1157, DOI 10.1007/s00122-003-1368-z; Zuo JR, 2001, NAT BIOTECHNOL, V19, P157, DOI 10.1038/84428	56	11	13	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2015	10	3							e0120780	10.1371/journal.pone.0120780	http://dx.doi.org/10.1371/journal.pone.0120780			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8HY	25793255	gold, Green Submitted, Green Published			2022-12-27	WOS:000352083900075
J	Bakke, SS; Feng, YZ; Nikolic, N; Kase, ET; Moro, C; Stensrud, C; Damlien, L; Ludahl, MO; Sandbu, R; Solheim, BM; Rustan, AC; Hjelmesaeth, J; Thoresen, GH; Aas, V				Bakke, Siril S.; Feng, Yuan Z.; Nikolic, Natasa; Kase, Eili T.; Moro, Cedric; Stensrud, Camilla; Damlien, Lisbeth; Ludahl, Marianne O.; Sandbu, Rune; Solheim, Brita Marie; Rustan, Arild C.; Hjelmesaeth, Joran; Thoresen, G. Hege; Aas, Vigdis			Myotubes from Severely Obese Type 2 Diabetic Subjects Accumulate Less Lipids and Show Higher Lipolytic Rate than Myotubes from Severely Obese Non-Diabetic Subjects	PLOS ONE			English	Article							HUMAN SKELETAL-MUSCLE; FATTY-ACID OXIDATION; HORMONE-SENSITIVE LIPASE; INSULIN-RESISTANCE; MITOCHONDRIAL-FUNCTION; EXPRESSION; MEN; TRIACYLGLYCEROL; DIACYLGLYCEROL; MYOCYTES	About 80% of patients with type 2 diabetes are classified as overweight. However, only about 1/3 of severely obese subjects have type 2 diabetes. This indicates that several severely obese individuals may possess certain characteristics that protect them against type 2 diabetes. We therefore hypothesized that this apparent paradox could be related to fundamental differences in skeletal muscle lipid handling. Energy metabolism and metabolic flexibility were examined in human myotubes derived from severely obese subjects without (BMI 44 +/- 7 kg/m(2)) and with type 2 diabetes (BMI 43 +/- 6 kg/m(2)). Lower insulin sensitivity was observed in myotubes from severely obese subjects with type 2 diabetes. Lipolysis rate was higher, and oleic acid accumulation, triacylglycerol content, and fatty acid adaptability were lower in myotubes from severely obese subjects with type 2 diabetes compared to severely obese non-diabetic subjects. There were no differences in lipid distribution and mRNA and protein expression of the lipases HSL and ATGL, the lipase cofactor CGI-58, or the lipid droplet proteins PLIN2 and PLIN3. Glucose and oleic acid oxidation were also similar in cells from the two groups. In conclusion, myotubes established from severely obese donors with established type 2 diabetes had lower ability for lipid accumulation and higher lipolysis rate than myotubes from severely obese donors without diabetes. This indicates that a difference in intramyocellular lipid turnover might be fundamental in evolving type 2 diabetes.	[Bakke, Siril S.; Feng, Yuan Z.; Nikolic, Natasa; Kase, Eili T.; Stensrud, Camilla; Damlien, Lisbeth; Rustan, Arild C.; Thoresen, G. Hege] Univ Oslo, Sch Pharm, Dept Pharmaceut Biosci, Oslo, Norway; [Moro, Cedric] Univ Toulouse, Inst Metab & Cardiovasc Dis, INSERM, Unite Mixte Rech 1048,Obes Res Lab, Toulouse, France; [Ludahl, Marianne O.; Aas, Vigdis] Oslo & Akershus Univ, Coll Appl Sci, Fac Hlth, Oslo, Norway; [Sandbu, Rune; Solheim, Brita Marie; Hjelmesaeth, Joran] Vestfold Hosp Trust, Morbid Obes Ctr, Tonsberg, Norway; [Hjelmesaeth, Joran; Thoresen, G. Hege] Univ Oslo, Fac Med, Inst Clin Med, Dept Pharmacol, Oslo, Norway; [Hjelmesaeth, Joran; Thoresen, G. Hege] Oslo Univ Hosp, Oslo, Norway	University of Oslo; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Oslo Metropolitan University (OsloMet); University of Oslo; University of Oslo	Aas, V (corresponding author), Oslo & Akershus Univ, Coll Appl Sci, Fac Hlth, Oslo, Norway.	vigdis.aas@hioa.no	, Natasa/X-3265-2019; Moro, Cedric/N-5754-2017	, Natasa/0000-0001-9614-9050; Moro, Cedric/0000-0003-4294-0597	Norwegian Research Council, Oslo and Akershus University College of Applied Sciences; National Research Agency [ANR-12-JSV1-0010-01]; Societe Francophone du Diabete	Norwegian Research Council, Oslo and Akershus University College of Applied Sciences; National Research Agency(French National Research Agency (ANR)); Societe Francophone du Diabete	This work was supported by grants from Norwegian Research Council, Oslo and Akershus University College of Applied Sciences. The authors would also thank NBS (Norwegian biochemical society) and Diabetesforbundet for their contributions. CM is supported by grants from the National Research Agency ANR-12-JSV1-0010-01 and Societe Francophone du Diabete. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aas V, 2006, J LIPID RES, V47, P366, DOI 10.1194/jlr.M500300-JLR200; Badin PM, 2013, TRENDS ENDOCRIN MET, V24, P607, DOI 10.1016/j.tem.2013.08.001; Badin PM, 2011, DIABETES, V60, P1734, DOI 10.2337/db10-1364; Bakke SS, 2012, BBA-MOL CELL BIOL L, V1821, P1323, DOI 10.1016/j.bbalip.2012.07.001; Bandyopadhyay GK, 2006, DIABETES, V55, P2277, DOI 10.2337/db06-0062; Bell JA, 2010, J CLIN ENDOCR METAB, V95, P3400, DOI 10.1210/jc.2009-1596; Bergman BC, 2012, DIABETOLOGIA, V55, P1140, DOI 10.1007/s00125-011-2419-7; Bezaire V, 2009, J BIOL CHEM, V284, P18282, DOI 10.1074/jbc.M109.008631; Bikman BT, 2010, AM J PHYSIOL-REG I, V298, pR1692, DOI 10.1152/ajpregu.00190.2009; Boyle KE, 2012, INT J OBESITY, V36, P1025, DOI 10.1038/ijo.2011.201; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Bucci M, 2011, AM J PHYSIOL-ENDOC M, V301, pE105, DOI 10.1152/ajpendo.00680.2010; Chomentowski P, 2011, J CLIN ENDOCR METAB, V96, P494, DOI 10.1210/jc.2010-0822; Coen PM, 2012, TRENDS ENDOCRIN MET, V23, P391, DOI 10.1016/j.tem.2012.05.009; Consitt LA, 2010, DIABETES, V59, P1407, DOI 10.2337/db09-1704; Corpeleijn E, 2008, OBESITY, V16, P1025, DOI 10.1038/oby.2008.24; Corpeleijn E, 2010, AM J PHYSIOL-ENDOC M, V299, pE14, DOI 10.1152/ajpendo.00187.2010; Dela F, 2013, INT J BIOCHEM CELL B, V45, P11, DOI 10.1016/j.biocel.2012.09.019; Galgani JE, 2013, J CLIN ENDOCR METAB, V98, pE646, DOI 10.1210/jc.2012-3111; Gaster M, 2004, DIABETES, V53, P542, DOI 10.2337/diabetes.53.3.542; Gaster M, 2001, APMIS, V109, P735, DOI 10.1034/j.1600-0463.2001.d01-140.x; Gaster M, 2011, BIOCHEM BIOPH RES CO, V404, P1023, DOI 10.1016/j.bbrc.2010.12.102; Gjelstad IMF, 2012, ARCH PHYSIOL BIOCHEM, V118, P22, DOI 10.3109/13813455.2011.630009; Hessvik NP, 2010, J LIPID RES, V51, P2090, DOI 10.1194/jlr.M003319; Hittel DS, 2009, DIABETES, V58, P30, DOI 10.2337/db08-0943; Hofso D, 2010, OBES SURG, V20, P302, DOI 10.1007/s11695-009-0022-5; Holloway GP, 2007, AM J PHYSIOL-ENDOC M, V292, pE1782, DOI 10.1152/ajpendo.00639.2006; Holm C, 2000, METH MOL B, V155, P97; Hulver MW, 2005, CELL METAB, V2, P251, DOI 10.1016/j.cmet.2005.09.002; Jocken JWE, 2008, DIABETES, V57, P1834, DOI 10.2337/db07-0857; Jocken JWE, 2010, J CLIN ENDOCR METAB, V95, P5449, DOI 10.1210/jc.2010-0776; Kelley DE, 2000, DIABETES, V49, P677, DOI 10.2337/diabetes.49.5.677; Kim JY, 2000, AM J PHYSIOL-ENDOC M, V279, pE1039, DOI 10.1152/ajpendo.2000.279.5.E1039; Kim YB, 2003, DIABETES, V52, P1935, DOI 10.2337/diabetes.52.8.1935; Kitzmann M, 2011, BBA-MOL BASIS DIS, V1812, P423, DOI 10.1016/j.bbadis.2010.12.007; Krssak M, 1999, DIABETOLOGIA, V42, P113, DOI 10.1007/s001250051123; Lanza IR, 2009, AM J CLIN NUTR, V89, p467S, DOI 10.3945/ajcn.2008.26717D; Moro C, 2008, AM J PHYSIOL-ENDOC M, V294, pE203, DOI 10.1152/ajpendo.00624.2007; Phielix E, 2011, GERONTOLOGY, V57, P387, DOI 10.1159/000317691; Ritov VB, 2005, DIABETES, V54, P8, DOI 10.2337/diabetes.54.1.8; Smyth S, 2006, NAT MED, V12, P75, DOI 10.1038/nm0106-75; Sparks LM, 2014, DIABETES, V63, P1583, DOI 10.2337/db13-1123; Straczkowski M, 2007, DIABETOLOGIA, V50, P2366, DOI 10.1007/s00125-007-0781-2; Timmers S, 2012, P NATL ACAD SCI USA, V109, P11711, DOI 10.1073/pnas.1206868109; TURINSKY J, 1990, J BIOL CHEM, V265, P16880; Ukropcova B, 2005, J CLIN INVEST, V115, P1934, DOI 10.1172/JCI24332; van Loon LJC, 2004, AM J PHYSIOL-ENDOC M, V287, pE558, DOI 10.1152/ajpendo.00464.2003; Wensaas AJ, 2007, J LIPID RES, V48, P961, DOI 10.1194/jlr.D600047-JLR200; Wensaas AJ, 2009, DIABETES, V58, P527, DOI 10.2337/db08-1043	49	18	18	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2015	10	3							e0119556	10.1371/journal.pone.0119556	http://dx.doi.org/10.1371/journal.pone.0119556			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD9NQ	25790476	Green Published, gold, Green Submitted			2022-12-27	WOS:000351425400089
J	Crew, JD; Galvin, JJ; Landsberger, DM; Fu, QJ				Crew, Joseph D.; Galvin, John J., III; Landsberger, David M.; Fu, Qian-Jie			Contributions of Electric and Acoustic Hearing to Bimodal Speech and Music Perception	PLOS ONE			English	Article							MELODIC CONTOUR IDENTIFICATION; COCHLEAR IMPLANT USERS; COMPETING INSTRUMENT; OPPOSITE EARS; RECOGNITION; STIMULATION; AID; RECIPIENTS; BENEFIT; NOISE	Cochlear implant (CI) users have difficulty understanding speech in noisy listening conditions and perceiving music. Aided residual acoustic hearing in the contralateral ear can mitigate these limitations. The present study examined contributions of electric and acoustic hearing to speech understanding in noise and melodic pitch perception. Data was collected with the CI only, the hearing aid (HA) only, and both devices together (CI+HA). Speech reception thresholds (SRTs) were adaptively measured for simple sentences in speech babble. Melodic contour identification (MCI) was measured with and without a masker instrument; the fundamental frequency of the masker was varied to be overlapping or non-overlapping with the target contour. Results showed that the CI contributes primarily to bimodal speech perception and that the HA contributes primarily to bimodal melodic pitch perception. In general, CI+HA performance was slightly improved relative to the better ear alone (CI-only) for SRTs but not for MCI, with some subjects experiencing a decrease in bimodal MCI performance relative to the better ear alone (HA-only). Individual performance was highly variable, and the contribution of either device to bimodal perception was both subject-and task-dependent. The results suggest that individualized mapping of CIs and HAs may further improve bimodal speech and music perception.	[Crew, Joseph D.] Univ So Calif, Dept Biomed Engn, Los Angeles, CA 90089 USA; [Galvin, John J., III; Fu, Qian-Jie] Univ Calif Los Angeles, Dept Head & Neck Surg, Los Angeles, CA USA; [Landsberger, David M.] NYU, Sch Med, Dept Otolaryngol, New York, NY USA	University of Southern California; University of California System; University of California Los Angeles; New York University	Crew, JD (corresponding author), Univ So Calif, Dept Biomed Engn, Los Angeles, CA 90089 USA.	jcrew@usc.edu			University of Southern California Provost Fellowship; University of Southern California Hearing and Communication Neuroscience Program; National Institutes of Health: National Institute on Deafness and Communication Disorders [R01-DC004993]; Paul Veneklasen Research Foundation; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [T32DC009975, R01DC004993] Funding Source: NIH RePORTER	University of Southern California Provost Fellowship; University of Southern California Hearing and Communication Neuroscience Program; National Institutes of Health: National Institute on Deafness and Communication Disorders(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); Paul Veneklasen Research Foundation; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was supported by the University of Southern California Provost Fellowship, the University of Southern California Hearing and Communication Neuroscience Program, National Institutes of Health: National Institute on Deafness and Communication Disorders R01-DC004993, and by the Paul Veneklasen Research Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armstrong M, 1997, AM J OTOL, V18, pS140; Brown CA, 2009, EAR HEARING, V30, P489, DOI 10.1097/AUD.0b013e3181ab2b87; Chan JCY, 2008, INT J AUDIOL, V47, P296, DOI 10.1080/14992020802075407; Dillon MT, 2014, J AM ACAD AUDIOL, V25, P133, DOI 10.3766/jaaa.25.2.2; Dorman MF, 2008, AUDIOL NEURO-OTOL, V13, P105, DOI 10.1159/000111782; Dorman MF, 2010, INT J AUDIOL, V49, P912, DOI 10.3109/14992027.2010.509113; El Fata F, 2009, AUDIOL NEURO-OTOL, V14, P14, DOI 10.1159/000206491; Galvin JJ, 2008, J ACOUST SOC AM, V124, pEL189, DOI 10.1121/1.2961171; Galvin JJ, 2007, EAR HEARING, V28, P302, DOI 10.1097/01.aud.0000261689.35445.20; Galvin John J. III, 2012, Seminars in Hearing, V33, P399, DOI 10.1055/s-0032-1329227; Galvin JJ, 2011, J ACOUST SOC AM, V129, pEL39, DOI 10.1121/1.3531708; Galvin JJ, 2009, ANN NY ACAD SCI, V1169, P518, DOI 10.1111/j.1749-6632.2009.04551.x; Galvin JJ, 2009, J ACOUST SOC AM, V125, pEL98, DOI 10.1121/1.3062148; Gfeller K, 2005, EAR HEARING, V26, P237, DOI 10.1097/00003446-200506000-00001; Gfeller K, 2000, J Am Acad Audiol, V11, P390; Gfeller K, 2007, EAR HEARING, V28, P412, DOI 10.1097/AUD.0b013e3180479318; Gfeller K, 2012, ANN OTO RHINOL LARYN, V121, P782, DOI 10.1177/000348941212101203; Gfeller K, 2012, J MUSIC THER, V49, P68, DOI 10.1093/jmt/49.1.68; Gfeller Kate E, 2006, Audiol Neurootol, V11 Suppl 1, P12, DOI 10.1159/000095608; Gifford RH, 2007, J SPEECH LANG HEAR R, V50, P835, DOI 10.1044/1092-4388(2007/058); Kong YY, 2012, EAR HEARING, V33, P645, DOI 10.1097/AUD.0b013e318252caae; Kong YY, 2011, J SPEECH LANG HEAR R, V54, P959, DOI 10.1044/1092-4388(2010/10-0197); Kong YY, 2005, J ACOUST SOC AM, V117, P1351, DOI 10.1121/1.1857526; Limb CJ, 2012, OTOLARYNG CLIN N AM, V45, P129, DOI 10.1016/j.otc.2011.08.021; Looi V, 2008, EAR HEARING, V29, P1; Looi V, 2007, EAR HEARING, V28, p59S, DOI 10.1097/AUD.0b013e31803150cb; Looi V, 2011, INT J PEDIATR OTORHI, V75, P472, DOI 10.1016/j.ijporl.2010.12.023; Macherey O, 2013, EAR HEARING, V34, P426, DOI 10.1097/AUD.0b013e31827535f8; McDermott Hugh J, 2004, Trends Amplif, V8, P49, DOI 10.1177/108471380400800203; Mok M, 2006, J SPEECH LANG HEAR R, V49, P338, DOI 10.1044/1092-4388(2006/027); Mok M, 2010, AUDIOL NEURO-OTOL, V15, P44, DOI 10.1159/000219487; NILSSON M, 1994, J ACOUST SOC AM, V95, P1085, DOI 10.1121/1.408469; Turner CW, 2004, J ACOUST SOC AM, V115, P1729, DOI 10.1121/1.1687425; Tyler RS, 2002, EAR HEARING, V23, P98, DOI 10.1097/00003446-200204000-00003; Yoon YS, 2012, J SPEECH LANG HEAR R, V55, P105, DOI 10.1044/1092-4388(2011/10-0325); Zhang T, 2013, EAR HEARING, V34, P133, DOI 10.1097/AUD.0b013e31826709af; Zhang T, 2010, EAR HEARING, V31, P195, DOI 10.1097/AUD.0b013e3181c4758d; Zhu MM, 2011, J ACOUST SOC AM, V130, P3562, DOI 10.1121/1.3658474	38	39	45	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2015	10	3							e0120279	10.1371/journal.pone.0120279	http://dx.doi.org/10.1371/journal.pone.0120279			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CD9NQ	25790349	Green Published, Green Submitted, gold			2022-12-27	WOS:000351425400148
J	Ferrin, G; Rodriguez-Peralvarez, M; Aguilar-Melero, P; Ranchal, I; Llamoza, C; Linares, CI; Gonzalez-Rubio, S; Muntane, J; Briceno, J; Lopez-Cillero, P; Montero-Alvarez, JL; de la Mata, M				Ferrin, Gustavo; Rodriguez-Peralvarez, Manuel; Aguilar-Melero, Patricia; Ranchal, Isidora; Llamoza, Camilo; Linares, Clara I.; Gonzalez-Rubio, Sandra; Muntane, Jordi; Briceno, Javier; Lopez-Cillero, Pedro; Luis Montero-Alvarez, Jose; de la Mata, Manuel			Plasma Protein Biomarkers of Hepatocellular Carcinoma in HCV-Infected Alcoholic Patients with Cirrhosis	PLOS ONE			English	Article							CHRONIC HEPATITIS-C; LIVER-DISEASE; SERUM IMMUNOGLOBULINS; ANAPHYLATOXIN C5A; COMPLEMENT; FIBRINOGEN; CANCER; VIRUS; DYSFIBRINOGENEMIA; CARBOXYPEPTIDASE	Hepatocellular carcinoma (HCC) is one of the most common and lethal cancers in the world, with limited options for treatment unless timely diagnosed. Chronic hepatitis C virus (HCV) infection and persistent heavy alcohol consumption are independent risk factors for HCC development, which may induce a specific protein expression pattern different from those caused separately. The aim of the study was to identify protein biomarkers for the detection of HCC in HCV-infected alcoholic patients with cirrhosis in order to improve survival. We compared protein expression profiles of plasma samples from 52 HCV-infected alcoholic patients with and without HCC, using 2-D DIGE coupled with MALDI-TOF/TOF mass spectrometry. The 2-D DIGE results were analyzed statistically using Decyder software, and verified by western-blot and ELISA. In plasma samples from HCV-infected alcoholic patients, we found significantly differential expression profiles of carboxypeptidase-N, ceruloplasmin (CP), complement component 4a (C4a), fibrinogen-alpha (FGA), immunoglobulin mu chain C region, serum albumin, and serum paraoxonase/arylesterase 1 (PON1). Deregulation of plasma/serum levels of the identified proteins was associated to HCV, ethanol consumption, and/or HCC progression. In the validation through ELISA, C4a serum concentration was increased in HCC patients (2.4 +/- 1 ng/mg vs 1.8 +/- 0.6 ng/mg; p = 0.029), being the only independent predictor of HCC in the multivariate analysis (OR = 2.15; p = 0.015), with an AUROC = 0.70. The combination of C4a, FGA, CP and PON1 improved slightly the predictive ability of C4a alone (AUROC 0.81). In conclusion, we identified proteins related to acute-phase response, oxidative stress, or immune response, whose differential expression in plasma may be attributed to the presence of HCC. Among them, C4a, and its combination with CP, FGA and PON1, could be considered as potentially reliable biomarkers for the detection of HCC in HCV-infected alcoholic patients.	[Ferrin, Gustavo; Rodriguez-Peralvarez, Manuel; Aguilar-Melero, Patricia; Ranchal, Isidora; Linares, Clara I.; Gonzalez-Rubio, Sandra; Muntane, Jordi; Briceno, Javier; Lopez-Cillero, Pedro; Luis Montero-Alvarez, Jose; de la Mata, Manuel] Reina Sofia Univ Hosp, Maimonides Inst Biomed Res Cordoba IMBIC, Cordoba, Spain; [Ferrin, Gustavo; Rodriguez-Peralvarez, Manuel; Ranchal, Isidora; Muntane, Jordi; Briceno, Javier; Lopez-Cillero, Pedro; Luis Montero-Alvarez, Jose; de la Mata, Manuel] Digest & Liver Dis CIBERehd, Biomed Res Ctr Network, Cordoba, Spain; [Rodriguez-Peralvarez, Manuel; Llamoza, Camilo; Briceno, Javier; Lopez-Cillero, Pedro; Luis Montero-Alvarez, Jose; de la Mata, Manuel] Reina Sofia Univ Hosp, Hepatol & Liver Transplantat Unit, Cordoba, Spain	CIBER - Centro de Investigacion Biomedica en Red; CIBEREHD	Ferrin, G (corresponding author), Reina Sofia Univ Hosp, Maimonides Inst Biomed Res Cordoba IMBIC, Cordoba, Spain.	gusfesa@gmail.com	Rodríguez-Perálvarez, Manuel/AAO-8616-2021; Rodríguez-perálvarez, Manuel/AGR-2409-2022; aguilar, patricia/L-6986-2014	Rodríguez-perálvarez, Manuel/0000-0002-1795-2919; aguilar, patricia/0000-0003-1396-5445; Linares, Clara Isabel/0000-0002-7621-5089; Ferrin, Gustavo/0000-0002-5744-3289; Ranchal, Isidora/0000-0001-7870-7768; Lopez Cillero, Pedro/0000-0002-2568-6438	Instituto de Salud Carlos III [FIS 07/0157]; Centro de Investigacion Biomedica en Red Enfermedades Hepaticas y Digestivas(CIBEREHD)	Instituto de Salud Carlos III(Instituto de Salud Carlos IIIEuropean Commission); Centro de Investigacion Biomedica en Red Enfermedades Hepaticas y Digestivas(CIBEREHD)	This study was supported by grants to MDLM from the Instituto de Salud Carlos III (FIS 07/0157; http://www.isciii.es/), and to GF from the Centro de Investigacion Biomedica en Red Enfermedades Hepaticas y Digestivas(CIBEREHD; https://www.ciberehd.org/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Banerjee A, 2011, J VIROL, V85, P4157, DOI 10.1128/JVI.02449-10; Beneduce L, 2005, CANCER-AM CANCER SOC, V103, P2558, DOI 10.1002/cncr.21106; Biro L, 2000, IMMUNOL LETT, V72, P69, DOI 10.1016/S0165-2478(00)00183-8; Chang ML, 2009, BMC MED GENOMICS, V2, DOI 10.1186/1755-8794-2-51; CHANG WY, 1988, CANCER-AM CANCER SOC, V62, P227, DOI 10.1002/1097-0142(19880715)62:2<227::AID-CNCR2820620202>3.0.CO;2-D; ENTWISTLE RA, 1988, BIOCHEMISTRY-US, V27, P507, DOI 10.1021/bi00401a073; ERDOS EG, 1965, CLIN CHIM ACTA, V11, P39, DOI 10.1016/0009-8981(65)90087-2; Feng JT, 2005, PROTEOMICS, V5, P4581, DOI 10.1002/pmic.200401309; Ferrin G, 2014, LIVER INT, V34, P438, DOI 10.1111/liv.12277; Fye HKS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068381; Garige M, 2010, METABOLISM, V59, P1372, DOI 10.1016/j.metabol.2009.12.025; Gonzalez-Quintela A, 2003, HEPATO-GASTROENTEROL, V50, P2121; GRALNICK HR, 1978, NEW ENGL J MED, V299, P221, DOI 10.1056/NEJM197808032990503; Gros P, 2008, NAT REV IMMUNOL, V8, P48, DOI 10.1038/nri2231; GUTTERIDGE JMC, 1985, CHEM-BIOL INTERACT, V56, P113, DOI 10.1016/0009-2797(85)90043-2; Kang XN, 2010, J CANCER RES CLIN, V136, P1151, DOI 10.1007/s00432-010-0762-6; Kanmura S, 2010, J GASTROENTEROL, V45, P459, DOI 10.1007/s00535-009-0160-5; Kim H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101422; Kolev M, 2011, ARCH IMMUNOL THER EX, V59, P407, DOI 10.1007/s00005-011-0146-x; Lakshman R, 2010, GENES NUTR, V5, P111, DOI 10.1007/s12263-009-0161-2; LANE DA, 1977, BRIT J HAEMATOL, V35, P301, DOI 10.1111/j.1365-2141.1977.tb00586.x; Liang Cynthia, 2012, Methods Mol Biol, V854, P181, DOI 10.1007/978-1-61779-573-2_13; LIPPI G, 1992, ITAL J GASTROENTEROL, V24, P383; Llovet JM, 2012, J HEPATOL, V56, P908, DOI 10.1016/j.jhep.2011.12.001; Lok AS, 2010, GASTROENTEROLOGY, V138, P493, DOI 10.1053/j.gastro.2009.10.031; LORENTZ K, 1979, CLIN CHEM, V25, P1714; LUZZATTO G, 1990, SEMIN ONCOL, V17, P147; Markiewski MM, 2008, NAT IMMUNOL, V9, P1225, DOI 10.1038/ni.1655; MARTIN DM, 1984, LIVER, V4, P214; Matthews KW, 2004, MOL IMMUNOL, V40, P785, DOI 10.1016/j.molimm.2003.10.002; Mazumdar B, 2013, J VIROL, V87, P7902, DOI [10.1128/JVI.00917-13, 10.1128/JVI.00174-13]; Mazumdar B, 2012, J VIROL, V86, P2221, DOI 10.1128/JVI.06577-11; McKillop IH, 2009, SEMIN LIVER DIS, V29, P222, DOI 10.1055/s-0029-1214377; Na Keun, 2012, Methods Mol Biol, V854, P223, DOI 10.1007/978-1-61779-573-2_16; Nitta H, 2014, ONCOL REP, V32, P1715, DOI 10.3892/or.2014.3341; Nitta H, 2013, CLIN CANCER RES, V19, P2004, DOI 10.1158/1078-0432.CCR-12-1204; Precourt LP, 2011, ATHEROSCLEROSIS, V214, P20, DOI 10.1016/j.atherosclerosis.2010.08.076; Qin XB, 2006, CELL MOL IMMUNOL, V3, P333; Schiff ER, 2003, ALCOHOL RES HEALTH, V27, P232; SCHWEISFURTH H, 1985, CLIN BIOCHEM, V18, P242, DOI 10.1016/S0009-9120(85)80049-7; Simpson-Haidaris PJ, 2001, ANN NY ACAD SCI, V936, P406; Siu L, 2009, SEMIN LIVER DIS, V29, P188, DOI 10.1055/s-0029-1214374; VERHAEGEN H, 1976, CANCER, V38, P1608, DOI 10.1002/1097-0142(197610)38:4<1608::AID-CNCR2820380427>3.0.CO;2-6; Vollmers HP, 2009, NEW BIOTECHNOL, V25, P294, DOI 10.1016/j.nbt.2009.03.016; Yang MH, 2007, ANAL BIOANAL CHEM, V388, P637, DOI 10.1007/s00216-007-1263-6; YUKI N, 1995, HEPATOLOGY, V22, P402, DOI 10.1002/hep.1840220205; Zhu WL, 2009, ANTICANCER RES, V29, P2531	47	24	25	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2015	10	3							e0118527	10.1371/journal.pone.0118527	http://dx.doi.org/10.1371/journal.pone.0118527			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD9NQ	25789864	gold, Green Published, Green Submitted			2022-12-27	WOS:000351425400033
J	Karlsen, M; Hansen, T; Nordal, HH; Brun, JG; Jonsson, R; Appel, S				Karlsen, Marie; Hansen, Torbjorn; Nordal, Hilde H.; Brun, Johan G.; Jonsson, Roland; Appel, Silke			Expression of Toll-Like Receptor-7 and-9 in B Cell Subsets from Patients with Primary Sjogren's Syndrome	PLOS ONE			English	Article							SYSTEMIC-LUPUS-ERYTHEMATOSUS; BLOOD MONONUCLEAR-CELLS; CLASSIFICATION CRITERIA; AUTOANTIBODY PRODUCTION; SALIVARY-GLANDS; UP-REGULATION; DOUBLE-BLIND; ACTIVATION; TLR9; RITUXIMAB	Introduction Sjogren's syndrome (SS) is a rheumatic autoimmune disease characterized by inflammation of exocrine glands. As autoantibodies are present in a majority of patients, B cells have been suggested to play an important role in onset and development of the disease. Toll-like receptors (TLRs) are pattern recognition receptors triggering innate immune responses. Since an increased expression of TLRs has been detected in other rheumatic diseases the purpose of this study was to explore TLRs in B cells of SS patients. Methods The expression of TLR-7 and -9 in B cell subsets of 25 patients with primary SS (pSS) and 25 healthy controls was analysed in peripheral blood using flow cytometry and real time quantitative PCR. Results We detected similar levels of CD19(+) B cells in pSS patients and healthy controls. An increased number of naive B cells, as well as fewer pre-switched memory B cells were found in pSS patients. No significant differences were observed in TLR-7 and -9 expression in B cells between pSS patients and healthy controls. Conclusion This study shows that pSS patients have an alteration in the B cell subpopulation composition compared to controls, with less pre-switched memory B cells and more naive B cells. We did not detect any significant disparities in TLR-7 and -9 expression between the two groups.	[Karlsen, Marie; Nordal, Hilde H.; Jonsson, Roland; Appel, Silke] Univ Bergen, Dept Clin Sci, Broegelmann Res Lab, Bergen, Norway; [Hansen, Torbjorn; Brun, Johan G.] Univ Bergen, Dept Clin Sci, Bergen, Norway; [Hansen, Torbjorn] Haukeland Hosp, Dept Immunol & Transfus Med, N-5021 Bergen, Norway; [Nordal, Hilde H.; Brun, Johan G.; Jonsson, Roland] Haukeland Hosp, Dept Rheumatol, N-5021 Bergen, Norway	University of Bergen; University of Bergen; University of Bergen; Haukeland University Hospital; University of Bergen; Haukeland University Hospital	Appel, S (corresponding author), Univ Bergen, Dept Clin Sci, Broegelmann Res Lab, Bergen, Norway.	Silke.Appel@k2.uib.no		Appel, Silke/0000-0002-2199-2315	Bergen Research Foundation; Broegelmann Foundation	Bergen Research Foundation; Broegelmann Foundation	This work was funded by Bergen Research Foundation and Broegelmann Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bekeredjian-Ding IB, 2005, J IMMUNOL, V174, P4043, DOI 10.4049/jimmunol.174.7.4043; Bernasconi NL, 2003, BLOOD, V101, P4500, DOI 10.1182/blood-2002-11-3569; Bohnhorst JO, 2001, SCAND J IMMUNOL, V54, P421, DOI 10.1046/j.1365-3083.2001.00989.x; Capolunghi F, 2010, RHEUMATOLOGY, V49, P2281, DOI 10.1093/rheumatology/keq226; Carubbi F, 2013, ARTHRITIS RES THER, V15, DOI 10.1186/ar4359; Chauhan SK, 2013, J CLIN IMMUNOL, V33, P954, DOI 10.1007/s10875-013-9887-0; Cognasse F, 2008, IMMUNOLOGY, V125, P430, DOI 10.1111/j.1365-2567.2008.02844.x; Dass S, 2008, ANN RHEUM DIS, V67, P1541, DOI 10.1136/ard.2007.083865; Devauchelle-Pensec V, 2014, ANN INTERN MED, V160, P233, DOI 10.7326/M13-1085; Eaton-Bassiri A, 2004, INFECT IMMUN, V72, P7202, DOI 10.1128/IAI.72.12.7202-7211.2004; Emamian ES, 2009, GENES IMMUN, V10, P285, DOI 10.1038/gene.2009.20; Goransson LG, 2011, SCAND J RHEUMATOL, V40, P221, DOI 10.3109/03009742.2010.536164; Guerrier T, 2014, J AUTOIMMUN, V51, P23, DOI 10.1016/j.jaut.2014.02.005; Hajas A, 2013, HUM IMMUNOL, V74, P833, DOI 10.1016/j.humimm.2013.04.007; Hamza N, 2012, ANN RHEUM DIS, V71, P1881, DOI 10.1136/annrheumdis-2011-201189; Hansen A, 2002, ARTHRITIS RHEUM-US, V46, P2160, DOI 10.1002/art.10445; Hwang SH, 2012, J IMMUNOL, V189, P5786, DOI 10.4049/jimmunol.1202195; Janeway CA, 2002, ANNU REV IMMUNOL, V20, P197, DOI 10.1146/annurev.immunol.20.083001.084359; Jonsson R, 2013, JAMA-J AM MED ASSOC, V310, P1854, DOI 10.1001/jama.2013.278448; Jonsson R, 2011, IMMUNOL LETT, V141, P1, DOI 10.1016/j.imlet.2011.06.007; Komatsuda A, 2008, CLIN EXP IMMUNOL, V152, P482, DOI 10.1111/j.1365-2249.2008.03646.x; Lanzavecchia A, 2007, CURR OPIN IMMUNOL, V19, P268, DOI 10.1016/j.coi.2007.04.002; LUBECK MD, 1985, J IMMUNOL, V135, P1299; Lundberg E, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.106; Marshak-Rothstein A, 2006, NAT REV IMMUNOL, V6, P823, DOI 10.1038/nri1957; McKelvey KJ, 2011, J AUTOIMMUN, V36, P76, DOI 10.1016/j.jaut.2010.11.001; Meijer JM, 2010, ARTHRITIS RHEUM-US, V62, P960, DOI 10.1002/art.27314; Meyer-Bahlburg A, 2008, AUTOIMMUN REV, V7, P313, DOI 10.1016/j.autrev.2007.11.027; Mignogna MD, 2005, J ORAL PATHOL MED, V34, P1, DOI 10.1111/j.1600-0714.2004.00264.x; Moura RA, 2010, RHEUMATOLOGY, V49, P1082, DOI 10.1093/rheumatology/keq029; Poe J C, 2001, Int Rev Immunol, V20, P739, DOI 10.3109/08830180109045588; Ruprecht CR, 2006, EUR J IMMUNOL, V36, P810, DOI 10.1002/eji.200535744; Schwanhausser B, 2011, NATURE, V473, P337, DOI 10.1038/nature10098; Shiboski SC, 2012, ARTHRIT CARE RES, V64, P475, DOI 10.1002/acr.21591; Vitali C, 2002, ANN RHEUM DIS, V61, P554, DOI 10.1136/ard.61.6.554; Wong CK, 2010, CLIN EXP IMMUNOL, V159, P11, DOI 10.1111/j.1365-2249.2009.04036.x; Youinou P, 2010, ARTHRITIS RHEUM-US, V62, P2605, DOI 10.1002/art.27564; Zheng LY, 2010, ORAL SURG ORAL MED O, V109, P844, DOI 10.1016/j.tripleo.2010.01.006; Zheng LY, 2009, ORAL SURG ORAL MED O, V107, pE12, DOI 10.1016/j.tripleo.2008.09.015	39	13	14	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2015	10	3							e0120383	10.1371/journal.pone.0120383	http://dx.doi.org/10.1371/journal.pone.0120383			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD9NQ	25790192	Green Published, gold, Green Submitted			2022-12-27	WOS:000351425400156
J	Ke, YF; Wu, YX; Cui, X; Liu, X; Yu, M; Yang, CB; Li, XR				Ke, Yifeng; Wu, Yixiang; Cui, Xuan; Liu, Xun; Yu, Min; Yang, Chunbo; Li, Xiaorong			Polysaccharide Hydrogel Combined with Mesenchymal Stem Cells Promotes the Healing of Corneal Alkali Burn in Rats	PLOS ONE			English	Article							ANTIINFLAMMATORY ACTIVITIES; SUBCONJUNCTIVAL INJECTION; SULFATED POLYSACCHARIDES; BLETILLA-STRIATA; HYALURONIC-ACID; IN-VITRO; NEOVASCULARIZATION; EYE; PROLIFERATION; THROMBOSPONDIN-1	Corneal chemical burns are common ophthalmic injuries that may result in permanent visual impairment. Although significant advances have been achieved on the treatment of such cases, the structural and functional restoration of a chemical burn-injured cornea remains challenging. The applications of polysaccharide hydrogel and subconjunctival injection of mesenchymal stem cells (MSCs) have been reported to promote the healing of corneal wounds. In this study, polysaccharide was extracted from Hardy Orchid and mesenchymal stem cells (MSCs) were derived from Sprague-Dawley rats. Supplementation of the polysaccharide significantly enhanced the migration rate of primarily cultured rat corneal epithelial cells. We examined the therapeutic effects of polysaccharide in conjunction with MSCs application on the healing of corneal alkali burns in rats. Compared with either treatment alone, the combination strategy resulted in significantly better recovery of corneal epithelium and reduction in inflammation, neovascularization and opacity of healed cornea. Polysaccharide and MSCs acted additively to increase the expression of anti-inflammatory cytokine (TGF-beta), antiangiogenic cytokine (TSP-1) and decrease those promoting inflammation (TNF-alpha), chemotaxis (MIP-1 alpha and MCP-1) and angiogenesis (VEGF and MMP-2). This study provided evidence that Hardy Orchid derived polysaccharide and MSCs are safe and effective treatments for corneal alkali burns and that their benefits are additive when used in combination. We concluded that combination therapy with polysaccharide and MSCs is a promising clinical treatment for corneal alkali burns and may be applicable for other types of corneal disorder.	[Ke, Yifeng; Wu, Yixiang; Cui, Xuan; Liu, Xun; Yang, Chunbo; Li, Xiaorong] Tianjin Med Univ, Hosp Eye, Coll Optometry, Inst Eye, Tianjin, Peoples R China; [Yu, Min] Tianjin Med Univ, Sch Publ Hlth, Tianjin, Peoples R China	Tianjin Medical University; Tianjin Medical University	Yang, CB (corresponding author), Tianjin Med Univ, Hosp Eye, Coll Optometry, Inst Eye, Tianjin, Peoples R China.	yangcbxh@gmail.com; xiaorli@163.com			National Sciences Foundation of China [81371037]	National Sciences Foundation of China(National Natural Science Foundation of China (NSFC))	Supported by the grant from National Sciences Foundation of China (81371037); http://www.nsfc.gov.cn/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamis A P, 1999, Angiogenesis, V3, P9, DOI 10.1023/A:1009071601454; ANSETH A, 1962, INVEST OPHTH VISUAL, V1, P195; Azar Dimitri T, 2006, Trans Am Ophthalmol Soc, V104, P264; Barabino S, 2014, EUR J OPHTHALMOL, V24, P173, DOI 10.5301/ejo.5000355; Bhatia SK, 2007, CURR EYE RES, V32, P1045, DOI 10.1080/02713680701767876; Blackmore SJ, 2010, CONTACT LENS ANTERIO, V33, P239, DOI 10.1016/j.clae.2010.06.004; Brodovsky SC, 2000, OPHTHALMOLOGY, V107, P1829, DOI 10.1016/S0161-6420(00)00289-X; Coura CO, 2012, BASIC CLIN PHARMACOL, V110, P335, DOI 10.1111/j.1742-7843.2011.00811.x; Daniels JT, 2016, STEM CELL REV, V2, P247; Diao HJ, 2008, J BIOSCI BIOENG, V105, P85, DOI 10.1263/jbb.105.85; Fish R, 2010, CURR OPIN OPHTHALMOL, V21, P317, DOI 10.1097/ICU.0b013e32833a8da2; He JC, 2006, ARCH OPHTHALMOL-CHIC, V124, P70, DOI 10.1001/archopht.124.1.70; Hou HY, 2010, MOL THER, V18, P1837, DOI 10.1038/mt.2010.144; INOUE M, 1993, INVEST OPHTH VIS SCI, V34, P2313; Jiang TS, 2010, MOL VIS, V16, P1304; Kuckelkorn R, 2002, ACTA OPHTHALMOL SCAN, V80, P4, DOI 10.1034/j.1600-0420.2002.800102.x; Lee KY, 2001, CHEM REV, V101, P1869, DOI 10.1021/cr000108x; Luo Y, 2010, J BIOMED MATER RES A, V94A, P193, DOI 10.1002/jbm.a.32711; Ma YL, 2006, STEM CELLS, V24, P315, DOI 10.1634/stemcells.2005-0046; Maggini J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009252; MEYER K, 1953, J BIOL CHEM, V205, P611; Nakamura M, 1999, CORNEA, V18, P686, DOI 10.1097/00003226-199911000-00011; NAKAMURA M, 1994, J CELL PHYSIOL, V159, P415, DOI 10.1002/jcp.1041590305; Oh JY, 2008, STEM CELLS, V26, P1047, DOI 10.1634/stemcells.2007-0737; Park CM, 2014, FOOD CHEM TOXICOL, V66, P56, DOI 10.1016/j.fct.2014.01.019; Rodrigues JAG, 2012, PHARMACOL REP, V64, P282, DOI 10.1016/S1734-1140(12)70766-1; Sener E, 2011, CURR EYE RES, V36, P1005, DOI 10.3109/02713683.2011.601840; Sheng XH, 2011, NEUROSCI LETT, V503, P37, DOI 10.1016/j.neulet.2011.08.003; Singh Parul, 2013, Oman J Ophthalmol, V6, P83, DOI 10.4103/0974-620X.116624; SONODA Y, 1993, J IMMUNOL, V150, P1727; Stevenson W, 2012, OCUL SURF, V10, P67, DOI 10.1016/j.jtos.2012.01.005; Su WR, 2011, GRAEF ARCH CLIN EXP, V249, P421, DOI 10.1007/s00417-010-1539-y; Sun LX, 2011, J PHARM PHARMACOL, V63, P1595, DOI 10.1111/j.2042-7158.2011.01367.x; Tseng SCG, 1996, MOL BIOL REP, V23, P47, DOI 10.1007/BF00357072; Wagoner MD, 1997, SURV OPHTHALMOL, V41, P275, DOI 10.1016/S0039-6257(96)00007-0; Wu XG, 2012, J OCUL PHARMACOL TH, V28, P369, DOI 10.1089/jop.2011.0200; Yang GH, 2010, VET OPHTHALMOL, V13, P144, DOI 10.1111/j.1463-5224.2010.00771.x; Yang LL, 2009, MOL VIS, V15, P1951; Yao L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030842; Yoon SY, 2013, CORNEA, V32, P1488, DOI 10.1097/ICO.0b013e3182a48009; Zak S, 2008, INT J COLORECTAL DIS, V23, P297, DOI 10.1007/s00384-007-0397-5; Zhang SX, 2007, PROG RETIN EYE RES, V26, P1, DOI 10.1016/j.preteyeres.2006.09.002; Zhou L, 2006, ONCOGENE, V25, P536, DOI 10.1038/sj.onc.1209069	43	45	50	3	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2015	10	3							e0119725	10.1371/journal.pone.0119725	http://dx.doi.org/10.1371/journal.pone.0119725			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD9NQ	25789487	Green Submitted, gold, Green Published			2022-12-27	WOS:000351425400100
J	Krone, CL; Wyllie, AL; van Beek, J; Rots, NY; Oja, AE; Chu, MLJN; Bruin, JP; Bogaert, D; Sanders, EAM; Trzcinski, K				Krone, Cassandra L.; Wyllie, Anne L.; van Beek, Josine; Rots, Nynke Y.; Oja, Anna E.; Chu, Mei Ling J. N.; Bruin, Jacob P.; Bogaert, Debby; Sanders, Elisabeth A. M.; Trzcinski, Krzysztof			Carriage of Streptococcus pneumoniae in Aged Adults with Influenza-Like-Illness	PLOS ONE			English	Article							PNEUMOCOCCAL CARRIAGE; PCR; CHILDREN; SEROTYPE; DISEASE; COLONIZATION; COINFECTION	Incidence of pneumococcal disease is disproportionally high in infants and elderly. Nasopharyngeal colonisation by Streptococcus pneumoniae is considered a prerequisite for disease but unlike in children, carriage in elderly is rarely detected. Here, we tested for S. pneumoniae in nasopharyngeal and saliva samples collected from community-dwelling elderly with influenza-like-illness (ILI). Trans-nasal nasopharyngeal, trans-oral nasopharyngeal and saliva samples (n = 270 per sample type) were collected during winter/spring 2011/2012 from 135 persons aged 60-89 at onset of ILI and 7-9 weeks later following recovery. After samples were tested for pneumococci by conventional culture, all plate growth was collected. DNA extracted from plate harvests was tested by quantitative-PCRs (qPCR) specific for S. pneumoniae and serotypes included in the 13-valent pneumococcal conjugated vaccine (PCV13). Pneumococci were cultured from 14 of 135 (10%) elderly with none of the sampled niches showing superiority in carriage detection. With 76/270 (28%) saliva, 31/270 (11%) trans-oral and 13/270 (5%) trans-nasal samples positive by qPCR, saliva was superior to nasopharyngeal swabs (p<0.001) in qPCR-based carriage detection. Overall, from all methods used in the study, 65 of 135 (48%) elderly carried pneumococci at least once and 26 (19%) at both study time points. The difference between carriage prevalence at ILI (n = 49 or 36%) versus recovery (n = 42 or 31%) was not significant (p = 0.38). At least 23 of 91 (25%) carriage events in 19 of 65 (29%) carriers were associated with PCV13-serotypes. We detected a large reservoir of pneumococci in saliva of elderly, with PCV13-serotype distribution closely resembling the contemporary carriage of serotypes reported in the Netherlands for PCV-vaccinated infants.	[Krone, Cassandra L.; Wyllie, Anne L.; Oja, Anna E.; Chu, Mei Ling J. N.; Bogaert, Debby; Sanders, Elisabeth A. M.; Trzcinski, Krzysztof] Univ Med Ctr Utrecht, Wilhelmina Childrens Hosp, Paediat Immunol & Infect Dis, Utrecht, Netherlands; [van Beek, Josine; Rots, Nynke Y.] Natl Inst Publ Hlth & Environm RIVM, Ctr Infect Dis Control Netherlands, Bilthoven, Netherlands; [Bruin, Jacob P.] Reg Publ Hlth Lab, Haarlem, Netherlands	Utrecht University; Utrecht University Medical Center; Wilhelmina Kinderziekenhuis; Netherlands National Institute for Public Health & the Environment	Trzcinski, K (corresponding author), Univ Med Ctr Utrecht, Wilhelmina Childrens Hosp, Paediat Immunol & Infect Dis, Utrecht, Netherlands.	K.Trzcinski@umcutrecht.nl	Trzcinski, Krzysztof/I-8840-2019	Trzcinski, Krzysztof/0000-0002-5433-8846; Bogaert, Debby/0000-0003-2651-7000; Wyllie, Anne/0000-0001-6015-0279	Pfizer	Pfizer(Pfizer)	A research grant from Pfizer to EAMS and KT provided support that contributed to salaries for CLK and ALW, but Pfizer did not have any additional role in study design, data collection and analysis, decision to publish or preparation of the manuscript. The specific roles of these authors are articulated in the "author contributions" section.	Aliberti S, 2014, CLIN MICROBIOL INFEC, V20, P52, DOI 10.1111/1469-0691.12518; Almeida ST, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090974; Ansaldi F, 2013, HUM VACCINES, V9, P1, DOI [10.4161/hv.23606, DOI 10.4161/HV.23606]; Azzari C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009282; Carvalho MDG, 2013, PEERJ, V1, DOI 10.7717/peerj.97; Carvalho MD, 2012, J CLIN MICROBIOL, V50, P3146, DOI 10.1128/JCM.01505-12; Carvalho MD, 2010, J CLIN MICROBIOL, V48, P1611, DOI 10.1128/JCM.02243-09; Carvalho MDS, 2007, J CLIN MICROBIOL, V45, P2460, DOI 10.1128/JCM.02498-06; de Waroux OL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086136; Dhoubhadel BG, 2014, J MED MICROBIOL, V63, P528, DOI 10.1099/jmm.0.071464-0; Flamaing J, 2010, J AM GERIATR SOC, V58, P396, DOI 10.1111/j.1532-5415.2009.02700.x; Hamaluba M, 2015, MEDICINE, V94, DOI 10.1097/MD.0000000000000335; Heffron R, 1979, PNEUMOCOCCUS CARRIER, P342; Janssens JP, 2004, LANCET INFECT DIS, V4, P112, DOI 10.1016/S1473-3099(04)00931-4; Krone CL, 2014, LANCET RESP MED, V2, P141, DOI 10.1016/S2213-2600(13)70165-6; Mackenzie G M, 1941, Trans Am Clin Climatol Assoc, V57, P88; Magomani V, 2014, J CLIN MICROBIOL, V52, P3271, DOI 10.1128/JCM.01061-14; McCullers JA, 2002, J INFECT DIS, V186, P341, DOI 10.1086/341462; McCullers JA, 2014, NAT REV MICROBIOL, V12, P252, DOI 10.1038/nrmicro3231; Mina MJ, 2014, MBIO, V5, DOI 10.1128/mBio.01040-13; Mina MJ, 2014, LANCET RESP MED, V2, P750, DOI 10.1016/S2213-2600(14)70131-6; Palmu AA, 2012, SCAND J INFECT DIS, V44, P433, DOI 10.3109/00365548.2011.652162; Park IH, 2015, CLIN VACCINE IMMUNOL; Pel J.Z.S., 1965, HUISARTS WETENSCHAP, V86, P321; Pimenta FC, 2013, J CLIN MICROBIOL, V51, P647, DOI 10.1128/JCM.02927-12; Regev-Yochay G, 2004, CLIN INFECT DIS, V38, P632, DOI 10.1086/381547; Ridda I, 2010, VACCINE, V28, P3902, DOI 10.1016/j.vaccine.2010.03.073; Satzke C, 2013, VACCINE, V32, P165, DOI 10.1016/j.vaccine.2013.08.062; Siegel SJ, 2014, CELL HOST MICROBE, V16, P55, DOI 10.1016/j.chom.2014.06.005; Simell B, 2012, EXPERT REV VACCINES, V11, P841, DOI [10.1586/ERV.12.53, 10.1586/erv.12.53]; Spijkerman J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039730; Trzcinski K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060520; van den Bergh MR, 2013, CLIN INFECT DIS, V56, pE30, DOI 10.1093/cid/cis922; van Hoek AJ, 2014, VACCINE, V32, P4349, DOI 10.1016/j.vaccine.2014.03.017; Versalovic J, 2011, MANUAL CLIN MICROBIO; WEBSTER LESLIE T., 1931, JOUR EXP MED, V53, P535, DOI 10.1084/jem.53.4.535; Weinberger DM, 2015, PLOS MED, V12, DOI 10.1371/journal.pmed.1001776; Weinberger DM, 2011, LANCET, V378, P1962, DOI 10.1016/S0140-6736(10)62225-8; White B, 1938, BIOL PNEUMOCOCCUS, P230; White B, 1938, BIOLOGY PNEUMOCOCCUS, P30; Wolter N, 2014, J INFECT DIS, V210, P1649, DOI 10.1093/infdis/jiu326; Wyllie AL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102045	42	49	49	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2015	10	3							e0119875	10.1371/journal.pone.0119875	http://dx.doi.org/10.1371/journal.pone.0119875			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD9NQ	25789854	Green Published, Green Submitted, gold			2022-12-27	WOS:000351425400113
J	Loizou, D; Enav, B; Komlodi-Pasztor, E; Hider, P; Kim-Chang, J; Noonan, L; Taber, T; Kaushal, S; Limgala, R; Brown, M; Gupta, R; Balba, N; Goker-Alpan, O; Khojah, A; Alpan, O				Loizou, Denise; Enav, Benjamin; Komlodi-Pasztor, Edina; Hider, Pamela; Kim-Chang, Julie; Noonan, Laura; Taber, Tabitha; Kaushal, Suhasini; Limgala, Renuka; Brown, Margaret; Gupta, Raavi; Balba, Nader; Goker-Alpan, Ozlem; Khojah, Amer; Alpan, Oral			A Pilot Study of Omalizumab in Eosinophilic Esophagitis	PLOS ONE			English	Article							NATURAL-HISTORY; GASTROINTESTINAL DISORDERS; ELIMINATION DIET; ALLERGIC-ASTHMA; RI EXPRESSION; CHILDREN; INFLAMMATION; THERAPY; CELLS; IGE	Eosinophilic disorders of the gastrointestinal tract are an emerging subset of immune pathologies within the spectrum of allergic inflammation. Eosinophilic Esophagitis (EoE), once considered a rare disease, is increasing in incidence, with a rate of over 1 in 10,000 in the US, for unknown reasons. The clinical management of EoE is challenging, thus there is an urgent need for understanding the etiology and pathophysiology of this eosinophilic disease to develop better therapeutic approaches. In this open label, single arm, unblinded study, we evaluated the effects of an anti-IgE treatment, omalizumab, on local inflammation in the esophagus and clinical correlates in patients with EoE. Omalizumab was administered for 12 weeks to 15 subjects with long standing EoE. There were no serious side effects from the treatment. Esophageal tissue inflammation was assessed both before and after therapy. After 3 months on omalizumab, although tissue Immunoglobulin E (IgE) levels were significantly reduced in all but two of the subjects, we found that full remission of EoE, which is defined as histologic and clinical improvement only in 33% of the patients. The decrease in tryptase-positive cells and eosinophils correlated significantly with the clinical outcome as measured by improvement in endoscopy and symptom scores, respectively. Omalizumabinduced remission of EoE was limited to subjects with low peripheral blood absolute eosinophil counts. These findings demonstrate that in a subset of EoE patients, IgE plays a role in the pathophysiology of the disease and that anti-IgE therapy with omalizumab may result in disease remission. Since this study is open label there is the potential for bias, hence the need for a larger double blind placebo controlled study. The data presented in this pilot study provides a foundation for proper patient selection to maximize clinical efficacy.	[Loizou, Denise; Komlodi-Pasztor, Edina; Hider, Pamela; Kim-Chang, Julie; Noonan, Laura; Taber, Tabitha; Kaushal, Suhasini; Limgala, Renuka; Khojah, Amer; Alpan, Oral] O&O ALPAN LLC, Food Allergy & Eosinophil Disorders Program, Sect Immunopathogenesis, Fairfax, VA 22030 USA; [Loizou, Denise; Brown, Margaret; Gupta, Raavi; Balba, Nader; Alpan, Oral] Amerimmune, Fairfax, VA USA; [Enav, Benjamin] Pediat Gastroenterol Northern Virginia, Lorton, VA USA; [Komlodi-Pasztor, Edina; Hider, Pamela; Taber, Tabitha; Limgala, Renuka; Goker-Alpan, Ozlem] O&O ALPAN LLC, Lysosomal Storage Disorders Sect, Fairfax, VA USA; [Balba, Nader] Gastroenterol Associates Northern Virginia, Fairfax, VA USA		Alpan, O (corresponding author), O&O ALPAN LLC, Food Allergy & Eosinophil Disorders Program, Sect Immunopathogenesis, Fairfax, VA 22030 USA.	oalpan@oandoalpan.com	khojah, Amer/AAS-6015-2021	khojah, Amer/0000-0002-4120-5307; Limgala, Renuka/0000-0001-6957-6284; Failla, Laura/0000-0002-1382-4768; khojah, amer/0000-0003-3357-4863	Genentech, Inc.; OO Alpan, LLC.	Genentech, Inc.(Roche HoldingGenentech); OO Alpan, LLC.	The study was funded by Genentech, Inc. and by O&O Alpan, LLC. Genentech, Inc. supplied the study drug and provided financial support, and O&O Alpan, LLC provided clinical services for the study. Genentech, Inc. had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The funder O&O Alpan, LLC provided support in the form of salaries for authors DL, EK-P, PH, LN, RL, MB, RG, OG-A & OA. O&O Alpan is owned and managed by the author OA; author OG-A is the President and CMO. The specific roles of the authors are articulated in the 'author contributions' section.	Antico A, 2014, J ALLERGY CLIN IMMUN; Assa'ad AH, 2011, GASTROENTEROLOGY, V141, P1593, DOI 10.1053/j.gastro.2011.07.044; Baxi S, 2006, GASTROINTEST ENDOSC, V64, P473, DOI 10.1016/j.gie.2006.03.931; Beck LA, 2004, J ALLERGY CLIN IMMUN, V114, P527, DOI 10.1016/j.jaci.2004.06.032; Bochner BS, 2012, J ALLERGY CLIN IMMUN, V130, P587, DOI 10.1016/j.jaci.2012.07.024; Busse W, 2013, J ALLERGY CLIN IMMUN; Clayton F, 2014, GASTROENTEROLOGY; Dellon ES, 2014, CLIN GASTROENTEROL H, V12, P589, DOI 10.1016/j.cgh.2013.09.008; Djukanovic R, 2004, AM J RESP CRIT CARE, V170, P583, DOI 10.1164/rccm.200312-1651OC; Foroughi S, 2007, J ALLERGY CLIN IMMUN, V120, P594, DOI 10.1016/j.jaci.2007.06.015; Furuta GT, 2013, GUT, V62, P1395, DOI 10.1136/gutjnl-2012-303171; Gonsalves N, 2012, GASTROENTEROLOGY, V142, P1451, DOI 10.1053/j.gastro.2012.03.001; Hanania NA, 2011, ANN INTERN MED, V154, P573, DOI 10.7326/0003-4819-154-9-201105030-00002; Hasan SA, 2013, ALLERGY ASTHMA PROC, V34, P26, DOI 10.2500/aap.2013.34.3621; Henderson CJ, 2012, J ALLERGY CLIN IMMUN, V129, P1570, DOI 10.1016/j.jaci.2012.03.023; Hirano I, 2013, GUT, V62, P489, DOI 10.1136/gutjnl-2011-301817; Jyonouchi S, 2009, IMMUNOL ALLERGY CLIN, V29, P85, DOI 10.1016/j.iac.2008.09.008; Le-Carlson M, 2013, J PEDIATR GASTR NUTR, V56, P257, DOI 10.1097/MPG.0b013e3182758d49; Liacouras CA, 2005, CLIN GASTROENTEROL H, V3, P1198, DOI 10.1016/S1542-3565(05)00885-2; Liacouras C, 2011, J ALLERGY CLIN IMMUN, V128, P3, DOI 10.1016/j.jaci.2011.02.040; Maurer M, 2013, NEW ENGL J MED, V368, P924, DOI 10.1056/NEJMoa1215372; Meng YF, 2012, NEW ENGL J MED, V367, P1471, DOI 10.1056/NEJMc1209949; Miehlke Stephan, 2013, Case Rep Gastroenterol, V7, P363, DOI 10.1159/000355161; Mulder DJ, 2011, MUCOSAL IMMUNOL, V4, P139, DOI 10.1038/mi.2010.88; Plewako H, 2002, J ALLERGY CLIN IMMUN, V110, P68, DOI 10.1067/mai.2002.125488; Prussin C, 2003, J ALLERGY CLIN IMMUN, V112, P1147, DOI 10.1016/j.jaci.2003.10.003; Ridolo E, 2011, ANN ALLERG ASTHMA IM, V106, P73, DOI 10.1016/j.anai.2010.10.010; Rocha R, 2011, EUR J PEDIATR, V170, P1471, DOI 10.1007/s00431-011-1540-4; Rodrigues M, 2013, J PEDIAT-BRAZIL, V89, P197, DOI 10.1016/j.jped.2013.03.001; Savage JH, 2010, J ALLERGY CLIN IMMUN, V125, P683, DOI 10.1016/j.jaci.2009.12.994; Schoepfer AM, 2013, GASTROENTEROLOGY, V145, P1230, DOI 10.1053/j.gastro.2013.08.015; Skripak JM, 2007, J ALLERGY CLIN IMMUN, V120, P1172, DOI 10.1016/j.jaci.2007.08.023; Spergel JM, 2012, J ALLERGY CLIN IMMUN, V130, P461, DOI 10.1016/j.jaci.2012.05.021; Spergel JM, 2012, J ALLERGY CLIN IMMUN, V129, P456, DOI 10.1016/j.jaci.2011.11.044; Stein ML, 2006, J ALLERGY CLIN IMMUN, V118, P1312, DOI 10.1016/j.jaci.2006.09.007; Straumann A, 2001, J ALLERGY CLIN IMMUN, V108, P954, DOI 10.1067/mai.2001.119917; Straumann A, 2013, ALLERGY, V68, P375, DOI 10.1111/all.12096; Straumann A, 2012, ALLERGY, V67, P477, DOI 10.1111/j.1398-9995.2012.02787.x; Straumann A, 2010, GUT, V59, P21, DOI 10.1136/gut.2009.178558; Straumann A, 2012, NAT REV GASTRO HEPAT, V9, P697, DOI 10.1038/nrgastro.2012.182; Straumann A, 2011, THORAC SURG CLIN, V21, P575, DOI 10.1016/j.thorsurg.2011.09.004; Suzuki R, 2014, SCIENCE, V343, P1021, DOI 10.1126/science.1246976; Nguyen T, 2011, J PEDIATR GASTR NUTR, V53, P40, DOI 10.1097/MPG.0b013e318212647a; Upadhyaya B, 2011, J IMMUNOL, V187, P3111, DOI 10.4049/jimmunol.1101283; Wang YH, 2013, J ALLERGY CLIN IMMUN, V131, P1583, DOI 10.1016/j.jaci.2013.04.010; Wechsler ME, 2012, J ALLERGY CLIN IMMUN, V130, P563, DOI 10.1016/j.jaci.2012.07.027	46	92	96	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2015	10	3							e0113483	10.1371/journal.pone.0113483	http://dx.doi.org/10.1371/journal.pone.0113483			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD9NQ	25789989	Green Submitted, Green Published, gold			2022-12-27	WOS:000351425400004
J	Matos, I; Machado, MP; Schartl, M; Coelho, MM				Matos, I.; Machado, M. P.; Schartl, M.; Coelho, M. M.			Gene Expression Dosage Regulation in an Allopolyploid Fish	PLOS ONE			English	Article							SQUALIUS-ALBURNOIDES; RNA-SEQ; BALANCE HYPOTHESIS; HYBRID; EVOLUTION; GENOME; COMPLEX; PLOIDY; GROWTH; SIZE	How allopolyploids are able not only to cope but profit from their condition is a question that remains elusive, but is of great importance within the context of successful allopolyploid evolution. One outstanding example of successful allopolyploidy is the endemic Iberian cyprinid Squalius alburnoides. Previously, based on the evaluation of a few genes, it was reported that the transcription levels between diploid and triploid S. alburnoides were similar. If this phenomenon occurs on a full genomic scale, a wide functional "diploidization'' could be related to the success of these polyploids. We generated RNA-seq data from whole juvenile fish and from adult livers, to perform the first comparative quantitative transcriptomic analysis between diploid and triploid individuals of a vertebrate allopolyploid. Together with an assay to estimate relative expression per cell, it was possible to infer the relative sizes of transcriptomes. This showed that diploid and triploid S. alburnoides hybrids have similar liver transcriptome sizes. This in turn made it valid to directly compare the S. alburnoides RNA-seq transcript data sets and obtain a profile of dosage responses across the S. alburnoides transcriptome. We found that 64% of transcripts in juveniles' samples and 44% in liver samples differed less than twofold between diploid and triploid hybrids (similar expression). Yet, respectively 29% and 15% of transcripts presented accurate dosage compensation (PAA/PA expression ratio of 1 instead of 1.5). Therefore, an exact functional diploidization of the triploid genome does not occur, but a significant down regulation of gene expression in triploids was observed. However, for those genes with similar expression levels between diploids and triploids, expression is not globally strictly proportional to gene dosage nor is it set to a perfect diploid level. This quantitative expression flexibility may be a strong contributor to overcome the genomic shock, and be an immediate evolutionary advantage of allopolyploids.	[Matos, I.; Machado, M. P.; Coelho, M. M.] Univ Lisbon, Fac Ciencias, Ctr Ecol Evolut & Environm Changes CE3C, P-1749016 Lisbon, Portugal; [Matos, I.; Machado, M. P.; Schartl, M.] Univ Wurzburg, Physiol Chem, D-97070 Wurzburg, Germany; [Schartl, M.] Univ Clin Wurzburg, Ctr Comprehens Canc, D-97074 Wurzburg, Germany	Universidade de Lisboa; University of Wurzburg; University of Wurzburg	Coelho, MM (corresponding author), Univ Lisbon, Fac Ciencias, Ctr Ecol Evolut & Environm Changes CE3C, P-1749016 Lisbon, Portugal.	mmcoelho@fc.ul.pt	Coelho, Maria M/B-8672-2009; Machado, Miguel/F-6846-2015	Coelho, Maria M/0000-0003-3288-1693; Machado, Miguel/0000-0002-1786-8522; Schartl, Manfred/0000-0001-9882-5948	Fundacao para a Ciencia e Tecnologia [PTDC/BIA-BIC/110277/2009, SFRH/BD/61217/2009, SFRH/BD/73335/2010]	Fundacao para a Ciencia e Tecnologia(Portuguese Foundation for Science and TechnologyEuropean Commission)	Funding for this study was provided by Fundacao para a Ciencia e Tecnologia (http://www.fct.pt/index.phtml.pt): [Project PTDC/BIA-BIC/110277/2009 to MC, PhD grant SFRH/BD/61217/2009 to IM and PhD grant SFRH/BD/73335/2010 to MPM]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alves MJ, 2001, GENETICA, V111, P375, DOI 10.1023/A:1013783029921; [Anonymous], 2012, ANIM BEHAV, V83, P301, DOI 10.1016/j.anbehav.2011.10.031; Auger DL, 2005, GENETICS, V169, P389, DOI 10.1534/genetics.104.032987; Beyea MM, 2005, FISH PHYSIOL BIOCHEM, V31, P303, DOI 10.1007/s10695-005-1552-y; Birchler JA, 2007, PLANT CELL, V19, P395, DOI 10.1105/tpc.106.049338; Birchler JA, 2012, P NATL ACAD SCI USA, V109, P14746, DOI 10.1073/pnas.1207726109; Birchler JA, 2010, PLANT CELL, V22, P2105, DOI 10.1105/tpc.110.076133; Chang PL, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-12-r125; Christodoulou D. C., 2011, CURR PROTOC MOL BIOL, V94, P4121, DOI DOI 10.1002/0471142727.MB0412S94; Coate JE, 2010, GENOME BIOL EVOL, V2, P534, DOI 10.1093/gbe/evq038; Collares-Pereira MJ, 2013, CYTOGENET GENOME RES, V140, P97, DOI 10.1159/000351729; Crespo-Lopez ME, 2006, ZOOLOGY, V109, P277, DOI 10.1016/j.zool.2006.03.008; Cunha C, 2009, J EVOLUTION BIOL, V22, P718, DOI 10.1111/j.1420-9101.2009.01695.x; Feldman M, 2012, J EXP BOT, V63, P5045, DOI 10.1093/jxb/ers192; Fraser BA, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-202; Gao ZX, 2007, COMP BIOCHEM PHYS A, V147, P1001, DOI 10.1016/j.cbpa.2007.03.006; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Grimplet J, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-187; Guo M, 2006, THEOR APPL GENET, V113, P831, DOI 10.1007/s00122-006-0335-x; He GM, 2010, PLANT CELL, V22, P17, DOI 10.1105/tpc.109.072041; Hedgecock D, 2007, P NATL ACAD SCI USA, V104, P2313, DOI 10.1073/pnas.0610880104; Hotz H, 1999, P NATL ACAD SCI USA, V96, P2171, DOI 10.1073/pnas.96.5.2171; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Inacio A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041158; Iseli C, 1999, Proc Int Conf Intell Syst Mol Biol, P138; Kakumanu A, 2012, PLANT PHYSIOL, V160, P846, DOI 10.1104/pp.112.200444; Lampert KP, 2008, PHILOS T R SOC B, V363, P2901, DOI 10.1098/rstb.2008.0040; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Loven J, 2012, CELL, V151, P476, DOI 10.1016/j.cell.2012.10.012; Mable BK, 2013, HEREDITY, V110, P95, DOI 10.1038/hdy.2012.105; Mable BK, 2011, J ZOOL, V284, P151, DOI 10.1111/j.1469-7998.2011.00829.x; Marguerat S, 2012, TRENDS GENET, V28, P560, DOI 10.1016/j.tig.2012.07.003; Marioni JC, 2008, GENOME RES, V18, P1509, DOI 10.1101/gr.079558.108; McManus CJ, 2010, GENOME RES, V20, P816, DOI 10.1101/gr.102491.109; Miller M, 2012, G3-GENES GENOM GENET, V2, P505, DOI 10.1534/g3.112.002162; Morgado-Santos M, 2010, J FISH BIOL, V76, P1228, DOI 10.1111/j.1095-8649.2010.02591.x; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Osborn TC, 2003, TRENDS GENET, V19, P141, DOI 10.1016/S0168-9525(03)00015-5; Otto SP, 2000, ANNU REV GENET, V34, P401, DOI 10.1146/annurev.genet.34.1.401; Pala I, 2008, CURR BIOL, V18, P1344, DOI 10.1016/j.cub.2008.07.096; Pala I, 2010, P ROY SOC B-BIOL SCI, V277, P3519, DOI 10.1098/rspb.2010.1071; Pertea G, 2003, BIOINFORMATICS, V19, P651, DOI 10.1093/bioinformatics/btg034; Pittman K, 2013, REV AQUACULT, V5, pS224, DOI 10.1111/raq.12034; Pontes O, 2003, P NATL ACAD SCI USA, V100, P11418, DOI 10.1073/pnas.1932522100; Raj A, 2006, PLOS BIOL, V4, P1707, DOI 10.1371/journal.pbio.0040309; Ribeiro F, 2003, ARCH HYDROBIOL, V156, P471, DOI 10.1127/0003-9136/2003/0156-0471; Ritz CM, 2011, BMC PLANT BIOL, V23, P11; Schwarz EM, 2012, P NATL ACAD SCI USA, V109, P16246, DOI 10.1073/pnas.1203045109; SMALL SA, 1987, J EXP ZOOL, V241, P339, DOI 10.1002/jez.1402410309; Sousa-Santos C, 2005, DNA SEQUENCE, V16, P462, DOI 10.1080/10425170500356065; Stock M, 2002, NAT GENET, V30, P325, DOI 10.1038/ng839; Stupar RM, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-33; Swanson-Wagner RA, 2006, P NATL ACAD SCI USA, V103, P6805, DOI 10.1073/pnas.0510430103; Vogel C, 2013, SCIENCE, V342, P1052, DOI 10.1126/science.1247833; Wang XY, 2005, NEW PHYTOL, V165, P937, DOI 10.1111/j.1469-8137.2004.01293.x; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; Wu CY, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000523; Xu Y, 2012, PLANT BIOLOGY, V14, P734, DOI 10.1111/j.1438-8677.2011.00553.x	58	8	8	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2015	10	3							e0116309	10.1371/journal.pone.0116309	http://dx.doi.org/10.1371/journal.pone.0116309			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD9NQ	25789776	Green Submitted, Green Published, gold			2022-12-27	WOS:000351425400012
J	Shah, N; Singh, R; Sarangi, U; Saxena, N; Chaudhary, A; Kaur, G; Kaul, SC; Wadhwa, R				Shah, Navjot; Singh, Rumani; Sarangi, Upasana; Saxena, Nishant; Chaudhary, Anupama; Kaur, Gurcharan; Kaul, Sunil C.; Wadhwa, Renu			Combinations of Ashwagandha Leaf Extracts Protect Brain-Derived Cells against Oxidative Stress and Induce Differentiation	PLOS ONE			English	Article							WITHANIA-SOMNIFERA; MITOCHONDRIAL DYSFUNCTION; WITHAFERIN-A; CANCER-CELLS; ALCOHOLIC EXTRACT; GLUTAMATE; IDENTIFICATION; CONCOMITANT; COMPONENTS; INHIBITOR	Background Ashwagandha, a traditional Indian herb, has been known for its variety of therapeutic activities. We earlier demonstrated anticancer activities in the alcoholic and water extracts of the leaves that were mediated by activation of tumor suppressor functions and oxidative stress in cancer cells. Low doses of these extracts were shown to possess neuroprotective activities in vitro and in vivo assays. Methodology/Principal Findings We used cultured glioblastoma and neuroblastoma cells to examine the effect of extracts (alcoholic and water) as well as their bioactive components for neuroprotective activities against oxidative stress. Various biochemical and imaging assays on the marker proteins of glial and neuronal cells were performed along with their survival profiles in control, stressed and recovered conditions. We found that the extracts and one of the purified components, withanone, when used at a low dose, protected the glial and neuronal cells from oxidative as well as glutamate insult, and induced their differentiation per se. Furthermore, the combinations of extracts and active component were highly potent endorsing the therapeutic merit of the combinational approach. Conclusion Ashwagandha leaf derived bioactive compounds have neuroprotective potential and may serve as supplement for brain health.	[Shah, Navjot; Singh, Rumani; Sarangi, Upasana; Saxena, Nishant; Chaudhary, Anupama; Kaul, Sunil C.; Wadhwa, Renu] Natl Inst Adv Ind Sci & Technol, Cell Proliferat Res Grp, Tsukuba, Ibaraki 3058562, Japan; [Shah, Navjot; Singh, Rumani; Sarangi, Upasana; Saxena, Nishant; Chaudhary, Anupama; Kaul, Sunil C.; Wadhwa, Renu] Natl Inst Adv Ind Sci & Technol, DBT AIST Int Lab Adv Biomed DAILAB, Tsukuba, Ibaraki 3058562, Japan; [Kaur, Gurcharan] Guru Nanak Dev Univ, Dept Biotechnol, Amritsar 143005, Punjab, India	National Institute of Advanced Industrial Science & Technology (AIST); National Institute of Advanced Industrial Science & Technology (AIST); Guru Nanak Dev University	Kaul, SC (corresponding author), Natl Inst Adv Ind Sci & Technol, Cell Proliferat Res Grp, Tsukuba, Ibaraki 3058562, Japan.	s-kaul@aist.go.jp; renu-wadhwa@aist.go.jp	Chaudhary, Anupama/AAF-8156-2020; Wadhwa, Renu/L-8898-2018; Kaul, Sunil C/L-8671-2018; Kaur, Gurcharan/V-6033-2019	Chaudhary, Anupama/0000-0001-9619-8813; Wadhwa, Renu/0000-0001-8248-5192; Kaul, Sunil C/0000-0002-0046-3916; 	Department of Biotechnology (India)-National Institute of Advanced Industrial Science & Technology (Japan) Bilateral Project Grant; Ministry of Education, Culture, Sports, Science & Technology (MEXT) Scholarships, Japan	Department of Biotechnology (India)-National Institute of Advanced Industrial Science & Technology (Japan) Bilateral Project Grant; Ministry of Education, Culture, Sports, Science & Technology (MEXT) Scholarships, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	The study was supported by Department of Biotechnology (India)-National Institute of Advanced Industrial Science & Technology (Japan) Bilateral Project Grant. Navjot Shah and Rumani Singh were supported by the Ministry of Education, Culture, Sports, Science & Technology (MEXT) Scholarships, Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Di Carlo M, 2012, FREE RADICAL RES, V46, P1327, DOI 10.3109/10715762.2012.714466; Dobrek L, 2011, POSTEP HIG MED DOSW, V65, P338; Gautam A, 2013, NEUROBIOL LEARN MEM, V106, P177, DOI 10.1016/j.nlm.2013.08.009; Grover A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030890; Grover A, 2012, INT J BIOCHEM CELL B, V44, P496, DOI 10.1016/j.biocel.2011.11.021; Gupta MS, 2006, PHARM BIOL, V44, P263, DOI 10.1080/13880200600713949; Hahm ER, 2013, JNCI-J NATL CANCER I, V105, P1111, DOI 10.1093/jnci/djt153; Hahm ER, 2013, CANCER LETT, V334, P101, DOI 10.1016/j.canlet.2012.08.026; Hahm ER, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023354; Hamilton NB, 2010, NAT REV NEUROSCI, V11, P227, DOI 10.1038/nrn2803; Hynd MR, 2004, NEUROCHEM INT, V45, P583, DOI 10.1016/j.neuint.2004.03.007; Jain S, 2001, PHYTOTHER RES, V15, P544, DOI 10.1002/ptr.802; Jeyanthi Thangavel, 2010, Journal of Basic and Clinical Physiology and Pharmacology, V21, P61; Kaileh M, 2007, J BIOL CHEM, V282, P4253, DOI 10.1074/jbc.M606728200; Kataria H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055316; Kataria H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037080; Kataria H, 2011, EVID-BASED COMPL ALT, V2011, DOI 10.1093/ecam/nep188; Konar A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027265; Kulkarni SK, 2008, PROG NEURO-PSYCHOPH, V32, P1093, DOI 10.1016/j.pnpbp.2007.09.011; Mah LJ, 2010, LEUKEMIA, V24, P679, DOI 10.1038/leu.2010.6; Malik F, 2007, APOPTOSIS, V12, P2115, DOI 10.1007/s10495-007-0129-x; Malik F, 2009, EUR J CANCER, V45, P1494, DOI 10.1016/j.ejca.2009.01.034; Matute C, 2011, J ANAT, V219, P53, DOI 10.1111/j.1469-7580.2010.01339.x; Nakatsu Y, 2009, TOXICOL APPL PHARM, V240, P292, DOI 10.1016/j.taap.2009.06.024; Pedrazzi M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044518; Priyandoko D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019552; Roy RV, 2013, J NAT PROD, V76, P1909, DOI 10.1021/np400441f; Ryu J, 2014, J BIOL CHEM, V289, P24832, DOI 10.1074/jbc.M114.565929; Saito Y, 2010, FREE RADICAL BIO MED, V49, P1542, DOI 10.1016/j.freeradbiomed.2010.08.016; Shah N, 2009, CANCER SCI, V100, P1740, DOI 10.1111/j.1349-7006.2009.01236.x; Shih YY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026236; Shukla V, 2011, ADV PHARMACOL SCI, V2011, DOI 10.1155/2011/572634; Sinha P, 2013, CANCER IMMUNOL IMMUN, V62, P1663, DOI 10.1007/s00262-013-1470-2; Thaiparambil JT, 2011, INT J CANCER, V129, P2744, DOI 10.1002/ijc.25938; Trushina E, 2007, NEUROSCIENCE, V145, P1233, DOI 10.1016/j.neuroscience.2006.10.056; Uttara B, 2009, CURR NEUROPHARMACOL, V7, P65, DOI 10.2174/157015909787602823; Vaishnavi K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044419; Wadegaonkar VP, 2013, J BIOTECHNOL, V168, P229, DOI 10.1016/j.jbiotec.2013.08.028; Wadhwa R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077189; Widodo N, 2008, CANCER LETT, V262, P37, DOI 10.1016/j.canlet.2007.11.037; Widodo N, 2007, CLIN CANCER RES, V13, P2298, DOI 10.1158/1078-0432.CCR-06-0948; Widodo N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013536; Widodo N, 2009, J GERONTOL A-BIOL, V64, P1031, DOI 10.1093/gerona/glp088; Yan J, 2010, BRAIN RES, V1347, P132, DOI 10.1016/j.brainres.2010.05.074; Yu Y, 2009, BIOCHEM PHARMACOL, V79, P542; Zheng XY, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/457079	46	22	22	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2015	10	3							e0120554	10.1371/journal.pone.0120554	http://dx.doi.org/10.1371/journal.pone.0120554			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD9NQ	25789768	Green Submitted, Green Published, gold			2022-12-27	WOS:000351425400162
J	Uppu, DSSM; Manjunath, GB; Yarlagadda, V; Kaviyil, JE; Ravikumar, R; Paramanandham, K; Shome, BR; Haldar, J				Uppu, Divakara S. S. M.; Manjunath, Goutham B.; Yarlagadda, Venkateswarlu; Kaviyil, Jyothi E.; Ravikumar, Raju; Paramanandham, Krishnamoorthy; Shome, Bibek R.; Haldar, Jayanta			Membrane-Active Macromolecules Resensitize NDM-1 Gram-Negative Clinical Isolates to Tetracycline Antibiotics	PLOS ONE			English	Article							ESCHERICHIA-COLI; ACINETOBACTER-BAUMANNII; KLEBSIELLA-PNEUMONIAE; RESISTANCE; BACTERIA; POLYMERS; MECHANISMS; DESIGN; AGENTS	Gram-negative 'superbugs' such as New Delhi metallo-beta-lactamase-1 (bla(NDM-1)) producing pathogens have become world's major public health threats. Development of molecular strategies that can rehabilitate the 'old antibiotics' and halt the antibiotic resistance is a promising approach to target them. We report membrane-active macromolecules (MAMs) that restore the antibacterial efficacy (enhancement by >80-1250 fold) of tetracycline antibiotics towards blaNDM-1 Klebsiella pneumonia and blaNDM-1 Escherichia coli clinical isolates. Organismic studies showed that bacteria had an increased and faster uptake of tetracycline in the presence of MAMs which is attributed to the mechanism of re-sensitization. Moreover, bacteria did not develop resistance to MAMs and MAMs stalled the development of bacterial resistance to tetracycline. MAMs displayed membrane-active properties such as dissipation of membrane potential and membrane-permeabilization that enabled higher uptake of tetracycline in bacteria. In-vivo toxicity studies displayed good safety profiles and preliminary in-vivo antibacterial efficacy studies showed that mice treated with MAMs in combination with antibiotics had significantly decreased bacterial burden compared to the untreated mice. This report of re-instating the efficacy of the antibiotics towards blaNDM-1 pathogens using membrane-active molecules advocates their potential for synergistic co-delivery of antibiotics to combat Gram-negative superbugs.	[Uppu, Divakara S. S. M.; Manjunath, Goutham B.; Yarlagadda, Venkateswarlu; Haldar, Jayanta] JNCASR, Chem Biol & Med Chem Lab, New Chem Unit, Bangalore 560064, Karnataka, India; [Kaviyil, Jyothi E.; Ravikumar, Raju] NIMHANS, Dept Neuromicrobiol, Bangalore 560029, Karnataka, India; [Paramanandham, Krishnamoorthy; Shome, Bibek R.] NIVEDI, Bengaluru 560024, Karnataka, India	Department of Science & Technology (India); Jawaharlal Nehru Center for Advanced Scientific Research (JNCASR); National Institute of Mental Health & Neurosciences - India; Indian Council of Agricultural Research (ICAR); ICAR - National Institute of Veterinary Epidemiology & Disease Informatics	Haldar, J (corresponding author), JNCASR, Chem Biol & Med Chem Lab, New Chem Unit, Bangalore 560064, Karnataka, India.	jayanta@jncasr.ac.in	Uppu, Divakara SSM/U-1848-2019	Uppu, Divakara SSM/0000-0002-7271-9538; PARAMANANDHAM, KRISHNAMOORTHY/0000-0001-7495-1333; Shome, Bibek/0000-0003-4741-7076; Yarlagadda, Venkateswarlu/0000-0001-7476-0078	Department of Science and Technology (DST), Govt. of India [SR/S2/RJN-43/2009]	Department of Science and Technology (DST), Govt. of India(Department of Science & Technology (India))	This work was supported by the grant "Ramanujan fellowship" [SR/S2/RJN-43/2009] from the Department of Science and Technology (DST), Govt. of India. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arpin C, 2012, ANTIMICROB AGENTS CH, V56, P3432, DOI 10.1128/AAC.00230-12; Choi S, 2009, P NATL ACAD SCI USA, V106, P6968, DOI 10.1073/pnas.0811818106; Clinical Laboratory Standards Institute, M100 S22, V32, pM100; Deng M, 2014, ANTIMICROB AGENTS CH, V58, P297, DOI 10.1128/AAC.01727-13; DOCKTER ME, 1978, P NATL ACAD SCI USA, V75, P1319, DOI 10.1073/pnas.75.3.1319; Ejim L, 2011, NAT CHEM BIOL, V7, P348, DOI [10.1038/NCHEMBIO.559, 10.1038/nchembio.559]; Goldberg K, 2013, FASEB J, V27, P3818, DOI 10.1096/fj.13-227942; Harris TL, 2014, ACS CHEM BIOL, V9, P122, DOI 10.1021/cb400490k; KASHKET ER, 1985, ANNU REV MICROBIOL, V39, P219, DOI 10.1146/annurev.mi.39.100185.001251; King AM, 2014, NATURE, V510, P503, DOI 10.1038/nature13445; LIPNICK RL, 1995, FOOD CHEM TOXICOL, V33, P223, DOI 10.1016/0278-6915(94)00136-C; Liu RH, 2014, J AM CHEM SOC, V136, P4410, DOI 10.1021/ja500367u; Manchanda V, 2011, INDIAN J MED MICROBI, V29, P249, DOI 10.4103/0255-0857.83907; Ng VWL, 2013, ADV MATER, V25, P6730, DOI 10.1002/adma.201302952; Niu YH, 2012, J MED CHEM, V55, P4003, DOI 10.1021/jm300274p; Odds FC, 2003, J ANTIMICROB CHEMOTH, V52, P1, DOI 10.1093/jac/dkg301; Pena-Miller R, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001540; Pieri C, 2014, J MED CHEM, V57, P4263, DOI 10.1021/jm500194e; Morones-Ramirez JR, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3006276; Sakoulas G, 2014, ANTIMICROB AGENTS CH, V58, P1494, DOI 10.1128/AAC.02274-13; Sgolastra F, 2013, ACCOUNTS CHEM RES, V46, P2977, DOI 10.1021/ar400066v; Takahashi H, 2013, MACROMOL BIOSCI, V13, P1285, DOI 10.1002/mabi.201300126; Taylor PL, 2012, ACS CHEM BIOL, V7, P1547, DOI 10.1021/cb300269g; Uppu DSSM, 2013, CHEM COMMUN, V49, P9389, DOI 10.1039/c3cc43751e; Velkov T, 2014, ACS CHEM BIOL, V9, P1172, DOI 10.1021/cb500080r; Walsh C, 2000, NATURE, V406, P775, DOI 10.1038/35021219; Walsh TR, 2011, LANCET INFECT DIS, V11, P355, DOI 10.1016/S1473-3099(11)70059-7; World Health Organization, 2014, ANT RES GLOB REP SUR; Worthington RJ, 2012, ACS MED CHEM LETT, V3, P357, DOI 10.1021/ml200290p; YAMAGUCHI A, 1991, ANTIMICROB AGENTS CH, V35, P53, DOI 10.1128/AAC.35.1.53; Yarlagadda V, 2014, J MED CHEM, V57, P4558, DOI 10.1021/jm500270w; Zhang JY, 2014, J AM CHEM SOC, V136, P4873, DOI 10.1021/ja5011338	32	24	25	1	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2015	10	3							e0119422	10.1371/journal.pone.0119422	http://dx.doi.org/10.1371/journal.pone.0119422			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD9NQ	25789871	Green Submitted, Green Published, gold			2022-12-27	WOS:000351425400083
J	van Velthoven, MH; Li, Y; Wang, W; Chen, L; Du, XZ; Wu, Q; Zhang, YF; Rudan, I; Car, J				van Velthoven, Michelle Helena; Li, Ye; Wang, Wei; Chen, Li; Du, Xiaozhen; Wu, Qiong; Zhang, Yanfeng; Rudan, Igor; Car, Josip			Prevalence of Mobile Phones and Factors Influencing Usage by Caregivers of Young Children in Daily Life and for Health Care in Rural China: A Mixed Methods Study	PLOS ONE			English	Article							DATA-COLLECTION; ADHERENCE; REMINDERS; OUTCOMES; SERVICE; INFANT; COUNTY; POCKET; FIELD	Introduction To capitalise on mHealth, we need to understand the use of mobile phones both in daily life and for health care. Objective To assess the prevalence and factors that influence usage of mobile phones by caregivers of young children. Materials and Methods A mixed methods approach was used, whereby a survey (N=1854) and semi-structured interviews (N=17) were conducted concurrently. The quantitative and qualitative data obtained were compared and integrated. Participants were caregivers of young children in Zhao County, Hebei Province, China. Results Four main themes were found: (i) trends in mobile phone ownership; (ii) usage of mobile phone functions; (iii) factors influencing replying to text messages; and (iv) uses of mobile phones for health care. The majority of 1,854 survey participants (1,620; 87.4%) used mobile phones, but usage was much higher among mothers (1,433; 92.6%) and fathers (41; 100.0%) compared to grandparents (142; 54.6%). Parents were able to send text messages, grandparents often not. Factors influencing the decision to reply to text messages in daily life were checking the mobile phone, trusting the sender, emotion or feeling when receiving a text message, the importance of replying and ease of use of text messages. Of 1,620 survey participants who used a mobile phone, about one in four (432; 26.7%) had used it for health care in the past three months and most (1,110; 93.5%) of 1,187 who had not wished to use their phone to receive health information. Conclusion We found that usage of mobile phones is high, several factors influencing usage and an interest of caregivers to use phones for health care in Zhao County, rural China, which can be used to inform studies in settings with similar characteristics. Future work needs to assess factors influencing mobile phone usage in-depth to optimize experiences of users for specific mHealth-based interventions.	[van Velthoven, Michelle Helena; Car, Josip] Univ London Imperial Coll Sci Technol & Med, Dept Primary Care & Publ Hlth, Global eHlth Unit, London, England; [Li, Ye; Wang, Wei; Chen, Li; Du, Xiaozhen; Wu, Qiong; Zhang, Yanfeng] Capital Inst Paediat, Dept Integrated Early Childhood Dev, Beijing, Peoples R China; [Rudan, Igor] Univ Edinburgh, Sch Med, Ctr Populat Hlth Sci, Edinburgh, Midlothian, Scotland; [Rudan, Igor] Univ Edinburgh, Sch Med, Global Hlth Acad, Edinburgh, Midlothian, Scotland	Imperial College London; University of Edinburgh; University of Edinburgh	Zhang, YF (corresponding author), Capital Inst Paediat, Dept Integrated Early Childhood Dev, Beijing, Peoples R China.	summyzh@126.com	van Velthoven, Michelle Helena/AAA-6819-2019; Rudan, Igor/I-1467-2012; Car, Josip/H-6755-2015	van Velthoven, Michelle Helena/0000-0003-1245-8759; Rudan, Igor/0000-0001-6993-6884; Car, Josip/0000-0001-8969-371X	Capital Institute of Pediatrics [Fangxiang-14-05]; National Institute for Health Research Biomedical Research Centre Funding scheme; National Institute for Health Research Collaboration for Leadership in Applied Health Research and Care scheme; Imperial Centre for Patient Safety and Service Quality; Imperial's Global eHealth Unit; Santander	Capital Institute of Pediatrics; National Institute for Health Research Biomedical Research Centre Funding scheme(National Institute for Health Research (NIHR)); National Institute for Health Research Collaboration for Leadership in Applied Health Research and Care scheme; Imperial Centre for Patient Safety and Service Quality; Imperial's Global eHealth Unit; Santander	The study was funded by the Capital Institute of Pediatrics (http://www.shouer.com.cn/en/web/) (Project No. Fangxiang-14-05). The Department of Primary Care and Public Health at Imperial College is grateful for support from the National Institute for Health Research Biomedical Research Centre Funding scheme (http://www.imperial.nhs.uk/research/about/brc/index.htm), the National Institute for Health Research Collaboration for Leadership in Applied Health Research and Care scheme (http://www.clahrc-northwestlondon.nihr.ac.uk/), and the Imperial Centre for Patient Safety and Service Quality (http://www1.imperial.ac.uk/cpssq/). Michelle Helena van Velthoven is funded by Imperial's Global eHealth Unit and received a small grant from Santander (http://www3.imperial.ac.uk/studentfinance/prospectivepgstudents/ phdscholarships/ santandermobility) for travelling to China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2010, STAT COMM HEB PROV 2; [Anonymous], 1989, MAXQDA SOFTW QUAL DA; [Anonymous], 2013, WHAT ARE HLTH RISKS; [Anonymous], 2013, OPERATIONS REPORT TE; Barros AJD, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001390; Bloch A, 2010, POTENTIAL MOBILE TEC; Braun V., 2006, QUAL RES PSYCHOL, V3, P77, DOI [DOI 10.1191/1478088706QP063OA, 10.1191/1478088706qp063oa]; Chen HY, 2010, J CLIN NURS, V19, P234, DOI 10.1111/j.1365-2702.2009.02896.x; Creswell JW, 2009, MIXED METHODS PROCED, P203; Curioso WH, 2010, HEALTH AFFAIR, V29, P264, DOI 10.1377/hlthaff.2009.1057; Deglise C, 2012, J MED INTERNET RES, V14, DOI 10.2196/jmir.1823; Du XZ, 2013, J GLOB HEALTH, V3, P99, DOI 10.7189/jogh.03.020403; Hughes LD, 2011, HEALTH INFORM J, V17, P266, DOI 10.1177/1460458211422019; International Telecommunications Union, 2014, GLOB MOB STAT 2014; ITU-D, 2014, WORLD 2014 ICT FACTS; Kahn JG, 2010, HEALTH AFFAIR, V29, P254, DOI 10.1377/hlthaff.2009.0965; Kaplan WA, 2006, GLOBALIZATION HEALTH, V2, DOI 10.1186/1744-8603-2-9; Klasnja P, 2012, J BIOMED INFORM, V45, P184, DOI 10.1016/j.jbi.2011.08.017; Lacohee H, 2003, BT TECHNOLOGY J, V21; Lei X, 2013, T ROY SOC TROP MED H, V107, P666, DOI 10.1093/trstmh/trt070; Lester RT, 2010, LANCET, V376, P1838, DOI 10.1016/S0140-6736(10)61997-6; Li Y, 2013, J MED INTERNET RES, V15, DOI 10.2196/jmir.2906; Lingard L, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.39602.690162.47; Macedo LG, 2012, SPINE, V37, P1151, DOI 10.1097/BRS.0b013e3182422df0; Malterud K, 2001, LANCET, V358, P483, DOI 10.1016/S0140-6736(01)05627-6; Mechael P., 2010, BARRIERS GAPS AFFECT; Mechael P. N., 2009, Innovations: Technology / Governance / Globalisation, V4, P103, DOI 10.1162/itgg.2009.4.1.103; Mechael PN, 2008, DEV MHEALTH STRATEGY; National Centre for Research Methodology (NCRM), 2012, MAN QUAL INT IS EN; Odeny TA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043832; Oreglia E, 2012, P ACM C COMPUTER SUP, P137, DOI [10.1145/2145204.2145228, DOI 10.1145/2145204.2145228]; Pop-Eleches C, 2011, AIDS, V25, P825, DOI 10.1097/QAD.0b013e32834380c1; Ranck J, 2011, HLTH INFORM HLTH CAR; SAS Institute Inc, 2008, SAS VERS 9 2; Smith C, 2013, JMTM, V2, P20, DOI [10.5339/qmj.2013.11, DOI 10.5339/QMJ.2013.11]; Smith HJ, 2008, BMC MED RES METHODOL, V8, DOI 10.1186/1471-2288-8-44; SPSS Inc, 2007, SPSS WIND VERS 16 0; Strauss A, 2008, BASICS QUALITATIVE R; Tamrat T, 2012, MATERN CHILD HLTH J, V16, P1092, DOI 10.1007/s10995-011-0836-3; van Heerden A, 2012, B WORLD HEALTH ORGAN, V90, P393, DOI 10.2471/BLT.11.099788; van Velthoven MHMMT, 2013, PSYCHOL HEALTH MED, V18, P182, DOI 10.1080/13548506.2012.701310; van Velthoven MH, 2013, J GLOB HEALTH, V3, P2, DOI 10.7189/jogh.03.020101; van Velthoven MH, 2013, J GLOB HEALTH, V3, P48, DOI 10.7189/jogh.03.020401; van Velthoven MH, 2013, J GLOB HEALTH, V3, P70, DOI 10.7189/jogh.03.020404; Wesolowski A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035319; Zhang SY, 2012, J MED INTERNET RES, V14, DOI 10.2196/jmir.2183; Zhang YF, 2013, J GLOB HEALTH, V3, P91, DOI 10.7189/jogh.03.020402; Zurovac D, 2013, GLOBALIZATION HEALTH, V9, DOI 10.1186/1744-8603-9-20; Zurovac D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052045; Zurovac D, 2011, LANCET, V378, P795, DOI 10.1016/S0140-6736(11)60783-6	50	6	6	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2015	10	3							e0116216	10.1371/journal.pone.0116216	http://dx.doi.org/10.1371/journal.pone.0116216			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CD9NQ	25789477	Green Published, Green Submitted, gold			2022-12-27	WOS:000351425400010
J	Zhao, BS; Song, XR; Hu, PY; Meng, LX; Tan, YH; She, YJ; Ding, YY				Zhao, Bai-Song; Song, Xing-Rong; Hu, Pei-Ying; Meng, Ling-Xin; Tan, Yong-Hong; She, Ying-Jun; Ding, Yuan-Yuan			Hyperbaric Oxygen Treatment at Various Stages following Chronic Constriction Injury Produces Different Antinociceptive Effects via Regulation of P2X(4)R Expression and Apoptosis	PLOS ONE			English	Article							PREDOMINANTLY NEUROPATHIC ORIGIN; SPINAL-CORD-INJURY; QUALITY-OF-LIFE; CHRONIC PAIN; GENERAL-POPULATION; NERVE INJURY; P2X4 RECEPTORS; UP-REGULATION; RAT MODEL; MICROGLIA	Purpose The aims of this study were to investigate the effect of hyperbaric oxygen (HBO) treatment at various stages following chronic constriction injury (CCI) and to explore the underlying mechanisms of HBO treatment. Methods Forty adult male Sprague-Dawley rats were randomly assigned to five groups (n = 8 for each group): the sham group, CCI group, HBO1 group, HBO2 group, and HBO3 group. Neuropathic pain was induced by CCI of the sciatic nerve. HBO treatment began on postoperative days 1, 6, and 11 and continued for 5 days. The mechanical withdrawal threshold and thermal withdrawal latency were tested on preoperative day 3 and postoperative days 1, 3, 5, 7, 10, 14, and 21. The expression of P2X(4)R was determined by immunohistochemistry and western blot analysis. Cell apoptosis was measured using TUNEL staining. The expression of caspase 3 was measured using reverse transcription polymerase chain reaction (RT-PCR). Electron microscopy was used to determine the ultrastructural changes. Results Early HBO treatment beginning on postoperative day 1 produced a persistent antinociceptive effect and inhibited the CCI-induced increase in the expression of P2X(4)R without changing CCI-induced apoptosis. In contrast, late HBO treatment beginning on postoperative day 11 produced a persistent antinociceptive effect and inhibited CCI-induced apoptosis and upregulation of caspase-3 without changing the expression of P2X(4)R. In addition, late HBO treatment reduced CCI-induced ultrastructural damage. However, HBO treatment beginning on postoperative day 6 produced a transient antinociceptive effect without changing the expression of P2X(4)R or CCI-induced apoptosis. Conclusion HBO treatment at various stages following CCI can produce antinociceptive effects via different mechanisms. Early HBO treatment is associated with inhibition of P2X(4)R expression, and late HBO treatment is associated with inhibition of cell apoptosis.	[Zhao, Bai-Song; Song, Xing-Rong; Hu, Pei-Ying; Tan, Yong-Hong; She, Ying-Jun] Guangzhou Women & Childrens Med Ctr, Dept Anesthesiol, Guangzhou 510623, Guangdong, Peoples R China; [Meng, Ling-Xin; Ding, Yuan-Yuan] China Med Univ, Shengjing Hosp, Dept Pain, Shenyang 110004, Peoples R China	China Medical University	Song, XR (corresponding author), Guangzhou Women & Childrens Med Ctr, Dept Anesthesiol, Guangzhou 510623, Guangdong, Peoples R China.	zhaobaisong819@163.com	ding, yy/HHS-9589-2022		BBraun Anesthesia Scientific Research Fund [F10-205-1-41, BBF 2012-012]; Science and Technology Plan Project	BBraun Anesthesia Scientific Research Fund; Science and Technology Plan Project	This work is supported by the Science and Technology Plan Project and BBraun Anesthesia Scientific Research Fund (grant no. F10-205-1-41 and BBF 2012-012). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Waili NS, 2005, ADV THER, V22, P659, DOI 10.1007/BF02849960; Attal N, 2011, PAIN, V152, P2836, DOI 10.1016/j.pain.2011.09.014; Beggs S, 2012, NAT NEUROSCI, V15, P1068, DOI 10.1038/nn.3155; BENNETT GJ, 1988, PAIN, V33, P87, DOI 10.1016/0304-3959(88)90209-6; Block ML, 2007, NAT REV NEUROSCI, V8, P57, DOI 10.1038/nrn2038; Bouhassira D, 2008, PAIN, V136, P380, DOI 10.1016/j.pain.2007.08.013; Bridges D, 2001, BRIT J ANAESTH, V87, P12, DOI 10.1093/bja/87.1.12; Costigan M, 2009, ANNU REV NEUROSCI, V32, P1, DOI 10.1146/annurev.neuro.051508.135531; Dayan K, 2012, LIFE SCI, V90, P360, DOI 10.1016/j.lfs.2011.12.005; Doth AH, 2010, PAIN, V149, P338, DOI 10.1016/j.pain.2010.02.034; Erturk A, 2014, J NEUROSCI, V34, P1672, DOI 10.1523/JNEUROSCI.3121-13.2014; Gibbons CR, 2013, BRAIN RES, V1537, P111, DOI 10.1016/j.brainres.2013.08.050; Gu N, 2012, EUR J PAIN, V16, P1094, DOI 10.1002/j.1532-2149.2012.00113.x; Haanpaa M, 2011, PAIN, V152, P14, DOI 10.1016/j.pain.2010.07.031; Helms A, 2011, UNDERSEA HYPERBAR M, V38, P309; Inoue K, 2012, CNS NEUROL DISORD-DR, V11, P699, DOI 10.2174/187152712803581065; Ishihara H, 2001, J Orthop Sci, V6, P385, DOI 10.1007/s007760170003; Li FH, 2011, ANESTH ANALG, V113, P626, DOI 10.1213/ANE.0b013e31821f9544; Milligan ED, 2009, NAT REV NEUROSCI, V10, P23, DOI 10.1038/nrn2533; Nakai K, 2010, NEUROREPORT, V21, P559, DOI 10.1097/WNR.0b013e32833980b2; Ohayon MM, 2012, J PSYCHIATR RES, V46, P444, DOI 10.1016/j.jpsychires.2012.01.001; Sanchez EC, 2007, NEUROL RES, V29, P184, DOI 10.1179/016164107X181824; Schwab JM, 2005, J NEUROIMMUNOL, V163, P185, DOI 10.1016/j.jneuroim.2005.02.016; Sekiguchi M, 2009, EUR SPINE J, V18, P1978, DOI 10.1007/s00586-009-1064-z; Smith BH, 2007, CLIN J PAIN, V23, P143, DOI 10.1097/01.ajp.0000210956.31997.89; Smith BH, 2012, CURR PAIN HEADACHE R, V16, P191, DOI 10.1007/s11916-012-0256-0; SUGIMOTO T, 1990, PAIN, V42, P205, DOI 10.1016/0304-3959(90)91164-E; Tanga FY, 2004, NEUROCHEM INT, V45, P397, DOI 10.1016/j.neuint.2003.06.002; Torrance N, 2006, J PAIN, V7, P281, DOI 10.1016/j.jpain.2005.11.008; Treede RD, 2008, NEUROLOGY, V70, P1630, DOI 10.1212/01.wnl.0000282763.29778.59; Tsuda M, 2003, NATURE, V424, P778, DOI 10.1038/nature01786; Ulmann L, 2008, J NEUROSCI, V28, P11263, DOI 10.1523/JNEUROSCI.2308-08.2008; Ulmann L, 2013, GLIA, V61, P1306, DOI 10.1002/glia.22516; Yamada K, 2014, AM J PATHOL, V184, P753, DOI 10.1016/j.ajpath.2013.11.010; Yamashita S, 2009, BRAIN RES, V1301, P171, DOI 10.1016/j.brainres.2009.08.096; Zhang John H, 2005, Pathophysiology, V12, P63, DOI 10.1016/j.pathophys.2005.01.003; Zhang Z, 2008, NEUROSCIENCE, V152, P495, DOI 10.1016/j.neuroscience.2007.12.042; Zhao BS, 2014, J MOL NEUROSCI, V53, P251, DOI 10.1007/s12031-013-0213-3	38	13	19	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2015	10	3							e0120122	10.1371/journal.pone.0120122	http://dx.doi.org/10.1371/journal.pone.0120122			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD9NQ	25789619	gold, Green Published, Green Submitted			2022-12-27	WOS:000351425400131
J	Gutschalk, A; Rupp, A; Dykstra, AR				Gutschalk, Alexander; Rupp, Andre; Dykstra, Andrew R.			Interaction of Streaming and Attention in Human Auditory Cortex	PLOS ONE			English	Article							PERCEPTUAL ORGANIZATION; BRAIN POTENTIALS; FREQUENCY SEPARATION; SELECTIVE ATTENTION; SEGREGATION; INTERVALS; PATTERN; MONKEY; SOUND; CUES	Serially presented tones are sometimes segregated into two perceptually distinct streams. An ongoing debate is whether this basic streaming phenomenon reflects automatic processes or requires attention focused to the stimuli. Here, we examined the influence of focused attention on streaming-related activity in human auditory cortex using magnetoencephalography (MEG). Listeners were presented with a dichotic paradigm in which left-ear stimuli consisted of canonical streaming stimuli (ABA_ or ABAA) and right-ear stimuli consisted of a classical oddball paradigm. In phase one, listeners were instructed to attend the right-ear oddball sequence and detect rare deviants. In phase two, they were instructed to attend the left ear streaming stimulus and report whether they heard one or two streams. The frequency difference (Delta F) of the sequences was set such that the smallest and largest Delta F conditions generally induced one-and two-stream percepts, respectively. Two intermediate Delta F conditions were chosen to elicit bistable percepts (i.e., either one or two streams). Attention enhanced the peak-to-peak amplitude of the P1-N1 complex, but only for ambiguous Delta F conditions, consistent with the notion that automatic mechanisms for streaming tightly interact with attention and that the latter is of particular importance for ambiguous sound sequences.	[Gutschalk, Alexander; Rupp, Andre; Dykstra, Andrew R.] Heidelberg Univ, Dept Neurol, Heidelberg, Germany	Ruprecht Karls University Heidelberg	Gutschalk, A (corresponding author), Heidelberg Univ, Dept Neurol, Heidelberg, Germany.	Alexander.Gutschalk@med.uni-heidelberg.de			Bundesministerium fur Bildung und Forschung (BMBF) [01EV0712]; Deutsche Forschungsgemeinschaft; Ruprecht-Karls-Universitat Heidelberg	Bundesministerium fur Bildung und Forschung (BMBF)(Federal Ministry of Education & Research (BMBF)); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Ruprecht-Karls-Universitat Heidelberg	Research supported by Bundesministerium fur Bildung und Forschung (BMBF grant 01EV0712 to A. Gutschalk). Open access publishing supported by Deutsche Forschungsgemeinschaft and Ruprecht-Karls-Universitat Heidelberg. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALAIN C, 1993, PSYCHOPHYSIOLOGY, V30, P572, DOI 10.1111/j.1469-8986.1993.tb02083.x; ANSTIS S, 1985, J EXP PSYCHOL HUMAN, V11, P257, DOI 10.1037/0096-1523.11.3.257; Bendixen A, 2013, CLIN NEUROPHYSIOL, V124, P928, DOI 10.1016/j.clinph.2012.11.012; Bregman A.S., 1990, AUDITORY SCENE ANAL; BREGMAN AS, 1978, J EXP PSYCHOL HUMAN, V4, P380, DOI 10.1037/0096-1523.4.3.380; Bregman AS, 2000, PERCEPT PSYCHOPHYS, V62, P626, DOI 10.3758/BF03212114; Carl D, 2013, EXP BRAIN RES, V224, P557, DOI 10.1007/s00221-012-3333-z; Carlyon RP, 2003, PERCEPTION, V32, P1393, DOI 10.1068/p5035; Carlyon RP, 2001, J EXP PSYCHOL HUMAN, V27, P115, DOI 10.1037/0096-1523.27.1.115; Cusack R, 2005, J COGNITIVE NEUROSCI, V17, P641, DOI 10.1162/0898929053467541; Deike S, 2010, HEARING RES, V265, P30, DOI 10.1016/j.heares.2010.03.005; Fishman YI, 2004, J ACOUST SOC AM, V116, P1656, DOI 10.1121/1.1778903; Fishman YI, 2001, HEARING RES, V151, P167, DOI 10.1016/S0378-5955(00)00224-0; Gutschalk A, 2004, EUR J NEUROSCI, V20, P3141, DOI 10.1111/j.1460-9568.2004.03767.x; Gutschalk A, 2005, J NEUROSCI, V25, P5382, DOI 10.1523/JNEUROSCI.0347-05.2005; Gutschalk A, 2007, J NEUROSCI, V27, P13074, DOI 10.1523/JNEUROSCI.2299-07.2007; Gutschalk A, 2014, HEARING RES, V307, P98, DOI 10.1016/j.heares.2013.08.003; HANSEN JC, 1980, ELECTROEN CLIN NEURO, V49, P277, DOI 10.1016/0013-4694(80)90222-9; Hill KT, 2012, FRONT HUM NEUROSCI, V6, DOI 10.3389/fnhum.2012.00158; Hill KT, 2011, BMC NEUROSCI, V12, DOI 10.1186/1471-2202-12-85; HILLYARD SA, 1973, SCIENCE, V182, P177, DOI 10.1126/science.182.4108.177; Kondo HM, 2009, J NEUROSCI, V29, P12695, DOI 10.1523/JNEUROSCI.1549-09.2009; Micheyl C, 2005, NEURON, V48, P139, DOI 10.1016/j.neuron.2005.08.039; MILLER GA, 1950, J ACOUST SOC AM, V22, P637, DOI 10.1121/1.1906663; Moore BCJ, 2002, ACTA ACUST UNITED AC, V88, P320; Naatanen R, 2011, PSYCHOPHYSIOLOGY, V48, P4, DOI 10.1111/j.1469-8986.2010.01114.x; Pressnitzer D, 2006, CURR BIOL, V16, P1351, DOI 10.1016/j.cub.2006.05.054; Rif J., 1991, CLIN NEUROPHYSIOL, V79, P464, DOI [10.1016/0013-4694(91)90166-2, DOI 10.1016/0013-4694(91)90166-2]; Schadwinkel S, 2011, J NEUROPHYSIOL, V105, P1977, DOI 10.1152/jn.00461.2010; Schadwinkel S, 2010, CEREB CORTEX, V20, P2863, DOI 10.1093/cercor/bhq037; Snyder JS, 2012, FRONT PSYCHOL, V3, DOI 10.3389/fpsyg.2012.00015; Snyder JS, 2006, J COGNITIVE NEUROSCI, V18, P1, DOI 10.1162/089892906775250021; Sussman E, 2007, HEARING RES, V225, P117, DOI 10.1016/j.heares.2006.12.013; Sussman E, 1999, PSYCHOPHYSIOLOGY, V36, P22, DOI 10.1017/S0048577299971056; Szalardy O, 2013, BIOL PSYCHOL, V93, P97, DOI 10.1016/j.biopsycho.2013.01.015; van Noorden LPAS, 1975, TEMPORAL COHERENCE P; WOLDORFF MG, 1993, P NATL ACAD SCI USA, V90, P8722, DOI 10.1073/pnas.90.18.8722	37	13	13	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2015	10	3							e0118962	10.1371/journal.pone.0118962	http://dx.doi.org/10.1371/journal.pone.0118962			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9BN	25785997	Green Published, Green Submitted, gold			2022-12-27	WOS:000352138500061
J	Melis, AP; Floedl, A; Tomasello, M				Melis, Alicia P.; Floedl, Anja; Tomasello, Michael			Non-Egalitarian Allocations among Preschool Peers in a Face-to-Face Bargaining Task	PLOS ONE			English	Article							DISTRIBUTIVE JUSTICE; YOUNG-CHILDREN; PROSOCIAL BEHAVIOR; RESOURCE UTILIZATION; CHIMPANZEES; EQUITY; COOPERATION; FRIENDSHIP; DOMINANCE; 3-YEAR-OLDS	In face-to-face bargaining tasks human adults almost always agree on an equal split of resources. This is due to mutually recognized fairness and equality norms. Early developmental studies on sharing and equality norms found that egalitarian allocations of resources are not common before children are 5 or 6 years old. However, recent studies have shown that in some face-to face collaborative situations, or when recipients express their desires, children at much younger ages choose equal allocations. We investigated the ability of 3.5 and 5-year-olds to negotiate face-to-face, whether to collaborate to obtain an equal or an unequal distribution of rewards. We hypothesized that the face-to-face interaction and interdependency between partners would facilitate egalitarian outcomes at both ages. In the first experiment we found that 5-year-olds were more egalitarian than 3.5-year-olds, but neither of the age classes shared equally. In the second experiment, in which we increased the magnitude of the inequality, we found that children at both ages mostly agreed on the unequal distribution. These results show that communication and face-to-face interactions are not sufficient to guarantee equal allocations at 3-5 years of age. These results add to previous findings suggesting that in the context of non-collaboratively produced resources it is only after 5 years of age that children use equality norms to allocate resources.	[Melis, Alicia P.] Univ Warwick, Warwick Business Sch, Behav Sci Grp, Coventry CV4 7AL, W Midlands, England; [Melis, Alicia P.; Tomasello, Michael] Max Planck Inst Evolutionary Anthropol, Dept Dev & Comparat Psychol, Leipzig, Germany; [Floedl, Anja] Saale Unstrut Klinikum Naumburg, Klin Psych Erkrankungen, Naumburg Saale, Germany	University of Warwick; Max Planck Society	Melis, AP (corresponding author), Univ Warwick, Warwick Business Sch, Behav Sci Grp, Coventry CV4 7AL, W Midlands, England.	Alicia.melis@wbs.ac.uk			Max-Planck Society	Max-Planck Society(Max Planck SocietyFoundation CELLEX)	Support was provided by the Max-Planck Society. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2010, R LANG ENV STAT COMP; Benenson JF, 2007, EVOL HUM BEHAV, V28, P168, DOI 10.1016/j.evolhumbehav.2006.10.003; BENTON AA, 1971, J PERS SOC PSYCHOL, V18, P68, DOI 10.1037/h0030702; BIRCH LL, 1986, CHILD DEV, V57, P387, DOI 10.1111/j.1467-8624.1986.tb00038.x; Blake PR, 2011, COGNITION, V120, P215, DOI 10.1016/j.cognition.2011.04.006; Blake PR, 2010, EVOL HUM BEHAV, V31, P210, DOI 10.1016/j.evolhumbehav.2009.06.012; Brownell CA, 2009, INFANCY, V14, P117, DOI 10.1080/15250000802569868; CHARLESWORTH WR, 1983, ETHOL SOCIOBIOL, V4, P175, DOI 10.1016/0162-3095(83)90028-6; COSTIN SE, 1992, DEV PSYCHOL, V28, P941, DOI 10.1037/0012-1649.28.5.941; DAMON W, 1975, CHILD DEV, V46, P301, DOI 10.2307/1128122; DAMON W, 1980, CHILD DEV, V51, P1010, DOI 10.2307/1129538; Dunfield K, 2011, INFANCY, V16, P227, DOI 10.1111/j.1532-7078.2010.00041.x; Dunfield KA, 2013, CHILD DEV, V84, P1766, DOI 10.1111/cdev.12075; Eisenberg N., 2006, HDB CHILD PSYCHOL VO, V(6th ed., pp., P646, DOI 10.1002/9780470147658.chpsy0311; Fehr E, 2008, NATURE, V454, P1079, DOI 10.1038/nature07155; Gummerum M, 2008, CHILD DEV, V79, P562, DOI 10.1111/j.1467-8624.2008.01143.x; Gummerum M, 2010, J ECON PSYCHOL, V31, P25, DOI 10.1016/j.joep.2009.09.002; Hamann K, 2011, NATURE, V476, P328, DOI 10.1038/nature10278; Harbaugh WT, 2007, J ECON PSYCHOL, V28, P127, DOI 10.1016/j.joep.2006.03.005; Hawley PH, 2002, INT J BEHAV DEV, V26, P167, DOI 10.1080/01650250042000726; Hirata S, 2007, PRIMATES, V48, P13, DOI 10.1007/s10329-006-0022-1; House BR, 2013, P NATL ACAD SCI USA, V110, P14586, DOI 10.1073/pnas.1221217110; Jensen K, 2007, SCIENCE, V318, P107, DOI 10.1126/science.1145850; Kanngiesser P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043979; LAFRENIERE PJ, 1987, INT J BEHAV DEV, V10, P345, DOI 10.1177/016502548701000305; Lane IM, 1992, CHILD DEV, V43, P1382; LERNER MJ, 1974, J PERS SOC PSYCHOL, V29, P539, DOI 10.1037/h0036206; LEVENTHAL GS, 1970, J PERS SOC PSYCHOL, V15, P57, DOI 10.1037/h0029173; LoBue V, 2011, SOC DEV, V20, P154, DOI 10.1111/j.1467-9507.2009.00560.x; MCGILLICUDDYDELISI AV, 1994, CHILD DEV, V65, P1694; Melis AP, 2006, ANIM BEHAV, V72, P275, DOI 10.1016/j.anbehav.2005.09.018; Melis AP, 2013, J EXP CHILD PSYCHOL, V114, P364, DOI 10.1016/j.jecp.2012.08.006; Melis AP, 2009, EVOL HUM BEHAV, V30, P381, DOI 10.1016/j.evolhumbehav.2009.05.003; MISCHEL W, 1962, J ABNORM PSYCHOL, V64, P425, DOI 10.1037/h0045046; Moore C, 2009, PSYCHOL SCI, V20, P944, DOI 10.1111/j.1467-9280.2009.02378.x; MORGAN WR, 1967, J PERS SOC PSYCHOL, V6, P139, DOI 10.1037/h0024644; Murnighan JK, 1998, J ECON PSYCHOL, V19, P415, DOI 10.1016/S0167-4870(98)00017-8; Olson KR, 2008, COGNITION, V108, P222, DOI 10.1016/j.cognition.2007.12.003; Rochat P, 2009, J CROSS CULT PSYCHOL, V40, P416, DOI 10.1177/0022022109332844; Sheskin M, 2014, COGNITION, V130, P152, DOI 10.1016/j.cognition.2013.10.008; SIGELMAN CK, 1991, CHILD DEV, V62, P1367, DOI 10.1111/j.1467-8624.1991.tb01611.x; STREATER AL, 1976, CHILD DEV, V47, P800; Takagishi H, 2010, J EXP CHILD PSYCHOL, V105, P130, DOI 10.1016/j.jecp.2009.09.005; Thompson C, 1997, COGNITIVE DEV, V12, P199, DOI 10.1016/S0885-2014(97)90013-7; Tomasello M, 2012, CURR ANTHROPOL, V53, P673, DOI 10.1086/668207; Warneken F, 2011, PSYCHOL SCI, V22, P267, DOI 10.1177/0956797610395392	46	5	5	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2015	10	3							e0120494	10.1371/journal.pone.0120494	http://dx.doi.org/10.1371/journal.pone.0120494			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CE9BN	25786250	Green Submitted, Green Published, gold			2022-12-27	WOS:000352138500177
J	Russell, M; West, DJ; Briggs, MA; Bracken, RM; Cook, CJ; Giroud, T; Gill, N; Kilduff, LP				Russell, Mark; West, Daniel J.; Briggs, Marc A.; Bracken, Richard M.; Cook, Christian J.; Giroud, Thibault; Gill, Nicholas; Kilduff, Liam P.			A Passive Heat Maintenance Strategy Implemented during a Simulated Half-Time Improves Lower Body Power Output and Repeated Sprint Ability in Professional Rugby Union Players	PLOS ONE			English	Article							SOCCER MATCH-PLAY; WARM-UP; MUSCLE TEMPERATURE; CARBOHYDRATE INGESTION; PERFORMANCE; EXERCISE; VALIDITY; METABOLISM; 2ND-HALF; PROTOCOL	Reduced physical performance has been observed following the half-time period in team sports players, likely due to a decrease in muscle temperature during this period. We examined the effects of a passive heat maintenance strategy employed between successive exercise bouts on core temperature (Tcore) and subsequent exercise performance. Eighteen professional Rugby Union players completed this randomised and counter-balanced study. After a standardised warm-up (WU) and 15 min of rest, players completed a repeated sprint test (RSSA 1) and countermovement jumps (CMJ). Thereafter, in normal training attire (Control) or a survival jacket (Passive), players rested for a further 15 min (simulating a typical half-time) before performing a second RSSA (RSSA 2) and CMJ's. Measurements of Tcore were taken at baseline, post-WU, pre-RSSA 1, post-RSSA 1 and pre-RSSA 2. Peak power output (PPO) and repeated sprint ability was assessed before and after the simulated half-time. Similar Tcore responses were observed between conditions at baseline (Control: 37.06 +/- 0.05 degrees C; Passive: 37.03 +/- 0.05 degrees C) and for all other Tcore measurements taken before half-time. After the simulated half-time, the decline in Tcore was lower (-0.74 +/- 0.08% vs. -1.54 +/- 0.06%, p<0.001) and PPO was higher (5610 +/- 105Wvs. 5440 +/- 105W, p<0.001) in the Passive versus Control condition. The decline in PPO over half-time was related to the decline in Tcore (r = 0.632, p = 0.005). In RSSA 2, best, mean and total sprint times were 1.39 +/- 0.17% (p<0.001), 0.55 +/- 0.06% (p<0.001) and 0.55 +/- 0.06%(p<0.001) faster for Passive versus Control. Passive heat maintenance reduced declines in Tcore that were observed during a simulated half-time period and improved subsequent PPO and repeated sprint ability in professional Rugby Union players.	[Russell, Mark; West, Daniel J.; Briggs, Marc A.] Northumbria Univ, Dept Sport Exercise & Rehabil, Hlth & Life Sci, Newcastle Upon Tyne NE1 8ST, Tyne & Wear, England; [Bracken, Richard M.; Gill, Nicholas; Kilduff, Liam P.] Swansea Univ, Appl Sports Technol Exercise & Med Res Ctr A STEM, Hlth & Sport Portfolio, Swansea, W Glam, Wales; [Cook, Christian J.] Bangor Univ, Sch Sport Hlth & Exercise Sci, Bangor, Gwynedd, Wales; [Giroud, Thibault] Biarritz Olymp Rugby, Biarritz, France	Northumbria University; Swansea University; Bangor University	Kilduff, LP (corresponding author), Swansea Univ, Appl Sports Technol Exercise & Med Res Ctr A STEM, Hlth & Sport Portfolio, Swansea, W Glam, Wales.	l.kilduff@swansea.ac.uk	Russell, Mark/M-1652-2019; Bracken, Rich/AAC-2586-2021; West, Daniel/O-4127-2014	Russell, Mark/0000-0002-7305-1090; Bracken, Rich/0000-0002-6986-6449; Cook, Christian/0000-0001-9677-0306; Briggs, Marc/0000-0001-5920-7223; West, Daniel/0000-0003-2246-4925				Allen PB, 2010, J TRAUMA, V69, pS154, DOI 10.1097/TA.0b013e3181e45ba5; BENNETT AF, 1984, AM J PHYSIOL, V247, pR217, DOI 10.1152/ajpregu.1984.247.2.R217; Bradley PS, 2009, J SPORT SCI, V27, P159, DOI 10.1080/02640410802512775; Byrne C, 2007, BRIT J SPORT MED, V41, P126, DOI 10.1136/bjsm.2006.026344; Cook C, 2013, INT J SPORT PHYSIOL, V8, P213, DOI 10.1123/ijspp.8.2.213; DAVIES CTM, 1983, J APPL PHYSIOL, V55, P191, DOI 10.1152/jappl.1983.55.1.191; Deutsch MU, 2007, J SPORT SCI, V25, P461, DOI 10.1080/02640410600631298; EDWARDS RHT, 1972, J PHYSIOL-LONDON, V220, P335, DOI 10.1113/jphysiol.1972.sp009710; Faulkner SH, 2013, MED SCI SPORT EXER, V45, P359, DOI 10.1249/MSS.0b013e31826fba7f; Febbraio MA, 1996, AM J PHYSIOL-REG I, V271, pR1251, DOI 10.1152/ajpregu.1996.271.5.R1251; Hatze H, 1998, J APPL BIOMECH, V14, P127, DOI 10.1123/jab.14.2.127; HILL DK, 1972, J PHYSIOL-LONDON, V221, P161, DOI 10.1113/jphysiol.1972.sp009746; Kilduff LP, 2013, J SCI MED SPORT, V16, P482, DOI 10.1016/j.jsams.2012.11.889; Lovell R, 2013, SCAND J MED SCI SPOR, V23, P105, DOI 10.1111/j.1600-0838.2011.01353.x; MacDonald M, 1997, J APPL PHYSIOL, V83, P1318, DOI 10.1152/jappl.1997.83.4.1318; Mohr M, 2004, SCAND J MED SCI SPOR, V14, P156, DOI 10.1111/j.1600-0838.2004.00349.x; Owen NJ, 2014, J STRENGTH COND RES, V28, P1552, DOI 10.1519/JSC.0000000000000311; Rampinini E, 2007, INT J SPORTS MED, V28, P228, DOI 10.1055/s-2006-924340; Russell M, 2011, INT J SPORTS MED, V32, P511, DOI 10.1055/s-0031-1273742; Russell M, 2015, SPORTS MED, V45, P353, DOI 10.1007/s40279-014-0297-0; Russell M, 2014, J ATHL TRAINING, V49, P447, DOI 10.4085/1062-6050-49.3.12; Russell M, 2012, J STRENGTH COND RES, V26, P2593, DOI 10.1519/JSC.0b013e31823f284e; Russell M, 2012, J SCI MED SPORT, V15, P348, DOI 10.1016/j.jsams.2011.12.006; SARGEANT AJ, 1987, EUR J APPL PHYSIOL, V56, P693, DOI 10.1007/BF00424812; Smart D, 2014, EUR J SPORT SCI, V14, pS8, DOI 10.1080/17461391.2011.635812; Sugiura K, 1998, MED SCI SPORT EXER, V30, P1624, DOI 10.1097/00005768-199811000-00011; Towlson C, 2013, J SPORT SCI, V31, P1393, DOI 10.1080/02640414.2013.792946; West DJ, 2013, J SCI MED SPORT, V16, P172, DOI 10.1016/j.jsams.2012.06.002; West DJ, 2011, J STRENGTH COND RES, V25, P3070, DOI 10.1519/JSC.0b013e318212dcd5; Weston M, 2011, INT J SPORT PHYSIOL, V6, P174, DOI 10.1123/ijspp.6.2.174	30	19	19	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2015	10	3							e0119374	10.1371/journal.pone.0119374	http://dx.doi.org/10.1371/journal.pone.0119374			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9BN	25785393	Green Published, Green Accepted, Green Submitted, gold			2022-12-27	WOS:000352138500098
J	Vockenhuber, MP; Heueis, N; Suess, B				Vockenhuber, Michael-Paul; Heueis, Nona; Suess, Beatrix			Identification of metE as a Second Target of the sRNA scr5239 in Streptomyces coelicolor	PLOS ONE			English	Article							SMALL NONCODING RNAS; ESCHERICHIA-COLI; METABOLISM; METHIONINE; EXPRESSION; GENE; PREDICTION; BACTERIA; BINDING; ROLES	While transcriptional regulation of the primary and secondary metabolism of the model organism Streptomyces coelicolor is well studied, little is still known about the role small noncoding RNAs (sRNAs) play in regulating gene expression in this organism. Here, we report the identification of a second target of the sRNA scr5239, an sRNA highly conserved in streptomycetes. The 159 nt long sRNA binds its target, the mRNA of the cobalamin independent methionine synthase metE (SCO0985), at the 5' end of its open reading frame thereby repressing translation. We show that a high methionine level induces expression of scr5239 itself. This leads, in a negative feedback loop, to the repression of methionine biosynthesis. In contrast to the first reported target of this sRNA, the agarase dagA, this interaction seems to be conserved in a wide number of streptomycetes.	[Vockenhuber, Michael-Paul; Heueis, Nona; Suess, Beatrix] Tech Univ Darmstadt, Dept Biol, Darmstadt, Germany	Technical University of Darmstadt	Vockenhuber, MP (corresponding author), Tech Univ Darmstadt, Dept Biol, Darmstadt, Germany.	vockenhuber@bio.tu-darmstadt.de; bsuess@bio.tu-darmstadt.de			Deutsche Forschungsgemeinschaft; priority programme Sensory and Regulatory RNAs in Prokaryotes SPP1258/1;  [SU402/2-1];  [SU402/2-2]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); priority programme Sensory and Regulatory RNAs in Prokaryotes SPP1258/1; ; 	The study was supported by the Deutsche Forschungsgemeinschaft (www.dfg.de), priority programme Sensory and Regulatory RNAs in Prokaryotes SPP1258/1 and the grants SU402/2-1 and 2-2. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bouvier M, 2008, MOL CELL, V32, P827, DOI 10.1016/j.molcel.2008.10.027; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; D'Alia D, 2010, J BACTERIOL, V192, P1160, DOI 10.1128/JB.01374-09; Ferla MP, 2014, MICROBIOL-SGM, V160, P1571, DOI 10.1099/mic.0.077826-0; Gonzalez JC, 1996, BIOCHEMISTRY-US, V35, P12228, DOI 10.1021/bi9615452; Gottesman S, 2005, TRENDS GENET, V21, P399, DOI 10.1016/j.tig.2005.05.008; Gottesman S, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a003798; Grillo MA, 2005, AMINO ACIDS, V28, P357, DOI 10.1007/s00726-005-0197-6; Heueis N, 2014, RNA BIOL, V11, P464, DOI 10.4161/rna.28262; Hodgson DA, 2000, ADV MICROB PHYSIOL, V42, P47, DOI 10.1016/S0065-2911(00)42003-5; Kieser T., 2000, PRACTICAL STREPTOMYC, V4362; Kim SH, 2012, J BACTERIOL, V194, P6837, DOI 10.1128/JB.00695-12; Koutmos M, 2009, P NATL ACAD SCI USA, V106, P18527, DOI 10.1073/pnas.0906132106; Loh E, 2009, CELL, V139, P770, DOI 10.1016/j.cell.2009.08.046; Malm S, 2009, MICROBIOL-SGM, V155, P1332, DOI 10.1099/mic.0.023275-0; Mattatall NR, 1996, J BACTERIOL, V178, P2272, DOI 10.1128/jb.178.8.2272-2278.1996; Moody MJ, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-558; Muller M, 2006, NUCLEIC ACIDS RES, V34, P2607, DOI 10.1093/nar/gkl347; Myronovskyi M, 2011, APPL ENVIRON MICROB, V77, P5370, DOI 10.1128/AEM.00434-11; Papenfort K, 2013, CELL, V153, P426, DOI 10.1016/j.cell.2013.03.003; Rehmsmeier M, 2004, RNA, V10, P1507, DOI 10.1261/rna.5248604; Reining A, 2013, NATURE, V499, P355, DOI 10.1038/nature12378; Reuther J, 2007, J MOL MICROB BIOTECH, V12, P139, DOI 10.1159/000096469; RodriguezGarcia A, 1997, MOL MICROBIOL, V25, P219, DOI 10.1046/j.1365-2958.1997.4511815.x; Rudolph MM, 2013, MICROBIOL-SGM, V159, P1416, DOI 10.1099/mic.0.067322-0; Schagger H, 2006, NAT PROTOC, V1, P16, DOI 10.1038/nprot.2006.4; Sharma CM, 2011, MOL MICROBIOL, V81, P1144, DOI 10.1111/j.1365-2958.2011.07751.x; Sharma CM, 2010, NATURE, V464, P250, DOI 10.1038/nature08756; Sittka A, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000163; Song TY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101280; Storz G, 2011, MOL CELL, V43, P880, DOI 10.1016/j.molcel.2011.08.022; Straub J, 2009, RNA BIOL, V6, P281, DOI 10.4161/rna.6.3.8357; Sudarsan N, 2006, SCIENCE, V314, P300, DOI 10.1126/science.1130716; Torres-Quesada O, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068147; Urban JH, 2007, NUCLEIC ACIDS RES, V35, P1018, DOI 10.1093/nar/gkl1040; Vitreschak AG, 2003, RNA, V9, P1084, DOI 10.1261/rna.5710303; Vockenhuber MP, 2012, MICROBIOL-SGM, V158, P424, DOI 10.1099/mic.0.054205-0; Vockenhuber MP, 2011, RNA BIOL, V8, P468, DOI 10.4161/rna.8.3.14421; Vogel J, 2003, NUCLEIC ACIDS RES, V31, P6435, DOI 10.1093/nar/gkg867; Watson PY, 2011, NAT STRUCT MOL BIOL, V18, P359, DOI 10.1038/nsmb.1989; Wright PR, 2013, P NATL ACAD SCI USA, V110, pE3487, DOI 10.1073/pnas.1303248110	41	10	11	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2015	10	3							e0120147	10.1371/journal.pone.0120147	http://dx.doi.org/10.1371/journal.pone.0120147			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9BN	25785836	Green Submitted, Green Published, gold			2022-12-27	WOS:000352138500157
J	Borst, J; Marquering, HA; Beenen, LFM; Berkhemer, OA; Dankbaar, JW; Riordan, AJ; Majoie, CBLM				Borst, Jordi; Marquering, Henk A.; Beenen, Ludo F. M.; Berkhemer, Olvert A.; Dankbaar, Jan Willem; Riordan, Alan J.; Majoie, Charles B. L. M.		MR CLEAN Investigators	Effect of Extended CT Perfusion Acquisition Time on Ischemic Core and Penumbra Volume Estimation in Patients with Acute Ischemic Stroke due to a Large Vessel Occlusion	PLOS ONE			English	Article							COMPUTED-TOMOGRAPHY PERFUSION; CEREBRAL-BLOOD-FLOW; QUANTITATIVE ASSESSMENT; DIFFUSION MISMATCH; INFARCT CORE; SELECTION; BRAIN; THERAPY; MRI; REVASCULARIZATION	Background and Purpose It has been suggested that CT Perfusion acquisition times <60 seconds are too short to capture the complete in and out-wash of contrast in the tissue, resulting in incomplete time attenuation curves. Yet, these short acquisitions times are not uncommon in clinical practice. The purpose of this study was to investigate the occurrence of time attenuation curve truncation in 48 seconds CT Perfusion acquisition and to quantify its effect on ischemic core and penumbra estimation in patients with acute ischemic stroke due to a proximal intracranial arterial occlusion of the anterior circulation. Materials and Methods We analyzed CT Perfusion data with 48 seconds and extended acquisition times, assuring full time attenuation curves, of 36 patients. Time attenuation curves were classified as complete or truncated. Ischemic core and penumbra volumes resulting from both data sets were compared by median paired differences and interquartile ranges. Controlled experiments were performed using a digital CT Perfusion phantom to investigate the effect of time attenuation curve truncation on ischemic core and penumbra estimation. Results In 48 seconds acquisition data, truncation was observed in 24 (67%) cases for the time attenuation curves in the ischemic core, in 2 cases for the arterial input function and in 5 cases for the venous output function. Analysis of extended data resulted in smaller ischemic cores and larger penumbras with a median difference of 13.2 (IQR: 4.3-26.0) ml (P<0.001) and; 12.4 (IQR: 4.1-25.7) ml (P<0.001), respectively. The phantom data showed increasing ischemic core overestimation with increasing tissue time attenuation curve truncation. Conclusions Truncation is common in patients with large vessel occlusion and results in repartitioning of the area of hypoperfusion into larger ischemic core and smaller penumbra estimations. Phantom experiments confirmed that truncation results in overestimation of the ischemic core.	[Borst, Jordi; Marquering, Henk A.; Beenen, Ludo F. M.; Berkhemer, Olvert A.; Majoie, Charles B. L. M.] Univ Amsterdam, Acad Med Ctr, Dept Radiol, NL-1105 AZ Amsterdam, Netherlands; [Marquering, Henk A.] Univ Amsterdam, Acad Med Ctr, Biomed Engn & Phys, NL-1105 AZ Amsterdam, Netherlands; [Dankbaar, Jan Willem; Riordan, Alan J.] Univ Med Ctr Utrecht, Dept Radiol, Utrecht, Netherlands	University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; Utrecht University; Utrecht University Medical Center	Borst, J (corresponding author), Univ Amsterdam, Acad Med Ctr, Dept Radiol, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands.	j.borst@amc.uva.nl	Jenniskens, S.F.M./L-4415-2015; Beenen, Ludo F/AAA-3114-2021; van Dijk, Ewoud J/J-7951-2012	Beenen, Ludo F/0000-0001-9204-1026; Brouwer, Patrick A./0000-0003-0041-2833; Dippel, Diederik/0000-0002-9234-3515; Marquering, Henk/0000-0002-1414-6313	ITEA2 project, MEDUSA - Medical Distributed Utilization of Services Applications [10004]	ITEA2 project, MEDUSA - Medical Distributed Utilization of Services Applications	Part of this research has been sponsored by the ITEA2 project, label 10004: MEDUSA - Medical Distributed Utilization of Services & Applications (https://itea3.org/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abels B, 2011, AM J NEURORADIOL, V32, P1632, DOI 10.3174/ajnr.A2576; Campbell BCV, 2012, STROKE, V43, P2648, DOI 10.1161/STROKEAHA.112.660548; Campbell BCV, 2011, STROKE, V42, P3435, DOI 10.1161/STROKEAHA.111.618355; Cortijo E, 2014, ACTA NEUROL SCAND, V129, P178, DOI 10.1111/ane.12160; d'Esterre CD, 2012, ACTA RADIOL, V53, P461, DOI 10.1258/ar.2012.110582; Delpolyi AR, 2012, J MAGN RESON IMAGING, V36, P1083, DOI 10.1002/jmri.23740; Donnan GA, 2009, LANCET NEUROL, V8, P261, DOI 10.1016/S1474-4422(09)70041-9; Fahmi F, 2014, MED BIOL ENG COMPUT, V52, P141, DOI 10.1007/s11517-013-1125-7; Fahmi F, 2013, EUR J RADIOL, V82, P2334, DOI 10.1016/j.ejrad.2013.08.039; Ferreira RM, 2010, AM J ROENTGENOL, V194, P1330, DOI 10.2214/AJR.09.2845; Fieselmann A, 2011, INT J BIOMED IMAGING, V2011, DOI 10.1155/2011/467563; Finitsis S, 2014, NEURORADIOLOGY, V56, P325, DOI 10.1007/s00234-014-1329-z; Forkert ND, 2013, AM J NEURORADIOL, V34, P1697, DOI 10.3174/ajnr.A3460; Fransen PSS, 2014, ME CLEAN MULTICENTER; Hu CH, 2007, CLIN IMAG, V31, P151, DOI 10.1016/j.clinimag.2007.01.008; Jauch EC, 2013, STROKE, V44, P870, DOI 10.1161/STR.0b013e318284056a; Kamalian S, 2012, AM J NEURORADIOL, V33, P545, DOI 10.3174/ajnr.A2809; Kidwell CS, 2013, NEW ENGL J MED, V368, P914, DOI 10.1056/NEJMoa1212793; Kim JJ, 2010, AM J NEURORADIOL, V31, P91, DOI 10.3174/ajnr.A1768; Klotz E, 1999, EUR J RADIOL, V30, P170, DOI 10.1016/S0720-048X(99)00009-1; Konstas AA, 2010, RADIOLOGY, V254, P22, DOI 10.1148/radiol.09091610; Kudo K, 2010, RADIOLOGY, V254, P200, DOI 10.1148/radiol.254082000; Leiva-Salinas C, 2011, AM J ROENTGENOL, V196, P53, DOI 10.2214/AJR.10.5705; Lev MH, 2013, RADIOLOGY, V266, P22, DOI 10.1148/radiol.12121355; Lin LT, 2014, STROKE, V45, P1727, DOI 10.1161/STROKEAHA.114.005419; Mangla R, 2014, EMERG RADIOL, V21, P49, DOI 10.1007/s10140-013-1125-9; Marquering HA, 2013, CLIN NEUROL NEUROSUR, V115, P1591, DOI 10.1016/j.clineuro.2013.02.008; Mui K, 2011, AM J NEURORADIOL, V32, P846, DOI 10.3174/ajnr.A2415; Murphy BD, 2006, STROKE, V37, P1771, DOI 10.1161/01.STR.0000227243.96808.53; Riordan AJ, 2011, MED PHYS, V38, P3212, DOI 10.1118/1.3592639; Rosso C, 2009, RADIOLOGY, V250, P184, DOI 10.1148/radiol.2493080107; Saake M, 2014, CLIN NEUROL NEUROSUR, V121, P39, DOI 10.1016/j.clineuro.2014.03.007; Sanak D, 2006, NEURORADIOLOGY, V48, P632, DOI 10.1007/s00234-006-0105-0; Schaefer PW, 2008, STROKE, V39, P2986, DOI 10.1161/STROKEAHA.107.513358; Schaefer PW, 2009, STROKE, V40, P2875, DOI 10.1161/STROKEAHA.109.547679; Schellinger PD, 2010, NEUROLOGY, V75, P177, DOI 10.1212/WNL.0b013e3181e7c9dd; Smit EJ, 2013, STROKE, V44, P2194, DOI 10.1161/STROKEAHA.111.000675; Smith WS, 2003, AM J NEURORADIOL, V24, P688; Turk AS, 2013, J NEUROINTERV SURG, V5, P523, DOI 10.1136/neurintsurg-2012-010491; van Seeters T, 2014, BMC NEUROL, V14, DOI 10.1186/1471-2377-14-37; Waaijer A, 2007, RADIOLOGY, V245, P541, DOI 10.1148/radiol.2451061493; Wintermark M, 2006, STROKE, V37, P979, DOI 10.1161/01.STR.0000209238.61459.39; Wintermark M, 2008, STROKE, V39, P1621, DOI 10.1161/STROKEAHA.107.512319; Wintermark M, 2013, STROKE, V44, P2628, DOI 10.1161/STROKEAHA.113.002015; Yoo AJ, 2013, J NEUROINTERV SURG, V5, P1, DOI 10.1136/neurintsurg-2013-010741; Yoo AJ, 2009, STROKE, V40, P2046, DOI 10.1161/STROKEAHA.108.541656	46	16	17	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2015	10	3							e0119409	10.1371/journal.pone.0119409	http://dx.doi.org/10.1371/journal.pone.0119409			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD9NQ	25789631	Green Published, gold			2022-12-27	WOS:000351425400081
J	Bouchard, J; Malhotra, R; Shah, S; Kao, YT; Vaida, F; Gupta, A; Berg, DT; Grinnell, BW; Stofan, B; Tolwani, AJ; Mehta, RL				Bouchard, Josee; Malhotra, Rakesh; Shah, Shamik; Kao, Yu-Ting; Vaida, Florin; Gupta, Akanksha; Berg, David T.; Grinnell, Brian W.; Stofan, Brenda; Tolwani, Ashita J.; Mehta, Ravindra L.			Levels of Protein C and Soluble Thrombomodulin in Critically Ill Patients with Acute Kidney Injury: A Multicenter Prospective Observational Study	PLOS ONE			English	Article							CYCLE ARREST BIOMARKERS; ACUTE LUNG INJURY; ORGAN FAILURE; SEVERE SEPSIS; CARDIAC-SURGERY; POOR OUTCOMES; SEPTIC SHOCK; MORTALITY; VALIDATION; DYSFUNCTION	Endothelial dysfunction contributes to the development of acute kidney injury (AKI) in animal models of ischemia reperfusion injury and sepsis. There are limited data on markers of endothelial dysfunction in human AKI. We hypothesized that Protein C (PC) and soluble thrombomodulin (sTM) levels could predict AKI. We conducted a multicenter prospective study in 80 patients to assess the relationship of PC and sTM levels to AKI, defined by the AKIN creatinine (AKI Scr) and urine output criteria (AKI UO). We measured marker levels for up to 10 days from intensive care unit admission. We used area under the curve (AUC) and time-dependent multivariable Cox proportional hazard model to predict AKI and logistic regression to predict mortality/non-renal recovery. Protein C and sTM were not different in patients with AKI UO only versus no AKI. On intensive care unit admission, as PC levels are usually lower with AKI Scr, the AUC to predict the absence of AKI was 0.63 (95%CI 0.44-0.78). The AUC using log10 sTM levels to predict AKI was 0.77 (95%CI 0.62-0.89), which predicted AKI Scr better than serum and urine neutrophil gelatinase-associated lipocalin (NGAL) and cystatin C, urine kidney injury molecule-1 and liver-fatty acid-binding protein. In multivariable models, PC and urine NGAL levels independently predicted AKI (p=0.04 and 0.02) and PC levels independently predicted mortality/non-renal recovery (p=0.04). In our study, PC and sTM levels can predict AKI Scr but are not modified during AKI UO alone. PC levels could independently predict mortality/non-renal recovery. Additional larger studies are needed to define the relationship between markers of endothelial dysfunction and AKI.	[Bouchard, Josee; Malhotra, Rakesh; Shah, Shamik; Mehta, Ravindra L.] Univ Calif San Diego, Dept Med, Div Nephrol & Hypertens, San Diego, CA 92103 USA; [Bouchard, Josee] Univ Montreal, Dept Med, Div Nephrol, Montreal, PQ H3C 3J7, Canada; [Kao, Yu-Ting; Vaida, Florin] Univ Calif San Diego, Div Biostat & Bioinformat, San Diego, CA 92103 USA; [Gupta, Akanksha; Berg, David T.; Grinnell, Brian W.] Lilly Corp Ctr, Lilly Res Labs, Biotechnol Discovery Res, Indianapolis, IN 46285 USA; [Stofan, Brenda; Tolwani, Ashita J.] Univ Alabama Birmingham, Div Nephrol, Birmingham, AL USA	University of California System; University of California San Diego; Universite de Montreal; University of California System; University of California San Diego; Eli Lilly; University of Alabama System; University of Alabama Birmingham	Mehta, RL (corresponding author), Univ Calif San Diego, Dept Med, Div Nephrol & Hypertens, San Diego, CA 92103 USA.	rmehta@ucsd.edu	Mehta, Ravindra/ACD-4769-2022	Mehta, Ravindra/0000-0002-0908-2968	Eli Lilly and Company	Eli Lilly and Company(Eli Lilly)	This is an investigator-initiated study supported through a grant from Eli Lilly and Company. RLM received a research grant from Eli Lilly to conduct the study. AG, DTB, and BWG were employees of Eli Lilly and Company at the time of the study conduct. The company did not have any role in data collection, and interpretation of data. Soluble thrombomodulin levels were measured blinded at Eli Lily and Company. AG, DTB and BWG participated in writing of the manuscript but neither these authors nor the company had a role in the decision to submit the manuscript for publication.	Bernard GR, 2001, NEW ENGL J MED, V344, P699, DOI 10.1056/NEJM200103083441001; Bihorac A, 2014, AM J RESP CRIT CARE, V189, P932, DOI 10.1164/rccm.201401-0077OC; BONE RC, 1992, CRIT CARE MED, V20, P864, DOI 10.1097/00003246-199206000-00025; Brohi K, 2007, ANN SURG, V245, P812, DOI 10.1097/01.sla.0000256862.79374.31; Brunkhorst F, 2007, ANESTHESIOLOGY, V107, P15, DOI 10.1097/01.anes.0000267531.39410.d3; Chawla LS, 2007, CLIN J AM SOC NEPHRO, V2, P22, DOI 10.2215/CJN.02510706; Devarajan P, 2007, CONTRIB NEPHROL, V156, P203; Endre ZH, 2011, KIDNEY INT, V79, P1119, DOI 10.1038/ki.2010.555; FOURRIER F, 1992, CHEST, V101, P816, DOI 10.1378/chest.101.3.816; Gupta A, 2007, J AM SOC NEPHROL, V18, P860, DOI 10.1681/ASN.2006101167; Haase M, 2010, CURR OPIN CRIT CARE, V16, P526, DOI 10.1097/MCC.0b013e328340063b; Haase M, 2009, AM J KIDNEY DIS, V54, P1012, DOI 10.1053/j.ajkd.2009.07.020; HESSELVIK JF, 1991, THROMB HAEMOSTASIS, V65, P126; Hoste EAJ, 2014, NEPHROL DIAL TRANSPL, V29, P2054, DOI 10.1093/ndt/gfu292; Kashani K, 2013, CRIT CARE, V17, DOI 10.1186/cc12503; KNAUS WA, 1991, CHEST, V100, P1619, DOI 10.1378/chest.100.6.1619; Levey AS, 1999, ANN INTERN MED, V130, P461, DOI 10.7326/0003-4819-130-6-199903160-00002; Liu KD, 2007, CRIT CARE MED, V35, P2755, DOI 10.1097/01.CCM.0000291649.72238.6D; Macedo E, 2011, KIDNEY INT, V80, P760, DOI 10.1038/ki.2011.150; Macias WL, 2004, CRIT CARE MED, V32, pS223, DOI 10.1097/01.CCM.0000126120.49367.AC; Matthay MA, 2004, CRIT CARE MED, V32, pS229, DOI 10.1097/01.CCM.0000126121.56990.D3; Mehta RL, 2007, CRIT CARE, V11, DOI 10.1186/cc5713; Neyrinck AP, 2009, BRIT J PHARMACOL, V158, P1034, DOI 10.1111/j.1476-5381.2009.00251.x; Parikh CR, 2008, CRIT CARE MED, V36, pS159, DOI 10.1097/CCM.0b013e318168c652; Parikh CR, 2011, J AM SOC NEPHROL, V22, P1748, DOI 10.1681/ASN.2010121302; Parikh CR, 2011, J AM SOC NEPHROL, V22, P1737, DOI 10.1681/ASN.2010111163; Parikh CR, 2005, J AM SOC NEPHROL, V16, P3046, DOI 10.1681/ASN.2005030236; Vincent JL, 1996, INTENS CARE MED, V22, P707, DOI 10.1007/BF01709751; Waikar SS, 2006, J AM SOC NEPHROL, V17, P1143, DOI 10.1681/ASN.2005091017; Wlodzimirow KA, 2012, CRIT CARE, V16, DOI 10.1186/cc11808	30	13	15	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2015	10	3							e0120770	10.1371/journal.pone.0120770	http://dx.doi.org/10.1371/journal.pone.0120770			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD9NQ	25790110	Green Published, Green Submitted, gold			2022-12-27	WOS:000351425400175
J	Gonzalez-Delgado, M; Gomez-Dantes, H; Fernandez-Nino, JA; Robles, E; Borja, VH; Aguilar, M				Gonzalez-Delgado, Mery; Gomez-Dantes, Hector; Alfredo Fernandez-Nino, Julian; Robles, Eduardo; Borja, Victor H.; Aguilar, Miriam			Factors Associated with Fatal Occupational Accidents among Mexican Workers: A National Analysis	PLOS ONE			English	Article							INJURY MORTALITY; UNITED-STATES; REGISTRATION; INDUSTRY; SAFETY; BURDEN; HEALTH; SECTOR; COSTS; RATES	Objective To identify the factors associated with fatal occupational injuries in Mexico in 2012 among workers affiliated with the Mexican Social Security Institute. Methods Analysis of secondary data using information from the National Occupational Risk Information System, with the consequence of the occupational injury (fatal versus non-fatal) as the response variable. The analysis included 406,222 non-fatal and 1,140 fatal injuries from 2012. The factors associated with the lethality of the injury were identified using a logistic regression model with the Firth approach. Results Being male (OR=5.86; CI95%: 4.22-8.14), age (OR=1.04; CI95%: 1.03-1.06), employed in the position for 1 to 10 years (versus less than 1 year) (OR=1.37; CI95%: 1.15-1.63), working as a facilities or machine operator or assembler (OR: 3.28; CI95%: 2.12-5.07) and being a worker without qualifications (OR=1.96; CI95%: 1.18-3.24) (versus an office worker) were associated with fatality in the event of an injury. Additionally, companies classified as maximum risk (OR=1.90; CI95%: 1.38-2.62), workplace conditions (OR=7.15; CI95%: 3.63-14.10) and factors related to the work environment (OR=9.18; CI95%: 4.36-19.33) were identified as risk factors for fatality in the event of an occupational injury. Conclusions Fatality in the event of an occupational injury is associated with factors related to sociodemographics (age, sex and occupation), the work environment and workplace conditions. Worker protection policies should be created for groups with a higher risk of fatal occupational injuries in Mexico.	[Gonzalez-Delgado, Mery] Escuela Salud Publ Mexico, Cuernavaca, Morelos, Mexico; [Gomez-Dantes, Hector] Inst Nacl Salud Publ, Ctr Invest Sistemas Salud, Cuernavaca, Morelos, Mexico; [Alfredo Fernandez-Nino, Julian] Inst Nacl Salud Publ, Ctr Informac Decisiones Salud Publ CENIDSP, Cuernavaca, Morelos, Mexico; [Robles, Eduardo; Aguilar, Miriam] Inst Mexicano Seguro Social, Coordinac Salud El Trabajo, Mexico City, DF, Mexico; [Borja, Victor H.] Inst Mexicano Seguro Social, Unidad Atenc Primaria Salud, Mexico City, DF, Mexico	Instituto Nacional de Salud Publica; Instituto Nacional de Salud Publica; Instituto Mexicano del Seguro Social; Instituto Mexicano del Seguro Social	Fernandez-Nino, JA (corresponding author), Inst Nacl Salud Publ, Ctr Informac Decisiones Salud Publ CENIDSP, Cuernavaca, Morelos, Mexico.	julian.fernandez@insp.mx	Fernández-Niño, Julián Alfredo/AHE-6038-2022	Fernández-Niño, Julián Alfredo/0000-0002-8948-8481				AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Akerstedt T, 2002, J SLEEP RES, V11, P69, DOI 10.1046/j.1365-2869.2002.00287.x; Alli BO, 2008, PRINCIPIOS FUNDAMENT; [Anonymous], 2014, CIUO88; Armengou LM, 2006, GEST PRACTICA RIESGO, V28, P42, DOI [10.1016/j.ijpharm.2009.05.017, DOI 10.1016/J.IJPHARM.2009.05.017]; Benavides FG, 2003, AM J IND MED, V44, P385, DOI 10.1002/ajim.10290; Biddle EA, 2013, J SAFETY RES, V44, P7, DOI 10.1016/j.jsr.2012.09.005; Carcoba A, 1999, WHOSE COST WHO BENEF; Carlos S., 2009, CIENC TRAB, V11, P32; Castillo D N, 1997, Inj Prev, V3, P277, DOI 10.1136/ip.3.4.277; Centers for Disease Control and Prevention (CDC), 2001, MMWR Morb Mortal Wkly Rep, V50, P317; Chaparro P, 1999, REV SALUD PUBLICA, V1, P274; Colak B, 2004, IND HEALTH, V42, P424, DOI 10.2486/indhealth.42.424; Dudarev AA, 2013, INT J CIRCUMPOL HEAL, V72, DOI 10.3402/ijch.v72i0.20458; Dumrak J, 2013, CONSTR ECON BUILD, V13, P32, DOI 10.5130/AJCEB.v13i4.3620; Estados Unidos Mexicanos, 2002, REGL LAY SEG SOC MAT, P1; Farrow A, 2012, OCCUP MED-OXFORD, V62, P4, DOI 10.1093/occmed/kqr148; Feitosa Ana Isabela Ramos, 2014, Rev. bras. saúde ocup., V39, P75, DOI 10.1590/0303-7657000072212; FIRTH D, 1993, BIOMETRIKA, V80, P27, DOI 10.2307/2336755; Garduño María de los Ángeles, 2008, Salud de los Trabajadores, V16, P5; Ghai D., 2003, REV INT TRABAJO, V122, P125, DOI [10.1111/j.1564-913X.2003.tb00171.x, DOI 10.1111/J.1564-913X.2003.TB00171.X]; Gobierno de Espana Ministerio de empleo y seguridad social Instituto nacional de seguridad e higiene en el trabajo, 2010, AGR COOP DEP PLANN D, P5; GuemezSandoval JC, 1996, SALUD PUBLICA MEXICO, V38, P110; Gyekye SA, 2010, INT J PSYCHOL, V45, P405, DOI 10.1080/00207594.2010.501337; Hamalainen P, 2006, SAFETY SCI, V44, P137, DOI 10.1016/j.ssci.2005.08.017; Hard David L, 2006, J Agromedicine, V11, P57, DOI 10.1300/J096v11n02_09; Herbert R, 2000, AM J PUBLIC HEALTH, V90, P541, DOI 10.2105/AJPH.90.4.541; INEGI, MEX CIFR; Instituto Mexicano del seguro social, 2012, MEM EST 2012 DAT INT; Instituto Nacional de Estadistica Geografia e Informatica, 1995, CLAS ACT EC ENC NAC, P1; International Labour Office, 2013, PROGR SAF HLTH WORK; Janicak CA, 2013, OPEN J SAF SCI TECHN, V3, P1, DOI [10.4236/ojsst.2013.31001, DOI 10.4236/OJSST.2013.31001]; Konstantinidis A, 2011, AM SURGEON, V77, P702; Laflamme L, 2001, EUR J PUBLIC HEALTH, V11, P309, DOI 10.1093/eurpub/11.3.309; Laneko Segurtasun eta Osasunerako Euskal Erakundea Instituto Vasco de Seguridad y salud labor- ales., 2012, ASIAN PACIFIC NEWSLE; Leigh JP, 2001, PUBLIC HEALTH REP, V116, P235, DOI 10.1093/phr/116.3.235; Loomis D, 2003, INJ PREV, V9, P9, DOI 10.1136/ip.9.1.9; Mora AM, 2011, INT J OCCUP ENV HEAL, V17, P243; Mehrdad R, 2013, INT J OCCUP ENV MED, V4, P205; Mehrdad R, 2014, IRAN RED CRESCENT ME, V16, DOI 10.5812/ircmj.10359; Moradinazar M, 2013, IRAN RED CRESCENT ME, V15, DOI 10.5812/ircmj.8011; Nguyen Thi Hong Tu, 2008, Asian-Pacific Newsletter on Occupational Health and Safety, V15, P7; Nishikitani M, 2008, SAFETY SCI, V46, P1078, DOI 10.1016/j.ssci.2007.06.017; ONUSIDA, 2013, SIDA CIFR GIN; Organizacion Internacional del Trabajo, 2003, SEG CIFR SUG CULT GL, P13; Pérez Martínez Patricia, 2008, Med. segur. trab., V54, P45, DOI 10.4321/s0465-546x2008000300005; Betzabé Pérez-Manriquez Gabriela, 2012, Med. segur. trab., V58, P13, DOI 10.4321/s0465-546x2012000100003; Perttula P, 2012, INT J OCCUP SAF ERGO, V18, P541, DOI 10.1080/10803548.2012.11076958; Pratt SG, 2013, MMWR-MORBID MORTAL W, V62, P653; Reddy R, 2013, OCCUP MED-OXFORD, V63, P284, DOI 10.1093/occmed/kqt024; Richardson DB, 2004, AM J PUBLIC HEALTH, V94, P1756, DOI 10.2105/AJPH.94.10.1756; Rubiales-Gutierrez E, 2010, SALUD PUBLICA MEXICO, V52, P199, DOI 10.1590/s0036-36342010000300003; Rydlewska-Liszkowska Izabela, 2006, Medycyna Pracy, V57, P317; Salim C, 2014, OCCUP ENVIRON MED, V71, pA79, DOI [10.1136/oemed-2014-102362.247, DOI 10.1136/OEMED-2014-102362.247]; Salinas-Tovar JS, 2004, SALUD PUBLICA MEXICO, V46, P204, DOI 10.1590/S0036-36342004000300009; Sanchez-Roman FR, 2006, INT J OCCUP ENV HEAL, V12, P346, DOI 10.1179/oeh.2006.12.4.346; Santana VS, 2009, REV SAUDE PUBL, V43, P750, DOI 10.1590/S0034-89102009005000061; Sarmiento-Salinas Rodrigo, 2004, Gac Med Mex, V140, P593; Secretaria del Trabajo y Prevision Social [Secretary of Labor and Social Prevision], 2014, EST ACC ENF TRAB 201; Smith CK, 2014, ACCIDENT ANAL PREV, V65, P63, DOI 10.1016/j.aap.2013.12.012; Sotelo-Suárez Nidia R, 2012, Rev. salud pública, V14, P32; Stout NA, 1996, AM J PUBLIC HEALTH, V86, P73, DOI 10.2105/AJPH.86.1.73; Takala J, 2014, J OCCUP ENVIRON HYG, V11, P326, DOI 10.1080/15459624.2013.863131; The PLoS Medicine, 2007, PLOS MED, pe221; The word Bank, 2014, DATABASE; Velazquez Y, 2013, SEGUR SALUD TRAB, V71, P20; Villanueva V, 2011, ACCIDENT ANAL PREV, V43, P123, DOI 10.1016/j.aap.2010.08.001; Xia ZL, 2000, J OCCUP ENVIRON MED, V42, P917, DOI 10.1097/00043764-200009000-00014; Zakaria NH., 2012, BUS MANAGE REV, V2, P75	69	12	13	3	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2015	10	3							e0121490	10.1371/journal.pone.0121490	http://dx.doi.org/10.1371/journal.pone.0121490			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CD9NQ	25790063	gold, Green Published			2022-12-27	WOS:000351425400195
J	Rouaud, A; Hanon, O; Boureau, AS; Chapelet, GG; de Decker, L				Rouaud, Agnes; Hanon, Olivier; Boureau, Anne-Sophie; Chapelet, Guillaume Gilles; de Decker, Laure			Comorbidities against Quality Control of VKA Therapy in Non-Valvular Atrial Fibrillation: A French National Cross-Sectional Study	PLOS ONE			English	Article							ORAL ANTICOAGULATION CONTROL; LONG-TERM; PATIENT CHARACTERISTICS; ANTITHROMBOTIC THERAPY; RISK-FACTOR; WARFARIN; PREDICTORS; CONSEQUENCES; POLYMORPHISM; METAANALYSIS	Background Given the prevalence of non-valvular atrial fibrillation in the geriatric population, thromboembolic prevention by means of vitamin K antagonists (VKA) is one of the most frequent daily concerns of practitioners. The effectiveness and safety of treatment with VKA correlates directly with maximizing the time in therapeutic range, with an International Normalized Ratio (INR) of 2.0-3.0. The older population concentrates many of factors known to influence INR rate, particularly concomitant medications and concurrent medical conditions, also defined as comorbidities. Objective Determine whether a high burden on comorbidities, defined by a Charlson Comorbidity Index (CCI) of 3 or greater, is associated a lower quality of INR control. Study-Design Cross-sectional study. Settings French geriatric care units nationwide. Participants 2164 patients aged 80 and over and treated with vitamin K antagonists. Measurements Comorbidities were assessed using the Charlson Comorbidity Index (CCI). The recorded data included age, sex, falls, kidney failure, hemorrhagic event, VKA treatment duration, and the number and type of concomitant medications. Quality of INR control, defined as time in therapeutic range (TTR), was assessed using the Rosendaal method. Results 487 patients were identified the low-quality control of INR group. On multivariate logistic regression analysis, low-quality control of INR was independently associated with a CCI >= 3 (OR = 1.487; 95% CI [1.15; 1.91]). The other variables associated with low-quality control of INR were: hemorrhagic event (OR = 3.151; 95% CI [1.64; 6.07]), hospitalization (OR = 1.614, 95% CI [1.21; 2.14]). Conclusion An elevated CCI score (>= 3) was associated with low-quality control of INR in elderly patients treated with VKA. Further research is needed to corroborate this finding.	[Rouaud, Agnes; Boureau, Anne-Sophie; Chapelet, Guillaume Gilles; de Decker, Laure] Nantes Univ Hosp, Dept Geriatr, EA 1156 12, Nantes, France; [Hanon, Olivier] Publ Hosp Paris, Broca Hosp, Dept Geriatr, Paris, France	Nantes Universite; CHU de Nantes; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Broca - APHP; UDICE-French Research Universities; Universite Paris Cite	Rouaud, A (corresponding author), Nantes Univ Hosp, Dept Geriatr, EA 1156 12, Nantes, France.	Agnes.ROUAUD@chu-nantes.fr	Hanon, Olivier/GWR-0220-2022	Hanon, Olivier/0000-0002-4697-122X; boureau, annesophie/0000-0002-2224-2014	French Society of Geriatrics and Gerontology (SFGG)	French Society of Geriatrics and Gerontology (SFGG)	None of the authors have any relevant financial interest in this manuscript. Funding was provided by The French Society of Geriatrics and Gerontology (SFGG), http://www.sfgg.fr/. The funders had no role in study design, analysis, decision to publish, or preparation of the manuscript.	Ageno W, 2012, CHEST, V141, pE44S, DOI 10.1378/chest.11-2292; [Anonymous], 2009, ASS CAR SEN MULT DRO; [Anonymous], 2003, BIOL MON VKA THER ST; Atrial Fibrillation, 2007, ATR FIBR 2007; Baker WL, 2009, J MANAGE CARE PHARM, V15, P244, DOI 10.18553/jmcp.2009.15.3.244; Cavallari LH, 2009, J THROMB THROMBOLYS, V27, P430, DOI 10.1007/s11239-008-0236-8; Charlemagne A, 2011, ARCH CARDIOVASC DIS, V104, P115, DOI 10.1016/j.acvd.2010.11.012; CHARLSON M, 1994, J CLIN EPIDEMIOL, V47, P1245, DOI 10.1016/0895-4356(94)90129-5; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Chatap G, 2008, THERAPIE, V63, P393, DOI 10.2515/therapie:2008058; Chute J P, 1997, Endocr Pract, V3, P77; Currie CJ, 2005, CURR MED RES OPIN, V21, P1905, DOI 10.1185/030079905X75050; D'Andrea G, 2005, BLOOD, V105, P645, DOI 10.1182/blood-2004-06-2111; Costa GLD, 2012, CLIN THER, V34, P1511, DOI 10.1016/j.clinthera.2012.06.002; de Decker L, 2013, J AM GERIATR SOC, V61, P1224, DOI 10.1111/jgs.12345; Dias A, 2014, AGING CLIN EXP RES; Extermann M, 1998, J CLIN ONCOL, V16, P1582, DOI 10.1200/JCO.1998.16.4.1582; Gijsen R, 2001, J CLIN EPIDEMIOL, V54, P661, DOI 10.1016/S0895-4356(00)00363-2; Hart RG, 2007, ANN INTERN MED, V146, P857, DOI 10.7326/0003-4819-146-12-200706190-00007; Holbrook AM, 2005, ARCH INTERN MED, V165, P1095, DOI 10.1001/archinte.165.10.1095; HYLEK EM, 1994, ANN INTERN MED, V120, P897, DOI 10.7326/0003-4819-120-11-199406010-00001; Hylek EM, 1996, NEW ENGL J MED, V335, P540, DOI 10.1056/NEJM199608223350802; Kaatz S, 2008, J THROMB THROMBOLYS, V25, P61, DOI 10.1007/s11239-007-0106-9; Katz JN, 1996, MED CARE, V34, P73, DOI 10.1097/00005650-199601000-00006; Khreizat HS, 2012, DRUG AGING, V29, P307, DOI 10.2165/11599060-000000000-00000; Kleinow ME, 2011, J MANAGE CARE PHARM, V17, P523, DOI 10.18553/jmcp.2011.17.7.523; Menzin J, 2012, THROMB HAEMOSTASIS, V107, P662, DOI 10.1160/TH11-09-0646; Morgan CL, 2009, THROMB RES, V124, P37, DOI 10.1016/j.thromres.2008.09.016; Newschaffer CJ, 1997, J CLIN EPIDEMIOL, V50, P725, DOI 10.1016/S0895-4356(97)00050-4; Palareti G, 2005, J THROMB HAEMOST, V3, P955, DOI 10.1111/j.1538-7836.2005.01330.x; Penning-van Beest FJA, 2001, THROMB HAEMOSTASIS, V86, P569, DOI 10.1055/s-0037-1616088; Phillips Katherine W, 2008, Expert Rev Cardiovasc Ther, V6, P57, DOI 10.1586/14779072.6.1.57; Plichart M, 2013, DRUG AGING, V30, P1019, DOI 10.1007/s40266-013-0127-3; Rose AJ, 2010, J THROMB HAEMOST, V8, P2182, DOI 10.1111/j.1538-7836.2010.03996.x; ROSENDAAL FR, 1993, THROMB HAEMOSTASIS, V69, P236; Sconce EA, 2005, BLOOD, V106, P2329, DOI 10.1182/blood-2005-03-1108; Self TH, 2006, CURR MED RES OPIN, V22, P2089, DOI 10.1185/030079906X132479; Tomita H, 2013, THROMB RES, V132, P537, DOI 10.1016/j.thromres.2013.09.003; van Walraven C, 2007, THROMB RES, V119, P705, DOI 10.1016/j.thromres.2006.05.017; White HD, 2007, ARCH INTERN MED, V167, P239, DOI 10.1001/archinte.167.3.239; Witt DM, 2010, J THROMB HAEMOST, V8, P744, DOI 10.1111/j.1538-7836.2010.03756.x; WOLF PA, 1991, STROKE, V22, P983, DOI 10.1161/01.STR.22.8.983	42	22	23	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2015	10	3							e0119043	10.1371/journal.pone.0119043	http://dx.doi.org/10.1371/journal.pone.0119043			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD9NQ	25789771	Green Submitted, Green Published, gold			2022-12-27	WOS:000351425400062
J	Alsayegh, KN; Gadepalli, VS; Iyer, S; Rao, RR				Alsayegh, Khaled N.; Gadepalli, Venkat S.; Iyer, Shilpa; Rao, Raj R.			Knockdown of CDK2AP1 in Primary Human Fibroblasts Induces p53 Dependent Senescence	PLOS ONE			English	Article							PROSTATE-CANCER; CELL-GROWTH; P12(DOC-1); ARF; TRANSCRIPTION; SUPPRESSOR; EXPRESSION; PROTEIN	Cyclin Dependent Kinase-2 Associated Protein-1 (CDK2AP1) is known to be a tumor suppressor that plays a role in cell cycle regulation by sequestering monomeric CDK2, and targeting it for proteolysis. A reduction of CDK2AP1 expression is considered to be a negative prognostic indicator in patients with oral squamous cell carcinoma and also associated with increased invasion in human gastric cancer tissue. CDK2AP1 overexpression was shown to inhibit growth, reduce invasion and increase apoptosis in prostate cancer cell lines. In this study, we investigated the effect of CDK2AP1 downregulation in primary human dermal fibroblasts. Using a short-hairpin RNA to reduce its expression, we found that knockdown of CDK2AP1in primary human fibroblasts resulted in reduced proliferation and in the induction of senescence associated beta-galactosidase activity. CDK2AP1 knockdown also resulted in a significant reduction in the percentage of cells in the S phase and an accumulation of cells in the G1 phase of the cell cycle. Immunocytochemical analysis also revealed that the CDK2AP1 knockdown significantly increased the percentage of cells that exhibited gamma-H2AX foci, which could indicate presence of DNA damage. CDK2AP1 knockdown also resulted in increased mRNA levels of p53, p21, BAX and PUMA and p53 protein levels. In primary human fibroblasts in which p53 and CDK2AP1 were simultaneously downregulated, there was: (a) no increase in senescence associated beta-galactosidase activity, (b) decrease in the number of cells in the G1-phase and increase in number of cells in the S-phase of the cell cycle, and (c) decrease in the mRNA levels of p21, BAX and PUMA when compared with CDK2AP1 knockdown only fibroblasts. Taken together, this suggests that the observed phenotype is p53 dependent. We also observed a prominent increase in the levels of ARF protein in the CDK2AP1 knockdown cells, which suggests a possible role of ARF in p53 stabilization following CDK2AP1 knockdown. Altogether, our results show that knockdown of CDK2AP1 in primary human fibroblasts reduced proliferation and induced premature senescence, with the observed phenotype being p53 dependent.	[Alsayegh, Khaled N.; Rao, Raj R.] Virginia Commonwealth Univ, Dept Human & Mol Genet, Richmond, VA 23284 USA; [Alsayegh, Khaled N.] King Saud bin Abdulaziz Univ Hlth Sci, King Abdullah Int Med Res Ctr, Jeddah, Saudi Arabia; [Gadepalli, Venkat S.; Rao, Raj R.] Virginia Commonwealth Univ, Integrated Life Sci Program, Richmond, VA 23284 USA; [Iyer, Shilpa; Rao, Raj R.] Virginia Commonwealth Univ, Ctr Study Biol Complex, Life Sci Program, Richmond, VA 23284 USA; [Iyer, Shilpa; Rao, Raj R.] Virginia Commonwealth Univ, Dept Chem & Life Sci Engn, Richmond, VA 23284 USA; [Rao, Raj R.] Virginia Commonwealth Univ, Massey Canc Ctr, Richmond, VA 23284 USA	Virginia Commonwealth University; King Saud Bin Abdulaziz University for Health Sciences; Virginia Commonwealth University; Virginia Commonwealth University; Virginia Commonwealth University; Virginia Commonwealth University	Rao, RR (corresponding author), Virginia Commonwealth Univ, Dept Human & Mol Genet, Richmond, VA 23284 USA.	rrrao@vcu.edu	Rao, Raj/AAW-4308-2021	Iyer, Shilpa/0000-0001-6287-2232	NSF-CAREER [074556]; NIH CTSA [UL1TR000058]; VCU's Center for Clinical and Translational Research; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000058] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R15NS080157] Funding Source: NIH RePORTER	NSF-CAREER(National Science Foundation (NSF)NSF - Office of the Director (OD)); NIH CTSA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); VCU's Center for Clinical and Translational Research; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	Supported in part by NSF-CAREER 074556 (R. Rao) and NIH CTSA UL1TR000058 (R. Rao and S. Iyer) by VCU's Center for Clinical and Translational Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham S, 2010, BIOTECHNOL PROGR, V26, P1126, DOI 10.1002/btpr.412; Adams BR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010001; Bates S, 1998, NATURE, V395, P124, DOI 10.1038/25867; Carlos AR, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3697; Choi MG, 2009, EUR SURG RES, V42, P223, DOI 10.1159/000208521; Deshpande AM, 2009, J BIOL CHEM, V284, P6043, DOI 10.1074/jbc.C800158200; Dimri GP, 2000, MOL CELL BIOL, V20, P273, DOI 10.1128/MCB.20.1.273-285.2000; DIMRI GP, 1995, P NATL ACAD SCI USA, V92, P9363, DOI 10.1073/pnas.92.20.9363; Evangelou K, 2013, CELL DEATH DIFFER, V20, P1485, DOI 10.1038/cdd.2013.76; Gadepalli Venkat S, 2013, Methods Mol Biol, V962, P183, DOI 10.1007/978-1-62703-236-0_15; Gartel AL, 2005, CANCER RES, V65, P3980, DOI 10.1158/0008-5472.CAN-04-3995; Hu MG, 2004, CANCER RES, V64, P490, DOI 10.1158/0008-5472.CAN-03-2284; Kai L, 2010, INT J CANCER, V126, P1538, DOI 10.1002/ijc.24928; Kim Y, 2009, J BIOL CHEM, V284, P23405, DOI 10.1074/jbc.M109.026088; Matsuo K, 2000, FASEB J, V14, P1318, DOI 10.1096/fj.14.10.1318; Peng H, 2006, NEOPLASIA, V8, P1028, DOI 10.1593/neo.06580; Sherr CJ, 2001, NAT REV MOL CELL BIO, V2, P731, DOI 10.1038/35096061; Shintani S, 2000, MOL CELL BIOL, V20, P6300, DOI 10.1128/MCB.20.17.6300-6307.2000; Spruijt CG, 2010, MOL BIOSYST, V6, P1700, DOI 10.1039/c004108d; Velimezi G, 2013, NAT CELL BIOL, V15, P967, DOI 10.1038/ncb2795; Xu YG, 2014, NEUROL RES, V36, P659, DOI 10.1179/1743132813Y.0000000298; Zolochevska O, 2009, PROSTATE, V69, P1586, DOI 10.1002/pros.21007	22	8	9	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2015	10	3							e0120782	10.1371/journal.pone.0120782	http://dx.doi.org/10.1371/journal.pone.0120782			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9BN	25785833	gold, Green Submitted, Green Published			2022-12-27	WOS:000352138500189
J	Liu, Y; Chotai, S; Chen, M; Jin, S; Qi, ST; Pan, J				Liu, Yi; Chotai, Silky; Chen, Ming; Jin, Shi; Qi, Song-tao; Pan, Jun			Preoperative Radiologic Classification of Convexity Meningioma to Predict the Survival and Aggressive Meningioma Behavior	PLOS ONE			English	Article							PERITUMORAL BRAIN EDEMA; INTRACRANIAL MENINGIOMAS; MALIGNANT MENINGIOMAS; RECURRENCE; PROBABILITY; LOCATION; SUBTYPES; MRI	Background A subgroup of meningioma demonstrates clinical aggressive behavior. We set out to determine if the radiological parameters can predict histopathological aggressive meningioma, and propose a classification to predict survival and aggressive meningioma behavior. Methods A retrospective review of medical records was conducted for patients who underwent surgical resection of their convexity meningioma. WHO-2007 grading was used for histopathological diagnosis. Preoperative radiologic parameters were analyzed, each parameter was scored 0 or 1. Signal intensity on diffusion weighted MRI (DWI) (hyperintensity=1), heterogeneity on T1-weighted gadolinium enhanced MRI (heterogeneity=1), disruption of arachnoid at brain-tumor interface=1 and peritumoral edema (PTE) on T2-weighted MRI (presence of PTE=1) and tumor shape (irregular shape=1). Multivariate logistic regression analyses were conducted to determine association of radiological parameters to histopathological grading. Kaplan-Meier and Cox regression models were used to determine the association of scoring system to overall survival and progression free survival (PFS). Reliability of the classification was tested using Kappa co-efficient analysis. Results Hyperintensity on DWI, disruption of arachnoid at brain-tumor interface, PTE, heterogenicitiy on T1-weighted enhanced MRI and irregular tumor shape were independent predictors of non-grade I meningioma. Mean follow-up period was 94.6 months (range, 12-117 months). Median survival and PFS in groups-I, II and III was 114.1 +/- 1.2 and 115.7 +/- 0.8, 88 +/- 3.3 and 58.5 +/- 3.9, 43.2 +/- 5.1 and 18.2 +/- 1.7 months respectively. In cox regression analysis model, age (P<0.0001, OR-1.039, CI-1.017-0.062), WHO non-grade-I meningioma (P=0.017, OR-3.014, CI-1.217-7.465), radiological classification groups II (P=0.002, OR-6.194, CI-1.956-19.610) and III (P<0.0001, OR-21.658, CI-5.701-82.273) were independent predictors of unfavorable survival outcomes. Conclusions Preoperative radiological classification can be used as a supplement to the histopathological grading. Group-I meningiomas demonstrate benign radiological, histopathological and clinical features; group-III demonstrates aggressive features. Group-II meningiomas demonstrate intermediate features; the need for more aggressive follow-up and/or treatment should be further investigated.	[Liu, Yi; Chotai, Silky; Chen, Ming; Jin, Shi; Qi, Song-tao; Pan, Jun] Southern Med Univ, Nanfang Hosp, Dept Neurosurg, Guangzhou, Guangdong, Peoples R China	Southern Medical University - China	Qi, ST (corresponding author), Southern Med Univ, Nanfang Hosp, Dept Neurosurg, Guangzhou, Guangdong, Peoples R China.	liuyi86818@126.com; panjundu@hotmail.com	Pan, Jun/GQQ-7313-2022					ALVAREZ F, 1987, NEUROSURGERY, V20, P688, DOI 10.1227/00006123-198705000-00003; Ayerbe J, 1999, ACTA NEUROCHIR, V141, P921, DOI 10.1007/s007010050398; Bitzer M, 1997, ACTA NEUROCHIR, V139, P1136, DOI 10.1007/BF01410973; Bitzer M, 1997, J NEUROSURG, V87, P368, DOI 10.3171/jns.1997.87.3.0368; Bondy M, 1996, J NEURO-ONCOL, V29, P197, DOI 10.1007/BF00165649; BRADAC GB, 1986, NEURORADIOLOGY, V28, P304, DOI 10.1007/BF00333435; CHEN TC, 1992, NEUROSURGERY, V31, P1015, DOI 10.1227/00006123-199212000-00005; DEVRIES J, 1993, ACTA NEUROCHIR, V125, P34, DOI 10.1007/BF01401825; Durand A, 2009, J NEURO-ONCOL, V95, P367, DOI 10.1007/s11060-009-9934-0; Filippi CG, 2001, AM J NEURORADIOL, V22, P65; Hakyemez B, 2006, NEURORADIOLOGY, V48, P513, DOI 10.1007/s00234-006-0094-z; Hashiba T, 2006, BRAIN TUMOR PATHOL, V23, P49, DOI 10.1007/s10014-006-0199-4; Hasseleid BF, 2012, J NEUROSURG, V117, P999, DOI 10.3171/2012.9.JNS12294; HIYAMA H, 1994, ACTA NEUROCHIR, V129, P31, DOI 10.1007/BF01400870; Holodny AI, 1999, NEURORADIOLOGY, V41, P820, DOI 10.1007/s002340050848; Ildan F, 1999, J NEUROSURG, V91, P384, DOI 10.3171/jns.1999.91.3.0384; Ildan F, 2007, SKULL BASE-INTERD AP, V17, P157, DOI 10.1055/s-2007-970554; INAMURA T, 1992, NEUROSURGERY, V31, P179, DOI 10.1227/00006123-199208000-00002; JAASKELAINEN J, 1986, SURG NEUROL, V26, P461, DOI 10.1016/0090-3019(86)90259-4; Jensen R, 2012, NEUROSURGERY, V71, P146, DOI 10.1227/NEU.0b013e3182567886; KAPLAN RD, 1992, J COMPUT ASSIST TOMO, V16, P366, DOI 10.1097/00004728-199205000-00006; Kawahara Y, 2012, J NEURO-ONCOL, V108, P147, DOI 10.1007/s11060-012-0809-4; Lee KJ, 2008, SURG NEUROL, V69, P350, DOI 10.1016/j.surneu.2007.03.027; Lobato RD, 1996, ACTA NEUROCHIR, V138, P485, DOI 10.1007/BF01411166; Mantle RE, 1999, J NEUROSURG, V91, P375, DOI 10.3171/jns.1999.91.3.0375; Mawrin C, 2010, J NEURO-ONCOL, V99, P379, DOI 10.1007/s11060-010-0342-2; McGovern SL, 2010, J NEUROSURG, V112, P925, DOI 10.3171/2009.9.JNS09617; Nakamura M, 2006, NEUROSURGERY, V58, P626, DOI 10.1227/01.NEU.0000197104.78684.5D; Nakasu S, 1999, J NEUROSURG, V90, P455, DOI 10.3171/jns.1999.90.3.0455; NAKASU S, 1990, SURG NEUROL, V33, P105, DOI 10.1016/0090-3019(90)90019-L; NEW PFJ, 1982, AM J NEURORADIOL, V3, P267; Ohba S, 2011, J NEUROSURG, V114, P1278, DOI 10.3171/2010.11.JNS10701; Otsuka S, 2004, J NEURO-ONCOL, V70, P349, DOI 10.1007/s11060-004-9164-4; Perry A, 1997, AM J SURG PATHOL, V21, P1455, DOI 10.1097/00000478-199712000-00008; Perry A, 2007, WHO CLASSIFICATION T, P164; Qi ST, 2012, J NEUROSURG, V117, P645, DOI 10.3171/2012.6.JNS111987; Riemenschneider MJ, 2006, LANCET NEUROL, V5, P1045, DOI 10.1016/S1474-4422(06)70625-1; Santelli L, 2010, ACTA NEUROCHIR, V152, P1315, DOI 10.1007/s00701-010-0657-y; Sanverdi SE, 2012, EUR J RADIOL, V81, P2389, DOI 10.1016/j.ejrad.2011.06.031; Simis A, 2008, SURG NEUROL, V70, P471, DOI 10.1016/j.surneu.2008.03.006; Sugahara T, 1999, JMRI-J MAGN RESON IM, V9, P53, DOI 10.1002/(SICI)1522-2586(199901)9:1<53::AID-JMRI7>3.0.CO;2-2; Szafer A, 1995, NMR BIOMED, V8, P289, DOI 10.1002/nbm.1940080704; Tamiya T, 2001, NEUROSURGERY, V49, P1046, DOI 10.1097/00006123-200111000-00003; Vranic A, 2010, NEUROSURGERY, V67, P1124, DOI 10.1227/NEU.0b013e3181eb95b7; Watanabe Y, 2013, EUR J RADIOL, V82, P658, DOI 10.1016/j.ejrad.2012.11.037; Weber DC, 2010, CURR OPIN NEUROL, V23, P563, DOI 10.1097/WCO.0b013e328340441e; Yashioka H, 1999, CANCER-AM CANCER SOC, V85, P936, DOI 10.1002/(SICI)1097-0142(19990215)85:4<936::AID-CNCR23>3.0.CO;2-J	47	26	27	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2015	10	3							e0118908	10.1371/journal.pone.0118908	http://dx.doi.org/10.1371/journal.pone.0118908			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9BN	25786236	gold, Green Published, Green Submitted			2022-12-27	WOS:000352138500056
J	Nishi, SPE; Zhang, W; Kuo, YF; Sharma, G				Nishi, Shawn P. E.; Zhang, Wei; Kuo, Yong-Fang; Sharma, Gulshan			Oxygen Therapy Use in Older Adults with Chronic Obstructive Pulmonary Disease	PLOS ONE			English	Article							GENDER-DIFFERENCE; SEX-DIFFERENCES; COPD; REHABILITATION; CARE; ADHERENCE	Rationale Oxygen therapy improves survival and function in severely hypoxemic chronic obstructive pulmonary disease (COPD) patients based on two landmark studies conducted over 40 years ago. We hypothesize that oxygen users in the current era may be very different. We examined trends and subject characteristics associated with oxygen therapy use from 2001-2010 in the United States. Methods We examined Medicare beneficiaries with COPD who received oxygen from 2001 to 2010. COPD subjects were identified by: 1) >= 2 outpatient visits >30 days apart within one year with an encounter diagnosis of COPD; or 2) an acute care hospitalization with COPD as the primary or secondary discharge diagnosis. Oxygen therapy and sustained oxygen therapy were defined as >= 1 and >= 11 claims for oxygen, respectively, in the durable medical equipment file in a calendar year. Primary outcome measures were factors associated with oxygen therapy and sustained oxygen therapy over the study period. Results Oxygen therapy increased from 33.7% in 2001 to 40.5% in 2010 (p-value of trend <0.001). Sustained oxygen therapy use increased from 19.5% in 2001, peaked in 2008 to 26.9% and declined to 18.5% in 2010. The majority of subjects receiving oxygen therapy and sustained oxygen therapy were female. Besides gender, factors associated with any oxygen use or sustained oxygen therapy were non-Hispanic white race, low socioeconomic status and >= 2 comorbidities. Conclusions Any oxygen use among fee-for service Medicare beneficiaries with COPD is high. Current users of oxygen are older females with multiple comorbidities. Decline in sustained oxygen therapy use after 2008 may be related to reimbursement policy change.	[Nishi, Shawn P. E.; Zhang, Wei; Sharma, Gulshan] Univ Texas Med Branch, Dept Internal Med, Div Pulm Crit Care & Sleep Med, Galveston, TX 77555 USA; [Kuo, Yong-Fang; Sharma, Gulshan] Univ Texas Med Branch, Sealy Ctr Aging, Galveston, TX 77555 USA	University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston	Nishi, SPE (corresponding author), Univ Texas Med Branch, Dept Internal Med, Div Pulm Crit Care & Sleep Med, Galveston, TX 77555 USA.	spnishi@utmb.edu	Nishi, Shawn/AAH-6998-2019; Sharma, Gulshan/AAC-5804-2019	Nishi, Shawn/0000-0002-7510-2664	Agency for Healthcare Research and Quality [R01-HS020642]; Patient Centered Outcomes Research Institute [HS02213401]; National Center for Advancing Translational Sciences [UL1TR000071]; Claude D. Pepper OAIC grant [5P30-AG024832]; AGENCY FOR HEALTHCARE RESEARCH AND QUALITY [R01HS020642] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000071] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P30AG024832] Funding Source: NIH RePORTER	Agency for Healthcare Research and Quality(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); Patient Centered Outcomes Research Institute(Patient-Centered Outcomes Research Institute - PCORI); National Center for Advancing Translational Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); Claude D. Pepper OAIC grant; AGENCY FOR HEALTHCARE RESEARCH AND QUALITY(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by the Agency for Healthcare Research and Quality (R01-HS020642) and by the Patient Centered Outcomes Research Institute (HS02213401). Clinical and Translational Science Award (UL1TR000071) from the National Center for Advancing Translational Sciences. Claude D. Pepper OAIC grant # 5P30-AG024832. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKPUNONU B, 1994, AM J MED SCI, V308, P244; [Anonymous], 1980, ANN INTERN MED, V93, P391; [Anonymous], 2013, DETAILS EXPANSION CO; [Anonymous], AM REV RESP DIS, P721; Borak J, 1996, Monaldi Arch Chest Dis, V51, P7; C. f. D. C. a. P. U. S. D. o. H. a. H. Services, 2011, BEH RISK FACT SURV U; Chaney JC, 2002, CHEST, V122, P1661, DOI 10.1378/chest.122.5.1661; Chapman KR, 2004, CLIN CHEST MED, V25, P331, DOI 10.1016/j.ccm.2004.01.003; Doherty DE, 2006, RESPIR CARE, V51, P519; Dransfield MT, 2006, RESP MED, V100, P1110, DOI 10.1016/j.rmed.2005.09.019; Elixhauser A, 1998, MED CARE, V36, P8, DOI 10.1097/00005650-199801000-00004; FLENLEY DC, 1981, LANCET, V1, P681; GOLD, 2011, GLOB STRAT DIAGN MAN; Guyatt GH, 2000, CHEST, V118, P1303, DOI 10.1378/chest.118.5.1303; Han MK, 2007, CHEST, V132, P403, DOI 10.1378/chest.06-2846; Hayton C, 2013, RESP MED, V107, P401, DOI 10.1016/j.rmed.2012.11.016; Johnston K, 2010, PHYSIOTHER CAN, V62, P368, DOI 10.3138/physio.62.4.368; Keating A, 2011, CHRON RESP DIS, V8, P89, DOI 10.1177/1479972310393756; Langhammer A, 2003, EUR RESPIR J, V21, P1017, DOI 10.1183/09031936.03.00053202; Mannino David M, 2007, Proc Am Thorac Soc, V4, P502, DOI 10.1513/pats.200701-001FM; MEDICARE HOME OXYGEN, 2011, REF PAYM METH HAS PO; MORRISON D, 1995, THORAX, V50, P1103, DOI 10.1136/thx.50.10.1103; Mularski RA, 2006, CHEST, V130, P1844, DOI 10.1378/chest.130.6.1844; O'Grady NP, 2002, CLIN INFECT DIS, V35, P1281, DOI 10.1086/344188; Oba Y, 2000, Respir Care, V45, P401; ODONOHUE WJ, 1995, CHEST, V107, P301, DOI 10.1378/chest.107.2.301; Prescott E, 1997, EUR RESPIR J, V10, P822; Ringbaek TJ, 2006, RESP MED, V100, P218, DOI 10.1016/j.rmed.2005.04.023; Ringbaek TJ, 2013, RESP MED; Strom K, 1993, Monaldi Arch Chest Dis, V48, P473; Suh DC, 2008, RESP CARE, V53, P1461; Wisely C, 2013, 5 THINGS PHYS PATIEN; XU X, 1994, EUR RESPIR J, V7, P477, DOI 10.1183/09031936.94.07030477; Zielinski J, 1998, CHEST, V113, P65, DOI 10.1378/chest.113.1.65	34	19	20	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2015	10	3							e0120684	10.1371/journal.pone.0120684	http://dx.doi.org/10.1371/journal.pone.0120684			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9BN	25785586	Green Published, gold, Green Submitted			2022-12-27	WOS:000352138500187
J	Patel, AS; Song, JW; Chu, SG; Mizumura, K; Osorio, JC; Shi, Y; El-Chemaly, S; Lee, CG; Rosas, IO; Elias, JA; Choi, AMK; Morse, D				Patel, Avignat S.; Song, Jin Woo; Chu, Sarah G.; Mizumura, Kenji; Osorio, Juan C.; Shi, Ying; El-Chemaly, Souheil; Lee, Chun Geun; Rosas, Ivan O.; Elias, Jack A.; Choi, Augustine M. K.; Morse, Danielle			Epithelial Cell Mitochondrial Dysfunction and PINK1 Are Induced by Transforming Growth Factor-Beta1 in Pulmonary Fibrosis	PLOS ONE			English	Article							PINK1-DEFICIENT MICE; DAMAGED MITOCHONDRIA; MITOPHAGY; PARKIN; PROMOTES; DEGRADATION; ACTIVATION; AUTOPHAGY; DISEASES; RECRUITMENT	Background Epithelial cell death is a major contributor to fibrogenesis in the lung. In this study, we sought to determine the function of mitochondria and their clearance (mitophagy) in alveolar epithelial cell death and fibrosis. Methods We studied markers of mitochondrial injury and the mitophagy marker, PTEN-induced putative kinase 1 (PINK1), in IPF lung tissues by Western blotting, transmission electron microscopy (TEM), and immunofluorescence. In vitro experiments were carried out in lung epithelial cells stimulated with transforming growth factor-beta 1 (TGF-beta 1). Changes in cell function were measured by Western blotting, flow cytometry and immunofluorescence. In vivo experiments were performed using the murine bleomycin model of lung fibrosis. Results Evaluation of IPF lung tissue demonstrated increased PINK1 expression by Western blotting and immunofluorescence and increased numbers of damaged mitochondria by TEM. In lung epithelial cells, TGF-beta 1 induced mitochondrial depolarization, mitochondrial ROS, and PINK1 expression; all were abrogated by mitochondrial ROS scavenging. Finally, Pink1(-/-) mice were more susceptible than control mice to bleomycin induced lung fibrosis. Conclusion TGF-beta 1 induces lung epithelial cell mitochondrial ROS and depolarization and stabilizes the key mitophagy initiating protein, PINK1. PINK1 ameliorates epithelial cell death and may be necessary to limit fibrogenesis.	[Patel, Avignat S.; Chu, Sarah G.; Osorio, Juan C.; Shi, Ying; El-Chemaly, Souheil; Rosas, Ivan O.; Morse, Danielle] Brigham & Womens Hosp, Div Pulm & Crit Care Med, Boston, MA 02115 USA; [Patel, Avignat S.; Chu, Sarah G.; Osorio, Juan C.; Shi, Ying; El-Chemaly, Souheil; Rosas, Ivan O.; Morse, Danielle] Harvard Univ, Sch Med, Boston, MA USA; [Song, Jin Woo] Univ Ulsan, Dept Pulm & Crit Care Med, Asan Med Ctr, Coll Med, Seoul, South Korea; [Lee, Chun Geun] Yale Univ, Sch Med, Sect Pulm & Crit Care Med, New Haven, CT USA; [Rosas, Ivan O.] Lovelace Resp Res Inst, Pulm Fibrosis Program, Albuquerque, NM USA; [Elias, Jack A.] Brown Univ, Alpert Med Sch, Providence, RI 02912 USA; [Mizumura, Kenji; Choi, Augustine M. K.] Weill Cornell Med Coll, Dept Med, New York, NY USA	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; University of Ulsan; Asan Medical Center; Yale University; Lovelace Respiratory Research Institute; Brown University; Cornell University	Song, JW (corresponding author), Univ Ulsan, Dept Pulm & Crit Care Med, Asan Med Ctr, Coll Med, Seoul, South Korea.	jwsong@amc.seoul.kr	song, jin woo/AAW-3876-2021; Lee, Chun Geun/AAC-2838-2021; Song, Jin/HHS-8731-2022	Osorio, Juan C/0000-0001-8090-1551; Lee, Chun Geun/0000-0002-9514-3658; Mizumura, Kenji/0000-0001-8532-9670	NIH [R01HL087122-01, P01HL114501]; Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education [NRF-2013R1A1A1064957]; Asan Institute for Life Sciences, Asan Medical Center, Seoul, Korea [14-495]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL087122, P01HL114501, F32HL124884] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education; Asan Institute for Life Sciences, Asan Medical Center, Seoul, Korea; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	D.M. was supported by NIH Grant R01HL087122-01. JWS was supported by Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education (NRF-2013R1A1A1064957) and by a grant (14-495) from the Asan Institute for Life Sciences, Asan Medical Center, Seoul, Korea. I. O.R. and A.M.K.C were supported by NIH Grant P01HL114501. The funders had no roles in study design, data colelction and analysis, decision to publish, or preparation of the manuscript.	Araya J, 2013, AM J PHYSIOL-LUNG C, V304, pL56, DOI 10.1152/ajplung.00213.2012; Baker TA, 2014, PHYSIOL RES, V63, P311, DOI 10.33549/physiolres.932607; Baloyannis SJ, 2006, J ALZHEIMERS DIS, V9, P119; Bueno M, 2015, J CLIN INVEST, V125, P521, DOI 10.1172/JCI74942; Cai Q, 2012, CURR BIOL, V22, P545, DOI 10.1016/j.cub.2012.02.005; Carnesecchi S, 2011, ANTIOXID REDOX SIGN, V15, P607, DOI 10.1089/ars.2010.3829; Chen HC, 2009, HUM MOL GENET, V18, pR169, DOI 10.1093/hmg/ddp326; Dagda RK, 2009, J BIOL CHEM, V284, P13843, DOI 10.1074/jbc.M808515200; Dostert C, 2008, SCIENCE, V320, P674, DOI 10.1126/science.1156995; Gispert S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005777; Greene AW, 2012, EMBO REP, V13, P378, DOI 10.1038/embor.2012.14; Hoshino A, 2012, J MOL CELL CARDIOL, V52, P175, DOI 10.1016/j.yjmcc.2011.10.008; Jain M, 2013, J BIOL CHEM, V288, P770, DOI 10.1074/jbc.M112.431973; Kim I, 2007, ARCH BIOCHEM BIOPHYS, V462, P245, DOI 10.1016/j.abb.2007.03.034; Kitada T, 1998, NATURE, V392, P605, DOI 10.1038/33416; Kitada T, 2007, P NATL ACAD SCI USA, V104, P11441, DOI 10.1073/pnas.0702717104; Lazarou M, 2012, DEV CELL, V22, P320, DOI 10.1016/j.devcel.2011.12.014; Liu RM, 2010, FREE RADICAL BIO MED, V48, P1, DOI 10.1016/j.freeradbiomed.2009.09.026; Matsuda N, 2010, J CELL BIOL, V189, P211, DOI 10.1083/jcb.200910140; Meissner C, 2011, J NEUROCHEM, V117, P856, DOI 10.1111/j.1471-4159.2011.07253.x; Mi S, 2011, J IMMUNOL, V187, P3003, DOI 10.4049/jimmunol.1004081; Muqit MMK, 2006, J NEUROCHEM, V98, P156, DOI 10.1111/j.1471-4159.2006.03845.x; Narendra D, 2008, J CELL BIOL, V183, P795, DOI 10.1083/jcb.200809125; Narendra DP, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000298; Osborn-Heaford HL, 2012, J BIOL CHEM, V287, P3301, DOI 10.1074/jbc.M111.308387; Park J, 2006, NATURE, V441, P1157, DOI 10.1038/nature04788; Parsons MJ, 2010, ESSAYS BIOCHEM, V47, P99, DOI [10.1042/BSE0470099, 10.1042/bse0470099]; Patel AS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041394; Pociask DA, 2004, LAB INVEST, V84, P1013, DOI 10.1038/labinvest.3700109; Saraste M, 1999, SCIENCE, V283, P1488, DOI 10.1126/science.283.5407.1488; Siegel PM, 2003, NAT REV CANCER, V3, P807, DOI 10.1038/nrc1208; Thannickal Victor J, 2006, Proc Am Thorac Soc, V3, P350, DOI 10.1513/pats.200601-001TK; Twig G, 2011, ANTIOXID REDOX SIGN, V14, P1939, DOI 10.1089/ars.2010.3779; Valente EM, 2004, SCIENCE, V304, P1158, DOI 10.1126/science.1096284; Wallace DC, 2005, ANNU REV GENET, V39, P359, DOI 10.1146/annurev.genet.39.110304.095751; Wang YQ, 2012, AUTOPHAGY, V8, P1462, DOI 10.4161/auto.21211; Wood-Kaczmar A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002455; Xu JF, 2012, AM J RESP CRIT CARE, V185, P547, DOI 10.1164/rccm.201108-1574OC; Yoon YS, 2005, ONCOGENE, V24, P1895, DOI 10.1038/sj.onc.1208262; Youle RJ, 2011, NAT REV MOL CELL BIO, V12, P9, DOI 10.1038/nrm3028	40	118	122	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2015	10	3							e0121246	10.1371/journal.pone.0121246	http://dx.doi.org/10.1371/journal.pone.0121246			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9BN	25785991	Green Published, Green Submitted, gold			2022-12-27	WOS:000352138500206
J	Planillo, A; Kramer-Schadt, S; Malo, JE				Planillo, Aimara; Kramer-Schadt, Stephanie; Malo, Juan E.			Transport Infrastructure Shapes Foraging Habitat in a Raptor Community	PLOS ONE			English	Article							MODEL SELECTION; ROAD VERGES; POPULATIONS; CONSERVATION; ABUNDANCE; RESPONSES; ECOLOGY; URBANIZATION; CONSEQUENCES; PARAMETERS	Transport infrastructure elements are widespread and increasing in size and length in many countries, with the subsequent alteration of landscapes and wildlife communities. Nonetheless, their effects on habitat selection by raptors are still poorly understood. In this paper, we analyzed raptors' foraging habitat selection in response to conventional roads and high capacity motorways at the landscape scale, and compared their effects with those of other variables, such as habitat structure, food availability, and presence of potential interspecific competitors. We also analyzed whether the raptors' response towards infrastructure depends on the spatial scale of observation, comparing the attraction or avoidance behavior of the species at the landscape scale with the response of individuals observed in the proximity of the infrastructure. Based on ecological hypotheses for foraging habitat selection, we built generalized linear mixed models, selected the best models according to Akaike Information Criterion and assessed variable importance by Akaike weights. At the community level, the traffic volume was the most relevant variable in the landscape for foraging habitat selection. Abundance, richness, and diversity values reached their maximum at medium traffic volumes and decreased at highest traffic volumes. Individual species showed different degrees of tolerance toward traffic, from higher abundance in areas with high traffic values to avoidance of it. Medium-sized opportunistic raptors increased their abundance near the traffic infrastructures, large scavenger raptors avoided areas with higher traffic values, and other species showed no direct response to traffic but to the presence of prey. Finally, our cross-scale analysis revealed that the effect of transport infrastructures on the behavior of some species might be detectable only at a broad scale. Also, food availability may attract raptor species to risky areas such as motorways.	[Planillo, Aimara; Malo, Juan E.] Univ Autonoma Madrid, Dept Ecol, TEG, Madrid, Spain; [Kramer-Schadt, Stephanie] Leibniz Inst Zoo & Wildlife Res, Dept Evolutionary Ecol, Berlin, Germany	Autonomous University of Madrid; Leibniz Institut fur Zoo und Wildtierforschung	Planillo, A (corresponding author), Univ Autonoma Madrid, Dept Ecol, TEG, Madrid, Spain.	aimara.planillo@uam.es	Arrazola, Juan Esteban Malo/Q-4819-2019; Planillo, Aimara/AAH-9886-2019; Kramer-Schadt, Stephanie/A-8778-2013; Malo, Juan E/K-8305-2014	Arrazola, Juan Esteban Malo/0000-0002-6033-5035; Planillo, Aimara/0000-0001-6763-9923; Kramer-Schadt, Stephanie/0000-0002-9269-4446; Malo, Juan E/0000-0002-6033-5035	Basque Government; Centro para el Desarrollo Tecnologico e Industrial of the Spanish Ministry of Science and Innovation [CENIT-2008 1016]; Comunidad de Madrid through the REMEDINAL Research Network [S-2009/AMB/1783]; European Social Fund through the REMEDINAL Research Network [S-2009/AMB/1783]	Basque Government(Basque Government); Centro para el Desarrollo Tecnologico e Industrial of the Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)); Comunidad de Madrid through the REMEDINAL Research Network; European Social Fund through the REMEDINAL Research Network	AP was supported by a PhD grant of the Basque Government. This study forms part of the CENIT-OASIS Project funded by a consortium of companies supported by the Centro para el Desarrollo Tecnologico e Industrial of the Spanish Ministry of Science and Innovation (CENIT-2008 1016). The Comunidad de Madrid, together with the European Social Fund, supports the TEG research group through the REMEDINAL Research Network (S-2009/AMB/1783). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnold TW, 2010, J WILDLIFE MANAGE, V74, P1175, DOI 10.2193/2009-367; Barrientos R, 2012, DIVERS DISTRIB, V18, P635, DOI 10.1111/j.1472-4642.2011.00850.x; Barton K., 2014, MULTIMODEL INFERENCE; Basille M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065493; Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; Bautista LM, 2004, CONSERV BIOL, V18, P726, DOI 10.1111/j.1523-1739.2004.00499.x; Beja P, 2009, EUR J WILDLIFE RES, V55, P227, DOI 10.1007/s10344-008-0236-1; Benitez-Lopez A, 2010, BIOL CONSERV, V143, P1307, DOI 10.1016/j.biocon.2010.02.009; BENNETT AF, 1990, LANDSCAPE ECOL, V4, P109, DOI 10.1007/BF00132855; Bernis F, 1974, ARDEOLA, V19, P225; Bibby CJ, 2000, BIRD CENSUS TECHNIQU, DOI 10.1016/b978-0-12-095830-6.50007-9; BLANCO G, 1994, J RAPTOR RES, V28, P242; Blumstein DT, 2005, J APPL ECOL, V42, P943, DOI 10.1111/j.1365-2664.2005.01071.x; Bolker B, 2012, OWLS EXAMPLE ZERO IN; Bolker BM, 2009, TRENDS ECOL EVOL, V24, P127, DOI 10.1016/j.tree.2008.10.008; Burnham K.P., 2002, PRACTICAL INFORM THE, V2nd ed., DOI [DOI 10.1007/B97636, 10.1007/b97636]; Carrete M, 2009, BIOL CONSERV, V142, P2002, DOI 10.1016/j.biocon.2009.02.012; Clarke GP, 1998, BIOL CONSERV, V86, P117, DOI 10.1016/S0006-3207(98)00018-4; Cody M.L., 1985, P3; Crawley M.J., 2007, R BOOK; Dean WRJ, 2003, OSTRICH, V74, P181, DOI 10.2989/00306520309485391; DEL HOYO J., 1996, HDB BIRDS WORLD, V3; Delibes M., 1984, Ardeola, V31, P115; Delibes M, 2001, ECOL LETT, V4, P401, DOI 10.1046/j.1461-0248.2001.00254.x; Devictor V, 2007, CONSERV BIOL, V21, P741, DOI 10.1111/j.1523-1739.2007.00671.x; Devictor V, 2009, DIVERS DISTRIB, V15, P122, DOI 10.1111/j.1472-4642.2008.00510.x; Diaz M., 1996, AVES IBERICAS; Donazar JA, 2009, SCIENCE, V326, P664, DOI 10.1126/science.326_664a; Erritzoe J, 2003, ACTA ORNITHOL, V38, P77, DOI 10.3161/068.038.0204; Estes JA, 2011, SCIENCE, V333, P301, DOI 10.1126/science.1205106; Fahrig L, 2009, ECOL SOC, V14; Forman RTT, 1998, ANNU REV ECOL SYST, V29, P207, DOI 10.1146/annurev.ecolsys.29.1.207; Forman RTT, 2002, ENVIRON MANAGE, V29, P782, DOI 10.1007/s00267-001-0065-4; Forman RTT, 2003, ROAD ECOLOGY SCI SOL; Fournier DA, 2012, OPTIM METHOD SOFTW, V27, P233, DOI 10.1080/10556788.2011.597854; Frey SN, 2006, J WILDLIFE MANAGE, V70, P1111, DOI 10.2193/0022-541X(2006)70[1111:HUBMIA]2.0.CO;2; Garcia-Heras MS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080523; Gomes L, 2009, ECOL RES, V24, P355, DOI 10.1007/s11284-008-0515-z; Grilo C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043811; Gunson KE, 2011, J ENVIRON MANAGE, V92, P1074, DOI 10.1016/j.jenvman.2010.11.027; IUCN, 2013, IUCN RED LIST THREAT; Jaeger JAG, 2005, ECOL MODEL, V185, P329, DOI 10.1016/j.ecolmodel.2004.12.015; Johnson CJ, 2006, J WILDLIFE MANAGE, V70, P347, DOI 10.2193/0022-541X(2006)70[347:RSFBOU]2.0.CO;2; Johnson JB, 2004, TRENDS ECOL EVOL, V19, P101, DOI 10.1016/j.tree.2003.10.013; KNIGHT RL, 1993, J WILDLIFE MANAGE, V57, P266, DOI 10.2307/3809423; Lambertucci SA, 2009, BIODIVERS CONSERV, V18, P2063, DOI 10.1007/s10531-008-9573-3; Le Viol I, 2012, BIOL LETTERS, V8, P780, DOI 10.1098/rsbl.2012.0496; Legagneux P, 2013, BIOL LETTERS, V9, DOI 10.1098/rsbl.2013.0417; Madrono A., 2004, LIBRO ROJO AVES ESPA; Malo JE, 2004, J APPL ECOL, V41, P701, DOI 10.1111/j.0021-8901.2004.00929.x; Manly B., 2007, RESOURCE SELECTION A; Margalida A, 2014, ECOL APPL, V24, P436, DOI 10.1890/13-0414.1; Margalida A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065857; McClure CJW, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.2290; McKinney ML, 2006, BIOL CONSERV, V127, P247, DOI 10.1016/j.biocon.2005.09.005; Meunier FD, 2000, BIOL CONSERV, V92, P291, DOI 10.1016/S0006-3207(99)00094-4; Moller Anders Pape, 2011, Zoological Research, V32, P115, DOI 10.3724/SP.J.1141.2011.02115; Monsarrat S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053077; Morelli Federico, 2011, Journal of Mediterranean Ecology, V11, P21; Mumme RL, 2000, CONSERV BIOL, V14, P501, DOI 10.1046/j.1523-1739.2000.98370.x; Northrup JM, 2013, ECOLOGY, V94, P1456, DOI 10.1890/12-1688.1; Olden JD, 2004, TRENDS ECOL EVOL, V19, P18, DOI 10.1016/j.tree.2003.09.010; Palomino D, 2007, LANDSCAPE URBAN PLAN, V83, P268, DOI 10.1016/j.landurbplan.2007.04.011; Quinn G.P., 2002, EXPT DESIGN DATA ANA; R Core Team, 2021, R LANGUAGE ENV STAT; Reijnen R, 1996, BIOL CONSERV, V75, P255, DOI 10.1016/0006-3207(95)00074-7; Rettie WJ, 2000, ECOGRAPHY, V23, P466, DOI 10.1034/j.1600-0587.2000.230409.x; Richards SA, 2011, BEHAV ECOL SOCIOBIOL, V65, P77, DOI 10.1007/s00265-010-1035-8; Rodewald AD, 2011, ECOL APPL, V21, P936, DOI 10.1890/10-0863.1; Rosa S., 2007, INT C EC TRANSP, P562; Ruiz-Capillas P, 2013, ECOSYSTEMS, V16, P617, DOI 10.1007/s10021-013-9634-7; Ruiz-Capillas P, 2013, BIOL CONSERV, V158, P223, DOI 10.1016/j.biocon.2012.09.025; Rytwinski T, 2012, BIOL CONSERV, V147, P87, DOI 10.1016/j.biocon.2011.11.023; Sanchez-Zapata JA, 1999, J APPL ECOL, V36, P254, DOI 10.1046/j.1365-2664.1999.00396.x; Sergio F, 2003, BIOL CONSERV, V112, P351, DOI 10.1016/S0006-3207(02)00332-4; Skaug H, 2012, GEN LINEAR MIXED MOD; Strasser EH, 2013, J APPL ECOL, V50, P912, DOI 10.1111/1365-2664.12103; Trombulak SC, 2000, CONSERV BIOL, V14, P18, DOI 10.1046/j.1523-1739.2000.99084.x; Veiga J.P., 1986, Raptor Research, V20, P120; Wood SN, 2011, J R STAT SOC B, V73, P3, DOI 10.1111/j.1467-9868.2010.00749.x; Zuberogoitia I, 2010, ORNIS FENNICA, V87, P52; Zuur Alain F., 2009, P1	82	13	14	0	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2015	10	3							e0118604	10.1371/journal.pone.0118604	http://dx.doi.org/10.1371/journal.pone.0118604			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9BN	25786218	Green Published, Green Submitted, gold			2022-12-27	WOS:000352138500039
J	Qian, YY; Zhong, P; Liang, DD; Xu, Z; Skibba, M; Zeng, CL; Li, XK; Wei, TM; Wu, LP; Liang, G				Qian, Yuanyuan; Zhong, Peng; Liang, Dandan; Xu, Zheng; Skibba, Melissa; Zeng, Chunlai; Li, Xiaokun; Wei, Tiemin; Wu, Lianpin; Liang, Guang			A Newly Designed Curcumin Analog Y20 Mitigates Cardiac Injury via Anti-Inflammatory and Anti-Oxidant Actions in Obese Rats	PLOS ONE			English	Article							NF-KAPPA-B; OXIDATIVE STRESS; HEART-FAILURE; INDUCED INFLAMMATION; IN-VITRO; HYPERTROPHY; DYSFUNCTION; INHIBITION; NRF2; EXPRESSION	Obesity is strongly associated with the cause of structural and functional changes of the heart in both human and animal models. Oxidative stress and inflammation play a critical role in the development of obesity-induced cardiac disorders. Curcumin is a natural product from Curcuma Longa with multiple bioactivities. In our previous study, in order to reach better anti-inflammatory and anti-oxidant dual activities, we designed a new mono-carbonyl curcumin analog, Y20, via the structural modification with both trifluoromethyl and bromine. This study was designed to investigate the protective effects of Y20 on obesity-induced cardiac injury and its underlying mechanisms. In high fat diet-fed rats, oral administration of Y20 at 20 mg/kg or curcumin at 50 mg/kg significantly decreased the cardiac inflammation and oxidative stress and eventually improved the cardiac remodeling by mitigating cardiac disorganization, hypertrophy, fibrosis and apoptosis. Y20 at 20 mg/kg showed comparable and even stronger bioactivities than curcumin at 50 mg/kg. The beneficial actions of Y20 are closely associated with its ability to increase Nrf2 expression and inhibit NF-kappa B activation. Taken together, these results suggest that Y20 may have a great therapeutic potential in the treatment of obesity-induced cardiac injury using Nrf2 and NF-kappa B as the therapeutic targets for treating obesity-related disorders.	[Qian, Yuanyuan; Zhong, Peng; Liang, Dandan; Xu, Zheng; Skibba, Melissa; Li, Xiaokun; Liang, Guang] Wenzhou Med Univ, Sch Pharmaceut Sci, Chem Biol Res Ctr, Wenzhou, Zhejiang, Peoples R China; [Zhong, Peng; Zeng, Chunlai; Wei, Tiemin] Wenzhou Med Univ, Affiliated Hosp 5, Dept Cardiol, Lishui, Zhejiang, Peoples R China; [Wu, Lianpin] Wenzhou Med Univ, Affiliated Hosp 2, Dept Cardiol, Wenzhou, Zhejiang, Peoples R China	Wenzhou Medical University; Wenzhou Medical University; Wenzhou Medical University	Wu, LP (corresponding author), Wenzhou Med Univ, Affiliated Hosp 2, Dept Cardiol, Wenzhou, Zhejiang, Peoples R China.	wzwlp@sina.com; wzmcliangguang@163.com			Natural Science Funding of China [21272179]; Natural Science Funding of Zhejiang Province [LY13H160022]; CIHR China-Canada Joint Health Research Initiative [81261120560]; Zhejiang Department of Health; Zhejiang Key Group in Scientific Innovation [2010R50042]	Natural Science Funding of China; Natural Science Funding of Zhejiang Province; CIHR China-Canada Joint Health Research Initiative(Canadian Institutes of Health Research (CIHR)); Zhejiang Department of Health; Zhejiang Key Group in Scientific Innovation	This study was supported by the Natural Science Funding of China (21272179 to G.L.), Natural Science Funding of Zhejiang Province (LY13H160022), CIHR China-Canada Joint Health Research Initiative (81261120560), High-level Innovative Talent Funding of Zhejiang Department of Health (to G.L. and C.Z.), and Zhejiang Key Group in Scientific Innovation (2010R50042 to X.L.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abel ED, 2008, PHYSIOL REV, V88, P389, DOI 10.1152/physrev.00017.2007; Alappat L, 2010, NUTR REV, V68, P729, DOI 10.1111/j.1753-4887.2010.00341.x; Anand P, 2008, BIOCHEM PHARMACOL, V76, P1590, DOI 10.1016/j.bcp.2008.08.008; Anand P, 2007, MOL PHARMACEUT, V4, P807, DOI 10.1021/mp700113r; Aukrust P, 2004, AUTOIMMUN REV, V3, P221, DOI 10.1016/S1568-9972(03)00103-4; Aurigemma GP, 2013, CIRC-CARDIOVASC IMAG, V6, P142, DOI 10.1161/CIRCIMAGING.111.964627; Ballal K, 2010, MOL CELL BIOCHEM, V344, P221, DOI 10.1007/s11010-010-0546-y; Cai L, 2006, J AM COLL CARDIOL, V48, P1688, DOI 10.1016/j.jacc.2006.07.022; Cavalera M, 2014, TRANSL RES, V164, P323, DOI 10.1016/j.trsl.2014.05.001; Fukuda M, 2010, J PHARMACOL EXP THER, V335, P70, DOI 10.1124/jpet.110.170373; He HJ, 2012, WORLD J DIABETES, V3, P94, DOI 10.4239/wjd.v3.i5.94; Hilfiker-Klemer D, 2006, J AM COLL CARDIOL, V48, pA56, DOI 10.1016/j.jacc.2006.07.007; Hu P, 2013, CELL BIOL INT, V37, P443, DOI 10.1002/cbin.10050; Huynh K, 2012, DIABETOLOGIA, V55, P1544, DOI 10.1007/s00125-012-2495-3; Ilkun O, 2013, CURR PHARM DESIGN, V19, P4806, DOI 10.2174/1381612811319270003; Jung KA, 2010, MOLECULES, V15, P7266, DOI 10.3390/molecules15107266; Justino GC, 2009, J MASS SPECTROM, V44, P1459, DOI 10.1002/jms.1630; Ko HJ, 2009, DIABETES, V58, P2536, DOI 10.2337/db08-1361; Kupper FC, 2013, J EXP BOT, V64, P2653, DOI 10.1093/jxb/ert110; Lee JE, 2012, CARDIOVASC DIABETOL, V11, DOI 10.1186/1475-2840-11-111; Liang G, 2009, EUR J MED CHEM, V44, P915, DOI 10.1016/j.ejmech.2008.01.031; Ma YG, 2012, EXPERT OPIN DRUG DIS, V7, P711, DOI 10.1517/17460441.2012.694862; Madonna R, 2013, INT J IMMUNOPATH PH, V26, P59, DOI 10.1177/039463201302600106; Meng Z, 2013, ACTA PHARMACOL SIN, V34, P901, DOI 10.1038/aps.2013.24; Pan Y, 2014, DIABETES, V63, P3497, DOI 10.2337/db13-1577; Pan Y, 2012, BRIT J PHARMACOL, V166, P1169, DOI 10.1111/j.1476-5381.2012.01854.x; Panchal SK, 2013, EUR J NUTR, V52, P559, DOI 10.1007/s00394-012-0358-9; Pongchaidecha A, 2009, NUTRITION, V25, P870, DOI 10.1016/j.nut.2009.02.001; Querejeta R, 2004, CIRCULATION, V110, P1263, DOI 10.1161/01.CIR.0000140973.60992.9A; Rial NS, 2012, MED HYPOTHESES, V78, P29, DOI 10.1016/j.mehy.2011.09.034; Seddon M, 2007, HEART, V93, P903, DOI 10.1136/hrt.2005.068270; Seo HA, 2013, OXID MED CELL LONGEV, V2013, DOI 10.1155/2013/184598; Sharma RA, 2004, CLIN CANCER RES, V10, P6847, DOI 10.1158/1078-0432.CCR-04-0744; Sharma RA, 2007, ADV EXP MED BIOL, V595, P453; Shehzad A, 2011, EUR J NUTR, V50, P151, DOI 10.1007/s00394-011-0188-1; Wang ZX, 2010, MEDIAT INFLAMM, V2010, DOI 10.1155/2010/535918; Wellen KE, 2005, J CLIN INVEST, V115, P1111, DOI 10.1172/JCI200525102; Wisse BE, 2007, SCIENCE, V318, P928, DOI 10.1126/science.1148032; Wong C, 2007, NAT CLIN PRACT CARD, V4, P436, DOI 10.1038/ncpcardio0943; Zeng CL, 2015, J MOL CELL CARDIOL, V79, P1, DOI 10.1016/j.yjmcc.2014.10.002; Zhao CG, 2013, CURR PHARM DESIGN, V19, P2114; Zhao CG, 2010, BIOORGAN MED CHEM, V18, P2388, DOI 10.1016/j.bmc.2010.03.001	42	35	35	5	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2015	10	3							e0120215	10.1371/journal.pone.0120215	http://dx.doi.org/10.1371/journal.pone.0120215			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9BN	25786209	Green Published, gold, Green Submitted			2022-12-27	WOS:000352138500160
J	Rakusa, M; Cano, SJ; Porter, B; Riazi, A; Thompson, AJ; Chataway, J; Hardy, TA				Rakusa, Martin; Cano, Stefan J.; Porter, Bernadette; Riazi, Afsane; Thompson, Alan J.; Chataway, Jeremy; Hardy, Todd A.			A Predictive Model for Corticosteroid Response in Individual Patients with MS Relapses	PLOS ONE			English	Article							MULTIPLE-SCLEROSIS RELAPSES; DISABILITY; RECOVERY; IMPACT; METHYLPREDNISOLONE; METAANALYSIS; IMPAIRMENT	Objectives To derive a simple predictive model to guide the use of corticosteroids in patients with relapsing remitting MS suffering an acute relapse. Materials and Methods We analysed individual patient randomised controlled trial data (n=98) using a binary logistic regression model based on age, gender, baseline disability scores [physician-observed: expanded disability status scale (EDSS) and patient reported: multiple sclerosis impact scale 29 (MSIS-29)], and the time intervals between symptom onset or referral and treatment. Results Based on two a priori selected cut-off points (improvement in EDSS >= 0.5 and >= 1.0), we found that variables which predicted better response to corticosteroids after 6 weeks were younger age and lower MSIS-29 physical score at the time of relapse (model fit 71.2%-73.1%). Conclusions This pilot study suggests two clinical variables which may predict the majority of the response to corticosteroid treatment in patients undergoing an MS relapse. The study is limited in being able to clearly distinguish factors associated with treatment response or spontaneous recovery and needs to be replicated in a larger prospective study.	[Rakusa, Martin; Porter, Bernadette; Thompson, Alan J.; Chataway, Jeremy; Hardy, Todd A.] UCL, UCL Inst Neurol, Dept Neuroinflammat, Queen Sq Multiple Sclerosis Ctr, London, England; [Rakusa, Martin; Porter, Bernadette; Thompson, Alan J.; Chataway, Jeremy; Hardy, Todd A.] Univ Coll London Hosp NHS Fdn Trust, Natl Hosp Neurol & Neurosurg, London, England; [Cano, Stefan J.] Univ Plymouth, Peninsula Sch Med & Dent, Clin Neurol Res Grp, Plymouth PL4 8AA, Devon, England; [Riazi, Afsane; Thompson, Alan J.] UCL, Inst Neurol, Dept Brain Repair & Rehabil, London, England; [Riazi, Afsane] Univ London, Dept Psychol, Surrey, England; [Hardy, Todd A.] Univ Sydney, MS Clin, Brain & Mind Res Inst, Sydney, NSW 2006, Australia; [Hardy, Todd A.] Concord Repatriat Gen Hosp, Neuroimmunol Clin, Sydney, NSW, Australia	University of London; University College London; University of London; University College London; UCL Medical School; University College London Hospitals NHS Foundation Trust; University of Plymouth; University of London; University College London; University of London; Royal Holloway University London; University of Sydney; Concord Repatriation General Hospital	Hardy, TA (corresponding author), UCL, UCL Inst Neurol, Dept Neuroinflammat, Queen Sq Multiple Sclerosis Ctr, London, England.	thardy@med.usyd.edu.au	Rakusa, Martin/AAI-4283-2021; Thompson, Alan J/C-2654-2008	Rakusa, Martin/0000-0003-4433-3985; Thompson, Alan J/0000-0002-4333-8496; Hardy, Todd/0000-0003-4145-3172; porter, bernadette/0000-0002-7939-8351; Riazi, Afsane/0000-0001-8397-414X	MS-Trust; National Institute of Health Research (NIHR) University College London Hospitals/UCL Biomedical Research Centres funding scheme	MS-Trust; National Institute of Health Research (NIHR) University College London Hospitals/UCL Biomedical Research Centres funding scheme(National Institute for Health Research (NIHR))	This work received no specific funding from any agency in the public, commercial, or not-for-profit sectors. The original study was funded by the MS-Trust. JC receives support from the National Institute of Health Research (NIHR) University College London Hospitals/UCL Biomedical Research Centres funding scheme. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amato MP, 1999, MULT SCLER, V5, P216, DOI 10.1177/135245859900500404; Brusaferri F, 2000, J NEUROL, V247, P435, DOI 10.1007/s004150070172; Burton JM, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006921.pub3; Chataway J, 2006, LANCET NEUROL, V5, P555, DOI 10.1016/S1474-4422(06)70482-3; Filippi M, 2001, NEUROLOGY, V56, P422, DOI 10.1212/WNL.56.3.422; Filippini G., 2000, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD001331; Finlayson Marcia, 2004, J Neurosci Nurs, V36, P245; Flensner G, 2011, BMC NEUROL, V11, DOI 10.1186/1471-2377-11-27; Halper J, 2007, J NEUROL SCI, V256, pS34, DOI 10.1016/j.jns.2007.01.059; Hirst C, 2008, J NEUROL, V255, P280, DOI 10.1007/s00415-008-0743-8; Hirst CL, 2012, MULT SCLER J, V18, P1152, DOI 10.1177/1352458511433919; Hobart J, 2001, BRAIN, V124, P962, DOI 10.1093/brain/124.5.962; KURTZKE JF, 1983, NEUROLOGY, V33, P1444, DOI 10.1212/WNL.33.11.1444; Lassmann H, 2007, BRAIN PATHOL, V17, P210, DOI 10.1111/j.1750-3639.2007.00064.x; Leone MA, 2008, MULT SCLER J, V14, P485, DOI 10.1177/1352458507084650; McDonald WI, 2001, ANN NEUROL, V50, P121, DOI 10.1002/ana.1032; Miller DM, 2000, MULT SCLER, V6, P267, DOI 10.1191/135245800678827770; Mowry EM, 2009, NEUROLOGY, V72, P602, DOI 10.1212/01.wnl.0000342458.39625.91; Myhr KM, 2009, ACTA NEUROL SCAND, V120, P73, DOI 10.1111/j.1600-0404.2009.01213.x; National Clinical Advisory Board of the National Multiple Sclerosis Society, 2008, RECOMMENDATIONS REGA; Nos C, 2004, MULT SCLER J, V10, P413, DOI 10.1191/1352458504ms1068oa; POSER CM, 1983, ANN NEUROL, V13, P227, DOI 10.1002/ana.410130302; Riazi A, 2011, HEALTH QUAL LIFE OUT, V9, DOI 10.1186/1477-7525-9-80; Schweingruber N, 2012, J NEUROENDOCRINOL, V24, P174, DOI 10.1111/j.1365-2826.2011.02161.x; Sellebjerg F, 2005, EUR J NEUROL, V12, P939, DOI 10.1111/j.1468-1331.2005.01352.x; Vercellino M, 2009, ACTA NEUROL SCAND, V119, P126, DOI 10.1111/j.1600-0404.2008.01076.x; West T, 2006, NEUROLOGY, V67, P809, DOI 10.1212/01.wnl.0000234031.30756.a0	27	3	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2015	10	3							e0120829	10.1371/journal.pone.0120829	http://dx.doi.org/10.1371/journal.pone.0120829			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9BN	25785460	gold, Green Published, Green Submitted			2022-12-27	WOS:000352138500194
J	Schwing, PT; Romero, IC; Brooks, GR; Hastings, DW; Larson, RA; Hollander, DJ				Schwing, Patrick T.; Romero, Isabel C.; Brooks, Gregg R.; Hastings, David W.; Larson, Rebekka A.; Hollander, David J.			A Decline in Benthic Foraminifera following the Deepwater Horizon Event in the Northeastern Gulf of Mexico	PLOS ONE			English	Article							CONTINENTAL-SHELF; INDICATORS; DENITRIFICATION; CONTAMINATION; SEDIMENTS; RESPONSES; SURVIVAL; BATHYAL; BIOMASS; FATE	Sediment cores were collected from three sites (1000-1200 m water depth) in the north-eastern Gulf of Mexico from December 2010 to June 2011 to assess changes in benthic foraminiferal density related to the Deepwater Horizon (DWH) event (April-July 2010, 1500 m water depth). Short-lived radioisotope geochronologies (Pb-210, Th-234), organic geochemical assessments, and redox metal concentrations were determined to relate changes in sediment accumulation rate, contamination, and redox conditions with benthic foraminiferal density. Cores collected in December 2010 indicated a decline in density (80-93%). This decline was characterized by a decrease in benthic foraminiferal density and benthic foraminiferal accumulation rate (BFAR) in the surface 10 mm relative to the down-core mean in all benthic foraminifera, including the dominant genera (Bulimina spp., Uvigerina spp., and Cibicidoides spp.). Cores collected in February 2011 documented a site-specific response. There was evidence of a recovery in the benthic foraminiferal density and BFAR at the site closest to the wellhead (45 NM, NE). However, the site farther afield (60 NM, NE) recorded a continued decline in benthic foraminiferal density and BFAR down to near-zero values. This decline in benthic foraminiferal density occurred simultaneously with abrupt increases in sedimentary accumulation rates, polycyclic aromatic hydrocarbon (PAH) concentrations, and changes in redox conditions. Persistent reducing conditions (as many as 10 months after the event) in the surface of these core records were a possible cause of the decline. Another possible cause was the increase (2-3 times background) in PAH's, which are known to cause benthic foraminifera mortality and inhibit reproduction. Records of benthic foraminiferal density coupled with short-lived radionuclide geochronology and organic geochemistry were effective in quantifying the benthic response and will continue to be a valuable tool in determining the long-term effects of the DWH event on a larger spatial scale.	[Schwing, Patrick T.; Romero, Isabel C.; Larson, Rebekka A.; Hollander, David J.] Univ S Florida, Coll Marine Sci, St Petersburg, FL 33701 USA; [Brooks, Gregg R.; Hastings, David W.; Larson, Rebekka A.] Eckerd Coll, St Petersburg, FL 33733 USA	State University System of Florida; University of South Florida	Schwing, PT (corresponding author), Univ S Florida, Coll Marine Sci, St Petersburg, FL 33701 USA.	pschwing@mail.usf.edu	Schwing, Patrick/AAK-8593-2020	Schwing, Patrick/0000-0001-8466-4952; Romero, Isabel C./0000-0002-8590-5989	British Petroleum/Florida Institute of Oceanography (BP/FIO)-Gulf Oil Spill Prevention, Response, and Recovery Grants Program; Gulf of Mexico Research Initiative (GOMRI); Center for Integrated Modeling and Analysis of the Gulf Ecosystem (C-IMAGE); Deep Sea to Coast Connectivity in the Eastern Gulf of Mexico (Deep-C) consortia	British Petroleum/Florida Institute of Oceanography (BP/FIO)-Gulf Oil Spill Prevention, Response, and Recovery Grants Program; Gulf of Mexico Research Initiative (GOMRI); Center for Integrated Modeling and Analysis of the Gulf Ecosystem (C-IMAGE); Deep Sea to Coast Connectivity in the Eastern Gulf of Mexico (Deep-C) consortia	This research received funding from these sources: The British Petroleum/Florida Institute of Oceanography (BP/FIO)-Gulf Oil Spill Prevention, Response, and Recovery Grants Program provided funding for several of the initial research cruises and laboratory analyses during 2010 and 2011. http://www.fio.usf.edu (PS, IR, GB, DWH, RL, DJH). The Gulf of Mexico Research Initiative (GOMRI), specifically the Center for Integrated Modeling and Analysis of the Gulf Ecosystem (C-IMAGE) and the Deep Sea to Coast Connectivity in the Eastern Gulf of Mexico (Deep-C) consortia, provided funding in support of field, laboratory, and personnel efforts. http://gulfresearchinitiative.org (PS, IR, GB, DWH, RL, DJH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altenbach AV, 1999, J FORAMIN RES, V29, P173; ALVE E, 1995, J FORAMIN RES, V25, P190, DOI 10.2113/gsjfr.25.3.190; [Anonymous], 1951, GEOLOGICAL SOC AM ME; APPLEBY PG, 1983, HYDROBIOLOGIA, V103, P29, DOI 10.1007/BF00028424; Bejarano AC, 2010, ENVIRON POLLUT, V158, P1561, DOI 10.1016/j.envpol.2009.12.019; Bernhard JM, 1996, MAR MICROPALEONTOL, V28, P5, DOI 10.1016/0377-8398(95)00036-4; Bernhard JM, 2008, DEEP-SEA RES PT II, V55, P2617, DOI 10.1016/j.dsr2.2008.07.011; BERNSTEIN BB, 1978, LIMNOL OCEANOGR, V23, P401, DOI 10.4319/lo.1978.23.3.0401; Binford, 1990, J PALEOLIMNOL, V3, P253, DOI DOI 10.1007/BF00219461; Brooks GR, 2014, P ASS SCI LIMN OC HO; Buzas MA, 2007, MAR MICROPALEONTOL, V65, P43, DOI 10.1016/j.marmicro.2007.05.006; Camilli R, 2010, SCIENCE, V330, P201, DOI 10.1126/science.1195223; CORLISS B, 1993, GEOLOGY, V21, P991, DOI 10.1130/0091-7613(1993)021<0991:RGODSB>2.3.CO;2; CULVER SJ, 1983, J FORAMIN RES, V13, P21, DOI 10.2113/gsjfr.13.1.21; Cutshall NH, 1983, DIRECT ANAL 210PB SE; DENNE RA, 1991, MAR MICROPALEONTOL, V17, P173, DOI 10.1016/0377-8398(91)90013-V; Denoyelle M, 2010, MAR POLLUT BULL, V60, P2007, DOI 10.1016/j.marpolbul.2010.07.024; Di Leonardo R, 2007, SCI TOTAL ENVIRON, V388, P168, DOI 10.1016/j.scitotenv.2007.08.009; Eichler PPB, 2012, MAR POLLUT BULL, V64, P22, DOI 10.1016/j.marpolbul.2011.10.032; EPA, 2007, 8015C EPA, P1; Ernst SR, 2006, MAR MICROPALEONTOL, V61, P76, DOI 10.1016/j.marmicro.2006.05.005; Geslin E, 2004, MAR MICROPALEONTOL, V53, P227, DOI 10.1016/j.marmicro.2004.05.010; Geslin E, 2011, J EXP MAR BIOL ECOL, V396, P108, DOI 10.1016/j.jembe.2010.10.011; Gooday AJ, 2003, ADV MAR BIOL, V46, P1, DOI 10.1016/S0065-2881(03)46002-1; Gross O, 2000, J FORAMIN RES, V32, P414; Handwerger DA, 2003, PALEOCEANOGRAPHY, V18, DOI 10.1029/2002PA000850; Hastings DW, 2016, DEEP-SEA RES PT II, V129, P167, DOI 10.1016/j.dsr2.2014.12.009; HERGUERA JC, 1991, GEOLOGY, V19, P1173, DOI 10.1130/0091-7613(1991)019<1173:PFBFAG>2.3.CO;2; Joye SB, 2011, NAT GEOSCI, V4, P160, DOI [10.1038/ngeo1067, 10.1038/NGEO1067]; Kessler JD, 2011, SCIENCE, V331, P312, DOI 10.1126/science.1199697; Khare N, 2000, ONGC B, V37, P53; KITTO ME, 1991, APPL RADIAT ISOTOPES, V42, P835, DOI 10.1016/0883-2889(91)90221-L; Koho KA, 2011, FEMS MICROBIOL ECOL, V75, P273, DOI 10.1111/j.1574-6941.2010.01010.x; Langlet D, 2013, BIOGEOSCIENCES DISCU, V10, P9243; Martinez-Colon M, 2009, J FORAMIN RES, V39, P278, DOI 10.2113/gsjfr.39.4.278; Mojtahid M, 2006, MAR MICROPALEONTOL, V61, P58, DOI 10.1016/j.marmicro.2006.05.004; Moodley L, 1998, MAR MICROPALEONTOL, V34, P91, DOI 10.1016/S0377-8398(97)00044-3; Osterman LE, 2003, ESTUAR COAST SHELF S, V58, P17, DOI 10.1016/S0272-7714(02)00352-9; Paris CB, 2012, ENVIRON SCI TECHNOL, V46, P13293, DOI 10.1021/es303197h; Parker F. L., 1954, B MUS COMP ZOOL HARV, V111, P453; Passow U, 2012, ENVIRON RES LETT, V7, DOI 10.1088/1748-9326/7/3/035301; Pina-Ochoa E, 2010, P NATL ACAD SCI USA, V107, P1148, DOI 10.1073/pnas.0908440107; POAG CW, 1984, PALAEOGEOGR PALAEOCL, V48, P25, DOI 10.1016/0031-0182(84)90090-7; Risgaard-Petersen N, 2006, NATURE, V443; Romero IC, 2014, P ASS SCI LIMN OC HO, P16336; Rowe G. T., 2009, 2009039 OCS MMS US D; Rowe GT, 2008, DEEP-SEA RES PT II, V55, P2699, DOI 10.1016/j.dsr2.2008.07.020; Ryerson TB, 2012, P NATL ACAD SCI USA, V109, P20246, DOI 10.1073/pnas.1110564109; SCOTT DB, 1980, J PALEONTOL, V54, P814; Sen Gupta B. K., 2009, 2009013 OCS MMS US D, P385; SENGUPTA BK, 1994, GEO-MAR LETT, V14, P88, DOI 10.1007/BF01203719; Thibodeaux LJ, 2011, ENVIRON ENG SCI, V28, P87, DOI 10.1089/ees.2010.0276; Valsangkar AB, 2007, CURRENT SCI, V92, P5; VERSCHUREN D, 1993, LIMNOL OCEANOGR, V38, P1796, DOI 10.4319/lo.1993.38.8.1796; Yanko V, 1999, MODERN FORAMINIFERA, P217; Ziervogel K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034816	56	29	30	1	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2015	10	3							e0120565	10.1371/journal.pone.0120565	http://dx.doi.org/10.1371/journal.pone.0120565			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9BN	25785988	Green Submitted, gold, Green Published			2022-12-27	WOS:000352138500182
J	Wynn, JK; Roach, BJ; Lee, J; Horan, WP; Ford, JM; Jimenez, AM; Green, MF				Wynn, Jonathan K.; Roach, Brian J.; Lee, Junghee; Horan, William P.; Ford, Judith M.; Jimenez, Amy M.; Green, Michael F.			EEG Findings of Reduced Neural Synchronization during Visual Integration in Schizophrenia	PLOS ONE			English	Article							GESTALT PERCEPTION; ILLUSORY CONTOURS; BIPOLAR DISORDER; INTERNEURONS; MODULATION; RESPONSES; COGNITION; DYNAMICS; DEFICITS	Schizophrenia patients exhibit well-documented visual processing deficits. One area of disruption is visual integration, the ability to form global objects from local elements. However, most studies of visual integration in schizophrenia have been conducted in the context of an active attention task, which may influence the findings. In this study we examined visual integration using electroencephalography (EEG) in a passive task to elucidate neural mechanisms associated with poor visual integration. Forty-six schizophrenia patients and 30 healthy controls had EEG recorded while passively viewing figures comprised of real, illusory, or no contours. We examined visual P100, N100, and P200 event-related potential (ERP) components, as well as neural synchronization in the gamma (30-60 Hz) band assessed by the EEG phase locking factor (PLF). The N100 was significantly larger to illusory vs. no contour, and illusory vs. real contour stimuli while the P200 was larger only to real vs. illusory stimuli; there were no significant interactions with group. Compared to controls, patients failed to show increased phase locking to illusory versus no contours between 40-60 Hz. Also, controls, but not patients, had larger PLF between 30-40 Hz when viewing real vs. illusory contours. Finally, the positive symptom factor of the BPRS was negatively correlated with PLF values between 40-60 Hz to illusory stimuli, and with PLF between 30-40 Hz to real contour stimuli. These results suggest that the pattern of results across visual processing conditions is similar in patients and controls. However, patients have deficits in neural synchronization in the gamma range during basic processing of illusory contours when attentional demand is limited.	[Wynn, Jonathan K.; Lee, Junghee; Horan, William P.; Jimenez, Amy M.; Green, Michael F.] Vet Affairs Greater Los Angeles Healthcare Syst, Los Angeles, CA 90073 USA; [Wynn, Jonathan K.; Lee, Junghee; Horan, William P.; Green, Michael F.] Univ Calif Los Angeles, Psychiat & Biobehav Sci, Los Angeles, CA USA; [Roach, Brian J.; Ford, Judith M.] Vet Affairs San Francisco Med Ctr, San Francisco, CA USA; [Ford, Judith M.] Univ Calif San Francisco, San Francisco, CA 94143 USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Greater Los Angeles Healthcare System; University of California System; University of California Los Angeles; University of California System; University of California San Francisco	Wynn, JK (corresponding author), Vet Affairs Greater Los Angeles Healthcare Syst, Los Angeles, CA 90073 USA.	jkwynn@ucla.edu	Lee, Junghee/AAX-6124-2021; Jimenez, Amy M./AAX-6262-2021; Wynn, Jonathan/H-3749-2014	Lee, Junghee/0000-0001-9567-8700; Wynn, Jonathan/0000-0002-1763-8540; Jimenez, Amy/0000-0001-6077-1307; Roach, Brian/0000-0002-3264-1465	VA Career Development Award; NIMH [MH43292, MH065707]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH043292, R29MH043292, R01MH065707] Funding Source: NIH RePORTER	VA Career Development Award; NIMH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	Support for this study came from a VA Career Development Award to Jonathan K. Wynn, Ph.D., and NIMH Grants MH43292 and MH065707 (PI: Michael F. Green, Ph.D). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andreasen N., 1984, SCALE ASSESSMENT POS; Angelucci A, 2002, J NEUROSCI, V22, P8633; Butler PD, 2008, BIOL PSYCHIAT, V64, P40, DOI 10.1016/j.biopsych.2008.03.023; Di Russo F, 1999, VISION RES, V39, P2975, DOI 10.1016/S0042-6989(99)00031-0; Doniger GM, 2001, AM J PSYCHIAT, V158, P1818, DOI 10.1176/appi.ajp.158.11.1818; First M.B., 2014, STRUCTURED CLIN INTE; First M. D., 1996, USERS GUIDE STRUCTUR; Foxe JJ, 2005, CEREB CORTEX, V15, P1914, DOI 10.1093/cercor/bhi069; Fries P, 2001, SCIENCE, V291, P1560, DOI 10.1126/science.1055465; GRATTON G, 1983, ELECTROEN CLIN NEURO, V55, P468, DOI 10.1016/0013-4694(83)90135-9; Grunze HCR, 1996, J NEUROSCI, V16, P2034; Herrmann CS, 1999, CLIN NEUROPHYSIOL, V110, P636, DOI 10.1016/S1388-2457(99)00002-4; Herrmann CS, 2001, VIS COGN, V8, P593, DOI 10.1080/13506280143000142; Herrmann CS, 2001, NEUROREPORT, V12, P901, DOI 10.1097/00001756-200104170-00007; Hong LE, 2004, SCHIZOPHR RES, V70, P293, DOI 10.1016/j.schres.2003.12.011; Ikeda C, 2011, NEUROPSYCHOBIOLOGY, V64, P231, DOI 10.1159/000327706; Jahshan C, 2012, BIOL PSYCHIAT, V71, p81S; Javitt DC, 2009, ANNU REV CLIN PSYCHO, V5, P249, DOI 10.1146/annurev.clinpsy.032408.153502; JAVITT DC, 1991, AM J PSYCHIAT, V148, P1301; KANIZSA G, 1976, SCI AM, V234, P48, DOI 10.1038/scientificamerican0476-48; Keane BP, 2014, NEUROPSYCHOLOGIA, V65, P221, DOI 10.1016/j.neuropsychologia.2014.10.031; Keane BP, 2014, NEUROPSYCHOLOGIA, V56, P302, DOI 10.1016/j.neuropsychologia.2014.02.001; Kopelowicz A, 2008, PSYCHOPATHOLOGY, V41, P77, DOI 10.1159/000111551; Kruggel F, 2001, NEUROIMAGE, V14, P1327, DOI 10.1006/nimg.2001.0948; Lee TS, 2001, P NATL ACAD SCI USA, V98, P1907, DOI 10.1073/pnas.031579998; Makin ADJ, 2011, NEUROPSYCHOLOGIA, V49, P2798, DOI 10.1016/j.neuropsychologia.2011.06.001; McBain CJ, 2001, NAT REV NEUROSCI, V2, P11, DOI 10.1038/35049047; Murray MM, 2006, J NEUROSCI, V26, P12043, DOI 10.1523/JNEUROSCI.3225-06.2006; Murray MM, 2002, J NEUROSCI, V22, P5055, DOI 10.1523/JNEUROSCI.22-12-05055.2002; Olney JW, 1999, J PSYCHIAT RES, V33, P523, DOI 10.1016/S0022-3956(99)00029-1; Oostenveld R, 2011, COMPUT INTEL NEUROSC, V2011, DOI 10.1155/2011/156869; Pernet C, 2003, COGNITIVE BRAIN RES, V17, P327, DOI 10.1016/S0926-6410(03)00134-4; SHIPLEY TF, 1992, PERCEPT PSYCHOPHYS, V52, P97, DOI 10.3758/BF03206762; Silverstein SM, 2012, SCHIZOPHRENIA BULL, V38, P125, DOI 10.1093/schbul/sbr141; Spencer KM, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.00068; Spencer KM, 2004, P NATL ACAD SCI USA, V101, P17288, DOI 10.1073/pnas.0406074101; Spencer KM, 2003, J NEUROSCI, V23, P7407; Stanley DA, 2003, NEURON, V37, P323, DOI 10.1016/S0896-6273(02)01148-0; Tallon-Baudry C, 1999, TRENDS COGN SCI, V3, P151, DOI 10.1016/S1364-6613(99)01299-1; Uhlhaas PJ, 2006, J NEUROSCI, V26, P8168, DOI 10.1523/JNEUROSCI.2002-06.2006; Ventura J, 1995, SYMPTOM DIMENSIONS R; Whittington MA, 2003, TRENDS NEUROSCI, V26, P676, DOI 10.1016/j.tins.2003.09.016; Wokke ME, 2013, PSYCHOL SCI, V24, P63, DOI 10.1177/0956797612449175; Wynn JK, 2013, PSYCHOL MED, V43, P109, DOI 10.1017/S0033291712001006; Yuval-Greenberg S, 2008, NEURON, V58, P429, DOI 10.1016/j.neuron.2008.03.027	45	28	29	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2015	10	3							e0119849	10.1371/journal.pone.0119849	http://dx.doi.org/10.1371/journal.pone.0119849			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9BN	25785939	gold, Green Published			2022-12-27	WOS:000352138500134
J	Yurko-Mauro, K; Alexander, DD; Van Elswyk, ME				Yurko-Mauro, Karin; Alexander, Dominik D.; Van Elswyk, Mary E.			Docosahexaenoic Acid and Adult Memory: A Systematic Review and Meta-Analysis	PLOS ONE			English	Article							N-3 FATTY-ACIDS; MILD COGNITIVE IMPAIRMENT; HEALTHY-YOUNG ADULTS; OLDER-ADULTS; FISH-OIL; SUPPLEMENTATION; AGE; PERFORMANCE; DHA; IMPROVES	Introduction Subjective memory complaints are common with aging. Docosahexaenoic acid (DHA; 22:6 n-3) is a long-chain polyunsaturated fatty acid (LCPUFA) and an integral part of neural membrane phospholipids that impacts brain structure and function. Past research demonstrates a positive association between DHA plasma status/dietary intake and cognitive function. Objectives The current meta-analysis was designed to determine the effect of DHA intake, alone or combined with eicosapentaenoic acid (EPA; 20:5 n-3), on specific memory domains:episodic, working, and semantic in healthy adults aged 18 years and older. A secondary objective was to systematically review/summarize the related observational epidemiologic literature. Methods A systematic literature search of clinical trials and observational studies that examined the relationship between n-3 LCPUFA on memory outcomes in healthy adults was conducted in Ovid MEDLINE and EMBASE databases. Studies of subjects free of neurologic disease at baseline, with or without mild memory complaints (MMC), were included. Random effects meta-analyses were conducted to generate weighted group mean differences, standardized weighted group mean differences (Hedge's g), z-scores, and p-values for heterogeneity comparing DHA/EPA to a placebo. A priorisub-group analyses were conducted to evaluate the effect of age at enrollment, dose level, and memory type tested. Results Episodic memory outcomes of adults with MMC were significantly (P<.004) improved with DHA/EPA supplementation. Regardless of cognitive status at baseline, > 1 g/day DHA/EPA improved episodic memory (P<.04). Semantic and working memory changes from baseline were significant with DHA but no between group differences were detected.Observational studies support a beneficial association between intake/blood levels of DHA/ EPA and memory function in older adults. Conclusion DHA, alone or combined with EPA, contributes to improved memory function in older adults with mild memory complaints.	[Yurko-Mauro, Karin] DSM Nutr Prod, Clin Res, Nutr Lipids, Columbia, MD 21045 USA; [Alexander, Dominik D.] EpidStat Inst, Epidemiol, Evergreen, CO USA; [Van Elswyk, Mary E.] Van Elswyk Consulting Inc, Sci Affairs, Longmont, CO USA	DSM NV	Yurko-Mauro, K (corresponding author), DSM Nutr Prod, Clin Res, Nutr Lipids, Columbia, MD 21045 USA.	karin.yurko-mauro@dsm.com			DSM Nutritional Products	DSM Nutritional Products	DSM Nutritional Products provided funding for the preparation of this manuscript. The funders had no role in data collection or analysis but contributed to study design and manuscript preparation as KYM is an employee of DSM Nutritional Products.	Abubakari AR, 2014, INT J GEN MED, V7, P463, DOI 10.2147/IJGM.S67065; Barcelo-Coblijn G, 2003, P NATL ACAD SCI USA, V100, P11321, DOI 10.1073/pnas.1734008100; Benton D, 2013, BRIT J NUTR, V109, P155, DOI 10.1017/S0007114512000566; Beydoun MA, 2007, AM J CLIN NUTR, V85, P1103; Braun SMG, 2014, DEVELOPMENT, V141, P1983, DOI 10.1242/dev.104596; Carver JD, 2001, BRAIN RES BULL, V56, P79, DOI 10.1016/S0361-9230(01)00551-2; Dacks PA, 2013, J NUTR HEALTH AGING, V17, P240, DOI 10.1007/s12603-012-0431-3; Daiello LA, 2014, ALZHEIMERS DEMENT; Dangour AD, 2010, AM J CLIN NUTR, V91, P1725, DOI 10.3945/ajcn.2009.29121; de Groot RHM, 2007, PROSTAG LEUKOTR ESS, V76, P165, DOI 10.1016/j.plefa.2007.01.001; De Jager CA, 2002, PSYCHOL MED, V32, P483, DOI 10.1017/S003329170200524X; de Jager CA, 2014, NUTR REV, V72, P162, DOI 10.1111/nure.12094; Diau GY, 2005, BMC MED, V3, DOI 10.1186/1741-7015-3-11; Dubois B, 2007, LANCET NEUROL, V6, P734, DOI 10.1016/S1474-4422(07)70178-3; Dullemeijer C, 2007, AM J CLIN NUTR, V86, P1479, DOI 10.1093/ajcn/86.5.1479; EFSA NDA Panel (EFSA Panel on Dietetic Products Nutrition and Allergies), 2014, EFSA J, V12, P37602; Gamoh S, 2001, CLIN EXP PHARMACOL P, V28, P266, DOI 10.1046/j.1440-1681.2001.03437.x; Harada CN, 2013, CLIN GERIATR MED, V29, P737, DOI 10.1016/j.cger.2013.07.002; Hedges LV, 2014, STAT METHODS META AN; Higgins JPT., 2008, COCHRANE HDB SYSTEMA, V1 edn; Jackson PA, 2012, BRIT J NUTR, V107, P1232, DOI 10.1017/S000711451100403X; Jiao JJ, 2014, AM J CLIN NUTR, V100, P1422, DOI 10.3945/ajcn.114.095315; Joffre C, 2014, PROSTAG LEUKOTR ESS, V91, P1, DOI 10.1016/j.plefa.2014.05.001; Johnson EJ, 2008, NUTR NEUROSCI, V11, P75, DOI 10.1179/147683008X301450; Kalmijn S, 2004, NEUROLOGY, V62, P275, DOI 10.1212/01.WNL.0000103860.75218.A5; Karr JE, 2012, EXP CLIN PSYCHOPHARM, V20, P236, DOI 10.1037/a0026945; Katakura M, 2013, STEM CELLS INT, V2013, DOI 10.1155/2013/490476; Kesse-Guyot E, 2011, J NUTR HEALTH AGING, V15, P115, DOI 10.1007/s12603-011-0023-7; Kotani S, 2006, NEUROSCI RES, V56, P159, DOI 10.1016/j.neures.2006.06.010; Lee LK, 2013, PSYCHOPHARMACOLOGY, V225, P605, DOI 10.1007/s00213-012-2848-0; Lin PY, 2012, J CLIN PSYCHIAT, V73, P1245, DOI 10.4088/JCP.11r07546; Martinez M, 1998, J NEUROCHEM, V71, P2528; Mazereeuw G, 2012, NEUROBIOL AGING, V33, DOI 10.1016/j.neurobiolaging.2011.12.014; Milte CM, 2011, PROSTAG LEUKOTR ESS, V84, P153, DOI 10.1016/j.plefa.2011.02.002; Muldoon MF, 2010, J NUTR, V140, P848, DOI 10.3945/jn.109.119578; Noel K, 2006, RES PRACT ALZHEIMERS, V11, P381; Pan JP, 2011, BRAIN RES, V1412, P18, DOI 10.1016/j.brainres.2011.07.015; Petursdottir AL, 2008, J GERONTOL A-BIOL, V63, P1153, DOI 10.1093/gerona/63.11.1153; Phillips MA, 2012, NUTR NEUROSCI, V15, P271, DOI 10.1179/1476830512Y.0000000026; Richter Y, 2010, CLIN INTERV AGING, V5, P313, DOI 10.2147/CIA.S13432; Samieri C, 2011, NEUROBIOL AGING, V32, DOI 10.1016/j.neurobiolaging.2010.03.020; Sinn N, 2012, BRIT J NUTR, V107, P1682, DOI 10.1017/S0007114511004788; Small SA, 1999, NEUROLOGY, V52, P1392, DOI 10.1212/WNL.52.7.1392; Solfrizzi V, 2009, THESCIENTIFICWORLDJO, V9, P792, DOI 10.1100/tsw.2009.82; Stonehouse W, 2014, NUTRIENTS, V6, P2730, DOI 10.3390/nu6072730; Stonehouse W, 2013, AM J CLIN NUTR, V97, P1134, DOI 10.3945/ajcn.112.053371; Stough C, 2012, NEUROBIOL AGING, V33, DOI 10.1016/j.neurobiolaging.2011.03.019; SVENNERHOLM L, 1968, J LIPID RES, V9, P570; Sydenham E, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005379.pub3; Tan ZS, 2012, NEUROLOGY, V78, P658, DOI 10.1212/WNL.0b013e318249f6a9; Titova OE, 2013, AGE, V35, P1495, DOI 10.1007/s11357-012-9453-3; Vakhapova V, 2010, DEMENT GERIATR COGN, V29, P467, DOI 10.1159/000310330; van de Rest O., 2008, NEUROLOGY, V71, P430, DOI DOI 10.1212/01.WNL.0000324268.45138.86; Whalley LJ, 2008, AM J CLIN NUTR, V87, P449, DOI 10.1093/ajcn/87.2.449; Whalley LJ, 2004, AM J CLIN NUTR, V80, P1650, DOI 10.1093/ajcn/80.6.1650; Witte AV, 2014, CEREB CORTEX, V24, P3059, DOI 10.1093/cercor/bht163; Yurko-Mauro K, 2010, ALZHEIMERS DEMENT, V6, P456, DOI 10.1016/j.jalz.2010.01.013	57	123	125	5	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2015	10	3							e0120391	10.1371/journal.pone.0120391	http://dx.doi.org/10.1371/journal.pone.0120391			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9BN	25786262	Green Submitted, gold, Green Published			2022-12-27	WOS:000352138500169
J	Cazares-Dominguez, V; Cruz-Cordova, A; Ochoa, SA; Escalona, G; Arellano-Galindo, J; Rodriguez-Leviz, A; Hernandez-Castro, R; Lopez-Villegas, EO; Xicohtencatl-Cortes, J				Cazares-Dominguez, Vicenta; Cruz-Cordova, Ariadnna; Ochoa, Sara A.; Escalona, Gerardo; Arellano-Galindo, Jose; Rodriguez-Leviz, Alejandra; Hernandez-Castro, Rigoberto; Lopez-Villegas, Edgar O.; Xicohtencatl-Cortes, Juan			Vancomycin Tolerant, Methicillin-Resistant Staphylococcus aureus Reveals the Effects of Vancomycin on Cell Wall Thickening	PLOS ONE			English	Article							CHROMOSOME MEC TYPE; REGULATOR AGR GROUP; REDUCED SUSCEPTIBILITY; INHIBITORY CONCENTRATION; BACTERICIDAL ACTIVITIES; CLINICAL-FEATURES; GROUP-II; GENE; INTERMEDIATE; STRAINS	Methicillin-resistant Staphylococcus aureus (MRSA) is an important opportunistic pathogen that causes both healthcare-and community-acquired infections. An increase in the incidence of these infections may lead to a substantial change in the rate of vancomycin usage. Incidence of reduced susceptibility to vancomycin has been increasing worldwide for the last few years, conferring different levels of resistance to vancomycin as well as producing changes in the cell wall structure. The aim of the present study was to determine the effect of vancomycin on cell wall thickening in clinical isolates of vancomycin-tolerant (VT) MRSA obtained from pediatric patients. From a collection of 100 MRSA clinical isolates from pediatric patients, 12% (12/100) were characterized as VT-MRSA, and from them, 41.66% (5/ 12) exhibited the heterogeneous vancomycin-intermediate S. aureus (hVISA) phenotype. Multiplex-PCR assays revealed 66.66% (8/12), 25% (3/12), and 8.33% (1/12) of the VT-MRSA isolates were associated with agr group II, I, and III polymorphisms, respectively; the II-mec gene was amplified from 83.3%(10/12) of the isolates, and the mecIVa gene was amplified from 16.66% (2/12) of the isolates. Pulsed field electrophoresis (PFGE) fingerprint analysis showed 62% similarity among the VT-MRSA isolates. Thin transverse sections analyzed by transmission electron microscopy (TEM) revealed an average increase of 24 nm (105.55%) in the cell wall thickness of VT-MRSA compared with untreated VT-MRSA isolates. In summary, these data revealed that the thickened cell walls of VT-MRSA clinical isolates with agr type II and SCCmec group II polymorphisms are associated with an adaptive resistance to vancomycin.	[Cazares-Dominguez, Vicenta; Cruz-Cordova, Ariadnna; Ochoa, Sara A.; Escalona, Gerardo; Xicohtencatl-Cortes, Juan] Hosp Infantil Mexico Dr Federico Gomez, Lab Invest Bacteriol Intestinal, Mexico City, DF, Mexico; [Arellano-Galindo, Jose] Hosp Infantil Mexico Dr Federico Gomez, Dept Infectol, Mexico City, DF, Mexico; [Rodriguez-Leviz, Alejandra] Hosp Infantil Mexico Dr Federico Gomez, Lab Patol, Mexico City, DF, Mexico; [Hernandez-Castro, Rigoberto] Hosp Gen Dr Manuel Gea Gonzalez, Dept Ecol Agentes Patogenos, Mexico City, DF, Mexico; [Lopez-Villegas, Edgar O.] Inst Politecn Nacl, Escuela Nacl Ciencias Biol, Lab Cent Microscopia, Mexico City, DF, Mexico	Hospital Infantil de Mexico Federico Gomez; Hospital Infantil de Mexico Federico Gomez; Hospital Infantil de Mexico Federico Gomez; Instituto Politecnico Nacional - Mexico	Xicohtencatl-Cortes, J (corresponding author), Hosp Infantil Mexico Dr Federico Gomez, Lab Invest Bacteriol Intestinal, Dr Marquez 162, Mexico City, DF, Mexico.	juanxico@yahoo.com	Córdova, Ariadnna Cruz/AAF-9654-2021; Xicohtencatl-Cortes, Juan/ABD-5463-2020	Lopez Villegas, Edgar Oliver/0000-0002-9995-2145	Children Hospital of Mexico "Federico Gomez" [HIM/2010/016]; CONACYT [133451]; Fondo Sectorial de Investigacion en Salud y Seguridad Social, FOSSIS-CONACYT [2012-01-182651]	Children Hospital of Mexico "Federico Gomez"; CONACYT(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); Fondo Sectorial de Investigacion en Salud y Seguridad Social, FOSSIS-CONACYT	This work was partially supported through a federal grant (HIM/2010/016) from the Children Hospital of Mexico "Federico Gomez" and through additional grants from CONACYT (133451) and the Fondo Sectorial de Investigacion en Salud y Seguridad Social, FOSSIS-CONACYT 2012-01-182651. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahoyo TA, 2014, ANTIMICROB RESIST IN, V3, DOI 10.1186/2047-2994-3-17; Aiken AM, 2014, ANTIMICROB RESIST IN, V3, DOI 10.1186/2047-2994-3-22; Appelbaum PC, 2006, CLIN MICROBIOL INFEC, V12, P16, DOI 10.1111/j.1469-0691.2006.01344.x; Bae IG, 2009, J INFECT DIS, V200, P1355, DOI 10.1086/606027; Bardiau M, 2013, LETT APPL MICROBIOL, V57, P181, DOI 10.1111/lam.12099; Bibalan MH, 2014, J CLIN DIAGN RES, V8, pDC07, DOI [10.7860/JCDR/2014/9713.5088, DOI 10.7860/JCDR/2014/9713.5088]; Biedenbacha DJ, 2007, INT J ANTIMICROB AG, V30, P143, DOI 10.1016/j.ijantimicag.2007.03.015; Charles PGP, 2004, CLIN INFECT DIS, V38, P448, DOI 10.1086/381093; Clinical and Laboratory Standards Institute, 2013, PERF STAND ANT SUSC; Cui L, 2003, J CLIN MICROBIOL, V41, P5, DOI 10.1128/JCM.41.1.5-14.2003; David MZ, 2010, CLIN MICROBIOL REV, V23, P616, DOI 10.1128/CMR.00081-09; Deresinski S, 2009, J INFECT DIS, V199, P605, DOI 10.1086/596630; Fong RKC, 2009, EUR J CLIN MICROBIOL, V28, P983, DOI 10.1007/s10096-009-0741-5; Fowler VG, 2004, J INFECT DIS, V190, P1140, DOI 10.1086/423145; Fukutsuji K, 2013, MED MOL MORPHOL, V46, P70, DOI 10.1007/s00795-013-0009-0; Gilot P, 2002, J CLIN MICROBIOL, V40, P4060, DOI 10.1128/JCM.40.11.4060-4067.2002; Hanaki H, 1998, J ANTIMICROB CHEMOTH, V42, P315, DOI 10.1093/jac/42.3.315; Hill-Cawthorne GA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101419; Holmes RL, 2008, ANTIMICROB AGENTS CH, V52, P757, DOI 10.1128/AAC.00945-07; Howden BP, 2010, CLIN MICROBIOL REV, V23, P99, DOI 10.1128/CMR.00042-09; Hyo Y, 2013, MED MOL MORPHOL, V46, P217, DOI 10.1007/s00795-013-0027-y; Jarraud S, 2002, INFECT IMMUN, V70, P631, DOI 10.1128/IAI.70.2.631-641.2002; Jones RN, 2008, CLIN MICROBIOL INFEC, V14, P3, DOI 10.1111/j.1469-0691.2008.01923.x; May J, 1998, J ANTIMICROB CHEMOTH, V42, P189, DOI 10.1093/jac/42.2.189; McDougal LK, 2003, J CLIN MICROBIOL, V41, P5113, DOI 10.1128/JCM.41.11.5113-5120.2003; Borbon-Esquer EM, 2014, SCAND J INFECT DIS, V46, P523, DOI 10.3109/00365548.2014.912349; Moise-Broder PA, 2004, CLIN INFECT DIS, V38, P1700, DOI 10.1086/421092; Norazah Ahmad, 2012, Med J Malaysia, V67, P269; Pitz AM, 2011, J CLIN MICROBIOL, V49, P269, DOI 10.1128/JCM.00914-10; Reipert A, 2003, ANTIMICROB AGENTS CH, V47, P568, DOI 10.1128/AAC.47.2.568-576.2003; Rose WE, 2007, J ANTIMICROB CHEMOTH, V59, P1190, DOI 10.1093/jac/dkm091; Rose WE, 2012, ANTIMICROB AGENTS CH, V56, P4422, DOI 10.1128/AAC.00676-12; Sader HS, 2009, J ANTIMICROB CHEMOTH, V64, P1024, DOI 10.1093/jac/dkp319; Safdar A, 2006, CANCER-AM CANCER SOC, V106, P1815, DOI 10.1002/cncr.21801; Sakoulas G, 2003, J INFECT DIS, V187, P929, DOI 10.1086/368128; Sakoulas G, 2006, J ANTIMICROB CHEMOTH, V57, P699, DOI 10.1093/jac/dkl030; Sakoulas G, 2004, J CLIN MICROBIOL, V42, P2398, DOI 10.1128/JCM.42.6.2398-2402.2004; Sakoulas G, 2005, ANTIMICROB AGENTS CH, V49, P2687, DOI 10.1128/AAC.49.7.2687-2692.2005; Sakoulas G, 2002, ANTIMICROB AGENTS CH, V46, P1492, DOI 10.1128/AAC.46.5.1492-1502.2002; Soriano A, 2008, CLIN INFECT DIS, V46, P193, DOI 10.1086/524667; Stojanov M, 2014, EUR J CLIN MICROBIOL, V33, P1967, DOI 10.1007/s10096-014-2169-9; Sujatha S, 2012, INTERDIS CIP PERSPEC; Tenover FC, 2007, CLIN INFECT DIS, V44, P1208, DOI 10.1086/513203; Tiwari HK, 2006, BMC INFECT DIS, V6, DOI 10.1186/1471-2334-6-156; Traczewski MM, 2009, ANTIMICROB AGENTS CH, V53, P1735, DOI 10.1128/AAC.01022-08; Tsuji BT, 2007, ANTIMICROB AGENTS CH, V51, P1089, DOI 10.1128/AAC.00671-06; Vindel A, 2009, J CLIN MICROBIOL, V47, P1620, DOI 10.1128/JCM.01579-08; Ward PB, 2001, MED J AUSTRALIA, V175, P480, DOI 10.5694/j.1326-5377.2001.tb143681.x; Wootton M, 2001, J ANTIMICROB CHEMOTH, V47, P399, DOI 10.1093/jac/47.4.399; Zhang KY, 2009, ANTIMICROB AGENTS CH, V53, P531, DOI 10.1128/AAC.01118-08; Zhang KY, 2005, J CLIN MICROBIOL, V43, P5026, DOI 10.1128/JCM.43.10.5026-5033.2005	51	20	20	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2015	10	3							e0118791	10.1371/journal.pone.0118791	http://dx.doi.org/10.1371/journal.pone.0118791			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8IA	25793280	gold, Green Published, Green Submitted			2022-12-27	WOS:000352084200041
J	Patki, G; Salvi, A; Liu, HS; Atrooz, F; Alkadhi, I; Kelly, M; Salim, S				Patki, Gaurav; Salvi, Ankita; Liu, Hesong; Atrooz, Fatin; Alkadhi, Isam; Kelly, Matthew; Salim, Samina			Tempol Treatment Reduces Anxiety-Like Behaviors Induced by Multiple Anxiogenic Drugs in Rats	PLOS ONE			English	Article							PERMEABLE RADICAL SCAVENGER; OXIDATIVE STRESS; MEMORY IMPAIRMENT; C-FOS; RGS2; CAFFEINE; INFLAMMATION; MODEL; BRAIN; DEPRESSION	We have published that pharmacological induction of oxidative stress (OS) causes anxiety-like behavior in rats. Using animal models, we also have established that psychological stress induces OS and leads to anxiety-like behaviors. All evidence points towards the causal role of OS in anxiety-like behaviors. To fully ascertain the role of OS in anxiety-like behaviors, it is reasonable to test whether the pro-anxiety effects of anxiogenic drugs caffeine or N-methyl-beta-carboline-3-carboxamide (FG-7142) can be mitigated using agents that minimize OS. In this study, osmotic pumps were either filled with antioxidant tempol or saline. The pumps were attached to the catheter leading to the brain cannula and inserted into the subcutaneous pocket in the back pocket of the rat. Continuous i.c.v. infusion of saline or tempol in the lateral ventricle of the brain (4.3mmol/day) was maintained for 1 week. Rats were intraperitoneally injected either with saline or an anxiogenic drug one at a time. Two hours later all groups were subjected to behavioral assessments. Anxiety-like behavior tests (open-field, light-dark and elevated plus maze) suggested that tempol prevented anxiogenic drug-induced anxiety-like behavior in rats. Furthermore, anxiogenic drug-induced increase in stress examined via plasma corticosterone and increased oxidative stress levels assessed via plasma 8-isoprostane were prevented with tempol treatment. Protein carbonylation assay also suggested preventive effect of tempol in the prefrontal cortex brain region of rats. Antioxidant protein expression and pro-inflammatory cytokine levels indicate compromised antioxidant defense as well as an imbalance of inflammatory response.	[Patki, Gaurav; Salvi, Ankita; Liu, Hesong; Atrooz, Fatin; Alkadhi, Isam; Kelly, Matthew; Salim, Samina] Univ Houston, Dept Pharmacol & Pharmaceut Sci, Coll Pharm, Houston, TX 77204 USA	University of Houston System; University of Houston	Salim, S (corresponding author), Univ Houston, Dept Pharmacol & Pharmaceut Sci, Coll Pharm, Houston, TX 77204 USA.	ssalim@uh.edu	Liu, Hesong/ABC-2805-2021	Liu, Hesong/0000-0003-3768-1463; Atrooz, Fatin/0000-0002-1358-7926	NIMH [1R15MH093918-01A1]; NATIONAL INSTITUTE OF MENTAL HEALTH [R15MH093918] Funding Source: NIH RePORTER	NIMH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This study was supported by a NIMH 1R15MH093918-01A1 grant awarded to SS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrams JK, 2005, NEUROSCIENCE, V133, P983, DOI 10.1016/j.neuroscience.2005.03.025; Allam F, 2013, J NUTR, V143, P835, DOI 10.3945/jn.113.174649; BALDWIN HA, 1989, PHARMACOL BIOCHEM BE, V32, P181, DOI 10.1016/0091-3057(89)90230-X; BALDWIN HA, 1989, EUR J PHARMACOL, V159, P211, DOI 10.1016/0014-2999(89)90709-7; Banday AA, 2005, DIABETES, V54, P2219, DOI 10.2337/diabetes.54.7.2219; Banday AA, 2011, AM J PHYSIOL-RENAL, V301, pF364, DOI 10.1152/ajprenal.00121.2011; Bert B, 2002, NEUROBIOL LEARN MEM, V78, P11, DOI 10.1006/nlme.2001.4040; Bhattacharya SK, 1997, J PSYCHOPHARMACOL, V11, P219, DOI 10.1177/026988119701100304; Chakraborty S, 2009, INDIAN J CLIN BIOCHE, V24, P194, DOI 10.1007/s12291-009-0035-9; Chatterjee PK, 2000, KIDNEY INT, V58, P658, DOI 10.1046/j.1523-1755.2000.00212.x; Cui H, 2008, NEUROPSYCHOPHARMACOL, V33, P1537, DOI 10.1038/sj.npp.1301557; Di Paola R, 2005, J CLIN PERIODONTOL, V32, P1062, DOI 10.1111/j.1600-051X.2005.00818.x; El Yacoubi M, 2000, PSYCHOPHARMACOLOGY, V148, P153; FILE SE, 1984, ARCH INT PHARMACOD T, V271, P198; Flint J, 2003, SEMIN CELL DEV BIOL, V14, P37, DOI 10.1016/S1084-9521(02)00170-2; Hale MW, 2010, PROG NEURO-PSYCHOPH, V34, P1285, DOI 10.1016/j.pnpbp.2010.07.012; Haleagrahara N, 2009, EUR J PHARMACOL, V621, P46, DOI 10.1016/j.ejphar.2009.08.030; Heo K, 2006, CELL SIGNAL, V18, P2182, DOI 10.1016/j.cellsig.2006.05.006; Hollinger S, 2002, PHARMACOL REV, V54, P527, DOI 10.1124/pr.54.3.527; Kawabata K, 2010, J NUTR BIOCHEM, V21, P374, DOI 10.1016/j.jnutbio.2009.01.008; Kovacs KJ, 1998, NEUROCHEM INT, V33, P287, DOI 10.1016/S0197-0186(98)00023-0; Kurumaji A, 2012, BEHAV BRAIN FUNCT, V8, DOI 10.1186/1744-9081-8-43; Leker RR, 2002, EXP NEUROL, V176, P355, DOI 10.1006/exnr.2002.7910; McEwen BS, 2012, NEUROPHARMACOLOGY, V62, P3, DOI 10.1016/j.neuropharm.2011.07.014; Ng F, 2008, INT J NEUROPSYCHOPH, V11, P851, DOI 10.1017/S1461145707008401; Nguyen CH, 2012, BIOCHEM BIOPH RES CO, V426, P129, DOI 10.1016/j.bbrc.2012.08.050; Nlend MC, 2002, AM J RESP CELL MOL, V27, P436, DOI 10.1165/rcmb.2002-0012OC; Okimoto N, 2012, BRAIN RES, V1453, P26, DOI 10.1016/j.brainres.2012.03.012; Oliveira-dos-Santos AJ, 2000, P NATL ACAD SCI USA, V97, P12272, DOI 10.1073/pnas.220414397; Otter MH, 1997, METHOD FIND EXP CLIN, V19, P683; Patki G, 2013, BRAIN RES, VS0006-8993; Patki G, 2013, BRAIN RES, V1539, P73, DOI 10.1016/j.brainres.2013.09.033; Patki G, 2014, PHYSIOL BEHAV, V130, P135, DOI 10.1016/j.physbeh.2014.04.011; Patki G, 2014, PHYSIOL BEHAV, V130, P47, DOI 10.1016/j.physbeh.2014.03.016; Patki G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074522; Paxinos GaW C, 1986, RAT BRAIN STEREOTAXI; Rahal A, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/761264; ROBERTSON D, 1978, NEW ENGL J MED, V298, P181, DOI 10.1056/NEJM197801262980403; Salim S, 2003, J BIOL CHEM, V278, P15842, DOI 10.1074/jbc.M210663200; Salim S., 2011, AM J INTEGR MED, V1, P11; Salim S, 2012, ADV PROTEIN CHEM STR, V88, P1, DOI 10.1016/B978-0-12-398314-5.00001-5; Salim S, 2011, BRAIN RES, V1404, P63, DOI 10.1016/j.brainres.2011.06.024; Salim S, 2011, FEBS LETT, V585, P1375, DOI 10.1016/j.febslet.2011.04.023; Salim S, 2010, BEHAV BRAIN RES, V208, P545, DOI 10.1016/j.bbr.2009.12.039; Singewald N, 2003, BIOL PSYCHIAT, V53, P275, DOI 10.1016/S0006-3223(02)01574-3; Smoller JW, 2008, ARCH GEN PSYCHIAT, V65, P298, DOI 10.1001/archgenpsychiatry.2007.48; Vogelzangs N, 2013, TRANSL PSYCHIAT, V3, DOI 10.1038/tp.2013.27; Vollert C, 2011, BEHAV BRAIN RES, V224, P233, DOI 10.1016/j.bbr.2011.05.010; Yalcin B, 2004, NAT GENET, V36, P1197, DOI 10.1038/ng1450; Yeung M, 2013, NEUROPHARMACOLOGY, V75, P47, DOI 10.1016/j.neuropharm.2013.06.027	50	19	19	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2015	10	3							e0117498	10.1371/journal.pone.0117498	http://dx.doi.org/10.1371/journal.pone.0117498			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8IA	25793256	Green Published, gold, Green Submitted			2022-12-27	WOS:000352084200014
J	Zhou, F; Lu, ZQ; Wang, C; Sun, W; Xia, ST; Liao, QM				Zhou, Fei; Lu, Zongqing; Wang, Can; Sun, Wen; Xia, Shu-Tao; Liao, Qingmin			Image Quality Assessment Based on Inter-Patch and Intra-Patch Similarity	PLOS ONE			English	Article							STRUCTURAL SIMILARITY; DECOMPOSITION; INDEX	In this paper, we propose a full-reference (FR) image quality assessment (IQA) scheme, which evaluates image fidelity from two aspects: the inter-patch similarity and the intra-patch similarity. The scheme is performed in a patch-wise fashion so that a quality map can be obtained. On one hand, we investigate the disparity between one image patch and its adjacent ones. This disparity is visually described by an inter-patch feature, where the hybrid effect of luminance masking and contrast masking is taken into account. The inter-patch similarity is further measured by modifying the normalized correlation coefficient (NCC). On the other hand, we also attach importance to the impact of image contents within one patch on the IQA problem. For the intra-patch feature, we consider image curvature as an important complement of image gradient. According to local image contents, the intra-patch similarity is measured by adaptively comparing image curvature and gradient. Besides, a nonlinear integration of the inter-patch and intra-patch similarity is presented to obtain an overall score of image quality. The experiments conducted on six publicly available image databases show that our scheme achieves better performance in comparison with several state-of-the-art schemes.	[Zhou, Fei; Lu, Zongqing; Sun, Wen; Liao, Qingmin] Tsinghua Univ, Dept Elect Engn, Beijing 10084, Peoples R China; [Zhou, Fei; Lu, Zongqing; Sun, Wen; Xia, Shu-Tao; Liao, Qingmin] Tsinghua Univ, Shenzhen Key Lab Informat Sci & Technol, Grad Sch Shenzhen, Shenzhen 518055, Peoples R China; [Wang, Can] Commonwealth Sci & Ind Res Org CSIRO, Digital Prod Flagship, Hobart, Tas, Australia	Tsinghua University; Tsinghua University; University Town of Shenzhen; Tsinghua Shenzhen International Graduate School; Commonwealth Scientific & Industrial Research Organisation (CSIRO)	Zhou, F (corresponding author), Tsinghua Univ, Dept Elect Engn, Beijing 10084, Peoples R China.	flying.zhou@163.com; liaoqm@tsinghua.edu.cn	WANG, CAN/GWV-0969-2022	Wang, Can/0000-0002-2890-0057	Natural Science Foundation of China [61271393, 61301183]; China Postdoctoral Science Foundation [2013M540947, 2014T70083]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); China Postdoctoral Science Foundation(China Postdoctoral Science Foundation)	This work was supported by the Natural Science Foundation of China under Grant 61271393 and 61301183, and by China Postdoctoral Science Foundation under Grant 2013M540947 and 2014T70083. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ATTNEAVE F, 1954, PSYCHOL REV, V61, P183, DOI 10.1037/h0054663; Behrmann M, 2003, J EXP PSYCHOL HUMAN, V29, P19, DOI 10.1037/0096-1523.29.1.19; Chandler DM, 2007, IEEE T IMAGE PROCESS, V16, P2284, DOI 10.1109/TIP.2007.901820; Chandler DM, 2007, VSNR WAVELET BASED V; Chang HW, 2013, IEEE T IMAGE PROCESS, V22, P4007, DOI 10.1109/TIP.2013.2266579; Channappayya SS, 2008, IEEE T IMAGE PROCESS, V17, P1624, DOI 10.1109/TIP.2008.2001400; Chen G., 2006, P 2006 INT C AC SPEE, P14; Chen GH, 2006, IEEE IMAGE PROC, P2929, DOI 10.1109/ICIP.2006.313132; Cheng G, 2009, ELECTRON LETT, V45, P1305, DOI 10.1049/el.2009.2368; Cheng GQ, 2010, IEEE IMAGE PROC, P325, DOI 10.1109/ICIP.2010.5649265; Engelke U, 2011, IEEE SIGNAL PROC MAG, V28, P50, DOI 10.1109/MSP.2011.942473; Eskicioglu AM, 2008, IEEE T IMAGE PROCESS, V17, P422; Farah MJ, 2005, VISUAL AGNOSIA; Farias MCQ, 2007, IEEE T SIGNAL PROCES, V55, P2954, DOI 10.1109/TSP.2007.893963; FUHRMANN DR, 1995, J ELECTRON IMAGING, V4, P397, DOI 10.1117/12.220346; GRANRATH DJ, 1981, P IEEE, V69, P552, DOI 10.1109/PROC.1981.12024; Horita Y., 2008, MICT IMAGE QUALITY E; Huynh-Thu Q, 2008, ELECTRON LETT, V44, P800, DOI 10.1049/el:20080522; Kaiser PK, 1996, JOY VISUAL PERCEPTIO; Kanizsa G., 1974, GIORNALE ITALIANO PS, V9, P93; Khellah FM, 2011, IEEE T IMAGE PROCESS, V20, P3270, DOI 10.1109/TIP.2011.2143422; Larson E. C., 2010, CATEGORICAL IMAGE QU; Larson EC, 2010, J ELECTRON IMAGING, V19, DOI 10.1117/1.3267105; Li CF, 2010, SIGNAL PROCESS-IMAGE, V25, P517, DOI 10.1016/j.image.2010.03.004; Li SN, 2011, IEEE T MULTIMEDIA, V13, P935, DOI 10.1109/TMM.2011.2152382; Lin WS, 2011, J VIS COMMUN IMAGE R, V22, P297, DOI 10.1016/j.jvcir.2011.01.005; Liu AM, 2012, IEEE T IMAGE PROCESS, V21, P1500, DOI 10.1109/TIP.2011.2175935; Liu AM, 2010, IEEE T CIRC SYST VID, V20, P1648, DOI 10.1109/TCSVT.2010.2087432; MANNOS JL, 1974, IEEE T INFORM THEORY, V20, P525, DOI 10.1109/TIT.1974.1055250; Narwaria M, 2010, IEEE T NEURAL NETWOR, V21, P515, DOI 10.1109/TNN.2010.2040192; Ninassi A., 2006, SUBJECTIVE QUALITY A; Ponomarenko N., 2008, TAMPERE IMAGE DATABA; Qian JJ, 2013, IEEE T IMAGE PROCESS, V22, P3591, DOI 10.1109/TIP.2013.2264676; RIGGS LA, 1973, SCIENCE, V181, P1070, DOI 10.1126/science.181.4104.1070; RIGGS LA, 1974, SCIENCE, V184, P1200; Sampat MP, 2009, IEEE T IMAGE PROCESS, V18, P2385, DOI 10.1109/TIP.2009.2025923; Seshadrinathan K, 2008, IEEE IMAGE PROC, P1200, DOI 10.1109/ICIP.2008.4711976; Sheikh HR, 2006, IEEE T IMAGE PROCESS, V15, P3440, DOI 10.1109/TIP.2006.881959; Sheikh HR, 2006, IEEE T IMAGE PROCESS, V15, P430, DOI 10.1109/TIP.2005.859378; Snowden R., 2012, BASIC VISION INTRO V; Valenti R, 2012, IEEE T PATTERN ANAL, V34, P1785, DOI 10.1109/TPAMI.2011.251; Video Quality Expert Group, 2003, FIN REP VID QUAL ECP; Wang Q, 2007, IEEE T IMAGE PROCESS, V16, P889, DOI 10.1109/TIP.2007.891794; Wang Z, 2003, CONF REC ASILOMAR C, P1398; Wang Z, 2004, IEEE T IMAGE PROCESS, V13, P600, DOI 10.1109/TIP.2003.819861; Wang Z, 2002, INT CONF ACOUST SPEE, P3313; Wang Z., 2006, MODERN IMAGE QUALITY; Wang Z., 2003, SSIM INDEX IMAGE QUA; Wang Z, 2011, IEEE T IMAGE PROCESS, V20, P1185, DOI 10.1109/TIP.2010.2092435; Wang Z, 2009, IEEE SIGNAL PROC MAG, V26, P98, DOI 10.1109/MSP.2008.930649; Watson A.B, 1993, P SOC INF DISPL, DOI DOI 10.1109/DCC.1993.253132; WATT RJ, 1987, VISION RES, V27, P1659, DOI 10.1016/0042-6989(87)90172-6; WATT RJ, 1982, VISION RES, V22, P449, DOI 10.1016/0042-6989(82)90193-6; Winkler S, 1999, SIGNAL PROCESS, V78, P231, DOI 10.1016/S0165-1684(99)00062-6; Yuan T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086528; Zhang L, 2011, IEEE T IMAGE PROCESS, V20, P2378, DOI 10.1109/TIP.2011.2109730; Zhou F, 2012, IEEE T IMAGE PROCESS, V21, P3312, DOI 10.1109/TIP.2012.2189576; Zhu JY, 2012, IEEE T IMAGE PROCESS, V21, P919, DOI 10.1109/TIP.2011.2169971	58	17	17	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2015	10	3							e0116312	10.1371/journal.pone.0116312	http://dx.doi.org/10.1371/journal.pone.0116312			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8IA	25793282	Green Published, Green Submitted, gold			2022-12-27	WOS:000352084200005
J	Balietti, S; Mas, M; Helbing, D				Balietti, Stefano; Maes, Michael; Helbing, Dirk			On Disciplinary Fragmentation and Scientific Progress	PLOS ONE			English	Article							HIERARCHY; CREATIVITY; DIVISION; MODEL	Why are some scientific disciplines, such as sociology and psychology, more fragmented into conflicting schools of thought than other fields, such as physics and biology? Furthermore, why does high fragmentation tend to coincide with limited scientific progress? We analyzed a formal model where scientists seek to identify the correct answer to a research question. Each scientist is influenced by three forces: (i) signals received from the correct answer to the question; (ii) peer influence; and (iii) noise. We observed the emergence of different macroscopic patterns of collective exploration, and studied how the three forces affect the degree to which disciplines fall apart into divergent fragments, or so-called "schools of thought". We conducted two simulation experiments where we tested (A) whether the three forces foster or hamper progress, and (B) whether disciplinary fragmentation causally affects scientific progress and vice versa. We found that fragmentation critically limits scientific progress. Strikingly, there is no effect in the opposite causal direction. What is more, our results shows that at the heart of the mechanisms driving scientific progress we find (i) social interactions, and (ii) peer disagreement. In fact, fragmentation is increased and progress limited if the simulated scientists are open to influence only by peers with very similar views, or when within-school diversity is lost. Finally, disciplines where the scientists received strong signals from the correct answer were less fragmented and experienced faster progress. We discuss model's implications for the design of social institutions fostering interdisciplinarity and participation in science.	[Balietti, Stefano; Maes, Michael; Helbing, Dirk] Swiss Fed Inst Technol, Professorship Computat Social Sci, Zurich, Switzerland	Swiss Federal Institutes of Technology Domain; ETH Zurich	Balietti, S (corresponding author), Swiss Fed Inst Technol, Professorship Computat Social Sci, Zurich, Switzerland.	sbalietti@ethz.ch	Maes, Michael/K-9603-2013	Maes, Michael/0000-0001-9416-3211	European Commission through the ERC Advanced Investigator Grant "Momentum" [324247]	European Commission through the ERC Advanced Investigator Grant "Momentum"	The authors acknowledge support by the European Commission through the ERC Advanced Investigator Grant "Momentum" (Grant No. 324247). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abelson R.P., 1964, MATH MODELS DISTRIBU, P142; [Anonymous], 1986, LAB LIFE SOCIAL CONS; BARON RM, 1986, J PERS SOC PSYCHOL, V51, P1173, DOI 10.1037/0022-3514.51.6.1173; BECHER T, 1987, STUD HIGH EDUC, V12, P261, DOI 10.1080/03075078712331378052; Becher T., 2001, ACAD TRIBES TERRITOR; BERGER RL, 1981, J AM STAT ASSOC, V76, P415, DOI 10.2307/2287844; Cole, 2001, WHATS WRONG SOCIOLOG; COLE S, 1983, AM J SOCIOL, V89, P111, DOI 10.1086/227835; COLLINS HM, 1983, ANNU REV SOCIOL, V9, P265, DOI 10.1146/annurev.so.09.080183.001405; CRONBACH LJ, 1957, AM PSYCHOL, V12, P671, DOI 10.1037/h0043943; De Langhe R, 2013, SYNTHESE, V190, P2547, DOI 10.1007/s11229-012-0149-0; De Langhe R, 2009, J POST KEYNESIAN EC, V32, P137, DOI 10.2753/PKE0160-3477320109; DEGROOT MH, 1974, J AM STAT ASSOC, V69, P118, DOI 10.2307/2285509; Epstein J.M., 2006, GENERATIVE SOCIAL SC; Fanelli D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066938; Fanelli D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010068; Feyerabend P, 1994, WORLD FUTURES, V40, P87, DOI [10.1080/02604027.1994.9972421, DOI 10.1080/02604027.1994.9972421]; Flache A, 2008, COMPUT MATH ORGAN TH, V14, P23, DOI 10.1007/s10588-008-9019-1; FOGEL DB, 1994, IEEE T NEURAL NETWOR, V5, P3, DOI 10.1109/72.265956; Fortunato S, 2005, INT J MOD PHYS C, V16, P1535, DOI 10.1142/S0129183105008126; Gintis Herbert, 2009, BOUNDS REASON GAME T; Harary F, 1959, STUDIES SOCIAL POWER, P168; Hegselmann R, 2002, JASSS-J ARTIF SOC S, V5; Hegselmann R, 2006, JASSS-J ARTIF SOC S, V9; Hirsch W, 1964, RES SUPPORT MULTIPLE; Kitts James A., 2007, Computational & Mathematical Organization Theory, V13, P333, DOI 10.1007/s10588-007-9015-x; Kuhn T. S., 1996, STRUCTURE SCI REVOLU; Lehrer K., 1975, SYNTHESE, V31, P141, DOI [10.1007/BF00869475, DOI 10.1007/BF00869475]; Longino H.E., 2002, FATE KNOWLEDGE; Macy MW, 2003, DYNAMIC SOCIAL NETWORK MODELING AND ANALYSIS, P162; Mas M, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000959; March JG, 1991, ORGAN SCI, V2, P71, DOI 10.1287/orsc.2.1.71; McPherson M, 2001, ANNU REV SOCIOL, V27, P415, DOI 10.1146/annurev.soc.27.1.415; Mouzelis N., 1995, SOCIOL THEOR; Muldoon R, 2013, PHILOS COMPASS, V8, P117, DOI 10.1111/phc3.12000; Nicolaisen J, 2012, J INFORMETR, V6, P276, DOI 10.1016/j.joi.2011.08.001; Park IU, 2014, NATURE, V506, P93, DOI 10.1038/nature12786; SANDSTROM PE, 1999, B AM SOC INFORM SCI, V25, P17, DOI DOI 10.1002/BULT.116; Shwed U, 2010, AM SOCIOL REV, V75, P817, DOI 10.1177/0003122410388488; Simonton DK, 2009, PERSPECT PSYCHOL SCI, V4, P441, DOI 10.1111/j.1745-6924.2009.01152.x; Simonton DK, 2004, REV GEN PSYCHOL, V8, P59, DOI 10.1037/1089-2680.8.1.59; Simonton DK, 2003, PSYCHOL BULL, V129, P475, DOI 10.1037/0033-2909.129.4.475; Smith LD, 2000, SOC STUD SCI, V30, P73, DOI 10.1177/030631200030001003; Sobkowicz P, 2011, SCIENTOMETRICS, V87, P233, DOI 10.1007/s11192-011-0339-4; TAJFEL H., 1986, DIFFERENTIATION SOCI, P7, DOI [10.4324/9780203505984-16, DOI 10.4324/9780203505984-16]; Turner Stephen, 1990, IMPOSSIBLE SCI I ANA; VICSEK T, 1995, PHYS REV LETT, V75, P1226, DOI 10.1103/PhysRevLett.75.1226; Weinberg S, 1998, DAEDALUS, V127, P151; Weisberg M, 2009, PHILOS SCI, V76, P225, DOI 10.1086/644786; Whitley R, 1984, INTELLECTUAL SOCIAL, V1; Zollman KJS, 2010, ERKENNTNIS, V72, P17, DOI 10.1007/s10670-009-9194-6	51	29	29	1	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2015	10	3							e0118747	10.1371/journal.pone.0118747	http://dx.doi.org/10.1371/journal.pone.0118747			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CD9NQ	25790025	Green Submitted, Green Published, gold			2022-12-27	WOS:000351425400044
J	Bianco, E; Nevado, B; Ramos-Onsins, SE; Perez-Enciso, M				Bianco, Erica; Nevado, Bruno; Ramos-Onsins, Sebastian E.; Perez-Enciso, Miguel			A Deep Catalog of Autosomal Single Nucleotide Variation in the Pig	PLOS ONE			English	Article							DOMESTIC PIG; SELECTION; SEQUENCE; REVEALS; GENOMES; VARIANTS; DISTINCT; FORMAT	A comprehensive catalog of variability in a given species is useful for many important purposes, e. g., designing high density arrays or pinpointing potential mutations of economic or physiological interest. Here we provide a genomewide, worldwide catalog of single nucleotide variants by simultaneously analyzing the shotgun sequence of 128 pigs and five suid outgroups. Despite the high SNP missing rate of some individuals (up to 88%), we retrieved over 48 million high quality variants. Of them, we were able to assess the ancestral allele of more than 39M biallelic SNPs. We found SNPs in 21,455 out of the 25,322 annotated genes in pig assembly 10.2. The annotation showed that more than 40% of the variants were novel variants, not present in dbSNP. Surprisingly, we found a large variability in transition /transversion rate along the genome, which is very well explained (R-2=0.79) primarily by genome differences in in CpG content and recombination rate. The number of SNPs per window also varied but was less dependent of known factors such as gene density, missing rate or recombination (R-2=0.48). When we divided the samples in four groups, Asian wild boar (ASWB), Asian domestics (ASDM), European wild boar (EUWB) and European domestics (EUDM), we found a marked correlation in allele frequencies between domestics and wild boars within Asia and within Europe, but not across continents, due to the large evolutive distance between pigs of both continents (similar to 1.2 MYA). In general, the porcine species showed a small percentage of SNPs exclusive of each population group. EUWB and EUDM were predicted to harbor a larger fraction of potentially deleterious mutations, according to the SIFT algorithm, than Asian samples, perhaps a result of background selection being less effective due to a lower effective population size in Europe.	[Bianco, Erica; Nevado, Bruno; Ramos-Onsins, Sebastian E.; Perez-Enciso, Miguel] CSIC IRTA UAB UB Consortium, Ctr Res Agr Genom, Bellaterra, Spain; [Bianco, Erica; Nevado, Bruno; Perez-Enciso, Miguel] Univ Autonoma Barcelona, Dept Anim Sci, Bellaterra, Spain; [Perez-Enciso, Miguel] Inst Catala Recerca & Estudis Avancats, Barcelona, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); Centre de Recerca en Agrigenomica (CRAG); IRTA; Autonomous University of Barcelona; ICREA	Perez-Enciso, M (corresponding author), CSIC IRTA UAB UB Consortium, Ctr Res Agr Genom, Bellaterra, Spain.	miguel.perez@uab.es	Perez-Enciso, Miguel/H-6057-2015; Bianco, Erica/K-5361-2015; Ramos-Onsins, Sebastian/B-4822-2015	Perez-Enciso, Miguel/0000-0003-3524-995X; Bianco, Erica/0000-0002-8967-2203; Ramos-Onsins, Sebastian/0000-0002-1776-140X; Nevado, Bruno/0000-0002-9765-2907	Ministry of Economy and Science, Spain [AGL2010-14822, AGL2013-41834-R]	Ministry of Economy and Science, Spain	This work was funded by AGL2010-14822 and AGL2013-41834-R (Ministry of Economy and Science, Spain) to MPE and SERO. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amaral AJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014782; Auton A, 2012, SCIENCE, V336, P193, DOI 10.1126/science.1216872; BEGUN DJ, 1992, NATURE, V356, P519, DOI 10.1038/356519a0; Bosse M, 2014, MOL ECOL, V23, P4089, DOI 10.1111/mec.12807; Bosse M, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1003100; Burgos-Paz W, 2013, HEREDITY, V110, P321, DOI 10.1038/hdy.2012.109; Carneiro M, 2014, SCIENCE, V345, P1074, DOI 10.1126/science.1253714; CHARLESWORTH B, 1993, GENETICS, V134, P1289; Chen GK, 2009, GENOME RES, V19, P136, DOI 10.1101/gr.083634.108; CROW J F, 1970, P591, DOI 10.1093/bioinformatics/btr330; Daetwyler HD, 2014, NAT GENET, V46, P858, DOI 10.1038/ng.3034; Esteve-Codina A, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-148; Fang XD, 2012, GIGASCIENCE, V1, DOI 10.1186/2047-217X-1-16; Frantz LAF, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-9-r107; Giuffra E, 2000, GENETICS, V154, P1785; Groenen MAM, 2012, NATURE, V491, P393, DOI 10.1038/nature11622; Gutenkunst RN, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000695; Huang WC, 2012, BIOINFORMATICS, V28, P593, DOI 10.1093/bioinformatics/btr708; Huang W, 2014, GENOME RES, V24, P1193, DOI 10.1101/gr.171546.113; Kijas JW, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001258; Kumar P, 2009, NAT PROTOC, V4, P1073, DOI 10.1038/nprot.2009.86; Larson G, 2005, SCIENCE, V307, P1618, DOI 10.1126/science.1106927; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li MZ, 2013, NAT GENET, V45, P1431, DOI 10.1038/ng.2811; Lindblad-Toh K, 2000, NAT GENET, V24, P381, DOI 10.1038/74215; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; McLaren W, 2010, BIOINFORMATICS, V26, P2069, DOI 10.1093/bioinformatics/btq330; Neuman JA, 2013, BRIEF BIOINFORM, V14, P46, DOI 10.1093/bib/bbs013; Nevado B, 2015, MOL ECOL RESOUR, V15, P99, DOI 10.1111/1755-0998.12286; Ng PC, 2001, GENOME RES, V11, P863, DOI 10.1101/gr.176601; Perez-Enciso M, 2014, J ANIM BREED GENET, V131, P85, DOI 10.1111/jbg.12074; Porter V., 1993, Pigs. A handbook to the breeds of the world.; Ramirez O, 2015, HEREDITY, V114, P175, DOI 10.1038/hdy.2014.81; Ramos-Onsins S, 2014, MSTATSPOP; Ramos-Onsins SE, 2014, HEREDITY, V113, P471, DOI 10.1038/hdy.2014.68; Rubin CJ, 2012, P NATL ACAD SCI USA, V109, P19529, DOI 10.1073/pnas.1217149109; Rubin CJ, 2010, NATURE, V464, P587, DOI 10.1038/nature08832; Sarkar D, 2003, LATTICE GRAPHICS; SVED J, 1990, P NATL ACAD SCI USA, V87, P4692, DOI 10.1073/pnas.87.12.4692; Team R, 2013, R LANG ENV STAT COMP; Tortereau F, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-586; Warnes GR, 2012, J PHYCOL, DOI [10.1111/j.0022-3646.1997.00569.x, DOI 10.1111/J.0022-3646.1997.00569.X]; White S, 2011, ENVIRON HIST-US, V16, P94, DOI 10.1093/envhis/emq143	43	19	19	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2015	10	3							e0118867	10.1371/journal.pone.0118867	http://dx.doi.org/10.1371/journal.pone.0118867			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD9NQ	25789620	Green Submitted, Green Published, gold			2022-12-27	WOS:000351425400051
J	Bose, O; Baluk, P; Looney, MR; Cheng, LE; McDonald, DM; Caughey, GH; Krummel, MF				Bose, Oishee; Baluk, Peter; Looney, Mark R.; Cheng, Laurence E.; McDonald, Donald M.; Caughey, George H.; Krummel, Matthew F.			Mast Cells Present Protrusions into Blood Vessels upon Tracheal Allergen Challenge in Mice	PLOS ONE			English	Article							IMMUNE-SYSTEM; IN-VIVO; DENDRITIC CELLS; LUNG; ASTHMA	Mast cells (MC) and myeloid dendritic cells (DC) act proximally in detecting and processing antigens and immune insults. We sought to understand their comparative dynamic behavior with respect to the airway epithelium in the steady state and in response to an allergic stimulus in mouse trachea. We devised methods to label MC in living trachea and to demonstrate that MC and DC occupy distinct layers of the tracheal mucosa, with DC being closer to the lumen. DC numbers doubled after allergen challenge, but MC numbers remained stable. MC and DC migrated minimally in either steady state or allergen-challenge conditions, and their interactions with one another appeared to be stochastic and relatively infrequent. While DC, unlike MC, exhibited probing behaviors involving dendrites, these projections did not cross the epithelium into the airway lumen. MC typically were located too far from the epithelial surface to contact the tracheal lumen. However, MC had protrusions toward and into blood vessels, likely to load with IgE. Thus, DC and MC occupy distinct niches and engage in sessile surveillance in the mouse trachea. Little or no access of these cell types to the airway lumen suggests that trans-epithelial transport of proteins in the steady state would be required for them to access luminal antigens.	[Bose, Oishee; Krummel, Matthew F.] Univ Calif San Francisco, Dept Pathol, San Francisco, CA 94140 USA; [Baluk, Peter; McDonald, Donald M.] Univ Calif San Francisco, Dept Anat, San Francisco, CA 94143 USA; [Looney, Mark R.] Univ Calif San Francisco, Dept Lab Med, San Francisco, CA 94143 USA; [Cheng, Laurence E.] Univ Calif San Francisco, Dept Pediat, San Francisco, CA USA; [Caughey, George H.] Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA; [Baluk, Peter; McDonald, Donald M.; Caughey, George H.] Univ Calif San Francisco, Cardiovasc Res Inst, San Francisco, CA 94143 USA; [Krummel, Matthew F.] Univ Calif San Francisco, Helen Diller Family Comprehens Canc Ctr, San Francisco, CA 94143 USA; [Krummel, Matthew F.] Vet Affairs Med Ctr, San Francisco, CA 94121 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; UCSF Medical Center; UCSF Helen Diller Family Comprehensive Cancer Center; US Department of Veterans Affairs; Veterans Health Administration (VHA)	Caughey, GH (corresponding author), Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA.	george.caughey@ucsf.edu; matthew.krummel@ucsf.edu			National Institutes of Health [HL024136, U19AI077439]; National Heart Lung and Blood Institute [HL059157]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL127402, P01HL024136, R01HL059157] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI077439] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Heart Lung and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported in part by National Institutes of Health grants HL024136 (Caughey, Krummel, McDonald), U19AI077439 (Krummel), and HL059157 (McDonald) from the National Heart Lung and Blood Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AIDA Y, 1990, J IMMUNOL METHODS, V132, P191, DOI 10.1016/0022-1759(90)90029-U; Blyth DI, 1996, AM J RESP CELL MOL, V14, P425, DOI 10.1165/ajrcmb.14.5.8624247; Bullen A, 2009, CURR TOP MICROBIOL, V334, P1, DOI 10.1007/978-3-540-93864-4_1; Cheng LE, 2013, IMMUNITY, V38, P166, DOI 10.1016/j.immuni.2012.09.022; Chieppa M, 2006, J EXP MED, V203, P2841, DOI 10.1084/jem.20061884; de Heer HJ, 2005, SEMIN IMMUNOL, V17, P295, DOI 10.1016/j.smim.2005.05.002; Gerard A, 2014, CELL, V158, P492, DOI 10.1016/j.cell.2014.05.044; Germain RN, 2008, IMMUNOL REV, V221, P163, DOI 10.1111/j.1600-065X.2008.00591.x; Hadjantonakis Anna-Katerina, 2002, BMC Biotechnol, V2, P11, DOI 10.1186/1472-6750-2-11; Hamada K, 2003, J IMMUNOL, V170, P1683, DOI 10.4049/jimmunol.170.4.1683; HUME DA, 1984, ANAT REC, V210, P503, DOI 10.1002/ar.1092100311; Kissenpfennig A, 2005, IMMUNITY, V22, P643, DOI 10.1016/j.immuni.2005.04.004; Lelkes E, 2014, TRENDS IMMUNOL, V35, P379, DOI 10.1016/j.it.2014.05.005; Lindquist RL, 2004, NAT IMMUNOL, V5, P1243, DOI 10.1038/ni1139; Sullivan BM, 2011, NAT IMMUNOL, V12, P527, DOI 10.1038/ni.2036; Thornton Emily E, 2012, Curr Protoc Cytom, VChapter 12, DOI 10.1002/0471142956.cy1228s60; Thornton EE, 2012, J EXP MED, V209, P1183, DOI 10.1084/jem.20112667	18	10	10	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2015	10	3							e0118513	10.1371/journal.pone.0118513	http://dx.doi.org/10.1371/journal.pone.0118513			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD9NQ	25789765	Green Published, gold			2022-12-27	WOS:000351425400032
J	Capra, GF; Ganga, A; Buondonno, A; Grilli, E; Gaviano, C; Vacca, S				Capra, Gian Franco; Ganga, Antonio; Buondonno, Andrea; Grilli, Eleonora; Gaviano, Carla; Vacca, Sergio			Ethnopedology in the Study of Toponyms Connected to the Indigenous Knowledge on Soil Resource	PLOS ONE			English	Article							GENES	In taking an integrated ethnopedological approach, this study aims to investigate the meaning of the distribution of the toponyms used in traditional and recent cartography of Sardinia (southern Italy). It is particularly, but not only, focused on those related to soil resources. Sardinia is particularly interesting in this respect, as its unique history, geography, and linguistic position makes it one of the Italian and Mediterranean regions with the greatest number of toponyms. This research investigated the toponyms belonging to an important subregion of Sardinia, called Ogliastra (central-eastern Sardinia). The research was conducted through the following integrated approach: i) toponymy research and collection from different sources; ii) database creation and translation of toponyms from the Sardinian language (SL); iii) categorization of toponyms; and iv) graphical, statistical, and cartographic data processing. Distribution and diversity of toponyms were assessed using the compiled database, coupled with a geographical information system (GIS). Of around 7700 toponyms collected, 79% had already been reported in SL, while just 21% were in Italian. Of the toponyms in SL, 77% are of known meaning and 54% of these toponyms were characterized by a meaning directly and/or indirectly connected to specific environmental features. On the whole, morphology would appear to be the primary environmental factor able to explain the complex, articulated presence, distribution, and typology of the investigated toponyms. A least squares regression analysis of pedodiversity vs. topodiversity shows a very closed distribution, with an impressive high correlation index (R-2 = 0.824). The principal factor analysis (PFA) shows that such a connection may be morphologically based, thereby confirming that pedodiversity and topodiversity are strongly linked each other. Overall, the research shows that an integrated ethnopedological approach, combining indigenous and scientific knowledge may be of great interest in order to mitigate the impressive phenomena of the indigenous knowledge lost.	[Capra, Gian Franco; Ganga, Antonio; Vacca, Sergio] Univ Sassari, Dipartimento Architettura Design & Urbanist, Nuoro, Italy; [Buondonno, Andrea] Univ Naples 2, Dipartimento Architettura & Disegno Ind Luigi Van, Abazia San Lorenzo Septimum, Aversa, Caserta, Italy; [Grilli, Eleonora] Univ Naples 2, Dipartimento Sci & Tecnol Ambientali, Biol & Farmaceut, Caserta, Italy; [Gaviano, Carla] Univ Cagliari, Dipartimento Sci Chim & Geol, Cagliari, Italy	University of Sassari; Universita della Campania Vanvitelli; Universita della Campania Vanvitelli; University of Cagliari	Capra, GF (corresponding author), Univ Sassari, Dipartimento Architettura Design & Urbanist, Via Colombo 1, Nuoro, Italy.	pedolnu@uniss.it	Ganga, Antonio/AAP-9161-2020; Eleonora, Grilli/AAO-2495-2020; grilli, eleonora/ABE-3364-2020	Eleonora, Grilli/0000-0003-0803-315X; 				Agnesi V, 1990, REND SEM FS U CAGLIA, V60, P233; Ardau F, 1999, BALANCED MANAGEMENT, P87; Aru A., 1991, NOTA ILLUSTRATIVA CA; Barrera-Bassols N, 2003, GEODERMA, V111, P171, DOI 10.1016/S0016-7061(02)00263-X; Barrera-Bassols N, 1998, P 16 INT C SOIL SCI; Blasco Ferrer E., 2010, PALEOSARDO RADICI LI; Blasco Ferrer Eduardo, 1994, ELLO ELLUS GRAMMATIC; Cabboi N, 2005, REND SEM FS U CAGLIA, V75, P173; Caramelli D, 2007, HUM GENET, V122, P327, DOI 10.1007/s00439-007-0403-6; Caria MC, 2013, PLANT BIOSYST; Carmignani L., 2001, GEOLOGIA SARDEGNA NO, V60; Casagrande D, 2012, ENCY EARTH EOE; Cavalli-Sforza L. L., 1994, HIST GEOGRAPHY HUMAN; CAVALLISFORZA LL, 1992, P NATL ACAD SCI USA, V89, P5620, DOI 10.1073/pnas.89.12.5620; CavalliSforza LL, 1997, P NATL ACAD SCI USA, V94, P7719, DOI 10.1073/pnas.94.15.7719; Corda F, 1994, GRAMMATICA MODERNA S; De Waele J, 1998, ATT 18 CONV NAZ SPEL, P139; De Waele J., 2005, QUATERNARIO, V18, P211; Dedola S, 2012, TOPONOMASTICA SARDEG; Elerie H, 2010, CULTURAL LANDSCAPE & HERITAGE PARADOX: PROTECTION AND DEVELOPMENT OF THE DUTCH ARCHAEOLOGICAL-HISTORICAL LANDSCAPE AND ITS EUROPEAN DIMENSION, P83; FRAKE CO, 1962, AM ANTHROPOL, V64, P53, DOI 10.1525/aa.1962.64.1.02a00060; Fraumene C, 2003, HUM GENET, V114, P1, DOI 10.1007/s00439-003-1008-3; Fraumene C, 2006, MOL BIOL EVOL, V23, P2101, DOI 10.1093/molbev/msl084; Ilies DC, 2009, GEO J TOUR GEOSITES, V3, P78; Kadmon N, 2000, TOPONYMY LORE LAWS L; Lupinu G, 2007, LINGUE SARDI RICERCA; Marini A., 1977, RENDICONTI SEMINARIO, V47, P192; Mensching G., 2000, P C MULT MULT MIN LA; Minasny B, 2010, GEODERMA, V155, P132, DOI 10.1016/j.geoderma.2009.04.024; Paulis G, 1997, NAZIONE OPERAIA CULT, P7; Paulis Giulio., 1987, NOMI LUOGO SARDEGNA; Pittau M., 1984, LESSICO ETRUSCO LATI; Pittau M, 2011, TOPONIMI SARDEGNA SI; Pittau Massimo., 2013, NUOVO VOCABOLARIO LI; Pugliatti M, 2007, THESIS U BERGEN; Regione Autonoma della Sardegna, 2007, PIAN REG FOR ALL 1 S; Salminen T, 1993, UNESCO RED BOOK ENDA; Sanna G, 2004, SARDOA GRAMMATA DIO; Siderius W, 2003, GEODERMA, V111, P521, DOI 10.1016/S0016-7061(02)00280-X; Sistema Informativo Territoriale della Regione Autonoma della Sardegna, 2012, SARD GEOP RIC TOP; SOIL SURVEY STAFF, 2014, KEYS SOIL TAXONOMY, V12th; Sotgiu S, 2004, NEUROBIOL DIS, V17, P131, DOI 10.1016/j.nbd.2004.07.015; Spano Giovanni, 1872, VOCABOLARIO SARDO GE; Tagliavini Carlo, 1982, ORIGINI LINGUE NEOLA; Tetti V, 2001, NOMI LUOGO QUARTA DI; Toledo V., 1992, ETNOECOLOGICA, V1, P5; Toledo VM, 2000, ETHNOPEDOLOGY WORLDW, V77, P1; UNESCO, 1996, NUESTR DIV CREAT INF; Virdis M, 2009, P C NUM LOG MON LUOG; VONA G, 1997, INT J ANTHR, V12, P71, DOI DOI 10.1007/BF02447890; WAGNER Max Leopold, 1997, LINGUA SARDA STORIA; Wagner ML, 1964, DIZIONARIO ETIMOLOGI, V1-3; Winklerprins AMGA, 1999, SOC NATUR RESOUR, V12, P151, DOI 10.1080/089419299279812; Zanetti D, 2012, J NEUROLINGUIST, V25, P642, DOI 10.1016/j.jneuroling.2011.11.003	54	13	13	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2015	10	3							e0120240	10.1371/journal.pone.0120240	http://dx.doi.org/10.1371/journal.pone.0120240			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD9NQ	25789985	Green Published, Green Submitted, gold			2022-12-27	WOS:000351425400144
J	Cucinotta, FA				Cucinotta, Francis A.			A New Approach to Reduce Uncertainties in Space Radiation Cancer Risk Predictions	PLOS ONE			English	Article							INDUCTION; MICE; CARCINOGENESIS; IRRADIATION; CARCINOMA; SPECTRUM; PARTICLE; RAT	The prediction of space radiation induced cancer risk carries large uncertainties with two of the largest uncertainties being radiation quality and dose-rate effects. In risk models the ratio of the quality factor (QF) to the dose and dose-rate reduction effectiveness factor (DDREF) parameter is used to scale organ doses for cosmic ray proton and high charge and energy (HZE) particles to a hazard rate for gamma-rays derived from human epidemiology data. In previous work, particle track structure concepts were used to formulate a space radiation QF function that is dependent on particle charge number Z, and kinetic energy per atomic mass unit, E. QF uncertainties where represented by subjective probability distribution functions (PDF) for the three QF parameters that described its maximum value and shape parameters for Z and E dependences. Here I report on an analysis of a maximum QF parameter and its uncertainty using mouse tumor induction data. Because experimental data for risks at low doses of gamma-rays are highly uncertain which impacts estimates of maximum values of relative biological effectiveness (RBEmax), I developed an alternate QF model, denoted QF(gamma Acute) where QFs are defined relative to higher acute gamma-ray doses (0.5 to 3 Gy). The alternate model reduces the dependence of risk projections on the DDREF, however a DDREF is still needed for risk estimates for high-energy protons and other primary or secondary sparsely ionizing space radiation components. Risk projections (upper confidence levels (CL)) for space missions show a reduction of about 40% (CL similar to 50%) using the QF(gamma Acute) model compared the QFs based on RBEmax and about 25% (CL similar to 35%) compared to previous estimates. In addition, I discuss how a possible qualitative difference leading to increased tumor lethality for HZE particles compared to low LET radiation and background tumors remains a large uncertainty in risk estimates.	Univ Nevada, Dept Hlth Phys & Diagnost Sci, Las Vegas, NV 89154 USA	Nevada System of Higher Education (NSHE); University of Nevada Las Vegas	Cucinotta, FA (corresponding author), Univ Nevada, Dept Hlth Phys & Diagnost Sci, Las Vegas, NV 89154 USA.	francis.cucinotta@unlv.edu	Cucinotta, Francis/AAZ-5941-2020		University of Nevada, Las Vegas; Department of Energy	University of Nevada, Las Vegas; Department of Energy(United States Department of Energy (DOE))	The University of Nevada, Las Vegas and the Department of Energy partially funded this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alpen E.L., 1993, RADIAT RES, V88, P132, DOI DOI 10.2307/3575758; [Anonymous], [No title captured]; Barcellos-Hoff MH, 2009, HEALTH PHYS, V97, P446, DOI 10.1097/HP.0b013e3181b08a10; Barkas H, 1963, NUCL RES EMULSIONS; BEIR VII, 2006, HLTH RISKS EXP LOW L; Bissell M, 1997, LBNL PUBLICATION; Cucinotta FA, 2001, RADIAT RES, V156, P682, DOI 10.1667/0033-7587(2001)156[0682:SRCRAU]2.0.CO;2; Cucinotta FA, 2013, SPACE RAD CANC RISK; Cucinotta FA, 1994, TP19943412 NASA; Cucinotta FA, 2014, LIFE SCI SPACE RES, V2, P54, DOI 10.1016/j.lssr.2014.06.003; Cucinotta FA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096099; Cucinotta FA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074988; Cucinotta FA, 2010, MUTAT RES-FUND MOL M, V687, P49, DOI 10.1016/j.mrfmmm.2010.01.012; Datta K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059295; Dicello JF, 2004, PHYS MED BIOL, V49, P3817, DOI 10.1088/0031-9155/49/16/024; Edwards A. A., 1999, Journal of Radiological Protection, V19, P93, DOI 10.1088/0952-4746/19/2/201; EDWARDS AA, 1975, PHYS MED BIOL, V20, P395, DOI 10.1088/0031-9155/20/3/004; FRY RJM, 1985, RADIAT RES, V104, pS188, DOI 10.2307/3576646; FRY RJM, 1987, ADV RADIAT BIOL, V13, P31; GRAHN D, 1992, RADIAT RES, V129, P19, DOI 10.2307/3577899; Hada M, 2014, RADIAT RES, V182, P368, DOI 10.1667/RR13721.1; ICRP, 2003, ICRP PUBL; Illa-Bochaca I, 2014, CANCER RES, V74, P7137, DOI 10.1158/0008-5472.CAN-14-1212; Imaoka T, 2007, INT J RADIAT ONCOL, V69, P194, DOI 10.1016/j.ijrobp.2007.05.026; Kadhim M, 2013, MUTAT RES-REV MUTAT, V752, P84, DOI 10.1016/j.mrrev.2012.12.001; KATZ R, 1971, RADIAT RES, V47, P402, DOI 10.2307/3573247; NAS, 1996, RAD HAZ CREWS INT MI; NAS/NRC, 2012, TECHNICAL EVALUATION; National Council on Radiation Protection and Measurements (NCRP), 1997, 126 NCRP; NCRP, 2000, 132 NCRP; NCRP, 2014, RAD PROT SPAC ACT SU; NCRP, 1989, 98 NCRP; NCRP, 1990, 104 NCRP; NCRP, 2006, 153 NCRP; NCRP, 2010, 167 NCRP; NRC, 2008, MANAGING SPACE RAD R, DOI DOI 10.17226/12045; Preston DL, 2007, RADIAT RES, V168, P1, DOI 10.1667/RR0763.1; SMITH AB, 1957, PHYS REV, V108, P411, DOI 10.1103/PhysRev.108.411; Trani D, 2010, RADIAT ENVIRON BIOPH, V49, P389, DOI 10.1007/s00411-010-0292-2; ULLRICH RL, 1979, RADIAT RES, V80, P325, DOI 10.2307/3575061; ULLRICH RL, 1977, RADIAT RES, V72, P487, DOI 10.2307/3574612; ULLRICH RL, 1983, RADIAT RES, V93, P506, DOI 10.2307/3576029; ULLRICH RL, 1984, RADIAT RES, V97, P587, DOI 10.2307/3576150; United Nations Scientific Committee on the Effects of Atomic Radiation, 2008, SOURC EFF ION RAD UN; Weil MM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104819; Weil MM, 2009, RADIAT RES, V172, P213, DOI 10.1667/RR1648.1	46	45	46	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2015	10	3							e0120717	10.1371/journal.pone.0120717	http://dx.doi.org/10.1371/journal.pone.0120717			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD9NQ	25789764	Green Submitted, Green Published, gold			2022-12-27	WOS:000351425400172
J	Hanold, LE; Oruganty, K; Ton, NT; Beedle, AM; Kannan, N; Kennedy, EJ				Hanold, Laura E.; Oruganty, Krishnadev; Ton, Norman T.; Beedle, Aaron M.; Kannan, Natarajan; Kennedy, Eileen J.			Inhibiting EGFR Dimerization Using Triazolyl-Bridged Dimerization Arm Mimics	PLOS ONE			English	Article							EPIDERMAL-GROWTH-FACTOR; CLICK CHEMISTRY; RECEPTOR ACTIVATION; PEPTIDE; CYCLIZATION; ENDOCYTOSIS; ANTAGONIST; MIGRATION; INSIGHTS; SURFACE	The epidermal growth factor receptor (EGFR) is overexpressed in multiple carcinomas and is the focus of a variety of targeted therapies. Here we report the design of peptide-based compounds that mimic the EGFR dimerization arm and inhibit allosteric activation of EGFR. These peptides are modified to contain a triazolyl bridge between the peptide strands to constrain the EGFR dimerization arm beta-loop. In this study, we demonstrate that these peptides have significantly improved proteolytic stability over the non-modified peptide sequence, and their inhibitory effects are dependent on the number of the methylene units and orientation of the introduced triazolyl bridge. We identified a peptide, EDA2, which downregulates receptor phosphorylation and dimerization and reduces cell viability. This is the first example of a biologically active triazolyl-bridged peptide targeting the EGFR dimerization interface that effectively downregulates EGFR activation.	[Hanold, Laura E.; Ton, Norman T.; Beedle, Aaron M.; Kennedy, Eileen J.] Univ Georgia, Coll Pharm, Dept Pharmaceut & Biomed Sci, Athens, GA 30602 USA; [Oruganty, Krishnadev; Kannan, Natarajan] Univ Georgia, Dept Biochem & Mol Biol, Athens, GA 30602 USA	University System of Georgia; University of Georgia; University System of Georgia; University of Georgia	Kennedy, EJ (corresponding author), Univ Georgia, Coll Pharm, Dept Pharmaceut & Biomed Sci, Athens, GA 30602 USA.	ekennedy@uga.edu	Oruganty, KrishnaDev/N-9465-2017; Beedle, Aaron/AAI-7014-2020; Beedle, Aaron M/K-1902-2015	Oruganty, KrishnaDev/0000-0003-0866-6862; Beedle, Aaron M/0000-0002-1019-3235; Kennedy, Eileen/0000-0001-5610-1677	National Institutes of Health [1K22CA154600]; NATIONAL CANCER INSTITUTE [K22CA154600, R03CA188439] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Funding provided by 1K22CA154600 (EJK), National Institutes of Health, (www.nih.gov). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aileron Therapeutics, 2000, SAF STUD ALRN 6924 P; Angell Y, 2008, J AM CHEM SOC, V130, P556, DOI 10.1021/ja074717z; Angelo NG, 2005, J AM CHEM SOC, V127, P17134, DOI 10.1021/ja056406z; Arkhipov A, 2013, CELL, V152, P557, DOI 10.1016/j.cell.2012.12.030; Bock VD, 2006, ORG LETT, V8, P919, DOI 10.1021/ol053095o; Burgess AW, 2003, MOL CELL, V12, P541, DOI 10.1016/S1097-2765(03)00350-2; Case D. A., 2012, AMBER 13; Ceresa BP, 2013, INT J MOL SCI, V14, P72, DOI 10.3390/ijms14010072; Chung I, 2010, NATURE, V464, P783, DOI 10.1038/nature08827; Clayton AHA, 2005, J BIOL CHEM, V280, P30392, DOI 10.1074/jbc.M504770200; Franklin MC, 2004, CANCER CELL, V5, P317, DOI 10.1016/S1535-6108(04)00083-2; Goncalves V, 2007, BIOORG MED CHEM LETT, V17, P5590, DOI 10.1016/j.bmcl.2007.07.087; Holland-Nell K, 2011, ANGEW CHEM INT EDIT, V50, P5204, DOI 10.1002/anie.201005846; Izetti P, 2014, INVEST NEW DRUG, V32, P783, DOI 10.1007/s10637-014-0090-9; Jagasia R, 2009, J ORG CHEM, V74, P2964, DOI 10.1021/jo802097m; Kolb HC, 2001, ANGEW CHEM INT EDIT, V40, P2004, DOI 10.1002/1521-3773(20010601)40:11<2004::AID-ANIE2004>3.3.CO;2-X; Kulczar C, 2015, DRUG DELIV, P405; Lemmon MA, 1997, EMBO J, V16, P281, DOI 10.1093/emboj/16.2.281; Li HY, 2013, MOLECULES, V18, P9797, DOI 10.3390/molecules18089797; Mizuguchi T, 2012, BIOORGAN MED CHEM, V20, P5730, DOI 10.1016/j.bmc.2012.08.013; Mizuguchi T, 2009, BIOORG MED CHEM LETT, V19, P3279, DOI 10.1016/j.bmcl.2009.04.080; Nyffeler PT, 2002, J AM CHEM SOC, V124, P10773, DOI 10.1021/ja0264605; Ogiso H, 2002, CELL, V110, P775, DOI 10.1016/S0092-8674(02)00963-7; Oh K, 2006, CHEM COMMUN, P3069, DOI 10.1039/b606185k; Olayioye MA, 2000, EMBO J, V19, P3159, DOI 10.1093/emboj/19.13.3159; Rostovtsev VV, 2002, ANGEW CHEM INT EDIT, V41, P2596, DOI 10.1002/1521-3773(20020715)41:14<2596::AID-ANIE2596>3.0.CO;2-4; Sako Y, 2000, NAT CELL BIOL, V2, P168, DOI 10.1038/35004044; Sawyer TK, 2009, CHEM BIOL DRUG DES, V73, P3, DOI 10.1111/j.1747-0285.2008.00744.x; Schlessinger J, 2002, CELL, V110, P669, DOI 10.1016/S0092-8674(02)00966-2; Sliwkowski MX, 2013, SCIENCE, V341, P1192, DOI 10.1126/science.1241145; Sorkin A, 2002, NAT REV MOL CELL BIO, V3, P600, DOI 10.1038/nrm883; Sousa da Silva Alan W, 2012, BMC Res Notes, V5, P367, DOI 10.1186/1756-0500-5-367; Staberg M, 2013, CELL ONCOL, V36, P201, DOI 10.1007/s13402-013-0128-6; Tebbutt N, 2013, NAT REV CANCER, V13, P663, DOI 10.1038/nrc3559; Tornoe CW, 2002, J ORG CHEM, V67, P3057, DOI 10.1021/jo011148j; Wang Q, 2005, EMBO REP, V6, P942, DOI 10.1038/sj.embor.7400491; Wojtkowiak JW, 2011, MOL PHARMACEUT, V8, P2032, DOI 10.1021/mp200292c; Wolfson W, 2009, CHEM BIOL, V16, P910, DOI 10.1016/j.chembiol.2009.09.008; Xu RD, 2010, CELL ONCOL, V32, P259, DOI 10.3233/CLO-2010-0515; Yarden Y, 2001, NAT REV MOL CELL BIO, V2, P127, DOI 10.1038/35052073; Zhang XW, 2006, CELL, V125, P1137, DOI 10.1016/j.cell.2006.05.013	41	32	32	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2015	10	3							e0118796	10.1371/journal.pone.0118796	http://dx.doi.org/10.1371/journal.pone.0118796			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD9NQ	25790232	Green Submitted, Green Published, gold			2022-12-27	WOS:000351425400046
J	Llopart, A				Llopart, Ana			Parallel Faster-X Evolution of Gene Expression and Protein Sequences in Drosophila: Beyond Differences in Expression Properties and Protein Interactions	PLOS ONE			English	Article							EFFECTIVE POPULATION-SIZE; MOLECULAR EVOLUTION; ADAPTIVE EVOLUTION; PHYLOGENETIC ANALYSIS; RECOMBINATION RATE; RAPID EVOLUTION; SEX-CHROMOSOMES; LINKED GENES; CODON USAGE; PATTERNS	Population genetics models predict that the X (or Z) chromosome will evolve at faster rates than the autosomes in XY (or ZW) systems. Studies of molecular evolution using large datasets in multiple species have provided evidence supporting this faster-X effect in protein-coding sequences and, more recently, in transcriptomes. However, X-linked and autosomal genes differ significantly in important properties besides hemizygosity in males, including gene expression levels, tissue specificity in gene expression, and the number of interactions in which they are involved (i.e., protein-protein or DNA-protein interactions). Most important, these properties are known to correlate with rates of evolution, which raises the question of whether differences between the X chromosome and autosomes in gene properties, rather than hemizygosity, are sufficient to explain faster-X evolution. Here I investigate this possibility using whole genome sequences and transcriptomes of Drosophila yakuba and D. santomea and show that this is not the case. Additional factors are needed to account for faster-X evolution of both gene expression and protein-coding sequences beyond differences in gene properties, likely a higher incidence of positive selection in combination with the accumulation of weakly deleterious mutations.	[Llopart, Ana] Univ Iowa, Dept Biol, Iowa City, IA 52242 USA; [Llopart, Ana] Univ Iowa, Interdisciplinary Grad Program Genet, Iowa City, IA USA	University of Iowa; University of Iowa	Llopart, A (corresponding author), Univ Iowa, Dept Biol, Iowa City, IA 52242 USA.	ana-llopart@uiowa.edu			US National Science Foundation [DEB 1354921]; University of Iowa; Direct For Biological Sciences [1354921] Funding Source: National Science Foundation	US National Science Foundation(National Science Foundation (NSF)); University of Iowa; Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work was partially funded by US National Science Foundation DEB 1354921 grant and University of Iowa funds to AL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashburner M., 2004, DROSOPHILA LAB MANUA, V2nd; Bachtrog D, 2009, PLOS BIOL, V7, P712, DOI 10.1371/journal.pbio.1000082; Baines JF, 2008, MOL BIOL EVOL, V25, P1639, DOI 10.1093/molbev/msn111; Baines JF, 2007, GENETICS, V175, P1911, DOI 10.1534/genetics.106.069419; Begun DJ, 2007, PLOS BIOL, V5, P2534, DOI 10.1371/journal.pbio.0050310; Begun DJ, 2000, GENETICS, V156, P1879; Begun DJ, 2000, P NATL ACAD SCI USA, V97, P5960, DOI 10.1073/pnas.97.11.5960; Betancourt AJ, 2002, MOL BIOL EVOL, V19, P1816, DOI 10.1093/oxfordjournals.molbev.a004006; Blankenberg D, 2001, GALAXY WEB BASED GEN, DOI [10.1002/0471142700.nca01bs00, DOI 10.1002/0471142700.NCA01BS00]; Campos JL, 2014, MOL BIOL EVOL, V31, P1010, DOI 10.1093/molbev/msu056; Campos JL, 2013, MOL BIOL EVOL, V30, P811, DOI 10.1093/molbev/mss222; Cariou ML, 2001, MOL ECOL, V10, P649, DOI 10.1046/j.1365-294x.2001.01225.x; Catalan A, 2012, BMC GENOMICS, V13, P1, DOI 10.1186/1471-2164-13-654; Chang PL, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-364; CHARLESWORTH B, 1987, AM NAT, V130, P113, DOI 10.1086/284701; Charlesworth B, 2001, GENET RES, V77, P153, DOI 10.1017/S0016672301004979; Charlesworth B, 2012, GENETICS, V191, P233, DOI 10.1534/genetics.111.138073; Chintapalli VR, 2007, NAT GENET, V39, P715, DOI 10.1038/ng2049; Clark AG, 2007, NATURE, V450, P203, DOI 10.1038/nature06341; Comeron JM, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004434; Comeron JM, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002905; Connallon T, 2007, MOL BIOL EVOL, V24, P2566, DOI 10.1093/molbev/msm199; Counterman BA, 2004, EVOLUTION, V58, P656, DOI 10.1111/j.0014-3820.2004.tb01688.x; Drummond DA, 2005, P NATL ACAD SCI USA, V102, P14338, DOI 10.1073/pnas.0504070102; Ellegren H, 2009, P ROY SOC B-BIOL SCI, V276, P361, DOI 10.1098/rspb.2008.1135; Fraser HB, 2002, SCIENCE, V296, P750, DOI 10.1126/science.1068696; Garrigan D, 2014, GENOME BIOL EVOL, V6, P2444, DOI 10.1093/gbe/evu198; Giardine B, 2005, GENOME RES, V15, P1451, DOI 10.1101/gr.4086505; Gillespie JH, 2000, GENETICS, V155, P909; Goecks J, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-8-r86; Grath S, 2012, GENOME BIOL EVOL, V4, P346, DOI 10.1093/gbe/evs012; Haerty W, 2007, GENETICS, V177, P1321, DOI 10.1534/genetics.107.078865; Hansen Matthew E B, 2013, Int J Evol Biol, V2013, P545392, DOI 10.1155/2013/545392; Herrig DK, 2014, ENCY LIFE SCI, DOI [10.1002/9780470015902.a0025537, DOI 10.1002/9780470015902.A0025537]; Hu TT, 2013, GENOME RES, V23, P89, DOI 10.1101/gr.141689.112; Hvilsom C, 2012, P NATL ACAD SCI USA, V109, P2054, DOI 10.1073/pnas.1106877109; Jaquiery J, 2012, MOL BIOL EVOL, V29, P837, DOI 10.1093/molbev/msr252; Jiang ZF, 2009, GENETICS, V183, P1175, DOI 10.1534/genetics.109.105775; Jovelin R, 2013, J MOL EVOL, V77, P206, DOI 10.1007/s00239-013-9588-6; Kayserili MA, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1003200; Khaitovich P, 2005, SCIENCE, V309, P1850, DOI 10.1126/science.1108296; Kousathanas A, 2014, GENETICS, V196, P1131, DOI 10.1534/genetics.113.158246; LANGLEY CH, 1988, GENET RES, V52, P223, DOI 10.1017/S0016672300027695; Langley CH, 2012, GENETICS, V192, P533, DOI 10.1534/genetics.112.142018; Larracuente AM, 2008, TRENDS GENET, V24, P114, DOI 10.1016/j.tig.2007.12.001; Leffler EM, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001388; Lemos B, 2005, MOL BIOL EVOL, V22, P1345, DOI 10.1093/molbev/msi122; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Llopart A, 2005, EVOLUTION, V59, P2602, DOI 10.1111/j.0014-3820.2005.tb00972.x; Llopart A, 2005, GENETICS, V171, P197, DOI 10.1534/genetics.104.033597; Llopart A, 2012, MOL BIOL EVOL, V29, P3873, DOI 10.1093/molbev/mss190; Lu J, 2005, P NATL ACAD SCI USA, V102, P4063, DOI 10.1073/pnas.0500436102; Mank JE, 2007, GENOME RES, V17, P618, DOI 10.1101/gr.6031907; Mank JE, 2010, MOL BIOL EVOL, V27, P661, DOI 10.1093/molbev/msp282; Mank JE, 2010, EVOLUTION, V64, P663, DOI 10.1111/j.1558-5646.2009.00853.x; Marais G, 2004, J MOL EVOL, V59, P771, DOI 10.1007/s00239-004-2671-2; Marbach D, 2012, GENOME RES, V22, P1334, DOI 10.1101/gr.127191.111; Meiklejohn CD, 2012, GENOME BIOL EVOL, V4, P1007, DOI 10.1093/gbe/evs077; Meiklejohn CD, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001126; Meisel RP, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1003013; Meisel RP, 2012, GENOME RES, V22, P1255, DOI 10.1101/gr.132100.111; Meisel RP, 2011, MOL BIOL EVOL, V28, P1893, DOI 10.1093/molbev/msr010; Mikhaylova LM, 2011, BMC BIOL, V9, DOI 10.1186/1741-7007-9-29; Muller Lena, 2012, Int J Evol Biol, V2012, P963976, DOI 10.1155/2012/963976; Musters H, 2006, J MOL EVOL, V62, P693, DOI 10.1007/s00239-005-0165-5; Nielsen R, 2005, PLOS BIOL, V3, P976, DOI 10.1371/journal.pbio.0030170; Nuzhdin SV, 2004, MOL BIOL EVOL, V21, P1308, DOI 10.1093/molbev/msh128; Pal C, 2001, GENETICS, V158, P927; Parisi M, 2003, SCIENCE, V299, P697, DOI 10.1126/science.1079190; Perry JC, 2014, MOL BIOL EVOL, V31, P1206, DOI 10.1093/molbev/msu072; Proschel M, 2006, GENETICS, V174, P893, DOI 10.1534/genetics.106.058008; Sackton TB, 2014, EVOLUTION; Singh ND, 2008, MOL BIOL EVOL, V25, P454, DOI 10.1093/molbev/msm275; Singh ND, 2005, GENETICS, V171, P145, DOI 10.1534/genetics.105.043497; Singh ND, 2005, J MOL EVOL, V61, P315, DOI 10.1007/s00239-004-0287-1; Smith JM, 2007, GENET RES, V89, P391, DOI [10.1017/S0016672308009579, 10.1017/S0016672300014634]; Sturgill D, 2007, NATURE, V450, P238, DOI 10.1038/nature06330; Thornton K, 2006, GENOME RES, V16, P498, DOI 10.1101/gr.4447906; Thornton K, 2005, MOL BIOL EVOL, V22, P273, DOI 10.1093/molbev/msi015; Thornton K, 2002, MOL BIOL EVOL, V19, P918, DOI 10.1093/oxfordjournals.molbev.a004149; Veeramah KR, 2014, MOL BIOL EVOL; Vibranovski MD, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000731; Vicario S, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-226; Vicoso B, 2006, NAT REV GENET, V7, P645, DOI 10.1038/nrg1914; Vicoso B, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001643; Vicoso B, 2009, GENETICS, V181, P1699, DOI 10.1534/genetics.108.098004; Vicoso B, 2009, EVOLUTION, V63, P2413, DOI 10.1111/j.1558-5646.2009.00719.x; Vicoso B, 2008, GENET RES, V90, P421, DOI 10.1017/S0016672308009804; Wu CI, 1996, TRENDS ECOL EVOL, V11, P281, DOI 10.1016/0169-5347(96)10033-1; WU CI, 1993, AM NAT, V142, P187, DOI 10.1086/285534; Yanai I, 2005, BIOINFORMATICS, V21, P650, DOI 10.1093/bioinformatics/bti042; Yang ZH, 1997, COMPUT APPL BIOSCI, V13, P555; Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088; Zhang Y, 2007, NATURE, V450, P233, DOI 10.1038/nature06323; Zhang Z, 2004, MOL BIOL EVOL, V21, P2130, DOI 10.1093/molbev/msh223	95	8	8	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2015	10	3							e0116829	10.1371/journal.pone.0116829	http://dx.doi.org/10.1371/journal.pone.0116829			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD9NQ	25789611	Green Published, gold, Green Submitted			2022-12-27	WOS:000351425400021
J	Stapleton, JM; Poirier, MP; Flouris, AD; Boulay, P; Sigal, RJ; Malcolm, J; Kenny, GP				Stapleton, Jill M.; Poirier, Martin P.; Flouris, Andreas D.; Boulay, Pierre; Sigal, Ronald J.; Malcolm, Janine; Kenny, Glen P.			At What Level of Heat Load Are Age-Related Impairments in the Ability to Dissipate Heat Evident in Females?	PLOS ONE			English	Article							SKIN BLOOD-FLOW; HUMID HEAT; THERMOREGULATORY RESPONSES; REGIONAL DIFFERENCES; SWEATING RESPONSES; PHYSICAL-FITNESS; AEROBIC FITNESS; OLDER MALES; DRY HEAT; EXERCISE	Studies have reported that older females have impaired heat loss responses during work in the heat compared to young females. However, it remains unclear at what level of heat stress these differences occur. Therefore, we examined whole-body heat loss [evaporative (H-E) and dry heat loss, via direct calorimetry] and changes in body heat storage (Delta H-b, via direct and indirect calorimetry) in 10 young (23 +/- 4 years) and 10 older (58 +/- 5 years) females matched for body surface area and aerobic fitness (VO(2)peak) during three 30-min exercise bouts performed at incremental rates of metabolic heat production of 250 (Ex1), 325 (Ex2) and 400 (Ex3) Win the heat (40 degrees C, 15% relative humidity). Exercise bouts were separated by 15 min of recovery. Since dry heat gain was similar between young and older females during exercise (p=0.52) and recovery (p=0.42), differences in whole-body heat loss were solely due to HE. Our results show that older females had a significantly lower H-E at the end of Ex2 (young: 383 +/- 34 W; older: 343 +/- 39 W, p=0.04) and Ex3 (young: 437 +/- 36 W; older: 389 +/- 29 W, p=0.008), however no difference was measured at the end of Ex1 (p=0.24). Also, the magnitude of difference in the maximal level of HE achieved between the young and older females became greater with increasing heat loads (Ex1=10.2%, Ex2=11.6% and Ex3=12.4%). Furthermore, a significantly greater Delta H-b was measured for all heat loads for the older females (Ex1: 178 +/- 44 kJ; Ex2: 151 +/- 38 kJ; Ex3: 216 +/- 25 kJ, p=0.002) relative to the younger females (Ex1: 127 +/- 35 kJ; Ex2: 96 +/- 45 kJ; Ex3: 146 +/- 46 kJ). In contrast, no differences in HE or Delta H-b were observed during recovery (p>0.05). We show that older habitually active females have an impaired capacity to dissipate heat compared to young females during exercise-induced heat loads of >= 325 W when performed in the heat.	[Stapleton, Jill M.; Poirier, Martin P.; Kenny, Glen P.] Univ Ottawa, Human & Environm Physiol Res Unit, Ottawa, ON, Canada; [Flouris, Andreas D.] Univ Thessaly, Dept Exercise Sci, FAME Lab, Trikala, Greece; [Boulay, Pierre] Univ Sherbrooke, Fac Phys Act Sci, Sherbrooke, PQ J1K 2R1, Canada; [Sigal, Ronald J.] Univ Calgary, Fac Med, Dept Med, Dept Cardiac Sci, Calgary, AB, Canada; [Sigal, Ronald J.] Univ Calgary, Fac Med, Dept Community Hlth Sci, Calgary, AB, Canada; [Sigal, Ronald J.] Univ Calgary, Fac Kinesiol, Dept Med, Dept Cardiac Sci, Calgary, AB, Canada; [Sigal, Ronald J.] Univ Calgary, Fac Kinesiol, Dept Community Hlth Sci, Calgary, AB, Canada; [Malcolm, Janine] Ottawa Hosp Riverside Campus, Div Endocrinol & Metab, Ottawa, ON, Canada; [Kenny, Glen P.] Ottawa Hosp, Res Inst, Clin Epidemiol Program, Ottawa, ON, Canada	University of Ottawa; University of Thessaly; University of Sherbrooke; University of Calgary; University of Calgary; University of Calgary; University of Calgary; University of Ottawa; University of Ottawa; Ottawa Hospital Research Institute	Kenny, GP (corresponding author), Univ Ottawa, Human & Environm Physiol Res Unit, Ottawa, ON, Canada.	gkenny@uottawa.ca	Sigal, Ronald/AAU-6081-2020; Sigal, Ron/AAK-7627-2020; Flouris, Andreas/GXG-4893-2022; Flouris, Andreas/I-5930-2014	Flouris, Andreas/0000-0002-9823-3915; Poirier, Martin/0000-0001-8914-1421	Canadian Institutes of Health Research [286363]; Leaders Opportunity Fund from the Canada Foundation for Innovation; University of Ottawa Research Chair Award; Human and Environmental Physiology Research Unit; Queen Elizabeth II graduate scholarships in science and technology; Ontario's Ministry of Training, Colleges, and Universities	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Leaders Opportunity Fund from the Canada Foundation for Innovation; University of Ottawa Research Chair Award; Human and Environmental Physiology Research Unit; Queen Elizabeth II graduate scholarships in science and technology; Ontario's Ministry of Training, Colleges, and Universities	This study was supported by grants from the Canadian Institutes of Health Research (grant no: 286363) and a Leaders Opportunity Fund from the Canada Foundation for Innovation (all grants held by Dr. Kenny). GPK was supported by a University of Ottawa Research Chair Award. JMS was supported by the Human and Environmental Physiology Research Unit. MPP was supported by Queen Elizabeth II graduate scholarships in science and technology, which was funded by the Ontario's Ministry of Training, Colleges, and Universities. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSON RK, 1987, J APPL PHYSIOL, V63, P1089, DOI 10.1152/jappl.1987.63.3.1089; Brooks EM, 1997, J APPL PHYSIOL, V83, P477, DOI 10.1152/jappl.1997.83.2.477; BUONO MJ, 1988, J APPL PHYSIOL, V65, P811, DOI 10.1152/jappl.1988.65.2.811; Cheung SS, 1998, J APPL PHYSIOL, V84, P1731, DOI 10.1152/jappl.1998.84.5.1731; Cheuvront SN, 2009, J APPL PHYSIOL, V107, P69, DOI 10.1152/japplphysiol.00250.2009; COLLINS KJ, 1977, BRIT MED J, V1, P353, DOI 10.1136/bmj.1.6057.353; CROWE JP, 1974, J PHYSIOL-LONDON, V236, pP43; DRINKWATER BL, 1979, MED SCI SPORT EXER, V11, P49; DUBOIS D, 1989, NUTRITION, V5, P303; Dufour A, 2007, EUR J APPL PHYSIOL, V100, P19, DOI 10.1007/s00421-007-0396-9; FENNELL WH, 1973, J PHYSIOL-LONDON, V231, pP118; FOSTER K G, 1976, Age and Ageing, V5, P91, DOI 10.1093/ageing/5.2.91; GISOLFI C, 1969, J APPL PHYSIOL, V26, P530, DOI 10.1152/jappl.1969.26.5.530; HAVENITH G, 1990, EUR J APPL PHYSIOL, V61, P419, DOI 10.1007/BF00236062; HELLON RF, 1956, J PHYSIOL-LONDON, V133, P132, DOI 10.1113/jphysiol.1956.sp005571; Inbar O, 2004, EXP PHYSIOL, V89, P691, DOI 10.1113/expphysiol.2004.027979; Inoue Y, 1996, EUR J APPL PHYSIOL O, V74, P78, DOI 10.1007/BF00376498; Inoue Y, 1999, EUR J APPL PHYSIOL O, V79, P121, DOI 10.1007/s004210050485; INOUE Y, 1991, J APPL PHYSIOL, V71, P2453, DOI 10.1152/jappl.1991.71.6.2453; Inoue Yoshimitsu, 2004, Journal of Physiological Anthropology and Applied Human Science, V23, P289, DOI 10.2114/jpa.23.289; Kenney WL, 1997, AM J PHYSIOL-HEART C, V272, pH1609, DOI 10.1152/ajpheart.1997.272.4.H1609; Kenney WL, 2003, J APPL PHYSIOL, V95, P2598, DOI 10.1152/japplphysiol.00202.2003; KENNEY WL, 1988, MED SCI SPORT EXER, V20, P155; Kenny GP, 2007, APPL PHYSIOL NUTR ME, V32, P818, DOI 10.1139/H07-044; Kenny GP, 2013, COMPR PHYSIOL, V3, P1689, DOI 10.1002/cphy.c130011; KOHL HW, 1988, AM J EPIDEMIOL, V127, P1228, DOI 10.1093/oxfordjournals.aje.a114915; Larose J, 2014, J APPL PHYSIOL, V117, P69, DOI 10.1152/japplphysiol.00123.2014; Larose J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083148; Larose J, 2013, MED SCI SPORT EXER, V45, P2265, DOI 10.1249/MSS.0b013e31829d24cc; Larose J, 2013, AM J PHYSIOL-REG I, V305, pR619, DOI 10.1152/ajpregu.00157.2013; LIND AR, 1970, J APPL PHYSIOL, V28, P50; McKenzie JE, 2004, J THERM BIOL, V29, P605, DOI 10.1016/j.jtherbio.2004.08.020; NADEL ER, 1971, J APPL PHYSIOL, V31, P828, DOI 10.1152/jappl.1971.31.6.828; RAMANATHAN NL, 1964, J APPL PHYSIOL, V19, P531, DOI 10.1152/jappl.1964.19.3.531; Reardon FD, 2006, MED BIOL ENG COMPUT, V44, P721, DOI 10.1007/s11517-006-0086-5; SAGAWA S, 1988, J GERONTOL, V43, pM1, DOI 10.1093/geronj/43.1.M1; Selkirk GA, 2001, J APPL PHYSIOL, V91, P2055, DOI 10.1152/jappl.2001.91.5.2055; Shibasaki M, 2006, J APPL PHYSIOL, V100, P1692, DOI 10.1152/japplphysiol.01124.2005; SIRI W E, 1956, Adv Biol Med Phys, V4, P239; Smith CJ, 2013, AM J PHYSIOL-REG I, V305, pR877, DOI 10.1152/ajpregu.00290.2013; Smith CJ, 2013, AM J PHYSIOL-REG I, V304, pR566, DOI 10.1152/ajpregu.00514.2012; Smith CJ, 2012, MED SCI SPORT EXER, V44, P2350, DOI 10.1249/MSS.0b013e318267b0c4; SMOLANDER J, 1990, EUR J APPL PHYSIOL O, V61, P413, DOI 10.1007/BF00236061; TANKERSLEY CG, 1991, J APPL PHYSIOL, V71, P236, DOI 10.1152/jappl.1991.71.1.236; TANKERSLEY CG, 1992, J APPL PHYSIOL, V73, P1238, DOI 10.1152/jappl.1992.73.4.1238; TAYLOR WF, 1984, J APPL PHYSIOL, V57, P191, DOI 10.1152/jappl.1984.57.1.191	46	36	36	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2015	10	3							e0119079	10.1371/journal.pone.0119079	http://dx.doi.org/10.1371/journal.pone.0119079			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD9NQ	25790024	Green Published, gold, Green Submitted			2022-12-27	WOS:000351425400064
J	Yang, Y; Zhang, F; Skrip, L; Lei, H; Luo, SX; Lu, K; Hu, DY				Yang, Yuan; Zhang, Fan; Skrip, Laura; Lei, Han; Luo, Suxin; Lu, Kai; Hu, Dayi			Lack of an Association between Angiotensin Receptor Blocker Based Therapy and Increased Risk of Cancer: Evidence from Large Observational Studies	PLOS ONE			English	Article							HYPOXIA-INDUCIBLE FACTOR-1-ALPHA; CANDESARTAN COMBINATION THERAPY; LONG-TERM USE; LUNG-CANCER; CELL-GROWTH; INHIBITION; SYSTEM; METAANALYSIS; TRIAL; GEMCITABINE	Background A previous meta-analysis of randomized controlled studies that were not designed to investigate cancer as a primary outcome suggested that ARB-based therapy is associated with increased risk of cancer; however, results of recent observational studies considering the association have been contradictory. This study sought to evaluate the association between angiotensin receptor blocker (ARB)-based therapy and risk of cancer by conducting a meta-analysis of observational studies. Methods Relevant articles published before February 2014 were identified by searching PubMed and the Cochrane Library. Pooled relative risks (RRs) were determined using a random effects model and were used to assess the strength of association between use of ARB-based therapy and risk of cancer. Results Six retrospective cohort studies involving a total of 3,827,109 participants and four case-control studies involving a total of 193,029 cases were included. The present study found that ARB-based therapy was not significantly associated with an increased risk of cancer (RR = 0.87, 95% CI: [0.75, 1.01]). However, an analysis including only cohort studies suggested a significantly decreased risk of cancer among individuals with any history of ARB use as compared to those with no history of ARB use (RR = 0.80, 95% CI: [0.55, 0.95]); no significant association was found between ARB use and risk of cancer when the case-control studies were separately considered (RR = 1.03, 95% CI: [0.93, 1.13]). Subgroup analyses showed that use of ARB-based therapy was associated with decreased risk of lung cancer (RR = 0.81, 95% CI: [0.69, 0.94]); however, no significant associations were found with the other cancer sites investigated. Furthermore, no association was observed upon adjustment by type of ARB drug. No publication bias was detected. Conclusion Overall, ARB-based therapy was not associated with increased risk of cancer. However, its use may be related to decreased incidence of lung cancer; this finding should be considered carefully and confirmed with further studies.	[Yang, Yuan; Lei, Han; Luo, Suxin; Lu, Kai; Hu, Dayi] Chongqing Med Univ, Affiliated Hosp 1, Dept Cardiovasc Med, Chongqing, Peoples R China; [Zhang, Fan] Chongqing Med Univ, Sch Publ Hlth & Hlth Management, Chongqing, Peoples R China; [Skrip, Laura] Yale Univ, Sch Publ Hlth, Dept Epidemiol Microbial Dis, New Haven, CT USA	Chongqing Medical University; Chongqing Medical University; Yale University	Hu, DY (corresponding author), Chongqing Med Univ, Affiliated Hosp 1, Dept Cardiovasc Med, Chongqing, Peoples R China.	ebm_cq@126.com		Lu, Kai/0000-0002-4332-0042	National Key Clinical Specialties Construction Program of China	National Key Clinical Specialties Construction Program of China	The work was supported by National Key Clinical Specialties Construction Program of China.	Azoulay L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050893; Bangalore S, 2011, LANCET ONCOL, V12, P65, DOI 10.1016/S1470-2045(10)70260-6; BATRA VK, 1994, CANCER LETT, V76, P19, DOI 10.1016/0304-3835(94)90129-5; BEGG CB, 1994, BIOMETRICS, V50, P1088, DOI 10.2307/2533446; Bhaskaran K, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e2697; Chang CH, 2011, J CLIN ONCOL, V29, P3001, DOI 10.1200/JCO.2011.35.1908; Chiang YY, 2014, J CLIN HYPERTENS, V16, P27, DOI 10.1111/jch.12228; Chin HJ, 2011, J KOREAN MED SCI, V26, P59, DOI 10.3346/jkms.2011.26.1.59; Deshayes F, 2005, TRENDS ENDOCRIN MET, V16, P293, DOI 10.1016/j.tem.2005.07.009; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Fujita M, 2005, CARCINOGENESIS, V26, P271, DOI 10.1093/carcin/bgh324; Gallagher PE, 2004, CARCINOGENESIS, V25, P2045, DOI 10.1093/carcin/bgh236; Hallas J, 2012, BRIT J CLIN PHARMACO, V74, P180, DOI 10.1111/j.1365-2125.2012.04170.x; Hamling J, 2008, STAT MED, V27, P954, DOI 10.1002/sim.3013; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; Huang CC, 2011, AM J CARDIOL, V107, P1028, DOI 10.1016/j.amjcard.2010.11.026; Kim ST, 2012, ONCOLOGY-BASEL, V83, P354, DOI 10.1159/000337979; Kinoshita J, 2009, INT J ONCOL, V34, P1573, DOI 10.3892/ijo_00000287; Koomen ER, 2009, CANCER EPIDEMIOL, V33, P391, DOI 10.1016/j.canep.2009.10.005; Kosaka T, 2010, PROSTATE, V70, P162, DOI 10.1002/pros.21049; Makar GA, 2014, JNCI-J NATL CANCER I, V106, DOI 10.1093/jnci/djt374; Matsuyama M, 2010, EXP THER MED, V1, P301, DOI 10.3892/etm_00000046; Moher D, 2009, PLOS MED, V6, DOI [10.1136/bmj.b4037, 10.1371/journal.pmed.1000097]; Nakai Y, 2010, BRIT J CANCER, V103, P1644, DOI 10.1038/sj.bjc.6605955; Nakai Y, 2013, INVEST NEW DRUG, V31, P1294, DOI 10.1007/s10637-013-9972-5; Nakai Y, 2012, CANCER SCI, V103, P1489, DOI 10.1111/j.1349-7006.2012.02311.x; Overton RC, 1998, PSYCHOL METHODS, V3, P354, DOI 10.1037/1082-989X.3.3.354; Page EL, 2002, J BIOL CHEM, V277, P48403, DOI 10.1074/jbc.M209114200; Pasternak B, 2011, CIRCULATION, V123, P1729, DOI 10.1161/CIRCULATIONAHA.110.007336; Pickel L, 2010, CANCER BIOL THER, V9, P277, DOI 10.4161/cbt.9.4.10643; Qian YR, 2013, ONCOL REP, V29, P2408, DOI 10.3892/or.2013.2370; Rao GA, 2013, J CLIN PHARMACOL, V53, P773, DOI 10.1002/jcph.98; Rao GA, 2013, J HYPERTENS, V31, P1669, DOI 10.1097/HJH.0b013e3283621ea3; Sipahi I, 2010, LANCET ONCOL, V11, P627, DOI 10.1016/S1470-2045(10)70106-6; Sorensen GV, 2013, J CLIN ONCOL, V31, P2265, DOI 10.1200/JCO.2012.43.9190; Spiegelman BM, 1998, DIABETES, V47, P507, DOI 10.2337/diabetes.47.4.507; Sugiura R, 2012, AM J CARDIOL, V109, P576, DOI 10.1016/j.amjcard.2011.09.050; Teo KK, 2011, J HYPERTENS, V29, P623, DOI 10.1097/HJH.0b013e328344a7de; Wang KL, 2013, INT J CARDIOL, V167, P2162, DOI 10.1016/j.ijcard.2012.05.096; WASYLYK B, 1993, EUR J BIOCHEM, V211, P7, DOI 10.1111/j.1432-1033.1993.tb19864.x; Wells GA, 2012, NEWCASTLE OTTAWA SCA, DOI [10.2307/632432, DOI 10.2307/632432]; Wilop S, 2009, J CANCER RES CLIN, V135, P1429, DOI 10.1007/s00432-009-0587-3; Yilmaz MI, 2010, CLIN J AM SOC NEPHRO, V5, P1174, DOI 10.2215/CJN.01110210; Yoon GJ, 2010, J AM COLL CARDIOL, V56, P1644, DOI 10.1016/j.jacc.2010.07.023; Yuge K, 2012, ANN SURG ONCOL, V19, P3987, DOI 10.1245/s10434-012-2568-z; Zhan YM, 2005, J CLIN INVEST, V115, P2508, DOI 10.1172/JCI24403	46	11	11	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2015	10	3							e0119775	10.1371/journal.pone.0119775	http://dx.doi.org/10.1371/journal.pone.0119775			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD9NQ	25790107	Green Submitted, Green Published, gold			2022-12-27	WOS:000351425400105
J	Chang, HHD; Xu, Y; Lai, HY; Yang, XY; Tseng, CC; Lai, YJJ; Pan, Y; Zhou, E; Johnson, MD; Wang, JK; Lin, CY				Chang, Hsiang-Hua D.; Xu, Yuan; Lai, Hongyu; Yang, Xiaoyu; Tseng, Chun-Che; Lai, Ying-Jung J.; Pan, Yu; Zhou, Emily; Johnson, Michael D.; Wang, Jehng-Kang; Lin, Chen-Yong			Differential Subcellular Localization Renders HAI-2 a Matriptase Inhibitor in Breast Cancer Cells but Not in Mammary Epithelial Cells	PLOS ONE			English	Article							HEPATOCYTE GROWTH-FACTOR; FACTOR ACTIVATOR INHIBITOR; SERINE-PROTEASE INHIBITOR; PROTEOLYTIC CASCADE; ZYMOGEN ACTIVATION; HUMAN TISSUES; EXPRESSION; CARCINOMA; DOMAIN; LINES	The type 2 transmembrane serine protease matriptase is under tight control primarily by the actions of the integral membrane Kunitz-type serine protease inhibitor HAI-1. Growing evidence indicates that HAI-2 might also be involved in matriptase inhibition in some contexts. Here we showed that matriptase inhibition by HAI-2 depends on the subcellular localizations of HAI-2, and is observed in breast cancer cells but not in mammary epithelial cells. HAI-2 is co-expressed with matriptase in 21 out of 26 human epithelial and carcinoma cells examined. HAI-2 is also a potent matriptase inhibitor in solution, but in spite of this, HAI-2 inhibition of matriptase is not observed in all contexts where HAI-2 is expressed, unlike what is seen for HAI-1. Induction of matriptase zymogen activation in mammary epithelial cells results in the formation of matriptase-HAI-1 complexes, but matriptase-HAI-2 complexes are not observed. In breast cancer cells, however, in addition to the appearance of matriptase-HAI-1 complex, three different matriptase-HAI-2 complexes, are formed following the induction of matriptase activation. Immunofluorescent staining reveals that activated matriptase is focused at the cell-cell junctions upon the induction of matriptase zymogen activation in both mammary epithelial cells and breast cancer cells. HAI-2, in contrast, remains localized in vesicle/granule-like structures during matriptase zymogen activation in human mammary epithelial cells. In breast cancer cells, however, a proportion of the HAI-2 reaches the cell surface where it can gain access to and inhibit active matriptase. Collectively, these data suggest that matriptase inhibition by HAI-2 requires the translocation of HAI-2 to the cell surface, a process which is observed in some breast cancer cells but not in mammary epithelial cells.	[Chang, Hsiang-Hua D.; Xu, Yuan; Lai, Hongyu; Yang, Xiaoyu; Tseng, Chun-Che; Lai, Ying-Jung J.; Pan, Yu; Johnson, Michael D.; Lin, Chen-Yong] Georgetown Univ, Lombardi Comprehens Canc Ctr, Dept Oncol, Washington, DC 20057 USA; [Chang, Hsiang-Hua D.; Wang, Jehng-Kang] Natl Def Med Ctr, Dept Biochem, Taipei 10764, Taiwan; [Tseng, Chun-Che] Carleton Coll, Dept Biol, Northfield, MN 55057 USA; [Zhou, Emily] Thomas Jefferson High Sch Sci & Technol, Alexandria, VA 22046 USA	Georgetown University; National Defense Medical Center; Carleton College	Wang, JK (corresponding author), Natl Def Med Ctr, Dept Biochem, Taipei 10764, Taiwan.	jkwang@ndmctsgh.edu.tw	Lin, Chen/GRR-2799-2022	Tseng, Chun-che/0000-0001-9637-4127; johnson, Michael/0000-0001-6260-7586	National Cancer Institute (NCI) [RO1 CA 123223]; Taiwan Department of Defense [DOD97-13-02]; NATIONAL CANCER INSTITUTE [R01CA123223, P30CA051008] Funding Source: NIH RePORTER	National Cancer Institute (NCI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Taiwan Department of Defense; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study was supported by National Cancer Institute (NCI) Grants RO1 CA 123223 (to M. Johnson and C.-Y. Lin), and Taiwan Department of Defense Grant DOD97-13-02 (to J.-K. Wang). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BARTEK J, 1991, P NATL ACAD SCI USA, V88, P3520, DOI 10.1073/pnas.88.9.3520; Benaud C, 2002, J BIOL CHEM, V277, P10539, DOI 10.1074/jbc.M109064200; Benaud C, 2001, EUR J BIOCHEM, V268, P1439, DOI 10.1046/j.1432-1327.2001.02016.x; Benaud CM, 2002, CLIN EXP METASTAS, V19, P639, DOI 10.1023/A:1020985632550; Chen YW, 2010, J BIOL CHEM, V285, P31755, DOI 10.1074/jbc.M110.150367; Cho EG, 2001, J BIOL CHEM, V276, P44581, DOI 10.1074/jbc.M107059200; Chou FP, 2013, AM J PATHOL, V183, P1306, DOI 10.1016/j.ajpath.2013.06.024; Chu LL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092244; Heinz-Erian P, 2009, AM J HUM GENET, V84, P188, DOI 10.1016/j.ajhg.2009.01.004; HEO DS, 1989, CANCER RES, V49, P5167; Hung RJ, 2004, AM J PHYSIOL-CELL PH, V286, pC1159, DOI 10.1152/ajpcell.00400.2003; Itoh H, 1999, BIOCHEM BIOPH RES CO, V255, P740, DOI 10.1006/bbrc.1999.0268; Kataoka H, 1999, J HISTOCHEM CYTOCHEM, V47, P673, DOI 10.1177/002215549904700509; Kawaguchi T, 1997, J BIOL CHEM, V272, P27558, DOI 10.1074/jbc.272.44.27558; Kirchhofer D, 2003, J BIOL CHEM, V278, P36341, DOI 10.1074/jbc.M304643200; Lee MS, 2005, AM J PHYSIOL-CELL PH, V288, pC932, DOI 10.1152/ajpcell.00497.2004; Lin CY, 1999, J BIOL CHEM, V274, P18237, DOI 10.1074/jbc.274.26.18237; MIYAZAWA K, 1993, J BIOL CHEM, V268, P10024; Oberst MD, 2005, AM J PHYSIOL-CELL PH, V289, pC462, DOI 10.1152/ajpcell.00076.2005; Oberst MD, 2003, J BIOL CHEM, V278, P26773, DOI 10.1074/jbc.M304282200; Oberst MD, 2003, J HISTOCHEM CYTOCHEM, V51, P1017, DOI 10.1177/002215540305100805; Shimomura T, 1997, J BIOL CHEM, V272, P6370, DOI 10.1074/jbc.272.10.6370; STAMPFER MR, 1985, P NATL ACAD SCI USA, V82, P2394, DOI 10.1073/pnas.82.8.2394; Szabo R, 2008, J BIOL CHEM, V283, P29495, DOI 10.1074/jbc.M801970200; Szabo R, 2009, DEVELOPMENT, V136, P2653, DOI 10.1242/dev.038430; TEICHER BA, 1987, CANCER RES, V47, P388; Tseng IC, 2010, J BIOL CHEM, V285, P3261, DOI 10.1074/jbc.M109.055640; Ustach CV, 2010, CANCER RES, V70, P9631, DOI 10.1158/0008-5472.CAN-10-0511; Wang JK, 2009, AM J PHYSIOL-CELL PH, V297, pC459, DOI 10.1152/ajpcell.00201.2009; Xu H, 2012, AM J PHYSIOL-CELL PH, V302, pC453, DOI 10.1152/ajpcell.00344.2011; Xu ZH, 2011, J MED CHEM, V54, P7567, DOI 10.1021/jm200920s; YASUMURA S, 1993, CANCER RES, V53, P1461	32	14	15	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2015	10	3							e0120489	10.1371/journal.pone.0120489	http://dx.doi.org/10.1371/journal.pone.0120489			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9BN	25786220	Green Submitted, Green Published, gold			2022-12-27	WOS:000352138500176
J	Deshpande, S; Pfohl, T				Deshpande, Siddharth; Pfohl, Thomas			Real-Time Dynamics of Emerging Actin Networks in Cell-Mimicking Compartments	PLOS ONE			English	Article							F-ACTIN; INTERNAL-STRESS; TRANSPORT; FILAMENTS; MYOSIN	Understanding the cytoskeletal functionality and its relation to other cellular components and properties is a prominent question in biophysics. The dynamics of actin cytoskeleton and its polymorphic nature are indispensable for the proper functioning of living cells. Actin bundles are involved in cell motility, environmental exploration, intracellular transport and mechanical stability. Though the viscoelastic properties of actin-based structures have been extensively probed, the underlying microstructure dynamics, especially their disassembly, is not fully understood. In this article, we explore the rich dynamics and emergent properties exhibited by actin bundles within flow-free confinements using a microfluidic setup and epifluorescence microscopy. After forming entangled actin filaments within cellsized quasi two-dimensional confinements, we induce their bundling using three different fundamental mechanisms: counterion condensation, depletion interactions and specific protein-protein interactions. Intriguingly, long actin filaments form emerging networks of actin bundles via percolation leading to remarkable properties such as stress generation and spindle-like intermediate structures. Simultaneous sharing of filaments in different links of the network is an important parameter, as short filaments do not form networks but segregated clusters of bundles instead. We encounter a hierarchical process of bundling and its subsequent disassembly. Additionally, our study suggests that such percolated networks are likely to exist within living cells in a dynamic fashion. These observations render a perspective about differential cytoskeletal responses towards numerous stimuli.	[Deshpande, Siddharth; Pfohl, Thomas] Univ Basel, Dept Chem, CH-4056 Basel, Switzerland	University of Basel	Pfohl, T (corresponding author), Univ Basel, Dept Chem, Klingelbergstr 80, CH-4056 Basel, Switzerland.	thomas.pfohl@unibas.ch	Pfohl, Thomas/D-7296-2016; Deshpande, Siddharth/Y-3825-2019; Deshpande, Siddharth/ABA-9055-2020	Pfohl, Thomas/0000-0002-7879-5216; Deshpande, Siddharth/0000-0002-7137-8962	Swiss National Science Foundation [SNF 200020_141270]; Swiss Nanoscience Institute (SNI)	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Swiss Nanoscience Institute (SNI)	SD and TP received financial support from the Swiss National Science Foundation, grant number SNF 200020_141270. Financial support from the Swiss Nanoscience Institute (SNI) is gratefully acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberts A, 2008, MOL BIOL CELL; ASAKURA S, 1954, J CHEM PHYS, V22, P1255, DOI 10.1063/1.1740347; Brangbour C, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000613; BURLACU S, 1992, AM J PHYSIOL, V262, pC569, DOI 10.1152/ajpcell.1992.262.3.C569; Claessens MMAE, 2006, NAT MATER, V5, P748, DOI 10.1038/nmat1718; Courson DS, 2010, J BIOL CHEM, V285, P26350, DOI 10.1074/jbc.M110.123117; Deshpande S, 2012, BIOMICROFLUIDICS, V6, DOI 10.1063/1.4752245; Ellis RJ, 2001, TRENDS BIOCHEM SCI, V26, P597, DOI 10.1016/S0968-0004(01)01938-7; Gardel ML, 2004, SCIENCE, V304, P1301, DOI 10.1126/science.1095087; Honda M, 1999, J MOL BIOL, V287, P293, DOI 10.1006/jmbi.1999.2592; Howard J., 2001, MECH MOTOR PROTEINS; Huber F, 2013, ADV PHYS, V62, P1, DOI 10.1080/00018732.2013.771509; Janmey PA, 1999, ACTIN FILAMENTS BIOP; Jegou A, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001161; Kohler S, 2011, NAT MATER, V10, P462, DOI [10.1038/NMAT3009, 10.1038/nmat3009]; Koster S, 2009, CELL MOTIL CYTOSKEL, V66, P771, DOI 10.1002/cm.20336; Koster S, 2005, J PHYS-CONDENS MAT, V17, pS4091, DOI 10.1088/0953-8984/17/49/006; Li MG, 1999, J CELL BIOL, V146, P1061, DOI 10.1083/jcb.146.5.1061; Lieleg O, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.088102; Lieleg O, 2011, NAT MATER, V10, P236, DOI [10.1038/nmat2939, 10.1038/NMAT2939]; Lieleg O, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.108101; Lieleg O, 2010, SOFT MATTER, V6, P218, DOI 10.1039/b912163n; Limozin L, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.168103; Maloney MT, 2011, DEV NEUROBIOL, V71, P795, DOI 10.1002/dneu.20908; MANNING GS, 1978, Q REV BIOPHYS, V11, P179, DOI 10.1017/S0033583500002031; PODOLSKI JL, 1990, J BIOL CHEM, V265, P1312; Popowicz GM, 2006, TRENDS BIOCHEM SCI, V31, P411, DOI 10.1016/j.tibs.2006.05.006; Reichl EM, 2008, CURR BIOL, V18, P471, DOI 10.1016/j.cub.2008.02.056; ROMANI A, 1993, MINER ELECTROL METAB, V19, P282; Sandquist JC, 2011, DEV CELL, V21, P410, DOI 10.1016/j.devcel.2011.07.018; SCHMIDT CF, 1989, MACROMOLECULES, V22, P3638, DOI 10.1021/ma00199a023; Schmoller KM, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1134; Schmoller KM, 2009, BIOPHYS J, V97, P83, DOI 10.1016/j.bpj.2009.04.040; Schmoller KM, 2008, SOFT MATTER, V4, P2365, DOI 10.1039/b808582j; Smith D, 2007, BIOPHYS J, V93, P4445, DOI 10.1529/biophysj.106.095919; Steinhauser D, 2012, ACS MACRO LETT, V1, P541, DOI 10.1021/mz3000539; Strehle D, 2011, EUR BIOPHYS J BIOPHY, V40, P93, DOI 10.1007/s00249-010-0621-z; Streichfuss M, 2011, NANO LETT, V11, P3676, DOI 10.1021/nl201630y; Takiguchi K, 2011, LANGMUIR, V27, P11528, DOI 10.1021/la2016287; Tang JX, 1996, J BIOL CHEM, V271, P8556, DOI 10.1074/jbc.271.15.8556; Thomas C, 2009, CELL MOTIL CYTOSKEL, V66, P940, DOI 10.1002/cm.20389	41	17	17	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2015	10	3							e0116521	10.1371/journal.pone.0116521	http://dx.doi.org/10.1371/journal.pone.0116521			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9BN	25785606	Green Published, Green Submitted, gold			2022-12-27	WOS:000352138500009
J	Filou, S; Korpetinou, A; Kyriakopoulou, D; Bounias, D; Stavropoulos, M; Ravazoula, P; Papachristou, DJ; Theocharis, AD; Vynios, DH				Filou, Serafula; Korpetinou, Aggeliki; Kyriakopoulou, Dora; Bounias, Dimitrios; Stavropoulos, Michael; Ravazoula, Panagiota; Papachristou, Dionysios J.; Theocharis, Achilleas D.; Vynios, Demitrios H.			ADAMTS Expression in Colorectal Cancer	PLOS ONE			English	Article							HUMAN ARTICULAR-CARTILAGE; AGGRECANASE ACTIVITY; HUMAN GLIOBLASTOMAS; FAMILY; VERSICAN; METALLOPROTEINASES; DISINTEGRIN; CARCINOMAS; ACCUMULATION; DECORIN	ADAMTSs are a family of secreted proteinases that share the metalloproteinase domain with matrix metalloproteinases (MMPs). By acting on a large panel of extracellular substrates, they control several cell functions such as fusion, adhesion, proliferation and migration. Through their thrombospondin motifs they also possess anti-angiogenic properties. We investigated whether ADAMTSs participate in colorectal cancer progression and invasion. Their expression was investigated at both mRNA and protein levels. Using RT-PCR, the expression of ADAMTS-1, -4, -5 and ADAMTS-20 was estimated in colorectal tumors of different cancer stage and anatomic site and 3 cell lines of different aggressiveness. An overexpression of ADAMTS-4 and -5 was observed, especially in tissue samples, whereas ADAMTS-1 and -20 were found to be down-regulated. Western blot analysis further supported the RT-PCR findings, revealing in addition the degradation of ADAMTS-1 and -20 in cancer. In situ expression and localization of ADAMTS-1, -4, -5 and -20 was also investigated by immunohistochemical analysis. Our data suggest a positive correlation between ADAMTS-4 and -5 expression and cancer progression, in contrast with the anti-angiogenic members of the family, ADAMTS-1 and -20, which were found to be down-regulated. Our findings support the notion that overexpression of ADAMTS-4 and ADAMTS-5 in colorectal cancer might be a possible invasive mechanism of cancer cells in order to degrade proteoglycans of ECM.	[Filou, Serafula; Korpetinou, Aggeliki; Theocharis, Achilleas D.; Vynios, Demitrios H.] Univ Patras, Dept Chem, Biochem Lab, Biochem Biochem Anal & Matrix Pathobiol Res Grp, Patras, Greece; [Kyriakopoulou, Dora; Bounias, Dimitrios; Stavropoulos, Michael] Sch Hlth Sci, Dept Surg, Patras, Greece; [Kyriakopoulou, Dora; Bounias, Dimitrios; Stavropoulos, Michael] Univ Hosp Patras, Patras, Greece; [Ravazoula, Panagiota] Univ Hosp Patras, Dept Histopathol, Patras, Greece; [Papachristou, Dionysios J.] Univ Patras, Dept Med, Anat Histol & Embryol Lab, Patras, Greece	University of Patras; University of Patras; University of Patras; University of Patras	Vynios, DH (corresponding author), Univ Patras, Dept Chem, Biochem Lab, Biochem Biochem Anal & Matrix Pathobiol Res Grp, Patras, Greece.	vynios@chemistry.upatras.gr	theocharis, achilleas/F-6903-2010					Abbaszade I, 1999, J BIOL CHEM, V274, P23443, DOI 10.1074/jbc.274.33.23443; Apte SS, 2004, INT J BIOCHEM CELL B, V36, P981, DOI 10.1016/j.biocel.2004.01.014; Bouga H, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-499; Cal S, 2002, GENE, V283, P49, DOI 10.1016/S0378-1119(01)00861-7; Center MM, 2009, CANCER EPIDEM BIOMAR, V18, P1688, DOI 10.1158/1055-9965.EPI-09-0090; Choi GCG, 2014, MOL CANCER RES, V12, P228, DOI 10.1158/1541-7786.MCR-13-0195; Cin PD, 1999, GENE CHROMOSOME CANC, V24, P94, DOI 10.1002/(SICI)1098-2264(199901)24:1<94::AID-GCC14>3.0.CO;2-2; Collins-Racie LA, 2004, MATRIX BIOL, V23, P219, DOI 10.1016/j.matbio.2004.05.004; Cross NA, 2005, PROSTATE, V63, P269, DOI 10.1002/pros.20182; Edwards BK, 2014, CANCER-AM CANCER SOC, V120, P1290, DOI 10.1002/cncr.28509; El-Rifai W, 2001, NEOPLASIA, V3, P173, DOI 10.1038/sj.neo.7900158; Fernandes RJ, 2001, J BIOL CHEM, V276, P31502, DOI 10.1074/jbc.M103466200; Filou S, 2013, BIOCHIMIE, V95, P725, DOI 10.1016/j.biochi.2012.10.022; Funayama M, 2002, ANN NEUROL, V51, P296, DOI 10.1002/ana.10113; Held-Feindt J, 2006, INT J CANCER, V118, P55, DOI 10.1002/ijc.21258; Hough RE, 2001, BRIT J CANCER, V84, P499, DOI 10.1054/bjoc.2000.1638; Lawler J, 2000, CURR OPIN CELL BIOL, V12, P634, DOI 10.1016/S0955-0674(00)00143-5; Lind GE, 2006, CELL ONCOL, V28, P259; Liu YJ, 2006, ONCOGENE, V25, P2452, DOI 10.1038/sj.onc.1209287; Matthews RT, 2000, J BIOL CHEM, V275, P22695, DOI 10.1074/jbc.M909764199; Mukaratirwa S, 2004, J COMP PATHOL, V131, P259, DOI 10.1016/j.jcpa.2004.04.007; Nakada M, 2005, ACTA NEUROPATHOL, V110, P239, DOI 10.1007/s00401-005-1032-6; PEDEUTOUR F, 1994, GENOMICS, V22, P512, DOI 10.1006/geno.1994.1424; Porter S, 2005, BIOCHEM J, V386, P15, DOI 10.1042/BJ20040424; Przemyslaw L, 2013, BMB REP, V46, P139, DOI 10.5483/BMBRep.2013.46.3.176; Rao N, 2013, INT J CANCER, V133, P294, DOI 10.1002/ijc.28037; Rocks N, 2006, BRIT J CANCER, V94, P724, DOI 10.1038/sj.bjc.6602990; Rodriguez-Manzaneque JC, 2000, J BIOL CHEM, V275, P33471, DOI 10.1074/jbc.M002599200; Sawaji Y, 2008, ARTHRITIS RHEUM, V58, P3498, DOI 10.1002/art.24025; Skandalis SS, 2006, BIOCHIMIE, V88, P1135, DOI 10.1016/j.biochi.2006.03.011; Skandalis SS, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-314; Thirunavukkarasu K, 2006, BIOCHEM BIOPH RES CO, V345, P197, DOI 10.1016/j.bbrc.2006.04.023; Tsara ME, 2002, ANTICANCER RES, V22, P2893; Van Der Jagt MFP, 2010, J SURG ONCOL, V101, P259, DOI 10.1002/jso.21462; Vazquez F, 1999, J BIOL CHEM, V274, P23349, DOI 10.1074/jbc.274.33.23349; Zeng WL, 2006, BBA-GEN SUBJECTS, V1760, P517, DOI 10.1016/j.bbagen.2006.01.013	36	23	25	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2015	10	3							e0121209	10.1371/journal.pone.0121209	http://dx.doi.org/10.1371/journal.pone.0121209			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9BN	25786261	Green Published, gold, Green Submitted			2022-12-27	WOS:000352138500201
J	Gross, CM; Rafikov, R; Kumar, S; Aggarwal, S; Ham, PB; Meadows, ML; Cherian-Shaw, M; Kangath, A; Sridhar, S; Lucas, R; Black, SM				Gross, Christine M.; Rafikov, Ruslan; Kumar, Sanjiv; Aggarwal, Saurabh; Ham, P. Benson, III; Meadows, Mary Louise; Cherian-Shaw, Mary; Kangath, Archana; Sridhar, Supriya; Lucas, Rudolf; Black, Stephen M.			Endothelial Nitric Oxide Synthase Deficient Mice Are Protected from Lipopolysaccharide Induced Acute Lung Injury	PLOS ONE			English	Article							ARGININE METHYL-ESTER; KAPPA-B-ALPHA; ASYMMETRIC DIMETHYLARGININE; RESPIRATORY-DISTRESS; PULMONARY-CIRCULATION; ENDOGENOUS INHIBITOR; INDUCIBLE ISOFORM; ENDOTOXIC-SHOCK; CECAL LIGATION; MOUSE MODEL	Lipopolysaccharide (LPS) derived from the outer membrane of gram-negative bacteria induces acute lung injury (ALI) in mice. This injury is associated with lung edema, inflammation, diffuse alveolar damage, and severe respiratory insufficiency. We have previously reported that LPS-mediated nitric oxide synthase (NOS) uncoupling, through increases in asymmetric dimethylarginine (ADMA), plays an important role in the development of ALI through the generation of reactive oxygen and nitrogen species. Therefore, the focus of this study was to determine whether mice deficient in endothelial NOS (eNOS(-/-)) are protected against ALI. In both wild-type and eNOS(-/-) mice, ALI was induced by the intratracheal instillation of LPS (2 mg/kg). After 24 hours, we found that eNOS(-/-)mice were protected against the LPS mediated increase in inflammatory cell infiltration, inflammatory cytokine production, and lung injury. In addition, LPS exposed eNOS(-/-) mice had increased oxygen saturation and improved lung mechanics. The protection in eNOS(-/-) mice was associated with an attenuated production of NO, NOS derived superoxide, and peroxynitrite. Furthermore, we found that eNOS(-/-) mice had less RhoA activation that correlated with a reduction in RhoA nitration at Tyr(34). Finally, we found that the reduction in NOS uncoupling in eNOS(-/-) mice was due to a preservation of dimethylarginine dimethylaminohydrolase (DDAH) activity that prevented the LPS-mediated increase in ADMA. Together our data suggest that eNOS derived reactive species play an important role in the development of LPS-mediated lung injury.	[Gross, Christine M.; Rafikov, Ruslan; Kumar, Sanjiv; Aggarwal, Saurabh; Ham, P. Benson, III; Meadows, Mary Louise; Cherian-Shaw, Mary; Kangath, Archana; Sridhar, Supriya; Lucas, Rudolf; Black, Stephen M.] Georgia Regents Univ, Vasc Biol Ctr, Pulm Dis Program, Augusta, GA 30912 USA	University System of Georgia; Augusta University	Black, SM (corresponding author), Georgia Regents Univ, Vasc Biol Ctr, Pulm Dis Program, Augusta, GA 30912 USA.	sblack@gru.edu	Rafikov, Ruslan/AAG-9352-2019; Lucas, Rudolf/ABA-3011-2020	Lucas, Rudolf/0000-0003-3805-8868; Rafikov, Ruslan/0000-0001-5950-4076	 [P01HL0101902];  [HL60190];  [HL67841];  [HL094609];  [12PRE12060224]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL101902, R01HL094609, R01HL060190, R01HL067841] Funding Source: NIH RePORTER	; ; ; ; ; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	All our funding sources are as follows: P01HL0101902 (SMB), HL60190 (SMB), and HL67841 (SMB) and HL094609 (RL) 12PRE12060224 (CG) AHA SDG (RR) and that the funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ader F, 2007, INTENS CARE MED, V33, P503, DOI 10.1007/s00134-006-0497-7; Aggarwal S, 2014, J BIOL CHEM, V289, P7948, DOI 10.1074/jbc.M113.534313; Aggarwal S, 2014, AM J RESP CELL MOL, V50, P614, DOI 10.1165/rcmb.2013-0193OC; Aggarwal S, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00161; Aggarwal S, 2011, J CELL PHYSIOL, V226, P3104, DOI 10.1002/jcp.22692; Arkovitz MS, 1996, J PEDIATR SURG, V31, P1009, DOI 10.1016/S0022-3468(96)90075-5; Balasubramaniam V, 2003, AM J PHYSIOL-LUNG C, V284, pL964, DOI 10.1152/ajplung.00421.2002; Balasubramaniam V, 2006, AM J PHYSIOL-LUNG C, V291, pL119, DOI 10.1152/ajplung.00395.2005; BERNARD GR, 1994, AM J RESP CRIT CARE, V149, P818, DOI 10.1164/ajrccm.149.3.7509706; Bloomfield GL, 1997, CRIT CARE MED, V25, P584, DOI 10.1097/00003246-199704000-00006; Boger RH, 2004, J NUTR, V134, p2842S, DOI 10.1093/jn/134.10.2842S; BUXTON ILO, 1993, CIRC RES, V72, P387, DOI 10.1161/01.RES.72.2.387; Cardounel AJ, 2007, J BIOL CHEM, V282, P879, DOI 10.1074/jbc.M603606200; Connelly L, 2005, J BIOL CHEM, V280, P10040, DOI 10.1074/jbc.M411991200; Connelly L, 2003, J BIOL CHEM, V278, P26480, DOI 10.1074/jbc.M302238200; DEKIMPE SJ, 1995, BRIT J PHARMACOL, V114, P1317; Druhan LJ, 2008, BIOCHEMISTRY-US, V47, P7256, DOI 10.1021/bi702377a; Fagan KA, 1999, AM J PHYSIOL-LUNG C, V277, pL472, DOI 10.1152/ajplung.1999.277.3.L472; Fagan KA, 1999, J CLIN INVEST, V103, P291, DOI 10.1172/JCI3862; Feletou M, 2001, AM J PHYSIOL-LUNG C, V281, pL258, DOI 10.1152/ajplung.2001.281.1.L258; Han RNN, 2004, CIRC RES, V94, P1115, DOI 10.1161/01.RES.0000125624.85852.1E; Iuvone T, 1996, LIFE SCI, V59, pPL207; Kabir K, 2002, SHOCK, V17, P300, DOI 10.1097/00024382-200204000-00010; Kengatharan KM, 1996, BRIT J PHARMACOL, V119, P1411, DOI 10.1111/j.1476-5381.1996.tb16053.x; Koizumi T, 2004, ANESTHESIOLOGY, V101, P59, DOI 10.1097/00000542-200407000-00011; Komarova Y, 2010, ANNU REV PHYSIOL, V72, P463, DOI 10.1146/annurev-physiol-021909-135833; Kristof AS, 1998, AM J RESP CRIT CARE, V158, P1883, DOI 10.1164/ajrccm.158.6.9802100; KUBES P, 1991, P NATL ACAD SCI USA, V88, P4651, DOI 10.1073/pnas.88.11.4651; Lange M, 2011, BIOCHEM BIOPH RES CO, V404, P877, DOI 10.1016/j.bbrc.2010.12.078; Lange M, 2010, ANESTHESIOLOGY, V113, P1376, DOI 10.1097/ALN.0b013e3181fc5588; Lange M, 2010, BIOCHEM BIOPH RES CO, V399, P286, DOI 10.1016/j.bbrc.2010.07.071; Lange M, 2009, CRIT CARE MED, V37, P223, DOI 10.1097/CCM.0b013e3181926104; LASZLO F, 1995, EUR J PHARMACOL, V283, P47, DOI 10.1016/0014-2999(95)00281-O; LAUBACH VE, 1995, P NATL ACAD SCI USA, V92, P10688, DOI 10.1073/pnas.92.23.10688; Leiper J, 2002, P NATL ACAD SCI USA, V99, P13527, DOI 10.1073/pnas.212269799; Lien E, 2000, J CLIN INVEST, V105, P497, DOI 10.1172/JCI8541; MACMICKING JD, 1995, CELL, V81, P641, DOI 10.1016/0092-8674(95)90085-3; Matthay MA, 2012, J CLIN INVEST, V122, P2731, DOI 10.1172/JCI60331; Matute-Bello G, 2001, AM J PATHOL, V158, P153, DOI 10.1016/S0002-9440(10)63953-3; Miller AA, 2005, AM J PHYSIOL-LUNG C, V289, pL299, DOI 10.1152/ajplung.00022.2005; Okamoto I, 2000, AM J RESP CRIT CARE, V162, P716, DOI 10.1164/ajrccm.162.2.9907039; PENG HB, 1995, J BIOL CHEM, V270, P14214, DOI 10.1074/jbc.270.23.14214; Perona R, 1997, GENE DEV, V11, P463, DOI 10.1101/gad.11.4.463; PETERSON DA, 1992, BIOCHEM BIOPH RES CO, V187, P797, DOI 10.1016/0006-291X(92)91266-S; PHENG LH, 1995, INFLAMMATION, V19, P599, DOI 10.1007/BF01539139; POU S, 1992, J BIOL CHEM, V267, P24173; Qin LZ, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/932340; Rafikov R, 2014, J BIOL CHEM, V289, P4710, DOI 10.1074/jbc.M114.547596; Ruetten H, 1996, BRIT J PHARMACOL, V118, P261, DOI 10.1111/j.1476-5381.1996.tb15397.x; Sharma S, 2013, PEDIATR RES, V74, P39, DOI 10.1038/pr.2013.71; Sharma S, 2010, VASC PHARMACOL, V52, P182, DOI 10.1016/j.vph.2009.11.010; Shelton JL, 2007, MICROVASC RES, V74, P23, DOI 10.1016/j.mvr.2007.02.008; Speyer CL, 2003, AM J PATHOL, V163, P2319, DOI 10.1016/S0002-9440(10)63588-2; Spindler V, 2010, CARDIOVASC RES, V87, P243, DOI 10.1093/cvr/cvq086; Steudel W, 1998, J CLIN INVEST, V101, P2468, DOI 10.1172/JCI2356; Steudel W, 1997, CIRC RES, V81, P34, DOI 10.1161/01.RES.81.1.34; Sud N, 2008, AM J PHYSIOL-CELL PH, V294, pC1407, DOI 10.1152/ajpcell.00384.2007; Suda O, 2004, ARTERIOSCL THROM VAS, V24, P1682, DOI 10.1161/01.ATV.0000136656.26019.6e; Suda O, 2002, CIRCULATION, V106, P1729, DOI 10.1161/01.CIR.0000029749.16101.44; VALLANCE P, 1992, LANCET, V339, P572; Vo PA, 2005, J BIOL CHEM, V280, P7236, DOI 10.1074/jbc.M411317200; Vromen A, 1996, SHOCK, V6, P248, DOI 10.1097/00024382-199610000-00004; Ware LB, 2000, NEW ENGL J MED, V342, P1334, DOI 10.1056/NEJM200005043421806; WEI XQ, 1995, NATURE, V375, P408, DOI 10.1038/375408a0; Wells SM, 2007, AM J RESP CELL MOL, V36, P520, DOI 10.1165/rcmb.2006-0302SM; Wojciak-Stothard B, 2007, J CELL SCI, V120, P929, DOI 10.1242/jcs.002212; Wojciak-Stothard B, 2009, MOL BIOL CELL, V20, P33, DOI 10.1091/mbc.E08-04-0395; Worrall NK, 1997, AM J PHYSIOL-HEART C, V273, pH2565, DOI 10.1152/ajpheart.1997.273.6.H2565; Wu CH, 2003, J TRAUMA, V55, P540, DOI 10.1097/01.TA.0000033496.62796.3B; Xia Y, 1998, J BIOL CHEM, V273, P25804, DOI 10.1074/jbc.273.40.25804; Xia Y, 1996, P NATL ACAD SCI USA, V93, P6770, DOI 10.1073/pnas.93.13.6770; Yakovlev VA, 2007, BIOCHEMISTRY-US, V46, P11671, DOI 10.1021/bi701107z; Zeidler PC, 2004, TOXICOL APPL PHARM, V195, P45, DOI 10.1016/j.taap.2003.10.005	74	33	34	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2015	10	3							e0119918	10.1371/journal.pone.0119918	http://dx.doi.org/10.1371/journal.pone.0119918			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9BN	25786132	Green Published, gold, Green Submitted			2022-12-27	WOS:000352138500143
J	Jung, S; von Thulen, T; Laukemper, V; Pigisch, S; Hangel, D; Wagner, H; Kaufmann, A; Bauer, S				Jung, Stephanie; von Thuelen, Tina; Laukemper, Viktoria; Pigisch, Stephanie; Hangel, Doris; Wagner, Hermann; Kaufmann, Andreas; Bauer, Stefan			A Single Naturally Occurring 2 '-O-Methylation Converts a TLR7-and TLR8-Activating RNA into a TLR8-Specific Ligand	PLOS ONE			English	Article							TOLL-LIKE RECEPTORS; DENDRITIC CELLS; IN-VIVO; INTERFERING RNA; MODIFIED SIRNAS; MESSENGER-RNA; RIBOSOMAL-RNA; CUTTING EDGE; STRANDED-RNA; RECOGNITION	TLR7 and TLR8 recognize RNA from pathogens and lead to subsequent immune stimulation. Here we demonstrate that a single naturally occurring 2'-O-methylation within a synthetic 18s rRNA derived RNA sequence prevents IFN-alpha production, however secretion of proinflammatory cytokines such as IL-6 is not impaired. By analysing TLR-deficient plasmacytoid dendritic cells and performing HEK293 genetic complementation assays we could demonstrate that the single 2'-O-methylation containing RNA still activated TLR8 but not TLR7. Therefore this specific 2'-O-ribose methylation in rRNA converts a TLR7 / TLR8 ligand to an exclusively TLR8-specific ligand. Interestingly, other modifications at this position such as 2'-O-deoxy or 2'-fluoro had no strong modulating effect on TLR7 or TLR8 activation suggesting an important role of 2'-O-methylation for shaping differential TLR7 or TLR8 activation.	[Jung, Stephanie; von Thuelen, Tina; Laukemper, Viktoria; Kaufmann, Andreas; Bauer, Stefan] Univ Marburg, Inst Immunol, BMFZ, D-35032 Marburg, Germany; [Pigisch, Stephanie; Hangel, Doris; Wagner, Hermann] Tech Univ Munich, Inst Med Mikrobiol Immunol & Hyg, D-80290 Munich, Germany	Philipps University Marburg; Technical University of Munich	Bauer, S (corresponding author), Univ Marburg, Inst Immunol, BMFZ, Robert Koch Str 17, D-35032 Marburg, Germany.	stefan.bauer@staff.uni-marburg.de	Jung, Stephanie/AAC-4902-2022	Jung, Stephanie/0000-0002-1454-9358; Bauer, Stefan/0000-0002-8462-1845	German Center for Infection Research (DZIF); DFG [BA 1618/5-1]; Behring Rontgen Stiftung [56-0034]; German National Academic Foundation;  [Transregio-84];  [SFB1021]	German Center for Infection Research (DZIF); DFG(German Research Foundation (DFG)); Behring Rontgen Stiftung; German National Academic Foundation; ; 	SB was funded by Transregio-84, the German Center for Infection Research (DZIF), SFB1021, DFG grant BA 1618/5-1 and grant 56-0034 from the Behring Rontgen Stiftung. SJ was funded by the German National Academic Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexopoulou L, 2001, NATURE, V413, P732, DOI 10.1038/35099560; Bachellerie JP, 1997, TRENDS BIOCHEM SCI, V22, P257, DOI 10.1016/S0968-0004(97)01057-8; Baenziger S, 2009, BLOOD, V113, P377, DOI 10.1182/blood-2008-04-151712; Blasius AL, 2010, IMMUNITY, V32, P305, DOI 10.1016/j.immuni.2010.03.012; Boczkowski D, 1996, J EXP MED, V184, P465, DOI 10.1084/jem.184.2.465; Czauderna F, 2003, NUCLEIC ACIDS RES, V31, P2705, DOI 10.1093/nar/gkg393; Diebold SS, 2004, SCIENCE, V303, P1529, DOI 10.1126/science.1093616; Eberle F, 2008, J IMMUNOL, V180, P3229, DOI 10.4049/jimmunol.180.5.3229; Forsbach A, 2008, J IMMUNOL, V180, P3729, DOI 10.4049/jimmunol.180.6.3729; Ganguly D, 2009, J EXP MED, V206, P1983, DOI 10.1084/jem.20090480; Gehrig S, 2012, J EXP MED, V209, P225, DOI 10.1084/jem.20111044; Gorden KKB, 2006, J IMMUNOL, V177, P6584, DOI 10.4049/jimmunol.177.10.6584; Gunzer M, 2005, BLOOD, V106, P2424, DOI 10.1182/blood-2005-01-0342; Hamm S, 2010, IMMUNOBIOLOGY, V215, P559, DOI 10.1016/j.imbio.2009.09.003; Heil F, 2004, SCIENCE, V303, P1526, DOI 10.1126/science.1093620; Hemmi H, 2002, NAT IMMUNOL, V3, P196, DOI 10.1038/ni758; Hemmi H, 2000, NATURE, V408, P740, DOI 10.1038/35047123; Hidmark A, 2012, J IMMUNOL, V189, P2717, DOI 10.4049/jimmunol.1200898; Hornung V, 2005, NAT MED, V11, P263, DOI 10.1038/nm1191; Hornung V, 2002, J IMMUNOL, V168, P4531, DOI 10.4049/jimmunol.168.9.4531; Jockel S, 2012, J EXP MED, V209, P235, DOI 10.1084/jem.20111075; Judge AD, 2006, MOL THER, V13, P494, DOI 10.1016/j.ymthe.2005.11.002; Jurk M, 2002, NAT IMMUNOL, V3, P499, DOI 10.1038/ni0602-499; Jurk M, 2006, EUR J IMMUNOL, V36, P1815, DOI 10.1002/eji.200535806; Kaiser S, 2014, RNA, V20, P1351, DOI 10.1261/rna.044024.113; Kariko K, 2005, IMMUNITY, V23, P165, DOI 10.1016/j.immuni.2005.06.008; Kawai T, 2010, NAT IMMUNOL, V11, P373, DOI 10.1038/ni.1863; Lund JM, 2004, P NATL ACAD SCI USA, V101, P5598, DOI 10.1073/pnas.0400937101; Maden B E, 1990, Prog Nucleic Acid Res Mol Biol, V39, P241, DOI 10.1016/S0079-6603(08)60629-7; Morrissey DV, 2005, NAT BIOTECHNOL, V23, P1002, DOI 10.1038/nbt1122; Oldenburg M, 2012, SCIENCE, V337, P1111, DOI 10.1126/science.1220363; Peng GY, 2005, SCIENCE, V309, P1380, DOI 10.1126/science.1113401; Rajagopal D, 2010, BLOOD, V115, P1949, DOI 10.1182/blood-2009-08-238543; Robbins M, 2007, MOL THER, V15, P1663, DOI 10.1038/sj.mt.6300240; Savage P, 1996, BRIT J CANCER, V74, P1482, DOI 10.1038/bjc.1996.569; Scheel B, 2005, EUR J IMMUNOL, V35, P1557, DOI 10.1002/eji.200425656; Soutschek J, 2004, NATURE, V432, P173, DOI 10.1038/nature03121; Spies B, 2003, J IMMUNOL, V171, P5908, DOI 10.4049/jimmunol.171.11.5908; Tanji H, 2013, SCIENCE, V339, P1426, DOI 10.1126/science.1229159; Vasilakos JP, 2013, EXPERT REV VACCINES, V12, P809, DOI 10.1586/14760584.2013.811208	40	16	16	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2015	10	3							e0120498	10.1371/journal.pone.0120498	http://dx.doi.org/10.1371/journal.pone.0120498			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9BN	25785446	Green Published, gold			2022-12-27	WOS:000352138500178
J	Lanz, TA; Joshi, JJ; Reinhart, V; Johnson, K; Grantham, LE; Volfson, D				Lanz, Thomas A.; Joshi, J. Julie; Reinhart, Veronica; Johnson, Kjell; Grantham, Lonnie E., II; Volfson, Dmitri			STEP Levels Are Unchanged in Pre-Frontal Cortex and Associative Striatum in Post-Mortem Human Brain Samples from Subjects with Schizophrenia, Bipolar Disorder and Major Depressive Disorder	PLOS ONE			English	Article							EXPRESSION; PROTEIN	Increased protein levels of striatal-enriched tyrosine phosphatase (STEP) have recently been reported in postmortem schizophrenic cortex. The present study sought to replicate this finding in a separate cohort of postmortem samples and to extend observations to striatum, including subjects with bipolar disorder and major depressive disorder in the analysis. No statistically significant changes between disease and control subjects were found in STEP mRNA or protein levels in dorsolateral prefrontal cortex or associative striatum. Although samples were matched for several covariates, postmortem interval correlated negatively with STEP protein levels, emphasizing the importance of including these analyses in postmortem studies.	[Lanz, Thomas A.; Joshi, J. Julie; Reinhart, Veronica; Volfson, Dmitri] Pfizer Res & Dev, Cambridge, MA 02139 USA; [Johnson, Kjell; Grantham, Lonnie E., II] Arbor Analyt, Ann Arbor, MI USA	Pfizer	Lanz, TA (corresponding author), Pfizer Res & Dev, Cambridge, MA 02139 USA.	Thomas.a.lanz@pfizer.com		Volfson, Dmitri/0000-0002-5167-7834; Lanz, Thomas/0000-0003-2483-3122	Pfizer, Inc.	Pfizer, Inc.(Pfizer)	Authors were employed by Pfizer, Inc., where the work was funded internally. However, the funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BOULANGER LM, 1995, J NEUROSCI, V15, P1532; Braithwaite SP, 2006, EUR J NEUROSCI, V23, P2847, DOI 10.1111/j.1460-9568.2006.04837.x; Carty NC, 2012, TRANSL PSYCHIAT, V2, DOI 10.1038/tp.2012.63; Curley AA, 2011, AM J PSYCHIAT, V168, P921, DOI 10.1176/appi.ajp.2011.11010052; Fung SJ, 2010, AM J PSYCHIAT, V167, P1479, DOI 10.1176/appi.ajp.2010.09060784; Gilmour G, 2012, NEUROPHARMACOLOGY, V62, P1401, DOI 10.1016/j.neuropharm.2011.03.015; Glausier JR, 2014, BIOL PSYCHIAT; Gonzalez-Burgos G, 2012, SCHIZOPHRENIA BULL, V38, P950, DOI 10.1093/schbul/sbs010; Gonzalez-Burgos G, 2011, NEURAL PLAST, V2011, DOI 10.1155/2011/723184; Hashimoto T, 2008, AM J PSYCHIAT, V165, P479, DOI 10.1176/appi.ajp.2007.07081223; Iwamoto K, 2005, HUM MOL GENET, V14, P241, DOI 10.1093/hmg/ddi022; Lin CH, 2012, PHARMACOL BIOCHEM BE, V100, P665, DOI 10.1016/j.pbb.2011.03.023; Mellios N, 2009, BIOL PSYCHIAT, V65, P1006, DOI 10.1016/j.biopsych.2008.11.019; Reinhart VL, 2014, NEUROSCIENCE, V278, P62, DOI 10.1016/j.neuroscience.2014.08.002; Sibille E, 2011, INT J NEUROPSYCHOPH, V14, P721, DOI 10.1017/S1461145710001616; Weickert CS, 2013, MOL PSYCHIATR, V18, P1185, DOI 10.1038/mp.2012.137; Zhang Y, 2008, J NEUROSCI, V28, P10561, DOI 10.1523/JNEUROSCI.2666-08.2008	17	43	44	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2015	10	3							e0121744	10.1371/journal.pone.0121744	http://dx.doi.org/10.1371/journal.pone.0121744			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9BN	25786133	Green Published, gold, Green Submitted			2022-12-27	WOS:000352138500215
J	Cardenas-Cardenas, LM; Cotes-Cantillo, K; Chaparro-Narvaez, PE; Fernandez-Nino, JA; Paternina-Caicedo, A; Castaneda-Orjuela, C; De la Hoz-Restrepo, F				Mery Cardenas-Cardenas, Luz; Cotes-Cantillo, Karol; Enrique Chaparro-Narvaez, Pablo; Alfredo Fernandez-Nino, Julian; Paternina-Caicedo, Angel; Castaneda-Orjuela, Carlos; De la Hoz-Restrepo, Fernando			Maternal Mortality in Colombia in 2011: A Two Level Ecological Study	PLOS ONE			English	Article							CARE; INEQUALITY; HEALTH	Objective Maternal mortality reduction is a Millennium Development Goal. In Colombia, there is a large disparity in the maternal mortality ratio (MMR) between and into departments (states) and also between municipalities. We examined socioeconomics variables at the municipal and departmental levels which could be associated to the municipal maternal mortality in Colombia. Methods A multilevel ecology study was carried out using different national data sources in Colombia. The outcome variable was the MMR at municipal level in 2011 with multidimensional poverty at municipal and department level as the principal independent variables and other measures of the social and economic characteristics at municipal and departmental level were also considered explicative variables (overall fertility municipal rate, percentage of local rural population, health insurance coverage, per capita territorial participation allocated to the health sector, transparency index and Gini coefficient). The association between MMR and socioeconomic contextual conditions at municipal and departmental level was assessed using a multilevel Poisson regression model. Results The MMR in the Colombian municipalities was associated significantly with the multidimensional poverty (relative ratio of MMR: 3.52; CI 95%: 1.09-11.38). This association was stronger in municipalities from departments with the highest poverty (relative ratio of MMR: 7.14; CI 95%: 2.01-25.35). Additionally, the MMR at municipal level was marginally associated with municipally health insurance coverage (relative ratio of MMR: 0.99; CI 95%: 0.98-1.00), and significantly with transparency index at departmental level (relative ratio of MMR: 0.98; CI 95%: 0.97-0.99). Conclusion Poverty and transparency in a contextual level were associated with the increase of the municipal MMR in Colombia. The results of this study are useful evidence for informing the public policies discussion and formulation processes with a differential approach.	[Mery Cardenas-Cardenas, Luz; Cotes-Cantillo, Karol; Enrique Chaparro-Narvaez, Pablo; Castaneda-Orjuela, Carlos] Inst Nacl Salud, Colombian Natl Hlth Observ, Bogota, Colombia; [Alfredo Fernandez-Nino, Julian] Natl Inst Publ Hlth, Informat Ctr Publ Hlth Decis, Cuernavaca, Morelos, Mexico; [Paternina-Caicedo, Angel] Univ Cartagena, Grp Econ Salud, Cartagena De Indias, Colombia; [De la Hoz-Restrepo, Fernando] Inst Nacl Salud, Bogota, Colombia	Instituto Nacional de Salud (Colombia); Instituto Nacional de Salud Publica; Universidad de Cartagena; Instituto Nacional de Salud (Colombia)	Cardenas-Cardenas, LM (corresponding author), Inst Nacl Salud, Colombian Natl Hlth Observ, Bogota, Colombia.	lcardenasc@ins.gov.co	Paternina-Caicedo, Angel/N-4496-2015; Fernández-Niño, Julián Alfredo/AHE-6038-2022; Castañeda-Orjuela, Carlos/N-2601-2017	Paternina-Caicedo, Angel/0000-0002-6332-5174; Fernández-Niño, Julián Alfredo/0000-0002-8948-8481; Castañeda-Orjuela, Carlos/0000-0002-8735-6223; Cardenas Cardenas, Luz Mery/0000-0003-3218-2876				AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Angulo R, 2011, ARCH EC, P9228; Aristizabal AS, 1996, COLOMB MEDICA, V27, P117; Carrillo U. Abelardo, 2007, Rev. Cienc. Salud, V5, P72; Departamento Administrativo Nacional de Estadisticas, 2013, POBL DEM; Departamento Administrativo Nacional de Estadisticas, CONC BAS; Departamento Nacional de Planeacion, 2013, AS HIST PART TERR 19; HAUSMAN JA, 1978, ECONOMETRICA, V46, P1251, DOI 10.2307/1913827; Hogan MC, 2010, LANCET, V375, P1609, DOI 10.1016/S0140-6736(10)60518-1; Houweling TAJ, 2007, B WORLD HEALTH ORGAN, V85, P745, DOI 10.2471/BLT.06.038588; Instituto Nacional de Salud Observatorio Nacional de Salud., 2013, MORT 1998 2011 SIT S, DOI [10.1016/j.ciresp.2014.03.017, DOI 10.1016/J.CIRESP.2014.03.017]; Islam R., 2006, EC POLIT, V18, P121, DOI [https://doi.org/10.1111/j.1468-0343.2006.00166.x, DOI 10.1111/J.1468-0343.2006.00166.X, 10.1111/j.1468-0343.2006.00166.x]; Jain AK, 2011, STUD FAMILY PLANN, V42, P247, DOI 10.1111/j.1728-4465.2011.00288.x; Koblinsky M, 2008, J HEALTH POPUL NUTR, V26, P280; Koch E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036613; Osorio AM, 2014, CAD SAUDE PUBLICA, V30, P1079, DOI 10.1590/0102-311X00073513; Marín-Blandón Adiela, 2010, Hacia promoc. Salud, V15, P110; Ministerio de Salud y Proteccion Social, 2011, COB SAL; Muldoon KA, 2011, GLOBALIZATION HEALTH, V7, DOI 10.1186/1744-8603-7-42; Naciones Unidas, 1986, MAN 10 TECN IND EST; Ononokpono DN, 2014, MATERN CHILD HLTH J, V18, P950, DOI 10.1007/s10995-013-1323-9; Organizacion Mundial de la Salud, 2014, MORT MAT; Organizacion Panamericana de la Salud Organizacion Mundial de la Salud, 2008, CLAS EST INT ENF PRO; Florez CEP, 2014, REV PANAM SALUD PUBL, V35, P1; Rodriguez D, 2001, INF QUINC EPIDEMIOL, V6, P345; Villamizar LAR, 2011, REV PANAM SALUD PUBL, V29, P213, DOI 10.1590/S1020-49892011000400001; Rose G, 2001, B WORLD HEALTH ORGAN, V79, P990; Sagynbekov KI, 2013, J OBSTET GYNAECOL CA, V35, P612, DOI 10.1016/S1701-2163(15)30878-1; Sandoval-Vargas Yirdley G, 2013, Rev Salud Publica (Bogota), V15, P529; Schnijder T.A.B., 2012, MULTILEVEL ANAL INTR, V2nd ed; Singh Poonam Khetrapal, 2012, Indian J Public Health, V56, P259, DOI 10.4103/0019-557X.106412; Tajik P, 2012, INT J PREVENTIVE MED, V3, P116; Transparencia por Colombia, 2010, IND TRASNP DEP 2008	33	10	16	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2015	10	3							e0118944	10.1371/journal.pone.0118944	http://dx.doi.org/10.1371/journal.pone.0118944			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9BN	25785719	gold, Green Published			2022-12-27	WOS:000352138500059
J	Saccenti, E; van Duynhoven, J; Jacobs, DM; Smilde, AK; Hoefsloot, HCJ				Saccenti, Edoardo; van Duynhoven, John; Jacobs, Doris M.; Smilde, Age K.; Hoefsloot, Huub C. J.			Strategies for Individual Phenotyping of Linoleic and Arachidonic Acid Metabolism Using an Oral Glucose Tolerance Test	PLOS ONE			English	Article							FAT	The ability to restore homeostasis upon environmental challenges has been proposed as a measure for health. Metabolic profiling of plasma samples during the challenge response phase should offer a profound view on the flexibility of a phenotype to cope with daily stressors. Current data modeling approaches, however, struggle to extract biological descriptors from time-resolved metabolite profiles that are able to discriminate between different phenotypes. Thus, for the case of oxylipin responses in plasma upon an oral glucose tolerance test we developed a modeling approach that incorporates a priori biological pathway knowledge. The degradation pathways of arachidonic and linoleic acids were modeled using a regression model based on a pseudo-steady-state approximated model, resulting in a parameter A that summarizes the relative enzymatic activity in these pathways. Analysis of the phenotypic parameters As suggests that different phenotypes can be discriminated according to preferred relative activity of the arachidonic and linoleic pathway. Correlation analysis shows that there is little or no competition between the arachidonic and linoleic acid pathways, although they share the same enzymes.	[Saccenti, Edoardo] Univ Wageningen & Res Ctr, Lab Syst & Synthet Biol, Wageningen, Netherlands; [Saccenti, Edoardo; Smilde, Age K.; Hoefsloot, Huub C. J.] Univ Amsterdam, Biosyst Data Anal Grp, Amsterdam, Netherlands; [van Duynhoven, John; Jacobs, Doris M.] Unilever Res Labs, Vlaardingen, Netherlands; [van Duynhoven, John] Univ Wageningen & Res Ctr, Biophys Lab, Wageningen, Netherlands; [Saccenti, Edoardo; van Duynhoven, John; Jacobs, Doris M.; Smilde, Age K.; Hoefsloot, Huub C. J.] Netherlands Metabol Ctr, Leiden, Netherlands	Wageningen University & Research; University of Amsterdam; Unilever; Wageningen University & Research	Hoefsloot, HCJ (corresponding author), Univ Amsterdam, Biosyst Data Anal Grp, Amsterdam, Netherlands.	h.c.j.hoefsloot@uva.nl	van Duynhoven, John/F-8935-2011	van Duynhoven, John/0000-0001-9769-0113; Saccenti, Edoardo/0000-0001-8284-4829; Smilde, Age/0000-0002-3052-4644	Netherlands Metabolomics Centre (NMC) - Netherlands Genomics Initiative (NGI)/Netherlands Organization for Scientific Research	Netherlands Metabolomics Centre (NMC) - Netherlands Genomics Initiative (NGI)/Netherlands Organization for Scientific Research	This project was financed by The Netherlands Metabolomics Centre (NMC), which is part of The Netherlands Genomics Initiative (NGI)/Netherlands Organization for Scientific Research. DJ and JvD are employees of Unilever, a company that markets food products enriched with unsaturated fatty acids. Unilever provided support in the form of salaries for authors JvD and DJ, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal S, 2009, EXPERT REV CLIN IMMU, V5, P145, DOI 10.1586/1744666X.5.2.145; Aitchison J, 1986, STAT ANAL COMPOSITIO, DOI DOI 10.1007/978-94-009-4109-0; Apgar JF, 2010, MOL BIOSYST, V6, P1890, DOI 10.1039/b918098b; Balvers MGJ, 2012, METABOLOMICS, V8, P1130, DOI 10.1007/s11306-012-0421-9; Bernini P, 2009, J PROTEOME RES, V8, P4264, DOI 10.1021/pr900344m; Buczynski MW, 2009, J LIPID RES, V50, P1015, DOI 10.1194/jlr.R900004-JLR200; CATTELL RB, 1966, MULTIVAR BEHAV RES, V1, P245, DOI 10.1207/s15327906mbr0102_10; GOLDYNE ME, 1984, J BIOL CHEM, V259, P8815; GRIFFITHS AJ, 1994, AM J CLIN NUTR, V59, P53, DOI 10.1093/ajcn/59.1.53; Gupta S, 2009, BIOPHYS J, V96, P4542, DOI 10.1016/j.bpj.2009.03.011; Gutenkunst RN, 2007, PLOS COMPUT BIOL, V3, P1871, DOI 10.1371/journal.pcbi.0030189; Holmes E, 2008, CELL, V134, P714, DOI 10.1016/j.cell.2008.08.026; Huber Machteld, 2011, BMJ, V343, pd4163, DOI 10.1136/bmj.d4163; Kroetz DL, 2002, CURR OPIN LIPIDOL, V13, P273, DOI 10.1097/00041433-200206000-00007; Murray JD.., 2003, MATH BIOL, DOI DOI 10.1007/B98869; Nestorov IA, 1998, J PHARMACOKINET BIOP, V26, P21, DOI 10.1023/A:1023272707390; Nicholson G, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.57; Saccenti E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106077; SEGEL LA, 1988, B MATH BIOL, V50, P579, DOI 10.1007/BF02460092; Smilowitz JT, 2013, MOL NUTR FOOD RES, V57, P1319, DOI 10.1002/mnfr.201200808; Spector AA, 2009, J LIPID RES, V50, pS52, DOI 10.1194/jlr.R800038-JLR200; Stephanopoulos G., 1998, METAB ENG; Strassburg K, 2014, MOL NUTR FOOD RES, V58, P591, DOI 10.1002/mnfr.201300321; Strassburg K, 2012, ANAL BIOANAL CHEM, V404, P1413, DOI 10.1007/s00216-012-6226-x; van Ommen B, 2014, GENES NUTR, V9, DOI 10.1007/s12263-014-0423-5; van Ommen B, 2010, GENES NUTR, V5, P189, DOI 10.1007/s12263-010-0167-9; Vance DE, 2008, N COMP BIOC, P1; Vis D., 2014, METABOLOMICS, P1, DOI DOI 10.5339/GCSP.2014.4; Wopereis S, 2013, BMC MED GENOMICS, V6, DOI 10.1186/1755-8794-6-44; Zhang HJ, 2007, EXPERT OPIN DRUG MET, V3, P667, DOI 10.1517/17425225.3.5.667	30	6	6	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2015	10	3							e0119856	10.1371/journal.pone.0119856	http://dx.doi.org/10.1371/journal.pone.0119856			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9BN	25786212	Green Submitted, Green Published, gold			2022-12-27	WOS:000352138500136
J	Closson, EF; Mimiaga, MJ; Sherman, SG; Tangmunkongvorakul, A; Friedman, RK; Limbada, M; Moore, AT; Srithanaviboonchai, K; Alves, CA; Roberts, S; Oldenburg, CE; Elharrar, V; Mayer, KH; Safren, SA				Closson, Elizabeth F.; Mimiaga, Matthew J.; Sherman, Susan G.; Tangmunkongvorakul, Arunrat; Friedman, Ruth K.; Limbada, Mohammed; Moore, Ayana T.; Srithanaviboonchai, Kriengkrai; Alves, Carla A.; Roberts, Sarah; Oldenburg, Catherine E.; Elharrar, Vanessa; Mayer, Kenneth H.; Safren, Steven A.		HPTN063 Study Team	Intimacy versus Isolation: A Qualitative Study of Sexual Practices among Sexually Active HIV-Infected Patients in HIV Care in Brazil, Thailand, and Zambia	PLOS ONE			English	Article							POSITIVE MEN; ANTIRETROVIRAL THERAPY; TRANSMISSION RISK; PREVENTION; BEHAVIOR; WOMEN; PARTNERS; PEOPLE; DISCLOSURE; SEROSTATUS	The success of global treatment as prevention (TasP) efforts for individuals living with HIV/AIDS (PLWHA) is dependent on successful implementation, and therefore the appropriate contribution of social and behavioral science to these efforts. Understanding the psychosocial context of condomless sex among PLWHA could shed light on effective points of intervention. HPTN 063 was an observational mixed-methods study of sexually active, in-care PLWHA in Thailand, Zambia, and Brazil as a foundation for integrating secondary HIV prevention into HIV treatment. From 2010-2012, 80 qualitative interviews were conducted with PLWHA receiving HIV care and reported recent sexual risk. Thirty men who have sex with women (MSW) and 30 women who have sex with men (WSM) participated in equal numbers across the sites. Thailand and Brazil also enrolled 20 biologically-born men who have sex with men (MSM). Part of the interview focused on the impact of HIV on sexual practices and relationships. Interviews were recorded, transcribed, translated into English and examined using qualitative descriptive analysis. The mean age was 25 (SD = 3.2). There were numerous similarities in experiences and attitudes between MSM, MSW and WSM across the three settings. Participants had a high degree of HIV transmission risk awareness and practiced some protective sexual behaviors such as reduced sexual activity, increased use of condoms, and external ejaculation. Themes related to risk behavior can be categorized according to struggles for intimacy and fears of isolation, including: fear of infecting a sex partner, guilt about sex, sexual communication difficulty, HIV-stigma, and worry about sexual partnerships. Emphasizing sexual health, intimacy and protective practices as components of nonjudgmental sex-positive secondary HIV prevention interventions is recommended. For in-care PLWHA, this approach has the potential to support TasP. The overlap of themes across groups and countries indicates that similar intervention content may be effective for a range of settings.	[Closson, Elizabeth F.; Mimiaga, Matthew J.; Oldenburg, Catherine E.; Mayer, Kenneth H.; Safren, Steven A.] Fenway Hlth, Fenway Inst, Boston, MA 02215 USA; [Mimiaga, Matthew J.; Safren, Steven A.] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Boston, MA USA; [Mimiaga, Matthew J.; Oldenburg, Catherine E.; Mayer, Kenneth H.] Harvard Univ, Sch Publ Hlth, Boston, MA 02115 USA; [Sherman, Susan G.] Johns Hopkins Sch Publ Hlth, Baltimore, MD USA; [Tangmunkongvorakul, Arunrat; Srithanaviboonchai, Kriengkrai] Chiang Mai Univ, Res Inst Hlth Sci, Chiang Mai 50000, Thailand; [Friedman, Ruth K.; Alves, Carla A.] Fundacao Oswaldo Cruz Fiocruz, Inst Pesquisa Clin Evandro Chagas, Rio De Janeiro, Brazil; [Limbada, Mohammed; Roberts, Sarah] Ctr Infect Dis Res Zambia, Lusaka, Zambia; [Moore, Ayana T.] FHI360, Durham, NC USA; [Srithanaviboonchai, Kriengkrai] Chiang Mai Univ, Fac Med, Chiang Mai 50000, Thailand; [Elharrar, Vanessa] NIAID, Bethesda, MD 20892 USA; [Mayer, Kenneth H.] Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Boston, MA 02215 USA	Fenway Health; Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Harvard T.H. Chan School of Public Health; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Chiang Mai University; Fundacao Oswaldo Cruz; Chiang Mai University; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School	Mimiaga, MJ (corresponding author), Fenway Hlth, Fenway Inst, Boston, MA 02215 USA.	mmimiaga@mgh.harvard.edu	., ksrithan/AAO-2228-2020; Roberts, Sarah/AAG-2768-2020	., ksrithan/0000-0002-1683-4259; Roberts, Sarah/0000-0002-3318-9781; limbada, mohammed/0000-0002-3736-1462	Division of AIDS, National Institute of Allergy and Infectious Disease (NIAID); National Institute on Drug Abuse (NIDA); National Institute of Mental Health (NIMH) of the U.S. National Institutes of Health (NIH), U.S. Department of Health and Human Services [UM1 AI068619, UM1 AI068617, UM1 AI068613]; NIAID [T32AI007535]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [UM1AI069412, UM1AI068619, T32AI007535, UM1AI068617, U01AI069412, UM1AI068613, UM1AI069476] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R25MH083620] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [T32DA013911] Funding Source: NIH RePORTER	Division of AIDS, National Institute of Allergy and Infectious Disease (NIAID); National Institute on Drug Abuse (NIDA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); National Institute of Mental Health (NIMH) of the U.S. National Institutes of Health (NIH), U.S. Department of Health and Human Services; NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	The study HPTN 063 was funded by the Division of AIDS, National Institute of Allergy and Infectious Disease (NIAID); National Institute on Drug Abuse (NIDA); and the National Institute of Mental Health (NIMH) of the U.S. National Institutes of Health (NIH), U.S. Department of Health and Human Services, under Cooperative Agreements #UM1 AI068619, UM1 AI068617, and UM1 AI068613. CEO is supported by a NIAID T32 NRSA grant (T32AI007535; PI: Seage). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health (NIH) or The HIV Prevention Trials Network (HPTN).	Ajose O, 2012, AIDS, V26, P929, DOI 10.1097/QAD.0b013e328351f5b2; Alvarez-Uria G., 2013, Interdisciplinary Perspectives on Infectious Diseases, V2013, P384805, DOI 10.1155/2013/384805; Ayres L, 2003, QUAL HEALTH RES, V13, P871, DOI 10.1177/1049732303013006008; Bravo P, 2010, AIDS REV, V12, P76; Brown Jennifer L, 2011, Curr HIV/AIDS Rep, V8, P269, DOI 10.1007/s11904-011-0092-6; Chaiyamahapurk Sakchai, 2010, J Int Assoc Physicians AIDS Care (Chic), V9, P278, DOI 10.1177/1545109710373831; Chen JL, 2001, FAM PLANN PERSPECT, V33, P144, DOI 10.2307/2673717; Clum G, 2009, AIDS CARE, V21, P1455, DOI 10.1080/09540120902883069; Cohen MS, 2016, NEW ENGL J MED, V375, P830, DOI [10.1056/NEJMoa1600693, 10.1056/NEJMoa1105243]; Cusick L., 2000, Culture, Health & Sexuality, V2, P473, DOI 10.1080/13691050050174468; De Rosa CJ, 1998, HEALTH PSYCHOL, V17, P224, DOI 10.1037/0278-6133.17.3.224; Doyal L, 2005, SOC SCI MED, V60, P1729, DOI 10.1016/j.socscimed.2004.08.041; Du P, 2015, J PUBLIC HEALTH MAN, V21, pE1, DOI 10.1097/PHH.0000000000000038; Edwards-Jackson N, 2012, AIDS RES THER, V9, DOI 10.1186/1742-6405-9-38; El-Bassel N, 2010, JAIDS-J ACQ IMM DEF, V55, pS98, DOI 10.1097/QAI.0b013e3181fbf407; Erickson E., 1950, CHILDHOOD SOC; Flowers P, 2006, PSYCHOL HEALTH, V21, P109, DOI 10.1080/14768320500286286; Gardner EM, 2011, CLIN INFECT DIS, V52, P793, DOI 10.1093/cid/ciq243; Goggin K, 1998, PSYCHOSOM MED, V60, P11, DOI 10.1097/00006842-199801000-00003; Gonzalez JS, 2011, JAIDS-J ACQ IMM DEF, V58, P181, DOI [10.1097/QAI.0B013E31822D490A, 10.1097/QAI.0b013e31822d490a]; Gorbach PM, 2006, JAIDS-J ACQ IMM DEF, V42, P80, DOI 10.1097/01.qai.0000196665.78497.f1; Guimaraes MDC, 2008, AIDS BEHAV, V12, P741, DOI 10.1007/s10461-008-9407-z; Harzke AJ, 2004, AIDS CARE, V16, P458, DOI 10.1080/09540120410001683394; Horton KL, 2013, ADV NURS SCI, V36, P42, DOI 10.1097/ANS.0b013e3182807813; Joint United Nations Programme on HIV/AIDS, 2013, UNAIDS REP GLOB AIDS; Jones DL, 2005, J URBAN HEALTH, V82, pIV92, DOI 10.1093/jurban/jti111; Kalichman SC, 2000, CLIN PSYCHOL-SCI PR, V7, P32, DOI 10.1093/clipsy/7.1.32; Kalichman SC, 2013, HIV TREATMENT PREVEN; Kerrigan D, 2006, SOC SCI MED, V62, P2386, DOI 10.1016/j.socscimed.2005.10.037; Kirshenbaum SB, 2004, PERSPECT SEX REPRO H, V36, P106, DOI 10.1111/j.1931-2393.2004.tb00198.x; Marks G, 1999, AIDS, V13, P297, DOI [10.1097/00002030-199902250-00001, 10.1080/088395199117432]; O'Cleirigh C, 2013, AIDS BEHAV, V17, P1764, DOI 10.1007/s10461-013-0462-8; Pence BW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082974; Pettifor A, 2011, AIDS BEHAV, V15, P1243, DOI 10.1007/s10461-010-9839-0; Redd AD, 2013, LANCET INFECT DIS, V13, P622, DOI 10.1016/S1473-3099(13)70066-5; Reynolds HW, 2013, AIDS CARE, V25, P592, DOI 10.1080/09540121.2012.726340; Sandelowski M, 2010, RES NURS HEALTH, V33, P77, DOI 10.1002/nur.20362; Siedner MJ, 2014, AIDS, V28, P267, DOI 10.1097/QAD.0000000000000136; Siegel K, 2006, ARCH SEX BEHAV, V35, P437, DOI 10.1007/s10508-006-9043-5; Silverman D., 2013, DOING QUALITATIVE RE; Tunthanathip P, 2009, SEX TRANSM INFECT, V85, P36, DOI 10.1136/sti.2008.032532; Vamos S, 2013, AIDS CARE, V25, P1102, DOI 10.1080/09540121.2012.749339; Vermund SH, 2013, JAIDS-J ACQ IMM DEF, V63, pS12, DOI 10.1097/QAI.0b013e31829202a2	43	17	17	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2015	10	3							e0120957	10.1371/journal.pone.0120957	http://dx.doi.org/10.1371/journal.pone.0120957			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CE8HY	25793283	Green Published, Green Submitted, gold			2022-12-27	WOS:000352083900093
J	Chung-Delgado, K; Guillen-Bravo, S; Revilla-Montag, A; Bernabe-Ortiz, A				Chung-Delgado, Kocfa; Guillen-Bravo, Sonia; Revilla-Montag, Alejandro; Bernabe-Ortiz, Antonio			Mortality among MDR-TB Cases: Comparison with Drug-Susceptible Tuberculosis and Associated Factors	PLOS ONE			English	Article							MULTIDRUG-RESISTANT TUBERCULOSIS; RISK-FACTORS; TREATMENT OUTCOMES; SURVIVAL; DEFAULT; PROGRAM; BURDEN; IMPACT; DEATH; LIMA	Background An increase in multidrug-resistant tuberculosis (MDR-TB) cases is evident worldwide. Its management implies a complex treatment, high costs, more toxic anti-tuberculosis drug use, longer treatment time and increased treatment failure and mortality. The aims of this study were to compare mortality between MDR and drug-susceptible cases of tuberculosis, and to determine risk factors associated with mortality among MDR-TB cases. Methods and Results A retrospective cohort study was performed using data from clinical records of the National Strategy for Prevention and Control of Tuberculosis in Lima, Peru. In the first objective, MDR-TB, compared to drug-susceptible cases, was the main exposure variable and time to death, censored at 180 days, the outcome of interest. For the second objective, different variables obtained from clinical records were assessed as potential risk factors for death among MDR-TB cases. Cox regression analysis was used to determine hazard ratios (HR) and 95% confidence intervals (95% CI). A total of 1,232 patients were analyzed: mean age 30.9 +/- 14.0 years, 60.0% were males. 61 patients (5.0%) died during treatment, whereas the MDR-TB prevalence was 19.2%. MDR-TB increased the risk of death during treatment (HR = 7.5; IC95%: 4.1-13.4) when compared to presumed drug-susceptible cases after controlling for potential confounders. Education level (p = 0.01), previous TB episodes (p<0.001), diabetes history (p<0.001) and HIV infection (p = 0.04) were factors associated with mortality among MDR-TB cases. Conclusions MDR-TB is associated with an increased risk of death during treatment. Lower education, greater number of previous TB episodes, diabetes history, and HIV infection were independently associated with mortality among MDR-TB cases. New strategies for appropriate MDR-TB detection and management should be implemented, including drug sensitivity tests, diabetes and HIV screening, as well as guarantee for a complete adherence to therapy.	[Chung-Delgado, Kocfa; Guillen-Bravo, Sonia; Revilla-Montag, Alejandro; Bernabe-Ortiz, Antonio] Univ Peruana Ciencias Aplicadas, Escuela Med, Lima, Peru	Universidad Peruana de Ciencias Aplicadas (UPC)	Chung-Delgado, K (corresponding author), Univ Peruana Ciencias Aplicadas, Escuela Med, Lima, Peru.	kocfachung@gmail.com		Chung-Delgado, Kocfa/0000-0003-1962-9434; Bernabe-Ortiz, Antonio/0000-0002-6834-1376				Asencios Luis, 2009, Rev. perú. med. exp. salud publica, V26, P278; Becerra MC, 2010, CLIN INFECT DIS, V51, P709, DOI 10.1086/655892; Bernabe-Ortiz A, 2008, REV CHIL INFECTOL, V25, P104, DOI /S0716-10182008000300002; Bonilla Cesar A, 2008, PLoS One, V3, pe2957, DOI 10.1371/journal.pone.0002957; Chu R, 2013, AIDS RES THER, V10, DOI 10.1186/1742-6405-10-19; Chung-Delgado K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027610; Chuquiyauri Haro Raul, 2004, Rev Med Hered, V15, P203; Corbett EL, 2003, ARCH INTERN MED, V163, P1009, DOI 10.1001/archinte.163.9.1009; Dalton T, 2012, LANCET, V380, P1406, DOI 10.1016/S0140-6736(12)60734-X; Franke MF, 2008, CLIN INFECT DIS, V46, P1844, DOI 10.1086/588292; Kang YA, 2013, RESPIRATION, V86, P472, DOI 10.1159/000348374; Kawai V, 2006, AM J TROP MED HYG, V75, P1027, DOI 10.4269/ajtmh.2006.75.1027; Kliiman K, 2010, INT J TUBERC LUNG D, V14, P454; Lawn SD, 2006, AIDS, V20, P1605, DOI 10.1097/01.aids.0000238406.93249.cd; Lerner Alana G, 2013, Crit Pathw Cardiol, V12, P53, DOI 10.1097/HPC.0b013e318285ef60; Lockman S, 2001, CLIN INFECT DIS, V32, P373, DOI 10.1086/318489; Manosuthi W, 2006, JAIDS-J ACQ IMM DEF, V43, P42, DOI 10.1097/01.qai.0000230521.86964.86; Ministerio de Salud, 2006, NORM TECN SAL CONTR; Mitnick C, 2003, NEW ENGL J MED, V348, P119, DOI 10.1056/NEJMoa022928; Mitnick CD, 2008, NEW ENGL J MED, V359, P563, DOI 10.1056/NEJMoa0800106; Reed GW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058044; Santha T, 2002, INT J TUBERC LUNG D, V6, P780; Shieh SH, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-174; Shin SS, 2006, EMERG INFECT DIS, V12, P687, DOI 10.3201/eid1204.041256; Sileshi B, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-297; Sterling TR, 2006, INT J TUBERC LUNG D, V10, P542; Suarez PG, 2002, LANCET, V359, P1980, DOI 10.1016/S0140-6736(02)08830-X; Waitt CJ, 2011, INT J TUBERC LUNG D, V15, P871, DOI 10.5588/ijtld.10.0352; WHO, 2012, GLOBAL TUBERCULOSIS REPORT 2012, P1; World Health Organization, MULTIDRUG AND EXTENS	30	59	62	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2015	10	3							e0119332	10.1371/journal.pone.0119332	http://dx.doi.org/10.1371/journal.pone.0119332			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD9NQ	25790076	Green Submitted, Green Published, gold			2022-12-27	WOS:000351425400075
J	Kocarnik, JM; Park, SL; Han, JL; Dumitrescu, L; Cheng, IN; Wilkens, LR; Schumacher, FR; Kolonel, L; Carlson, CS; Crawford, DC; Goodloe, RJ; Dilks, HH; Baker, P; Richardson, D; Matise, TC; Ambite, JL; Song, FJ; Qureshi, AA; Zhang, MF; Duggan, D; Hutter, C; Hindorff, L; Bush, WS; Kooperberg, C; Le Marchand, L; Peters, U				Kocarnik, Jonathan M.; Park, S. Lani; Han, Jiali; Dumitrescu, Logan; Cheng, Iona; Wilkens, Lynne R.; Schumacher, Fredrick R.; Kolonel, Laurence; Carlson, Chris S.; Crawford, Dana C.; Goodloe, Robert J.; Dilks, Holli H.; Baker, Paxton; Richardson, Danielle; Matise, Tara C.; Ambite, Jose Luis; Song, Fengju; Qureshi, Abrar A.; Zhang, Mingfeng; Duggan, David; Hutter, Carolyn; Hindorff, Lucia; Bush, William S.; Kooperberg, Charles; Le Marchand, Loic; Peters, Ulrike			Pleiotropic and Sex-Specific Effects of Cancer GWAS SNPs on Melanoma Risk in the Population Architecture Using Genomics and Epidemiology (PAGE) Study	PLOS ONE			English	Article							BASAL-CELL CARCINOMA; WIDE ASSOCIATION; PROSTATE-CANCER; SUSCEPTIBILITY LOCI; NURSES HEALTH; VARIANTS; PIGMENTATION; METAANALYSIS; GENETICS; 5P15.33	Background Several regions of the genome show pleiotropic associations with multiple cancers. We sought to evaluate whether 181 single-nucleotide polymorphisms previously associated with various cancers in genome-wide association studies were also associated with melanoma risk. Methods We evaluated 2,131 melanoma cases and 20,353 controls from three studies in the Population Architecture using Genomics and Epidemiology (PAGE) study (EAGLE-BioVU, MEC, WHI) and two collaborating studies (HPFS, NHS). Overall and sex-stratified analyses were performed across studies. Results We observed statistically significant associations with melanoma for two lung cancer SNPs in the TERT-CLPTM1L locus (Bonferroni-corrected p<2.8x10(-4)), replicating known pleiotropic effects at this locus. In sex-stratified analyses, we also observed a potential male-specific association between prostate cancer risk variant rs12418451 and melanoma risk (OR=1.22, p=8.0x10(-4)). No other variants in our study were associated with melanoma after multiple comparisons adjustment (p>2.8e(-4)). Conclusions We provide confirmatory evidence of pleiotropic associations with melanoma for two SNPs previously associated with lung cancer, and provide suggestive evidence for a male-specific association with melanoma for prostate cancer variant rs12418451. This SNP is located near TPCN2, an ion transport gene containing SNPs which have been previously associated with hair pigmentation but not melanoma risk. Previous evidence provides biological plausibility for this association, and suggests a complex interplay between ion transport, pigmentation, and melanoma risk that may vary by sex. If confirmed, these pleiotropic relationships may help elucidate shared molecular pathways between cancers and related phenotypes.	[Kocarnik, Jonathan M.; Carlson, Chris S.; Kooperberg, Charles; Peters, Ulrike] Fred Hutchinson Canc Res Ctr, Div Publ Hlth Sci, Seattle, WA 98104 USA; [Park, S. Lani; Schumacher, Fredrick R.] Univ So Calif, Keck Sch Med, Norris Comprehens Canc Ctr, Dept Prevent Med, Los Angeles, CA 90033 USA; [Han, Jiali] Indiana Univ, Melvin & Bren Simon Canc Ctr, Richard M Fairbanks Sch Publ Hlth, Dept Epidemiol, Indianapolis, IN 46204 USA; [Dumitrescu, Logan; Goodloe, Robert J.; Dilks, Holli H.; Baker, Paxton; Richardson, Danielle; Bush, William S.] Vanderbilt Univ, Ctr Human Genet Res, Nashville, TN 37235 USA; [Dumitrescu, Logan] Vanderbilt Univ, Dept Mol Physiol & Biophys, Nashville, TN 37232 USA; [Cheng, Iona] Canc Prevent Inst Calif, Fremont, CA USA; [Wilkens, Lynne R.; Kolonel, Laurence; Le Marchand, Loic] Univ Hawaii, Ctr Canc, Program Epidemiol, Honolulu, HI 96822 USA; [Crawford, Dana C.] Case Western Reserve Univ, Dept Epidemiol, Cleveland, OH 44106 USA; [Crawford, Dana C.] Case Western Reserve Univ, Biosta Inst Computat Biol, Cleveland, OH 44106 USA; [Matise, Tara C.] Rutgers State Univ, Dept Genet, Piscataway, NJ USA; [Ambite, Jose Luis] Univ So Calif, Inst Informat Sci, Marina Del Rey, CA 90292 USA; [Song, Fengju] Tianjin Med Univ, Canc Inst & Hosp, Dept Epidemiol, Tianjin, Peoples R China; [Song, Fengju] Harvard Univ, Brigham & Womens Hosp, Sch Med, Dept Med,Channing Lab, Boston, MA 02115 USA; [Qureshi, Abrar A.; Zhang, Mingfeng] Brigham & Womens Hosp, Dept Dermatol, Boston, MA 02115 USA; [Duggan, David] Translat Genom Res Inst, Phoenix, AZ USA; [Hutter, Carolyn] NCI, Epidemiol & Genom Res Program, Div Canc Control & Populat Sci, NIH, Bethesda, MD 20892 USA; [Hindorff, Lucia] NHGRI, Div Genom Med, NIH, Bethesda, MD 20892 USA; [Bush, William S.] Vanderbilt Univ, Dept Biomed Informat, Nashville, TN 37235 USA	Fred Hutchinson Cancer Center; University of Southern California; Indiana University System; Indiana University-Purdue University Indianapolis; Vanderbilt University; Vanderbilt University; Cancer Prevention Institute of California; Cancer Research Center of Hawaii; University of Hawaii System; Case Western Reserve University; Case Western Reserve University; Rutgers State University New Brunswick; University of Southern California; Tianjin Medical University; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Translational Genomics Research Institute; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); Vanderbilt University	Kocarnik, JM (corresponding author), Fred Hutchinson Canc Res Ctr, Div Publ Hlth Sci, 1124 Columbia St, Seattle, WA 98104 USA.	jkocarni@fhcrc.org	Crawford, Dana/O-5578-2019; Schumacher, Fredrick/R-6043-2019; Bush, William/N-1369-2019	Crawford, Dana/0000-0002-6437-6248; Schumacher, Fredrick/0000-0002-3073-7463; Bush, William/0000-0002-9729-6519; Ambite, Jose Luis/0000-0003-0087-080X	National Human Genome Research Institute (NHGRI) [U01HG004803, U01HG004798, U01HG004802, U01HG004790, U01HG004801]; "Epidemiologic Architecture for Genes Linked to Environment (EAGLE)" through the NHGRI PAGE program [U01HG004798-01]; NCATS/NIH [UL1 TR000445]; Multiethnic Cohort study (MEC) [U01HG004802]; National Cancer Institute [R37CA54281, R01 CA63, P01CA33619, U01CA136792, U01CA98758]; "Epidemiology of putative genetic variants: The Women's Health Initiative" study is provided through the NHGRI PAGE program [U01HG004790]; National Heart, Lung, and Blood Institute; NIH; U.S. Department of Health and Human Services [N01WH22110, 24152, 32100-2, 32105-6, 32108-9, 32111-13, 32115, 32118-32119, 32122, 42107-26, 42129-32, 44221]; PAGE Coordinating Center [U01HG004801-01]; National Institutes of Mental Health; NCI [R25CA94880]; NIH [CA122838, CA87969, CA055075, CA49449, CA100264, CA093459]; NATIONAL CANCER INSTITUTE [P30CA071789] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U01HG007376, U01HG004803, U01HG004801, U01HG007419, U01HG004802, U01HG004790, U01HG004798] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM080178] Funding Source: NIH RePORTER	National Human Genome Research Institute (NHGRI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); "Epidemiologic Architecture for Genes Linked to Environment (EAGLE)" through the NHGRI PAGE program; NCATS/NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); Multiethnic Cohort study (MEC); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); "Epidemiology of putative genetic variants: The Women's Health Initiative" study is provided through the NHGRI PAGE program; National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); U.S. Department of Health and Human Services; PAGE Coordinating Center; National Institutes of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The Population Architecture Using Genomics and Epidemiology (PAGE) program is funded by the National Human Genome Research Institute (NHGRI), supported by U01HG004803 (CALiCo), U01HG004798 (EAGLE), U01HG004802 (MEC), U01HG004790 (WHI), and U01HG004801 (Coordinating Center), and their respective NHGRI ARRA supplements. The contents of this paper are solely the responsibility of the authors and do not necessarily represent the official views of the NIH. The complete list of PAGE members can be found at http://www.pagestudy.org. The data and materials included in this report results from collaboration between the following studies: The "Epidemiologic Architecture for Genes Linked to Environment (EAGLE)" is funded through the NHGRI PAGE program (U01HG004798-01 and its NHGRI ARRA supplement). The dataset(s) used for the analyses described were obtained from Vanderbilt University Medical; Center's BioVU which is supported by institutional funding and by the Vanderbilt CTSA grant UL1 TR000445 from NCATS/NIH. The Vanderbilt University Center for Human Genetics Research, Computational Genomics Core provided computational and/or analytical support for this work; The Multiethnic Cohort study (MEC) characterization of epidemiological architecture is funded through the NHGRI PAGE program (U01HG004802 and its NHGRI ARRA supplement). The MEC study is funded through the National Cancer Institute (R37CA54281, R01 CA63, P01CA33619, U01CA136792, and U01CA98758). Funding support for the "Epidemiology of putative genetic variants: The Women's Health Initiative" study is provided through the NHGRI PAGE program (U01HG004790 and its NHGRI ARRA supplement). The WHI program is funded by the National Heart, Lung, and Blood Institute; NIH; and U.S. Department of Health and Human Services through contracts N01WH22110, 24152, 32100-2, 32105-6, 32108-9, 32111-13, 32115, 32118-32119, 32122, 42107-26, 42129-32, and 44221. The authors thank the WHI investigators and staff for their dedication, and the study participants for making the program possible. A full listing of WHI investigators can be found at: http://www.whiscience.org/publications/WHI_investigators_ shortlist.pdf. Assistance with phenotype harmonization, SNP selection and annotation, data cleaning, data management, integration and dissemination, and general study coordination was provided by the PAGE Coordinating Center (U01HG004801-01 and its NHGRI ARRA supplement). The National Institutes of Mental Health also contributes to the support for the Coordinating Center. Author JMK was supported by grant R25CA94880 from NCI. The Nurses' Health Study and the Health Professionals Followup Study were funded by NIH grants CA122838, CA87969, CA055075, CA49449, CA100264, and CA093459. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baird DM, 2010, EXPERT REV MOL MED, V12, DOI 10.1017/S146239941000147X; Barrett JH, 2011, NAT GENET, V43, P1108, DOI 10.1038/ng.959; BELANGER CF, 1978, AM J NURS, V78, P1039, DOI 10.2307/3462013; Boniol M, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e4757; Broderick P, 2009, CANCER RES, V69, P6633, DOI 10.1158/0008-5472.CAN-09-0680; Bush William S, 2013, Pac Symp Biocomput, P373; Calcraft PJ, 2009, NATURE, V459, P596, DOI 10.1038/nature08030; Chung CC, 2011, HUM MOL GENET, V20, P2869, DOI 10.1093/hmg/ddr189; Colditz GA, 2005, NAT REV CANCER, V5, P388, DOI 10.1038/nrc1608; Gerstenblith MR, 2010, PIGM CELL MELANOMA R, V23, P587, DOI 10.1111/j.1755-148X.2010.00730.x; Ghoussaini M, 2008, JNCI-J NATL CANCER I, V100, P962, DOI 10.1093/jnci/djn190; Gibbs RA, 2003, NATURE, V426, P789, DOI 10.1038/nature02168; Gruber SB, 2006, CANC EPIDEMIOLOGY PR, P1126; Gudbjartsson DF, 2008, NAT GENET, V40, P886, DOI 10.1038/ng.161; Hays J, 2003, ANN EPIDEMIOL, V13, pS18, DOI 10.1016/S1047-2797(03)00042-5; Hindorff LA, 2009, P NATL ACAD SCI USA, V106, P9362, DOI 10.1073/pnas.0903103106; Howlader N, 2013, SEER CANC STAT REV 1; Johnson AD, 2008, BIOINFORMATICS, V24, P2938, DOI 10.1093/bioinformatics/btn564; Joosse A, 2011, J INVEST DERMATOL, V131, P719, DOI 10.1038/jid.2010.354; Kim NH, 2012, J INVEST DERMATOL, V132, P2622, DOI 10.1038/jid.2012.175; Kocarnik JM, 2014, J INVEST DERMATOL, V134, P2049, DOI 10.1038/jid.2014.53; Kolonel LN, 2000, AM J EPIDEMIOL, V151, P346, DOI 10.1093/oxfordjournals.aje.a010213; Kondo Taisuke, 2011, Expert Rev Dermatol, V6, P97, DOI 10.1586/edm.10.70; Kosoy R, 2009, HUM MUTAT, V30, P69, DOI 10.1002/humu.20822; Law MH, 2012, J INVEST DERMATOL, V132, P485, DOI 10.1038/jid.2011.322; Matise TC, 2011, AM J EPIDEMIOL, V174, P849, DOI 10.1093/aje/kwr160; Mocellin S, 2012, JNCI-J NATL CANCER I, V104, P840, DOI 10.1093/jnci/djs222; Petersen GM, 2010, NAT GENET, V42, P224, DOI 10.1038/ng.522; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Rafnar T, 2009, NAT GENET, V41, P221, DOI 10.1038/ng.296; Randall JC, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003500; Rimm E B, 1990, Epidemiology, V1, P466, DOI 10.1097/00001648-199011000-00009; Roden DM, 2008, CLIN PHARMACOL THER, V84, P362, DOI 10.1038/clpt.2008.89; Scherer D, 2010, MUTAT RES-REV MUTAT, V705, P141, DOI 10.1016/j.mrrev.2010.06.002; Stacey SN, 2009, NAT GENET, V41, P909, DOI 10.1038/ng.412; StataCorp, 2011, STAT STAT SOFTW REL, P173; Sturm RA, 2009, HUM MOL GENET, V18, pR9, DOI 10.1093/hmg/ddp003; Sulem P, 2008, NAT GENET, V40, P835, DOI 10.1038/ng.160; Tadokoro T, 2003, PIGM CELL RES, V16, P190, DOI 10.1034/j.1600-0749.2003.00019.x; Tao S, 2012, CARCINOGENESIS, V33, P598, DOI 10.1093/carcin/bgr316; Wang YF, 2008, NAT GENET, V40, P1407, DOI 10.1038/ng.273; Zheng SL, 2009, CANCER EPIDEM BIOMAR, V18, P1815, DOI 10.1158/1055-9965.EPI-08-0983	42	12	12	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2015	10	3							e0120491	10.1371/journal.pone.0120491	http://dx.doi.org/10.1371/journal.pone.0120491			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD9NQ	25789475	Green Published, gold, Green Submitted			2022-12-27	WOS:000351425400160
J	Larrinaga, G; Perez, I; Sanz, B; Beitia, M; Errarte, P; Fernandez, A; Blanco, L; Etxezarraga, MC; Gil, J; Lopez, JI				Larrinaga, Gorka; Perez, Itxaro; Sanz, Begona; Beitia, Maider; Errarte, Peio; Fernandez, Ainhoa; Blanco, Lorena; Etxezarraga, Maria C.; Gil, Javier; Lopez, Jose I.			Dipeptidyl-Peptidase IV Activity Is Correlated with Colorectal Cancer Prognosis	PLOS ONE			English	Article							FIBROBLAST ACTIVATION PROTEIN; CARCINOMA-ASSOCIATED FIBROBLASTS; COLON-CANCER; AMINOPEPTIDASE N/CD13; SERUM CD26; EXPRESSION; MARKERS; IMPACT	Background Dipeptidyl-peptidase IV (EC 3.4.14.5) (DPPIV) is a serine peptidase involved in cell differentiation, adhesion, immune modulation and apoptosis, functions that control neoplastic transformation. Previous studies have demonstrated altered expression and activity of tissue and circulating DPPIV in several cancers and proposed its potential usefulness for early diagnosis in colorectal cancer (CRC). Methods and principal findings The activity and mRNA and protein expression of DPPIV was prospectively analyzed in adenocarcinomas, adenomas, uninvolved colorectal mucosa and plasma from 116 CRC patients by fluorimetric, quantitative RT-PCR and immunohistochemical methods. Results were correlated with the most important classic pathological data related to aggressiveness and with 5-year survival rates. Results showed that: 1) mRNA levels and activity of DPPIV increased in colorectal neoplasms (Kruskal-Wallis test, p<0.01); 2) Both adenomas and CRCs displayed positive cytoplasmic immunostaining with luminal membrane reinforcement; 3) Plasmatic DPPIV activity was lower in CRC patients than in healthy subjects (Mann-U test, p<0.01); 4) Plasmatic DPPIV activity was associated with worse overall and disease-free survivals (log-rank p<0.01, Cox analysis p<0.01). Conclusion/significance 1) Up-regulation of DPPIV in colorectal tumors suggests a role for this enzyme in the neoplastic transformation of colorectal tissues. This finding opens the possibility for new therapeutic targets in these patients. 2) Plasmatic DPPIV is an independent prognostic factor in survival of CRC patients. The determination of DPPIV activity levels in the plasma may be a safe, minimally invasive and inexpensive way to define the aggressiveness of CRC in daily practice.	[Larrinaga, Gorka; Perez, Itxaro; Beitia, Maider] Univ Basque Country, UPV EHU, Sch Nursing, Dept Nursing 1, Leioa, Bizkaia, Spain; [Larrinaga, Gorka; Perez, Itxaro; Sanz, Begona; Beitia, Maider; Errarte, Peio; Fernandez, Ainhoa; Blanco, Lorena; Gil, Javier] Univ Basque Country, UPV EHU, Fac Med & Dent, Dept Physiol, Leioa, Bizkaia, Spain; [Etxezarraga, Maria C.] Univ Basque Country, UPV EHU, Basurto Univ Hosp, Dept Anat Pathol, Bilbao, Bizkaia, Spain; [Lopez, Jose I.] Univ Basque Country, UPV EHU, Cruces Univ Hosp, Dept Anat Pathol, Baracaldo, Bizkaia, Spain; [Larrinaga, Gorka; Perez, Itxaro; Sanz, Begona; Beitia, Maider; Errarte, Peio; Fernandez, Ainhoa; Blanco, Lorena; Etxezarraga, Maria C.; Gil, Javier; Lopez, Jose I.] BioCruces Hlth Res Inst, Baracaldo, Bizkaia, Spain	University of Basque Country; University of Basque Country; Basurto Hospital; University of Basque Country; Hospital Universitario Cruces; University of Basque Country	Larrinaga, G (corresponding author), Univ Basque Country, UPV EHU, Sch Nursing, Dept Nursing 1, Leioa, Bizkaia, Spain.	gorka.larrinaga@ehu.es	Errarte, Peio/AAD-4169-2020; Fernández-Atutxa, Ainhoa/AAZ-1764-2021; Lopez, Jose Ignacio/L-3884-2019; Sanz, Begoña/ABE-7948-2020; Lopez, Jose Ignacio/E-2973-2012; Beitia, Maider/AAD-1618-2020	Errarte, Peio/0000-0002-1581-5152; Fernández-Atutxa, Ainhoa/0000-0002-1554-0291; Lopez, Jose Ignacio/0000-0003-0842-5348; Lopez, Jose Ignacio/0000-0003-0842-5348; LARRINAGA ENBEITA, GORKA/0000-0002-6744-818X; Sanz Echevarria, Begona/0000-0002-6354-6401; Perez Urzelai, Itxaro/0000-0003-1860-1755	Basque Government [IT8-11/13]; University of the Basque Country UPV/EHU [UFI 11/44]; Gangoiti Barrera Foundation	Basque Government(Basque Government); University of the Basque Country UPV/EHU; Gangoiti Barrera Foundation	This work was supported by grants from the Basque Government (IT8-11/13), the University of the Basque Country UPV/EHU (UFI 11/44), and the Gangoiti Barrera Foundation. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alponti RF, 2011, METABOLISM, V60, P234, DOI 10.1016/j.metabol.2009.12.031; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brennen WN, 2012, JNCI-J NATL CANCER I, V104, P1320, DOI 10.1093/jnci/djs336; Brennen WN, 2012, MOL CANCER THER, V11, P257, DOI 10.1158/1535-7163.MCT-11-0340; Candenas L, 2006, EUR J PHARMACOL, V541, P9, DOI 10.1016/j.ejphar.2006.04.025; Carl-McGrath S, 2006, HISTOL HISTOPATHOL, V21, P1339, DOI 10.14670/HH-21.1339; Cordero OJ, 2000, BRIT J CANCER, V83, P1139, DOI 10.1054/bjoc.2000.1410; Cordero OJ, 2011, WORLD J CLIN ONCOL, V2, P245, DOI 10.5306/wjco.v2.i6.245; Cordero OJ, 2009, CANCER IMMUNOL IMMUN, V58, P1725, DOI 10.1007/s00262-009-0728-1; De Chiara L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107470; De Chiara L, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-333; Edge SB, 2010, AJCC CANC STAGING MA; Ferlay J, 2013, EUR J CANCER, V49, P1374, DOI 10.1016/j.ejca.2012.12.027; Hashida H, 2002, GASTROENTEROLOGY, V122, P376, DOI 10.1053/gast.2002.31095; Havre PA, 2008, FRONT BIOSCI-LANDMRK, V13, P1634, DOI 10.2741/2787; Henry LR, 2007, CLIN CANCER RES, V13, P1736, DOI 10.1158/1078-0432.CCR-06-1746; Hundt S, 2007, CANCER EPIDEM BIOMAR, V16, P1935, DOI 10.1158/1055-9965.EPI-06-0994; Jass JR, 2007, HISTOPATHOLOGY, V50, P113, DOI 10.1111/j.1365-2559.2006.02549.x; Javidroozi M, 2012, DIS MARKERS, V32, P309, DOI [10.3233/DMA-2011-0889, 10.1155/2012/706745]; Kim EC, 1997, GASTROENTEROL CLIN N, V26, P1, DOI 10.1016/S0889-8553(05)70280-6; Lam CSC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098582; Larrinaga G, 2014, INT J MED SCI, V11, P199, DOI 10.7150/ijms.7178; Larrinaga G, 2013, TRANSL RES, V162, P297, DOI 10.1016/j.trsl.2013.07.010; Larrinaga G, 2012, AM J PHYSIOL-RENAL, V303, pF1584, DOI 10.1152/ajprenal.00477.2012; Larrinaga G, 2010, REGUL PEPTIDES, V163, P102, DOI 10.1016/j.regpep.2010.03.012; Leslie A, 2002, BRIT J SURG, V89, P845, DOI 10.1046/j.1365-2168.2002.02120.x; de la Fuente IM, 2014, SPRINGER SER BIOPHYS, V16, P179, DOI 10.1007/978-3-642-38505-6_8; Murakami H, 2005, CLIN CANCER RES, V11, P8674, DOI 10.1158/1078-0432.CCR-05-1005; Nazarian A, 2014, MOL CELL PROTEOMICS, V13, P3082, DOI 10.1074/mcp.M114.038836; Siegel R, 2014, CA-CANCER J CLIN, V64, P104, DOI 10.3322/caac.21220; Thirunavukarasu P, 2011, JNCI-J NATL CANCER I, V103, P689, DOI 10.1093/jnci/djr078; van Hensbergen Y, 2002, CLIN CANCER RES, V8, P3747; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Vargas AJ, 2012, NUTR CLIN PRACT, V27, P613, DOI 10.1177/0884533612454885; Varona A, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-193; Washington MK, 2009, ARCH PATHOL LAB MED, V133, P1539, DOI 10.1043/1543-2165-133.10.1539; Wickstrom M, 2011, CANCER SCI, V102, P501, DOI 10.1111/j.1349-7006.2010.01826.x; Wikberg ML, 2013, TUMOR BIOL, V34, P1013, DOI 10.1007/s13277-012-0638-2	38	26	27	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2015	10	3							e0119436	10.1371/journal.pone.0119436	http://dx.doi.org/10.1371/journal.pone.0119436			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD9NQ	25790122	Green Published, gold, Green Submitted			2022-12-27	WOS:000351425400085
J	Liu, LJ; Guo, LN; Zhao, C; Wu, XW; Wang, RF; Liu, C				Liu, Lijia; Guo, Lina; Zhao, Can; Wu, Xiuwen; Wang, Rufeng; Liu, Chen			Characterization of the Intestinal Absorption of Seven Flavonoids from the Flowers of Trollius chinensis Using the Caco-2 Cell Monolayer Model	PLOS ONE			English	Article							TRANSPORT	The human Caco-2 cell monolayer model was used to investigate the absorption property, mechanism, and structure-property relationship of seven representative flavonoids, namely, orientin, vitexin, 2 ''-O-beta-L-galactopyranosylorientin, 2 ''-O-beta-L-galactopyranosylvitexin, iso-swertisin, isoswertiajaponin, and 2 ''-O-(2'''-methylbutanoyl) isoswertisin from the flowers of Trollius chinensis. The results showed that these flavonoids were hardly transported through the Caco-2 cell monolayer. The compounds with 7-OCH3 including isoswertisin, isoswertiajaponin and 2 ''-O-(2'''-methylbutanoyl) isoswertisin were absorbed in a passive diffusion manner, and their absorbability was increased in the same order as their polarity. The absorption of the remaining compounds with 7-OH including orientin, vitexin, 2 ''-O-beta-L-galactopyranosylorientin, and 2 ''-O-beta-L-galactopyranosylvitexin involved transporter mediated efflux in addition to passive diffusion. Among the four compounds with 7-OH, those with a free hydroxyl group at C-2 '' such as orientin and vitexin were the substrates of P-glycoprotein (P-gp) and that with a free hydroxyl group at C-2' such as 2 ''-O-beta-L-galactopyranosylorientin was the substrate of multidrug resistance protein 2 (MRP2). The results of this study also implied that the absorbability of the flavonoids should be taken into account when estimating the effective components of T. chinensis.	[Liu, Lijia; Guo, Lina; Zhao, Can; Wu, Xiuwen; Wang, Rufeng; Liu, Chen] Beijing Univ Chinese Med, Sch Chinese Mat Med, Beijing, Peoples R China	Beijing University of Chinese Medicine	Wang, RF (corresponding author), Beijing Univ Chinese Med, Sch Chinese Mat Med, Beijing, Peoples R China.	wangrf2003@sina.com			National Natural Science Foundation of China	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by the National Natural Science Foundation of China (http://www.nsfc.gov.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1974, J TSINGHUA U SCI TEC, V1, P165; Cai SQ, 2006, CHEM BIODIVERS, V3, P343, DOI 10.1002/cbdv.200690037; Chong SH, 1997, PHARMACEUT RES, V14, P1835, DOI 10.1023/A:1012112820371; Gao J, 2001, Curr Protoc Pharmacol, VChapter 7, DOI 10.1002/0471141755.ph0702s08; Hao YF, 2013, J SHENYANG PHARM U, V30, P197; Jiangsu New College of Medicine, 1997, CHIN MAT MED DICT, P1398; Li YL, 2002, J ETHNOPHARMACOL, V79, P365, DOI 10.1016/S0378-8741(01)00410-X; [林俊芝 Lin Junzhi], 2013, [中成药, Chinese Traditional Patent Medicine], V35, P483; Lin QF, 2003, CHIN J ANAL LAB, V22, P310; [林秋凤 Lin Qiufeng], 2004, [浙江大学学报. 理学版, Journal of Zhejiang University], V31, P412; Liu Zhi, 2004, Zhongguo Zhongyao Zazhi, V29, P1049; Qu CH, 2009, J HEBEI N U, V25, P21; Su LJ, 2005, FOREIGN MED SCI, V20, P14; Tang JZ, 2003, FOOD SCI, V23, P88; van der Sandt ICJ, 2000, EUR J PHARM SCI, V11, P207, DOI 10.1016/S0928-0987(00)00097-X; Versantvoort CHM, 1995, INT J CANCER, V63, P855, DOI 10.1002/ijc.2910630617; Walle UK, 1999, RES COMMUN MOL PATH, V103, P45; Wang GJ, 2005, PHARMACOKINETICS, P6; Wang RF, 2004, J ASIAN NAT PROD RES, V6, P139, DOI 10.1080/1028602031000147393; Wang RF, 2004, HETEROCYCLES, V63, P1443; [王如峰 Wang Rufeng], 2012, [时珍国医国药, Lishizhen Medicine and Materia Medica Research], V23, P2115; [吴新安 Wu Xinan], 2012, [时珍国医国药, Lishizhen Medicine and Materia Medica Research], V23, P632; Yang YX, 2006, CHIN MED MAT, V29, P1312; Yee SY, 1997, PHARMACEUT RES, V14, P763, DOI 10.1023/A:1012102522787; Yuan M, 2013, CHIN J NAT MEDICINES, V11, P699, DOI [10.1016/S1875-5364(13)60082-5, 10.3724/SP.J.1009.2013.00699]; Yuan M, 2013, CHIN J NAT MEDICINES, V11, P449, DOI [10.1016/S1875-5364(13)60083-7, 10.3724/SP.J.1009.2013.00449]; 王凌云, 2003, [中药新药与临床药理, Traditional Chinese Drug Research and Clinical Plarmacology], V14, P252	27	15	19	2	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2015	10	3							e0119263	10.1371/journal.pone.0119263	http://dx.doi.org/10.1371/journal.pone.0119263			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD9NQ	25789809	Green Submitted, Green Published, gold			2022-12-27	WOS:000351425400073
J	Qi, JJ; Sun, P; Liao, DQ; Sun, TY; Zhu, J; Li, XN				Qi, Jianjun; Sun, Peng; Liao, Dengqun; Sun, Tongyu; Zhu, Juan; Li, Xianen			Transcriptomic Analysis of American Ginseng Seeds during the Dormancy Release Process by RNA-Seq	PLOS ONE			English	Article							GENE-EXPRESSION; GIBBERELLIN BIOSYNTHESIS; LOW-TEMPERATURE; ARABIDOPSIS; TOOL; GIGANTEA; BARLEY	American ginseng (Panax quinquefolius L.) is an important herb that is cultivated in China, North American, and South Korea. It is propagated from seed, but the seed has deep dormancy characteristics described as morphophysiological dormancy. Two-stage temperature stratification, a warm (15-20 degrees C) and cold (2 degrees C) stratification period of 6 months, has been used successfully for seed dormancy release. However, little is known about the molecular mechanisms of seed dormancy release in the stratification process. In this study, seed development after pollination and seed development in the dormancy release process were investigated in American ginseng. The transcriptome during seed dormancy release was analyzed using RNA-Seq technology and 78,207 unigenes (mean length 531 bp) were generated. Based on similarity searches of public databases, 54,292 of the unigenes (69.4%) were functionally annotated. Further, three digital gene expression (DGE) libraries were sequenced and differences in gene expression at three stages during seed cold stratification were examined. The greatest number of differentially expressed genes occurred in the 90DCS versus 180DCS libraries, while the lowest number of differentially expressed genes occurred in the 135DCS verus 180DCS libraries. GO enrichment analysis revealed that 59, 29, and 39 GO terms were significantly enriched in the biological process, molecular function, and cell component GO categories, respectively. There were 25,190 genes with KEGG pathway annotation in the three DGE libraries and their enrichment pathways were compared. The gene expressions of 30 selected unigenes were validated using quantitative PCR. This study is the first to provide the transcriptome sequences for seed dormancy release in American ginseng, and demonstrates the successful use of DGE profiling data for analyzing transcriptomic variation during dormancy release. These data provide a basis for future researches of seed dormancy in morphophysiological dormancy seeds in non-model plants.	[Qi, Jianjun; Sun, Peng; Liao, Dengqun; Sun, Tongyu; Zhu, Juan; Li, Xianen] Chinese Acad Med Sci, Peking Union Med Coll, Inst Med Plants Dev, Beijing 100730, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Medicinal Plant Development - CAMS; Peking Union Medical College	Li, XN (corresponding author), Chinese Acad Med Sci, Peking Union Med Coll, Inst Med Plants Dev, Beijing 100730, Peoples R China.	xeli@implad.ac.cn			National Science and Technology Major Project of the Ministry of Science and Technology of China [2012ZX09304006]	National Science and Technology Major Project of the Ministry of Science and Technology of China	This work was funded by the National Science and Technology Major Project of the Ministry of Science and Technology of China (2012ZX09304006) (http//www.nmp.gov.cn). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Audic S, 1997, GENOME RES, V7, P986, DOI 10.1101/gr.7.10.986; Baskin CC, 1998, SEEDS ECOLOGY BIOGEO; Cadman CS, 2006, PLANT, V46, P67; Chen Shi-lin, 2008, Yaoxue Xuebao, V43, P657; Chen Y, 1998, TECHNICAL MANUAL CHI; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Fei HM, 2007, GENOMICS, V89, P419, DOI 10.1016/j.ygeno.2006.11.008; Finch-Savage WE, 2007, PLANT J, V51, P60, DOI 10.1111/j.1365-313X.2007.03118.x; Finkelstein R, 2008, ANNU REV PLANT BIOL, V59, P387, DOI 10.1146/annurev.arplant.59.032607.092740; Gao JJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088804; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Hecht V, 2001, PLANT PHYSIOL, V127, P803, DOI 10.1104/pp.010324; Hedden P, 2012, BIOCHEM J, V444, P11, DOI 10.1042/BJ20120245; Hedley PE, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-202; Helliwell CA, 2001, P NATL ACAD SCI USA, V98, P2065, DOI 10.1073/pnas.041588998; Huq E, 2000, P NATL ACAD SCI USA, V97, P9789, DOI 10.1073/pnas.170283997; Iseli C, 1999, Proc Int Conf Intell Syst Mol Biol, P138; Li HQ, 1995, SPECIAL WILD EC ANIM, V3, P4; Li RQ, 2009, BIOINFORMATICS, V25, P1966, DOI 10.1093/bioinformatics/btp336; Li T. S. C., 2000, HortTechnology, V10, P131; Li T. S. C., 1995, HortTechnology, V5, P27; Li T. S. C., 2002, Native Plants Journal, V3, P109; Li XZ, 2000, RENSHEN YAN JIU, V12, P11; Liu GQ, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-700; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lopez-Molina L, 2002, PLANT J, V32, P317, DOI 10.1046/j.1365-313X.2002.01430.x; Meng XL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064485; Millar AA, 2006, PLANT J, V45, P942, DOI 10.1111/j.1365-313X.2006.02659.x; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Park DH, 1999, SCIENCE, V285, P1579, DOI 10.1126/science.285.5433.1579; Qi JJ, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-358; ROSS JJ, 1995, PLANT J, V7, P513, DOI 10.1046/j.1365-313X.1995.7030513.x; Seiler C, 2011, J EXP BOT, V62, P2615, DOI 10.1093/jxb/erq446; Suarez-Lopez P, 2001, NATURE, V410, P1116, DOI 10.1038/35074138; Sun C, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-262; Sun Yong-zhen, 2011, Yaoxue Xuebao, V46, P1008; Wang WQ, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-60; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; Wu D, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-564; Wu Q, 2010, PHYSIOL PLANTARUM, V138, P134, DOI 10.1111/j.1399-3054.2009.01309.x; Yamauchi Y, 2004, PLANT CELL, V16, P367, DOI 10.1105/tpc.018143; Ye J, 2006, NUCLEIC ACIDS RES, V34, pW293, DOI 10.1093/nar/gkl031	42	15	21	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2015	10	3							e0118558	10.1371/journal.pone.0118558	http://dx.doi.org/10.1371/journal.pone.0118558			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD9NQ	25790114	Green Published, Green Submitted, gold			2022-12-27	WOS:000351425400035
J	Sun, WQ; Zhou, QL; Yao, Y; Qiu, XJ; Xie, K; Yu, SB				Sun, Wenqian; Zhou, Qiaoling; Yao, Yue; Qiu, Xianjin; Xie, Kun; Yu, Sibin			Identification of Genomic Regions and the Isoamylase Gene for Reduced Grain Chalkiness in Rice	PLOS ONE			English	Article							QUANTITATIVE TRAIT LOCI; AMYLOPECTIN BIOSYNTHESIS; FLOURY ENDOSPERM; STARCH SYNTHESIS; QUALITY TRAITS; ENCODES; SIZE; QTL; MUTATIONS; KNOCKOUT	Grain chalkiness is an important grain quality related to starch granules in the endosperm. A high percentage of grain chalkiness is a major problem because it diminishes grain quality in rice. Here, we report quantitative trait loci identification for grain chalkiness using high-throughput single nucleotide polymorphism genotyping of a chromosomal segment substitution line population in which each line carried one or a few introduced japonica cultivar Nipponbare segments in the genetic background of the indica cultivar ZS97. Ten quantitative trait loci regions were commonly identified for the percentage of grain chalkiness and the degree of endosperm chalkiness. The allelic effects at nine of these quantitative trait loci reduced grain chalkiness. Furthermore, a quantitative trait locus (qPGC8-2) on chromosome 8 was validated in a chromosomal segment substitution line-derived segregation population, and had a stable effect on chalkiness in a multiple-environment evaluation of the near-isogenic lines. Residing on the qPGC8-2 region, the isoamylase gene (ISA1) was preferentially expressed in the endosperm and revealed some nucleotide polymorphisms between two varieties, Nipponbare and ZS97. Transgenic lines with suppression of ISA1 by RNA interference produced grains with 20% more chalkiness than the control. The results support that the gene may underlie qPGC8-2 for grain chalkiness. The multiple-environment trials of the near-isogenic lines also show that combination of the favorable alleles such as the ISA1 gene for low chalkiness and the GS3 gene for long grains considerably improved grain quality of ZS97, which proves useful for grain quality improvement in rice breeding programs.	[Sun, Wenqian; Qiu, Xianjin; Yu, Sibin] Natl Key Lab Crop Genet Improvement, Wuhan, Peoples R China; [Sun, Wenqian; Zhou, Qiaoling; Yao, Yue; Qiu, Xianjin; Xie, Kun; Yu, Sibin] Huazhong Agr Univ, Coll Plant Sci & Technol, Wuhan, Peoples R China	Huazhong Agricultural University	Yu, SB (corresponding author), Natl Key Lab Crop Genet Improvement, Wuhan, Peoples R China.	ysb@mail.hzau.edu.cn		, sibin/0000-0003-0458-7526	National Natural Science Foundation of China [31261140369, 31271695]; Ministry of Science and Technology [2013CB127006]; Bill & Melinda Gates Foundation	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea); Bill & Melinda Gates Foundation(Bill & Melinda Gates FoundationCGIAR)	This work was supported by the National Natural Science Foundation of China (Grant No. 31261140369, 31271695), the Ministry of Science and Technology (Grant No. 2013CB127006), and the Bill & Melinda Gates Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aluko G, 2004, THEOR APPL GENET, V109, P630, DOI 10.1007/s00122-004-1668-y; Burton RA, 2002, PLANT J, V31, P97, DOI 10.1046/j.1365-313X.2002.01339.x; Butardo VM, 2011, J EXP BOT, V62, P4927, DOI 10.1093/jxb/err188; Calingacion M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085106; Chen QQ, 2007, SCI AGR SIN, V40, P2379; Chu ZH, 2006, GENE DEV, V20, P1250, DOI 10.1101/gad.1416306; Cule E, 2013, GENET EPIDEMIOL, V37, P704, DOI 10.1002/gepi.21750; Fitzgerald MA, 2009, TRENDS PLANT SCI, V14, P133, DOI 10.1016/j.tplants.2008.12.004; Fujita N, 2003, PLANT CELL PHYSIOL, V44, P607, DOI 10.1093/pcp/pcg079; Groemping U., 2006, J STAT SOFTW, V17, P1, DOI DOI 10.18637/JSS.V017.I01; Guo T, 2011, J INTEGR PLANT BIOL, V53, P598, DOI 10.1111/j.1744-7909.2011.01041.x; Hao W, 2009, J INTEGR PLANT BIOL, V51, P500, DOI 10.1111/j.1744-7909.2009.00822.x; HIEI Y, 1994, PLANT J, V6, P271, DOI 10.1046/j.1365-313X.1994.6020271.x; Jeon JS, 2010, PLANT PHYSIOL BIOCH, V48, P383, DOI 10.1016/j.plaphy.2010.03.006; Kang HG, 2005, PLANT J, V42, P901, DOI 10.1111/j.1365-313X.2005.02423.x; Kubo A, 1999, PLANT PHYSIOL, V121, P399, DOI 10.1104/pp.121.2.399; Kubo A, 2005, PLANT PHYSIOL, V137, P43, DOI 10.1104/pp.104.051359; Li JJ, 2011, BREEDING SCI, V61, P338, DOI 10.1270/jsbbs.61.338; Li M, 2011, THEOR APPL GENET, V123, P411, DOI 10.1007/s00122-011-1593-9; Li YB, 2014, NAT GENET, V46, P398, DOI 10.1038/ng.2923; Liu XL, 2011, GENOME, V54, P64, DOI 10.1139/G10-070; Mao HL, 2010, P NATL ACAD SCI USA, V107, P19579, DOI 10.1073/pnas.1014419107; McCouch SR, 2008, RICE, V1, P72, DOI 10.1007/s12284-008-9004-9; Nishi A, 2001, PLANT PHYSIOL, V127, P459, DOI [10.1104/pp.010127, 10.1104/pp.127.2.459]; Ohdan T, 2005, J EXP BOT, V56, P3229, DOI 10.1093/jxb/eri292; Pandey MK, 2012, BIOTECHNOL ADV, V30, P1697, DOI 10.1016/j.biotechadv.2012.08.011; Paran I, 2003, TRENDS GENET, V19, P303, DOI 10.1016/S0168-9525(03)00117-3; Peng C, 2014, PLANT J, V77, P917, DOI 10.1111/tpj.12444; Ryoo N, 2007, PLANT CELL REP, V26, P1083, DOI 10.1007/s00299-007-0309-8; She KC, 2010, PLANT CELL, V22, P3280, DOI 10.1105/tpc.109.070821; Shomura A, 2008, NAT GENET, V40, P1023, DOI 10.1038/ng.169; Song XJ, 2007, NAT GENET, V39, P623, DOI 10.1038/ng2014; StatSoft, 1997, STATSOFT STAT; Tan YF, 2000, THEOR APPL GENET, V101, P823, DOI 10.1007/s001220051549; Utsumi Y, 2011, PLANT PHYSIOL, V156, P61, DOI 10.1104/pp.111.173435; Wan XY, 2005, THEOR APPL GENET, V110, P1334, DOI 10.1007/s00122-005-1976-x; Wang E, 2008, NAT GENET, V40, P1370, DOI 10.1038/ng.220; Wang P, 2011, THEOR APPL GENET, V123, P1319, DOI 10.1007/s00122-011-1669-6; Yamakawa H, 2007, PLANT PHYSIOL, V144, P258, DOI 10.1104/pp.107.098665; Yan CJ, 2011, THEOR APPL GENET, V122, P63, DOI 10.1007/s00122-010-1423-5; Yu HH, 2014, PLANT BIOTECHNOL J, V12, P28, DOI 10.1111/pbi.12113; [余四斌 Yu Sibin], 2005, [分子植物育种, Molecular Plant Breeding], V3, P629; Zhang DP, 2012, PLANT MOL BIOL REP, V30, P1303, DOI 10.1007/s11105-012-0435-5; Zhou LJ, 2009, THEOR APPL GENET, V118, P581, DOI 10.1007/s00122-008-0922-0; Zhou PH, 2003, THEOR APPL GENET, V106, P326, DOI 10.1007/s00122-002-1023-0	45	39	48	3	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2015	10	3							e0122013	10.1371/journal.pone.0122013	http://dx.doi.org/10.1371/journal.pone.0122013			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD9NQ	25790260	Green Submitted, gold, Green Published			2022-12-27	WOS:000351425400207
J	Alarcon, D; Cavieres, LA				Alarcon, Diego; Cavieres, Lohengrin A.			In the Right Place at the Right Time: Habitat Representation in Protected Areas of South American Nothofagus-Dominated Plants after a Dispersal Constrained Climate Change Scenario	PLOS ONE			English	Article							LONG-DISTANCE DISPERSAL; SPECIES DISTRIBUTIONS; GENETIC DIVERSITY; SPATIAL-PATTERNS; RESERVE NETWORKS; RAIN-FOREST; CONSERVATION; CHILE; PREDICTIONS; HISTORY	In order to assess the effects of climate change in temperate rainforest plants in southern South America in terms of habitat size, representation in protected areas, considering also if the expected impacts are similar for dominant trees and understory plant species, we used niche modeling constrained by species migration on 118 plant species, considering two groups of dominant trees and two groups of understory ferns. Representation in protected areas included Chilean national protected areas, private protected areas, and priority areas planned for future reserves, with two thresholds for minimum representation at the country level: 10% and 17%. With a 10% representation threshold, national protected areas currently represent only 50% of the assessed species. Private reserves are important since they increase up to 66% the species representation level. Besides, 97% of the evaluated species may achieve the minimum representation target only if the proposed priority areas were included. With the climate change scenario representation levels slightly increase to 53%, 69%, and 99%, respectively, to the categories previously mentioned. Thus, the current location of all the representation categories is useful for overcoming climate change by 2050. Climate change impacts on habitat size and representation of dominant trees in protected areas are not applicable to understory plants, highlighting the importance of assessing these effects with a larger number of species. Although climate change will modify the habitat size of plant species in South American temperate rainforests, it will have no significant impact in terms of the number of species adequately represented in Chile, where the implementation of the proposed reserves is vital to accomplish the present and future minimum representation. Our results also show the importance of using migration dispersal constraints to develop more realistic future habitat maps from climate change predictions.	[Alarcon, Diego; Cavieres, Lohengrin A.] Univ Concepcion, Dept Bot, Concepcion, Chile; [Alarcon, Diego; Cavieres, Lohengrin A.] Inst Ecol & Biodiversidad, Santiago, Chile	Universidad de Concepcion	Alarcon, D (corresponding author), Univ Concepcion, Dept Bot, Concepcion, Chile.	chilebosque@gmail.com	Cavieres, Lohengrin/A-9542-2010; Alarcon, Diego/I-1990-2016	Cavieres, Lohengrin/0000-0001-9122-3020; Alarcon, Diego/0000-0003-3751-047X	Chilean National Commission for Scientific and Technological Research; Institute of Ecology and Biodiversity (IEB) - [FICM P05-002, PFB-023]	Chilean National Commission for Scientific and Technological Research; Institute of Ecology and Biodiversity (IEB) -	DA received funding from the Chilean National Commission for Scientific and Technological Research (http://www.conicyt.cl) as a doctoral grant. DA and LAC received funding from the Institute of Ecology and Biodiversity (IEB, http://www.ieb-chile.cl) funded by projects FICM P05-002 and PFB-023. The funders had no role in study design, data collection and analyses, decision to publish, or preparation of the manuscript.	Aguayo M, 2009, REV CHIL HIST NAT, V82, P361, DOI 10.4067/S0716-078X2009000300004; Anderson RP, 2003, ECOL MODEL, V162, P211, DOI 10.1016/S0304-3800(02)00349-6; Andrew ME, 2014, ENVIRON REV, V22, P135, DOI 10.1139/er-2013-0056; Araujo MB, 2007, CONSERV BIOL, V21, P1423, DOI 10.1111/j.1523-1739.2007.00827.x; Araujo MB, 2011, ECOL LETT, V14, P484, DOI 10.1111/j.1461-0248.2011.01610.x; Armesto JJ, 1998, SCIENCE, V282, P1271, DOI 10.1126/science.282.5392.1271; ARMESTO JJ, 1989, J BIOGEOGR, V16, P219, DOI 10.2307/2845258; Armesto JJ, 2001, AUSTRAL ECOL, V26, P311, DOI 10.1046/j.1442-9993.2001.01116.x; Bateman BL, 2013, DIVERS DISTRIB, V19, P1224, DOI 10.1111/ddi.12107; Burgess N, 2005, BIODIVERS CONSERV, V14, P1877, DOI 10.1007/s10531-004-1299-2; Cabeza M, 2001, TRENDS ECOL EVOL, V16, P242, DOI 10.1016/S0169-5347(01)02125-5; Carvalho SB, 2011, BIOL CONSERV, V144, P2020, DOI 10.1016/j.biocon.2011.04.024; CONAF/CONAMA/BIRF, 1999, CAT EV REC VEG NAT C; CONAMA, 2005, PLAN ACC PAIS IMPL E; Cuevas JG, 2000, J ECOL, V88, P840, DOI 10.1046/j.1365-2745.2000.00497.x; D'Amen M, 2011, BIOL CONSERV, V144, P989, DOI 10.1016/j.biocon.2010.11.004; De Groot GA, 2012, ANN BOT-LONDON, V109, P965, DOI 10.1093/aob/mcs013; Donoso C., 1993, ECOLOGIA FORESTAL; Donoso C, 1998, SILVICULTURA DE LOS; Echeverria C, 2006, BIOL CONSERV, V130, P481, DOI 10.1016/j.biocon.2006.01.017; Echeverria C, 2012, APPL GEOGR, V32, P822, DOI 10.1016/j.apgeog.2011.08.014; Engler R, 2012, ECOGRAPHY, V35, P872, DOI 10.1111/j.1600-0587.2012.07608.x; Engler R, 2009, ECOGRAPHY, V32, P34, DOI 10.1111/j.1600-0587.2009.05789.x; Escobar B., 2006, AUTOECOLOGIA ESPECIE, P345; Figueroa JA, 2003, PLANT ECOL, V166, P227, DOI 10.1023/A:1023286521721; Gajardo R., 1994, VEGETACION NATURAL C; Gallo JA, 2009, BIOL CONSERV, V142, P446, DOI 10.1016/j.biocon.2008.10.025; Gillespie RG, 2012, TRENDS ECOL EVOL, V27, P47, DOI 10.1016/j.tree.2011.08.009; Guisan A, 2000, ECOL MODEL, V135, P147, DOI 10.1016/S0304-3800(00)00354-9; Guisan A, 2000, PHYTOCOENOLOGIA, V30, P353; Guisan A, 2006, J APPL ECOL, V43, P386, DOI 10.1111/j.1365-2664.2006.01164.x; Hannah L, 2007, FRONT ECOL ENVIRON, V5, P131, DOI 10.1890/1540-9295(2007)5[131:PANIAC]2.0.CO;2; Hechenleitner P., 2005, PLANTAS AMENAZADAS C; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Hijmans RJ., 2012, RASTER GEOGRAPHIC AN; Jackson SF, 2008, ECOL APPL, V18, P1050, DOI 10.1890/07-0662.1; Jump AS, 2009, TRENDS ECOL EVOL, V24, P694, DOI 10.1016/j.tree.2009.06.007; Kuhlmann M, 2012, DIVERS DISTRIB, V18, P885, DOI 10.1111/j.1472-4642.2011.00877.x; Kukkala AS, 2013, BIOL REV, V88, P443, DOI 10.1111/brv.12008; Lenoir J, 2008, SCIENCE, V320, P1768, DOI 10.1126/science.1156831; Loehle C, 2000, AM NAT, V156, P14, DOI 10.1086/303369; Margules CR, 2007, ECOL BIODIVERS CONS, P1; Margules CR, 2000, NATURE, V405, P243, DOI 10.1038/35012251; Ministerio de Agricultura de Chile, 2014, SIST INF TERR; Ministerio del Medio Ambiente de Chile, 2014, INFR DAT ESP; Moilanen A, 2013, DIVERS DISTRIB, V19, P171, DOI 10.1111/ddi.12000; Moreira-Munoz A, 2011, PLANT VEG, V5, P293, DOI 10.1007/978-90-481-8748-5_11; Myers Norman, 2000, Nature (London), V403, P853, DOI 10.1038/35002501; Nunez-Avila MC, 2013, J ECOL, V101, P1439, DOI 10.1111/1365-2745.12148; Pauchard A, 2002, NAT AREA J, V22, P318; Pliscoff P, 2011, ENVIRON CONSERV, V38, P303, DOI 10.1017/S0376892911000208; R Development Core Team, 2012, R LANG ENV STAT COMP; Ramirez J, 2008, HIGH RESOLUTION STAT; Rodrigues ASL, 2004, NATURE, V428, P640, DOI 10.1038/nature02422; Rodriguez R., 1995, FLORA CHILE, V1, P119, DOI DOI 10.1007/S12228-009-9078-8; Sala OE, 2000, SCIENCE, V287, P1770, DOI 10.1126/science.287.5459.1770; SINIA, 2012, CUB LOC AR SILV PROT; Smith-Ramirez C, 2007, BIODIVERSITY LOSS AND CONSERVATION IN FRAGMENTED FOREST LANDSCAPES: THE FORESTS OF MONTANE MEXICO AND TEMPERATE SOUTH AMERICA, P102, DOI 10.1079/9781845932619.0102; Squeo FA, 2012, PLANT ECOL DIVERS, V5, P233, DOI 10.1080/17550874.2012.679012; Summers DM, 2012, GLOBAL CHANGE BIOL, V18, P3268, DOI 10.1111/j.1365-2486.2012.02771.x; Thuiller W, 2003, GLOBAL CHANGE BIOL, V9, P1353, DOI 10.1046/j.1365-2486.2003.00666.x; Thuiller W, 2005, P NATL ACAD SCI USA, V102, P8245, DOI 10.1073/pnas.0409902102; Thuiller W, 2009, ECOGRAPHY, V32, P369, DOI 10.1111/j.1600-0587.2008.05742.x; Tognelli MF, 2008, DIVERS DISTRIB, V14, P148, DOI 10.1111/j.1472-4642.2007.00437.x; TRYON R, 1970, Biotropica, V2, P76, DOI 10.2307/2989765; TRYON R, 1986, BOT REV, V52, P117, DOI 10.1007/BF02860999; Vergara R, 2014, ECOL EVOL, V4, P2450, DOI 10.1002/ece3.1108; Walther GR, 2004, PERSPECT PLANT ECOL, V6, P169, DOI 10.1078/1433-8319-00076; Wiens JA, 2009, P NATL ACAD SCI USA, V106, P19729, DOI 10.1073/pnas.0901639106; Zimmermann NE, 2009, P NATL ACAD SCI USA, V106, P19723, DOI 10.1073/pnas.0901643106; Zuloaga FO., 2008, MONOGR SYST BOT MISS, V107, P136	72	18	18	2	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2015	10	3							e0119952	10.1371/journal.pone.0119952	http://dx.doi.org/10.1371/journal.pone.0119952			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9BN	25786226	gold, Green Submitted, Green Published			2022-12-27	WOS:000352138500144
J	Chesov, D; Lange, C; Daduna, F; Crudu, V; Preyer, R; Ernst, M; Kalsdorf, B				Chesov, Dumitru; Lange, Christoph; Daduna, Franziska; Crudu, Valeriu; Preyer, Rosemarie; Ernst, Martin; Kalsdorf, Barbara			Combined Antigen-Specific Interferon-gamma and Interleukin-2 Release Assay (FluoroSpot) for the Diagnosis of Mycobacterium tuberculosis Infection	PLOS ONE			English	Article							T-CELL RESPONSES; TBNET CONSENSUS STATEMENT; LATENT TUBERCULOSIS; IFN-GAMMA; ACTIVE TB; IMMUNODIAGNOSIS; INDIVIDUALS; CYTOKINES; PROFILE; DISEASE	Background To evaluate interleukin (IL)-2 and interferon (IFN)-gamma secreting T-cells in parallel for the differentiation of latent infection with Mycobacterium tuberculosis infection (LTBI) from active tuberculosis. Methods Following ex-vivo stimulation of peripheral blood mononuclear cells (PBMC) with M. tuberculosis-specific antigens early secretory antigenic target (ESAT)-6 and culture filtrate protein (CFP)-10, immune responses were assessed by enzyme-linked immunospot IFN-. release assay (EliSpot-IGRA) and a novel dual cytokine detecting fluorescence-linked immunospot (FluoroSpot) in 18 patients with pulmonary tuberculosis, 10 persons with previously cured tuberculosis, 25 individuals with LTBI and 16 healthy controls. Results Correlation of IFN-gamma(+) spot-forming cells in EliSpot-IGRA and FluoroSpot were R-2 = 0.67 for ESAT-6 and R-2 = 0.73 for CFP-10. The number of IL-2-IFN-gamma(+) producing cells was higher in patients with tuberculosis compared with past tuberculosis (CFP-10-induced p = 0.0068) or individuals with LTBI (ESAT-6-induced p = 0.0136). A cutoff value of >16 CFP-10-induced IFN-gamma(+) secreting cells/200.000 PBMC in the EliSpot-IGRA discriminated with highest sensitivity and specificity (89% and 76%, respectively). However, overlap in cytokine responses precludes distinction between the cohorts on an individual basis. Conclusions Combined analysis of IFN-gamma and IL-2 secretion by antigen specific T-cells does not allow a reliable differentiation between different states of M. tuberculosis infection in clinical practice.	[Chesov, Dumitru] State Univ Med & Pharm Nicolae Testemitanu, Div Pneumol & Allergol, Kishinev, Moldova; [Chesov, Dumitru; Lange, Christoph; Daduna, Franziska; Kalsdorf, Barbara] Res Ctr Borstel, Div Clin Infect Dis, Borstel, Germany; [Lange, Christoph; Daduna, Franziska; Kalsdorf, Barbara] German Ctr Infect Res, TB Unit, Borstel, Germany; [Lange, Christoph] Med Univ Lubeck, Int Hlth Infect Dis, D-23538 Lubeck, Germany; [Lange, Christoph] Karolinska Inst, Dept Med, Stockholm, Sweden; [Crudu, Valeriu] Inst Phthisiopneumol Chiril Draganiuc, Lab Microbiol & Morphol TB, Kishinev, Moldova; [Preyer, Rosemarie] Autoimmun Diagnost GmbH, Strassberg, Germany; [Ernst, Martin] Res Ctr Borstel, Div Immune Cell Analyt, Borstel, Germany	Nicolae Testemitanu State University of Medicine & Pharmacy; Forschungszentrum Borstel; German Center for Infection Research; University of Lubeck; Karolinska Institutet; Forschungszentrum Borstel	Lange, C (corresponding author), Res Ctr Borstel, Div Clin Infect Dis, Borstel, Germany.	clange@fz-borstel.de	Chesov, Dumitru/AAR-5114-2020; Lange, Christoph/J-6289-2012	Chesov, Dumitru/0000-0001-6203-5020; Lange, Christoph/0000-0002-9691-4741	ERS Walther Guerrero CiqueroTuberculosis Fellowship [STRTF 2013-2889]; German Center for Infection Research (DZIF)	ERS Walther Guerrero CiqueroTuberculosis Fellowship; German Center for Infection Research (DZIF)	Dumitru Chesov is the recipient of ERS Walther Guerrero CiqueroTuberculosis Fellowship (STRTF 2013-2889). Christoph Lange and Barbara Kalsdorf are supported by the German Center for Infection Research (DZIF). FluoroSpot reagents have been provided by Autoimmun Diagnostika (AID) GmbH, (Strassberg, Germany). The funder provided support in the form of salaries for authors [Rosemarie Preyer], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Biselli R, 2010, CLIN MICROBIOL INFEC, V16, P1282, DOI 10.1111/j.1469-0691.2009.03104.x; Bland JM, 1999, STAT METHODS MED RES, V8, P135, DOI 10.1191/096228099673819272; Caccamo N, 2010, EUR J IMMUNOL, V40, P2211, DOI 10.1002/eji.201040455; Casey R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015619; Chegou NN, 2014, EUR RESPIR J, V43, P1472, DOI 10.1183/09031936.00151413; Chiacchio T, 2014, J INFECTION, V69, P533, DOI 10.1016/j.jinf.2014.06.009; Day CL, 2011, J IMMUNOL, V187, P2222, DOI 10.4049/jimmunol.1101122; Essone PN, 2014, RESPIRATION, V88, P251, DOI 10.1159/000365816; Harari A, 2011, NAT MED, V17, P372, DOI 10.1038/nm.2299; Jafari C, 2009, AM J RESP CRIT CARE, V180, P666, DOI 10.1164/rccm.200904-0557OC; Lange C, 2014, EUR RESPIR J, V44, P23, DOI 10.1183/09031936.00188313; Lobue PA, 2012, JAMA-J AM MED ASSOC, V308, P241, DOI 10.1001/jama.2012.7511; Mack U, 2009, EUR RESPIR J, V33, P956, DOI 10.1183/09031936.00120908; Marin ND, 2013, TUBERCULOSIS, V93, P155, DOI 10.1016/j.tube.2012.12.002; Millington KA, 2007, J IMMUNOL, V178, P5217, DOI 10.4049/jimmunol.178.8.5217; Nemeth J, 2010, EUR CYTOKINE NETW, V21, P34, DOI 10.1684/ecn.2009.0182; Oxford Immunotec Limited, 2013, T SPOT TB PACK INS; Pai M, 2004, LANCET INFECT DIS, V4, P761, DOI 10.1016/S1473-3099(04)01206-X; Pai M, 2007, INFECTION, V35, P98, DOI 10.1007/s15010-007-6114-z; Prezzemolo T, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00180; Rovina N, 2013, CLIN DEV IMMUNOL, DOI 10.1155/2013/464039; Sargentini V, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-99; Sester U, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017813; Stop TB Partnership and World Health Organization, 2006, GLOB PLAN STOP TB 20; Sutherland JS, 2009, EUR J IMMUNOL, V39, P723, DOI 10.1002/eji.200838693; World Health Organization, 2014, GLOB TUB REP	26	10	10	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2015	10	3							e0120006	10.1371/journal.pone.0120006	http://dx.doi.org/10.1371/journal.pone.0120006			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9BN	25785445	gold, Green Submitted, Green Published			2022-12-27	WOS:000352138500146
J	Hall, ML; Ferreira, VS; Mayberry, RI				Hall, Matthew L.; Ferreira, Victor S.; Mayberry, Rachel I.			Syntactic Priming in American Sign Language	PLOS ONE			English	Article							2ND-LANGUAGE ACQUISITION; 1ST-LANGUAGE ACQUISITION; CRITICAL PERIOD; LEXICAL ACCESS; DEAF SIGNERS; BILINGUALS; AGE; REPRESENTATIONS; COMPREHENSION; ORGANIZATION	Psycholinguistic studies of sign language processing provide valuable opportunities to assess whether language phenomena, which are primarily studied in spoken language, are fundamentally shaped by peripheral biology. For example, we know that when given a choice between two syntactically permissible ways to express the same proposition, speakers tend to choose structures that were recently used, a phenomenon known as syntactic priming. Here, we report two experiments testing syntactic priming of a noun phrase construction in American Sign Language (ASL). Experiment 1 shows that second language (L2) signers with normal hearing exhibit syntactic priming in ASL and that priming is stronger when the head noun is repeated between prime and target (the lexical boost effect). Experiment 2 shows that syntactic priming is equally strong among deaf native L1 signers, deaf late L1 learners, and hearing L2 signers. Experiment 2 also tested for, but did not find evidence of, phonological or semantic boosts to syntactic priming in ASL. These results show that despite the profound differences between spoken and signed languages in terms of how they are produced and perceived, the psychological representation of sentence structure (as assessed by syntactic priming) operates similarly in sign and speech.	[Hall, Matthew L.] Univ Connecticut, Linguist, Storrs, CT 06269 USA; [Ferreira, Victor S.] Univ Calif San Diego, Psychol, San Diego, CA USA; [Mayberry, Rachel I.] Univ Calif San Diego, Linguist, San Diego, CA USA	University of Connecticut; University of California System; University of California San Diego; University of California System; University of California San Diego	Hall, ML (corresponding author), Univ Connecticut, Linguist, Storrs, CT 06269 USA.	matthall.research@gmail.com			National Institutes of Health (NIH) [R01DC012797, HD051030, 5T32DC000041-19]; Rita L. Atkinson Graduate Fellowship; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC012797] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Rita L. Atkinson Graduate Fellowship; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	The research reported here was supported in part by National Institutes of Health (NIH) grants R01DC012797, HD051030, and 5T32DC000041-19 and also by the Rita L. Atkinson Graduate Fellowship. The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BAKER CL, 1970, FOUND LANG, V6, P197; Baus C, 2008, COGNITION, V108, P856, DOI 10.1016/j.cognition.2008.05.012; Bellugi U, 1983, Hum Neurobiol, V2, P155; Bernolet S, 2007, J EXP PSYCHOL LEARN, V33, P931, DOI 10.1037/0278-7393.33.5.931; Bernolet S, 2013, COGNITION, V127, P287, DOI 10.1016/j.cognition.2013.02.005; Bernolet S, 2012, BILING-LANG COGN, V15, P503, DOI 10.1017/S1366728911000162; BOCK JK, 1986, COGNITIVE PSYCHOL, V18, P355, DOI 10.1016/0010-0285(86)90004-6; Boudreault P, 2006, LANG COGNITIVE PROC, V21, P608, DOI 10.1080/01690960500139363; Brentari Diane, 1998, PROSODIC MODEL SIGN; Carreiras M, 2008, J MEM LANG, V58, P100, DOI 10.1016/j.jml.2007.05.004; Cecchetto C, 2004, GLOW NEWSLETTER, V52, P30; Chang F, 2006, PSYCHOL REV, V113, P234, DOI 10.1037/0033-295X.113.2.234; Cleland AA, 2003, J MEM LANG, V49, P214, DOI 10.1016/S0749-596X(03)00060-3; Cormier K, 2012, COGNITION, V124, P50, DOI 10.1016/j.cognition.2012.04.003; DAMASIO A, 1986, NATURE, V322, P363, DOI 10.1038/322363a0; DELL GS, 1986, PSYCHOL REV, V93, P283, DOI 10.1037/0033-295X.93.3.283; Dye M. W. G., 2006, LAB PHONOL, V8, P243; EMMOREY K, 1991, J PSYCHOLINGUIST RES, V20, P365, DOI 10.1007/BF01067970; EMMOREY K, 1990, PERCEPT MOTOR SKILL, V71, P1227, DOI 10.2466/PMS.71.7.1227-1252; EMMOREY K, 1995, APPL PSYCHOLINGUIST, V16, P1, DOI 10.1017/S0142716400006391; Fernald TB., 2000, SIGN LANG LINGUIST, V3, P3, DOI [10.1075/sll.3.1.03fer, DOI 10.1075/SLL.3.1.03FER]; Flett S., 2003 LING POSTGR C U; Geraci Carlo, 2013, RIGHTWARD MOVEMENT C, P211, DOI [10.1075/la.200.08ger, DOI 10.1075/LA.200.08GER]; Greenberg JH, 1966, UNIVERSALS LANG, P73; Hall ML, 2012, SIGN LANG LINGUIST, V15, P104, DOI 10.1075/sll.15.1.05hal; Hickok G, 1996, APHASIOLOGY, V10, P577, DOI 10.1080/02687039608248438; Hickok G, 1996, NATURE, V381, P699, DOI 10.1038/381699a0; Hickok G, 1997, REV NEUROSCIENCE, V8, P205; Hohenberger A., 2002, MODALITY STRUCTURE S, P112; Keenan Edward L., 1976, SUBJECT TOPIC, P303; Lehmann Christian, 1988, AGREEMENT NATURAL LA, P55; Levelt WJM, 1999, BEHAV BRAIN SCI, V22, P1; Liddell S., 1989, SIGN LANGUAGE STUDIE, V64, P197; MacLaughlin D., 1997, THESIS BOSTON U; MacSweeney M, 2006, HUM BRAIN MAPP, V27, P63, DOI 10.1002/hbm.20167; Mayberry RI, 2011, BRAIN LANG, V119, P16, DOI 10.1016/j.bandl.2011.05.007; Mayberry RI, 2002, NATURE, V417, P38, DOI 10.1038/417038a; MAYBERRY RI, 1993, J SPEECH HEAR RES, V36, P1258, DOI 10.1044/jshr.3606.1258; MAYBERRY RI, 1989, MEM COGNITION, V17, P740, DOI 10.3758/BF03202635; MAYBERRY RI, 1991, J MEM LANG, V30, P486, DOI 10.1016/0749-596X(91)90018-F; Meir I, 2007, J LINGUIST, V43, P531, DOI 10.1017/S0022226707004768; Morford JP, 2011, LANG LEARN DEV, V7, P149, DOI 10.1080/15475441.2011.543393; Morford JP, 2011, COGNITION, V118, P286, DOI 10.1016/j.cognition.2010.11.006; Neidle C, 1998, LANGUAGE, V74, P819, DOI 10.2307/417004; Neidle C., 2000, SYNTAX AM SIGN LANGU; Newkirk Don, 1980, ERRORS LINGUISTIC PE, P165; Newman AJ, 2002, NAT NEUROSCI, V5, P76, DOI 10.1038/nn775; NEWPORT EL, 1990, COGNITIVE SCI, V14, P11, DOI 10.1207/s15516709cog1401_2; Orfanidou E, 2009, MEM COGNITION, V37, P302, DOI 10.3758/MC.37.3.302; Pickering MJ, 2008, PSYCHOL BULL, V134, P427, DOI 10.1037/0033-2909.134.3.427; Pickering MJ, 1998, J MEM LANG, V39, P633, DOI 10.1006/jmla.1998.2592; Sakai KL, 2005, BRAIN, V128, P1407, DOI 10.1093/brain/awh465; Sandler W, 2006, SIGN LANGUAGE AND LINGUISTIC UNIVERSALS, P1, DOI 10.2277/ 0521483956; Sandler W., 1989, PHONOLOGICAL REPRESE; Santesteban M, 2010, J MEM LANG, V63, P347, DOI 10.1016/j.jml.2010.07.001; Scheepers C., 2010, 6 INT WORKSH LANG PR; Schoonbaert S, 2007, J MEM LANG, V56, P153, DOI 10.1016/j.jml.2006.10.002; Soderfeldt B, 1997, NEUROLOGY, V49, P82, DOI 10.1212/WNL.49.1.82; Stokoe WC, 1960, STUD LINGUIST, P7; Sutton-Spence Rachel, 1999, LINGUISTICS BRIT SIG; Szekely A, 2004, J MEM LANG, V51, P247, DOI 10.1016/j.jml.2004.03.002; Thompson R, 2005, PSYCHOL SCI, V16, P856, DOI 10.1111/j.1467-9280.2005.01626.x; Tooley KM, 2009, J EXP PSYCHOL LEARN, V35, P19, DOI 10.1037/a0013984; Vinson DP, 2010, PSYCHOL SCI, V21, P1158, DOI 10.1177/0956797610377340	64	17	17	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2015	10	3							e0119611	10.1371/journal.pone.0119611	http://dx.doi.org/10.1371/journal.pone.0119611			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CE9BN	25786230	Green Published, gold, Green Submitted			2022-12-27	WOS:000352138500120
J	Nystrom, J; Stenkvist, J; Haggblom, A; Weiland, O; Nowak, P				Nystrom, Jessica; Stenkvist, Jenny; Haggblom, Amanda; Weiland, Ola; Nowak, Piotr			Low Levels of Microbial Translocation Marker LBP Are Associated with Sustained Viral Response after Anti-HCV Treatment in HIV-1/HCV Co-Infected Patients	PLOS ONE			English	Article							LIPOPOLYSACCHARIDE-BINDING-PROTEIN; HUMAN-IMMUNODEFICIENCY-VIRUS; CHRONIC LIVER-DISEASES; T-CELL-ACTIVATION; HEPATITIS-C; MACROPHAGE ACTIVATION; MOLECULAR-MECHANISMS; COINFECTED PATIENTS; ENDOTOXEMIA; HIV	Background Microbial translocation (MT) contributes to immune activation during HIV and HCV infections. We investigated the kinetics of MT markers during anti-HCV and anti-HIV treatments, and if baseline plasma levels of lipopolysaccharide (LPS), lipopolysaccharide binding protein (LBP) and soluble CD14 (sCD14) could predict anti-HCV treatment outcome. Methods Plasma from 78 HIV-infected patients was evaluated for LPS, LBP and sCD14. The patients starting anti-HCV treatment (with ongoing antiretroviral (ART) treatment) were categorized into sustained viral responders (SVR; n = 21) or non-responders (NR; n = 15) based on treatment outcome. ART starting subjects-were categorized into chronically HCV-infected (CH; n = 24) and mono-infected (HIV; n = 18), based on the HCV infection status. Samples were collected before start (at baseline) of pegylated-interferon-alpha/ribavirin (peg-IFN/RBV) or antiretroviral-therapy and two years after treatment start (at follow up). chi(2)-test, non-parametric statistics and logistic regression were applied to determine the associations with treatment response and changes of the soluble markers. Results Plasma levels of LPS and sCD14 were elevated in all subjects before antiviral-treatment but remained unchanged at follow-up. Elevated levels of LBP were present in patients with HIV and HIV/HCV co-infection and were reduced by ART. Additionally, higher levels of LBP were present at baseline in NR vs. SVR. Higher levels of LBP at baseline were associated with non-response to peg-IFN/RBV treatment in both bivariate (OR: 0.19 95% CI: 0.06-0.31, p = 0.004) and multivariate analysis (OR: 1.43, 95% CI: 1.1-1.86, p = 0.07). Conclusion In HIV/HCV co-infected patients high baseline LBP levels are associated with non-response to peg-IFN/RBV therapy. Plasma LBP (decreased by ART) may be a more relevant MT marker than LPS and sCD14.	[Nystrom, Jessica; Nowak, Piotr] Karolinska Inst, Karolinska Univ Hosp, Div Clin Microbiol, Dept Lab Med, Stockholm, Sweden; [Stenkvist, Jenny; Haggblom, Amanda; Weiland, Ola; Nowak, Piotr] Karolinska Inst, Karolinska Univ Hosp, Dept Med, Infect Dis Unit, Stockholm, Sweden; [Haggblom, Amanda] Cty Council Gavleborg, Dept Infect Dis, Gavle, Sweden	Karolinska Institutet; Karolinska University Hospital; Karolinska Institutet; Karolinska University Hospital	Nystrom, J (corresponding author), Karolinska Inst, Karolinska Univ Hosp, Div Clin Microbiol, Dept Lab Med, Stockholm, Sweden.	jessica.nystrom@ki.se		Weiland, Ola/0000-0002-6934-9724; Nowak, Piotr/0000-0003-2747-0734	Swedish society for medical research; Ake Wiberg foundation; Swedish Research Council; Karolinska Institutet/Sodertorn University	Swedish society for medical research; Ake Wiberg foundation; Swedish Research Council(Swedish Research CouncilEuropean Commission); Karolinska Institutet/Sodertorn University	This study was supported by grants from Swedish society for medical research, Ake Wiberg foundation, Swedish Research Council and Karolinska Institutet/Sodertorn University (postdoctoral grant to JN). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Albillos A, 2003, HEPATOLOGY, V37, P208, DOI 10.1053/jhep.2003.50038; Anadol E, 2014, HEPATOLOGY; Anas A, 2010, CRIT CARE, V14, DOI 10.1186/cc8850; Ancuta P, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002516; Anthony DD, 2012, J INFECT DIS, V206, P969, DOI 10.1093/infdis/jis434; Balagopal A, 2008, GASTROENTEROLOGY, V135, P226, DOI 10.1053/j.gastro.2008.03.022; Balagopal A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041258; BIGATELLO LM, 1987, AM J GASTROENTEROL, V82, P11; BODE C, 1987, J HEPATOL, V4, P8, DOI 10.1016/S0168-8278(87)80003-X; Moreira APB, 2012, BRIT J NUTR, V108, P801, DOI 10.1017/S0007114512001213; Brenchley JM, 2006, NAT MED, V12, P1365, DOI 10.1038/nm1511; Caradonna L, 2002, CURR PHARM DESIGN, V8, P995, DOI 10.2174/1381612024606983; Arjona MMD, 2011, JAIDS-J ACQ IMM DEF, V56, P420, DOI 10.1097/QAI.0b013e31820ef408; Dolganiuc A, 2007, GASTROENTEROLOGY, V133, P1627, DOI 10.1053/j.gastro.2007.08.003; Fernandez J, 2002, HEPATOLOGY, V35, P140, DOI 10.1053/jhep.2002.30082; French AL, 2013, J INFECT DIS, V208, P679, DOI 10.1093/infdis/jit225; GAETA GB, 1982, DIGESTION, V23, P239, DOI 10.1159/000198756; Ge DL, 2009, NATURE, V461, P399, DOI 10.1038/nature08309; GELLER DA, 1993, ARCH SURG-CHICAGO, V128, P22; Gioannini TL, 2003, J ENDOTOXIN RES, V9, P401, DOI 10.1179/096805103225002773; Gonzalez-Quintela A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054600; GRUBE BJ, 1994, J BIOL CHEM, V269, P8477; Guadalupe M, 2003, J VIROL, V77, P11708, DOI 10.1128/JVI.77.21.11708-11717.2003; Gutsmann T, 2001, INFECT IMMUN, V69, P6942, DOI 10.1128/IAI.69.11.6942-6950.2001; Haissman JM, 2009, JAIDS-J ACQ IMM DEF, V52, P493, DOI 10.1097/QAI.0b013e3181b627dc; Han DW, 2002, WORLD J GASTROENTERO, V8, P961, DOI 10.3748/wjg.v8.i6.961; Hernandez MD, 2011, CURR OPIN HIV AIDS, V6, P478, DOI 10.1097/COH.0b013e32834bd365; Huang HJ, 2007, HEPATOLOGY, V46, P297, DOI 10.1002/hep.21695; Isayama F, 2006, AM J PHYSIOL-GASTR L, V290, pG1318, DOI 10.1152/ajpgi.00405.2005; Jirillo E, 1998, IMMUNOPHARM IMMUNOT, V20, P1, DOI 10.3109/08923979809034805; Kim AY, 2009, GASTROENTEROLOGY, V137, P795, DOI 10.1053/j.gastro.2009.06.040; LEVIN J, 1970, J LAB CLIN MED, V75, P903; Lichtfuss GF, 2011, BIOMARK MED, V5, P171, DOI [10.2217/bmm.11.15, 10.2217/BMM.11.15]; LIN RS, 1995, J HEPATOL, V22, P165, DOI 10.1016/0168-8278(95)80424-2; Malherbe G, 2014, MEDIAT INFLAMM, V2014, DOI 10.1155/2014/198413; Marchetti G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032028; Mastroianni CM, 2014, INT J MOL SCI, V15, P9184, DOI 10.3390/ijms15069184; Merlini E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018580; Page EE, 2011, CURR OPIN HIV AIDS, V6, P472, DOI 10.1097/COH.0b013e32834bbc71; Resino S, 2012, CURR OPIN INFECT DIS, V25, P564, DOI 10.1097/QCO.0b013e32835635df; Resino S, 2011, J INFECTION, V63, P402, DOI 10.1016/j.jinf.2011.07.017; Sandler NG, 2011, GASTROENTEROLOGY, V141, P1220, DOI 10.1053/j.gastro.2011.06.063; Schletter J, 1995, ARCH MICROBIOL, V164, P383, DOI 10.1007/BF02529735; Schumann RR, 1996, MOL CELL BIOL, V16, P3490; Seki E, 2007, NAT MED, V13, P1324, DOI 10.1038/nm1663; Shah AG, 2011, DIGEST DIS SCI, V56, P3038, DOI 10.1007/s10620-011-1710-2; Shin WG, 2008, DIGEST LIVER DIS, V40, P267, DOI 10.1016/j.dld.2007.10.011; Sozinov AS, 2002, B EXP BIOL MED+, V133, P153, DOI 10.1023/A:1015546821875; Sterling RK, 2006, HEPATOLOGY, V43, P1317, DOI 10.1002/hep.21178; Stuyver L, 1996, J CLIN MICROBIOL, V34, P2259, DOI 10.1128/JCM.34.9.2259-2266.1996; Taiwo B, 2013, J ANTIMICROB CHEMOTH, V68, P1857, DOI 10.1093/jac/dkt120; Troseid M, 2010, AIDS, V24, P1733, DOI 10.1097/QAD.0b013e32833b254d; Urbaschek R, 2001, ALCOHOL CLIN EXP RES, V25, P261; Vesterbacka J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055038; Wallet MA, 2010, AIDS, V24, P1281, DOI 10.1097/QAD.0b013e328339e228; Weiss J, 2003, BIOCHEM SOC T, V31, P785, DOI 10.1042/BST0310785; Wiese S, 2014, LIVER INT, V34, pE19, DOI 10.1111/liv.12428; Yun AB, 1996, J MED VIROL, V49, P155, DOI 10.1002/(SICI)1096-9071(199607)49:3<155::AID-JMV1>3.0.CO;2-3	59	14	14	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2015	10	3							e0118643	10.1371/journal.pone.0118643	http://dx.doi.org/10.1371/journal.pone.0118643			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9BN	25785448	Green Published, Green Submitted, gold			2022-12-27	WOS:000352138500041
J	Yang, SS; He, Y; Liu, M; Wang, YY; Wu, L; Wang, JH; Zhang, D; Zeng, J; Jiang, B; Li, XY				Yang, Shanshan; He, Yao; Liu, Miao; Wang, Yiyan; Wu, Lei; Wang, Jianhua; Zhang, Di; Zeng, Jing; Jiang, Bin; Li, Xiaoying			Changes in and Patterns of Smoking Exposure in an Elderly Urban Population in Beijing: 2001-2010	PLOS ONE			English	Article							PASSIVE SMOKING; CIGARETTE-SMOKING; TOBACCO USE; PREVALENCE; RISK; MORTALITY; BEHAVIOR; DISEASE; COHORT; ADULTS	Objective The study aims to explore the patterns and changes of active and passive smoking in the elderly population. Methods Two cross-sectional surveys with representative samples of urban populations, aged between 60 and 95 years old, were conducted in 2001 and 2010 in Beijing. A current smoker was defined as a person who smoked a tobacco product at the time of the survey, and a passive smoker was defined as a person who had been exposed to smoke exhaled by a smoker for more than 15 minutes per day more than once per week. Results A total of 2,277 participants in 2001 and 2,102 participants in 2010 completed the survey. The current smoking prevalence changed slightly in males (24.7 vs. 21.2%, P = 0.081), while the prevalence in females decreased significantly from 8.8% (95% CI: 7.3-10.3%) in 2001 to 4.1% (95% CI: 3.0-5.2%) in 2010 (P<0.001). The prevalence of passive smoking was 30.5% (95% CI: 28.6-32.4%) in 2001 and 30.0% (95% CI: 28.1-32.0%) in 2010. The main source of secondhand smoke switched from a spouse in 2001 to offspring in 2010. This trend was observed in both sexes. Passive smoking in males from a smoking spouse decreased from 5.7% to 2.4% (P<0.001), while that from smoking offspring increased from 7.3 to 14.5%(P<0.001). Passive smoking in females from a spouse decreased from 30.6 to 17.6%, while that from offspring increased from 5.3 to 15.4% (P<0.001). Conclusion Offspring became the main source of secondhand smoke for the elderly. Our findings demonstrated the importance of implementing smoking prevention programs, to educate older adults who live with a smoking spouse and/or offspring.	[Yang, Shanshan; He, Yao; Liu, Miao; Wang, Yiyan; Wu, Lei; Wang, Jianhua; Zhang, Di; Zeng, Jing] Chinese Peoples Liberat Army Gen Hosp, Inst Geriatr, Beijing 100853, Peoples R China; [Yang, Shanshan; He, Yao; Liu, Miao; Wang, Yiyan; Wu, Lei; Wang, Jianhua; Zhang, Di; Zeng, Jing] Chinese Peoples Liberat Army Gen Hosp, Beijing Key Lab Aging & Geriatr, Beijing 100853, Peoples R China; [He, Yao] Chinese Peoples Liberat Army Gen Hosp, State Key Lab Kidney Dis, Beijing 100853, Peoples R China; [Jiang, Bin] Chinese Peoples Liberat Army Gen Hosp, Dept Chinese Tradit Med & Acupuncture, Beijing 100853, Peoples R China; [Li, Xiaoying] Chinese Peoples Liberat Army Gen Hosp, Dept Geriatr Cardiol, Beijing 100853, Peoples R China; [Yang, Shanshan] Jinan Mil Area CDC, Jinan 250014, Shandong, Peoples R China	Chinese People's Liberation Army General Hospital; Chinese People's Liberation Army General Hospital; Chinese People's Liberation Army General Hospital; Chinese People's Liberation Army General Hospital; Chinese People's Liberation Army General Hospital	He, Y (corresponding author), Chinese Peoples Liberat Army Gen Hosp, Inst Geriatr, 28 Fuxing Rd, Beijing 100853, Peoples R China.	yhe301@sina.com	Zeng, jing/AGY-9325-2022; 刘, 淼/X-1216-2019	Zeng, jing/0000-0002-4736-4210; Liu, Miao/0000-0002-7975-6702; He, Yao/0000-0001-6205-7895	National Natural Science Foundation of China [81373080]; Beijing Municipal Science and Technology Commission [Z121107001012070, D121100004912003]; Chinese PLA General Hospital Doctor Innovation Foundation [13BCZ07]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Beijing Municipal Science and Technology Commission(Beijing Municipal Science & Technology Commission); Chinese PLA General Hospital Doctor Innovation Foundation	This study was supported by the National Natural Science Foundation of China (81373080, http://www.nsfc.gov.cn/), received by YH), Beijing Municipal Science and Technology Commission (Z121107001012070, D121100004912003, http://www.bjkw.gov.cn/n8785584/index.html, received by YH) and Chinese PLA General Hospital Doctor Innovation Foundation (13BCZ07, http://www.301hospital.com.cn/index.php, received by SSY). The funders had roles in study design, data collection and analysis, decision to publish and preparation of the manuscript.	Desormais I, 2014, EUR J PREV CARDIOL; Gallus S, 2014, EUR J CANCER PREV, V23, P177, DOI 10.1097/CEJ.0000000000000009; Hagstad S, 2014, CHEST, V145, P1298, DOI 10.1378/chest.13-1349; He Y, 2006, J AM COLL CARDIOL, V47, P1588, DOI 10.1016/j.jacc.2005.11.074; HE Y, 1989, Zhonghua Yufang Yixue Zazhi, V23, P19; He Y, 2008, CIRCULATION, V118, P1535, DOI 10.1161/CIRCULATIONAHA.108.784801; He Y, 2014, AM J EPIDEMIOL, V179, P1060, DOI 10.1093/aje/kwu011; He Y, 2012, CHEST, V142, P909, DOI 10.1378/chest.11-2884; Hovell ME, 2009, NICOTINE TOB RES, V11, P1254, DOI 10.1093/ntr/ntp133; Jemal A, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-512; Jha P, 2014, NEW ENGL J MED, V370, P60, DOI 10.1056/NEJMra1308383; Jiang Yuan, 2011, Zhonghua Liu Xing Bing Xue Za Zhi, V32, P1181; Katanoda K, 2014, TOB CONTROL, V23, P359, DOI 10.1136/tobaccocontrol-2012-050852; Kim SK, 2013, ARCH GERONTOL GERIAT, V56, P214, DOI 10.1016/j.archger.2012.08.018; Lam TH, 2012, ARCH INTERN MED, V172, P845, DOI 10.1001/archinternmed.2012.1927; Lam TH, 2014, ADDICTION; Lopez AD, 1994, TOB CONTROL, V3, P242, DOI [DOI 10.1136/TC.3.3.242, 10.1136/tc.3.3.242]; Lugo A, 2013, INT J ENV RES PUB HE, V10, P4418, DOI 10.3390/ijerph10094418; Marinho V, 2010, CAD SAUDE PUBLICA, V26, P2213, DOI 10.1590/S0102-311X2010001200002; Markides KS, 1999, PREV MED, V28, P251, DOI 10.1006/pmed.1998.0411; McNeill A, 2014, UNDERSTANDING INCREA; Michalopoulos A, 2005, TOB INDUC DIS, V3, P30; Nishino Y, 2014, PREV MED; Nwhator SO, 2012, J PUBLIC HEALTH POL, V33, P16, DOI 10.1057/jphp.2011.58; Park S, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-406; RIMM EB, 1995, BRIT MED J, V310, P555, DOI 10.1136/bmj.310.6979.555; SHINTON R, 1989, BMJ-BRIT MED J, V298, P789, DOI 10.1136/bmj.298.6676.789; Simoni M, 2003, EUR RESPIR J, V21, p15S, DOI 10.1183/09031936.03.00403603; Soliman S, 2004, AM J PUBLIC HEALTH, V94, P314, DOI 10.2105/AJPH.94.2.314; STELL PM, 1972, LANCET, V1, P617; Tresch DD, 1996, CLIN GERIATR MED, V12, P23, DOI 10.1016/S0749-0690(18)30241-6; US Department of Health Human Services, 2014, HLTHH CONS SMOK 50 Y; WATSON WL, 1954, CANCER-AM CANCER SOC, V7, P245, DOI 10.1002/1097-0142(195403)7:2<245::AID-CNCR2820070206>3.0.CO;2-V; Willi C, 2007, JAMA-J AM MED ASSOC, V298, P2654, DOI 10.1001/jama.298.22.2654; World Health Organization, 1984, WHO M HELD WINN CAN; Yang GH, 1999, JAMA-J AM MED ASSOC, V282, P1247, DOI 10.1001/jama.282.13.1247; Yang Gong-huan, 2005, Zhonghua Liu Xing Bing Xue Za Zhi, V26, P77; Yang GH, 2008, LANCET, V372, P1697, DOI 10.1016/S0140-6736(08)61366-5; Yang Y, 2010, BIOMED ENVIRON SCI, V23, P437, DOI 10.1016/S0895-3988(11)60004-4; Zhang DM, 2013, BIOMED ENVIRON SCI, V26, P453, DOI 10.3967/0895-3988.2013.06.006	40	14	14	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2015	10	3							e0118500	10.1371/journal.pone.0118500	http://dx.doi.org/10.1371/journal.pone.0118500			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CE9BN	25785722	Green Submitted, Green Published, gold			2022-12-27	WOS:000352138500035
J	Rajput, A; Gupta, AK; Kumar, M				Rajput, Akanksha; Gupta, Amit Kumar; Kumar, Manoj			Prediction and Analysis of Quorum Sensing Peptides Based on Sequence Features	PLOS ONE			English	Article							GRAM-POSITIVE BACTERIA; TO-CELL COMMUNICATION; ESCHERICHIA-COLI; ENTEROCOCCUS-FAECALIS; STREPTOCOCCUS-MUTANS; TRYPTOPHAN RESIDUES; SIGNALING PEPTIDES; ANTIVIRAL PEPTIDES; CYSTEINE RESIDUES; PROTEIN	Quorum sensing peptides (QSPs) are the signaling molecules used by the Gram-positive bacteria in orchestrating cell-to-cell communication. In spite of their enormous importance in signaling process, their detailed bioinformatics analysis is lacking. In this study, QSPs and non-QSPs were examined according to their amino acid composition, residues position, motifs and physicochemical properties. Compositional analysis concludes that QSPs are enriched with aromatic residues like Trp, Tyr and Phe. At the N-terminal, Ser was a dominant residue at maximum positions, namely, first, second, third and fifth while Phe was a preferred residue at first, third and fifth positions from the C-terminal. A few motifs from QSPs were also extracted. Physicochemical properties like aromaticity, molecular weight and secondary structure were found to be distinguishing features of QSPs. Exploiting above properties, we have developed a Support Vector Machine (SVM) based predictive model. During 10-fold cross-validation, SVM achieves maximum accuracy of 93.00%, Mathew's correlation coefficient (MCC) of 0.86 and Receiver operating characteristic (ROC) of 0.98 on the training/testing dataset (T200p+200n). Developed models performed equally well on the validation dataset (V20p+20n). The server also integrates several useful analysis tools like "QSMotifScan", "ProtFrag", "MutGen" and "PhysicoProp". Our analysis reveals important characteristics of QSPs and on the basis of these unique features, we have developed a prediction algorithm "QSPpred" (freely available at: http://crdd.osdd.net/servers/qsppred).	[Rajput, Akanksha; Gupta, Amit Kumar; Kumar, Manoj] CSIR, Inst Microbial Technol, Bioinformat Ctr, Chandigarh 160036, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Institute of Microbial Technology (IMTECH)	Kumar, M (corresponding author), CSIR, Inst Microbial Technol, Bioinformat Ctr, Sect 39-A, Chandigarh 160036, India.	manojk@imtech.res.in	Gupta, Amit K/M-4358-2017; Kumar, Manoj/G-1274-2010	Gupta, Amit K/0000-0002-8395-1201; Kumar, Manoj/0000-0003-3769-052X; RAJPUT, AKANKSHA/0000-0001-8176-6697	Council of Scientific and Industrial Research, India; Department of Biotechnology, Government of India [GAP0001]	Council of Scientific and Industrial Research, India(Council of Scientific & Industrial Research (CSIR) - India); Department of Biotechnology, Government of India(Department of Biotechnology (DBT) India)	This study was supported by the Council of Scientific and Industrial Research, India, (http://www.csir.res.in/); Department of Biotechnology, Government of India, (http://dbtindia.nic.in/index.asp) (GAP0001). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bailey TL, 2009, NUCLEIC ACIDS RES, V37, pW202, DOI 10.1093/nar/gkp335; Biegert A, 2006, NUCLEIC ACIDS RES, V34, pW335, DOI 10.1093/nar/gkl217; Brurberg MB, 1997, MOL MICROBIOL, V26, P347, DOI 10.1046/j.1365-2958.1997.5821951.x; Chang KY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070166; CLEWELL DB, 1989, PLASMID, V21, P175, DOI 10.1016/0147-619X(89)90041-3; de Jesus AJ, 2013, BBA-BIOMEMBRANES, V1828, P864, DOI 10.1016/j.bbamem.2012.09.009; Dong YH, 2007, PHILOS T R SOC B, V362, P1201, DOI 10.1098/rstb.2007.2045; Garsin DA, 2004, SCIENCE, V306, P2202, DOI 10.1126/science.1107236; Gautam A, 2013, J TRANSL MED, V11, DOI 10.1186/1479-5876-11-74; Guo Xiaopeng, 2011, Weishengwu Xuebao, V51, P1200; GURUPRASAD K, 1990, PROTEIN ENG, V4, P155, DOI 10.1093/protein/4.2.155; Haag AF, 2012, J BIOL CHEM, V287, P10791, DOI 10.1074/jbc.M111.311316; Havarstein LS, 1997, J BACTERIOL, V179, P6589, DOI 10.1128/jb.179.21.6589-6594.1997; Jimenez JC, 2014, FRONT CELL INFECT MI, V4, DOI 10.3389/fcimb.2014.00127; Johnsborg O, 2006, J BACTERIOL, V188, P1744, DOI 10.1128/JB.188.5.1744-1749.2006; Kalkum M, 2003, P NATL ACAD SCI USA, V100, P2795, DOI 10.1073/pnas.0436605100; Kawashima S, 1999, NUCLEIC ACIDS RES, V27, P368, DOI 10.1093/nar/27.1.368; Kolodkin-Gal I, 2007, SCIENCE, V318, P652, DOI 10.1126/science.1147248; Kramer R., 2009, BACTERIAL SIGNALING; Kumar S, 2013, MBIO, V4, DOI 10.1128/mBio.00314-13; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; LOBRY JR, 1994, NUCLEIC ACIDS RES, V22, P3174, DOI 10.1093/nar/22.15.3174; Martin CA, 2008, EUR J CLIN MICROBIOL, V27, P635, DOI 10.1007/s10096-008-0489-3; Meitzler JL, 2013, J BIOL CHEM, V288, P7147, DOI 10.1074/jbc.M112.414797; Michiels J, 2001, TRENDS MICROBIOL, V9, P164, DOI 10.1016/S0966-842X(01)01979-5; Miller MB, 2001, ANNU REV MICROBIOL, V55, P165, DOI 10.1146/annurev.micro.55.1.165; Nakayama J, 2007, J BACTERIOL, V189, P1358, DOI 10.1128/JB.00969-06; Nakayama J, 2009, ANTIMICROB AGENTS CH, V53, P580, DOI 10.1128/AAC.00995-08; NEALSON KH, 1970, J BACTERIOL, V104, P313, DOI 10.1128/JB.104.1.313-322.1970; Ni NT, 2009, MED RES REV, V29, P65, DOI 10.1002/med.20145; Nishiguchi K, 2009, J BACTERIOL, V191, P641, DOI 10.1128/JB.01029-08; Paggi RA, 2003, FEMS MICROBIOL LETT, V221, P49, DOI 10.1016/S0378-1097(03)00174-5; Park J, 2007, CHEM BIOL, V14, P1119, DOI 10.1016/j.chembiol.2007.08.013; Pesci EC, 1999, P NATL ACAD SCI USA, V96, P11229, DOI 10.1073/pnas.96.20.11229; Petersen FC, 2006, MOL MICROBIOL, V61, P1322, DOI 10.1111/j.1365-2958.2006.05312.x; Qureshi A, 2014, NUCLEIC ACIDS RES, V42, pD1147, DOI 10.1093/nar/gkt1191; Rasmussen A, 2007, BIOCHEMISTRY-US, V46, P10899, DOI 10.1021/bi701056k; Samanta U, 2001, PROTEIN ENG, V14, P7, DOI 10.1093/protein/14.1.7; Schauder S, 2001, GENE DEV, V15, P1468, DOI 10.1101/gad.899601; Sing T, 2005, BIOINFORMATICS, V21, P3940, DOI 10.1093/bioinformatics/bti623; Stalmans S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071752; Steiner E, 2012, APPL ENVIRON MICROB, V78, P1113, DOI 10.1128/AEM.06376-11; Sturme MHJ, 2002, ANTON LEEUW INT J G, V81, P233, DOI 10.1023/A:1020522919555; Syvitski RT, 2007, J BACTERIOL, V189, P1441, DOI 10.1128/JB.00832-06; Thakur N, 2012, NUCLEIC ACIDS RES, V40, pW199, DOI 10.1093/nar/gks450; Thoendel M, 2010, ADV APPL MICROBIOL, V71, P91, DOI 10.1016/S0065-2164(10)71004-2; Tian XL, 2009, BIOL PROCED ONLINE, V11, P207, DOI 10.1007/s12575-009-9009-9; TOMASZ A, 1965, NATURE, V208, P155, DOI 10.1038/208155a0; Torrent M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016968; Vacic V, 2006, BIOINFORMATICS, V22, P1536, DOI 10.1093/bioinformatics/btl151; Wynendaele E, 2012, MED HYPOTHESES, V78, P814, DOI 10.1016/j.mehy.2012.03.018; Wynendaele E, 2015, PEPTIDES, V64, P40, DOI 10.1016/j.peptides.2014.12.009; Wynendaele E, 2013, NUCLEIC ACIDS RES, V41, pD655, DOI 10.1093/nar/gks1137; Zhang Y, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-40	54	56	57	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2015	10	3							e0120066	10.1371/journal.pone.0120066	http://dx.doi.org/10.1371/journal.pone.0120066			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7QC	25781990	Green Submitted, Green Published, gold			2022-12-27	WOS:000351284600124
J	Mazumdar, S; Arendt, LM; Phillips, S; Sedic, M; Kuperwasser, C; Gill, G				Mazumdar, Sohini; Arendt, Lisa M.; Phillips, Sarah; Sedic, Maja; Kuperwasser, Charlotte; Gill, Grace			CoREST1 Promotes Tumor Formation and Tumor Stroma Interactions in a Mouse Model of Breast Cancer	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; MONOCYTE CHEMOATTRACTANT PROTEIN-1; EPITHELIAL-MESENCHYMAL TRANSITION; DEMETHYLASE 1; HISTONE DEMETHYLASE; GENE-EXPRESSION; STEM-CELLS; LSD1; MACROPHAGES; COMPLEX	Regulators of chromatin structure and gene expression contribute to tumor formation and progression. The co-repressor CoREST1 regulates the localization and activity of associated histone modifying enzymes including lysine specific demethylase 1 (LSD1) and histone deacetylase 1 (HDAC1). Although several CoREST1 associated proteins have been reported to enhance breast cancer progression, the role of CoREST1 in breast cancer is currently unclear. Here we report that knockdown of CoREST1 in the basal-type breast cancer cell line, MDA-MB-231, led to significantly reduced incidence and diminished size of tumors compared to controls in mouse xenograft studies. Notably, CoREST1-depleted cells gave rise to tumors with a marked decrease in angiogenesis. CoREST1 knockdown led to a decrease in secreted angiogenic and inflammatory factors, and mRNA analysis suggests that CoREST1 promotes expression of genes related to angiogenesis and inflammation including VEGF-A and CCL2. CoREST1 knockdown decreased the ability of MDA-MB-231 conditioned media to promote endothelial cell tube formation and migration. Further, tumors derived from CoREST1-depleted cells had reduced macrophage infiltration and the secretome of CoREST1 knockdown cells was deficient in promoting macrophage migration and macrophage-mediated angiogenesis. Taken together, these findings reveal that the epigenetic regulator CoREST1 promotes tumorigenesis in a breast cancer model at least in part through regulation of gene expression patterns in tumor cells that have profound non-cell autonomous effects on endothelial and inflammatory cells in the tumor microenvironment.	[Mazumdar, Sohini; Arendt, Lisa M.; Phillips, Sarah; Sedic, Maja; Kuperwasser, Charlotte; Gill, Grace] Tufts Univ, Sackler Sch Grad Biomed Sci, Sch Med, Dept Dev Mol & Chem Biol, Boston, MA 02111 USA; [Mazumdar, Sohini; Phillips, Sarah] Tufts Univ, Sackler Sch Grad Biomed Sci, Sch Med, Genet Program, Boston, MA 02111 USA; [Sedic, Maja] Tufts Univ, Sackler Sch Grad Biomed Sci, Sch Med, Cellular Mol & Dev Biol Program, Boston, MA 02111 USA; [Arendt, Lisa M.; Phillips, Sarah; Sedic, Maja; Kuperwasser, Charlotte] Tufts Med Ctr, Mol Oncol Res Inst, Boston, MA USA	Tufts University; Tufts University; Tufts University; Tufts Medical Center	Gill, G (corresponding author), Tufts Univ, Sackler Sch Grad Biomed Sci, Sch Med, Dept Dev Mol & Chem Biol, Boston, MA 02111 USA.	Grace.Gill@tufts.edu		Arendt, Lisa/0000-0002-7954-3635	Sackler Families Fund for Collaborative Cancer Biology Research Award; Breast Cancer Research Foundation; National Institutes of Health/National Cancer Institute [CA125554, CA170851]; NATIONAL CANCER INSTITUTE [R01CA170851, R01CA125554, P01CA092644] Funding Source: NIH RePORTER	Sackler Families Fund for Collaborative Cancer Biology Research Award; Breast Cancer Research Foundation; National Institutes of Health/National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Funding: This work was supported by a Sackler Families Fund for Collaborative Cancer Biology Research Award (G.G. and S.M.), the Breast Cancer Research Foundation (C.K.), and the National Institutes of Health/National Cancer Institute Awards CA125554 and CA170851 (C.K.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andres ME, 1999, P NATL ACAD SCI USA, V96, P9873, DOI 10.1073/pnas.96.17.9873; Arendt LM, 2013, CANCER RES, V73, P6080, DOI 10.1158/0008-5472.CAN-13-0926; Ballas N, 2001, NEURON, V31, P353, DOI 10.1016/S0896-6273(01)00371-3; Barrios AP, 2014, MOL CELL BIOL, V34, P2760, DOI 10.1128/MCB.00083-14; Cai CM, 2014, CELL REP, V9, P1618, DOI 10.1016/j.celrep.2014.11.008; Deshmane SL, 2009, J INTERF CYTOK RES, V29, P313, DOI 10.1089/jir.2008.0027; Domanitskaya E, 2012, J CELL SCI, V125, P399, DOI 10.1242/jcs.089797; DVORAK HF, 1986, NEW ENGL J MED, V315, P1650; Fan QM, 2014, CANCER LETT, V352, P160, DOI 10.1016/j.canlet.2014.05.008; Ferrari-Amorotti G, 2014, NEOPLASIA, V16, P1047, DOI 10.1016/j.neo.2014.10.006; Foekens JA, 2001, CANCER RES, V61, P5407; Gasparini G, 1997, J NATL CANCER I, V89, P139, DOI 10.1093/jnci/89.2.139; Gocke CB, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003255; Gordillo GM, 2004, AM J PHYSIOL-CELL PH, V287, pC866, DOI 10.1152/ajpcell.00238.2003; Guo CQ, 2013, VASC CELL, V5, DOI 10.1186/2045-824X-5-20; Hakimi MA, 2002, P NATL ACAD SCI USA, V99, P7420, DOI 10.1073/pnas.112008599; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Huang Y, 2012, BREAST CANCER RES TR, V131, P777, DOI 10.1007/s10549-011-1480-8; Huang Y, 2009, CLIN CANCER RES, V15, P7217, DOI 10.1158/1078-0432.CCR-09-1293; Humphrey GW, 2001, J BIOL CHEM, V276, P6817, DOI 10.1074/jbc.M007372200; Jian OY, 2009, MOL CELL, V34, P145, DOI 10.1016/j.molcel.2009.03.013; Jin LH, 2013, BIOCHEM J, V449, P459, DOI 10.1042/BJ20121360; Kang FW, 2012, ONCOL REP, V28, P193, DOI 10.3892/or.2012.1784; Kashyap V, 2013, MOL ONCOL, V7, P555, DOI 10.1016/j.molonc.2013.01.003; Keller PJ, 2012, P NATL ACAD SCI USA, V109, P2772, DOI 10.1073/pnas.1017626108; Komohara Y, 2012, CANCER SCI, V103, P2165, DOI 10.1111/cas.12015; LaMarca HL, 2010, STEM CELLS, V28, P535, DOI 10.1002/stem.297; Laugesen A, 2014, CELL STEM CELL, V14, P735, DOI 10.1016/j.stem.2014.05.006; Lee MG, 2005, NATURE, V437, P432, DOI 10.1038/nature04021; Lee MG, 2006, MOL CELL BIOL, V26, P6395, DOI 10.1128/MCB.00723-06; Lim S, 2010, CARCINOGENESIS, V31, P512, DOI 10.1093/carcin/bgp324; Lin T, 2010, ONCOGENE, V29, P4896, DOI 10.1038/onc.2010.234; Lin YW, 2010, EMBO J, V29, P1803, DOI 10.1038/emboj.2010.63; Linderholm B, 2000, J CLIN ONCOL, V18, P1423, DOI 10.1200/JCO.2000.18.7.1423; Liu CY, 2013, LAB INVEST, V93, P844, DOI 10.1038/labinvest.2013.69; Lv T, 2009, PLOS ONE, V7; Mao Y, 2013, CANCER METAST REV, V32, P303, DOI 10.1007/s10555-012-9415-3; Meier K, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002676; Metzger E, 2005, NATURE, V437, P436, DOI 10.1038/nature04020; Mulligan P, 2011, MOL CELL, V42, P689, DOI 10.1016/j.molcel.2011.04.020; Orimo A, 2006, CELL CYCLE, V5, P1597, DOI 10.4161/cc.5.15.3112; Pollock JA, 2012, ACS CHEM BIOL, V7, P1221, DOI 10.1021/cb300108c; Porta C, 2007, ADV EXP MED BIOL, V604, P67, DOI 10.1007/978-0-387-69116-9_5; Qian BZ, 2010, CELL, V141, P39, DOI 10.1016/j.cell.2010.03.014; Salcedo R, 2000, BLOOD, V96, P34, DOI 10.1182/blood.V96.1.34.013a49_34_40; Saleque S, 2007, MOL CELL, V27, P562, DOI 10.1016/j.molcel.2007.06.039; Schulte JH, 2009, CANCER RES, V69, P2065, DOI 10.1158/0008-5472.CAN-08-1735; Serce N, 2012, BMC CLIN PATHOL, V12, DOI 10.1186/1472-6890-12-13; Shi YJ, 2005, MOL CELL, V19, P857, DOI 10.1016/j.molcel.2005.08.027; Shi YJ, 2004, CELL, V119, P941, DOI 10.1016/j.cell.2004.12.012; Shima DT, 1996, J BIOL CHEM, V271, P3877, DOI 10.1074/jbc.271.7.3877; Stamatovic SM, 2006, J IMMUNOL, V177, P2651, DOI 10.4049/jimmunol.177.4.2651; Thillainadesan G, 2008, MOL CELL BIOL, V28, P6066, DOI 10.1128/MCB.00246-08; Toney LM, 2000, NAT IMMUNOL, V1, P214, DOI 10.1038/79749; Tsai MC, 2010, SCIENCE, V329, P689, DOI 10.1126/science.1192002; Upadhyay G, 2014, P NATL ACAD SCI USA, V111, P8071, DOI 10.1073/pnas.1404292111; Wang Y, 2009, CELL, V138, P660, DOI 10.1016/j.cell.2009.05.050; Witt O, 2009, CANCER LETT, V277, P8, DOI 10.1016/j.canlet.2008.08.016; Yang J, 2013, STEM CELLS, V31, P248, DOI 10.1002/stem.1281; Yang P, 2011, STEM CELLS, V29, P791, DOI 10.1002/stem.634; You A, 2001, P NATL ACAD SCI USA, V98, P1454, DOI 10.1073/pnas.98.4.1454; Zhu QS, 2012, AMINO ACIDS, V42, P887, DOI 10.1007/s00726-011-1004-1	62	3	3	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2015	10	3							e0121281	10.1371/journal.pone.0121281	http://dx.doi.org/10.1371/journal.pone.0121281			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8HY	25793264	Green Published, Green Submitted, gold			2022-12-27	WOS:000352083900120
J	Huang, CK; Wu, J; Cheng, KY; Pan, LK				Huang, Cheng-Kai; Wu, Jay; Cheng, Kai-Yuan; Pan, Lung-Kwang			Optimization of Imaging Parameters for SPECT scans of [Tc-99m] TRODAT-1 Using Taguchi Analysis	PLOS ONE			English	Article							DOPAMINE TRANSPORTER DENSITY; PARKINSONS-DISEASE PATIENTS; MAJOR DEPRESSION; TC-99M-TRODAT-1; DIAGNOSIS; MOVEMENT; DISORDER	Parkinson's disease (PD) is a neurodegenerative disease characterized by progressive loss of dopaminergic neurons in the basal ganglia. Single photon emission computed tomography (SPECT) scans using [Tc-99m] TRODAT-1 can image dopamine transporters and provide valuable diagnostic information of PD. In this study, we optimized the scanning parameters for [Tc-99m] TRODAT-1/SPECT using the Taguchi analysis to improve image quality. SPECT scans were performed on forty-five healthy volunteers according to an L-9 orthogonal array. Three parameters were considered, including the injection activity, uptake duration, and acquisition time per projection. The signal-to-noise ratio (SNR) was calculated from the striatum/occipital activity ratio as an image quality index. Ten healthy subjects and fifteen PD patients were used to verify the optimal parameters. The estimated optimal parameters were 962 MBq for [Tc-99m] TRODAT-1 injection, 260 min for uptake duration, and 60 s/projection for data acquisition. The uptake duration and time per projection were the two dominant factors which had an F-value of 18.638 (38%) and 25.933 (53%), respectively. Strong cross interactions existed between the injection activity/uptake duration and injection activity/time per projection. Therefore, under the consideration of as low as reasonably achievable (ALARA) for radiation protection, we can decrease the injection activity to 740 MBq. The image quality remains almost the same for clinical applications.	[Huang, Cheng-Kai; Cheng, Kai-Yuan; Pan, Lung-Kwang] Cent Taiwan Univ Sci & Technol, Dept Med Imaging & Radiol Sci, Taichung 406, Taiwan; [Wu, Jay] Natl Yang Ming Univ, Dept Biomed Imaging & Radiol Sci, Taipei 112, Taiwan	Central Taiwan University Science & Technology; National Yang Ming Chiao Tung University	Wu, J (corresponding author), Natl Yang Ming Univ, Dept Biomed Imaging & Radiol Sci, Taipei 112, Taiwan.	iamjaywu@gmail.com		PAN, Lung-Kwang/0000-0002-9485-4722				Acton PD, 2006, PHYS MED BIOL, V51, P3057, DOI 10.1088/0031-9155/51/12/004; Acton PD, 2006, PHYS MED BIOL, V51, P575, DOI 10.1088/0031-9155/51/3/007; Braga-Neto P, 2012, PARKINSONISM RELAT D, V18, P854, DOI 10.1016/j.parkreldis.2012.04.015; CHANG LT, 1978, IEEE T NUCL SCI, V25, P638, DOI 10.1109/TNS.1978.4329385; Chi CT, 2008, VACUUM, V82, P1177, DOI 10.1016/j.vacuum.2007.12.019; Felicio AC, 2010, PSYCHOPHARMACOLOGY, V211, P27, DOI 10.1007/s00213-010-1867-y; Felicio AC, 2010, CLIN NEUROL NEUROSUR, V112, P282, DOI 10.1016/j.clineuro.2009.12.010; Felicio AC, 2010, J NEUROL SCI, V291, P64, DOI 10.1016/j.jns.2009.12.024; Fisher R. A., 1935, DESIGN ANAL EXPT; Gelb DJ, 1999, ARCH NEUROL-CHICAGO, V56, P33, DOI 10.1001/archneur.56.1.33; GREEN MV, 1994, J NUCL MED, V35, P1538; Hsu WH, 2009, MED ENG PHYS, V31, P287, DOI 10.1016/j.medengphy.2008.07.001; Huang WS, 2004, EUR J NUCL MED MOL I, V31, P155, DOI 10.1007/s00259-003-1331-x; Hwang WJ, 2008, PSYCHIAT RES-NEUROIM, V162, P159, DOI 10.1016/j.pscychresns.2007.04.006; Kao PF, 2001, NUCL MED COMMUN, V22, P151, DOI 10.1097/00006231-200102000-00006; Koch W, 2005, J NUCL MED, V46, P1804; Koch W, 2007, NUCL MED COMMUN, V28, P603, DOI 10.1097/MNM.0b013e328273bc6f; Kushner SA, 1999, J NUCL MED, V40, P150; la Fougere C, 2006, NUCL MED COMMUN, V27, P733, DOI 10.1097/01.mnm.0000230077.48480.68; Lai SC, 2004, NUCL MED COMMUN, V25, P339, DOI 10.1097/00006231-200404000-00005; Lin CL, 2009, DENT MATER, V25, P1073, DOI 10.1016/j.dental.2009.01.105; Lin CY, 2007, CLIN NUCL MED, V32, P484, DOI 10.1097/RLU.0b013e3180537814; Lombardi MH, 2012, RAD SAFETY NUCL MED; Moriyama TS, 2011, J NEUROL SCI, V310, P53, DOI 10.1016/j.jns.2011.06.056; Mozley PD, 1998, J NUCL MED, V39, P2069; Nian CY, 1999, J MATER PROCESS TECH, V95, P90, DOI 10.1016/S0924-0136(99)00271-X; Pan LK, 2007, J MATER PROCESS TECH, V182, P107, DOI 10.1016/j.jmatprotec.2006.07.015; Roy R. K., 2001, DESIGN EXPT USING TA; Taguchi G., 1986, INTRO QUALITY ENG DE; Tatsch K, 2002, EUR J NUCL MED MOL I, V29, pBP30; Tzen KY, 2001, J NUCL MED, V42, P408; Wu H, 2011, J NEUROPSYCH CLIN N, V23, P63, DOI 10.1176/appi.neuropsych.23.1.63; Yang YK, 2008, PSYCHIAT RES-NEUROIM, V162, P230, DOI 10.1016/j.pscychresns.2007.08.008; Yeh DM, 2013, HELL J NUCL MED, V16, P25, DOI 10.1967/s002449910068	34	10	10	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2015	10	3							e0113817	10.1371/journal.pone.0113817	http://dx.doi.org/10.1371/journal.pone.0113817			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD9NQ	25790100	Green Published, gold, Green Submitted			2022-12-27	WOS:000351425400005
J	Huang, LH; Lee, WC; You, ST; Cheng, CC; Yu, CJ				Huang, Lien-Hung; Lee, Wei-Chung; You, Shu-Ting; Cheng, Chia-Chen; Yu, Chia-Jung			Arfaptin-1 Negatively Regulates Arl1-Mediated Retrograde Transport	PLOS ONE			English	Article							BIN/AMPHIPHYSIN/RVS BAR DOMAIN; INHIBITS PHOSPHOLIPASE-D; ADP-RIBOSYLATION FACTOR; ARF-LIKE GTPASES; GOLGI NETWORK; STRUCTURAL BASIS; GRIP DOMAIN; ARL1 GTPASE; MEMBRANE; PROTEIN	The small GTPase Arf-like protein 1 (Arl1) is well known for its role in intracellular vesicular transport at the trans-Golgi network (TGN). In this study, we used differential affinity chromatography combined with mass spectrometry to identify Arf-interacting protein 1b (arfaptin- 1b) as an Arl1-interacting protein and characterized a novel function for arfaptin-1 (including the arfaptin-1a and 1b isoforms) in Arl1-mediated retrograde transport. Using a Shiga-toxin subunit B (STxB) transportation assay, we demonstrated that knockdown of arfaptin-1 accelerated the retrograde transport of STxB from the endosome to the Golgi apparatus, whereas Arl1 knockdown inhibited STxB transport compared with control cells. Arfaptin-1 overexpression, but not an Arl1 binding-defective mutant (arfaptin-1b-F317A), consistently inhibited STxB transport. Exogenous arfaptin-1 expression did not interfere with the localization of the Arl1-interacting proteins golgin-97 and golgin-245 to the TGN and vice versa. Moreover, we found that the N-terminal region of arfaptin-1 was involved in the regulation of retrograde transport. Our results show that arfaptin-1 acts as a negative regulator in Arl1-mediated retrograde transport and suggest that different functional complexes containing Arl1 form in distinct microdomains and are responsible for different functions.	[Huang, Lien-Hung; Lee, Wei-Chung; Yu, Chia-Jung] Chang Gung Univ, Coll Med, Grad Inst Biomed Sci, Taoyuan, Taiwan; [You, Shu-Ting] Natl Taiwan Univ, Coll Med, Inst Mol Med, Taipei 10764, Taiwan; [Cheng, Chia-Chen; Yu, Chia-Jung] Chang Gung Univ, Coll Med, Dept Cell & Mol Biol, Taoyuan, Taiwan; [Yu, Chia-Jung] Chang Gung Univ, Mol Med Res Ctr, Taoyuan, Taiwan	Chang Gung University; National Taiwan University; Chang Gung University; Chang Gung University	Yu, CJ (corresponding author), Chang Gung Univ, Coll Med, Grad Inst Biomed Sci, Taoyuan, Taiwan.	yucj1124@mail.cgu.edu.tw		Huang, Lien-Hung/0000-0001-8641-9897	National Science Council, R.O.C. [97-2320-B182-026-MY3, 101-2320-B-182-035-MY3]	National Science Council, R.O.C.(Ministry of Science and Technology, Taiwan)	This work was supported by grants from the National Science Council, R.O.C. (97-2320-B182-026-MY3 and 101-2320-B-182-035-MY3). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Benjamin JJR, 2011, MOL BIOL CELL, V22, P2337, DOI 10.1091/mbc.E10-09-0765; Boucrot E, 2012, CELL, V149, P124, DOI 10.1016/j.cell.2012.01.047; Burd CG, 2004, TRENDS CELL BIOL, V14, P687, DOI 10.1016/j.tcb.2004.10.004; Chen KY, 2012, J CELL SCI, V125, P4586, DOI 10.1242/jcs.107797; Christis C, 2012, J CELL BIOL, V196, P327, DOI 10.1083/jcb.201107115; Cruz-Garcia D, 2013, EMBO J, V32, P1717, DOI 10.1038/emboj.2013.116; D'Souza-Schorey C, 1997, EMBO J, V16, P5445, DOI 10.1093/emboj/16.17.5445; Derby MC, 2004, J CELL SCI, V117, P5865, DOI 10.1242/jcs.01497; Gehart H, 2012, DEV CELL, V23, P756, DOI 10.1016/j.devcel.2012.07.019; Gleeson PA, 2004, TRAFFIC, V5, P315, DOI 10.1111/j.1398-9219.2004.00182.x; Graham TR, 2013, P NATL ACAD SCI USA, V110, P2691, DOI 10.1073/pnas.1300420110; Kahn RA, 2006, J CELL BIOL, V172, P645, DOI 10.1083/jcb.200512057; Kanoh H, 1997, J BIOL CHEM, V272, P5421, DOI 10.1074/jbc.272.9.5421; Liu YW, 2006, J CELL SCI, V119, P3845, DOI 10.1242/jcs.03148; Lu L, 2005, METHOD ENZYMOL, V404, P432, DOI 10.1016/S0076-6879(05)04038-3; Lu L, 2004, MOL BIOL CELL, V15, P4426, DOI 10.1091/mbc.E03-12-0872; Lu L, 2001, J CELL SCI, V114, P4543; Man ZQ, 2011, J BIOL CHEM, V286, P11569, DOI 10.1074/jbc.M110.201442; Munson AM, 2004, J CELL SCI, V117, P2309, DOI 10.1242/jcs.01050; Munson AM, 2004, BIOCHEM BIOPH RES CO, V315, P617, DOI 10.1016/j.bbrc.2004.01.099; Nakamura K, 2012, J BIOL CHEM, V287, P25478, DOI 10.1074/jbc.M112.365783; Nishimoto-Morita K, 2009, J BIOL CHEM, V284, P10583, DOI 10.1074/jbc.M900847200; Panic B, 2003, MOL CELL, V12, P863, DOI 10.1016/S1097-2765(03)00356-3; Panic B, 2003, CURR BIOL, V13, P405, DOI 10.1016/S0960-9822(03)00091-5; Peters PJ, 2002, NAT CELL BIOL, V4, P240, DOI 10.1038/ncb761; Rangone H, 2005, J BIOL CHEM, V280, P22021, DOI 10.1074/jbc.M407528200; Rao YJ, 2011, CELL MOL LIFE SCI, V68, P3983, DOI 10.1007/s00018-011-0768-5; Tai GH, 2005, METHOD ENZYMOL, V404, P442, DOI 10.1016/S0076-6879(05)04039-5; Tarricone C, 2001, NATURE, V411, P215, DOI 10.1038/35075620; Tsai PC, 2013, P NATL ACAD SCI USA, V110, pE668, DOI 10.1073/pnas.1221484110; Van Valkenburgh H, 2001, J BIOL CHEM, V276, P22826, DOI 10.1074/jbc.M102359200; Venter JC, 2001, SCIENCE, V291, P1304, DOI 10.1126/science.1058040; Williger BT, 1999, FEBS LETT, V443, P197, DOI 10.1016/S0014-5793(98)01707-4; Williger BT, 1999, FEBS LETT, V454, P85, DOI 10.1016/S0014-5793(99)00771-1; Wu MS, 2004, NAT STRUCT MOL BIOL, V11, P86, DOI 10.1038/nsmb714; Yoshino A, 2005, J CELL SCI, V118, P2279, DOI 10.1242/jcs.02358	36	6	6	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2015	10	3							e0118743	10.1371/journal.pone.0118743	http://dx.doi.org/10.1371/journal.pone.0118743			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD9NQ	25789876	Green Published, gold			2022-12-27	WOS:000351425400043
J	Liu, B; Li, Q; Li, KW; Deng, N; He, P; Qin, CC; Yang, DY; Li, ZW; Xie, P				Liu, Bo; Li, Qi; Li, Kewei; Deng, Nan; He, Peng; Qin, Chunchang; Yang, Deyu; Li, Zhiwei; Xie, Peng			A Non-Invasive Method to Assess Cerebral Perfusion Pressure in Geriatric Patients with Suspected Cerebrovascular Disease	PLOS ONE			English	Article							TO-DOOR SURVEY; PREVALENCE	Background Cerebral perfusion pressure (CPP) can adversely impact cerebrovascular hemodynamics but cannot be practically measured in most clinical settings. Here, we aimed to establish a representative mathematical model for CPP in geriatric patients with suspected cerebrovascular disease. Methods A total of 100 patients (54 males and 46 females between 60-80 years of age) with suspected cerebrovascular disease and no obvious cerebrovascular stenosis were selected for invasive CPP monitoring via catheterization of the middle segment of the common carotid arteries and openings of the vertebral arteries bilaterally. Curves were function-fitted using MATLAB 7.0, and data was statistically processed by SPSS 20.0. Results MATLAB 7.0 constructed eighth-order Fourier functions that fit all recorded CPP curves. Since the coefficients of the 100 functions were significantly different, all functions were standardized to derive one representative function. By manipulating the heart rate and maximum/minimum CPP of the representative function, estimated CPP curves can be constructed for patients with differing heart rates, intracranial pressures (ICPs) and blood pressures. Conclusions CPP can be well-modeled through an eighth-order Fourier function that can be constructed from a patient's brachial artery blood pressure (BABP), ICP and heart rate. This function is representative of geriatric patients with cerebrovascular disease and can be used in the future study of cerebral hemodynamics.	[Liu, Bo; Deng, Nan; Yang, Deyu; Li, Zhiwei; Xie, Peng] Chongqing Med Univ, Yong Chuan Hosp, Dept Neurol, Chongqing, Peoples R China; [Li, Qi; Xie, Peng] Chongqing Med Univ, Affiliated Hosp 1, Dept Neurol, Chongqing, Peoples R China; [Liu, Bo; Li, Qi; He, Peng; Yang, Deyu; Xie, Peng] Chongqing Med Univ, Inst Neurosci, Chongqing, Peoples R China; [Liu, Bo; Li, Qi; He, Peng; Yang, Deyu; Xie, Peng] Chongqing Med Univ, Chongqing Key Lab Neurobiol, Chongqing, Peoples R China; [Li, Kewei] Chongqing Med Univ, Affiliated Hosp 1, Dept Gastroenterol, Chongqing, Peoples R China; [Qin, Chunchang] Chongqing Med Univ, Affiliated Hosp 1, Dept Cardiol, Chongqing, Peoples R China	Chongqing Medical University; Chongqing Medical University; Chongqing Medical University; Chongqing Medical University; Chongqing Medical University; Chongqing Medical University	Li, ZW (corresponding author), Chongqing Med Univ, Yong Chuan Hosp, Dept Neurol, Chongqing, Peoples R China.	lzw023@126.com; xiepeng818@126.com	Li, Qi/ABE-4182-2021; 秦, 春/GRJ-9478-2022	Li, Qi/0000-0002-9144-148X; 	Natural Science Foundation of the Yongchuan District of Chongqing Municipality [2013nc8031, Ycstc]; Foundation of the Chongqing Health and Family Planning Commission [20143001]; National Natural Science Foundation of China [81200899]	Natural Science Foundation of the Yongchuan District of Chongqing Municipality; Foundation of the Chongqing Health and Family Planning Commission; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by the Natural Science Foundation of the Yongchuan District of Chongqing Municipality (grant no. Ycstc, 2013nc8031), the Foundation of the Chongqing Health and Family Planning Commission (grant no. 20143001), and the National Natural Science Foundation of China (grant No. 81200899). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn S, 2012, J KOREAN MED SCI, V27, P625, DOI 10.3346/jkms.2012.27.6.625; Annaidh AN, 2012, ANN BIOMED ENG, V40, P1666, DOI 10.1007/s10439-012-0542-3; ATTINGER EO, 1966, BIOPHYS J, V6, P291, DOI 10.1016/S0006-3495(66)86657-2; Bracewell R., 1999, FOURIER TRANSFORM IT, P62; Brandi G, 2010, ACTA NEUROCHIR, V152, P965, DOI 10.1007/s00701-010-0643-4; Brosche TM, 2011, CRIT CARE NURSE, V31, P18, DOI 10.4037/ccn2011812; Kadojic D., 2007, Acta Medica Croatica, V61, P315; Kim BR, 2008, GENETICS, V180, P821, DOI 10.1534/genetics.108.093690; Liu WH, 2013, J BIOMED OPT, V18, DOI 10.1117/1.JBO.18.2.026005; Oncel C, 2014, NEUROL SCI, V35, P373, DOI 10.1007/s10072-013-1521-7; Pedelty L, 2008, AM J MED, V121, pS23, DOI 10.1016/j.amjmed.2008.05.019; Prasad K, 2012, JRSM CARDIOVASC DIS, V1; Schmidt JM, 2011, STROKE, V42, P1351, DOI 10.1161/STROKEAHA.110.596874; Sende J, 2009, EMERG MED J, V26, P210, DOI 10.1136/emj.2008.060608; Shinohara Y., 2006, NIHON RINSHO, V6, P201; Veglio F, 1994, J CARDIOVASC PHARM S, V5, pS113; Vibha D, 2012, JRSM CARDIOVASC DIS, V1	17	3	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2015	10	3							e0120146	10.1371/journal.pone.0120146	http://dx.doi.org/10.1371/journal.pone.0120146			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD9NQ	25789855	Green Submitted, Green Published, gold			2022-12-27	WOS:000351425400133
J	Song, HW; Bettegowda, A; Oliver, D; Yan, W; Phan, MH; de Rooij, DG; Corbett, MA; Wilkinson, MF				Song, Hye-Won; Bettegowda, Anilkumar; Oliver, Daniel; Yan, Wei; Phan, Mimi H.; de Rooij, Dirk G.; Corbett, Mark A.; Wilkinson, Miles F.			shRNA Off-Target Effects In Vivo: Impaired Endogenous siRNA Expression and Spermatogenic Defects	PLOS ONE			English	Article							HOMEOBOX GENE-CLUSTER; MALE GERM-CELLS; SEX-CHROMOSOME INACTIVATION; INDUCED RNA INTERFERENCE; SHORT HAIRPIN RNAS; SERTOLI-CELLS; MOUSE OOCYTES; MICE; DICER; RHOX	RNA interference (RNAi) is widely used to determine the function of genes. We chose this approach to assess the collective function of the highly related reproductive homeobox 3 (Rhox3) gene paralogs. Using a Rhox3 short hairpin (sh) RNA with 100% complementarity to all 8 Rhox3 paralogs, expressed from a CRE-regulated transgene, we successfully knocked down Rhox3 expression in male germ cells in vivo. These Rhox3-shRNA transgenic mice had dramatic defects in spermatogenesis, primarily in spermatocytes and round spermatids. To determine whether this phenotype was caused by reduced Rhox3 expression, we generated mice expressing the Rhox3-shRNA but lacking the intended target of the shRNA-Rhox3. These double-mutant mice had a phenotype indistinguishable from Rhox3-shRNA-expressing mice that was different from mice lacking the Rhox3 paralogs, indicating that the Rhox3 shRNA disrupts spermatogenesis independently of Rhox3. Rhox3-shRNA transgenic mice displayed few alterations in the expression of protein-coding genes, but instead exhibited reduced levels of all endogenous siRNAs we tested. This supported a model in which the Rhox3 shRNA causes spermatogenic defects by sequestering one or more components of the endogenous small RNA biogenesis machinery. Our study serves as a warning for those using shRNA approaches to investigate gene functions in vivo.	[Song, Hye-Won; Bettegowda, Anilkumar; Phan, Mimi H.; Wilkinson, Miles F.] Univ Calif San Diego, Sch Med, Dept Reprod Med, La Jolla, CA 92093 USA; [Oliver, Daniel; Yan, Wei] Univ Nevada, Sch Med, Dept Physiol & Cell Biol, Reno, NV 89557 USA; [de Rooij, Dirk G.] Univ Amsterdam, Acad Med Ctr, Ctr Reprod Med, NL-1105 AZ Amsterdam, Netherlands; [Corbett, Mark A.] Univ Adelaide, Sch Pediat & Reprod Hlth, Adelaide, SA, Australia	University of California System; University of California San Diego; Nevada System of Higher Education (NSHE); University of Nevada Reno; University of Amsterdam; Academic Medical Center Amsterdam; University of Adelaide	Wilkinson, MF (corresponding author), Univ Calif San Diego, Sch Med, Dept Reprod Med, La Jolla, CA 92093 USA.	mfwilkinson@ucsd.edu	Yan, Wei/AAH-7943-2019; de Rooij, D.G./AAW-1195-2021; Corbett, Mark/A-8063-2010	Corbett, Mark/0000-0001-9298-3072; de Rooij, Dirk/0000-0003-3932-4419	National Institutes of Health [R01-HD053808, R01-HD45595]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD045595] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD053808] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [P30CA016672] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P30GM110767] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the National Institutes of Health (www.nih.gov/) R01-HD053808 and-HD45595 (to MFW). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Babiarz JE, 2008, GENE DEV, V22, P2773, DOI 10.1101/gad.1705308; Baek ST, 2014, NEURON, V82, P1255, DOI 10.1016/j.neuron.2014.04.036; Bhardwaj A, 2008, MOL CELL BIOL, V28, P2138, DOI 10.1128/MCB.01170-07; Birmingham A, 2006, NAT METHODS, V3, P199, DOI 10.1038/NMETH854; Brown JR, 2014, GENESIS, V52, P39, DOI 10.1002/dvg.22718; Chan WK, 2007, EMBO J, V26, P1820, DOI 10.1038/sj.emboj.7601628; Cifuentes D, 2010, SCIENCE, V328, P1694, DOI 10.1126/science.1190809; Coumoul X, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni100; Coumoul X, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh083; de Rooij DG, 1999, BIOL REPROD, V61, P842, DOI 10.1095/biolreprod61.3.842; Ehlert EM, 2010, BMC NEUROSCI, V11, DOI 10.1186/1471-2202-11-20; Elliott MR, 2010, NATURE, V467, P333, DOI 10.1038/nature09356; Gao X, 2007, PHYSIOLOGY, V22, P161, DOI 10.1152/physiol.00002.2007; Geyer CB, 2008, GENE, V423, P194, DOI 10.1016/j.gene.2008.06.031; Geyer CB, 2012, BIOL REPROD, V86, DOI 10.1095/biolreprod.111.094938; Greenlee AR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046359; Grimm D, 2006, NATURE, V441, P537, DOI 10.1038/nature04791; Hu Z, 2008, J BIOL CHEM, V283, P3866, DOI 10.1074/jbc.M706717200; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Jackson AL, 2010, NAT REV DRUG DISCOV, V9, P57, DOI 10.1038/nrd3010; Jackson M, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-212; Kan L, 2005, BIOESSAYS, V27, P14, DOI 10.1002/bies.20172; Kaneda M, 2009, EPIGENET CHROMATIN, V2, DOI 10.1186/1756-8935-2-9; Khan AA, 2009, NAT BIOTECHNOL, V27, P549, DOI 10.1038/nbt.1543; Kim VN, 2009, NAT REV MOL CELL BIO, V10, P126, DOI 10.1038/nrm2632; Lawrence RJ, 2003, PLANT J, V36, P114, DOI 10.1046/j.1365-313X.2003.01857.x; Lee HY, 2013, NUCLEIC ACIDS RES, V41, P6568, DOI 10.1093/nar/gkt361; Lindsey JS, 1996, DEV BIOL, V179, P471, DOI 10.1006/dbio.1996.0276; Liu DK, 2012, BIOCHEM BIOPH RES CO, V422, P114, DOI 10.1016/j.bbrc.2012.04.118; Liu HC, 2010, J ASSIST REPROD GEN, V27, P571, DOI 10.1007/s10815-010-9456-x; Ma HM, 2014, MOL THER-NUCL ACIDS, V3, DOI 10.1038/mtna.2014.27; Ma J, 2010, CURR BIOL, V20, P265, DOI 10.1016/j.cub.2009.12.042; MacLean JA, 2005, CELL, V120, P369, DOI 10.1016/j.cell.2004.12.022; MacLean JA, 2006, GENESIS, V44, P122, DOI 10.1002/gene.20193; McBride JL, 2008, P NATL ACAD SCI USA, V105, P5868, DOI 10.1073/pnas.0801775105; Morris L, 2006, MAMM GENOME, V17, P178, DOI 10.1007/s00335-005-0138-4; Mueller JL, 2008, NAT GENET, V40, P794, DOI 10.1038/ng.126; Mueller JL, 2013, NAT GENET, V45, P1083, DOI 10.1038/ng.2705; Murchison EP, 2007, GENE DEV, V21, P682, DOI 10.1101/gad.1521307; Muto S, 2010, P NATL ACAD SCI USA, V107, P8011, DOI 10.1073/pnas.0912901107; Namekawa SH, 2006, CURR BIOL, V16, P660, DOI 10.1016/j.cub.2006.01.066; Rao MK, 2003, MOL ENDOCRINOL, V17, P223, DOI 10.1210/me.2002-0232; Richardson ME, 2014, HUM MOL GENET, V23, P12, DOI 10.1093/hmg/ddt392; Romero Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025241; ROTTER V, 1993, P NATL ACAD SCI USA, V90, P9075, DOI 10.1073/pnas.90.19.9075; Sadate-Ngatchou PI, 2008, GENESIS, V46, P738, DOI 10.1002/dvg.20437; Sandy P, 2005, BIOTECHNIQUES, V39, P215, DOI 10.2144/05392RV01; Shukla V, 2007, INT J BIOL SCI, V3, P91; Song HW, 2013, HUM REPROD, V28, P1635, DOI 10.1093/humrep/det043; Song HW, 2012, REPRODUCTION, V143, P611, DOI 10.1530/REP-11-0479; Song R, 2011, P NATL ACAD SCI USA, V108, P13159, DOI 10.1073/pnas.1108567108; Song R, 2009, NAT GENET, V41, P488, DOI 10.1038/ng.338; Suh N, 2010, CURR BIOL, V20, P271, DOI 10.1016/j.cub.2009.12.044; Sui GC, 2002, P NATL ACAD SCI USA, V99, P5515, DOI 10.1073/pnas.082117599; Sutton KA, 1997, J MOL EVOL, V45, P579, DOI 10.1007/PL00006262; Tam OH, 2008, NATURE, V453, P534, DOI 10.1038/nature06904; Turner JMA, 2007, DEVELOPMENT, V134, P1823, DOI 10.1242/dev.000018; Wang XX, 2006, GENOMICS, V88, P34, DOI 10.1016/j.ygeno.2006.02.007; Watanabe T, 2008, NATURE, V453, P539, DOI 10.1038/nature06908; Wu QX, 2012, J BIOL CHEM, V287, P25173, DOI 10.1074/jbc.M112.362053; Yamamoto Y, 2013, GENOME RES, V23, P292, DOI 10.1101/gr.137224.112; Yang JS, 2011, MOL CELL, V43, P892, DOI 10.1016/j.molcel.2011.07.024; Yang JS, 2010, P NATL ACAD SCI USA, V107, P15163, DOI 10.1073/pnas.1006432107; Yi R, 2005, RNA, V11, P220, DOI 10.1261/rna.7233305; Zhu XC, 2007, BMC MOL BIOL, V8, DOI 10.1186/1471-2199-8-98	65	6	6	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2015	10	3							e0118549	10.1371/journal.pone.0118549	http://dx.doi.org/10.1371/journal.pone.0118549			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD9NQ	25790000	Green Published, Green Submitted, gold			2022-12-27	WOS:000351425400034
J	Yuan, G; Yan, SF; Xue, H; Zhang, P; Sun, JT; Li, G				Yuan, Guang; Yan, Shaofeng; Xue, Hao; Zhang, Ping; Sun, Jintang; Li, Gang			JSI-124 Suppresses Invasion and Angiogenesis of Glioblastoma Cells In Vitro	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; CENTRAL-NERVOUS-SYSTEM; SIGNALING PATHWAY; CANCER-CELLS; TUMOR ANGIOGENESIS; ANTITUMOR-ACTIVITY; GASTRIC-CANCER; CUCURBITACIN-I; BRAIN-TUMORS; STAT3	Glioblastoma multiforme (GBM) is one of the utmost malignant tumors. Excessive angiogenesis and invasiveness are the major reasons for their uncontrolled growth and resistance toward conventional strategies resulting in poor prognosis. In this study, we found that low-dose JSI-124 reduced invasiveness and tumorigenicity of GBM cells. JSI-124 effectively inhibited VEGF expression in GBM cells. In a coculture study, JSI-124 completely prevented U87MG cell-mediated capillary formation of HUVECs and the migration of HUVECs when cultured alone or cocultured with U87MG cells. Furthermore, JSI-124 inhibited VEGF-induced cell proliferation, motility, invasion and the formation of capillary-like structures in HUVECs in a dose-dependent manner. JSI-124 suppressed VEGF-induced pVEGFR2 activity through STAT3 signaling cascade in HUVECs. Immunohistochemistry analysis showed that the expression of CD34, Ki67, p-STAT3 and p-VEGFR2 protein in xenografts was remarkably decreased. Taken together, our findings provide the first evidence that JSI-124 effectively inhibits tumor angiogenesis and invasion, which might be a viable drug in anti-angiogenesis and anti-invasion therapies.	[Yuan, Guang; Yan, Shaofeng; Xue, Hao; Zhang, Ping; Li, Gang] Shandong Univ, Qilu Hosp, Dept Neurosurg, Jinan 250012, Peoples R China; [Yuan, Guang; Li, Gang] Shandong Univ, Brain Sci Res Inst, Jinan 250012, Peoples R China; [Sun, Jintang] Shandong Univ, Qilu Hosp, Inst Basic Med Sci, Jinan 250012, Peoples R China; [Sun, Jintang] Shandong Univ, Qilu Hosp, Key Lab Cardiovasc Prote Shandong Prov, Jinan 250012, Peoples R China; [Yuan, Guang] Cent Hosp Zibo City, Dept Neurosurg, Zibo 255036, Peoples R China	Shandong University; Shandong University; Shandong University; Shandong University	Li, G (corresponding author), Shandong Univ, Qilu Hosp, Dept Neurosurg, 107 Wenhua Xi Rd, Jinan 250012, Peoples R China.	doctorligang@126.com	Xue, Hao/GXV-4717-2022		Natural Science Foundation of China [81172403, 81372719]; Promotive Research Fund for Excellent Young and Middle-aged Scientists of Shandong Province [BS2010SW013]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Promotive Research Fund for Excellent Young and Middle-aged Scientists of Shandong Province	This work was supported by Natural Science Foundation of China (81172403 and 81372719) and Promotive Research Fund for Excellent Young and Middle-aged Scientists of Shandong Province (BS2010SW013). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bao SD, 2006, CANCER RES, V66, P7843, DOI 10.1158/0008-5472.CAN-06-1010; Bellou S, 2013, CANCER LETT, V338, P219, DOI 10.1016/j.canlet.2013.05.015; Blaskovich MA, 2003, CANCER RES, V63, P1270; Buettner R, 2002, CLIN CANCER RES, V8, P945; Carmeliet P, 2005, ONCOLOGY-BASEL, V69, P4, DOI 10.1159/000088478; Chaudhry IH, 2001, HISTOPATHOLOGY, V39, P409, DOI 10.1046/j.1365-2559.2001.01230.x; Chen J, 2012, MOL CANCER THER, V11, P277, DOI 10.1158/1535-7163.MCT-11-0648; Chen Z, 2008, MED RES REV, V28, P185, DOI 10.1002/med.20101; Cook KM, 2010, CA-CANCER J CLIN, V60, P222, DOI 10.3322/caac.20075; de Groot J, 2012, ONCOTARGET, V3, P1036; Doucette TA, 2012, NEURO-ONCOLOGY, V14, P1136, DOI 10.1093/neuonc/nos139; Dunn IF, 2000, J NEURO-ONCOL, V50, P121, DOI 10.1023/A:1006436624862; Dvorak HF, 1999, CURR TOP MICROBIOL, V237, P97; DVORAK HF, 1995, INT ARCH ALLERGY IMM, V107, P233, DOI 10.1159/000236988; Fan SZ, 2010, CANCER LETT, V291, P158, DOI 10.1016/j.canlet.2009.10.011; Ferrara N, 2001, ACTA HAEMATOL-BASEL, V106, P148, DOI 10.1159/000046610; Ferrara N, 2003, NAT MED, V9, P669, DOI 10.1038/nm0603-669; Ferrara N, 1999, J MOL MED, V77, P527, DOI 10.1007/s001099900019; FOLKMAN J, 1995, NAT MED, V1, P27, DOI 10.1038/nm0195-27; Furnari FB, 2007, GENE DEV, V21, P2683, DOI 10.1101/gad.1596707; Gamero AM, 2004, CANCER CELL, V5, P111, DOI 10.1016/S1535-6108(04)00028-5; Grunstein J, 1999, CANCER RES, V59, P1592; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Heath VL, 2009, NAT REV CLIN ONCOL, V6, P395, DOI 10.1038/nrclinonc.2009.52; Holash J, 1999, SCIENCE, V284, P1994, DOI 10.1126/science.284.5422.1994; Ishdorj G, 2010, MOL CANCER THER, V9, P3302, DOI 10.1158/1535-7163.MCT-10-0550; Jain RK, 2007, NAT REV NEUROSCI, V8, P610, DOI 10.1038/nrn2175; Jing N, 2005, ANTI-CANCER DRUG, V16, P601, DOI 10.1097/00001813-200507000-00002; Jung JE, 2005, FASEB J, V19, P1296, DOI 10.1096/fj.04-3099fje; Kandala PK, 2012, BMC MED, V10, DOI 10.1186/1741-7015-10-9; Kerbel RS, 2008, NEW ENGL J MED, V358, P2039, DOI 10.1056/NEJMra0706596; Kim MJ, 2013, CANCER LETT, V335, P145, DOI 10.1016/j.canlet.2013.02.010; Kwiatkowska A, 2013, ADV EXP MED BIOL, V986, P121, DOI 10.1007/978-94-007-4719-7_7; Louis DN, 2007, ACTA NEUROPATHOL, V114, P97, DOI 10.1007/s00401-007-0243-4; Louis DN, 2002, CANCER CELL, V1, P125, DOI 10.1016/S1535-6108(02)00040-5; Lu JM, 2010, CARCINOGENESIS, V31, P481, DOI 10.1093/carcin/bgp292; Machein MR, 2000, J NEURO-ONCOL, V50, P109, DOI 10.1023/A:1006416003964; Omuro AMP, 2007, MOL CANCER THER, V6, P1909, DOI 10.1158/1535-7163.MCT-07-0047; Onishi M, 2011, BRAIN TUMOR PATHOL, V28, P13, DOI 10.1007/s10014-010-0007-z; Patan S, 2004, CANC TREAT, V117, P3; Pathak AK, 2007, MOL CANCER RES, V5, P943, DOI 10.1158/1541-7786.MCR-06-0348; Ren ZY, 2002, J BIOL CHEM, V277, P38486, DOI 10.1074/jbc.M112438200; Salhia B, 2006, EXPERT REV MOL DIAGN, V6, P613, DOI 10.1586/14737159.6.4.613; Saraswati S, 2013, CANCER LETT, V332, P83, DOI 10.1016/j.canlet.2013.01.012; Shibuya M, 2006, ENDOTHELIUM-J ENDOTH, V13, P63, DOI 10.1080/10623320600697955; Siegelin MD, 2010, NEUROSCI LETT, V478, P165, DOI 10.1016/j.neulet.2010.05.009; Skobe M, 1997, NAT MED, V3, P1222, DOI 10.1038/nm1197-1222; Su YH, 2008, CANCER BIOL THER, V7, P1243, DOI 10.4161/cbt.7.8.6263; Tsujii M, 1998, CELL, V93, P705, DOI 10.1016/S0092-8674(00)81433-6; Yuan G, 2014, J BIOL CHEM, V289, P10607, DOI 10.1074/jbc.M113.528760; Zachary I, 2001, CARDIOVASC RES, V49, P568, DOI 10.1016/S0008-6363(00)00268-6	51	20	24	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2015	10	3							e0118894	10.1371/journal.pone.0118894	http://dx.doi.org/10.1371/journal.pone.0118894			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD9NQ	25789853	Green Submitted, Green Published, gold			2022-12-27	WOS:000351425400053
J	Baldy, V; Thiebaut, G; Fernandez, C; Sagova-Mareckova, M; Korboulewsky, N; Monnier, Y; Perez, T; Tremolieres, M				Baldy, Virginie; Thiebaut, Gabrielle; Fernandez, Catherine; Sagova-Mareckova, Marketa; Korboulewsky, Nathalie; Monnier, Yogan; Perez, Thierry; Tremolieres, Michele			Experimental Assessment of the Water Quality Influence on the Phosphorus Uptake of an Invasive Aquatic Plant: Biological Responses throughout Its Phenological Stage	PLOS ONE			English	Article							ELODEA-NUTTALLII; ST-JOHN; GROWTH LIMITATION; RANUNCULUS-PELTATUS; FLOODPLAIN FRANCE; RUNNING WATERS; GENUS ELODEA; MACROPHYTES; PLASTICITY; NUTRIENTS	Understanding how an invasive plant can colonize a large range of environments is still a great challenge in freshwater ecology. For the first time, we assessed the relative importance of four factors on the phosphorus uptake and growth of an invasive macrophyte Elodea nuttallii (Planch.) St. John. This study provided data on its phenotypic plasticity, which is frequently suggested as an important mechanism but remains poorly investigated. The phosphorus uptake of two Elodea nuttallii subpopulations was experimentally studied under contrasting environmental conditions. Plants were sampled in the Rhine floodplain and in the Northern Vosges mountains, and then maintained in aquaria in hard (Rhine) or soft (Vosges) water. Under these conditions, we tested the influence of two trophic states (eutrophic state, 100 mu g.l(-1) P-PO43- and hypertrophic state, 300 mu g.l(-1) P-PO43-) on the P metabolism of plant subpopulations collected at three seasons (winter, spring and summer). Elodea nuttallii was able to absorb high levels of phosphorus through its shoots and enhance its phosphorus uptake, continually, after an increase of the resource availability (hypertrophic > eutrophic). The lowest efficiency in nutrient use was observed in winter, whereas the highest was recorded in spring, what revealed thus a storage strategy which can be beneficial to new shoots. This experiment provided evidence that generally, the water trophic state is the main factor governing P uptake, and the mineral status (softwater > hardwater) of the stream water is the second main factor. The phenological stage appeared to be a confounding factor to P level in water. Nonetheless, phenology played a role in P turnover in the plant. Finally, phenotypic plasticity allows both subpopulations to adapt to a changing environment.	[Baldy, Virginie; Tremolieres, Michele] UdS, CNRS, Inst Bot, LHyGeS,UMR 7517, F-67083 Strasbourg, France; [Baldy, Virginie; Fernandez, Catherine; Korboulewsky, Nathalie; Monnier, Yogan; Perez, Thierry] Aix Marseille Univ, CNRS, IRD, Avignon Univ,IMBE,UMR 7263, F-13331 Marseille 03, France; [Thiebaut, Gabrielle] CNRS, UMR 6553, Lab Ecosyst Biodivers Evolut ECOBIO, F-35042 Rennes, France; [Sagova-Mareckova, Marketa] Res Inst Crop Prod, Epidemiol & Ecol Microorganisms, CR-16106 Prague, Czech Republic; [Korboulewsky, Nathalie] Irstea, UR EFNO, Ctr Nogent Sur Vernisson, F-45290 Nogent Sur Vernisson, France; [Monnier, Yogan] INRA, UMR AMAP, F-34000 Montpellier, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Earth Sciences & Astronomy (INSU); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Avignon Universite; UDICE-French Research Universities; Aix-Marseille Universite; Centre National de la Recherche Scientifique (CNRS); Institut de Recherche pour le Developpement (IRD); Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Czech Crop Research Institute (CRI); INRAE; CIRAD; Centre National de la Recherche Scientifique (CNRS); Institut de Recherche pour le Developpement (IRD); Universite de Montpellier; INRAE	Baldy, V (corresponding author), UdS, CNRS, Inst Bot, LHyGeS,UMR 7517, 28 Rue Goethe, F-67083 Strasbourg, France.	virginie.baldy@imbe.fr	FERNANDEZ, Catherine/A-2556-2009; Mareckova, Marketa/D-9898-2017; Mareckova, Marketa/AAD-7361-2021	FERNANDEZ, Catherine/0000-0002-6868-4774; Mareckova, Marketa/0000-0002-0331-8570; Mareckova, Marketa/0000-0002-0331-8570; BALDY, Virginie/0000-0002-4048-5132; Korboulewsky, Nathalie/0000-0002-6017-1114	national research Programme "Environnement, Vie et Societes" of the CNRS; Ministry of Education, Youth and Sports of the Czech Republic [ME 09077]	national research Programme "Environnement, Vie et Societes" of the CNRS; Ministry of Education, Youth and Sports of the Czech Republic(Ministry of Education, Youth & Sports - Czech Republic)	This work was supported by the national research Programme "Environnement, Vie et Societes" of the CNRS and Ministry of Education, Youth and Sports of the Czech Republic, ME 09077. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	*AFNOR, 1986, T90023 NF AFNOR, P270; Angelstein S, 2008, AQUAT BIOL, V3, P209, DOI 10.3354/ab00080; Baldy V, 2007, HYDROBIOLOGIA, V575, P343, DOI 10.1007/s10750-006-0380-0; Barrat-Segretain MH, 2001, ARCH HYDROBIOL, V152, P237; Best EPH, 1996, FRESHWATER BIOL, V36, P33, DOI 10.1046/j.1365-2427.1996.d01-474.x; BLOSSEY B, 1995, J ECOL, V83, P887, DOI 10.2307/2261425; BOWES G, 1989, AQUAT BOT, V34, P233, DOI 10.1016/0304-3770(89)90058-2; CARPENTER S R, 1977, Aquatic Botany, V3, P239, DOI 10.1016/0304-3770(77)90026-2; Chambers PA, 2001, FRESHWATER BIOL, V46, P1121, DOI 10.1046/j.1365-2427.2001.00794.x; COOK CDK, 1985, AQUAT BOT, V21, P111, DOI 10.1016/0304-3770(85)90084-1; Davis MA, 2000, J ECOL, V88, P528, DOI 10.1046/j.1365-2745.2000.00473.x; DAWSON F H, 1976, Aquatic Botany, V2, P51, DOI 10.1016/0304-3770(76)90007-3; Demars BOL, 2007, FRESHWATER BIOL, V52, P2073, DOI 10.1111/j.1365-2427.2007.01817.x; Di Nino F, 2007, FUND APPL LIMNOL, V168, P335, DOI 10.1127/1863-9135/2007/0168-0335; Di Nino F, 2008, THESIS U METZ; Dykyjova D, 1979, ALGAL ASSAYS, P131; Engelhardt KAM, 2002, ECOLOGY, V83, P2911; Garbey C, 2004, PLANT ECOL, V173, P125, DOI 10.1023/B:VEGE.0000026336.44576.ff; Garbey C, 2004, FRESHWATER BIOL, V49, P346, DOI 10.1111/j.1365-2427.2004.01188.x; GERLOFF GC, 1966, LIMNOL OCEANOGR, V11, P529, DOI 10.4319/lo.1966.11.4.0529; Golterman HL, 1994, ANN LIMNOL-INT J LIM, V30, P221, DOI 10.1051/limn/1994017; Greulich S, 2006, HYDROBIOLOGIA, V570, P249, DOI 10.1007/s10750-006-0188-y; Grime J.P., 1988, PLANT EVOLUTIONARY B, P371, DOI DOI 10.1007/978-94-009-1207-6_14; James CS, 2006, AQUAT BOT, V84, P347, DOI 10.1016/j.aquabot.2006.01.002; JONES RL, 1993, J EXP BOT, V44, P207; KUNII H, 1984, AQUAT BOT, V18, P239, DOI 10.1016/0304-3770(84)90065-2; Lacoul P, 2006, ENVIRON REV, V14, P89, DOI 10.1139/a06-001; MABERLY SC, 1983, J ECOL, V71, P705, DOI 10.2307/2259587; Madsen TV, 2002, FRESHWATER BIOL, V47, P283, DOI 10.1046/j.1365-2427.2002.00802.x; Mony C, 2007, PLANT ECOL, V191, P109, DOI 10.1007/s11258-006-9219-z; Pelton DK, 1998, FRESHWATER BIOL, V39, P285, DOI 10.1046/j.1365-2427.1998.00281.x; Pietro KC, 2006, ECOL ENG, V27, P290, DOI 10.1016/j.ecoleng.2006.05.014; Richards CL, 2006, ECOL LETT, V9, P981, DOI 10.1111/j.1461-0248.2006.00950.x; Robach F, 1995, ACTA BOT GALLICA, V142, P719, DOI 10.1080/12538078.1995.10515296; SELL Y, 1959, B ASS PHIL ALS LORR, V10, P121; SIMPSON D A, 1988, Watsonia, V17, P121; Simpson DA., 1984, WATSONIA J BOT SOC I, V15, P1; SIMPSON PS, 1986, AQUAT BOT, V24, P1, DOI 10.1016/0304-3770(86)90112-9; Szabo S, 2010, FRESHWATER BIOL, V55, P681, DOI 10.1111/j.1365-2427.2009.02308.x; Thiebaut G, 2005, WATER RES, V39, P3385, DOI 10.1016/j.watres.2005.05.036; Thiebaut G, 2003, ANN LIMNOL-INT J LIM, V39, P307, DOI 10.1051/limn/2003025; Thiebaut Gabrielle, 2008, V7, P31; van Wijk MT, 2003, J ECOL, V91, P664, DOI 10.1046/j.1365-2745.2003.00788.x; VANWIJK RJ, 1989, AQUAT BOT, V35, P319, DOI 10.1016/0304-3770(89)90005-3; VITOUSEK P, 1982, AM NAT, V119, P553, DOI 10.1086/283931; WELSH RPH, 1979, NEW PHYTOL, V82, P645, DOI 10.1111/j.1469-8137.1979.tb01659.x; Zar J.H., 1999, ZAR KUHR 5 2019, V4th	47	13	13	0	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2015	10	3							e0118844	10.1371/journal.pone.0118844	http://dx.doi.org/10.1371/journal.pone.0118844			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9BN	25785687	Green Published, Green Submitted, gold			2022-12-27	WOS:000352138500051
J	Begum, H; Spindel, JE; Lalusin, A; Borromeo, T; Gregorio, G; Hernandez, J; Virk, P; Collard, B; McCouch, SR				Begum, Hasina; Spindel, Jennifer E.; Lalusin, Antonio; Borromeo, Teresita; Gregorio, Glenn; Hernandez, Jose; Virk, Parminder; Collard, Bertrand; McCouch, Susan R.			Genome-Wide Association Mapping for Yield and Other Agronomic Traits in an Elite Breeding Population of Tropical Rice (Oryza sativa)	PLOS ONE			English	Article							CONTROLLING HEADING DATE; FLOWERING TIME; COMPLEX TRAITS; PLANT HEIGHT; SELECTION; GENE; LOCUS; ORTHOLOG; OSMADS50; HD3A	Genome-wide association mapping studies (GWAS) are frequently used to detect QTL in diverse collections of crop germplasm, based on historic recombination events and linkage disequilibrium across the genome. Generally, diversity panels genotyped with high density SNP panels are utilized in order to assay a wide range of alleles and haplotypes and to monitor recombination breakpoints across the genome. By contrast, GWAS have not generally been performed in breeding populations. In this study we performed association mapping for 19 agronomic traits including yield and yield components in a breeding population of elite irrigated tropical rice breeding lines so that the results would be more directly applicable to breeding than those from a diversity panel. The population was genotyped with 71,710 SNPs using genotyping-by-sequencing (GBS), and GWAS performed with the explicit goal of expediting selection in the breeding program. Using this breeding panel we identified 52 QTL for 11 agronomic traits, including large effect QTLs for flowering time and grain length/grain width/grain-length-breadth ratio. We also identified haplotypes that can be used to select plants in our population for short stature (plant height), early flowering time, and high yield, and thus demonstrate the utility of association mapping in breeding populations for informing breeding decisions. We conclude by exploring how the newly identified significant SNPs and insights into the genetic architecture of these quantitative traits can be leveraged to build genomic-assisted selection models.	[Begum, Hasina; Gregorio, Glenn; Collard, Bertrand] Int Rice Res Inst, Los Banos, Philippines; [Spindel, Jennifer E.; McCouch, Susan R.] Cornell Univ, Dept Plant Breeding & Genet, Ithaca, NY 14850 USA; [Lalusin, Antonio; Borromeo, Teresita; Hernandez, Jose] Univ Philippines Los Banos, Crop Sci Cluster, Los Banos, Philippines; [Virk, Parminder] Ctr Int Agr Trop, Cali, Colombia	CGIAR; International Rice Research Institute (IRRI); Cornell University; University of the Philippines System; University of the Philippines Los Banos; Alliance; International Center for Tropical Agriculture - CIAT	McCouch, SR (corresponding author), Cornell Univ, Dept Plant Breeding & Genet, Ithaca, NY 14850 USA.	srm4@cornell.edu	Spindel, Jennifer/F-1373-2017	Collard, Bertrand/0000-0003-2566-4148	NSF PGRP [102655]; Global Diversity Trust; NSF graduate research fellowship; Organization for Women in Science for the Developing World (OWSD); Japan Government via the Japan Rice Breeding Project at IRRI	NSF PGRP(National Science Foundation (NSF)NSF - Office of the Director (OD)); Global Diversity Trust; NSF graduate research fellowship(National Science Foundation (NSF)); Organization for Women in Science for the Developing World (OWSD); Japan Government via the Japan Rice Breeding Project at IRRI	Funding was provided by NSF PGRP #102655 to SMc, Global Diversity Trust to SMc, an NSF graduate research fellowship to JS, the Organization for Women in Science for the Developing World (OWSD) for the PhD scholarship for HB, and the Japan Government via the Japan Rice Breeding Project at IRRI. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bernardo R, 2014, CROP SCI, V54, P68, DOI 10.2135/cropsci2013.05.0315; Bradbury PJ, 2007, BIOINFORMATICS, V23, P2633, DOI 10.1093/bioinformatics/btm308; Collard BCY, 2008, PHILOS T R SOC B, V363, P557, DOI 10.1098/rstb.2007.2170; Dalrymple DG, 1986, Development and spread of high -yielding wheat varieties in developing countries, V7th; Elshire RJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019379; Famoso AN, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002221; Faraway J.J., 2002, PRACTICAL REGRESSION; Flint-Garcia SA, 2003, ANNU REV PLANT BIOL, V54, P357, DOI 10.1146/annurev.arplant.54.031902.134907; Fujino K, 2013, THEOR APPL GENET, V126, P611, DOI 10.1007/s00122-012-2005-5; Gregorio G. B., 2013, SABRAO Journal of Breeding and Genetics, V45, P31; Heffner EL, 2009, CROP SCI, V49, P1, DOI 10.2135/cropsci2008.08.0512; Huang XH, 2014, ANNU REV PLANT BIOL, V65, P531, DOI 10.1146/annurev-arplant-050213-035715; Huang XH, 2012, NAT GENET, V44, P32, DOI 10.1038/ng.1018; Huang XH, 2010, NAT GENET, V42, P961, DOI 10.1038/ng.695; Jain M, 2007, PLANT PHYSIOL, V143, P1467, DOI 10.1104/pp.106.091900; Kojima S, 2002, PLANT CELL PHYSIOL, V43, P1096, DOI 10.1093/pcp/pcf156; Komiya R, 2008, DEVELOPMENT, V135, P767, DOI 10.1242/dev.008631; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Lee SY, 2004, PLANT J, V38, P754, DOI 10.1111/j.1365-313X.2004.02082.x; Lin HX, 2003, BREEDING SCI, V53, P51, DOI 10.1270/jsbbs.53.51; Lin HX, 2002, BREEDING SCI, V52, P35, DOI 10.1270/jsbbs.52.35; Lorenz AJ, 2011, ADV AGRON, V110, P77, DOI 10.1016/B978-0-12-385531-2.00002-5; Meuwissen THE, 2001, GENETICS, V157, P1819; Rao NN, 2008, P NATL ACAD SCI USA, V105, P3646, DOI 10.1073/pnas.0709059105; Romay MC, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-6-r55; Ryu CH, 2009, PLANT CELL ENVIRON, V32, P1412, DOI 10.1111/j.1365-3040.2009.02008.x; Seck PA, 2012, FOOD SECUR, V4, P7, DOI 10.1007/s12571-012-0168-1; Spindel J, 2014, PLOS GENETI IN PRESS; Spindel J, 2013, THEOR APPL GENET, P1, DOI [10.1007/s13197-013-0993-z, DOI 10.1007/S13197-013-0993-Z]; Varshney RK, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1001883; Walsh MLaB, 1998, GENETICS ANAL QUANTI; Wei XJ, 2010, PLANT PHYSIOL, V153, P1747, DOI 10.1104/pp.110.156943; Xu X, 2012, NAT BIOTECHNOL, V30, P105, DOI 10.1038/nbt.2050; Yang W., 2014, NAT COMMUN, V5; Yano M, 2000, PLANT CELL, V12, P2473, DOI 10.1105/tpc.12.12.2473; Yonemaru J, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-346; Yoo SK, 2005, PLANT PHYSIOL, V139, P770, DOI 10.1104/pp.105.066928; Yu JM, 2008, GENETICS, V178, P539, DOI 10.1534/genetics.107.074245; Zhang ZH, 2014, PLOS ONE, V9; Zhao K, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1467; Zhao Y, 2014, HEREDITY, V112, P638, DOI 10.1038/hdy.2014.1; Zhou X, 2012, NAT GENET, V44, P821, DOI 10.1038/ng.2310; Zhu CS, 2008, PLANT GENOME-US, V1, P5, DOI 10.3835/plantgenome2008.02.0089	44	107	112	0	72	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2015	10	3							e0119873	10.1371/journal.pone.0119873	http://dx.doi.org/10.1371/journal.pone.0119873			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9BN	25785447	Green Submitted, gold, Green Published			2022-12-27	WOS:000352138500138
J	Bouchut, A; Chawla, AR; Jeffers, V; Hudmon, A; Sullivan, WJ				Bouchut, Anne; Chawla, Aarti R.; Jeffers, Victoria; Hudmon, Andy; Sullivan, William J., Jr.			Proteome-Wide Lysine Acetylation in Cortical Astrocytes and Alterations That Occur during Infection with Brain Parasite Toxoplasma gondii	PLOS ONE			English	Article							NEUROPROTECTIVE FACTOR; METABOLIC PATHWAYS; DIVERSE FUNCTION; B GPNMB; PROTEINS; NEURONS; MODULATION; ACETYLOME; ALPHA; ACETYLTRANSFERASE	Lysine acetylation is a reversible post-translational modification (PTM) that has been detected on thousands of proteins in nearly all cellular compartments. The role of this widespread PTM has yet to be fully elucidated, but can impact protein localization, interactions, activity, and stability. Here we present the first proteome-wide survey of lysine acetylation in cortical astrocytes, a subtype of glia that is a component of the blood-brain barrier and a key regulator of neuronal function and plasticity. We identified 529 lysine acetylation sites across 304 proteins found in multiple cellular compartments that largely function in RNA processing/transcription, metabolism, chromatin biology, and translation. Two hundred and seventy-seven of the acetylated lysines we identified on 186 proteins have not been reported previously in any other cell type. We also mapped an acetylome of astrocytes infected with the brain parasite, Toxoplasma gondii. It has been shown that infection with T. gondii modulates host cell gene expression, including several lysine acetyltransferase (KAT) and deacetylase (KDAC) genes, suggesting that the host acetylome may also be altered during infection. In the T. gondii-infected astrocytes, we identified 34 proteins exhibiting a level of acetylation >2-fold and 24 with a level of acetylation <2-fold relative to uninfected astrocytes. Our study documents the first acetylome map for cortical astrocytes, uncovers novel lysine acetylation sites, and demonstrates that T. gondii infection produces an altered acetylome.	[Bouchut, Anne; Jeffers, Victoria; Sullivan, William J., Jr.] Indiana Univ Sch Med, Dept Pharmacol & Toxicol, Indianapolis, IN 46202 USA; [Sullivan, William J., Jr.] Indiana Univ Sch Med, Dept Microbiol & Immunol, Indianapolis, IN 46202 USA; [Chawla, Aarti R.; Hudmon, Andy] Indiana Univ Sch Med, Dept Biochem & Mol Biol, Indianapolis, IN 46202 USA	Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington	Sullivan, WJ (corresponding author), Indiana Univ Sch Med, Dept Pharmacol & Toxicol, Indianapolis, IN 46202 USA.	wjsulliv@iu.edu		Jeffers, Victoria/0000-0003-1233-1088	National Institutes of Health [NS078171, AI106435]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS078171] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	Support for this study was provided by funding from the National Institutes of Health (http://www.nih.gov/), NS078171 (AH) and AI106435 (to WJS). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdelmagid SM, 2008, EXP CELL RES, V314, P2334, DOI 10.1016/j.yexcr.2008.02.006; Ablack JNG, 2012, J VIROL, V86, P8198, DOI 10.1128/JVI.00289-12; Alaganan A, 2014, P NATL ACAD SCI USA, V111, P1126, DOI 10.1073/pnas.1313501111; Andoh A, 2000, INT J MOL MED, V6, P51; [Anonymous], 2012, NUCL ACIDS RES; [Anonymous], 2005, EMBO J; Apweiler R, 2014, NUCLEIC ACIDS RES, V42, pD191, DOI 10.1093/nar/gkt1140; Ashpole NM, 2013, J BIOL CHEM, V288, P14599, DOI 10.1074/jbc.M113.466235; Bendtsen JD, 2005, BMC MICROBIOL, V5, DOI 10.1186/1471-2180-5-58; Bhatti MM, 2005, J BIOL CHEM, V280, P5902, DOI 10.1074/jbc.M410656200; Blader IJ, 2001, J BIOL CHEM, V276, P24223, DOI 10.1074/jbc.M100951200; Braun L, 2013, J EXP MED, V210, P2071, DOI 10.1084/jem.20130103; Burli RW, 2013, J MED CHEM, V56, P9934, DOI 10.1021/jm4011884; Cahoy JD, 2008, J NEUROSCI, V28, P264, DOI 10.1523/JNEUROSCI.4178-07.2008; Chi HB, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.141pe44; Choudhary C, 2009, SCIENCE, V325, P834, DOI 10.1126/science.1175371; Chung JS, 2007, J IMMUNOL, V179, P5778, DOI 10.4049/jimmunol.179.9.5778; Col E, 2005, EMBO J, V24, P2634, DOI 10.1038/sj.emboj.7600734; Colaert N, 2009, NAT METHODS, V6, P786, DOI 10.1038/nmeth1109-786; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Deponte M, 2013, BBA-GEN SUBJECTS, V1830, P3217, DOI 10.1016/j.bbagen.2012.09.018; Dowell JA, 2009, J PROTEOME RES, V8, P4135, DOI 10.1021/pr900248y; Dramsi S, 1998, INFECT IMMUN, V66, P4461; Drogemuller K, 2008, J IMMUNOL, V181, P2683, DOI 10.4049/jimmunol.181.4.2683; Du J, 2014, J BIOL CHEM, V289, P12578, DOI 10.1074/jbc.M113.544718; ENG LF, 1971, BRAIN RES, V28, P351, DOI 10.1016/0006-8993(71)90668-8; Eugenin EA, 2011, J NEUROSCI, V31, P9456, DOI 10.1523/JNEUROSCI.1460-11.2011; FERGUSON DJP, 1987, PARASITOL RES, V73, P483, DOI 10.1007/BF00535321; Fields RD, 2002, SCIENCE, V298, P556, DOI 10.1126/science.298.5593.556; Finkemeier I, 2011, PLANT PHYSIOL, V155, P1779, DOI 10.1104/pp.110.171595; Foster DB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067513; Gnad F, 2013, MOL CELL PROTEOMICS, V12, P2070, DOI 10.1074/mcp.M112.027052; Greco TM, 2010, J PROTEOME RES, V9, P2764, DOI 10.1021/pr100134n; Halonen SK, 1996, J NEUROPATH EXP NEUR, V55, P1150, DOI 10.1097/00005072-199611000-00006; Halonen SK, 2001, INFECT IMMUN, V69, P5573, DOI 10.1128/IAI.69.9.5573-5576.2001; Han D, 2014, PROTEOMICS, V14, P1604, DOI 10.1002/pmic.201300495; Harrison IF, 2013, PHARMACOL THERAPEUT, V140, P34, DOI 10.1016/j.pharmthera.2013.05.010; Hill Dolores E., 2005, Animal Health Research Reviews, V6, P41, DOI 10.1079/AHR2005100; Hornbeck PV, 2004, PROTEOMICS, V4, P1551, DOI 10.1002/pmic.200300772; Hu LI, 2010, MOL MICROBIOL, V77, P15, DOI 10.1111/j.1365-2958.2010.07204.x; Hu XF, 2013, J CELL BIOCHEM, V114, P2729, DOI 10.1002/jcb.24621; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; HUNTER CA, 1992, EUR J IMMUNOL, V22, P2317, DOI 10.1002/eji.1830220921; Janke C, 2014, J CELL BIOL, V206, P461, DOI 10.1083/jcb.201406055; Jeffers V, 2012, EUKARYOT CELL, V11, P735, DOI 10.1128/EC.00088-12; Kazantsev AG, 2008, NAT REV DRUG DISCOV, V7, P854, DOI 10.1038/nrd2681; Kim SC, 2006, MOL CELL, V23, P607, DOI 10.1016/j.molcel.2006.06.026; Kim W, 2011, MOL CELL, V44, P325, DOI 10.1016/j.molcel.2011.08.025; Lang C, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002483; Lee KK, 2007, NAT REV MOL CELL BIO, V8, P284, DOI 10.1038/nrm2145; Li B, 2010, FASEB J, V24, P4767, DOI 10.1096/fj.10-154757; Lodewick J, 2009, VIROLOGY, V386, P68, DOI 10.1016/j.virol.2008.12.043; Lundby A, 2012, CELL REP, V2, P419, DOI 10.1016/j.celrep.2012.07.006; Lundgren DH, 2009, PROTEIN IDENTIFICATI; Maric G, 2013, ONCOTARGETS THER, V6, P839, DOI 10.2147/OTT.S44906; Melo MB, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003779; Miao J, 2013, MOL MICROBIOL, V89, P660, DOI 10.1111/mmi.12303; Mollapour M, 2012, BBA-MOL CELL RES, V1823, P648, DOI 10.1016/j.bbamcr.2011.07.018; Molofsky AV, 2012, GENE DEV, V26, P891, DOI 10.1101/gad.188326.112; Montoya JG, 2004, LANCET, V363, P1965, DOI 10.1016/S0140-6736(04)16412-X; Munoz-Fontela C, 2011, CELL CYCLE, V10, P3701, DOI 10.4161/cc.10.21.17899; Nakano Y, 2014, NEUROSCIENCE, V277, P123, DOI 10.1016/j.neuroscience.2014.06.065; Nelson MM, 2008, INFECT IMMUN, V76, P828, DOI 10.1128/IAI.01115-07; Norris KL, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.297pe76; PALFREYMAN JW, 1979, J NEUROL SCI, V41, P101, DOI 10.1016/0022-510X(79)90144-8; Pan JY, 2014, J PROTEOME RES, V13, P3294, DOI 10.1021/pr500133t; Patel JH, 2004, MOL CELL BIOL, V24, P10826, DOI 10.1128/MCB.24.24.10826-10834.2004; PIPERNO G, 1987, J CELL BIOL, V104, P289, DOI 10.1083/jcb.104.2.289; Rao RSP, 2014, TRENDS PLANT SCI, V19, P550, DOI 10.1016/j.tplants.2014.05.001; ROOS DS, 1994, METHOD CELL BIOL, V45, P27; Saeij JPJ, 2007, NATURE, V445, P324, DOI 10.1038/nature05395; Scheidegger A, 2005, J PARASITOL, V91, P307, DOI 10.1645/GE-379R; Shahbazian MD, 2007, ANNU REV BIOCHEM, V76, P75, DOI 10.1146/annurev.biochem.76.052705.162114; SIMS TA, 1989, BRIT J EXP PATHOL, V70, P317; Skorupa A, 2013, J PROTEOMICS, V91, P274, DOI 10.1016/j.jprot.2013.07.028; Sofroniew MV, 2010, ACTA NEUROPATHOL, V119, P7, DOI 10.1007/s00401-009-0619-8; Stokes MP, 2012, MOL CELL PROTEOMICS, V11, P187, DOI 10.1074/mcp.M111.015883; Strack A, 2002, ACTA NEUROPATHOL, V103, P458, DOI 10.1007/s00401-001-0491-7; Sullivan WJ, 2012, FEMS MICROBIOL REV, V36, P717, DOI 10.1111/j.1574-6976.2011.00305.x; Tanaka H, 2012, SCI REP-UK, V2, DOI 10.1038/srep00573; Terreni M, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-18; Vogel R, 1999, NEUROSCI LETT, V275, P97, DOI 10.1016/S0304-3940(99)00748-X; Wagner SA, 2012, MOL CELL PROTEOMICS, V11, P1578, DOI 10.1074/mcp.M112.017905; Wang XQ, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-228; Weinert BT, 2014, MOL SYST BIOL, V10, DOI 10.1002/msb.134766; Weinert BT, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001902; Whitesell L, 2005, NAT REV CANCER, V5, P761, DOI 10.1038/nrc1716; Wilson EH, 2004, INT J PARASITOL, V34, P543, DOI 10.1016/j.ijpara.2003.12.010; Wu SP, 2010, AM J PHYSIOL-GASTR L, V298, pG784, DOI 10.1152/ajpgi.00526.2009; Wu X, 2011, PLANT PHYSIOL, V155, P1769, DOI 10.1104/pp.110.165852; Xue B, 2013, MOL BIOSYST, V9, P645, DOI 10.1039/c3mb25517d; Yang C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032886; Yang JW, 2005, J PROTEOME RES, V4, P768, DOI 10.1021/pr049774v; Yang JW, 2005, NEUROCHEM INT, V47, P159, DOI 10.1016/j.neuint.2005.04.017; Yin P, 2012, J PROTEOME RES, V11, P3965, DOI 10.1021/pr201066t; Yu W, 2012, J BIOL CHEM, V287, P14078, DOI 10.1074/jbc.M112.355206; Zhao SM, 2010, SCIENCE, V327, P1000, DOI 10.1126/science.1179689; Zhou DH, 2011, PARASITOL RES, V109, P1637, DOI 10.1007/s00436-011-2435-z	99	16	16	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2015	10	3							e0117966	10.1371/journal.pone.0117966	http://dx.doi.org/10.1371/journal.pone.0117966			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9BN	25786129	Green Published, gold			2022-12-27	WOS:000352138500021
J	Czaprowski, D; Kedra, A; Pawlowska, P; Kolwicz-Ganko, A; Leszczewska, J; Tyrakowski, M				Czaprowski, Dariusz; Kedra, Agnieszka; Pawlowska, Paulina; Kolwicz-Ganko, Aleksandra; Leszczewska, Justyna; Tyrakowski, Marcin			The Examination of the Musculoskeletal System Based Only on the Evaluation of Pelvic-Hip Complex Muscle and Trunk Flexibility May Lead to Failure to Screen Children for Generalized Joint Hypermobility	PLOS ONE			English	Article							STRAIGHT-LEG RAISE	Objective The aim of the study was to evaluate whether the clinical assessment of the pelvic-hip complex muscle and trunk flexibility is sufficient for diagnosing generalized joint hypermobility (GJH). Design A cross-sectional study. Setting Center of Body Posture in Olsztyn, North East Poland. Participants The study included 136 females and 113 males aged 10-13 years. Main outcome measures In order to assess muscle flexibility, the straight leg raise (SLR) test (for hamstring) and modified Thomas test for one-(O-JHF) and two-joint (T-JHF) hip flexors were performed. To evaluate trunk flexibility the fingertip-to-floor (FTF) and lateral trunk flexion (LTF) tests were used. The GJH occurrence was assessed with the use of nine-point Beighton scale (threshold value >= 5 points for females, >= 4 for males). The analysis was carried out separately for females and males. Results There were no significant differences between females with versus without GJH, and males with versus without GJH regarding SLR (p = 0.86, p = 0.19 for females and males, respectively), O-JHF (p = 0.89, p = 0.35 for females and males, respectively), T-JHF (p = 0.77, p = 0.4 for females and males, respectively), FTF (p = 0.19, p = 0.84 for females and males, respectively) and LTF (p = 0.58, p = 0.35 for females and males, respectively) tests results. Conclusions Clinical examination of the pelvic-hip complex muscles and trunk flexibility by use of SLR, O-JHF, T-JHF, FTF and LTF revealed to be insufficient in diagnosing GJH in children aged 10-13 years. Thus, the Beighton scale should be considered a standard element of physiotherapeutic examination of the musculoskeletal system in children and youth.	[Czaprowski, Dariusz] Univ Phys Educ, Dept Rehabil, PL-00968 Warsaw, Poland; [Czaprowski, Dariusz] Jozef Rusiecki Univ Coll Olsztyn, Dept Physiotherapy, PL-10243 Olsztyn, Poland; [Kedra, Agnieszka] Jozef Pilsudski Univ Phys Educ Warsaw, Fac Phys Educ & Sport Biala Podlaska, Dept Posture Correct & Compensat, PL-21500 Biala Podlaska, Poland; [Pawlowska, Paulina; Kolwicz-Ganko, Aleksandra; Leszczewska, Justyna] Univ Phys Educ, Dept Phys Educ, PL-00968 Warsaw, Poland; [Tyrakowski, Marcin] Ctr Postgrad Med Educ Warsaw, Dept Orthoped Pediat Orthoped & Traumatol, PL-05400 Otwock, Poland	Jozef Pilsudski University Physical Education in Warsaw; Jozef Pilsudski University Physical Education in Warsaw; Jozef Pilsudski University Physical Education in Warsaw	Czaprowski, D (corresponding author), Univ Phys Educ, Dept Rehabil, Marymoncka 34, PL-00968 Warsaw, Poland.	dariusz.czaprowski@interia.pl						Anderson B., 2000, STRETCHING; [Anonymous], 2004, PHYSIOTHERAPY, DOI DOI 10.1016/J.PHYSI0.2004.02.009; Armiger P, 2010, STRETCHING FUNCTIONA; Beighton P, 1999, HYPERMOBILITY JOINTS; Boyd BS, 2012, PHYSIOTHERAPY, V98, P174, DOI 10.1016/j.physio.2011.04.352; Chaitow L, 2006, MUSCLE ENERGY TECHNI; Cornbleet SL, 1996, PHYS THER, V76, P850, DOI 10.1093/ptj/76.8.850; Czaprowski Dariusz, 2012, Ortop Traumatol Rehabil, V14, P407, DOI 10.5604/15093492.1016368; Czaprowski D, 2011, SCOLIOSIS SPINAL DIS, V6, DOI 10.1186/1748-7161-6-22; Davis DS, 2005, J STRENGTH COND RES, V19, P27; Gablankowski A, 1994, STRECHING AT SCH; GAUVIN MG, 1990, PHYS THER, V70, P443, DOI 10.1093/ptj/70.7.443; Grahame R, 2009, CURR PAIN HEADACHE R, V13, P427, DOI 10.1007/s11916-009-0070-5; Greenwood NL, 2011, MANUAL THER, V16, P623, DOI 10.1016/j.math.2011.07.005; Hakim A, 2003, BEST PRACT RES CL RH, V17, P989, DOI 10.1016/j.berh.2003.08.001; Hakim A, 2010, HYPERMOBILITY FIBROM, P6; HOWELL DW, 1984, AM J SPORT MED, V12, P278, DOI 10.1177/036354658401200407; Juhas I., 2011, PHYS CULTURE, V65, P42; Keer R., 2003, HYPERMOBILITY SYNDRO; Kendall F.P., 2005, MUSCLES TESTING FUNC, Vfifth; Kerr AJ, 2000, PHYSIOTHERAPY, V86, P313, DOI DOI 10.1016/S0031-9406(05)61005-X; Kisner C, 2012, THERAPEUTIC EXERCISE, V6th; Lamari Neuseli Marino, 2005, Sao Paulo Med. J., V123, P119; Magee DJ, 2011, ORTHOPEDIC PHYS ASSE; Medina FMS, 2007, J SPORT MED PHYS FIT, V47, P304; Murray KJ, 2006, BEST PRACT RES CL RH, V20, P329, DOI 10.1016/j.berh.2005.12.003; Raisin L, 2006, STRETCHING EVERYONE; Russek LN, 1999, PHYS THER, V79, P591, DOI 10.1093/ptj/79.6.591; Russek LN, 2000, PHYS THER, V80, P386, DOI 10.1093/ptj/80.4.386; Sherry DD, 2001, TXB PEDIAT RHEUMATOL, P362; SHROUT PE, 1979, PSYCHOL BULL, V86, P420, DOI 10.1037/0033-2909.86.2.420; Sjolie AN, 2004, SCAND J MED SCI SPOR, V14, P168, DOI 10.1111/j.1600-0838.2003.00334.x; Smits-Engelsman B, 2011, J PEDIATR-US, V158, P130, DOI 10.1016/j.jpeds.2010.07.021; Solberg G., 2008, POSTURAL DISORDERS M, V2n; Streiner D, 2008, HLTH MEASUREMENT SCA, V4; Vougiouka O, 2000, EUR J PEDIATR, V159, P628, DOI 10.1007/PL00008391; Young W, 2004, J SCI MED SPORT, V7, P23, DOI 10.1016/S1440-2440(04)80040-9; [No title captured]	38	6	6	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2015	10	3							e0121360	10.1371/journal.pone.0121360	http://dx.doi.org/10.1371/journal.pone.0121360			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9BN	25786251	gold, Green Published, Green Submitted			2022-12-27	WOS:000352138500209
J	Feng, IJ; Jack, AI; Tatsuoka, C				Feng, I. Jung; Jack, Anthony I.; Tatsuoka, Curtis			Dynamic Adjustment of Stimuli in Real Time Functional Magnetic Resonance Imaging	PLOS ONE			English	Article							BRAIN ACTIVATION; COGNITIVE RESERVE; FMRI; DEMENTIA; NETWORK; PLAQUES; YOUNG	The conventional fMRI image analysis approach to associating stimuli to brain activation is performed by carrying out a massive number of parallel univariate regression analyses. fMRI blood-oxygen-level dependent (BOLD) signal, the basis of these analyses, is known for its low signal-noise-ratio and high spatial and temporal signal correlation. In order to ensure accurate localization of brain activity, stimulus administration in an fMRI session is often lengthy and repetitive. Real-time fMRI BOLD signal analysis is carried out as the signal is observed. This method allows for dynamic, real-time adjustment of stimuli through sequential experimental designs. We have developed a voxel-wise sequential probability ratio test (SPRT) approach for dynamically determining localization, as well as decision rules for stopping stimulus administration. SPRT methods and general linear model (GLM) approaches are combined to identify brain regions that are activated by specific elements of stimuli. Stimulus administration is dynamically stopped when sufficient statistical evidence is collected to determine activation status across regions of interest, following predetermined statistical error thresholds. Simulation experiments and an example based on real fMRI data show that scan volumes can be substantially reduced when compared with pre-determined, fixed designs while achieving similar or better accuracy in detecting activated voxels. Moreover, the proposed approach is also able to accurately detect differentially activated areas, and other comparisons between task-related GLM parameters that can be formulated in a hypothesis-testing framework. Finally, we give a demonstration of SPRT being employed in conjunction with a halving algorithm to dynamically adjust stimuli.	[Feng, I. Jung; Tatsuoka, Curtis] Case Western Reserve Univ, Dept Epidemiol & Biostat, Cleveland, OH 44106 USA; [Jack, Anthony I.] Case Western Reserve Univ, Dept Cognit Sci, Cleveland, OH 44106 USA; [Tatsuoka, Curtis] Case Western Reserve Univ, Dept Neurol, Cleveland, OH 44106 USA	Case Western Reserve University; Case Western Reserve University; Case Western Reserve University	Tatsuoka, C (corresponding author), Case Western Reserve Univ, Dept Epidemiol & Biostat, Cleveland, OH 44106 USA.	cmt66@case.edu	Jack, Anthony Ian/AAJ-7153-2021	Jack, Anthony Ian/0000-0001-9613-3964	Spitz Brain Health Innovation Fund; G.R. Lincoln Family Foundation	Spitz Brain Health Innovation Fund; G.R. Lincoln Family Foundation	This research was supported in part by the Spitz Brain Health Innovation Fund, and the G.R. Lincoln Family Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashby F., 2011, STAT ANAL FMRI DATA; Bartsch AJ, 2006, J MAGN RESON IMAGING, V23, P921, DOI 10.1002/jmri.20579; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Buxton RB, 1998, MAGNET RESON MED, V39, P855, DOI 10.1002/mrm.1910390602; Caria A, 2011, REAL TIME FMRI TOOL; Cohen MS, 2001, METHODS, V25, P201, DOI 10.1006/meth.2001.1235; Cox D. R., 1963, INDIAN J STAT A, V25, P5; COX RW, 1995, MAGNET RESON MED, V33, P230, DOI 10.1002/mrm.1910330213; CRYSTAL H, 1988, NEUROLOGY, V38, P1682, DOI 10.1212/WNL.38.11.1682; De SK, 2012, J STAT PLAN INFER, V142, P2059, DOI 10.1016/j.jspi.2012.02.005; Decharms RC, 2007, TRENDS COGN SCI, V11, P473, DOI 10.1016/j.tics.2007.08.014; Esiri MM, 2001, LANCET, V357, P169; Etzel JA, 2009, BRAIN RES, V1282, P114, DOI 10.1016/j.brainres.2009.05.090; Feng IJ, 2013, THESIS CASE W RESERV; Friston KJ, 2006, NEUROIMAGE, V30, P1077, DOI 10.1016/j.neuroimage.2005.08.012; Genovese CR, 2002, NEUROIMAGE, V15, P870, DOI 10.1006/nimg.2001.1037; Govindarajulu Zakkula, 2004, SEQUENTIAL STAT; HOLMAN BL, 1992, J NUCL MED, V33, P181; Jack AI, 2013, NEUROIMAGE, V66, P385, DOI 10.1016/j.neuroimage.2012.10.061; Jack AI, 2013, NEUROIMAGE, V79, P313, DOI 10.1016/j.neuroimage.2013.04.109; KATZMAN R, 1988, ANN NEUROL, V23, P138, DOI 10.1002/ana.410230206; Lazar NA, 2008, STAT BIOL HEALTH, P1, DOI 10.1007/978-0-387-78191-4_1; Li J.X., 2010, SEQUENTIAL PROBABILI; Magland JF, 2011, NEUROIMAGE, V55, P1044, DOI 10.1016/j.neuroimage.2010.12.085; Maus B, 2011, NEUROIMAGE, V56, P1338, DOI 10.1016/j.neuroimage.2011.03.019; Meyer FG, 2008, IEEE T MED IMAGING, V27, P87, DOI 10.1109/TMI.2007.903251; Morris JC, 1996, NEUROLOGY, V46, P707, DOI 10.1212/WNL.46.3.707; Mortimer JA, 2003, J CLIN EXP NEUROPSYC, V25, P671, DOI 10.1076/jcen.25.5.671.14584; Posse S, 2003, NEUROIMAGE, V18, P760, DOI 10.1016/S1053-8119(03)00004-1; Price JL, 1999, ANN NEUROL, V45, P358, DOI 10.1002/1531-8249(199903)45:3<358::AID-ANA12>3.0.CO;2-X; Purdon PL, 1998, HUM BRAIN MAPP, V6, P239, DOI 10.1002/(SICI)1097-0193(1998)6:4<239::AID-HBM4>3.3.CO;2-0; Richard S. J., 2004, HUMAN BRAIN FUNCTION; Saxe R, 2006, NEUROIMAGE, V30, P1088, DOI 10.1016/j.neuroimage.2005.12.062; Shah PK, 2009, J ECON ENTOMOL, V102, P1970, DOI 10.1603/029.102.0530; Stern Y, 2005, CEREB CORTEX, V15, P394, DOI 10.1093/cercor/bhh142; Stern Y, 2002, J INT NEUROPSYCH SOC, V8, P448, DOI 10.1017/S1355617702813248; Stern Y, 2007, COGNITIVE RESERVE TH; Stern Y, 2012, BRAIN RES, V1435, P130, DOI 10.1016/j.brainres.2011.11.061; Stern Y, 2009, NEUROPSYCHOLOGIA, V47, P2015, DOI 10.1016/j.neuropsychologia.2009.03.004; TANTARATANA S, 1977, INFORM SCIENCES, V13, P283, DOI 10.1016/0020-0255(77)90050-0; WALD A, 1948, ANN MATH STAT, V19, P326, DOI 10.1214/aoms/1177730197; Wald A., 1947, SEQUENTIAL ANAL; Weiskopf N, 2007, MAGN RESON IMAGING, V25, P989, DOI 10.1016/j.mri.2007.02.007; Yan CG, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005743; Zarahn E, 2007, NEUROBIOL AGING, V28, P784, DOI 10.1016/j.neurobiolaging.2006.03.002	46	5	5	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2015	10	3							e0117942	10.1371/journal.pone.0117942	http://dx.doi.org/10.1371/journal.pone.0117942			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9BN	25785856	Green Published, Green Submitted, gold			2022-12-27	WOS:000352138500019
J	Huang, XH; Leggas, M; Dickson, RC				Huang, Xinhe; Leggas, Markos; Dickson, Robert C.			Drug Synergy Drives Conserved Pathways to Increase Fission Yeast Lifespan	PLOS ONE			English	Article							ATF1 TRANSCRIPTION FACTOR; MAP KINASE PATHWAY; STRESS-RESPONSE; SCHIZOSACCHAROMYCES-POMBE; SEXUAL DEVELOPMENT; PROTEIN-KINASE; TORC1; EXTENDS; MTOR; METABOLISM	Aging occurs over time with gradual and progressive loss of physiological function. Strategies to reduce the rate of functional loss and mitigate the subsequent onset of deadly age-related diseases are being sought. We demonstrated previously that a combination of rapamycin and myriocin reduces age-related functional loss in the Baker's yeast Saccharomyces cerevisiae and produces a synergistic increase in lifespan. Here we show that the same drug combination also produces a synergistic increase in the lifespan of the fission yeast Schizosaccharomyces pombe and does so by controlling signal transduction pathways conserved across a wide evolutionary time span ranging from yeasts to mammals. Pathways include the target of rapamycin complex 1 (TORC1) protein kinase, the protein kinase A (PKA) and a stress response pathway, which in fission yeasts contains the Sty1 protein kinase, an ortholog of the mammalian p38 MAP kinase, a type of Stress Activated Protein Kinase (SAPK). These results along with previous studies in S. cerevisiae support the premise that the combination of rapamycin and myriocin enhances lifespan by regulating signaling pathways that couple nutrient and environmental conditions to cellular processes that fine-tune growth and stress protection in ways that foster long term survival. The molecular mechanisms for fine-tuning are probably species-specific, but since they are driven by conserved nutrient and stress sensing pathways, the drug combination may enhance survival in other organisms.	[Huang, Xinhe; Dickson, Robert C.] Univ Kentucky, Coll Med, Dept Mol & Cellular Biochem, Lexington, KY USA; [Huang, Xinhe; Dickson, Robert C.] Univ Kentucky, Coll Med, Lucille Markey Canc Ctr, Lexington, KY USA; [Leggas, Markos] Univ Kentucky, Coll Pharm, Dept Pharmaceut Sci, Lexington, KY USA; [Leggas, Markos] Univ Kentucky, Coll Pharm, Lucille Markey Canc Ctr, Lexington, KY USA	University of Kentucky; University of Kentucky; University of Kentucky; University of Kentucky	Huang, XH (corresponding author), Southwest Jiaotong Univ, Sch Life Sci & Engn, Chengdu, Peoples R China.	2196000@qq.com; bobd@uky.edu	Leggas, Markos/E-6618-2011	Leggas, Markos/0000-0003-4314-4533	NIH/NIA [AG024377]; National Institute of General Medical Sciences [P20GM103486]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103486] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG024377, R56AG024377] Funding Source: NIH RePORTER	NIH/NIA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This study was funded by the NIH/NIA grant AG024377 to RCD and by the National Institute of General Medical Sciences grant P20GM103486 to Louis Hersh. The funders had no role in the study design, data collection and analysis, decisions to publish, or preparation of the manuscript.	Bjedov I, 2011, BIOCHEM SOC T, V39, P460, DOI 10.1042/BST0390460; Blagosklonny MV, 2008, CELL CYCLE, V7, P3344, DOI 10.4161/cc.7.21.6965; Blagosklonny MV, 2011, AGING-US, V3, P1051, DOI 10.18632/aging.100411; Broach JR, 2012, GENETICS, V192, P73, DOI 10.1534/genetics.111.135731; Chen BR, 2009, EXP GERONTOL, V44, P493, DOI 10.1016/j.exger.2009.04.004; Chen DR, 2003, MOL BIOL CELL, V14, P214, DOI 10.1091/mbc.E02-08-0499; CHOU TC, 1984, ADV ENZYME REGUL, V22, P27, DOI 10.1016/0065-2571(84)90007-4; Conrad M, 2014, FEMS MICROBIOL REV, V38, P254, DOI 10.1111/1574-6976.12065; Cornu M, 2013, CURR OPIN GENET DEV, V23, P53, DOI 10.1016/j.gde.2012.12.005; Das J, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2003350; De Virgilio C, 2012, FEMS MICROBIOL REV, V36, P306, DOI 10.1111/j.1574-6976.2011.00287.x; Degols G, 1996, MOL CELL BIOL, V16, P2870; Enns LC, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005963; Fabrizio Paola, 2007, Methods Mol Biol, V371, P89; Fontana L, 2010, SCIENCE, V328, P321, DOI 10.1126/science.1172539; Gaits F, 1998, GENE DEV, V12, P1464, DOI 10.1101/gad.12.10.1464; Gems D, 2008, CELL METAB, V7, P200, DOI 10.1016/j.cmet.2008.01.001; Gems D, 2013, ANNU REV PHYSIOL, V75, P621, DOI 10.1146/annurev-physiol-030212-183712; GRECO WR, 1990, CANCER RES, V50, P5318; Harrison DE, 2009, NATURE, V460, P392, DOI 10.1038/nature08221; Heckman DS, 2001, SCIENCE, V293, P1129, DOI 10.1126/science.1061457; HOFFMAN CS, 1990, GENETICS, V124, P807; Huang XH, 2014, BBA-MOL CELL BIOL L, V1841, P657, DOI 10.1016/j.bbalip.2013.08.006; Huang XH, 2013, AGING CELL, V12, P652, DOI 10.1111/acel.12090; Huang XH, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002493; Hyman AA, 2012, SCIENCE, V337, P1047, DOI 10.1126/science.1223728; Jia K, 2004, DEVELOPMENT, V131, P3897, DOI 10.1242/dev.01255; Johnson SC, 2013, NATURE, V493, P338, DOI 10.1038/nature11861; Kapahi P, 2004, CURR BIOL, V14, P885, DOI 10.1016/j.cub.2004.03.059; Kato T, 1996, FEBS LETT, V378, P207, DOI 10.1016/0014-5793(95)01442-X; Kourtis N, 2011, EMBO J, V30, P2520, DOI 10.1038/emboj.2011.162; Laplante M, 2012, CELL, V149, P274, DOI 10.1016/j.cell.2012.03.017; Lawrence CL, 2007, J BIOL CHEM, V282, P5160, DOI 10.1074/jbc.M608526200; Lin SJ, 2002, NATURE, V418, P344, DOI 10.1038/nature00829; Liu J, 2013, AGING CELL, V12, P833, DOI 10.1111/acel.12107; Longo VD, 2003, EXP GERONTOL, V38, P807, DOI 10.1016/S0531-5565(03)00113-X; Lopez-Otin C, 2013, CELL, V153, P1194, DOI 10.1016/j.cell.2013.05.039; Maceyka M, 2012, TRENDS CELL BIOL, V22, P50, DOI 10.1016/j.tcb.2011.09.003; Magnuson B, 2012, BIOCHEM J, V441, P1, DOI 10.1042/BJ20110892; MILLAR JBA, 1995, GENE DEV, V9, P2117, DOI 10.1101/gad.9.17.2117; Morad SAF, 2013, NAT REV CANCER, V13, P51, DOI 10.1038/nrc3398; Mullen TD, 2012, BIOCHEM J, V441, P789, DOI 10.1042/BJ20111626; Nakashima A, 2012, J CELL SCI, V125, P5840, DOI 10.1242/jcs.111146; Ohtsuka H, 2008, FEMS YEAST RES, V8, P520, DOI 10.1111/j.1567-1364.2008.00379.x; Perez P, 2010, CURR PROTEIN PEPT SC, V11, P680, DOI 10.2174/138920310794557718; PLUMMER JL, 1990, J PHARMACOL METHOD, V23, P297, DOI 10.1016/0160-5402(90)90058-S; Powers RW, 2006, GENE DEV, V20, P174, DOI 10.1101/gad.1381406; Rallis C, 2014, BIOL OPEN, V3, P161, DOI 10.1242/bio.20147245; Rallis C, 2013, AGING CELL, V12, P563, DOI 10.1111/acel.12080; Roguev A, 2008, SCIENCE, V322, P405, DOI 10.1126/science.1162609; Rotolo J, 2012, J CLIN INVEST, V122, P1786, DOI 10.1172/JCI59920; Roux AE, 2006, AGING CELL, V5, P345, DOI 10.1111/j.1474-9726.2006.00225.x; Roux AE, 2010, J GERONTOL A-BIOL, V65, P1, DOI 10.1093/gerona/glp152; Roux AE, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000408; Sanso M, 2011, MOL MICROBIOL, V82, P542, DOI 10.1111/j.1365-2958.2011.07851.x; Selman C, 2009, SCIENCE, V326, P140, DOI 10.1126/science.1177221; SHIOZAKI K, 1995, NATURE, V378, P739, DOI 10.1038/378739a0; Shiozaki K, 1996, GENE DEV, V10, P2276, DOI 10.1101/gad.10.18.2276; Sipiczki M, 2000, GENOME BIOL, V1, DOI [10.1186/gb-2000-1-2-reviews1011, DOI 10.1186/GB-2000-1-2-REVIEWS1011]; Swinnen E, 2014, FEMS YEAST RES, V14, P17, DOI 10.1111/1567-1364.12097; Takahara T, 2012, GENES CELLS, V17, P698, DOI 10.1111/j.1365-2443.2012.01618.x; Takeda T, 1995, EMBO J, V14, P6193, DOI 10.1002/j.1460-2075.1995.tb00310.x; Urban J, 2007, MOL CELL, V26, P663, DOI 10.1016/j.molcel.2007.04.020; Vellai T, 2003, NATURE, V426, P620, DOI 10.1038/426620a; Wanke V, 2008, MOL MICROBIOL, V69, P277, DOI 10.1111/j.1365-2958.2008.06292.x; Wilkinson MG, 1996, GENE DEV, V10, P2289, DOI 10.1101/gad.10.18.2289; Wullschleger S, 2006, CELL, V124, P471, DOI 10.1016/j.cell.2006.01.016; Xu YX, 2014, TRENDS BIOCHEM SCI, V39, P268, DOI 10.1016/j.tibs.2014.04.004; Yanagida M, 2009, TRENDS CELL BIOL, V19, P705, DOI 10.1016/j.tcb.2009.09.006; Yun J, 2014, CELL METAB, V19, P757, DOI 10.1016/j.cmet.2014.01.011; Zuin A, 2010, EMBO J, V29, P981, DOI 10.1038/emboj.2009.407	71	9	9	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2015	10	3							e0121877	10.1371/journal.pone.0121877	http://dx.doi.org/10.1371/journal.pone.0121877			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9BN	25786258	Green Submitted, Green Published, gold			2022-12-27	WOS:000352138500217
J	Janbaz, KH; Ahsan, MZ; Saqib, F; Imran, I; Zia-Ul-Haq, M; Rashid, MA; Jaafar, HZE; Moga, M				Janbaz, Khalid Hussain; Ahsan, Muhammad Zaeem; Saqib, Fatima; Imran, Imran; Zia-Ul-Haq, Muhammad; Rashid, Muhammad Abid; Jaafar, Hawa Z. E.; Moga, Marius			Scientific Basis for Use of Pyrus pashia Buch.-Ham. ex D. Don. Fruit in Gastrointestinal, Respiratory and Cardiovascular Ailments	PLOS ONE			English	Article							PHENOLIC-COMPOUNDS; MEDICINAL-PLANTS; IN-VITRO; PHARMACOLOGICAL BASIS; ANTIOXIDANT; CALCIUM; BRONCHODILATOR; COMMUNITIES; DISTRICT; EXTRACT	Background Pyrus pashia Buch.-Ham. ex D. Don. has been used conventionally by many communities in the Himalayan region for the management of gastrointestinal, respiratory, and vascular complications. Set against this background, this study was carried out to justify the scientific basis to validate folkloric uses of fruits of Pyrus pashia Buch.-Ham. ex D. Don. (Pp.Cr) in traditional systems of medicine. Methods The crude ethanol extract of fruits of Pyrus pashia Buch.-Ham. ex D. Don. (Pp.Cr) was tested in vitro on isolated rabbit jejunum, tracheal, and aorta preparations. The responses of tissues were recorded using isotonic transducers coupled with a PowerLab data acquisition system. Results The Pp.Cr on application (0.01-5.0 mg/ml) to isolated rabbit jejunum preparation exhibited relaxation through decrease in magnitude and frequency of spontaneous contractions. The Pp.Cr also exerted a relaxant (0.01-5.0 mg/ml) effect on K+(80 mM) induced contractions in isolated rabbit jejunum preparations and caused shifting of the Ca2+ curves (1.0-3.0 mg/ml) toward right in a manner similar to that of verapamil (3 mu M), possibly suggesting presence of Ca2+ channel blocking activity. Subsequently, Pp.Cr in a concentration-dependent fashion (0.01-10.0 mg/ml) caused relaxation of CCh (1 mu M) and K+ (80 mM) induced contractions in isolated rabbit tracheal preparations in a manner comparable to that of dicyclomine, suggesting that the observed relaxant effect is likely to be mediated through antimuscarinic and/or Ca2+ channel blocking activities. Moreover, when evaluated against isolated rabbit aortic preparations, the Pp.Cr in concentrations up to 10 mg/ml exhibited a contractile response that was found to be abolished subsequent to pretreatment of isolated tissue preparation with cyproheptadine (1 mu M), phentolamine (1 mu M), and losartan (1 mu M), suggesting that Pp.Cr may have some alpha-adrenergic, muscarinic, serotonergic, and angiotensin II activities. Conclusions The aqueous ethanolic extract of Pyrus pashia (Pp.Cr) exhibited spasmolytic, bronchodilator, and vaso-constrictive activities possibly through different mechanisms. The spasmolytic and bronchodilator activities are likely to be mediated through blockade of Ca2+ channels, while vasoconstrictive activity may be due to presence of a alpha-adrenergic, muscarinic, serotonergic, and angiotensin II agonistic component.	[Janbaz, Khalid Hussain; Ahsan, Muhammad Zaeem; Saqib, Fatima; Imran, Imran] Bahauddin Zakariya Univ, Fac Pharm, Multan, Pakistan; [Zia-Ul-Haq, Muhammad] Patent Off, Karachi, Pakistan; [Rashid, Muhammad Abid] Univ Agr Faisalabad, Dept Chem & Biochem, Faisalabad, Pakistan; [Jaafar, Hawa Z. E.] Fac Agr, Dept Crop Sci, Selangor, Malaysia; [Moga, Marius] Transilvania Univ Brasov, Dept Med, Brasov, Romania	Bahauddin Zakariya University; University of Agriculture Faisalabad; Universiti Putra Malaysia; Transylvania University of Brasov	Zia-Ul-Haq, M (corresponding author), Patent Off, Karachi, Pakistan.	ahirzia@gmail.com; hawazej@gmail.com	Ahsan, Muhammad Zaeem/GRF-3151-2022; Rashid, Muhammad Abid/G-8109-2015; Janbaz, Khalid Hussain/L-2426-2015; MOGA, MARIUS ALEXANDRU/AHC-2310-2022; Imran, Imran/AAL-5734-2020; Rashid, Muhammad Abid/C-2800-2015; Zia-Ul-Haq, Muhammad/J-1798-2015	Ahsan, Muhammad Zaeem/0000-0002-7367-3818; Imran, Imran/0000-0003-1337-8574; Rashid, Muhammad Abid/0000-0002-3053-2767; saqib, fatima/0000-0001-6242-7147				Abbasi AM, 2013, J ETHNOPHARMACOL, V148, P528, DOI 10.1016/j.jep.2013.04.050; Ahmad Z, 2007, COUNTRY REPORT PLANT; BOLTON TB, 1979, PHYSIOL REV, V59, P606, DOI 10.1152/physrev.1979.59.3.606; BRADING AF, 1980, BRIT J PHARMACOL, V70, P229, DOI 10.1111/j.1476-5381.1980.tb07928.x; CHALLICE JS, 1968, PHYTOCHEMISTRY, V7, P1781, DOI 10.1016/S0031-9422(00)86651-0; CHAMBERS R., 1979, J ETHNOPHARMACOL, V10, P1, DOI DOI 10.1016/0378-8741(79)90013-8; Chaudhary MA, 2012, BMC COMPLEM ALTERN M, V12, DOI 10.1186/1472-6882-12-166; Council NR, 2010, GUIDE CARE USE LAB A, DOI 10.17226/5140; Farooquee Nehal A., 2004, Journal of Human Ecology, V16, P33; FARRE AJ, 1991, GEN PHARMACOL, V22, P177, DOI 10.1016/0306-3623(91)90331-Y; FLECKENSTEIN A, 1977, ANNU REV PHARMACOL, V17, P149, DOI 10.1146/annurev.pa.17.040177.001053; Gilani AH, 2005, LIFE SCI, V76, P3089, DOI 10.1016/j.lfs.2004.12.021; Gilani SN, 2010, PHYTOTHER RES, V24, P553, DOI 10.1002/ptr.2979; GODFRAIND T, 1986, PHARMACOL REV, V38, P321; Guven K, 2006, PHARM BIOL, V44, P79, DOI 10.1080/13880200600591253; Hussein FTK, 1983, MED PLANTS LIBYA, P7; Janbaz KH, 2013, J PHYSIOL PHARMACOL, V64, P479; Janbaz KH, 2014, BMC COMPLEM ALTERN M, V14, DOI 10.1186/1472-6882-14-71; Janbaz Khalid Hussain, 2012, Evid Based Complement Alternat Med, V2012, P735653, DOI 10.1155/2012/735653; Jiangsu New Medical College, 1986, DICT CHIN TRAD MED; JOSHI AR, 1990, ECON BOT, V44, P71, DOI 10.1007/BF02861069; Kala CP, 2002, MED PLANTS INDIAN TR; Karaki H, 1997, PHARMACOL REV, V49, P157; KARAKI H, 1988, LIFE SCI, V42, P111, DOI 10.1016/0024-3205(88)90674-1; Khandelwal R, 2008, ORIENT J CHEM, V24, P773; Lama Y C, 2001, MED PLANTS DOLPO AMC; MAGA JA, 1978, CRC CR REV FOOD SCI, V10, P323, DOI 10.1080/10408397809527255; Main A., 2001, PAK J BIOL SCI, V4, P1101, DOI DOI 10.3923/pjbs.2001.1101.1107; MANANDHAR N P, 1990, International Journal of Crude Drug Research, V28, P17; Manandhar Narayan P., 1994, Fitoterapia, V65, P7; MANANDHAR NP, 1995, J ETHNOPHARMACOL, V48, P1, DOI 10.1016/0378-8741(95)01269-J; Meyers KJ, 2003, J AGR FOOD CHEM, V51, P6887, DOI 10.1021/jf034506n; Nakul Chettri, 2005, Lyonia, V8, P89; Nassar MI, 2011, CARBOHYD RES, V346, P64, DOI 10.1016/j.carres.2010.11.007; Prajapati N.D, 2003, PLANT PHYSL FUNDAMEN, P1; Saklani S, 2012, INT J PHARM SCI RES, V3, P268, DOI 10.13040/IJPSR.0975-8232.3(1).268-72; Sarla Saklani, 2012, Journal of Pharmacy Research, V5, P3030; Shinwari M.I., 1998, HAMDARD MED, V42, P5; Shrestha PM, 2003, J ETHNOPHARMACOL, V86, P81, DOI 10.1016/S0378-8741(03)00051-5; Shui GH, 2002, J CHROMATOGR A, V977, P89, DOI 10.1016/S0021-9673(02)01345-6; SINGH MP, 1979, ECON BOT, V33, P185, DOI 10.1007/BF02858287; Thapa B, 1997, ANIM FEED SCI TECH, V67, P97, DOI 10.1016/S0377-8401(96)01129-7; Tona L, 1998, J ETHNOPHARMACOL, V61, P57, DOI 10.1016/S0378-8741(98)00015-4; Tsering J, 2012, INT J PHARM SCI RES, V3, P2721, DOI 10.13040/IJPSR.0975-8232.3(8).2721-25; VAN ROSSUM J. M., 1963, ARCH INTERNATL PHARMACODYN ET THER, V143, P299; Zia-Ul-Haq M, 2013, OXID COMMUN, V36, P15; Zia-Ul-Haq M, 2014, BIOL RES, V47, DOI 10.1186/0717-6287-47-23; Zia-Ul-Haq M, 2013, ACTA BOT CROAT, V72, P133, DOI 10.2478/v10184-012-0005-9; Zia-Ul-Haq M, 2013, TURK J BIOL, V37, P25, DOI 10.3906/biy-1204-38; Zia-Ul-Haq M, 2013, PAK J PHARM SCI, V26, P185; Zia-Ul-Haq M, 2013, MOLECULES, V18, P2005, DOI 10.3390/molecules18022005	51	27	27	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2015	10	3							e0118605	10.1371/journal.pone.0118605	http://dx.doi.org/10.1371/journal.pone.0118605			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9BN	25786248	Green Published, Green Submitted, gold			2022-12-27	WOS:000352138500040
J	Kraemer, MMS; Kraemer, AS; Stebner, F; Bickel, DJ; Rust, J				Kraemer, Monica M. Solorzano; Kraemer, Atahualpa S.; Stebner, Frauke; Bickel, Daniel J.; Rust, Jes			Entrapment Bias of Arthropods in Miocene Amber Revealed by Trapping Experiments in a Tropical Forest in Chiapas, Mexico	PLOS ONE			English	Article							DOMINICAN-REPUBLIC AMBER; FOSSIL PSYCHODIDAE; BODY-SIZE; TAPHONOMY; EVOLUTION; DIPTERA; RESIN; CAESALPINIOIDEAE; PALEOECOLOGY; PRESERVATION	All entomological traps have a capturing bias, and amber, viewed as a trap, is no exception. Thus the fauna trapped in amber does not represent the total existing fauna of the former amber forest, rather the fauna living in and around the resin producing tree. In this paper we compare arthropods from a forest very similar to the reconstruction of the Miocene Mexican amber forest, and determine the bias of different trapping methods, including amber. We also show, using cluster analyses, measurements of the trapped arthropods, and guild distribution, that the amber trap is a complex entomological trap not comparable with a single artificial trap. At the order level, the most similar trap to amber is the sticky trap. However, in the case of Diptera, at the family level, the Malaise trap is also very similar to amber. Amber captured a higher diversity of arthropods than each of the artificial traps, based on our study of Mexican amber from the Middle Miocene, a time of climate optimum, where temperature and humidity were probably higher than in modern Central America. We conclude that the size bias is qualitatively independent of the kind of trap for non-extreme values. We suggest that frequent specimens in amber were not necessarily the most frequent arthropods in the former amber forest. Selected taxa with higher numbers of specimens appear in amber because of their ecology and behavior, usually closely related with a tree-inhabiting life. Finally, changes of diversity from the Middle Miocene to Recent time in Central and South America can be analyzed by comparing the rich amber faunas from Mexico and the Dominican Republic with the fauna trapped using sticky and Malaise traps in Central America.	[Kraemer, Monica M. Solorzano; Stebner, Frauke; Rust, Jes] Univ Bonn, Steinmann Inst Geol Mineral & Palaontol, Bonn, Germany; [Kraemer, Atahualpa S.] Univ Nacl Autonoma Mexico, Dept Fis, Fac Ciencias, Mexico City 04510, DF, Mexico; [Kraemer, Monica M. Solorzano] Senckenberg Forschungsinst & Nat Museum, Frankfurt, Germany; [Bickel, Daniel J.] Australian Museum, Sydney, NSW 2010, Australia	University of Bonn; Universidad Nacional Autonoma de Mexico; Senckenberg Gesellschaft fur Naturforschung (SGN); Australian Museum	Kraemer, MMS (corresponding author), Univ Bonn, Steinmann Inst Geol Mineral & Palaontol, Bonn, Germany.	monica.solorzano-kraemer@senckenberg.de	Kraemer, Atahualpa Solórzano/GQQ-2931-2022	Kraemer, Atahualpa/0000-0001-8146-2124; Solorzano Kraemer, Monica Morayma/0000-0003-3065-119X	German Research Foundation (DFG) [SO894/3-1]; Spanish Ministry of Economy and Competitiveness [GL2011-23948 AMBARES]	German Research Foundation (DFG)(German Research Foundation (DFG)); Spanish Ministry of Economy and Competitiveness(Spanish Government)	This research was possible thanks to a postdoctoral fellowship awarded to M.M.S.K., No. SO894/3-1 from the German Research Foundation (DFG) and the Spanish Ministry of Economy and Competitiveness GL2011-23948 AMBARES 2012-2014. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Becerra JX, 2005, P NATL ACAD SCI USA, V102, P10919, DOI 10.1073/pnas.0409127102; Bickel D.J., 2009, MANUAL CENTRAL AM DI, V1, P671; Bickel DJ, 2004, CONSERVATION OF AUTRALIA'S, SECOND EDITION, P888; BISHOP JE, 1969, ECOLOGY, V50, P371, DOI 10.2307/1933885; BLACKBURN TM, 1994, TRENDS ECOL EVOL, V9, P471, DOI 10.1016/0169-5347(94)90311-5; Breedlove D. E., 1986, LISTADOS FLORISTICOS; Breton G, 2014, B SOC GEOL MEX, V66, P199, DOI 10.18268/BSGM2014v66n1a14; BROWN JH, 1993, AM NAT, V142, P573, DOI 10.1086/285558; Brues CT, 1933, AM NAT, V67, P385, DOI 10.1086/280501; Carabias Lillo J, 1999, PRORAMA MANEJO RESER; Coty D, 2013, INSECT EVOLUTION IN AN AMBERIFEROUS AND STONE ALPHABET, P13; Perrilliat MD, 2010, J S AM EARTH SCI, V30, P111, DOI 10.1016/j.jsames.2010.04.005; dos Santos BB, 2010, ACTA BOT BRAS, V24, P243, DOI 10.1590/S0102-33062010000100026; DUNLOP J. A., 2008, REV IBERICA ARACNOLO, V15, P9; Duran-Ruiz C, 2013, CAN J EARTH SCI, V50, P495, DOI 10.1139/cjes-2012-0166; Evenhuis N.L., 1994, CATALOGUE FOSSIL FLI; FEARNSIDE PM, 1989, BIOSCIENCE, V39, P387, DOI 10.2307/1311068; Graham A, 1999, AM J BOT, V86, P17, DOI 10.2307/2656951; Grimaldi DA., 1996, AMBER WINDOW; Grimaldi David, 2005, pi; Grund M, 2006, THESIS U BONN; Grund M, 2006, PALAEOGEOGR PALAEOCL, V241, P410, DOI 10.1016/j.palaeo.2006.04.005; HENWOOD AA, 1993, LETHAIA, V26, P237, DOI 10.1111/j.1502-3931.1993.tb01525.x; Henwood Alison, 1993, Modern Geology, V19, P35; Hoffeins Christel, 2004, Studia Dipterologica, V10, P381; Hopkin S.P., 1997, BIOL SPRINGTAILS INS; IturraldeVinent MA, 1996, SCIENCE, V273, P1850, DOI 10.1126/science.273.5283.1850; Jaramillo C, 2006, SCIENCE, V311, P1893, DOI 10.1126/science.1121380; Kaandorp RJG, 2005, PALAEOGEOGR PALAEOCL, V221, P1, DOI 10.1016/j.palaeo.2004.12.024; Kraemer MMS, 2007, PALAEONTOGR ABT A, V282, P1; Krebs C.J., 1999, ECOLOGICAL METHODOLO; Kurschner WM, 2008, P NATL ACAD SCI USA, V105, P449, DOI 10.1073/pnas.0708588105; LANGENHEIM JH, 1974, BRITTONIA, V26, P3, DOI 10.2307/2805914; LANGENHEIM JH, 1967, J ARNOLD ARBORETUM, V48, P203; LANGENHEIM JH, 1979, BIOCHEM SYST ECOL, V7, P21, DOI 10.1016/0305-1978(79)90036-X; Larsson SG., 1978, BALTIC AMBER PALAEOB; Martinez-Delclos X, 2004, PALAEOGEOGR PALAEOCL, V203, P19, DOI 10.1016/S0031-0182(03)00643-6; Martinez-Hernandez E., 1992, INSTITUTO GEOLOG IA, V10, P54; McKay WAB, 2013, PLANT PHYSIOL, V133, P368; Meades L, 2002, AUSTRAL ECOL, V27, P451, DOI 10.1046/j.1442-9993.2002.01199.x; Medeiros LCD, 1999, STUD NEOTROP FAUNA E, V34, P76, DOI 10.1076/snfe.34.2.76.2103; MENESESROCHA JJ, 2001, AAPG MEMOIR, V75, P183; MORAN VC, 1982, J ANIM ECOL, V51, P289, DOI 10.2307/4325; Penney D, 2005, PALAEOGEOGR PALAEOCL, V223, P1, DOI 10.1016/j.palaeo.2005.03.022; Penney D, 2002, PALEOBIOLOGY, V28, P389, DOI 10.1666/0094-8373(2002)028<0389:PODAPS>2.0.CO;2; Penney D, 2006, BIOL LETTERS, V2, P266, DOI 10.1098/rsbl.2006.0442; Penney David, 2010, P22; Perrichot Vincent, 2010, P192; PIKE EM, 1993, PALAIOS, V8, P411, DOI 10.2307/3515016; Poinar G, 2002, BOT J LINN SOC, V139, P125, DOI 10.1046/j.1095-8339.2002.00053.x; Poinar GO., 1992, LIFE AMBER; Poinar Jr. G.O., 1999, AMBER FOREST; Poinar R, 1994, QUEST LIFE AMBER; QUATE LW, 1961, J PALEONTOL, V35, P949; QUATE LW, 1963, J PALEONTOL, V37, P110; Ragazzi E., 2011, ENCY GEOBIOLOGY, P24, DOI [DOI 10.1007/978-1-4020-9212-1_9, 10.1007/978-1-4020-9212-1_9]; Solorzano Kraemer Monica M., 2010, P42; Sontag Elzbieta, 2003, Acta Zoologica Cracoviensia, V46, P431; Stebner F, 2014, PALAEONTO A IN PRESS; Tappert R, 2013, GEOCHIM COSMOCHIM AC, V121, P240, DOI 10.1016/j.gca.2013.07.011; Thien LB, 2000, INT J PLANT SCI, V161, pS225, DOI 10.1086/317575; Wichard W, 2009, WASSERINSEKTEN BALTI; Wilf P, 2005, P NATL ACAD SCI USA, V102, P8944, DOI 10.1073/pnas.0500516102; Willis KJ, 2006, SCIENCE, V314, P1261, DOI 10.1126/science.1122667; Zherikhin VV, 2009, PALEONTOL J+, V43, P987, DOI 10.1134/S0031030109090019	65	46	47	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2015	10	3							e0118820	10.1371/journal.pone.0118820	http://dx.doi.org/10.1371/journal.pone.0118820			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9BN	25785584	Green Submitted, Green Published, gold			2022-12-27	WOS:000352138500050
J	Lu, MS; Fang, YJ; Pan, ZZ; Zhong, X; Zheng, MC; Chen, YM; Zhang, CX				Lu, Min-Shan; Fang, Yu-Jing; Pan, Zhi-Zhong; Zhong, Xiao; Zheng, Mei-Chun; Chen, Yu-Ming; Zhang, Cai-Xia			Choline and Betaine Intake and Colorectal Cancer Risk in Chinese Population: A Case-Control Study	PLOS ONE			English	Article							BREAST-CANCER; DNA METHYLATION; WOMEN; NUTRIENT; ADULTS; MEN	Background Few studies have examined the association of choline and betaine intake with colorectal cancer risk, although they might play an important role in colorectal cancer development because of their role as methyl donors. The aim of this study was to examine the relationship between consumption of choline and betaine and colorectal cancer risk in a Chinese population. Methodology/Principal Findings A case-control study was conducted between July 2010 and December 2013 in Guangzhou, China. Eight hundred and ninety consecutively recruited colorectal cancer cases were frequency matched to 890 controls by age (5-year interval) and sex. Dietary information was assessed with a validated food frequency questionnaire by face-to-face interviews. The logistic regression model was used to estimate multivariate odds ratios (ORs) and 95% confidence intervals (CIs). Total choline intake was inversely associated with colorectal cancer risk after adjustment for various lifestyle and dietary factors. The multivariate-adjusted OR was 0.54 (95% CI = 0.37-0.80, Ptrend <0.01) comparing the highest with the lowest quartile. No significant associations were observed for betaine or total choline+betaine intakes. For choline-containing compounds, lower colorectal cancer risk was associated with higher intakes of choline from phosphatidylcholine, glycerophosphocholine and sphingomyelin but not for free choline and phosphocholine. The inverse association of total choline intake with colorectal cancer risk was observed in both men and women, colon and rectal cancer. These inverse associations were not modified by folate intake. Conclusions These results indicate that high intake of total choline is associated with a lower risk of colorectal cancer.	[Lu, Min-Shan; Zhong, Xiao; Chen, Yu-Ming; Zhang, Cai-Xia] Sun Yat Sen Univ, Sch Publ Hlth, Dept Med Stat & Epidemiol, Guangzhou 510275, Guangdong, Peoples R China; [Fang, Yu-Jing; Pan, Zhi-Zhong] Sun Yat Sen Univ, Ctr Canc, State Key Lab Oncol South China, Collaborat Innovat Ctr Canc Med, Guangzhou 510275, Guangdong, Peoples R China; [Zheng, Mei-Chun] Sun Yat Sen Univ, Ctr Canc, Dept Colorectal Surg, Guangzhou 510275, Guangdong, Peoples R China	Sun Yat Sen University; State Key Lab Oncology South China; Sun Yat Sen University; Sun Yat Sen University	Chen, YM (corresponding author), Sun Yat Sen Univ, Sch Publ Hlth, Dept Med Stat & Epidemiol, Guangzhou 510275, Guangdong, Peoples R China.	chenyum@mail.sysu.edu.cn; zhangcx3@mail.sysu.edu.cn	Chen, Yu/Y-3292-2019; Chen, Yi/HIR-2608-2022	chen, Yu-ming/0000-0003-1658-5528	Sun Yat-sen University [51000-3181301]; Danone Nutrition Research and Education Foundation [DIC2011-03]	Sun Yat-sen University; Danone Nutrition Research and Education Foundation(Danone Nutricia)	This study was jointly supported by the Sun Yat-sen University Hundred Talents Program (51000-3181301) and Danone Nutrition Research and Education Foundation (No: DIC2011-03). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cho E, 2010, BRIT J CANCER, V102, P489, DOI 10.1038/sj.bjc.6605510; Cho E, 2008, CANCER EPIDEM BIOMAR, V16, P2787; Cho E, 2007, JNCI-J NATL CANCER I, V99, P1224, DOI 10.1093/jnci/djm082; Dai Zhen, 2012, Zhonghua Yu Fang Yi Xue Za Zhi, V46, P598; Davis CD, 2004, EXP BIOL MED, V229, P988, DOI 10.1177/153537020422901002; Jacob RA, 1999, J NUTR, V129, P712, DOI 10.1093/jn/129.3.712; Kondo Y, 2010, EXPERT REV MOL MED, V12, DOI 10.1017/S1462399410001559; Kotsopoulos J, 2010, EUR J CLIN NUTR, V64, P111, DOI 10.1038/ejcn.2009.109; LAIRD PW, 1994, HUM MOL GENET, V3, P1487, DOI 10.1093/hmg/3.suppl_1.1487; Lee JE, 2011, AM J CLIN NUTR, V93, P817, DOI 10.3945/ajcn.110.007781; Lee JE, 2010, CANCER EPIDEM BIOMAR, V19, P884, DOI 10.1158/1055-9965.EPI-09-1295; MacDonald HM, 2005, PUBLIC HEALTH NUTR, V8, P409, DOI 10.1079/PHN2005705; Richman EL, 2012, AM J CLIN NUTR, V96, P855, DOI 10.3945/ajcn.112.039784; Wan D, 2001, GUANGDONG MED J, V07, P557; Willett WC, 1997, AM J CLIN NUTR, V65, P1220, DOI 10.1093/ajcn/65.4.1220S; Xu An-gao, 2006, Zhonghua Yi Xue Za Zhi, V86, P272; Xu XR, 2008, FASEB J, V22, P2045, DOI 10.1096/fj.07-101279; Yang Y., 2002, CHINA FOOD COMPOSITI, V2002nd ed.; Ying J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054561; ZEISEL SH, 1994, ANNU REV NUTR, V14, P269, DOI 10.1146/annurev.nu.14.070194.001413; Zeisel SH, 2003, J NUTR, V133, P2918; Zeisel SH, 2003, J NUTR, V133, P1302; Zeisel SH, 2009, NUTR REV, V67, P615, DOI 10.1111/j.1753-4887.2009.00246.x; Zeng FF, 2014, BRIT J CANCER, V110, P808, DOI 10.1038/bjc.2013.686; Zhang CX, 2013, CANCER SCI, V104, P250, DOI 10.1111/cas.12064; Zhang CX, 2009, ASIA PAC J CLIN NUTR, V18, P240; Zhong X, 2013, EUR J CANCER PREV, V22, P438, DOI 10.1097/CEJ.0b013e32835e88c4	27	21	24	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2015	10	3							e0118661	10.1371/journal.pone.0118661	http://dx.doi.org/10.1371/journal.pone.0118661			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9BN	25785727	Green Submitted, gold, Green Published			2022-12-27	WOS:000352138500043
J	Medina-Trillo, C; Sanchez-Sanchez, F; Aroca-Aguilar, JD; Ferre-Fernandez, JJ; Morales, L; Mendez-Hernandez, CD; Blanco-Kelly, F; Ayuso, C; Garcia-Feijoo, J; Escribano, J				Medina-Trillo, Cristina; Sanchez-Sanchez, Francisco; Aroca-Aguilar, Jose-Daniel; Ferre-Fernandez, Jesus-Jose; Morales, Laura; Mendez-Hernandez, Carmen-Dora; Blanco-Kelly, Fiona; Ayuso, Carmen; Garcia-Feijoo, Julian; Escribano, Julio			Hypo-and Hypermorphic FOXC1 Mutations in Dominant Glaucoma: Transactivation and Phenotypic Variability	PLOS ONE			English	Article							PRIMARY OPEN-ANGLE; PRIMARY CONGENITAL GLAUCOMA; FORKHEAD/WINGED-HELIX GENE; AXENFELD-RIEGER-SYNDROME; ANTERIOR-CHAMBER; FUNCTIONAL ANALYSES; CYTOCHROME P4501B1; MISSENSE MUTATIONS; SPANISH PATIENTS; CYP1B1	Dominant glaucoma, a heterogeneous, infrequent and irreversible optic neuropathy, is often associated with elevated intraocular pressure and early-onset. The role of FOXC1 in this type of glaucoma was investigated in twelve Spanish probands via nucleotide variation screening of its proximal promoter and unique exon. Functional evaluations of the identified variants included analyses of the transcriptional activity, protein stability, DNA binding ability and subcellular localization. Four different mutations that were identified in four probands (33.3%) were associated with remarkable phenotypic variability and were functionally classified as either hypermorphic (p.Y47X, p.Q106X and p.G447_G448insDG) or hypomorphic (p.I126S) alleles. To the best of our knowledge, three of the variants are novel (p.Y47X, p.I126S and p.G447_G448insDG) and, in addition, hypermorphic FOXC1 mutations are reported herein for the first time. The presence of an intact N-terminal activation domain in the truncated proteins p.Y47X and p.Q106X may underlie their associated transactivation hyperactivity by a gain-of-function mechanism involving dysregulated protein-protein interactions. Similarly, alteredmolecular interactionsmay also lead to increased p.G447_G448insDG activity. In contrast, the partial loss-of-function associated with p.I126S was due to impaired protein stability, DNA binding, protein phosphorylation and subcellular distribution. These results support that moderate and variable FOXC1 transactivation changes are associated with moderate goniodysgenesis, dominant glaucoma and remarkable phenotypic variability.	[Medina-Trillo, Cristina; Sanchez-Sanchez, Francisco; Aroca-Aguilar, Jose-Daniel; Ferre-Fernandez, Jesus-Jose; Escribano, Julio] Univ Castilla La Mancha, Fac Med, Area Genet, Albacete, Spain; [Medina-Trillo, Cristina; Sanchez-Sanchez, Francisco; Aroca-Aguilar, Jose-Daniel; Escribano, Julio] Inst Salud Carlos III, Cooperat Res Network Age Related Ocular Pathol Vi, Madrid, Spain; [Morales, Laura; Mendez-Hernandez, Carmen-Dora; Garcia-Feijoo, Julian] Hosp Clin San Carlos, Serv Oftalmol, Madrid, Spain; [Morales, Laura; Mendez-Hernandez, Carmen-Dora; Garcia-Feijoo, Julian] Hosp Clin San Carlos, Inst Invest Sanitaria, Madrid, Spain; [Blanco-Kelly, Fiona; Ayuso, Carmen] IIS FJD, Serv Genet, Madrid, Spain; [Blanco-Kelly, Fiona; Ayuso, Carmen] CIBERER, Madrid, Spain	Universidad de Castilla-La Mancha; Instituto de Salud Carlos III; Hospital Clinico San Carlos; Hospital Clinico San Carlos; Fundacion Jimenez Diaz; CIBER - Centro de Investigacion Biomedica en Red; CIBERER	Escribano, J (corresponding author), Univ Castilla La Mancha, Fac Med, Area Genet, Albacete, Spain.	julio.escribano@uclm.es	Mendez-Hernandez, Carmen/D-6385-2017; Fernandez, Jesus J Ferre/AAA-3760-2021; Escribano, Julio/D-9742-2015; Aroca-Aguilar, Jose Daniel/R-5513-2019; Aroca-Aguilar, J.Daniel/B-7842-2008; , francisco/ABF-7718-2021; GARCIA FEIJOO, JULIAN/G-9762-2017	Mendez-Hernandez, Carmen/0000-0003-3413-5248; Fernandez, Jesus J Ferre/0000-0002-9511-2894; Escribano, Julio/0000-0002-8919-8134; Aroca-Aguilar, Jose Daniel/0000-0001-6487-1612; Aroca-Aguilar, J.Daniel/0000-0001-6487-1612; Blanco-Kelly, Fiona/0000-0003-0052-5651; Ayuso, Carmen/0000-0002-9242-7065; GARCIA FEIJOO, JULIAN/0000-0002-7772-5718	Regional Ministry of Health [GCS-2006_C/12]; Regional Ministry of Science and Technology of the Board of the Communities of "Castilla-La Mancha" [PAI-05-002, PCI08-0036]; Instituto de Salud Carlos III [RD07/0062/0014, RD12/0034/0003, PI11/00662]	Regional Ministry of Health; Regional Ministry of Science and Technology of the Board of the Communities of "Castilla-La Mancha"; Instituto de Salud Carlos III(Instituto de Salud Carlos IIIEuropean Commission)	This study has been supported by research grants from the Regional Ministry of Health (GCS-2006_C/12), the Regional Ministry of Science and Technology of the Board of the Communities of "Castilla-La Mancha" (PAI-05-002 and PCI08-0036), and the "Instituto de Salud Carlos III" (RD07/0062/0014, RD12/0034/0003 and PI11/00662). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali M, 2009, AM J HUM GENET, V84, P664, DOI 10.1016/j.ajhg.2009.03.017; Aroca-Aguilar JD, 2005, J BIOL CHEM, V280, P21043, DOI 10.1074/jbc.M501340200; Bagiyeva S, 2007, MOL VIS, V13, P1458; Bejjani BA, 1998, AM J HUM GENET, V62, P325, DOI 10.1086/301725; Berry FB, 2006, HUM MOL GENET, V15, P905, DOI 10.1093/hmg/ddl008; Berry FB, 2002, J BIOL CHEM, V277, P10292, DOI 10.1074/jbc.M110266200; Campos-Mollo E, 2009, MOL VIS, V15, P417; Chakrabarti S, 2005, MOL VIS, V11, P111; Chakrabarti S, 2009, INVEST OPHTH VIS SCI, V50, P75, DOI 10.1167/iovs.08-2253; D'haene B, 2011, INVEST OPHTH VIS SCI, V52, P324, DOI 10.1167/iovs.10-5309; Hayashi H, 2008, BIOCHEM BIOPH RES CO, V367, P584, DOI 10.1016/j.bbrc.2007.12.183; JERNDAL T, 1983, AM J HUM GENET, V35, P645; Kaur K, 2005, CLIN GENET, V67, P335, DOI 10.1111/j.1399-0004.2005.00411.x; Kidson SH, 1999, DEV BIOL, V211, P306, DOI 10.1006/dbio.1999.9314; Komatireddy S, 2003, MOL VIS, V9, P43; Kume T, 1998, CELL, V93, P985, DOI 10.1016/S0092-8674(00)81204-0; Lehmann OJ, 2002, INVEST OPHTH VIS SCI, V43, P1843; Lehmann OJ, 2000, AM J HUM GENET, V67, P1129; Linding R, 2003, NUCLEIC ACIDS RES, V31, P3701, DOI 10.1093/nar/gkg519; Linding R, 2003, STRUCTURE, V11, P1453, DOI 10.1016/j.str.2003.10.002; Lines MA, 2002, HUM MOL GENET, V11, P1177, DOI 10.1093/hmg/11.10.1177; Lopez-Garrido MP, 2006, MOL VIS, V12, P748; Lopez-Garrido MP, 2013, OPHTHALMOLOGY, V120, P716, DOI 10.1016/j.ophtha.2012.09.016; Mears AJ, 1998, AM J HUM GENET, V63, P1316, DOI 10.1086/302109; Monemi S, 2005, HUM MOL GENET, V14, P725, DOI 10.1093/hmg/ddi068; Murphy TC, 2004, INVEST OPHTH VIS SCI, V45, P2531, DOI 10.1167/iovs.04-0167; Nishimura DY, 1998, NAT GENET, V19, P140, DOI 10.1038/493; Nishimura DY, 2001, AM J HUM GENET, V68, P364, DOI 10.1086/318183; Papadopoulos M., 2013, CHILDHOOD GLAUCOMA, P15, DOI [10.1186/1687-9856-2013-15, DOI 10.1186/1687-9856-2013-15]; Pasutto F, 2012, HUM MOL GENET, V21, P1336, DOI 10.1093/hmg/ddr572; Perry LP, 2012, J AAPOS, V16, P565, DOI 10.1016/j.jaapos.2012.06.012; Perveen R, 2000, INVEST OPHTH VIS SCI, V41, P2456; Rezaie T, 2002, SCIENCE, V295, P1077, DOI 10.1126/science.1066901; Romero-Calvo I, 2010, ANAL BIOCHEM, V401, P318, DOI 10.1016/j.ab.2010.02.036; Saleem RA, 2004, NUCLEIC ACIDS RES, V32, P4182, DOI 10.1093/nar/gkh742; Saleem RA, 2003, HUM MOL GENET, V12, P2993, DOI 10.1093/hmg/ddg324; Saleem RA, 2003, INVEST OPHTH VIS SCI, V44, P4608, DOI 10.1167/iovs.03-0090; Saleem RA, 2001, AM J HUM GENET, V68, P627, DOI 10.1086/318792; Sanchez-Sanchez F, 2007, J BIOL CHEM, V282, P27810, DOI 10.1074/jbc.M609608200; SCHAGGER H, 1987, ANAL BIOCHEM, V166, P368, DOI 10.1016/0003-2697(87)90587-2; Simha N, 1989, Bull Soc Ophtalmol Fr, V89, P1149; Smith RS, 2000, HUM MOL GENET, V9, P1021, DOI 10.1093/hmg/9.7.1021; Stoilov I, 1997, HUM MOL GENET, V6, P641, DOI 10.1093/hmg/6.4.641; Stone EM, 1997, SCIENCE, V275, P668, DOI 10.1126/science.275.5300.668; Strungaru MH, 2007, INVEST OPHTH VIS SCI, V48, P228, DOI 10.1167/iovs.06-0472; Sugase K, 2007, NATURE, V447, P1021, DOI 10.1038/nature05858; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Tidow H, 2007, P NATL ACAD SCI USA, V104, P12324, DOI 10.1073/pnas.0705069104; Uversky VN, 2000, PROTEINS, V41, P415, DOI 10.1002/1097-0134(20001115)41:3<415::AID-PROT130>3.3.CO;2-Z; Walter MA, 2003, INVEST OPHTH VIS SCI, V44, P1402, DOI 10.1167/iovs.02-0618; Weisschuh N, 2008, CLIN GENET, V74, P476, DOI 10.1111/j.1399-0004.2008.01025.x; Wiggs JL, 1998, AM J HUM GENET, V63, P1549, DOI 10.1086/302098	52	18	20	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2015	10	3							e0119272	10.1371/journal.pone.0119272	http://dx.doi.org/10.1371/journal.pone.0119272			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9BN	25786029	Green Published, Green Submitted, gold			2022-12-27	WOS:000352138500094
J	Rhodes, SD; Zhang, W; Yang, DL; Yang, H; Chen, S; Wu, XH; Li, XH; Yang, XL; Mohammad, KS; Guise, TA; Bergner, AL; Stevenson, DA; Yang, FC				Rhodes, Steven D.; Zhang, Wei; Yang, Dalong; Yang, Hao; Chen, Shi; Wu, Xiaohua; Li, Xiaohong; Yang, Xianlin; Mohammad, Khalid S.; Guise, Theresa A.; Bergner, Amanda L.; Stevenson, David A.; Yang, Feng-Chun			Dystrophic Spinal Deformities in a Neurofibromatosis Type 1 Murine Model	PLOS ONE			English	Article							BONE-MINERAL-DENSITY; CONGENITAL PSEUDOARTHROSIS; DESCRIPTIVE ANALYSIS; CHILDREN; SCOLIOSIS; GROWTH; MICE; PATHOGENESIS; PREVALENCE; DYSPLASIA	Despite the high prevalence and significant morbidity of spinal anomalies in neurofibromatosis type 1 (NF1), the pathogenesis of these defects remains largely unknown. Here, we present two murine models: Nf1(flox/-); PeriCre and Nf1(flox/-); Col.2.3Cre mice, which recapitulate spinal deformities seen in the human disease. Dynamic histomorphometry and microtomographic studies show recalcitrant bone remodeling and distorted bone microarchitecture within the vertebral spine of Nf1(flox/-); PeriCre and Nf1(flox/-); Col2.3Cre mice, with analogous histological features present in a human patient with dystrophic scoliosis. Intriguingly, 36-60% of Nf1(flox/-); PeriCre and Nf1(flox/-); Col2.3Cre mice exhibit segmental vertebral fusion anomalies with boney obliteration of the intervertebral disc (IVD). While analogous findings have not yet been reported in the NF1 patient population, we herein present two case reports of IVD defects and interarticular vertebral fusion in patients with NF1. Collectively, these data provide novel insights regarding the pathophysiology of dystrophic spinal anomalies in NF1, and provide impetus for future radiographic analyses of larger patient cohorts to determine whether IVD and vertebral fusion defects may have been previously overlooked or underreported in the NF1 patient population.	[Rhodes, Steven D.; Yang, Feng-Chun] Indiana Univ Sch Med, Dept Anat & Cell Biol, Indianapolis, IN 46202 USA; [Rhodes, Steven D.; Zhang, Wei; Yang, Dalong; Yang, Hao; Chen, Shi; Wu, Xiaohua; Li, Xiaohong; Yang, Xianlin; Yang, Feng-Chun] Indiana Univ Sch Med, Herman B Wells Ctr Pediat Res, Indianapolis, IN 46202 USA; [Zhang, Wei; Yang, Dalong; Chen, Shi; Wu, Xiaohua; Li, Xiaohong; Yang, Xianlin; Yang, Feng-Chun] Indiana Univ Sch Med, Dept Pediat, Indianapolis, IN 46202 USA; [Zhang, Wei; Yang, Dalong] Hebei Med Univ, Hosp 3, Shijiazhuang, Peoples R China; [Mohammad, Khalid S.; Guise, Theresa A.] Indiana Univ Sch Med, Dept Endocrinol, Indianapolis, IN 46202 USA; [Bergner, Amanda L.] Johns Hopkins Univ Hosp, Dept Neurol, Baltimore, MD 21287 USA; [Stevenson, David A.] Stanford Univ, Dept Pediat, Div Med Genet, Stanford, CA 94305 USA	Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington; Hebei Medical University; Indiana University System; Indiana University Bloomington; Johns Hopkins University; Johns Hopkins Medicine; Stanford University	Yang, FC (corresponding author), Indiana Univ Sch Med, Dept Anat & Cell Biol, Indianapolis, IN 46202 USA.	fyang@iupui.edu	Mohammad, Khalid/AAE-9569-2022; Mohammad, Khalid/AFE-4205-2022		Department of Defense (DOD) [NF043032, NF073112, NIH/NCI/5R01CA074177]; Children's Tumor Foundation (CTF) Young Investigator Award [2011-01-010]; Indiana CTSI Career Development Award (PHS (NCCR)) [5TL1RR025759-03]; NATIONAL CANCER INSTITUTE [R01CA074177] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR002529, UL1TR001108] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [TL1RR025759] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM077229] Funding Source: NIH RePORTER	Department of Defense (DOD)(United States Department of Defense); Children's Tumor Foundation (CTF) Young Investigator Award; Indiana CTSI Career Development Award (PHS (NCCR)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by the Department of Defense (DOD) NF043032 (FCY), NF073112 (FCY) and NIH/NCI/5R01CA074177 (FCY). SDR was supported in part by a Children's Tumor Foundation (CTF) Young Investigator Award (2011-01-010) and an Indiana CTSI Career Development Award (PHS (NCCR) Grant No: 5TL1RR025759-03). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdel-Wanis ME, 2002, MED HYPOTHESES, V58, P395, DOI 10.1054/mehy.2001.1467; AKBARNIA BA, 1992, SPINE, V17, pS244; Alwan S, 2007, AM J MED GENET A, V143A, P1326, DOI 10.1002/ajmg.a.31754; Alwan S, 2005, CLIN GENET, V67, P378, DOI 10.1111/j.1399-0004.2005.00410.x; BRADFORD DS, 1974, J BONE JOINT SURG AM, VA 56, P740, DOI 10.2106/00004623-197456040-00009; Clementi M, 1999, AM J MED GENET, V87, P317, DOI 10.1002/(SICI)1096-8628(19991203)87:4<317::AID-AJMG7>3.0.CO;2-X; Cobb J., 1948, AM ACADEMY ORTHOPAED, V5, P261; CRAWFORD AH, 1989, CLIN ORTHOP RELAT R, P29; Crawford AH, 2007, J BONE JOINT SURG AM, V89A, P123, DOI 10.2106/JBJS.F.00836; Dacquin R, 2002, DEV DYNAM, V224, P245, DOI 10.1002/dvdy.10100; Davis MM, 2006, ARCH SURG-CHICAGO, V141, P71, DOI 10.1001/archsurg.141.1.71; Dulai S, 2007, J PEDIATR ORTHOPED, V27, P472, DOI 10.1097/01.bpb.0000271310.87997.ae; Durrani AA, 2000, SPINE, V25, P69, DOI 10.1097/00007632-200001010-00013; Friedman JM, 1997, AM J MED GENET, V70, P138, DOI 10.1002/(SICI)1096-8628(19970516)70:2<138::AID-AJMG7>3.0.CO;2-U; FUNASAKI H, 1994, J BONE JOINT SURG AM, V76A, P692, DOI 10.2106/00004623-199405000-00010; GILBERT A, 1995, CLIN ORTHOP RELAT R, P37; GOFF CW, 1957, J BONE JOINT SURG AM, V39, P616, DOI 10.2106/00004623-195739030-00014; Heerva E, 2012, J BONE MINER RES, V27, P2333, DOI 10.1002/jbmr.1685; Heerva E, 2010, BONE, V47, P583, DOI 10.1016/j.bone.2010.06.001; HUSON SM, 1989, J MED GENET, V26, P704, DOI 10.1136/jmg.26.11.704; Illes T, 2001, OSTEOPOROSIS INT, V12, P823, DOI 10.1007/s001980170032; JACKS T, 1994, NAT GENET, V7, P353, DOI 10.1038/ng0794-353; Khong PL, 2003, AM J ROENTGENOL, V180, P413, DOI 10.2214/ajr.180.2.1800413; Kim HW, 1997, SPINE, V22, P2770, DOI 10.1097/00007632-199712010-00014; Koptan W, 2010, EUR SPINE J, V19, P1569, DOI 10.1007/s00586-010-1464-0; Kuorilehto T, 2005, OSTEOPOROSIS INT, V16, P928, DOI 10.1007/s00198-004-1801-4; Lammert M, 2005, OSTEOPOROSIS INT, V16, P1161, DOI 10.1007/s00198-005-1940-2; Lindsley A, 2007, DEV BIOL, V307, P340, DOI 10.1016/j.ydbio.2007.04.041; Machida M, 1999, SPINE, V24, P1985, DOI 10.1097/00007632-199910010-00004; MARTIN GA, 1990, CELL, V63, P843, DOI 10.1016/0092-8674(90)90150-D; MORRISSY RT, 1981, J BONE JOINT SURG BR, V63, P367, DOI 10.1302/0301-620X.63B3.6790551; Ramachandran M, 2004, J SPINAL DISORD TECH, V17, P483, DOI 10.1097/01.bsd.0000133466.97241.50; REZAIAN SM, 1976, ACTA ORTHOP SCAND, V47, P534, DOI 10.3109/17453677608988733; RICCARDI VM, 1981, NEW ENGL J MED, V305, P1617, DOI 10.1056/NEJM198112313052704; SARTORIS DJ, 1986, SKELETAL RADIOL, V15, P60, DOI 10.1007/BF00355076; SOFIELD HA, 1971, CLIN ORTHOP RELAT R, P33, DOI 10.1097/00003086-197105000-00008; Stevenson DA, 1999, AM J MED GENET, V84, P413, DOI 10.1002/(SICI)1096-8628(19990611)84:5<413::AID-AJMG5>3.0.CO;2-1; Stevenson DA, 2007, J PEDIATR-US, V150, P83, DOI 10.1016/j.jpeds.2006.10.048; Stevenson DA, 2011, AM J MED GENET A, V155A, P1050, DOI 10.1002/ajmg.a.33965; Szudek J, 2000, J MED GENET, V37, P933, DOI 10.1136/jmg.37.12.933; Tsirikos AI, 2004, CLIN RADIOL, V59, P1009, DOI 10.1016/j.crad.2004.04.006; Tucker T, 2009, J MED GENET, V46, P259, DOI 10.1136/jmg.2008.061895; Virdis R, 2003, J PEDIATR ENDOCR MET, V16, P289; Vitale MG, 2002, CLIN ORTHOP RELAT R, P107, DOI 10.1097/01.blo.0000022199.37246.c9; Wang WX, 2011, HUM MOL GENET, V20, P3910, DOI 10.1093/hmg/ddr310; Wu XH, 2006, HUM MOL GENET, V15, P2837, DOI 10.1093/hmg/ddl208; Yan JC, 2008, HUM MOL GENET, V17, P936, DOI 10.1093/hmg/ddm366; Yang FC, 2006, J CLIN INVEST, V116, P2880, DOI 10.1172/JCI29092; Yilmaz K, 2007, ACTA PAEDIATR, V96, P1220, DOI 10.1111/j.1651-2227.2007.00401.x; Yu X, 2005, BONE, V36, P793, DOI 10.1016/j.bone.2005.01.022; Zhang W, 2011, BONE, V48, P1378, DOI 10.1016/j.bone.2011.03.760; Zhu Y, 2002, SCIENCE, V296, P920, DOI 10.1126/science.1068452	52	9	10	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2015	10	3							e0119093	10.1371/journal.pone.0119093	http://dx.doi.org/10.1371/journal.pone.0119093			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9BN	25786243	Green Published, Green Submitted, gold			2022-12-27	WOS:000352138500072
J	Ye, TQ; Wang, Q; Zhang, Y; Song, XF; Yang, DC; Li, D; Li, D; Su, LN; Yang, YJ; Ma, ST				Ye, Tingqiao; Wang, Qiang; Zhang, Yan; Song, Xiaofeng; Yang, Dachun; Li, De; Li, Dan; Su, Linan; Yang, Yongjian; Ma, Shuangtao			Over-Expression of Calpastatin Inhibits Calpain Activation and Attenuates Post-Infarction Myocardial Remodeling	PLOS ONE			English	Article							HEART-FAILURE; FAILING HEART; ACE-INHIBITOR; INFARCTION; HYPERTROPHY; DYSTROPHIN; FIBROSIS; SYSTEM; TYPE-1; AT(1)	Background Calpain is activated following myocardial infarction and ablation of calpastatin (CAST), an endogenous inhibitor of calpains, promotes left ventricular remodeling after myocardial infarction (MI). The present study aimed to investigate the effect of transgenic overexpression of CAST on the post-infarction myocardial remodeling process. Method We established transgenic mice (TG) ubiquitously over-expressing human CAST protein and produced MI in TG mice and C57BL/6J wild-type (WT) littermates. Results The CAST protein expression was profoundly upregulated in the myocardial tissue of TG mice compared with WT littermates (P < 0.01). Overexpression of CAST significantly reduced the infarct size (P < 0.01) and blunted MI-induced interventricular hypertrophy, global myocardial fibrosis and collagen I and collagen III deposition, hypotension and hemodynamic disturbances at 21 days after MI. Moreover, the MI-induced up-regulation and activation of calpains were obviously attenuated in CAST TG mice. MI-induced down-regulation of CAST was partially reversed in TG mice. Additionally, the MI-caused imbalance of matrix metalloproteinases and their inhibitors was improved in TG mice. Conclusions Transgenic over-expression of CAST inhibits calpain activation and attenuates post-infarction myocardial remodeling.	[Ye, Tingqiao; Wang, Qiang; Zhang, Yan; Song, Xiaofeng; Yang, Dachun; Li, De; Li, Dan; Su, Linan; Yang, Yongjian; Ma, Shuangtao] Chengdu Mil Gen Hosp, Dept Cardiol, Chengdu, Sichuan, Peoples R China		Yang, YJ (corresponding author), Chengdu Mil Gen Hosp, Dept Cardiol, Chengdu, Sichuan, Peoples R China.	yangyongjian38@yahoo.com; ma.shuangtao@gmail.com	Ma, Shuangtao/L-5543-2016	Ma, Shuangtao/0000-0001-7582-8724; Yang, Yongjian/0000-0003-1268-166X	Natural Science Foundation of China [81070191]; Chengdu Military General Hospital [2011YG-A11]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chengdu Military General Hospital	This work was supported by a grant from the Natural Science Foundation of China (No. 81070191) and a grant from the Chengdu Military General Hospital (No. 2011YG-A11). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chen M, 2002, J BIOL CHEM, V277, P29181, DOI 10.1074/jbc.M204951200; French Brent A, 2007, Drug Discov Today Dis Mech, V4, P185, DOI 10.1016/j.ddmec.2007.12.006; Gajarsa JJ, 2011, HEART FAIL REV, V16, P13, DOI 10.1007/s10741-010-9181-7; Inserte J, 2012, CARDIOVASC RES, V96, P9, DOI 10.1093/cvr/cvs245; Kudo-Sakamoto Y, 2014, J BIOL CHEM, V289, P19408, DOI 10.1074/jbc.M114.567206; Letavernier E, 2008, CIRC RES, V102, P720, DOI 10.1161/CIRCRESAHA.107.160077; Letavernier E, 2012, CARDIOVASC RES, V96, P38, DOI 10.1093/cvr/cvs099; Li XP, 2009, CARDIOVASC RES, V83, P72, DOI 10.1093/cvr/cvp100; Li Y, 2011, DIABETES, V60, P2985, DOI 10.2337/db10-1333; Ma J, 2012, J BIOL CHEM, V287, P27480, DOI 10.1074/jbc.M112.358929; Ma ST, 2014, INT J CARDIOL, V175, P206, DOI 10.1016/j.ijcard.2014.04.256; Ma ST, 2012, EXP THER MED, V4, P545, DOI 10.3892/etm.2012.620; Mani SK, 2009, AM J PHYSIOL-HEART C, V297, pH1744, DOI 10.1152/ajpheart.00338.2009; Sandmann S, 2001, BRIT J PHARMACOL, V132, P767, DOI 10.1038/sj.bjp.0703860; Scherrer-Crosbie M, 2001, CIRCULATION, V104, P1286, DOI 10.1161/hc3601.094298; Takahashi M, 2006, J CARDIOVASC PHARM, V47, P413; Takahashi M, 2005, CARDIOVASC RES, V65, P356, DOI 10.1016/j.cardiores.2004.09.022; Wang Q, 2014, AM J HYPERTENS, V27, P1521, DOI 10.1093/ajh/hpu068; Wang YP, 2013, CARDIOVASC RES, V98, P381, DOI 10.1093/cvr/cvt048; Yang DC, 2009, BIOCHEM BIOPH RES CO, V388, P606, DOI 10.1016/j.bbrc.2009.08.073; Yoshida H, 2003, CARDIOVASC RES, V59, P419, DOI 10.1016/S0008-6363(03)00385-7	21	17	19	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2015	10	3							e0120178	10.1371/journal.pone.0120178	http://dx.doi.org/10.1371/journal.pone.0120178			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9BN	25786109	gold, Green Submitted, Green Published			2022-12-27	WOS:000352138500159
J	Zakirova, Z; Tweed, M; Crynen, G; Reed, J; Abdullah, L; Nissanka, N; Mullan, M; Mullan, MJ; Mathura, V; Crawford, F; Ait-Ghezala, G				Zakirova, Zuchra; Tweed, Miles; Crynen, Gogce; Reed, Jon; Abdullah, Laila; Nissanka, Nadee; Mullan, Myles; Mullan, Michael J.; Mathura, Venkatarajan; Crawford, Fiona; Ait-Ghezala, Ghania			Gulf War Agent Exposure Causes Impairment of Long-Term Memory Formation and Neuropathological Changes in a Mouse Model of Gulf War Illness	PLOS ONE			English	Article							ADULT HIPPOCAMPAL NEUROGENESIS; CHEMICAL WEAPONS FALLOUT; PYRIDOSTIGMINE BROMIDE; COGNITIVE IMPAIRMENT; ALZHEIMERS-DISEASE; DISTANCE TRANSIT; RAT-BRAIN; STRESS; DYSFUNCTION; VETERANS	Gulf War Illness (GWI) is a chronic multisymptom illness with a central nervous system component such as memory deficits, neurological, and musculoskeletal problems. There are ample data that demonstrate that exposure to Gulf War (GW) agents, such as pyridostigmine bromide (PB) and pesticides such as permethrin (PER), were key contributors to the etiology of GWI post deployment to the Persian GW. In the current study, we examined the consequences of acute (10 days) exposure to PB and PER in C57BL6 mice. Learning and memory tests were performed at 18 days and at 5 months post-exposure. We investigated the relationship between the cognitive phenotype and neuropathological changes at short and long-term time points post-exposure. No cognitive deficits were observed at the short-term time point, and only minor neuropathological changes were detected. However, cognitive deficits emerged at the later time point and were associated with increased astrogliosis and reduction of synaptophysin staining in the hippocampi and cerebral cortices of exposed mice, 5 months post exposure. In summary, our findings in this mouse model of GW agent exposure are consistent with some GWI symptom manifestations, including delayed onset of symptoms and CNS disturbances observed in GWI veterans.	[Zakirova, Zuchra; Tweed, Miles; Crynen, Gogce; Reed, Jon; Abdullah, Laila; Mullan, Myles; Mullan, Michael J.; Mathura, Venkatarajan; Crawford, Fiona; Ait-Ghezala, Ghania] Roskamp Inst, Sarasota, FL 34243 USA; [Zakirova, Zuchra; Tweed, Miles; Crynen, Gogce; Abdullah, Laila; Mathura, Venkatarajan; Crawford, Fiona; Ait-Ghezala, Ghania] Open Univ, Milton Keynes MK7 6AA, Bucks, England; [Zakirova, Zuchra; Tweed, Miles; Reed, Jon; Abdullah, Laila; Crawford, Fiona; Ait-Ghezala, Ghania] James A Haley Vet Hosp, Tampa, FL 33612 USA; [Nissanka, Nadee] Univ Miami, Miller Sch Med, Miami, FL 33136 USA	Open University - UK; US Department of Veterans Affairs; Veterans Health Administration (VHA); James A. Haley Veterans Hospital; University of Miami	Zakirova, Z (corresponding author), Roskamp Inst, Sarasota, FL 34243 USA.	zzakirova@roskampinstitute.net		Crynen, Gogce/0000-0001-6066-9900; Ait-Ghezala, Ghania/0000-0002-9836-8617; Nissanka, Nadee/0000-0002-4639-7192	Congressionally Directed Medical Research Program [GW100076]; VA merit award	Congressionally Directed Medical Research Program(United States Department of Defense); VA merit award(US Department of Veterans Affairs)	This research was funded by a Congressionally Directed Medical Research Program award to Dr. Ait-Ghezala (GW100076), VA merit award to Dr. Fiona Crawford and by the Roskamp Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdel-Rahman A, 2002, NEUROBIOL DIS, V10, P306, DOI 10.1006/nbdi.2002.0524; Abdel-Rahman A, 2004, J TOXICOL ENV HEAL A, V67, P163, DOI 10.1080/15287390490264802; Abdullah L, 2013, NEUROTOXICOL TERATOL, V40, P74, DOI 10.1016/j.ntt.2013.10.002; Abdullah L, 2012, NEUROMOL MED, V14, P349, DOI 10.1007/s12017-012-8192-z; Abdullah L, 2011, NEUROMOL MED, V13, P275, DOI 10.1007/s12017-011-8160-z; Abou-Donia MB, 2004, PHARMACOL BIOCHEM BE, V77, P253, DOI 10.1016/j.pbb.2003.10.018; Abou-Donia MB, 2001, TOXICOL SCI, V60, P305, DOI 10.1093/toxsci/60.2.305; Amato AA, 1997, JAMA-J AM MED ASSOC, V278, P384, DOI 10.1001/jama.1997.03550050046022; Apfel BA, 2011, BIOL PSYCHIAT, V69, P541, DOI 10.1016/j.biopsych.2010.09.044; Axmacher N, 2009, J NEUROSCI, V29, P1052, DOI 10.1523/JNEUROSCI.5277-08.2009; BALABAN CD, 1988, NEUROSCIENCE, V26, P337, DOI 10.1016/0306-4522(88)90150-9; BARNES CA, 1979, J COMP PHYSIOL PSYCH, V93, P74, DOI 10.1037/h0077579; Berg DA, 2013, DEVELOPMENT, V140, P2548, DOI 10.1242/dev.088005; Brimfield AA, 2012, PROG MOL BIOL TRANSL, V112, P209, DOI 10.1016/B978-0-12-415813-9.00007-6; BROCK TO, 1987, J NEUROSCI, V7, P931; Cardenas H, 2003, BRAIN RES, V985, P89, DOI 10.1016/S0006-8993(03)03172-X; Chaney LA, 2002, INT J TOXICOL, V21, P287, DOI 10.1080/10915810290096450; Dahlgren JG, 2004, J TOXICOL-CLIN TOXIC, V42, P579, DOI 10.1081/CLT-200026979; David AS, 2002, PSYCHOL MED, V32, P1357, DOI 10.1017/S0033291702006359; DEKOSKY ST, 1990, ANN NEUROL, V27, P457, DOI 10.1002/ana.410270502; Everson MP, 1999, ANN NY ACAD SCI, V876, P413, DOI 10.1111/j.1749-6632.1999.tb07665.x; Friedman A, 1996, NAT MED, V2, P1382, DOI 10.1038/nm1296-1382; Fukuda K, 1998, JAMA-J AM MED ASSOC, V280, P981, DOI 10.1001/jama.280.11.981; Fulco CE, 2003, GULF WAR HLTH, V2; Ge YA, 2010, P NATL ACAD SCI USA, V107, P16697, DOI 10.1073/pnas.1008200107; Gillette JS, 2003, TOXICOL APPL PHARM, V192, P287, DOI 10.1016/S0041-008X(03)00326-0; Golomb B.A, 2012, NATURE PRECEDINGS; Graves J. C., 2008, GULF WAR ILLNESS HLT; Hailer NP, 2001, EUR J NEUROSCI, V14, P315, DOI 10.1046/j.0953-816x.2001.01649.x; Haley RW, 2013, NEUROEPIDEMIOLOGY, V40, P178, DOI 10.1159/000345124; Haley RW, 1997, AM J EPIDEMIOL, V146, P695; Harrell FE, 2001, REGRESSION MODELING; Hattiangady B, 2014, FRONT BEHAV NEUROSCI, V8, DOI 10.3389/fnbeh.2014.00078; Hilborne LH, 2005, EXAMINING POSSIBLE C; Hyams KC, 1996, ANN INTERN MED, V125, P398, DOI 10.7326/0003-4819-125-5-199609010-00007; Ikonomovic MD, 2003, J ALZHEIMERS DIS, V5, P39, DOI 10.3233/JAD-2003-5106; Izquierdo I, 1997, NEUROBIOL LEARN MEM, V68, P285, DOI 10.1006/nlme.1997.3799; Izquierdo LA, 2000, BEHAV BRAIN RES, V111, P93, DOI 10.1016/S0166-4328(00)00137-6; Katz MH, 2011, MULTIVARIABLE ANAL P; Kotani S, 2006, NEUROSCIENCE, V142, P505, DOI 10.1016/j.neuroscience.2006.06.035; Krengel M, 2008, NEUROPSYCHOLOGICAL F; Lallement G, 1998, J PHYSIOLOGY-PARIS, V92, P369, DOI 10.1016/S0928-4257(99)80007-2; Lee LW, 2003, NEUROMOL MED, V4, P179, DOI 10.1385/NMM:4:3:179; Li XF, 2011, RADIOLOGY, V261, P218, DOI 10.1148/radiol.11101715; Lotti Marcello, 2005, Toxicol Rev, V24, P37, DOI 10.2165/00139709-200524010-00003; MCMILLIAN MK, 1994, TRENDS NEUROSCI, V17, P138, DOI 10.1016/0166-2236(94)90086-8; Menon PM, 2004, BRAIN RES, V1009, P189, DOI 10.1016/j.brainres.2004.02.063; Mohapel P, 2005, NEUROBIOL AGING, V26, P939, DOI 10.1016/j.neurobiolaging.2004.07.015; Ojo B, 2012, BRAIN BEHAV IMMUN, V26, P778, DOI 10.1016/j.bbi.2011.09.013; Ojo JO, 2013, NEUROPATHOLOGY; Page WF, 2005, MIL MED, V170, P935, DOI 10.7205/MILMED.170.11.935; Parihar VK, 2013, NEUROPSYCHOPHARMACOL; Pirttimaki TM, 2013, NEUROSCIENTIST, V19, P604, DOI 10.1177/1073858413504999; Rayhan RU, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0058493, 10.1371/journal.pone.0063903]; Rayhan RU, 2013, AM J TRANSL RES, V5, P212; Roy TS, 2005, DEV BRAIN RES, V155, P71, DOI 10.1016/j.devbrainres.2004.12.004; Scheff SW, 2007, NEUROLOGY, V68, P1501, DOI 10.1212/01.wnl.0000260698.46517.8f; Scheff SW, 2006, NEUROBIOL AGING, V27, P1372, DOI 10.1016/j.neurobiolaging.2005.09.012; Scheff SW, 2006, ALZHEIMER'S DISEASE: A CENTURY OF SCIENTIFIC AND CLINICAL RESEARCH, P101; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; Serrano-Pozo A, 2011, CSH PERSPECT MED, V1, DOI 10.1101/cshperspect.a006189; Shoenfeld Y, 2011, J AUTOIMMUN, V36, P4, DOI 10.1016/j.jaut.2010.07.003; Slotkin TA, 2008, BRAIN RES BULL, V75, P640, DOI 10.1016/j.brainresbull.2007.10.008; Slotkin TA, 2006, ENVIRON HEALTH PERSP, V114, P1542, DOI 10.1289/ehp.9337; Speed HE, 2012, TOXICOL SCI, V125, P196, DOI 10.1093/toxsci/kfr253; Steele L, 2000, AM J EPIDEMIOL, V152, P992, DOI 10.1093/aje/152.10.992; Sunyer B., 2007, NATURE PROTOCOL EXCH; Suzuki A, 2011, CELL, V144, P810, DOI 10.1016/j.cell.2011.02.018; Tillman GD, 2012, NEUROTOXICOLOGY, V33, P1096, DOI 10.1016/j.neuro.2012.06.001; Tuite JJ, 2013, NEUROEPIDEMIOLOGY, V40, P160, DOI 10.1159/000345123; Unwin C, 1999, LANCET, V353, P169, DOI 10.1016/S0140-6736(98)11338-7; Veena J, 2011, J Nat Sci Biol Med, V2, P26, DOI 10.4103/0976-9668.82312; Vianna MRM, 2000, LEARN MEMORY, V7, P333, DOI 10.1101/lm.34600; von Bohlen und Halbach O, 2013, CELL TISSUE RES, V354, P41, DOI 10.1007/s00441-012-1547-9; Vythilingam M, 2005, PSYCHIAT RES-NEUROIM, V139, P89, DOI 10.1016/j.pscychresns.2005.04.003; Wille T, 2011, CHEM-BIOL INTERACT, V190, P79, DOI 10.1016/j.cbi.2011.02.022; WILLIAMSON EG, 1989, ECOTOX ENVIRON SAFE, V18, P27, DOI 10.1016/0147-6513(89)90089-4; World Health Organization, 2009, WHO SPEC EV PUBL HLT	78	56	57	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2015	10	3							e0119579	10.1371/journal.pone.0119579	http://dx.doi.org/10.1371/journal.pone.0119579			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9BN	25785457	Green Published, Green Submitted, gold			2022-12-27	WOS:000352138500114
J	Zheng, ZQ; Huang, C; Guo, YT; Niu, KJ; Momma, H; Kobayashi, Y; Fukudo, S; Nagatomi, R				Zheng, Zhaoqiu; Huang, Cong; Guo, Yinting; Niu, Kaijun; Momma, Haruki; Kobayashi, Yoritoshi; Fukudo, Shin; Nagatomi, Ryoichi			Staple Foods Consumption and Irritable Bowel Syndrome in Japanese Adults: A Cross-Sectional Study	PLOS ONE			English	Article							DIET HISTORY QUESTIONNAIRES; QUALITY-OF-LIFE; GASTROINTESTINAL SYMPTOMS; NORTH-AMERICA; IMPACT; RESTRICTION; PREVALENCE; FREQUENCY; VALIDITY; PROTEIN	Background Carbohydrates can cause gastrointestinal symptoms due to incomplete absorption in the small bowel. Thus, high-carbohydrate diets may induce symptoms of irritable bowel syndrome (IBS). Objective This observational and cross-sectional study assessed the association between consumption of several carbohydrate-enriched staple foods, such as rice, Japanese wheat noodles, Chinese noodles, bread, pasta, and buckwheat noodles, and the prevalence of IBS in Japanese adults. Subjects and Methods One thousand and eighty-two (837 men) Japanese adult employees aged 19-85 were included in this cross-sectional study conducted in 2011. IBS diagnosis was based on the Rome III criteria. Consumption of staple foods was assessed using a brief self-administered diet history questionnaire, and divided into three categories (low, middle, high) depending on their distribution. Results In the multivariate analysis, daily consumption of rice (odds ratios [ORs] and [95% confidence interval (CI)]: middle, 1.36 [0.93-1.99]; high, 1.67 [1.12-2.49]; P for trend = 0.01), bread (middle, 1.88 [1.28-2.75]; high, 1.63 [1.10-2.41]; P for trend = 0.01), pasta (middle, 1.47 [1.01-2.15]; high, 1.68 [1.12-2.52]; P for trend = 0.01), and buckwheat noodles (middle, 1.76 [1.18-2.61]; high, 1.98 [1.31-3.00]; P for trend = 0.001) were associated with higher prevalence of IBS after adjustment for socio-demographic, anthropometric, and lifestyle-related factors. Buckwheat noodles, but not other staple foods, retained an association with the prevalence of IBS even after adjustment for daily intake of carbohydrates or plant proteins. Conclusions This cross-sectional study demonstrated that the consumption of staple foods, such as rice, bread, pasta, and buckwheat noodles is associated with the prevalence of IBS. Of these, the consumption of buckwheat noodles, but not other staple foods, is associated with IBS independent of carbohydrate or plant protein contents.	[Zheng, Zhaoqiu; Kobayashi, Yoritoshi; Nagatomi, Ryoichi] Tohoku Univ, Grad Sch Med, Dept Med & Sci Sports & Exercise, Sendai, Miyagi 980, Japan; [Huang, Cong; Momma, Haruki; Nagatomi, Ryoichi] Tohoku Univ, Grad Sch Biomed Engn, Div Biomed Engn Hlth & Welf, Sendai, Miyagi 980, Japan; [Guo, Yinting; Fukudo, Shin] Tohoku Univ, Grad Sch Med, Dept Behav Med, Sendai, Miyagi 980, Japan; [Niu, Kaijun] Tianjin Med Univ, Sch Publ Hlth, Dept Epidemiol, Tianjin, Peoples R China	Tohoku University; Tohoku University; Tohoku University; Tianjin Medical University	Nagatomi, R (corresponding author), Tohoku Univ, Grad Sch Med, Dept Med & Sci Sports & Exercise, Sendai, Miyagi 980, Japan.	nagatomi@med.tohoku.ac.jp	Huang, Cong/N-4401-2019; Nagatomi, Ryoichi/Q-8792-2016; Nagatomi, Ryoichi/T-5296-2019; Fukudo, Shin/J-4813-2014	Nagatomi, Ryoichi/0000-0003-3038-7202; Momma, Haruki/0000-0003-1134-0898; Niu, Kaijun/0000-0002-8772-2481; Huang, Cong/0000-0002-2307-864X	Ministry of Education, Culture, Sports, Science and Technology of Japan; Center of Innovation Program from Japan Science and Technology Agency, JST	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Center of Innovation Program from Japan Science and Technology Agency, JST	This study was supported by a Grant-in-Aid under the Knowledge Cluster Initiative from the Ministry of Education, Culture, Sports, Science and Technology of Japan, and partially supported by the Center of Innovation Program from Japan Science and Technology Agency, JST. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1998, TECH B; Austin GL, 2009, CLIN GASTROENTEROL H, V7, P706, DOI 10.1016/j.cgh.2009.02.023; Biesiekierski JR, 2011, AM J GASTROENTEROL, V106, P508, DOI 10.1038/ajg.2010.487; Carlson RV, 2004, BRIT J CLIN PHARMACO, V57, P695, DOI 10.1111/j.1365-2125.2004.02103.x; Craig CL, 2003, MED SCI SPORT EXER, V35, P1381, DOI 10.1249/01.MSS.0000078924.61453.FB; Dong L, 2005, PEDIATRICS, V116, pE393, DOI 10.1542/peds.2004-2764; Fountoulakis K, 2001, BMC PSYCHIATRY, V1, DOI 10.1186/1471-244X-1-3; Fukuda K, 1973, Seishin Shinkeigaku Zasshi, V75, P673; Goldstein R, 2000, ISRAEL MED ASSOC J, V2, P583; Gralnek IM, 2000, GASTROENTEROLOGY, V119, P654, DOI 10.1053/gast.2000.16484; Guo H, 2012, NUTR METAB CARDIOVAS, V22, P277, DOI 10.1016/j.numecd.2010.06.006; Huang C, 2014, NUTR METAB CARDIOVAS, V24, P648, DOI 10.1016/j.numecd.2013.12.013; Hungin APS, 2005, ALIMENT PHARM THER, V21, P1365, DOI 10.1111/j.1365-2036.2005.02463.x; Ishikawa-Takata K, 2007, J EPIDEMIOL, V17, P177; Jun DW, 2006, WORLD J GASTROENTERO, V12, P2382, DOI 10.3748/wjg.v12.i15.2382; Kobayashi S, 2012, J EPIDEMIOL, V22, P151, DOI 10.2188/jea.JE20110075; Kobayashi S, 2011, PUBLIC HEALTH NUTR, V14, P1200, DOI 10.1017/S1368980011000504; Longstreth GF, 2006, GASTROENTEROLOGY, V130, P1480, DOI 10.1053/j.gastro.2005.11.061; Mehr SS, 2009, ARCH DIS CHILD, V94, P220, DOI 10.1136/adc.2008.145144; Muller-Lissner SA, 2001, DIGESTION, V64, P200, DOI 10.1159/000048862; Nakamura S, 1974, Allerg Immunol (Leipz), V20-21, P457; Parry SD, 2005, EUR J GASTROEN HEPAT, V17, P1071, DOI 10.1097/00042737-200510000-00010; Saito YA, 2002, AM J GASTROENTEROL, V97, P1910; Sasaki S, 2005, SERUM BIOMARKER BASE, P10; Shinozaki M, 2008, J CLIN GASTROENTEROL, V42, P1010, DOI 10.1097/MCG.0b013e318150d006; Simren M, 2001, DIGESTION, V63, P108, DOI 10.1159/000051878; Staudacher HM, 2011, J HUM NUTR DIET, V24, P487, DOI 10.1111/j.1365-277X.2011.01162.x; Staudacher HM, 2012, J NUTR, V142, P1510, DOI 10.3945/jn.112.159285; Tanaka K, 2002, INT ARCH ALLERGY IMM, V129, P49, DOI 10.1159/000065173; Tokudome S, 1998, JPN J CLIN ONCOL, V28, P679, DOI 10.1093/jjco/28.11.679; Urisu A., 1995, CURR ADV BUCKWHEAT R, P965; Wang YT, 2012, BMC GASTROENTEROL, V12, DOI 10.1186/1471-230X-12-104	32	6	7	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2015	10	3							e0119097	10.1371/journal.pone.0119097	http://dx.doi.org/10.1371/journal.pone.0119097			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9BN	25785440	Green Published, gold, Green Submitted			2022-12-27	WOS:000352138500073
J	Ang, LF; Por, LY; Yam, MF				Ang, Lee Fung; Por, Lip Yee; Yam, Mun Fei			Development of an Amperometric-Based Glucose Biosensor to Measure the Glucose Content of Fruit	PLOS ONE			English	Article							HORSERADISH-PEROXIDASE; HYDROGEN-PEROXIDE; IMMOBILIZATION; ELECTRODE; OXIDASE; CHITIN; FILMS; FLOW	An amperometric enzyme-electrode was introduced where glucose oxidase (GOD) was immobilized on chitosan membrane via crosslinking, and then fastened on a platinum working electrode. The immobilized enzyme showed relatively high retention activity. The activity of the immobilized enzyme was influenced by its loading, being suppressed when more than 0.6 mg enzyme was used in the immobilization. The biosensor showing the highest response to glucose utilized 0.21 ml/cm(2) thick chitosan membrane. The optimum experimental conditions for the biosensors in analysing glucose dissolved in 0.1 M phosphate buffer (pH 6.0) were found to be 35 degrees C and 0.6 V applied potential. The introduced biosensor reached a steady-state current at 60 s. The apparent Michaelis-Menten constant (K-M(app)) of the biosensor was 14.2350 mM, and its detection limit was 0.05 mM at s/n > 3, determined experimentally. The RSD of repeatability and reproducibility of the biosensor were 2.30% and 3.70%, respectively. The biosensor was showed good stability; it retained similar to 36% of initial activity after two months of investigation. The performance of the biosensors was evaluated by determining the glucose content in fruit homogenates. Their accuracy was compared to that of a commercial glucose assay kit. There was no significance different between two methods, indicating the introduced biosensor is reliable.	[Ang, Lee Fung; Yam, Mun Fei] Univ Sains Malaysia, Sch Pharmaceut Sci, George Town 11800, Malaysia; [Por, Lip Yee] Univ Malaya, Fac Comp Sci & Informat Technol, Kuala Lumpur 50603, Malaysia	Universiti Sains Malaysia; Universiti Malaya	Yam, MF (corresponding author), Univ Sains Malaysia, Sch Pharmaceut Sci, George Town 11800, Malaysia.	yammunfei@yahoo.com	POR, LIP YEE/B-5309-2010	POR, LIP YEE/0000-0001-5865-1533	Malaysia Toray Science Foundation (MTSF) [304, PFARMASI 650295, T102]; High Impact Research Grant from the University of Malaya [UM.C/625/1/HIR/MOHE/FCSIT/15]	Malaysia Toray Science Foundation (MTSF); High Impact Research Grant from the University of Malaya	This project was supported by research grant from the Malaysia Toray Science Foundation (MTSF) (Grant No. 304, PFARMASI 650295, T102) and High Impact Research Grant (UM.C/625/1/HIR/MOHE/FCSIT/15) from the University of Malaya. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bean LS, 2005, THIN SOLID FILMS, V477, P104, DOI 10.1016/j.tsf.2004.08.156; BRIGHT HJ, 1969, J BIOL CHEM, V244, P3625; Chen C, 2006, BIOSENS BIOELECTRON, V22, P639, DOI 10.1016/j.bios.2006.01.023; Gamburzev S, 1996, SENSOR ACTUAT B-CHEM, V30, P179, DOI 10.1016/0925-4005(96)80046-3; Hsieh BC, 2003, MAR BIOTECHNOL, V5, P119, DOI 10.1007/s10126-002-0094-x; Hu SS, 1999, ANAL SCI, V15, P585, DOI 10.2116/analsci.15.585; KARNES HT, 1991, PHARMACEUT RES, V8, P421, DOI 10.1023/A:1015882607690; Krajewska B, 2004, ENZYME MICROB TECH, V35, P126, DOI 10.1016/j.enzmictec.2003.12.013; Li J, 1996, ANAL CHIM ACTA, V335, P137, DOI 10.1016/S0003-2670(96)00337-6; Lim SH, 2005, BIOSENS BIOELECTRON, V20, P2341, DOI 10.1016/j.bios.2004.08.005; Lin JH, 2007, ANAL BIOCHEM, V360, P288, DOI 10.1016/j.ab.2006.10.030; Magalhaes JMCS, 1998, TALANTA, V47, P183, DOI 10.1016/S0039-9140(98)00066-6; Mishima Y, 2000, SENSOR ACTUAT B-CHEM, V65, P343, DOI 10.1016/S0925-4005(99)00471-2; Muzzarelli R.A, 1983, CARBOHYD POLYM, V3, P53, DOI 10.1016/0144-8617(83)90012-7; Muzzarelli RAA., 1973, NATURAL CHELATING PO; Sakuragawa A, 1998, ANAL CHIM ACTA, V374, P191, DOI 10.1016/S0003-2670(98)00469-3; SHU FR, 1976, ANAL CHEM, V48, P1679, DOI 10.1021/ac50006a014; Singhal R, 2002, SENSOR ACTUAT B-CHEM, V86, P42, DOI 10.1016/S0925-4005(02)00145-4; Thevenot DR, 2001, BIOSENS BIOELECTRON, V16, P121, DOI 10.1081/AL-100103209; Wang G, 2003, BIOSENS BIOELECTRON, V18, P335, DOI 10.1016/S0956-5663(02)00152-5; Wang G, 2002, BIOELECTROCHEMISTRY, V57, P33, DOI 10.1016/S1567-5394(01)00174-8; Wang HS, 2005, SENSORS-BASEL, V5, P266, DOI 10.3390/s5040266; Ward WK, 2002, BIOSENS BIOELECTRON, V17, P181, DOI 10.1016/S0956-5663(01)00268-8; Wilson GS, 2005, BIOSENS BIOELECTRON, V20, P2388, DOI 10.1016/j.bios.2004.12.003; Xu JJ, 2000, ANAL CHIM ACTA, V423, P101, DOI 10.1016/S0003-2670(00)01098-9; Xue HG, 2003, SYNTHETIC MET, V135, P831, DOI 10.1016/S0379-6779(02)00919-0; Yang YH, 2004, ANAL CHIM ACTA, V525, P213, DOI 10.1016/j.aca.2004.07.071; Yang YM, 2004, ENZYME MICROB TECH, V34, P126, DOI 10.1016/j.enzmictec.2003.09.007; Yusof NA, 2002, SENSOR ACTUAT B-CHEM, V86, P127, DOI 10.1016/S0925-4005(02)00157-0; Zhang M, 2002, BIOMATERIALS, V23, P2641, DOI 10.1016/S0142-9612(01)00403-3; Zhou GJ, 2002, SENSOR ACTUAT B-CHEM, V81, P334, DOI 10.1016/S0925-4005(01)00978-9	31	48	48	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2015	10	3							e0111859	10.1371/journal.pone.0111859	http://dx.doi.org/10.1371/journal.pone.0111859			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD9NQ	25789757	Green Published, Green Submitted, gold			2022-12-27	WOS:000351425400002
J	Chen, SB; Hu, H; Gao, YS; He, HY; Jin, DX; Zhang, CQ				Chen, Sheng-Bao; Hu, Hai; Gao, You-Shui; He, Hai-Yan; Jin, Dong-Xu; Zhang, Chang-Qing			Prevalence of Clinical Anxiety, Clinical Depression and Associated Risk Factors in Chinese Young and Middle-Aged Patients with Osteonecrosis of the Femoral Head	PLOS ONE			English	Article							AVASCULAR NECROSIS; NATURAL-HISTORY; SURGERY; DISORDERS; SYSTEM; PAIN	Objective To investigate the prevalence of clinical anxiety and clinical depression in Chinese young and mid-aged patients with osteonecrosis of the femoral head (ONFH) and to analyze their potential risk factors. Methods Two hundred and sixteen Chinese patients with ONFH were consecutively enrolled in this cross-sectional study from January 2010 to December 2010. The Zung self-rating anxiety scale (SAS) and the Zung self-rating depression scale (SDS) were used to assess the prevalence of clinical anxiety and clinical depression. An additional questionnaire containing seventeen items of potential risk factors was completed by all patients. Binary logistic regression analysis was employed to reveal potential risk factors of anxiety and depression. Results The prevalence of clinical anxiety and clinical depression was 20.4% and 21.8% in Chinese young and middle-aged patients with ONFH, respectively. Binary regression analysis showed that independent risk factors correlated with high incidence of clinical anxiety included involved femoral head (OR = 3.168, 95% CI: 1.496 - 6.708) and stages of ONFH (ORIV-V/II = 5.383, 95% CI: 1.664-17.416). Independent risk factors correlated with high incidence of depression included gender (OR = 2.853, 95% CI: 1.467-5.778), comorbid diseases (OR = 4.243, 95% CI: 1.940-9.278) and stages of the disease (OR (IV-V/II) = 16.963, 95% CI: 4.404-65.331). Conclusions Patients with bilateral ONFH are inclined to have clinical anxiety, while female patients and patients with comorbid diseases might tend to get clinical depression. Advanced stages of ONFH are independent risk factors for both clinical anxiety and clinical depression.	[Chen, Sheng-Bao; Hu, Hai; Gao, You-Shui; He, Hai-Yan; Jin, Dong-Xu; Zhang, Chang-Qing] Shanghai Jiao Tong Univ, Affiliated Peoples Hosp 6, Dept Orthoped Surg, Shanghai 200030, Peoples R China	Shanghai Jiao Tong University	Zhang, CQ (corresponding author), Shanghai Jiao Tong Univ, Affiliated Peoples Hosp 6, Dept Orthoped Surg, Shanghai 200030, Peoples R China.	changqing.zhang@yahoo.com	GAO, YOUSHUI/U-8349-2019	zhang, changqing/0000-0002-7408-4126	Key Medical Project of Shanghai Science and Technology Committee [11411950400]; Project of Shanghai Novel and Frontier Technology [SHDC12012115]	Key Medical Project of Shanghai Science and Technology Committee; Project of Shanghai Novel and Frontier Technology	The current study was funded by the Key Medical Project of Shanghai Science and Technology Committee (No: 11411950400) and the Project of Shanghai Novel and Frontier Technology (No: SHDC12012115). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Fava M, 2008, AM J PSYCHIAT, V165, P342, DOI 10.1176/appi.ajp.2007.06111868; Gupta A, 2007, RHEUMATOLOGY, V46, P666, DOI 10.1093/rheumatology/kel363; Hernigou P, 2003, J BONE JOINT SURG AM, V85A, P500, DOI 10.2106/00004623-200303000-00016; Hirschfeld Robert M A, 2012, J Clin Psychiatry, V73 Suppl 1, P5, DOI 10.4088/JCP.11096su1c.01; Ito H, 2003, J BONE JOINT SURG BR, V85B, P796, DOI 10.1302/0301-620X.85B6.13794; Kang JS, 2009, J ARTHROPLASTY, V24, P1178, DOI 10.1016/j.arth.2009.05.022; Kessler RC, 2009, EPIDEMIOL PSICHIAT S, V18, P23, DOI 10.1017/S1121189X00001421; Korompilias AV, 2009, J BONE JOINT SURG BR, V91B, P287, DOI 10.1302/0301-620X.91B3.21846; Leung KK, 1998, FAM PRACT, V15, P67, DOI 10.1093/fampra/15.1.67; Liu XC, 1997, SOC PSYCH PSYCH EPID, V32, P63, DOI 10.1007/BF00788922; Malizos KN, 2007, EUR J RADIOL, V63, P16, DOI 10.1016/j.ejrad.2007.03.019; MONT MA, 1995, J BONE JOINT SURG AM, V77A, P459, DOI 10.2106/00004623-199503000-00018; Mont MA, 2010, J BONE JOINT SURG AM, V92A, P2165, DOI 10.2106/JBJS.I.00575; Oztekin HH, 2008, KNEE, V15, P368, DOI 10.1016/j.knee.2008.05.007; Rolfson O, 2009, J BONE JOINT SURG BR, V91B, P157, DOI 10.1302/0301-620X.91B2.20765; Rugh J D, 1993, Adv Dent Res, V7, P127; Sayarlioglu M, 2012, RHEUMATOL INT, V32, P177, DOI 10.1007/s00296-010-1597-9; STEINBERG ME, 1995, J BONE JOINT SURG BR, V77B, P34, DOI 10.1302/0301-620X.77B1.7822393; Steinberg ME, 2004, ORTHOP CLIN N AM, V35, P273, DOI 10.1016/j.ocl.2004.02.005; Strine TW, 2008, PSYCHIAT SERV, V59, P1383, DOI 10.1176/appi.ps.59.12.1383; Stundner O, 2013, PSYCHOSOMATICS, V54, P149, DOI 10.1016/j.psym.2012.08.009; Sullivan M, 2009, PAIN, V143, P123, DOI 10.1016/j.pain.2009.02.011; Sun Y, 2009, LUPUS, V18, P1061, DOI 10.1177/0961203309106490; Sutherland AG, 2006, J TRAUMA, V61, P1408, DOI 10.1097/01.ta.0000197562.34651.df; Trief PM, 2000, SPINE, V25, P2616, DOI 10.1097/00007632-200010150-00012; Wang Z.Y., 1984, J SHANGHAI PSYCHIAT, V2, P73; Zhao De-wei, 2012, Orthop Surg, V4, P125, DOI 10.1111/j.1757-7861.2012.00192.x; ZUNG WWK, 1971, PSYCHOSOMATICS, V12, P371; ZUNG WWK, 1965, ARCH GEN PSYCHIAT, V12, P63, DOI 10.1001/archpsyc.1965.01720310065008	29	23	26	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2015	10	3							e0120234	10.1371/journal.pone.0120234	http://dx.doi.org/10.1371/journal.pone.0120234			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD9NQ	25789850	Green Published, gold, Green Submitted			2022-12-27	WOS:000351425400143
J	Guler, R; Parihar, SP; Savvi, S; Logan, E; Schwegmann, A; Roy, S; Nieuwenhuizen, NE; Ozturk, M; Schmeier, S; Suzuki, H; Brombacher, F				Guler, Reto; Parihar, Suraj P.; Savvi, Suzana; Logan, Erin; Schwegmann, Anita; Roy, Sugata; Nieuwenhuizen, Natalie E.; Ozturk, Mumin; Schmeier, Sebastian; Suzuki, Harukazu; Brombacher, Frank			IL-4R alpha-Dependent Alternative Activation of Macrophages Is Not Decisive for Mycobacterium tuberculosis Pathology and Bacterial Burden in Mice	PLOS ONE			English	Article							PULMONARY TUBERCULOSIS; IMMUNE-RESPONSE; T-CELLS; EXPRESSION; RECEPTOR; IL-4; INTERLEUKIN-4; DEPENDS; ALPHA; DELTA	Classical activation of macrophages (caMph or M1) is crucial for host protection against Mycobacterium tuberculosis (Mtb) infection. Evidence suggests that IL-4/IL-13 alternatively activated macrophages (aaMph or M2) are exploited by Mtb to divert microbicidal functions of caMph. To define the functions of M2 macrophages during tuberculosis (TB), we infected mice deficient for IL-4 receptor alpha on macrophages (LysM(cre)IL-4R alpha(-/lox)) with Mtb. We show that absence of IL-4R alpha on macrophages does not play a major role during infection with Mtb H37Rv, or the clinical Beijing strain HN878. This was demonstrated by similar mortality, bacterial burden, histopathology and T cell proliferation between infected wild-type (WT) and LysM(cre)IL-4R alpha(-/lox) mice. Interestingly, we observed no differences in the lung expression of inducible nitric oxide synthase (iNOS) and Arginase 1 (Arg1), well-established markers for M1/M2 macrophages among the Mtb-infected groups. Kinetic expression studies of IL-4/IL-13 activated bone marrow-derived macrophages (BMDM) infected with HN878, followed by gene set enrichment analysis, revealed that the MyD88 and IL-6, IL-10, G-CSF pathways are significantly enriched, but not the IL-4R alpha driven pathway. Together, these results suggest that IL-4R alpha-macrophages do not play a central role in TB disease progression.	[Guler, Reto; Parihar, Suraj P.; Savvi, Suzana; Logan, Erin; Schwegmann, Anita; Nieuwenhuizen, Natalie E.; Ozturk, Mumin; Brombacher, Frank] Univ Cape Town, Int Ctr Genet Engn & Biotechnol, Cape Town Component & Inst Infect Dis & Mol Med I, Div Immunol, ZA-7925 Cape Town, South Africa; [Schmeier, Sebastian] Massey Univ, Inst Nat & Math Sci, Auckland, New Zealand; [Roy, Sugata; Suzuki, Harukazu] RIKEN, Ctr Life Sci Technol, Div Genom Technol, Yokohama, Kanagawa, Japan	International Center for Genetic Engineering & Biotechnology (ICGEB); ICGEB Cape Town; University of Cape Town; Massey University; RIKEN	Brombacher, F (corresponding author), Univ Cape Town, Int Ctr Genet Engn & Biotechnol, Cape Town Component & Inst Infect Dis & Mol Med I, Div Immunol, ZA-7925 Cape Town, South Africa.	frank.brombacher@icgeb.org	Parihar, Suraj/HCI-2597-2022; Schmeier, Sebastian/D-4731-2011; Nieuwenhuizen, Natalie/AAP-2400-2021; Ozturk, Mumin/G-9739-2016; Suzuki, Harukazu/N-9553-2015	Parihar, Suraj/0000-0002-4932-7990; Schmeier, Sebastian/0000-0002-3947-8226; Ozturk, Mumin/0000-0001-9152-7614; Suzuki, Harukazu/0000-0002-8087-0836; Aldera, Erin/0000-0001-7935-1337; Roy, Sugata/0000-0001-7183-7957; Nieuwenhuizen, Natalie/0000-0001-5749-2462	International Centre for Genetic Engineering & Biotechnology (ICGEB); Cape Town Component with Arturo Falaschi; Claude Leon Foundation; CIDRI; Wellcome trust [084323]; South African Medical Research Council; ICGEB Arturo Falaschi PhD Fellowship	International Centre for Genetic Engineering & Biotechnology (ICGEB)(Department of Biotechnology (DBT) India); Cape Town Component with Arturo Falaschi; Claude Leon Foundation; CIDRI; Wellcome trust(Wellcome TrustEuropean Commission); South African Medical Research Council(South African Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)); ICGEB Arturo Falaschi PhD Fellowship	This work was supported by the International Centre for Genetic Engineering & Biotechnology (ICGEB), Cape Town Component with Arturo Falaschi, Claude Leon Foundation and CIDRI, Wellcome trust (Grant No. 084323) post-doctoral fellowships to SPP. South African Medical Research Council (SAMRC) Unit on Immunology of Infectious Diseases (FB). A National Research Funding (NRF) South Africa and the South African Research Chair initiative (SARChi) to FB, the NRF Competitive Programme for Unrated Researchers (CSUR) and South African Medical Research Council (Self-Initiated Research Grant) to RG, the JST Strategic International Research Cooperative Program to HS and ICGEB Arturo Falaschi PhD Fellowship to MO. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashenafi S, 2014, CLIN IMMUNOL, V151, P84, DOI 10.1016/j.clim.2014.01.010; Benoit M, 2008, J IMMUNOL, V181, P3733, DOI 10.4049/jimmunol.181.6.3733; Cerami EG, 2011, NUCLEIC ACIDS RES, V39, pD685, DOI 10.1093/nar/gkq1039; Clausen BE, 1999, TRANSGENIC RES, V8, P265, DOI 10.1023/A:1008942828960; Dewals BG, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000689; Dheda K, 2007, TUBERCULOSIS, V87, P237, DOI 10.1016/j.tube.2006.11.001; El Kasmi KC, 2008, NAT IMMUNOL, V9, P1399, DOI 10.1038/ni.1671; Gonzalez-Juarrero M, 2003, J IMMUNOL, V171, P3128, DOI 10.4049/jimmunol.171.6.3128; Gordon S, 2003, NAT REV IMMUNOL, V3, P23, DOI 10.1038/nri978; Gray MJ, 2005, GENE, V353, P98, DOI 10.1016/j.gene.2005.04.004; Guler R, 2011, VACCINE, V29, P1339, DOI 10.1016/j.vaccine.2010.10.045; Herbert DR, 2004, IMMUNITY, V20, P623, DOI 10.1016/S1074-7613(04)00107-4; Holscher C, 2006, J IMMUNOL, V176, P1115, DOI 10.4049/jimmunol.176.2.1115; Howard AD, 1999, CLIN EXP IMMUNOL, V115, P428; Huber S, 2010, BLOOD, V116, P3311, DOI 10.1182/blood-2010-02-271981; Kahnert A, 2006, EUR J IMMUNOL, V36, P631, DOI 10.1002/eji.200535496; Lowe DM, 2012, TRENDS IMMUNOL, V33, P14, DOI 10.1016/j.it.2011.10.003; Manca C, 2004, INFECT IMMUN, V72, P5511, DOI 10.1128/IAI.72.9.5511-5514.2004; Martinez FO, 2009, ANNU REV IMMUNOL, V27, P451, DOI 10.1146/annurev.immunol.021908.132532; Muller U, 2013, INT IMMUNOL, V25, P459, DOI 10.1093/intimm/dxt003; Nieuwenhuizen NE, 2012, J ALLERGY CLIN IMMUN, V130, P743, DOI 10.1016/j.jaci.2012.03.011; Nolan A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059461; O'Garra A, 2013, ANNU REV IMMUNOL, V31, P475, DOI 10.1146/annurev-immunol-032712-095939; Ordway DJ, 2004, J INFECT DIS, V190, P756, DOI 10.1086/422532; Pathak SK, 2007, NAT IMMUNOL, V8, P610, DOI 10.1038/ni1468; Pauleau AL, 2004, J IMMUNOL, V172, P7565, DOI 10.4049/jimmunol.172.12.7565; Pesce JT, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000371; Pessanha AP, 2012, FEMS IMMUNOL MED MIC, V66, P265, DOI 10.1111/j.1574-695X.2012.01012.x; Qualls JE, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000955; Reich M, 2006, NAT GENET, V38, P500, DOI 10.1038/ng0506-500; Schaefer CF, 2009, NUCLEIC ACIDS RES, V37, pD674, DOI 10.1093/nar/gkn653; Schwegmann A, 2007, P NATL ACAD SCI USA, V104, P16251, DOI 10.1073/pnas.0703496104; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; van Crevel R, 2000, J INFECT DIS, V181, P1194, DOI 10.1086/315325; Welsh KJ, 2008, MICROBIOL-SGM, V154, P1813, DOI 10.1099/mic.0.2008/016923-0; Wolf AJ, 2007, J IMMUNOL, V179, P2509, DOI 10.4049/jimmunol.179.4.2509	36	20	21	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2015	10	3							e0121070	10.1371/journal.pone.0121070	http://dx.doi.org/10.1371/journal.pone.0121070			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD9NQ	25790379	Green Published, gold, Green Submitted			2022-12-27	WOS:000351425400188
J	Johansson, PI; Bro-Jeppesen, J; Kjaergaard, J; Wanscher, M; Hassager, C; Ostrowski, SR				Johansson, Par I.; Bro-Jeppesen, John; Kjaergaard, Jesper; Wanscher, Michael; Hassager, Christian; Ostrowski, Sisse R.			Sympathoadrenal Activation and Endothelial Damage Are Inter Correlated and Predict Increased Mortality in Patients Resuscitated after Out-Of-Hospital Cardiac Arrest. A Post Hoc Sub-Study of Patients from the TTM-Trial	PLOS ONE			English	Article							THERAPEUTIC STRATEGIES; TEMPERATURE MANAGEMENT; REDUCED MORTALITY; HEART-ASSOCIATION; CLINICAL-TRIAL; GLYCOCALYX; COAGULOPATHY; SURGERY; SEPSIS; INJURY	Objective Sympathoadrenal activation and endothelial damage are hallmarks of acute critical illness. This study investigated their association and predictive value in patients resuscitated from out-of-hospital cardiac arrest (OHCA). Methods Post-hoc analysis of patients included at a single site in The Targeted Temperature Management at 33 degrees versus 36 degrees after Cardiac Arrest (TTM) trial. The main study reported similar outcomes with targeting 33 versus 36 degrees. TTM main study ClinicalTrials.gov: NCT01020916. One hundred sixty three patients resuscitated from OHCA were included at a single site ICU. Blood was sampled a median 135 min (Inter Quartile Range (IQR) 103-169) after OHCA. Plasma catecholamines (adrenaline, noradrenaline) and serum endothelial biomarkers (syndecan-1, thrombomodulin, sE-selectin, sVE-cadherin) were measured at admission (immediately after randomization). We had access to data on demography, medical history, characteristics of the OHCA, patients and 180-day outcome. Results Adrenaline and noradrenaline correlated positively with syndecan-1 and thrombomodulin i.e., biomarkers reflecting endothelial damage (both p<0.05). Overall 180-day mortality was 35%. By Cox analyses, plasma adrenaline, serum sE-selectin, reflecting endothelial cell activation, and thrombomodulin levels predicted mortality. However, thrombomodulin was the only biomarker independently associated with mortality after adjusting for gender, age, rhythm (shockable vs. non-shockable), OHCA to return of spontaneous circulation (ROSC) time, shock at admission and ST elevation myocardial infarction (30-day Hazards Ratio 1.71 (IQR 1.05-2.77), p=0.031 and 180-day Hazards Ratio 1.65 (IQR 1.03-2.65), p=0.037 for 2-fold higher thrombomodulin levels). Conclusions Circulating catecholamines and endothelial damage were intercorrelated and predicted increased mortality. Interventions aiming at protecting and/or restoring the endothelium may be beneficial in OHCA patients.	[Johansson, Par I.; Ostrowski, Sisse R.] Rigshosp, Sect Transfus Med Capital Reg Blood Bank, DK-2100 Copenhagen, Capital Region, Denmark; [Johansson, Par I.] Univ Texas Houston, Sch Med, Dept Surg, Ctr Translat Injury Res CeTIR, Houston, TX USA; [Bro-Jeppesen, John; Kjaergaard, Jesper; Hassager, Christian] Univ Texas Houston, Sch Med, Div Acute Care Surg, Ctr Translat Injury Res CeTIR, Houston, TX USA; [Wanscher, Michael] Rigshosp, Dept Cardiol, DK-2100 Copenhagen, Capital Region, Denmark; [Wanscher, Michael] Rigshosp, Ctr Heart, Dept Cardiothorac Anesthesiol, DK-2100 Copenhagen, Capital Region, Denmark	Rigshospitalet; University of Copenhagen; University of Texas System; University of Texas Health Science Center Houston; University of Texas System; University of Texas Health Science Center Houston; Rigshospitalet; University of Copenhagen; Rigshospitalet; University of Copenhagen	Johansson, PI (corresponding author), Rigshosp, Sect Transfus Med Capital Reg Blood Bank, DK-2100 Copenhagen, Capital Region, Denmark.	per.johansson@regionh.dk	Ostrowski, Sisse R/E-7423-2011; Johansson, Pär/GQB-1032-2022; Johansson, Pär I/P-9283-2015	Ostrowski, Sisse R/0000-0001-5288-3851; Johansson, Pär/0000-0001-9778-5964; Johansson, Pär I/0000-0001-9778-5964; Kjaergaard, Jesper/0000-0001-5244-0399; Hassager, Christian/0000-0002-1199-0981	Trygfonden	Trygfonden	This work was funded by Trygfonden. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adrie C, 2002, CIRCULATION, V106, P562, DOI 10.1161/01.CIR.0000023891.80661.AD; Becker BF, 2010, CARDIOVASC RES, V87, P300, DOI 10.1093/cvr/cvq137; Becker RC, 2005, AM HEART J, V150, P189, DOI 10.1016/j.ahj.2005.04.006; Bernard SA, 2002, NEW ENGL J MED, V346, P557, DOI 10.1056/NEJMoa003289; Blann A, 1997, CLIN HEMORHEOL MICRO, V17, P3; Blann AD, 2000, BLOOD COAGUL FIBRIN, V11, P623, DOI 10.1097/00001721-200010000-00006; Bukur M, 2012, AM J SURG, V204, P697, DOI 10.1016/j.amjsurg.2012.02.007; Callaway CW, 2012, JAMA-J AM MED ASSOC, V307, P1198, DOI 10.1001/jama.2012.313; Christensen S, 2011, CRIT CARE, V15, DOI 10.1186/cc10085; CRYER PE, 1980, NEW ENGL J MED, V303, P436; Dunser Martin W, 2009, J Intensive Care Med, V24, P293, DOI 10.1177/0885066609340519; Gando S, 2000, INTENS CARE MED, V26, P38, DOI 10.1007/s001340050009; Gando S, 2011, ANN SURG, V254, P10, DOI 10.1097/SLA.0b013e31821221b1; Gando S, 2010, CRIT CARE MED, V38, pS35, DOI 10.1097/CCM.0b013e3181c9e31d; Grundmann S, 2012, RESUSCITATION, V83, P715, DOI 10.1016/j.resuscitation.2012.01.028; Hagihara A, 2012, JAMA-J AM MED ASSOC, V307, P1161, DOI 10.1001/jama.2012.294; Haywood-Watson RJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023530; Hess JR, 2006, J TRAUMA, V60, pS12, DOI 10.1097/01.ta.0000199545.06536.22; Holcomb JB, 2011, ANN SURG, V254, P201, DOI 10.1097/SLA.0b013e318226483d; Holzer M, 2002, NEW ENGL J MED, V346, P549; ISHII H, 1991, THROMB HAEMOSTASIS, V65, P618; Johansson PI, 2010, MED HYPOTHESES, V75, P564, DOI 10.1016/j.mehy.2010.07.031; Johansson PI, 2011, ANN SURG, V254, P194, DOI 10.1097/SLA.0b013e318226113d; Johansson PI, 2012, J TRAUMA ACUTE CARE, V72, P428, DOI 10.1097/TA.0b013e31821e0f93; Kozar RA, 2011, ANESTH ANALG, V112, P1289, DOI 10.1213/ANE.0b013e318210385c; Kristova Viera, 1993, Acta Physiologica Hungarica, V81, P363; London MJ, 2013, JAMA-J AM MED ASSOC, V309, P1704, DOI 10.1001/jama.2013.4135; Macchia A, 2012, CRIT CARE MED, V40, P2768, DOI 10.1097/CCM.0b013e31825b9509; MAKHMUDOV RM, 1985, COR VASA, V27, P456; Morelli A, 2013, JAMA-J AM MED ASSOC, V310, P1683, DOI 10.1001/jama.2013.278477; Myrup B, 2004, DIABETIC MED, V21, P1135, DOI 10.1111/j.1464-5491.2004.01313.x; Neumar RW, 2008, CIRCULATION, V118, P2452, DOI 10.1161/CIRCULATIONAHA.108.190652; Nichol G, 2008, JAMA-J AM MED ASSOC, V300, P1423, DOI 10.1001/jama.300.12.1423; Nielsen N, 2013, NEW ENGL J MED, V369, P2197, DOI 10.1056/NEJMoa1310519; Nielsen N, 2012, AM HEART J, V163, P541, DOI 10.1016/j.ahj.2012.01.013; O'Gara PT, 2013, CIRCULATION, V127, P529, DOI 10.1161/CIR.0b013e3182742c84; Olasveengen TM, 2009, JAMA-J AM MED ASSOC, V302, P2222, DOI 10.1001/jama.2009.1729; Ostrowski SR, 2013, J CRIT CARE, V28, P586, DOI 10.1016/j.jcrc.2013.04.010; Ostrowski SR, 2013, CRIT CARE, V17, DOI 10.1186/cc12532; Rehm M, 2007, CIRCULATION, V116, P1896, DOI 10.1161/CIRCULATIONAHA.106.684852; Reynolds JC, 2013, CIRCULATION, V128, P2488, DOI 10.1161/CIRCULATIONAHA.113.002408; Salmon AHJ, 2012, J PATHOL, V226, P562, DOI 10.1002/path.3964; Schroeppel TJ, 2010, J TRAUMA, V69, P776, DOI 10.1097/TA.0b013e3181e981b8; Steppan J, 2011, J SURG RES, V165, P136, DOI 10.1016/j.jss.2009.04.034; Stub D, 2011, CIRCULATION, V123, P1428, DOI 10.1161/CIRCULATIONAHA.110.988725; VanTeeffelen JWGE, 2007, HYPERTENSION, V50, P261, DOI 10.1161/HYPERTENSIONAHA.107.089250; Vestweber D, 2008, ARTERIOSCL THROM VAS, V28, P223, DOI 10.1161/ATVBAHA.107.158014; von Kanel R, 2000, EUR J HAEMATOL, V65, P357, DOI 10.1034/j.1600-0609.2000.065006357.x; Wada T, 2012, CRIT CARE, V16, DOI 10.1186/cc11648	49	42	43	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2015	10	3							e0120914	10.1371/journal.pone.0120914	http://dx.doi.org/10.1371/journal.pone.0120914			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD9NQ	25789868	Green Published, Green Submitted, gold			2022-12-27	WOS:000351425400183
J	Luz, D; Chen, G; Maranhao, AQ; Rocha, LB; Sidhu, S; Piazza, RMF				Luz, Daniela; Chen, Gang; Maranhao, Andrea Q.; Rocha, Leticia B.; Sidhu, Sachdev; Piazza, Roxane M. F.			Development and Characterization of Recombinant Antibody Fragments That Recognize and Neutralize In Vitro Stx2 Toxin from Shiga Toxin-Producing Escherichia coli	PLOS ONE			English	Article							HEMOLYTIC-UREMIC SYNDROME; MONOCLONAL-ANTIBODIES; TYPE-2 STX2; BINDING; DIARRHEA; CHAIN; MICE; PATHOGENESIS; DISEASE	Background Stx toxin is a member of the AB(5) family of bacterial toxins: the active A subunit has N-glyco-sidase activity against 28S rRNA, resulting in inhibition of protein synthesis in eukaryotic cells, and the pentamer ligand B subunits (StxB) bind to globotria(tetra) osylceramide receptors (Gb3/Gb4) on the cell membrane. Shiga toxin-producing Escherichia coli strains (STEC) may produce Stx1 and/or Stx2 and variants. Strains carrying Stx2 are considered more virulent and related to the majority of outbreaks, besides being usually associated with hemolytic uremic syndrome in humans. The development of tools for the detection and/or neutralization of these toxins is a turning point for early diagnosis and therapeutics. Antibodies are an excellent paradigm for the design of high-affinity, protein-based binding reagents used for these purposes. Methods and Findings In this work, we developed two recombinant antibodies; scFv fragments from mouse hybridomas and Fab fragments by phage display technology using a human synthetic antibody library. Both fragments showed high binding affinity to Stx2, and they were able to bind specifically to the GKIEFSKYNEDDTF region of the Stx2 B subunit and to neutralize in vitro the cytotoxicity of the toxin up to 80%. Furthermore, the scFv fragments showed 79% sensitivity and 100% specificity in detecting STEC strains by ELISA. Conclusion In this work, we developed and characterized two recombinant antibodies against Stx2, as promising tools to be used in diagnosis or therapeutic approaches against STEC, and for the first time, we showed a human monovalent molecule, produced in bacteria, able to neutralize the cytotoxicity of Stx2 in vitro.	[Luz, Daniela; Rocha, Leticia B.; Piazza, Roxane M. F.] Inst Butantan, Lab Bacteriol, Sao Paulo, Brazil; [Maranhao, Andrea Q.] Univ Toronto, Banting & Best Dept Med Res, Terrence Donnelly Ctr Cellular & Biomol Res, Toronto, ON, Canada; [Maranhao, Andrea Q.] Univ Brasilia, Lab Imunol, Brasilia, DF, Brazil	Instituto Butantan; University of Toronto; Universidade de Brasilia	Piazza, RMF (corresponding author), Inst Butantan, Lab Bacteriol, Sao Paulo, Brazil.	roxane@butantan.gov.br	Piazza, Roxane/ABD-9196-2020; Maranhão, Andrea Q/L-4474-2013; Piazza, Roxane MF/A-9915-2018; Maranhão, Andrea/AAC-3560-2019; Piazza, Roxane Maria F/K-9807-2016; Rocha, Letícia/F-1225-2015; Maranhão, Andrea Queiroz/S-8696-2019; Luz, Daniela/C-2374-2019	Piazza, Roxane/0000-0003-0068-8506; Maranhão, Andrea Q/0000-0002-1946-7191; Piazza, Roxane MF/0000-0003-0068-8506; Maranhão, Andrea/0000-0002-1946-7191; Chen, Gang/0000-0002-6304-9173; Luz, Daniela/0000-0001-9622-0320	Sao Paulo Research Foundation (FAPESP) [11/12928-2]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) [-301302/2013-8]; FAPESP [10/20148-4, 13/03160-9]; FAPESP fellowships	Sao Paulo Research Foundation (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); FAPESP fellowships(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	This research was supported by grants 11/12928-2 from Sao Paulo Research Foundation (FAPESP) and from Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq -301302/2013-8) to RMFP. DL (FAPESP - 10/20148-4 and 13/03160-9) and LBR were recipients of FAPESP fellowships. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akiyoshi DE, 2010, INFECT IMMUN, V78, P1376, DOI 10.1128/IAI.00867-09; Bielaszewska M, 2011, LANCET INFECT DIS, V11, P671, DOI 10.1016/S1473-3099(11)70165-7; Boerlin P, 1999, J CLIN MICROBIOL, V37, P497, DOI 10.1128/JCM.37.3.497-503.1999; Caldas C, 2000, PROTEIN ENG, V13, P353, DOI 10.1093/protein/13.5.353; Cheng LW, 2013, TOXINS, V5, P1845, DOI 10.3390/toxins5101845; CHUNG CT, 1989, P NATL ACAD SCI USA, V86, P2172, DOI 10.1073/pnas.86.7.2172; Cornick NA, 2002, J INFECT DIS, V186, P57, DOI 10.1086/341295; Davis TK, 2013, INFECT DIS CLIN N AM, V27, P577, DOI 10.1016/j.idc.2013.05.010; de Andrade EV, 2005, BBA-GEN SUBJECTS, V1726, P293, DOI 10.1016/j.bbagen.2005.08.013; Fellouse FAS, 2007, MAKING USING ANTIBOD, P157; Fernandez-Brando RJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019136; Fraser ME, 2004, J BIOL CHEM, V279, P27511, DOI 10.1074/jbc.M401939200; FRIGUET B, 1985, J IMMUNOL METHODS, V77, P305, DOI 10.1016/0022-1759(85)90044-4; Gould L. Hannah, 2009, Morbidity and Mortality Weekly Report, V58, P1; He XH, 2013, J IMMUNOL METHODS, V389, P18, DOI 10.1016/j.jim.2012.12.005; Holliger P, 2005, NAT BIOTECHNOL, V23, P1126, DOI 10.1038/nbt1142; Hudson PJ, 2003, NAT MED, V9, P129, DOI 10.1038/nm0103-129; Ibarra C, 2013, IUBMB LIFE, V65, P827, DOI 10.1002/iub.1206; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; Laing CR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037362; Lopez EL, 2010, ANTIMICROB AGENTS CH, V54, P239, DOI 10.1128/AAC.00343-09; Ma Y, 2008, IMMUNOL LETT, V121, P110, DOI 10.1016/j.imlet.2008.09.008; Mendes-Ledesma MRB, 2008, MICROBIOL IMMUNOL, V52, P484, DOI 10.1111/j.1348-0421.2008.00068.x; Miethe S, 2014, MABS-AUSTIN, V6, P446, DOI 10.4161/mabs.27773; Mohawk KL, 2010, VACCINE, V28, P4777, DOI 10.1016/j.vaccine.2010.04.099; Mukherjee J, 2002, INFECT IMMUN, V70, P5896, DOI 10.1128/IAI.70.10.5896-5899.2002; Mukherjee J, 2002, INFECT IMMUN, V70, P612, DOI 10.1128/IAI.70.2.612-619.2002; Murase K, 2003, CHEM BIOL, V10, P161, DOI 10.1016/S1074-5521(03)00025-5; Nakao H, 1999, INFECT IMMUN, V67, P5717, DOI 10.1128/IAI.67.11.5717-5722.1999; Neri P, 2011, VACCINE, V29, P5340, DOI 10.1016/j.vaccine.2011.05.093; Palermo MS, 2009, EXPERT REV ANTI-INFE, V7, P697, DOI [10.1586/eri.09.49, 10.1586/ERI.09.49]; Parma YR, 2011, TOXICON, V58, P380, DOI 10.1016/j.toxicon.2011.07.009; Persson H, 2013, J MOL BIOL, V425, P803, DOI 10.1016/j.jmb.2012.11.037; RILEY LW, 1983, NEW ENGL J MED, V308, P681, DOI 10.1056/NEJM198303243081203; Rivas M, 2006, FOODBORNE PATHOG DIS, V3, P88, DOI 10.1089/fpd.2006.3.88; Rocha B, 2007, LETT APPL MICROBIOL, V45, P411, DOI 10.1111/j.1472-765X.2007.02214.x; Rocha LB, 2012, TOXINS, V4, P729, DOI 10.3390/toxins4090729; Scheutz F, 2012, J CLIN MICROBIOL, V50, P2951, DOI 10.1128/JCM.00860-12; Sheoran AS, 2005, INFECT IMMUN, V73, P4607, DOI 10.1128/IAI.73.8.4607-4613.2005; Skinner C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099854; Skinner C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076563; Thompson GS, 2000, BIOCHEMISTRY-US, V39, P13153, DOI 10.1021/bi001394+; Tonikian R, 2007, NAT PROTOC, V2, P1368, DOI 10.1038/nprot.2007.151; Tremblay JM, 2013, INFECT IMMUN, V81, P4592, DOI 10.1128/IAI.01033-13; YAMADA S, 1993, MICROBIOL IMMUNOL, V37, P111, DOI 10.1111/j.1348-0421.1993.tb03187.x; Yamagami S, 2001, J INFECT DIS, V184, P738, DOI 10.1086/323082	46	25	26	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2015	10	3							e0120481	10.1371/journal.pone.0120481	http://dx.doi.org/10.1371/journal.pone.0120481			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD9NQ	25790467	Green Published, Green Submitted, gold			2022-12-27	WOS:000351425400159
J	Paech, D; Burth, S; Windschuh, J; Meissner, JE; Zaiss, M; Eidel, O; Kickingereder, P; Nowosielski, M; Wiestler, B; Sahm, F; Floca, RO; Neumann, JO; Wick, W; Heiland, S; Bendszus, M; Schlemmer, HP; Ladd, ME; Bachert, P; Radbruch, A				Paech, Daniel; Burth, Sina; Windschuh, Johannes; Meissner, Jan-Eric; Zaiss, Moritz; Eidel, Oliver; Kickingereder, Philipp; Nowosielski, Martha; Wiestler, Benedikt; Sahm, Felix; Floca, Ralf Omar; Neumann, Jan-Oliver; Wick, Wolfgang; Heiland, Sabine; Bendszus, Martin; Schlemmer, Heinz-Peter; Ladd, Mark Edward; Bachert, Peter; Radbruch, Alexander			Nuclear Overhauser Enhancement Imaging of Glioblastoma at 7 Tesla: Region Specific Correlation with Apparent Diffusion Coefficient and Histology	PLOS ONE			English	Article							EXCHANGE SATURATION-TRANSFER; TUMORS IN-VIVO; HUMAN BRAIN; MAGNETIZATION-TRANSFER; PERITUMORAL EDEMA; TRANSFER CEST; WEIGHTED MRI; GLIOMA; PH; SPECTROSCOPY	Objective To explore the correlation between Nuclear Overhauser Enhancement (NOE)-mediated signals and tumor cellularity in glioblastoma utilizing the apparent diffusion coefficient (ADC) and cell density from histologic specimens. NOE is one type of chemical exchange saturation transfer (CEST) that originates from mobile macromolecules such as proteins and might be associated with tumor cellularity via altered protein synthesis in proliferating cells. Patients and Methods For 15 patients with newly diagnosed glioblastoma, NOE-mediated CEST-contrast was acquired at 7 Tesla (asymmetric magnetization transfer ratio (MTRasym) at 3.3ppm, B1 = 0.7 mu T). Contrast enhanced T1 (CE-T1), T2 and diffusion-weighted MRI (DWI) were acquired at 3 Tesla and coregistered. The T2 edema and the CE-T1 tumor were segmented. ADC and MTRasym values within both regions of interest were correlated voxelwise yielding the correlation coefficient r(Spearman) (r(Sp)). In three patients who underwent stereotactic biopsy, cell density of 12 specimens per patient was correlated with corresponding MTRasym and ADC values of the biopsy site. Results Eight of 15 patients showed a weak or moderate positive correlation of MTRasym and ADC within the T2 edema (0.16 <= r(Sp)<= 0.53, p< 0.05). Seven correlations were statistically insignificant (p>0.05, n = 4) or yielded r(Sp)approximate to 0 (p< 0.05, n = 3). No trend towards a correlation between MTRasym and ADC was found in CE-T1 tumor (-0.31<r(Sp)<0.28,p< 0.05, n = 9; p>0.05, n = 6). The biopsy-analysis within CE-T1 tumor revealed a strong positive correlation between tumor cellularity and MTRasym values in two of the three patients (r(Sp)(patient3) = 0.69 and r(S)(patient15) = 0.87, p<0.05), while the correlation of ADC and cellularity was heterogeneous (r(Sp)(patient3) = 0.545 (p = 0.067), r(Sp)(patient4) = -0.021 (p = 0.948), r(Sp)(patient15) = -0.755 (p = 0.005)). Discussion NOE-imaging is a new contrast promising insight into pathophysiologic processes in glioblastoma regarding cell density and protein content, setting itself apart from DWI. Future studies might be based on the assumption that NOE-mediated CEST visualizes cellularity more accurately than ADC, especially in the CE-T1 tumor region.	[Paech, Daniel; Burth, Sina; Eidel, Oliver; Kickingereder, Philipp; Heiland, Sabine; Bendszus, Martin; Radbruch, Alexander] Heidelberg Univ, Med Ctr, Dept Neuroradiol, Heidelberg, Germany; [Paech, Daniel; Burth, Sina; Meissner, Jan-Eric; Radbruch, Alexander] Deutsch Krebsforschungszentrum DKFZ, Dept Radiol, Neurooncol Imaging, Heidelberg, Germany; [Windschuh, Johannes; Meissner, Jan-Eric; Zaiss, Moritz; Ladd, Mark Edward; Bachert, Peter] Deutsch Krebsforschungszentrum DKFZ, Dept Med Phys Radiol, Heidelberg, Germany; [Nowosielski, Martha] Med Univ Innsbruck, Dept Neurol, A-6020 Innsbruck, Austria; [Wiestler, Benedikt; Wick, Wolfgang] Heidelberg Univ, Med Ctr, Dept Neurol, Heidelberg, Germany; [Sahm, Felix] Heidelberg Univ, Dept Neuropathol, Med Ctr, Heidelberg, Germany; [Floca, Ralf Omar; Schlemmer, Heinz-Peter] Deutsch Krebsforschungszentrum DKFZ, Dept Radiol, Heidelberg, Germany; [Neumann, Jan-Oliver] Heidelberg Univ, Dept Neurosurg, Med Ctr, Heidelberg, Germany	Ruprecht Karls University Heidelberg; Helmholtz Association; German Cancer Research Center (DKFZ); Helmholtz Association; German Cancer Research Center (DKFZ); Medical University of Innsbruck; Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg; Helmholtz Association; German Cancer Research Center (DKFZ); Ruprecht Karls University Heidelberg	Radbruch, A (corresponding author), Heidelberg Univ, Med Ctr, Dept Neuroradiol, Heidelberg, Germany.	a.radbruch@dkfz.de	Wick, Wolfgang/AAA-2545-2020; Radbruch, Alexander/ABA-6277-2021; Sahm, Felix/GQY-8202-2022; Nowosielski, Martha/AAD-5442-2022; Vollmuth, Philipp/AAK-3267-2021	Wick, Wolfgang/0000-0002-6171-634X; Sahm, Felix/0000-0001-5441-1962; Paech, Daniel/0000-0001-5755-6833; Zaiss, Moritz/0000-0001-9780-3616; Ladd, Mark/0000-0002-4128-9440; Vollmuth (ne Kickingereder), Philipp/0000-0002-6224-0064; Radbruch, Alexander/0000-0001-6238-6525; Wiestler, Benedikt/0000-0002-2963-7772	"Intramurales Forderprogramm" of the German Cancer Research Center (DKFZ)	"Intramurales Forderprogramm" of the German Cancer Research Center (DKFZ)	This study was supported by a grant from the "Intramurales Forderprogramm" of the German Cancer Research Center (DKFZ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], AUT NUCL COUNT PLUG; Bentaib A, 2015, J PROTEOMICS, V113, P292, DOI 10.1016/j.jprot.2014.09.019; Bonett DG, 2002, STAT MED, V21, P1331, DOI 10.1002/sim.1108; Chen LH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079008; Cramer W, 1916, J PHYSIOL-LONDON, V50, P322; Crawford FW, 2009, J NEURO-ONCOL, V91, P337, DOI 10.1007/s11060-008-9719-x; DeAngelis LM, 2001, NEW ENGL J MED, V344, P114, DOI 10.1056/NEJM200101113440207; Deistung A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057924; Ellingson BM, 2010, J MAGN RESON IMAGING, V31, P538, DOI 10.1002/jmri.22068; Engelhorn T, 2009, CANCER SCI, V100, P1856, DOI 10.1111/j.1349-7006.2009.01259.x; Floca R, 2010, IFMBE PROC, V25, P1105; Gerweck LE, 1996, CANCER RES, V56, P1194; Greenberg SM, 2009, LANCET NEUROL, V8, P165, DOI 10.1016/S1474-4422(09)70013-4; GRIFFITHS JR, 1991, BRIT J CANCER, V64, P425, DOI 10.1038/bjc.1991.326; Gupta RK, 2000, J NEURO-ONCOL, V50, P215, DOI 10.1023/A:1006431120031; Hattingen E, 2011, NEURO-ONCOLOGY, V13, P1349, DOI 10.1093/neuonc/nor132; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; Helmlinger G, 1997, NAT MED, V3, P177, DOI 10.1038/nm0297-177; Henkelman RM, 2001, NMR BIOMED, V14, P57, DOI 10.1002/nbm.683; Iwadate Y, 2004, CANCER RES, P64; Jin T, 2013, MAGN RESON MED, V69, P760, DOI 10.1002/mrm.24315; Jones CK, 2006, MAGN RESON MED, V56, P585, DOI 10.1002/mrm.20989; Jones CK, 2013, NEUROIMAGE, V77, P114, DOI 10.1016/j.neuroimage.2013.03.047; Kalkanis SN, 2014, J NEURO-ONCOL, V116, P477, DOI 10.1007/s11060-013-1326-9; KALLINOWSKI F, 1988, BRIT J CANCER, V58, P314, DOI 10.1038/bjc.1988.210; Kono K, 2001, AM J NEURORADIOL, V22, P1081; Liu DP, 2013, MAGN RESON MED, V70, P1070, DOI 10.1002/mrm.24560; Lu S, 2003, AM J NEURORADIOL, V24, P937; Morita KI, 2005, J NEUROSURG, V102, P336, DOI 10.3171/jns.2005.102.2.0336; Murakami R, 2007, RADIOLOGY, V243, P493, DOI 10.1148/radiol.2432060450; Nolden M, 2013, INT J COMPUT ASS RAD, V8, P607, DOI 10.1007/s11548-013-0840-8; OBERHAENSLI RD, 1986, LANCET, V2, P8, DOI 10.1016/S0140-6736(86)92558-4; Paech D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104181; Pope WB, 2012, J NEURO-ONCOL, V108, P491, DOI 10.1007/s11060-012-0847-y; Radbruch A, 2013, EUR J RADIOL, V82, P552, DOI 10.1016/j.ejrad.2012.11.002; Saraswathy S, 2009, J NEURO-ONCOL, V91, P69, DOI 10.1007/s11060-008-9685-3; Schmitt B, 2011, RADIOLOGY, V260, P257, DOI 10.1148/radiol.11101841; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Stadlbauer A, 2006, RADIOLOGY, V240, P803, DOI 10.1148/radiol.2403050937; Sugahara T, 1999, JMRI-J MAGN RESON IM, V9, P53, DOI 10.1002/(SICI)1522-2586(199901)9:1<53::AID-JMRI7>3.0.CO;2-2; Sun PZ, 2008, MAGN RESON MED, V59, P1175, DOI 10.1002/mrm.21591; Sun PZ, 2007, MAGN RESON MED, V57, P405, DOI 10.1002/mrm.21151; Togao O, 2014, NEURO-ONCOLOGY, V16, P441, DOI 10.1093/neuonc/not158; van Zijl PCM, 2011, MAGN RESON MED, V65, P927, DOI 10.1002/mrm.22761; VAUPEL P, 1989, CANCER RES, V49, P6449; Vinogradov E, 2013, J MAGN RESON, V229, P155, DOI 10.1016/j.jmr.2012.11.024; Wang M, 2014, NAT REV CANCER, V14, P581, DOI 10.1038/nrc3800; Wang SL, 2012, J COMPUT ASSIST TOMO, V36, P739, DOI 10.1097/RCT.0b013e3182685436; Wu RH, 2012, CONTRAST MEDIA MOL I, V7, P384, DOI 10.1002/cmmi.505; Xu J, 2014, NMR BIOMED; Zaiss M, 2014, NMR BIOMED, V27, P240, DOI 10.1002/nbm.3054; Zaiss M, 2013, PHYS MED BIOL, V58, pR221, DOI 10.1088/0031-9155/58/22/R221; Zaiss M, 2013, NMR BIOMED, V26, P1815, DOI 10.1002/nbm.3021; Zhou JY, 2008, MAGN RESON MED, V60, P842, DOI 10.1002/mrm.21712; Zhou JY, 2013, MAGN RESON MED, V70, P320, DOI 10.1002/mrm.24784; Zhou JY, 2011, NAT MED, V17, P130, DOI 10.1038/nm.2268; Zhou JY, 2003, MAGNET RESON MED, V50, P1120, DOI 10.1002/mrm.10651; Zou KH, 2003, RADIOLOGY, V227, P617, DOI 10.1148/radiol.2273011499	58	27	27	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2015	10	3							e0121220	10.1371/journal.pone.0121220	http://dx.doi.org/10.1371/journal.pone.0121220			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD9NQ	25789657	Green Published, Green Submitted, gold			2022-12-27	WOS:000351425400192
J	Tapia, O; Fong, LG; Huber, MD; Young, SG; Gerace, L				Tapia, Olga; Fong, Loren G.; Huber, Michael D.; Young, Stephen G.; Gerace, Larry			Nuclear Envelope Protein Lem2 is Required for Mouse Development and Regulates MAP and AKT Kinases	PLOS ONE			English	Article							MEMBRANE-PROTEIN; ESSENTIAL ROLES; DOMAIN PROTEIN; MAN1; EMERIN; LAMINA; INTERACTS; ERYTHROPOIETIN; ACTIVATION; MECHANISMS	The nuclear lamina, along with associated nuclear membrane proteins, is a nexus for regulating signaling in the nucleus. Numerous human diseases arise from mutations in lamina proteins, and experimental models for these disorders have revealed aberrant regulation of various signaling pathways. Previously, we reported that the inner nuclear membrane protein Lem2, which is expressed at high levels in muscle, promotes the differentiation of cultured myoblasts by attenuating ERK signaling. Here, we have analyzed mice harboring a disrupted allele for the Lem2 gene (Lemd2). No gross phenotypic defects were seen in heterozygotes, although muscle regeneration induced by cardiotoxin was delayed. By contrast, homozygous Lemd2 knockout mice died by E11.5. Although many normal morphogenetic hallmarks were observed in E10.5 knockout embryos, most tissues were substantially reduced in size. This was accompanied by activation of multiple MAP kinases (ERK1/2, JNK, p38) and AKT. Knockdown of Lem2 expression in C2C12 myoblasts also led to activation of MAP kinases and AKT. These findings indicate that Lemd2 plays an essential role in mouse embryonic development and that it is involved in regulating several signaling pathways. Since increased MAP kinase and AKT/mTORC signaling is found in other animal models for diseases linked to nuclear lamina proteins, LEMD2 should be considered to be another candidate gene for human disease.	[Tapia, Olga; Huber, Michael D.; Gerace, Larry] Scripps Res Inst, Dept Cell & Mol Biol, La Jolla, CA 92037 USA; [Fong, Loren G.; Young, Stephen G.] Univ Calif Los Angeles, Dept Med, Los Angeles, CA 90095 USA; [Young, Stephen G.] Univ Calif Los Angeles, Dept Human Genet, Los Angeles, CA 90095 USA	Scripps Research Institute; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles	Gerace, L (corresponding author), Scripps Res Inst, Dept Cell & Mol Biol, 10550 N Torrey Pines Rd, La Jolla, CA 92037 USA.	lgerace@scripps.edu	Tapia, Olga/AAN-2427-2020; Tapia, Olga/AAH-8651-2020	Tapia, Olga/0000-0002-0802-7975; Young, Stephen/0000-0001-7270-3176	NIH [GM028521, HL086683, HL089781, AG035626]; Imaging Core of NIH grant [AR061303]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL086683, R01HL089781] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P30AR061303] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM028521] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG035626] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Imaging Core of NIH grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by NIH grants GM028521 to L.G., HL086683 and HL089781 (to L.G. F.), and AG035626 (to S.G.Y.). Support also was provided by the Imaging Core of NIH grant AR061303 (San Diego Skeletal Muscle Research Center).	Asencio C, 2012, CELL, V150, P122, DOI 10.1016/j.cell.2012.04.043; Barkan R, 2012, MOL BIOL CELL, V23, P543, DOI 10.1091/mbc.E11-06-0505; Barton LJ, 2014, GENETICS, V197, P653, DOI 10.1534/genetics.114.162941; BIONE S, 1994, NAT GENET, V8, P323, DOI 10.1038/ng1294-323; Bourgeois B, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2003411; Brachner A, 2005, J CELL SCI, V118, P5797, DOI 10.1242/jcs.02701; Burke B, 2014, CURR TOP DEV BIOL, V109, P1, DOI 10.1016/B978-0-12-397920-9.00006-8; Burke B, 2013, NAT REV MOL CELL BIO, V14, P13, DOI 10.1038/nrm3488; Cagnol S, 2010, FEBS J, V277, P2, DOI 10.1111/j.1742-4658.2009.07366.x; Caputo S, 2006, J BIOL CHEM, V281, P18208, DOI 10.1074/jbc.M601980200; Chen IHB, 2006, BMC CELL BIOL, V7, DOI 10.1186/1471-2121-7-38; Choi JC, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003875; Cohen TV, 2007, DEVELOPMENT, V134, P1385, DOI 10.1242/dev.02816; Dauer WT, 2009, DEV CELL, V17, P626, DOI 10.1016/j.devcel.2009.10.016; Gerace L, 2012, J STRUCT BIOL, V177, P24, DOI 10.1016/j.jsb.2011.11.007; Hellemans J, 2004, NAT GENET, V36, P1213, DOI 10.1038/ng1453; Huber MD, 2009, MOL CELL BIOL, V29, P5718, DOI 10.1128/MCB.00270-09; Ishimura A, 2006, DEVELOPMENT, V133, P3919, DOI 10.1242/DEV.02538; Li L, 2007, GENESIS, V45, P560, DOI 10.1002/dvg.20325; Lin CS, 1996, GENE DEV, V10, P154, DOI 10.1101/gad.10.2.154; Lin F, 2005, HUM MOL GENET, V14, P437, DOI 10.1093/hmg/ddi040; Lin F, 2000, J BIOL CHEM, V275, P4840, DOI 10.1074/jbc.275.7.4840; Liu J, 2003, P NATL ACAD SCI USA, V100, P4598, DOI 10.1073/pnas.0730821100; Massague J, 2012, NAT REV MOL CELL BIO, V13, P616, DOI 10.1038/nrm3434; Melcon G, 2006, HUM MOL GENET, V15, P637, DOI 10.1093/hmg/ddi479; Muchir A, 2007, HUM MOL GENET, V16, P1884, DOI 10.1093/hmg/ddm137; Muchir A, 2007, J CLIN INVEST, V117, P1282, DOI 10.1172/JCI29042; Muchir A, 2009, BBA-MOL BASIS DIS, V1792, P75, DOI 10.1016/j.bbadis.2008.10.012; Pan D, 2005, J BIOL CHEM, V280, P15992, DOI 10.1074/jbc.M411234200; Raju GP, 2003, J BIOL CHEM, V278, P428, DOI 10.1074/jbc.M210505200; Ramos FJ, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003802; Reil M, 2013, EUR J CELL BIOL, V92, P280, DOI 10.1016/j.ejcb.2013.10.008; ROBER RA, 1989, DEVELOPMENT, V105, P365; Schirmer EC, 2003, SCIENCE, V301, P1380, DOI 10.1126/science.1088176; Shimi T, 2010, COLD SH Q B, V75, P525, DOI 10.1101/sqb.2010.75.045; Shin JY, 2013, DEV CELL, V26, P591, DOI 10.1016/j.devcel.2013.08.012; Somech R, 2005, J CELL SCI, V118, P4017, DOI 10.1242/jcs.02521; Tompa P, 2012, TRENDS BIOCHEM SCI, V37, P509, DOI 10.1016/j.tibs.2012.08.004; Ulbert S, 2006, FEBS LETT, V580, P6435, DOI 10.1016/j.febslet.2006.10.060; Wilson KL, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000554; Wong XR, 2014, CURR OPIN CELL BIOL, V28, P105, DOI 10.1016/j.ceb.2014.04.005; Worman HJ, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000760; Wu H, 1995, BLOOD, V86, P2356; Young SG, 2012, J BIOL CHEM, V287, P16103, DOI 10.1074/jbc.R112.354407; Zoncu R, 2011, NAT REV MOL CELL BIO, V12, P21, DOI 10.1038/nrm3025; Zuela N, 2012, EMBO REP, V13, P1070, DOI 10.1038/embor.2012.167; Zuleger N, 2012, CELL MOL LIFE SCI, V69, P2205, DOI 10.1007/s00018-012-0929-1; Zullo JM, 2012, CELL, V149, P1474, DOI 10.1016/j.cell.2012.04.035	48	23	24	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2015	10	3							e0116196	10.1371/journal.pone.0116196	http://dx.doi.org/10.1371/journal.pone.0116196			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD9NQ	25790465	Green Submitted, Green Published, gold			2022-12-27	WOS:000351425400009
J	Xing, JL; Wang, G; Zhang, QX; Liu, XM; Gu, ZN; Zhang, H; Chen, YQ; Chen, W				Xing, Jiali; Wang, Gang; Zhang, Qiuxiang; Liu, Xiaoming; Gu, Zhennan; Zhang, Hao; Chen, Yong Q.; Chen, Wei			Determining Antioxidant Activities of Lactobacilli Cell-Free Supernatants by Cellular Antioxidant Assay: A Comparison with Traditional Methods	PLOS ONE			English	Article							LACTIC-ACID BACTERIA; IN-VITRO; OXIDATIVE STRESS; CULTURE SUPERNATANT; LIPID-PEROXIDATION; PHENOLIC-COMPOUNDS; CAPACITY; ACIDOPHILUS; ABILITY; PROLIFERATION	Antioxidant activity of lactic acid bacteria is associated with multiple health-protective effects. Traditional indexes of chemical antioxidant activities poorly reflect the antioxidant effects of these bacteria in vivo. Cellular antioxidant activity (CAA) assay was used in this study to determine the antioxidant activity of cell-free supernatants (CFSs) of 10 Lactobacillus strains. The performance of the CAA assay was compared with that of four chemical antioxidant activity assays, namely, DPPH radical scavenging, hydroxyl radical scavenging (HRS), reducing power (RP), and inhibition of linoleic acid peroxidation (ILAP). Results of the CAA assay were associated with those of DPPH and ILAP assays, but not with those of RP and HRS assays. The inter-and intra-specific antioxidant activities of CFS were characterized by chemical and CAA assays. L. rhamnosus CCFM 1107 displayed a high antioxidative effect similar to positive control L. rhamnosus GG ATCC 53103 in all of the assays. The CAA assay is a potential method for the detection of antioxidant activities of lactobacilli CFSs.	[Xing, Jiali; Wang, Gang; Zhang, Qiuxiang; Liu, Xiaoming; Gu, Zhennan; Zhang, Hao; Chen, Yong Q.; Chen, Wei] Jiangnan Univ, Sch Food Sci & Technol, State Key Lab Food Sci & Technol, Wuxi, Peoples R China; [Chen, Wei] Synergist Innovat Ctr Food Safety & Nutr, Wuxi, Peoples R China	Jiangnan University	Wang, G (corresponding author), Jiangnan Univ, Sch Food Sci & Technol, State Key Lab Food Sci & Technol, Wuxi, Peoples R China.	wanggang@jiangnan.edu.cn; chenwei66@jiangnan.edu.cn	Chen, Wei/GZK-7348-2022; Wang, Gang/AEO-7822-2022; Zhang, Hao/HHM-1940-2022; Chen, Yong Q/AAI-9864-2021	Chen, Yong Q/0000-0003-4747-4708; Wang, Gang/0000-0003-2007-2143	National High Technology Research and Development Program of China (863 Program) [2013BAD18B01, 2013BAD18B02, 2012BAD28B07, 2012BAD12B08]; National Natural Science Foundation of China [31301407, 31200691]; National Basic Research Program of China (973 Program) [2012CB720802]; key projects in the National Science and Technology Pillar Program during the 12th Five-Year Plan [2012BAD28B07, 2012BAD12B08]; 111 project [B07029]; Priority Academic Program Development of Jiangsu Higher Education Institutions	National High Technology Research and Development Program of China (863 Program)(National High Technology Research and Development Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China (973 Program)(National Basic Research Program of China); key projects in the National Science and Technology Pillar Program during the 12th Five-Year Plan; 111 project(Ministry of Education, China - 111 Project); Priority Academic Program Development of Jiangsu Higher Education Institutions	This work was supported by the National High Technology Research and Development Program of China (863 Program Nos. 2013BAD18B01, 2013BAD18B02, 2012BAD28B07, 2012BAD12B08), the National Natural Science Foundation of China (Nos. 31301407, 31200691), the National Basic Research Program of China (973 Program No. 2012CB720802), key projects in the National Science and Technology Pillar Program during the 12th Five-Year Plan (Nos. 2012BAD12B08, 2012BAD28B07), the 111 project B07029, and a project funded by the Priority Academic Program Development of Jiangsu Higher Education Institutions. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Apak R, 2007, MOLECULES, V12, P1496, DOI 10.3390/12071496; Asikin Y, 2013, FOOD CHEM, V141, P466, DOI 10.1016/j.foodchem.2013.03.045; Beckman KB, 1998, PHYSIOL REV, V78, P547, DOI 10.1152/physrev.1998.78.2.547; Bermudez-Brito M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059370; Bing SR, 1998, MICROBIOL IMMUNOL, V42, P745, DOI 10.1111/j.1348-0421.1998.tb02348.x; Cederbaum AI, 2009, ARCH TOXICOL, V83, P519, DOI 10.1007/s00204-009-0432-0; Chen P, 2014, FOOD CONTROL, V35, P65, DOI 10.1016/j.foodcont.2013.06.027; Choi SS, 2006, LETT APPL MICROBIOL, V42, P452, DOI 10.1111/j.1472-765X.2006.01913.x; Felice DL, 2009, J FUNCT FOODS, V1, P109, DOI 10.1016/j.jff.2008.09.014; Forsyth CB, 2009, ALCOHOL, V43, P163, DOI 10.1016/j.alcohol.2008.12.009; Gazi MR, 2007, ANIM SCI J, V78, P34, DOI 10.1111/j.1740-0929.2006.00401.x; Halliwell B, 1985, FREE RADICAL BIO MED, P23; Hathout AS, 2011, TOXICON, V58, P179, DOI 10.1016/j.toxicon.2011.05.015; Hirawan R, 2011, J AGR FOOD CHEM, V59, P12330, DOI 10.1021/jf202662a; Huang DJ, 2005, J AGR FOOD CHEM, V53, P1841, DOI 10.1021/jf030723c; Huang HZ, 2014, FOOD CHEM, V146, P363, DOI 10.1016/j.foodchem.2013.09.071; Kanno T, 2012, LWT-FOOD SCI TECHNOL, V47, P25, DOI 10.1016/j.lwt.2012.01.007; Faller ALK, 2012, J AGR FOOD CHEM, V60, P4826, DOI 10.1021/jf300602w; Lee J, 2005, J FOOD SCI, V70, pM388, DOI 10.1111/j.1365-2621.2005.tb11524.x; Lee J, 2005, J MED FOOD, V8, P299, DOI 10.1089/jmf.2005.8.299; Li WX, 2013, J AGR FOOD CHEM, V61, P6328, DOI 10.1021/jf400982c; Li WI, 2005, EXP BIOL MED, V230, P494; Lin MY, 1999, J AGR FOOD CHEM, V47, P3661, DOI 10.1021/jf981235l; Lin MY, 1999, J DAIRY SCI, V82, P1629, DOI 10.3168/jds.S0022-0302(99)75391-9; Lin MY, 1999, J AGR FOOD CHEM, V47, P1460, DOI 10.1021/jf981149l; Lin MY, 2000, DIGEST DIS SCI, V45, P1617, DOI 10.1023/A:1005577330695; Liu CF, 2010, J FOOD DRUG ANAL, V18, P77; Lopez-Alarcon C, 2013, ANAL CHIM ACTA, V763, P1, DOI 10.1016/j.aca.2012.11.051; Malta LG, 2013, FOOD RES INT, V53, P417, DOI 10.1016/j.foodres.2013.04.024; Maudsdotter L, 2011, ANTIMICROB AGENTS CH, V55, P1622, DOI 10.1128/AAC.00770-10; MEIR S, 1995, J AGR FOOD CHEM, V43, P1813, DOI 10.1021/jf00055a012; Mustapha N, 2014, APPL BIOCHEM BIOTECH, V172, P2266, DOI 10.1007/s12010-013-0667-3; Niki E, 2010, FREE RADICAL BIO MED, V49, P503, DOI 10.1016/j.freeradbiomed.2010.04.016; Nobili V, 2010, INT J MOL MED, V26, P471, DOI 10.3892/ijmm_00000487; Persichetti E, 2014, NUTRITION, V30, P936, DOI 10.1016/j.nut.2013.12.009; Puertollano E, 2013, ENDOCR METAB IMMUNE, V13, P195, DOI 10.2174/1871530311313020008; Ramesh V, 2012, DAIRY SCI TECHNOL, V92, P179, DOI 10.1007/s13594-011-0048-z; Shen QA, 2011, CURR MICROBIOL, V62, P1097, DOI 10.1007/s00284-010-9827-7; SIES H, 1993, EUR J BIOCHEM, V215, P213, DOI 10.1111/j.1432-1033.1993.tb18025.x; Song W, 2010, J AGR FOOD CHEM, V58, P6621, DOI 10.1021/jf9035832; Sun J, 2010, LETT APPL MICROBIOL, V50, P264, DOI 10.1111/j.1472-765X.2009.02786.x; Tabart J, 2012, FOOD CHEM, V131, P1116, DOI 10.1016/j.foodchem.2011.09.076; Velioglu YS, 1998, J AGR FOOD CHEM, V46, P4113, DOI 10.1021/jf9801973; Wang J, 2012, ASIAN AUSTRAL J ANIM, V25, P1153, DOI 10.5713/ajas.2012.12079; Wang LF, 2013, J AGR FOOD CHEM, V61, P5103, DOI 10.1021/jf400556s; [王曦 Wang Xi], 2010, [食品科学, Food Science], V31, P197; Wang YH, 2012, AM J PHYSIOL-GASTR L, V303, pG32, DOI 10.1152/ajpgi.00024.2012; Wolfe KL, 2007, J AGR FOOD CHEM, V55, P8896, DOI 10.1021/jf0715166; Yang J, 2009, J AGR FOOD CHEM, V57, P8581, DOI 10.1021/jf8039796; Yi Y, 2013, MOLECULES, V18, P11601, DOI 10.3390/molecules180911601; Yu Ji Hoon, 2014, J Cancer Prev, V19, P97, DOI 10.15430/JCP.2014.19.2.97; Zhang Jing, 2012, Food Science and Technology, V37, P235; Zhang L, 2013, INT J BIOL MACROMOL, V54, P270, DOI 10.1016/j.ijbiomac.2012.12.037; Zhang SW, 2011, AFR J MICROBIOL RES, V5, P5194, DOI 10.5897/AJMR11.997; Zhu YP, 2008, FOOD CONTROL, V19, P654, DOI 10.1016/j.foodcont.2007.07.009	55	78	81	2	84	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2015	10	3							e0119058	10.1371/journal.pone.0119058	http://dx.doi.org/10.1371/journal.pone.0119058			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD9NQ	25789875	Green Published, Green Submitted, gold			2022-12-27	WOS:000351425400063
J	Babinsky, VN; Hannan, FM; Youhanna, SC; Marechal, C; Jadoul, M; Devuyst, O; Thakker, RV				Babinsky, Valerie N.; Hannan, Fadil M.; Youhanna, Sonia C.; Marechal, Celine; Jadoul, Michel; Devuyst, Olivier; Thakker, Rajesh V.			Association Studies of Calcium-Sensing Receptor (CaSR) Polymorphisms with Serum Concentrations of Glucose and Phosphate, and Vascular Calcification in Renal Transplant Recipients	PLOS ONE			English	Article							CORONARY-ARTERY CALCIFICATION; GROWTH-FACTOR 23; EXTRACELLULAR CALCIUM; CARDIOVASCULAR EVENTS; ASYMPTOMATIC SUBJECTS; PARATHYROID-HORMONE; RISK-FACTORS; PROGRESSION; PHOSPHORUS; CELLS	Background Cardiovascular disease is the major cause of death in renal transplant recipients (RTRs) and linked to arterial calcification. The calcium-sensing receptor (CaSR), a G-protein coupled receptor, plays a pivotal role in extracellular calcium homeostasis and is expressed in the intimal and medial layers of the arterial wall. We investigated whether common CASR gene variants are predictors for aortic and coronary artery calcification or influence risk factors such as serum calcium, phosphate and glucose concentrations in RTRs. Methods Two hundred and eighty four RTRs were investigated for associations between three CASR promoter region single nucleotide polymorphisms (SNPs) (rs115759455, rs7652589, rs1501899), three non-synonymous CASR coding region SNPs (A986S, R990G, Q1011E), and aortic and coronary artery calcium mass scores, cardiovascular outcomes and calcification risk factors that included serum phosphate, calcium, total cholesterol and glucose concentrations. Results Multivariate analysis revealed that RTRs homozygous for the minor allele (SS) of the A986S SNP, when compared to those homozygous for the major allele (AA), had raised serum glucose concentrations (8.7 +/- 5.4 vs. 5.7 +/- 2.1 mmol/L, P<0.05). In addition, RTRs who were heterozygous (CT) at the rs115759455 SNP, when compared to those homozygous for the major allele (CC), had higher serum phosphate concentrations (1.1 +/- 0.3 vs. 1.0 +/- 0.2 mmol/ L, P<0.05). CASR SNPs were not significant determinants for aortic or coronary artery calcification, and were not associated with cardiovascular outcomes or mortality in this RTR cohort. Conclusions Common CASR SNPs may be independent predictors of serum glucose and phosphate concentrations, but are not determinants of vascular calcification or cardiovascular outcomes.	[Babinsky, Valerie N.; Hannan, Fadil M.; Thakker, Rajesh V.] Univ Oxford, OCDEM, Radcliffe Dept Med, Acad Endocrine Unit, Oxford, England; [Youhanna, Sonia C.; Devuyst, Olivier] Univ Zurich, Zurich Ctr Integrat Human Physiol ZIHP, Inst Physiol, Zurich, Switzerland; [Marechal, Celine; Jadoul, Michel; Devuyst, Olivier] Catholic Univ Louvain, Div Nephrol, Clin Univ St Luc, B-1200 Brussels, Belgium	University of Oxford; University of Zurich; Zurich Center Integrative Human Physiology (ZIHP); Universite Catholique Louvain; Cliniques Universitaires Saint-Luc	Thakker, RV (corresponding author), Univ Oxford, OCDEM, Radcliffe Dept Med, Acad Endocrine Unit, Oxford, England.	rajesh.thakker@ndm.ox.ac.uk		Devuyst, Olivier/0000-0003-3744-4767; Thakker, Rajesh/0000-0002-1438-3220; youhanna, sonia/0000-0002-9376-8478; Hannan, Fadil/0000-0002-2975-5170	United Kingdom Medical Research Council (MRC) [G1000467]; European Commission [FP7-264663, FP7-305608]; FNRS; FRSM; NCCR Kidney; Gebert Ruf Stiftung [GRS-038/12]; MRC [MR/K006312/1, G1000467] Funding Source: UKRI; Medical Research Council [G1000467, MR/K006312/1] Funding Source: researchfish; National Institute for Health Research [NF-SI-0514-10091] Funding Source: researchfish	United Kingdom Medical Research Council (MRC)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); European Commission(European CommissionEuropean Commission Joint Research Centre); FNRS(Fonds de la Recherche Scientifique - FNRS); FRSM(Fonds de la Recherche Scientifique - FNRS); NCCR Kidney; Gebert Ruf Stiftung; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR))	This work was supported by the United Kingdom Medical Research Council (MRC) programme grant - G1000467 (to FMH and RVT); the European Commission Seventh Framework Programme (FP7-264663 (to VNB) and FP7-305608 (EURenOmics) (to OD)); the FNRS and FRSM, the NCCR Kidney. CH program (Swiss National Science Foundation), and the Gebert Ruf Stiftung (Project GRS-038/12) (to OD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alam M, 2009, CARDIOVASC RES, V81, P260, DOI 10.1093/cvr/cvn279; Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632; Amann K, 2008, CLIN J AM SOC NEPHRO, V3, P1599, DOI 10.2215/CJN.02120508; Ba JM, 2003, AM J PHYSIOL-RENAL, V285, pF1233, DOI 10.1152/ajprenal.00249.2003; Block GA, 1998, AM J KIDNEY DIS, V31, P607, DOI 10.1053/ajkd.1998.v31.pm9531176; Chakravarti B, 2012, ADV EXP MED BIOL, V740, P103, DOI 10.1007/978-94-007-2888-2_5; Cifuentes M, 2008, MOL CELL BIOCHEM, V319, P17, DOI 10.1007/s11010-008-9872-8; Fu WQ, 2013, NATURE, V493, P216, DOI 10.1038/nature11690; Gauderman W, 2006, QUANTO 1 2 A COMPUTE; Gray E, 2006, J ENDOCRINOL, V190, P703, DOI 10.1677/joe.1.06891; Guerin AP, 2000, NEPHROL DIAL TRANSPL, V15, P1014, DOI 10.1093/ndt/15.7.1014; Hough TA, 2004, P NATL ACAD SCI USA, V101, P13566, DOI 10.1073/pnas.0405516101; Hu MC, 2013, ANNU REV PHYSIOL, V75, P503, DOI 10.1146/annurev-physiol-030212-183727; Kapur K, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001035; Kestenbaum B, 2010, J AM SOC NEPHROL, V21, P1223, DOI 10.1681/ASN.2009111104; Kim KJ, 2013, HEART, V99, P1113, DOI 10.1136/heartjnl-2013-303631; Kronmal RA, 2007, CIRCULATION, V115, P2722, DOI 10.1161/CIRCULATIONAHA.106.674143; Marz W, 2007, J CLIN ENDOCR METAB, V92, P2363, DOI 10.1210/jc.2006-0071; Malecki R, 2013, J PHYSIOL PHARMACOL, V64, P521; Marechal C, 2012, AM J KIDNEY DIS, V59, P258, DOI 10.1053/j.ajkd.2011.07.019; Marechal C, 2011, CLIN J AM SOC NEPHRO, V6, P974, DOI 10.2215/CJN.06150710; Nakamura S, 2009, CLIN J AM SOC NEPHRO, V4, P1892, DOI 10.2215/CJN.04320709; Nesbit MA, 2013, NAT GENET, V45, P93, DOI 10.1038/ng.2492; Neves KR, 2007, KIDNEY INT, V71, P1262, DOI 10.1038/sj.ki.5002241; Nguyen PTH, 2007, AM J NEPHROL, V27, P329, DOI 10.1159/000102978; Nguyen PTH, 2010, NEPHROL DIAL TRANSPL, V25, P3773, DOI 10.1093/ndt/gfq268; O'Donnell CJ, 2002, CIRCULATION, V106, P337, DOI 10.1161/01.CIR.0000022663.26468.5B; Ojo AO, 2000, KIDNEY INT, V57, P307, DOI 10.1046/j.1523-1755.2000.00816.x; Parkash J, 2011, LIFE SCI, V88, P440, DOI 10.1016/j.lfs.2010.12.022; Quinn SJ, 2013, AM J PHYSIOL-ENDOC M, V304, pE310, DOI 10.1152/ajpendo.00460.2012; Rampersaud E, 2008, AM J EPIDEMIOL, V168, P1016, DOI 10.1093/aje/kwn211; Ranjzad F, 2011, J ASSIST REPROD GEN, V28, P225, DOI 10.1007/s10815-010-9506-4; Reynolds JL, 2004, J AM SOC NEPHROL, V15, P2857, DOI 10.1097/01.ASN.0000141960.01035.28; Scillitani A, 2004, J CLIN ENDOCR METAB, V89, P5634, DOI 10.1210/jc.2004-0129; Smajilovic S, 2006, BIOCHEM BIOPH RES CO, V348, P1215, DOI 10.1016/j.bbrc.2006.07.192; Squires PE, 2000, DIABETES, V49, P409, DOI 10.2337/diabetes.49.3.409; Vezzoli G, 2011, EUR J ENDOCRINOL, V164, P421, DOI 10.1530/EJE-10-0915; Weston AH, 2005, CIRC RES, V97, P391, DOI 10.1161/01.RES.0000178787.59594.a0; Wexler L, 1996, CIRCULATION, V94, P1175, DOI 10.1161/01.CIR.94.5.1175; Yano S, 2000, NEPHRON, V85, P317, DOI 10.1159/000045681; Yoshikawa K, 2013, CLIN EXP NEPHROL, V17, P882, DOI 10.1007/s10157-013-0785-9; Zhang Y, 2006, AM J HUM GENET, V79, P313, DOI 10.1086/506276; Ziegelstein RC, 2006, BIOCHEM BIOPH RES CO, V342, P153, DOI 10.1016/j.bbrc.2006.01.135	43	12	12	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2015	10	3							e0119459	10.1371/journal.pone.0119459	http://dx.doi.org/10.1371/journal.pone.0119459			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9BN	25786244	Green Submitted, Green Published, gold, Green Accepted			2022-12-27	WOS:000352138500105
J	Chen, XS; Cao, CS; Deng, ZM; Xie, YH; Li, F; Hou, ZY; Li, X				Chen, Xinsheng; Cao, Chenshu; Deng, Zhengmiao; Xie, Yonghong; Li, Feng; Hou, Zhiyong; Li, Xu			Assessment of Regeneration Potential in the Clonal Macrophyte Miscanthus sacchariflorus (Poaceae) after Burial Disturbance Based on Bud Bank Size and Sprouting Capacity	PLOS ONE			English	Article							VEGETATIVE REPRODUCTION; MERISTEM LIMITATION; GROWTH; SHOOT; WATER; CLASSIFICATION; PROPAGATION; RECRUITMENT; DEMOGRAPHY; TENUIS	The demography of the bud bank and its sprouting capacity are important for understanding the population dynamics of clonal plants and their potential responses to disturbances. To this end, we investigated the size and composition of the bud bank of Miscanthus sacchariflorus (Maxim.) Hack. immediately after flooding (November), in winter (January), in spring (March), and before flooding (May) in the wetlands of Dongting Lake. We then examined the sprouting capacity of axillary buds after sediment burial at 0, 5, 10, 15, and 20 cm. Total bud density of M. sacchariflorus ranged from 2524 buds m(-2) in November to 4293 buds m(-2) in March. Rhizome segments with inactive axillary buds, which represented the majority of the bud population (88.7% in November, 93.3% in May), did not sprout during the 140 days of the experiment (n = 250). The sprouting ratio was the highest for active axillary buds buried at 0 cm (64%) and decreased when buried at 10-20 cm (34%-40%). Due to the large number of active axillary buds in the bud bank (211-277 buds m(-2) from November to the following March), M. sacchariflorus could completely replace its aboveground shoot population, except in May (142 buds m(-2)). Increasing burial depth delayed bud emergence and reduced the growth period of shoots; however, burial depth did not affect the resulting plant height and only reduced the accumulated biomass at 20 cm. Therefore, the belowground bud bank and its strong sprouting capacity are important factors in the maintenance of local populations and colonization of new habitats for M. sacchariflorus after burial disturbances. The present methodology, which combined measurements of bud bank demography and sprouting capacity, may reflect the regeneration potential of clonal plants after burial disturbances.	[Chen, Xinsheng; Cao, Chenshu; Deng, Zhengmiao; Xie, Yonghong; Li, Feng; Hou, Zhiyong; Li, Xu] Chinese Acad Sci, Key Lab Agroecol Proc Subtrop Reg, Changsha, Hunan, Peoples R China; [Chen, Xinsheng; Deng, Zhengmiao; Xie, Yonghong; Li, Feng; Hou, Zhiyong; Li, Xu] Chinese Acad Sci, Inst Subtrop Agr, Dongting Lake Stn Wetland Ecosyst Res, Yueyang, Hunan, Peoples R China; [Cao, Chenshu] Shangqiu Polytech, Dept Garden & Food Proc, Shangqiu, Henan, Peoples R China	Chinese Academy of Sciences; Chinese Academy of Sciences; Institute of Subtropical Agriculture, CAS	Xie, YH (corresponding author), Chinese Acad Sci, Key Lab Agroecol Proc Subtrop Reg, Changsha, Hunan, Peoples R China.	yonghongxie@163.com	LI, feng/HIR-1703-2022	, Xinsheng/0000-0002-3720-247X	Basic Work Program of the Ministry of Science and Technology of China [2013FY111800]; National Natural Science Foundation of China [31000143]; Hunan Provincial Natural Science Foundation of China [14JJ2137]	Basic Work Program of the Ministry of Science and Technology of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Hunan Provincial Natural Science Foundation of China(Natural Science Foundation of Hunan Province)	This research is supported by the Basic Work Program of the Ministry of Science and Technology of China (2013FY111800) to YHX, the National Natural Science Foundation of China (31000143) to XSC, and the Hunan Provincial Natural Science Foundation of China (14JJ2137) to XSC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atkinson CJ, 2009, BIOMASS BIOENERG, V33, P752, DOI 10.1016/j.biombioe.2009.01.005; Becker GF, 1997, J ARID ENVIRON, V35, P233, DOI 10.1006/jare.1995.0130; Bellingham PJ, 2000, OIKOS, V89, P409, DOI 10.1034/j.1600-0706.2000.890224.x; Benson EJ, 2004, AM J BOT, V91, P416, DOI 10.3732/ajb.91.3.416; Benson EJ, 2006, PLANT ECOL, V187, P163, DOI 10.1007/s11258-005-0975-y; Bonser SP, 1996, OIKOS, V77, P347, DOI 10.2307/3546076; CHAPIN FS, 1990, ANNU REV ECOL SYST, V21, P423, DOI 10.1146/annurev.ecolsys.21.1.423; Chen S, 2006, FLORA CHINA, V12, P165; Chen X, 2009, ANN BOT-LONDON, V104, P1057, DOI 10.1093/aob/mcp198; Chen XS, 2015, AQUAT BOT, V122, P9, DOI 10.1016/j.aquabot.2014.12.006; Chen XS, 2014, NORD J BOT, V32, P251, DOI 10.1111/j.1756-1051.2013.00094.x; Chen XS, 2014, AQUAT ECOL, V48, P409, DOI 10.1007/s10452-014-9493-0; Chen XS, 2014, PAK J BOT, V46, P881; Dalgleish HJ, 2006, NEW PHYTOL, V171, P81, DOI 10.1111/j.1469-8137.2006.01739.x; Decruyenaere JG, 2001, WEED SCI, V49, P760, DOI 10.1614/0043-1745(2001)049[0760:SOCPIG]2.0.CO;2; Del Tredici P, 2001, BOT REV, V67, P121, DOI 10.1007/BF02858075; Deng ZM, 2013, AQUAT BOT, V104, P121, DOI 10.1016/j.aquabot.2012.08.004; Deng ZF, 2008, ESTUAR COAST SHELF S, V76, P818, DOI 10.1016/j.ecss.2007.08.008; Dong C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023942; Gao J F, 2001, ACTA GEOGRAPHICA SIN, V56, P269; Harper J. L, 1977, POPULATION BIOL PLAN; [黄菊梅 Huang Jumei], 2013, [气象科学, Journal of the Meteorological Sciences], V33, P457; [黄群 Huang Qun], 2013, [长江流域资源与环境, Resources and Environment in the Yangtze Basin], V22, P922; Klimes L, 1997, ECOLOGY AND EVOLUTION OF CLONAL PLANTS, P1; KLIMES L, 1993, VEGETATIO, V109, P153, DOI 10.1007/BF00044747; Klimesova J, 2007, PERSPECT PLANT ECOL, V8, P115, DOI 10.1016/j.ppees.2006.10.002; Klimesova J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088093; Klimesova J, 2009, J VEG SCI, V20, P511, DOI 10.1111/j.1654-1103.2009.01050.x; Li XX, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084657; Manzur ME, 2009, ANN BOT-LONDON, V104, P1163, DOI 10.1093/aob/mcp203; Maun MA, 1998, CAN J BOT, V76, P713, DOI 10.1139/cjb-76-5-713; MCKONE MJ, 1993, OIKOS, V67, P184, DOI 10.2307/3545109; Nishihiro J, 2004, AQUAT BOT, V79, P333, DOI 10.1016/j.aquabot.2004.05.005; Ott JP, 2012, PLANT ECOL, V213, P1437, DOI 10.1007/s11258-012-0102-9; Sosnova M, 2010, AQUAT BOT, V92, P33, DOI 10.1016/j.aquabot.2009.09.005; TUOMI J, 1994, ECOLOGY, V75, P1429, DOI 10.2307/1937466; Vesk PA, 2004, OIKOS, V106, P200, DOI 10.1111/j.0030-1299.2004.13204.x; Weber E, 2011, BIOL INVASIONS, V13, P2947, DOI 10.1007/s10530-011-9977-y; Xie YongHong, 2008, Research of Agricultural Modernization, V29, P684; ZASADA JC, 1994, CAN J FOREST RES, V24, P272, DOI 10.1139/x94-039; Zhang JT, 2009, BOTANY, V87, P1242, DOI 10.1139/B09-080	41	7	8	0	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2015	10	3							e0120846	10.1371/journal.pone.0120846	http://dx.doi.org/10.1371/journal.pone.0120846			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9BN	25785628	Green Published, Green Submitted, gold			2022-12-27	WOS:000352138500195
J	Mi, G; Di, YM; Schafer, DW				Mi, Gu; Di, Yanming; Schafer, Daniel W.			Goodness-of-Fit Tests and Model Diagnostics for Negative Binomial Regression of RNA Sequencing Data	PLOS ONE			English	Article							DIFFERENTIAL EXPRESSION ANALYSIS; SEQ; NORMALIZATION; BIOCONDUCTOR	This work is about assessing model adequacy for negative binomial (NB) regression, particularly (1) assessing the adequacy of the NB assumption, and (2) assessing the appropriateness of models for NB dispersion parameters. Tools for the first are appropriate for NB regression generally; those for the second are primarily intended for RNA sequencing (RNA-Seq) data analysis. The typically small number of biological samples and large number of genes in RNA-Seq analysis motivate us to address the trade-offs between robustness and statistical power using NB regression models. One widely-used power-saving strategy, for example, is to assume some commonalities of NB dispersion parameters across genes via simple models relating them to mean expression rates, and many such models have been proposed. As RNA-Seq analysis is becoming ever more popular, it is appropriate to make more thorough investigations into power and robustness of the resulting methods, and into practical tools for model assessment. In this article, we propose simulation-based statistical tests and diagnostic graphics to address model adequacy. We provide simulated and real data examples to illustrate that our proposed methods are effective for detecting the misspecification of the NB mean-variance relationship as well as judging the adequacy of fit of several NB dispersion models.	[Mi, Gu; Di, Yanming; Schafer, Daniel W.] Oregon State Univ, Dept Stat, Corvallis, OR 97331 USA; [Di, Yanming] Oregon State Univ, Mol & Cellular Biol Program, Corvallis, OR 97331 USA	Oregon State University; Oregon State University	Mi, G (corresponding author), Oregon State Univ, Dept Stat, Corvallis, OR 97331 USA.	neo.migu@gmail.com	Mi, Gu/M-6559-2015	Mi, Gu/0000-0001-8778-954X	National Institute of General Medical Sciences of the National Institutes of Health [R01GM104977]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM104977] Funding Source: NIH RePORTER	National Institute of General Medical Sciences of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	YD and GM were supported by the National Institute of General Medical Sciences of the National Institutes of Health under award number R01GM104977. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; [Anonymous], 2014, R LANG ENV STAT COMP; ATKINSON AC, 1981, BIOMETRIKA, V68, P13, DOI 10.1093/biomet/68.1.13; Best DJ, 2009, J STAT THEORY PRACT, V3, P555, DOI 10.1080/15598608.2009.10411946; Buja A., 2003, CALIBRATION SIMULTAN; Bullard JH, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-94; Cumbie JS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025279; Davison AC, 1997, BOOTSTRAP METHODS TH, V1; Di Y, 2014, NBPSEQ NEGATIVE BINO; Di YM, 2011, STAT APPL GENET MOL, V10, DOI 10.2202/1544-6115.1637; Esnaola M, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-254; Fisher R., 1970, STAT METHODS RES WOR; Garay AM, 2011, COMPUT STAT DATA AN, V55, P1304, DOI 10.1016/j.csda.2010.09.019; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Greene W, 2008, ECON LETT, V99, P585, DOI 10.1016/j.econlet.2007.10.015; Hilbe J., 2011, NEGATIVE BINOMIAL RE; LANDWEHR JM, 1984, J AM STAT ASSOC, V79, P61, DOI 10.2307/2288334; LAWLESS JF, 1987, J AM STAT ASSOC, V82, P808, DOI 10.2307/2288790; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Lund SP, 2012, STAT APPL GENET MOL, V11, DOI 10.1515/1544-6115.1826; Marioni JC, 2008, GENOME RES, V18, P1509, DOI 10.1101/gr.079558.108; McCarthy DJ, 2012, NUCLEIC ACIDS RES, V40, P4288, DOI 10.1093/nar/gks042; Mi G, 2015, PLOS ONE UNPUB; North BV, 2002, AM J HUM GENET, V71, P439, DOI 10.1086/341527; PIERCE DA, 1986, J AM STAT ASSOC, V81, P977, DOI 10.2307/2289071; Robinson MD, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-3-r25; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Svetliza CF, 2003, COMMUN STAT-THEOR M, V32, P1227, DOI 10.1081/STA-120021329; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; Wu H, 2013, BIOSTATISTICS, V14, P232, DOI 10.1093/biostatistics/kxs033	31	11	11	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2015	10	3							e0119254	10.1371/journal.pone.0119254	http://dx.doi.org/10.1371/journal.pone.0119254			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9BN	25787144	Green Published, Green Submitted, gold			2022-12-27	WOS:000352138500091
J	Wang, SQ; Tu, J; Wang, L; Lu, ZH				Wang, Shengqin; Tu, Jing; Wang, Lei; Lu, Zuhong			Entropy-Based Model for MiRNA Isoform Analysis	PLOS ONE			English	Article							MICRORNAS; ISOMIRS; SEQUENCE; IDENTIFICATION; REPERTOIRE; BIOGENESIS; COMPLEXITY; GENERATION; ENRICHMENT; DISCOVERY	MiRNAs have been widely studied due to their important post-transcriptional regulatory roles in gene expression. Many reports have demonstrated the evidence of miRNA isoform products (isomiRs) in high-throughput small RNA sequencing data. However, the biological function involved in these molecules is still not well investigated. Here, we developed a Shannon entropy-based model to estimate isomiR expression profiles of high-throughput small RNA sequencing data extracted from miRBase webserver. By using the Kolmogorov-Smirnov statistical test (KS test), we demonstrated that the 5p and 3p miRNAs present more variants than the single arm miRNAs. We also found that the isomiR variant, except the 3' isomiR variant, is strongly correlated with Minimum Free Energy (MFE) of pre-miRNA, suggesting the intrinsic feature of pre-miRNA should be one of the important factors for the miRNA regulation. The functional enrichment analysis showed that the miRNAs with high variation, particularly the 5' end variation, are enriched in a set of critical functions, supporting these molecules should not be randomly produced. Our results provide a probabilistic framework for miRNA isoforms analysis, and give functional insights into pre-miRNA processing.	[Wang, Shengqin; Tu, Jing; Wang, Lei; Lu, Zuhong] Southeast Univ, Sch Biol Sci & Med Engn, State Key Lab Bioelect, Nanjing 210096, Jiangsu, Peoples R China; [Wang, Shengqin] Wenzhou Univ, Coll Life & Environm Sci, Zhejiang Prov Key Lab Water Environm & Marine Bio, Wenzhou 325035, Peoples R China; [Lu, Zuhong] Peking Univ, Coll Engn, Dept Biomed Engn, Beijing 100781, Peoples R China	Southeast University - China; Wenzhou University; Peking University	Lu, ZH (corresponding author), Southeast Univ, Sch Biol Sci & Med Engn, State Key Lab Bioelect, Nanjing 210096, Jiangsu, Peoples R China.	zhlu@seu.edu.cn		Tu, Jing/0000-0002-1310-5915; Lu, Zuhong/0000-0003-3332-2615	National Natural Science Foundation of China [61227803]; National Basic Research Program of China [2012CB316501]; Natural Science Foundation of Jiangsu Province of China [BK2012331]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China(National Basic Research Program of China); Natural Science Foundation of Jiangsu Province of China(Natural Science Foundation of Jiangsu Province)	This work was supported by the National Natural Science Foundation of China (61227803), the National Basic Research Program of China (project 2012CB316501), and the Natural Science Foundation of Jiangsu Province of China (BK2012331). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alon S, 2012, GENOME RES, V22, P1533, DOI 10.1101/gr.131573.111; Ameres SL, 2013, NAT REV MOL CELL BIO, V14, P475, DOI 10.1038/nrm3611; Bar M, 2008, STEM CELLS, V26, P2496, DOI 10.1634/stemcells.2008-0356; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bizuayehu TT, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-11; Chang HT, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-S7-S18; Chiang HR, 2010, GENE DEV, V24, P992, DOI 10.1101/gad.1884710; Cloonan N, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-12-r126; Ebhardt H Alexander, 2010, Silence, V1, P12, DOI 10.1186/1758-907X-1-12; Ebhardt HA, 2009, NUCLEIC ACIDS RES, V37, P2461, DOI 10.1093/nar/gkp093; Fernandez-Valverde SL, 2010, RNA, V16, P1881, DOI 10.1261/rna.2379610; Friedman RC, 2009, GENOME RES, V19, P92, DOI 10.1101/gr.082701.108; Garcia DM, 2011, NAT STRUCT MOL BIOL, V18, P1139, DOI 10.1038/nsmb.2115; Giles KM, 2011, METHODS MOL BIOL, V676, P147, DOI 10.1007/978-1-60761-863-8_11; Grimson A, 2007, MOL CELL, V27, P91, DOI 10.1016/j.molcel.2007.06.017; Guo L, 2014, GENE, V533, P149, DOI 10.1016/j.gene.2013.09.102; Guo L, 2013, GENE, V527, P624, DOI 10.1016/j.gene.2013.06.083; Guo L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021072; Guo L, 2010, COMPUT BIOL CHEM, V34, P165, DOI 10.1016/j.compbiolchem.2010.06.001; Hinton A, 2014, STEM CELLS; Hsu SD, 2014, NUCLEIC ACIDS RES, V42, pD78, DOI 10.1093/nar/gkt1266; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Humphreys DT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030933; Huntzinger E, 2011, NAT REV GENET, V12, P99, DOI 10.1038/nrg2936; Jones MR, 2009, NAT CELL BIOL, V11, P1157, DOI 10.1038/ncb1931; Katoh T, 2009, GENE DEV, V23, P433, DOI 10.1101/gad.1761509; Kim VN, 2009, NAT REV MOL CELL BIO, V10, P126, DOI 10.1038/nrm2632; Korbes AP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050663; Kozomara A, 2014, NUCLEIC ACIDS RES, V42, pD68, DOI 10.1093/nar/gkt1181; Kuchen S, 2010, IMMUNITY, V32, P828, DOI 10.1016/j.immuni.2010.05.009; Langenberger D, 2012, BIOINFORMATICS, V28, P17, DOI 10.1093/bioinformatics/btr598; Lee LW, 2010, RNA, V16, P2170, DOI 10.1261/rna.2225110; Li SC, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-S1-S13; Lu M, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-419; Neilsen CT, 2012, TRENDS GENET, V28, P544, DOI 10.1016/j.tig.2012.07.005; Pritchard CC, 2012, NAT REV GENET, V13, P358, DOI 10.1038/nrg3198; Saito K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071480; Seitz H, 2008, CURR BIOL, V18, P147, DOI 10.1016/j.cub.2007.12.049; Stark MS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009685; Tan GC, 2014, NUCL ACIDS RES; Vickers KC, 2013, J LIPID RES, V54, P1182, DOI 10.1194/jlr.R034801; Wang SQ, 2014, ARCHAEA, V2014, DOI 10.1155/2014/671059; Wang XW, 2014, BIOINFORMATICS, V30, P1377, DOI 10.1093/bioinformatics/btu045; Witten D, 2010, BMC BIOL, V8, DOI 10.1186/1741-7007-8-58; Wyman SK, 2011, GENOME RES, V21, P1450, DOI 10.1101/gr.118059.110; Zhou HJ, 2012, NUCLEIC ACIDS RES, V40, P5864, DOI 10.1093/nar/gks247; Zhu JY, 2009, J VIROL, V83, P3333, DOI 10.1128/JVI.01689-08	48	5	5	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2015	10	3							e0118856	10.1371/journal.pone.0118856	http://dx.doi.org/10.1371/journal.pone.0118856			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9BN	25785816	Green Published, Green Submitted, gold			2022-12-27	WOS:000352138500052
J	Ye, T; Zhen, JH; Du, Y; Zhou, JK; Peng, A; Vaziri, ND; Mohan, C; Xu, Y; Zhou, XJ				Ye, Ting; Zhen, Junhui; Du, Yong; Zhou, Jason K.; Peng, Ai; Vaziri, Nosratola D.; Mohan, Chandra; Xu, Yan; Zhou, Xin J.			Green Tea Polyphenol (-)-Epigallocatechin-3-Gallate Restores Nrf2 Activity and Ameliorates Crescentic Glomerulonephritis	PLOS ONE			English	Article							ROSIGLITAZONE; PATHWAY; LUPUS; INFLAMMATION; AUTOANTIGEN; EXPRESSION; PROTECTION; INDUCTION; DISEASE; STRESS	Crescentic glomerulonephritis (GN) is the most severe form of GN and is associated with significant morbidity and mortality despite aggressive immunotherapy with steroids, cytotoxic drugs, and plasmapheresis. We examined the therapeutic efficacy of the green tea polyphenol (-)-epigallocatechin-3-gallate (EGCG, 50 mg/kg BW/day x3weeks), a potent antiinflammatory and anti-oxidant agent, on experimental crescentic GN induced in 129/svJ mice by administration of rabbit anti-mouse glomerular basement membrane sera. Routine histology and key molecules involved in inflammatory and redox signaling were studied. EGCG treatment significantly reduced mortality, decreased proteinuria and serum creatinine, and markedly improved renal histology when compared with vehicle-treated mice. The improvements in renal function and histology were accompanied by the restoration of Nrf2 signaling (which was impaired in vehicle-treated mice) as shown by increased nuclear translocation of Nrf2 and cytoplasmic glutamate cysteine ligase catalytic subunit, glutamate cysteine ligase modifier subunit, and glutathione peroxidase. EGCG-treated mice also showed reduction in p-Akt, p-JNK, p-ERK1/2 and p-P38 as well as restoration of PPAR. and SIRT1 levels. Lower dose of EGCG (25 mg/kg BW/day x2 weeks) treatment also significantly decreased proteinuria and serum creatinine, and markedly improved renal histology when compared with vehicle-treated mice. Thus, our data illustrate the efficacy of EGCG in reversing the progression of crescentic GN in mice by targeting multiple signaling and inflammatory pathways as well as countering oxidative stress.	[Ye, Ting] Huazhong Univ Sci & Technol, Tongji Med Coll, Tongji Hosp, Dept Clin Nutr, Wuhan 430074, Hubei, Peoples R China; [Ye, Ting; Zhen, Junhui; Zhou, Xin J.] Univ Texas SW Med Ctr Dallas, Dept Pathol, Dallas, TX 75390 USA; [Zhen, Junhui] Shandong Univ, Sch Med, Dept Pathol, Jinan 250100, Shandong, Peoples R China; [Du, Yong; Mohan, Chandra] Univ Houston, Dept Biomed Engn, Houston, TX 77004 USA; [Du, Yong; Zhou, Jason K.; Mohan, Chandra] Univ Texas SW Med Ctr Dallas, Div Rheumatol, Dallas, TX 75390 USA; [Peng, Ai] Tongji Univ, Sch Med, Ctr Nephrol & Clin Metabol, Dept Nephrol & Rheumatol,Shanghai Peoples Hosp 10, Shanghai 200092, Peoples R China; [Vaziri, Nosratola D.] Univ Calif Irvine, Div Nephrol & Hypertens, Irvine, CA USA; [Xu, Yan] Qingdao Univ, Affiliated Hosp, Dept Nephrol, Qingdao 266071, Shandong, Peoples R China; [Zhou, Xin J.] Pathologist BioMed Labs, Renal Path Diagnost, Lewisville, TX USA; [Zhou, Xin J.] Baylor Univ, Med Ctr, Dept Pathol, Dallas, TX USA	Huazhong University of Science & Technology; University of Texas System; University of Texas Southwestern Medical Center Dallas; Shandong University; University of Houston System; University of Houston; University of Texas System; University of Texas Southwestern Medical Center Dallas; Tongji University; University of California System; University of California Irvine; Qingdao University; Baylor University; Baylor University Medical Center	Mohan, C (corresponding author), Univ Houston, Dept Biomed Engn, Houston, TX 77004 USA.	cmohan@central.uh.edu; xuyan67@126.com; jzhou@pbmlabs.com	Mohan, Chandra/GPX-8233-2022; DU, YONG/B-9964-2011; ye, ting/HGC-5924-2022	DU, YONG/0000-0003-1687-9024	NIH [R21 AT004436]; Drs. George and Anne Race Distinguished Professorship in Pathology; NATIONAL CENTER FOR COMPLEMENTARY &ALTERNATIVE MEDICINE [R21AT004436] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Drs. George and Anne Race Distinguished Professorship in Pathology; NATIONAL CENTER FOR COMPLEMENTARY &ALTERNATIVE MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Complementary & Alternative Medicine)	This work was supported in part by grants from NIH (R21 AT004436) and by funds from the Drs. George and Anne Race Distinguished Professorship in Pathology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afaq F, 2003, ONCOGENE, V22, P1035, DOI 10.1038/sj.onc.1206206; Aprahamian T, 2009, J IMMUNOL, V182, P340, DOI 10.4049/jimmunol.182.1.340; Cho HY, 2010, AM J RESP CRIT CARE, V182, P170, DOI 10.1164/rccm.200907-1047OC; Copple IM, 2010, HDB EXP PHARM, V196, P233, DOI DOI 10.1007/978-3-642-00663-0_; Goodin MG, 2002, TOXICOL SCI, V69, P354, DOI 10.1093/toxsci/69.2.354; Hagiya Yuichiro, 2008, J Exp Ther Oncol, V7, P153; Hao CM, 2010, J AM SOC NEPHROL, V21, P1620, DOI 10.1681/ASN.2010010046; Haraguchi Kazutaka, 2003, Clin Exp Nephrol, V7, P27, DOI 10.1007/s101570300003; Itoh K, 1997, BIOCHEM BIOPH RES CO, V236, P313, DOI 10.1006/bbrc.1997.6943; Jaiswal AK, 2000, FREE RADICAL BIO MED, V29, P254, DOI 10.1016/S0891-5849(00)00306-3; KALLURI R, 1995, J AM SOC NEPHROL, V6, P1178; Khan N, 2006, CANCER RES, V66, P2500, DOI 10.1158/0008-5472.CAN-05-3636; Kim HS, 2014, REDOX BIOL, V2, P187, DOI 10.1016/j.redox.2013.12.022; Kim HJ, 2011, J PHARMACOL EXP THER, V337, P583, DOI 10.1124/jpet.110.175828; Kim HJ, 2010, AM J PHYSIOL-RENAL, V298, pF662, DOI 10.1152/ajprenal.00421.2009; Kincaid-Smith P, 2008, NEPHROLOGY, V13, P58, DOI 10.1111/j.1440-1797.2007.00903.x; Lu H, 2010, AM J PHYSIOL-RENAL, V299, pF445, DOI 10.1152/ajprenal.00583.2009; Ma LJ, 2001, KIDNEY INT, V59, P1899, DOI 10.1046/j.1523-1755.2001.0590051899.x; Miyazaki Y, 2007, KIDNEY INT, V72, P1367, DOI 10.1038/sj.ki.5002516; Moroni G, 2014, AUTOIMMUN REV, V13, P723, DOI 10.1016/j.autrev.2014.02.007; Paine A, 2010, BIOCHEM PHARMACOL, V80, P1895, DOI 10.1016/j.bcp.2010.07.014; Peairs A, 2010, CELL MOL IMMUNOL, V7, P123, DOI 10.1038/cmi.2010.1; Pedchenko V, 2010, NEW ENGL J MED, V363, P343, DOI 10.1056/NEJMoa0910500; Peng A, 2011, KIDNEY INT, V80, P601, DOI 10.1038/ki.2011.121; REHAN A, 1984, LAB INVEST, V51, P396; Sahin K, 2010, LIFE SCI, V87, P240, DOI 10.1016/j.lfs.2010.06.014; Sandberg M, 2014, NEUROPHARMACOLOGY, V79, P298, DOI 10.1016/j.neuropharm.2013.11.004; Sarafidis PA, 2006, KIDNEY INT, V70, P1223, DOI 10.1038/sj.ki.5001620; Sykiotis GP, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.3112re3; Tsai PY, 2011, FREE RADICAL BIO MED, V51, P744, DOI 10.1016/j.freeradbiomed.2011.05.016; Turner JE, 2011, KIDNEY INT, V80, P563, DOI 10.1038/ki.2011.173; Wu TF, 2007, J CLIN INVEST, V117, P2186, DOI 10.1172/JCI30398; Wu TF, 2014, ARTHRITIS RHEUMATOL, V66, P3129, DOI 10.1002/art.38782; Xie C, 2004, J IMMUNOL, V172, P5047, DOI 10.4049/jimmunol.172.8.5047; Yeligar SM, 2010, J BIOL CHEM, V285, P35359, DOI 10.1074/jbc.M110.138636; Yoh K, 2001, KIDNEY INT, V60, P1343, DOI 10.1046/j.1523-1755.2001.00939.x; Yu MA, 2011, CELL SIGNAL, V23, P883, DOI 10.1016/j.cellsig.2011.01.014; Zhen JH, 2008, AM J HYPERTENS, V21, P28, DOI 10.1038/ajh.2007.14; Zhou XJ, 2000, LAB INVEST, V80, P1905, DOI 10.1038/labinvest.3780200; Zhou XJ, 2009, SILVAS DIAGNOSTIC RE, P178; Zinellu A, 2005, ANAL BIOCHEM, V342, P186, DOI 10.1016/j.ab.2005.01.045	41	32	34	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2015	10	3							e0119543	10.1371/journal.pone.0119543	http://dx.doi.org/10.1371/journal.pone.0119543			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9BN	25785827	gold, Green Published			2022-12-27	WOS:000352138500109
J	Agorastos, T; Chatzistamatiou, K; Katsamagkas, T; Koliopoulos, G; Daponte, A; Constantinidis, T; Constantinidis, TC				Agorastos, Theodoros; Chatzistamatiou, Kimon; Katsamagkas, Taxiarchis; Koliopoulos, George; Daponte, Alexandros; Constantinidis, Theocharis; Constantinidis, Theodoros C.		HERMES Study Grp	Primary Screening for Cervical Cancer Based on High-Risk Human Papillomavirus (HPV) Detection and HPV 16 and HPV 18 Genotyping, in Comparison to Cytology	PLOS ONE			English	Article							FOLLOW-UP; INTRAEPITHELIAL NEOPLASIA; WOMEN; PREVENTION; METAANALYSIS; PREVALENCE; INFECTION; TRIAGE; TESTS; DNA	Objectives The objective of the present study is to assess the performance of a high-risk human papillomavirus (HR-HPV) DNA test with individual HPV-16/HPV-18 genotyping as a method for primary cervical cancer screening compared with liquid-based cytology (LBC) in a population of Greek women taking part in routine cervical cancer screening. Methods The study, conducted by the "HEllenic Real life Multicentric cErvical Screening" (HERMES) study group, involved the recruitment of 4,009 women, aged 25-55, who took part in routine cervical screening at nine Gynecology Departments in Greece. At first visit cervical specimens were collected for LBC and HPV testing using the Roche Cobas 4800 system. Women found positive for either cytology or HPV were referred for colposcopy, whereas women negative for both tests will be retested after three years. The study is ongoing and the results of the first screening round are reported herein. Results Valid results for cytology and HPV testing were obtained for 3,993 women. The overall prevalence of HR-HPV was 12.7%, of HPV-16 2.7% and of HPV-18 1.4%. Of those referred for colposcopy, cervical intraepithelial neoplasia grade 2 or worse (CIN2+) was detected in 41 women (1.07%). At the threshold of CIN2+, cytology [atypical squamous cells of undetermined significance (ASC-US) or worse] and HPV testing showed a sensitivity of 53.7% and 100% respectively, without change between age groups. Cytology and HPV testing showed specificity of 96.8% and 90.3% respectively, which was increased in older women (>= 30) in comparison to younger ones (25-29). Genotyping for HPV16/18 had similar accuracy to cytology for the detection of CIN2+ (sensitivity: 58.5%; specificity 97.5%) as well as for triage to colposcopy (sensitivity: 58.5% vs 53.7% for cytology). Conclusion HPV testing has much better sensitivity than cytology to identify high-grade cervical lesions with slightly lower specificity. HPV testing with individual HPV-16/HPV-18 genotyping could represent a more accurate methodology for primary cervical cancer screening in comparison to liquid-based cytology, especially in older women.	[Agorastos, Theodoros; Chatzistamatiou, Kimon; Katsamagkas, Taxiarchis] Aristotle Univ Thessaloniki, Dept Obstet & Gynecol 4, Hippokratio Gen Hosp, GR-54006 Thessaloniki, Greece; [Koliopoulos, George] Univ Athens, Dept Obstet & Gynecol 3, Attikon Hosp, Athens, Greece; [Daponte, Alexandros] Univ Thessaly, Dept Obstet & Gynecol, Gen Univ Hosp, Larisa, Greece; [Constantinidis, Theocharis] Minist Hlth, Peripheral Lab Publ Hlth, Hellen Ctr Dis Control & Prevent, Alexandroupolis, Greece; [Constantinidis, Theodoros C.] Democritus Univ Thrace, Microbiol Lab, Lab Hyg & Environm Protect, Alexandroupolis, Greece	Aristotle University of Thessaloniki; National & Kapodistrian University of Athens; University Hospital Attikon; General University Hospital of Larissa; University of Thessaly; Democritus University of Thrace	Chatzistamatiou, K (corresponding author), Aristotle Univ Thessaloniki, Dept Obstet & Gynecol 4, Hippokratio Gen Hosp, GR-54006 Thessaloniki, Greece.	kimon.chatzistamatiou@gmail.com	Chatzistamatiou, Kimon/H-3490-2019	Chatzistamatiou, Kimon/0000-0002-5357-4708; Konstantinidis, Theocharis/0000-0003-4296-3414	Roche Diagnostics; Vianex/Sanofi Pasteur MSD	Roche Diagnostics; Vianex/Sanofi Pasteur MSD	The authors have read the journal's policy and the authors of this manuscript have the following competing interests: KC and TK had their travel expenses and fees for two Congresses (EUROGIN 2012 and EUROGIN 2013) covered by Roche Diagnostics. GK, AD, TC and TCC have declared that no competing interests exist. TA has performed research trials partially supported by Vianex/Sanofi Pasteur MSD and has had travel expenses for conferences/meetings/symposia occasionally Cover Letter covered by either Vianex/Sanofi Pasteur MSD, GlaxoSmithKline and Roche Diagnostics. This does not alter the authors' adherence to PLOS ONE policies on sharing data and materials. All the authors declare no competing interests related to the commercial funder, Roche Diagnostics, concerning employment, consultancy, patents, products in development, marketed products etc.	Agorastos T, 2005, GYNECOL ONCOL, V96, P714, DOI 10.1016/j.ygyno.2004.11.042; Agorastos T, 2014, EUR J CANCER PREV, V23, P425, DOI 10.1097/CEJ.0000000000000060; Agorastos Theodoros, 2009, Cancer Inform, V8, P31; Agorastos T, 2009, EUR J CANCER PREV, V18, P504, DOI 10.1097/CEJ.0b013e32832abd5e; Arbyn M, 2004, JNCI-J NATL CANCER I, V96, P280, DOI 10.1093/jnci/djh037; Arbyn M, 2008, OBSTET GYNECOL, V111, P167, DOI 10.1097/01.AOG.0000296488.85807.b3; Arbyn M, 2012, VACCINE, V30, pF88, DOI 10.1016/j.vaccine.2012.06.095; Bornstein J, 2012, OBSTET GYNECOL, V120, P166, DOI 10.1097/AOG.0b013e318254f90c; BOSCH FX, 1992, INT J CANCER, V52, P171, DOI 10.1002/ijc.2910520202; Bosch XF, 2003, J NATL CANC I MONOGR, V31, P3, DOI DOI 10.1093/OXFORDJOURNALS.JNCIMONOGRAPHS.A003479; Bossuyt PM, 2003, ANN INTERN MED, V138, P40, DOI 10.7326/0003-4819-138-1-200301070-00010; Bouvard V, 2009, LANCET ONCOL, V10, P321, DOI 10.1016/S1470-2045(09)70096-8; Bruni L, 2010, J INFECT DIS, V202, P1789, DOI 10.1086/657321; Bulk S, 2007, INT J CANCER, V121, P361, DOI 10.1002/ijc.22677; Bulkmans NWJ, 2004, INT J CANCER, V110, P94, DOI 10.1002/ijc.20076; Castle PE, 2011, LANCET ONCOL, V12, P880, DOI 10.1016/S1470-2045(11)70188-7; Cox JT, 2013, AM J OBSTET GYNECOL, V208, DOI 10.1016/j.ajog.2012.11.020; Cuzick J, 2013, BRIT J CANCER, V108, P908, DOI 10.1038/bjc.2013.22; Cuzick J, 2008, VACCINE, V26, pK29, DOI 10.1016/j.vaccine.2008.06.019; Cuzick J, 2008, INT J CANCER, V122, P2294, DOI 10.1002/ijc.23339; Cuzick J, 2006, INT J CANCER, V119, P1095, DOI 10.1002/ijc.21955; Datta SD, 2008, ANN INTERN MED, V148, P493, DOI 10.7326/0003-4819-148-7-200804010-00004; de Sanjose S, 2007, LANCET INFECT DIS, V7, P453, DOI 10.1016/S1473-3099(07)70158-5; de Sanjose S, 2010, LANCET ONCOL, V11, P1048, DOI 10.1016/S1470-2045(10)70230-8; Dillner J, 2013, CURR OPIN OBSTET GYN, V25, P11, DOI 10.1097/GCO.0b013e32835c5d10; Elfstrom KM, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g130; Franco EL, 2009, ARCH MED RES, V40, P478, DOI 10.1016/j.arcmed.2009.06.003; Gage JC, 2014, JNCI-J NATL CANCER I, V106, DOI 10.1093/jnci/dju153; HAUSEN HZ, 1977, CURR TOP MICROBIOL, P1; Heideman DAM, 2011, J CLIN MICROBIOL, V49, P3983, DOI 10.1128/JCM.05552-11; Jemal A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009584; Katki HA, 2011, LANCET ONCOL, V12, P663, DOI 10.1016/S1470-2045(11)70145-0; Khan MJ, 2005, JNCI-J NATL CANCER I, V97, P1072, DOI 10.1093/jnci/dji187; Kinney W, 2011, GYNECOL ONCOL, V121, P309, DOI 10.1016/j.ygyno.2010.12.361; Kitchener HC, 2014, HEALTH TECHNOL ASSES, V18, P1, DOI 10.3310/hta18230; Kitchener HC, 2009, LANCET ONCOL, V10, P672, DOI 10.1016/S1470-2045(09)70156-1; Koliopoulos G, 2007, GYNECOL ONCOL, V104, P232, DOI 10.1016/j.ygyno.2006.08.053; KOSS LG, 1989, JAMA-J AM MED ASSOC, V261, P737, DOI 10.1001/jama.261.5.737; Leinonen M, 2009, JNCI-J NATL CANCER I, V101, P1612, DOI 10.1093/jnci/djp367; Mayrand M, 2007, NEW ENGL J MED, V357, P1579, DOI 10.1056/NEJMoa071430; Meijer CJLM, 2009, INT J CANCER, V124, P516, DOI 10.1002/ijc.24010; Munoz N, 2003, NEW ENGL J MED, V348, P518, DOI 10.1056/NEJMoa021641; Munoz N, 2000, J CLIN VIROL, V19, P1, DOI 10.1016/S1386-6532(00)00125-6; Naucler P, 2007, NEW ENGL J MED, V357, P1589, DOI 10.1056/NEJMoa073204; Peto J, 2004, LANCET, V364, P249, DOI 10.1016/S0140-6736(04)16674-9; Quinn M, 1999, BRIT MED J, V318, P904, DOI 10.1136/bmj.318.7188.904; Rijkaart DC, 2012, LANCET ONCOL, V13, P78, DOI 10.1016/S1470-2045(11)70296-0; Ronco G, 2014, LANCET, V383, P524, DOI 10.1016/S0140-6736(13)62218-7; Ronco G, 2010, LANCET ONCOL, V11, P249, DOI 10.1016/S1470-2045(09)70360-2; Roura E, 2014, INT J CANCER, V135, P453, DOI 10.1002/ijc.28666; Sankaranarayanan R, 2009, NEW ENGL J MED, V360, P1385, DOI 10.1056/NEJMoa0808516; Saslow D, 2012, AM J CLIN PATHOL, V137, P516, DOI [10.1309/AJCPTGD94EVRSJCG, 10.3322/caac.21139]; Schiffman M, 2015, J CLIN MICROBIOL, V53, P52, DOI 10.1128/JCM.02116-14; Schiffman M, 2011, CANCER EPIDEM BIOMAR, V20, P1398, DOI 10.1158/1055-9965.EPI-11-0206; Schiffman M, 2011, JNCI-J NATL CANCER I, V103, P368, DOI 10.1093/jnci/djq562; Schmidt CO, 2008, INT J PUBLIC HEALTH, V53, P165, DOI 10.1007/s00038-008-7068-3; Sherman ME, 2002, J NATL CANCER I, V94, P102, DOI 10.1093/jnci/94.2.102; Solomon D, 2002, JAMA-J AM MED ASSOC, V287, P2114, DOI 10.1001/jama.287.16.2114; Stoler MH, 2011, AM J CLIN PATHOL, V135, P468, DOI 10.1309/AJCPZ5JY6FCVNMOT; Traut H F, 1943, Cal West Med, V59, P121; Walboomers JMM, 1999, J PATHOL, V189, P12, DOI 10.1002/(SICI)1096-9896(199909)189:1&lt;12::AID-PATH431&gt;3.0.CO;2-F; Wang SS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008667; Wilber ST, 2010, ACAD EMERG MED, V17, P649, DOI 10.1111/j.1553-2712.2010.00773.x; Wright Thomas C Jr, 2007, J Low Genit Tract Dis, V11, P201, DOI 10.1097/LGT.0b013e3181585870; Wright TC, 2012, AM J OBSTET GYNECOL, V206, DOI 10.1016/j.ajog.2011.07.024; Wright TC, 2011, AM J CLIN PATHOL, V136, P578, DOI 10.1309/AJCPTUS5EXAS6DKZ	66	77	86	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2015	10	3							e0119755	10.1371/journal.pone.0119755	http://dx.doi.org/10.1371/journal.pone.0119755			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8IA	25793281	Green Submitted, Green Published, gold			2022-12-27	WOS:000352084200113
J	Brennan, MS; Matos, MF; Li, B; Hronowski, X; Gao, BB; Juhasz, P; Rhodes, KJ; Scannevin, RH				Brennan, Melanie S.; Matos, Maria F.; Li, Bing; Hronowski, Xiaoping; Gao, Benbo; Juhasz, Peter; Rhodes, Kenneth J.; Scannevin, Robert H.			Dimethyl Fumarate and Monoethyl Fumarate Exhibit Differential Effects on KEAP1, NRF2 Activation, and Glutathione Depletion In Vitro	PLOS ONE			English	Article							PHASE-II ENZYMES; MULTIPLE-SCLEROSIS; HEME OXYGENASE-1; CYSTEINE RESIDUES; OXIDATIVE STRESS; INDUCTION; SULFORAPHANE; MECHANISMS; PROTEIN; GENES	Delayed-release dimethyl fumarate (also known as gastro-resistant dimethyl fumarate), an oral therapeutic containing dimethyl fumarate (DMF) as the active ingredient, is currently approved for the treatment of relapsing multiple sclerosis. DMF is also a component in a distinct mixture product with 3 different salts of monoethyl fumarate (MEF), which is marketed for the treatment of psoriasis. Previous studies have provided insight into the pharmacologic properties of DMF, including modulation of kelch-like ECH-associated protein 1 (KEAP1), activation of the nuclear factor (erythroid-derived 2)-like 2 (NRF2) pathway, and glutathione (GSH) modulation; however, those of MEF remain largely unexplored. Therefore, the aim of this study was to evaluate the in vitro effects of DMF and MEF on KEAP1 modification, activation of the NRF2 pathway, and GSH conjugation. Using mass spectrometry, DMF treatment resulted in a robust modification of specific cysteine residues on KEAP1. In comparison, the overall degree of KEAP1 modification following MEF treatment was significantly less or undetectable. Consistent with KEAP1 cysteine modification, DMF treatment resulted in nuclear translocation of NRF2 and a robust transcriptional response in treated cells, as did MEF; however, the responses to MEF were of a lower magnitude or distinct compared to DMF. DMF was also shown to produce an acute concentration-dependent depletion of GSH; however, GSH levels eventually recovered and rose above baseline by 24 hours. In contrast, MEF did not cause acute reductions in GSH, but did produce an increase by 24 hours. Overall, these studies demonstrate that DMF and MEF are both pharmacologically active, but have differing degrees of activity as well as unique actions. These differences would be expected to result in divergent effects on downstream biology.	[Brennan, Melanie S.; Matos, Maria F.; Li, Bing; Rhodes, Kenneth J.; Scannevin, Robert H.] Biogen Idec Inc, Dept Neurol Res, Cambridge, MA 02142 USA; [Hronowski, Xiaoping; Gao, Benbo; Juhasz, Peter] Biogen Idec Inc, Dept Discovery Prote & Mass Spectrometry, Cambridge, MA USA	Biogen; Biogen	Scannevin, RH (corresponding author), Biogen Idec Inc, Dept Neurol Res, Cambridge, MA 02142 USA.	robert.scannevin@biogenidec.com		Scannevin, Robert/0000-0002-5749-2785	Biogen Idec, Inc.	Biogen Idec, Inc.(Biogen)	This study was funded by Biogen Idec, Inc. The authors had full editorial control of the content of manuscript, and all authors approved the content of the submitted manuscript. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angeloni C, 2009, J AGR FOOD CHEM, V57, P5615, DOI 10.1021/jf900549c; [Anonymous], 2009, FUM SUMM PROD CHAR; Aschner M, 2000, NEUROTOXICOLOGY, V21, P1101; Balogun E, 2003, BIOCHEM J, V371, P887, DOI 10.1042/BJ20021619; Chen H, 2014, J CLIN INVEST; Chen ZH, 2005, J BIOL CHEM, V280, P41921, DOI 10.1074/jbc.M508556200; Dinkova-Kostova AT, 2002, P NATL ACAD SCI USA, V99, P11908, DOI 10.1073/pnas.172398899; Eggler AL, 2005, P NATL ACAD SCI USA, V102, P10070, DOI 10.1073/pnas.0502402102; EWING JF, 1993, J NEUROCHEM, V60, P1512, DOI 10.1111/j.1471-4159.1993.tb03315.x; Fox RJ, 2006, CLEV CLIN J MED, V73, P91, DOI 10.3949/ccjm.73.1.91; Freedman MS, 2006, EXPERT OPIN PHARMACO, V7, pS1, DOI 10.1517/14656566.7.1.S1; Garg R, 2008, CARCINOGENESIS, V29, P1022, DOI 10.1093/carcin/bgn064; Ghoreschi K, 2011, J EXP MED, V208, P2291, DOI 10.1084/jem.20100977; Gilgun-Sherki Y, 2004, J NEUROL, V251, P261, DOI 10.1007/s00415-004-0348-9; Holland R, 2010, ANTIOXID REDOX SIGN, V13, P1749, DOI 10.1089/ars.2010.3273; Hong F, 2005, CHEM RES TOXICOL, V18, P1917, DOI 10.1021/tx0502138; Horikawa S, 2002, FEBS LETT, V510, P221, DOI 10.1016/S0014-5793(01)03270-7; Itoh K, 2003, GENES CELLS, V8, P379, DOI 10.1046/j.1365-2443.2003.00640.x; Itoh K, 1997, BIOCHEM BIOPH RES CO, V236, P313, DOI 10.1006/bbrc.1997.6943; Kobayashi A, 2004, MOL CELL BIOL, V24, P7130, DOI 10.1128/MCB.24.16.7130-7139.2004; Lehmann JCU, 2007, J INVEST DERMATOL, V127, P835, DOI 10.1038/sj.jid.5700686; Lin SX, 2011, ASN NEURO, V3, DOI 10.1042/AN20100033; Linker RA, 2011, BRAIN, V134, P678, DOI 10.1093/brain/awq386; Loewe R, 2002, J IMMUNOL, V168, P4781, DOI 10.4049/jimmunol.168.9.4781; Matusheski NV, 2004, PHYTOCHEMISTRY, V65, P1273, DOI 10.1016/j.phytochem.2004.04.013; Morris G, 2014, MOL NEUROBIOL, V50, P1059, DOI 10.1007/s12035-014-8705-x; Nathens AB, 1998, J SURG RES, V77, P75, DOI 10.1006/jsre.1998.5338; Nelson KC, 1999, INVEST OPHTH VIS SCI, V40, P1927; Nguyen T, 2005, J BIOL CHEM, V280, P32485, DOI 10.1074/jbc.M503074200; Nguyen T, 2003, ANNU REV PHARMACOL, V43, P233, DOI 10.1146/annurev.pharmtox.43.100901.140229; Noseworthy JH, 2000, NEW ENGL J MED, V343, P938, DOI 10.1056/NEJM200009283431307; Scannevin RH, 2012, J PHARMACOL EXP THER, V341, P274, DOI 10.1124/jpet.111.190132; Schmidt MM, 2010, NEUROCHEM INT, V57, P460, DOI 10.1016/j.neuint.2010.01.006; Schmidt TJ, 2007, BIOORGAN MED CHEM, V15, P333, DOI 10.1016/j.bmc.2006.09.053; Taguchi K, 2011, GENES CELLS, V16, P123, DOI 10.1111/j.1365-2443.2010.01473.x; Thimmulappa RK, 2002, CANCER RES, V62, P5196; van Horssen J, 2011, BBA-MOL BASIS DIS, V1812, P141, DOI 10.1016/j.bbadis.2010.06.011; Wiesner D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076670; Witherick J, 2011, AUTOIMMUN DIS, V2011, DOI 10.4061/2011/164608; Yamamoto T, 2008, MOL CELL BIOL, V28, P2758, DOI 10.1128/MCB.01704-07; Zhang DD, 2003, MOL CELL BIOL, V23, P8137, DOI 10.1128/MCB.23.22.8137-8151.2003	41	105	106	3	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2015	10	3							e0120254	10.1371/journal.pone.0120254	http://dx.doi.org/10.1371/journal.pone.0120254			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8HY	25793262	Green Submitted, gold, Green Published			2022-12-27	WOS:000352083900003
J	Dewa, CS; Hees, H; Trojanowski, L; Schene, AH				Dewa, Carolyn S.; Hees, Hiske; Trojanowski, Lucy; Schene, Aart H.			Clinician Experiences Assessing Work Disability Related to Mental Disorders	PLOS ONE			English	Article							DISENTANGLING DISABILITY; PHYSICIANS; DSM-5	Objective Medical certification is one of the basic administrative mechanisms used by social policies aimed at income protection. The assessment of work disability is central to the income protection application. Yet, there is evidence suggesting that determining work disability related to mental disorders is challenging. Although essential to the disability application process, few studies have looked at physician and other clinician experiences with the process. However, this type of information is critical to developing processes to support providers who participate in the assessments. This purpose of this paper is to explore the experiences of physicians and other clinicians assessing public long-term work disability related to mental disorders. Methods This is an exploratory and descriptive study using qualitative methods. Clinician input was gathered through focus groups and individual in-depth interviews. Verbatim transcripts were analyzed to identify recurrent and significant themes that arose during the focus groups and individual interviews. Results Many of the experiences that the clinicians in this sample discussed related to the difficulty of trying to fill the roles of advocate and medical expert as well as the challenge of determining the impact of functional capacity and work ability. The findings also highlight the current gap in knowledge about the factors that affect successful functioning in general and at work in particular. Conclusions Given the challenges created by the current state of knowledge, it may be useful to consider a category of "partial disability". In addition, the fact that work disability depends on the interaction between the experience of the mental disorder and specific job requirements and the fact that people applying for public long-term disability are not working, it might be helpful to offer a clear description and guidelines of the meaning of work ability.	[Dewa, Carolyn S.; Trojanowski, Lucy] Ctr Addict & Mental Hlth, Ctr Res Employment & Workplace Hlth, Toronto, ON, Canada; [Hees, Hiske] Pro Persona, Dept Mood Disorders, Nijmegen, Netherlands; [Schene, Aart H.] Radboud Umc, Dept Psychiat, Nijmegen, Netherlands	University of Toronto; University Toronto Affiliates; Centre for Addiction & Mental Health - Canada; Radboud University Nijmegen	Dewa, CS (corresponding author), Ctr Addict & Mental Hlth, Ctr Res Employment & Workplace Hlth, Toronto, ON, Canada.	carolyn.dewa@camh.ca	Schene, A.H./H-8085-2014	Schene, A.H./0000-0002-1756-3235; Dewa, Carolyn/0000-0001-5647-3905	Ontario Ministry of Community and Social Services; Dr. Dewa's Canadian Institutes of Health Research/Public Health Agency of Canada Applied Public Health Chair	Ontario Ministry of Community and Social Services; Dr. Dewa's Canadian Institutes of Health Research/Public Health Agency of Canada Applied Public Health Chair	The data collection was supported by the Ontario Ministry of Community and Social Services. The analysis was supported by Dr. Dewa's Canadian Institutes of Health Research/Public Health Agency of Canada Applied Public Health Chair. The funders had no role in study design, decision to publish, or preparation of the manuscript.	American psychiatric association, 2013, DIAGNOSTIC STAT MANU, DOI 10.1176/appi.books.9780890425596; Cassis I, 1996, INT J QUAL HEALTH C, V8, P567, DOI 10.1093/intqhc/8.6.567; Creswell J.W., 2015, RES DESIGN QUALITATI, V4th ed.; Creswell J.W., 2012, ED RES PLANNING COND, V4th; D'Amato A, 2010, J OCCUP ENVIRON MED, V52, P67, DOI 10.1097/JOM.0b013e3181c75291; GLASER BG, 1965, SOC PROBL, V12, P436, DOI 10.1525/sp.1965.12.4.03a00070; Gold LH, 2014, J AM ACAD PSYCHIATRY, V42, P173; Gold LH, 2009, EVALUATING MENTAL HEALTH DISABILITY IN THE WORKPLACE: MODEL, PROCESS, AND ANALYSIS, P1, DOI 10.1007/978-1-4419-0152-1_1; Kamberelis G., 2011, COLLECTING INTERPRET, P545; Konecky B, 2014, AM J PSYCHIAT, V171, P818, DOI 10.1176/appi.ajp.2014.14050587; Leo Raphael J., 2001, Prim Care Companion J Clin Psychiatry, V3, P255; Lindholm C, 2010, BMC PUBLIC HEALTH, P10; Main, 2003, SCREENING IDENTIFY P; MASSEL HK, 1990, PSYCHIATRY, V53, P31; Narrow WE, 2009, WORLD PSYCHIATRY, V8, P88; OECD, 2012, SICK JOB MYTHS REAL; OKPAKU SO, 1994, AM J PUBLIC HEALTH, V84, P1791, DOI 10.2105/AJPH.84.11.1791; Organisation for economic Co-operation and development, 2010, SICKN DIS WORK BREAK; Patton MQ., 2002, QUALITATIVE RES EVAL, V3rd; Saldana J, 2021, CODING MANUAL QUALIT; Schierenbeck I, 2010, WORK, V37, P241, DOI 10.3233/WOR-2010-1076; Slebus FG, 2007, DISABIL REHABIL, V29, P1295, DOI 10.1080/09638280600976111; Soderberg E, 2005, SCAND J PUBLIC HEALT, V33, P314, DOI 10.1080/14034940510005798; Soderberg E, 2003, SCAND J PUBLIC HEALT, V31, P460, DOI 10.1080/14034940310005367; Timpka T, 1995, EUROPEAN J PUBLIC HL, V5, P215; Ustun B, 2009, WORLD PSYCHIATRY, V8, P82; Ustun T. B., 2010, Measuring health and disability: manual for WHO Disability Assessment Schedule (WHODAS 2.0); Wahlstrom R, 2004, SCAND J PUBLIC HEALT, V32, P222, DOI 10.1080/14034950410021916; WHO, 2011, WORLD REPORT ON DISABILITY, P1; ZOLA IK, 1989, MILBANK Q, V67, P401, DOI 10.2307/3350151	30	6	6	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2015	10	3							e0119009	10.1371/journal.pone.0119009	http://dx.doi.org/10.1371/journal.pone.0119009			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CD9NQ	25789478	Green Published, Green Submitted, gold			2022-12-27	WOS:000351425400060
J	Lagman, M; Ly, J; Saing, T; Singh, MK; Tudela, EV; Morris, D; Chi, PT; Ochoa, C; Sathananthan, A; Venketaraman, V				Lagman, Minette; Ly, Judy; Saing, Tommy; Singh, Manpreet Kaur; Tudela, Enrique Vera; Morris, Devin; Chi, Po-Ting; Ochoa, Cesar; Sathananthan, Airani; Venketaraman, Vishwanath			Investigating the Causes for Decreased Levels of Glutathione in Individuals with Type II Diabetes	PLOS ONE			English	Article							MYCOBACTERIUM-TUBERCULOSIS; OXIDATIVE STRESS; RESISTANCE; INFECTION; RESPONSES; INNATE; CELLS; SUPPRESSION; CYTOKINES; IMMUNITY	Tuberculosis (TB) remains an eminent global burden with one third of the world's population latently infected with Mycobacterium tuberculosis (M. tb). Individuals with compromised immune systems are especially vulnerable to M. tb infection. In fact, individuals with Type 2 Diabetes Mellitus (T2DM) are two to three times more susceptible to TB than those without T2DM. In this study, we report that individuals with T2DM have lower levels of glutathione (GSH) due to compromised levels of GSH synthesis and metabolism enzymes. Transforming growth factor beta (TGF-beta), a cytokine that is known to decrease the expression of the catalytic subunit of glutamine-cysteine ligase (GCLC) was found in increased levels in the plasma samples from individuals with T2DM, explaining the possible underlying mechanism that is responsible for decreased levels of GSH in individuals with T2DM. Moreover, increased levels of pro-inflammatory cytokines such as interleukin-6 (IL-6) and interleukin-17 (IL-17) were observed in plasma samples isolated from individuals with T2DM. Increased levels of IL-6 and IL-17 was accompanied by enhanced production of free radicals further indicating an alternative mechanism for the decreased levels of GSH in individuals with T2DM. Augmenting the levels of GSH in macrophages isolated from individuals with T2DM resulted in improved control of M. tb infection. Furthermore, cytokines that are responsible for controlling M. tb infection at the cellular and granuloma level such as tumor necrosis factor alpha (TNF-alpha), interleukin-1 beta (IL-1 beta), interleukin-2 (IL-2), interferon-gamma (IFN-gamma), and interleukin-12 (IL-12), were found to be compromised in plasma samples isolated from individuals with T2DM. On the other hand, interleukin-10 (IL-10), an immunosuppressive cytokine was increased in plasma samples isolated from individuals with T2DM. Overall, these findings suggest that lower levels of GSH in individuals with T2DM lead to their increased susceptibility to M. tb infection.	[Lagman, Minette; Saing, Tommy; Singh, Manpreet Kaur; Tudela, Enrique Vera; Chi, Po-Ting; Venketaraman, Vishwanath] Western Univ Hlth Sci, Grad Coll Biomed Sci, Pomona, CA 91766 USA; [Lagman, Minette; Ly, Judy; Singh, Manpreet Kaur; Tudela, Enrique Vera; Morris, Devin; Chi, Po-Ting; Venketaraman, Vishwanath] Western Univ Hlth Sci, Coll Osteopath Med Pacific, Dept Basic Med Sci, Pomona, CA USA; [Ochoa, Cesar; Sathananthan, Airani] Western Diabet Inst, Pomona, CA USA	Western University of Health Sciences; Western University of Health Sciences	Venketaraman, V (corresponding author), Western Univ Hlth Sci, Grad Coll Biomed Sci, Pomona, CA 91766 USA.	vvenketaraman@westernu.edu	venketaraman, Vishwanath/AAW-6945-2020	venketaraman, Vishwanath/0000-0002-2586-1160	Western University of Health Sciences; Your Energy Systems	Western University of Health Sciences; Your Energy Systems	This work was supported in part by Western University of Health Sciences and Your Energy Systems to VV. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alam K, 2010, J IMMUNOL, V184, P2918, DOI 10.4049/jimmunol.0900439; Alkozai Edris M, 2014, F1000Res, V3, P85, DOI 10.12688/f1000research.3316.1; American Diabetes Association, 2013, DAT STAT DIAB; [Anonymous], 2014, TUB; Bakin AV, 2005, FREE RADICAL BIO MED, V38, P375, DOI 10.1016/j.freeradbiomed.2004.10.033; CDC, 2014, NAT DIAB STAT REP; Chung SSM, 2003, J AM SOC NEPHROL, V14, pS233, DOI 10.1097/01.ASN.0000077408.15865.06; Cilfone NA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068680; COUSENS LP, 1995, J IMMUNOL, V155, P5690; Franklin CC, 2003, FASEB J, V17, P1535, DOI 10.1096/fj.02-0867fje; Gan YH, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003794; Griffith OW, 1999, FREE RADICAL BIO MED, V27, P922, DOI 10.1016/S0891-5849(99)00176-8; Guerra C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028378; Kilpatrick ES, 2009, DIABETES CARE, V32, P1901, DOI [10.2337/dc09-0109, 10.2337/dc09-1231]; Lai YP, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007766; Lee YJ, 2007, AM J PHYSIOL-RENAL, V293, pF1036, DOI 10.1152/ajprenal.00034.2007; Liu PT, 2008, CURR OPIN IMMUNOL, V20, P371, DOI 10.1016/j.coi.2008.05.014; Mayer-Barber KD, 2011, IMMUNITY, V35, P1023, DOI 10.1016/j.immuni.2011.12.002; Mayer-Barber KD, 2010, J IMMUNOL, V184, P3326, DOI 10.4049/jimmunol.0904189; Millman AC, 2008, J INTERF CYTOK RES, V28, P153, DOI 10.1089/jir.2007.0095; Morris D, 2013, J INTERF CYTOK RES, V33, P270, DOI 10.1089/jir.2012.0103; Morris D, 2013, BBA-GEN SUBJECTS, V1830, P3329, DOI 10.1016/j.bbagen.2012.10.012; Oni T, 2013, LANCET RESP MED, V1, P356, DOI 10.1016/S2213-2600(13)70116-4; ORLOWSKI M, 1970, P NATL ACAD SCI USA, V67, P1248, DOI 10.1073/pnas.67.3.1248; Peterson JD, 1998, P NATL ACAD SCI USA, V95, P3071, DOI 10.1073/pnas.95.6.3071; Restrepo BI, 2011, B WORLD HEALTH ORGAN, V89, P352, DOI 10.2471/BLT.10.085738; Roberts CK, 2006, METABOLISM, V55, P928, DOI 10.1016/j.metabol.2006.02.022; Roca FJ, 2013, CELL, V153, P521, DOI 10.1016/j.cell.2013.03.022; Tan KS, 2012, J CLIN INVEST, V122, P2289, DOI 10.1172/JCI57817; Tobin DM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067828; Trinchieri G, 2003, NAT REV IMMUNOL, V3, P133, DOI 10.1038/nri1001; Venketaraman V, 2005, INFECT IMMUN, V73, P1886, DOI 10.1128/IAI.73.3.1886-1889.2005; Venketaraman V, 2003, INFECT IMMUN, V71, P1864, DOI 10.1128/IAI.71.4.1864-1871.2003; Venketaraman V, 2008, MICROB PATHOGENESIS, V44, P255, DOI 10.1016/j.micpath.2007.09.002; Wieser V, 2013, ARCH IMMUNOL THER EX, V61, P119, DOI 10.1007/s00005-012-0210-1; World Health Organization, 2011, TUB DIAB; World Health Organization, 2011, US GLYC HAEM HBA1C D; Zhang HQ, 2005, METHOD ENZYMOL, V401, P468, DOI 10.1016/S0076-6879(05)01028-1	38	51	56	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2015	10	3							e0118436	10.1371/journal.pone.0118436	http://dx.doi.org/10.1371/journal.pone.0118436			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD9NQ	25790445	Green Published, gold, Green Submitted			2022-12-27	WOS:000351425400029
J	Odell, AV; Tran, F; Foderaro, JE; Poupart, S; Pathak, R; Westwood, NJ; Ward, GE				Odell, Anahi V.; Tran, Fanny; Foderaro, Jenna E.; Poupart, Severine; Pathak, Ravi; Westwood, Nicholas J.; Ward, Gary E.			Yeast Three-Hybrid Screen Identifies TgBRADIN/GRA24 as a Negative Regulator of Toxoplasma gondii Bradyzoite Differentiation	PLOS ONE			English	Article							DEPENDENT PROTEIN-KINASE; PROTOZOAN PARASITE; MOLECULAR CHARACTERIZATION; SELECTABLE MARKER; GENE-EXPRESSION; CYST FORMATION; SYSTEM; TRANSFORMATION; TACHYZOITE; INHIBITION	Differentiation of the protozoan parasite Toxoplasma gondii into its latent bradyzoite stage is a key event in the parasite's life cycle. Compound 2 is an imidazopyridine that was previously shown to inhibit the parasite lytic cycle, in part through inhibition of parasite cGMP-dependent protein kinase. We show here that Compound 2 can also enhance parasite differentiation, and we use yeast three-hybrid analysis to identify TgBRADIN/GRA24 as a parasite protein that interacts directly or indirectly with the compound. Disruption of the TgBRADIN/GRA24 gene leads to enhanced differentiation of the parasite, and the TgBRADIN/GRA24 knockout parasites show decreased susceptibility to the differentiation-enhancing effects of Compound 2. This study represents the first use of yeast three-hybrid analysis to study small-molecule mechanism of action in any pathogenic microorganism, and it identifies a previously unrecognized inhibitor of differentiation in T. gondii. A better understanding of the proteins and mechanisms regulating T. gondii differentiation will enable new approaches to preventing the establishment of chronic infection in this important human pathogen.	[Odell, Anahi V.; Foderaro, Jenna E.; Ward, Gary E.] Univ Vermont, Dept Microbiol & Mol Genet, Burlington, VT 05405 USA; [Tran, Fanny; Poupart, Severine; Pathak, Ravi; Westwood, Nicholas J.] Univ St Andrews, Sch Chem & Biomed Sci Res Complex, St Andrews, Fife, Scotland; [Tran, Fanny; Poupart, Severine; Pathak, Ravi; Westwood, Nicholas J.] EaStCHEM, St Andrews, Fife, Scotland	University of Vermont; University of St Andrews; University of St Andrews	Westwood, NJ (corresponding author), Univ St Andrews, Sch Chem & Biomed Sci Res Complex, St Andrews, Fife, Scotland.	njw3@st-andrews.ac.uk; Gary.Ward@uvm.edu		Ward, Gary/0000-0003-4138-3055; Westwood, Nicholas/0000-0003-0630-0138; Foderaro, Jenna/0000-0001-5974-3827	National Institutes of Health (NIH) [AI054961]; Royal Society University Research [516002. K5682/KK]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI054961, R01AI054961] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103496] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Royal Society University Research(Royal Society of London); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health (NIH) grant AI054961 to GEW, and Royal Society University Research grant 516002. K5682/KK to NJW. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baker K, 2003, ANAL BIOCHEM, V315, P134, DOI 10.1016/S0003-2697(02)00698-X; Becker F, 2004, CHEM BIOL, V11, P211, DOI 10.1016/j.chembiol.2004.02.001; Biftu T, 2006, BIOORG MED CHEM LETT, V16, P2479, DOI 10.1016/j.bmcl.2006.01.092; Bohne W, 1997, MOL BIOCHEM PARASIT, V88, P115, DOI 10.1016/S0166-6851(97)00087-X; Boothroyd JC, 1997, PHILOS T ROY SOC B, V352, P1347, DOI 10.1098/rstb.1997.0119; Bougdour A, 2009, J EXP MED, V206, P953, DOI 10.1084/jem.20082826; Braun L, 2013, J EXP MED, V210, P2071, DOI 10.1084/jem.20130103; Brown T, 2001, Curr Protoc Mol Biol, VChapter 2, DOI 10.1002/0471142727.mb0209as21; Burnett AJ, 1998, OPHTHALMOLOGY, V105, P1032, DOI 10.1016/S0161-6420(98)96004-3; Chidley C, 2011, NAT CHEM BIOL, V7, P375, DOI [10.1038/NCHEMBIO.557, 10.1038/nchembio.557]; Cleary MD, 2002, EUKARYOT CELL, V1, P329, DOI 10.1128/EC.1.3.329-340.2002; Donald RGK, 2002, MOL BIOCHEM PARASIT, V120, P165, DOI 10.1016/S0166-6851(01)00451-0; DONALD RGK, 1995, P NATL ACAD SCI USA, V92, P5749, DOI 10.1073/pnas.92.12.5749; Donald RGK, 2006, MOL BIOCHEM PARASIT, V149, P86, DOI 10.1016/j.molbiopara.2006.05.003; Eaton MS, 2006, INT J PARASITOL, V36, P107, DOI 10.1016/j.ijpara.2005.08.014; Fox BA, 2004, INT J PARASITOL, V34, P323, DOI 10.1016/j.ijpara.2003.12.001; Fox BA, 2009, EUKARYOT CELL, V8, P520, DOI 10.1128/EC.00357-08; Francis CL, 2002, AUST J CHEM, V55, P635, DOI 10.1071/CH02125; Gajria B, 2008, NUCLEIC ACIDS RES, V36, pD553, DOI 10.1093/nar/gkm981; Gietz RD, 2007, NAT PROTOC, V2, P31, DOI 10.1038/nprot.2007.13; Gross U, 1996, CURR TOP MICROBIOL, V219, P235; Gurnett AM, 2002, J BIOL CHEM, V277, P15913, DOI 10.1074/jbc.M108393200; GYURIS J, 1993, CELL, V75, P791, DOI 10.1016/0092-8674(93)90498-F; Hassan MA, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-696; Hua SB, 1997, PLASMID, V38, P91, DOI 10.1006/plas.1997.1305; Huynh MH, 2009, EUKARYOT CELL, V8, P530, DOI 10.1128/EC.00358-08; Jerome ME, 1998, INFECT IMMUN, V66, P4838, DOI 10.1128/IAI.66.10.4838-4844.1998; Knoll LJ, 2014, TOXOPLASMA GONDII: THE MODEL APICOMPLEXAN - PERSPECTIVES AND METHODS, 2ND EDITION, P521, DOI 10.1016/B978-0-12-396481-6.00015-5; Knoll LJ, 1998, MOL CELL BIOL, V18, P807, DOI 10.1128/MCB.18.2.807; Lescault PJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014463; Licitra EJ, 1996, P NATL ACAD SCI USA, V93, P12817, DOI 10.1073/pnas.93.23.12817; LUFT BJ, 1992, CLIN INFECT DIS, V15, P211, DOI 10.1093/clinids/15.2.211; MESSINA M, 1995, GENE, V165, P213, DOI 10.1016/0378-1119(95)00548-K; Pszenny V, 2012, INFECT IMMUN, V80, P1156, DOI 10.1128/IAI.06167-11; Radke JR, 2006, PLOS PATHOG, V2, P964, DOI 10.1371/journal.ppat.0020105; Radke JB, 2013, P NATL ACAD SCI USA, V110, P6871, DOI 10.1073/pnas.1300059110; Radke JR, 2005, BMC BIOL, V3, DOI 10.1186/1741-7007-3-26; Radke JR, 2003, MOL BIOCHEM PARASIT, V131, P119, DOI 10.1016/S0166-6851(03)00198-1; Rooney PJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019570; ROOS DS, 1994, METHOD CELL BIOL, V45, P27; Ross M.T., 1999, CURRENT PROTOCOLS HU; Saksouk N, 2005, MOL CELL BIOL, V25, P10301, DOI 10.1128/MCB.25.23.10301-10314.2005; Sambrook J., 2001, MOL CLONING LAB MANU; Scribner A, 2007, EUR J MED CHEM, V42, P1334, DOI 10.1016/j.ejmech.2007.02.006; Singh U, 2002, MOL MICROBIOL, V44, P721, DOI 10.1046/j.1365-2958.2002.02903.x; SOETE M, 1994, EXP PARASITOL, V78, P361, DOI 10.1006/expr.1994.1039; Su C, 2003, SCIENCE, V299, P414, DOI 10.1126/science.1078035; Tenter AM, 2000, INT J PARASITOL, V30, P1217, DOI 10.1016/S0020-7519(00)00124-7; TOMAVO S, 1995, INT J PARASITOL, V25, P1293, DOI 10.1016/0020-7519(95)00066-B; Tran F, 2013, MOLECULES, V18, P11639, DOI 10.3390/molecules180911639; Walker R, 2013, MOL MICROBIOL, V87, P641, DOI 10.1111/mmi.12121; Walton JGA, 2009, ORG BIOMOL CHEM, V7, P3049, DOI 10.1039/b902319d; Watson MA, 1996, BIOTECHNIQUES, V21, P255; WEISS LM, 1995, J EUKARYOT MICROBIOL, V42, P150, DOI 10.1111/j.1550-7408.1995.tb01556.x; White MW, 2014, CELL MICROBIOL, V16, P466, DOI 10.1111/cmi.12267; Wiersma HI, 2004, INT J PARASITOL, V34, P369, DOI 10.1016/j.ijpara.2003.11.019	56	7	8	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2015	10	3							e0120331	10.1371/journal.pone.0120331	http://dx.doi.org/10.1371/journal.pone.0120331			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD9NQ	25789621	Green Published, gold, Green Submitted			2022-12-27	WOS:000351425400151
J	Tang, ED; Wang, CY				Tang, Eric D.; Wang, Cun-Yu			Single Amino Acid Change in STING Leads to Constitutive Active Signaling	PLOS ONE			English	Article							CYCLIC GMP-AMP; INNATE IMMUNE SENSOR; DI-GMP; DNA SENSOR; CGAS; SYNTHASE; PATHWAY; ADAPTER; MPYS; ACTIVATION	The production of cytokines by the immune system in response to cytosolic DNA plays an important role in host defense, autoimmune disease, and cancer immunogenicity. Recently a cytosolic DNA signaling pathway that is dependent on the endoplasmic reticulum adaptor and cyclic dinucleotide sensor protein STING has been identified. Association of cytosolic DNA with cyclic-GMP-AMP synthase (cGAS) activates its enzymatic activity to synthesize the cyclic dinucleotide second messenger cGAMP from GTP and ATP. Direct detection of cGAMP by STING triggers the activation of IRF3 and NF-kB, and the production of type I interferons and proinflammatory cytokines. The mechanism of how STING is able to mediate downstream signaling remains incompletely understood although it has been shown that dimerization is a prerequisite. Here, we identify a single amino acid change in STING that confers constitutive active signaling. This mutation appears to both enhance ability of STING to both dimerize and associate with its downstream target TBK1.	[Tang, Eric D.; Wang, Cun-Yu] Univ Calif Los Angeles, Sch Dent, Div Oral Biol & Med, Lab Mol Signaling, Los Angeles, CA 90024 USA	University of California System; University of California Los Angeles	Tang, ED (corresponding author), Univ Calif Los Angeles, Sch Dent, Div Oral Biol & Med, Lab Mol Signaling, Los Angeles, CA 90024 USA.	edtang@ucla.edu; cwang@dentistry.ucla.edu			National Institutes of Health [R01DE023874, K99DE21083]; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE023874] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [K99DE021083] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was funded by grants from the National Institutes of Health to C.Y.W. (R01DE023874) and E.D.T. (K99DE21083). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn J, 2012, P NATL ACAD SCI USA, V109, P19386, DOI 10.1073/pnas.1215006109; Burdette DL, 2011, NATURE, V478, P515, DOI 10.1038/nature10429; Cai X, 2014, MOL CELL, V54, P289, DOI 10.1016/j.molcel.2014.03.040; Civril F, 2013, NATURE, V498, P332, DOI 10.1038/nature12305; Diner EJ, 2013, CELL REP, V3, P1355, DOI 10.1016/j.celrep.2013.05.009; Fitzgerald KA, 2003, NAT IMMUNOL, V4, P491, DOI 10.1038/ni921; Gall A, 2012, IMMUNITY, V36, P120, DOI 10.1016/j.immuni.2011.11.018; Gao DX, 2013, SCIENCE, V341, P903, DOI 10.1126/science.1240933; Gao P, 2013, CELL, V153, P1094, DOI 10.1016/j.cell.2013.04.046; Huang YH, 2012, NAT STRUCT MOL BIOL, V19, P728, DOI 10.1038/nsmb.2333; Ishikawa H, 2008, NATURE, V455, P674, DOI 10.1038/nature07317; Jin L, 2011, GENES IMMUN, V12, P263, DOI 10.1038/gene.2010.75; Jin L, 2008, MOL CELL BIOL, V28, P5014, DOI 10.1128/MCB.00640-08; Jin L, 2011, J IMMUNOL, V187, P2595, DOI 10.4049/jimmunol.1100088; Kranzusch PJ, 2013, CELL REP, V3, P1362, DOI 10.1016/j.celrep.2013.05.008; Li XD, 2013, SCIENCE, V341, P1390, DOI 10.1126/science.1244040; Li X, 2013, IMMUNITY, V39, P1019, DOI 10.1016/j.immuni.2013.10.019; Liu Y, 2014, NEW ENGL J MED, V371, P507, DOI 10.1056/NEJMoa1312625; Ouyang SY, 2012, IMMUNITY, V36, P1073, DOI 10.1016/j.immuni.2012.03.019; Schoggins JW, 2014, NATURE, V505, P691, DOI 10.1038/nature12862; Sun LJ, 2013, SCIENCE, V339, P786, DOI 10.1126/science.1232458; Sun WX, 2009, P NATL ACAD SCI USA, V106, P8653, DOI 10.1073/pnas.0900850106; Tanaka Y, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2002521; Tang ED, 2009, J VIROL, V83, P3420, DOI 10.1128/JVI.02623-08; Zhang L, 2014, IMMUNITY, V40, P329, DOI 10.1016/j.immuni.2014.01.010; Zhang X, 2014, CELL REP, V6, P421, DOI 10.1016/j.celrep.2014.01.003; Zhang X, 2013, MOL CELL, V51, P226, DOI 10.1016/j.molcel.2013.05.022; Zhong B, 2008, IMMUNITY, V29, P538, DOI 10.1016/j.immuni.2008.09.003	28	16	18	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2015	10	3							e0120090	10.1371/journal.pone.0120090	http://dx.doi.org/10.1371/journal.pone.0120090			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD9NQ	25790474	Green Submitted, gold, Green Published			2022-12-27	WOS:000351425400129
J	van der Eijk, C; Rose, J				van der Eijk, Cees; Rose, Jonathan			Risky Business: Factor Analysis of Survey Data - Assessing the Probability of Incorrect Dimensionalisation	PLOS ONE			English	Article							EXPLORATORY FACTOR-ANALYSIS; COMMON FACTOR-ANALYSIS; CONFIRMATORY FACTOR-ANALYSIS; STRUCTURAL EQUATION MODELS; PARALLEL ANALYSIS; COMPONENT ANALYSIS; PRINCIPAL COMPONENTS; EMPIRICAL-EVALUATION; DETERMINING NUMBER; CUTOFF CRITERIA	This paper undertakes a systematic assessment of the extent to which factor analysis the correct number of latent dimensions (factors) when applied to ordered-categorical survey items (so-called Likert items). We simulate 2400 data sets of uni-dimensional Likert items that vary systematically over a range of conditions such as the underlying population distribution, the number of items, the level of random error, and characteristics of items and item-sets. Each of these datasets is factor analysed in a variety of ways that are frequently used in the extant literature, or that are recommended in current methodological texts. These include exploratory factor retention heuristics such as Kaiser's criterion, Parallel Analysis and a non-graphical scree test, and (for exploratory and confirmatory analyses) evaluations of model fit. These analyses are conducted on the basis of Pearson and poly-choric correlations. We find that, irrespective of the particular mode of analysis, factor analysis applied to ordered-categorical survey data very often leads to over-dimensionalisation. The magnitude of this risk depends on the specific way in which factor analysis is conducted, the number of items, the properties of the set of items, and the underlying population distribution. The paper concludes with a discussion of the consequences of over-dimensionalisation, and a brief mention of alternative modes of analysis that are much less prone to such problems.	[van der Eijk, Cees; Rose, Jonathan] Univ Nottingham, Methods & Data Inst, Sch Polit & Int Relat, Nottingham NG7 2RD, England	University of Nottingham	van der Eijk, C (corresponding author), Univ Nottingham, Methods & Data Inst, Sch Polit & Int Relat, Nottingham NG7 2RD, England.	cees.vandereijk@nottingham.ac.uk	van der Eijk, Cees/AAO-2700-2020	van der Eijk, Cees/0000-0002-7967-968X; Rose, Jonathan/0000-0001-5187-3221	ESRC [ES/F018517/1] Funding Source: UKRI	ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC))		Asparouhov T, 2009, STRUCT EQU MODELING, V16, P397, DOI 10.1080/10705510903008204; Azzalini A, 2013, R PACKAGE SN SKEW NO; Bandalos DL, 2009, STATISTICAL AND METHODOLOGICAL MYTHS AND URBAN LEGENDS: DOCTRINE, VERITY AND FABLE IN THE ORGANIZATIONAL AND SOCIAL SCIENCES, P61; Bartholomew D.J., 2001, INT ENCY SOCIAL BEHA, P5249; Basto M, 2012, J STAT SOFTW, V46, P1; Bentler PM, 2007, PERS INDIV DIFFER, V42, P825, DOI 10.1016/j.paid.2006.09.024; BENTLER PM, 1990, MULTIVAR BEHAV RES, V25, P67, DOI 10.1207/s15327906mbr2501_8; Bond TG, 2013, APPL RASCH MODEL FUN, DOI [10.1186/1471-2377-13-78, DOI 10.1186/1471-2377-13-78]; Browne M.W., 1992, SOCIOL METHOD RES, V21, P230, DOI 10.1177/0049124192021002005; Budaev S V, 1997, PARANAL PARALLEL ANA; Budaev SV, 2010, ETHOLOGY, V116, P472, DOI 10.1111/j.1439-0310.2010.01758.x; Byrne B.M., 2010, STRUCTURAL EQUATION, DOI DOI 10.4324/9781410600219; CAMPBELL DT, 1959, PSYCHOL BULL, V56, P81, DOI 10.1037/h0046016; CATTELL RB, 1966, MULTIVAR BEHAV RES, V1, P245, DOI 10.1207/s15327906mbr0102_10; Chen FN, 2008, SOCIOL METHOD RES, V36, P462, DOI 10.1177/0049124108314720; Cho SJ, 2009, EDUC PSYCHOL MEAS, V69, P748, DOI 10.1177/0013164409332229; CLIFF N, 1988, PSYCHOL BULL, V103, P276, DOI 10.1037/0033-2909.103.2.276; Conway JM, 2003, ORGAN RES METHODS, V6, P147, DOI 10.1177/1094428103251541; Corbetta P., 2003, SOCIAL RES THEORY ME; Courtney M., 2013, PRACT ASSESS RES EVA, V18, P8; Dinno, 2014, GENTLY CLARIFYING AP; Eid M, 2000, PSYCHOMETRIKA, V65, P241, DOI 10.1007/BF02294377; Embretson S. E., 2013, ITEM RESPONSE THEORY; Fabrigar L. R., 2012, EXPLORATORY FACTOR A; Fabrigar LR, 1999, PSYCHOL METHODS, V4, P272, DOI 10.1037/1082-989X.4.3.272; Ferguson GA, 1941, PSYCHOMETRIKA, V6, P323, DOI 10.1007/BF02288588; FIGUEREDO AJ, 1991, RES NURS HEALTH, V14, P387, DOI 10.1002/nur.4770140510; Flora DB, 2012, FRONT PSYCHOL, V3, DOI 10.3389/fpsyg.2012.00055; Flora DB, 2004, PSYCHOL METHODS, V9, P466, DOI 10.1037/1082-989X.9.4.466; Floyd FJ, 1995, PSYCHOL ASSESSMENT, V7, P286, DOI 10.1037/1040-3590.7.3.286; Forero CG, 2009, STRUCT EQU MODELING, V16, P625, DOI 10.1080/10705510903203573; Fox J., 2010, POLYCOR POLYCHORIC P; Fox J., 2013, SEM STRUCTURAL EQUAT; Frankfort-Nachmias C, 2019, SOCIAL STAT DIVERSE; French BF, 2006, STRUCT EQU MODELING, V13, P378, DOI 10.1207/s15328007sem1303_3; Garson GD., 2013, HIERARCHICAL LINEAR; GIBSON WA, 1960, PSYCHOMETRIKA, V25, P381, DOI 10.1007/BF02289755; GLORFELD LW, 1995, EDUC PSYCHOL MEAS, V55, P377, DOI 10.1177/0013164495055003002; Gorsuch R., 1983, FACTOR ANAL; GORSUCH RL, 1990, MULTIVAR BEHAV RES, V25, P33, DOI 10.1207/s15327906mbr2501_3; Green SB, 2009, PSYCHOMETRIKA, V74, P155, DOI 10.1007/s11336-008-9099-3; Hagenaars Jacques A, 2002, APPL LATENT CLASS AN, DOI [10.1017/CBO9780511499531, DOI 10.1017/CBO9780511499531]; Henson RK, 2006, EDUC PSYCHOL MEAS, V66, P393, DOI 10.1177/0013164405282485; HORN JL, 1965, PSYCHOMETRIKA, V30, P179, DOI 10.1007/BF02289447; Hu LT, 1999, STRUCT EQU MODELING, V6, P1, DOI 10.1080/10705519909540118; HUBBARD R, 1987, SOCIOL METHOD RES, V16, P301, DOI 10.1177/0049124187016002005; HUMPHREYS LG, 1975, MULTIVAR BEHAV RES, V10, P193, DOI 10.1207/s15327906mbr1002_5; Iacobucci D, 2010, J CONSUM PSYCHOL, V20, P90, DOI 10.1016/j.jcps.2009.09.003; Jolliffe I.T., 2002, PRINCIPAL COMPONENT, V87, P513; Kankaras M, 2011, SOCIOL METHOD RES, V40, P279, DOI 10.1177/0049124111405301; Kim J, 1978, FACTOR ANAL STAT MET; Lance CE, 2006, ORGAN RES METHODS, V9, P202, DOI 10.1177/1094428105284919; Larsen R, 2010, BEHAV RES METHODS, V42, P871, DOI 10.3758/BRM.42.3.871; Ledesma RD, 2007, PRACT ASSESS RES EVA, V12, P1, DOI [https://doi.org/10.7275/wjnc-nm63, DOI 10.7275/WJNC-NM63]; Lodge M., 1981, MAGNITUDE SCALING QU, DOI [https://doi.org/10.4135/9781412984874.n3, DOI 10.4135/9781412984874.N3]; MacCallum R.C., 2009, SAGE HDB QUANTITATIV, P124, DOI [10.4135/9780857020994.n6, DOI 10.4135/9780857020994.N6, 10.4135/9780857020994]; Marsh HW, 2011, J PSYCHOEDUC ASSESS, V29, P322, DOI 10.1177/0734282911406657; Marsh HW, 2009, STRUCT EQU MODELING, V16, P439, DOI 10.1080/10705510903008220; Meade AW, 2004, STRUCT EQU MODELING, V11, P60, DOI 10.1207/S15328007SEM1101_5; Mimiaga MJ, 2008, AIDS CARE, V20, P346, DOI 10.1080/09540120701562070; Mokken R. J., 1971, THEORY PROCEDURE SCA, DOI DOI 10.1515/9783110813203; Muthen B., 2010, MPLUS USERS GUIDE; Norris M, 2010, J AUTISM DEV DISORD, V40, P8, DOI 10.1007/s10803-009-0816-2; Nunnally JC, 1994, PSYCHOMETRIC THEORY, V3rd, DOI DOI 10.1037/018882; O'Connor BP, 2000, BEHAV RES METH INS C, V32, P396, DOI 10.3758/BF03200807; OLSSON U, 1979, PSYCHOMETRIKA, V44, P443, DOI 10.1007/BF02296207; Olsson UH, 2000, STRUCT EQU MODELING, V7, P557, DOI 10.1207/S15328007SEM0704_3; Osborne J., 2005, PRACTICAL ASSESSMENT, V10, P1, DOI [10.7275/jyj1-4868, DOI 10.7275/JYJ1-4868, 10.4135/9781412995627.d8, DOI 10.4135/9781412995627.D8]; Holgado-Tello FP, 2010, QUAL QUANT, V44, P153, DOI 10.1007/s11135-008-9190-y; Pallant J., 2007, SPSS SURVIVAL MANUAL, VVolume 15, DOI DOI 10.1111/1753-6405.12166; Paran Dinno A., 2009, PARAN PERFORMS HORNS; Preacher KJ, 2013, MULTIVAR BEHAV RES, V48, P28, DOI 10.1080/00273171.2012.710386; R Core Team, 2021, R LANGUAGE ENV STAT; Raiche G., 2005, RASCH MEASUREMENT T, V19, P1012; Raiche G., 2010, NFACTORS R PACKAGE P, V2, p3.1; Raiche G, 2013, METHODOLOGY-EUR, V9, P23, DOI 10.1027/1614-2241/a000051; Rasch G., 1960, PROBABILISTIC MODELS; Reckase MD, 2009, STAT SOC BEHAV SC, P1, DOI 10.1007/978-0-387-89976-3_1; Reinard John C, 2006, COMMUNICATION RES ST; Revelle W, 1979, Multivariate Behav Res, V14, P403, DOI 10.1207/s15327906mbr1404_2; Revelle William, 2020, CRAN; Rice Stewart., 1928, QUANTITATIVE METHODS; Rickards H, 2011, J NEUROL NEUROSUR PS, V82, P411, DOI 10.1136/jnnp.2009.181149; Rose J., 2014, PUBLIC UNDERSTANDING; Ruscio J, 2012, PSYCHOL ASSESSMENT, V24, P282, DOI 10.1037/a0025697; Russell DW, 2002, PERS SOC PSYCHOL B, V28, P1629, DOI 10.1177/014616702237645; Saris WE, 2009, STRUCT EQU MODELING, V16, P561, DOI 10.1080/10705510903203433; Sawaki Y, 2012, ENCY APPL LINGUISTIC; Schmitt N, 1996, PSYCHOL ASSESSMENT, V8, P350, DOI 10.1037/1040-3590.8.4.350; Schmitt N, 2008, HUM RESOUR MANAGE R, V18, P210, DOI 10.1016/j.hrmr.2008.03.003; Schmitt TA, 2011, J PSYCHOEDUC ASSESS, V29, P304, DOI 10.1177/0734282911406653; Sijtsma K, 1998, SEARCH STRUCTURE ESS, P29; Sijtsma K, 2009, PSYCHOMETRIKA, V74, P107, DOI 10.1007/s11336-008-9101-0; Skrondal A., 2004, GEN LATENT VARIABLE, DOI [10.1201/9780203489437, DOI 10.1201/9780203489437]; Smith R. M., 1994, OBJECTIVE MEASUREMEN, P316; Spitzer RL, 2006, ARCH INTERN MED, V166, P1092, DOI 10.1001/archinte.166.10.1092; Thompson B., 2004, EXPLORATORY CONFIRMA, DOI 10.1037/10694-000; Timmerman ME, 2011, PSYCHOL METHODS, V16, P209, DOI 10.1037/a0023353; Uebersax J. S, 2006, INTRO TETRACHORIC PO; Van der Linden W.J., 1997, HDB MODERN ITEM RESP; van Schuur WH, 2003, POLIT ANAL, V11, P139, DOI 10.1093/pan/mpg002; Van Schuur WH., 2011, ORDINAL ITEM RESPONS; Velicer W.F., 2000, PROBLEMS SOLUTIONS H, P41, DOI [10.1007/978-1-4615-4397-8_3, DOI 10.1007/978-1-4615-4397-8_3]; VELICER WF, 1976, PSYCHOMETRIKA, V41, P321, DOI 10.1007/BF02293557; VELICER WF, 1990, MULTIVAR BEHAV RES, V25, P1, DOI 10.1207/s15327906mbr2501_1; Vermunt JK., 2004, SAGE ENCY SOCIAL SCI; Watkins M.W., 2000, MONTE CARLO PCA PARA; WIDAMAN KF, 1993, MULTIVAR BEHAV RES, V28, P263, DOI 10.1207/s15327906mbr2803_1; Wilkinson L., 1996, DESKTOP DATA ANAL SY; Worthington RL, 2006, COUNS PSYCHOL, V34, P806, DOI 10.1177/0011000006288127; Zientek LR, 2007, BEHAV RES METHODS, V39, P318, DOI 10.3758/BF03193163; ZWICK WR, 1986, PSYCHOL BULL, V99, P432, DOI 10.1037/0033-2909.99.3.432	114	83	84	1	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2015	10	3							e0118900	10.1371/journal.pone.0118900	http://dx.doi.org/10.1371/journal.pone.0118900			31	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CD9NQ	25789992	gold, Green Published, Green Submitted			2022-12-27	WOS:000351425400054
J	Boyer, B; Ezelin, J; Poulain, P; Saladin, A; Zacharias, M; Robert, CH; Prevost, C				Boyer, Benjamin; Ezelin, Johann; Poulain, Pierre; Saladin, Adrien; Zacharias, Martin; Robert, Charles H.; Prevost, Chantal			An Integrative Approach to the Study of Filamentous Oligomeric Assemblies, with Application to RecA	PLOS ONE			English	Article							PROTEIN QUATERNARY STRUCTURE; HOMOLOGOUS RECOMBINATION; HELICAL FILAMENTS; CRYSTAL-STRUCTURE; MACROMOLECULAR ASSEMBLIES; NUCLEOPROTEIN FILAMENTS; C-N; DNA; DOCKING; RING	Oligomeric macromolecules in the cell self-organize into a wide variety of geometrical motifs such as helices, rings or linear filaments. The recombinase proteins involved in homologous recombination present many such assembly motifs. Here, we examine in particular the polymorphic characteristics of RecA, the most studied member of the recombinase family, using an integrative approach that relates local modes of monomer/monomer association to the global architecture of their screw-type organization. In our approach, local modes of association are sampled via docking or Monte Carlo simulations. This enables shedding new light on fiber morphologies that may be adopted by the RecA protein. Two distinct RecA helical morphologies, the so-called "extended" and "compressed" forms, are known to play a role in homologous recombination. We investigate the variability within each form in terms of helical parameters and steric accessibility. We also address possible helical discontinuities in RecA filaments due to multiple monomer-monomer association modes. By relating local interface organization to global filament morphology, the strategies developed here to study RecA self-assembly are particularly well suited to other DNA-binding proteins and to filamentous protein assemblies in general.	[Boyer, Benjamin; Ezelin, Johann; Robert, Charles H.; Prevost, Chantal] Univ Paris Diderot, Sorbonne Paris Cite, CNRS, Lab Biochim Theor,UPR 9080, 13 Rue Pierre & Marie Curie, F-75005 Paris, France; [Poulain, Pierre] Inserm UMR S 665, DSIMB Team, F-75015 Paris, France; [Poulain, Pierre] Univ Paris Diderot, Sorbonne Paris Cite, INTS, F-75015 Paris, France; [Poulain, Pierre] Ets Poulain, Pointe Noire, Rep Congo; [Boyer, Benjamin; Saladin, Adrien] Univ Paris 07, MTI, INSERM UMR M 973, F-75205 Paris 13, France; [Zacharias, Martin] Tech Univ Munich, Dept Phys, D-85748 Garching, Germany	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Technical University of Munich	Prevost, C (corresponding author), Univ Paris Diderot, Sorbonne Paris Cite, CNRS, Lab Biochim Theor,UPR 9080, 13 Rue Pierre & Marie Curie, F-75005 Paris, France.	Chantal.Prevost@ibpc.fr	; Poulain, Pierre/A-8287-2009	Chantal, Prevost/0000-0003-3516-6687; Poulain, Pierre/0000-0003-4177-3619; Robert, Charles/0000-0003-0337-1504	Universite Paris 6; French CNRS (Centre National de la Recherche Scientifique); IFCPAR (Indo-French Center for the Promotion of Advanced Research); German DFG (Deutsche Forschungsgemeinschaft) [SFB749, C5]; French State (Grant "DYNAMO") [ANR-11-LABX-0011-01]	Universite Paris 6; French CNRS (Centre National de la Recherche Scientifique)(Centre National de la Recherche Scientifique (CNRS)); IFCPAR (Indo-French Center for the Promotion of Advanced Research)(French National Research Agency (ANR)); German DFG (Deutsche Forschungsgemeinschaft)(German Research Foundation (DFG)); French State (Grant "DYNAMO")	The authors acknowledge support from Universite Paris 6 (to B.B.), the French CNRS (Centre National de la Recherche Scientifique, to J.E.), IFCPAR (Indo-French Center for the Promotion of Advanced Research, to C.H.R.), the German DFG (Deutsche Forschungsgemeinschaft, within SFB749, project C5, to M.Z.), and the "Initiative d'Excellence" program from the French State (Grant "DYNAMO", ANR-11-LABX-0011-01, to C.P. and C.H.R.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adikesavan AK, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002244; Andre I, 2007, P NATL ACAD SCI USA, V104, P17656, DOI 10.1073/pnas.0702626104; Andrusier N, 2008, PROTEINS, V73, P271, DOI 10.1002/prot.22170; Angelidis A, 2004, TECHNICAL REPORT; Atwell S, 2012, NUCLEIC ACIDS RES, V40, P11769, DOI 10.1093/nar/gks1131; Bastard K, 2006, PROTEINS, V62, P956, DOI 10.1002/prot.20770; Bastard K, 2007, RECENT RES ADV STRUC, P249; Berchanski A, 2005, PROTEINS, V60, P202, DOI 10.1002/prot.20558; Berchanski A, 2003, PROTEINS, V53, P817, DOI 10.1002/prot.10480; BERNSTEIN FC, 1977, J MOL BIOL, V112, P535, DOI 10.1016/S0022-2836(77)80200-3; Bianco P R, 1998, Front Biosci, V3, pD570; Bosaeus N, 2012, P NATL ACAD SCI USA, V109, P15179, DOI 10.1073/pnas.1213172109; Bottema O., 1979, THEORETICAL KINEMATI; BRENNER SL, 1988, J MOL BIOL, V204, P959, DOI 10.1016/0022-2836(88)90055-1; CameriniOtero RD, 1995, ANNU REV GENET, V29, P509, DOI 10.1146/annurev.genet.29.1.509; Canutescu AA, 2003, PROTEIN SCI, V12, P2001, DOI 10.1110/ps.03154503; Casciari D, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-340; Chang YC, 2005, BIOCHEMISTRY-US, V44, P6052, DOI 10.1021/bi048897q; Chang YW, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004890; Chen LT, 2007, NUCLEIC ACIDS RES, V35, P1787, DOI 10.1093/nar/gkl1131; Chen ZC, 2008, NATURE, V453, P489, DOI 10.1038/nature06971; Comeau SR, 2005, J STRUCT BIOL, V150, P233, DOI 10.1016/j.jsb.2005.03.006; Conover AJ, 2011, NUCLEIC ACIDS RES, V39, P8833, DOI 10.1093/nar/gkr561; Conway AB, 2004, NAT STRUCT MOL BIOL, V11, P791, DOI 10.1038/nsmb795; Cox JM, 2005, PLOS BIOL, V3, P231, DOI 10.1371/journal.pbio.0030052; Cox MM, 2007, NAT REV MOL CELL BIO, V8, P127, DOI 10.1038/nrm2099; de Vries S, 2013, PROTEINS, V81, P2167, DOI 10.1002/prot.24400; EGELMAN EH, 1993, MICRON, V24, P309, DOI 10.1016/0968-4328(93)90056-7; Egelman EH, 2001, J MOL BIOL, V309, P539, DOI 10.1006/jmbi.2001.4686; Eisenstein M, 1997, J MOL BIOL, V266, P135, DOI 10.1006/jmbi.1996.0773; ELLOUZE C, 1995, EUR J BIOCHEM, V233, P579, DOI 10.1111/j.1432-1033.1995.579_2.x; Emekli U, 2008, PROTEINS, V70, P1219, DOI 10.1002/prot.21613; Esquivel-Rodriguez J, 2012, PROTEINS, V80, P1818, DOI 10.1002/prot.24079; FRANKLIN RE, 1953, NATURE, V172, P156, DOI 10.1038/172156a0; Goodsell DS, 2000, ANNU REV BIOPH BIOM, V29, P105, DOI 10.1146/annurev.biophys.29.1.105; Grudinin S, 2010, J COMPUT CHEM, V31, P1799, DOI 10.1002/jcc.21434; Guharoy M, 2010, PROTEINS, V78, P3219, DOI 10.1002/prot.22821; Halperin I, 2002, PROTEINS, V47, P409, DOI 10.1002/prot.10115; Hegner M, 1999, P NATL ACAD SCI USA, V96, P10109, DOI 10.1073/pnas.96.18.10109; Henrick K, 1998, TRENDS BIOCHEM SCI, V23, P358, DOI 10.1016/S0968-0004(98)01253-5; HOWARDFLANDERS P, 1984, NATURE, V309, P215, DOI 10.1038/309215a0; Hubbard SJ, 1993, NACCESS COMPUTER PRO; Inbar Y, 2005, J MOL BIOL, V349, P435, DOI 10.1016/j.jmb.2005.03.039; JANIN J, 1990, J BIOL CHEM, V265, P16027; Janin J, 2003, PROTEINS, V52, P2, DOI 10.1002/prot.10381; Karaca E, 2010, MOL CELL PROTEOMICS, V9, P1784, DOI 10.1074/mcp.M000051-MCP201; Karlin S, 1996, J BACTERIOL, V178, P1881, DOI 10.1128/jb.178.7.1881-1894.1996; Kinebuchi T, 2004, MOL CELL, V14, P363, DOI 10.1016/S1097-2765(04)00218-7; King NP, 2012, SCIENCE, V336, P1171, DOI 10.1126/science.1219364; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Lee CD, 2009, J BIOMED SCI, V16, DOI 10.1186/1423-0127-16-37; LITTLE JW, 1991, BIOCHIMIE, V73, P411, DOI 10.1016/0300-9084(91)90108-D; Logan KM, 1997, J MOL BIOL, V266, P306, DOI 10.1006/jmbi.1996.0751; May A, 2005, BBA-PROTEINS PROTEOM, V1754, P225, DOI 10.1016/j.bbapap.2005.07.045; Nishinaka T, 1998, P NATL ACAD SCI USA, V95, P11071, DOI 10.1073/pnas.95.19.11071; Nivaskumar M, 2014, STRUCTURE, V22, P685, DOI 10.1016/j.str.2014.03.001; PAULING L, 1951, P NATL ACAD SCI USA, V37, P251, DOI 10.1073/pnas.37.5.251; PAULING L, 1951, P NATL ACAD SCI USA, V37, P205, DOI 10.1073/pnas.37.4.205; Pierce B, 2005, BIOINFORMATICS, V21, P1472, DOI 10.1093/bioinformatics/bti229; Ponstingl H, 2003, J APPL CRYSTALLOGR, V36, P1116, DOI 10.1107/S0021889803012421; Riemann RN, 2005, PROTEIN ENG DES SEL, V18, P465, DOI 10.1093/protein/gzi052; Saladin A, 2009, BMC STRUCT BIOL, V9, DOI 10.1186/1472-6807-9-27; Schneider S, 2012, METHODS MOL BIOL, V819, P221, DOI 10.1007/978-1-61779-465-0_15; Schneidman-Duhovny D, 2005, PROTEINS, V60, P224, DOI 10.1002/prot.20562; Shi WX, 2005, NANO LETT, V5, P2476, DOI 10.1021/nl051783v; Singleton MR, 2000, CELL, V101, P589, DOI 10.1016/S0092-8674(00)80871-5; STASIAK A, 1982, NATURE, V299, P185, DOI 10.1038/299185a0; STASIAK A, 1981, J MOL BIOL, V151, P557, DOI 10.1016/0022-2836(81)90010-3; STORY RM, 1992, NATURE, V355, P318, DOI 10.1038/355318a0; van Loenhout MTJ, 2009, NUCLEIC ACIDS RES, V37, P4089, DOI 10.1093/nar/gkp326; VanLoock MS, 2003, J MOL BIOL, V333, P345, DOI 10.1016/j.jmb.2003.08.053; VanLoock MS, 2003, STRUCTURE, V11, P187, DOI 10.1016/S0969-2126(03)00003-0; WANG AHJ, 1981, SCIENCE, V211, P171, DOI 10.1126/science.7444458; Wang TF, 2008, BIOESSAYS, V30, P48, DOI 10.1002/bies.20694; Wolfson HJ, 2005, CURR PROTEIN PEPT SC, V6, P171, DOI 10.2174/1389203053545435; Wu HY, 2014, CHEMPHYSCHEM, V15, P80, DOI 10.1002/cphc.201300835; Yang SX, 2002, J MOL BIOL, V321, P839, DOI 10.1016/S0022-2836(02)00711-8; Yang SX, 2001, J MOL BIOL, V314, P1077, DOI 10.1006/jmbi.2000.5213; YU X, 1992, J MOL BIOL, V227, P334, DOI 10.1016/0022-2836(92)90702-L; Yu X, 1997, NAT STRUCT BIOL, V4, P101, DOI 10.1038/nsb0297-101; YU X, 1991, J STRUCT BIOL, V106, P243, DOI 10.1016/1047-8477(91)90074-7; Yu X, 2001, P NATL ACAD SCI USA, V98, P8419, DOI 10.1073/pnas.111005398; Zacharias M, 2003, PROTEIN SCI, V12, P1271, DOI 10.1110/ps.0239303	83	10	10	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2015	10	3							e0116414	10.1371/journal.pone.0116414	http://dx.doi.org/10.1371/journal.pone.0116414			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9BN	25785454	gold, Green Published, Green Submitted			2022-12-27	WOS:000352138500008
J	Curtis, DJ; Muresan, P; Nachman, S; Fenton, T; Richardson, KM; Dominguez, T; Flynn, PM; Spector, SA; Cunningham, CK; Bloom, A; Weinberg, A				Curtis, Donna J.; Muresan, Petronella; Nachman, Sharon; Fenton, Terence; Richardson, Kelly M.; Dominguez, Teresa; Flynn, Patricia M.; Spector, Stephen A.; Cunningham, Coleen K.; Bloom, Anthony; Weinberg, Adriana			Characterization of Functional Antibody and Memory B-Cell Responses to pH1N1 Monovalent Vaccine in HIV-Infected Children and Youth	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; RESPIRATORY-TRACT INFECTIONS; INFLUENZA VACCINE; YOUNG-ADULTS; T-CELLS; ANTIRETROVIRAL THERAPY; H1N1; IMMUNOGENICITY; INDIVIDUALS; TRIVALENT	Objectives We investigated immune determinants of antibody responses and B-cell memory to pH1N1 vaccine in HIV-infected children. Methods Ninety subjects 4 to <25 years of age received two double doses of pH1N1 vaccine. Serum and cells were frozen at baseline, after each vaccination, and at 28 weeks post-immunization. Hemagglutination inhibition (HAI) titers, avidity indices (AI), B-cell subsets, and pH1N1 IgG and IgA antigen secreting cells (ASC) were measured at baseline and after each vaccination. Neutralizing antibodies and pH1N1-specific Th1, Th2 and Tfh cytokines were measured at baseline and post-dose 1. Results At entry, 26 (29%) subjects had pH1N1 protective HAI titers (>= 1:40). pH1N1-specific HAI, neutralizing titers, AI, IgG ASC, IL-2 and IL-4 increased in response to vaccination (p<0.05), but IgA ASC, IL-5, IL-13, IL-21, IFN gamma and B-cell subsets did not change. Subjects with baseline HAI >= 1:40 had significantly greater increases in IgG ASC and AI after immunization compared with those with HAI <1:40. Neutralizing titers and AI after vaccination increased with older age. High pH1N1 HAI responses were associated with increased IgG ASC, IFN gamma, IL-2, microneutralizion titers, and AI. Microneutralization titers after vaccination increased with high IgG ASC and IL-2 responses. IgG ASC also increased with high IFN gamma responses. CD4% and viral load did not predict the immune responses post-vaccination, but the B-cell distribution did. Notably, vaccine immunogenicity increased with high CD19 +CD21+CD27+% resting memory, high CD19+CD10+CD27+% immature activated, low CD19+CD21-CD27-CD20-% tissue-like, low CD19+CD21-CD27-CD20-% transitional and low CD19+CD38+HLADR+% activated B-cell subsets. Conclusions HIV-infected children on HAART mount a broad B-cell memory response to pH1N1 vaccine, which was higher for subjects with baseline HAI >= 1:40 and increased with age, presumably due to prior exposure to pH1N1 or to other influenza vaccination/infection. The response to the vaccine was dependent on B-cell subset distribution, but not on CD4 counts or viral load.	[Curtis, Donna J.; Richardson, Kelly M.; Dominguez, Teresa; Weinberg, Adriana] Univ Colorado, Sch Med, Pediat Infect Dis, Aurora, CO 80045 USA; [Muresan, Petronella; Fenton, Terence] Harvard Univ, Sch Publ Hlth, Stat & Data Anal Ctr, Boston, MA 02115 USA; [Nachman, Sharon] SUNY Stony Brook, Stony Brook, NY 11794 USA; [Flynn, Patricia M.] St Jude Childrens Res Hosp, Memphis, TN USA; [Spector, Stephen A.] Univ Calif San Diego, La Jolla, CA 92093 USA; [Spector, Stephen A.] Rady Childrens Hosp, San Diego, CA USA; [Cunningham, Coleen K.] Duke Univ, Med Ctr, Durham, NC USA; [Bloom, Anthony] Frontier Sci & Technol Res Fdn Inc, Amherst, NY USA; [Weinberg, Adriana] Univ Colorado, Sch Med, Dept Med, Aurora, CO USA; [Weinberg, Adriana] Univ Colorado, Sch Med, Dept Pathol, Aurora, CO USA	University of Colorado System; University of Colorado Anschutz Medical Campus; Harvard University; Harvard T.H. Chan School of Public Health; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; St Jude Children's Research Hospital; University of California System; University of California San Diego; Rady Childrens Hospital San Diego; Duke University; Frontier Science Foundation; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus	Curtis, DJ (corresponding author), Univ Colorado, Sch Med, Pediat Infect Dis, Aurora, CO 80045 USA.	donna.curtis@ucdenver.edu; adriana.weinberg@ucdenver.edu	Flynn, Patricia M/N-8146-2018		Statistical and Data Analysis Center at Harvard School of Public Health, under the National Institute of Allergy and Infectious Diseases; Pediatric AIDS Clinical Trials Group (PACTG) [5 U01 AI41110]; IMPAACT Group [1 U01 AI068616]; National Institute of Allergy and Infectious Diseases (NIAID); NICHD International and Domestic Pediatric and Maternal HIV Clinical Trials Network - NICHD [N01-DK-9-001/HHSN267200800001C]; National Institutes of Health (NIH) [P30-AI064518]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000154, UL1TR001445, UL1TR001082] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025771, UL1RR029893, UL1RR029890, UL1RR031982] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [UM1AI069536, UM1AI068632, U01AI068616, U01AI068632, P30AI064518, UM1AI068616, U01AI041110] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [F32DK009001] Funding Source: NIH RePORTER	Statistical and Data Analysis Center at Harvard School of Public Health, under the National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Pediatric AIDS Clinical Trials Group (PACTG); IMPAACT Group; National Institute of Allergy and Infectious Diseases (NIAID)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NICHD International and Domestic Pediatric and Maternal HIV Clinical Trials Network - NICHD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Overall support for the International Maternal Pediatric Adolescent AIDS Clinical Trials Group (IMPAACT) was provided by the National Institute of Allergy and Infectious Diseases (NIAID) [U01 AI068632], www.niaid.nih.gov; the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), www.nichd.nih.gov; and the National Institute of Mental Health (NIMH) [AI068632], www.nimh.nih.gov. This work was supported by the Statistical and Data Analysis Center at Harvard School of Public Health, under the National Institute of Allergy and Infectious Diseases cooperative agreement #5 U01 AI41110 with the Pediatric AIDS Clinical Trials Group (PACTG) and #1 U01 AI068616 with the IMPAACT Group. Support of the sites was provided by the National Institute of Allergy and Infectious Diseases (NIAID) and the NICHD International and Domestic Pediatric and Maternal HIV Clinical Trials Network funded by NICHD (contract number N01-DK-9-001/HHSN267200800001C). Coleen K. Cunningham was funded in part by the National Institutes of Health (NIH) for the Duke Center for Aids Research (P30-AI064518). The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bodewes R, 2012, VACCINE, V30, P7407, DOI 10.1016/j.vaccine.2012.04.086; CHADWICK EG, 1994, PEDIATR INFECT DIS J, V13, P206, DOI 10.1097/00006454-199403000-00008; Cubas RA, 2013, NAT MED, V19, P494, DOI 10.1038/nm.3109; Eto D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017739; Fange Y, 2012, J VIROL, V86, P2229, DOI 10.1128/JVI.05540-11; Fine AD, 2001, CLIN INFECT DIS, V32, P1784, DOI 10.1086/320747; Flynn PM, 2012, J INFECT DIS, V206, P421, DOI 10.1093/infdis/jis360; Fontaine J, 2011, BLOOD, V117, P145, DOI 10.1182/blood-2010-08-301887; Garten RJ, 2009, SCIENCE, V325, P197, DOI 10.1126/science.1176225; Hancock K., 2011, IMMUNOLOGY PATHOGENE, P1; Hart M, 2007, J IMMUNOL, V178, P8212, DOI 10.4049/jimmunol.178.12.8212; HEDMAN K, 1989, J MED VIROL, V27, P288, DOI 10.1002/jmv.1890270406; Ho J, 2006, P NATL ACAD SCI USA, V103, P19436, DOI 10.1073/pnas.0609515103; Ho J, 2011, AIDS, V25, P295, DOI 10.1097/QAD.0b013e328342328b; Imbeault M, 2011, J VIROL, V85, P2189, DOI 10.1128/JVI.01993-10; Jacobsen MC, 2008, J INFECT DIS, V198, P481, DOI 10.1086/590215; Jegaskanda S, 2013, J INFECT DIS, V208, P1051, DOI 10.1093/infdis/jit294; Perise-Barrios AJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039472; Khurana S, 2012, J INFECT DIS, V205, P610, DOI 10.1093/infdis/jir791; King JC, 2000, J INFECT DIS, V181, P725, DOI 10.1086/315246; KROON FP, 1994, AIDS, V8, P469, DOI 10.1097/00002030-199404000-00008; Laurie KL, 2010, J INFECT DIS, V202, P1011, DOI 10.1086/656188; Lee VJ, 2010, VACCINE, V28, P6852, DOI 10.1016/j.vaccine.2010.08.031; Levesque MC, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000107; Levin MJ, 2008, VACCINE, V26, P4210, DOI 10.1016/j.vaccine.2008.05.054; Madhi SA, 2002, PEDIATR INFECT DIS J, V21, P291, DOI 10.1097/00006454-200204000-00007; Madhi SA, 2000, J PEDIATR-US, V137, P78, DOI 10.1067/mpd.2000.105350; Marcelin G, 2010, J INFECT DIS, V202, P1634, DOI 10.1086/657084; Martin G, 2007, J VIROL, V81, P5872, DOI 10.1128/JVI.02542-06; Miller MS, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3006637; MIOTTI PG, 1989, JAMA-J AM MED ASSOC, V262, P779, DOI 10.1001/jama.262.6.779; Moir S, 2004, J EXP MED, V200, P587, DOI 10.1084/jem.20032236; Moir S, 2008, J EXP MED, V205, P1797, DOI 10.1084/jem.20072683; Moir S, 2009, NAT REV IMMUNOL, V9, P235, DOI 10.1038/nri2524; Pallikkuth S, 2012, BLOOD, V120, P985, DOI 10.1182/blood-2011-12-396648; Pallikkuth S, 2011, J IMMUNOL, V186, P6173, DOI 10.4049/jimmunol.1100264; Pedersen GK, 2012, J INFECT DIS, V206, P158, DOI 10.1093/infdis/jis330; Pensieroso S, 2013, AIDS, V27, P1209, DOI 10.1097/QAD.0b013e32835edc47; Qiao XG, 2006, NAT IMMUNOL, V7, P302, DOI 10.1038/ni1302; Qiu C, 2012, CLIN INFECT DIS, V54, P17, DOI 10.1093/cid/cir753; Rappocciolo G, 2006, PLOS PATHOG, V2, P691, DOI 10.1371/journal.ppat.0020070; Richardson K, 2011, AIDS, V25, P595, DOI 10.1097/QAD.0b013e32834411a8; Rowe T, 1999, J CLIN MICROBIOL, V37, P937, DOI 10.1128/JCM.37.4.937-943.1999; Swingler S, 2003, NATURE, V424, P213, DOI 10.1038/nature01749; Titanji K, 2006, BLOOD, V108, P1580, DOI 10.1182/blood-2005-11-013383; Verma N, 2012, J VIROL, V86, P5515, DOI 10.1128/JVI.07085-11; Viau M, 2007, MOL IMMUNOL, V44, P2124, DOI 10.1016/j.molimm.2006.07.302; Vigano A, 2008, JAIDS-J ACQ IMM DEF, V48, P289, DOI 10.1097/QAI.0b013e3181632cda; Weinberg A, 2013, HUM VACC IMMUNOTHER, V9, P957, DOI 10.4161/hv.23774; Weinberg A, 2010, JAIDS-J ACQ IMM DEF, V55, P189, DOI 10.1097/QAI.0b013e3181e46308	50	9	10	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2015	10	3							e0118567	10.1371/journal.pone.0118567	http://dx.doi.org/10.1371/journal.pone.0118567			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9BN	25785995	Green Published, gold, Green Submitted			2022-12-27	WOS:000352138500037
J	Jayasena, T; Poljak, A; Braidy, N; Smythe, G; Raftery, M; Hill, M; Brodaty, H; Trollor, J; Kochan, N; Sachdev, P				Jayasena, Tharusha; Poljak, Anne; Braidy, Nady; Smythe, George; Raftery, Mark; Hill, Mark; Brodaty, Henry; Trollor, Julian; Kochan, Nicole; Sachdev, Perminder			Upregulation of Glycolytic Enzymes, Mitochondrial Dysfunction and Increased Cytotoxicity in Glial Cells Treated with Alzheimer's Disease Plasma	PLOS ONE			English	Article							MILD COGNITIVE IMPAIRMENT; HUMAN MICROGLIAL CELLS; COMPLEMENT ACTIVATION; CEREBROSPINAL-FLUID; NEUROFIBRILLARY TANGLES; MULTIPLE-SCLEROSIS; AMYLOID-BETA; A-BETA; LIPID-PEROXIDATION; CLASSICAL PATHWAY	Alzheimer's disease (AD) is a neurodegenerative disorder associated with increased oxidative stress and neuroinflammation. Markers of increased protein, lipid and nucleic acid oxidation and reduced activities of antioxidant enzymes have been reported in AD plasma. Amyloid plaques in the AD brain elicit a range of reactive inflammatory responses including complement activation and acute phase reactions, which may also be reflected in plasma. Previous studies have shown that human AD plasma may be cytotoxic to cultured cells. We investigated the effect of pooled plasma (n = 20 each) from healthy controls, individuals with amnestic mild cognitive impairment (aMCI) and Alzheimer's disease (AD) on cultured microglial cells. AD plasma and was found to significantly decrease cell viability and increase glycolytic flux in microglia compared to plasma from healthy controls. This effect was prevented by the heat inactivation of complement. Proteomic methods and isobaric tags (iTRAQ) found the expression level of complement and other acute phase proteins to be altered in MCI and AD plasma and an upregulation of key enzymes involved in the glycolysis pathway in cells exposed to AD plasma. Altered expression levels of acute phase reactants in AD plasma may alter the energy metabolism of glia.	[Jayasena, Tharusha; Poljak, Anne; Smythe, George; Raftery, Mark] Univ New S Wales, MW Analyt Ctr, Bioanalyt Mass Spectrometry Facil, Sydney, NSW, Australia; [Jayasena, Tharusha; Poljak, Anne; Braidy, Nady; Brodaty, Henry; Trollor, Julian; Kochan, Nicole; Sachdev, Perminder] Univ New S Wales, Ctr Hlth Brain Ageing, Sch Psychiat, Sydney, NSW, Australia; [Trollor, Julian; Kochan, Nicole; Sachdev, Perminder] Prince Wales Hosp, Inst Neuropsychiat, Sydney, NSW, Australia; [Poljak, Anne; Smythe, George; Hill, Mark] Univ New S Wales, Sch Med Sci, Sydney, NSW, Australia; [Brodaty, Henry] Univ New S Wales, Dementia Collaborat Res Ctr, Sydney, NSW, Australia	University of New South Wales Sydney; University of New South Wales Sydney; University of New South Wales Sydney; University of New South Wales Sydney	Poljak, A (corresponding author), Univ New S Wales, MW Analyt Ctr, Bioanalyt Mass Spectrometry Facil, Sydney, NSW, Australia.	a.poljak@unsw.edu.au	Sachdev, Perminder/ABC-1137-2020	Sachdev, Perminder/0000-0002-9595-3220; Trollor, Julian/0000-0002-7685-2977; Jayasena, Tharusha/0000-0001-9655-9359; Poljak, Anne/0000-0001-9953-1984; Braidy, Nady/0000-0002-0497-5572	Rebecca L Cooper Medical Research Foundation; University of New South Wales, Equity and Diversity Unit; NHMRC [ID 350833, ID 568969]; Australian Government Systemic Infrastructure Initiative and Major National Research Facilities Program; UNSW Capital Grants Scheme	Rebecca L Cooper Medical Research Foundation; University of New South Wales, Equity and Diversity Unit; NHMRC(National Health and Medical Research Council (NHMRC) of Australia); Australian Government Systemic Infrastructure Initiative and Major National Research Facilities Program(Australian Government); UNSW Capital Grants Scheme	This work was facilitated by the generous financial support of the Rebecca L Cooper Medical Research Foundation (http://www.cooperfoundation.org.au) and The University of New South Wales, Equity and Diversity Unit. This study is supported by the NHMRC Program Grants (ID 350833 and ID 568969) awarded to Professors Sachdev and Brodaty and Dr Trollor. None of the authors have any conflicts of interests with regard to this work. Mass spectrometry analyses were carried out at the Bioanalytical Mass Spectrometry Facility, UNSW, and was supported in part by grants from the Australian Government Systemic Infrastructure Initiative and Major National Research Facilities Program and by the UNSW Capital Grants Scheme (http://www.bmsf.unsw.edu.au/aboutus/funding.htm). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agoropoulou C, 1996, NEUROREPORT, V7, P997, DOI 10.1097/00001756-199604100-00009; AKIYAMA H, 1992, NEUROSCI LETT, V146, P152, DOI 10.1016/0304-3940(92)90065-F; Akuffo EL, 2008, BIOMARKERS, V13, P618, DOI [10.1080/13547500802445199, 10.1080/13547500802445199 ]; Andreu CI, 2012, FEBS LETT, V586, P2826, DOI 10.1016/j.febslet.2012.07.023; Arai T, 2006, J NEUROPATH EXP NEUR, V65, P19, DOI 10.1097/01.jnen.0000196133.74087.cb; Asuni AA, 2014, J BIOL CHEM, V289, P4532, DOI 10.1074/jbc.M113.502690; Asuni AA, 2013, NEUROSCI LETT, V538, P26, DOI 10.1016/j.neulet.2013.01.027; ATANASSOV CL, 1995, NEUROCHEM INT, V27, P417, DOI 10.1016/0197-0186(95)00023-2; BARNUM SR, 1995, CRIT REV ORAL BIOL M, V6, P132, DOI 10.1177/10454411950060020301; Bennett S, 2012, ALZ DIS ASSOC DIS, V26, P329, DOI 10.1097/WAD.0b013e318239dcbd; BERNOFSKY C, 1973, ANAL BIOCHEM, V53, P452, DOI 10.1016/0003-2697(73)90094-8; Bhattacharya R, 2008, DRUG CHEM TOXICOL, V31, P149, DOI 10.1080/01480540701688865; Bigl M, 1999, J NEURAL TRANSM, V106, P499, DOI 10.1007/s007020050174; Blalock EM, 2004, P NATL ACAD SCI USA, V101, P2173, DOI 10.1073/pnas.0308512100; BOURAS C, 1994, CEREB CORTEX, V4, P138, DOI 10.1093/cercor/4.2.138; BRADBURY K, 1984, J NEUROL SCI, V65, P293, DOI 10.1016/0022-510X(84)90092-3; BRADFORD HF, 1989, CAN J NEUROL SCI, V16, P528, DOI 10.1017/S0317167100029875; Braidy N, 2014, NEUROTOX RES, V25, P170, DOI 10.1007/s12640-013-9420-5; Braidy N, 2013, TRANSL NEURODEGENER, V2, DOI 10.1186/2047-9158-2-20; BREWER GJ, 1992, J NEUROSCI RES, V33, P355, DOI 10.1002/jnr.490330302; Butterfield DA, 2002, NEUROBIOL AGING, V23, P655; CARMICHAEL J, 1987, CANCER RES, V47, P936; Castano EM, 2006, NEUROL RES, V28, P155, DOI 10.1179/016164106X98035; Cocciolo A, 2012, FREE RADICAL BIO MED, V53, P1868, DOI 10.1016/j.freeradbiomed.2012.08.596; Davidsson P, 2002, NEUROREPORT, V13, P611, DOI 10.1097/00001756-200204160-00015; de Gannes FMP, 1998, NEUROCHEM INT, V33, P61, DOI 10.1016/S0197-0186(05)80010-5; DEFAZIO G, 1994, BRAIN RES, V633, P206, DOI 10.1016/0006-8993(94)91541-5; Di Domenico F, 2014, FREE RADICAL BIO MED, V71, P270, DOI 10.1016/j.freeradbiomed.2014.03.027; Du H, 2012, ANTIOXID REDOX SIGN, V16, P1467, DOI 10.1089/ars.2011.4277; Fonseca MI, 2009, J IMMUNOL, V183, P1375, DOI 10.4049/jimmunol.0901005; Gestwicki JE, 2012, PROG MOL BIOL TRANSL, V107, P327, DOI 10.1016/B978-0-12-385883-2.00003-5; Grammas P, 2006, J ALZHEIMERS DIS, V9, P51; Guntert A, 2010, J ALZHEIMERS DIS, V21, P585, DOI 10.3233/JAD-2010-100279; Gut P, 2013, NATURE, V502, P489, DOI 10.1038/nature12752; HAGA S, 1993, BRAIN RES, V601, P88, DOI 10.1016/0006-8993(93)91698-R; HAMOS JE, 1991, NEUROLOGY, V41, P345, DOI 10.1212/WNL.41.3.345; HARRISON PJ, 1993, NEUROPATH APPL NEURO, V19, P10, DOI 10.1111/j.1365-2990.1993.tb00400.x; HIRAYAMA M, 1986, NEUROLOGY, V36, P276, DOI 10.1212/WNL.36.2.276; HOWARD J, 1990, NEUROSCI LETT, V118, P71, DOI 10.1016/0304-3940(90)90251-4; Hye A, 2006, BRAIN, V129, P3042, DOI 10.1093/brain/awl279; Hye A, 2014, ALZHEIMERS DEMENT; Ishihama Y, 2005, MOL CELL PROTEOMICS, V4, P1265, DOI 10.1074/mcp.M500061-MCP200; Johnson Ginger, 1992, Applied and Theoretical Electrophoresis, V3, P47; Jung SM, 2008, NEUROSCI LETT, V436, P153, DOI 10.1016/j.neulet.2008.03.010; Kawada K, 2002, ACTA MED OKAYAMA, V56, P129; Keller A, 2002, ANAL CHEM, V74, P5383, DOI 10.1021/ac025747h; KEMP AS, 1985, AUST PAEDIATR J, V21, P169; Kiddle SJ, 2014, J ALZHEIMERS DIS, V38, P515, DOI 10.3233/JAD-130380; Kima E, 2014, J ALZHEIMERS DIS, V42, P421, DOI 10.3233/JAD-132165; Korolainen MA, 2006, NEUROBIOL AGING, V27, P42, DOI 10.1016/j.neurobiolaging.2004.11.010; Krako N, 2013, J ALZHEIMERS DIS, V37, P747, DOI 10.3233/JAD-130728; Kumar A, 2005, J BIOL CHEM, V280, P42619, DOI 10.1074/jbc.M508416200; Lau P, 2014, AGEING RES REV; Lee JW, 2007, BMC NEUROL, V7, DOI 10.1186/1471-2377-7-14; Liang WS, 2008, P NATL ACAD SCI USA, V105, P4441, DOI 10.1073/pnas.0709259105; Lim YA, 2010, PROTEOMICS, V10, P1621, DOI 10.1002/pmic.200900651; Liu TF, 2012, J LEUKOCYTE BIOL, V92, P499, DOI 10.1189/jlb.0212078; Maffioletti E, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00075; MCGEER PL, 1991, BRAIN RES, V544, P315, DOI 10.1016/0006-8993(91)90071-3; McGrath LT, 2001, QJM-MON J ASSOC PHYS, V94, P485, DOI 10.1093/qjmed/94.9.485; MCKHANN G, 1984, NEUROLOGY, V34, P939, DOI 10.1212/WNL.34.7.939; MITCHELL DB, 1981, J TOXICOL ENV HEALTH, V7, P83, DOI 10.1080/15287398109529960; Mocali Alessandra, 2014, Int J Alzheimers Dis, V2014, P520152, DOI 10.1155/2014/520152; Morales I, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00112; Moreno-Flores MT, 2001, NEUROSCI LETT, V314, P87, DOI 10.1016/S0304-3940(01)02286-8; Mosconi L, 2007, EXP GERONTOL, V42, P129, DOI 10.1016/j.exger.2006.05.016; Mufson EJ, 2010, NEURODEGENER DIS, V7, P139, DOI 10.1159/000289224; Newington Jordan T, 2013, J Neurodegener Dis, V2013, P234572, DOI 10.1155/2013/234572; Newington JT, 2012, J BIOL CHEM, V287, P37245, DOI 10.1074/jbc.M112.366195; Ossenkoppele R, 2013, IS VERBAL EPISODIC M; Paul J, 2007, J EXP MED, V204, P1999, DOI 10.1084/jem.20070304; Pesta D, 2012, METHODS MOL BIOL, V810, P25, DOI 10.1007/978-1-61779-382-0_3; Petersen RC, 2004, J INTERN MED, V256, P183, DOI 10.1111/j.1365-2796.2004.01388.x; PEUDENIER S, 1991, ANN NEUROL, V29, P152, DOI 10.1002/ana.410290207; Powers WJ, 1998, J CEREBR BLOOD F MET, V18, P632, DOI 10.1097/00004647-199806000-00005; Pratico D, 2002, ARCH NEUROL-CHICAGO, V59, P972, DOI 10.1001/archneur.59.6.972; Pratico D, 2000, ANN NEUROL, V48, P809, DOI 10.1002/1531-8249(200011)48:5<809::AID-ANA19>3.0.CO;2-9; Pratico D, 2010, BBA-MOL CELL BIOL L, V1801, P930, DOI 10.1016/j.bbalip.2010.01.009; Price JL, 1999, ANN NEUROL, V45, P358, DOI 10.1002/1531-8249(199903)45:3<358::AID-ANA12>3.0.CO;2-X; Puchades M, 2003, MOL BRAIN RES, V118, P140, DOI 10.1016/j.molbrainres.2003.08.005; Rainard P, 2002, J DAIRY RES, V69, P1, DOI 10.1017/S0022029901005337; ROGERS J, 1992, P NATL ACAD SCI USA, V89, P10016, DOI 10.1073/pnas.89.21.10016; Rojo LE, 2008, ARCH MED RES, V39, P1, DOI 10.1016/j.arcmed.2007.10.001; RUIJS TCG, 1990, BRAIN RES, V517, P99, DOI 10.1016/0006-8993(90)91013-7; Sachdev PS, 2010, INT PSYCHOGERIATR, V22, P1248, DOI 10.1017/S1041610210001067; Schrijvers EMC, 2011, JAMA-J AM MED ASSOC, V305, P1322, DOI 10.1001/jama.2011.381; Schuh RA, 2011, J NEUROSCI RES, V89, P1979, DOI 10.1002/jnr.22650; Searle BC, 2010, PROTEOMICS, V10, P1265, DOI 10.1002/pmic.200900437; Shen Y, 2003, PROG NEUROBIOL, V70, P463, DOI 10.1016/j.pneurobio.2003.08.001; Shen Y, 1997, BRAIN RES, V769, P391, DOI 10.1016/S0006-8993(97)00850-0; Shen Y, 2001, NEUROSCI LETT, V305, P165, DOI 10.1016/S0304-3940(01)01842-0; Silajdzic E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050237; Simpson Richard J, 2007, CSH Protoc, V2007, DOI 10.1101/pdb.prot4719; Singhrao SK, 2000, AM J PATHOL, V157, P905, DOI 10.1016/S0002-9440(10)64604-4; Solinet S, 2013, J CELL BIOL, V202, P251, DOI 10.1083/jcb.201304052; Song F, 2014, PROTEOME SCI, V12, DOI 10.1186/1477-5956-12-5; Starr JM, 2009, PSYCHIAT RES-NEUROIM, V171, P232, DOI 10.1016/j.pscychresns.2008.04.003; Tanskanen M, 2005, NEUROPATH APPL NEURO, V31, P589, DOI 10.1111/j.1365-2990.2005.00652.x; Thambisetty M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028527; Thambisetty M, 2010, ARCH GEN PSYCHIAT, V67, P739, DOI 10.1001/archgenpsychiatry.2010.78; Thambisetty M, 2008, J NEUROL, V255, P1712, DOI 10.1007/s00415-008-0006-8; TRIGLIA RP, 1980, MOL IMMUNOL, V17, P741, DOI 10.1016/0161-5890(80)90144-3; Trouw LA, 2008, MOL IMMUNOL, V45, P3649, DOI 10.1016/j.molimm.2008.04.025; Tsukita S, 1997, TRENDS BIOCHEM SCI, V22, P53, DOI 10.1016/S0968-0004(96)10071-2; ULRICH J, 1978, J NEUROL, V218, P7, DOI 10.1007/BF00314713; van Oijen M, 2005, STROKE, V36, P2637, DOI 10.1161/01.STR.0000189721.31432.26; Velliquette RA, 2005, J NEUROSCI, V25, P10874, DOI 10.1523/JNEUROSCI.2350-05.2005; Vlassenko AG, 2010, P NATL ACAD SCI USA, V107, P17763, DOI 10.1073/pnas.1010461107; Voloboueva LA, 2013, FEBS LETT, V587, P756, DOI 10.1016/j.febslet.2013.01.067; WALKER DG, 1995, BRAIN RES, V675, P75, DOI 10.1016/0006-8993(95)00041-N; Wirth M, 2013, JAMA NEUROL, V70, P1512, DOI 10.1001/jamaneurol.2013.4013; Yang LB, 2000, J NEUROSCI, V20, P7505; Yasojima K, 1999, AM J PATHOL, V154, P927, DOI 10.1016/S0002-9440(10)65340-0; Yu HL, 2003, PROTEOMICS, V3, P2240, DOI 10.1002/pmic.200300475; ZAMAN Z, 1992, AGE AGEING, V21, P91, DOI 10.1093/ageing/21.2.91; Zhang RL, 2004, PROTEOMICS, V4, P244, DOI 10.1002/pmic.200300495; Zhang XL, 2008, TOXICOL IN VITRO, V22, P1520, DOI 10.1016/j.tiv.2008.05.006; Zipser BD, 2007, NEUROBIOL AGING, V28, P977, DOI 10.1016/j.neurobiolaging.2006.05.016	118	18	18	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2015	10	3							e0116092	10.1371/journal.pone.0116092	http://dx.doi.org/10.1371/journal.pone.0116092			30	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9BN	25785936	Green Published, Green Submitted, gold			2022-12-27	WOS:000352138500003
J	Koskiniemi, S; Garza-Sanchez, F; Edman, N; Chaudhuri, S; Poole, SJ; Manoil, C; Hayes, CS; Low, DA				Koskiniemi, Sanna; Garza-Sanchez, Fernando; Edman, Natasha; Chaudhuri, Swarnava; Poole, Stephen J.; Manoil, Colin; Hayes, Christopher S.; Low, David A.			Genetic Analysis of the CDI Pathway from Burkholderia pseudomallei 1026b	PLOS ONE			English	Article							VI SECRETION SYSTEM; OUTER-MEMBRANE BIOGENESIS; COLICIN E9; GROWTH; INHIBITION; PROTEIN; TOXIN; IMMUNITY; DOMAIN; IDENTIFICATION	Contact-dependent growth inhibition (CDI) is a mode of inter-bacterial competition mediated by the CdiB/CdiA family of two-partner secretion systems. CdiA binds to receptors on susceptible target bacteria, then delivers a toxin domain derived from its C-terminus. Studies with Escherichia coli suggest the existence of multiple CDI growth-inhibition pathways, whereby different systems exploit distinct target-cell proteins to deliver and activate toxins. Here, we explore the CDI pathway in Burkholderia using the CDIIIBp1026b system encoded on chromosome II of Burkholderia pseudomallei 1026b as a model. We took a genetic approach and selected Burkholderia thailandensis E264 mutants that are resistant to growth inhibition by CDIIIBp1026b. We identified mutations in three genes, BTH_I0359, BTH_II0599, and BTH_I0986, each of which confers resistance to CDIIIBp1026b. BTH_I0359 encodes a small peptide of unknown function, whereas BTH_II0599 encodes a predicted inner membrane transport protein of the major facilitator superfamily. The inner membrane localization of BTH_II0599 suggests that it may facilitate translocation of CdiA-CTIIBp1026b toxin from the periplasm into the cytoplasm of target cells. BTH_I0986 encodes a putative transglycosylase involved in lipopolysaccharide (LPS) synthesis. Delta BTH_I0986 mutants have altered LPS structure and do not interact with CDI+ inhibitor cells to the same extent as BTH_I0986(+) cells, suggesting that LPS could function as a receptor for CdiA(II)(Bp1026b). Although Delta BTH_I0359, Delta BTH_II0599, and Delta BTH_I0986 mutations confer resistance to CDIIIBp1026b, they provide no protection against the CDIE264 system deployed by B. thailandensis E264. Together, these findings demonstrate that CDI growth-inhibition pathways are distinct and can differ significantly even between closely related species.	[Koskiniemi, Sanna; Garza-Sanchez, Fernando; Edman, Natasha; Chaudhuri, Swarnava; Poole, Stephen J.; Hayes, Christopher S.; Low, David A.] Univ Calif Santa Barbara, Dept Mol Cellular & Dev Biol, Santa Barbara, CA 93106 USA; [Hayes, Christopher S.; Low, David A.] Univ Calif Santa Barbara, Biomol Sci & Engn Program, Santa Barbara, CA 93106 USA; [Manoil, Colin] Univ Washington, Dept Genome Sci, Seattle, WA 98195 USA	University of California System; University of California Santa Barbara; University of California System; University of California Santa Barbara; University of Washington; University of Washington Seattle	Low, DA (corresponding author), Univ Calif Santa Barbara, Dept Mol Cellular & Dev Biol, Santa Barbara, CA 93106 USA.	david.low@lifesci.ucsb.edu		Edman, Natasha/0000-0002-7315-7127	National Institutes of Health [U54 AI065359, UO1 GM102318]; Santa Barbara Cottage Hospital; Carl Tryggers Stiftelse; Wenner-Gren Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U54AI065359] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Santa Barbara Cottage Hospital; Carl Tryggers Stiftelse; Wenner-Gren Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work received support from the following sources: National Institutes of Health U54 AI065359 (DAL); National Institutes of Health UO1 GM102318 (CSH); Santa Barbara Cottage Hospital (SK), http://cottagehealthsystem.org/tabid/1026/Default.aspx; Carl Tryggers Stiftelse (SK); Wenner-Gren Foundation (SK), http://www.swgc.org/welcome.aspx. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aiyar A, 1996, Methods Mol Biol, V57, P177; Anderson MS, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004076; Anderson MS, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002877; Aoki SK, 2009, J BACTERIOL, V191, P1777, DOI 10.1128/JB.01437-08; Aoki SK, 2005, SCIENCE, V309, P1245, DOI 10.1126/science.1115109; Aoki SK, 2008, MOL MICROBIOL, V70, P323, DOI 10.1111/j.1365-2958.2008.06404.x; Aoki SK, 2010, NATURE, V468, P439, DOI 10.1038/nature09490; Arenas J, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-622; Barrett AR, 2008, APPL ENVIRON MICROB, V74, P4498, DOI 10.1128/AEM.00531-08; Beck CM, 2014, MOL MICROBIOL, V93, P276, DOI 10.1111/mmi.12658; Beck CM, 2014, STRUCTURE, V22, P707, DOI 10.1016/j.str.2014.02.012; Brett PJ, 1998, INT J SYST BACTERIOL, V48, P317, DOI 10.1099/00207713-48-1-317; Broadbent SE, 2010, MOL MICROBIOL, V77, P337, DOI 10.1111/j.1365-2958.2010.07203.x; Burtnick MN, 2011, INFECT IMMUN, V79, P1512, DOI 10.1128/IAI.01218-10; Cardona ST, 2005, PLASMID, V54, P219, DOI 10.1016/j.plasmid.2005.03.004; Choi KH, 2008, APPL ENVIRON MICROB, V74, P1064, DOI 10.1128/AEM.02430-07; Cota I, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036863; Diner EJ, 2012, GENE DEV, V26, P515, DOI 10.1101/gad.182345.111; DITTA G, 1980, P NATL ACAD SCI-BIOL, V77, P7347, DOI 10.1073/pnas.77.12.7347; Fluman N, 2009, BBA-PROTEINS PROTEOM, V1794, P738, DOI 10.1016/j.bbapap.2008.11.020; Gallagher LA, 2013, MBIO, V4, DOI 10.1128/mBio.00604-13; Gentle I, 2004, J CELL BIOL, V164, P19, DOI 10.1083/jcb.200310092; Hayes CS, 2014, CSH PERSPECT MED, V4, DOI 10.1101/cshperspect.a010025; Hayes CS, 2003, MOL CELL, V12, P903, DOI 10.1016/S1097-2765(03)00385-X; Hoang TT, 1998, GENE, V212, P77, DOI 10.1016/S0378-1119(98)00130-9; Hood RD, 2010, CELL HOST MICROBE, V7, P25, DOI 10.1016/j.chom.2009.12.007; Kajava AV, 2001, MOL MICROBIOL, V42, P279, DOI 10.1046/j.1365-2958.2001.02598.x; Law CJ, 2008, ANNU REV MICROBIOL, V62, P289, DOI 10.1146/annurev.micro.61.080706.093329; MA D, 1995, MOL MICROBIOL, V16, P45, DOI 10.1111/j.1365-2958.1995.tb02390.x; MacIntyre DL, 2010, P NATL ACAD SCI USA, V107, P19520, DOI 10.1073/pnas.1012931107; MILLER VL, 1988, J BACTERIOL, V170, P2575, DOI 10.1128/JB.170.6.2575-2583.1988; Morse RP, 2012, P NATL ACAD SCI USA, V109, P21480, DOI 10.1073/pnas.1216238110; Mosbahi K, 2006, PROTEIN SCI, V15, P620, DOI 10.1110/ps.051890306; Mosbahi K, 2004, J BIOL CHEM, V279, P22145, DOI 10.1074/jbc.M400402200; Mosbahi K, 2002, NAT STRUCT BIOL, V9, P476, DOI 10.1038/nsb797; Nikolakakis K, 2012, MOL MICROBIOL, V84, P516, DOI 10.1111/j.1365-2958.2012.08039.x; Noinaj N, 2013, NATURE, V501, P385, DOI 10.1038/nature12521; Poole SJ, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002217; Ruhe ZC, 2014, MOL MICROBIOL, V94, P466, DOI 10.1111/mmi.12779; Ruhe ZC, 2013, MBIO, V4, DOI 10.1128/mBio.00480-13; Ruhe ZC, 2013, TRENDS MICROBIOL, V21, P230, DOI 10.1016/j.tim.2013.02.003; Schwarz S, 2014, INFECT IMMUN, V82, P1445, DOI 10.1128/IAI.01368-13; Schwarz S, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001068; Seed KD, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002917; Stone JK, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-250; Toesca IJ, 2014, INFECT IMMUN, V82, P1436, DOI 10.1128/IAI.01367-13; Trakulsomboon Suwanna, 1999, Southeast Asian Journal of Tropical Medicine and Public Health, V30, P756; Tuanyok A, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001453; Voulhoux R, 2003, SCIENCE, V299, P262, DOI 10.1126/science.1078973; Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033; Werner J, 2005, MOL MICROBIOL, V57, P1450, DOI 10.1111/j.1365-2958.2005.04775.x; Wu T, 2005, CELL, V121, P235, DOI 10.1016/j.cell.2005.02.015; Zhang DP, 2012, BIOL DIRECT, V7, DOI 10.1186/1745-6150-7-18; Zhang DP, 2011, NUCLEIC ACIDS RES, V39, P4532, DOI 10.1093/nar/gkr036; Zheng J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023876	55	22	22	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2015	10	3							e0120265	10.1371/journal.pone.0120265	http://dx.doi.org/10.1371/journal.pone.0120265			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9BN	25786241	Green Published, gold			2022-12-27	WOS:000352138500161
J	Scheinemann, HA; Dittmar, K; Stockel, FS; Muller, H; Kruger, ME				Scheinemann, Hendrik A.; Dittmar, Katja; Stoeckel, Frank S.; Mueller, Hermann; Krueger, Monika E.			Hygienisation and Nutrient Conservation of Sewage Sludge or Cattle Manure by Lactic Acid Fermentation	PLOS ONE			English	Article							ESCHERICHIA-COLI; CLOSTRIDIUM; POPULATION; WASTE	Manure from animal farms and sewage sludge contain pathogens and opportunistic organisms in various concentrations depending on the health of the herds and human sources. Other than for the presence of pathogens, these waste substances are excellent nutrient sources and constitute a preferred organic fertilizer. However, because of the pathogens, the risks of infection of animals or humans increase with the indiscriminate use of manure, especially liquid manure or sludge, for agriculture. This potential problem can increase with the global connectedness of animal herds fed imported feed grown on fields fertilized with local manures. This paper describes a simple, easy-to-use, low-tech hygienization method which conserves nutrients and does not require large investments in infrastructure. The proposed method uses the microbiotic shift during mesophilic fermentation of cow manure or sewage sludge during which gram-negative bacteria, enterococci and yeasts were inactivated below the detection limit of 3 log(10) cfu/g while lactobacilli increased up to a thousand fold. Pathogens like Salmonella, Listeria monocytogenes, Staphylococcus aureus, E. coli EHEC O:157 and vegetative Clostridium perfringens were inactivated within 3 days of fermentation. In addition, ECBO-viruses and eggs of Ascaris suum were inactivated within 7 and 56 days, respectively. Compared to the mass lost through composting (15-57%), the loss of mass during fermentation (< 2.45%) is very low and provides strong economic and ecological benefits for this process. This method might be an acceptable hygienization method for developed as well as undeveloped countries, and could play a key role in public and animal health while safely closing the nutrient cycle by reducing the necessity of using energy-inefficient inorganic fertilizer for crop production.	[Scheinemann, Hendrik A.; Krueger, Monika E.] Univ Leipzig, Inst Bacteriol & Mycol, Fac Vet Med, D-04103 Leipzig, Germany; [Dittmar, Katja; Stoeckel, Frank S.] Univ Leipzig, Inst Parasitol, Fac Vet Med, D-04103 Leipzig, Germany; [Mueller, Hermann] Univ Leipzig, Inst Virol, Fac Vet Med, D-04103 Leipzig, Germany; [Scheinemann, Hendrik A.] Gesell Forderung Med Bio & Umwelttechnol eV, D-06120 Halle, Saale, Germany	Leipzig University; Leipzig University; Leipzig University	Scheinemann, HA (corresponding author), Univ Leipzig, Inst Bacteriol & Mycol, Fac Vet Med, Tierkliniken 29, D-04103 Leipzig, Germany.	scheinemann@gmbu.de		Scheinemann, Hendrik/0000-0002-4275-7672	Deutsche Bundesstifung Umwelt (DBU) [AZ 27937/1, AZ 27937/2]; Sachsisches Landesamt Umwelt; German Research Foundation (DFG); Universitat Leipzig within the program of Open Access Publishing	Deutsche Bundesstifung Umwelt (DBU); Sachsisches Landesamt Umwelt; German Research Foundation (DFG)(German Research Foundation (DFG)); Universitat Leipzig within the program of Open Access Publishing	This study was funded by Deutsche Bundesstifung Umwelt (DBU) (AZ 27937/1&2) and by Sachsisches Landesamt Umwelt. The authors acknowledge support from the German Research Foundation (DFG) and Universitat Leipzig within the program of Open Access Publishing. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ade-Kappelmann K, 2008, THESIS FREIE U BERLI; Al-Ghazali MR, 1990, J APPL BACTERIOLOGY, V69; Alberto F, 2003, LETT APPL MICROBIOL, V36, P41, DOI 10.1046/j.1472-765X.2003.01260.x; [Anonymous], 2007, RICHTL PRUF CHEM DES; Appel B, 2012, EHEC OUTBREAK 2011 I; Back W, 2008, MIKROBIOLOGIE LEBENS; Bagge E, 2005, WATER RES, V39, P4879, DOI 10.1016/j.watres.2005.03.016; Batmanglij N, 2000, MILK DAIRY, P64; Bernal MP, 1998, AGR ECOSYSTEMS ENV, V69; Biermann U, 1990, BERLINER MUNCHENER T, V103; Boegel K, 1960, ZBL VET MED, V7, P534; Boisvenue RJ, 1990, J HELMINTHOLOGICAL S, V57; Buchholz U, 2011, NEW ENGL J MED, V365, P1763, DOI 10.1056/NEJMoa1106482; Christensen K.K., 2002, SUPERVISION SANITARY; COLLINS MD, 1994, INT J SYST BACTERIOL, V44, P812, DOI 10.1099/00207713-44-4-812; Colwell RR, 1979, NATIVE AQUATIC BACTE, P56, DOI DOI 10.1520/STP36003S; Conn VM, 2004, APPL ENVIRON MICROB, V70, P1787, DOI 10.1128/AEM.70.3.1787-1794.2004; Csonka LN, 1989, MICROBIOLOGICAL REV, V53; Denevan WM, 2002, CULTIVATED LANDSCAPE; Eghball B, 1997, J ENVIRON QUAL, V26, P189, DOI 10.2134/jeq1997.00472425002600010027x; Factura H, 2010, WATER SCI TECHNOL, V61, P2673, DOI 10.2166/wst.2010.201; Germans W, 1954, Z PARASITENKD, V16, DOI [10.1107/S0108767309007235, DOI 10.1107/S0108767309007235]; Glaser B, 2001, TERRA PRETA PHENOMEN; GLATHE H., 1963, Z. PflErnuhr. Dung., V101, P109, DOI 10.1002/jpln.19631010205; GOEPFERT JM, 1969, J BACTERIOL, V97, P956, DOI 10.1128/JB.97.2.956-958.1969; Haacker K, 1983, ARCH TIERERNAEHRUNG, V33, DOI [10.1055/s-0033-1360260, DOI 10.1055/S-0033-1360260]; Hammes W. P., 1992, The prokaryotes: a handbook on the biology of bacteria: ecophysiology, isolation, identification, applications, vol. II., P1535; HARTMANN FA, 1995, J VET DIAGN INVEST, V7, P159, DOI 10.1177/104063879500700128; Herrmann C, 2011, BIORESOURCE TECHNOL, V102, P5153, DOI 10.1016/j.biortech.2011.01.012; HRUBANT GR, 1975, APPL MICROBIOL, V30, P113, DOI 10.1128/AEM.30.1.113-119.1975; Jeffers GT, 2001, MICROBIOL-SGM, V147, P1095, DOI 10.1099/00221287-147-5-1095; Jiang X, 2002, APPL ENV MICROBIOLOG, V68; Johnson PW, 1998, INT J PARASITOL, V28, P627, DOI 10.1016/S0020-7519(97)00210-5; Jones P., 2003, REV LIT OCCURRENCE S; Knarreborg A, 2002, ANIM FEED SCI TECH, V99, P131, DOI 10.1016/S0377-8401(02)00069-X; Kulp K, 2003, HDB DOUGH FERMENTATI; Lehmann E, 1960, Z PFLANZENERNAHR DUN, V89, P42, DOI [10.1002/jpln.19600890105, DOI 10.1002/JPLN.19600890105]; Levine AS, 1940, J BACTERIOL, V39, P499, DOI 10.1128/JB.39.5.499-515.1940; Lind O, 1937, UNTERSUCHUNGEN BAKTE; Linde K, 1981, ZBL BAKT HYG 1; Linde K, 1990, VACCINE, V8; Linde K, 2012, METABOLIC DRIFT MD M; Lund B, 1996, A VANLEEUWENHOEK, V69; Martens W, 1998, P RAMIRAN 98 8 INT C, P529; Maya C, 2010, WATER SCI TECHNOLOGY, V62; Minamisawa K, 2004, APPL ENVIRON MICROB, V70, P3096, DOI 10.1128/AEM.70.5.3096-3102.2004; Naylor SW, 2003, INFECT IMMUN, V71, P1505, DOI 10.1128/IAI.71.3.1505-1512.2003; Nazir J, 2011, PERSISTENCE H4N6 H5N; NG H, 1969, APPL MICROBIOL, V17, P78, DOI 10.1108/03321649810202991; O'Donell CJ, 1984, APPL ENV MICROBIOLOG, V48; Pourcher AM, 2005, J APPL MICROBIOL, V99, P528, DOI 10.1111/j.1365-2672.2005.02642.x; Presser KA, 1998, APPL ENVIRON MICROB, V64, P1773; Scheffer F, 1963, NEUE AUSGRABUNGEN FO, V1; Schikora A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002279; Schmidt MWI, 2002, GLOBAL BIOGEOCHEM CY, V16, DOI 10.1029/2002GB001939; Seamster AP, 1958, AM MIDLAND NATURALIS, V43; Shehata AA, 2012, AVIAN DIS IN PRESS; Skjemstad JO, 1996, AUSTR J SOIL RES; Slepecky RA, 1992, PROKARYOTES, P1663; Smith NJ, 1980, ANN ASS AM GEOGRAPHE, V70; Sommer SG, 2001, EUROPEAN J AGRONOMY, V14; Songer GJ, 2010, VET MICROBIOLOGY; Steiner C., 2009, P423, DOI 10.1007/978-1-4020-9031-8_24; Tavechio AT, 2002, J FOOD PROTECTION, V65; Tiquia SM, 2002, NUTR CYCLING AGROECO, V62; Tyler HL, 2008, ANNU REV PHYTOPATHOL, V46, P53, DOI 10.1146/annurev.phyto.011708.103102; Van Hofwegen G., 2009, P393; VDLUFA Methodenbuch Band III Die chemische Untersuchung von Futtermitteln, VDLUFA METH; Wilkinson J.M., 2003, SILAGE SCI TECHNOLOG, V42, P1, DOI DOI 10.2134/AGRONMONOGR42.C1	69	14	14	1	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2015	10	3							e0118230	10.1371/journal.pone.0118230	http://dx.doi.org/10.1371/journal.pone.0118230			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9BN	25786255	gold, Green Published, Green Submitted			2022-12-27	WOS:000352138500023
J	Welsh, AH; Lindenmayer, DB; Donnelly, CF				Welsh, Alan H.; Lindenmayer, David B.; Donnelly, Christine F.			Adjusting for One Issue while Ignoring Others Can Make Things Worse	PLOS ONE			English	Letter									[Welsh, Alan H.; Lindenmayer, David B.; Donnelly, Christine F.] Australian Natl Univ, Canberra, ACT, Australia	Australian National University	Welsh, AH (corresponding author), Australian Natl Univ, Canberra, ACT, Australia.	Alan.Welsh@anu.edu.au	Lindenmayer, David B/P-7183-2017	Lindenmayer, David B/0000-0002-4766-4088; Welsh, Alan/0000-0002-3165-9559				Guillera-Arroita G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099571; Welsh AH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0052015	2	6	6	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2015	10	3							e0120817	10.1371/journal.pone.0120817	http://dx.doi.org/10.1371/journal.pone.0120817			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9BN	25786210	Green Published, Green Submitted, gold			2022-12-27	WOS:000352138500192
J	Allen, HK; An, R; Handelsman, J; Moe, LA				Allen, Heather K.; An, Ran; Handelsman, Jo; Moe, Luke A.			A Response Regulator from a Soil Metagenome Enhances Resistance to the beta-Lactam Antibiotic Carbenicillin in Escherichia coli	PLOS ONE			English	Article							FUNCTIONAL METAGENOMICS; GENES; PERMEABILITY; PROTEINS; STRESS; SYSTEM	Functional metagenomic analysis of soil metagenomes is a method for uncovering as-yet unidentified mechanisms for antibiotic resistance. Here we report an unconventional mode by which a response regulator derived from a soil metagenome confers resistance to the beta-lactam antibiotic carbenicillin in Escherichia coli. A recombinant clone (beta lr16) harboring a 5,169 bp DNA insert was selected from a metagenomic library previously constructed from a remote Alaskan soil. The beta lr16 clone conferred specific resistance to carbenicillin, with limited increases in resistance to other tested antibiotics, including other beta-lactams (penicillins and cephalosporins), rifampin, ciprofloxacin, erythromycin, chloramphenicol, nalidixic acid, fusidic acid, and gentamicin. Resistance was more pronounced at 24 degrees C than at 37 degrees C. Zone-of-inhibition assays suggested that the mechanism of carbenicillin resistance was not due to antibiotic inactivation. The DNA insert did not encode any genes known to confer antibiotic resistance, but did have two putative open reading frames (ORFs) that were annotated as a metallopeptidase and a two-component response regulator. Transposon mutagenesis and subcloning of the two ORFs followed by phenotypic assays showed that the response regulator gene was necessary and sufficient to confer the resistance phenotype. Quantitative reverse transcriptase PCR showed that the response regulator suppressed expression of the ompF porin gene, independently of the small RNA regulator micF, and enhanced expression of the acrD, mdtA, and mdtB efflux pump genes. This work demonstrates that antibiotic resistance can be achieved by the modulation of gene regulation by heterologous DNA. Functional analyses such as these can be important for making discoveries in antibiotic resistance gene biology and ecology.	[Allen, Heather K.] ARS, Food Safety & Enter Pathogens Res Unit, Natl Anim Dis Ctr, USDA, Ames, IA 50010 USA; [An, Ran; Moe, Luke A.] Univ Kentucky, Dept Plant & Soil Sci, Lexington, KY 40546 USA; [Handelsman, Jo] Yale Univ, Dept Mol Cellular & Dev Biol, New Haven, CT 06520 USA	United States Department of Agriculture (USDA); University of Kentucky; Yale University	Moe, LA (corresponding author), Univ Kentucky, Dept Plant & Soil Sci, Lexington, KY 40546 USA.	luke.moe@uky.edu		Moe, Luke/0000-0001-6864-4660; Allen, Heather K./0000-0002-4232-0462	United States Department of Agriculture National Institute of Food and Agriculture [2011-67020-30195]; National Research Initiative of the United States Department of Agriculture Cooperative State Research, Education and Extension Service [WIS01312]	United States Department of Agriculture National Institute of Food and Agriculture(United States Department of Agriculture (USDA)); National Research Initiative of the United States Department of Agriculture Cooperative State Research, Education and Extension Service(United States Department of Agriculture (USDA)National Institute of Food and Agriculture)	This work was funded in part by grants from United States Department of Agriculture National Institute of Food and Agriculture (2011-67020-30195) and the National Research Initiative of the United States Department of Agriculture Cooperative State Research, Education and Extension Service (WIS01312) to LAM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen HK, 2010, NAT REV MICROBIOL, V8, P251, DOI 10.1038/nrmicro2312; Allen HK, 2009, ISME J, V3, P243, DOI 10.1038/ismej.2008.86; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Baranova N, 2002, J BACTERIOL, V184, P4168, DOI 10.1128/JB.184.15.4168-4176.2002; Capra EJ, 2012, ANNU REV MICROBIOL, V66, P325, DOI 10.1146/annurev-micro-092611-150039; CDC, 2013, ANTIBIOTIC RESISTANC; Choudhury HG, 2013, PROTEIN SCI, V22, P1287, DOI 10.1002/pro.2311; Davies J, 2010, MICROBIOL MOL BIOL R, V74, P417, DOI 10.1128/MMBR.00016-10; Donato JJ, 2010, APPL ENVIRON MICROB, V76, P4396, DOI 10.1128/AEM.01763-09; Fisher JF, 2005, CHEM REV, V105, P395, DOI 10.1021/cr030102i; Galperin MY, 2010, CURR OPIN MICROBIOL, V13, P150, DOI 10.1016/j.mib.2010.01.005; Hamad B, 2010, NAT REV DRUG DISCOV, V9, P675, DOI 10.1038/nrd3267; Handelsman J, 2004, MICROBIOL MOL BIOL R, V68, P669, DOI 10.1128/MMBR.68.4.669-685.2004; HARDER KJ, 1981, ANTIMICROB AGENTS CH, V20, P549, DOI 10.1128/AAC.20.4.549; Lang KS, 2010, APPL ENVIRON MICROB, V76, P5321, DOI 10.1128/AEM.00323-10; Leblanc SKD, 2011, J BACTERIOL, V193, P3367, DOI 10.1128/JB.01534-10; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Marchler-Bauer A, 2013, NUCLEIC ACIDS RES, V41, pD348, DOI 10.1093/nar/gks1243; Mazzariol A, 2000, ANTIMICROB AGENTS CH, V44, P1387, DOI 10.1128/AAC.44.5.1387-1390.2000; McGarvey KM, 2012, APPL ENVIRON MICROB, V78, P1708, DOI 10.1128/AEM.06759-11; NCCLS, 2004, PERF STAND ANT SUSC, P96; Newman JR, 1999, GENE, V227, P197, DOI 10.1016/S0378-1119(98)00601-5; Nikaido H, 2003, MICROBIOL MOL BIOL R, V67, P593, DOI 10.1128/MMBR.67.4.593-656.2003; Nikaido H, 2012, FEMS MICROBIOL REV, V36, P340, DOI 10.1111/j.1574-6976.2011.00290.x; Nishino K, 2009, BBA-PROTEINS PROTEOM, V1794, P834, DOI 10.1016/j.bbapap.2009.02.002; Okusu H, 1996, J BACTERIOL, V178, P306, DOI 10.1128/JB.178.1.306-308.1996; Pages JM, 2008, NAT REV MICROBIOL, V6, P893, DOI 10.1038/nrmicro1994; Poole K, 2004, CELL MOL LIFE SCI, V61, P2200, DOI 10.1007/s00018-004-4060-9; Riesenfeld CS, 2004, ENVIRON MICROBIOL, V6, P981, DOI 10.1111/j.1462-2920.2004.00664.x; Sambrook J., 2001, MOL CLONING LAB MANU; Stock AM, 2000, ANNU REV BIOCHEM, V69, P183, DOI 10.1146/annurev.biochem.69.1.183; Torres-Cortes G, 2011, ENVIRON MICROBIOL, V13, P1101, DOI 10.1111/j.1462-2920.2010.02422.x; Viveiros M, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000365; WAXMAN DJ, 1983, ANNU REV BIOCHEM, V52, P825, DOI 10.1146/annurev.bi.52.070183.004141; Wichmann F, 2014, MBIO, V5, P9	35	8	10	2	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2015	10	3							e0120094	10.1371/journal.pone.0120094	http://dx.doi.org/10.1371/journal.pone.0120094			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7QC	25782011	Green Published, gold, Green Submitted			2022-12-27	WOS:000351284600125
J	Li, MH; Holmes, V; Ni, HP; Sanzari, JK; Romero-Weaver, AL; Lin, LY; Carabe-Fernandez, A; Diffenderfer, ES; Kennedy, AR; Weissman, D				Li, Minghong; Holmes, Veronica; Ni, Houping; Sanzari, Jenine K.; Romero-Weaver, Ana L.; Lin, Liyong; Carabe-Fernandez, Alejandro; Diffenderfer, Eric S.; Kennedy, Ann R.; Weissman, Drew			Broad-Spectrum Antibiotic or G-CSF as Potential Countermeasures for Impaired Control of Bacterial Infection Associated with an SPE Exposure during Spaceflight	PLOS ONE			English	Article							HINDLIMB-UNLOADING MODEL; INDUCED OXIDATIVE STRESS; SOLAR PARTICLE EVENTS; SPACE-FLIGHT; IMMUNE FUNCTION; GENE-EXPRESSION; RODENT MODEL; IN-VITRO; RADIATION; MICE	A major risk for astronauts during prolonged space flight is infection as a result of the combined effects of microgravity, situational and confinement stress, alterations in food intake, altered circadian rhythm, and radiation that can significantly impair the immune system and the body's defense systems. We previously reported a massive increase in morbidity with a decrease in the ability to control a bacterial challenge when mice were maintained under hindlimb suspension (HS) conditions and exposed to solar particle event (SPE)-like radiation. HS and SPE-like radiation treatment alone resulted in a borderline significant increase in morbidity. Therefore, development and testing of countermeasures that can be used during extended space missions in the setting of exposure to SPE radiation becomes a serious need. In the present study, we investigated the efficacy of enrofloxacin (an orally bioavailable antibiotic) and Granulocyte colony stimulating factor (G-CSF) (Neulasta) on enhancing resistance to Pseudomonas aeruginosa infection in mice subjected to HS and SPE-like radiation. The results revealed that treatment with enrofloxacin or G-CSF enhanced bacterial clearance and significantly decreased morbidity and mortality in challenged mice exposed to suspension and radiation. These results establish that antibiotics, such as enrofloxacin, and G-CSF could be effective countermeasures to decrease the risk of bacterial infections after exposure to SPE radiation during extended space flight, thereby reducing both the risk to the crew and the danger of mission failure.	[Li, Minghong; Holmes, Veronica; Ni, Houping; Weissman, Drew] Univ Penn, Perelman Sch Med, Dept Med, Div Infect Dis, Philadelphia, PA 19104 USA; [Sanzari, Jenine K.; Romero-Weaver, Ana L.; Lin, Liyong; Carabe-Fernandez, Alejandro; Diffenderfer, Eric S.; Kennedy, Ann R.] Univ Penn, Perelman Sch Med, Dept Radiat Oncol, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine	Weissman, D (corresponding author), Univ Penn, Perelman Sch Med, Dept Med, Div Infect Dis, 3610 Hamilton Walk, Philadelphia, PA 19104 USA.	dreww@mail.med.upenn.edu	Lin, Liyong/I-1195-2019; Carabe Fernandez, Alejandro/J-8719-2012	Lin, Liyong/0000-0002-0820-8063; Carabe Fernandez, Alejandro/0000-0002-1378-3337	National Space Biomedical Research Institute (NSBRI)-Center of Acute Radiation Research (CARR) grant; NIH [2T32CA009677]; NASA [NCC 9-58]; NATIONAL CANCER INSTITUTE [T32CA009677] Funding Source: NIH RePORTER	National Space Biomedical Research Institute (NSBRI)-Center of Acute Radiation Research (CARR) grant; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NASA(National Aeronautics & Space Administration (NASA)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the National Space Biomedical Research Institute (NSBRI)-Center of Acute Radiation Research (CARR) grant and NIH Training Grant 2T32CA009677 to ALRW. The NSBRI is funded through NASA NCC 9-58. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alali WQ, 2008, APPL ENVIRON MICROB, V74, P3672, DOI 10.1128/AEM.02624-07; Aponte VM, 2006, LIFE SCI, V79, P1317, DOI 10.1016/j.lfs.2006.04.007; ARMSTRONG JW, 1993, J APPL PHYSIOL, V75, P2734, DOI 10.1152/jappl.1993.75.6.2734; Aviles H, 2005, NEUROIMMUNOMODULAT, V12, P173, DOI 10.1159/000084850; Aviles H, 2004, J APPL PHYSIOL, V97, P1437, DOI 10.1152/japplphysiol.00259.2004; Aviles H, 2003, J APPL PHYSIOL, V95, P491, DOI 10.1152/japplphysiol.00259.2003; Aviles H, 2003, J APPL PHYSIOL, V95, P73, DOI 10.1152/japplphysiol.00968.2002; Aviles Hernan, 2006, Surg Infect (Larchmt), V7, P527, DOI 10.1089/sur.2006.7.527; Baqai FP, 2009, J APPL PHYSIOL, V106, P1935, DOI 10.1152/japplphysiol.91361.2008; Cena H, 2003, EUR J NUTR, V42, P99, DOI 10.1007/s00394-003-0392-8; Cermakian N, 2013, CHRONOBIOL INT, V30, P870, DOI 10.3109/07420528.2013.782315; CHOI KH, 1994, J ANTIMICROB CHEMOTH, V33, P1233, DOI 10.1093/jac/33.6.1233; Crucian B, 2009, RISK OF CREW ADVERSE; Crucian BE, 2000, J INTERF CYTOK RES, V20, P547, DOI 10.1089/10799900050044741; Crucian B, 2009, J LEUKOCYTE BIOL, V86, P1017, DOI 10.1189/jlb.0709500; Dhabhar FS, 1996, J IMMUNOL, V157, P1638; DHABHAR FS, 1995, J IMMUNOL, V154, P5511; Fischer JC, 2011, TRANSFUSION, V51, P1431, DOI 10.1111/j.1537-2995.2010.02998.x; FLEMING SD, 1990, AVIAT SPACE ENVIR MD, V61, P327; Goud SR, 1999, TOXICOLOGY, V135, P69, DOI 10.1016/S0300-483X(99)00037-2; Gridley DS, 2008, IN VIVO, V22, P159; Gridley DS, 2006, IN VIVO, V20, P781; Gridley DS, 2009, J APPL PHYSIOL, V106, P194, DOI 10.1152/japplphysiol.91126.2008; Gueguinou N, 2009, J LEUKOCYTE BIOL, V86, P1027, DOI 10.1189/jlb.0309167; Hamilton-Miller JMT, 2000, J ANTIMICROB CHEMOTH, V46, P852, DOI 10.1093/jac/46.5.852; Hu SW, 2009, HEALTH PHYS, V96, P465, DOI 10.1097/01.HP.0000339020.92837.61; Kantemiris I, 2011, MED PHYS, V38, P6585, DOI 10.1118/1.3662911; Kaur I, 2004, BRAIN BEHAV IMMUN, V18, P443, DOI 10.1016/j.bbi.2003.10.005; Kennedy AR, 2007, RADIAT ENVIRON BIOPH, V46, P201, DOI 10.1007/s00411-007-0105-4; Kim MHY, 2009, HEALTH PHYS, V97, P68, DOI 10.1097/01.HP.0000346799.65001.9c; Kita M, 2004, J GRAVIT PHYSL, V11, pP67; Klaus DM, 2006, TRENDS BIOTECHNOL, V24, P131, DOI 10.1016/j.tibtech.2006.01.008; Lee EH, 2005, AVIAT SPACE ENVIR MD, V76, P536; Levine DS, 1998, AVIAT SPACE ENVIR MD, V69, P172; Li MH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085665; Maks CJ, 2011, RADIAT RES, V176, P170, DOI 10.1667/RR2413.1; Matsui Y, 2002, J HEPATOL, V37, P78, DOI 10.1016/S0168-8278(02)00091-0; Mavroudis PD, 2013, J INNATE IMMUN, V5, P153, DOI 10.1159/000342427; MEEHAN R, 1993, J LEUKOCYTE BIOL, V54, P236, DOI 10.1002/jlb.54.3.236; Mehta SK, 2000, J INFECT DIS, V182, P1761, DOI 10.1086/317624; Mehta SK, 2004, J MED VIROL, V72, P174, DOI 10.1002/jmv.10555; Mermel LA, 2013, CLIN INFECT DIS, V56, P123, DOI 10.1093/cid/cis861; Morey-Holton E, 2005, ADV SPACE B, V10, P7, DOI 10.1016/S1569-2574(05)10002-1; Morey-Holton ER, 2002, J APPL PHYSIOL, V92, P1367, DOI 10.1152/japplphysiol.00969.2001; Musacchia X J, 1985, Physiologist, V28, pS237; NASH PV, 1991, EXP CELL RES, V195, P353, DOI 10.1016/0014-4827(91)90384-7; Nickerson CA, 2004, MICROBIOL MOL BIOL R, V68, P345, DOI 10.1128/MMBR.68.2.345-361.2004; Novikova N, 2006, RES MICROBIOL, V157, P5, DOI 10.1016/j.resmic.2005.07.010; Pierson DL, 2005, BRAIN BEHAV IMMUN, V19, P235, DOI 10.1016/j.bbi.2004.08.001; Romero-Weaver AL, 2013, RADIAT RES, V180, P177, DOI 10.1667/RR3055.1; Romero-Weaver AL, 2013, ASTROBIOLOGY, V13, P570, DOI 10.1089/ast.2012.0916; Romero-Weaver Ana L, 2012, Int J Biomed Sci, V8, P7; Sanzari JK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071757; Sastry KJ, 2001, IN VITRO CELL DEV-AN, V37, P203; Satomi M, 2006, INT J SYST EVOL MICR, V56, P1735, DOI 10.1099/ijs.0.64189-0; Secher T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073396; Shearer WT, 2005, J ALLERGY CLIN IMMUN, V115, P1297, DOI 10.1016/j.jaci.2005.03.003; Song B, 2005, MICROBIOL RES, V160, P111, DOI 10.1016/j.micres.2004.10.005; Sonnenfeld G, 1999, ADV SPACE RES, V23, P1945, DOI 10.1016/S0273-1177(99)00455-X; Sonnenfeld G, 2002, NUTRITION, V18, P899, DOI 10.1016/S0899-9007(02)00903-6; STEFFEN JM, 1986, AVIAT SPACE ENVIR MD, V57, P162; Stowe RP, 1999, J LEUKOCYTE BIOL, V65, P179, DOI 10.1002/jlb.65.2.179; TAYLOR GR, 1974, AEROSPACE MED, V45, P824; Vieira A, 2012, EUR J CLIN MICROBIOL, V31, P3241, DOI 10.1007/s10096-012-1691-x; Wainwright M, 1998, J ANTIMICROB CHEMOTH, V42, P13, DOI 10.1093/jac/42.1.13; Walker Clare, 2006, Curr Protoc Cytom, VChapter 6, DOI 10.1002/0471142956.cy0624s36; Wan XS, 2006, INT J RADIAT ONCOL, V64, P1475, DOI 10.1016/j.ijrobp.2005.11.024; Wang KX, 2007, P NATL ACAD SCI USA, V104, P14777, DOI 10.1073/pnas.0703236104; Ware JH, 2010, RADIAT RES, V174, P325, DOI 10.1667/RR1979.1; Yamauchi K, 2002, J APPL PHYSIOL, V93, P161, DOI 10.1152/japplphysiol.01084.2001	70	9	10	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2015	10	3							e0120126	10.1371/journal.pone.0120126	http://dx.doi.org/10.1371/journal.pone.0120126			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8IA	25793272	Green Published, gold, Green Submitted			2022-12-27	WOS:000352084200149
J	Chitra, S; Kumaratharan, N				Chitra, S.; Kumaratharan, N.			Intercarrier Interference Reduction in MC-CDMA System through Second Order Duobinary Coded Phase Rotated Conjugate Cancellation Scheme	PLOS ONE			English	Article							ICI REDUCTION; OFDM; TRANSMISSION; MITIGATION	Multi-carrier code division multiple access (MC-CDMA) technique is one of the strong candidates for next generation wireless mobile communication systems. Multi-carrier systems are very much sensitive to carrier frequency offset (CFO) results in intercarrier interference (ICI). To mitigate ICI without any spectral loss, a second order duobinary coded phase rotated conjugate cancellation algorithm is proposed in this paper. In the conventional phase rotated conjugate cancellation (PRCC) technique, one path carries the MC-CDMA signal with a phase spin of phi and the other path carries the conjugate of the first path signal with -phi phase spin. This artificial phase rotation allows the transmitter to tune the transmitted signals so that the ICI effects could be mutually cancelled at the receiver. Although the PRCC technique reduces the spectral efficiency, the limitation can be overcome by the joint second order duobinary coding scheme with PRCC technique. In the proposed method, the correlative coding between the binary symbols modulated on adjacent subcarriers is used to reduce the ICI without any spectral loss. Simulation results show that the proposed PRCC method provides better carrier to interference ratio (CIR) and bit error rate (BER) performances compared to the conventional conjugate cancellation (CC) technique.	[Chitra, S.] Rajalakshmi Engn Coll, Dept Elect & Commun Engn, Madras, Tamil Nadu, India; [Kumaratharan, N.] Sri Venkateswara Coll Engn, Dept Informat Technol, Madras, Tamil Nadu, India	Rajalakshmi Engineering College	Chitra, S (corresponding author), Rajalakshmi Engn Coll, Dept Elect & Commun Engn, Madras, Tamil Nadu, India.	chitraece80@gmail.com	Chitra, S./AAA-8906-2019; S, CHITRA/AAB-6253-2019; N, KUMARATHARAN/S-1774-2019	S, CHITRA/0000-0002-9161-5857; N, KUMARATHARAN/0000-0002-0097-3385				Dwivedi VK, 2012, IET COMMUN, V6, P599, DOI 10.1049/iet-com.2010.0870; Dwivedi VK, 2009, J INFRARED MILLIM TE, V30, P1170, DOI 10.1007/s10762-009-9543-1; Entesargemeay MK, 2011, INT J COMPUT ELECT E, V3, P130; Fazel K, 2008, MULTICARRIER SPREAD, P151; Hara S, 1997, IEEE COMMUN MAG, V35, P126, DOI 10.1109/35.642841; Khedr ME, 2010, INT CONF ADV COMMUN, P859; Lin KY, 2012, IEEE T BROADCAST, V58, P472, DOI 10.1109/TBC.2012.2197450; Mohseni S, 2012, INT J COMPUT SCI NET, V12, P472, DOI DOI 10.1109/90.87934318; Morelli M, 2014, IEEE T WIREL COMMUN, V13, P1582, DOI 10.1109/TWC.2014.011714.131271; Sanguinetti L, 2009, IEEE T WIREL COMMUN, V8, P5461, DOI 10.1109/TWC.2009.090236; Steendam H, 2001, IEEE J SEL AREA COMM, V19, P2528, DOI 10.1109/49.974617; Wang CL, 2010, IEEE T COMMUN, V58, P812, DOI 10.1109/TCOMM.2010.03.080288; Wen MW, 2014, IEEE T VEH TECHNOL, V63, P987, DOI 10.1109/TVT.2013.2277575; Yeh HG, 2007, IEEE T WIREL COMMUN, V6, P3, DOI 10.1109/TWC.2007.04541; Zhao YP, 2001, IEEE T COMMUN, V49, P1185, DOI 10.1109/26.935159	15	8	8	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2015	10	3							e0116326	10.1371/journal.pone.0116326	http://dx.doi.org/10.1371/journal.pone.0116326			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD9NQ	25790029	Green Published, Green Submitted, gold			2022-12-27	WOS:000351425400014
J	Davis, NE; Forsyth, DM; Triggs, B; Pascoe, C; Benshemesh, J; Robley, A; Lawrence, J; Ritchie, EG; Nimmo, DG; Lumsden, LF				Davis, Naomi E.; Forsyth, David M.; Triggs, Barbara; Pascoe, Charlie; Benshemesh, Joe; Robley, Alan; Lawrence, Jenny; Ritchie, Euan G.; Nimmo, Dale G.; Lumsden, Lindy F.			Interspecific and Geographic Variation in the Diets of Sympatric Carnivores: Dingoes/Wild Dogs and Red Foxes in South-Eastern Australia	PLOS ONE			English	Article							CANIS-LUPUS-DINGO; FLUCTUATING PREY POPULATIONS; VULPES-VULPES; WESTERN-AUSTRALIA; WILD DOGS; FEEDING ECOLOGY; GREY KANGAROOS; ARID AUSTRALIA; TOP-PREDATOR; BIODIVERSITY CONSERVATION	Dingoes/wild dogs (Canis dingo/familiaris) and red foxes (Vulpes vulpes) are widespread carnivores in southern Australia and are controlled to reduce predation on domestic livestock and native fauna. We used the occurrence of food items in 5875 dingo/wild dog scats and 11,569 fox scats to evaluate interspecific and geographic differences in the diets of these species within nine regions of Victoria, south-eastern Australia. The nine regions encompass a wide variety of ecosystems. Diet overlap between dingoes/wild dogs and foxes varied among regions, from low to near complete overlap. The diet of foxes was broader than dingoes/wild dogs in all but three regions, with the former usually containing more insects, reptiles and plant material. By contrast, dingoes/wild dogs more regularly consumed larger mammals, supporting the hypothesis that niche partitioning occurs on the basis of mammalian prey size. The key mammalian food items for dingoes/wild dogs across all regions were black wallaby (Wallabia bicolor), brushtail possum species (Trichosurus spp.), common wombat (Vombatus ursinus), sambar deer (Rusa unicolor), cattle (Bos taurus) and European rabbit (Oryctolagus cuniculus). The key mammalian food items for foxes across all regions were European rabbit, sheep (Ovis aries) and house mouse (Mus musculus). Foxes consumed 6.1 times the number of individuals of threatened Critical Weight Range native mammal species than did dingoes/wild dogs. The occurrence of intraguild predation was asymmetrical; dingoes/wild dogs consumed greater biomass of the smaller fox. The substantial geographic variation in diet indicates that dingoes/wild dogs and foxes alter their diet in accordance with changing food availability. We provide checklists of taxa recorded in the diets of dingoes/wild dogs and foxes as a resource for managers and researchers wishing to understand the potential impacts of policy and management decisions on dingoes/wild dogs, foxes and the food resources they interact with.	[Davis, Naomi E.; Forsyth, David M.] Univ Melbourne, Sch BioSci, Melbourne, Vic 3010, Australia; [Forsyth, David M.; Robley, Alan; Lumsden, Lindy F.] Arthur Rylah Inst Environm Res, Dept Environm Land Water & Planning, Heidelberg, Vic, Australia; [Triggs, Barbara] Dead Finish, Genoa, Vic, Australia; [Pascoe, Charlie] Parks Victoria, Bright, Vic, Australia; [Benshemesh, Joe] La Trobe Univ, Melbourne, Vic, Australia; [Lawrence, Jenny] Parks Victoria, Heyfield, Vic, Australia; [Ritchie, Euan G.; Nimmo, Dale G.] Deakin Univ, Ctr Integrat Ecol, Burwood, Vic, Australia; [Ritchie, Euan G.; Nimmo, Dale G.] Deakin Univ, Sch Life & Environm Sci, Burwood, Vic, Australia	University of Melbourne; Arthur Rylah Institute for Environmental Research (ARI); La Trobe University; Deakin University; Deakin University	Davis, NE (corresponding author), Univ Melbourne, Sch BioSci, Melbourne, Vic 3010, Australia.	ndavis@unimelb.edu.au	Ritchie, Euan/N-1088-2014	Ritchie, Euan/0000-0003-4410-8868; Forsyth, David/0000-0001-5356-9573; Lumsden, Lindy/0000-0002-4967-4626	Biosecurity Division of the Victorian Department of Environment and Primary Industries	Biosecurity Division of the Victorian Department of Environment and Primary Industries	The work presented was funded by the Biosecurity Division of the Victorian Department of Environment and Primary Industries (www.depi.vic.gov.au). The funder had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript, other than in the form of two of the authors being employees within the organization.	Abbott I., 2014, CARNIVORES AUSTR PRE, P69; Allen BL, 2012, WILDLIFE RES, V39, P35, DOI 10.1071/WR11128; Allen BL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036426; Allen Benjamin L., 2011, Ecological Management & Restoration, V12, P26, DOI 10.1111/j.1442-8903.2011.00571.x; Allen Benjamin L., 2010, Australian Mammalogy, V32, P207, DOI 10.1071/AM10012; Allen L. R., 2004, Sheep & Goat Research Journal, V19, P97; Allen L, 2012, RANGELAND J, V34, P211, DOI 10.1071/RJ11092; Amundsen PA, 1996, J FISH BIOL, V48, P607, DOI 10.1111/j.1095-8649.1996.tb01455.x; [Anonymous], 1995, CONSERVATION ATLAS P; ARNOLD GW, 1994, WILDLIFE RES, V21, P307, DOI 10.1071/WR9940307; Australian Government Bureau of Meteorology, 2014, VICT FOR AR MAP; Banks PB, 2000, AUSTRAL ECOL, V25, P283, DOI 10.1046/j.1442-9993.2000.01039.x; BELOVSKY GE, 1991, OECOLOGIA, V88, P521, DOI 10.1007/BF00317715; Breckwoldt R., 1988, VERY ELEGANT ANIMAL; Brook LA, 2011, RANGELAND J, V33, P79, DOI 10.1071/RJ10052; Brook LA, 2012, J APPL ECOL, V49, P1278, DOI 10.1111/j.1365-2664.2012.02207.x; BROWN G W, 1990, Australian Mammalogy, V13, P209; BRUNNER H, 1975, Australian Wildlife Research, V2, P147, DOI 10.1071/WR9750147; Brunner H., 1986, Victorian Naturalist (Blackburn), V103, P79; Burbidge A.A., 2014, P15; BURBIDGE AA, 1989, BIOL CONSERV, V50, P143, DOI 10.1016/0006-3207(89)90009-8; Caro TM, 2003, BIOL CONSERV, V110, P67, DOI 10.1016/S0006-3207(02)00177-5; CATLING PC, 1988, AUST WILDLIFE RES, V15, P307, DOI 10.1071/WR9880307; CAUGHLEY G, 1980, AUST WILDLIFE RES, V7, P1, DOI 10.1071/WR9800001; Choquenot D, 2013, OIKOS, V122, P1292, DOI 10.1111/j.1600-0706.2012.20976.x; Claridge A. W., 2014, CARNIVORES AUSTR PRE, P151; Claridge Andrew W., 2010, Australian Mammalogy, V32, P117, DOI 10.1071/AM09038; Coates T. D., 2003, Australian Mammalogy, V25, P107; COMAN B J, 1973, Australian Journal of Zoology, V21, P391, DOI 10.1071/ZO9730391; COMAN BJ, 1972, AUST VET J, V48, P456, DOI 10.1111/j.1751-0813.1972.tb02281.x; Conner MM, 1998, J WILDLIFE MANAGE, V62, P690, DOI 10.2307/3802345; Corbett L. K., 2001, DINGO AUSTR ASIA; CORBETT LK, 1987, OECOLOGIA, V74, P215, DOI 10.1007/BF00379362; Corbett LK, 1974, THESIS MONASH U; Courchamp F, 1999, J ANIM ECOL, V68, P282, DOI 10.1046/j.1365-2656.1999.00285.x; Cox JG, 2006, TRENDS ECOL EVOL, V21, P674, DOI 10.1016/j.tree.2006.07.011; Cozzi B, 2014, BRAIN BEHAV EVOLUT, V83, P9, DOI 10.1159/000356527; Creel S, 2001, CONSERV BIOL, V15, P271, DOI 10.1046/j.1523-1739.2001.99534.x; Crowther MS, 2014, J ZOOL, V293, P192, DOI 10.1111/jzo.12134; Cupples JB, 2011, J MAMMAL, V92, P590, DOI 10.1644/10-MAMM-A-164.1; Department of Environment and Primary Industries, 2013, ACT PLAN MAN WILD DO; Department of Environment and Primary Industries, 2014, VICT BIOD ATL; DeVault TL, 2003, OIKOS, V102, P225, DOI 10.1034/j.1600-0706.2003.12378.x; Dexter N, 2009, WILDLIFE RES, V36, P252, DOI 10.1071/WR08135; Diaz-Ruiz F, 2013, MAMMAL REV, V43, P59, DOI 10.1111/j.1365-2907.2011.00206.x; Dickman CR, 1996, WILDLIFE BIOL, V2, P185, DOI 10.2981/wlb.1996.018; DICKMAN CR, 1992, TRENDS ECOL EVOL, V7, P194, DOI 10.1016/0169-5347(92)90072-J; Duncan J. S., 1982, ATLAS OF VICTORIA; EDWARDS G P, 1975, Australian Mammalogy, V1, P307; Fedriani JM, 2000, OECOLOGIA, V125, P258, DOI 10.1007/s004420000448; Ferreras P, 2011, BASIC APPL ECOL, V12, P116, DOI 10.1016/j.baae.2011.01.005; Fleming P., 2001, MANAGING IMPACTS DIN; Fleming PJS, 2006, AUST J EXP AGR, V46, P753, DOI 10.1071/EA06009; Fleming PJS, 1986, P AUST SOC ANIM PROD, V16, P87; FLOYD TJ, 1978, J WILDLIFE MANAGE, V42, P528, DOI 10.2307/3800814; Forsyth DM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097937; Forsyth DM, 2012, WILDLIFE RES, V39, P555, DOI 10.1071/WR12033; Foster CN, 2014, J APPL ECOL, V51, P929, DOI 10.1111/1365-2664.12268; Friend GR, 1978, WILDLIFE RES, V5, P75; Gelin U, 2013, ANIM BEHAV, V86, P885, DOI 10.1016/j.anbehav.2013.08.016; GITTLEMAN JL, 1985, OECOLOGIA, V67, P540, DOI 10.1007/BF00790026; Gittleman JL, 2001, SCIENCE, V291, P997, DOI 10.1126/science.291.5506.997; Glen A. S., 2006, Australian Mammalogy, V28, P101; Glen AS, 2008, J APPL ECOL, V45, P700, DOI 10.1111/j.1365-2664.2007.01449.x; Glen AS, 2011, AUSTRAL ECOL, V36, P290, DOI 10.1111/j.1442-9993.2010.02149.x; Glen AS, 2005, BIOL REV, V80, P387, DOI 10.1017/S1464793105006718; Gormley AM, 2011, J APPL ECOL, V48, P25, DOI 10.1111/j.1365-2664.2010.01911.x; GOSZCZYNSKI J, 1974, Acta Theriologica, V19, P1; Grainger HJ, 1996, INT J PARASITOL, V26, P1263, DOI 10.1016/S0020-7519(96)00109-9; Green K, 2002, AUSTRAL ECOL, V27, P353, DOI 10.1046/j.1442-9993.2002.01187.x; Greentree C, 2000, J APPL ECOL, V37, P935, DOI 10.1046/j.1365-2664.2000.00530.x; Handasyde, 1999, KOALA NATURAL HIST C; Hornsby P.E., 1982, Australian Mammalogy, V5, P225; HURLBERT SH, 1978, ECOLOGY, V59, P67, DOI 10.2307/1936632; IUCN, 2013, IUCN RED LIST THREAT; Jacomo ATDA, 2004, J ZOOL, V262, P99; Jedrzejewska B., 1998, PREDATION VERTEBRATE; Jenkins DJ, 2003, PARASITOLOGY, V127, pS63, DOI 10.1017/S0031182003003871; Johnson C, 2006, AUSTR MAMMAL EXTINCT; Johnson CN, 2009, J APPL ECOL, V46, P641, DOI 10.1111/j.1365-2664.2009.01650.x; Johnson CN, 2007, P R SOC B, V274, P341, DOI 10.1098/rspb.2006.3711; Karanth KU, 2004, P NATL ACAD SCI USA, V101, P4854, DOI 10.1073/pnas.0306210101; Karanth KU, 2000, J ZOOL, V250, P255; Kinnear JE, 2002, BIOL CONSERV, V108, P335, DOI 10.1016/S0006-3207(02)00116-7; Klare U, 2011, MAMMAL REV, V41, P294, DOI 10.1111/j.1365-2907.2011.00183.x; Krebs C.J., 1999, ECOLOGICAL METHODOLO; Latham ADM, 2013, ECOGRAPHY, V36, P1276, DOI 10.1111/j.1600-0587.2013.00035.x; Leckie FM, 1998, ECOGRAPHY, V21, P599, DOI 10.1111/j.1600-0587.1998.tb00552.x; Letnic M., 2014, CARNIVORES AUSTR PRE, P53; Letnic M, 2013, OIKOS, V122, P761, DOI 10.1111/j.1600-0706.2012.20425.x; Letnic M, 2012, BIOL REV, V87, P390, DOI 10.1111/j.1469-185X.2011.00203.x; Letnic M, 2009, P ROY SOC B-BIOL SCI, V276, P3249, DOI 10.1098/rspb.2009.0574; Lobert B, 2001, WILDLIFE RES, V28, P637, DOI 10.1071/WR00124; LOCKIE J. D., 1959, JOUR WILDLIFE MANAGEMENT, V23, P224, DOI 10.2307/3797647; Lugton IW., 1993, RANGELAND J, V15, P39, DOI [10.1071/RJ9930039, DOI 10.1071/RJ9930039]; MARSACK P, 1990, AUST WILDLIFE RES, V17, P349, DOI 10.1071/WR9900349; McINTOSH D. L., 1963, C S I R O WILD LIFE RES, V8, P1; Mech LD., 1970, WOLF ECOLOGY BEHAV E; Menkhorst KA, 1995, MAMMALS VICTORIA DIS; Menkhorst P.W., 2011, FIELD GUIDE MAMMALS, V3rd; Meriggi A, 1996, J APPL ECOL, V33, P1561, DOI 10.2307/2404794; Meriggi A, 1996, ECOGRAPHY, V19, P287, DOI 10.1111/j.1600-0587.1996.tb00238.x; Miller EJ, 2010, REPROD FERT DEVELOP, V22, P539, DOI 10.1071/RD09061; Mitchell BD, 2005, AUSTRAL ECOL, V30, P581, DOI 10.1111/j.1442-9993.2005.01473.x; Moseby Katherine E., 2012, International Journal of Ecology, P1; NEWSOME AE, 1983, AUST WILDLIFE RES, V10, P477; NEWSOME AE, 1983, AUST J ECOL, V8, P345, DOI 10.1111/j.1442-9993.1983.tb01332.x; Newsome AE, 1989, FAUNA AUSTR B; Newsome TM, 2014, OECOLOGIA, V175, P139, DOI 10.1007/s00442-014-2889-7; Owen-Smith N, 2008, J ANIM ECOL, V77, P173, DOI 10.1111/j.1365-2656.2007.01314.x; Palomares F, 1999, AM NAT, V153, P492, DOI 10.1086/303189; Paltridge R, 2002, WILDLIFE RES, V29, P389, DOI 10.1071/WR00010; PAQUET PC, 1992, J MAMMAL, V73, P337, DOI 10.2307/1382067; Pascoe JH, 2011, AUST J ZOOL, V59, P295, DOI 10.1071/ZO11082; Planka E.R., 1973, Annual Rev Ecol Syst, V4, P53; Polisar J, 2003, BIOL CONSERV, V109, P297, DOI 10.1016/S0006-3207(02)00157-X; Pople AR, 2000, WILDLIFE RES, V27, P269, DOI 10.1071/WR99030; Ray JC, 2001, OECOLOGIA, V127, P395, DOI 10.1007/s004420000604; Read J, 2001, WILDLIFE RES, V28, P195, DOI 10.1071/WR99065; Reddiex B, 2006, WILDLIFE RES, V33, P691, DOI 10.1071/WR05102; REYNOLDS JC, 1991, MAMMAL REV, V21, P97, DOI 10.1111/j.1365-2907.1991.tb00113.x; Ripple WJ, 2014, SCIENCE, V343, P151, DOI 10.1126/science.1241484; Risbey DA, 1999, WILDLIFE RES, V26, P621; Ritchie EG, 2009, ECOL LETT, V12, P982, DOI 10.1111/j.1461-0248.2009.01347.x; ROBERTSHAW JD, 1985, AUST WILDLIFE RES, V12, P39; ROBERTSHAW JD, 1986, AUST WILDLIFE RES, V13, P141, DOI 10.1071/WR9860141; Rolls E.C., 1969, THEY ALL RAN WILD; Ruhe F, 2008, WILDLIFE BIOL, V14, P500, DOI 10.2981/0909-6396-14.4.500; Ruscoe WA, 2011, ECOL LETT, V14, P1035, DOI 10.1111/j.1461-0248.2011.01673.x; Salo P, 2007, P ROY SOC B-BIOL SCI, V274, P1237, DOI 10.1098/rspb.2006.0444; Salo P, 2010, ECOL MONOGR, V80, P531, DOI 10.1890/09-1260.1; Saunders G, 1999, WILDLIFE RES, V26, P335, DOI 10.1071/WR98056; Saunders G., 1995, MANAGING VERTEBRATE; Saunders GR, 2010, MAMMAL REV, V40, P181, DOI 10.1111/j.1365-2907.2010.00159.x; Savolainen P, 2004, P NATL ACAD SCI USA, V101, P12387, DOI 10.1073/pnas.0401814101; Scott Thos. G., 1943, ECOL MONOGR, V13, P427, DOI 10.2307/1948591; Selva N, 2005, CAN J ZOOL, V83, P1590, DOI 10.1139/Z05-158; Sheskin D., 2011, HDB PARAMETRIC NONPA, V5th; SHORT J, 1994, J MAMMAL, V75, P288, DOI 10.2307/1382547; Sinclair ARE, 2003, NATURE, V425, P288, DOI 10.1038/nature01934; Smith AP, 1996, BIOL CONSERV, V77, P243, DOI 10.1016/0006-3207(96)00002-X; Soule ME, 1989, CONSERV BIOL, V2, P75; Sweitzer RA, 1997, CONSERV BIOL, V11, P1407, DOI 10.1046/j.1523-1739.1997.96138.x; THOMSON PC, 1992, WILDLIFE RES, V19, P531, DOI 10.1071/WR9920531; Treves A, 2003, CONSERV BIOL, V17, P1491, DOI 10.1111/j.1523-1739.2003.00059.x; TRIGGS B, 1984, AUST WILDLIFE RES, V11, P491; Trites AW, 2005, J MAMMAL, V86, P704, DOI 10.1644/1545-1542(2005)086[0704:DAFFSH]2.0.CO;2; Van Valkenburgh B, 2004, SCIENCE, V306, P101, DOI 10.1126/science.1102417; Wallis RL., 1986, AUST MAMMAL, V10, P43; WEAVER JL, 1993, J WILDLIFE MANAGE, V57, P534, DOI 10.2307/3809278; White JG, 2006, WILDLIFE RES, V33, P175, DOI 10.1071/WR05037	151	53	59	0	190	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2015	10	3							e0120975	10.1371/journal.pone.0120975	http://dx.doi.org/10.1371/journal.pone.0120975			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD9NQ	25790230	Green Published, gold			2022-12-27	WOS:000351425400186
J	Franz, E; van Hoek, AHAM; Wuite, M; van der Wal, FJ; de Boer, AG; Bouw, EI; Aarts, HJM				Franz, Eelco; van Hoek, Angela H. A. M.; Wuite, Mark; van der Wal, Fimme J.; de Boer, Albert G.; Bouw, E. I.; Aarts, Henk J. M.			Molecular Hazard Identification of Non-O157 Shiga Toxin-Producing Escherichia coli (STEC)	PLOS ONE			English	Article							VIRULENCE FACTORS; 5'-NUCLEASE PCR; GENOMIC ISLAND; STRAINS; O157; GENE; RPOS; COLONIZATION; ASSOCIATION; UREASE	The complexity regarding Shiga toxin-producing Escherichia coli (STEC) in food safety enforcement as well as clinical care primarily relates to the current inability of an accurate risk assessment of individual strains due to the large variety in serotype and genetic content associated with (severe) disease. In order to classify the clinical and/or epidemic potential of a STEC isolate at an early stage it is crucial to identify virulence characteristics of putative pathogens from genomic information, which is referred to as 'predictive hazard identification'. This study aimed at identifying associations between virulence factors, phylogenetic groups, isolation sources and seropathotypes. Most non-O157 STEC in the Netherlands belong to phylogroup B1 and are characterized by the presence of ehxA, iha and stx(2), but absence of eae. The large variability in the number of virulence factors present among serogroups and seropathotypes demonstrated that this was merely indicative for the virulence potential. While all the virulence gene associations have been worked out, it appeared that there is no specific pattern that would unambiguously enable hazard identification for an STEC strain. However, the strong correlations between virulence factors indicate that these arrays are not a random collection but are rather specific sets. Especially the presence of eae was strongly correlated to the presence of many of the other virulence genes, including all non-LEE encoded effectors. Different stx-subtypes were associated with different virulence profiles. The factors ehxA and ureC were significantly associated with HUS-associated- strains (HAS) and not correlated to the presence of eae. This indicates their candidacy as important pathogenicity markers next to eae and stx(2)a.	[Franz, Eelco; van Hoek, Angela H. A. M.; Wuite, Mark; Bouw, E. I.; Aarts, Henk J. M.] Natl Inst Publ Hlth & Environm RIVM, Ctr Infect Dis Control, Bilthoven, Netherlands; [van der Wal, Fimme J.; de Boer, Albert G.] Wageningen Univ & Res Ctr, Cent Vet Inst, Lelystad, Netherlands	Netherlands National Institute for Public Health & the Environment; Wageningen University & Research	Franz, E (corresponding author), Natl Inst Publ Hlth & Environm RIVM, Ctr Infect Dis Control, Bilthoven, Netherlands.	eelco.franz@rivm.nl		van der Wal, Fimme/0000-0002-6859-1252	Ministry of Economic Affairs	Ministry of Economic Affairs	This work was funded by the Ministry of Economic Affairs. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andreoletti O, 2013, EFSA J, V11, DOI 10.2903/j.efsa.2013.3138; Battesti A, 2011, ANNU REV MICROBIOL, V65, P189, DOI 10.1146/annurev-micro-090110-102946; BEUTIN L, 1994, MED MICROBIOL IMMUN, V183, P13, DOI 10.1007/BF00193627; Bolton DJ, 2011, FOODBORNE PATHOG DIS, V8, P357, DOI 10.1089/fpd.2010.0699; Bosilevac JM, 2011, APPL ENVIRON MICROB, V77, P2103, DOI 10.1128/AEM.02833-10; Bugarel M, 2010, APPL ENVIRON MICROB, V76, P203, DOI 10.1128/AEM.01921-09; Buvens G, 2012, FOODBORNE PATHOG DIS, V9, P530, DOI 10.1089/fpd.2011.1073; Chaudhuri RR, 2012, INFECT GENET EVOL, V12, P214, DOI 10.1016/j.meegid.2012.01.005; Clermont O, 2000, APPL ENVIRON MICROB, V66, P4555, DOI 10.1128/AEM.66.10.4555-4558.2000; Coombes BK, 2011, FRONT MICROBIOL, V2; Coombes BK, 2008, APPL ENVIRON MICROB, V74, P2153, DOI 10.1128/AEM.02566-07; Dong T, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-349; Escobar-Paramo P, 2004, MOL BIOL EVOL, V21, P1085, DOI 10.1093/molbev/msh118; European Food Safety Authority, 2014, EFSA J, V12, DOI 10.2903/j.efsa.2014.3547; Fabich AJ, 2008, INFECT IMMUN, V76, P1143, DOI 10.1128/IAI.01386-07; Frankel G, 1998, MOL MICROBIOL, V30, P911, DOI 10.1046/j.1365-2958.1998.01144.x; Franz E, 2014, INT J FOOD MICROBIOL, V187, P57, DOI 10.1016/j.ijfoodmicro.2014.07.002; Friedrich AW, 2006, CLIN MICROBIOL INFEC, V12, P483, DOI 10.1111/j.1469-0691.2006.01379.x; Friesema I, 2014, EUROSURVEILLANCE, V19, P20787; Friesema IHM, 2013, INFECT B, V9, P285; Girardeau JP, 2005, J CLIN MICROBIOL, V43, P6098, DOI 10.1128/JCM.43.12.6098-6107.2005; Gould LH, 2013, FOODBORNE PATHOG DIS, V10, P453, DOI 10.1089/fpd.2012.1401; Grant M. A., 2011, Food Protection Trends, V31, P33; Imamovic L, 2010, INFECT IMMUN, V78, P4697, DOI 10.1128/IAI.00512-10; Johnson KE, 2006, CLIN INFECT DIS, V43, P1587, DOI 10.1086/509573; Ju WT, 2013, APPL ENVIRON MICROB, V79, P3406, DOI 10.1128/AEM.03661-12; Karmali MA, 2003, J CLIN MICROBIOL, V41, P4930, DOI 10.1128/JCM.41.11.4930-4940.2003; Karmali MA, 2010, VET MICROBIOL, V140, P360, DOI 10.1016/j.vetmic.2009.04.011; King T, 2004, J BACTERIOL, V186, P5614, DOI 10.1128/JB.186.17.5614-5620.2004; Krogfelt KA, 2000, INFECT IMMUN, V68, P2518, DOI 10.1128/IAI.68.5.2518-2524.2000; Mellmann A, 2008, EMERG INFECT DIS, V14, P1287, DOI 10.3201/eid1408.071082; Meric G, 2013, ENVIRON MICROBIOL, V15, P487, DOI 10.1111/j.1462-2920.2012.02852.x; Nakano M, 2001, J CLIN MICROBIOL, V39, P4541, DOI 10.1128/JCM.39.12.4541-4543.2001; Newton HJ, 2009, EMERG INFECT DIS, V15, P372, DOI [10.3201/eid1502.080631, 10.3201/eid1503.080631]; Nielsen EM, 2003, J CLIN MICROBIOL, V41, P2884, DOI 10.1128/JCM.41.7.2884-2893.2003; Nowrouzian FL, 2005, J INFECT DIS, V191, P1078, DOI 10.1086/427996; Paton AW, 2010, TOXINS, V2, P215, DOI 10.3390/toxins2020215; Paton AW, 2001, INFECT IMMUN, V69, P6999, DOI 10.1128/IAI.69.11.6999-7009.2001; Paton AW, 2002, J CLIN MICROBIOL, V40, P271, DOI 10.1128/JCM.40.1.271-274.2002; Paton AW, 2005, J CLIN MICROBIOL, V43, P2944, DOI 10.1128/JCM.43.6.2944-2947.2005; Perelle S, 2004, MOL CELL PROBE, V18, P185, DOI 10.1016/j.mcp.2003.12.004; Price SB, 2000, APPL ENVIRON MICROB, V66, P632, DOI 10.1128/AEM.66.2.632-637.2000; Ratajczak M, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-222; Scheutz F, 2012, J CLIN MICROBIOL, V50, P2951, DOI 10.1128/JCM.00860-12; Schmidt H, 1997, FEMS MICROBIOL LETT, V148, P265, DOI 10.1016/S0378-1097(97)00047-5; Schmidt H, 2001, INFECT IMMUN, V69, P6863, DOI 10.1128/IAI.69.11.6863-6873.2001; Skinner C, 2013, PLOS ONE, V8; Steyert SR, 2012, FRONT CELL INFECT MI, V2, DOI 10.3389/fcimb.2012.00133; Steyert SR, 2012, INFECT IMMUN, V80, P2589, DOI 10.1128/IAI.00210-12; Tarr PI, 2000, INFECT IMMUN, V68, P1400, DOI 10.1128/IAI.68.3.1400-1407.2000; Tzschoppe M, 2012, INT J FOOD MICROBIOL, V152, P19, DOI 10.1016/j.ijfoodmicro.2011.10.009; van Hoek AHAM, 2013, FEMS MICROBIOL LETT, V338, P18, DOI 10.1111/1574-6968.12024; Vanaja SK, 2010, APPL ENVIRON MICROB, V76, P60, DOI 10.1128/AEM.01666-09; White AP, 2011, APPL ENVIRON MICROB, V77, P7620, DOI 10.1128/AEM.05909-11; Yamamoto T, 1996, INFECT IMMUN, V64, P1441, DOI 10.1128/IAI.64.4.1441-1445.1996; Yin XH, 2009, APPL ENVIRON MICROB, V75, P5779, DOI 10.1128/AEM.00507-09	56	32	32	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2015	10	3							e0120353	10.1371/journal.pone.0120353	http://dx.doi.org/10.1371/journal.pone.0120353			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD9NQ	25789994	gold, Green Published, Green Submitted			2022-12-27	WOS:000351425400154
J	Guo, JC; Li, J; Zhao, YP; Zhou, L; Cui, QC; Zhou, WX; Zhang, TP; You, L				Guo, Jun-Chao; Li, Jian; Zhao, Yu-Pei; Zhou, Li; Cui, Quan-Cai; Zhou, Wei-Xun; Zhang, Tai-Ping; You, Lei			Expression of c-fos Was Associated with Clinicopathologic Characteristics and Prognosis in Pancreatic Cancer	PLOS ONE			English	Article							PREDICTS POOR-PROGNOSIS; LYMPH-NODE METASTASIS; CELL LUNG CARCINOMAS; DUCTAL ADENOCARCINOMA; PROGRESSION; SURVIVAL; PANCREATICODUODENECTOMY; RESECTION; INVASION; PROTEIN	It has long been regarded that pancreatic cancer (PC) is a life-threatening malignant tumor. Thus, much attention has been paid for factors, especially relative molecules, predictive for prognosis of PC. However, c-fos expression in PC was less investigated. In addition, its association with clinicopathologic variables and prognosis remains unknown. In the present study, expression of c-fos was detected by tissue microarray-based immunohistochemical staining in cancer and adjacent tissues from 333 patients with PC. The staining results were correlated with clinicopathologic parameters and overall survival. Furthermore, prognostic significance of c-fos in subsets of PC was also evaluated. It was shown that low expression of c-fos was more often in cancer than in adjacent tissues of PC (P<0.001). Besides, high cancerous c-fos expression was significantly associated with tumor site and T stage, whereas peri-neural invasion was of a borderline significant relevance. Log-rank test revealed that high expression of c-fos in cancer tissues was a significant marker of poor overall survival, accompanied by some conventional clinicopathologic variables, such as sex, grade, peri-neural invasion, T and N stages. More importantly, cancerous c-fos expression was identified as an independent prognosticator in multivariate analysis. Finally, the prognostic implication of c-fos expression was proven in four subsets of patients with PC. These data suggested that c-fos expression was of relationships with progression and dismal prognosis of PC.	[Guo, Jun-Chao; Li, Jian; Zhao, Yu-Pei; Zhou, Li; Zhang, Tai-Ping; You, Lei] Chinese Acad Med Sci, Dept Gen Surg, Peking Union Med Coll Hosp, Peking Union Med Coll, Beijing 100730, Peoples R China; [Cui, Quan-Cai; Zhou, Wei-Xun] Chinese Acad Med Sci, Peking Union Med Coll, Dept Pathol, Peking Union Med Coll Hosp, Beijing 100730, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Peking Union Medical College Hospital; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Peking Union Medical College Hospital	Zhao, YP (corresponding author), Chinese Acad Med Sci, Dept Gen Surg, Peking Union Med Coll Hosp, Peking Union Med Coll, Beijing 100730, Peoples R China.	zhao8028@263.net	Zhou, Li/GSE-4531-2022		National High Technology Research and Development Program (863 Program), China [2014AA020609]	National High Technology Research and Development Program (863 Program), China(National High Technology Research and Development Program of China)	This work was supported by National High Technology Research and Development Program (863 Program, 2014AA020609, http://program. most. gov.cn/), China. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akagi J, 1997, INVAS METAST, V17, P16; Andersen H, 2002, ONCOGENE, V21, P4843, DOI 10.1038/sj.onc.1205590; Ansari D, 2011, BRIT J SURG, V98, P1041, DOI 10.1002/bjs.7574; BLAND KI, 1995, ANN SURG, V221, P706, DOI 10.1097/00000658-199506000-00010; Briso EM, 2013, GENE DEV, V27, P1959, DOI 10.1101/gad.223339.113; Chatterjee D, 2012, AM J SURG PATHOL, V36, P552, DOI 10.1097/PAS.0b013e318240c1c0; Chatterjee D, 2012, AM J SURG PATHOL, V36, P409, DOI 10.1097/PAS.0b013e31824104c5; Distler M, 2013, INT J SURG, V11, P1067, DOI 10.1016/j.ijsu.2013.10.005; Gamberi G, 1998, ONCOLOGY-BASEL, V55, P556, DOI 10.1159/000011912; Guo JC, 2014, WORLD J SURG, V38, P2126, DOI 10.1007/s00268-014-2500-8; Hidalgo M, 2010, NEW ENGL J MED, V362, P1605, DOI 10.1056/NEJMra0901557; Jin SP, 2007, PATHOL ONCOL RES, V13, P284, DOI 10.1007/BF02940306; Kim JH, 2010, TUMOR BIOL, V31, P541, DOI 10.1007/s13277-010-0067-z; La Torre M, 2011, J SURG ONCOL, V104, P629, DOI 10.1002/jso.22013; Lee C. Soon, 1994, Zentralblatt fuer Pathologie, V140, P271; Li BW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057818; Li SQ, 2013, BIOCHEM BIOPH RES CO, V441, P976, DOI 10.1016/j.bbrc.2013.11.006; Ling SB, 2014, ONCOL LETT, V7, P1747, DOI 10.3892/ol.2014.2003; Mahner S, 2008, BRIT J CANCER, V99, P1269, DOI 10.1038/sj.bjc.6604650; Milde-Langosch K, 2005, EUR J CANCER, V41, P2449, DOI 10.1016/j.ejca.2005.08.008; Murakami Y, 2010, WORLD J SURG, V34, P1900, DOI 10.1007/s00268-010-0577-2; O'Donnell A, 2012, BIOCHEM SOC T, V40, P58, DOI 10.1042/BST20110636; Oliveira-Ferrer L, 2014, BRIT J CANCER, V110, P753, DOI 10.1038/bjc.2013.774; Poi MJ, 2013, BIOCHEM BIOPH RES CO, V436, P217, DOI 10.1016/j.bbrc.2013.05.078; Sakorafas G H, 1995, Eur J Surg Oncol, V21, P251, DOI 10.1016/S0748-7983(95)91294-0; Shi RZ, 2013, J CELL BIOCHEM, V114, P1890, DOI 10.1002/jcb.24533; Singh A, 1998, AM J CLIN ONCOL-CANC, V21, P466, DOI 10.1097/00000421-199810000-00009; Song B, 2013, MOL CANCER THER, V12, P58, DOI 10.1158/1535-7163.MCT-12-0632; Tao T, 2013, EUR J CANCER, V49, P3055, DOI 10.1016/j.ejca.2013.05.010; VOLM M, 1993, J CANCER RES CLIN, V119, P507, DOI 10.1007/BF01686458; Volm M, 1998, BRIT J CANCER, V77, P663, DOI 10.1038/bjc.1998.106; Winter JM, 2013, J SURG ONCOL, V107, P15, DOI 10.1002/jso.23192; Witkowski ER, 2013, J SURG ONCOL, V107, P97, DOI 10.1002/jso.23267; Zhang YJ, 2012, J GASTROINTEST SURG, V16, P1875, DOI 10.1007/s11605-012-1985-4; Zhou L, 2010, ARCH MED RES, V41, P201, DOI 10.1016/j.arcmed.2010.04.009	35	18	18	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2015	10	3							e0120332	10.1371/journal.pone.0120332	http://dx.doi.org/10.1371/journal.pone.0120332			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD9NQ	25789763	Green Published, gold, Green Submitted			2022-12-27	WOS:000351425400152
J	Lai, YC; Kao, CF; Lu, ML; Chen, HC; Chen, PY; Chen, CH; Shen, WW; Wu, JY; Lu, RB; Kuo, PH				Lai, Yin-Chieh; Kao, Chung-Feng; Lu, Mong-Liang; Chen, Hsi-Chung; Chen, Po-Yu; Chen, Chien-Hsiun; Shen, Winston W.; Wu, Jer-Yuarn; Lu, Ru-Band; Kuo, Po-Hsiu			Investigation of Associations between NR1D1, RORA and RORB Genes and Bipolar Disorder	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; MULTIFACTOR DIMENSIONALITY REDUCTION; ERB-ALPHA-GENE; CIRCADIAN-RHYTHMS; MOOD DISORDERS; CLOCK; SLEEP; POPULATION; DEPRESSION; EXPRESSION	Several genes that are involved in the regulation of circadian rhythms are implicated in the susceptibility to bipolar disorder (BD). The current study aimed to investigate the relationships between genetic variants in NR1D1 RORA, and RORB genes and BD in the Han Chinese population. We conducted a case-control genetic association study with two samples of BD patients and healthy controls. Sample I consisted of 280 BD patients and 200 controls. Sample II consisted of 448 BD patients and 1770 healthy controls. 27 single nucleotide polymorphisms in the NR1D1, RORA, and RORB genes were genotyped using GoldenGate VeraCode assays in sample I, and 492 markers in the three genes were genotyped using Affymetrix Genome-Wide CHB Array in sample II. Single marker and genebased association analyses were performed using PLINK. A combined p-value for the joining effects of all markers within a gene was calculated using the rank truncated product method. Multifactor dimensionality reduction (MDR) method was also applied to test gene-gene interactions in sample I. All markers were in Hardy-Weinberg equilibrium (P>0.001). In sample I, the associations with BD were observed for rs4774388 in RORA (OR = 1.53, empirical p-value, P = 0.024), and rs1327836 in RORB (OR = 1.75, P = 0.003). In Sample II, there were 45 SNPs showed associations with BD, and the most significant marker in RORA was rs11639084 (OR = 0.69, P = 0.002), and in RORB was rs17611535 (OR = 3.15, P = 0.027). A combined p-value of 1.6x10-6, 0.7, and 1.0 was obtained for RORA, RORB and NR1D1, respectively, indicting a strong association for RORA with the risk of developing BD. A four way interaction was found among markers in NR1D1, RORA, and RORB with the testing accuracy 53.25% and a cross-validation consistency of 8 out of 10. In sample II, 45 markers had empirical p-values less than 0.05. The most significant markers in RORA and RORB genes were rs11639084 (OR = 0.69, P = 0.002), and rs17611535 (OR = 3.15, P = 0.027), respectively. Gene-based association was significant for RORA gene (P = 0.0007). Our results support for the involvement of RORs genes in the risk of developing BD. Investigation of the functional properties of genes in the circadian pathway may further enhance our understanding about the pathogenesis of bipolar illness.	[Lai, Yin-Chieh; Kao, Chung-Feng; Kuo, Po-Hsiu] Natl Taiwan Univ, Coll Publ Hlth, Dept Publ Hlth, Taipei 10764, Taiwan; [Lai, Yin-Chieh; Kao, Chung-Feng; Kuo, Po-Hsiu] Natl Taiwan Univ, Coll Publ Hlth, Inst Epidemiol & Prevent Med, Taipei 10764, Taiwan; [Lu, Mong-Liang; Shen, Winston W.] Taipei Med Univ, Wan Fang Med Ctr, Dept Psychiat, Taipei, Taiwan; [Chen, Hsi-Chung] Natl Taiwan Univ Hosp, Dept Psychiat, Taipei, Taiwan; [Chen, Hsi-Chung] Natl Taiwan Univ Hosp, Ctr Sleep Disorders, Taipei, Taiwan; [Chen, Po-Yu] Taipei City Hosp, Taipei City Psychiat Ctr, Dept Psychiat, Taipei, Taiwan; [Chen, Chien-Hsiun; Wu, Jer-Yuarn] Acad Sinica, Inst Biomed Sci, Taipei, Taiwan; [Lu, Ru-Band] Natl Cheng Kung Univ Hosp, Dept Psychiat, Tainan 70428, Taiwan; [Kuo, Po-Hsiu] Natl Taiwan Univ, Res Ctr Genes Environm & Human Hlth, Taipei 10764, Taiwan	National Taiwan University; National Taiwan University; Taipei Medical University; Taipei Municipal WanFang Hospital; National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University Hospital; Taipei City Hospital; Academia Sinica - Taiwan; National Cheng Kung University; National Cheng Kung University Hospital; National Taiwan University	Kuo, PH (corresponding author), Natl Taiwan Univ, Coll Publ Hlth, Dept Publ Hlth, Taipei 10764, Taiwan.	phkuo@ntu.edu.tw	Chen, Hsi-Chung/E-9949-2017; Wu, Jer-Yuarn/S-7010-2018; Chen, Chien Hsiun/Q-3826-2018	Chen, Hsi-Chung/0000-0003-3191-0093; Lu, Mong-Liang/0000-0003-3184-6554; Kuo, Po-Hsiu/0000-0003-0365-3587	National Science Council [NSC 99-2314-B-002-140-MY3, NSC 102-2314-B-002-117-MY3]; National Health Research Institute [NHRI-EX101-9918NC]	National Science Council(Ministry of Science and Technology, Taiwan); National Health Research Institute(National Health Research Institutes - Taiwan)	This research was supported by National Science Council (NSC 99-2314-B-002-140-MY3, NSC 102-2314-B-002-117-MY3) and National Health Research Institute (NHRI-EX101-9918NC) Grants to Dr.P.-H. Kuo (PI). The funding sources had no further role in the study design, collection, analysis, or interpretation of data; in writing of the report; and in the decision to submit the paper for publication.	Akashi M, 2005, NAT STRUCT MOL BIOL, V12, P441, DOI 10.1038/nsmb925; Baum AE, 2008, MOL PSYCHIATR, V13, P197, DOI 10.1038/sj.mp.4002012; Benedetti F, 2007, AM J MED GENET B, V144B, P631, DOI 10.1002/ajmg.b.30475; Borenstein M., 2005, COMPREHENSIVE META A; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Campos-de-Sousa S, 2010, J BIOL RHYTHM, V25, P132, DOI 10.1177/0748730410362713; Edvardsen J, 2008, J AFFECT DISORDERS, V106, P229, DOI 10.1016/j.jad.2007.07.001; Ferreira MAR, 2008, NAT GENET, V40, P1056, DOI 10.1038/ng.209; Giguere V, 1999, ENDOCR REV, V20, P689, DOI 10.1210/er.20.5.689; Hahn LW, 2003, BIOINFORMATICS, V19, P376, DOI 10.1093/bioinformatics/btf869; Harvey AG, 2006, DEV PSYCHOPATHOL, V18, P1147, DOI 10.1017/S095457940606055X; Jetten Anton M, 2009, Nucl Recept Signal, V7, pe003, DOI 10.1621/nrs.07003; Kessler RC, 2004, INT J METH PSYCH RES, V13, P93, DOI 10.1002/mpr.168; King DP, 2000, ANNU REV NEUROSCI, V23, P713, DOI 10.1146/annurev.neuro.23.1.713; Kishi T, 2008, NEUROSCI RES, V62, P211, DOI 10.1016/j.neures.2008.08.008; Klein PS, 1996, P NATL ACAD SCI USA, V93, P8455, DOI 10.1073/pnas.93.16.8455; Kripke Daniel F, 2009, J Circadian Rhythms, V7, P2, DOI 10.1186/1740-3391-7-2; Le Hir H, 2003, TRENDS BIOCHEM SCI, V28, P215, DOI 10.1016/S0968-0004(03)00052-5; Le-Niculescu H, 2008, AM J MED GENET B, V147B, P134, DOI 10.1002/ajmg.b.30707; Le-Niculescu H, 2009, AM J MED GENET B, V150B, P155, DOI 10.1002/ajmg.b.30887; Lee MTM, 2011, MOL PSYCHIATR, V16, P548, DOI 10.1038/mp.2010.43; Liu AC, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000023; Mansour HA, 2009, BIPOLAR DISORD, V11, P701, DOI 10.1111/j.1399-5618.2009.00756.x; McGrath CL, 2009, BMC PSYCHIATRY, V9, DOI 10.1186/1471-244X-9-70; Merikangas KR, 2011, ARCH GEN PSYCHIAT, V68, P241, DOI 10.1001/archgenpsychiatry.2011.12; Moore JH, 2004, EXPERT REV MOL DIAGN, V4, P795, DOI 10.1586/14737159.4.6.795; Murray G, 2010, BIPOLAR DISORD, V12, P459, DOI 10.1111/j.1399-5618.2010.00843.x; Pan WH, 2006, HUM HERED, V61, P27, DOI 10.1159/000091834; Perlman CA, 2006, BIPOLAR DISORD, V8, P271, DOI 10.1111/j.1399-5618.2006.00330.x; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Reppert SM, 2002, NATURE, V418, P935, DOI 10.1038/nature00965; Ritchie MD, 2003, GENET EPIDEMIOL, V24, P150, DOI 10.1002/gepi.10218; Serretti A, 2003, AM J MED GENET B, V121B, P35, DOI 10.1002/ajmg.b.20053; Severino G, 2009, BIPOLAR DISORD, V11, P215, DOI 10.1111/j.1399-5618.2009.00667.x; Shi JJ, 2008, AM J MED GENET B, V147B, P1047, DOI 10.1002/ajmg.b.30714; Sklar P, 2008, MOL PSYCHIATR, V13, P558, DOI 10.1038/sj.mp.4002151; Smith EN, 2009, MOL PSYCHIATR, V14, P755, DOI 10.1038/mp.2009.43; Solt LA, 2010, CURR OPIN LIPIDOL, V21, P204, DOI 10.1097/MOL.0b013e328338ca18; Soria V, 2010, NEUROPSYCHOPHARMACOL, V35, P1279, DOI 10.1038/npp.2009.230; Tsai HC, 2012, J AFFECT DISORDERS, V136, P81, DOI 10.1016/j.jad.2011.08.015; Ueda HR, 2002, NATURE, V418, P534, DOI 10.1038/nature00906; Utge SJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009259; Yang XY, 2006, CELL, V126, P801, DOI 10.1016/j.cell.2006.06.050; Yin L, 2006, SCIENCE, V311, P1002, DOI 10.1126/science.1121613; Zaykin DV, 2002, GENET EPIDEMIOL, V22, P170, DOI 10.1002/gepi.0042; Zheng G, 2003, ANN HUM GENET, V67, P589, DOI 10.1046/j.1529-8817.2003.00065.x	46	21	21	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2015	10	3							e0121245	10.1371/journal.pone.0121245	http://dx.doi.org/10.1371/journal.pone.0121245			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD9NQ	25789810	Green Published, gold, Green Submitted			2022-12-27	WOS:000351425400193
J	Ngunjiri, JM; Ali, A; Boyaka, P; Marcus, PI; Lee, CW				Ngunjiri, John M.; Ali, Ahmed; Boyaka, Prosper; Marcus, Philip I.; Lee, Chang-Won			In Vivo Assessment of NS1-Truncated Influenza Virus with a Novel SLSYSINWRH Motif as a Self-Adjuvanting Live Attenuated Vaccine	PLOS ONE			English	Article							A VIRUS; NS1 PROTEIN; IMMUNE-RESPONSE; T-CELLS; INFECTION; IFN; SUBPOPULATIONS; DIMERIZATION; PREVENTION; INDUCTION	Mutants of influenza virus that encode C-terminally truncated NS1 proteins (NS1-truncated mutants) characteristically induce high interferon responses. The dual activity of interferon in blocking virus replication and enhancing the development of adaptive immune responses makes these mutants promising as self-adjuvanting live-attenuated influenza vaccine (LAIV) candidates. Yet, among the NS1-truncated mutants, the length of NS1 is not directly correlated with the interferon-inducing efficiency, the level of attenuation, or effectiveness as LAIV. Using quantitative in vitro biologically active particle subpopulation analysis as a tool to identify potential LAIV candidates from a pool of NS1-truncated mutants, we previously predicted that a NS1-truncated mutant pc2, which was less effective as a LAIV in chickens, would be sufficiently effective as a LAIV in mammalian hosts. In this study, we confirmed that pc2 protected mice and pigs against heterologous virus challenge in terms of preventing clinical signs and reducing virus shedding. pc2 expresses a unique SLSYSINWRH motif at the C-terminus of its truncated NS1. Deletion of the SLSYSINWRH motif led to similar to 821-fold reduction in the peak yield of type I interferon induced in murine cells. Furthermore, replacement of the SLSYSINWRH motif with the wildtype MVKMDQAIMD sequence did not restore the interferon-inducing efficiency. The diminished interferon induction capacity in the absence of the SLSYSINWRH motif was similar to that observed in other mutants which are less effective LAIV candidates. Remarkably, pc2 induced 16-fold or more interferon in human lung and monkey kidney cells compared to the temperature-sensitive, cold-adapted Ann Arbor virus that is currently used as a master backbone for LAIVs such as FluMist. Although the mechanism by which the SLSYSINWRH motif regulates the vaccine properties of pc2 has not been elucidated, this motif has potential use in engineering self-adjuvanting NS1-truncated-based LAIVs.	[Ngunjiri, John M.; Marcus, Philip I.] Univ Connecticut, Dept Mol & Cell Biol, Storrs, CT USA; [Ngunjiri, John M.; Lee, Chang-Won] Ohio State Univ, Food Anim Hlth Res Program, Wooster, OH 44691 USA; [Ali, Ahmed] Beni Suef Univ, Dept Poultry Dis, Fac Vet Med, Bani Suwayf 62511, Egypt; [Ali, Ahmed; Lee, Chang-Won] Ohio State Univ, Dept Prevent Med, Columbus, OH 43210 USA; [Boyaka, Prosper] Ohio State Univ, Dept Vet Biosci, Columbus, OH 43210 USA	University of Connecticut; University System of Ohio; Ohio State University; Egyptian Knowledge Bank (EKB); Beni Suef University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University	Lee, CW (corresponding author), Ohio State Univ, Food Anim Hlth Res Program, Wooster, OH 44691 USA.	lee.2854@osu.edu	Ali, Ahmed/B-5108-2013; Ngunjiri, John/AAB-3798-2021	Ali, Ahmed/0000-0002-2576-2031; Ngunjiri, John/0000-0002-2131-1698; Boyaka, Prosper/0000-0001-6857-9088	Ohio Agricultural Research and Development Center, The Ohio State University [2012009]; NIH [R01 AI04197]	Ohio Agricultural Research and Development Center, The Ohio State University(Ohio State University); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This study was partially supported by the SEEDS fund (2012009) from the Ohio Agricultural Research and Development Center, The Ohio State University, a donation to the University of Connecticut's Virus and Interferon Research Laboratory, and NIH grant R01 AI04197. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali A, 2011, J CLIN MICROBIOL, V49, P4101, DOI 10.1128/JCM.05415-11; Ayllon J, 2012, J VIROL, V86, P13095, DOI 10.1128/JVI.02237-12; BEAN WJ, 1985, J VIROL, V54, P151, DOI 10.1128/JVI.54.1.151-160.1985; Beigel H, 2005, NEW ENGL J MED, V353, P1374, DOI 10.1056/NEJMra052211; Bornholdt ZA, 2008, NATURE, V456, P985, DOI 10.1038/nature07444; Bracci L, 2006, VACCINE, V24, pS56, DOI 10.1016/j.vaccine.2005.01.121; Bracci L, 2005, VACCINE, V23, P2994, DOI 10.1016/j.vaccine.2004.12.006; Capua I, 2002, ACTA TROP, V83, P7, DOI 10.1016/S0001-706X(02)00057-8; Cyranoski D, 2001, NATURE, V412, P261, DOI 10.1038/35085715; de Veer MJ, 2001, J LEUKOCYTE BIOL, V69, P912; EDWARDS KM, 1994, J INFECT DIS, V169, P68, DOI 10.1093/infdis/169.1.68; Fouchier RAM, 2004, P NATL ACAD SCI USA, V101, P1356, DOI 10.1073/pnas.0308352100; Garcia-Sastre A, 1998, VIROLOGY, V252, P324, DOI 10.1006/viro.1998.9508; GORSE GJ, 1995, J INFECT DIS, V172, P1, DOI 10.1093/infdis/172.1.1; Kochs G, 2007, J GEN VIROL, V88, P1403, DOI 10.1099/vir.0.82764-0; Kochs G, 2009, J GEN VIROL, V90, P2990, DOI 10.1099/vir.0.015727-0; LaMere MW, 2011, J IMMUNOL, V186, P4331, DOI 10.4049/jimmunol.1003057; Le Bon A, 2003, NAT IMMUNOL, V4, P1009, DOI 10.1038/ni978; Le Bon A, 2002, CURR OPIN IMMUNOL, V14, P432, DOI 10.1016/S0952-7915(02)00354-0; Le Bon A, 2001, IMMUNITY, V14, P461, DOI 10.1016/S1074-7613(01)00126-1; Le Bon A, 2006, J IMMUNOL, V176, P4682, DOI 10.4049/jimmunol.176.8.4682; Lee CW, 2014, METHODS MOL BIOL, V1161, P37, DOI 10.1007/978-1-4939-0758-8_4; Marcus PI, 2010, J VIROL, V84, P10974, DOI 10.1128/JVI.00502-10; Marcus PI, 2009, J VIROL, V83, P8122, DOI 10.1128/JVI.02680-08; Marcus PI, 2005, J VIROL, V79, P2880, DOI 10.1128/JVI.79.5.2880-2890.2005; Molinari NAM, 2007, VACCINE, V25, P5086, DOI 10.1016/j.vaccine.2007.03.046; Mueller SN, 2010, J VIROL, V84, P1847, DOI 10.1128/JVI.01317-09; Nagao Y, 1998, J INTERF CYTOK RES, V18, P661, DOI 10.1089/jir.1998.18.661; Nelson KM, 1998, VACCINE, V16, P1306, DOI 10.1016/S0264-410X(98)00009-7; NEMEROFF ME, 1995, VIROLOGY, V212, P422, DOI 10.1006/viro.1995.1499; Neumann G, 2011, INFLUENZA OTHER RESP, V5, P157, DOI 10.1111/j.1750-2659.2011.00231.x; Ngunjiri JM, 2012, NAT MED, V18, P1456, DOI 10.1038/nm.2879; Ngunjiri JM, 2012, J INTERF CYTOK RES, V32, P280, DOI 10.1089/jir.2011.0102; Ohmit SE, 2006, NEW ENGL J MED, V355, P2513, DOI 10.1056/NEJMoa061850; Osterholm MT, 2012, LANCET INFECT DIS, V12, P36, DOI 10.1016/S1473-3099(11)70295-X; Palese P, 2002, J CLIN INVEST, V110, P9, DOI 10.1172/JCI200215999; Powell TJ, 2007, J IMMUNOL, V178, P1030, DOI 10.4049/jimmunol.178.2.1030; Proietti E, 2002, J IMMUNOL, V169, P375, DOI 10.4049/jimmunol.169.1.375; Quinlivan M, 2005, J VIROL, V79, P8431, DOI 10.1128/JVI.79.13.8431-8439.2005; Richt JA, 2009, CURR TOP MICROBIOL, V333, P177, DOI 10.1007/978-3-540-92165-3_9; Salvatore M, 2002, J VIROL, V76, P1206, DOI 10.1128/JVI.76.3.1206-1212.2002; Solorzano A, 2005, J VIROL, V79, P7535, DOI 10.1128/JVI.79.12.7535-7543.2005; Staats HF, 2001, J IMMUNOL, V167, P5386, DOI 10.4049/jimmunol.167.9.5386; Steel J, 2009, J VIROL, V83, P1742, DOI 10.1128/JVI.01920-08; Tang Y, 2005, AVIAN DIS, V49, P207, DOI 10.1637/7288-101304R; Van Reeth K, 2013, CURR TOP MICROBIOL, V370, P173, DOI 10.1007/82_2012_266; Vincent AL, 2008, ADV VIRUS RES, V72, P127, DOI 10.1016/S0065-3527(08)00403-X; Wang L, 2008, VACCINE, V26, P3580, DOI 10.1016/j.vaccine.2008.05.001; Wang XY, 2002, J VIROL, V76, P12951, DOI 10.1128/JVI.76.24.12951-12962.2002	49	6	6	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2015	10	3							e0118934	10.1371/journal.pone.0118934	http://dx.doi.org/10.1371/journal.pone.0118934			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD9NQ	25790187	Green Submitted, Green Published, gold			2022-12-27	WOS:000351425400056
J	Taylor, NJ; Busam, KJ; From, L; Groben, PA; Anton-Culver, H; Cust, AE; Begg, CB; Dwyer, T; Gallagher, RP; Gruber, SB; Orlow, I; Rosso, S; Thomas, NE; Zanetti, R; Rebbeck, TR; Berwick, M; Kanetsky, PA				Taylor, Nicholas J.; Busam, Klaus J.; From, Lynn; Groben, Pamela A.; Anton-Culver, Hoda; Cust, Anne E.; Begg, Colin B.; Dwyer, Terence; Gallagher, Richard P.; Gruber, Stephen B.; Orlow, Irene; Rosso, Stefano; Thomas, Nancy E.; Zanetti, Roberto; Rebbeck, Timothy R.; Berwick, Marianne; Kanetsky, Peter A.			Inherited Variation at MC1R and Histological Characteristics of Primary Melanoma	PLOS ONE			English	Article							MELANOCORTIN 1 RECEPTOR; PRIMARY CUTANEOUS MELANOMA; STAGE-I MELANOMA; RISK PHENOTYPES; CANCER RISK; HAIR COLOR; SKIN TYPE; RED HAIR; POPULATION; GENE	Variation in the melanocortin-1receptor (MC1R) gene is associated with pigmentary phenotypes and risk of malignant melanoma. Few studies have reported on MC1R variation with respect to tumor characteristics, especially clinically important prognostic features. We examined associations between MC1R variants and histopathological melanoma characteristics. Study participants were enrolled from nine geographic regions in Australia, Canada, Italy and the United States and were genotyped for MC1R variants classified as high-risk [R] (D84E, R142H, R151C, R160W, and D294H, all nonsense and insertion/deletion) or low-risk [r] (all other nonsynonymous) variants. Tissue was available for 2,160 white participants of the Genes, Environment and Melanoma (GEM) Study with a first incident primary melanoma diagnosis, and underwent centralized pathologic review. No statistically significant associations were observed between MC1R variants and AJCC established prognostic tumor characteristics: Breslow thickness, presence of mitoses or presence of ulceration. However, MC1R was significantly associated with anatomic site of melanoma (p = 0.002) and a positive association was observed between carriage of more than one [ R] variant and melanomas arising on the arms (OR = 2.39; 95% CI: 1.40, 4.09). We also observed statistically significant differences between sun-sensitive and sun-resistant individuals with respect to associations between MC1R genotype and AJCC prognostic tumor characteristics. Our results suggest inherited variation in MC1R may play an influential role in anatomic site presentation of melanomas and may differ with respect to skin pigmentation phenotype.	[Taylor, Nicholas J.; Kanetsky, Peter A.] Univ S Florida, H Lee Moffitt Canc Ctr, Dept Canc Epidemiol, Tampa, FL 33682 USA; [Busam, Klaus J.] Mem Sloan Kettering Canc Ctr, Dept Pathol, New York, NY 10021 USA; [From, Lynn] Womens Coll Hosp, Toronto, ON, Canada; [Groben, Pamela A.] Univ N Carolina, Lineberger Comprehens Canc Ctr, Dept Dermatol, Chapel Hill, NC 27599 USA; [Groben, Pamela A.] Univ N Carolina, Lineberger Comprehens Canc Ctr, Dept Pathol, Chapel Hill, NC 27599 USA; [Groben, Pamela A.] Univ N Carolina, Lineberger Comprehens Canc Ctr, Dept Lab Med, Chapel Hill, NC 27599 USA; [Anton-Culver, Hoda] Univ Calif Irvine, Dept Epidemiol, Irvine, CA USA; [Cust, Anne E.] Univ Sydney, Sydney Sch Publ Hlth, Sydney, NSW 2006, Australia; [Begg, Colin B.; Orlow, Irene] Mem Sloan Kettering Canc Ctr, Dept Epidemiol & Biostat, New York, NY 10021 USA; [Dwyer, Terence] Int Agcy Res Canc, F-69372 Lyon, France; [Gallagher, Richard P.] British Columbia Canc Agcy, Vancouver, BC V5Z 4E6, Canada; [Gruber, Stephen B.] Univ So Calif, Kenneth Norris Jr Comprehens Canc Ctr, Keck Sch Med, Los Angeles, CA 90033 USA; [Rosso, Stefano; Zanetti, Roberto] Piedmont Tumor Registry, Turin, Italy; [Thomas, Nancy E.] Univ N Carolina, Lineberger Comprehens Canc Ctr, Dept Dermatol, Chapel Hill, NC 27599 USA; [Rebbeck, Timothy R.] Univ Penn, Ctr Clin Epidemiol & Biostat, Perelman Sch Med, Philadelphia, PA 19104 USA; [Rebbeck, Timothy R.] Univ Penn, Perelman Sch Med, Abramson Canc Ctr, Philadelphia, PA 19104 USA; [Berwick, Marianne] Univ New Mexico, Dept Internal Med, Albuquerque, NM 87131 USA; [Berwick, Marianne] Univ New Mexico, Dept Dermatol, Albuquerque, NM 87131 USA	H Lee Moffitt Cancer Center & Research Institute; State University System of Florida; University of South Florida; Memorial Sloan Kettering Cancer Center; University of Toronto; University Toronto Affiliates; Womens College Hospital; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of California System; University of California Irvine; University of Sydney; Memorial Sloan Kettering Cancer Center; World Health Organization; International Agency for Research on Cancer (IARC); British Columbia Cancer Agency; University of Southern California; University of North Carolina; University of North Carolina Chapel Hill; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; University of New Mexico; University of New Mexico	Kanetsky, PA (corresponding author), Univ S Florida, H Lee Moffitt Canc Ctr, Dept Canc Epidemiol, Tampa, FL 33682 USA.	peter.kanetsky@moffitt.org	Rebbeck, Timothy/GLU-8348-2022; Cust, Anne/J-1797-2019; Taylor, Nicholas/B-7960-2018	Rebbeck, Timothy/0000-0002-4799-1900; Cust, Anne/0000-0002-5331-6370; Taylor, Nicholas/0000-0003-4811-8529; Orlow, Irene/0000-0001-6234-6961; Berwick, Marianne/0000-0001-5062-2180	National Cancer Institute, US [U01CA83180, R01CA112524, P30CA008748, R01CA112243, R01CA112243S1, R01CA112524S2, R01CA098438, R25CA147832]; University of Sydney Medical Foundation Program; Michael Smith Foundation for Health Research Infrastructure Award; NATIONAL CANCER INSTITUTE [R01CA163251, R25CA147832, U01CA083180, R01CA112243, P30CA008748, R01CA112524, R01CA098438] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES010126] Funding Source: NIH RePORTER	National Cancer Institute, US(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); University of Sydney Medical Foundation Program(University of Sydney); Michael Smith Foundation for Health Research Infrastructure Award(Michael Smith Foundation for Health Research); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	Results presented in this report represent work from the Genes, Environment, and Melanoma (GEM) Study that was funded by the following grant awards: U01CA83180 (MB), R01CA112524 (MB), P30CA008748 (CBB), R01CA112243 (NET), R01CA112243S1 (NET), R01CA112524S2 (NET), and R01CA098438 (CBB) from the National Cancer Institute, US, the University of Sydney Medical Foundation Program, and by the Michael Smith Foundation for Health Research Infrastructure Award (RPG). NJT is supported by a training award R25CA147832 from the National Cancer Institute, US. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Azzola MF, 2003, CANCER-AM CANCER SOC, V97, P1488, DOI 10.1002/cncr.11196; Balch CM, 2009, J CLIN ONCOL, V27, P6199, DOI 10.1200/JCO.2009.23.4799; Barnhill RL, 1996, CANCER-AM CANCER SOC, V78, P427; Begg CB, 2004, CANCER CAUSE CONTROL, V15, P957, DOI 10.1007/s10552-004-2474-1; Begg CB, 2006, INT J EPIDEMIOL, V35, P756, DOI 10.1093/ije/dyl044; Callender GG, 2011, AM J SURG, V202, P659, DOI 10.1016/j.amjsurg.2011.06.048; CLARK WH, 1969, CANCER RES, V29, P705; CLARK WH, 1989, JNCI-J NATL CANCER I, V81, P1893, DOI 10.1093/jnci/81.24.1893; Cust AE, 2012, INT J CANCER, V131, pE269, DOI 10.1002/ijc.27357; DAY CL, 1981, AM J SURG, V142, P247, DOI 10.1016/0002-9610(81)90286-5; Debniak T, 2006, INT J CANCER, V119, P2597, DOI 10.1002/ijc.22210; Flanagan N, 2000, HUM MOL GENET, V9, P2531, DOI 10.1093/hmg/9.17.2531; Gimotty PA, 2007, J CLIN ONCOL, V25, P1129, DOI 10.1200/JCO.2006.08.1463; Hoiom V, 2009, PIGM CELL MELANOMA R, V22, P196, DOI 10.1111/j.1755-148X.2008.00526.x; Ichii-Jones F, 1998, J INVEST DERMATOL, V111, P218, DOI 10.1046/j.1523-1747.1998.00287.x; Kanetsky PA, 2004, CANCER EPIDEM BIOMAR, V13, P808; Kanetsky PA, 2006, CANCER RES, V66, P9330, DOI 10.1158/0008-5472.CAN-06-1634; Kanetsky PA, 2010, CANCER-AM CANCER SOC, V116, P2416, DOI 10.1002/cncr.24994; Kennedy C, 2001, J INVEST DERMATOL, V117, P294, DOI 10.1046/j.0022-202x.2001.01421.x; MCGOVERN VJ, 1973, CANCER, V32, P1446, DOI 10.1002/1097-0142(197312)32:6<1446::AID-CNCR2820320623>3.0.CO;2-8; Mervic L, 2012, ACTA DERMATOVEN ALP, V21, P27, DOI 10.2478/v10162-012-0008-1; Millikan RC, 2006, CARCINOGENESIS, V27, P610, DOI 10.1093/carcin/bgi252; Pasquali E, 2014, INT J CANC; Pena-Vilabelda MM, 2014, ACTAS DERMO-SIFILOGR, V105, P159, DOI 10.1016/j.ad.2013.10.001; Raimondi S, 2008, INT J CANCER, V122, P2753, DOI 10.1002/ijc.23396; Schioth HB, 1999, BIOCHEM BIOPH RES CO, V260, P488, DOI 10.1006/bbrc.1999.0935; Stratigos AJ, 2006, J INVEST DERMATOL, V126, P1842, DOI 10.1038/sj.jid.5700292; Sturm RA, 2003, PIGM CELL RES, V16, P266, DOI 10.1034/j.1600-0749.2003.00041.x; Thomas NE, 2013, J CLIN ONCOL, V31, P4252, DOI 10.1200/JCO.2013.51.3002; Williams PF, 2011, INT J CANCER, V129, P1730, DOI 10.1002/ijc.25804	30	21	21	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2015	10	3							e0119920	10.1371/journal.pone.0119920	http://dx.doi.org/10.1371/journal.pone.0119920			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD9NQ	25790105	Green Published, gold			2022-12-27	WOS:000351425400115
J	do Rego, JL; Vaudry, D; Vaudry, H				do Rego, Jean Luc; Vaudry, David; Vaudry, Hubert			The Non-Benzodiazepine Anxiolytic Drug Etifoxine Causes a Rapid, Receptor-Independent Stimulation of Neurosteroid Biosynthesis	PLOS ONE			English	Article							PERIPHERAL BENZODIAZEPINE-RECEPTOR; PROTEIN 18 KDA; SEROTONIN REUPTAKE INHIBITORS; 17,20 LYASE ACTIVITY; BIOLOGICAL-ACTIVITY; NERVOUS-SYSTEM; IMMUNOCYTOCHEMICAL LOCALIZATION; OCTADECANEUROPEPTIDE ODN; SERINE PHOSPHORYLATION; PROGESTERONE SYNTHESIS	Neurosteroids can modulate the activity of the GABAA receptors, and thus affect anxiety-like behaviors. The non-benzodiazepine anxiolytic compound etifoxine has been shown to increase neurosteroid concentrations in brain tissue but the mode of action of etifoxine on neurosteroid formation has not yet been elucidated. In the present study, we have thus investigated the effect and the mechanism of action of etifoxine on neurosteroid biosynthesis using the frog hypothalamus as an experimental model. Exposure of frog hypothalamic explants to graded concentrations of etifoxine produced a dose-dependent increase in the biosynthesis of 17-hydroxypregnenolone, dehydroepiandrosterone, progesterone and tetrahydroprogesterone, associated with a decrease in the production of dihydroprogesterone. Time-course experiments revealed that a 15-min incubation of hypothalamic explants with etifoxine was sufficient to induce a robust increase in neurosteroid synthesis, suggesting that etifoxine activates steroidogenic enzymes at a post-translational level. Etifoxine-evoked neurosteroid biosynthesis was not affected by the central-type benzodiazepine (CBR) receptor antagonist flumazenil, the translocator protein (TSPO) antagonist PK11195 or the GABAA receptor antagonist bicuculline. In addition, the stimulatory effects of etifoxine and the triakontatetraneuropeptide TTN, a TSPO agonist, were additive, indicating that these two compounds act through distinct mechanisms. Etifoxine also induced a rapid stimulation of neurosteroid biosynthesis from frog hypothalamus homogenates, a preparation in which membrane receptor signalling is disrupted. In conclusion, the present study demonstrates that etifoxine stimulates neurosteroid production through a membrane receptor-independent mechanism.	[do Rego, Jean Luc; Vaudry, David; Vaudry, Hubert] Univ Rouen, IRIB, Mont St Aignan, France; [do Rego, Jean Luc; Vaudry, David; Vaudry, Hubert] Univ Rouen, Int Associated Lab Samuel Champlain, Reg Platform Cell Imaging PRIMACEN, Mont St Aignan, France; [Vaudry, David; Vaudry, Hubert] Univ Rouen, INSERM, Neurotroph Factors & Neuronal Differentiat, U982, Mont St Aignan, France	Universite de Rouen Normandie; Universite de Rouen Normandie; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Rouen Normandie	Vaudry, H (corresponding author), Univ Rouen, IRIB, Mont St Aignan, France.	hubert.vaudry@univ-rouen.fr	VAUDRY, David/M-1454-2018	VAUDRY, David/0000-0003-3567-7452	Inserm [U413]; University of Rouen; Region Haute-Normandie; pharmaceutical company BIOCODEX;  [IFRPM23/IRIB]	Inserm(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); University of Rouen; Region Haute-Normandie(Region Normandie); pharmaceutical company BIOCODEX; 	This work was partially supported by grants from Inserm (U413), IFRPM23/IRIB, University of Rouen and Region Haute-Normandie. Partial funding support was also provided by the pharmaceutical company BIOCODEX, which had no role in study design, data collection, analysis and interpretation, and writing of this manuscript.	Akwa Y, 1999, BEHAV BRAIN RES, V106, P119, DOI 10.1016/S0166-4328(99)00101-1; AKWA Y, 1991, J STEROID BIOCHEM, V40, P71, DOI 10.1016/0960-0760(91)90169-6; Aouad M, 2009, PAIN, V147, P54, DOI 10.1016/j.pain.2009.08.001; ASHTON H, 1994, DRUGS, V48, P25, DOI 10.2165/00003495-199448010-00004; Baulieu EE, 2001, INT REV NEUROBIOL, V46, P1; Beaujean D, 2002, ENDOCRINOLOGY, V143, P1950, DOI 10.1210/en.143.5.1950; Beaujean D, 1999, J NEUROCHEM, V72, P848, DOI 10.1046/j.1471-4159.1999.720848.x; Beyer C, 1999, HORM BEHAV, V35, P1, DOI 10.1006/hbeh.1998.1457; BOISSIER JR, 1972, THERAPIE, V27, P325; Burel D, 2013, ENDOCRINOLOGY, V154, P2114, DOI 10.1210/en.2013-1095; Chen MK, 2008, PHARMACOL THERAPEUT, V118, P1, DOI 10.1016/j.pharmthera.2007.12.004; Do Rego JL, 2007, J MED CHEM, V50, P3070, DOI 10.1021/jm0610548; Do Rego JL, 2007, J NEUROCHEM, V100, P251, DOI 10.1111/j.1471-4159.2006.04209.x; Do Rego Jean Luc, 2012, Front Endocrinol (Lausanne), V3, P4, DOI 10.3389/fendo.2012.00004; Do Rego JL, 2009, FRONT NEUROENDOCRIN, V30, P259, DOI 10.1016/j.yfrne.2009.05.006; Do-Rego JL, 2006, J NEUROSCI, V26, P6749, DOI 10.1523/JNEUROSCI.4469-05.2006; Do-Rego JL, 2000, P NATL ACAD SCI USA, V97, P13925, DOI 10.1073/pnas.240269897; Do-Rego JL, 2001, J NEUROCHEM, V76, P128, DOI 10.1046/j.1471-4159.2001.00053.x; Do-Rego JL, 1998, NEUROSCIENCE, V83, P555, DOI 10.1016/S0306-4522(97)00362-X; Dubrovsky B, 2000, BRAIN RES BULL, V51, P443, DOI 10.1016/S0361-9230(99)00269-5; Dubrovsky B, 2006, PHARMACOL BIOCHEM BE, V84, P644, DOI 10.1016/j.pbb.2006.06.016; Dubrovsky BO, 2005, PROG NEURO-PSYCHOPH, V29, P169, DOI 10.1016/j.pnpbp.2004.11.001; Duparc C, 2003, J CLIN ENDOCR METAB, V88, P5521, DOI 10.1210/jc.2003-030783; Girard C, 2012, J NEUROENDOCRINOL, V24, P71, DOI 10.1111/j.1365-2826.2011.02215.x; Girard C, 2008, P NATL ACAD SCI USA, V105, P20505, DOI 10.1073/pnas.0811201106; Griffin LD, 1999, P NATL ACAD SCI USA, V96, P13512, DOI 10.1073/pnas.96.23.13512; Guidotti A, 1998, BIOL PSYCHIAT, V44, P865, DOI 10.1016/S0006-3223(98)00070-5; Hamon A, 2003, NEUROPHARMACOLOGY, V45, P293, DOI 10.1016/S0028-3908(03)00187-4; Jefcoate C, 2002, J CLIN INVEST, V110, P881, DOI 10.1172/JCI200216771; Karchewski LA, 2004, EUR J NEUROSCI, V20, P671, DOI 10.1111/j.1460-9568.2004.03530.x; KOENIG HL, 1995, SCIENCE, V268, P1500, DOI 10.1126/science.7770777; Koenig HL, 2000, REV REPROD, V5, P189; Kokate TG, 1999, J PHARMACOL EXP THER, V288, P679; KRUSE HJ, 1985, ARZNEIMITTEL-FORSCH, V35, P133; Lacor P, 1996, NEUROSCI LETT, V220, P61, DOI 10.1016/S0304-3940(96)13187-6; Laurijssens BE, 1996, CLIN PHARMACOKINET, V30, P52, DOI 10.2165/00003088-199630010-00004; Lesouhaitier O, 1998, J MOL ENDOCRINOL, V20, P45, DOI 10.1677/jme.0.0200045; LIN D, 1993, ENDOCRINOLOGY, V132, P2498, DOI 10.1210/en.132.6.2498; MAJEWSKA MD, 1992, PROG NEUROBIOL, V38, P379, DOI 10.1016/0301-0082(92)90025-A; MELCHIOR CL, 1994, PHARMACOL BIOCHEM BE, V47, P437, DOI 10.1016/0091-3057(94)90140-6; Mellon SH, 2001, BRAIN RES REV, V37, P3, DOI 10.1016/S0165-0173(01)00109-6; Mellon SH, 2001, INT REV NEUROBIOL, V46, P33; MENSAHNYAGAN AG, 1994, J NEUROSCI, V14, P7306; MensahNyagan AG, 1996, P NATL ACAD SCI USA, V93, P1423, DOI 10.1073/pnas.93.4.1423; MensahNyagan AG, 1996, J NEUROCHEM, V67, P413; Micallef J, 2001, FUND CLIN PHARMACOL, V15, P209, DOI 10.1046/j.1472-8206.2001.00025.x; Midzak A, 2011, MOL CELL ENDOCRINOL, V336, P70, DOI 10.1016/j.mce.2010.12.007; Miller WL, 2015, MOL CELL ENDOCRINOL, V408, P99, DOI 10.1016/j.mce.2014.09.010; Miller WL, 2011, ENDOCR REV, V32, P81, DOI 10.1210/er.2010-0013; Mills CD, 2005, MOL CELL NEUROSCI, V30, P228, DOI 10.1016/j.mcn.2005.07.010; Nguyen N, 2006, HUM PSYCHOPHARM CLIN, V21, P139, DOI 10.1002/hup.757; Pandey AV, 2005, J BIOL CHEM, V280, P13265, DOI 10.1074/jbc.M414673200; PAPADOPOULOS V, 1993, ENDOCR REV, V14, P222, DOI 10.1210/er.14.2.222; Papadopoulos V, 2006, NEUROSCIENCE, V138, P749, DOI 10.1016/j.neuroscience.2005.05.063; Papadopoulos V, 2001, THERAPIE, V56, P549; Papadopoulos V, 2006, TRENDS PHARMACOL SCI, V27, P402, DOI 10.1016/j.tips.2006.06.005; Papadopoulos V, 2014, ENDOCRINOLOGY, V155, P15, DOI 10.1210/en.2013-2033; Papadopoulos V, 2012, BEST PRACT RES CL EN, V26, P771, DOI 10.1016/j.beem.2012.05.002; Graziano P, 2006, PSYCHOPHARMACOLOGY, V186, P362, DOI 10.1007/s00213-005-0213-2; POTTS GO, 1978, STEROIDS, V32, P257, DOI 10.1016/0039-128X(78)90010-7; Prasad A, 1997, PHYSIOL BEHAV, V62, P1053, DOI 10.1016/S0031-9384(97)00239-4; Reddy DS, 1997, BRAIN RES, V752, P61, DOI 10.1016/S0006-8993(96)01447-3; Robert G, 2011, BEHAV BRAIN RES, V220, P344, DOI 10.1016/j.bbr.2011.01.051; Rogoz Z, 2011, PHARMACOL REP, V63, P1547, DOI 10.1016/S1734-1140(11)70719-8; Rupprecht R, 2010, NAT REV DRUG DISCOV, V9, P971, DOI 10.1038/nrd3295; Schlichter R, 2000, NEUROPHARMACOLOGY, V39, P1523, DOI 10.1016/S0028-3908(99)00253-1; Schule C, 2011, NEUROSCIENCE, V191, P55, DOI 10.1016/j.neuroscience.2011.03.025; Schumacher M, 1996, DEV NEUROSCI-BASEL, V18, P6, DOI 10.1159/000111391; Schumacher M, 2001, BRAIN RES REV, V37, P343, DOI 10.1016/S0165-0173(01)00139-4; Schumacher M, 2000, J NEUROCYTOL, V29, P307, DOI 10.1023/A:1007152904926; Schweizer E, 1998, ACTA PSYCHIAT SCAND, V98, P95, DOI 10.1111/j.1600-0447.1998.tb05973.x; Servant D, 1998, ENCEPHALE, V24, P569; Takase M, 1999, ENDOCRINOLOGY, V140, P1936, DOI 10.1210/en.140.4.1936; Tee MK, 2008, ENDOCRINOLOGY, V149, P2667, DOI 10.1210/en.2007-1527; Tee MK, 2013, J BIOL CHEM, V288, P23903, DOI 10.1074/jbc.M113.460048; Tsutsui K, 2000, NEUROSCI RES, V36, P261, DOI 10.1016/S0168-0102(99)00132-7; Ugale RR, 2007, BRAIN RES, V1184, P193, DOI 10.1016/j.brainres.2007.09.041; Uzunov DP, 1996, P NATL ACAD SCI USA, V93, P12599, DOI 10.1073/pnas.93.22.12599; van Broekhoven F, 2003, PSYCHOPHARMACOLOGY, V165, P97, DOI 10.1007/s00213-002-1257-1; Verleye M, 2005, PHARMACOL BIOCHEM BE, V82, P712, DOI 10.1016/j.pbb.2005.11.013; Verleye M, 2004, PHYSIOL BEHAV, V82, P891, DOI 10.1016/j.physbeh.2004.07.010; Verleye M, 2002, NEUROSCI RES, V44, P167, DOI 10.1016/S0168-0102(02)00121-9; Verleye M, 1999, NEUROREPORT, V10, P3207, DOI 10.1097/00001756-199910190-00015; Verleye M, 2001, NEUROSCI LETT, V301, P191, DOI 10.1016/S0304-3940(01)01647-0; Verleye M, 2006, NEUROSCI RES, V56, P53, DOI 10.1016/j.neures.2006.05.005; WOODS JH, 1992, PHARMACOL REV, V44, P151; ZHANG LH, 1995, P NATL ACAD SCI USA, V92, P10619, DOI 10.1073/pnas.92.23.10619	87	26	30	2	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2015	10	3							e0120473	10.1371/journal.pone.0120473	http://dx.doi.org/10.1371/journal.pone.0120473			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9BN	25785994	Green Submitted, Green Published, gold			2022-12-27	WOS:000352138500174
J	Dolan, EB; Haugh, MG; Voisin, MC; Tallon, D; McNamara, LM				Dolan, Eimear B.; Haugh, Matthew G.; Voisin, Muriel C.; Tallon, David; McNamara, Laoise M.			Thermally Induced Osteocyte Damage Initiates a Remodelling Signaling Cascade	PLOS ONE			English	Article							MESENCHYMAL STEM-CELLS; MECHANICALLY STIMULATED OSTEOCYTES; GAP-JUNCTIONS; OSTEOGENIC DIFFERENTIATION; OSTEOCLAST DIFFERENTIATION; BONE-RESORPTION; IN-VIVO; APOPTOSIS; PROLIFERATION; ACTIVATION	Thermal elevations experienced by bone during orthopaedic procedures, such as cutting and drilling, exothermal reactions from bone cement, and thermal therapies such as tumor ablation, can result in thermal damage leading to death of native bone cells (osteocytes, osteoblasts, osteoclasts and mesenchymal stem cells). Osteocytes are believed to be the orchestrators of bone remodeling, which recruit nearby osteoclast and osteoblasts to control resorption and bone growth in response to mechanical stimuli and physical damage. However, whether heat-induced osteocyte damage can directly elicit bone remodelling has yet to be determined. This study establishes the link between osteocyte thermal damage and the remodeling cascade. We show that osteocytes directly exposed to thermal elevations (47 degrees C for 1 minute) become significantly apoptotic and alter the expression of osteogenic genes (Opg and Cox2). The Rankl/Opg ratio is consistently down-regulated, at days 1, 3 and 7 in MLO-Y4s heat-treated to 47 degrees C for 1 minute. Additionally, the pro-osteoblastogenic signaling marker Cox2 is significantly up-regulated in heat-treated MLO-Y4s by day 7. Furthermore, secreted factors from heat-treated MLO-Y4s administered to MSCs using a novel co-culture system are shown to activate pre-osteoblastic MSCs to increase production of the pro-osteoblastic differentiation marker, alkaline phosphatase (day 7, 14), and calcium deposition (day 21). Most interestingly, an initial pro-osteoclastogenic signaling response (increase Rankl and Rankl/Opg ratio at day 1) followed by later stage pro-osteoblastogenic signaling (down-regulation in Rankl and the Rankl/Opg ratio and an up-regulation in Opg and Cox2 by day 7) was observed in non-heat-treated MLO-Y4s in co-culture when these were exposed to the biochemicals produced by heat-treated MLO-Y4s. Taken together, these results elucidate the vital role of osteocytes in detecting and responding to thermal damage by means of thermally induced apoptosis followed by a cascade of remodelling responses.	[Dolan, Eimear B.; Haugh, Matthew G.; Voisin, Muriel C.; McNamara, Laoise M.] Natl Univ Ireland, Coll Engn & Informat, Biomed Engn, Biomech Res Ctr BMEC, Galway, Ireland; [Dolan, Eimear B.; Haugh, Matthew G.; Voisin, Muriel C.; McNamara, Laoise M.] Natl Univ Ireland, Natl Ctr Biomed Engn Sci, Galway, Ireland; [Tallon, David] Stryker Ireland, Cork, Ireland	Ollscoil na Gaillimhe-University of Galway; Ollscoil na Gaillimhe-University of Galway	McNamara, LM (corresponding author), Natl Univ Ireland, Coll Engn & Informat, Biomed Engn, Biomech Res Ctr BMEC, Galway, Ireland.	Laoise.McNamara@nuigalway.ie		McNamara, Laoise/0000-0002-5050-9230; Dolan, Eimear/0000-0002-6742-8461	National University of Ireland, Galway Fellowship Scheme; National University of Ireland Travelling Scholarships in Engineering; European Research Council (ERC) [258992]	National University of Ireland, Galway Fellowship Scheme; National University of Ireland Travelling Scholarships in Engineering; European Research Council (ERC)(European Research Council (ERC))	The work was supported by National University of Ireland, Galway Fellowship Scheme (ED LMcN), The National University of Ireland Travelling Scholarships in Engineering (ED LMcN), and the European Research Council (ERC) (under grant no. 258992; BONEMECHBIO) (LMcN). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BERMAN AT, 1984, CLIN ORTHOP RELAT R, P284; Birmingham E, 2012, EUR CELLS MATER, V23, P13, DOI 10.22203/eCM.v023a02; Birmingham E., 2012, OSTEOGENIC DIFFERENT; Bonewald LF, 1999, J BONE MINER METAB, V17, P61, DOI 10.1007/s007740050066; Bonewald LF, 2011, J BONE MINER RES, V26, P229, DOI 10.1002/jbmr.320; Boyce BF, 2008, ARCH BIOCHEM BIOPHYS, V473, P139, DOI 10.1016/j.abb.2008.03.018; Boyle WJ, 2003, NATURE, V423, P337, DOI 10.1038/nature01658; Cardoso L, 2009, J BONE MINER RES, V24, P597, DOI 10.1359/JBMR.081210; Dolan EB, 2012, J R SOC INTERFACE, V9, P3503, DOI 10.1098/rsif.2012.0520; Dolan EB, 2014, J BIOMECH ENG-T ASME, V136, DOI 10.1115/1.4026177; DOTY SB, 1981, CALCIFIED TISSUE INT, V33, P509, DOI 10.1007/BF02409482; ERIKSSON A, 1982, INT J ORAL MAXILLOF, V11, P115, DOI 10.1016/S0300-9785(82)80020-3; ERIKSSON AR, 1984, ACTA ORTHOP SCAND, V55, P629, DOI 10.3109/17453678408992410; Feng X, 2002, ENDOCRINOLOGY, V143, P4868, DOI 10.1210/en.2002-220467; Freeman F, 2013, J TISSUE ENG REGENER; Grimaud E, 2003, AM J PATHOL, V163, P2021, DOI 10.1016/S0002-9440(10)63560-2; Heino TJ, 2004, EXP CELL RES, V294, P458, DOI 10.1016/j.yexcr.2003.11.016; Hoey DA, 2011, BIOCHEM BIOPH RES CO, V412, P182, DOI 10.1016/j.bbrc.2011.07.072; Kato Y, 1997, J BONE MINER RES, V12, P2014, DOI 10.1359/jbmr.1997.12.12.2014; Kennedy OD, 2014, BONE; Kennedy OD, 2012, BONE, V50, P1115, DOI 10.1016/j.bone.2012.01.025; Khosla S, 2001, ENDOCRINOLOGY, V142, P5050, DOI 10.1210/en.142.12.5050; Kirkham G.R., 2007, TOPICS TISSUE ENG, V3; Kobayashi D, 2013, PROSTATE, V73, P913, DOI 10.1002/pros.22637; Kogianni G, 2008, J BONE MINER RES, V23, P915, DOI 10.1359/JBMR.080207; Kogianni Giolanta, 2007, Curr Osteoporos Rep, V5, P81; LEON SA, 1993, INT J HYPERTHER, V9, P77, DOI 10.3109/02656739309061480; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lundskog J, 1972, Scand J Plast Reconstr Surg, V9, P1; Mann V., 2006, Journal of Musculoskeletal & Neuronal Interactions, V6, P408; MARTIN SJ, 1995, J EXP MED, V182, P1545, DOI 10.1084/jem.182.5.1545; Mulcahy LE, 2011, BONE, V48, P182, DOI 10.1016/j.bone.2010.09.014; Mullen CA, 2013, J MECH BEHAV BIOMED, V28, P183, DOI 10.1016/j.jmbbm.2013.06.013; Noble Brendon, 2003, European Cells & Materials, V6, P46; Norgaard R, 2006, ANN NY ACAD SCI, V1067, P443, DOI 10.1196/annals.1354.063; Peister A, 2004, BLOOD, V103, P1662, DOI 10.1182/blood-2003-09-3070; Qiu S-J, 1997, T ORTHOPEDIC RES SOC, V22; Rucci N, 2007, J CELL BIOCHEM, V100, P464, DOI 10.1002/jcb.21059; Santiago FR, 2009, CURR REV MUSCULOSKE, V2, P43, DOI 10.1007/s12178-008-9042-3; Schaffler MB, 2014, CALCIFIED TISSUE INT, V94, P5, DOI 10.1007/s00223-013-9790-y; Schaffler MB, 2012, CURR OSTEOPOROS REP, V10, P118, DOI 10.1007/s11914-012-0105-4; Shui CX, 2001, J BONE MINER RES, V16, P731, DOI 10.1359/jbmr.2001.16.4.731; Simonet WS, 1997, CELL, V89, P309, DOI 10.1016/S0092-8674(00)80209-3; Sims NA, 2012, CURR OSTEOPOROS REP, V10, P109, DOI 10.1007/s11914-012-0096-1; Stanczyk M, 2004, J BIOMECH, V37, P1803, DOI [10.1016/j.biomech.2004.03.002, 10.1016/j.jbiomech.2004.03.002]; Taylor AF, 2007, AM J PHYSIOL-CELL PH, V292, pC545, DOI 10.1152/ajpcell.00611.2005; TOKSVIGLARSEN S, 1991, J BONE JOINT SURG BR, V73, P13, DOI 10.1302/0301-620X.73B1.1991747; Verborgt O, 2000, J BONE MINER RES, V15, P60, DOI 10.1359/jbmr.2000.15.1.60; Wang JH, 2013, BONE, V57, P311, DOI 10.1016/j.bone.2013.08.015; Yellowley CE, 2000, J BONE MINER RES, V15, P209, DOI 10.1359/jbmr.2000.15.2.209; You LD, 2008, BONE, V42, P172, DOI 10.1016/j.bone.2007.09.047; Zhang KQ, 2006, MOL CELL BIOL, V26, P4539, DOI 10.1128/MCB.02120-05	52	22	22	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2015	10	3							e0119652	10.1371/journal.pone.0119652	http://dx.doi.org/10.1371/journal.pone.0119652			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9BN	25785846	Green Submitted, Green Published, gold			2022-12-27	WOS:000352138500125
J	Kawada, M; Inoue, H; Ohba, S; Yoshida, J; Masuda, T; Yamasaki, M; Usami, I; Sakamoto, S; Abe, H; Watanabe, T; Yamori, T; Shibasaki, M; Nomoto, A				Kawada, Manabu; Inoue, Hiroyuki; Ohba, Shun-ichi; Yoshida, Junjiro; Masuda, Tohru; Yamasaki, Manabu; Usami, Ihomi; Sakamoto, Shuichi; Abe, Hikaru; Watanabe, Takumi; Yamori, Takao; Shibasaki, Masakatsu; Nomoto, Akio			Stromal Cells Positively and Negatively Modulate the Growth of Cancer Cells: Stimulation via the PGE2-TNF alpha-IL-6 Pathway and Inhibition via Secreted GAPDH-E-Cadherin Interaction	PLOS ONE			English	Article							HUMAN PROSTATE-CANCER; ANCHORAGE-INDEPENDENT GROWTH; MESENCHYMAL STEM-CELLS; REACTIVE STROMA; GASTRIC-CANCER; GLYCERALDEHYDE-3-PHOSPHATE DEHYDROGENASE; PROSTAGLANDIN E-2; MICROPLATE ASSAY; TUMOR-CELLS; IN-VITRO	Fibroblast-like stromal cells modulate cancer cells through secreted factors and adhesion, but those factors are not fully understood. Here, we have identified critical stromal factors that modulate cancer growth positively and negatively. Using a cell co-culture system, we found that gastric stromal cells secreted IL-6 as a growth and survival factor for gastric cancer cells. Moreover, gastric cancer cells secreted PGE2 and TNF alpha that stimulated IL-6 secretion by the stromal cells. Furthermore, we found that stromal cells secreted glyceraldehyde 3-phosphate dehydrogenase (GAPDH). Extracellular GAPDH, or its N-terminal domain, inhibited gastric cancer cell growth, a finding confirmed in other cell systems. GAPDH bound to E-cadherin and downregulated the mTOR-p70S6 kinase pathway. These results demonstrate that stromal cells could regulate cancer cell growth through the balance of these secreted factors. We propose that negative regulation of cancer growth using GAPDH could be a new anti-cancer strategy.	[Kawada, Manabu; Inoue, Hiroyuki; Ohba, Shun-ichi; Yoshida, Junjiro; Masuda, Tohru; Usami, Ihomi; Sakamoto, Shuichi; Nomoto, Akio] Microbial Chem Res Fdn, Inst Microbial Chem BIKAKEN, Numazu, Shizuoka, Japan; [Yamasaki, Manabu; Abe, Hikaru; Watanabe, Takumi; Shibasaki, Masakatsu] Microbial Chem Res Fdn, Inst Microbial Chem BIKAKEN, Shinagawa Ku, Tokyo, Japan; [Yamori, Takao] Japanese Fdn Canc Res, Ctr Canc Chemotherapy, Koto Ku, Tokyo 170, Japan	Japanese Foundation for Cancer Research	Kawada, M (corresponding author), Microbial Chem Res Fdn, Inst Microbial Chem BIKAKEN, Numazu, Shizuoka, Japan.	kawadam@bikaken.or.jp		Kawada, Manabu/0000-0001-9348-4240; Sakamoto, Shuichi/0000-0001-9396-9475	MEXT KAKENHI [23112522]	MEXT KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported by MEXT KAKENHI Grant Number 23112522. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ara T, 2009, CANCER RES, V69, P329, DOI 10.1158/0008-5472.CAN-08-0613; Bhowmick NA, 2004, NATURE, V432, P332, DOI 10.1038/nature03096; Bhowmick NA, 2004, SCIENCE, V303, P848, DOI 10.1126/science.1090922; CAMPS JL, 1990, P NATL ACAD SCI USA, V87, P75, DOI 10.1073/pnas.87.1.75; Ding SZ, 2010, FUTURE ONCOL, V6, P851, DOI [10.2217/fon.10.37, 10.2217/FON.10.37]; DVORAK HF, 1986, NEW ENGL J MED, V315, P1650; FUKAZAWA H, 1995, ANAL BIOCHEM, V228, P83, DOI 10.1006/abio.1995.1318; Hodge DR, 2005, EUR J CANCER, V41, P2502, DOI 10.1016/j.ejca.2005.08.016; Hwang RF, 2008, CANCER RES, V68, P918, DOI 10.1158/0008-5472.CAN-07-5714; Ishimoto T, 2010, CANCER SCI, V101, P673, DOI 10.1111/j.1349-7006.2009.01430.x; Kai H, 2005, ANTICANCER RES, V25, P709; Kaida D, 2007, NAT CHEM BIOL, V3, P576, DOI 10.1038/nchembio.2007.18; Karnoub AE, 2007, NATURE, V449, P557, DOI 10.1038/nature06188; Katsuda T, 2013, SCI REP-UK, V3, DOI 10.1038/srep01197; Kawada M, 2006, CANCER RES, V66, P4419, DOI 10.1158/0008-5472.CAN-05-4239; Kawada M, 1998, JPN J CANCER RES, V89, P110, DOI 10.1111/j.1349-7006.1998.tb00537.x; Kawada M, 2004, ANTICANCER RES, V24, P1561; Kawada M, 2002, J BIOL CHEM, V277, P27765, DOI 10.1074/jbc.M200318200; Kawada M, 1999, JPN J CANCER RES, V90, P546, DOI 10.1111/j.1349-7006.1999.tb00782.x; Kawada M, 2008, ANTICANCER RES, V28, P721; Kawada M, 2006, CANCER LETT, V242, P46, DOI 10.1016/j.canlet.2005.10.040; Kawada M, 2010, J ANTIBIOT, V63, P319, DOI 10.1038/ja.2010.42; Kawada M, 2010, INT J CANCER, V126, P810, DOI 10.1002/ijc.24915; Kawada M, 2009, J ANTIBIOT, V62, P243, DOI 10.1038/ja.2009.20; Kawada M, 2009, CANCER SCI, V100, P150, DOI 10.1111/j.1349-7006.2008.00996.x; Kinoshita H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060914; Liao CP, 2010, CANCER RES, V70, P7294, DOI 10.1158/0008-5472.CAN-09-3982; Malanchi I, 2012, NATURE, V481, P85, DOI 10.1038/nature10694; Micke P, 2004, LUNG CANCER, V45, pS163, DOI 10.1016/j.lungcan.2004.07.977; Nakamura T, 1997, CANCER RES, V57, P3305; Nakatsu N, 2007, MOL PHARMACOL, V72, P1171, DOI 10.1124/mol.107.038836; Oshima H, 2006, GASTROENTEROLOGY, V131, P1086, DOI 10.1053/j.gastro.2006.07.014; PICARD O, 1986, CANCER RES, V46, P3290; RONNOVJESSEN L, 1993, LAB INVEST, V68, P696; Ruvinsky I, 2006, TRENDS BIOCHEM SCI, V31, P342, DOI 10.1016/j.tibs.2006.04.003; Sekikawa A, 2008, CARCINOGENESIS, V29, P76, DOI 10.1093/carcin/bgm250; Shiraishi K, 2005, J IMMUNOL, V175, P1014, DOI 10.4049/jimmunol.175.2.1014; Straussman R, 2012, NATURE, V487, P500, DOI 10.1038/nature11183; Tuxhorn JA, 2002, CANCER RES, V62, P6021; Tuxhorn JA, 2002, CLIN CANCER RES, V8, P2912; Tuxhorn JA, 2001, J UROLOGY, V166, P2472, DOI 10.1016/S0022-5347(05)65620-0; VEDIA LM, 1992, J BIOL CHEM, V267, P24929; Wagener J, 2013, J INVEST DERMATOL, V133, P144, DOI 10.1038/jid.2012.254; Wang TP, 2010, BIOCONJUGATE CHEM, V21, P1642, DOI 10.1021/bc1001505; Wernert N, 1997, VIRCHOWS ARCH, V430, P433, DOI 10.1007/s004280050053; Wiseman BS, 2002, SCIENCE, V296, P1046, DOI 10.1126/science.1067431; Yamaji R, 2005, BBA-GEN SUBJECTS, V1726, P261, DOI 10.1016/j.bbagen.2005.07.013; Yamashita M, 2012, BREAST CANCER-TOKYO, V19, P170, DOI 10.1007/s12282-010-0234-5; Yamori T, 1999, CANCER RES, V59, P4042; Yanagihara K, 2005, CANCER SCI, V96, P323, DOI 10.1111/j.1349-7006.2005.00054.x; Yano S, 2008, CANCER RES, V68, P9479, DOI 10.1158/0008-5472.CAN-08-1643; Yashiro M, 2010, CANCER MICROENVIRON, V3, P127, DOI 10.1007/s12307-010-0036-5; Yokozaki H, 2000, PATHOL INT, V50, P767, DOI 10.1046/j.1440-1827.2000.01117.x; Zhang JG, 2010, WORLD J GASTROENTERO, V16, P571, DOI 10.3748/wjg.v16.i5.571	54	16	18	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2015	10	3							e0119415	10.1371/journal.pone.0119415	http://dx.doi.org/10.1371/journal.pone.0119415			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9BN	25785838	Green Published, gold, Green Submitted			2022-12-27	WOS:000352138500101
J	Li, RH; Hempel, LU; Jiang, TB				Li, Renhua; Hempel, Leonie U.; Jiang, Tingbo			A Non-Parametric Peak Calling Algorithm for DamID-Seq	PLOS ONE			English	Article							PROTEIN-DNA INTERACTIONS; GENOME	Protein-DNA interactions play a significant role in gene regulation and expression. In order to identify transcription factor binding sites (TFBS) of double sex (DSX)-an important transcription factor in sex determination, we applied the DNA adenine methylation identification (DamID) technology to the fat body tissue of Drosophila, followed by deep sequencing (DamID-Seq). One feature of DamID-Seq data is that induced adenine methylation signals are not assured to be symmetrically distributed at TFBS, which renders the existing peak calling algorithms for ChIP-Seq, including SPP and MACS, inappropriate for DamID-Seq data. This challenged us to develop a new algorithm for peak calling. A challenge in peaking calling based on sequence data is estimating the averaged behavior of background signals. We applied a bootstrap resampling method to short sequence reads in the control (Dam only). After data quality check and mapping reads to a reference genome, the peaking calling procedure compromises the following steps: 1) reads resampling; 2) reads scaling (normalization) and computing signal-to-noise fold changes; 3) filtering; 4) Calling peaks based on a statistically significant threshold. This is a non-parametric method for peak calling (NPPC). We also used irreproducible discovery rate (IDR) analysis, as well as ChIP-Seq data to compare the peaks called by the NPPC. We identified approximately 6,000 peaks for DSX, which point to 1,225 genes related to the fat body tissue difference between female and male Drosophila. Statistical evidence from IDR analysis indicated that these peaks are reproducible across biological replicates. In addition, these peaks are comparable to those identified by use of ChIP-Seq on S2 cells, in terms of peak number, location, and peaks width.	[Li, Renhua; Jiang, Tingbo] Northeast Forestry Univ, State Key Lab Tree Genet & Breeding, Harbin 150040, Peoples R China; [Li, Renhua; Hempel, Leonie U.] NIDDK, Lab Cellular & Dev Biol, NIH, Bethesda, MD 20892 USA	Northeast Forestry University - China; National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)	Jiang, TB (corresponding author), Northeast Forestry Univ, State Key Lab Tree Genet & Breeding, Harbin 150040, Peoples R China.	tbjiang@yahoo.com						Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; BURTIS KC, 1991, EMBO J, V10, P2577, DOI 10.1002/j.1460-2075.1991.tb07798.x; BURTIS KC, 1989, CELL, V56, P997, DOI 10.1016/0092-8674(89)90633-8; EFRON B, 2005, 200520B234 STANF U D; Greil F, 2006, METHOD ENZYMOL, V410, P342, DOI 10.1016/S0076-6879(06)10016-6; Johnson DS, 2007, SCIENCE, V316, P1497, DOI 10.1126/science.1141319; Kharchenko PV, 2008, NAT BIOTECHNOL, V26, P1351, DOI 10.1038/nbt.1508; Landt SG, 2012, GENOME RES, V22, P1813, DOI 10.1101/gr.136184.111; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Li QH, 2011, ANN APPL STAT, V5, P1752, DOI 10.1214/11-AOAS466; Luo SZD, 2011, DEVELOPMENT, V138, P2761, DOI 10.1242/dev.065227; Schneider I, 1972, J EMBRYOL EXP MORPH, V27, P363; Schwartz YB, 2012, GENOME RES, V22, P2188, DOI 10.1101/gr.138156.112; Vogel MJ, 2007, NAT PROTOC, V2, P1467, DOI 10.1038/nprot.2007.148; Wand M., 1995, KERNEL SMOOTHING CHA; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137	17	4	4	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2015	10	3							e0117415	10.1371/journal.pone.0117415	http://dx.doi.org/10.1371/journal.pone.0117415			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9BN	25785608	gold, Green Submitted, Green Published			2022-12-27	WOS:000352138500017
J	McGaha, TW; Young, RM; Burkett-Cadena, ND; Iburg, JP; Beau, JM; Hassan, S; Katholi, CR; Cupp, EW; Baker, BJ; Unnasch, TR; Noblet, R				McGaha, Tommy W., Jr.; Young, Ryan M.; Burkett-Cadena, Nathan D.; Iburg, Joseph P.; Beau, Jeremy M.; Hassan, Sayed; Katholi, Charles R.; Cupp, Eddie W.; Baker, Bill J.; Unnasch, Thomas R.; Noblet, Raymond			Identification of Communal Oviposition Pheromones from the Black Fly Simulium vittatum	PLOS ONE			English	Article							AGGREGATED OVIPOSITION; DAMNOSUM COMPLEX; REPTANS DIPTERA; BEETLE	The suite of pheromones that promote communal oviposition by Simulium vittatum, a North American black fly species, was identified and characterized using gas chromatography-mass spectrometry, electrophysiological, and behavioral bioassays. Behavioral assays demonstrated that communal oviposition was induced by egg-derived compounds that were active at short range and whose effect was enhanced through direct contact. Three compounds (cis-9-tetradecen-1-ol, 1-pentadecene, and 1-tridecene) were identified in a non-polar solvent extract of freshly deposited S. vittatum eggs that were capable of inducing the oviposition response. Electroantennography demonstrated that two of these three compounds (1-pentadecene and 1-tridecene) actively stimulated antennal neurons. Identification of the oviposition pheromones of this family may be helpful in developing control measures for nuisance black flies and for medically-important species such as Simulium damnosum sensu lato.	[McGaha, Tommy W., Jr.; Iburg, Joseph P.; Noblet, Raymond] Univ Georgia, Dept Entomol, Athens, GA 30602 USA; [Young, Ryan M.; Beau, Jeremy M.; Baker, Bill J.] Univ S Florida, Dept Chem, Tampa, FL 33620 USA; [Young, Ryan M.; Beau, Jeremy M.; Baker, Bill J.] Univ S Florida, Ctr Drug Discovery & Innovat, Tampa, FL USA; [Burkett-Cadena, Nathan D.; Unnasch, Thomas R.] Univ S Florida, Dept Global Hlth, Global Hlth Infect Dis Res Program, Tampa, FL 33620 USA; [Hassan, Sayed] Univ Georgia, Dept Crop & Soil Sci, Athens, GA 30602 USA; [Katholi, Charles R.] Univ Alabama Birmingham, Dept Biostat, Birmingham, AL 35294 USA; [Cupp, Eddie W.] Auburn Univ, Dept Entomol & Plant Pathol, Auburn, AL 36849 USA	University System of Georgia; University of Georgia; State University System of Florida; University of South Florida; State University System of Florida; University of South Florida; State University System of Florida; University of South Florida; University System of Georgia; University of Georgia; University of Alabama System; University of Alabama Birmingham; Auburn University System; Auburn University	Unnasch, TR (corresponding author), Univ S Florida, Dept Global Hlth, Global Hlth Infect Dis Res Program, Tampa, FL 33620 USA.	tunnasch@health.usf.edu	Baker, Bill/N-4312-2019	Burkett-Cadena, Nathan/0000-0001-6168-1637; McGaha Jr., Tommy/0000-0003-0374-6214	Bill and Melinda Gates Foundation [1017870]	Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation)	This work was supported by the Bill and Melinda Gates Foundation (grant # 1017870). The funder had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bellec C, 1976, MED PARASITOL ENTOMO, V14, P209; COUPLAND JB, 1991, ECOL ENTOMOL, V16, P11, DOI 10.1111/j.1365-2311.1991.tb00187.x; COUPLAND JB, 1992, J MED ENTOMOL, V29, P293, DOI 10.1093/jmedent/29.2.293; DAVIES JB, 1962, NATURE, V196, P149, DOI 10.1038/196149a0; Dougherty M, 1997, J CHEM ECOL, V23, P2657, DOI 10.1023/A:1022598523803; DUMESNIL JG, 1982, ARCH MAL COEUR VAISS, V75, P1149; Geiselhardt S, 2008, NATURWISSENSCHAFTEN, V95, P247, DOI 10.1007/s00114-007-0312-5; GOLINI VI, 1975, CAN J ZOOL, V53, P521, DOI 10.1139/z75-067; Gray EW, 1999, MAINTENANCE OF HUMAN, ANIMAL, AND PLANT PATHOGEN VECTORS, P83; LAURENCE BR, 1985, J CHEM ECOL, V11, P643, DOI 10.1007/BF00988573; McCall PJ, 1997, PHYSIOL ENTOMOL, V22, P224, DOI 10.1111/j.1365-3032.1997.tb01162.x; MCCALL PJ, 1994, MED VET ENTOMOL, V8, P76, DOI 10.1111/j.1365-2915.1994.tb00390.x; MCCALL PJ, 1995, MED VET ENTOMOL, V9, P101, DOI 10.1111/j.1365-2915.1995.tb00165.x; MCCALL PJ, 1995, PARASITOL TODAY, V11, P352, DOI 10.1016/0169-4758(95)80192-8; MUIRHEADTHOMSON RC, 1956, NATURE, V178, P1297, DOI 10.1038/1781297a0; OSGOOD CE, 1971, J ECON ENTOMOL, V64, P1038, DOI 10.1093/jee/64.5.1038; OZAKI M, 1995, EUR J BIOCHEM, V230, P298; Prokopy RJ, 2001, ANNU REV ENTOMOL, V46, P631, DOI 10.1146/annurev.ento.46.1.631; Rai MM, 1997, J INSECT PHYSIOL, V43, P83, DOI 10.1016/S0022-1910(96)00051-0; Rodriguez-Perez MA, 2003, ANN TROP MED PARASIT, V97, P203, DOI 10.1179/000349803235001534; Saini RK, 1996, J CHEM ECOL, V22, P1211, DOI 10.1007/BF02266961; Seenivasagan T, 2009, PARASITOL RES, V104, P827, DOI 10.1007/s00436-008-1263-2; SUTCLIFFE JF, 1976, CAN J ZOOL, V54, P1779, DOI 10.1139/z76-207; Velcheva N, 2012, RASTENIEVUDNI NAUKI, V49, P15; Verheggen F, 2007, J CHEM ECOL, V33, P525, DOI 10.1007/s10886-006-9236-3; Wiegmann BM, 2011, P NATL ACAD SCI USA, V108, P5690, DOI 10.1073/pnas.1012675108	26	6	6	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2015	10	3							e0118904	10.1371/journal.pone.0118904	http://dx.doi.org/10.1371/journal.pone.0118904			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9BN	25786206	gold, Green Published, Green Submitted			2022-12-27	WOS:000352138500055
J	Meguro, S; Hasumura, T; Hase, T				Meguro, Shinichi; Hasumura, Takahiro; Hase, Tadashi			Body Fat Accumulation in Zebrafish Is Induced by a Diet Rich in Fat and Reduced by Supplementation with Green Tea Extract	PLOS ONE			English	Article							SALMO-SALAR L.; INDUCED OBESITY; SUBCUTANEOUS FAT; LIPID-METABOLISM; RAINBOW-TROUT; BROWN TROUT; ADIPOSITY; GROWTH; SEX; DEPOSITION	Fat-rich diets not only induce obesity in humans but also make animals obese. Therefore, animals that accumulate body fat in response to a high-fat diet (especially rodents) are commonly used in obesity research. The effect of dietary fat on body fat accumulation is not fully understood in zebrafish, an excellent model of vertebrate lipid metabolism. Here, we explored the effects of dietary fat and green tea extract, which has anti-obesity properties, on body fat accumulation in zebrafish. Adult zebrafish were allocated to four diet groups and over 6 weeks were fed a high-fat diet containing basal diet plus two types of fat or a low-fat diet containing basal diet plus carbohydrate or protein. Another group of adult zebrafish was fed a high-fat diet with or without 5% green tea extract supplementation. Zebrafish fed the high-fat diets had nearly twice the body fat (visceral, subcutaneous, and total fat) volume and body fat volume ratio (body fat volume/body weight) of those fed low-fat diets. There were no differences in body fat accumulation between the two high-fat groups, nor were there any differences between the two low-fat groups. Adding green tea extract to the high-fat diet significantly suppressed body weight, body fat volume, and body fat volume ratio compared with the same diet lacking green tea extract. 3-Hydroxyacyl-coenzyme A dehydrogenase and citrate synthase activity in the liver and skeletal muscle were significantly higher in fish fed the diet supplemented with green tea extract than in those fed the unsupplemented diet. Our results suggest that a diet rich in fat, instead of protein or carbohydrate, induced body fat accumulation in zebrafish with mechanisms that might be similar to those in mammals. Consequently, zebrafish might serve as a good animal model for research into obesity induced by high-fat diets.	[Meguro, Shinichi; Hasumura, Takahiro; Hase, Tadashi] Kao Corp, Biol Sci Res, Tokyo, Tochigi, Japan	KAO Corporation	Meguro, S (corresponding author), Kao Corp, Biol Sci Res, Tokyo, Tochigi, Japan.			Meguro, Shinichi/0000-0002-3072-2632				Anderson JL, 2011, METHOD CELL BIOL, V101, P111, DOI 10.1016/B978-0-12-387036-0.00005-0; [Anonymous], 2010, GUIDE CARE USE LAB A; BASS A, 1969, EUR J BIOCHEM, V10, P198, DOI 10.1111/j.1432-1033.1969.tb00674.x; Bertrais S, 1999, INT J OBESITY, V23, P1085, DOI 10.1038/sj.ijo.0801033; BOOZER CN, 1995, AM J PHYSIOL-ENDOC M, V268, pE546; Bose M, 2008, J NUTR, V138, P1677, DOI 10.1093/jn/138.9.1677; BOURGEOIS F, 1983, BRIT J NUTR, V49, P17, DOI 10.1079/BJN19830006; Buettner R, 2007, OBESITY, V15, P798, DOI 10.1038/oby.2007.608; Chu CY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036474; Cnop M, 2002, DIABETES, V51, P1005, DOI 10.2337/diabetes.51.4.1005; Collins S, 2004, PHYSIOL BEHAV, V81, P243, DOI 10.1016/j.physbeh.2004.02.006; Eckel RH, 2005, LANCET, V365, P1415, DOI 10.1016/S0140-6736(05)66378-7; ENZI G, 1986, AM J CLIN NUTR, V44, P739, DOI 10.1093/ajcn/44.6.739; Ghibaudi L, 2002, OBES RES, V10, P956, DOI 10.1038/oby.2002.130; GRAUER WO, 1984, AM J CLIN NUTR, V39, P631, DOI 10.1093/ajcn/39.4.631; Hariri N, 2010, NUTR RES REV, V23, P270, DOI 10.1017/S0954422410000168; Hasumura T, 2012, NUTR METAB, V9, DOI 10.1186/1743-7075-9-73; HILL JO, 1992, INT J OBESITY, V16, P321; Holtta-Vuori M, 2010, BIOCHEM J, V429, P235, DOI 10.1042/BJ20100293; Ikemoto S, 1996, METABOLISM, V45, P1539, DOI 10.1016/S0026-0495(96)90185-7; Jobling M, 1998, AQUAC RES, V29, P601, DOI 10.1111/j.1365-2109.1998.tb01174.x; Jobling M, 2003, AQUAC RES, V34, P311, DOI 10.1046/j.1365-2109.2003.00820.x; Jobling M, 2002, AQUAC RES, V33, P533, DOI 10.1046/j.1365-2109.2002.00738.x; Jobling M, 2002, AQUAC RES, V33, P739, DOI 10.1046/j.1365-2109.2002.00712.x; Kause A, 2007, AQUACULTURE, V271, P162, DOI 10.1016/j.aquaculture.2007.06.005; Kishida K, 2012, ANN MED, V44, P233, DOI 10.3109/07853890.2011.564202; Lieschke GJ, 2007, NAT REV GENET, V8, P353, DOI 10.1038/nrg2091; Lowenstein JM, 1969, METHOD ENZYMOL, P3, DOI [10.1016/0076-6879(69)13005-0, DOI 10.1016/0076-6879(69)13005-0]; Lu C, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0034833, 10.1371/journal.pone.0038332]; Matsumoto T, 2010, DIS MODEL MECH, V3, P431, DOI 10.1242/dmm.002311; MATSUZAWA Y, 1995, OBES RES, V3, pS187, DOI 10.1002/j.1550-8528.1995.tb00462.x; Meguro S, 2001, J OLEO SCI, V50, P593, DOI DOI 10.5650/JOS.50.593; Mori T, 2007, J NUTR, V137, P2629, DOI 10.1093/jn/137.12.2629; Murase T, 2006, AM J PHYSIOL-REG I, V290, pR1550, DOI 10.1152/ajpregu.00752.2005; Murase T, 2006, INT J OBESITY, V30, P561, DOI 10.1038/sj.ijo.0803135; Murase T, 2002, INT J OBESITY, V26, P1459, DOI 10.1038/sj.ijo.0802141; Niva T, 1999, ANN ZOOL FENN, V36, P103; Oka Takehiko, 2010, BMC Physiol, V10, P21, DOI 10.1186/1472-6793-10-21; Petro AE, 2004, METABOLISM, V53, P454, DOI 10.1016/j.metabol.2003.11.018; Refstie Stale, 2001, Aquaculture, V193, P91, DOI 10.1016/S0044-8486(00)00473-7; Regost C, 2001, AQUACULTURE, V193, P325, DOI 10.1016/S0044-8486(00)00498-1; Schreiner PJ, 1996, AM J EPIDEMIOL, V144, P335, DOI 10.1093/oxfordjournals.aje.a008934; Shen CL, 2012, NUTR RES, V32, P448, DOI 10.1016/j.nutres.2012.05.001; Shimotoyodome A, 2005, MED SCI SPORT EXER, V37, P1884, DOI 10.1249/01.mss.0000178062.66981.a8; Song Y, 2007, FASEB J, V21, P2042, DOI 10.1096/fj.06-7503com; Takahashi M, 1999, J NUTR SCI VITAMINOL, V45, P583, DOI 10.3177/jnsv.45.583; Truett AA, 1998, OBES RES, V6, P137, DOI 10.1002/j.1550-8528.1998.tb00328.x; Tschop M, 2001, EXP CLIN ENDOCR DIAB, V109, P307, DOI 10.1055/s-2001-17297; WARWICK ZS, 1992, NEUROSCI BIOBEHAV R, V16, P585, DOI 10.1016/S0149-7634(05)80198-8; Westerbacka J, 2004, DIABETOLOGIA, V47, P1360, DOI 10.1007/s00125-004-1460-1; Westerfield M, 2007, ZEBRAFISH BOOK EDITI; WIEGAND G, 1986, ANNU REV BIOPHYS BIO, V15, P97; World Health Organization, OB OV; Yang SY, 1999, ADV EXP MED BIOL, V466, P133	54	44	46	4	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2015	10	3							e0120142	10.1371/journal.pone.0120142	http://dx.doi.org/10.1371/journal.pone.0120142			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9BN	25785691	Green Published, gold, Green Submitted			2022-12-27	WOS:000352138500156
J	Oved, K; Cohen, A; Boico, O; Navon, R; Friedman, T; Etshtein, L; Kriger, O; Bamberger, E; Fonar, Y; Yacobov, R; Wolchinsky, R; Denkberg, G; Dotan, Y; Hochberg, A; Reiter, Y; Grupper, M; Srugo, I; Feigin, P; Gorfine, M; Chistyakov, I; Dagan, R; Klein, A; Potasman, I; Eden, E				Oved, Kfir; Cohen, Asi; Boico, Olga; Navon, Roy; Friedman, Tom; Etshtein, Liat; Kriger, Or; Bamberger, Ellen; Fonar, Yura; Yacobov, Renata; Wolchinsky, Ron; Denkberg, Galit; Dotan, Yaniv; Hochberg, Amit; Reiter, Yoram; Grupper, Moti; Srugo, Isaac; Feigin, Paul; Gorfine, Malka; Chistyakov, Irina; Dagan, Ron; Klein, Adi; Potasman, Israel; Eden, Eran			A Novel Host-Proteome Signature for Distinguishing between Acute Bacterial and Viral Infections	PLOS ONE			English	Article							C-REACTIVE PROTEIN; LOWER RESPIRATORY-TRACT; COMMUNITY-ACQUIRED PNEUMONIA; QUALITY-OF-CARE; ADULT PATIENTS; PROCALCITONIN; BIOMARKERS; CHILDREN; DIAGNOSIS; OUTCOMES	Bacterial and viral infections are often clinically indistinguishable, leading to inappropriate patient management and antibiotic misuse. Bacterial-induced host proteins such as procalcitonin, C-reactive protein (CRP), and Interleukin-6, are routinely used to support diagnosis of infection. However, their performance is negatively affected by inter-patient variability, including time from symptom onset, clinical syndrome, and pathogens. Our aim was to identify novel viral-induced host proteins that can complement bacterial-induced proteins to increase diagnostic accuracy. Initially, we conducted a bioinformatic screen to identify putative circulating host immune response proteins. The resulting 600 candidates were then quantitatively screened for diagnostic potential using blood samples from 1002 prospectively recruited patients with suspected acute infectious disease and controls with no apparent infection. For each patient, three independent physicians assigned a diagnosis based on comprehensive clinical and laboratory investigation including PCR for 21 pathogens yielding 319 bacterial, 334 viral, 112 control and 98 indeterminate diagnoses; 139 patients were excluded based on predetermined criteria. The best performing host-protein was TNF-related apoptosis-inducing ligand (TRAIL) (area under the curve [AUC] of 0.89; 95% confidence interval [CI], 0.86 to 0.91), which was consistently up-regulated in viral infected patients. We further developed a multi-protein signature using logistic-regression on half of the patients and validated it on the remaining half. The signature with the highest precision included both viral-and bacterial-induced proteins: TRAIL, Interferon gamma-induced protein-10, and CRP (AUC of 0.94; 95% CI, 0.92 to 0.96). The signature was superior to any of the individual proteins (P<0.001), as well as routinely used clinical parameters and their combinations (P<0.001). It remained robust across different physiological systems, times from symptom onset, and pathogens (AUCs 0.87-1.0). The accurate differential diagnosis provided by this novel combination of viral-and bacterial-induced proteins has the potential to improve management of patients with acute infections and reduce antibiotic misuse.	[Oved, Kfir; Cohen, Asi; Boico, Olga; Navon, Roy; Friedman, Tom; Etshtein, Liat; Kriger, Or; Bamberger, Ellen; Fonar, Yura; Eden, Eran] MeMed Diagnost, Tirat Carmel, Israel; [Friedman, Tom] Rambam Med Ctr, Haifa, Israel; [Etshtein, Liat; Bamberger, Ellen; Dotan, Yaniv; Grupper, Moti; Srugo, Isaac; Chistyakov, Irina; Potasman, Israel] Technion Israel Inst Technol, Rappaport Fac Med, Haifa, Israel; [Yacobov, Renata; Hochberg, Amit; Klein, Adi] Hillel Yaffe Med Ctr, Dept Pediat, Hadera, Israel; [Bamberger, Ellen; Srugo, Isaac; Chistyakov, Irina] Bnai Zion Med Ctr, Dept Pediat, Haifa, Israel; [Wolchinsky, Ron; Reiter, Yoram] Technion Israel Inst Technol, Fac Biol, Haifa, Israel; [Denkberg, Galit] Appl Immune Technol, Haifa, Israel; [Dotan, Yaniv] Bnai Zion Med Ctr, Dept Internal Med, Haifa, Israel; [Grupper, Moti; Potasman, Israel] Bnai Zion Med Ctr, Infect Dis Unit, Haifa, Israel; [Feigin, Paul; Gorfine, Malka] Technion Israel Inst Technol, Fac Ind Engn & Management, IL-32000 Haifa, Israel; [Dagan, Ron] Soroka Med Ctr, Pediat Infect Dis Unit, IL-84101 Beer Sheva, Israel; [Dagan, Ron] Soroka Med Ctr, Clin Microbiol Lab, IL-84101 Beer Sheva, Israel	Rambam Health Care Campus; Technion Israel Institute of Technology; Technion Israel Institute of Technology; Rappaport Faculty of Medicine; Bnai Zion Medical Center; Technion Israel Institute of Technology; Bnai Zion Medical Center; Bnai Zion Medical Center; Technion Israel Institute of Technology; Ben Gurion University; Soroka Medical Center; Ben Gurion University; Soroka Medical Center	Oved, K (corresponding author), MeMed Diagnost, Tirat Carmel, Israel.	kfiroved@me-med.com; eraneden@me-med.com	Gorfine, Malka/AAV-1242-2021; Oved, Kfir/AAP-6807-2021; Gorfine, Malka/AAD-1468-2022	Feigin, Paul/0000-0002-5665-0331; Oved, Kfir/0000-0003-3611-2218	MeMed	MeMed	This study was funded by MeMed. KO, AC, OB, RN, TF, LE, EB and EE are employed by MeMed. YF and OK were previously employed by MeMed. MeMed provided support in the form of salaries for authors KO, AC, OB, RN, TF, LE, EB, EE, YF and OK, and was responsible for protein measurements and multiparametric signature development. Clinical investigators and MeMed affiliated authors collaborated on the study design, data collection and analysis, decision to publish, and preparation of the manuscript as articulated in the 'author contributions' section. Galit Denkberg is employed by Applied Immune Technologies. GD contributed to this work in her free time without any compensation from MeMed or Applied Immune Technologies. Applied Immune Technologies did not have a role in the study, design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific role of this author is articulated in the ` author contributions' section.	[Anonymous], THREAT REPORT 2013; Bafadhel M, 2011, CHEST, V139, P1410, DOI 10.1378/chest.10-1747; Bertens LCM, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001531; Bogaert D, 2004, LANCET INFECT DIS, V4, P144, DOI 10.1016/S1473-3099(04)00938-7; Bossuyt PM, 2003, ANN INTERN MED, V138, P40, DOI 10.7326/0003-4819-138-1-200301070-00010; Caterino JM, 2008, BMC EMERG MED, V8, DOI 10.1186/1471-227X-8-6; Craig JC, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c1594; Engel MF, 2012, FAM PRACT, V29, P383, DOI 10.1093/fampra/cmr119; Falk G, 2009, FAM PRACT, V26, P10, DOI 10.1093/fampra/cmn095; Falschlehner C, 2009, IMMUNOLOGY, V127, P145, DOI 10.1111/j.1365-2567.2009.03058.x; Falsey AR, 2013, J INFECT DIS, V208, P432, DOI 10.1093/infdis/jit190; Gabay C, 1999, NEW ENGL J MED, V340, P448, DOI 10.1056/NEJM199902113400607; Galetto-Lacour A, 2003, PEDIATRICS, V112, P1054, DOI 10.1542/peds.112.5.1054; Gibot S, 2012, AM J RESP CRIT CARE, V186, P65, DOI 10.1164/rccm.201201-0037OC; Hall KK, 2006, CLIN MICROBIOL REV, V19, P788, DOI 10.1128/CMR.00062-05; Henriquez-Camacho C, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/547818; Houck PM, 2004, ARCH INTERN MED, V164, P637, DOI 10.1001/archinte.164.6.637; Kunze W, 2010, RESP INFECTIONS CHIL; Lacour AG, 2001, EUR J PEDIATR, V160, P95, DOI 10.1007/s004310000681; Laxminarayan R, 2013, LANCET INFECT DIS, V13, P1057, DOI 10.1016/S1473-3099(13)70318-9; Limper M, 2010, J INFECTION, V60, P409, DOI 10.1016/j.jinf.2010.03.016; Liu ML, 2011, CYTOKINE GROWTH F R, V22, P121, DOI 10.1016/j.cytogfr.2011.06.001; Lodise Thomas P., 2003, Clinical Infectious Diseases, V36, P1418, DOI 10.1086/375057; Meehan TP, 1997, JAMA-J AM MED ASSOC, V278, P2080, DOI 10.1001/jama.278.23.2080; Musher DM, 2014, J INFECT DIS, V209, P631, DOI 10.1093/infdis/jit579; Musher DM, 2013, J INFECTION, V67, P11, DOI 10.1016/j.jinf.2013.03.003; Pierrakos C, 2010, CRIT CARE, V14, DOI 10.1186/cc8872; Polzin A, 2003, EUR RESPIR J, V21, P939, DOI 10.1183/09031936.03.00055103; Proulx N, 2005, QJM-INT J MED, V98, P291, DOI 10.1093/qjmed/hci047; Quenot JP, 2013, ANN INTENSIVE CARE, V3, DOI 10.1186/2110-5820-3-21; Ramilo O, 2007, BLOOD, V109, P2066, DOI 10.1182/blood-2006-02-002477; Ramilo O, 2009, CELL HOST MICROBE, V6, P199, DOI 10.1016/j.chom.2009.08.007; Reinhart K, 2011, CRIT CARE CLIN, V27, P253, DOI 10.1016/j.ccc.2011.01.002; Rhedin S, 2014, PEDIATRICS, V133, pE538, DOI 10.1542/peds.2013-3042; Richter SS, 2002, J CLIN MICROBIOL, V40, P2437, DOI 10.1128/JCM.40.7.2437-2444.2002; Robriquet L, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-159; Rutjes AWS., 2007, HEALTH TECHNOL ASSES, V11, P1; Schuetz P, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007498.pub2; Shaikh N, 2010, PEDIATRICS, V126, pE557, DOI 10.1542/peds.2009-2648; Tang BMP, 2007, LANCET INFECT DIS, V7, P210, DOI 10.1016/S1473-3099(07)70052-X; Thayyil S, 2005, ACTA PAEDIATR, V94, P155, DOI 10.1080/08035250410025140; Thorburn K, 2006, THORAX, V61, P611, DOI 10.1136/thx.2005.048397; Van den Bruel A, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d3082; van der Meer V, 2005, BRIT MED J, V331, P26, DOI 10.1136/bmj.38483.478183.EB; Van Zuijlen DA, 2001, PEDIATR INFECT DIS J, V20, P140, DOI 10.1097/00006454-200102000-00004; WAAGE A, 1989, J EXP MED, V169, P333, DOI 10.1084/jem.169.1.333; Woodhead M, 2011, CLIN MICROBIOL INFEC, V17, pE1, DOI 10.1111/j.1469-0691.2011.03672.x; Woods CW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0052198; Zaas AK, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3006280; Zaas AK, 2009, CELL HOST MICROBE, V6, P207, DOI 10.1016/j.chom.2009.07.006	50	105	119	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2015	10	3							e0120012	10.1371/journal.pone.0120012	http://dx.doi.org/10.1371/journal.pone.0120012			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9BN	25785720	Green Published, gold, Green Submitted			2022-12-27	WOS:000352138500148
J	Pereira, I; Weber, S; Holzer, S; Fischer, G; Vass, C; Resch, H				Pereira, Ivania; Weber, Stephanie; Holzer, Stephan; Fischer, Georg; Vass, Clemens; Resch, Hemma			Compensation for Retinal Vessel Density Reduces the Variation of Circumpapillary RNFL in Healthy Subjects	PLOS ONE			English	Article							NERVE-FIBER LAYER; OPTICAL COHERENCE TOMOGRAPHY; SCANNING LASER POLARIMETRY; THICKNESS PROFILES; BLOOD-VESSELS; GDX VCC; GLAUCOMA; MECHANISMS; EYES; SIZE	This work intends to assess circumpapillary retinal vessel density (RVD) at a 3.46 mm diameter circle and correlate it with circumpapillary retinal nerve fiber layer (RNFL) thickness measured with Fourier-Domain Optical Coherence Tomography. Furthermore, it aims to evaluate the reduction of intersubject variability of RNFL when considering RVD as a source of information for RNFL distribution. For that, 106 healthy subjects underwent circumpapillary RNFL measurement. Using the scanning laser ophthalmoscope fundus image, thickness and position of retinal vessels were assessed and integrated in a 256-sector RVD profile. The relationship between local RVD value and local RNFL thickness was modeled by linear regression. RNFL was then compensated for RVD variation by regression formulas. A strong statistically significant intrasubject correlation was found for all subjects between RVD and RNFL profiles (mean R = 0.769). In the intersubject regression analysis, 247 of 256 RNFL sectors showed a statistically significant positive correlation with RVD (mean R = 0.423). RVD compensation of RNFL resulted in a relative reduction of up to 20% of the intersubject variance. In conclusion, RVD in a 3.46mm circle has a clinically relevant influence on the RNFL distribution. RVD may be used to develop more individualized normative values for RNFL measurement, which might improve early diagnosis of glaucoma.	[Pereira, Ivania; Fischer, Georg] Med Univ Vienna, Sect Med Informat Management & Imaging, Ctr Med Stat Informat & Intelligent Syst, Vienna, Austria; [Pereira, Ivania; Weber, Stephanie; Holzer, Stephan; Vass, Clemens; Resch, Hemma] Med Univ Vienna, Dept Ophthalmol & Optometry, Vienna, Austria	Medical University of Vienna; Medical University of Vienna	Resch, H (corresponding author), Med Univ Vienna, Dept Ophthalmol & Optometry, Vienna, Austria.	hemma.resch@meduniwien.ac.at	Vass, Clemens/AAZ-2564-2020; Fischer, Georg/Y-3059-2019	Vass, Clemens/0000-0003-4756-9088; Fischer, Georg/0000-0002-4033-2005; Resch, Hemma/0000-0001-9931-1834	Wiener Wissenschafts-, Forschungs- and Technologiefonds, WWTF [LS11-046]	Wiener Wissenschafts-, Forschungs- and Technologiefonds, WWTF	The study was funded by: Wiener Wissenschafts-, Forschungs- and Technologiefonds, WWTF - LS11-046. The persons responsible for the funding are GF and CV. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bowd C, 2002, J OPT SOC AM A, V19, P197, DOI 10.1364/JOSAA.19.000197; Bowd C, 2001, INVEST OPHTH VIS SCI, V42, P1993; Carmeliet P, 2005, NATURE, V436, P193, DOI 10.1038/nature03875; Chi Q M, 1995, J Glaucoma, V4, P406; Dorrell MI, 2006, PROG RETIN EYE RES, V25, P277, DOI 10.1016/j.preteyeres.2006.01.001; Funaki S, 1998, BRIT J OPHTHALMOL, V82, P1242, DOI 10.1136/bjo.82.11.1242; Hirasawa H, 2010, ARCH OPHTHALMOL-CHIC, V128, P1420, DOI 10.1001/archophthalmol.2010.244; Hong SW, 2010, INVEST OPHTH VIS SCI, V51, P3515, DOI 10.1167/iovs.09-4888; Hood DC, 2008, J GLAUCOMA, V17, P519, DOI 10.1097/IJG.0b013e3181629a02; Hood DC, 2010, J GLAUCOMA, V19, P158, DOI 10.1097/IJG.0b013e3181af31ec; Kanamori A, 2006, GRAEF ARCH CLIN EXP, V244, P58, DOI 10.1007/s00417-005-0029-0; Kanamori A, 2003, AM J OPHTHALMOL, V135, P513, DOI 10.1016/S0002-9394(02)02003-2; Kang SH, 2010, INVEST OPHTH VIS SCI, V51, P4075, DOI 10.1167/iovs.09-4737; Medeiros FA, 2004, ARCH OPHTHALMOL-CHIC, V122, P827, DOI 10.1001/archopht.122.6.827; Pereira I, 2014, BRIT J OPHTHALMOL, V98, P538, DOI 10.1136/bjophthalmol-2013-303910; Poinoosawmy D, 1997, BRIT J OPHTHALMOL, V81, P350, DOI 10.1136/bjo.81.5.350; Quigley HA, 2006, BRIT J OPHTHALMOL, V90, P262, DOI 10.1136/bjo.2005.081224; Resch H, 2011, BRIT J OPHTHALMOL, V95, P680, DOI 10.1136/bjo.2009.170068; Savini G, 2005, BRIT J OPHTHALMOL, V89, P489, DOI 10.1136/bjo.2004.052498; SCHUMAN JS, 1995, ARCH OPHTHALMOL-CHIC, V113, P586, DOI 10.1001/archopht.1995.01100050054031; STONE J, 1995, J NEUROSCI, V15, P4738, DOI 10.1523/jneurosci.15-07-04738.1995; Townsend KA, 2009, BRIT J OPHTHALMOL, V93, P139, DOI 10.1136/bjo.2008.145540; Yoo YC, 2012, OPTOMETRY VISION SCI, V89, P4, DOI 10.1097/OPX.0b013e3182358008	23	7	7	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2015	10	3							e0120378	10.1371/journal.pone.0120378	http://dx.doi.org/10.1371/journal.pone.0120378			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9BN	25786232	Green Published, gold, Green Submitted			2022-12-27	WOS:000352138500168
J	Poleszczuk, J; Hahnfeldt, P; Enderling, H				Poleszczuk, Jan; Hahnfeldt, Philip; Enderling, Heiko			Therapeutic Implications from Sensitivity Analysis of Tumor Angiogenesis Models	PLOS ONE			English	Article								Anti-angiogenic cancer treatments induce tumor starvation and regression by targeting the tumor vasculature that delivers oxygen and nutrients. Mathematical models prove valuable tools to study the proof-of-concept, efficacy and underlying mechanisms of such treatment approaches. The effects of parameter value uncertainties for two models of tumor development under angiogenic signaling and anti-angiogenic treatment are studied. Data fitting is performed to compare predictions of both models and to obtain nominal parameter values for sensitivity analysis. Sensitivity analysis reveals that the success of different cancer treatments depends on tumor size and tumor intrinsic parameters. In particular, we show that tumors with ample vascular support can be successfully targeted with conventional cytotoxic treatments. On the other hand, tumors with curtailed vascular support are not limited by their growth rate and therefore interruption of neovascularization emerges as the most promising treatment target.	[Poleszczuk, Jan; Hahnfeldt, Philip; Enderling, Heiko] Tufts Univ, Sch Med, GeneSys Res Inst, Ctr Canc Syst Biol, Boston, MA 02111 USA; [Poleszczuk, Jan] Univ Warsaw, Coll Interfac Individual Studies Math & Nat Sci, Warsaw, Poland	Tufts University; University of Warsaw	Poleszczuk, J (corresponding author), Univ S Florida, Coll Med, H Lee Moffitt Canc Ctr & Res Inst, Dept Integrated Math Oncol, Tampa, FL 33612 USA.	Jan.Poleszczuk@moffitt.org	Enderling, Heiko/AAA-2423-2021	Enderling, Heiko/0000-0002-9696-6410; Poleszczuk, Jan/0000-0001-8758-7200	Foundation for Polish Science; National Cancer Institute [U54CA149233]	Foundation for Polish Science(Foundation for Polish ScienceEuropean Commission); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This project was supported by the Foundation for Polish Science (JP) and the National Cancer Institute under Award Number U54CA149233 (to Lynn Hlatky). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Cancer Institute or the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bonate PL, 2011, PHARMACOKINETIC-PHARMACODYNAMIC MODELING AND SIMULATION, SECOND EDITION, P1, DOI 10.1007/978-1-4419-9485-1; BYRD RH, 1987, SIAM J NUMER ANAL, V24, P1152, DOI 10.1137/0724076; Cooke R., 2001, FOLKMANS WAR ANGIOGE; CUKIER RI, 1973, J CHEM PHYS, V59, P3873, DOI 10.1063/1.1680571; d'Onofrio A, 2004, MATH BIOSCI, V191, P159, DOI 10.1016/j.mbs.2004.06.003; Ergun A, 2003, B MATH BIOL, V65, P407, DOI 10.1016/S0092-8240(03)00006-5; FOLKMAN J, 1971, NEW ENGL J MED, V285, P1182; Fujita K, 2007, ONCOL REP, V18, P47; Hahnfeldt P, 1999, CANCER RES, V59, P4770; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Klamka J., 2013, CONTROL CYBERN, V42, P125, DOI DOI 10.1109/TSMCB.2011.2162234; Leach MO, 2005, BRIT J CANCER, V92, P1599, DOI 10.1038/sj.bjc.6602550; Ledzewicz U, 2008, J THEOR BIOL, V252, P295, DOI 10.1016/j.jtbi.2008.02.014; Loeb LA, 2001, CANCER RES, V61, P3230; MCKAY MD, 1979, TECHNOMETRICS, V21, P239, DOI 10.2307/1268522; Poleszczuk J, 2011, MATH BIOSCI ENG, V8, P591, DOI 10.3934/mbe.2011.8.591; Saltelli A, 1999, TECHNOMETRICS, V41, P39, DOI 10.2307/1270993	18	23	23	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2015	10	3							e0120007	10.1371/journal.pone.0120007	http://dx.doi.org/10.1371/journal.pone.0120007			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9BN	25785600	Green Published, gold, Green Submitted			2022-12-27	WOS:000352138500147
J	Samuel, MS; Abigail, EAM; Chidambaram, R				Samuel, Melvin S.; Abigail, Evy Alice M.; Chidambaram, Ramalingam			Isotherm Modelling, Kinetic Study and Optimization of Batch Parameters Using Response Surface Methodology for Effective Removal of Cr(VI) Using Fungal Biomass	PLOS ONE			English	Article							HEXAVALENT CHROMIUM; AQUEOUS-SOLUTIONS; BIOSORPTION; ADSORPTION; IONS; SORPTION; GASES; REDUCTION; EQUATIONS; CADMIUM	Biosorption is a promising alternative method to replace the existing conventional technique for Cr(VI) removal from the industrial effluent. In the present experimental design, the removal of Cr(VI) from the aqueous solution was studied by Aspergillus niger MSR4 under different environmental conditions in the batch systems. The optimum conditions of biosorption were determined by investigating pH (2.0) and temperature (27 degrees C). The effects of parameters such as biomass dosage (g/L), initial Cr(VI) concentration (mg/L) and contact time (min) on Cr(VI) biosorption were analyzed using a three parameter Box-Behnken design (BBD). The experimental data well fitted to the Langmuir isotherm, in comparison to the other isotherm models tested. The results of the D-R isotherm model suggested that a chemical ion-exchange mechanism was involved in the biosorption process. The biosorption process followed the pseudo-second-order kinetic model, which indicates that the rate limiting step is chemisorption process. Fourier transform infrared (FT-IR) spectroscopic studies revealed the possible involvement of functional groups, such as hydroxyl, carboxyl, amino and carbonyl group in the biosorption process. The thermodynamic parameters for Cr(VI) biosorption were also calculated, and the negative Delta G degrees values indicated the spontaneous nature of biosorption process.	[Samuel, Melvin S.; Abigail, Evy Alice M.; Chidambaram, Ramalingam] VIT Univ, Sch Biosci & Technol, Vellore, Tamil Nadu, India	Vellore Institute of Technology	Chidambaram, R (corresponding author), VIT Univ, Sch Biosci & Technol, Vellore, Tamil Nadu, India.	cramalingam@vit.ac.in	Chidambaram, Ramalingam/U-7922-2019	Chidambaram, Ramalingam/0000-0001-9549-7686	VIT University	VIT University	The authors are thankful to VIT University for providing laboratory facility and financial assistance. The isolated fungus was identified by Yaazh Xenomics, Chennai, India.	AHARONI C, 1991, SOIL SCI SOC AM J, V55, P1307, DOI 10.2136/sssaj1991.03615995005500050019x; Ajjabi LC, 2009, J ENVIRON MANAGE, V90, P3485, DOI 10.1016/j.jenvman.2009.06.001; Arica MY, 2005, COLLOID SURFACE A, V253, P203, DOI 10.1016/j.colsurfa.2004.11.012; Cheung CW, 2001, WATER RES, V35, P605, DOI 10.1016/S0043-1354(00)00306-7; Costa M, 2003, TOXICOL APPL PHARM, V188, P1, DOI 10.1016/S0041-008X(03)00011-5; Covelo EF, 2004, J COLLOID INTERF SCI, V280, P1, DOI 10.1016/j.jcis.2004.07.024; Deepa KK, 2006, CHEMOSPHERE, V62, P833, DOI 10.1016/j.chemosphere.2005.04.087; DUBININ MM, 1960, CHEM REV, V60, P235, DOI 10.1021/cr60204a006; Edrissi M, 2008, TURK J CHEM, V32, P505; Elangovan R, 2008, J HAZARD MATER, V152, P100, DOI 10.1016/j.jhazmat.2007.06.067; Farooq U, 2010, BIORESOURCE TECHNOL, V101, P5043, DOI 10.1016/j.biortech.2010.02.030; Freundlich H, 1906, Z PHYS CHEM-STOCH VE, V57, P385; Gupta VK, 2001, WATER RES, V35, P1125, DOI 10.1016/S0043-1354(00)00389-4; HALSEY G, 1948, J CHEM PHYS, V16, P931, DOI 10.1063/1.1746689; Harkins WD, 1944, J CHEM PHYS, V12, P112, DOI 10.1063/1.1723913; Ho YS, 2006, WATER RES, V40, P119, DOI 10.1016/j.watres.2005.10.040; Ho YS, 2004, SCIENTOMETRICS, V59, P171, DOI 10.1023/B:SCIE.0000013305.99473.cf; Kang SY, 2007, BIOCHEM ENG J, V36, P54, DOI 10.1016/j.bej.2006.06.005; KATZ SA, 1993, J APPL TOXICOL, V13, P217, DOI 10.1002/jat.2550130314; KAUFMAN DB, 1970, AM J DIS CHILD, V119, P374, DOI 10.1001/archpedi.1970.02100050376021; Kocberber N, 2007, BIORESOURCE TECHNOL, V98, P2178, DOI 10.1016/j.biortech.2006.08.017; Kotas J, 2000, ENVIRON POLLUT, V107, P263, DOI 10.1016/S0269-7491(99)00168-2; Langmuir I, 1918, J AM CHEM SOC, V40, P1361, DOI 10.1021/ja02242a004; Liu T, 2007, WORLD J MICROB BIOT, V23, P1685, DOI 10.1007/s11274-007-9416-5; LOW MJD, 1960, CHEM REV, V60, P267, DOI 10.1021/cr60205a003; Malkoc E, 2007, CHEM ENG PROCESS, V46, P1020, DOI 10.1016/j.cep.2007.05.007; Mungasavalli DP, 2007, COLLOID SURFACE A, V301, P214, DOI 10.1016/j.colsurfa.2006.12.060; Ozer A, 2003, J HAZARD MATER, V100, P219, DOI 10.1016/S0304-3894(03)00109-2; Ozer A, 2009, CHEM ENG J, V146, P377, DOI 10.1016/j.cej.2008.06.041; Park D, 2005, CHEMOSPHERE, V60, P1356, DOI 10.1016/j.chemosphere.2005.02.020; Prakasham RS, 1999, ENVIRON POLLUT, V104, P421, DOI 10.1016/S0269-7491(98)00174-2; Ramrakhiani L, 2011, CHEM ENG J, V171, P1060, DOI 10.1016/j.cej.2011.05.002; Sanghi R, 2009, J HAZARD MATER, V169, P1074, DOI 10.1016/j.jhazmat.2009.04.056; Say R, 2004, ENG LIFE SCI, V4, P276, DOI 10.1002/elsc.200420032; Shen L, 2007, J CENT SOUTH UNIV T, V14, P157, DOI 10.1007/s11771-007-0032-1; Temkin M.I., 1940, ACTA PHYSIOCHIM, V2, P217, DOI DOI 10.1016/J.JHAZMAT.2008.12.093; Tewari N, 2005, BIOCHEM ENG J, V23, P185, DOI 10.1016/j.bej.2005.01.011; U.S, 1988, TOX REV HEX CHROM; Vieira Regine H. S. F., 2000, International Microbiology, V3, P17; WANG YT, 1995, J IND MICROBIOL, V14, P159, DOI 10.1007/BF01569898; Weber W.J., 1963, J SANIT ENG DIV, V89, P31, DOI [10.1061/JSEDAI.0000430, DOI 10.1061/JSEDAI.0000430]; Yang L, 2008, BIORESOURCE TECHNOL, V99, P297, DOI 10.1016/j.biortech.2006.12.021	42	49	50	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2015	10	3							e0116884	10.1371/journal.pone.0116884	http://dx.doi.org/10.1371/journal.pone.0116884			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9BN	25786227	Green Published, gold, Green Submitted			2022-12-27	WOS:000352138500014
J	Zhang, Q; Li, Y; Han, T; Nie, CY; Cai, JJ; Liu, H; Liu, Y				Zhang, Qian; Li, Ying; Han, Tao; Nie, CaiYun; Cai, JunJun; Liu, Hua; Liu, Ying			Comparison of Current Diagnostic Criteria for Acute-On-Chronic Liver Failure	PLOS ONE			English	Article							CIRRHOTIC-PATIENTS; SERUM SODIUM; ACUTE DECOMPENSATION; PROGNOSTIC MODELS; INTENSIVE-CARE; ORGAN FAILURE; WAITING-LIST; MORTALITY; DISEASE; SCORE	Background and Aims Currently, acute-on-chronic liver failure (ACLF) has been defined differently by Asia-Pacific Association for the Study of the Liver (APASL) and Chinese Medical Association (CMA) in the East, as well as EASL-Chronic Liver Failure (EASL-CLIF) Consortium in the West. This study aimed to compare current different diagnostic criteria for ACLF and to determine predictors of the progression into post-enrollment EASL-CLIF ACLF from ACLF at enrollment defined by APASL alone or by both APASL and CMA but not by EASL-CLIF Consortium. Methods We retrospectively analyzed clinical data from 394 eligible cirrhotic patients fulfilling at least APASL criteria for ACLF at enrollment. Patient survival was estimated by Kaplan-Meier analysis and subsequently compared by log-rank test. Independent predictors of disease progression were determined using univariate analysis and multivariate Cox regression analysis. Results The 90-day mortality rate was 13.1% in patients with ACLF at enrollment defined by APASL alone, 25.3% in patients with ACLF at enrollment defined by both APASL and CMA but not EASL-CLIF Consortium, and 59.3% in patients with ACLF at enrollment defined by EASL-CLIF Consortium in addition to APASL. Baseline Chronic Liver Failure-Sequential Organ Failure Assessment (CLIF-SOFA) score, and the maximum rising rates of CLIF-SOFA score, Model for End-Stage Liver Disease-Sodium (MELD-Na) score and total bilirubin were independent predictors of progression into post-enrollment EASL-CLIF ACLF from ACLF at enrollment defined by APASL alone or by both APASL and CMA but not by EASL-CLIF Consortium. Conclusion Different diagnostic criteria for ACLF caused different patient prognosis. So, it is imperative to formulate a unifying diagnostic criteria for ACLF worldwide, thus attaining early identification and treatment, and eventual improvement in survival of ACLF patients. Baseline CLIF-SOFA score, and the maximum rising rates of CLIF-SOFA score, MELD-Na score and total bilirubin may early predict post-enrollment development of EASL-CLIF ACLF.	[Zhang, Qian; Nie, CaiYun; Cai, JunJun] Tianjin Med Univ, Cent Clin Coll 3, Tianjin, Peoples R China; [Zhang, Qian; Li, Ying; Han, Tao; Nie, CaiYun; Cai, JunJun; Liu, Hua; Liu, Ying] Tianjin Third Cent Hosp, Dept Hepatol, Tianjin, Peoples R China; [Li, Ying; Han, Tao; Liu, Hua; Liu, Ying] Tianjin Inst Hepatobiliary Dis, Tianjin, Peoples R China; [Li, Ying; Han, Tao; Liu, Hua; Liu, Ying] Tianjin Key Lab Artificial Cells, Tianjin, Peoples R China	Tianjin Medical University	Han, T (corresponding author), Tianjin Third Cent Hosp, Dept Hepatol, Tianjin, Peoples R China.	hantaomd@126.com			National 12th 5-year Plan for Hepatitis Research [2012ZX10002004-011]; Tianjin Science and Technology Fund, China [13RCGFSY19200]	National 12th 5-year Plan for Hepatitis Research; Tianjin Science and Technology Fund, China	This study was supported by the National 12th 5-year Plan for Hepatitis Research (No. 2012ZX10002004-011) and Tianjin Science and Technology Fund, China (No. 13RCGFSY19200). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bajaj JS, 2013, GASTROENTEROLOGY, V144, P1337, DOI 10.1053/j.gastro.2013.04.024; Biggins SW, 2006, GASTROENTEROLOGY, V130, P1652, DOI 10.1053/j.gastro.2006.02.010; Cholongitas E, 2006, ALIMENT PHARM THER, V23, P883, DOI 10.1111/j.1365-2036.2006.02842.x; Fayad L, 2015, ANN HEPATOL, V14, P83, DOI 10.1016/S1665-2681(19)30804-X; Garg H, 2012, DIGEST LIVER DIS, V44, P166, DOI 10.1016/j.dld.2011.08.029; Gines P, 2008, HEPATOLOGY, V48, P1002, DOI 10.1002/hep.22418; Hassan EA, 2013, ARAB J GASTROENTEROL, V14, P158, DOI 10.1016/j.ajg.2013.08.007; Hsu CY, 2010, DIGEST LIVER DIS, V42, P137, DOI 10.1016/j.dld.2009.06.004; Huang K, 2011, WORLD J GASTROENTERO, V17, P3448, DOI 10.3748/wjg.v17.i29.3448; Jalan R, 2012, CRIT CARE, V16, DOI 10.1186/cc11882; Jalan R, 2012, J HEPATOL, V57, P1336, DOI 10.1016/j.jhep.2012.06.026; Kim TY, 2013, CLIN MOL HEPATOL, V19, P349, DOI 10.3350/cmh.2013.19.4.349; Kim WR, 2008, NEW ENGL J MED, V359, P1018, DOI 10.1056/NEJMoa0801209; Kumar R, 2014, GASTROENTER IN PRESS; Laleman W, 2011, EXPERT REV GASTROENT, V5, P523, DOI [10.1586/egh.11.47, 10.1586/EGH.11.47]; Liver Failure and Artificial Liver Group Chinese Society of Infectious Diseases Chinese Medical Association, 2013, Zhonghua Gan Zang Bing Za Zhi, V21, P177; Lv XH, 2009, J GASTROEN HEPATOL, V24, P1547, DOI 10.1111/j.1440-1746.2009.05913.x; Malinchoc M, 2000, HEPATOLOGY, V31, P864, DOI 10.1053/he.2000.5852; Marroni CP, 2012, CLIN TRANSPLANT, V26, pE395, DOI 10.1111/j.1399-0012.2012.01688.x; Martin P Y, 1997, Praxis (Bern 1994), V86, P1194; Moreau R, 2014, CLIN GASTRO IN PRESS; Moreau R, 2013, GASTROENTEROLOGY, V144, P1426, DOI 10.1053/j.gastro.2013.02.042; Olson JC, 2011, HEPATOLOGY, V54, P1864, DOI 10.1002/hep.24622; Olson JC, 2011, CURR OPIN CRIT CARE, V17, P165, DOI 10.1097/MCC.0b013e328344b42d; PUGH RNH, 1973, BRIT J SURG, V60, P646, DOI 10.1002/bjs.1800600817; Ruf AE, 2005, LIVER TRANSPLANT, V11, P336, DOI 10.1002/lt.20329; Said A, 2004, J HEPATOL, V40, P897, DOI 10.1016/j.jhep.2004.02.010; Sarin SK, 2014, HEPATOL INT, V8, P453, DOI 10.1007/s12072-014-9580-2; Tsai MH, 2004, DIGESTION, V69, P190, DOI 10.1159/000078789; Wlodzimirow KA, 2013, LIVER INT, V33, P40, DOI 10.1111/j.1478-3231.2012.02790.x; Xia Q, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064379; Zheng YB, 2013, INT J MED SCI, V10, P1658, DOI 10.7150/ijms.6415	32	35	43	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2015	10	3							e0122158	10.1371/journal.pone.0122158	http://dx.doi.org/10.1371/journal.pone.0122158			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9BN	25785855	Green Published, Green Submitted, gold			2022-12-27	WOS:000352138500221
J	Zhao, J; Li, H; Fu, SB; Chen, B; Sun, WT; Zhang, JQ; Zhang, JF				Zhao, Jian; Li, Hui; Fu, Shuangbin; Chen, Bo; Sun, Wenting; Zhang, Junqi; Zhang, Jinfeng			An iTRAQ-Based Proteomics Approach to Clarify the Molecular Physiology of Somatic Embryo Development in Prince Rupprecht's Larch (Larix principis-rupprechtii Mayr)	PLOS ONE			English	Article							MEDICAGO-TRUNCATULA; OXIDATIVE STRESS; BINDING-PROTEIN; AUXIN TRANSPORT; PLANT-CELLS; EMBRYOGENESIS; ARABIDOPSIS; INDUCTION; KINASE; GENES	Prince Rupprecht's larch (Larix principis-rupprechtii Mayr) is a native high-value forest tree species in North China whose clonal propagation through somatic embryogenesis (SE) has the potential to rapidly capture the benefits of breeding or genetic engineering programs and to improve raw material uniformity and quality. To date, research has focused on clarifying the molecular mechanism of SE, but proteomic studies are still in the early stages. In this study, isobaric tags for relative and absolute quantitation (iTRAQ) analysis was performed on three developmental stages of SE in L. principis-rupprechtii in an attempt to identify a wide range of proteins that are regulated differentially during this process. Proteins were extracted and analyzed from the pro-embryogenic mass (PEM), globular embryo (GE), and cotyledon embryo (CE) stages of embryo development. We detected 503 proteins in total and identified 96 proteins expressed differentially during different developmental stages. The identified proteins were analyzed further to provide information about their expression patterns and functions during SE. Four clusters of proteins based on shared expression profiles were generated. Functional analysis showed that proteins involved in primary metabolism, phosphorylation, and oxidation reduction were upregulated during somatic embryo development. This work provides novel insights into the process of larch embryo development in vitro and a basis for further study of the biological process and opportunities for practical application of this knowledge.	[Zhao, Jian; Li, Hui; Fu, Shuangbin; Chen, Bo; Sun, Wenting; Zhang, Junqi; Zhang, Jinfeng] Beijing Forestry Univ, Tree & Ornamental Plant Breeding & Biotechnol Lab, State Forestry Adm,Coll Biol Sci & Biotechnol,Min, Natl Engn Lab Tree Breeding,Key Lab Genet & Breed, Beijing 100083, Peoples R China	Beijing Forestry University	Zhang, JF (corresponding author), Beijing Forestry Univ, Tree & Ornamental Plant Breeding & Biotechnol Lab, State Forestry Adm,Coll Biol Sci & Biotechnol,Min, Natl Engn Lab Tree Breeding,Key Lab Genet & Breed, Beijing 100083, Peoples R China.	zjf@bjfu.edu.cn			"948" Project of China [2014-4-59]; Program for Changjiang Scholars and Innovative Research Team in University [IRT13047]; Special Fund for Forestry Scientific Research in the Public Interest [201404422]; Project of National Natural Science Foundation of China [J1103516, 31370658]	"948" Project of China; Program for Changjiang Scholars and Innovative Research Team in University(Program for Changjiang Scholars & Innovative Research Team in University (PCSIRT)); Special Fund for Forestry Scientific Research in the Public Interest; Project of National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by "948" Project of China (2014-4-59), Program for Changjiang Scholars and Innovative Research Team in University (IRT13047), the Special Fund for Forestry Scientific Research in the Public Interest (No. 201404422) and the Project of National Natural Science Foundation of China (J1103516 and 31370658). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agati G, 2012, PLANT SCI, V196, P67, DOI 10.1016/j.plantsci.2012.07.014; Almeida AM, 2012, PHYSIOL PLANTARUM, V146, P236, DOI 10.1111/j.1399-3054.2012.01633.x; Bian FH, 2010, PLANT MOL BIOL REP, V28, P22, DOI 10.1007/s11105-009-0104-5; Boutilier K, 2002, PLANT CELL, V14, P1737, DOI 10.1105/tpc.001941; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Bunney TD, 2001, P NATL ACAD SCI USA, V98, P4249, DOI 10.1073/pnas.061437498; Cabiscol E, 2000, J BIOL CHEM, V275, P27393; Carrari F, 2006, J EXP BOT, V57, P1883, DOI 10.1093/jxb/erj020; Cassells AC, 2001, PLANT CELL TISS ORG, V64, P145, DOI 10.1023/A:1010692104861; Chivasa S, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.003905; Clague MJ, 2010, CELL, V143, P682, DOI 10.1016/j.cell.2010.11.012; Coppolino MG, 2002, J BIOL CHEM, V277, P43849, DOI 10.1074/jbc.M209046200; Correia S, 2012, J PROTEOME RES, V11, P1666, DOI 10.1021/pr200856w; Dalal K, 2011, TRENDS CELL BIOL, V21, P506, DOI 10.1016/j.tcb.2011.04.005; Desrivieres S, 1998, J BIOL CHEM, V273, P15787, DOI 10.1074/jbc.273.25.15787; DevilleBonne D, 1996, BIOCHEMISTRY-US, V35, P14643, DOI 10.1021/bi960945m; Ek-Ramos MJ, 2003, PHYSIOL PLANTARUM, V119, P270, DOI 10.1034/j.1399-3054.2003.00171.x; Fait A, 2006, PLANT PHYSIOL, V142, P839, DOI 10.1104/pp.106.086694; Feher A, 2003, PLANT CELL TISS ORG, V74, P201, DOI 10.1023/A:1024033216561; Gaj MD, 2005, PLANTA, V222, P977, DOI 10.1007/s00425-005-0041-y; Gazzarrini S, 2004, DEV CELL, V7, P373, DOI 10.1016/j.devcel.2004.06.017; Gendra E, 2004, PLANT J, V38, P875, DOI 10.1111/j.1365-313X.2004.02095.x; Imin N, 2005, PLANT PHYSIOL, V137, P1250, DOI 10.1104/pp.104.055277; Jo L, 2014, TREE PHYSIOL, V34, P94, DOI 10.1093/treephys/tpt102; Kambiranda D, 2014, J PROTEOME RES, V13, P555, DOI 10.1021/pr400731p; Kitakura S, 2011, PLANT CELL, V23, P1920, DOI 10.1105/tpc.111.083030; Kitamiya E, 2000, PLANT CELL REP, V19, P551, DOI 10.1007/s002990050772; Koizumi N, 1996, PLANT CELL PHYSIOL, V37, P862, DOI 10.1093/oxfordjournals.pcp.a029023; KONG LS, 1994, PLANT SCI, V104, P71, DOI 10.1016/0168-9452(94)90192-9; Laohavisit A, 2011, NEW PHYTOL, V189, P40, DOI 10.1111/j.1469-8137.2010.03533.x; Larsson E, 2008, NEW PHYTOL, V177, P356, DOI 10.1111/j.1469-8137.2007.02289.x; Lippert D, 2005, PROTEOMICS, V5, P461, DOI 10.1002/pmic.200400986; Luan S, 2002, PLANT CELL, V14, pS389, DOI 10.1105/tpc.001115; Malerba M, 2008, PHYSIOL PLANTARUM, V133, P449, DOI 10.1111/j.1399-3054.2008.01085.x; Marsoni M, 2008, PLANT CELL REP, V27, P347, DOI 10.1007/s00299-007-0438-0; Moss SE, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-4-219; Neilson KA, 2011, PROTEOMICS, V11, P1696, DOI 10.1002/pmic.201000727; Pan ZY, 2010, PLANT CELL TISS ORG, V103, P145, DOI 10.1007/s11240-010-9762-0; Pan ZY, 2009, PLANT CELL REP, V28, P281, DOI 10.1007/s00299-008-0633-7; Peer WA, 2007, TRENDS PLANT SCI, V12, P556, DOI 10.1016/j.tplants.2007.10.003; Pliyev BK, 1999, BIOCHEMISTRY-MOSCOW+, V64, P738; Rabl J, 2011, SCIENCE, V331, P730, DOI 10.1126/science.1198308; Ramakrishnan V, 2011, SCIENCE, V331, P681, DOI 10.1126/science.1202093; Randazzo PA, 2000, P NATL ACAD SCI USA, V97, P4011, DOI 10.1073/pnas.070552297; Rigbolt KTG, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.O110.007450; Roberts MR, 2002, PLANT MOL BIOL, V50, P1031, DOI 10.1023/A:1021261614491; Rode C, 2012, PLANTA, V235, P995, DOI 10.1007/s00425-011-1554-1; Schmidt EDL, 1997, DEVELOPMENT, V124, P2049; Sghaier-Hammami B, 2009, J PROTEOMICS, V73, P161, DOI 10.1016/j.jprot.2009.07.003; Smertenko A, 2011, CELL DEATH DIFFER, V18, P1263, DOI 10.1038/cdd.2011.39; Sun LF, 2013, PLANT CELL TISS ORG, V113, P103, DOI 10.1007/s11240-012-0255-1; Sun TT, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00512; Teyssier C, 2014, PHYSIOL PLANTARUM, V150, P271, DOI 10.1111/ppl.12081; Varhanikova M, 2014, J PROTEOMICS, V104, P57, DOI 10.1016/j.jprot.2014.02.003; Wiweger M, 2003, J EXP BOT, V54, P2691, DOI 10.1093/jxb/erg299; Yang QS, 2012, MOL CELL PROTEOMICS, V11, P1853, DOI 10.1074/mcp.M112.022079; Zhang JW, 2009, PLANT SCI, V177, P103, DOI 10.1016/j.plantsci.2009.04.003; Zhang SG, 2010, PLANT CELL TISS ORG, V100, P21, DOI 10.1007/s11240-009-9612-0; Zhao J, 2015, PLANT CELL TISS ORG, V120, P655, DOI 10.1007/s11240-014-0633-y; ZIMMERMAN JL, 1993, PLANT CELL, V5, P1411, DOI 10.1105/tpc.5.10.1411; Zuo JR, 2002, PLANT J, V30, P349, DOI 10.1046/j.1365-313X.2002.01289.x	61	7	8	0	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2015	10	3							e0119987	10.1371/journal.pone.0119987	http://dx.doi.org/10.1371/journal.pone.0119987			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7QC	25781987	Green Submitted, Green Published, gold			2022-12-27	WOS:000351284600115
J	Aguilera, SE; Cole, J; Finkbeiner, EM; Le Cornu, E; Ban, NC; Carr, MH; Cinner, JE; Crowder, LB; Gelcich, S; Hicks, CC; Kittinger, JN; Martone, R; Malone, D; Pomeroy, C; Starr, RM; Seram, S; Zuercher, R; Broad, K				Aguilera, Stacy E.; Cole, Jennifer; Finkbeiner, Elena M.; Le Cornu, Elodie; Ban, Natalie C.; Carr, Mark H.; Cinner, Joshua E.; Crowder, Larry B.; Gelcich, Stefan; Hicks, Christina C.; Kittinger, John N.; Martone, Rebecca; Malone, Daniel; Pomeroy, Carrie; Starr, Richard M.; Seram, Sanah; Zuercher, Rachel; Broad, Kenneth			Managing Small-Scale Commercial Fisheries for Adaptive Capacity: Insights from Dynamic Social-Ecological Drivers of Change in Monterey Bay	PLOS ONE			English	Article							CLIMATE-CHANGE; SUSTAINABILITY; MANAGEMENT; OUTCOMES; RISK; FISH	Globally, small-scale fisheries are influenced by dynamic climate, governance, and market drivers, which present social and ecological challenges and opportunities. It is difficult to manage fisheries adaptively for fluctuating drivers, except to allow participants to shift effort among multiple fisheries. Adapting to changing conditions allows small-scale fishery participants to survive economic and environmental disturbances and benefit from optimal conditions. This study explores the relative influence of large-scale drivers on shifts in effort and outcomes among three closely linked fisheries in Monterey Bay since the Magnuson-Stevens Fisheries Conservation and Management Act of 1976. In this region, Pacific sardine (Sardinops sagax), northern anchovy (Engraulis mordax), and market squid (Loligo opalescens) fisheries comprise a tightly linked system where shifting focus among fisheries is a key element to adaptive capacity and reduced social and ecological vulnerability. Using a cluster analysis of landings, we identify four modes from 1974 to 2012 that are dominated (i.e., a given species accounting for the plurality of landings) by squid, sardine, anchovy, or lack any dominance, and seven points of transition among these periods. This approach enables us to determine which drivers are associated with each mode and each transition. Overall, we show that market and climate drivers are predominantly attributed to dominance transitions. Model selection of external drivers indicates that governance phases, reflected as perceived abundance, dictate long-term outcomes. Our findings suggest that globally, small-scale fishery managers should consider enabling shifts in effort among fisheries and retaining existing flexibility, as adaptive capacity is a critical determinant for social and ecological resilience.	[Aguilera, Stacy E.; Broad, Kenneth] Univ Miami, Leonard & Jayne Abess Ctr Ecosyst Sci & Policy, Coral Gables, FL 33124 USA; [Cole, Jennifer; Finkbeiner, Elena M.; Crowder, Larry B.] Stanford Univ, Hopkins Marine Stn, Pacific Grove, CA 93950 USA; [Le Cornu, Elodie; Crowder, Larry B.; Hicks, Christina C.; Kittinger, John N.; Martone, Rebecca] Stanford Univ, Stanford Woods Inst Environm, Ctr Ocean Solut, Monterey, CA 93940 USA; [Ban, Natalie C.] Univ Victoria, Sch Environm Studies, Victoria, BC V8W 2Y2, Canada; [Carr, Mark H.] Univ Calif Santa Cruz, Long Marine Lab, Ecol & Evolutionary Biol, Santa Cruz, CA 95060 USA; [Cinner, Joshua E.; Hicks, Christina C.] James Cook Univ, Australian Res Council, Ctr Excellence Coral Reef Studies, Townsville, Qld 4811, Australia; [Gelcich, Stefan] Pontificia Univ Catolica Chile, Ctr Appl Ecol & Sustainabil CAPES, Fac Ciencias Biol, Santiago, Chile; [Gelcich, Stefan] Pontificia Univ Catolica Chile, Ctr Conservac Marina, Fac Ciencias Biol, Dept Ecol, Santiago, Chile; [Kittinger, John N.] Betty & Gordon Moore Ctr Sci & Oceans, Conservat Int, Honolulu, HI 96825 USA; [Pomeroy, Carrie] Univ Calif Santa Cruz, Univ Calif Sea Grant Extens Program, Ctr Ocean Hlth, Santa Cruz, CA 95060 USA; [Pomeroy, Carrie] Univ Calif Santa Cruz, Inst Marine Sci, Ctr Ocean Hlth, Santa Cruz, CA 95060 USA; [Starr, Richard M.] Univ Calif Sea Grant Extens Program, Moss Landing Marine Labs, Moss Landing, CA 95039 USA; [Zuercher, Rachel] McGill Univ, McGill Sch Environm, Montreal, PQ H3A 2A7, Canada	University of Miami; Stanford University; Stanford University; University of Victoria; University of California System; University of California Santa Cruz; James Cook University; Pontificia Universidad Catolica de Chile; Pontificia Universidad Catolica de Chile; Conservation International; University of California System; University of California Santa Cruz; University of California System; University of California Santa Cruz; Moss Landing Marine Laboratories; McGill University	Aguilera, SE (corresponding author), Univ Miami, Leonard & Jayne Abess Ctr Ecosyst Sci & Policy, 1365 Mem Dr,Ungar Bldg 230M, Coral Gables, FL 33124 USA.	s.aguilera1@umiami.edu	Hicks, Christina/M-6182-2015; Cinner, Joshua/AAA-6823-2021; Cinner, Joshua e/E-8966-2011	Hicks, Christina/0000-0002-7399-4603; Cinner, Joshua e/0000-0003-2675-9317; Ban, Natalie/0000-0002-4682-2144	Center for Ocean Solutions at Stanford University; David and Lucile and Packard Foundation; Leonard and Jayne Abess Center for Ecosystem Science and Policy at the University of Miami	Center for Ocean Solutions at Stanford University; David and Lucile and Packard Foundation; Leonard and Jayne Abess Center for Ecosystem Science and Policy at the University of Miami	This work was supported by the Center for Ocean Solutions at Stanford University (LCB) (http://www.centerforoceansolutions.org), the David and Lucile and Packard Foundation (LCB) (http://www.packard.org), and the Leonard and Jayne Abess Center for Ecosystem Science and Policy at the University of Miami (KB) (http://abess.miami.edu). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allison EH, 2001, MAR POLICY, V25, P377, DOI 10.1016/S0308-597X(01)00023-9; Anderson SC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024368; Andrew NL, 2007, FISH FISH, V8, P227, DOI 10.1111/j.1467-2679.2007.00252.x; Aseltine-Neilson D, 2006, CAL COOP OCEAN FISH, V47, P9; Badjeck M.-C., 2008, THESIS U BREMEN; Badjeck MC, 2010, MAR POLICY, V34, P375, DOI 10.1016/j.marpol.2009.08.007; Bakgaard M., 1992, Fishing for development: small scale fisheries in Africa., P173; BAKUN A, 1990, SCIENCE, V247, P198, DOI 10.1126/science.247.4939.198; Berkes F., 2003, ENVIRONMENTS, V31, P5; Berkes F., 2001, MANAGING SMALL SCALE; Bodin O, 2012, GLOBAL ENVIRON CHANG, V22, P430, DOI 10.1016/j.gloenvcha.2012.01.005; BREAKER LC, 1994, OCEANOGR MAR BIOL, V32, P1; Brewer JF, 2011, ECOL SOC, V16; BUTLER JL, 1989, FISH B-NOAA, V87, P645; CalCOFI, 1984, CAL COOP OCEAN FISH, V25, P7; California Department of Fish and Wildlife, 2014, 2014 CAL LEG FISH FO; California Department of Fish and Wildlife, 2013, TABL 18 PUB POUND VA; California Wetfish Producers Association, 2013, CAL WETF IND TRAD IN; Chavez FP, 2003, SCIENCE, V299, P217, DOI 10.1126/science.1075880; Chen C, 2012, ESTABLISHING BASELIN; Chuenpagdee R, 2006, 148 FISH CTR, V14, P1, DOI DOI 10.14288/1.0074761; Cinner JE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074321; Cinner JE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011999; Clark C.W., 1990, MATH BIOECONOMICS OP; Dalton MG, 2001, J ENVIRON ECON MANAG, V42, P336, DOI 10.1006/jeem.2000.1158; Degnbol P, 2007, ICES J MAR SCI, V64, P793, DOI 10.1093/icesjms/fsm040; Ernst B, 2013, GLOBAL ENVIRON CHANG, V23, P1381, DOI 10.1016/j.gloenvcha.2013.08.002; Essington TE, 2006, P NATL ACAD SCI USA, V103, P3171, DOI 10.1073/pnas.0510964103; Evans LS, 2013, HUM ECOL, V41, P841, DOI 10.1007/s10745-013-9601-0; Food and Agriculture Organization, 2012, FAO WORKSH INT GUID; Gelcich S, 2010, P NATL ACAD SCI USA, V107, P16794, DOI 10.1073/pnas.1012021107; Hanan D, 1996, CAL COOP OCEAN FISH, V37, P7; Hilborn R, 2001, CAN J FISH AQUAT SCI, V58, P99, DOI 10.1139/cjfas-58-1-99; Hilborn R, 2007, AMBIO, V36, P296, DOI 10.1579/0044-7447(2007)36[296:MTSBLF]2.0.CO;2; Hobday AJ, 2011, VULNERABILITY TROPIC, P493; Holland DS, 1999, CAN J FISH AQUAT SCI, V56, P253, DOI 10.1139/cjfas-56-2-253; Jacquet J, 2008, CONSERV BIOL, V22, P832, DOI 10.1111/j.1523-1739.2008.00978.x; Johnson J, 2005, SMALL SCALE ARTISANA, V1, P1; Kasperski S, 2013, P NATL ACAD SCI USA, V110, P2076, DOI 10.1073/pnas.1212278110; Kittinger JN, 2013, CURR OPIN ENV SUST, V5, P352, DOI 10.1016/j.cosust.2013.06.008; Kittinger JN, 2013, PAC SCI, V67, P315, DOI 10.2984/67.3.1; Koslow JA, 2011, CAL COOP OCEAN FISH, V52, P205; Le Gallic B, 2006, P 13 IIFET C 2006 JU; LYNN RJ, 1983, GEOPHYS RES LETT, V10, P1093, DOI 10.1029/GL010i011p01093; Martin TG, 2012, CONSERV BIOL, V26, P29, DOI 10.1111/j.1523-1739.2011.01806.x; MCCAY BJ, 1978, HUM ECOL, V6, P397, DOI 10.1007/BF00889417; McEvoy Arthur, 1986, FISHERMANS PROBLEM E; National Research Council, 1999, SHAR FISH NAT POL IN; Nislow KH, 2006, FRESHWATER BIOL, V51, P388, DOI 10.1111/j.1365-2427.2005.01492.x; Norman KC, 2012, RESILIENT EC VIABLE; Ostrom E, 2009, SCIENCE, V325, P419, DOI 10.1126/science.1172133; Pacific Fishery Management Council, 2011, COAST PEL SPEC FISH; Pacific Fishery Management Council, 2013, PAC SARD HARV PAR WO; Pacific Fishery Management Council, 2011, STAT PAC COAST COAST; Palumbi S.R., 2010, DEATH LIFE MONTEREY; Phillips G, 2002, MAR POLICY, V26, P459, DOI 10.1016/S0308-597X(02)00026-X; Pinkerton E, 2009, MAR POLICY, V33, P707, DOI 10.1016/j.marpol.2009.02.004; POMEROY C, 2002, CALIFORNIAS WETFISH, P46; Pomeroy C., 2004, MARINE SANCTUARIES C, VMSD-04-2, P73; Pomeroy C, 2005, ITS NOT JUST FISH PR; Pradhan NC, 2004, FISH RES, V68, P209, DOI 10.1016/j.fishres.2003.12.006; Purcell SW, 2013, FISH FISH, V14, P34, DOI 10.1111/j.1467-2979.2011.00443.x; Radovich J., 1982, CALCOFI REPORTS, V23, P56; Randall RG, 1996, CAN J FISH AQUAT SCI, V53, P35, DOI 10.1139/cjfas-53-S1-35; Rogers-Bennett L, 2002, CAL COOP OCEAN FISH, V43, P13; Salmi P, 2005, SOCIOL RURALIS, V45, P22, DOI 10.1111/j.1467-9523.2005.00288.x; Sanchirico JN, 2006, MAR POLICY, V30, P767, DOI 10.1016/j.marpol.2006.02.002; Schindler DE, 2010, NATURE, V465, P609, DOI 10.1038/nature09060; Shivlani M, 2010, P 62 GULF CAR FISH I; Silvano RAM, 2001, FISH RES, V51, P69, DOI 10.1016/S0165-7836(00)00229-0; State of California Resources Agency, 2005, FIN MARK SQUID FISH; Steneck RS, 2011, CONSERV BIOL, V25, P904, DOI 10.1111/j.1523-1739.2011.01717.x; Sweetnam D, 2005, CAL COOP OCEAN FISH, V46, P10; Sweetnam D, 2010, CAL COOP OCEAN FISH, V51, P14; Travis J, 2014, P NATL ACAD SCI USA, V111, P581, DOI 10.1073/pnas.1305853111; Ueber E., 1992, P31, DOI 10.1017/CBO9780511565625.003; USA California Department of Fish and Game, 2003, California Cooperative Oceanic Fisheries Investigations Reports, V44, P10; Vestergaard TA, 1997, SOCIAL IMPLICATIONS, P297; Wallace C, 1999, NZJEL, V3, P33; Windle MJS, 2008, MAR POLICY, V32, P701, DOI 10.1016/j.marpol.2007.12.003	80	40	40	1	54	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2015	10	3							e0118992	10.1371/journal.pone.0118992	http://dx.doi.org/10.1371/journal.pone.0118992			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD9NQ	25790464	gold, Green Accepted, Green Published			2022-12-27	WOS:000351425400059
J	Coeytaux, K; Bey, E; Christensen, D; Glassman, ES; Murdock, B; Doucet, C				Coeytaux, Karen; Bey, Eric; Christensen, Doran; Glassman, Erik S.; Murdock, Becky; Doucet, Christelle			Reported Radiation Overexposure Accidents Worldwide, 1980-2013: A Systematic Review	PLOS ONE			English	Article							INDUCED SKIN INJURIES; PERCUTANEOUS CORONARY INTERVENTIONS; FLUOROSCOPICALLY GUIDED PROCEDURES; RADIOFREQUENCY CATHETER ABLATION; X-RAY-EXPOSURE; CHRONIC RADIODERMATITIS; FOLLOW-UP; CARDIAC-CATHETERIZATION; PROTRACTED OVEREXPOSURE; BIOLOGICAL DOSIMETRY	Background Radiation overexposure accidents are rare but can have severe long-term health consequences. Although underreporting can be an issue, some extensive literature reviews of reported radiation overexposures have been performed and constitute a sound basis for conclusions on general trends. Building further on this work, we performed a systematic review that completes previous reviews and provides new information on characteristics and trends of reported radiation accidents. Methods We searched publications and reports from MEDLINE, EMBASE, the International Atomic Energy Agency, the International Radiation Protection Association, the United Nations Scientific Committee on the Effects of Atomic Radiation, the United States Nuclear Regulatory Commission, and the Radiation Emergency Assistance Center/Training Site radiation accident registry over 1980-2013. We retrieved the reported overexposure cases, systematically extracted selected information, and performed a descriptive analysis. Results 297 out of 5189 publications and reports and 194 records from the REAC/TS registry met our eligibility criteria. From these, 634 reported radiation accidents were retrieved, involving 2390 overexposed people, of whom 190 died from their overexposure. The number of reported cases has decreased for all types of radiation use, but the medical one. 64% of retrieved overexposure cases occurred with the use of radiation therapy and fluoroscopy. Additionally, the types of reported accidents differed significantly across regions. Conclusions This review provides an updated and broader view of reported radiation overexposures. It suggests an overall decline in reported radiation overexposures over 1980-2013. The greatest share of reported overexposures occurred in the medical fields using radiation therapy and fluoroscopy; this larger number of reported overexposures accidents indicates the potential need for enhanced quality assurance programs. Our data also highlights variations in characteristics of reported accidents by region. The main limitation of this study is the likely underreporting of radiation overexposures. Ensuring a comprehensive monitoring and reporting of radiation overexposures is paramount to inform and tailor prevention interventions to local needs.	[Coeytaux, Karen] Episight Consulting, Summit, NJ USA; [Bey, Eric] Percy Mil Hosp, Dept Plast & Reconstruct Surg, Clamart, France; [Christensen, Doran; Glassman, Erik S.; Murdock, Becky] Radiat Emergency Assistance Ctr, Oak Ridge, TN USA; [Doucet, Christelle] Celogos, Paris, France		Coeytaux, K (corresponding author), Episight Consulting, Summit, NJ USA.	karen.coeytaux@yahoo.com			HRA Pharma, 15 rue Beranger, Paris, France; Celogos; Episight Consulting	HRA Pharma, 15 rue Beranger, Paris, France; Celogos; Episight Consulting	This work was supported by HRA Pharma, 15 rue Beranger, 75003 Paris, France. Celogos and Episight Consulting provided support in the form of salaries for authors KC and CD. The specific roles of these authors are articulated in the "Author Contributions" section. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aerts A, 2003, J EUR ACAD DERMATOL, V17, P340, DOI 10.1046/j.1468-3083.2003.00687.x; Akashi M, 2001, J Radiat Res, V42 Suppl, pS157; Akita S, 2012, RADIAT PROT DOSIM, V151, P656, DOI 10.1093/rpd/ncs176; Allen B, 2009, J BURN CARE RES, V30, P349, DOI 10.1097/BCR.0b013e318198a710; [Anonymous], 2013, Wkly Epidemiol Rec, V88, P115; [Anonymous], 1995, FED REG, V60, P38059; Archer B R, 2000, J Appl Clin Med Phys, V1, P32, DOI 10.1120/1.308248; Aslan G, 2004, ANN PLAS SURG, V52, P325, DOI 10.1097/01.sap.0000100420.50662.aa; Aydin A, 2004, ANN PLAS SURG, V53, P300, DOI 10.1097/01.sap.0000136302.41814.13; Aydin A, 2005, EUR J PLAST SURG, V27, P341, DOI 10.1007/s00238-004-0691-1; Baeza M., 2012, Annals of the ICRP, V41, P179, DOI 10.1016/j.icrp.2012.06.001; Balter S, 2010, RADIOLOGY, V254, P326, DOI 10.1148/radiol.2542082312; Banaag Liza De Olazo, 2008, J Invasive Cardiol, V20, pE233; Banic B, 2011, RADIOL RES PRACT, V2011, DOI 10.1155/2011/201839; Baranov AE, 1999, RADIAT PROT DOSIM, V81, P91, DOI 10.1093/oxfordjournals.rpd.a032581; Barnea Y, 2002, ANN PLAS SURG, V49, P668, DOI 10.1097/00000637-200212000-00018; Barriga LE, 2012, RADIAT PROT DOSIM, V151, P652, DOI 10.1093/rpd/ncs175; BECKER J, 1989, SOUTHERN MED J, V82, P1561, DOI 10.1097/00007611-198912000-00026; Belliniani SA, 1992, 8 IRPA C P MONTR, pM1; Berger ME, 1997, HEALTH PHYS, V72, P343, DOI 10.1097/00004032-199703000-00001; Berlin L, 2001, AM J ROENTGENOL, V177, P21, DOI 10.2214/ajr.177.1.1770021; Bertho JM, 2008, RADIAT RES, V169, P543, DOI 10.1667/RR1259.1; Bertho JM, 2009, BIOMARKERS, V14, P94, DOI 10.1080/13547500902773904; Bomben A, 1988, 7 IRPA C P SYDN, pS2; Boncher J, 2012, J CUTAN PATHOL, V39, P63, DOI 10.1111/j.1600-0560.2011.01754.x; Borras C, 2006, REV PANAM SALUD PUBL, V20, P173; Brown N, 2013, J MED IMAG RADIAT ON, V57, P8, DOI 10.1111/j.1754-9485.2012.02469.x; Cante V, 2011, ANN DERMATOL VENER, V138, P424, DOI 10.1016/j.annder.2011.01.041; Carpeggiani C, 2012, INT J CARDIOVAS IMAG, V28, P1369, DOI 10.1007/s10554-011-9937-8; Carsin H, 2000, 10 IRPA C P HIR, pT; Carstens GJ, 1996, NEURORADIOLOGY, V38, pS160; Chiba S, 2002, BONE MARROW TRANSPL, V29, P935, DOI 10.1038/sj.bmt.1703568; Clairand I, 2008, RADIAT MEAS, V43, P698, DOI 10.1016/j.radmeas.2007.12.051; Compton KL, 2003, IR03009; CONDESALAZAR L, 1986, CONTACT DERMATITIS, V15, P202; Corbett RH, 2001, BRIT J RADIOL, V74, P883, DOI 10.1259/bjr.74.886.740883; Cosset JM, 2002, RADIOTHER ONCOL, V63, P1, DOI 10.1016/S0167-8140(02)00059-2; Cosset JM., 2002, CANCER RADIOTHER, V6, p166s; Cunningham J, 2010, RADIOTHER ONCOL, V97, P601, DOI 10.1016/j.radonc.2010.10.023; Da Silva FCA, 2005, J RADIOL PROT, V25, P289, DOI 10.1088/0952-4746/25/3/005; Dandurand M, 1999, ANN DERMATOL VENER, V126, P413; Valverde NJD, 2010, HEALTH PHYS, V98, P868, DOI 10.1097/01.HP.0000345070.33576.f9; Dehen L, 1999, HEART, V81, P308, DOI 10.1136/hrt.81.3.308; Derreumaux S, 2008, RADIAT PROT DOSIM, V131, P130, DOI 10.1093/rpd/ncn235; Dichtl W, 2012, CIRCULATION, V126, P1407, DOI 10.1161/CIRCULATIONAHA.112.105494; DIncan M, 1997, ARCH DERMATOL, V133, P242, DOI 10.1001/archderm.133.2.242; Dousset M, 1984, IRRADIATIONS THERAPE; FDA, 2010, SAF INV CT BRAIN PER; Fierens H, 2000, ANN DERMATOL VENER, V127, P619; Food and Drug Administration (FDA), 1994, AV SER XRAY IND SKIN; Forbach Chanteur J., 1992, MED RAYONNEN IONIS, V3, P5; Frazier TH, 2007, ARCH DERMATOL, V143, P637, DOI 10.1001/archderm.143.5.637; Freixas PB, 2007, MED CLIN-BARCELONA, V129, P397, DOI 10.1157/13110224; Fujimoto K, 1999, J Radiol Prot, V19, P377; Fujimoto K, 2000, 10 IRPA C P HIR, pS; Garnacho GM, 2009, ACTAS DERMO-SIFILOGR, V100, P909, DOI 10.1016/S0001-7310(09)72924-2; Gironet N, 1998, ANN DERMATOL VENER, V125, P598; Glazier JJ, 2012, QJM-INT J MED, V105, P571, DOI 10.1093/qjmed/hcr089; Gonzalez A. J., 1999, IAEA B, V41, P2; Gonzalez AJ, 2004, HEALTH PHYS, V87, P258, DOI 10.1097/01.HP.0000130400.90548.5e; Gottlober P, 2000, J AM ACAD DERMATOL, V42, P453, DOI 10.1016/S0190-9622(00)90218-4; Gourmelon P, 2010, HEALTH PHYS, V98, P825, DOI 10.1097/HP.0b013e3181ce64d4; Granel F, 1998, ANN DERMATOL VENER, V125, P405; Gregoire E, 2013, RADIAT PROT DOSIM, V155, P418, DOI 10.1093/rpd/nct032; GUIMARAENS D, 1992, CONTACT DERMATITIS, V26, P266, DOI 10.1111/j.1600-0536.1992.tb00243.x; Guo M, 2014, J RADIAT RES, V55, P205, DOI 10.1093/jrr/rrt102; Gupta ML, 2013, HUM EXP TOXICOL, V32, P1311, DOI 10.1177/0960327113482477; Gusev I., 2001, MED MANAGEMENT RAD A; Hadjidekova V, 2010, HEALTH PHYS, V98, P252, DOI 10.1097/HP.0b013e3181ab3ccf; Hashimoto I, 2008, J PLAST RECONSTR AES, V61, P704, DOI 10.1016/j.bjps.2007.01.003; Henry M. A., 2009, DERMATOL ONLINE J, V14, P15; Hoashi T, 2008, BRIT J DERMATOL, V158, P597, DOI 10.1111/j.1365-2133.2008.08475.x; Holmberg O, 2010, EUR J RADIOL, V76, P6, DOI 10.1016/j.ejrad.2010.06.031; Hosoda M, 2013, ENVIRON INT, V61, P73, DOI 10.1016/j.envint.2013.09.013; HUDA W, 1994, RADIOLOGY, V193, P642, DOI 10.1148/radiology.193.3.7972801; Hutt G, 1996, APPL RADIAT ISOTOPES, V47, P1329, DOI 10.1016/S0969-8043(96)00189-3; IAEA, 1988, RAD ACC GOIAN; IAEA, 2012, ACC IND RAD; *IAEA, 1993, RAD ACC SOR; IAEA, 2006, IAEA SAF REP SER, V38; IAEA, 2011, RAD PROT SAF RAD S 3, VInterim; *IAEA, 1996, RAD ACC IRR FAC NESV; IAEA, 2002, FOLL UP DEL HLTH CON; IAEA, 2011, RAD SAF IND RAD; IAEA, 2009, RAD ACC NEUV ALD; IAEA, 2011, NUCL SAF REV YEAR 20; IAEA, GLOSSARY; IAEA, 2009, RUSS RW MAN OP; IAEA, 1999, RAD PROT SAF IND RAD, V13; IAEA, 2001, CRIT ACC SAR; *IAEA, 1998, IAEA SAF REP SER, V2; *IAEA, 2000, RAD ACC IST; *IAEA, 1998, ACC OV RAD PAT SAN J; *IAEA, 1990, RAD ACC SAN SALV; IAEA, 2007, NUCL SAF REV YEAR 20; IAEA, 2000, RADIOLOGICAL ACCIDEN; IAEA, 1998, RAD ACC TAMM; IAEA, 2009, NUCL SAF REV YEAR 20; *IAEA, 2002, RAD ACC SAM PRAK; IAEA, 1998, IAEA SAF REP SER, V4; IAEA, 1996, EL ACC ACC HAN VIET; IAEA, 2008, NUCL SAF REV YEAR 20; IAEA, 2011, OV RAD TR EXTR; IAEA, 2002, RAD ACC GIL; IAEA, RAD PROT PAT SAFRON; IAEA, 2002, NUCL SAF REV YEAR 20; IAEA, 2005, SEV RAD ACC INV 23 P; ICRP, 2000, ANN ICRP, V30; Igaki H, 2008, J RADIAT RES, V49, P55, DOI 10.1269/jrr.07058; Ilyin LA, 2002, 11 INT C IRPA; Institut de Radioprotection et de Surete Nucleaire, 2007, ACC RAY ION BIL DEM; Institut de Radioprotection et de Surete Nucleaire, 2006, RAY ION ACC IRR; International Atomic Energy Agency (IAEA), 2010, NUCL SAF REV YEAR 20; International Atomic Energy Agency (IAEA), 1999, REP PREL FACT FIND M; Iorio ML, 2011, ANN PLAS SURG, V67, P109, DOI 10.1097/SAP.0b013e318209a5c9; Ishii T, 2001, J Radiat Res, V42 Suppl, pS167; Jamshed N, 2011, ANN EMERG MED, V58, P395, DOI 10.1016/j.annemergmed.2011.02.018; Jeskowiak A, 2011, INTERACT CARDIOV TH, V12, P290, DOI 10.1510/icvts.2010.247395; Johnston A. M., 2006, UNINTENDED OVEREXPOS; Kaga K, 2011, ACTA OTO-LARYNGOL, V131, P451, DOI 10.3109/00016489.2010.533700; Kanamori M, 2000, 10 IRPA C P HIR, pS; Kato M, 2012, ACTA RADIOL, V53, P1040, DOI 10.1258/ar.2012.120192; Kawakami T, 1999, BRIT J DERMATOL, V141, P150; Ketiku K K, 1994, West Afr J Med, V13, P63; Kim HS, 2005, J AM ACAD DERMATOL, V53, P1083, DOI 10.1016/j.jaad.2005.04.048; Knautz MA, 1997, SOUTHERN MED J, V90, P352, DOI 10.1097/00007611-199703000-00020; Koenig TR, 2001, AM J ROENTGENOL, V177, P3, DOI 10.2214/ajr.177.1.1770003; Koenig TR, 2001, AM J ROENTGENOL, V177, P13, DOI 10.2214/ajr.177.1.1770013; Kramer R, 2005, PHYS MED BIOL, V50, P3681, DOI 10.1088/0031-9155/50/16/003; Krasovec M, 1998, HAUTARZT, V49, P307, DOI 10.1007/s001050050746; Kusama T, 1992, 8 IRPA C P MONTR, pM1; Lataillade JJ, 2007, REGEN MED, V2, P785, DOI 10.2217/17460751.2.5.785; Lee J, 2003, ARCH DERMATOL, V139, P140, DOI 10.1001/archderm.139.2.140; Lee JI, 2012, MICROSURG, V32, P401, DOI 10.1002/micr.21966; Lee WS, 2004, J DERMATOL, V31, P848, DOI 10.1111/j.1346-8138.2004.tb00614.x; LEVESON NG, 1993, COMPUTER, V26, P18, DOI 10.1109/MC.1993.274940; Levine Norman, 2008, Geriatrics, V63, P33; Lichtenstein DA, 1996, ARCH DERMATOL, V132, P663, DOI 10.1001/archderm.132.6.663; Lisovsky IV, 2000, 10 IRPA C P; Lister BAJ, 1985, J SOC RADIOL PROT, V5, P145; Litzner B, 2009, ARCH DERMATOL, V145, P829, DOI 10.1001/archdermatol.2009.141-a; Liu Q, 2008, J RADIAT RES, V49, P63, DOI 10.1269/jrr.07071; Liu Q, 2010, HEALTH PHYS, V98, P885, DOI 10.1097/HP.0b013e3181c4b9c1; Lloyd D, 2002, E B RADIOLOGICAL PRO, V2; LLOYD DC, 1994, OCCUP ENVIRON MED, V51, P713, DOI 10.1136/oem.51.10.713; Aventin DL, 2012, DERMATOLOGY, V224, P198, DOI 10.1159/000338891; Lopez P. Ortiz, 2009, Annals of the ICRP, V39, P13, DOI 10.1016/j.icrp.2010.02.002; Loria D, 2009, SCIENCE, V20; Mahesh M, 2001, RADIOGRAPHICS, V21, P1033, DOI 10.1148/radiographics.21.4.g01jl271033; Mahmoud NS, 2005, J HAZARD MATER, V118, P1, DOI 10.1016/j.jhazmat.2004.08.001; MARSHALL E, 1984, SCIENCE, V225, P395; MARSHALL E, 1984, SCIENCE, V223, P1152, DOI 10.1126/science.6701516; Marti Nuria, 2008, Dermatol Online J, V14, P19; Matsuda N, 2013, RADIAT RES, V179, P663, DOI 10.1667/RR3232.1; Mclaughlin Neil, 2009, Mod Healthc, V39, P22; Mettler FA, 2012, J RADIOL PROT, V32, pN9, DOI 10.1088/0952-4746/32/1/N9; Milacic Snezana, 2008, Kobe J Med Sci, V54, pE108; Miralbell R, 1999, J VASC INTERV RADIOL, V10, P1190, DOI 10.1016/S1051-0443(99)70219-8; Miura N, 2008, JPN J CLIN ONCOL, V38, P623, DOI 10.1093/jjco/hyn063; Monaco JoAn L, 2003, J Invasive Cardiol, V15, P451; Mosokotso EA, 2012, P 18 WORLD C NOND TE; Mundi Jyoti P, 2013, Dermatol Online J, V19, P20712; Nahass GT, 1998, AM J GASTROENTEROL, V93, P1546, DOI 10.1111/j.1572-0241.1998.00479.x; Nahass GT, 1997, J AM ACAD DERMATOL, V36, P881, DOI 10.1016/S0190-9622(97)70047-1; Nakagawa K, 1997, CURR THER RES CLIN E, V58, P323, DOI 10.1016/S0011-393X(97)80030-6; Nannapaneni R, 2007, J CLIN NEUROSCI, V14, P157, DOI 10.1016/j.jocn.2005.12.031; Natsoulas A, 2002, DANGERS FOOD IRRADIA; NENOT J C, 1985, Journal of the Society for Radiological Protection, V5, P55, DOI 10.1088/0260-2814/5/2/301; Nenot JC, 2009, J RADIOL PROT, V29, P301, DOI 10.1088/0952-4746/29/3/R01; Norwegian Radiation Protection Authority, 2005, 4 NORW RAD PROT AUTH; Norwegian Radiation Protection Authority, 2004, NRPA B; NRC USA, 1998, NUREG1556 NRC US, V2; Oak ridge institute for science and education, RAD ACC REG; OGUNRANTI JO, 1989, LANCET, V2, P667; Ortiz P, 1999, IAEA B; Ortiz P, 2000, LESSONS MAJOR RAD AC; OTHEA-RELIR, 1995, DET EFF WORK HAND UN; Otterburn D, 2010, ANN PLAS SURG, V65, P462, DOI 10.1097/SAP.0b013e3181d6e2d3; PAGLIARO L, 1984, SCIENCE, V224, P110, DOI 10.1126/science.224.4645.110-a; Pan ZQ, 1996, J RADIOAN NUCL CH AR, V206, P239; Parajuli D, 2013, ENVIRON SCI TECHNOL, V47, P3800, DOI 10.1021/es303467n; Pass B, 1997, HEALTH PHYS, V72, P390, DOI 10.1097/00004032-199703000-00006; Pass B, 1997, ENVIRON HEALTH PERSP, V105, P1397, DOI 10.2307/3433639; Peiffert D, 2007, CANCER RADIOTHER, V11, P309, DOI 10.1016/j.canrad.2007.09.004; Perrot P, 2013, ANN CHIR PLAST ESTH, V58, P700, DOI 10.1016/j.anplas.2013.05.003; Petit F, 2002, PLAST RECONSTR SURG, V109, P1655, DOI 10.1097/00006534-200204150-00026; Pezzano M, 1999, ARCH MAL COEUR VAISS, V92, P1197; Phend C, 2009, MEDPAGE TODAY; Poletti J L, 1997, Australas Radiol, V41, P82, DOI 10.1111/j.1440-1673.1997.tb00480.x; RAINA S, 1992, CLIN NUCL MED, V17, P646, DOI 10.1097/00003072-199208000-00008; Rehani MM, 2012, EUR J RADIOL, V81, pE968, DOI 10.1016/j.ejrad.2012.07.004; Rehani MM, 2011, RADIAT PROT DOSIM, V147, P8, DOI 10.1093/rpd/ncr257; Reitan JB, 2005, BJR S, V27, P36; Reitbock JG, 2013, J DTSCH DERMATOL GES, V11, P265, DOI 10.1111/ddg.12004; Repacholi M, 2000, P 8 COORD M WHO COLL; Rojkind RH, 1996, 7 IRPA C P, pV3; Rosenthal LS, 1997, PACE, V20, P1834, DOI 10.1111/j.1540-8159.1997.tb03574.x; Sajben FP, 1999, CUTIS, V64, P57; Schauer DA, 1996, APPL RADIAT ISOTOPES, V47, P1345, DOI 10.1016/S0969-8043(96)00203-5; SCHAUER DA, 1993, HEALTH PHYS, V65, P131, DOI 10.1097/00004032-199308000-00001; Schecter Amy K, 2003, J Drugs Dermatol, V2, P425; Schmoor P, 2001, CATHETER CARDIO INTE, V52, P235, DOI 10.1002/1522-726X(200102)52:2<235::AID-CCD1056>3.0.CO;2-J; Sevan'kaev AV, 2002, RADIAT PROT DOSIM, V102, P201, DOI 10.1093/oxfordjournals.rpd.a006090; Sevan'kaev AV, 1999, RADIAT PROT DOSIM, V81, P85, DOI 10.1093/oxfordjournals.rpd.a032580; Shope TB, 1996, RADIOGRAPHICS, V16, P1195, DOI 10.1148/radiographics.16.5.8888398; Slovut DP, 2009, JACC-CARDIOVASC INTE, V2, P701, DOI 10.1016/j.jcin.2009.04.015; Socie G, 1996, CR ACAD SCI III-VIE, V319, P711; Soga F, 2004, JPN J CLIN DERMATOL, V58, P908; Soleo L, 1996, AM J IND MED, V30, P207, DOI 10.1002/(SICI)1097-0274(199608)30:2<207::AID-AJIM12>3.3.CO;2-3; Sovik E, 1996, ACTA RADIOL, V37, P305; Spiker A, 2012, AM J CARDIOL, V110, P1861, DOI 10.1016/j.amjcard.2012.08.023; Srimahachota S, 2012, INT J CARDIOL, V154, pE31, DOI 10.1016/j.ijcard.2011.05.016; STABIN MG, 1991, J NUCL MED, V32, P808; STAVEM P, 1985, ACTA RADIOL ONCOL, V24, P61, DOI 10.3109/02841868509134366; Stewart F. A., 2012, Annals of the ICRP, V41, P37, DOI 10.1016/j.icrp.2012.02.001; Stone MS, 1998, J AM ACAD DERMATOL, V38, P333, DOI 10.1016/S0190-9622(98)70577-8; Sugawara Y, 2005, DERMATOLOGY, V211, P293, DOI 10.1159/000087028; Sung DW, 2013, J KOREAN MED SCI, V28, P495, DOI 10.3346/jkms.2013.28.4.495; Suzuki T, 2003, CARDIOVASC RES, V58, P487, DOI 10.1016/S0008-6363(02)00780-0; Task Force for Monitoring Patient Dose during Fluoroscopy, 2010, TASK FORC MON PAT DO; Thomadsen BR, 2000, MED PHYS, V27, P1681, DOI 10.1118/1.599036; Thorat Jayant Daniel, 2007, J Stroke Cerebrovasc Dis, V16, P40, DOI 10.1016/j.jstrokecerebrovasdis.2006.10.003; TOBIAS JS, 1988, BRIT MED J, V297, P372, DOI 10.1136/bmj.297.6645.372; United Nations Scientifc Committee on the Efects of Atomic Radiation (UNSCEAR), 2000, SOURC EFF ION RAD, P453; UNSCEAR, 2000, SOURC EFF ION RAD, P497; UNSCEAR, 2008, SOURC EFF ION RAD, P21; UNSCEAR, 1988, SOURC EFF RISKS ION, P1; UNSCEAR, 2000, SCI TOTAL ENVIRON, V258, P209; UNSCEAR, 1993, SOURC EFF ION RAD, P507; UNSCEAR Sources and effects of ionizing radiation, 2008, SOURC EFF ION RAD, P1; US Nuclear Regulatory Commission, 1987, C ABN OCC Q REP JAN, Vv10; US Nuclear Regulatory Commission, 1994, C ABN OCC Q REP JAN, Vv17; US Nuclear Regulatory Commission, 1991, ACC RAD OV PERS DUE; US Nuclear Regulatory Commission, 2001, C ABN OCC FISC YEAR, pv23; US Nuclear Regulatory Commission, 1981, C ABN OCC Q REP APR, Vv4; US Nuclear Regulatory Commission, 1981, C ABN OCC Q REP JUL, Vv3; US Nuclear Regulatory Commission, 2005, C ABN OCC FISC YEAR, pv27; US Nuclear Regulatory Commission, 1993, C ABN OCC Q REP APR, Vv16; US Nuclear Regulatory Commission, 1995, C ABN OCC Q REP APR, Vv18; US Nuclear Regulatory Commission, 1990, C ABN OCC Q REP JUL, Vv12; US Nuclear Regulatory Commission, 1989, C ABN OCC Q REP APR, Vv12; US Nuclear Regulatory Commission, 1993, C ABN OCC Q REP JAN, Vv16; US Nuclear Regulatory Commission, 1994, C ABN OCC Q REP JUL, Vv16; US Nuclear Regulatory Commission, 1986, C ABN OCC Q REP JUL, Vv8; US Nuclear Regulatory Commission, 1992, C ABN OCC Q REP APR, Vv15; US Nuclear Regulatory Commission, 1995, C ABN OCC Q REP JUL, Vv17; US Nuclear Regulatory Commission, 1997, C ABN OCC FISC YEAR, pv19; US Nuclear Regulatory Commission, 1982, C ABN OCC Q REP JUL, Vv4; US Nuclear Regulatory Commission, 2004, C ABN OCC FISC YEAR, pv26; US Nuclear Regulatory Commission, 1989, C ABN OCC Q REP JAN, Vv12; US Nuclear Regulatory Commission, 1993, C ABN OCC Q REP OCT, Vv15; US Nuclear Regulatory Commission, 1994, C ABN OCC Q REP OCT, Vv16; US Nuclear Regulatory Commission, 2010, C ABN OCC FISC YEAR, pv32; US Nuclear Regulatory Commission, 1990, C ABN OCC Q REP JAN, Vv13; US Nuclear Regulatory Commission, 1987, C ABN OCC Q REP JUL, Vv9(; US Nuclear Regulatory Commission, 2003, C ABN OCC FISC YEAR, pv25; US Nuclear Regulatory Commission, 1990, C ABN OCC Q REP OCT, Vv12; US Nuclear Regulatory Commission, 1986, C ABN OCC Q REP APR, Vv9; US Nuclear Regulatory Commission, 2007, GAMM KNIF TREATM WRO; US Nuclear Regulatory Commission, 1989, C ABN OCC Q REP OCT, Vv11; US Nuclear Regulatory Commission, 1998, C ABN OCC FISC YEAR, pv20; US Nuclear Regulatory Commission, 1985, C ABN OCC Q REP OCT, Vv7; US Nuclear Regulatory Commission, 2006, C ABN OCC FISC YEAR, pv28; US Nuclear Regulatory Commission, 1988, C ABN OCC Q REP JAN, Vv11; US Nuclear Regulatory Commission, 1985, C ABN OCC Q REP APR, Vv8; US Nuclear Regulatory Commission, 1990, C ABN OCC Q REP APR, Vv13; US Nuclear Regulatory Commission, 1986, C ABN OCC Q REP OCT, Vv8; US Nuclear Regulatory Commission, 1988, C ABN OCC Q REP JUL, Vv10; US Nuclear Regulatory Commission, 1991, C ABN OCC Q REP JAN, Vv14; US Nuclear Regulatory Commission, 2012, C ABN OCC FISC YEAR, pv34; US Nuclear Regulatory Commission, 1987, C ABN OCC Q REP APR, Vv10; US Nuclear Regulatory Commission, 1995, C ABN OCC Q REP JAN, Vv18; US Nuclear Regulatory Commission, 1985, C ABN OCC Q REP JAN, Vv8; US Nuclear Regulatory Commission, 2013, US OF RAD; US Nuclear Regulatory Commission, 1990, ERR US RAD IOD 131; US Nuclear Regulatory Commission, 1992, C ABN OCC Q REP OCT, Vv14; US Nuclear Regulatory Commission, 2000, C ABN OCC FISC YEAR, pv22; US Nuclear Regulatory Commission, 1989, C ABN OCC Q REP JUL, Vv11; US Nuclear Regulatory Commission, 2013, C ABN OCC FISC YEAR, pv35; US Nuclear Regulatory Commission, 2007, C ABN OCC FISC YEAR, pv29; US Nuclear Regulatory Commission, 2008, C ABN OCC FISC YEAR, pv30; US Nuclear Regulatory Commission, 1996, C ABN OCC Q REP JUL, Vv18; US Nuclear Regulatory Commission, 1999, C ABN OCC FISC YEAR, pv21; US Nuclear Regulatory Commission, 1981, C ABN OCC Q REP JAN, Vv4; US Nuclear Regulatory Commission, 1995, C ABN OCC Q REP OCT, Vv17; US Nuclear Regulatory Commission, 1991, C ABN OCC Q REP APR, Vv14; US Nuclear Regulatory Commission, 1991, C ABN OCC Q REP JUL, Vv13; US Nuclear Regulatory Commission, 1991, C ABN OCC Q REP OCT, Vv13; US Nuclear Regulatory Commission, 2009, C ABN OCC FISC YEAR, pv31; US Nuclear Regulatory Commission, 1994, C ABN OCC Q REP APR, Vv17; US Nuclear Regulatory Commission, 1986, C ABN OCC Q REP JAN, Vv9; US Nuclear Regulatory Commission, 1993, C ABN OCC Q REP JUL, Vv15; US Nuclear Regulatory Commission, 1987, C ABN OCC Q REP OCT, Vv9; US Nuclear Regulatory Commission, 2011, C ABN OCC FISC YEAR, pv33; Valentin J, 2000, Ann ICRP, V30, P7, DOI 10.1016/S0146-6453(01)00004-5; Valentin Jack, 2007, Annals of the ICRP, V37, P3; Valverde N J, 2000, Rev Assoc Med Bras (1992), V46, P81; Vano E, 1998, BRIT J RADIOL, V71, P510, DOI 10.1259/bjr.71.845.9691896; Vargo GJ, 1999, HEALTH PHYS, V77, P505, DOI 10.1097/00004032-199911000-00003; Vatnitsky S, 2001, RADIOTHER ONCOL, V60, P237, DOI 10.1016/S0167-8140(01)00417-0; Vlietstra Ronald E, 2004, J Interv Cardiol, V17, P131, DOI 10.1111/j.1540-8183.2004.09885.x; Wack G, 2007, INSPECTION GEN AFFAI; WAGNER LK, 1994, J VASC INTERV RADIOL, V5, P71, DOI 10.1016/S1051-0443(94)71456-1; Wagner LK, 1999, RADIOLOGY, V213, P773, DOI 10.1148/radiology.213.3.r99dc16773; WAGNER LK, 2000, MINIMIZING RISKS FLU; Wagner LK, 2008, HEALTH PHYS, V95, P645, DOI 10.1097/01.HP.0000334210.85567.7b; Wen CS, 2003, CLIN NEUROL NEUROSUR, V105, P215, DOI 10.1016/S0303-8467(03)00007-6; Wong L, 2004, NEW ENGL J MED, V350, pE23, DOI 10.1056/NEJMicm030503; WOUDSTRA E, 1993, RADIOTHER ONCOL, V29, P39, DOI 10.1016/0167-8140(93)90171-4; Xu ZY, 2003, RADIAT PROT DOSIM, V103, P163, DOI 10.1093/oxfordjournals.rpd.a006128; Yao B, 2010, INT J RADIAT BIOL, V86, P800, DOI 10.3109/09553002.2010.481320; Yao B, 2013, MUTAT RES-GEN TOX EN, V751, P66, DOI 10.1016/j.mrgentox.2012.11.005; Yoneda K, 2010, EUR J DERMATOL, V20, P654, DOI 10.1684/ejd.2010.1035; [No title captured]	314	42	44	2	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2015	10	3							e0118709	10.1371/journal.pone.0118709	http://dx.doi.org/10.1371/journal.pone.0118709			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD9NQ	25789482	Green Published, gold, Green Submitted			2022-12-27	WOS:000351425400040
J	Oliveira, J; Etain, B; Lajnef, M; Hamdani, N; Bennabi, M; Bengoufa, D; Sundaresh, A; Ben Chaabane, A; Bellivier, F; Henry, C; Kahn, JP; Charron, D; Krishnamoorthy, R; Leboyer, M; Tamouza, R				Oliveira, Jose; Etain, Bruno; Lajnef, Mohamed; Hamdani, Nora; Bennabi, Meriem; Bengoufa, Djaouida; Sundaresh, Aparna; Ben Chaabane, Arij; Bellivier, Frank; Henry, Chantal; Kahn, Jean-Pierre; Charron, Dominique; Krishnamoorthy, Rajagopal; Leboyer, Marion; Tamouza, Ryad			Combined Effect of TLR2 Gene Polymorphism and Early Life Stress on the Age at Onset of Bipolar Disorders	PLOS ONE			English	Article							TOLL-LIKE RECEPTORS; TOXOPLASMA-GONDII INFECTION; HERPES-SIMPLEX-VIRUS; CHILDHOOD TRAUMA; PSYCHOLOGICAL STRESS; NEUROTROPHIC FACTOR; IMMUNE ACTIVATION; ASSOCIATION; DISEASE; ABUSE	Gene-environment interactions may play an important role in modulating the impact of earlylife stressful events on the clinical course of bipolar disorder (BD), particularly associated to early age at onset. Immune dysfunction is thought to be an important mechanism linking childhood trauma with early-onset BD, thus the genetic diversity of immune-related loci may account for an important part of the interindividual susceptibility to this severe subform. Here we investigated the potential interaction between genetic variants of Toll-like receptors 2 (TLR2) and 4 (TLR4), major innate immune response molecules to pathogens, and the childhood trauma questionnaire (CTQ) in age at onset of BD. We recruited 531 BD patients (type I and II or not otherwise specified), genotyped for the TLR2 rs4696480 and rs3804099 and TLR4 rs1927914 and rs11536891 single-nucleotide polymorphisms and recorded for history of childhood trauma using the CTQ. TLR2 and TLR4 risk genotype carrier state and history of childhood emotional, physical and sexual abuses were evaluated in relation to age at onset as defined by the age at first manic or depressive episode. We observed a combined effect of TLR2 rs3804099 TT genotype and reported sexual abuse on determining an earlier age at onset of BD by means of a Kaplan-Meier survival curve (p = 0.002; corrected p = 0.02). Regression analysis, however, was non-significant for the TLR2-CTQ sexual abuse interaction term. The negative effects of childhood sexual abuse on age at onset of BD may be amplified in TLR2 rs3804099 risk genotype carriers through immune-mediated pathways. Clinical characteristics of illness severity, immune phenotypes and history of early life infectious insults should be included in future studies involving large patient cohorts.	[Oliveira, Jose; Bennabi, Meriem; Bengoufa, Djaouida; Sundaresh, Aparna; Ben Chaabane, Arij; Charron, Dominique; Krishnamoorthy, Rajagopal; Tamouza, Ryad] Hop St Louis, INSERM, U1160, Paris, France; [Etain, Bruno; Lajnef, Mohamed; Hamdani, Nora; Bellivier, Frank; Henry, Chantal; Leboyer, Marion] INSERM, Psychiat Genet U955, Creteil, France; [Bengoufa, Djaouida; Charron, Dominique; Tamouza, Ryad] Hop St Louis, Lab Jean Dausset, Paris, France; [Bengoufa, Djaouida; Charron, Dominique; Tamouza, Ryad] Hop St Louis, LabEx Transplantex, Paris, France; [Etain, Bruno; Lajnef, Mohamed; Hamdani, Nora; Bellivier, Frank; Henry, Chantal; Leboyer, Marion] Univ Paris Est, Fac Med, Creteil, France; [Etain, Bruno; Hamdani, Nora; Bellivier, Frank; Henry, Chantal; Leboyer, Marion] DHU PePSY, Hop Univ Henri Mondor, AP HP, Pole Psychiat, Creteil, France; [Oliveira, Jose; Etain, Bruno; Lajnef, Mohamed; Hamdani, Nora; Bennabi, Meriem; Sundaresh, Aparna; Ben Chaabane, Arij; Bellivier, Frank; Henry, Chantal; Kahn, Jean-Pierre; Charron, Dominique; Krishnamoorthy, Rajagopal; Leboyer, Marion; Tamouza, Ryad] Fdn FondaMental, Creteil, France; [Kahn, Jean-Pierre] CHU Nancy, Hop Brabois, Serv Psychiat & Psychol Clin, Vandoeuvre Les Nancy, France; [Charron, Dominique; Tamouza, Ryad] Univ Paris Diderot, Sorbonne Paris Cite, Paris, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Louis - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Louis - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Louis - APHP; UDICE-French Research Universities; Universite Paris Cite; Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Assistance Publique Hopitaux Paris (APHP); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Hopital Universitaire Henri-Mondor - APHP; CHU de Nancy; UDICE-French Research Universities; Universite Paris Cite	Tamouza, R (corresponding author), Hop St Louis, INSERM, U1160, Paris, France.	tamouza.ryad@gmail.com	Leboyer, Marion/AAW-3648-2021; Tamouza, Ryad/AGQ-6644-2022; Etain, Bruno/L-6647-2017	Leboyer, Marion/0000-0001-5473-3697; BELLIVIER, FRANK/0000-0002-3660-6640; SUNDARESH, Aparna/0000-0001-7579-8959; Oliveira, Jose/0000-0003-3475-4794; Etain, Bruno/0000-0002-5377-1488; Charron, Dominique/0000-0001-7689-8038	Foundation for Science and Technology (Portugal) [SFRH/BD/76170/2011]	Foundation for Science and Technology (Portugal)(Portuguese Foundation for Science and Technology)	J. Oliveira acknowledges the financial support of the Foundation for Science and Technology (Portugal) doctoral degree grant (SFRH/BD/76170/2011).	Abu-Maziad A, 2010, PEDIATR RES, V68, P323, DOI 10.1203/00006450-201011001-00632; Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; American Psychiatric Association, 1994, DIAGN STAT MAN MENT; Aravalli RN, 2005, J IMMUNOL, V175, P4189, DOI 10.4049/jimmunol.175.7.4189; Arji N, 2014, J INFECT DEV COUNTR, V8, P430, DOI 10.3855/jidc.3820; Bayer TA, 1999, J PSYCHIATR RES, V33, P543, DOI 10.1016/S0022-3956(99)00039-4; BECH P, 1978, NEUROPHARMACOLOGY, V17, P430, DOI 10.1016/0028-3908(78)90022-9; Bergink V, 2014, BIOL PSYCHIAT, V75, P324, DOI 10.1016/j.biopsych.2013.09.037; BERNSTEIN DP, 1994, AM J PSYCHIAT, V151, P1132, DOI 10.1176/ajp.151.8.1132; Bernstein DP, 1998, CHILDHOOD TRAUMA QUE; Binder EB, 2008, JAMA-J AM MED ASSOC, V299, P1291, DOI 10.1001/jama.299.11.1291; Cai MS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054586; Carpenter LL, 2010, NEUROPSYCHOPHARMACOL, V35, P2617, DOI 10.1038/npp.2010.159; Caspi A, 2003, SCIENCE, V301, P386, DOI 10.1126/science.1083968; Chen KH, 2011, SHOCK, V35, P35, DOI 10.1097/SHK.0b013e3181eb45b3; Coelho R, 2014, ACTA PSYCHIAT SCAND, V129, P180, DOI 10.1111/acps.12217; Collins PY, 2011, NATURE, V475, P27, DOI 10.1038/475027a; Copeland WE, 2014, P NATL ACAD SCI USA, V111, P7570, DOI 10.1073/pnas.1323641111; Danese A, 2007, P NATL ACAD SCI USA, V104, P1319, DOI 10.1073/pnas.0610362104; Debierre-Grockiego F, 2007, J IMMUNOL, V179, P1129, DOI 10.4049/jimmunol.179.2.1129; Dickerson FB, 2004, BIOL PSYCHIAT, V55, P588, DOI 10.1016/j.biopsych.2003.10.008; Etain B, 2008, BIPOLAR DISORD, V10, P867, DOI 10.1111/j.1399-5618.2008.00635.x; Etain B, 2013, J CLIN PSYCHIAT, V74, P991, DOI 10.4088/JCP.13m08353; Etain Bruno, 2012, J Clin Psychiatry, V73, pe561, DOI 10.4088/JCP.10m06504; Fang J, 2013, INVEST OPHTH VIS SCI, V54, P8384, DOI 10.1167/iovs.13-12878; Femenia T, 2012, BRAIN RES, V1476, P58, DOI 10.1016/j.brainres.2012.03.053; Frey BN, 2007, BEHAV PHARMACOL, V18, P419, DOI 10.1097/FBP.0b013e3282df3cde; FU ZF, 1993, J AFFECT DISORDERS, V27, P61, DOI 10.1016/0165-0327(93)90098-5; Geoffroy PA, 2013, J PHYSIOL-PARIS, V107, P278, DOI 10.1016/j.jphysparis.2013.03.006; Giovanoli S, 2013, SCIENCE, V339, P1095, DOI 10.1126/science.1228261; Goldstein BI, 2011, J CHILD ADOL PSYCHOP, V21, P479, DOI 10.1089/cap.2011.0009; Gore FM, 2011, LANCET, V377, P2093, DOI 10.1016/S0140-6736(11)60512-6; Hamdani N, 2013, J AFFECT DISORDERS, V148, P444, DOI 10.1016/j.jad.2012.11.034; Hanke ML, 2011, CLIN SCI, V121, P367, DOI 10.1042/CS20110164; Henn A, 2011, J IMMUNOL, V186, P3237, DOI 10.4049/jimmunol.1002787; Jerrell JM, 2010, J CLIN PSYCHIAT, V71, P1518, DOI 10.4088/JCP.09m05585ora; Junpee A, 2010, PARASITOL RES, V107, P807, DOI 10.1007/s00436-010-1932-9; Kang WS, 2013, GENE, V526, P182, DOI 10.1016/j.gene.2013.04.058; Kelly-Irving M, 2013, EUR J EPIDEMIOL, V28, P721, DOI 10.1007/s10654-013-9832-9; Kelly-Irving M, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-767; Khandaker GM, 2014, JAMA PSYCHIAT, V71, P1121, DOI 10.1001/jamapsychiatry.2014.1332; Kim C, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2534; Klengel T, 2013, NAT NEUROSCI, V16, P33, DOI 10.1038/nn.3275; Koga K, 2014, AM J REPROD IMMUNOL, V72, P192, DOI 10.1111/aji.12258; Leboyer M, 2005, BIPOLAR DISORD, V7, P111, DOI 10.1111/j.1399-5618.2005.00181.x; Leboyer M, 2010, J CLIN PSYCHIAT, V71, P1689, DOI 10.4088/JCP.10m06347yel; Lichtenstein P, 2009, LANCET, V373, P234, DOI 10.1016/S0140-6736(09)60072-6; Liu SR, 2012, J IMMUNOL, V188, P1098, DOI 10.4049/jimmunol.1101121; Meyer U, 2014, BIOL PSYCHIAT, V75, P307, DOI 10.1016/j.biopsych.2013.07.011; Miller GE, 2011, PSYCHOL BULL, V137, P959, DOI 10.1037/a0024768; Miller S, 2013, J PSYCHIATR RES, V47, P252, DOI 10.1016/j.jpsychires.2012.10.015; MONTGOMERY SA, 1979, BRIT J PSYCHIAT, V134, P382, DOI 10.1192/bjp.134.4.382; Mun HS, 2003, INT IMMUNOL, V15, P1081, DOI 10.1093/intimm/dxg108; NURNBERGER JI, 1994, ARCH GEN PSYCHIAT, V51, P849, DOI 10.1001/archpsyc.1994.03950110009002; Oliveira J, 2014, J AFFECT DISORDERS, V165, P135, DOI 10.1016/j.jad.2014.04.059; Oliveira J, 2014, J AFFECT DISORDERS, V152, P395, DOI 10.1016/j.jad.2013.09.043; Olson JK, 2004, J IMMUNOL, V173, P3916, DOI 10.4049/jimmunol.173.6.3916; Padmos RC, 2008, ARCH GEN PSYCHIAT, V65, P395, DOI 10.1001/archpsyc.65.4.395; Paquette Daniel, 2004, Sante Ment Que, V29, P201; Parboosing R, 2013, JAMA PSYCHIAT, V70, P677, DOI 10.1001/jamapsychiatry.2013.896; Perroud N, 2008, GENES BRAIN BEHAV, V7, P314, DOI 10.1111/j.1601-183X.2007.00354.x; Perroud N, 2010, GENES BRAIN BEHAV, V9, P193, DOI 10.1111/j.1601-183X.2009.00547.x; Rich-Edwards JW, 2010, AM J PREV MED, V39, P529, DOI 10.1016/j.amepre.2010.09.007; Rivest S, 2009, NAT REV IMMUNOL, V9, P429, DOI 10.1038/nri2565; Rolls A, 2007, NAT CELL BIOL, V9, P1081, DOI 10.1038/ncb1629; Romens SE, 2015, CHILD DEV, V86, P303, DOI 10.1111/cdev.12270; Roth TL, 2009, BIOL PSYCHIAT, V65, P760, DOI 10.1016/j.biopsych.2008.11.028; Shonkoff JP, 2012, PEDIATRICS, V129, pE232, DOI 10.1542/peds.2011-2663; Slopen N, 2012, BRAIN BEHAV IMMUN, V26, P239, DOI 10.1016/j.bbi.2011.11.003; Stein MB, 1997, PSYCHOL MED, V27, P951, DOI 10.1017/S0033291797005242; Steptoe A, 2007, BRAIN BEHAV IMMUN, V21, P901, DOI 10.1016/j.bbi.2007.03.011; Wang X, 2013, NEOPLASMA, V60, P459, DOI 10.4149/neo_2013_060; Yu JT, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-136; Zhang F, 2013, INFECTION, V41, P941, DOI 10.1007/s15010-013-0444-9	74	39	39	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2015	10	3							e0119702	10.1371/journal.pone.0119702	http://dx.doi.org/10.1371/journal.pone.0119702			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD9NQ	25790282	Green Published, gold			2022-12-27	WOS:000351425400097
J	Tareen, SHK; Ahmad, J				Tareen, Samar Hayat Khan; Ahmad, Jamil			Modelling and Analysis of the Feeding Regimen Induced Entrainment of Hepatocyte Circadian Oscillators Using Petri Nets	PLOS ONE			English	Article							BIOLOGICAL REGULATORY NETWORKS; LIFE-SPAN; SIRT1; CLOCK; RHYTHMS; METABOLISM; EXPRESSION; NAD(+); DEACETYLASE; INHIBITION	Circadian rhythms are certain periodic behaviours exhibited by living organism at different levels, including cellular and system-wide scales. Recent studies have found that the circadian rhythms of several peripheral organs in mammals, such as the liver, are able to entrain their clocks to received signals independent of other system level clocks, in particular when responding to signals generated during feeding. These studies have found SIRT1, PARP1, and HSF1 proteins to be the major influencers of the core CLOCKBMAL1: PER-CRY circadian clock. These entities, along with abstracted feeding induced signals were modelled collectively in this study using Petri Nets. The properties of the model show that the circadian system itself is strongly robust, and is able to continually evolve. The modelled feeding regimens suggest that the usual 3 meals/day and 2 meals/day feeding regimens are beneficial with any more or less meals/day negatively affecting the system.	[Tareen, Samar Hayat Khan; Ahmad, Jamil] Natl Univ Sci & Technol, Dept Computat Sci, Res Ctr Modeling & Simulat, Islamabad, Pakistan	National University of Sciences & Technology - Pakistan	Ahmad, J (corresponding author), Natl Univ Sci & Technol, Dept Computat Sci, Res Ctr Modeling & Simulat, Islamabad, Pakistan.	jamil.ahmad@rcms.nust.edu.pk	Ahmad, Jamil/AAF-5499-2021; Tareen, Samar Hayat Khan/P-3416-2014	Ahmad, Jamil/0000-0001-6618-6811; Tareen, Samar Hayat Khan/0000-0002-3902-6633				Ahmad J, 2006, LECT NOTES COMPUT SC, V3992, P887, DOI 10.1007/11758525_118; Ahmad J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033532; Ahmad J, 2010, INT J DATA MIN BIOIN, V4, P553, DOI 10.1504/IJDMB.2010.035900; Asher G, 2008, CELL, V134, P317, DOI 10.1016/j.cell.2008.06.050; Asher G, 2011, CELL METAB, V13, P125, DOI 10.1016/j.cmet.2011.01.006; Asher G, 2010, CELL, V142, P943, DOI 10.1016/j.cell.2010.08.016; Baier C, 2008, PRINCIPLES OF MODEL CHECKING, P1; Bass J, 2012, NATURE, V491, P348, DOI 10.1038/nature11704; Becker-Weimann S, 2004, BIOPHYS J, V87, P3023, DOI 10.1529/biophysj.104.040824; Bellet MM, 2011, COLD SH Q B, V76, P31, DOI 10.1101/sqb.2011.76.010520; Bellet MM, 2010, J CELL SCI, V123, P3837, DOI 10.1242/jcs.051649; Bernot G, 2004, J THEOR BIOL, V229, P339, DOI 10.1016/j.jtbi.2004.04.003; Blatke M. A., 2011, TECHNICAL REPORT; Brauer W, 2009, C ADAM PETRI PETRI N, V3; Chaouiya C, 2007, BRIEF BIOINFORM, V8, P210, DOI 10.1093/bib/bbm029; Chaouiya C, 2012, METHODS MOL BIOL, V804, P463, DOI 10.1007/978-1-61779-361-5_23; Chaouiya C, 2008, J DISCRET ALGORITHMS, V6, P165, DOI 10.1016/j.jda.2007.06.003; Choi SE, 2013, AGING CELL, V12, P1062, DOI 10.1111/acel.12135; Cimatti A, 2002, TECHNICAL REPORT; Damiola F, 2000, GENE DEV, V14, P2950, DOI 10.1101/gad.183500; David R, 2010, DISCRETE, CONTINUOUS, AND HYBRID PETRI NETS, SECOND EDITION, P1, DOI 10.1007/978-3-642-10669-9; De Jong H, 2002, J COMPUT BIOL, V9, P67, DOI 10.1089/10665270252833208; Ehrenfried JA, 1996, ANN SURG, V223, P592, DOI 10.1097/00000658-199605000-00015; Ethier C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047978; Formanowicz D, 2007, J BIOMED INFORM, V40, P476, DOI 10.1016/j.jbi.2006.12.001; Franzke A, 2009, THESIS BTU COTTBUS; Froy O, 2011, PHYSIOLOGY, V26, P225, DOI 10.1152/physiol.00012.2011; Froy O, 2010, AGING-US, V2, P7, DOI 10.18632/aging.100116; Gao ZG, 2008, BIOCHEM BIOPH RES CO, V376, P793, DOI 10.1016/j.bbrc.2008.09.079; Gross Liza, 2007, PLoS Biol, V5, pe50, DOI 10.1371/journal.pbio.0050050; Hahn JS, 2004, J BIOL CHEM, V279, P5169, DOI 10.1074/jbc.M311005200; Heiner M, 2004, BIOSYSTEMS, V75, P15, DOI 10.1016/j.biosystems.2004.03.003; Heiner M., 2012, LNCS, P398, DOI [DOI 10.1007/978-3-642-31131-4_22, DOI 10.1007/978-3-642-31131-422]; Huang WY, 2011, J CLIN INVEST, V121, P2133, DOI 10.1172/JCI46043; Imai S, 2014, TRENDS CELL BIOL, V24, P464, DOI 10.1016/j.tcb.2014.04.002; Imai S, 2011, FEBS LETT, V585, P1657, DOI 10.1016/j.febslet.2011.04.060; Imai SI, 2010, BBA-PROTEINS PROTEOM, V1804, P1584, DOI 10.1016/j.bbapap.2009.10.024; Inoue K., 2011, P 22 INT JOINT C ART, P924, DOI DOI 10.5591/978-1-57735-516-8/IJCAI11-160; Jr Clarke EM, 1999, MODEL CHECKING; Katsuki K, 2004, FEBS LETT, V571, P187, DOI 10.1016/j.febslet.2004.06.087; KAUFFMAN SA, 1969, J THEOR BIOL, V22, P437, DOI 10.1016/0022-5193(69)90015-0; Khalis Z, 2009, GENES GENOMES GENOMI; Koch I, 2011, COMPUT BIOL SER, V16, P3, DOI 10.1007/978-1-84996-474-6_1; Le Minh N, 2001, EMBO J, V20, P7128, DOI 10.1093/emboj/20.24.7128; Leloup JC, 2004, J THEOR BIOL, V230, P541, DOI 10.1016/j.jtbi.2004.04.040; Li L, 2009, GENE REGUL SYST BIO, V3, P105; Liu F, 2013, NAT COMPUT, V12, P617, DOI 10.1007/s11047-013-9367-8; Luna Augustin, 2013, Genome Integr, V4, P6, DOI 10.1186/2041-9414-4-6; Lynch CJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013502; Majumdar A, 2014, BMC BIOINFORMATICS, V15, DOI 10.1186/1471-2105-15-S7-S13; Matsuno Hiroshi, 2006, Journal of Bioinformatics and Computational Biology, V4, P139, DOI 10.1142/S021972000600176X; Mitchell SJ, 2014, CELL REP, V6, P836, DOI 10.1016/j.celrep.2014.01.031; Mohawk JA, 2012, ANNU REV NEUROSCI, V35, P445, DOI 10.1146/annurev-neuro-060909-153128; Nakahata Y, 2008, CELL, V134, P329, DOI 10.1016/j.cell.2008.07.002; Noriega LG, 2011, EMBO REP, V12, P1069, DOI 10.1038/embor.2011.151; Paetkau V, 2006, THEOR BIOL MED MODEL, V3, DOI 10.1186/1742-4682-3-12; Panda S, 2002, NATURE, V417, P329, DOI 10.1038/417329a; Rajamohan SB, 2009, MOL CELL BIOL, V29, P4116, DOI 10.1128/MCB.00121-09; Ramsey KM, 2009, SCIENCE, V324, P651, DOI 10.1126/science.1171641; Raynes Rachel, 2013, Genes Cancer, V4, P172, DOI 10.1177/1947601913484497; Richard A., 2006, MODERN FORMAL METHOD, V5, P83, DOI [DOI 10.1007/1-4020-4223-X5, 10.1007/1-4020-4223-X_5, DOI 10.1007/1-4020-4223-X_5]; Richard A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0024651; Rutter J, 2001, SCIENCE, V293, P510, DOI 10.1126/science.1060698; Scheer FAJL, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000721; Schuldt A, 2010, NAT REV MOL CELL BIO, V11, DOI 10.1038/nrm2998; Simao E, 2005, BIOINFORMATICS, V21, P190, DOI 10.1093/bioinformatics/bti1130; Sriram K., 2006, ComPlexUs, V3, P185, DOI 10.1159/000095479; Stein LR, 2012, TRENDS ENDOCRIN MET, V23, P420, DOI 10.1016/j.tem.2012.06.005; STROGATZ SH, 1987, J MATH BIOL, V25, P327, DOI 10.1007/BF00276440; Tamaru T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082006; Tamaru T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024521; THOMAS R, 1991, J THEOR BIOL, V153, P1, DOI 10.1016/S0022-5193(05)80350-9; Thomas R., 1990, BIOL FEEDBACK; Thomas R, 1979, LECT NOTES BIOMATH, V29, P107, DOI [10.1007/978-3-642-49321-8_6, DOI 10.1007/978-3-642-49321-8_]; Trepanowski JF, 2010, NUTR J, V9, DOI 10.1186/1475-2891-9-57; Wang E, 2010, SYSTEMS BIOL; Wang T, 2013, ONCOL LETT, V6, P600, DOI 10.3892/ol.2013.1400	77	10	10	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2015	10	3							e0117519	10.1371/journal.pone.0117519	http://dx.doi.org/10.1371/journal.pone.0117519			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD9NQ	25789928	Green Published, Green Submitted, gold			2022-12-27	WOS:000351425400024
J	van Rennings, L; von Munchhausen, C; Ottilie, H; Hartmann, M; Merle, R; Honscha, W; Kasbohrer, A; Kreienbrock, L				van Rennings, Lisa; von Muenchhausen, Christiane; Ottilie, Henry; Hartmann, Maria; Merle, Roswitha; Honscha, Walther; Kaesbohrer, Annemarie; Kreienbrock, Lothar			Cross-Sectional Study on Antibiotic Usage in Pigs in Germany	PLOS ONE			English	Article							ANTIMICROBIAL DRUG-USE; SWINE FARMS; VETERINARY-MEDICINE; CONSUMPTION; ONTARIO	To be able to analyze the relationship between the level of resistance and the use of antimicrobials, it is necessary to collect detailed data on antimicrobial usage. For this reason, data on antimicrobial use on 495 pig farms from entire Germany were collected and analyzed. In Germany, each application and dispensing of medicines to food-producing animals is documented in detail obligatorily by the veterinarian. This information was collected retrospectively for the year 2011. The analyses undertook separate examinations on the age groups sow, piglet, weaner and fattening pig; both the route of administration and indication per active ingredient, and active ingredient class, were evaluated. In total, 20,374 kg of antimicrobial substances were used in the study population. Tetracyclines were used in highest amounts, followed by beta-lactams, trimethoprim-sulfonamides and macrolides. Concerning the frequency of using an active substance per animal, polypeptides were most commonly administered. In all age groups, respiratory infections were the main indication for using antimicrobials, followed by intestinal diseases in piglets, weaners and fattening pigs and diseases of reproductive organs in sows. Over a period of 100 days, the median number of treatment days with one antimicrobial substance for piglets was 15 days, for weaners about 6 days, for fattening pigs about 4 days and for sows about 1 day. A multifactorial ANOVA was conducted to investigate which factors are associated with the treatment frequency. The factors "veterinarian" and "age group" were related to the treatment frequency, just as the interaction between "veterinarian" and "farm size" as well as the interaction between "veterinarian" and "age group".	[van Rennings, Lisa; von Muenchhausen, Christiane; Hartmann, Maria; Merle, Roswitha; Kreienbrock, Lothar] Univ Vet Med Hannover, WHO Collaborating Ctr Res & Training Vet Publ Hlt, Dept Biometry Epidemiol & Informat Proc, Hannover, Germany; [Ottilie, Henry; Honscha, Walther] Univ Leipzig, Fac Vet, Inst Pharmacol Pharm & Toxicol, D-04109 Leipzig, Germany; [Kaesbohrer, Annemarie] Fed Inst Risk Assessment, Berlin, Germany	University of Veterinary Medicine Hannover, Foundation; Leipzig University; Federal Institute for Risk Assessment	van Rennings, L (corresponding author), Univ Vet Med Hannover, WHO Collaborating Ctr Res & Training Vet Publ Hlt, Dept Biometry Epidemiol & Informat Proc, Hannover, Germany.	lisa.van.rennings@tiho-hannover.de		Merle, Roswitha/0000-0002-8688-2926	Federal Institute for Risk Assessment, Berlin [FK 1329-441, FK 1329-482]	Federal Institute for Risk Assessment, Berlin	This study was supported by research grants from the Federal Institute for Risk Assessment, Diedersdorfer Weg 1, D-12277 Berlin (Grant No.: FK 1329-441 and FK 1329-482). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aarestrup FM, 2010, AM J VET RES, V71, P726, DOI 10.2460/ajvr.71.7.726; Arnold S, 2004, PHARMACOEPIDEM DR S, V13, P323, DOI 10.1002/pds.874; AURES, 2013, RES OST AURES 2012 A; Bondt N, 2013, PREV VET MED, V108, P10, DOI 10.1016/j.prevetmed.2012.07.009; Bos MEH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077525; BTK ArgeVET, 2000, DTSCH TIERARZTEBLATT, V48; Bundesamt Statistisches, 2012, LAND UND FORSTW FISC; Callens B, 2012, PREV VET MED, V106, P53, DOI 10.1016/j.prevetmed.2012.03.001; Casal J, 2007, VET RES, V38, P481, DOI 10.1051/vetres:2007010; Chauvin C, 2002, PREV VET MED, V55, P109, DOI 10.1016/S0167-5877(02)00091-0; Chavin C, 2001, VET RES, V32, P533, DOI 10.1051/vetres:2001145; DANMAP,, 2021, US ANT AG OCC ANT RE; DART, 2011, DART DTSCH ANT RES; Dunlop RH, 1998, CAN VET J, V39, P87; Dunlop RH, 1998, PREV VET MED, V34, P247, DOI 10.1016/S0167-5877(97)00093-7; EMA, 2013, EMA2864162012REV1; European commission, 2003, OFFICIAL J, VL268, P29; European Medicines Agency (EMA), 2013, SAL VET ANT AG 25 EU; Hajek P, 2009, J VET PHARMACOL THER, V32, P60; Jensen VF, 2012, J VET PHARMACOL THER, V35, P33, DOI 10.1111/j.1365-2885.2011.01291.x; Jensen VF, 2004, PREV VET MED, V64, P201, DOI 10.1016/j.prevetmed.2004.04.001; Jordan D, 2009, AUST VET J, V87, P222, DOI 10.1111/j.1751-0813.2009.00430.x; KTBL, 2012, BETR LANDW 2012 13 K; LAVES, 2011, BER ANT LANDW NUTZT; MARAN, 2013, MARAN 2012 MON ANT R; Merle R, 2014, BMC VET RES, V10, DOI 10.1186/1746-6148-10-7; Merle R, 2013, BERL MUNCH TIERARZTL, V126, P326, DOI 10.2376/0005-9366-126-326; Merle R, 2012, PREV VET MED, V104, P34, DOI 10.1016/j.prevetmed.2011.10.013; Merle R, 2012, BERL MUNCH TIERARZTL, V125, P52, DOI 10.2376/0005-9366-125-52; Mollenhauer Y., 2010, THESIS TIERARZTLICHE; Moreno MA, 2012, VET REC, V171, DOI 10.1136/vr.100818; Morley PS, 2005, J VET INTERN MED, V19, P617, DOI 10.1892/0891-6640(2005)19[617:ADUIVM]2.0.CO;2; Rajic A, 2006, CAN VET J, V47, P446; Robanus M, 2011, THESIS U LEIPZIG; Sanchez-Vazquez MJ, 2012, PREV VET MED, V104, P65, DOI 10.1016/j.prevetmed.2011.11.003; SVARM, 2013, SVARM 2012 SWED VET; Timmerman T, 2006, PREV VET MED, V74, P251, DOI 10.1016/j.prevetmed.2005.10.003; Ungemach FR, 2006, INT J MED MICROBIOL, V296, P33, DOI 10.1016/j.ijmm.2006.01.059; van der Fels-Klerx HJ, 2011, J ANIM SCI, V89, P1922, DOI 10.2527/jas.2010-3046; van Rennings L, 2014, BERL MUNCH TIERARZTL, V127, P10; van Rennings L, 2013, BERL MUNCH TIERARZTL, V126, P297, DOI 10.2376/0005-9366-126-297; Vieira AR, 2011, EPIDEMIOL INFECT, V139, P1601, DOI 10.1017/S0950268810002724; Wallmann J, 2013, DT TIERARZTEBL, V9, P1230; Wassenaar TM, 2005, CRIT REV MICROBIOL, V31, P155, DOI 10.1080/10408410591005110; WHO, 2009, ATC DDD IND 2013; WHO, 2011, WHO CRIT IMP ANT HUM	46	87	89	0	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2015	10	3							e0119114	10.1371/journal.pone.0119114	http://dx.doi.org/10.1371/journal.pone.0119114			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9BN	25785688	gold, Green Submitted, Green Published			2022-12-27	WOS:000352138500075
J	Vasalou, C; Helmlinger, G; Gomes, B				Vasalou, Christina; Helmlinger, Gabriel; Gomes, Bruce			A Mechanistic Tumor Penetration Model to Guide Antibody Drug Conjugate Design	PLOS ONE			English	Article							MONOCLONAL-ANTIBODIES; VASCULAR-PERMEABILITY; MOLECULAR-SIZE; SOLID TUMORS; BINDING; MACROMOLECULES; GROWTH; AFFINITY; PLASMA; CELLS	Antibody drug conjugates (ADCs) represent novel anti-cancer modalities engineered to specifically target and kill tumor cells expressing corresponding antigens. Due to their large size and their complex kinetics, these therapeutic agents often face heterogeneous distributions in tumors, leading to large untargeted regions that escape therapy. We present a modeling framework which includes the systemic distribution, vascular permeability, interstitial transport, as well as binding and payload release kinetics of ADC-therapeutic agents in mouse xenografts. We focused, in particular, on receptor dynamics such as endocytic trafficking mechanisms within cancer cells, to simulate their impact on tumor mass shrinkage upon ADC administration. Our model identified undesirable tumor properties that can impair ADC tissue homogeneity, further compromising ADC success, and explored ADC design optimization scenarios to counteract upon such unfavorable intrinsic tumor tissue attributes. We further demonstrated the profound impact of cytotoxic payload release mechanisms and the role of bystander killing effects on tumor shrinkage. This model platform affords a customizable simulation environment which can aid with experimental data interpretation and the design of ADC therapeutic treatments.	[Vasalou, Christina; Helmlinger, Gabriel; Gomes, Bruce] Novartis, Adv Quantitat Sci, Cambridge, MA 02139 USA	Novartis	Gomes, B (corresponding author), Novartis, Adv Quantitat Sci, Cambridge, MA 02139 USA.	bruce.gomes@novartis.com			Novartis Institute for Biomedical Research	Novartis Institute for Biomedical Research	The authors would like to state that Novartis Institute for Biomedical Research provided support in the form of salaries for authors CV, BG, GH, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Ackerman ME, 2008, MOL CANCER THER, V7, P2233, DOI 10.1158/1535-7163.MCT-08-0067; Adams GP, 2001, CANCER RES, V61, P4750; Alley SC, 2010, CURR OPIN CHEM BIOL, V14, P529, DOI 10.1016/j.cbpa.2010.06.170; BAXTER LT, 1991, MICROVASC RES, V41, P252, DOI 10.1016/0026-2862(91)90026-8; Berk DA, 1997, P NATL ACAD SCI USA, V94, P1785, DOI 10.1073/pnas.94.5.1785; Burris HA, 2011, J CLIN ONCOL, V29, P398, DOI 10.1200/JCO.2010.29.5865; Dellian M, 2000, BRIT J CANCER, V82, P1513; Doronina SO, 2003, NAT BIOTECHNOL, V21, P778, DOI 10.1038/nbt832; Erickson HK, 2010, BIOCONJUGATE CHEM, V21, P84, DOI 10.1021/bc900315y; Erickson HK, 2006, CANCER RES, V66, P4426, DOI 10.1158/0008-5472.CAN-05-4489; FELDER S, 1992, J CELL BIOL, V117, P203, DOI 10.1083/jcb.117.1.203; FUJIMORI K, 1989, CANCER RES, V49, P5656; Gerber HP, 2013, NAT PROD REP, V30, P625, DOI 10.1039/c3np20113a; Goh LK, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a017459; Hendriks BS, 2003, CANCER RES, V63, P1130; Hendriks BS, 2003, BIOPHYS J, V85, P2732, DOI 10.1016/S0006-3495(03)74696-7; HILMAS DE, 1974, CANCER, V33, P103, DOI 10.1002/1097-0142(197401)33:1<103::AID-CNCR2820330116>3.0.CO;2-7; Holliger P, 2005, NAT BIOTECHNOL, V23, P1126, DOI 10.1038/nbt1142; ISOBE T, 1979, BLOOD, V53, P1028; JAIN RK, 1988, CANCER RES, V48, P7022; JUWEID M, 1992, CANCER RES, V52, P5144; Kovtun YV, 2006, CANCER RES, V66, P3214, DOI 10.1158/0008-5472.CAN-05-3973; Krop I, 2009, CANCER RES, V69, p795S; Lauffenburger DA, 1993, RECEPTORS MODELS BIN, P30; Less JR, 1997, MICROCIRCULATION-LON, V4, P25, DOI 10.3109/10739689709148315; LESS JR, 1991, CANCER RES, V51, P265; Lin YS, 1999, J PHARMACOL EXP THER, V288, P371; Mehrara E, 2007, CANCER RES, V67, P3970, DOI 10.1158/0008-5472.CAN-06-3822; Netti PA, 2000, CANCER RES, V60, P2497; Okeley NM, 2010, CLIN CANCER RES, V16, P888, DOI 10.1158/1078-0432.CCR-09-2069; Panetta JC, 1997, MATH BIOSCI, V146, P89, DOI 10.1016/S0025-5564(97)00077-1; Panetta JC, 2008, CLIN CANCER RES, V14, P318, DOI 10.1158/1078-0432.CCR-07-1243; Pluen A, 2001, P NATL ACAD SCI USA, V98, P4628, DOI 10.1073/pnas.081626898; PORSCHEN R, 1994, CANCER RES, V54, P587; Rudnick SI, 2011, CANCER RES, V71, P2250, DOI 10.1158/0008-5472.CAN-10-2277; Schmidt MM, 2009, MOL CANCER THER, V8, P2861, DOI 10.1158/1535-7163.MCT-09-0195; Shah DK, 2013, MABS-AUSTIN, V5, P297, DOI 10.4161/mabs.23684; Shah DK, 2012, J PHARMACOKINET PHAR, V39, P67, DOI 10.1007/s10928-011-9232-2; Stoletov K, 2007, P NATL ACAD SCI USA, V104, P17406, DOI 10.1073/pnas.0703446104; Szakacs G, 2006, NAT REV DRUG DISCOV, V5, P219, DOI 10.1038/nrd1984; Thurber GM, 2007, J NUCL MED, V48, P995, DOI 10.2967/jnumed.106.037069; Thurber GM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024696; Vona G, 2000, AM J PATHOL, V156, P57, DOI 10.1016/S0002-9440(10)64706-2; Wadleigh M, 2003, BLOOD, V102, P1578, DOI 10.1182/blood-2003-01-0255; WATERS CM, 1990, BIOCHEMISTRY-US, V29, P3563, DOI 10.1021/bi00466a020; Wiig H, 2005, J PHYSIOL-LONDON, V567, P557, DOI 10.1113/jphysiol.2005.089615; Younes A, 2011, ASCO MEETING ABSTRAC, V15; YUAN F, 1995, CANCER RES, V55, P3752	48	50	50	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2015	10	3							e0118977	10.1371/journal.pone.0118977	http://dx.doi.org/10.1371/journal.pone.0118977			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9BN	25786126	gold, Green Submitted, Green Published			2022-12-27	WOS:000352138500062
J	Vayalil, PK; Oh, JY; Zhou, F; Diers, AR; Smith, MR; Golzarian, H; Oliver, PG; Smith, RAJ; Murphy, MP; Velu, SE; Landar, A				Vayalil, Praveen K.; Oh, Joo-Yeun; Zhou, Fen; Diers, Anne R.; Smith, M. Ryan; Golzarian, Hafez; Oliver, Patsy G.; Smith, Robin A. J.; Murphy, Michael P.; Velu, Sadanandan E.; Landar, Aimee			A Novel Class of Mitochondria-Targeted Soft Electrophiles Modifies Mitochondrial Proteins and Inhibits Mitochondrial Metabolism in Breast Cancer Cells through Redox Mechanisms	PLOS ONE			English	Article							SENSITIVE K+ CHANNEL; OXIDATIVE STRESS; CELLULAR BIOENERGETICS; THIOL MODIFICATION; IN-VIVO; GLUTATHIONYLATION; DEHYDROGENASE; MUTATIONS; GLIOMAS; ATP	Despite advances in screening and treatment over the past several years, breast cancer remains a leading cause of cancer-related death among women in the United States. A major goal in breast cancer treatment is to develop safe and clinically useful therapeutic agents that will prevent the recurrence of breast cancers after front-line therapeutics have failed. Ideally, these agents would have relatively low toxicity against normal cells, and will specifically inhibit the growth and proliferation of cancer cells. Our group and others have previously demonstrated that breast cancer cells exhibit increased mitochondrial oxygen consumption compared with non-tumorigenic breast epithelial cells. This suggests that it may be possible to deliver redox active compounds to the mitochondria to selectively inhibit cancer cell metabolism. To demonstrate proof-of-principle, a series of mitochondria-targeted soft electrophiles (MTSEs) has been designed which selectively accumulate within the mitochondria of highly energetic breast cancer cells and modify mitochondrial proteins. A prototype MTSE, IBTP, significantly inhibits mitochondrial oxidative phosphorylation, resulting in decreased breast cancer cell proliferation, cell attachment, and migration in vitro. These results suggest MTSEs may represent a novel class of anti-cancer agents that prevent cancer cell growth by modification of specific mitochondrial proteins.	[Vayalil, Praveen K.; Oh, Joo-Yeun; Zhou, Fen; Diers, Anne R.; Smith, M. Ryan; Landar, Aimee] Univ Alabama Birmingham, Dept Pathol, Birmingham, AL 35294 USA; [Vayalil, Praveen K.; Oh, Joo-Yeun; Zhou, Fen; Diers, Anne R.; Smith, M. Ryan; Landar, Aimee] Univ Alabama Birmingham, Ctr Free Rad Biol, Birmingham, AL 35294 USA; [Oliver, Patsy G.] Univ Alabama Birmingham, Dept Radiat Oncol, Birmingham, AL 35294 USA; [Golzarian, Hafez; Velu, Sadanandan E.] Univ Alabama Birmingham, Dept Chem, Birmingham, AL 35294 USA; [Smith, Robin A. J.] Univ Otago, Dept Chem, Dunedin, New Zealand; [Murphy, Michael P.] MRC, Mitochondrial Biol Unit, Cambridge, England	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Otago	Landar, A (corresponding author), Univ Alabama Birmingham, Dept Pathol, Birmingham, AL 35294 USA.	landar@uab.edu	Murphy, Michael P/C-2120-2009	Murphy, Michael P/0000-0003-1115-9618; Velu, Sadanandan/0000-0002-0342-2378; Smith, Matthew Ryan/0000-0002-8889-3477	UAB Department of Pathology; National Institutes of Health (NIH) [T32 HL007918]; UAB Comprehensive Cancer Center [P30 CA013148]; UAB College of Arts and Sciences (CAS) [201307];  [HL096638]; NATIONAL CANCER INSTITUTE [P30CA013148] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007918, R01HL096638] Funding Source: NIH RePORTER; Medical Research Council [MC_U105663142] Funding Source: researchfish; MRC [MC_U105663142] Funding Source: UKRI	UAB Department of Pathology; National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); UAB Comprehensive Cancer Center; UAB College of Arts and Sciences (CAS); ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by HL096638 (to AL), Start-up Funds from the UAB Department of Pathology (to AL), National Institutes of Health (NIH) Training Grant T32 HL007918 (ARD), a Pilot Award from the UAB Comprehensive Cancer Center P30 CA013148 (to AL), and UAB College of Arts and Sciences (CAS) Interdisciplinary Team Award No. 201307 (to AL and SEV). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn YH, 2010, P NATL ACAD SCI USA, V107, P9590, DOI 10.1073/pnas.1004104107; Astuti D, 2001, AM J HUM GENET, V69, P49, DOI 10.1086/321282; Baker LMS, 2007, J BIOL CHEM, V282, P31085, DOI 10.1074/jbc.M704085200; Brookes PS, 2004, AM J PHYSIOL-CELL PH, V287, pC817, DOI 10.1152/ajpcell.00139.2004; Chen YR, 2007, J BIOL CHEM, V282, P32640, DOI 10.1074/jbc.M702294200; Cheng G, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-285; Cheng G, 2012, CANCER RES, V72, P2634, DOI 10.1158/0008-5472.CAN-11-3928; Cooper CE, 2002, TRENDS BIOCHEM SCI, V27, P489, DOI 10.1016/S0968-0004(02)02191-6; Costa ADT, 2008, AM J PHYSIOL-HEART C, V295, pH874, DOI 10.1152/ajpheart.01189.2007; Costa ADT, 2006, J BIOL CHEM, V281, P20801, DOI 10.1074/jbc.M600959200; Dent R, 2007, CLIN CANCER RES, V13, P4429, DOI 10.1158/1078-0432.CCR-06-3045; Diers AR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068348; Diers AR, 2010, BIOCHEM J, V430, P69, DOI 10.1042/BJ20091193; Diers AR, 2010, BIOCHEM J, V426, P31, DOI 10.1042/BJ20091293; Dranka BP, 2011, FREE RADICAL BIO MED, V51, P1621, DOI 10.1016/j.freeradbiomed.2011.08.005; Ferrick DA, 2008, DRUG DISCOV TODAY, V13, P268, DOI 10.1016/j.drudis.2007.12.008; Forman HJ, 2014, FREE RADICAL BIO MED, V66, P24, DOI 10.1016/j.freeradbiomed.2013.05.045; Griguer CE, 2005, J NEURO-ONCOL, V74, P123, DOI 10.1007/s11060-004-6404-6; Griguer CE, 2011, CURR PHARM DESIGN, V17, P2421; Hansen JM, 2006, ANNU REV PHARMACOL, V46, P215, DOI 10.1146/annurev.pharmtox.46.120604.141122; Hill BG, 2009, BIOCHEM J, V424, P99, DOI 10.1042/BJ20090934; Kil IS, 2005, J BIOL CHEM, V280, P10846, DOI 10.1074/jbc.M411306200; Kowaltowski AJ, 2001, AM J PHYSIOL-HEART C, V280, pH649, DOI 10.1152/ajpheart.2001.280.2.H649; Landar A, 2006, FREE RADICAL BIO MED, V40, P459, DOI 10.1016/j.freeradbiomed.2005.08.046; Li ZX, 2009, CANCER BIOTHER RADIO, V24, P579, DOI 10.1089/cbr.2008.0606; Lin NU, 2008, CANCER-AM CANCER SOC, V113, P2638, DOI 10.1002/cncr.23930; Lin TK, 2002, J BIOL CHEM, V277, P17048, DOI 10.1074/jbc.M110797200; LoPachin RM, 2007, TOXICOL SCI, V98, P561, DOI 10.1093/toxsci/kfm127; LoPachin RM, 2012, CHEM RES TOXICOL, V25, P239, DOI 10.1021/tx2003257; Lu J, 2009, J BIOL CHEM, V284, P723, DOI 10.1074/jbc.R800045200; Marin-Valencia I, 2012, CELL METAB, V15, P827, DOI 10.1016/j.cmet.2012.05.001; Marley K, 2005, J PROTEOME RES, V4, P1403, DOI 10.1021/pr050078k; McCleland ML, 2012, CANCER RES, V72, P5812, DOI 10.1158/0008-5472.CAN-12-1098; Millard M, 2013, J MED CHEM, V56, P9170, DOI 10.1021/jm4012438; Nulton-Persson AC, 2003, BIOCHEMISTRY-US, V42, P4235, DOI 10.1021/bi027370f; Oh JY, 2008, BIOCHEM J, V411, P297, DOI [10.1042/BJ20071189, 10.1042/bj20071189]; Oliva CR, 2010, J BIOL CHEM, V285, P39759, DOI 10.1074/jbc.M110.147504; Porporato PE, 2014, CELL REP, V8, P754, DOI 10.1016/j.celrep.2014.06.043; Reily C, 2013, REDOX BIOL, V1, P86, DOI 10.1016/j.redox.2012.11.009; Ricart KC, 2009, BIOCHEM J, V419, P427, DOI 10.1042/BJ20081350; Roberts DW, 2011, CHEM RES TOXICOL, V24, P1003, DOI 10.1021/tx100420w; Ross MF, 2006, BIOCHEM J, V400, P199, DOI 10.1042/BJ20060919; Sanchez-Gomez FJ, 2004, MOL PHARMACOL, V66, P1349, DOI 10.1124/mol.104.002824; Schopfer FJ, 2011, CHEM REV, V111, P5997, DOI 10.1021/cr200131e; Taylor ER, 2003, J BIOL CHEM, V278, P19603, DOI 10.1074/jbc.M209359200; Tomlinson IPM, 2002, NAT GENET, V30, P406, DOI 10.1038/ng849; Venkatraman A, 2004, AM J PHYSIOL-GASTR L, V286, pG521, DOI 10.1152/ajpgi.00399.2003; Wall SB, 2014, BBA-GEN SUBJECTS, V1840, P913, DOI 10.1016/j.bbagen.2013.09.003; Wall SB, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00369; WARBURG O, 1956, SCIENCE, V124, P269; Whitaker-Menezes D, 2011, CELL CYCLE, V10, P4047, DOI 10.4161/cc.10.23.18151; Wu M, 2007, AM J PHYSIOL-CELL PH, V292, pC125, DOI 10.1152/ajpcell.00247.2006; Yan H, 2009, NEW ENGL J MED, V360, P765, DOI 10.1056/NEJMoa0808710; Zhao J, 2013, ONCOGENE, V32, P4814, DOI 10.1038/onc.2012.494	54	10	10	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2015	10	3							e0120460	10.1371/journal.pone.0120460	http://dx.doi.org/10.1371/journal.pone.0120460			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9BN	25785718	Green Published, gold, Green Submitted			2022-12-27	WOS:000352138500172
J	Muneer, S; Ko, CH; Soundararajan, P; Manivnnan, A; Park, YG; Jeong, BR				Muneer, Sowbiya; Ko, Chung Ho; Soundararajan, Prabhakaran; Manivnnan, Abinaya; Park, Yoo Gyeong; Jeong, Byoung Ryong			Proteomic Study Related to Vascular Connections in Watermelon Scions Grafted onto Bottle-Gourd Rootstock under Different Light Intensities	PLOS ONE			English	Article							CONTRASTING RESPONSE; ARABIDOPSIS-THALIANA; GENE-EXPRESSION; EMITTING-DIODES; ROOT PROTEOME; HYBRID ASPEN; GROWTH; PROTEINS; UNION; TRANSCRIPTION	Although grafting is broadly used in the production of crops, no information is available about the proteins involved in vascular connections between rootstock and scion. Similarly, proteome changes under the light intensities widely used for grafted seedlings are of practical use. The objective of this study was to determine the proteome of vascular connections using watermelon (Citrullus vulgaris Schrad.) 'Sambok Honey' and 'Speed' as the scion and bottle gourd (Lagenaria siceraria Stanld.) 'RS Dongjanggun' as the rootstock grown under different light intensities (25, 50, 75 and 100 mu mol m(-2) s(-1)). Our proteomic analysis revealed 24 and 27 differentially expressed proteins in 'Sambok Honey' and 'Speed', respectively, under different light intensities. The identified proteins were largely involved in ion binding, amino acid metabolism, transcriptional regulation and defense response. The enhancement of ion-binding, transcriptional regulation, amino acid metabolism, and defense response proteins suggests a strengthening of the connection between the rootstock and scion under high light intensity. Indeed, the accumulation of key enzymes in the biological processes described above appears to play an important role in the vascular connections of grafted seedlings. Moreover, it appears that 100 mu mol m(-2) s(-1) results in better protein expression responses in grafted seedlings.	[Muneer, Sowbiya; Ko, Chung Ho; Soundararajan, Prabhakaran; Manivnnan, Abinaya; Jeong, Byoung Ryong] Gyeongsang Natl Univ, Div Appl Life Sci, Plus BK21, Jinju 660701, South Korea; [Park, Yoo Gyeong; Jeong, Byoung Ryong] Gyeongsang Natl Univ, Inst Agr & Life Sci, Jinju 660701, South Korea; [Jeong, Byoung Ryong] Gyeongsang Natl Univ, Life Sci Res Inst, Jinju 660701, South Korea	Gyeongsang National University; Gyeongsang National University; Gyeongsang National University	Jeong, BR (corresponding author), Gyeongsang Natl Univ, Div Appl Life Sci, Plus BK21, Jinju 660701, South Korea.	brjeong@gnu.ac.kr	Muneer, Sowbiya/S-5382-2019; Jeong, Byoung Ryong/D-7667-2014	Jeong, Byoung Ryong/0000-0002-4146-7278; Muneer, Sowbiya/0000-0003-0230-772X	Korea Institute of Planning and Evaluation for Technology in Food, Agriculture Forestry and Fisheries [312034-04]; BK21 programme, Ministry of Education, Korea	Korea Institute of Planning and Evaluation for Technology in Food, Agriculture Forestry and Fisheries; BK21 programme, Ministry of Education, Korea	This work was supported by Korea Institute of Planning and Evaluation for Technology in Food, Agriculture Forestry and Fisheries (Project No. 312034-04). SM, CHK, PS, AM and YGP were supported by a scholarship from BK21 programme, Ministry of Education, Korea. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdelmageed AHA, 2009, EUR J HORTIC SCI, V74, P16; Alluvada J, 2014, ACTA PHYSIOL PLANT, V36, P2385, DOI 10.1007/s11738-014-1611-z; Aloni B, 2008, J HORTIC SCI BIOTECH, V83, P777, DOI 10.1080/14620316.2008.11512460; Baba K, 2011, P NATL ACAD SCI USA, V108, P3418, DOI 10.1073/pnas.1011506108; Baima S, 2001, PLANT PHYSIOL, V126, P643, DOI 10.1104/pp.126.2.643; Berta M, 2010, PLANT BIOLOGY, V12, P341, DOI 10.1111/j.1438-8677.2009.00320.x; Busch W, 2005, PLANT J, V41, P1, DOI 10.1111/j.1365-313X.2004.02272.x; Martinez-Ballesta MC, 2010, SCI HORTIC-AMSTERDAM, V127, P112, DOI 10.1016/j.scienta.2010.08.002; Colla G, 2010, SCI HORTIC-AMSTERDAM, V127, P147, DOI 10.1016/j.scienta.2010.08.004; Cookson SJ, 2014, J EXP BOT, V65, P2473, DOI 10.1093/jxb/eru145; Cookson SJ, 2013, J EXP BOT, V64, P2997, DOI 10.1093/jxb/ert144; Fuentes I, 2014, NATURE, V511, P232, DOI 10.1038/nature13291; Geigenberger P, 2003, J EXP BOT, V54, P457, DOI 10.1093/jxb/erg074; Giavalisco P, 2006, PROTEOMICS, V6, P896, DOI 10.1002/pmic.200500155; Henriksson E, 2005, PLANT CELL ENVIRON, V28, P202, DOI 10.1111/j.1365-3040.2004.01263.x; Herald VL, 2003, FEBS LETT, V537, P96, DOI 10.1016/S0014-5793(03)00101-7; Jensen PJ, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-9; Jensen PJ, 2010, TREE GENET GENOMES, V6, P57, DOI 10.1007/s11295-009-0228-7; Kang HG, 2000, PLANT J, V21, P329, DOI 10.1046/j.1365-313x.2000.00678.x; Karpinska B, 2004, PLANT MOL BIOL, V56, P255, DOI 10.1007/s11103-004-3354-5; Kehr J, 2005, BMC PLANT BIOL, V5, DOI 10.1186/1471-2229-5-11; Kim K., 2013, PLANT PATHOLOGY MICR, V4, P49; Lee JM, 2010, SCI HORTIC-AMSTERDAM, V127, P93, DOI 10.1016/j.scienta.2010.08.003; Liu YS, 2006, ADV GENET, V56, P101, DOI 10.1016/S0065-2660(06)56003-1; Milien M, 2012, SCI HORTIC-AMSTERDAM, V144, P130, DOI 10.1016/j.scienta.2012.06.045; Mudge K., 2009, Horticultural Reviews, V35, P437; Muneer S, 2014, INT J MOL SCI, V15, P6343, DOI 10.3390/ijms15046343; Muneer S, 2014, INT J MOL SCI, V15, P4657, DOI 10.3390/ijms15034657; Muneer S, 2012, PLANT GROWTH REGUL, V68, P421, DOI 10.1007/s10725-012-9731-1; Nam MH, 2012, PROTEOME SCI, V10, DOI 10.1186/1477-5956-10-25; Oka Y, 2004, J NEMATOL, V36, P137; Olmstead MA, 2006, HORTSCIENCE, V41, P674, DOI 10.21273/HORTSCI.41.3.674; Olmstead MA, 2006, J AM SOC HORTIC SCI, V131, P577, DOI 10.21273/JASHS.131.5.577; Pina A, 2005, SCI HORT, V127, P93; Qureshi MI, 2010, ADV BOT RES, V56, P1, DOI 10.1016/S0065-2296(10)56001-4; Raju Saravanan, 2013, Indian Journal of Plant Physiology, V18, P285, DOI 10.1007/s40502-013-0038-7; Rivard CL, 2008, HORTSCIENCE, V43, P2104, DOI 10.21273/HORTSCI.43.7.2104; Shabala S, 2010, PLANT J, V61, P839, DOI 10.1111/j.1365-313X.2009.04110.x; Smith DL, 2000, PLANT PHYSIOL, V123, P1173, DOI 10.1104/pp.123.3.1173; Sorce C, 2013, PLANT CELL REP, V32, P885, DOI 10.1007/s00299-013-1431-4; SOUMELIDOU K, 1994, ANN BOT-LONDON, V74, P605, DOI 10.1006/anbo.1994.1161; Stegemann S, 2009, SCIENCE, V324, P649, DOI 10.1126/science.1170397; Vilaine F, 2003, PLANT J, V36, P67, DOI 10.1046/j.1365-313X.2003.01855.x; Vitale A, 2014, PLANT PHYSIOL BIOCH, V83, P207, DOI 10.1016/j.plaphy.2014.08.006; Vu NT, 2014, PROTECTED HORT PLANT, V23, P43, DOI DOI 10.12791/KSBEC.2014.23.1.043; Walz C, 2004, PHYTOCHEMISTRY, V65, P1795, DOI 10.1016/j.phytochem.2004.04.006; Wang H, 2006, J EXP BOT, V57, P827, DOI 10.1093/jxb/erj066; Witzel K, 2009, J EXP BOT, V60, P3545, DOI 10.1093/jxb/erp198; Yang YJ, 2012, PLANT PHYSIOL BIOCH, V58, P54, DOI 10.1016/j.plaphy.2012.05.026; Yano A, 2012, PLANT METHODS, V8, DOI 10.1186/1746-4811-8-46; Yin H, 2012, J EXP BOT, V63, P4219, DOI 10.1093/jxb/ers109; Yorio NC, 2001, HORTSCIENCE, V36, P380, DOI 10.21273/HORTSCI.36.2.380; Yuan K, 2011, AFR J BIOTECHNOL, V10, P14816, DOI 10.5897/AJB11.1844; Zhao FG, 2007, PLANT PHYSIOL, V145, P1061, DOI 10.1104/pp.107.105882; Zheng BS, 2010, TREE PHYSIOL, V30, P297, DOI 10.1093/treephys/tpp102	55	14	17	2	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2015	10	3							e0120899	10.1371/journal.pone.0120899	http://dx.doi.org/10.1371/journal.pone.0120899			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD9NQ	25789769	Green Published, Green Submitted, gold			2022-12-27	WOS:000351425400182
J	Braun, M; Hettinger, N; Koentges, C; Pfeil, K; Cimolai, MC; Hoffmann, MM; Osterholt, M; Doenst, T; Bode, C; Bugger, H				Braun, Martin; Hettinger, Niko; Koentges, Christoph; Pfeil, Katharina; Cimolai, Maria C.; Hoffmann, Michael M.; Osterholt, Moritz; Doenst, Torsten; Bode, Christoph; Bugger, Heiko			Myocardial Mitochondrial and Contractile Function Are Preserved in Mice Lacking Adiponectin	PLOS ONE			English	Article							DIET-INDUCED OBESITY; ISCHEMIA-REPERFUSION; PROTEIN; OXIDATION; MUSCLE; DYSFUNCTION; DECREASE; ADIPOSE; CLONING; FAMILY	Adiponectin deficiency leads to increased myocardial infarct size following ischemia reperfusion and to exaggerated cardiac hypertrophy following pressure overload, entities that are causally linked to mitochondrial dysfunction. In skeletal muscle, lack of adiponectin results in impaired mitochondrial function. Thus, it was our objective to investigate whether adiponectin deficiency impairs mitochondrial energetics in the heart. At 8 weeks of age, heart weight-to-body weight ratios were not different between adiponectin knockout (ADQ(-/-)) mice and wildtypes (WT). In isolated working hearts, cardiac output, aortic developed pressure and cardiac power were preserved in ADQ(-/-) mice. Rates of fatty acid oxidation, glucose oxidation and glycolysis were unchanged between groups. While myocardial oxygen consumption was slightly reduced (-24%) in ADQ(-/-) mice in isolated working hearts, rates of maximal ADP-stimulated mitochondrial oxygen consumption and ATP synthesis in saponin-permeabilized cardiac fibers were preserved in ADQ(-/-) mice with glutamate, pyruvate or palmitoyl-carnitine as a substrate. In addition, enzymatic activity of respiratory complexes I and II was unchanged between groups. Phosphorylation of AMP-activated protein kinase and SIRT1 activity were not decreased, expression and acetylation of PGC-1a were unchanged, and mitochondrial content of OXPHOS subunits was not decreased in ADQ(-/-) mice. Finally, increasing energy demands due to prolonged subcutaneous infusion of isoproterenol did not differentially affect cardiac contractility or mitochondrial function in ADQ(-/-) mice compared to WT. Thus, mitochondrial and contractile function are preserved in hearts of mice lacking adiponectin, suggesting that adiponectin may be expendable in the regulation of mitochondrial energetics and contractile function in the heart under non-pathological conditions.	[Braun, Martin; Hettinger, Niko; Koentges, Christoph; Pfeil, Katharina; Cimolai, Maria C.; Hoffmann, Michael M.; Bode, Christoph; Bugger, Heiko] Univ Freiburg, Ctr Heart, Div Cardiol & Angiol 1, D-79106 Freiburg, Germany; [Osterholt, Moritz; Doenst, Torsten] Jena Univ Hosp, Dept Cardiothorac Surg, Jena, Germany; [Hoffmann, Michael M.] Freiburg Univ Hosp, Inst Clin Chem & Lab Med, Freiburg, Germany	University of Freiburg; University of Hamburg; University Medical Center Hamburg-Eppendorf; Friedrich Schiller University of Jena; University of Freiburg	Bugger, H (corresponding author), Univ Freiburg, Ctr Heart, Div Cardiol & Angiol 1, Hugstetter Str 55, D-79106 Freiburg, Germany.	heiko.bugger@universitaets-herzzentrum.de	Hoffmann, Michael M/D-4074-2015; Bugger, Heiko/ABA-4180-2021	Hoffmann, Michael M/0000-0001-8459-6080; Bugger, Heiko/0000-0002-3524-0405				Arita Y, 1999, BIOCHEM BIOPH RES CO, V257, P79, DOI 10.1006/bbrc.1999.0255; Boudina S, 2005, CIRCULATION, V112, P2686, DOI 10.1161/CIRCULATIONAHA.105.554360; Bugger H, 2008, DIABETES, V57, P2924, DOI 10.2337/db08-0079; Bugger H, 2010, CARDIOVASC RES, V88, P229, DOI 10.1093/cvr/cvq239; Bugger H, 2009, DIABETES, V58, P1986, DOI 10.2337/db09-0259; Civitarese AE, 2006, CELL METAB, V4, P75, DOI 10.1016/j.cmet.2006.05.002; Fruebis J, 2001, P NATL ACAD SCI USA, V98, P2005, DOI 10.1073/pnas.041591798; Guo R, 2013, BBA-MOL BASIS DIS, V1832, P1136, DOI 10.1016/j.bbadis.2013.03.013; Hong SJ, 2004, BLOOD PRESSURE, V13, P236, DOI 10.1080/08037050410021397; Iwabu M, 2010, NATURE, V464, P1313, DOI 10.1038/nature08991; Janssen AJM, 2007, CLIN CHEM, V53, P729, DOI 10.1373/clinchem.2006.078873; KRAHENBUHL S, 1991, J BIOL CHEM, V266, P20998; Lesnefsky EJ, 2001, J MOL CELL CARDIOL, V33, P1065, DOI 10.1006/jmcc.2001.1378; Ma K, 2002, J BIOL CHEM, V277, P34658, DOI 10.1074/jbc.C200362200; Maeda K, 1996, BIOCHEM BIOPH RES CO, V221, P286, DOI 10.1006/bbrc.1996.0587; Nawrocki AR, 2006, J BIOL CHEM, V281, P2654, DOI 10.1074/jbc.M505311200; O'Shea KM, 2010, LIPIDS HEALTH DIS, V9, DOI 10.1186/1476-511X-9-95; O'Shea KM, 2010, AM J PHYSIOL-HEART C, V298, pH1639, DOI 10.1152/ajpheart.00957.2009; Ouchi N, 1999, CIRCULATION, V100, P2473, DOI 10.1161/01.CIR.100.25.2473; Peterson JM, 2013, AM J PHYSIOL-REG I, V305, pR522, DOI 10.1152/ajpregu.00110.2013; Schaffler A, 2012, TRENDS ENDOCRIN MET, V23, P194, DOI 10.1016/j.tem.2011.12.003; Shibata R, 2004, NAT MED, V10, P1384, DOI 10.1038/nm1137; Shibata R, 2005, NAT MED, V11, P1096, DOI 10.1038/nm1295; Tomas E, 2002, P NATL ACAD SCI USA, V99, P16309, DOI 10.1073/pnas.222657499; TZAGOLOFF A, 1965, J BIOL CHEM, V240, P2628; Weibel ER, 1979, INT REV CYTOL, V26, P235; Yamauchi T, 2003, NATURE, V423, P762, DOI 10.1038/nature01705; Yan WJ, 2013, BASIC RES CARDIOL, V108, DOI 10.1007/s00395-013-0329-1; Yi W, 2012, CIRCULATION, V125, P3159, DOI 10.1161/CIRCULATIONAHA.112.099937; Zheng QJ, 2011, ARTERIOSCL THROM VAS, V31, P2616, DOI 10.1161/ATVBAHA.111.231050	30	9	9	2	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2015	10	3							e0119416	10.1371/journal.pone.0119416	http://dx.doi.org/10.1371/journal.pone.0119416			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9BN	25785965	Green Submitted, gold, Green Published			2022-12-27	WOS:000352138500102
J	Gauld, NJ; Kelly, FS; Emmerton, LM; Buetow, SA				Gauld, Natalie J.; Kelly, Fiona S.; Emmerton, Lynne M.; Buetow, Stephen A.			Widening Consumer Access to Medicines: A Comparison of Prescription to Non-Prescription Medicine Switch in Australia and New Zealand	PLOS ONE			English	Article							PHARMACIES; BOARD	Background Despite similarities in health systems and Trans-Tasman Harmonization of medicines scheduling, New Zealand is more active than Australia in 'switching' (reclassifying) medicines from prescription to non-prescription. Objectives To identify and compare enablers and barriers to switch in New Zealand and Australia. Methods We conducted and analyzed 27 in-depth personal interviews with key participants in NZ and Australia and international participants previously located in Australia, and analyzed records of meetings considering switches (2000-2013). Analysis of both sets of data entailed a heuristic qualitative approach that embraced the lead researcher's knowledge and experience. Results The key themes identified were conservatism and political influences in Australia, and an open attitude, proactivity and flexibility in NZ. Pharmacist-only medicine schedules and individuals holding a progressive attitude were proposed to facilitate switch in both countries. A pharmacy retail group drove many switches in NZ ('third-party switch'), unlike Australia. Barriers to switch in both countries included small market sizes, funding of prescription medicines and cost of doctor visits, and lack of market exclusivity. In Australia, advertising limitations for pharmacist-only medicines reportedly discouraged industry from submitting switch applications. Perceptions of pharmacy performance could help or hinder switches. Conclusion Committee and regulator openness to switch, and confidence in pharmacy appear to influence consumer access to medicines. The pharmacist-only medicine schedule in Australasia and the rise of third-party switch and flexibility in switch in NZ could be considered elsewhere to enable switch.	[Gauld, Natalie J.; Buetow, Stephen A.] Univ Auckland, Dept Gen Practice & Primary Hlth Care, Auckland 1, New Zealand; [Kelly, Fiona S.] Univ Auckland, Sch Pharm, Auckland 1, New Zealand; [Kelly, Fiona S.] Griffith Univ, Griffith Hlth Inst, Brisbane, Qld 4111, Australia; [Emmerton, Lynne M.] Curtin Univ, Fac Hlth Sci, Sch Pharm, Perth, WA 6845, Australia	University of Auckland; University of Auckland; Griffith University; Menzies Health Institute Queensland; Curtin University	Gauld, NJ (corresponding author), Univ Auckland, Dept Gen Practice & Primary Hlth Care, Auckland 1, New Zealand.	n.gauld@auckland.ac.nz	Gauld, Natalie/I-6018-2019	Gauld, Natalie/0000-0003-0366-0357; Buetow, Stephen/0000-0002-9771-248X; Kelly, Fiona/0000-0001-7360-4655	University of Auckland	University of Auckland	A travel grant was provided by the University of Auckland for travel to Australia for interviews. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achanta AS, 2003, CLIN RES REGUL AFF, V20, P1, DOI 10.1081/CRP-120018736; AESGP, 2012, OTC INGR; Alarcon C, 2006, COMPLAINT WEIGHT LOS; [Anonymous], 2006, INT J PHARM PRACT; [Anonymous], 2003, CONSUMER, V425, P6; [Anonymous], 2010, AUSTR MED ASS MIN AI; Armstrong ME, 2006, PLAN B CONTRACEPTIVE; Aronson JK, 2009, BRIT MED BULL, V90, P63, DOI 10.1093/bmb/ldp015; Associate Minister of Health Minister of Health, 2010, ACT MED NZ 2010; Benrimoj SI, 2007, QUAL SAF HEALTH CARE, V16, P354, DOI 10.1136/qshc.2006.019463; Bialy Leisa H., 2007, Journal of Pharmacy Practice and Research, V37, P277; Blenkinsopp A, 2005, COUNTER MEDICATION; Brass EP, 2001, NEW ENGL J MED, V345, P810, DOI 10.1056/NEJMra011080; Brass EP, 2012, J CLIN PHARMACOL, V52, P1277, DOI 10.1177/0091270011412962; Brooker C, 2010, MED OBSERVER    0514; Cohen Joshua, 2003, Am J Ther, V10, P370, DOI 10.1097/00045391-200309000-00010; Davis P, 2009, GLOBAL PUBLIC HLTH; DEMB A, 1992, LONG RANGE PLANN, V25, P9, DOI 10.1016/0024-6301(92)90364-8; Devetak R, 2006, AUST J POLIT SCI, V41, P241, DOI 10.1080/10361140600672451; Duckett S, 2011, AUSTR HLTH CARE SYST; Endacott R, 2013, J HEALTH SERV RES PO, V18, P13, DOI 10.1258/jhsrp.2012.011154; Gauld N, 2012, SELFCARE, V3, P88; Gauld N, 2012, CLIN THER, V34, P1324, DOI 10.1016/j.clinthera.2012.04.019; Gauld N, 2011, J ANTIMICROB CHEMOTH, V66, P201, DOI 10.1093/jac/dkq409; Gauld NJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107726; Gauld NJ, 2012, J ANTIMICROB CHEMOTH, V67, P2949, DOI 10.1093/jac/dks337; Gauld NJ, 2007, PHARM TODAY     0406; Hardman D., 2009, JUDGMENT DECISION MA; Hillson D, 2008, MANAGING GROUP RISK; Hofstede G., 1980, CULTURES CONSEQUENCE; Kashyap Krishneeta C, 2014, Int J Pharm Pract, V22, P125, DOI 10.1111/ijpp.12052; Kelly FS, 2009, ANN PHARMACOTHER, V43, P1877, DOI 10.1345/aph.1L121; Klein G., 1999, SOURCES POWER; Marris S, 2007, THE AUSTR       0830; Medsafe, 2014, CHANG LEG CLASS MED; Ministry of Health, 2011, BETT SOON MOR CONV H; Morse JM, 1998, QUAL HEALTH RES, V8, P733, DOI 10.1177/104973239800800601; Moustakas C, 1990, HEURISTIC RES; Nelson M., 2003, PHARM EXEC, V23, P66; Nguyen NT, 2006, CLIN THER, V28, P1231, DOI 10.1016/j.clinthera.2006.08.007; Norris PT, 2002, PHARM WORLD SCI, V24, P149, DOI 10.1023/A:1019506120713; Patton M. Q., 2002, QUALITATIVE RES EVAL, V3rd; Pharmaceutical Society of New Zealand, 2002, ANN REPORT; Piper D, 2014, PHARM TODAY     1031; Reardon R, 2008, SPINE, V33, pS24, DOI 10.1097/BRS.0b013e3181642f07; ROHRMANN B, 1994, AUST J PSYCHOL, V46, P150, DOI 10.1080/00049539408259490; Schneider CR, 2011, ANN PHARMACOTHER, V45, P402, DOI 10.1345/aph.1P514; Strongman S, 2014, NZ HERALD       0929; United States General Accounting Office, 1995, NONPR DRUGS VAL PHAR; United States Government Accountability Office, 2009, NONPR DRUGS CONS REG; Wallace DM, 2009, SMALL GR RES, V40, P52, DOI 10.1177/1046496408326576; WHO, 2011, NIH PUBL; Yeats J, 2014, PHARM TODAY     1105	53	13	13	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2015	10	3							e0119011	10.1371/journal.pone.0119011	http://dx.doi.org/10.1371/journal.pone.0119011			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CE9BN	25785589	Green Published, gold, Green Submitted			2022-12-27	WOS:000352138500066
J	Gordon-Dseagu, VLZ; Mindell, JS; Steptoe, A; Moody, A; Wardle, J; Demakakos, P; Shelton, NJ				Gordon-Dseagu, Vanessa L. Z.; Mindell, Jennifer S.; Steptoe, Andrew; Moody, Alison; Wardle, Jane; Demakakos, Panayotes; Shelton, Nicola J.			Impaired Glucose Metabolism among Those with and without Diagnosed Diabetes and Mortality: A Cohort Study Using Health Survey for England Data	PLOS ONE			English	Article							ALL-CAUSE MORTALITY; CARDIOVASCULAR-DISEASE; GLYCATED HEMOGLOBIN; CANCER-RISK; HBA(1C); ASSOCIATION; HBA1C; INDIVIDUALS; PREVALENCE; MELLITUS	Background The extent that controlled diabetes impacts upon mortality, compared with uncontrolled diabetes, and how pre-diabetes alters mortality risk remain issues requiring clarification. Methods We carried out a cohort study of 22,106 Health Survey for England participants with a HbA1(C) measurement linked with UK mortality records. We estimated hazard ratios (HRs) of all-cause, cancer and cardiovascular disease (CVD) mortality and 95% confidence intervals (CI) using Cox regression. Results Average follow-up time was seven years and there were 1,509 deaths within the sample. Compared with the non-diabetic and normoglycaemic group (HbA1C <5.7% [<39mmol/mol] and did not indicate diabetes), undiagnosed diabetes (HbA1(C) >= 6.5% [>= 48mmol/mol] and did not indicate diabetes) inferred an increased risk of mortality for all-causes (HR 1.40, 1.09-1.80) and CVD (1.99, 1.35-2.94), as did uncontrolled diabetes (diagnosed diabetes and HbA1(C)>= 6.5% [>= 48mmol/mol]) and diabetes with moderately raised HbA1(C) (diagnosed diabetes and HbA1(C) 5.7-< 6.5% [39-<48mmol/mol]). Those with controlled diabetes (diagnosed diabetes and HbA<5.7% [<39mmol/mol]) had an increased HR in relation to mortality from CVD only. Pre-diabetes (those who did not indicate diagnosed diabetes and HbA1(C) 5.7-< 6.5% [39-<48mmol/mol]) was not associated with increased mortality, and raised HbA1(C) did not appear to have a statistically significant impact upon cancer mortality. Adjustment for BMI and socioeconomic status had a limited impact upon our results. We also found women had a higher all-cause and CVD mortality risk compared with men. Conclusions We found higher rates of all-cause and CVD mortality among those with raised HbA1(C), but not for those with pre-diabetes, compared with those without diabetes. This excess differed by sex and diabetes status. The large number of deaths from cancer and CVD globally suggests that controlling blood glucose levels and policies to prevent hyperglycaemia should be considered public health priorities.	[Gordon-Dseagu, Vanessa L. Z.; Mindell, Jennifer S.; Steptoe, Andrew; Moody, Alison; Wardle, Jane; Demakakos, Panayotes; Shelton, Nicola J.] UCL, Dept Epidemiol & Publ Hlth, London WC1E 6BT, England	University of London; University College London	Gordon-Dseagu, VLZ (corresponding author), UCL, Dept Epidemiol & Publ Hlth, 1-19 Torrington Pl, London WC1E 6BT, England.	vanessa.gordon-dseagu@ucl.ac.uk	Steptoe, Andrew/Y-2440-2019; Mindell, Jennifer S/G-2241-2011	Mindell, Jennifer S/0000-0002-7604-6131; Demakakos, Panayotes/0000-0002-7663-2122; Gordon-Dseagu, Vanessa/0000-0003-1867-2238; Moody, Alison/0000-0002-8199-4830	Department of Health; Health and Social Care Information Centre; Cancer Research UK [14133] Funding Source: researchfish	Department of Health; Health and Social Care Information Centre; Cancer Research UK(Cancer Research UK)	The HSE was funded in 2003 by the Department of Health and since 2004 by the Health and Social Care Information Centre. The funders played no part in this study nor the decision to publish the findings and there are no relevant conflicts of interest to disclose.	Andersson C, 2012, DIABETOLOGIA, V55, P2348, DOI 10.1007/s00125-012-2584-3; Bao CP, 2013, J DIABETES COMPLICAT, V27, P357, DOI 10.1016/j.jdiacomp.2013.01.004; Craig R, 2009, HEALTH SURVEY FOR EN; Craig R, 2009, HEALTH SURVEY FOR EN; Dabrowski M, 2013, ANN AGR ENV MED, V20, P116; De Beer JC, 2014, BR J CANCER; Elley CR, 2008, DIABETIC MED, V25, P1295, DOI 10.1111/j.1464-5491.2008.02581.x; Eskesen K, 2013, J INTERN MED, V273, P94, DOI 10.1111/j.1365-2796.2012.02594.x; Farmer A, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e7293; Fullerton B, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD009122.pub2; Gallagher EJ, 2011, ENDOCRINOLOGY, V152, P2546, DOI 10.1210/en.2011-0231; Gapstur SM, 2001, CANCER CAUSE CONTROL, V12, P763, DOI 10.1023/A:1011279907108; Gerstein HC, 2008, NEW ENGL J MED, V358, P2545, DOI 10.1056/NEJMoa0802743; Gray L, 2010, INT J EPIDEMIOL, V39, P345, DOI 10.1093/ije/dyp155; Holman N, 2011, DIABETIC MED, V28, P575, DOI 10.1111/j.1464-5491.2010.03216.x; Huang YP, 2014, ROUTLEDGE STUD GROWT, V124, P1; Jee SH, 2005, JAMA-J AM MED ASSOC, V293, P194, DOI 10.1001/jama.293.2.194; Jonasson JM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038784; Joshu CE, 2012, INT J CANCER, V131, P1667, DOI 10.1002/ijc.27394; Kaaks Rudolf, 2004, Novartis Found Symp, V262, P247; Khaw KT, 2004, ANN INTERN MED, V141, P413, DOI 10.7326/0003-4819-141-6-200409210-00006; Mindell J, 2012, INT J EPIDEMIOL; Monami M, 2013, NUTR METAB CARDIOVAS, V23, P300, DOI 10.1016/j.numecd.2012.01.003; Nathan DM, 2009, DIABETES CARE, V32, P1327, DOI 10.2337/dc09-9033; ONS, 2011, POPULATION ESTIMATES; Ostgren CJ, 2013, DIABETIC MED, V30, pE170, DOI 10.1111/dme.12145; Roche MM, 2013, DIABETES CARE, V36, P2582, DOI 10.2337/dc12-1272; Sakurai M, 2013, DIABETES CARE, V36, P3759, DOI 10.2337/dc12-2412; Saydah SH, 2003, AM J EPIDEMIOL, V157, P1092, DOI 10.1093/aje/kwg100; Saydah S, 2010, PUBLIC HEALTH REP, V125, P377, DOI 10.1177/003335491012500306; Selvin E, 2005, DIABETES CARE, V28, P1965, DOI 10.2337/diacare.28.8.1965; Seshasai SRK, 2011, NEW ENGL J MED, V364, P829, DOI 10.1056/NEJMoa1008862; Skriver MV, 2012, DIABETOLOGIA, V55, P2361, DOI 10.1007/s00125-012-2614-1; Sluik D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038877; Stocks T, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000201; Turner RC, 1998, LANCET, V352, P837, DOI 10.1016/s0140-6736(98)07019-6; Whiting DR, 2011, DIABETES RES CLIN PR, V94, P311, DOI 10.1016/j.diabres.2011.10.029; Xu L, 2012, DIABETIC MED, V29, P393, DOI 10.1111/j.1464-5491.2011.03456.x; Yu H, 1999, JNCI-J NATL CANCER I, V91, P151, DOI 10.1093/jnci/91.2.151	39	11	11	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2015	10	3							e0119882	10.1371/journal.pone.0119882	http://dx.doi.org/10.1371/journal.pone.0119882			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9BN	25785731	Green Published, gold			2022-12-27	WOS:000352138500140
J	Peffer, ME; Beckler, ML; Schunn, C; Renken, M; Revak, A				Peffer, Melanie E.; Beckler, Matthew L.; Schunn, Christian; Renken, Maggie; Revak, Amanda			Science Classroom Inquiry (SCI) Simulations: A Novel Method to Scaffold Science Learning	PLOS ONE			English	Article							MEANINGFUL ASSESSMENT; SCIENTIFIC INQUIRY; VIEWS; QUESTIONNAIRE; FRAMEWORK	Science education is progressively more focused on employing inquiry-based learning methods in the classroom and increasing scientific literacy among students. However, due to time and resource constraints, many classroom science activities and laboratory experiments focus on simple inquiry, with a step-by-step approach to reach predetermined outcomes. The science classroom inquiry (SCI) simulations were designed to give students real life, authentic science experiences within the confines of a typical classroom. The SCI simulations allow students to engage with a science problem in a meaningful, inquiry-based manner. Three discrete SCI simulations were created as website applications for use with middle school and high school students. For each simulation, students were tasked with solving a scientific problem through investigation and hypothesis testing. After completion of the simulation, 67% of students reported a change in how they perceived authentic science practices, specifically related to the complex and dynamic nature of scientific research and how scientists approach problems. Moreover, 80% of the students who did not report a change in how they viewed the practice of science indicated that the simulation confirmed or strengthened their prior understanding. Additionally, we found a statistically significant positive correlation between students' self-reported changes in understanding of authentic science practices and the degree to which each simulation benefitted learning. Since SCI simulations were effective in promoting both student learning and student understanding of authentic science practices with both middle and high school students, we propose that SCI simulations are a valuable and versatile technology that can be used to educate and inspire a wide range of science students on the real-world complexities inherent in scientific study.	[Peffer, Melanie E.; Renken, Maggie] Georgia State Univ, Dept Educ Psychol Special Educ & Commun Disorders, Atlanta, GA 30303 USA; [Peffer, Melanie E.; Revak, Amanda] Pittsburgh Zoo & PPG Aquarium, Conservat Educ Dept, Pittsburgh, PA USA; [Beckler, Matthew L.] Wayne & Layne LLC, Minneapolis, MN USA; [Schunn, Christian] Univ Pittsburgh, Learning Res & Dev Ctr, Pittsburgh, PA USA	University System of Georgia; Georgia State University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Peffer, ME (corresponding author), Georgia State Univ, Dept Educ Psychol Special Educ & Commun Disorders, Atlanta, GA 30303 USA.	mpeffer@gsu.edu	Beckler, Matthew/GWZ-5595-2022; Schunn, Christian D./H-2468-2011	Beckler, Matthew/0000-0003-2282-090X; Schunn, Christian D./0000-0003-3589-297X	Google Community [TFR13-02980]; Wayne Layne LLC	Google Community(Google Incorporated); Wayne Layne LLC	MEP received Google Community Grant #TFR13-02980, http://www.google.com/about/locations/pittsburgh/grants.html. The funder had no role in study design, data collection and analysis, decisions to publish, or preparation of the manuscript. Wayne & Layne LLC provided support in the form of salaries for Mr. Beckler, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. As stated in the author contributions section, Mr. Beckler's contribution to this project was in designing and building the engine that runs the SCI simulations. His written description of the engine was included in the methods section of the manuscript and he approved the final version of the manuscript. Mr. Beckler did not participate in the research design, or in the collection and analysis of data.	CAREY S, 1989, INT J SCI EDUC, V11, P514, DOI 10.1080/0950069890110504; Chinn CA, 2002, SCI EDUC, V86, P175, DOI 10.1002/sce.10001; Collins A., 1991, AM EDUC, V15, P6, DOI DOI 10.1007/S10833-009-9107-0; Harris C., 2014, SIMULATIONS STEM LEA; Hirumi Atsusi., 2010, PLAYING GAMES SCH VI; Honey M. A, 2011, LEARNING SCI COMPUTE; Lederman JS, 2014, J RES SCI TEACH, V51, P65, DOI 10.1002/tea.21125; Lederman NG, 2002, J RES SCI TEACH, V39, P497, DOI 10.1002/tea.10034; Next Generation Science Standards Lead States, 2013, NEXT GEN SCI STAND S; Quintana C, 2004, J LEARN SCI, V13, P337, DOI 10.1207/s15327809jls1303_4; Renken M, 2014, INNOV HIGH EDUC TEAC, V1, P147, DOI 10.1108/S2055-364120140000001009; Sandoval WA, 2005, SCI EDUC, V89, P634, DOI 10.1002/sce.20065; Sandoval W, 2014, SCI EDUC, V98, P383, DOI 10.1002/sce.21107; Scholin CA, 2000, NATURE, V403, P80, DOI 10.1038/47481; Schwartz R. S., 2004, SCI INQUIRY NATURE S, P331; Schwartz RS, 2004, SCI EDUC, V88, P610, DOI 10.1002/sce.10128; Schweingruber H., 2012, FRAMEWORK K 12 SCI E; Schweingruber H. A., 2007, TAKING SCI SCH LEARN; Tsai CC, 2011, LEARN INSTR, V21, P757, DOI 10.1016/j.learninstruc.2011.05.002	19	21	21	3	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2015	10	3							e0120638	10.1371/journal.pone.0120638	http://dx.doi.org/10.1371/journal.pone.0120638			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CE9BN	25786245	Green Submitted, Green Published, gold, Green Accepted			2022-12-27	WOS:000352138500185
J	Yang, ZM; Chen, Y; Hu, BY; Tan, ZQ; Huang, BT				Yang, Zhimin; Chen, Yu; Hu, Baoyun; Tan, Zhiqun; Huang, Bingru			Identification and Validation of Reference Genes for Quantification of Target Gene Expression with Quantitative Real-time PCR for Tall Fescue under Four Abiotic Stresses	PLOS ONE			English	Article							TRANSCRIPT NORMALIZATION; HOUSEKEEPING GENES; FREEZING TOLERANCE; INTERNAL CONTROL; RT-PCR; ARABIDOPSIS; SELECTION; FAMILY; MODEL; GRASS	Tall fescue (Festuca arundinacea Schreb.) is widely utilized as a major forage and turfgrass species in the temperate regions of the world and is a valuable plant material for studying molecular mechanisms of grass stress tolerance due to its superior drought and heat tolerance among cool-season species. Selection of suitable reference genes for quantification of target gene expression is important for the discovery of molecular mechanisms underlying improved growth traits and stress tolerance. The stability of nine potential reference genes (ACT, TUB, EF1a, GAPDH, SAND, CACS, F-box, PEPKR1 and TIP41) was evaluated using four programs, GeNorm, NormFinder, BestKeeper, and RefFinder. The combinations of SAND and TUB or TIP41 and TUB were most stably expressed in salt-treated roots or leaves. The combinations of GAPDH with TIP41 or TUB were stable in roots and leaves under drought stress. TIP41 and PEPKR1 exhibited stable expression in cold-treated roots, and the combination of F-box, TIP41 and TUB was also stable in cold-treated leaves. CACS and TUB were the two most stable reference genes in heat-stressed roots. TIP41 combined with TUB and ACT was stably expressed in heat-stressed leaves. Finally, quantitative real-time polymerase chain reaction (qRT-PCR) assays of the target gene FaWRKY1 using the identified most stable reference genes confirmed the reliability of selected reference genes. The selection of suitable reference genes in tall fescue will allow for more accurate identification of stress-tolerance genes and molecular mechanisms conferring stress tolerance in this stress-tolerant species.	[Yang, Zhimin; Chen, Yu; Hu, Baoyun; Tan, Zhiqun] Nanjing Agr Univ, Coll Agrograssland Sci, Nanjing, Jiangsu, Peoples R China; [Huang, Bingru] Rutgers State Univ, Dept Plant Biol & Pathol, New Brunswick, NJ 08903 USA	Nanjing Agricultural University; Rutgers State University New Brunswick	Yang, ZM (corresponding author), Nanjing Agr Univ, Coll Agrograssland Sci, Nanjing, Jiangsu, Peoples R China.	nauyzm@njau.edu.cn; huang@aesop.rutgers.edu	tan, zhiqun/GZM-9890-2022		China Postdoctoral Science Foundation [2014M551612]; Jiangsu Postdoctoral Science Foundation [1302018B]	China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); Jiangsu Postdoctoral Science Foundation(China Postdoctoral Science Foundation)	This research was supported by the China Postdoctoral Science Foundation (2014M551612) and Jiangsu Postdoctoral Science Foundation (1302018B). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen CL, 2004, CANCER RES, V64, P5245, DOI 10.1158/0008-5472.CAN-04-0496; Borges A, 2012, PLANT CELL REP, V31, P827, DOI 10.1007/s00299-011-1204-x; Chen Y, 2014, PHYSL PLANT; Chen Y, 2014, MOL BIOL REP, V41, P815, DOI 10.1007/s11033-013-2921-8; Chen Y, 2013, BMC BIOL, V11, DOI 10.1186/1741-7007-11-121; Chi XY, 2012, MOL GENET GENOMICS, V287, P167, DOI 10.1007/s00438-011-0665-5; Czechowski T, 2005, PLANT PHYSIOL, V139, P5, DOI 10.1104/pp.105.063743; De Ketelaere A, 2006, J DAIRY SCI, V89, P4066, DOI 10.3168/jds.S0022-0302(06)72450-X; Demidenko NV, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019434; Gimeno J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091474; Guo CL, 2014, J EXP BOT, V65, P1513, DOI 10.1093/jxb/eru007; Huang LK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093724; Jain M, 2006, BIOCHEM BIOPH RES CO, V345, P646, DOI 10.1016/j.bbrc.2006.04.140; Kundu A, 2013, PLANT CELL REP, V32, P1647, DOI 10.1007/s00299-013-1478-2; Li W, 2014, GENE, V547, P55, DOI 10.1016/j.gene.2014.06.015; Lin LY, 2013, MOL GENET GENOMICS, V288, P727, DOI 10.1007/s00438-013-0785-1; Lumba S, 2012, BMC BIOL, V10, DOI 10.1186/1741-7007-10-8; Ma SH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075271; Marum L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035113; Mian MAR, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-27; Pfaffl MW, 2004, BIOTECHNOL LETT, V26, P509, DOI 10.1023/B:BILE.0000019559.84305.47; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Ramakers C, 2003, NEUROSCI LETT, V339, P62, DOI 10.1016/S0304-3940(02)01423-4; Ruijter JM, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp045; Silveira ED, 2009, BMC PLANT BIOL, V9, DOI 10.1186/1471-2229-9-84; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Wang HL, 2014, PHYSIOL PLANTARUM, V152, P529, DOI 10.1111/ppl.12206; Wang Z, 2014, MOL GENET GENOMICS, V289, P1023, DOI 10.1007/s00438-014-0853-1; Wang ZY, 2006, IN VITRO CELL DEV-PL, V42, P1, DOI 10.1079/IVP2005726; Wei Q, 2011, PLANT CELL REP, V30, P1201, DOI 10.1007/s00299-011-1028-8; Wen F, 2014, DNA RES, V21, P327, DOI 10.1093/dnares/dst060; Xia SJ, 2013, MOL BIOL REP, V40, P237, DOI 10.1007/s11033-012-2054-5; Yang Q, 2014, MOL BIOL REP, V41, P2325, DOI 10.1007/s11033-014-3086-9; Zhu JY, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0054411, 10.1371/journal.pone.0053196]; Zhu XY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044405	35	50	54	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2015	10	3							e0119569	10.1371/journal.pone.0119569	http://dx.doi.org/10.1371/journal.pone.0119569			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9BN	25786207	Green Published, Green Submitted, gold			2022-12-27	WOS:000352138500112
J	Yang, SF; Wei, K; Jia, FJ; Zhao, X; Cui, GL; Guo, FX; Zhu, RL				Yang, Shifa; Wei, Kai; Jia, Fengjuan; Zhao, Xue; Cui, Guolin; Guo, Fanxia; Zhu, Ruiliang			Characterization and Biological Activity of Taishan Pinus massoniana Pollen Polysaccharide In Vitro	PLOS ONE			English	Article							IMMUNOMODULATORY ACTIVITY; ANTICANCER ACTIVITY; PROLIFERATION; ENHANCE; VACCINE; VIRUS	Taishan Pinus massoniana pollen polysaccharide (TPPPS) improves cellular and humoral immune responses of animals and is a novel potential immunomodulator. However, the components of TPPPS have not been recognized. To investigate the composition of TPPPS, crude polysaccharide was obtained from Taishan P. massoniana pollen through water extraction and ethanol precipitation. Three homogeneous polysaccharide fractions (TPPPS1, TPPPS2, and TPPPS3) were purified fromTPPPS by DEAE-cellulose column chromatography. The average molecular weights of the three polysaccharides were 56, 25, and 128 kDa, respectively. Results of high-performance liquid chromatography (HPLC) showed that TPPPS comprised mannose, ribose, xylose, glucuronic acid, galacturonic acid, glucose, galactose, and arabinose. The biological activity assays showed that TPPPS2 and TPPPS3 significantly promoted spleen lymphocyte proliferation, and that TPPPS3 showed better effect than TPPPS2. TPPPS3 enhanced the secretion of cytokine IL-2 and TNF, whereas TPPPS2 mainly elevated IL-2 secretion. By contrast, TPPPS1 exhibited other effects, and it induced the highest amount of NO production, thereby indicating that TPPPS1 had the best antioxidant activity. TPPPS3 at 50 mu g/mL significantly inhibited the proliferation of subgroup B Avian Leukosis virus (ALV-B) through virus adsorption interference in vitro. Results indicated that TPPPS comprised three main components, among which, TPPPS1 mainly showed antioxidant effects, whereas TPPPS2 and TPPPS3 played key roles in immunomodulation, especially TPPPS3. Further studies on the use of a reasonable proportion of TPPPS1-3 may facilitate the development of an effective immunomodulator.	[Yang, Shifa; Wei, Kai; Jia, Fengjuan; Zhao, Xue; Cui, Guolin; Guo, Fanxia; Zhu, Ruiliang] Shandong Agr Univ, Coll Anim Sci & Technol, Shandong Prov Key Lab Anim Biotechnol & Dis Contr, Tai An 271018, Shandong, Peoples R China	Key Laboratory of Animal Biotechnology & Disease Control & Prevention of Shandong Province; Shandong Agricultural University	Zhu, RL (corresponding author), Shandong Agr Univ, Coll Anim Sci & Technol, Shandong Prov Key Lab Anim Biotechnol & Dis Contr, Tai An 271018, Shandong, Peoples R China.	zhurl1963@163.com			Technology Development Plan of Shandong Province [2012GNC11020]; Specific Technology Development Projects of Taian [20103001]	Technology Development Plan of Shandong Province; Specific Technology Development Projects of Taian	This study was funded by Technology Development Plan of Shandong Province (2012GNC11020) and Specific Technology Development Projects of Taian (20103001).	Bao H, 2010, BIOSCI BIOTECH BIOCH, V74, P1408, DOI 10.1271/bbb.100076; Chen HL, 2003, POULTRY SCI, V82, P760, DOI 10.1093/ps/82.5.760; Chen JR, 2010, FITOTERAPIA, V81, P1117, DOI 10.1016/j.fitote.2010.07.009; Chen SG, 2010, CARBOHYD POLYM, V81, P560, DOI 10.1016/j.carbpol.2010.03.009; Cui GL, 2013, INT J BIOL MACROMOL, V56, P94, DOI 10.1016/j.ijbiomac.2013.02.006; DAWSON VL, 1991, P NATL ACAD SCI USA, V88, P6368, DOI 10.1073/pnas.88.14.6368; Dinarello CA, 2000, CHEST, V118, P503, DOI 10.1378/chest.118.2.503; DING AH, 1988, J IMMUNOL, V141, P2407; Ge Y, 2009, CARBOHYD POLYM, V77, P188, DOI 10.1016/j.carbpol.2008.12.020; Guo FX, 2014, RES VET SCI, V96, P260, DOI 10.1016/j.rvsc.2013.11.010; Harden EA, 2009, ANTIVIR RES, V83, P282, DOI 10.1016/j.antiviral.2009.06.007; He XiaoYan, 2007, Journal of Northeast Forestry University, V35, P78; Himly M, 1998, VIROLOGY, V248, P295, DOI 10.1006/viro.1998.9290; Huang R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077355; IALENTI A, 1992, EUR J PHARMACOL, V211, P177, DOI 10.1016/0014-2999(92)90526-A; IRIBE H, 1984, CELL IMMUNOL, V88, P9, DOI 10.1016/0008-8749(84)90047-9; Jaulneau V, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/525291; Komatsu T, 2013, IMMUNOPHARM IMMUNOT, V35, P1, DOI 10.3109/08923973.2012.710636; Lee CJ, 2002, BIOLOGICALS, V30, P97, DOI 10.1006/biol.2001.0320; Lee KY, 2006, J ETHNOPHARMACOL, V103, P372, DOI 10.1016/j.jep.2005.08.037; Lee TV, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003547; Li RJ, 2007, BIOL PHARM BULL, V30, P470, DOI 10.1248/bpb.30.470; Lim TS, 2004, J MED FOOD, V7, P1, DOI 10.1089/109662004322984626; Liu M, 2013, FOOD HYDROCOLLOID, V33, P186, DOI 10.1016/j.foodhyd.2013.03.003; Luo AX, 2010, CARBOHYD POLYM, V79, P1014, DOI 10.1016/j.carbpol.2009.10.033; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; MULLIGAN MS, 1991, P NATL ACAD SCI USA, V88, P6338, DOI 10.1073/pnas.88.14.6338; Ooi VEC, 2000, CURR MED CHEM, V7, P715; SAHA SK, 1994, CARBOHYD RES, V254, P157; Schaer DA, 2010, CURR OPIN INVEST DR, V11, P1378; Schepetkin IA, 2006, INT IMMUNOPHARMACOL, V6, P317, DOI 10.1016/j.intimp.2005.10.005; STEINMULLER C, 1993, INT J IMMUNOPHARMACO, V15, P605, DOI 10.1016/0192-0561(93)90078-D; Wei K, 2011, VACCINE, V29, P2530, DOI 10.1016/j.vaccine.2011.01.068; Wong KH, 2011, FOOD HYDROCOLLOID, V25, P150, DOI 10.1016/j.foodhyd.2010.04.008; Wu J, 2012, INT J BIOL MACROMOL, V51, P663, DOI 10.1016/j.ijbiomac.2012.06.040; Yang TH, 2006, INT J BIOL MACROMOL, V39, P179, DOI 10.1016/j.ijbiomac.2006.02.013; Zhao X, 2013, INT IMMUNOPHARMACOL, V17, P793, DOI 10.1016/j.intimp.2013.09.008; Zhu XL, 2007, J ETHNOPHARMACOL, V111, P219, DOI 10.1016/j.jep.2006.11.013	38	17	24	0	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2015	10	3							e0115638	10.1371/journal.pone.0115638	http://dx.doi.org/10.1371/journal.pone.0115638			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7QC	25782009	Green Published, Green Submitted, gold			2022-12-27	WOS:000351284600005
J	Bhutani, I; Loharch, S; Gupta, P; Madathil, R; Parkesh, R				Bhutani, Isha; Loharch, Saurabh; Gupta, Pawan; Madathil, Rethi; Parkesh, Raman			Structure, Dynamics, and Interaction of Mycobacterium tuberculosis (Mtb) DprE1 and DprE2 Examined by Molecular Modeling, Simulation, and Electrostatic Studies	PLOS ONE			English	Article							D-RIBOSE 2'-EPIMERASE; PROTEIN-STRUCTURE; CELL-WALL; RESISTANT TUBERCULOSIS; TRANSIENT POCKETS; DRUG-RESISTANT; D-ARABINOSE; WEB SERVER; DOCKING; CLUSPRO	The enzymes decaprenylphosphoryl-beta-D-ribose oxidase (DprE1) and decaprenylphosphoryl-beta-D-ribose-2-epimerase (DprE2) catalyze epimerization of decaprenylphosporyl ribose (DPR) todecaprenylphosporyl arabinose (DPA) and are critical for the survival of Mtb. Crystal structures of DprE1 so far reported display significant disordered regions and no structural information is known for DprE2. We used homology modeling, protein threading, molecular docking and dynamics studies to investigate the structural and dynamic features of Mtb DprE1 and DprE2 and DprE1-DprE2 complex. A three-dimensional model for DprE2 was generated using the threading approach coupled with ab initio modeling. A 50 ns simulation of DprE1 and DprE2 revealed the overall stability of the structures. Principal Component Analysis (PCA) demonstrated the convergence of sampling in both DprE1 and DprE2. In DprE1, residues in the 269-330 area showed considerable fluctuation in agreement with the regions of disorder observed in the reported crystal structures. In DprE2, large fluctuations were detected in residues 95-113, 146-157, and 197-226. The study combined docking and MD simulation studies to map and characterize the key residues involved in DprE1-DprE2 interaction. A 60 ns MD simulation for DprE1-DprE2 complex was also performed. Analysis of data revealed that the docked complex is stabilized by H-bonding, hydrophobic and ionic interactions. The key residues of DprE1 involved in DprE1-DprE2 interactions belong to the disordered region. We also examined the docked complex of DprE1-BTZ043 to investigate the binding pocket of DprE1 and its interactions with the inhibitor BTZ043. In summary, we hypothesize that DprE1-DprE2 interaction is crucial for the synthesis of DPA and DprE1-DprE2 complex may be a new therapeutic target amenable to pharmacological validation. The findings have important implications in tuberculosis (TB) drug discovery and will facilitate drug development efforts against TB.	[Bhutani, Isha; Loharch, Saurabh; Gupta, Pawan; Madathil, Rethi; Parkesh, Raman] Inst Microbial Technol, Council Sci & Ind Res, Chandigarh 160036, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Institute of Microbial Technology (IMTECH)	Parkesh, R (corresponding author), Inst Microbial Technol, Council Sci & Ind Res, Chandigarh 160036, India.	rparkesh@imtech.res.in		Loharch, Saurabh/0000-0002-5496-8784	Institute of Microbial Technology [Infra 62]; DST [SB/SO/BB/023/2014]; DBT [BT/Bio-CARe/ 05/9923/2013-14]; IMTECH	Institute of Microbial Technology(Council of Scientific & Industrial Research (CSIR) - India); DST(Department of Science & Technology (India)); DBT(Department of Biotechnology (DBT) India); IMTECH	The authors acknowledge the Institute of Microbial Technology (grant Infra 62 to R.P.) and DST (SB/SO/BB/023/2014 to R. P.) and DBT (BT/Bio-CARe/ 05/9923/2013-14 to R. M.) for financial support. I.B. and S.L. are grateful to IMTECH for a Research Intern Fellowship and CSIR for JRF respectively. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alderwick LJ, 2011, GLYCOBIOLOGY, V21, P410, DOI 10.1093/glycob/cwq173; Amadei A, 1999, PROTEINS, V36, P419, DOI 10.1002/(SICI)1097-0134(19990901)36:4<419::AID-PROT5>3.3.CO;2-L; AMADEI A, 1993, PROTEINS, V17, P412, DOI 10.1002/prot.340170408; ANFINSEN CB, 1961, P NATL ACAD SCI USA, V47, P1309, DOI 10.1073/pnas.47.9.1309; ANFINSEN CB, 1973, SCIENCE, V181, P223, DOI 10.1126/science.181.4096.223; Arvind A, 2012, INTERDISCIP SCI, V4, P223, DOI 10.1007/s12539-012-0133-x; Bakan A, 2011, BIOINFORMATICS, V27, P1575, DOI 10.1093/bioinformatics/btr168; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Batt SM, 2012, P NATL ACAD SCI USA, V109, P11354, DOI 10.1073/pnas.1205735109; BERENDSEN HJC, 1984, J CHEM PHYS, V81, P3684, DOI 10.1063/1.448118; Brennan PJ, 2003, TUBERCULOSIS, V83, P91, DOI 10.1016/S1472-9792(02)00089-6; Brooijmans N, 2003, ANNU REV BIOPH BIOM, V32, P335, DOI 10.1146/annurev.biophys.32.110601.142532; Burman WJ, 2010, CLIN INFECT DIS, V50, pS165, DOI 10.1086/651487; Campbell AJ, 2014, J CHEM INF MODEL, V54, P2127, DOI 10.1021/ci400729j; Chahine EB, 2014, ANN PHARMACOTHER, V48, P107, DOI 10.1177/1060028013504087; Chatterji M, 2014, ANTIMICROB AGENTS CH, V58, P5325, DOI 10.1128/AAC.03233-14; Cheng J, 2005, NUCLEIC ACIDS RES, V33, pW72, DOI 10.1093/nar/gki396; Cohen EML, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-S4-S7; COLOVOS C, 1993, PROTEIN SCI, V2, P1511, DOI 10.1002/pro.5560020916; Comeau SR, 2004, NUCLEIC ACIDS RES, V32, pW96, DOI 10.1093/nar/gkh354; Comeau SR, 2007, PROTEINS, V69, P781, DOI 10.1002/prot.21795; Corbett EL, 2003, ARCH INTERN MED, V163, P1009, DOI 10.1001/archinte.163.9.1009; Daniel J, 2004, J BACTERIOL, V186, P5017, DOI 10.1128/jb.186.15.5017-5030.2004; Daura X, 1999, ANGEW CHEM INT EDIT, V38, P236, DOI 10.1002/(SICI)1521-3773(19990115)38:1/2<236::AID-ANIE236>3.3.CO;2-D; Deb C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006077; Diacon AH, 2014, NEW ENGL J MED, V371, P723, DOI 10.1056/NEJMoa1313865; Dolinsky TJ, 2004, NUCLEIC ACIDS RES, V32, pW665, DOI 10.1093/nar/gkh381; Dolinsky TJ, 2007, NUCLEIC ACIDS RES, V35, pW522, DOI 10.1093/nar/gkm276; Duan Y, 2003, J COMPUT CHEM, V24, P1999, DOI 10.1002/jcc.10349; Dunlap NE, 2000, AM J RESP CRIT CARE, V161, P1376, DOI 10.1164/ajrccm.161.4.16141; EVANS DJ, 1985, J CHEM PHYS, V83, P4069, DOI 10.1063/1.449071; Eyrisch S, 2007, J MED CHEM, V50, P3457, DOI 10.1021/jm070095g; Fiser A, 2003, BIOINFORMATICS, V19, P2500, DOI 10.1093/bioinformatics/btg362; Fiser A, 2003, METHOD ENZYMOL, V374, P461, DOI 10.1016/S0076-6879(03)74020-8; Gabdoulline RR, 2003, NUCLEIC ACIDS RES, V31, P3349, DOI 10.1093/nar/gkg588; Gabdoulline RR, 1999, TRENDS BIOCHEM SCI, V24, P285, DOI 10.1016/S0968-0004(99)01412-7; Garnier J., 1989, PREDICTION PROTEIN S, P417; Gohlke H, 2004, PROTEINS, V56, P322, DOI 10.1002/prot.20116; Gouet P, 2002, BIOINFORMATICS, V18, P767, DOI 10.1093/bioinformatics/18.5.767; Halperin I, 2002, PROTEINS, V47, P409, DOI 10.1002/prot.10115; Hess B, 1997, J COMPUT CHEM, V18, P1463, DOI 10.1002/(SICI)1096-987X(199709)18:12<1463::AID-JCC4>3.0.CO;2-H; Hess B, 2008, J CHEM THEORY COMPUT, V4, P435, DOI 10.1021/ct700301q; Holm L, 1996, SCIENCE, V273, P595, DOI 10.1126/science.273.5275.595; HOLM L, 1992, J MOL BIOL, V225, P93, DOI 10.1016/0022-2836(92)91028-N; Horta BAC, 2007, PROTEINS, V67, P517, DOI 10.1002/prot.21306; Huang SY, 2007, PROTEINS, V66, P399, DOI 10.1002/prot.21214; ICHIYE T, 1991, PROTEINS, V11, P205, DOI 10.1002/prot.340110305; Jolliffe I., 2005, ENCY STAT BEHAV SCI, V1, DOI DOI 10.1002/0470013192.BSA501; Jones DT, 1999, J MOL BIOL, V292, P195, DOI 10.1006/jmbi.1999.3091; Kolly GS, 2014, MOL MICROBIOL, V92, P194, DOI 10.1111/mmi.12546; Korf J, 2005, EUR J IMMUNOL, V35, P890, DOI 10.1002/eji.200425332; Kozakov D, 2010, PROTEINS, V78, P3124, DOI 10.1002/prot.22835; Laberge M, 2008, BIOPHYS J, V94, P2737, DOI 10.1529/biophysj.107.114942; Larrouy-Maumus G, 2012, J BIOL CHEM, V287, DOI 10.1074/jbc.M112.400986; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Laskowski RA, 2011, J CHEM INF MODEL, V51, P2778, DOI 10.1021/ci200227u; Li H, 2013, PROTEINS, V81, P538, DOI 10.1002/prot.24220; Li SC, 2008, PROTEIN SCI, V17, P1925, DOI 10.1110/ps.036442.108; Lin JH, 2003, BIOPOLYMERS, V68, P47, DOI 10.1002/bip.10218; Lin K, 2005, BIOINFORMATICS, V21, P152, DOI 10.1093/bioinformatics/bth487; Liu ZJ, 2004, J AM CHEM SOC, V126, P8515, DOI 10.1021/ja032018q; LUTHY R, 1992, NATURE, V356, P83, DOI 10.1038/356083a0; Madhusudana P, 2012, INTERDISCIP SCI, V4, P142, DOI 10.1007/s12539-012-0127-8; Mahajan Rajiv, 2013, Int J Appl Basic Med Res, V3, P1, DOI 10.4103/2229-516X.112228; Makarov V, 2014, EMBO MOL MED, V6, P372, DOI 10.1002/emmm.201303575; Makarov V, 2009, SCIENCE, V324, P801, DOI 10.1126/science.1171583; Manina G, 2010, CURR MED CHEM, V17, P3099, DOI 10.2174/092986710791959693; Mashiach E, 2008, NUCLEIC ACIDS RES, V36, pW229, DOI 10.1093/nar/gkn186; McGuffin LJ, 2000, BIOINFORMATICS, V16, P404, DOI 10.1093/bioinformatics/16.4.404; Meniche X, 2008, MICROBIOL-SGM, V154, P2315, DOI 10.1099/mic.0.2008/016378-0; Metz A, 2012, J CHEM INF MODEL, V52, P120, DOI 10.1021/ci200322s; Morris GM, 2009, J COMPUT CHEM, V30, P2785, DOI 10.1002/jcc.21256; Mustyala KK, 2014, J RECEPT SIG TRANSD, V34, P162, DOI 10.3109/10799893.2013.868903; Neres J, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004395; PARRINELLO M, 1981, J APPL PHYS, V52, P7182, DOI 10.1063/1.328693; Robert X, 2014, NUCLEIC ACIDS RES, V42, pW320, DOI 10.1093/nar/gku316; Schneidman-Duhovny D, 2005, NUCLEIC ACIDS RES, V33, pW363, DOI 10.1093/nar/gki481; Schroeder EK, 2005, BIOPHYS J, V89, P876, DOI 10.1529/biophysj.104.053512; Seiler P, 2003, J INFECT DIS, V188, P1326, DOI 10.1086/378563; Shirude PS, 2013, J MED CHEM, V56, P9701, DOI 10.1021/jm401382v; Silhavy TJ, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000414; SUDRE P, 1992, B WORLD HEALTH ORGAN, V70, P149; Tina KG, 2007, NUCLEIC ACIDS RES, V35, pW473, DOI 10.1093/nar/gkm423; Tovchigrechko A, 2006, NUCLEIC ACIDS RES, V34, pW310, DOI 10.1093/nar/gkl206; Udwadia ZF, 2014, INT J TUBERC LUNG D, V18, P1315, DOI 10.5588/ijtld.14.0284; VanAalten DMF, 1997, J COMPUT CHEM, V18, P169, DOI 10.1002/(SICI)1096-987X(19970130)18:2<169::AID-JCC3>3.0.CO;2-T; VANAALTEN DMF, 1995, PROTEINS, V22, P45, DOI 10.1002/prot.340220107; Vangone A, 2011, BIOINFORMATICS, V27, P2915, DOI 10.1093/bioinformatics/btr484; von Mering C, 2003, NUCLEIC ACIDS RES, V31, P258, DOI 10.1093/nar/gkg034; von Mering C, 2005, NUCLEIC ACIDS RES, V33, pD433, DOI 10.1093/nar/gki005; VRIEND G, 1990, J MOL GRAPHICS, V8, P52, DOI 10.1016/0263-7855(90)80070-V; Wallner B, 2003, PROTEIN SCI, V12, P1073, DOI 10.1110/ps.0236803; Wang F, 2013, P NATL ACAD SCI USA, V110, pE2510, DOI 10.1073/pnas.1309171110; Wang JM, 2006, J MOL GRAPH MODEL, V25, P247, DOI 10.1016/j.jmgm.2005.12.005; Wolucka BA, 2008, FEBS J, V275, P2691, DOI 10.1111/j.1742-4658.2008.06395.x; Wright A, 2009, LANCET, V373, P1861, DOI 10.1016/S0140-6736(09)60331-7; Yoon HJ, 2013, J SYNCHROTRON RADIAT, V20, P929, DOI 10.1107/S0909049513021341; Zhang Y, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-40	98	20	23	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2015	10	3							e0119771	10.1371/journal.pone.0119771	http://dx.doi.org/10.1371/journal.pone.0119771			31	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD9NQ	25789990	Green Submitted, Green Published, gold			2022-12-27	WOS:000351425400104
J	Bucci, MP; Wiener-Vacher, S; Trousson, C; Baud, O; Biran, V				Bucci, Maria Pia; Wiener-Vacher, Sylvette; Trousson, Clemence; Baud, Olivier; Biran, Valerie			Subjective Visual Vertical and Postural Capability in Children Born Prematurely	PLOS ONE			English	Article							BIRTH-WEIGHT CHILDREN; PRETERM INFANTS; PUSHER SYNDROME; BRAIN-INJURY; PERCEPTION; INFORMATION; INTEGRATION; PARAMETERS; LESIONS; HUMANS	Purpose We compared postural stability and subjective visual vertical performance in a group of very preterm-born children aged 3-4 years and in a group of age-matched full-term children. Materials and Methods A platform (from TechnoConcept) was used to measure postural control in children. Perception of subjective visual vertical was also recorded with posture while the child had to adjust the vertical in the dark or with visual perturbation. Two other conditions (control conditions) were also recorded while the child was on the platform: for a fixation of the vertical bar, and in eyes closed condition. Results Postural performance was poor in preterm-born children compared to that of age-matched full-term children: the surface area, the length in medio-lateral direction and the mean speed of the center of pressure (CoP) were significantly larger in the preterm-born children group (p < 0.04, p < 0.01, and p < 0.04, respectively). Dual task in both groups of children significantly affected postural control. The subjective visual vertical (SVV) values were more variable and less precise in preterm-born children. Discussion-Conclusions We suggest that poor postural control as well as perception of verticality observed in preterm-born children could be due to immaturity of the cortical processes involved in the motor control and in the treatment of perception and orientation of verticality.	[Bucci, Maria Pia; Wiener-Vacher, Sylvette; Baud, Olivier; Biran, Valerie] Univ Paris 07, Hop Robert Debre, INSERM, UMR1141, F-75019 Paris, France; [Bucci, Maria Pia; Wiener-Vacher, Sylvette] Robert Debre Paediat Hosp, ENT Dept, Vestibular & Oculomotor Evaluat Unit EFEE, F-75019 Paris, France; [Trousson, Clemence] Hop Robert Debre, DHU PROTECT, Neuropsychol, F-75019 Paris, France; [Baud, Olivier; Biran, Valerie] Hop Robert Debre, Neonatal Intens Care Unit, F-75019 Paris, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Robert-Debre - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Robert-Debre - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Robert-Debre - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Robert-Debre - APHP; UDICE-French Research Universities; Universite Paris Cite	Bucci, MP (corresponding author), Univ Paris 07, Hop Robert Debre, INSERM, UMR1141, 48 Blvd Serurier, F-75019 Paris, France.	maria-pia.bucci@inserm.fr	Biran, Valerie/GQY-8192-2022					AFP, 1984, AGRESSOLOGIE, V25, P1001; Ajrezo L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081066; ASSAIANTE C, 1995, HUM MOVEMENT SCI, V14, P13, DOI 10.1016/0167-9457(94)00048-J; Assaiante Christine, 2005, Neural Plasticity, V12, P109, DOI 10.1155/NP.2005.109; Bair WN, 2007, EXP BRAIN RES, V183, P435, DOI 10.1007/s00221-007-1057-2; Barela JA, 2003, EXP BRAIN RES, V150, P434, DOI 10.1007/s00221-003-1441-5; Barra J, 2010, BRAIN, V133, P3552, DOI 10.1093/brain/awq311; Bertenthal BI, 1997, J EXP PSYCHOL HUMAN, V23, P1631, DOI 10.1037/0096-1523.23.6.1631; BERTENTHAL BI, 1989, DEV PSYCHOL, V25, P936, DOI 10.1037/0012-1649.25.6.936; Borel L, 2008, NEUROPHYSIOL CLIN, V38, P375, DOI 10.1016/j.neucli.2008.09.002; Bortolami SB, 2006, EXP BRAIN RES, V173, P374, DOI 10.1007/s00221-006-0387-9; BRANDT T, 1994, ANN NEUROL, V35, P403, DOI 10.1002/ana.410350406; Brunet O., 1997, BRUNET LEZINE REVISE; Bucci MP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077920; Bucci MP, 2013, ISRN NEUROSCIENCE; Chiari L, 2002, CLIN BIOMECH, V17, P666, DOI 10.1016/S0268-0033(02)00107-9; de Bruine FT, 2011, RADIOLOGY, V261, P899, DOI 10.1148/radiol.11110797; Flamant C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020004; FORSSBERG H, 1982, J NEUROSCI, V2, P545; Foster EC, 1996, J MOTOR BEHAV, V28, P101, DOI 10.1080/00222895.1996.9941737; Gaertner C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079623; Gagey P.M., 1999, POSTUROLOGIE REGULAT; Geldof CJA, 2012, RES DEV DISABIL, V33, P726, DOI 10.1016/j.ridd.2011.08.025; GEURTS ACH, 1993, ARCH PHYS MED REHAB, V74, P1144; Haas G, 1988, POSTURE GAIT DEV ADA; Huxhold O, 2006, BRAIN RES BULL, V69, P294, DOI 10.1016/j.brainresbull.2006.01.002; Johannsen L, 2006, J NEUROL, V253, P1367, DOI 10.1007/s00415-006-0216-x; Karnath HO, 2005, NEUROLOGY, V64, P1014, DOI 10.1212/01.WNL.0000154527.72841.4A; Kim S, 2004, THESIS U MARYLAND CO; LEE DN, 1974, PERCEPT PSYCHOPHYS, V15, P529, DOI 10.3758/BF03199297; Lopez C, 2011, NEUROSCIENCE, V181, P134, DOI 10.1016/j.neuroscience.2011.02.009; Lopez C., 2005, BIPEDIE CONTROLE POS, P35; MAKI BE, 1990, J AM GERIATR SOC, V38, P1, DOI 10.1111/j.1532-5415.1990.tb01588.x; Mallau S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013078; MASDEU JC, 1988, ANN NEUROL, V23, P596, DOI 10.1002/ana.410230612; Mazibrada G, 2008, GAIT POSTURE, V27, P202, DOI 10.1016/j.gaitpost.2007.03.006; Miller SP, 2005, J PEDIATR-US, V147, P609, DOI 10.1016/j.jpeds.2005.06.033; Milner AD, 2008, NEUROPSYCHOLOGIA, V46, P774, DOI 10.1016/j.neuropsychologia.2007.10.005; Ohlmann T, 2001, NOUVEAUTES CONCEPTUE; Olivier I, 2010, GAIT POSTURE, V32, P494, DOI 10.1016/j.gaitpost.2010.07.008; Perennou DA, 2008, BRAIN, V131, P2401, DOI 10.1093/brain/awn170; Peterson ML, 2006, GAIT POSTURE, V23, P455, DOI 10.1016/j.gaitpost.2005.05.003; Rutherford MA, 2010, NEURORADIOLOGY, V52, P505, DOI 10.1007/s00234-010-0700-y; Schmitz C, 2002, EXP BRAIN RES, V142, P354, DOI 10.1007/s00221-001-0910-y; Schmuckler MA, 1997, J EXP PSYCHOL HUMAN, V23, P528, DOI 10.1037/0096-1523.23.2.528; Scott MN, 2012, J DEV BEHAV PEDIATR, V33, P202, DOI 10.1097/DBP.0b013e3182475287; SHUMWAYCOOK A, 1985, J MOTOR BEHAV, V17, P131; Volpe JJ, 2009, LANCET NEUROL, V8, P110, DOI 10.1016/S1474-4422(08)70294-1; Woodward LJ, 2006, NEW ENGL J MED, V355, P685, DOI 10.1056/NEJMoa053792; Wright WG, 2005, J VESTIBUL RES-EQUIL, V15, P185	50	9	9	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2015	10	3							e0121616	10.1371/journal.pone.0121616	http://dx.doi.org/10.1371/journal.pone.0121616			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD9NQ	25790327	Green Published, Green Submitted, gold			2022-12-27	WOS:000351425400198
J	Hause, BM; Collin, EA; Anderson, J; Hesse, RA; Anderson, G				Hause, Ben M.; Collin, Emily A.; Anderson, Joe; Hesse, Richard A.; Anderson, Gary			Bovine Rhinitis Viruses Are Common in US Cattle with Bovine Respiratory Disease	PLOS ONE			English	Article							STRAIN RS 3X; RHINOVIRUS; TRANSLATION; PATHOGENESIS; INITIATION; PROTEIN; ORIGIN; CALVES; SITES; CALF	Bovine rhinitis viruses (BRV) are established etiological agents of bovine respiratory disease complex however little research into their epidemiology and ecology has been published for several decades. In the U.S., only bovine rhinitis A virus 1 (BRAV1) has been identified while bovine rhinitis A virus 2 (BRAV2) and bovine rhinitis B virus (BRBV) were previously only identified in England and Japan, respectively. Metagenomic sequencing of a nasal swab from a bovine respiratory disease (BRD) diagnostic submission from Kansas identified contigs with approximately 90% nucleotide similarity to BRAV2 and BRBV. A combination of de novo and templated assemblies using reference genomes yielded near complete BRAV2 and BRBV genomes. The near complete genome of bovine rhinitis A virus 1 (BRAV1) was also determined from a historical isolate to enable further molecular epidemiological studies. A 5'-nuclease reverse transcription PCR assay targeting the 3D polymerase gene was designed and used to screen 204 archived BRD clinical specimens. Thirteen (6.4%) were positive. Metagenomic sequencing of six positive samples identified mixed BRAV1/BRAV2, BRAV1/BRBV and BRAV2/BRBV infections for five samples. One sample showed infection only with BRAV1. Seroprevalence studies using a cell culture adapted BRBV found immunofluorescence assay-reactive antibodies were common in the herds analyzed. Altogether, these results demonstrate that BRV infections are common in cattle with respiratory disease and that BRAV1, BRAV2 and BRBV co-circulate in U.S. cattle and have high similarity to viruses isolated more than 30 years ago from diverse locations.	[Hause, Ben M.] Kansas State Univ, Vet Diagnost Lab, Manhattan, KS 66506 USA; Kansas State Univ, Dept Diagnost Med & Pathobiol, Manhattan, KS 66506 USA	Kansas State University; Kansas State University	Hause, BM (corresponding author), Kansas State Univ, Vet Diagnost Lab, Manhattan, KS 66506 USA.	bhause@vet.k-state.edu			Kansas State Veterinary Diagnostic Laboratory, College of Veterinary Medicine; Kansas Agricultural Experiment Station; USDA's Animal Health and Disease Research Program [95-113]	Kansas State Veterinary Diagnostic Laboratory, College of Veterinary Medicine; Kansas Agricultural Experiment Station; USDA's Animal Health and Disease Research Program	This work was supported by the Kansas State Veterinary Diagnostic Laboratory, College of Veterinary Medicine and the Kansas Agricultural Experiment Station and by funds through USDA's Animal Health and Disease Research Program under the provisions of Section 1433 of Subtitle E, Title XIV of Public Law 95-113. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allander T, 2005, P NATL ACAD SCI USA, V102, P12891, DOI 10.1073/pnas.0504666102; BAXT B, 1984, J VIROL, V51, P298, DOI 10.1128/JVI.51.2.298-305.1984; BETTS AO, 1971, J COMP PATHOL, V81, P41, DOI 10.1016/0021-9975(71)90053-3; BOGEL K, 1968, J AM VET MED ASSOC, V152, P780; BOGEL K, 1962, ZBL BAKT PARASIT, V187, P2; CLARKE BE, 1985, J GEN VIROL, V66, P2615, DOI 10.1099/0022-1317-66-12-2615; Collin EA, 2015, J VIROL, V89, P1036, DOI 10.1128/JVI.02718-14; Dan A, 1998, J GEN VIROL, V79, P1453; Gorden PJ, 2010, VET CLIN N AM-FOOD A, V26, P243, DOI 10.1016/j.cvfa.2010.03.004; Griffin D, 1997, VET CLIN N AM-FOOD A, V13, P367, DOI 10.1016/S0749-0720(15)30302-9; Hause BM, 2014, MBIO, V5, DOI 10.1128/mBio.00031-14; Hause BM, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003176; Hilton WM, 2014, ANIM HEALTH RES REV, V15, P120, DOI 10.1017/S1466252314000115; Hinton TM, 2000, J VIROL, V74, P11708, DOI 10.1128/JVI.74.24.11708-11716.2000; Hollister JR, 2008, VIROLOGY, V373, P411, DOI 10.1016/j.virol.2007.12.019; Ide P R, 1969, Br Vet J, V125, P7; IDE PR, 1972, ARCH GES VIRUSFORSCH, V36, P335, DOI 10.1007/BF01249864; IDE PR, 1972, ARCH GES VIRUSFORSCH, V36, P343, DOI 10.1007/BF01249865; KOZAK M, 1989, J CELL BIOL, V108, P229, DOI DOI 10.1083/JCB.108.2.229; KUROGI H, 1974, ARCH GES VIRUSFORSCH, V44, P215, DOI 10.1007/BF01240609; LEA S, 1994, STRUCTURE, V2, P123, DOI 10.1016/S0969-2126(00)00014-9; MEDINA M, 1993, VIROLOGY, V194, P355, DOI 10.1006/viro.1993.1267; MOHANTY SB, 1969, AM J VET RES, V30, P1105; MOHANTY SB, 1968, P SOC EXP BIOL MED, V128, P850, DOI 10.3181/00379727-128-33140; Mosier D, 2014, ANIM HEALTH RES REV, V15, P166, DOI 10.1017/S1466252314000176; Neill JD, 2014, J VIROL METHODS, V201, P68, DOI 10.1016/j.jviromet.2014.02.016; Palmenberg AC, 1997, SEMIN VIROL, V8, P231, DOI 10.1006/smvy.1997.0126; Persechino A., 1974, Acta Medica Veterinaria, V20, P333; PILIPENKO EV, 1989, NUCLEIC ACIDS RES, V17, P5701, DOI 10.1093/nar/17.14.5701; REED SE, 1971, J COMP PATHOL, V81, P33, DOI 10.1016/0021-9975(71)90052-1; ROSENQUIST BD, 1971, AM J VET RES, V32, P685; Shan TL, 2011, J VIROL, V85, P11697, DOI 10.1128/JVI.05217-11; SHIMIZU Y, 1974, NATL I ANIM HEALTH Q, V14, P35; Stewart SR, 1997, SEMIN VIROL, V8, P242, DOI 10.1006/smvy.1997.0127; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; THOMAS AAM, 1988, J VIROL, V62, P2782, DOI 10.1128/JVI.62.8.2782-2789.1988; Urban-Chmiel R, 2012, J LIVEST SCI, V3, P27; YAMASHITA H, 1985, ARCH VIROL, V83, P113, DOI 10.1007/BF01310969; Zhang X, 2007, VIROLOGY, V363, P1, DOI 10.1016/j.virol.2007.03.018	39	36	36	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2015	10	3							e0121998	10.1371/journal.pone.0121998	http://dx.doi.org/10.1371/journal.pone.0121998			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD9NQ	25789939	gold, Green Submitted, Green Published			2022-12-27	WOS:000351425400204
J	Konno, Y; Ueki, S; Takeda, M; Kobayashi, Y; Tamaki, M; Moritoki, Y; Oyamada, H; Itoga, M; Kayaba, H; Omokawa, A; Hirokawa, M				Konno, Yasunori; Ueki, Shigeharu; Takeda, Masahide; Kobayashi, Yoshiki; Tamaki, Mami; Moritoki, Yuki; Oyamada, Hajime; Itoga, Masamichi; Kayaba, Hiroyuki; Omokawa, Ayumi; Hirokawa, Makoto			Functional Analysis of Free Fatty Acid Receptor GPR120 in Human Eosinophils: Implications in Metabolic Homeostasis	PLOS ONE			English	Article							ALTERNATIVELY ACTIVATED MACROPHAGES; ALLERGIC INFLAMMATION; PROTEIN-KINASE; PPAR-GAMMA; CHEMOTAXIS; APOPTOSIS; RELEASE; AGONIST; OBESITY; POTENT	Recent evidence has shown that eosinophils play an important role in metabolic homeostasis through Th2 cytokine production. GPR120 (FFA4) is a G protein-coupled receptor (GPCR) for long-chain fatty acids that functions as a regulator of physiological energy metabolism. In the present study, we aimed to investigate whether human eosinophils express GPR120 and, if present, whether it possesses a functional capacity on eosinophils. Eosinophils isolated from peripheral venous blood expressed GPR120 at both the mRNA and protein levels. Stimulation with a synthetic GPR120 agonist, GW9508, induced rapid down-regulation of cell surface expression of GPR120, suggesting ligand-dependent receptor internalization. Although GPR120 activation did not induce eosinophil chemotactic response and degranulation, we found that GW9508 inhibited eosinophil spontaneous apoptosis and Fas receptor expression. The anti-apoptotic effect was attenuated by phosphoinositide 3-kinase (PI3K) inhibitors and was associated with inhibition of caspase-3 activity. Eosinophil response investigated using ELISpot assay indicated that stimulation with a GPR120 agonist induced IL-4 secretion. These findings demonstrate the novel functional properties of fatty acid sensor GPR120 on human eosinophils and indicate the previously unrecognized link between nutrient metabolism and the immune system.	[Konno, Yasunori; Ueki, Shigeharu; Takeda, Masahide; Kobayashi, Yoshiki; Tamaki, Mami; Moritoki, Yuki; Oyamada, Hajime; Itoga, Masamichi; Kayaba, Hiroyuki; Omokawa, Ayumi; Hirokawa, Makoto] Akita Univ, Grad Sch Med, Dept Gen Internal Med & Clin Lab Med, Akita 010, Japan; [Kobayashi, Yoshiki] Kansai Med Univ, Dept Otolaryngol, Hirakata, Osaka, Japan; [Itoga, Masamichi; Kayaba, Hiroyuki] Hirosaki Univ, Grad Sch Med, Dept Clin Lab Med, Hirosaki, Aomori, Japan	Akita University; Kansai Medical University; Hirosaki University	Ueki, S (corresponding author), Akita Univ, Grad Sch Med, Dept Gen Internal Med & Clin Lab Med, Akita 010, Japan.	ueki-shige@nifty.com	Ueki, Shigeharu/I-3566-2019	Ueki, Shigeharu/0000-0002-3537-7735; Itoga, Masamichi/0000-0002-9400-5245	Ministry of Education, Culture, Sports, Science and Technology of Japan [24590952, 13383320, 23791097, 26860743, 24790547]; Grants-in-Aid for Scientific Research [25460670] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	Funding was provided in part by Grants-in-Aid for Scientific Research (C) (24590952 Y. Moritoki, 13383320 S. Ueki) and Grants-in-Aid for Young Scientists (23791097 and 26860743 M. Takeda, 24790547 Y. Kobayashi) supported by the Ministry of Education, Culture, Sports, Science and Technology of Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adachi T, 2000, J IMMUNOL, V165, P2198, DOI 10.4049/jimmunol.165.4.2198; Bandeira-Melo C, 2003, J IMMUNOL METHODS, V276, P227, DOI 10.1016/S0022-1759(03)00076-0; Briscoe CP, 2006, BRIT J PHARMACOL, V148, P619, DOI 10.1038/sj.bjp.0706770; Carvalheira JBC, 2013, BLOOD, V122, P3263, DOI 10.1182/blood-2013-04-459446; Cartoni C, 2010, J NEUROSCI, V30, P8376, DOI 10.1523/JNEUROSCI.0496-10.2010; Druilhe A, 1996, BLOOD, V87, P2822, DOI 10.1182/blood.V87.7.2822.bloodjournal8772822; Fredriksson R, 2003, FEBS LETT, V554, P381, DOI 10.1016/S0014-5793(03)01196-7; Giembycz MA, 1999, PHARMACOL REV, V51, P213; Hirasawa A, 2005, NAT MED, V11, P90, DOI 10.1038/nm1168; Hudson BD, 2013, MOL PHARMACOL, V84, P710, DOI 10.1124/mol.113.087783; Ichimura A, 2012, NATURE, V483, P350, DOI 10.1038/nature10798; Kato H, 2011, INT ARCH ALLERGY IMM, V155, P335, DOI 10.1159/000321195; Katsuma S, 2005, J BIOL CHEM, V280, P19507, DOI 10.1074/jbc.M412385200; KITA H, 1992, J IMMUNOL, V149, P629; Kobayashi Y, 2005, J IMMUNOL, V175, P5744, DOI 10.4049/jimmunol.175.9.5744; Lloyd CM, 2013, NAT MED, V19, P976, DOI 10.1038/nm.3296; Matsuwaki Y, 2005, PHARMACOLOGY, V74, P169, DOI 10.1159/000085034; Miyata J, 2013, J ALLERGY CLIN IMMUN, V131, P353, DOI 10.1016/j.jaci.2012.07.048; Molofsky AB, 2013, J EXP MED, V210, P535, DOI 10.1084/jem.20121964; Oh DY, 2010, CELL, V142, P687, DOI 10.1016/j.cell.2010.07.041; Rao RR, 2014, CELL, V157, P1279, DOI 10.1016/j.cell.2014.03.065; Rothenberg ME, 2006, ANNU REV IMMUNOL, V24, P147, DOI 10.1146/annurev.immunol.24.021605.090720; Saito Y, 2014, PULM PHARMACOL THER, V27, P164, DOI 10.1016/j.pupt.2013.11.006; Sanchez-Reyes OB, 2014, EUR J PHARMACOL, V723, P368, DOI 10.1016/j.ejphar.2013.11.003; Shamri R, 2011, CELL TISSUE RES, V343, P57, DOI 10.1007/s00441-010-1049-6; Talukdar S, 2011, TRENDS PHARMACOL SCI, V32, P543, DOI 10.1016/j.tips.2011.04.004; Tamaki M, 2014, IMMUNOL LETT, V160, P72, DOI 10.1016/j.imlet.2014.03.012; Taneera J, 2012, CELL METAB, V16, P122, DOI 10.1016/j.cmet.2012.06.006; Tanigai T, 2012, INT ARCH ALLERGY IMM, V158, P375, DOI 10.1159/000332965; Ueki S, 2003, IMMUNOL LETT, V86, P183, DOI 10.1016/S0165-2478(03)00003-8; Ueki S, 2008, J IMMUNOL, V181, P7689, DOI 10.4049/jimmunol.181.11.7689; Watson SJ, 2012, MOL PHARMACOL, V81, P631, DOI 10.1124/mol.111.077388; Woerly G, 2003, J EXP MED, V198, P411, DOI 10.1084/jem.20021384; Wong CK, 2007, EUR J IMMUNOL, V37, P2337, DOI 10.1002/eji.200636866; Wu D, 2011, SCIENCE, V332, P243, DOI 10.1126/science.1201475; Wu Q, 2013, ONCOGENE, V32, P5541, DOI 10.1038/onc.2013.264; Yamamoto R, 2013, J ASTHMA	37	26	26	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2015	10	3							e0120386	10.1371/journal.pone.0120386	http://dx.doi.org/10.1371/journal.pone.0120386			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD9NQ	25790291	gold, Green Published			2022-12-27	WOS:000351425400157
J	Mirza, Z; Schulten, HJ; Farsi, HM; Al-Maghrabi, JA; Gari, MA; Chaudhary, AG; Abuzenadah, AM; Al-Qahtani, MH; Karim, S				Mirza, Zeenat; Schulten, Hans-Juergen; Farsi, Hasan Ma; Al-Maghrabi, Jaudah A.; Gari, Mamdooh A.; Chaudhary, Adeel Ga; Abuzenadah, Adel M.; Al-Qahtani, Mohammed H.; Karim, Sajjad			Molecular Interaction of a Kinase Inhibitor Midostaurin with Anticancer Drug Targets, S100A8 and EGFR: Transcriptional Profiling and Molecular Docking Study for Kidney Cancer Therapeutics	PLOS ONE			English	Article							GROWTH-FACTOR RECEPTOR; AKT PATHWAY; IN-SITU; PROTEINS; EXPRESSION; DISCOVERY; CARCINOMAS; THERAPY; OVEREXPRESSION; PROGRESSION	The S100A8 and epidermal growth factor receptor (EGFR) proteins are proto-oncogenes that are strongly expressed in a number of cancer types. EGFR promotes cellular proliferation, differentiation, migration and survival by activating molecular pathways. Involvement of proinflammatory S100A8 in tumor cell differentiation and progression is largely unclear and not studied in kidney cancer (KC). S100A8 and EGFR are potential therapeutic biomarkers and anticancer drug targets for KC. In this study, we explored molecular mechanisms of interaction profiles of both molecules with potential anticancer drugs. We undertook transcriptional profiling in Saudi KCs using Affymetrix HuGene 1.0 ST arrays. We identified 1478 significantly expressed genes, including S100A8 and EGFR overexpression, using cut-off p=value <0.05 and fold change >= 2. Additionally, we compared and confirmed our findings with expression data available at NCBI's GEO database. A significant number of genes associated with cancer showed involvement in cell cycle progression, DNA repair, tumor morphology, tissue development, and cell survival. Atherosclerosis signaling, leukocyte extravasation signaling, notch signaling, and IL-12 signaling were the most significantly disrupted signaling pathways. The present study provides an initial transcriptional profiling of Saudi KC patients. Our analysis suggests distinct transcriptomic signatures and pathways underlying molecular mechanisms of KC progression. Molecular docking analysis revealed that the kinase inhibitor "midostaurin" has amongst the selected drug targets, the best ligand properties to S100A8 and EGFR, with the implication that its binding inhibits downstream signaling in KC. This is the first structure-based docking study for the selected protein targets and anticancer drug, and the results indicate S100A8 and EGFR as attractive anticancer targets and midostaurin with effective drug properties for therapeutic intervention in KC.	[Mirza, Zeenat; Chaudhary, Adeel Ga; Abuzenadah, Adel M.] King Abdulaziz Univ, King Fahd Med Res Ctr, Jeddah 21589, Saudi Arabia; [Schulten, Hans-Juergen; Gari, Mamdooh A.; Chaudhary, Adeel Ga; Abuzenadah, Adel M.; Al-Qahtani, Mohammed H.; Karim, Sajjad] King Abdulaziz Univ, Fac Appl Med Sci, Ctr Excellence Genom Med Res, Jeddah 21589, Saudi Arabia; [Farsi, Hasan Ma] King Abdulaziz Univ Hosp, Fac Med, Dept Urol, Jeddah, Saudi Arabia; [Al-Maghrabi, Jaudah A.] King Abdulaziz Univ Hosp, Fac Med, Dept Pathol, Jeddah, Saudi Arabia; [Al-Maghrabi, Jaudah A.] King Faisal Specialist Hosp & Res Ctr, Dept Pathol, Jeddah, Saudi Arabia; [Chaudhary, Adeel Ga] King Abdulaziz Univ, KACST Technol Innovat Ctr Personalized Med, Jeddah 21589, Saudi Arabia	King Abdulaziz University; King Abdulaziz University; King Abdulaziz University; King Abdulaziz University Hospital - Jeddah; King Saud University; King Abdulaziz University Hospital - Riyadh; King Abdulaziz University; King Abdulaziz University Hospital - Jeddah; King Saud University; King Abdulaziz University Hospital - Riyadh; King Faisal Specialist Hospital & Research Center; King Abdulaziz University	Al-Qahtani, MH (corresponding author), King Abdulaziz Univ, Fac Appl Med Sci, Ctr Excellence Genom Med Res, POB 80216, Jeddah 21589, Saudi Arabia.	mhalqahtani@kau.edu.sa; skarim1@kau.edu.sa	Mirza, Zeenat/H-9498-2012; Schulten, Hans-Juergen/AAP-4754-2021; Al-Maghrabi, Jaudah/L-4367-2013; Karim, Sajjad/H-9897-2012; Schulten, Hans-Juergen/H-9854-2012; Al-Qahtani, Mohammed Hussain/AAZ-1729-2020	Mirza, Zeenat/0000-0002-6222-4873; Schulten, Hans-Juergen/0000-0002-4907-3222; Al-Maghrabi, Jaudah/0000-0002-0812-9592; Karim, Sajjad/0000-0003-0907-2097; 	King Abdullah City for Science and Technology, Riyadh, Saudi Arabia (KACST) [10-BIO1258-03, 10-BIO1073-03]; Deanship of Research, King Abdulaziz University [HiCi-1434-1172]	King Abdullah City for Science and Technology, Riyadh, Saudi Arabia (KACST); Deanship of Research, King Abdulaziz University	This work was supported by King Abdullah City for Science and Technology, Riyadh, Saudi Arabia (KACST, Strategic Project ID. 10-BIO1258-03 and 10-BIO1073-03) and Deanship of Research, King Abdulaziz University (Project ID: HiCi-1434-1172). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Auffinger P, 2004, P NATL ACAD SCI USA, V101, P16789, DOI 10.1073/pnas.0407607101; Baba Y, 2012, J ONCOL, V2012, DOI 10.1155/2012/986725; Bikadi Z, 2009, J CHEMINFORMATICS, V1, DOI 10.1186/1758-2946-1-15; Blencke S, 2004, CHEM BIOL, V11, P691, DOI 10.1016/j.chembiol.2004.02.029; BURNETT G, 1954, J BIOL CHEM, V211, P969; Chen KT, 2014, PANCREAS, V43, P22, DOI 10.1097/MPA.0b013e3182a6867e; Chow WH, 2000, NEW ENGL J MED, V343, P1305, DOI 10.1056/NEJM200011023431804; Ciardiello F, 2003, EUR J CANCER, V39, P1348, DOI 10.1016/S0959-8049(03)00235-1; Citri A, 2006, NAT REV MOL CELL BIO, V7, P505, DOI 10.1038/nrm1962; Cross SS, 2005, HISTOPATHOLOGY, V46, P256, DOI 10.1111/j.1365-2559.2005.02097.x; Debouck C, 1999, NAT GENET, V21, P48, DOI 10.1038/4475; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Donato R, 2013, CURR MOL MED, V13, P24, DOI 10.2174/156652413804486214; Drews J, 2000, SCIENCE, V287, P1960, DOI 10.1126/science.287.5460.1960; Duan L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062092; El Fitori J, 2007, CANCER-AM CANCER SOC, V110, P1457, DOI 10.1002/cncr.22931; El-Rifai W, 2002, CANCER RES, V62, P6823; Fabbro D, 2012, METHODS MOL BIOL, V795, P1, DOI 10.1007/978-1-61779-337-0_1; Fischer T, 2010, J CLIN ONCOL, V28, P4339, DOI 10.1200/JCO.2010.28.9678; Frye SV, 1999, CHEM BIOL, V6, pR3, DOI 10.1016/S1074-5521(99)80013-1; Fukihara J, 2014, ONCOLOGY-BASEL, V86, P86, DOI 10.1159/000357129; Gajiwala KS, 2013, STRUCTURE, V21, P209, DOI 10.1016/j.str.2012.11.014; Gelardi T, 2008, BRIT J CANCER, V99, P473, DOI 10.1038/sj.bjc.6604493; Godl K, 2003, P NATL ACAD SCI USA, V100, P15434, DOI 10.1073/pnas.2535024100; Graff JR, 2005, CANCER RES, V65, P7462, DOI 10.1158/0008-5472.CAN-05-0071; Grebhardt S, 2014, J CELL PHYSIOL, V229, P661, DOI 10.1002/jcp.24489; Halgren TA, 1996, J COMPUT CHEM, V17, P490, DOI [10.1002/(SICI)1096-987X(199604)17:5/6<490::AID-JCC1>3.0.CO;2-P, 10.1002/(SICI)1096-987X(199604)17:5/6<616::AID-JCC5>3.0.CO;2-X]; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Heizmann C. W., 2007, V45, P93; Heizmann CW, 2002, FRONT BIOSCI-LANDMRK, V7, pD1356, DOI 10.2741/heizmann; Hermani A, 2005, EXP CELL RES, V312, P184, DOI 10.1016/j.yexcr.2005.10.013; HESSIAN PA, 1993, J LEUKOCYTE BIOL, V53, P197, DOI 10.1002/jlb.53.2.197; Higgins RJ, 2010, J NEURO-ONCOL, V98, P49, DOI 10.1007/s11060-009-0072-5; Hiratsuka S, 2006, NAT CELL BIOL, V8, P1369, DOI 10.1038/ncb1507; Hynes NE, 2005, NAT REV CANCER, V5, P341, DOI 10.1038/nrc1609; Kerkhoff C, 2012, EXP DERMATOL, V21, P822, DOI 10.1111/j.1600-0625.2012.01571.x; Kim Y, 2012, BIOCHEMISTRY-US, V51, P5212, DOI 10.1021/bi300476v; Knight ZA, 2005, CHEM BIOL, V12, P621, DOI 10.1016/j.chembiol.2005.04.011; Lee HJ, 2010, LUNG CANCER, V68, P375, DOI 10.1016/j.lungcan.2009.07.014; Luo AP, 2004, ONCOGENE, V23, P1291, DOI 10.1038/sj.onc.1207218; Lynch TJ, 2004, NEW ENGL J MED, V350, P2129, DOI 10.1056/NEJMoa040938; Manning G, 2002, SCIENCE, V298, P1912, DOI 10.1126/science.1075762; Marenholz I, 2004, BIOCHEM BIOPH RES CO, V322, P1111, DOI 10.1016/j.bbrc.2004.07.096; Moody TW, 2014, LIFE SCI; Morris GM, 2009, J COMPUT CHEM, V30, P2785, DOI 10.1002/jcc.21256; Morris GM, 1998, J COMPUT CHEM, V19, P1639, DOI 10.1002/(SICI)1096-987X(19981115)19:14<1639::AID-JCC10>3.0.CO;2-B; Motzer RJ, 2006, J CLIN ONCOL, V24, P5601, DOI 10.1200/JCO.2006.08.5415; Muhsin M, 2003, NAT REV DRUG DISCOV, V2, P515, DOI 10.1038/nrd1136; Nemeth J, 2009, HEPATOLOGY, V50, P1251, DOI 10.1002/hep.23099; Pao W, 2005, PLOS MED, V2, P225, DOI 10.1371/journal.pmed.0020073; Passey RJ, 1999, J IMMUNOL, V163, P2209; Pomerantz RG, 2004, SEMIN ONCOL, V31, P734, DOI 10.1053/j.seminoncol.2004.09.015; Pu YS, 2009, J BIOMED SCI, V16, DOI 10.1186/1423-0127-16-82; Rafii S, 2006, NAT CELL BIOL, V8, P1321, DOI 10.1038/ncb1206-1321; Rizvi MA, 2006, MOL CANCER THER, V5, P1783, DOI 10.1158/1535-7163.MCT-05-0465; Santamaria-Kisiel L, 2006, BIOCHEM J, V396, P201, DOI 10.1042/BJ20060195; Seth A, 2003, ANTICANCER RES, V23, P2043; Shiogama K, 2013, INT J CLIN EXP PATHO, V6, P24; Shiomitsu K, 2009, VET COMP ONCOL, V7, P106, DOI 10.1111/j.1476-5829.2009.00178.x; Siegel R, 2013, CA-CANCER J CLIN, V63, P11, DOI 10.3322/caac.21166; SOLIS FJ, 1981, MATH OPER RES, V6, P19, DOI 10.1287/moor.6.1.19; Stone RM, 2012, LEUKEMIA, V26, P2061, DOI 10.1038/leu.2012.115; Stulik J, 1999, ELECTROPHORESIS; Turovskaya O, 2008, CARCINOGENESIS, V29, P2035, DOI 10.1093/carcin/bgn188; Vogl T, 2006, BBA-MOL CELL RES, V1763, P1298, DOI 10.1016/j.bbamcr.2006.08.028; WAKELING AE, 2002, ZD1839 IRESSA ORALLY, V62, P5749; Yamaguchi NH, 2014, J GASTROINTEST ONCOL, V5, P57, DOI 10.3978/j.issn.2078-6891.2013.056; Yin CG, 2013, BREAST CANCER RES TR, V142, P297, DOI 10.1007/s10549-013-2737-1; Yong HY, 2007, ARCH PHARM RES, V30, P75, DOI 10.1007/BF02977781	70	17	19	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2015	10	3							e0119765	10.1371/journal.pone.0119765	http://dx.doi.org/10.1371/journal.pone.0119765			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD9NQ	25789858	Green Submitted, Green Published, gold			2022-12-27	WOS:000351425400103
J	Nzakizwanayo, J; Kumar, S; Ogilvie, LA; Patel, BA; Dedi, C; Macfarlane, WM; Jones, BV				Nzakizwanayo, Jonathan; Kumar, Sandeep; Ogilvie, Lesley A.; Patel, Bhavik A.; Dedi, Cinzia; Macfarlane, Wendy M.; Jones, Brian V.			Disruption of Escherichia coli Nissle 1917 K5 Capsule Biosynthesis, through Loss of Distinct kfi genes, Modulates Interaction with Intestinal Epithelial Cells and Impact on Cell Health	PLOS ONE			English	Article							TOLL-LIKE RECEPTORS; MAINTAINING REMISSION; STRAIN NISSLE-1917; BIOFILM FORMATION; EXPRESSION; POLYSACCHARIDE; COLONIZATION; PROTEINS; ACID; GLYCOSYLTRANSFERASE	Escherichia coli Nissle 1917 (EcN) is among the best characterised probiotics, with a proven clinical impact in a range of conditions. Despite this, the mechanisms underlying these "probiotic effects" are not clearly defined. Here we applied random transposon mutagenesis to identify genes relevant to the interaction of EcN with intestinal epithelial cells. This demonstrated mutants disrupted in the kfiB gene, of the K5 capsule biosynthesis cluster, to be significantly enhanced in attachment to Caco-2 cells. However, this phenotype was distinct from that previously reported for EcN K5 deficient mutants (kfiC null mutants), prompting us to explore further the role of kfiB in EcN: Caco-2 interaction. Isogenic mutants with deletions in kfiB (EcN Delta kfiB), or the more extensively characterised K5 capsule biosynthesis gene kfiC (EcN Delta kfiC), were both shown to be capsule deficient, but displayed divergent phenotypes with regard to impact on Caco-2 cells. Compared with EcN Delta kfiC and the EcN wildtype, EcN Delta kfiB exhibited significantly greater attachment to Caco-2 cells, as well as apoptotic and cytotoxic effects. In contrast, EcN Delta kfiC was comparable to the wild-type in these assays, but was shown to induce significantly greater COX-2 expression in Caco-2 cells. Distinct differences were also apparent in the pervading cell morphology and cellular aggregation between mutants. Overall, these observations reinforce the importance of the EcN K5 capsule in host-EcN interactions, but demonstrate that loss of distinct genes in the K5 pathway can modulate the impact of EcN on epithelial cell health.	[Nzakizwanayo, Jonathan; Kumar, Sandeep; Ogilvie, Lesley A.; Patel, Bhavik A.; Dedi, Cinzia; Macfarlane, Wendy M.; Jones, Brian V.] Univ Brighton, Sch Pharm & Biomol Sci, Brighton, E Sussex, England; [Jones, Brian V.] Queen Victoria Hosp NHS Fdn Trust, E Grinstead, W Sussex, England	University of Brighton	Jones, BV (corresponding author), Univ Brighton, Sch Pharm & Biomol Sci, Brighton, E Sussex, England.	B.V.Jones@brighton.ac.uk		Nzakizwanayo, Jonathan/0000-0003-2673-6051; Jones, Brian/0000-0002-1211-9186; Ogilvie, Lesley/0000-0001-9794-2915	Medical Research Council [G0901553]; University of Brighton Studentship; Society of Applied Microbiology; Queen Victoria Hospital Charitable Trust; MRC [G0901553] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); University of Brighton Studentship; Society of Applied Microbiology; Queen Victoria Hospital Charitable Trust; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	Support is provided by the Medical Research Council (G0901553) awarded to BVJ; University of Brighton Studentship to JN; Society of Applied Microbiology; BVJ is also supported by the Queen Victoria Hospital Charitable Trust. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bliss JM, 1996, MOL MICROBIOL, V21, P221, DOI 10.1046/j.1365-2958.1996.6461357.x; Bloor AE, 2006, APPL ENVIRON MICROB, V72, P2520, DOI 10.1128/AEM.72.4.2520-2525.2006; Boudeau J, 2003, ALIMENT PHARM THER, V18, P45, DOI 10.1046/j.1365-2036.2003.01638.x; Chilcott GS, 2000, MICROBIOL MOL BIOL R, V64, P694, DOI 10.1128/MMBR.64.4.694-708.2000; Corbett D, 2008, ADV APPL MICROBIOL, V65, P1, DOI 10.1016/S0065-2164(08)00601-1; Cress BF, 2013, GENOME ANNOUNCEMENTS, V1, DOI 10.1128/genomeA.00047-13; Cukrowska B, 2002, SCAND J IMMUNOL, V55, P204, DOI 10.1046/j.1365-3083.2002.01005.x; Food and Agriculture Organization of the United Nations World Health Organization, 2002, GUIDELINES EVALUATIO; Fox-Orenstein A. E, 2012, AM J GASTROENTEROL S, V1, P41, DOI DOI 10.1038/AJGSUP.2012.8; Grabig A, 2006, INFECT IMMUN, V74, P4075, DOI 10.1128/IAI.01449-05; Griffiths G, 1998, J BIOL CHEM, V273, P11752, DOI 10.1074/jbc.273.19.11752; Grozdanov L, 2004, J BACTERIOL, V186, P5432, DOI 10.1128/JB.186.16.5432-5441.2004; Grozdanov L, 2002, J BACTERIOL, V184, P5912, DOI 10.1128/JB.184.21.5912-5925.2002; GUPTA DS, 1982, FEMS MICROBIOL LETT, V14, P75, DOI 10.1111/j.1574-6968.1982.tb08638.x; Guzy C, 2008, INT IMMUNOL, V20, P829, DOI 10.1093/intimm/dxn041; Hafez M, 2010, INFECT IMMUN, V78, P2153, DOI 10.1128/IAI.01406-09; Hafez M, 2009, INFECT IMMUN, V77, P2995, DOI 10.1128/IAI.00040-09; Hanna A, 2003, APPL ENVIRON MICROB, V69, P4474, DOI 10.1128/AEM.69.8.4474-4481.2003; Henker J, 2007, EUR J PEDIATR, V166, P311, DOI 10.1007/s00431-007-0419-x; Hodson N, 2000, J BIOL CHEM, V275, P27311; Jones BV, 2004, INFECT IMMUN, V72, P3941, DOI 10.1128/IAI.72.7.3941-3950.2004; Klemm P, 2000, INT J MED MICROBIOL, V290, P27; Kruis W, 1997, ALIMENT PHARM THER, V11, P853, DOI 10.1046/j.1365-2036.1997.00225.x; Kruis W, 2004, GUT, V53, P1617, DOI 10.1136/gut.2003.037747; Larsen RA, 2002, ARCH MICROBIOL, V178, P193, DOI 10.1007/s00203-002-0442-2; Lasaro MA, 2009, APPL ENVIRON MICROB, V75, P246, DOI 10.1128/AEM.01144-08; LodinovaZadnikova R, 1997, BIOL NEONATE, V71, P224, DOI 10.1159/000244421; Lundin A, 2008, CELL MICROBIOL, V10, P1093, DOI 10.1111/j.1462-5822.2007.01108.x; Manoil C, 2000, METHOD ENZYMOL, V326, P35; Matthes H, 2010, BMC COMPLEM ALTERN M, V10, DOI 10.1186/1472-6882-10-13; Nissle, 1918, MED KLIN, V2, P29; O'Sullivan GC, 2005, CURR PHARM DESIGN, V11, P3, DOI 10.2174/1381612053382368; O'Toole GA, 1998, MOL MICROBIOL, V30, P295, DOI 10.1046/j.1365-2958.1998.01062.x; Otte JM, 2009, NUTR CANCER, V61, P103, DOI 10.1080/01635580802372625; Palsson-McDermott EM, 2004, IMMUNOLOGY, V113, P153, DOI 10.1111/j.1365-2567.2004.01976.x; PELKONEN S, 1990, CURR MICROBIOL, V21, P23, DOI 10.1007/BF02090095; PELKONEN S, 1992, J BACTERIOL, V174, P7757, DOI 10.1128/JB.174.23.7757-7761.1992; PETIT C, 1995, MOL MICROBIOL, V17, P611, DOI 10.1111/j.1365-2958.1995.mmi_17040611.x; Pratt LA, 1998, MOL MICROBIOL, V30, P285, DOI 10.1046/j.1365-2958.1998.01061.x; Rakoff-Nahoum S, 2004, CELL, V118, P229, DOI 10.1016/j.cell.2004.07.002; Rhodes JM, 2002, TRENDS MOL MED, V8, P10, DOI 10.1016/S1471-4914(01)02194-3; Rigg GP, 1998, MICROBIOL-SGM, V144, P2905, DOI 10.1099/00221287-144-10-2905; Ringel Y, 2012, AM J GASTROENTEROL S, V1, P34, DOI DOI 10.1038/AJGSUP.2012.7; Ritland SR, 1999, CARCINOGENESIS, V20, P51, DOI 10.1093/carcin/20.1.51; Schembri MA, 2004, J BACTERIOL, V186, P1249, DOI 10.1128/JB.186.5.1249-1257.2004; Schlee M, 2007, INFECT IMMUN, V75, P2399, DOI 10.1128/IAI.01563-06; Schultz M, 2008, INFLAMM BOWEL DIS, V14, P1012, DOI 10.1002/ibd.20377; Shanahan F, 2009, J PHYSIOL-LONDON, V587, P4175, DOI 10.1113/jphysiol.2009.174649; Sonnenborn Ulrich, 2009, Microbial Ecology in Health and Disease, V21, P122, DOI 10.3109/08910600903444267; Sturm A, 2005, INFECT IMMUN, V73, P1452, DOI 10.1128/IAI.73.3.1452-1465.2005; Troge A, 2012, INT J MED MICROBIOL, V302, P304, DOI 10.1016/j.ijmm.2012.09.004; Ukena SN, 2005, BMC MED GENET, V6, DOI 10.1186/1471-2350-6-43; Ulett GC, 2007, INFECT IMMUN, V75, P3233, DOI 10.1128/IAI.01952-06; Vejborg RM, 2010, MOL GENET GENOMICS, V283, P469, DOI 10.1007/s00438-010-0532-9; Wallace JL, 2001, GASTROENTEROL CLIN N, V30, P971, DOI 10.1016/S0889-8553(05)70223-5; Wang D, 2010, ONCOGENE, V29, P781, DOI 10.1038/onc.2009.421; Whitfield C, 1999, MOL MICROBIOL, V31, P1307, DOI 10.1046/j.1365-2958.1999.01276.x; Whitfield C, 2006, ANNU REV BIOCHEM, V75, P39, DOI 10.1146/annurev.biochem.75.103004.142545; Willis LM, 2013, P NATL ACAD SCI USA, V110, P20753, DOI 10.1073/pnas.1312637110	59	8	8	3	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2015	10	3							e0120430	10.1371/journal.pone.0120430	http://dx.doi.org/10.1371/journal.pone.0120430			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD9NQ	25790373	Green Published, Green Submitted, gold			2022-12-27	WOS:000351425400158
J	Ragone, PG; Brandan, CP; Rumi, MM; Tomasini, N; Lauthier, JJ; Cimino, RO; Uncos, A; Ramos, F; D'Amato, AMA; Basombrio, MA; Diosque, P				Ragone, Paula G.; Perez Brandan, Cecilia; Monje Rumi, Mercedes; Tomasini, Nicolas; Lauthier, Juan J.; Cimino, Ruben O.; Uncos, Alejandro; Ramos, Federico; Alberti D'Amato, Anahi M.; Basombrio, Miguel A.; Diosque, Patricio			Experimental Evidence of Biological Interactions among Different Isolates of Trypanosoma cruzi from the Chaco Region	PLOS ONE			English	Article							POLYMERASE-CHAIN-REACTION; CHAGAS-DISEASE; MOLECULAR EPIDEMIOLOGY; CLONAL EVOLUTION; ENDEMIC AREA; INFECTIONS; PARASITE; POPULATIONS; IMPACT; HOST	Many infectious diseases arise from co-infections or re-infections with more than one genotype of the same pathogen. These mixed infections could alter host fitness, the severity of symptoms, success in pathogen transmission and the epidemiology of the disease. Trypanosoma cruzi, the etiological agent of Chagas disease, exhibits a high biological variability often correlated with its genetic diversity. Here, we developed an experimental approach in order to evaluate biological interaction between three T. cruzi isolates belonging to different Discrete Typing Units (DTUs TcIII, TcV and TcVI). These isolates were obtained from a restricted geographical area in the Chaco Region. Different mixed infections involving combinations of two isolates (TcIII + TcV, TcIII + TcVI and TcV + TcVI) were studied in a mouse model. The parameters evaluated were number of parasites circulating in peripheral blood, histopathology and genetic characterization of each DTU in different tissues by DNA hybridization probes. We found a predominance of TcVI isolate in blood and tissues respect to TcIII and TcV; and a decrease of the inflammatory response in heart when the damage of mice infected with TcVI and TcIII + TcVI mixture were compared. In addition, simultaneous presence of two isolates in the same tissue was not detected. Our results show that biological interactions between isolates with different biological behaviors lead to changes in their biological properties. The occurrence of interactions among different genotypes of T. cruzi observed in our mouse model suggests that these phenomena could also occur in natural cycles in the Chaco Region.	[Ragone, Paula G.; Perez Brandan, Cecilia; Monje Rumi, Mercedes; Tomasini, Nicolas; Lauthier, Juan J.; Alberti D'Amato, Anahi M.; Diosque, Patricio] Univ Nacl Salta, CONICET, Inst Patol Expt, Unidad Epidemiol Mol, Salta Capital, Argentina; [Ragone, Paula G.; Perez Brandan, Cecilia; Monje Rumi, Mercedes; Tomasini, Nicolas; Lauthier, Juan J.; Uncos, Alejandro; Ramos, Federico; Alberti D'Amato, Anahi M.; Basombrio, Miguel A.; Diosque, Patricio] Univ Nacl Salta, CONICET, Inst Patol Expt, Salta Capital, Argentina; [Cimino, Ruben O.] Univ Nacl Salta, Fac Ciencias Nat, Catedra Quim Biol, Salta Capital, Argentina	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)	Ragone, PG (corresponding author), Univ Nacl Salta, CONICET, Inst Patol Expt, Unidad Epidemiol Mol, Salta Capital, Argentina.	p_ragone@yahoo.com.ar	Cimino, Rubén Oscar/AAH-1847-2020; Lauthier, Juan Jose/AAX-8493-2021	Cimino, Rubén Oscar/0000-0002-4253-9077; Perez Brandan, Cecilia/0000-0002-9282-0959; Lauthier, Juan Jose/0000-0002-7604-4128	Argentina: Agencia Nacional de Promocion Cientifica y Tecnologica [PICT-2012-2174]	Argentina: Agencia Nacional de Promocion Cientifica y Tecnologica	This manuscript was supported by funding agency Argentina: Agencia Nacional de Promocion Cientifica y Tecnologica (http://www.agencia.mincyt.gob.ar), through a grant given to Dr. Patricio Diosque (PICT-2012-2174). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrade LO, 2005, NAT REV MICROBIOL, V3, P819, DOI 10.1038/nrmicro1249; Andrade LO, 1999, MOL BIOCHEM PARASIT, V100, P163, DOI 10.1016/S0166-6851(99)90035-X; Andrade SG, 2006, REV SOC BRAS MED TRO, V39, P1, DOI 10.1590/S0037-86822006000100001; Balmer O, 2006, ACTA TROP, V97, P94, DOI 10.1016/j.actatropica.2005.09.002; Bastrenta B, 2003, MEM I OSWALDO CRUZ, V98, P255, DOI 10.1590/S0074-02762003000200015; Bell AS, 2006, EVOLUTION, V60, P1358, DOI 10.1111/j.0014-3820.2006.tb01215.x; Bosseno MF, 2000, MEM I OSWALDO CRUZ, V95, P601, DOI 10.1590/S0074-02762000000500002; Burgos JM, 2010, CLIN INFECT DIS, V51, P485, DOI 10.1086/655680; Cardinal MV, 2008, INT J PARASITOL, V38, P1533, DOI 10.1016/j.ijpara.2008.04.010; Coronado X, 2006, AM J TROP MED HYG, V74, P1008, DOI 10.4269/ajtmh.2006.74.1008; Corrales RM, 2009, INFECT GENET EVOL, V9, P278, DOI 10.1016/j.meegid.2008.12.008; Cox FEG, 2001, PARASITOLOGY, V122, pS23, DOI 10.1017/S003118200001698X; D'Avila DA, 2009, J CLIN MICROBIOL, V47, P1718, DOI 10.1128/JCM.01658-08; del Puerto R, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000687; Diez C, 2010, AM J TROP MED HYG, V82, P67, DOI 10.4269/ajtmh.2010.09-0391; Dinko B, 2013, INT J PARASITOL-DRUG, V3, P45, DOI 10.1016/j.ijpddr.2013.01.001; Diosque P, 2003, INT J PARASITOL, V33, P997, DOI 10.1016/S0020-7519(03)00139-5; dos Reis D, 2012, EXP PARASITOL, V130, P321, DOI 10.1016/j.exppara.2012.02.016; dos Santos DM, 2009, EXP PARASITOL, V121, P8, DOI 10.1016/j.exppara.2008.09.012; Ezeokonkwo RC, 2010, VET PARASITOL, V173, P48, DOI 10.1016/j.vetpar.2010.06.020; Flores-Mendoza C, 2004, J MED ENTOMOL, V41, P489, DOI 10.1603/0022-2585-41.3.489; Franco DJ, 2003, EXP PARASITOL, V104, P54, DOI 10.1016/S0014-4894(03)00119-X; Garcia A, 2014, PARASITOL INT, V63, P138, DOI 10.1016/j.parint.2013.10.010; Gomes ML, 1998, EXP PARASITOL, V88, P28, DOI 10.1006/expr.1998.4191; Grossblatt A, 1996, GUIDE USE CARE LAB A; Kollien AH, 2000, PARASITOL TODAY, V16, P381, DOI 10.1016/S0169-4758(00)01724-5; Lauthier JJ, 2012, INFECT GENET EVOL, V12, P350, DOI 10.1016/j.meegid.2011.12.008; Lisboa CV, 2007, EXP PARASITOL, V116, P150, DOI 10.1016/j.exppara.2006.12.005; Macedo AM, 2004, MEM I OSWALDO CRUZ, V99, P1, DOI 10.1590/S0074-02762004000100001; Martins HR, 2007, ANTIMICROB AGENTS CH, V51, P3282, DOI 10.1128/AAC.01590-06; Martins HR, 2006, EXP PARASITOL, V112, P237, DOI 10.1016/j.exppara.2005.11.006; Mendes DG, 2007, TROP MED INT HEALTH, V12, P629, DOI 10.1111/j.1365-3156.2007.01831.x; Rumi MMM, 2013, ACTA TROP, V128, P130, DOI 10.1016/j.actatropica.2013.07.003; Monje-Rumi MM, 2015, INFECT GENET EVOL, V29, P53, DOI 10.1016/j.meegid.2014.11.001; Omeje JN, 2012, VET PARASITOL, V190, P368, DOI 10.1016/j.vetpar.2012.07.008; Pedersen AB, 2007, TRENDS ECOL EVOL, V22, P133, DOI 10.1016/j.tree.2006.11.005; Pena DA, 2011, J INFECT DIS, V204, P478, DOI 10.1093/infdis/jir292; Ragone PG, 2012, ACTA TROP, V123, P196, DOI 10.1016/j.actatropica.2012.05.003; Revollo S, 1998, EXP PARASITOL, V89, P30, DOI 10.1006/expr.1998.4216; Rodrigues CM, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000846; Rozas M, 2007, AM J TROP MED HYG, V77, P647, DOI 10.4269/ajtmh.2007.77.647; Sales-Campos H, 2014, PARASITOL RES, V113, P375, DOI 10.1007/s00436-013-3665-z; Lo Presti MS, 2014, ACTA TROP, V133, P98, DOI 10.1016/j.actatropica.2014.02.010; Telfer S, 2008, PARASITOLOGY, V135, P767, DOI 10.1017/S0031182008000395; Toledo MJD, 2003, ANTIMICROB AGENTS CH, V47, P223, DOI 10.1128/AAC.47.1.223-230.2003; Toledo MJD, 2002, EXP PARASITOL, V100, P161, DOI 10.1016/S0014-4894(02)00003-6; VEAS F, 1991, CELL MOL BIOL, V37, P73; Veland N, 2013, AM J TROP MED HYG, V88, P774, DOI 10.4269/ajtmh.12-0594; Zingales B, 2012, INFECT GENET EVOL, V12, P240, DOI 10.1016/j.meegid.2011.12.009	49	15	15	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2015	10	3							e0119866	10.1371/journal.pone.0119866	http://dx.doi.org/10.1371/journal.pone.0119866			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD9NQ	25789617	Green Published, Green Submitted, gold			2022-12-27	WOS:000351425400111
J	Shen, XY; Li, T; Chen, S; Fan, L; Gao, J; Hou, CL				Shen, Xiao-Ye; Li, Tong; Chen, Shuang; Fan, Li; Gao, Jian; Hou, Cheng-Lin			Characterization and Phylogenetic Analysis of the Mitochondrial Genome of Shiraia bambusicola Reveals Special Features in the Order of Pleosporales	PLOS ONE			English	Article							TRANSFER-RNA GENES; FUNGUS; HYPOCRELLIN; SEQUENCE; EVOLUTION; PROGRAM; ORIGIN; WHEAT; IDENTIFICATION; VERTICILLIUM	Shiraia bambusicola P. Henn. is a pathogenic fungus of bamboo, and its fruiting bodies are regarded as folk medicine. We determined and analyzed its complete mitochondrial DNA sequence (circular DNA molecule of 39,030 bp, G + C content of 25.19%). It contains the typical genes encoding proteins involved in electron transport and coupled oxidative phosphorylation (nad1-6 and nad4L, cob and cox1-3), one ATP synthase subunit (atp6), 4 hypothetical proteins, and two genes for large and small rRNAs (rnl and rns). There is a set of 32 tRNA genes comprising all 20 amino acids, and these genes are evenly distributed on the two strands. Phylogenetic analyses based on concatenated mitochondrial proteins indicated that S. bambusicola clustered with members of the order Pleosporales, which is in agreement with previous results. The gene arrangements of Dothideomycetes species contained three regions of gene orders partitioned in their mitochondrial genomes, including block 1 (nad6-atp6), block 2 (nad1-cox3) and block 3 (genes around rns). S. bambusicola displayed unique special features that differed from the other Pleosporales species, especially in the coding regions around rns (trnR-trnY). Moreover, a comparison of gene orders in mitochondrial genomes from Pezizomycotina revealed that although all encoded regions are located on the same strand in most Pezizomycotina mtDNAs, genes from Dothideomycetes species had different orientations, as well as diverse positions and colocalization of genes (such as cox3, cox1-cox2 and nad2-nad3); these distinctions were regarded as classspecific features. Interestingly, two incomplete copies of the atp6 gene were found on different strands of the mitogenomic DNA, a finding that has not been observed in the other analyzed fungal species. In our study, mitochondrial genomes from Dothideomycetes species were comprehensively analyzed for the first time, including many species that have not appeared in previous reports.	[Shen, Xiao-Ye; Li, Tong; Chen, Shuang; Fan, Li; Hou, Cheng-Lin] Capital Normal Univ, Coll Life Sci, Beijing, Peoples R China; [Gao, Jian] Int Ctr Bamboo & Rattan, Key Lab Bamboo & Rattan Sci & Technol, SFA, Beijing, Peoples R China	Capital Normal University; International Centre for Bamboo & Rattan	Fan, L (corresponding author), Capital Normal Univ, Coll Life Sci, Beijing, Peoples R China.	fanli@mail.cnu.edu.cn			Key Program of Science and Technology Development Project of Beijing Municipal Education Commission [KZ201110028036]; National Natural Science Foundation of China [31170019, 31270058]; Beijing Natural Science Foundation [5132009, 5122003]	Key Program of Science and Technology Development Project of Beijing Municipal Education Commission; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Beijing Natural Science Foundation(Beijing Natural Science Foundation)	CLH was supported by Key Program of Science and Technology Development Project of Beijing Municipal Education Commission (KZ201110028036), the National Natural Science Foundation of China (No. 31170019), and the Beijing Natural Science Foundation (and No. 5132009). LF was supported by the National Natural Science Foundation of China (No. 31270058) and the Beijing Natural Science Foundation (No. 5122003). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguileta G, 2014, GENOME BIOL EVOL, V6, P451, DOI 10.1093/gbe/evu028; Ali SM, 2002, INT J ONCOL, V21, P1229; Ali SM, 2001, J PHOTOCH PHOTOBIO B, V65, P59, DOI 10.1016/S1011-1344(01)00252-4; Amano N, 1980, B NATL SCI MUSEUM B; Andersson SGE, 1998, NATURE, V396, P133, DOI 10.1038/24094; Beck N., 2010, MFANNOT ORGANELLE GE; Benson G, 1999, NUCLEIC ACIDS RES, V27, P573, DOI 10.1093/nar/27.2.573; Bhathal JS, 2003, EUR J PLANT PATHOL, V109, P435, DOI 10.1023/A:1024277420773; BORNER GV, 1995, MOL GEN GENET, V246, P739, DOI 10.1007/BF00290721; Cardoso MAG, 2007, YEAST, V24, P607, DOI 10.1002/yea.1500; CHAPDELAINE Y, 1991, CELL, V65, P465, DOI 10.1016/0092-8674(91)90464-A; Cheng TF, 2004, J BASIC MICROB, V44, P339, DOI 10.1002/jobm.200410434; Daub ME, 2013, ANTIOXID REDOX SIGN, V19, P970, DOI 10.1089/ars.2012.5080; Diwu ZJJ, 1996, FREE RADICAL BIO MED, V20, P589, DOI 10.1016/0891-5849(95)02061-6; Dyall SD, 2004, SCIENCE, V304, P253, DOI 10.1126/science.1094884; Ferandon C, 2013, FUNGAL GENET BIOL, V55, P85, DOI 10.1016/j.fgb.2013.01.009; GARDES M, 1993, MOL ECOL, V2, P113, DOI 10.1111/j.1365-294X.1993.tb00005.x; Gautheret D, 2001, J MOL BIOL, V313, P1003, DOI 10.1006/jmbi.2001.5102; Ghikas DV, 2006, ARCH MICROBIOL, V185, P393, DOI 10.1007/s00203-006-0104-x; Gray MW, 1999, SCIENCE, V283, P1476, DOI 10.1126/science.283.5407.1476; Hane JK, 2007, PLANT CELL, V19, P3347, DOI 10.1105/tpc.107.052829; Hennings P, 1900, BOT JB, V28, P259; Herrmann JM, 2003, TRENDS MICROBIOL, V11, P74, DOI 10.1016/S0966-842X(02)00033-1; Hino I., 1961, ICONES FUNGORUM BAMB; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Kirk P.M., 2011, AINSWORTH BISBYS DIC; Kirk PM., 2008, DICT FUNGI, V10th ed; Kosa P, 2006, NUCLEIC ACIDS RES, V34, P2472, DOI 10.1093/nar/gkl327; Kouvelis VN, 2004, FUNGAL GENET BIOL, V41, P930, DOI 10.1016/j.fgb.2004.07.003; Kruys A, 2006, MYCOL RES, V110, P527, DOI 10.1016/j.mycres.2006.03.002; Kurtz S, 2001, NUCLEIC ACIDS RES, V29, P4633, DOI 10.1093/nar/29.22.4633; Lang BF, 2007, NAT PROTOC, V2, P652, DOI 10.1038/nprot.2007.58; Lang BF, 1999, ANNU REV GENET, V33, P351, DOI 10.1146/annurev.genet.33.1.351; Laslett D, 2004, NUCLEIC ACIDS RES, V32, P11, DOI 10.1093/nar/gkh152; Laslett D, 2008, BIOINFORMATICS, V24, P172, DOI 10.1093/bioinformatics/btm573; Li Xiang-min, 2009, Forest Research, V22, P279; Liu YX, 2013, PHYTOTAXA, V103, P51, DOI 10.11646/phytotaxa.103.1.4; Losada L, 2014, FEMS MICROBIOL LETT, V352, P165, DOI 10.1111/1574-6968.12387; Ma GY, 2004, ANTIMICROB AGENTS CH, V48, P4450, DOI 10.1128/AAC.48.11.4450-4452.2004; Ma L, 2013, FASEB J, V27, P1962, DOI 10.1096/fj.12-224444; Mirossay A, 2000, PHYTOMEDICINE, V7, P471, DOI 10.1016/S0944-7113(00)80032-X; Morakotkarn D, 2008, MYCOSCIENCE, V49, P258, DOI 10.1007/s10267-008-0419-3; Mulrooney CA, 2012, EUR J ORG CHEM, V2012, P3887, DOI 10.1002/ejoc.201200184; Nadimi M, 2012, MOL BIOL EVOL, V29, P2199, DOI 10.1093/molbev/mss088; Ohm RA, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1003037; Olivo M, 2006, J ENVIRON PATHOL TOX, V25, P223, DOI 10.1615/JEnvironPatholToxicolOncol.v25.i1-2.140; Pantou MP, 2006, CURR GENET, V50, P125, DOI 10.1007/s00294-006-0079-9; Pelin A, 2012, NEW PHYTOL, V194, P836, DOI 10.1111/j.1469-8137.2012.04072.x; Poole AM, 2007, BIOESSAYS, V29, P74, DOI 10.1002/bies.20516; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Saccardo PA, 1901, SYLLOGE FUNGORUM OMN; Saraste M, 1999, SCIENCE, V283, P1488, DOI 10.1126/science.283.5407.1488; Schattner P, 2005, NUCLEIC ACIDS RES, V33, pW686, DOI 10.1093/nar/gki366; Schoch CL, 2009, STUD MYCOL, P1, DOI 10.3114/sim.2009.64.01; Shen XY, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0095838, 10.1371/journal.pone.0092845]; Su YJ, 2011, EUR FOOD RES TECHNOL, V232, P935, DOI 10.1007/s00217-011-1461-5; Su YJ, 2011, J PHOTOCH PHOTOBIO B, V103, P29, DOI 10.1016/j.jphotobiol.2011.01.008; Tambor JHM, 2006, CURR GENET, V49, P302, DOI 10.1007/s00294-006-0057-2; Torriani SFF, 2008, FUNGAL GENET BIOL, V45, P628, DOI 10.1016/j.fgb.2007.12.005; van de Sande WWJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038654; West JS, 2001, PLANT PATHOL, V50, P10, DOI 10.1046/j.1365-3059.2001.00546.x; White DG, 1999, COMPENDIUM CORN DIS; Wu T, 2000, J PHOTOCH PHOTOBIO B, V57, P14, DOI 10.1016/S1011-1344(00)00068-3; Xia X, 2001, J HERED, V92, P371, DOI 10.1093/jhered/92.4.371; Youssar L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074792; Zhang Y, 2012, FUNGAL DIVERS, V53, P1, DOI 10.1007/s13225-011-0117-x	66	22	23	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2015	10	3							e0116466	10.1371/journal.pone.0116466	http://dx.doi.org/10.1371/journal.pone.0116466			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD9NQ	25790308	Green Published, gold, Green Submitted			2022-12-27	WOS:000351425400017
J	Song, DP; Huang, DY; Peng, Q; Huang, T; Chen, YJ; Zhang, TS; Nie, XW; He, HJ; Wang, P; Liu, QL; Tang, YX				Song, Deping; Huang, Dongyan; Peng, Qi; Huang, Tao; Chen, Yanjun; Zhang, Tiansheng; Nie, Xiaowei; He, Houjun; Wang, Ping; Liu, Qinglan; Tang, Yuxin			Molecular Characterization and Phylogenetic Analysis of Porcine Epidemic Diarrhea Viruses Associated with Outbreaks of Severe Diarrhea in Piglets in Jiangxi, China 2013	PLOS ONE			English	Article							COMPLETE GENOME SEQUENCE; 5'-UNTRANSLATED REGION; STEM-LOOP; STRAINS; IDENTIFICATION; GENES	Porcine epidemic diarrhea (PED), caused by porcine epidemic diarrhea virus (PEDV), is a highly contagious, acute enteric viral disease of swine characterized by vomiting, watery diarrhea, dehydration and death. To identify and characterize the field PEDVs associated with the outbreaks of severe diarrhea in piglets in Jiangxi, 2013, the complete genome sequences of two representative strains of PEDV, designated CH/JX-1/2013 and CH/JX-2/2013, were determined and analyzed. The genome sequences of both emergent Jiangxi PEDV strains, CH/JX-1/2013 and CH/JX-2/2013, were 28,038 nucleotides in length excluding 3 ' poly (A) tail. Compared to the PEDV CV777 strain, CH/JX-1/2013 and CH/JX-2/2013 had some unique genetic characteristics in the proximal region of the 5 '-UTRs. Phylogenetic analysis of the complete genomes and the structural proteins revealed that CH/JX-1/2013 and CH/JX-2/2013 had a close relationship with post-2010 Chinese PEDV strains and US strains identified in 2013. The nucleotide identity between the two Jiangxi strains (CH/JX-1/2013 and CH/JX-2/2013) and 30 strains of PEDV identified ante-2010 and post-2010 ranged from 96.3-97.0% and 97.3-99.7%, respectively. Multiple nucleotide and deduced amino acid mutations were observed in the ORF1a/b, S, ORF3, E, M and N genes among the current field PEDV strains when compared to the CV777 strain. Some of the mutations altered the amino acid charge and hydrophilicity, and notably, there was an amino acid substitution in the middle of one neutralizing epitope (L1371I) of the S gene of both CH/JX-1/2013 and CH/JX-2/2013. Taken together, the accumulated genetic variations of the current field PEDV strains might have led to antigenic changes of the viruses, which might confer the less effectiveness or failure of the CV777-based vaccines currently being widely used in Jiangxi, China.	[Song, Deping; Huang, Dongyan; Peng, Qi; Huang, Tao; Chen, Yanjun; Zhang, Tiansheng; Nie, Xiaowei; He, Houjun; Wang, Ping; Tang, Yuxin] Jiangxi Agr Univ, Dept Vet Prevent Med, Coll Anim Sci & Technol, Nanchang, Jiangxi, Peoples R China; [Liu, Qinglan] Jiangxi Acad Agr Sci, Nanchang, Jiangxi, Peoples R China	Jiangxi Agricultural University	Tang, YX (corresponding author), Jiangxi Agr Univ, Dept Vet Prevent Med, Coll Anim Sci & Technol, Nanchang, Jiangxi, Peoples R China.	tang53ster@gmail.com	tang, yuxin/GZN-2336-2022	Song, Deping/0000-0001-5949-287X	National Natural Science Foundation of China [31260611, 31372457]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	Funding from the National Natural Science Foundation of China (grant numbers: 31260611 and 31372457; URLs: http://www.nsfc.gov.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonso S, 2002, J VIROL, V76, P1293, DOI 10.1128/JVI.76.3.1293-1308.2002; Bi J, 2012, J VIROL, V86, P10910, DOI 10.1128/JVI.01919-12; Bridgen A, 1998, ADV EXP MED BIOL, V440, P781; Chang SH, 2002, MOL CELLS, V14, P295; Chen JF, 2011, J VIROL, V85, P11538, DOI 10.1128/JVI.06024-11; Chen JF, 2010, ARCH VIROL, V155, P1471, DOI 10.1007/s00705-010-0720-2; Cima Greg, 2013, J Am Vet Med Assoc, V243, P469; Cruz DJM, 2006, VIROLOGY, V354, P28, DOI 10.1016/j.virol.2006.04.027; DUARTE M, 1993, ADV EXP MED BIOL, V342, P55; Gao YY, 2013, ARCH VIROL, V158, P711, DOI 10.1007/s00705-012-1541-2; Ge FF, 2013, ARCH VIROL, V158, P2227, DOI 10.1007/s00705-013-1722-7; Huang YW, 2013, MBIO, V4, DOI 10.1128/mBio.00737-13; Kocherhans R, 2001, VIRUS GENES, V23, P137, DOI 10.1023/A:1011831902219; Lee DK, 2010, VIRUS RES, V149, P175, DOI 10.1016/j.virusres.2010.01.015; Lee S, 2014, EMERG INFECT DIS, V20, P1223, DOI 10.3201/eid2007.140294; Li WT, 2012, EMERG INFECT DIS, V18, P1350, DOI 10.3201/eid1808.120002; Li ZL, 2013, ARCH VIROL, V158, P1267, DOI 10.1007/s00705-012-1592-4; Liu PH, 2007, RNA, V13, P763, DOI 10.1261/rna.261807; Luo YW, 2012, J VIROL, V86, P9551, DOI 10.1128/JVI.01455-12; Marthaler D, 2013, GENOME ANNOUNCEMENTS, V1, DOI 10.1128/genomeA.00555-13; Mole B, 2013, NATURE, V499, P388, DOI 10.1038/499388a; Oldham J, 1972, PIG FARMING S    OCT, P72; Pan YF, 2012, VIROL J, V9, DOI 10.1186/1743-422X-9-195; Park SJ, 2008, VIRUS GENES, V36, P95, DOI 10.1007/s11262-007-0164-2; Park SJ, 2007, VIRUS GENES, V35, P321, DOI 10.1007/s11262-007-0096-x; PENSAERT MB, 1978, ARCH VIROL, V58, P243, DOI 10.1007/BF01317606; Raman S, 2005, J VIROL, V79, P12434, DOI 10.1128/JVI.79.19.12434-12446.2005; Sola I, 2005, J VIROL, V79, P2506, DOI 10.1128/JVI.79.4.2506-2516.2005; Song D, 2012, VIRUS GENES, V44, P167, DOI 10.1007/s11262-012-0713-1; SPAAN W, 1988, J GEN VIROL, V69, P2939, DOI 10.1099/0022-1317-69-12-2939; Sun DB, 2008, VET MICROBIOL, V131, P73, DOI 10.1016/j.vetmic.2008.02.022; Sun RQ, 2012, EMERG INFECT DIS, V18, P161, DOI 10.3201/eid1801.111259; Sun RQ, 2014, SCI WORLD J, DOI 10.1155/2014/208439; VANREETH K, 1994, VET REC, V135, P594; Yang X, 2013, VIRUS GENES, V46, P337, DOI 10.1007/s11262-012-0867-x	35	49	54	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2015	10	3							e0120310	10.1371/journal.pone.0120310	http://dx.doi.org/10.1371/journal.pone.0120310			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD9NQ	25790462	gold, Green Submitted, Green Published			2022-12-27	WOS:000351425400149
J	Xu, CH; Zhu, L; Chan, T; Lu, XX; Shen, WY; Gillies, MC; Zhou, FF				Xu, Chenghao; Zhu, Ling; Chan, Ting; Lu, Xiaoxi; Shen, Weiyong; Gillies, Mark C.; Zhou, Fanfan			The Altered Renal and Hepatic Expression of Solute Carrier Transporters (SLCs) in Type 1 Diabetic Mice	PLOS ONE			English	Article							FUNCTIONAL-ANALYSIS; DRUG TRANSPORTERS; INSULIN; MELLITUS; GENE; PHARMACOKINETICS; POLYMORPHISMS; ROSUVASTATIN; NEPHROPATHY; DISPOSITION	Diabetes mellitus is a chronic metabolic disorder that significantly affects human health and well-being. The Solute carrier transporters (SLCs), particularly the Organic anion/cation transporters (Oats/Octs/Octns), Organic anion transporting polypeptides (Oatps) and Oligopeptide transporters (Pepts) are essential membrane proteins responsible for cellular uptake of many endogenous and exogenous substances such as clinically important drugs. They are widely expressed in mammalian key organs especially the kidney and liver, in which they facilitate the influx of various drug molecules, thereby determining their distribution and elimination in body. The altered expression of SLCs in diabetes mellitus could have a profound and clinically significant influence on drug therapies. In this study, we extensively investigated the renal and hepatic expression of twenty essential SLCs in the type 1 diabetic Ins2(Akita) murine model that develops both hyperglycemia and diabetes-related complications using real-time PCR and immunoblotting analysis. We found that the renal expression of mOatp1a1, mOatp1a6, mOat1, mOat3, mOat5, mOct2 and mPept2 was decreased; while that of mPept1 was increased at the mRNA level in the diabetic mice compared with non-diabetic controls. We found up-regulated mRNA expression of mOatp1a4, mOatp1c1, mOctn2, mOct3 and mPept1 as well as down-regulation of mOatp1a1 in the livers of diabetic mice. We confirmed the altered protein expression of several SLCs in diabetic mice, especially the decreased renal and hepatic expression of mOatp1a1. We also found down-regulated protein expression of mOat3 and mOctn1 in the kidneys as well as increased protein expression of mOatp1a4 and mOct3 in the livers of diabetic mice. Our findings contribute to better understanding the modulation of SLC transporters in type 1 diabetes mellitus, which is likely to affect the pharmacokinetic performance of drugs that are transported by these transporters and therefore, forms the basis of future therapeutic optimization of regimens in patients with type 1 diabetes mellitus.	[Xu, Chenghao; Chan, Ting; Lu, Xiaoxi; Zhou, Fanfan] Univ Sydney, Fac Pharm, Sydney, NSW 2006, Australia; [Zhu, Ling; Shen, Weiyong; Gillies, Mark C.] Univ Sydney, Save Sight Inst, Retinal Therapeut Res Grp, Sydney, NSW 2000, Australia	University of Sydney; University of Sydney	Zhou, FF (corresponding author), Univ Sydney, Fac Pharm, Sydney, NSW 2006, Australia.	fanfan.zhou@sydney.edu.au	Zhou, Fanfan/M-4404-2013; Zhou, Fanfan/J-2327-2019; Zhu, Ling/M-3887-2013	Zhou, Fanfan/0000-0002-1982-1541; Zhou, Fanfan/0000-0002-1982-1541; Zhu, Ling/0000-0003-0776-1630				Arabi YM, 2011, CRIT CARE, V15, DOI 10.1186/cc10420; Barthelmes D, 2014, CARDIOVASC DIABETOL, V13, DOI 10.1186/1475-2840-13-42; Bikhazi AB, 2004, MOL PHARMACEUT, V1, P300, DOI 10.1021/mp049972u; Chan T, 2014, MOL PHARM; Chang Jae-Hyung, 2012, Methods Mol Biol, V933, P17, DOI 10.1007/978-1-62703-068-7_2; Chen LG, 2010, PHARMACOGENET GENOM, V20, P687, DOI 10.1097/FPC.0b013e32833fe789; Cheng QQ, 2008, MOL PHARMACEUT, V5, P77, DOI 10.1021/mp700114j; DeGorter MK, 2012, ANNU REV PHARMACOL, V52, P249, DOI 10.1146/annurev-pharmtox-010611-134529; DOMINGUEZ JH, 1994, J AM SOC NEPHROL, V5, pS29; Durmus S, 2014, INT J CANCER, V135, P1700, DOI 10.1002/ijc.28797; El Feghali R, 2007, VASC HEALTH RISK MAN, V3, P165; Gangopadhyay A, 2002, AM J PHYSIOL-GASTR L, V283, pG133, DOI 10.1152/ajpgi.00445.2001; Giannoukakis N, 2002, DIABETES NUTR METAB, V15, P173; Gong L, 2011, TOXICOL SCI, V122, P587, DOI 10.1093/toxsci/kfr114; Grover B, 2004, J PHARMACOL EXP THER, V308, P949, DOI 10.1124/jpet.103.058388; Gurley SB, 2006, AM J PHYSIOL-RENAL, V290, pF214, DOI 10.1152/ajprenal.00204.2005; Gurley SB, 2010, AM J PHYSIOL-RENAL, V298, pF788, DOI 10.1152/ajprenal.90515.2008; Hobbs M, 2012, XENOBIOTICA, V42, P327, DOI 10.3109/00498254.2011.625452; Horiuchi I, 2009, BIOPHARM DRUG DISPOS, V30, P326, DOI 10.1002/bdd.671; Imbert P, 2014, THROMB RES, V133, P756, DOI 10.1016/j.thromres.2014.02.003; Iusuf D, 2013, MOL PHARMACOL, V83, P919, DOI 10.1124/mol.112.081927; Janghorbani M, 2007, AM J EPIDEMIOL, V166, P495, DOI 10.1093/aje/kwm106; Kasichayanula S, 2013, BRIT J CLIN PHARMACO, V76, P432, DOI 10.1111/bcp.12056; Kaul K, 2013, ADV EXP MED BIOL, V771, P1; Kidokoro K, 2013, J AM SOC NEPHROL, V24, P1139, DOI 10.1681/ASN.2012080783; Kikawa K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095451; Kim HJ, 2011, TOXICOL RES-GER, V27, P37, DOI 10.5487/TR.2011.27.1.037; Lungkaphin A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096236; Mallat SG, 2012, CARDIOVASC DIABETOL, V11, DOI 10.1186/1475-2840-11-32; More Vijay R, 2012, Comp Hepatol, V11, P1, DOI 10.1186/1476-5926-11-1; More VR, 2011, DRUG METAB DISPOS, V39, P992, DOI 10.1124/dmd.110.037507; Nishimura M, 2008, DRUG METAB PHARMACOK, V23, P22, DOI 10.2133/dmpk.23.22; Nishimura Masuhiro, 2005, Drug Metab Pharmacokinet, V20, P452, DOI 10.2133/dmpk.20.452; Nowicki Michael T, 2008, Drug Metab Lett, V2, P11; Nunez C, 2008, IMMUNOGENETICS, V60, P19, DOI 10.1007/s00251-007-0265-z; Ontawong A, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/820786; Patel H, 2013, J ORAL PATHOL MED, V42, P250, DOI 10.1111/j.1600-0714.2012.01196.x; Patti Mary-Elizabeth, 2004, Curr Diab Rep, V4, P176, DOI 10.1007/s11892-004-0020-x; Pfefferkorn JA, 2012, J MED CHEM, V55, P1318, DOI 10.1021/jm2014887; Phatchawan A, 2014, AM J MED SCI, V347, P221, DOI 10.1097/MAJ.0b013e3182831740; Planas R, 2010, IMMUNOL LETT, V133, P55, DOI 10.1016/j.imlet.2010.08.001; Powell DA, 2011, BIOORG MED CHEM LETT, V21, P7281, DOI 10.1016/j.bmcl.2011.10.040; Qi ZH, 2005, DIABETES, V54, P2628, DOI 10.2337/diabetes.54.9.2628; RETT K, 1995, J HYPERTENS, V13, pS81, DOI 10.1097/00004872-199508001-00013; Roth M, 2012, BRIT J PHARMACOL, V165, P1260, DOI 10.1111/j.1476-5381.2011.01724.x; Sakamoto K, 1990, Gan No Rinsho, V36, P865; Salem ESB, 2014, AM J PHYSIOL-RENAL, V306, pF629, DOI 10.1152/ajprenal.00516.2013; Sciullo E, 1997, Early Pregnancy, V3, P172; Seok SJ, 2013, NEPHROL DIAL TRANSPL, V28, P1700, DOI 10.1093/ndt/gfs555; Smith DE, 2013, MOL ASPECTS MED, V34, P323, DOI 10.1016/j.mam.2012.11.003; Song IS, 2014, BMC COMPLEM ALTERN M, V14, DOI 10.1186/1472-6882-14-251; SURWIT RS, 1988, DIABETES, V37, P1163, DOI 10.2337/diabetes.37.9.1163; Toh DSL, 2011, BIOCHEM PHARMACOL, V82, P1692, DOI 10.1016/j.bcp.2011.08.008; Tramonti G, 2006, AM J PHYSIOL-RENAL, V291, pF972, DOI 10.1152/ajprenal.00110.2006; van de Steeg E, 2013, CLIN CANCER RES, V19, P821, DOI 10.1158/1078-0432.CCR-12-2080; Vogt L, 2004, Minerva Med, V95, P395; Wang CP, 2010, J PHARM PHARM SCI, V13, P411, DOI 10.18433/J3Q30H; Wang J, 1999, J CLIN INVEST, V103, P27, DOI 10.1172/JCI4431; Yoshioka M, 1997, DIABETES, V46, P887, DOI 10.2337/diabetes.46.5.887; Zhang Y, 2012, FUNGAL DIVERS, V53, P1, DOI 10.1007/s13225-011-0117-x; Zheng J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094712; Zhou FF, 2007, PHARM RES-DORDR, V24, P28, DOI 10.1007/s11095-006-9144-9; Zhou FF, 2013, AAPS J, V15, P1099, DOI 10.1208/s12248-013-9515-1; Zhou FF, 2011, BRIT J PHARMACOL, V162, P1380, DOI 10.1111/j.1476-5381.2010.01144.x; Zhou FF, 2010, BRIT J PHARMACOL, V159, P419, DOI 10.1111/j.1476-5381.2009.00545.x	65	11	11	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2015	10	3							e0120760	10.1371/journal.pone.0120760	http://dx.doi.org/10.1371/journal.pone.0120760			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD9NQ	25789863	gold, Green Published, Green Submitted			2022-12-27	WOS:000351425400173
J	Agrawal, S; Fledderjohann, J; Vellakkal, S; Stuckler, D				Agrawal, Sutapa; Fledderjohann, Jasmine; Vellakkal, Sukumar; Stuckler, David			Adequately Diversified Dietary Intake and Iron and Folic Acid Supplementation during Pregnancy Is Associated with Reduced Occurrence of Symptoms Suggestive of Pre-Eclampsia or Eclampsia in Indian Women	PLOS ONE			English	Article							PERICONCEPTIONAL MULTIVITAMIN USE; RISK-FACTORS; GESTATIONAL HYPERTENSION; OXIDATIVE STRESS; CARBOHYDRATE INTOLERANCE; ALCOHOL-CONSUMPTION; MATERNAL HEALTH; FOOD; NUTRITION; SMOKING	Background/Objective Pre-eclampsia or Eclampsia (PE or E) accounts for 25% of cases of maternal mortality worldwide. There is some evidence of a link to dietary factors, but few studies have explored this association in developing countries, where the majority of the burden falls. We examined the association between adequately diversified dietary intake, iron and folic acid supplementation during pregnancy and symptoms suggestive of PE or E in Indian women. Methods Cross-sectional data from India's third National Family Health Survey (NFHS-3, 2005-06) was used for this study. Self-reported symptoms suggestive of PE or E during pregnancy were obtained from 39,657 women aged 15-49 years who had had a live birth in the five years preceding the survey. Multivariable logistic regression analysis was used to estimate the association between adequately diversified dietary intake, iron and folic acid supplementation during pregnancy and symptoms suggestive of PE or E after adjusting for maternal, health and lifestyle factors, and socio-demographic characteristics of the mother. Results In their most recent pregnancy, 1.2% (n=456) of the study sample experienced symptoms suggestive of PE or E. Mothers who consumed an adequately diversified diet were 34% less likely (OR: 0.66; 95% CI: 0.51-0.87) to report PE or E symptoms than mothers with inadequately diversified dietary intake. The likelihood of reporting PE or E symptoms was also 36% lower (OR: 0.64; 95% CI: 0.47-0.88) among those mothers who consumed iron and folic acid supplementation for at least 90 days during their last pregnancy. As a sensitivity analysis, we stratified our models sequentially by education, wealth, antenatal care visits, birth interval, and parity. Our results remained largely unchanged: both adequately diversified dietary intake and iron and folic acid supplementation during pregnancy were associated with a reduced occurrence of PE or E symptoms. Conclusion Having a adequately diversified dietary intake and iron and folic acid supplementation in pregnancy was associated with a reduced occurrence of symptoms suggestive of PE or E in Indian women.	[Agrawal, Sutapa; Vellakkal, Sukumar; Stuckler, David] Publ Hlth Fdn India, South Asia Network Chron Dis, Gurgaon 122022, Haryana, India; [Fledderjohann, Jasmine; Vellakkal, Sukumar; Stuckler, David] Univ Oxford, Dept Sociol, Oxford, England	Public Health Foundation of India; University of Oxford	Agrawal, S (corresponding author), Publ Hlth Fdn India, South Asia Network Chron Dis, Gurgaon 122022, Haryana, India.	sutapa.agrawal@phfi.org	Vellakkal, Sukumar/AAD-4893-2020	Vellakkal, Sukumar/0000-0003-2635-1944; Fledderjohann, Jasmine/0000-0003-4952-7658; Stuckler, David/0000-0002-1288-8401; Vellakkal, Sukumar/0000-0002-0594-1454	Economic and Social Research Council; NWO-WOTRO; Population Reference Bureau; Population, Reproductive Health, and Economic Development; RCN foundation joint research scheme [ES/K13130/1]; Economic and Social Research Council [ES/K013130/1] Funding Source: researchfish; ESRC [ES/K013130/1] Funding Source: UKRI	Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); NWO-WOTRO(Netherlands Organization for Scientific Research (NWO)); Population Reference Bureau; Population, Reproductive Health, and Economic Development; RCN foundation joint research scheme; Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC))	Support for this project was provided by a grant from the Economic and Social Research Council, NWO-WOTRO, Population Reference Bureau, and Population, Reproductive Health, and Economic Development, and the RCN foundation joint research scheme (Grant number: ES/K13130/1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aagaard-Tillery KM, 2005, CLIN OBSTET GYNECOL, V48, P12, DOI 10.1097/01.grf.0000153882.58132.ba; Agrawal S, 2014, INDOOR AIR; Agrawal S, 2014, NUTR J, V13, DOI 10.1186/1475-2891-13-89; Ali Abdelaziem A, 2011, BMC Res Notes, V4, P311, DOI 10.1186/1756-0500-4-311; [Anonymous], 2001, CONFIDENTIAL ENQUIRI; [Anonymous], 2012, GUID DAIL IR FOL AC; Antony AC, 2007, AM J CLIN NUTR, V85, p598S, DOI 10.1093/ajcn/85.2.598S; ARORA R, 1994, AUST NZ J OBSTET GYN, V34, P537, DOI 10.1111/j.1479-828X.1994.tb01104.x; Barba C, 2004, LANCET, V363, P157, DOI 10.1016/S0140-6736(03)15268-3; Bdolah Y, 2008, AM J OBSTET GYNECOL, V198, DOI 10.1016/j.ajog.2007.10.783; Beck Laurie F, 2002, MMWR Surveill Summ, V51, P1; Begum Mosammat Rashida, 2004, MedGenMed, V6, P52; Bhutta ZA, 2010, SEMIN PERINATOL, V34, P434, DOI 10.1053/j.semperi.2010.09.002; Bianco A, 1996, OBSTET GYNECOL, V87, P917, DOI 10.1016/0029-7844(96)00045-2; Bilodeau Jean-Francois, 2003, J Obstet Gynaecol Can, V25, P742; Bodnar LM, 2006, AM J EPIDEMIOL, V164, P470, DOI 10.1093/aje/kwj218; Brantsaeter AL, 2009, J NUTR, V139, P1162, DOI 10.3945/jn.109.104968; BREWER T, 1969, OBSTET GYNECOL, V33, P448; Bryson CL, 2003, AM J EPIDEMIOL, V158, P1148, DOI 10.1093/aje/kwg273; Burchi F, 2011, INT J ENV RES PUB HE, V8, P358, DOI 10.3390/ijerph8020358; Catov JM, 2009, AM J EPIDEMIOL, V169, P1304, DOI 10.1093/aje/kwp052; Center for Disease Control and Prevention, 1998, MMWR MORB MORTAL WKL, V47, P1; Charles DHM, 2005, PAEDIATR PERINAT EP, V19, P112, DOI 10.1111/j.1365-3016.2005.00633.x; Chesley L, 1978, HYPERTENSIVE DISORDE; Christian P, 2010, ANNU REV NUTR, V30, P83, DOI 10.1146/annurev.nutr.012809.104813; Concato J, 1995, J CLIN EPIDEMIOL, V48, P1495, DOI 10.1016/0895-4356(95)00510-2; Conde-Agudelo A, 1999, AM J OBSTET GYNECOL, V181, P1026, DOI 10.1016/S0002-9378(99)70341-8; Conde-Agudelo A, 2000, BRIT J OBSTET GYNAEC, V107, P75, DOI 10.1111/j.1471-0528.2000.tb11582.x; Conde-Agudelo A, 2007, AM J OBSTET GYNECOL, V196, P297, DOI 10.1016/j.ajog.2006.05.055; Duckitt K, 2005, BRIT MED J, V330, P565, DOI 10.1136/bmj.38380.674340.E0; Duley L, 2006, BMJ-BRIT MED J, V332, P463, DOI 10.1136/bmj.332.7539.463; England LJ, 2002, AM J OBSTET GYNECOL, V186, P1035, DOI 10.1067/mob.2002.122404; England L, 2007, FRONT BIOSCI-LANDMRK, V12, P2471, DOI 10.2741/2248; Feig DS, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001425; GOI, 2007, 11 5 YEAR PLAN 2007; GUIDOTTI R, 1988, AM J OBSTET GYNECOL, V158, P80; Hernandez-Diaz S, 2002, AM J EPIDEMIOL, V156, P806, DOI 10.1093/aje/kwf129; Herrera JA, 1998, OBSTET GYNECOL, V91, P585, DOI 10.1016/S0029-7844(97)00711-4; Hiby SE, 2008, HUM REPROD, V23, P972, DOI 10.1093/humrep/den011; Hidalgo B, 2013, AM J PUBLIC HEALTH, V103, P39, DOI 10.2105/AJPH.2012.300897; Hofmeyr GJ, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001059.pub4; Indian Consensus Group, 1996, J NUTR ENV MED, V6, P309, DOI DOI 10.3109/13590849609007257; International Institute for Population Sciences (IIPS) and Macro International, 2007, NAT FAM HLTH SURV NF; Jain S, 2010, BIOL TRACE ELEM RES, V133, P162, DOI 10.1007/s12011-009-8423-9; Joffe GM, 1998, AM J OBSTET GYNECOL, V179, P1032, DOI 10.1016/S0002-9378(98)70210-8; Kaaja R, 2005, EUR HEART J, V26, P44, DOI 10.1093/eurheartj/ehi015; Kahn SR, 2011, BMC PREGNANCY CHILDB, V11, DOI 10.1186/1471-2393-11-91; Kiondo P, 2012, TROP MED INT HEALTH, V17, P480, DOI 10.1111/j.1365-3156.2011.02926.x; Lamminpaa R, 2012, BMC PREGNANCY CHILDB, V12, DOI 10.1186/1471-2393-12-47; Lee CJ, 2000, INT J GYNECOL OBSTET, V70, P327, DOI 10.1016/S0020-7292(00)00240-X; Li ZW, 2013, HYPERTENSION, V61, P873, DOI 10.1161/HYPERTENSIONAHA.111.00230; Lichtenstein AH, 2005, JAMA-J AM MED ASSOC, V294, P351, DOI 10.1001/jama.294.3.351; Lindheimer MD, 2009, CHESLEY'S HYPERTENSIVE DISORDERS IN PREGNANCY, 3RD EDITION, P1, DOI 10.1016/B978-0-12-374213-1.00001-X; Longo-Mbenza B, 2008, Niger J Med, V17, P265; MARDONESSANTANDER F, 1988, AM J CLIN NUTR, V47, P413, DOI 10.1093/ajcn/47.3.413; McCarthy FP, 2013, OBSTET GYNECOL, V122, P830, DOI 10.1097/AOG.0b013e3182a6b226; Mehendale S, 2008, INT J GYNECOL OBSTET, V100, P234, DOI 10.1016/j.ijgo.2007.08.011; Misra A, 2009, J Assoc Physicians India, V57, P163; Morris CD, 2001, AM J OBSTET GYNECOL, V184, P643, DOI 10.1067/mob.2001.111101; National Center for Health Statistics, 1997, REP FIN NAT STAT 199; North CJ, 2009, EUR J CLIN NUTR, V63, P921, DOI 10.1038/ejcn.2009.8; Ogle BM, 2001, ASIA PAC J CLIN NUTR, V10, P21, DOI 10.1046/j.1440-6047.2001.00206.x; Pal A, 2011, Bangladesh Med Res Counc Bull, V37, P66; Parretti E, 2006, HYPERTENSION, V47, P449, DOI 10.1161/01.HYP.0000205122.47333.7f; Pathak Priyali, 2004, Indian Journal of Pediatrics, V71, P1007; Peduzzi P, 1995, J CLIN EPIDEMIOL, V48, P1503, DOI 10.1016/0895-4356(95)00048-8; Peduzzi P, 1996, J CLIN EPIDEMIOL, V49, P1373, DOI 10.1016/S0895-4356(96)00236-3; Phares Tanya M, 2004, MMWR Surveill Summ, V53, P1; Pipkin FB, 2008, HYPERTENSION, V51, P1042, DOI 10.1161/HYPERTENSIONAHA.107.106559; Prasannan-Nair C, 2006, J Obstet Gynaecol, V26, P817; Qiu CF, 2008, AM J HYPERTENS, V21, P903, DOI 10.1038/ajh.2008.209; Radhika G, 2008, BRIT J NUTR, V99, P398, DOI 10.1017/S0007114507803965; Ray JG, 2002, ARCH INTERN MED, V162, P1776, DOI 10.1001/archinte.162.15.1776; Reddy KS, 2004, PUBLIC HEALTH NUTR, V7, P167, DOI 10.1079/PHN2003587; Roberts JM, 2000, BMJ-BRIT MED J, V321, P33, DOI 10.1136/bmj.321.7252.33; Roberts JM, 2002, PLACENTA, V23, P359, DOI 10.1053/plac.2002.0819; Roberts JM, 2003, J NUTR, V133, p1684S, DOI 10.1093/jn/133.5.1684S; Roberts JM, 2007, REPORT WIC NUTR RISK; Rosenberg TJ, 2003, OBSTET GYNECOL, V102, P1022, DOI [10.1016/j.obstetgynecol.2003.07.005, 10.1016/S0029-7844(03)00878-0]; Rudra CB, 2011, ENVIRON HEALTH PERSP, V119, P886, DOI 10.1289/ehp.1002947; Rudra CB, 2006, J REPROD MED, V51, P94; Ruel MT, 2003, IS DIETARY DIVERSITY; Sacks FM, 1999, CLIN CARDIOL, V22, P6, DOI 10.1002/clc.4960221503; SAFTLAS AF, 1990, AM J OBSTET GYNECOL, V163, P460, DOI 10.1016/0002-9378(90)91176-D; Salihu HM, 2011, ALCOHOL, V45, P73, DOI 10.1016/j.alcohol.2010.05.010; Salihu HM, 2007, EARLY HUM DEV, V83, P713, DOI 10.1016/j.earlhumdev.2007.08.002; Scholl TO, 2005, AM J CLIN NUTR, V81, P1390; SERMER M, 1995, AM J OBSTET GYNECOL, V173, P146, DOI 10.1016/0002-9378(95)90183-3; Sharma JB, 2006, INT J GYNECOL OBSTET, V94, P23, DOI 10.1016/j.ijgo.2006.03.025; Shetty PS, 2002, PUBLIC HEALTH NUTR, V5, P175, DOI 10.1079/PHN2001291; Sibai B, 2005, LANCET, V365, P785, DOI 10.1016/S0140-6736(05)71003-5; Sibai B M, 2000, J Matern Fetal Med, V9, P62; Sibai BM, 2005, OBSTET GYNECOL, V105, P402, DOI 10.1097/01.AOG.0000152351.13671.99; Sibai BM, 2000, AM J OBSTET GYNECOL, V182, P938, DOI 10.1016/S0002-9378(00)70350-4; Sierra-Laguado J, 2007, AM J HYPERTENS, V20, P437, DOI 10.1016/j.amjhyper.2006.10.009; Silva LM, 2008, J HYPERTENS, V26, P1200, DOI 10.1097/HJH.0b013e3282fcc36e; Singh S, 2010, INTERNET J GYNECOLOG, V15; Swain S, 1993, Indian Pediatr, V30, P771; TAYLOR DJ, 1982, BRIT J OBSTET GYNAEC, V89, P1011, DOI 10.1111/j.1471-0528.1982.tb04656.x; Timmermans S, 2011, NUTR METAB CARDIOVAS, V21, P54, DOI 10.1016/j.numecd.2009.07.002; Torheim LE, 2004, EUR J CLIN NUTR, V58, P594, DOI 10.1038/sj.ejcn.1601853; Torheim LE, 2003, EUR J CLIN NUTR, V57, P1283, DOI 10.1038/sj.ejcn.1601686; Torjusen H, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2014-006143; Trogstad L, 2009, BJOG-INT J OBSTET GY, V116, P108, DOI 10.1111/j.1471-0528.2008.01978.x; Tsai AC, 2013, AM J PUBLIC HEALTH, V103, pE1, DOI 10.2105/AJPH.2013.301234; US Congress Office of Technology Assessment, 1988, US C PUBL; Vambergue A, 2002, EUR J OBSTET GYN R B, V102, P31, DOI 10.1016/S0301-2115(01)00556-5; Villamor E, 2006, LANCET, V368, P1164, DOI 10.1016/S0140-6736(06)69473-7; Vittinghoff E, 2012, SERIES STAT BIOL HLT; Wen SW, 2013, J PREGNANCY, V2013, DOI 10.1155/2013/294312; Wen SW, 2008, CAN MED ASSOC J, V179, P1263, DOI 10.1503/cmaj.080859; Wen SW, 2008, AM J OBSTET GYNECOL, V198, DOI 10.1016/j.ajog.2007.06.067; WHO, 2008, CONCL CONS M HELD 1; World Health Organization, 2009, GLOB HLTH RISKS; World Health Organization, 2007, INT MAN PREGN CHILDB; Xu HR, 2009, NUTR REV, V67, P639, DOI 10.1111/j.1753-4887.2009.00249.x	116	29	33	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2015	10	3							e0119120	10.1371/journal.pone.0119120	http://dx.doi.org/10.1371/journal.pone.0119120			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9BN	25785774	Green Accepted, gold, Green Published			2022-12-27	WOS:000352138500076
J	Au, WM; Ho, SY; Wang, MP; Lo, WS; Tin, SPP; Huang, R; Lam, TH				Au, Wing Man; Ho, Sai Yin; Wang, Man Ping; Lo, Wing Sze; Tin, Sze Pui Pamela; Huang, Rong; Lam, Tai Hing			Correlates of Pro-Drinking Practices in Drinking Parents of Adolescents in Hong Kong	PLOS ONE			English	Article							MODERATE ALCOHOL-CONSUMPTION; SOCIOECONOMIC DIFFERENCES; BEHAVIORS; RISK	Introduction and Aims Parental alcohol-related practices are important risk factors of adolescent drinking, but little is known about the factors associated with these parental pro-drinking practices (PPDPs). We investigated the correlates of 9 PPDPs in drinking parents of adolescents in Hong Kong. Methods A total of 2200 students (age 14.8 +/- 2.0; boys 63.2%) participated in a school-based cross-sectional survey in 2012. Analysis was restricted to 1087 (61.8%) students with at least 1 drinking parent as PPDPs were much more common in these families. Logistic regression was used to identify correlates of each PPDP. Results Among 1087 students, the prevalence of PPDPs ranged from 8.2% for training drinking capacity to 65.7% for seeing parents drink. Only 14.8% of students had not experienced any of these practices. More frequent maternal drinking predicted parental training of drinking capacity. Older age predicted helping parents buy alcohol and parental encouragement of drinking. Adolescent girls were more likely to have received parental training of drinking capacity than boys. Higher perceived family affluence was associated with hearing parents saying benefits of drinking, and helping parents open bottle and pour alcohol. Conclusions PPDPs were associated with parental drinking frequency and various socio-demographic factors. These results have implications on alcohol control programmes involving parents to tailor messages for reducing PPDPs based on the characteristics of adolescents and parents.	[Au, Wing Man; Ho, Sai Yin; Lo, Wing Sze; Tin, Sze Pui Pamela; Huang, Rong; Lam, Tai Hing] Univ Hong Kong, Sch Publ Hlth, Hong Kong, Hong Kong, Peoples R China; [Wang, Man Ping] Univ Hong Kong, Sch Nursing, Hong Kong, Hong Kong, Peoples R China	University of Hong Kong; University of Hong Kong	Ho, SY (corresponding author), Univ Hong Kong, Sch Publ Hlth, Hong Kong, Hong Kong, Peoples R China.	syho@hku.hk	; Lam, Tai Hing/C-4317-2009; Ho, Daniel Sai Yin/C-4307-2009	Wang, Man Ping/0000-0003-4000-2388; Lam, Tai Hing/0000-0002-2033-9971; Ho, Daniel Sai Yin/0000-0001-9485-0273	Health Care and Promotion Fund [25110534]	Health Care and Promotion Fund	This work was supported by the Health Care and Promotion Fund (#25110534, to HSY, http://www.fhb.gov.hk/en/committees/hcpf.htm). The funders took the role in approving study design, data collection and analysis but have no roles in decision to publish, or preparation of the manuscript	[Anonymous], 2011, MMWR SURVEILL SUMM, DOI DOI 10.2307/24806047; Au WM, 2014, ALCOHOL ALCOHOLISM, V49, P668, DOI 10.1093/alcalc/agu063; BAUMBAICKER C, 1985, DRUG ALCOHOL DEPEN, V15, P305, DOI 10.1016/0376-8716(85)90008-0; Bond M. H., 1996, HDB CHINESE PSYCHOL; Bonomo Y, 2001, ADDICTION, V96, P1485, DOI 10.1046/j.1360-0443.2001.9610148512.x; Boyle JR, 2006, J AM COLL HEALTH, V54, P238, DOI 10.3200/JACH.54.4.238-244; Census and Statistics Department, 2012, HONG KONG ANN DIG ST; Champion HLO, 2004, J ADOLESCENT HEALTH, V35, P321, DOI 10.1016/j.jadohealth.2003.09.023; Clark L, 2008, MIDDLE CLASS PARENTS; Cox David, 2009, Journal of Wine Research, V20, P209, DOI 10.1080/09571260903450963; Ennet ST, 2001, J MARRIAGE FAM, V63, P48, DOI 10.1111/j.1741-3737.2001.00048.x; Gruber E, 1996, PREV MED, V25, P293, DOI 10.1006/pmed.1996.0059; Hoschild A., 1989, 2 SHIFT WORKING PARE; Huckle T, 2010, ADDICTION, V105, P1192, DOI 10.1111/j.1360-0443.2010.02931.x; Jackson C, 2013, J YOUTH ADOLESCENCE, V42, P1687, DOI 10.1007/s10964-012-9870-8; Janghorbani M, 2003, ADDICTION, V98, P215, DOI 10.1046/j.1360-0443.2003.00268.x; Komro KA, 2007, ADDICTION, V102, P1597, DOI 10.1111/j.1360-0443.2007.01941.x; Lee E, 1996, CHINESE FAMILIES ETH, P302; Li R, 2013, 2011 12 SURVEY DRUG; Mares SHW, 2011, ADDICT BEHAV, V36, P209, DOI 10.1016/j.addbeh.2010.10.013; Niyonsenga T, 2010, J PSYCHOACTIVE DRUGS, V42, P457; OMALLEY SS, 1986, J STUD ALCOHOL, V47, P433, DOI 10.15288/jsa.1986.47.433; Sandberg JF, 2001, DEMOGRAPHY, V38, P423, DOI 10.1353/dem.2001.0031; Spijkerman R, 2008, EUR ADDICT RES, V14, P26, DOI 10.1159/000110408; STAMPFER MJ, 1988, NEW ENGL J MED, V319, P267, DOI 10.1056/NEJM198808043190503; STRUNIN L, 1992, INT J ADDICT, V27, P129, DOI 10.3109/10826089209068734; Swahn MH, 2004, ADDICT BEHAV, V29, P959, DOI 10.1016/j.addbeh.2004.02.043; van der Vorst H, 2005, ADDICTION, V100, P1464, DOI 10.1111/j.1360-0443.2005.01193.x; Wang MP, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2013-002740; Ward BM, 2011, DRUG ALCOHOL REV, V30, P338, DOI 10.1111/j.1465-3362.2010.00228.x; Wardle J, 2003, J EPIDEMIOL COMMUN H, V57, P440, DOI 10.1136/jech.57.6.440; YAU OHM, 1988, EUR J MARKETING, V22, P44, DOI 10.1108/EUM0000000005285	32	6	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2015	10	3							e0119554	10.1371/journal.pone.0119554	http://dx.doi.org/10.1371/journal.pone.0119554			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CE9BN	25786105	Green Published, gold			2022-12-27	WOS:000352138500111
J	Frost, SHL; Frayo, SL; Miller, BW; Orozco, JJ; Booth, GC; Hylarides, MD; Lin, YK; Green, DJ; Gopal, AK; Pagel, JM; Back, TA; Fisher, DR; Press, OW				Frost, Sofia H. L.; Frayo, Shani L.; Miller, Brian W.; Orozco, Johnnie J.; Booth, Garrett C.; Hylarides, Mark D.; Lin, Yukang; Green, Damian J.; Gopal, Ajay K.; Pagel, John M.; Back, Tom A.; Fisher, Darrell R.; Press, Oliver W.			Comparative Efficacy of Lu-177 and Y-90 for Anti-CD20 Pretargeted Radioimmunotherapy in Murine Lymphoma Xenograft Models	PLOS ONE			English	Article							B-CELL LYMPHOMAS; STREPTAVIDIN FUSION PROTEIN; NON-HODGKIN-LYMPHOMA; MONOCLONAL-ANTIBODY; PHASE I/II; INTRAPERITONEAL RADIOIMMUNOTHERAPY; OVARIAN-CANCER; MOUSE MODEL; THERAPY; TUMORS	Purpose Pretargeted radioimmunotherapy (PRIT) is a multi-step method of selectively delivering high doses of radiotherapy to tumor cells while minimizing exposure to surrounding tissues. Yttrium-90 (Y-90) and lutetium-177 (Lu-177) are two of the most promising beta-particle emitting radionuclides used for radioimmunotherapy, which despite having similar chemistries differ distinctly in terms of radiophysical features. These differences may have important consequences for the absorbed dose to tumors and normal organs. Whereas Y-90 has been successfully applied in a number of preclinical and clinical radioimmunotherapy settings, there have been few published pretargeting studies with Lu-177. We therefore compared the therapeutic potential of targeting either Y-90 or Lu-177 to human B-cell lymphoma xenografts in mice. Methods Parallel experiments evaluating the biodistribution, imaging, dosimetry, therapeutic efficacy, and toxicity were performed in female athymic nude mice bearing either Ramos (Burkitt lymphoma) or Granta (mantle cell lymphoma) xenografts, utilizing an anti-CD20 antibody-streptavidin conjugate (1F5-SA) and an Y-90- or Lu-177-labeled 1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid (DOTA)-biotin second step reagent. Results The two radionuclides displayed comparable biodistributions in tumors and normal organs; however, the absorbed radiation dose delivered to tumor was more than twice as high for Y-90 (1.3 Gy/MBq) as for Lu-177 (0.6 Gy/MBq). More importantly, therapy with Y-90-DOTA-biotin was dramatically more effective than with Lu-177-DOTA-biotin, with 100% of Ramos xenograft-bearing mice cured with 37 MBq Y-90, whereas 0% were cured using identical amounts of Lu-177-DOTA-biotin. Similar results were observed in mice bearing Granta xenografts, with 80% of the mice cured with Y-90-PRIT and 0% cured with 177Lu-PRIT. Toxicities were comparable with both isotopes. Conclusion Y-90 was therapeutically superior to 177Lu for streptavidin-biotin PRIT approaches in these human lymphoma xenograft models.	[Frost, Sofia H. L.; Frayo, Shani L.; Orozco, Johnnie J.; Booth, Garrett C.; Hylarides, Mark D.; Lin, Yukang; Green, Damian J.; Gopal, Ajay K.; Pagel, John M.; Press, Oliver W.] Fred Hutchinson Canc Res Ctr, Div Clin Res, Seattle, WA 98104 USA; [Miller, Brian W.] Pacific Northwest Natl Lab, Richland, WA USA; [Miller, Brian W.] Univ Arizona, Coll Opt Sci, Tucson, AZ USA; [Green, Damian J.; Gopal, Ajay K.; Pagel, John M.; Press, Oliver W.] Univ Washington, Dept Med, Seattle, WA USA; [Green, Damian J.; Gopal, Ajay K.; Pagel, John M.; Press, Oliver W.] Univ Washington, Dept Bioengn, Seattle, WA 98195 USA; [Back, Tom A.] Univ Gothenburg, Sahlgrenska Acad, Gothenburg, Sweden; [Fisher, Darrell R.] Dade Moeller Hlth Grp, Richland, WA USA	Fred Hutchinson Cancer Center; United States Department of Energy (DOE); Pacific Northwest National Laboratory; University of Arizona; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Gothenburg	Frost, SHL (corresponding author), Fred Hutchinson Canc Res Ctr, Div Clin Res, 1124 Columbia St, Seattle, WA 98104 USA.	sfrost@fredhutch.org		Back, Tom/0000-0002-3375-9473; Gopal, Ajay/0000-0003-3023-6834; Press, Oliver/0000-0002-3147-8037	Walker Immunotherapy Research Fellowship from Doug and Maggie Walker; David & Patricia Giuliani Family Foundation; Geoffrey Sally White; Wyner-Stokes Foundation; Frederick Kullman Memorial Fund; National Cancer Institute [P01CA044991, R01CA076287, R01CA138720, R01CA172582, R01CA136639, R01CA154897, R01CA109663, K08CA151682]; Dade Moeller Health Group; NATIONAL CANCER INSTITUTE [R01CA154897, R01CA076287, R01CA109663, R01CA136639, P01CA044991, R01CA138720, K08CA151682] Funding Source: NIH RePORTER	Walker Immunotherapy Research Fellowship from Doug and Maggie Walker; David & Patricia Giuliani Family Foundation; Geoffrey Sally White; Wyner-Stokes Foundation; Frederick Kullman Memorial Fund; National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Dade Moeller Health Group; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Research reported in this manuscript was supported by a Walker Immunotherapy Research Fellowship from Doug and Maggie Walker (SHLF); by the David & Patricia Giuliani Family Foundation (OWP); by Geoffrey & Sally White (OWP); by the Wyner-Stokes Foundation (OWP); by the Frederick Kullman Memorial Fund (JMP); and by the National Cancer Institute under award numbers P01CA044991 (OWP, MDH, YL, AKG, JMP, DRF), R01CA076287 (OWP, SLF, GCB, MDH, YL, JMP), R01CA138720 (JMP, JJO), R01CA172582 (JMP), R01CA136639 (OWP, YL), R01CA154897 (OWP, DJG), R01CA109663 (OWP, SLF, GCB, MDH, YL, JMP), and K08CA151682 (DJG). Dade Moeller Health Group provided support in the form of salary for author DRF, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific role of this author is articulated in the 'author contributions' section.	Alvarez RD, 1997, GYNECOL ONCOL, V65, P94, DOI 10.1006/gyno.1996.4577; Axworthy DB, 2000, P NATL ACAD SCI USA, V97, P1802, DOI 10.1073/pnas.97.4.1802; Axworthy DB, 1999, US patent, Patent No. [5 955 605, 5955605]; Bernhardt P, 2001, ACTA ONCOL, V40, P602; Buchsbaum DJ, 2005, CLIN CANCER RES, V11, P8180, DOI 10.1158/1078-0432.CCR-05-0607; Donnou Sabrina, 2012, Adv Hematol, V2012, P701704, DOI 10.1155/2012/701704; Ferlay J, 2013, GLOBOCAN 2012 V1 0 C; Forrer F, 2005, J NUCL MED, V46, P1310; Forrer F, 2013, J NUCL MED, V54, P1045, DOI 10.2967/jnumed.112.115170; Goldenberg DM, 2006, J CLIN ONCOL, V24, P823, DOI 10.1200/JCO.2005.03.8471; Gopal AK, 2003, BLOOD, V102, P2351, DOI 10.1182/blood-2003-02-0622; HUI TE, 1994, CANCER, V73, P951; HUMM JL, 1990, J NUCL MED, V31, P75; Jadayel DM, 1997, LEUKEMIA, V11, P64, DOI 10.1038/sj.leu.2400555; Kaminski MS, 2000, BLOOD, V96, P1259, DOI 10.1182/blood.V96.4.1259.h8001259_1259_1266; KLEIN G, 1975, INTERVIROLOGY, V5, P319, DOI 10.1159/000149930; Lewis MR, 2004, NUCL MED BIOL, V31, P213, DOI 10.1016/j.nucmedbio.2003.08.004; Meredith RF, 1996, J NUCL MED, V37, P1491; Miller BW, 2014, NUCL INSTRUMENTS M A; Miller WH, 2005, CANCER BIOTHER RADIO, V20, P436, DOI 10.1089/cbr.2005.20.436; Mohsin H, 2011, BIOCONJUGATE CHEM, V22, P2444, DOI 10.1021/bc200258x; Mulligan T, 1995, CLIN CANCER RES, V1, P1447; NCRP, 1985, HDB RAD MEAS PROC, Vxvi; Paganelli G, 1999, EUR J NUCL MED, V26, P348, DOI 10.1007/s002590050397; Pagel JM, 2003, BLOOD, V101, P2340, DOI 10.1182/blood-2002-03-0874; Pagel JM, 2006, BLOOD, V108, P328, DOI 10.1182/blood-2005-11-4327; Pagel JM, 2009, BLOOD, V113, P4903, DOI 10.1182/blood-2008-11-187401; Persson M, 2007, CANCER RES, V67, P326, DOI 10.1158/0008-5472.CAN-06-2363; PRESS OW, 1993, NEW ENGL J MED, V329, P1219, DOI 10.1056/NEJM199310213291702; Press OW, 2000, BLOOD, V96, P2934; Press OW, 2001, BLOOD, V98, P2535, DOI 10.1182/blood.V98.8.2535; SCHLOM J, 1991, CANCER RES, V51, P2889; Schoffelen R, 2010, J NUCL MED, V51, P1780, DOI 10.2967/jnumed.110.079376; Seidl C, 2011, EUR J NUCL MED MOL I, V38, P312, DOI 10.1007/s00259-010-1639-2; Sharkey RM, 2003, CANCER RES, V63, P354; Stein R, 2001, J NUCL MED, V42, P967; Subbiah K, 2003, J NUCL MED, V44, P437; Uusijarvi H, 2006, J NUCL MED, V47, P807; Walter RB, 2010, CANCER BIOTHER RADIO, V25, P125, DOI 10.1089/cbr.2010.0759; Witzig TE, 2002, J CLIN ONCOL, V20, P2453, DOI 10.1200/JCO.2002.11.076	40	14	14	2	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2015	10	3							e0120561	10.1371/journal.pone.0120561	http://dx.doi.org/10.1371/journal.pone.0120561			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9BN	25785845	gold, Green Submitted, Green Published			2022-12-27	WOS:000352138500181
J	Lv, XF; Liu, K; Qiu, YW; Cai, PQ; Li, J; Jiang, GH; Deng, YJ; Zhang, XL; Wu, PH; Xie, CM; Wen, G				Lv, Xiao-Fei; Liu, Kai; Qiu, Ying-Wei; Cai, Pei-Qiang; Li, Jing; Jiang, Gui-Hua; Deng, Yan-Jia; Zhang, Xue-Lin; Wu, Pei-Hong; Xie, Chuan-Miao; Wen, Ge			Anomalous Gray Matter Structural Networks in Patients with Hepatitis B Virus-Related Cirrhosis without Overt Hepatic Encephalopathy	PLOS ONE			English	Article							HBV-RELATED CIRRHOSIS; CORTICAL NETWORKS; BRAIN ACTIVITY; ORGANIZATION; VOXEL; ABNORMALITIES	Background and Purpose Increasing evidence suggests that cirrhosis may affect the connectivity among different brain regions in patients before overt hepatic encephalopathy (OHE) occurs. However, there has been no study investigating the structural reorganization of these altered connections at the network level. The primary focus of this study was to investigate the abnormal topological organization of the structural network in patients with hepatitis B virus-related cirrhosis (HBV-RC) without OHE using structural MRI. Methods Using graph theoretical analysis, we compared the global and regional topological properties of gray matter structural networks between 28 patients with HBV-RC without OHE and 30 age-, sex-and education-matched healthy controls. The structural correlation networks were constructed for the two groups based on measures of gray matter volume. Results The brain network of the HBV-RC group exhibited a significant decrease in the clustering coefficient and reduced small-worldness at the global level across a range of network densities. Regionally, brain areas with altered nodal degree/betweenness centrality were observed predominantly in association cortices (frontal and temporal regions) (p < 0.05, uncorrected), including a significantly decreased nodal degree in the inferior temporal gyrus (p < 0.001, uncorrected). Furthermore, the HBV-RC group exhibited a loss of association hubs and the emergence of an increased number of non-association hubs compared with the healthy controls. Conclusion The results of this large-scale gray matter structural network study suggest reduced topological organization efficiency in patients with HBV-RC without OHE. Our findings provide new insight concerning the mechanisms of neurobiological reorganization in the HBV-RC brain from a network perspective.	[Lv, Xiao-Fei; Cai, Pei-Qiang; Li, Jing; Wu, Pei-Hong; Xie, Chuan-Miao] Sun Yat Sen Univ, Ctr Canc, Imaging & Intervent Radiol, Guangzhou 510275, Guangdong, Peoples R China; [Lv, Xiao-Fei; Cai, Pei-Qiang; Li, Jing; Wu, Pei-Hong; Xie, Chuan-Miao] State Key Lab Oncol South China, Guangzhou, Guangdong, Peoples R China; [Lv, Xiao-Fei; Cai, Pei-Qiang; Li, Jing; Wu, Pei-Hong; Xie, Chuan-Miao] Collaborat Innovat Ctr Canc Med, Guangzhou, Guangdong, Peoples R China; [Liu, Kai; Deng, Yan-Jia; Zhang, Xue-Lin; Wen, Ge] Southern Medial Univ, Nanfang Hosp, Med Imaging Ctr, Guangzhou, Guangdong, Peoples R China; [Qiu, Ying-Wei] Gannan Med Univ, Affiliated Hosp 1, Dept Med Imaging, Ganzhou, Peoples R China; [Qiu, Ying-Wei; Jiang, Gui-Hua] Guangdong 2 Prov Peoples Hosp, Dept Med Imaging, Guangzhou, Guangdong, Peoples R China	Sun Yat Sen University; State Key Lab Oncology South China; Southern Medical University - China; Gannan Medical University	Xie, CM (corresponding author), Sun Yat Sen Univ, Ctr Canc, Imaging & Intervent Radiol, Guangzhou 510275, Guangdong, Peoples R China.	xiecm_image@163.com; wenge67@aliyun.com			Natural Science Foundation of China [81401399]; Medical Scientific Research Foundation of Guangdong Province [B2014162]; Science and Technology Planning Project of Guangdong Province, China [2010B031600226]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Medical Scientific Research Foundation of Guangdong Province; Science and Technology Planning Project of Guangdong Province, China	This work was supported by the grants from the Natural Science Foundation of China (Grant No. 81401399 for XFL), Medical Scientific Research Foundation of Guangdong Province (Grant No. B2014162 for XFL) and Science and Technology Planning Project of Guangdong Province (Grant No. 2010B031600226 for CMX), China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander-Bloch A, 2013, NAT REV NEUROSCI, V14, P322, DOI 10.1038/nrn3465; Ashburner J, 2007, NEUROIMAGE, V38, P95, DOI 10.1016/j.neuroimage.2007.07.007; Bassett DS, 2008, J NEUROSCI, V28, P9239, DOI 10.1523/JNEUROSCI.1929-08.2008; Bassett DS, 2006, NEUROSCIENTIST, V12, P512, DOI 10.1177/1073858406293182; Buckner RL, 2008, ANN NY ACAD SCI, V1124, P1, DOI 10.1196/annals.1440.011; Bullmore ET, 1999, IEEE T MED IMAGING, V18, P32, DOI 10.1109/42.750253; Burra P, 2004, EUR J GASTROEN HEPAT, V16, P885, DOI 10.1097/00042737-200409000-00012; Chen HJ, 2012, EUR J RADIOL, V81, P2463, DOI 10.1016/j.ejrad.2011.10.008; Cordoba J, 2011, J HEPATOL, V54, P1030, DOI 10.1016/j.jhep.2010.11.015; FREEMAN LC, 1977, SOCIOMETRY, V40, P35, DOI 10.2307/3033543; Guan R, 2011, INT J HEPATOL, V2011, DOI 10.4061/2011/918017; Guevara M, 2011, J HEPATOL, V55, P564, DOI 10.1016/j.jhep.2010.12.008; He Y, 2008, J NEUROSCI, V28, P4756, DOI 10.1523/JNEUROSCI.0141-08.2008; He Y, 2007, CEREB CORTEX, V17, P2407, DOI 10.1093/cercor/bhl149; Hosseini SMH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040709; Hsu TW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035266; Iwasa M, 2012, METAB BRAIN DIS, V27, P551, DOI 10.1007/s11011-012-9314-x; Kaiser M, 2006, PLOS COMPUT BIOL, V2, P805, DOI 10.1371/journal.pcbi.0020095; Kravitz DJ, 2011, NAT REV NEUROSCI, V12, P217, DOI 10.1038/nrn3008; Latora V, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.198701; Lee HW, 2000, NEUROLOGY, V54, P849, DOI 10.1212/WNL.54.4.849; Li YY, 2004, WORLD J GASTROENTERO, V10, P2397; Lv XF, 2013, METAB BRAIN DIS, V28, P485, DOI 10.1007/s11011-013-9420-4; Lv XF, 2013, LIVER INT, V33, P375, DOI 10.1111/liv.12096; Maslov S, 2002, SCIENCE, V296, P910, DOI 10.1126/science.1065103; Matsusue E, 2005, AM J NEURORADIOL, V26, P347; Montoliu C, 2012, NEUROIMAGE, V61, P1165, DOI 10.1016/j.neuroimage.2012.03.041; Moriwaki H, 2010, J GASTROEN HEPATOL, V25, P858, DOI 10.1111/j.1440-1746.2010.06242.x; Qi RF, 2013, EUR RADIOL, V23, P3370, DOI 10.1007/s00330-013-2963-2; Qi RF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041376; Qi RF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037400; Randolph C, 2009, LIVER INT, V29, P629, DOI 10.1111/j.1478-3231.2009.02009.x; Rubinov M, 2010, NEUROIMAGE, V52, P1059, DOI 10.1016/j.neuroimage.2009.10.003; Singh MK, 2013, BIOL PSYCHIAT, V74, P777, DOI 10.1016/j.biopsych.2013.03.005; Tao R, 2013, EUR J RADIOL, V82, pE715, DOI 10.1016/j.ejrad.2013.07.029; Tzourio-Mazoyer N, 2002, NEUROIMAGE, V15, P273, DOI 10.1006/nimg.2001.0978; Wandell BA, 2007, NEURON, V56, P366, DOI 10.1016/j.neuron.2007.10.012; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; Weissenborn K, 2008, J HEPATOL, V49, P308, DOI 10.1016/j.jhep.2008.06.023; Wu K, 2012, HUM BRAIN MAPP, V33, P552, DOI 10.1002/hbm.21232; Zhang LJ, 2012, RADIOLOGY, V265, P528, DOI 10.1148/radiol.12120185; Zhang YC, 2012, SCHIZOPHR RES, V141, P109, DOI 10.1016/j.schres.2012.08.021; Zheng G, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/727452	43	5	5	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2015	10	3							e0119339	10.1371/journal.pone.0119339	http://dx.doi.org/10.1371/journal.pone.0119339			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9BN	25786256	Green Published, Green Submitted, gold			2022-12-27	WOS:000352138500097
J	Poluzzi, E; Raschi, E; Godman, B; Koci, A; Moretti, U; Kalaba, M; Wettermark, B; Sturkenboom, M; De Ponti, F				Poluzzi, Elisabetta; Raschi, Emanuel; Godman, Brian; Koci, Ariola; Moretti, Ugo; Kalaba, Marija; Wettermark, Bjorn; Sturkenboom, Miriam; De Ponti, Fabrizio			Pro-Arrhythmic Potential of Oral Antihistamines (H1): Combining Adverse Event Reports with Drug Utilization Data across Europe	PLOS ONE			English	Article							TORSADES-DE-POINTES; QT PROLONGATION; CETIRIZINE; LORATADINE; RISK; KETOCONAZOLE; FEXOFENADINE; BILASTINE; INTERVAL; CURRENTS	Background There is appreciable utilisation of antihistamines (H1) in European countries, either prescribed by physician and purchased by patients for self-medication. Terfenadine and astemizole underwent regulatory restrictions in '90 because of their cardiac toxicity, but only scarce clinical data are available on other antihistamines. Aim To investigate the pro-arrhythmic potential of antihistamines by combining safety reports of the FDA Adverse Event Reporting System (FAERS) with drug utilization data from 13 European Countries. Methods We identified signals of antihistamine arrhythmogenic potential by analyzing FAERS database for all cases of Torsades de Pointes (TdP), QT abnormalities (QTabn), ventricular arrhythmia (VA) and sudden cardiac death/cardiac arrest (SCD/CA). Number of cases >= 3 and disproportionality were used to define alert signals: TdP and QTabn identified stronger signals, whereas SCD/CA identified weaker signals. Drug utilization data from 2005 to 2010 were collected from administrative databases through health authorities and insurance. Results Antihistamines were reported in 109 cases of TdP/QT prolongation, 278 VA and 610 SCD/CA. Five agents resulted in stronger signals (cetirizine, desloratadine, diphenhydramine, fexofenadine, loratadine) and 6 in weaker signals (alimemazine, carbinoxamine, cyclizine, cyproeptadine, dexchlorpheniramine and doxylamine). Exposure to antihistamines with stronger signal was markedly different across European countries and was at least 40% in each Country. Cetirizine was > 29 Defined Daily Doses per 1000 inhabitants per day (DID) in Norway, desloratadine > 11 DID in France and loratadine > 9 DID in Sweden and Croatia. Drugs with weaker signals accounted for no more than 10% (in Sweden) and in most European countries their use was negligible. Conclusions Some second-generation antihistamines are associated with signal of torsadogenicity and largely used in most European countries. Although confirmation by analytical studies is required, regulators and clinicians should consider risk-minimisation activities. Also antihistamines without signal but with peculiar use in a few Countries (e.g., levocetirizine) or with increasing consumption (e.g., rupatadine) deserve careful surveillance.	[Poluzzi, Elisabetta; Raschi, Emanuel; Koci, Ariola; De Ponti, Fabrizio] Univ Bologna, Alma Mater Studiorum, Dept Med & Surg Sci, Bologna, Italy; [Godman, Brian; Wettermark, Bjorn] Karolinska Inst, Div Clin Pharmacol, Stockholm, Sweden; [Godman, Brian] Univ Strathclyde, Strathclyde Inst Pharm & Biomed Sci, Glasgow, Lanark, Scotland; [Moretti, Ugo] Univ Verona, Clin Pharmacol Unit, I-37100 Verona, Italy; [Kalaba, Marija] Republ Fund Hlth Insurance, Belgrade, Serbia; [Wettermark, Bjorn] Karolinska Univ Hosp, Ctr Pharmacoepidemiol, Stockholm, Sweden; [Wettermark, Bjorn] Cty Council, Stockholm, Sweden; [Sturkenboom, Miriam] Erasmus Univ, Med Ctr, Rotterdam, Netherlands	University of Bologna; Karolinska Institutet; University of Strathclyde; University of Verona; Karolinska Institutet; Karolinska University Hospital; Erasmus University Rotterdam; Erasmus MC	De Ponti, F (corresponding author), Univ Bologna, Alma Mater Studiorum, Dept Med & Surg Sci, Bologna, Italy.	fabrizio.deponti@unibo.it	Raschi, Emanuel/H-8821-2019; De Ponti, Fabrizio/H-8701-2019; Godman, Brian/R-8897-2019	Raschi, Emanuel/0000-0003-0487-7996; De Ponti, Fabrizio/0000-0002-0367-9595; Godman, Brian/0000-0001-6539-6972; POLUZZI, ELISABETTA/0000-0002-7209-0426; Sturkenboom, Miriam/0000-0003-1360-2388	European Community [241679]	European Community(European Commission)	The research leading to these results has received funding from the European Community's Seventh Framework Programme (FP7/2007-2013) under grant agreement no 241679 - the ARITMO project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antonelli D, 2005, ISRAEL MED ASSOC J, V7, P163; Atar S, 2003, PACE, V26, P785, DOI 10.1046/j.1460-9592.2003.00137.x; Bate A, 2009, PHARMACOEPIDEM DR S, V18, P427, DOI 10.1002/pds.1742; Caillet C, 2012, BRIT J CLIN PHARMACO, V74, P886, DOI 10.1111/j.1365-2125.2012.04262.x; Craig-McFeely PM, 2000, BRIT J GEN PRACT, V50, P148; de Abajo FJ, 1999, BRIT J CLIN PHARMACO, V47, P307; Dhar S, 2000, BRIT J DERMATOL, V142, P1260, DOI 10.1046/j.1365-2133.2000.03576.x; Donado E, 2010, BRIT J CLIN PHARMACO, V69, P401, DOI 10.1111/j.1365-2125.2009.03599.x; Garuoliene K, 2011, EXPERT REV PHARM OUT, V11, P343, DOI [10.1586/ERP.11.24, 10.1586/erp.11.24]; Graff C, 2012, CLIN DRUG INVEST, V32, P339, DOI 10.2165/11599270-000000000-00000; Grant JA, 2000, ALLERGY ASTHMA PROC, V21, P135, DOI 10.2500/108854100778149034; Hoffman KB, 2014, DRUG SAFETY, V37, P971, DOI 10.1007/s40264-014-0225-0; Hoffman KB, 2014, DRUG SAFETY, V37, P283, DOI 10.1007/s40264-014-0150-2; Hulhoven R, 2007, EUR J CLIN PHARMACOL, V63, P1011, DOI 10.1007/s00228-007-0366-5; Katchman AN, 2006, J PHARMACOL EXP THER, V316, P1098, DOI 10.1124/jpet.105.093393; Kosoglou T, 2000, BRIT J CLIN PHARMACO, V50, P581, DOI 10.1046/j.1365-2125.2000.00290.x; Lacerda AE, 1997, MOL PHARMACOL, V52, P314, DOI 10.1124/mol.52.2.314; Layton D, 2009, DRUG SAFETY, V32, P169, DOI 10.2165/00002018-200932020-00009; Pinto YM, 1999, LANCET, V353, P980, DOI 10.1016/S0140-6736(99)01009-0; Poluzzi E, 2012, DATA MINING APPLICATIONS IN ENGINEERING AND MEDICINE, P265, DOI 10.5772/50095; Poluzzi E, 2013, DRUG SAFETY, V36, P467, DOI 10.1007/s40264-013-0032-z; Poluzzi E, 2010, DRUG SAFETY, V33, P303, DOI 10.2165/11531850-000000000-00000; Raschi E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081208; Ravera S, 2009, EUR J CLIN PHARMACOL, V65, P1139, DOI 10.1007/s00228-009-0695-7; Renard S, 2005, ARCH MAL COEUR VAISS, V98, P157; Scherer CR, 2002, BRIT J PHARMACOL, V137, P892, DOI 10.1038/sj.bjp.0704873; Simons FER, 2011, J ALLERGY CLIN IMMUN, V128, P1139, DOI 10.1016/j.jaci.2011.09.005; Taglialatela M, 1998, MOL PHARMACOL, V54, P113, DOI 10.1124/mol.54.1.113; Tsuruoka S, 2006, CLIN PHARMACOL THER, V79, P389, DOI 10.1016/j.clpt.2005.12.302; Tyl B, 2012, J CLIN PHARMACOL, V52, P893, DOI 10.1177/0091270011407191; WHO, 2003, INTR DRUG UT RES	31	37	40	2	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2015	10	3							e0119551	10.1371/journal.pone.0119551	http://dx.doi.org/10.1371/journal.pone.0119551			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9BN	25785934	Green Accepted, Green Submitted, Green Published, gold			2022-12-27	WOS:000352138500110
J	Thacker, PC; Karunagaran, D				Thacker, Pooja Chandrakant; Karunagaran, Devarajan			Curcumin and Emodin Down-Regulate TGF-beta Signaling Pathway in Human Cervical Cancer Cells	PLOS ONE			English	Article							GROWTH-FACTOR-BETA; EPITHELIAL-MESENCHYMAL TRANSITION; HUMAN-PAPILLOMAVIRUS; BREAST-CANCER; TRANSCRIPTION FACTOR; GENE-EXPRESSION; MECHANISMS; ACTIVATION; MIGRATION; APOPTOSIS	Cervical cancer is the major cause of cancer related deaths in women, especially in developing countries and Human Papilloma Virus infection in conjunction with multiple deregulated signaling pathways leads to cervical carcinogenesis. TGF-beta signaling in later stages of cancer is known to induce epithelial to mesenchymal transition promoting tumor growth. Phytochemicals, curcumin and emodin, are effective as chemopreventive and chemotherapeutic compounds against several cancers including cervical cancer. The main objective of this work was to study the effect of curcumin and emodin on TGF-beta signaling pathway and its functional relevance to growth, migration and invasion in two cervical cancer cell lines, SiHa and HeLa. Since TGF-beta and Wnt/beta-catenin signaling pathways are known to cross talk having common downstream targets, we analyzed the effect of TGF-beta on beta-catenin (an important player in Wnt/beta-catenin signaling) and also studied whether curcumin and emodin modulate them. We observed that curcumin and emodin effectively down regulate TGF-beta signaling pathway by decreasing the expression of TGF-beta Receptor II, P-Smad3 and Smad4, and also counterbalance the tumorigenic effects of TGF-beta by inhibiting the TGF-beta-induced migration and invasion. Expression of downstream effectors of TGF-beta signaling pathway, cyclinD1, p21 and Pin1, was inhibited along with the down regulation of key mesenchymal markers (Snail and Slug) upon curcumin and emodin treatment. Curcumin and emodin were also found to synergistically inhibit cell population and migration in SiHa and HeLa cells. Moreover, we found that TGF-beta activates Wnt/beta-catenin signaling pathway in HeLa cells, and curcumin and emodin down regulate the pathway by inhibiting beta-catenin. Taken together our data provide a mechanistic basis for the use of curcumin and emodin in the treatment of cervical cancer.	[Thacker, Pooja Chandrakant; Karunagaran, Devarajan] Indian Inst Technol, Bhupat & Jyoti Mehta Sch Biosci, Dept Biotechnol, Madras 600036, Tamil Nadu, India	Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT) - Madras	Karunagaran, D (corresponding author), Indian Inst Technol, Bhupat & Jyoti Mehta Sch Biosci, Dept Biotechnol, Madras 600036, Tamil Nadu, India.	karuna@iitm.ac.in						Abbas T, 2009, NAT REV CANCER, V9, P400, DOI 10.1038/nrc2657; Arbyn M, 2011, ANN ONCOL, V22, P2675, DOI 10.1093/annonc/mdr015; Bakhshayesh M, 2012, CL LYMPH MYELOM LEUK, V12, P138, DOI 10.1016/j.clml.2011.12.001; BRAUN L, 1990, CANCER RES, V50, P7324; Burd EM, 2003, CLIN MICROBIOL REV, V16, P1, DOI 10.1128/CMR.16.1.1-17.2003; Carlson ME, 2008, NATURE, V454, P528, DOI 10.1038/nature07034; Chen Ting-fang, 2009, Zhong Xi Yi Jie He Xue Bao, V7, P59, DOI 10.3736/jcim20090109; Chen WC, 2013, J AGR FOOD CHEM, V61, P11817, DOI 10.1021/jf404092f; Chou TC, 2010, CANCER RES, V70, P440, DOI 10.1158/0008-5472.CAN-09-1947; COSSARIZZA A, 1993, BIOCHEM BIOPH RES CO, V197, P40, DOI 10.1006/bbrc.1993.2438; Dai M, 2013, BREAST CANCER RES, V15, DOI 10.1186/bcr3441; Datta R, 2013, J CANCER RES CLIN, V139, P563, DOI 10.1007/s00432-012-1352-6; Debata PR, 2013, GYNECOL ONCOL, V129, P145, DOI 10.1016/j.ygyno.2012.12.005; Donovan J, 2000, BREAST CANCER RES, V2, P116, DOI 10.1186/bcr43; Dyer BW, 2000, ANAL BIOCHEM, V282, P158, DOI 10.1006/abio.2000.4605; Fabregat I, 2014, CURR PHARM DESIGN, V20, P2934, DOI 10.2174/13816128113199990591; Fan DM, 2012, MOL BIOL REP, V39, P3925, DOI 10.1007/s11033-011-1171-x; Farrand L, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/890141; Florenes VA, 1996, ONCOGENE, V13, P2447; Geback T, 2009, BIOTECHNIQUES, V46, P265, DOI 10.2144/000113083; Gold LI, 1999, CRIT REV ONCOGENESIS, V10, P303; Gonzalez-Vallinas M, 2013, NUTR REV, V71, P585, DOI 10.1111/nure.12051; Gross A, 1999, GENE DEV, V13, P1899, DOI 10.1101/gad.13.15.1899; Guo JL, 2013, MOL CELL BIOCHEM, V382, P103, DOI 10.1007/s11010-013-1723-6; Hazelbag S, 2002, HUM PATHOL, V33, P1193, DOI 10.1053/hupa.2002.130109; Herbst Andreas, 2007, Methods Mol Biol, V361, P63; Hossain Dewan Md Sakib, 2012, Front Biosci (Schol Ed), V4, P335; Katsuno Y, 2013, CURR OPIN ONCOL, V25, P76, DOI 10.1097/CCO.0b013e32835b6371; Kitano A, 2007, INVEST OPHTH VIS SCI, V48, P5013, DOI 10.1167/iovs.07-0393; Kloth JN, 2005, CARCINOGENESIS, V26, P1493, DOI 10.1093/carcin/bgi110; Lee SH, 2001, INT J CANCER, V94, P500, DOI 10.1002/ijc.1494; Li Mu, 2013, Nan Fang Yi Ke Da Xue Xue Bao, V33, P1752; Li TF, 2006, J BIOL CHEM, V281, P21296, DOI 10.1074/jbc.M600514200; Li Yu, 2011, Zhongguo Zhong Xi Yi Jie He Za Zhi, V31, P1224; Liu A, 2011, ONCOL REP, V26, P81, DOI 10.3892/or.2011.1257; Lopez-Munoz H, 2013, ARCH GYNECOL OBSTET, V287, P755, DOI 10.1007/s00404-012-2621-y; Lou K X, 2001, Zhongguo Zhong Xi Yi Jie He Za Zhi, V21, P433; MacDonald BT, 2009, DEV CELL, V17, P9, DOI 10.1016/j.devcel.2009.06.016; Maliekal TT, 2004, J BIOL CHEM, V279, P36287, DOI 10.1074/jbc.M404568200; Maliekal TT, 2003, ONCOGENE, V22, P4889, DOI 10.1038/sj.onc.1206806; Massague J, 2000, GENE DEV, V14, P627; Matsuura I, 2010, J BIOL CHEM, V285, P1754, DOI 10.1074/jbc.M109.063826; Medici D, 2008, MOL BIOL CELL, V19, P4875, DOI 10.1091/mbc.E08-05-0506; Mo N, 2012, ASIAN PAC J CANCER P, V13, P5709, DOI 10.7314/APJCP.2012.13.11.5709; Moustakas A, 2002, IMMUNOL LETT, V82, P85, DOI 10.1016/S0165-2478(02)00023-8; Nakano A, 2009, J BIOL CHEM, V284, P6109, DOI 10.1074/jbc.M804659200; Nakao A, 1997, EMBO J, V16, P5353, DOI 10.1093/emboj/16.17.5353; Noordhuis MG, 2011, CLIN CANCER RES, V17, P1317, DOI 10.1158/1078-0432.CCR-10-2320; Nyati S, 2011, CLIN CANCER RES, V17, P7424, DOI 10.1158/1078-0432.CCR-11-1248; O'Brien J, 2000, EUR J BIOCHEM, V267, P5421, DOI 10.1046/j.1432-1327.2000.01606.x; Ok S, 2012, IMMUNOPHARM IMMUNOT, V34, P768, DOI 10.3109/08923973.2012.654494; Peinado H, 2003, J BIOL CHEM, V278, P21113, DOI 10.1074/jbc.M211304200; Perez-Plasencia Carlos, 2008, Int Arch Med, V1, P10, DOI 10.1186/1755-7682-1-10; Pooja T, 2014, EUR J PHARMACOL, V742, P55, DOI 10.1016/j.ejphar.2014.08.028; Prusty BK, 2005, INT J CANCER, V113, P951, DOI 10.1002/ijc.20668; Rao Cui, 2013, Zhejiang Da Xue Xue Bao Yi Xue Ban, V42, P591; Robson CN, 1999, J ENDOCRINOL, V160, P257, DOI 10.1677/joe.0.1600257; Roy M, 2014, ASIAN PAC J CANCER P, V15, P1403, DOI 10.7314/APJCP.2014.15.3.1403; Shehzad A, 2010, ARCH PHARM, V343, P489, DOI 10.1002/ardp.200900319; Singh M, 2011, MOL CELL BIOCHEM, V347, P1, DOI 10.1007/s11010-010-0606-3; Srinivas G, 2003, EUR J PHARMACOL, V473, P117, DOI 10.1016/S0014-2999(03)01976-9; Sun XD, 2013, ONCOL REP, V29, P2401, DOI 10.3892/or.2013.2385; Tang T, 2007, EUR J PHARMACOL, V567, P177, DOI 10.1016/j.ejphar.2007.02.033; Teng ZH, 2007, BIOSCI BIOTECH BIOCH, V71, P1636, DOI 10.1271/bbb.70025; Veeman MT, 2003, CURR BIOL, V13, P680, DOI 10.1016/S0960-9822(03)00240-9; Wang YX, 2013, CANCER CELL INT, V13, DOI 10.1186/1475-2867-13-71; Wei WT, 2013, ONCOL REP, V30, P2555, DOI 10.3892/or.2013.2741; Wendt MK, 2012, CELL TISSUE RES, V347, P85, DOI 10.1007/s00441-011-1199-1; WOODWORTH CD, 1990, J VIROL, V64, P4767, DOI 10.1128/JVI.64.10.4767-4775.1990; Xu J, 2009, CELL RES, V19, P156, DOI 10.1038/cr.2009.5; Yi JY, 2002, EUR J CELL BIOL, V81, P457, DOI 10.1078/0171-9335-00265; Yoysungnoen-Chintana P, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/817972; Zawel L, 1998, MOL CELL, V1, P611, DOI 10.1016/S1097-2765(00)80061-1; ZerfassThome K, 1996, ONCOGENE, V13, P2323	74	71	77	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2015	10	3							e0120045	10.1371/journal.pone.0120045	http://dx.doi.org/10.1371/journal.pone.0120045			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9BN	25786122	Green Submitted, Green Published, gold			2022-12-27	WOS:000352138500151
J	Tomioka, H; Yamagata, B; Kawasaki, S; Pu, SH; Iwanami, A; Hirano, J; Nakagome, K; Mimura, M				Tomioka, Hiroi; Yamagata, Bun; Kawasaki, Shingo; Pu, Shenghong; Iwanami, Akira; Hirano, Jinichi; Nakagome, Kazuyuki; Mimura, Masaru			A Longitudinal Functional Neuroimaging Study in Medication-Naive Depression after Antidepressant Treatment	PLOS ONE			English	Article							NEAR-INFRARED SPECTROSCOPY; GRAY-MATTER REDUCTION; VERBAL FLUENCY TASK; MAJOR DEPRESSION; FOLLOW-UP; PREFRONTAL ACTIVATION; EMOTION REGULATION; BIPOLAR DISORDER; DSM-IV; BRAIN	Recent studies have indicated the potential clinical use of near infrared spectroscopy (NIRS) as a tool in assisting the diagnosis of major depressive disorder (MDD); however, it is still unclear whether NIRS signal changes during cognitive task are state-or trait-dependent, and whether NIRS could be a neural predictor of treatment response. Therefore, we conducted a longitudinal study to explore frontal haemodynamic changes following antidepressant treatment in medication-naive MDD using 52-channel NIRS. This study included 25 medication-naive individuals with MDD and 62 healthy controls (HC). We performed NIRS scans before and after antidepressant treatment and measured changes of [oxy-Hb] activation during a verbal fluency task (VFT) following treatment. Individuals with MDD showed significantly decreased [oxy-Hb] values during a VFT compared with HC in the bilateral frontal and temporal cortices at baseline. There were no [oxy-Hb] changes between pre- and post-antidepressant treatment time points in the MDD cohort despite significant improvement in depressive symptoms. There was a significant association between mean [oxy-Hb] values during a VFT at baseline and improvement in depressive symptoms following treatment in the bilateral inferior frontal and middle temporal gyri in MDD. These findings suggest that hypofrontality response to a VFT may represent a potential trait marker for depression rather than a state marker. Moreover, the correlation analysis indicates that the NIRS signals before the initiation of treatment may be a biological marker to predict patient's clinical response to antidepressant treatment. The present study provides further evidence to support a potential application of NIRS for the diagnosis and treatment of depression.	[Tomioka, Hiroi; Yamagata, Bun; Iwanami, Akira] Showa Univ, Sch Med, Dept Psychiat, Tokyo 1578577, Japan; [Yamagata, Bun; Hirano, Jinichi; Mimura, Masaru] Keio Univ, Sch Med, Dept Neuropsychiat, Tokyo 1608582, Japan; [Kawasaki, Shingo] Hitachi Med Corp, Applicat Dev Off, Chiba 2770804, Japan; [Pu, Shenghong; Nakagome, Kazuyuki] Tottori Univ, Fac Med, Dept Brain & Neurosci, Div Neuropsychiat, Tottori 6838504, Japan; [Nakagome, Kazuyuki] Natl Ctr Neurol & Psychiat, Tokyo 1878551, Japan	Showa University; Keio University; Hitachi Limited; Tottori University; National Center for Neurology & Psychiatry - Japan	Yamagata, B (corresponding author), Showa Univ, Sch Med, Dept Psychiat, Tokyo 1578577, Japan.	yamagata@a6.keio.jp		Nakagome, Kazuyuki/0000-0003-2919-8180	Intramural Research Grant [23-10]; Hitachi Medical Corporation	Intramural Research Grant; Hitachi Medical Corporation	This study was supported by the Intramural Research Grant (23-10) for Neurological and Psychiatric Disorders of NCNP (National Center of Neurology and Psychiatry). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Hitachi Medical Corporation provided support in the form of a salary for author SK, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific role of this author is articulated in the 'author contributions' section.	American Psychiatric Association, 2000, DIAGN STAT MAN MENT; [Anonymous], 1985, Am J Psychiatry, V142, P469; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bora E, 2012, PSYCHOL MED, V42, P671, DOI 10.1017/S0033291711001668; Delaveau P, 2011, J AFFECT DISORDERS, V130, P66, DOI 10.1016/j.jad.2010.09.032; Drevets WC, 2002, EUR NEUROPSYCHOPHARM, V12, P527, DOI 10.1016/S0924-977X(02)00102-5; Du MY, 2012, PROG NEURO-PSYCHOPH, V36, P11, DOI 10.1016/j.pnpbp.2011.09.014; Elliott R, 2012, ARCH GEN PSYCHIAT, V69, P37, DOI 10.1001/archgenpsychiatry.2011.139; Fitzgerald PB, 2008, HUM BRAIN MAPP, V29, P683, DOI 10.1002/hbm.20426; FRANK E, 1991, ARCH GEN PSYCHIAT, V48, P851, DOI 10.1001/archpsyc.1991.01810330075011; Fu CHY, 2003, GUIDE NEUROIMAGING P, P131; GELLER B, 1994, J AM ACAD CHILD PSY, V33, P461, DOI 10.1097/00004583-199405000-00003; Geller B, 2001, AM J PSYCHIAT, V158, P125, DOI 10.1176/appi.ajp.158.1.125; Heller AS, 2013, JAMA PSYCHIAT, V70, P1181, DOI 10.1001/jamapsychiatry.2013.2430; Hulvershorn LA, 2011, BRAIN IMAGING BEHAV, V5, P307, DOI 10.1007/s11682-011-9134-3; Kameyama M, 2006, NEUROIMAGE, V29, P172, DOI 10.1016/j.neuroimage.2005.07.025; Kanske P, 2012, NEUROIMAGE, V61, P686, DOI 10.1016/j.neuroimage.2012.03.089; Kessler RC, 2005, ARCH GEN PSYCHIAT, V62, P593, DOI 10.1001/archpsyc.62.6.593; Lee HY, 2011, J AFFECT DISORDERS, V133, P128, DOI 10.1016/j.jad.2011.04.006; Matsuo K, 2002, PSYCHOL MED, V32, P1029, DOI 10.1017/S0033291702005974; Mayberg HS, 2003, BRIT MED BULL, V65, P193, DOI 10.1093/bmb/65.1.193; Mayberg HS, 2000, BIOL PSYCHIAT, V48, P830, DOI 10.1016/S0006-3223(00)01036-2; Obrig H, 2003, J CEREBR BLOOD F MET, V23, P1, DOI 10.1097/01.WCB.0000043472.45775.29; Okada G, 2009, PSYCHIAT CLIN NEUROS, V63, P423, DOI 10.1111/j.1440-1819.2009.01952.x; Okamoto M, 2004, NEUROIMAGE, V21, P99, DOI 10.1016/j.neuroimage.2003.08.026; Otsubo T, 2005, PSYCHIAT CLIN NEUROS, V59, P517, DOI 10.1111/j.1440-1819.2005.01408.x; Peng J, 2011, EUR J RADIOL, V80, P395, DOI 10.1016/j.ejrad.2010.04.006; Pu SH, 2008, PSYCHIAT CLIN NEUROS, V62, P728, DOI 10.1111/j.1440-1819.2008.01882.x; RAO U, 1995, J AM ACAD CHILD PSY, V34, P566, DOI 10.1097/00004583-199505000-00009; Rao Uma, 2009, Dialogues Clin Neurosci, V11, P45; Ritchey M, 2011, J PSYCHIATR RES, V45, P577, DOI 10.1016/j.jpsychires.2010.09.007; Schecklmann M, 2008, NEUROIMAGE, V43, P147, DOI 10.1016/j.neuroimage.2008.06.032; SHEA MT, 1992, ARCH GEN PSYCHIAT, V49, P782, DOI 10.1001/archpsyc.1992.01820100026006; Sheehan DV, 1998, J CLIN PSYCHIAT, V59, P34, DOI 10.4088/JCP.09m05305whi; Smoski MJ, 2013, J AFFECT DISORDERS, V151, P171, DOI 10.1016/j.jad.2013.05.073; Strangman G, 2002, NEUROIMAGE, V17, P719, DOI 10.1006/nimg.2002.1227; Suto T, 2004, BIOL PSYCHIAT, V55, P501, DOI 10.1016/j.biopsych.2003.09.008; Takizawa R, 2014, NEUROIMAGE, V85, P498, DOI 10.1016/j.neuroimage.2013.05.126; Tsuzuki D, 2007, NEUROIMAGE, V34, P1506, DOI 10.1016/j.neuroimage.2006.10.043; Usami M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086290; Wagner G, 2008, J PSYCHIATR NEUROSCI, V33, P199; Walsh ND, 2007, BIOL PSYCHIAT, V62, P1236, DOI 10.1016/j.biopsych.2006.12.022; Zhang HJ, 2015, PSYCHIAT CLIN NEUROS, V69, P22, DOI 10.1111/pcn.12209; Zhang JR, 2011, BIOL PSYCHIAT, V70, P334, DOI 10.1016/j.biopsych.2011.05.018; Zhong MT, 2011, BIOL PSYCHOL, V88, P233, DOI 10.1016/j.biopsycho.2011.08.007	45	46	48	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2015	10	3							e0120828	10.1371/journal.pone.0120828	http://dx.doi.org/10.1371/journal.pone.0120828			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9BN	25786240	Green Submitted, gold, Green Published			2022-12-27	WOS:000352138500193
J	Xie, LN; Guo, HY; Gabler, CA; Li, QF; Ma, CC				Xie, Li-Na; Guo, Hong-Yu; Gabler, Christopher A.; Li, Qing-Fang; Ma, Cheng-Cang			Changes in Spatial Patterns of Caragana stenophylla along a Climatic Drought Gradient on the Inner Mongolian Plateau	PLOS ONE			English	Article							SOIL SEED BANK; DESERT; DYNAMICS; ESTABLISHMENT; FACILITATION; VEGETATION; PLANT	Few studies have investigated the influence of water availability on plant population spatial patterns. We studied changes in the spatial patterns of Caragana stenophylla along a climatic drought gradient within the Inner Mongolian Plateau, China. We examined spatial patterns, seed density, "nurse effects" of shrubs on seedlings, transpiration rates and water use efficiency (WUE) of C. stenophylla across semi-arid, arid, and intensively arid zones. Our results showed that patches of C. stenophylla populations shifted from a random to a clumped spatial pattern towards drier environments. Seed density and seedling survival rate of C. stenophylla decreased from the semi-arid zone to the intensively arid zone. Across the three zones, there were more C. stenophylla seeds and seedlings underneath shrub canopies than outside shrub canopies; and in the intensively arid zone, there were almost no seeds or seedlings outside shrub canopies. Transpiration rates of outer-canopy leaves and WUE of both outer-canopy and inner-canopy leaves increased from the semi-arid zone to the intensively arid zone. In the intensively arid zone, transpiration rates and WUE of inner-canopy leaves were significantly lower and higher, respectively, than those of outer-canopy leaves. We conclude that, as drought stress increased, seed density decreased, seed proportions inside shrubs increased, and "nurse effects" of shrubs on seedlings became more important. These factors, combined with water-saving characteristics associated with clumped spatial patterns, are likely driving the changes in C. stenophylla spatial patterns.	[Xie, Li-Na; Guo, Hong-Yu; Li, Qing-Fang; Ma, Cheng-Cang] Tianjin Normal Univ, Tianjin Key Lab Anim & Plant Resistance, Coll Life Sci, Tianjin, Peoples R China; [Gabler, Christopher A.] Univ Houston, Dept Biol & Biochem, Houston, TX 77204 USA	Tianjin Normal University; University of Houston System; University of Houston	Ma, CC (corresponding author), Tianjin Normal Univ, Tianjin Key Lab Anim & Plant Resistance, Coll Life Sci, Tianjin, Peoples R China.	machengcang@163.com		Gabler, Christopher/0000-0001-9311-7248	National Natural Science Foundation of China [31170381]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Foundation of China (31170381) (http://www.nsfc.gov.cn/). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguiar MR, 1997, ECOLOGY, V78, P93, DOI 10.1890/0012-9658(1997)078[0093:SDCTDO]2.0.CO;2; Barot S, 1999, ECOLOGY, V80, P1987, DOI 10.1890/0012-9658(1999)080[1987:DOASPT]2.0.CO;2; Bleher B, 2001, OECOLOGIA, V129, P385, DOI 10.1007/s004420100747; Burns SL, 2013, FOREST SYST, V22, P170, DOI 10.5424/fs/2013222-02834; [崔艳 CUI Yan], 2010, [生态学报, Acta Ecologica Sinica], V30, P1981; Dong XW, 2009, PLANT SOIL ENVIRON, V55, P288, DOI 10.17221/13/2009-PSE; Greig-Smith P., 1983, QUANTITATIVE PLANT E; Guo QF, 1998, J ARID ENVIRON, V38, P465, DOI 10.1006/jare.1997.0353; [贺山峰 He Shanfeng], 2013, [水土保持研究, Research of Soil and Water Conservation], V20, P145; JIMENEZ HE, 1992, J VEG SCI, V3, P579, DOI 10.2307/3235824; [张钦弟 Zhang Qindi], 2012, [生态学报, Acta Ecologica Sinica], V32, P5713; Li Qiu-shuang, 2009, Yingyong Shengtai Xuebao, V20, P2105; [李秋艳 LI Qiuyan], 2008, [干旱区研究, Arid Zone Research], V25, P502; Liu Z, 2015, ARID ZONE R IN PRESS; Ma CC, 2008, J ARID ENVIRON, V72, P247, DOI 10.1016/j.jaridenv.2007.05.009; Ma CC, 2003, ACTA BOT SIN, V45, P1218; Ma CC, 2014, ARID LAND RES MANAG, V28, P87, DOI 10.1080/15324982.2013.808717; Ma CC, 2013, FLORA, V208, P97, DOI 10.1016/j.flora.2013.02.002; [马成仓 Ma Chengcang], 2004, [生态学报, Acta Ecologica Sinica], V24, P1594; [马成仓 MA ChengCang], 2006, [生态学报, Acta Ecologica Sinica], V26, P2308; [马成仓 Ma Chengcang], 2004, [生态学报, Acta Ecologica Sinica], V24, P1442; Malkinson D, 2007, ECOGRAPHY, V30, P339, DOI 10.1111/j.2007.0906-7590.04983.x; Matesanz S, 2009, J ARID ENVIRON, V73, P784, DOI 10.1016/j.jaridenv.2009.03.009; Osem Y, 2007, ISR J PLANT SCI, V55, P35, DOI 10.1560/IJPS.55.1.35; Schade JD, 2005, BIOGEOCHEMISTRY, V73, P541, DOI 10.1007/s10533-004-1718-1; Shaukat SS, 2004, J ARID ENVIRON, V57, P311, DOI 10.1016/S0140-1963(03)00112-5; SKARPE C, 1991, J VEG SCI, V2, P565, DOI 10.2307/3236039; Smit C, 2006, FOREST ECOL MANAG, V237, P471, DOI 10.1016/j.foreco.2006.09.069; Sun B, 1994, B BOT RES, V14, P201; Titus JH, 2002, J ARID ENVIRON, V52, P269, DOI 10.1006/jare.2002.1010; Vanderklein DW, 2004, NORTHEAST NAT, V11, P343, DOI 10.1656/1092-6194(2004)011[0343:PAALDI]2.0.CO;2; Wei Xin-Zeng, 2008, Zhiwu Shengtai Xuebao, V32, P825, DOI 10.3773/j.issn.1005-264x.2008.04.011; [熊小刚 Xiong Xiaogang], 2003, [生态学报, Acta Ecologica Sinica], V23, P2436; Yang MH, 1987, APPL STUDY REMOTE SE, P46; Yin ZY, 2005, PLANT ECOL, V178, P189, DOI 10.1007/s11258-004-3285-x; Zhang J.T., 1998, ACTA PHYTOECCOL SIN, V22, P344; Zhao HL, 2007, ECOL ENG, V31, P1, DOI 10.1016/j.ecoleng.2007.04.010	37	14	14	3	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2015	10	3							e0121234	10.1371/journal.pone.0121234	http://dx.doi.org/10.1371/journal.pone.0121234			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9BN	25785848	Green Published, Green Submitted, gold			2022-12-27	WOS:000352138500205
J	Zhang, X; Cui, J; Liu, LN; Jiang, P; Wang, H; Qi, X; Wu, XQ; Wang, ZQ				Zhang, Xi; Cui, Jing; Liu, Li Na; Jiang, Peng; Wang, Han; Qi, Xin; Wu, Xing Qi; Wang, Zhong Quan			Genetic Structure Analysis of Spirometra erinaceieuropaei Isolates from Central and Southern China	PLOS ONE			English	Article							MITOCHONDRIAL-DNA REGIONS; TAPEWORM TAENIA-SOLIUM; SEQUENCE VARIABILITY; POPULATION-GROWTH; HUMAN SPARGANOSIS; DIVERSITY; PHYLOGEOGRAPHY; HYPOTHESIS; EVOLUTION; PROVINCE	Background Sparganosis caused by invasion of the plerocercoid larvae (spargana) of Spirometra erinaceieuropaei have increased in recent years in China. However, the population genetic structure regarding this parasite is still unclear. In this study, we used the sequences of two mitochondrial genes cytochrome b (cytb) and cytochrome c oxidase subunit I (cox1) to analyze genetic variation and phylogeographic structure of the S. erinaceieuropaei populations. Methodology/Principal Findings A total of 88 S. erinaceieuropaei isolates were collected from naturally infected frogs in 14 geographical locations of China. The complete cytb and cox1 genes of each sample was amplified and sequenced. Total 61 haplotypes were found in these 88 concatenated sequences. Each sampled population and the total population have high haplotype diversity (Hd), accompanied by very low nucleotide diversity (Pi). Phylogenetic analyses of haplotypes revealed two distinct clades (HeN+ HuN+ GZ-AS clade and GX+ HN+ GZ-GY clade) corresponding two sub-networks yielded by the median-joining network. Pairwise F-ST values supported great genetic differentiation between S. erinaceieuropaei populations. Both negative Fu's F-S value of neutrality tests and unimodal curve of mismatch distribution analyses supported demographic population expansion in the HeN+ HuN+ GZ-AS clade. The BEAST analysis showed that the divergence time between the two clades took place in the early Pleistocene (1.16 Myr), and by Bayesian skyline plot (BSP) an expansion occurred after about 0.3 Myr ago. Conclusions S. erinaceieuropaei from central and southern China has significant phylogeographic structure, and climatic oscillations during glacial periods in the Quaternary may affect the demography and diversification of this species.	[Zhang, Xi; Cui, Jing; Liu, Li Na; Jiang, Peng; Wang, Han; Qi, Xin; Wu, Xing Qi; Wang, Zhong Quan] Zhengzhou Univ, Dept Parasitol, Coll Med, Zhengzhou 450052, Peoples R China	Zhengzhou University	Cui, J (corresponding author), Zhengzhou Univ, Dept Parasitol, Coll Med, Zhengzhou 450052, Peoples R China.	cuij@zzu.edu.cn; wangzq@zzu.edu.cn			National Natural Science Foundation of China [81172612]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Foundation of China (No. 81172612). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anantaphruti MT, 2011, ACTA TROP, V118, P171, DOI 10.1016/j.actatropica.2011.03.011; Balloux F, 2002, MOL ECOL, V11, P155, DOI 10.1046/j.0962-1083.2001.01436.x; Bryson RW, 2011, J BIOGEOGR, V38, P697, DOI 10.1111/j.1365-2699.2010.02431.x; Cui J, 2014, PARASITOL RES, V113, P3511, DOI 10.1007/s00436-014-4065-8; Cui J, 2011, EMERG INFECT DIS, V17, P146, DOI 10.3201/eid1701.101095; Dai RS, 2012, J HELMINTHOL, V86, P245, DOI 10.1017/S0022149X11000319; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Drummond AJ, 2006, PLOS BIOL, V4, P699, DOI 10.1371/journal.pbio.0040088; EXCOFFIER L, 1992, GENETICS, V131, P479; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Fu YX, 1997, GENETICS, V147, P915; Fukushima T, 1999, PARASITOL TODAY, V15, P124, DOI 10.1016/S0169-4758(99)01405-2; Glenn TC, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-300; Hoberg EP, 2001, P ROY SOC B-BIOL SCI, V268, P781, DOI 10.1098/rspb.2000.1579; Jia WZ, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-447; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Li MW, 2009, EMERG INFECT DIS, V15, P1317, DOI 10.3201/eid1508.090099; Liang L, 2013, THAI J VET MED, V43, P291; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Liu W, 2012, J HELMINTHOL, V86, P271, DOI 10.1017/S0022149X1100037X; Lourenco-De-Oliveira R, 2004, T ROY SOC TROP MED H, V98, P43, DOI 10.1016/S0035-9203(03)00006-3; Magnino S, 2009, INT J FOOD MICROBIOL, V134, P163, DOI 10.1016/j.ijfoodmicro.2009.07.001; Makhawi AM, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-290; Martinez-Hernandez F, 2009, INFECT GENET EVOL, V9, P1108, DOI 10.1016/j.meegid.2009.09.005; Michelet L, 2012, BIOL REV, V87, P731, DOI 10.1111/j.1469-185X.2012.00217.x; Michelet L, 2010, MOL PHYLOGENET EVOL, V55, P744, DOI 10.1016/j.ympev.2010.01.008; Nakao M, 2002, PARASITOLOGY, V124, P657, DOI 10.1017/S0031182002001725; NEI M, 1975, EVOLUTION, V29, P1, DOI 10.2307/2407137; NEIGEL JE, 1993, GENETICS, V135, P1209; Nithiuthai S, 2004, VET PARASITOL, V126, P167, DOI 10.1016/j.vetpar.2004.09.018; Okamoto M, 2007, PARASITOL INT, V56, P235, DOI 10.1016/j.parint.2007.03.003; Polzin T, 2003, OPER RES LETT, V31, P12, DOI 10.1016/S0167-6377(02)00185-2; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Qiu Ming-Hua, 2009, Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi, V27, P251; Rambaut A, FIGTREE 1 3; Rambaut A, TRACER V1 5; Roberts L., 2009, FDN PARASITOLOGY, V8th ed.; ROGERS AR, 1992, MOL BIOL EVOL, V9, P552; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Seah IM, 2013, INT J PARASITOL, V43, P825, DOI 10.1016/j.ijpara.2013.05.004; SIMON C, 1994, ANN ENTOMOL SOC AM, V87, P651, DOI 10.1093/aesa/87.6.651; SLATKIN M, 1995, GENETICS, V139, P457; Swofford D.L, 1998, PAUP 4 0 PHYLOGENETI; Tajima F, 1996, GENETICS, V143, P1457; TAJIMA F, 1989, GENETICS, V123, P585; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Valderrama A, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-9; Wang HW, 2006, MOL ECOL, V15, P4109, DOI 10.1111/j.1365-294X.2006.03086.x; Wiwanitkit V, 2005, INT J INFECT DIS, V9, P312, DOI 10.1016/j.ijid.2004.08.003; Yanagida T, 2010, PARASITOL INT, V59, P268, DOI 10.1016/j.parint.2009.12.006; Yang DY, 2013, KOREAN J PARASITOL, V51, P449, DOI 10.3347/kjp.2013.51.4.449; Zhang X, 2014, IRAN J PARASITOL, V9, P319; Zink RM, 2008, MOL ECOL, V17, P2107, DOI 10.1111/j.1365-294X.2008.03737.x	53	15	16	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2015	10	3							e0119295	10.1371/journal.pone.0119295	http://dx.doi.org/10.1371/journal.pone.0119295			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8IA	25793277	Green Submitted, Green Published, gold			2022-12-27	WOS:000352084200068
J	Bartsch, E; Park, AL; Kingdom, JC; Ray, JG				Bartsch, Emily; Park, Alison L.; Kingdom, John C.; Ray, Joel G.			Risk Threshold for Starting Low Dose Aspirin in Pregnancy to Prevent Preeclampsia: An Opportunity at a Low Cost	PLOS ONE			English	Article							FETAL; MORTALITY; PRETERM; TREAT	Background Preeclampsia (PE) increases maternal and perinatal morbidity and mortality. Based on a multitude of data from randomized clinical trials, clinical practice guidelines endorse using ASA to prevent PE in women who are "at risk." However, data are lacking about the level of absolute risk to warrant starting ASA prophylaxis. Methods and Findings We present two approaches for objectively determining the minimum absolute risk for PE at which ASA prophylaxis is justified. The first is a new approach-the minimum control event rate (CERmin). The second approach uses a pre-existing concept-the minimum event rate for treatment (MERT). Here we show how the CERmin is derived, and then use the CERmin and the MERT to guide us to a reasonable risk threshold for starting a woman on ASA prophylaxis against PE based on clinical risk assessment. We suggest that eligible women need not be at "high risk" for preeclampsia to warrant ASA, but rather at some modestly elevated absolute risk of 6-10%. Conclusions Given its very low cost, its widespread availability, ease of administration and its safety profile, ASA is a highly attractive agent for the prevention of maternal and perinatal morbidity worldwide.	[Bartsch, Emily] Univ Western Ontario, London, ON, Canada; [Park, Alison L.] Inst Clin Evaluat Sci, Toronto, ON, Canada; [Kingdom, John C.] Univ Toronto, Dept Obstet & Gynaecol, Toronto, ON M5B 1W8, Canada; [Ray, Joel G.] Univ Toronto, St Michaels Hosp, Dept Med, Toronto, ON M5B 1W8, Canada	Western University (University of Western Ontario); University of Toronto; University of Toronto; University of Toronto; University Toronto Affiliates; Saint Michaels Hospital Toronto	Ray, JG (corresponding author), Univ Toronto, St Michaels Hosp, Dept Med, Toronto, ON M5B 1W8, Canada.	rayj@smh.ca	Kingdom, John/AAF-2145-2020; Kingdom, John/A-3247-2013		Canadian Institutes for Health Research	Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR))	This work was supported by a Knowledge Synthesis Grant from the Canadian Institutes for Health Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ananth CV, 2014, SEMIN PERINATOL, V38, P151, DOI 10.1053/j.semperi.2014.03.007; Ananth CV, 1997, AM J PERINAT, V14, P17, DOI 10.1055/s-2007-994090; [Anonymous], 1994, Circulation, V89, P1333; Askie LM, 2007, LANCET, V369, P1791, DOI 10.1016/S0140-6736(07)60712-0; Basso O, 2006, JAMA-J AM MED ASSOC, V296, P1357, DOI 10.1001/jama.296.11.1357; BEROYZ G, 1994, LANCET, V343, P619; Bramham K, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g2301; Bujold E, 2010, OBSTET GYNECOL, V116, P402, DOI 10.1097/AOG.0b013e3181e9322a; Caritis S, 1998, NEW ENGL J MED, V338, P701, DOI 10.1056/NEJM199803123381101; Chappell LC, 2010, BJOG-INT J OBSTET GY, V117, P695, DOI 10.1111/j.1471-0528.2010.02507.x; COOK RJ, 1995, BRIT MED J, V310, P452, DOI 10.1136/bmj.310.6977.452; Duley L, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004659.pub2; Earnshaw SR, 2011, ARCH INTERN MED, V171, P218, DOI 10.1001/archinternmed.2010.525; Hutcheon JA, 2011, BEST PRACT RES CL OB, V25, P391, DOI 10.1016/j.bpobgyn.2011.01.006; IMPERIALE T F, 1991, Journal of the American Medical Association, V266, P260, DOI 10.1001/jama.266.2.260; LAUPACIS A, 1988, NEW ENGL J MED, V318, P1728, DOI 10.1056/NEJM198806303182605; LAUPACIS A, 1992, CAN MED ASSOC J, V146, P473; Li R, 2010, DIABETES CARE, V33, P1193, DOI 10.2337/dc09-1888; Loverro G, 2001, Arch Gynecol Obstet, V265, P195, DOI 10.1007/s004040000160; National Collaborating Centre for Women's and Children's Health (UK), 2010, HYPERTENSION PREGNAN; North RA, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d1875; Odegard RA, 2000, OBSTET GYNECOL, V96, P950, DOI 10.1016/S0029-7844(00)01040-1; Public Health Agency of Canada, 2013, PER HLTH IND CAN 201; Ray JG, 2012, CAN MED ASSOC J, V184, pE956, DOI 10.1503/cmaj.121283; Roberge S, 2013, ULTRASOUND OBST GYN, V41, P491, DOI 10.1002/uog.12421; Roberge S, 2012, FETAL DIAGN THER, V31, P141, DOI 10.1159/000336662; Schisterman EF, 2014, LANCET, V384, P29, DOI 10.1016/S0140-6736(14)60157-4; Schwartz LM, 2006, BMJ-BRIT MED J, V333, P1248, DOI 10.1136/bmj.38985.564317.7C; Shimbo T, 2002, J CLIN EPIDEMIOL, V55, P531; Sinclair JC, 2001, J CLIN EPIDEMIOL, V54, P253, DOI 10.1016/S0895-4356(01)00347-X; Walter SD, 2009, J CLIN EPIDEMIOL, V62, P816, DOI 10.1016/j.jclinepi.2008.09.017; Whitlock E.P., 2014, 1405207EF1 AG HEALTH; Xiong X, 1999, AM J OBSTET GYNECOL, V180, P207, DOI 10.1016/S0002-9378(99)70176-6	33	22	22	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2015	10	3							e0116296	10.1371/journal.pone.0116296	http://dx.doi.org/10.1371/journal.pone.0116296			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD9NQ	25789633	gold, Green Published, Green Submitted			2022-12-27	WOS:000351425400011
J	Haile, Y; Nakhaei-Nejad, M; Boakye, PA; Baker, G; Smith, PA; Murray, AG; Giuliani, F; Jahroudi, N				Haile, Yohannes; Nakhaei-Nejad, Maryam; Boakye, Paul A.; Baker, Glen; Smith, Peter A.; Murray, Allan G.; Giuliani, Fabrizio; Jahroudi, Nadia			Reprogramming of HUVECs into Induced Pluripotent Stem Cells (HiPSCs), Generation and Characterization of HiPSC-Derived Neurons and Astrocytes	PLOS ONE			English	Article							MICROTUBULE-ASSOCIATED PROTEIN-2; MULTIPLE-SCLEROSIS; ALZHEIMERS-DISEASE; CLINICAL-TRIAL; AMINO-ACIDS; ACTIVIN-A; IPS CELLS; EXPRESSION; DIFFERENTIATION; INDUCTION	Neurodegenerative diseases are characterized by chronic and progressive structural or functional loss of neurons. Limitations related to the animal models of these human diseases have impeded the development of effective drugs. This emphasizes the need to establish disease models using human-derived cells. The discovery of induced pluripotent stem cell (iPSC) technology has provided novel opportunities in disease modeling, drug development, screening, and the potential for "patient-matched" cellular therapies in neurodegenerative diseases. In this study, with the objective of establishing reliable tools to study neurodegenerative diseases, we reprogrammed human umbilical vein endothelial cells (HUVECs) into iPSCs (HiPSCs). Using a novel and direct approach, HiPSCs were differentiated into cells of central nervous system (CNS) lineage, including neuronal, astrocyte and glial cells, with high efficiency. HiPSCs expressed embryonic genes such as nanog, sox2 and Oct-3/4, and formed embryoid bodies that expressed markers of the 3 germ layers. Expression of endothelial-specific genes was not detected in HiPSCs at RNA or protein levels. HiPSC-derived neurons possess similar morphology but significantly longer neurites compared to primary human fetal neurons. These stem cell-derived neurons are susceptible to inflammatory cell-mediated neuronal injury. HiPSC-derived neurons express various amino acids that are important for normal function in the CNS. They have functional receptors for a variety of neurotransmitters such as glutamate and acetylcholine. HiPSC-derived astrocytes respond to ATP and acetylcholine by elevating cytosolic Ca2+ concentrations. In summary, this study presents a novel technique to generate differentiated and functional HiPSC-derived neurons and astrocytes. These cells are appropriate tools for studying the development of the nervous system, the pathophysiology of various neurodegenerative diseases and the development of potential drugs for their treatments.	[Haile, Yohannes; Nakhaei-Nejad, Maryam; Murray, Allan G.; Giuliani, Fabrizio; Jahroudi, Nadia] Univ Alberta, Dept Med, Edmonton, AB, Canada; [Boakye, Paul A.; Smith, Peter A.] Univ Alberta, Dept Pharmacol, Edmonton, AB, Canada; [Boakye, Paul A.; Baker, Glen; Smith, Peter A.; Giuliani, Fabrizio] Univ Alberta, Neurosci & Mental Hlth Inst, Edmonton, AB, Canada; [Baker, Glen] Univ Alberta, Dept Psychiat, Neurochem Res Unit, Edmonton, AB, Canada	University of Alberta; University of Alberta; University of Alberta; University of Alberta	Giuliani, F (corresponding author), Univ Alberta, Dept Med, Edmonton, AB, Canada.	giuliani@ualberta.ca; nadia.jahroudi@ualberta.ca		BOAKYE, PAUL/0000-0002-6351-5437	Canadian Institutes of Health Research	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	The study was supported by the Canadian Institutes of Health Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al Jumah M, 2012, MULT SCLER J, V18, P1395, DOI 10.1177/1352458512440832; Badger JL, 2014, NEUROPHARMACOLOGY, V76, P88, DOI 10.1016/j.neuropharm.2013.08.035; Bateman RJ, 2012, NEW ENGL J MED, V367, P795, DOI 10.1056/NEJMoa1202753; Bellin M, 2012, NAT REV MOL CELL BIO, V13, P713, DOI 10.1038/nrm3448; BREWER GJ, 1993, J NEUROSCI RES, V35, P567, DOI 10.1002/jnr.490350513; Butt AM, 2011, SEMIN CELL DEV BIOL, V22, P205, DOI 10.1016/j.semcdb.2011.02.023; Cataldo A, 2001, ANN NEUROL, V50, P661, DOI 10.1002/ana.1254.abs; Chakrabarti S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052357; Chambers SM, 2009, NAT BIOTECHNOL, V27, P275, DOI 10.1038/nbt.1529; Chan EM, 2009, NAT BIOTECHNOL, V27, P1033, DOI 10.1038/nbt.1580; Chklovskii DB, 2004, NEURON, V43, P609, DOI 10.1016/j.neuron.2004.08.012; Dell'Era P, 2001, ONCOGENE, V20, P2655, DOI 10.1038/sj.onc.1204368; Desnuelle C, 2001, AMYOTROPH LATERAL SC, V2, P9, DOI 10.1080/146608201300079364; Frischer JM, 2009, BRAIN, V132, P1175, DOI 10.1093/brain/awp070; Fu W, 2012, J BIOL CHEM, V287, P18820, DOI 10.1074/jbc.M111.331181; Gao ZY, 1998, BIOCHEM BIOPH RES CO, V247, P407, DOI 10.1006/bbrc.1998.8826; Garate Z, 2013, HUM GENE THER, V24, P571, DOI 10.1089/hum.2012.251; Giuliani F, 2003, J IMMUNOL, V171, P368, DOI 10.4049/jimmunol.171.1.368; Gourraud PA, 2012, IMMUNOL REV, V248, P87, DOI 10.1111/j.1600-065X.2012.01134.x; Grant SL, 2006, J CHROMATOGR B, V844, P278, DOI 10.1016/j.jchromb.2006.07.022; Haile Y, 2011, J IMMUNOL, V187, P4861, DOI 10.4049/jimmunol.1100943; HASHIMOTO M, 1990, BIOCHEM BIOPH RES CO, V173, P193, DOI 10.1016/S0006-291X(05)81040-X; Ho PJ, 2010, ARTERIOSCL THROM VAS, V30, P1905, DOI 10.1161/ATVBAHA.110.206540; Hockemeyer D, 2011, NAT BIOTECHNOL, V29, P731, DOI 10.1038/nbt.1927; Hockemeyer D, 2009, NAT BIOTECHNOL, V27, P851, DOI 10.1038/nbt.1562; ICHIKAWA M, 1993, SYNAPSE, V13, P50, DOI 10.1002/syn.890130107; Iwahori Y, 1997, BRAIN RES, V760, P52, DOI 10.1016/S0006-8993(97)00275-8; Kastenberg Zachary J, 2008, Transplant Rev (Orlando), V22, P215, DOI 10.1016/j.trre.2008.04.002; Kerkovich DM, 1999, INT J DEV NEUROSCI, V17, P347, DOI 10.1016/S0736-5748(99)00036-2; KERNELL D, 1981, BRAIN RES, V204, P311, DOI 10.1016/0006-8993(81)90591-6; Laflamme MA, 2007, NAT BIOTECHNOL, V25, P1015, DOI 10.1038/nbt1327; Lagarkova MA, 2010, CELL CYCLE, V9, P937, DOI 10.4161/cc.9.5.10869; Lin Rui, 2012, Pract Neurol, V12, P279, DOI 10.1136/practneurol-2012-000276; Ludwig TE, 2006, NAT METHODS, V3, P637, DOI 10.1038/NMETH902; MATESIC DF, 1994, J NEUROCHEM, V63, P1012; Moon BS, 2009, EXP MOL MED, V41, P116, DOI 10.3858/emm.2009.41.2.014; More SV, 2013, MEDIAT INFLAMM, V2013, DOI 10.1155/2013/952375; Murashov AK, 2005, BIOCHEM BIOPH RES CO, V332, P653, DOI 10.1016/j.bbrc.2005.04.167; Opitz T, 2002, J NEUROPHYSIOL, V88, P2196, DOI 10.1152/jn.00316.2002; Panopoulos AD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019743; Paulsen JS, 2013, PROG NEUROBIOL, V110, P2, DOI 10.1016/j.pneurobio.2013.08.003; Rajan P, 2003, J CELL BIOL, V161, P911, DOI 10.1083/jcb.200211021; Rayment EA, 2010, STEM CELLS, V28, P996, DOI 10.1002/stem.416; Rodriguez-Martinez G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043797; Roep BO, 2010, NAT REV IMMUNOL, V10, P145, DOI 10.1038/nri2705; ROSENSTEIN JM, 1995, CELL TRANSPLANT, V4, P83, DOI 10.1016/0963-6897(94)00041-H; Ruangkittisakul A, 2006, J NEUROSCI, V26, P11870, DOI 10.1523/JNEUROSCI.3357-06.2006; Saatman KE, 1998, J NEUROTRAUM, V15, P1047, DOI 10.1089/neu.1998.15.1047; Sanchez-Danes A, 2013, CNS NEUROL DISORD-DR, V6, P6; Shah AJ, 2002, J CHROMATOGR B, V781, P151, DOI 10.1016/S1570-0232(02)00621-9; Shefner JM, 2004, NEUROLOGY, V63, P1656, DOI 10.1212/01.WNL.0000142992.81995.F0; Shutova MV, 2009, ACTA NATURAE, V1, P91, DOI 10.32607/20758251-2009-1-2-91-92; Sun N, 2009, P NATL ACAD SCI USA, V106, P15720, DOI 10.1073/pnas.0908450106; Suzuki K, 2010, BIOCHEM BIOPH RES CO, V394, P639, DOI 10.1016/j.bbrc.2010.03.039; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Takahashi K, 2013, DEVELOPMENT, V140, P2457, DOI 10.1242/dev.092551; Tang X, 2013, STEM CELL RES, V11, P743, DOI 10.1016/j.scr.2013.05.002; Tretter YP, 2000, NAT MED, V6, P812, DOI 10.1038/77548; van Elburg RAJ, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000781; van Pelt J, 2013, FRONT COMPUT NEUROSC, V7, DOI 10.3389/fncom.2013.00160; Varga AC, 2005, ONCOGENE, V24, P5713, DOI 10.1038/sj.onc.1208919; Vargas-Lowy D, 2012, J CHILD NEUROL, V27, P1394, DOI 10.1177/0883073812456084; Vazin T, 2010, RESTOR NEUROL NEUROS, V28, P589, DOI 10.3233/RNN-2010-0543; Vecil GG, 2000, J NEUROSCI RES, V61, P212, DOI 10.1002/1097-4547(20000715)61:2<212::AID-JNR12>3.0.CO;2-9; Wilcock DM, 2014, NEURODEGENER DIS, V13, P183, DOI 10.1159/000354228; Pinto MCX, 2014, J CHEM NEUROANAT, V55, P24, DOI 10.1016/j.jchemneu.2013.11.002; Yagita Y, 1999, NEUROSCIENCE, V92, P1417, DOI 10.1016/S0306-4522(99)00079-2; YOUNKIN DP, 1993, P NATL ACAD SCI USA, V90, P2174, DOI 10.1073/pnas.90.6.2174; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526; Yuan SH, 2013, AGEING RES REV, V12, P739, DOI 10.1016/j.arr.2013.04.002; Yuan T, 2013, STEM CELL RES THER, V4, DOI 10.1186/scrt224; Zhang SX, 2000, J NEUROPATH EXP NEUR, V59, P287, DOI 10.1093/jnen/59.4.287; Zhu SY, 2010, CELL STEM CELL, V7, P651, DOI 10.1016/j.stem.2010.11.015; Zotova E, 2013, BRAIN, V136, P2677, DOI 10.1093/brain/awt210	75	9	9	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2015	10	3							e0119617	10.1371/journal.pone.0119617	http://dx.doi.org/10.1371/journal.pone.0119617			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD9NQ	25789622	Green Published, Green Submitted, gold			2022-12-27	WOS:000351425400091
J	Liu, M; Zhao, YX; Zhang, XM				Liu, Min; Zhao, Yunxue; Zhang, Xiumei			Knockdown of Glutamate Cysteine Ligase Catalytic Subunit by siRNA Causes the Gold Nanoparticles-Induced Cytotoxicity in Lung Cancer Cells	PLOS ONE			English	Article							OXIDATIVE STRESS; GLUTATHIONE; APOPTOSIS; RADIOSENSITIZATION; NECROSIS; ASSOCIATION; SURVIVAL; THERAPY; PATHWAY; LEVEL	Gold nanoparticles (GNPs) have shown promising medical applications in cancer treatment involved in the regulation of intracellular redox balance. Previously, we have reported that GNPs can trigger apoptosis and necrosis in human lung cancer cells (A549) when L-buthionine-sulfoximine (BSO) was used to decrease the expression of intracellular glutathione (GSH). Herein, we investigated the cytotoxicity of GNPs toward lung cancer cells under the glutamate cysteine ligase catalytic subunit (GCLC) was silenced by siRNA. Our results showed that GNPs cause apoptosis and necrosis in cells transfected with GCLC siRNA by elevating intracellular reactive oxygen species (ROS). These findings demonstrated that the regulation of glutathione synthesis by GCLC siRNA in A549 cells can initiate the gold nanoparticles-induced cytotoxicity.	[Liu, Min; Zhao, Yunxue; Zhang, Xiumei] Shandong Univ, Dept Pharmacol, Sch Med, Jinan 250100, Shandong, Peoples R China	Shandong University	Zhang, XM (corresponding author), Shandong Univ, Dept Pharmacol, Sch Med, Jinan 250100, Shandong, Peoples R China.	zhangxm@sdu.edu.cn			National Natural Science Foundation of China [81102468]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Foundation of China (81102468 to Y. Zhao). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akai S, 2007, J BIOL CHEM, V282, P23996, DOI 10.1074/jbc.M702819200; Aydogan B, 2010, MOL IMAGING BIOL, V12, P463, DOI 10.1007/s11307-010-0299-8; Bahadur KCR, 2006, J BIOMAT SCI-POLYM E, V17, P579, DOI 10.1163/156856206776986279; Beurel E, 2009, BIOCHEM PHARMACOL, V77, P54, DOI 10.1016/j.bcp.2008.09.026; Burger N, 2014, NANOMED-NANOTECHNOL, V10, P1365, DOI 10.1016/j.nano.2014.03.011; Calabro V, 2002, J BIOL CHEM, V277, P2674, DOI 10.1074/jbc.M107173200; Calixto G, 2014, INT J NANOMED, V9, P3719, DOI 10.2147/IJN.S61670; Cardinal J, 2008, SURGERY, V144, P125, DOI 10.1016/j.surg.2008.03.036; Chatterjee A, 2013, NUTRIENTS, V5, P525, DOI 10.3390/nu5020525; Das S, 2011, CHEM-BIOL INTERACT, V193, P129, DOI 10.1016/j.cbi.2011.06.002; Diaz-Hernandez JI, 2005, J BIOL CHEM, V280, P38992, DOI 10.1074/jbc.M507065200; Diehn M, 2009, NATURE, V458, P780, DOI 10.1038/nature07733; Ernst IMA, 2011, PHARMACOL RES, V63, P233, DOI 10.1016/j.phrs.2010.11.005; Estrela JM, 2006, CRIT REV CL LAB SCI, V43, P143, DOI 10.1080/10408360500523878; Fooladi AAI, 2008, BIOTECHNOL LETT, V30, P2053, DOI 10.1007/s10529-008-9805-3; Freitas M, 2012, FEBS OPEN BIO, V2, P119, DOI 10.1016/j.fob.2012.05.001; Geng F, 2011, NANOTECHNOLOGY, V22, DOI 10.1088/0957-4484/22/28/285101; Glazer ES, 2011, THER DELIV, V2, P1325, DOI 10.4155/TDE.11.102; Jeong JW, 2011, TOXICOL IN VITRO, V25, P817, DOI 10.1016/j.tiv.2011.02.001; Jeremic B, 2013, CLIN TRANSL ONCOL, V15, P593, DOI 10.1007/s12094-013-1003-7; Joh DY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062425; Kausar H, 2013, CANCER LETT, V332, P35, DOI 10.1016/j.canlet.2013.01.008; Khan M, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/719858; Kim Y, 2010, FEBS LETT, V584, P3550, DOI 10.1016/j.febslet.2010.07.006; Li MN, 2014, BIOMED REP, V2, P831, DOI 10.3892/br.2014.359; Li N, 2014, SCI REP-UK, V4, DOI 10.1038/srep04164; Lim SC, 2010, INT J CANCER, V126, P1582, DOI 10.1002/ijc.24853; Liu M, 2013, J NANOPART RES, V15, DOI 10.1007/s11051-013-1745-8; Liu T, 2014, NANOTECHNOLOGY, V25, DOI 10.1088/0957-4484/25/34/345103; Masella R, 2004, J NUTR, V134, P785, DOI 10.1093/jn/134.4.785; Mateo D, 2014, TOXICOL MECH METHOD, V24, P161, DOI 10.3109/15376516.2013.869783; Nagy D, 2014, ARCH DERMATOL RES, V306, P885, DOI 10.1007/s00403-014-1511-5; Ngwa W, 2013, NANOMED-NANOTECHNOL, V9, P25, DOI 10.1016/j.nano.2012.09.001; Ortega Angel L, 2011, Cancers (Basel), V3, P1285, DOI 10.3390/cancers3011285; Piao JG, 2014, ACS NANO, V8, P10414, DOI 10.1021/nn503779d; Slyusarenko K, 2014, NANOSCALE, V6, P13527, DOI 10.1039/c4nr04155k; Solecki GM, 2013, CHEM RES TOXICOL, V26, P252, DOI 10.1021/tx300435p; Sun HJ, 2013, ASIAN PAC J CANCER P, V14, P6379, DOI 10.7314/APJCP.2013.14.11.6379; Valverde M, 2006, MUTAT RES-FUND MOL M, V594, P172, DOI 10.1016/j.mrfmmm.2005.08.004; Wang J, 2013, MOL BIOSYST, V9, P1489, DOI 10.1039/c3mb25461e; Xia DL, 2014, APPL BIOCHEM BIOTECH, V174, P2458, DOI 10.1007/s12010-014-1193-7; Yuan XH, 2012, J CELL PHYSIOL, V227, P194, DOI 10.1002/jcp.22717; Zeng J, 2013, ANGEW CHEM INT EDIT, V52, P4169, DOI 10.1002/anie.201210359; Zhao YX, 2011, J PHYS CHEM C, V115, P12797, DOI 10.1021/jp2025413	44	13	15	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2015	10	3							e0118870	10.1371/journal.pone.0118870	http://dx.doi.org/10.1371/journal.pone.0118870			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD9NQ	25789740	gold, Green Published, Green Submitted			2022-12-27	WOS:000351425400052
J	Mourah, S; Denis, MG; Narducci, FE; Solassol, J; Merlin, JL; Sabourin, JC; Scoazec, JY; Ouafik, L; Emile, JF; Heller, R; Souvignet, C; Bergougnoux, L; Merlio, JP				Mourah, Samia; Denis, Marc G.; Narducci, Fabienne Escande; Solassol, Jerome; Merlin, Jean-Louis; Sabourin, Jean-Christophe; Scoazec, Jean-Yves; Ouafik, L'Houcine; Emile, Jean-Francois; Heller, Remy; Souvignet, Claude; Bergougnoux, Loic; Merlio, Jean-Philippe			Detection of BRAF V600 Mutations in Melanoma: Evaluation of Concordance between the Cobas (R) 4800 BRAF V600 Mutation Test and the Methods Used in French National Cancer Institute (INCa) Platforms in a Real-Life Setting	PLOS ONE			English	Article							METASTATIC MELANOMA; MALIGNANT-MELANOMA; IMPROVED SURVIVAL; OPEN-LABEL; VEMURAFENIB; THERAPY; ASSAY; PERFORMANCE; INHIBITION; P.V600E	Vemurafenib is approved for the treatment of metastatic melanoma in patients with BRAF V600 mutation. In pivotal clinical trials, BRAF testing has always been done with the approved cobas 4800 BRAF test. In routine practice, several methods are available and are used according to the laboratories usual procedures. A national, multicenter, non-interventional study was conducted with prospective and consecutive collection of tumor samples. A parallel evaluation was performed in routine practice between the cobas 4800 BRAF V600 mutation test and home brew methods (HBMs) of 12 national laboratories, labelled and funded by the French National Cancer Institute (INCa). For 420 melanoma samples tested, the cobas method versus HBM showed a high concordance (93.3%; kappa = 0.86) in BRAF V600 genotyping with similar mutation rates (34.0% versus 35.7%, respectively). Overall, 97.4% and 98.6% of samples gave valid results using the cobas and HBM, respectively. Of the 185 samples strictly fulfilling the cobas guidelines, the concordance rate was even higher (95.7%; kappa = 0.91; 95% CI [0.85; 0.97]). Out of the 420 samples tested, 28 (6.7%) showed discordance between HBM and cobas. This prospective study shows a high concordance rate between the cobas 4800 BRAF V600 test and home brew methods in the routine detection of BRAF V600E mutations.	[Mourah, Samia] Hop St Louis, AP HP, Dept Pharmacol Genet, Paris, France; [Mourah, Samia] INSERM, UMRS 976, F-75010 Paris, France; [Denis, Marc G.] Nantes Univ Hosp, Dept Biochem, Nantes, France; [Narducci, Fabienne Escande] Lille Reg Univ Hosp, Dept Mol Biol & Biochem, Lille, France; [Solassol, Jerome] Montpellier Univ Hosp, Dept Biol Pathol, Montpellier, France; [Merlin, Jean-Louis] Ctr Alexis Vautrin, Dept Tumor Biol, Vandoeuvre Les Nancy, France; [Sabourin, Jean-Christophe] Rouen Univ Hosp, Dept Pathol Cytopathol, Rouen, France; [Scoazec, Jean-Yves] Hop Edouard Herriot, Lab Pathol & Cytopathol, Lyon, France; [Scoazec, Jean-Yves] Gustave Roussy Hosp, Dept Biol & Pathol, Villejuif, France; [Ouafik, L'Houcine] Marseille Nord Univ Hosp, Dept Canc Biol, Marseille, France; [Emile, Jean-Francois] Ambroise Pare Hosp, Dept Pathol, Boulogne, France; [Heller, Remy] Colmar Hosp, Dept Microbiol & Mol Biol, Colmar, France; [Souvignet, Claude; Bergougnoux, Loic] Roche, Boulogne, France; [Merlio, Jean-Philippe] Bordeaux Univ Hosp, Dept Tumor Biol, Bordeaux, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Louis - APHP; UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Nantes Universite; CHU de Nantes; Universite de Lille - ISITE; CHU Lille; Universite de Montpellier; CHU de Montpellier; UNICANCER; Institut de cancerologie de Lorraine (ICL); CHU de Rouen; CHU Lyon; UNICANCER; Gustave Roussy; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Ambroise-Pare - APHP; CHU Bordeaux	Mourah, S (corresponding author), Hop St Louis, AP HP, Dept Pharmacol Genet, Paris, France.	samia.mourah@sls.aphp.fr	Solassol, Jerome/G-2320-2018; Denis, Marc G/K-8049-2015	Solassol, Jerome/0000-0002-0293-6158; Denis, Marc G/0000-0001-5865-3248; Ouafik, L'Houcine/0000-0002-4848-1232	Roche - France; INCa	Roche - France(Roche Holding); INCa(Institut National du Cancer (INCA) France)	Roche - France and INCa for funding tests. The funders participated in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amaria RN, 2012, DRUG TODAY, V48, P109, DOI 10.1358/dot.2012.48.2.1745274; Anderson S, 2012, ARCH PATHOL LAB MED, V136, P1385, DOI 10.5858/arpa.2011-0505-OA; Boursault L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070826; Chapman PB, 2011, NEW ENGL J MED, V364, P2507, DOI 10.1056/NEJMoa1103782; Cheng S, 2012, NEW BIOTECHNOL, V29, P682, DOI 10.1016/j.nbt.2012.02.002; Colomba E, 2013, J MOL DIAGN, V15, P94, DOI 10.1016/j.jmoldx.2012.09.001; Cousins MM, 2013, J MOL DIAGN, V15, P130, DOI 10.1016/j.jmoldx.2012.08.008; Curry JL, 2012, SEMIN CUTAN MED SURG, V31, P267, DOI 10.1016/j.sder.2012.07.007; Davies H, 2002, NATURE, V417, P949, DOI 10.1038/nature00766; Fecher LA, 2008, CURR OPIN ONCOL, V20, P183, DOI 10.1097/CCO.0b013e3282f5271c; Flaherty KT, 2012, NEW ENGL J MED, V367, P107, DOI 10.1056/NEJMoa1203421; Flaherty KT, 2010, NEW ENGL J MED, V363, P809, DOI 10.1056/NEJMoa1002011; Forsea AM, 2012, BRIT J DERMATOL, V167, P1124, DOI 10.1111/j.1365-2133.2012.11125.x; Gray-Schopfer V, 2007, NATURE, V445, P851, DOI 10.1038/nature05661; Halait H, 2012, DIAGN MOL PATHOL, V21, P1, DOI 10.1097/PDM.0b013e31823b216f; Hauschild A, 2012, LANCET, V380, P358, DOI 10.1016/S0140-6736(12)60868-X; Ihle MA, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-13; INCa, 2010, SIT CANC FRANC 2010; INCa. Les tests de genetique moleculaire pour l'acces aux therapies ciblees en, 2012, TESTS GEN MOL ACC TH; INCa. Synthese de l'activite des plateformes hospitalieres de genetique moleculaire des cancers en, 2011, SYNTH ACT PLAT HOSP; Lade-Keller J, 2013, J MOL DIAGN, V15, P70, DOI 10.1016/j.jmoldx.2012.08.003; Lee JH, 2011, BRIT J DERMATOL, V164, P776, DOI 10.1111/j.1365-2133.2010.10185.x; Long GV, 2011, J CLIN ONCOL, V29, P1239, DOI 10.1200/JCO.2010.32.4327; McArthur GA, 2014, LANCET ONCOL, V15, P323, DOI 10.1016/S1470-2045(14)70012-9; Nowak Frederique, 2013, Am Soc Clin Oncol Educ Book, P332, DOI 10.1200/EdBook_AM.2013.33.332; Nowak F, 2012, NAT REV CLIN ONCOL, V9, P479, DOI 10.1038/nrclinonc.2012.42; Pollock PM, 2003, NAT GENET, V33, P19, DOI 10.1038/ng1054; Qu K, 2013, J MOL DIAGN, V15, P790, DOI 10.1016/j.jmoldx.2013.07.003; Saint-Jean M, 2014, J INVEST DERMATOL, V134, P1468, DOI 10.1038/jid.2013.378; Siegel R, 2012, CA-CANCER J CLIN, V62, P10, DOI 10.3322/caac.20138; Skorokhod A, 2012, J AM ACAD DERMATOL, V67, P488, DOI 10.1016/j.jaad.2012.03.022; Sosman JA, 2012, NEW ENGL J MED, V366, P707, DOI 10.1056/NEJMoa1112302; Tsai J, 2008, P NATL ACAD SCI USA, V105, P3041, DOI 10.1073/pnas.0711741105; Yancovitz M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029336	34	19	19	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2015	10	3							e0120232	10.1371/journal.pone.0120232	http://dx.doi.org/10.1371/journal.pone.0120232			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD9NQ	25789737	gold, Green Published, Green Submitted			2022-12-27	WOS:000351425400142
J	Reuchlin-Hugenholtz, E; Shackell, NL; Hutchings, JA				Reuchlin-Hugenholtz, Emilie; Shackell, Nancy L.; Hutchings, Jeffrey A.			The Potential for Spatial Distribution Indices to Signal Thresholds in Marine Fish Biomass	PLOS ONE			English	Article							COD GADUS-MORHUA; ATLANTIC COD; HABITAT SELECTION; TRAWL SURVEYS; ABUNDANCE; DENSITY; SEA; CATCHABILITY; INDICATORS; OCCUPANCY	The frequently observed positive relationship between fish population abundance and spatial distribution suggests that changes in distribution can be indicative of trends in abundance. If contractions in spatial distribution precede declines in spawning stock biomass (SSB), spatial distribution reference points could complement the SSB reference points that are commonly used in marine conservation biology and fisheries management. When relevant spatial distribution information is integrated into fisheries management and recovery plans, risks and uncertainties associated with a plan based solely on the SSB criterion would be reduced. To assess the added value of spatial distribution data, we examine the relationship between SSB and four metrics of spatial distribution intended to reflect changes in population range, concentration, and density for 10 demersal populations (9 species) inhabiting the Scotian Shelf, Northwest Atlantic. Our primary purpose is to assess their potential to serve as indices of SSB, using fisheries independent survey data. We find that metrics of density offer the best correlate of spawner biomass. A decline in the frequency of encountering high density areas is associated with, and in a few cases preceded by, rapid declines in SSB in 6 of 10 populations. Density-based indices have considerable potential to serve both as an indicator of SSB and as spatially based reference points in fisheries management.	[Reuchlin-Hugenholtz, Emilie; Hutchings, Jeffrey A.] Dalhousie Univ, Dept Biol, POB 15000, Halifax, NS B3H 4R2, Canada; [Shackell, Nancy L.] Bedford Inst Oceanog, Dept Fisheries & Oceans, Oceans Sci Div, Dartmouth, NS B2Y 4A2, Canada; [Hutchings, Jeffrey A.] Univ Oslo, Ctr Ecol & Evolutionary Synth, Dept Biosci, NO-0316 Oslo, Norway	Dalhousie University; Bedford Institute of Oceanography; Fisheries & Oceans Canada; University of Oslo	Reuchlin-Hugenholtz, E (corresponding author), Dalhousie Univ, Dept Biol, POB 15000, Halifax, NS B3H 4R2, Canada.	ereuchlin@gmail.com	Shackell, Nancy L/AAF-8209-2019; Hutchings, Jeffrey/ABA-1098-2020	Shackell, Nancy L/0000-0001-5128-948X; Hutchings, Jeffrey/0000-0003-1572-5429	Prins Bernhard Cultuurfonds; Dalhousie University Biology Department	Prins Bernhard Cultuurfonds; Dalhousie University Biology Department	This work was supported by Prins Bernhard Cultuurfonds (http://www.cultuurfonds.nl/), and Dalhousie University Biology Department (http://www.dal.ca). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Berkeley SA, 2004, FISHERIES, V29, P23, DOI 10.1577/1548-8446(2004)29[23:FSVPOA]2.0.CO;2; Blanchard JL, 2005, CAN J FISH AQUAT SCI, V62, P2001, DOI 10.1139/F05-109; BROWN JH, 1977, ECOLOGY, V58, P445, DOI 10.2307/1935620; BROWN JH, 1984, AM NAT, V124, P255, DOI 10.1086/284267; Caddy JF, 2004, REV FISH BIOL FISHER, V14, P43, DOI 10.1007/s11160-004-3770-2; Caddy JF, 1995, FOOD AGR ORG UN FISH, V349, P1; Ciannelli L, 2012, P ROY SOC B-BIOL SCI, V279, P3635, DOI 10.1098/rspb.2012.0849; Cotter J, 2009, AQUAT LIVING RESOUR, V22, P243, DOI 10.1051/alr/2009025; Cotter J, 2009, AQUAT LIVING RESOUR, V22, P135, DOI 10.1051/alr/2009016; CRECCO V, 1990, CAN J FISH AQUAT SCI, V47, P385, DOI 10.1139/f90-040; DFO, 2009, 2009025 DFO, V2009, P025; Doubleday W. G., 1981, MANUAL GROUNDFISH SU; FAO, 2012, REV STAT WORLD MAR F, P209; Fisher JAD, 2004, MAR ECOL PROG SER, V279, P201, DOI 10.3354/meps279201; FRETWELL S D, 1969, Acta Biotheoretica, V19, P16, DOI 10.1007/BF01601953; Frisk MG, 2011, ECOL APPL, V21, P227, DOI 10.1890/09-1698.1; Garrison LP, 2000, ICES J MAR SCI, V57, P723, DOI 10.1006/jmsc.2000.0713; Gaston KJ, 1999, OIKOS, V84, P353, DOI 10.2307/3546417; Gaston KJ, 2003, STRUCTURE DYNAMICS G; HANSKI I, 1992, AM NAT, V139, P657, DOI 10.1086/285349; Harley SJ, 2001, CAN J FISH AQUAT SCI, V58, P1760, DOI 10.1139/cjfas-58-9-1760; HILBORN R, 1992; Horsman T, 2009, CANADIAN TECHNICAL R; Hsieh CH, 2010, AQUAT SCI, V72, P165, DOI 10.1007/s00027-009-0122-2; HUTCHINGS JA, 1994, CAN J FISH AQUAT SCI, V51, P2126, DOI 10.1139/f94-214; Hutchings JA, 1996, CAN J FISH AQUAT SCI, V53, P943, DOI 10.1139/f96-097; Jakobsen T., 2009, FISH REPROD BIOL IMP; Jennings S., 2009, MARINE FISHERIES ECO; Kritzer JP, 2004, FISH FISH, V5, P131, DOI 10.1111/j.1467-2979.2004.00131.x; LANDE R, 1993, AM NAT, V142, P911, DOI 10.1086/285580; Larson RJ, 1999, CAL COOP OCEAN FISH, V40, P94; LAWTON JH, 1993, TRENDS ECOL EVOL, V8, P409, DOI 10.1016/0169-5347(93)90043-O; Levins R., 1970, SOME MATH PROBLEMS B, P77; MacCall AD., 1990, DYNAMIC GEOGRAPHY MA; McKinney Michael L., 1997, Population and Community Biology Series, V17, P110; Mesnil B, 2009, AQUAT LIVING RESOUR, V22, P207, DOI 10.1051/alr/2009003; MYERS RA, 1995, CAN J FISH AQUAT SCI, V52, P1274, DOI 10.1139/f95-124; Myers RA, 1989, ICES CM, P15; Neubauer P, 2013, SCIENCE, V340, P347, DOI 10.1126/science.1230441; PERRY RI, 1994, CAN J FISH AQUAT SCI, V51, P589, DOI 10.1139/f94-061; Pitcher Tony J., 1993, Fish and Fisheries Series, V7, P363; Quinn TJ, 1999, GEOPHYS J INT; R Development Core Team, 2014, R LANG ENV STAT COMP; Rangeley RW, 1998, ECOLOGY, V79, P943; Ricard D, 2013, MAP PRODUCED BEDFORD; Ricard D, 2012, THESIS; Rowe S, 2004, ICES J MAR SCI, V61, P1144, DOI 10.1016/j.icesjms.2004.07.007; Schindler DE, 2010, NATURE, V465, P609, DOI 10.1038/nature09060; Shackell NL, 2005, ECOL APPL, V15, P1440, DOI 10.1890/04-0642; Shepherd TD, 2004, FISH FISH, V5, P141, DOI 10.1111/j.1467-2979.2004.00143.x; Shumway R.H., 2006, TIME SERIES ANAL ITS; Simmonds EJ, 2010, STECF STUD GROUP EV, P227; SWAIN DP, 1995, MAR ECOL PROG SER, V116, P11, DOI 10.3354/meps116011; SWAIN DP, 1994, CAN J FISH AQUAT SCI, V51, P1046, DOI 10.1139/f94-104; Trenkel VM, 2013, AQUAT LIVING RESOUR, V26, P319, DOI 10.1051/alr/2013060; Wilberg MJ, 2010, REV FISH SCI, V18, P7, DOI 10.1080/10641260903294647; Wilson RJ, 2004, NATURE, V432, P393, DOI 10.1038/nature03031; Woillez M, 2009, AQUAT LIVING RESOUR, V22, P155, DOI 10.1051/alr/2009017; Ying YP, 2011, CAN J FISH AQUAT SCI, V68, P2101, DOI 10.1139/F2011-116; Zwanenburg KC, 2002, INDICES FISH DISTRIB	61	24	24	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2015	10	3							e0120500	10.1371/journal.pone.0120500	http://dx.doi.org/10.1371/journal.pone.0120500			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD9NQ	25789624	Green Submitted, Green Published, gold			2022-12-27	WOS:000351425400161
J	Shin, JY; Choi, NK; Lee, J; Seong, JM; Park, MJ; Lee, SH; Park, BJ				Shin, Ju-Young; Choi, Nam-Kyong; Lee, Joongyub; Seong, Jong-Mi; Park, Mi-Ju; Lee, Shin Haeng; Park, Byung-Joo			Risk of Ischemic Stroke Associated with the Use of Antipsychotic Drugs in Elderly Patients: A Retrospective Cohort Study in Korea	PLOS ONE			English	Article							CEREBROVASCULAR EVENTS; ATYPICAL ANTIPSYCHOTICS; LOGISTIC-REGRESSION; DEMENTIA; 2ND-GENERATION; METAANALYSIS; MEDICATION; ADJUSTMENT; DISORDERS; BEHAVIORS	Objective Strong concerns have been raised about whether the risk of ischemic stroke differs between conventional antipsychotics (CAPs) and atypical antipsychotics (AAPs). This study compared the risk of ischemic stroke in elderly patients taking CAPs and AAPs. Method We conducted a retrospective cohort study of 71,584 elderly patients who were newly prescribed the CAPs (haloperidol or chlorpromazine) and those prescribed the AAPs (risperidone, quetiapine, or olanzapine). We used the National Claims Database from the Health Insurance Review and Assessment Service (HIRA) from January 1, 2006 to December 31, 2009. Incident cases for ischemic stroke (ICD-10, I63) were identified. The hazard ratios (HR) for AAPs, CAPs, and for each antipsychotic were calculated using multivariable Cox regression models, with risperidone as a reference. Results Among a total of 71,584 patients, 24,668 patients were on risperidone, 15,860 patients on quetiapine, 3,888 patients on olanzapine, 19,564 patients on haloperidol, and 7,604 patients on chlorpromazine. A substantially higher risk was observed with chlorpromazine (HR = 3.47, 95% CI, 1.97-5.38), which was followed by haloperidol (HR = 2.43, 95% CI, 1.18-3.14), quetiapine (HR = 1.23, 95% CI, 0.78-2.12), and olanzapine (HR = 1.12, 95% CI, 0.59-2.75). Patients who were prescribed chlorpromazine for longer than 150 days showed a higher risk (HR = 3.60, 95% CI, 1.83-6.02) than those who took it for a shorter period of time. Conclusions A much greater risk of ischemic stroke was observed in patients who used chlorpromazine and haloperidol compared to risperidone. The evidence suggested that there is a strong need to exercise caution while prescribing these agents to the elderly in light of severe adverse events with atypical antipsychotics.	[Shin, Ju-Young; Seong, Jong-Mi; Park, Mi-Ju; Lee, Shin Haeng; Park, Byung-Joo] Korea Inst Drug Safety & Risk Management, Seoul, South Korea; [Choi, Nam-Kyong; Lee, Joongyub] Seoul Natl Univ Hosp, Seoul Natl Univ Coll Med, Med Res Collaborating Ctr, Seoul 110744, South Korea; [Park, Byung-Joo] Seoul Natl Univ, Coll Med, Dept Prevent Med, Seoul, South Korea	Seoul National University (SNU); Seoul National University Hospital; Seoul National University (SNU)	Park, BJ (corresponding author), Korea Inst Drug Safety & Risk Management, Seoul, South Korea.	bjpark@snu.ac.kr		Shin, Ju-Young/0000-0003-1010-7525; Lee, Shin Haeng/0000-0002-4062-7903; Choi, Nam-Kyong/0000-0003-1153-9928	Ministry of Food and Drug Safety [14172MFDS174]	Ministry of Food and Drug Safety(Ministry of Food & Drug Safety (MFDS), Republic of Korea)	This study was supported by a grant (14172MFDS174) from the Ministry of Food and Drug Safety. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abidi S, 2003, CAN J PSYCHIAT, V48, P749, DOI 10.1177/070674370304801107; Becg CB, 1984, BIOMETRIKA, V71, P11; Brookhart MA, 2006, AM J EPIDEMIOL, V163, P1149, DOI 10.1093/aje/kwj149; Burke AD, 2009, EXPERT OPIN PHARMACO, V10, P2407, DOI 10.1517/14656560903200659; Cadarette SM, 2010, PHARMACOEPIDEM DR S, V19, P2, DOI 10.1002/pds.1845; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Davis JM, 2004, J CLIN PSYCHOPHARM, V24, P192, DOI 10.1097/01.jcp.0000117422.05703.ae; Devanand DP, 1998, AM J PSYCHIAT, V155, P1512, DOI 10.1176/ajp.155.11.1512; Douglas IJ, 2008, BMJ-BRIT MED J, P337, DOI DOI 10.1136/BMJ.A1277; Dusetzina SB, 2012, MED CARE, V50, P466, DOI 10.1097/MLR.0b013e318245a160; Falissard B, 2011, INT CLIN PSYCHOPHARM, V26, P291, DOI 10.1097/YIC.0b013e32834a5bf6; Finkel S, 2005, INT PSYCHOGERIATR, V17, P617, DOI 10.1017/S1041610205002280; Gill SS, 2005, BMJ-BRIT MED J, V330, P445, DOI 10.1136/bmj.38330.470486.8F; Goldstein LB, 2011, STROKE, V42, P517, DOI 10.1161/STR.0b013e3181fcb238; Haddad PM, 2007, CNS DRUGS, V21, P911, DOI 10.2165/00023210-200721110-00004; Huybrechts K, 2012, BMJ-BRIT MED J, P344; Kales HC, 2012, AM J PSYCHIAT, V169, P71, DOI 10.1176/appi.ajp.2011.11030347; Kim Y, 2013, JPERM, V6, P93; Kinon BJ, 2003, PSYCHONEUROENDOCRINO, V28, P69, DOI 10.1016/S0306-4530(02)00128-2; Kleijer BC, 2009, J PSYCHOPHARMACOL, V23, P909, DOI 10.1177/0269881108093583; Kurth T, 2006, AM J EPIDEMIOL, V163, P262, DOI 10.1093/aje/kwj047; Kwon S, 2003, HEALTH POLICY PLANN, V18, P84, DOI 10.1093/heapol/18.1.84; Laredo L, 2011, J AM GERIATR SOC, V59, P1182, DOI 10.1111/j.1532-5415.2011.03479.x; Leucht S, 2013, LANCET, V382, P951, DOI 10.1016/S0140-6736(13)60733-3; Leucht S, 2009, LANCET, V373, P31, DOI 10.1016/S0140-6736(08)61764-X; Ministry of Health and Welfare, 2000, NAT CARD DIS SURV SY; Park B., 2003, REPORT EVALUATION VA, P19; Park JK, 2000, KOREAN J PREV MED, V33, P76, DOI DOI 10.1161/01.STR.0000078562.82918.F6; Patrick AR, 2011, PHARMACOEPIDEM DR S, V20, P551, DOI 10.1002/pds.2098; Quan HD, 2005, MED CARE, V43, P1130, DOI 10.1097/01.mlr.0000182534.19832.83; Rafaniello C, 2014, EUR J CLIN PHARMACOL, V70, P187, DOI 10.1007/s00228-013-1588-3; Roukema J, 2008, J CLIN EPIDEMIOL, V61, P135, DOI 10.1016/j.jclinepi.2007.07.005; Sacchetti E, 2010, J PSYCHOPHARMACOL, V24, P1131, DOI 10.1177/0269881109103202; Sacchetti E, 2008, J PSYCHOPHARMACOL, V22, P39, DOI 10.1177/0269881107080792; Sacchetti E, 2010, DRUG SAFETY, V33, P273, DOI 10.2165/11319120-000000000-00000; Sato T, 2003, EPIDEMIOLOGY, V14, P680, DOI 10.1097/01.EDE.0000081989.82616.7d; Schneeweiss S, 2009, EPIDEMIOLOGY, V20, P512, DOI 10.1097/EDE.0b013e3181a663cc; Shin JY, 2011, J KOREAN MED SCI, V26, P1461, DOI 10.3346/jkms.2011.26.11.1461; Small GW, 1997, JAMA-J AM MED ASSOC, V278, P1363, DOI 10.1001/jama.278.16.1363; Sultana J, 2014, INT J GERIATR PSYCH, V29, P1249, DOI 10.1002/gps.4101; Sung SK, 2009, CLIN THER, V31, P1309, DOI 10.1016/j.clinthera.2009.06.011; Vasilyeva I, 2013, J CLIN PSYCHOPHARM, V33, P24, DOI 10.1097/JCP.0b013e31827934a4; Wallaschofski H, 2001, J CLIN ENDOCR METAB, V86, P5912, DOI 10.1210/jc.86.12.5912; Wang PS, 2005, NEW ENGL J MED, V353, P2335, DOI 10.1056/NEJMoa052827; Wooltorton E, 2002, CAN MED ASSOC J, V167, P1269; Wu CS, 2013, BIOL PSYCHIAT, V73, P414, DOI 10.1016/j.biopsych.2012.07.006; Zhang JP, 2013, INT J NEUROPSYCHOPH, V16, P1205, DOI 10.1017/S1461145712001277	47	84	87	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2015	10	3							e0119931	10.1371/journal.pone.0119931	http://dx.doi.org/10.1371/journal.pone.0119931			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD9NQ	25790285	Green Submitted, Green Published, gold			2022-12-27	WOS:000351425400117
J	Dively, GP; Embrey, MS; Kamel, A; Hawthorne, DJ; Pettis, JS				Dively, Galen P.; Embrey, Michael S.; Kamel, Alaa; Hawthorne, David J.; Pettis, Jeffery S.			Assessment of Chronic Sublethal Effects of Imidacloprid on Honey Bee Colony Health	PLOS ONE			English	Article							APIS-MELLIFERA HYMENOPTERA; NEONICOTINOID INSECTICIDES; PESTICIDE-RESIDUES; COLLAPSE DISORDER; NATIONAL-SURVEY; UNITED-STATES; POLLEN; LOSSES; EXPOSURE; TOXICITY	Here we present results of a three-year study to determine the fate of imidacloprid residues in hive matrices and to assess chronic sublethal effects on whole honey bee colonies fed supplemental pollen diet containing imidacloprid at 5, 20 and 100 mu g/kg over multiple brood cycles. Various endpoints of colony performance and foraging behavior were measured during and after exposure, including winter survival. Imidacloprid residues became diluted or non-detectable within colonies due to the processing of beebread and honey and the rapid metabolism of the chemical. Imidacloprid exposure doses up to 100 mu g/kg had no significant effects on foraging activity or other colony performance indicators during and shortly after exposure. Diseases and pest species did not affect colony health but infestations of Varroa mites were significantly higher in exposed colonies. Honey stores indicated that exposed colonies may have avoided the contaminated food. Imidacloprid dose effects was delayed later in the summer, when colonies exposed to 20 and 100 mu g/kg experienced higher rates of queen failure and broodless periods, which led to weaker colonies going into the winter. Pooled over two years, winter survival of colonies averaged 85.7, 72.4, 61.2 and 59.2% in the control, 5, 20 and 100 mu g/kg treatment groups, respectively. Analysis of colony survival data showed a significant dose effect, and all contrast tests comparing survival between control and treatment groups were significant, except for colonies exposed to 5 mu g/kg. Given the weight of evidence, chronic exposure to imidacloprid at the higher range of field doses (20 to 100 mu g/kg) in pollen of certain treated crops could cause negative impacts on honey bee colony health and reduced overwintering success, but the most likely encountered high range of field doses relevant for seed-treated crops (5 mu g/kg) had negligible effects on colony health and are unlikely a sole cause of colony declines.	[Dively, Galen P.; Embrey, Michael S.; Hawthorne, David J.] Univ Maryland, Dept Entomol, College Pk, MD 20742 USA; [Kamel, Alaa] US EPA, Analyt Chem Branch, Biol & Econ Anal Div, Off Pesticide Programs, Ft George G Meade, MD USA; [Pettis, Jeffery S.] USDA ARS Bee Res Lab, Beltsville, MD USA	University System of Maryland; University of Maryland College Park; United States Environmental Protection Agency	Dively, GP (corresponding author), Univ Maryland, Dept Entomol, College Pk, MD 20742 USA.	galen@umd.edu	Serrano, Jose/A-2854-2009	Serrano, Jose/0000-0002-1565-5216	USDA-ARS Bee Research Laboratory; Maryland Agricultural Experiment Station; UMD Libraries Open Access Publishing Fund; National Socio-Environmental Synthesis Center (SESYNC) - National Science Foundation (NSF) [DBI-1052875]; ARS [ARS-0425645] Funding Source: Federal RePORTER; Div Of Biological Infrastructure [1052875] Funding Source: National Science Foundation	USDA-ARS Bee Research Laboratory; Maryland Agricultural Experiment Station; UMD Libraries Open Access Publishing Fund; National Socio-Environmental Synthesis Center (SESYNC) - National Science Foundation (NSF)(National Science Foundation (NSF)); ARS(United States Department of Agriculture (USDA)USDA Agricultural Research Service); Div Of Biological Infrastructure(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	Funded primarily by a Cooperative Agreement with the USDA-ARS Bee Research Laboratory. Partial funding by the Maryland Agricultural Experiment Station. Funding for Open Access provided by the UMD Libraries Open Access Publishing Fund. D.J.H. received support from the National Socio-Environmental Synthesis Center (SESYNC) - National Science Foundation (NSF) award DBI-1052875. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2014, ENV SCI POLLUT RES; [Anonymous], 2011, FINE CHEM IND BUSINE, DOI DOI 10.1002/9780470946404; Bernal J, 2010, J ECON ENTOMOL, V103, P1964, DOI 10.1603/EC10235; Biesmeijer JC, 2006, SCIENCE, V313, P351, DOI 10.1126/science.1127863; Blacquiere T, 2012, ECOTOXICOLOGY, V21, P973, DOI 10.1007/s10646-012-0863-x; Bonmatin JM, 2003, ANAL CHEM, V75, P2027, DOI 10.1021/ac020600b; Bortolotti Laura, 2003, Bulletin of Insectology, V56, P63; Cameron SA, 2011, P NATL ACAD SCI USA, V108, P662, DOI 10.1073/pnas.1014743108; Charvet R., 2004, Annales Pharmaceutiques Francaises, V62, P29, DOI 10.1016/S0003-4509(04)94278-2; Chauzat MP, 2009, ENVIRON ENTOMOL, V38, P514, DOI 10.1603/022.038.0302; Chauzat MP, 2011, ENVIRON TOXICOL CHEM, V30, P103, DOI 10.1002/etc.361; Chauzat MP, 2006, J ECON ENTOMOL, V99, P253, DOI 10.1603/0022-0493-99.2.253; Cornman RS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043562; Cresswell JE, 2012, PEST MANAG SCI, V68, P819, DOI 10.1002/ps.3290; Cresswell JE, 2011, ECOTOXICOLOGY, V20, P149, DOI 10.1007/s10646-010-0566-0; Cutler GC, 2007, J ECON ENTOMOL, V100, P765, DOI 10.1603/0022-0493(2007)100[765:ETCSCH]2.0.CO;2; Decourtye A, 2013, NATURE, V497, P188, DOI 10.1038/497188a; Decourtye A, 2010, ADV EXP MED BIOL, V683, P85; DeGrandi-Hoffman G, 2008, J APICULT RES, V47, P265, DOI 10.3896/IBRA.1.47.4.06; DeGrandi-Hoffman G, 2010, J INSECT PHYSIOL, V56, P1184, DOI 10.1016/j.jinsphys.2010.03.017; Desneux N, 2007, ANNU REV ENTOMOL, V52, P81, DOI 10.1146/annurev.ento.52.110405.091440; Di Prisco G, 2013, P NATL ACAD SCI USA, V110, P18466, DOI 10.1073/pnas.1314923110; Dively GP, 2012, J AGR FOOD CHEM, V60, P4449, DOI 10.1021/jf205393x; Elbert A, 2008, PEST MANAG SCI, V64, P1099, DOI 10.1002/ps.1616; Faucon JP, 2005, PEST MANAG SCI, V61, P111, DOI 10.1002/ps.957; Faucon JP, 2002, BEE WORLD, V83, P14, DOI 10.1080/0005772X.2002.11099532; Feltham H, 2014, ECOTOXICOLOGY, V23, P317, DOI 10.1007/s10646-014-1189-7; FRAZIER J., 2011, AM BEE J, V151, P779; Gallai N, 2009, ECOL ECON, V68, P810, DOI 10.1016/j.ecolecon.2008.06.014; Genersch E, 2010, APIDOLOGIE, V41, P332, DOI 10.1051/apido/2010014; Girolami V, 2009, J ECON ENTOMOL, V102, P1808, DOI 10.1603/029.102.0511; Goulson D, 2013, J APPL ECOL, V50, P977, DOI 10.1111/1365-2664.12111; Hawthorne DJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026796; Henry M, 2012, SCIENCE, V336, P348, DOI 10.1126/science.1215039; Holden C, 2006, SCIENCE, V314, P397, DOI 10.1126/science.314.5798.397; Hrassnigg N, 2005, APIDOLOGIE, V36, P255, DOI 10.1051/apido:2005015; Jeschke P, 2011, J AGR FOOD CHEM, V59, P2897, DOI 10.1021/jf101303g; Johnson RM, 2010, APIDOLOGIE, V41, P312, DOI 10.1051/apido/2010018; Johnson RM, 2009, J ECON ENTOMOL, V102, P474, DOI 10.1603/029.102.0202; Kamel A, 2010, J AGR FOOD CHEM, V58, P5926, DOI 10.1021/jf904120n; Krieger R. I, 2001, HDB PESTICIDE TOXICO, V2, P1123; Krupke CH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029268; Kunkel GR., 2014, THESIS; Laurent FM, 2003, J AGR FOOD CHEM, V51, P8005, DOI 10.1021/jf034310n; Lu CS, 2012, B INSECTOL, V65, P99; Matsuda K, 2005, ACS SYM SER, P172; Maus Christian, 2003, Bulletin of Insectology, V56, P51; Mullin CA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009754; National Research Council, 2007, STAT POLL N AM; Nauen R, 2001, PEST MANAG SCI, V57, P577, DOI 10.1002/ps.331; Nguyen BK, 2009, J ECON ENTOMOL, V102, P616, DOI 10.1603/029.102.0220; Oldroyd BP, 2007, PLOS BIOL, V5, P1195, DOI 10.1371/journal.pbio.0050168; Pettis JS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070182; Pettis JS, 2012, NATURWISSENSCHAFTEN, V99, P153, DOI 10.1007/s00114-011-0881-1; Pilling E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077193; Pohorecka K, 2012, J APIC SCI, V56, P115, DOI 10.2478/v10289-012-0029-3; Potts SG, 2010, TRENDS ECOL EVOL, V25, P345, DOI 10.1016/j.tree.2010.01.007; Rondeau G, 2014, SCI REP-UK, V4, DOI 10.1038/srep05566; Rortais A, 2005, APIDOLOGIE, V36, P71, DOI 10.1051/apido:2004071; Rose R, 2007, APIDOLOGIE, V38, P368, DOI 10.1051/apido:2007022; Sanchez-Bayo F, 2014, SCIENCE, V346, P806, DOI 10.1126/science.1259159; Sandrock C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103592; Schmuck R, 2001, PEST MANAG SCI, V57, P225, DOI 10.1002/ps.270; Schneider CW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030023; Spleen AM, 2013, J APICULT RES, V52, DOI 10.3896/IBRA.1.52.2.07; Starner K, 2012, B ENVIRON CONTAM TOX, V88, P316, DOI 10.1007/s00128-011-0515-5; Staveley JP, 2014, HUM ECOL RISK ASSESS, V20, P566, DOI 10.1080/10807039.2013.831263; Stoner KA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039114; Suchail S, 2004, PEST MANAG SCI, V60, P291, DOI 10.1002/ps.772; Tapparo A, 2011, J ENVIRON MONITOR, V13, P1564, DOI 10.1039/c1em10085h; van der Zee R, 2012, J APICULT RES, V51, P91, DOI 10.3896/IBRA.1.51.1.12; Vanengelsdorp D, 2012, J APICULT RES, V51, P115, DOI 10.3896/IBRA.1.51.1.14; vanEngelsdorp D, 2010, J ECON ENTOMOL, V103, P1517, DOI 10.1603/EC09429; vanEngelsdorp D, 2010, J APICULT RES, V49, P7, DOI 10.3896/IBRA.1.49.1.03; vanEngelsdorp D, 2010, J INVERTEBR PATHOL, V103, pS80, DOI 10.1016/j.jip.2009.06.011; vanEngelsdorp D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006481	76	146	150	6	227	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2015	10	3							e0118748	10.1371/journal.pone.0118748	http://dx.doi.org/10.1371/journal.pone.0118748			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9BN	25786127	Green Published, gold, Green Submitted			2022-12-27	WOS:000352138500046
J	Hu, YD; Teng, WP; Liu, LM; Chen, K; Liu, L; Hua, R; Chen, J; Zhou, Y; Chen, L				Hu, Yuedong; Teng, Weiping; Liu, Limin; Chen, Kang; Liu, Lei; Hua, Rui; Chen, Jun; Zhou, Yun; Chen, Lei			Prevalence and Risk Factors of Diabetes and Diabetic Retinopathy in Liaoning Province, China: A Population-Based Cross-Sectional Study	PLOS ONE			English	Article							SUBCLINICAL HYPOTHYROIDISM; MICROVASCULAR OUTCOMES; ASSOCIATION; MELLITUS; SMOKING; HEALTH; MEN; ATHEROSCLEROSIS; COMPLICATIONS; TRIAL	Aim To evaluate the prevalence and risk factors of diabetes and diabetic retinopathy (DR) in northeast area of China with a population-based study. Methods A population of 3173 (aged from 20 to 80 years old) was stratified by geographical location and age in Liaoning province, China. Prediabetes and diabetes were diagnosed according to the guideline of American Diabetes Association. Retinal photographs were obtained by using digital non-mydriatic camera for the presence and grading of DR according to the modified ETDRS Airlie house classification. Blood samples and comprehensive questionnaires were obtained for evaluation of laboratory results and risk factors. Results The prevalence of prediabetes and diabetes was 20.7% and 10.4%, respectively. Among diabetes patients, DR prevalence was 11.9%. Age, obesity, total cholesterol, triglycerides, hypertension, living in rural areas and diabetes family history are all risk factors for prediabetes and diabetes. Waist-to-hip circumference rate served as a better obesity index to estimate diabetes risk compared with body mass index and waist circumference. Among all risk factors that we investigated, only the length of diabetes history was associated with the incidence of DR. However, DR prevalence in the newly discovered patients in rural areas was significantly higher than that in urban areas. Conclusion According to this study, 1 in 10 people has diabetes, 2 in 10 people have prediabetes, and 1 in 10 diabetics has DR in Liaoning province. In rural areas, diabetes was poorly recognized with limited medical resources, which probably resulted in more diabetes patient at a high risk of DR.	[Hu, Yuedong; Liu, Limin; Chen, Kang; Liu, Lei; Hua, Rui; Chen, Jun; Zhou, Yun; Chen, Lei] China Med Univ, Affiliated Hosp 1, Dept Ophthalmol, Shenyang 110001, Liaoning Provin, Peoples R China; [Hu, Yuedong; Liu, Limin; Liu, Lei; Chen, Lei] Diabet Eye Ctr Liaoning Prov, Shenyang, Liaoning Provin, Peoples R China; [Teng, Weiping] China Med Univ, Affiliated Hosp 1, Dept Endocrinol, Shenyang 110001, Liaoning Provin, Peoples R China; [Teng, Weiping; Chen, Lei] Key Lab Endocrine Dis Liaoning Prov, Shenyang, Liaoning Provin, Peoples R China	China Medical University; China Medical University	Chen, L (corresponding author), China Med Univ, Affiliated Hosp 1, Dept Ophthalmol, Shenyang 110001, Liaoning Provin, Peoples R China.	leichen1952@163.com	liu, li/HGC-0900-2022		Science and technique projects of Liaoning province [2009225005]; 11th five-year national technology support program [2007BAI18B07]	Science and technique projects of Liaoning province; 11th five-year national technology support program	This study was supported by grants of Science and technique projects of Liaoning province (2009225005) and the 11th five-year national technology support program (2007BAI18B07). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aiello LM, 2003, AM J OPHTHALMOL, V136, P122, DOI 10.1016/S0002-9394(03)00219-8; Al Sayed A, 2006, ENDOCR J, V53, P653, DOI 10.1507/endocrj.K06-018; Amer Diabet Assoc, 2005, DIABETES CARE, V28, pS37; [Anonymous], 1991, OPHTHALMOLOGY, V98, P786; [Anonymous], GLOB BURD DIS 2004 U; Antonetti DA, 2012, NEW ENGL J MED, V366, P1227, DOI 10.1056/NEJMra1005073; Bener A, 2013, J OBES, V2013, DOI 10.1155/2013/269038; Beulens JWJ, 2009, DIABETOLOGIA, V52, P2027, DOI 10.1007/s00125-009-1457-x; Cai XL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091174; Chan JCN, 2009, JAMA-J AM MED ASSOC, V301, P2129, DOI 10.1001/jama.2009.726; Cho NH, 2009, CLIN ENDOCRINOL, V71, P679, DOI 10.1111/j.1365-2265.2009.03586.x; Deladoey J, 2013, J CLIN ENDOCR METAB, V98, pE882, DOI 10.1210/jc.2013-1212; Garg A, 2004, J CLIN ENDOCR METAB, V89, P4206, DOI 10.1210/jc.2004-0631; Hansen AB, 2004, ACTA OPHTHALMOL SCAN, V82, P656, DOI 10.1111/j.1600-0420.2004.00347.x; Ismail-Beigi F, 2010, LANCET, V376, P419, DOI 10.1016/S0140-6736(10)60576-4; Jee SH, 2010, DIABETES CARE, V33, P2567, DOI 10.2337/dc10-0261; Kastelan S, 2010, REPROD BIOL ENDOCRIN, V8, DOI 10.1186/1477-7827-8-124; Klein R, 2002, OPHTHALMOLOGY, V109, P1225, DOI 10.1016/S0161-6420(02)01074-6; Namperumalsamy P, 2009, BRIT J OPHTHALMOL, V93, P429, DOI 10.1136/bjo.2008.147934; Pan XR, 1997, DIABETES CARE, V20, P1664, DOI 10.2337/diacare.20.11.1664; Patel A, 2007, LANCET, V370, P829, DOI 10.1016/S0140-6736(07)61303-8; Porta M, 2002, DIABETOLOGIA, V45, P1617, DOI 10.1007/s00125-002-0990-7; Society CD, 2011, CHIN GUID TYP 2 DIAB; Uchimoto S, 1999, DIABETIC MED, V16, P951, DOI 10.1046/j.1464-5491.1999.00173.x; VAGUE J, 1956, AM J CLIN NUTR, V4, P20, DOI 10.1093/ajcn/4.1.20; van Dieren S, 2010, EUR J CARDIOV PREV R, V17, pS3, DOI 10.1097/01.hjr.0000368191.86614.5a; Wang FH, 2009, OPHTHALMOLOGY, V116, P461, DOI 10.1016/j.ophtha.2008.10.003; Wannamethee SG, 2001, DIABETES CARE, V24, P1590, DOI 10.2337/diacare.24.9.1590; World Health Organization, 2001, OB PREV MAN GLOB EP, V894, pi; Xie XW, 2009, EUR J OPHTHALMOL, V19, P91, DOI 10.1177/112067210901900114; Yang JK, 2010, DIABETES CARE, V33, P1018, DOI 10.2337/dc09-1784; Yang JY, 2013, DIABETES RES CLIN PR, V102, P218, DOI 10.1016/j.diabres.2013.10.016; Yang L, 2013, J DIABETES RES, V2013, DOI 10.1155/2013/264579; Yang WY, 2010, NEW ENGL J MED, V362, P1090, DOI 10.1056/NEJMoa0908292; Zhang Hong-Xia, 2009, Zhonghua Yi Xue Za Zhi, V89, P1749; Zhang K, 2012, NAT REV DRUG DISCOV, V11, P541, DOI 10.1038/nrd3745; Zhang LY, 2001, DIABETES CARE, V24, P1275, DOI 10.2337/diacare.24.7.1275	37	37	38	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2015	10	3							e0121477	10.1371/journal.pone.0121477	http://dx.doi.org/10.1371/journal.pone.0121477			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9BN	25785633	Green Published, gold, Green Submitted			2022-12-27	WOS:000352138500211
J	Koukoui, F; Desmoulin, F; Galinier, M; Barutaut, M; Caubere, C; Evaristi, MF; Murat, G; De Boer, R; Berry, M; Smih, F; Rouet, P				Koukoui, Francois; Desmoulin, Franck; Galinier, Michel; Barutaut, Manon; Caubere, Celine; Evaristi, Maria Francesca; Murat, Gurbuz; De Boer, Rudolf; Berry, Matthieu; Smih, Fatima; Rouet, Philippe			The Prognostic Value of Plasma Galectin-3 in Chronic Heart Failure Patients Is Maintained when Treated with Mineralocorticoid Receptor Antagonists	PLOS ONE			English	Article							EXTRACELLULAR-MATRIX TURNOVER; SERUM GALECTIN-3; TASK-FORCE; FIBROSIS; ALDOSTERONE; SPIRONOLACTONE; THERAPY; MARKER; MACROPHAGES; EPLERENONE	Objective Galectin-3 (Gal-3) is considered as a myocardial fibrosis biomarker with prognostic value in heart failure (HF). Since aldosterone is a neurohormone with established fibrotic properties, we aimed to investigate if mineralocorticoid receptor antagonists (MRAs) would modulate the prognostic value of Gal-3. Methods The IBLOMAVED cohort comprised 427 eligible chronic HF patients (CHF) with echocardiography and heart failure biomarkers assessments (BNP). After propensity score matching CHF patients for cardiovascular risk factors, to form balanced groups, Gal-3 levels were measured at baseline in plasma from patients treated with MRAs (MRA-Plus, n=101) or not (MRA-Neg, n=101). The primary end point was all-cause mortality with a follow-up of 3 years. Results Gal-3 in plasma from these patients were similar with median values of 14.0 ng/mL [IQR, 9.9-19.3] and 14.4 ng/mL [IQR, 12.3-19.8] (P=0.132) in MRA-Neg and MRA-Plus, respectively. Patients with Gal-3 <= 17.8 ng/mL had an HR of 1 (reference group) and 1.5 [0.4-5.7] in MRA-Neg and MRA-Plus, respectively (p=0.509). Patients with Gal-3 <= 17.8 ng/mL had an HR of 7.4 [2.2-24.6] and 9.0 [2.9-27.8] in MRA-Plus and MRA-Neg, respectively (p=0.539) and a median survival time of 2.4 years [95% CI, 1.8-2.4]. Multivariate Cox proportional hazard analysis confirmed that MRA and the interaction term between MRA treatment and Gal-3 >17.8 ng/mL were not factors associated with survival. Conclusions MRA treatment did not impair the prognostic value of Gal-3 assessed with a 17.8 ng/mL cut off. Gal-3 levels maintained its strong prognostic value in CHF also in patients treated with MRAs. The significance of the observed lack of an interaction between Gal-3 and treatment effect of MRAs remains to be elucidated.	[Koukoui, Francois; Desmoulin, Franck; Galinier, Michel; Barutaut, Manon; Caubere, Celine; Evaristi, Maria Francesca; Murat, Gurbuz; Berry, Matthieu; Smih, Fatima; Rouet, Philippe] Univ UPS, UMR 1048, INSERM I2MC, Equipe,Obes & Insuffisance Cardiaque Approche Mol, F-31432 Toulouse, France; [Galinier, Michel; Murat, Gurbuz; Berry, Matthieu] CHU Rangueil, Serv Cardiol A, F-31432 Toulouse, France; [De Boer, Rudolf] Univ Groningen, Univ Med Ctr Groningen, Dept Cardiol, Groningen, Netherlands	Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; CHU de Toulouse; University of Groningen	Rouet, P (corresponding author), Univ UPS, UMR 1048, INSERM I2MC, Equipe,Obes & Insuffisance Cardiaque Approche Mol, F-31432 Toulouse, France.	Philippe.rouet@inserm.fr	de Boer, Rudolf/ABE-9879-2020; desmoulin, franck/AAU-4544-2020; DESMOULIN, Franck/O-1895-2018	desmoulin, franck/0000-0003-0560-6266; DESMOULIN, Franck/0000-0003-0560-6266; Rouet, Philippe/0000-0001-6204-2079; Evaristi, Maria Francesca/0000-0002-5188-4446; GALINIER, Michel/0000-0003-1735-3390	BioMerieux	BioMerieux	This work was supported by BioMerieux. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Austin PC, 2011, PHARM STAT, V10, P150, DOI 10.1002/pst.433; BARONDES SH, 1994, J BIOL CHEM, V269, P20807; Brilla CG, 2000, HERZ, V25, P299, DOI 10.1007/s000590050024; Calvier L, 2013, ARTERIOSCL THROM VAS, V33, P67, DOI 10.1161/ATVBAHA.112.300569; Collier TJ, 2013, EUR HEART J, V34, P2823, DOI 10.1093/eurheartj/eht247; Cooper DNW, 2002, BBA-GEN SUBJECTS, V1572, P209, DOI 10.1016/S0304-4165(02)00310-0; De Berardinis B, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/983098; de Boer RA, 2012, J INTERN MED, V272, P55, DOI 10.1111/j.1365-2796.2011.02476.x; de Boer RA, 2011, ANN MED, V43, P60, DOI 10.3109/07853890.2010.538080; de Boer RA, 2009, EUR J HEART FAIL, V11, P811, DOI 10.1093/eurjhf/hfp097; Dumic J, 2006, BBA-GEN SUBJECTS, V1760, P616, DOI 10.1016/j.bbagen.2005.12.020; Fiuzat M, 2014, J CARD FAIL, V20, P38, DOI 10.1016/j.cardfail.2013.11.011; Gopal DM, 2012, J AM HEART ASSOC, V1, DOI 10.1161/JAHA.112.000760; Gullestad L, 2012, EUR HEART J, V33, P2290, DOI 10.1093/eurheartj/ehs077; Henderson NC, 2006, P NATL ACAD SCI USA, V103, P5060, DOI 10.1073/pnas.0511167103; Henderson NC, 2008, AM J PATHOL, V172, P288, DOI 10.2353/ajpath.2008.070726; Hernandez AF, 2012, JAMA-J AM MED ASSOC, V308, P2097, DOI 10.1001/jama.2012.14795; Ho DE, 2007, POLIT ANAL, V15, P199, DOI 10.1093/pan/mpl013; Ho JE, 2012, J AM COLL CARDIOL, V60, P1249, DOI 10.1016/j.jacc.2012.04.053; Carrasco-Sanchez FJ, 2013, INT J CARDIOL, V169, P177, DOI 10.1016/j.ijcard.2013.08.081; Kasama S, 2013, INT J CARDIOL, V167, P244, DOI 10.1016/j.ijcard.2011.12.080; Lin YH, 2009, CLIN CHIM ACTA, V409, P96, DOI 10.1016/j.cca.2009.09.001; Lok DJA, 2010, CLIN RES CARDIOL, V99, P323, DOI 10.1007/s00392-010-0125-y; MacKinnon AC, 2012, AM J RESP CRIT CARE, V185, P537, DOI 10.1164/rccm.201106-0965OC; McCullough PA, 2011, REV CARDIOVASC MED, V12, P200, DOI 10.3909/ricm0624; McMurray JJV, 2012, EUR J HEART FAIL, V14, P803, DOI 10.1093/eurjhf/hfs105; Peacock William Frank, 2014, Crit Pathw Cardiol, V13, P73, DOI 10.1097/HPC.0000000000000012; Pitt B, 1999, NEW ENGL J MED, V341, P709, DOI 10.1056/NEJM199909023411001; Rossignol P, 2011, J AM COLL CARDIOL, V58, P1958, DOI 10.1016/j.jacc.2011.04.049; Seferovic JP, 2014, CLIN CHEM LAB MED, V52, P1499, DOI 10.1515/cclm-2014-0265; Sharma UC, 2004, CIRCULATION, V110, P3121, DOI 10.1161/01.CIR.0000147181.65298.4D; Smih F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020414; van der Velde AR, 2013, CIRC-HEART FAIL, V6, P219, DOI 10.1161/CIRCHEARTFAILURE.112.000129; van Kimmenade RR, 2006, J AM COLL CARDIOL, V48, P1217, DOI 10.1016/j.jacc.2006.03.061; White PC, 2003, J CLIN ENDOCR METAB, V88, P2376, DOI 10.1210/jc.2003-030373; Yancy CW, 2013, J AM COLL CARDIOL, V62, pE147, DOI 10.1016/j.jacc.2013.05.019; Yu LL, 2013, CIRC-HEART FAIL, V6, P107, DOI 10.1161/CIRCHEARTFAILURE.112.971168; Zannad F, 2000, CIRCULATION, V102, P2700, DOI 10.1161/01.CIR.102.22.2700	38	16	16	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2015	10	3							e0119160	10.1371/journal.pone.0119160	http://dx.doi.org/10.1371/journal.pone.0119160			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9BN	25786035	Green Published, Green Submitted, gold			2022-12-27	WOS:000352138500078
J	Riesgo, A; Taboada, S; Sanchez-Vila, L; Sola, J; Bertran, A; Avila, C				Riesgo, Ana; Taboada, Sergio; Sanchez-Vila, Laura; Sola, Joan; Bertran, Andrea; Avila, Conxita			Some Like It Fat: Comparative Ultrastructure of the Embryo in Two Demosponges of the Genus Mycale (Order Poecilosclerida) from Antarctica and the Caribbean	PLOS ONE			English	Article							ORANGE ICING SPONGE; MARINE-INVERTEBRATES; REPRODUCTIVE STRATEGIES; ECOLOGICAL IMPLICATIONS; BENTHIC INVERTEBRATES; ENERGY-METABOLISM; LIPID-METABOLISM; COLD ADAPTATION; MATURE OOCYTE; SEA-URCHIN	During embryogenesis, organisms with lecithotrophic indirect development usually accumulate large quantities of energetic reserves in the form of yolk that are necessary for larval survival. Since all sponges have lecithotrophic development, yolk formation is an ineludible step of their embryogenesis. Sponge yolk platelets have a wide range of morphological forms, from entirely lipid or protein platelets to a combined platelet showing both lipids and proteins and even glycogen. So far, there are no comparative studies on the nature and content of yolk in congeneric species of sponges inhabiting contrasting environments, which could have putative effects on the larval adaptation to environmental conditions. Here, we have taken advantage of the worldwide distribution of the sponge genus Mycale, in order to compare the embryogenesis and yolk formation in two species inhabiting contrasting latitudinal areas: M. acerata from Antarctic waters and M. laevis from the Caribbean. We have compared their brooded embryos and larvae using scanning and transmission electron microscopy, and calculated their energetic signatures based on the nature of their yolk. While the general morphological feature of embryos and larvae of both species were very similar, the main difference resided in the yolk nature. The Antarctic species, M. acerata, showed exclusively lipid yolk, whereas the Caribbean species, M. laevis, showed combined platelets of lipids and proteins and less frequently protein yolk platelets. The larvae of M. acerata were estimated to possess a two-fold energetic signature compared to that of M. laevis, which may have important ecological implications for their survival and for maintaining large population densities in the cold waters of the Southern Ocean.	[Riesgo, Ana; Taboada, Sergio; Sanchez-Vila, Laura; Sola, Joan; Bertran, Andrea; Avila, Conxita] Univ Barcelona, Fac Biol, Dept Anim Biol, Barcelona, Spain; [Riesgo, Ana; Taboada, Sergio; Avila, Conxita] Univ Barcelona, Fac Biol, Biodivers Res Inst IrBIO, Barcelona, Spain	University of Barcelona; University of Barcelona	Riesgo, A (corresponding author), Univ Barcelona, Fac Biol, Dept Anim Biol, Barcelona, Spain.	anariesgogil@gmail.com	Riesgo, Ana/E-3341-2014; Avila, Conxita/B-9466-2008; Taboada, Sergi/AAB-9390-2021	Riesgo, Ana/0000-0002-7993-1523; Avila, Conxita/0000-0002-5489-8376; Taboada, Sergi/0000-0003-1669-1152	Ministerio de Ciencia e Innovacion, Gobierno de Espana [CTM2010-17415/ANT]	Ministerio de Ciencia e Innovacion, Gobierno de Espana(Ministry of Science and Innovation, Spain (MICINN)Spanish Government)	Funding provided by CTM2010-17415/ANT - Ministerio de Ciencia e Innovacion, Gobierno de Espana: http://www.idi.mineco.gob.es/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSON E, 1974, INT REV CYTOL, P1; Bergquist P.R., 1979, Colloques Internationaux du Centre National de la Recherche Scientifique, P103; BERGQUIST P R, 1968, New Zealand Journal of Marine and Freshwater Research, V2, P426; BERGQUIST PR, 1973, MAR BIOL, V20, P35, DOI 10.1007/BF00387672; Bienati NL, 1977, POLAR OCEANS, P377; BOROJEVIC R, 1966, DEV BIOL, V14, P130, DOI 10.1016/0012-1606(66)90009-1; BOULEKBACHE H, 1981, AM ZOOL, V21, P377; Brien P, 1973, TRAITE ZOOL, P133; Cerrano C, 2004, POLAR BIOL, V27, P231, DOI 10.1007/s00300-003-0581-1; Clarke A., 1990, P9; CLARKE A, 1988, COMP BIOCHEM PHYS B, V90, P461, DOI 10.1016/0305-0491(88)90285-4; CLARKE A, 1980, BIOL J LINN SOC, V14, P77, DOI 10.1111/j.1095-8312.1980.tb00099.x; Corriero G, 1998, MAR BIOL, V131, P319, DOI 10.1007/s002270050325; Day R, 1984, ASPECTS PHYSL ECOLOG; DAYTON PK, 1974, ECOL MONOGR, V44, P105, DOI 10.2307/1942321; Delage Y, 1892, ARCH ZOOL EXP GEN, V10, P345; DIAZ J-P, 1973, Bulletin de la Societe Zoologique de France, V98, P145; ECKELBARGER KJ, 1986, B MAR SCI, V39, P426; Ereskovsky AV, 2008, ZOOMORPHOLOGY, V127, P175, DOI 10.1007/s00435-008-0061-9; Ereskovsky AV, 2010, COMPARATIVE EMBRYOLOGY OF SPONGES, P1, DOI 10.1007/978-90-481-8575-7; Fell P.E., 1974, pUnpaginated; Fell P.E., 1983, P1; Feller G, 2003, NAT REV MICROBIOL, V1, P200, DOI 10.1038/nrmicro773; GAINO E, 1986, INT J INVER REP DEV, V10, P297, DOI 10.1080/01688170.1986.10510253; GAINO E, 1994, INVERTEBR REPROD DEV, V26, P99, DOI 10.1080/07924259.1994.9672406; GALLISSIAN MF, 1976, ANN SCI NAT ZOOL, V18, P381; Giese AC, 1996, PHYS REV, V46, P244; GOREAU TF, 1966, SCIENCE, V151, P343, DOI 10.1126/science.151.3708.343; Hagen W, 2001, MAR BIOL, V139, P95, DOI 10.1007/s002270000527; Heras H, 2000, LIPIDS, V35, P645, DOI 10.1007/s11745-000-0569-z; Hill MS, 1998, OECOLOGIA, V117, P143, DOI 10.1007/s004420050642; Kattner G, 1998, MAR ECOL PROG SER, V170, P203, DOI 10.3354/meps170203; Kinne O, 1970, MARINE ECOLOGY     1, P407, DOI [DOI 10.1080/10417946609371849, 10.1080/10417946609371849]; Kowalke J, 2000, J EXP MAR BIOL ECOL, V247, P85, DOI 10.1016/S0022-0981(00)00141-6; LEPORE E, 1995, CAH BIOL MAR, V36, P15; LEVI C, 1976, ANN SCI NAT ZOOL, V18, P367; Levi C., 1964, Cahiers de Biologie Marine, V5, P97; Lieberkuhn N, 1859, ARCH ANAT PHYSL, P515; Lindquist N, 1966, ECOL MONOGR, P431; Loh TL, 2012, HYDROBIOLOGIA, V687, P205, DOI 10.1007/s10750-011-0806-1; Maas O, 1892, ANN MAG NAT HIS, V59, P399; Maldonado M, 2006, CAN J ZOOL, V84, P175, DOI 10.1139/Z05-177; Maldonado M, 2004, INVERTEBR BIOL, V123, P1; Maldonado M, 1997, MAR ECOL PROG SER, V148, P115, DOI 10.3354/meps148115; Maldonado M, 2008, TREBALLS SOC CATALAN, V59, P29; Maldonado M, 2009, MAR BIOL, V156, P2181, DOI 10.1007/s00227-009-1248-4; Maldonado Manuel, 2002, P21; Marsh AG, 1999, J EXP BIOL, V202, P2041; McClintock JB, 2005, INTEGR COMP BIOL, V45, P359, DOI 10.1093/icb/45.2.359; Meroz E, 1995, MAR BIOL, V124, P443, DOI 10.1007/BF00363918; Norrevang A., 1968, International Review of Cytology, V23, P113; Pace DA, 2007, BIOL BULL-US, V212, P115, DOI 10.2307/25066589; PAWLIK JR, 1995, MAR ECOL PROG SER, V127, P183, DOI 10.3354/meps127183; Pearse JS, 2009, SMITHSONIAN AT THE POLES: CONTRIBUTIONS TO INTERNATIONAL POLAR YEAR SCIENCE, P181, DOI 10.5479/si.097884601X.13; PEARSE JS, 1991, AM ZOOL, V31, P65; Peck LS, 2006, MAR ECOL PROG SER, V318, P213, DOI 10.3354/meps318213; Peck LS, 2006, BIOL REV, V81, P75, DOI 10.1017/S1464793105006871; Perez-Porro AR, 2012, HYDROBIOLOGIA, V687, P315, DOI 10.1007/s10750-011-0919-6; PICKEN GB, 1980, BIOL J LINN SOC, V14, P67, DOI 10.1111/j.1095-8312.1980.tb00098.x; Riesgo A, 2007, MAR FRESHWATER RES, V58, P398, DOI 10.1071/MF06052; Riesgo A, 2014, ZOOL SCR, V43, P101, DOI 10.1111/zsc.12031; Riesgo A, 2009, TISSUE CELL, V41, P51, DOI 10.1016/j.tice.2008.07.004; Schmitt S, 2012, ISME J, V6, P564, DOI 10.1038/ismej.2011.116; Sciscioli M, 2002, CAH BIOL MAR, V43, P1; Sciscioli M., 1989, Oebalia, V15, P939; SCISCIOLI M, 1991, MOL REPROD DEV, V28, P346, DOI 10.1002/mrd.1080280406; Sharp KH, 2007, APPL ENVIRON MICROB, V73, P622, DOI 10.1128/AEM.01493-06; Simpson TL, 1984, CELL BIOL SPONGES, P341, DOI DOI 10.1007/978-1-4612-5214-6_7; SMITH AE, 1980, LIMNOL OCEANOGR, V25, P865, DOI 10.4319/lo.1980.25.5.0865; Taboada S, 2013, POLAR BIOL, V36, P13, DOI 10.1007/s00300-012-1234-z; THOMPSON JE, 1983, ACTA ZOOL-STOCKHOLM, V64, P199, DOI 10.1111/j.1463-6395.1983.tb00801.x; Loh TL, 2012, INVERTEBR BIOL, V131, P155, DOI 10.1111/j.1744-7410.2012.00271.x; Uriz MJ, 2001, INVERTEBR BIOL, V120, P295; Waddell B, 2000, MAR ECOL PROG SER, V195, P125, DOI 10.3354/meps195125; Waddell B, 2000, MAR ECOL PROG SER, V195, P133, DOI 10.3354/meps195133; Wapstra M., 1987, NATO ASI Series Series G Ecological Sciences, V13, P281; Watanabe Y., 1978, Natural Science Report of the Ochanomizu University, V29, P71; Whiteley NM, 2001, COMP BIOCHEM PHYS A, V128, P595, DOI 10.1016/S1095-6433(00)00337-8; Wilson HV, 1935, J MORPHOL, V58, P285, DOI 10.1002/jmor.1050580202; Wilson HV, 1894, J MORPHOL, V9, P277	80	12	13	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2015	10	3							e0118805	10.1371/journal.pone.0118805	http://dx.doi.org/10.1371/journal.pone.0118805			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9BN	25785444	Green Published, Green Submitted, gold			2022-12-27	WOS:000352138500049
J	Velkoska, E; Patel, SK; Griggs, K; Pickering, RJ; Tikellis, C; Burrell, LM				Velkoska, Elena; Patel, Sheila K.; Griggs, Karen; Pickering, Raelene J.; Tikellis, Chris; Burrell, Louise M.			Short-Term Treatment with Diminazene Aceturate Ameliorates the Reduction in Kidney ACE2 Activity in Rats with Subtotal Nephrectomy	PLOS ONE			English	Article							ANGIOTENSIN-CONVERTING ENZYME; URINARY ACE2; EXPRESSION; INJURY; DISEASE; RENIN; LOCALIZATION; PROGRESSION; ACTIVATORS; INCREASES	Angiotensin converting enzyme (ACE) 2 is an important modulator of the renin angiotensin system (RAS) through its role to degrade angiotensin (Ang) II. Depletion of kidney ACE2 occurs following kidney injury due to renal mass reduction and may contribute to progressive kidney disease. This study assessed the effect of diminazine aceturate (DIZE), which has been described as an ACE2 activator, on kidney ACE2 mRNA and activity in rats with kidney injury due to subtotal nephrectomy (STNx). Sprague Dawley rats were divided into Control groups or underwent STNx; rats then received vehicle or the DIZE (s.c. 15 mg/kg/day) for 2 weeks. STNx led to hypertension (P<0.01), kidney hypertrophy (P<0.001) and impaired kidney function (P<0.001) compared to Control rats. STNx was associated with increased kidney cortical ACE activity, and reduced ACE2 mRNA in the cortex (P<0.01), with reduced cortical and medullary ACE2 activity (P<0.05), and increased urinary ACE2 excretion (P<0.05) compared to Control rats. Urinary ACE2 activity correlated positively with urinary protein excretion (P<0.001), and negatively with creatinine clearance (P=0.04). In STNx rats, DIZE had no effect on blood pressure or kidney function, but was associated with reduced cortical ACE activity (P<0.01), increased cortical ACE2 mRNA (P<0.05) and increased cortical and medullary ACE2 activity (P<0.05). The precise in vivo mechanism of action of DIZE is not clear, and its effects to increase ACE2 activity may be secondary to an increase in ACE2 mRNA abundance. In ex vivo studies, DIZE did not increase ACE2 activity in either Control or STNx kidney cortical membranes. It is not yet known if chronic administration of DIZE has long-term benefits to slow the progression of kidney disease.	[Velkoska, Elena; Patel, Sheila K.; Griggs, Karen; Burrell, Louise M.] Univ Melbourne, Austin Hlth, Dept Med, Heidelberg, Vic, Australia; [Pickering, Raelene J.; Tikellis, Chris] Baker IDI Heart & Diabet Inst, Melbourne, Vic, Australia	Austin Research Institute; Florey Institute of Neuroscience & Mental Health; University of Melbourne; Baker Heart and Diabetes Institute	Velkoska, E (corresponding author), Univ Melbourne, Austin Hlth, Dept Med, Heidelberg, Vic, Australia.	velkoska@unimelb.edu.au	Pickering, Raelene/AAM-8647-2021	Pickering, Raelene/0000-0002-2128-1281; Patel, Sheila/0000-0002-0626-1899	National Health and Medical Research Council of Australia [APP1048285]	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported by funding granted to EV from National Health and Medical Research Council of Australia (APP1048285). https://www.nhmrc.gov.au/.	Burchill L, 2008, EXP PHYSIOL, V93, P622, DOI 10.1113/expphysiol.2007.040386; Burrell LM, 2012, EXP PHYSIOL, V97, P477, DOI 10.1113/expphysiol.2011.063156; Cao ZM, 2001, SEMIN NEPHROL, V21, P554, DOI 10.1053/snep.2001.26794; Cao ZM, 2001, KIDNEY INT, V60, P715, DOI 10.1046/j.1523-1755.2001.060002715.x; CHERNEY DZ, 2014, CAN J PHYSIOL PHARM, P1, DOI DOI 10.1139/CJPP-2013-0063; da Silveira KD, 2010, CLIN SCI, V119, P385, DOI 10.1042/CS20090554; Donoghue M, 2000, CIRC RES, V87, pE1, DOI 10.1161/01.res.87.5.e1; Go AS, 2004, NEW ENGL J MED, V351, P1296, DOI 10.1056/NEJMoa041031; Griffin KA, 2006, CLIN J AM SOC NEPHRO, V1, P1054, DOI 10.2215/CJN.02231205; Gupta A, 2007, AM J PHYSIOL-RENAL, V293, pF245, DOI 10.1152/ajprenal.00477.2006; Haber PK, 2014, HYPERTENSION, V63, P774, DOI 10.1161/HYPERTENSIONAHA.113.02856; Ibrahim HS, 2014, REPROD TOXICOL, V49, P155, DOI 10.1016/j.reprotox.2014.08.006; Kulemina LV, 2011, J BIOMOL SCREEN, V16, P878, DOI 10.1177/1087057111413919; Lautrette A, 2005, NAT MED, V11, P867, DOI 10.1038/nm1275; Mizuiri S, 2008, AM J KIDNEY DIS, V51, P613, DOI 10.1053/j.ajkd.2007.11.022; Mizuiri S, 2011, NEPHROLOGY, V16, P567, DOI 10.1111/j.1440-1797.2011.01467.x; Murca TM, 2012, REGUL PEPTIDES, V177, P107, DOI 10.1016/j.regpep.2012.05.093; Oudit GY, 2010, DIABETES, V59, P529, DOI 10.2337/db09-1218; Park SE, 2013, EUR J ENDOCRINOL, V168, P203, DOI 10.1530/EJE-12-0782; PEREGRINE AS, 1993, ACTA TROP, V54, P185, DOI 10.1016/0001-706X(93)90092-P; Prada JAH, 2008, HYPERTENSION, V51, P1312, DOI 10.1161/HYPERTENSIONAHA.107.108944; Prieto MC, 2011, AM J PHYSIOL-RENAL, V300, pF749, DOI 10.1152/ajprenal.00383.2009; Qi YF, 2013, HYPERTENSION, V62, P746, DOI 10.1161/HYPERTENSIONAHA.113.01337; Raffai G, 2014, J CARDIOVASC PHARM, V63, P453, DOI 10.1097/FJC.0000000000000069; Santos RAS, 2003, P NATL ACAD SCI USA, V100, P8258, DOI 10.1073/pnas.1432869100; Shaltout HA, 2007, AM J PHYSIOL-RENAL, V292, pF82, DOI 10.1152/ajprenal.00139.2006; Shenoy V, 2013, AM J RESP CRIT CARE, V187, P648, DOI 10.1164/rccm.201205-0880OC; Soler MJ, 2007, KIDNEY INT, V72, P614, DOI 10.1038/sj.ki.5002373; Soler MJ, 2009, AM J PHYSIOL-RENAL, V296, pF398, DOI 10.1152/ajprenal.90488.2008; Taal MW, 2008, BRENNER RECTORS KIDN, V8, P783; Thatcher SE, 2014, ARTERIOSCL THROM VAS, V34, P2617, DOI 10.1161/ATVBAHA.114.304613; Thomas MC, 2005, J AM SOC NEPHROL, V16, P2976, DOI 10.1681/ASN.2005010013; Tikellis C, 2006, KIDNEY INT, V70, P34, DOI 10.1038/sj.ki.5000428; Tipnis SR, 2000, J BIOL CHEM, V275, P33238, DOI 10.1074/jbc.M002615200; Varagic J, 2014, CURR HYPERTENS REP, V16, DOI 10.1007/s11906-014-0420-5; Velkoska E, 2011, CLIN SCI, V120, P335, DOI 10.1042/CS20100280; Velkoska E, 2010, CLIN SCI, V118, P269, DOI 10.1042/CS20090318; Wang G, 2011, KIDNEY BLOOD PRESS R, V34, P141, DOI 10.1159/000324521; Wong DW, 2007, AM J PATHOL, V171, P438, DOI 10.2353/ajpath.2007.060977; Wysocki J, 2013, AM J PHYSIOL-RENAL, V305, pF600, DOI 10.1152/ajprenal.00600.2012; Xiao FX, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037649; Ye MH, 2006, J AM SOC NEPHROL, V17, P3067, DOI 10.1681/ASN.2006050423; Zhong JC, 2011, HYPERTENSION, V57, P314, DOI 10.1161/HYPERTENSIONAHA.110.164244	43	31	31	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2015	10	3							e0118758	10.1371/journal.pone.0118758	http://dx.doi.org/10.1371/journal.pone.0118758			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9BN	25786223	Green Published, gold			2022-12-27	WOS:000352138500047
J	Lee, DK; Jeong, JH; Oh, S; Jo, YH				Lee, Dong Kun; Jeong, Jae Hoon; Oh, Seunghoon; Jo, Young-Hwan			Apelin-13 Enhances Arcuate POMC Neuron Activity via Inhibiting M-Current	PLOS ONE			English	Article							REGULATES GLUCOSE-HOMEOSTASIS; PROOPIOMELANOCORTIN NEURONS; PHOSPHOLIPASE-C; PERTUSSIS TOXIN; BETA-GAMMA; INSULIN SENSITIVITY; POTASSIUM CHANNELS; TRPC CHANNELS; AGRP NEURONS; RECEPTOR APJ	The hypothalamus is a key element of the neural circuits that control energy homeostasis. Specific neuronal populations within the hypothalamus are sensitive to a variety of homeostatic indicators such as circulating nutrient levels and hormones that signal circulating glucose and body fat content. Central injection of apelin secreted by adipose tissues regulates feeding and glucose homeostasis. However, the precise neuronal populations and cellular mechanisms involved in these physiological processes remain unclear. Here we examine the electrophysiological impact of apelin-13 on proopiomelanocortin (POMC) neuron activity. Approximately half of POMC neurons examined respond to apelin-13. Apelin-13 causes a dose-dependent depolarization. This effect is abolished by the apelin (APJ) receptor antagonist. POMC neurons from animals pre-treated with pertussis toxin still respond to apelin, whereas the G beta gamma. signaling inhibitor gallein blocks apelin-mediated depolarization. In addition, the effect of apelin is inhibited by the phospholipase C and protein kinase inhibitors. Furthermore, single-cell qPCR analysis shows that POMC neurons express the APJ receptor, PLC-beta isoforms, and KCNQ subunits (2, 3 and 5) which contribute to M-type current. Apelin-13 inhibits M-current that is blocked by the KCNQ channel inhibitor. Therefore, our present data indicate that apelin activates APJ receptors, and the resultant dissociation of the G alpha q heterotrimer triggers a G beta gamma-dependent activation of PLC-beta signaling that inhibits M-current.	[Lee, Dong Kun; Jeong, Jae Hoon; Jo, Young-Hwan] Yeshiva Univ, Albert Einstein Coll Med, Dept Med, Div Endocrinol, Bronx, NY 10461 USA; [Jo, Young-Hwan] Yeshiva Univ, Albert Einstein Coll Med, Dept Mol Pharmacol, Bronx, NY 10461 USA; [Oh, Seunghoon] Dankook Univ, Coll Med, Dept Physiol, Cheonan 330714, South Korea	Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Dankook University	Jo, YH (corresponding author), Yeshiva Univ, Albert Einstein Coll Med, Dept Med, Div Endocrinol, 1300 Morris Pk Ave, Bronx, NY 10461 USA.	young-hwan.jo@einstein.yu.edu		Jo, Young-Hwan/0000-0001-6939-8000; Lee, Dong Kun/0000-0001-9969-0117	National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) [RO1DK092246]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK092246] Funding Source: NIH RePORTER	National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK; RO1DK092246) to Y.- H. J. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Qassab H, 2009, CELL METAB, V10, P343, DOI 10.1016/j.cmet.2009.09.008; BARRY PH, 1991, J MEMBRANE BIOL, V121, P101, DOI 10.1007/BF01870526; Berglund ED, 2012, J CLIN INVEST, V122, P1000, DOI 10.1172/JCI59816; Boucher J, 2005, ENDOCRINOLOGY, V146, P1764, DOI 10.1210/en.2004-1427; Brailoiu GC, 2002, NEUROSCI LETT, V327, P193, DOI 10.1016/S0304-3940(02)00411-1; Castan-Laurell I, 2011, ENDOCRINE, V40, P1, DOI 10.1007/s12020-011-9507-9; CLAPHAM DE, 1993, NATURE, V365, P403, DOI 10.1038/365403a0; Claret M, 2007, J CLIN INVEST, V117, P2325, DOI 10.1172/JCI31516; Clarke KJ, 2009, J NEUROENDOCRINOL, V21, P83, DOI 10.1111/j.1365-2826.2008.01815.x; Cowley MA, 2001, NATURE, V411, P480, DOI 10.1038/35078085; Delmas P, 2005, NAT REV NEUROSCI, V6, P850, DOI 10.1038/nrn1785; Diano S, 2011, NAT MED, V17, P1121, DOI 10.1038/nm.2421; Drougard A, 2014, ANTIOXID REDOX SIGN, V20, P557, DOI 10.1089/ars.2013.5182; Duparc T, 2011, ANTIOXID REDOX SIGN, V15, P1477, DOI 10.1089/ars.2010.3454; Fields TA, 1997, BIOCHEM J, V321, P561, DOI 10.1042/bj3210561; FUNADA M, 1993, BRAIN RES, V619, P163, DOI 10.1016/0006-8993(93)91608-U; Jo YH, 2012, J NEUROPHYSIOL, V107, P42, DOI 10.1152/jn.00353.2011; KATZ A, 1992, NATURE, V360, P686, DOI 10.1038/360686a0; Knauf C, 2013, HORM METAB RES, V45, P928, DOI 10.1055/s-0033-1351321; Korolkiewicz R, 1996, PHARMACOL RES, V33, P211, DOI 10.1006/phrs.1996.0029; Leao RN, 2009, J NEUROSCI, V29, P13353, DOI 10.1523/JNEUROSCI.1463-09.2009; Marino JS, 2011, TRENDS ENDOCRIN MET, V22, P275, DOI 10.1016/j.tem.2011.03.001; Masri B, 2004, FASEB J, V18, P1909, DOI 10.1096/fj.04-1930fje; Nelson TJ, 2008, EUR J PHARMACOL, V585, P76, DOI 10.1016/j.ejphar.2008.01.051; O'Carroll AM, 2013, J ENDOCRINOL, V219, pR13, DOI 10.1530/JOE-13-0227; Parton LE, 2007, NATURE, V449, P228, DOI 10.1038/nature06098; Pope GR, 2012, PEPTIDES, V33, P139, DOI 10.1016/j.peptides.2011.12.005; Qiu J, 2014, CELL METAB, V19, P682, DOI 10.1016/j.cmet.2014.03.004; Qiu J, 2010, J NEUROSCI, V30, P1560, DOI 10.1523/JNEUROSCI.4816-09.2010; Reaux A, 2001, J NEUROCHEM, V77, P1085, DOI 10.1046/j.1471-4159.2001.00320.x; Reaux A, 2002, NEUROSCIENCE, V113, P653, DOI 10.1016/S0306-4522(02)00192-6; Reaux-Le Goazigo A, 2011, AM J PHYSIOL-ENDOC M, V301, pE955, DOI 10.1152/ajpendo.00090.2011; Robbins J, 2001, PHARMACOL THERAPEUT, V90, P1, DOI 10.1016/S0163-7258(01)00116-4; Roepke TA, 2012, AM J PHYSIOL-ENDOC M, V302, pE1399, DOI 10.1152/ajpendo.00565.2011; Roepke TA, 2011, J NEUROSCI, V31, P11825, DOI 10.1523/JNEUROSCI.1395-11.2011; Sohn JW, 2011, NEURON, V71, P488, DOI 10.1016/j.neuron.2011.06.012; Sternson SM, 2013, NEURON, V77, P810, DOI 10.1016/j.neuron.2013.02.018; STERNWEIS PC, 1992, TRENDS BIOCHEM SCI, V17, P502, DOI 10.1016/0968-0004(92)90340-F; Sunter D, 2003, NEUROSCI LETT, V353, P1, DOI 10.1016/S0304-3940(03)00351-3; Szokodi I, 2002, CIRC RES, V91, P434, DOI 10.1161/01.RES.0000033522.37861.69; Tatemoto K, 1998, BIOCHEM BIOPH RES CO, V251, P471, DOI 10.1006/bbrc.1998.9489; van den Top M, 2006, PROG BRAIN RES, V153, P141, DOI 10.1016/S0079-6123(06)53008-0; WU DQ, 1993, P NATL ACAD SCI USA, V90, P5297, DOI 10.1073/pnas.90.11.5297; Wu ZQ, 2006, MOL PHARMACOL, V69, P866, DOI 10.1124/mol.106.016501; Yue P, 2010, AM J PHYSIOL-ENDOC M, V298, pE59, DOI 10.1152/ajpendo.00385.2009	45	12	12	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2015	10	3							e0119457	10.1371/journal.pone.0119457	http://dx.doi.org/10.1371/journal.pone.0119457			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7QC	25782002	Green Submitted, Green Published, gold			2022-12-27	WOS:000351284600065
J	Penailillo, R; Guajardo, A; Llanos, M; Hirsch, S; Ronco, AM				Penailillo, Reyna; Guajardo, Angelica; Llanos, Miguel; Hirsch, Sandra; Maria Ronco, Ana			Folic Acid Supplementation during Pregnancy Induces Sex-Specific Changes in Methylation and Expression of Placental 11 beta-Hydroxysteroid Dehydrogenase 2 in Rats	PLOS ONE			English	Article							NEURAL-TUBE DEFECTS; EPIGENETIC MECHANISMS; FOLATE-DEFICIENCY; DNA METHYLATION; BIRTH-WEIGHT; FETAL-GROWTH; GLUCOCORTICOIDS; PRETERM; GENE; TRANSCRIPTION	In the placenta, 11 beta-hydroxysteroid dehydrogenase type 2 (11 beta-HSD2) limits fetal glucocorticoid exposure and its inhibition has been associated to low birth weight. Its expression, encoded by the HSD11B2 gene is regulated by DNA methylation. We hypothesized that maternal diets supplemented with folic acid (FA) during pregnancy modify the expression of placental HSD11B2 through gene methylation. Wistar rats were fed with high (8 mg/kg) or normal low (1mg/kg, control) levels of FA during pregnancy. Concentrations of mRNA and protein in placentas were determined by qRT-PCR and Western blot respectively. Methylation in five CpG sites of the placental HSD11B2 promoter (-378 to -275) was analyzed by bacterial cloning and subsequent sequencing. In the FA-supplemented group, mRNA and protein levels of 11 beta-HSD2 decreased by 58% and increased by 89%, respectively, only in placentas attached to males. In controls, most CpG sites were not methylated except for the CpG2 site which was 80% methylated. CpG2 methylation level increased under the FA treatment; however, only in placentas attached to females was this increase significant (113%). This change was not related to HSD11B2 expression. Fetal weight of females from FA-supplemented mothers was 6% higher than females from control mothers. In conclusion, this is the first study reporting that FA over supplementation during pregnancy modifies the placental HSD11B2 gene expression and methylation in a sex-dependent manner, suggesting that maternal diets with high content of FA can induce early sex-specific responses, which may lead to long-term consequences for the offspring.	[Penailillo, Reyna; Guajardo, Angelica; Llanos, Miguel; Hirsch, Sandra; Maria Ronco, Ana] Univ Chile, Lab Nutr & Metab Regulat, Human Nutr Unit, Inst Nutr & Food Technol INTA, Santiago, Chile	Universidad de Chile	Ronco, AM (corresponding author), Univ Chile, Lab Nutr & Metab Regulat, Human Nutr Unit, Inst Nutr & Food Technol INTA, Santiago, Chile.	amronco@inta.uchile.cl	Ronco, Ana M/F-9393-2015; Hirsch, Sandra/R-2431-2016; Llanos, Miguel/M-9595-2017		Fondo Nacional de Ciencia y Tecnologia, Gobierno de Chile (Fondecyt) [1130188]	Fondo Nacional de Ciencia y Tecnologia, Gobierno de Chile (Fondecyt)(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT)	This work was supported by the Fondo Nacional de Ciencia y Tecnologia, Gobierno de Chile (Fondecyt # 1130188 to AMR). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alikhani-Koopaei R, 2004, J CLIN INVEST, V114, P1146, DOI 10.1172/JCI200421647; Anderson OS, 2012, J NUTR BIOCHEM, V23, P853, DOI 10.1016/j.jnutbio.2012.03.003; AVMA Panel on Euthanasia. American Veterinary Medical Association, 2000, J AM VET MED ASSOC, V218, P669; Baserga M, 2010, AM J PHYSIOL-REG I, V299, pR334, DOI 10.1152/ajpregu.00122.2010; Benediktsson R, 1997, CLIN ENDOCRINOL, V46, P161, DOI 10.1046/j.1365-2265.1997.1230939.x; Burdge GC, 2008, BRIT J NUTR, V99, P540, DOI 10.1017/S0007114507815819; Burdge GC, 2007, BRIT J NUTR, V97, P1036, DOI 10.1017/S0007114507682920; Burdge GC, 2012, BRIT J NUTR, V108, P1924, DOI 10.1017/S0007114512003765; Burton PJ, 1999, BIOL REPROD, V60, P234, DOI 10.1095/biolreprod60.2.234; Castillo P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044139; Catov JM, 2011, AM J CLIN NUTR, V94, P906, DOI 10.3945/ajcn.111.012393; Challis J, 2013, PLACENTA, V34, P95, DOI 10.1016/j.placenta.2012.11.007; Cuffe JSM, 2012, ENDOCRINOLOGY, V153, P5500, DOI 10.1210/en.2012-1479; Fekete K, 2012, NUTR J, V11, DOI 10.1186/1475-2891-11-75; Fowden AL, 2006, J PHYSIOL-LONDON, V572, P5, DOI 10.1113/jphysiol.2005.104141; Green NS, 2002, J NUTR, V132, p2356S, DOI 10.1093/jn/132.8.2356S; Harris A, 2011, HORM BEHAV, V59, P279, DOI 10.1016/j.yhbeh.2010.06.007; Hertrampf E, 2003, J NUTR, V133, P3166, DOI 10.1093/jn/133.10.3166; Hogg K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062969; Imbard A, 2013, INT J ENV RES PUB HE, V10, P4352, DOI 10.3390/ijerph10094352; Jagerstad M, 2012, ACTA PAEDIATR, V101, P1007, DOI 10.1111/j.1651-2227.2012.02781.x; Jansson T, 2007, CLIN SCI, V113, P1, DOI 10.1042/CS20060339; Jiang XY, 2012, FASEB J, V26, P3563, DOI 10.1096/fj.12-207894; Kim HW, 2011, NUTR RES PRACT, V5, P112, DOI 10.4162/nrp.2011.5.2.112; Kim JM, 2009, J NUTR BIOCHEM, V20, P172, DOI 10.1016/j.jnutbio.2008.01.010; Kulkarni A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017706; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Ly A, 2011, CANCER RES, V71, P988, DOI 10.1158/0008-5472.CAN-10-2379; Marsit CJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033794; Meaney MJ, 2007, TRENDS MOL MED, V13, P269, DOI 10.1016/j.molmed.2007.05.003; Mericq V, 2009, EUR J ENDOCRINOL, V161, P419, DOI 10.1530/EJE-09-0308; [National Research Council National Research Council], 1995, NUTR REQ LAB AN, P11, DOI DOI 10.17226/4758; Nelissen ECM, 2011, HUM REPROD UPDATE, V17, P397, DOI 10.1093/humupd/dmq052; O'Connell BA, 2011, BIOL REPROD, V85, P1040, DOI 10.1095/biolreprod.111.093369; Pandrangi S, 2004, INT J FOOD SCI TECH, V39, P525, DOI 10.1111/j.1365-2621.2004.00812.x; Pena CJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039791; Rani S, 2022, SPAT INF RES, V30, P417, DOI 10.1007/s41324-022-00442-9; Rinaudo P, 2012, ANNU REV PHYSIOL, V74, P107, DOI 10.1146/annurev-physiol-020911-153245; Seckl JR, 2007, NAT CLIN PRACT ENDOC, V3, P479, DOI 10.1038/ncpendmet0515; Seckl JR, 2004, EUR J ENDOCRINOL, V151, pU49, DOI 10.1530/eje.0.151u049; Seckl JR, 2000, KIDNEY INT, V57, P1412, DOI 10.1046/j.1523-1755.2000.00984.x; Sie KKY, 2013, MOL NUTR FOOD RES, V57, P677, DOI 10.1002/mnfr.201200186; Sie KKY, 2011, GUT, V60, P1687, DOI 10.1136/gut.2011.238782; Stark MJ, 2009, AM J PHYSIOL-REG I, V297, pR510, DOI 10.1152/ajpregu.00175.2009; Steegers-Theunissen RP, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007845; Tamura T, 2006, AM J CLIN NUTR, V83, P993, DOI 10.1093/ajcn/83.5.993; Timmermans S, 2009, BRIT J NUTR, V102, P777, DOI 10.1017/S0007114509288994; World Health Organization, 2006, JOINT FAO WHO TECHN, P151; Wyrwoll CS, 2009, ENDOCRINOLOGY, V150, P1287, DOI 10.1210/en.2008-1100	49	22	22	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2015	10	3							e0121098	10.1371/journal.pone.0121098	http://dx.doi.org/10.1371/journal.pone.0121098			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8HY	25793274	Green Submitted, gold, Green Published			2022-12-27	WOS:000352083900102
J	Escobar, C; Pateira, S; Lobo, E; Lobo, L; Teodosio, R; Dias, F; Fernandes, N; Arez, AP; Varandas, L; Nogueira, F				Escobar, Carlos; Pateira, Sara; Lobo, Elsa; Lobo, Lis; Teodosio, Rosa; Dias, Fernanda; Fernandes, Natercia; Arez, Ana Paula; Varandas, Luis; Nogueira, Fatima			Polymorphisms in Plasmodium falciparum K13-Propeller in Angola and Mozambique after the Introduction of the ACTs	PLOS ONE			English	Article							RESISTANCE; MALARIA	We report the presence of SNPs in Plasmodium falciparum K13-propeller gene in two African countries, Angola and Mozambique, where malaria is a serious public health problem. Samples were collected before and after ACT introduction as first-line treatment. In each country 50 samples collected before and 50 after ACT introduction were analysed. A total of three different mutations (R471R and R575R in Angola and V494I in Mozambique) were identified in five samples, all collected after the introduction of ACT. The R471R mutation detected in Angola has already been reported in Africa (DR-Congo and Gabon). However, the mutations R575R (Angola) and V494I (Mozambique), have never been reported. V494I is adjacent to the known K13 resistance-associated mutation Y493H, although functional analysis did not predict a deleterious effect on protein function.	[Escobar, Carlos] Hosp Prof Doutor Fernando Fonseca EPE, Dept Pediat, Amadora, Portugal; [Escobar, Carlos; Teodosio, Rosa; Varandas, Luis] Univ Nova Lisboa, Inst Higiene & Med Trop, UEICT, P-1200 Lisbon, Portugal; [Pateira, Sara; Lobo, Elsa; Arez, Ana Paula; Nogueira, Fatima] Univ Nova Lisboa, Inst Higiene & Med Trop, Unidade Parasitol Med, P-1200 Lisbon, Portugal; [Lobo, Elsa; Lobo, Lis] Univ Eduardo Mondlane, Fac Med, Dept Ciencias Fisiol, Maputo, Mozambique; [Lobo, Lis; Arez, Ana Paula; Varandas, Luis; Nogueira, Fatima] Univ Nova Lisboa, Inst Higiene & Med Trop, CMDT, P-1200 Lisbon, Portugal; [Dias, Fernanda] Univ Agostinho Neto, Fac Med, Dept Med Interna, Luanda, Angola; [Fernandes, Natercia] Univ Eduardo Mondlane, Fac Med, Dept Pediat, Maputo, Mozambique	Hospital Professor Doutor Fernando Fonseca, EPE; Universidade Nova de Lisboa; Institute of Hygiene & Tropical Medicine - UNL; Universidade Nova de Lisboa; Institute of Hygiene & Tropical Medicine - UNL; Eduardo Mondlane University; Universidade Nova de Lisboa; Institute of Hygiene & Tropical Medicine - UNL; University Agostinho Neto; Eduardo Mondlane University	Nogueira, F (corresponding author), Univ Nova Lisboa, Inst Higiene & Med Trop, Unidade Parasitol Med, P-1200 Lisbon, Portugal.	fnogueira@ihmt.unl.pt	nogueira, fatima/I-2148-2012; Arez, Ana Paula/I-1729-2012; Ibáñez, Carlos Escobar/B-3761-2017; Varandas, Luis/K-4592-2013	nogueira, fatima/0000-0003-0313-0778; Arez, Ana Paula/0000-0002-0497-6532; Ibáñez, Carlos Escobar/0000-0003-4442-4537; Tavares Coelho Lobo, Lis/0000-0001-7251-5538; Teodosio, Rosa/0000-0001-7330-6930; Varandas, Luis/0000-0002-8419-6033	Universidade Eduardo Mondlane, Maputo, Mocambique; Universidade Agostinho Neto, Luanda, Angola; Centro de Malaria e outras Doencas Tropicais [PEst-OE/SAU/LA0018/2011, LA0018 2011/2012]	Universidade Eduardo Mondlane, Maputo, Mocambique; Universidade Agostinho Neto, Luanda, Angola; Centro de Malaria e outras Doencas Tropicais	Field work was supported by Universidade Eduardo Mondlane (http://www.uem.mz/index.php/faculdades-e-escolas/faculdades/faculdade-demedicina), Maputo, Mocambique and by Universidade Agostinho Neto (http://www.agostinhoneto.co.ao), Luanda, Angola. Molecular analysis was supported by Centro de Malaria e outras Doencas Tropicais [PEst-OE/SAU/LA0018/2011 - Proj. Estrategico LA0018 2011/2012 (more information available at: http://cmdt.ihmt.unl.pt/index.php/pt/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amambua-Ngwa A, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002992; [Anonymous], J INFECT DIS; Ariey F, 2014, NATURE, V505, P50, DOI 10.1038/nature12876; Conrad MD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105690; DHS program, 2011, ANG INQ IND MAL; Fernandes N, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-35; Figueiredo P, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-236; Kamau E., 2014, J INFECT DIS; Lobo E, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-300; Mbogo GW, 2014, AM J TROP MED HYG, V91, P54, DOI 10.4269/ajtmh.13-0647; Ministerio de Saude da Republica de Mocambique, 2011, PLAN ESTR MAL 2012 2; Sisowath C, 2009, J INFECT DIS, V199, P750, DOI 10.1086/596738; Taylor SM, 2014, J INFECT DIS; Wongsrichanalai C, 2002, LANCET INFECT DIS, V2, P209, DOI 10.1016/S1473-3099(02)00239-6; World Health Organization, 2014, STAT REP ART RES SEP	15	31	31	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2015	10	3							e0119215	10.1371/journal.pone.0119215	http://dx.doi.org/10.1371/journal.pone.0119215			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD9NQ	25789669	Green Published, gold			2022-12-27	WOS:000351425400072
J	Tran, TT; Gordon, SC; Fung, S; Dinh, P; Yee, L; Martins, EB; Buti, M; Marcellin, P				Tran, Tram T.; Gordon, Stuart C.; Fung, Scott; Dinh, Phillip; Yee, Leland; Martins, Eduardo Bruno; Buti, Maria; Marcellin, Patrick			Hepatitis B e Antigen Status and Hepatitis B DNA Levels in Women of Childbearing Age with Chronic Hepatitis B Infection Screening for Clinical Trials	PLOS ONE			English	Article							PREVENT PERINATAL TRANSMISSION; TO-CHILD TRANSMISSION; VERTICAL TRANSMISSION; VIRUS INFECTION; PREGNANT-WOMEN; FAILURE; LAMIVUDINE; MOTHERS; IMMUNOPROPHYLAXIS; INTERRUPTION	Background Perinatal or mother-to-child transmission of hepatitis B virus (HBV) results in a high frequency of chronic infection. Risk of mother-to-child transmission is associated with maternal viral factors including hepatitis B e antigen (HBeAg) positivity and viral load. Aim To investigate associations between age, HBeAg status, HBV DNA levels and genotype in female patients screened for inclusion into two contemporary, randomized HBV trials. Methods Retrospective analyses focused on differences between women of childbearing age (<= 44 years) and older women. Female patients (N = 355; 18-69 years) were included in the analysis: 41.7% of patients were Asian. In total, 44.4% were HBeAg-positive. Results Significantly more women aged <= 44 years were HBeAg-positive compared to women >= 45 years (57.2% versus 27.5%, respectively, p<0.0001), this proportion declined with increasing age. Younger women were significantly more likely to have high HBV viral load (HBV DNA>10(8) copies mL: <= 44 years 46.0% vs >= 45 years 25.5%, respectively; p<0.0001), and this declined with increasing age. HBeAg positivity was slightly higher in Asian women, associated with a higher proportion of HBV genotypes B and C in this population. There was no obvious relationship between genotype and viral load. Conclusions Women of childbearing age with CHB are more likely to have high HBV viral load and HBeAg positivity than older women; this likelihood decreases with age. Maternal serological and virological status should therefore be established early in pregnancy, taking into account age and genotype, and a risk-reducing strategy implemented in any patient who is HBeAg positive and has a high viral load.	[Tran, Tram T.] Cedars Sinai Med Ctr, Liver Dis & Transplant Ctr, Los Angeles, CA 90048 USA; [Gordon, Stuart C.] Henry Ford Hosp, Div Hepatol, Detroit, MI 48202 USA; [Fung, Scott] Univ Toronto, Dept Med, Toronto, ON, Canada; [Dinh, Phillip; Yee, Leland; Martins, Eduardo Bruno] Gilead Sci, Foster City, CA USA; [Buti, Maria] Univ Valle Hebron & Ciberehd, Dept Hepatol, Inst Carlos 3, Gen Hosp, Barcelona, Spain; [Marcellin, Patrick] Univ Paris, Dept Hepatol, F-75252 Paris, France	Cedars Sinai Medical Center; Henry Ford Health System; Henry Ford Hospital; University of Toronto; Gilead Sciences; CIBER - Centro de Investigacion Biomedica en Red; CIBEREHD; UDICE-French Research Universities; Universite Paris Cite	Tran, TT (corresponding author), Cedars Sinai Med Ctr, Liver Dis & Transplant Ctr, Los Angeles, CA 90048 USA.	Tram.Tran@cshs.org		Martins, Eduardo/0000-0003-1947-7784; Buti Ferret, Maria/0000-0002-0732-3078; Yee, Leland Jonathan/0000-0002-0369-5878	Gilead Sciences, Foster City, USA; Gilead Sciences	Gilead Sciences, Foster City, USA; Gilead Sciences(Gilead Sciences)	This study was funded by Gilead Sciences (www.Gilead.com), Foster City, USA. (Study 102; NCT00117676, Study 103; NCT00116805) The writing of this paper was funded by Gilead Sciences, Foster City, USA. Initial data analyses were undertaken by and funded by Gilead Sciences. The funders participated in the study design and data collection and analysis, and funded editorial assistance with the preparation of the manuscript.	BURK RD, 1994, J INFECT DIS, V170, P1418, DOI 10.1093/infdis/170.6.1418; DELCANHO R, 1994, J HEPATOL, V20, P483, DOI 10.1016/S0168-8278(05)80494-5; Ding Y, 2013, VIROL J, V10, DOI [10.1186/1743-422X-10-17, 10.1186/1743-422X-10-78]; Gilead Sciences, TENOFOVIR PRESCRIBIN; Han GR, 2011, J HEPATOL, V55, P1215, DOI 10.1016/j.jhep.2011.02.032; Han L, 2011, WORLD J GASTROENTERO, V17, P4321, DOI 10.3748/wjg.v17.i38.4321; Inui A, 2007, J MED VIROL, V79, P670, DOI 10.1002/jmv.20884; Li XM, 2004, WORLD J GASTROENTERO, V10, P3215; Liu SL, 2009, ARCH VIROL, V154, P437, DOI 10.1007/s00705-009-0315-y; Marcellin P, 2008, NEW ENGL J MED, V359, P2442, DOI 10.1056/NEJMoa0802878; Merrill RM, 2011, INT J INFECT DIS, V15, pE78, DOI 10.1016/j.ijid.2010.09.005; Oshitani H, 1996, T ROY SOC TROP MED H, V90, P235, DOI 10.1016/S0035-9203(96)90227-8; Ott JJ, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-131; Pan CVQ, 2012, CLIN GASTROENTEROL H, V10, P520, DOI 10.1016/j.cgh.2012.01.019; Pan CVQ, 2012, CLIN GASTROENTEROL H, V10, P452, DOI 10.1016/j.cgh.2011.10.041; Singh AE, 2011, J VIRAL HEPATITIS, V18, P468, DOI 10.1111/j.1365-2893.2010.01333.x; Soderstrom A, 2003, SCAND J INFECT DIS, V35, P814, DOI 10.1080/00365540310016547; Song YM, 2007, EUR J PEDIATR, V166, P813, DOI 10.1007/s00431-006-0327-5; Sun KX, 2012, VACCINE, V30, P5335, DOI 10.1016/j.vaccine.2012.06.036; van Zonneveld M, 2003, J VIRAL HEPATITIS, V10, P294, DOI 10.1046/j.1365-2893.2003.00440.x; Wiseman E, 2009, MED J AUSTRALIA, V190, P489, DOI 10.5694/j.1326-5377.2009.tb02524.x; Xu DZ, 2002, J MED VIROL, V67, P20, DOI 10.1002/jmv.2187; Xu WM, 2009, J VIRAL HEPATITIS, V16, P94, DOI 10.1111/j.1365-2893.2008.01056.x; Zou H, 2012, J VIRAL HEPATITIS, V19, pE18, DOI 10.1111/j.1365-2893.2011.01492.x	24	17	17	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2015	10	3							e0121632	10.1371/journal.pone.0121632	http://dx.doi.org/10.1371/journal.pone.0121632			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD9NQ	25789483	Green Submitted, Green Published, gold			2022-12-27	WOS:000351425400200
J	Kines, RC; Zarnitsyn, V; Johnson, TR; Pang, YYS; Corbett, KS; Nicewonger, JD; Gangopadhyay, A; Chen, M; Liu, J; Prausnitz, MR; Schiller, JT; Graham, BS				Kines, Rhonda C.; Zarnitsyn, Vladimir; Johnson, Teresa R.; Pang, Yuk-Ying S.; Corbett, Kizzmekia S.; Nicewonger, John D.; Gangopadhyay, Anu; Chen, Man; Liu, Jie; Prausnitz, Mark R.; Schiller, John T.; Graham, Barney S.			Vaccination with Human Papillomavirus Pseudovirus-Encapsidated Plasmids Targeted to Skin Using Microneedles	PLOS ONE			English	Article							RESPIRATORY SYNCYTIAL VIRUS; WEST-NILE-VIRUS; FUSION GLYCOPROTEIN; MONOCLONAL-ANTIBODY; CELL RESPONSES; MOUSE MODEL; DNA; DELIVERY; INFECTION; PROTECTION	Human papilloma virus-like particles (HPV VLP) serve as the basis of the current licensed vaccines for HPV. We have previously shown that encapsidation of DNA expressing the model antigen M/M2 from respiratory syncytial virus (RSV) in HPV pseudovirions (PsV) is immunogenic when delivered intravaginally. Because the HPV capsids confer tropism for basal epithelium, they represent attractive carriers for vaccination targeted to the skin using microneedles. In this study we asked: 1) whether HPV16 VLP administered by microneedles could induce protective immune responses to HPV16 and 2) whether HPV16 PsV-encapsidated plasmids delivered by microneedles could elicit immune responses to both HPV and the antigen delivered by the transgene. Mice immunized with HPV16 VLP coated microneedles generated robust neutralizing antibody responses and were protected from HPV16 challenge. Microneedle arrays coated with HPV16-M/M2 or HPV16-F protein (genes of RSV) were then tested and dose-dependent HPV and F-specific antibody responses were detected post-immunization, and M/M2-specific T-cell responses were detected post RSV challenge, respectively. HPV16 PsV-F immunized mice were fully protected from challenge with HPV16 PsV and had reduced RSV viral load in lung and nose upon intranasal RSV challenge. In summary, HPV16 PsV-encapsidated DNA delivered by microneedles induced neutralizing antibody responses against HPV and primed for antibody and T-cell responses to RSV antigens encoded by the encapsidated plasmids. Although the immunogenicity of the DNA component was just above the dose response threshold, the HPV-specific immunity was robust. Taken together, these data suggest microneedle delivery of lyophilized HPV PsV could provide a practical, thermostable combined vaccine approach that could be developed for clinical evaluation.	[Kines, Rhonda C.; Pang, Yuk-Ying S.; Schiller, John T.] NCI, Cellular Oncol Lab, NIH, Bethesda, MD 20892 USA; [Zarnitsyn, Vladimir; Prausnitz, Mark R.] Georgia Inst Technol, Sch Chem & Biomol Engn, Atlanta, GA 30332 USA; [Johnson, Teresa R.; Corbett, Kizzmekia S.; Nicewonger, John D.; Gangopadhyay, Anu; Chen, Man; Liu, Jie; Graham, Barney S.] NIAID, Viral Pathogenesis Lab, Vaccine Res Ctr, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); University System of Georgia; Georgia Institute of Technology; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Graham, BS (corresponding author), NIAID, Viral Pathogenesis Lab, Vaccine Res Ctr, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA.	bgraham@nih.gov	Graham, Barney S./AAC-5898-2019; Schiller, John/ABK-8287-2022	Graham, Barney S./0000-0001-8112-0853; Prausnitz, Mark/0000-0002-9076-8448	National Institute of Allergy and Infectious Diseases; National Cancer Institute; NATIONAL CANCER INSTITUTE [ZIABC009052] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI005061, ZIAAI005029] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by intramural funding from the National Institute of Allergy and Infectious Diseases and the National Cancer Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bachy V, 2013, P NATL ACAD SCI USA, V110, P3041, DOI 10.1073/pnas.1214449110; BEELER JA, 1989, J VIROL, V63, P2941, DOI 10.1128/JVI.63.7.2941-2950.1989; Buck C. B., 2007, CURR PROTOC CELL BIO, V26, P261; Corbett HJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013460; Cuburu N, 2012, J CLIN INVEST, V122, P4606, DOI 10.1172/JCI63287; de Martel C, 2012, LANCET ONCOL, V13, DOI 10.1016/S1470-2045(12)70137-7; de Sanjose S, 2010, LANCET ONCOL, V11, P1048, DOI 10.1016/S1470-2045(10)70230-8; Edens C, 2013, VACCINE, V31, P3403, DOI 10.1016/j.vaccine.2012.09.062; Favard C, 2007, CURR GENE THER, V7, P67, DOI 10.2174/156652307779940207; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; Gill HS, 2010, GENE THER, V17, P811, DOI 10.1038/gt.2010.22; Gill HS, 2007, J CONTROL RELEASE, V117, P227, DOI 10.1016/j.jconrel.2006.10.017; Gonzalez-Gonzalez E, 2011, SCI REP-UK, V1, DOI 10.1038/srep00158; Gordon SN, 2012, J IMMUNOL, V188, P714, DOI 10.4049/jimmunol.1101404; Graham BS, 2010, MUCOSAL IMMUNOL, V3, P475, DOI 10.1038/mi.2010.31; Graham BS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059340; Graham BS, 2011, IMMUNE RESPONSE TO INFECTION, P559; GRAHAM BS, 1988, J MED VIROL, V26, P153, DOI 10.1002/jmv.1890260207; Hall CB, 2009, NEW ENGL J MED, V360, P588, DOI 10.1056/NEJMoa0804877; Hirao LA, 2010, MOL THER, V18, P1568, DOI 10.1038/mt.2010.112; Hopkins TG, 2013, VACCINE, V31, P1673, DOI 10.1016/j.vaccine.2013.01.028; Johnson S, 1997, J INFECT DIS, V176, P1215, DOI 10.1086/514115; Johnson TR, 1998, J VIROL, V72, P2871, DOI 10.1128/JVI.72.4.2871-2880.1998; Kenney RT, 2004, NEW ENGL J MED, V351, P2295, DOI 10.1056/NEJMoa043540; Khurana S, 2013, J INFECT DIS, V208, P413, DOI 10.1093/infdis/jit178; Kim YC, 2012, ADV DRUG DELIVER REV, V64, P1547, DOI 10.1016/j.addr.2012.04.005; Ledgerwood JE, 2013, J INFECT DIS, V208, P418, DOI 10.1093/infdis/jit180; Ledgerwood JE, 2011, LANCET INFECT DIS, V11, P916, DOI 10.1016/S1473-3099(11)70240-7; Ledgerwood JE, 2011, J INFECT DIS, V203, P1396, DOI 10.1093/infdis/jir054; Liu J, 2009, J VIROL, V83, P4934, DOI 10.1128/JVI.02140-08; McLellan JS, 2013, SCIENCE, V340, P1113, DOI 10.1126/science.1234914; McLellan JS, 2011, J VIROL, V85, P7788, DOI 10.1128/JVI.00555-11; Meissner HC, 1999, PEDIATR INFECT DIS J, V18, P223, DOI 10.1097/00006454-199903000-00004; Mitsunaga M, 2011, CANCER PREV RES, V4, P767, DOI 10.1158/1940-6207.CAPR-10-0334; Nestle FO, 2009, NAT REV IMMUNOL, V9, P679, DOI 10.1038/nri2622; Pastrana DV, 2004, VIROLOGY, V321, P205, DOI 10.1016/j.virol.2003.12.027; Pearton M, 2012, J CONTROL RELEASE, V160, P561, DOI 10.1016/j.jconrel.2012.04.005; Quan FS, 2010, J VIROL, V84, P7760, DOI 10.1128/JVI.01849-09; Roberts JN, 2007, NAT MED, V13, P857, DOI 10.1038/nm1598; Rutigliano JA, 2007, VIROLOGY, V362, P314, DOI 10.1016/j.virol.2006.12.023; Sheets RL, 2006, TOXICOL SCI, V91, P610, DOI 10.1093/toxsci/kfj169; Song JM, 2012, MOL THER, V20, P1472, DOI 10.1038/mt.2012.69; Song JM, 2010, CLIN VACCINE IMMUNOL, V17, P1381, DOI 10.1128/CVI.00100-10; Stockman LJ, 2012, PEDIATR INFECT DIS J, V31, P5, DOI 10.1097/INF.0b013e31822e68e6; Sullivan SP, 2010, NAT MED, V16, P915, DOI 10.1038/nm.2182; Vasan S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019252	46	36	39	0	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2015	10	3							e0120797	10.1371/journal.pone.0120797	http://dx.doi.org/10.1371/journal.pone.0120797			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9BN	25785935	gold, Green Published, Green Submitted			2022-12-27	WOS:000352138500190
J	Kwon, CW; Park, KM; Kang, BC; Kweon, DH; Kim, MD; Shin, SW; Je, YH; Chang, PS				Kwon, Chang Woo; Park, Kyung-Min; Kang, Byoung-Cheorl; Kweon, Dae-Hyuk; Kim, Myoung-Dong; Shin, Sang Woon; Je, Yeon Ho; Chang, Pahn-Shick			Cysteine Protease Profiles of the Medicinal Plant Calotropis procera R. Br. Revealed by De Novo Transcriptome Analysis	PLOS ONE			English	Article							CATHEPSIN-L; LATEX; EXPRESSION; PURIFICATION; PROPEPTIDE; ACTIVATION	Calotropis procera R. Br., a traditional medicinal plant in India, is a promising source of commercial proteases, because the cysteine proteases from the plant exhibit high thermostability, broad pH optima, and plasma-clotting activity. Though several proteases such as Procerain, Procerain B, CpCp-1, CpCp-2, and CpCp-3 have been isolated and characterized, the information of their transcripts is limited to cDNAs encoding their mature peptides. Due to this limitation, in this study, to determine the cDNA sequences encoding full open reading frame of these cysteine proteases, transcripts were sequenced with an Illumina Hiseq2000 sequencer. A total of 171,253,393 clean reads were assembled into 106,093 contigs with an average length of 1,614 bp and an N50 of 2,703 bp, and 70,797 contigs with an average length of 1,565 bp and N50 of 2,082 bp using Trinity and Velvet-Oases software, respectively. Among these contigs, we found 20 unigenes related to papain-like cysteine proteases by BLASTX analysis against a non-redundant NCBI protein database. Our expression analysis revealed that the cysteine protease contains an N-terminal pro-peptide domain (inhibitor region), which is necessary for correct folding and proteolytic activity. It was evident that expression yields using an inducible T7 expression system in Escherichia coli were considerably higher with the pro-peptide domain than without the domain, which could contribute to molecular cloning of the Calotropis procera protease as an active form with correct folding.	[Kwon, Chang Woo; Park, Kyung-Min; Shin, Sang Woon; Je, Yeon Ho; Chang, Pahn-Shick] Seoul Natl Univ, Dept Agr Biotechnol, Seoul, South Korea; [Kang, Byoung-Cheorl] Seoul Natl Univ, Plant Genom & Breeding Inst, Dept Plant Sci, Seoul, South Korea; [Kang, Byoung-Cheorl; Shin, Sang Woon; Je, Yeon Ho; Chang, Pahn-Shick] Seoul Natl Univ, Res Inst Agr & Life Sci, Seoul, South Korea; [Kweon, Dae-Hyuk] Sungkyunkwan Univ, Dept Genet Engn, Suwon, South Korea; [Kweon, Dae-Hyuk] Sungkyunkwan Univ, Ctr Human Interface Nanotechnol, Suwon, South Korea; [Kim, Myoung-Dong] Kangwon Natl Univ, Dept Food Sci & Biotechnol, Chunchon, South Korea; [Chang, Pahn-Shick] Seoul Natl Univ, Ctr Food & Bioconvergence, Seoul, South Korea	Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU); Sungkyunkwan University (SKKU); Sungkyunkwan University (SKKU); Kangwon National University; Seoul National University (SNU)	Chang, PS (corresponding author), Seoul Natl Univ, Dept Agr Biotechnol, Seoul, South Korea.	pschang@snu.ac.kr	Kang, Byoung-Cheorl/Q-6174-2019	Park, Kyung-Min/0000-0002-4706-8681; Chang, Pahn-Shick/0000-0001-9645-7010	National Research Foundation of Korea (NRF) - Ministry of Science, ICT & Future Planning, Republic of Korea [NRF-2013R1A1A2074378]	National Research Foundation of Korea (NRF) - Ministry of Science, ICT & Future Planning, Republic of Korea	This research was supported by Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Science, ICT & Future Planning (NRF-2013R1A1A2074378), Republic of Korea. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn SJ, 2007, MOL BIOCHEM PARASIT, V156, P191, DOI 10.1016/j.molbiopara.2007.07.021; Bromme D, 2004, METHODS, V32, P199, DOI 10.1016/S1046-2023(03)00212-3; Choedon T, 2006, WORLD J GASTROENTERO, V12, P2517, DOI 10.3748/wjg.v12.i16.2517; Demidyuk Ilya V, 2010, Biomol Concepts, V1, P305, DOI 10.1515/bmc.2010.025; Dewan Soneera, 2000, Indian Journal of Pharmacology, V32, P252; Dhanasekaran S, 2010, J IMMUNOL METHODS, V354, P34, DOI 10.1016/j.jim.2010.01.004; Dubey VK, 2003, PHYTOCHEMISTRY, V62, P1057, DOI 10.1016/S0031-9422(02)00676-3; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Grudkowska M, 2004, ACTA BIOCHIM POL, V51, P609; Hellberg A, 2002, PROTEIN EXPRES PURIF, V24, P131, DOI 10.1006/prep.2001.1548; Helm M, 2008, AM J BOT, V95, P1049, DOI 10.3732/ajb.2007404; Hwang HS, 2002, PROTEIN EXPRES PURIF, V25, P541, DOI 10.1016/S1046-5928(02)00033-5; Jerala R, 1998, J BIOL CHEM, V273, P11498, DOI 10.1074/jbc.273.19.11498; KARRER KM, 1993, P NATL ACAD SCI USA, V90, P3063, DOI 10.1073/pnas.90.7.3063; Kumar VL, 2007, MEDIAT INFLAMM, V2007, DOI 10.1055/2007/47523; KUMAR VL, 1994, J ETHNOPHARMACOL, V44, P123, DOI 10.1016/0378-8741(94)90078-7; Mardis ER, 2008, TRENDS GENET, V24, P133, DOI 10.1016/j.tig.2007.12.007; Martinez M, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-198; Metzker ML, 2010, NAT REV GENET, V11, P31, DOI 10.1038/nrg2626; Nandana V, 2014, PROTEIN EXPRES PURIF, V103, P16, DOI 10.1016/j.pep.2014.08.003; Ramos MV, 2013, INT J BIOL MACROMOL, V58, P211, DOI 10.1016/j.ijbiomac.2013.04.001; Roy S, 2012, ACTA CRYSTALLOGR D, V68, P1591, DOI 10.1107/S0907444912038607; Schulz MH, 2012, BIOINFORMATICS, V28, P1086, DOI 10.1093/bioinformatics/bts094; Shivkar YM, 2003, PHARM BIOL, V41, P263, DOI 10.1076/phbi.41.4.263.15666; Singh AN, 2010, PROCESS BIOCHEM, V45, P399, DOI 10.1016/j.procbio.2009.10.014; Singh AN, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059806; Wiederanders B, 2003, CURR PROTEIN PEPT SC, V4, P309, DOI 10.2174/1389203033487081; Zhang WY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017915	28	15	16	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2015	10	3							e0119328	10.1371/journal.pone.0119328	http://dx.doi.org/10.1371/journal.pone.0119328			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9BN	25786229	Green Submitted, Green Published, gold			2022-12-27	WOS:000352138500096
J	Li, S; Sun, X; Bai, YM; Qin, HM; Wu, XM; Zhang, X; Jolkkonen, J; Boltze, J; Wang, SP				Li, Shen; Sun, Xin; Bai, Yu-meng; Qin, Hua-min; Wu, Xiao-mei; Zhang, Xiao; Jolkkonen, Jukka; Boltze, Johannes; Wang, Su-ping			Infarction of the Corpus Callosum: A Retrospective Clinical Investigation	PLOS ONE			English	Article							ALIEN HAND SYNDROME; CEREBROVASCULAR-DISEASE; LESIONS; ARTERY; CHINA	Objectives The aim of this study was to investigate patients with ischemic infarctions in the territory of the corpus callosum to advance our understanding of this rare stroke subtype by providing comprehensive descriptive and epidemiological data. Methods From January 1, 2010 to June 30, 2014, all cases of acute ischemic stroke diagnosed by clinical manifestation and diffusion weighted imaging in Dalian Municipal Central Hospital were investigated. The patients presenting with corpus callosum infarctions were selected and further allocated into genu and/or body and splenium infarction groups. Proportion, lesion patterns, clinical features, risk factors and etiology of corpus callosum infarction were analyzed. Results Out of 1,629 cases, 59 patients (3.6%) with corpus callosum infarctions were identified by diffusion weighted imaging, including 7 patients who had ischemic lesions restricted to the corpus callosum territory. Thirty six patients had lesions in the splenium (61.0%). Corpus callosum infarction patients suffered from a broad spectrum of symptoms including weakness and/or numbness of the limbs, clumsy speech, and vertigo, which could not be explained by lesions in corpus callosum. A classical callosal disconnection syndrome was found in 2 out of all patients with corpus callosum infarctions. Statistical differences in the risk factor and infarct pattern between the genu and/or body group and splenium group were revealed. Conclusion Corpus callosum infarction and the callosal disconnection syndrome were generally rare. The most susceptible location of ischemic corpus callosum lesion was the splenium. Splenium infarctions were often associated with bilateral cerebral hemisphere involvement (46.2%). The genu and/or body infarctions were associated with atherosclerosis. The most common cause of corpus callosum infarction probably was embolism.	[Li, Shen; Sun, Xin; Bai, Yu-meng; Wang, Su-ping] Dalian Med Univ, Dalian Municipal Cent Hosp, Dept Neurol, Dalian 116033, Peoples R China; [Qin, Hua-min] Dalian Med Univ, Hosp 2, Dept Pathol, Dalian 116027, Peoples R China; [Wu, Xiao-mei] China Med Univ, Hosp 1, Dept Clin Epidemiol, Shenyang 110001, Peoples R China; [Wu, Xiao-mei] China Med Univ, Hosp 1, Ctr Evidence Based Med, Shenyang 110001, Peoples R China; [Zhang, Xiao] Dalian Med Univ, Dalian Municipal Cent Hosp, Dept Radiol, Dalian 116033, Peoples R China; [Jolkkonen, Jukka] Univ Eastern Finland, Inst Clin Med, Dept Neurol, Kuopio 70210, Finland; [Boltze, Johannes] Fraunhofer Inst Cell Therapy & Immunol, Dept Cell Therapy, D-04103 Leipzig, Germany; [Boltze, Johannes] Translat Ctr Regenerat Med, D-04103 Leipzig, Germany	Dalian Medical University; Dalian Medical University; China Medical University; China Medical University; Dalian Medical University; University of Eastern Finland; Fraunhofer Gesellschaft	Wang, SP (corresponding author), Dalian Med Univ, Dalian Municipal Cent Hosp, Dept Neurol, Dalian 116033, Peoples R China.	wangsuping@medmail.com		Boltze, Johannes/0000-0003-3956-4164				Adams Jr HP, 1993, ARTERIOSCLER THROMB, V24, P35, DOI DOI 10.1161/01.STR.24.1.35; Bourekas EC, 2002, AM J ROENTGENOL, V179, P251, DOI 10.2214/ajr.179.1.1790251; Chrysikopoulos H, 1997, EUR J RADIOL, V25, P2, DOI 10.1016/S0720-048X(96)01155-2; Devinsky O, 2003, EPILEPSY BEHAV, V4, P607, DOI 10.1016/j.yebeh.2003.08.029; FELDMANN E, 1990, NEUROLOGY, V40, P1541, DOI 10.1212/wnl.40.10.1540; Gass A, 2004, LANCET NEUROL, V3, P39, DOI 10.1016/S1474-4422(03)00621-5; GIROUD M, 1995, J NEUROL NEUROSUR PS, V59, P238, DOI 10.1136/jnnp.59.3.238; Huang WY, 2002, J CLIN EPIDEMIOL, V55, P959, DOI 10.1016/S0895-4356(02)00462-6; Kahilogullari G, 2008, CLIN ANAT, V21, P383, DOI 10.1002/ca.20647; Kasow DL, 2000, AM J NEURORADIOL, V21, P1876; LI SC, 1985, NEUROLOGY, V35, P1708, DOI 10.1212/WNL.35.12.1708; Liu LS, 2007, BIOCHEM CELL BIOL, V85, P157, DOI 10.1139/O07-004; Murthy SB, 2013, J CLIN NEUROSCI, V20, P175, DOI 10.1016/j.jocn.2012.05.013; Sharma B, 2014, AM J EMERG MED, V32, DOI [10.1016/j.ajem.2014.04.015, DOI 10.1016/J.AJEM.2014.04.015]; Suwanwela NC, 2002, J NEUROL NEUROSUR PS, V72, P533; Uchino A, 2006, EUR RADIOL, V16, P905, DOI 10.1007/s00330-005-0037-9; Yuan JL, 2011, BMC NEUROL, V11, DOI 10.1186/1471-2377-11-142	17	33	34	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2015	10	3							e0120409	10.1371/journal.pone.0120409	http://dx.doi.org/10.1371/journal.pone.0120409			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9BN	25785450	Green Published, Green Submitted, gold			2022-12-27	WOS:000352138500170
J	Sharma, H; Nagaraj, R				Sharma, Himanshu; Nagaraj, Ramakrishnan			Human beta-Defensin 4 with Non-Native Disulfide Bridges Exhibit Antimicrobial Activity	PLOS ONE			English	Article							MU-CONOTOXIN-PIIIA; ESCHERICHIA-COLI; ANTIBACTERIAL ACTIVITIES; HUMAN BETA-DEFENSIN-2; BACTERICIDAL-ACTIVITY; ALPHA-DEFENSINS; MAMMALIAN DEFENSINS; BIOLOGICAL-ACTIVITY; INDUCIBLE PEPTIDE; SODIUM-CHANNELS	Human defensins play multiple roles in innate immunity including direct antimicrobial killing and immunomodulatory activity. They have three disulfide bridges which contribute to the stability of three anti-parallel beta-strands. The exact role of disulfide bridges and canonical beta-structure in the antimicrobial action is not yet fully understood. In this study, we have explored the antimicrobial activity of human beta-defensin 4 (HBD4) analogs that differ in the number and connectivity of disulfide bridges. The cysteine framework was similar to the disulfide bridges present in mu-conotoxins, an unrelated class of peptide toxins. All the analogs possessed enhanced antimicrobial potency as compared to native HBD4. Among the analogs, the single disulfide bridged peptide showedmaximum potency. However, there were no marked differences in the secondary structure of the analogs. Subtle variations were observed in the localization and membrane interaction of the analogs with bacteria and Candida albicans, suggesting a role for disulfide bridges in modulating their antimicrobial action. All analogs accumulated in the cytosol where they can bind to anionic molecules such as nucleic acids which would affect several cellular processes leading to cell death. Our study strongly suggests that native disulfide bridges or the canonical beta-strands in defensins have not evolved for maximal activity but they play important roles in determining their antimicrobial potency.	[Sharma, Himanshu; Nagaraj, Ramakrishnan] CSIR Ctr Cellular & Mol Biol, Hyderabad, Telangana, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Centre for Cellular & Molecular Biology (CCMB)	Nagaraj, R (corresponding author), CSIR Ctr Cellular & Mol Biol, Hyderabad, Telangana, India.	nraj@ccmb.res.in			Council of Scientific and Industrial Research (CSIR) Network [NWP 05]; Department of Science and Technology (DST); JC Bose fellowship from the Department of Science and Technology (DST), India	Council of Scientific and Industrial Research (CSIR) Network(Council of Scientific & Industrial Research (CSIR) - India); Department of Science and Technology (DST)(Department of Science & Technology (India)); JC Bose fellowship from the Department of Science and Technology (DST), India	This work was supported by funding from the Council of Scientific and Industrial Research (CSIR) Network project NWP 05 and Department of Science and Technology (DST). RN is the recipient of the JC Bose fellowship from the Department of Science and Technology (DST), India. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atherton E., 1990, SOLID PHASE PEPTIDE; Bauer F, 2001, PROTEIN SCI, V10, P2470, DOI 10.1110/ps.ps.24401; Bohling A, 2006, BIOCHEMISTRY-US, V45, P5663, DOI 10.1021/bi052026e; Brogden KA, 2005, NAT REV MICROBIOL, V3, P238, DOI 10.1038/nrmicro1098; Circo R, 2002, BIOCHEM BIOPH RES CO, V293, P586, DOI 10.1016/S0006-291X(02)00267-X; Daly NL, 2009, IUBMB LIFE, V61, P144, DOI 10.1002/iub.158; de Leeuw E, 2010, FEBS LETT, V584, P1543, DOI 10.1016/j.febslet.2010.03.004; Dowhan W, 1997, ANNU REV BIOCHEM, V66, P199, DOI 10.1146/annurev.biochem.66.1.199; Ericksen B, 2005, ANTIMICROB AGENTS CH, V49, P269, DOI 10.1128/AAC.49.1.269-275.2005; Fishov I, 1999, MOL MICROBIOL, V32, P1166, DOI 10.1046/j.1365-2958.1999.01425.x; Ganz T, 2003, NAT REV IMMUNOL, V3, P710, DOI 10.1038/nri1180; Garcia JRC, 2001, FASEB J, V15, P1819, DOI 10.1096/fj.00-0865fje; Goldman MJ, 1997, CELL, V88, P553, DOI 10.1016/S0092-8674(00)81895-4; Han TS, 2009, CHEMMEDCHEM, V4, P406, DOI 10.1002/cmdc.200800292; Harder J, 2001, J BIOL CHEM, V276, P5707, DOI 10.1074/jbc.M008557200; Harder J, 1997, NATURE, V387, P861, DOI 10.1038/43088; HILL CP, 1991, SCIENCE, V251, P1481, DOI 10.1126/science.2006422; Hoover DM, 2000, J BIOL CHEM, V275, P32911, DOI 10.1074/jbc.M006098200; Hoover DM, 2001, J BIOL CHEM, V276, P39021, DOI 10.1074/jbc.M103830200; Hoover DM, 2003, ANTIMICROB AGENTS CH, V47, P2804, DOI 10.1128/AAC.47.9.2804-2809.2003; Ishitsuka R, 2004, BIOPHYS J, V86, P296, DOI 10.1016/S0006-3495(04)74105-3; Jacob RB, 2010, CELL MOL LIFE SCI, V67, P17, DOI 10.1007/s00018-009-0125-0; Khoo KK, 2012, BIOCHEMISTRY-US, V51, P9826, DOI 10.1021/bi301256s; Khoo KK, 2009, BIOCHEMISTRY-US, V48, P1210, DOI 10.1021/bi801998a; Kluver E, 2005, BIOCHEMISTRY-US, V44, P9804, DOI 10.1021/bi050272k; Krishnakumari V, 2006, PEPTIDES, V27, P2607, DOI 10.1016/j.peptides.2006.06.004; LANCELIN JM, 1991, BIOCHEMISTRY-US, V30, P6908, DOI 10.1021/bi00242a014; LEHRER RI, 1993, ANNU REV IMMUNOL, V11, P105, DOI 10.1146/annurev.iy.11.040193.000541; LEHRER RI, 1989, J CLIN INVEST, V84, P553, DOI 10.1172/JCI114198; Lewis RJ, 2012, PHARMACOL REV, V64, P259, DOI 10.1124/pr.111.005322; Liu SP, 2008, CHEMBIOCHEM, V9, P964, DOI 10.1002/cbic.200700560; Lourenzoni MR, 2007, J PHYS CHEM B, V111, P11318, DOI 10.1021/jp067127g; MACDONALD RC, 1991, BIOCHIM BIOPHYS ACTA, V1061, P297, DOI 10.1016/0005-2736(91)90295-J; Maemoto A, 2004, J BIOL CHEM, V279, P44188, DOI 10.1074/jbc.M406154200; Mandal M, 2002, PEPTIDES, V23, P413, DOI 10.1016/S0196-9781(01)00628-3; Mandal M, 2002, J PEPT RES, V59, P95, DOI 10.1034/j.1399-3011.2002.01945.x; Maria-Neto S, 2012, ANTIMICROB AGENTS CH, V56, P1714, DOI 10.1128/AAC.05558-11; Matsuzaki K, 1999, BBA-BIOMEMBRANES, V1462, P1, DOI 10.1016/S0005-2736(99)00197-2; Morgera F, 2008, J PEPT SCI, V14, P518, DOI 10.1002/psc.981; Murzyn K, 2005, BIOPHYS J, V88, P1091, DOI 10.1529/biophysj.104.048835; Nielsen KJ, 2002, J BIOL CHEM, V277, P27247, DOI 10.1074/jbc.M201611200; Norton RS, 2006, TOXICON, V48, P780, DOI 10.1016/j.toxicon.2006.07.022; Park CB, 1998, BIOCHEM BIOPH RES CO, V244, P253, DOI 10.1006/bbrc.1998.8159; Pazgier M, 2006, CELL MOL LIFE SCI, V63, P1294, DOI 10.1007/s00018-005-5540-2; SABERWAL G, 1994, BBA-REV BIOMEMBRANES, V1197, P109, DOI 10.1016/0304-4157(94)90002-7; Sass V, 2010, INFECT IMMUN, V78, P2793, DOI 10.1128/IAI.00688-09; Sawai MV, 2001, BIOCHEMISTRY-US, V40, P3810, DOI 10.1021/bi002519d; Schibli DJ, 2002, J BIOL CHEM, V277, P8279, DOI 10.1074/jbc.M108830200; Schmidt NW, 2012, J BIOL CHEM, V287, P21866, DOI 10.1074/jbc.M112.358721; Schmidt NW, 2011, J AM CHEM SOC, V133, P6720, DOI 10.1021/ja200079a; Schneider JJ, 2005, J MOL MED, V83, P587, DOI 10.1007/s00109-005-0657-1; Schulz A, 2005, BIOPOLYMERS, V80, P34, DOI 10.1002/bip.20193; Selsted ME, 2005, NAT IMMUNOL, V6, P551, DOI 10.1038/ni1206; SELSTED ME, 1989, J BIOL CHEM, V264, P4003; Semple F, 2012, J INNATE IMMUN, V4, P337, DOI 10.1159/000336619; Shai Y, 2002, BIOPOLYMERS, V66, P236, DOI 10.1002/bip.10260; Sharma H, 2012, PEPTIDES, V38, P255, DOI 10.1016/j.peptides.2012.08.024; Subbalakshmi C, 1998, FEMS MICROBIOL LETT, V160, P91, DOI 10.1016/S0378-1097(98)00008-1; TAM JP, 1991, J AM CHEM SOC, V113, P6657, DOI 10.1021/ja00017a044; TANG YQ, 1993, J BIOL CHEM, V268, P6649; Tang YQ, 1999, SCIENCE, V286, P498, DOI 10.1126/science.286.5439.498; Terlau H, 2004, PHYSIOL REV, V84, P41, DOI 10.1152/physrev.00020.2003; Thennarasu S, 1999, BIOCHEM BIOPH RES CO, V254, P281, DOI 10.1006/bbrc.1998.9933; Tietze AA, 2012, ANGEW CHEM INT EDIT, V51, P4058, DOI 10.1002/anie.201107011; Vermeer LS, 2012, J BIOL CHEM, V287, P34120, DOI 10.1074/jbc.M112.359067; Weber PJA, 1998, BIOORG MED CHEM LETT, V8, P597, DOI 10.1016/S0960-894X(98)00084-5; Wehkamp J, 2005, J LEUKOCYTE BIOL, V77, P460, DOI 10.1189/jlb.0904543; WHITE SH, 1995, CURR OPIN STRUC BIOL, V5, P521, DOI 10.1016/0959-440X(95)80038-7; WIMLEY WC, 1994, PROTEIN SCI, V3, P1362, DOI 10.1002/pro.5560030902; Wu ZB, 2003, P NATL ACAD SCI USA, V100, P8880, DOI 10.1073/pnas.1533186100; Xie C, 2005, J BIOL CHEM, V280, P32921, DOI 10.1074/jbc.M503084200; Xu Z, 2006, APPL MICROBIOL BIOT, V72, P471, DOI 10.1007/s00253-005-0287-0; Yao SG, 2008, BIOCHEMISTRY-US, V47, P10940, DOI 10.1021/bi801010u; Zhang YA, 2010, BIOCHEMISTRY-US, V49, P9770, DOI 10.1021/bi101512j; Zou GZ, 2007, J BIOL CHEM, V282, P19653, DOI 10.1074/jbc.M611003200	75	28	30	2	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2015	10	3							e0119525	10.1371/journal.pone.0119525	http://dx.doi.org/10.1371/journal.pone.0119525			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9BN	25785690	gold, Green Published, Green Submitted			2022-12-27	WOS:000352138500108
J	Akil, H; Abbaci, A; Lalloue, F; Bessette, B; Costes, LMM; Domballe, L; Charreau, S; Guilloteau, K; Karayan-Tapon, L; Bernard, FX; Morel, F; Jauberteau, MO; Lecron, JC				Akil, Hussein; Abbaci, Amazigh; Lalloue, Fabrice; Bessette, Barbara; Costes, Lea M. M.; Domballe, Linda; Charreau, Sandrine; Guilloteau, Karline; Karayan-Tapon, Lucie; Bernard, Francois-Xavier; Morel, Franck; Jauberteau, Marie-Odile; Lecron, Jean-Claude			IL22/IL-22R Pathway Induces Cell Survival in Human Glioblastoma Cells	PLOS ONE			English	Article							INDUCIBLE FACTOR; GENE-EXPRESSION; IL-22 RECEPTOR; STEM-CELLS; IL-TIF; INTERLEUKIN-22; CANCER; ACTIVATION; IL-10; STAT3	Interleukin-22 (IL-22) is a member of the IL-10 cytokine family that binds to a heterodimeric receptor consisting of IL-22 receptor 1 (IL-22R1) and IL-10R2. IL-22R expression was initially characterized on epithelial cells, and plays an essential role in a number of inflammatory diseases. Recently, a functional receptor was detected on cancer cells such as hepatocarcinoma and lung carcinoma, but its presence was not reported in glioblastoma (GBM). Two GBM cell lines and 10 primary cell lines established from patients undergoing surgery for malignant GBM were used to investigate the expression of IL-22 and IL-22R by using quantitative RT-PCR, western blotting and confocal microscopy studies. The role of IL-22 in proliferation and survival of GBM cell lines was investigated in vitro by BrdU and ELISA cell death assays. We report herein that the two subunits of the IL-22R complex are expressed on human GBM cells. Their activation, depending on exogenous IL-22, induced antiapoptotic effect and cell proliferation. IL-22 treatment of GBM cells resulted in increased levels of phosphorylated Akt, STAT3 signaling protein and its downstream antiapoptotic protein Bcl-xL and decreased level of phosphorylated ERK1/2. In addition, IL-22R subunits were expressed in all the 10 tested primary cell lines established from GBM tumors. Our results showed that IL-22R is expressed on GBM established and primary cell lines. Depending on STAT3, ERK1/2 and PI3K/Akt pathways, IL-22 induced GBM cell survival. These data are consistent with a potential role of IL-22R in tumorigenesis of GBM. Since endogenous IL-22 was not detected in all studied GBM cells, we hypothesize that IL-22R could be activated by immune microenvironmental IL-22 producing cells.	[Akil, Hussein; Abbaci, Amazigh; Lalloue, Fabrice; Bessette, Barbara; Costes, Lea M. M.; Domballe, Linda; Jauberteau, Marie-Odile] Univ Limoges, Fac Med & Pharm, LHCP, EA 3842, Limoges, France; [Charreau, Sandrine; Bernard, Francois-Xavier; Morel, Franck; Lecron, Jean-Claude] Univ Poitiers, LITEC, EA 4331, Poitiers, France; [Guilloteau, Karline; Karayan-Tapon, Lucie] Univ Poitiers, INSERM, U1084, Poitiers, France; [Guilloteau, Karline; Karayan-Tapon, Lucie] CHU Poitiers, Lab Cancerol Biol, Poitiers, France; [Bernard, Francois-Xavier] BIOalternatives, Gencay, France; [Lecron, Jean-Claude] CHU Poitiers, Serv Immunol & Inflammat, Poitiers, France	Universite de Limoges; Universite de Poitiers; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Poitiers; CHU Poitiers; Universite de Poitiers; CHU Poitiers; Universite de Poitiers	Akil, H (corresponding author), Univ Limoges, Fac Med & Pharm, LHCP, EA 3842, Limoges, France.	hussein.akil@outlook.fr	Bessette, Barbara/G-2317-2015; Morel, Franck/AAI-4274-2021	Bessette, Barbara/0000-0001-6673-3694; Morel, Franck/0000-0003-3812-9304; Jauberteau, Marie-Odile/0000-0002-8811-8948; AKIL, Hussein/0000-0002-8177-6833; Lalloue, Fabrice/0000-0003-0382-4948; LECRON, Jean-Claude/0000-0003-3990-5213	Pole de Recherche et d'Enseignement Superieur (PRES) Limousin Poitou-Charentes; Conseil Regional du Limousin; BIOalternatives	Pole de Recherche et d'Enseignement Superieur (PRES) Limousin Poitou-Charentes(Region Nouvelle-Aquitaine); Conseil Regional du Limousin(Region Nouvelle-Aquitaine); BIOalternatives	This work was supported by grants from the Pole de Recherche et d'Enseignement Superieur (PRES) Limousin Poitou-Charentes and the Conseil Regional du Limousin; MOJ JCL. BIOalternatives provided support in the form of salaries for authors [FXB], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of this author are articulated in the 'author contributions' section.	Aggarwal S, 2001, J INTERF CYTOK RES, V21, P1047, DOI 10.1089/107999001317205178; Boniface K, 2007, CLIN EXP IMMUNOL, V150, P407, DOI 10.1111/j.1365-2249.2007.03511.x; Boniface K, 2005, J IMMUNOL, V174, P3695, DOI 10.4049/jimmunol.174.6.3695; Brand S, 2007, AM J PHYSIOL-GASTR L, V292, pG1019, DOI 10.1152/ajpgi.00239.2006; Cha JH, 2012, ONCOL REP, V28, P41, DOI 10.3892/or.2012.1772; Chen YL, 2007, J PHARMACOL EXP THER, V323, P746, DOI 10.1124/jpet.107.126193; Cheray M, 2011, CANCER LETT, V312, P24, DOI 10.1016/j.canlet.2011.07.027; Curd LM, 2012, CLIN EXP IMMUNOL, V168, P192, DOI 10.1111/j.1365-2249.2012.04570.x; Dumoutier L, 2000, P NATL ACAD SCI USA, V97, P10144, DOI 10.1073/pnas.170291697; Dumoutier L, 2000, J IMMUNOL, V164, P1814, DOI 10.4049/jimmunol.164.4.1814; Dumoutier L, 2009, J BIOL CHEM, V284, P26377, DOI 10.1074/jbc.M109.007955; Fukui H, 2014, BRIT J CANCER, V111, P763, DOI 10.1038/bjc.2014.336; Giraud S, 2007, INT J ONCOL, V30, P273; Guilloteau K, 2010, J IMMUNOL, V184, P5263, DOI 10.4049/jimmunol.0902464; Gurney AL, 2004, INT IMMUNOPHARMACOL, V4, P669, DOI 10.1016/j.intimp.2004.01.016; Jiang RQ, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-59; Jiang RQ, 2011, HEPATOLOGY, V54, P900, DOI 10.1002/hep.24486; Kebir H, 2007, NAT MED, V13, P1173, DOI 10.1038/nm1651; Kim G, 2015, ONCOGENE, V34, P671, DOI 10.1038/onc.2014.4; Kim K, 2014, CARCINOGENESIS, V35, P1352, DOI 10.1093/carcin/bgu044; Kotenko SV, 2001, J BIOL CHEM, V276, P2725, DOI 10.1074/jbc.M007837200; Kronblad A, 2005, ONCOGENE, V24, P6835, DOI 10.1038/sj.onc.1208830; Lecart S, 2002, INT IMMUNOL, V14, P1351, DOI 10.1093/intimm/dxf096; Lejeune D, 2002, J BIOL CHEM, V277, P33676, DOI 10.1074/jbc.M204204200; Li RH, 2010, ONCOL REP, V23, P1553, DOI 10.3892/or_00000795; Lim C, 2014, CYTOKINE GROWTH F R, V25, P257, DOI 10.1016/j.cytogfr.2014.04.005; MALEFYT RD, 1991, J EXP MED, V174, P915; Mitra A, 2012, CYTOKINE, V60, P38, DOI 10.1016/j.cyto.2012.06.316; Nagalakshmi ML, 2004, INT IMMUNOPHARMACOL, V4, P679, DOI 10.1016/j.intimp.2004.01.008; Naher L, 2012, INT J ONCOL, V41, P1577, DOI 10.3892/ijo.2012.1594; Petanidis S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073616; Qiu B, 2011, MOL BIOL REP, V38, P3585, DOI 10.1007/s11033-010-0469-4; Rabeony H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101937; Reya T, 2001, NATURE, V414, P105, DOI 10.1038/35102167; Sabat R, 2014, NAT REV DRUG DISCOV, V13, P21, DOI 10.1038/nrd4176; Sanai N, 2005, NEW ENGL J MED, V353, P811, DOI 10.1056/NEJMra043666; Tchirkov A, 2001, BRIT J CANCER, V85, P518, DOI 10.1054/bjoc.2001.1942; Tewari R, 2008, J NEUROCHEM, V107, P616, DOI 10.1111/j.1471-4159.2008.05625.x; Todaro M, 2006, CANCER RES, V66, P1491, DOI 10.1158/0008-5472.CAN-05-2514; Villalva C, 2011, INT J CANCER, V128, P826, DOI 10.1002/ijc.25416; Wainwright DA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015390; Weber GF, 2006, J IMMUNOL, V177, P8266, DOI 10.4049/jimmunol.177.11.8266; Wechsler-Reya R, 2001, ANNU REV NEUROSCI, V24, P385, DOI 10.1146/annurev.neuro.24.1.385; Wen Z, 2014, ANN SURG ONCOL, V21, P125, DOI 10.1245/s10434-013-3322-x; Whittington HA, 2004, AM J RESP CELL MOL, V31, P220, DOI 10.1165/rcmb.2003-0285OC; Wu TY, 2013, CLIN IMMUNOL, V147, P38, DOI 10.1016/j.clim.2013.02.007; Xie MH, 2000, J BIOL CHEM, V275, P31335, DOI 10.1074/jbc.M005304200; Ye ZJ, 2012, CANCER LETT, V326, P23, DOI 10.1016/j.canlet.2012.07.013; Yeh HH, 2006, ONCOGENE, V25, P4300, DOI 10.1038/sj.onc.1209464; Zhang FB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020382; Zhang WC, 2008, CLIN CANCER RES, V14, P6432, DOI 10.1158/1078-0432.CCR-07-4401; Zhu VF, 2012, CANCER LETT, V316, P139, DOI 10.1016/j.canlet.2011.11.001	52	20	22	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2015	10	3							e0119872	10.1371/journal.pone.0119872	http://dx.doi.org/10.1371/journal.pone.0119872			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8IA	25793261	Green Published, Green Submitted, gold			2022-12-27	WOS:000352084200122
J	Hippert, C; Graca, AB; Barber, AC; West, EL; Smith, AJ; Ali, RR; Pearson, RA				Hippert, Claire; Graca, Anna B.; Barber, Amanda C.; West, Emma L.; Smith, Alexander J.; Ali, Robin R.; Pearson, Rachael A.			Muller Glia Activation in Response to Inherited Retinal Degeneration Is Highly Varied and Disease-Specific	PLOS ONE			English	Article							TRANSPLANTED PHOTORECEPTOR PRECURSORS; CHONDROITIN SULFATE PROTEOGLYCANS; RECESSIVE RETINITIS-PIGMENTOSA; LEBERS CONGENITAL AMAUROSIS; EXTERNAL LIMITING MEMBRANE; FIBRILLARY ACIDIC PROTEIN; MEDIATED GENE-TRANSFER; REACTIVE ASTROCYTES; LENTIVIRAL VECTOR; TARGETED DISRUPTION	Despite different aetiologies, most inherited retinal disorders culminate in photoreceptor loss, which induces concomitant changes in the neural retina, one of the most striking being reactive gliosis by Muller cells. It is typically assumed that photoreceptor loss leads to an upregulation of glial fibrilliary acidic protein (Gfap) and other intermediate filament proteins, together with other gliosis-related changes, including loss of integrity of the outer limiting membrane (OLM) and deposition of proteoglycans. However, this is based on a mix of both injury-induced and genetic causes of photoreceptor loss. There are very few longitudinal studies of gliosis in the retina and none comparing these changes across models over time. Here, we present a comprehensive spatiotemporal assessment of features of gliosis in the degenerating murine retina that involves Muller glia. Specifically, we assessed Gfap, vimentin and chondroitin sulphate proteoglycan (CSPG) levels and outer limiting membrane (OLM) integrity over time in four murine models of inherited photoreceptor degeneration that encompass a range of disease severities (Crb1(rd8/rd8), Prph2(+/Delta 307), Rho(-/-), Pde6b(rd1/rd1)). These features underwent very different changes, depending upon the disease-causing mutation, and that these changes are not correlated with disease severity. Intermediate filament expression did indeed increase with disease progression in Crb1(rd8/rd8) and Prph2(+/Delta 307), but decreased in the Prph2(+/Delta 307) and Pde6b(rd1/rd1) models. CSPG deposition usually, but not always, followed the trends in intermediate filament expression. The OLM adherens junctions underwent significant remodelling in all models, but with differences in the composition of the resulting junctions; in Rho(-/-) mice, the adherens junctions maintained the typical rod-Muller glia interactions, while in the Pde6b(rd1/rd1) model they formed predominantly between Muller cells in late stage of degeneration. Together, these results show that gliosis and its associated processes are variable and disease-dependent.	[Hippert, Claire; Graca, Anna B.; Barber, Amanda C.; West, Emma L.; Smith, Alexander J.; Ali, Robin R.; Pearson, Rachael A.] UCL, Inst Ophthalmol, Dept Genet, London EC1V 9EL, England; [Ali, Robin R.] Moorfields Eye Hosp NHS Fdn Trust, NIHR Biomed Res Ctr, London EC1V 2PD, England; [Ali, Robin R.] UCL Inst Ophthalmol, London EC1V 2PD, England	University of London; University College London; University of London; University College London; Moorfields Eye Hospital NHS Foundation Trust; University of London; University College London	Pearson, RA (corresponding author), UCL, Inst Ophthalmol, Dept Genet, 11-43 Bath St, London EC1V 9EL, England.	rachael.pearson@ucl.ac.uk	Pearson, Rachael/Y-3339-2018; Smith, Alexander/A-5142-2009; West, Emma L/C-5252-2013	Pearson, Rachael/0000-0002-1107-1969; Ali, Robin/0000-0003-3126-6517; West, Emma/0000-0002-7006-3686	Fight For Sight [1448/1449]; Medical Research Council UK [mr/j004553/1]; Retinitis Pigmentosa Fighting Blindness [GR566]; National Institute for Health Research (NIHR) Biomedical Research Centre for Ophthalmology at Moorfields Eye Hospital; UCL Institute of Ophthalmology; Alcon Research Institute; MRC [MR/J004553/1] Funding Source: UKRI; Medical Research Council [1085159, MR/J004553/1] Funding Source: researchfish; National Institute for Health Research [NF-SI-0508-10130, NF-SI-0513-10074] Funding Source: researchfish; Fight for Sight [1448/49] Funding Source: researchfish	Fight For Sight; Medical Research Council UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Retinitis Pigmentosa Fighting Blindness; National Institute for Health Research (NIHR) Biomedical Research Centre for Ophthalmology at Moorfields Eye Hospital; UCL Institute of Ophthalmology; Alcon Research Institute(Novartis); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); Fight for Sight	This work was supported by grants from Fight For Sight (http://www.fightforsight.org.uk/ grant number: 1448/1449), the Medical Research Council UK (http://www.mrc.ac.uk/ grant number: mr/j004553/1), and Retinitis Pigmentosa Fighting Blindness (http://www.rpfightingblindness.org.uk/ grant number: GR566). A.B.G. is an MRC-DTA Clinical Neuroscience Ph.D. student. R.R.A. is part-funded by National Institute for Health Research (NIHR) Biomedical Research Centre for Ophthalmology at Moorfields Eye Hospital (http://www.moorfields.nhs.uk/), UCL Institute of Ophthalmology (http://www.ucl.ac.uk/ioo/), and the Alcon Research Institute (http://www.alcon.com/en/ARI/index.asp). R.A.P. is a Royal Society University Research Fellow (https://royalsociety.org/) and supported by the Alcon Research Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afshari FT, 2010, GLIA, V58, P857, DOI 10.1002/glia.20970; Ali SAM, 2011, J VET MED SCI, V73, P13, DOI 10.1292/jvms.10-0201; Bainbridge JWB, 2008, NEW ENGL J MED, V358, P2231, DOI 10.1056/NEJMoa0802268; Barber AC, 2013, P NATL ACAD SCI USA, V110, P354, DOI 10.1073/pnas.1212677110; Bringmann A, 2009, GRAEF ARCH CLIN EXP, V247, P865, DOI 10.1007/s00417-009-1082-x; BUNTMILAM AH, 1985, INVEST OPHTH VIS SCI, V26, P1377; Busch SA, 2007, CURR OPIN NEUROBIOL, V17, P120, DOI 10.1016/j.conb.2006.09.004; Campbell M, 2006, EXP EYE RES, V83, P484, DOI 10.1016/j.exer.2006.01.032; Campbell M, 2007, EXP EYE RES, V85, P714, DOI 10.1016/j.exer.2007.08.004; Clark SJ, 2006, J BIOL CHEM, V281, P24713, DOI 10.1074/jbc.M605083200; Crespo D, 2007, EXP NEUROL, V206, P159, DOI 10.1016/j.expneurol.2007.05.001; DANCIGER M, 1995, GENOMICS, V30, P1, DOI 10.1006/geno.1995.0001; Day AJ, 2011, EXPERT REV OPHTHALMO, V6, P123, DOI 10.1586/EOP.11.10; Dinet V, 2012, AGING CELL, V11, P683, DOI 10.1111/j.1474-9726.2012.00834.x; Dornowicz MS, 2008, DEV BIOL, V315, P114, DOI 10.1016/j.ydbio.2007.12.014; EKSTROM P, 1988, INVEST OPHTH VIS SCI, V29, P1363; Escher P, 2008, MOL VIS, V14, P2126; Fan W, 1996, EXP EYE RES, V63, P9, DOI 10.1006/exer.1996.0086; Fawcett JW, 1999, BRAIN RES BULL, V49, P377, DOI 10.1016/S0361-9230(99)00072-6; Fisher SK, 2003, VISION RES, V43, P887, DOI 10.1016/S0042-6989(02)00680-6; Fisher SK, 2005, PROG RETIN EYE RES, V24, P395, DOI 10.1016/j.preteyeres.2004.10.004; Gonzalez-Cordero A, 2013, NAT BIOTECHNOL, V31, P741, DOI 10.1038/nbt.2643; Gruter O, 2005, GENE THER, V12, P942, DOI 10.1038/sj.gt.3302485; Humphries MM, 1997, NAT GENET, V15, P216, DOI 10.1038/ng0297-216; Inatani M, 2001, INVEST OPHTH VIS SCI, V42, P1930; Inatani M, 2000, INVEST OPHTH VIS SCI, V41, P2748; Inman DM, 2007, GLIA, V55, P942, DOI 10.1002/glia.20516; Jacobson SG, 2012, ARCH OPHTHALMOL-CHIC, V130, P9, DOI 10.1001/archophthalmol.2011.298; Jones BW, 2005, EXP EYE RES, V81, P123, DOI 10.1016/j.exer.2005.03.006; Jones BW, 2003, J COMP NEUROL, V464, P1, DOI 10.1002/cne.10703; Keenan TDL, 2012, INVEST OPHTH VIS SCI, V53, P7528, DOI 10.1167/iovs.12-10797; Kim KY, 2004, NEUROBIOL AGING, V25, P491, DOI 10.1016/j.neurobiolaging.2003.07.005; Kinouchi R, 2003, NAT NEUROSCI, V6, P863, DOI 10.1038/nn1088; Kostic C, 2003, GENE THER, V10, P818, DOI 10.1038/sj.gt.3301948; Laties AM, 1978, PROCEEDINGS OF THE F, P285; Lewis GP, 2010, MOL VIS, V16, P1361; Lewis GP, 2003, INT REV CYTOL, V230, P263, DOI 10.1016/S0074-7696(03)30005-1; Luhmann UFO, 2015, HUM MOL GENET, V24, P128, DOI 10.1093/hmg/ddu424; Lundkvist A, 2004, J CELL SCI, V117, P3481, DOI 10.1242/jcs.01221; Ma J, 2011, MOL VIS, V17, P1759; Maguire AM, 2008, NEW ENGL J MED, V358, P2240, DOI 10.1056/NEJMoa0802315; MCKEON RJ, 1991, J NEUROSCI, V11, P3398; McNally N, 2002, HUM MOL GENET, V11, P1005, DOI 10.1093/hmg/11.9.1005; Mehalow AK, 2003, HUM MOL GENET, V12, P2179, DOI 10.1093/hmg/ddg232; Miyoshi H, 1997, P NATL ACAD SCI USA, V94, P10319, DOI 10.1073/pnas.94.19.10319; Myer DJ, 2006, BRAIN, V129, P2761, DOI 10.1093/brain/awl165; Nishida A, 2000, INVEST OPHTH VIS SCI, V41, P4268; OAKLEY RA, 1991, DEV BIOL, V147, P187, DOI 10.1016/S0012-1606(05)80017-X; Omri S, 2010, CLIN OPHTHALMOL, V4, P183; Pardue MT, 2001, EXP EYE RES, V73, P333, DOI 10.1006/exer.2001.1041; Pearson RA, 2012, NATURE, V485, P99, DOI 10.1038/nature10997; Pearson RA, 2010, CELL TRANSPLANT, V19, P487, DOI 10.3727/096368909X486057; Pearson RA, 2014, VISUAL NEUROSCI, V31, P333, DOI 10.1017/S0952523814000200; Pekny M, 2007, INT REV NEUROBIOL, V82, P95, DOI 10.1016/S0074-7742(07)82005-8; Popp S, 2004, EXP EYE RES, V79, P351, DOI 10.1016/j.exer.2004.05.016; Properzi F, 2005, EUR J NEUROSCI, V21, P378, DOI 10.1111/j.1460-9568.2005.03876.x; RICH KA, 1995, EXP EYE RES, V61, P235, DOI 10.1016/S0014-4835(05)80043-0; Ridet JL, 1997, TRENDS NEUROSCI, V20, P570, DOI 10.1016/S0166-2236(97)01139-9; Roesch K, 2008, J COMP NEUROL, V509, P225, DOI 10.1002/cne.21730; Roesch Karin, 2012, Mol Vis, V18, P1197; Schwartz NB, 1996, PERSPECT DEV NEUROBI, V3, P291; SHEEDLO HJ, 1995, DEV BRAIN RES, V85, P171, DOI 10.1016/0165-3806(94)00203-C; Smith GM, 2005, GLIA, V52, P209, DOI 10.1002/glia.20236; Sofroniew MV, 2005, NEUROSCIENTIST, V11, P400, DOI 10.1177/1073858405278321; Stingl K, 2013, OPHTHALMIC RES, V50, P215, DOI 10.1159/000354424; Strettoi E, 2002, J NEUROSCI, V22, P5492; Suzuki T, 2007, CELL TRANSPLANT, V16, P493, DOI 10.3727/000000007783464966; Takahashi M, 1999, J VIROL, V73, P7812, DOI 10.1128/JVI.73.9.7812-7816.1999; Taylor KR, 2006, FASEB J, V20, P9, DOI 10.1096/fj.05-4682rev; Tepass U, 2002, BIOESSAYS, V24, P690, DOI 10.1002/bies.10129; Tserentsoodol N, 1998, HISTOCHEM CELL BIOL, V110, P543, DOI 10.1007/s004180050316; van de Pavert SA, 2004, J CELL SCI, V117, P4169, DOI 10.1242/jcs.01301; Vazquez-Chona FR, 2011, BMC NEUROSCI, V12, DOI 10.1186/1471-2202-12-98; Verardo MR, 2008, INVEST OPHTH VIS SCI, V49, P3659, DOI 10.1167/iovs.07-1474; Wang H, 2008, J CELL SCI, V121, P3083, DOI 10.1242/jcs.032649; West EL, 2008, EXP EYE RES, V86, P601, DOI 10.1016/j.exer.2008.01.004; Zhang YQ, 2003, INVEST OPHTH VIS SCI, V44, P4936, DOI 10.1167/iovs.02-0640	77	78	79	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2015	10	3							e0120415	10.1371/journal.pone.0120415	http://dx.doi.org/10.1371/journal.pone.0120415			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8HY	25793273	Green Published, Green Submitted, gold			2022-12-27	WOS:000352083900030
J	Assis-Marques, MA; Oliveira, AF; Ruas, LP; dos Reis, TF; Roque-Barreira, MC; Coelho, PSR				Assis-Marques, Mariana Aprigio; Oliveira, Aline Ferreira; Ruas, Luciana Pereira; dos Reis, Thaila Fernanda; Roque-Barreira, Maria Cristina; Rodrigues Coelho, Paulo Sergio			Saccharomyces cerevisiae Expressing Gp43 Protects Mice against Paracoccidioides brasiliensis Infection	PLOS ONE			English	Article							GAMMA-INTERFERON; DENDRITIC CELLS; IFN-GAMMA; BLASTOMYCES-DERMATITIDIS; LYMPHOCYTE-PROLIFERATION; VACCINE; MACROPHAGES; IMMUNITY; ACTIVATION; CYTOKINES	The dimorphic fungus Paracoccidioides brasiliensis is the etiological agent of paracoccidioidomycosis (PCM). It is believed that approximately 10 million people are infected with the fungus and approximately 2% will eventually develop the disease. Unlike viral and bacterial diseases, fungal diseases are the ones against which there is no commercially available vaccine. Saccharomyces cerevisiae may be a suitable vehicle for immunization against fungal infections, as they require the stimulation of different arms of the immune response. Here we evaluated the efficacy of immunizing mice against PCM by using S. cerevisiae yeast expressing gp43. When challenged by inoculation of P. brasiliensis yeasts, immunized animals showed a protective profile in three different assays. Their lung parenchyma was significantly preserved, exhibiting fewer granulomas with fewer fungal cells than found in non-immunized mice. Fungal burden was reduced in the lung and spleen of immunized mice, and both organs contained higher levels of IL-12 and IFN-gamma. compared to those of non-vaccinated mice, a finding that suggests the occurrence of Th1 immunity. Taken together, our results indicate that the recombinant yeast vaccine represents a new strategy to confer protection against PCM.	[Assis-Marques, Mariana Aprigio; Oliveira, Aline Ferreira; Ruas, Luciana Pereira; dos Reis, Thaila Fernanda; Roque-Barreira, Maria Cristina; Rodrigues Coelho, Paulo Sergio] Univ Sao Paulo, Fac Med Ribeirao Preto, Dept Biol Celular & Mol & Bioagentes Patogen, BR-14049900 Ribeirao Preto, SP, Brazil	Universidade de Sao Paulo	Coelho, PSR (corresponding author), Univ Sao Paulo, Fac Med Ribeirao Preto, Dept Biol Celular & Mol & Bioagentes Patogen, Av Bandeirantes 3900, BR-14049900 Ribeirao Preto, SP, Brazil.	pacoelho@fmrp.usp.br	de Oliveira Pereira, Aline Ferreira/AAT-5134-2020; Ruas, Luciana/A-4259-2013; Roque-Barreira, Maria-Cristina/A-4552-2008; dos Reis, Thaila F/N-6237-2014	Ruas, Luciana/0000-0002-1028-7872; Roque-Barreira, Maria-Cristina/0000-0001-7425-0908; dos Reis, Thaila F/0000-0002-7776-977X	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo-FAPESP [2006/60642-2, 2013/04088-0, 2014/05359-0, 08/558316]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico, CNPq [306298/2013-9]; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior, CAPES	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo-FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico, CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior, CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	This work was partially funded by Fundacao de Amparo a Pesquisa do Estado de Sao Paulo-FAPESP (grant numbers 2006/60642-2; 2013/04088-0; 2014/05359-0 to M.C.R.-B. and 08/558316 to P.S.R.C.) (www.fapesp.br), and Conselho Nacional de Desenvolvimento Cientifico e Tecnologico, CNPq (grant number 306298/2013-9 to M.C.R.-B. and a scholarship to P.S.R.C.). M.A.A.-M. received a scholarship from Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior, CAPES. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allendoerfer R, 1997, INFECT IMMUN, V65, P2564, DOI 10.1128/IAI.65.7.2564-2569.1997; Benard G, 2001, CYTOKINE, V13, P248, DOI 10.1006/cyto.2000.0824; Bernstein MB, 2008, VACCINE, V26, P509, DOI 10.1016/j.vaccine.2007.11.033; Blotta MHSL, 1999, AM J TROP MED HYG, V61, P390, DOI 10.4269/ajtmh.1999.61.390; Borges-Walmsley MI, 2002, TRENDS MICROBIOL, V10, P80, DOI 10.1016/S0966-842X(01)02292-2; Borghi M, 2014, FRONTIERS IMMUNOLOGY; BRUMMER E, 1988, J IMMUNOL, V140, P2786; BRUMMER E, 1993, CLIN MICROBIOL REV, V6, P89, DOI 10.1128/CMR.6.2.89-117.1993; BRUMMER E, 1988, INT J IMMUNOPHARMACO, V10, P945, DOI 10.1016/0192-0561(88)90041-0; CALICH VLG, 1979, MYCOPATHOLOGIA, V66, P175, DOI 10.1007/BF00683967; Cano LE, 1998, INFECT IMMUN, V66, P800, DOI 10.1128/IAI.66.2.800-806.1998; Capilla J, 2009, VACCINE, V27, P3662, DOI 10.1016/j.vaccine.2009.03.030; Da Silva FC, 2009, AM J TROP MED HYG, V80, P798, DOI 10.4269/ajtmh.2009.80.798; Soares CMD, 2008, MYCOPATHOLOGIA, V165, P179, DOI 10.1007/s11046-008-9114-3; de Oliveira LL, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000183; Franco M, 1987, MED MYCOL, V25, P5, DOI [DOI 10.1080/02681-218780000021, DOI 10.1080/02681218780000021]; Gelperin DM, 2005, GENE DEV, V19, P2816, DOI 10.1101/gad.1362105; Gonzalez A, 2000, INFECT IMMUN, V68, P2546, DOI 10.1128/IAI.68.5.2546-2552.2000; Hahn RC, 2003, MYCOSES, V46, P342; Haller AA, 2007, VACCINE, V25, P1452, DOI 10.1016/j.vaccine.2006.10.035; Karhawi ASK, 2000, MED MYCOL, V38, P225, DOI 10.1080/714030939; KASHINO SS, 1985, MYCOPATHOLOGIA, V92, P173, DOI 10.1007/BF00437630; Liu M, 2012, IMMUNOL INVEST, V41, P847, DOI 10.3109/08820139.2012.692418; Liu M, 2011, VACCINE, V29, P1745, DOI 10.1016/j.vaccine.2010.12.119; Majumder T, 2014, MYCOPATHOLOGIA, V178, P189, DOI 10.1007/s11046-014-9798-5; Mendes RP., 1994, PARACOCCIDIOIDOMYCOS, V1st ed, P373; MIYAJI M, 1983, MYCOPATHOLOGIA, V82, P129, DOI 10.1007/BF00439218; MODY CH, 1993, INFECT IMMUN, V61, P464, DOI 10.1128/IAI.61.2.464-469.1993; MODY CH, 1991, AM J RESP CELL MOL, V5, P19, DOI 10.1165/ajrcmb/5.1.19; Mota F T, 1979, Rev Inst Med Trop Sao Paulo, V21, P82; Oliveira SJ, 2002, MICROBES INFECT, V4, P139, DOI 10.1016/S1286-4579(01)01521-0; PUCCIA R, 1986, INFECT IMMUN, V53, P199, DOI 10.1128/IAI.53.1.199-206.1986; Restrepo-Moreno A., 1993, PARACOCCIDIOIDOMYCOS, P251; Ribeiro AM, 2010, VACCINE, V28, P1528, DOI 10.1016/j.vaccine.2009.11.062; Ribeiro AM, 2009, VACCINE, V27, P606, DOI 10.1016/j.vaccine.2008.10.022; Rittner GMG, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001519; Roy RM, 2012, CELL HOST MICROBE, V11, P436, DOI 10.1016/j.chom.2012.04.005; Ruas LP, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004519; San-Blas G, 2002, MED MYCOL, V40, P225, DOI 10.1080/mmy.40.3.225.242; SCOTT P, 1991, IMMUNOL TODAY, V12, P346, DOI 10.1016/0167-5699(91)90063-Y; Shikanai-Yasuda MA, 2006, REV SOC BRAS MED TRO, V39, P297, DOI 10.1590/S0037-86822006000300017; Souto JT, 2003, AM J PATHOL, V163, P583, DOI 10.1016/S0002-9440(10)63686-3; Stevens DA, 2011, MED MYCOL, V49, pS170, DOI 10.3109/13693786.2010.497775; Stubbs AC, 2001, NAT MED, V7, P625, DOI 10.1038/87974; Taborda CP, 1998, INFECT IMMUN, V66, P786, DOI 10.1128/IAI.66.2.786-793.1998; Travassos LR, 2012, HUM VACC IMMUNOTHER, V8, P1450, DOI 10.4161/hv.21283; Wansley EK, 2008, CLIN CANCER RES, V14, P4316, DOI 10.1158/1078-0432.CCR-08-0393	47	16	17	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2015	10	3							e0120201	10.1371/journal.pone.0120201	http://dx.doi.org/10.1371/journal.pone.0120201			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD9NQ	25790460	gold, Green Published, Green Submitted			2022-12-27	WOS:000351425400139
J	da Silva, R; Uno, M; Marie, SKN; Oba-Shinjo, SM				da Silva, Roseli; Uno, Miyuki; Nagahashi Marie, Suely K.; Oba-Shinjo, Sueli M.			LOX Expression and Functional Analysis in Astrocytomas and Impact of IDH1 Mutation	PLOS ONE			English	Article							FOCAL ADHESION KINASE; LYSYL OXIDASE EXPRESSION; BETA-AMINOPROPIONITRILE; GENE-EXPRESSION; HYPOXIA; CELL; MIGRATION; GLIOBLASTOMA; ANGIOGENESIS; METASTASIS	Lysyl oxidase (LOX) is involved in vital biological processes such as cell motility, cell signaling and gene regulation. Deregulation of this protein can contribute to tumor formation and progression. Although it is known that LOX is involved in invasion, proliferation and tumor migration in other types of tumors, studies of LOX in astrocytomas of different grades are scarce. The purpose of our study was to characterize LOX, BMP1 and HIF1A expression by real-time PCR in astrocytomas with WHO grades I to IV compared to non-neoplastic brain tissue. IDH1 mutational status was determined by PCR and sequencing. LOX protein expression was also analyzed by immunohistochemistry. LOX functional analyses were performed using siRNA knockdown and the specific inhibitor BAPN in two glioblastoma cell lines. The expression levels of LOX, BMP1 and HIF1A were correlated and analyzed according to IDH1 mutation status and to the clinical end-point of overall survival of glioblastoma patients. The results demonstrate that increased expression and activity of LOX, BMP1 and HIF1A were positively correlated with the malignant grade of astrocytomas. LOX protein expression also increased according to the degree of malignancy, with localization in the cytoplasm and nucleus and staining observed in endothelial cells. Glioblastoma with a mutation in IDH1 expressed lower levels of LOX in the nucleus, and IDH1-mutated cases showed lower LOX expression levels when compared to wild-type IDH1 cases. LOX knockdown and inhibition by BAPN in U87MG and A172 cell lines affected migration, invasion and soft agar colony formation. Taken together, these results corroborate the role of LOX in the migration, invasion and angiogenesis of astrocytomas. Furthermore, LOX expression is influenced by IDH1 mutational status. This work provides new insights for researchers aiming to design targeted therapies to control astrocytomas.	[da Silva, Roseli; Nagahashi Marie, Suely K.; Oba-Shinjo, Sueli M.] Univ Sao Paulo, Fac Med, Dept Neurol, Lab Mol & Cellular Biol, BR-01246903 Sao Paulo, Brazil; [Uno, Miyuki] ICESP, Ctr Translat Res Oncol, BR-01246000 Sao Paulo, Brazil; [Nagahashi Marie, Suely K.] Univ Sao Paulo, Ctr Studies Cellular & Mol Therapy NETCEM, BR-01246903 Sao Paulo, Brazil	Universidade de Sao Paulo; Universidade de Sao Paulo	da Silva, R (corresponding author), Univ Sao Paulo, Fac Med, Dept Neurol, Lab Mol & Cellular Biol, BR-01246903 Sao Paulo, Brazil.	roselis@usp.br	Marie, Suely Kazue Nagahashi/D-1870-2012; Oba-Shinjo, Sueli M./C-4017-2012; Uno, Miyuki/AAB-5486-2022	Marie, Suely Kazue Nagahashi/0000-0003-4419-7928; Oba-Shinjo, Sueli M./0000-0002-1650-5973; 	Sao Paulo Research Foundation (FAPESP) [04/12133-6]; Ludwig Institute for Cancer Research, National Council for Scientific and Technological Development (CNPq); Fundacao Faculdade de Medicina (FFM); National Council for Scientific and Technological Development (CNPq)	Sao Paulo Research Foundation (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Ludwig Institute for Cancer Research, National Council for Scientific and Technological Development (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao Faculdade de Medicina (FFM); National Council for Scientific and Technological Development (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This work was supported by Sao Paulo Research Foundation (FAPESP, grant #04/12133-6), the Ludwig Institute for Cancer Research, National Council for Scientific and Technological Development (CNPq), and Fundacao Faculdade de Medicina (FFM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abourbih DA, 2010, MELANOMA RES, V20, P97, DOI 10.1097/CMR.0b013e328336edfe; Albinger-Hegyi A, 2010, INT J CANCER, V126, P2653, DOI 10.1002/ijc.24948; AREM AJ, 1975, SURG FORUM, V26, P67; Baker AM, 2013, CANCER RES, V73, P583, DOI 10.1158/0008-5472.CAN-12-2447; Baker AM, 2011, JNCI-J NATL CANCER I, V103, P407, DOI 10.1093/jnci/djq569; Balss J, 2008, ACTA NEUROPATHOL, V116, P597, DOI 10.1007/s00401-008-0455-2; Basuroy S, 2010, AM J PHYSIOL-GASTR L, V299, pG186, DOI 10.1152/ajpgi.00368.2009; Bleeker FE, 2009, HUM MUTAT, V30, P7, DOI 10.1002/humu.20937; BOND JS, 1995, PROTEIN SCI, V4, P1247, DOI 10.1002/pro.5560040701; Bondareva A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005620; Carvalho PO, 2014, INT J BIOL MARKER, V29, pE120, DOI 10.5301/JBM.5000045; Chen LC, 2012, BREAST CANCER RES TR, V134, P989, DOI 10.1007/s10549-012-1986-8; Chesnelong C, 2014, NEURO-ONCOLOGY, V16, P686, DOI 10.1093/neuonc/not243; Cox TR, 2011, DIS MODEL MECH, V4, P165, DOI 10.1242/dmm.004077; Csiszar K, 2001, PROG NUCLEIC ACID RE, V70, P1, DOI 10.1016/S0079-6603(01)70012-8; Dong YY, 2014, BIOCHEM BIOPH RES CO, V444, P427, DOI 10.1016/j.bbrc.2014.01.079; El-Osta A, 2000, GENE EXPRESSION, V9, P63; Erler JT, 2009, CLIN EXP METASTAS, V26, P35, DOI 10.1007/s10585-008-9209-8; Erler JT, 2006, NATURE, V440, P1222, DOI 10.1038/nature04695; Ge Gaoxiang, 2006, Birth Defects Research, V78, P47, DOI 10.1002/bdrc.20060; Gravendeel LAM, 2010, HUM MUTAT, V31, pE1186, DOI 10.1002/humu.21201; Ichimura K, 2009, NEURO-ONCOLOGY, V11, P341, DOI 10.1215/15228517-2009-025; Ji F, 2013, INT J ONCOL, V42, P1578, DOI 10.3892/ijo.2013.1878; Kagan HM, 2003, J CELL BIOCHEM, V88, P660, DOI 10.1002/jcb.10413; KAGAN HM, 1991, AM J RESP CELL MOL, V5, P206, DOI 10.1165/ajrcmb/5.3.206; Kaneda A, 2004, CANCER RES, V64, P6410, DOI 10.1158/0008-5472.CAN-04-1543; Kessler E, 1996, SCIENCE, V271, P360, DOI 10.1126/science.271.5247.360; Kirschmann DA, 2002, CANCER RES, V62, P4478; Laczko R, 2007, NEUROPATH APPL NEURO, V33, P631, DOI 10.1111/j.1365-2990.2007.00858.x; Lai A, 2011, J CLIN ONCOL, V29, P4482, DOI 10.1200/JCO.2010.33.8715; Lazarus HM, 1995, MATRIX BIOL, V14, P727, DOI 10.1016/S0945-053X(05)80015-0; Lee K, 2006, CHEM RES TOXICOL, V19, P1284, DOI 10.1021/tx060068d; Levental KR, 2009, CELL, V139, P891, DOI 10.1016/j.cell.2009.10.027; Li PA, 2004, MOL BRAIN RES, V120, P115, DOI 10.1016/j.molbrainres.2003.10.013; Li WD, 1997, P NATL ACAD SCI USA, V94, P12817, DOI 10.1073/pnas.94.24.12817; Louis DN, 2007, ACTA NEUROPATHOL, V114, P97, DOI 10.1007/s00401-007-0243-4; Mammoto T, 2013, AM J PATHOL, V183, P1293, DOI 10.1016/j.ajpath.2013.06.026; Maruhashi T, 2010, J BIOL CHEM, V285, P13294, DOI 10.1074/jbc.M109.088864; Mustafa D, 2013, J NEUROPATH EXP NEUR, V72, P1171, DOI 10.1097/NEN.0000000000000015; Nellaiappan K, 2000, J CELL BIOCHEM, V79, P576, DOI 10.1002/1097-4644(20001215)79:4<576::AID-JCB60>3.0.CO;2-A; Nishioka T, 2012, CELL STRUCT FUNCT, V37, P75, DOI 10.1247/csf.11015; Nobusawa S, 2009, CLIN CANCER RES, V15, P6002, DOI 10.1158/1078-0432.CCR-09-0715; Noushmehr H, 2010, CANCER CELL, V17, P510, DOI 10.1016/j.ccr.2010.03.017; Ohgaki H, 2013, CLIN CANCER RES, V19, P764, DOI 10.1158/1078-0432.CCR-12-3002; Ohgaki H, 2011, BRAIN TUMOR PATHOL, V28, P177, DOI 10.1007/s10014-011-0029-1; Osawa T, 2013, BRIT J CANCER, V109, P2237, DOI 10.1038/bjc.2013.535; Parsons DW, 2008, SCIENCE, V321, P1807, DOI 10.1126/science.1164382; Pez F, 2011, CANCER RES, V71, P1647, DOI 10.1158/0008-5472.CAN-10-1516; Ping W, 2013, ASIAN PAC J CANCER P, V14, P3613, DOI 10.7314/APJCP.2013.14.6.3613; Saad FA, 2010, BIOCHEM BIOPH RES CO, V396, P944, DOI 10.1016/j.bbrc.2010.05.028; Sakai M, 2009, ANN SURG ONCOL, V16, P2494, DOI 10.1245/s10434-009-0559-5; Schietke R, 2010, J BIOL CHEM, V285, P6658, DOI 10.1074/jbc.M109.042424; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; SHERIDAN PJ, 1979, EXP MOL PATHOL, V30, P315, DOI 10.1016/0014-4800(79)90063-7; Shih YH, 2013, HEAD NECK-J SCI SPEC, V35, P250, DOI 10.1002/hed.22959; Smith-Mungo LI, 1998, MATRIX BIOL, V16, P387, DOI 10.1016/S0945-053X(98)90012-9; Sterchi EE, 2008, MOL ASPECTS MED, V29, P309, DOI 10.1016/j.mam.2008.08.002; Stewart GD, 2008, ONCOL REP, V20, P1561, DOI 10.3892/or_00000180; Uno M, 2005, CANCER LETT, V224, P321, DOI 10.1016/j.canlet.2004.10.022; Uno M, 2011, CLINICS, V66, P163, DOI 10.1590/S1807-59322011000100028; Watanabe T, 2009, AM J PATHOL, V174, P1149, DOI 10.2353/ajpath.2009.080958; Weller M, 2011, GLIA, V59, P1200, DOI 10.1002/glia.21130; Wiel C, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.382; Yan H, 2009, NEW ENGL J MED, V360, P765, DOI 10.1056/NEJMoa0808710; Yang XX, 2013, ONCOL REP, V29, P541, DOI 10.3892/or.2012.2146	65	26	28	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2015	10	3							e0119781	10.1371/journal.pone.0119781	http://dx.doi.org/10.1371/journal.pone.0119781			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD9NQ	25790191	Green Submitted, Green Published, gold			2022-12-27	WOS:000351425400106
J	Fredriksson, K; Van Itallie, CM; Aponte, A; Gucek, M; Tietgens, AJ; Anderson, JM				Fredriksson, Karin; Van Itallie, Christina M.; Aponte, Angel; Gucek, Marjan; Tietgens, Amber J.; Anderson, James M.			Proteomic Analysis of Proteins Surrounding Occludin and Claudin-4 Reveals Their Proximity to Signaling and Trafficking Networks	PLOS ONE			English	Article							TIGHT JUNCTION PROTEIN; CANINE KIDNEY-CELLS; ADHESION MOLECULE; EPITHELIAL-CELLS; INTERCELLULAR-JUNCTIONS; REGULATED EXPRESSION; ACTIN CYTOSKELETON; MEMBRANE-PROTEIN; IMMUNOGLOBULIN SUPERFAMILY; PARACELLULAR PERMEABILITY	Tight junctions are complex membrane structures that regulate paracellular movement of material across epithelia and play a role in cell polarity, signaling and cytoskeletal organization. In order to expand knowledge of the tight junction proteome, we used biotin ligase (BioID) fused to occludin and claudin-4 to biotinylate their proximal proteins in cultured MDCK II epithelial cells. We then purified the biotinylated proteins on streptavidin resin and identified them by mass spectrometry. Proteins were ranked by relative abundance of recovery by mass spectrometry, placed in functional categories, and compared not only among the N- and C-termini of occludin and the N-terminus of claudin-4, but also with our published inventory of proteins proximal to the adherens junction protein E-cadherin and the tight junction protein ZO-1. When proteomic results were analyzed, the relative distribution among functional categories was similar between occludin and claudin-4 proximal proteins. Apart from already known tight junction-proteins, occludin and claudin-4 proximal proteins were enriched in signaling and trafficking proteins, especially endocytic trafficking proteins. However there were significant differences in the specific proteins comprising the functional categories near each of the tagging proteins, revealing spatial compartmentalization within the junction complex. Taken together, these results expand the inventory of known and unknown proteins at the tight junction to inform future studies of the organization and physiology of this complex structure.	[Fredriksson, Karin; Van Itallie, Christina M.; Tietgens, Amber J.; Anderson, James M.] NHLBI, Lab Tight Junct Struct & Funct, NIH, Bethesda, MD 20892 USA; [Aponte, Angel; Gucek, Marjan] NHLBI, Prote Core Facil, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI)	Fredriksson, K (corresponding author), NHLBI, Lab Tight Junct Struct & Funct, NIH, Bldg 10, Bethesda, MD 20892 USA.	fredrikssonk@nhlbi.nih.gov		Anderson, James/0000-0003-2765-7996	Intramural Program of the National Institutes of Health; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [ZIAHL006176, ZICHL005903, ZICHL006019] Funding Source: NIH RePORTER	Intramural Program of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This study was funded by the Intramural Program of the National Institutes of Health to JMA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamsky K, 2003, J CELL SCI, V116, P1279, DOI 10.1242/jcs.00302; Anderson JM, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a002584; ANDERSON JM, 1988, J CELL BIOL, V106, P1141, DOI 10.1083/jcb.106.4.1141; Apweiler R, 2012, NUCLEIC ACIDS RES, V40, pD71, DOI 10.1093/nar/gkr981; Arstikaitis P, 2008, MOL BIOL CELL, V19, P2026, DOI 10.1091/mbc.E07-08-0802; Arvanitis D, 2008, GENE DEV, V22, P416, DOI 10.1101/gad.1630408; BACALLAO R, 1994, J CELL SCI, V107, P3301; Balda MS, 2000, J CELL BIOCHEM, V78, P85, DOI 10.1002/(SICI)1097-4644(20000701)78:1<85::AID-JCB8>3.3.CO;2-6; Beardsley DI, 2003, EXP CELL RES, V290, P402, DOI 10.1016/S0014-4827(03)00353-7; Bosse F, 2003, J NEUROCHEM, V86, P508, DOI 10.1046/j.1471-4159.2003.01870.x; Bottcher RT, 2004, NAT CELL BIOL, V6, P38, DOI 10.1038/ncb1082; Braga VMM, 2002, CURR OPIN CELL BIOL, V14, P546, DOI 10.1016/S0955-0674(02)00373-3; BUCCI C, 1992, CELL, V70, P715, DOI 10.1016/0092-8674(92)90306-W; BUTZ S, 1994, FEBS LETT, V355, P195, DOI 10.1016/0014-5793(94)01205-9; Cao XW, 2012, CELL RES, V22, P793, DOI 10.1038/cr.2012.64; Chen YH, 2002, MOL BIOL CELL, V13, P1227, DOI 10.1091/mbc.01-08-0423; Chen YH, 1997, J CELL BIOL, V138, P891, DOI 10.1083/jcb.138.4.891; Cipriano R, 2012, J CLIN INVEST, V122, P3197, DOI 10.1172/JCI60517; Cohen CJ, 2001, P NATL ACAD SCI USA, V98, P15191, DOI 10.1073/pnas.261452898; Cummins PM, 2012, MOL CELL BIOL, V32, P242, DOI 10.1128/MCB.06029-11; Davanger S, 1997, MOL BIOL CELL, V8, P1261, DOI 10.1091/mbc.8.7.1261; Deora AA, 2004, MOL BIOL CELL, V15, P4148, DOI 10.1091/mbc.E04-01-0058; Ding L, 2012, GASTROENTEROLOGY, V142, P305, DOI 10.1053/j.gastro.2011.10.025; Dorfel MJ, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/807356; Dudek SM, 2001, J APPL PHYSIOL, V91, P1487, DOI 10.1152/jappl.2001.91.4.1487; Ebnet K, 2001, EMBO J, V20, P3738, DOI 10.1093/emboj/20.14.3738; Engelhardt B, 2011, J CEREBR BLOOD F MET, V31, P1969, DOI 10.1038/jcbfm.2011.98; Fanning AS, 1998, J BIOL CHEM, V273, P29745, DOI 10.1074/jbc.273.45.29745; Firestein BL, 2001, MOL BIOL CELL, V12, P3465, DOI 10.1091/mbc.12.11.3465; Fletcher SJ, 2012, BIOL CELL, V104, P238, DOI 10.1111/boc.201100004; Furuse M, 1998, J CELL BIOL, V143, P391, DOI 10.1083/jcb.143.2.391; FURUSE M, 1993, J CELL BIOL, V123, P1777, DOI 10.1083/jcb.123.6.1777; Furuse M, 1998, J CELL BIOL, V141, P1539, DOI 10.1083/jcb.141.7.1539; FURUSE M, 1994, J CELL BIOL, V127, P1617, DOI 10.1083/jcb.127.6.1617; Furuse M, 2012, ANN NY ACAD SCI, V1257, P54, DOI 10.1111/j.1749-6632.2012.06486.x; Furuse M, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a002907; Gonzalez-Mariscal L, 2008, BBA-BIOMEMBRANES, V1778, P729, DOI 10.1016/j.bbamem.2007.08.018; Gosens I, 2007, EXP CELL RES, V313, P3959, DOI 10.1016/j.yexcr.2007.08.025; Haines BP, 2006, DEV BIOL, V297, P14, DOI 10.1016/j.ydbio.2006.04.004; Hartsock A, 2008, BBA-BIOMEMBRANES, V1778, P660, DOI 10.1016/j.bbamem.2007.07.012; Haskins J, 1998, J CELL BIOL, V141, P199, DOI 10.1083/jcb.141.1.199; Holmes JL, 2006, GENE EXPR PATTERNS, V6, P581, DOI 10.1016/j.modgep.2005.12.001; Hou JH, 2013, ANNU REV PHYSIOL, V75, P479, DOI 10.1146/annurev-physiol-030212-183705; Iacono KT, 2007, EXP MOL PATHOL, V83, P283, DOI 10.1016/j.yexmp.2007.08.014; Ide N, 1999, ONCOGENE, V18, P7810, DOI 10.1038/sj.onc.1203153; Ivanov AI, 2010, AM J PATHOL, V176, P134, DOI 10.2353/ajpath.2010.090220; JESAITIS LA, 1994, J CELL BIOL, V124, P949, DOI 10.1083/jcb.124.6.949; Kammerer R, 2001, J IMMUNOL, V166, P6537, DOI 10.4049/jimmunol.166.11.6537; Kirschner N, 2011, J INVEST DERMATOL, V131, P932, DOI 10.1038/jid.2010.390; Kohjima M, 2002, BIOCHEM BIOPH RES CO, V299, P641, DOI 10.1016/S0006-291X(02)02698-0; Koval M, 2013, ANNU REV PHYSIOL, V75, P551, DOI 10.1146/annurev-physiol-030212-183809; Lacaz-Vieira F, 1999, J MEMBRANE BIOL, V168, P289, DOI 10.1007/s002329900518; Lacy SE, 1999, GENOMICS, V62, P417, DOI 10.1006/geno.1999.6033; Ladwein M, 2005, EXP CELL RES, V309, P345, DOI 10.1016/j.yexcr.2005.06.013; Lal-Nag M, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-8-235; Lapierre LA, 2012, MOL BIOL CELL, V23, P2302, DOI 10.1091/mbc.E11-08-0681; Li YH, 2005, J MOL BIOL, V352, P151, DOI 10.1016/j.jmb.2005.07.017; Low SH, 2000, MOL BIOL CELL, V11, P3045, DOI 10.1091/mbc.11.9.3045; Marchiando AM, 2010, J CELL BIOL, V189, P111, DOI 10.1083/jcb.200902153; Martin-Padura I, 1998, J CELL BIOL, V142, P117, DOI 10.1083/jcb.142.1.117; Massari S, 2009, TRAFFIC, V10, P246, DOI 10.1111/j.1600-0854.2008.00854.x; Matsuda M, 2004, J CELL SCI, V117, P1247, DOI 10.1242/jcs.00972; Matter K, 2003, NAT REV MOL CELL BIO, V4, P225, DOI 10.1038/nrm1055; Mauris J, 2014, J CELL SCI, V127, P3141, DOI 10.1242/jcs.148510; McCarthy KM, 1996, J CELL SCI, V109, P2287; McNew JA, 1997, J BIOL CHEM, V272, P17776, DOI 10.1074/jbc.272.28.17776; Mineta K, 2011, FEBS LETT, V585, P606, DOI 10.1016/j.febslet.2011.01.028; Morimoto S, 2005, J BIOL CHEM, V280, P2220, DOI 10.1074/jbc.M406906200; Morita K, 1999, P NATL ACAD SCI USA, V96, P511, DOI 10.1073/pnas.96.2.511; Muller PS, 2011, DEVELOPMENT, V138, P1297, DOI 10.1242/dev.059386; Murakami T, 2009, J BIOL CHEM, V284, P21036, DOI 10.1074/jbc.M109.016766; Nakatsukasa M, 2010, AM J PATHOL, V177, P1344, DOI 10.2353/ajpath.2010.100149; Nethe M, 2012, J CELL SCI, V125, P3430, DOI 10.1242/jcs.100925; Oda K, 1999, CYTOGENET CELL GENET, V84, P75, DOI 10.1159/000015219; Oehrl W, 1998, ONCOGENE, V17, P1893, DOI 10.1038/sj.onc.1202108; Ogata S, 2007, GENE DEV, V21, P1817, DOI 10.1101/gad.1541807; Ooshio T, 2010, J BIOL CHEM, V285, P5003, DOI 10.1074/jbc.M109.043760; Papageorgiou DN, 2013, PROTEIN EXPRES PURIF, V89, P80, DOI 10.1016/j.pep.2013.02.015; Park M, 2013, J BIOL CHEM, V288, P33324, DOI 10.1074/jbc.M113.483487; Pisitkun T, 2012, PROTEOM CLIN APPL, V6, P268, DOI 10.1002/prca.201100108; Popoff MR, 2009, BBA-BIOMEMBRANES, V1788, P797, DOI 10.1016/j.bbamem.2009.01.011; Raleigh DR, 2011, J CELL BIOL, V193, P565, DOI 10.1083/jcb.201010065; Raleigh DR, 2010, MOL BIOL CELL, V21, P1200, DOI 10.1091/mbc.E09-08-0734; Rodgers LS, 2011, CYTOSKELETON, V68, P653, DOI 10.1002/cm.20547; Rojas R, 2001, MOL BIOL CELL, V12, P2257, DOI 10.1091/mbc.12.8.2257; Roux KJ, 2012, J CELL BIOL, V196, P801, DOI 10.1083/jcb.201112098; Ruffer C, 2004, EUR J CELL BIOL, V83, P135, DOI 10.1078/0171-9335-00366; Saitou M, 2000, MOL BIOL CELL, V11, P4131, DOI 10.1091/mbc.11.12.4131; Sakakibara A, 1997, J CELL BIOL, V137, P1393, DOI 10.1083/jcb.137.6.1393; Schluter OM, 2004, J NEUROSCI, V24, P6629, DOI 10.1523/JNEUROSCI.1610-04.2004; Schluter OM, 2002, J BIOL CHEM, V277, P40919, DOI 10.1074/jbc.M203704200; Scott BJ, 2009, INT J CANCER, V125, P1193, DOI 10.1002/ijc.24465; Simon DB, 1999, SCIENCE, V285, P103, DOI 10.1126/science.285.5424.103; Sonoda N, 1999, J CELL BIOL, V147, P195, DOI 10.1083/jcb.147.1.195; Stamatovic SM, 2009, J BIOL CHEM, V284, P19053, DOI 10.1074/jbc.M109.000521; STEVENSON BR, 1986, J CELL BIOL, V103, P755, DOI 10.1083/jcb.103.3.755; Tachibana K, 2000, J CELL BIOL, V150, P1161, DOI 10.1083/jcb.150.5.1161; Tai G, 2004, MOL BIOL; Takai Y, 2003, J CELL SCI, V116, P17, DOI 10.1242/jcs.00167; Tanaka M, 2005, J BIOL CHEM, V280, P42375, DOI 10.1074/jbc.M503786200; Tanaka M, 2005, EMBO J, V24, P3700, DOI 10.1038/sj.emboj.7600831; Tanaka Y, 2003, MOL BIOL CELL, V14, P1597, DOI 10.1091/mbc.E02-10-0632; Tsukamoto T, 1997, J BIOL CHEM, V272, P16133, DOI 10.1074/jbc.272.26.16133; Tsukita S, 2001, NAT REV MOL CELL BIO, V2, P285, DOI 10.1038/35067088; Van Itallie C, 2001, J CLIN INVEST, V107, P1319, DOI 10.1172/JCI12464; Van Itallie CM, 2013, TISSUE BARRIERS, V1, DOI 10.4161/tisb.25247; Van Itallie CM, 2014, J CELL SCI, V127, P885, DOI 10.1242/jcs.140475; Van Itallie CM, 2013, J BIOL CHEM, V288, P13775, DOI 10.1074/jbc.M113.466193; Van Itallie CM, 2010, J CELL SCI, V123, P2844, DOI 10.1242/jcs.065581; Van Itallie CM, 2003, AM J PHYSIOL-RENAL, V285, pF1078, DOI 10.1152/ajprenal.00116.2003; Van Itallie CM, 2004, J MEMBRANE BIOL, V199, P29, DOI 10.1007/s00232-004-0673-z; Walter JK, 2009, CELL MOL LIFE SCI, V66, P3655, DOI 10.1007/s00018-009-0150-z; Walter JK, 2009, ANN NY ACAD SCI, V1165, P19, DOI 10.1111/j.1749-6632.2009.04058.x; Wesolowski J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049886; WILLOTT E, 1992, AM J PHYSIOL, V262, pC1119, DOI 10.1152/ajpcell.1992.262.5.C1119; Wong V, 1997, J CELL BIOL, V136, P399, DOI 10.1083/jcb.136.2.399; Wu CJ, 2013, J BIOL CHEM, V288, P12253, DOI 10.1074/jbc.M113.457499; Wu J, 2011, ONCOGENE, V30, P4410, DOI 10.1038/onc.2011.149; Xu J, 2007, MOL CANCER RES, V5, P605, DOI 10.1158/1541-7786.MCR-06-0286; Yasuda T, 2014, J CELL SCI, V127, P557, DOI 10.1242/jcs.134056; Yonemura S, 2010, NAT CELL BIOL, V12, P533, DOI 10.1038/ncb2055; Zahraoui A, 2000, J CELL BIOL, V151, pF31, DOI 10.1083/jcb.151.5.F31; Zimmermann P, 2001, MOL BIOL CELL, V12, P339, DOI 10.1091/mbc.12.2.339	123	58	58	2	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2015	10	3							e0117074	10.1371/journal.pone.0117074	http://dx.doi.org/10.1371/journal.pone.0117074			35	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD9NQ	25789658	Green Published, gold, Green Submitted			2022-12-27	WOS:000351425400022
J	Fromer, R; Dimigen, O; Niefind, F; Krause, N; Kliegl, R; Sommer, W				Froemer, Romy; Dimigen, Olaf; Niefind, Florian; Krause, Niels; Kliegl, Reinhold; Sommer, Werner			Are Individual Differences in Reading Speed Related to Extrafoveal Visual Acuity and Crowding?	PLOS ONE			English	Article							EYE-MOVEMENT CONTROL; PERCEPTUAL SPAN; PREVIEW BENEFIT; SYNTACTIC AMBIGUITY; RECOGNITION; FIXATION; READERS; RESOLUTION; ENGLISH	Readers differ considerably in their speed of self-paced reading. One factor known to influence fixation durations in reading is the preprocessing of words in parafoveal vision. Here we investigated whether individual differences in reading speed or the amount of information extracted from upcoming words (the preview benefit) can be explained by basic differences in extrafoveal vision-i.e., the ability to recognize peripheral letters with or without the presence of flanking letters. Forty participants were given an adaptive test to determine their eccentricity thresholds for the identification of letters presented either in isolation (extrafoveal acuity) or flanked by other letters (crowded letter recognition). In a separate eye-tracking experiment, the same participants read lists of words from left to right, while the preview of the upcoming words was manipulated with the gaze-contingent moving window technique. Relationships between dependent measures were analyzed on the observational level and with linear mixed models. We obtained highly reliable estimates both for extrafoveal letter identification (acuity and crowding) and measures of reading speed (overall reading speed, size of preview benefit). Reading speed was higher in participants with larger uncrowded windows. However, the strength of this relationship was moderate and it was only observed if other sources of variance in reading speed (e.g., the occurrence of regressive saccades) were eliminated. Moreover, the size of the preview benefit-an important factor in normal reading-was larger in participants with better extrafoveal acuity. Together, these results indicate a significant albeit moderate contribution of extrafoveal vision to individual differences in reading speed.	[Froemer, Romy; Dimigen, Olaf; Niefind, Florian; Krause, Niels; Sommer, Werner] Humboldt Univ, D-10099 Berlin, Germany; [Dimigen, Olaf; Kliegl, Reinhold] Univ Potsdam, Potsdam, Germany	Humboldt University of Berlin; University of Potsdam	Fromer, R (corresponding author), Humboldt Univ, D-10099 Berlin, Germany.	froemero@cms.hu-berlin.de	Kliegl, Reinhold/AAD-3463-2019; Kliegl, Reinhold/A-1276-2009; Dimigen, Olaf/A-6810-2012; Froemer, Romy/Q-8058-2019; Sommer, Werner/H-4672-2011; Sommer, Werner/N-1945-2019	Kliegl, Reinhold/0000-0002-0180-8488; Kliegl, Reinhold/0000-0002-0180-8488; Dimigen, Olaf/0000-0002-2507-2823; Froemer, Romy/0000-0002-9468-4014; Sommer, Werner/0000-0001-5266-3445; Sommer, Werner/0000-0001-5266-3445	Deutsche Forschungsgemeinschaft [868]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	The study was funded by Deutsche Forschungsgemeinschaft (http://www.dfg.de/) with the grant number research group 868. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTMAN DG, 1995, BRIT MED J, V311, P485, DOI 10.1136/bmj.311.7003.485; Andrews TJ, 1999, VISION RES, V39, P2947, DOI 10.1016/S0042-6989(99)00019-X; Ashby J, 2012, ATTEN PERCEPT PSYCHO, V74, P634, DOI 10.3758/s13414-012-0277-0; Azuma M, 2012, JOURNAL OF EYE MOVEM, P5; Bach M, 1996, OPTOMETRY VISION SCI, V73, P49, DOI 10.1097/00006324-199601000-00008; Bates D. M., 2014, J STAT SOFTWARE; Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; Bornkessel ID, 2004, COGNITIVE BRAIN RES, V21, P11, DOI 10.1016/j.cogbrainres.2004.05.007; BOUMA H, 1970, NATURE, V226, P177, DOI 10.1038/226177a0; BOUMA H, 1973, VISION RES, V13, P767, DOI 10.1016/0042-6989(73)90041-2; Dimigen O, 2012, NEUROIMAGE, V62, P381, DOI 10.1016/j.neuroimage.2012.04.006; Engbert R, 2006, P NATL ACAD SCI USA, V103, P7192, DOI 10.1073/pnas.0509557103; EVERATT J, 1994, LANG SPEECH, V37, P283, DOI 10.1177/002383099403700305; Falkenberg HK, 2007, VISION RES, V47, P126, DOI 10.1016/j.visres.2006.09.014; Friederici AD, 1998, BIOL PSYCHOL, V47, P193, DOI 10.1016/S0301-0511(97)00033-1; Gelman A., 2007, DATA ANAL USING REGR, DOI 10.1017/CBO9780511790942; Greenwood JA, 2009, P NATL ACAD SCI USA, V106, P13130, DOI 10.1073/pnas.0901352106; Harrison WJ, 2013, J NEUROSCI, V33, P2927, DOI 10.1523/JNEUROSCI.4172-12.2013; Heister J, 2011, PSYCHOL RUNDSCH, V62, P10, DOI 10.1026/0033-3042/a000029; Hohenstein S, 2010, J EXP PSYCHOL LEARN, V36, P1150, DOI 10.1037/a0020233; Intriligator J, 2001, COGNITIVE PSYCHOL, V43, P171, DOI 10.1006/cogp.2001.0755; Kaakinen JK, 2007, MEMORY, V15, P634, DOI 10.1080/09658210701457096; KENNISON SM, 1995, J EXP PSYCHOL LEARN, V21, P68, DOI 10.1037/0278-7393.21.1.68; KING JW, 1995, J COGNITIVE NEUROSCI, V7, P376, DOI 10.1162/jocn.1995.7.3.376; Kliegl R, 2010, VIS COGN, V18, P655, DOI 10.1080/13506280902986058; Korinth SP, 2013, NEUROREPORT, V24, P96, DOI 10.1097/WNR.0b013e32835d20b1; Legge GE, 2001, VISION RES, V41, P725, DOI 10.1016/S0042-6989(00)00295-9; Levi DM, 2008, VISION RES, V48, P635, DOI 10.1016/j.visres.2007.12.009; Louie EG, 2007, J VISION, V7, DOI 10.1167/7.2.24; Makowski S, 2014, SHRINKAGE APPL TUTOR; Martelli M, 2005, J VISION, V5, P58, DOI 10.1167/5.1.6; MCCONKIE GW, 1975, PERCEPT PSYCHOPHYS, V17, P578, DOI 10.3758/BF03203972; Nandy AS, 2007, J VISION, V7, DOI 10.1167/7.2.5; Nuthmann A, 2005, VISION RES, V45, P2201, DOI 10.1016/j.visres.2005.02.014; Parrila R, 2005, J EDUC PSYCHOL, V97, P299, DOI 10.1037/0022-0663.97.3.299; Pelli DG, 2008, NAT NEUROSCI, V11, P1129, DOI 10.1038/nn.2187; Pelli DG, 2007, J VISION, V7, DOI 10.1167/7.2.20; Pelli DG, 2008, CURR OPIN NEUROBIOL, V18, P445, DOI 10.1016/j.conb.2008.09.008; Pelli DG, 2004, J VISION, V4, P1136, DOI 10.1167/4.12.12; R Core Team, 2021, R LANGUAGE ENV STAT; Rayner K, 1998, PSYCHOL BULL, V124, P372, DOI 10.1037/0033-2909.124.3.372; Rayner K, 2003, MIND'S EYE: COGNITIVE AND APPLIED ASPECTS OF EYE MOVEMENT RESEARCH, P213, DOI 10.1016/B978-044451020-4/50013-X; RAYNER K, 1975, COGNITIVE PSYCHOL, V7, P65, DOI 10.1016/0010-0285(75)90005-5; Rayner K, 2007, VISION RES, V47, P2714, DOI 10.1016/j.visres.2007.05.007; Rayner K, 2007, J EXP PSYCHOL HUMAN, V33, P230, DOI 10.1037/0096-1523.33.1.230; Rayner K, 2010, PSYCHON B REV, V17, P834, DOI 10.3758/PBR.17.6.834; Risse S, 2014, J VISION, V14, DOI 10.1167/14.8.11; Schroyens W, 1999, Q J EXP PSYCHOL-A, V52, P1021, DOI 10.1080/713755859; STRASBURGER H, 1991, PERCEPT PSYCHOPHYS, V49, P495, DOI 10.3758/BF03212183; Strasburger H, 2005, J VISION, V5, P1024, DOI 10.1167/5.11.8; Strasburger H, 2011, J VIS, V11; TAYLOR MM, 1967, J ACOUST SOC AM, V41, P782, DOI 10.1121/1.1910407; TINKER MA, 1946, PSYCHOL BULL, V43, P93, DOI 10.1037/h0063378; Traxler MJ, 2012, J EYE MOVEMENT RES, V5; van den Berg R, 2007, J VISION, V7, DOI 10.1167/7.2.14; Welcome SE, 2012, BRAIN LANG, V120, P360, DOI 10.1016/j.bandl.2011.12.011; Whitney D, 2011, TRENDS COGN SCI, V15, P160, DOI 10.1016/j.tics.2011.02.005; Wolfe BA, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00103; Yap MJ, 2012, J EXP PSYCHOL HUMAN, V38, P53, DOI 10.1037/a0024177; Yeshurun Y, 2010, J VISION, V10, DOI 10.1167/10.10.16; Yu DY, 2010, VISION RES, V50, P860, DOI 10.1016/j.visres.2010.02.006; Yu DY, 2007, J VISION, V7, DOI 10.1167/7.2.2	62	10	11	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2015	10	3							e0121986	10.1371/journal.pone.0121986	http://dx.doi.org/10.1371/journal.pone.0121986			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CD9NQ	25789812	Green Published, gold, Green Submitted			2022-12-27	WOS:000351425400203
J	Hamed, YA; Yasuda, H; Persson, M; Berndtsson, R; Wang, XP				Hamed, Yasser Ahmed; Yasuda, Hiroshi; Persson, Magnus; Berndtsson, Ronny; Wang, Xin-ping			Modeling Solute Transport by DLA in Soils of Northeastern Egypt	PLOS ONE			English	Article							DIFFUSION-LIMITED AGGREGATION; DYE TRACER; GENETIC ALGORITHM; FLOOD IRRIGATION; IMAGE-ANALYSIS; CLAY SOIL; FIELD; RESOLUTION	Arid soils in Egypt display large variability in solute transport properties, causing problems in soil management. To characterize this variability, dye infiltration experiments were conducted on four plots representing three main soil types in northeastern Egypt. The plots represented both cultivated and uncultivated land use. The observed dye patterns displayed a large variability and especially the clay soils indicated a high degree of preferential flow. The loamy sand and sandy soils displayed a more uniform dye distribution indicating more homogeneous soil properties. The observed dye patterns were modeled using a diffusion limited aggregation (DLA) model. The DLA is a random walk model where model parameters can be optimized using genetic algorithms (GA). The DLA model reproduced the observed dye patterns for all soils in an excellent way. The best fit was obtained with a specific combination of directional random walk probabilities P-u, P-d, P-r, and P-l for each plot (correlation 0.97-0.99). To account for soil layers with different hydraulic properties a two layer DLA model was developed. For all plots the Pu (upward random walk probability) was higher for the upper more homogeneous soil layer. The overall results showed that spatial variability resulting from solute transport for the investigated soils can be modeled using a DLA approach.	[Hamed, Yasser Ahmed] Port Said Univ, Fac Engn, Dept Civil Engn, Port Fouad Port Said, Egypt; [Yasuda, Hiroshi] Tottori Univ, Arid Land Res Ctr, Hamasaka Tottori, Japan; [Persson, Magnus; Berndtsson, Ronny] Lund Univ, Dept Water Resources Engn, Lund, Sweden; [Berndtsson, Ronny] Lund Univ, Ctr Middle Eastern Studies, Lund, Sweden; [Wang, Xin-ping] Chinese Acad Sci, Cold & Arid Reg Environm & Engn Res Inst, Shapotou Desert Res & Expt Stn, Lanzhou, Peoples R China	Egyptian Knowledge Bank (EKB); Port Said University; Lund University; Lund University; Chinese Academy of Sciences; Cold & Arid Regions Environmental & Engineering Research Institute, CAS	Berndtsson, R (corresponding author), Lund Univ, Dept Water Resources Engn, Lund, Sweden.	ronny.berndtsson@tvrl.lth.se	Wang, Xin/GYU-1129-2022; YASUDA, Hiroshi/D-5835-2019; Hamed, Yasser/AAB-3710-2022; Wang, Xin/AAN-8435-2021; Berndtsson, Ronny/C-7449-2015; Persson, Magnus/A-4062-2009	Wang, Xin/0000-0002-4457-7376; Berndtsson, Ronny/0000-0003-1473-0138; Persson, Magnus/0000-0003-0013-2321	Swedish International Development Authority (SIDA); MECW project at the Center for Middle Eastern Studies, Lund University; Swedish Institute; MFS SIDA scholarships; Chinese Academy of Sciences [2012T1Z0029]	Swedish International Development Authority (SIDA); MECW project at the Center for Middle Eastern Studies, Lund University; Swedish Institute; MFS SIDA scholarships; Chinese Academy of Sciences(Chinese Academy of Sciences)	This work was financially supported by the Swedish International Development Authority (SIDA) and the MECW project at the Center for Middle Eastern Studies, Lund University. The research was also supported by the Swedish Institute through a scholarship to the first author and MFS SIDA scholarships to M.Sc. students Martin Karlsson and Mikael Winqvist. RB was supported by the Chinese Academy of Sciences visiting professorship for senior international scientists, grant no. 2012T1Z0029. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abd-Elhamid HF, 2011, WATER RESOUR MANAG, V25, P2755, DOI 10.1007/s11269-011-9837-7; Aeby P, 1997, SOIL SCI SOC AM J, V61, P33, DOI 10.2136/sssaj1997.03615995006100010006x; Baveye P, 1998, WATER RESOUR RES, V34, P2783, DOI 10.1029/98WR01209; BOWMAN RS, 1986, WATER RESOUR RES, V22, P1531, DOI 10.1029/WR022i011p01531; Cey EE, 2009, HYDROL PROCESS, V23, P1768, DOI 10.1002/hyp.7302; FLURY M, 1994, J ENVIRON QUAL, V23, P1108, DOI 10.2134/jeq1994.00472425002300050037x; FLURY M, 1995, WATER RESOUR RES, V31, P2443, DOI 10.1029/95WR02039; Gwo JP, 2001, WATER RESOUR RES, V37, P1589, DOI 10.1029/2000WR900384; Hamed Y, 2008, HYDROLOG SCI J, V53, P466, DOI 10.1623/hysj.53.2.466; JAYNES DB, 1988, SOIL SCI SOC AM J, V52, P618, DOI 10.2136/sssaj1988.03615995005200030003x; Jha MK, 2008, J HYDROL, V359, P71, DOI 10.1016/j.jhydrol.2008.06.018; KEMBLOWSKI MW, 1993, WATER RESOUR RES, V29, P419, DOI 10.1029/92WR01861; Li SJ, 2005, MOD PHYS LETT B, V19, P1727, DOI 10.1142/S0217984905010323; MEAKIN P, 1983, PHYS REV A, V27, P2616, DOI 10.1103/PhysRevA.27.2616; Olsson J, 2002, WATER RESOUR RES, V38, DOI 10.1029/2001WR000880; Pachepsky Y, 2006, GEODERMA, V134, P253, DOI 10.1016/j.geoderma.2006.03.003; Perret JS, 2003, EUR J SOIL SCI, V54, P569, DOI 10.1046/j.1365-2389.2003.00546.x; Persson M, 1998, J HYDROL, V205, P232, DOI 10.1016/S0022-1694(97)00151-0; Persson M, 2005, VADOSE ZONE J, V4, P856, DOI 10.2136/vzj2004.0129; Persson M, 2001, J HYDROL, V250, P98, DOI 10.1016/S0022-1694(01)00422-X; Prasad KL, 2001, J HYDROL, V243, P149, DOI 10.1016/S0022-1694(00)00364-4; Wang M, 1997, GROUND WATER, V35, P757, DOI 10.1111/j.1745-6584.1997.tb00144.x; Yasuda H, 1998, SOIL SCI, V163, P544, DOI 10.1097/00010694-199807000-00004; Yasuda H, 2001, GEODERMA, V100, P49, DOI 10.1016/S0016-7061(00)00080-X; YASUDA H, 1994, SOIL SCI SOC AM J, V58, P1052, DOI 10.2136/sssaj1994.03615995005800040008x	25	2	2	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2015	10	3							e0119943	10.1371/journal.pone.0119943	http://dx.doi.org/10.1371/journal.pone.0119943			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD9NQ	25790463	Green Published, Green Submitted, gold			2022-12-27	WOS:000351425400119
J	Kohler, P; Wolff, A; Ejserholm, F; Wallman, L; Schouenborg, J; Linsmeier, CE				Kohler, Per; Wolff, Anette; Ejserholm, Fredrik; Wallman, Lars; Schouenborg, Jens; Linsmeier, Cecilia E.			Influence of Probe Flexibility and Gelatin Embedding on Neuronal Density and Glial Responses to Brain Implants	PLOS ONE			English	Article							TISSUE; BIOCOMPATIBILITY; INTERFACES; MOTION; CORTEX	To develop long-term high quality communication between brain and computer, a key issue is how to reduce the adverse foreign body responses. Here, the impact of probe flexibility and gelatine embedding on long-term (6w) tissue responses, was analyzed. Probes of same polymer material, size and shape, flexible mainly in one direction, were implanted in rat cerebral cortex (n(implants) = 3 x 8) in two orientations with respect to the major movement direction of the brain relative to the skull: parallel to (flex mode) or transverse to (rigid mode). Flex mode implants were either embedded in gelatin or non-embedded. Neurons, activated microglia and astrocytes were visualized using immunohistochemistry. The astrocytic reactivity, but not microglial response, was significantly lower to probes implanted in flex mode as compared to rigid mode. The microglial response, but not astrocytic reactivity, was significantly smaller to gelatin embedded probes (flex mode) than non-embedded. Interestingly, the neuronal density was preserved in the inner zone surrounding gelatin embedded probes. This contrasts to the common reports of reduced neuronal density close to implanted probes. In conclusion, sheer stress appears to be an important factor for astrocytic reactivity to implanted probes. Moreover, gelatin embedding can improve the neuronal density and reduce the microglial response close to the probe.	[Kohler, Per; Wolff, Anette; Ejserholm, Fredrik; Wallman, Lars; Schouenborg, Jens; Linsmeier, Cecilia E.] Lund Univ, Dept Expt Med Sci, Neuronano Res Ctr, Lund, Sweden; [Ejserholm, Fredrik; Wallman, Lars] Lund Univ, Fac Engn, Dept Measurement Technol & Ind Elect Engn, Elect Measurements, Lund, Sweden	Lund University; Lund University	Schouenborg, J (corresponding author), Lund Univ, Dept Expt Med Sci, Neuronano Res Ctr, Lund, Sweden.	Jens.Schouenborg@med.lu.se; Cecilia.Eriksson_Linsmeier@med.lu.se	LInsmeier, Cecilia Eriksson/N-2212-2015	Schouenborg, Jens/0000-0002-2815-6918; Ejserholm, Fredrik/0000-0003-0849-1185	Swedish research council [600012701]; Medical Faculty at Lund University; Knut and Alice Wallenberg foundation [KAW 2004.0119]	Swedish research council(Swedish Research CouncilEuropean Commission); Medical Faculty at Lund University; Knut and Alice Wallenberg foundation(Knut & Alice Wallenberg Foundation)	This study was financed by a Linnaeus grant (Project number 600012701) from the Swedish research council and the Medical Faculty at Lund University as well as a grant from the Knut and Alice Wallenberg foundation (KAW 2004.0119). The funding sources were not involved in the design, analysis or writing of this study in any way.	Basu S, 2005, TISSUE ENG, V11, P940, DOI 10.1089/ten.2005.11.940; Biran R, 2005, EXP NEUROL, V195, P115, DOI 10.1016/j.expneurol.2005.04.020; Chen TY, 2010, LECT NOTES COMPUT SC, V6363, P473; EDELL DJ, 1992, IEEE T BIO-MED ENG, V39, P635, DOI 10.1109/10.141202; Ejserholm F, 2014, IEEE J TRANSLATIONAL, V2, P1, DOI DOI 10.1109/JTEHM.2014.2326859; Freire MAM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027554; Grill WM, 2009, ANNU REV BIOMED ENG, V11, P1, DOI 10.1146/annurev-bioeng-061008-124927; He W, 2005, BIOMATERIALS, V26, P2983, DOI 10.1016/j.biomaterials.2004.08.021; Karumbaiah L, 2012, BIOMATERIALS, V33, P5983, DOI 10.1016/j.biomaterials.2012.05.021; Kim TH, 2013, SEMICOND SCI TECH, V28, DOI 10.1088/0268-1242/28/4/045001; Lebedev MA, 2011, CLINICS, V66, P25, DOI 10.1590/S1807-59322011001300004; Lind G, 2013, SCI REP-UK, V3, DOI 10.1038/srep02942; Lind G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047509; Lind G, 2010, J NEURAL ENG, V7, DOI 10.1088/1741-2560/7/4/046005; Linsmeier CE, 2011, PROG BRAIN RES, V194, P181, DOI 10.1016/B978-0-444-53815-4.00008-X; McConnell GC, 2009, J NEURAL ENG, V6, DOI 10.1088/1741-2560/6/5/056003; Neary JT, 2003, J NEUROSCI, V23, P2348, DOI 10.1523/jneurosci.23-06-02348.2003; Parker-Ure RA CM, 2008, SOC NEUR ABSTR VIEW; Polikov VS, 2005, J NEUROSCI METH, V148, P1, DOI 10.1016/j.jneumeth.2005.08.015; PONCELET BP, 1992, RADIOLOGY, V185, P645, DOI 10.1148/radiology.185.3.1438740; Purcell E TD, 2009, SOC NEUR ABSTR VIEW; Seymour JP, 2007, BIOMATERIALS, V28, P3594, DOI 10.1016/j.biomaterials.2007.03.024; Stice P, 2007, J NEURAL ENG, V4, P42, DOI 10.1088/1741-2560/4/2/005; Subbaroyan Jeyakumar, 2006, Conf Proc IEEE Eng Med Biol Soc, V2006, P3588; Szarowski DH, 2003, BRAIN RES, V983, P23, DOI 10.1016/S0006-8993(03)03023-3; Thelin J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016267; Ward MP, 2009, BRAIN RES, V1282, P183, DOI 10.1016/j.brainres.2009.05.052; Winslow BD, 2010, BIOMATERIALS, V31, P1558, DOI 10.1016/j.biomaterials.2009.11.049	28	28	28	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2015	10	3							e0119340	10.1371/journal.pone.0119340	http://dx.doi.org/10.1371/journal.pone.0119340			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD9NQ	25790172	Green Published, gold, Green Submitted			2022-12-27	WOS:000351425400076
J	Li, L; Long, Y; Zhang, LB; Dalton-Morgan, J; Batley, J; Yu, LJ; Meng, JL; Li, MT				Li, Lun; Long, Yan; Zhang, Libin; Dalton-Morgan, Jessica; Batley, Jacqueline; Yu, Longjiang; Meng, Jinling; Li, Maoteng			Genome Wide Analysis of Flowering Time Trait in Multiple Environments via High-Throughput Genotyping Technique in Brassica napus L.	PLOS ONE			English	Article							SUPPORT VECTOR REGRESSION; ASSISTED PREDICTION; RIDGE-REGRESSION; GENETIC VALUE; SELECTION; ACCURACY; PLANT; ASSOCIATION; POPULATIONS; ALIGNMENT	The prediction of the flowering time (FT) trait in Brassica napus based on genome-wide markers and the detection of underlying genetic factors is important not only for oilseed producers around the world but also for the other crop industry in the rotation system in China. In previous studies the low density and mixture of biomarkers used obstructed genomic selection in B. napus and comprehensive mapping of FT related loci. In this study, a high-density genome-wide SNP set was genotyped from a double-haploid population of B. napus. We first performed genomic prediction of FT traits in B. napus using SNPs across the genome under ten environments of three geographic regions via eight existing genomic predictive models. The results showed that all the models achieved comparably high accuracies, verifying the feasibility of genomic prediction in B. napus. Next, we performed a large-scale mapping of FT related loci among three regions, and found 437 associated SNPs, some of which represented known FT genes, such as AP1 and PHYE. The genes tagged by the associated SNPs were enriched in biological processes involved in the formation of flowers. Epistasis analysis showed that significant interactions were found between detected loci, even among some known FT related genes. All the results showed that our large scale and high-density genotype data are of great practical and scientific values for B. napus. To our best knowledge, this is the first evaluation of genomic selection models in B. napus based on a high-density SNP dataset and large-scale mapping of FT loci.	[Li, Lun; Zhang, Libin; Yu, Longjiang; Li, Maoteng] Huazhong Univ Sci & Technol, Coll Life Sci & Technol, Wuhan 430074, Peoples R China; [Li, Lun; Zhang, Libin] Huazhong Univ Sci & Technol, Hubei Bioinformat & Mol Imaging Key Lab, Wuhan 430074, Peoples R China; [Long, Yan; Meng, Jinling] Huazhong Agr Univ, Natl Key Lab Crop Genet Improvement, Wuhan, Peoples R China; [Long, Yan] Chinese Acad Agr Sci, Biotechnol Res Inst, Wuhan, Peoples R China; [Dalton-Morgan, Jessica; Batley, Jacqueline] Univ Queensland, Sch Agr & Food Sci, Brisbane, Qld, Australia	Huazhong University of Science & Technology; Huazhong University of Science & Technology; Huazhong Agricultural University; Chinese Academy of Agricultural Sciences; Biotechnology Research Institute, CAAS; University of Queensland	Li, MT (corresponding author), Huazhong Univ Sci & Technol, Coll Life Sci & Technol, Wuhan 430074, Peoples R China.	limaoteng426@hust.edu.cn	Batley, Jacqueline/A-5723-2008	Batley, Jacqueline/0000-0002-5391-5824	National Key Technology RD Program [2010BAD01B03]; National Natural Science Foundation of China [31171582, 31071447]; New Century Talents Support Program of the Ministry of Education of China [NCET110172]	National Key Technology RD Program(National Key Technology R&D Program); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); New Century Talents Support Program of the Ministry of Education of China	The work was supported by National Key Technology R&D Program (2010BAD01B03), the National Natural Science Foundation of China (31171582, 31071447) and the New Century Talents Support Program of the Ministry of Education of China (NCET110172). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atwell S, 2010, NATURE, V465, P627, DOI 10.1038/nature08800; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Chao DY, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002923; Crossa J, 2013, HEREDITY EDINB  0310; Daetwyler HD, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003395; de los Campos G, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003608; de los Campos G, 2013, GENETICS, V193, P327, DOI 10.1534/genetics.112.143313; Dimitriadou E, MISC FUNCTIONS DEP S; Drucker H, 1997, ADV NEUR IN, V9, P155; Endelman JB, 2011, PLANT GENOME-US, V4, P250, DOI 10.3835/plantgenome2011.08.0024; Fritsche S, 2012, FRONT PLANT SCI, V3, DOI 10.3389/fpls.2012.00129; GdlCaPP Rodriguez, 2013, BGLR BAYESIAN GEN LI; Genuer R, 2010, PATTERN RECOGN LETT, V31, P2225, DOI 10.1016/j.patrec.2010.03.014; Gianola D, 2006, GENETICS, V173, P1761, DOI 10.1534/genetics.105.049510; Gouy M, 2013, THEOR APPL GENET, V126, P2575, DOI 10.1007/s00122-013-2156-z; Hayes BJ, 2009, J DAIRY SCI, V92, P433, DOI 10.3168/jds.2008-1646; Hayes BJ, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001139; Heffner EL, 2011, PLANT GENOME-US, V4, P65, DOI [10.3835/plantgenome2010.12.0029, 10.3835/plantgenome.2010.12.0029]; Heslot N, 2012, CROP SCI, V52, P146, DOI 10.2135/cropsci2011.06.0297; Huang DW, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-9-r183; Huang XH, 2012, NAT GENET, V44, P32, DOI 10.1038/ng.1018; Jimenez-Montero JA, 2013, J DAIRY SCI, V96, P625, DOI 10.3168/jds.2012-5631; Kump KL, 2011, NAT GENET, V43, P163, DOI 10.1038/ng.747; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Lin HY, 2008, J HUM GENET, V53, P802, DOI 10.1007/s10038-008-0313-z; Lin HY, 2012, ANN HUM GENET, V76, P53, DOI 10.1111/j.1469-1809.2011.00692.x; Long N, 2011, THEOR APPL GENET, V123, P1065, DOI 10.1007/s00122-011-1648-y; Long Y, 2007, GENETICS, V177, P2433, DOI 10.1534/genetics.107.080705; Lorenz AJ, 2011, ADV AGRON, V110, P77, DOI 10.1016/B978-0-12-385531-2.00002-5; Lorenzana RE, 2009, THEOR APPL GENET, V120, P151, DOI 10.1007/s00122-009-1166-3; Makowsky R, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002051; Massman JM, 2013, THEOR APPL GENET, V126, P13, DOI 10.1007/s00122-012-1955-y; Meuwissen THE, 2001, GENETICS, V157, P1819; Meuwissen Theo, 2010, Genetics, V185, P623, DOI 10.1534/genetics.110.116590; Morota G, 2013, GENET SEL EVOL, V45, DOI 10.1186/1297-9686-45-17; Morrell PL, 2012, NAT REV GENET, V13, P85, DOI 10.1038/nrg3097; Moser G, 2009, GENET SEL EVOL, V41, DOI 10.1186/1297-9686-41-56; Neves HHR, 2012, BMC GENET, V13, DOI 10.1186/1471-2156-13-100; Ober U, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002685; Ogutu Joseph O, 2011, BMC Proc, V5 Suppl 3, pS11, DOI 10.1186/1753-6561-5-S3-S11; Park T, 2008, J AM STAT ASSOC, V103, P681, DOI 10.1198/016214508000000337; Pasam RK, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-16; Perez-Rodriguez P, 2012, G3-GENES GENOM GENET, V2, P1595, DOI 10.1534/g3.112.003665; Piepho HP, 2009, CROP SCI, V49, P1165, DOI 10.2135/cropsci2008.10.0595; Qiu D, 2006, THEOR APPL GENET, V114, P67, DOI 10.1007/s00122-006-0411-2; Qiu J., 2003, GEOCARTO INT, V18, P3, DOI [10.1080/10106040308542268, DOI 10.1080/10106040308542268]; Rahman M, 2008, THEOR APPL GENET, V117, P895, DOI 10.1007/s00122-008-0829-9; Raman H, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-277; Raman H, 2013, THEOR APPL GENET, V126, P119, DOI 10.1007/s00122-012-1966-8; Resende MFR, 2012, GENETICS, V190, P1503, DOI 10.1534/genetics.111.137026; Riedelsheimer C, 2013, GENETICS, V194, P493, DOI 10.1534/genetics.113.150227; Riedelsheimer C, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-452; Schon CC, 2004, GENETICS, V167, P485, DOI 10.1534/genetics.167.1.485; Storlie E, 2013, PLANT GENOME-US, V6, DOI 10.3835/plantgenome2013.01.0001; Strobl C, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-307; Sun YV, 2010, ADV GENET, V72, P73, DOI [10.1016/S0065-2660(10)72004-6, 10.1016/B978-0-12-380862-2.00004-7]; VanRaden PM, 2008, J DAIRY SCI, V91, P4414, DOI 10.3168/jds.2007-0980; VanRaden PM., 2007, INTERBULL B, V37, P33; Wang XX, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050038; Wimmer V, 2013, GENETICS, V195, P573, DOI 10.1534/genetics.113.150078; Wurschum T, 2012, THEOR APPL GENET, V124, P153, DOI 10.1007/s00122-011-1694-5; Zhong SQ, 2009, GENETICS, V182, P355, DOI 10.1534/genetics.108.098277	62	21	24	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2015	10	3							e0119425	10.1371/journal.pone.0119425	http://dx.doi.org/10.1371/journal.pone.0119425			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD9NQ	25790019	gold, Green Published, Green Submitted			2022-12-27	WOS:000351425400084
J	Otero-Losada, M; Cao, G; Gonzalez, J; Muller, A; Ottaviano, G; Lillig, C; Capani, F; Ambrosio, G; Milei, J				Otero-Losada, Matilde; Cao, Gabriel; Gonzalez, Julian; Muller, Angelica; Ottaviano, Graciela; Lillig, Christopher; Capani, Francisco; Ambrosio, Giuseppe; Milei, Jose			Functional and Morphological Changes in Endocrine Pancreas following Cola Drink Consumption in Rats	PLOS ONE			English	Article							BETA-CELL DEDIFFERENTIATION; GLUCOSE; SWEETENERS; BEVERAGES; PLASMA; ADULTS; MODEL	Aim We report the effects of long-term cola beverage drinking on glucose homeostasis, endocrine pancreas function and morphology in rats. Methods Wistar rats drank: water (group W), regular cola beverage (group C, sucrose sweetened) or "light" cola beverage (group L, artificially sweetened). After 6 months, 50% of the animals in each group were euthanized and the remaining animals consumed water for the next 6 months when euthanasia was performed. Biochemical assays, insulinemia determination, estimation of insulin resistance (HOMA-IR), morphometry and immunohistochemistry evaluations were performed in pancreas. Results Hyperglycemia (16%, p < 0.05), CoQ(10) (coenzyme-Q(10)) decrease (-52%, p < 0.01), strong hypertriglyceridemia (2.8-fold, p < 0.01), hyperinsulinemia (2.4 fold, p < 0.005) and HOMA-IR increase (2.7 fold, p < 0.01) were observed in C. Group C showed a decrease in number of alpha cells (-42%, p < 0.01) and beta cells (-58%, p < 0.001) and a moderate increase in alpha cells' size after wash-out (+ 14%, p < 0.001). Group L showed reduction in beta cells' size (-9%, p < 0.001) and only after wash-out (L-12) a 19% increase in size (p < 0.0001) with 35% decrease in number of a cells (p< 0.01). Groups C and L showed increase in alpha/beta-cell ratio which was irreversible only in C (alpha/beta = +38% in C-6,+30% in C-12, p < 0.001vs. W-6). Regular cola induced a striking increase in the cytoplasmic expression of Trx1 (Thioredoxin-1) (2.25-fold in C-6 vs. W-6; 2.7-fold in C-12 vs. W-12, p < 0.0001) and Prx2 (Peroxiredoxin-2) (3-fold in C-6 vs. W-6; 2-fold in C-12 vs. W-12, p < 0.0001). Light cola induced increase in Trx1 (3-fold) and Prx2 (2-fold) after wash-out (p < 0.0001, L-12 vs. W-12). Conclusion Glucotoxicity may contribute to the loss of beta cell function with depletion of insulin content. Oxidative stress, suggested by increased expression of thioredoxins and low circulating levels of CoQ(10), may follow sustained hyperglycemia. A likely similar panorama may result from the effects of artificially sweetened cola though via other downstream routes.	[Otero-Losada, Matilde; Cao, Gabriel; Gonzalez, Julian; Muller, Angelica; Ottaviano, Graciela; Capani, Francisco; Milei, Jose] Univ Buenos Aires, CONICET, ININCA, Inst Invest Cardiol, Buenos Aires, DF, Argentina; [Lillig, Christopher] Ernst Moritz Arndt Univ Greifswald, Univ Med Greifswald KdoR, Dept Biochem & Mol Biol, Greifswald, Germany; [Ambrosio, Giuseppe] Univ Perugia, Cardiol & Fisiopatol Cardiovasc, I-06100 Perugia, Italy	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); University of Buenos Aires; Ernst Moritz Arndt Universitat Greifswald; Greifswald Medical School; University of Perugia	Otero-Losada, M (corresponding author), Univ Buenos Aires, CONICET, ININCA, Inst Invest Cardiol, Buenos Aires, DF, Argentina.	mol@fmed.uba.ar	Lillig, Christopher Horst/AAD-7098-2019; capani, Francisco/D-9781-2016; Otero-Losada, Matilde/J-3050-2019; Ambrosio, Giuseppe/C-6596-2013	Lillig, Christopher Horst/0000-0003-2509-5117; Otero-Losada, Matilde/0000-0001-6650-1033; Ambrosio, Giuseppe/0000-0002-9677-980X	Consejo Nacional de Investigaciones Cientificas y Tecnicas, Buenos Aires, Argentina [PIP 6549]; Universidad de Buenos Aires, Argentina [UBACYT M052]; University of Buenos Aires - Instituto de Investigaciones Cardiologicas; University of Perugia Division of Cardiology	Consejo Nacional de Investigaciones Cientificas y Tecnicas, Buenos Aires, Argentina(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); Universidad de Buenos Aires, Argentina(University of Buenos Aires); University of Buenos Aires - Instituto de Investigaciones Cardiologicas; University of Perugia Division of Cardiology	This work was supported by PIP 6549, http://www.conicet.gov.ar/, Consejo Nacional de Investigaciones Cientificas y Tecnicas, Buenos Aires, Argentina (JM); UBACYT M052, http://www.uba.ar/, Universidad de Buenos Aires, Argentina (JM); Framework Agreement between the University of Buenos Aires - Instituto de Investigaciones Cardiologicas - and the University of Perugia Division of Cardiology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aon MA, 2012, J GEN PHYSIOL, V139, P479, DOI 10.1085/jgp.201210772; Bonner-Weir S, 2001, DIABETES, V50, pS20, DOI 10.2337/diabetes.50.2007.S20; Brown RJ, 2009, DIABETES CARE, V32, P2184, DOI 10.2337/dc09-1185; Cacho J, 2008, AM J PHYSIOL-ENDOC M, V295, pE1269, DOI 10.1152/ajpendo.90207.2008; Canadian Council on Animal Care, 1993, GUIDE CARE USE EXPT; Carpenter KLH, 2014, EUR J PHARM SCI, V57, P87, DOI 10.1016/j.ejps.2013.12.012; Dhingra R, 2007, CIRCULATION, V116, P480, DOI 10.1161/CIRCULATIONAHA.107.689935; Ejarque M, 2013, J BIOL CHEM, V288, P11705, DOI 10.1074/jbc.M112.388173; Humphries P, 2008, EUR J CLIN NUTR, V62, P451, DOI 10.1038/sj.ejcn.1602866; Kaplan A, 1995, CLIN CHEM INTERPRETA, P220; Karpinska J, 2006, J PHARMACEUT BIOMED, V42, P232, DOI 10.1016/j.jpba.2006.03.037; Ladeia AM, 2014, WORLD J DIABETES, V5, P601, DOI 10.4239/wjd.v5.i5.601; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; Mezza T, 2014, DIABETOLOGIA, V57, P1291, DOI 10.1007/s00125-014-3251-7; Milei J, 2011, WORLD J CARDIOL, V3, P111, DOI 10.4330/wjc.v3.i4.111; Montonen J, 2007, J NUTR, V137, P1447, DOI 10.1093/jn/137.6.1447; Naryzhny SN, 2010, FEBS LETT, V584, P4292, DOI 10.1016/j.febslet.2010.09.021; Nseir W, 2010, WORLD J GASTROENTERO, V16, P2579, DOI 10.3748/wjg.v16.i21.2579; Otero-Losada M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089838; Otero-Losada ME, 2013, CARDIOVASC DIABETOL, V12, DOI 10.1186/1475-2840-12-57; Otero-Losada ME, 2011, INT J CARDIOL, V146, P106, DOI 10.1016/j.ijcard.2010.09.066; Palmnas MSA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109841; Puri S, 2013, GENE DEV, V27, P2563, DOI 10.1101/gad.227785.113; Rochette L, 2014, BBA-GEN SUBJECTS, V1840, P2709, DOI 10.1016/j.bbagen.2014.05.017; Romaguera D, 2013, DIABETOLOGIA, V56, P1520, DOI 10.1007/s00125-013-2899-8; Slack JMW, 2001, CURR OPIN GENET DEV, V11, P581, DOI 10.1016/S0959-437X(00)00236-7; Suez J, 2014, NATURE, V514, P181, DOI 10.1038/nature13793; Wang ZY, 2014, CELL METAB, V19, P872, DOI 10.1016/j.cmet.2014.03.010; WEIBEL ER, 1963, LAB INVEST, V12, P131; Weir GC, 2001, DIABETES, V50, pS154, DOI 10.2337/diabetes.50.2007.S154; Weir GC, 2013, ISLETS, V5, P233, DOI 10.4161/isl.27494; Zheng J, 2014, CHEM-BIOL INTERACT, V215, P1, DOI 10.1016/j.cbi.2014.02.016	32	13	13	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2015	10	3							e0118700	10.1371/journal.pone.0118700	http://dx.doi.org/10.1371/journal.pone.0118700			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD9NQ	25790473	gold, Green Submitted, Green Published			2022-12-27	WOS:000351425400039
J	Papageorgiou, A; Rapley, J; Mesirov, JP; Tamayo, P; Avruch, J				Papageorgiou, Angela; Rapley, Joseph; Mesirov, Jill P.; Tamayo, Pablo; Avruch, Joseph			A Genome-Wide siRNA Screen in Mammalian Cells for Regulators of S6 Phosphorylation	PLOS ONE			English	Article							RIBOSOMAL-PROTEIN S6; AMINO-ACID SUFFICIENCY; MTOR COMPLEX 1; RAG GTPASES; TUMOR-SUPPRESSOR; GROWTH-CONTROL; TRANSFER-RNA; DNA-DAMAGE; IN-VITRO; RAPAMYCIN	mTOR complex1, the major regulator of mRNA translation in all eukaryotic cells, is strongly activated in most cancers. We performed a genome-wide RNAi screen in a human cancer cell line, seeking genes that regulate S6 phosphorylation, readout of mTORC1 activity. Applying a stringent selection, we retrieved nearly 600 genes wherein at least two RNAis gave significant reduction in S6-P. This cohort contains known regulators of mTOR complex 1 and is significantly enriched in genes whose depletion affects the proliferation/viability of the large set of cancer cell lines in the Achilles database in a manner paralleling that caused by mTOR depletion. We next examined the effect of RNAi pools directed at 534 of these gene products on S6-P in TSC1 null mouse embryo fibroblasts. 76 RNAis reduced S6 phosphorylation significantly in 2 or 3 replicates. Surprisingly, among this cohort of genes the only elements previously associated with the maintenance of mTORC1 activity are two subunits of the vacuolar ATPase and the CUL4 subunit DDB1. RNAi against a second set of 84 targets reduced S6-P in only one of three replicates. However, an indication that this group also bears attention is the presence of rpS6KB1 itself, Rac1 and MAP4K3, a protein kinase that supports amino acid signaling to rpS6KB1. The finding that S6 phosphorylation requires a previously unidentified, functionally diverse cohort of genes that participate in fundamental cellular processes such as mRNA translation, RNA processing, DNA repair and metabolism suggests the operation of feedback pathways in the regulation of mTORC1 operating through novel mechanisms.	[Papageorgiou, Angela; Rapley, Joseph; Avruch, Joseph] Massachusetts Gen Hosp, Dept Mol Biol, Boston, MA 02114 USA; [Papageorgiou, Angela; Rapley, Joseph; Avruch, Joseph] Massachusetts Gen Hosp, Med Serv, Diabet Unit, Boston, MA 02114 USA; [Papageorgiou, Angela; Rapley, Joseph; Avruch, Joseph] Harvard Univ, Sch Med, Dept Med, Boston, MA 02115 USA; [Mesirov, Jill P.; Tamayo, Pablo] Broad Inst MIT & Harvard, Cambridge, MA 02142 USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute	Avruch, J (corresponding author), Massachusetts Gen Hosp, Dept Mol Biol, Boston, MA 02114 USA.	avruch@molbio.mgh.harvard.edu	Mesirov, Jill/AGF-7626-2022		NIH [CA73818, DK17776, NIH-R37DK17776, NIH-R01CA73818]; NATIONAL CANCER INSTITUTE [R01CA073818, R01CA121941] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK017776, P30DK040561, R37DK017776, DP2DK083111] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This study was supported by NIH grants (CA73818 and DK17776) and institutional funds. JA received funding from the NIH (NIH-R37DK17776 and NIH-R01CA73818). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alessi DR, 1998, CURR BIOL, V8, P69, DOI 10.1016/S0960-9822(98)70037-5; Bar-Peled L, 2013, SCIENCE, V340, P1100, DOI 10.1126/science.1232044; Bar-Peled L, 2012, CELL, V150, P1196, DOI 10.1016/j.cell.2012.07.032; Beugnet A, 2003, BIOCHEM J, V372, P555, DOI 10.1042/BJ20021266; Cam M, 2014, J BIOL CHEM, V289, P4083, DOI 10.1074/jbc.M113.530303; Cheung HW, 2011, P NATL ACAD SCI USA, V108, P12372, DOI 10.1073/pnas.1109363108; Cowley GS, 2014, SCI DATA, V1, DOI 10.1038/sdata.2014.35; DeBerardinis RJ, 2008, CELL METAB, V7, P11, DOI 10.1016/j.cmet.2007.10.002; Deer EL, 2010, PANCREAS, V39, P425, DOI 10.1097/MPA.0b013e3181c15963; Dewez M, 2008, P NATL ACAD SCI USA, V105, P5459, DOI 10.1073/pnas.0709404105; Duran A, 2011, MOL CELL, V44, P134, DOI 10.1016/j.molcel.2011.06.038; Duran RV, 2012, MOL CELL, V47, P349, DOI 10.1016/j.molcel.2012.05.043; Goehring AS, 2003, MOL BIOL CELL, V14, P4329, DOI 10.1091/mbc.e03-02-0079; Grewe M, 1999, CANCER RES, V59, P3581; Gwinn DM, 2008, MOL CELL, V30, P214, DOI 10.1016/j.molcel.2008.03.003; Han JM, 2012, CELL, V149, P410, DOI 10.1016/j.cell.2012.02.044; Hara K, 2002, CELL, V110, P177, DOI 10.1016/S0092-8674(02)00833-4; Hara K, 1998, J BIOL CHEM, V273, P14484, DOI 10.1074/jbc.273.23.14484; Horejsi Z, 2010, MOL CELL, V39, P839, DOI 10.1016/j.molcel.2010.08.037; Huang J, 2008, BIOCHEM J, V412, P179, DOI 10.1042/BJ20080281; Hussain S, 2013, MOL CELL BIOL, V33, P1188, DOI 10.1128/MCB.01389-12; Isotani S, 1999, J BIOL CHEM, V274, P34493, DOI 10.1074/jbc.274.48.34493; Kim DH, 2002, CELL, V110, P163, DOI 10.1016/S0092-8674(02)00808-5; Kim E, 2008, NAT CELL BIOL, V10, P935, DOI 10.1038/ncb1753; Kim YM, 2012, MOL CELL, V46, P833, DOI 10.1016/j.molcel.2012.04.007; Kimball SR, 2008, J BIOL CHEM, V283, P3465, DOI 10.1074/jbc.M706643200; Kwiatkowski DJ, 2002, HUM MOL GENET, V11, P525, DOI 10.1093/hmg/11.5.525; Lai KP, 2010, EMBO J, V29, P2994, DOI 10.1038/emboj.2010.166; Laplante M, 2012, CELL, V149, P274, DOI 10.1016/j.cell.2012.03.017; Lappano R, 2011, NAT REV DRUG DISCOV, V10, P47, DOI 10.1038/nrd3320; Lee DF, 2007, CELL, V130, P440, DOI 10.1016/j.cell.2007.05.058; Leidel S, 2009, NATURE, V458, P228, DOI 10.1038/nature07643; Linfoot EH, 1957, INFORM CONTR, V1, P85, DOI DOI 10.1016/S0019-9958(57)90116-X; Loewith R, 2002, MOL CELL, V10, P457, DOI 10.1016/S1097-2765(02)00636-6; Long X, 2005, CURR BIOL, V15, P702, DOI 10.1016/j.cub.2005.02.053; Lu J, 2013, BLOOD, V122, P1610, DOI 10.1182/blood-2013-01-481457; Magnuson B, 2012, BIOCHEM J, V441, P1, DOI 10.1042/BJ20110892; Meyuhas O, 2008, INT REV CEL MOL BIO, V268, P1, DOI 10.1016/S1937-6448(08)00801-0; Meyuhas O, 2009, PROG MOL BIOL TRANSL, V90, P109, DOI 10.1016/S1877-1173(09)90003-5; Mi HY, 2013, NUCLEIC ACIDS RES, V41, pD377, DOI 10.1093/nar/gks1118; Nemazanyy I, 2004, FEBS LETT, V578, P357, DOI 10.1016/j.febslet.2004.10.091; Ogmundsdottir MH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036616; Orlova KA, 2010, J CLIN INVEST, V120, P1591, DOI 10.1172/JCI41592; Papageorgiou A, 2012, METHODS MOL BIOL, V821, P187, DOI 10.1007/978-1-61779-430-8_11; Parsons AB, 2004, NAT BIOTECHNOL, V22, P62, DOI 10.1038/nbt919; PRICE DJ, 1992, SCIENCE, V257, P973, DOI 10.1126/science.1380182; Rapley J, 2011, J BIOL CHEM, V286, P38043, DOI 10.1074/jbc.M111.245449; Roccio M, 2006, ONCOGENE, V25, P657, DOI 10.1038/sj.onc.1209106; Rubio-Texeira M, 2007, FEBS LETT, V581, P541, DOI 10.1016/j.febslet.2007.01.019; Saci A, 2011, MOL CELL, V42, P50, DOI 10.1016/j.molcel.2011.03.017; Sancak Y, 2008, SCIENCE, V320, P1496, DOI 10.1126/science.1157535; Sancak Y, 2010, CELL, V141, P290, DOI 10.1016/j.cell.2010.02.024; Shao DD, 2013, GENOME RES, V23, P665, DOI 10.1101/gr.143586.112; Shimobayashi M, 2014, NAT REV MOL CELL BIO, V15, P155, DOI 10.1038/nrm3757; Smith EM, 2005, J BIOL CHEM, V280, P18717, DOI 10.1074/jbc.M414499200; Song H, 2007, NAT CELL BIOL, V9, P573, DOI 10.1038/ncb1571; Tsun ZY, 2013, MOL CELL, V52, P495, DOI 10.1016/j.molcel.2013.09.016; Van der Veen AG, 2011, P NATL ACAD SCI USA, V108, P1763, DOI 10.1073/pnas.1014402108; Wu XN, 2011, J BIOL CHEM, V286, P31501, DOI 10.1074/jbc.M111.233122; Yan LJ, 2010, MOL CELL, V37, P633, DOI 10.1016/j.molcel.2010.01.031; Zheng M, 2011, NAT CELL BIOL, V13, P263, DOI 10.1038/ncb2168; Zoncu R, 2011, SCIENCE, V334, P678, DOI 10.1126/science.1207056	62	10	10	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2015	10	3							e0116096	10.1371/journal.pone.0116096	http://dx.doi.org/10.1371/journal.pone.0116096			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD9NQ	25790369	Green Published, gold, Green Submitted			2022-12-27	WOS:000351425400008
J	Saqib, NU; Khan, I				Saqib, Najam-Us; Khan, Imdad			A Hybrid Antenna Array Design for 3-D Direction of Arrival Estimation	PLOS ONE			English	Article							PARTICLE SWARM OPTIMIZATION	A 3-D beam scanning antenna array design is proposed that gives a whole 3-D spherical coverage and also suitable for various radar and body-worn devices in the Body Area Networks applications. The Array Factor (AF) of the proposed antenna is derived and its various parameters like directivity, Half Power Beam Width (HPBW) and Side Lobe Level (SLL) are calculated by varying the size of the proposed antenna array. Simulations were carried out in MATLAB 2012b. The radiators are considered isotropic and hence mutual coupling effects are ignored. The proposed array shows a considerable improvement against the existing cylindrical and coaxial cylindrical arrays in terms of 3-D scanning, size, directivity, HPBW and SLL.	[Saqib, Najam-Us; Khan, Imdad] COMSATS Inst Informat Technol, Abbottabad, Pakistan	COMSATS University Islamabad (CUI)	Khan, I (corresponding author), COMSATS Inst Informat Technol, Abbottabad, Pakistan.	imdad@ciit.net.pk	Khan, Imdad/F-4199-2015	Khan, Imdad/0000-0001-7430-9738				Abouda AA, 2006, PROG ELECTROMAGN RES, V64, P257, DOI 10.2528/PIER06050801; Balanis C.A., 2012, ANTENNA THEORY ANAL; Chryssomallis M, 2000, IEEE ANTENN PROPAG M, V42, P129, DOI 10.1109/74.848965; Dessouky M, 2006, PROG ELECTROMAGN RES, V65, P187, DOI 10.2528/PIER06092503; Du KL, 2004, IEEE T ANTENN PROPAG, V52, P1125, DOI 10.1109/TAP.2004.825802; El-Khamy SE, 1998, INT GEOSCI REMOTE SE, P559, DOI 10.1109/IGARSS.1998.699510; Hao X, 2013, THESIS U NOTTINGHAM; Holtrup G., 2001, IEEE Antennas and Propagation Society International Symposium. 2001 Digest. Held in conjunction with: USNC/URSI National Radio Science Meeting (Cat. No.01CH37229), P800, DOI 10.1109/APS.2001.960218; Ioannides P, 2005, IEEE ANTENN PROPAG M, V47, P192, DOI 10.1109/MAP.2005.1589932; Mahmoud KR, 2007, PROG ELECTROMAGN RES, V72, P75, DOI 10.2528/PIER07030904; Mangoud MA, 2014, IET MICROW ANTENNA P, V8, P657, DOI 10.1049/iet-map.2013.0132; Sadeghzadeh R. A., 2008, Iranian Journal of Electrical and Computer Engineering, V7, P98; Yaacoub E., 2007, IRAN J ELECT COMPUT, V6, P48; Yuan H, 1991, IEEE ANT PROP SOC IN, P1416; Zotkin DN, 2010, IEEE T AUDIO SPEECH, V18, P2, DOI 10.1109/TASL.2009.2022000	15	3	3	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2015	10	3							e0118914	10.1371/journal.pone.0118914	http://dx.doi.org/10.1371/journal.pone.0118914			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD9NQ	25790103	gold, Green Published, Green Submitted			2022-12-27	WOS:000351425400055
J	Ye, C; Li, SY; Yang, YY; Shu, X; Zhang, JQ; Zhang, QF				Ye, Chen; Li, Siyue; Yang, Yuyi; Shu, Xiao; Zhang, Jiaquan; Zhang, Quanfa			Advancing Analysis of Spatio-Temporal Variations of Soil Nutrients in the Water Level Fluctuation Zone of China's Three Gorges Reservoir Using Self-Organizing Map	PLOS ONE			English	Article							ARTIFICIAL NEURAL-NETWORKS; RIPARIAN BUFFER ZONES; NITROGEN DYNAMICS; RIVER FLOODPLAIN; LAND-USE; SEDIMENT; DAMS; DENITRIFICATION; VEGETATION; QUALITY	The similar to 350 km(2) water level fluctuation zone (WLFZ) in the Three Gorges Reservoir (TGR) of China, situated at the intersection of terrestrial and aquatic ecosystems, experiences a great hydrological change with prolonged winter inundation. Soil samples were collected in 12 sites pre- (September 2008) and post submergence (June 2009) in the WLFZ and analyzed for soil nutrients. Self-organizing map (SOM) and statistical analysis including multi-way ANOVA, paired-T test, and stepwise least squares multiple regression were employed to determine the spatio-temporal variations of soil nutrients in relation to submergence, and their correlations with soil physical characteristics. Results showed significant spatial variability in nutrients along similar to 600 km long shoreline of the TGR before and after submergence. There were higher contents of organic matter, total nitrogen (TN), and nitrate (NO3-) in the lower reach and total phosphorus (TP) in the upper reach that were primarily due to the spatial variations in soil particle size composition and anthropogenic activities. Submergence enhanced soil available potassium (K), while significantly decreased soil N, possibly due to the alterations of soil particle size composition and increase in soil pH. In addition, SOM analysis determined important roles of soil pH value, bulk density, soil particle size (i.e., silt and sand) and nutrients (TP, TK, and AK) on the spatial and temporal variations in soil quality. Our results suggest that urban sewage and agricultural runoffs are primary pollutants that affect soil nutrients in the WLFZ of TGR.	[Ye, Chen; Li, Siyue; Yang, Yuyi; Shu, Xiao; Zhang, Jiaquan; Zhang, Quanfa] Chinese Acad Sci, Wuhan Bot Garden, Key Lab Aquat Bot & Watershed Ecol, Wuhan 430074, Peoples R China; [Zhang, Jiaquan] Hubei Polytech Univ, Coll Environm Sci & Engn, Huangshi 435003, Peoples R China	Chinese Academy of Sciences; Wuhan Botanical Garden, CAS; Hubei Polytechnic University	Zhang, QF (corresponding author), Chinese Acad Sci, Wuhan Bot Garden, Key Lab Aquat Bot & Watershed Ecol, Wuhan 430074, Peoples R China.	qzhang@wbgcas.cn	Yang, Yuyi/N-5428-2015; Zhang, Quanfa/H-1922-2011; Yang, Yuyi/H-6600-2015; Li, Siyue/DCN-3040-2022; Zhang, Jiaquan/D-4905-2013; Li, Siyue/E-8297-2012	Yang, Yuyi/0000-0001-9807-6844; Yang, Yuyi/0000-0001-9807-6844; Li, Siyue/0000-0002-3097-6819; Zhang, Jiaquan/0000-0002-1559-1240; Li, Siyue/0000-0002-3097-6819; Ye, Chen/0000-0001-7204-246X	National Natural Science Foundation of China [31130010, 31300441, 31100347]; Executive Office of the State Council Three Gorges Construction Committee [SX2011-037]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Executive Office of the State Council Three Gorges Construction Committee	This work was supported by National Natural Science Foundation of China (No. 31130010, 31300441 and 31100347) and the Executive Office of the State Council Three Gorges Construction Committee (SX2011-037). The funders had no role in study design, data collection and analysis, decsion to publish, or preparation of the manuscript.	Alvarez-Guerra M, 2008, ENVIRON INT, V34, P782, DOI 10.1016/j.envint.2008.01.006; Antheunisse AM, 2007, PLANT SOIL, V292, P45, DOI 10.1007/s11104-007-9200-1; BAXTER RM, 1977, ANNU REV ECOL SYST, V8, P255, DOI 10.1146/annurev.es.08.110177.001351; Beumer V, 2008, SCI TOTAL ENVIRON, V402, P70, DOI 10.1016/j.scitotenv.2008.03.044; Bieroza M, 2011, ENVIRONMETRICS, V22, P256, DOI 10.1002/env.1045; Brady N.C, 2000, NATURE PROPERTIES SO; Brunet RC, 1997, LANDSCAPE ECOL, V12, P171, DOI 10.1023/A:1007937201321; Burt TP, 2002, J HYDROL, V262, P1, DOI 10.1016/S0022-1694(01)00567-4; Casey RE, 2001, J ENVIRON QUAL, V30, P1732, DOI 10.2134/jeq2001.3051732x; Cho KH, 2009, SCI TOTAL ENVIRON, V407, P2536, DOI 10.1016/j.scitotenv.2009.01.017; DEJONGE VN, 1995, LIMNOL OCEANOGR, V40, P766; Forshay KJ, 2011, HYDROBIOLOGIA, V668, P21, DOI 10.1007/s10750-011-0619-2; Forshay KJ, 2005, BIOGEOCHEMISTRY, V75, P43, DOI 10.1007/s10533-004-6016-4; Gergel SE, 2005, GLOBAL CHANGE BIOL, V11, P1352, DOI 10.1111/j.1365-2486.2005.00966.x; Hefting MM, 2005, ECOL ENG, V24, P465, DOI 10.1016/j.ecoleng.2005.01.003; Hoffmann CC, 2006, J HYDROL, V331, P315, DOI 10.1016/j.jhydrol.2006.05.019; Keeney D.R, 1982, AGRON MONOGR, P643; Kennedy R.H., 1990, RESERVOIR LIMNOLOGY; Ki SJ, 2011, WATER RES, V45, P4183, DOI 10.1016/j.watres.2011.05.021; Knoepp JD, 2007, PEDOBIOLOGIA, V51, P89, DOI 10.1016/j.pedobi.2007.02.002; Kohonen T., 2001, SELF ORG MAPS; Li SY, 2008, CATENA, V75, P216, DOI 10.1016/j.catena.2008.06.005; Li SY, 2009, J HAZARD MATER, V165, P317, DOI 10.1016/j.jhazmat.2008.09.123; Liu WZ, 2013, ENVIRON RES LETT, V8, DOI 10.1088/1748-9326/8/4/044007; Liu WZ, 2012, ENVIRON SCI POLLUT R, V19, P858, DOI 10.1007/s11356-011-0616-z; Liu YG, 2011, SELF ORGANIZING MAPS - APPLICATIONS AND NOVEL ALGORITHM DESIGN, P253; Lu Zhi-Jun, 2010, Wuhan Zhiwuxue Yanjiu, V28, P303, DOI 10.3724/SP.J.1142.2010.30303; Lu ZJ, 2010, PLANT ECOL, V209, P153, DOI 10.1007/s11258-010-9732-y; Ludwig W, 2009, PROG OCEANOGR, V80, P199, DOI 10.1016/j.pocean.2009.02.001; McCartney M, 2009, WATER POLICY, V11, P121, DOI 10.2166/wp.2009.108; Meynendonckx J, 2006, HYDROL EARTH SYST SC, V3, P653, DOI DOI 10.5194/HESSD-3-653-2006; New T, 2008, BIODIVERS CONSERV, V17, P3149, DOI 10.1007/s10531-008-9416-2; Pinay G, 2002, ENVIRON MANAGE, V30, P481, DOI 10.1007/s00267-002-2736-1; Pinay G, 2000, BIOGEOCHEMISTRY, V50, P163, DOI 10.1023/A:1006317004639; Rinklebe J, 2006, SOIL BIOL BIOCHEM, V38, P2144, DOI 10.1016/j.soilbio.2006.01.018; Rivett MO, 2008, WATER RES, V42, P4215, DOI 10.1016/j.watres.2008.07.020; Schade JD, 2001, ECOLOGY, V82, P3363, DOI 10.1890/0012-9658(2001)082[3363:TIOARS]2.0.CO;2; Schramm HL, 2009, WETLANDS, V29, P476, DOI 10.1672/08-62.1; State Environmental Protection Administration of China (SEPA), 2009, EC ENV MON COMM 3 GO; Subida MD, 2013, SCI TOTAL ENVIRON, V450, P289, DOI 10.1016/j.scitotenv.2013.02.009; Venterink HO, 2002, PLANT SOIL, V243, P119, DOI 10.1023/A:1019993510737; [王洪杰 Wang Hongjie], 2003, [水土保持学报, Journal of Soil and Water Conservation], V17, P44; Wang Xiao-rong, 2010, Shengtaixue Zazhi, V29, P281; Weissteiner CJ, 2013, KNOWL MANAG AQUAT EC, DOI 10.1051/kmae/2013044; West JB, 2006, GLOBAL CHANGE BIOL, V12, P1400, DOI 10.1111/j.1365-2486.2006.01177.x; Ye C, 2014, ENVIRON SCI POLLUT R, V21, P2018, DOI 10.1007/s11356-013-2128-5; Ye C, 2013, ENVIRON SCI POLLUT R, V20, P1794, DOI 10.1007/s11356-012-1148-x; Ye C, 2012, ECOL ENG, V38, P37, DOI 10.1016/j.ecoleng.2011.10.005; Ye C, 2011, J HAZARD MATER, V191, P366, DOI 10.1016/j.jhazmat.2011.04.090; [詹艳慧 ZHAN Yanhui], 2006, [重庆大学学报. 自然科学版, Journal of Chongqing University(Natural Science Edition)], V29, P10; Zhang QF, 2011, ENVIRON SCI POLICY, V14, P1132, DOI 10.1016/j.envsci.2011.07.008; Zhou JJ, 2013, WATER RESOUR RES, V49, P3659, DOI 10.1002/wrcr.20283	52	15	18	9	72	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2015	10	3							e0121210	10.1371/journal.pone.0121210	http://dx.doi.org/10.1371/journal.pone.0121210			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD9NQ	25789612	gold, Green Submitted, Green Published			2022-12-27	WOS:000351425400191
J	Zhang, WJ; Yang, GW; Sun, JJ; Chen, JS; Zhang, YJ				Zhang, Wenjun; Yang, Gaowen; Sun, Juanjuan; Chen, Jishan; Zhang, Yingjun			Clonal Integration Enhances the Performance of a Clonal Plant Species under Soil Alkalinity Stress	PLOS ONE			English	Article							PHYSIOLOGICAL INTEGRATION; WATER TRANSLOCATION; LEYMUS-CHINENSIS; DAUGHTER RAMETS; GROWTH; HETEROGENEITY; BENEFITS; SALINE; HERB; POPULATIONS	Clonal plants have been shown to successfully survive in stressful environments, including salinity stress, drought and depleted nutrients through clonal integration between original and subsequent ramets. However, relatively little is known about whether clonal integration can enhance the performance of clonal plants under alkalinity stress. We investigated the effect of clonal integration on the performance of a typical rhizomatous clonal plant, Leymus chinensis, using a factorial experimental design with four levels of alkalinity and two levels of rhizome connection treatments, connected (allowing integration) and severed (preventing integration). Clonal integration was estimated by comparing physiological and biomass features between the rhizome-connected and rhizome-severed treatments. We found that rhizome-connected treatment increased the biomass, height and leaf water potential of subsequent ramets at highly alkalinity treatments but did not affect them at low alkalinity treatments. However, rhizome-connected treatment decreased the root biomass of subsequent ramets and did not influence the photosynthetic rates of subsequent ramets. The biomass of original ramets was reduced by rhizome-connected treatment at the highest alkalinity level. These results suggest that clonal integration can increase the performance of clonal plants under alkalinity stress. Rhizome-connected plants showed dramatically increased survival of buds with negative effects on root weight, indicating that clonal integration influenced the resource allocation pattern of clonal plants. A cost-benefit analysis based on biomass measures showed that original and subsequent ramets significantly benefited from clonal integration in highly alkalinity stress, indicating that clonal integration is an important adaptive strategy by which clonal plants could survive in local alkalinity soil.	[Zhang, Wenjun; Yang, Gaowen; Sun, Juanjuan; Chen, Jishan; Zhang, Yingjun] China Agr Univ, Dept Grassland Sci, Beijing 100094, Peoples R China; [Yang, Gaowen] Nanjing Agr Univ, Coll Agrograssland Sci, Nanjing, Jiangsu, Peoples R China	China Agricultural University; Nanjing Agricultural University	Zhang, YJ (corresponding author), China Agr Univ, Dept Grassland Sci, Beijing 100094, Peoples R China.	zhangyj@cau.edu.cn	Yang, Gaowen/P-7854-2019	Yang, Gaowen/0000-0001-5154-011X; Zhang, Yingjun/0000-0001-5776-4392	Modern Agro-industry Technology Research System [CARS-35]	Modern Agro-industry Technology Research System	This study was supported by the Modern Agro-industry Technology Research System (CARS-35). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal AA, 2000, ECOLOGY, V81, P1804, DOI 10.1890/0012-9658(2000)081[1804:BACOIP]2.0.CO;2; ALPERT P, 1991, ECOLOGY, V72, P69, DOI 10.2307/1938903; ALPERT P, 1986, OECOLOGIA, V70, P227, DOI 10.1007/BF00379244; Alpert P, 1999, OECOLOGIA, V120, P69, DOI 10.1007/s004420050834; Alpert P, 1996, J ECOL, V84, P395, DOI 10.2307/2261201; Chen JS, 2010, ACTA OECOL, V36, P23, DOI 10.1016/j.actao.2009.09.006; De Kroon H, 2009, PLANT CELL ENVIRON, V32, P704, DOI 10.1111/j.1365-3040.2009.01936.x; Degenhardt B, 2000, PLANT SOIL, V225, P83, DOI 10.1023/A:1026539311358; deKroon H, 1996, OECOLOGIA, V106, P73, DOI 10.1007/BF00334409; Dorken ME, 2004, J ECOL, V92, P32, DOI 10.1111/j.1365-2745.2004.00857.x; EVANS JP, 1992, AM J BOT, V79, P1344, DOI 10.2307/2445132; Gao L, 2013, AQUAT BOT, V107, P47, DOI 10.1016/j.aquabot.2013.01.010; Gomez S, 2007, OECOLOGIA, V153, P921, DOI 10.1007/s00442-007-0792-1; Herben T, 2004, EVOL ECOL, V18, P493, DOI 10.1007/s10682-004-5141-9; Hodge A, 2009, PLANT SOIL, V321, P153, DOI 10.1007/s11104-009-9929-9; Hutchings MJ, 1997, TRENDS ECOL EVOL, V12, P390, DOI 10.1016/S0169-5347(97)87382-X; Jonsdottir I.S., 1997, ECOLOGY EVOLUTION CL, P109; Li Q, 2011, FLORA, V206, P712, DOI 10.1016/j.flora.2010.11.013; Liu J, 2010, PHOTOSYNTHETICA, V48, P278, DOI 10.1007/s11099-010-0034-3; Lv BS, 2013, AGRON J, V105, P1119, DOI 10.2134/agronj2013.0017; Oborny B, 2000, ECOLOGY, V81, P3291; Pennings SC, 2000, ECOLOGY, V81, P709; Peterson AG, 2002, AUSTRAL ECOL, V27, P647, DOI 10.1046/j.1442-9993.2002.01219.x; Roiloa SR, 2006, ANN BOT-LONDON, V98, P1043, DOI 10.1093/aob/mcl185; Roiloa SR, 2005, INT J PLANT SCI, V166, P795, DOI 10.1086/431804; SALZMAN AG, 1985, OECOLOGIA, V65, P273, DOI 10.1007/BF00379229; SHUMWAY SW, 1995, ANN BOT-LONDON, V76, P225, DOI 10.1006/anbo.1995.1091; Tworkoski TJ, 2001, SCI HORTIC-AMSTERDAM, V88, P97, DOI 10.1016/S0304-4238(00)00198-9; van Kleunen M, 1999, OIKOS, V85, P135, DOI 10.2307/3546799; Wang N, 2009, PLANT BIOLOGY, V11, P483, DOI 10.1111/j.1438-8677.2008.00133.x; Wang ZW, 2004, ACTA OECOL, V26, P255, DOI 10.1016/j.actao.2004.08.007; Xiao Y, 2011, FLORA, V206, P736, DOI 10.1016/j.flora.2010.12.003; Xiao Y, 2010, AQUAT BOT, V92, P9, DOI 10.1016/j.aquabot.2009.09.001; Xie YC, 2010, ISPRS J PHOTOGRAMM, V65, P182, DOI 10.1016/j.isprsjprs.2009.10.007; Yu FH, 2001, EVOL ECOL, V15, P303, DOI 10.1023/A:1016032831038; Yu FH, 2002, ACTA BOT SIN, V44, P468; Zhang XQ, 2006, FLORA, V201, P547, DOI 10.1016/j.flora.2005.12.002; Zhu MJ, 2013, FEMS MICROBIOL LETT, V340, P135, DOI 10.1111/1574-6968.12083; Zhu T.C., 1981, P 14 INT GRASSL C, P429	39	15	18	4	53	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2015	10	3							e0119942	10.1371/journal.pone.0119942	http://dx.doi.org/10.1371/journal.pone.0119942			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD9NQ	25790352	Green Published, gold, Green Submitted			2022-12-27	WOS:000351425400118
J	Al-Husseini, A; Wijesinghe, DS; Farkas, L; Kraskauskas, D; Drake, JI; Van Tassel, B; Abbate, A; Chalfant, CE; Voelkel, NF				Al-Husseini, Aysar; Wijesinghe, Dayanjan S.; Farkas, Laszlo; Kraskauskas, Donatas; Drake, Jennifer I.; Van Tassel, Ben; Abbate, Antonio; Chalfant, Charles E.; Voelkel, Norbert F.			Increased Eicosanoid Levels in the Sugen/Chronic Hypoxia Model of Severe Pulmonary Hypertension	PLOS ONE			English	Article							ARTERIAL-HYPERTENSION; RAT LUNG; CELLS; CYCLOOXYGENASE-2; VASOCONSTRICTION; INHIBITION; PROSTAGLANDIN; INFLAMMATION; THROMBOXANE; EXPRESSION	Inflammation and altered immunity are recognized components of severe pulmonary arterial hypertension in human patients and in animal models of PAH. While eicosanoid metabolites of cyclooxygenase and lipoxygenase pathways have been identified in the lungs from pulmonary hypertensive animals their role in the pathogenesis of severe angioobliterative PAH has not been examined. Here we investigated whether a cyclooxygenase-2 (COX-2) inhibitor or diethylcarbamazine (DEC), that is known for its 5-lipoxygenase inhibiting and antioxidant actions, modify the development of PAH in the Sugen 5416/hypoxia (SuHx) rat model. The COX-2 inhibitor SC-58125 had little effect on the right ventricular pressure and did not prevent the development of pulmonary angioobliteration. In contrast, DEC blunted the muscularization of pulmonary arterioles and reduced the number of fully obliterated lung vessels. DEC treatment of SuHx rats, after the lung vascular disease had been established, reduced the degree of PAH, the number of obliterated arterioles and the degree of perivascular inflammation. We conclude that the non-specific anti-inflammatory drug DEC affects developing PAH and is partially effective once angioobliterative PAH has been established.	[Al-Husseini, Aysar; Farkas, Laszlo; Kraskauskas, Donatas; Drake, Jennifer I.; Voelkel, Norbert F.] Victoria Johnson Ctr Lung Res, Pulm & Crit Care Med Div, Richmond, VA 23298 USA; [Al-Husseini, Aysar] Montefiore Mt Vernon Hosp, Dept Internal Med, Westchester, NY USA; [Wijesinghe, Dayanjan S.; Chalfant, Charles E.] Virginia Commonwealth Univ, Sch Med, Dept Biochem & Mol Biol, Richmond, VA USA; [Van Tassel, Ben; Abbate, Antonio] Virginia Commonwealth Univ, Div Cardiol, Richmond, VA USA; [Chalfant, Charles E.] Hunter Holmes McGuire Vet Adm Med Ctr, Richmond, VA USA; [Chalfant, Charles E.] Virginia Commonwealth Univ, Med Coll Virginia, Massey Canc Ctr, Richmond, VA 23298 USA; [Chalfant, Charles E.] Virginia Commonwealth Univ, Reanimat Engn Sci Ctr VCURES, Richmond, VA USA	Virginia Commonwealth University; Virginia Commonwealth University; Hunter Holmes McGuire Veterinary Affairs Medical Center; Virginia Commonwealth University; Virginia Commonwealth University	Voelkel, NF (corresponding author), Victoria Johnson Ctr Lung Res, Pulm & Crit Care Med Div, Richmond, VA 23298 USA.	nfvoelkel@gmail.com	Abbate, Antonio/G-8805-2016	Abbate, Antonio/0000-0002-1930-785X; Drake, Jennifer/0000-0002-2808-4475	Victoria Johnson Center for Lung Research of the Virginia Commonwealth University; Veteran's Administration (VA Merit Award) [BX001792]; Veteran's Administration (Research Career Scientist Award); National Institutes of Health [HL072925, CA154314, S10OD10641-1A1]; US-Israel Binational Science Foundation [2011380, NH1C06-RR17393]; NIH/NCI Cancer Center [P30 CA016059]; National Research Service [GM008695]; Department of Veterans Affairs; VCU Developing Lipidomics Core via the VCU Massey Cancer Center; State of Virginia HEETF funds; NATIONAL CANCER INSTITUTE [P30CA016059, R01CA154314] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL125353, R01HL072925] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008695] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [S10OD010641] Funding Source: NIH RePORTER; Veterans Affairs [I01BX001792] Funding Source: NIH RePORTER	Victoria Johnson Center for Lung Research of the Virginia Commonwealth University; Veteran's Administration (VA Merit Award)(US Department of Veterans Affairs); Veteran's Administration (Research Career Scientist Award); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); US-Israel Binational Science Foundation(US-Israel Binational Science Foundation); NIH/NCI Cancer Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Research Service; Department of Veterans Affairs(US Department of Veterans Affairs); VCU Developing Lipidomics Core via the VCU Massey Cancer Center; State of Virginia HEETF funds; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Veterans Affairs(US Department of Veterans Affairs)	This work was supported by the funds from the Victoria Johnson Center for Lung Research of the Virginia Commonwealth University; research grants from the Veteran's Administration (VA Merit Award BX001792 to C.E.C. and a Research Career Scientist Award to C.E.C.); from the National Institutes of Health via HL072925 (C.E.C.), CA154314 (C.E.C.); from the US-Israel Binational Science Foundation via BSF#2011380 (C.E.C.), NH1C06-RR17393 (to Virginia Commonwealth University for renovation), NIH/NCI Cancer Center Support Grant P30 CA016059 (to Massey Cancer Center), a National Research Service Award-T32 Post-Doctoral Fellowship in Wound Healing GM008695 (D.S.W.), a Career Development Award (CDA1) from the Department of Veterans Affairs (D.S.W.). This work was also supported by the VCU Developing Lipidomics Core via the VCU Massey Cancer Center as well as an instrument grant from the National Institutes of Health (S10OD10641-1A1 (C.E.C.)) and State of Virginia HEETF funds. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe K, 2010, CIRCULATION, V121, P2747, DOI 10.1161/CIRCULATIONAHA.109.927681; Al Husseini A, 2013, EUR RESPIR J, V41, P104, DOI 10.1183/09031936.00196511; Barst R, 2010, INT J CLIN PRACT, V64, P23, DOI 10.1111/j.1742-1241.2010.02525.x; Bogaard HJ, 2012, AM J RESP CELL MOL, V46, P582, DOI 10.1165/rcmb.2011-0296OC; Bogaard HJ, 2009, CIRCULATION, V120, P1951, DOI 10.1161/CIRCULATIONAHA.109.883843; Cathcart MC, 2008, J PHARMACOL EXP THER, V326, P51, DOI 10.1124/jpet.107.134221; Chen JH, 2011, CIRCULATION, V123, P584, DOI 10.1161/CIRCULATIONAHA.110.971853; Chida M, 1996, AM J PHYSIOL-LUNG C, V270, pL872, DOI 10.1152/ajplung.1996.270.5.L872; CHRISTMAN BW, 1992, NEW ENGL J MED, V327, P70, DOI 10.1056/NEJM199207093270202; Delannoy E, 2010, CARDIOVASC RES, V85, P582, DOI 10.1093/cvr/cvp292; Dhakal HP, 2012, HISTOL HISTOPATHOL, V27, P1315, DOI 10.14670/HH-27.1315; Drake JI, 2011, AM J RESP CELL MOL, V45, P1239, DOI 10.1165/rcmb.2010-0412OC; Farkas L, 2009, J CLIN INVEST, V119, P1298, DOI 10.1172/JCI36136; Fredenburgh LE, 2008, CIRCULATION, V117, P2114, DOI 10.1161/CIRCULATIONAHA.107.716241; HAUGE A, 1969, J APPL PHYSIOL, V26, P693, DOI 10.1152/jappl.1969.26.6.693; Janssen LJ, 2008, AM J RESP CELL MOL B, V39, P3383, DOI [10.1165/rcmb.2008-0117TR, DOI 10.1165/RCMB.2008-0117TR]; Karavitis J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046342; Kawut SM, 2011, CIRCULATION, V123, P2985, DOI 10.1161/CIRCULATIONAHA.110.015693; KAY JM, 1967, AM J PATHOL, V51, P1031; Maciag A, 2004, CARCINOGENESIS, V25, P2231, DOI 10.1093/carcin/bgh245; MCDONNELL TJ, 1990, AM J PHYSIOL, V259, pH751, DOI 10.1152/ajpheart.1990.259.3.H751; MORGANROTH ML, 1985, AM REV RESPIR DIS, V131, P488, DOI 10.1164/arrd.1985.131.4.488; Nicolls Mark R, 2012, Pulm Circ, V2, P434, DOI 10.4103/2045-8932.105031; Nicolls MR, 2005, EUR RESPIR J, V26, P1110, DOI 10.1183/09031936.05.00045705; Obermajer N, 2012, ONCOIMMUNOLOGY, V1, P762, DOI 10.4161/onci.19681; Oka M, 2007, CIRC RES, V100, P923, DOI 10.1161/01.RES.0000261658.12024.18; ONO S, 1992, J APPL PHYSIOL, V73, P1084, DOI 10.1152/jappl.1992.73.3.1084; Rai PR, 2008, AM J RESP CRIT CARE, V178, P558, DOI 10.1164/rccm.200709-1369PP; REEVES JT, 1987, AM REV RESPIR DIS, V136, P196, DOI 10.1164/ajrccm/136.1.196; Robbins IM, 2006, EUR RESPIR J, V27, P578, DOI 10.1183/09031936.06.00095705; Ryan EP, 2008, CANCER IMMUNOL IMMUN, V57, P347, DOI 10.1007/s00262-007-0374-4; Sagliani KD, 2013, PULM CIRC, V3, P82, DOI 10.4103/2045-8932.109918; Seta F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023439; Stacher E, 2012, AM J RESP CRIT CARE, V186, P261, DOI 10.1164/rccm.201201-0164OC; STENMARK KR, 1983, NEW ENGL J MED, V309, P77, DOI 10.1056/NEJM198307143090204; STENMARK KR, 1985, AM J PHYSIOL, V248, pH859, DOI 10.1152/ajpheart.1985.248.6.H859; Tabata T, 1997, Nihon Kyobu Shikkan Gakkai Zasshi, V35, P160; Taraseviciene-Stewart L, 2001, FASEB J, V15, P427, DOI 10.1096/fj.00-0343com; Tian W, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3006674; Tuder RM, 1998, J LAB CLIN MED, V132, P16, DOI 10.1016/S0022-2143(98)90020-8; Tuder RM, 1999, AM J RESP CRIT CARE, V159, P1925, DOI 10.1164/ajrccm.159.6.9804054; van Heumen BWH, 2012, EXP CELL RES, V318, P819, DOI 10.1016/j.yexcr.2012.02.004; Voelkel NF, 1996, J CLIN INVEST, V97, P2491, DOI 10.1172/JCI118696; VOELKEL NF, 1981, CIRC RES, V48, P207, DOI 10.1161/01.RES.48.2.207; Voelkel NF, 2012, EUR RESPIR J, V40, P1555, DOI 10.1183/09031936.00046612; WALKER BR, 1982, J APPL PHYSIOL, V52, P705, DOI 10.1152/jappl.1982.52.3.705; Wright L, 1998, AM J RESP CRIT CARE, V157, P219, DOI 10.1164/ajrccm.157.1.9704003; Zuo X, 2012, PROSTAG OTH LIPID M, V139, P104	48	21	21	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2015	10	3							e0120157	10.1371/journal.pone.0120157	http://dx.doi.org/10.1371/journal.pone.0120157			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9BN	25785937	Green Submitted, Green Published, gold			2022-12-27	WOS:000352138500158
J	Bauer, S; Olson, J; Cockrill, A; van Hattem, M; Miller, L; Tauzer, M; Leppig, G				Bauer, Scott; Olson, Jennifer; Cockrill, Adam; van Hattem, Michael; Miller, Linda; Tauzer, Margaret; Leppig, Gordon			Impacts of Surface Water Diversions for Marijuana Cultivation on Aquatic Habitat in Four Northwestern California Watersheds	PLOS ONE			English	Article							REGIONAL CLIMATE-CHANGE; INSTREAM DIVERSIONS; STREAM AMPHIBIANS; PACIFIC-NORTHWEST; DISSOLVED-OXYGEN; FLOW REGIMES; TEMPERATURE; GROWTH; CONSEQUENCES; BIODIVERSITY	Marijuana (Cannabis sativa L.) cultivation has proliferated in northwestern California since at least the mid-1990s. The environmental impacts associated with marijuana cultivation appear substantial, yet have been difficult to quantify, in part because cultivation is clandestine and often occurs on private property. To evaluate the impacts of water diversions at a watershed scale, we interpreted high-resolution aerial imagery to estimate the number of marijuana plants being cultivated in four watersheds in northwestern California, USA. Lowaltitude aircraft flights and search warrants executed with law enforcement at cultivation sites in the region helped to validate assumptions used in aerial imagery interpretation. We estimated the water demand of marijuana irrigation and the potential effects water diversions could have on stream flow in the study watersheds. Our results indicate that water demand for marijuana cultivation has the potential to divert substantial portions of streamflow in the study watersheds, with an estimated flow reduction of up to 23% of the annual sevenday low flow in the least impacted of the study watersheds. Estimates from the other study watersheds indicate that water demand for marijuana cultivation exceeds streamflow during the low-flow period. In the most impacted study watersheds, diminished streamflow is likely to have lethal or sub-lethal effects on state-and federally-listed salmon and steelhead trout and to cause further decline of sensitive amphibian species.	[Bauer, Scott; Olson, Jennifer; Cockrill, Adam; van Hattem, Michael; Miller, Linda; Leppig, Gordon] Calif Dept Fish & Wildlife, Eureka, CA 95501 USA; [Tauzer, Margaret] Natl Marine Fisheries Serv, Arcata, CA USA	National Oceanic Atmospheric Admin (NOAA) - USA	Bauer, S (corresponding author), Calif Dept Fish & Wildlife, Eureka, CA 95501 USA.	scott.bauer@wildlife.ca.gov						Abell R., 2000, FRESHWATER ECOREGION; [Anonymous], 2013, EXECUTIVE OFFICE OF; [Anonymous], 1915, J AGR RES; [Anonymous], 2015, SPEC AN LIST; Arismendi I, 2013, HYDROBIOLOGIA, V712, P61, DOI 10.1007/s10750-012-1327-2; Arnold JM, 2013, THESIS HUMBOLDT STAT; Averyt K, 2013, ENVIRON RES LETT, V8, DOI 10.1088/1748-9326/8/1/015001; Bailey L. H., 1935, STANDARD CYCLOPEDIA; Bondi CA, 2013, HERPETOL CONSERV BIO, V8, P88; Bunn SE, 2002, ENVIRON MANAGE, V30, P492, DOI 10.1007/s00267-002-2737-0; Bury RB, 2008, APPL HERPETOL, V5, P63, DOI 10.1163/157075408783489211; California Department of Fish and Game, 2004, REC STRAT CAL COH SA; California Interagency Watershed Mapping Committee, 2004, CAL INT WAT MAP 1999; Cashman SM, 1995, 1454B US GEOL SURV; Cervantes J., 2006, MARIJUANA HORTICULTU; Clipp HL, 2014, FORESTS, V5, P2679, DOI 10.3390/f5112679; Corva D, 2014, INT J DRUG POLICY, V25, P71, DOI 10.1016/j.drugpo.2013.02.003; Deitch MJ, 2009, AQUAT CONSERV, V19, P274, DOI 10.1002/aqc.1012; Deitch MJ, 2009, RIVER RES APPL, V25, P118, DOI 10.1002/rra.1100; DeOreo W.B., 2011, CALIFORNIA SINGLE FA; Dudgeon D, 2006, BIOL REV, V81, P163, DOI 10.1017/S1464793105006950; Gabriel M.W., 2013, WILDL PROF, P46; Gabriel MW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040163; Gleick PH, 2010, P NATL ACAD SCI USA, V107, P11155, DOI 10.1073/pnas.1004812107; Gleick PH, 2003, ANNU REV ENV RESOUR, V28, P275, DOI 10.1146/annurev.energy.28.040202.122849; Harvey BC, 2006, T AM FISH SOC, V135, P998, DOI 10.1577/T05-233.1; Hayhoe K, 2004, P NATL ACAD SCI USA, V101, P12422, DOI 10.1073/pnas.0404500101; HGA [Humboldt Growers Association], 2010, HUMBOLDT COUNTY OUTD; Howell TA, 2001, AGRON J, V93, P281, DOI 10.2134/agronj2001.932281x; Humboldt County Planning and Building Department, 2002, FOR RES; JENSEN M. E., 1968, Water Deficits and Plant Growth., V2, P1; Katz J, 2013, ENVIRON BIOL FISH, V96, P1169, DOI 10.1007/s10641-012-9974-8; Kelsey Kathryn A., 1998, P235; Kim J, 2002, J CLIMATE, V15, P1926, DOI [10.1175/1520-0442(2002)015<1926:IOIACO>2.0.CO;2, 10.1175/1520-0442(2002)015&lt;1926:IOIACO&gt;2.0.CO;2]; Knowles N, 2002, GEOPHYS RES LETT, V29, DOI 10.1029/2001GL014339; Kupferberg SJ, 2012, CONSERV BIOL, V26, P513, DOI 10.1111/j.1523-1739.2012.01837.x; Lang M., 2004, IMPROVING STREAM CRO; Lannoo M, 2005, AMPHIBIAN DECLINES: THE CONSERVATION STATUS OF UNITED STATES SPECIES, P1; Leeper Joseph, 1990, CALIFORNIA GEOGRAPHE, V30, P93; Leung LR, 2004, CLIMATIC CHANGE, V62, P75, DOI 10.1023/B:CLIM.0000013692.50640.55; Lytle DA, 2004, TRENDS ECOL EVOL, V19, P94, DOI 10.1016/j.tree.2003.10.002; Madej MA, 2011, P 4 INT C RES WAT US; Mallery M, 2011, BERKELEY UNDERGRAD J, V23; Marine KR, 2004, N AM J FISH MANAGE, V24, P198, DOI 10.1577/M02-142; Mayer TD, 2011, J AM WATER RESOUR AS, V47, P724, DOI 10.1111/j.1752-1688.2011.00537.x; Milestone JF, 2012, RETHINKING PROTECTED; Miller NL, 2003, J AM WATER RESOUR AS, V39, P771, DOI 10.1111/j.1752-1688.2003.tb04404.x; Mills E, 2012, ENERG POLICY, V46, P58, DOI 10.1016/j.enpol.2012.03.023; Mohseni O, 2003, CLIMATIC CHANGE, V59, P389, DOI 10.1023/A:1024847723344; Moore MK, 1998, OIKOS, V81, P329, DOI 10.2307/3547053; Moyle P.B., 2002, INLAND FISHES CALIFO; North Coast Water Quality Control Board, 2011, WAT QUAL CONTR PLAN; ONeal K., 2002, EFFECTS GLOBAL WARMI; Pilliod DS, 2008, HABITAT MANAGEMENT G; Poff N.L., 2002, AQUATIC ECOSYSTEMS G; Poff NL, 1997, BIOSCIENCE, V47, P769, DOI 10.2307/1313099; Power ME, 1996, ENVIRON MANAGE, V20, P887, DOI 10.1007/BF01205969; PRWEB, 2012, LEAD CAL MAR ATT SAY; Rantz SE., 1964, 1758 US GEOL SURV US; Rantz SE, 1968, HA298 US GEOL SURV; RAY C, 1958, ECOLOGY, V39, P75, DOI 10.2307/1929968; Ricketts T. H., 1999, TERRESTRIAL ECOREGIO; Sawyer J.O., 2009, MANUAL CALIFORNIA VE; Schlenker W, 2007, CLIMATIC CHANGE, V81, P19, DOI 10.1007/s10584-005-9008-z; Shaw MR, 2011, CLIMATIC CHANGE, V109, P465, DOI 10.1007/s10584-011-0313-4; SILVER STUART J., 1963, TRANS AMER FISH SOC, V92, P327, DOI 10.1577/1548-8659(1963)92[327:DORODS]2.0.CO;2; Snyder MA, 2004, J AM WATER RESOUR AS, V40, P591, DOI 10.1111/j.1752-1688.2004.tb04445.x; Snyder MA, 2002, GEOPHYS RES LETT, V29, DOI 10.1029/2001GL014431; Snyder MA, 2005, EARTH INTERACT, V9; Starrs P.F, 2010, FIELD GUIDE CALIFORN; State Water Resources Control Board, 2013, MAR CULT N COAST THR; Stevens PW, 2006, ESTUARIES COASTS, V29, P997, DOI 10.1007/BF02798661; Suttle KB, 2004, ECOL APPL, V14, P969, DOI 10.1890/03-5190; Thompson C, 2014, CONSERV LETT, V7, P91, DOI 10.1111/conl.12038; Tockner Klement, 2008, P45, DOI 10.1017/CBO9780511751790.006; United States Department of Justice, 2007, DOM CANN CULT ASS 20; Vorosmarty CJ, 2010, NATURE, V467, P555, DOI 10.1038/nature09440; Wake DB, 2008, P NATL ACAD SCI USA, V105, P11466, DOI 10.1073/pnas.0801921105; Welsh HH, 2008, FRESHWATER BIOL, V53, P1470, DOI 10.1111/j.1365-2427.2008.01963.x; Welsh HH, 1998, ECOL APPL, V8, P1118; Welsh HH, 1996, J HERPETOL, V30, P385, DOI 10.2307/1565176; Wenger SJ, 2011, P NATL ACAD SCI USA, V108, P14175, DOI 10.1073/pnas.1103097108; Western Regional Climate Center, 2014, COOP CLIM DAT SUMM; Williams L.E., 2001, PRACT WINERY VINEYAR, P42; Yates D, 2008, CLIMATIC CHANGE, V91, P335, DOI 10.1007/s10584-008-9427-8	85	51	54	2	57	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2015	10	3							e0120016	10.1371/journal.pone.0120016	http://dx.doi.org/10.1371/journal.pone.0120016			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9BN	25785849	Green Submitted, Green Published, gold			2022-12-27	WOS:000352138500149
J	Bode, NWF; Holl, S; Mehner, W; Seyfried, A				Bode, Nikolai W. F.; Holl, Stefan; Mehner, Wolfgang; Seyfried, Armin			Disentangling the Impact of Social Groups on Response Times and Movement Dynamics in Evacuations	PLOS ONE			English	Article							BEHAVIOR; ORGANIZATION	Crowd evacuations are paradigmatic examples for collective behaviour, as interactions between individuals lead to the overall movement dynamics. Approaches assuming that all individuals interact in the same way have significantly improved our understanding of pedestrian crowd evacuations. However, this scenario is unlikely, as many pedestrians move in social groups that are based on friendship or kinship. We test how the presence of social groups affects the egress time of individuals and crowds in a representative crowd evacuation experiment. Our results suggest that the presence of social groups increases egress times and that this is largely due to differences at two stages of evacuations. First, individuals in social groups take longer to show a movement response at the start of evacuations, and, second, they take longer to move into the vicinity of the exits once they have started to move towards them. Surprisingly, there are no discernible time differences between the movement of independent individuals and individuals in groups directly in front of the exits. We explain these results and discuss their implications. Our findings elucidate behavioural differences between independent individuals and social groups in evacuations. Such insights are crucial for the control of crowd evacuations and for planning mass events.	[Bode, Nikolai W. F.] Univ Essex, Dept Math Sci, Colchester CO4 3SQ, Essex, England; [Holl, Stefan; Mehner, Wolfgang; Seyfried, Armin] Julich Supercomp Ctr, Julich, Germany; [Holl, Stefan; Seyfried, Armin] Univ Wuppertal, Wuppertal, Germany	University of Essex; University of Wuppertal	Seyfried, A (corresponding author), Julich Supercomp Ctr, Julich, Germany.	a.seyfried@fz-juelich.de	Seyfried, Armin/T-4868-2017	Seyfried, Armin/0000-0001-8888-0978; Bode, Nikolai/0000-0003-0958-5191	AXA; German Federal Ministry of Education and Research	AXA; German Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF))	NWFB is supported by an AXA research fellowship. The project "Basigo - Bausteine fur die Sicherheit von Grossveranstaltungen" is funded by the German Federal Ministry of Education and Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bode NWF, 2013, ANIM BEHAV, V86, P347, DOI 10.1016/j.anbehav.2013.05.025; Bode NWF, 2012, AM NAT, V179, P621, DOI 10.1086/665005; Braun A, 2003, COMP ANIM CONF PROC, P143, DOI 10.1109/CASA.2003.1199317; Camazine S., 2001, SELF ORG BIOL SYSTEM, DOI DOI 10.1515/9780691212920; Clement RJG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077943; Conradt L, 2009, PHILOS T R SOC B, V364, P719, DOI 10.1098/rstb.2008.0276; Couzin ID, 2003, ADV STUD BEHAV, V32, P1, DOI 10.1016/S0065-3454(03)01001-5; Drury J, 2009, BRIT J SOC PSYCHOL, V48, P487, DOI 10.1348/014466608X357893; French JRP, 1944, U IOWA STUD CHILD WE, V20, P229; Ge WN, 2012, IEEE T PATTERN ANAL, V34, P1003, DOI 10.1109/TPAMI.2011.176; Hoogendoorn SP, 2005, TRANSPORT SCI, V39, P147, DOI 10.1287/trsc.1040.0102; Johnson C. W., 2005, Cognition, Technology & Work, V7, P214, DOI 10.1007/s10111-005-0009-5; Koster G, 2011, CONTEMP SOC SCI, V6, P397, DOI 10.1080/21582041.2011.619867; Krause J, 2010, TRENDS ECOL EVOL, V25, P28, DOI 10.1016/j.tree.2009.06.016; LATANE B, 1968, J PERS SOC PSYCHOL, V10, P215, DOI 10.1037/h0026570; Moussaid M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010047; Ozel F, 2001, SAFETY SCI, V38, P95, DOI 10.1016/S0925-7535(00)00061-8; Pinheiro J, 2020, R PACKAGE VERSION 31; Proulx G., 2002, SFPE HDB FIRE PROTEC, P343; Qiu FS, 2010, SIMUL MODEL PRACT TH, V18, P190, DOI 10.1016/j.simpat.2009.10.005; R Core Team, 2013, LANG ENV STAT COMP; RUTKOWSKI GK, 1983, J PERS SOC PSYCHOL, V44, P545, DOI 10.1037/0022-3514.44.3.545; Schadschneider A., 2011, ENCY COMPLEXITY SYST, P517, DOI [DOI 10.1007/978-0-387-30440-3_187, 10.1007/978-1-4419-7695-6_29, 10.1007/978-0-387-30440-3_187]; Seyfried A, 2009, TRANSPORT SCI, V43, P395, DOI 10.1287/trsc.1090.0263; SHI JB, 1994, 1994 IEEE COMPUTER SOCIETY CONFERENCE ON COMPUTER VISION AND PATTERN RECOGNITION, PROCEEDINGS, P593, DOI 10.1109/CVPR.1994.323794; Sime JD, 1983, J ENVIRON PSYCHOL, V3, P21, DOI [10.1016/S0272-4944(83)80019-X, DOI 10.1016/S0272-4944(83)80019-X]; Sochman J., 2011, 2011 IEEE International Conference on Computer Vision Workshops (ICCV Workshops), P830, DOI 10.1109/ICCVW.2011.6130338; Sumpter DJT, 2009, PHILOS T R SOC B, V364, P743, DOI 10.1098/rstb.2008.0204; vom Lehn D, 2013, LINGUAE LITT, V20, P65; Yang LZ, 2005, BUILD ENVIRON, V40, P411, DOI 10.1016/j.buildenv.2004.08.005	30	53	53	2	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2015	10	3							e0121227	10.1371/journal.pone.0121227	http://dx.doi.org/10.1371/journal.pone.0121227			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CE9BN	25785603	Green Published, Green Submitted, gold			2022-12-27	WOS:000352138500203
J	Bottazzi, B; Santini, L; Savino, S; Giuliani, MM; Diez, AID; Mancuso, G; Beninati, C; Sironi, M; Valentino, S; Deban, L; Garlanda, C; Teti, G; Pizza, M; Rappuoli, R; Mantovani, A				Bottazzi, Barbara; Santini, Laura; Savino, Silvana; Giuliani, Marzia M.; Duenas Diez, Ana I.; Mancuso, Giuseppe; Beninati, Concetta; Sironi, Marina; Valentino, Sonia; Deban, Livija; Garlanda, Cecilia; Teti, Giuseppe; Pizza, Mariagrazia; Rappuoli, Rino; Mantovani, Alberto			Recognition of Neisseria meningitidis by the Long Pentraxin PTX3 and Its Role as an Endogenous Adjuvant	PLOS ONE			English	Article							C-REACTIVE PROTEIN; SEROGROUP-B; INNATE IMMUNITY; FACTOR-H; MENINGOCOCCAL DISEASE; LIGAND RECOGNITION; MOLECULE PTX3; COMPLEMENT; VACCINE; BINDING	Long pentraxin 3 (PTX3) is a non-redundant component of the humoral arm of innate immunity. The present study was designed to investigate the interaction of PTX3 with Neisseria meningitidis. PTX3 bound acapsular meningococcus, Neisseria-derived outer membrane vesicles (OMV) and 3 selected meningococcal antigens (GNA0667, GNA1030 and GNA2091). PTX3-recognized microbial moieties are conserved structures which fulfil essential microbial functions. Ptx3-deficient mice had a lower antibody response in vaccination protocols with OMV and co-administration of PTX3 increased the antibody response, particularly in Ptx3-deficient mice. Administration of PTX3 reduced the bacterial load in infant rats challenged with Neisseria meningitidis. These results suggest that PTX3 recognizes a set of conserved structures from Neisseria meningitidis and acts as an amplifier/endogenous adjuvant of responses to this bacterium.	[Bottazzi, Barbara; Sironi, Marina; Valentino, Sonia; Deban, Livija; Garlanda, Cecilia; Mantovani, Alberto] Humanitas Clin & Res Ctr, Dept Inflammat & Immunol, Milan, Italy; [Santini, Laura; Savino, Silvana; Giuliani, Marzia M.; Pizza, Mariagrazia; Rappuoli, Rino] Novartis Vaccines & Diagnost Res Ctr, Siena, Italy; [Duenas Diez, Ana I.] Hosp Clin Univ, Unidad Invest, Valladolid, Spain; [Mancuso, Giuseppe; Beninati, Concetta; Teti, Giuseppe] Univ Messina, Metchnikoff Lab, Messina, Italy; [Mantovani, Alberto] Humanitas Univ, Milan, Italy	Novartis; Universidad de la Laguna; University of Messina; Humanitas University	Bottazzi, B (corresponding author), Humanitas Clin & Res Ctr, Dept Inflammat & Immunol, Milan, Italy.	barbara.bottazzi@humanitasresearch.it	Valentino, Sonia/AAB-4066-2020; sironi, marina/AAB-5757-2020; bottazzi, barbara/ABH-9274-2020; Mantovani, Alberto/HCI-7449-2022; Garlanda, Cecilia/K-4601-2016	Valentino, Sonia/0000-0001-8652-3168; sironi, marina/0000-0002-3342-1149; bottazzi, barbara/0000-0002-1930-9257; Mantovani, Alberto/0000-0001-5578-236X; Garlanda, Cecilia/0000-0002-1510-7703; BENINATI, Concetta/0000-0001-8305-1337; Mancuso, Giuseppe/0000-0001-5454-3228	European Research Council (ERC project HIIS); European Commission [FP7-HEALTH-2011-ADITEC-280873]	European Research Council (ERC project HIIS); European Commission(European CommissionEuropean Commission Joint Research Centre)	BB and AM were founded by the European Research Council (ERC project HIIS) and by the European Commission (FP7-HEALTH-2011-ADITEC-280873). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beninati C, 2006, J EXP MED, V203, P111, DOI 10.1084/jem.20051540; Bottazzi B, 1997, J BIOL CHEM, V272, P32817, DOI 10.1074/jbc.272.52.32817; Bottazzi B, 2010, ANNU REV IMMUNOL, V28, P157, DOI 10.1146/annurev-immunol-030409-101305; Braunschweig A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023991; Casey R, 2008, INFECT IMMUN, V76, P1298, DOI 10.1128/IAI.00741-07; Chiarini M, 2010, GENES IMMUN, V11, P665, DOI 10.1038/gene.2010.41; Claus H, 2002, MICROBIOL-SGM, V148, P1813, DOI 10.1099/00221287-148-6-1813; Coureuil M, 2012, VIRULENCE, V3, P164, DOI 10.4161/viru.18639; Cunha C, 2014, NEW ENGL J MED, V370, P421, DOI 10.1056/NEJMoa1211161; D'Angelo C, 2009, J IMMUNOL, V183, P4609, DOI 10.4049/jimmunol.0900345; Deban L, 2010, NAT IMMUNOL, V11, P328, DOI 10.1038/ni.1854; Deban L, 2008, J IMMUNOL, V181, P8433, DOI 10.4049/jimmunol.181.12.8433; Diniz SN, 2004, J LEUKOCYTE BIOL, V75, P649, DOI 10.1189/jlb.0803371; DUCLOS TW, 1991, J IMMUNOL, V146, P1220; Ferrari G, 2006, PROTEOMICS, V6, P1856, DOI 10.1002/pmic.200500164; Gantner BN, 2003, J EXP MED, V197, P1107, DOI 10.1084/jem.20021787; Garlanda C, 2002, NATURE, V420, P182, DOI 10.1038/nature01195; Garlanda C, 2005, ANNU REV IMMUNOL, V23, P337, DOI 10.1146/annurev.immunol.23.021704.115756; Gaziano R, 2004, ANTIMICROB AGENTS CH, V48, P4414, DOI 10.1128/AAC.48.11.4414-4421.2004; Giuliani MM, 2006, P NATL ACAD SCI USA, V103, P10834, DOI 10.1073/pnas.0603940103; Gout E, 2011, J IMMUNOL, V186, P5815, DOI 10.4049/jimmunol.1100180; Granoff DM, 2009, INFECT IMMUN, V77, P764, DOI 10.1128/IAI.01191-08; Haralambous E, 2006, SCAND J INFECT DIS, V38, P764, DOI 10.1080/00365540600643203; Hill DJ, 2010, CLIN SCI, V118, P547, DOI 10.1042/CS20090513; Holst J, 2009, VACCINE, V27, pB3, DOI 10.1016/j.vaccine.2009.04.071; Inforzato A, 2013, SEMIN IMMUNOL; Inforzato A, 2010, J BIOL CHEM, V285, P17681, DOI 10.1074/jbc.M109.085639; Ingalls RR, 2001, INFECT IMMUN, V69, P2230, DOI 10.1128/IAI.69.4.2230-2236.2001; Jacobsson S, 2009, VACCINE, V27, P1579, DOI 10.1016/j.vaccine.2008.12.052; Jaillon S, 2007, J EXP MED, V204, P793, DOI 10.1084/jem.20061301; Jaillon S, 2014, IMMUNITY, V40, P621, DOI 10.1016/j.immuni.2014.02.015; Janeway CA, 2001, MICROBES INFECT, V3, P1167, DOI 10.1016/S1286-4579(01)01477-0; Jeannin P, 2005, IMMUNITY, V22, P551, DOI 10.1016/j.immuni.2005.03.008; Lewis LA, 2014, VIRULENCE, V5, P98, DOI 10.4161/viru.26515; Lewis LA, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001027; Lo H, 2009, LANCET INFECT DIS, V9, P418, DOI 10.1016/S1473-3099(09)70132-X; Lu JH, 2008, NATURE, V456, P989, DOI 10.1038/nature07468; Lucidarme J, 2010, CLIN VACCINE IMMUNOL, V17, P919, DOI 10.1128/CVI.00027-10; Ma YJ, 2009, J BIOL CHEM, V284, P28263, DOI 10.1074/jbc.M109.009225; Ma YJ, 2011, J BIOL CHEM, V286, P3405, DOI 10.1074/jbc.M110.190637; Madico G, 2006, J IMMUNOL, V177, P501, DOI 10.4049/jimmunol.177.1.501; Mantovani A, 2013, ANN NY ACAD SCI, V1285, P1, DOI 10.1111/nyas.12043; Masignani V, 2003, J EXP MED, V197, P789, DOI 10.1084/jem.20021911; Mathew S, 2006, PEDIATR INFECT DIS J, V25, P255, DOI 10.1097/01.inf.0000209215.65445.04; Moalli F, 2011, J IMMUNOL, V186, P5425, DOI 10.4049/jimmunol.1002035; Moalli F, 2010, BLOOD, V116, P5170, DOI 10.1182/blood-2009-12-258376; Mosca F, 2008, P NATL ACAD SCI USA, V105, P10501, DOI 10.1073/pnas.0804699105; Moya-Quiles MR, 2013, GENE, V521, P204, DOI 10.1016/j.gene.2013.03.027; Muzzi A, 2013, MBIO, V4, DOI 10.1128/mBio.00163-13; Nauta AJ, 2003, EUR J IMMUNOL, V33, P465, DOI 10.1002/immu.200310022; Noursadeghi M, 2000, P NATL ACAD SCI USA, V97, P14584, DOI 10.1073/pnas.97.26.14584; Olesen R, 2007, GENES IMMUN, V8, P456, DOI 10.1038/sj.gene.6364410; Paroni M, 2013, J INFECT DIS, V208, P130, DOI 10.1093/infdis/jis636; Pizza M, 2000, SCIENCE, V287, P1816, DOI 10.1126/science.287.5459.1816; Pluddemann A, 2009, J INNATE IMMUN, V1, P153, DOI 10.1159/000155227; Pluddemann A, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000297; Reading PC, 2008, J IMMUNOL, V180, P3391, DOI 10.4049/jimmunol.180.5.3391; Ricklin D, 2010, NAT IMMUNOL, V11, P785, DOI 10.1038/ni.1923; Sadarangani M, 2010, LANCET INFECT DIS, V10, P112, DOI 10.1016/S1473-3099(09)70324-X; Schejbel L, 2013, IMMUNOBIOLOGY; Schenten D, 2011, ADV IMMUNOL, V109, P87, DOI 10.1016/B978-0-12-387664-5.00003-0; Schneider MC, 2007, TRENDS MICROBIOL, V15, P233, DOI 10.1016/j.tim.2007.03.005; Seib KL, 2010, VACCINE, V28, P2416, DOI 10.1016/j.vaccine.2009.12.082; Serruto D, 2012, VACCINE, V30, pB87, DOI 10.1016/j.vaccine.2012.01.033; Serruto D, 2010, P NATL ACAD SCI USA, V107, P3770, DOI 10.1073/pnas.0915162107; Souza DG, 2009, AM J PATHOL, V174, P1309, DOI 10.2353/ajpath.2009.080240; Sprong T, 2001, J LEUKOCYTE BIOL, V70, P283; Sprong T, 2009, SHOCK, V31, P28, DOI 10.1097/SHK.0b013e31817fd543; Stephens DS, 2007, LANCET, V369, P2196, DOI 10.1016/S0140-6736(07)61016-2; Stephens DS, 2007, FEMS MICROBIOL REV, V31, P3, DOI 10.1111/j.1574-6976.2006.00051.x; Stephens DS, 2009, VACCINE, V27, pB71, DOI 10.1016/j.vaccine.2009.04.070; Szalai AJ, 2002, MICROBES INFECT, V4, P201, DOI 10.1016/S1286-4579(01)01528-3; Tettelin H, 2000, SCIENCE, V287, P1809, DOI 10.1126/science.287.5459.1809; Tzeng YL, 2000, MICROBES INFECT, V2, P687, DOI 10.1016/S1286-4579(00)00356-7; Uronen H, 2000, CLIN EXP IMMUNOL, V122, P312, DOI 10.1046/j.1365-2249.2000.01409.x; Vogel U, 1999, MOL MICROBIOL, V32, P1133, DOI 10.1046/j.1365-2958.1999.01469.x; Welsch JA, 2003, J INFECT DIS, V188, P1730, DOI 10.1086/379375; Wong HEE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026130	79	26	26	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2015	10	3							e0120807	10.1371/journal.pone.0120807	http://dx.doi.org/10.1371/journal.pone.0120807			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9BN	25786110	gold, Green Published, Green Submitted			2022-12-27	WOS:000352138500191
J	Ding, D; Su, DF; Li, XR; Li, ZX; Wang, YJ; Qiu, J; Lin, PQ; Zhang, Y; Guo, P; Xia, M; Li, D; Yang, Y; Hu, G; Ling, WH				Ding, Ding; Su, Dongfang; Li, Xinrui; Li, Zhongxia; Wang, Yujie; Qiu, Jian; Lin, Puqing; Zhang, Yuan; Guo, Pi; Xia, Min; Li, Dan; Yang, Yan; Hu, Gang; Ling, Wenhua			Serum Levels of Monocyte Chemoattractant Protein-1 and All-Cause and Cardiovascular Mortality among Patients with Coronary Artery Disease	PLOS ONE			English	Article							PRACTICE GUIDELINES COMMITTEE; ASSOCIATION TASK-FORCE; AMERICAN-COLLEGE; PLASMA-LEVELS; TISSUE FACTOR; EXPRESSION; MCP-1; ATHEROSCLEROSIS; RECOMMENDATIONS; INFLAMMATION	Background Monocyte chemoattractant protein-1 (MCP-1) is an important chemokine at multiple phases of atherosclerosis in animals, but human studies are few and inconsistent. The aim of this study is to investigate the association of serum MCP-1with all-cause and cardiovascular disease (CVD) mortality among coronary artery disease (CAD) patients and determine whether this biomarker can add secondary prognostic value to standard risk predictors. Methods MCP-1 was measured at baseline in 1411 CAD patients who were 40-85 years of age. Cox proportional hazards regression models were used to estimate the association of MCP-1 levels with death risk. Results During a median follow-up of 3.3 years, 117 deaths were recorded, 88 of which were due to CVD. The multivariable-adjusted hazard ratios across tertiles of MCP-1 were 1.51 (95% confidence intervals [CI] 0.89-2.58), 1.00, and 2.11 (95% CI 1.31-3.40) for all-cause mortality, and 1.50 (95% CI 0.80-2.81), 1.00, and 2.21 (95% CI 1.27-3.87) for CVD mortality. The addition of serum MCP-1 to the fully adjusted model increased the C-index by 0.009 (p<0.0001) for all-cause mortality and 0.008 (p<0.0001) for CVD mortality and significantly improved the predictive ability by 12.1%(P = 0.006) on all-cause mortality and 12.6% (P = 0.003) on CVD mortality using the net reclassification improvement method. Conclusions Both lower and higher MCP-1 levels are associated with an increased risk of all-cause and CVD mortality among CAD patients. More research is needed to confirm its clinical relevance.	[Ding, Ding; Su, Dongfang; Li, Xinrui; Li, Zhongxia; Xia, Min; Li, Dan; Yang, Yan; Ling, Wenhua] Sun Yat Sen Univ, Sch Publ Hlth, Guangdong Prov Key Lab Food Nutr & Hlth, Dept Nutr, Guangzhou 510275, Guangdong, Peoples R China; [Ding, Ding; Wang, Yujie; Hu, Gang] Pennington Biomed Res Ctr, Chron Dis Epidemiol Lab, Baton Rouge, LA 70808 USA; [Qiu, Jian; Lin, Puqing; Zhang, Yuan] Guangzhou Mil Command Peoples Liberat Army, Dept Cardiol, Gen Hosp, Guangzhou, Guangdong, Peoples R China; [Guo, Pi] Sun Yat Sen Univ, Sch Publ Hlth, Dept Med Stat & Epidemiol, Guangzhou 510275, Guangdong, Peoples R China	Sun Yat Sen University; Louisiana State University System; Louisiana State University; Pennington Biomedical Research Center; Sun Yat Sen University	Li, D (corresponding author), Sun Yat Sen Univ, Sch Publ Hlth, Guangdong Prov Key Lab Food Nutr & Hlth, Dept Nutr, Guangzhou 510275, Guangdong, Peoples R China.	dolphin_danli@yahoo.com.cn; gang.hu@pbrc.edu	Lang, Ming/HIK-0758-2022; yang, yang/GWB-9426-2022; Hu, Gang/V-7947-2019; Stefanadis, Christodoulos/ABH-2232-2020; Hu, Gang/N-1971-2017	Hu, Gang/0000-0002-6172-8017; Stefanadis, Christodoulos/0000-0001-5974-6454; Hu, Gang/0000-0002-6172-8017; Li, Dan/0000-0001-6458-6096	Key Project of National Natural Science Fund, China [81130052]	Key Project of National Natural Science Fund, China	This work was supported by the Key Project of National Natural Science Fund [grant number 81130052], China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Birdsall HH, 1997, CIRCULATION, V95, P684, DOI 10.1161/01.CIR.95.3.684; Braunwald E, 2000, CIRCULATION, V102, P1193, DOI 10.1161/01.CIR.102.10.1193; Cipollone F, 2001, ARTERIOSCL THROM VAS, V21, P327, DOI 10.1161/01.ATV.21.3.327; de Lemos JA, 2003, CIRCULATION, V107, P690, DOI 10.1161/01.CIR.0000049742.68848.99; Deo R, 2004, J AM COLL CARDIOL, V44, P1812, DOI 10.1016/j.jacc.2004.07.047; Ding D, 2014, DIABETES CARE, V37, P546, DOI 10.2337/dc13-1387; Economou E, 2001, INT J CARDIOL, V80, P55, DOI 10.1016/S0167-5273(01)00454-5; Feng AN, 1999, CIRCULATION, V100, P2254, DOI 10.1161/01.CIR.100.22.2254; Ghanim H, 2001, J CLIN ENDOCR METAB, V86, P1306, DOI 10.1210/jc.86.3.1306; Gibbons RJ, 1999, CIRCULATION, V99, P2829, DOI 10.1161/01.CIR.99.21.2829; Gu L, 1998, MOL CELL, V2, P275, DOI 10.1016/S1097-2765(00)80139-2; Hansson GK, 2005, NEW ENGL J MED, V352, P1685, DOI 10.1056/NEJMra043430; Harrell FE, 1996, STAT MED, V15, P361, DOI 10.1002/(SICI)1097-0258(19960229)15:4<361::AID-SIM168>3.0.CO;2-4; Hokimoto S, 2000, JPN CIRC J, V64, P831, DOI 10.1253/jcj.64.831; Kavsak PA, 2007, CLIN CHEM, V53, P2112, DOI 10.1373/clinchem.2007.090613; Kervinen H, 2004, AM J CARDIOL, V94, P993, DOI 10.1016/j.amjcard.2004.06.052; Lee PC, 2005, TOXICOL SCI, V85, P541, DOI 10.1093/toxsci/kfi101; Levey AS, 2006, ANN INTERN MED, V145, P247, DOI 10.7326/0003-4819-145-4-200608150-00004; Li ZS, 2013, J NANOPART RES, V15, DOI 10.1007/s11051-012-1365-8; LIBBY P, 1995, CIRCULATION, V91, P2844, DOI 10.1161/01.CIR.91.11.2844; Martinez-Gonzalez J, 2001, ATHEROSCLEROSIS, V159, P27, DOI 10.1016/S0021-9150(01)00469-5; Nahrendorf M, 2010, CIRCULATION, V121, P2437, DOI 10.1161/CIRCULATIONAHA.109.916346; Namiki M, 2002, ARTERIOSCL THROM VAS, V22, P115, DOI 10.1161/hq0102.102278; NELKEN NA, 1991, J CLIN INVEST, V88, P1121, DOI 10.1172/JCI115411; Nishiyama K, 1998, JPN CIRC J, V62, P710, DOI 10.1253/jcj.62.710; Pencina MJ, 2008, STAT MED, V27, P157, DOI 10.1002/sim.2929; Pencina MJ, 2004, STAT MED, V23, P2109, DOI 10.1002/sim.1802; Sakamoto T, 2005, ARTERIOSCL THROM VAS, V25, P2005, DOI 10.1161/01.ATV.0000178171.61754.cd; Stork S, 2002, CARDIOVASC RES, V53, P642, DOI 10.1016/S0008-6363(01)00461-8; World Health Organization, GLOB HLTH OBS DAT RE; Zhang B, 2010, PUBLIC HEALTH NUTR, V13, P1546, DOI 10.1017/S1368980009992849	31	21	21	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2015	10	3							e0120633	10.1371/journal.pone.0120633	http://dx.doi.org/10.1371/journal.pone.0120633			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9BN	25786118	Green Submitted, Green Published, gold			2022-12-27	WOS:000352138500183
J	Khan, JA; Mustafa, M; Hayat, T; Sheikholeslami, M; Alsaedi, A				Khan, Junaid Ahmad; Mustafa, M.; Hayat, T.; Sheikholeslami, M.; Alsaedi, A.			Three-Dimensional Flow of Nanofluid Induced by an Exponentially Stretching Sheet: An Application to Solar Energy	PLOS ONE			English	Article							BOUNDARY-LAYER-FLOW; HEAT-TRANSFER ENHANCEMENT; STAGNATION-POINT FLOW; ALUMINA/WATER NANOFLUID; VISCOELASTIC FLUID; WATER NANOFLUID; MASS-TRANSFER; MHD FLOW; CONVECTION; EQUATIONS	This work deals with the three-dimensional flow of nanofluid over a bi-directional exponentially stretching sheet. The effects of Brownian motion and thermophoretic diffusion of nanoparticles are considered in the mathematical model. The temperature and nanoparticle volume fraction at the sheet are also distributed exponentially. Local similarity solutions are obtained by an implicit finite difference scheme known as Keller-box method. The results are compared with the existing studies in some limiting cases and found in good agreement. The results reveal the existence of interesting Sparrow-Gregg-type hills for temperature distribution corresponding to some range of parametric values.	[Khan, Junaid Ahmad] NUST, RCMS, Islamabad 44000, Pakistan; [Mustafa, M.] NUST, SNS, Islamabad 44000, Pakistan; [Hayat, T.] Quaid I Azam Univ, Dept Math, Islamabad 44000, Pakistan; [Hayat, T.; Alsaedi, A.] King Abdulaziz Univ, Fac Sci, Dept Math, Jeddah 21589, Saudi Arabia; [Sheikholeslami, M.] Babol Univ Technol, Dept Mech Engn, Babol Sar, Iran	National University of Sciences & Technology - Pakistan; National University of Sciences & Technology - Pakistan; Quaid I Azam University; King Abdulaziz University; Babol Noshirvani University of Technology	Mustafa, M (corresponding author), NUST, SNS, Islamabad 44000, Pakistan.	meraj_mm@hotmail.com	Alsaedi, Ahmed/A-2094-2013; Mustafa Hashmi, Meraj/P-1769-2014; Hayat, Tasawar/E-9449-2015; Ahmad, Junaid/AAE-8872-2019; Sheikholeslami, Mohsen/G-9034-2015; Hayat, Tasawar/Y-2524-2019; Hayat, Tasawar/A-3853-2013; Ganji, Davood Domiri/Z-3664-2019	Alsaedi, Ahmed/0000-0003-3452-8922; Sheikholeslami, Mohsen/0000-0002-8839-0458; Ganji, Davood Domiri/0000-0002-2344-526X				Abbas Z, 2014, HEAT TRANSF-ASIAN RE, V43, P233, DOI 10.1002/htj.21074; Abramowitz M., 1965, HDB MATH FUNCTIONS; ALI ME, 1995, INT J HEAT FLUID FL, V16, P280, DOI 10.1016/0142-727X(95)00001-7; Ashorynejad HR, 2013, HEAT MASS TRANSFER, V49, P427, DOI 10.1007/s00231-012-1087-6; BANKS WHH, 1983, J MEC THEOR APPL, V2, P375; Beg OA, 2013, APPL NANOSCI; Buongiorno J, 2006, J HEAT TRANS-T ASME, V128, P240, DOI 10.1115/1.2150834; Cebeci T, 1988, PHYS COMPUTATIONAL A; CHEN CK, 1988, J MATH ANAL APPL, V135, P568, DOI 10.1016/0022-247X(88)90172-2; Choi SUS., 1995, ASME PUBLICATIONS FE, P99; CRANE LJ, 1970, Z ANGEW MATH PHYS, V21, P645, DOI 10.1007/BF01587695; Ebaid A, 2013, COMPUT MATH METHODS; GRUBKA LJ, 1985, J HEAT TRANS-T ASME, V107, P248, DOI 10.1115/1.3247387; Hayat T, 2008, NONLINEAR ANAL-REAL, V9, P1811, DOI 10.1016/j.nonrwa.2007.05.010; Hayat T, 2011, NUMER METH PART D E, V27, P915, DOI 10.1002/num.20561; Ibrahim W, 2014, J HEAT TRANS-T ASME, V136, DOI 10.1115/1.4026118; Ibrahim W, 2013, COMPUT FLUIDS, V75, P1, DOI 10.1016/j.compfluid.2013.01.014; Javed T, 2013, CHEM ENG COMMUN, V200, P327, DOI 10.1080/00986445.2012.703151; Karimipour A, 2014, PHYSICA A, V402, P150, DOI 10.1016/j.physa.2014.01.057; Khan JA, 2014, J MOL LIQ, V194, P41, DOI 10.1016/j.molliq.2013.12.045; Khan SK, 2005, INT J HEAT MASS TRAN, V48, P1534, DOI 10.1016/j.ijheatmasstransfer.2004.10.032; Khan WA, 2010, INT J HEAT MASS TRAN, V53, P2477, DOI 10.1016/j.ijheatmasstransfer.2010.01.032; Kumar H, 2013, CHEM ENG COMMUN, V200, P895, DOI 10.1080/00986445.2012.727509; Kuznetsov AV, 2010, INT J THERM SCI, V49, P243, DOI 10.1016/j.ijthermalsci.2009.07.015; Ladjevardi SM, 2013, SOL ENERGY, V94, P327, DOI 10.1016/j.solener.2013.05.012; LAWRENCE PS, 1992, ACTA MECH, V93, P53, DOI 10.1007/BF01182572; Liao SJ, 2003, J FLUID MECH, V488, P189, DOI 10.1017/S0022112003004865; Liu IC, 2008, INT J HEAT MASS TRAN, V51, P4018, DOI 10.1016/j.ijheatmasstransfer.2007.10.041; Liu IC, 2013, CHEM ENG COMMUN, V200, P253, DOI 10.1080/00986445.2012.703148; Magyari E, 1999, J PHYS D APPL PHYS, V32, P577, DOI 10.1088/0022-3727/32/5/012; Magyari E, 2000, EUR J MECH B-FLUID, V19, P109, DOI 10.1016/S0997-7546(00)00104-7; Maiga SE, 2006, INT J NUMER METHOD H, V16, P275, DOI 10.1108/09615530610649717; Makinde OD, 2013, INT J HEAT MASS TRAN, V62, P526, DOI 10.1016/j.ijheatmasstransfer.2013.03.049; Makinde OD, 2011, INT J THERM SCI, V50, P1326, DOI 10.1016/j.ijthermalsci.2011.02.019; Malvandi A, 2014, ADV POWDER TECHNOL, V25, P1369, DOI 10.1016/j.apt.2014.03.017; Malvandi A, 2014, INT J THERM SCI, V84, P196, DOI 10.1016/j.ijthermalsci.2014.05.013; Malvandi A, 2014, POWDER TECHNOL, V263, P37, DOI 10.1016/j.powtec.2014.04.084; Masuda H., 1993, NETSU BUSSEI, V4, P227, DOI [10.2963/jjtp.7.227, DOI 10.2963/JJTP.7.227]; Mushtaq A, 2014, J TAIWAN INST CHEM E, V45, P1176, DOI 10.1016/j.jtice.2013.11.008; Mustafa M, 2013, J MECH, V29, P423, DOI 10.1017/jmech.2013.9; Mustafa M, 2011, INT J HEAT MASS TRAN, V54, P5588, DOI 10.1016/j.ijheatmasstransfer.2011.07.021; Mustafa M, 2013, PLOS ONE, V8; Mustafaa M, 2013, INT J NUMER METHOD H, V23, P945, DOI 10.1108/HFF-09-2011-0179; Nadeem S, 2011, NUMER ALGORITHMS, V57, P187, DOI 10.1007/s11075-010-9423-8; Nield DA, 2009, INT J HEAT MASS TRAN, V52, P5792, DOI 10.1016/j.ijheatmasstransfer.2009.07.024; Otanicar TP, 2010, J RENEW SUSTAIN ENER, V2, DOI 10.1063/1.3429737; Pop I, 1998, MECH RES COMMUN, V25, P263, DOI 10.1016/S0093-6413(98)00037-8; RAJAGOPAL KR, 1984, RHEOL ACTA, V23, P213, DOI 10.1007/BF01332078; Rana P, 2012, COMMUN NONLINEAR SCI, V17, P212, DOI 10.1016/j.cnsns.2011.05.009; Rasekh A, 2012, FRONT HEAT MASS TRAN, V3, DOI 10.5098/hmt.v3.4.3003; Sadeqi S, 2011, COMMUN NONLINEAR SCI, V16, P711, DOI 10.1016/j.cnsns.2010.05.009; Safaei MR, 2014, NUMER HEAT TR A-APPL, V66, P1321, DOI 10.1080/10407782.2014.916101; Sajid M, 2008, INT COMMUN HEAT MASS, V35, P347, DOI 10.1016/j.icheatmasstransfer.2007.08.006; SAKIADIS BC, 1961, AICHE J, V7, P26, DOI 10.1002/aic.690070108; Sheikholeslami M, 2014, J MAGN MAGN MATER, V349, P188, DOI 10.1016/j.jmmm.2013.08.040; Shijun Liao, 2006, Communications in Nonlinear Science and Numerical Simulation, V11, P326, DOI 10.1016/j.cnsns.2004.09.004; Trieb F, 1998, RENEW ENERG, V14, P17, DOI 10.1016/S0960-1481(98)00041-X; Turkyilmazoglu M, 2014, J HEAT TRANS-T ASME, V136, DOI 10.1115/1.4025730; Turkyilmazoglu M, 2014, COMPUT FLUIDS, V94, P139, DOI 10.1016/j.compfluid.2014.02.009; Uddin MJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049499; Xu H, 2007, EUR J MECH B-FLUID, V26, P15, DOI 10.1016/j.euromechflu.2005.12.003; Xu H, 2009, COMPUT MATH APPL, V57, P1425, DOI 10.1016/j.camwa.2009.01.029	62	70	70	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2015	10	3							e0116603	10.1371/journal.pone.0116603	http://dx.doi.org/10.1371/journal.pone.0116603			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9BN	25785857	Green Submitted, Green Published, gold			2022-12-27	WOS:000352138500011
J	Maura, F; Mosca, L; Fabris, S; Cutrona, G; Matis, S; Lionetti, M; Agnelli, L; Barbieri, M; D'Anca, M; Manzoni, M; Colombo, M; Massucco, C; Reverberi, D; Gentile, M; Recchia, AG; Bossio, S; Ilariucci, F; Musolino, C; Di Raimondo, F; Cortelezzi, A; Morabito, F; Ferrarini, M; Neri, A				Maura, Francesco; Mosca, Laura; Fabris, Sonia; Cutrona, Giovanna; Matis, Serena; Lionetti, Marta; Agnelli, Luca; Barbieri, Marzia; D'Anca, Marianna; Manzoni, Martina; Colombo, Monica; Massucco, Carlotta; Reverberi, Daniele; Gentile, Massimo; Recchia, Anna Grazia; Bossio, Sabrina; Ilariucci, Fiorella; Musolino, Caterina; Di Raimondo, Francesco; Cortelezzi, Agostino; Morabito, Fortunato; Ferrarini, Manlio; Neri, Antonino			Insulin Growth Factor 1 Receptor Expression Is Associated with NOTCH1 Mutation, Trisomy 12 and Aggressive Clinical Course in Chronic Lymphocytic Leukaemia	PLOS ONE			English	Article							FACTOR-I RECEPTOR; BORTEZOMIB; SURVIVAL; ZAP-70; IMPACT; GENES; IGF1R; STAGE; RISK; CD38	IGF1R is emerging as an important gene in the pathogenesis of many solid and haematological cancers and its over-expression has been reported as frequently associated with aggressive disease and chemotherapy resistance. In this study we performed an investigation of the role of IGF1R expression in a large and representative prospective series of 217 chronic lymphocytic leukaemia (CLL) patients enrolled in the multicentre O-CLL1 protocol (clinicaltrial.gov #NCT00917540). High IGF1R gene expression was significantly associated with IGHV unmutated (IGHV-UM) status (p<0.0001), high CD38 expression (p<0.0001), trisomy 12 (p<0.0001), and del(11)(q23) (p=0.014). Interestingly, higher IGF1R expression (p=0.002) characterized patients with NOTCH1 mutation (c.7541_7542delCT), identified in 15.5% of cases of our series by next generation sequencing and ARMS-PCR. Furthermore, IGF1R expression has been proven as an independent prognostic factor associated with time to first treatment in our CLL prospective cohort. These data suggest that IGF1R may play an important role in CLL biology, in particular in aggressive CLL clones characterized by IGHV-UM, trisomy 12 and NOTCH1 mutation.	[Maura, Francesco; Mosca, Laura; Fabris, Sonia; Lionetti, Marta; Agnelli, Luca; Barbieri, Marzia; D'Anca, Marianna; Manzoni, Martina; Cortelezzi, Agostino; Neri, Antonino] Univ Milan, Dept Clin Sci & Community Hlth, Milan, Italy; [Maura, Francesco; Mosca, Laura; Fabris, Sonia; Lionetti, Marta; Agnelli, Luca; Barbieri, Marzia; D'Anca, Marianna; Manzoni, Martina; Cortelezzi, Agostino; Neri, Antonino] Osped Maggiore Policlin, Fdn IRCCS Ca Granda, Hematol CTMO 1, Milan, Italy; [Cutrona, Giovanna] IRCCS S Martino IST, SS Mol Diagnost, Genoa, Italy; [Matis, Serena; Colombo, Monica; Massucco, Carlotta; Ferrarini, Manlio] Sci Direct IRCCS S Martino IST, Genoa, Italy; [Reverberi, Daniele; Morabito, Fortunato] Dept Pathol IRCCS S Martino IST, Genoa, Italy; [Gentile, Massimo; Recchia, Anna Grazia; Bossio, Sabrina] Azienda Osped Cosenza, UOC Ematol, Cosenza, Italy; [Ilariucci, Fiorella] AO Arcispedale Santa Maria Nuova IRCCS, Div Hematol, Reggio Emilia, Italy; [Musolino, Caterina] Univ Messina, Div Haematol, Messina, Italy; [Di Raimondo, Francesco] Univ Catania, Dept Biomed Sci, Div Hematol, Catania, Italy; [Di Raimondo, Francesco] Ferrarotto Hosp, Catania, Italy	University of Milan; IRCCS Ca Granda Ospedale Maggiore Policlinico; Azienda Ospedaliera di Cosenza; IRCCS Arcispedale S. Maria Nuova; University of Messina; University of Catania	Neri, A (corresponding author), Univ Milan, Dept Clin Sci & Community Hlth, Milan, Italy.	antonino.neri@unimi.it	Neri, Antonino/I-9690-2014; D'Anca, Marianna/K-5759-2016; Di Raimondo, Francesco/K-7965-2016; Colombo, Monica/AAI-2484-2019; cortelezzi, agostino/L-2633-2016; Morabito, Francesco Carlo/AAB-9698-2019; Cutrona, Giovanna/I-7868-2018; Bossio, Sabrina/GVS-5999-2022; Gentile, Massimo/R-3270-2016; Matis, Serena/AAB-2832-2020; ilariucci, fiorella/AAA-8256-2019; Recchia, Anna Grazia/ABA-5228-2020	Neri, Antonino/0000-0001-9047-5912; D'Anca, Marianna/0000-0001-8625-6506; Di Raimondo, Francesco/0000-0002-7749-0293; Colombo, Monica/0000-0001-5512-8106; Morabito, Francesco Carlo/0000-0003-0734-9136; Cutrona, Giovanna/0000-0002-3335-1101; Gentile, Massimo/0000-0002-5256-0726; Matis, Serena/0000-0003-3023-0213; ilariucci, fiorella/0000-0002-4279-3358; Agnelli, Luca/0000-0003-0582-6170; CORTELEZZI, AGOSTINO/0000-0001-9283-4800; Barbieri, Marzia/0000-0002-9027-1888; Ferrarini, Manlio/0000-0002-6154-2570; Fabris, Sonia/0000-0003-1341-0503; MANZONI, MARTINA/0000-0003-0861-9951	Associazione Italiana Ricerca sul Cancro (AIRC) [AN-IG10136, MF464 IG10492, FM-RG6432]; AIRC-Special Program Molecular Clinical Oncology (5 per Mille) [9980]; Ricerca Finalizzata from the Italian Ministry of Health; Fondo Investimento per la Ricerca di Base [RBIP06LCA9]; progetto Compagnia San Paolo; AIRC; Fondazione Italiana Ricerca sul Cancro (FIRC)	Associazione Italiana Ricerca sul Cancro (AIRC)(Fondazione AIRC per la ricerca sul cancro); AIRC-Special Program Molecular Clinical Oncology (5 per Mille)(Fondazione AIRC per la ricerca sul cancro); Ricerca Finalizzata from the Italian Ministry of Health(Ministry of Health, ItalyMinistry of Health Italy - Ricerca Finalizzata (MOH-RF)); Fondo Investimento per la Ricerca di Base; progetto Compagnia San Paolo; AIRC(Fondazione AIRC per la ricerca sul cancro); Fondazione Italiana Ricerca sul Cancro (FIRC)(Fondazione AIRC per la ricerca sul cancro)	This work was supported by Associazione Italiana Ricerca sul Cancro (AIRC, AN-IG10136, MF464 IG10492, and FM-RG6432), AIRC-Special Program Molecular Clinical Oncology (5 per Mille, grant 9980, 2010-15; Antonino Neri, Manlio Ferrarini, and Fortunato Morabito), Ricerca Finalizzata from the Italian Ministry of Health 2006 (Giovanna Cutrona, Fortunato Morabito, and Manlio Ferrarini) and 2007 (Giovanna Cutrona), Fondo Investimento per la Ricerca di Base (grant RBIP06LCA9; Manlio Ferrarini), progetto Compagnia San Paolo (G.C.). Sabrina Bossio was supported by fellowships from the AIRC. Marta Lionetti was supported by a fellowship from the Fondazione Italiana Ricerca sul Cancro (FIRC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahlen J, 2005, CLIN CANCER RES, V11, P206; Byrd JC, 2013, NEW ENGL J MED, V369, P32, DOI 10.1056/NEJMoa1215637; Cheson BD, 1996, BLOOD, V87, P4990, DOI 10.1182/blood.V87.12.4990.bloodjournal87124990; Crespo M, 2003, NEW ENGL J MED, V348, P1764, DOI 10.1056/NEJMoa023143; Cutrona G, 2006, EUR J IMMUNOL, V36, P558, DOI 10.1002/eji.200526355; Cutrona G, 2008, HAEMATOLOGICA, V93, P413, DOI 10.3324/haematol.11646; Damle RN, 1999, BLOOD, V94, P1840, DOI 10.1182/blood.V94.6.1840; Dohner H, 2000, NEW ENGL J MED, V343, P1910, DOI 10.1056/NEJM200012283432602; Dziadziuszko R, 2010, J CLIN ONCOL, V28, P2174, DOI 10.1200/JCO.2009.24.6611; Fabbri G, 2011, J EXP MED, V208, P1389, DOI 10.1084/jem.20110921; Fabris S, 2008, GENE CHROMOSOME CANC, V47, P781, DOI 10.1002/gcc.20579; Fu PF, 2011, BREAST CANCER RES TR, V130, P307, DOI 10.1007/s10549-011-1605-0; Furman RR, 2014, N ENGL J MED; Gopal AK, 2014, N ENGL J MED; Hallek M, 2008, BLOOD, V111, P5446, DOI 10.1182/blood-2007-06-093906; Hamblin TJ, 1999, BLOOD, V94, P1848, DOI 10.1182/blood.V94.6.1848; Hartog H, 2011, BREAST CANCER RES TR, V129, P725, DOI 10.1007/s10549-010-1256-6; Kuhn DJ, 2012, BLOOD, V120, P3260, DOI 10.1182/blood-2011-10-386789; Landau DA, 2013, CELL, V152, P714, DOI 10.1016/j.cell.2013.01.019; Liang Z, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087474; Lionetti M, 2014, BRIT J HAEMATOL, V165, P629, DOI 10.1111/bjh.12800; Maura F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024313; Medyouf H, 2011, J EXP MED, V208, P1809, DOI 10.1084/jem.20110121; Monod MY, 2004, BIOINFORMATICS, V20, P379, DOI 10.1093/bioinformatics/bth945; Morabito F, 2013, CLIN CANCER RES, V19, P5890, DOI 10.1158/1078-0432.CCR-13-0622; Morabito F, 2009, BRIT J HAEMATOL, V146, P44, DOI 10.1111/j.1365-2141.2009.07703.x; Moreau P, 2011, LEUKEMIA, V25, P872, DOI 10.1038/leu.2011.4; PAPA V, 1993, CANCER RES, V53, P3736; Pollak M, 2012, NAT REV CANCER, V12, P159, DOI 10.1038/nrc3215; Puente XS, 2011, NATURE, V475, P101, DOI 10.1038/nature10113; Rossi D, 2014, BLOOD, V123, P2139, DOI 10.1182/blood-2013-11-539726; Rossi D, 2012, BLOOD, V119, P521, DOI 10.1182/blood-2011-09-379966; Schillaci R, 2005, BRIT J HAEMATOL, V130, P58, DOI 10.1111/j.1365-2141.2005.05579.x; Stamatopoulos K, 2007, BLOOD, V109, P259, DOI 10.1182/blood-2006-03-012948; Vishwamitra D, 2011, HAEMATOL-HEMATOL J, V96, P871, DOI 10.3324/haematol.2010.031567; Wang LL, 2011, NEW ENGL J MED, V365, P2497, DOI 10.1056/NEJMoa1109016; Yaktapour N, 2013, BLOOD, V122, P1621, DOI 10.1182/blood-2013-02-484386	37	12	12	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2015	10	3							e0118801	10.1371/journal.pone.0118801	http://dx.doi.org/10.1371/journal.pone.0118801			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9BN	25786252	Green Submitted, Green Published, gold			2022-12-27	WOS:000352138500048
J	Pozzi, LM; Borboroglu, PG; Boersma, PD; Pascual, MA				Pozzi, Luciana M.; Borboroglu, Pablo Garcia; Boersma, P. Dee; Pascual, Miguel A.			Population Regulation in Magellanic Penguins: What Determines Changes in Colony Size?	PLOS ONE			English	Article							ENVIRONMENTAL VARIABILITY; SPHENISCUS-MAGELLANICUS; REPRODUCTIVE SUCCESS; DENSITY-DEPENDENCE; HABITAT SELECTION; WINTER MIGRATION; FORAGING EFFORT; SEABIRD; DYNAMICS; DISPERSAL	Seabirds are often studied at individual colonies, but the confounding effects of emigration and mortality processes in open populations may lead to inappropriate conclusions on the mechanisms underlying population changes. Magellanic penguin (Spheniscus magellanicus) colonies of variable population sizes are distributed along the Argentine coastline. In recent decades, several population and distributional changes have occurred, with some colonies declining and others newly established or increasing. We integrated data of eight colonies scattered along similar to 600 km in Northern Patagonia (from 41 degrees 26'S, 65 degrees 01'W to 45 degrees 11 'S, 66 degrees 30'W, Rio Negro and Chubut provinces) and conducted analysis in terms of their growth rates, production of young and of the dependence of those vital rates on colony age, size, and location. We contrasted population trends estimated from abundance data with those derived from population modeling to understand if observed growth rates were attainable under closed population scenarios. Population trends were inversely related to colony size, suggesting a density dependent growth pattern. All colonies located in the north-which were established during the last decades-increased at high rates, with the smallest, recently established colonies growing at the fastest rate. In central-southern Chubut, where colonies are the oldest, the largest breeding aggregations declined, but smaller colonies remained relatively stable. Results provided strong evidence that dispersal played a major role in driving local trends. Breeding success was higher in northern colonies, likely mediated by favorable oceanographic conditions. However, mean foraging distance and body condition of chicks at fledging were influenced by colony size. Recruitment of penguins in the northern area may have been triggered by a combination of density dependence, likely exacerbated by less favorable oceanographic conditions in the southern sector. Our results reaffirm the idea that individual colony trends do not provide confident indicators of population health, highlighting the need to redefine the scale for the study of population changes.	[Pozzi, Luciana M.; Borboroglu, Pablo Garcia; Pascual, Miguel A.] Ctr Nacl Patagon CONICET, RA-9120 Puerto Madryn, Chubut, Argentina; [Borboroglu, Pablo Garcia; Boersma, P. Dee] Global Penguin Soc, Seattle, WA USA; [Borboroglu, Pablo Garcia; Boersma, P. Dee] Univ Washington, Dept Biol, Seattle, WA 98195 USA; [Pascual, Miguel A.] Univ Nacl Patagonia San Juan Bosco, Puerto Madryn, Chubut, Argentina	Centro Nacional Patagonico (CENPAT); Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); University of Washington; University of Washington Seattle; Universidad Nacional de la Patagonia San Juan Bosco	Pozzi, LM (corresponding author), Ctr Nacl Patagon CONICET, Blvd Brown 2915, RA-9120 Puerto Madryn, Chubut, Argentina.	pozzi@cenpat.edu.ar		Chiaradia, Andre/0000-0002-6178-4211	Rufford Small Grants; Whitley Fund for Nature; Pew Fellows Program in Marine Conservation	Rufford Small Grants; Whitley Fund for Nature; Pew Fellows Program in Marine Conservation	The research was funded by Rufford Small Grants, Whitley Fund for Nature and Pew Fellows Program in Marine Conservation, Luc Hoffman and Tom and Kathy Leiden. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acha EM, 2004, J MARINE SYST, V44, P83, DOI 10.1016/j.jmarsys.2003.09.005; Ainley DG, 2006, ECOLOGY, V87, P2080, DOI 10.1890/0012-9658(2006)87[2080:CAPACR]2.0.CO;2; Ainley DG, 2004, ECOL MONOGR, V74, P159, DOI 10.1890/02-4073; Alemany D, 2009, J BIOGEOGR, V36, P2111, DOI 10.1111/j.1365-2699.2009.02148.x; ANDREWARTHA HG, 1954, DISTRIBUTION ABUNDAN; ASHMOLE N. P., 1963, IBIS, V103b, P458, DOI 10.1111/j.1474-919X.1963.tb06766.x; Ballance LT, 2009, J AVIAN BIOL, V40, P279, DOI 10.1111/j.1600-048X.2008.04538.x; Barbraud C, 2003, P ROY SOC B-BIOL SCI, V270, P2111, DOI 10.1098/rspb.2003.2488; Bates D., 2014, LINEAR MIXED EFFECTS; Bertellotti M, 2005, 11 REUN ARG ORN, V66; Bicknell AWJ, 2014, DIVERS DISTRIB, V20, DOI 10.1111/ddi.12137; BIRT VL, 1987, MAR ECOL PROG SER, V40, P205, DOI 10.3354/meps040205; Bivand R., 2013, BINDINGS GEOSPATIAL; Boersma PD, 2008, BIOSCIENCE, V58, P597, DOI 10.1641/B580707; Boersma PD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085602; Boersma PD, 2010, J FIELD ORNITHOL, V81, P195, DOI 10.1111/j.1557-9263.2010.00277.x; Boersma PD, 2009, MAR ECOL PROG SER, V375, P263, DOI 10.3354/meps07753; Boersma PD, 2009, ECOL MONOGR, V79, P59, DOI 10.1890/06-0419.1; Boersma PD, 1990, PENGUIN BIOL; Bonenfant C, 2009, ADV ECOL RES, V41, P313, DOI 10.1016/S0065-2504(09)00405-X; Borboroglu PG, 2013, PENGUINS: NATURAL HISTORY AND CONSERVATION, P1; Borboroglu PG, 2002, AUK, V119, P233, DOI 10.1642/0004-8038(2002)119[0233:HUABDO]2.0.CO;2; Boulinier T, 1996, J AVIAN BIOL, V27, P252, DOI 10.2307/3677230; Bouzat JL, 2009, AUK, V126, P326, DOI 10.1525/auk.2009.07122; Carribero Alejandro, 1995, Hornero, V14, P33; Caswell, 2000, MATRIX POPULATION MO; Caughley G., 1977, ANAL VERTEBRATE POPU; Danchin E, 1998, ECOLOGY, V79, P2415, DOI 10.2307/176832; Danchin E., 1991, P1641; Davies RD, 2013, MAR ECOL PROG SER, V485, P287, DOI 10.3354/meps10348; DEEBOERSMA P, 1978, SCIENCE, V200, P1481, DOI 10.1126/science.200.4349.1481; Delord K, 2004, POLAR BIOL, V27, P793, DOI 10.1007/s00300-004-0651-z; Dumrauf C, 1991, HIST DE CHUBUT; Efron B., 1993, INTRO BOOSTRAP; Elliott KH, 2009, AUK, V126, P613, DOI 10.1525/auk.2009.08245; Frederiksen M, 2000, IBIS, V142, P48, DOI 10.1111/j.1474-919X.2000.tb07683.x; Frere E., 1996, Ornitologia Neotropical, V7, P35; Frere E, 1996, INFORME TECNICO NUME, V8; Furness R.W., 1987, SEABIRD ECOLOGY; FURNESS RW, 1984, NATURE, V311, P655, DOI 10.1038/311655a0; Gandini P., 1996, Bird Conservation International, V6, P307; GASTON AJ, 1983, CAN J ZOOL, V61, P2465, DOI 10.1139/z83-327; GREENWOOD PJ, 1982, ANNU REV ECOL SYST, V13, P1, DOI 10.1146/annurev.es.13.110182.000245; Gremillet D, 2004, MAR ECOL PROG SER, V268, P265, DOI 10.3354/meps268265; Hansen JE, 2001, FISH OCEANOGR, V10, P193, DOI 10.1046/j.1365-2419.2001.00166.x; HANSKI I, 1997, METAPOPULATION BIOL; Hilborn Ray, 1997, V28; Hunt G.L. Jr, 1990, Polar Research, V8, P43, DOI 10.1111/j.1751-8369.1990.tb00374.x; HUNT GL, 1986, AUK, V103, P306, DOI 10.1093/auk/103.2.306; Inchausti P, 2003, J AVIAN BIOL, V34, P170, DOI 10.1034/j.1600-048X.2003.03031.x; Inchausti P, 2002, J ANIM ECOL, V71, P765, DOI 10.1046/j.1365-2656.2002.00638.x; James D, 2013, CHRON CHRONOLOGICAL, P4; Kildaw S. Dean, 2005, Marine Ornithology, V33, P49; Koenig WD, 1996, TRENDS ECOL EVOL, V11, P514, DOI 10.1016/S0169-5347(96)20074-6; Lewis S, 2001, NATURE, P412; Lewison R., 2012, Endangered Species Research, V17, P93, DOI 10.3354/esr00419; Martinez-Abrain A, 2001, WATERBIRDS, V24, P97, DOI 10.2307/1522248; McCarthy MA, 1996, J APPL ECOL, V33, P45, DOI 10.2307/2405014; Pozzi LM, 2013, ARDEOLA, V60, P279, DOI 10.13157/arla.60.2.2013.279; Nicholson AJ, 1933, J ANIM ECOL, V2, P132, DOI 10.2307/954; Numata M, 2000, NEW ZEAL J ZOOL, V27, P277, DOI 10.1080/03014223.2000.9518236; Orians G.H., 1979, P155; Oro D, 2003, SCI MAR, V67, P13, DOI 10.3989/scimar.2003.67s213; Oro D, 2001, J ANIM ECOL, V70, P527, DOI 10.1046/j.1365-2656.2001.00511.x; Pascual MA, 1997, CONSERV BIOL, V11, P966, DOI 10.1046/j.1523-1739.1997.95437.x; Pinaud D, 2005, MAR ECOL PROG SER, V298, P295, DOI 10.3354/meps298295; Putz K, 2007, MAR BIOL, V152, P1227, DOI 10.1007/s00227-007-0770-5; Putz K, 2000, IBIS, V142, P614, DOI 10.1111/j.1474-919X.2000.tb04461.x; QGIS DevelopmentTeam, 2012, QGIS GEOGR INF SYST; R Core Team, 2012, R LANG ENV STAT COMP; Robinson S, 2005, IBIS, V147, P483, DOI 10.1111/j.1474-919x.2005.00431.x; Sabatini Marina E., 2004, Revista de Investigacion y Desarrollo Pesquero, V16, P5; Sala JE, 2012, MAR ECOL PROG SER, V464, P273, DOI 10.3354/meps09887; Sala JE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051487; Sandvik H, 2012, MAR ECOL PROG SER, V454, P273, DOI 10.3354/meps09558; Schiavini Adrián, 2005, Hornero, V20, P5; Schreiber Elizabeth, 2002, BIOL MARINE BIRDS, DOI 10.1201/9781420036305; Scolaro JA, 1999, WATERBIRDS, V22, P104, DOI 10.2307/1521999; SCOLARO JA, 1978, PUBLICACIONES OCASIO, V8, P1; STUBBEN C, 2007, J STAT SOFTWARE, V22; THOMPSON KR, 1991, J ZOOL, V225, P427, DOI 10.1111/j.1469-7998.1991.tb03826.x; Turchin P, 1999, OIKOS, V84, P153, DOI 10.2307/3546876; Villanueva C, 2012, J ORNITHOL, V153, P219, DOI 10.1007/s10336-011-0730-1; Wakefield ED, 2013, SCIENCE, V341, P68, DOI 10.1126/science.1236077; Warnes GR, 2013, GPLOTS VARIOUS R PRO; Weimerskirch H, 2001, BEHAV ECOL, V12, P22, DOI 10.1093/oxfordjournals.beheco.a000374; Whittington PA, 2002, THESIS U CAPE TOWN; WIENS JA, 1989, FUNCT ECOL, V3, P385, DOI 10.2307/2389612; Wilson Rory P., 2007, Marine Ornithology, V35, P109; Wilson RP, 2005, ECOL MONOGR, V75, P379, DOI 10.1890/04-1238; Yorio P., 2001, Marine Ornithology, V29, P75; Yorio P, 1998, PLAN MANEJO INTEGRAD; [No title captured]	93	30	30	0	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2015	10	3							e0119002	10.1371/journal.pone.0119002	http://dx.doi.org/10.1371/journal.pone.0119002			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9BN	25786254	gold, Green Published, Green Submitted			2022-12-27	WOS:000352138500064
J	Ren, ZY; Do, LD; Bechkoff, G; Mebarek, S; Keloglu, N; Ahamada, S; Meena, S; Magne, D; Pikula, S; Wu, YQ; Buchet, R				Ren, Zhongyuan; Le Duy Do; Bechkoff, Geraldine; Mebarek, Saida; Keloglu, Nermin; Ahamada, Saandia; Meena, Saurabh; Magne, David; Pikula, Slawomir; Wu, Yuqing; Buchet, Rene			Direct Determination of Phosphatase Activity from Physiological Substrates in Cells	PLOS ONE			English	Article							ALKALINE-PHOSPHATASE; RAPID IDENTIFICATION; CANCER CELLS; SPECTROSCOPY; TISSUE; QUANTIFICATION; DISCRIMINATION; MECHANISM; VESICLES	A direct and continuous approach to determine simultaneously protein and phosphate concentrations in cells and kinetics of phosphate release from physiological substrates by cells without any labeling has been developed. Among the enzymes having a phosphatase activity, tissue non-specific alkaline phosphatase (TNAP) performs indispensable, multiple functions in humans. It is expressed in numerous tissues with high levels detected in bones, liver and neurons. It is absolutely required for bone mineralization and also necessary for neurotransmitter synthesis. We provided the proof of concept that infrared spectroscopy is a reliable assay to determine a phosphatase activity in the osteoblasts. For the first time, an overall specific phosphatase activity in cells was determined in a single step by measuring simultaneously protein and substrate concentrations. We found specific activities in osteoblast like cells amounting to 116 +/- 13 nmol min(-1) mg(-1) for PPi, to 56 +/- 11 nmol min(-1) mg(-1) for AMP, to 79 +/- 23 nmol min(-1) mg(-1) for beta-glycerophosphate and to 73 +/- 15 nmol min(-1) mg(-1) for 1-alpha-D glucose phosphate. The assay was also effective to monitor phosphatase activity in primary osteoblasts and in matrix vesicles. The use of levamisole - a TNAP inhibitorserved to demonstrate that a part of the phosphatase activity originated from this enzyme. An IC50 value of 1.16 +/- 0.03 mM was obtained for the inhibition of phosphatase activity of levamisole in osteoblast like cells. The infrared assay could be extended to determine any type of phosphatase activity in other cells. It may serve as a metabolomic tool to monitor an overall phosphatase activity including acid phosphatases or other related enzymes.	[Ren, Zhongyuan; Le Duy Do; Bechkoff, Geraldine; Mebarek, Saida; Keloglu, Nermin; Ahamada, Saandia; Meena, Saurabh; Magne, David; Buchet, Rene] Univ Lyon, Villeurbanne, France; [Ren, Zhongyuan; Le Duy Do; Bechkoff, Geraldine; Mebarek, Saida; Keloglu, Nermin; Ahamada, Saandia; Meena, Saurabh; Magne, David; Buchet, Rene] Univ Lyon 1, F-69622 Villeurbanne, France; [Ren, Zhongyuan; Le Duy Do; Bechkoff, Geraldine; Mebarek, Saida; Keloglu, Nermin; Ahamada, Saandia; Meena, Saurabh; Magne, David; Buchet, Rene] INSA Lyon, Villeurbanne, France; [Ren, Zhongyuan; Le Duy Do; Bechkoff, Geraldine; Mebarek, Saida; Keloglu, Nermin; Ahamada, Saandia; Meena, Saurabh; Magne, David; Buchet, Rene] CPE Lyon, Villeurbanne, France; [Ren, Zhongyuan; Le Duy Do; Bechkoff, Geraldine; Mebarek, Saida; Keloglu, Nermin; Ahamada, Saandia; Meena, Saurabh; Magne, David; Buchet, Rene] Inst Chim & Biochim Mol & Supramol, Villeurbanne, France; [Ren, Zhongyuan; Le Duy Do; Bechkoff, Geraldine; Mebarek, Saida; Keloglu, Nermin; Ahamada, Saandia; Meena, Saurabh; Magne, David; Buchet, Rene] CNRS, UMR 5246, Villeurbanne, France; [Ren, Zhongyuan; Wu, Yuqing] Jilin Univ Changchun, State Key Lab Supramol Struct & Mat, Changchun 130012, Peoples R China; [Le Duy Do; Pikula, Slawomir] M Nencki Inst Expt Biol, Dept Biochem, PL-02093 Warsaw, Poland; [Le Duy Do; Pikula, Slawomir] Polish Acad Sci, PL-02093 Warsaw, Poland	UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Institut National des Sciences Appliquees de Lyon - INSA Lyon; Institut National des Sciences Appliquees de Lyon - INSA Lyon; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); Institut National des Sciences Appliquees de Lyon - INSA Lyon; Jilin University; Polish Academy of Sciences; Nencki Institute of Experimental Biology of the Polish Academy of Sciences; Polish Academy of Sciences	Buchet, R (corresponding author), Univ Lyon, Villeurbanne, France.	rbuchet@univ-lyon1.fr	Rene, Buchet/I-9781-2019; Mebarek, Saida/AAI-8237-2020	Rene, Buchet/0000-0002-7966-3856; DO, Le Duy/0000-0001-7664-533X; Pikula, Slawomir/0000-0003-4640-3094; Magne, David/0000-0002-6511-9390; Ren, Zhongyuan/0000-0002-0300-7801	China Scholarship Council; International PhD program in Neurobiology [06]; French Agency for the promotion of higher education and international mobility (Campus France) [27727TA]; CNRS International project of scientific cooperation (PICS) [5096]; Polish Ministry of Science and Higher Education [N401 140639]; European Union [264173]	China Scholarship Council(China Scholarship Council); International PhD program in Neurobiology; French Agency for the promotion of higher education and international mobility (Campus France); CNRS International project of scientific cooperation (PICS); Polish Ministry of Science and Higher Education(Ministry of Science and Higher Education, Poland); European Union(European Commission)	Mr. Zhongyuan Ren received a PhD scholarship from the China Scholarship Council http://en.csc.edu.cn. Mr. Le Duy Do is a recipient of the fellowship from the International PhD program in Neurobiology (project No 06 - collaborative PhD project between the Nencki Institute of Experimental Biology and Universite Lyon 1) http://neurophd.nencki.gov.pl. This research was supported by the following: the French Agency for the promotion of higher education and international mobility (Campus France) (Grant: Polonium No 27727TA), http://www.campusfrance.org/fr/; CNRS International project of scientific cooperation (PICS) (Grant No 5096) http://www.cnrs.fr/derci/spip.php?article51; Polish Ministry of Science and Higher Education (Grant No N401 140639) http://www.nauka.gov.pl/en/ and European Union Capacities Programme (Research potential) (Grant No EU FP7 Project Bio-imaging in research Innovation and education, GA No. 264173) http://bioimagine.nencki.gov.pl/en/?p = glowna&lng = en. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barth A, 2002, Q REV BIOPHYS, V35, P369, DOI 10.1017/S0033583502003815; Benard A, 2014, ANALYST, V139, P1044, DOI 10.1039/c3an01454a; Bhargava R, 2007, ANAL BIOANAL CHEM, V389, P1155, DOI 10.1007/s00216-007-1511-9; Bleicher KH, 2003, NAT REV DRUG DISCOV, V2, P369, DOI 10.1038/nrd1086; Bosch A, 2008, J CLIN MICROBIOL, V46, P2535, DOI 10.1128/JCM.02267-07; Bosch A, 2010, J BIOPHOTONICS, V3, P522, DOI 10.1002/jbio.201000027; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Buchet R, 2013, METHODS MOL BIOL, V1053, P27, DOI 10.1007/978-1-62703-562-0_3; COX RP, 1967, BIOCHEM J, V105, P155, DOI 10.1042/bj1050155; Dahl R, 2009, J MED CHEM, V52, P6919, DOI 10.1021/jm900383s; Derenne A, 2014, BBA-MOL CELL BIOL L, V1841, P1200, DOI 10.1016/j.bbalip.2013.10.010; Diem M, 2004, ANALYST, V129, P880, DOI 10.1039/b408952a; Diem M, 2009, APPL SPECTROSC, V63, p307A, DOI 10.1366/000370209789806894; Do L, 2012, ANAL BIOCHEM, V430, P32, DOI 10.1016/j.ab.2012.07.017; Flower KR, 2011, ANALYST, V136, P498, DOI 10.1039/c0an00564a; Gasper R, 2011, BBA-BIOMEMBRANES, V1808, P597, DOI 10.1016/j.bbamem.2010.11.033; Gasper R, 2010, BBA-MOL BASIS DIS, V1802, P1087, DOI 10.1016/j.bbadis.2010.07.012; Gasper R, 2009, BBA-BIOMEMBRANES, V1788, P1263, DOI 10.1016/j.bbamem.2009.02.016; Harvey TJ, 2007, ANALYST, V132, P292, DOI 10.1039/b618618a; HELM D, 1991, J GEN MICROBIOL, V137, P69, DOI 10.1099/00221287-137-1-69; Holton SE, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096878; Holton SE, 2011, ANALYST, V136, P2953, DOI 10.1039/c1an15112f; Krishna CM, 2006, BIOPOLYMERS, V82, P462, DOI 10.1002/bip.20485; Kumar S, 2013, ANALYST, V138, P4058, DOI 10.1039/c3an00241a; Lendl B, 1998, FRESEN J ANAL CHEM, V360, P717, DOI 10.1007/s002160050788; Lomashvili KA, 2008, KIDNEY INT, V73, P1024, DOI 10.1038/ki.2008.26; Matthaus C, 2008, METHOD CELL BIOL, V89, P275, DOI 10.1016/S0091-679X(08)00610-9; NAUMANN D, 1991, NATURE, V351, P81, DOI 10.1038/351081a0; Pereira TM, 2013, ANALYST, V138, P7094, DOI 10.1039/c3an00296a; Rebuffo CA, 2006, APPL ENVIRON MICROB, V72, P994, DOI 10.1128/AEM.72.2.994-1000.2006; Sergienko EA, 2010, NAT PROTOC, V5, P1431, DOI 10.1038/nprot.2010.86; Thouverey C, 2011, J PROTEOMICS, V74, P1123, DOI 10.1016/j.jprot.2011.04.005; TSUBOI M, 1957, J AM CHEM SOC, V79, P1351, DOI 10.1021/ja01563a026; Vileno B, 2010, BIOPHYS CHEM, V152, P164, DOI 10.1016/j.bpc.2010.09.004; Wang JH, 1998, BIOCHEMISTRY-US, V37, P11106, DOI 10.1021/bi980471m; WU LNY, 1993, J BIOL CHEM, V268, P25084; YAMAMOTO I, 1995, BBA-BIOMEMBRANES, V1233, P21, DOI 10.1016/0005-2736(94)00220-J; Zalatan JG, 2006, BIOCHEMISTRY-US, V45, P9788, DOI 10.1021/bi060847t; Zwielly A, 2009, ANALYST, V134, P294, DOI 10.1039/b805223a	39	11	11	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2015	10	3							e0120087	10.1371/journal.pone.0120087	http://dx.doi.org/10.1371/journal.pone.0120087			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9BN	25785438	Green Published, gold, Green Submitted			2022-12-27	WOS:000352138500154
J	Schendzielorz, T; Schirmer, K; Stolte, P; Stengl, M				Schendzielorz, Thomas; Schirmer, Katja; Stolte, Paul; Stengl, Monika			Octopamine Regulates Antennal Sensory Neurons via Daytime-Dependent Changes in cAMP and IP3 Levels in the Hawkmoth Manduca sexta	PLOS ONE			English	Article							OLFACTORY RECEPTOR NEURONS; UNPAIRED MEDIAN NEURONS; CENTRAL-NERVOUS-SYSTEM; PHEROMONE-RESPONSE; CIRCADIAN-RHYTHMS; MODULATORY ACTION; IMMUNOREACTIVE NEURONS; SUBESOPHAGEAL GANGLION; PHOTOPERIOD CUES; BIOGENIC-AMINES	The biogenic amine octopamine (OA) mediates reward signals in olfactory learning and memory as well as circadian rhythms of sleep and activity. In the crepuscular hawkmoth Manduca sexta, OA changed pheromone detection thresholds daytime-dependently, suggesting that OA confers circadian control of olfactory transduction. Thus, with enzyme-linked immunosorbent assays we searched hawkmoth antennae for daytime-dependent changes in the concentration of OA and its respective second messengers. Antennal stimulation with OA raised cAMP-and IP3 levels. Furthermore, antennae expressed daytime-dependent changes in the concentration of OA, with maxima at Zeitgebertime (ZT) 20 when moths were active and also maximal concentrations of cAMP occurred. Maximal IP3 levels at ZT 18 and 23 correlated with maximal flight activity of male moths, while minimal IP3 levels at dusk correlated with peaks of feeding activity. Half maximal effective concentration (EC50) for activation of the OA-receptor decreased during the moth's activity phase suggesting daytime-dependent changes in OA receptor sensitivity. With an antiserum against tyramine, the precursor of OA, two centrifugal neurons were detected projecting out into the sensory cell layer of the antenna, possibly mediating more rapid stimulus-dependent OA actions. Indeed, in fast kinetic assays OA receptor stimulation increased cAMP concentrations within 50 msec. Thus, we hypothesize that fast, stimulus-dependent centrifugal control of OA-release in the antenna occurs. Additional slow systemic OA actions might be based upon circadian release of OA into the hemolymph mediating circadian rhythms of antennal second messenger levels. The resulting rhythms of odor sensitivity are suggested to underlie circadian rhythms in odor-mediated behavior.	[Schendzielorz, Thomas; Schirmer, Katja; Stolte, Paul; Stengl, Monika] Univ Kassel, Biol, Anim Physiol, D-34132 Kassel, Germany	Universitat Kassel	Stengl, M (corresponding author), Univ Kassel, Biol, Anim Physiol, D-34132 Kassel, Germany.	stengl@uni-kassel.d			Deutsche Forschungsgemeinschaft [STE531/21-1 TS]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This study was supported by the Deutsche Forschungsgemeinschaft STE531/21-1 TS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balfanz S, 2005, J NEUROCHEM, V93, P440, DOI 10.1111/j.1471-4159.2005.03034.x; BELL RA, 1976, ANN ENTOMOL SOC AM, V69, P365, DOI 10.1093/aesa/69.2.365; Bischof LJ, 2004, INSECT BIOCHEM MOLEC, V34, P511, DOI 10.1016/j.ibmb.2004.02.003; BOEKHOFF I, 1993, INSECT BIOCHEM MOLEC, V23, P757, DOI 10.1016/0965-1748(93)90063-X; Braunig P, 2001, ADV INSECT PHYSIOL, V28, P185, DOI 10.1016/S0065-2806(01)28011-4; BREER H, 1990, NATURE, V345, P65, DOI 10.1038/345065a0; Crocker A, 2010, NEURON, V65, P670, DOI 10.1016/j.neuron.2010.01.032; Dacks AM, 2005, J COMP NEUROL, V488, P255, DOI 10.1002/cne.20556; Dacks AM, 2006, INSECT BIOCHEM MOLEC, V36, P741, DOI 10.1016/j.ibmb.2006.07.002; DUDAI Y, 1987, J COMP PHYSIOL A, V161, P739, DOI 10.1007/BF00605015; ECKERT M, 1992, J COMP NEUROL, V322, P1, DOI 10.1002/cne.903220102; Evans P.D., 1980, Advances in Insect Physiology, V15, P317, DOI 10.1016/S0065-2806(08)60143-5; Farooqui T, 2003, J NEUROSCI, V23, P5370; Farooqui T, 2007, NEUROCHEM RES, V32, P1511, DOI 10.1007/s11064-007-9344-7; Field LH, 2008, J INSECT PHYSIOL, V54, P240, DOI 10.1016/j.jinsphys.2007.09.006; Flecke C, 2010, J EXP BIOL, V213, P842, DOI 10.1242/jeb.032839; Flecke C, 2009, J COMP PHYSIOL A, V195, P529, DOI 10.1007/s00359-009-0429-4; Goyret J, 2006, J EXP BIOL, V209, P1585, DOI 10.1242/jeb.02169; Goyret J, 2008, NATURWISSENSCHAFTEN, V95, P569, DOI 10.1007/s00114-008-0350-7; Grohmann L, 2003, J NEUROCHEM, V86, P725, DOI 10.1046/j.1471-4159.2003.01876.x; Grosmaitre X, 2001, CHEM SENSES, V26, P653, DOI 10.1093/chemse/26.6.653; Guerenstein PG, 2004, NATURWISSENSCHAFTEN, V91, P329, DOI 10.1007/s00114-004-0532-x; HAMMER M, 1995, J NEUROSCI, V15, P1617, DOI 10.1523/JNEUROSCI.15-03-01617.1995; Hammer M, 1998, LEARN MEMORY, V5, P146; HERTEL W, 1992, ACTA BIOL HUNG, V43, P113; Homberg U, 2003, CHRONOBIOL INT, V20, P577, DOI 10.1081/CBI-120022412; ITAGAKI H, 1988, ANN ENTOMOL SOC AM, V81, P798, DOI 10.1093/aesa/81.5.798; Kononenko NL, 2009, J COMP NEUROL, V512, P433, DOI 10.1002/cne.21911; Krannich S, 2008, J NEUROPHYSIOL, V100, P2866, DOI 10.1152/jn.01400.2007; KREISSL S, 1994, J COMP NEUROL, V348, P583, DOI 10.1002/cne.903480408; Krishnan B, 1999, NATURE, V400, P375, DOI 10.1038/22566; LEHMAN H K, 1990, Society for Neuroscience Abstracts, V16, P1334; LINGREN PD, 1977, ANN ENTOMOL SOC AM, V70, P161, DOI 10.1093/aesa/70.2.161; LINN CE, 1992, ARCH INSECT BIOCHEM, V20, P265, DOI 10.1002/arch.940200404; LINN CE, 1986, ARCH INSECT BIOCHEM, V3, P161, DOI 10.1002/arch.940030206; LINN CE, 1992, ARCH INSECT BIOCHEM, V20, P285, DOI 10.1002/arch.940200405; Linn CE, 1996, J INSECT PHYSIOL, V42, P881, DOI 10.1016/0022-1910(96)00034-0; Madden AH, 1945, DC TECHNICAL BULLETI, P896; MERCER AR, 1982, J COMP PHYSIOL, V145, P363, DOI 10.1007/BF00619340; Nakagawa T, 2009, CURR OPIN NEUROBIOL, V19, P284, DOI 10.1016/j.conb.2009.07.015; Nolte A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062648; Ohtani A, 2006, INSECT MOL BIOL, V15, P763, DOI 10.1111/j.1365-2583.2006.00676.x; Page TL, 2003, J INSECT PHYSIOL, V49, P697, DOI 10.1016/S0022-1910(03)00071-4; Pfluger HJ, 2004, ACTA BIOL HUNG, V55, P3, DOI 10.1556/ABiol.55.2004.1-4.2; Plautz JD, 1997, SCIENCE, V278, P1632, DOI 10.1126/science.278.5343.1632; Pophof B, 2000, J COMP PHYSIOL A, V186, P307, DOI 10.1007/s003590050431; Pophof B, 2002, J COMP PHYSIOL A, V188, P659, DOI 10.1007/s00359-002-0343-5; Riffell JA, 2008, P NATL ACAD SCI USA, V105, P3404, DOI 10.1073/pnas.0709811105; Riffell JA, 2009, CURR BIOL, V19, P335, DOI 10.1016/j.cub.2009.01.041; Roeder T, 1999, PROG NEUROBIOL, V59, P533, DOI 10.1016/S0301-0082(99)00016-7; Rosen WQ, 2003, J BIOL RHYTHM, V18, P402, DOI 10.1177/0748730403256869; Rosen WQ, 2002, ARCH INSECT BIOCHEM, V50, P21, DOI 10.1002/arch.10026; Rymer J, 2007, J BIOL RHYTHM, V22, P43, DOI 10.1177/0748730406295462; Saifullah ASM, 2009, J BIOL RHYTHM, V24, P144, DOI 10.1177/0748730408331166; SANES JR, 1976, DEV BIOL, V51, P282, DOI 10.1016/0012-1606(76)90144-5; SASAKI M, 1984, PHYSIOL ENTOMOL, V9, P315, DOI 10.1111/j.1365-3032.1984.tb00713.x; Sato K, 2008, NATURE, V452, P1002, DOI 10.1038/nature06850; Schendzielorz T, 2012, J BIOL RHYTHM, V27, P388, DOI 10.1177/0748730412456265; Schuckel J, 2007, CELL TISSUE RES, V330, P271, DOI 10.1007/s00441-007-0471-x; Schwaerzel M, 2003, J NEUROSCI, V23, P10495, DOI 10.1523/jneurosci.23-33-10495.2003; Silvegren G, 2005, J INSECT PHYSIOL, V51, P277, DOI 10.1016/j.jinsphys.2004.11.013; Sinakevitch I, 2005, J COMP NEUROL, V488, P233, DOI 10.1002/cne.20572; SOMBATI S, 1984, J NEUROBIOL, V15, P481, DOI 10.1002/neu.480150607; SPORHASEEICHMANN U, 1992, CELL TISSUE RES, V268, P287, DOI 10.1007/BF00318798; Stengl M, 2001, CELL TISSUE RES, V304, P409, DOI 10.1007/s004410000336; STENGL M, 1994, J COMP PHYSIOL A, V174, P187; Stengl M, 2013, J COMP PHYSIOL A, V199, P897, DOI 10.1007/s00359-013-0837-3; Stengl M, 2010, FRONT CELL NEUROSCI, V4, DOI 10.3389/fncel.2010.00133; STEVENSON PA, 1995, COMP BIOCHEM PHYS A, V110, P203, DOI 10.1016/0300-9629(94)00152-J; Tanoue S, 2004, CURR BIOL, V14, P638, DOI 10.1016/j.cub.2004.04.009; Thom C, 2004, J CHEM ECOL, V30, P1285, DOI 10.1023/B:JOEC.0000030298.77377.7d; Tomioka K, 2012, J COMP PHYSIOL B, V182, P729, DOI 10.1007/s00360-012-0651-1; Verlinden H, 2010, J INSECT PHYSIOL, V56, P854, DOI 10.1016/j.jinsphys.2010.05.018; VonNickischRosenegk E, 1996, INSECT BIOCHEM MOLEC, V26, P817, DOI 10.1016/S0965-1748(96)00031-8; Wicher D, 2008, NATURE, V452, P1007, DOI 10.1038/nature06861; Yu WJ, 2006, J CELL SCI, V119, P4793, DOI 10.1242/jcs.03174; Zhou XJ, 2005, J BIOL RHYTHM, V20, P237, DOI 10.1177/0748730405274451; ZIEGELBERGER G, 1990, J NEUROSCI, V10, P1217	78	20	22	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2015	10	3							e0121230	10.1371/journal.pone.0121230	http://dx.doi.org/10.1371/journal.pone.0121230			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9BN	25785721	gold, Green Published, Green Submitted			2022-12-27	WOS:000352138500204
J	Ascenzi, P; Leboffe, L; di Masi, A; Trezza, V; Fanali, G; Gioia, M; Coletta, M; Fasano, M				Ascenzi, Paolo; Leboffe, Loris; di Masi, Alessandra; Trezza, Viviana; Fanali, Gabriella; Gioia, Magda; Coletta, Massimo; Fasano, Mauro			Ligand Binding to the FA3-FA4 Cleft Inhibits the Esterase-Like Activity of Human Serum Albumin	PLOS ONE			English	Article							PSEUDO-ENZYMATIC HYDROLYSIS; PLASMA-CONCENTRATIONS; INDOXYL SULFATE; NITROPHENYL ESTERS; PRACTICAL ASPECTS; INDIVIDUAL STEPS; PH-DEPENDENCE; PROPOFOL; DIAZEPAM; MECHANISM	The hydrolysis of 4-nitrophenyl esters of hexanoate (NphOHe) and decanoate (NphODe) by human serum albumin (HSA) at Tyr411, located at the FA3-FA4 site, has been investigated between pH 5.8 and 9.5, at 22.0 degrees C. Values of K-s, k(+2), and k(+2)/K-s obtained at [HSA] >= 5x[NphOXx] and [NphOXx] >= 5x[HSA] (Xx is NphOHe or NphODe) match very well each other; moreover, the deacylation step turns out to be the rate limiting step in catalysis (i.e., k(+3) << k(+2)). The pH dependence of the kinetic parameters for the hydrolysis of NphOHe and NphODe can be described by the acidic pK(a)-shift of a single amino acid residue, which varies from 8.9 in the free HSA to 7.6 and 7.0 in the HSA: NphOHe and HSA: NphODe complex, respectively; the pK>(a)-shift appears to be correlated to the length of the fatty acid tail of the substrate. The inhibition of the HSA-Tyr411-catalyzed hydrolysis of NphOHe, NphODe, and 4-nitrophenyl myristate (NphOMy) by five inhibitors (i.e., diazepam, diflunisal, ibuprofen, 3-indoxyl-sulfate, and propofol) has been investigated at pH 7.5 and 22.0 degrees C, resulting competitive. The affinity of diazepam, diflunisal, ibuprofen, 3-indoxyl-sulfate, and propofol for HSA reflects the selectivity of the FA3-FA4 cleft. Under conditions where Tyr411 is not acylated, the molar fraction of diazepam, diflunisal, ibuprofen, and 3-indoxylsulfate bound to HSA is higher than 0.9 whereas the molar fraction of propofol bound to HSA is ca. 0.5.	[Ascenzi, Paolo] Univ Rome Tre, Interdept Lab Electron Microscopy, I-00146 Rome, Italy; [Leboffe, Loris; di Masi, Alessandra; Trezza, Viviana] Univ Rome Tre, Dept Sci, I-00146 Rome, Italy; [Fanali, Gabriella; Fasano, Mauro] Univ Insubria, Dept Theoret & Appl Sci, Biomed Res Div, I-21052 Busto Arsizio, VA, Italy; [Gioia, Magda; Coletta, Massimo] Univ Roma Tor Vergata, Dept Clin Sci & Translat Med, I-00133 Rome, Italy; [Gioia, Magda; Coletta, Massimo] Interuniv Consortium Res Chem Met Biol Syst, I-70126 Bari, Italy	Roma Tre University; Italfarmaco; Roma Tre University; University of Insubria; University of Rome Tor Vergata	Ascenzi, P (corresponding author), Univ Rome Tre, Interdept Lab Electron Microscopy, Via Vasca Navale 79, I-00146 Rome, Italy.	ascenzi@uniroma3.it	Gioia, Magda/AAD-4781-2022; Leboffe, Loris/K-7838-2016; di Masi, Alessandra/K-2300-2018; Coletta, Massimo/N-9049-2015; Gioia, Magda/ABF-8909-2020; Fasano, Mauro/A-7100-2008; Coletta, Massimiliano/GSN-5927-2022; Trezza, Viviana/K-4418-2016	Leboffe, Loris/0000-0001-8272-1896; Fasano, Mauro/0000-0003-0628-5871; Gioia, Magda/0000-0003-0352-3547; COLETTA, Massimiliano/0000-0002-5489-9467	Ministero dell'Istruzione; dell'Universita e della Ricerca of Italy (Universita Roma Tre, Roma, Italy [CLAR 2014]; Consorzio Interuniversitario Italiano per l'Argentina [CUIA 2014]	Ministero dell'Istruzione(Ministry of Education, Universities and Research (MIUR)); dell'Universita e della Ricerca of Italy (Universita Roma Tre, Roma, Italy; Consorzio Interuniversitario Italiano per l'Argentina	This work was supported by Ministero dell'Istruzione, dell'Universita e della Ricerca of Italy (Universita Roma Tre, Roma, Italy; CLAR 2014 to PA) and Consorzio Interuniversitario Italiano per l'Argentina (CUIA 2014 to PA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSON SR, 1968, J BIOL CHEM, V243, P2918; ANTONINI E, 1981, J BIOL CHEM, V256, P2449; ASCENZI P, 1987, BIOCHEM EDUC, V15, P134, DOI 10.1016/0307-4412(87)90043-4; Ascenzi P, 2013, IUBMB LIFE, V65, P836, DOI 10.1002/iub.1208; Ascenzi P, 2012, BIOCHEM BIOPH RES CO, V424, P451, DOI 10.1016/j.bbrc.2012.06.131; Ascenzi P, 2012, BIOCHEM BIOPH RES CO, V422, P219, DOI 10.1016/j.bbrc.2012.04.111; Bhattacharya AA, 2000, J BIOL CHEM, V275, P38731, DOI 10.1074/jbc.M005460200; Buller AR, 2013, P NATL ACAD SCI USA, V110, pE653, DOI 10.1073/pnas.1221050110; Cheruvallath VK, 1997, J PHARMACEUT BIOMED, V15, P1719, DOI 10.1016/S0731-7085(96)01956-5; Curry S, 2009, DRUG METAB PHARMACOK, V24, P342, DOI 10.2133/dmpk.24.342; Davilas A, 2006, J PHARM PHARMACOL, V58, P1467, DOI 10.1211/jpp.58.11.0007; Devine E, 2014, TOXINS, V6, P416, DOI 10.3390/toxins6020416; Diaz N, 2001, J MED CHEM, V44, P250, DOI 10.1021/jm000340v; Fanali G, 2012, MOL ASPECTS MED, V33, P209, DOI 10.1016/j.mam.2011.12.002; Fanali G, 2011, IUBMB LIFE, V63, P446, DOI 10.1002/iub.466; Ghuman J, 2005, J MOL BIOL, V353, P38, DOI 10.1016/j.jmb.2005.07.075; HOLLAWAY MR, 1971, EUR J BIOCHEM, V24, P332, DOI 10.1111/j.1432-1033.1971.tb19691.x; JANSSEN GME, 1985, J INT MED RES, V13, P68, DOI 10.1177/030006058501300110; KANTO J, 1989, CLIN PHARMACOKINET, V17, P308, DOI 10.2165/00003088-198917050-00002; KANTO J, 1974, PSYCHOPHARMACOLOGIA, V36, P123, DOI 10.1007/BF00421784; Khan MS, 2014, BASIC CLIN PHARMACOL, V115, P565, DOI 10.1111/bcpt.12277; Kragh-Hansen U, 2002, BIOL PHARM BULL, V25, P695, DOI 10.1248/bpb.25.695; Kragh-Hansen U, 2013, BBA-GEN SUBJECTS, V1830, P5535, DOI 10.1016/j.bbagen.2013.03.015; KRAGHHANSEN U, 1981, PHARMACOL REV, V33, P17; KURONO Y, 1992, CHEM PHARM BULL, V40, P2169; LASKA EM, 1986, CLIN PHARMACOL THER, V40, P1, DOI 10.1038/clpt.1986.129; Liyasova MS, 2010, BIOCHEM PHARMACOL, V79, P784, DOI 10.1016/j.bcp.2009.10.007; Lockridge O, 2008, J BIOL CHEM, V283, P22582, DOI 10.1074/jbc.M802555200; Macquaire V, 2002, ACTA ANAESTH SCAND, V46, P1010, DOI 10.1034/j.1399-6576.2002.460814.x; MEANS GE, 1975, BIOCHEMISTRY-US, V14, P4989, DOI 10.1021/bi00693a031; MOJAVERIAN P, 1985, PHARMACOTHERAPY, V5, P336; OHTA N, 1983, J PHARM SCI, V72, P385, DOI 10.1002/jps.2600720416; PELLER L, 1959, J AM CHEM SOC, V81, P5907, DOI 10.1021/ja01531a017; Peters Jr T., 1996, ALL ALBUMIN BIOCH GE, DOI [10.1021/jp076583h, DOI 10.1021/JP076583H]; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; REIDENBERG MM, 1978, CLIN PHARMACOL THER, V23, P371; RUTHERFORD DM, 1978, BRIT J CLIN PHARMACO, V6, P69, DOI 10.1111/j.1365-2125.1978.tb01684.x; Sakai T, 2001, PHARMACEUT RES, V18, P520, DOI 10.1023/A:1011014629551; Sakurai Y, 2004, PHARM RES-DORDR, V21, P285, DOI 10.1023/B:PHAM.0000016241.84630.06; Sawas AH, 2004, BIOCHEMISTRY-US, V43, P12675, DOI 10.1021/bi035941d; STANFEL LA, 1986, CLIN CHEM, V32, P938; Sugio S, 1999, PROTEIN ENG, V12, P439, DOI 10.1093/protein/12.6.439; Tempero KF, 1977, BR J CLIN PHARM, V1, p31S; WALKER JE, 1976, FEBS LETT, V66, P173, DOI 10.1016/0014-5793(76)80496-6; Watanabe H, 2000, BIOCHEM J, V349, P813, DOI 10.1042/bj3490813; Yang F, 2007, J STRUCT BIOL, V157, P348, DOI 10.1016/j.jsb.2006.08.015	46	7	8	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2015	10	3							e0120603	10.1371/journal.pone.0120603	http://dx.doi.org/10.1371/journal.pone.0120603			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD9NQ	25790235	Green Published, Green Submitted, gold			2022-12-27	WOS:000351425400166
J	DaCosta, RS; Kulbatski, I; Lindvere-Teene, L; Starr, D; Blackmore, K; Silver, JI; Opoku, J; Wu, YC; Medeiros, PJ; Xu, W; Xu, LZ; Wilson, BC; Rosen, C; Linden, R				DaCosta, Ralph S.; Kulbatski, Iris; Lindvere-Teene, Liis; Starr, Danielle; Blackmore, Kristina; Silver, Jason I.; Opoku, Julie; Wu, Yichao Charlie; Medeiros, Philip J.; Xu, Wei; Xu, Lizhen; Wilson, Brian C.; Rosen, Cheryl; Linden, Ron			Point-of-Care Autofluorescence Imaging for Real-Time Sampling and Treatment Guidance of Bioburden in Chronic Wounds: First-in-Human Results	PLOS ONE			English	Article							DEEP TISSUE; INFECTION; MICROBIOLOGY; COLONIZATION; PORPHYRIN; BACTERIA; BIOSYNTHESIS; BIOLOGY; HOST	Background Traditionally, chronic wound infection is diagnosed by visual inspection under white light and microbiological sampling, which are subjective and suboptimal, respectively, thereby delaying diagnosis and treatment. To address this, we developed a novel handheld, fluorescence imaging device (PRODIGI) that enables non-contact, real-time, high-resolution visualization and differentiation of key pathogenic bacteria through their endogenous autofluorescence, as well as connective tissues in wounds. Methods and Findings This was a two-part Phase I, single center, non-randomized trial of chronic wound patients (male and female, >= 18 years; UHN REB #09-0015-A for part 1; UHN REB #12-5003 for part 2; clinicaltrials.gov Identifier: NCT01378728 for part 1 and NCT01651845 for part 2). Part 1 (28 patients; 54% diabetic foot ulcers, 46% non-diabetic wounds) established the feasibility of autofluorescence imaging to accurately guide wound sampling, validated against blinded, gold standard swab-based microbiology. Part 2 (12 patients; 83.3% diabetic foot ulcers, 16.7% non-diabetic wounds) established the feasibility of autofluorescence imaging to guide wound treatment and quantitatively assess treatment response. We showed that PRODIGI can be used to guide and improve microbiological sampling and debridement of wounds in situ, enabling diagnosis, treatment guidance and response assessment in patients with chronic wounds. PRODIGI is safe, easy to use and integrates into the clinical workflow. Clinically significant bacterial burden can be detected in seconds, quantitatively tracked over days-to-months and their biodistribution mapped within the wound bed, periphery, and other remote areas. Conclusions PRODIGI represents a technological advancement in wound sampling and treatment guidance for clinical wound care at the point-of-care.	[DaCosta, Ralph S.; Kulbatski, Iris; Lindvere-Teene, Liis; Starr, Danielle; Silver, Jason I.; Wu, Yichao Charlie; Medeiros, Philip J.; Wilson, Brian C.] Univ Hlth Network, Princess Margaret Canc Ctr, Toronto, ON M5G 1L7, Canada; [DaCosta, Ralph S.; Kulbatski, Iris; Lindvere-Teene, Liis; Starr, Danielle; Silver, Jason I.; Wu, Yichao Charlie; Medeiros, Philip J.; Wilson, Brian C.] Univ Toronto, Toronto, ON M5G 1L7, Canada; [DaCosta, Ralph S.] Univ Hlth Network, Techna Inst Adv Technol Hlth, Toronto, ON M5G 1L5, Canada; [Blackmore, Kristina] Mt Sinai Hosp, Lunenfeld Tanenbaum Res Inst, Prosserman Ctr Hlth Res, Toronto, ON M5T 3L9, Canada; [Rosen, Cheryl] Univ Hlth Network, Toronto Western Hosp, Dermatol, Toronto, ON M5T 2S8, Canada; [Opoku, Julie; Linden, Ron] Judy Dan Treatment & Res Ctr, Toronto, ON M2R 1N5, Canada; [Xu, Wei] Univ Hlth Network, Dept Biostat, Toronto, ON M5G 2M9, Canada; [Xu, Wei; Xu, Lizhen] Univ Toronto, Dalla Lana Sch Publ Hlth, Toronto, ON M5T 3M7, Canada	University of Toronto; University Toronto Affiliates; University Health Network Toronto; Princess Margaret Cancer Centre; University of Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto	DaCosta, RS (corresponding author), Univ Hlth Network, Princess Margaret Canc Ctr, Toronto Med Discovery Tower,15th Floor, Toronto, ON M5G 1L7, Canada.	rdacosta@uhnres.utoronto.ca	xu, wei/HHD-2891-2022	Wilson, Brian C./0000-0001-5543-666X; Blackmore, Kristina/0000-0001-6662-6741	Canadian Institutes of Health Research operating grant (CIHR MOP) [93578]; Ontario Centres of Excellence [MR60015-08]; Health Technologies Exchange, Biodiscovery Toronto [BDT04-035-S3A]; Ontario Ministry of Health and Long Term Care (OMOHLTC); Canadian Institute for Photonic Innovation, Cancer Care Ontario Research Chair in Cancer Imaging	Canadian Institutes of Health Research operating grant (CIHR MOP)(Canadian Institutes of Health Research (CIHR)); Ontario Centres of Excellence; Health Technologies Exchange, Biodiscovery Toronto; Ontario Ministry of Health and Long Term Care (OMOHLTC)(Ministry of Health and Long-Term Care, Ontario); Canadian Institute for Photonic Innovation, Cancer Care Ontario Research Chair in Cancer Imaging	This work was funded, in part, by a Canadian Institutes of Health Research operating grant (CIHR MOP #93578), Ontario Centres of Excellence (MR60015-08), Health Technologies Exchange, Biodiscovery Toronto (project #BDT04-035-S3A), Canadian Institute for Photonic Innovation, Cancer Care Ontario Research Chair in Cancer Imaging to RSD and by the Ontario Ministry of Health and Long Term Care (OMOHLTC). No funding for this project (including the gathering, analysis or publication of any data obtained from it) or salary support for RSD or LT was provided by the company for any part of this project. No funding bodies had any role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angel DE, 2011, INT WOUND J, V8, P176, DOI 10.1111/j.1742-481X.2010.00765.x; Armstrong D G, 1998, Clin Podiatr Med Surg, V15, P105; Aukhil I, 2000, PERIODONTOL 2000, V22, P44, DOI 10.1034/j.1600-0757.2000.2220104.x; Bates-Jensen B M, 1997, Adv Wound Care, V10, P65; Bergen GA, 1998, CRIT CARE CLIN, V14, P71, DOI 10.1016/S0749-0704(05)70382-1; Bill T J, 2001, Ostomy Wound Manage, V47, P34; Bowler PG, 2001, CLIN MICROBIOL REV, V14, P244, DOI 10.1128/CMR.14.2.244-269.2001; Bowler PG, 2002, ANN MED, V34, P419, DOI 10.1080/078538902321012360; Broughton G, 2006, PLAST RECONSTR SURG, V117, p6S, DOI 10.1097/01.prs.0000225429.76355.dd; Browne A C, 2001, Ostomy Wound Manage, V47, P44; BROWNE RH, 1995, STAT MED, V14, P1933, DOI 10.1002/sim.4780141709; Burke JP, 2003, NEW ENGL J MED, V348, P651, DOI 10.1056/NEJMhpr020557; Casadevall A, 2000, INFECT IMMUN, V68, P6511, DOI 10.1128/IAI.68.12.6511-6518.2000; CODY YS, 1987, APPL ENVIRON MICROB, V53, P928, DOI 10.1128/AEM.53.5.928-934.1987; COX CD, 1985, INFECT IMMUN, V48, P130, DOI 10.1128/IAI.48.1.130-138.1985; Cunha BA, 2007, INFECT DIS CLIN N AM, V21, P1137, DOI 10.1016/j.idc.2007.09.004; Cutting Keith F, 2004, Br J Community Nurs, V9, pS6; Cutting KF, 2005, OSTOMY WOUND MANAG, V51, P28; DaCosta RS, 2003, PHOTOCHEM PHOTOBIOL, V78, P384, DOI 10.1562/0031-8655(2003)078<0384:MFEMRT>2.0.CO;2; Davies CE, 2007, WOUND REPAIR REGEN, V15, P17, DOI 10.1111/j.1524-475X.2006.00180.x; Dietel W, 2007, J PHOTOCH PHOTOBIO B, V86, P77, DOI 10.1016/j.jphotobiol.2006.07.006; Diggle P., 2002, ANAL LONGITUDINAL DA, DOI DOI 10.2307/2983303; Dow G, 1999, Ostomy Wound Manage, V45, P23; Edwards R, 2004, CURR OPIN INFECT DIS, V17, P91, DOI 10.1097/00001432-200404000-00004; Flanagan Madeleine, 2003, Ostomy Wound Manage, V49, P28; Gardner S E, 2001, Ostomy Wound Manage, V47, P40; Gardner SE, 2001, WOUND REPAIR REGEN, V9, P178, DOI 10.1046/j.1524-475x.2001.00178.x; Griswold A, 2008, NATURE ED, V1; Haesler E., 2019, PREVENTION TREATMENT; Haghpanah S, 2006, ARCH PHYS MED REHAB, V87, P1396, DOI 10.1016/j.apmr.2006.06.014; Harding K, 2000, Adv Skin Wound Care, V13, P215; Harding K, 2000, ADV SKIN WOUND CARE, V13, P215; Harding KG, 2002, BRIT MED J, V324, P160, DOI 10.1136/bmj.324.7330.160; Jeffcoate WJ, 2004, DIABETES-METAB RES, V20, pS78, DOI 10.1002/dmrr.476; KJELDSTAD B, 1985, ADV EXP MED BIOL, V193, P155; Lieber MLA, 1998, 23 SUGI, V23; Lipsky BA, 2012, CLIN INFECT DIS, V54, pE132, DOI [10.1093/cid/cis460, 10.1093/cid/cis346]; Liu XW, 2006, IEEE T IMAGE PROCESS, V15, P3066, DOI 10.1109/TIP.2006.877511; Liu Y, 2009, DIABETES CARE, V32, P117, DOI [10.2337/dc08-0763, 10.2337/dc09-1394]; Martin JM, 2010, J INVEST DERMATOL, V130, P38, DOI 10.1038/jid.2009.221; McCarty SM, 2012, WOUND REPAIR REGEN, V20, P125, DOI 10.1111/j.1524-475X.2012.00763.x; Meyer JM, 2000, ARCH MICROBIOL, V174, P135, DOI 10.1007/s002030000188; Moore Z, 2007, NURS STAND, V21, P72; Moore Z, 2007, NURS STAND, V21, P70; Moore Zena, 2007, Nurs Stand, V21, ppassim; Mueller C, 2006, GUT, V55, P276, DOI 10.1136/gut.2004.054098; MURRAY P R, 1985, Diagnostic Microbiology and Infectious Disease, V3, p9S, DOI 10.1016/0732-8893(85)90048-3; Mutluoglu M, 2012, J DIABETES COMPLICAT, V26, P225, DOI 10.1016/j.jdiacomp.2012.03.015; Nitzan Y, 2004, PHOTOCH PHOTOBIO SCI, V3, P430, DOI 10.1039/b315633h; Papasian C J, 1997, Crit Care Nurs Q, V20, P44; Pellizzer G, 2001, DIABETIC MED, V18, P822, DOI 10.1046/j.1464-5491.2001.00584.x; PHILIPPD.WK, 1973, ENZYME, V16, P57, DOI 10.1159/000459362; Queen D, 2012, INT WOUND J, V9, P349, DOI 10.1111/j.1742-481X.2012.01053.x; SAPICO FL, 1986, DIAGN MICR INFEC DIS, V5, P31, DOI 10.1016/0732-8893(86)90089-1; Schaffer CJ, 1996, INT REV CYTOL, V169, P151, DOI 10.1016/S0074-7696(08)61986-5; Sibbald R Gary, 2006, Adv Skin Wound Care, V19, P447, DOI 10.1097/00129334-200610000-00012; Spear M., 2014, WOUND CARE ADVISOR, V3, P23; Starr Sue, 2003, Nurs Times, V99, P57; Steed DL, 1996, J AM COLL SURGEONS, V183, P61; Stone FM, 1932, J GEN PHYSIOL, V15, P629, DOI 10.1085/jgp.15.6.629; Stremitzer Stefan, 2007, Int Wound J, V4, P156, DOI 10.1111/j.1742-481X.2007.00334.x; Sussman C., 2012, WOUND CARE COLLABORA, V4th; Thomas D R, 1997, Adv Wound Care, V10, P96; Thomas DW, 2002, BRIT J SURG, V89, P1203, DOI 10.1046/j.1365-2168.2002.02181.x; Warriner Robert, 2005, Adv Skin Wound Care, V18 Suppl 1, P2, DOI 10.1097/00129334-200510001-00001; White RJ, 2006, OSTOMY WOUND MANAG, V52, P50; Wu YC, 2014, J BIOMED OPT, V19, DOI 10.1117/1.JBO.19.8.085002; Xu L, 2007, DIABETES CARE, V30, P378, DOI 10.2337/dc06-1383	68	49	49	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2015	10	3							e0116623	10.1371/journal.pone.0116623	http://dx.doi.org/10.1371/journal.pone.0116623			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD9NQ	25790480	Green Published, Green Submitted, gold			2022-12-27	WOS:000351425400019
J	Narsale, AA; Enos, RT; Puppa, MJ; Chatterjee, S; Murphy, EA; Fayad, R; O'Pena, M; Durstine, JL; Carson, JA				Narsale, Aditi A.; Enos, Reilly T.; Puppa, Melissa J.; Chatterjee, Saurabh; Murphy, E. Angela; Fayad, Raja; O'Pena, Majorette; Durstine, J. Larry; Carson, James A.			Liver Inflammation and Metabolic Signaling in Apc(Min/+) Mice: The Role of Cachexia Progression	PLOS ONE			English	Article							UNFOLDED PROTEIN RESPONSE; CANCER CACHEXIA; COLORECTAL-CANCER; GLYCOGEN-SYNTHESIS; APCMIN/+ MOUSE; KAPPA-B; INTERLEUKIN-6; INFILTRATION; ACTIVATION; EXPRESSION	The Apc(Min/+) mouse exhibits an intestinal tumor associated loss of muscle and fat that is accompanied by chronic inflammation, insulin resistance and hyperlipidemia. Since the liver governs systemic energy demands through regulation of glucose and lipid metabolism, it is likely that the liver is a pathological target of cachexia progression in the Apc(Min/+) mouse. The purpose of this study was to determine if cancer and the progression of cachexia affected liver endoplasmic reticulum (ER)-stress, inflammation, metabolism, and protein synthesis signaling. The effect of cancer (without cachexia) was examined in wild-type and weight-stable Apc(Min/+) mice. Cachexia progression was examined in weight-stable, pre-cachectic, and severely-cachectic Apc(Min/+) mice. Livers were analyzed for morphology, glycogen content, ER-stress, inflammation, and metabolic changes. Cancer induced hepatic expression of ER-stress markers BiP (binding immunoglobulin protein), IRE-1 alpha (endoplasmic reticulum to nucleus signaling 1), and inflammatory intermediate STAT-3 (signal transducer and activator of transcription 3). While gluconeogenic enzyme phosphoenolpyruvate carboxykinase (PEPCK) mRNA expression was suppressed by cancer, glycogen content or protein synthesis signaling remained unaffected. Cachexia progression depleted liver glycogen content and increased mRNA expression of glycolytic enzyme PFK (phosphofrucktokinase) and gluconeogenic enzyme PEPCK. Cachexia progression further increased pSTAT-3 but suppressed p-65 and JNK (c-Jun NH2-terminal kinase) activation. Interestingly, progression of cachexia suppressed upstream ER-stress markers BiP and IRE-1 alpha, while inducing its downstream target CHOP (DNA-damage inducible transcript 3). Cachectic mice exhibited a dysregulation of protein synthesis signaling, with an induction of p-mTOR (mechanistic target of rapamycin), despite a suppression of Akt (thymoma viral proto-oncogene 1) and S6 (ribosomal protein S6) phosphorylation. Thus, cancer induced ER-stress markers in the liver, however cachexia progression further deteriorated liver ER-stress, disrupted protein synthesis regulation and caused a differential inflammatory response related to STAT-3 and NF-kappa B (Nuclear factor-kappa B) signaling.	[Narsale, Aditi A.; Puppa, Melissa J.; Carson, James A.] Univ S Carolina, Dept Exercise Sci, Integrat Muscle Biol Lab, Columbia, SC 29208 USA; [Fayad, Raja; O'Pena, Majorette; Carson, James A.] Ctr Colon Canc Res, Columbia, SC USA; [Narsale, Aditi A.; Puppa, Melissa J.; Fayad, Raja; Durstine, J. Larry; Carson, James A.] Univ S Carolina, Dept Exercise Sci, Div Appl Physiol, Columbia, SC 29208 USA; [Enos, Reilly T.; Murphy, E. Angela] Univ S Carolina, Sch Med, Dept Pathol Microbiol & Immunol, Columbia, SC USA; [Chatterjee, Saurabh] Univ S Carolina, Dept Environm Hlth Sci, Environm Hlth & Dis Lab, Columbia, SC 29208 USA	University of South Carolina; University of South Carolina System; University of South Carolina Columbia; University of South Carolina; University of South Carolina System; University of South Carolina Columbia; University of South Carolina; University of South Carolina System; University of South Carolina Columbia; University of South Carolina; University of South Carolina System; University of South Carolina Columbia	Carson, JA (corresponding author), Univ S Carolina, Dept Exercise Sci, Integrat Muscle Biol Lab, Columbia, SC 29208 USA.	carsonj@mailbox.sc.edu	Carson, James/Q-5693-2019; Enos, Reilly/AFO-4814-2022; Narsale, Aditi/U-4643-2019	Carson, James/0000-0003-3733-8796; Enos, Reilly/0000-0001-5571-4586; Puppa, Melissa/0000-0003-3826-0003; Narsale, Aditi/0000-0002-1421-5104	National Institute of Health [R01 CA121249, R00ES019875]; NATIONAL CANCER INSTITUTE [R01CA121249] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R00ES019875] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	Grant #: R01 CA121249 - awarded to JAC by the National Institute of Health - http://grants.nih.gov/grants/oer.htm. Grant # R00ES019875 - awarded to SC by the National Institute of Health - http://grants.nih.gov/grants/oer.htm.	Agustsson T, 2007, CANCER RES, V67, P5531, DOI 10.1158/0008-5472.CAN-06-4585; Argiles JM, 2014, NAT REV CANCER, V14, P754, DOI 10.1038/nrc3829; Baltgalvis KA, 2007, ROLE IL 6 MUSCLE WAS; Baltgalvis KA, 2008, AM J PHYSIOL-REG I, V294, pR393, DOI 10.1152/ajpregu.00716.2007; Bansal MB, 2005, J HEPATOL, V42, P548, DOI 10.1016/j.jhep.2004.11.043; Barton BE, 2001, CYTOKINE, V16, P251, DOI 10.1006/cyto.2001.0968; Bautista AP, 2002, ALCOHOL, V27, P17, DOI 10.1016/S0741-8329(02)00206-9; Bonetto A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022538; BRADLEY SG, 1979, ANNU REV MICROBIOL, V33, P67, DOI 10.1146/annurev.mi.33.100179.000435; BRAUER M, 1994, CANCER RES, V54, P6383; Brunt EM, 2000, HEPATOLOGY, V31, P241, DOI 10.1002/hep.510310136; Connolly MK, 2009, J CLIN INVEST, V119, P3213, DOI 10.1172/JCI37581; Elsharkawy AM, 2007, HEPATOLOGY, V46, P590, DOI 10.1002/hep.21802; Fearon KCH, 2012, CELL METAB, V16, P153, DOI 10.1016/j.cmet.2012.06.011; Hagens WI, 2008, J PHARMACOL EXP THER, V324, P902, DOI 10.1124/jpet.107.132290; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; Hetz C, 2013, NAT REV DRUG DISCOV, V12, P703, DOI 10.1038/nrd3976; HOLROYDE CP, 1984, CANCER RES, V44, P5910; Hsu PP, 2008, CELL, V134, P703, DOI 10.1016/j.cell.2008.08.021; Jassem W, 2003, TRANSPLANTATION, V75, P2001, DOI 10.1097/01.TP.0000061605.30685.03; Ji C, 2006, J HEPATOL, V45, P321, DOI 10.1016/j.jhep.2006.06.004; Jin XL, 2006, HEPATOLOGY, V43, P474, DOI 10.1002/hep.21087; Johnson JL, 2011, INFECT IMMUN, V79, P3607, DOI 10.1128/IAI.05043-11; Jones A, 2013, EMBO MOL MED, V5, P294, DOI 10.1002/emmm.201201869; KAHN CR, 1989, MOL ENDOCRINOL, V3, P840, DOI 10.1210/mend-3-5-840; Keeffe E B, 1997, Liver Transpl Surg, V3, P197; Kolattukudy PE, 2012, CIRC RES, V110, P174, DOI 10.1161/CIRCRESAHA.111.243212; Koukourakis MI, 2006, CANCER SCI, V97, P582, DOI 10.1111/j.1349-7006.2006.00220.x; Lavon I, 2000, NAT MED, V6, P573, DOI 10.1038/75057; Leitch EF, 2007, BRIT J CANCER, V97, P1266, DOI 10.1038/sj.bjc.6604027; Lieffers JR, 2009, AM J CLIN NUTR, V89, P1173, DOI 10.3945/ajcn.2008.27273; Lunz JG, 2007, HEPATOLOGY, V46, P1946, DOI 10.1002/hep.21906; Ma YJ, 2002, J MOL BIOL, V318, P1351, DOI 10.1016/S0022-2836(02)00234-6; MCCALLUM RE, 1973, INFECT IMMUN, V7, P642, DOI 10.1128/IAI.7.4.642-654.1973; McClellan JL, 2012, CYTOKINE, V57, P113, DOI 10.1016/j.cyto.2011.09.027; McMillan DC, 1998, NUTR CANCER, V31, P101, DOI 10.1080/01635589809514687; Narsale AA, 2014, CURR OPIN SUPPORT PA, V8, P321, DOI 10.1097/SPC.0000000000000091; Preston T, 1998, J NUTR, V128, P1355, DOI 10.1093/jn/128.8.1355; Puppa MJ, 2011, BBA-MOL BASIS DIS, V1812, P1601, DOI 10.1016/j.bbadis.2011.08.010; Quinn P. G., 2005, Current Drug Targets - Immune Endocrine and Metabolic Disorders, V5, P423, DOI 10.2174/156800805774912962; SASSE D, 1975, HISTOCHEMISTRY, V45, P237, DOI 10.1007/BF00507698; Seth RK, 2013, TOXICOL SCI, V134, P291, DOI 10.1093/toxsci/kft104; Sutherland C, 1996, PHILOS T ROY SOC B, V351, P191, DOI 10.1098/rstb.1996.0016; Taub R, 2003, J CLIN INVEST, V112, P978, DOI 10.1172/JCI20031200319974; Tazi E, 2010, INDIAN J PALLIAT CAR, V16, P129, DOI 10.4103/0973-1075.73644; Tisdale MJ, 2009, PHYSIOL REV, V89, P381, DOI 10.1152/physrev.00016.2008; Tisdale MJ, 2002, NAT REV CANCER, V2, P862, DOI 10.1038/nrc927; Uskokovic A, 2012, MOL BIOL REP, V39, P167, DOI 10.1007/s11033-011-0722-5; Wang B, 2012, HEPATOLOGY, V56, P186, DOI 10.1002/hep.25632; White JP, 2009, ACTA PHYSIOL, V197, P321, DOI 10.1111/j.1748-1716.2009.02029.x; White JP, 2013, BIOL OPEN, V2, P1346, DOI 10.1242/bio.20136544; White JP, 2013, AM J PHYSIOL-ENDOC M, V304, pE1042, DOI 10.1152/ajpendo.00410.2012; White JP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024650; White JP, 2011, AM J PHYSIOL-REG I, V300, pR201, DOI 10.1152/ajpregu.00300.2010; White JP, 2009, J APPL PHYSIOL, V107, P1420, DOI 10.1152/japplphysiol.00668.2009; Zhang YQ, 2006, P NATL ACAD SCI USA, V103, P1006, DOI 10.1073/pnas.0506982103; Zimmers TA, 2003, HEPATOLOGY, V38, P326, DOI 10.1053/jhep.2003.50318	57	40	41	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2015	10	3							e0119888	10.1371/journal.pone.0119888	http://dx.doi.org/10.1371/journal.pone.0119888			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD9NQ	25789991	gold, Green Submitted, Green Published			2022-12-27	WOS:000351425400114
J	Peeling, RW; Sollis, KA; Glover, S; Crowe, SM; Landay, AL; Cheng, B; Barnett, D; Denny, TN; Spira, TJ; Stevens, WS; Crowley, S; Essajee, S; Vitoria, M; Ford, N				Peeling, Rosanna W.; Sollis, Kimberly A.; Glover, Sarah; Crowe, Suzanne M.; Landay, Alan L.; Cheng, Ben; Barnett, David; Denny, Thomas N.; Spira, Thomas J.; Stevens, Wendy S.; Crowley, Siobhan; Essajee, Shaffiq; Vitoria, Marco; Ford, Nathan			CD4 Enumeration Technologies: A Systematic Review of Test Performance for Determining Eligibility for Antiretroviral Therapy	PLOS ONE			English	Article							T-CELL ENUMERATION; HIV-INFECTED INDIVIDUALS; RESOURCE-LIMITED SETTINGS; LOW-COST METHOD; FLOW-CYTOMETRY; ABSOLUTE CD4(+); SINGLE-PLATFORM; LYMPHOCYTE COUNTS; ALTERNATIVE METHODS; FACSCOUNT SYSTEM	Background Measurement of CD4(+) T-lymphocytes (CD4) is a crucial parameter in the management of HIV patients, particularly in determining eligibility to initiate antiretroviral treatment (ART). A number of technologies exist for CD4 enumeration, with considerable variation in cost, complexity, and operational requirements. We conducted a systematic review of the performance of technologies for CD4 enumeration. Methods and Findings Studies were identified by searching electronic databases MEDLINE and EMBASE using a pre-defined search strategy. Data on test accuracy and precision included bias and limits of agreement with a reference standard, and misclassification probabilities around CD4 thresholds of 200 and 350 cells/beta l over a clinically relevant range. The secondary outcome measure was test imprecision, expressed as % coefficient of variation. Thirty-two studies evaluating 15 CD4 technologies were included, of which less than half presented data on bias and misclassification compared to the same reference technology. At CD4 counts <350 cells/mu l, bias ranged from -35.2 to +13.1 cells/mu l while at counts >350 cells/mu l, bias ranged from -70.7 to +47 cells/mu l, compared to the BD FACSCount as a reference technology. Misclassification around the threshold of 350 cells/mu l ranged from 1-29% for upward classification, resulting in under-treatment, and 7-68% for downward classification resulting in overtreatment. Less than half of these studies reported within laboratory precision or reproducibility of the CD4 values obtained. Conclusions A wide range of bias and percent misclassification around treatment thresholds were reported on the CD4 enumeration technologies included in this review, with few studies reporting assay precision. The lack of standardised methodology on test evaluation, including the use of different reference standards, is a barrier to assessing relative assay performance and could hinder the introduction of new point-of-care assays in countries where they are most needed.	[Peeling, Rosanna W.; Sollis, Kimberly A.; Glover, Sarah] London Sch Hyg & Trop Med, London WC1E 7HT, England; [Crowe, Suzanne M.] Burnet Inst, Ctr Biomed Res, Melbourne, Vic 3004, Australia; [Landay, Alan L.] Rush Univ, Med Ctr, Dept Immunol Microbiol, Chicago, IL 60612 USA; [Cheng, Ben] Pangaea Global AIDS Fdn, Oakland, CA USA; [Barnett, David] UK NEQAS Leucocyte Immunophenotyping, Sheffield S10 2QD, S Yorkshire, England; [Denny, Thomas N.] Duke Human Vaccine Inst, Durham, NC 27710 USA; [Denny, Thomas N.] Immunol & Virol Qual Assessment Ctr, Ctr HIV AIDS, Durham, NC 27710 USA; [Spira, Thomas J.] Ctr Dis Control & Prevent, Natl Ctr Infect Dis, Div AIDS STD & TB Lab Res, Atlanta, GA 30333 USA; [Stevens, Wendy S.] Univ Witwatersrand, ZA-2193 Parktown, South Africa; [Crowley, Siobhan] ELMA Philanthropies, Director Hlth Programs, New York, NY USA; [Essajee, Shaffiq] Clinton Hlth Access Initiat, Boston, MA 02127 USA; [Vitoria, Marco; Ford, Nathan] WHO, CH-1211 Geneva, Switzerland	University of London; London School of Hygiene & Tropical Medicine; Burnet Institute; Rush University; Centers for Disease Control & Prevention - USA; University of Witwatersrand; World Health Organization	Peeling, RW (corresponding author), London Sch Hyg & Trop Med, London WC1E 7HT, England.	rosanna.peeling@lshtm.ac.uk		Barnett, David/0000-0002-7658-5856	World Health Organization	World Health Organization(World Health Organization)	The funding for this study was provided by the World Health Organization to the London School of Hygiene and Tropical Medicine. The decision to write this article was not influenced by any diagnostic or commercial company. The mention of specific companies or of certain manufacturers' products does not imply that they are endorsed or recommended by the World Health Organization in preference to others of a similar nature that are not mentioned. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2009, SYSTEMATIC REV CRDS; Balakrishnan P, 2004, JAIDS-J ACQ IMM DEF, V36, P1006, DOI 10.1097/00126334-200408150-00002; Balakrishnan P, 2006, JAIDS-J ACQ IMM DEF, V43, P23, DOI 10.1097/01.qai.0000227791.92203.d5; Barnett D, 2008, NAT REV MICROBIOL, V6, pS7, DOI 10.1038/nrmicro1998; Bergeron M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041166; Bergeron M, 2010, CYTOM PART B-CLIN CY, V78B, P188, DOI 10.1002/cyto.b.20501; Bossuyt PM, 2003, ANN INTERN MED, V138, P40, DOI 10.7326/0003-4819-138-1-200301070-00010; Briggs C, 2009, INT J LAB HEMATOL, V31, P169, DOI 10.1111/j.1751-553X.2007.01017.x; CARELLA AV, 1995, CLIN DIAGN LAB IMMUN, V2, P623, DOI 10.1128/CDLI.2.5.623-625.1995; Cassens U, 2004, ANTIVIR THER, V9, P395; Denny TN, 2008, CYTOM PART B-CLIN CY, V74B, pS52, DOI 10.1002/cyto.b.20417; Diagbouga S, 2003, AIDS, V17, P2201, DOI 10.1097/00002030-200310170-00008; Didier JM, 2001, J ACQ IMMUN DEF SYND, V26, P193, DOI 10.1097/00126334-200102010-00017; Dieye TN, 2011, J IMMUNOL METHODS, V372, P7, DOI 10.1016/j.jim.2011.07.012; Dieye TN, 2005, JAIDS-J ACQ IMM DEF, V39, P32, DOI 10.1097/01.qai.0000160515.20581.ad; FEI DTW, 1993, BIOLOGICALS, V21, P221, DOI 10.1006/biol.1993.1079; Fryland M, 2006, T ROY SOC TROP MED H, V100, P980, DOI 10.1016/j.trstmh.2005.11.014; GERNOW A, 1995, CLIN IMMUNOL IMMUNOP, V76, P135, DOI 10.1006/clin.1995.1107; GIORGI JV, 1993, ANN NY ACAD SCI, V677, P126, DOI 10.1111/j.1749-6632.1993.tb38771.x; Glencross D, 2002, CYTOMETRY, V50, P69, DOI 10.1002/cyto.10068; Herbert S, 2013, SEXUALLY TRANSMITTED, V88, P413; Higgins J, 2007, CLIN VACCINE IMMUNOL, V14, P1342, DOI 10.1128/CVI.00168-07; Idigbe E O, 2006, East Afr Med J, V83, P105; Imade GE, 2005, CLIN DIAGN LAB IMMUN, V12, P224, DOI 10.1128/CDLI.12.1.224-227.2005; Jani IV, 2011, AIDS, V25, P807, DOI 10.1097/QAD.0b013e328344f424; Jeganathan S, 2008, HIV MED, V9, P192, DOI 10.1111/j.1468-1293.2008.00544.x; JOHNSON D, 1995, J ACQ IMMUN DEF SYND, V10, P522, DOI 10.1097/00042560-199510050-00005; Kandathil AJ, 2005, CLIN DIAGN LAB IMMUN, V12, P1006, DOI 10.1128/CDLI.12.8.1006-1009.2005; Karcher H, 2006, CYTOM PART B-CLIN CY, V70B, P163, DOI 10.1002/cyto.b.20093; Korenromp EL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005950; LANDAY A, 1993, AIDS, V7, P1565, DOI 10.1097/00002030-199312000-00004; Liberati A, 2009, PLOS MED, V6, DOI [10.1371/journal.pmed.1000100, 10.1136/bmj.b2700, 10.7326/0003-4819-151-4-200908180-00136]; Logan C, 2013, J IMMUNOL METHODS, V387, P107, DOI 10.1016/j.jim.2012.10.002; Lopez A, 1999, CYTOMETRY, V38, P231, DOI 10.1002/(SICI)1097-0320(19991015)38:5<231::AID-CYTO5>3.0.CO;2-Y; Lutwama F, 2008, JAIDS-J ACQ IMM DEF, V48, P297, DOI 10.1097/QAI.0b013e31817bbc3a; Lyamuya EF, 1996, J IMMUNOL METHODS, V195, P103, DOI 10.1016/0022-1759(96)00094-4; Lynen L, 2006, JAIDS-J ACQ IMM DEF, V43, P179, DOI 10.1097/01.qai.0000242447.82403.c2; Manasa J, 2007, CLIN VACCINE IMMUNOL, V14, P293, DOI 10.1128/CVI.00416-06; Mbopi-Keou FX, 2012, CLIN VACCINE IMMUNOL, V19, P609, DOI 10.1128/CVI.00023-12; Mbopi-Keou FX, 2012, J TRANSL MED, V10, DOI 10.1186/1479-5876-10-22; Moher D, 2009, PLOS MED, V6, DOI [10.1136/bmj.b4037, 10.1371/journal.pmed.1000097]; Mtapuri-Zinyowera S, 2010, JAIDS-J ACQ IMM DEF, V55, P1, DOI 10.1097/QAI.0b013e3181e93071; Nicholson JKA, 1997, CLIN DIAGN LAB IMMUN, V4, P309, DOI 10.1128/CDLI.4.3.309-313.1997; NICHOLSON JKA, 1994, J IMMUNOL METHODS, V177, P43, DOI 10.1016/0022-1759(94)90142-2; Pattanapanyasat K, 2005, CLIN DIAGN LAB IMMUN, V12, P1416, DOI 10.1128/CDLI.12.12.1416-1424.2005; Pattanapanyasat K, 2005, CYTOM PART B-CLIN CY, V65B, P29, DOI 10.1002/cyto.b.20052; Pattanapanyasat K, 2008, JAIDS-J ACQ IMM DEF, V49, P339, DOI 10.1097/QAI.0b013e31818c1721; Pattanapanyasat K, 2007, CYTOM PART B-CLIN CY, V72B, P387, DOI 10.1002/cyto.b.20167; RABOUD JM, 1995, J ACQ IMMUN DEF SYND, V10, pS67; Reimann KA, 2000, CLIN DIAGN LAB IMMUN, V7, P344, DOI 10.1128/CDLI.7.3.344-351.2000; Renault Cybele A, 2010, Open AIDS J, V4, P171, DOI 10.2174/1874613601004010171; Schnizlein-Bick CT, 2000, CLIN DIAGN LAB IMMUN, V7, P336, DOI 10.1128/CDLI.7.3.336-343.2000; Sippy-Chatrani N, 2008, CYTOM PART B-CLIN CY, V74B, pS65, DOI 10.1002/cyto.b.20406; Sitoe N, 2011, J IMMUNOL METHODS, V372, P1, DOI 10.1016/j.jim.2011.07.008; Spacek LA, 2006, JAIDS-J ACQ IMM DEF, V41, P607, DOI 10.1097/01.qai.0000214807.98465.a2; Srithanaviboonchai K, 2008, JAIDS-J ACQ IMM DEF, V47, P135, DOI 10.1097/QAI.0b013e3181624ab5; Sterling TR, 2001, AIDS, V15, P2251, DOI 10.1097/00002030-200111230-00006; Stevens W, 2008, NAT REV MICROBIOL, V6, pS29, DOI 10.1038/nrmicro2000; Storie I, 2004, CYTOM PART B-CLIN CY, V57B, P47, DOI 10.1002/cyto.b.10065; Storie I, 2003, CYTOM PART B-CLIN CY, V55B, P8, DOI 10.1002/cyto.b.10050; Strauss K, 1996, CYTOMETRY, V26, P52; Sukapirom K, 2011, JAIDS-J ACQ IMM DEF, V58, P141, DOI 10.1097/QAI.0b013e31822866a2; Tayler-Smith K, 2010, T ROY SOC TROP MED H, V104, P313, DOI 10.1016/j.trstmh.2010.01.007; Thakar Madhuri R, 2006, AIDS Res Ther, V3, P26, DOI 10.1186/1742-6405-3-26; Vitoria M, 2013, CURR OPIN HIV AIDS, V8, P12, DOI 10.1097/COH.0b013e32835b8123; Whitby L, 2013, CYTOM PART B-CLIN CY, V84B, P248, DOI 10.1002/cyto.b.21094; WHO, 2013, GLOB UPD HIV TREATM; Wilson GA, 1995, EVALUATION COULTER M; World Health Organization, 2013, CONSOLIDATED GUIDELI; Wynberg E, 2014, J INT AIDS SOC, V17, DOI 10.7448/IAS.17.1.18809; Zijenah LS, 2006, J TRANSL MED, V4, DOI 10.1186/1479-5876-4-33	71	21	21	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2015	10	3							e0115019	10.1371/journal.pone.0115019	http://dx.doi.org/10.1371/journal.pone.0115019			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD9NQ	25790185	Green Published, Green Accepted, gold			2022-12-27	WOS:000351425400006
J	Xu, FF; Sun, W; Li, P; Chen, JL; Zhu, DD; Sun, XL; Wang, JX; Feng, JR; Song, K; Duan, YN				Xu, Feifan; Sun, Wei; Li, Pan; Chen, Jinling; Zhu, Dandan; Sun, Xiaolei; Wang, Jianxin; Feng, Jinrong; Song, Ke; Duan, Yinong			Specificity Protein 1 Transcription Factor Regulates Human ARTS Promoter Activity through Multiple Binding Sites	PLOS ONE			English	Article							EXPRESSION; SEPTINS; GENE; APOPTOSIS; FAMILY; CYTOKINESIS; METHYLATION; COMPLEX; ROLES; SP1	Apoptosis-related protein in the TGF-beta signaling pathway (ARTS) is an unusual mitochondrial Septin-like protein which functions as a tumor suppressor. There are various splice variants derived from the human Septin4 gene, one of which is ARTS, also known as Septin4_i2. Unlike other Septin4 members, ARTS can induce apoptosis in many cells, however, the underlying molecular mechanism for the transcriptional regulation of ARTS has yet to be deciphered. In this study, we attempted to analyze the promoter region of ARTS in cultured HEK-293T and LX-2 cells with the purpose of elucidating the underlying transcriptional mechanisms driving ARTS expression. We effectively demonstrated that the -824 to -5 bp region of the ARTS promoter was essential for ARTS transcription and identified four putative specificity protein 1 (Sp1) binding sites within this core promoter region. ChIP analysis showed that Sp1 protein could bind to two of these sites (-735/-718 and -173/-157) and mutation of each Sp1 binding site led to a significant decrease in ARTS promoter activity. In conclusion, all the results indicated that the Sp1 transcription factor could contribute to ARTS gene transcription. The underlying molecular events of the specific promoter of ARTS could also be used to explain why ARTS is selectively silenced during some human diseases. This would provide basis for further study on the function of ARTS on cell apoptosis.	[Xu, Feifan; Sun, Wei; Li, Pan; Chen, Jinling; Zhu, Dandan; Sun, Xiaolei; Wang, Jianxin; Feng, Jinrong; Song, Ke; Duan, Yinong] Nantong Univ, Sch Med, Dept Pathogen Biol, Nantong 226001, Jiangsu, Peoples R China; [Xu, Feifan] Sixth Peoples Hosp Nantong, Clin Lab, Nantong 226001, Jiangsu, Peoples R China; [Wang, Jianxin] Nantong Univ, Affiliated Hosp, Lab Med Ctr, Nantong 226001, Jiangsu, Peoples R China	Nantong University; Nantong University	Duan, YN (corresponding author), Nantong Univ, Sch Med, Dept Pathogen Biol, 19 Qixiu Rd, Nantong 226001, Jiangsu, Peoples R China.	yinongduan@gmail.com	Duan, yinong/GSD-9438-2022	Chen, Jinling/0000-0003-2992-6571	National Natural Science Foundation of China [81171589, 81471975, 81401683]; Jiangsu provincial Natural Science Foundation [BK20140435]; Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD); Graduate Student Research and Innovation Program of Nantong University [YKC13060]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Jiangsu provincial Natural Science Foundation(Natural Science Foundation of Jiangsu Province); Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD); Graduate Student Research and Innovation Program of Nantong University	This work was supported by National Natural Science Foundation of China (Grant Numbers 81171589, 81471975, 81401683), the Jiangsu provincial Natural Science Foundation (Grant Number BK20140435), the Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD) and the Graduate Student Research and Innovation Program of Nantong University (Grant Number YKC13060). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cerveira Nuno, 2009, Critical Reviews in Oncogenesis, V15, P91; Connolly D, 2011, BIOL CHEM, V392, P725, DOI 10.1515/BC.2011.073; Cook T, 1999, ANN NY ACAD SCI, V880, P94, DOI 10.1111/j.1749-6632.1999.tb09513.x; Dolat L, 2014, BIOL CHEM, V395, P123, DOI 10.1515/hsz-2013-0233; Edison N, 2012, CELL DEATH DIFFER, V19, P356, DOI 10.1038/cdd.2011.112; Elhasid R, 2004, ONCOGENE, V23, P5468, DOI 10.1038/sj.onc.1207725; Esteller M, 2007, HUM MOL GENET, V16, pR50, DOI 10.1093/hmg/ddm018; Furihata K, 2002, ARTERIOSCL THROM VAS, V22, P1733, DOI 10.1161/01.ATV.0000034493.76465.FF; Futscher BW, 2002, NAT GENET, V31, P175, DOI 10.1038/ng886; Garber ME, 2001, P NATL ACAD SCI USA, V98, P13784, DOI 10.1073/pnas.241500798; Gottfried Y, 2004, EMBO J, V23, P1627, DOI 10.1038/sj.emboj.7600155; Gottfried Y, 2007, SCHIZOPHR RES, V96, P257, DOI 10.1016/j.schres.2007.05.031; Hall PA, 2004, J PATHOL, V204, P489, DOI 10.1002/path.1654; HARTWELL LH, 1971, EXP CELL RES, V69, P265, DOI 10.1016/0014-4827(71)90223-0; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; Ihara M, 2007, NEURON, V53, P519, DOI 10.1016/j.neuron.2007.01.019; Kemeny S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038837; Larisch S, 2000, NAT CELL BIOL, V2, P915, DOI 10.1038/35046566; Lee JW, 2006, PATHOL RES PRACT, V202, P67, DOI 10.1016/j.prp.2005.11.001; Lin Ying-Hung, 2011, Spermatogenesis, V1, P298; Longtine MS, 1996, CURR OPIN CELL BIOL, V8, P106, DOI 10.1016/S0955-0674(96)80054-8; Lotan R, 2005, J BIOL CHEM, V280, P25802, DOI 10.1074/jbc.M501955200; Mandel-Gutfreund Y, 2011, BIOL CHEM, V392, P783, DOI 10.1515/BC.2011.089; Mostowy S, 2011, BIOL CHEM, V392, P831, DOI 10.1515/BC.2011.078; Pang RTK, 2004, MOL ENDOCRINOL, V18, P471, DOI 10.1210/me.2003-0245; Peterson EA, 2010, CLIN GENET, V77, P511, DOI 10.1111/j.1399-0004.2010.01392.x; PUGH BF, 1991, GENE DEV, V5, P1935, DOI 10.1101/gad.5.11.1935; Reingewertz TH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024655; Roeseler S, 2009, KLIN PADIATR, V221, P150, DOI 10.1055/s-0029-1220706; Singh DP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037012; Suske G, 1999, GENE, V238, P291, DOI 10.1016/S0378-1119(99)00357-1; Wang JX, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003106; Xu L, 2005, GUT, V54, P142, DOI 10.1136/gut.2004.042127; Zhao LX, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076581	34	3	3	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2015	10	3							e0120072	10.1371/journal.pone.0120072	http://dx.doi.org/10.1371/journal.pone.0120072			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD9NQ	25790304	Green Submitted, Green Published, gold			2022-12-27	WOS:000351425400127
J	Fernandez, M; Hamilton, H				Fernandez, Miguel; Hamilton, Healy			Ecological Niche Transferability Using Invasive Species as a Case Study	PLOS ONE			English	Article							POPULATION GENETIC-ANALYSIS; BIOCLIMATE ENVELOPE MODELS; CLIMATE-CHANGE; DISTRIBUTIONAL AREAS; AMERICAN BULLFROG; RAPID EVOLUTION; ARGENTINE ANTS; RANGE SHIFTS; DATA SETS; CONSERVATISM	Species distribution modeling is widely applied to predict invasive species distributions and species range shifts under climate change. Accurate predictions depend upon meeting the assumption that ecological niches are conserved, i.e., spatially or temporally transferable. Here we present a multi-taxon comparative analysis of niche conservatism using biological invasion events well documented in natural history museum collections. Our goal is to assess spatial transferability of the climatic niche of a range of noxious terrestrial invasive species using two complementary approaches. First we compare species' native versus invasive ranges in environmental space using two distinct methods, Principal Components Analysis and Mahalanobis distance. Second we compare species' native versus invaded ranges in geographic space as estimated using the species distribution modeling technique Maxent and the comparative index Hellinger's I. We find that species exhibit a range of responses, from almost complete transferability, in which the invaded niches completely overlap with the native niches, to a complete dissociation between native and invaded ranges. Intermediate responses included expansion of dimension attributable to either temperature or precipitation derived variables, as well as niche expansion in multiple dimensions. We conclude that the ecological niche in the native range is generally a poor predictor of invaded range and, by analogy, the ecological niche may be a poor predictor of range shifts under climate change. We suggest that assessing dimensions of niche transferability prior to standard species distribution modeling may improve the understanding of species' dynamics in the invaded range.	[Fernandez, Miguel] Univ Calif Berkeley, Dept Integrat Biol, Berkeley, CA 94720 USA; [Fernandez, Miguel] German Ctr Integrat Biodivers Res iDiv, Leipzig, Germany; [Hamilton, Healy] NatureServe, Arlington, VA USA	University of California System; University of California Berkeley; Nature Conservancy	Fernandez, M (corresponding author), Univ Calif Berkeley, Dept Integrat Biol, Berkeley, CA 94720 USA.	miguel.fernandez@berkeley.edu		Fernandez, Miguel/0000-0002-8301-1340	Russell E. Train Education for Nature Fellowship	Russell E. Train Education for Nature Fellowship	This work was supported by the Russell E. Train Education for Nature Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson RP, 2006, SOUTHWEST NAT, V51, P471, DOI 10.1894/0038-4909(2006)51[471:VMPAVT]2.0.CO;2; Anderson RP, 2003, ECOL MODEL, V162, P211, DOI 10.1016/S0304-3800(02)00349-6; Araujo MB, 2005, GLOBAL CHANGE BIOL, V11, P1504, DOI 10.1111/j.1365-2486.2005.01000.x; Araujo MB, 2006, SCIENCE, V313, P1396, DOI 10.1126/science.1131758; Araujo MB, 2006, J BIOGEOGR, V33, P1677, DOI 10.1111/j.1365-2699.2006.01584.x; Barson NJ, 2009, J EVOLUTION BIOL, V22, P485, DOI 10.1111/j.1420-9101.2008.01675.x; Beale CM, 2008, P NATL ACAD SCI USA, V105, P14908, DOI 10.1073/pnas.0803506105; Beever EA, 2006, DIVERS DISTRIB, V12, P229, DOI 10.1111/j.1366-9516.2006.00260.x; Broennimann O, 2007, ECOL LETT, V10, P701, DOI 10.1111/j.1461-0248.2007.01060.x; Brotons L, 2004, ECOGRAPHY, V27, P437, DOI 10.1111/j.0906-7590.2004.03764.x; Carroll C, 2010, BIOL CONSERV, V143, P1432, DOI 10.1016/j.biocon.2010.03.018; Colwell RK, 2009, P NATL ACAD SCI USA, V106, P19651, DOI 10.1073/pnas.0901650106; Davis AJ, 1998, NATURE, V391, P783, DOI 10.1038/35842; Dawson MN, 2010, MOL ECOL, V19, P1585, DOI 10.1111/j.1365-294X.2010.04588.x; De Maesschalck R, 2000, CHEMOMETR INTELL LAB, V50, P1, DOI 10.1016/S0169-7439(99)00047-7; Dormann CF, 2009, ECOGRAPHY, V32, P379, DOI 10.1111/j.1600-0587.2009.05907.x; Dunlop EA, 2006, WEED RES, V46, P404, DOI 10.1111/j.1365-3180.2006.00524.x; Elith J, 2006, ECOGRAPHY, V29, P129, DOI 10.1111/j.2006.0906-7590.04596.x; Elith J, 2009, ANNU REV ECOL EVOL S, V40, P677, DOI 10.1146/annurev.ecolsys.110308.120159; Fernandez M., 2009, BIODIVERSITY INFORM, V6, DOI 10.17161/bi.v6i1.3314; Ficetola GF, 2007, DIVERS DISTRIB, V13, P476, DOI 10.1111/j.1472-4642.2007.00377.x; Fielding AH, 1997, ENVIRON CONSERV, V24, P38, DOI 10.1017/S0376892997000088; Franklin J, 2009, MAPPING SPECIES DIST; Gilman SE, 2010, TRENDS ECOL EVOL, V25, P325, DOI 10.1016/j.tree.2010.03.002; Giovanelli JGR, 2008, BIOL INVASIONS, V10, P585, DOI 10.1007/s10530-007-9154-5; Graham CH, 2006, GLOBAL ECOL BIOGEOGR, V15, P578, DOI 10.1111/j.1466-8238.2006.00257.x; Graham CH, 2004, EVOLUTION, V58, P1781, DOI 10.1554/03-274; Guisan A, 2005, ECOL LETT, V8, P993, DOI 10.1111/j.1461-0248.2005.00792.x; Hampe A, 2004, GLOBAL ECOL BIOGEOGR, V13, P469, DOI 10.1111/j.1466-822X.2004.00090.x; Hegel TM, 2010, SPATIAL COMPLEXITY, INFORMATICS, AND WILDLIFE CONSERVATION, P273, DOI 10.1007/978-4-431-87771-4_16; Heikkinen RK, 2006, PROG PHYS GEOG, V30, P751, DOI 10.1177/0309133306071957; Hernandez PA, 2006, ECOGRAPHY, V29, P773, DOI 10.1111/j.0906-7590.2006.04700.x; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Hoopes M.F., 2013, INVASION ECOLOGY, V2nd; Hortal J, 2010, ECOGRAPHY, V33, P51, DOI 10.1111/j.1600-0587.2009.06428.x; Hotelling H, 1933, J EDUC PSYCHOL, V24, P417, DOI 10.1037/h0071325; Jeschke JM, 2008, ANN NY ACAD SCI, V1134, P1, DOI 10.1196/annals.1439.002; Kanda LL, 2009, ECOLOGY, V90, P1574, DOI 10.1890/08-1263.1; Lavergne S, 2010, ANN BOT-LONDON, V105, P109, DOI 10.1093/aob/mcp271; Lenoir J, 2010, ECOGRAPHY, V33, P295, DOI 10.1111/j.1600-0587.2010.06279.x; Liu CR, 2005, ECOGRAPHY, V28, P385, DOI 10.1111/j.0906-7590.2005.03957.x; Lowe S., 2000, ENCY BIOL INVASIONS; Mahalanobis P.C., 1936, P NAT I SCI INDIA, V2, P49; Martinez-Meyer E, 2006, J BIOGEOGR, V33, P1779, DOI [10.1111/j.1365-2699.2006.01612.x, 10.1111/j.1365-2699.2006.01482_33_10.x]; McGarigal K., 2000, MULTIVARIATE STAT WI; Menke SB, 2009, GLOBAL ECOL BIOGEOGR, V18, P50, DOI 10.1111/j.1466-8238.2008.00420.x; Midgley GF, 2006, DIVERS DISTRIB, V12, P555, DOI 10.1111/j.1366-9516.2006.00273.x; Neubert MG, 2004, RISK ANAL, V24, P817, DOI 10.1111/j.0272-4332.2004.00481.x; Oberhauser K, 2003, P NATL ACAD SCI USA, V100, P14063, DOI 10.1073/pnas.2331584100; Odland A, 1999, ECOGRAPHY, V22, P548, DOI 10.1111/j.1600-0587.1999.tb01285.x; Ozesmi U, 1997, ECOL MODEL, V101, P139, DOI 10.1016/S0304-3800(97)01983-2; Parra JL, 2004, ECOGRAPHY, V27, P350, DOI 10.1111/j.0906-7590.2004.03822.x; Pearman PB, 2008, TRENDS ECOL EVOL, V23, P149, DOI 10.1016/j.tree.2007.11.005; Pearson K, 1901, PHILOS MAG, V2, P559, DOI 10.1080/14786440109462720; Pearson RG, 2003, GLOBAL ECOL BIOGEOGR, V12, P361, DOI 10.1046/j.1466-822X.2003.00042.x; Peterson AT, 2008, GLOBAL ECOL BIOGEOGR, V17, P135, DOI 10.1111/j.1466-8238.2007.00347.x; Peterson AT, 2008, ECOL MODEL, V213, P63, DOI 10.1016/j.ecolmodel.2007.11.008; Peterson AT, 2007, ECOGRAPHY, V30, P550, DOI 10.1111/j.2007.0906-7590.05102.x; Peterson AT, 2001, BIOSCIENCE, V51, P363, DOI 10.1641/0006-3568(2001)051[0363:PSIUEN]2.0.CO;2; Peterson AT, 1999, SCIENCE, V285, P1265, DOI 10.1126/science.285.5431.1265; Peterson AT, 2003, Q REV BIOL, V78, P419, DOI 10.1086/378926; Phillips SJ, 2008, ECOGRAPHY, V31, P161, DOI 10.1111/j.0906-7590.2008.5203.x; Phillips SJ, 2008, ECOGRAPHY, V31, P272, DOI 10.1111/j.0906-7590.2008.5378.x; Randin CF, 2006, J BIOGEOGR, V33, P1689, DOI 10.1111/j.1365-2699.2006.01466.x; Ridley CE, 2010, EVOL APPL, V3, P64, DOI 10.1111/j.1752-4571.2009.00099.x; Rodder D, 2009, GLOBAL ECOL BIOGEOGR, V18, P674, DOI 10.1111/j.1466-8238.2009.00477.x; Roura-Pascual N, 2006, ECOL APPL, V16, P1832, DOI 10.1890/1051-0761(2006)016[1832:NDAFPF]2.0.CO;2; Roura-Pascual N, 2009, BIOL INVASIONS, V11, P1017, DOI 10.1007/s10530-008-9313-3; Sax DF, 2007, TRENDS ECOL EVOL, V22, P465, DOI 10.1016/j.tree.2007.06.009; Smolik MG, 2010, J BIOGEOGR, V37, P411, DOI 10.1111/j.1365-2699.2009.02227.x; Soberon J, 2007, ECOL LETT, V10, P1115, DOI 10.1111/j.1461-0248.2007.01107.x; Soberon J, 2009, P NATL ACAD SCI USA, V106, P19644, DOI 10.1073/pnas.0901637106; Strauss B, 2007, ECOL MODEL, V204, P104, DOI 10.1016/j.ecolmodel.2006.12.027; Thuiller W, 2006, DIVERS DISTRIB, V12, P49, DOI 10.1111/j.1366-9516.2006.00216.x; Thuiller W, 2004, ECOGRAPHY, V27, P165, DOI 10.1111/j.0906-7590.2004.03673.x; Tingley MW, 2009, P NATL ACAD SCI USA, V106, P19637, DOI 10.1073/pnas.0901562106; Urban MC, 2007, P ROY SOC B-BIOL SCI, V274, P1413, DOI 10.1098/rspb.2007.0114; Vaughan IP, 2005, J APPL ECOL, V42, P720, DOI 10.1111/j.1365-2664.2005.01052.x; Warren DL, 2008, EVOLUTION, V62, P2868, DOI 10.1111/j.1558-5646.2008.00482.x; Whitney KD, 2008, DIVERS DISTRIB, V14, P569, DOI 10.1111/j.1472-4642.2008.00473.x; Wiens JJ, 2005, ANNU REV ECOL EVOL S, V36, P519, DOI 10.1146/annurev.ecolsys.36.102803.095431; Zanini F, 2009, DIVERS DISTRIB, V15, P469, DOI 10.1111/j.1472-4642.2008.00556.x	82	39	40	0	55	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2015	10	3							e0119891	10.1371/journal.pone.0119891	http://dx.doi.org/10.1371/journal.pone.0119891			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9BN	25785858	Green Published, Green Submitted, gold			2022-12-27	WOS:000352138500141
J	Kolarova, J; Ammerpohl, O; Gutwein, J; Welzel, M; Baus, I; Riepe, FG; Eggermann, T; Caliebe, A; Holterhus, PM; Siebert, R; Bens, S				Kolarova, Julia; Ammerpohl, Ole; Gutwein, Jana; Welzel, Maik; Baus, Inka; Riepe, Felix G.; Eggermann, Thomas; Caliebe, Almuth; Holterhus, Paul-Martin; Siebert, Reiner; Bens, Susanne			In vivo Investigations of the Effect of Short- and Long-Term Recombinant Growth Hormone Treatment on DNA-Methylation in Humans	PLOS ONE			English	Article							BLOOD MONONUCLEAR-CELLS; GENE-EXPRESSION; DEFICIENCY; CHILDHOOD; CANCER; MORTALITY; CHILDREN; GH; EPIGENETICS; RECEPTOR	Treatment with recombinant human growth hormone (rhGH) has been consistently reported to induce transcriptional changes in various human tissues including peripheral blood. For other hormones it has been shown that the induction of such transcriptional effects is conferred or at least accompanied by DNA-methylation changes. To analyse effects of short term rhGH treatment on the DNA-methylome we investigated a total of 24 patients at baseline and after 4-day rhGH stimulation. We performed array-based DNA-methylation profiling of paired peripheral blood mononuclear cell samples followed by targeted validation using bisulfite pyrosequencing. Unsupervised analysis of DNA-methylation in this short-term treated cohort revealed clustering according to individuals rather than treatment. Supervised analysis identified 239 CpGs as significantly differentially methylated between baseline and rhGH-stimulated samples (p<0.0001, unadjusted paired t-test), which nevertheless did not retain significance after adjustment for multiple testing. An individualized evaluation strategy led to the identification of 2350 CpG and 3 CpH sites showing methylation differences of at least 10% in more than 2 of the 24 analyzed sample pairs. To investigate the long term effects of rhGH treatment on the DNA-methylome, we analyzed peripheral blood cells from an independent cohort of 36 rhGH treated children born small for gestational age (SGA) as compared to 18 untreated controls. Median treatment interval was 33 months. In line with the groupwise comparison in the short-term treated cohort no differentially methylated targets reached the level of significance in the long-term treated cohort. We identified marked intra-individual responses of DNA-methylation to short-term rhGH treatment. These responses seem to be predominately associated with immunologic functions and show considerable inter-individual heterogeneity. The latter is likely the cause for the lack of a rhGH induced homogeneous DNA-methylation signature after short- and long-term treatment, which nevertheless is well in line with generally assumed safety of rhGH treatment.	[Kolarova, Julia; Ammerpohl, Ole; Gutwein, Jana; Caliebe, Almuth; Siebert, Reiner; Bens, Susanne] Univ Kiel, Inst Human Genet, Kiel, Germany; [Kolarova, Julia; Ammerpohl, Ole; Gutwein, Jana; Welzel, Maik; Baus, Inka; Riepe, Felix G.; Caliebe, Almuth; Holterhus, Paul-Martin; Siebert, Reiner; Bens, Susanne] Univ Hosp Schleswig Holstein, Kiel, Germany; [Welzel, Maik; Baus, Inka; Riepe, Felix G.; Holterhus, Paul-Martin] Univ Kiel, Dept Pediat, Div Pediat Endocrinol & Diabet, Kiel, Germany; [Eggermann, Thomas] Univ Hosp Aachen, Inst Human Genet, Aachen, Germany	University of Kiel; University of Kiel; Schleswig Holstein University Hospital; University of Kiel; RWTH Aachen University; RWTH Aachen University Hospital	Bens, S (corresponding author), Univ Kiel, Inst Human Genet, Campus Kiel, Kiel, Germany.	sbens@medgen.uni-kiel.de	Siebert, Reiner/A-8049-2010; Ammerpohl, Ole/G-2691-2010; Caliebe, Almuth/G-1248-2018; Eggermann, Thomas/F-3807-2014	Caliebe, Almuth/0000-0003-2157-425X; 	German national BMBF (Ministry of Education and Science) [FKZ: 01GM0886, 01GM1114]; Medical Faculty of the Christian-Albrechts-University Kiel	German national BMBF (Ministry of Education and Science)(Federal Ministry of Education & Research (BMBF)); Medical Faculty of the Christian-Albrechts-University Kiel	The research leading to these results received funding from the German national BMBF (Ministry of Education and Science)-funded consortium 'Diseases caused by imprinting defects: clinical spectrum and pathogenetic mechanisms' (FKZ: 01GM0886 and 01GM1114) and the Medical Faculty of the Christian-Albrechts-University Kiel. The study used for the short-term rhGH treatment cohort left-over samples from a different study supported by Novo Nordisk. The authors confirm that the funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahrens M, 2013, CELL METAB, V18, P296, DOI 10.1016/j.cmet.2013.07.004; Alisch RS, 2012, GENOME RES, V22, P623, DOI 10.1101/gr.125187.111; Ammerpohl O, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073288; [Anonymous], 2010, HEALTH TECHNOL ASSES, V14, P1, DOI 10.3310/hta14420; BADOLATO R, 1994, J CLIN ENDOCR METAB, V79, P984, DOI 10.1210/jc.79.4.984; Bell J, 2010, J CLIN ENDOCR METAB, V95, P167, DOI 10.1210/jc.2009-0178; Bens S, 2011, SEX DEV, V5, P70, DOI 10.1159/000323807; Bens S, 2013, EUR J HUM GENET, V21, P838, DOI 10.1038/ejhg.2012.262; Bibikova M, 2011, GENOMICS, V98, P288, DOI 10.1016/j.ygeno.2011.07.007; Buckway CK, 2001, J CLIN ENDOCR METAB, V86, P5176, DOI 10.1210/jc.86.11.5176; Bunting KL, 2013, CURR OPIN IMMUNOL, V25, P339, DOI 10.1016/j.coi.2013.05.003; Campisi J, 2009, AGING CELL, V8, P221, DOI 10.1111/j.1474-9726.2009.00475.x; Carel JC, 2012, J CLIN ENDOCR METAB, V97, P416, DOI 10.1210/jc.2011-1995; Chang JT, 2006, BIOINFORMATICS, V22, P2926, DOI 10.1093/bioinformatics/btl483; Ergun-Longmire B, 2006, J CLIN ENDOCR METAB, V91, P3494, DOI 10.1210/jc.2006-0656; Fernandez-Perez L, 2010, CLIN ENDOCRINOL, V72, P800, DOI 10.1111/j.1365-2265.2009.03732.x; Frick KM, 2011, EPIGENETICS-US, V6, P675, DOI 10.4161/epi.6.6.16177; GLASBRENNER K, 1986, JAMA-J AM MED ASSOC, V255, P443; Gut P, 2013, NATURE, V502, P489, DOI 10.1038/nature12752; HERMANUSSEN M, 1988, ANN HUM BIOL, V15, P1, DOI 10.1080/03014468800009411; KELLEY KW, 1990, ANN NY ACAD SCI, V594, P95; KIESS W, 1988, CLIN IMMUNOL IMMUNOP, V48, P85, DOI 10.1016/0090-1229(88)90159-6; Le Roith D, 2001, ENDOCR REV, V22, P53, DOI 10.1210/er.22.1.53; Martin-Subero JI, 2009, BLOOD, V113, P2488, DOI 10.1182/blood-2008-04-152900; Mills JL, 2004, J PEDIATR-US, V144, P430, DOI 10.1016/j.jpeds.2003.12.036; Niklasson A, 2008, BMC PEDIATR, V8, DOI 10.1186/1471-2431-8-8; PETERSEN BH, 1990, J CLIN ENDOCR METAB, V70, P1756, DOI 10.1210/jcem-70-6-1756; RAPAPORT R, 1995, J CLIN ENDOCR METAB, V80, P2612, DOI 10.1210/jc.80.9.2612; RAPAPORT R, 1987, LIFE SCI, V41, P2319, DOI 10.1016/0024-3205(87)90545-5; Reinius LE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041361; Savendahl L, 2012, J CLIN ENDOCR METAB, V97, pE213, DOI 10.1210/jc.2011-2882; Sookoian S, 2013, CURR DIABETES REP, V13, P229, DOI 10.1007/s11892-012-0361-9; Swerdlow AJ, 2002, LANCET, V360, P273, DOI 10.1016/S0140-6736(02)09519-3; Teschendorff AE, 2010, GENOME RES, V20, P440, DOI 10.1101/gr.103606.109; Trovato L, 2012, PITUITARY, V15, P482, DOI 10.1007/s11102-011-0354-8; WATANABE S, 1988, LANCET, V1, P1159; Welzel M, 2011, GROWTH HORM IGF RES, V21, P336, DOI 10.1016/j.ghir.2011.09.001; Whatmore AJ, 2009, CLIN ENDOCRINOL, V70, P429, DOI 10.1111/j.1365-2265.2008.03477.x; Wilton P, 2010, J PEDIATR-US, V157, P265, DOI 10.1016/j.jpeds.2010.02.028	39	6	6	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2015	10	3							e0120463	10.1371/journal.pone.0120463	http://dx.doi.org/10.1371/journal.pone.0120463			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9BN	25785847	Green Published, gold, Green Submitted			2022-12-27	WOS:000352138500173
J	Schwalbe, B; Schreiber, M				Schwalbe, Birco; Schreiber, Michael			Effect of Lysine to Arginine Mutagenesis in the V3 Loop of HIV-1 gp120 on Viral Entry Efficiency and Neutralization	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; N-LINKED GLYCOSYLATION; CORECEPTOR USAGE PREDICTION; ENVELOPE GLYCOPROTEIN; PROTEIN TRANSDUCTION; DOMAIN; CCR5; SEQUENCE; REGION; ANTIBODY	HIV-1 infection is characterized by an ongoing replication leading to T-lymphocyte decline which is paralleled by the switch from CCR5 to CXCR4 coreceptor usage. To predict coreceptor usage, several computer algorithms using gp120 V3 loop sequence data have been developed. In these algorithms an occupation of the V3 positions 11 and 25, by one of the amino acids lysine (K) or arginine (R), is an indicator for CXCR4 usage. Amino acids R and K dominate at these two positions, but can also be identified at positions 9 and 10. Generally, CXCR4-viruses possess V3 sequences, with an overall positive charge higher than the V3 sequences of R5-viruses. The net charge is calculated by subtracting the number of negatively charged amino acids (D, aspartic acid and E, glutamic acid) from the number of positively charged ones (K and R). In contrast to D and E, which are very similar in their polar and acidic properties, the characteristics of the R guanidinium group differ significantly from the K ammonium group. However, in coreceptor predictive computer algorithms R and K are both equally rated. The study was conducted to analyze differences in infectivity and coreceptor usage because of R-to-K mutations at the V3 positions 9, 10 and 11. V3 loop mutants with all possible RRR-to-KKK triplets were constructed and analyzed for coreceptor usage, infectivity and neutralization by SDF-1a and RANTES. Virus mutants R9R10R11 showed the highest infectivity rates, and were inhibited more efficiently in contrast to the K9K10K11 viruses. They also showed higher efficiency in a virus-gp120 paired infection assay. Especially V3 loop position 9 was relevant for a switch to higher infectivity when occupied by R. Thus, K-to-R exchanges play a role for enhanced viral entry efficiency and should therefore be considered when the viral phenotype is predicted based on V3 sequence data.	[Schwalbe, Birco; Schreiber, Michael] Bernhard Nocht Inst Trop Med, Dept Virol, D-20359 Hamburg, Germany	Bernhard Nocht Institut fur Tropenmedizin	Schreiber, M (corresponding author), Bernhard Nocht Inst Trop Med, Dept Virol, Bernhard Nocht Str 74, D-20359 Hamburg, Germany.	Michael.Schreiber@bnitm.de		Schreiber, Michael/0000-0002-0690-6431				Alkhatib G, 1996, SCIENCE, V272, P1955, DOI 10.1126/science.272.5270.1955; Arroyo MA, 2002, AIDS RES HUM RETROV, V18, P447, DOI 10.1089/088922202753614218; Ashur-Fabian C, 2004, P NATL ACAD SCI USA, V101, P12236, DOI 10.1073/pnas.0404998101; BACK NKT, 1994, VIROLOGY, V199, P431, DOI 10.1006/viro.1994.1141; Berger EA, 1998, NATURE, V391, P240, DOI 10.1038/34571; Borggren M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020135; Bozek K, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1002977; CANN AJ, 1992, J VIROL, V66, P305, DOI 10.1128/JVI.66.1.305-309.1992; Cardozo T, 2007, AIDS RES HUM RETROV, V23, P415, DOI 10.1089/aid.2006.0130; Cashin K, 2013, RETROVIROLOGY, V10, DOI 10.1186/1742-4690-10-24; Clevestig P, 2006, J GEN VIROL, V87, P607, DOI 10.1099/vir.0.81510-0; Cocchi F, 1996, NAT MED, V2, P1244, DOI 10.1038/nm1196-1244; DEJONG JJ, 1992, J VIROL, V66, P757, DOI 10.1128/JVI.66.2.757-765.1992; Delobel P, 2007, J CLIN MICROBIOL, V45, P1572, DOI 10.1128/JCM.02090-06; Derdeyn CA, 2000, J VIROL, V74, P8358, DOI 10.1128/JVI.74.18.8358-8367.2000; Dybowski JN, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000743; Fatkenheuer G, 2005, NAT MED, V11, P1170, DOI 10.1038/nm1319; Foley B, 1995, HUM RETROVIRUSES AID, P77; FOUCHIER RAM, 1992, J VIROL, V66, P3183, DOI 10.1128/JVI.66.5.3183-3187.1992; Gallay P, 2004, MICROBES INFECT, V6, P617, DOI 10.1016/j.micinf.2004.02.004; Gilbert PB, 2003, VACCINE, V21, P2933, DOI 10.1016/S0264-410X(03)00158-0; Huang CC, 2005, SCIENCE, V310, P1025, DOI 10.1126/science.1118398; Huang CC, 2007, SCIENCE, V317, P1930, DOI 10.1126/science.1145373; Hung CS, 1999, J VIROL, V73, P8216, DOI 10.1128/JVI.73.10.8216-8226.1999; HWANG SS, 1991, SCIENCE, V253, P71, DOI 10.1126/science.1905842; Jensen MA, 2003, J VIROL, V77, P13376, DOI 10.1128/JVI.77.24.13376-13388.2003; Kalinina OV, 2013, RETROVIROLOGY, V10, DOI 10.1186/1742-4690-10-130; Koch M, 2003, VIROLOGY, V313, P387, DOI 10.1016/S0042-6822(03)00294-0; Lundberg M, 2003, MOL THER, V8, P143, DOI 10.1016/S1525-0016(03)00135-7; Mai JC, 2002, J BIOL CHEM, V277, P30208, DOI 10.1074/jbc.M204202200; Mefford ME, 2008, AIDS RES HUM RETROV, V24, P1215, DOI 10.1089/aid.2008.0009; MILICH L, 1993, J VIROL, V67, P5623, DOI 10.1128/JVI.67.9.5623-5634.1993; Mitchell DJ, 2000, J PEPT RES, V56, P318, DOI 10.1034/j.1399-3011.2000.00723.x; Oberlin E, 1996, NATURE, V382, P833, DOI 10.1038/382833a0; OH SK, 1992, J ACQ IMMUN DEF SYND, V5, P251; PANTALEO G, 1993, NATURE, V362, P355, DOI 10.1038/362355a0; Pfeifer N, 2012, BIOINFORMATICS, V28, pI589, DOI 10.1093/bioinformatics/bts373; Pillai S, 2003, AIDS RES HUM RETROV, V19, P145, DOI 10.1089/088922203762688658; Platt EJ, 2009, J VIROL, V83, P8289, DOI 10.1128/JVI.00709-09; Pollakis G, 2001, J BIOL CHEM, V276, P13433, DOI 10.1074/jbc.M009779200; Polzer S, 2002, VIROLOGY, V304, P70, DOI 10.1006/viro.2002.1760; Polzer S, 2001, GLYCOBIOLOGY, V11, P11, DOI 10.1093/glycob/11.1.11; Polzer Svenja, 2010, BMC Res Notes, V3, P155, DOI 10.1186/1756-0500-3-155; Polzer S, 2009, FEBS LETT, V583, P1201, DOI 10.1016/j.febslet.2009.03.010; PYLE SW, 1988, J VIROL, V62, P2258, DOI 10.1128/JVI.62.7.2258-2264.1988; REED L. J., 1938, AMER JOUR HYG, V27, P493; Resch W, 2001, VIROLOGY, V288, P51, DOI 10.1006/viro.2001.1087; RODERIQUEZ G, 1995, J VIROL, V69, P2233, DOI 10.1128/JVI.69.4.2233-2239.1995; Sander O, 2007, PLOS COMPUT BIOL, V3, P555, DOI 10.1371/journal.pcbi.0030058; SCHNEIDER J, 1986, J GEN VIROL, V67, P2533, DOI 10.1099/0022-1317-67-11-2533; Schreiber M, 1996, J GEN VIROL, V77, P2403, DOI 10.1099/0022-1317-77-10-2403; Schreiber M, 1997, CLIN EXP IMMUNOL, V107, P15, DOI 10.1046/j.1365-2249.1996.d01-909.x; SCHREIBER M, 1994, J VIROL, V68, P3908, DOI 10.1128/JVI.68.6.3908-3916.1994; Schwalbe B, 2014, J VIROL METHODS, V205, P91, DOI 10.1016/j.jviromet.2014.05.009; Siddiqui KS, 2006, PROTEINS, V64, P486, DOI 10.1002/prot.20989; Sierra S, 2007, EUR J MED RES, V12, P453; Sing T, 2007, ANTIVIR THER, V12, P1097; THOMPSON PD, 1991, BIOCHEMISTRY-US, V30, P8124, DOI 10.1021/bi00247a005; Tsuchiya K, 2013, SCI REP-UK, V3, DOI 10.1038/srep02389; Van Baelen K, 2007, J VIROL METHODS, V146, P61, DOI 10.1016/j.jviromet.2007.06.003; Wender PA, 2000, P NATL ACAD SCI USA, V97, P13003, DOI 10.1073/pnas.97.24.13003; Wilkin TJ, 2011, CLIN INFECT DIS, V52, P925, DOI 10.1093/cid/cir072; Xiang SH, 2010, J VIROL, V84, P3147, DOI 10.1128/JVI.02587-09; Zhang M, 2004, GLYCOBIOLOGY, V14, P1229, DOI 10.1093/glycob/cwh106	64	6	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2015	10	3							e0119879	10.1371/journal.pone.0119879	http://dx.doi.org/10.1371/journal.pone.0119879			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9BN	25785610	Green Published, Green Submitted, gold			2022-12-27	WOS:000352138500139
J	Bayne, RAL; Kinnell, HL; Coutts, SM; He, J; Childs, AJ; Anderson, RA				Bayne, Rosemary A. L.; Kinnell, Hazel L.; Coutts, Shiona M.; He, Jing; Childs, Andrew J.; Anderson, Richard A.			GDF9 is Transiently Expressed in Oocytes before Follicle Formation in the Human Fetal Ovary and is Regulated by a Novel NOBOX Transcript	PLOS ONE			English	Article							GROWTH-DIFFERENTIATION FACTOR-9; BONE MORPHOGENETIC PROTEIN-15; GERM-CELLS; GENE-EXPRESSION; SOMATIC-CELLS; DNA; FOLLICULOGENESIS; INITIATION; MUTATIONS; RECEPTORS	During human fetal ovary development, the process of primordial follicle formation is immediately preceded by a highly dynamic period of germ cell and somatic cell reorganisation. This is regulated by germ-cell specific transcription regulators, by the conserved RNA binding proteins DAZL and BOLL and by secreted growth factors of the TGF beta family, including activin beta A: these all show changing patterns of expression preceding follicle formation. In mice, the transcription factor Nobox is essential for follicle formation and oocyte survival, and NOBOX regulates the expression of GDF9 in humans. We have therefore characterised the expression of GDF9 in relation to these known key factors during follicle formation in the human fetal ovary. mRNA levels of GDF9, BMP15 and NOBOX were quantified by qRT-PCR and showed dramatic increases across gestation. GDF9 protein expression was localised by immunohistochemistry to the same population of germ cells as those expressing activin beta A prior to follicle formation but did not co-localise with either BOLL or DAZL. A novel NOBOX isoform was identified in fetal ovary that was shown to be capable of up-regulating the GDF9 promoter in reporter assays. Thus, during oogenesis in humans, oocytes go through a dynamic and very sharply demarcated sequence of changes in expression of these various proteins, even within individual germ cell nests, likely to be of major functional significance in determining selective germ cell survival at this key stage in ovarian development. Transcriptional variation may contribute to the range of age of onset of POI in women with NOBOX mutations.	[Bayne, Rosemary A. L.; Kinnell, Hazel L.; Coutts, Shiona M.; He, Jing; Anderson, Richard A.] Univ Edinburgh, MRC Ctr Reprod Hlth, Queens Med Res Inst, Edinburgh, Midlothian, Scotland; [Childs, Andrew J.] Univ London Royal Vet Coll, Dept Comparat Biomed Sci, London, England	University of Edinburgh; University of London; University of London Royal Veterinary College	Bayne, RAL (corresponding author), Univ Edinburgh, MRC Ctr Reprod Hlth, Queens Med Res Inst, Edinburgh, Midlothian, Scotland.	r.bayne@ed.ac.uk		Bayne, Rosemary (Rosey)/0000-0001-5820-6050	UK Medical Research Council [G1100357]; MRC [G1100357] Funding Source: UKRI; Medical Research Council [G1100357] Funding Source: researchfish	UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by the UK Medical Research Council [grant G1100357 to RAA]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albertini DF, 2011, J ASSIST REPROD GEN, V28, P567, DOI 10.1007/s10815-011-9615-8; Anderson RA, 2007, BMC DEV BIOL, V7, DOI 10.1186/1471-213X-7-136; Bendsen E, 2006, HUM REPROD, V21, P30, DOI 10.1093/humrep/dei280; Bouilly J, 2011, HUM MUTAT, V32, P1108, DOI 10.1002/humu.21543; Childs AJ, 2012, STEM CELLS DEV, V21, P2343, DOI 10.1089/scd.2011.0730; Childs AJ, 2012, METHODS MOL BIOL, V825, P199, DOI 10.1007/978-1-61779-436-0_15; Childs AJ, 2009, FERTIL STERIL, V92, P1416, DOI 10.1016/j.fertnstert.2009.03.095; Choi M, 2010, FEBS LETT, V584, P3629, DOI 10.1016/j.febslet.2010.07.037; Choi YS, 2007, BIOL REPROD, V77, P312, DOI 10.1095/biolreprod.107.060459; Choi Y, 2006, J BIOL CHEM, V281, P35747, DOI 10.1074/jbc.M604008200; Coutts SM, 2008, DEV BIOL, V314, P189, DOI 10.1016/j.ydbio.2007.11.026; da Silva SJM, 2004, DEV BIOL, V266, P334, DOI 10.1016/j.ydbio.2003.10.030; Dong JW, 1996, NATURE, V383, P531, DOI 10.1038/383531a0; Feng CW, 2014, MOL CELL ENDOCRINOL, V382, P488, DOI 10.1016/j.mce.2013.09.026; Fowler PA, 2014, HUM REPROD, V29, P1471, DOI 10.1093/humrep/deu117; Fowler PA, 2009, J CLIN ENDOCR METAB, V94, P1427, DOI 10.1210/jc.2008-2619; Gilchrist RB, 2008, HUM REPROD UPDATE, V14, P159, DOI 10.1093/humupd/dmm040; GONDOS B, 1986, AM J OBSTET GYNECOL, V155, P189, DOI 10.1016/0002-9378(86)90109-2; GRAHAM FL, 1977, J GEN VIROL, V36, P59, DOI 10.1099/0022-1317-36-1-59; Hanrahan JP, 2004, BIOL REPROD, V70, P900, DOI 10.1095/biolreprod.103.023093; He J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073996; Huntriss J, 2006, MOL HUM REPROD, V12, P283, DOI 10.1093/molehr/gal035; Joyce IM, 2000, BIOL REPROD, V63, P1669, DOI 10.1095/biolreprod63.6.1669; Knight PG, 2006, REPRODUCTION, V132, P191, DOI 10.1530/rep.1.01074; Lechowska A, 2011, J ASSIST REPROD GEN, V28, P583, DOI 10.1007/s10815-011-9553-5; Lin YF, 2008, SCIENCE, V322, P1685, DOI 10.1126/science.1166340; Margulis S, 2009, FERTIL STERIL, V92, P1666, DOI 10.1016/j.fertnstert.2008.08.119; MAXWELL IH, 1989, BIOTECHNIQUES, V7, P276; Mottershead DG, 2008, MOL CELL ENDOCRINOL, V283, P58, DOI 10.1016/j.mce.2007.11.007; Nilsson EE, 2002, BIOL REPROD, V67, P1018, DOI 10.1095/biolreprod.101.002527; Norling A, 2014, HUM REPROD, V29, P1818, DOI 10.1093/humrep/deu149; Oron G, 2010, REPROD BIOMED ONLINE, V21, P109, DOI 10.1016/j.rbmo.2010.03.011; Pangas SA, 2006, HUM REPROD UPDATE, V12, P65, DOI 10.1093/humupd/dmi033; Pangas SA, 2012, MOL CELL ENDOCRINOL, V356, P40, DOI 10.1016/j.mce.2011.06.021; Pepling ME, 1999, TRENDS CELL BIOL, V9, P257, DOI 10.1016/S0962-8924(99)01594-9; Peterson AJ, 2013, DEVELOPMENT, V140, P649, DOI 10.1242/dev.085605; Pulkki MM, 2011, MOL CELL ENDOCRINOL, V332, P106, DOI 10.1016/j.mce.2010.10.002; Qin YY, 2007, AM J HUM GENET, V81, P576, DOI 10.1086/519496; Rajkovic A, 2004, SCIENCE, V305, P1157, DOI 10.1126/science.1099755; Sarraj MA, 2012, REPRODUCTION, V143, P151, DOI 10.1530/REP-11-0247; Simpson CM, 2012, ENDOCRINOLOGY, V153, P1301, DOI 10.1210/en.2011-1632; Sun RZ, 2010, J MOL HISTOL, V41, P325, DOI 10.1007/s10735-010-9294-2; Suzumori N, 2002, MECH DEVELOP, V111, P137, DOI 10.1016/S0925-4773(01)00620-7; Tingen C, 2009, MOL HUM REPROD, V15, P795, DOI 10.1093/molehr/gap073; Wang C, 2006, ENDOCRINOLOGY, V147, P1725, DOI 10.1210/en.2005-1208; Wang JR, 2004, BIOL REPROD, V70, P577, DOI 10.1095/biolreprod.103.023234; Yan CN, 2001, MOL ENDOCRINOL, V15, P854, DOI 10.1210/me.15.6.854	47	34	36	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2015	10	3							e0119819	10.1371/journal.pone.0119819	http://dx.doi.org/10.1371/journal.pone.0119819			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD9NQ	25790371	Green Published, Green Accepted, gold			2022-12-27	WOS:000351425400108
J	Bogdanova, VS; Zaytseva, OO; Mglinets, AV; Shatskaya, NV; Kosterin, OE; Vasiliev, GV				Bogdanova, Vera S.; Zaytseva, Olga O.; Mglinets, Anatoliy V.; Shatskaya, Natalia V.; Kosterin, Oleg E.; Vasiliev, Gennadiy V.			Nuclear-Cytoplasmic Conflict in Pea (Pisum sativum L.) Is Associated with Nuclear and Plastidic Candidate Genes Encoding Acetyl-CoA Carboxylase Subunits	PLOS ONE			English	Article							COMPLETE NUCLEOTIDE-SEQUENCES; REPRODUCTIVE ISOLATION; SUBSECTION OENOTHERA; MALE-STERILITY; INCOMPATIBILITY; MITOCHONDRIAL; GENOME; COMPATIBILITY; PROTEIN; INHERITANCE	In crosses of wild and cultivated peas (Pisum sativum L.), nuclear-cytoplasmic incompatibility frequently occurs manifested as decreased pollen fertility, male gametophyte lethality, sporophyte lethality. High-throughput sequencing of plastid genomes of one cultivated and four wild pea accessions differing in cross-compatibility was performed. Candidate genes for involvement in the nuclear-plastid conflict were searched in the reconstructed plastid genomes. In the annotated Medicago truncatula genome, nuclear candidate genes were searched in the portion syntenic to the pea chromosome region known to harbor a locus involved in the conflict. In the plastid genomes, a substantial variability of the accD locus represented by nucleotide substitutions and indels was found to correspond to the pattern of cross-compatibility among the accessions analyzed. Amino acid substitutions in the polypeptides encoded by the alleles of a nuclear locus, designated as Bccp3, with a complementary function to accD, fitted the compatibility pattern. The accD locus in the plastid genome encoding beta subunit of the carboxyltransferase of acetyl-coA carboxylase and the nuclear locus Bccp3 encoding biotin carboxyl carrier protein of the same multi-subunit enzyme were nominated as candidate genes for main contribution to nuclear-cytoplasmic incompatibility in peas. Existence of another nuclear locus involved in the accD-mediated conflict is hypothesized.	[Bogdanova, Vera S.; Zaytseva, Olga O.; Mglinets, Anatoliy V.; Shatskaya, Natalia V.; Kosterin, Oleg E.; Vasiliev, Gennadiy V.] Russian Acad Sci, Inst Cytol & Genet, Siberian Div, Novosibirsk 630090, Russia; [Zaytseva, Olga O.; Kosterin, Oleg E.] Novosibirsk State Univ, Novosibirsk 630090, Russia	Russian Academy of Sciences; Institute of Cytology & Genetics ICG SB RAS; Novosibirsk State University	Kosterin, OE (corresponding author), Russian Acad Sci, Inst Cytol & Genet, Siberian Div, Novosibirsk 630090, Russia.	kosterin@bionet.nsc.ru	Vasiliev, Gennady V/U-7686-2018; Kosterin, Oleg/AAC-6480-2019	Kosterin, Oleg/0000-0001-5955-4057; Zaytseva, Olga/0000-0003-3960-5157	Presidium of Russian Academy of Sciences [30.27]	Presidium of Russian Academy of Sciences(Russian Academy of Sciences)	This work was supported by the grant 30.27 of the Presidium of Russian Academy of Sciences within the program 'Live Nature'. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; BENZEEV N, 1973, ISRAEL J BOT, V22, P73; Bogdanova V S, 2006, Dokl Biol Sci, V406, P44, DOI 10.1134/S0012496606010121; Bogdanova VS, 2014, THEOR APPL GENET, V127, P1163, DOI 10.1007/s00122-014-2288-9; Bogdanova VS, 2007, THEOR APPL GENET, V114, P333, DOI 10.1007/s00122-006-0436-6; Bogdanova VS, 2012, THEOR APPL GENET, V124, P1503, DOI 10.1007/s00122-012-1804-z; Bogdanova VS, 2009, THEOR APPL GENET, V118, P801, DOI 10.1007/s00122-008-0940-y; Bomblies K, 2010, ANNU REV PLANT BIOL, V61, P109, DOI 10.1146/annurev-arplant-042809-112146; Burke JM, 2001, ANNU REV GENET, V35, P31, DOI 10.1146/annurev.genet.35.102401.085719; Burton RS, 2013, ANNU REV ECOL EVOL S, V44, P281, DOI 10.1146/annurev-ecolsys-110512-135758; Chase CD, 2007, TRENDS GENET, V23, P81, DOI 10.1016/j.tig.2006.12.004; Chen JJ, 2008, P NATL ACAD SCI USA, V105, P11436, DOI 10.1073/pnas.0804761105; Chevreux B., 1999, GERMAN C BIOINFORMAT, V99, P45; Desviat LR, 2004, MOL GENET METAB, V83, P28, DOI 10.1016/j.ymgme.2004.08.001; Drescher A, 2000, PLANT J, V22, P97, DOI 10.1046/j.1365-313x.2000.00722.x; FROHMAN MA, 1994, PCR METH APPL, V4, pS40; Greiner S, 2008, MOL BIOL EVOL, V25, P2019, DOI 10.1093/molbev/msn149; Greiner S, 2008, NUCLEIC ACIDS RES, V36, P2366, DOI 10.1093/nar/gkn081; Gurdon C, 2014, DNA RES, V21, P417, DOI 10.1093/dnares/dsu007; Hanson MR, 2004, PLANT CELL, V16, pS154, DOI 10.1105/tpc.015966; Jansen RK, 2005, METHOD ENZYMOL, V395, P348, DOI 10.1016/S0076-6879(05)95020-9; Johnson NA, 2010, TRENDS GENET, V26, P317, DOI 10.1016/j.tig.2010.04.005; Kalo P, 2004, MOL GENET GENOMICS, V272, P235, DOI 10.1007/s00438-004-1055-z; Kikuchi S, 2013, SCIENCE, V339, P571, DOI 10.1126/science.1229262; KONIECZNY A, 1993, PLANT J, V4, P403, DOI 10.1046/j.1365-313X.1993.04020403.x; Kosterin OE, 2014, GENET RES CROP EVOL; Kozaki AK, 2001, J BIOL CHEM, V276, P39919, DOI 10.1074/jbc.M103525200; Kubo T, 2013, BREEDING SCI, V63, P359, DOI 10.1270/jsbbs.63.359; KUSHNIR S, 1991, MOL GEN GENET, V225, P225, DOI 10.1007/BF00269852; LANDER E S, 1987, Genomics, V1, P174, DOI 10.1016/0888-7543(87)90010-3; Lee HL, 2007, MOL BIOL EVOL, V24, P1161, DOI 10.1093/molbev/msm036; Levin DA, 2003, SYST BOT, V28, P5; Long YM, 2008, P NATL ACAD SCI USA, V105, P18871, DOI 10.1073/pnas.0810108105; Lowry DB, 2008, PHILOS T R SOC B, V363, P3009, DOI 10.1098/rstb.2008.0064; Magee AM, 2010, GENOME RES, V20, P1700, DOI 10.1101/gr.111955.110; Maxted N, 2001, CURR PLANT SCI BIOT, V39, P181; Milne I, 2013, BRIEF BIOINFORM, V14, P193, DOI 10.1093/bib/bbs012; Mizuta Y, 2010, P NATL ACAD SCI USA, V107, P20417, DOI 10.1073/pnas.1003124107; NAGANO Y, 1991, CURR GENET, V20, P431, DOI 10.1007/BF00317074; Osada N, 2012, MOL BIOL EVOL, V29, P337, DOI 10.1093/molbev/msr211; Ouyang YD, 2013, ANNU REV PLANT BIOL, V64, P111, DOI 10.1146/annurev-arplant-050312-120205; PALMER JD, 1985, GENETICS, V109, P195; Pershina LA, 2014, RUSS J GENET+, V50, P1017, DOI 10.1134/S102279541410010X; Quail MA, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-341; SASAKI Y, 1993, J BIOL CHEM, V268, P25118; Sasaki Y, 2004, BIOSCI BIOTECH BIOCH, V68, P1175, DOI 10.1271/bbb.68.1175; Schmitz-Linneweber C, 2005, PLANT CELL, V17, P1815, DOI 10.1105/tpc.105.032474; Schweer J, 2010, ENDOCYTOBIOSIS CELL, V20, P1; Simons KJ, 2003, GENETICS, V165, P2129; STUBBE W, 1959, Z VEREBUNGSL, V90, P288, DOI 10.1007/BF00888761; Tanksley SD, 1997, SCIENCE, V277, P1063, DOI 10.1126/science.277.5329.1063; Thelen JJ, 2001, PLANT PHYSIOL, V125, P2016, DOI 10.1104/pp.125.4.2016; Tong L, 2013, CELL MOL LIFE SCI, V70, P863, DOI 10.1007/s00018-012-1096-0; Yadrikhinskiy AK, 2011, DOKL AKAD NAUK, V441, P392; Zhao ZG, 2011, PLANTA, V233, P485, DOI 10.1007/s00425-010-1313-8; Zubko MK, 2001, PLANT J, V25, P627, DOI 10.1046/j.1365-313x.2001.00997.x	56	25	29	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2015	10	3							e0119835	10.1371/journal.pone.0119835	http://dx.doi.org/10.1371/journal.pone.0119835			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD9NQ	25789472	Green Published, Green Submitted, gold			2022-12-27	WOS:000351425400110
J	Johnson, FA; Frempong-Ainguah, F; Matthews, Z; Harfoot, AJP; Nyarko, P; Baschieri, A; Gething, PW; Falkingham, J; Atkinson, PM				Johnson, Fiifi Amoako; Frempong-Ainguah, Faustina; Matthews, Zoe; Harfoot, Andrew J. P.; Nyarko, Philomena; Baschieri, Angela; Gething, Peter W.; Falkingham, Jane; Atkinson, Peter M.			Evaluating the Impact of the Community-Based Health Planning and Services Initiative on Uptake of Skilled Birth Care in Ghana	PLOS ONE			English	Article							MATERNAL MORTALITY; BANGLADESH; INEQUALITIES; MODELS	Background The Community-based Health Planning and Services (CHPS) initiative is a major government policy to improve maternal and child health and accelerate progress in the reduction of maternal mortality in Ghana. However, strategic intelligence on the impact of the initiative is lacking, given the persistant problems of patchy geographical access to care for rural women. This study investigates the impact of proximity to CHPS on facilitating uptake of skilled birth care in rural areas. Methods and Findings Data from the 2003 and 2008 Demographic and Health Survey, on 4,349 births from 463 rural communities were linked to georeferenced data on health facilities, CHPS and topographic data on national road-networks. Distance to nearest health facility and CHPS was computed using the closest facility functionality in ArcGIS 10.1. Multilevel logistic regression was used to examine the effect of proximity to health facilities and CHPS on use of skilled care at birth, adjusting for relevant predictors and clustering within communities. The results show that a substantial proportion of births continue to occur in communities more than 8 km from both health facilities and CHPS. Increases in uptake of skilled birth care are more pronounced where both health facilities and CHPS compounds are within 8 km, but not in communities within 8 km of CHPS but lack access to health facilities. Where both health facilities and CHPS are within 8 km, the odds of skilled birth care is 16% higher than where there is only a health facility within 8km. Conclusion Where CHPS compounds are set up near health facilities, there is improved access to care, demonstrating the facilitatory role of CHPS in stimulating access to better care at birth, in areas where health facilities are accessible.	[Johnson, Fiifi Amoako; Matthews, Zoe; Baschieri, Angela; Falkingham, Jane] Univ Southampton, Fac Social & Human Sci, Div Social Stat & Demog, Southampton, Hants, England; [Johnson, Fiifi Amoako; Matthews, Zoe; Baschieri, Angela; Falkingham, Jane] Univ Southampton, Fac Social & Human Sci, Ctr Global Hlth Populat Poverty & Policy, Southampton, Hants, England; [Frempong-Ainguah, Faustina] Univ Ghana, Reg Inst Populat Studies, Legon, Accra, Ghana; [Harfoot, Andrew J. P.] Univ Southampton, GeoData Inst, Southampton, Hants, England; [Nyarko, Philomena] Ghana Stat Serv, Head Off Bldg, Accra, Ghana; [Gething, Peter W.] Univ Oxford, Dept Zool, Spatial Ecol & Epidemiol Grp, Oxford, England; [Atkinson, Peter M.] Univ Southampton, Geog & Environm, Southampton, Hants, England	University of Southampton; University of Southampton; University of Ghana; University of Southampton; Ghana Health Service; University of Oxford; University of Southampton	Johnson, FA (corresponding author), Univ Southampton, Fac Social & Human Sci, Div Social Stat & Demog, Southampton, Hants, England.	faj100@soton.ac.uk	Amoako Johnson, Fiifi/GWC-1466-2022; Gething, Peter/ABD-2110-2020; Matthews, Zoe/HGD-0506-2022; Gething, Peter/GQR-1884-2022	Gething, Peter/0000-0001-6759-5449; Harfoot, Andrew/0000-0001-9923-5018; Atkinson, Peter/0000-0002-5489-6880; Matthews, Zoe/0000-0003-1533-6618; Falkingham, Jane/0000-0002-7135-5875	UK Department for International Development (DfID); Economic & Social Research Council (ESRC) [Res-167-25-0343]	UK Department for International Development (DfID); Economic & Social Research Council (ESRC)(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC))	The study was funded by the UK Department for International Development (DfID) and the Economic & Social Research Council (ESRC) grant number Res-167-25-0343. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adongo PB, 2014, HEALTH RES POLICY SY, V12, DOI 10.1186/1478-4505-12-16; Ahmed T, 2009, REPROD HEALTH MATTER, V17, P45, DOI 10.1016/S0968-8080(09)33446-1; [Anonymous], GHAN MULT IND CLUST; Bailey PE, 2011, INT J GYNECOL OBSTET, V115, P300, DOI 10.1016/j.ijgo.2011.09.004; Bhutta ZA, 2012, JAMA-J AM MED ASSOC, V307, P2035, DOI 10.1001/jama.2012.4659; Binka FN, 2009, IN DEPTH REV COMMUNI; Boutayeb A, 2011, INT J EQUITY HEALTH, V10, DOI 10.1186/1475-9276-10-23; BRESLOW NE, 1993, J AM STAT ASSOC, V88, P9, DOI 10.1080/01621459.1993.10594284; Debpuur C, 2002, STUD FAMILY PLANN, V33, P141, DOI 10.1111/j.1728-4465.2002.00141.x; Dhakal S, 2007, LANCET, V370, P1301, DOI 10.1016/S0140-6736(07)61560-8; FAUVEAU V, 1991, LANCET, V338, P1183, DOI 10.1016/0140-6736(91)92041-Y; Gabrysch S, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1000394; Gething PW, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-991; Ghana Statistical Service (GSS), 2012, GHANA STAT SERV; Ghana Statistical Service (GSS) Noguchi Memorial Institute for Medical Research (NMIMR) and ORC Macro, 2004, GHAN DEM HLTH SURV 2; GHS, 2011, 2011 ANN REP GHS; GHS, 2002, COMM BAS HLTH PLANN; GHS, 2001, RED MAT NEWB DEATHS; GHS, 2007, REPR HLTH STRAT PLAN, DOI [10.1111/j.1447-0756.2012.02046.x, DOI 10.1111/J.1447-0756.2012.02046.X]; GHS, 2005, 20 GHS; Goldstein H, 1996, J ROY STAT SOC A STA, V159, P505, DOI 10.2307/2983328; Goldstein H, 1995, MULTILEVEL STAT MODE, DOI 10.1002/9780470973394; GSS, 2003, 2000 GHAN POP CENS A; Johnson FA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065527; Koblinsky M, 2008, J HEALTH POPUL NUTR, V26, P280; Kok MC, 2013, MALAWI MED J, V25, P5; Lee ACC, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-S3-S10; Mba CJ, 2010, J INT WOMENS STUDIES, V11, P143; MoH, 2008, NAT CONS M RED MAT M; MoH, 1999, COMM BAS HLTH PLANN; MoH GoG UN, 2011, NAT ASS EM OBST NEWB, DOI [10.1016/j.ijgo.2011.09.004, DOI 10.1016/J.IJGO.2011.09.004]; NDC, 2012, 2012 MAN ADV BETT GH; Nyonator FK, 2005, HEALTH POLICY PLANN, V20, P25, DOI 10.1093/heapol/czi003; Paruzzolo S., 2010, TARGETING POVERTY GE; Quarshie RT., 2010, EVALUATING RELEVANCE; Rasbash J., 2012, USERS GUIDE MLWIN VE; Sakeah E, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-344; UNFPA, 2012, GLOB PROGR ENH REPR; WHO, 2013, SOM SIT REP MAY JUL; World Health Organization (WHO), 2012, TRENDS MAT MORT 1990; World Health Organization (WHO), 2004, MAK PREGN SAF CRIT R; World Health Organization (WHO); UNFPA; UNICEF; Columbia University. Mailman School of Public Health, 2009, MON EM OBST CAR HDB; Zainullah P, 2013, AFGHANISTANS MIDWIFE	43	31	31	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2015	10	3							e0120556	10.1371/journal.pone.0120556	http://dx.doi.org/10.1371/journal.pone.0120556			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD9NQ	25789874	Green Published, gold, Green Accepted, Green Submitted			2022-12-27	WOS:000351425400163
J	Lee, HJ; Cho, H; Kim, MG; Heo, YK; Cho, Y; Gwon, YD; Park, KH; Jin, H; Kim, J; Oh, YK; Kim, YB				Lee, Hee-Jung; Cho, Hansam; Kim, Mi-Gyeong; Heo, Yoon-Ki; Cho, Yeondong; Gwon, Yong-Dae; Park, Ki Hoon; Jin, Hyerim; Kim, Jinyoung; Oh, Yu-Kyoung; Kim, Young Bong			Sublingual Immunization of Trivalent Human Papillomavirus DNA Vaccine in Baculovirus Nanovector for Protection against Vaginal Challenge	PLOS ONE			English	Article							VIRUS-LIKE PARTICLES; IMMUNE-RESPONSES; SENSITIVE MEASURE; MUCOSAL VACCINES; PROTEIN; ORGANS; MODEL; HPV	Here, we report the immunogenicity of a sublingually delivered, trivalent human papillomavirus (HPV) DNA vaccine encapsidated in a human endogenous retrovirus (HERV) envelopecoated, nonreplicable, baculovirus nanovector. The HERV envelope-coated, nonreplicable, baculovirus-based DNA vaccine, encoding HPV16L1, -18L1 and -58L1 (AcHERV-triHPV), was constructed and sublingually administered to mice without adjuvant. Following sublingual (SL) administration, AcHERV-triHPV was absorbed and distributed throughout the body. At 15 minutes and 1 day post-dose, the distribution of AcHERV-triHPV to the lung was higher than that to other tissues. At 30 days post-dose, the levels of AcHERV-triHPV had diminished throughout the body. Six weeks after the first of three doses, 1x10(8) copies of SL AcHERV-triHPV induced HPV type-specific serum IgG and neutralizing antibodies to a degree comparable to that of IM immunization with 1x10(9) copies. AcHERV-triHPV induced HPV type-specific vaginal IgA titers in a dose-dependent manner. SL immunization with 1x10(10) copies of AcHERV-triHPV induced Th1 and Th2 cellular responses comparable to IM immunization with 1x10(9) copies. Molecular imaging revealed that SL AcHERV-triHPV in mice provided complete protection against vaginal challenge with HPV16, HPV18, and HPV58 pseudoviruses. These results support the potential of SL immunization using multivalent DNA vaccine in baculovirus nanovector for induction of mucosal, systemic, and cellular immune responses.	[Lee, Hee-Jung; Cho, Hansam; Heo, Yoon-Ki; Cho, Yeondong; Gwon, Yong-Dae; Park, Ki Hoon; Kim, Young Bong] Konkuk Univ, Dept Bioind Technol, Seoul, South Korea; [Kim, Mi-Gyeong; Jin, Hyerim; Kim, Jinyoung; Oh, Yu-Kyoung] Seoul Natl Univ, Coll Pharm, Seoul, South Korea; [Kim, Mi-Gyeong; Jin, Hyerim; Kim, Jinyoung; Oh, Yu-Kyoung] Seoul Natl Univ, Pharmaceut Sci Res Inst, Seoul, South Korea	Konkuk University; Seoul National University (SNU); Seoul National University (SNU)	Oh, YK (corresponding author), Seoul Natl Univ, Coll Pharm, Seoul, South Korea.	ohyk@snu.ac.kr; kimera@konkuk.ac.kr	Oh, Yu Kyoung/G-8754-2013	Gwon, Yong-Dae/0000-0002-0703-4188; Oh, Yu-Kyoung/0000-0002-0969-3339	Korean Health Technology RD Project [A092010]	Korean Health Technology RD Project	The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. This work has been financially supported by grants from the Korean Health Technology R&D Project (No. A092010).	Azegami T, 2014, INT IMMUNOL, V26, P517, DOI 10.1093/intimm/dxu063; Bello A, 2014, SCI REP-UK, V4, DOI 10.1038/srep06644; Borde A, 2012, EUR J PHARM SCI, V47, P695, DOI 10.1016/j.ejps.2012.08.014; Buck CB, 2005, J VIROL, V79, P2839, DOI 10.1128/JVI.79.5.2839-2846.2005; Buck CB, 2004, J VIROL, V78, P751, DOI 10.1128/JVI.78.2.751-757.2004; Cho H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095961; Cho HJ, 2012, PHARM RES-DORDR, V29, P585, DOI 10.1007/s11095-011-0598-z; Cho HJ, 2010, VACCINE, V28, P2598, DOI 10.1016/j.vaccine.2010.01.013; Cuburu N, 2007, VACCINE, V25, P8598, DOI 10.1016/j.vaccine.2007.09.073; Cuburu N, 2009, J IMMUNOL, V183, P7851, DOI 10.4049/jimmunol.0803740; Day PM, 2012, CLIN VACCINE IMMUNOL, V19, P1075, DOI 10.1128/CVI.00139-12; Fields PA, 2000, MOL THER, V1, P225, DOI 10.1006/mthe.2000.0032; Hervouet C, 2014, MUCOSAL IMMUNOL, V7, P280, DOI 10.1038/mi.2013.45; Hervouet C, 2010, VACCINE, V28, P5582, DOI 10.1016/j.vaccine.2010.06.033; Huo ZM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033736; Jun S, 2012, INT IMMUNOL, V24, P117, DOI 10.1093/intimm/dxr106; Kim S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032226; Kraan H, 2014, J CONTROL RELEASE, V190, P580, DOI 10.1016/j.jconrel.2014.05.060; Kumar SR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063856; Lee HJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050296; Lee HJ, 2010, VACCINE, V28, P1613, DOI 10.1016/j.vaccine.2009.11.044; Liu XS, 1998, VIROLOGY, V252, P39, DOI 10.1006/viro.1998.9442; Liu XS, 2002, IMMUNOL CELL BIOL, V80, P21, DOI 10.1046/j.1440-1711.2002.01051.x; Longet S, 2011, J VIROL, V85, P13253, DOI 10.1128/JVI.06093-11; Luo WY, 2013, J VIROL, V87, P4965, DOI 10.1128/JVI.03510-12; Martinez X, 1997, P NATL ACAD SCI USA, V94, P8726, DOI 10.1073/pnas.94.16.8726; Nagai Y, 2015, CLIN EXP ALLERGY, V45, P677, DOI 10.1111/cea.12329; Neutra MR, 2006, NAT REV IMMUNOL, V6, P148, DOI 10.1038/nri1777; Park HK, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0032847, 10.1371/journal.pone.0039921]; Pavot V, 2012, VACCINE, V30, P142, DOI 10.1016/j.vaccine.2011.11.003; Roberts JN, 2007, NAT MED, V13, P857, DOI 10.1038/nm1598; Rossi A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107377; Shim Byoung-Shik, 2013, Immune Netw, V13, P81, DOI 10.4110/in.2013.13.3.81; Shim BS, 2012, VIROL J, V9, DOI 10.1186/1743-422X-9-215; Singh S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090001; Song JH, 2008, P NATL ACAD SCI USA, V105, P1644, DOI 10.1073/pnas.0708684105; Xu YF, 2006, ARCH VIROL, V151, P2133, DOI 10.1007/s00705-006-0798-8	37	12	12	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2015	10	3							e0119408	10.1371/journal.pone.0119408	http://dx.doi.org/10.1371/journal.pone.0119408			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD9NQ	25789464	Green Published, gold, Green Submitted			2022-12-27	WOS:000351425400080
J	Li, ZJ; Hou, Y; Qin, DA; Jin, ZM; Hu, ML				Li, Zhao-Jun; Hou, Yong; Qin, Da-An; Jin, Zhi-Min; Hu, Mao-Lin			Two Half-Sandwiched Ruthenium (II) Compounds Containing 5-Fluorouracil Derivatives: Synthesis and Study of DNA Intercalation	PLOS ONE			English	Article							COORDINATION CHEMISTRY; BINDING-PROPERTIES; COMPLEXES; SPECTROSCOPY; BERBERINE; DESIGN; MOTIFS; RNA	Two novel coordination compounds of half-sandwiched ruthenium(II) containing 2-(5-fluorouracil)-yl-N-(pyridyl)-acetamide were synthesized, and their intercalation binding modes with calf thymus DNA were revealed by hyperchromism of ultraviolet-visible spectroscopy; the binding constants were determined according to a Langmuir adsorption equation that was deduced on the base of careful cyclic voltammetry measurements. The two compounds exhibited DNA intercalation binding activities with the binding constants of 1.13x10(6) M-1 and 5.35 x10(5) M-1, respectively.	[Li, Zhao-Jun] Chinese Acad Agr Sci, Inst Agr Resources & Reg Planning, Key Lab Plant Nutr & Fertilizer, Minist Agr, Beijing 100193, Peoples R China; [Hou, Yong] Sichuan Acad Agr Sci, Inst Biotechnol & Nucle Technol, Chengdu, Peoples R China; [Qin, Da-An; Hu, Mao-Lin] Wenzhou Univ, Coll Chem & Mat Engn, Wenzhou, Peoples R China; [Jin, Zhi-Min] Zhejiang Univ Technol, Coll Pharmaceut Sci, Hangzhou, Zhejiang, Peoples R China	Chinese Academy of Agricultural Sciences; Institute of Agricultural Resources & Regional Planning, CAAS; Ministry of Agriculture & Rural Affairs; Sichuan Academy of Agricultural Sciences (SAAS); Wenzhou University; Zhejiang University of Technology	Jin, ZM (corresponding author), Zhejiang Univ Technol, Coll Pharmaceut Sci, Hangzhou, Zhejiang, Peoples R China.	zimichem@sina.com; maolin@wzu.edu.cn	Li, zhaojun/E-5735-2012		Natural Science Foundation of Institute of Agricultural Resources and Regional Planning, Chinese Academy of Agricultural Sciences [20143]; special projects foundation of Beijing Municipal Science & Technology Commission [Z141105000614012]; Natural Science Foundation of China [21071111, 21371137]	Natural Science Foundation of Institute of Agricultural Resources and Regional Planning, Chinese Academy of Agricultural Sciences; special projects foundation of Beijing Municipal Science & Technology Commission; Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was jointly supported by the Natural Science Foundation of Institute of Agricultural Resources and Regional Planning, Chinese Academy of Agricultural Sciences (Project No. 20143; website: http://www.iarrp.cn) and the special projects foundation of Beijing Municipal Science & Technology Commission (Z141105000614012). This research was also supported by the Natural Science Foundation of China (Nos. 21071111 and 21371137); website: http://www.nsfc.gov.cn (Nos. 21071111 and 21371137). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akiyama Y, 2008, J AM CHEM SOC, V130, P9650, DOI 10.1021/ja802905g; Arjmand F, 2005, EUR J MED CHEM, V40, P1103, DOI 10.1016/j.ejmech.2005.05.005; Arjmand F, 2006, BIOINORG CHEM APPL, V2006, DOI 10.1155/BCA/2006/32896; Baldini M, 2003, INORG CHEM, V42, P2049, DOI 10.1021/ic026131d; Bathaie SZ, 1999, NUCLEIC ACIDS RES, V27, P1001, DOI 10.1093/nar/27.4.1001; Campbell NH, 2011, ORG BIOMOL CHEM, V9, P1328, DOI 10.1039/c0ob00886a; CARTER MT, 1989, J AM CHEM SOC, V111, P8901, DOI 10.1021/ja00206a020; Conejo-Garcia A, 2005, BIOORG MED CHEM LETT, V15, P4004, DOI 10.1016/j.bmcl.2005.06.026; Ding YH, 2010, J PHYS CHEM B, V114, P2033, DOI 10.1021/jp9104757; Dougan SJ, 2007, CHIMIA, V61, P704, DOI 10.2533/chimia.2007.704; Elder RM, 2011, BIOMACROMOLECULES, V12, P3870, DOI 10.1021/bm201113y; Erkkila KE, 1999, CHEM REV, V99, P2777, DOI 10.1021/cr9804341; Froehlich E, 2011, BIOMACROMOLECULES, V12, P2780, DOI 10.1021/bm200547e; Hobro AJ, 2007, NUCLEIC ACIDS RES, V35, P1169, DOI 10.1093/nar/gkm012; Jin BK, 2004, ELECTROCHIM ACTA, V50, P1049, DOI 10.1016/j.electacta.2004.08.017; Kalanur SS, 2011, COLLOID SURFACE B, V82, P438, DOI 10.1016/j.colsurfb.2010.09.017; Kashanian S, 2007, SPECTROCHIM ACTA A, V67, P472, DOI 10.1016/j.saa.2006.08.017; Kashanian S, 2008, DNA CELL BIOL, V27, P325, DOI 10.1089/dna.2007.0718; Li LL, 2012, DALTON T, V41, P12766, DOI 10.1039/c2dt30665d; Li QS, 1996, J INORG BIOCHEM, V64, P181, DOI 10.1016/0162-0134(96)00039-6; Li XC, 2012, J MOL STRUCT, V1027, P104, DOI 10.1016/j.molstruc.2012.05.070; Li XL, 2012, BIOMACROMOLECULES, V13, P873, DOI 10.1021/bm2017959; Liang MM, 2011, MOL PHARMACEUT, V8, P126, DOI 10.1021/mp100229z; Liu KG, 2012, INORG CHIM ACTA, V388, P78, DOI 10.1016/j.ica.2012.02.046; Liu SQ, 2004, COLLOID SURFACE B, V36, P155, DOI 10.1016/j.colsurfb.2004.03.020; Lyles MB, 2002, BIOPHYS CHEM, V96, P53, DOI 10.1016/S0301-4622(02)00036-4; Pang DW, 1998, ANAL CHEM, V70, P3162, DOI 10.1021/ac980211a; Ping Y, 2008, J MOL STRUCT, V882, P75, DOI 10.1016/j.molstruc.2007.09.017; Rahban M, 2010, J PHYS CHEM C, V114, P5798, DOI 10.1021/jp910656g; Ronconi L, 2007, COORDIN CHEM REV, V251, P1633, DOI 10.1016/j.ccr.2006.11.017; Ruiz J, 2011, INORG CHEM, V50, P9164, DOI 10.1021/ic201388n; Shi Y, 2011, BIOMACROMOLECULES, V12, P797, DOI 10.1021/bm101414w; Sinha R, 2011, CHEM BIODIVERS, V8, P1512, DOI 10.1002/cbdv.201000182; Tan JH, 2007, EUR J MED CHEM, V42, P1169, DOI 10.1016/j.ejmech.2007.02.002; Tong CL, 2010, J AGR FOOD CHEM, V58, P5257, DOI 10.1021/jf1000748; Wang BD, 2007, J INORG BIOCHEM, V101, P1492, DOI 10.1016/j.jinorgbio.2007.04.007; Wang BD, 2006, BIOORGAN MED CHEM, V14, P6012, DOI 10.1016/j.bmc.2006.05.015; Xu ZQ, 2013, COLLOID SURFACE B, V110, P321, DOI 10.1016/j.colsurfb.2013.04.040	38	5	5	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2015	10	3							e0120211	10.1371/journal.pone.0120211	http://dx.doi.org/10.1371/journal.pone.0120211			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD9NQ	25789618	gold, Green Published, Green Submitted			2022-12-27	WOS:000351425400141
J	Ogata, Y; Matono, K; Tsuda, H; Ushijima, M; Uchida, S; Akagi, Y; Shirouzu, K				Ogata, Yutaka; Matono, Keiko; Tsuda, Hideaki; Ushijima, Masataka; Uchida, Shinji; Akagi, Yoshito; Shirouzu, Kazuo			Randomized Phase II Study of 5-Fluorouracil Hepatic Arterial Infusion with or without Antineoplastons as an Adjuvant Therapy after Hepatectomy for Liver Metastases from Colorectal Cancer	PLOS ONE			English	Article							HISTONE DEACETYLASE INHIBITORS; CELLS-IN-VITRO; HEPATOCELLULAR-CARCINOMA; COLON-CANCER; RESECTION; DIFFERENTIATION; PHENYLBUTYRATE; PHENYLACETATE; SURVIVAL; GROWTH	Background Antineoplastons are naturally occurring peptides and amino acid derivatives found in human blood and urine. Antineoplaston A10 and AS2-1 reportedly control neoplastic growth and do not significantly inhibit normal cell growth. Antineoplastons contain 3-phenylacetyla-mino-2, 6-piperidinedione (A10), phenylacetylglutamine plus phenylacetylisoglutamine (A10-I), and phenylacetylglutamine plus phenylacetate (AS2-1). This open label, non-blinded randomized phase II study compared the efficacy of hepatic arterial infusion (HAI) with 5-fluorouracil, with or without antineoplastons as a postoperative therapy for colorectal metastasis to the liver. Methods Sixty-five patients with histologically confirmed metastatic colon adenocarcinoma in liver, who had undergone hepatectomy, and/or thermal ablation for liver metastases were enrolled between 1998-2004 in Kurume University Hospital. Patients were randomly assigned to receive systemic antineoplastons (A10-I infusion followed by per-oral AS2-1) plus HAI (AN arm) or HAI alone (control arm) based on the number of metastases and presence/absence of extra-hepatic metastasis at the time of surgery. Primary endpoint was cancer-specific survival (CSS); secondary endpoints were relapse-free survival (RFS), status and extent of recurrence, salvage surgery (rate) and toxicity. Findings Overall survival was not statistically improved (p=0.105) in the AN arm (n=32). RFS was not significant (p=0.343). Nevertheless, the CSS rate was significantly higher in the AN arm versus the control arm (n=33) with a median survival time 67 months (95% CI 43-not calculated) versus 39 months (95% CI 28-47) (p=0.037) and 5 year CSS rate 60% versus 32% respectively. Cancer recurred more often in a single organ than in multiple organs in the AN arm versus the control arm. The limited extent of recurrent tumours in the AN arm meant more patients remained eligible for salvage surgery. Major adverse effects of antineoplastons were fullness of the stomach and phlebitis. No serious toxicity, including bone marrow suppression, liver or renal dysfunction, were found in the AN arm. Interpretation Antineoplastons (A10 Injection and AS2-1) might be useful as adjunctive therapy in addition to HAI after hepatectomy in colorectal metastases to the liver.	[Ogata, Yutaka; Uchida, Shinji] Kurume Univ, Med Ctr, Dept Surg, Kurume, Fukuoka 830, Japan; [Matono, Keiko; Ushijima, Masataka; Akagi, Yoshito; Shirouzu, Kazuo] Kurume Univ, Sch Med, Dept Surg, Kurume, Fukuoka 830, Japan; [Tsuda, Hideaki] Kurume Daiichi Social Insurance Hosp, Kurume, Fukuoka, Japan	Kurume University; Kurume University	Ogata, Y (corresponding author), Kurume Univ, Med Ctr, Dept Surg, Kurume, Fukuoka 830, Japan.	yogata@med.kurume-u.ac.jp			Ministry of Education, Culture, Sports, Science and Technology of Japan [13671364, 14770672]	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by a Grant-in-Aid for Scientific Research (C) (No. 13671364) and a Grant-in-Aid for Young Scientist (B) (No. 14770672) from the Ministry of Education, Culture, Sports, Science and Technology of Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Buckner JC, MAYO CLIN P; BURZYNSKI SR, 1976, PHYSIOL CHEM PHYS M, V8, P275; ENSMINGER WD, 1978, CANCER RES, V38, P3784; Fong Y, 1999, ANN SURG, V230, P309, DOI 10.1097/00000658-199909000-00004; Harrison LE, 1998, SURGERY, V124, P541, DOI 10.1067/msy.1998.90180; Iannitti T, 2011, DRUGS R&D, V11, P227, DOI 10.2165/11591280-000000000-00000; Kanas Gena P, 2012, Clin Epidemiol, V4, P283, DOI 10.2147/CLEP.S34285; Kanat O, 2012, J GASTROINTEST ONCOL, V3, P130, DOI 10.3978/j.issn.2078-6891.2011.025; Kemeny N, 1999, NEW ENGL J MED, V341, P2039, DOI 10.1056/NEJM199912303412702; Kemeny NE, 2005, NEW ENGL J MED, V352, P734, DOI 10.1056/NEJM200502173520723; LIAU M C, 1989, International Journal of Experimental and Clinical Chemotherapy, V2, P187; LIU L, 1994, J INVEST DERMATOL, V103, P335, DOI 10.1111/1523-1747.ep12394874; Marks PA, 2000, JNCI-J NATL CANCER I, V92, P1210, DOI 10.1093/jnci/92.15.1210; Matono K, 2005, ONCOL REP, V13, P389; Melchior SW, 1999, INT J ONCOL, V14, P501; Mitry E, 2008, J CLIN ONCOL, V26, P4906, DOI 10.1200/JCO.2008.17.3781; Mocellin S, 2007, J CLIN ONCOL, V25, P5649, DOI 10.1200/JCO.2007.12.1764; Nelson R, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003770.pub3; Nishida H, 1991, J JPN SOC CANC THER, V26, P595; Nordlinger B, 2008, LANCET, V371, P1007, DOI 10.1016/S0140-6736(08)60455-9; Ogata Y, 2010, ANN ONCOL, V21, P221; Portier G, 2006, J CLIN ONCOL, V24, P4976, DOI 10.1200/JCO.2006.06.8353; Qiu TZ, 2013, FUTURE ONCOL, V9, P255, DOI [10.2217/fon.12.173, 10.2217/FON.12.173]; Rees M, 2008, ANN SURG, V247, P125, DOI 10.1097/SLA.0b013e31815aa2c2; SAMID D, 1993, J CLIN INVEST, V91, P2288, DOI 10.1172/JCI116457; Sung MW, 2007, ANTICANCER RES, V27, P995; Tomlinson JS, 2007, J CLIN ONCOL, V25, P4575, DOI 10.1200/JCO.2007.11.0833; TSUDA H, 1992, JPN J CANCER RES, V83, P527, DOI 10.1111/j.1349-7006.1992.tb01960.x; Tsuda Hideaki, 1995, Kurume Medical Journal, V42, P241; Tsuda Hideaki, 1996, Kurume Medical Journal, V43, P137; Ushijima M, 2014, ONCOL REP, V31, P19, DOI 10.3892/or.2013.2839; Wagner JM, 2010, CLIN EPIGENETICS, V1, DOI 10.1007/s13148-010-0012-4; Weber SM, 2000, ANN SURG ONCOL, V7, P643, DOI 10.1007/s10434-000-0643-3; Yeo W, 2012, J CLIN ONCOL, V30, P3361, DOI 10.1200/JCO.2011.41.2395	34	2	3	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2015	10	3							e0120064	10.1371/journal.pone.0120064	http://dx.doi.org/10.1371/journal.pone.0120064			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD9NQ	25790229	Green Published, Green Submitted, gold			2022-12-27	WOS:000351425400126
J	Suzuki, K; Kumei, S; Ohhira, M; Nozu, T; Okumura, T				Suzuki, Keiko; Kumei, Shima; Ohhira, Masumi; Nozu, Tsukasa; Okumura, Toshikatsu			Screening for Major Depressive Disorder with the Patient Health Questionnaire (PHQ-9 and PHQ-2) in an Outpatient Clinic Staffed by Primary Care Physicians in Japan: A Case Control Study	PLOS ONE			English	Article							INTERNATIONAL NEUROPSYCHIATRIC INTERVIEW; VALIDITY; METAANALYSIS; VERSION	Objective The Patient Health Questionnaire (PHQ-9) is a self-report questionnaire commonly used to screen for depression, with >= 8-11 generally recommended as the cut-off. In Japan, studies of the validity of the PHQ-9 and PHQ-2 have been limited. In this study, we examined the utility of the PHQ-9 and PHQ-2 at an outpatient clinic in a Medical University Hospital in Japan. Methods New consecutive outpatients were included in the study. We administered the PHQ-9 to 574 patients, and acquired complete PHQ-9 and PHQ-2 data for 521 patients. Major depressive disorders were diagnosed according to the DSM-IV-TR. Results Forty-two patients were diagnosed with major depressive disorders. The mean PHQ-9 (15.7) and PHQ-2 (3.8) scores of the patients with major depressive disorders were significantly higher than the scores of the patients without depression (6.0 (PHQ-9) and 1.8 (PHQ-2)). The best cut-off points for the PHQ-9 and PHQ-2 summary scores were >= 11 (sensitivity 0.76, specificity 0.81) and >= 3 (sensitivity 0.76, specificity 0.82), respectively. No relationship was observed between the age and PHQ-9 scores. Conclusion The PHQ-9 and PHQ-2 were useful instruments for screening for major depressive disorders. The best cut-off point for the PHQ-9 summary score should be >= 11 to detect depression in the primary care setting in Japan.	[Suzuki, Keiko; Kumei, Shima; Ohhira, Masumi; Okumura, Toshikatsu] Asahikawa Univ Hosp, Dept Gen Med, Asahikawa, Hokkaido, Japan; [Suzuki, Keiko] Asahikawa City Hosp, Dept Gen Internal Med, Asahikawa, Hokkaido, Japan; [Nozu, Tsukasa] Asahikawa Univ Hosp, Dept Reg Med & Educ, Asahikawa, Hokkaido, Japan		Suzuki, K (corresponding author), Asahikawa Univ Hosp, Dept Gen Med, Asahikawa, Hokkaido, Japan.	kii_suzu@yahoo.co.jp		Okumura, Toshikatsu/0000-0003-1810-007X; Suzuki, Keiko/0000-0002-4285-0658				Arroll B, 2010, ANN FAM MED, V8, P348, DOI 10.1370/afm.1139; Gilbody S, 2007, J GEN INTERN MED, V22, P1596, DOI 10.1007/s11606-007-0333-y; Inagaki M, 2013, GEN HOSP PSYCHIAT, V35, P592, DOI 10.1016/j.genhosppsych.2013.08.001; Inoue T, 2012, BMC PSYCHIATRY, V12, DOI 10.1186/1471-244X-12-73; Lowe B, 2005, J PSYCHOSOM RES, V58, P163, DOI 10.1016/j.jpsychores.2004.09.006; Manea L, 2012, CAN MED ASSOC J, V184, pE191, DOI 10.1503/cmaj.110829; McManus D, 2005, AM J CARDIOL, V96, P1076, DOI 10.1016/j.amjcard.2005.06.037; Muramatsu K, 2007, PSYCHOL REP, V101, P952, DOI 10.2466/pr0.101.3.952-960; National Collaborating Centre for Mental Health, 2004, CG90 NAT I HLTH CLIN; Otsubo T, 2005, PSYCHIAT CLIN NEUROS, V59, P517, DOI 10.1111/j.1440-1819.2005.01408.x; Sartorius N, 1996, BRIT J PSYCHIAT, V168, P38, DOI 10.1192/S0007125000298395; Simon GE, 2002, GEN HOSP PSYCHIAT, V24, P328, DOI 10.1016/S0163-8343(02)00201-3; Tylee Andre, 2005, Prim Care Companion J Clin Psychiatry, V7, P167	13	18	18	4	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2015	10	3							e0119147	10.1371/journal.pone.0119147	http://dx.doi.org/10.1371/journal.pone.0119147			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CD9NQ	25789476	Green Published, gold, Green Submitted			2022-12-27	WOS:000351425400070
J	Tribouillois, H; Fort, F; Cruz, P; Charles, R; Flores, O; Garnier, E; Justes, E				Tribouillois, Helene; Fort, Florian; Cruz, Pablo; Charles, Raphael; Flores, Olivier; Garnier, Eric; Justes, Eric			A Functional Characterisation of a Wide Range of Cover Crop Species: Growth and Nitrogen Acquisition Rates, Leaf Traits and Ecological Strategies	PLOS ONE			English	Article							PLANT TRAITS; CATCH CROPS; WILD; GRASSLANDS; ROOT; DECOMPOSABILITY; PHOTOSYNTHESIS; TOLERANCE; ECONOMICS; DEPEND	Cover crops can produce ecosystem services during the fallow period, as reducing nitrate leaching and producing green manure. Crop growth rate (CGR) and crop nitrogen acquisition rate (CNR) can be used as two indicators of the ability of cover crops to produce these services in agrosystems. We used leaf functional traits to characterise the growth strategies of 36 cover crops as an approach to assess their ability to grow and acquire N rapidly. We measured specific leaf area (SLA), leaf dry matter content (LDMC), leaf nitrogen content (LNC) and leaf area (LA) and we evaluated their relevance to characterise CGR and CNR. Cover crop species were positioned along the Leaf Economics Spectrum (LES), the SLA-LDMC plane, and the CSR triangle of plant strategies. LA was positively correlated with CGR and CNR, while LDMC was negatively correlated with CNR. All cover crops could be classified as resource-acquisitive species from their relative position on the LES and the SLA-LDMC plane. Most cover crops were located along the Competition/Ruderality axis in the CSR triangle. In particular, Brassicaceae species were classified as very competitive, which was consistent with their high CGR and CNR. Leaf functional traits, especially LA and LDMC, allowed to differentiate some cover crops strategies related to their ability to grow and acquire N. LDMC was lower and LNC was higher in cover crop than in wild species, pointing to an efficient acquisitive syndrome in the former, corresponding to the high resource availability found in agrosystems. Combining several leaf traits explained approximately half of the CGR and CNR variances, which might be considered insufficient to precisely characterise and rank cover crop species for agronomic purposes. We hypothesised that may be the consequence of domestication process, which has reduced the range of plant strategies and modified the leaf trait syndrome in cultivated species.	[Tribouillois, Helene; Fort, Florian; Cruz, Pablo; Justes, Eric] INRA, UMR AGIR, 24 Chem Borde Rouge Auzeville,CS 52627, F-31326 Castanet Tolosan, France; [Charles, Raphael] Agroscope, Inst Plant Prod Sci, CH-1260 Nyon 1, Switzerland; [Flores, Olivier] Univ Reunion, CIRAD, UMR Peuplements Vegetaux & Bioagresseurs Milieu T, F-97410 St Pierre, France; [Garnier, Eric] Univ Paul Valery Montpellier, Univ Montpellier, CNRS, EPHE,Ctr Ecol Fonct & Evolut,UMR 5175, F-34293 Montpellier 5, France	INRAE; Swiss Federal Research Station Agroscope; CIRAD; University of La Reunion; UDICE-French Research Universities; PSL Research University Paris; Ecole Pratique des Hautes Etudes (EPHE); Institut Agro; Montpellier SupAgro; CIRAD; Centre National de la Recherche Scientifique (CNRS); Institut de Recherche pour le Developpement (IRD); Universite Paul-Valery; Universite de Montpellier	Justes, E (corresponding author), INRA, UMR AGIR, 24 Chem Borde Rouge Auzeville,CS 52627, F-31326 Castanet Tolosan, France.	eric.justes@toulouse.inra.fr	Garnier, Eric/D-1650-2012; Justes, Eric/GLT-6299-2022; Fort, Florian/H-4827-2019; Charles, Raphaël/AAA-8722-2022	Garnier, Eric/0000-0002-9392-5154; Justes, Eric/0000-0001-7390-7058; Fort, Florian/0000-0001-7983-6254; Flores, Olivier/0000-0002-1416-0449; Charles, Raphael/0000-0001-6563-7764	Arvalis-Institut du Vegetal; Midi-Pyrenees Region; UMR AGIR lab; INRA (Institut national de la recherche agronomique); ANR (Agence nationale de la recherche) (MicMac-design, Programme STRA) [ANR-09-STRA-06]	Arvalis-Institut du Vegetal; Midi-Pyrenees Region(Region Occitanie); UMR AGIR lab; INRA (Institut national de la recherche agronomique); ANR (Agence nationale de la recherche) (MicMac-design, Programme STRA)(French National Research Agency (ANR))	This study was supported by Arvalis-Institut du Vegetal, the Midi-Pyrenees Region, the UMR AGIR lab, INRA (Institut national de la recherche agronomique) and the ANR (Agence nationale de la recherche) (project ANR-09-STRA-06; MicMac-design, Programme STRA 2009). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aerts R, 2000, ADV ECOL RES, V30, P1, DOI 10.1016/S0065-2504(08)60016-1; Al Haj Khaled R, 2005, J VEG SCI, V16, P391, DOI 10.1111/j.1654-1103.2005.tb02378.x; Bedoussac L, 2010, PLANT SOIL, V330, P37, DOI 10.1007/s11104-010-0303-8; Cornelissen JHC, 2003, AUST J BOT, V51, P335, DOI 10.1071/BT02124; Cruz P, 2010, RANGELAND ECOL MANAG, V63, P350, DOI 10.2111/08-016.1; Damour G, 2014, EUR J AGRON, V52, P218, DOI 10.1016/j.eja.2013.09.004; Diaz S, 2004, J VEG SCI, V15, P295, DOI 10.1111/j.1654-1103.2004.tb02266.x; Fortunel C, 2009, ECOLOGY, V90, P598, DOI 10.1890/08-0418.1; Gambino P, 2011, IND CROP PROD, V34, P1269, DOI 10.1016/j.indcrop.2010.07.014; Garcia-Palacios P, 2013, NEW PHYTOL, V198, P504, DOI 10.1111/nph.12127; Garnier E, 2001, FUNCT ECOL, V15, P688, DOI 10.1046/j.0269-8463.2001.00563.x; Garnier E, 2007, ANN BOT-LONDON, V99, P967, DOI 10.1093/aob/mcl215; Garnier E, 2012, AGRON SUSTAIN DEV, V32, P365, DOI 10.1007/s13593-011-0036-y; Grime J. P., 1979, Plant strategies and vegetation processes.; GRIME JP, 1977, AM NAT, V111, P1169, DOI 10.1086/283244; Grime JP, 1997, OIKOS, V79, P259, DOI 10.2307/3546011; GRIME JP, 1975, J ECOL, V63, P393, DOI 10.2307/2258728; Hajek P, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00415; Hodgson JG, 1999, OIKOS, V85, P282, DOI 10.2307/3546494; JENSEN ES, 1991, ACTA AGR SCAND, V41, P333, DOI 10.1080/00015129109439917; Justes E, 2009, PLANT SOIL, V325, P171, DOI 10.1007/s11104-009-9966-4; Justes E., 2012, INT FERT SOC M CAMBR, P4; Justes E, 2012, REDUIRE FUITES NITRA, P404; KARIMI MM, 1991, AUST J AGR RES, V42, P13, DOI 10.1071/AR9910013; Kattge J, 2011, GLOBAL CHANGE BIOL, V17, P2905, DOI 10.1111/j.1365-2486.2011.02451.x; Kazakou E, 2014, J VEG SCI, V25, P235, DOI 10.1111/jvs.12066; Kazakou E, 2009, ANN BOT-LONDON, V104, P1151, DOI 10.1093/aob/mcp202; Kristensen HL, 2004, SOIL SCI SOC AM J, V68, P529, DOI 10.2136/sssaj2004.0529; LAMBERS H, 1992, ADV ECOL RES, V23, P187, DOI 10.1016/S0065-2504(08)60148-8; Lopes MS, 2011, J EXP BOT, V62, P3135, DOI 10.1093/jxb/err105; LUDLOW MM, 1990, ADV AGRON, V43, P107; Pierce S, 2013, FUNCT ECOL, V27, P1002, DOI 10.1111/1365-2435.12095; POORTER H, 1992, PLANT CELL ENVIRON, V15, P221, DOI 10.1111/j.1365-3040.1992.tb01476.x; Poorter H., 2007, FUNCTIONAL PLANT ECO, P67, DOI DOI 10.1201/9781420007626; Pujol B, 2008, BIOTROPICA, V40, P305, DOI 10.1111/j.1744-7429.2007.00373.x; Reich PB, 1998, FUNCT ECOL, V12, P395, DOI 10.1046/j.1365-2435.1998.00209.x; REICH PB, 1992, ECOL MONOGR, V62, P365, DOI 10.2307/2937116; Thorup-Kristensen K, 2003, ADV AGRON, V79, P227, DOI 10.1016/S0065-2113(02)79005-6; Tonitto C, 2006, AGR ECOSYST ENVIRON, V112, P58, DOI 10.1016/j.agee.2005.07.003; Violle C, 2007, OIKOS, V116, P882, DOI 10.1111/j.2007.0030-1299.15559.x; Westoby M, 2002, ANNU REV ECOL SYST, V33, P125, DOI 10.1146/annurev.ecolsys.33.010802.150452; Westoby M, 1998, PLANT SOIL, V199, P213, DOI 10.1023/A:1004327224729; WILSON JW, 1981, ANN BOT-LONDON, V48, P507, DOI 10.1093/oxfordjournals.aob.a086154; Wilson PJ, 1999, NEW PHYTOL, V143, P155, DOI 10.1046/j.1469-8137.1999.00427.x; Wright IJ, 2004, NATURE, V428, P821, DOI 10.1038/nature02403	45	67	72	2	129	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2015	10	3							e0122156	10.1371/journal.pone.0122156	http://dx.doi.org/10.1371/journal.pone.0122156			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD9NQ	25789485	Green Published, gold, Green Submitted			2022-12-27	WOS:000351425400210
J	Yao, FC; Hoteit, I				Yao, Fengchao; Hoteit, Ibrahim			Thermocline Regulated Seasonal Evolution of Surface Chlorophyll in the Gulf of Aden	PLOS ONE			English	Article							RED-SEA; ARABIAN SEA; MONSOON	The Gulf of Aden, although subject to seasonally reversing monsoonal winds, has been previously reported as an oligotrophic basin during summer, with elevated chlorophyll concentrations only occurring during winter due to convective mixing. However, the Sea-Viewing Wide Field-of-View Sensor (SeaWiFS) ocean color data reveal that the Gulf of Aden also exhibits a prominent summer chlorophyll bloom and sustains elevated chlorophyll concentrations throughout the fall, and is a biophysical province distinct from the adjacent Arabian Sea. Climatological hydrographic data suggest that the thermocline, hence the nutricline, in the entire gulf is markedly shoaled by the southwest monsoon during summer and fall. Under this condition, cyclonic eddies in the gulf can effectively pump deep nutrients to the surface layer and lead to the chlorophyll bloom in late summer, and, after the transition to the northeast monsoon in fall, coastal upwelling driven by the northeasterly winds produces a pronounced increase in surface chlorophyll concentrations along the Somali coast.	[Yao, Fengchao; Hoteit, Ibrahim] King Abdullah Univ Sci & Technol, Div Phys Sci & Engn, Thuwal, Makkah, Saudi Arabia	King Abdullah University of Science & Technology	Hoteit, I (corresponding author), King Abdullah Univ Sci & Technol, Div Phys Sci & Engn, Thuwal, Makkah, Saudi Arabia.	ibrahim.hoteit@kaust.edu.sa		Yao, Fengchao/0000-0002-8218-0150; Hoteit, Ibrahim/0000-0002-3751-4393	King Abdullah University of Science and Technology	King Abdullah University of Science and Technology(King Abdullah University of Science & Technology)	Research reported in this publication was supported by the King Abdullah University of Science and Technology (http://www.kaust.edu.sa). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aiki H, 2006, CONT SHELF RES, V26, P1448, DOI 10.1016/j.csr.2006.02.017; Al Saafani MA, 2007, J GEOPHYS RES-OCEANS, V112, DOI 10.1029/2006JC004020; Almogi-Labina A, 2000, MAR MICROPALEONTOL, V40, P295, DOI 10.1016/S0377-8398(00)00043-8; Beal LM, 2013, J PHYS OCEANOGR, V43, P2008, DOI 10.1175/JPO-D-13-033.1; Bower AS, 2012, PROG OCEANOGR, V96, P14, DOI 10.1016/j.pocean.2011.09.003; Brewin RJW, 2013, REMOTE SENS ENVIRON, V136, P218, DOI 10.1016/j.rse.2013.04.018; BROCK JC, 1991, J GEOPHYS RES-OCEANS, V96, P20623, DOI 10.1029/91JC01711; Fratantoni DM, 2006, J GEOPHYS RES-OCEANS, V111, DOI 10.1029/2005JC003338; Garcia HE, 2010, NOAA ATLAS NESDIS, V4; Levy M, 2007, J GEOPHYS RES-OCEANS, V112, DOI 10.1029/2007JC004090; Locarnini RA, 2010, NOAA ATLAS NESDIS 68, V1; McGillicuddy DJ, 1998, NATURE, V394, P263, DOI 10.1038/28367; POISSON A, 1984, DEEP-SEA RES, V31, P707, DOI 10.1016/0198-0149(84)90036-0; Resplandy L, 2011, J GEOPHYS RES-OCEANS, V116, DOI 10.1029/2011JC007006; Risien CM, 2008, J PHYS OCEANOGR, V38, P2379, DOI 10.1175/2008JPO3881.1; Sofianos SS, 2007, J GEOPHYS RES-OCEANS, V112, DOI 10.1029/2006JC003886; Tegen I, 1997, J GEOPHYS RES-ATMOS, V102, P23895, DOI 10.1029/97JD01864; Triantafyllou G, 2014, J GEOPHYS RES-OCEANS, V119, P1791, DOI 10.1002/2013JC009641; Van Couwelaar M, 1997, DEEP-SEA RES PT II, V44, P1213, DOI 10.1016/S0967-0645(97)00009-X; Wiggert JD, 2005, PROG OCEANOGR, V65, P176, DOI 10.1016/j.pocean.2005.03.008; Wilson C, 2002, GEOPHYS RES LETT, V29, DOI 10.1029/2001GL014063; Yao FC, 2014, J GEOPHYS RES-OCEANS, V119, P2238, DOI 10.1002/2013JC009004	22	7	7	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2015	10	3							e0119951	10.1371/journal.pone.0119951	http://dx.doi.org/10.1371/journal.pone.0119951			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD9NQ	25789465	Green Published, gold, Green Submitted			2022-12-27	WOS:000351425400120
J	Bao, CD; Zhang, DF; Sun, B; Lan, L; Cui, WX; Xu, GH; Sui, CL; Wang, YBN; Zhao, YS; Wang, J; Li, HY				Bao, Chundan; Zhang, Dianfeng; Sun, Bo; Lan, Li; Cui, Wenxiu; Xu, Guohua; Sui, Conglan; Wang, Yibaina; Zhao, Yashuang; Wang, Jian; Li, Hongyuan			Optimal Cut-Off Points of Fasting Plasma Glucose for Two-Step Strategy in Estimating Prevalence and Screening Undiagnosed Diabetes and Pre-Diabetes in Harbin, China	PLOS ONE			English	Article							CARDIOVASCULAR-DISEASE; POPULATION; RISK	To identify optimal cut-off points of fasting plasma glucose (FPG) for two-step strategy in screening abnormal glucose metabolism and estimating prevalence in general Chinese population. A population-based cross-sectional study was conducted on 7913 people aged 20 to 74 years in Harbin. Diabetes and pre-diabetes were determined by fasting and 2 hour post-load glucose from the oral glucose tolerance test in all participants. Screening potential of FPG, cost per case identified by two-step strategy, and optimal FPG cut-off points were described. The prevalence of diabetes was 12.7%, of which 65.2% was undiagnosed. Twelve percent or 9.0% of participants were diagnosed with pre-diabetes using 2003 ADA criteria or 1999 WHO criteria, respectively. The optimal FPG cut-off points for two-step strategy were 5.6 mmol/l for previously undiagnosed diabetes (area under the receiver-operating characteristic curve of FPG 0.93; sensitivity 82.0%; cost per case identified by two-step strategy (sic)261), 5.3 mmol/l for both diabetes and pre-diabetes or pre-diabetes alone using 2003 ADA criteria (0.89 or 0.85; 72.4% or 62.9%; (sic)110 or (sic)258), 5.0 mmol/l for pre-diabetes using 1999 WHO criteria (0.78; 66.8%; (sic)399), and 4.9 mmol/l for IGT alone (0.74; 62.2%; (sic)502). Using the two-step strategy, the underestimates of prevalence reduced to nearly 38% for prediabetes or 18.7% for undiagnosed diabetes, respectively. Approximately a quarter of the general population in Harbin was in hyperglycemic condition. Using optimal FPG cut-off points for two-step strategy in Chinese population may be more effective and less costly for reducing the missed diagnosis of hyperglycemic condition.	[Bao, Chundan; Zhang, Dianfeng; Wang, Yibaina; Zhao, Yashuang; Li, Hongyuan] Harbin Med Univ, Coll Publ Hlth, Dept Epidemiol, Harbin, Heilongjiang Pr, Peoples R China; [Zhang, Dianfeng; Sun, Bo; Lan, Li; Cui, Wenxiu; Xu, Guohua; Sui, Conglan; Wang, Jian] Harbin Ctr Dis Control & Prevent, Dept Chron Noncommunicable Dis Control & Prevent, Harbin, Heilongjiang Pr, Peoples R China	Harbin Medical University	Zhao, YS (corresponding author), Harbin Med Univ, Coll Publ Hlth, Dept Epidemiol, Harbin, Heilongjiang Pr, Peoples R China.	zhao_yashuang@263.net; Wjwjwj111@sina.com; lihy09@yahoo.com	Zhao, Yashuang/I-6145-2019		Harbin Science and Technology Bureau [2007AA3CS084-2]; Heilongjiang Province Health and Family Planning Commission [2014-425]	Harbin Science and Technology Bureau; Heilongjiang Province Health and Family Planning Commission	The study was supported by the scientific and technological project of Harbin Science and Technology Bureau (2007AA3CS084-2) and the scientific research project of Heilongjiang Province Health and Family Planning Commission (2014-425). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amer Diabet Assoc, 2012, DIABETES CARE, V35, pS64, DOI [10.2337/dc12-S064, 10.2337/dc09-S062, 10.2337/dc11-S011]; Borch-Johnsen K, 2004, DIABETOLOGIA, V47, P1396, DOI 10.1007/s00125-004-1468-6; Borch-Johnsen K, 1999, LANCET, V354, P617; Cowie CC, 2009, DIABETES CARE, V32, P287, DOI 10.2337/dc08-1296; de Vegt F, 2001, JAMA-J AM MED ASSOC, V285, P2109, DOI 10.1001/jama.285.16.2109; Ford ES, 2010, J AM COLL CARDIOL, V55, P1310, DOI 10.1016/j.jacc.2009.10.060; Gu D, 2003, DIABETOLOGIA, V46, P1190, DOI 10.1007/s00125-003-1167-8; Ito C, 2000, DIABETES RES CLIN PR, V49, P181, DOI 10.1016/S0168-8227(00)00156-X; Kim SM, 2006, DIABETES CARE, V29, P226, DOI 10.2337/diacare.29.02.06.dc05-0481; Melidonis Andrew M, 2006, Rural Remote Health, V6, P534; Moadab MH, 2010, PEDIATR DIABETES, V11, P101, DOI 10.1111/j.1399-5448.2009.00534.x; Nakagami T, 2002, DIABETIC MED, V19, P549; Nathan DM, 2007, DIABETIC MED, V24, P137; Onat A, 2013, ACTA DIABETOL, V50, P519, DOI 10.1007/s00592-011-0313-x; Onat A, 2011, DIABETES RES CLIN PR, V91, P220, DOI 10.1016/j.diabres.2010.11.035; Qiao Q, 2003, DIABETES CARE, V26, P688; SAS Institute Inc, 2010, SAS STAT 9 22 US GUI; Tai ES, 2004, DIABETES CARE, V27, P1728, DOI 10.2337/diacare.27.7.1728; Wang H, 2009, DIABETES METAB, V35, P378, DOI 10.1016/j.diabet.2009.03.006; Wei W, 2010, PUBLIC HEALTH, V124, P593, DOI 10.1016/j.puhe.2010.05.014; World Health Organization, 2006, DEF DIAGN DIAB MELL; Yang WY, 2010, NEW ENGL J MED, V362, P1090, DOI 10.1056/NEJMoa0908292; Ye Z, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087690; Zhang P, 2005, DIABETES CARE, V28, P1321, DOI 10.2337/diacare.28.6.1321; Zhang SY, 2009, DIABETES RES CLIN PR, V86, P124, DOI 10.1016/j.diabres.2009.07.013; Zhang YL, 2013, PRIM CARE DIABETES, V7, P275, DOI 10.1016/j.pcd.2013.08.003; Zhao Jing-bo, 2009, Zhonghua Liu Xing Bing Xue Za Zhi, V30, P110; Zhou XH, 2013, DIABETES CARE, V36, P3944, DOI 10.2337/dc13-0593; Zhou XH, 2010, DIABETES CARE, V33, P545, DOI 10.2337/dc09-1410	29	10	11	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2015	10	3							e0119510	10.1371/journal.pone.0119510	http://dx.doi.org/10.1371/journal.pone.0119510			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9BN	25785585	Green Published, Green Submitted, gold			2022-12-27	WOS:000352138500107
J	Chikaev, AN; Bakulina, AY; Burdick, RC; Karpenko, LI; Pathak, VK; Ilyichev, AA				Chikaev, Anton N.; Bakulina, Anastasiya Yu.; Burdick, Ryan C.; Karpenko, Larisa I.; Pathak, Vinay K.; Ilyichev, Alexander A.			Selection of Peptide Mimics of HIV-1 Epitope Recognized by Neutralizing Antibody VRC01	PLOS ONE			English	Article							MONOCLONAL-ANTIBODIES; PHAGE DISPLAY; MIMOTOPE; DESIGN; VACCINATION; PROTEIN	The ability to induce anti-HIV-1 antibodies that can neutralize a broad spectrum of viral isolates from different subtypes seems to be a key requirement for development of an effective HIV-1 vaccine. The epitopes recognized by the most potent broadly neutralizing antibodies that have been characterized are largely discontinuous. Mimetics of such conformational epitopes could be potentially used as components of a synthetic immunogen that can elicit neutralizing antibodies. Here we used phage display technology to identify peptide motifs that mimic the epitope recognized by monoclonal antibody VRC01, which is able to neutralize up to 91% of circulating primary isolates. Three rounds of biopanning were performed against 2 different phage peptide libraries for this purpose. The binding specificity of selected phage clones to monoclonal antibody VRC01 was estimated using dot blot analysis. The putative peptide mimics exposed on the surface of selected phages were analyzed for conformational and linear homology to the surface of HIV-1 gp120 fragment using computational analysis. Corresponding peptides were synthesized and checked for their ability to interfere with neutralization activity of VRC01 in a competitive inhibition assay. One of the most common peptides selected from 12-mer phage library was found to partially mimic a CD4-binding loop fragment, whereas none of the circular C7C-mer peptides was able to mimic any HIV-1 domains. However, peptides identified from both the 12-mer and C7C-mer peptide libraries showed rescue of HIV-1 infectivity in the competitive inhibition assay. The identification of epitope mimics may lead to novel immunogens capable of inducing broadly reactive neutralizing antibodies.	[Chikaev, Anton N.; Bakulina, Anastasiya Yu.; Karpenko, Larisa I.; Ilyichev, Alexander A.] State Res Ctr Virol & Biotechnol VECTOR, Koltsov 630559, Novosibirsk Reg, Russia; [Burdick, Ryan C.; Pathak, Vinay K.] NCI, HIV Drug Resistance Program, Viral Mutat Sect, Frederick, MD 21702 USA	State Research Center of Virology & Biotechnology VECTOR; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Chikaev, AN (corresponding author), State Res Ctr Virol & Biotechnol VECTOR, Koltsov 630559, Novosibirsk Reg, Russia.	chikaev@vector.nsc.ru	Karpenko, Larisa Ivanovna/A-9682-2014; Ilyichev, Alexander/AAT-9390-2020; Chikaev, Anton/A-8117-2014; Ilyicheva, Tatyana N./B-1327-2012	Ilyichev, Alexander/0000-0001-5356-0843; Chikaev, Anton/0000-0001-5423-3457; Ilyicheva, Tatyana N./0000-0002-2354-7688; Pathak, Vinay/0000-0003-2441-8412; Karpenko, Larisa/0000-0003-4365-8809	National Institute of Allergy and Infectious Diseases (NIAID); Russian Foundation for Basic Research (RFBR) [RUB1-31084-NO-12]; Russian Science Foundation [14-14-00660]; NATIONAL CANCER INSTITUTE [ZIABC010595] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases (NIAID)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Russian Foundation for Basic Research (RFBR)(Russian Foundation for Basic Research (RFBR)); Russian Science Foundation(Russian Science Foundation (RSF)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the joint grant from the National Institute of Allergy and Infectious Diseases (NIAID) and the Russian Foundation for Basic Research (RFBR) RUB1-31084-NO-12. http://www.rfbr.ru/rffi/eng/contests international announcement/o 60903. Homology modeling and molecular docking experiments were also supported by Russian Science Foundation grant 14-14-00660. http://www.rscf.ru/sites/default/files/docfiles/Spisok pobediteley.pdf. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Buchwald UK, 2005, INFECT IMMUN, V73, P325, DOI 10.1128/IAI.73.1.325-333.2005; BURTON DR, 1994, SCIENCE, V266, P1024, DOI 10.1126/science.7973652; Delhalle S, 2012, INT J MOL SCI, V13, P4727, DOI 10.3390/ijms13044727; Eroshkin AM, 2014, NUCLEIC ACIDS RES, V42, pD1133, DOI 10.1093/nar/gkt1083; EROSHKIN AM, 1995, PROTEIN ENG, V8, P167, DOI 10.1093/protein/8.2.167; Gazarian KG, 2013, MOL IMMUNOL, V54, P148, DOI 10.1016/j.molimm.2012.11.016; Gershoni JM, 2007, BIODRUGS, V21, P145, DOI 10.2165/00063030-200721030-00002; James TC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049728; Karpenko LI, 2012, MOL IMMUNOL, V50, P193, DOI 10.1016/j.molimm.2012.01.003; Kovacs JM, 2012, P NATL ACAD SCI USA, V109, P12111, DOI 10.1073/pnas.1204533109; Kwong PD, 2013, NAT REV IMMUNOL, V13, P693, DOI 10.1038/nri3516; Larralde OG, 2007, J VIROL METHODS, V140, P49, DOI 10.1016/j.jviromet.2006.10.015; Li M, 2006, CELL IMMUNOL, V239, P136, DOI 10.1016/j.cellimm.2006.05.005; Mascola JR, 2013, IMMUNOL REV, V254, P225, DOI 10.1111/imr.12075; Mascola JR, 2010, ANNU REV IMMUNOL, V28, P413, DOI 10.1146/annurev-immunol-030409-101256; Mayrose I, 2007, BIOINFORMATICS, V23, P3244, DOI 10.1093/bioinformatics/btm493; Ofek G, 2010, P NATL ACAD SCI USA, V107, P17880, DOI 10.1073/pnas.1004728107; Riemer AB, 2005, JNCI-J NATL CANCER I, V97, P1663, DOI 10.1093/jnci/dji373; Schiavone M, 2012, INT J MOL SCI, V13, P5674, DOI 10.3390/ijms13055674; Shmelkov E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089987; SMITH GP, 1993, METHOD ENZYMOL, V217, P228; Sykes KF, 2013, TRENDS BIOTECHNOL, V31, P45, DOI 10.1016/j.tibtech.2012.10.012; Tumanova OY, 2002, MOL BIOL+, V36, P517, DOI 10.1023/A:1019804511163; Wierzbicki A, 2008, J IMMUNOL, V181, P6644, DOI 10.4049/jimmunol.181.9.6644; Wu XL, 2010, SCIENCE, V329, P856, DOI 10.1126/science.1187659; Yang XZ, 2002, J VIROL, V76, P4634, DOI 10.1128/JVI.76.9.4634-4642.2002; Yasmeen A, 2014, RETROVIROLOGY, V11, DOI 10.1186/1742-4690-11-41; Zhang Y, 2012, FUNGAL DIVERS, V53, P1, DOI 10.1007/s13225-011-0117-x; Zhou TQ, 2007, NATURE, V445, P732, DOI 10.1038/nature05580; Zhou TQ, 2010, SCIENCE, V329, P811, DOI 10.1126/science.1192819; Zolla-Pazner S, 2004, NAT REV IMMUNOL, V4, P199, DOI 10.1038/nri1307; Zolla-Pazner S, 2010, NAT REV IMMUNOL, V10, P527, DOI 10.1038/nri2801; Zwick MB, 2003, J VIROL, V77, P5863, DOI 10.1128/JVI.77.10.5863-5876.2003	33	10	11	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2015	10	3							e0120847	10.1371/journal.pone.0120847	http://dx.doi.org/10.1371/journal.pone.0120847			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9BN	25785734	Green Published, Green Submitted, gold			2022-12-27	WOS:000352138500196
J	Costanzo, AE; Taylor, KR; Dutt, S; Han, PP; Fujioka, K; Jameson, JM				Costanzo, Anne E.; Taylor, Kristen R.; Dutt, Shelley; Han, Peggy P.; Fujioka, Ken; Jameson, Julie M.			Obesity Impairs gamma delta T Cell Homeostasis and Antiviral Function in Humans	PLOS ONE			English	Article							PRENYL PYROPHOSPHATE ANTIGENS; IFN-GAMMA; LYMPH-NODES; INFLUENZA; LYMPHOCYTES; ACTIVATION; RESPONSES; MEMORY; DIFFERENTIATION; PROLIFERATION	Obese patients are susceptible to increased morbidity and mortality associated with infectious diseases such as influenza A virus gamma delta T cells and memory alpha beta T cells play key roles in reducing viral load by rapidly producing IFN-gamma and lysing infected cells. In this article we analyze the impact of obesity on T lymphocyte antiviral immunity. Obese donors exhibit a reduction in gamma delta T cells in the peripheral blood. The severity of obesity negatively correlates with the number of gamma delta T cells. The remaining gamma delta T cells have a skewed maturation similar to that observed in aged populations. This skewed gamma delta T cell population exhibits a blunted antiviral IFN-gamma response. Full gamma delta T cell function can be restored by potent stimulation with 1-Hydroxy- 2-methyl-buten-4yl 4-diphosphate (HDMAPP), suggesting that gamma delta T cells retain the ability to produce IFN-gamma. Additionally, gamma delta T cells from obese donors have reduced levels of IL-2R alpha. IL-2 is able to restore gamma delta T cell antiviral cytokine production, which suggests that gamma delta T cells lack key T cell specific growth factor signals. These studies make the novel finding that the gamma delta T cell antiviral immune response to influenza is compromised by obesity. This has important implications for the development of therapeutic strategies to improve vaccination and antiviral responses in obese patients.	[Costanzo, Anne E.; Dutt, Shelley; Jameson, Julie M.] Calif State Univ San Marcos, Dept Biol, San Marcos, CA 92096 USA; [Costanzo, Anne E.; Taylor, Kristen R.; Jameson, Julie M.] Scripps Res Inst, Dept Immunol & Microbial Sci, La Jolla, CA 92037 USA; [Han, Peggy P.] PHDataGroup, San Diego, CA 92119 USA; [Fujioka, Ken] Scripps Clin, Res Ctr, La Jolla, CA 92037 USA	California State University System; California State University San Marcos; Scripps Research Institute; Scripps Research Institute	Jameson, JM (corresponding author), Calif State Univ San Marcos, Dept Biol, 333 South Twin Oaks Dr, San Marcos, CA 92096 USA.	jjameson@csusm.edu		Jameson, Julie/0000-0003-0727-4066	NIH/NCRR Grant [UL1 RR025774]; Department of Immunology and Microbial Sciences Institutional Training grant [5T32 AI007244-24]; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025774] Funding Source: NIH RePORTER	NIH/NCRR Grant; Department of Immunology and Microbial Sciences Institutional Training grant; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	JJ was supported by NIH/NCRR Grant Number UL1 RR025774 and KT was funded by Department of Immunology and Microbial Sciences Institutional Training grant 5T32 AI007244-24. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altincicek B, 2001, J IMMUNOL, V166, P3655, DOI 10.4049/jimmunol.166.6.3655; Argentati K, 2002, J LEUKOCYTE BIOL, V72, P65; Aygun AD, 2005, MEDIAT INFLAMM, P180, DOI 10.1155/MI.2005.180; Boullier S, 1997, J IMMUNOL, V159, P3629; Boyman O, 2012, NAT REV IMMUNOL, V12, P180, DOI 10.1038/nri3156; Caccamo N, 2005, EUR J IMMUNOL, V35, P1764, DOI 10.1002/eji.200525983; CARDING SR, 1990, J EXP MED, V172, P1225, DOI 10.1084/jem.172.4.1225; Cavanagh MM, 2012, CURR OPIN IMMUNOL, V24, P488, DOI 10.1016/j.coi.2012.04.003; Dieli F, 2003, J EXP MED, V198, P391, DOI 10.1084/jem.20030235; Fezeu L, 2011, OBES REV, V12, P653, DOI 10.1111/j.1467-789X.2011.00864.x; Gioia C, 2002, J IMMUNOL, V168, P1484, DOI 10.4049/jimmunol.168.3.1484; HACKER G, 1992, J IMMUNOL, V149, P3984; Hayday AC, 2000, ANNU REV IMMUNOL, V18, P975, DOI 10.1146/annurev.immunol.18.1.975; Hearps AC, 2012, AGING CELL, V11, P867, DOI 10.1111/j.1474-9726.2012.00851.x; Huttunen R, 2013, INT J OBESITY, V37, P333, DOI 10.1038/ijo.2012.62; Jameson J, 2007, IMMUNOL REV, V215, P114, DOI 10.1111/j.1600-065X.2006.00483.x; Jameson JM, 2010, CELL IMMUNOL, V264, P71, DOI 10.1016/j.cellimm.2010.04.013; Kabelitz D, 2011, CELL MOL LIFE SCI, V68, P2331, DOI 10.1007/s00018-011-0696-4; Karlsson EA, 2010, EXP BIOL MED, V235, P1412, DOI 10.1258/ebm.2010.010227; KASAHARA T, 1983, J IMMUNOL, V130, P1784; Kwong JC, 2011, CLIN INFECT DIS, V53, P413, DOI 10.1093/cid/cir442; LANG F, 1995, J IMMUNOL, V154, P5986; Morita CT, 2007, IMMUNOL REV, V215, P59, DOI 10.1111/j.1600-065X.2006.00479.x; MORITA CT, 1995, IMMUNITY, V3, P495, DOI 10.1016/1074-7613(95)90178-7; Nguyen-Van-Tam JS, 2010, THORAX, V65, P645, DOI 10.1136/thx.2010.135210; PARKER CM, 1990, J EXP MED, V171, P1597, DOI 10.1084/jem.171.5.1597; Qin G, 2011, J VIROL, V85, P10109, DOI 10.1128/JVI.05341-11; Qin G, 2009, J INFECT DIS, V200, P858, DOI 10.1086/605413; Re F, 2005, EXP GERONTOL, V40, P59, DOI 10.1016/j.exger.2004.09.008; Ribot JC, 2012, J IMMUNOL, V189, P1202, DOI 10.4049/jimmunol.1200268; Smith AG, 2009, IMMUNOLOGY, V126, P268, DOI 10.1111/j.1365-2567.2008.02895.x; Su HC, 1998, J IMMUNOL, V160, P5007; Taylor KR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011422; Tu WW, 2011, J EXP MED, V208, P1511, DOI 10.1084/jem.20110226; Wei CH, 2005, J IMMUNOL, V175, P6615, DOI 10.4049/jimmunol.175.10.6615	35	64	66	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2015	10	3							e0120918	10.1371/journal.pone.0120918	http://dx.doi.org/10.1371/journal.pone.0120918			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9BN	25785862	Green Published, Green Submitted, gold			2022-12-27	WOS:000352138500197
J	Flesch, AD; Hutto, RL; van Leeuwen, WJD; Hartfield, K; Jacobs, S				Flesch, Aaron D.; Hutto, Richard L.; van Leeuwen, Willem J. D.; Hartfield, Kyle; Jacobs, Sky			Spatial, Temporal, and Density-Dependent Components of Habitat Quality for a Desert Owl	PLOS ONE			English	Article							LIFETIME REPRODUCTIVE SUCCESS; NEST-SITE SELECTION; POPULATION-DENSITY; TERRITORY-QUALITY; BREEDING PERFORMANCE; FITNESS COMPONENTS; RIPARIAN ISLAND; CLUTCH SIZE; CLIMATE; DEMOGRAPHY	Spatial variation in resources is a fundamental driver of habitat quality but the realized value of resources at any point in space may depend on the effects of conspecifics and stochastic factors, such as weather, which vary through time. We evaluated the relative and combined effects of habitat resources, weather, and conspecifics on habitat quality for ferruginous pygmy-owls (Glaucidium brasilianum) in the Sonoran Desert of northwest Mexico by monitoring reproductive output and conspecific abundance over 10 years in and around 107 territory patches. Variation in reproductive output was much greater across space than time, and although habitat resources explained a much greater proportion of that variation (0.70) than weather (0.17) or conspecifics (0.13), evidence for interactions among each of these components of the environment was strong. Relative to habitat that was persistently low in quality, high-quality habitat buffered the negative effects of conspecifics and amplified the benefits of favorable weather, but did not buffer the disadvantages of harsh weather. Moreover, the positive effects of favorable weather at low conspecific densities were offset by intraspecific competition at high densities. Although realized habitat quality declined with increasing conspecific density suggesting interference mechanisms associated with an Ideal Free Distribution, broad spatial heterogeneity in habitat quality persisted. Factors linked to food resources had positive effects on reproductive output but only where nest cavities were sufficiently abundant to mitigate the negative effects of heterospecific enemies. Annual precipitation and brooding-season temperature had strong multiplicative effects on reproductive output, which declined at increasing rates as drought and temperature increased, reflecting conditions predicted to become more frequent with climate change. Because the collective environment influences habitat quality in complex ways, integrated approaches that consider habitat resources, stochastic factors, and conspecifics are necessary to accurately assess habitat quality.	[Flesch, Aaron D.; van Leeuwen, Willem J. D.; Hartfield, Kyle] Univ Arizona, Sch Nat Resources & Environm, Tucson, AZ 85721 USA; [Flesch, Aaron D.; Hutto, Richard L.] Univ Montana, Div Biol Sci, Missoula, MT 59812 USA; [Jacobs, Sky] Watershed Management Grp, Tucson, AZ USA	University of Arizona; University of Montana System; University of Montana	Flesch, AD (corresponding author), Univ Arizona, Sch Nat Resources & Environm, Tucson, AZ 85721 USA.	flesch@email.arizona.edu	van Leeuwen, Willem/ABB-6711-2020	van Leeuwen, Willem/0000-0002-3188-7172	U.S. National Park Service; Desert Southwest Cooperative Ecosystem Studies Unit; Tucson Audubon Society,; Arizona Department of Transportation; TE Inc.; Defenders of Wildlife; Center for Biological Diversity; Sonoran Joint Venture; U.S. Fish and Wildlife Service; Arizona Zoological Society; Global Owl Project; Sierra Club; University of Montana Graduate College; Shared Earth Foundation	U.S. National Park Service; Desert Southwest Cooperative Ecosystem Studies Unit; Tucson Audubon Society,; Arizona Department of Transportation; TE Inc.; Defenders of Wildlife; Center for Biological Diversity; Sonoran Joint Venture; U.S. Fish and Wildlife Service(US Fish & Wildlife Service); Arizona Zoological Society; Global Owl Project; Sierra Club; University of Montana Graduate College; Shared Earth Foundation	Agencies and organizations that funded this work include the U.S. National Park Service, Desert Southwest Cooperative Ecosystem Studies Unit, Tucson Audubon Society, Arizona Department of Transportation, T&E Inc., Defenders of Wildlife, Center for Biological Diversity, Sonoran Joint Venture, U.S. Fish and Wildlife Service, Arizona Zoological Society, Global Owl Project, Sierra Club, University of Montana Graduate College and Shared Earth Foundation. Additionally, the authors acknowledge	ALATALO RV, 1986, NATURE, V323, P152, DOI 10.1038/323152a0; Altwegg R, 2007, AM NAT, V169, P47, DOI 10.1086/510215; ANDREWARTHA HG, 1954, DISTRIBUTION ABUNDAN; Arlt D, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003006; Armstrong DP, 2005, J ANIM ECOL, V74, P160, DOI 10.1111/j.1365-2656.2004.00908.x; Bernstein C., 1991, Oxford Ornithology Series, P317; BLANCHER PJ, 1985, J ANIM ECOL, V54, P1017, DOI 10.2307/4394; Block William M., 1993, Current Ornithology, V11, P35; Bonenfant C, 2009, ADV ECOL RES, V41, P313, DOI 10.1016/S0065-2504(09)00405-X; Both C, 1998, J ANIM ECOL, V67, P659, DOI 10.1046/j.1365-2656.1998.00227.x; Both C, 2000, J ANIM ECOL, V69, P1021, DOI 10.1046/j.1365-2656.2000.00458.x; BOWMAN GB, 1980, J WILDLIFE MANAGE, V44, P806, DOI 10.2307/3808308; Breininger DR, 2004, ECOL APPL, V14, P1079, DOI 10.1890/03-5002; BROWN CR, 1986, ECOLOGY, V67, P1206, DOI 10.2307/1938676; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Carrete M, 2006, ECOL APPL, V16, P1674, DOI 10.1890/1051-0761(2006)016[1674:DPDIPB]2.0.CO;2; Chalfoun AD, 2009, J ANIM ECOL, V78, P497, DOI 10.1111/j.1365-2656.2008.01506.x; CODY ML, 1981, BIOSCIENCE, V31, P107, DOI 10.2307/1308252; Coulson T, 2006, P ROY SOC B-BIOL SCI, V273, P547, DOI 10.1098/rspb.2005.3357; Coulson T, 1997, ECOLOGY, V78, P852, DOI 10.1890/0012-9658(1997)078[0852:PSLDAC]2.0.CO;2; DHONDT AA, 1992, J ANIM ECOL, V61, P643, DOI 10.2307/5619; Dugger KM, 2005, CONDOR, V107, P863, DOI 10.1650/7824.1; DUNHAM AE, 1989, PHYSIOL ZOOL, V62, P335, DOI 10.1086/physzool.62.2.30156174; Easterling DR, 2000, SCIENCE, V289, P2068, DOI 10.1126/science.289.5487.2068; Ezard THG, 2008, AM NAT, V172, P424, DOI 10.1086/589897; Fahrig L, 2003, ANNU REV ECOL EVOL S, V34, P487, DOI 10.1146/annurev.ecolsys.34.011802.132419; Ferrer M, 2003, AUK, V120, P180, DOI 10.1642/0004-8038(2003)120[0180:AATEOF]2.0.CO;2; Flesch AD, 2007, J WILDLIFE MANAGE, V71, P981, DOI 10.2193/2006-081; Flesch AD, 2014, BIOL CONSERV, V175, P110, DOI 10.1016/j.biocon.2014.04.021; Flesch AD, 2010, ECOL APPL, V20, P1021, DOI 10.1890/09-0076.1; Flesch AD, 2003, THESIS; Fowler C.W., 1987, Current Mammalogy, V1, P401; Franklin AB, 2000, ECOL MONOGR, V70, P539, DOI 10.1890/0012-9615(2000)070[0539:CHQAFI]2.0.CO;2; FRETWELL S D, 1972, P217; Fretwell S.D., 1969, THEOR DEV ACTA BIOTH, V19, P16, DOI [DOI 10.1007/BF01601953, 10.1007/BF01601953]; Gaillard JM, 2000, ANNU REV ECOL SYST, V31, P367, DOI 10.1146/annurev.ecolsys.31.1.367; GONZALEZ-ROMERO A, 1989, Amphibia-Reptilia, V10, P1, DOI 10.1163/156853889X00250; Grant P. R., 1986, ECOLOGY EVOLUTION DA; Gullett P, 2014, OIKOS, V123, P389, DOI 10.1111/j.1600-0706.2013.00620.x; Hardy PC, 1999, SOUTHWEST NAT, V44, P311; Holmes RT, 1996, J ANIM ECOL, V65, P183, DOI 10.2307/5721; Holmgren M, 2006, FRONT ECOL ENVIRON, V4, P87, DOI 10.1890/1540-9295(2006)004[0087:ECESAA]2.0.CO;2; HUTCHINSON GE, 1957, COLD SPRING HARB SYM, V22, P415, DOI 10.1101/SQB.1957.022.01.039; Hutto R.L., 1985, P455; Huxley J. S., 1934, British Birds, V27, P270; JAENIKE J, 1991, AM NAT, V137, pS67, DOI 10.1086/285140; Johnson MD, 2007, CONDOR, V109, P489, DOI 10.1650/8347.1; Johnson RR, 2003, SOUTHWEST NAT, V48, P389, DOI 10.1894/0038-4909(2003)048<0389:CFPIA>2.0.CO;2; Jones K.B., 1985, U S Forest Service General Technical Report RM, P342; KLUYVER H. N., 1953, ARCH NEERLAND ZOOL, V10, P265; KNOPF FL, 1988, WILSON BULL, V100, P272; KORPIMAKI E, 1988, J ANIM ECOL, V57, P97, DOI 10.2307/4766; KREBS CJ, 1995, SCIENCE, V269, P1112, DOI 10.1126/science.269.5227.1112; Lack D., 1954, P343; Lima M, 2002, ECOL LETT, V5, P273, DOI 10.1046/j.1461-0248.2002.00312.x; Lima SL, 1998, BIOSCIENCE, V48, P25, DOI 10.2307/1313225; Lloyd J, 1998, WILSON BULL, V110, P403; LOMNICKI A, 1980, OIKOS, V35, P185, DOI 10.2307/3544426; Lopez-Sepulcre A, 2010, P ROY SOC B-BIOL SCI, V277, P3477, DOI 10.1098/rspb.2010.0819; MacArthur R.H., 1972, pvii; MARTIN TE, 1988, CONDOR, V90, P51, DOI 10.2307/1368432; McClure CJW, 2012, CONDOR, V114, P482, DOI 10.1525/cond.2012.110139; McDonald TL, 2010, J WILDLIFE MANAGE, V74, P514, DOI 10.2193/2009-270; McGarigal K., 2012, TECH REP; McGraw JB, 1996, AM NAT, V147, P47, DOI 10.1086/285839; Mcloughlin PD, 2007, ECOLOGY, V88, P3192, DOI 10.1890/06-1974.1; McLoughlin PD, 2006, P ROY SOC B-BIOL SCI, V273, P1449, DOI 10.1098/rspb.2006.3486; Morris DW, 2003, OECOLOGIA, V136, P1, DOI 10.1007/s00442-003-1241-4; MORRIS DW, 1989, EVOL ECOL, V3, P80, DOI 10.1007/BF02147934; Morris DW, 1985, B I MATH ITS APPLICA, V21, P193; Morrison ML, 2007, WILDLIFE HABITAT REL; Mosser A, 2009, ECOL LETT, V12, P1050, DOI 10.1111/j.1461-0248.2009.01359.x; Nevoux M, 2011, P ROY SOC B-BIOL SCI, V278, P2173, DOI 10.1098/rspb.2010.2352; NEWTON I, 1991, IBIS, V133, P76, DOI 10.1111/j.1474-919X.1991.tb07671.x; NEWTON I, 1977, J ANIM ECOL, V46, P425, DOI 10.2307/3821; NEWTON I, 1994, BIOL CONSERV, V70, P265, DOI 10.1016/0006-3207(94)90172-4; Newton I., 1998, POPULATION LIMITATIO; NILSSON SG, 1984, ORNIS SCAND, V15, P167, DOI 10.2307/3675958; Overpeck J, 2010, SCIENCE, V328, P1642, DOI 10.1126/science.1186591; OWENSMITH N, 1990, J ANIM ECOL, V59, P893, DOI 10.2307/5021; Ozgul A, 2007, OECOLOGIA, V154, P95, DOI 10.1007/s00442-007-0817-9; PARKER GA, 1986, ANIM BEHAV, V34, P1222, DOI 10.1016/S0003-3472(86)80182-8; Part T, 2001, P ROY SOC B-BIOL SCI, V268, P2267, DOI 10.1098/rspb.2001.1803; Petit LJ, 1996, ECOL MONOGR, V66, P367, DOI 10.2307/2963523; Pettorelli N, 2005, J ANIM ECOL, V74, P972, DOI 10.1111/j.1365-2656.2005.00988.x; Pettorelli N, 2005, TRENDS ECOL EVOL, V20, P503, DOI 10.1016/j.tree.2005.05.011; Pettorelli N, 2003, ECOLOGY, V84, P3307, DOI 10.1890/02-0602; Pettorelli N, 2001, OECOLOGIA, V128, P400, DOI 10.1007/s004420100682; Pettorelli N, 2007, ECOLOGY, V88, P381, DOI 10.1890/06-0875; Pinheiro J, 2001, MIXED EFFECTS MODELS; Preston KL, 2006, ECOLOGY, V87, P160, DOI 10.1890/05-0344; PRICE MV, 1978, ECOLOGY, V59, P910, DOI 10.2307/1938543; Ray C, 1996, J ANIM ECOL, V65, P556, DOI 10.2307/5736; Ricklefs R., 1969, SMITHSON CONTRIB ZOO, P1, DOI [10.5479/si.00810282.9, DOI 10.5479/SI.00810282.9]; Rossiter MC, 1996, ANNU REV ECOL SYST, V27, P451, DOI 10.1146/annurev.ecolsys.27.1.451; Saether B.-E., 1990, Current Ornithology, V7, P251; Saether BE, 2004, ADV ECOL RES, V35, P185, DOI 10.1016/S0065-2504(04)35009-9; Saether BE, 1999, J ANIM ECOL, V68, P628, DOI 10.1046/j.1365-2656.1999.00314.x; Seager R, 2007, SCIENCE, V316, P1181, DOI 10.1126/science.1139601; Searle SR., 1992, VARIANCE COMPONENTS; Sergio F, 2009, OECOLOGIA, V160, P507, DOI 10.1007/s00442-009-1314-0; Shaffer M., 1987, P69, DOI 10.1017/CBO9780511623400.006; SHERRY TW, 1989, BEHAV ECOL SOCIOBIOL, V25, P327, DOI 10.1007/BF00302990; Sillett TS, 2004, ECOLOGY, V85, P2467, DOI 10.1890/03-0272; Sinclair A.R.E., 1989, P197; SOUTHWOOD TRE, 1977, J ANIM ECOL, V46, P337; STAMPS JA, 1990, AM NAT, V135, P614, DOI 10.1086/285065; Stenseth NC, 2002, SCIENCE, V297, P1292, DOI 10.1126/science.1071281; SVARDSON G, 1949, OIKOS, V1, P157, DOI 10.2307/3564710; SZARO RC, 1985, CONDOR, V87, P511, DOI 10.2307/1367948; SZARO RC, 1986, J WILDLIFE MANAGE, V50, P752, DOI 10.2307/3800996; Tafani M, 2013, ECOLOGY, V94, P580, DOI 10.1890/12-0833.1; Tuljapurkar S.D., 1990, POPULATION DYNAMICS; Turchin Peter, 1995, P19, DOI 10.1016/B978-012159270-7/50003-8; USFWS [U.S. Fish and Wildlife Service], 2011, FED REGISTER, V76, P61856; Van valen L, 1976, EVOL THEORY, V1, P179; VanHorne B, 1997, ECOL MONOGR, V67, P295, DOI 10.1890/0012-9615(1997)067[0295:EODAPW]2.0.CO;2; VANHORNE B, 1983, J WILDLIFE MANAGE, V47, P893; WAUTERS LA, 1995, ECOLOGY, V76, P2460, DOI 10.2307/2265820; Wiens J.A., 1989, ECOLOGY BIRD COMMUNI, V1; Wiens JA, 1989, ECOLOGY BIRD COMMUNT; Williams DW, 2000, OECOLOGIA, V124, P544, DOI 10.1007/s004420000412; Zanette L, 2003, P ROY SOC B-BIOL SCI, V270, P799, DOI 10.1098/rspb.2002.2311	123	6	6	0	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2015	10	3							e0119986	10.1371/journal.pone.0119986	http://dx.doi.org/10.1371/journal.pone.0119986			36	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9BN	25786257	Green Published, Green Submitted, gold			2022-12-27	WOS:000352138500145
J	Frost, R; Quinones, I; Veldhuizen, M; Alava, JI; Small, D; Carreiras, M				Frost, Ram; Quinones, Ileana; Veldhuizen, Maria; Alava, Jose-Inaki; Small, Dana; Carreiras, Manuel			What Can the Brain Teach Us about Winemaking? An fMRI Study of Alcohol Level Preferences	PLOS ONE			English	Article							NEURAL REPRESENTATIONS; ACTIVATION; ACQUISITION; INFORMATION; INTENSITY; ATTENTION; CORTEX; TASTE	Over the last few decades, wine makers have been producing wines with a higher alcohol content, assuming that they are more appreciated by consumers. To test this hypothesis, we used functional magnetic imaging to compare reactions of human subjects to different types of wine, focusing on brain regions critical for flavor processing and food reward. Participants were presented with carefully matched pairs of high- and low- alcohol content red wines, without informing them of any of the wine attributes. Contrary to expectation, significantly greater activation was found for low- alcohol than for high- alcohol content wines in brain regions that are sensitive to taste intensity, including the insula as well as the cerebellum. Wines were closely matched for all physical attributes except for alcohol content, thus we interpret the preferential response to the low- alcohol content wines as arising from top-down modulation due to the low alcohol content wines inducing greater attentional exploration of aromas and flavours. The findings raise intriguing possibilities for objectively testing hypotheses regarding methods of producing a highly complex product such as wine.	[Frost, Ram] Hebrew Univ Jerusalem, Jerusalem, Israel; [Frost, Ram; Quinones, Ileana; Carreiras, Manuel] Basque Ctr Cognit Brain & Language, BCBL, Donostia San Sebastian, Spain; [Frost, Ram] Haskins Labs Inc, New Haven, CT USA; [Veldhuizen, Maria; Small, Dana] John B Pierce Fdn Lab, New Haven, CT 06519 USA; [Alava, Jose-Inaki] Basque Culinary Ctr, Donostia San Sebastian, Spain; [Small, Dana] Yale Univ, Sch Med, New Haven, CT USA; [Small, Dana] Univ Cologne, D-50931 Cologne, Germany; [Carreiras, Manuel] Ikerbasque, Basque Fdn Sci, E-48011 Bilbao, Spain; [Carreiras, Manuel] Univ Basque Country EHU UPV, Dept Basque Language & Commun, Bilbao, Spain	Hebrew University of Jerusalem; Yale University; Haskins Laboratories; Yale University; The John B Pierce Laboratory, Inc; Mondragon Unibertsitatea; Yale University; University of Cologne; Basque Foundation for Science; University of Basque Country	Frost, R (corresponding author), Hebrew Univ Jerusalem, Jerusalem, Israel.	ram.frost@mail.huji.ac.il	Quiñones, Ileana/I-1574-2015; Veldhuizen, Maria G/P-6209-2018; Carreiras, Manuel/D-5267-2009; Veldhuizen, Maria Geraldine/P-8149-2019	Quiñones, Ileana/0000-0002-0288-364X; Carreiras, Manuel/0000-0001-6726-7613; Veldhuizen, Maria Geraldine/0000-0001-8375-7719; Small, Dana/0000-0001-7363-1100; Basque Center on Cognition, Brain and Language, BCBL./0000-0002-8345-6892; Frost, Ram/0000-0002-5625-0813				Anderson AK, 2003, NAT NEUROSCI, V6, P196, DOI 10.1038/nn1001; Barros-Loscertales A, 2012, CEREB CORTEX, V22, P2554, DOI 10.1093/cercor/bhr324; BOWER JM, 1981, BRAIN BEHAV EVOLUT, V18, P1, DOI 10.1159/000121772; Bower JM, 1997, INT REV NEUROBIOL, V41, P489, DOI 10.1016/S0074-7742(08)60367-0; Cerf-Ducastel B, 2001, CHEM SENSES, V26, P371, DOI 10.1093/chemse/26.4.371; COLLIGNON A, 1995, COMP IMAG VIS, V3, P263; EVANS AC, 1993, NUCLEAR SCIENCE SYMPOSIUM & MEDICAL IMAGING CONFERENCE, VOLS 1-3, P1813, DOI 10.1109/NSSMIC.1993.373602; Gil J. M., 1997, British Food Journal, V99, P3, DOI 10.1108/00070709810202167; Gottfried J. A., 2006, ORBITOFRONTAL CORTEX, P125; Macey PM, 2004, NEUROIMAGE, V22, P360, DOI 10.1016/j.neuroimage.2003.12.042; Ogawa H, 2005, CHEM SENSES, V30, P583, DOI 10.1093/chemse/bji052; Parsons LM, 1997, LEARN MEMORY, V4, P49, DOI 10.1101/lm.4.1.49; Plassmann H, 2008, P NATL ACAD SCI USA, V105, P1050, DOI 10.1073/pnas.0706929105; PRITCHARD TC, 1989, J NEUROPHYSIOL, V61, P1; Small DM, 2008, NEURON, V57, P786, DOI 10.1016/j.neuron.2008.01.021; Small DM, 2003, NEURON, V39, P701, DOI 10.1016/S0896-6273(03)00467-7; Smeets PAM, 2006, AM J CLIN NUTR, V83, P1297, DOI 10.1093/ajcn/83.6.1297; Sobel N, 1998, J NEUROSCI, V18, P8990; Veldhuizen MG, 2007, CHEM SENSES, V32, P569, DOI 10.1093/chemse/bjm025; Veldhuizen MG, 2012, CHEMOSENS PERCEPT, V5, P117, DOI 10.1007/s12078-012-9122-z; Veldhuizen MG, 2011, J NEUROSCI, V31, P14735, DOI 10.1523/JNEUROSCI.1502-11.2011	21	20	21	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2015	10	3							e0119220	10.1371/journal.pone.0119220	http://dx.doi.org/10.1371/journal.pone.0119220			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9BN	25785844	Green Submitted, gold, Green Published			2022-12-27	WOS:000352138500084
J	Gupta, A; Nitoiu, D; Brennan-Crispi, D; Addya, S; Riobo, NA; Kelsell, DP; Mahoney, MG				Gupta, Abhilasha; Nitoiu, Daniela; Brennan-Crispi, Donna; Addya, Sankar; Riobo, Natalia A.; Kelsell, David P.; Mahoney, My. G.			Cell Cycle- and Cancer-Associated Gene Networks Activated by Dsg2: Evidence of Cystatin A Deregulation and a Potential Role in Cell-Cell Adhesion	PLOS ONE			English	Article							CYSTEINE PROTEINASE-INHIBITOR; STEFIN-A; PROTEASE INHIBITOR; DESMOGLEIN 2; CATHEPSIN-B; EXPRESSION; MUTATIONS; PEMPHIGUS; APOPTOSIS; CSTA	Cell-cell adhesion is paramount in providing and maintaining multicellular structure and signal transmission between cells. In the skin, disruption to desmosomal regulated intercellular connectivity may lead to disorders of keratinization and hyperproliferative disease including cancer. Recently we showed transgenic mice overexpressing desmoglein 2 (Dsg2) in the epidermis develop hyperplasia. Following microarray and gene network analysis, we demonstrate that Dsg2 caused a profound change in the transcriptome of keratinocytes in vivo and altered a number of genes important in epithelial dysplasia including: calcium-binding proteins (S100A8 and S100A9), members of the cyclin protein family, and the cysteine protease inhibitor cystatin A (CSTA). CSTA is deregulated in several skin cancers, including squamous cell carcinomas (SCC) and loss of function mutations lead to recessive skin fragility disorders. The microarray results were confirmed by qPCR, immunoblotting, and immunohistochemistry. CSTA was detected at high level throughout the newborn mouse epidermis but dramatically decreased with development and was detected predominantly in the differentiated layers. In human keratinocytes, knockdown of Dsg2 by siRNA or shRNA reduced CSTA expression. Furthermore, siRNA knockdown of CSTA resulted in cytoplasmic localization of Dsg2, perturbed cytokeratin 14 staining and reduced levels of desmoplakin in response to mechanical stretching. Both knockdown of either Dsg2 or CSTA induced loss of cell adhesion in a dispase-based assay and the effect was synergistic. Our findings here offer a novel pathway of CSTA regulation involving Dsg2 and a potential crosstalk between Dsg2 and CSTA that modulates cell adhesion. These results further support the recent human genetic findings that loss of function mutations in the CSTA gene result in skin fragility due to impaired cell-cell adhesion: autosomal-recessive exfoliative ichthyosis or acral peeling skin syndrome.	[Gupta, Abhilasha; Brennan-Crispi, Donna; Mahoney, My. G.] Thomas Jefferson Univ, Dept Dermatol & Cutaneous Biol, Philadelphia, PA 19107 USA; [Nitoiu, Daniela; Kelsell, David P.] Queen Mary Univ London, Barts & London Sch Med & Dent, Blizard Inst, Ctr Cutaneous Res, London, England; [Brennan-Crispi, Donna; Riobo, Natalia A.; Mahoney, My. G.] Thomas Jefferson Univ, Dept Biochem & Mol Biol, Philadelphia, PA 19107 USA; [Addya, Sankar] Thomas Jefferson Univ, Dept Canc Biol, Kimmel Canc Ctr, Philadelphia, PA 19107 USA	Jefferson University; University of London; Queen Mary University London; Jefferson University; Jefferson University	Mahoney, MG (corresponding author), Thomas Jefferson Univ, Dept Dermatol & Cutaneous Biol, Philadelphia, PA 19107 USA.	my.mahoney@jefferson.edu	Galdo, Natalia Riobo-Del/AAP-2938-2020; Kelsell, David P/F-8767-2011	Galdo, Natalia Riobo-Del/0000-0002-8942-7873; Kelsell, David/0000-0002-9910-7144	National Institutes of Health [R01AR056067, RO1 GM088256]; British Heart Foundation [RG/13/19/30568] Funding Source: researchfish; NATIONAL CANCER INSTITUTE [P30CA056036] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR056067] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM088256] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); British Heart Foundation(British Heart Foundation); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by grants from the National Institutes of Health (Mahoney, R01AR056067; Riobo, RO1 GM088256). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amagai M, 1999, J AM ACAD DERMATOL, V40, P167, DOI 10.1016/S0190-9622(99)70183-0; Barber AG, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098786; BARRETT AJ, 1986, BIOMED BIOCHIM ACTA, V45, P1363; Battula VL, 2010, STEM CELLS, V28, P1435, DOI 10.1002/stem.467; Biedermann K, 2005, J PATHOL, V207, P199, DOI 10.1002/path.1821; Bilodeau M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007500; Bitu CC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070925; Blaydon DC, 2011, AM J HUM GENET, V89, P564, DOI 10.1016/j.ajhg.2011.09.001; Brennan D, 2004, DIFFERENTIATION, V72, P434, DOI 10.1111/j.1432-0436.2004.07208009.x; Brennan D, 2012, ONCOGENE, V31, P1636, DOI 10.1038/onc.2011.346; Brennan D, 2007, J CELL SCI, V120, P758, DOI 10.1242/jcs.03392; Brennan D, 2010, DERMAT RES PRACT, V2010, DOI 10.1155/2010/410278; Brennan D, 2009, CELL ADHES MIGR, V3, P148, DOI 10.4161/cam.3.2.7539; Brown WM, 1997, PROTEIN SCI, V6, P5; Butler MW, 2011, CANCER RES, V71, P2572, DOI 10.1158/0008-5472.CAN-10-2046; Delva E, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a002543; Dubin G, 2005, CELL MOL LIFE SCI, V62, P653, DOI 10.1007/s00018-004-4445-9; Estrada S, 1998, BIOCHEMISTRY-US, V37, P7551, DOI 10.1021/bi980026r; Foghsgaard L, 2001, J CELL BIOL, V153, P999, DOI 10.1083/jcb.153.5.999; Galbiati F, 2000, J BIOL CHEM, V275, P23368, DOI 10.1074/jbc.M002020200; Galderisi U, 2003, ONCOGENE, V22, P5208, DOI 10.1038/sj.onc.1206558; Gelb BD, 1996, SCIENCE, V273, P1236, DOI 10.1126/science.273.5279.1236; Green KJ, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000125; Hartlieb E, 2014, J BIOL CHEM, V289, P17043, DOI 10.1074/jbc.M113.489336; Hartlieb E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053739; HAWLEYNELSON P, 1988, MOL CARCINOGEN, V1, P202, DOI 10.1002/mc.2940010309; Ishida M, 2013, J EUR ACAD DERMATOL, V27, pe128, DOI 10.1111/j.1468-3083.2011.04436.x; Iwatsuki K, 1999, BRIT J DERMATOL, V140, P35; Kavaklieva S, 2013, CASE REP DERMATOL, V5, P210, DOI 10.1159/000354572; Keim SA, 2008, HYBRIDOMA, V27, P249, DOI 10.1089/hyb.2008.0020; Krunic AL, 2013, PEDIATR DERMATOL, V30, pE87, DOI 10.1111/pde.12092; Kuopio T, 1998, CANCER RES, V58, P432; Kuracha MR, 2013, DEV BIOL, V383, P227, DOI 10.1016/j.ydbio.2013.09.014; Kurzen H, 2003, J CUTAN PATHOL, V30, P621, DOI 10.1034/j.1600-0560.2003.00122.x; Lazic D, 2011, J DERMATOL SCI, V62, P84, DOI 10.1016/j.jdermsci.2011.02.006; Magister S, 2013, J CANCER, V4, P45, DOI 10.7150/jca.5044; Mahoney MG, 2006, EXP DERMATOL, V15, P101, DOI 10.1111/j.1600-0625.2006.00391.x; Mahoney MG, 1999, J CLIN INVEST, V103, P461, DOI 10.1172/JCI5252; Mani SA, 2007, P NATL ACAD SCI USA, V104, P10069, DOI 10.1073/pnas.0703900104; Merritt AJ, 2002, MOL CELL BIOL, V22, P5846, DOI 10.1128/MCB.22.16.5846-5858.2002; Morey JS, 2006, BIOL PROCED ONLINE, V8, P175, DOI 10.1251/bpo126; Nuber UA, 1996, EUR J CELL BIOL, V71, P1; Parker BS, 2008, J PATHOL, V214, P337, DOI 10.1002/path.2265; PARRISH EP, 1987, J PATHOL, V153, P265, DOI 10.1002/path.1711530311; PASDAR M, 1991, J CELL BIOL, V113, P645, DOI 10.1083/jcb.113.3.645; Pavlova A, 2003, BIOCHEMISTRY-US, V42, P11326, DOI 10.1021/bi030119v; Pennacchio LA, 1996, SCIENCE, V271, P1731, DOI 10.1126/science.271.5256.1731; Petrof G, 2012, BRIT J DERMATOL, V166, P36, DOI 10.1111/j.1365-2133.2011.10640.x; RAWLINGS ND, 1990, J MOL EVOL, V30, P60, DOI 10.1007/BF02102453; Rinne A, 2010, PATHOL RES PRACT, V206, P259, DOI 10.1016/j.prp.2009.12.005; Ruffell B, 2013, GENE DEV, V27, P2086, DOI 10.1101/gad.224899.113; Scott DK, 2007, BRIT J DERMATOL, V156, P1156, DOI 10.1111/j.1365-2133.2007.07875.x; Sorenson BS, 2012, MUCOSAL IMMUNOL, V5, P66, DOI 10.1038/mi.2011.48; STEVEN AC, 1994, J CELL SCI, V107, P693; STRAUSS M, 1988, BIOL CHEM H-S, V369, P1019, DOI 10.1515/bchm3.1988.369.2.1019; Strojan P, 2007, INT J RADIAT ONCOL, V68, P1335, DOI 10.1016/j.ijrobp.2007.02.004; Takahashi H, 1997, J INVEST DERMATOL, V108, P843, DOI 10.1111/1523-1747.ep12292575; Takahashi H, 2001, J BIOL CHEM, V276, P36632, DOI 10.1074/jbc.M102021200; Takahashi H, 2007, J DERMATOL SCI, V46, P179, DOI 10.1016/j.jdermsci.2007.02.003; Takai T, 2009, J IMMUNOL, V183, P7958, DOI 10.4049/jimmunol.0713276; Teh MT, 2011, J ORAL PATHOL MED, V40, P67, DOI 10.1111/j.1600-0714.2010.00951.x; Toomes C, 1999, NAT GENET, V23, P421, DOI 10.1038/70525; TSUI FWL, 1993, GENOMICS, V15, P507, DOI 10.1006/geno.1993.1101; Vasilopoulos Y, 2007, ALLERGY, V62, P514, DOI 10.1111/j.1398-9995.2007.01350.x; Vray B, 2002, CELL MOL LIFE SCI, V59, P1503, DOI 10.1007/s00018-002-8525-4; Yashiro M, 2006, EUR J CANCER, V42, P2397, DOI 10.1016/j.ejca.2006.03.024; ZETTERGREN JG, 1984, P NATL ACAD SCI-BIOL, V81, P238, DOI 10.1073/pnas.81.1.238	67	17	19	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2015	10	3							e0120091	10.1371/journal.pone.0120091	http://dx.doi.org/10.1371/journal.pone.0120091			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9BN	25785582	Green Submitted, Green Published, gold			2022-12-27	WOS:000352138500155
J	Johst, S; Maderwald, S; Fischer, A; Quick, HH; Ladd, ME; Orzada, S				Johst, Soeren; Maderwald, Stefan; Fischer, Anja; Quick, Harald H.; Ladd, Mark E.; Orzada, Stephan			Investigation of the Saturation Pulse Artifact in Non-Enhanced MR Angiography of the Lower Extremity Arteries at 7 Tesla	PLOS ONE			English	Article							MAGNETIC-RESONANCE ANGIOGRAPHY; TIME-INTERLEAVED ACQUISITION; STEADY-STATE; DISEASE; MODES; SAR; TOF	When performing non-enhanced time-of-flight MR angiography of the lower extremity arteries at 7 T with cardiac triggering, the acquisition time is a crucial consideration. Therefore, in previous studies, saturation RF pulses were applied only every second TR. In the axial source images a slight artifact with an appearance similar to aliasing could be observed. The purpose of this study was to investigate the origin of this artifact. The reason for the artifact is supposed to be related to the two effective TRs during acquisition caused by the sparsely applied saturation RF pulse. Several sequence variants were simulated and implemented within the sequence source code to examine this hypothesis. An adaptation of the excitation flip angles for each TR as well as a correction factor for the k-space data was calculated. Additionally, a different ordering of the k-space data during acquisition was implemented as well as the combination of the latter with the k-space correction factor. The observations from the simulations were verified using both a static and a flow phantom and, finally, in a healthy volunteer using the same measurement setup as in previous volunteer and patient studies. Of all implemented techniques, only the reordering of the k-space was capable of suppressing the artifact almost completely at the cost of creating a ringing artifact. The phantom measurements showed the same results as the simulations and could thus confirm the hypothesis regarding the origin of the artifact. This was additionally verified in the healthy volunteer. The origin of the artifact could be confirmed to be the periodic signal variation caused by two effective TRs during acquisition.	[Johst, Soeren; Maderwald, Stefan; Fischer, Anja; Quick, Harald H.; Ladd, Mark E.; Orzada, Stephan] Univ Duisburg Essen, Erwin L Hahn Inst Magnet Resonance Imaging, Essen, Germany; [Fischer, Anja] Univ Duisburg Essen, Univ Hosp Essen, Dept Diagnost & Intervent Radiol & Neuroradiol, Essen, Germany; [Quick, Harald H.] Univ Duisburg Essen, Univ Hosp Essen, High Field & Hybrid MR Imaging, Essen, Germany; [Ladd, Mark E.] German Canc Res Ctr, Med Phys Radiol, Heidelberg, Germany	University of Duisburg Essen; University of Duisburg Essen; University of Duisburg Essen; Helmholtz Association; German Cancer Research Center (DKFZ)	Johst, S (corresponding author), Univ Duisburg Essen, Erwin L Hahn Inst Magnet Resonance Imaging, Essen, Germany.	soeren.johst@uni-duisburg-essen.de	Maderwald, Stefan/B-4241-2011; Orzada, Stephan/H-6745-2019	Orzada, Stephan/0000-0001-9784-4354; Ladd, Mark/0000-0002-4128-9440	European Research Council under the European Union's Seventh Framework Programme (FP)/ERC [291903]	European Research Council under the European Union's Seventh Framework Programme (FP)/ERC(European Research Council (ERC))	The research leading to these results has received funding from the European Research Council under the European Union's Seventh Framework Programme (FP/2007-2013)/ERC Grant Agreement n. 291903. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The article processing charge was supported by the library of the University Duisburg-Essen.	Ackerman M J, 1995, Medinfo, V8 Pt 2, P1195; [Anonymous], 2011, P INT SOC MAGN RESON; Bernstein M.A., 2004, HDB MRI PULSE SEQUEN, DOI 10.1016/B978-012092861-3/50021-2; Bitz AK, 2009, P INT SOC MAG RESON, V17, P4767; Christ A, 2010, PHYS MED BIOL, V55, pN23, DOI 10.1088/0031-9155/55/2/N01; Cukur T, 2009, MAGN RESON MED, V61, P1533, DOI 10.1002/mrm.21921; Fan ZY, 2009, MAGN RESON MED, V62, P1523, DOI 10.1002/mrm.22142; Fischer A, 2014, INVEST RADIOL, V49, P331, DOI 10.1097/RLI.0000000000000044; Fischer A, 2013, INVEST RADIOL, V48, P525, DOI 10.1097/RLI.0b013e3182839c2b; Gutzeit A, 2011, EUR RADIOL, V21, P1979, DOI 10.1007/s00330-011-2132-4; Herborn CU, 2004, AM J ROENTGENOL, V182, P1427, DOI 10.2214/ajr.182.6.1821427; Hodnett PA, 2011, RADIOLOGY, V260, P282, DOI 10.1148/radiol.11101336; Johst S, 2014, P 22 ANN M ISMRM MIL, P2191; Johst S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086274; Lanzman RS, 2010, ROFO-FORTSCHR RONTG, V182, P861, DOI 10.1055/s-0029-1245328; Leupold J, 2006, MAGN RESON MED, V55, P557, DOI 10.1002/mrm.20790; Maderwald S, 2008, MAGN RESON MATER PHY, V21, P159, DOI 10.1007/s10334-007-0096-9; Nakamura K, 2011, MAGN RESON MED, V65, P595, DOI 10.1002/mrm.22614; Nassenstein K, 2012, EUR RADIOL, V22, P2679, DOI 10.1007/s00330-012-2547-6; Nassenstein K, 2012, EUR RADIOL, V22, P559, DOI 10.1007/s00330-011-2279-z; Nayak KS, 2007, MAGN RESON MED, V58, P931, DOI 10.1002/mrm.21296; Nowinski WL, 2013, J NEUROIMAGING, V23, P86, DOI 10.1111/j.1552-6569.2011.00597.x; Oppenheim A.V.B., 2001, DISCRETE TIME SIGNAL, VVolume 2; Orzada S, 2012, MAGN RESON MED, V67, P1033, DOI 10.1002/mrm.23081; Orzada S., 2010, 18 P INT SOC MRM, V18, P50; Orzada S, 2010, MAGN RESON MED, V64, P327, DOI 10.1002/mrm.22527; Prince MR, 2009, J MAGN RESON IMAGING, V30, P1298, DOI 10.1002/jmri.21973; Quick HH, 2004, ROFO-FORTSCHR RONTG, V176, P163, DOI 10.1055/s-2004-817623; Schmitter S, 2012, MAGN RESON MED, V68, P188, DOI 10.1002/mrm.23226; Thomsen HS, 2006, EUR RADIOL, V16, P2619, DOI 10.1007/s00330-006-0495-8; Van De Moortele PF, 2005, MAGN RESON MED, V54, P1503, DOI 10.1002/mrm.20708; Voigt T, 2010, MAGN RESON MED, V64, P725, DOI 10.1002/mrm.22333; Yarnykh VL, 2007, MAGN RESON MED, V57, P192, DOI 10.1002/mrm.21120; Yazdanbakhsh P, 2009, VARIABLE POWER COMBI, P397; Zwanenburg JJM, 2008, J MAGN RESON IMAGING, V28, P1519, DOI 10.1002/jmri.21591	35	2	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2015	10	3							e0119845	10.1371/journal.pone.0119845	http://dx.doi.org/10.1371/journal.pone.0119845			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9BN	25785837	Green Published, gold, Green Submitted			2022-12-27	WOS:000352138500133
J	Sohn, I				Sohn, Insoo			Access Point Selection Game with Mobile Users Using Correlated Equilibrium	PLOS ONE			English	Article							COOPERATION	One of the most important issues in wireless local area network (WLAN) systems with multiple access points (APs) is the AP selection problem. Game theory is a mathematical tool used to analyze the interactions in multiplayer systems and has been applied to various problems in wireless networks. Correlated equilibrium (CE) is one of the powerful game theory solution concepts, which is more general than the Nash equilibrium for analyzing the interactions in multiplayer mixed strategy games. A game-theoretic formulation of the AP selection problem with mobile users is presented using a novel scheme based on a regretbased learning procedure. Through convergence analysis, we show that the joint actions based on the proposed algorithm achieve CE. Simulation results illustrate that the proposed algorithm is effective in a realistic WLAN environment with user mobility and achieves maximum system throughput based on the game-theoretic formulation.	Dongguk Univ, Div Elect & Elect Engn, Seoul, South Korea	Dongguk University	Sohn, I (corresponding author), Dongguk Univ, Div Elect & Elect Engn, Seoul, South Korea.	isohn@dongguk.edu			Dongguk University Research Fund	Dongguk University Research Fund	This work was supported by the Dongguk University Research Fund.	Akkarajitsakul K, 2011, IEEE COMMUN SURV TUT, V13, P372, DOI 10.1109/SURV.2011.122310.000119; AUMANN RJ, 1987, ECONOMETRICA, V55, P1, DOI 10.2307/1911154; Axelrod R., 2006, EVOLUTION COOPERATIO; Barabasi AL, 2005, NATURE, V435, P207, DOI 10.1038/nature03459; Fukuda Y, 2004, 2004 WIRELESS TELECOMMUNICATIONS SYMPOSIUM, PROCEEDINGS, P137; Ghazvini M, 2013, IEEE COMMUN SURV TUT, V15, P1062, DOI 10.1109/SURV.2012.111412.00167; Hart S, 2001, J ECON THEORY, V98, P26, DOI 10.1006/jeth.2000.2746; Huang JW, 2011, IEEE T COMMUN, V59, P3485, DOI 10.1109/TCOMM.2011.093011.100693; Larsson EG, 2009, IEEE SIGNAL PROC MAG, V26, P18, DOI 10.1109/MSP.2009.933370; Ma ZQ, 2011, INT J MOD PHYS C, V22, P1257, DOI 10.1142/S0129183111016877; Mittal K, 2008, COMPUT COMMUN, V31, P2049, DOI 10.1016/j.comcom.2008.01.025; Myerson R., 1997, GAME THEORY ANAL CON; Srivastava V, 2005, IEEE COMMUN SURV TUT, V7, P46, DOI 10.1109/COMST.2005.1593279; Trestian R, 2012, IEEE COMMUN SURV TUT, V14, P1212, DOI 10.1109/SURV.2012.010912.00081; Wang J, 2012, CHINESE SCI BULL, V57, P724, DOI 10.1007/s11434-011-4890-4; Wu D, 2012, IET COMMUN, V6, P659, DOI 10.1049/iet-com.2011.0625; Wu D, 2012, IEEE COMMUN LETT, V16, P349, DOI 10.1109/LCOMM.2012.012412.112200; Yen  L.-H., 2010, P WIREL OPT COMMUN N, P1, DOI DOI 10.1109/WOCN.2010.5587341; Young H.P., 2010, STRATEGIC LEARNING I; Zhang JJ, 2012, FRONT PHYS-BEIJING, V7, P366, DOI 10.1007/s11467-011-0208-x	21	3	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2015	10	3							e0116592	10.1371/journal.pone.0116592	http://dx.doi.org/10.1371/journal.pone.0116592			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9BN	25785726	Green Submitted, Green Published, gold			2022-12-27	WOS:000352138500010
J	Teixeira, AL; Ramos, PS; Vianna, LC; Ricardo, DR				Teixeira, Andre L.; Ramos, Plinio S.; Vianna, Lauro C.; Ricardo, Djalma R.			Effects of Ovarian Hormones and Oral Contraceptive Pills on Cardiac Vagal Withdrawal at the Onset of Dynamic Exercise	PLOS ONE			English	Article							HEART-RATE-VARIABILITY; MENSTRUAL-CYCLE; RATE RESPONSES; YOUNG-WOMEN; ESTROGEN; REACTIVATION; GENDER; RISK; SEX	The purpose of this study was to investigate the effects of the ovarian hormones and the use of oral contraceptive pills (OCP) on cardiac vagal withdrawal at the onset of dynamic exercise. Thirty physically active women aged 19-32 years were divided into two groups: OCP users (n = 17) and non-OCP users (n = 13). Participants were studied randomly at three different phases of the menstrual cycle: early follicular (day 3.6 +/- 1.2; range 1-5), ovulatory (day 14.3 +/- 0.8; range 13-16) and midluteal (day 21.3 +/- 0.8; range 20-24), according to endogenous (in non-OCP users) or exogenous (in OCP users) estradiol and progesterone variations. The cardiac vagal withdrawal was represented by the cardiac vagal index (CVI), which was obtained by the 4-s exercise test. Additionally, resting heart rate, systolic (SBP) and diastolic blood pressure (DBP) were obtained. The CVI was not significantly different between the three phases of the menstrual cycle in either the non-OCP users (early follicular: 1.58 +/- 0.1; ovulatory: 1.56 +/- 0.1; midluteal: 1.58 +/- 0.1, P > 0.05) or OCP users (early follicular: 1.47 +/- 0.1; ovulatory: 1.49 +/- 0.1; midluteal: 1.47 +/- 0.1, P > 0.05) (mean +/- SEM). Resting cardiovascular responses were not affected by hormonal phase or OCP use, except that the SBP was higher in the OCP users than non-OCP users in all phases of the cycle (P < 0.05). In summary, our results demonstrate that cardiac vagal withdrawal at the onset of dynamic exercise was not impacted by the menstrual cycle or OCP use in physically active women.	[Teixeira, Andre L.; Ramos, Plinio S.; Ricardo, Djalma R.] Matern Hosp Therezinha de Jesus, Fac Med & Hlth Sci SUPREMA, Juiz De Fora, MG, Brazil; [Teixeira, Andre L.; Ramos, Plinio S.; Ricardo, Djalma R.] State Univ Rio de Janeiro UERJ, Postgrad Program Exercise & Sports Sci, Rio De Janeiro, Brazil; [Vianna, Lauro C.] Univ Brasilia, Fac Phys Educ, Brasilia, DF, Brazil	Universidade do Estado do Rio de Janeiro; Universidade de Brasilia	Ricardo, DR (corresponding author), Matern Hosp Therezinha de Jesus, Fac Med & Hlth Sci SUPREMA, Juiz De Fora, MG, Brazil.	djalmaricardo@suprema.edu.br	Vianna, Lauro/A-8188-2008; Ramos, Plinio/J-1291-2018; Teixeira, André L./H-8588-2013; Ramos, Plinio/F-7453-2012	Vianna, Lauro/0000-0002-5747-0295; Ramos, Plinio/0000-0003-4035-3890; Teixeira, André L./0000-0003-4268-7560; Ramos, Plinio/0000-0003-4035-3890	CNPq - Brazil [481481/2011-7]	CNPq - Brazil(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This study was partially supported by CNPq - Brazil scholarships. Website: http://www.cnpq.br/. The grant numbers are: CNPq-Brazil (481481/2011-7). DRR received grants from the CNPq - Brazil scholarships. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almeida Marcos Bezerra de, 2004, Arq Bras Cardiol, V83, P160; Araujo C G, 1992, Clin Auton Res, V2, P35, DOI 10.1007/BF01824209; Araujo CG, 1993, J CARDIOPULM REHABIL, V13, P348; ARAUJO CGS, 1989, BRAZ J MED BIOL RES, V22, P909; Araújo Claudio Gil Soares de, 2003, Rev Bras Med Esporte, V9, P293, DOI 10.1590/S1517-86922003000500005; Bai XP, 2009, AM J PHYSIOL-HEART C, V297, pH765, DOI 10.1152/ajpheart.01283.2008; Beller JP, 2013, AM J OBSTET GYNECOL, V208, P39, DOI 10.1016/j.ajog.2012.01.037; Cohen J.E., 1988, STAT POWER ANAL BEHA; FAGRAEUS L, 1976, J APPL PHYSIOL, V40, P679, DOI 10.1152/jappl.1976.40.5.679; Freyschuss U, 1970, Acta Physiol Scand Suppl, V342, P1; Hage FG, 2013, CURR OPIN CARDIOL, V28, P411, DOI 10.1097/HCO.0b013e32836205e7; HOLLANDER AP, 1975, J APPL PHYSIOL, V38, P272, DOI 10.1152/jappl.1975.38.2.272; Knopfli BH, 1999, CLIN J SPORT MED, V9, P170; Leicht AS, 2003, EXP PHYSIOL, V88, P441, DOI 10.1113/eph8802535; Magder SA, 2012, CRIT CARE MED, V40, P239, DOI 10.1097/CCM.0b013e318232e50c; Mairer K, 2013, INT J SPORTS MED, V34, P700, DOI 10.1055/s-0032-1327577; Matsuo H, 2003, EUR J APPL PHYSIOL, V90, P100, DOI 10.1007/s00421-003-0873-8; Matthews KA, 2009, J AM COLL CARDIOL, V54, P2366, DOI 10.1016/j.jacc.2009.10.009; McKinley PS, 2009, PSYCHOPHYSIOLOGY, V46, P904, DOI 10.1111/j.1469-8986.2009.00811.x; Mendelsohn ME, 1999, NEW ENGL J MED, V340, P1801, DOI 10.1056/NEJM199906103402306; Middlekauff HR, 2012, AM J PHYSIOL-HEART C, V302, pH2560, DOI 10.1152/ajpheart.00579.2011; Miles J., 2001, APPL REGRESSION CORR; Millar PJ, 2009, EUR J APPL PHYSIOL, V107, P509, DOI 10.1007/s00421-009-1142-2; NOBREGA ACL, 1993, MED SCI SPORT EXER, V25, P37; Oliveira RB, 2006, EUR J APPL PHYSIOL, V97, P607, DOI 10.1007/s00421-006-0222-9; Ricardo DR, 2010, EUR J APPL PHYSIOL, V110, P933, DOI 10.1007/s00421-010-1555-y; Ricardo DR, 2005, CHEST, V127, P318, DOI 10.1378/chest.127.1.318; SATO N, 1995, PSYCHOSOM MED, V57, P331, DOI 10.1097/00006842-199507000-00004; Tanaka M, 2003, AM J PHYSIOL-REG I, V285, pR1091, DOI 10.1152/ajpregu.00162.2003; Teixeira AL, 2015, INT J SPORTS MED, V36, P204, DOI 10.1055/s-0034-1389971; Teixeira ALS., 2012, J EXERCISE PHYSIOLOG, V15, P47, DOI 10.7860/JCDR/2015/13795.6592; Vianna LC, 2008, EUR J APPL PHYSIOL, V102, P283, DOI 10.1007/s00421-007-0584-7; Weissman A, 2009, EUR J APPL PHYSIOL, V105, P381, DOI 10.1007/s00421-008-0914-4; Xing DQ, 2009, ARTERIOSCL THROM VAS, V29, P289, DOI 10.1161/ATVBAHA.108.182279	34	8	8	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2015	10	3							e0119626	10.1371/journal.pone.0119626	http://dx.doi.org/10.1371/journal.pone.0119626			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9BN	25785599	Green Published, gold, Green Submitted			2022-12-27	WOS:000352138500123
J	Li, ZY; Wang, JB; Zhang, XQ; Xu, L				Li, Zhiying; Wang, Jiabin; Zhang, Xuequan; Xu, Li			Comparative Transcriptome Analysis of Anthurium "Albama" and Its Anthocyanin-Loss Mutant	PLOS ONE			English	Article							BIOSYNTHETIC GENES; EXPRESSION; ANNOTATION; MAIZE; KEGG; TOOL	Anthurium is one of the most important tropical ornamental plants in the world. The traded value of anthurium is second only to that of tropical orchids among the tropical flowers. The spathe is the main ornamental organ and its color variation mainly arises from anthocyanin contents. Understanding the molecular regulation of spathe color will accelerate new variety creation of anthurium. To announce gene expression differences between Anthurium andraeanum 'Albama' and its one unique anthocyanin-loss mutant, we collected spathes of the wild-type and the mutant from two stages in spathe development (the flower separates protrude from the sheath and the spathe is fully expanded) and extracted total RNAs for transcriptome profiling. Using short read sequencing technology (Illumina), 51,955,564, 53,822,224, 54,221,990 and 52,276,418 sequencing raw reads, respectively, for wild-type and mutant in the two stages were assembled de novo into 111,268 unique sequences (unigenes) with a mean length of 652 bp. 47,563 unigenes had significant hits to the sequences in the Nr database, and 32,768 unigenes showed significant similarity to known proteins in the Swiss-Prot database. 28,350 and 19,293 unigenes had significant similarity to existing sequences in the KEGG and COG databases, respectively. Further, analysis of differentially expressed genes in the comparison between wild-type and mutant and between the two different developmental stages was carried out, indicating that the expression of an extensive set of genes changed as the result of mutation. Taken together, these data demonstrated that the Illumina sequencing allowed de novo transcriptome assembly and could obtain differentially expressed genes between A. andraeanum wild-type and the anthocyanin-loss mutant. The expression differences of AN2 and UFGT might cause the anthocyaninloss mutation.	[Li, Zhiying; Wang, Jiabin; Zhang, Xuequan; Xu, Li] Chinese Acad Trop Agr Sci, Minist Agr, Key Lab Crop Gene Resources & Germplasm Enhanceme, Inst Trop Crop Genet Resources, Danzhou 571737, Hainan, Peoples R China; [Li, Zhiying; Zhang, Xuequan; Xu, Li] Hainan Univ, Haikou 571700, Hainan Province, Peoples R China	Chinese Academy of Tropical Agricultural Sciences; Ministry of Agriculture & Rural Affairs; Hainan University	Xu, L (corresponding author), Chinese Acad Trop Agr Sci, Minist Agr, Key Lab Crop Gene Resources & Germplasm Enhanceme, Inst Trop Crop Genet Resources, Danzhou 571737, Hainan, Peoples R China.	xllzy@263.net			Hainan Province Natural Science Foundation [313069]; Species Conservation Project [14RZZY-4]	Hainan Province Natural Science Foundation; Species Conservation Project	This work was funded by the Hainan Province Natural Science Foundation (313069) and the Species Conservation Project (14RZZY-4). LX and ZL received the funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alfenito MR, 1998, PLANT CELL, V10, P1135, DOI 10.1105/tpc.10.7.1135; Boyle EI, 2004, BIOINFORMATICS, V20, P3710, DOI 10.1093/bioinformatics/bth456; Castellarin SD, 2007, BMC PLANT BIOL, V7, DOI 10.1186/1471-2229-7-46; Chen WH, 2011, PLANT CELL REP, V30, P1007, DOI 10.1007/s00299-011-1006-1; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; COCCIOLONE SM, 1993, GENETICS, V135, P575; Collette VE, 2004, PHYSIOL PLANTARUM, V122, P297, DOI 10.1111/j.1399-3054.2004.00402.x; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Elibox W, 2008, HORTSCIENCE, V43, P787, DOI 10.21273/HORTSCI.43.3.787; Goodman CD, 2004, PLANT CELL, V16, P1812, DOI 10.1105/tpc.022574; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Hichri I, 2011, J EXP BOT, V62, P2465, DOI 10.1093/jxb/erq442; HOLTON TA, 1995, PLANT CELL, V7, P1071, DOI 10.1105/tpc.7.7.1071; Iseli C, 1999, Proc Int Conf Intell Syst Mol Biol, P138; Kanehisa M, 2008, NUCLEIC ACIDS RES, V36, pD480, DOI 10.1093/nar/gkm882; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Li B, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-323; Mao XZ, 2005, BIOINFORMATICS, V21, P3787, DOI 10.1093/bioinformatics/bti430; Matus JT, 2010, PLANT MOL BIOL, V72, P607, DOI 10.1007/s11103-010-9597-4; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Ng'oma E, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-754; Pairoba CF, 2003, PLANT MOL BIOL, V53, P75, DOI 10.1023/B:PLAN.0000009267.76482.ce; Petersen M, 2010, ANNU PLANT REV, V40, P182, DOI 10.1002/9781444320503.ch4; Petroni K, 2011, PLANT SCI, V181, P219, DOI 10.1016/j.plantsci.2011.05.009; Procissi A, 2002, PLANT MOL BIOL, V49, P239, DOI 10.1023/A:1014959230492; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Sharma M, 2011, GENETICS, V188, P69, DOI 10.1534/genetics.110.126136; Tian DQ, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-827; Toledo-Ortiz G, 2003, PLANT CELL, V15, P1749, DOI 10.1105/tpc.013839; WILLIAMS CA, 1981, PHYTOCHEMISTRY, V20, P217, DOI 10.1016/0031-9422(81)85096-0; Winkel-Shirley B, 2001, PLANT PHYSIOL, V127, P1399, DOI 10.1104/pp.127.4.1399; Wu BH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105959; Yamagishi M, 2010, PLANT CELL PHYSIOL, V51, P463, DOI 10.1093/pcp/pcq011; Ye J, 2006, NUCLEIC ACIDS RES, V34, pW293, DOI 10.1093/nar/gkl031; Zhang F, 2003, DEVELOPMENT, V130, P4859, DOI 10.1242/dev.00681; Zhao DQ, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-689	36	16	20	5	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2015	10	3							e0119027	10.1371/journal.pone.0119027	http://dx.doi.org/10.1371/journal.pone.0119027			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7QC	25781998	Green Submitted, gold, Green Published			2022-12-27	WOS:000351284600045
J	Suchomel, P; Kvitek, L; Panacek, A; Prucek, R; Hrbac, J; Vecerova, R; Zboril, R				Suchomel, Petr; Kvitek, Libor; Panacek, Ales; Prucek, Robert; Hrbac, Jan; Vecerova, Renata; Zboril, Radek			Comparative Study of Antimicrobial Activity of AgBr and Ag Nanoparticles (NPs)	PLOS ONE			English	Article							SILVER NANOPARTICLES; ANTIBACTERIAL ACTIVITY; CHEMICAL-REDUCTION; MECHANISM; SURFACE; NANOCOMPOSITE; POWDER; SIZE; PVP; RESISTANCE	The diverse mechanism of antimicrobial activity of Ag and AgBr nanoparticles against gram-positive and gram-negative bacteria and also against several strains of candida was explored in this study. The AgBr nanoparticles (NPs) were prepared by simple precipitation of silver nitrate by potassium bromide in the presence of stabilizing polymers. The used polymers (PEG, PVP, PVA, and HEC) influence significantly the size of the prepared AgBr NPs dependently on the mode of interaction of polymer with Ag+ ions. Small NPs (diameter of about 60-70 nm) were formed in the presence of the polymer with low interaction as are PEG and HEC, the polymers which interact with Ag+ strongly produce nearly two times bigger NPs (120-130 nm). The prepared AgBr NPs were transformed to Ag NPs by the reduction using NaBH4. The sizes of the produced Ag NPs followed the same trends - the smallest NPs were produced in the presence of PEG and HEC polymers. Prepared AgBr and Ag NPs dispersions were tested for their biological activity. The obtained results of antimicrobial activity of AgBr and Ag NPs are discussed in terms of possible mechanism of the action of these NPs against tested microbial strains. The AgBr NPs are more effective against gram-negative bacteria and tested yeast strains while Ag NPs show the best antibacterial action against gram-positive bacteria strains.	[Suchomel, Petr; Kvitek, Libor; Panacek, Ales; Prucek, Robert; Zboril, Radek] Palacky Univ, Reg Ctr Adv Technol & Mat, Fac Sci, CR-77147 Olomouc, Czech Republic; [Suchomel, Petr; Kvitek, Libor; Panacek, Ales; Prucek, Robert; Hrbac, Jan; Zboril, Radek] Palacky Univ, Dept Phys Chem, Fac Sci, CR-77147 Olomouc, Czech Republic; [Vecerova, Renata] Palacky Univ, Dept Microbiol, Fac Med & Dent, CR-77147 Olomouc, Czech Republic	Palacky University Olomouc; Palacky University Olomouc; Palacky University Olomouc	Kvitek, L (corresponding author), Palacky Univ, Reg Ctr Adv Technol & Mat, Fac Sci, CR-77147 Olomouc, Czech Republic.	libor.kvitek@upol.cz	Zboril, Radek/F-5153-2015; Kvitek, Libor/L-1539-2018; Panacek, Ales/F-3867-2010	Zboril, Radek/0000-0002-3147-2196; Kvitek, Libor/0000-0003-2005-560X; Suchomel, Petr/0000-0003-0578-6383; Vecerova, Renata/0000-0002-7546-530X	Operational Program Research and Development for Innovations - European Regional Development Fund; Ministry of Education, Youth and Sports of the Czech Republic [CZ.1.05/2.1.00/03.0058, CZ.1.07/2.3.00/20.0056]; Operational Program Education for Competitiveness - European Social Fund; Internal Grant of Palacky University in Olomouc [PrF_2014_032]	Operational Program Research and Development for Innovations - European Regional Development Fund; Ministry of Education, Youth and Sports of the Czech Republic(Ministry of Education, Youth & Sports - Czech Republic); Operational Program Education for Competitiveness - European Social Fund(European Social Fund (ESF)); Internal Grant of Palacky University in Olomouc	Funding from Operational Program Research and Development for Innovations - European Regional Development Fund, project CZ.1.05/2.1.00/03.0058 of the Ministry of Education, Youth and Sports of the Czech Republic (http://www.opvavpi.cz/) to PS, LK, AP, RP, and RZ; Operational Program Education for Competitiveness - European Social Fund, project CZ.1.07/2.3.00/20.0056 of the Ministry of Education, Youth and Sports of the Czech Republic (http://www.op-vk.cz/) to PS, LK, AP, and RP; and Internal Grant of Palacky University in Olomouc, project PrF_2014_032 (http://www.upol.cz/) to PS, LK, AP, RP, and JH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbasi AR, 2010, J INORG ORGANOMET P, V20, P825, DOI 10.1007/s10904-010-9408-z; Castanon JIR, 2007, POULTRY SCI, V86, P2466, DOI 10.3382/ps.2007-00249; Chang SJ, 2011, J PHYS CHEM C, V115, P7979, DOI 10.1021/jp2010088; Chen DP, 2011, J MATER SCI-MATER EL, V22, P1335, DOI 10.1007/s10854-011-0309-x; Chen SH, 1998, J PHYS CHEM B, V102, P6169, DOI 10.1021/jp9809991; Chen X, 2008, TOXICOL LETT, V176, P1, DOI 10.1016/j.toxlet.2007.10.004; Cheng Y, 2007, ELECTROCHEM SOLID ST, V10, pF5, DOI 10.1149/1.2422752; Chih YK, 2014, J TAIWAN INST CHEM E, V45, P833, DOI 10.1016/j.jtice.2013.09.005; Chiu CK, 2012, CRYST GROWTH DES, V12, P4727, DOI 10.1021/cg300996k; Cui L, 2013, ANAL CHEM, V85, P5436, DOI 10.1021/ac400245j; Deng JP, 2007, J PHYS CHEM C, V111, P9723, DOI 10.1021/jp0690042; DeVasConCellos P, 2012, MAT SCI ENG C-MATER, V32, P1112, DOI 10.1016/j.msec.2012.02.020; Dong XY, 2010, J PHYS CHEM C, V114, P2070, DOI 10.1021/jp909964k; El-Shamy AG, 2014, J ALLOY COMPD, V590, P309, DOI 10.1016/j.jallcom.2013.11.203; Feng QL, 2000, J BIOMED MATER RES, V52, P662, DOI 10.1002/1097-4636(20001215)52:4<662::AID-JBM10>3.0.CO;2-3; Ghosh IN, 2013, INT J NANOMED, V8, P4721, DOI 10.2147/IJN.S49649; Guang-Nian X, 2008, COLLOID SURFACE A, V320, P222, DOI 10.1016/j.colsurfa.2008.01.056; Guo YG, 2006, SOLID STATE IONICS, V177, P2467, DOI 10.1016/j.ssi.2006.02.043; Halouzka V, 2013, J ELECTROCHEM SOC, V160, pB54, DOI 10.1149/2.003306jes; Hawari NL, 2011, J ALLOY COMPD, V509, P2001, DOI 10.1016/j.jallcom.2010.10.116; Husein MA, 2006, LANGMUIR, V22, P2264, DOI 10.1021/la052618y; Husein MM, 2005, J COLLOID INTERF SCI, V288, P457, DOI 10.1016/j.jcis.2005.03.023; Irizarry R, 2011, IND ENG CHEM RES, V50, P8023, DOI 10.1021/ie1024936; Juby KA, 2012, CARBOHYD POLYM, V89, P906, DOI 10.1016/j.carbpol.2012.04.033; Jung WK, 2008, APPL ENVIRON MICROB, V74, P2171, DOI 10.1128/AEM.02001-07; Khan Z, 2010, COLLOID SURFACE B, V76, P164, DOI 10.1016/j.colsurfb.2009.10.029; Khanna PK, 2005, MATER CHEM PHYS, V93, P117, DOI 10.1016/j.matchemphys.2005.02.029; Khaydarov RA, 2009, J NANOPART RES, V11, P1193, DOI 10.1007/s11051-008-9513-x; Khurana C, 2014, J BIOMED MATER RES A, V102, P3361, DOI 10.1002/jbm.a.35005; Kvitek L, 2008, J PHYS CHEM C, V112, P5825, DOI 10.1021/jp711616v; Lahtinen RM, 2004, LANGMUIR, V20, P3289, DOI 10.1021/la036145b; Lara HH, 2010, WORLD J MICROB BIOT, V26, P615, DOI 10.1007/s11274-009-0211-3; Li R, 2003, J MATER PROCESS TECH, V137, P55, DOI 10.1016/S0924-0136(02)01062-2; Li WR, 2011, BIOMETALS, V24, P135, DOI 10.1007/s10534-010-9381-6; Li XA, 2010, LANGMUIR, V26, P16690, DOI 10.1021/la101768n; Liang HO, 2013, APPL SURF SCI, V270, P617, DOI 10.1016/j.apsusc.2013.01.095; Lok CN, 2007, J BIOL INORG CHEM, V12, P527, DOI 10.1007/s00775-007-0208-z; Lu Z, 2013, J MATER SCI-MATER M, V24, P1465, DOI 10.1007/s10856-013-4894-5; Marambio-Jones C, 2010, J NANOPART RES, V12, P1531, DOI 10.1007/s11051-010-9900-y; Mdluli PS, 2011, J MOL STRUCT, V1004, P131, DOI 10.1016/j.molstruc.2011.07.049; Mirzajani F, 2011, RES MICROBIOL, V162, P542, DOI 10.1016/j.resmic.2011.04.009; Morones JR, 2005, NANOTECHNOLOGY, V16, P2346, DOI 10.1088/0957-4484/16/10/059; Nateghi MR, 2014, J TEXT I, V105, P806, DOI 10.1080/00405000.2013.855377; Nies DH, 2003, FEMS MICROBIOL REV, V27, P313, DOI 10.1016/S0168-6445(03)00048-2; Niitsoo O, 2011, J COLLOID INTERF SCI, V354, P887, DOI 10.1016/j.jcis.2010.11.013; Panacek A, 2006, J PHYS CHEM B, V110, P16248, DOI 10.1021/jp063826h; Panacek A, 2009, BIOMATERIALS, V30, P6333, DOI 10.1016/j.biomaterials.2009.07.065; Perelshtein I, 2013, CELLULOSE, V20, P1215, DOI 10.1007/s10570-013-9929-z; Qin YQ, 2010, COLLOID SURFACE A, V372, P172, DOI 10.1016/j.colsurfa.2010.10.013; Tran QH, 2013, ADV NAT SCI-NANOSCI, V4, DOI 10.1088/2043-6262/4/3/033001; Rahman MM, 2012, CHEM ENG J, V192, P122, DOI 10.1016/j.cej.2012.03.045; Rai M, 2009, BIOTECHNOL ADV, V27, P76, DOI 10.1016/j.biotechadv.2008.09.002; Ray M, 2011, IND ENG CHEM RES, V50, P11601, DOI 10.1021/ie2009247; Rupp ME, 2004, AM J INFECT CONTROL, V32, P445, DOI 10.1016/j.ajic.2004.05.002; Samuel U, 2004, INT J ANTIMICROB AG, V23, pS75, DOI 10.1016/j.ijantimicag.2003.12.004; Sataev MS, 2014, COLLOID SURFACE A, V442, P146, DOI 10.1016/j.colsurfa.2013.02.018; Secinti KD, 2011, J CLIN NEUROSCI, V18, P391, DOI 10.1016/j.jocn.2010.06.022; Silver S, 2003, FEMS MICROBIOL REV, V27, P341, DOI 10.1016/S0168-6445(03)00047-0; Spirin MG, 2002, COLLOID J+, V64, P364, DOI 10.1023/A:1015981028758; Stevens KNJ, 2011, BIOMATERIALS, V32, P1264, DOI 10.1016/j.biomaterials.2010.10.042; Sun CH, 2007, MATER LETT, V61, P1645, DOI 10.1016/j.matlet.2006.07.091; Wang HS, 2005, MATER CHEM PHYS, V94, P449, DOI 10.1016/j.matchemphys.2005.05.005; Wang H, 2012, CHEM-EUR J, V18, P4620, DOI 10.1002/chem.201102694; Yang L, 2010, MATER LETT, V64, P1598, DOI 10.1016/j.matlet.2010.04.054; Yang M, 2007, COLLOID SURFACE A, V295, P81, DOI 10.1016/j.colsurfa.2006.08.035; Yang M, 2011, APPL SURF SCI, V257, P2503, DOI 10.1016/j.apsusc.2010.10.011; Yeo SY, 2010, POLYM DEGRAD STABIL, V95, P1299, DOI 10.1016/j.polymdegradstab.2010.02.025; Zahran MK, 2014, CARBOHYD POLYM, V108, P145, DOI 10.1016/j.carbpol.2014.03.005; Zhang JH, 2002, J COLLOID INTERF SCI, V255, P115, DOI 10.1006/jcis.2002.8615; Zhang ZT, 1996, J SOLID STATE CHEM, V121, P105, DOI 10.1006/jssc.1996.0015; Zielinska A, 2009, PROCEDIA CHEM, V1, P1560, DOI 10.1016/j.proche.2009.11.004; Zienkiewicz-Strzalka M, 2013, APPL SURF SCI, V266, P337, DOI 10.1016/j.apsusc.2012.12.021	72	37	38	2	78	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2015	10	3							e0119202	10.1371/journal.pone.0119202	http://dx.doi.org/10.1371/journal.pone.0119202			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7QC	25781988	gold, Green Submitted, Green Published			2022-12-27	WOS:000351284600055
J	Berron, D; Fruhholz, S; Herrmann, M				Berron, David; Fruehholz, Sascha; Herrmann, Manfred			Neural Control of Enhanced Filtering Demands in a Combined Flanker and Garner Conflict Task	PLOS ONE			English	Article							EVENT-RELATED POTENTIALS; MEDIAL TEMPORAL-LOBE; RESPONSE-CONFLICT; HUMAN BRAIN; ELECTROPHYSIOLOGICAL EVIDENCE; INTERFERENCE RESOLUTION; CONTROL MECHANISMS; COGNITIVE CONTROL; PARIETAL CORTEX; FMRI	Several studies demonstrated that visual filtering mechanisms might underlie both conflict resolution of the Flanker conflict and the control of the Garner effect. However, it remains unclear whether the mechanisms involved in the processing of both effects depend on similar filter mechanisms, such that especially the Garner effect is able to modulate filtering needs in the Flanker conflict. In the present experiment twenty-four subjects participated in a combined Garner and Flanker task during two runs of functional magnetic resonance imaging (fMRI) recordings. Behavioral data showed a significant Flanker but no Garner effect. A run-wise analysis, however, revealed a Flanker effect in the Garner filtering condition in the first experimental run, while we found a Flanker effect in the Garner baseline condition in the second experimental run. The fMRI data revealed a fronto-parietal network involved in the processing of both types of effects. Flanker interference was associated with activity in the inferior frontal gyrus, the anterior cingulate cortex, the precuneus as well as the inferior (IPL) and superior parietal lobule (SPL). Garner interference was associated with activation in middle frontal and middle temporal gyrus, the lingual gyrus as well as the IPL and SPL. Interaction analyses between the Garner and the Flanker effect additionally revealed differences between the two experimental runs. In the first experimental run, activity specifically related to the interaction of effects was found in frontal and parietal regions, while in the second run we found activity in the hippocampus, the parahippocampal cortex and the basal ganglia. This shift in activity for the interaction effects might be associated with a taskrelated learning process to control filtering demands. Especially perceptual learning mechanisms might play a crucial role in the present Flanker and Garner task design and, therefore, increased performance in the second experimental run could be the reason for the lack of behavioral Garner interference on the level of the whole experiment.	[Berron, David; Fruehholz, Sascha; Herrmann, Manfred] Univ Bremen, Dept Neuropsychol & Behav Neurobiol, D-28359 Bremen, Germany; [Berron, David] Otto Von Guericke Univ, Inst Cognit Neurol & Dementia Res, Magdeburg, Germany; [Fruehholz, Sascha; Herrmann, Manfred] Univ Bremen, Ctr Cognit Sci ZKW, D-28359 Bremen, Germany; [Fruehholz, Sascha] Univ Geneva, Swiss Ctr Affect Sci, Geneva, Switzerland	University of Bremen; Otto von Guericke University; University of Bremen; University of Geneva	Berron, D (corresponding author), Univ Bremen, Dept Neuropsychol & Behav Neurobiol, D-28359 Bremen, Germany.	david.berron@med.ovgu.de	Herrmann, Manfred/H-3931-2011; Berron, David/V-2886-2018	Herrmann, Manfred/0000-0003-1872-8406; Berron, David/0000-0003-1558-1883	BMBF Neuroimaging program from the Center for Advanced Imaging (CAI) 'Magdeburg/Bremen [01GO0202]; Center for Cognitive Sciences (ZKW) at Bremen University	BMBF Neuroimaging program from the Center for Advanced Imaging (CAI) 'Magdeburg/Bremen; Center for Cognitive Sciences (ZKW) at Bremen University	The study was part of the BMBF Neuroimaging program (01GO0202) from the Center for Advanced Imaging (CAI) 'Magdeburg/Bremen (MH) and supported by the Center for Cognitive Sciences (ZKW) at Bremen University (SF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akyurek EG, 2013, BIOL PSYCHOL, V93, P269, DOI 10.1016/j.biopsycho.2013.02.009; Akyurek EG, 2010, NEUROPSYCHOLOGIA, V48, P3335, DOI 10.1016/j.neuropsychologia.2010.07.019; Behrmann M, 2004, CURR OPIN NEUROBIOL, V14, P212, DOI 10.1016/j.conb.2004.03.012; BENARTZI E, 1995, PERCEPT PSYCHOPHYS, V57, P1151, DOI 10.3758/BF03208371; Boenke LT, 2009, NEUROIMAGE, V45, P1272, DOI 10.1016/j.neuroimage.2009.01.019; Caclin A, 2008, J COGNITIVE NEUROSCI, V20, P49, DOI 10.1162/jocn.2008.20001; Casey BJ, 2000, P NATL ACAD SCI USA, V97, P8728, DOI 10.1073/pnas.97.15.8728; Desseilles M, 2011, NEUROIMAGE, V54, P1662, DOI 10.1016/j.neuroimage.2010.08.061; Dosher BA, 2010, VISION RES, V50, P402, DOI 10.1016/j.visres.2009.09.010; Durston S, 2003, NEUROIMAGE, V20, P2135, DOI 10.1016/j.neuroimage.2003.08.004; Dyson BJ, 2010, ATTEN PERCEPT PSYCHO, V72, P1676, DOI 10.3758/APP.72.6.1676; Egner T, 2008, TRENDS COGN SCI, V12, P374, DOI 10.1016/j.tics.2008.07.001; Egner T, 2007, NEUROIMAGE, V35, P940, DOI 10.1016/j.neuroimage.2006.11.061; Egner T, 2011, J COGNITIVE NEUROSCI, V23, P3903, DOI 10.1162/jocn_a_00064; ERIKSEN BA, 1974, PERCEPT PSYCHOPHYS, V16, P143, DOI 10.3758/BF03203267; Fan J, 2003, NEUROIMAGE, V18, P42, DOI 10.1006/nimg.2002.1319; Fan J, 2007, J NEUROSCI, V27, P2272, DOI 10.1523/JNEUROSCI.3470-06.2007; Friedman-Hill SR, 2003, P NATL ACAD SCI USA, V100, P4263, DOI 10.1073/pnas.0730772100; Fruhholz S, 2011, BIOL PSYCHOL, V87, P265, DOI 10.1016/j.biopsycho.2011.03.008; Fruhholz S, 2011, NEUROIMAGE, V54, P622, DOI 10.1016/j.neuroimage.2010.07.071; Garner W. R., 1974, PROCESSING INFORM ST; GARNER WR, 1976, COGNITIVE PSYCHOL, V8, P98, DOI 10.1016/0010-0285(76)90006-2; Goldstone RL, 1998, ANNU REV PSYCHOL, V49, P585, DOI 10.1146/annurev.psych.49.1.585; GRATTON G, 1992, J EXP PSYCHOL GEN, V121, P480, DOI 10.1037/0096-3445.121.4.480; Johnstone T, 2006, HUM BRAIN MAPP, V27, P779, DOI 10.1002/hbm.20219; Kaganovich N, 2006, BRAIN RES, V1114, P161, DOI 10.1016/j.brainres.2006.07.049; Kuchinke L, 2011, NEUROIMAGE, V54, P2412, DOI 10.1016/j.neuroimage.2010.08.062; Lew H, 1997, J Am Acad Audiol, V8, P104; Mansouri FA, 2009, NAT REV NEUROSCI, V10, P141, DOI 10.1038/nrn2538; McCarley JS, 2008, ACTA PSYCHOL, V128, P102, DOI 10.1016/j.actpsy.2007.10.005; Melara RD, 2008, BRAIN RES, V1215, P147, DOI 10.1016/j.brainres.2008.03.026; Nee DE, 2007, COGN AFFECT BEHAV NE, V7, P1, DOI 10.3758/CABN.7.1.1; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Packard MG, 2002, ANNU REV NEUROSCI, V25, P563, DOI 10.1146/annurev.neuro.25.112701.142937; Petersen SE, 2012, NEUROIMAGE, V62, P1177, DOI 10.1016/j.neuroimage.2011.09.084; Poldrack RA, 2001, NATURE, V414, P546, DOI 10.1038/35107080; Pomerantz J. R., 1989, OBJECT PERCEPTION ST, P53; POMERANTZ JR, 1983, J EXP PSYCHOL GEN, V112, P516, DOI 10.1037/0096-3445.112.4.516; Rose M, 2002, NEURON, V36, P1221, DOI 10.1016/S0896-6273(02)01105-4; SIMON JR, 1969, J EXP PSYCHOL, V81, P174, DOI 10.1037/h0027448; Squire LR, 2004, ANNU REV NEUROSCI, V27, P279, DOI 10.1146/annurev.neuro.27.070203.144130; Stroop JR, 1935, J EXP PSYCHOL, V18, P643, DOI 10.1037/h0054651; van Veen V, 2001, NEUROIMAGE, V14, P1302, DOI 10.1006/nimg.2001.0923; Verbruggen F, 2006, PSYCHON B REV, V13, P328, DOI 10.3758/BF03193852; Visscher KM, 2003, NEUROIMAGE, V19, P1694, DOI 10.1016/S1053-8119(03)00178-2; Wendt M, 2012, J EXP PSYCHOL HUMAN, V38, P675, DOI 10.1037/a0025902; Williams JR, 2008, B WORLD HEALTH ORGAN, V86, P650, DOI 10.2471/BLT.08.050955; WORSLEY KJ, 1995, NEUROIMAGE, V2, P173, DOI 10.1006/nimg.1995.1023; Zhu DC, 2010, NEUROIMAGE, V50, P810, DOI 10.1016/j.neuroimage.2009.12.087	49	8	8	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2015	10	3							e0120582	10.1371/journal.pone.0120582	http://dx.doi.org/10.1371/journal.pone.0120582			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD9NQ	25790026	Green Published, gold, Green Submitted			2022-12-27	WOS:000351425400164
J	Hamza, E; Mirkovitch, J; Steinbach, F; Marti, E				Hamza, Eman; Mirkovitch, Jelena; Steinbach, Falko; Marti, Eliane			Regulatory T Cells in Early Life: Comparative Study of CD4(+)CD25(high) T Cells from Foals and Adult Horses	PLOS ONE			English	Article							INSECT BITE HYPERSENSITIVITY; ALLERGEN EXPOSURE; ICELANDIC HORSES; RHODOCOCCUS-EQUI; TGF-BETA; EXPANSION; RESPONSES; EXPRESSION; GENERATION; INFANCY	The immune system of mammals is subject to continuous development during the postnatal phase of life. Studies following the longitudinal development of the immune system in healthy children are limited both by ethical considerations and sample volumes. Horses represent a particular valuable large animal model for T regulatory (Treg) cells and allergy research. We have recently characterised Treg cells from horses, demonstrated their regulatory capability and showed both their expansion and induction in vitro. Insect bite hypersensitivity (IBH) is a common allergy in horses resembling atopic dermatitis and studies have shown that first exposure to allergens in adult life results in an increased incidence of IBH. The aim of the present study was to characterize circulating CD4(+)CD25(high)FoxP3(+-) cells in foals, evaluate their suppressive capability and their in vitro induction compared to adult horses. 19 foals (age range, 1-5 months), their adult mothers and six one-year-old horses (yearlings) were included in the study. The proportion of FoxP3(+) cells within the circulating CD4(+)CD25(high) population was significantly higher in foals (47%) compared to their mothers (18%) and to yearlings (26%). Treg cells from foals also displayed a higher suppressive capability. Furthermore, CD4(+)CD25(high) cells in foals could be induced in vitro from CD4(+)CD25(-) cells in a significantly higher proportion compared to mares. These cells also displayed a significantly enhanced suppressive capability. In summary these findings support the notion that exposure of horses to allergens during maturation of the immune system assists the establishment of induced (i) Treg driven tolerance.	[Hamza, Eman; Mirkovitch, Jelena; Marti, Eliane] Univ Bern, Vetsuisse Fac, Dept Clin Res & Vet Publ Hlth, Bern, Switzerland; [Steinbach, Falko] Univ Surrey, Fac Hlth & Med Sci, Sch Vet Med, Guildford GU2 5XH, Surrey, England	University of Bern; University of Surrey	Hamza, E (corresponding author), Univ Bern, Vetsuisse Fac, Dept Clin Res & Vet Publ Hlth, Bern, Switzerland.	e.hamza@gmx.ch	Steinbach, Falko/V-1682-2019	Steinbach, Falko/0000-0003-1236-2837; Hamza, Eman/0000-0001-9798-842X	Swiss National Science Foundation [310000-116803/1]; Agricultural Productivity Fund of Iceland	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Agricultural Productivity Fund of Iceland	This work was supported by the Swiss National Science Foundation grant no. 310000-116803/1 and by grants from the Agricultural Productivity Fund of Iceland. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akdis M, 2009, CURR OPIN IMMUNOL, V21, P700, DOI 10.1016/j.coi.2009.07.012; Amoah AS, 2014, PEDIAT ALLERG IMM-UK, V25, P208, DOI 10.1111/pai.12174; BILLINGHAM RE, 1953, NATURE, V172, P603, DOI 10.1038/172603a0; Bjornsdottir S, 2006, ACTA VET SCAND, V48, DOI 10.1186/1751-0147-48-3; Boyd NK, 2003, VET IMMUNOL IMMUNOP, V92, P75, DOI 10.1016/S0165-2427(03)00021-7; Breathnach CC, 2006, VET IMMUNOL IMMUNOP, V112, P199, DOI 10.1016/j.vetimm.2006.02.010; Brent L, 1997, HUM IMMUNOL, V52, P75, DOI 10.1016/S0198-8859(96)00289-3; Fujimaki W, 2008, CLIN DEV IMMUNOL, V2008, P305; Hamza E, 2007, INT ARCH ALLERGY IMM, V144, P325, DOI 10.1159/000106459; Hamza E, 2013, CLIN EXP ALLERGY, V43, P889, DOI 10.1111/cea.12131; Hamza E, 2012, VET IMMUNOL IMMUNOP, V148, P139, DOI 10.1016/j.vetimm.2011.05.033; Hamza E, 2011, IMMUNOLOGY, V134, P292, DOI 10.1111/j.1365-2567.2011.03489.x; Harris JM, 2007, BRIT J DERMATOL, V156, P698, DOI 10.1111/j.1365-2133.2006.07710.x; Holt PG, 2010, J ALLERGY CLIN IMMUN, V125, P653, DOI 10.1016/j.jaci.2009.12.018; Jacks S, 2007, CLIN VACCINE IMMUNOL, V14, P669, DOI 10.1128/CVI.00042-07; Jacks S, 2007, CLIN VACCINE IMMUNOL, V14, P369, DOI 10.1128/CVI.00448-06; Jacks S, 2010, VET IMMUNOL IMMUNOP, V133, P282, DOI 10.1016/j.vetimm.2009.08.004; Kachroo P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062879; Liu RL, 2010, EUR J IMMUNOL, V40, P1577, DOI 10.1002/eji.200939792; Ly NP, 2009, CLIN MOL ALLERGY, V7, P1, DOI [10.1186/1476-7961-7-1, DOI 10.1186/1476-7961-7-1]; Lynch SV, 2014, J ALLERGY CLIN IMMUN, V134, P593, DOI 10.1016/j.jaci.2014.04.018; Marti E, 2008, VET IMMUNOL IMMUNOP, V126, P351, DOI 10.1016/j.vetimm.2008.07.008; McLoughlin RM, 2012, CLIN EXP ALLERGY, V42, P392, DOI 10.1111/j.1365-2222.2011.03882.x; Michaelsson J, 2006, J IMMUNOL, V176, P5741, DOI 10.4049/jimmunol.176.10.5741; Mold JE, 2008, SCIENCE, V322, P1562, DOI 10.1126/science.1164511; Nwaru BI, 2013, ALLERGY, V68, P507, DOI 10.1111/all.12118; Prescott SL, 2014, MIDDLETONS ALLERGY P, P790; Ryan C, 2010, VET IMMUNOL IMMUNOP, V133, P66, DOI 10.1016/j.vetimm.2009.06.010; Sakaguchi S, 2004, ANNU REV IMMUNOL, V22, P531, DOI 10.1146/annurev.immunol.21.120601.141122; Schaffartzik A, 2012, VET IMMUNOL IMMUNOP, V147, P113, DOI 10.1016/j.vetimm.2012.03.017; Schaub B, 2008, ALLERGY, V63, P1438, DOI 10.1111/j.1398-9995.2008.01685.x; Scott M, 2012, THORAX, V67, P1046, DOI 10.1136/thoraxjnl-2012-202150; SIEGAL FP, 1981, AM J REPROD IMMUNOL, V1, P65, DOI 10.1111/j.1600-0897.1981.tb00018.x; Sommer-Locher B, 2012, J EQUINE VET SCI, V32, P158, DOI 10.1016/j.jevs.2011.08.013; Sponseller B, 2009, VET IMMUNOL IMMUNOP, V126, P351; Strickland DH, 2012, MUCOSAL IMMUNOL, V5, P332, DOI 10.1038/mi.2012.13; Wagner B, 2010, VET RES, V41, DOI 10.1051/vetres/2010019; Wang GH, 2010, J IMMUNOL, V185, P71, DOI 10.4049/jimmunol.0903806; Yamagiwa S, 2001, J IMMUNOL, V166, P7282, DOI 10.4049/jimmunol.166.12.7282; Zheng SG, 2007, J IMMUNOL, V178, P2018, DOI 10.4049/jimmunol.178.4.2018	40	11	12	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2015	10	3							e0120661	10.1371/journal.pone.0120661	http://dx.doi.org/10.1371/journal.pone.0120661			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD9NQ	25790481	Green Published, gold, Green Submitted			2022-12-27	WOS:000351425400169
J	Heine, M; van den Akker, LE; Verschuren, O; Visser-Meily, A; Kwakkel, G				Heine, Martin; van den Akker, Lizanne Eva; Verschuren, Olaf; Visser-Meily, Anne; Kwakkel, Gert		TREFAMS-ACE Study Grp	Reliability and Responsiveness of Cardiopulmonary Exercise Testing in Fatigued Persons with Multiple Sclerosis and Low to Mild Disability	PLOS ONE			English	Article							UPTAKE EFFICIENCY SLOPE; QUALITY-OF-LIFE; OXYGEN-UPTAKE; FITNESS; VALIDITY; REPRODUCIBILITY; PARAMETERS; AGREEMENT; THERAPY; IMPACT	Background Peak oxygen uptake (VO(2)peak) via cardiopulmonary exercise testing is considered the gold standard for testing aerobic capacity in healthy participants and people with various medical conditions. The reliability and responsiveness of cardiopulmonary exercise testing outcomes in persons with MS (PwMS) have not been extensively studied. Objective (1) to investigate the reliability of cardiopulmonary exercise parameters in PwMS; (2) to determine the responsiveness, in terms of the smallest detectable change (SDC), for each parameter. Design Two repeated measurements of cardiopulmonary exercise outcomes were obtained, with a median time interval of 16 days. Methods Thirty-two PwMS suffering from subjective fatigue performed cardiopulmonary exercise tests on a cycle ergometer, to voluntary exhaustion. We calculated the reliability, in terms of the intra-class correlation coefficient (ICC [2, k]; absolute agreement), and the measurement error, in terms of standard error of measurement (SEM) and SDC at individual (SDCindividual) and group level (SDCgroup). Results The ICC for VO(2)peak was 0.951, with an SEM of 0.131 L.min(-1) and an SDCindividual of 0.364 L.min(-1). When corrected for bodyweight, the ICC of VO(2)peak was 0.933, with an SEM of 1.7 mL.kg(-1).min(-1) and in an SDCindividual of 4.6 mL.kg(-1).min(-1). Limitations Generalization of our study results is restricted to fatigued PwMS with a low to mild level of disability. Conclusions At individual level, cardiopulmonary exercise testing can be used reliably to assess physical fitness in terms of VO(2)peak, but less so to determine significant changes. At group level, VO(2)peak can be reliably used to determine physical fitness status and establish change over time.	[Heine, Martin; Verschuren, Olaf; Visser-Meily, Anne] Univ Med Ctr Utrecht, Brain Ctr Rudolf Magnus, NL-3583 TM Utrecht, Netherlands; [Heine, Martin; Verschuren, Olaf; Visser-Meily, Anne] Univ Med Ctr Utrecht, Ctr Excellence Rehabil Med, NL-3583 TM Utrecht, Netherlands; [Heine, Martin; Verschuren, Olaf; Visser-Meily, Anne] Rehabil Ctr Hoogstr, NL-3583 TM Utrecht, Netherlands; [van den Akker, Lizanne Eva] Vrije Univ Amsterdam Med Ctr, Dept Rehabil Med, Amsterdam, Netherlands; [van den Akker, Lizanne Eva] Vrije Univ Amsterdam Med Ctr, EMGO Inst Hlth & Care Res, Amsterdam, Netherlands; [Kwakkel, Gert] Vrije Univ Amsterdam Med Ctr, MOVE Res Inst Amsterdam, Dept Rehabil Med, Amsterdam, Netherlands; [Kwakkel, Gert] Ctr Rehabil & Rheumatol READE, Dept Neurorehabil, Amsterdam, Netherlands	Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center; Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER; Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER; Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER	Heine, M (corresponding author), Univ Med Ctr Utrecht, Brain Ctr Rudolf Magnus, Rembrandtkade 10, NL-3583 TM Utrecht, Netherlands.	m.heine@dehoogstraat.nl	de Groot, Vincent/J-8977-2013; Heine, Martin/C-8674-2012; Knoop, Hans/D-3264-2009	de Groot, Vincent/0000-0002-6073-6250; Heine, Martin/0000-0003-4131-2863; Knoop, Hans/0000-0001-7763-3517; Blikman, Lyan/0000-0002-3334-2504; Kwakkel, Gert/0000-0002-4041-4043	Fonds NutsOhra [ZonMw 89000005]	Fonds NutsOhra	The TREFAMS-ACE study is funded by the Fonds NutsOhra (ZonMw 89000005). The funders had no role in study desgin, data collection and analysis, decision to publish, or preparation of the manuscript.	Akkerman M, 2010, J CARDIOPULM REHABIL, V30, P357, DOI 10.1097/HCR.0b013e3181ebf316; Baba R, 1996, J AM COLL CARDIOL, V28, P1567, DOI 10.1016/S0735-1097(96)00412-3; Barron A, 2014, EUR J PREV CARDIOL, V21, P445, DOI 10.1177/2047487313518474; Beckerman H, 2001, QUAL LIFE RES, V10, P571, DOI 10.1023/A:1013138911638; Beckerman H, 2013, TRIALS, V14, DOI 10.1186/1745-6215-14-250; BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; Borg G, 1970, Lakartidningen, V67, P4548; Brehm MA, 2004, GAIT POSTURE, V20, P67, DOI 10.1016/S0966-6362(03)00097-3; BUCHFUHRER MJ, 1983, J APPL PHYSIOL, V55, P1558, DOI 10.1152/jappl.1983.55.5.1558; Compston A, 2008, LANCET, V372, P1502, DOI 10.1016/S0140-6736(08)61620-7; de Vet HCW, 2006, J CLIN EPIDEMIOL, V59, P1033, DOI 10.1016/j.jclinepi.2005.10.015; Golzari Z, 2010, INT IMMUNOPHARMACOL, V10, P1415, DOI 10.1016/j.intimp.2010.08.008; Heine M, 2014, PHYS THER, V94, P1168, DOI 10.2522/ptj.20130418; Heine M, 2014, J REHABIL MED, V46, P656, DOI 10.2340/16501977-1825; Herdy AH, 2011, ARQ BRAS CARDIOL, V96, P54, DOI 10.1590/S0066-782X2010005000155; KURTZKE JF, 1983, NEUROLOGY, V33, P1444, DOI 10.1212/WNL.33.11.1444; Langeskov-Christensen M, 2015, SPORTS MED IN PRESS; Langeskov-Christensen M, 2014, J NEUROL SCI, V342, P79, DOI 10.1016/j.jns.2014.04.028; Latimer-Cheung AE, 2013, ARCH PHYS MED REHAB, V94, P1800, DOI 10.1016/j.apmr.2013.04.020; Marrie Ruth Ann, 2013, Continuum (Minneap Minn), V19, P1046, DOI 10.1212/01.CON.0000433284.07844.6b; Medbo JI, 2002, SCAND J CLIN LAB INV, V62, P585, DOI 10.1080/003655102764654321; Meyer T, 2001, INT J SPORTS MED, V22, P593, DOI 10.1055/s-2001-18523; Mokkink LB, 2010, J CLIN EPIDEMIOL, V63, P737, DOI 10.1016/j.jclinepi.2010.02.006; Morrie RA, 2010, LANCET NEUROL, V9, P820, DOI 10.1016/S1474-4422(10)70135-6; Mostert S, 2002, MULT SCLER J, V8, P161, DOI 10.1191/1352458502ms779oa; Motl RW, 2012, NAT REV NEUROL, V8, P487, DOI 10.1038/nrneurol.2012.136; Motl RW, 2012, ARCH PHYS MED REHAB, V93, P490, DOI 10.1016/j.apmr.2011.08.025; Petajan JH, 1996, ANN NEUROL, V39, P432, DOI 10.1002/ana.410390405; Portney LG, 2000, FDN CLIN RES APPL PR, V2; Rampello A, 2007, PHYS THER, V87, P545, DOI 10.2522/ptj.20060085; Rasova K, 2006, MULT SCLER J, V12, P227, DOI 10.1191/135248506ms1248oa; Rietberg MB, 2005, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003980.pub2; Schulz KH, 2004, J NEUROL SCI, V225, P11, DOI 10.1016/j.jns.2004.06.009; Stickland MK, 2012, PULM MED, V2012, DOI 10.1155/2012/824091; Streiner DL, 2000, HLTH MEASUREMENT SCA; Thompson WR, 2000, ACSMS GUID EX TEST P, P105; Van Laethem C, 2009, EUR J CARDIOV PREV R, V16, P493, DOI 10.1097/HJR.0b013e32832c88a8; Vercoulen JHMM, 1996, ARCH NEUROL-CHICAGO, V53, P642, DOI 10.1001/archneur.1996.00550070080014; Wens I, 2013, MULT SCLER J, V19, P1556, DOI 10.1177/1352458513504252; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x	40	10	10	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2015	10	3							e0122260	10.1371/journal.pone.0122260	http://dx.doi.org/10.1371/journal.pone.0122260			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD9NQ	25789625	Green Published, gold, Green Submitted			2022-12-27	WOS:000351425400211
J	Hozumi, H; Enomoto, N; Kono, M; Fujisawa, T; Inui, N; Nakamura, Y; Sumikawa, H; Johkoh, T; Nakashima, R; Imura, Y; Mimori, T; Suda, T				Hozumi, Hironao; Enomoto, Noriyuki; Kono, Masato; Fujisawa, Tomoyuki; Inui, Naoki; Nakamura, Yutaro; Sumikawa, Hiromitsu; Johkoh, Takeshi; Nakashima, Ran; Imura, Yoshitaka; Mimori, Tsuneyo; Suda, Takafumi			Prognostic Significance of Anti-Aminoacyl-tRNA Synthetase Antibodies in Polymyositis/Dermatomyositis-Associated Interstitial Lung Disease: A Retrospective Case Control Study	PLOS ONE			English	Article							MYOSITIS-SPECIFIC AUTOANTIBODIES; AMYOPATHIC DERMATOMYOSITIS; CLINICAL-FEATURES; GENE 5; POLYMYOSITIS; MANIFESTATIONS; CLASSIFICATION; AUTOANTIGEN; SOCIETY; HRCT	Background In polymyositis/dermatomyositis (PM/DM), anti-aminoacyl-tRNA synthetase (ARS) antibodies are closely associated with interstitial lung disease (ILD), a frequent pulmonary complication. However, the clinical significance of anti-ARS antibodies is not well established. Objective We aimed to evaluate the clinical significance of anti-ARS antibodies in PM/DM-ILD patients. Methods Forty-eight consecutive PM/DM-ILD patients were studied retrospectively. Anti-ARS antibodies were screened by ELISA and confirmed by RNA immunoprecipitation test. Medical records, high-resolution computed tomography images, and surgical lung biopsy specimens were compared between ARS-positive (ARS group) and ARS-negative patients (non-ARS group). Results Anti-ARS antibodies were detected in 23 of 48 patients (48%). Radiologically, nonspecific interstitial pneumonia (NSIP) pattern was observed more frequently in the ARS group than in the non-ARS group (73.9% vs. 40%, P = 0.02). Pathologically, NSIP was the most frequent in both groups. Ten-year survival rate was also significantly higher in the ARS group than in the non-ARS group (91.6% vs. 58.7%, P = 0.02). Univariate Cox hazards analysis revealed that the presence of anti-ARS antibodies was associated with better prognosis (HR = 0.34, 95% CI 0.08-0.80; P = 0.01). Conclusions The presence of anti-ARS antibodies is a possible prognostic marker in patients with PM/DM-ILD.	[Hozumi, Hironao; Enomoto, Noriyuki; Kono, Masato; Fujisawa, Tomoyuki; Nakamura, Yutaro; Suda, Takafumi] Hamamatsu Univ, Sch Med, Dept Internal Med, Div 2, Hamamatsu, Shizuoka 4312102, Japan; [Inui, Naoki] Hamamatsu Univ, Sch Med, Dept Clin Pharmacol & Therapeut, Hamamatsu, Shizuoka 4312102, Japan; [Sumikawa, Hiromitsu] Osaka Univ, Grad Sch Med, Diagnost & Intervent Radiol, Suita, Osaka, Japan; [Johkoh, Takeshi] Kinki Cent Hosp, Mutual Aid Assoc, Publ Sch Teachers, Dept Radiol, Itami, Hyogo, Japan; [Nakashima, Ran; Imura, Yoshitaka; Mimori, Tsuneyo] Kyoto Univ, Grad Sch Med, Dept Rheumatol & Clin Immunol, Kyoto, Japan	Hamamatsu University School of Medicine; Hamamatsu University School of Medicine; Osaka University; Kyoto University	Enomoto, N (corresponding author), Hamamatsu Univ, Sch Med, Dept Internal Med, Div 2, Hamamatsu, Shizuoka 4312102, Japan.	norieno@hama-med.ac.jp	Enomoto, Noriyuki/GLS-0691-2022	Enomoto, Noriyuki/0000-0003-3187-4264				Aggarwal R, 2014, ANN RHEUM DIS, V73, P227, DOI 10.1136/annrheumdis-2012-201800; *AM THOR SOC, 2000, AM J RESP CRIT CARE, V161, P646, DOI DOI 10.1164/AJRCCM.161.2.ATS3-00; American Thoracic Society/European Respiratory Society International Multidisciplinary Consensus Classification of the Idiopathic Interstitial Pneumonias, 2002, AM J RESP CRIT CARE, V165, P277, DOI [DOI 10.1164/AJRCCM.165.2.ATS01, 10.1164/ajrccm.165.2.ats01]; BOHAN A, 1975, NEW ENGL J MED, V292, P403, DOI 10.1056/NEJM197502202920807; BOHAN A, 1975, NEW ENGL J MED, V292, P344, DOI 10.1056/NEJM197502132920706; Cottin V, 2003, EUR RESPIR J, V22, P245, DOI 10.1183/09031936.03.00026703; Douglas WW, 2001, AM J RESP CRIT CARE, V164, P1182, DOI 10.1164/ajrccm.164.7.2103110; Fischer A, 2010, CHEST, V138, P251, DOI 10.1378/chest.10-0194; Fujisawa T, 2005, J RHEUMATOL, V32, P58; Fujisawa T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098824; Gono T, 2010, RHEUMATOLOGY, V49, P1713, DOI 10.1093/rheumatology/keq149; Gunawardena H, 2009, RHEUMATOLOGY, V48, P607, DOI 10.1093/rheumatology/kep078; Hamaguchi Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060442; Hansell DM, 2008, RADIOLOGY, V246, P697, DOI 10.1148/radiol.2462070712; Hervier B, 2013, CURR RHEUMATOL REP, V15, DOI 10.1007/s11926-013-0349-8; Hoshino K, 2010, RHEUMATOLOGY, V49, P1726, DOI 10.1093/rheumatology/keq153; Huh JW, 2007, RESP MED, V101, P1761, DOI 10.1016/j.rmed.2007.02.017; Kalluri M, 2009, CHEST, V135, P1550, DOI 10.1378/chest.08-2233; LOVE LA, 1991, MEDICINE, V70, P360, DOI 10.1097/00005792-199111000-00002; Marie I, 2002, ARTHRIT RHEUM-ARTHR, V47, P614, DOI 10.1002/art.10794; Marie I, 2013, ARTHRIT CARE RES, V65, P800, DOI 10.1002/acr.21895; Marie I, 2011, ARTHRITIS RHEUM-US, V63, P3439, DOI 10.1002/art.30513; Nakashima R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085062; Nakashima R, 2010, RHEUMATOLOGY, V49, P433, DOI 10.1093/rheumatology/kep375; Raghu G, 2011, AM J RESP CRIT CARE, V183, P788, DOI 10.1164/rccm.2009-040GL; Richards TJ, 2009, ARTHRITIS RHEUM-US, V60, P2183, DOI 10.1002/art.24631; Sato S, 2009, ARTHRITIS RHEUM-US, V60, P2193, DOI 10.1002/art.24621; Schneider F, 2014, J CLIN PATHOL, V67, P678, DOI 10.1136/jclinpath-2014-202367; Sontheimer RD, 2002, J AM ACAD DERMATOL, V46, P626, DOI 10.1067/mjd.2002.120621; Suda T, 2006, EUR RESPIR J, V28, P1005, DOI 10.1183/09031936.06.00038806; Suda T, 2010, RESP MED, V104, P1527, DOI 10.1016/j.rmed.2010.04.022; Takato H, 2013, RESP MED, V107, P128, DOI 10.1016/j.rmed.2012.09.005; Tanizawa K, 2013, RESP MED, V107, P745, DOI 10.1016/j.rmed.2013.01.014; Tanizawa K, 2011, RESP MED, V105, P1380, DOI 10.1016/j.rmed.2011.05.006; TAZELAAR HD, 1990, AM REV RESPIR DIS, V141, P727, DOI 10.1164/ajrccm/141.3.727; Travis WD, 2013, AM J RESP CRIT CARE, V188, P733, DOI 10.1164/rccm.201308-1483ST; Watanabe K, 2011, RESP MED, V105, P1238, DOI 10.1016/j.rmed.2011.03.022; Yoshifuji H, 2006, AUTOIMMUNITY, V39, P233, DOI 10.1080/08916930600622884; Yousem SA, 2014, HUM PATHOL, V45, P1199, DOI 10.1016/j.humpath.2014.01.018	39	59	67	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2015	10	3							e0120313	10.1371/journal.pone.0120313	http://dx.doi.org/10.1371/journal.pone.0120313			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD9NQ	25789468	Green Published, gold, Green Submitted			2022-12-27	WOS:000351425400150
J	Huang, JP; Dang, RH; Torigoe, D; Lei, CZ; Lan, XY; Chen, H; Sasaki, N; Wang, JX; Agui, T				Huang, Jieping; Dang, Ruihua; Torigoe, Daisuke; Lei, Chuzhao; Lan, Xianyong; Chen, Hong; Sasaki, Nobuya; Wang, Jinxi; Agui, Takashi			Identification of Genetic Loci Affecting the Severity of Symptoms of Hirschsprung Disease in Rats Carrying Ednrb(sl) Mutations by Quantitative Trait Locus Analysis	PLOS ONE			English	Article							ENTERIC NERVOUS-SYSTEM; ENDOTHELIN RECEPTOR-B; MICE LACKING GDNF; ALBINISM TYPE-IV; MOUSE MODEL; TRANSCRIPTIONAL REGULATION; NEURON PRECURSORS; MODIFIER GENE; SOX10; RET	Hirschsprung's disease (HSCR) is a congenital disease in neonates characterized by the absence of the enteric ganglia in a variable length of the distal colon. This disease results from multiple genetic interactions that modulate the ability of enteric neural crest cells to populate developing gut. We previously reported that three rat strains with different backgrounds (susceptible AGH-Ednrb(sl/sl), resistant F344-Ednrb(sl/sl), and LEH-Ednrb(sl/sl)) but the same null mutation of Ednrb show varying severity degrees of aganglionosis. This finding suggests that strain-specific genetic factors affect the severity of HSCR. Consistent with this finding, a quantitative trait locus (QTL) for the severity of HSCR on chromosome (Chr) 2 was identified using an F-2 intercross between AGH and F344 strains. In the present study, we performed QTL analysis using an F-2 intercross between the susceptible AGH and resistant LEH strains to identify the modifier/resistant loci for HSCR in Ednrb-deficient rats. A significant locus affecting the severity of HSCR was also detected within the Chr 2 region. These findings strongly suggest that a modifier gene of aganglionosis exists on Chr 2. In addition, two potentially causative SNPs (or mutations) were detected upstream of a known HSCR susceptibility gene, Gdnf. These SNPs were possibly responsible for the varied length of gut affected by aganglionosis.	[Huang, Jieping; Dang, Ruihua; Lei, Chuzhao; Lan, Xianyong; Chen, Hong] Northwest A&F Univ, Coll Anim Sci & Technol, Yangling, Shaanxi, Peoples R China; [Torigoe, Daisuke; Wang, Jinxi; Agui, Takashi] Hokkaido Univ, Grad Sch Vet Med, Dept Dis Control, Lab Lab Anim Sci & Med, Sapporo, Hokkaido 060, Japan; [Sasaki, Nobuya] Kitasato Univ, Sch Vet Med, Lab Lab Anim Sci & Med, Aomori, Japan	Northwest A&F University - China; Hokkaido University; Kitasato University	Dang, RH (corresponding author), Northwest A&F Univ, Coll Anim Sci & Technol, Yangling, Shaanxi, Peoples R China.	dangruihua@nwsuaf.edu.cn; leichuzhao1118@126.com			National Natural Science Foundation of China [81270439]; Fundamental Research Funds for the Central Universities [Z109021204]; Research Foundation for Advanced Talents [Z111021202]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); Research Foundation for Advanced Talents	This work was supported by the National Natural Science Foundation of China (grant 81270439), the Fundamental Research Funds for the Central Universities (grant Z109021204) and the Research Foundation for Advanced Talents (grant Z111021202). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alves MMM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015144; Brooks AS, 2005, AM J HUM GENET, V77, P120, DOI 10.1086/431244; Cantrell VA, 2004, HUM MOL GENET, V13, P2289, DOI 10.1093/hmg/ddh243; Carrasquillo MM, 2002, NAT GENET, V32, P237, DOI 10.1038/ng998; Chan AYK, 2005, BRIT J DERMATOL, V153, P1072, DOI 10.1111/j.1365-2133.2005.06912.x; COHEN IT, 1982, J PEDIATR SURG, V17, P632, DOI 10.1016/S0022-3468(82)80124-3; Cozma D, 2002, GENOME RES, V12, P969, DOI 10.1101/gr.210502; Dang RH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027902; Dang RH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024086; Du JY, 2002, J BIOL CHEM, V277, P402, DOI 10.1074/jbc.M110229200; Fitze G, 2003, HUM MOL GENET, V12, P3207, DOI 10.1093/hmg/ddg354; Glas J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052873; Gui HS, 2013, HUM GENET, V132, P591, DOI 10.1007/s00439-013-1272-9; Hori R, 2013, AURIS NASUS LARYNX, V40, P539, DOI 10.1016/j.anl.2013.05.003; HOSODA K, 1994, CELL, V79, P1267, DOI 10.1016/0092-8674(94)90017-5; Jiang Q, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021219; Karaki H, 1996, BIOCHEM BIOPH RES CO, V222, P139, DOI 10.1006/bbrc.1996.0711; Konno T, 2009, AM J MED GENET A, V149A, P1773, DOI 10.1002/ajmg.a.32964; Lang D, 2003, HUM MOL GENET, V12, P937, DOI 10.1093/hmg/ddg107; Lee HO, 2003, DEV BIOL, V259, P162, DOI 10.1016/S0012-1606(03)00160-X; Leon TYY, 2009, J PEDIATR SURG, V44, P1904, DOI 10.1016/j.jpedsurg.2008.11.055; Manolio TA, 2009, NATURE, V461, P747, DOI 10.1038/nature08494; McCallion AS, 2003, P NATL ACAD SCI USA, V100, P1826, DOI 10.1073/pnas.0337540100; Moore MW, 1996, NATURE, V382, P76, DOI 10.1038/382076a0; Mundt E, 2010, SEMIN PEDIATR SURG, V19, P107, DOI 10.1053/j.sempedsurg.2009.11.015; Nadeau JH, 2003, CURR OPIN GENET DEV, V13, P290, DOI 10.1016/S0959-437X(03)00061-3; Parisi MA, 2002, AM J MED GENET, V108, P51, DOI 10.1002/ajmg.10185; Pellerin D, 1992, Cir Pediatr, V5, P57; Pingault V, 1998, NAT GENET, V18, P171, DOI 10.1038/ng0298-171; Ruiz-Ferrer M, 2011, J MOL MED, V89, P471, DOI 10.1007/s00109-010-0714-2; Sanchez MP, 1996, NATURE, V382, P70, DOI 10.1038/382070a0; Sasongko Teguh Haryo, 2007, Kobe J Med Sci, V53, P157; Southard-Smith EM, 1998, NAT GENET, V18, P60, DOI 10.1038/ng0198-60; Stanchina L, 2006, DEV BIOL, V295, P232, DOI 10.1016/j.ydbio.2006.03.031; Stanchina L, 2010, DEV BIOL, V341, P416, DOI 10.1016/j.ydbio.2010.02.036; Tanaka M, 2000, BBA-GENE STRUCT EXPR, V1494, P63, DOI 10.1016/S0167-4781(00)00218-9; Wallace AS, 2011, NEUROGASTROENT MOTIL, V23, pE510, DOI 10.1111/j.1365-2982.2011.01692.x; Wallace AS, 2010, NEUROBIOL DIS, V40, P622, DOI 10.1016/j.nbd.2010.08.006; Walters LC, 2010, HUM MOL GENET, V19, P4353, DOI 10.1093/hmg/ddq357; Winkler PA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092127; Woodbury D, 1998, BRAIN RES, V803, P95, DOI 10.1016/S0006-8993(98)00627-1; Xu Bei, 2012, Zhonghua Yi Xue Za Zhi, V92, P254; Zhu L, 2004, NAT GENET, V36, P732, DOI 10.1038/ng1371	43	4	5	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2015	10	3							e0122068	10.1371/journal.pone.0122068	http://dx.doi.org/10.1371/journal.pone.0122068			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD9NQ	25790447	Green Published, Green Submitted, gold			2022-12-27	WOS:000351425400209
J	Martellos, S; Nimis, PL				Martellos, Stefano; Nimis, Pier Luigi			From Local Checklists to Online Identification Portals: A Case Study on Vascular Plants	PLOS ONE			English	Article							INFORMATION-SYSTEM; KEYS	Checklists, the result of time-consuming exploration and painstaking bibliographic research, can be easily converted into online databases, which have the advantage of being updatable online in real time, and of reaching a much wider audience. However, thousands of local checklists (Natural Parks, protected areas, etc.) are still available on paper only, and most of those published online appear as dry lists of latin names, which strongly reduces their outreach for a wider audience. The University of Trieste has recently started the publication of several local checklists in a way that may be more appealing for the general public, by linking species' names to archives of digital resources, and especially to digital identification tools produced by software FRIDA (FRiendly IDentificAtion). The query interfaces were developed on the basis of feedback from a wide range of users. The result is no longer a simple list of names accessible on the Web, but a veritable multimedial, interactive portal to the biodiversity of a given area. This paper provides an example of how relevant added value can be given to local lists of taxa by embedding them in a complex system of biodiversity-related resources, making them usable for a much wider audience than a restricted circle of specialists, as testified by the almost 1.000.000 unique visitors reached in 2014. A critical mass of digital resources is also put at disposal of the scientific community by releasing them under a Creative Commons license.	[Martellos, Stefano; Nimis, Pier Luigi] Univ Trieste, Dept Life Sci, Trieste, Italy	University of Trieste	Martellos, S (corresponding author), Univ Trieste, Dept Life Sci, Via L Giorgieri 10, Trieste, Italy.	martelst@units.it		Martellos, Stefano/0000-0001-5201-8948				Attorre F, 2013, PLANT BIOSYST, V147, P1101, DOI 10.1080/11263504.2013.860054; Castello M, 2006, POLAR BIOL, V29, P604, DOI 10.1007/s00300-005-0095-0; Conti F., 2005, ANNOTATED CHECKLIST, V4, P227; Conti F, 2007, NATURA VICENTINA, V10, p[2006, 5]; Dalla Fior G, 1981, GUIDA CONOSCENZA FLO; Euro+Med PlantBase-the information resource for Euro-Mediterranean plant diversity, 2006, EUR MED PLANTBASE I; Fischer Eberhard, 2010, Journal of East African Natural History, V99, P129; Germishuizen G., 2003, STRELITZIA; Hagedorn G, 2010, TOOLS IDENTIFYING BI, P59; Lauber K, 2012, FLORA HELVETICA, P5; Llimona X., 2001, BOCCONEA, V14, P5; Martellos S, 2012, PLANT BIOSYST, V146, P764, DOI 10.1080/11263504.2012.740088; Martellos S, 2011, PLANT BIOSYST, V145, P758, DOI 10.1080/11263504.2011.620342; Martellos S., 2008, P IASK INT C TEACH L, P863; Martellos S, 2013, PLANT BIOSYST, V147, P529, DOI 10.1080/11263504.2012.760497; Martellos S, 2010, TAXON, V59, P922, DOI 10.1002/tax.593020; Nimis PL, 2012, PLANT BIOSYST, V146, P783, DOI 10.1080/11263504.2012.740089; NIMIS P. L., 2003, MUSEO REGIONALE SCI, VIV; Nimis PL, 2009, ECO MONT, V1, P61, DOI 10.1553/ecomont2s61; Nimis PL, 2002, BIBLIOTHECA LICHENOL, V82, P271; Nimis PL, 2013, GUIDA FLORA ALPI CAR; Onofri S., 2005, CHECKLIST ITALIAN FU; Pignatti S., 1982, FLORA DITALIA, VVolume I; Smith VS, 2011, ZOOKEYS, P53, DOI 10.3897/zookeys.150.2193; Tutin T.G., 1964, FLORA EUROPAEA, V1-5	25	8	12	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2015	10	3							e0120970	10.1371/journal.pone.0120970	http://dx.doi.org/10.1371/journal.pone.0120970			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD9NQ	25790121	Green Published, Green Submitted, gold			2022-12-27	WOS:000351425400185
J	Mehta, V; Sen, R; Moshiri, H; Salavati, R				Mehta, Vaibhav; Sen, Rajashree; Moshiri, Houtan; Salavati, Reza			Mutational Analysis of Trypanosoma brucei RNA Editing Ligase Reveals Regions Critical for Interaction with KREPA2	PLOS ONE			English	Article							COMPLEX; DNA; TRANSCRIPT; PROTEINS; DELETION; ENZYME	The Trypanosoma brucei parasite causes the vector-borne disease African sleeping sickness. Mitochondrial mRNAs of T. brucei undergo posttranscriptional RNA editing to make mature, functional mRNAs. The final step of this process is catalyzed by the essential ligase, T. brucei RNA Editing Ligase 1 (TbREL1) and the closely related T. brucei RNA Editing Ligase 2 (TbREL2). While other ligases such as T7 DNA ligase have both a catalytic and an oligonucleotide/oligosaccharide-binding (OB)-fold domain, T. brucei RNA editing ligases contain only the catalytic domain. The OB-fold domain, which is required for interaction with the substrate RNA, is provided in trans by KREPA2 (for TbREL1) and KREPA1 (for TbREL2). KREPA2 enhancement of TbREL1 ligase activity is presumed to occur via an OB-fold-mediated increase in substrate specificity and catalysis. We characterized the interaction between TbREL1 and KREPA2 in vitro using full-length, truncated, and point-mutated ligases. As previously shown, our data indicate strong, specific stimulation of TbREL1 catalytic activity by KREPA2. We narrowed the region of contact to the final 59 C-terminal residues of TbREL1. Specifically, the TbREL1 C-terminal KWKE (441-444) sequence appear to coordinate the KREPA2-mediated enhancement of TbREL1 activities. N-terminal residues F206, T264 and Y275 are crucial for the overall activity of TbREL1, particularly for F206, a mutation of this residue also disrupts KREPA2 interaction. Thus, we have identified the critical TbREL1 regions and amino acids that mediate the KREPA2 interaction.	[Mehta, Vaibhav; Sen, Rajashree; Moshiri, Houtan; Salavati, Reza] McGill Univ, Dept Biochem, Montreal, PQ H3G 1Y6, Canada; [Salavati, Reza] McGill Univ, Inst Parasitol, Montreal, PQ H9X 3V9, Canada; [Salavati, Reza] McGill Univ, McGill Ctr Bioinformat, Montreal, PQ H3A 2B4, Canada	McGill University; McGill University; McGill University	Salavati, R (corresponding author), McGill Univ, Dept Biochem, McIntyre Med Bldg, Montreal, PQ H3G 1Y6, Canada.	reza.salavati@mcgill.ca			Canadian Institutes of Health Research (CIHR) [259835]; CIHR Chemical Biology Fellowship	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); CIHR Chemical Biology Fellowship	This work was supported in part by the Canadian Institutes of Health Research (CIHR) grant 259835 (to R. S.). VM is supported by CIHR Chemical Biology Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amaro RE, 2008, P NATL ACAD SCI USA, V105, P17278, DOI 10.1073/pnas.0805820105; Amaro RE, 2007, PLOS NEGLECT TROP D, V1, DOI 10.1371/journal.pntd.0000068; Aphasizhev R, 2011, WIRES RNA, V2, P669, DOI 10.1002/wrna.82; BENNE R, 1986, CELL, V46, P819, DOI 10.1016/0092-8674(86)90063-2; Deng JP, 2004, J MOL BIOL, V343, P601, DOI 10.1016/j.jmb.2004.08.041; Doherty AJ, 2000, NUCLEIC ACIDS RES, V28, P4051, DOI 10.1093/nar/28.21.4051; Drozdz M, 2002, EMBO J, V21, P1791, DOI 10.1093/emboj/21.7.1791; FEAGIN JE, 1988, CELL, V53, P413, DOI 10.1016/0092-8674(88)90161-4; Gao GH, 2005, P NATL ACAD SCI USA, V102, P4712, DOI 10.1073/pnas.0500553102; Hajduk S, 2010, RNA BIOL, V7, P229, DOI 10.4161/rna.7.2.11393; Ho CK, 2002, P NATL ACAD SCI USA, V99, P12709, DOI 10.1073/pnas.192184699; Huang CE, 2002, MOL CELL BIOL, V22, P3194, DOI 10.1128/MCB.22.9.3194-3203.2002; Huang CE, 2001, EMBO J, V20, P4694, DOI 10.1093/emboj/20.17.4694; Kang XD, 2004, J BIOL CHEM, V279, P3893, DOI 10.1074/jbc.M310185200; KLEISEN CM, 1976, EUR J BIOCHEM, V64, P153, DOI 10.1111/j.1432-1033.1976.tb10283.x; Matthews JM, 2002, IUBMB LIFE, V54, P351, DOI 10.1080/15216540216035; Moshiri H, 2011, J BIOL CHEM, V286, P14178, DOI 10.1074/jbc.M110.199646; Moshiri H, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq333; Nandakumar J, 2004, J BIOL CHEM, V279, P31337, DOI 10.1074/jbc.M402394200; Palazzo SS, 2003, MOL BIOCHEM PARASIT, V127, P161, DOI 10.1016/S0166-6851(02)00333-X; Panigrahi AK, 2001, MOL CELL BIOL, V21, P6833, DOI 10.1128/MCB.21.20.6833-6840.2001; RIOU G, 1969, P NATL ACAD SCI USA, V62, P210, DOI 10.1073/pnas.62.1.210; Samai P, 2012, J BIOL CHEM, V287, P28609, DOI 10.1074/jbc.M112.380428; Schnaufer A, 2003, MOL CELL, V12, P307, DOI 10.1016/S1097-2765(03)00286-7; Schnaufer A, 2001, SCIENCE, V291, P2159, DOI 10.1126/science.1058655; Schnaufer A, 2010, J BIOL CHEM, V285, P5282, DOI 10.1074/jbc.M109.059378; Shaneh A, 2010, J MOL MODEL, V16, P61, DOI 10.1007/s00894-009-0506-1; Shuman S, 2004, CURR OPIN STRUC BIOL, V14, P757, DOI 10.1016/j.sbi.2004.10.006; Stuart KD, 2005, TRENDS BIOCHEM SCI, V30, P97, DOI 10.1016/j.tibs.2004.12.006; Theobald DL, 2003, ANNU REV BIOPH BIOM, V32, P115, DOI 10.1146/annurev.biophys.32.110601.142506; Yin SM, 2004, VIROLOGY, V319, P141, DOI 10.1016/j.virol.2003.10.037	31	3	3	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2015	10	3							e0120844	10.1371/journal.pone.0120844	http://dx.doi.org/10.1371/journal.pone.0120844			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD9NQ	25790471	Green Published, gold, Green Submitted			2022-12-27	WOS:000351425400179
J	Petrzik, K; Vondrak, J; Kviderova, J; Lukavsky, J				Petrzik, Karel; Vondrak, Jan; Kviderova, Jana; Lukavsky, Jaromir			Platinum Anniversary: Virus and Lichen Alga Together More than 70 Years	PLOS ONE			English	Article							CAULIFLOWER-MOSAIC-VIRUS; CHLOROPHYLL FLUORESCENCE; VIRAL-INFECTION; BLOOM; TRANSMISSION; ABUNDANCE; SEQUENCE	Trebouxia aggregata (Archibald) Gartner (phylum Chlorophyta, family Trebouxiaceae), a lichen symbiotic alga, has been identified as host of the well-known herbaceous plant virus Cauliflower mosaic virus (CaMV, family Caulimoviridae). The alga had been isolated from Xanthoria parietina more than 70 years ago and has been maintained in a collection since that time. The CaMV detected in this collection entry has now been completely sequenced. The virus from T. aggregata is mechanically transmissible to a herbaceous host and induces disease symptoms there. Its genome differs by 173 nt from the closest European CaMV-D/H isolate from cauliflower. No site under positive selection was found on the CaMV genome from T. aggregata. We therefore assume that the virus's presence in this alga was not sufficiently long to fix any specific changes in its genome. Apart from this symbiotic alga, CaMV capsid protein sequences were amplified from many other non-symbiotic algae species maintained in a collection (e.g., Oonephris obesa, Elliptochlorissp., Microthamnion kuetzingianum, Chlorella vulgaris, Pseudococcomyxasp.). CaMV-free Chlorella vulgaris was treated with CaMV to establish virus infection. The virus was still detected there after five passages. The virus infection is morphologically symptomless on Chlorellaalgae and the photosynthesis activity is slightly decreased in comparison to CaMV-free alga culture. This is the first proof as to the natural presence of CaMV in algae and the first demonstration of algae being artificially infected with this virus.	[Petrzik, Karel] Acad Sci Czech Republ, Dept Plant Virol, Inst Plant Mol Biol, Ctr Biol, Ceske Budejovice, Czech Republic; [Vondrak, Jan] Czech Univ Life Sci Prague, Fac Environm Sci, Prague 6, Suchdol, Czech Republic; [Kviderova, Jana; Lukavsky, Jaromir] Acad Sci Czech Republ, Inst Bot, Trebon, Czech Republic	Czech Academy of Sciences; Biology Centre of the Czech Academy of Sciences; Czech University of Life Sciences Prague; Czech Academy of Sciences; Institute of Botany of the Czech Academy of Sciences	Petrzik, K (corresponding author), Acad Sci Czech Republ, Dept Plant Virol, Inst Plant Mol Biol, Ctr Biol, Ceske Budejovice, Czech Republic.	petrzik@umbr.cas.cz	Petrzik, Karel/B-6957-2008	Petrzik, Karel/0000-0001-9668-1223; Kviderova, Jana/0000-0002-5700-477X; Vondrak, Jan/0000-0001-7568-6711	Czech Science Foundation [P501/12/1747]; Biology Centre [RVO60077344]; Institute of Botany [RVO67985939]; Technology Agency of the Czech Republic [TE01020080]; Ministry of Education, youth and sports [LM2010009]	Czech Science Foundation(Grant Agency of the Czech Republic); Biology Centre; Institute of Botany; Technology Agency of the Czech Republic; Ministry of Education, youth and sports(Ministry of Education, Youth & Sports - Czech Republic)	P501/12/1747 Czech Science Foundation, http://www.gacr.cz/en/ KP - funded the study design, consumables, preparation of the manuscript; RVO60077344 - governmental support for Biology Centre, KP - funded personal costs of KP; RVO67985939 - governmental support for Institute of Botany, JL - funded personal costs of JV, JL, JK; TE01020080 - Technology Agency of the Czech Republic, http://www.tacr.cz JL - funded sample collection and maintaining in collection; LM2010009 - Ministry of Education, youth and sports, http://www.msmt.cz - funded FluorCam instrument and data analysis.	Ahmadjian V, 1993, THE LICHEN SYMBIOSIS; ALLEN MM, 1976, ARCH MICROBIOL, V110, P55, DOI 10.1007/BF00416969; BABICH H, 1980, WATER RES, V14, P185, DOI 10.1016/0043-1354(80)90236-5; BERGH O, 1989, NATURE, V340, P467, DOI 10.1038/340467a0; Blanc Stephane, 2001, P143, DOI 10.1016/B978-012327681-0/50011-X; Brown Jr RM, 1964, PUBL U TEXAS, V6417, P1; CABI, 2014, CROP PROT COMP; Chen MH, 2000, EMBO J, V19, P913, DOI 10.1093/emboj/19.5.913; Dunigan DD, 2006, VIRUS RES, V117, P119, DOI 10.1016/j.virusres.2006.01.024; Farzadfar S, 2013, VIRUS GENES, V47, P347, DOI 10.1007/s11262-013-0948-5; FRANCK A, 1980, CELL, V21, P285, DOI 10.1016/0092-8674(80)90136-1; Friedl T, 2008, LICHEN BIOLOGY, 2ND EDITION, P9, DOI 10.1017/CBO9780511790478.003; Froissart R, 2005, PLOS BIOL, V3, P389, DOI 10.1371/journal.pbio.0030089; Galloway DJ, 2008, LICHEN BIOLOGY, 2ND EDITION, P315, DOI 10.1017/CBO9780511790478.017; Guiry MD, 2014, ALGAEBASE; Harris EH, 2001, ANNU REV PLANT PHYS, V52, P363, DOI 10.1146/annurev.arplant.52.1.363; HULL R, 1976, J GEN VIROL, V31, P93, DOI 10.1099/0022-1317-31-1-93; Huson DH, 2006, MOL BIOL EVOL, V23, P254, DOI 10.1093/molbev/msj030; Juneau P, 2003, AQUAT MICROB ECOL, V31, P9, DOI 10.3354/ame031009; Khelifa M, 2010, VIROLOGY, V396, P238, DOI 10.1016/j.virol.2009.09.032; Lawrence J., 2005, ALGAL CULTURING TECH, P365; MACKENZIE JJ, 1972, VIROLOGY, V49, P517, DOI 10.1016/0042-6822(72)90503-X; Marco S., 1985, Phytopathologia Mediterranea, V24, P211; Martin DP, 2010, BIOINFORMATICS, V26, P2462, DOI 10.1093/bioinformatics/btq467; Martinez F, 2009, J GEN VIROL, V90, P3057, DOI 10.1099/vir.0.013425-0; Maxwell K, 2000, J EXP BOT, V51, P659, DOI 10.1093/jexbot/51.345.659; MAYER JA, 1979, NATURE, V281, P299, DOI 10.1038/281299a0; Meier FA, 2002, BIOL J LINN SOC, V76, P259, DOI 10.1111/j.1095-8312.2002.tb02087.x; MEINTS RH, 1981, VIROLOGY, V113, P698, DOI 10.1016/0042-6822(81)90198-7; NAMBA R, 1981, J ECON ENTOMOL, V74, P546, DOI 10.1093/jee/74.5.546; Nedbal L, 2000, PHOTOSYNTH RES, V66, P3, DOI 10.1023/A:1010729821876; Petrzik K, 1998, VIRUS GENES, V16, P303, DOI 10.1023/A:1008039024963; Petrzik K, 2014, EUR J PLANT PATHOL, V138, P549, DOI 10.1007/s10658-013-0246-z; Pietschmann SM, 1989, COLLOIDAL GOLD PRINC, P255; PIQUE M, 1995, GENE, V155, P305, DOI 10.1016/0378-1119(94)00927-K; Polischuk V, 2007, FEMS MICROBIOL ECOL, V59, P409, DOI 10.1111/j.1574-6941.2006.00242.x; Qiu SG, 1997, VIROLOGY, V227, P180, DOI 10.1006/viro.1996.8314; Quispel A., 1943, THESIS U GRONINGEN; Rohacek K, 1999, PHOTOSYNTHETICA, V37, P339, DOI 10.1023/A:1007172424619; Rosario K, 2009, ENVIRON MICROBIOL, V11, P2806, DOI 10.1111/j.1462-2920.2009.01964.x; Shepherd RJ, 1981, CMI AAB DESCRIPTIONS; Spak J, 1989, OCHRANA ROSTLIN, V25, P177; Syngouna VI, 2010, ENVIRON SCI TECHNOL, V44, P4539, DOI 10.1021/es100107a; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tarutani K, 2000, APPL ENVIRON MICROB, V66, P4916, DOI 10.1128/AEM.66.11.4916-4920.2000; Van Etten JL, 2012, TRENDS PLANT SCI, V17, P1, DOI 10.1016/j.tplants.2011.10.005; VANETTEN JL, 1983, VIROLOGY, V126, P117, DOI 10.1016/0042-6822(83)90466-X; Weber MX, 2012, ADV BOT RES, V64, P119, DOI 10.1016/B978-0-12-391499-6.00004-9; Whon TW, 2012, J VIROL, V86, P8221, DOI 10.1128/JVI.00293-12; Wilhelm SW, 2008, FRESHWATER BIOL, V53, P1076, DOI 10.1111/j.1365-2427.2008.01980.x; Wilson WH, 2002, J MAR BIOL ASSOC UK, V82, P369, DOI 10.1017/S002531540200560X; Yamada T, 2006, ADV VIRUS RES, V66, P293, DOI 10.1016/S0065-3527(06)66006-5; Yasaka R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085641; Zaady E, 2000, SOIL BIOL BIOCHEM, V32, P959, DOI 10.1016/S0038-0717(00)00004-3; Zfang X, 2011, P NATL ACAD SCI USA, V108, P14837, DOI [10.1073/pnas.1107847108, DOI 10.1073/PNAS.1107847108]	55	6	6	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2015	10	3							e0120768	10.1371/journal.pone.0120768	http://dx.doi.org/10.1371/journal.pone.0120768			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD9NQ	25789995	gold, Green Published, Green Submitted			2022-12-27	WOS:000351425400174
J	Sierakowiak, A; Monnot, C; Aski, SN; Uppman, M; Li, TQ; Damberg, P; Brene, S				Sierakowiak, Adam; Monnot, Cyril; Aski, Sahar Nikkhou; Uppman, Martin; Li, Tie-Qiang; Damberg, Peter; Brene, Stefan			Default Mode Network, Motor Network, Dorsal and Ventral Basal Ganglia Networks in the Rat Brain: Comparison to Human Networks Using Resting State-fMRI	PLOS ONE			English	Article							FUNCTIONAL CONNECTIVITY NETWORKS; GLOBAL SIGNAL; ANIMAL-MODELS; BOLD; PATHOPHYSIOLOGY; FLUCTUATIONS; ARCHITECTURE; DISEASE; CORTEX; MOUSE	Rodent models are developed to enhance understanding of the underlying biology of different brain disorders. However, before interpreting findings from animal models in a translational aspect to understand human disease, a fundamental step is to first have knowledge of similarities and differences of the biological systems studied. In this study, we analyzed and verified four known networks termed: default mode network, motor network, dorsal basal ganglia network, and ventral basal ganglia network using resting state functional MRI (rsfMRI) in humans and rats. Our work supports the notion that humans and rats have common robust resting state brain networks and that rsfMRI can be used as a translational tool when validating animal models of brain disorders. In the future, rsfMRI may be used, in addition to short-term interventions, to characterize longitudinal effects on functional brain networks after long-term intervention in humans and rats.	[Sierakowiak, Adam; Brene, Stefan] Karolinska Inst, Care Sci & Soc NVS, Dept Neurobiol, Stockholm, Sweden; [Monnot, Cyril] Karolinska Inst, Dept Clin Neurosci, Stockholm, Sweden; [Aski, Sahar Nikkhou; Uppman, Martin; Li, Tie-Qiang; Damberg, Peter] Karolinska Inst, Dept Clin Sci Intervent & Technol CLINTEC, Stockholm, Sweden	Karolinska Institutet; Karolinska Institutet; Karolinska Institutet	Sierakowiak, A (corresponding author), Karolinska Inst, Care Sci & Soc NVS, Dept Neurobiol, Stockholm, Sweden.	adam.sierakowiak@ki.se		Li, Tie-Qiang/0000-0002-4866-5904; Sierakowiak, Adam/0000-0003-2273-2133	Swedish Research Council [3474]; Karolinska Institutet-National Institutes of Health Graduate Partnerships Program; Karolinska Experimental Research Imaging Center	Swedish Research Council(Swedish Research CouncilEuropean Commission); Karolinska Institutet-National Institutes of Health Graduate Partnerships Program; Karolinska Experimental Research Imaging Center	Funding from Swedish Research Council grant no 3474, Karolinska Institutet-National Institutes of Health Graduate Partnerships Program, and the Karolinska Experimental Research Imaging Center. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson JS, 2011, HUM BRAIN MAPP, V32, P919, DOI 10.1002/hbm.21079; Angenstein F, 2010, NEUROIMAGE, V50, P1364, DOI 10.1016/j.neuroimage.2010.01.070; Arguello PA, 2006, NEURON, V52, P179, DOI 10.1016/j.neuron.2006.09.023; Arnberg F, 2012, STROKE, V43, P2437, DOI 10.1161/STROKEAHA.112.655126; Becerra L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025701; Beckmann CF, 2005, PHILOS T R SOC B, V360, P1001, DOI 10.1098/rstb.2005.1634; Benveniste H, 2002, PROG NEUROBIOL, V67, P393, DOI 10.1016/S0301-0082(02)00020-5; BISWAL B, 1995, MAGNET RESON MED, V34, P537, DOI 10.1002/mrm.1910340409; Boveroux P, 2010, ANESTHESIOLOGY, V113, P1038, DOI 10.1097/ALN.0b013e3181f697f5; Castellanos FX, 2013, NEUROIMAGE, V80, P527, DOI 10.1016/j.neuroimage.2013.04.083; Chai XQJ, 2012, NEUROIMAGE, V59, P1420, DOI 10.1016/j.neuroimage.2011.08.048; Cordes D, 2000, AM J NEURORADIOL, V21, P1636; Cox RW, 1996, COMPUT BIOMED RES, V29, P162, DOI 10.1006/cbmr.1996.0014; DeFelipe J, 2011, FRONT NEUROANAT, V5, DOI 10.3389/fnana.2011.00029; Di Martino A, 2008, CEREB CORTEX, V18, P2735, DOI 10.1093/cercor/bhn041; DICHIARA G, 1988, P NATL ACAD SCI USA, V85, P5274; Durukan A, 2007, PHARMACOL BIOCHEM BE, V87, P179, DOI 10.1016/j.pbb.2007.04.015; Fox MD, 2005, P NATL ACAD SCI USA, V102, P9673, DOI 10.1073/pnas.0504136102; Fox MD, 2009, J NEUROPHYSIOL, V101, P3270, DOI 10.1152/jn.90777.2008; Fransson P, 2005, HUM BRAIN MAPP, V26, P15, DOI 10.1002/hbm.20113; Gopinath K, 2011, NEUROIMAGE, V54, P380, DOI 10.1016/j.neuroimage.2010.07.021; Graner J, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00016; Greicius MD, 2004, P NATL ACAD SCI USA, V101, P4637, DOI 10.1073/pnas.0308627101; Greicius MD, 2003, P NATL ACAD SCI USA, V100, P253, DOI 10.1073/pnas.0135058100; Hutchison RM, 2010, J NEUROPHYSIOL, V103, P3398, DOI 10.1152/jn.00141.2010; Jonckers E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018876; Kalthoff D, 2013, NMR BIOMED, V26, P638, DOI 10.1002/nbm.2908; Liang ZF, 2011, J NEUROSCI, V31, P3776, DOI 10.1523/JNEUROSCI.4557-10.2011; Lu HB, 2012, P NATL ACAD SCI USA, V109, P3979, DOI [10.1073/pnas.1101934108, 10.1073/pnas.1200506109]; Ma N, 2010, NEUROIMAGE, V49, P738, DOI 10.1016/j.neuroimage.2009.08.037; Magnuson ME, 2014, NMR BIOMED, V27, P291, DOI 10.1002/nbm.3062; Majeed W, 2011, NEUROIMAGE, V54, P1140, DOI 10.1016/j.neuroimage.2010.08.030; Mehler-Wex C, 2006, NEUROTOX RES, V10, P167, DOI 10.1007/BF03033354; Mishra AM, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0095280, 10.1371/journal.pone.0086852]; Nestler EJ, 2010, NAT NEUROSCI, V13, P1161, DOI 10.1038/nn.2647; Overstreet DH, 2012, METHODS MOL BIOL, V829, P125, DOI 10.1007/978-1-61779-458-2_7; Pawela CP, 2008, MAGN RESON MED, V59, P1021, DOI 10.1002/mrm.21524; Paxinos G, 1998, RAT BRAIN IN STEREOTAXIC COORDINATES, FOURTH ED., pix; Raichle ME, 2001, P NATL ACAD SCI USA, V98, P676, DOI 10.1073/pnas.98.2.676; Razafsha M, 2013, NEUROSCIENCE, V240, P204, DOI 10.1016/j.neuroscience.2013.02.045; Rocco-Donovan M, 2011, SOMATOSENS MOT RES, V28, P63, DOI 10.3109/08990220.2011.606660; Rubinov M, 2013, TRENDS COGN SCI, V17, P641, DOI 10.1016/j.tics.2013.10.007; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Schwarz AJ, 2013, NEUROSCIENCE, V228, P243, DOI 10.1016/j.neuroscience.2012.10.032; Schwarz AJ, 2013, BRAIN CONNECT, V3, P503, DOI 10.1089/brain.2013.0168; Sforazzini F, 2014, NEUROIMAGE, V87, P403, DOI 10.1016/j.neuroimage.2013.09.050; SHARP T, 1986, PHARMACOL BIOCHEM BE, V24, P1755, DOI 10.1016/0091-3057(86)90516-2; Smith SM, 2009, P NATL ACAD SCI USA, V106, P13040, DOI 10.1073/pnas.0905267106; Song XW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025031; Upadhyay J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027839; van Buuren M, 2009, HUM BRAIN MAPP, V30, P3031, DOI 10.1002/hbm.20729; van den Heuvel MP, 2010, EUR NEUROPSYCHOPHARM, V20, P519, DOI 10.1016/j.euroneuro.2010.03.008; van der Marel K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057780; Vogt BA, 2014, BRAIN STRUCT FUNCT, V219, P185, DOI 10.1007/s00429-012-0493-3; WISE RA, 1987, PSYCHOL REV, V94, P469, DOI 10.1037/0033-295X.94.4.469; Yushkevich PA, 2006, NEUROIMAGE, V31, P1116, DOI 10.1016/j.neuroimage.2006.01.015	56	40	40	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2015	10	3							e0120345	10.1371/journal.pone.0120345	http://dx.doi.org/10.1371/journal.pone.0120345			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD9NQ	25789862	Green Published, gold, Green Submitted			2022-12-27	WOS:000351425400153
J	Xiao, YD; Zhang, XQ; Ji, P				Xiao, Yundan; Zhang, Xiongqing; Ji, Ping			Modeling Forest Fire Occurrences Using Count-Data Mixed Models in Qiannan Autonomous Prefecture of Guizhou Province in China	PLOS ONE			English	Article							ZERO-INFLATED POISSON; REGRESSION-MODELS; TREE RECRUITMENT; CLIMATE	Forest fires can cause catastrophic damage on natural resources. In the meantime, it can also bring serious economic and social impacts. Meteorological factors play a critical role in establishing conditions favorable for a forest fire. Effective prediction of forest fire occurrences could prevent or minimize losses. This paper uses count data models to analyze fire occurrence data which is likely to be dispersed and frequently contain an excess of zero counts (no fire occurrence). Such data have commonly been analyzed using count data models such as a Poisson model, negative binomial model (NB), zero-inflated models, and hurdle models. Data we used in this paper is collected from Qiannan autonomous prefecture of Guizhou province in China. Using the fire occurrence data from January to April (spring fire season) for the years 1996 through 2007, we introduced random effects to the count data models. In this study, the results indicated that the prediction achieved through NB model provided a more compelling and credible inferential basis for fitting actual forest fire occurrence, and mixed-effects model performed better than corresponding fixed-effects model in forest fire forecasting. Besides, among all meteorological factors, we found that relative humidity and wind speed is highly correlated with fire occurrence.	[Xiao, Yundan; Ji, Ping] Chinese Acad Forestry, Res Inst Forest Resource Informat Tech, Beijing, Peoples R China; [Zhang, Xiongqing] Chinese Acad Forestry, Res Inst Forestry, Beijing, Peoples R China	Chinese Academy of Forestry; Research Institute of Forest Resources Information Technique, CAF; Chinese Academy of Forestry; Research Institute of Forestry, CAF	Ji, P (corresponding author), Chinese Acad Forestry, Res Inst Forest Resource Informat Tech, Beijing, Peoples R China.	jiping@caf.ac.cn	Zhang, Xiongqing/AAW-6171-2020	Zhang, Xiongqing/0000-0001-5592-6730	National Natural Science Foundation of China and International S&T Cooperation program of China (ISTCP) [2014DFG32140-2]	National Natural Science Foundation of China and International S&T Cooperation program of China (ISTCP)	The research was sponsored by the National Natural Science Foundation of China and International S&T Cooperation program of China (ISTCP) (No. 2014DFG32140-2). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Affleck DLR, 2006, CAN J FOREST RES, V36, P2994, DOI 10.1139/X06-189; Alvarez Gonzalez Juan Gabriel, 2004, Annals of Forest Science, V61, P439, DOI 10.1051/forest:2004037; Calama R, 2005, SILVA FENN, V39, P37, DOI 10.14214/sf.394; Chuvieco E, 2008, GLOBAL CHANGE BIOL, V14, P1488, DOI 10.1111/j.1365-2486.2008.01585.x; Conedera M, 2000, ADV GLOB CHANGE RES, V3, P247; Fortin M, 2007, FOREST SCI, V53, P529; Gurmu S, 1997, J APPL ECONOMET, V12, P225; Hall DB, 2000, BIOMETRICS, V56, P1030, DOI 10.1111/j.0006-341X.2000.01030.x; Holsten A, 2013, EGU GEN ASS; Karazsia BT, 2008, J PEDIATR PSYCHOL, V33, P1076, DOI 10.1093/jpepsy/jsn055; Keeley JE, 2001, CONSERV BIOL, V15, P1536, DOI 10.1046/j.1523-1739.2001.00097.x; LAMBERT D, 1992, TECHNOMETRICS, V34, P1, DOI 10.2307/1269547; Lexerod NL, 2005, FOREST ECOL MANAG, V206, P91, DOI 10.1016/j.foreco.2004.11.001; Li L, 2012, INNER MONOLIA FOR IN, V35, P124; Li RX, 2011, CAN J FOREST RES, V41, P2077, DOI [10.1139/x11-117, 10.1139/X11-117]; Little RC, 1996, SAS SYSTEM MIXED MOD; Liu W, 2008, CIICT 2008: PROCEEDINGS OF CHINA-IRELAND INTERNATIONAL CONFERENCE ON INFORMATION AND COMMUNICATIONS TECHNOLOGIES 2008, P1; Lu A. F, 2011, J ANHUI AGR SCI, V39, P15332; MacNeil MA, 2009, ICES J MAR SCI, V66, P708, DOI 10.1093/icesjms/fsp022; Mandallaz D, 1997, CAN J FOREST RES, V27, P1685, DOI 10.1139/cjfr-27-10-1685; Min YY, 2005, STAT MODEL, V5, P1, DOI 10.1191/1471082X05st084oa; MULLAHY J, 1986, J ECONOMETRICS, V33, P341, DOI 10.1016/0304-4076(86)90002-3; Munns EN, 1921, MONTHLY WEATHER REV, V49, P149, DOI [DOI 10.1175/1520-0493(1921)492.0.CO;2, 10.1175/1520-0493(1921)49<149:EAFF>2.0.CO;2, DOI 10.1175/1520-0493(1921)49<149:EAFF>2.0.CO;2]; Pausas JG, 2004, CLIMATIC CHANGE, V63, P337, DOI 10.1023/B:CLIM.0000018508.94901.9c; Pyne S, 1996, INTRO WILDLAND FIRE; Shonkwiler JS, 1996, J AGR RESOUR ECON, V21, P210; Skvarenina J., 2003, INT BIOCL WORKSH SLO; Tian XR, 2014, INT J WILDLAND FIRE, V23, P185, DOI 10.1071/WF13014; Wallenius TH, 2004, CAN J FOREST RES, V34, P1400, DOI [10.1139/x04-023, 10.1139/X04-023]; Westerling AL, 2006, SCIENCE, V313, P940, DOI 10.1126/science.1128834; Wotton BM, 2003, CLIMATIC CHANGE, V60, P275, DOI 10.1023/A:1026075919710; Wykoff WR, 1986, USERS GUIDE STAND S; Xiao YunDan, 2011, Scientia Silvae Sinicae, V47, P128; Xu S, 2011, J W CHINA FOR SCI, V42, P98; Zhang XiongQing, 2012, Scientia Silvae Sinicae, V48, P54; Zhang XQ, 2012, FOREST ECOL MANAG, V270, P209, DOI 10.1016/j.foreco.2012.01.028; Zhao Feng, 2007, THESIS CHINESE ACAD; Zhu B, 2007, METEOROL DISASTER RE, V30, P65; Zumbrunnen T, 2012, REG ENVIRON CHANGE, V12, P935, DOI 10.1007/s10113-012-0307-4; [No title captured]	40	11	13	3	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2015	10	3							e0120621	10.1371/journal.pone.0120621	http://dx.doi.org/10.1371/journal.pone.0120621			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD9NQ	25790309	Green Published, gold			2022-12-27	WOS:000351425400167
J	Zhang, Y; Zhao, PW; Feng, G; Xie, G; Wang, AQ; Yang, YH; Wang, D; Du, XB				Zhang, Yu; Zhao, Ping-Wu; Feng, Gang; Xie, Gang; Wang, An-Qun; Yang, Yong-Hong; Wang, Dong; Du, Xiao-Bo			The Expression Level and Prognostic Value of Y-Box Binding Protein-1 in Rectal Cancer	PLOS ONE			English	Article							TRANSCRIPTION FACTOR YB-1; PREDICTIVE MARKER; POOR SURVIVAL; RISK-FACTORS; RESISTANCE; CELLS; PROLIFERATION; SENSITIVITY; CISPLATIN; DISEASE	The aims of this study were to simultaneously evaluate the expression of Y-box binding protein-1 (YB-1) in non-neoplastic rectal tissue and rectal cancer tissue, and to collect clinical follow-up data for individual patients. Additionally, we aimed to investigate the developmental functions and prognostic value of YB-1 in rectal cancer. We performed immunohistochemical studies to examine YB-1 expression in tissue samples from 80 patients with rectal cancer, 30 patients with rectal tubular adenoma, and 30 patients with rectitis. The mean YB-1 histological scores for rectal cancer, rectal tubular adenoma, and rectitis tissue specimens were 205.5, 164.3, and 137.7, respectively. Shorter disease-free and overall survival times were found in patients with rectal cancer who had higher YB-1 expression than in those with lower expression (38.2 months vs. 52.4 months, P = 0.013; and 44.4 months vs. 57.3 months, P = 0.008, respectively). Our results indicate that YB-1 expression is higher in rectal cancer tissue than in rectal tubular adenoma and rectitis tissue and that it may be an independent prognostic factor for rectal cancer.	[Zhang, Yu; Feng, Gang; Du, Xiao-Bo] MianYang Cent Hosp, Dept Oncol, Mianyang, Peoples R China; [Zhang, Yu; Wang, Dong] LuZhou Med Coll, Dept Surg, Luzhou, Peoples R China; [Zhao, Ping-Wu; Wang, Dong] MianYang Cent Hosp, Dept Surg, Mianyang, Peoples R China; [Xie, Gang; Wang, An-Qun; Yang, Yong-Hong] MianYang Cent Hosp, Dept Pathol, Mianyang, Peoples R China	Southwest Medical University	Wang, D (corresponding author), LuZhou Med Coll, Dept Surg, Luzhou, Peoples R China.	1572612023@qq.com; duxiaobo2005@126.com						Astanehe A, 2009, ONCOGENE, V28, P2406, DOI 10.1038/onc.2009.81; Bargou RC, 1997, NAT MED, V3, P447, DOI 10.1038/nm0497-447; Basaki Y, 2010, EUR J CANCER, V46, P954, DOI 10.1016/j.ejca.2009.12.024; Chatterjee M, 2008, BLOOD, V111, P3714, DOI 10.1182/blood-2007-05-089151; Chen ZH, 2012, WORLD J GASTROENTERO, V18, P64, DOI 10.3748/wjg.v18.i1.64; den Dulk M, 2007, ANN SURG, V246, P83, DOI 10.1097/01.sla.0000259432.29056.9d; Dhillon J, 2010, ONCOGENE, V29, P6294, DOI 10.1038/onc.2010.365; Finkbeiner MR, 2009, ONCOGENE, V28, P1421, DOI 10.1038/onc.2008.485; Fujiwara-Okada Y, 2013, BRIT J CANCER, V108, P836, DOI 10.1038/bjc.2012.579; Gimenez-Bonafe P, 2004, PROSTATE, V59, P337, DOI 10.1002/pros.20023; Ito T, 2012, BREAST CANCER RES TR, V133, P145, DOI 10.1007/s10549-011-1731-8; Karlson D, 2002, J BIOL CHEM, V277, P35248, DOI 10.1074/jbc.M205774200; Kashihara M, 2009, J THORAC ONCOL, V4, P1066, DOI 10.1097/JTO.0b013e3181ae2828; Kohno K, 2003, BIOESSAYS, V25, P691, DOI 10.1002/bies.10300; Kolk A, 2011, BRIT J CANCER, V105, P1864, DOI 10.1038/bjc.2011.491; Lasham A, 2003, J BIOL CHEM, V278, P35516, DOI 10.1074/jbc.M303920200; Lasham A, 2000, GENE, V252, P1, DOI 10.1016/S0378-1119(00)00220-1; Li XJ, 2014, MED ONCOL, V31, DOI 10.1007/s12032-013-0781-7; Li Y, 2011, ANN SURG ONCOL, V18, P3370, DOI 10.1245/s10434-011-1725-0; Maciejczyk A, 2012, ANTICANCER RES, V32, P3177; MCCARTY KS, 1986, CANCER RES, V46, P4244; Mertens PR, 2002, J BIOL CHEM, V277, P24875, DOI 10.1074/jbc.M200445200; Ohga T, 1998, J BIOL CHEM, V273, P5997, DOI 10.1074/jbc.273.11.5997; Ohga T, 1996, CANCER RES, V56, P4224; Schittek B, 2007, INT J CANCER, V120, P2110, DOI 10.1002/ijc.22512; Shibahara K, 2004, CANCER SCI, V95, P348, DOI 10.1111/j.1349-7006.2004.tb03214.x; Stein U, 2005, ONCOGENE, V24, P3606, DOI 10.1038/sj.onc.1208386; Stein U, 2001, J BIOL CHEM, V276, P28562, DOI 10.1074/jbc.M100311200; Stratford AL, 2007, BREAST CANCER RES, V9, DOI 10.1186/bcr1767; Szczuraszek K, 2011, ANTICANCER RES, V31, P2963; Tabung FK, 2014, CANC CAUSES IN PRESS; Tay WL, 2009, MODERN PATHOL, V22, P282, DOI 10.1038/modpathol.2008.181; Toulany M, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr2845; Valadao AF, 2002, MOL BIOCHEM PARASIT, V125, P47, DOI 10.1016/S0166-6851(02)00210-4; Wu Y, 2012, J SURG ONCOL, V105, P724, DOI 10.1002/jso.23030; Yan YC, 2014, MED ONCOL, V31, DOI 10.1007/s12032-013-0816-0; Zhang Y, 2012, FUNGAL DIVERS, V53, P1, DOI 10.1007/s13225-011-0117-x	37	1	1	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2015	10	3							e0119385	10.1371/journal.pone.0119385	http://dx.doi.org/10.1371/journal.pone.0119385			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD9NQ	25790262	Green Submitted, gold, Green Published			2022-12-27	WOS:000351425400077
J	Ahmed, A; Wan-Yuen, C; Marret, MJ; Guat-Sim, C; Othman, S; Chinna, K				Ahmed, Ayesha; Wan-Yuen, Choo; Marret, Mary Joseph; Guat-Sim, Cheah; Othman, Sajaratulnisah; Chinna, Karuthan			Child Maltreatment Experience among Primary School Children: A Large Scale Survey in Selangor State, Malaysia	PLOS ONE			English	Article							RISK-FACTORS; VICTIMIZATION EXPERIENCES; CORPORAL PUNISHMENT; ABUSE; PARENTS; ADOLESCENTS; PREVENTION; DISORDER; STUDENTS; FAMILY	Official reports of child maltreatment in Malaysia have persistently increased throughout the last decade. However there is a lack of population surveys evaluating the actual burden of child maltreatment, its correlates and its consequences in the country. This cross sectional study employed 2 stage stratified cluster random sampling of public primary schools, to survey 3509 ten to twelve year old school children in Selangor state. It aimed to estimate the prevalence of parental physical and emotional maltreatment, parental neglect and teacher-inflicted physical maltreatment. It further aimed to examine the associations between child maltreatment and important socio-demographic factors; family functioning and symptoms of depression among children. Logistic regression on weighted samples was used to extend results to a population level. Three quarters of 10-12 year olds reported at least one form of maltreatment, with parental physical maltreatment being most common. Males had higher odds of maltreatment in general except for emotional maltreatment. Ethnicity and parental conflict were key factors associated with maltreatment. The study contributes important evidence towards improving public health interventions for child maltreatment prevention in the country.	[Ahmed, Ayesha; Wan-Yuen, Choo; Chinna, Karuthan] Univ Malaya, Fac Med, Dept Social & Prevent Med, Kuala Lumpur, Malaysia; [Wan-Yuen, Choo; Chinna, Karuthan] Univ Malaya, Julius Ctr Univ Malaya, Ctr Clin Epidemiol & Evidence Based Med, Kuala Lumpur, Malaysia; [Marret, Mary Joseph] Univ Malaya, Fac Med, Dept Paediat, Kuala Lumpur, Malaysia; [Guat-Sim, Cheah] Gen Hosp Kuala Lumpur, Paediat Inst, Kuala Lumpur, Malaysia; [Othman, Sajaratulnisah] Univ Malaya, Fac Med, Dept Primary Care Med, Kuala Lumpur, Malaysia	Universiti Malaya; Universiti Malaya; Universiti Malaya; Universiti Malaya	Ahmed, A (corresponding author), Univ Malaya, Fac Med, Dept Social & Prevent Med, Kuala Lumpur, Malaysia.	ayesha_ah@hotmail.com; ccwy@ummc.edu.my	Othman, Sajaratulnisah/K-4077-2019; OTHMAN, SAJARATULNISAH/B-9673-2010; CHOO, WAN YUEN/B-8399-2010; Marret, Mary J/B-8951-2010; Choo, Wan Yuen/ABH-3055-2021	Choo, Wan Yuen/0000-0002-2644-6073; Ahmed, Ayesha/0000-0003-0912-3544	University of Malaya [CG052-2013]; University of Malaya/Ministry of Higher Education (UM/MOHE) High Impact Research Grant [E000010-20001]	University of Malaya(Universiti Malaya); University of Malaya/Ministry of Higher Education (UM/MOHE) High Impact Research Grant	CWY work was supported by University of Malaya Research Grant (CG052-2013) and University of Malaya/Ministry of Higher Education (UM/MOHE) High Impact Research Grant (Grant no: E000010-20001) [http://umresearch.um.edu.my/]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ammerman RT, 1999, CHILD ABUSE NEGLECT, V23, P1225, DOI 10.1016/S0145-2134(99)00089-7; Benbenishty R, 2002, CHILD ABUSE NEGLECT, V26, P1291, DOI 10.1016/S0145-2134(02)00416-7; Berger LM, 2004, CHILD YOUTH SERV REV, V26, P725, DOI 10.1016/j.childyouth.2004.02.017; Cheah IGS, 2012, CHILD MALTREATMENT P; Chen JQ, 2007, CHILD ABUSE NEGLECT, V31, P747, DOI 10.1016/j.chiabu.2006.12.013; Choo WY, 2011, J ADOLESCENT HEALTH, V49, P627, DOI 10.1016/j.jadohealth.2011.04.020; Cyr K, 2013, CHILD ABUSE NEGLECT, V37, P814, DOI 10.1016/j.chiabu.2013.03.009; Dubowitz H, 2011, CHILD ABUSE NEGLECT, V35, P96, DOI 10.1016/j.chiabu.2010.09.003; Dunne MP, 2008, ASIA-PAC J PUBLIC HE, V20, P267, DOI 10.1177/1010539508325047; Felitti VJ, 1998, AM J PREV MED, V14, P245, DOI 10.1016/S0749-3797(98)00017-8; FENDRICH M, 1990, AM J EPIDEMIOL, V131, P538, DOI 10.1093/oxfordjournals.aje.a115529; Fergusson D., 1999, CHILDHOOD SEXUAL ABU; Fry D, 2012, TRAUMA VIOLENCE ABUS, V13, P209, DOI 10.1177/1524838012455873; Gilbert R, 2009, LANCET, V373, P68, DOI 10.1016/S0140-6736(08)61706-7; Greydanus DE, 2003, J ADOLESCENT HEALTH, V32, P385, DOI 10.1016/S1054-139X(03)00042-9; Holt MK, 2007, CHILD ABUSE NEGLECT, V31, P503, DOI 10.1016/j.chiabu.2006.12.006; Hong JS, 2011, CHILD YOUTH SERV REV, V33, P1058, DOI 10.1016/j.childyouth.2011.01.012; Hunter WM, 2000, J PEDIATR PSYCHOL, V25, P435, DOI 10.1093/jpepsy/25.6.435; Huong TN, 2010, B WORLD HEALTH ORGAN, V88, P22, DOI [10.2471/BLT.08-060061, 10.2471/BLT.08.060061]; Kelly-Irving M, 2013, EUR J EPIDEMIOL, V28, P721, DOI 10.1007/s10654-013-9832-9; Loh S F, 2010, East Asian Arch Psychiatry, V20, P87; Ma YT, 2011, CHILD ABUSE NEGLECT, V35, P592, DOI 10.1016/j.chiabu.2011.04.006; Mikton C, 2013, CHILD ABUSE NEGLECT, V37, P1237, DOI 10.1016/j.chiabu.2013.07.009; Ministry of Human Resources, 2008, MAL STAND CLASS OCC; Paavilainen E, 2001, INT J NURS STUD, V38, P297, DOI 10.1016/S0020-7489(00)00074-2; Palusci VJ, 2011, CHILD YOUTH SERV REV, V33, P1374, DOI 10.1016/j.childyouth.2011.04.025; Pillay S, 2012, NEWSTRAITS TIME 0603; Radford L, 2013, CHILD ABUSE NEGLECT, V37, P801, DOI 10.1016/j.chiabu.2013.02.004; Runyan D. K., 2002, WORLD REPORT VIOLENC, P57, DOI DOI 10.1136/IP.9.1.93; Sennyah P, 2007, NEW STRAITS TIM 0729; Sidebotham P, 2006, CHILD ABUSE NEGLECT, V30, P497, DOI 10.1016/j.chiabu.2005.11.005; Singh HSSA, 1996, CHILD ABUSE NEGLECT, V20, P487, DOI 10.1016/0145-2134(96)00030-0; Stephenson R, 2006, CHILD ABUSE NEGLECT, V30, P231, DOI 10.1016/j.chiabu.2005.10.009; Stoltenborgh M, 2012, J AGGRESS MALTREAT T, V21, P870, DOI DOI 10.1080/10926771.2012.708014; Theoklitou D, 2012, CHILD ABUSE NEGLECT, V36, P64, DOI 10.1016/j.chiabu.2011.05.007; UNICEF, 2012, MEAS MON CHILD PROT; Wong PY, 2013, SINGAP MED J, V54, P533; Youssef RM, 1998, CHILD ABUSE NEGLECT, V22, P959, DOI 10.1016/S0145-2134(98)00077-5; Zolotor AJ, 2009, CHILD ABUSE NEGLECT, V33, P833, DOI 10.1016/j.chiabu.2009.09.004	39	14	14	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2015	10	3							e0119449	10.1371/journal.pone.0119449	http://dx.doi.org/10.1371/journal.pone.0119449			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CE9BN	25786214	gold, Green Published, Green Submitted			2022-12-27	WOS:000352138500104
J	Balmant, W; Sugai-Guerios, MH; Coradin, JH; Krieger, N; Furigo, A; Mitchell, DA				Balmant, Wellington; Sugai-Guerios, Maura Harumi; Coradin, Juliana Hey; Krieger, Nadia; Furigo Junior, Agenor; Mitchell, David Alexander			A Model for Growth of a Single Fungal Hypha Based on Well-Mixed Tanks in Series: Simulation of Nutrient and Vesicle Transport in Aerial Reproductive Hyphae	PLOS ONE			English	Article							SPREADING COLONIAL MUTANTS; NEUROSPORA-CRASSA; CHITIN SYNTHASES; TIP GROWTH; WILD-TYPE; SPITZENKORPER; MORPHOGENESIS; PHYCOMYCES; NETWORKS; MICROORGANISMS	Current models that describe the extension of fungal hyphae and development of a mycelium either do not describe the role of vesicles in hyphal extension or do not correctly describe the experimentally observed profile for distribution of vesicles along the hypha. The present work uses the n-tanks-in-series approach to develop a model for hyphal extension that describes the intracellular transport of nutrient to a sub-apical zone where vesicles are formed and then transported to the tip, where tip extension occurs. The model was calibrated using experimental data from the literature for the extension of reproductive aerial hyphae of three different fungi, and was able to describe different profiles involving acceleration and deceleration of the extension rate. A sensitivity analysis showed that the supply of nutrient to the sub-apical vesicle-producing zone is a key factor influencing the rate of extension of the hypha. Although this model was used to describe the extension of a single reproductive aerial hypha, the use of the n-tanks-in-series approach to representing the hypha means that the model has the flexibility to be extended to describe the growth of other types of hyphae and the branching of hyphae to form a complete mycelium.	[Balmant, Wellington; Mitchell, David Alexander] Univ Fed Parana, Dept Bioquim & Biol Mol, BR-81531980 Curitiba, Parana, Brazil; [Sugai-Guerios, Maura Harumi; Furigo Junior, Agenor] Univ Fed Santa Catarina, Dept Engn Quim & Engn Alimentos, BR-88040900 Florianopolis, SC, Brazil; [Coradin, Juliana Hey] Univ Fed Parana, Dept Engn Quim, BR-81531980 Curitiba, Parana, Brazil; [Krieger, Nadia] Univ Fed Parana, Dept Quim, BR-81531980 Curitiba, Parana, Brazil	Universidade Federal do Parana; Universidade Federal de Santa Catarina (UFSC); Universidade Federal do Parana; Universidade Federal do Parana	Mitchell, DA (corresponding author), Univ Fed Parana, Dept Bioquim & Biol Mol, Cx P 19046 Ctr Politecn, BR-81531980 Curitiba, Parana, Brazil.	davidmitchell@ufpr.br	Sugai-Guerios, Maura Harumi/AAF-7090-2020; Krieger, Nadia/A-5749-2011; Mitchell, David A/A-8935-2008; balmant, wellington/AAG-5537-2020	Sugai-Guerios, Maura Harumi/0000-0002-3576-2879; Krieger, Nadia/0000-0003-0492-7308; Mitchell, David A/0000-0001-9355-5520; 	CAPES (Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior), a Brazilian government agency for the development of personnel in higher education; CNPq (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico), a Brazilian government agency for the advancement of science; Fundacao Araucaria, a funding agency of the state of Parana	CAPES (Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior), a Brazilian government agency for the development of personnel in higher education; CNPq (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico), a Brazilian government agency for the advancement of science; Fundacao Araucaria, a funding agency of the state of Parana	Research scholarships were granted to Wellington Balmant and Juliana Hey Coradin by CAPES (Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior), a Brazilian government agency for the development of personnel in higher education, and to Nadia Krieger, Agenor Furigo Junior and David Alexander Mitchell by CNPq (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico), a Brazilian government agency for the advancement of science. This research was supported by a grant from Fundacao Araucaria, a funding agency of the state of Parana. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BARTNICKIGARCIA S, 1989, PROTOPLASMA, V153, P46, DOI 10.1007/BF01322464; Boswell GP, 2002, J THEOR BIOL, V217, P459, DOI 10.1006/jtbi.2002.3048; Boswell GP, 2008, MYCOL RES, V112, P1015, DOI 10.1016/j.mycres.2008.02.006; Boswell GP, 2007, B MATH BIOL, V69, P605, DOI 10.1007/s11538-005-9056-6; Boswell Graeme P., 2012, Fungal Biology Reviews, V26, P30, DOI 10.1016/j.fbr.2012.02.002; Bull A T, 1977, Adv Microb Physiol, V15, P1, DOI 10.1016/S0065-2911(08)60314-8; BUTLER EE, 1970, RHIZOCTONIA SOLANI B, P32; Cairney JWG, 2005, MYCOL RES, V109, P7, DOI 10.1017/S0953756204001753; COLLINGE AJ, 1974, ARCH MICROBIOL, V99, P353, DOI 10.1007/BF00696249; Coradin JH, 2011, BIOCHEM ENG J, V54, P164, DOI 10.1016/j.bej.2011.02.012; COWAN MC, 1972, T BRIT MYCOL SOC, V58, P113, DOI 10.1016/S0007-1536(72)80077-9; Davidson Fordyce A., 2007, Fungal Biology Reviews, V21, P30, DOI 10.1016/j.fbr.2007.02.005; Dyson P, 2011, STREPTOMYCES: MOLECULAR BIOLOGY AND BIOTECHNOLOGY, P1; GOODAY GW, 1971, J GEN MICROBIOL, V67, P125, DOI 10.1099/00221287-67-2-125; GRUEN HE, 1959, PLANT PHYSIOL, V34, P158, DOI 10.1104/pp.34.2.158; Harris SD, 2005, EUKARYOT CELL, V4, P225, DOI 10.1128/EC.4.2.225-229.2005; Harris SD, 2008, MYCOLOGIA, V100, P823, DOI 10.3852/08-177; HAYDUK W, 1974, AICHE J, V20, P611, DOI 10.1002/aic.690200329; JOHNSON DL, 1972, PLANT PHYSIOL, V49, P898, DOI 10.1104/pp.49.6.898; LopezIsunza F, 1997, CHEM ENG SCI, V52, P2629, DOI 10.1016/S0009-2509(97)00078-X; Lu JP, 2009, CURR GENET, V55, P461, DOI 10.1007/s00294-009-0259-5; MIMS CW, 1988, PROTOPLASMA, V144, P132, DOI 10.1007/BF01637246; Nopharatana M, 2003, BIOTECHNOL BIOENG, V84, P71, DOI 10.1002/bit.10752; Nopharatana M, 1998, BIOTECHNOL TECH, V12, P313, DOI 10.1023/A:1008810500243; Nopharatana M, 1999, THESIS U QUEENSLAND; Oostra J, 2001, BIOTECHNOL BIOENG, V75, P13, DOI 10.1002/bit.1159; PETZOLD L, 1989, NUMERICAL SOLUTION I; PROSSER JI, 1991, CRIT REV BIOTECHNOL, V10, P253, DOI 10.3109/07388559109038211; PROSSER JI, 1979, J GEN MICROBIOL, V111, P153, DOI 10.1099/00221287-111-1-153; Regalado CM, 1997, PHILOS T R SOC B, V352, P1963, DOI 10.1098/rstb.1997.0182; Riquelme M, 2007, EUKARYOT CELL, V6, P1853, DOI 10.1128/EC.00088-07; Riquelme Meritxell, 2008, Fungal Biology Reviews, V22, P56, DOI 10.1016/j.fbr.2008.05.003; Steinberg G, 2007, EUKARYOT CELL, V6, P351, DOI 10.1128/EC.00381-06; Steinberg G, 2011, CURR OPIN MICROBIOL, V14, P660, DOI 10.1016/j.mib.2011.09.013; Steyaert JM, 2010, MICROBIOL-SGM, V156, P2887, DOI 10.1099/mic.0.041715-0; Tindemans SH, 2006, J THEOR BIOL, V238, P937, DOI 10.1016/j.jtbi.2005.07.004; TRINCI APJ, 1971, J GEN MICROBIOL, V67, P325, DOI 10.1099/00221287-67-3-325; TRINCI APJ, 1967, T BRIT MYCOL SOC, V50, P525, DOI 10.1016/S0007-1536(67)80084-6; TRINCI APJ, 1973, ARCH MIKROBIOL, V91, P127, DOI 10.1007/BF00424756; Trinci APJ, 1965, THESIS DURHAM U; WESSELS JGH, 1994, ANNU REV PHYTOPATHOL, V32, P413, DOI 10.1146/annurev.py.32.090194.002213; Wosten HAB, 2001, ANNU REV MICROBIOL, V55, P625, DOI 10.1146/annurev.micro.55.1.625; YANG H, 1992, BIOTECHNOL BIOENG, V39, P49, DOI 10.1002/bit.260390109	43	21	21	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2015	10	3							e0120307	10.1371/journal.pone.0120307	http://dx.doi.org/10.1371/journal.pone.0120307			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9BN	25785863	Green Published, Green Submitted, gold			2022-12-27	WOS:000352138500165
J	Bradfute, SB; Anthony, SM; Stuthman, KS; Ayithan, N; Tailor, P; Shaia, CI; Bray, M; Ozato, K; Bavari, S				Bradfute, Steven B.; Anthony, Scott M.; Stuthman, Kelly S.; Ayithan, Natarajan; Tailor, Prafullakumar; Shaia, Carl I.; Bray, Mike; Ozato, Keiko; Bavari, Sina			Mechanisms of Immunity in Post-Exposure Vaccination against Ebola Virus Infection	PLOS ONE			English	Article							PROTECTS NONHUMAN-PRIMATES; MARBURG HEMORRHAGIC-FEVER; T-CELL RESPONSES; DENDRITIC CELLS; MOUSE MODEL; GUINEA-PIGS; PATHOGENESIS; ANTIBODY; PROPHYLAXIS; PARTICLES	Ebolaviruses can cause severe hemorrhagic fever that is characterized by rapid viral replication, coagulopathy, inflammation, and high lethality rates. Although there is no clinically proven vaccine or treatment for Ebola virus infection, a virus-like particle (VLP) vaccine is effective in mice, guinea pigs, and non-human primates when given pre-infection. In this work, we report that VLPs protect Ebola virus-infected mice when given 24 hours post-infection. Analysis of cytokine expression in serum revealed a decrease in pro-inflammatory cytokine and chemokine levels in mice given VLPs post-exposure compared to infected, untreated mice. Using knockout mice, we show that VLP-mediated post-exposure protection requires perforin, B cells, macrophages, conventional dendritic cells (cDCs), and either CD4+ or CD8+ T cells. Protection was Ebola virus-specific, as marburgvirus VLPs did not protect Ebola virus-infected mice. Increased antibody production in VLP-treated mice correlated with protection, and macrophages were required for this increased production. However, NK cells, IFN-gamma, and TNF-alpha were not required for post-exposure-mediated protection. These data suggest that a non-replicating Ebola virus vaccine can provide post-exposure protection and that the mechanisms of immune protection in this setting require both increased antibody production and generation of cytotoxic T cells.	[Bradfute, Steven B.; Anthony, Scott M.; Stuthman, Kelly S.; Shaia, Carl I.; Bavari, Sina] US Army Med Res Inst Infect Dis, Ft Detrick, MD 21702 USA; [Ayithan, Natarajan; Ozato, Keiko] NICHHD, Lab Mol Growth Regulat, NIH, Bethesda, MD 20892 USA; [Tailor, Prafullakumar] Natl Inst Immunol, New Delhi 110067, India; [Bray, Mike] NIAID, Div Clin Res, NIH, Bethesda, MD 20892 USA	United States Army Medical Research Institute of Infectious Diseases; United States Department of Defense; United States Army; National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); Department of Biotechnology (DBT) India; National Institute of Immunology (NII); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Bavari, S (corresponding author), US Army Med Res Inst Infect Dis, Ft Detrick, MD 21702 USA.	sina.bavari.civ@mail.mil	Shaia, Carl/X-3555-2019; Bavari, Sina/L-3642-2019; Ayithan, Natarajan/ABH-3392-2020	Shaia, Carl/0000-0001-8907-8821; Bavari, Sina/0000-0001-8424-5635; Anthony, Scott/0000-0002-1590-7401	Defense Threat Reduction Agency [1.1C003_08_RD_B]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD008815, ZIAHD001310] Funding Source: NIH RePORTER	Defense Threat Reduction Agency(United States Department of DefenseDefense Threat Reduction Agency); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was supported by a grant from the Defense Threat Reduction Agency to SB (1.1C003_08_RD_B). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Appay V, 2004, CLIN EXP IMMUNOL, V138, P10, DOI 10.1111/j.1365-2249.2004.02605.x; Arora S, 2006, INFECT IMMUN, V74, P4339, DOI 10.1128/IAI.01989-05; Ayithan N, 2015, PLOS ONE IN PRESS; Baize S, 1999, NAT MED, V5, P423, DOI 10.1038/7422; Bedoui S, 2009, J IMMUNOL, V182, P4200, DOI 10.4049/jimmunol.0802286; Bradfute SB, 2011, HUM VACCIN, V7; Bradfute SB, 2008, J IMMUNOL, V180, P4058, DOI 10.4049/jimmunol.180.6.4058; Bradfute SB, 2013, CURR OPIN MICROBIOL, V16, P355, DOI 10.1016/j.mib.2013.05.003; Bradfute SB, 2011, VIRUSES-BASEL, V3, P982, DOI 10.3390/v3070982; Bray M, 1998, J INFECT DIS, V178, P651, DOI 10.1086/515386; Calain P, 1999, VIROLOGY, V262, P114, DOI 10.1006/viro.1999.9915; Christiansen AJ, 2011, P NATL ACAD SCI USA, V108, P4141, DOI 10.1073/pnas.1011037108; Connolly BM, 1999, J INFECT DIS, V179, pS203, DOI 10.1086/514305; Cote M, 2011, NATURE, V477, P344, DOI 10.1038/nature10380; Daddario-DiCaprio KM, 2006, LANCET, V367, P1399, DOI 10.1016/S0140-6736(06)68546-2; Davis KJ, 1997, ARCH PATHOL LAB MED, V121, P805; Duffield JS, 2005, AM J PATHOL, V167, P1207, DOI 10.1016/S0002-9440(10)61209-6; Duffield JS, 2005, J CLIN INVEST, V115, P56, DOI 10.1172/JCI200522675; Dunne PJ, 2009, J IMMUNOL, V183, P400, DOI 10.4049/jimmunol.0900169; Dye JM, 2012, P NATL ACAD SCI USA, V109, P5034, DOI 10.1073/pnas.1200409109; Feldmann H, 2007, PLOS PATHOG, V3, P54, DOI 10.1371/journal.ppat.0030002; Geisbert TW, 2008, J VIROL, V82, P5664, DOI 10.1128/JVI.00456-08; Geisbert TW, 2010, EMERG INFECT DIS, V16, P1119, DOI 10.3201/eid1607.100159; Geisbert TW, 2010, LANCET, V375, P1896, DOI 10.1016/S0140-6736(10)60357-1; Geisbert TW, 2003, AM J PATHOL, V163, P2347, DOI 10.1016/S0002-9440(10)63591-2; Geisbert TW, 1998, ULTRASTRUCT PATHOL, V22, P3, DOI 10.3109/01913129809032253; GEISBERT TW, 1992, J COMP PATHOL, V106, P137, DOI 10.1016/0021-9975(92)90043-T; Gibb TR, 2001, J COMP PATHOL, V125, P233, DOI 10.1053/jcpa.2001.0502; Hensley LE, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000904; Hevey M, 1998, VIROLOGY, V251, P28, DOI 10.1006/viro.1998.9367; Huffnagle GB, 1996, J IMMUNOL, V157, P4529; Iversen PL, 2012, VIRUSES-BASEL, V4, P2806, DOI 10.3390/v4112806; Jones SM, 2005, NAT MED, V11, P786, DOI 10.1038/nm1258; Jones SM, 2007, J INFECT DIS, V196, pS404, DOI 10.1086/520591; Jung S, 2002, IMMUNITY, V17, P211, DOI 10.1016/S1074-7613(02)00365-5; Kim IJ, 2002, J IMMUNOL, V168, P3958, DOI 10.4049/jimmunol.168.8.3958; Ksiazek TG, 1999, J INFECT DIS, V179, pS192, DOI 10.1086/514313; Kudoyarova-Zubavichene NM, 1999, J INFECT DIS, V179, pS218, DOI 10.1086/514294; Kuhn Jens H, 2008, Arch Virol Suppl, V20, P13; Lauterbach H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009659; Marzi A, 2013, P NATL ACAD SCI USA, V110, P1893, DOI 10.1073/pnas.1209591110; Muniz LR, 2011, J IMMUNOL, V187, P828, DOI 10.4049/jimmunol.1004233; Olinger GG, 2012, P NATL ACAD SCI USA, V109, P18030, DOI 10.1073/pnas.1213709109; Onyango CO, 2007, J INFECT DIS, V196, pS193, DOI 10.1086/520609; Panchal RG, 2009, CELL HOST MICROBE, V6, P162, DOI 10.1016/j.chom.2009.07.003; Pettitt J, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3006608; Qiu XG, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003876; Rasmussen AL, 2014, SCIENCE, V346, P987, DOI 10.1126/science.1259595; Richardson JS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005308; Rubins KH, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-8-r174; Ryabchikova EI, 1999, J INFECT DIS, V179, pS199, DOI 10.1086/514293; Sullivan NJ, 2011, NAT MED, V17, P1128, DOI 10.1038/nm.2447; Sullivan NJ, 2009, NAT REV MICROBIOL, V7, P393, DOI 10.1038/nrmicro2129; Sullivan NJ, 2000, NATURE, V408, P605, DOI 10.1038/35046108; Sullivan NJ, 2003, NATURE, V424, P681, DOI 10.1038/nature01876; Swenson DL, 2008, EXPERT REV VACCINES, V7, P417, DOI 10.1586/14760584.7.4.417; Towner JS, 2004, J VIROL, V78, P4330, DOI 10.1128/JVI.78.8.4330-4341.2004; van Rooijen N, 2002, J LIPOSOME RES, V12, P81, DOI 10.1081/LPR-120004780; Villinger F, 1999, J INFECT DIS, V179, pS188, DOI 10.1086/514283; Warfield KL, 2007, J INFECT DIS, V196, pS430, DOI 10.1086/520583; Warfield KL, 2005, J IMMUNOL, V175, P1184, DOI 10.4049/jimmunol.175.2.1184; Warfield KL, 2004, J EXP MED, V200, P169, DOI 10.1084/jem.20032141; Warfield KL, 2003, P NATL ACAD SCI USA, V100, P15889, DOI 10.1073/pnas.2237038100; Wauquier N, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000837; Wong G, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004582; Wyers M, 1999, J INFECT DIS, V179, pS54, DOI 10.1086/514300; Yang CL, 2008, EXPERT REV VACCINES, V7, P333, DOI 10.1586/14760584.7.3.333; Zampieri CA, 2007, NAT IMMUNOL, V8, P1159, DOI 10.1038/ni1519; Zhong WM, 2001, J IMMUNOL, V167, P1379, DOI 10.4049/jimmunol.167.3.1379	69	12	13	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2015	10	3							e0118434	10.1371/journal.pone.0118434	http://dx.doi.org/10.1371/journal.pone.0118434			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9BN	25785602	Green Published, Green Submitted, gold			2022-12-27	WOS:000352138500034
J	Colloca, F; Garofalo, G; Bitetto, I; Facchini, MT; Grati, F; Martiradonna, A; Mastrantonio, G; Nikolioudakis, N; Ordinas, F; Scarcella, G; Tserpes, G; Tugores, MP; Valavanis, V; Carlucci, R; Fiorentino, F; Follesa, MC; Iglesias, M; Knittweis, L; Lefkaditou, E; Lembo, G; Manfredi, C; Massuti, E; Pace, ML; Papadopoulou, N; Sartor, P; Smith, CJ; Spedicato, MT				Colloca, Francesco; Garofalo, Germana; Bitetto, Isabella; Facchini, Maria Teresa; Grati, Fabio; Martiradonna, Angela; Mastrantonio, Gianluca; Nikolioudakis, Nikolaos; Ordinas, Francesc; Scarcella, Giuseppe; Tserpes, George; Pilar Tugores, M.; Valavanis, Vasilis; Carlucci, Roberto; Fiorentino, Fabio; Follesa, Maria C.; Iglesias, Magdalena; Knittweis, Leyla; Lefkaditou, Eugenia; Lembo, Giuseppe; Manfredi, Chiara; Massuti, Enric; Pace, Marie Louise; Papadopoulou, Nadia; Sartor, Paolo; Smith, Christopher J.; Spedicato, Maria Teresa			The Seascape of Demersal Fish Nursery Areas in the North Mediterranean Sea, a First Step Towards the Implementation of Spatial Planning for Trawl Fisheries	PLOS ONE			English	Article							HAKE MERLUCCIUS-MERLUCCIUS; EFFECTIVE JUVENILE HABITATS; WATER ROSE SHRIMP; PARAPENAEUS-LONGIROSTRIS; MARINE NURSERIES; ENVIRONMENTAL-FACTORS; STRAIT; ASSEMBLAGES; VARIABILITY; MANAGEMENT	The identification of nursery grounds and other essential fish habitats of exploited stocks is a key requirement for the development of spatial conservation planning aimed at reducing the adverse impact of fishing on the exploited populations and ecosystems. The reduction in juvenile mortality is particularly relevant in the Mediterranean and is considered as one of the main prerequisites for the future sustainability of trawl fisheries. The distribution of nursery areas of 11 important commercial species of demersal fish and shellfish was analysed in the European Union Mediterranean waters using time series of bottom trawl survey data with the aim of identifying the most persistent recruitment areas. A high interspecific spatial overlap between nursery areas was mainly found along the shelf break of many different sectors of the Northern Mediterranean indicating a high potential for the implementation of conservation measures. Overlap of the nursery grounds with existing spatial fisheries management measures and trawl fisheries restricted areas was also investigated. Spatial analyses revealed considerable variation depending on species and associated habitat/depth preferences with increased protection seen in coastal nurseries and minimal protection seen for deeper nurseries (e.g. Parapenaeus longirostris 6%). This is partly attributed to existing environmental policy instruments (e.g. Habitats Directive and Mediterranean Regulation EC 1967/2006) aiming at minimising impacts on coastal priority habitats such as seagrass, coralligenous and maerl beds. The new knowledge on the distribution and persistence of demersal nurseries provided in this study can support the application of spatial conservation measures, such as the designation of no-take Marine Protected Areas in EU Mediterranean waters and their inclusion in a conservation network. The establishment of no-take zones will be consistent with the objectives of the Common Fisheries Policy applying the ecosystem approach to fisheries management and with the requirements of the Marine Strategy Framework Directive to maintain or achieve seafloor integrity and good environmental status.	[Colloca, Francesco; Garofalo, Germana; Fiorentino, Fabio] CNR, IAMC, Mazara Del Vallo, Italy; [Bitetto, Isabella; Facchini, Maria Teresa; Martiradonna, Angela; Lembo, Giuseppe; Spedicato, Maria Teresa] COISPA Tecnol & Ric, Bari, Italy; [Grati, Fabio; Scarcella, Giuseppe] CNR, Ist Sci Marine ISMAR, Ancona, Italy; [Mastrantonio, Gianluca] Univ Rome Tre, Dept Econ, I-00146 Rome, Italy; [Nikolioudakis, Nikolaos; Tserpes, George; Valavanis, Vasilis; Lefkaditou, Eugenia; Papadopoulou, Nadia; Smith, Christopher J.] Hellen Ctr Marine Res, Iraklion, Greece; [Ordinas, Francesc; Pilar Tugores, M.; Iglesias, Magdalena; Massuti, Enric] Ctr Oceanog Balears, Inst Espanol Oceanog, Palma De Mallorca, Spain; [Carlucci, Roberto] Univ Bari, Dept Biol, Bari, Italy; [Follesa, Maria C.] Univ Cagliari, Dept Life & Environm Sci, Cagliari, Italy; [Knittweis, Leyla] Univ Malta, Dept Biol, Msida, Malta; [Manfredi, Chiara] Univ Bologna, Lab Biol Marina Fano, Bologna, Italy; [Pace, Marie Louise] Minist Sustainable Dev Environm & Climate Change, Dept Fisheries & Aquaculture, Santa Venera, Malta; [Sartor, Paolo] Ctr Interuniv Biol Marina & Ecol Applicata G Bacc, Livorno, Italy	Consiglio Nazionale delle Ricerche (CNR); L'Istituto per l'Ambiente Marino Costiero (IAMC-CNR); Consiglio Nazionale delle Ricerche (CNR); Istituto di Scienze Marine (ISMAR-CNR); Roma Tre University; Hellenic Centre for Marine Research; Spanish Institute of Oceanography; Universita degli Studi di Bari Aldo Moro; University of Cagliari; University of Malta; University of Bologna	Colloca, F (corresponding author), CNR, IAMC, Mazara Del Vallo, Italy.	francesco.colloca@iamc.cnr.it	Tugores, M.P./AAE-5569-2020; mastrantonio, gianluca/ABE-5936-2021; Nikolioudakis, Nikolaos/A-9986-2013; Massutí, Enric/AAG-5117-2021; Fiorentino, Fabio/AAX-2883-2020; Isajlovic, Igor/AAP-9861-2020; Valavanis, Vasilis D/G-8869-2011; Scarcella, Giuseppe/AAW-3850-2020; Tserpes, George/L-6201-2013; Carlucci, Roberto/C-5728-2009; Ordinas, Francesc/AAG-7079-2021; Carlucci, Roberto/ABC-7196-2020; Grati, Fabio/AAT-4760-2020	Tugores, M.P./0000-0003-2923-3038; mastrantonio, gianluca/0000-0002-2963-6729; Nikolioudakis, Nikolaos/0000-0002-5029-5164; Fiorentino, Fabio/0000-0002-6302-649X; Valavanis, Vasilis D/0000-0001-6288-6044; Tserpes, George/0000-0001-9052-4091; Carlucci, Roberto/0000-0002-9287-6936; Colloca, Francesco/0000-0002-0574-2893; martiradonna, angela/0000-0001-9147-1200; Spedicato, Maria Teresa/0000-0001-9939-9426; Iglesias, M. (Magdalena)/0000-0002-9983-558X; Lembo, Giuseppe/0000-0002-9899-6189; GRATI, FABIO/0000-0002-1793-303X; SARTOR, PAOLO/0000-0001-7239-8255; Papadopoulou, Nadia/0000-0003-4767-9949; Smith, Christopher/0000-0002-3031-5316; Scarcella, Giuseppe/0000-0001-6540-1997; Ordines, F. (Francesc)/0000-0002-2456-2214; Knittweis-Mifsud, Leyla/0000-0001-9023-2750; Massuti, Enric/0000-0002-9524-5873; Lefkaditou, Evgenia/0000-0002-7868-5375	Commission of the European Union (DG MARE) [MAREA/2009/05]	Commission of the European Union (DG MARE)	This study was supported and financed by the Commission of the European Union (DG MARE) through the Project MEDISEH: Mediterranean Sensitive Habitats within the MAREA Framework contract (Call for tenders MAREA/2009/05). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abella A, 2008, J MARINE SYST, V71, P279, DOI 10.1016/j.jmarsys.2007.05.010; Abello P, 2002, SCI MAR, V66, P125, DOI 10.3989/scimar.2002.66s2125; Agostini VN, 2002, FISH OCEANOGR, V11, P129, DOI 10.1046/j.1365-2419.2002.00201.x; Apostolaki P, 2002, CAN J FISH AQUAT SCI, V59, P405, DOI 10.1139/F02-018; Ardizzone GD, 1997, ATLAS ITALIAN DEMERS; Artegiani A, 1997, J PHYS OCEANOGR, V27, P1515, DOI 10.1175/1520-0485(1997)027<1515:TASGCP>2.0.CO;2; Artioli Y, 2005, ECOL MODEL, V184, P55, DOI 10.1016/j.ecolmodel.2004.11.008; Bakun A., 1996, OCEAN PROCESSES MARI; Bartolino V, 2008, ICES J MAR SCI, V65, P963, DOI 10.1093/icesjms/fsn079; Beck MW, 2001, BIOSCIENCE, V51, P633, DOI 10.1641/0006-3568(2001)051[0633:TICAMO]2.0.CO;2; Bertrand JA, 2002, SCI MAR, V66, P9, DOI 10.3989/scimar.2002.66s29; Beverton R.J.H., 1957, FISHERY INVESTIGAT 2, V2; BHATTACHARYA CG, 1967, BIOMETRICS, V23, P115, DOI 10.2307/2528285; Bradai M. N., 2012, ELASMOBRANCHS MEDITE; Caddy JF, 1993, SCI MAR, V57, P121; Carlucci R, 2009, ESTUAR COAST SHELF S, V83, P529, DOI 10.1016/j.ecss.2009.04.034; Carpentieri P, 2005, ESTUAR COAST SHELF S, V63, P577, DOI 10.1016/j.ecss.2005.01.005; CASANOVA B, 1970, Revue des Travaux de l'Institut des Peches Maritimes, V34, P205; Cau A, 2002, SCI MAR, V66, P103, DOI 10.3989/scimar.2002.66s2103; Cheminee A, 2013, J EXP MAR BIOL ECOL, V442, P70, DOI 10.1016/j.jembe.2013.02.003; Colloca F, 2004, MAR BIOL, V145, P1129, DOI 10.1007/s00227-004-1405-8; Colloca F, 2013, FISH FISH, V14, P89, DOI 10.1111/j.1467-2979.2011.00453.x; Colloca F, 2009, MAR ECOL PROG SER, V381, P287, DOI 10.3354/meps07942; Dahlgren CP, 2006, MAR ECOL PROG SER, V312, P291, DOI 10.3354/meps312291; de Juan S, 2012, OCEAN COAST MANAGE, V65, P51, DOI 10.1016/j.ocecoaman.2012.04.024; Diggle PJ, 2007, SPRINGER SER STAT, P1, DOI 10.1007/978-0-387-48536-2; Early R, 2008, J APPL ECOL, V45, P228, DOI 10.1111/j.1365-2664.2007.01424.x; Estrada M, 1996, SCI MAR, V60, P55; Fiorentino F, 2003, HYDROBIOLOGIA, V503, P223, DOI 10.1023/B:HYDR.0000008485.85468.ef; Fortibuoni T, 2010, J CRUSTACEAN BIOL, V30, P167, DOI 10.1651/09-3167.1; Francour P, 1997, MAR ECOL-P S Z N I, V18, P157, DOI 10.1111/j.1439-0485.1997.tb00434.x; Garofalo G, 2011, J SEA RES, V66, P29, DOI 10.1016/j.seares.2011.04.008; GETIS A, 1992, GEOGR ANAL, V24, P189, DOI 10.1111/j.1538-4632.1992.tb00261.x; Grati F, 2013, J SEA RES, V84, P122, DOI 10.1016/j.seares.2013.05.001; Guidetti P, 2000, ESTUAR COAST SHELF S, V50, P515, DOI 10.1006/ecss.1999.0584; Hall DB, 2000, BIOMETRICS, V56, P1030, DOI 10.1111/j.0006-341X.2000.01030.x; Hinckley S, 2001, ICES J MAR SCI, V58, P1042, DOI 10.1006/jmsc.2001.1096; Hueter Robert E., 1998, Shark News, V12, P1; Lavaleye MSS, 2002, PROG OCEANOGR, V52, P459, DOI 10.1016/S0079-6611(02)00019-8; Lembo G., 2000, Biologia Marina Mediterranea, V7, P98; Lembo G, 2000, CRUSTACEANA, V73, P39, DOI 10.1163/156854000504101; Lermusiaux PFJ, 2001, DEEP-SEA RES PT I, V48, P1953, DOI 10.1016/S0967-0637(00)00114-X; Maiorano L, 2009, ICES J MAR SCI, V66, P137, DOI 10.1093/icesjms/fsn148; Manson FJ, 2005, FISH RES, V74, P69, DOI 10.1016/j.fishres.2005.04.001; Massuti E, 2003, ICES J MAR SCI, V60, P753, DOI 10.1016/S1054-3139(03)00089-4; Maynou F, 2003, FISH RES, V60, P65, DOI 10.1016/S0165-7836(02)00062-0; McCullagh P, 1989, GEN LINEAR MODELS; Micheli F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059038; MMO, 2013, MMO PROJECT NO 1044; Morfin M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037907; Murenu M, 2010, GIS SPATIAL ANAL FIS, P51; Nagelkerken I, 2013, FISH FISH; Nagelkerken I, 2009, ECOLOGICAL CONNECTIVITY AMONG TROPICAL COASTAL ECOSYSTEMS, P357, DOI 10.1007/978-90-481-2406-0_10; Ordines F, 2011, CONT SHELF RES, V31, P1835, DOI 10.1016/j.csr.2011.08.007; Pinazo C, 1996, J MARINE SYST, V7, P161, DOI 10.1016/0924-7963(95)00028-3; Planque B, 2011, FISH OCEANOGR, V20, P1, DOI 10.1111/j.1365-2419.2010.00546.x; Ragonese S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074865; Richardson EA, 2006, CONSERV BIOL, V20, P1191, DOI 10.1111/j.1523-1739.2006.00426.x; Roberts CM, 2003, ECOL APPL, V13, pS199; Robinson AR, 1999, J MARINE SYST, V20, P129, DOI 10.1016/S0924-7963(98)00079-7; Rochet MJ, 2013, E21 ICES CM, VE, P21; Rue H, 2009, J R STAT SOC B, V71, P319, DOI 10.1111/j.1467-9868.2008.00700.x; Russo T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086222; SABATES A, 1989, MAR BIOL, V103, P153, DOI 10.1007/BF00543342; Salat J, 1996, SCI MAR, V60, P21; Sartor P, 2002, SCI MAR, V66, P83, DOI 10.3989/scimar.2002.66s283; Sbrocco E.J., 2013, ECOLOGY, V94, P979, DOI DOI 10.1890/12-1358.1; Scarcella G, 2014, J SEA RES, V89, P12, DOI 10.1016/j.seares.2014.02.002; Schumaker LL, 1976, APPROXIMATION THEORY, VII, P203; Sheaves M, 2006, MAR ECOL PROG SER, V318, P303, DOI 10.3354/meps318303; STECF (Scientific Technical Economic Committee for Fisheries), 2011, STECF1114; STECF (Scientific Technical Economic Committee for Fisheries), 2013, EUR SCI TECHN RES SE; Tsagarakis K., 2013, ICES J MAR SCI; Tserpes G, 2008, HYDROBIOLOGIA, V612, P125, DOI 10.1007/s10750-008-9486-x; Tsikliras AC, 2010, REV FISH BIOL FISHER, V20, P499, DOI 10.1007/s11160-010-9158-6; Tudela S., 2004, FAO STUDIES REV, V74; Turner SJ, 1999, FISHERIES MANAG ECOL, V6, P401, DOI 10.1046/j.1365-2400.1999.00167.x; Vasconcelos RP, 2011, ECOL INDIC, V11, P1123, DOI 10.1016/j.ecolind.2010.12.012; Vilibic I, 2002, DEEP-SEA RES PT I, V49, P1321, DOI 10.1016/S0967-0637(02)00028-6; Wood S, 2017, GEN ADDITIVE MODELS, DOI 10.1201/9781315370279; Zuur Alain F., 2009, P1	81	77	77	0	75	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2015	10	3							e0119590	10.1371/journal.pone.0119590	http://dx.doi.org/10.1371/journal.pone.0119590			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9BN	25785737	Green Published, gold			2022-12-27	WOS:000352138500116
J	Holland, EP; James, A; Ruscoe, WA; Pech, RP; Byrom, AE				Holland, E. Penelope; James, Alex; Ruscoe, Wendy A.; Pech, Roger P.; Byrom, Andrea E.			Climate-Based Models for Pulsed Resources Improve Predictability of Consumer Population Dynamics: Outbreaks of House Mice in Forest Ecosystems	PLOS ONE			English	Article							MAST; PREDATION; RODENT; SEED; MOUSE; RESPONSES; DISEASE; FLUCTUATIONS; TEMPERATURE; AUSTRALIA	Accurate predictions of the timing and magnitude of consumer responses to episodic seeding events (masts) are important for understanding ecosystem dynamics and for managing outbreaks of invasive species generated by masts. While models relating consumer populations to resource fluctuations have been developed successfully for a range of natural and modified ecosystems, a critical gap that needs addressing is better prediction of resource pulses. A recent model used change in summer temperature from one year to the next (Delta T) for predicting masts for forest and grassland plants in New Zealand. We extend this climate-based method in the framework of a model for consumer-resource dynamics to predict invasive house mouse (Mus musculus) outbreaks in forest ecosystems. Compared with previous mast models based on absolute temperature, the Delta T method for predicting masts resulted in an improved model for mouse population dynamics. There was also a threshold effect of Delta T on the likelihood of an outbreak occurring. The improved climate-based method for predicting resource pulses and consumer responses provides a straightforward rule of thumb for determining, with one year's advance warning, whether management intervention might be required in invaded ecosystems. The approach could be applied to consumer-resource systems worldwide where climatic variables are used to model the size and duration of resource pulses, and may have particular relevance for ecosystems where global change scenarios predict increased variability in climatic events.	[Holland, E. Penelope; Ruscoe, Wendy A.; Pech, Roger P.; Byrom, Andrea E.] Landcare Res, Canterbury, New Zealand; [Holland, E. Penelope] Univ York, Dept Biol, York YO10 5DD, N Yorkshire, England; [James, Alex] Univ Canterbury, Biomath Res Ctr, Christchurch 1, New Zealand; [Ruscoe, Wendy A.] Univ Canberra, Inst Appl Ecol, Bruce, ACT, Australia	Landcare Research - New Zealand; University of York - UK; University of Canterbury; University of Canberra	Holland, EP (corresponding author), Landcare Res, Canterbury, New Zealand.	pen.holland@york.ac.uk	Ruscoe, Wendy A./A-5273-2018	Ruscoe, Wendy A./0000-0002-7763-0356; James, Alex/0000-0002-1543-7139	Science and Innovation Group of the New Zealand Ministry of Business, Innovation and Employment [C09X0909]	Science and Innovation Group of the New Zealand Ministry of Business, Innovation and Employment(New Zealand Ministry of Business, Innovation and Employment (MBIE))	The authors were funded by the Science and Innovation Group of the New Zealand Ministry of Business, Innovation and Employment (contract C09X0909 and core funding to Crown Research Institutes). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrams PA, 2000, TRENDS ECOL EVOL, V15, P337, DOI 10.1016/S0169-5347(00)01908-X; Ackerley D, 2012, WEATHER CLIM, V32, P3; Allen RB, 2012, OIKOS, V121, P367, DOI 10.1111/j.1600-0706.2011.19306.x; Bayliss P., 1987, P119; Burnham K.P., 2002, PRACTICAL INFORM THE, V2nd ed., DOI [DOI 10.1007/B97636, 10.1007/b97636]; Choquenot D, 2006, CONSERV BIOL, V20, P480, DOI 10.1111/j.1523-1739.2006.00343.x; Choquenot D, 2003, J ANIM ECOL, V72, P14, DOI 10.1046/j.1365-2656.2003.00676.x; Choquenot D, 2000, J ANIM ECOL, V69, P1058, DOI 10.1046/j.1365-2656.2000.00462.x; Cleaveland S, 2007, SERENGETI, P209; Clotfelter ED, 2007, OECOLOGIA, V154, P493, DOI 10.1007/s00442-007-0859-z; Courchamp F, 2003, BIOL REV, V78, P347, DOI 10.1017/S1464793102006061; Davis SA, 2002, PHILOS T ROY SOC B, V357, P1249, DOI 10.1098/rstb.2002.1125; Drobyshev I, 2010, FOREST ECOL MANAG, V259, P2160, DOI 10.1016/j.foreco.2010.01.037; EILER JH, 1989, J WILDLIFE MANAGE, V53, P353, DOI 10.2307/3801137; FITZGERALD BM, 1979, NEW ZEAL J ZOOL, V6, P107; Hansen J, 2012, P NATL ACAD SCI USA, V109, pE2415, DOI 10.1073/pnas.1205276109; Haynes KJ, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2012.2373; Holland EP, 2015, THEOR ECOL-NETH, V8, P121, DOI 10.1007/s12080-014-0238-4; Innes J, 2010, NEW ZEAL J ECOL, V34, P86; Jedrzejewska B., 1998, PREDATION VERTEBRATE; Jones CG, 1998, SCIENCE, V279, P1023, DOI 10.1126/science.279.5353.1023; Kelly D, 2002, ANNU REV ECOL SYST, V33, P427, DOI 10.1146/annurev.ecolsys.33.020602.095433; Kelly D, 2008, POPUL ECOL, V50, P343, DOI 10.1007/s10144-008-0109-1; Kelly D, 2013, ECOL LETT, V16, P90, DOI [1, 10.1111/ele.12020]; KING CM, 1983, J ANIM ECOL, V52, P141, DOI 10.2307/4593; Koenig WD, 2014, POPUL ECOL, V56, P63, DOI 10.1007/s10144-013-0408-z; Korpela K, 2013, GLOBAL CHANGE BIOL, V19, P697, DOI 10.1111/gcb.12099; Krebs CJ, 2012, BOTANY, V90, P113, DOI [10.1139/B11-088, 10.1139/b11-088]; Krebs CJ, 2004, WILDLIFE RES, V31, P465, DOI 10.1071/WR03131; LaMontagne JM, 2009, J VEG SCI, V20, P745, DOI 10.1111/j.1654-1103.2009.01068.x; Leirs H, 1996, J APPL ECOL, V33, P937, DOI 10.2307/2404675; Liebhold A, 2004, ANNU REV ECOL EVOL S, V35, P467, DOI 10.1146/annurev.ecolsys.34.011802.132516; McKone MJ, 1998, GLOB CHANGE BIOL, V4, P591, DOI 10.1046/j.1365-2486.1998.00172.x; McShea WJ, 2000, ECOLOGY, V81, P228, DOI 10.1890/0012-9658(2000)081[0228:TIOACO]2.0.CO;2; Nakicenovic N., 2000, INTERGOVERNMENTAL PA, P599; ODonnell CFJ, 1996, NEW ZEAL J ZOOL, V23, P287, DOI 10.1080/03014223.1996.9518087; Ostfeld RS, 2008, J ANIM ECOL, V77, P201, DOI 10.1111/j.1365-2656.2008.01364.x; Ostfeld RS, 2000, TRENDS ECOL EVOL, V15, P232, DOI 10.1016/S0169-5347(00)01862-0; Ostfeld RS, 1997, AM SCI, V85, P338; Ostfeld RS, 1996, BIOSCIENCE, V46, P323, DOI 10.2307/1312946; Pearse IS, 2014, OIKOS, V123, P179, DOI 10.1111/j.1600-0706.2013.00608.x; Pech R, 1997, REPROD FERT DEVELOP, V9, P41, DOI 10.1071/R96059; Pech R.P., 2002, ACIAR Monograph Series, V96, P311; Pech R. P., 1999, Ecologically-based management of rodent pests., P81; Pech RP, 1998, J APPL ECOL, V35, P434, DOI 10.1046/j.1365-2664.1998.00318.x; Pedersen AB, 2008, J ANIM ECOL, V77, P370, DOI 10.1111/j.1365-2656.2007.01321.x; Poncet BN, 2009, OECOLOGIA, V159, P527, DOI 10.1007/s00442-008-1233-5; Ruscoe W.A., 2010, RODENT OUTBREAKS ECO, P239; Ruscoe WA, 2005, J ANIM ECOL, V74, P1005, DOI 10.1111/j.1365-2656.2005.00998.x; Ruscoe WA, 2013, CONSERV BIOL, V27, P74, DOI 10.1111/j.1523-1739.2012.01932.x; Schauber EM, 2002, ECOLOGY, V83, P1214, DOI 10.1890/0012-9658(2002)083[1214:MBENZP]2.0.CO;2; Shi DZ, 2002, J APPL ECOL, V39, P337, DOI 10.1046/j.1365-2664.2002.00716.x; Singleton GR, 2005, BIOL J LINN SOC, V84, P617, DOI 10.1111/j.1095-8312.2005.00458.x; Skalski GT, 2001, ECOLOGY, V82, P3083; Stenseth NC, 2003, FRONT ECOL ENVIRON, V1, P367, DOI 10.2307/3868189; Tompkins DM, 2013, ECOL APPL, V23, P1075, DOI 10.1890/12-0915.1; Turnbull MH, 2012, FUNCT PLANT BIOL, V39, P38, DOI 10.1071/FP11116; Wardle J., 1984, NZ BEECHES ECOLOGY U; Wilson DJ, 2007, ECOGRAPHY, V30, P105, DOI [10.1111/j.2006.0906-7590.04771.x, 10.1111/j.0906-7590.2007.04771.x]; Wilson PR, 1998, BIOL CONSERV, V83, P175, DOI 10.1016/S0006-3207(97)00055-4; Wolff JO, 1996, J MAMMAL, V77, P850, DOI 10.2307/1382690; Yang LH, 2008, ECOLOGY, V89, P621, DOI 10.1890/07-0175.1; Yang LH, 2010, ECOL MONOGR, V80, P125, DOI 10.1890/08-1996.1; Zhang ZB, 2003, OIKOS, V100, P299, DOI 10.1034/j.1600-0706.2003.11810.x	64	12	12	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2015	10	3							e0119139	10.1371/journal.pone.0119139	http://dx.doi.org/10.1371/journal.pone.0119139			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9BN	25785866	gold, Green Published, Green Submitted			2022-12-27	WOS:000352138500077
J	Li, QJ; Serb, A; Prodromakis, T; Xu, H				Li, Qingjiang; Serb, Alexander; Prodromakis, Themistoklis; Xu, Hui			A Memristor SPICE Model Accounting for Synaptic Activity Dependence	PLOS ONE			English	Article							PLASTICITY; SYSTEMS	In this work, we propose a new memristor SPICE model that accounts for the typical synaptic characteristics that have been previously demonstrated with practical memristive devices. We show that this model could account for both volatile and non-volatile memristance changes under distinct stimuli. We then demonstrate that our model is capable of supporting typical STDP with simple non-overlapping digital pulse pairs. Finally, we investigate the capability of our model to simulate the activity dependence dynamics of synaptic modification and present simulated results that are in excellent agreement with biological results.	[Li, Qingjiang; Xu, Hui] Natl Univ Def Technol, Coll Elect Sci & Engn, Changsha, Hunan, Peoples R China; [Serb, Alexander; Prodromakis, Themistoklis] Univ Southampton, Southampton Nanofabricat Ctr, Dept Elect & Comp Sci, Nano Grp, Southampton, Hants, England	National University of Defense Technology - China; University of Southampton	Xu, H (corresponding author), Natl Univ Def Technol, Coll Elect Sci & Engn, Changsha, Hunan, Peoples R China.	xuhui@nudt.edu.cn	Serb, Alexantrou/AAI-4054-2020; Prodromakis, Themistoklis/N-9315-2015	Serb, Alexantrou/0000-0002-8034-2398; Prodromakis, Themistoklis/0000-0002-6267-6909	National Natural Science Foundation of China [61171017]; Engineering and Physical Sciences Research Council [EP/K017829/1]; EPSRC [EP/K017829/1] Funding Source: UKRI	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	1. National Natural Science Foundation of China, 61171017, http://www.nsfc.gov.cn/. L.Q. and X.H. 2. Engineering and Physical Sciences Research Council EP/K017829/1, http://www.epsrc.ac.uk/. A.S. and T.P. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ascoli A, 2013, IEEE CIRC SYST MAG, V13, P89, DOI 10.1109/MCAS.2013.2256272; Berdan R, 2014, IEEE ELECTR DEVICE L, V35, P135, DOI 10.1109/LED.2013.2291158; Bi GQ, 1998, J NEUROSCI, V18, P10464, DOI 10.1523/jneurosci.18-24-10464.1998; Biolek Z, 2009, RADIOENGINEERING, V18, P210; Chang T, 2012, CELL NAN NETW THEIR, P29; Chang T, 2011, ACS NANO, V5, P7669, DOI 10.1021/nn202983n; CHUA LO, 1971, IEEE T CIRCUITS SYST, VCT18, P507, DOI 10.1109/TCT.1971.1083337; Dan Y, 2006, PHYSIOL REV, V86, P1033, DOI 10.1152/physrev.00030.2005; Fursina AA, 2009, PHYS REV B, V79, DOI 10.1103/PhysRevB.79.245131; Giacomo I, 2013, NANOTECHNOLOGY, V24, DOI [10.1088/0957-4484/24/38/384010, DOI 10.1088/0957-4484/24/38/384010]; Jo SH, 2010, NANO LETT, V10, P1297, DOI 10.1021/nl904092h; Kumar S, 2013, ADV MATER, V25, P6128, DOI 10.1002/adma.201302046; Li Y, 2013, SCI REP-UK, V3, DOI 10.1038/srep01619; Pershin YV, ARXIV201212042600; Pfister JP, 2005, ADV NEURAL INFORM PR, P1081; Serb A, 2014, CIRC SYST ISCAS 2014, P2085; Strukov DB, 2008, NATURE, V453, P80, DOI 10.1038/nature06932; Wang ZQ, 2012, ADV FUNCT MATER, V22, P2759, DOI 10.1002/adfm.201103148; Williamson A, 2013, NANOSCALE, V5, P7297, DOI 10.1039/c3nr01834b; Zamarreno-Ramos C, 2011, FRONT NEUROSCI-SWITZ, V5, DOI 10.3389/fnins.2011.00026	20	22	24	3	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2015	10	3							e0120506	10.1371/journal.pone.0120506	http://dx.doi.org/10.1371/journal.pone.0120506			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9BN	25785597	gold, Green Accepted, Green Published, Green Submitted			2022-12-27	WOS:000352138500179
J	Portovedo, M; Ignacio-Souza, LM; Bombassaro, B; Coope, A; Reginato, A; Razolli, DS; Torsoni, MA; Torsoni, AS; Leal, RF; Velloso, LA; Milanski, M				Portovedo, Mariana; Ignacio-Souza, Leticia M.; Bombassaro, Bruna; Coope, Andressa; Reginato, Andressa; Razolli, Daniela S.; Torsoni, Marcio A.; Torsoni, Adriana S.; Leal, Raquel F.; Velloso, Licio A.; Milanski, Marciane			Saturated Fatty Acids Modulate Autophagy's Proteins in the Hypothalamus	PLOS ONE			English	Article							N-TERMINAL KINASE; BETA/NF-KAPPA-B; INSULIN-RESISTANCE; ENERGY-METABOLISM; CELL-DEATH; ER STRESS; OBESITY; BRAIN; MECHANISM; NEURONS	Autophagy is an important process that regulates cellular homeostasis by degrading dysfunctional proteins, organelles and lipids. In this study, the hypothesis that obesity could lead to impairment in hypothalamic autophagy in mice was evaluated by examining the hypothalamic distribution and content of autophagic proteins in animal with obesity induced by 8 or 16 weeks high fat diet to induce obesity and in response to intracerebroventricular injections of palmitic acid. The results showed that chronic exposure to a high fat diet leads to an increased expression of inflammatory markers and downregulation of autophagic proteins. In obese mice, autophagic induction leads to the downregulation of proteins, such as JNK and Bax, which are involved in the stress pathways. In neuron cell-line, palmitate has a direct effect on autophagy even without inflammatory activity. Understanding the cellular and molecular bases of overnutrition is essential for identifying new diagnostic and therapeutic targets for obesity.	[Portovedo, Mariana; Reginato, Andressa; Torsoni, Marcio A.; Torsoni, Adriana S.; Milanski, Marciane] Univ Estadual Campinas, UNICAMP, Fac Sci Appl, Limeira, Brazil; [Portovedo, Mariana; Bombassaro, Bruna; Coope, Andressa; Reginato, Andressa; Razolli, Daniela S.; Torsoni, Marcio A.; Torsoni, Adriana S.; Leal, Raquel F.; Velloso, Licio A.; Milanski, Marciane] Univ Estadual Campinas, UNICAMP, Obes & Comorbid Res Ctr, Campinas, SP, Brazil; [Ignacio-Souza, Leticia M.] Univ Fed Mato Grosso, Fac Nutr, Cuiaba, Brazil	Universidade Estadual de Campinas; Universidade Estadual de Campinas; Universidade Federal de Mato Grosso	Milanski, M (corresponding author), Univ Estadual Campinas, UNICAMP, Fac Sci Appl, Limeira, Brazil.	marciane.milanski@fca.unicamp.br	Leal, Raquel/W-7997-2019; Torsoni, Marcio A/E-9982-2012; Milanski, Marciane/F-5410-2012; Razolli, Daniela S/B-1630-2014; Velloso, Licio/AAJ-3778-2020; Torsoni, Marcio/AAH-3450-2020; Torsoni, Adriana/HGC-4584-2022; Ignacio-Souza, Leticia/D-7510-2013	Leal, Raquel/0000-0003-4285-4402; Milanski, Marciane/0000-0002-6322-5368; Razolli, Daniela S/0000-0002-2217-0946; Torsoni, Adriana/0000-0003-2287-7180; Ignacio-Souza, Leticia/0000-0002-2040-1851; Torsoni, Marcio/0000-0002-9663-5291; Coope, Andressa/0000-0002-7356-9690; Portovedo, Mariana/0000-0001-6417-8252	Sao Paulo Research Foundation (FAPESP) [2011/14565-4, RA 2011/51205-6]	Sao Paulo Research Foundation (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	This project has been funded by grants 2011/14565-4 (MP) and RA 2011/51205-6 (MM), Sao Paulo Research Foundation (FAPESP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alirezaei M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002906; Baehrecke EH, 2003, CELL DEATH DIFFER, V10, P940, DOI 10.1038/sj.cdd.4401280; Belgardt BF, 2010, P NATL ACAD SCI USA, V107, P6028, DOI 10.1073/pnas.1001796107; Choi SJ, 2010, AM J PHYSIOL-ENDOC M, V298, pE1122, DOI 10.1152/ajpendo.00006.2010; Coupe B, 2012, CELL METAB, V15, P247, DOI 10.1016/j.cmet.2011.12.016; De Souza CT, 2005, ENDOCRINOLOGY, V146, P4192, DOI 10.1210/en.2004-1520; Degterev A, 2005, NAT CHEM BIOL, V1, P112, DOI 10.1038/nchembio711; Ebrahimi-Fakhari D, 2011, J NEUROSCI, V31, P14508, DOI 10.1523/JNEUROSCI.1560-11.2011; Fang YM, 2013, CELL METAB, V17, P456, DOI 10.1016/j.cmet.2013.02.008; Farooqi IS, 2007, OBES REV, V8, P37, DOI 10.1111/j.1467-789X.2007.00315.x; Galgani J, 2008, INT J OBESITY, V32, pS109, DOI 10.1038/ijo.2008.246; Glick D, 2010, J PATHOL, V221, P3, DOI 10.1002/path.2697; Guo J, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000511; Harris J, 2011, J BIOL CHEM, V286, P9587, DOI 10.1074/jbc.M110.202911; Itakura E, 2011, J CELL BIOL, V192, P17, DOI 10.1083/jcb.201009067; Kalsbeek A, 2010, ANN NY ACAD SCI, V1212, P114, DOI 10.1111/j.1749-6632.2010.05800.x; Kamada Y, 2003, CURR TOP MICROBIOL, V279, P73; Kang R, 2011, CELL DEATH DIFFER, V18, P571, DOI 10.1038/cdd.2010.191; Kaushik S, 2011, CELL METAB, V14, P173, DOI 10.1016/j.cmet.2011.06.008; Kegel KB, 2000, J NEUROSCI, V20, P7268, DOI 10.1523/jneurosci.20-19-07268.2000; Kleinridders A, 2009, CELL METAB, V10, P249, DOI 10.1016/j.cmet.2009.08.013; Klionsky DJ, 2008, AUTOPHAGY, V4, P151, DOI 10.4161/auto.5338; Kraschnewski JL, 2010, INT J OBESITY, V34, P1644, DOI 10.1038/ijo.2010.94; Levine B, 2011, NATURE, V469, P323, DOI 10.1038/nature09782; Li JX, 2012, NAT CELL BIOL, V14, P999, DOI 10.1038/ncb2562; Marriott I, 2006, J REPROD IMMUNOL, V71, P12, DOI 10.1016/j.jri.2006.01.004; McNay DEG, 2012, J CLIN INVEST, V122, P142, DOI 10.1172/JCI43134; Meng QY, 2011, J BIOL CHEM, V286, P32324, DOI 10.1074/jbc.M111.254417; Milanski M, 2009, J NEUROSCI, V29, P359, DOI 10.1523/JNEUROSCI.2760-08.2009; Moraes JC, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005045; National Research Council, GUIDE CARE USE LAB A; Neufeld TP, 2010, CURR OPIN CELL BIOL, V22, P157, DOI 10.1016/j.ceb.2009.11.005; Nixon RA, 2005, J NEUROPATH EXP NEUR, V64, P113, DOI 10.1093/jnen/64.2.113; Pamenter ME, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051469; Pankiv S, 2007, J BIOL CHEM, V282, P24131, DOI 10.1074/jbc.M702824200; PAXINOS G, 1980, J NEUROSCI METH, V3, P129, DOI 10.1016/0165-0270(80)90021-7; Purkayastha S, 2011, P NATL ACAD SCI USA, V108, P2939, DOI 10.1073/pnas.1006875108; Quan W, 2012, ENDOCRINOLOGY, V153, P1817, DOI 10.1210/en.2011-1882; Ravikumar B, 2010, PHYSIOL REV, V90, P1383, DOI 10.1152/physrev.00030.2009; Romanatto T, 2009, J BIOL CHEM, V284, P36213, DOI 10.1074/jbc.M109.030874; Sabio G, 2010, GENE DEV, V24, P256, DOI 10.1101/gad.1878510; Schwartz MW, 2005, SCIENCE, V307, P375, DOI 10.1126/science.1104344; Shi CS, 2012, NAT IMMUNOL, V13, P255, DOI 10.1038/ni.2215; Singh R, 2011, CELL METAB, V13, P495, DOI 10.1016/j.cmet.2011.04.004; Steinberg GR, 2009, PHYSIOL REV, V89, P1025, DOI 10.1152/physrev.00011.2008; Thaler JP, 2012, J CLIN INVEST, V122, P153, DOI 10.1172/JCI59660; Unger EK, 2010, ENDOCRINOLOGY, V151, P671, DOI 10.1210/en.2009-0711; van de Sande-Lee S, 2011, DIABETES, V60, P1699, DOI 10.2337/db10-1614; Velloso LA, 2011, INT J OBESITY, V35, P1455, DOI 10.1038/ijo.2011.56; Vogiatzi T, 2008, J BIOL CHEM, V283, P23542, DOI 10.1074/jbc.M801992200; Williams KW, 2012, NAT NEUROSCI, V15, P1350, DOI 10.1038/nn.3217; Yang L, 2010, CELL METAB, V11, P467, DOI 10.1016/j.cmet.2010.04.005; Yang SB, 2012, NEURON, V75, P425, DOI 10.1016/j.neuron.2012.03.043; Yang YP, 2013, ACTA PHARMACOL SIN, V34, P625, DOI 10.1038/aps.2013.5; Yang ZF, 2009, CURR TOP MICROBIOL, V335, P1, DOI 10.1007/978-3-642-00302-8_1; Zhang X, 2013, AUTOPHAGY, V12, P9; Zhang XQ, 2008, CELL, V135, P61, DOI 10.1016/j.cell.2008.07.043	57	42	42	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2015	10	3							e0119850	10.1371/journal.pone.0119850	http://dx.doi.org/10.1371/journal.pone.0119850			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9BN	25786112	Green Submitted, Green Published, gold			2022-12-27	WOS:000352138500135
J	Sathyapalan, T; Thatcher, NJ; Hammersley, R; Rigby, AS; Pechlivanis, A; Gooderham, NJ; Holmes, E; le Roux, CW; Atkin, SL; Courts, F				Sathyapalan, Thozhukat; Thatcher, Natalie J.; Hammersley, Richard; Rigby, Alan S.; Pechlivanis, Alexandros; Gooderham, Nigel J.; Holmes, Elaine; le Roux, Carel W.; Atkin, Stephen L.; Courts, Fraser			Aspartame Sensitivity? A Double Blind Randomised Crossover Study	PLOS ONE			English	Article							PERFORMANCE; INGESTION; HEADACHE; ALCOHOL; MOOD	Background Aspartame is a commonly used intense artificial sweetener, being approximately 200 times sweeter than sucrose. There have been concerns over aspartame since approval in the 1980s including a large anecdotal database reporting severe symptoms. The objective of this study was to compare the acute symptom effects of aspartame to a control preparation. Methods This was a double-blind randomized cross over study conducted in a clinical research unit in United Kingdom. Forty-eight individual who has self reported sensitivity to aspartame were compared to 48 age and gender matched aspartame non-sensitive individuals. They were given aspartame (100mg)-containing or control snack bars randomly at least 7 days apart. The main outcome measures were acute effects of aspartame measured using repeated ratings of 14 symptoms, biochemistry and metabonomics. Results Aspartame sensitive and non-sensitive participants differed psychologically at baseline in handling feelings and perceived stress. Sensitive participants had higher triglycerides (2.05 +/- 1.44 vs. 1.26 +/- 0.84mmol/L; p value 0.008) and lower HDL-C (1.16 +/- 0.34 vs. 1.35 +/- 0.54 mmol/L; p value 0.04), reflected in H-1 NMR serum analysis that showed differences in the baseline lipid content between the two groups. Urine metabonomic studies showed no significant differences. None of the rated symptoms differed between aspartame and control bars, or between sensitive and control participants. However, aspartame sensitive participants rated more symptoms particularly in the first test session, whether this was placebo or control. Aspartame and control bars affected GLP-1, GIP, tyrosine and phenylalanine levels equally in both aspartame sensitive and non-sensitive subjects. Conclusion Using a comprehensive battery of psychological tests, biochemistry and state of the art metabonomics there was no evidence of any acute adverse responses to aspartame. This independent study gives reassurance to both regulatory bodies and the public that acute ingestion of aspartame does not have any detectable psychological or metabolic effects in humans.	[Sathyapalan, Thozhukat] Univ Hull, Hull York Med Sch, Acad Endocrinol Diabet & Metab, Kingston Upon Hull, N Humberside, England; [Thatcher, Natalie J.] Food Stand Agcy, London, England; [Hammersley, Richard] Univ Hull, Dept Psychol, Kingston Upon Hull HU6 7RX, N Humberside, England; [Rigby, Alan S.] Univ Hull, Dept Acad Cardiol, Kingston Upon Hull, N Humberside, England; [Pechlivanis, Alexandros; Gooderham, Nigel J.; Holmes, Elaine] Univ London Imperial Coll Sci Technol & Med, Fac Med, London, England; [le Roux, Carel W.] Univ Coll Dublin, Conway Inst, Diabet Complicat Res Ctr, Belfield, Ireland; [Atkin, Stephen L.] Weill Cornell Med Coll Qatar, Doha, Qatar; [Courts, Fraser] Norwich Res Pk, Inst Food Res, Norwich NR4 7UA, Norfolk, England	University of Hull; University of York - UK; University of Hull; University of Hull; Imperial College London; University College Dublin; Qatar Foundation (QF); Weill Cornell Medical College Qatar; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Quadram Institute; University of East Anglia	Sathyapalan, T (corresponding author), Univ Hull, Hull York Med Sch, Acad Endocrinol Diabet & Metab, Kingston Upon Hull, N Humberside, England.	Thozhukat.sathyapalan@hyms.ac.uk	Holmes, Elaine/A-2189-2015; Sathyapalan, Thozhukat/J-5212-2012; Rigby, Alan/AFM-1194-2022; Pechlivanis, Alexandros/AAR-7809-2020; Holmes, Elaine/ABE-6606-2020; Atkin, stephen/ABE-7047-2020; Hammersley, Richard/I-9347-2012; Atkin, Stephen/D-7400-2014	Sathyapalan, Thozhukat/0000-0003-3544-2231; Rigby, Alan/0000-0001-8331-3907; Pechlivanis, Alexandros/0000-0002-3448-2461; Holmes, Elaine/0000-0002-0556-8389; Le Roux, Carel/0000-0001-5521-5445; Atkin, Stephen/0000-0002-5887-7257; Gooderham, Nigel/0000-0001-7645-8219	Food Standards Agency, United Kingdom [T01054]	Food Standards Agency, United Kingdom	This study was supported by the Food Standards Agency, United Kingdom, T01054.	Belpoggi F, 2006, ANN NY ACAD SCI, V1076, P559, DOI 10.1196/annals.1371.080; CAMFIELD PR, 1992, NEUROLOGY, V42, P1000, DOI 10.1212/WNL.42.5.1000; Cloarec O, 2005, ANAL CHEM, V77, P517, DOI 10.1021/ac048803i; Committee of toxicity of chemicals in food consumer products and the environment, 2011, COT STAT CHRON DAIL; Dhareshwar SS, 2008, J PHARM SCI-US, V97, P4184, DOI 10.1002/jps.21319; Enck P, 2008, NEURON, V59, P195, DOI 10.1016/j.neuron.2008.06.030; European Food Safety Authority, 2013, PUBL CONS DRAFT SCI; European Food Safety Authority, 2010, M ASP NAT EXP; Ferland A, 2007, ACTA DIABETOL, V44, P114, DOI 10.1007/s00592-007-0251-9; FILER LJ, 1989, DIABETES CARE, V12, P67, DOI 10.2337/diacare.12.1.67; Food and Drug Adminstration, 2007, FDA STAT EUR ASP STU; Hertzog MA, 2008, RES NURS HEALTH, V31, P180, DOI 10.1002/nur.20247; Jang W, 2011, MOL CELLS, V31, P461, DOI 10.1007/s10059-011-1009-3; KOEHLER SM, 1988, HEADACHE, V28, P10, DOI 10.1111/j.1365-2524.1988.hed2801010.x; LAPIERRE KA, 1990, J CLIN PHARMACOL, V30, P454, DOI 10.1002/j.1552-4604.1990.tb03485.x; Lean MEJ, 2004, BMJ-BRIT MED J, V329, P755, DOI 10.1136/bmj.329.7469.755; Lindinger W, 1997, ALCOHOL CLIN EXP RES, V21, P939; LIPTON RB, 1989, HEADACHE, V29, P90, DOI 10.1111/j.1526-4610.1989.hed2902090.x; Magnuson BA, 2007, CRIT REV TOXICOL, V37, P629, DOI 10.1080/10408440701516184; PIVONKA EEA, 1990, J AM DIET ASSOC, V90, P250; Prankerd RJ, 1992, INT J PHARMACEUT, V88, P188; Robbins PI, 1999, J OCCUP ENVIRON MED, V41, P418, DOI 10.1097/00043764-199906000-00006; ROBERTS H J, 1988, Journal of Applied Nutrition, V40, P85; Roberts HJ, 1996, ARCH INTERN MED, V156, P1027, DOI 10.1001/archinte.156.9.1027; Roberts HJ, 2001, ASPARTAME DIS IGNORE; RYANHARSHMAN M, 1987, PHYSIOL BEHAV, V39, P247, DOI 10.1016/0031-9384(87)90017-5; SCHIFFMAN SS, 1987, NEW ENGL J MED, V317, P1181, DOI 10.1056/NEJM198711053171903; Smith CA, 2006, ANAL CHEM, V78, P779, DOI 10.1021/ac051437y; Spiers PA, 1998, AM J CLIN NUTR, V68, P531, DOI 10.1093/ajcn/68.3.531; STOKES AF, 1994, AVIAT SPACE ENVIR MD, V65, P7; STOKES AF, 1991, AVIAT SPACE ENVIR MD, V62, P648; Strathman I, 1991, J Reprod Med, V36, P572; VANDENEEDEN SK, 1994, NEUROLOGY, V44, P1787, DOI 10.1212/WNL.44.10.1787; Veselkov KA, 2011, ANAL CHEM, V83, P5864, DOI 10.1021/ac201065j; WALTON RG, 1993, BIOL PSYCHIAT, V34, P13, DOI 10.1016/0006-3223(93)90251-8; WATTS RS, 1991, HEADACHE, V31, P181, DOI 10.1111/j.1526-4610.1991.hed3103181.x; Zehetner A, 1999, LANCET, V354, P78, DOI 10.1016/S0140-6736(05)75350-2	37	7	8	6	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2015	10	3							e0116212	10.1371/journal.pone.0116212	http://dx.doi.org/10.1371/journal.pone.0116212			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9BN	25786106	gold, Green Submitted, Green Published			2022-12-27	WOS:000352138500005
J	Solodenko, N; Zupancich, A; Cesaro, SN; Marder, O; Lemorini, C; Barkai, R				Solodenko, Natalya; Zupancich, Andrea; Cesaro, Stella Nunziante; Marder, Ofer; Lemorini, Cristina; Barkai, Ran			Fat Residue and Use-Wear Found on Acheulian Biface and Scraper Associated with Butchered Elephant Remains at the Site of Revadim, Israel	PLOS ONE			English	Article							STONE TOOL FUNCTION; OLDUVAI GORGE; EARLY HUMANS; FT-IR; BONE; SPECTROSCOPY; AGE; IDENTIFICATION; NEANDERTHAL; WOODWORKING	The archaeological record indicates that elephants must have played a significant role in early human diet and culture during Palaeolithic times in the Old World. However, the nature of interactions between early humans and elephants is still under discussion. Elephant remains are found in Palaeolithic sites, both open-air and cave sites, in Europe, Asia, the Levant, and Africa. In some cases elephant and mammoth remains indicate evidence for butchering and marrow extraction performed by humans. Revadim Quarry (Israel) is a Late Acheulian site where elephant remains were found in association with characteristic Lower Palaeolithic flint tools. In this paper we present results regarding the use of Palaeolithic tools in processing animal carcasses and rare identification of fat residue preserved on Lower Palaeolithic tools. Our results shed new light on the use of Palaeolithic stone tools and provide, for the first time, direct evidence (residue) of animal exploitation through the use of an Acheulian biface and a scraper. The association of an elephant rib bearing cut marks with these tools may reinforce the view suggesting the use of Palaeolithic stone tools in the consumption of large game.	[Solodenko, Natalya; Zupancich, Andrea; Barkai, Ran] Tel Aviv Univ, Jacob M Alkow Dept Archaeol & Ancient Near Easter, IL-69978 Tel Aviv, Israel; [Cesaro, Stella Nunziante] Univ Roma La Sapienza, Dept Chem, ISMN CNR, SMATCH, I-00185 Rome, Italy; [Marder, Ofer] Ben Gurion Univ Negev, Dept Bible Archaeol & Ancient Near Eastern Studie, IL-84105 Beer Sheva, Israel; [Lemorini, Cristina] Univ Roma La Sapienza, Dept Class, I-00185 Rome, Italy	Tel Aviv University; Consiglio Nazionale delle Ricerche (CNR); Istituto per lo Studio dei Materiali Nanostrutturati (ISMN-CNR); Sapienza University Rome; Ben Gurion University; Sapienza University Rome	Barkai, R (corresponding author), Tel Aviv Univ, Jacob M Alkow Dept Archaeol & Ancient Near Easter, IL-69978 Tel Aviv, Israel.	barkaran@post.tau.ac.il	Barkai, Ran/L-6495-2019; lemorini, cristina/ABD-5327-2020	lemorini, cristina/0000-0002-6998-1615; BARKAI, RAN/0000-0002-8125-8788; Zupancich, Andrea/0000-0002-9503-1234				Acerbo AS, 2012, ANAL CHEM, V84, P3607, DOI 10.1021/ac203375d; Adler DS, 2014, SCIENCE, V345, P1609, DOI 10.1126/science.1256484; Agam A, 2014, QUAT INT IN PRESS; Anderson PC, 2013, INTERDISCIPLINARY FO, P89; Anderson-Gerfaud P., 1990, EMERGENCE MODERN HUM, P389; Anzidel AP, 2012, QUATERN INT, V255, P171, DOI 10.1016/j.quaint.2011.06.005; Ashton N., 1992, P PREHIST SOC, V58, P21; Bar-Yosef O, 2011, QUATERNARY SCI REV, V30, P1318, DOI 10.1016/j.quascirev.2010.02.016; Barkai R., 2013, DYNAMICS LEARNING NE, V1, P115, DOI DOI 10.1007/978-4-431-54511-8_7; Barkai R, 2009, CURR ANTHROPOL, V50, P356; BARYOSEF O, 1994, J WORLD PREHIST, V8, P211, DOI 10.1007/BF02221050; Ben-Dor M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028689; Bisson MS, 2001, CAMB ARCHAEOL J, V11, P165, DOI 10.1017/S0959774301000099; Boschian G, 2010, QUATERN INT, V214, P3, DOI 10.1016/j.quaint.2009.10.016; Brumm A, 2011, J HUM EVOL, V60, P185, DOI 10.1016/j.jhevol.2010.09.005; Burdukiewicz J. M., 2003, LOWER PALAEOLITHIC S; Cesaro SN, 2012, SPECTROCHIM ACTA A, V86, P299, DOI 10.1016/j.saa.2011.10.040; Chazan M, 2000, MITEKUFAT HAEVEN J I, V30, P7; Chazan M, 2006, J ANTHROPOL ARCHAEOL, V25, P436, DOI 10.1016/j.jaa.2006.03.005; Claud E, 2012, GALLIA PREHISTOIRE, V54, P332; Demay L, 2012, QUATERN INT, V276, P212, DOI 10.1016/j.quaint.2011.11.019; Dominguez-Rodrigo M, 2002, J WORLD PREHIST, V16, P1, DOI 10.1023/A:1014507129795; Dominguez-Rodrigo M, 2001, J HUM EVOL, V40, P289, DOI 10.1006/jhev.2000.0466; Dominguez-Rodrigo M, 2014, QUATERN INT, V322, P32, DOI 10.1016/j.quaint.2013.09.042; Forbes SL, 2005, FORENSIC SCI INT, V154, P24, DOI 10.1016/j.forsciint.2004.09.107; Gaudzinski S, 2005, QUATERN INT, V126, P179, DOI 10.1016/j.quaint.2004.04.022; Genestar C, 2005, ANAL BIOANAL CHEM, V382, P269, DOI 10.1007/s00216-005-3085-8; Germonpre M, 2014, QUATERN INT, V337, P28, DOI 10.1016/j.quaint.2012.10.035; Germonpre M, 2008, J ANTHROPOL ARCHAEOL, V27, P475, DOI 10.1016/j.jaa.2008.07.003; Goren-Inbar N, 2008, J HUM EVOL, V55, P702, DOI 10.1016/j.jhevol.2008.07.005; Goren-Inbar N., 1994, PALEORIENT, V20, P99, DOI DOI 10.3406/PALEO.1994.4604; Goren-Inbar N., 1985, PALEORIENT, V11, P7; Goren-Inbar N, 1998, ARCHAEOLOGY SOC HOLY; Gowlett JAJ, 2001, PALEOANTHROPOLOGY SO, P174; Hardy BL, 2004, ANTIQUITY, V78, P547, DOI 10.1017/S0003598X00113213; Hardy BL, 1998, J ARCHAEOL SCI, V25, P177, DOI 10.1006/jasc.1997.0234; Hardy BL, 2001, P NATL ACAD SCI USA, V98, P10972, DOI 10.1073/pnas.191384498; Hardy BL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023768; HARRIS JWK, 1978, THESIS U CALIFORNIA; Herrygers C., 2002, MCNAIR SCHOLARS J, V6, P65; Howell FC, 1962, ACT 4 C PAN PREH ET, P43; HUNT GR, 1972, APPL OPTICS, V11, P142, DOI 10.1364/AO.11.000142; Izzo FC, 2013, J ARCHAEOL SCI, V40, P595, DOI 10.1016/j.jas.2012.06.017; Keeley L.H., 1980, EXPT DETERMINATION S; KEELEY LH, 1977, J ARCHAEOL SCI, V4, P29, DOI 10.1016/0305-4403(77)90111-X; KEELEY LH, 1981, NATURE, V293, P464, DOI 10.1038/293464a0; Kohn M, 1999, ANTIQUITY, V73, P518, DOI 10.1017/S0003598X00065078; Koirala B, 2009, J ARCHAEOL SCI, V36, P1229, DOI 10.1016/j.jas.2009.01.012; Lemorini C, 1999, ANNUARIO STORICO VAL, P47; Lombard M, 2004, S AFR J SCI, V100, P159; Lombard M, 2005, J HUM EVOL, V48, P279, DOI 10.1016/j.jhevol.2004.11.006; LOY TH, 1983, SCIENCE, V220, P1269, DOI 10.1126/science.220.4603.1269; Lycett SJ, 2008, WORLD ARCHAEOL, V40, P295, DOI 10.1080/00438240802260970; Machin AJ, 2007, J ARCHAEOL SCI, V34, P883, DOI 10.1016/j.jas.2006.09.008; Machin A, 2009, J SOC ARCHAEOL, V9, P35, DOI 10.1177/1469605308099370; Madejova J, 2003, VIB SPECTROSC, V31, P1, DOI 10.1016/S0924-2031(02)00065-6; Marder O, 1999, J ISRAEL PREHISTORIC, V28, P21; Marder O, 2011, J HUM EVOL, V60, P508, DOI 10.1016/j.jhevol.2010.01.007; Matheson CD, 2014, J ARCHAEOL SCI, V52, P116, DOI 10.1016/j.jas.2014.08.016; Mazza PPA, 2006, J ARCHAEOL SCI, V33, P1310, DOI 10.1016/j.jas.2006.01.006; Nowell A, 2010, STONE TOOLS AND THE EVOLUTION OF HUMAN COGNITION, P67; Odell GH, 1980, J FIELD ARCHAEOL, V7, P87120; Odell GH, 2004, LITHIC ANAL, P135; Pickering TR, 2013, J ARCHAEOL SCI, V40, P1295, DOI 10.1016/j.jas.2012.09.025; Pope M., 2006, LITHICS J LITHIC STU, V27, P47; Preysler J.B., 2003, EXPT INTERPRETATION, P171; Prinsloo LC, 2014, J ARCHAEOL SCI, V41, P732, DOI 10.1016/j.jas.2013.10.011; Rabinovich R, 2012, QUATERN INT, V276, P183, DOI 10.1016/j.quaint.2012.05.009; Rosenfeld A, 1971, BRIT MUSEUM Q, V35, P176; Rots V., 2009, QUARTAR, V56, P37; Schwanninger M, 2004, VIB SPECTROSC, V36, P23, DOI 10.1016/j.vibspec.2004.02.003; Semenov SA, 1957, ARCHAEOLOGICAL MAT R, V54; Sharon G, 2010, QUATERN INT, V223, P226, DOI 10.1016/j.quaint.2009.11.023; Sharon G, 2009, CURR ANTHROPOL, V50, P335, DOI 10.1086/598849; Shillito LM, 2009, SPECTROCHIM ACTA A, V72, P120, DOI 10.1016/j.saa.2008.08.016; Shimelmitz R, 2014, QUAT INT IN PRESS; Solodenko N., 2010, THESIS TEL AVIV U; Stuart BH, 2000, VIB SPECTROSC, V24, P233, DOI 10.1016/S0924-2031(00)00097-7; TCHERNOV E, 1994, QUATERNARY RES, V42, P328, DOI 10.1006/qres.1994.1083; Tringham R., 1974, J FIELD ARCHAEOL, V1, P171, DOI 10.1179/jfa.1974.1.1-2.171; Vaculikova L., 2005, ACTA GEODYN GEOMATER, V2, P167; van Gijn AL, 1990, ANALECTA PREHISTORIC, P22; Wenban-Smith FF, 2006, J QUATERNARY SCI, V21, P471, DOI 10.1002/jqs.1033; Yravedra J, 2010, J ARCHAEOL SCI, V37, P2469, DOI 10.1016/j.jas.2010.05.007; Zaidner Y, 2003, ANTHROPOLOGIE, V107, P203, DOI 10.1016/S0003-5521(03)00010-4; Zaidner Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066851	86	76	76	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2015	10	3							e0118572	10.1371/journal.pone.0118572	http://dx.doi.org/10.1371/journal.pone.0118572			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Arts &amp; Humanities Citation Index (A&amp;HCI)	Science & Technology - Other Topics	CE9BN	25786123	Green Published, gold, Green Submitted			2022-12-27	WOS:000352138500038
J	Specht, IO; Bonde, JP; Toft, G; Lindh, CH; Jonsson, BAG; Jorgensen, KT				Specht, Ina Olmer; Bonde, Jens Peter; Toft, Gunnar; Lindh, Christian H.; Jonsson, Bo A. G.; Jorgensen, Kristian T.			Serum Phthalate Levels and Time to Pregnancy in Couples from Greenland, Poland and Ukraine	PLOS ONE			English	Article							EXPERT PANEL REPORT; DI(2-ETHYLHEXYL) PHTHALATE; BISPHENOL-A; SEMEN QUALITY; ORGANOCHLORINE PESTICIDES; POLYCHLORINATED-BIPHENYLS; DEVELOPMENTAL TOXICITY; REPRODUCTIVE HORMONES; TO-PREGNANCY; NTP CENTER	Phthalates are ubiquitous industrial chemicals that have been associated with altered reproductive function in rodents. Several human studies have reported an inverse association between male testosterone and phthalate levels. Our aim was to investigate time to pregnancy (TTP) according to serum levels of diethylhexyl phthalate (DEHP) and diisononyl phthalate (DiNP) metabolites in both partners. In 2002-2004 we enrolled 938 pregnant women and 401 male spouses from Greenland, Poland and Ukraine. Six oxidized metabolites of DEHP and DiNP were summarized for each of the two parent compounds to provide proxies of the internal exposure. We used Cox discrete-time models to estimate fecundability ratios (FR) and 95% confidence intervals (95% CIs) for men and women according to their proxy-DEHP or -DiNP serum levels adjusted for a fixed set of covariates. The FR was slightly elevated among women with high levels of DEHP (FR=1.14, 95% CI 1.00; 1.30) suggesting a shorter TTP in these women. The FR was unrelated to DiNP in women, whereas the results for men were inconsistent pointing in opposite directions. First-time pregnant women from Greenland with high serum DiNP levels had a longer TTP. This study spanning large contrast in environmental exposure does not indicate adverse effects of phthalates on couple fecundity. The shorter TTP in women with high levels of DEHP metabolites is unexplained and needs further investigation.	[Specht, Ina Olmer; Bonde, Jens Peter; Jorgensen, Kristian T.] Bispebjerg Hosp, Dept Occupat & Environm Med, Copenhagen NV, Denmark; [Toft, Gunnar] Aarhus Univ Hosp, Dept Occupat Med, Aarhus C, Denmark; [Lindh, Christian H.; Jonsson, Bo A. G.] Lund Univ, Div Occupat & Environm Med, Lund, Sweden	University of Copenhagen; Bispebjerg Hospital; Aarhus University; Lund University	Specht, IO (corresponding author), Bispebjerg Hosp, Dept Occupat & Environm Med, Copenhagen NV, Denmark.	ina.olmer.specht@regionh.dk		Toft, Gunnar/0000-0002-7542-6853; Lindh, Christian/0000-0001-7435-9890; Specht, Ina Olmer/0000-0002-3114-4715	European Commission [FP7-ENV-2008-1, 226217]; Danish Research Council [10-082745]; ReproHigh a Oresund-Kattegat-Skagerrak-Program - European Regional Development Fund	European Commission(European CommissionEuropean Commission Joint Research Centre); Danish Research Council(Det Frie Forskningsrad (DFF)); ReproHigh a Oresund-Kattegat-Skagerrak-Program - European Regional Development Fund	The study was part of the CLEAR Project: Climate, Environmental Contaminants and Reproductive Health (www.inuendo.dk/clear) supported by The European Commission 7th Framework Programme FP7-ENV-2008-1 Environment (including Climate Change) Grant no.: 226217; the Danish Research Council (10-082745), and ReproHigh a Oresund-Kattegat-Skagerrak-Program funded by the European Regional Development Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albert O, 2014, HUM REPROD UPDATE, V20, P231, DOI 10.1093/humupd/dmt050; Boberg J, 2011, REPROD TOXICOL, V31, P200, DOI 10.1016/j.reprotox.2010.11.001; Bonde JP, 2008, ENVIRON HEALTH PERSP, V116, P269, DOI 10.1289/ehp.10700; Bonde JP, 2006, EPIDEMIOLOGY, V17, P347, DOI 10.1097/01.ede.0000210239.80406.46; Braun JM, 2012, ENVIRON HEALTH PERSP, V120, P739, DOI 10.1289/ehp.1104139; Burdorf A, 2011, OCCUP ENVIRON MED, V68, P197, DOI 10.1136/oem.2009.046516; Calafat AM, 2013, BREAST CANCER RES, V15, DOI 10.1186/bcr3494; Chevrier C, 2013, EPIDEMIOLOGY, V24, P251, DOI 10.1097/EDE.0b013e31827f53ec; Cohn BA, 2003, LANCET, V361, P2205, DOI 10.1016/S0140-6736(03)13776-2; Duty SM, 2005, ENVIRON HEALTH PERSP, V113, P1530, DOI 10.1289/ehp.8083; Eskenazi B, 2010, EPIDEMIOLOGY, V21, P224, DOI 10.1097/EDE.0b013e3181cb8b95; Fromme H, 2007, INT J HYG ENVIR HEAL, V210, P21, DOI 10.1016/j.ijheh.2006.09.005; Gennings C, 2013, ENVIRON HEALTH-GLOB, V12, DOI 10.1186/1476-069X-12-66; Gupta RK, 2010, TOXICOL APPL PHARM, V242, P224, DOI 10.1016/j.taap.2009.10.011; Hauser R, 2004, ENVIRON HEALTH PERSP, V112, P1734, DOI 10.1289/ehp.7212; Hauser R, 2008, INT J ANDROL, V31, P112, DOI 10.1111/j.1365-2605.2007.00844.x; Heinze G, 2006, STAT MED, V25, P4216, DOI 10.1002/sim.2687; Hougaard KS, 2009, REPROD TOXICOL, V27, P186, DOI 10.1016/j.reprotox.2009.01.003; Huang LP, 2011, FERTIL STERIL, V96, P90, DOI 10.1016/j.fertnstert.2011.04.093; Inada H, 2012, J TOXICOL SCI, V37, P483; Jarfelt K, 2005, REPROD TOXICOL, V19, P505, DOI 10.1016/j.reprotox.2004.11.005; Joensen UN, 2012, ENVIRON HEALTH PERSP, V120, P1397, DOI 10.1289/ehp.1205113; Joffe M, 2005, AM J EPIDEMIOL, V162, P115, DOI 10.1093/aje/kwi172; Kavlock R, 2002, REPROD TOXICOL, V16, P529, DOI 10.1016/S0890-6238(02)00032-1; Kavlock R, 2002, REPROD TOXICOL, V16, P679, DOI 10.1016/S0890-6238(02)00034-5; Klinefelter GR, 2012, REPRODUCTION, V144, P747, DOI 10.1530/REP-12-0266; Kristensen SL, 2013, HUM REPROD, V28, P3337, DOI 10.1093/humrep/det382; Li XW, 2012, TOXICOL LETT, V215, P84, DOI 10.1016/j.toxlet.2012.10.001; Louis GMB, 2014, FERTIL STERIL, V101, P1359, DOI 10.1016/j.fertnstert.2014.01.022; Lubin JH, 2004, ENVIRON HEALTH PERSP, V112, P1691, DOI 10.1289/ehp.7199; Meeker JD, 2009, J ANDROL, V30, P287, DOI 10.2164/jandrol.108.006403; Mendiola J, 2011, INT J ANDROL, V34, P369, DOI 10.1111/j.1365-2605.2010.01095.x; Modigh CM, 2002, SCAND J WORK ENV HEA, V28, P418, DOI 10.5271/sjweh.694; Mutsaerts MAQ, 2012, HUM REPROD, V27, P583, DOI 10.1093/humrep/der429; OLSEN J, 1991, AM J EPIDEMIOL, V133, P734, DOI 10.1093/oxfordjournals.aje.a115948; Pan GW, 2006, ENVIRON HEALTH PERSP, V114, P1643, DOI 10.1289/ehp.9016; Park Moon-seo, 2010, J Prev Med Public Health, V43, P301, DOI 10.3961/jpmph.2010.43.4.301; ROCK G, 1986, ENVIRON HEALTH PERSP, V65, P309, DOI 10.2307/3430198; Snijder CA, 2012, HUM REPROD UPDATE, V18, P284, DOI 10.1093/humupd/dms005; Specht IO, 2014, ENVIRON INT, V66, P146, DOI 10.1016/j.envint.2014.02.002; Toft Gunnar, 2005, Environ Health, V4, P26, DOI 10.1186/1476-069X-4-26; Toshima H, 2012, INT J HYG ENVIR HEAL, V215, P502, DOI 10.1016/j.ijheh.2011.09.005; Vagi SJ, 2014, BMC ENDOCR DISORD, V14, DOI 10.1186/1472-6823-14-86; Vested A, 2013, ENVIRON HEALTH PERSP, V121, P453, DOI 10.1289/ehp.1205118; WEINBERG CR, 1994, STAT MED, V13, P671, DOI 10.1002/sim.4780130528; Wittassek M, 2007, INT J HYG ENVIR HEAL, V210, P319, DOI 10.1016/j.ijheh.2007.01.037	46	26	26	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2015	10	3							e0120070	10.1371/journal.pone.0120070	http://dx.doi.org/10.1371/journal.pone.0120070			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9BN	25786246	Green Submitted, Green Published, gold			2022-12-27	WOS:000352138500153
J	Tezuka, T; Ogawa, H; Azuma, M; Goto, H; Uehara, H; Aono, Y; Hanibuchi, M; Yamaguchi, Y; Fujikawa, T; Itai, A; Nishioka, Y				Tezuka, Toshifumi; Ogawa, Hirohisa; Azuma, Masahiko; Goto, Hisatsugu; Uehara, Hisanori; Aono, Yoshinori; Hanibuchi, Masaki; Yamaguchi, Yoichi; Fujikawa, Tomoyuki; Itai, Akiko; Nishioka, Yasuhiko			IMD-4690, a Novel Specific Inhibitor for Plasminogen Activator Inhibitor-1, Reduces Allergic Airway Remodeling in a Mouse Model of Chronic Asthma via Regulating Angiogenesis and Remodeling-Related Mediators	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; KINASE-BETA INHIBITOR; MURINE MODEL; PAI-1; INFLAMMATION; MICE; CELLS; LUNG; UPA; HYPERRESPONSIVENESS	Plasminogen activator inhibitor (PAI)-1 is the principal inhibitor of plasminogen activators, and is responsible for the degradation of fibrin and extracellular matrix. IMD-4690 is a newly synthesized inhibitor for PAI-1, whereas the effect on allergic airway inflammation and remodeling is still unclear. We examined the in vivo effects by using a chronic allergen exposure model of bronchial asthma in mice. The model was generated by an immune challenge for 8 weeks with house dust mite antigen, Dermatophagoides pteronyssinus (Dp). IMD-4690 was intraperitoneally administered during the challenge. Lung histopathology, hyper-responsiveness and the concentrations of mediators in lung homogenates were analyzed. The amount of active PAI-1 in the lungs was increased in mice treated with Dp. Administration with IMD-4690 reduced an active/total PAI-1 ratio. IMD-4690 also reduced the number of bronchial eosinophils in accordance with the decreased expressions of Th2 cytokines in the lung homogenates. Airway remodeling was inhibited by reducing subepithelial collagen deposition, smooth muscle hypertrophy, and angiogenesis. The effects of IMD-4690 were partly mediated by the regulation of TGF-beta, HGF and matrix metalloproteinase. These results suggest that PAI-1 plays crucial roles in airway inflammation and remodeling, and IMD-4690, a specific PAI-1 inhibitor, may have therapeutic potential for patients with refractory asthma due to airway remodeling.	[Tezuka, Toshifumi; Azuma, Masahiko; Goto, Hisatsugu; Aono, Yoshinori; Hanibuchi, Masaki; Nishioka, Yasuhiko] Univ Tokushima, Inst Hlth Biosci, Grad Sch, Dept Resp Med & Rheumatol, Tokushima 770, Japan; [Ogawa, Hirohisa; Uehara, Hisanori] Univ Tokushima, Dept Mol & Environm Pathol, Inst Hlth Biosci, Grad Sch, Tokushima 770, Japan; [Yamaguchi, Yoichi; Fujikawa, Tomoyuki; Itai, Akiko] Inst Med Mol Design Inc, Tokyo, Japan	Tokushima University; Tokushima University	Nishioka, Y (corresponding author), Univ Tokushima, Inst Hlth Biosci, Grad Sch, Dept Resp Med & Rheumatol, Tokushima 770, Japan.	yasuhiko@tokushima-u.ac.jp			Institute of Medicinal Molecular Design, Inc.; Grants-in-Aid for Scientific Research [24591167] Funding Source: KAKEN	Institute of Medicinal Molecular Design, Inc.; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	Institute of Medicinal Molecular Design, Inc. provided support in the form of salaries for authors YY, TF, and AI, but did not have any additional role in the study design, data collection and analysis (except for Fig. 1B), decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the author contributions section with a slight modification.	Bajou K, 2001, J CELL BIOL, V152, P777, DOI 10.1083/jcb.152.4.777; Bajou K, 1998, NAT MED, V4, P923, DOI 10.1038/nm0898-923; Bosse Y, 2006, AM J RESP CELL MOL, V34, P746, DOI 10.1165/rcmb.2005-0309OC; Cesari M, 2010, CARDIOVASC THER, V28, pe72, DOI 10.1111/j.1755-5922.2010.00171.x; Chen G, 2006, RESP RES, V7, DOI 10.1186/1465-9921-7-2; Cho S, 2011, ANN ALLERG ASTHMA IM, V106, P371, DOI 10.1016/j.anai.2010.12.021; Cho SH, 2004, EXP BIOL MED, V229, P138, DOI 10.1177/153537020422900202; Cho SH, 2000, J IMMUNOL, V165, P3154, DOI 10.4049/jimmunol.165.6.3154; DENG G, 1995, THROMB HAEMOSTASIS, V74, P66; Durrani SR, 2011, J ALLERGY CLIN IMMUN, V128, P439, DOI 10.1016/j.jaci.2011.06.002; Gutierrez LS, 2000, CANCER RES, V60, P5839; Holgate ST, 2001, INT ARCH ALLERGY IMM, V124, P253, DOI 10.1159/000053726; Inayama M, 2006, AM J RESP CRIT CARE, V173, P1016, DOI 10.1164/rccm.200506-947OC; Ito W, 2005, AM J RESP CELL MOL, V32, P268, DOI 10.1165/rcmb.2004-0058OC; Kowal K, 2010, FOLIA HISTOCHEM CYTO, V48, P518, DOI 10.2478/v10042-010-0075-2; Kuramoto E, 2009, AM J PHYSIOL-LUNG C, V296, pL337, DOI 10.1152/ajplung.90434.2008; Lee CG, 2004, NAT MED, V10, P1095, DOI 10.1038/nm1105; Lee KS, 2008, EUR RESPIR J, V31, P523, DOI 10.1183/09031936.00125007; Lee SH, 2012, AM J RESP CELL MOL, V46, P842, DOI 10.1165/rcmb.2011-0369OC; Lee YC, 2002, J IMMUNOL, V168, P3595, DOI 10.4049/jimmunol.168.7.3595; LINDAHL TL, 1989, THROMB HAEMOSTASIS, V62, P748; Ma Z, 2009, CLIN EXP ALLERGY, V39, P1136, DOI 10.1111/j.1365-2222.2009.03272.x; MARS WM, 1993, AM J PATHOL, V143, P949; Mautino G, 1997, AM J RESP CELL MOL, V17, P583, DOI 10.1165/ajrcmb.17.5.2562; Miyamoto S, 2011, AM J PHYSIOL-LUNG C, V301, pL908, DOI 10.1152/ajplung.00115.2011; Mura M, 2004, J APPL PHYSIOL, V97, P1605, DOI 10.1152/japplphysiol.00202.2004; Nishioka Y, 1997, INT J CANCER, V71, P170; Oh CK, 2002, BIOCHEM BIOPH RES CO, V294, P1155, DOI 10.1016/S0006-291X(02)00577-6; Okunishi K, 2005, J IMMUNOL, V175, P4745, DOI 10.4049/jimmunol.175.7.4745; Pappot H, 2006, LUNG CANCER, V51, P193, DOI 10.1016/j.lungcan.2005.10.002; Ribatti D, 2009, CLIN EXP ALLERGY, V39, P1815, DOI 10.1111/j.1365-2222.2009.03385.x; Sejima T, 2005, J IMMUNOL, V174, P8135, DOI 10.4049/jimmunol.174.12.8135; Sillalber C, 1999, J IMMUNOL, V162, P1032; Sugita A, 2009, INT ARCH ALLERGY IMM, V148, P186, DOI 10.1159/000161579; Tagaya Etsuko, 2007, Allergol Int, V56, P331; Wakugawa M, 2001, J DERMATOL SCI, V25, P116, DOI 10.1016/S0923-1811(00)00118-3; Wen FQ, 2003, J ALLERGY CLIN IMMUN, V111, P1307, DOI 10.1067/mai.2003.1455; [No title captured]	38	9	10	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2015	10	3							e0121615	10.1371/journal.pone.0121615	http://dx.doi.org/10.1371/journal.pone.0121615			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9BN	25785861	Green Published, gold, Green Submitted			2022-12-27	WOS:000352138500213
J	Vermeulen, E; Brager, S				Vermeulen, Els; Braeger, Stefan			Demographics of the Disappearing Bottlenose Dolphin in Argentina: A Common Species on Its Way Out?	PLOS ONE			English	Article							TURSIOPS-TRUNCATUS; CAPTURE-RECAPTURE; TEMPORARY EMIGRATION; SMALL CETACEANS; SITE FIDELITY; HEAVY-METALS; GROUP-SIZE; REPRODUCTIVE SUCCESS; POPULATION-STRUCTURE; RELATIVE ABUNDANCE	Populations of the once common bottlenose dolphin (Tursiops truncatus) in Argentina have precipitously declined throughout the country in the past decades. Unfortunately, local declines of common species are easily overlooked when establishing priorities for conservation. In this study, demographics of what may well be the last remaining resident population in the country were assessed using mark-recapture analysis (Pollock's Robust Design) of a photo-identification dataset collected during 2006-2011 in Bahia San Antonio (Patagonia, Argentina). Total abundance, corrected for unmarked individuals, ranged from 40 (95% CI: 16.1-98.8) to 83 (95% CI = 45.8-151.8) individuals and showed a decrease over the years. Adult survival rates varied between 0.97 (+/- 0.037 SE) and 0.99 (+/- 0.010 SE). Average calving interval equalled 3.5 +/- 1.03 years, with 3.5 births/year in the entire population and a minimum annual birth rate of 4.2%. However, data suggest that calves may have been born and lost before being documented, underestimating birth rate, calf mortality, and possibly the number of reproductive females. Either way, the recruitment rate of calves appears to be insufficient to support the size of the population. This population is relatively small and declining. Considering the disappearance of populations north and south of the study area, an incessant decline will have severe consequences for the continuous existence of this species in Argentina, indicating an urgent need for serious conservation efforts. This study provides insight into how the failure to recognize local population declines can threaten the national (and eventually the international) status of a common species like the bottlenose dolphin.	[Vermeulen, Els] Univ Liege, Lab Oceanol, MARE Res Ctr, Liege, Belgium; [Braeger, Stefan] Int Seabed Author, Kingston, Jamaica	University of Liege	Vermeulen, E (corresponding author), Univ Liege, Lab Oceanol, MARE Res Ctr, Liege, Belgium.	elsvermeulen5@gmail.com	Vermeulen, Els/AAW-2716-2020	Vermeulen, Els/0000-0002-3667-1290	Cetacean Society International; Trigon N.V.; Marybio Foundation	Cetacean Society International; Trigon N.V.; Marybio Foundation	The funding received for this research was very limited because there was no PhD scholarship available for the corresponding author. Most funds came from investments of personal money. Received funds came from the following organisations: 1. Cetacean Society International (www.csiwhalesalive.com): US$3,000 was given for the completion of fieldwork in 2007 and 2008. No specific grant number is available. 2. Trigon N.V. (www.trigon.be): This software company contributed to the project by donating portable computers and hard drives. 3. Marybio Foundation (www.marybio.org): The Marybio foundation was the NGO the corresponding author created and directed over the course of the study period. With this NGO, the corresponding author was able to receive the above-mentioned funds, gather membership fees, and receive students who contributed to the project with work and funds (for their dissertation research) from their respective universities. The funders of this research had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen SJ, 2013, P 20 BIENN C BIOL MA; ANDERSON DR, 1994, ECOLOGY, V75, P1780, DOI 10.2307/1939637; Ansmann IC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065239; Baines ME, 2002, P 16 ANN C EUR CET S; Barragan-Barrera DC, 2013, SC65ASM15 IWC; Bastida R., 2003, MAMIFEROS MARINOS PA; Bearzi G, 2005, AQUAT CONSERV, V15, P243, DOI 10.1002/aqc.667; Bearzi G, 2004, AQUAT CONSERV, V14, P363, DOI 10.1002/aqc.626; Bearzi G, 2008, AQUAT CONSERV, V18, P130, DOI 10.1002/aqc.843; Bejder L, 2006, CONSERV BIOL, V20, P1791, DOI 10.1111/j.1523-1739.2006.00540.x; Berghan J, 2008, NEW ZEAL J MAR FRESH, V42, P465, DOI 10.1080/00288330809509974; Birkun A, 2002, CETACEANS MEDITERRAN; Birkun A.A. Jr, 2004, P64; Bonuccelli R, 2004, IBPM SERIE PUBLICACI, V3, P63; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Burnham KP, 1987, AM FISHERIES SOC MON; Campbell Gregory S., 2002, Aquatic Mammals, V28, P170; Casey JM, 1998, SCIENCE, V281, P690, DOI 10.1126/science.281.5377.690; Cauhepe M.E., 1999, MANAGEMENT ARGENTINE; Claps EL., 2005, MINES COMMUNITIE OCT; Cockcroft V.G., 1990, P295; COCKCROFT VG, 1990, S AFR J MARINE SCI, V9, P1; Coscarella MA, 2012, J MAR BIOL ASSOC UK, V92, P1843, DOI 10.1017/S0025315411001901; Currey RJC, 2009, BIOL CONSERV, V142, P1570, DOI 10.1016/j.biocon.2009.02.036; Currey RJC, 2009, AQUAT CONSERV, V19, P658, DOI 10.1002/aqc.1015; Currey RJC, 2008, NEW ZEAL J MAR FRESH, V42, P439, DOI 10.1080/00288330809509972; Currey Rohan J. C., 2007, Pacific Conservation Biology, V13, P274; Daura-Jorge FG, 2013, MAR MAMMAL SCI, V29, P293, DOI 10.1111/j.1748-7692.2012.00571.x; Doyle J, 2007, P 21 ANN C EUR CET S; Englund A., 2007, POPULATION STATUS RE; Evans PGH, 2003, UK CETACEAN STATUS R; Felix F., 1994, ECOLOGY, V25, P235; Fernandez R, 2011, HYDROBIOLOGIA, V670, P111, DOI 10.1007/s10750-011-0669-5; Frodello JP, 2002, MAR POLLUT BULL, V44, P551, DOI 10.1016/S0025-326X(02)00067-X; Fruet PF, 2014, CONSERV GENET, V15, P879, DOI 10.1007/s10592-014-0586-z; Fruet PF, 2011, ZOOLOGIA-CURITIBA, V28, P23, DOI 10.1590/S1984-46702011000100004; Fruet PF, 2012, J MAR BIOL ASSOC UK, V92, P1865, DOI 10.1017/S0025315410001888; Fury CA, 2011, ESTUAR COAST SHELF S, V93, P389, DOI 10.1016/j.ecss.2011.05.003; Gaspar R., 2003, THESIS ST ANDREWS U; Genov Tilen, 2008, Annales Series Historia Naturalis, V18, P227; Gil MN, 1999, B ENVIRON CONTAM TOX, V63, P52, DOI 10.1007/s001289900947; Gil Mónica N, 2006, Rev. biol. mar. oceanogr., V41, P167; Gilpin M, 1996, CONSERV BIOL, V10, P1491, DOI 10.1046/j.1523-1739.1996.10061491.x; Gonzalez J., 1989, ESTUDIOS OCEANOL, V8, P67; Grellier K, 2003, CAN J ZOOL, V81, P1421, DOI 10.1139/Z03-132; Grellier K, 1995, MANAGEMENT RECOMMEND; Grellier Kate, 2003, Aquatic Mammals, V29, P378, DOI 10.1578/01675420360736550; Haase PA, 2001, NEW ZEAL J MAR FRESH, V35, P675, DOI 10.1080/00288330.2001.9517034; Hammond PS, IUCN 2012 IUCN RES L; HARRIS R B, 1987, Conservation Biology, V1, P72, DOI 10.1111/j.1523-1739.1987.tb00011.x; Ingram S, 1999, EUROPEAN RES CETACEA, V13, P328; IRVINE AB, 1981, FISH B-NOAA, V79, P671; *IUCN, IUCN RED LIST CAT CR; Kendall WL, 1997, ECOLOGY, V78, P563; KENDALL WL, 1995, BIOMETRICS, V51, P293, DOI 10.2307/2533335; Kendall WL, 1995, J APPL STAT, V22, P751, DOI 10.1080/02664769524595; Kerr KA, 2005, CARIBB J SCI, V41, P172; Kogi K, 2004, MAR MAMMAL SCI, V20, P510, DOI 10.1111/j.1748-7692.2004.tb01176.x; La Manna G, 2013, AQUAT CONSERV, V23, P745, DOI 10.1002/aqc.2355; Lahaye V, 2001, EUROPEAN RES CETACEA, V14, P335; Laporta P, 2008, THESIS U FEDERAL RIO; Lauriano G., 2004, Journal of Cetacean Research and Management, V6, P165; LEBRETON JD, 1992, ECOL MONOGR, V62, P67, DOI 10.2307/2937171; Lemos LS, 2013, ECOTOX ENVIRON SAFE, V97, P166, DOI 10.1016/j.ecoenv.2013.07.025; Lodi Liliane, 2012, Biotemas, V25, P157; Lopez A, 2004, J MAR BIOL ASSOC UK, V84, P283; Lopez A., 2003, THESIS U SANTIAGO CO; Lopez-Hernandez I, 1997, THESIS U NACL AUTONO, DOI [10.1016/j.watres.2013.08.031, DOI 10.1016/J.WATRES.2013.08.031]; Lusseau D., 2006, Tourism in Marine Environments, V3, P173, DOI 10.3727/154427306779435184; Lusseau D, 2006, J ANIM ECOL, V75, P14, DOI 10.1111/j.1365-2656.2005.01013.x; Mann J, 2005, ANIM BEHAV, V69, P899, DOI 10.1016/j.anbehav.2004.04.024; Mann J, 2000, BEHAV ECOL, V11, P210, DOI 10.1093/beheco/11.2.210; Mann J, 1999, BEHAVIOUR, V136, P529, DOI 10.1163/156853999501469; Mansur RM, 2012, MAR MAMMAL SCI, V28, P561, DOI 10.1111/j.1748-7692.2011.00520.x; MARCOVECCHIO JE, 1990, MAR POLLUT BULL, V21, P299, DOI 10.1016/0025-326X(90)90595-Y; MARCOVECCHIO JE, 1994, SCI TOTAL ENVIRON, V154, P141, DOI 10.1016/0048-9697(94)90084-1; Merriman MG, 2007, THESIS MASSEY U NZ; Miller PS., 2005, VORTEX STOCHASTIC SI; Moeller L. M., 2002, Australian Mammalogy, V24, P11; Natoli A, 2008, CONSERV GENET, V9, P627, DOI 10.1007/s10592-007-9379-y; Nicholson K, 2012, MAR FRESHWATER RES, V63, P1059, DOI 10.1071/MF12210; OTIS DL, 1978, WILDLIFE MONOGR, P1; Oviedo L, 2005, REV BIOL TROP, V53, P595; Pace D.S., 1999, European Research on Cetaceans, V12, P165; Parsons KM, 2002, BIOL CONSERV, V108, P175, DOI 10.1016/S0006-3207(02)00103-9; Peddemors V. M., 1999, Journal of Cetacean Research and Management, V1, P157; Pereira A, 2013, AFR J MAR SCI, V35, P501, DOI 10.2989/1814232X.2013.850444; Pikesley SK, 2012, J MAR BIOL ASSOC UK, V92, P1809, DOI 10.1017/S0025315411000464; Pleslic G, 2015, AQUAT CONSERV, V25, P125, DOI 10.1002/aqc.2416; POLLOCK KH, 1990, WILDLIFE MONOGR, P1; POLLOCK KH, 1982, J WILDLIFE MANAGE, V46, P752, DOI 10.2307/3808568; Pulcini M, 2013, J MAR BIOL ASSOC UK, P1; Rako N, 2013, MAR POLLUT BULL, V68, P77, DOI 10.1016/j.marpolbul.2012.12.019; READ AJ, 1993, J ZOOL, V231, P107, DOI 10.1111/j.1469-7998.1993.tb05356.x; Reid J.B., 2003, ATLAS CETACEAN DISTR; Rogan E, 2000, MARINE RESOURCE SERI, V9, P48; Rojas-Bracho L, 1999, MAR MAMMAL SCI, V15, P974, DOI 10.1111/j.1748-7692.1999.tb00873.x; Rojas-Bracho L, 2013, ENDANGER SPECIES RES, V21, P77, DOI 10.3354/esr00501; Ryan GE, 2011, ECOSPHERE, V2, DOI 10.1890/ES10-00171.1; Sanders-Reed CA, 1999, 156 SCOTT NAT HER; SANINO G.P., 2000, REVISTA GESTION AMBI, V6, P41; Sanino GP, 2008, SC60SM18 IWC; Scheinin A, 2005, P 16 BIENN C BIOL MA; Scott M.D., 1990, P235; Shane SH, 1990, BOTTLENOSE DOLPHIN, P653; Silva CA, 2008, THESIS U LISBOA PORT, DOI [10.1503/cmaj.081050, DOI 10.1503/CMAJ.081050]; Silva MA, 2009, MAR ECOL PROG SER, V392, P263, DOI 10.3354/meps08233; Simoes-Lopes PC, 2008, PARCEIROS SOBREVIVEN, V52; Smith H., 2012, THESIS MURDOCH U AUS; Stanton MA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047508; Steckenreuter A, 2012, J ENVIRON MANAGE, V97, P14, DOI 10.1016/j.jenvman.2011.11.002; Stensland E, 2006, MAR MAMMAL SCI, V22, P667, DOI 10.1111/j.1748-7692.2006.00051.x; Stolen MK, 2003, MAR MAMMAL SCI, V19, P630, DOI 10.1111/j.1748-7692.2003.tb01121.x; Sutherland W., 2000, CONSERVATION HDB RES; Tezanos-Pinto G, 2013, POPULATION VIABILITY; Tezanos-Pinto G, 2013, MAR MAMMAL SCI, V29, pE390, DOI 10.1111/mms.12008; Thompson PM, 2000, CONSERV BIOL, V14, P1253, DOI 10.1046/j.1523-1739.2000.00099-410.x; Valdes-Arellanes MP, 2011, REV MEX BIODIVERS, P82; Van Waerebeek K, 2008, 9 FDN INT BANC ARG; VanWaerebeek K, 1997, BIOL CONSERV, V81, P43, DOI 10.1016/S0006-3207(96)00152-8; Vazquez NN, 2007, B ENVIRON CONTAM TOX, V79, P121, DOI 10.1007/s00128-007-9084-z; Vermeulen Els, 2009, Aquatic Mammals, V35, P378, DOI 10.1578/AM.35.3.2009.378; Vidal ML, 2004, IBMP SERIE PUBLICACI, V3, P67; Vos J. G, 2003, TOXICOLOGY MARINE MA; Wells R.S., 1990, Reports of the International Whaling Commission Special Issue, P407; Wells R.S., 1987, Current Mammalogy, V1, P247; Wells R.S., 2004, ECOHEALTH, V1, P246, DOI [10.1007/s10393-004-0094-6, DOI 10.1007/S10393-004-0094-6]; Wells RS, 2005, SCI TOTAL ENVIRON, V349, P106, DOI 10.1016/j.scitotenv.2005.01.010; Wells RS, 1999, HDB MARINE MAMMALS S, P1; White GC, 1999, BIRD STUDY, V46, P120, DOI 10.1080/00063659909477239; Williams B. K., 2002, ANAL MANAGEMENT ANIM; WILLIAMS JA, 1993, CAN J ZOOL, V71, P2080, DOI 10.1139/z93-293; Wilson B, 1999, ECOL APPL, V9, P288, DOI 10.1890/1051-0761(1999)009[0288:ESAATI]2.0.CO;2; WILSON B, 1995, THESIS U ABERDEEN SC; Wood CJ, 1998, J ZOOL, V246, P155, DOI 10.1017/S0952836998010048; WURSIG B, 1977, SCIENCE, V198, P755, DOI 10.1126/science.198.4318.755; Wursig B., 1990, Reports of the International Whaling Commission Special Issue, P43; Yoshizaki J, 2009, ECOLOGY, V90, P3, DOI 10.1890/08-0304.1; Zappes CA, 2013, OCEAN COAST MANAGE, V85, P46, DOI 10.1016/j.ocecoaman.2013.09.004	140	27	28	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2015	10	3							e0119182	10.1371/journal.pone.0119182	http://dx.doi.org/10.1371/journal.pone.0119182			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9BN	25786234	gold, Green Published, Green Submitted			2022-12-27	WOS:000352138500080
J	Wong, CW; Liao, JM; Cheung, GC; Khor, CC; Vithana, EN; Wang, JJ; Mitchell, P; Aung, T; Wong, TY; Cheng, CY				Wong, Chee Wai; Liao, Jiemin; Cheung, Gemmy C.; Khor, Chiea Chuen; Vithana, Eranga N.; Wang, Jie Jin; Mitchell, Paul; Aung, Tin; Wong, Tien Y.; Cheng, Ching-Yu			Lens Status Influences the Association between CFH Polymorphisms and Age-Related Macular Degeneration: Findings from Two Population-Based Studies in Singapore	PLOS ONE			English	Article							COMPLEMENT FACTOR-H; BLUE MOUNTAINS EYE; BEAVER DAM EYE; INTRAOCULAR LENSES; CATARACT-SURGERY; RISK-FACTORS; POOLED FINDINGS; MALAY EYE; MACULOPATHY; SUSCEPTIBILITY	Aims To determine the differential effects of genetic polymorphism in CFH and ARMS2 on risk of age-related macular degeneration (AMD) between phakic vs. pseudophakic/aphakic eyes. Methods 9,529 eyes of 4,918 participants from the Singapore Malay Eye Study and Singapore Indian Eye Study were analyzed. Participants had detailed eye examinations, including slit-lamp examinations and dilated fundus photography. AMD grading was performed according to the Wisconsin age-related maculopathy grading system. Lens status was defined. Single nucleotide polymorphisms (SNPs) rs10801555 (Y402H) within CFH and rs3750847 in ARMS2 were assessed. The main outcome measure was early AMD or any AMD. Results No significant associations between the CFH Y402H genotypes and early AMD were found in phakic individuals. In contrast, among pseudophakic/aphakic individuals, the CFH Y402H risk genotypes were significantly associated with higher odds of early AMD, with an OR of 1.57 (95% CI: 1.07-2.29) for GA genotype and 2.40 (95% CI: 1.25-4.61) for AA genotype, compared to those with GG genotype. There was significant interaction between pseudophakic/aphakic status and CFH Y402H variant on risk of early AMD (p = 0.037), adjusting for age, gender, and the first 5 genetic principal components. No significant interaction was found between lens status and ARMS2 rs3750847. Conclusions CFH genetic polymorphism and pseudophakic/aphakic status may have a potential synergistic effect on early AMD, suggesting roles for the complement system and related pathways in the pathogenesis of AMD in eyes after cataract surgery.	[Wong, Chee Wai; Liao, Jiemin; Cheung, Gemmy C.; Vithana, Eranga N.; Aung, Tin; Wong, Tien Y.; Cheng, Ching-Yu] Singapore Natl Eye Ctr, Singapore Eye Res Inst, Singapore, Singapore; [Liao, Jiemin; Aung, Tin; Wong, Tien Y.; Cheng, Ching-Yu] Natl Univ Singapore, Dept Ophthalmol, Singapore 117548, Singapore; [Liao, Jiemin; Aung, Tin; Wong, Tien Y.; Cheng, Ching-Yu] Natl Univ Hlth Syst, Singapore, Singapore; [Cheung, Gemmy C.; Vithana, Eranga N.; Wong, Tien Y.; Cheng, Ching-Yu] Duke NUS Grad Med Sch, Singapore, Singapore; [Khor, Chiea Chuen] Genome Inst Singapore, Div Human Genet, Singapore, Singapore; [Wang, Jie Jin; Mitchell, Paul] Univ Sydney, Westmead Millennium Inst, Dept Ophthalmol, Ctr Vis Res, Sydney, NSW 2006, Australia	National University of Singapore; Singapore National Eye Center; National University of Singapore; National University of Singapore; National University of Singapore; Agency for Science Technology & Research (A*STAR); A*STAR - Genome Institute of Singapore (GIS); University of Sydney; Westmead Institute for Medical Research	Cheng, CY (corresponding author), Singapore Natl Eye Ctr, Singapore Eye Res Inst, Singapore, Singapore.	chingyu.cheng@duke-nus.edu.sg	Wong, Tien Yin/AAC-9724-2020; Mitchell, Paul/P-1498-2014; Wang, Jie Jin/P-1499-2014; wang, jie/GRS-0942-2022; Cheng, Ching-Yu/Y-2229-2019	Wong, Tien Yin/0000-0002-8448-1264; Wang, Jie Jin/0000-0001-9491-4898; Cheng, Ching-Yu/0000-0003-0655-885X; Khor, Chiea Chuen/0000-0002-1128-4729; Cheung, Chui Ming Gemmy/0000-0003-3358-3516	American Health Assistance Foundation [M2011068]; National Medical Research Council, Singapore [NMRC 0976/2003, STaR/0003/2008, CSA/033/2012, CG/SERI/2010]; Biomedical Research Council, Singapore [BMRC 09/1/35/19/616, 08/1/35/19/550]; NMRC [CSA/033/2012]	American Health Assistance Foundation; National Medical Research Council, Singapore(National Medical Research Council, SingaporeUK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biomedical Research Council, Singapore(Agency for Science Technology & Research (A*STAR)); NMRC(National Medical Research Council, Singapore)	Supported by funding from the American Health Assistance Foundation (M2011068), and grants from the National Medical Research Council, Singapore (NMRC 0976/2003, STaR/0003/2008, CSA/033/2012, CG/SERI/2010), and the Biomedical Research Council, Singapore (BMRC 09/1/35/19/616 and 08/1/35/19/550). Ching-Yu Cheng is supported by an award from NMRC (CSA/033/2012). The Singapore Tissue Network and the Genome Institute of Singapore, Agency for Science, Technology and Research, Singapore provided services for tissue archival and genotyping, respectively. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abela-Formanek C, 2002, J CATARACT REFR SURG, V28, P50, DOI 10.1016/S0886-3350(01)01122-1; Algvere PV, 2006, ACTA OPHTHALMOL SCAN, V84, P4, DOI 10.1111/j.1600-0420.2005.00627.x; Barbour W, 2005, OPHTHAL RES, V37, P255, DOI 10.1159/000087100; BOULTON M, 1993, J PHOTOCH PHOTOBIO B, V19, P201, DOI 10.1016/1011-1344(93)87085-2; Bron AJ, 2000, OPHTHALMOLOGICA, V214, P86, DOI 10.1159/000027475; Buch H, 2005, OPHTHALMOLOGY, V112, P787, DOI 10.1016/j.ophtha.2004.11.040; Chakravarthy U, 2010, BMC OPHTHALMOL, V10, DOI 10.1186/1471-2415-10-31; Cheung CMG, 2012, ARCH OPHTHALMOL-CHIC, V130, P480, DOI 10.1001/archophthalmol.2011.376; Clark SJ, 2010, BIOCHEM SOC T, V38, P1342, DOI 10.1042/BST0381342; Cugati S, 2006, OPHTHALMOLOGY, V113, P2020, DOI 10.1016/j.ophtha.2006.05.047; DeAngelis MM, 2011, SEMIN OPHTHALMOL, V26, P77, DOI 10.3109/08820538.2011.577129; Edwards AO, 2005, SCIENCE, V308, P421, DOI 10.1126/science.1110189; Edwards KH, 2010, CLIN EXP OPTOM, V93, P390, DOI 10.1111/j.1444-0938.2010.00538.x; Foong AWP, 2007, OPHTHAL EPIDEMIOL, V14, P25, DOI 10.1080/09286580600878844; Fritsche LG, 2013, NAT GENET; GAILLARD ER, 1995, PHOTOCHEM PHOTOBIOL, V61, P448, DOI 10.1111/j.1751-1097.1995.tb02343.x; Gemmy Cheung CM, 2012, AM J OPHTHALMOL; Gold G, 2003, AM J MED GENET B, V119B, P44, DOI 10.1002/ajmg.b.10010; Haines JL, 2005, SCIENCE, V308, P419, DOI 10.1126/science.1110359; Ho L, 2008, INVEST OPHTH VIS SCI, V49, P4795, DOI 10.1167/iovs.08-2066; Hollick EJ, 1998, J CATARACT REFR SURG, V24, P361, DOI 10.1016/S0886-3350(98)80324-6; Holliday EG, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0082305, 10.1371/journal.pone.0053830]; Hunter JJ, 2012, PROG RETIN EYE RES, V31, P28, DOI 10.1016/j.preteyeres.2011.11.001; Jakobsdottir J, 2005, AM J HUM GENET, V77, P389, DOI 10.1086/444437; Jonasson F, 2011, OPHTHALMOLOGY, V118, P825, DOI 10.1016/j.ophtha.2010.08.044; Kanda A, 2007, P NATL ACAD SCI USA, V104, P16227, DOI 10.1073/pnas.0703933104; Kawasaki R, 2008, OPHTHALMOLOGY, V115, P1735, DOI 10.1016/j.ophtha.2008.02.012; KLEIN R, 1992, OPHTHALMOLOGY, V99, P933; Klein R, 2002, ARCH OPHTHALMOL-CHIC, V120, P1551, DOI 10.1001/archopht.120.11.1551; KLEIN R, 1991, OPHTHALMOLOGY, V98, P1128; Klein RJ, 2005, SCIENCE, V308, P385, DOI 10.1126/science.1109557; Lavanya R, 2009, OPHTHAL EPIDEMIOL, V16, P325, DOI 10.3109/09286580903144738; Levey AS, 2009, ANN INTERN MED, V150, P604, DOI 10.7326/0003-4819-150-9-200905050-00006; Lim LS, 2012, LANCET, V379, P1728, DOI 10.1016/S0140-6736(12)60282-7; MITCHELL P, 1995, OPHTHALMOLOGY, V102, P1450; Nakata I, 2012, INVEST OPHTH VIS SCI, V53, P6576, DOI 10.1167/iovs.12-10219; Pan W, 2001, BIOMETRICS, V57, P120, DOI 10.1111/j.0006-341X.2001.00120.x; Pokidysheva EN, 2001, ARTIF ORGANS, V25, P453, DOI 10.1046/j.1525-1594.2001.025006453.x; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Rivera A, 2005, HUM MOL GENET, V14, P3227, DOI 10.1093/hmg/ddi353; Seddon JM, 2007, JAMA-J AM MED ASSOC, V297, P1793, DOI 10.1001/jama.297.16.1793; Smith W, 2001, OPHTHALMOLOGY, V108, P697, DOI 10.1016/S0161-6420(00)00580-7; Sobrin L, 2011, AM J OPHTHALMOL, V151, P345, DOI 10.1016/j.ajo.2010.08.015; Ufret-Vincenty RL, 2010, INVEST OPHTH VIS SCI, V51, P5878, DOI 10.1167/iovs.09-4457; Wang JJ, 2003, OPHTHALMOLOGY, V110, P1960, DOI 10.1016/S0161-6420(03)00816-9; WENZEL M, 1988, GRAEF ARCH CLIN EXP, V226, P449, DOI 10.1007/BF02170007; Werner L, 2008, CURR OPIN OPHTHALMOL, V19, P41, DOI 10.1097/ICU.0b013e3282f20132; Xu L, 2011, GRAEF ARCH CLIN EXP, V249, P981, DOI 10.1007/s00417-010-1571-y; Xu YT, 2012, INT J OPHTHALMOL-CHI, V5, P125, DOI 10.3980/j.issn.2222-3959.2012.02.02	49	3	3	4	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2015	10	3							e0119570	10.1371/journal.pone.0119570	http://dx.doi.org/10.1371/journal.pone.0119570			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9BN	25786237	Green Submitted, Green Published, gold			2022-12-27	WOS:000352138500113
J	Gounder, K; Padayachi, N; Mann, JK; Radebe, M; Mokgoro, M; van der Stok, M; Mkhize, L; Mncube, Z; Jaggernath, M; Reddy, T; Walker, BD; Ndung'u, T				Gounder, Kamini; Padayachi, Nagavelli; Mann, Jaclyn K.; Radebe, Mopo; Mokgoro, Mammekwa; van der Stok, Mary; Mkhize, Lungile; Mncube, Zenele; Jaggernath, Manjeetha; Reddy, Tarylee; Walker, Bruce D.; Ndung'u, Thumbi			High Frequency of Transmitted HIV-1 Gag HLA Class I-Driven Immune Escape Variants but Minimal Immune Selection over the First Year of Clade C Infection	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; T-CELL RESPONSES; VIRAL LOAD; LYMPHOCYTE ESCAPE; REPLICATION CAPACITY; MALE CIRCUMCISION; P24 GAG; SUBTYPE; MUTATIONS; EVOLUTION	In chronic HIV infection, CD8+ T cell responses to Gag are associated with lower viral loads, but longitudinal studies of HLA-restricted CD8+ T cell-driven selection pressure in Gag from the time of acute infection are limited. In this study we examined Gag sequence evolution over the first year of infection in 22 patients identified prior to seroconversion. A total of 310 and 337 full-length Gag sequences from the earliest available samples (median = 14 days after infection [Fiebig stage I/II]) and at one-year post infection respectively were generated. Six of 22 (27%) individuals were infected with multiple variants. There was a trend towards early intra-patient viral sequence diversity correlating with viral load set point (p = 0.07, r = 0.39). At 14 days post infection, 59.7% of Gag CTL epitopes contained non-consensus polymorphisms and over half of these (35.3%) comprised of previously described CTL escape variants. Consensus and variant CTL epitope proportions were equally distributed irrespective of the selecting host HLA allele and most epitopes remained unchanged over 12 months post infection. These data suggest that intrapatient diversity during acute infection is an indicator of disease outcome. In this setting, there is a high rate of transmitted CTL escape variants and limited immune selection in Gag during the first year of infection. These data have relevance for vaccine strategies designed to elicit effective CD8+ T cell immune responses.	[Gounder, Kamini; Padayachi, Nagavelli; Mann, Jaclyn K.; Radebe, Mopo; Mokgoro, Mammekwa; van der Stok, Mary; Mkhize, Lungile; Mncube, Zenele; Jaggernath, Manjeetha; Walker, Bruce D.; Ndung'u, Thumbi] Univ KwaZulu Natal, Nelson R Mandela Sch Med, Doris Duke Med Res Inst, HIV Pathogenesis Programme, Durban, South Africa; [Gounder, Kamini; Padayachi, Nagavelli; Mann, Jaclyn K.; Radebe, Mopo; Mokgoro, Mammekwa; van der Stok, Mary; Mkhize, Lungile; Mncube, Zenele; Jaggernath, Manjeetha; Ndung'u, Thumbi] Univ KwaZulu Natal, Nelson R Mandela Sch Med, KwaZulu Natal Res Inst TB & HIV, Durban, South Africa; [Reddy, Tarylee] MRC, Biostat Unit, Durban, South Africa; [Walker, Bruce D.; Ndung'u, Thumbi] MIT, Massachusetts Gen Hosp, Ragon Inst, Boston, MA USA; [Walker, Bruce D.; Ndung'u, Thumbi] Harvard Univ, Boston, MA 02115 USA; [Walker, Bruce D.] Howard Hughes Med Inst, Chevy Chase, MD USA; [Ndung'u, Thumbi] Max Planck Inst Infect Biol, Berlin, Germany	University of Kwazulu Natal; University of Kwazulu Natal; Harvard University; Massachusetts General Hospital; Massachusetts Institute of Technology (MIT); Ragon Institute; Harvard University; Howard Hughes Medical Institute; Max Planck Society	Ndung'u, T (corresponding author), Univ KwaZulu Natal, Nelson R Mandela Sch Med, Doris Duke Med Res Inst, HIV Pathogenesis Programme, 719 Umbilo Rd, Durban, South Africa.	ndungu@ukzn.ac.za		Ndung'u, Thumbi/0000-0003-2962-3992; Reddy, Tarylee/0000-0002-9521-2692; Radebe, Mopo/0000-0002-2672-5232; Gounder, Kamini/0000-0002-1674-6021	National Institutes of Health (NIH) [RO1 AI067073-02]; South African NRF/DST (Ndung'u); Gates Foundation, IAVI; Victor Daitz Chair in HIV/TB Research; International Early Career Scientist Award from the Howard Hughes Medical Institute; NIH Fogarty International Clinical Research Fellows (FICRF); Medical Research Council; K-RITH Collaborative grant award; National Research Foundation; Ragon Institute of Massachusetts General Hospital, Massachusetts Institute of Technology; Harvard University; UNESCO/ L'Oreal Corporate Foundation fellowship; Technology Innovation Agency of the Department of Science and Technology of South Africa; Victor Daitz Information Gateway; initiative of the Victor Daitz Foundation; University of KwaZulu-Natal; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI067073, UM1AI100663] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); South African NRF/DST (Ndung'u); Gates Foundation, IAVI; Victor Daitz Chair in HIV/TB Research; International Early Career Scientist Award from the Howard Hughes Medical Institute; NIH Fogarty International Clinical Research Fellows (FICRF); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); K-RITH Collaborative grant award; National Research Foundation; Ragon Institute of Massachusetts General Hospital, Massachusetts Institute of Technology; Harvard University; UNESCO/ L'Oreal Corporate Foundation fellowship(L'Oreal Group); Technology Innovation Agency of the Department of Science and Technology of South Africa; Victor Daitz Information Gateway; initiative of the Victor Daitz Foundation; University of KwaZulu-Natal; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This research was supported by National Institutes of Health (NIH) grants RO1 AI067073-02 (Walker), South African NRF/DST (Ndung'u), Gates Foundation, IAVI. Partial funding was also received from the Victor Daitz Chair in HIV/TB Research and an International Early Career Scientist Award from the Howard Hughes Medical Institute to TN. KG was funded by the NIH Fogarty International Clinical Research Fellows (FICRF), Medical Research Council and K-RITH Collaborative grant award. JKM was supported by the National Research Foundation and the Ragon Institute of Massachusetts General Hospital, Massachusetts Institute of Technology and Harvard University. MR was funded by a UNESCO/ L'Oreal Corporate Foundation fellowship and the Technology Innovation Agency of the Department of Science and Technology of South Africa. Open Access publication of this article has been made possible through support from the Victor Daitz Information Gateway, an initiative of the Victor Daitz Foundation and the University of KwaZulu-Natal. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrahams MR, 2009, J VIROL, V83, P3556, DOI 10.1128/JVI.02132-08; Abrahams MR, 2013, AIDS, V27, P507, DOI 10.1097/QAD.0b013e32835cab64; Allen TM, 2005, J VIROL, V79, P13239, DOI 10.1128/JVI.79.21.13239-13249.2005; Auvert B, 2005, PLOS MED, V2, P1112, DOI 10.1371/journal.pmed.0020298; Baalwa J, 2013, VIROLOGY, V436, P33, DOI 10.1016/j.virol.2012.10.009; Baeten JM, 2012, SEX TRANSM DIS, V39, P21, DOI 10.1097/OLQ.0b013e31823b50c6; Bailey RC, 2007, LANCET, V369, P643, DOI 10.1016/S0140-6736(07)60312-2; Bimber BN, 2009, J VIROL, V83, P8247, DOI 10.1128/JVI.00897-09; Borrow P, 1997, NAT MED, V3, P205, DOI 10.1038/nm0297-205; BORROW P, 1994, J VIROL, V68, P6103, DOI 10.1128/JVI.68.9.6103-6110.1994; Boutwell CL, 2010, J INFECT DIS, V202, pS309, DOI 10.1086/655653; Brockman MA, 2007, J VIROL, V81, P12608, DOI 10.1128/JVI.01369-07; Brockman MA, 2010, J VIROL, V84, P11937, DOI 10.1128/JVI.01086-10; Brumme ZL, 2008, J VIROL, V82, P9216, DOI 10.1128/JVI.01041-08; Carlson JM, 2008, MICROBES INFECT, V10, P455, DOI 10.1016/j.micinf.2008.01.013; Carlson JM, 2012, J VIROL, V86, P13202, DOI 10.1128/JVI.01998-12; Carlson JM, 2012, J VIROL, V86, P5230, DOI 10.1128/JVI.06728-11; Carlson JM, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000225; Chopera DR, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000033; Cohen MS, 2016, NEW ENGL J MED, V375, P830, DOI [10.1056/NEJMoa1600693, 10.1056/NEJMoa1105243]; Crawford H, 2009, J EXP MED, V206, P909, DOI 10.1084/jem.20081984; Davenport MP, 2008, TRENDS MICROBIOL, V16, P561, DOI 10.1016/j.tim.2008.09.001; Draenert R, 2004, J EXP MED, V199, P905, DOI 10.1084/jem.20031982; Edwards BH, 2002, J VIROL, V76, P2298, DOI 10.1128/JVI.76.5.2298-2305.2002; Feeney ME, 2004, J VIROL, V78, P8927, DOI 10.1128/JVI.78.16.8927-8930.2004; Fischer W, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012303; Geldmacher C, 2007, AIDS, V21, P135, DOI 10.1097/01.aids.0000247589.77061.f7; Goepfert PA, 2008, J EXP MED, V205, P1009, DOI 10.1084/jem.20072457; Goonetilleke N, 2009, J EXP MED, V206, P1253, DOI 10.1084/jem.20090365; Gottlieb GS, 2004, LANCET, V363, P619, DOI 10.1016/S0140-6736(04)15596-7; Goulder P, 1997, IMMUNOL REV, V159, P17, DOI 10.1111/j.1600-065X.1997.tb01004.x; Goulder PJR, 2004, NAT REV IMMUNOL, V4, P630, DOI 10.1038/nri1417; Grant RM, 2010, NEW ENGL J MED, V363, P2587, DOI 10.1056/NEJMoa1011205; Hansasuta P, 2001, BRIT MED BULL, V58, P109, DOI 10.1093/bmb/58.1.109; Hansen SG, 2011, NATURE, V473, P523, DOI 10.1038/nature10003; Hansen SG, 2009, NAT MED, V15, P293, DOI 10.1038/nm.1935; Henn MR, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002529; Huang KHG, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019018; Jordan MR, 2010, J VIROL METHODS, V168, P114, DOI 10.1016/j.jviromet.2010.04.030; Karim QA, 2010, SCIENCE, V329, P1168, DOI 10.1126/science.1193748; Kawashima Y, 2009, NATURE, V458, P641, DOI 10.1038/nature07746; Kearney M, 2009, J VIROL, V83, P2715, DOI 10.1128/JVI.01960-08; Keele BF, 2008, P NATL ACAD SCI USA, V105, P7552, DOI 10.1073/pnas.0802203105; Kiepiela P, 2007, NAT MED, V13, P46, DOI 10.1038/nm1520; Korber B, 2000, COMPUTATIONAL ANAL H; KOUP RA, 1994, J VIROL, V68, P4650, DOI 10.1128/JVI.68.7.4650-4655.1994; Leslie AJ, 2004, NAT MED, V10, P282, DOI 10.1038/nm992; Li H, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000890; Lichterfeld M, 2007, J VIROL, V81, P4199, DOI 10.1128/JVI.01388-06; Liu JY, 2009, NATURE, V457, P87, DOI 10.1038/nature07469; Liu MKP, 2013, J CLIN INVEST, V123, P380, DOI 10.1172/JCI65330; Mani I, 2002, J VIROL, V76, P10745, DOI 10.1128/JVI.76.21.10745-10755.2002; Martinez-Picado J, 2006, J VIROL, V80, P3617, DOI 10.1128/JVI.80.7.3617-3623.2006; Matthews PC, 2008, J VIROL, V82, P8548, DOI 10.1128/JVI.00580-08; McMichael AJ, 2010, NAT REV IMMUNOL, V10, P11, DOI 10.1038/nri2674; Mellors JW, 1996, SCIENCE, V272, P1167, DOI 10.1126/science.272.5265.1167; Monaco D, 2014, HIV R4P; Novitsky V, 2003, J VIROL, V77, P882, DOI 10.1128/JVI.77.2.882-890.2003; Novitsky V, 2011, AIDS, V25, P1515, DOI 10.1097/QAD.0b013e3283471eb2; Novitsky V, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016714; Novitsky V, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007727; O'Connell KA, 2010, J VIROL, V84, P7018, DOI 10.1128/JVI.00548-10; Payne R, 2014, P NATL ACAD SCI USA, V111, pE5393, DOI 10.1073/pnas.1413339111; PHILLIPS RE, 1991, NATURE, V354, P453, DOI 10.1038/354453a0; Piantadosi A, 2009, AIDS, V23, P579, DOI 10.1097/QAD.0b013e328328f76e; Price DA, 1997, P NATL ACAD SCI USA, V94, P1890, DOI 10.1073/pnas.94.5.1890; Prince JL, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1003041; Radebe M, 2011, J INFECT DIS, V204, P768, DOI 10.1093/infdis/jir394; Rodrigo A.G., 2001, COMPUTATIONAL EVOLUT; Rousseau CM, 2008, J VIROL, V82, P6434, DOI 10.1128/JVI.02455-07; SAFRIT JT, 1994, J EXP MED, V179, P463, DOI 10.1084/jem.179.2.463; Sagar M, 2003, J VIROL, V77, P12921, DOI 10.1128/JVI.77.23.12921-12926.2003; Salazar-Gonzalez JF, 2009, J EXP MED, V206, P1273, DOI 10.1084/jem.20090378; Schaefer M, 2009, AIDS VACCINE; Schellens IMM, 2011, AIDS, V25, P1691, DOI 10.1097/QAD.0b013e32834981b3; Schmitz JE, 1999, SCIENCE, V283, P857, DOI 10.1126/science.283.5403.857; Schneidewind A, 2007, J VIROL, V81, P12382, DOI 10.1128/JVI.01543-07; Shaw GM, 2012, COLD SPRING HARB PER, V2; Streeck H, 2007, J VIROL, V81, P7725, DOI 10.1128/JVI.00708-07; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Thobakgale CF, 2009, J VIROL, V83, P10234, DOI 10.1128/JVI.00921-09; Virgin HW, 2010, NATURE, V464, P224, DOI 10.1038/nature08898; Walker B., 2012, COLD SPRING HARB PER, P2; Wang YYE, 2009, J VIROL, V83, P1845, DOI 10.1128/JVI.01061-08; Watkins DI, 2008, MEM I OSWALDO CRUZ, V103, P119, DOI 10.1590/S0074-02762008000200001; Wright JK, 2012, J VIROL, V86, P3193, DOI 10.1128/JVI.06682-11; Wright JK, 2011, J VIROL, V85, P3996, DOI 10.1128/JVI.02520-10; Wright JK, 2010, J VIROL, V84, P10820, DOI 10.1128/JVI.01084-10; Yusim K, 2009, THEORETICAL BIOL BIO, P3	89	8	8	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2015	10	3							e0119886	10.1371/journal.pone.0119886	http://dx.doi.org/10.1371/journal.pone.0119886			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7QC	25781986	Green Published, Green Submitted, gold			2022-12-27	WOS:000351284600105
J	Cennamo, N; Di Giovanni, S; Varriale, A; Staiano, M; Di Pietrantonio, F; Notargiacomo, A; Zeni, L; D'Auria, S				Cennamo, Nunzio; Di Giovanni, Stefano; Varriale, Antonio; Staiano, Maria; Di Pietrantonio, Fabio; Notargiacomo, Andrea; Zeni, Luigi; D'Auria, Sabato			Easy to Use Plastic Optical Fiber-Based Biosensor for Detection of Butanal	PLOS ONE			English	Article							ODORANT-BINDING-PROTEIN; SOLID-PHASE MICROEXTRACTION; SURFACE-PLASMON RESONANCE; STABILITY; MECHANISM; DERIVATIZATION; ALDEHYDES; DYNAMICS; SPR	The final goal of this work is to achieve a selective detection of butanal by the realization of a simple, small-size and low cost experimental approach. To this end, a porcine odorant-binding protein was used in connection with surface plasmon resonance transduction in a plastic optical fiber tool for the selective detection of butanal by a competitive assay. This allows to reduce the cost and the size of the sensing device and it offers the possibility to design a "Lab-on-a-chip" platform. The obtained results showed that this systema pproach is able to selectively detect the presence of butanal in the concentration range from 20 mu M to 1000 mu M.	[Cennamo, Nunzio; Zeni, Luigi] SUN, Dept Ind & Informat Engn, Aversa, Italy; [Di Giovanni, Stefano; Varriale, Antonio; Staiano, Maria; D'Auria, Sabato] CNR, Inst Prot Biochem, I-80125 Naples, Italy; [Di Pietrantonio, Fabio] OM Corbino Inst Acoust & Sensors, Rome, Italy; [Notargiacomo, Andrea] CNR, Inst Photon & Nanotechnol, Rome, Italy; [D'Auria, Sabato] CNR, Inst Food Sci, Avellino, Italy	Universita della Campania Vanvitelli; Consiglio Nazionale delle Ricerche (CNR); Istituto di Biochimica delle Proteine (IBP-CNR); Consiglio Nazionale delle Ricerche (CNR); Istituto di Acustica e Sensoristica "Orso Mario Corbino" (IDASC-CNR); Consiglio Nazionale delle Ricerche (CNR); Istituto di Fotonica e Nanotecnologie (IFN-CNR); Consiglio Nazionale delle Ricerche (CNR); Istituto di Scienze dell' Alimentazione (ISA-CNR)	Zeni, L (corresponding author), SUN, Dept Ind & Informat Engn, Aversa, Italy.	luigi.zeni@unina2.it; sabato.dauria@cnr.it	Varriale, Antonio/AAL-1439-2020; Di Pietrantonio, Fabio/AAB-3685-2019; STAIANO, MARIA/B-9584-2015; Zeni, Luigi/AAC-5044-2022; Cennamo, Nunzio/AAC-5026-2022; Notargiacomo, Andrea/C-3178-2013	Di Pietrantonio, Fabio/0000-0002-6629-6401; STAIANO, MARIA/0000-0003-0223-1825; Zeni, Luigi/0000-0001-8356-7480; Cennamo, Nunzio/0000-0001-7769-0984; Notargiacomo, Andrea/0000-0002-7177-9096				Abbas A, 2011, BIOSENS BIOELECTRON, V26, P1815, DOI 10.1016/j.bios.2010.09.030; Beranek J, 2008, J CHROMATOGR A, V1209, P44, DOI 10.1016/j.chroma.2008.09.013; Bonnot K, 2014, ANAL CHEM, V86, P5125, DOI 10.1021/ac500903s; Briand L, 2002, BIOCHEMISTRY-US, V41, P7241, DOI 10.1021/bi015916c; Cennamo N, 2013, SENSOR ACTUAT B-CHEM, V188, P221, DOI 10.1016/j.snb.2013.07.005; Cennamo N, 2013, SENSOR ACTUAT B-CHEM, V176, P1008, DOI 10.1016/j.snb.2012.10.055; Cennamo N, 2013, SENSORS-BASEL, V13, P721, DOI 10.3390/s130100721; Cennamo N, 2011, SENSORS-BASEL, V11, P11752, DOI 10.3390/s111211752; Dal Monte M, 1993, CHEM SENSES, V18, P713; Deng CH, 2004, RAPID COMMUN MASS SP, V18, P1715, DOI 10.1002/rcm.1544; Korndorfer IP, 2003, J MOL BIOL, V330, P385, DOI 10.1016/S0022-2836(03)00573-4; Lobel D, 2002, CHEM SENSES, V27, P39, DOI 10.1093/chemse/27.1.39; McGregor D, 2006, CRIT REV TOXICOL, V36, P821, DOI 10.1080/10408440600977669; Schmarr HG, 2008, ANAL CHIM ACTA, V617, P119, DOI 10.1016/j.aca.2008.02.002; Scott PK, 2007, ANAL BIOANAL CHEM, V387, P1831; Spinelli S, 1998, BIOCHEMISTRY-US, V37, P7913, DOI 10.1021/bi980179e; Staiano M, 2008, BIOPOLYMERS, V89, P284, DOI 10.1002/bip.20908; Staiano M, 2007, BIOCHEMISTRY-US, V46, P11120, DOI 10.1021/bi7008129; Stepanenko OV, 2008, PROTEINS, V71, P35, DOI 10.1002/prot.21658; Verma R, 2013, SENSOR ACTUAT B-CHEM, V177, P279, DOI 10.1016/j.snb.2012.10.135	20	21	22	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2015	10	3							e0116770	10.1371/journal.pone.0116770	http://dx.doi.org/10.1371/journal.pone.0116770			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD9NQ	25789470	Green Published, Green Submitted, gold			2022-12-27	WOS:000351425400020
J	Hososhima, S; Sakai, S; Ishizuka, T; Yawo, H				Hososhima, Shoko; Sakai, Seiichiro; Ishizuka, Toru; Yawo, Hiromu			Kinetic Evaluation of Photosensitivity in Bi-Stable Variants of Chimeric Channelrhodopsins	PLOS ONE			English	Article							LIGHT; CHANNEL; PHOTOCYCLE; CHLAMYDOMONAS; RHODOPSINS; MODEL	Channelrhodopsin-1 and 2 (ChR1 and ChR2) form cation channels that are gated by light through an unknown mechanism. We tested the DC-gate hypothesis that C167 and D195 are involved in the stabilization of the cation-permeable state of ChRWR/C1C2 which consists of TM1-5 of ChR1 and TM6-7 of ChR2 and ChRFR which consists of TM1-2 of ChR1 and TM3-7 of ChR2. The cation permeable state of each ChRWR and ChRFR was markedly prolonged in the order of several tens of seconds when either C167 or D195 position was mutated to alanine (A). Therefore, the DC-gate function was conserved among these chimeric ChRs. We next investigated the kinetic properties of the ON/OFF response of these bi-stable ChR mutants as they are important in designing the photostimulation protocols for the optogenetic manipulation of neuronal activities. The turning-on rate constant of each photocurrent followed a linear relationship to 0-0.12 mWmm(-2) of blue LED light or to 0-0.33 mWmm(-2) of cyan LED light. Each photocurrent of bi-stable ChR was shut off to the non-conducting state by yellow or orange LED light in a manner dependent on the irradiance. As the magnitude of the photocurrent was mostly determined by the turning-on rate constant and the irradiation time, the minimal irradiance that effectively evoked an action potential (threshold irradiance) was decreased with time only if the neuron, which expresses bi-stable ChRs, has a certain large membrane time constant (eg. tau(m) > 20 ms). On the other hand, in another group of neurons, the threshold irradiance was not dependent on the irradiation time. Based on these quantitative data, we would propose that these bi-stable ChRs would be most suitable for enhancing the intrinsic activity of excitatory pyramidal neurons at a minimal magnitude of irradiance.	[Hososhima, Shoko; Ishizuka, Toru; Yawo, Hiromu] Tohoku Univ, Grad Sch Life Sci, Dept Dev Biol & Neurosci, Sendai, Miyagi 980, Japan; [Hososhima, Shoko; Sakai, Seiichiro; Ishizuka, Toru; Yawo, Hiromu] Japan Sci & Technol Agcy JST, CREST, Tokyo, Japan; [Sakai, Seiichiro] RIKEN, Brain Sci Inst, Lab Local Neuronal Circuits, Wako, Saitama, Japan; [Yawo, Hiromu] Tohoku Univ, Grad Sch Med, Ctr Neurosci, Sendai, Miyagi 980, Japan	Tohoku University; Japan Science & Technology Agency (JST); RIKEN; Tohoku University	Yawo, H (corresponding author), Tohoku Univ, Grad Sch Life Sci, Dept Dev Biol & Neurosci, Sendai, Miyagi 980, Japan.	yawo-hiromu@m.tohoku.ac.jp	Ishizuka, Toru/L-8191-2017; Yawo, Hiromu/I-4871-2015	Ishizuka, Toru/0000-0003-4405-8792; Yawo, Hiromu/0000-0002-4299-3288	Japan Society for the Promotion of Science (JSPS) [13J06372]; Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan [23115501, 25115701]; MEXT, Japan [25250001, 25670103, 25290002]; Program for Promotion of Fundamental Studies in Health Sciences of the National Institute of Biomedical Innovation (NIBIO); Research Foundation for Opto-Science and Technology	Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); MEXT, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Program for Promotion of Fundamental Studies in Health Sciences of the National Institute of Biomedical Innovation (NIBIO)(National Institute of Biomedical Innovation); Research Foundation for Opto-Science and Technology	This work was supported by a Grant-in-Aid for JSPS Fellows (No. 13J06372) of Japan Society for the Promotion of Science (JSPS) (http://www.jsps.go.jp/english/e-grants/grants01.html), a Grant-in-Aid for Scientific Research on Innovative Areas "Mesoscopic Neurocircuitry" (Nos. 23115501 & 25115701) of the Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan (http://www.jsps.go.jp/english/e-grants/grants01.html), a Grant-in Aid for Scientific Research (No. 25250001), MEXT, Japan (http://www.jsps.go.jp/english/e-grants/grants01.html), a Grant-in-Aid for challenging Exploratory Research (No. 25670103), MEXT, Japan (http://www.jsps.go.jp/english/e-grants/grants01.html), a Grant-in Aid for Scientific Research (No. 25290002), MEXT, Japan (http://www.jsps.go.jp/english/e-grants/grants01.html), the Program for Promotion of Fundamental Studies in Health Sciences of the National Institute of Biomedical Innovation (NIBIO) (http://www.nibio.go.jp/english/index.html), and Research Foundation for Opto-Science and Technology (http://www.refost-hq.jp/kenkyu.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bamann C, 2008, J MOL BIOL, V375, P686, DOI 10.1016/j.jmb.2007.10.072; Bamann C, 2010, BIOCHEMISTRY-US, V49, P267, DOI 10.1021/bi901634p; Berndt A, 2009, NAT NEUROSCI, V12, P229, DOI 10.1038/nn.2247; Boyden ES, 2005, NAT NEUROSCI, V8, P1263, DOI 10.1038/nn1525; Ernst OP, 2008, J BIOL CHEM, V283, P1637, DOI 10.1074/jbc.M708039200; Govorunova EG, 2011, MBIO, V2, DOI 10.1128/mBio.00115-11; Hegemann P, 2005, BIOPHYS J, V89, P3911, DOI 10.1529/biophysj.105.069716; Hou SY, 2012, PHOTOCHEM PHOTOBIOL, V88, P119, DOI 10.1111/j.1751-1097.2011.01027.x; Ishizuka T, 2006, NEUROSCI RES, V54, P85, DOI 10.1016/j.neures.2005.10.009; Kato HE, 2012, NATURE, V482, P369, DOI 10.1038/nature10870; Klapoetke NC, 2014, NAT METHODS, V11, P338, DOI [10.1038/NMETH.2836, 10.1038/nmeth.2836]; Lorenz-Fonfria VA, 2014, BBA-BIOENERGETICS, V1837, P626, DOI 10.1016/j.bbabio.2013.10.014; Lorenz-Fonfria VA, 2013, P NATL ACAD SCI USA, V110, pE1273, DOI 10.1073/pnas.1219502110; Mattis J, 2012, NAT METHODS, V9, P159, DOI [10.1038/nmeth.1808, 10.1038/NMETH.1808]; Nack M, 2010, PHOTOCH PHOTOBIO SCI, V9, P194, DOI 10.1039/b9pp00157c; Nagai T, 2002, NAT BIOTECHNOL, V20, P87, DOI 10.1038/nbt0102-87; Nagel G, 2002, SCIENCE, V296, P2395, DOI 10.1126/science.1072068; Nagel G, 2003, P NATL ACAD SCI USA, V100, P13940, DOI 10.1073/pnas.1936192100; Okada Y, 2012, J PHYSIOL-LONDON, V590, P4933, DOI 10.1113/jphysiol.2012.231464; Prigge M, 2012, J BIOL CHEM, V287, P31804, DOI 10.1074/jbc.M112.391185; Ritter E, 2013, J BIOL CHEM, V288, P10451, DOI 10.1074/jbc.M112.446427; Sasaki T, 2012, P NATL ACAD SCI USA, V109, P20720, DOI 10.1073/pnas.1213458109; Sineshchekov OA, 2002, P NATL ACAD SCI USA, V99, P8689, DOI 10.1073/pnas.122243399; Stehfest K, 2010, CHEMPHYSCHEM, V11, P1120, DOI 10.1002/cphc.200900980; Sugiyama Y, 2009, PHOTOCH PHOTOBIO SCI, V8, P328, DOI 10.1039/b815762f; Suzuki T, 2003, BIOCHEM BIOPH RES CO, V301, P711, DOI 10.1016/S0006-291X(02)03079-6; Tanaka KF, 2012, CELL REP, V2, P397, DOI 10.1016/j.celrep.2012.06.011; Tsunoda SP, 2009, PHOTOCHEM PHOTOBIOL, V85, P564, DOI 10.1111/j.1751-1097.2008.00519.x; Wang HX, 2009, J BIOL CHEM, V284, P5685, DOI 10.1074/jbc.M807632200; Watanabe HC, 2013, J MOL BIOL, V425, P1795, DOI 10.1016/j.jmb.2013.01.033; Watanabe HC, 2012, J BIOL CHEM, V287, P7456, DOI 10.1074/jbc.M111.320309; WOOD JN, 1990, P ROY SOC B-BIOL SCI, V241, P187, DOI 10.1098/rspb.1990.0084; Yamazaki Y, 2014, GLIA, V62, P1299, DOI 10.1002/glia.22681; Yizhar O, 2011, NATURE, V477, P171, DOI 10.1038/nature10360; Zhang F, 2011, CELL, V147, P1446, DOI 10.1016/j.cell.2011.12.004	35	18	18	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2015	10	3							e0119558	10.1371/journal.pone.0119558	http://dx.doi.org/10.1371/journal.pone.0119558			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD9NQ	25789474	Green Published, Green Submitted, gold			2022-12-27	WOS:000351425400090
J	Pan, YH; Zhang, HL; Zhang, DL; Li, JJ; Xiong, HY; Yu, JP; Li, JL; Rashid, MAR; Li, GL; Ma, XD; Cao, GL; Han, LZ; Li, ZC				Pan, Yinghua; Zhang, Hongliang; Zhang, Dongling; Li, Jinjie; Xiong, Haiyan; Yu, Jianping; Li, Jilong; Rashid, Muhammad Abdul Rehman; Li, Gangling; Ma, Xiaoding; Cao, Guilan; Han, Longzhi; Li, Zichao			Genetic Analysis of Cold Tolerance at the Germination and Booting Stages in Rice by Association Mapping	PLOS ONE			English	Article							QUANTITATIVE TRAIT LOCI; LOW-TEMPERATURE GERMINABILITY; GENOME-WIDE ASSOCIATION; SSR-MARKERS; IDENTIFICATION	Low temperature affects the rice plants at all stages of growth. It can cause severe seedling injury and male sterility resulting in severe yield losses. Using a mini core collection of 174 Chinese rice accessions and 273 SSR markers we investigated cold tolerance at the germination and booting stages, as well as the underlying genetic bases, by association mapping. Two distinct populations, corresponding to subspecies indica and japonica showed evident differences in cold tolerance and its genetic basis. Both subspecies were sensitive to cold stress at both growth stages. However, japonica was more tolerant than indica at all stages as measured by seedling survival and seed setting. There was a low correlation in cold tolerance between the germination and booting stages. Fifty one quantitative trait loci (QTLs) for cold tolerance were dispersed across all 12 chromosomes; 22 detected at the germination stage and 33 at the booting stage. Eight QTLs were identified by at least two of four measures. About 46% of the QTLs represented new loci. The only QTL shared between indica and japonica for the same measure was qLTSSvR6-2 for SSvR. This implied a complicated mechanism of old tolerance between the two subspecies. According to the relative genotypic effect (RGE) of each genotype for each QTL, we detected 18 positive genotypes and 21 negative genotypes in indica, and 19 positive genotypes and 24 negative genotypes in japonica. In general, the negative effects were much stronger than the positive effects in both subspecies. Markers for QTL with positive effects in one subspecies were shown to be effective for selection of cold tolerance in that subspecies, but not in the other subspecies. QTL with strong negative effects on cold tolerance should be avoided during MAS breeding so as to not cancel the effect of favorable QTL at other loci.	[Pan, Yinghua; Zhang, Hongliang; Li, Jinjie; Xiong, Haiyan; Yu, Jianping; Li, Jilong; Rashid, Muhammad Abdul Rehman; Li, Gangling; Li, Zichao] China Agr Univ, Beijing Key Lab Crop Genet Improvement, Key Lab Crop Heterosis & Utilizat, Minist Educ, Beijing 100193, Peoples R China; [Zhang, Dongling; Ma, Xiaoding; Cao, Guilan; Han, Longzhi] Chinese Acad Agr Sci, Inst Crop Sci, Key Lab Crop Germplasm Resources & Biotechnol,Min, Natl Key Facil Crop Gene Resources & Genet Improv, Beijing 100081, Peoples R China; [Ma, Xiaoding] Guangxi Acad Agr Sci, Rice Res Inst, Nanning 530005, Guangxi, Peoples R China	China Agricultural University; Chinese Academy of Agricultural Sciences; Institute of Crop Sciences, CAAS; Guangxi Academy of Agricultural Sciences	Han, LZ (corresponding author), Chinese Acad Agr Sci, Inst Crop Sci, Key Lab Crop Germplasm Resources & Biotechnol,Min, Natl Key Facil Crop Gene Resources & Genet Improv, Beijing 100081, Peoples R China.	hanlongzhi@caas.cn; lizichao@cau.edu.cn	Xiong, Haiyan/AAL-9383-2021; Li, Zichao/AAS-8954-2021; Rashid, Muhammad Abdul Rehman/R-5982-2018	Xiong, Haiyan/0000-0003-4145-2719; Li, Zichao/0000-0002-3186-1132; Rashid, Muhammad Abdul Rehman/0000-0002-4941-3469	National Natural Science Foundation of China [31471456, 31371584]; 973 Project [2010CB125904]; China National Key Technologies RD Program [2013BAD01B02-15, 2015BAD02B01]; 948 Project of MOA [2011-G2B and 2011-G1(2)-25]; Project of National Species Resources Protection [2014NWB015]; Guangxi Natural Science Foundation Program [0991053]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); 973 Project(National Basic Research Program of China); China National Key Technologies RD Program(National Key Technology R&D Program); 948 Project of MOA; Project of National Species Resources Protection; Guangxi Natural Science Foundation Program(National Natural Science Foundation of Guangxi Province)	This work was funded by the National Natural Science Foundation of China(31471456 and 31371584), the 973 Project (2010CB125904), China National Key Technologies R&D Program (2013BAD01B02-15 and 2015BAD02B01), the 948 Project of MOA(2011-G2B and 2011-G1(2)-25), Project of National Species Resources Protection (2014NWB015), and Guangxi Natural Science Foundation Program (0991053). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrama HA, 2007, MOL BREEDING, V19, P341, DOI 10.1007/s11032-006-9066-6; Andaya VC, 2003, THEOR APPL GENET, V106, P1084, DOI 10.1007/s00122-002-1126-7; Barrett JC, 2008, NAT GENET, V40, P955, DOI 10.1038/ng.175; Bolormaa S, 2011, J ANIM SCI, V89, P1684, DOI 10.2527/jas.2010-3079; Chang T T, 1976, P S CLIM RIC, P87; Cui D, 2013, EUPHYTICA, V193, P369, DOI 10.1007/s10681-013-0935-x; Dai LY, 2004, BREEDING SCI, V54, P253, DOI 10.1270/jsbbs.54.253; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Falush D, 2003, GENETICS, V164, P1567; Flint-Garcia SA, 2005, PLANT J, V44, P1054, DOI 10.1111/j.1365-313X.2005.02591.x; Fujino K, 2004, THEOR APPL GENET, V108, P794, DOI 10.1007/s00122-003-1509-4; Fujino K, 2008, P NATL ACAD SCI USA, V105, P12623, DOI 10.1073/pnas.0805303105; Guirguis K, 2011, GEOPHYS RES LETT, DOI [10.1029/2011GL0487622, DOI 10.1029/2011GL0487622]; Huang XH, 2012, NAT GENET, V44, P32, DOI 10.1038/ng.1018; Huang XH, 2010, NAT GENET, V42, P961, DOI 10.1038/ng.695; Iwata H, 2007, THEOR APPL GENET, V114, P1437, DOI 10.1007/s00122-007-0529-x; Ji SuLan, 2008, Acta Agronomica Sinica, V34, P551, DOI 10.3724/SP.J.1006.2008.00551; Jia LM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032703; KATO SHIGEMOTO, 1928, BULT SCI FAK TERK KJUSU IMP UNIV, V3, P132; Kodra E, 2011, GEOPHYS RES LETT, V38, DOI 10.1029/2011GL047103; Lawson MJ, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-2-r14; Li XB, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0029350, 10.1371/journal.pone.0051199]; Liu XF, 2010, ACTA GEOGRAPHICA SIN, V67, P1223; Meuwissen THE, 2001, GENETICS, V157, P1819; Narayanan NN, 2004, MOL BREEDING, V14, P61, DOI 10.1023/B:MOLB.0000037995.63856.2d; NISHIYAMA I, 1982, JPN J CROP SCI, V51, P462, DOI 10.1626/jcs.51.462; Saito K, 2010, PLANT SCI, V179, P97, DOI 10.1016/j.plantsci.2010.04.004; Sthapit BR, 1998, CROP SCI, V38, P660, DOI 10.2135/cropsci1998.0011183X003800030007x; Sun W, 2011, AGR FOREST METEOROL, V151, P1193, DOI 10.1016/j.agrformet.2011.04.009; Tai LM, 2006, SW CHINA J AGARIC SC, V19, P49; Thiel T, 2003, THEOR APPL GENET, V106, P411, DOI 10.1007/s00122-002-1031-0; Xu LM, 2008, PLANT SCI, V174, P340, DOI 10.1016/j.plantsci.2007.12.003; Ye C, 2009, CROP PASTURE SCI, V60, P328, DOI 10.1071/CP09006; Zeng Y., 2001, ACTA AGRON SIN, V27, P15; Zhang DL, 2009, THEOR APPL GENET, V119, P1105, DOI 10.1007/s00122-009-1112-4; Zhang Yan-mei, 2012, Chinese Journal of Rice Science, V26, P423, DOI 10.3969/j.issn.1001-7216.2012.04.006; Zhou L, 2010, THEOR APPL GENET, V121, P895, DOI 10.1007/s00122-010-1358-x	37	60	66	2	60	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2015	10	3							e0120590	10.1371/journal.pone.0120590	http://dx.doi.org/10.1371/journal.pone.0120590			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD9NQ	25790128	gold, Green Published, Green Submitted			2022-12-27	WOS:000351425400165
J	Rutsche, B; Hauser, TU; Jancke, L; Grabner, RH				Ruetsche, Bruno; Hauser, Tobias U.; Jaencke, Lutz; Grabner, Roland H.			When Problem Size Matters: Differential Effects of Brain Stimulation on Arithmetic Problem Solving and Neural Oscillations	PLOS ONE			English	Article							TRANSCRANIAL DC STIMULATION; HUMAN MOTOR CORTEX; ELECTRICAL-STIMULATION; THETA OSCILLATIONS; PREFRONTAL CORTEX; NEURONAL-ACTIVITY; MENTAL ADDITION; UPPER ALPHA; EEG; RETRIEVAL	The problem size effect is a well-established finding in arithmetic problem solving and is characterized by worse performance in problems with larger compared to smaller operand size. Solving small and large arithmetic problems has also been shown to involve different cognitive processes and distinct electroencephalography (EEG) oscillations over the left posterior parietal cortex (LPPC). In this study, we aimed to provide further evidence for these dissociations by using transcranial direct current stimulation (tDCS). Participants underwent anodal (30min, 1.5 mA, LPPC) and sham tDCS. After the stimulation, we recorded their neural activity using EEG while the participants solved small and large arithmetic problems. We found that the tDCS effects on performance and oscillatory activity critically depended on the problem size. While anodal tDCS improved response latencies in large arithmetic problems, it decreased solution rates in small arithmetic problems. Likewise, the lower-alpha desynchronization in large problems increased, whereas the theta synchronization in small problems decreased. These findings reveal that the LPPC is differentially involved in solving small and large arithmetic problems and demonstrate that the effects of brain stimulation strikingly differ depending on the involved neuro-cognitive processes.	[Ruetsche, Bruno] Swiss Fed Inst Technol, Inst Behav Sci, Res Learning & Instruct, Zurich, Switzerland; [Ruetsche, Bruno; Hauser, Tobias U.] Univ Zurich, Neurosci Ctr Zurich ZNZ, Zurich, Switzerland; [Ruetsche, Bruno; Hauser, Tobias U.] Swiss Fed Inst Technol, Zurich, Switzerland; [Hauser, Tobias U.] UCL, Wellcome Trust Ctr Neuroimaging, Inst Neurol, London, England; [Hauser, Tobias U.] Univ Zurich, Univ Clin Child & Adolescent Psychiat, Zurich, Switzerland; [Jaencke, Lutz] Univ Zurich, Div Neuropsychol, Inst Psychol, Zurich, Switzerland; [Jaencke, Lutz] Univ Zurich, Int Normal Aging & Plast Imaging Ctr, Zurich, Switzerland; [Jaencke, Lutz] Univ Zurich, Ctr Integrat Human Physiol ZIHP, Zurich, Switzerland; [Jaencke, Lutz] Univ Zurich, Univ Res Prior Program, Dynam Healthy Aging, Zurich, Switzerland; [Jaencke, Lutz] King Abdulaziz Univ, Dept Special Educ, Jeddah 21413, Saudi Arabia; [Grabner, Roland H.] Graz Univ, Sect Educ Neurosci, Dept Psychol, Graz, Austria; [Grabner, Roland H.] Univ Gottingen, Inst Psychol, Dept Educ Psychol, D-37073 Gottingen, Germany	Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Zurich; Swiss Federal Institutes of Technology Domain; ETH Zurich; University of London; University College London; University of Zurich; University of Zurich; University of Zurich; University of Zurich; Zurich Center Integrative Human Physiology (ZIHP); University of Zurich; King Abdulaziz University; University of Graz; University of Gottingen	Rutsche, B (corresponding author), Swiss Fed Inst Technol, Inst Behav Sci, Res Learning & Instruct, Zurich, Switzerland.	bruno.ruetsche@ifv.gess.ethz.ch	Grabner, Roland/AAE-7272-2020	Grabner, Roland/0000-0003-0385-8910; Rutsche, Bruno/0000-0002-5432-2721; Hauser, Tobias U./0000-0002-7997-8137	Swiss National Science Foundation [100014_140515 / 1]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	This study was funded by a grant awarded to TUH and RHG by the Swiss National Science Foundation (100014_140515 / 1; http://www.snf.ch). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANNETT M, 1970, BRIT J PSYCHOL, V61, P303, DOI 10.1111/j.2044-8295.1970.tb01248.x; Ansari D, 2008, NAT REV NEUROSCI, V9, P278, DOI 10.1038/nrn2334; Ashcraft M. H., 1987, FORMAL METHODS DEV P, P302, DOI DOI 10.1007/978-1-4612-4694-7_9; Ashcraft MH, 2009, PSYCHOL LEARN MOTIV, V51, P121, DOI 10.1016/S0079-7421(09)51004-3; ASHCRAFT MH, 1981, MEM COGNITION, V9, P185, DOI 10.3758/BF03202334; Balconi M, 2012, NEUROSCI LETT, V517, P25, DOI 10.1016/j.neulet.2012.04.010; Bastiaansen M, 2006, PROG BRAIN RES, V159, P179, DOI 10.1016/S0079-6123(06)59012-0; Bastiaansen MCM, 2005, J COGNITIVE NEUROSCI, V17, P530, DOI 10.1162/0898929053279469; BINDMAN LJ, 1964, J PHYSIOL-LONDON, V172, P369, DOI 10.1113/jphysiol.1964.sp007425; Bolognini N, 2010, BRAIN RES, V1349, P76, DOI 10.1016/j.brainres.2010.06.053; Campbell, 1995, MATH COGNITION, V1, P121, DOI DOI 10.3758/BF03197037; Campbell JID, 2001, J EXP PSYCHOL GEN, V130, P299, DOI 10.1037//0096-3445.130.2.299; CAMPBELL JID, 1987, J EXP PSYCHOL LEARN, V13, P109, DOI 10.1037/0278-7393.13.1.109; Chi RP, 2010, BRAIN RES, V1353, P168, DOI 10.1016/j.brainres.2010.07.062; Cohen J.E., 1988, STAT POWER ANAL BEHA; De Smedt B, 2009, EXP BRAIN RES, V195, P635, DOI 10.1007/s00221-009-1839-9; de Vries MH, 2010, J COGNITIVE NEUROSCI, V22, P2427, DOI 10.1162/jocn.2009.21385; Dehaene S, 2003, COGN NEUROPSYCHOL, V20, P487, DOI 10.1080/02643290244000239; Delorme A, 2004, J NEUROSCI METH, V134, P9, DOI 10.1016/j.jneumeth.2003.10.009; Elmer S, 2009, BEHAV BRAIN FUNCT, V5, DOI 10.1186/1744-9081-5-29; Filmer HL, 2014, TRENDS NEUROSCI, V37, P742, DOI 10.1016/j.tins.2014.08.003; Fiori V, 2011, J COGNITIVE NEUROSCI, V23, P2309, DOI 10.1162/jocn.2010.21579; Fregni F, 2005, EXP BRAIN RES, V166, P23, DOI 10.1007/s00221-005-2334-6; Gandiga PC, 2006, CLIN NEUROPHYSIOL, V117, P845, DOI 10.1016/j.clinph.2005.12.003; Grabner RH, 2007, NEUROIMAGE, V38, P346, DOI 10.1016/j.neuroimage.2007.07.041; Grabner RH, 2007, BRAIN RES BULL, V72, P57, DOI 10.1016/j.brainresbull.2007.01.001; Grabner RH, 2012, FRONT PSYCHOL, V3, DOI 10.3389/fpsyg.2012.00428; Grabner RH, 2011, BIOL PSYCHOL, V87, P128, DOI 10.1016/j.biopsycho.2011.02.019; Grabner RH, 2009, NEUROPSYCHOLOGIA, V47, P604, DOI 10.1016/j.neuropsychologia.2008.10.013; Hauser TU, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00244; Herwig U, 2003, BRAIN TOPOGR, V16, P95, DOI 10.1023/B:BRAT.0000006333.93597.9d; HOMAN RW, 1987, ELECTROEN CLIN NEURO, V66, P376, DOI 10.1016/0013-4694(87)90206-9; Iuculano T, 2013, J NEUROSCI, V33, P4482, DOI 10.1523/JNEUROSCI.4927-12.2013; Iyer MB, 2005, NEUROLOGY, V64, P872, DOI 10.1212/01.WNL.0000152986.07469.E9; Jacobs J, 2006, NEUROIMAGE, V32, P978, DOI 10.1016/j.neuroimage.2006.02.018; Jacobson L, 2012, BRAIN RES, V1439, P66, DOI 10.1016/j.brainres.2011.12.036; Jacobson L, 2012, EXP BRAIN RES, V216, P1, DOI 10.1007/s00221-011-2891-9; Jensen O, 2002, EUR J NEUROSCI, V15, P1395, DOI 10.1046/j.1460-9568.2002.01975.x; Kadosh RC, 2013, TRENDS NEUROSCI EDUC, V2, P85, DOI 10.1016/j.tine.2013.04.001; Kadosh RC, 2010, CURR BIOL, V20, P2016, DOI 10.1016/j.cub.2010.10.007; Kasashima Y, 2012, EXP BRAIN RES, V221, P263, DOI 10.1007/s00221-012-3166-9; Keeser D, 2011, NEUROIMAGE, V55, P644, DOI 10.1016/j.neuroimage.2010.12.004; Kirk EP, 2001, J EXP PSYCHOL LEARN, V27, P157, DOI 10.1037/0278-7393.27.1.157; Klimesch W, 1996, INT J PSYCHOPHYSIOL, V24, P61, DOI 10.1016/S0167-8760(96)00057-8; Klimesch W, 2005, EXP PSYCHOL, V52, P99, DOI 10.1027/1618-3169.52.2.99; Klimesch W, 1998, NEUROSCI LETT, V244, P73, DOI 10.1016/S0304-3940(98)00122-0; Klimesch W., 1993, Brain Topography, V5, P241, DOI 10.1007/BF01128991; Klimesch W, 1997, NEUROSCI LETT, V238, P9, DOI 10.1016/S0304-3940(97)00771-4; Klimesch W, 1999, BRAIN RES REV, V29, P169, DOI 10.1016/S0165-0173(98)00056-3; Klimesch W., 1992, J PSYCHOPHYSIOL, V6, P185; Koessler L, 2009, NEUROIMAGE, V46, P64, DOI 10.1016/j.neuroimage.2009.02.006; Kong H, 2005, COGNITIVE BRAIN RES, V22, P397, DOI 10.1016/j.cogbrainres.2004.09.011; Krause B, 2013, DEV COGN NEUROSCI; Lang N, 2005, EUR J NEUROSCI, V22, P495, DOI 10.1111/j.1460-9568.2005.04233.x; Laufs H, 2003, NEUROIMAGE, V19, P1463, DOI 10.1016/S1053-8119(03)00286-6; LeFevre J, 1996, J EXP PSYCHOL LEARN, V22, P216, DOI 10.1037/0278-7393.22.1.216; Maeoka H, 2012, NEUROSCI LETT, V512, P12, DOI 10.1016/j.neulet.2012.01.037; Marshall L, 2004, J NEUROSCI, V24, P9985, DOI 10.1523/JNEUROSCI.2725-04.2004; Matsumoto J, 2010, J NEUROENG REHABIL, V7, DOI 10.1186/1743-0003-7-27; Miniussi C, 2012, CLIN EEG NEUROSCI, V43, P184, DOI 10.1177/1550059412444976; Miranda PC, 2006, CLIN NEUROPHYSIOL, V117, P1623, DOI 10.1016/j.clinph.2006.04.009; Mognon A, 2011, PSYCHOPHYSIOLOGY, V48, P229, DOI 10.1111/j.1469-8986.2010.01061.x; Monte-Silva K, 2013, BRAIN STIMUL, V6, P424, DOI 10.1016/j.brs.2012.04.011; Nitsche MA, 2000, J PHYSIOL-LONDON, V527, P633, DOI 10.1111/j.1469-7793.2000.t01-1-00633.x; Nitsche MA, 2009, EXP NEUROL, V219, P14, DOI 10.1016/j.expneurol.2009.03.038; Nitsche MA, 2008, BRAIN STIMUL, V1, P206, DOI 10.1016/j.brs.2008.06.004; Nyhus E, 2010, NEUROSCI BIOBEHAV R, V34, P1023, DOI 10.1016/j.neubiorev.2009.12.014; Ohn SH, 2008, NEUROREPORT, V19, P43, DOI 10.1097/WNR.0b013e3282f2adfd; Osipova D, 2006, J NEUROSCI, V26, P7523, DOI 10.1523/JNEUROSCI.1948-06.2006; PARKMAN JM, 1971, J EXP PSYCHOL, V89, P335, DOI 10.1037/h0031198; Parsons S., 2005, DOES NUMERACY MATTER; PFURTSCHELLER G, 1970, Z GES EXP MED, V152, P284, DOI 10.1007/BF02044912; Pfurtscheller G, 2005, ELECTROENCEPHALOGRAP, P1004; Pisoni A, 2012, NEUROSCIENCE, V223, P56, DOI 10.1016/j.neuroscience.2012.07.046; Polania R, 2011, NEUROIMAGE, V54, P2287, DOI 10.1016/j.neuroimage.2010.09.085; PURPURA DP, 1965, J NEUROPHYSIOL, V28, P166, DOI 10.1152/jn.1965.28.1.166; R Development Core Team, 2012, R LANG ENV STAT COMP, DOI [10.1002/jcc.22917, DOI 10.1002/JCC.22917]; Royer JM, 1999, CONTEMP EDUC PSYCHOL, V24, P181, DOI 10.1006/ceps.1999.1004; Sarkar A, 2014, J NEUROSCI, V34, P16605, DOI 10.1523/JNEUROSCI.3129-14.2014; Schlaug G, 2011, NEUROPSYCHOL REV, V21, P288, DOI 10.1007/s11065-011-9181-y; Sparing R, 2009, BRAIN, V132, P3011, DOI 10.1093/brain/awp154; Sparing R, 2008, NEUROPSYCHOLOGIA, V46, P261, DOI 10.1016/j.neuropsychologia.2007.07.009; Stagg CJ, 2011, NEUROPSYCHOLOGIA, V49, P800, DOI 10.1016/j.neuropsychologia.2011.02.009; Stanescu-Cosson R, 2000, BRAIN, V123, P2240, DOI 10.1093/brain/123.11.2240; Stone DB, 2009, NEUROREPORT, V20, P1115, DOI 10.1097/WNR.0b013e32832e9aa2; Utz KS, 2010, NEUROPSYCHOLOGIA, V48, P2789, DOI 10.1016/j.neuropsychologia.2010.06.002; Varela F, 2001, NAT REV NEUROSCI, V2, P229, DOI 10.1038/35067550; Verguts T, 2005, MEM COGNITION, V33, P1, DOI 10.3758/BF03195293; Vines BW, 2006, NEUROREPORT, V17, P1047, DOI 10.1097/01.wnr.0000223396.05070.a2; Zago L, 2001, NEUROIMAGE, V13, P314, DOI 10.1006/nimg.2000.0697; Zbrodoff W., 2005, HDB MATH COGNITION, P331; Zhou XL, 2007, NEUROIMAGE, V35, P871, DOI 10.1016/j.neuroimage.2006.12.017; Zion-Golumbic E, 2010, J COGNITIVE NEUROSCI, V22, P263, DOI 10.1162/jocn.2009.21251	93	17	17	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2015	10	3							e0120665	10.1371/journal.pone.0120665	http://dx.doi.org/10.1371/journal.pone.0120665			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD9NQ	25789486	Green Accepted, Green Published, gold, Green Submitted			2022-12-27	WOS:000351425400170
J	Scherer, A; Kuhl, S; Wessels, D; Lusche, DF; Hanson, B; Ambrose, J; Voss, E; Fletcher, E; Goldman, C; Soll, DR				Scherer, Amanda; Kuhl, Spencer; Wessels, Deborah; Lusche, Daniel F.; Hanson, Brett; Ambrose, Joseph; Voss, Edward; Fletcher, Emily; Goldman, Charles; Soll, David R.			A Computer-Assisted 3D Model for Analyzing the Aggregation of Tumorigenic Cells Reveals Specialized Behaviors and Unique Cell Types that Facilitate Aggregate Coalescence	PLOS ONE			English	Article							BREAST-CANCER; MOTION ANALYSIS; 3-DIMENSIONAL RECONSTRUCTION; FLUORESCENCE MICROSCOPY; EXTRACELLULAR-MATRIX; LIVE CELLS; TUMOR; CULTURE; INVADOPODIA; PHENOTYPE	We have developed a 4D computer-assisted reconstruction and motion analysis system, J3D-DIAS 4.1, and applied it to the reconstruction and motion analysis of tumorigenic cells in a 3D matrix. The system is unique in that it is fast, high-resolution, acquires optical sections using DIC microscopy (hence there is no associated photoxicity), and is capable of long-term 4D reconstruction. Specifically, a z-series at 5 mu m increments can be acquired in less than a minute on tissue samples embedded in a 1.5 mm thick 3D Matrigel matrix. Reconstruction can be repeated at intervals as short as every minute and continued for 30 days or longer. Images are converted to mathematical representations from which quantitative parameters can be derived. Application of this system to cancer cells from established lines and fresh tumor tissue has revealed unique behaviors and cell types not present in non-tumorigenic lines. We report here that cells from tumorigenic lines and tumors undergo rapid coalescence in 3D, mediated by specific cell types that we have named "facilitators" and "probes." A third cell type, the "dervish", is capable of rapid movement through the gel and does not adhere to it. These cell types have never before been described. Our data suggest that tumorigenesis in vitro is a developmental process involving coalescence facilitated by specialized cells that culminates in large hollow spheres with complex architecture. The unique effects of select monoclonal antibodies on these processes demonstrate the usefulness of the model for analyzing the mechanisms of anticancer drugs.	[Scherer, Amanda; Kuhl, Spencer; Wessels, Deborah; Lusche, Daniel F.; Hanson, Brett; Ambrose, Joseph; Voss, Edward; Soll, David R.] Univ Iowa, Dept Biol, Monoclonal Antibody Res Inst, Dev Studies Hybridoma Bank, Iowa City, IA 52242 USA; [Fletcher, Emily; Goldman, Charles] Mercy Hosp Syst Des Moines, Des Moines, IA USA	University of Iowa	Soll, DR (corresponding author), Univ Iowa, Dept Biol, Monoclonal Antibody Res Inst, Dev Studies Hybridoma Bank, Iowa City, IA 52242 USA.	david-soll@uiowa.edu		Lusche, Daniel Felix/0000-0002-8848-4198	Monoclonal Antibody Research Institute; Developmental Studies Hybridoma Bank	Monoclonal Antibody Research Institute; Developmental Studies Hybridoma Bank	This work was supported by the Monoclonal Antibody Research Institute and the Developmental Studies Hybridoma Bank, the latter a National Resource created by the National Institutes of Health (NIH) and housed at the University of Iowa. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baugher PJ, 2005, BREAST CANCER RES, V7, pR965, DOI 10.1186/bcr1329; Beaty BT, 2014, J CELL BIOL, V205, P737, DOI 10.1083/jcb.201312046; Bertolini F, 2006, NAT REV CANCER, V6, P833, DOI 10.1039/nrc1971; Buccione R, 2009, CANCER METAST REV, V28, P137, DOI 10.1007/s10555-008-9176-1; CAILLEAU R, 1978, IN VITRO CELL DEV B, V14, P911; Chambers AF, 2009, CANCER RES, V69, P5292, DOI 10.1158/0008-5472.CAN-09-1528; Debnath J, 2003, METHODS, V30, P256, DOI 10.1016/S1046-2023(03)00032-X; Dixit R, 2003, PLANT J, V36, P280, DOI 10.1046/j.1365-313X.2003.01868.x; Dobrucki JW, 2007, BIOPHYS J, V93, P1778, DOI 10.1529/biophysj.106.096636; Ellison G, 2002, J CLIN PATHOL-MOL PA, V55, P294, DOI 10.1136/mp.55.5.294; Freshney R. I., 2005, CULTURE ANIMAL CELLS, V5th; Fridlender ZG, 2012, CARCINOGENESIS, V33, P949, DOI 10.1093/carcin/bgs123; George SP, 2013, J CELL SCI, V126, P312, DOI 10.1242/jcs.116244; Godugu C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053708; Guo XY, 2008, J BIOL CHEM, V283, P19864, DOI 10.1074/jbc.M800798200; Heid PJ, 2005, J CELL SCI, V118, P2225, DOI 10.1242/jcs.02342; Heid PJ, 2002, DEV BIOL, V245, P329, DOI 10.1006/dbio.2002.0631; HOWLETT AR, 1995, J CELL SCI, V108, P1945; Jaiswal R, 2013, CURR BIOL, V23, P1373, DOI 10.1016/j.cub.2013.06.013; Jensen EC, 2012, ANAT REC, V295, P2031, DOI 10.1002/ar.22602; Keller PJ, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2755; KELLY T, 1994, J CELL PHYSIOL, V158, P299, DOI 10.1002/jcp.1041580212; Kharaishvili G, 2014, CANCER CELL INT, V14, DOI 10.1186/1475-2867-14-41; Krause S, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-263; Laplantine E, 2000, J CELL SCI, V113, P1167; Lee GY, 2007, NAT METHODS, V4, P359, DOI 10.1038/NMETH1015; Li LY, 2011, J CANCER, V2, P458, DOI 10.7150/jca.2.458; Lusche DF, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108495; Martin MD, 2008, CLIN EXP METASTAS, V25, P877, DOI 10.1007/s10585-008-9206-y; Moin K, 2012, METHOD ENZYMOL, V506, P175, DOI 10.1016/B978-0-12-391856-7.00034-2; Ohlund D, 2014, J EXP MED, V211, P1503, DOI 10.1084/jem.20140692; Pampaloni F, 2014, INTEGR BIOL-UK, V6, P988, DOI 10.1039/c4ib00121d; Park CC, 2008, CANCER RES, V68, P4398, DOI 10.1158/0008-5472.CAN-07-6390; Park CC, 2006, CANCER RES, V66, P1526, DOI 10.1158/0008-5472.CAN-05-3071; PETERSEN OW, 1992, P NATL ACAD SCI USA, V89, P9064, DOI 10.1073/pnas.89.19.9064; Poston T, 1998, COMPUT GRAPH FORUM, V17, pC137, DOI 10.1111/1467-8659.00261; PRICE JE, 1990, CANCER RES, V50, P717; Rae JM, 2007, BREAST CANCER RES TR, V104, P13, DOI 10.1007/s10549-006-9392-8; Riabov V, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00075; Rohan TE, 2014, JNCI-J NATL CANCER I, P106; Sameni M, 2012, JOVE-J VIS EXP, DOI 10.3791/3661; SATYASWAROOP PG, 1991, CANCER RES, V51, P5661; Scales TME, 2013, ONCOGENE, V32, P3965, DOI 10.1038/onc.2012.415; Scherer A, 2010, J CELL SCI, V123, P3756, DOI 10.1242/jcs.068619; Scott RW, 2010, J CELL BIOL, V191, P169, DOI 10.1083/jcb.201002041; Sharma Ved P, 2012, Intravital, V1, P77; Sidani M, 2007, J CELL BIOL, V179, P777, DOI 10.1083/jcb.200707009; Sionov RV, 2015, CANCER MICROENVIRON, V8, P125, DOI 10.1007/s12307-014-0147-5; Soll DR, 2009, EUKARYOT CELL, V8, P1381, DOI 10.1128/EC.00121-09; Soll David R, 2003, ScientificWorldJournal, V3, P827; Soll David R., 2007, P365, DOI 10.1007/978-3-540-71331-9_13; Soll DR, 1999, COMPUT MED IMAG GRAP, V23, P3, DOI 10.1016/S0895-6111(98)00058-5; Soll DR, 1995, INT REV CYTOL, V163, P43; Soll DR, 2000, SCANNING, V22, P249, DOI 10.1002/sca.4950220404; Soll DR, 2001, METH MOL B, V161, P45; Soll DR, 1998, TECH MOD B, P25; SOULE HD, 1990, CANCER RES, V50, P6075; Sung Myong-Hee, 2013, Cells, V2, P284, DOI 10.3390/cells2020284; Varzavand A, 2013, CLIN EXP METASTAS, V30, P541, DOI 10.1007/s10585-012-9558-1; Victor BC, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr3058; Vidi Pierre-Alexandre, 2013, Methods Mol Biol, V945, P193, DOI 10.1007/978-1-62703-125-7_13; Vinci M, 2012, BMC BIOL, V10, DOI 10.1186/1741-7007-10-29; Vitolo MI, 2009, CANCER RES, V69, P8275, DOI 10.1158/0008-5472.CAN-09-1067; Weaver VM, 1997, J CELL BIOL, V137, P231, DOI 10.1083/jcb.137.1.231; Wessels D, 1998, CELL MOTIL CYTOSKEL, V41, P225, DOI 10.1002/(SICI)1097-0169(1998)41:3<225::AID-CM4>3.3.CO;2-9; Wessels Deborah, 2006, V346, P261; Wessels D, 2009, METHODS MOL BIOL, V586, P315, DOI 10.1007/978-1-60761-376-3_18	67	10	10	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2015	10	3							e0118628	10.1371/journal.pone.0118628	http://dx.doi.org/10.1371/journal.pone.0118628			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD9NQ	25790299	Green Submitted, Green Published, gold			2022-12-27	WOS:000351425400037
J	Yanagi, T; Shi, RX; Aza-Blanc, P; Reed, JC; Matsuzawa, S				Yanagi, Teruki; Shi, Ranxin; Aza-Blanc, Pedro; Reed, John C.; Matsuzawa, Shu-ichi			PCTAIRE1-Knockdown Sensitizes Cancer Cells to TNF Family Cytokines	PLOS ONE			English	Article							PROTEIN-KINASE; CYCLIN Y; PHOSPHORYLATION; APOPTOSIS; CASPASE-8; SURVIVAL; TRAIL; DEATH; FADD; DEGRADATION	While PCTAIRE1/PCTK1/Cdk16 is overexpressed in malignant cells and is crucial in tumorigenesis, its function in apoptosis remains unclear. Here we investigated the role of PCTAIRE1 in apoptosis, especially in the extrinsic cell death pathway. Gene-knockdown of PCTAIRE1 sensitized prostate cancer PPC1 and Du145 cells, and breast cancer MDA-MB-468 cells to TNF-family cytokines, including TNF-related apoptosis-inducing ligand ( TRAIL). Meanwhile, PCTAIRE1-knockdown did not sensitize non-malignant cells, including diploid fibroblasts IMR-90 and the immortalized prostate epithelial cell line 267B1. PCTAIRE1-knockdown did not up-regulate death receptor expression on the cell surface or affect caspase-8, FADD and FLIP expression levels. PCTAIRE1-knockdown did promote caspase-8 cleavage and RIPK1 degradation, while RIPK1 mRNA knockdown sensitized PPC1 cells to TNF-family cytokines. Furthermore, the kinase inhibitor SNS-032, which inhibits PCTAIRE1 kinase activity, sensitized PPC1 cells to TRAIL-induced apoptosis. Together these results suggest that PCTAIRE1 contributes to the resistance of cancer cell lines to apoptosis induced by TNF-family cytokines, which implies that PCTAIRE1 inhibitors could have synergistic effects with TNF-family cytokines for cytodestruction of cancer cells.	[Yanagi, Teruki; Shi, Ranxin; Aza-Blanc, Pedro; Reed, John C.; Matsuzawa, Shu-ichi] Sanford Burnham Med Res Inst, La Jolla, CA 92037 USA	Sanford Burnham Prebys Medical Discovery Institute	Reed, JC (corresponding author), Sanford Burnham Med Res Inst, 10901 N Torrey Pines Rd, La Jolla, CA 92037 USA.	reedoffice@sanfordburnham.org; smatsuzawa@sanfordburnham.org	Yanagi, Teruki/D-4222-2017	Yanagi, Teruki/0000-0003-2196-7600	JSPS fellowships; Kanae foundation; Sumitomo life social welfare service foundation; NATIONAL CANCER INSTITUTE [P30CA030199] Funding Source: NIH RePORTER	JSPS fellowships(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Kanae foundation; Sumitomo life social welfare service foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Teruki Yanagi is supported by JSPS fellowships for research abroad, Kanae foundation, and Sumitomo life social welfare service foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alappat EC, 2005, MOL CELL, V19, P321, DOI 10.1016/j.molcel.2005.06.024; Alvarado-Kristensson M, 2004, J EXP MED, V199, P449, DOI 10.1084/jem.20031771; Cheresh DA, 2008, ONCOGENE, V27, P6285, DOI 10.1038/onc.2008.304; Cole AR, 2009, NEUROSIGNALS, V17, P288, DOI 10.1159/000231895; Dan HC, 2004, J BIOL CHEM, V279, P5405, DOI 10.1074/jbc.M312044200; Desagher S, 2001, MOL CELL, V8, P601, DOI 10.1016/S1097-2765(01)00335-5; Finnberg N, 2008, CELL CYCLE, V7, P1525, DOI 10.4161/cc.7.11.5975; Garcia-Garcia C, 2010, BIOCHEM PHARMACOL, V79, P853, DOI 10.1016/j.bcp.2009.10.022; Graeser R, 2002, J CELL SCI, V115, P3479; Jia SH, 2008, J BIOL CHEM, V283, P5402, DOI 10.1074/jbc.M706462200; Kennedy NJ, 1998, J IMMUNOL, V160, P4881; Le Bouffant F, 2000, MOL CELL NEUROSCI, V16, P388, DOI 10.1006/mcne.2000.0881; Lemke J, 2014, CELL DEATH DIFFER, V21, P491, DOI 10.1038/cdd.2013.179; Lewis J, 2000, J BIOL CHEM, V275, P10519, DOI 10.1074/jbc.275.14.10519; Liu YX, 2006, J BIOL CHEM, V281, P9852, DOI 10.1074/jbc.M513496200; Matthess Y, 2010, MOL CELL BIOL, V30, P5726, DOI 10.1128/MCB.00731-10; Mikolcevic P, 2012, CELL CYCLE, V11, P3758, DOI 10.4161/cc.21592; Mikolcevic P, 2012, MOL CELL BIOL, V32, P868, DOI 10.1128/MCB.06261-11; Ofengeim D, 2013, NAT REV MOL CELL BIO, V14, P727, DOI 10.1038/nrm3683; Palacios C, 2010, CANCER LETT, V287, P207, DOI 10.1016/j.canlet.2009.06.012; Palmer KJ, 2005, J CELL SCI, V118, P3839, DOI 10.1242/jcs.02496; PARDA DS, 1993, PROSTATE, V23, P91, DOI 10.1002/pros.2990230202; Rochat-Steiner V, 2000, J EXP MED, V192, P1165, DOI 10.1084/jem.192.8.1165; Ruvolo PP, 1998, J BIOL CHEM, V273, P25436, DOI 10.1074/jbc.273.39.25436; Sanchez-Perez T, 2010, CELL DEATH DIFFER, V17, P883, DOI 10.1038/cdd.2009.176; Scaffidi C, 2000, J IMMUNOL, V164, P1236, DOI 10.4049/jimmunol.164.3.1236; Scatena CD, 1998, J BIOL CHEM, V273, P30777, DOI 10.1074/jbc.273.46.30777; Sharma P, 2011, NAT REV CANCER, V11, P805, DOI 10.1038/nrc3153; Shimada K, 2004, CARCINOGENESIS, V25, P1089, DOI 10.1093/carcin/bgh130; Shirley S, 2013, CANCER LETT, V332, P141, DOI 10.1016/j.canlet.2010.10.009; Tang XQ, 2006, P NATL ACAD SCI USA, V103, P2087, DOI 10.1073/pnas.0507660103; Wiederschain D, 2009, CELL CYCLE, V8, P498, DOI 10.4161/cc.8.3.7701; Wu GS, 2009, CANCER LETT, V285, P1, DOI 10.1016/j.canlet.2009.02.029; Yanagi Teruki, 2014, Oncoscience, V1, P624; Yanagi T, 2014, CANCER RES, V74, P5795, DOI 10.1158/0008-5472.CAN-14-0872	35	15	16	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2015	10	3							e0119404	10.1371/journal.pone.0119404	http://dx.doi.org/10.1371/journal.pone.0119404			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD9NQ	25790448	Green Published, Green Submitted, gold			2022-12-27	WOS:000351425400079
J	Yuan, K; Liu, J; Liu, KP; Tan, TY				Yuan, Kai; Liu, Jian; Liu, Kaipei; Tan, Tianyuan			A Scalable Distribution Network Risk Evaluation Framework via Symbolic Dynamics	PLOS ONE			English	Article								Background Evaluations of electric power distribution network risks must address the problems of incomplete information and changing dynamics. A risk evaluation framework should be adaptable to a specific situation and an evolving understanding of risk. Methods This study investigates the use of symbolic dynamics to abstract raw data. After introducing symbolic dynamics operators, Kolmogorov-Sinai entropy and Kullback-Leibler relative entropy are used to quantitatively evaluate relationships between risk sub-factors and main factors. For layered risk indicators, where the factors are categorized into four main factors - device, structure, load and special operation - a merging algorithm using operators to calculate the risk factors is discussed. Finally, an example from the Sanya Power Company is given to demonstrate the feasibility of the proposed method. Conclusion Distribution networks are exposed and can be affected by many things. The topology and the operating mode of a distribution network are dynamic, so the faults and their consequences are probabilistic.	[Yuan, Kai] Wuhan Univ, Sch Elect Engn, Reliabil Evaluat Power Syst Grp, Hubei, Peoples R China; [Liu, Jian] Wuhan Univ, Sch Elect Engn, Distribut Network Risk Evaluat & Reliabil & Life, Hubei, Peoples R China; [Liu, Kaipei] Wuhan Univ, Sch Elect Engn, Distribut Network Power Qual Problem Grp, Hubei, Peoples R China; [Tan, Tianyuan] Wuhan Univ, Sch Elect Engn, Distribut Network Risk Evaluat & Reliabil Res Tea, Hubei, Peoples R China	Wuhan University; Wuhan University; Wuhan University; Wuhan University	Liu, J (corresponding author), Wuhan Univ, Sch Elect Engn, Hubei, Peoples R China.	liujian_whu@126.com						Billinton R, 2004, IEEE T POWER DELIVER, V19, P1759, DOI 10.1109/TPWRD.2004.832404; Caminal P, 2005, IEEE T BIO-MED ENG, V52, P1832, DOI 10.1109/TBME.2005.856293; Douglas AP, 1998, IEEE T POWER SYST, V13, P1493, DOI 10.1109/59.736296; Feng YQ, 2008, IEEE T POWER SYST, V23, P1309, DOI 10.1109/TPWRS.2008.922616; Friedlander D, 2003, P AM CONTR C, V6, P4590; Guocheng W, 2003, P CSEE, V23, P48; Janjic AD, 2007, IEEE T POWER SYST, V22, P597, DOI 10.1109/TPWRS.2007.894863; Jin X, 2011, IEEE T NUCL SCI, V58, P277, DOI 10.1109/TNS.2010.2088138; Li WY, 2008, IEEE T POWER SYST, V23, P336, DOI 10.1109/TPWRS.2008.919201; Li WY, 2005, IEEE T POWER SYST, V20, P1144, DOI 10.1109/TPWRS.2005.846112; Ni M, 2003, IEEE T POWER SYST, V18, P258, DOI 10.1109/TPWRS.2002.807091; Sandkuhl K, 2008, LECT NOTES BUS INF P, V15, P1; Stojanovski T, 1997, IEEE T CIRCUITS-I, V44, P1014, DOI 10.1109/81.633892; Street A, 2009, IEEE T POWER SYST, V24, P1136, DOI 10.1109/TPWRS.2009.2022981; Underbrink A, 2006, IEEE T POWER DELIVER, V8, P1; Wan Guo-cheng, 2004, Proceedings of the CSEE, V24, P92; Wu Kai-Gui, 2000, Proceedings of the CSEE, V20, P9; Xiao F, 2009, IEEE T POWER SYST, V24, P78, DOI 10.1109/TPWRS.2008.2004823; Zafra-Cabeza A, 2008, IEEE T POWER SYST, V23, P938, DOI 10.1109/TPWRS.2008.922255; Zhang J, 2002, IEEE T POWER DELIVER, V17, P770, DOI 10.1109/TPWRD.2002.1022802	20	0	0	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2015	10	3							e0112940	10.1371/journal.pone.0112940	http://dx.doi.org/10.1371/journal.pone.0112940			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD9NQ	25789859	Green Published, gold, Green Submitted			2022-12-27	WOS:000351425400003
J	Dias, JG; de Oliveira, IT				Dias, Jose G.; de Oliveira, Isabel Tiago			Multilevel Effects of Wealth on Women's Contraceptive Use in Mozambique	PLOS ONE			English	Article							FERTILITY; MODELS; EQUITY; COVERAGE; POOR	Objective This paper analyzes the impact of wealth on the use of contraception in Mozambique unmixing the contextual effects due to community wealth from the individual effects associated with the women's situation within the community of residence. Methods Data from the 2011 Mozambican Demographic and Health Survey on women who are married or living together are analyzed for the entire country and also for the rural and urban areas separately. We used single level and multilevel probit regression models. Findings A single level probit regression reveals that region, religion, age, previous fertility, education, and wealth impact contraceptive behavior. The multilevel analysis shows that average community wealth and the women's relative socioeconomic position within the community have significant positive effects on the use of modern contraceptives. The multilevel framework proved to be necessary in rural settings but not relevant in urban areas. Moreover, the contextual effects due to community wealth are greater in rural than in urban areas and this feature is associated with the higher socioeconomic heterogeneity within the richest communities. Conclusion This analysis highlights the need for the studies on contraceptive behavior to specifically address the individual and contextual effects arising from the poverty-wealth dimension in rural and urban areas separately. The inclusion in a particular community of residence is not relevant in urban areas, but it is an important feature in rural areas. Although the women's individual position within the community of residence has a similar effect on contraceptive adoption in rural and urban settings, the impact of community wealth is greater in rural areas and smaller in urban areas.	[Dias, Jose G.] Inst Univ Lisboa ISCTE IUL, BRU, Lisbon, Portugal; [de Oliveira, Isabel Tiago] Inst Univ Lisboa ISCTE IUL, CIES Ctr Estudos & Invest Sociol, Lisbon, Portugal	Instituto Universitario de Lisboa; Instituto Universitario de Lisboa	Dias, JG (corresponding author), Inst Univ Lisboa ISCTE IUL, BRU, Lisbon, Portugal.	jose.dias@iscte.pt	Dias, José G./N-6217-2015; Oliveira, Isabel/AAE-4688-2022	Oliveira, Isabel/0000-0002-9350-4130; Dias, Jose G./0000-0003-4732-7230	Fundacao para a Ciencia e Tecnologia (Portugal) [PTDC/CS-DEM/108033/2008]; Fundação para a Ciência e a Tecnologia [PTDC/CS-DEM/108033/2008] Funding Source: FCT	Fundacao para a Ciencia e Tecnologia (Portugal)(Portuguese Foundation for Science and Technology); Fundação para a Ciência e a Tecnologia	This research was supported by the Fundacao para a Ciencia e Tecnologia (Portugal), Grant PTDC/CS-DEM/108033/2008. (URL: http://www.fct.pt/index.phtml.pt) The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agadjanian V, 2001, POP STUD-J DEMOG, V55, P135, DOI 10.1080/00324720127691; Agadjanian V, 2011, DEMOGRAPHY, V48, P1029, DOI 10.1007/s13524-011-0039-y; Arnaldo C., 2004, Journal of Population Research, V21, P177; Boerma JT, 2008, LANCET, V371, P1259, DOI 10.1016/S0140-6736(08)60560-7; Bongaarts J, 1996, POPUL DEV REV, V22, P639, DOI 10.2307/2137804; Casterline JB, 2001, DIFFUSION PROCESSES AND FERTILITY TRANSITION: SELECTED PERSPECTIVES, P1; Creanga AA, 2011, B WORLD HEALTH ORGAN, V89, P258, DOI 10.2471/BLT.10.083329; Elfstrom KM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040670; Enders CK, 2007, PSYCHOL METHODS, V12, P121, DOI 10.1037/1082-989X.12.2.121; Filmer D, 2001, DEMOGRAPHY, V38, P115, DOI 10.2307/3088292; Fotso JC, 2013, INT J EQUITY HEALTH, V12, DOI 10.1186/1475-9276-12-71; Gakidou E, 2007, PLOS MED, V4, P381, DOI 10.1371/journal.pmed.0040031; Gillespie D, 2007, B WORLD HEALTH ORGAN, V85, P100, DOI 10.2471/BLT.06.033829; GRANOVETTER MS, 1973, AM J SOCIOL, V78, P1360, DOI 10.1086/225469; Gwatkin D., 2005, SOCIOECONOMIC DIFFER, V2nd ed.; Hofmann DA, 1998, J MANAGE, V24, P623, DOI 10.1177/014920639802400504; Hosseinpoor AR, 2011, B WORLD HEALTH ORGAN, V89, P881, DOI 10.2471/BLT.11.087536; Hox JJ, 2010, MULTILEVEL ANAL TECH, V2nd; Instituto Nacional de Estatistica, 2013, MO AMBIQUE INQU RITO; Jacobstein R, 2009, STUD FAMILY PLANN, V40, P147, DOI 10.1111/j.1728-4465.2009.00197.x; Kreft I. G., 1998, INTRO MULTILEVEL MOD, DOI DOI 10.4135/9781849209366; Montgomery MR, 1996, POPUL DEV REV, V22, P151, DOI 10.2307/2808010; Ortayli N, 2010, STUD FAMILY PLANN, V41, P101, DOI 10.1111/j.1728-4465.2010.00230.x; Rogers E.M., 1995, DIFFUSION INNOVATION; Rutstein S. O., 2008, 60 DHS MACR INC; Stephenson R, 2008, INT FAM PLAN PERSPEC, V34, P62, DOI 10.1363/ifpp.34.062.08; Stephenson R, 2007, AM J PUBLIC HEALTH, V97, P1233, DOI 10.2105/AJPH.2005.071522; Yazbeck A. S., 2005, Reaching the poor with health, nutrition, and population services: what works, what doesn't and why, P3	28	16	16	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2015	10	3							e0121758	10.1371/journal.pone.0121758	http://dx.doi.org/10.1371/journal.pone.0121758			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CE9BN	25786228	Green Published, Green Submitted, gold			2022-12-27	WOS:000352138500216
J	Gomez-Carballa, A; Pardo-Seco, J; Amigo, J; Martinon-Torres, F; Salas, A				Gomez-Carballa, Alberto; Pardo-Seco, Jacobo; Amigo, Jorge; Martinon-Torres, Federico; Salas, Antonio			Mitogenomes from The 1000 Genome Project Reveal New Near Eastern Features in Present-Day Tuscans	PLOS ONE			English	Article							MITOCHONDRIAL-DNA VARIATION; MTDNA VARIATION; MIDDLE-EAST; ETRUSCAN; ORIGIN; EUROPE; PERSPECTIVE; EXPANSION; GENETICS; SEQUENCE	Background Genetic analyses have recently been carried out on present-day Tuscans (Central Italy) in order to investigate their presumable recent Near East ancestry in connection with the long-standing debate on the origins of the Etruscan civilization. We retrieved mitogenomes and genome-wide SNP data from 110 Tuscans analyzed within the context of The 1000 Genome Project. For phylogeographic and evolutionary analysis we made use of a large worldwide database of entire mitogenomes (>26,000) and partial control region sequences (>180,000). Results Different analyses reveal the presence of typical Near East haplotypes in Tuscans representing isolated members of various mtDNA phylogenetic branches. As a whole, the Near East component in Tuscan mitogenomes can be estimated at about 8%; a proportion that is comparable to previous estimates but significantly lower than admixture estimates obtained from autosomal SNP data (21%). Phylogeographic and evolutionary inter-population comparisons indicate that the main signal of Near Eastern Tuscan mitogenomes comes from Iran. Conclusions Mitogenomes of recent Near East origin in present-day Tuscans do not show local or regional variation. This points to a demographic scenario that is compatible with a recent arrival of Near Easterners to this region in Italy with no founder events or bottlenecks.	[Gomez-Carballa, Alberto; Pardo-Seco, Jacobo; Amigo, Jorge; Salas, Antonio] Univ Santiago de Compostela, Fac Med, Dept Anat Patol & Ciencias Forenses, Unidade Xenet, Galicia 15872, Spain; [Gomez-Carballa, Alberto; Pardo-Seco, Jacobo; Amigo, Jorge; Salas, Antonio] Univ Santiago de Compostela, Fac Med, Inst Ciencias Forenses, Galicia 15872, Spain; [Gomez-Carballa, Alberto; Pardo-Seco, Jacobo; Martinon-Torres, Federico; Salas, Antonio] Hosp Clin Univ, Grp Invest Genet Vacunas Infecc & Pediat GENVIP, Galicia, Spain; [Gomez-Carballa, Alberto; Pardo-Seco, Jacobo; Martinon-Torres, Federico; Salas, Antonio] Univ Santiago Compostela, Galicia, Spain; [Martinon-Torres, Federico] Univ Santiago, Hosp Clin, Dept Pediat, Pediat Emergency & Crit Care Div, Santiago De Compostela, Galicia, Spain	Universidade de Santiago de Compostela; Universidade de Santiago de Compostela; Universidade de Santiago de Compostela; Complexo Hospitalario Universitario de Santiago de Compostela; Universidade de Santiago de Compostela	Salas, A (corresponding author), Univ Santiago de Compostela, Fac Med, Dept Anat Patol & Ciencias Forenses, Unidade Xenet, Galicia 15872, Spain.	antonio.salas@usc.es	Pardo-Seco, Jacobo J/G-3752-2016; Martinon-Torres, Federico/E-4982-2016; Amigo Lechuga, Jorge/A-4892-2010; Salas, Antonio/E-3977-2012; Salas, Antonio/U-2029-2019; Gómez-Carballa, Alberto/I-4610-2014	Pardo-Seco, Jacobo J/0000-0002-8059-8908; Martinon-Torres, Federico/0000-0002-9023-581X; Amigo Lechuga, Jorge/0000-0002-1362-2605; Salas, Antonio/0000-0002-2336-702X; Salas, Antonio/0000-0002-2336-702X; Gómez-Carballa, Alberto/0000-0003-0927-1272	Spanish Ministerio de Ciencia e Innovacion [SAF2011-26983]; Plan Galego IDT; Xunta de Galicia [EM 2012/045]; Conselleria de Sanidade/Xunta de Galicia [RHI07/2, 10PXIB918184PR]; Instituto Carlos III (Intensificacion de la Actividad Investigadora); Fondo de Investigacion Sanitaria (FIS) of the Plan Nacional de I+D+I and 'fondos FEDER' (F.M.T.) [PI070069, PI1000540]	Spanish Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); Plan Galego IDT; Xunta de Galicia(Xunta de GaliciaEuropean Commission); Conselleria de Sanidade/Xunta de Galicia(Xunta de Galicia); Instituto Carlos III (Intensificacion de la Actividad Investigadora)(Instituto de Salud Carlos III); Fondo de Investigacion Sanitaria (FIS) of the Plan Nacional de I+D+I and 'fondos FEDER' (F.M.T.)	This project received funding from the Spanish Ministerio de Ciencia e Innovacion (SAF2011-26983) and from the Plan Galego IDT, Xunta de Galicia (EM 2012/045) (A.S.) and Conselleria de Sanidade/Xunta de Galicia (RHI07/2-Intensificacion Actividad Investigadora and 10PXIB918184PR), Instituto Carlos III (Intensificacion de la Actividad Investigadora) and Fondo de Investigacion Sanitaria (FIS; PI070069 and PI1000540) of the Plan Nacional de I+D+I and 'fondos FEDER' (F.M.T.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achilli A, 2007, AM J HUM GENET, V80, P759, DOI 10.1086/512822; Al-Zahery N, 2003, MOL PHYLOGENET EVOL, V28, P458, DOI 10.1016/S1055-7903(03)00039-3; Amigo J, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-105; Amigo J, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-428; Andrews RM, 1999, NAT GENET, V23, P147, DOI 10.1038/13779; Badro DA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054616; Bandelt HJ, 2012, INT J LEGAL MED, V126, P901, DOI 10.1007/s00414-012-0762-y; Belle EMS, 2006, P NATL ACAD SCI USA, V103, P8012, DOI 10.1073/pnas.0509718103; Brandstatter A, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-191; Brisighelli F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050794; Brisighelli F, 2009, EUR J HUM GENET, V17, P693, DOI 10.1038/ejhg.2008.224; Cerezo M, 2012, GENOME RES, V22, P821, DOI 10.1101/gr.134452.111; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Forster P, 1996, AM J HUM GENET, V59, P935; Francalacci P, 1996, AM J PHYS ANTHROPOL, V100, P443, DOI 10.1002/(SICI)1096-8644(199608)100:4<443::AID-AJPA1>3.0.CO;2-S; Ghirotto S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055519; Gonzalez AM, 2008, ANN HUM BIOL, V35, P212, DOI 10.1080/03014460801946538; Guimaraes S, 2009, MOL BIOL EVOL, V26, P2157, DOI 10.1093/molbev/msp126; Hellenthal G, 2014, SCIENCE, V343, P747, DOI 10.1126/science.1243518; Mairal Q, 2013, FORENSIC SCI INT-GEN, V7, P618, DOI 10.1016/j.fsigen.2013.08.009; Pardo-Seco J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105920; Pellecchia M, 2007, P R SOC B, V274, P1175, DOI 10.1098/rspb.2006.0258; Richard C, 2007, ANN HUM BIOL, V34, P68, DOI 10.1080/03014460601076098; Roostalu U, 2007, MOL BIOL EVOL, V24, P436, DOI 10.1093/molbev/msl173; Saillard J, 2000, AM J HUM GENET, V67, P718, DOI 10.1086/303038; Salas A, 2002, AM J HUM GENET, V71, P1082, DOI 10.1086/344348; Salas A, 2012, FORENSIC SCI INT-GEN, V6, pE182, DOI 10.1016/j.fsigen.2012.06.015; Soares P, 2009, AM J HUM GENET, V84, P740, DOI 10.1016/j.ajhg.2009.05.001; Tassi F, 2013, AM J PHYS ANTHROPOL, V152, P11, DOI 10.1002/ajpa.22319; van Oven M, 2009, HUM MUTAT, V30, pE386, DOI 10.1002/humu.20921; Vernesi C, 2004, AM J HUM GENET, V74, P694, DOI 10.1086/383284; Yang ZH, 1997, COMPUT APPL BIOSCI, V13, P555; Zheng HX, 2012, SCI REP-UK, V2, DOI 10.1038/srep00745	33	14	14	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2015	10	3							e0119242	10.1371/journal.pone.0119242	http://dx.doi.org/10.1371/journal.pone.0119242			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9BN	25786119	Green Published, gold, Green Submitted			2022-12-27	WOS:000352138500086
J	Kim, NY; Kohn, JC; Huynh, J; Carey, SP; Mason, BN; Vouyouka, AG; Reinhart-King, CA				Kim, Na Young; Kohn, Julie C.; Huynh, John; Carey, Shawn P.; Mason, Brooke N.; Vouyouka, Ageliki G.; Reinhart-King, Cynthia A.			Biophysical Induction of Vascular Smooth Muscle Cell Podosomes	PLOS ONE			English	Article							EXTRACELLULAR-MATRIX DEGRADATION; ACTIN POLYMERIZATION; PULSE PRESSURE; KINASE; INVADOPODIA; MIGRATION; SRC; MECHANISMS; MORPHOLOGY; INHIBITOR	Vascular smooth muscle cell (VSMC) migration and matrix degradation occurs with intimal hyperplasia associated with atherosclerosis, vascular injury, and restenosis. One proposed mechanism by which VSMCs degrade matrix is through the use of podosomes, transient actin-based structures that are thought to play a role in extracellular matrix degradation by creating localized sites of matrix metalloproteinase (MMP) secretion. To date, podosomes in VSMCs have largely been studied by stimulating cells with phorbol esters, such as phorbol 12,13-dibutyrate (PDBu), however little is known about the physiological cues that drive podosome formation. We present the first evidence that physiological, physical stimuli mimicking cues present within the microenvironment of diseased arteries can induce podosome formation in VSMCs. Both microtopographical cues and imposed pressure mimicking stage II hypertension induce podosome formation in A7R5 rat aortic smooth muscle cells. Moreover, wounding using a scratch assay induces podosomes at the leading edge of VSMCs. Notably the effect of each of these biophysical stimuli on podosome stimulation can be inhibited using a Src inhibitor. Together, these data indicate that physical cues can induce podosome formation in VSMCs.	[Kim, Na Young; Kohn, Julie C.; Huynh, John; Carey, Shawn P.; Mason, Brooke N.; Reinhart-King, Cynthia A.] Cornell Univ, Dept Biomed Engn, Ithaca, NY 14850 USA; [Vouyouka, Ageliki G.] Mt Sinai Hosp, Div Vasc Surg, New York, NY 10029 USA	Cornell University; Icahn School of Medicine at Mount Sinai	Reinhart-King, CA (corresponding author), Cornell Univ, Dept Biomed Engn, Ithaca, NY 14850 USA.	cak57@cornell.edu	Kohn, Julie C/V-2566-2019; Reinhart-King, Cynthia/A-9264-2016	Reinhart-King, Cynthia/0000-0001-6959-3914	Presidential Council of Cornell Women; National Science Career Award [1055502]; National Science Foundation; National Science Foundation [ECCS-0335765]	Presidential Council of Cornell Women; National Science Career Award; National Science Foundation(National Science Foundation (NSF)); National Science Foundation(National Science Foundation (NSF))	This work was funded by a grant from the Presidential Council of Cornell Women and an National Science Career Award (Award number 1055502) to CAR and National Science Foundation Graduate Fellowships to BNM, SPC and JCK. The Cornell NanoScale Facility is supported by the National Science Foundation Grant ECCS-0335765. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABEDI H, 1995, CARDIOVASC RES, V30, P544, DOI 10.1016/0008-6363(95)00092-5; Aga M, 2008, INVEST OPHTH VIS SCI, V49, P5353, DOI 10.1167/iovs.07-1666; Bain J, 2003, BIOCHEM J, V371, P199, DOI 10.1042/BJ20021535; Baldassarre M, 2003, MOL BIOL CELL, V14, P1074, DOI 10.1091/mbc.E02-05-0308; Balzer EM, 2010, ONCOGENE, V29, P6402, DOI 10.1038/onc.2010.360; Biela SA, 2009, ACTA BIOMATER, V5, P2460, DOI 10.1016/j.actbio.2009.04.003; Buccione R, 2004, NAT REV MOL CELL BIO, V5, P647, DOI 10.1038/nrm1436; Burgstaller G, 2005, AM J PHYSIOL-HEART C, V288, pH3001, DOI 10.1152/ajpheart.01002.2004; Charest JM, 2012, MACROMOL BIOSCI, V12, P12, DOI 10.1002/mabi.201100264; Chen CS, 1997, SCIENCE, V276, P1425, DOI 10.1126/science.276.5317.1425; Chobanian AV, 2003, HYPERTENSION, V42, P1206, DOI 10.1161/01.HYP.0000107251.49515.c2; Cipolla MJ, 2002, FASEB J, V16, P72, DOI 10.1096/cj.01-0104hyp; Cullen JP, 2005, THROMB HAEMOSTASIS, V94, P639, DOI 10.1160/TH05-03-0174; Gerthoffer WT, 2007, CIRC RES, V100, P607, DOI 10.1161/01.RES.0000258492.96097.47; Gu ZZ, 2013, VASC PHARMACOL, V58, P87, DOI 10.1016/j.vph.2012.08.003; Hai CM, 2002, EXP CELL RES, V280, P64, DOI 10.1006/excr.2002.5592; Hanke JH, 1996, J BIOL CHEM, V271, P695, DOI 10.1074/jbc.271.2.695; HOLLANDER W, 1976, AM J CARDIOL, V38, P786, DOI 10.1016/0002-9149(76)90357-X; Kaverina I, 2003, J CELL SCI, V116, P4915, DOI 10.1242/jcs.00818; Kleinedler JJ, 2012, J CONTROL RELEASE, V159, P27, DOI 10.1016/j.jconrel.2012.01.008; Linder S, 1999, P NATL ACAD SCI USA, V96, P9648, DOI 10.1073/pnas.96.17.9648; Linder S, 2007, TRENDS CELL BIOL, V17, P107, DOI 10.1016/j.tcb.2007.01.002; Mak AS, 2011, CELL ADHES MIGR, V5, P144, DOI 10.4161/cam.5.2.14375; McDonald RA, 2012, CARDIOVASC RES, V93, P594, DOI 10.1093/cvr/cvr299; Murphy DA, 2011, NAT REV MOL CELL BIO, V12, P413, DOI 10.1038/nrm3141; Onoue N, 2008, J CARDIOVASC PHARM, V51, P55, DOI 10.1097/FJC.0b013e31815b9d26; Poellmann MJ, 2010, ACTA BIOMATER, V6, P3514, DOI 10.1016/j.actbio.2010.03.041; Prasad A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048854; Quintavalle M, 2010, J CELL BIOL, V189, P13, DOI 10.1083/jcb.200912096; Redmond EM, 1999, THROMB HAEMOSTASIS, V81, P293; Schmitz U, 2002, BIOCHEM BIOPH RES CO, V291, P687, DOI 10.1006/bbrc.2002.6493; Stegemann JP, 2005, J APPL PHYSIOL, V98, P2321, DOI 10.1152/japplphysiol.01114.2004; TARONE G, 1985, EXP CELL RES, V159, P141, DOI 10.1016/S0014-4827(85)80044-6; Tatin F, 2006, J CELL SCI, V119, P769, DOI 10.1242/jcs.02787; Vouyouka AG, 2006, J VASC SURG, V44, P1076, DOI 10.1016/j.jvs.2006.06.033; Wang JG, 2010, MAGNETIC FRINGE FIELDS AND INTERFERENCE IN HIGH INTENSITY ACCELERATORS, P1; Yamaguchi H, 2005, CURR OPIN CELL BIOL, V17, P559, DOI 10.1016/j.ceb.2005.08.002; Yim EKF, 2005, BIOMATERIALS, V26, P5405, DOI 10.1016/j.biomaterials.2005.01.058	38	9	9	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2015	10	3							e0119008	10.1371/journal.pone.0119008	http://dx.doi.org/10.1371/journal.pone.0119008			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9BN	25785437	Green Published, gold, Green Submitted			2022-12-27	WOS:000352138500065
J	Ma, XF; Jiang, GH; Li, SM; Wang, JH; Zhan, WF; Zeng, SQ; Tian, JZ; Xu, YK				Ma, Xiaofen; Jiang, Guihua; Li, Shumei; Wang, Jinhui; Zhan, Wenfeng; Zeng, Shaoqing; Tian, Junzhang; Xu, Yikai			Aberrant Functional Connectome in Neurologically Asymptomatic Patients with End-Stage Renal Disease	PLOS ONE			English	Article							CHRONIC KIDNEY-DISEASE; CEREBRAL-BLOOD-FLOW; GRAPH-THEORETICAL ANALYSIS; COMPLEX BRAIN NETWORKS; RESTING-STATE FMRI; DEFAULT-MODE; COGNITIVE FUNCTION; SMALL-WORLD; MODULAR ORGANIZATION; CONNECTIVITY MRI	Purpose This study aimed to investigate the topological organization of intrinsic functional brain networks in patients with end-stage renal disease (ESRD). Materials and Methods Resting-state functional MRI data were collected from 22 patients with ESRD (16 men, 18-61 years) and 29age- and gender-matched healthy controls (HCs, 19 men, 32-61 years). Whole-brain functional networks were obtained by calculating the interregional correlation of low-frequency fluctuations in spontaneous brain activity among 1,024 parcels that cover the entire cerebrum. Weighted graph-based models were then employed to topologically characterize these networks at different global, modular and nodal levels. Results Compared to HCs, the patients exhibited significant disruption in parallel information processing over the whole networks (P < 0.05). The disruption was present in all the functional modules (default mode, executive control, sensorimotor and visual networks) although decreased functional connectivity was observed only within the default mode network. Regional analysis showed that the disease disproportionately weakened nodal efficiency of the default mode components and tended to preferentially affect central or hub-like regions. Intriguingly, the network abnormalities correlated with biochemical hemoglobin and serum calcium levels in the patients. Finally, the functional changes were substantively unchanged after correcting for gray matter atrophy in the patients. Conclusion Our findings provide evidence for the disconnection nature of ESRD's brain and therefore have important implications for understanding the neuropathologic substrate of the disease from disrupted network organization perspective.	[Ma, Xiaofen; Xu, Yikai] Southern Medial Univ, Nanfang Hosp, Dept Med Imaging Ctr, Guangzhou, Guangdong, Peoples R China; [Jiang, Guihua; Li, Shumei; Zhan, Wenfeng; Zeng, Shaoqing; Tian, Junzhang] Guangdong 2 Prov Peoples Hosp, Dept Med Imaging, Guangzhou, Guangdong, Peoples R China; [Wang, Jinhui] Hangzhou Normal Univ, Ctr Cognit & Brain Disorders, Hangzhou, Zhejiang, Peoples R China; [Wang, Jinhui] Zhejiang Key Lab Res Assessment Cognit Impairment, Hangzhou, Zhejiang, Peoples R China	Southern Medical University - China; Hangzhou Normal University	Tian, JZ (corresponding author), Guangdong 2 Prov Peoples Hosp, Dept Med Imaging, Guangzhou, Guangdong, Peoples R China.	jz.tian@163.com; mayuqin2004@163.com	Wang, jinhui/AAF-8668-2019	Tian, Junzhang/0000-0002-6212-1882	National Natural Science Foundation of China [81471639]; Science and Technology Planning Project of Guangdong Province, China [2011B031800044, 2012B031800170, 2012A030400019]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and Technology Planning Project of Guangdong Province, China	This research was supported by grants from National Natural Science Foundation of China (No. 81471639) and The Science and Technology Planning Project of Guangdong Province, China (No. 2011B031800044, 2012B031800170, 2012A030400019). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achard S, 2007, PLOS COMPUT BIOL, V3, P174, DOI 10.1371/journal.pcbi.0030017; Altmann P, 2007, KIDNEY INT, V71, P252, DOI 10.1038/sj.ki.5001932; Bassett DS, 2011, P NATL ACAD SCI USA, V108, P7641, DOI 10.1073/pnas.1018985108; Bassett DS, 2009, CURR OPIN NEUROL, V22, P340, DOI 10.1097/WCO.0b013e32832d93dd; Bassett DS, 2006, NEUROSCIENTIST, V12, P512, DOI 10.1177/1073858406293182; Bialonski S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022826; Birn RM, 2006, NEUROIMAGE, V31, P1536, DOI 10.1016/j.neuroimage.2006.02.048; Bornivelli C, 2012, J REN CARE, V38, P93, DOI 10.1111/j.1755-6686.2012.00259.x; Brouns R, 2004, CLIN NEUROL NEUROSUR, V107, P1, DOI 10.1016/j.clineuro.2004.07.012; Buckner RL, 2008, ANN NY ACAD SCI, V1124, P1, DOI 10.1196/annals.1440.011; Buckner RL, 2009, J NEUROSCI, V29, P1860, DOI 10.1523/JNEUROSCI.5062-08.2009; Bullmore ET, 2009, NAT REV NEUROSCI, V10, P186, DOI 10.1038/nrn2575; Chang C, 2009, NEUROIMAGE, V47, P1448, DOI 10.1016/j.neuroimage.2009.05.012; Chou MC, 2013, AM J NEURORADIOL, V34, P1945, DOI 10.3174/ajnr.A3511; Craddock RC, 2012, HUM BRAIN MAPP, V33, P1914, DOI 10.1002/hbm.21333; DEDEYN PP, 1992, ACTA NEUROL BELG, V92, P191; Fair DA, 2013, FRONT SYST NEUROSCI, V6, DOI 10.3389/fnsys.2012.00080; Fazekas G, 1996, NUCL MED COMMUN, V17, P603, DOI 10.1097/00006231-199607000-00011; Foley RN, 2007, J AM SOC NEPHROL, V18, P2644, DOI 10.1681/ASN.2007020220; Fornito A, 2010, FRONT SYST NEUROSCI, V4, DOI 10.3389/fnsys.2010.00022; Foti NJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016431; Fox MD, 2005, P NATL ACAD SCI USA, V102, P9673, DOI 10.1073/pnas.0504136102; Fox MD, 2009, J NEUROPHYSIOL, V101, P3270, DOI 10.1152/jn.90777.2008; Friston KJ, 1996, MAGNET RESON MED, V35, P346, DOI 10.1002/mrm.1910350312; GOTTLIEB D, 1987, J CEREBR BLOOD F MET, V7, P659, DOI 10.1038/jcbfm.1987.119; Greicius MD, 2003, P NATL ACAD SCI USA, V100, P253, DOI 10.1073/pnas.0135058100; Greicius MD, 2009, CEREB CORTEX, V19, P72, DOI 10.1093/cercor/bhn059; Guimera R, 2007, NAT PHYS, V3, P63, DOI 10.1038/nphys489; Hagmann P, 2008, PLOS BIOL, V6, P1479, DOI 10.1371/journal.pbio.0060159; HATA R, 1994, STROKE, V25, P408, DOI 10.1161/01.STR.25.2.408; He Y, 2007, NEUROIMAGE, V35, P488, DOI 10.1016/j.neuroimage.2006.11.042; He Y, 2010, CURR OPIN NEUROL, V23, P341, DOI 10.1097/WCO.0b013e32833aa567; He Y, 2009, NEUROSCIENTIST, V15, P333, DOI 10.1177/1073858409334423; He Y, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005226; Hermundstad AM, 2013, P NATL ACAD SCI USA, V110, P6169, DOI 10.1073/pnas.1219562110; Hlinka J, 2011, NEUROIMAGE, V54, P2218, DOI 10.1016/j.neuroimage.2010.08.042; HOLZER H, 1981, P EUR DIAL TRANS, V18, P126; Honey CJ, 2009, P NATL ACAD SCI USA, V106, P2035, DOI 10.1073/pnas.0811168106; Hosseini SMH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067354; Hsieh TJ, 2009, RADIOLOGY, V252, P518, DOI 10.1148/radiol.2523080484; Jassal SV, 2008, INT UROL NEPHROL, V40, P849, DOI 10.1007/s11255-008-9375-2; Jiang LL, 2015, BRAIN STRUCT FUNCT, V220, P2485, DOI 10.1007/s00429-014-0795-8; Kalender B, 2006, NEPHRON CLIN PRACT, V102, pC115, DOI 10.1159/000089669; Kim HS, 2011, NEUROREHABILITATION, V29, P111, DOI 10.3233/NRE-2011-0684; Kurella M, 2004, J AM GERIATR SOC, V52, P1863, DOI 10.1111/j.1532-5415.2004.52508.x; Kuwabara Y, 2002, KIDNEY INT, V61, P564, DOI 10.1046/j.1523-1755.2002.00142.x; Latora V, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.198701; Liang X, 2013, P NATL ACAD SCI USA, V110, P1929, DOI 10.1073/pnas.1214900110; Liang X, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032766; Liang X, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071507; LINDEGAARD KF, 1987, STROKE, V18, P1025, DOI 10.1161/01.STR.18.6.1025; Lu HB, 2012, P NATL ACAD SCI USA, V109, P3979, DOI [10.1073/pnas.1101934108, 10.1073/pnas.1200506109]; Madero M, 2008, SEMIN DIALYSIS, V21, P29, DOI 10.1111/j.1525-139X.2007.00384.x; Maslov S, 2002, SCIENCE, V296, P910, DOI 10.1126/science.1065103; Meunier D, 2010, FRONT NEUROSCI-SWITZ, V4, DOI 10.3389/fnins.2010.00200; Milo R, 2002, SCIENCE, V298, P824, DOI 10.1126/science.298.5594.824; Murphy K, 2009, NEUROIMAGE, V44, P893, DOI 10.1016/j.neuroimage.2008.09.036; Murray AM, 2007, AM J KIDNEY DIS, V50, P270, DOI 10.1053/j.ajkd.2007.05.010; Newman MEJ, 2006, PHYS REV E, V74, DOI 10.1103/PhysRevE.74.036104; Ni L, 2014, RADIOLOGY, V271, P543, DOI 10.1148/radiol.13130816; Park HJ, 2013, SCIENCE, V342, P579, DOI 10.1126/science.1238411; PAYNE RB, 1973, BMJ-BRIT MED J, V4, P643, DOI 10.1136/bmj.4.5893.643; Pliskin NH, 1996, KIDNEY INT, V49, P1435, DOI 10.1038/ki.1996.202; POSTIGLIONE A, 1991, STROKE, V22, P1508, DOI 10.1161/01.STR.22.12.1508; Power JD, 2012, NEUROIMAGE, V59, P2142, DOI 10.1016/j.neuroimage.2011.10.018; Prohovnik I, 2007, J CEREBR BLOOD F MET, V27, P1861, DOI 10.1038/sj.jcbfm.9600478; Raichle ME, 2001, P NATL ACAD SCI USA, V98, P676, DOI 10.1073/pnas.98.2.676; Raphael KL, 2012, AM J NEPHROL, V35, P49, DOI 10.1159/000334872; Regolisti G, 2013, NEPHROL DIAL TRANSPL, V28, P79, DOI 10.1093/ndt/gfs182; Rubinov M, 2010, NEUROIMAGE, V52, P1059, DOI 10.1016/j.neuroimage.2009.10.003; Rubinov M, 2013, TRENDS COGN SCI, V17, P641, DOI 10.1016/j.tics.2013.10.007; Schultz-Larsen K, 2007, J CLIN EPIDEMIOL, V60, P260, DOI 10.1016/j.jclinepi.2006.06.008; Schwarz AJ, 2011, NEUROIMAGE, V55, P1132, DOI 10.1016/j.neuroimage.2010.12.047; Skinner H, 2005, BRIT J ANAESTH, V94, P203, DOI 10.1093/bja/aei016; Song SH, 2008, PSYCHIAT CLIN NEUROS, V62, P554, DOI 10.1111/j.1440-1819.2008.01849.x; Song SH, 2009, PSYCHIAT RES-NEUROIM, V173, P243, DOI 10.1016/j.pscychresns.2008.08.007; Sporns O, 2000, CEREB CORTEX, V10, P127, DOI 10.1093/cercor/10.2.127; Sporns O, 2004, NEUROINFORMATICS, V2, P145, DOI 10.1385/NI:2:2:145; Stefanidis I, 2005, CLIN NEPHROL, V64, P129; Tamura MK, 2011, KIDNEY INT, V79, P14, DOI 10.1038/ki.2010.336; Teipel SJ, 2010, NEUROIMAGE, V49, P2021, DOI 10.1016/j.neuroimage.2009.10.067; Tomasi D, 2013, P NATL ACAD SCI USA, V110, P13642, DOI 10.1073/pnas.1303346110; Tomasi D, 2010, P NATL ACAD SCI USA, V107, P9885, DOI 10.1073/pnas.1001414107; Toppi J, 2012, COMPUT MATH METHOD M, V2012, DOI 10.1155/2012/130985; Tryc AB, 2011, NEPHROL DIAL TRANSPL, V26, P2635, DOI 10.1093/ndt/gfq729; van den Heuvel MP, 2013, TRENDS COGN SCI, V17, P683, DOI 10.1016/j.tics.2013.09.012; Van Dijk KRA, 2012, NEUROIMAGE, V59, P431, DOI 10.1016/j.neuroimage.2011.07.044; van Wijk BCM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013701; Vincent JL, 2007, NATURE, V447, P83, DOI 10.1038/nature05758; Wang JH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021976; Wang JH, 2013, BIOL PSYCHIAT, V73, P472, DOI 10.1016/j.biopsych.2012.03.026; Wang JH, 2010, FRONT SYST NEUROSCI, V4, DOI 10.3389/fnsys.2010.00016; Wang JH, 2009, HUM BRAIN MAPP, V30, P1511, DOI 10.1002/hbm.20623; Wang ZJ, 2015, NEUROSCIENTIST, V21, P290, DOI 10.1177/1073858414537560; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; Weissenbacher A, 2009, NEUROIMAGE, V47, P1408, DOI 10.1016/j.neuroimage.2009.05.005; Williams MA, 2004, AM J KIDNEY DIS, V43, P705, DOI 10.1053/j.ajkd.2003.12.031; Xia MR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068910; Xia MR, 2011, BRAIN CONNECT, V1, P349, DOI 10.1089/brain.2011.0062; Yan CG, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00910; Zalesky A, 2012, NEUROIMAGE, V60, P2096, DOI 10.1016/j.neuroimage.2012.02.001; Zalesky A, 2010, NEUROIMAGE, V50, P970, DOI 10.1016/j.neuroimage.2009.12.027; Zang YF, 2007, BRAIN DEV-JPN, V29, P83, DOI 10.1016/j.braindev.2006.07.002; Zhang LJ, 2013, METAB BRAIN DIS, V28, P647, DOI 10.1007/s11011-013-9438-7	104	23	29	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2015	10	3							e0121085	10.1371/journal.pone.0121085	http://dx.doi.org/10.1371/journal.pone.0121085			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9BN	25786231	Green Submitted, Green Published, gold			2022-12-27	WOS:000352138500200
J	MacIvor, JS; Packer, L				MacIvor, J. Scott; Packer, Laurence			'Bee Hotels' as Tools for Native Pollinator Conservation: A Premature Verdict?	PLOS ONE			English	Article							MEGACHILE-ROTUNDATA; LEAFCUTTING BEE; NESTING BEES; HYMENOPTERA; SCALE; PARASITISM; DIVERSITY; RICHNESS; DECLINES; BRITAIN	Society is increasingly concerned with declining wild bee populations. Although most bees nest in the ground, considerable effort has centered on installing 'bee hotels'-also known as nest boxes or trap nests-which artificially aggregate nest sites of above ground nesting bees. Campaigns to 'save the bees' often promote these devices despite the absence of data indicating they have a positive effect. From a survey of almost 600 bee hotels set up over a period of three years in Toronto, Canada, introduced bees nested at 32.9% of sites and represented 24.6% of more than 27,000 total bees and wasps recorded (47.1% of all bees recorded). Native bees were parasitized more than introduced bees and females of introduced bee species provisioned nests with significantly more female larva each year. Native wasps were significantly more abundant than both native and introduced bees and occupied almost 3/4 of all bee hotels each year; further, introduced wasps were the only group to significantly increase in relative abundance year over year. More research is needed to elucidate the potential pitfalls and benefits of using bee hotels in the conservation and population dynamics of wild native bees.	[MacIvor, J. Scott; Packer, Laurence] York Univ, Dept Biol, Toronto, ON M3J 2R7, Canada	York University - Canada	MacIvor, JS (corresponding author), York Univ, Dept Biol, Toronto, ON M3J 2R7, Canada.	jsmacivor@gmail.com		packer, laurence/0000-0002-1711-8203	Natural Science and Engineering Council of Canada [CGS D 408565]; Natural Science and Engineering Council of Canada	Natural Science and Engineering Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); Natural Science and Engineering Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC))	JSM received funding from a Natural Science and Engineering Council of Canada (CGS D 408565) (http://www.nserc-crsng.gc.ca/index_eng. asp). LP received funding from a Natural Science and Engineering Council of Canada Discovery Grant (http://www.nserc-crsng.gc.ca/index_eng. asp). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barthell JF, 1998, ENVIRON ENTOMOL, V27, P240, DOI 10.1093/ee/27.2.240; Biesmeijer JC, 2006, SCIENCE, V313, P351, DOI 10.1126/science.1127863; BOHART GE, 1972, ANNU REV ENTOMOL, V17, P287, DOI 10.1146/annurev.en.17.010172.001443; Bolger DT, 2000, ECOL APPL, V10, P1230, DOI 10.1890/1051-0761(2000)010[1230:AIUHFI]2.0.CO;2; Bosch J, 2002, B ENTOMOL RES, V92, P3, DOI 10.1079/BER2001139; Burkle LA, 2013, SCIENCE, V339, P1611, DOI 10.1126/science.1232728; Cane JH, 2003, FOR NONNATIVE CROPS; EVES J D, 1970, Melanderia, V4, P1; Garibaldi LA, 2011, ECOL LETT, V14, P1062, DOI 10.1111/j.1461-0248.2011.01669.x; Gaston KJ, 2005, BIODIVERS CONSERV, V14, P3327, DOI 10.1007/s10531-004-9513-9; Giles V, 2006, J HYMENOPT RES, V15, P208; Grissell E, 2010, BEES WASPS AND ANTS; Hanley M. E., 2003, Weed Biology and Management, V3, P204, DOI 10.1046/j.1444-6162.2003.00108.x; Jones D, 2010, BIRD BEE AND BUG HOU; Kearns CA, 1998, ANNU REV ECOL SYST, V29, P83, DOI 10.1146/annurev.ecolsys.29.1.83; Krombein K. V., 1967, TRAP NESTING WASPS A; Lee-Mader E., 2010, MANAGING ALTERNATIVE; Liu H, 2006, BIOL INVASIONS, V8, P1535, DOI 10.1007/s10530-005-5845-y; Lowenstein DM, 2014, BIODIVERS CONSERV, V23, P2857, DOI 10.1007/s10531-014-0752-0; Lowry H, 2013, BIOL REV, V88, P537, DOI 10.1111/brv.12012; MacIvor JS, 2014, URBAN ECOSYST, V17, P139, DOI 10.1007/s11252-013-0321-4; Macivor JS, 2014, ENVIRON ENTOMOL, V43, P1027, DOI 10.1603/EN13241; Martins CF, 2012, NEOTROP ENTOMOL, V41, P105, DOI 10.1007/s13744-012-0020-5; Matteson KC, 2008, ANN ENTOMOL SOC AM, V101, P140, DOI 10.1603/0013-8746(2008)101[140:BRAAIN]2.0.CO;2; Matteson KC, 2011, INSECT CONSERV DIVER, V4, P89, DOI 10.1111/j.1752-4598.2010.00103.x; Moore LJ., 2013, BUZZ URBAN BEEKEEPIN; Morales Carolina L., 2002, Biological Invasions, V4, P87, DOI 10.1023/A:1020513012689; Ollerton J, 2014, SCIENCE, V346, P1360, DOI 10.1126/science.1257259; PACKER L, 1986, INSECT SOC, V33, P190, DOI 10.1007/BF02224597; Packer L, CITY OF TORONTO BIOD; Pawelek JC, 2009, CITIES ENV, V2, P1; Pitts-Singer TL, 2011, ANNU REV ENTOMOL, V56, P221, DOI 10.1146/annurev-ento-120709-144836; Potts SG, 2005, ECOL ENTOMOL, V30, P78, DOI 10.1111/j.0307-6946.2005.00662.x; Potts SG, 2010, TRENDS ECOL EVOL, V25, P345, DOI 10.1016/j.tree.2010.01.007; Ratnasingham S, 2007, MOL ECOL NOTES, V7, P355, DOI 10.1111/j.1471-8286.2007.01678.x; ROSENHEIM JA, 1990, ANN ENTOMOL SOC AM, V83, P277, DOI 10.1093/aesa/83.3.277; Steffan-Dewenter I, 2002, ECOLOGY, V83, P1421, DOI 10.1890/0012-9658(2002)083[1421:SDEOLC]2.0.CO;2; STEPHEN WP, 1965, J ECON ENTOMOL, V58, P965, DOI 10.1093/jee/58.5.965; Stephen WP, 1961, PAN-PAC ENTOMOL, V37, P89; Taki H, 2004, CAN ENTOMOL, V136, P889; TORCHIO PF, 1980, EVOLUTION, V34, P993, DOI [10.2307/2408004, 10.1111/j.1558-5646.1980.tb04037.x]; Torne-Noguera A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097255; Tylianakis JM, 2006, J BIOGEOGR, V33, P1295, DOI 10.1111/j.1365-2699.2006.01493.x; Vickruck JL, 2012, ANIM BEHAV, V83, P1083, DOI 10.1016/j.anbehav.2012.01.039; Walker K, 2012, J BUS ETHICS, V109, P227, DOI 10.1007/s10551-011-1122-4; Wcislo WT, 1996, J INSECT BEHAV, V9, P643, DOI 10.1007/BF02213885; Westphal C, 2008, ECOL MONOGR, V78, P653, DOI 10.1890/07-1292.1; Williams NM, 2011, BASIC APPL ECOL, V12, P332, DOI 10.1016/j.baae.2010.11.008; Woodward DR, 1996, AUST J ENTOMOL, V35, P187, DOI 10.1111/j.1440-6055.1996.tb01385.x; Zurbuchen A, 2010, J ANIM ECOL, V79, P674, DOI 10.1111/j.1365-2656.2010.01675.x	50	69	77	4	155	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2015	10	3							e0122126	10.1371/journal.pone.0122126	http://dx.doi.org/10.1371/journal.pone.0122126			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9BN	25785609	Green Submitted, Green Published, gold			2022-12-27	WOS:000352138500219
J	Morse, AF; Benitez, VL; Belpaeme, T; Cangelosi, A; Smith, LB				Morse, Anthony F.; Benitez, Viridian L.; Belpaeme, Tony; Cangelosi, Angelo; Smith, Linda B.			Posture Affects How Robots and Infants Map Words to Objects	PLOS ONE			English	Article							ATTENTION; MOTOR; PERSPECTIVE; SIMULATION; MOVEMENTS; PARIETAL; CHILDREN; BEHAVIOR; TASK	For infants, the first problem in learning a word is to map the word to its referent; a second problem is to remember that mapping when the word and/or referent are again encountered. Recent infant studies suggest that spatial location plays a key role in how infants solve both problems. Here we provide a new theoretical model and new empirical evidence on how the body - and its momentary posture - may be central to these processes. The present study uses a name-object mapping task in which names are either encountered in the absence of their target (experiments 1-3, 6 & 7), or when their target is present but in a location previously associated with a foil (experiments 4, 5, 8 & 9). A humanoid robot model (experiments 1-5) is used to instantiate and test the hypothesis that body-centric spatial location, and thus the bodies' momentary posture, is used to centrally bind the multimodal features of heard names and visual objects. The robot model is shown to replicate existing infant data and then to generate novel predictions, which are tested in new infant studies (experiments 6-9). Despite spatial location being task-irrelevant in this second set of experiments, infants use body-centric spatial contingency over temporal contingency to map the name to object. Both infants and the robot remember the name-object mapping even in new spatial locations. However, the robot model shows how this memory can emerge -not from separating bodily information from the word-object mapping as proposed in previous models of the role of space in word-object mapping - but through the body's momentary disposition in space.	[Morse, Anthony F.; Belpaeme, Tony; Cangelosi, Angelo] Univ Plymouth, Ctr Robot & Neural Syst, Cognit Inst, Plymouth PL4 8AA, Devon, England; [Benitez, Viridian L.] Univ Wisconsin, Dept Psychol, Madison, WI 53706 USA; [Smith, Linda B.] Indiana Univ, Psychol & Brain Sci, Bloomington, IN 47405 USA	University of Plymouth; University of Wisconsin System; University of Wisconsin Madison; Indiana University System; Indiana University Bloomington	Morse, AF (corresponding author), Univ Plymouth, Ctr Robot & Neural Syst, Cognit Inst, Plymouth PL4 8AA, Devon, England.	anthony.morse@plymouth.ac.uk	Cangelosi, Angelo/D-6784-2011; Belpaeme, Tony/AAR-8743-2020	Cangelosi, Angelo/0000-0002-4709-2243; Belpaeme, Tony/0000-0001-5207-7745	EU [214668]; Poeticon++ [288382]; NIH [R21HD068475]; NSF GRFP; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R21HD068475] Funding Source: NIH RePORTER; Engineering and Physical Sciences Research Council [EP/G008353/1] Funding Source: researchfish; EPSRC [EP/G008353/1] Funding Source: UKRI	EU(European Commission); Poeticon++; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF GRFP(National Science Foundation (NSF)NSF - Office of the Director (OD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	This work has been supported by the EU FP7 projects ITALK (no. 214668) and Poeticon++ (no. 288382), NIH grant R21HD068475 and NSF GRFP.	[Anonymous], 2007, BODY SHAPES WAY WE T; Asada M, 2001, ROBOT AUTON SYST, V37, P185, DOI 10.1016/S0921-8890(01)00157-9; BALDWIN DA, 1993, DEV PSYCHOL, V29, P832, DOI 10.1037/0012-1649.29.5.832; Barsalou LW, 2008, ANNU REV PSYCHOL, V59, P617, DOI 10.1146/annurev.psych.59.103006.093639; Barsalou LW, 1999, BEHAV BRAIN SCI, V22, P577, DOI 10.1017/S0140525X99532147; Barsalou LW, 2003, LANG COGNITIVE PROC, V18, P513, DOI 10.1080/01690960344000026; Benitez VL, 2012, COGNITION, V125, P339, DOI 10.1016/j.cognition.2012.08.006; BERTENTHAL BI, 1994, CURR DIR PSYCHOL SCI, V3, P140, DOI 10.1111/1467-8721.ep10770621; Brooks R. A., 1990, Robotics and Autonomous Systems, V6, P3, DOI 10.1016/S0921-8890(05)80025-9; BROOKS RA, 1991, ARTIF INTELL, V47, P139, DOI 10.1016/0004-3702(91)90053-M; BURTON AM, 1991, COGNITION, V39, P129, DOI 10.1016/0010-0277(91)90041-2; Byrge L, 2014, DEVELOPMENTAL PROCES; Colby CL, 1999, ANNU REV NEUROSCI, V22, P319, DOI 10.1146/annurev.neuro.22.1.319; Einhauser W, 2007, NETWORK-COMP NEURAL, V18, P267, DOI 10.1080/09548980701671094; Flanders M, 1999, EXP BRAIN RES, V126, P19, DOI 10.1007/s002210050713; Fodor J. A., 1975, LANGUAGE THOUGHT; Fodor J. A., 2010, LOT 2 LANGUAGE THOUG; FODOR JA, 1988, COGNITION, V28, P3, DOI 10.1016/0010-0277(88)90031-5; Gallese V, 2005, COGN NEUROPSYCHOL, V22, P455, DOI 10.1080/02643290442000310; Grosbras MN, 2005, HUM BRAIN MAPP, V25, P140, DOI 10.1002/hbm.20145; Hagler DJ, 2007, NEUROIMAGE, V35, P1562, DOI 10.1016/j.neuroimage.2007.01.033; HARNAD S, 1990, PHYSICA D, V42, P335, DOI 10.1016/0167-2789(90)90087-6; Hartman E, 2010, J INTELL DISABIL RES, V54, P468, DOI 10.1111/j.1365-2788.2010.01284.x; Hesslow G, 2002, TRENDS COGN SCI, V6, P242, DOI 10.1016/S1364-6613(02)01913-7; Iverson JM, 2010, J CHILD LANG, V37, P229, DOI 10.1017/S0305000909990432; Jeannerod M., 1988, NEURAL BEHAV ORG GOA; Jovancevic-Misic J, 2009, J NEUROSCI, V29, P6234, DOI 10.1523/JNEUROSCI.5570-08.2009; Knudsen EI, 2007, ANNU REV NEUROSCI, V30, P57, DOI 10.1146/annurev.neuro.30.051606.094256; Kohonen T, 1998, NEUROCOMPUTING, V21, P1, DOI 10.1016/S0925-2312(98)00030-7; Lobo MA, 2008, CHILD DEV, V79, P1869, DOI 10.1111/j.1467-8624.2008.01231.x; Luck S, 2002, ATTENTION; MARKMAN EM, 1990, COGNITIVE SCI, V14, P57, DOI 10.1207/s15516709cog1401_4; MCCLELLAND JL, 1981, PSYCHOL REV, V88, P375, DOI 10.1037/0033-295X.88.5.375; Metta G., 2008, P 8 WORKSH PERF METR, P50, DOI [10.1145/1774674.1774683, DOI 10.1145/1774674.1774683]; Morse AF, 2010, IEEE T AUTON MENT DE, V2, P325, DOI 10.1109/TAMD.2010.2087020; Mostofsky SH, 2006, BIOL PSYCHIAT, V59, P48, DOI 10.1016/j.biopsych.2005.06.011; Munakata Y, 2004, DEV REV, V24, P133, DOI 10.1016/j.dr.2003.09.008; No? A., 2004, ACTION PERCEPTION; O'Regan J.K., 2011, WHY RED DOESNT SOUND; O'Regan JK, 2001, BEHAV BRAIN SCI, V24, P939, DOI 10.1017/S0140525X01000115; Osina MA, 2013, DEV PSYCHOL, V49, P138, DOI 10.1037/a0027903; RIZZOLATTI G, 1987, NEUROPSYCHOLOGIA, V25, P31, DOI 10.1016/0028-3932(87)90041-8; Samuelson LK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028095; SEARLE JR, 1982, BEHAV BRAIN SCI, V5, P345, DOI 10.1017/S0140525X00012425; Shapiro L., 2010, EMBODIED COGNITION; Smith LB, 1999, PSYCHOL REV, V106, P235, DOI 10.1037/0033-295X.106.2.235; Smith L, 2008, COGNITION, V106, P1558, DOI 10.1016/j.cognition.2007.06.010; Steels L, 2003, TRENDS COGN SCI, V7, P308, DOI 10.1016/S1364-6613(03)00129-3; Stein BE, 2008, NAT REV NEUROSCI, V9, P255, DOI 10.1038/nrn2331; Thaler L, 2009, NEUROPSYCHOLOGIA, V47, P1227, DOI 10.1016/j.neuropsychologia.2008.12.039; Thura D, 2008, BEHAV BRAIN RES, V186, P148, DOI 10.1016/j.bbr.2007.07.035; Tillman CM, 2008, CHILD NEUROPSYCHOL, V14, P42, DOI 10.1080/09297040701249020; VANBEEK Y, 1994, J CHILD PSYCHOL PSYC, V35, P1093, DOI 10.1111/j.1469-7610.1994.tb01811.x; Webb B, 2000, ANIM BEHAV, V60, P545, DOI 10.1006/anbe.2000.1514; Wilson M, 2002, PSYCHON B REV, V9, P625, DOI 10.3758/BF03196322; Wilson RA., 2009, CAMBRIDGE HDB SITUAT, P55; Woods RJ, 2013, DEV PSYCHOL, V49, P1413, DOI 10.1037/a0030344; Xu F, 2007, PSYCHOL REV, V114, P245, DOI 10.1037/0033-295X.114.2.245; Yantis S, 2008, CURR DIR PSYCHOL SCI, V17, P86, DOI 10.1111/j.1467-8721.2008.00554.x; Ziemke T, 2003, WHATS THING CALLED E, P1310; Ziemke T, 2009, COGN COMPUT, V1, P104, DOI 10.1007/s12559-009-9012-0	61	30	30	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2015	10	3							e0116012	10.1371/journal.pone.0116012	http://dx.doi.org/10.1371/journal.pone.0116012			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CE9BN	25785834	Green Published, Green Accepted, Green Submitted, gold			2022-12-27	WOS:000352138500002
J	Moyo, S; Cox, HS; Hughes, J; Daniels, J; Synman, L; De Azevedo, V; Shroufi, A; Cox, V; van Cutsem, G				Moyo, Sizulu; Cox, Helen S.; Hughes, Jennifer; Daniels, Johnny; Synman, Leigh; De Azevedo, Virginia; Shroufi, Amir; Cox, Vivian; van Cutsem, Gilles			Loss from Treatment for Drug Resistant Tuberculosis: Risk Factors and Patient Outcomes in a Community-Based Program in Khayelitsha, South Africa	PLOS ONE			English	Article							BEHAVIOR; DEFAULT	Background A community based drug resistant tuberculosis (DR-TB) program has been incrementally implemented in Khayelitsha, a high HIV and TB burden community in South Africa. We investigated loss from treatment (LFT), and post treatment outcomes of DR-TB patients in this setting. Methodology LFT, defined as interruption of treatment for >= 2 consecutive months was assessed among patients initiating DR-TB treatment for the first time between January 2009 and July 2011. Patients were traced through routine data sources to identify those who subsequently restarted treatment and those who died. Additional information on patient status and survival after LTF was obtained from community DR-TB counselors and from the national death registry. Post treatment outcomes were observed until July 2013. Results Among 452 patients initiating treatment for the first time within the given period, 30% (136) were LFT, with 67% retention at 18 months. Treatment was restarted in 27 (20%) patients, with additional resistance recorded in 2/25 (8%), excluding two with presumed DR-TB. Overall, 34 (25%) patients died, including 11 who restarted treatment. Males and those in the age category 15-25 years had a greater hazard of LFT; HR 1.93 (95% CI 1.35-2.75), and 2.43 (95% CI 1.52-3.88) respectively. Older age (>35 years) was associated with a greater hazard of death; HR 3.74 (1.13-12.37) post treatment. Overall two-year survival was 62%. It was lower ( 45%) in older patients, and was 92% among those who received >12 months treatment. Conclusion LFT was high, occurred throughout the treatment period and was particularly high among males and those aged 15-25 years. Overall long term survival was poor. High rates of LFT should however not preclude scale up of community based care given its impact in increasing access to treatment. Further research is needed to support retention of DR-TB patients on treatment, even within community based treatment programs.	[Moyo, Sizulu; Hughes, Jennifer; Daniels, Johnny; Synman, Leigh; Shroufi, Amir; Cox, Vivian; van Cutsem, Gilles] MSF Doctors Without Borders, Cape Town, South Africa; [Cox, Helen S.] Univ Cape Town, Dept Med Microbiol, ZA-7925 Cape Town, South Africa; [De Azevedo, Virginia] City Cape Town Dept Hlth, Cape Town, South Africa; [van Cutsem, Gilles] Univ Cape Town, Ctr Infect Dis Epidemiol & Res, ZA-7925 Cape Town, South Africa; [Moyo, Sizulu] Human Sci Res Council, HIV AIDS STIs & TB Programme, Cape Town, South Africa	University of Cape Town; University of Cape Town; Human Sciences Research Council-South Africa	Moyo, S (corresponding author), MSF Doctors Without Borders, Cape Town, South Africa.	sizulumoyo@gmail.com	Van Cutsem, Gilles/ABB-1171-2021	Van Cutsem, Gilles/0000-0002-8972-4480; Hughes, Jennifer/0000-0002-5349-9509; Cox, Helen/0000-0002-6538-7192	Medecins sans Frontieres	Medecins sans Frontieres	This work was funded by Medecins sans Frontieres. Staff from Medecins sans Frontieres were involved in study design, data collection and analysis, manuscript preparation and decision to publish the manuscript.	Barnard M, 2008, AM J RESP CRIT CARE, V177, P787, DOI 10.1164/rccm.200709-1436OC; Bassili A, 2013, AM J TROP MED HYG, V89, P271, DOI 10.4269/ajtmh.13-0004; Brust JCM, 2012, INT J TUBERC LUNG D, V16, P998, DOI 10.5588/ijtld.11.0713; Brust JCM, 2010, INT J TUBERC LUNG D, V14, P413; Chiang CY, 2003, INT J TUBERC LUNG D, V6, P714; City of Cape Town, 2013, CITY OF CAPE TOWN 20; City of Cape Town, 2006, SOCIOECONOMIC PROFIL; Cox H, 2014, INT J TUBERC LUNG D, V18, P441, DOI 10.5588/ijtld.13.0742; Cox HS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013901; Davidson H, 2000, INT J TUBERC LUNG D, V4, P860; De Azevedo V, 2013, INTERSECTORAL ACTION; Farley JE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020436; Fitzpatrick C, 2012, PHARMACOECONOMICS, V30, P63, DOI 10.2165/11595340-000000000-00000; Galdas PM, 2005, J ADV NURS, V49, P616, DOI 10.1111/j.1365-2648.2004.03331.x; Gandhi NR, 2010, AM J RESP CRIT CARE, V181, P80, DOI 10.1164/rccm.200907-0989OC; Geldenhuys H, 2011, AFR J PSYCHIATRY, V14, P383, DOI [10.4314/ajpsy.v14i5.6, http://dx.doi.org/10.4314/ajpsy.v14i5.6]; Heller T, 2010, INT J TUBERC LUNG D, V14, P420; Holtz TH, 2006, INT J TUBERC LUNG D, V10, P649; Isaakidis P, 2013, TROP MED INT HEALTH, V18, P1128, DOI 10.1111/tmi.12146; Isaakidis P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028066; Johnston JC, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006914; Lalor MK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078364; Leimane V, 2005, LANCET, V365, P318, DOI 10.1016/S0140-6736(05)17786-1; Letsela L, 2009, I AM TOTSI FROM SOPH; Liu CH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019399; Lutge E, 2013, TRIALS, V14, DOI 10.1186/1745-6215-14-154; Medecins sans Frontieres, 2011, SCALING UP DIAGNOSIS; Medecins sans Frontieres, 2013, DR TB DRUGS UNDER TH; National Department of Health, 2011, MANAGEMENT OF DRUG R; Nolan CM, 2005, AM J RESP CRIT CARE, V172, P1169, DOI 10.1164/rccm.2508001; Sanchez-Padilla E, 2014, INT J TUBERC LUNG D, V18, P160, DOI 10.5588/ijtld.13.0369; Shean KP, 2008, INT J TUBERC LUNG D, V12, P1182; Sripad A, 2014, INT J TUBERC LUNG D, V18, P44, DOI 10.5588/ijtld.13.0253; Toczek A, 2013, INT J TUBERC LUNG D, V17, P299, DOI 10.5588/ijtld.12.0537; Weiss P, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-333; WHO, 2012, GLOBAL TUBERCULOSIS REPORT 2012, P1; World Health Organization, 2013, DEFINITIONS AND REPO; World Health Organization, 2012, UPDATE IMPLEMENTATIO; World Health Organization, 2013, MULTI DRUG RESISTANT; World Health Organization, 2008, GUIDELINES FOR THE P; World Health Organization, 2013, COUNTDOWN TO 2015 GL	41	25	27	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2015	10	3							e0118919	10.1371/journal.pone.0118919	http://dx.doi.org/10.1371/journal.pone.0118919			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9BN	25785451	Green Published, gold			2022-12-27	WOS:000352138500057
J	Peng, DH; Shi, F; Li, G; Fralick, D; Shen, T; Qiu, MH; Liu, J; Jiang, KD; Shen, DG; Fang, YR				Peng, Daihui; Shi, Feng; Li, Gang; Fralick, Drew; Shen, Ting; Qiu, Meihui; Liu, Jun; Jiang, Kaida; Shen, Dinggang; Fang, Yiru			Surface Vulnerability of Cerebral Cortex to Major Depressive Disorder	PLOS ONE			English	Article							DEFAULT-MODE NETWORK; DIRECT-CURRENT STIMULATION; WHITE-MATTER INTEGRITY; CORTICAL THICKNESS; PSYCHOMOTOR RETARDATION; FUNCTIONAL CONNECTIVITY; COGNITIVE DEFICITS; SUBCORTICAL VOLUME; WORKING-MEMORY; ABNORMALITIES	Major depressive disorder (MDD) is accompanied by atypical brain structure. This study first presents the alterations in the cortical surface of patients with MDD using multidimensional structural patterns that reflect different neurodevelopment. Sixteen first-episode, untreated patients with MDD and 16 matched healthy controls underwent a magnetic resonance imaging (MRI) scan. The cortical maps of thickness, surface area, and gyrification were examined using the surface-based morphometry (SBM) approach. Increase of cortical thickness was observed in the right posterior cingulate region and the parietal cortex involving the bilateral inferior, left superior parietal and right paracentral regions, while decreased thickness was noted in the parietal cortex including bilateral pars opercularis and left precentral region, as well as the left rostral-middle frontal regions in patients with MDD. Likewise, increased or decreased surface area was found in five sub-regions of the cingulate gyrus, parietal and frontal cortices (e. g., bilateral inferior parietal and superior frontal regions). In addition, MDD patients exhibited a significant hypergyrification in the right precentral and supramarginal region. This integrated structural assessment of cortical surface suggests that MDD patients have cortical alterations of the frontal, parietal and cingulate regions, indicating a vulnerability to MDD during earlier neurodevelopmental process.	[Peng, Daihui; Shen, Ting; Qiu, Meihui; Fang, Yiru] Shanghai Jiao Tong Univ, Sch Med, Shanghai Mental Hlth Ctr, Div Mood Disorders, Shanghai 200030, Peoples R China; [Peng, Daihui; Shi, Feng; Li, Gang; Shen, Dinggang] Univ N Carolina, Dept Radiol, Chapel Hill, NC USA; [Peng, Daihui; Shi, Feng; Li, Gang; Shen, Dinggang] Univ N Carolina, BRIC, Chapel Hill, NC USA; [Fralick, Drew] Shanghai Jiao Tong Univ, Sch Med, Shanghai Mental Hlth Ctr, Suicide Res & Prevent Ctr, Shanghai 200030, Peoples R China; [Fralick, Drew] Palo Alto Univ, Palo Alto, CA USA; [Liu, Jun] Fudan Univ, Peoples Hosp Shanghai 5, Shanghai 200433, Peoples R China; [Jiang, Kaida] Fudan Univ, Huashan Hosp, Shanghai 200433, Peoples R China; Korea Univ, Dept Brain & Cognit Engn, Seoul, South Korea	Shanghai Jiao Tong University; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; Shanghai Jiao Tong University; Fudan University; Fudan University; Korea University	Peng, DH (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Shanghai Mental Hlth Ctr, Div Mood Disorders, Shanghai 200030, Peoples R China.	pdhsh@126.com; dgshen@med.unc.edu	Shen, Dinggang/ABF-6812-2020	Shen, Dinggang/0000-0002-7934-5698; Li, Gang/0000-0001-9585-1382	Shanghai Jiao Tong University [11XJ21006, YG2012MS11]; Science and Technology Commission of Shanghai Municipality [134119a6200]; Shanghai health bureau [GWHW201208]; "12th Five-year Plan" of National Key Technologies RD Program [2012BAI01B04]; National Natural Science Foundation of China [91232719]; National Key Clinical Disciplines at Shanghai Mental Health Center (OMA-MH) [2011-873]; National Institutes of Health (NIH) [EB006733, EB008374, EB009634, AG041721, MH100217, AG042599]; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB006733, R01EB009634, R01EB008374] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH100217] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG041721, R01AG042599] Funding Source: NIH RePORTER	Shanghai Jiao Tong University; Science and Technology Commission of Shanghai Municipality(Science & Technology Commission of Shanghai Municipality (STCSM)); Shanghai health bureau; "12th Five-year Plan" of National Key Technologies RD Program; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key Clinical Disciplines at Shanghai Mental Health Center (OMA-MH); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by Science Fund of Shanghai Jiao Tong University (Grant #11XJ21006 and Grant #YG2012MS11), Fund of Science and Technology Commission of Shanghai Municipality (Grant #134119a6200), Overseas Talent Project of Shanghai health bureau (Grant #GWHW201208), the "12th Five-year Plan" of National Key Technologies R&D Program (Grant #2012BAI01B04), National Natural Science Foundation of China (Grant #91232719), The National Key Clinical Disciplines at Shanghai Mental Health Center (OMA-MH, 2011-873). In addition, this grant is also partially supported by National Institutes of Health (NIH) grants (Grant #EB006733, EB008374, EB009634, AG041721, MH100217, and AG042599). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acheson DJ, 2013, J COGNITIVE NEUROSCI, V25, P1664, DOI 10.1162/jocn_a_00430; Aghajani M, 2014, PSYCHOL MED, V44, P2287, DOI 10.1017/S0033291713003000; Almeida LG, 2010, J PSYCHIATR RES, V44, P1214, DOI 10.1016/j.jpsychires.2010.04.026; Andrews SC, 2011, BRAIN STIMUL, V4, P84, DOI 10.1016/j.brs.2010.06.004; Benes FM, 2010, NEUROPSYCHOPHARMACOL, V35, P239, DOI 10.1038/npp.2009.116; Bracht T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052238; Brunoni AR, 2014, J AFFECT DISORDERS, V162, P43, DOI 10.1016/j.jad.2014.03.026; Canbeyli R, 2010, BEHAV BRAIN RES, V207, P249, DOI 10.1016/j.bbr.2009.11.002; Casanova MF, 2008, NEUROSCIENTIST, V14, P101, DOI 10.1177/1073858407309091; Colloby SJ, 2011, J AFFECT DISORDERS, V133, P158, DOI 10.1016/j.jad.2011.04.010; Culham JC, 2001, CURR OPIN NEUROBIOL, V11, P157, DOI 10.1016/S0959-4388(00)00191-4; Dinh L, 2009, NEUROCHEM RES, V34, P1896, DOI 10.1007/s11064-009-9966-z; DUM RP, 1991, J NEUROSCI, V11, P667; El Mansari M, 2010, CNS NEUROSCI THER, V16, pe1, DOI 10.1111/j.1755-5949.2010.00146.x; Fischl B, 2000, P NATL ACAD SCI USA, V97, P11050, DOI 10.1073/pnas.200033797; Furey ML, 2013, JAMA PSYCHIAT, V70, P280, DOI 10.1001/2013.jamapsychiatry.60; Genovese CR, 2002, NEUROIMAGE, V15, P870, DOI 10.1006/nimg.2001.1037; Goddard AW, 2010, DEPRESS ANXIETY, V27, P339, DOI 10.1002/da.20642; Goldman-Rakic P S, 1980, Prog Brain Res, V53, P1; GRAZIANO M, 2009, THE INTELLIGENT MOVE; Grimm S, 2009, HUM BRAIN MAPP, V30, P2617, DOI 10.1002/hbm.20693; Grimm S, 2009, NEUROPSYCHOPHARMACOL, V34, P932, DOI 10.1038/npp.2008.81; Habets P, 2011, BIOL PSYCHIAT, V69, P487, DOI 10.1016/j.biopsych.2010.08.010; Hamilton JP, 2011, BIOL PSYCHIAT, V70, P327, DOI 10.1016/j.biopsych.2011.02.003; HAMILTON M, 1967, BRIT J SOC CLIN PSYC, V6, P278; Han KM, 2014, J AFFECT DISORDERS, V155, P42, DOI 10.1016/j.jad.2013.10.021; Hester R, 2009, NEUROPSYCHOPHARMACOL, V34, P2450, DOI 10.1038/npp.2009.67; Honey CJ, 2009, P NATL ACAD SCI USA, V106, P2035, DOI 10.1073/pnas.0811168106; Hosp JA, 2011, J NEUROSCI, V31, P2481, DOI 10.1523/JNEUROSCI.5411-10.2011; Hulvershorn LA, 2011, BRAIN IMAGING BEHAV, V5, P307, DOI 10.1007/s11682-011-9134-3; Hwang JP, 2010, J GERIATR PSYCH NEUR, V23, P171, DOI 10.1177/0891988710363713; Ilamkar KR, 2014, J CLIN DIAGN RES, V8, P124, DOI 10.7860/JCDR/2014/7221.4026; Jarnum H, 2011, ACTA PSYCHIAT SCAND, V124, P435, DOI 10.1111/j.1600-0447.2011.01766.x; Kelly PA, 2013, BIOL PSYCHIAT, V74, P845, DOI 10.1016/j.biopsych.2013.06.020; Kessler RC, 2005, ARCH GEN PSYCHIAT, V62, P593, DOI 10.1001/archpsyc.62.6.593; Klein M., 2014, CEREB CORTEX; Koolschijn PCMP, 2010, EUR NEUROPSYCHOPHARM, V20, P398, DOI 10.1016/j.euroneuro.2010.02.010; Koolschijn PCMP, 2009, HUM BRAIN MAPP, V30, P3719, DOI 10.1002/hbm.20801; Kumar A, 2012, AM J GERIATR PSYCHIA; la Fougere C, 2011, NEUROIMAGE, V56, P951, DOI 10.1016/j.neuroimage.2010.11.015; Laird AR, 2009, J NEUROSCI, V29, P14496, DOI 10.1523/JNEUROSCI.4004-09.2009; LAUTER JL, 1985, HEARING RES, V20, P199, DOI 10.1016/0378-5955(85)90024-3; Leung KK, 2009, PSYCHOL MED, V39, P1097, DOI 10.1017/S0033291708004546; Li CT, 2010, NEUROIMAGE, V50, P347, DOI 10.1016/j.neuroimage.2009.11.021; Li G, 2014, J NEUROSCI, V34, P4228, DOI 10.1523/JNEUROSCI.3976-13.2014; Li G, 2013, CEREB CORTEX, V23, P2724, DOI 10.1093/cercor/bhs265; Lim HK, 2012, NEUROPSYCHOPHARMACOL, V37, P838, DOI 10.1038/npp.2011.264; Lim J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033767; Lyall A.E., 2014, CEREB CORTEX; Mackin RS, 2013, AM J GERIAT PSYCHIAT, V21, P794, DOI 10.1016/j.jagp.2013.01.013; Mayberg HS, 2003, BRIT MED BULL, V65, P193, DOI 10.1093/bmb/65.1.193; Mitchell JP, 2009, PHILOS T R SOC B, V364, P1309, DOI 10.1098/rstb.2008.0318; Nejad AB, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00666; Nixon NL, 2014, BRIT J PSYCHIAT, V204, P283, DOI 10.1192/bjp.bp.113.129965; Pontious A, 2008, DEV NEUROSCI-BASEL, V30, P24, DOI 10.1159/000109848; Price JL, 2010, NEUROPSYCHOPHARMACOL, V35, P192, DOI 10.1038/npp.2009.104; Qiu L, 2014, TRANSL PSYCHIAT, V4, DOI 10.1038/tp.2014.18; Qiu LH, 2014, J PSYCHIATR NEUROSCI, V39, P78, DOI 10.1503/jpn.130034; Radua J, 2010, NEUROIMAGE, V49, P939, DOI 10.1016/j.neuroimage.2009.08.030; Reynolds S, 2014, BMC PSYCHIATRY, V14, DOI 10.1186/1471-244X-14-83; RICHMAN DP, 1975, SCIENCE, V189, P18, DOI 10.1126/science.1135626; Rimes KA, 2005, BEHAV RES THER, V43, P1673, DOI 10.1016/j.brat.2004.12.002; Sakurai Y, 2008, BEHAV NEUROL, V19, P93, DOI 10.1155/2008/393912; Salvadore G, 2011, NEUROIMAGE, V54, P2643, DOI 10.1016/j.neuroimage.2010.11.011; Schaer M, 2008, IEEE T MED IMAGING, V27, P161, DOI 10.1109/TMI.2007.903576; Sheline YI, 2009, P NATL ACAD SCI USA, V106, P1942, DOI 10.1073/pnas.0812686106; Silani G, 2013, J NEUROSCI, V33, P15466, DOI 10.1523/JNEUROSCI.1488-13.2013; Singer T, 2009, ANN NY ACAD SCI, V1156, P81, DOI 10.1111/j.1749-6632.2009.04418.x; Sumner JA, 2010, BEHAV RES THER, V48, P614, DOI 10.1016/j.brat.2010.03.013; Sweeney JA, 2000, BIOL PSYCHIAT, V48, P674, DOI 10.1016/S0006-3223(00)00910-0; Taschereau-Dumouchel V, 2012, J NEUROSCI, V32, P759, DOI 10.1523/JNEUROSCI.5357-11.2012; Thomsen M, 2011, EXP CLIN PSYCHOPHARM, V19, P342, DOI 10.1037/a0024053; Tu PC, 2012, PSYCHIAT RES-NEUROIM, V202, P206, DOI 10.1016/j.pscychresns.2011.07.011; Urs NM, 2011, NEUROPSYCHOPHARMACOL, V36, P551, DOI 10.1038/npp.2010.186; van Eijndhoven P, 2013, AM J PSYCHIAT, V170, P1477, DOI 10.1176/appi.ajp.2013.12121504; VanEssen DC, 1997, NATURE, V385, P313, DOI 10.1038/385313a0; Voets NL, 2008, NEUROIMAGE, V43, P665, DOI 10.1016/j.neuroimage.2008.08.013; Wagner G, 2012, J PSYCHIATR RES, V46, P1449, DOI 10.1016/j.jpsychires.2012.07.013; Walther S, 2012, NEUROBIOL DIS, V47, P13, DOI 10.1016/j.nbd.2012.03.019; Whittle S, 2014, AM J PSYCHIATRY; Ye T, 2012, EUR J RADIOL, V81, P4035, DOI 10.1016/j.ejrad.2011.04.058; Yoon KL, 2014, J BEHAV THER EXP PSY, V45, P368, DOI 10.1016/j.jbtep.2014.03.004; Yuan YG, 2008, BIOL PSYCHIAT, V64, P541, DOI 10.1016/j.biopsych.2008.04.032; Zhang Mingyuan, 1998, RATING SCALES MANUAL; Zhang YC, 2009, NEUROREPORT, V20, P378, DOI 10.1097/WNR.0b013e3283249b34; Zhu XL, 2012, BIOL PSYCHIAT, V71, P611, DOI 10.1016/j.biopsych.2011.10.035; ZILLES K, 1988, ANAT EMBRYOL, V179, P173, DOI 10.1007/BF00304699	87	58	62	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2015	10	3							e0120704	10.1371/journal.pone.0120704	http://dx.doi.org/10.1371/journal.pone.0120704			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE8HY	25793287	gold, Green Submitted, Green Published			2022-12-27	WOS:000352083900066
J	Bo, M; Bavestrello, G; Angiolillo, M; Calcagnile, L; Canese, S; Cannas, R; Cau, A; D'Elia, M; D'Oriano, F; Follesa, MC; Quarta, G; Cau, A				Bo, Marzia; Bavestrello, Giorgio; Angiolillo, Michela; Calcagnile, Lucio; Canese, Simonepietro; Cannas, Rita; Cau, Alessandro; D'Elia, Marisa; D'Oriano, Filippo; Follesa, Maria Cristina; Quarta, Gianluca; Cau, Angelo			Persistence of Pristine Deep-Sea Coral Gardens in the Mediterranean Sea (SW Sardinia)	PLOS ONE			English	Article							BLACK CORAL; ANTHOZOA HEXACORALLIA; WATER ANTIPATHARIANS; ISIDELLA-ELONGATA; GROWTH-RATES; BIODIVERSITY; GORGONIANS; HABITAT; ASSEMBLAGES; DISTURBANCE	Leiopathes glaberrima is a tall arborescent black coral species structuring important facies of the deep-sea rocky bottoms of the Mediterranean Sea that are severely stifled by fishing activities. At present, however, no morphological in vivo description, ecological characterization, age dating and evaluation of the possible conservation actions have ever been made for any population of this species in the basin. A dense coral population was reported during two Remotely Operated Vehicle (ROV) surveys conducted on a rocky bank off the SW coasts of Sardinia (Western Mediterranean Sea). L. glaberrima forms up to 2 m-tall colonies with a maximal observed basal diameter of nearly 7 cm. The radiocarbon dating carried out on a colony from this site with a 4 cm basal diameter revealed an approximately age of 2000 years. Considering the size-frequency distribution of the colonies in the area it is possible to hypothesize the existence of other millennial specimens occupying a supposedly very stable ecosystem. The persistence of this ecosystem is likely guaranteed by the heterogeneous rocky substrate hosting the black coral population that represents a physical barrier against the mechanical impacts acted on the surrounding muddy areas, heavily exploited as trawling fishing grounds. This favorable condition, together with the existence of a nursery area for catsharks within the coral ramifications and the occurrence of a meadow of the now rare soft bottom alcyonacean Isidella elongata in small surviving muddy enclaves, indicates that this ecosystem have to be considered a pristine Mediterranean deep-sea coral sanctuary that would deserve special protection.	[Bo, Marzia; Bavestrello, Giorgio] Univ Genoa, Dipartimento Sci Terra Ambiente & Vita, Genoa, Italy; [Angiolillo, Michela; Canese, Simonepietro] Ist Super Protez & Ric Ambientale, Rome, Italy; [Calcagnile, Lucio; D'Elia, Marisa; Quarta, Gianluca] Univ Salento, Ctr Dataz & Diagnost, Dipartimento Ingn Innovaz, Lecce, Italy; [Cannas, Rita; Cau, Alessandro; Follesa, Maria Cristina; Cau, Angelo] Univ Cagliari, Dipartimento Sci Vita & Ambiente, Cagliari, Italy; [D'Oriano, Filippo] Geophi Srl, CNR, Res Area, Bologna, Italy	University of Genoa; Italian Institute for Environmental Protection & Research (ISPRA); University of Salento; University of Cagliari; Consiglio Nazionale delle Ricerche (CNR)	Bavestrello, G (corresponding author), Univ Genoa, Dipartimento Sci Terra Ambiente & Vita, Genoa, Italy.	giorgio.bavestrello@unige.it	Canese, Simonepietro/AAA-5499-2019; Cau, Alessandro/G-9537-2014; Angiolillo, Michela/L-2274-2015	Canese, Simonepietro/0000-0001-6049-4506; Cau, Alessandro/0000-0003-4082-7531; Angiolillo, Michela/0000-0001-5420-8868; Cannas, Rita/0000-0001-6627-4053; Bo, Marzia/0000-0001-8400-6722; d'Oriano, Filippo/0000-0003-4573-8909	Autonomous Region of Sardinia [3189/DecA/108 del 19.12.2008]	Autonomous Region of Sardinia(Regione Sardegna)	This work was financed by the Autonomous Region of Sardinia within the framework of the following scientific projects: 1) "Struttura spaziale, di popolazione e genetica dei banchi di Corallium rubrum del Mediterraneo centro occidentale. L.R. 7 Agosto 2007, n. 7 (AC). 2) "Misure gestionali volte al ripopolamento degli stock di corallo rosso (Corallium rubrum L., 1758). Decr Ass. Agricoltura n. 3189/DecA/108 del 19.12.2008 (AC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguiliar R., 2013, MEDITERRANEAN DEEP S; Andrews AH, 2009, MAR ECOL PROG SER, V397, P173, DOI 10.3354/meps08193; Angeletti L, 2014, MEDITERR MAR SCI, V15, P263, DOI 10.12681/mms.558; Bianchi CN, 2000, MAR POLLUT BULL, V40, P367, DOI 10.1016/S0025-326X(00)00027-8; Bo M, 2008, ITAL J ZOOL, V75, P185, DOI 10.1080/11250000701882908; Bo M, 2014, ITAL J ZOOL, V81, P112, DOI 10.1080/11250003.2013.859750; Bo M, 2011, ITAL J ZOOL, V78, P231, DOI 10.1080/11250001003652619; Bo M, 2009, MAR ECOL PROG SER, V397, P53, DOI 10.3354/meps08185; Bo M, 2009, ITAL J ZOOL, V76, P392, DOI 10.1080/11250000802684104; Bo M, 2014, BIOL CONSERV, V171, P167, DOI 10.1016/j.biocon.2014.01.011; Bo M, 2014, MAR ECOL-EVOL PERSP, V35, P332, DOI 10.1111/maec.12089; Bo M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049870; Bo M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016357; Bongiorni L, 2010, BIOL CONSERV, V143, P1687, DOI 10.1016/j.biocon.2010.04.009; Buhl-Mortensen L, 2010, MAR ECOL-EVOL PERSP, V31, P21, DOI 10.1111/j.1439-0485.2010.00359.x; Calcagnile L, 2004, NUCL INSTRUM METH B, V223, P16, DOI 10.1016/j.nimb.2004.04.007; Canepa Antonio, 2014, P237; Cannas Rita, 2011, Studi Trentini di Scienze Naturali, V89, P9; Carpine C, 1973, B I OCEANOGR MONACO, V71, P1; Carreiro-Silva M, 2013, MAR ECOL PROG SER, V473, P189, DOI 10.3354/meps10052; Cartes JE, 2013, DEEP-SEA RES PT I, V76, P52, DOI 10.1016/j.dsr.2013.01.006; Cau A, 2014, LEIOPATHES GLABERRIM, P40; Cerrano C, 2000, ECOL LETT, V3, P284, DOI 10.1046/j.1461-0248.2000.00152.x; Cerrano C, 2010, BIODIVERS CONSERV, V19, P153, DOI 10.1007/s10531-009-9712-5; Costantini F, 2007, MAR ECOL PROG SER, V340, P109, DOI 10.3354/meps340109; D'Elia M, 2004, NUCL INSTRUM METH B, V223, P278, DOI 10.1016/j.nimb.2004.04.056; D'Onghia G., 2003, Journal of Northwest Atlantic Fishery Science, V31, P263; D'Onghia G, 2010, DEEP-SEA RES PT II, V57, P397, DOI 10.1016/j.dsr2.2009.08.022; Damalas D, 2011, FISH RES, V108, P142, DOI 10.1016/j.fishres.2010.12.012; Danovaro R, 2001, TRENDS ECOL EVOL, V16, P505, DOI 10.1016/S0169-5347(01)02215-7; Deidun A., 2010, Marine Biodiversity Records, V3, pe90; DRUFFEL ERM, 1995, GEOCHIM COSMOCHIM AC, V59, P5031, DOI 10.1016/0016-7037(95)00373-8; Etnoyer P, 2007, B MAR SCI, V81, P553; Fabri MC, 2014, DEEP-SEA RES PT II, V104, P184, DOI 10.1016/j.dsr2.2013.06.016; Fabri MC, 2012, SRM MO INITIAL ASSES; Follesa MC, 2013, MAR FRESHWATER RES, V64, P706, DOI 10.1071/MF12235; Food and Agriculture Organization (FAO), 2006, 147 FAO, V147; Food and Agriculture Organization (FAO), 2009, INT GUID MAN DEEP SE, P73; Gianfrate G, 2007, NUCL INSTRUM METH B, V259, P316, DOI 10.1016/j.nimb.2007.01.309; Gori A, 2011, MAR BIOL, V158, P1721, DOI 10.1007/s00227-011-1686-7; Gori A, 2011, MAR BIOL, V158, P143, DOI 10.1007/s00227-010-1548-8; GRASSLE JF, 1977, NATURE, V265, P618, DOI 10.1038/265618a0; Hammer Oyvind, 2001, Palaeontologia Electronica, V4, pUnpaginated; Linares C, 2008, J APPL ECOL, V45, P688, DOI 10.1111/j.1365-2664.2007.01419.x; LONGIN R, 1971, NATURE, V230, P241, DOI 10.1038/230241a0; Mastrototaro F, 2010, DEEP-SEA RES PT II, V57, P412, DOI 10.1016/j.dsr2.2009.08.021; Maynou F, 2012, J MAR BIOL ASSOC UK, V92, P1501, DOI 10.1017/S0025315411001603; Maynou F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021818; Miller KJ, 1998, MAR ECOL PROG SER, V163, P225, DOI 10.3354/meps163225; Molodtsova TN, 2011, ZOOTAXA, P52; Mytilineou C, 2014, DEEP-SEA RES PT II, V99, P146, DOI 10.1016/j.dsr2.2013.07.007; Ocaû£a O., 2004, REV ACAD CANARIA CIE, V15, P159; Olita A, 2013, CONT SHELF RES, V71, P95, DOI 10.1016/j.csr.2013.10.011; Opresko Dennis M., 2001, Senckenbergiana Biologica, V81, P1; Opresko Dennis M., 1998, Records of the South Australian Museum (Adelaide), V31, P99; OPRESKO DM, 2004, MAR MEDITERRANEO FAU, V2, P506; Pardo E., 2011, CHRONICA NATURAE, V1, P20; Parker NR, 1997, MAR BIOL, V130, P11, DOI 10.1007/s002270050220; Ponti M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102782; Prouty NG, 2011, MAR ECOL PROG SER, V423, P101, DOI 10.3354/meps08953; Raimundo J, 2013, DEEP-SEA RES PT II, V98, P129, DOI 10.1016/j.dsr2.2013.01.012; Ramsey CB, 2001, RADIOCARBON, V43, P355; Reimer PJ, 2009, RADIOCARBON, V51, P1111, DOI 10.1017/S0033822200034202; Reimer PJ, 2002, RADIOCARBON, V44, P159, DOI 10.1017/S0033822200064766; Relini G., 1988, Bollettino dei Musei e degli Istituti Biologici dell'Universita di Genova, V52, P139; Risk MJ, 2009, MAR ECOL PROG SER, V397, P219, DOI 10.3354/meps08414; Roark EB, 2006, MAR ECOL PROG SER, V327, P1, DOI 10.3354/meps327001; Roark EB, 2009, P NATL ACAD SCI USA, V106, P5204, DOI 10.1073/pnas.0810875106; Sampaio I, 2012, J MAR BIOL ASSOC UK, V92, P1547, DOI 10.1017/S0025315412000045; Sherwood OA, 2009, MAR ECOL PROG SER, V397, P209, DOI 10.3354/meps08166; Sinniger F, 2009, J COR REEF STU, V11, P21, DOI DOI 10.3755/GALAXEA.11.21; STUIVER M, 1977, RADIOCARBON, V19, P355, DOI 10.1017/S0033822200003672; Tsounis G, 2010, OCEANOGR MAR BIOL, V48, P161, DOI 10.1201/EBK1439821169-c3; Vafidis D, 2006, P 10 ICZEGAR PATR GR; Vertino A, 2010, DEEP-SEA RES PT II, V57, P380, DOI 10.1016/j.dsr2.2009.08.023; Vogel S., 1994, LIFE MOVING FLUIDS P; Watling L, 1998, CONSERV BIOL, V12, P1180, DOI 10.1046/j.1523-1739.1998.0120061180.x; WEINBERG S, 1978, MAR BIOL, V49, P41, DOI 10.1007/BF00390729; Williams B, 2007, B MAR SCI, V81, P437; Williams B, 2006, GEOLOGY, V34, P773, DOI 10.1130/G22685.1	80	82	82	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2015	10	3							e0119393	10.1371/journal.pone.0119393	http://dx.doi.org/10.1371/journal.pone.0119393			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD9NQ	25790333	gold, Green Submitted, Green Published			2022-12-27	WOS:000351425400078
J	Girard, BJ; Anderson, TMR; Welch, SL; Nicely, J; Seewaldt, VL; Ostrander, JH				Girard, Brian J.; Anderson, Tarah M. Regan; Welch, Siya Lem; Nicely, Julie; Seewaldt, Victoria L.; Ostrander, Julie H.			Cytoplasmic PELP1 and ERRgamma Protect Human Mammary Epithelial Cells from Tam-Induced Cell Death	PLOS ONE			English	Article							ESTROGEN-RELATED RECEPTORS; BREAST-CANCER CELLS; ERR-GAMMA; TAMOXIFEN RESISTANCE; IN-VITRO; EXPRESSION; APOPTOSIS; AUTOPHAGY; 4-HYDROXYTAMOXIFEN; MECHANISMS	Tamoxifen (Tam) is the only FDA-approved chemoprevention agent for pre-menopausal women at high risk for developing breast cancer. While Tam reduces a woman's risk of developing estrogen receptor positive (ER+) breast cancer, the molecular mechanisms associated with risk reduction are poorly understood. Prior studies have shown that cytoplasmic proline, glutamic acid and leucine rich protein 1 (PELP1) promotes Tam resistance in breast cancer cell lines. Herein, we tested for PELP1 localization in breast epithelial cells from women at high risk for developing breast cancer and found that PELP1 was localized to the cytoplasm in 36% of samples. In vitro, immortalized HMECs expressing a nuclear localization signal (NLS) mutant of PELP1 (PELP1-cyto) were resistant to Tam-induced death. Furthermore, PELP1-cyto signaling through estrogen-related receptor gamma (ERR.) promoted cell survival in the presence of Tam. Overexpression of ERR gamma in immortalized HMECs protected cells from Tam-induced death, while knockdown of ERR gamma sensitized PELP1-cyto expressing HMECs to Tam. Moreover, Tam-induced HMEC cell death was independent of apoptosis and involved accumulation of the autophagy marker LC3-II. Expression of PELP1-cyto and ERR gamma reduced Tam-induced LC3-II accumulation, and knockdown of ERR gamma increased LC3-II levels in response to Tam. Additionally, PELP1-cyto expression led to the upregulation of MMP-3 and MAOB, known PELP1 and ERR gamma target genes, respectively. Our data indicate that cytoplasmic PELP1 induces signaling pathways that converge on ERR gamma to promote cell survival in the presence of Tam. These data suggest that PELP1 localization and/or ERR gamma activation could be developed as tissue biomarkers for Tam responsiveness.	[Girard, Brian J.; Anderson, Tarah M. Regan; Ostrander, Julie H.] Univ Minnesota, Mason Canc Ctr, Dept Med, Minneapolis, MN 55455 USA; [Welch, Siya Lem; Nicely, Julie; Seewaldt, Victoria L.] Duke Univ, Med Ctr, Dept Med, Durham, NC 27710 USA	University of Minnesota System; University of Minnesota Twin Cities; Duke University	Ostrander, JH (corresponding author), Univ Minnesota, Mason Canc Ctr, Dept Med, Minneapolis, MN 55455 USA.	hans1354@umn.edu	Nicely, Julie M/E-3668-2016	Nicely, Julie M/0000-0003-4828-0032	National Institutes of Health [K07CA131501]; American Cancer Society [124166-IRG-58-001-52-IRG5]; National Center for Advancing Translational Sciences of the National Institutes of Health [UL1TR000114]; NATIONAL CANCER INSTITUTE [K07CA131501, P30CA077598] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000114] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Cancer Society(American Cancer Society); National Center for Advancing Translational Sciences of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	JHO was supported by National Institutes of Health K07CA131501, an Institutional Research Grant #124166-IRG-58-001-52-IRG5 from the American Cancer Society, and National Center for Advancing Translational Sciences of the National Institutes of Health Award UL1TR000114 (K to R01 pilot funding to JHO). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson E, 1998, J MAMMARY GLAND BIOL, V3, P23, DOI 10.1023/A:1018718117113; Ariazi EA, 2002, CANCER RES, V62, P6510; Baker JC, 2008, CANCER EPIDEM BIOMAR, V17, P1884, DOI 10.1158/1055-9965.EPI-07-2696; Benson JR, 1996, BRIT J CANCER, V74, P352, DOI 10.1038/bjc.1996.365; Burscha W, 2008, TOXICOLOGY, V254, P147, DOI 10.1016/j.tox.2008.07.048; CHARLIER C, 1995, BIOCHEM PHARMACOL, V49, P351, DOI 10.1016/0006-2952(94)00492-5; Cho KS, 2012, INVEST OPHTH VIS SCI, V53, P5344, DOI 10.1167/iovs.12-9827; Deblois G, 2011, BBA-MOL BASIS DIS, V1812, P1032, DOI 10.1016/j.bbadis.2010.12.009; Debnath J, 2003, METHODS, V30, P256, DOI 10.1016/S1046-2023(03)00032-X; Dietze EC, 2004, ONCOGENE, V23, P3851, DOI 10.1038/sj.onc.1207480; Dietze EC, 2001, J BIOL CHEM, V276, P5384, DOI 10.1074/jbc.M007915200; Fisher B, 1998, J NATL CANCER I, V90, P1371, DOI 10.1093/jnci/90.18.1371; Frasor J, 2006, CANCER RES, V66, P7334, DOI 10.1158/0008-5472.CAN-05-4269; Friedman ZY, 1998, CANCER INVEST, V16, P391, DOI 10.3109/07357909809115779; Garbe JC, 2014, CELL CYCLE, V13, P3423, DOI 10.4161/15384101.2014.954456; Garbe JC, 2009, CANCER RES, V69, P7557, DOI 10.1158/0008-5472.CAN-09-0270; Girard BJ, 2014, MOL CELL ENDOCRINOL, V382, P642, DOI 10.1016/j.mce.2013.07.031; GRENMAN SE, 1990, INT J CANCER, V45, P920, DOI 10.1002/ijc.2910450524; GRENMAN SE, 1990, GYNECOL ONCOL, V37, P188, DOI 10.1016/0090-8258(90)90332-F; Greschik H, 2002, MOL CELL, V9, P303, DOI 10.1016/S1097-2765(02)00444-6; Habashy HO, 2010, BREAST CANCER RES TR, V120, P603, DOI 10.1007/s10549-009-0419-9; Heckler MM, 2014, FEBS J, V281, P2431, DOI 10.1111/febs.12797; Ijichi N, 2011, J STEROID BIOCHEM, V123, P1, DOI 10.1016/j.jsbmb.2010.09.002; Kohli L, 2013, CANCER RES, V73, P4395, DOI 10.1158/0008-5472.CAN-12-3765; Koritzinsky M, 2013, SEMIN RADIAT ONCOL, V23, P252, DOI 10.1016/j.semradonc.2013.05.006; KRISHAN A, 1975, J CELL BIOL, V66, P188, DOI 10.1083/jcb.66.1.188; Kumar R, 2009, CLIN CANCER RES, V15, P4123, DOI 10.1158/1078-0432.CCR-08-2347; Lee JE, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002901; Liu XH, 2010, J BIOCHEM, V148, P247, DOI 10.1093/jb/mvq056; LOPES MCF, 1990, CANCER RES, V50, P2753; Lu XY, 2012, CURR PHARM DESIGN, V18, P3421, DOI 10.2174/138161212801227113; MacGregor JI, 1998, PHARMACOL REV, V50, P151; Mandlekar S, 2001, APOPTOSIS, V6, P469, DOI 10.1023/A:1012437607881; OBRIAN CA, 1985, CANCER RES, V45, P2462; Ohshiro K, 2008, AUTOPHAGY, V4, P104, DOI 10.4161/auto.5223; Ohshiro K, 2007, CANCER RES, V67, P8164, DOI 10.1158/0008-5472.CAN-07-0038; Ostrander JH, 2010, CANCER RES, V70, P4759, DOI 10.1158/0008-5472.CAN-09-2572; Ren Y, 2011, HUM MOL GENET, V20, P1074, DOI 10.1093/hmg/ddq550; Riggins RB, 2008, CANCER RES, V68, P8908, DOI 10.1158/0008-5472.CAN-08-2669; Riggins RB, 2010, ENDOCR-RELAT CANCER, V17, pR213, DOI 10.1677/ERC-10-0058; ROBERTSON DW, 1982, J STEROID BIOCHEM, V16, P1, DOI 10.1016/0022-4731(82)90137-6; Roy S, 2012, MOL CANCER RES, V10, P25, DOI 10.1158/1541-7786.MCR-11-0456; Ryter SW, 2013, MOL CELLS, V36, P7, DOI 10.1007/s10059-013-0140-8; Seewaldt VL, 2001, CANCER RES, V61, P616; Tan CK, 2000, J GASTROEN HEPATOL, V15, P725, DOI 10.1046/j.1440-1746.2000.02235.x; Thomas P, 2005, ENDOCRINOLOGY, V146, P624, DOI 10.1210/en.2004-1064; Tremblay GB, 2001, ENDOCRINOLOGY, V142, P4572, DOI 10.1210/en.142.10.4572; TWENTYMAN PR, 1987, BRIT J CANCER, V56, P279, DOI 10.1038/bjc.1987.190; Vadlamudi RK, 2010, J STEROID BIOCHEM, V118, P211, DOI 10.1016/j.jsbmb.2009.09.009; Vadlamudi RK, 2005, CANCER RES, V65, P7724, DOI 10.1158/0008-5472.CAN-05-0614; Vadlamudi RK, 2001, J BIOL CHEM, V276, P38272; Vallabhaneni S, 2010, BREAST CANC RES TREA	52	13	14	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2015	10	3							e0121206	10.1371/journal.pone.0121206	http://dx.doi.org/10.1371/journal.pone.0121206			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD9NQ	25789479	Green Published, Green Submitted, gold			2022-12-27	WOS:000351425400190
J	Lopes, AM; Machado, JAT				Lopes, Antonio M.; Machado, J. A. Tenreiro			Dynamical Analysis and Visualization of Tornadoes Time Series	PLOS ONE			English	Article							POWER LAWS; INTENSITY; DISTRIBUTIONS; STATISTICS; COMPLEXITY; DAMAGE	In this paper we analyze the behavior of tornado time-series in the U.S. from the perspective of dynamical systems. A tornado is a violently rotating column of air extending from a cumulonimbus cloud down to the ground. Such phenomena reveal features that are well described by power law functions and unveil characteristics found in systems with long range memory effects. Tornado time series are viewed as the output of a complex system and are interpreted as a manifestation of its dynamics. Tornadoes are modeled as sequences of Dirac impulses with amplitude proportional to the events size. First, a collection of time series involving 64 years is analyzed in the frequency domain by means of the Fourier transform. The amplitude spectra are approximated by power law functions and their parameters are read as an underlying signature of the system dynamics. Second, it is adopted the concept of circular time and the collective behavior of tornadoes analyzed. Clustering techniques are then adopted to identify and visualize the emerging patterns.	[Lopes, Antonio M.] Univ Porto, Fac Engn, Inst Engn Mech, P-4100 Oporto, Portugal; [Machado, J. A. Tenreiro] Polytech Porto, Inst Engn, Oporto, Portugal	Universidade do Porto; Polytechnic Institute of Porto	Lopes, AM (corresponding author), Univ Porto, Fac Engn, Inst Engn Mech, Rua Campo Alegre 823, P-4100 Oporto, Portugal.	aml@fe.up.pt	Lopes, António M./A-2740-2016; Machado, J. A. Tenreiro/M-2173-2013	Lopes, António M./0000-0001-7359-4370; Machado, J. A. Tenreiro/0000-0003-4274-4879				BAK P, 1987, PHYS REV LETT, V59, P381, DOI 10.1103/PhysRevLett.59.381; Beran J., 1994, STAT LONG MEMORY PRO; BERRY MV, 1979, J PHYS A-MATH GEN, V12, P781, DOI 10.1088/0305-4470/12/6/008; Brooks H, 2001, ATMOS RES, V56, P191, DOI 10.1016/S0169-8095(00)00098-3; Brooks HE, 2004, WEATHER FORECAST, V19, P310, DOI 10.1175/1520-0434(2004)019<0310:OTROTP>2.0.CO;2; Carlson JM, 1999, PHYS REV E, V60, P1412, DOI 10.1103/PhysRevE.60.1412; Clauset A, 2009, SIAM REV, V51, P661, DOI 10.1137/070710111; Cox T. F., 2000, MULTIDIMENSIONAL SCA; Doswell CA, 2006, WEATHER FORECAST, V21, P939, DOI 10.1175/WAF959.1; Dotzec N, 2003, ATMOS RES, V67-8, P163, DOI 10.1016/S0169-8095(03)00050-4; Dotzek N, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2005GL024583; Dotzek N, 2009, ATMOS RES, V93, P564, DOI 10.1016/j.atmosres.2008.10.015; Edwards R, 2013, B AM METEOROL SOC, V94, P641, DOI 10.1175/BAMS-D-11-00006.1; Feuerstein B, 2011, ATMOS RES, V100, P547, DOI 10.1016/j.atmosres.2010.12.026; Fisher N., 1995, STAT ANAL CIRCULAR D; Fujita T, 1973, 8 C SEV LOC STORMS D, P142; Fujita T.T., 1971, 91 SMRP; FUJITA TT, 1981, J ATMOS SCI, V38, P1511, DOI 10.1175/1520-0469(1981)038<1511:TADITC>2.0.CO;2; Jain AK., 1988, TECHNOMETRICS; Kurgansky M. V., 2000, DOKL EARTH SCI, V371, P408; Machado JAT, 2012, COMMUN NONLINEAR SCI, V17, P2237, DOI 10.1016/j.cnsns.2011.09.041; Malamud BD, 2012, ATMOS CHEM PHYS, V12, P8459, DOI 10.5194/acp-12-8459-2012; MANDELBROT BB, 1968, SIAM REV, V10, P422, DOI 10.1137/1010093; Newman MEJ, 2005, CONTEMP PHYS, V46, P323, DOI 10.1080/00107510500052444; Pinto CMA, 2012, COMMUN NONLINEAR SCI, V17, P3558, DOI 10.1016/j.cnsns.2012.01.013; Potter S., 2007, WEATHERWISE, V62, P64; Schielicke L, 2013, NONLINEAR PROC GEOPH, V20, P47, DOI 10.5194/npg-20-47-2013; Schielicke L, 2011, ATMOS RES, V100, P357, DOI 10.1016/j.atmosres.2010.08.027; Schroeder M, 1991, FRACTALS CHAOS POWER; Simmons KM, 2013, ENVIRON HAZARDS-UK, V12, P132, DOI 10.1080/17477891.2012.738642; SOKAL ROBERT R., 1962, TAXON, V11, P33, DOI 10.2307/1217208; Sornette D, 2003, GEOPHYS RES LETT, V30; Machado JAT, 2015, NONLINEAR DYNAM, V79, P63, DOI 10.1007/s11071-014-1645-1; Machado JAT, 2012, NONLINEAR DYNAM, V70, P789, DOI 10.1007/s11071-012-0495-y; Tenreiro Machado JA, 2013, MATH PHYS; Turcotte D. L., 2002, INT GEOPHYS SER, V81, P209; Verbout SM, 2006, WEATHER FORECAST, V21, P86, DOI 10.1175/WAF910.1; Vuong QH, 1989, ECONOMETRICA J ECONO, P307; West BJ, 2014, REV MOD PHYS, V86, P1169, DOI 10.1103/RevModPhys.86.1169; West BJ, 2012, FRACT CALC APPL ANAL, V15, P70, DOI 10.2478/s13540-012-0006-3	40	3	3	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2015	10	3							e0120260	10.1371/journal.pone.0120260	http://dx.doi.org/10.1371/journal.pone.0120260			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD9NQ	25790281	gold, Green Published			2022-12-27	WOS:000351425400147
J	Motawi, TK; Shaker, OG; El-Maraghy, SA; Senousy, MA				Motawi, Tarek Kamal; Shaker, Olfat Gamil; El-Maraghy, Shohda Assem; Senousy, Mahmoud Ahmed			Serum Interferon-Related MicroRNAs as Biomarkers to Predict the Response to Interferon Therapy in Chronic Hepatitis C Genotype 4	PLOS ONE			English	Article							CIRCULATING MICRORNAS; HCV REPLICATION; VIRUS-INFECTION; EXPRESSION; GENE; EFFICACY; POLYMORPHISM; TELAPREVIR; INDUCTION; PROFILES	MicroRNAs are messengers during interferon-virus interplay and are involved in antiviral immunity, however, little is known about interferon-related microRNAs regarding their detection in serum and their potential use as non-invasive diagnostic and prognostic biomarkers in chronic hepatitis C (CHC). To elucidate some of the molecular aspects underlying failure of pegylated interferon-alpha/ribavirin therapy, we investigated pretreatment expression profiles of seven selected interferon-related microRNAs (miR-146a, miR-34a, miR-130a, miR-19a, miR-192, miR-195, and miR-296) by quantitative RT-PCR custom array technology in serum of Egyptian CHC genotype 4 patients and whether their pretreatment levels would predict patient response to the combination therapy. One hundred and six CHC patients and forty matched healthy controls were included. Patients were divided into sustained virological response (SVR) and non-responder (NR) groups. Serum miR-34a, miR-130a, miR-19a, miR-192, miR-195, and miR-296 were upregulated, whereas serum miR-146a was downregulated in CHC compared to controls. Significant correlations were found between expression levels of studied microRNAs and also with clinical data. Pretreatment levels of miR-34a, miR-130a, and miR-195 were significantly higher, whereas miR-192 and miR-296 levels were significantly lower in SVR than NR patients. miR-19a and miR-146a levels were not significantly different between the two groups. miR-34a was superior to differentiate CHC from controls, whereas miR-296 was superior to discriminate SVR from NR patients by receiver operating characteristic analysis. Multivariate logistic analysis revealed miR-34a and miR-195 as independent predictors for SVR and miR-192 as an independent variable for non-response. In conclusion, pretreatment expression profiles of five interferon-related microRNAs are associated with treatment outcome in CHC. Of these, miR-34a, miR-195, and miR-192 could predict treatment response. The profiling results could be used as novel non-invasive diagnostic and prognostic pharmacogenetic biomarkers for treatment personalization in CHC and could help to identify new microRNA-based antivirals.	[Motawi, Tarek Kamal; El-Maraghy, Shohda Assem; Senousy, Mahmoud Ahmed] Cairo Univ, Fac Pharm, Dept Biochem, Cairo, Egypt; [Shaker, Olfat Gamil] Cairo Univ, Fac Sci, Dept Med Biochem & Mol Biol, Cairo, Egypt	Egyptian Knowledge Bank (EKB); Cairo University; Egyptian Knowledge Bank (EKB); Cairo University	Senousy, MA (corresponding author), Cairo Univ, Fac Pharm, Dept Biochem, Cairo, Egypt.	mohmoud.ali@pharma.cu.edu.eg	Shaker, Olfat G/S-2010-2017; O, Shaker/Y-6125-2019; Issa, Randa @M.T/E-7144-2019; Senousy, Mahmoud Ahmed/AAB-6410-2022	O, Shaker/0000-0002-3031-3599; Issa, Randa @M.T/0000-0003-0619-1234; Motawi, Tarek/0000-0001-8925-9702				Abouheif MM, 2010, RHEUMATOLOGY, V49, P2054, DOI 10.1093/rheumatology/keq247; Allegra A, 2012, INT J ONCOL, V41, P1897, DOI 10.3892/ijo.2012.1647; Antaki N, 2010, LIVER INT, V30, P342, DOI 10.1111/j.1478-3231.2009.02188.x; Bala S, 2012, HEPATOLOGY, V56, P1946, DOI 10.1002/hep.25873; Bala S, 2012, J TRANSL MED, V10, DOI 10.1186/1479-5876-10-151; Bedossa P, 1996, HEPATOLOGY, V24, P289, DOI 10.1002/hep.510240201; Bellecave Pantxika, 2008, Hepatology, V48, P1330, DOI 10.1002/hep.22571; Bruni R, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-485; Burska AN, 2014, PHARMACOGENOMICS J, V14, P93, DOI 10.1038/tpj.2013.48; Cermelli S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023937; Chen YX, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-407; Chowdhury JB, 2012, J VIROL, V86, P10221, DOI 10.1128/JVI.00882-12; Collins AS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069090; Andrade LJD, 2009, J GLOB INFECT DIS, V1, P33, DOI 10.4103/0974-777X.52979; El-Ekiaby N, 2012, FEBS OPEN BIO, V2, P179, DOI 10.1016/j.fob.2012.07.005; Hatzakis A, 2013, J VIRAL HEPATITIS, V20, P1, DOI 10.1111/jvh.12120; Hermeking H, 2007, CANCER CELL, V12, P414, DOI 10.1016/j.ccr.2007.10.028; Ishida H, 2011, BIOCHEM BIOPH RES CO, V412, P92, DOI 10.1016/j.bbrc.2011.07.049; Jacobson IM, 2011, NEW ENGL J MED, V364, P2405, DOI 10.1056/NEJMoa1012912; Ji F, 2011, J VIRAL HEPATITIS, V18, pE242, DOI 10.1111/j.1365-2893.2011.01443.x; Kamal SM, 2011, LIVER INT, V31, P45, DOI 10.1111/j.1478-3231.2010.02385.x; Kim Y, 2014, J CLIN ONCOL, V32, P121, DOI 10.1200/JCO.2013.50.8556; Kurbanov F, 2011, J INFECT DIS, V204, P1391, DOI 10.1093/infdis/jir536; Li S, 2014, J VIRAL HEPATITIS, V21, P121, DOI 10.1111/jvh.12131; Liu XY, 2010, VIROLOGY, V398, P57, DOI 10.1016/j.virol.2009.11.036; Maasoumy B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055285; Mabrouk M, 2013, HEPATO-GASTROENTEROL, V60, P1731, DOI 10.5754/hge12745; Mohamoud YA, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-288; Mu Y, 2013, EXP MOL PATHOL, V95, P206, DOI 10.1016/j.yexmp.2013.07.005; Murakami Y, 2010, BMC MED GENOMICS, V3, DOI 10.1186/1755-8794-3-48; Ohno T, 1997, J CLIN MICROBIOL, V35, P201, DOI 10.1128/JCM.35.1.201-207.1997; Pedersen IM, 2007, NATURE, V449, P919, DOI 10.1038/nature06205; Peng XX, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-373; Pol S, 2011, HEPATOLOGY, V54, p374A; Randall G, 2007, P NATL ACAD SCI USA, V104, P12884, DOI 10.1073/pnas.0704894104; Razavi H, 2014, J VIRAL HEPATITIS, V21, P34, DOI 10.1111/jvh.12248; Reinsbach SE, 2012, RNA BIOL, V9, P978, DOI 10.4161/rna.20494; Sarasin-Filipowicz M, 2009, NAT MED, V15, P31, DOI 10.1038/nm.1902; Scagnolari C, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-311; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Sedger LM, 2013, MOL IMMUNOL, V56, P781, DOI 10.1016/j.molimm.2013.07.009; Sekiya Y, 2011, J CELL PHYSIOL, V226, P2535, DOI 10.1002/jcp.22598; Shaker OG, 2012, HUM IMMUNOL, V73, P1039, DOI 10.1016/j.humimm.2012.07.329; Shehab H, 2014, J INTERF CYTOK RES, V34, P727, DOI 10.1089/jir.2013.0127; Shwetha S, 2013, SCI REPORTS, V3, P1; Siegrist F, 2009, BIOL PROCED ONLINE, V11, P113, DOI 10.1007/s12575-009-9012-1; Sperveslage J, 2014, ENDOCRINE, V46, P226, DOI 10.1007/s12020-014-0202-5; Steuerwald NM, 2010, LIVER INT, V30, P1490, DOI 10.1111/j.1478-3231.2010.02321.x; Su TH, 2013, P NATL ACAD SCI USA, V110, P7844, DOI 10.1073/pnas.1306138110; Taganov KD, 2006, P NATL ACAD SCI USA, V103, P12481, DOI 10.1073/pnas.0605298103; Tan YW, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0105192, 10.1371/journal.pone.0094264]; Wang K, 2009, P NATL ACAD SCI USA, V106, P4402, DOI 10.1073/pnas.0813371106; Wang LG, 2012, CANCER EPIDEMIOL, V36, pE61, DOI 10.1016/j.canep.2011.05.002; Zhang XZ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055733	54	14	16	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2015	10	3							e0120794	10.1371/journal.pone.0120794	http://dx.doi.org/10.1371/journal.pone.0120794			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD9NQ	25790297	Green Submitted, Green Published, gold			2022-12-27	WOS:000351425400177
J	Zhang, HX; Zhuang, SY; Qian, HY; Wang, F; Ji, HB				Zhang, Houxi; Zhuang, Shunyao; Qian, Haiyan; Wang, Feng; Ji, Haibao			Spatial Variability of the Topsoil Organic Carbon in the Moso Bamboo Forests of Southern China in Association with Soil Properties	PLOS ONE			English	Article							NORTHEAST CHINA; CLIMATE-CHANGE; BLACK SOIL; LAND-USE; PH; MANAGEMENT; GRASSLAND; SEQUESTRATION; PLANTATIONS; TEMPERATURE	Understanding the spatial variability of soil organic carbon (SOC) must be enhanced to improve sampling design and to develop soil management strategies in terrestrial ecosystems. Moso bamboo (Phyllostachys pubescens Mazel ex Houz.) forests have a high SOC storage potential; however, they also vary significantly spatially. This study investigated the spatial variability of SOC (0-20 cm) in association with other soil properties and with spatial variables in the Moso bamboo forests of Jian'ou City, which is a typical bamboo hometown in China. 209 soil samples were collected from Moso bamboo stands and then analyzed for SOC, bulk density (BD), pH, cation exchange capacity (CEC), and gravel content (GC) based on spatial distribution. The spatial variability of SOC was then examined using geostatistics. A Kriging map was produced through ordinary interpolation and required sample numbers were calculated by classical and Kriging methods. An aggregated boosted tree (ABT) analysis was also conducted. A semivariogram analysis indicated that ln(SOC) was best fitted with an exponential model and that it exhibited moderate spatial dependence, with a nugget/sill ratio of 0.462. SOC was significantly and linearly correlated with BD (r = -0.373**), pH (r = -0.429**), GC (r = -0.163*), CEC (r = 0.263**), and elevation (r = 0.192**). Moreover, the Kriging method requires fewer samples than the classical method given an expected standard error level as per a variance analysis. ABT analysis indicated that the physicochemical variables of soil affected SOC variation more significantly than spatial variables did, thus suggesting that the SOC in Moso bamboo forests can be strongly influenced by management practices. Thus, this study provides valuable information in relation to sampling strategy and insight into the potential of adjustments in agronomic measure, such as in fertilization for Moso bamboo production.	[Zhang, Houxi; Zhuang, Shunyao; Qian, Haiyan; Wang, Feng; Ji, Haibao] Chinese Acad Sci, Inst Soil Sci, State Key Lab Soil & Sustainable Agr, Nanjing, Jiangsu, Peoples R China; [Zhang, Houxi; Qian, Haiyan; Wang, Feng; Ji, Haibao] Univ Chinese Acad Sci, Beijing, Peoples R China	Chinese Academy of Sciences; Institute of Soil Science, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Zhuang, SY (corresponding author), Chinese Acad Sci, Inst Soil Sci, State Key Lab Soil & Sustainable Agr, Nanjing, Jiangsu, Peoples R China.	syzhuang@issas.ac.cn			Strategic Priority Research Program of the Chinese Academy of Sciences [XDA05070303]	Strategic Priority Research Program of the Chinese Academy of Sciences(Chinese Academy of Sciences)	The authors thank for the financial support from Strategic Priority Research Program of the Chinese Academy of Sciences (XDA05070303). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson S, 2001, SOIL BIOL BIOCHEM, V33, P1181, DOI 10.1016/S0038-0717(01)00022-0; Cambardella CA, 1994, SOIL SCI SOC AM J, V58, P1505; Chen XG, 2009, FOREST ECOL MANAG, V258, P1489, DOI 10.1016/j.foreco.2009.06.051; Chuai XW, 2012, PEDOSPHERE, V22, P404, DOI 10.1016/S1002-0160(12)60026-5; Cline MG, 1944, SOIL SCI, V58, P275, DOI 10.1097/00010694-194410000-00003; Curran PJ, 1998, PROG PHYS GEOG, V22, P61, DOI 10.1177/030913339802200103; De'ath G, 2007, ECOLOGY, V88, P243, DOI 10.1890/0012-9658(2007)88[243:BTFEMA]2.0.CO;2; Evrendilek F, 2004, J ARID ENVIRON, V59, P743, DOI 10.1016/j.jaridenv.2004.03.002; Fu J., 2001, BAMBOO, V22, P5; Fu J., 2000, AM BAMBOO SOC MAG, V21, P12; Garten CT, 2011, GEODERMA, V167-68, P30, DOI 10.1016/j.geoderma.2011.08.007; Ge Y, 2008, ISME J, V2, P254, DOI 10.1038/ismej.2008.2; Goovaerts P, 1998, BIOL FERT SOILS, V27, P315, DOI 10.1007/s003740050439; Hati KA, 2007, AGR ECOSYST ENVIRON, V119, P127, DOI 10.1016/j.agee.2006.06.017; Lal R, 2004, GEODERMA, V123, P1, DOI 10.1016/j.geoderma.2004.01.032; Liu DW, 2006, AGR ECOSYST ENVIRON, V113, P73, DOI 10.1016/j.agee.2005.09.006; Liu G., 1996, SOIL PHYS CHEM ANAL; Lu R.K., 1999, ANAL METHOD SOIL AGR; Ludovisi A, 2005, ECOL MODEL, V181, P247, DOI 10.1016/j.ecolmodel.2004.06.033; Martin D, 2010, AGR ECOSYST ENVIRON, V138, P64, DOI 10.1016/j.agee.2010.04.001; Materechera SA, 1995, BIOL FERT SOILS, V19; MCBRATNEY AB, 1983, SOIL SCI, V135, P177, DOI 10.1097/00010694-198303000-00007; McGrath D, 2004, ENVIRON POLLUT, V127, P239, DOI 10.1016/j.envpol.2003.07.002; Olaleye AO, 2011, COMMUN SOIL SCI PLAN, V42, P2624, DOI 10.1080/00103624.2011.614038; Oueslati I, 2013, PEDOSPHERE, V23, P48, DOI 10.1016/S1002-0160(12)60079-4; PENG G, 2013, PLOS ONE, V0008; Pietri JCA, 2008, SOIL BIOL BIOCHEM, V40, P1856, DOI [10.1016/j.soilbio.2008.03.020, 10.1016/i.soilbio.2008.03.020]; Powers JS, 2002, GEODERMA, V109, P165, DOI 10.1016/S0016-7061(02)00147-7; Salako FK, 1999, GEODERMA, V91, P103, DOI 10.1016/S0016-7061(99)00006-3; Sebastia MT, 2004, BASIC APPL ECOL, V5, P331, DOI 10.1016/j.baae.2003.10.001; Shrestha BM, 2004, NUTR CYCL AGROECOSYS, V68, P155, DOI 10.1023/B:FRES.0000019044.52811.11; Song XZ, 2011, ENVIRON REV, V19, P418, DOI [10.1139/a11-015, 10.1139/A11-015]; Tesfahunegn GB, 2011, SOIL TILL RES, V117, P124, DOI 10.1016/j.still.2011.09.005; Tonon G, 2010, EUR J SOIL SCI, V61, P970, DOI 10.1111/j.1365-2389.2010.01310.x; Tsui CC, 2013, GEODERMA, V209, P119, DOI 10.1016/j.geoderma.2013.06.013; Wang B, 2013, J TROP FOR SCI, V25, P137; Wang HQ, 2002, LANDSCAPE ECOL, V17, P671, DOI 10.1023/A:1022962116313; Wang WJ, 2011, GLOBAL CHANGE BIOL, V17, P2657, DOI 10.1111/j.1365-2486.2011.02447.x; Wang YQ, 2009, PEDOSPHERE, V19, P486, DOI 10.1016/S1002-0160(09)60141-7; Wang ZM, 2010, PEDOSPHERE, V20, P80, DOI 10.1016/S1002-0160(09)60285-X; Webster R., 2000, GEOSTATISTICS ENV SC; Wei YC, 2009, AGR SCI CHINA, V8, P1103, DOI 10.1016/S1671-2927(08)60318-1; WEIGAND S, 1995, BIOL FERT SOILS, V19, P129, DOI 10.1007/BF00336148; Yen TM, 2011, FOREST ECOL MANAG, V261, P995, DOI 10.1016/j.foreco.2010.12.015; Zhang CS, 2004, GEODERMA, V119, P261, DOI 10.1016/j.geoderma.2003.08.004; Zhang XY, 2007, PEDOSPHERE, V17, P19, DOI 10.1016/S1002-0160(07)60003-4; Zhi JJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097757; Zhou GM, 2006, PEDOSPHERE, V16, P525, DOI 10.1016/S1002-0160(06)60084-2; [庄舜尧 Zhuang Shunyao], 2012, [生态环境学报, Ecology and Environmental Sciences], V21, P1200; Zhuang WM, 2008, SOIL ATLAS SUBCOUNTY	50	29	31	3	66	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2015	10	3							e0119175	10.1371/journal.pone.0119175	http://dx.doi.org/10.1371/journal.pone.0119175			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD9NQ	25789615	Green Published, Green Submitted, gold			2022-12-27	WOS:000351425400071
J	Zhang, JP; Wu, Y; Li, DQ; Wang, GQ; Li, X; Xia, YP				Zhang, Jiaping; Wu, Yun; Li, Danqing; Wang, Guanqun; Li, Xin; Xia, Yiping			Transcriptomic Analysis of the Underground Renewal Buds during Dormancy Transition and Release in 'Hangbaishao' Peony (Paeonia lactiflora)	PLOS ONE			English	Article							EXPRESSED SEQUENCE TAGS; PEROXIDASE-ACTIVITY; GENE-EXPRESSION; LOW-TEMPERATURES; TREE PEONY; CHILLING REQUIREMENT; ECTOPIC EXPRESSION; FLORAL DEVELOPMENT; STRESS TOLERANCE; RESPIRATION RATE	Paeonia lactiflora is one of the most famous species of herbaceous peonies with gorgeous flowers. Bud dormancy is a crucial developmental process that allows P. lactiflora to survive unfavorable environmental conditions. However, little information is available on the molecular mechanism of the bud dormancy in P. lactiflora. We performed de novo transcriptome sequencing using the Illumina RNA sequencing platform for the underground renewal buds of P. lactiflora 'Hangbaishao' to study the molecular mechanism underlying its bud dormancy transition (the period from endodormancy to ecodormancy) and release (the period from ecodormancy to bud elongation and sprouting). Approximately 300 million high-quality clean reads were generated and assembled into 207,827 (mean length = 828 bp) and 51,481 (mean length = 1250 bp) unigenes using two assembly methods named "Trinity" and "Trinity+PRICE", respectively. Based on the data obtained by the latter method, 32,316 unigenes were annotated by BLAST against various databases. Approximately 1,251 putative transcription factors were obtained, of which the largest number of unique transcripts belonged to the basic helix-loop-helix protein (bHLH) transcription factor family, and five of the top ten highly expressed transcripts were annotated as dehydrin (DHN). A total of 17,705 simple sequence repeat (SSR) motifs distributed in 13,797 sequences were obtained. The budbreak morphology, levels of indole-3-acetic acid (IAA) and abscisic acid (ABA), and activities of guaiacol peroxidase (POD) and catalase (CAT) were observed. The expression of 20 interested unigenes, which annotated as DHN, heat shock protein (HSP), histone, late elongated hypocotyl (LHY), and phytochrome (PHY), and so on, were also analyzed. These studies were based on morphological, physiological, biochemical, and molecular levels and provide comprehensive insight into the mechanism of dormancy transition and release in P. lactiflora. Transcriptome dataset can be highly valuable for future investigation on gene expression networks in P. lactiflora as well as research on dormancy in other non-model perennial horticultural crops of commercial significance.	[Zhang, Jiaping; Wu, Yun; Li, Danqing; Wang, Guanqun; Xia, Yiping] Zhejiang Univ, Coll Agr & Biotechnol, Inst Landscape Architecture, Hangzhou 310003, Zhejiang, Peoples R China; [Li, Xin] Nanjing Agr Univ, Dept Biochem & Mol Biol, Coll Life Sci, Nanjing, Jiangsu, Peoples R China	Zhejiang University; Nanjing Agricultural University	Xia, YP (corresponding author), Zhejiang Univ, Coll Agr & Biotechnol, Inst Landscape Architecture, Hangzhou 310003, Zhejiang, Peoples R China.	ypxia@zju.edu.cn	Li, Xin/AAT-3305-2021	Li, Danqing/0000-0002-1914-857X	Science Technology Department of Zhejiang Province, China [2012C12909]	Science Technology Department of Zhejiang Province, China	YX received the funding for creation of germplasm and breeding of the cultivar in herbaceous perennials (2012C12909) in Science Technology Department of Zhejiang Province, China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal M, 2008, PLANT CELL REP, V27, P617, DOI 10.1007/s00299-008-0507-z; Anderson JV, 2005, PLANT CELL ENVIRON, V28, P1567, DOI 10.1111/j.1365-3040.2005.01393.x; Arguello JA, 2001, BIOCELL, V25, P1; Bai SL, 2013, PLANT CELL PHYSIOL, V54, P1132, DOI 10.1093/pcp/pct067; Barzilay A, 2002, HORTSCIENCE, V37, P300, DOI 10.21273/HORTSCI.37.2.300; Ben Mohamed H, 2012, ACTA PHYSIOL PLANT, V34, P429, DOI 10.1007/s11738-011-0839-0; Benkeblia N, 2004, SCI AGR, V61, P281, DOI 10.1590/S0103-90162004000300007; Benkeblia N, 2003, ACTA AGR SCAND B-S P, V53, P16, DOI 10.1080/09064710310003358; Benkeblia N, 1999, ACTA AGR SCAND B-S P, V49, P98, DOI 10.1080/09064719950135605; Bi YD, 2011, MOL BIOL REP, V38, P721, DOI 10.1007/s11033-010-0159-2; Cantwell MI, 2003, POSTHARVEST BIOL TEC, V30, P57, DOI 10.1016/S0925-5214(03)00060-7; Castelain M, 2012, PHYSIOL PLANTARUM, V145, P450, DOI 10.1111/j.1399-3054.2012.01600.x; Chang L, 2011, INDIAN J HORTIC, V68, P522; Cheng FY, 2009, ISR J PLANT SCI, V57, P357, DOI 10.1560/IJPS.57.4.357; Cheng FY, 2001, J JPN SOC HORTIC SCI, V70, P46, DOI 10.2503/jjshs.70.46; Dogramaci M, 2010, PLANT MOL BIOL, V73, P207, DOI 10.1007/s11103-010-9621-8; Dube MP, 2013, THEOR APPL GENET, V126, P823, DOI 10.1007/s00122-012-2020-6; EVANS MR, 1990, HORTSCIENCE, V25, P923, DOI 10.21273/HORTSCI.25.8.923; Feng C, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-19; Feng XM, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-22; Fowler S, 2002, PLANT CELL, V14, P1675, DOI 10.1105/tpc.003483; Fulton TA, 2001, SCI HORTIC-AMSTERDAM, V89, P237, DOI 10.1016/S0304-4238(00)00237-5; Furuno M, 2003, GENOME RES, V13, P1478, DOI 10.1101/gr.1060303; Gai SP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055297; Gai SP, 2012, GENE, V497, P256, DOI 10.1016/j.gene.2011.12.013; Gonzalez RE, 2013, J FOOD BIOCHEM, V37, P449, DOI 10.1111/j.1745-4514.2011.00647.x; Habu T, 2012, J JPN SOC HORTIC SCI, V81, P239, DOI 10.2503/jjshs1.81.239; Habul T, 2014, J JPN SOC HORTIC SCI, V83, P1, DOI 10.2503/jjshs1.CH-077; Halaly T, 2008, PLANTA, V228, P79, DOI 10.1007/s00425-008-0720-6; Halevy AH, 2002, HORTSCIENCE, V37, P885, DOI 10.21273/HORTSCI.37.6.885; Hall AJ, 2007, SCI HORTIC-AMSTERDAM, V113, P188, DOI 10.1016/j.scienta.2007.03.001; Hemavathi, 2011, MOL BREEDING, V28, P105, DOI 10.1007/s11032-010-9465-6; Hong SI, 2001, J SCI FOOD AGR, V81, P397, DOI 10.1002/1097-0010(200103)81:4&lt;397::AID-JSFA831&gt;3.0.CO;2-R; Horvath DP, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-536; Horvath DP, 2002, PLANT PHYSIOL, V128, P1439, DOI 10.1104/pp.010885; HOSOKI T, 1992, J JPN SOC HORTIC SCI, V61, P121, DOI 10.2503/jjshs.61.121; Huang X, 2008, ACTA PHYSIOL PLANT, V30, P797, DOI 10.1007/s11738-008-0184-0; Huang X, 2008, PLANTA, V228, P545, DOI 10.1007/s00425-008-0757-6; Ibanez C, 2010, PLANT PHYSIOL, V153, P1823, DOI 10.1104/pp.110.158220; Imamura T, 2013, PLANT SCI, V213, P55, DOI 10.1016/j.plantsci.2013.08.012; Kamenetsky R, 2013, ORNAMENTAL GEOPHYTES: FROM BASIC SCIENCE TO SUSTAINABLE PRODUCTION, P1; Kamenetsky R, 2004, J AM SOC HORTIC SCI, V129, P144, DOI 10.21273/JASHS.129.2.0144; Kamenetsky R, 2003, NEW PHYTOL, V158, P109, DOI 10.1046/j.1469-8137.2003.00719.x; Kamenetsky R, 2003, SCI HORTIC-AMSTERDAM, V97, P309, DOI 10.1016/S0304-4238(02)00153-X; Kasraoui MF, 2014, J APPL BOT FOOD QUAL, V87, P1, DOI 10.5073/JABFQ.2014.087.001; Kim JY, 2003, EMBO J, V22, P935, DOI 10.1093/emboj/cdg075; Kumar G, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-107; Kumpatla SP, 2005, GENOME, V48, P985, DOI 10.1139/G05-060; Law RD, 2004, PHYSIOL PLANTARUM, V120, P642, DOI 10.1111/j.0031-9317.2004.0273.x; Lee BH, 2005, PLANT CELL, V17, P3155, DOI 10.1105/tpc.105.035568; Li L, 2011, AM J BOT, V98, pE16, DOI 10.3732/ajb.1000410; Li T, 2013, TURK J AGRIC FOR, V37, P517, DOI 10.3906/tar-1209-4; Liu B, 2004, THESIS SHANDONG AGR; Liu GQ, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-700; Lomax J, 2005, BRIEF BIOINFORM, V6, P298, DOI 10.1093/bib/6.3.298; Ma QB, 2009, PLANT PHYSIOL, V150, P244, DOI 10.1104/pp.108.133454; Marafon AC, 2009, REV BRAS FRUTIC, V31, P938, DOI 10.1590/S0100-29452009000400004; Mathiason K, 2009, FUNCT INTEGR GENOMIC, V9, P81, DOI 10.1007/s10142-008-0090-y; May MJ, 1998, J EXP BOT, V49, P649, DOI 10.1093/jexbot/49.321.649; Mornya PMP, 2011, HORTIC SCI, V38, P104, DOI 10.17221/11/2011-HORTSCI; Ni ZF, 2009, NATURE, V457, P327, DOI 10.1038/nature07523; Noriega X, 2007, PHYTOCHEMISTRY, V68, P1376, DOI 10.1016/j.phytochem.2007.02.003; Ofir M, 2007, ANN BOT-LONDON, V99, P293, DOI 10.1093/aob/mcl257; Page M., 2005, GARDENERS PEONY HERB; Peng HH, 2013, PLANTA, V238, P937, DOI 10.1007/s00425-013-1944-7; Pnueli L, 2002, PLANT J, V31, P319, DOI 10.1046/j.1365-313X.2002.01364.x; Provart NJ, 2003, PLANT PHYSIOL, V132, P893, DOI 10.1104/pp.103.021261; Rhie YH, 2012, HORTIC ENVIRON BIOTE, V53, P277, DOI 10.1007/s13580-012-0002-x; Ruby JG, 2013, G3-GENES GENOM GENET, V3, P865, DOI 10.1534/g3.113.005967; Schaart JG, 2013, NEW PHYTOL, V197, P454, DOI 10.1111/nph.12017; Seo JS, 2012, MOL BREEDING, V29, P601, DOI 10.1007/s11032-011-9576-8; Shahin A, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-640; Shu QY, 2009, PHYSIOL PLANTARUM, V135, P436, DOI 10.1111/j.1399-3054.2009.01206.x; Singh RK, 2011, PROTOPLASMA, V248, P839, DOI 10.1007/s00709-010-0249-y; Sun XD, 2013, THESIS SHANDONG AGR; Sun XD, 2012, PLANT CELL REP, V31, P1823, DOI 10.1007/s00299-012-1295-z; Suttle JC, 2004, J PLANT PHYSIOL, V161, P157, DOI 10.1078/0176-1617-01222; SUTTLE JC, 1995, PHYSIOL PLANTARUM, V95, P233, DOI 10.1111/j.1399-3054.1995.tb00832.x; Takahashi M, 2006, BREEDING SCI, V56, P39, DOI 10.1270/jsbbs.56.39; Theissen G, 2001, CURR OPIN PLANT BIOL, V4, P75, DOI 10.1016/S1369-5266(00)00139-4; Thiel T, 2003, THEOR APPL GENET, V106, P411, DOI 10.1007/s00122-002-1031-0; Tian DQ, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-827; van der Schoot C, 2011, PLANT SCI, V180, P120, DOI 10.1016/j.plantsci.2010.08.009; Vazquez-Barrios ME, 2006, SCI HORTIC-AMSTERDAM, V108, P127, DOI 10.1016/j.scienta.2006.01.013; Wang Q, 2005, CHROMATOGRAPHIA, V62, P581, DOI 10.1365/s10337-005-0660-2; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; Xu HX, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087575; Xu J, 2008, MOL BREEDING, V21, P431, DOI 10.1007/s11032-007-9143-5; Yamagishi M, 2011, MOL BREEDING, V28, P381, DOI 10.1007/s11032-010-9490-5; Yamazaki H, 2002, PLANT GROWTH REGUL, V36, P223, DOI 10.1023/A:1016577529378; Yang L, 2009, J LIQ CHROMATOGR R T, V32, P2893, DOI 10.1080/10826070903297376; Yang YM, 2001, PLANT GROWTH REGUL, V35, P233; Yano R, 2013, PLANT J, V74, P815, DOI 10.1111/tpj.12167; Yeo SM, 2012, HORTIC ENVIRON BIOTE, V53, P263, DOI 10.1007/s13580-012-0037-z; Yuan YanBo, 2014, Acta Agriculturae Zhejiangensis, V26, P54; Yun KY, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-16; Zha LP, 2011, J CHINESE MED MAT, V7, P1037; Zhang QX, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2290; Zheng GuoSheng, 2009, Scientia Silvae Sinicae, V45, P48; Zhong MT, 2013, BIOCHEM BIOPH RES CO, V431, P111, DOI 10.1016/j.bbrc.2012.12.065; Zhou YL, 2012, THESIS BEIJING FORES; Zhou ZC, 2014, MOL ECOL RESOUR, V14, P127, DOI 10.1111/1755-0998.12147; Zhu ZJ, 2004, PLANT SCI, V167, P527, DOI 10.1016/j.plantsci.2004.04.020; Zolfaghari R, 2005, ACTA BIOL HUNG, V56, P305, DOI 10.1556/ABiol.56.2005.3-4.13	104	16	21	4	71	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2015	10	3							e0119118	10.1371/journal.pone.0119118	http://dx.doi.org/10.1371/journal.pone.0119118			30	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD9NQ	25790307	Green Published, gold, Green Submitted			2022-12-27	WOS:000351425400067
J	Assady, S; Alter, J; Axelman, E; Zohar, Y; Sabo, E; Litvak, M; Kaplan, M; Ilan, N; Vlodavsky, I; Abassi, Z				Assady, Suheir; Alter, Joel; Axelman, Elena; Zohar, Yaniv; Sabo, Edmond; Litvak, Michael; Kaplan, Marielle; Ilan, Neta; Vlodavsky, Israel; Abassi, Zaid			Nephroprotective Effect of Heparanase in Experimental Nephrotic Syndrome	PLOS ONE			English	Article							GLOMERULAR-BASEMENT-MEMBRANE; FOCAL SEGMENTAL GLOMERULOSCLEROSIS; MAMMALIAN HEPARANASE; ADRIAMYCIN NEPHROPATHY; DIABETIC-NEPHROPATHY; FILTRATION BARRIER; COLLABORATIVE METAANALYSIS; ENDOTHELIAL GLYCOCALYX; INCREASED EXPRESSION; REDUCES PROTEINURIA	Background Heparanase, an endoglycosidase that cleaves heparan sulfate (HS), is involved in various biologic processes. Recently, an association between heparanase and glomerular injury was suggested. The present study examines the involvement of heparanase in the pathogenesis of Adriamycin-induced nephrotic syndrome (ADR-NS) in a mouse model. Methods BALB/c wild-type (wt) mice and heparanase overexpressing transgenic mice (hpa-TG) were tail-vein injected with either Adriamycin (ADR, 10 mg/kg) or vehicle. Albuminuria was investigated at days 0, 7, and 14 thereafter. Mice were sacrificed at day 15, and kidneys were harvested for various analyses: structure and ultrastructure alterations, podocyte proteins expression, and heparanase enzymatic activity. Results ADR-injected wt mice developed severe albuminuria, while ADR-hpa-TG mice showed only a mild elevation in urinary albumin excretion. In parallel, light microscopy of stained cross sections of kidneys from ADR-injected wt mice, but not hpa-TG mice, showed mild to severe glomerular and tubular damage. Western blot and immunofluorescence analyses revealed significant reduction in nephrin and podocin protein expression in ADR-wt mice, but not in ADR-hpa-TG mice. These results were substantiated by electron-microscopy findings showing massive foot process effacement in injected ADR-wt mice, in contrast to largely preserved integrity of podocyte architecture in ADR-hpa-TG mice. Conclusions Our results suggest that heparanase may play a nephroprotective role in ADR-NS, most likely independently of HS degradation. Moreover, hpa-TG mice comprise an invaluable in vivo platform to investigate the interplay between heparanase and glomerular injury.	[Assady, Suheir; Alter, Joel; Axelman, Elena; Litvak, Michael] Rambam Hlth Care Campus, Dept Nephrol, Haifa, Israel; [Zohar, Yaniv; Sabo, Edmond] Rambam Hlth Care Campus, Dept Pathol, Haifa, Israel; [Kaplan, Marielle] Rambam Hlth Care Campus, Div Clin Labs, Haifa, Israel; [Ilan, Neta; Vlodavsky, Israel] Technion Israel Inst Technol, Rappaport Fac Med, Canc & Vasc Biol Res Ctr, Haifa, Israel; [Abassi, Zaid] Rambam Hlth Care Campus, Res Unit, Haifa, Israel; [Abassi, Zaid] Technion Israel Inst Technol, Rappaport Fac Med, Dept Physiol, Haifa, Israel	Rambam Health Care Campus; Rambam Health Care Campus; Rambam Health Care Campus; Technion Israel Institute of Technology; Rappaport Faculty of Medicine; Rambam Health Care Campus; Technion Israel Institute of Technology; Rappaport Faculty of Medicine	Assady, S (corresponding author), Rambam Hlth Care Campus, Dept Nephrol, Haifa, Israel.	s_assady@rambam.health.gov.il		Abassi, Zaid/0000-0002-7272-197X	Ministry of Health (MOH, Israel) [3-00000-9895]; Israel Science Foundation (ISF) [593/10]	Ministry of Health (MOH, Israel); Israel Science Foundation (ISF)(Israel Science Foundation)	This work is in part supported by the Ministry of Health (MOH, Israel) grant 3-00000-9895 (awarded to SA and ZA) and by the Israel Science Foundation (ISF) grant 593/10 (awarded to IV). MOH and ISF had no role in study design, decision to publish, or preparation of the manuscript.	Abboud-Jarrous G, 2008, J BIOL CHEM, V283, P18167, DOI 10.1074/jbc.M801327200; Astor BC, 2011, KIDNEY INT, V79, P1331, DOI 10.1038/ki.2010.550; Beck LH, 2009, NEW ENGL J MED, V361, P11, DOI 10.1056/NEJMoa0810457; Boyango I, 2014, CANCER RES, V74, P4504, DOI 10.1158/0008-5472.CAN-13-2962; Chen S, 2008, KIDNEY INT, V74, P289, DOI 10.1038/ki.2008.159; Clement LC, 2011, NAT MED, V17, P117, DOI 10.1038/nm.2261; Dickson LE, 2014, J AM SOC NEPHROL, V25, P443, DOI 10.1681/ASN.2013090950; Foley RN, 2013, CLIN J AM SOC NEPHRO, V8, P845, DOI 10.2215/CJN.06840712; Fux L, 2009, TRENDS BIOCHEM SCI, V34, P511, DOI 10.1016/j.tibs.2009.06.005; Gil N, 2012, DIABETES, V61, P208, DOI 10.2337/db11-1024; Goldberg R, 2014, DIABETES, V63, P4302, DOI 10.2337/db14-0001; Goldberg S, 2009, NEPHROL DIAL TRANSPL, V24, P2044, DOI 10.1093/ndt/gfn758; Harvey SJ, 2007, AM J PATHOL, V171, P139, DOI 10.2353/ajpath.2007.061116; Hulett MD, 1999, NAT MED, V5, P803, DOI 10.1038/10525; Jeansson M, 2009, J AM SOC NEPHROL, V20, P114, DOI 10.1681/ASN.2007111205; Koop K, 2003, J AM SOC NEPHROL, V14, P2063, DOI 10.1097/01.ASN.0000078803.53165.C9; Kramer A, 2006, J AM SOC NEPHROL, V17, P2513, DOI 10.1681/ASN.2006020184; Lee VWS, 2011, NEPHROLOGY, V16, P30, DOI 10.1111/j.1440-1797.2010.01383.x; Levidiotis V, 2005, NEPHROLOGY, V10, P167, DOI 10.1111/j.1440-1797.2005.00388.x; Levidiotis V, 2004, J AM SOC NEPHROL, V15, P2882, DOI 10.1097/01.ASN.0000142426.55612.6D; Levidiotis V, 2004, J AM SOC NEPHROL, V15, P68, DOI 10.1097/01.ASN.0000103229.25389.40; Levidiotis V, 2001, KIDNEY INT, V60, P1287, DOI 10.1046/j.1523-1755.2001.00934.x; Lewis EJ, 2011, AM J KIDNEY DIS, V58, P729, DOI 10.1053/j.ajkd.2011.06.020; Maisonneuve P, 2000, AM J KIDNEY DIS, V35, P157, DOI 10.1016/S0272-6386(00)70316-7; Maxhimer JB, 2005, DIABETES, V54, P2172, DOI 10.2337/diabetes.54.7.2172; Nadir Y, 2012, THROMB RES, V129, pS76, DOI 10.1016/S0049-3848(12)70021-X; Reitsma S, 2007, PFLUG ARCH EUR J PHY, V454, P345, DOI 10.1007/s00424-007-0212-8; Rops ALWMM, 2004, KIDNEY INT, V65, P768, DOI 10.1111/j.1523-1755.2004.00451.x; Rops ALWMM, 2012, NEPHROL DIAL TRANSPL, V27, P2853, DOI 10.1093/ndt/gfr732; Rostgaard J, 2002, CELLS TISSUES ORGANS, V170, P132, DOI 10.1159/000046186; Salmon AHJ, 2009, CURR OPIN NEPHROL HY, V18, P197, DOI 10.1097/MNH.0b013e328329f837; Sarrazin S, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a004952; Satchell SC, 2009, AM J PHYSIOL-RENAL, V296, pF947, DOI 10.1152/ajprenal.90601.2008; Shafat I, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044076; Shafat I, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017312; Singh A, 2007, J AM SOC NEPHROL, V18, P2885, DOI 10.1681/ASN.2007010119; Szymczak M, 2010, ARCH IMMUNOL THER EX, V58, P45, DOI 10.1007/s00005-009-0061-6; Takemoto M, 2002, AM J PATHOL, V161, P799, DOI 10.1016/S0002-9440(10)64239-3; van den Hoven MJ, 2008, KIDNEY INT, V73, P278, DOI 10.1038/sj.ki.5002706; van den Hoven MJ, 2007, KIDNEY INT, V72, P543, DOI 10.1038/sj.ki.5002337; van den Hoven MJ, 2006, KIDNEY INT, V70, P2100, DOI 10.1038/sj.ki.5001985; van den Hoven MJ, 2009, NEPHROL DIAL TRANSPL, V24, P2637, DOI 10.1093/ndt/gfp182; van der Velde M, 2011, KIDNEY INT, V79, P1341, DOI 10.1038/ki.2010.536; Vlodavsky I, 2001, Curr Protoc Cell Biol, VChapter 10, DOI 10.1002/0471143030.cb1004s01; Vlodavsky I, 1999, NAT MED, V5, P793, DOI 10.1038/10518; Vreys V, 2007, J CELL MOL MED, V11, P427, DOI 10.1111/j.1582-4934.2007.00039.x; Wang Y, 2000, KIDNEY INT, V58, P1797, DOI 10.1046/j.1523-1755.2000.00342.x; Wei CL, 2011, NAT MED, V17, P952, DOI 10.1038/nm.2411; Zetser A, 2004, J CELL SCI, V117, P2249, DOI 10.1242/jcs.01068	50	8	11	3	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2015	10	3							e0119610	10.1371/journal.pone.0119610	http://dx.doi.org/10.1371/journal.pone.0119610			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9BN	25786136	gold, Green Published, Green Submitted			2022-12-27	WOS:000352138500119
J	Cohen, C; Moyes, J; Tempia, S; Groome, M; Walaza, S; Pretorius, M; Dawood, H; Chhagan, M; Haffejee, S; Variava, E; Kahn, K; von Gottberg, A; Wolter, N; Cohen, AL; Malope-Kgokong, B; Venter, M; Madhi, SA				Cohen, Cheryl; Moyes, Jocelyn; Tempia, Stefano; Groome, Michelle; Walaza, Sibongile; Pretorius, Marthi; Dawood, Halima; Chhagan, Meera; Haffejee, Summaya; Variava, Ebrahim; Kahn, Kathleen; von Gottberg, Anne; Wolter, Nicole; Cohen, Adam L.; Malope-Kgokong, Babatyi; Venter, Marietjie; Madhi, Shabir A.			Mortality amongst Patients with Influenza-Associated Severe Acute Respiratory Illness, South Africa, 2009-2013	PLOS ONE			English	Article							A H1N1 VIRUS; PANDEMIC INFLUENZA; SYNCYTIAL VIRUS; UNITED-STATES; HIV; PREVALENCE; INFECTION; ADULTS; HOSPITALIZATIONS	Introduction Data on the burden and risk groups for influenza-associated mortality from Africa are limited. We aimed to estimate the incidence and risk-factors for in-hospital influenza-associated severe acute respiratory illness (SARI) deaths. Methods Hospitalised patients with SARI were enrolled prospectively in four provinces of South Africa from 2009-2013. Using polymerase chain reaction, respiratory samples were tested for ten respiratory viruses and blood for pneumococcal DNA. The incidence of influenza-associated SARI deaths was estimated at one urban hospital with a defined catchment population. Results We enrolled 1376 patients with influenza-associated SARI and 3% (41 of 1358 with available outcome data) died. In patients with available HIV-status, the case-fatality proportion (CFP) was higher in HIV-infected (5%, 22/419) than HIV-uninfected individuals (2%, 13/620; p = 0.006). CFPs varied by age group, and generally increased with increasing age amongst individuals >5 years (p<0.001). On multivariable analysis, factors associated with death were age-group 45-64 years (odds ratio (OR) 4.0, 95% confidence interval (CI) 1.01-16.3) and >= 65 years (OR 6.5, 95% CI 1.2-34.3) compared to 1-4 year age-group who had the lowest CFP, HIV-infection (OR 2.9, 95% CI 1.1-7.8), underlying medical conditions other than HIV (OR 2.9, 95% CI 1.2-7.3) and pneumococcal co-infection (OR 4.1, 95% CI 1.5-11.2). The estimated incidence of influenza-associated SARI deaths per 100,000 population was highest in children <1 year (20.1, 95% CI 12.1-31.3) and adults aged 45-64 years (10.4, 95% CI 8.4-12.9). Adjusting for age, the rate of death was 20-fold (95% CI 15.0-27.8) higher in HIV-infected individuals than HIV-uninfected individuals. Conclusion Influenza causes substantial mortality in urban South Africa, particularly in infants aged <1 year and HIV-infected individuals. More widespread access to antiretroviral treatment and influenza vaccination may reduce this burden.	[Cohen, Cheryl; Moyes, Jocelyn; Walaza, Sibongile; von Gottberg, Anne; Wolter, Nicole; Malope-Kgokong, Babatyi; Madhi, Shabir A.] Natl Inst Communicable Dis, Natl Hlth Lab Serv, Ctr Resp Dis & Meningitis, Johannesburg, South Africa; [Cohen, Cheryl; Moyes, Jocelyn] Univ Witwatersrand, Fac Hlth Sci, Sch Publ Hlth, Johannesburg, South Africa; [Tempia, Stefano; Cohen, Adam L.] Ctr Dis Control & Prevent, Influenza Div, Atlanta, GA USA; [Tempia, Stefano; Cohen, Adam L.] Ctr Dis Control & Prevent South Africa, Influenza Programme, Pretoria, South Africa; [Groome, Michelle; von Gottberg, Anne; Wolter, Nicole; Madhi, Shabir A.] Univ Witwatersrand, Fac Hlth Sci, Med Res Council, Resp & Meningeal Pathogens Res Unit, Johannesburg, South Africa; [Groome, Michelle; Madhi, Shabir A.] Univ Witwatersrand, Dept Sci & Technol, Natl Res Fdn Vaccine Preventable Dis, Johannesburg, South Africa; [von Gottberg, Anne; Wolter, Nicole] Univ Witwatersrand, Sch Pathol, Fac Hlth Sci, Johannesburg, South Africa; [Pretorius, Marthi; Venter, Marietjie] Univ Pretoria, Dept Med Virol, Zoonosis Res Unit, ZA-0002 Pretoria, South Africa; [Variava, Ebrahim] Klerksdorp Tshepong Hosp, Dept Med, Uraniaville, South Africa; [Variava, Ebrahim] Univ Witwatersrand, Dept Med, Fac Hlth Sci, ZA-2001 Johannesburg, South Africa; [Kahn, Kathleen] Univ Witwatersrand, Fac Hlth Sci, Sch Publ Hlth, MRC Wits Rural Publ Hlth & Hlth Transit Res Unit, Johannesburg, South Africa; [Kahn, Kathleen] Umea Univ, Ctr Global Hlth Res, Umea, Sweden; [Kahn, Kathleen] INDEPTH Network, Accra, Ghana; [Chhagan, Meera] Univ KwaZulu Natal, Dept Paediat, Durban, South Africa; [Dawood, Halima] Pietermaritzburg Metropolitan Hosp, Dept Med, Pietermaritzburg, South Africa; [Dawood, Halima] Univ KwaZulu Natal, Dept Med, Durban, South Africa; [Haffejee, Summaya] Univ KwaZulu Natal, Sch Pathol, Durban, South Africa; [Venter, Marietjie] US Ctr Dis Control & Prevent South Africa, Global Dis Detect, Pretoria, South Africa	National Health Laboratory Service; National Institute for Communicable Diseases (NICD); University of Witwatersrand; Centers for Disease Control & Prevention - USA; South African Medical Research Council; University of Witwatersrand; National Research Foundation - South Africa; University of Witwatersrand; University of Witwatersrand; University of Pretoria; University of Witwatersrand; University of Witwatersrand; Umea University; INDEPTH Network; University of Kwazulu Natal; University of Kwazulu Natal; University of Kwazulu Natal	Cohen, C (corresponding author), Natl Inst Communicable Dis, Natl Hlth Lab Serv, Ctr Resp Dis & Meningitis, Johannesburg, South Africa.	cherylc@nicd.ac.za	Groome, Michelle Jennifer/AAI-9967-2021; Variava, Ebrahim/AAO-5717-2020; Venter, Marietjie/P-9604-2016; Dawood, Halima/AAF-6045-2020; Dawood, Halima/AAO-6963-2020; Moyes, Jocelyn/AAF-7882-2019	Groome, Michelle Jennifer/0000-0001-5893-3725; Variava, Ebrahim/0000-0003-2888-789X; Venter, Marietjie/0000-0003-2696-824X; Dawood, Halima/0000-0001-8180-6791; von Gottberg, Anne/0000-0002-0243-7455; Malope-Kgokong, Babatyi/0000-0001-7446-7664; Cohen, Cheryl/0000-0003-0376-2302; Pretorius, Marthi/0000-0003-2163-6158; Kahn, Kathleen/0000-0003-3339-3931	NICD/NHLS; United States Centers for Disease Control and Prevention (CDC), Atlanta, Georgia [U51/IP000155-04]; NATIONAL CENTER FOR IMMUNICATION AND RESPIRATORY DISEASES [U51IP000155] Funding Source: NIH RePORTER	NICD/NHLS; United States Centers for Disease Control and Prevention (CDC), Atlanta, Georgia(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); NATIONAL CENTER FOR IMMUNICATION AND RESPIRATORY DISEASES(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA)	This study received funding from the NICD/NHLS and was supported in part by funds from the United States Centers for Disease Control and Prevention (CDC), Atlanta, Georgia Preparedness and Response to Avian and Pandemic Influenza in South Africa (Cooperative Agreement Number: U51/IP000155-04). The contents are solely the responsibility of the authors and do not necessarily represent the official views of the CDC. The funders had no role in study design, implementation, manuscript writing or the decision to submit for publication. The corresponding author had full access to all the data in the study and takes final responsibility for the decision to submit for publication.	Actuarial Society of South Africa, AIDS DEM MOD 2008; [Anonymous], 2014, Wkly Epidemiol Rec, V89, P221; [Anonymous], 2012, Wkly Epidemiol Rec, V87, P461; [Anonymous], 2009, CDC PROTOCOL REALTIM; Archer BN, 2009, EUROSURVEILLANCE, V14, P11; Azzari C, 2008, J MED MICROBIOL, V57, P1205, DOI 10.1099/jmm.0.2008/000935-0; Carvalho MDS, 2007, J CLIN MICROBIOL, V45, P2460, DOI 10.1128/JCM.02498-06; Chowell G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041069; Cohen AL, 2014, EMERG INFECT DIS, V20, P1162, DOI 10.3201/eid2007.131869; Cohen C, 2013, EMERG INFECT DIS, V19, P1766, DOI 10.3201/eid1911.130546; Cohen C, 2012, CLIN INFECT DIS, V55, P996, DOI 10.1093/cid/cis549; Cohen C, 2010, CLIN INFECT DIS, V51, P1362, DOI 10.1086/657314; Day C., 2011, S AFRICAN HLTH REV 2, P119; Fajardo-Dolci G, 2010, THORAX, V65, P505, DOI 10.1136/thx.2009.126953; Feikin DR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043656; Feikin DR, 2012, B WORLD HEALTH ORGAN, V90, P256, DOI 10.2471/BLT.11.094326; Glencross D, 2002, CYTOMETRY, V50, P69, DOI 10.1002/cyto.10068; Homaira N, 2012, B WORLD HEALTH ORGAN, V90, P272, DOI 10.2471/BLT.11.095653; Jamieson DJ, 2009, LANCET, V374, P451, DOI 10.1016/S0140-6736(09)61304-0; Lee N, 2011, J INFECT DIS, V203, P1739, DOI 10.1093/infdis/jir187; Madhi SA, 2002, PEDIATR INFECT DIS J, V21, P291, DOI 10.1097/00006454-200204000-00007; Mayer KH, 2011, CLIN INFECT DIS, V52, pS205, DOI 10.1093/cid/ciq043; McMorrow M, 2015, JINFECTDIS IN PRESS; Peters PJ, 2011, CLIN INFECT DIS, V52, pS183, DOI 10.1093/cid/ciq036; Pretorius MA, 2012, J INFECT DIS, V206, pS159, DOI 10.1093/infdis/jis538; Schrag SJ, 2006, PEDIATR INFECT DIS J, V25, P395, DOI 10.1097/01.inf.0000214988.81379.71; Sheth Anandi N, 2011, Curr HIV/AIDS Rep, V8, P181, DOI 10.1007/s11904-011-0086-4; Singh E., 2008, COMMUNICABLE DIS SUR, V6, P16; Statistics South Africa, 2008, MID POP EST 2003 200; Statistics South Africa. Statistical release P030903, 2009, STAT REL P030903 MOR; Tempia S, 2015, EMERGINFECT IN PRESS; Tempia S, 2014, CLIN INFECT DIS, V58, P1241, DOI 10.1093/cid/ciu095; Van Kerkhove MD, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001053; Wolter N, 2014, J INFECT DIS, V209, P56, DOI 10.1093/infdis/jit427; World Health Organisation, 2007, WHO CAS DEF HIV SURV; World Health Organization, 2011, WHO GLOB TECHN CONS; Yu HJ, 2011, CLIN INFECT DIS, V52, P457, DOI 10.1093/cid/ciq144; Zhou H, 2012, CLIN INFECT DIS, V54, P1427, DOI 10.1093/cid/cis211	39	56	59	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2015	10	3							e0118884	10.1371/journal.pone.0118884	http://dx.doi.org/10.1371/journal.pone.0118884			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9BN	25786103	Green Submitted, Green Published, gold			2022-12-27	WOS:000352138500054
J	Collignon, P; Athukorala, PC; Senanayake, S; Khan, F				Collignon, Peter; Athukorala, Prema-chandra; Senanayake, Sanjaya; Khan, Fahad			Antimicrobial Resistance: The Major Contribution of Poor Governance and Corruption to This Growing Problem	PLOS ONE			English	Article							ANTIBIOTIC-RESISTANCE; EPIDEMIOLOGY; ASSOCIATION; BACTERIA; EUROPE	Objectives To determine how important governmental, social, and economic factors are in driving antibiotic resistance compared to the factors usually considered the main driving factors-antibiotic usage and levels of economic development. Design A retrospective multivariate analysis of the variation of antibiotic resistance in Europe in terms of human antibiotic usage, private health care expenditure, tertiary education, the level of economic advancement (per capita GDP), and quality of governance (corruption). The model was estimated using a panel data set involving 7 common human bloodstream isolates and covering 28 European countries for the period 1998-2010. Results Only 28% of the total variation in antibiotic resistance among countries is attributable to variation in antibiotic usage. If time effects are included the explanatory power increases to 33%. However when the control of corruption indicator is included as an additional variable, 63% of the total variation in antibiotic resistance is now explained by the regression. The complete multivariate regression only accomplishes an additional 7% in terms of goodness of fit, indicating that corruption is the main socioeconomic factor that explains antibiotic resistance. The income level of a country appeared to have no effect on resistance rates in the multivariate analysis. The estimated impact of corruption was statistically significant (p< 0.01). The coefficient indicates that an improvement of one unit in the corruption indicator is associated with a reduction in antibiotic resistance by approximately 0.7 units. The estimated coefficient of private health expenditure showed that one unit reduction is associated with a 0.2 unit decrease in antibiotic resistance. Conclusions These findings support the hypothesis that poor governance and corruption contributes to levels of antibiotic resistance and correlate better than antibiotic usage volumes with resistance rates. We conclude that addressing corruption and improving governance will lead to a reduction in antibiotic resistance.	[Collignon, Peter] Australian Natl Univ, Canberra Hosp, ACT Pathol, Garran, NSW, Australia; [Collignon, Peter] Australian Natl Univ, Canberra Clin Sch, Garran, ACT, Australia; [Athukorala, Prema-chandra; Khan, Fahad] Australian Natl Univ, Arndt Corden Dept Econ, Acton, ACT, Australia; [Athukorala, Prema-chandra] Univ Manchester, Sch Environm & Dev, Manchester, England; [Senanayake, Sanjaya] Australian Natl Univ, Garran, ACT, Australia; [Senanayake, Sanjaya] Canberra Hosp, Garran, ACT, Australia	Australian National University; Canberra Hospital; Australian National University; Australian National University; University of Manchester; Australian National University; Australian National University; Canberra Hospital	Collignon, P (corresponding author), Australian Natl Univ, Canberra Hosp, ACT Pathol, Garran, NSW, Australia.	peter.collignon@act.gov.au	Collignon, Peter/U-4846-2019	Collignon, Peter/0000-0001-8648-9203	Arndt-Corden Department of Economics, Australian National University	Arndt-Corden Department of Economics, Australian National University	These authors have no external funding to report. Some additional support for some of FK's time came from the Arndt-Corden Department of Economics, Australian National University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aarestrup FM, 2008, EXPERT REV ANTI-INFE, V6, P733, DOI 10.1586/14787210.6.5.733; Ades A, 1997, ECON J, V107, P1023, DOI 10.1111/1468-0297.00204; Albrich WC, 2004, EMERG INFECT DIS, V10, P514, DOI 10.3201/eid1003.030252; Bond S. R., 2001, CTR EC POLICY RES DI, V159, P99; Boucher HW, 2009, CLIN INFECT DIS, V48, P1, DOI 10.1086/595011; Canadian Integrated Program for Antimicrobial Resistance Surveillance, 2008, CIPARS 2008 REP; Carlet J, 2011, LANCET, V378, P369, DOI 10.1016/S0140-6736(11)60401-7; Danish Integrated Antimicrobial Resistance Monitoring and Research Programme, 2010, DANMAP 2010 REP; de Kraker MEA, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001104; Elbasha EH, 2003, HEALTH ECON, V12, P125, DOI 10.1002/hec.702; European Centre for Disease Prevention and Control, 2009, EUR SURV ANT CONS ES, P35; European Centre for Disease Prevention and Control, 2014, EARS NET RES DAT EUR; European Commission, 2014, EU ANT REP 2014; Finley RL, 2013, CLIN INFECT DIS, V57, P704, DOI 10.1093/cid/cit355; Goossens H, 2005, LANCET, V365, P579, DOI 10.1016/S0140-6736(05)17907-0; Hall RE, 1999, Q J ECON, V114, P83, DOI 10.1162/003355399555954; Hawkey PM, 2009, J ANTIMICROB CHEMOTH, V64, P3, DOI 10.1093/jac/dkp256; Joint Expert Advisory committee on antibiotic resistance, 2009, JETACAR 2009 REP ANT; Kennedy K, 2010, EUR J CLIN MICROBIOL, V29, P1501, DOI 10.1007/s10096-010-1031-y; Leung E, 2011, B WORLD HEALTH ORGAN, V89, P390, DOI 10.2471/BLT.11.088435; Nasrin D, 2002, BRIT MED J, V324, P28, DOI 10.1136/bmj.324.7328.28; Rodrik D., 2004, J EC GROWTH, V9; Roodman D, 2009, STATA J, V9, P86, DOI 10.1177/1536867X0900900106; Roodman D, 2009, OXFORD B ECON STAT, V71, P135, DOI 10.1111/j.1468-0084.2008.00542.x; Sen K, 2013, WORLD DEV, V47, P71, DOI 10.1016/j.worlddev.2013.02.015; The PRS Group Inc., 2008, INT COUNTR RISK GUID; Turnidge J, 2005, LANCET, V365, P548; Vieira AR, 2011, FOODBORNE PATHOG DIS, V8, P1295, DOI 10.1089/fpd.2011.0950; Walsh TR, 2011, LANCET INFECT DIS, V11, P355, DOI 10.1016/S1473-3099(11)70059-7; Waterfielf B, 2014, SYDNEY MORNING HERAL; WHO, 2003, JOINT FAO OIE WHO EX; World Bank, 2012, WORLDW GOV IND 2012; World Bank, 2012, WORLD DEV IND 2012; Xi CW, 2009, APPL ENVIRON MICROB, V75, P5714, DOI 10.1128/AEM.00382-09	34	69	69	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2015	10	3							e0116746	10.1371/journal.pone.0116746	http://dx.doi.org/10.1371/journal.pone.0116746			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CE9BN	25786027	Green Published, gold, Green Submitted			2022-12-27	WOS:000352138500012
J	Debowski, K; Warthemann, R; Lentes, J; Salinas-Riester, G; Dressel, R; Langenstroth, D; Gromoll, J; Sasaki, E; Behr, R				Debowski, Katharina; Warthemann, Rita; Lentes, Jana; Salinas-Riester, Gabriela; Dressel, Ralf; Langenstroth, Daniel; Gromoll, Joerg; Sasaki, Erika; Behr, Ruediger			Non-Viral Generation of Marmoset Monkey iPS Cells by a Six-Factor-in-One-Vector Approach	PLOS ONE			English	Article							PLURIPOTENT STEM-CELLS; MOUSE SOMATIC-CELLS; COMMON MARMOSET; HUMAN FIBROBLASTS; NEUROSCIENCE RESEARCH; SENDAI-VIRUS; INDUCTION; MODEL; PIGGYBAC; VECTOR	Groundbreaking studies showed that differentiated somatic cells of mouse and human origin could be reverted to a stable pluripotent state by the ectopic expression of only four proteins. The resulting pluripotent cells, called induced pluripotent stem(iPS) cells, could be an alternative to embryonic stem cells, which are under continuous ethical debate. Hence, iPS cell-derived functional cells such as neurons may become the key for an effective treatment of currently incurable degenerative diseases. However, besides the requirement of efficacy testing of the therapy also its long-term safety needs to be carefully evaluated in settings mirroring the clinical situation in an optimal way. In this context, we chose the long-lived common marmoset monkey (Callithrix jacchus) as a non-human primate species to generate iPS cells. The marmoset monkey is frequently used in biomedical research and is gaining more and more preclinical relevance due to the increasing number of disease models. Here, we describe, to our knowledge, the first-time generation of marmoset monkey iPS cells from postnatal skin fibroblasts by non-viral means. We used the transposon-based, fully reversible piggyback system. We cloned the marmoset monkey reprogramming factors and established robust and reproducible reprogramming protocols with a six-factor-in-one-construct approach. We generated six individual iPS cell lines and characterized them in comparison with marmoset monkey embryonic stem cells. The generated iPS cells are morphologically indistinguishable from marmoset ES cells. The iPS cells are fully reprogrammed as demonstrated by differentiation assays, pluripotency marker expression and transcriptome analysis. They are stable for numerous passages (more than 80) and exhibit euploidy. In summary, we have established efficient non-viral reprogramming protocols for the derivation of stable marmoset monkey iPS cells, which can be used to develop and test cell replacement therapies in preclinical settings.	[Debowski, Katharina; Warthemann, Rita; Lentes, Jana; Behr, Ruediger] German Primate Ctr Leibniz Inst Primate Res, Stem Cell Biol Unit, Gottingen, Germany; [Salinas-Riester, Gabriela] Univ Med Ctr Gottingen UMG, Microarray & Deep Sequencing Core Facil, Gottingen, Germany; [Dressel, Ralf] Univ Gottingen, Dept Cellular & Mol Immunol, D-37073 Gottingen, Germany; [Langenstroth, Daniel; Gromoll, Joerg] Univ Munster, Ctr Reprod Med & Androl, D-48149 Munster, Germany; [Sasaki, Erika] Cent Inst Expt Anim, Dept Appl Dev Biol, Kawasaki Ku, Kawasaki, Kanagawa, Japan; [Sasaki, Erika] Keio Univ, Keio Adv Res Ctr, Shinjuku Ku, Tokyo, Japan; [Behr, Ruediger] Partner Site Gottingen, DZHK German Ctr Cardiovasc Res, Gottingen, Germany	Deutsches Primatenzentrum (DPZ); University of Gottingen; University of Munster; Keio University; German Centre for Cardiovascular Research	Debowski, K (corresponding author), German Primate Ctr Leibniz Inst Primate Res, Stem Cell Biol Unit, Gottingen, Germany.	kdebowski@dpz.eu; rbehr@dpz.eu	Gromoll, Joerg/AAB-2146-2019; Dressel, Ralf/R-7065-2016	Gromoll, Joerg/0000-0002-7788-8138; Dressel, Ralf/0000-0002-1651-1214	Bundesministerium fur Bildung und Forschung [FKZ: 01GN0817]; Deutsche Forschungsgemeinschaft [DFG-FOR1041]; Collaborative Research Centre from the Deutsche Forschungsgemeinschaft [SFB1002, TP C05]	Bundesministerium fur Bildung und Forschung(Federal Ministry of Education & Research (BMBF)); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Collaborative Research Centre from the Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	The work was mainly supported by a grant from the Bundesministerium fur Bildung und Forschung (www.bmbf.de; grant title: Induced pluripotent stem cells in large animal models; FKZ: 01GN0817) to RB and by institutional resources of the German Primate Center. Epigenetic analysis was supported by a grant from the Deutsche Forschungsgemeinschaft (www.dfg.de) entitled "Pluripotent cells from marmoset testis" to JG, Stefan Schlatt, and RB (DFG-FOR1041; Research Unit Germ Cell Potential). The teratoma formation assays performed by Ralf Dressel were supported by a Collaborative Research Centre from the Deutsche Forschungsgemeinschaft (SFB1002, TP C05). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexopoulou AN, 2008, BMC CELL BIOL, V9, DOI 10.1186/1471-2121-9-2; Anokye-Danso F, 2011, CELL STEM CELL, V8, P376, DOI 10.1016/j.stem.2011.03.001; Ban H, 2011, P NATL ACAD SCI USA, V108, P14234, DOI 10.1073/pnas.1103509108; Behr R, 2005, STEM CELLS, V23, P805, DOI 10.1634/stemcells.2004-0234; BENIRSCHKE K, 1962, SCIENCE, V138, P513, DOI 10.1126/science.138.3539.513; Boyer LA, 2005, CELL, V122, P947, DOI 10.1016/j.cell.2005.08.020; Chen WW, 2012, STEM CELLS, V30, P2612, DOI 10.1002/stem.1240; Ding S, 2005, CELL, V122, P473, DOI 10.1016/j.cell.2005.07.013; Donnelly MLL, 2001, J GEN VIROL, V82, P1027, DOI 10.1099/0022-1317-82-5-1027; Donnelly MLL, 2001, J GEN VIROL, V82, P1013, DOI 10.1099/0022-1317-82-5-1013; Eildermann K, 2012, CELLS TISSUES ORGANS, V196, P206, DOI 10.1159/000335031; Fontes Andrew, 2013, Methods Mol Biol, V997, P57, DOI 10.1007/978-1-62703-348-0_6; Fusaki N, 2009, P JPN ACAD B-PHYS, V85, P348, DOI 10.2183/pjab.85.348; Holditch SJ, 2014, STEM CELL TRANSL MED, V3, P653, DOI 10.5966/sctm.2013-0184; Hou PP, 2013, SCIENCE, V341, P651, DOI 10.1126/science.1239278; Kaji K, 2009, NATURE, V458, P771, DOI 10.1038/nature07864; Kishi N, 2014, DEV GROWTH DIFFER, V56, P53, DOI 10.1111/dgd.12109; Kobayashi Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052787; Lin ZYC, 2012, REPRODUCTION, V143, P597, DOI 10.1530/REP-11-0215; Liu GY, 2004, J GENE MED, V6, P574, DOI 10.1002/jgm.486; Mack AA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027956; Mandal PK, 2013, NAT PROTOC, V8, P568, DOI 10.1038/nprot.2013.019; MIYAZAKI J, 1989, GENE, V79, P269; Montserrat N, 2013, CELL STEM CELL, V13, P341, DOI 10.1016/j.stem.2013.06.019; Muller T, 2009, HUM REPROD, V24, P1359, DOI 10.1093/humrep/dep012; Nakatsuji Norio, 2002, ScientificWorldJournal, V2, P1762; Nishishita Naoki, 2011, J Stem Cells, V6, P101; Okano H, 2012, SEMIN FETAL NEONAT M, V17, P336, DOI 10.1016/j.siny.2012.07.002; Okita K, 2011, NAT METHODS, V8, P409, DOI [10.1038/NMETH.1591, 10.1038/nmeth.1591]; Phillips KA, 2014, AM J PRIMATOL, V76, P801, DOI 10.1002/ajp.22281; Shiozawa S, 2011, STEM CELLS DEV, V20, P1588, DOI 10.1089/scd.2010.0351; Shu J, 2013, CELL, V153, P963, DOI 10.1016/j.cell.2013.05.001; Stadtfeld M, 2008, SCIENCE, V322, P945, DOI 10.1126/science.1162494; Szymczak AL, 2004, NAT BIOTECHNOL, V22, P589, DOI 10.1038/nbt957; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Tomioka I, 2010, GENES CELLS, V15, P959, DOI 10.1111/j.1365-2443.2010.01437.x; Vogt EJ, 2012, DEVELOPMENT, V139, P4514, DOI 10.1242/dev.083279; Wang Peizhe, 2013, Methods Mol Biol, V969, P221, DOI 10.1007/978-1-62703-260-5_14; Wang W, 2008, P NATL ACAD SCI USA, V105, P9290, DOI 10.1073/pnas.0801017105; Warren Luigi, 2013, Curr Protoc Stem Cell Biol, V27, DOI 10.1002/9780470151808.sc04a06s27; Warren L, 2012, SCI REP-UK, V2, DOI 10.1038/srep00657; Warren L, 2010, CELL STEM CELL, V7, P618, DOI 10.1016/j.stem.2010.08.012; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1; Wiedemann A, 2012, CELL REPROGRAM, V14, P485, DOI 10.1089/cell.2012.0036; Wislocki GB, 1939, AM J ANAT, V64, P445, DOI 10.1002/aja.1000640305; Wistuba J, 2013, REPRODUCTION, V145, P439, DOI 10.1530/REP-12-0373; Woltjen K, 2009, NATURE, V458, P766, DOI 10.1038/nature07863; Wu YH, 2010, STEM CELL RES, V4, P180, DOI 10.1016/j.scr.2010.02.003; Yang GH, 2013, BMC BIOL, V11, DOI 10.1186/1741-7007-11-86; Yu JY, 2009, SCIENCE, V324, P797, DOI 10.1126/science.1172482; Yusa K, 2011, P NATL ACAD SCI USA, V108, P1531, DOI 10.1073/pnas.1008322108; Zeng XM, 2013, STEM CELL RES THER, V4, DOI 10.1186/scrt173; Zhou HY, 2009, CELL STEM CELL, V4, P381, DOI 10.1016/j.stem.2009.04.005	54	28	28	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2015	10	3							e0118424	10.1371/journal.pone.0118424	http://dx.doi.org/10.1371/journal.pone.0118424			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9BN	25785453	Green Submitted, gold, Green Published			2022-12-27	WOS:000352138500033
J	Fite, BZ; Wong, A; Liu, Y; Mahakian, LM; Tam, SM; Aina, O; Hubbard, NE; Borowsky, A; Cardiff, RD; Dumont, E; Ferrara, KW				Fite, Brett Z.; Wong, Andrew; Liu, Yu; Mahakian, Lisa M.; Tam, Sarah M.; Aina, Olulanu; Hubbard, Neil E.; Borowsky, Alexander; Cardiff, Robert D.; Dumont, Erik; Ferrara, Katherine W.			Magnetic Resonance Imaging Assessment of Effective Ablated Volume following High Intensity Focused Ultrasound	PLOS ONE			English	Article							LOCALIZED PROSTATE-CANCER; COMBINED RADIOFREQUENCY ABLATION; MR THERMOMETRY; THERMAL ABLATION; BREAST-CANCER; HISTOPATHOLOGIC CORRELATION; TRANSRECTAL HIFU; UTERINE FIBROIDS; TISSUE-DAMAGE; TUMOR-MODEL	Under magnetic resonance (MR) guidance, high intensity focused ultrasound (HIFU) is capable of precise and accurate delivery of thermal dose to tissues. Given the excellent soft tissue imaging capabilities of MRI, but the lack of data on the correlation of MRI findings to histology following HIFU, we sought to examine tumor response to HIFU ablation to determine whether there was a correlation between histological findings and common MR imaging protocols in the assessment of the extent of thermal damage. Female FVB mice (n = 34), bearing bilateral neu deletion tumors, were unilaterally insonated under MR guidance, with the contralateral tumor as a control. Between one and five spots (focal size 0.5 x 0.5 x 2.5 mm(3)) were insonated per tumor with each spot receiving approximately 74.2 J of acoustic energy over a period of 7 seconds. Animals were then imaged on a 7T MR scanner with several protocols. T1 weighted images (with and without gadolinium contrast) were collected in addition to a series of T2 weighted and diffusion weighted images (for later reconstruction into T2 and apparent diffusion coefficient maps), immediately following ablation and at 6, 24, and 48 hours post treatment. Animals were sacrificed at each time point and both insonated/treated and contralateral tumors removed and stained for NADH-diaphorase, caspase 3, or with hematoxylin and eosin (H&E). We found the area of non-enhancement on contrast enhanced T1 weighted imaging immediately post ablation correlated with the region of tissue receiving a thermal dose CEM43 >= 240 min. Moreover, while both tumor T2 and apparent diffusion coefficient values changed from pre-ablation values, contrast enhanced T1 weighted images appeared to be more senstive to changes in tissue viability following HIFU ablation.	[Fite, Brett Z.; Wong, Andrew; Liu, Yu; Mahakian, Lisa M.; Tam, Sarah M.; Ferrara, Katherine W.] Univ Calif Davis, Dept Biomed Engn, Davis, CA 95616 USA; [Aina, Olulanu; Hubbard, Neil E.; Borowsky, Alexander; Cardiff, Robert D.] Univ Calif Davis, Ctr Comparat Med, Davis, CA 95616 USA; [Borowsky, Alexander; Cardiff, Robert D.] Univ Calif Davis, Sch Med, Dept Pathol & Lab Med, Davis, CA 95616 USA; [Dumont, Erik] Image Guided Therapy, Pessac, France	University of California System; University of California Davis; University of California System; University of California Davis; University of California System; University of California Davis	Ferrara, KW (corresponding author), Univ Calif Davis, Dept Biomed Engn, Davis, CA 95616 USA.	kwferrara@ucdavis.edu	Borowsky, Alexander D/S-5404-2017	Ferrara, Katherine/0000-0002-4976-9107	National Institutes of Health [R01CA103828, R01CA134659]; National Cancer Institute [U01 CA141582]; NATIONAL CANCER INSTITUTE [R01CA112356, R01CA134659, R01CA103828, P30CA093373, U01CA141582] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the National Institutes of Health grants R01CA103828, R01CA134659 (http://www.nih.gov), and the National Cancer Institute grant U01 CA141582 (http://www.cancer.gov). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional funding was received for this study.	Ahmed M, 2005, J VASC INTERV RADIOL, V16, P1365, DOI 10.1097/01.RVI.0000175324.63304.25; Blana A, 2008, EUR UROL, V53, P1194, DOI 10.1016/j.eururo.2007.10.062; Brace CL, 2009, IEEE ENG MED BIO, P4299, DOI 10.1109/IEMBS.2009.5333500; Chu KF, 2014, NAT REV CANCER, V14, P199, DOI 10.1038/nrc3672; Crouzet S, 2014, EUR UROL, V65, P907, DOI 10.1016/j.eururo.2013.04.039; Dewhirst MW, 2003, INT J HYPERTHER, V19, P267, DOI 10.1080/0265673031000119006; Fite BZ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035509; Germer CT, 1998, SURG ENDOSC-ULTRAS, V12, P1317, DOI 10.1007/s004649900849; Goldberg SN, 2002, RADIOLOGY, V222, P797, DOI 10.1148/radiol.2223010861; Grissom WA, 2010, MED PHYS, V37, P5014, DOI 10.1118/1.3475943; Grissom WA, 2009, MAGN RESON MED, V62, P1242, DOI 10.1002/mrm.22118; HARMON BV, 1991, INT J RADIAT BIOL, V59, P489, DOI 10.1080/09553009114550441; Harris GR, 2011, ULTRASOUND MED BIOL, V37, P580, DOI 10.1016/j.ultrasmedbio.2011.01.005; Hazle JD, 2002, J MAGN RESON IMAGING, V15, P409, DOI 10.1002/jmri.10076; Hectors SJCG, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099936; Hesley GK, 2013, CARDIOVASC INTER RAD, V36, P5, DOI 10.1007/s00270-012-0367-3; Holbrook AB, 2010, MAGN RESON MED, V63, P365, DOI 10.1002/mrm.22206; HYNYNEN K, 1993, EUR UROL, V23, P12; Janicke RU, 1998, J BIOL CHEM, V273, P9357, DOI 10.1074/jbc.273.16.9357; Kennedy JE, 2003, BRIT J RADIOL, V76, P590, DOI 10.1259/bjr/17150274; Lee JD, 2001, KOREAN J RADIOL, V2, P151, DOI 10.3348/kjr.2001.2.3.151; Leyendecker JR, 2002, AM J ROENTGENOL, V178, P1147, DOI 10.2214/ajr.178.5.1781147; Miller JK, 2008, CANCER RES, V68, P8286, DOI 10.1158/0008-5472.CAN-07-6316; Mumtaz H, 1996, RADIOLOGY, V200, P651, DOI 10.1148/radiology.200.3.8756910; Park MJ, 2013, EUR RADIOL, V23, P943, DOI 10.1007/s00330-012-2665-1; Quesson B, 2000, J MAGN RESON IMAGING, V12, P525, DOI 10.1002/1522-2586(200010)12:4<525::AID-JMRI3>3.0.CO;2-V; Quesson B, 2011, NMR BIOMED, V24, P145, DOI 10.1002/nbm.1563; Rieke V, 2008, J MAGN RESON IMAGING, V27, P376, DOI 10.1002/jmri.21265; Rieke V, 2007, IEEE T MED IMAGING, V26, P813, DOI 10.1109/TMI.2007.892647; Roubidoux MA, 2014, TECH VASC INTERV RAD, V17, P49, DOI 10.1053/j.tvir.2013.12.008; Rouviere O, 2001, EUR UROL, V40, P265, DOI 10.1159/000049786; Rueff LE, 2013, SEMIN INTERVENT RAD, V30, P347, DOI 10.1055/s-0033-1359728; Siegel PM, 1999, EMBO J, V18, P2149, DOI 10.1093/emboj/18.8.2149; Subramanian S, 2014, ULTRASOUND MED BIOL, V40, P102, DOI 10.1016/j.ultrasmedbio.2013.09.007; Uchida T, 2006, INT J UROL, V13, P228, DOI 10.1111/j.1442-2042.2006.01272.x; Vallancien G, 1996, UROLOGY, V47, P204, DOI 10.1016/S0090-4295(99)80417-8; Varghese T, 2004, J ULTRAS MED, V23, P535, DOI 10.7863/jum.2004.23.4.535; Viglianti BL, 2009, CLIN CANCER RES, V15, P4993, DOI 10.1158/1078-0432.CCR-08-2222; Wijlemans JW, 2013, INVEST RADIOL, V48, P381, DOI 10.1097/RLI.0b013e3182820257; Wu F, 2004, ULTRASON SONOCHEM, V11, P149, DOI 10.1016/j.ultsonch.2004.01.011; Wu F, 2006, AM J SURG, V192, P179, DOI 10.1016/j.amjsurg.2006.03.014; Zhang L, 2009, EUR RADIOL, V19, P437, DOI 10.1007/s00330-008-1137-0	42	12	13	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2015	10	3							e0120037	10.1371/journal.pone.0120037	http://dx.doi.org/10.1371/journal.pone.0120037			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9BN	25785992	Green Published, Green Submitted, gold			2022-12-27	WOS:000352138500150
J	Jia, JJ; Li, JH; Jiang, L; Zhang, J; Chen, SS; Wang, L; Zhou, YF; Xie, HY; Zhou, L; Zheng, SS				Jia, Junjun; Li, Jianhui; Jiang, Li; Zhang, Jing; Chen, Shasha; Wang, Li; Zhou, Yanfei; Xie, Haiyang; Zhou, Lin; Zheng, Shusen			Protective Effect of Remote Limb Ischemic Perconditioning on the Liver Grafts of Rats with a Novel Model	PLOS ONE			English	Article							REPERFUSION INJURY; HEPATIC ISCHEMIA/REPERFUSION; PRECONDITIONING PROTECTS; TRANSPLANTATION; MECHANISMS; HEART	Background Remote ischemic conditioning (RIC) is a known manual conditioning to decrease ischemic reperfusion injury (IRI) but not increase ischemic time. Here we tried to establish a rat RIC model of liver transplantation (LT), optimize the applicable protocols and investigate the protective mechanism. Methods The RIC model was developed by a standard tourniquet. Sprague-Dawley rats were assigned randomly to the sham operated control (N), standard rat liver transplantation (OLT) and RIC groups. According to the different protocols, RIC group was divided into 3 subgroups (10minx3, n = 6; 5minx3, n = 6; 1minx3, n = 6) respectively. Serum transaminases (ALT, AST), creatine kinase (CK), histopathologic changes, malondialdehyde (MDA), myeloperoxidase (MPO) and expressions of p-Akt were evaluated. Results Compared with the OLT group, the grafts subjected to RIC 5min*3 algorithm showed significant reduction of morphological damage and improved the graft function. Also, production of reactive oxygen species (MDA) and neutrophil accumulation (MPO) were markedly depressed and p-Akt was upregulated. Conclusion In conclusion, we successfully established a novel model of RIC in rat LT, the optimal RIC 5min*3 algorithm seemed to be more efficient to alleviate IRI of the liver graft in both functional and morphological categories, which due to its antioxidative, anti-inflammation activities and activating PI3K Akt pathway.	[Jia, Junjun; Li, Jianhui; Jiang, Li; Zhang, Jing; Wang, Li; Zhou, Yanfei; Xie, Haiyang; Zhou, Lin; Zheng, Shusen] Zhejiang Univ, Sch Med, Affiliated Hosp 1,Key Lab Combined Multiorgan Tra, Dept Hepatobiliary & Pancreat Surg,Minist Publ Hl, Hangzhou 310003, Zhejiang, Peoples R China; [Chen, Shasha] Zhejiang Univ, Sch Med, Affiliated Hosp 1, Dept Anesthesia, Hangzhou 310003, Zhejiang, Peoples R China	Zhejiang University; Zhejiang University	Zheng, SS (corresponding author), Zhejiang Univ, Sch Med, Affiliated Hosp 1,Key Lab Combined Multiorgan Tra, Dept Hepatobiliary & Pancreat Surg,Minist Publ Hl, Hangzhou 310003, Zhejiang, Peoples R China.	shusenzheng@zju.edu.cn			N National ST Major Project [2012ZX10002-017]; National Natural Science Foundation of China [81000137]; Qianjiang Talent Program of Zhejiang Province, China [2012R10045]; Scientific Research program for the Returned Overseas Chinese Scholars, Ministry of Health, Zhejiang Province, China [J20112008]	N National ST Major Project; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Qianjiang Talent Program of Zhejiang Province, China; Scientific Research program for the Returned Overseas Chinese Scholars, Ministry of Health, Zhejiang Province, China	This work was supported, in part, by N National S&T Major Project (NO: 2012ZX10002-017); National Natural Science Foundation of China (Nr 81000137); the Qianjiang Talent Program of Zhejiang Province, China (Nr2012R10045); and the Scientific Research program for the Returned Overseas Chinese Scholars, Ministry of Health, Zhejiang Province, China (J20112008). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anselm E, 2005, FASEB J, V19, pA1230; Czigany Z, 2014, J SURG RES, V185, P605; Czigany Z, 2013, J SURG RES, V185, P605, DOI 10.1016/j.jss.2013.07.018; Czigany Zoltan, 2012, Orvosi Hetilap, V153, P1579, DOI 10.1556/OH.2012.29469; Costa FLD, 2014, J SURG RES, V192, P98, DOI 10.1016/j.jss.2014.05.046; Eberlin KR, 2008, J SURG RES, V148, P24, DOI 10.1016/j.jss.2008.01.040; Hausenloy DJ, 2012, CARDIOVASC DRUG THER, V26, P87, DOI 10.1007/s10557-011-6364-y; Hausenloy DJ, 2008, CARDIOVASC RES, V79, P377, DOI 10.1093/cvr/cvn114; Hausenloy DJ, 2004, CARDIOVASC RES, V61, P448, DOI 10.1016/j.cardiores.2003.09.024; Hicks M, 2006, METH MOL B, V333, P331; Jin LM, 2010, PATHOBIOLOGY, V77, P136, DOI 10.1159/000292647; KAMADA N, 1983, SURGERY, V93, P64; Kanoria S, 2006, BRIT J SURG, V93, P762, DOI 10.1002/bjs.5331; Lai IR, 2006, TRANSPLANTATION, V81, P1311, DOI 10.1097/01.tp.0000203555.14546.63; Nardo B, 2001, TRANSPLANTATION, V71, P1816, DOI 10.1097/00007890-200106270-00018; Park KM, 2005, BIOCHEM BIOPH RES CO, V328, P312, DOI 10.1016/j.bbrc.2004.12.177; Pavione MA, 2012, J THORAC CARDIOV SUR, V144, P178, DOI 10.1016/j.jtcvs.2011.12.029; Peralta C, 2001, HEPATOLOGY, V33, P100, DOI 10.1053/jhep.2001.20529; Ren C, 2008, NEUROSCIENCE, V151, P1099, DOI 10.1016/j.neuroscience.2007.11.056; Schmidt MR, 2007, AM J PHYSIOL-HEART C, V292, pH1883, DOI 10.1152/ajpheart.00617.2006; Shen KZ, 2008, AM J PHYSIOL-GASTR L, V294, pG1070, DOI 10.1152/ajpgi.00554.2007; Skyschally A, 2009, BASIC RES CARDIOL, V104, P469, DOI 10.1007/s00395-009-0040-4; SUZUKI S, 1993, TRANSPLANTATION, V55, P1265; Takaoka A, 1999, J AM COLL CARDIOL, V33, P556, DOI 10.1016/S0735-1097(98)00559-2; Taki-Eldin A, 2012, J SURG RES, V178, P646, DOI 10.1016/j.jss.2012.05.069; Tapuria N, 2008, J SURG RES, V150, P304, DOI 10.1016/j.jss.2007.12.747; Van Gelder F, 2008, ACTA CHIR BELG, V108, P35, DOI 10.1080/00015458.2008.11680172; Vardanian AJ, 2008, MOL MED, V14, P337, DOI 10.2119/2007-00134.Vardanian; Wang F, 2009, GEOCHEM GEOPHY GEOSY, V10, DOI 10.1029/2009GC002874; Wang M, 2013, J SURG RES, V179, pE245, DOI 10.1016/j.jss.2012.02.007; Yan S, 2010, HEPATOB PANCREAT DIS, V9, P346; Zhai Y, 2013, NAT REV GASTRO HEPAT, V10, P79, DOI 10.1038/nrgastro.2012.225	32	20	21	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2015	10	3							e0121972	10.1371/journal.pone.0121972	http://dx.doi.org/10.1371/journal.pone.0121972			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9BN	25785455	Green Submitted, gold, Green Published			2022-12-27	WOS:000352138500218
J	Malik, SS; D'Souza, RC; Pashte, PM; Satoskar, SM; D'Souza, RJ				Malik, Seema S.; D'Souza, Roshni Cynthia; Pashte, Pramod Mukund; Satoskar, Smita Manohar; D'Souza, Remilda Joyce			Development of Indicators for Patient Care and Monitoring Standards for Secondary Health Care Services of Mumbai	PLOS ONE			English	Article								Background The Qualitative aspect of health care delivery is one of the major factors in reducing morbidity and mortality in a health care setup. The expanding suburban secondary health care delivery facilities of the Municipal Corporation of Greater Mumbai are an important part of the healthcare backbone of Mumbai and therefore the quality of care delivered here needed standardization. Material and Methods The project was completed over a period of one year from Jan to Dec, 2013 and implemented in three phases. The framework with components and sub-components were developed and formats for data collection were standardized. The benchmarks were based on past performance in the same hospital and probability was used for development of normal range. An Excel spreadsheet was developed to facilitate data analysis. Results The indicators comprise of 3 components - Statutory Requirements, Patient care & Cure and Administrative efficiency. The measurements made, pointed to the broad areas needing attention. Conclusion The Indicators for patient care and monitoring standards can be used as a self assessment tool for health care setups for standardization and improvement of delivery of health care services.	[Malik, Seema S.; D'Souza, Roshni Cynthia; Pashte, Pramod Mukund; Satoskar, Smita Manohar] Municipal Corp Greater Mumbai, Secondary Hlth Care Serv, Mumbai, Maharashtra, India		D'Souza, RC (corresponding author), Municipal Corp Greater Mumbai, Secondary Hlth Care Serv, Mumbai, Maharashtra, India.	drroshnicdsouza@gmail.com	Miranda, Roshni/AFN-9807-2022	MIRANDA, ROSHNI/0000-0002-6580-489X				Cercone J, 2010, BENCHMARKING HOSP PE; Groene O, 2008, INT J QUAL HEALTH C, V20, P155, DOI 10.1093/intqhc/mzn010; Shaw C, 2003, CAN HOSP PERFORMANCE, P6	3	0	0	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2015	10	3							e0119813	10.1371/journal.pone.0119813	http://dx.doi.org/10.1371/journal.pone.0119813			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CD7QC	25781989	Green Published, Green Submitted, gold			2022-12-27	WOS:000351284600094
J	Mehta, J; Asthana, S; Mandal, CC; Saxena, S				Mehta, Jatin; Asthana, Shailendra; Mandal, Chandi Charan; Saxena, Sunita			A Molecular Analysis Provides Novel Insights into Androgen Receptor Signalling in Breast Cancer	PLOS ONE			English	Article							TYROSINE KINASE; TUMOR-SUPPRESSOR; BINDING DOMAIN; EXPRESSION; PROTEIN; GROWTH; RESISTANCE; APOPTOSIS; GENE; TRANSCRIPTION	Background Androgen Receptor (AR) is an essential transcription factor for the development of secondary sex characteristics, spermatogenesis and carcinogenesis. Recently AR has been implicated in the development and progression of breast and prostate cancers. Although some of the functions of the AR are known but the mechanistic details of these divergent processes are still not clear. Therefore understanding the regulatory mechanisms of the functioning of the AR in ER-/AR+ breast cancer will provide many novel targets for the purpose of therapeutic intervention. Methods/Results Using bioinformatics tools, we have identified 75 AR targets having prominent roles in cell cycle, apoptosis and metabolism. Herein, we validated 10 genes as AR targets by studying the regulation of these genes in MDA-MB-453 cell line on stimulation by androgens like 5 alpha-dihydrotestosterone (DHT), using RT-qPCR and ChIP assay. It was observed that all the identified genes involved in cell cycle except MAD1L1 were found to be up regulated whereas expression of apoptosis related genes was decreased in response to DHT treatment. We performed an exhaustive, rigid-body docking between individual ARE and DNA binding domain (DBD) of the AR protein and it was found that novel residues K567, K588, K591 and R592 are involved in the process of DNA binding. To verify these specific DNA-protein interactions electrostatic energy term calculations for each residue was determined using the linearized Poisson-Boltzmann equation. Our experimental data showed that treatment of breast cancer cells with DHT promotes cell proliferation and decreases apoptosis. It was observed that bicalutamide treatment was able to reverse the effect of DHT. Conclusion Taken together, our results provide new insights into the mechanism by which AR promotes breast cancer progression. Moreover our work proposes to use bicalutamide along with taxanes as novel therapy for the treatment of TNBCs, which are positive for downstream AR signalling.	[Mehta, Jatin; Asthana, Shailendra; Saxena, Sunita] Safdarjang Hosp, ICMR, Natl Inst Pathol, New Delhi, India; [Mandal, Chandi Charan] Cent Univ Rajasthan, Dept Biochem, Ajmer, India	Indian Council of Medical Research (ICMR); ICMR - National Institute of Pathology (IOP); Vardhman Mahavir Medical College & Safdarjung Hospital; Central University of Rajasthan (CURAJ)	Saxena, S (corresponding author), Safdarjang Hosp, ICMR, Natl Inst Pathol, New Delhi, India.	sunita_saxena@yahoo.com		Mandal, Chandi/0000-0002-2292-6635	Indian Council of Medical Research (ICMR), New Delhi, India	Indian Council of Medical Research (ICMR), New Delhi, India(Indian Council of Medical Research (ICMR))	This work is financially supported by Indian Council of Medical Research (ICMR), New Delhi, India. JM is recipient of ICMR post doctoral fellowship from Indian Council of Medical Research (ICMR), New Delhi, India. The funding agency had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AQVIST J, 1990, J PHYS CHEM-US, V94, P8021, DOI 10.1021/j100384a009; Arora VK, 2013, CELL, V155, P1309, DOI 10.1016/j.cell.2013.11.012; Barila D, 1998, NAT GENET, V18, P280, DOI 10.1038/ng0398-280; BERENDSEN HJC, 1984, J CHEM PHYS, V81, P3684, DOI 10.1063/1.448118; Brinkmann AO, 2000, NAT MED, V6, P628, DOI 10.1038/76194; Chinnadurai G, 2008, ONCOGENE, V27, pS20, DOI 10.1038/onc.2009.40; Choi YH, 2012, ONCOL REP, V28, P2163, DOI 10.3892/or.2012.2060; Cleutjens KBJM, 1996, J BIOL CHEM, V271, P6379, DOI 10.1074/jbc.271.11.6379; Coffey K, 2012, J ENDOCRINOL, V215, P221, DOI 10.1530/JOE-12-0238; Denayer S, 2010, MOL ENDOCRINOL, V24, P898, DOI 10.1210/me.2009-0310; Doane AS, 2006, ONCOGENE, V25, P3994, DOI 10.1038/sj.onc.1209415; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Fan L, 2006, P NATL ACAD SCI USA, V103, P8384, DOI 10.1073/pnas.0508951103; Fargo KN, 2008, J NEUROTRAUM, V25, P561, DOI 10.1089/neu.2007.0466; Gan L, 2009, CANCER RES, V69, P8386, DOI 10.1158/0008-5472.CAN-09-1504; Ghosh-Choudhury N, 2013, J BIOL CHEM, V288, P24503, DOI 10.1074/jbc.M113.455733; GILSON MK, 1993, J PHYS CHEM-US, V97, P3591, DOI 10.1021/j100116a025; Goujon M, 2010, NUCLEIC ACIDS RES, V38, pW695, DOI 10.1093/nar/gkq313; Hatami R, 2013, SCIENCE TRANSLATIONA, V5; Helsen C, 2012, MOL CELL BIOL, V32, P3033, DOI 10.1128/MCB.00151-12; Hickey TE, 2012, MOL ENDOCRINOL, V26, P1252, DOI 10.1210/me.2012-1107; Hornak V, 2006, PROTEINS, V65, P712, DOI 10.1002/prot.21123; Hsu SY, 1997, P NATL ACAD SCI USA, V94, P12401, DOI 10.1073/pnas.94.23.12401; Huang HM, 2007, J CELL BIOL, V177, P413, DOI 10.1083/jcb.200701122; Kahn B, 2014, INT J BIOL SCI, V10, P588, DOI 10.7150/ijbs.8671; Kimmick GG, 2009, BREAST CANCER RES TR, V113, P479, DOI 10.1007/s10549-008-9943-2; Kitajima TS, 2006, NATURE, V441, P46, DOI 10.1038/nature04663; Lessard L, 2012, CANCER RES, V72, P1529, DOI 10.1158/0008-5472.CAN-11-2602; Li LY, 2001, NATURE, V412, P95, DOI 10.1038/35083620; Lose F, 2012, THE KALLIKREIN 14 GE; Ma S, 2014, LAB INVEST, V94, P430, DOI 10.1038/labinvest.2014.13; Magklara A, 2002, INT J CANCER, V100, P507, DOI 10.1002/ijc.10520; Mandal CC, 2011, BIOCHEM J, V433, P393, DOI 10.1042/BJ20100357; Mandal CC, 2009, ENDOCRINOLOGY, V150, P4989, DOI 10.1210/en.2009-0026; Mandal CC, 2012, CARCINOGENESIS, V33, P1897, DOI 10.1093/carcin/bgs198; Mandal CC, 2010, CALCIFIED TISSUE INT, V87, P533, DOI 10.1007/s00223-010-9419-3; Martin HL, 2014, BREAST CANCER-TARGET, V6, P1, DOI 10.2147/BCTT.S37638; Mishra AK, 2012, INDIAN J MED RES, V135, P843; Naderi A, 2008, NEOPLASIA, V10, P542, DOI 10.1593/neo.08274; Nelson M, 2014, INTERNATIONAL JOURNA; Nelson PS, 2002, P NATL ACAD SCI USA, V99, P11890, DOI 10.1073/pnas.182376299; Ni M, 2011, CANCER CELL, V20, P119, DOI 10.1016/j.ccr.2011.05.026; Oluwagbemiga LA, 2012, SPRINGERPLUS, V1, DOI 10.1186/2193-1801-1-83; Osaki M, 2007, VIRCHOWS ARCH, V451, P771, DOI 10.1007/s00428-007-0470-z; Pan YL, 2007, CANCER LETT, V246, P129, DOI 10.1016/j.canlet.2006.02.010; PEARSON WR, 1988, P NATL ACAD SCI USA, V85, P2444, DOI 10.1073/pnas.85.8.2444; Peddi PF, 2011, INTERNATIONAL JOURNA, V2012; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Pruitt KD, 2001, NUCLEIC ACIDS RES, V29, P137, DOI 10.1093/nar/29.1.137; Reid KJ, 2001, J BIOL CHEM, V276, P2943, DOI 10.1074/jbc.M009170200; Rialland M, 2002, J CELL SCI, V115, P1435; Roberts VA, 2013, J COMPUT CHEM, V34, P1743, DOI 10.1002/jcc.23304; ROCHE PJ, 1992, MOL ENDOCRINOL, V6, P2229, DOI 10.1210/me.6.12.2229; ROWINSKY EK, 1995, NEW ENGL J MED, V332, P1004, DOI 10.1056/NEJM199504133321507; Sanner MF, 1996, BIOPOLYMERS, V38, P305, DOI 10.1002/(SICI)1097-0282(199603)38:3<305::AID-BIP4>3.0.CO;2-Y; Shaffer PL, 2004, P NATL ACAD SCI USA, V101, P4758, DOI 10.1073/pnas.0401123101; Shang YF, 2002, MOL CELL, V9, P601, DOI 10.1016/S1097-2765(02)00471-9; Shi WF, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007398; Singh LC, 2012, MED ONCOL, V29, P539, DOI 10.1007/s12032-011-9952-6; Sonoda H, 2002, J BIOL CHEM, V277, P34254, DOI 10.1074/jbc.M201659200; Sui M, 2007, CANCER RES, V67, P5337, DOI 10.1158/0008-5472.CAN-06-4582; Tatsumi Y, 2006, J CELL SCI, V119, P3128, DOI 10.1242/jcs.03031; Tchirkov A, 2010, CLIN CHEM LAB MED, V48, P1167, DOI 10.1515/CCLM.2010.219; Ten Eyck LF, 1995, SURVEYING MOL INTERA, P22; Tetreault MP, 2013, NAT REV CANCER, V13, P701, DOI 10.1038/nrc3582; Tomomura M, 2003, MOL BRAIN RES, V112, P103, DOI 10.1016/S0169-328X(03)00054-8; Tomomura M, 2001, ONCOGENE, V20, P1022, DOI 10.1038/sj.onc.1204210; Tsukasaki K, 2001, ONCOGENE, V20, P3301, DOI 10.1038/sj.onc.1204421; Turashvili G, 2006, PATHOBIOLOGY, V73, P213, DOI 10.1159/000098207; van Dijk M, 2009, NUCLEIC ACIDS RES, V37, pW235, DOI 10.1093/nar/gkp287; WEINER SJ, 1984, J AM CHEM SOC, V106, P765, DOI 10.1021/ja00315a051; WELCH PJ, 1993, CELL, V75, P779, DOI 10.1016/0092-8674(93)90497-E	72	17	17	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2015	10	3							e0120622	10.1371/journal.pone.0120622	http://dx.doi.org/10.1371/journal.pone.0120622			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7QC	25781993	Green Submitted, Green Published, gold			2022-12-27	WOS:000351284600175
J	Wang, Z; Yang, Y; Yuan, LJ; Liu, J; Duan, YY; Cao, TS				Wang, Zhen; Yang, Yong; Yuan, Li-jun; Liu, Jie; Duan, Yun-you; Cao, Tie-sheng			Noninvasive Method for Measuring Local Pulse Wave Velocity by Dual Pulse Wave Doppler: In Vitro and In Vivo Studies	PLOS ONE			English	Article							ARTERIAL STIFFNESS; AORTIC STIFFNESS; 17.6 TESLA; ALL-CAUSE; MORTALITY; MICE; POPULATION; ULTRASOUND; INDEX; AGE	Objectives To evaluate the validity and reproducibility of a noninvasive dual pulse wave Doppler (DPWD) method, which involves simultaneous recording of flow velocity of two independent sample volumes with a measurable distance, for measuring the local arterial pulse wave velocity (PWV) through in vitro and in vivo studies. Methods The DPWD mode of Hitachi HI Vision Preirus ultrasound system with a 5-13MHz transducer was used. An in vitro model was designed to compare the PWV of a homogeneous rubber tubing with the local PWV of its middle part measured by DPWD method. In the in vivo study, local PWV of 45 hypertensive patients (25 male, 49.8 +/- 3.1 years) and 45 matched healthy subjects (25 male, 49.3 +/- 3.0 years) were investigated at the left common carotid artery (LCCA) by DPWD method. Results In the in vitro study, the local PWV measured by DPWP method and the PWV of the homogeneous rubber tubing did not show statistical difference (5.16 +/- 0.28 m/s vs 5.03 +/- 0.15 m/s, p = 0.075). The coefficient of variation (CV) of the intra-and inter-measurements for local PWV were 3.46% and 4.96%, for the PWV of the homogeneous rubber tubing were 0.99% and 1.98%. In the in vivo study, a significantly higher local PWV of LCCA was found in the hypertensive patients as compared to that in healthy subjects (6.29 +/- 1.04m/s vs. 5.31 +/- 0.72m/s, P = 0.019). The CV of the intra-and inter-measurements in hypertensive patients were 2.22% and 3.94%, in healthy subjects were 2.07% and 4.14%. Conclusions This study demonstrated the feasibility of the noninvasive DPWD method to determine the local PWV, which was accurate and reproducible not only in vitro but also in vivo studies. This noninvasive echocardiographic method may be illuminating to clinical use.	[Wang, Zhen; Yang, Yong; Yuan, Li-jun; Liu, Jie; Duan, Yun-you; Cao, Tie-sheng] Fourth Mil Med Univ, Tangdu Hosp, Dept Ultrasound Diagnost, Xian 710032, Peoples R China	Air Force Military Medical University	Yuan, LJ (corresponding author), Fourth Mil Med Univ, Tangdu Hosp, Dept Ultrasound Diagnost, Xian 710032, Peoples R China.	yuanlj@fmmu.edu.cn; caots4335@126.com	Ghosh, Amit/AAA-3490-2021; Liang, Yan/K-8199-2016; Stefanadis, Christodoulos/ABH-2232-2020; Ghosh, Amit/AAB-3140-2019; Liu, Jie/E-5484-2016	Ghosh, Amit/0000-0003-3514-885X; Liang, Yan/0000-0002-2144-1388; Stefanadis, Christodoulos/0000-0001-5974-6454; Liu, Jie/0000-0002-7441-2417; Tang, Ming/0000-0002-8158-6300	National Natural Science Foundation of China (NSFC) [81171348]	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC))	This study was supported by Grant 81171348 from the National Natural Science Foundation of China (NSFC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boutouyrie P, 2009, ARTERY RES, V3, P3, DOI 10.1016/j.artres.2008.11.002; Calabia J, 2011, CARDIOVASC ULTRASOUN, V9, DOI 10.1186/1476-7120-9-13; Cruickshank K, 2002, CIRCULATION, V106, P2085, DOI 10.1161/01.CIR.0000033824.02722.F7; DeLoach SS, 2008, CLIN J AM SOC NEPHRO, V3, P184, DOI 10.2215/CJN.03340807; Gosse P, 2008, J HYPERTENS, V26, P1138, DOI 10.1097/HJH.0b013e3282fa142b; Hansen TW, 2006, CIRCULATION, V113, P664, DOI 10.1161/CIRCULATIONAHA.105.579342; Hermeling E, 2007, ULTRASOUND MED BIOL, V33, P774, DOI 10.1016/j.ultrasmedbio.2006.11.018; Herold V, 2009, MAGN RESON MED, V61, P1293, DOI 10.1002/mrm.21957; Hickson SS, 2010, JACC-CARDIOVASC IMAG, V3, P1247, DOI 10.1016/j.jcmg.2010.09.016; Hoeks APG, 1997, ULTRASOUND MED BIOL, V23, P1017, DOI 10.1016/S0301-5629(97)00119-1; Laurent S, 2001, HYPERTENSION, V37, P1236, DOI 10.1161/01.HYP.37.5.1236; Laurent S, 2007, J NEPHROL, V20, pS45; Laurent S, 2006, EUR HEART J, V27, P2588, DOI 10.1093/eurheartj/ehl254; Liu J, 2011, ARTHRIT CARE RES, V63, P579, DOI 10.1002/acr.20306; Nichols WW, 1990, MCDONALDS BLOOD FLOW; Parczyk M, 2010, J CARDIOVASC MAGN R, V12, DOI 10.1186/1532-429X-12-72; Reneman RS, 2005, EUR HEART J, V26, P960, DOI 10.1093/eurheartj/ehi177; Rogers WJ, 2001, J AM COLL CARDIOL, V38, P1123, DOI 10.1016/S0735-1097(01)01504-2; Safar ME, 2004, HYPERTENSION, V43, P163, DOI 10.1161/01.HYP.0000114571.75762.b0; Vlachopoulos C, 2010, J AM COLL CARDIOL, V55, P1318, DOI 10.1016/j.jacc.2009.10.061; Wang Z, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053917; Wang Z, 2012, ULTRASOUND MED BIOL, V38, P1778, DOI 10.1016/j.ultrasmedbio.2012.05.016; Williams R, 2007, ULTRASOUND MED BIOL, V33, P1368, DOI 10.1016/j.ultrasmedbio.2007.03.012; Yu HY, 2006, MAGN RESON MED, V56, P876, DOI 10.1002/mrm.21034	24	163	176	12	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2015	10	3							e0120482	10.1371/journal.pone.0120482	http://dx.doi.org/10.1371/journal.pone.0120482			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9BN	25786124	gold, Green Published, Green Submitted			2022-12-27	WOS:000352138500175
J	Yang, YR; Han, XZ; Liang, Y; Ghosh, A; Chen, J; Tang, M				Yang, Yurong; Han, Xiaozhen; Liang, Yan; Ghosh, Amit; Chen, Jie; Tang, Ming			The Combined Effects of Arbuscular Mycorrhizal Fungi (AMF) and Lead (Pb) Stress on Pb Accumulation, Plant Growth Parameters, Photosynthesis, and Antioxidant Enzymes in Robinia pseudoacacia L.	PLOS ONE			English	Article							HEAVY-METAL UPTAKE; CHLOROPHYLL FLUORESCENCE; LIPID-PEROXIDATION; HYDROGEN-PEROXIDE; WATER STATUS; GLUTATHIONE; TOXICITY; DAMAGE; MAIZE; SOIL	Arbuscular mycorrhizal fungi (AMF) are considered as a potential biotechnological tool for improving phytostabilization efficiency and plant tolerance to heavy metal-contaminated soils. However, the mechanisms through which AMF help to alleviate metal toxicity in plants are still poorly understood. A greenhouse experiment was conducted to evaluate the effects of two AMF species (Funneliformis mosseae and Rhizophagus intraradices) on the growth, Pb accumulation, photosynthesis and antioxidant enzyme activities of a leguminous tree (Robinia pseudoacacia L.) at Pb addition levels of 0, 500, 1000 and 2000 mg kg(-1) soil. AMF symbiosis decreased Pb concentrations in the leaves and promoted the accumulation of biomass as well as photosynthetic pigment contents. Mycorrhizal plants had higher gas exchange capacity, non-photochemistry efficiency, and photochemistry efficiency compared with non-mycorrhizal plants. The enzymatic activities of superoxide dismutase (SOD), ascorbate peroxidases (APX) and glutathione peroxidase (GPX) were enhanced, and hydrogen peroxide (H2O2) and malondialdehyde (MDA) contents were reduced in mycorrhizal plants. These findings suggested that AMF symbiosis could protect plants by alleviating cellular oxidative damage in response to Pb stress. Furthermore, mycorrhizal dependency on plants increased with increasing Pb stress levels, indicating that AMF inoculation likely played a more important role in plant Pb tolerance in heavily contaminated soils. Overall, both F. mosseae and R. intraradices were able to maintain efficient symbiosis with R. pseudoacacia in Pb polluted soils. AMF symbiosis can improve photosynthesis and reactive oxygen species (ROS) scavenging capabilities and decrease Pb concentrations in leaves to alleviate Pb toxicity in R. pseudoacacia. Our results suggest that the application of the two AMF species associated with R. pseudoacacia could be a promising strategy for enhancing the phytostabilization efficiency of Pb contaminated soils.	[Yang, Yurong] Northwest A&F Univ, State Key Lab Soil Eros & Dryland Farming Loess P, Yangling 712100, Shaanxi, Peoples R China; [Yang, Yurong; Chen, Jie; Tang, Ming] Northwest A&F Univ, Coll Forestry, Yangling 712100, Shaanxi, Peoples R China; [Han, Xiaozhen] Natl Univ Ireland, Sch Nat Sci, Plant Syst Biol Lab, Bot & Plant Sci, Galway, Ireland; [Liang, Yan] Joint BioEnergy Inst, Emeryville, CA 94608 USA; [Liang, Yan] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Phys Biosci Div, Berkeley, CA 94720 USA; [Ghosh, Amit] Indian Inst Technol Kharagpur, Sch Energy Sci & Engn, PK Sinha Ctr Bioenergy, Kharagpur 721302, W Bengal, India	Northwest A&F University - China; Northwest A&F University - China; Ollscoil na Gaillimhe-University of Galway; United States Department of Energy (DOE); Joint BioEnergy Institute - JBEI; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT) - Kharagpur	Tang, M (corresponding author), Northwest A&F Univ, Coll Forestry, Yangling 712100, Shaanxi, Peoples R China.	tangm@nwsuaf.edu.cn	Ghosh, Amit/AAA-3490-2021; Liang, Yan/K-8199-2016; Stefanadis, Christodoulos/ABH-2232-2020; Ghosh, Amit/AAB-3140-2019; Liu, Jie/E-5484-2016	Ghosh, Amit/0000-0003-3514-885X; Liang, Yan/0000-0002-2144-1388; Stefanadis, Christodoulos/0000-0001-5974-6454; Liu, Jie/0000-0002-7441-2417; Tang, Ming/0000-0002-8158-6300	National Natural Science Foundation of China [31270639, 31170607, 31170567]; Program for Changjiang Scholars and Innovative Research Team in University of China [IRT1035]; PhD Programs Foundation of Education Ministry of China [20100204110033, 20110204130001]; China Scholarship Council [201306300018]; DOE Joint BioEnergy Institute; U.S. Department of Energy, Office of Science, Office of Biological and Environmental Research [DE-AC02-05CH11231]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Program for Changjiang Scholars and Innovative Research Team in University of China(Program for Changjiang Scholars & Innovative Research Team in University (PCSIRT)); PhD Programs Foundation of Education Ministry of China; China Scholarship Council(China Scholarship Council); DOE Joint BioEnergy Institute; U.S. Department of Energy, Office of Science, Office of Biological and Environmental Research(United States Department of Energy (DOE))	Yurong Yang, Jie Chen and Ming Tang were financially supported by the National Natural Science Foundation of China (31270639, 31170607, 31170567), the Program for Changjiang Scholars and Innovative Research Team in University of China (IRT1035) and the PhD Programs Foundation of Education Ministry of China (20100204110033, 20110204130001). Xiaozhen Han was supported by the China Scholarship Council (201306300018). Yan Liang was funded by the DOE Joint BioEnergy Institute (http://www.jbei.org) which is supported by the U.S. Department of Energy, Office of Science, Office of Biological and Environmental Research, through contract DE-AC02-05CH11231 between Lawrence Berkeley National Laboratory and the U.S. Department of Energy. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrade SAL, 2009, CHEMOSPHERE, V75, P1363, DOI 10.1016/j.chemosphere.2009.02.008; Azcon R, 2009, APPL SOIL ECOL, V41, P168, DOI 10.1016/j.apsoil.2008.10.008; Bago B, 2000, PLANT PHYSIOL, V124, P949, DOI 10.1104/pp.124.3.949; Baker NR, 2008, ANNU REV PLANT BIOL, V59, P89, DOI 10.1146/annurev.arplant.59.032607.092759; Baker NR, 2004, J EXP BOT, V55, P1607, DOI 10.1093/jxb/erh196; Blokhina O, 2003, ANN BOT-LONDON, V91, P179, DOI 10.1093/aob/mcf118; Chen X, 2005, CHEMOSPHERE, V60, P665, DOI 10.1016/j.chemosphere.2005.01.029; Deng CN, 2014, BIOL TRACE ELEM RES, V160, P268, DOI 10.1007/s12011-014-0039-z; Diaz G, 1996, PLANT SOIL, V180, P241, DOI 10.1007/BF00015307; Durnford DG, 2003, PHYSIOL PLANTARUM, V118, P193, DOI 10.1034/j.1399-3054.2003.00078.x; Eichler A, 2015, SCI ADV, V1, DOI 10.1126/sciadv.1400196; Fatima RA, 2005, SCI TOTAL ENVIRON, V346, P256, DOI 10.1016/j.scitotenv.2004.12.004; Foyer CH, 2002, ADV PHOTO RESPIRAT, V12, P1; FOYER CH, 1976, PLANTA, V133, P21, DOI 10.1007/BF00386001; Gajewska E, 2006, BIOL PLANTARUM, V50, P653, DOI 10.1007/s10535-006-0102-5; Gao J, 2000, EXPT TECHNIQUES PLAN; Garg N, 2015, PLANT GROWTH REGUL, V75, P521, DOI 10.1007/s10725-014-0016-8; Garrido I, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046137; Giannakoula A, 2010, ENVIRON EXP BOT, V67, P487, DOI 10.1016/j.envexpbot.2009.07.010; Gohre V, 2006, PLANTA, V223, P1115, DOI 10.1007/s00425-006-0225-0; Hadi F., 2015, J BIOL LIFE SCI, V6, P91, DOI 10.5296/jbls.v6i2.7152; HEATH RL, 1968, ARCH BIOCHEM BIOPHYS, V125, P189, DOI 10.1016/0003-9861(68)90654-1; HEGGO A, 1990, SOIL BIOL BIOCHEM, V22, P865, DOI 10.1016/0038-0717(90)90169-Z; HEMEDA HM, 1990, J FOOD SCI, V55, P184, DOI 10.1111/j.1365-2621.1990.tb06048.x; Hildebrandt U, 1999, J PLANT PHYSIOL, V154, P709, DOI 10.1016/S0176-1617(99)80249-1; HOAGLAND D. R., 1950, Circular. California Agricultural Experiment Station, V347; Hohnjec N, 2005, PLANT PHYSIOL, V137, P1283, DOI 10.1104/pp.104.056572; Islam E, 2008, J HAZARD MATER, V154, P914, DOI 10.1016/j.jhazmat.2007.10.121; Iturbe-Ormaetxe I, 2001, MOL PLANT MICROBE IN, V14, P1189, DOI 10.1094/MPMI.2001.14.10.1189; Jimenez A, 1997, PLANT PHYSIOL, V114, P275, DOI 10.1104/pp.114.1.275; Joner EJ, 2001, BIOL FERT SOILS, V33, P351, DOI 10.1007/s003740000331; Kosobrukhov A, 2004, PLANT GROWTH REGUL, V42, P145, DOI 10.1023/B:GROW.0000017490.59607.6b; KRAUSE GH, 1991, ANNU REV PLANT PHYS, V42, P313, DOI 10.1146/annurev.pp.42.060191.001525; Kupper H, 2017, METAL IONS LIFE SCI, V17, P491, DOI [10.1590/S1677-04202005000100004, 10.1515/9783110434330-015]; Latef AAHA, 2011, SCI HORTIC-AMSTERDAM, V127, P228, DOI 10.1016/j.scienta.2010.09.020; Li X, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124304; Lichtenthaler H., 1985, ANALYSIS-UK, V11, P591, DOI [10.1042/bst0110591, DOI 10.1042/BST0110591]; Lingua G, 2008, ENVIRON POLLUT, V153, P137, DOI 10.1016/j.envpol.2007.07.012; Mateos-Naranjo E, 2008, MAR ENVIRON RES, V66, P459, DOI 10.1016/j.marenvres.2008.07.007; Maxwell K, 2000, J EXP BOT, V51, P659, DOI 10.1093/jexbot/51.345.659; MIDDLETON EM, 1993, PLANT PHYSIOL, V103, P741, DOI 10.1104/pp.103.3.741; Milla MAR, 2003, PLANT J, V36, P602, DOI 10.1046/j.1365-313X.2003.01901.x; Miransari M, 2011, BIOTECHNOL ADV, V29, P645, DOI 10.1016/j.biotechadv.2011.04.006; Mishra S, 2006, CHEMOSPHERE, V65, P1027, DOI 10.1016/j.chemosphere.2006.03.033; NAKANO Y, 1981, PLANT CELL PHYSIOL, V22, P867; Ouziad F, 2006, ENVIRON EXP BOT, V57, P177, DOI 10.1016/j.envexpbot.2005.05.011; Padmavathiamma PK, 2007, WATER AIR SOIL POLL, V184, P105, DOI 10.1007/s11270-007-9401-5; Pande M, 2004, APPL SOIL ECOL, V26, P233, DOI 10.1016/j.apsoil.2003.12.009; PATTERSON BD, 1984, ANAL BIOCHEM, V139, P487, DOI 10.1016/0003-2697(84)90039-3; Pawlowska TE, 2004, APPL ENVIRON MICROB, V70, P6643, DOI 10.1128/AEM.70.11.6643-6649.2004; PLENCHETTE C, 1983, PLANT SOIL, V70, P211, DOI 10.1007/BF02374781; Pourrut B, 2011, REV ENVIRON CONTAM T, V213, P113, DOI 10.1007/978-1-4419-9860-6_4; Rahantaniaina MS, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00477; Ralph PJ, 1998, ENVIRON POLLUT, V103, P91, DOI 10.1016/S0269-7491(98)00121-3; Reddy AM, 2005, CHEMOSPHERE, V60, P97, DOI 10.1016/j.chemosphere.2004.11.092; Ruley AT, 2006, ENVIRON POLLUT, V144, P11, DOI 10.1016/j.envpol.2006.01.016; Sharma SS, 2009, TRENDS PLANT SCI, V14, P43, DOI 10.1016/j.tplants.2008.10.007; Sheng M, 2008, MYCORRHIZA, V18, P287, DOI 10.1007/s00572-008-0180-7; Shi GR, 2010, B ENVIRON CONTAM TOX, V85, P256, DOI 10.1007/s00128-010-0067-0; Singh S, 2006, CHEMOSPHERE, V62, P233, DOI 10.1016/j.chemosphere.2005.05.017; Smith S.E., 2010, MYCORRHIZAL SYMBIOSI, V3rd, DOI DOI 10.1097/00010694-198403000-00011; Sousa RHV, 2015, PLANT CELL ENVIRON, V38, P499, DOI 10.1111/pce.12409; Sudova R, 2007, PLANT SOIL, V296, P77, DOI 10.1007/s11104-007-9291-8; Sun SQ, 2010, ENVIRON MONIT ASSESS, V163, P303, DOI 10.1007/s10661-009-0835-7; Toussaint JP, 2007, MYCORRHIZA, V17, P349, DOI 10.1007/s00572-007-0133-6; Trouvelot A, 1986, PHYSIOLOGICAL GENETI, P217, DOI DOI 10.1177/004057368303900411; Varadi G, 2003, PHYSIOL PLANTARUM, V118, P47, DOI 10.1034/j.1399-3054.2003.00089.x; Verma S, 2003, PLANT SCI, V164, P645, DOI 10.1016/S0168-9452(03)00022-0; Vogel-Mikus K, 2006, ENVIRON POLLUT, V139, P362, DOI 10.1016/j.envpol.2005.05.005; Wang PF, 2012, ECOTOX ENVIRON SAFE, V78, P28, DOI 10.1016/j.ecoenv.2011.11.008; Wang YS, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0030635, 10.1371/journal.pone.0047302, 10.1371/journal.pone.0048669]; Wioleta W, 2015, BIOMETALS, V28, P151, DOI 10.1007/s10534-014-9811-y; Wu QS, 2006, J PLANT PHYSIOL, V163, P417, DOI 10.1016/j.jplph.2005.04.024; Xu ZY, 2014, ENVIRON SCI POLLUT R, V21, P12671, DOI 10.1007/s11356-014-3209-9; Yang YR, 2015, ENVIRON SCI POLLUT R, V22, P13179, DOI 10.1007/s11356-015-4521-8; Yang YR, 2015, SOIL BIOL BIOCHEM, V86, P146, DOI 10.1016/j.soilbio.2015.03.018; Yang YR, 2014, J PLANT GROWTH REGUL, V33, P612, DOI 10.1007/s00344-013-9410-0; Yemets O, 2015, ECOL INDIC, V55, P59, DOI 10.1016/j.ecolind.2015.03.015; Zhang HH, 2010, EUR J SOIL BIOL, V46, P306, DOI 10.1016/j.ejsobi.2010.05.006; Zhu XQ, 2014, PHOTOSYNTHETICA, V52, P247, DOI 10.1007/s11099-014-0031-z	80	163	176	12	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2015	10	12							e0145726	10.1371/journal.pone.0145726	http://dx.doi.org/10.1371/journal.pone.0145726			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ4SI	25786124	Green Published, gold, Green Submitted			2022-12-27	WOS:000367092600123
